id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
130207047|NCT00224406|468718803|FG000|Overall Study|Re-transplant|0|||
130207048|NCT00224406|468718804|FG001|Overall Study|Re-transplant|2|||
130207049|NCT00224406|468718803|FG000|Overall Study|Death|0|||
130207050|NCT00224406|468718804|FG001|Overall Study|Death|1|||
130207051|NCT00224406|468718803|FG000|Overall Study|Transplant cancelled|0|||
130207052|NCT00224406|468718804|FG001|Overall Study|Transplant cancelled|4|||
130207053|NCT00224406|468718803|FG000|Overall Study|Drug not delivered|2|||
130207054|NCT00224406|468718804|FG001|Overall Study|Drug not delivered|0|||
130207055|NCT00224406|468718803|FG000|Overall Study|Other|4|||
130207056|NCT00224406|468718804|FG001|Overall Study|Other|0|||
130207057|NCT00224406|468718803|FG000|Overall Study|Transplant cancelled|3|||
130207058|NCT00224406|468718804|FG001|Overall Study|Transplant cancelled|0|||
130207059|NCT01556997|468718805|FG000|Overall Study|Adverse Event|10|||
130207060|NCT01556997|468718806|FG001|Overall Study|Adverse Event|12|||
130207061|NCT01556997|468718807|FG002|Overall Study|Adverse Event|12|||
130207062|NCT01556997|468718805|FG000|Overall Study|Lost to Follow-up|6|||
130207063|NCT01556997|468718806|FG001|Overall Study|Lost to Follow-up|6|||
130207064|NCT01556997|468718807|FG002|Overall Study|Lost to Follow-up|4|||
130207065|NCT01556997|468718805|FG000|Overall Study|Physician Decision|1|||
130207066|NCT01556997|468718806|FG001|Overall Study|Physician Decision|1|||
130207067|NCT01556997|468718807|FG002|Overall Study|Physician Decision|1|||
130207068|NCT01556997|468718805|FG000|Overall Study|Withdrawal by Subject|7|||
130207069|NCT01556997|468718806|FG001|Overall Study|Withdrawal by Subject|6|||
130207070|NCT01556997|468718807|FG002|Overall Study|Withdrawal by Subject|8|||
130207071|NCT01556997|468718805|FG000|Overall Study|Other|2|||
130207072|NCT01556997|468718806|FG001|Overall Study|Other|3|||
130207073|NCT01556997|468718807|FG002|Overall Study|Other|7|||
130207074|NCT05459558|468718819|FG000|Overall Study|Adverse Event|1|||
130207075|NCT05459558|468718820|FG001|Overall Study|Adverse Event|0|||
130207076|NCT05459558|468718821|FG002|Overall Study|Adverse Event|0|||
130207077|NCT05459558|468718819|FG000|Overall Study|Scheduling issue|0|||
130207078|NCT05459558|468718820|FG001|Overall Study|Scheduling issue|1|||
130207079|NCT05459558|468718821|FG002|Overall Study|Scheduling issue|3|||
130207080|NCT05459558|468718819|FG000|Overall Study|Withdrawal by Subject|0|||
130207081|NCT05459558|468718820|FG001|Overall Study|Withdrawal by Subject|0|||
130207082|NCT05459558|468718821|FG002|Overall Study|Withdrawal by Subject|2|||
130207083|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
130207084|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
130207085|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
130207086|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
130207087|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
130207088|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
130207089|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
130207090|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
130207091|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
130207092|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
130207093|NCT01777139|468718822|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
130207094|NCT01777139|468718823|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
130207095|NCT01777139|468718822|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
130207096|NCT01777139|468718823|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
130207097|NCT01777139|468718822|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
130207098|NCT01777139|468718823|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
130207099|NCT05625477|468718824|FG000|Overall Study|Lost to Follow-up|2|||
130207100|NCT05625477|468718825|FG001|Overall Study|Lost to Follow-up|2|||
130207101|NCT05625477|468718826|FG002|Overall Study|Lost to Follow-up|1|||
130207102|NCT05625477|468718827|FG003|Overall Study|Lost to Follow-up|1|||
130207103|NCT05625477|468718828|FG004|Overall Study|Lost to Follow-up|0|||
130207104|NCT05625477|468718824|FG000|Overall Study|Covid quarantine|1|||
130207105|NCT05625477|468718825|FG001|Overall Study|Covid quarantine|0|||
130207106|NCT05625477|468718826|FG002|Overall Study|Covid quarantine|0|||
130207107|NCT05625477|468718827|FG003|Overall Study|Covid quarantine|0|||
130207108|NCT05625477|468718828|FG004|Overall Study|Covid quarantine|0|||
130207109|NCT01092637|468718829|FG000|Overall Study|Death|47|||
130207110|NCT01092637|468718830|FG001|Overall Study|Death|49|||
130207111|NCT03292458|468718831|FG000|Period 1|Adverse Event|2|||
130207112|NCT03292458|468718832|FG001|Period 1|Adverse Event|0|||
130207113|NCT00593606|468718833|FG000|Overall Study|Adverse Event|13|||
130207114|NCT00593606|468718833|FG000|Overall Study|Withdrawal by Subject|1|||
129983770|NCT02980731|467903757|FG000|Overall Study|Death|63|||
130207115|NCT00593606|468718833|FG000|Overall Study|Protocol Violation|3|||
129983771|NCT02980731|467903757|FG000|Overall Study|Withdrawal by Subject|6|||
130207116|NCT00593606|468718833|FG000|Overall Study|Lost to Follow-up|2|||
130207117|NCT00593606|468718833|FG000|Overall Study|Run-In Failure|5|||
130207118|NCT00593606|468718833|FG000|Overall Study|Screen Failure|3|||
130207119|NCT02278367|468718834|FG000|Overall Study|Physician Decision|5|||
130207120|NCT02278367|468718835|FG001|Overall Study|Physician Decision|0|||
130207121|NCT02278367|468718834|FG000|Overall Study|Withdrawal by Subject|5|||
130207122|NCT02278367|468718835|FG001|Overall Study|Withdrawal by Subject|0|||
130207123|NCT00308750|468718840|FG000|Overall Study|Adverse Event|9|||
130207124|NCT00308750|468718841|FG001|Overall Study|Adverse Event|9|||
130207125|NCT00308750|468718842|FG002|Overall Study|Adverse Event|13|||
130207126|NCT00308750|468718840|FG000|Overall Study|Withdrawal by Subject|6|||
130207127|NCT00308750|468718841|FG001|Overall Study|Withdrawal by Subject|2|||
130207128|NCT00308750|468718842|FG002|Overall Study|Withdrawal by Subject|3|||
130207129|NCT00308750|468718840|FG000|Overall Study|Physician Decision|3|||
130207130|NCT00308750|468718841|FG001|Overall Study|Physician Decision|4|||
130207131|NCT00308750|468718842|FG002|Overall Study|Physician Decision|3|||
130207132|NCT00308750|468718840|FG000|Overall Study|Sponsor Decision|1|||
129983772|NCT02980731|467903757|FG000|Overall Study|Lost to Follow-up|5|||
129983773|NCT02980731|467903757|FG000|Overall Study|Study terminated by Sponsor|4|||
129983774|NCT02980731|467903757|FG000|Overall Study|Completed survival follow-up period|65|||
129983775|NCT02980731|467903757|FG000|Overall Study|COVID-19 infection|1|||
129983776|NCT02980731|467903757|FG000|Overall Study|Other, not specified|66|||
129983777|NCT03809429|467903760|FG000|Overall Study|Withdrawal by Subject|7|||
129983778|NCT03809429|467903761|FG001|Overall Study|Withdrawal by Subject|3|||
129983779|NCT03809429|467903760|FG000|Overall Study|Adverse Event|6|||
129983780|NCT03809429|467903761|FG001|Overall Study|Adverse Event|9|||
129983781|NCT03809429|467903760|FG000|Overall Study|COVID-19|3|||
129983782|NCT03809429|467903761|FG001|Overall Study|COVID-19|1|||
129983783|NCT03809429|467903760|FG000|Overall Study|Participant was discontinued by investigator|12|||
129983784|NCT03809429|467903761|FG001|Overall Study|Participant was discontinued by investigator|7|||
129983785|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Adverse Event|6|||
129983786|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Adverse Event|6|||
129983787|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Death|1|||
129983788|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Death|1|||
129983789|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129983790|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129983791|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
129983792|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
129983793|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Physician Decision|1|||
129983794|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Physician Decision|4|||
129983795|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Various reasons|5|||
129983796|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Various reasons|3|||
129983797|NCT03828747|467903762|FG000|Open-Label Extension|Adverse Event|9|||
129983798|NCT03828747|467903763|FG001|Open-Label Extension|Adverse Event|7|||
129983799|NCT03828747|467903762|FG000|Open-Label Extension|Death|0|||
129983800|NCT03828747|467903763|FG001|Open-Label Extension|Death|2|||
129983801|NCT03828747|467903762|FG000|Open-Label Extension|Lost to Follow-up|4|||
129983802|NCT03828747|467903763|FG001|Open-Label Extension|Lost to Follow-up|0|||
129983803|NCT03828747|467903762|FG000|Open-Label Extension|Withdrawal by Subject|31|||
129983804|NCT03828747|467903763|FG001|Open-Label Extension|Withdrawal by Subject|30|||
129983805|NCT03828747|467903762|FG000|Open-Label Extension|Various reasons|4|||
129983806|NCT03828747|467903763|FG001|Open-Label Extension|Various reasons|4|||
129983807|NCT03828747|467903762|FG000|Open-Label Extension|Physician Decision|6|||
129983808|NCT03828747|467903763|FG001|Open-Label Extension|Physician Decision|2|||
129983809|NCT01144052|467903764|FG000|Overall Study|Withdrawal by Subject|1|||
129983810|NCT01144052|467903765|FG001|Overall Study|Withdrawal by Subject|1|||
129983811|NCT00424385|467903766|FG000|Cohort 0|Withdrawal by Subject|5|||
129983812|NCT00424385|467903766|FG000|Cohort 0|Physician Decision|1|||
129983813|NCT00424385|467903766|FG000|Cohort 1|Withdrawal by Subject|1|||
129983814|NCT02683876|467903767|FG000|Overall Study|samples damaged during shipping|2|||
129983815|NCT02683876|467903768|FG001|Overall Study|samples damaged during shipping|0|||
129983816|NCT03980808|467903785|FG000|Overall Study|Lost to Follow-up|2|||
129983817|NCT03980808|467903786|FG001|Overall Study|Lost to Follow-up|2|||
129983818|NCT01655693|467903787|FG000|Overall Study|Progression of Disease|92|||
129983819|NCT01655693|467903788|FG001|Overall Study|Progression of Disease|76|||
129983820|NCT01655693|467903789|FG002|Overall Study|Progression of Disease|58|||
129983821|NCT01655693|467903787|FG000|Overall Study|Death|8|||
129983822|NCT01655693|467903788|FG001|Overall Study|Death|9|||
129983823|NCT01655693|467903789|FG002|Overall Study|Death|12|||
129983824|NCT01655693|467903787|FG000|Overall Study|Serious Adverse Event|3|||
129983825|NCT01655693|467903788|FG001|Overall Study|Serious Adverse Event|15|||
129983826|NCT01655693|467903789|FG002|Overall Study|Serious Adverse Event|11|||
129983827|NCT01655693|467903787|FG000|Overall Study|Withdrawal by Subject|3|||
129983828|NCT01655693|467903788|FG001|Overall Study|Withdrawal by Subject|2|||
129983829|NCT01655693|467903789|FG002|Overall Study|Withdrawal by Subject|20|||
130095162|NCT00198107|468305433|FG000|Double-Blind Period|Adverse Event|1|||
130207133|NCT00308750|468718841|FG001|Overall Study|Sponsor Decision|0|||
130207134|NCT00308750|468718842|FG002|Overall Study|Sponsor Decision|0|||
130207135|NCT00308750|468718840|FG000|Overall Study|Disease Progression|47|||
130207136|NCT00308750|468718841|FG001|Overall Study|Disease Progression|24|||
130207137|NCT00308750|468718842|FG002|Overall Study|Disease Progression|28|||
129983830|NCT01655693|467903787|FG000|Overall Study|Adverse Event|3|||
129983831|NCT01655693|467903788|FG001|Overall Study|Adverse Event|11|||
129983832|NCT01655693|467903789|FG002|Overall Study|Adverse Event|3|||
129983833|NCT01655693|467903787|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
129983834|NCT01655693|467903788|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
129983835|NCT01655693|467903789|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
130207138|NCT00308750|468718840|FG000|Overall Study|Unrelated Complication|3|||
130207139|NCT00308750|468718841|FG001|Overall Study|Unrelated Complication|0|||
130207140|NCT00308750|468718842|FG002|Overall Study|Unrelated Complication|1|||
130207141|NCT00308750|468718840|FG000|Overall Study|Death|1|||
130207142|NCT00308750|468718841|FG001|Overall Study|Death|0|||
130207143|NCT00308750|468718842|FG002|Overall Study|Death|1|||
130207144|NCT00308750|468718840|FG000|Overall Study|Protocol Violation|1|||
130207145|NCT00308750|468718841|FG001|Overall Study|Protocol Violation|0|||
130207146|NCT00308750|468718842|FG002|Overall Study|Protocol Violation|0|||
130207147|NCT00308750|468718840|FG000|Overall Study|New Primary Disease Identified|1|||
130207148|NCT00308750|468718841|FG001|Overall Study|New Primary Disease Identified|1|||
130207149|NCT00308750|468718842|FG002|Overall Study|New Primary Disease Identified|0|||
130207150|NCT01358578|468718843|FG000|Induction Period|Adverse Event|2|||
130207151|NCT01358578|468718844|FG001|Induction Period|Adverse Event|4|||
129983836|NCT01655693|467903787|FG000|Overall Study|Non-Compliance|0|||
129983837|NCT01655693|467903788|FG001|Overall Study|Non-Compliance|0|||
129983838|NCT01655693|467903789|FG002|Overall Study|Non-Compliance|7|||
129983839|NCT01655693|467903787|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
130318538|NCT00948064|469133700|FG000|Phase I|No treatment received|1|||
130318539|NCT00948064|469133701|FG001|Phase I|No treatment received|0|||
130318540|NCT00948064|469133702|FG002|Phase I|No treatment received|0|||
130318541|NCT00948064|469133700|FG000|Phase II|Physician Decision|0|||
130318542|NCT00948064|469133701|FG001|Phase II|Physician Decision|0|||
130318543|NCT00948064|469133702|FG002|Phase II|Physician Decision|1|||
130318544|NCT00948064|469133700|FG000|Phase II|Withdrawal by Subject|0|||
130318545|NCT00948064|469133701|FG001|Phase II|Withdrawal by Subject|1|||
130318546|NCT00948064|469133702|FG002|Phase II|Withdrawal by Subject|0|||
130318547|NCT02741128|469133713|FG000|Overall Study|Protocol Violation|4|||
130318548|NCT02741128|469133714|FG001|Overall Study|Protocol Violation|1|||
130318549|NCT02741128|469133713|FG000|Overall Study|Withdrawal by Subject|2|||
130318550|NCT02741128|469133714|FG001|Overall Study|Withdrawal by Subject|0|||
130318551|NCT02741128|469133713|FG000|Overall Study|Lost to Follow-up|1|||
130318552|NCT02741128|469133714|FG001|Overall Study|Lost to Follow-up|0|||
129983840|NCT01655693|467903788|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
129983841|NCT01655693|467903789|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
129983842|NCT01655693|467903787|FG000|Overall Study|Protocol Violation|1|||
129983843|NCT01655693|467903788|FG001|Overall Study|Protocol Violation|0|||
129983844|NCT01655693|467903789|FG002|Overall Study|Protocol Violation|3|||
129983845|NCT01655693|467903787|FG000|Overall Study|Lost to Follow-up|1|||
129983846|NCT01655693|467903788|FG001|Overall Study|Lost to Follow-up|0|||
129983847|NCT01655693|467903789|FG002|Overall Study|Lost to Follow-up|1|||
129983848|NCT01655693|467903787|FG000|Overall Study|Screening Failure|1|||
129983849|NCT01655693|467903788|FG001|Overall Study|Screening Failure|0|||
129983850|NCT01655693|467903789|FG002|Overall Study|Screening Failure|0|||
129983851|NCT01655693|467903787|FG000|Overall Study|Other|8|||
129983852|NCT01655693|467903788|FG001|Overall Study|Other|6|||
129983853|NCT01655693|467903789|FG002|Overall Study|Other|15|||
129983854|NCT00929110|467903790|FG000|Overall Study|Adverse Event|40|||
129983855|NCT00929110|467903791|FG001|Overall Study|Adverse Event|29|||
129983856|NCT00929110|467903792|FG002|Overall Study|Adverse Event|18|||
129983857|NCT00929110|467903790|FG000|Overall Study|Subject withdrew consent|40|||
129983858|NCT00929110|467903791|FG001|Overall Study|Subject withdrew consent|23|||
129983859|NCT00929110|467903792|FG002|Overall Study|Subject withdrew consent|26|||
129983860|NCT00929110|467903790|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
129983861|NCT00929110|467903791|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
129983862|NCT00929110|467903792|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
129983863|NCT00929110|467903790|FG000|Overall Study|Lost to Follow-up|7|||
129983864|NCT00929110|467903791|FG001|Overall Study|Lost to Follow-up|7|||
129983865|NCT00929110|467903792|FG002|Overall Study|Lost to Follow-up|3|||
129983866|NCT00929110|467903790|FG000|Overall Study|Protocol deviation|5|||
129983867|NCT00929110|467903791|FG001|Overall Study|Protocol deviation|2|||
129983868|NCT00929110|467903792|FG002|Overall Study|Protocol deviation|4|||
129983869|NCT00929110|467903790|FG000|Overall Study|Administrative problems|4|||
130207152|NCT01358578|468718845|FG002|Induction Period|Adverse Event|2|||
130318553|NCT02973100|469133715|FG000|Overall Study|Adverse Event|1|||
129983870|NCT00929110|467903791|FG001|Overall Study|Administrative problems|1|||
130207153|NCT01358578|468718846|FG003|Induction Period|Adverse Event|6|||
129983871|NCT00929110|467903792|FG002|Overall Study|Administrative problems|2|||
129983872|NCT00929110|467903790|FG000|Overall Study|Death|2|||
129983873|NCT00929110|467903791|FG001|Overall Study|Death|2|||
129983874|NCT00929110|467903792|FG002|Overall Study|Death|2|||
129983875|NCT00929110|467903790|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129983876|NCT00929110|467903791|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129983877|NCT00929110|467903792|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129983878|NCT00929110|467903790|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130207154|NCT01358578|468718847|FG004|Induction Period|Adverse Event|0|||
130207155|NCT01358578|468718848|FG005|Induction Period|Adverse Event|0|||
129983879|NCT00929110|467903791|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130207156|NCT01358578|468718843|FG000|Induction Period|Lack of Efficacy|0|||
130207157|NCT01358578|468718844|FG001|Induction Period|Lack of Efficacy|0|||
130207158|NCT01358578|468718845|FG002|Induction Period|Lack of Efficacy|9|||
129983880|NCT00929110|467903792|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129983881|NCT00929110|467903790|FG000|Overall Study|Patient inability to use the device|0|||
129983882|NCT00929110|467903791|FG001|Overall Study|Patient inability to use the device|1|||
129983883|NCT00929110|467903792|FG002|Overall Study|Patient inability to use the device|0|||
129983884|NCT00620282|467903793|FG000|Overall Study|Adverse Event|0|||
129983885|NCT00620282|467903794|FG001|Overall Study|Adverse Event|1|||
129983886|NCT00620282|467903795|FG002|Overall Study|Adverse Event|0|||
129983887|NCT00620282|467903793|FG000|Overall Study|Arterial line unable to be placed|0|||
129983888|NCT00620282|467903794|FG001|Overall Study|Arterial line unable to be placed|0|||
129983889|NCT00620282|467903795|FG002|Overall Study|Arterial line unable to be placed|1|||
130207159|NCT01358578|468718846|FG003|Induction Period|Lack of Efficacy|1|||
130207160|NCT01358578|468718847|FG004|Induction Period|Lack of Efficacy|0|||
130207161|NCT01358578|468718848|FG005|Induction Period|Lack of Efficacy|0|||
130207162|NCT01358578|468718843|FG000|Induction Period|Lost to Follow-up|0|||
130207163|NCT01358578|468718844|FG001|Induction Period|Lost to Follow-up|0|||
130207164|NCT01358578|468718845|FG002|Induction Period|Lost to Follow-up|1|||
130207165|NCT01358578|468718846|FG003|Induction Period|Lost to Follow-up|4|||
130207166|NCT01358578|468718847|FG004|Induction Period|Lost to Follow-up|0|||
130207167|NCT01358578|468718848|FG005|Induction Period|Lost to Follow-up|0|||
130207168|NCT01358578|468718843|FG000|Induction Period|Physician Decision|2|||
130207169|NCT01358578|468718844|FG001|Induction Period|Physician Decision|1|||
130207170|NCT01358578|468718845|FG002|Induction Period|Physician Decision|2|||
129983890|NCT00620282|467903793|FG000|Overall Study|Withdrawal by Subject|0|||
129983891|NCT00620282|467903794|FG001|Overall Study|Withdrawal by Subject|1|||
130207171|NCT01358578|468718846|FG003|Induction Period|Physician Decision|0|||
130207172|NCT01358578|468718847|FG004|Induction Period|Physician Decision|0|||
130207173|NCT01358578|468718848|FG005|Induction Period|Physician Decision|0|||
130207174|NCT01358578|468718843|FG000|Induction Period|Protocol Deviation|3|||
130207175|NCT01358578|468718844|FG001|Induction Period|Protocol Deviation|5|||
130207176|NCT01358578|468718845|FG002|Induction Period|Protocol Deviation|0|||
130207177|NCT01358578|468718846|FG003|Induction Period|Protocol Deviation|3|||
130207178|NCT01358578|468718847|FG004|Induction Period|Protocol Deviation|0|||
130207179|NCT01358578|468718848|FG005|Induction Period|Protocol Deviation|0|||
130207180|NCT01358578|468718843|FG000|Induction Period|technical problems|0|||
130207181|NCT01358578|468718844|FG001|Induction Period|technical problems|0|||
130207182|NCT01358578|468718845|FG002|Induction Period|technical problems|1|||
130207183|NCT01358578|468718846|FG003|Induction Period|technical problems|1|||
130207184|NCT01358578|468718847|FG004|Induction Period|technical problems|0|||
130207185|NCT01358578|468718848|FG005|Induction Period|technical problems|0|||
130207186|NCT01358578|468718843|FG000|Induction Period|Withdrawal by Subject|5|||
130207187|NCT01358578|468718844|FG001|Induction Period|Withdrawal by Subject|5|||
130207188|NCT01358578|468718845|FG002|Induction Period|Withdrawal by Subject|10|||
129983892|NCT00620282|467903795|FG002|Overall Study|Withdrawal by Subject|0|||
129983893|NCT02703259|467903796|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
129983894|NCT02703259|467903797|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
130207189|NCT01358578|468718846|FG003|Induction Period|Withdrawal by Subject|6|||
130207190|NCT01358578|468718847|FG004|Induction Period|Withdrawal by Subject|0|||
130207191|NCT01358578|468718848|FG005|Induction Period|Withdrawal by Subject|0|||
130207192|NCT01358578|468718843|FG000|Maintenance Period|Adverse Event|2|||
130207193|NCT01358578|468718844|FG001|Maintenance Period|Adverse Event|7|||
130207194|NCT01358578|468718845|FG002|Maintenance Period|Adverse Event|0|||
130207195|NCT01358578|468718846|FG003|Maintenance Period|Adverse Event|6|||
130207196|NCT01358578|468718847|FG004|Maintenance Period|Adverse Event|4|||
130207197|NCT01358578|468718848|FG005|Maintenance Period|Adverse Event|3|||
130207198|NCT01358578|468718843|FG000|Maintenance Period|Lack of Efficacy|10|||
130207199|NCT01358578|468718844|FG001|Maintenance Period|Lack of Efficacy|2|||
130207200|NCT01358578|468718845|FG002|Maintenance Period|Lack of Efficacy|0|||
129983895|NCT02703259|467903796|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
129983896|NCT02703259|467903797|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
130207201|NCT01358578|468718846|FG003|Maintenance Period|Lack of Efficacy|11|||
130207202|NCT01358578|468718847|FG004|Maintenance Period|Lack of Efficacy|3|||
130207203|NCT01358578|468718848|FG005|Maintenance Period|Lack of Efficacy|0|||
130207204|NCT01358578|468718843|FG000|Maintenance Period|Lost to Follow-up|4|||
130207205|NCT01358578|468718844|FG001|Maintenance Period|Lost to Follow-up|0|||
130207206|NCT01358578|468718845|FG002|Maintenance Period|Lost to Follow-up|0|||
130318554|NCT02973100|469133716|FG001|Overall Study|Adverse Event|2|||
130207207|NCT01358578|468718846|FG003|Maintenance Period|Lost to Follow-up|5|||
129983897|NCT02703259|467903796|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
130207208|NCT01358578|468718847|FG004|Maintenance Period|Lost to Follow-up|1|||
130207209|NCT01358578|468718848|FG005|Maintenance Period|Lost to Follow-up|1|||
130207210|NCT01358578|468718843|FG000|Maintenance Period|Non-compliance with study treatment|3|||
130207211|NCT01358578|468718844|FG001|Maintenance Period|Non-compliance with study treatment|1|||
130207212|NCT01358578|468718845|FG002|Maintenance Period|Non-compliance with study treatment|0|||
130207213|NCT01358578|468718846|FG003|Maintenance Period|Non-compliance with study treatment|2|||
130207214|NCT01358578|468718847|FG004|Maintenance Period|Non-compliance with study treatment|1|||
130207215|NCT01358578|468718848|FG005|Maintenance Period|Non-compliance with study treatment|2|||
130207216|NCT01358578|468718843|FG000|Maintenance Period|Physician Decision|0|||
130207217|NCT01358578|468718844|FG001|Maintenance Period|Physician Decision|1|||
130207218|NCT01358578|468718845|FG002|Maintenance Period|Physician Decision|0|||
130207219|NCT01358578|468718846|FG003|Maintenance Period|Physician Decision|1|||
130207220|NCT01358578|468718847|FG004|Maintenance Period|Physician Decision|0|||
130207221|NCT01358578|468718848|FG005|Maintenance Period|Physician Decision|0|||
130207222|NCT01358578|468718843|FG000|Maintenance Period|Pregnancy|1|||
130207223|NCT01358578|468718844|FG001|Maintenance Period|Pregnancy|0|||
130207224|NCT01358578|468718845|FG002|Maintenance Period|Pregnancy|0|||
130207225|NCT01358578|468718846|FG003|Maintenance Period|Pregnancy|0|||
130207226|NCT01358578|468718847|FG004|Maintenance Period|Pregnancy|0|||
130207227|NCT01358578|468718848|FG005|Maintenance Period|Pregnancy|0|||
130207228|NCT01358578|468718843|FG000|Maintenance Period|Protocol deviation|7|||
130207229|NCT01358578|468718844|FG001|Maintenance Period|Protocol deviation|4|||
130207230|NCT01358578|468718845|FG002|Maintenance Period|Protocol deviation|0|||
130207231|NCT01358578|468718846|FG003|Maintenance Period|Protocol deviation|2|||
130207232|NCT01358578|468718847|FG004|Maintenance Period|Protocol deviation|2|||
130207233|NCT01358578|468718848|FG005|Maintenance Period|Protocol deviation|2|||
130207234|NCT01358578|468718843|FG000|Maintenance Period|Withdrawal by Subject|12|||
130207235|NCT01358578|468718844|FG001|Maintenance Period|Withdrawal by Subject|7|||
130207236|NCT01358578|468718845|FG002|Maintenance Period|Withdrawal by Subject|2|||
130207237|NCT01358578|468718846|FG003|Maintenance Period|Withdrawal by Subject|15|||
130207238|NCT01358578|468718847|FG004|Maintenance Period|Withdrawal by Subject|6|||
130207239|NCT01358578|468718848|FG005|Maintenance Period|Withdrawal by Subject|3|||
130207240|NCT01358578|468718843|FG000|Follow-up Period|Adverse Event|1|||
130207241|NCT01358578|468718844|FG001|Follow-up Period|Adverse Event|1|||
130207242|NCT01358578|468718845|FG002|Follow-up Period|Adverse Event|0|||
130207243|NCT01358578|468718846|FG003|Follow-up Period|Adverse Event|0|||
130207244|NCT01358578|468718847|FG004|Follow-up Period|Adverse Event|0|||
130207245|NCT01358578|468718848|FG005|Follow-up Period|Adverse Event|0|||
130207246|NCT01358578|468718843|FG000|Follow-up Period|Lack of Efficacy|3|||
130207247|NCT01358578|468718844|FG001|Follow-up Period|Lack of Efficacy|0|||
130207248|NCT01358578|468718845|FG002|Follow-up Period|Lack of Efficacy|4|||
130207249|NCT01358578|468718846|FG003|Follow-up Period|Lack of Efficacy|1|||
130207250|NCT01358578|468718847|FG004|Follow-up Period|Lack of Efficacy|0|||
130207251|NCT01358578|468718848|FG005|Follow-up Period|Lack of Efficacy|0|||
130207252|NCT01358578|468718843|FG000|Follow-up Period|Lost to Follow-up|0|||
130207253|NCT01358578|468718844|FG001|Follow-up Period|Lost to Follow-up|1|||
130207254|NCT01358578|468718845|FG002|Follow-up Period|Lost to Follow-up|0|||
130207255|NCT01358578|468718846|FG003|Follow-up Period|Lost to Follow-up|4|||
130207256|NCT01358578|468718847|FG004|Follow-up Period|Lost to Follow-up|0|||
130207257|NCT01358578|468718848|FG005|Follow-up Period|Lost to Follow-up|0|||
130207258|NCT01358578|468718843|FG000|Follow-up Period|non- compliance with study treatment|1|||
130207259|NCT01358578|468718844|FG001|Follow-up Period|non- compliance with study treatment|0|||
130207260|NCT01358578|468718845|FG002|Follow-up Period|non- compliance with study treatment|0|||
130318555|NCT02973100|469133717|FG002|Overall Study|Adverse Event|1|||
130318556|NCT02973100|469133718|FG003|Overall Study|Adverse Event|2|||
129983898|NCT02703259|467903797|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
129983899|NCT03122223|467903802|FG000|Overall Study|Withdrawal by Subject|2|||
129983900|NCT03122223|467903803|FG001|Overall Study|Withdrawal by Subject|2|||
129983901|NCT03122223|467903804|FG002|Overall Study|Withdrawal by Subject|1|||
129983902|NCT03122223|467903805|FG003|Overall Study|Withdrawal by Subject|0|||
129983903|NCT03122223|467903802|FG000|Overall Study|Lost to Follow-up|0|||
129983904|NCT03122223|467903803|FG001|Overall Study|Lost to Follow-up|2|||
129983905|NCT03122223|467903804|FG002|Overall Study|Lost to Follow-up|2|||
129983906|NCT03122223|467903805|FG003|Overall Study|Lost to Follow-up|0|||
130095163|NCT00198107|468305434|FG001|Double-Blind Period|Adverse Event|1|||
130207261|NCT01358578|468718846|FG003|Follow-up Period|non- compliance with study treatment|0|||
130207262|NCT01358578|468718847|FG004|Follow-up Period|non- compliance with study treatment|0|||
130207263|NCT01358578|468718848|FG005|Follow-up Period|non- compliance with study treatment|0|||
130207264|NCT01358578|468718843|FG000|Follow-up Period|Pregnancy|1|||
130207265|NCT01358578|468718844|FG001|Follow-up Period|Pregnancy|0|||
130207266|NCT01358578|468718845|FG002|Follow-up Period|Pregnancy|0|||
130207267|NCT01358578|468718846|FG003|Follow-up Period|Pregnancy|0|||
129983907|NCT03122223|467903802|FG000|Overall Study|Participant unable to adhere|1|||
130207268|NCT01358578|468718847|FG004|Follow-up Period|Pregnancy|0|||
130207269|NCT01358578|468718848|FG005|Follow-up Period|Pregnancy|0|||
130207270|NCT01358578|468718843|FG000|Follow-up Period|Withdrawal by Subject|3|||
130207271|NCT01358578|468718844|FG001|Follow-up Period|Withdrawal by Subject|3|||
130207272|NCT01358578|468718845|FG002|Follow-up Period|Withdrawal by Subject|1|||
130207273|NCT01358578|468718846|FG003|Follow-up Period|Withdrawal by Subject|12|||
130207274|NCT01358578|468718847|FG004|Follow-up Period|Withdrawal by Subject|0|||
130207275|NCT01358578|468718848|FG005|Follow-up Period|Withdrawal by Subject|0|||
130207276|NCT01358578|468718843|FG000|Follow-up Period|Physician Decision|1|||
130207277|NCT01358578|468718844|FG001|Follow-up Period|Physician Decision|1|||
129983908|NCT03122223|467903803|FG001|Overall Study|Participant unable to adhere|1|||
129983909|NCT03122223|467903804|FG002|Overall Study|Participant unable to adhere|1|||
129983910|NCT03122223|467903805|FG003|Overall Study|Participant unable to adhere|0|||
129983911|NCT01820585|467903807|FG000|Overall Study|Adverse Event|9|||
129983912|NCT01820585|467903808|FG001|Overall Study|Adverse Event|13|||
129983913|NCT01820585|467903809|FG002|Overall Study|Adverse Event|23|||
129983914|NCT01820585|467903810|FG003|Overall Study|Adverse Event|34|||
129983915|NCT01820585|467903807|FG000|Overall Study|Lack of Efficacy|9|||
130207278|NCT01358578|468718845|FG002|Follow-up Period|Physician Decision|0|||
130207279|NCT01358578|468718846|FG003|Follow-up Period|Physician Decision|2|||
129983916|NCT01820585|467903808|FG001|Overall Study|Lack of Efficacy|7|||
129983917|NCT01820585|467903809|FG002|Overall Study|Lack of Efficacy|5|||
129983918|NCT01820585|467903810|FG003|Overall Study|Lack of Efficacy|1|||
129983919|NCT01820585|467903807|FG000|Overall Study|Withdrawal by Subject|3|||
129983920|NCT01820585|467903808|FG001|Overall Study|Withdrawal by Subject|7|||
130207280|NCT01358578|468718847|FG004|Follow-up Period|Physician Decision|0|||
130207281|NCT01358578|468718848|FG005|Follow-up Period|Physician Decision|0|||
130207282|NCT02304380|468718849|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207283|NCT02304380|468718850|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207284|NCT02304380|468718851|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207285|NCT02304380|468718852|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
130207286|NCT02304380|468718853|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207287|NCT02304380|468718854|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
130207288|NCT01125813|468718855|FG000|Overall Study|Death|1|||
130207289|NCT01125813|468718855|FG000|Overall Study|Withdrawal by Subject|1|||
130207290|NCT01125813|468718855|FG000|Overall Study|Screen Failures|4|||
130207291|NCT02327013|468718856|FG000|Overall Study|Adverse Event|4|||
130207292|NCT02327013|468718857|FG001|Overall Study|Adverse Event|4|||
130207293|NCT02327013|468718858|FG002|Overall Study|Adverse Event|3|||
130207294|NCT02327013|468718859|FG003|Overall Study|Adverse Event|0|||
130207295|NCT02327013|468718860|FG004|Overall Study|Adverse Event|1|||
130207296|NCT02327013|468718856|FG000|Overall Study|Lack of Efficacy|2|||
130207297|NCT02327013|468718857|FG001|Overall Study|Lack of Efficacy|0|||
130207298|NCT02327013|468718858|FG002|Overall Study|Lack of Efficacy|5|||
130207299|NCT02327013|468718859|FG003|Overall Study|Lack of Efficacy|0|||
130207300|NCT02327013|468718860|FG004|Overall Study|Lack of Efficacy|1|||
130207301|NCT02327013|468718856|FG000|Overall Study|Non-compliance with IMP|1|||
130207302|NCT02327013|468718857|FG001|Overall Study|Non-compliance with IMP|2|||
130207303|NCT02327013|468718858|FG002|Overall Study|Non-compliance with IMP|7|||
130207304|NCT02327013|468718859|FG003|Overall Study|Non-compliance with IMP|0|||
130207305|NCT02327013|468718860|FG004|Overall Study|Non-compliance with IMP|0|||
130207306|NCT02327013|468718856|FG000|Overall Study|Withdrawal of Consent|1|||
130207307|NCT02327013|468718857|FG001|Overall Study|Withdrawal of Consent|0|||
130207308|NCT02327013|468718858|FG002|Overall Study|Withdrawal of Consent|3|||
130207309|NCT02327013|468718859|FG003|Overall Study|Withdrawal of Consent|0|||
130207310|NCT02327013|468718860|FG004|Overall Study|Withdrawal of Consent|0|||
130207311|NCT02327013|468718856|FG000|Overall Study|Lost to Follow-up|2|||
130207312|NCT02327013|468718857|FG001|Overall Study|Lost to Follow-up|4|||
129983921|NCT01820585|467903809|FG002|Overall Study|Withdrawal by Subject|3|||
129983922|NCT01820585|467903810|FG003|Overall Study|Withdrawal by Subject|8|||
129983923|NCT01820585|467903807|FG000|Overall Study|Lost to Follow-up|3|||
129983924|NCT01820585|467903808|FG001|Overall Study|Lost to Follow-up|3|||
129983925|NCT01820585|467903809|FG002|Overall Study|Lost to Follow-up|0|||
130207313|NCT02327013|468718858|FG002|Overall Study|Lost to Follow-up|5|||
130207314|NCT02327013|468718859|FG003|Overall Study|Lost to Follow-up|0|||
130207315|NCT02327013|468718860|FG004|Overall Study|Lost to Follow-up|0|||
130207316|NCT02327013|468718856|FG000|Overall Study|Administrative or other reason(s)|1|||
130207317|NCT02327013|468718857|FG001|Overall Study|Administrative or other reason(s)|5|||
130207318|NCT02327013|468718858|FG002|Overall Study|Administrative or other reason(s)|11|||
130207319|NCT02327013|468718859|FG003|Overall Study|Administrative or other reason(s)|1|||
130207320|NCT02327013|468718860|FG004|Overall Study|Administrative or other reason(s)|1|||
130207321|NCT02327013|468718856|FG000|Overall Study|Protocol Violation|0|||
130207322|NCT02327013|468718857|FG001|Overall Study|Protocol Violation|0|||
129983926|NCT01820585|467903810|FG003|Overall Study|Lost to Follow-up|3|||
129983927|NCT01820585|467903807|FG000|Overall Study|Protocol Violation|3|||
129983928|NCT01820585|467903808|FG001|Overall Study|Protocol Violation|1|||
130207323|NCT02327013|468718858|FG002|Overall Study|Protocol Violation|3|||
130207324|NCT02327013|468718859|FG003|Overall Study|Protocol Violation|0|||
130207325|NCT02327013|468718860|FG004|Overall Study|Protocol Violation|1|||
130207326|NCT02327013|468718856|FG000|Overall Study|Withdrawal before treatment|2|||
130207327|NCT02327013|468718857|FG001|Overall Study|Withdrawal before treatment|1|||
130207328|NCT02327013|468718858|FG002|Overall Study|Withdrawal before treatment|5|||
130207329|NCT02327013|468718859|FG003|Overall Study|Withdrawal before treatment|0|||
130207330|NCT02327013|468718860|FG004|Overall Study|Withdrawal before treatment|0|||
130207331|NCT04258254|468718861|FG000|Overall Study|Withdrawal by Subject|0|||
130207332|NCT04258254|468718862|FG001|Overall Study|Withdrawal by Subject|1|||
130207333|NCT04258254|468718863|FG002|Overall Study|Withdrawal by Subject|0|||
130207334|NCT04829331|468718864|FG000|Overall Study|Lost to Follow-up|1|||
130207335|NCT04829331|468718865|FG001|Overall Study|Lost to Follow-up|0|||
130207336|NCT00616603|468718867|FG000|Overall Study|Physician Decision|2|||
130207337|NCT00616603|468718868|FG001|Overall Study|Physician Decision|0|||
130207338|NCT00616603|468718869|FG002|Overall Study|Physician Decision|2|||
130207339|NCT02223819|468718883|FG000|Overall Study|Lost to Follow-up|2|||
130207340|NCT02956057|468718884|FG000|Overall Study|Discontinued intervention|14|||
130207341|NCT02956057|468718885|FG001|Overall Study|Discontinued intervention|10|||
130207342|NCT02956057|468718886|FG002|Overall Study|Discontinued intervention|7|||
130207343|NCT02956057|468718887|FG003|Overall Study|Discontinued intervention|14|||
130207344|NCT02956057|468718888|FG004|Overall Study|Discontinued intervention|4|||
130207345|NCT02956057|468718889|FG005|Overall Study|Discontinued intervention|17|||
130207346|NCT02956057|468718884|FG000|Overall Study|Lost to Follow-up|0|||
130207347|NCT02956057|468718885|FG001|Overall Study|Lost to Follow-up|2|||
130207348|NCT02956057|468718886|FG002|Overall Study|Lost to Follow-up|1|||
130207349|NCT02956057|468718887|FG003|Overall Study|Lost to Follow-up|1|||
130207350|NCT02956057|468718888|FG004|Overall Study|Lost to Follow-up|1|||
130207351|NCT02956057|468718889|FG005|Overall Study|Lost to Follow-up|0|||
130207352|NCT00367484|468718896|FG000|Overall Study|Adverse Event|7|||
130207353|NCT00367484|468718896|FG000|Overall Study|Withdrew informed consent|5|||
130207354|NCT00367484|468718896|FG000|Overall Study|Travel to USA|1|||
130207355|NCT00367484|468718896|FG000|Overall Study|Lost to Follow-up|1|||
130207356|NCT00367484|468718896|FG000|Overall Study|Protocol Violation|1|||
130207357|NCT00367484|468718896|FG000|Overall Study|The choice of the patient|1|||
130207358|NCT00367484|468718896|FG000|Overall Study|Lack of Efficacy|1|||
130207359|NCT00908076|468718897|FG000|Overall Study|Lack of Efficacy|1|||
130207360|NCT00908076|468718898|FG001|Overall Study|Lack of Efficacy|1|||
130207361|NCT02382796|468718899|FG000|Overall Study|Global deterioration of health status|1|||
130207362|NCT02382796|468718899|FG000|Overall Study|Objective progression or relapse|3|||
130207363|NCT02382796|468718899|FG000|Overall Study|Commercial dacomitinib became available|3|||
130207364|NCT04007107|468718906|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130207365|NCT04007107|468718907|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
130207366|NCT04007107|468718908|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130207367|NCT04007107|468718909|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
130207368|NCT04068688|468718915|FG000|Overall Study|Lost to Follow-up|1|||
130207369|NCT04068688|468718916|FG001|Overall Study|Lost to Follow-up|1|||
130207370|NCT04068688|468718917|FG002|Overall Study|Lost to Follow-up|0|||
130207371|NCT04068688|468718918|FG003|Overall Study|Lost to Follow-up|0|||
130207372|NCT04068688|468718919|FG004|Overall Study|Lost to Follow-up|5|||
130207373|NCT04068688|468718920|FG005|Overall Study|Lost to Follow-up|5|||
130207374|NCT04068688|468718921|FG006|Overall Study|Lost to Follow-up|0|||
130207375|NCT04068688|468718922|FG007|Overall Study|Lost to Follow-up|0|||
130207376|NCT04068688|468718923|FG008|Overall Study|Lost to Follow-up|1|||
130207377|NCT04068688|468718924|FG009|Overall Study|Lost to Follow-up|0|||
130207378|NCT04068688|468718915|FG000|Overall Study|Withdrawal by Subject|1|||
130207379|NCT04068688|468718916|FG001|Overall Study|Withdrawal by Subject|1|||
130207380|NCT04068688|468718917|FG002|Overall Study|Withdrawal by Subject|0|||
130207381|NCT04068688|468718918|FG003|Overall Study|Withdrawal by Subject|0|||
130207382|NCT04068688|468718919|FG004|Overall Study|Withdrawal by Subject|0|||
130207383|NCT04068688|468718920|FG005|Overall Study|Withdrawal by Subject|0|||
130207384|NCT04068688|468718921|FG006|Overall Study|Withdrawal by Subject|0|||
130207385|NCT04068688|468718922|FG007|Overall Study|Withdrawal by Subject|0|||
130207386|NCT04068688|468718923|FG008|Overall Study|Withdrawal by Subject|0|||
130207387|NCT04068688|468718924|FG009|Overall Study|Withdrawal by Subject|0|||
130207388|NCT04068688|468718915|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
130207389|NCT04068688|468718916|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
130207390|NCT04068688|468718917|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207391|NCT04068688|468718918|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207392|NCT04068688|468718919|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207393|NCT04068688|468718920|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207394|NCT04068688|468718921|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207395|NCT04068688|468718922|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207396|NCT04068688|468718923|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207397|NCT04068688|468718924|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
130207398|NCT04679051|468718925|FG000|Overall Study|felt tired after restricted time in bed|3|||
130207399|NCT04679051|468718926|FG001|Overall Study|felt tired after restricted time in bed|0|||
130207400|NCT04679051|468718925|FG000|Overall Study|discomfort with blood pressure cuff|2|||
130207401|NCT04679051|468718926|FG001|Overall Study|discomfort with blood pressure cuff|0|||
130207402|NCT04679051|468718925|FG000|Overall Study|scheduling conflict|1|||
130207403|NCT04679051|468718926|FG001|Overall Study|scheduling conflict|1|||
130207404|NCT04679051|468718925|FG000|Overall Study|Protocol Violation|0|||
130207405|NCT04679051|468718926|FG001|Overall Study|Protocol Violation|4|||
130207406|NCT02554318|468718927|FG000|Overall Study|Withdrawal by Subject|10|||
130207407|NCT02554318|468718928|FG001|Overall Study|Withdrawal by Subject|8|||
130207408|NCT01273155|468718933|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
130207409|NCT01273155|468718934|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
130207410|NCT01273155|468718935|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
130207411|NCT01273155|468718936|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
130207412|NCT01273155|468718937|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
130207413|NCT01273155|468718938|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
130207414|NCT01273155|468718939|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
130207415|NCT01273155|468718933|FG000|Overall Study|Change in liver function/no longer eval.|0|||
130207416|NCT01273155|468718934|FG001|Overall Study|Change in liver function/no longer eval.|1|||
130207417|NCT01273155|468718935|FG002|Overall Study|Change in liver function/no longer eval.|0|||
130207418|NCT01273155|468718936|FG003|Overall Study|Change in liver function/no longer eval.|0|||
130207419|NCT01273155|468718937|FG004|Overall Study|Change in liver function/no longer eval.|1|||
130207420|NCT01273155|468718938|FG005|Overall Study|Change in liver function/no longer eval.|0|||
130207421|NCT01273155|468718939|FG006|Overall Study|Change in liver function/no longer eval.|0|||
130207422|NCT01273155|468718933|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
130207423|NCT01273155|468718934|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
130207424|NCT01273155|468718935|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
130207425|NCT01273155|468718936|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
130207426|NCT01273155|468718937|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
130207427|NCT01273155|468718938|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
130207428|NCT01273155|468718939|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
130207429|NCT01273155|468718933|FG000|Overall Study|Died during Cycle 1|0|||
130207430|NCT01273155|468718934|FG001|Overall Study|Died during Cycle 1|0|||
130207431|NCT01273155|468718935|FG002|Overall Study|Died during Cycle 1|1|||
130207432|NCT01273155|468718936|FG003|Overall Study|Died during Cycle 1|1|||
130207433|NCT01273155|468718937|FG004|Overall Study|Died during Cycle 1|0|||
130207434|NCT01273155|468718938|FG005|Overall Study|Died during Cycle 1|2|||
130207435|NCT01273155|468718939|FG006|Overall Study|Died during Cycle 1|2|||
130207436|NCT01273155|468718933|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
130207437|NCT01273155|468718934|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
130207438|NCT01273155|468718935|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
130207439|NCT01273155|468718936|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
130207440|NCT01273155|468718937|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
130207441|NCT01273155|468718938|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
130207442|NCT01273155|468718939|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
130207443|NCT01438814|468718940|FG000|Overall Study|Adverse Event|3|||
130207444|NCT01438814|468718941|FG001|Overall Study|Adverse Event|3|||
130207445|NCT01438814|468718940|FG000|Overall Study|Protocol Violation|1|||
130207446|NCT01438814|468718941|FG001|Overall Study|Protocol Violation|2|||
130207447|NCT01438814|468718940|FG000|Overall Study|Lost to Follow-up|4|||
130207448|NCT01438814|468718941|FG001|Overall Study|Lost to Follow-up|3|||
130207449|NCT01438814|468718940|FG000|Overall Study|Withdrawal by Subject|4|||
130207450|NCT01438814|468718941|FG001|Overall Study|Withdrawal by Subject|2|||
130318557|NCT02973100|469133715|FG000|Overall Study|Lost to Follow-up|3|||
130318558|NCT02973100|469133716|FG001|Overall Study|Lost to Follow-up|1|||
130318559|NCT02973100|469133717|FG002|Overall Study|Lost to Follow-up|1|||
130318560|NCT02973100|469133718|FG003|Overall Study|Lost to Follow-up|0|||
130318561|NCT02973100|469133715|FG000|Overall Study|Withdrawal by Subject|3|||
130318562|NCT02973100|469133716|FG001|Overall Study|Withdrawal by Subject|5|||
130318563|NCT02973100|469133717|FG002|Overall Study|Withdrawal by Subject|1|||
130318564|NCT02973100|469133718|FG003|Overall Study|Withdrawal by Subject|4|||
130318565|NCT02973100|469133715|FG000|Overall Study|Notification of change in address|0|||
130318566|NCT02973100|469133716|FG001|Overall Study|Notification of change in address|0|||
130318567|NCT02973100|469133717|FG002|Overall Study|Notification of change in address|0|||
130318568|NCT02973100|469133718|FG003|Overall Study|Notification of change in address|1|||
130318569|NCT02973100|469133715|FG000|Overall Study|Failed to attend Safety followup period|0|||
130318570|NCT02973100|469133716|FG001|Overall Study|Failed to attend Safety followup period|0|||
130318571|NCT02973100|469133717|FG002|Overall Study|Failed to attend Safety followup period|1|||
130318572|NCT02973100|469133718|FG003|Overall Study|Failed to attend Safety followup period|0|||
130318573|NCT01419769|469133719|FG000|Overall Study|Did not receive the AXIOS stent|3|||
130318574|NCT01419769|469133719|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
130318575|NCT00878501|469133720|FG000|Overall Study|Adverse Event|11|||
130318576|NCT00878501|469133721|FG001|Overall Study|Adverse Event|3|||
130318577|NCT00878501|469133722|FG002|Overall Study|Adverse Event|3|||
130318578|NCT00878501|469133720|FG000|Overall Study|Lack of Efficacy|2|||
130318579|NCT00878501|469133721|FG001|Overall Study|Lack of Efficacy|1|||
130318580|NCT00878501|469133722|FG002|Overall Study|Lack of Efficacy|0|||
130318581|NCT00878501|469133720|FG000|Overall Study|Withdrawal by Subject|2|||
130318582|NCT00878501|469133721|FG001|Overall Study|Withdrawal by Subject|1|||
130318583|NCT00878501|469133722|FG002|Overall Study|Withdrawal by Subject|2|||
130318584|NCT00878501|469133720|FG000|Overall Study|Protocol Violation|0|||
130318585|NCT00878501|469133721|FG001|Overall Study|Protocol Violation|0|||
130318586|NCT00878501|469133722|FG002|Overall Study|Protocol Violation|1|||
130318587|NCT00878501|469133720|FG000|Overall Study|Incorrect enrolment|1|||
130318588|NCT00878501|469133721|FG001|Overall Study|Incorrect enrolment|2|||
130318589|NCT00878501|469133722|FG002|Overall Study|Incorrect enrolment|0|||
130318590|NCT00878501|469133720|FG000|Overall Study|Intake of prohibited concom. medication|0|||
130318591|NCT00878501|469133721|FG001|Overall Study|Intake of prohibited concom. medication|0|||
130318592|NCT00878501|469133722|FG002|Overall Study|Intake of prohibited concom. medication|1|||
130318593|NCT00878501|469133720|FG000|Overall Study|Mis-randomisation of patient|1|||
130318594|NCT00878501|469133721|FG001|Overall Study|Mis-randomisation of patient|0|||
130318595|NCT00878501|469133722|FG002|Overall Study|Mis-randomisation of patient|0|||
130318596|NCT00878501|469133720|FG000|Overall Study|Administrative|0|||
130318597|NCT00878501|469133721|FG001|Overall Study|Administrative|0|||
130318598|NCT00878501|469133722|FG002|Overall Study|Administrative|1|||
129983929|NCT01820585|467903809|FG002|Overall Study|Protocol Violation|1|||
129983930|NCT01820585|467903810|FG003|Overall Study|Protocol Violation|1|||
129983931|NCT01820585|467903807|FG000|Overall Study|Subject non-compliance|0|||
129983932|NCT01820585|467903808|FG001|Overall Study|Subject non-compliance|0|||
129983933|NCT01820585|467903809|FG002|Overall Study|Subject non-compliance|1|||
129983934|NCT01820585|467903810|FG003|Overall Study|Subject non-compliance|2|||
129983935|NCT01820585|467903807|FG000|Overall Study|at sponsor request|0|||
129983936|NCT01820585|467903808|FG001|Overall Study|at sponsor request|0|||
129983937|NCT01820585|467903809|FG002|Overall Study|at sponsor request|1|||
129983938|NCT01820585|467903810|FG003|Overall Study|at sponsor request|0|||
129983939|NCT01820585|467903807|FG000|Overall Study|Pregnancy|0|||
129983940|NCT01820585|467903808|FG001|Overall Study|Pregnancy|1|||
129983941|NCT01820585|467903809|FG002|Overall Study|Pregnancy|0|||
129983942|NCT01820585|467903810|FG003|Overall Study|Pregnancy|0|||
129983943|NCT01712659|467903811|FG000|Dose Escalation|Physician Decision|0|||
129983944|NCT01712659|467903812|FG001|Dose Escalation|Physician Decision|1|||
129983945|NCT01712659|467903813|FG002|Dose Escalation|Physician Decision|0|||
129983946|NCT01712659|467903814|FG003|Dose Escalation|Physician Decision|0|||
129983947|NCT01712659|467903815|FG004|Dose Escalation|Physician Decision|0|||
129983948|NCT01712659|467903811|FG000|Dose Escalation|Unable to take study drug|0|||
129983949|NCT01712659|467903812|FG001|Dose Escalation|Unable to take study drug|1|||
129983950|NCT01712659|467903813|FG002|Dose Escalation|Unable to take study drug|0|||
129983951|NCT01712659|467903814|FG003|Dose Escalation|Unable to take study drug|0|||
129983952|NCT01712659|467903815|FG004|Dose Escalation|Unable to take study drug|0|||
129983953|NCT01712659|467903811|FG000|Dose Expansion|Early disease progression|1|||
129983954|NCT01712659|467903812|FG001|Dose Expansion|Early disease progression|0|||
129983955|NCT01712659|467903813|FG002|Dose Expansion|Early disease progression|0|||
129983956|NCT01712659|467903814|FG003|Dose Expansion|Early disease progression|0|||
129983957|NCT01712659|467903815|FG004|Dose Expansion|Early disease progression|0|||
129983958|NCT01712659|467903811|FG000|Dose Expansion|Physician Decision|1|||
129983959|NCT01712659|467903812|FG001|Dose Expansion|Physician Decision|0|||
129983960|NCT01712659|467903813|FG002|Dose Expansion|Physician Decision|0|||
129983961|NCT01712659|467903814|FG003|Dose Expansion|Physician Decision|0|||
129983962|NCT01712659|467903815|FG004|Dose Expansion|Physician Decision|0|||
129983963|NCT00548262|467903816|FG000|Overall Study|Death|21|||
129983964|NCT00548262|467903816|FG000|Overall Study|Adverse Event|2|||
129983965|NCT00548262|467903816|FG000|Overall Study|Lack of Efficacy|4|||
129983966|NCT00548262|467903816|FG000|Overall Study|Lost to Follow-up|1|||
129983967|NCT00548262|467903816|FG000|Overall Study|Other|3|||
129983968|NCT00548262|467903816|FG000|Overall Study|Withdrawal by Subject|1|||
130095164|NCT00198107|468305435|FG002|Double-Blind Period|Adverse Event|0|||
130095165|NCT00198107|468305433|FG000|Double-Blind Period|Lack of Efficacy|2|||
130318599|NCT00812708|469133725|FG000|Overall Study|Device could not be implanted|2|||
130318600|NCT00812708|469133725|FG000|Overall Study|Lack of medical insurance|1|||
129983969|NCT02285153|467903817|FG000|Overall Study|Adverse Event|1|||
129983970|NCT02285153|467903818|FG001|Overall Study|Adverse Event|0|||
129983971|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
129983972|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
129983973|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
129983974|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
129983975|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
130095166|NCT00198107|468305434|FG001|Double-Blind Period|Lack of Efficacy|0|||
130318601|NCT00812708|469133725|FG000|Overall Study|Switched to another study|1|||
130318602|NCT00812708|469133725|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
130318603|NCT00812708|469133725|FG000|Overall Study|Signed consent but later withdrew|3|||
130318604|NCT01959503|469133726|FG000|Overall Study|Death|2|||
130318605|NCT01959503|469133727|FG001|Overall Study|Death|1|||
130318606|NCT01959503|469133726|FG000|Overall Study|Randomized but not treated|1|||
130318607|NCT01959503|469133727|FG001|Overall Study|Randomized but not treated|1|||
130318608|NCT01600326|469133728|FG000|Overall Study|Lost to Follow-up|1|||
130318609|NCT01600326|469133729|FG001|Overall Study|Lost to Follow-up|1|||
129983976|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
129983977|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
129983978|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
129983979|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
130318610|NCT03224130|469133730|FG000|Overall Study|consent issue|0|||
130318611|NCT03224130|469133731|FG001|Overall Study|consent issue|1|||
130318612|NCT03287791|469133734|FG000|Overall Study|Insufficient Therapeutic Response|0|||
130318613|NCT03287791|469133735|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130318614|NCT03287791|469133736|FG002|Overall Study|Insufficient Therapeutic Response|1|||
130318615|NCT03287791|469133734|FG000|Overall Study|Adverse Event|0|||
130318616|NCT03287791|469133735|FG001|Overall Study|Adverse Event|4|||
130318617|NCT03287791|469133736|FG002|Overall Study|Adverse Event|3|||
130318618|NCT03287791|469133734|FG000|Overall Study|Withdrawal by Subject|12|||
130318619|NCT03287791|469133735|FG001|Overall Study|Withdrawal by Subject|12|||
130318620|NCT03287791|469133736|FG002|Overall Study|Withdrawal by Subject|17|||
130318621|NCT03287791|469133734|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
130318622|NCT03287791|469133735|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
130318623|NCT03287791|469133736|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
130318624|NCT03287791|469133734|FG000|Overall Study|Lost to Follow-up|8|||
130318625|NCT03287791|469133735|FG001|Overall Study|Lost to Follow-up|14|||
130318626|NCT03287791|469133736|FG002|Overall Study|Lost to Follow-up|11|||
130318627|NCT03287791|469133734|FG000|Overall Study|Protocol Violation|7|||
129983980|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
129983981|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
129983982|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
129983983|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
129983984|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
129983985|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
130318628|NCT03287791|469133735|FG001|Overall Study|Protocol Violation|2|||
130318629|NCT03287791|469133736|FG002|Overall Study|Protocol Violation|1|||
130318630|NCT03287791|469133734|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
130318631|NCT03287791|469133735|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
130318632|NCT03287791|469133736|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
130318633|NCT03287791|469133734|FG000|Overall Study|Too much time between 2 visits|0|||
130318634|NCT03287791|469133735|FG001|Overall Study|Too much time between 2 visits|1|||
130318635|NCT03287791|469133736|FG002|Overall Study|Too much time between 2 visits|0|||
130318636|NCT03287791|469133734|FG000|Overall Study|Non-compliance|0|||
130318637|NCT03287791|469133735|FG001|Overall Study|Non-compliance|1|||
129983986|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
129983987|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
129983988|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
129983989|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
129983990|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
129983991|NCT02544451|467903820|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
129983992|NCT02544451|467903821|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
129983993|NCT02544451|467903822|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
129983994|NCT02544451|467903823|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
130318638|NCT03287791|469133736|FG002|Overall Study|Non-compliance|0|||
130318639|NCT03287791|469133734|FG000|Overall Study|Did not meet inclusion criteria|1|||
130318640|NCT03287791|469133735|FG001|Overall Study|Did not meet inclusion criteria|0|||
130318641|NCT03287791|469133736|FG002|Overall Study|Did not meet inclusion criteria|0|||
130318642|NCT03095651|469133738|FG000|Overall Study|Lost to Follow-up|1|||
130318643|NCT03095651|469133739|FG001|Overall Study|Lost to Follow-up|1|||
130318644|NCT03095651|469133740|FG002|Overall Study|Lost to Follow-up|0|||
130318645|NCT03095651|469133741|FG003|Overall Study|Lost to Follow-up|1|||
130318646|NCT03095651|469133742|FG004|Overall Study|Lost to Follow-up|0|||
130318647|NCT03095651|469133743|FG005|Overall Study|Lost to Follow-up|0|||
130318648|NCT03095651|469133744|FG006|Overall Study|Lost to Follow-up|0|||
130318649|NCT03095651|469133745|FG007|Overall Study|Lost to Follow-up|0|||
130318650|NCT03095651|469133738|FG000|Overall Study|Withdrawal by Subject|0|||
130318651|NCT03095651|469133739|FG001|Overall Study|Withdrawal by Subject|0|||
130318652|NCT03095651|469133740|FG002|Overall Study|Withdrawal by Subject|0|||
130318653|NCT03095651|469133741|FG003|Overall Study|Withdrawal by Subject|0|||
130318654|NCT03095651|469133742|FG004|Overall Study|Withdrawal by Subject|0|||
130318655|NCT03095651|469133743|FG005|Overall Study|Withdrawal by Subject|1|||
130318656|NCT03095651|469133744|FG006|Overall Study|Withdrawal by Subject|0|||
130318657|NCT03095651|469133745|FG007|Overall Study|Withdrawal by Subject|0|||
130318658|NCT04247347|469133752|FG000|Overall Study|Withdrawal by Subject|2|||
130318659|NCT04247347|469133753|FG001|Overall Study|Withdrawal by Subject|3|||
130318660|NCT04247347|469133754|FG002|Overall Study|Withdrawal by Subject|3|||
130318661|NCT04247347|469133752|FG000|Overall Study|Lost to Follow-up|1|||
130318662|NCT04247347|469133753|FG001|Overall Study|Lost to Follow-up|1|||
130318663|NCT04247347|469133754|FG002|Overall Study|Lost to Follow-up|1|||
130318664|NCT03562195|469133755|FG000|Overall Study|Adverse Event|0|||
130318665|NCT03562195|469133756|FG001|Overall Study|Adverse Event|6|||
130318666|NCT03562195|469133755|FG000|Overall Study|Lack of Efficacy|0|||
130318667|NCT03562195|469133756|FG001|Overall Study|Lack of Efficacy|5|||
130318668|NCT03562195|469133755|FG000|Overall Study|Protocol Violation|0|||
130318669|NCT03562195|469133756|FG001|Overall Study|Protocol Violation|1|||
130318670|NCT03562195|469133755|FG000|Overall Study|Lost to Follow-up|0|||
130318671|NCT03562195|469133756|FG001|Overall Study|Lost to Follow-up|1|||
130318672|NCT03562195|469133755|FG000|Overall Study|Physician Decision|1|||
130318673|NCT03562195|469133756|FG001|Overall Study|Physician Decision|0|||
130318674|NCT03562195|469133755|FG000|Overall Study|Withdrawal by Subject|3|||
130318675|NCT03562195|469133756|FG001|Overall Study|Withdrawal by Subject|0|||
130318676|NCT02529852|469133757|FG000|Overall Study|Withdrawal by Subject|2|||
130318677|NCT04664153|469133758|FG000|Overall Study|Lack of Efficacy|0|||
130207451|NCT01438814|468718940|FG000|Overall Study|Other|2|||
130207452|NCT01438814|468718941|FG001|Overall Study|Other|4|||
130207453|NCT00990665|468718947|FG000|Overall Study|Unsuccessful Implant|8|||
130207454|NCT00990665|468718947|FG000|Overall Study|Death|29|||
130207455|NCT00990665|468718947|FG000|Overall Study|Heart Transplant|1|||
130318678|NCT04664153|469133759|FG001|Overall Study|Lack of Efficacy|0|||
130318679|NCT04664153|469133760|FG002|Overall Study|Lack of Efficacy|1|||
130207456|NCT00990665|468718947|FG000|Overall Study|Withdrawal by Subject|6|||
130207457|NCT00990665|468718947|FG000|Overall Study|Lost to Follow-up|1|||
130207458|NCT00990665|468718947|FG000|Overall Study|System Explant|3|||
130207459|NCT00672841|468718948|FG000|Overall Study|Comfort care|1|||
130207460|NCT00672841|468718949|FG001|Overall Study|Comfort care|4|||
130207461|NCT00672841|468718948|FG000|Overall Study|icteric specimens|0|||
130207462|NCT00672841|468718949|FG001|Overall Study|icteric specimens|3|||
130207463|NCT00672841|468718948|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
130207464|NCT00672841|468718949|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
130207465|NCT00672841|468718948|FG000|Overall Study|Adverse Event|0|||
130207466|NCT00672841|468718949|FG001|Overall Study|Adverse Event|3|||
130207467|NCT00672841|468718948|FG000|Overall Study|Pregnancy|0|||
130207468|NCT00672841|468718949|FG001|Overall Study|Pregnancy|1|||
130207469|NCT03578146|468718950|FG000|Overall Study|Did Not Receive Treatment|1|||
130207470|NCT03578146|468718951|FG001|Overall Study|Did Not Receive Treatment|0|||
130207471|NCT03578146|468718952|FG002|Overall Study|Did Not Receive Treatment|0|||
130207472|NCT03578146|468718953|FG003|Overall Study|Did Not Receive Treatment|0|||
130207473|NCT03578146|468718954|FG004|Overall Study|Did Not Receive Treatment|0|||
130207474|NCT03578146|468718955|FG005|Overall Study|Did Not Receive Treatment|2|||
130207475|NCT03578146|468718950|FG000|Overall Study|Lost to Follow-up|0|||
130207476|NCT03578146|468718951|FG001|Overall Study|Lost to Follow-up|1|||
130207477|NCT03578146|468718952|FG002|Overall Study|Lost to Follow-up|1|||
130207478|NCT03578146|468718953|FG003|Overall Study|Lost to Follow-up|0|||
130207479|NCT03578146|468718954|FG004|Overall Study|Lost to Follow-up|0|||
130207480|NCT03578146|468718955|FG005|Overall Study|Lost to Follow-up|1|||
130207481|NCT01717391|468718956|FG000|Overall Study|Withdrawal by Subject|5|||
130207482|NCT01717391|468718956|FG000|Overall Study|Physician Decision|1|||
130207483|NCT01717391|468718956|FG000|Overall Study|FLT technical failure|3|||
130207484|NCT03677934|468718957|FG000|Overall Study|Adverse Event|1|||
130207485|NCT03677934|468718958|FG001|Overall Study|Adverse Event|1|||
130207486|NCT03677934|468718957|FG000|Overall Study|Death|8|||
130207487|NCT03677934|468718958|FG001|Overall Study|Death|4|||
130207488|NCT03677934|468718957|FG000|Overall Study|Lost to Follow-up|3|||
130207489|NCT03677934|468718958|FG001|Overall Study|Lost to Follow-up|0|||
130207490|NCT03677934|468718957|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130207491|NCT03677934|468718958|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130207492|NCT03677934|468718957|FG000|Overall Study|Physician Decision|0|||
130207493|NCT03677934|468718958|FG001|Overall Study|Physician Decision|1|||
130207494|NCT03677934|468718957|FG000|Overall Study|Withdrawal by Subject|1|||
130207495|NCT03677934|468718958|FG001|Overall Study|Withdrawal by Subject|7|||
130207496|NCT01731470|468718960|FG000|Overall Study|Withdrawal by Subject|1|||
130207497|NCT01731470|468718960|FG000|Overall Study|Did not meet study criteria|1|||
130207498|NCT00335959|468718961|FG000|Overall Study|Adverse Event|2|||
129983995|NCT01489891|467903824|FG000|Overall Study|Endoscopy failure|1|||
130207499|NCT00335959|468718961|FG000|Overall Study|Ineligible|1|||
130207500|NCT02450552|468718964|FG000|Overall Study|Withdrawal by Subject|4|||
130207501|NCT02450552|468718965|FG001|Overall Study|Withdrawal by Subject|0|||
130207502|NCT02450552|468718966|FG002|Overall Study|Withdrawal by Subject|4|||
130207503|NCT02450552|468718964|FG000|Overall Study|Physician Decision|1|||
130207504|NCT02450552|468718965|FG001|Overall Study|Physician Decision|0|||
130207505|NCT02450552|468718966|FG002|Overall Study|Physician Decision|1|||
130207506|NCT01876979|468718973|FG000|Overall Study|Physician Decision|2|||
130207507|NCT01876979|468718974|FG001|Overall Study|Physician Decision|3|||
130207508|NCT00948506|468718975|FG000|Overall Study|Withdrawal by Subject|3|||
130207509|NCT00948506|468718976|FG001|Overall Study|Withdrawal by Subject|1|||
130207510|NCT00824382|468718977|FG000|Overall Study|Adverse Event|4|||
130207511|NCT00824382|468718978|FG001|Overall Study|Adverse Event|1|||
130207512|NCT00824382|468718979|FG002|Overall Study|Adverse Event|1|||
130207513|NCT00824382|468718980|FG003|Overall Study|Adverse Event|4|||
130207514|NCT00824382|468718977|FG000|Overall Study|Protocol Violation|1|||
130207515|NCT00824382|468718978|FG001|Overall Study|Protocol Violation|0|||
130207516|NCT00824382|468718979|FG002|Overall Study|Protocol Violation|0|||
130207517|NCT00824382|468718980|FG003|Overall Study|Protocol Violation|1|||
130207518|NCT00824382|468718977|FG000|Overall Study|Investigator's decision|0|||
130207519|NCT00824382|468718978|FG001|Overall Study|Investigator's decision|1|||
130207520|NCT00824382|468718979|FG002|Overall Study|Investigator's decision|2|||
130207521|NCT00824382|468718980|FG003|Overall Study|Investigator's decision|0|||
130207522|NCT00721279|468718981|FG000|Overall Study|Lack of Efficacy|6|||
130207523|NCT00721279|468718982|FG001|Overall Study|Lack of Efficacy|3|||
130207524|NCT00721279|468718981|FG000|Overall Study|Tolerability insufficient|5|||
130207525|NCT00721279|468718982|FG001|Overall Study|Tolerability insufficient|2|||
130207526|NCT00721279|468718981|FG000|Overall Study|Withdrawal by Subject|13|||
130207527|NCT00721279|468718982|FG001|Overall Study|Withdrawal by Subject|3|||
130207528|NCT00721279|468718981|FG000|Overall Study|Other|12|||
130207529|NCT00721279|468718982|FG001|Overall Study|Other|16|||
130207530|NCT03467763|468718983|FG000|Overall Study|Lost to Follow-up|1|||
130318680|NCT04664153|469133761|FG003|Overall Study|Lack of Efficacy|0|||
130318681|NCT04664153|469133758|FG000|Overall Study|Physician Decision|0|||
130318682|NCT04664153|469133759|FG001|Overall Study|Physician Decision|0|||
130318683|NCT04664153|469133760|FG002|Overall Study|Physician Decision|1|||
130318684|NCT04664153|469133761|FG003|Overall Study|Physician Decision|0|||
130318685|NCT04664153|469133758|FG000|Overall Study|Withdrawal by Subject|3|||
130318686|NCT04664153|469133759|FG001|Overall Study|Withdrawal by Subject|2|||
130318687|NCT04664153|469133760|FG002|Overall Study|Withdrawal by Subject|1|||
130318688|NCT04664153|469133761|FG003|Overall Study|Withdrawal by Subject|2|||
130318689|NCT04664153|469133758|FG000|Overall Study|Other|0|||
130318690|NCT04664153|469133759|FG001|Overall Study|Other|1|||
130318691|NCT04664153|469133760|FG002|Overall Study|Other|0|||
130318692|NCT04664153|469133761|FG003|Overall Study|Other|0|||
130318693|NCT04664153|469133758|FG000|Overall Study|Adverse Event|4|||
130318694|NCT04664153|469133759|FG001|Overall Study|Adverse Event|0|||
130318695|NCT04664153|469133760|FG002|Overall Study|Adverse Event|1|||
130318696|NCT04664153|469133761|FG003|Overall Study|Adverse Event|0|||
130318697|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
130318698|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
130318699|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
130318700|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
130318701|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
130318702|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
130318703|NCT00097500|469133762|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130318704|NCT00097500|469133763|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
130318705|NCT00097500|469133762|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
130318706|NCT00097500|469133763|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
130318707|NCT00097500|469133762|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
130318708|NCT00097500|469133763|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
130318709|NCT00097500|469133762|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
130318710|NCT00097500|469133763|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
130318711|NCT00642356|469133769|FG000|Overall Study|Adverse Event|1|||
130318712|NCT00642356|469133770|FG001|Overall Study|Adverse Event|0|||
130318713|NCT00642356|469133769|FG000|Overall Study|Protocol Violation|0|||
130318714|NCT00642356|469133770|FG001|Overall Study|Protocol Violation|3|||
130318715|NCT00642356|469133769|FG000|Overall Study|Lack of Efficacy|1|||
130318716|NCT00642356|469133770|FG001|Overall Study|Lack of Efficacy|0|||
130318717|NCT01009060|469133771|FG000|Overall Study|Adverse Event|1|||
130318718|NCT01009060|469133772|FG001|Overall Study|Adverse Event|2|||
130318719|NCT01009060|469133771|FG000|Overall Study|Protocol Violation|0|||
130318720|NCT01009060|469133772|FG001|Overall Study|Protocol Violation|1|||
130318721|NCT01009060|469133771|FG000|Overall Study|Lost to Follow-up|1|||
130318722|NCT01009060|469133772|FG001|Overall Study|Lost to Follow-up|0|||
130095167|NCT00198107|468305435|FG002|Double-Blind Period|Lack of Efficacy|0|||
130318723|NCT01009060|469133771|FG000|Overall Study|Physician Decision|1|||
130318724|NCT01009060|469133772|FG001|Overall Study|Physician Decision|1|||
130207531|NCT03467763|468718983|FG000|Overall Study|Protocol Violation|2|||
130207532|NCT02407054|468718984|FG000|Overall Study|Adverse Event|1|||
130318725|NCT01009060|469133771|FG000|Overall Study|Withdrawal by Subject|1|||
130318726|NCT01009060|469133772|FG001|Overall Study|Withdrawal by Subject|1|||
130318727|NCT00265564|469133773|FG000|Overall Study|Lost to Follow-up|5|||
130318728|NCT00265564|469133774|FG001|Overall Study|Lost to Follow-up|7|||
130318729|NCT00265564|469133773|FG000|Overall Study|met exclusion criteria|5|||
130318730|NCT00265564|469133774|FG001|Overall Study|met exclusion criteria|2|||
130318731|NCT04913610|469133783|FG000|Randomized Participants|Did Not Receive Treatment|0|||
130318732|NCT04913610|469133784|FG001|Randomized Participants|Did Not Receive Treatment|0|||
130318733|NCT04913610|469133785|FG002|Randomized Participants|Did Not Receive Treatment|1|||
130318734|NCT04913610|469133786|FG003|Randomized Participants|Did Not Receive Treatment|1|||
130318735|NCT04913610|469133787|FG004|Randomized Participants|Did Not Receive Treatment|0|||
130318736|NCT04913610|469133783|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
130318737|NCT04913610|469133784|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130318738|NCT04913610|469133785|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130318739|NCT04913610|469133786|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
130318740|NCT04913610|469133787|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
130318741|NCT00659061|469133788|FG000|Overall Study|Migration due to political unrest|21|||
130318742|NCT00659061|469133789|FG001|Overall Study|Migration due to political unrest|15|||
130318743|NCT01277744|469133792|FG000|Overall Study|Physician Decision|2|||
130318744|NCT01650558|469133795|FG000|Overall Study|Migration out of study area|61|||
130318745|NCT01650558|469133796|FG001|Overall Study|Migration out of study area|71|||
130318746|NCT01650558|469133797|FG002|Overall Study|Migration out of study area|56|||
130318747|NCT01650558|469133795|FG000|Overall Study|Lost to Follow-up|10|||
130318748|NCT01650558|469133796|FG001|Overall Study|Lost to Follow-up|13|||
130318749|NCT01650558|469133797|FG002|Overall Study|Lost to Follow-up|6|||
130318750|NCT01650558|469133795|FG000|Overall Study|Death|10|||
130318751|NCT01650558|469133796|FG001|Overall Study|Death|6|||
130318752|NCT01650558|469133797|FG002|Overall Study|Death|8|||
130318753|NCT01650558|469133795|FG000|Overall Study|Withdrawal by Subject|1|||
130318754|NCT01650558|469133796|FG001|Overall Study|Withdrawal by Subject|1|||
130318755|NCT01650558|469133797|FG002|Overall Study|Withdrawal by Subject|3|||
130318756|NCT01650558|469133795|FG000|Overall Study|Non-compliant participant|1|||
130318757|NCT01650558|469133796|FG001|Overall Study|Non-compliant participant|0|||
130318758|NCT01650558|469133797|FG002|Overall Study|Non-compliant participant|2|||
130318759|NCT01650558|469133795|FG000|Overall Study|Physician Decision|0|||
130318760|NCT01650558|469133796|FG001|Overall Study|Physician Decision|1|||
130318761|NCT01650558|469133797|FG002|Overall Study|Physician Decision|0|||
130318762|NCT01069484|469133800|FG000|Overall Study|Death-in-near-family|1|||
130318763|NCT01069484|469133801|FG001|Overall Study|Death-in-near-family|0|||
130318764|NCT01069484|469133800|FG000|Overall Study|No specific reason|8|||
130318765|NCT01069484|469133801|FG001|Overall Study|No specific reason|2|||
130318766|NCT01069484|469133800|FG000|Overall Study|Illness mother or child|3|||
130318767|NCT01069484|469133801|FG001|Overall Study|Illness mother or child|1|||
130318768|NCT00644358|469133803|FG000|Overall Study|Adverse Event|124|||
130318769|NCT00644358|469133803|FG000|Overall Study|Lost to Follow-up|105|||
130318770|NCT00644358|469133803|FG000|Overall Study|Consent Withdrawal|64|||
130318771|NCT00644358|469133803|FG000|Overall Study|Lack of Effectiveness|39|||
130318772|NCT00644358|469133803|FG000|Overall Study|Protocol Violation|5|||
130318773|NCT00644358|469133803|FG000|Overall Study|Noncompliance|14|||
130318774|NCT00644358|469133803|FG000|Overall Study|Other Unspecified|11|||
130318775|NCT00758771|469133810|FG000|Overall Study|Withdrawal by Subject|1|||
130318776|NCT00758771|469133811|FG001|Overall Study|Withdrawal by Subject|1|||
130318777|NCT00758771|469133810|FG000|Overall Study|Did not meet eligibility criteria|2|||
130318778|NCT00758771|469133811|FG001|Overall Study|Did not meet eligibility criteria|4|||
130318779|NCT00528957|469133812|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
130318780|NCT00528957|469133813|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
130318781|NCT00528957|469133812|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
130318782|NCT00528957|469133813|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
130318783|NCT00528957|469133812|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
130318784|NCT00528957|469133813|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
130318785|NCT00528957|469133812|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
130318786|NCT00528957|469133813|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
130318787|NCT00528957|469133812|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
130207533|NCT02407054|468718985|FG001|Overall Study|Adverse Event|4|||
130207534|NCT02407054|468718986|FG002|Overall Study|Adverse Event|1|||
130318788|NCT00528957|469133813|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
130318789|NCT00528957|469133812|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
130318790|NCT00528957|469133813|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
130318791|NCT00528957|469133812|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
130318792|NCT00528957|469133813|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
130318793|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
130318794|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
130318795|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
130318796|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
130318797|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
130318798|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
130318799|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
130318800|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
130318801|NCT00528957|469133812|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
130318802|NCT00528957|469133813|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
130318803|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
130318804|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
130318805|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
130318806|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
130318807|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
130318808|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
130318809|NCT00528957|469133812|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
130318810|NCT00528957|469133813|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
130318811|NCT02051764|469133818|FG000|Overall Study|Study terminated by sponsor|0|||
130318812|NCT02051764|469133819|FG001|Overall Study|Study terminated by sponsor|7|||
130318813|NCT03624881|469133820|FG000|Overall Study|Screen Failure|14|||
130318814|NCT03624881|469133821|FG001|Overall Study|Screen Failure|0|||
130318815|NCT03624881|469133820|FG000|Overall Study|No Catheter Inserted|6|||
130318816|NCT03624881|469133821|FG001|Overall Study|No Catheter Inserted|1|||
130318817|NCT03624881|469133820|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
130318818|NCT03624881|469133821|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
130318819|NCT03624881|469133820|FG000|Overall Study|Death|2|||
130318820|NCT03624881|469133821|FG001|Overall Study|Death|0|||
130318821|NCT03624881|469133820|FG000|Overall Study|Lost to Follow-up|10|||
130318822|NCT03624881|469133821|FG001|Overall Study|Lost to Follow-up|4|||
130318823|NCT03624881|469133820|FG000|Overall Study|Withdrawal by Subject|12|||
130318824|NCT03624881|469133821|FG001|Overall Study|Withdrawal by Subject|1|||
129800163|NCT00925990|467236213|FG001|Overall Study|Lost to Follow-up|3|||
129800164|NCT00925990|467236212|FG000|Overall Study|Physician Decision|1|||
129800165|NCT00925990|467236213|FG001|Overall Study|Physician Decision|1|||
129983996|NCT01489891|467903825|FG001|Overall Study|Endoscopy failure|0|||
129983997|NCT00998790|467903826|FG000|Overall Study|Withdrawal by Subject|21|||
129983998|NCT03001076|467903827|FG000|Overall Study|Withdrawal by patient|2|||
129983999|NCT03001076|467903828|FG001|Overall Study|Withdrawal by patient|0|||
129800166|NCT00925990|467236212|FG000|Overall Study|moved out of state, missed medication|0|||
129800167|NCT00925990|467236213|FG001|Overall Study|moved out of state, missed medication|2|||
129800168|NCT00737438|467236216|FG000|Overall Study|Withdrawal by Subject|2|||
129800169|NCT00737438|467236216|FG000|Overall Study|Patient ineligible|1|||
129800170|NCT04950166|467236223|FG000|Overall Study|Withdrawal by Subject|1|||
129800171|NCT00857415|467236224|FG000|Overall Study|Image acquisition failure|2|||
129800172|NCT00857415|467236225|FG001|Overall Study|Image acquisition failure|0|||
129800173|NCT00857415|467236224|FG000|Overall Study|Invalid image or not imaged|3|||
129800174|NCT00857415|467236225|FG001|Overall Study|Invalid image or not imaged|0|||
129800175|NCT00857415|467236224|FG000|Overall Study|Subject still living at end of study|110|||
129800176|NCT00857415|467236225|FG001|Overall Study|Subject still living at end of study|0|||
129800177|NCT00857415|467236224|FG000|Overall Study|Deceased with no autopsy|2|||
129800178|NCT00857415|467236225|FG001|Overall Study|Deceased with no autopsy|0|||
129800179|NCT01822678|467236230|FG000|Overall Study|Withdrawal by Subject|5|||
129800180|NCT01822678|467236231|FG001|Overall Study|Withdrawal by Subject|4|||
129800181|NCT01822678|467236232|FG002|Overall Study|Withdrawal by Subject|4|||
129800182|NCT01822678|467236230|FG000|Overall Study|Adverse Event|4|||
129800183|NCT01822678|467236231|FG001|Overall Study|Adverse Event|3|||
129800184|NCT01822678|467236232|FG002|Overall Study|Adverse Event|1|||
129800185|NCT01822678|467236230|FG000|Overall Study|Lack of Efficacy|3|||
129800186|NCT01822678|467236231|FG001|Overall Study|Lack of Efficacy|6|||
129800187|NCT01822678|467236232|FG002|Overall Study|Lack of Efficacy|5|||
129800188|NCT01822678|467236230|FG000|Overall Study|Lost to Follow-up|0|||
129800189|NCT01822678|467236231|FG001|Overall Study|Lost to Follow-up|2|||
129800190|NCT01822678|467236232|FG002|Overall Study|Lost to Follow-up|1|||
129800191|NCT00764504|467236233|FG000|Overall Study|Death|12|||
129800192|NCT00764504|467236234|FG001|Overall Study|Death|6|||
129800193|NCT00764504|467236235|FG002|Overall Study|Death|13|||
129800194|NCT00764504|467236233|FG000|Overall Study|Revision of Device|12|||
129800195|NCT00764504|467236234|FG001|Overall Study|Revision of Device|23|||
129800196|NCT00764504|467236235|FG002|Overall Study|Revision of Device|14|||
129800197|NCT00764504|467236233|FG000|Overall Study|Physician Decision|1|||
129800198|NCT00764504|467236234|FG001|Overall Study|Physician Decision|0|||
129800199|NCT00764504|467236235|FG002|Overall Study|Physician Decision|0|||
129800200|NCT00764504|467236233|FG000|Overall Study|Withdrawal by Subject|1|||
129800201|NCT00764504|467236234|FG001|Overall Study|Withdrawal by Subject|7|||
129984000|NCT03001076|467903827|FG000|Overall Study|Other|1|||
130318825|NCT05435339|469133822|FG000|Overall Study|Death|1|||
130318826|NCT05435339|469133823|FG001|Overall Study|Death|0|||
130318827|NCT05435339|469133824|FG002|Overall Study|Death|3|||
130318828|NCT05435339|469133825|FG003|Overall Study|Death|1|||
130318829|NCT05435339|469133826|FG004|Overall Study|Death|3|||
130318830|NCT05435339|469133827|FG005|Overall Study|Death|2|||
130318831|NCT05435339|469133828|FG006|Overall Study|Death|4|||
130318832|NCT05435339|469133829|FG007|Overall Study|Death|6|||
130318833|NCT05435339|469133822|FG000|Overall Study|Sponsor Decision|0|||
130318834|NCT05435339|469133823|FG001|Overall Study|Sponsor Decision|1|||
130318835|NCT05435339|469133824|FG002|Overall Study|Sponsor Decision|0|||
130318836|NCT05435339|469133825|FG003|Overall Study|Sponsor Decision|0|||
130318837|NCT05435339|469133826|FG004|Overall Study|Sponsor Decision|2|||
130318838|NCT05435339|469133827|FG005|Overall Study|Sponsor Decision|1|||
130318839|NCT05435339|469133828|FG006|Overall Study|Sponsor Decision|2|||
130318840|NCT05435339|469133829|FG007|Overall Study|Sponsor Decision|2|||
130318841|NCT05435339|469133822|FG000|Overall Study|Withdrawal by Subject|0|||
130318842|NCT05435339|469133823|FG001|Overall Study|Withdrawal by Subject|0|||
130318843|NCT05435339|469133824|FG002|Overall Study|Withdrawal by Subject|0|||
130318844|NCT05435339|469133825|FG003|Overall Study|Withdrawal by Subject|0|||
130318845|NCT05435339|469133826|FG004|Overall Study|Withdrawal by Subject|1|||
130318846|NCT05435339|469133827|FG005|Overall Study|Withdrawal by Subject|0|||
130318847|NCT05435339|469133828|FG006|Overall Study|Withdrawal by Subject|1|||
130318848|NCT05435339|469133829|FG007|Overall Study|Withdrawal by Subject|1|||
130318849|NCT03473236|469133834|FG000|Overall Study|Withdrawal by Subject|0|||
130318850|NCT03473236|469133835|FG001|Overall Study|Withdrawal by Subject|0|||
130318851|NCT03473236|469133836|FG002|Overall Study|Withdrawal by Subject|0|||
130318852|NCT03473236|469133837|FG003|Overall Study|Withdrawal by Subject|0|||
130318853|NCT03473236|469133838|FG004|Overall Study|Withdrawal by Subject|0|||
130318854|NCT03473236|469133839|FG005|Overall Study|Withdrawal by Subject|1|||
130318855|NCT03473236|469133840|FG006|Overall Study|Withdrawal by Subject|0|||
130318856|NCT03473236|469133841|FG007|Overall Study|Withdrawal by Subject|0|||
130318857|NCT03473236|469133842|FG008|Overall Study|Withdrawal by Subject|1|||
130318858|NCT03473236|469133843|FG009|Overall Study|Withdrawal by Subject|0|||
130318859|NCT03155724|469133844|FG000|Overall Study|Death|3|||
130318860|NCT03155724|469133844|FG000|Overall Study|Physician Decision|1|||
130318861|NCT03155724|469133844|FG000|Overall Study|Study closure|7|||
130318862|NCT00849940|469133845|FG000|Overall Study|Physician Decision|4|||
130318863|NCT01400698|469133847|FG000|Overall Study|Lost to Follow-up|2|||
130318864|NCT01400698|469133848|FG001|Overall Study|Lost to Follow-up|5|||
130318865|NCT01400698|469133849|FG002|Overall Study|Lost to Follow-up|2|||
130318866|NCT01400698|469133850|FG003|Overall Study|Lost to Follow-up|1|||
130318867|NCT01400698|469133851|FG004|Overall Study|Lost to Follow-up|4|||
130318868|NCT01400698|469133852|FG005|Overall Study|Lost to Follow-up|3|||
130318869|NCT01400698|469133847|FG000|Overall Study|Withdrawal by Subject|8|||
130318870|NCT01400698|469133848|FG001|Overall Study|Withdrawal by Subject|2|||
130318871|NCT01400698|469133849|FG002|Overall Study|Withdrawal by Subject|0|||
130318872|NCT01400698|469133850|FG003|Overall Study|Withdrawal by Subject|4|||
130318873|NCT01400698|469133851|FG004|Overall Study|Withdrawal by Subject|1|||
130318874|NCT01400698|469133852|FG005|Overall Study|Withdrawal by Subject|3|||
130318875|NCT01400698|469133847|FG000|Overall Study|Protocol Violation|0|||
130318876|NCT01400698|469133848|FG001|Overall Study|Protocol Violation|1|||
130318877|NCT01400698|469133849|FG002|Overall Study|Protocol Violation|0|||
130318878|NCT01400698|469133850|FG003|Overall Study|Protocol Violation|0|||
130318879|NCT01400698|469133851|FG004|Overall Study|Protocol Violation|1|||
130318880|NCT01400698|469133852|FG005|Overall Study|Protocol Violation|0|||
130318881|NCT01400698|469133847|FG000|Overall Study|Non-compliance|0|||
130318882|NCT01400698|469133848|FG001|Overall Study|Non-compliance|1|||
130318883|NCT01400698|469133849|FG002|Overall Study|Non-compliance|0|||
130318884|NCT01400698|469133850|FG003|Overall Study|Non-compliance|1|||
130318885|NCT01400698|469133851|FG004|Overall Study|Non-compliance|0|||
130318886|NCT01400698|469133852|FG005|Overall Study|Non-compliance|0|||
130318887|NCT01400698|469133847|FG000|Overall Study|Adverse Event|1|||
130318888|NCT01400698|469133848|FG001|Overall Study|Adverse Event|0|||
130318889|NCT01400698|469133849|FG002|Overall Study|Adverse Event|0|||
130318890|NCT01400698|469133850|FG003|Overall Study|Adverse Event|0|||
130318891|NCT01400698|469133851|FG004|Overall Study|Adverse Event|0|||
130318892|NCT01400698|469133852|FG005|Overall Study|Adverse Event|0|||
130318893|NCT01400698|469133847|FG000|Overall Study|Other|4|||
130318894|NCT01400698|469133848|FG001|Overall Study|Other|2|||
130318895|NCT01400698|469133849|FG002|Overall Study|Other|0|||
130318896|NCT01400698|469133850|FG003|Overall Study|Other|2|||
130318897|NCT01400698|469133851|FG004|Overall Study|Other|1|||
130318898|NCT01400698|469133852|FG005|Overall Study|Other|0|||
130318899|NCT02587520|469135329|FG000|Overall Study|Protocol Violation|2|||
130318900|NCT02587520|469135330|FG001|Overall Study|Protocol Violation|0|||
130318901|NCT02587520|469135331|FG002|Overall Study|Protocol Violation|0|||
130318902|NCT02587520|469135332|FG003|Overall Study|Protocol Violation|2|||
130318903|NCT02587520|469135333|FG004|Overall Study|Protocol Violation|0|||
130318904|NCT02587520|469135334|FG005|Overall Study|Protocol Violation|1|||
130207535|NCT02407054|468718984|FG000|Overall Study|Non-compliance with Study|0|||
130318905|NCT02587520|469135335|FG006|Overall Study|Protocol Violation|1|||
130318906|NCT02587520|469135336|FG007|Overall Study|Protocol Violation|1|||
130318907|NCT02587520|469135337|FG008|Overall Study|Protocol Violation|3|||
130318908|NCT02587520|469135338|FG009|Overall Study|Protocol Violation|3|||
130318909|NCT02587520|469135339|FG010|Overall Study|Protocol Violation|1|||
130318910|NCT02587520|469135340|FG011|Overall Study|Protocol Violation|2|||
130318911|NCT02587520|469135341|FG012|Overall Study|Protocol Violation|0|||
130318912|NCT02587520|469135342|FG013|Overall Study|Protocol Violation|0|||
130318913|NCT02587520|469135343|FG014|Overall Study|Protocol Violation|0|||
130318914|NCT02587520|469135344|FG015|Overall Study|Protocol Violation|0|||
130318915|NCT02587520|469135345|FG016|Overall Study|Protocol Violation|0|||
130318916|NCT02587520|469135346|FG017|Overall Study|Protocol Violation|0|||
130318917|NCT02587520|469135329|FG000|Overall Study|Adverse Event|0|||
130318918|NCT02587520|469135330|FG001|Overall Study|Adverse Event|0|||
130318919|NCT02587520|469135331|FG002|Overall Study|Adverse Event|0|||
130318920|NCT02587520|469135332|FG003|Overall Study|Adverse Event|0|||
130318921|NCT02587520|469135333|FG004|Overall Study|Adverse Event|0|||
130318922|NCT02587520|469135334|FG005|Overall Study|Adverse Event|0|||
130318923|NCT02587520|469135335|FG006|Overall Study|Adverse Event|0|||
130207536|NCT02407054|468718985|FG001|Overall Study|Non-compliance with Study|2|||
130207537|NCT02407054|468718986|FG002|Overall Study|Non-compliance with Study|1|||
130207538|NCT02407054|468718984|FG000|Overall Study|Physician Decision|1|||
130207539|NCT02407054|468718985|FG001|Overall Study|Physician Decision|3|||
130207540|NCT02407054|468718986|FG002|Overall Study|Physician Decision|3|||
130207541|NCT02407054|468718984|FG000|Overall Study|Withdrawal by Subject|5|||
130207542|NCT02407054|468718985|FG001|Overall Study|Withdrawal by Subject|9|||
130207543|NCT02407054|468718986|FG002|Overall Study|Withdrawal by Subject|2|||
130207544|NCT00131365|468718987|FG000|Overall Study|Withdrawal by Subject|1|||
130207545|NCT00131365|468718987|FG000|Overall Study|Alternative treatment|3|||
130207546|NCT04608344|468718988|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
130207547|NCT04608344|468718989|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
130207548|NCT04608344|468718988|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
130207549|NCT04608344|468718989|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
130207550|NCT02044874|468718990|FG000|Overall Study|Adverse Event|5|||
130207551|NCT02044874|468718991|FG001|Overall Study|Adverse Event|6|||
130207552|NCT02044874|468718992|FG002|Overall Study|Adverse Event|6|||
130207553|NCT02044874|468718990|FG000|Overall Study|Withdrawal by Subject|8|||
130207554|NCT02044874|468718991|FG001|Overall Study|Withdrawal by Subject|16|||
130207555|NCT02044874|468718992|FG002|Overall Study|Withdrawal by Subject|23|||
130207556|NCT02044874|468718990|FG000|Overall Study|Physician Decision|0|||
130207557|NCT02044874|468718991|FG001|Overall Study|Physician Decision|2|||
130207558|NCT02044874|468718992|FG002|Overall Study|Physician Decision|1|||
130207559|NCT02044874|468718990|FG000|Overall Study|Lost to Follow-up|10|||
130207560|NCT02044874|468718991|FG001|Overall Study|Lost to Follow-up|27|||
130207561|NCT02044874|468718992|FG002|Overall Study|Lost to Follow-up|21|||
130207562|NCT02044874|468718990|FG000|Overall Study|Sponsor Decision|0|||
130207563|NCT02044874|468718991|FG001|Overall Study|Sponsor Decision|1|||
130207564|NCT02044874|468718992|FG002|Overall Study|Sponsor Decision|1|||
130207565|NCT02044874|468718990|FG000|Overall Study|Other|7|||
130207566|NCT02044874|468718991|FG001|Overall Study|Other|3|||
130207567|NCT02044874|468718992|FG002|Overall Study|Other|8|||
130207568|NCT00415597|468718993|FG000|Enrollment|Withdrawal by Subject|1|||
130207569|NCT00415597|468718993|FG000|Enrollment|Protocol Violation|1|||
130207570|NCT00415597|468718993|FG000|Treatment|Adverse Event|110|||
130207571|NCT00415597|468718993|FG000|Treatment|Lack of Efficacy|39|||
130207572|NCT00415597|468718993|FG000|Treatment|Protocol Violation|67|||
130207573|NCT00415597|468718993|FG000|Treatment|Physician Decision|3|||
130207574|NCT00415597|468718993|FG000|Treatment|Withdrawal by Subject|51|||
130207575|NCT00415597|468718993|FG000|Treatment|Lost to Follow-up|28|||
130207576|NCT00415597|468718993|FG000|Treatment|Drug Screen|2|||
130207577|NCT00415597|468718993|FG000|Treatment|Administrative|3|||
130207578|NCT00415597|468718993|FG000|Treatment|Sponsor Decision|1|||
130207579|NCT00415597|468718993|FG000|Treatment|Multiple Reasons|1|||
130207580|NCT01447927|468718994|FG000|Overall Study|Adverse Event|4|||
130207581|NCT01447927|468718995|FG001|Overall Study|Adverse Event|3|||
130207582|NCT01447927|468718994|FG000|Overall Study|Withdrawal by Subject|1|||
130207583|NCT01447927|468718995|FG001|Overall Study|Withdrawal by Subject|0|||
130207584|NCT04102865|468718997|FG000|Overall Study|Adverse Event|4|||
130207585|NCT04102865|468718998|FG001|Overall Study|Adverse Event|0|||
130207586|NCT04102865|468718997|FG000|Overall Study|Lost to Follow-up|1|||
130207587|NCT04102865|468718998|FG001|Overall Study|Lost to Follow-up|0|||
130207588|NCT04102865|468718997|FG000|Overall Study|Withdrawal by Subject|2|||
130207589|NCT04102865|468718998|FG001|Overall Study|Withdrawal by Subject|0|||
130207590|NCT01764997|468718999|FG000|Run-in Period|Adverse Event|15|||
130207591|NCT01764997|468719000|FG001|Run-in Period|Adverse Event|0|||
130207592|NCT01764997|468719001|FG002|Run-in Period|Adverse Event|0|||
130207593|NCT01764997|468719002|FG003|Run-in Period|Adverse Event|0|||
130207594|NCT01764997|468719003|FG004|Run-in Period|Adverse Event|0|||
130318924|NCT02587520|469135336|FG007|Overall Study|Adverse Event|0|||
129872987|NCT00766675|467494090|FG000|Overall Study|Adverse Event|16|||
129872988|NCT00766675|467494090|FG000|Overall Study|Lost to Follow-up|2|||
129872989|NCT00766675|467494090|FG000|Overall Study|Withdrawal by Subject|11|||
129872990|NCT00766675|467494090|FG000|Overall Study|Protocol Violation|8|||
129872991|NCT00766675|467494090|FG000|Overall Study|Participant took prohibited medication|1|||
129872992|NCT00766675|467494090|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
129872993|NCT00766675|467494090|FG000|Overall Study|Insufficient therapy|1|||
129872994|NCT01984697|467494091|FG000|Overall Study|Adverse Event|0|||
129872995|NCT01984697|467494092|FG001|Overall Study|Adverse Event|0|||
129872996|NCT01984697|467494093|FG002|Overall Study|Adverse Event|2|||
129872997|NCT01984697|467494094|FG003|Overall Study|Adverse Event|0|||
129872998|NCT01984697|467494095|FG004|Overall Study|Adverse Event|0|||
129872999|NCT01984697|467494091|FG000|Overall Study|Lost to Follow-up|14|||
129873000|NCT01984697|467494092|FG001|Overall Study|Lost to Follow-up|5|||
129873001|NCT01984697|467494093|FG002|Overall Study|Lost to Follow-up|10|||
129873002|NCT01984697|467494094|FG003|Overall Study|Lost to Follow-up|6|||
129873003|NCT01984697|467494095|FG004|Overall Study|Lost to Follow-up|21|||
129873004|NCT01984697|467494091|FG000|Overall Study|Physician Decision|3|||
129873005|NCT01984697|467494092|FG001|Overall Study|Physician Decision|0|||
129873006|NCT01984697|467494093|FG002|Overall Study|Physician Decision|0|||
129873007|NCT01984697|467494094|FG003|Overall Study|Physician Decision|1|||
129873008|NCT01984697|467494095|FG004|Overall Study|Physician Decision|0|||
129873009|NCT01984697|467494091|FG000|Overall Study|Protocol Violation|8|||
129873010|NCT01984697|467494092|FG001|Overall Study|Protocol Violation|5|||
129873011|NCT01984697|467494093|FG002|Overall Study|Protocol Violation|3|||
129873012|NCT01984697|467494094|FG003|Overall Study|Protocol Violation|2|||
129873013|NCT01984697|467494095|FG004|Overall Study|Protocol Violation|0|||
129873014|NCT01984697|467494091|FG000|Overall Study|Withdrawal by Subject|15|||
129873015|NCT01984697|467494092|FG001|Overall Study|Withdrawal by Subject|21|||
129873016|NCT01984697|467494093|FG002|Overall Study|Withdrawal by Subject|13|||
129873017|NCT01984697|467494094|FG003|Overall Study|Withdrawal by Subject|11|||
129873018|NCT01984697|467494095|FG004|Overall Study|Withdrawal by Subject|13|||
129873019|NCT01984697|467494091|FG000|Overall Study|Missed last follow-up visit|1|||
129873020|NCT01984697|467494092|FG001|Overall Study|Missed last follow-up visit|0|||
129873021|NCT01984697|467494093|FG002|Overall Study|Missed last follow-up visit|0|||
129873022|NCT01984697|467494094|FG003|Overall Study|Missed last follow-up visit|0|||
129873023|NCT01984697|467494095|FG004|Overall Study|Missed last follow-up visit|0|||
129873024|NCT01984697|467494091|FG000|Overall Study|Death|0|||
129873025|NCT01984697|467494092|FG001|Overall Study|Death|0|||
129873026|NCT01984697|467494093|FG002|Overall Study|Death|0|||
129873027|NCT01984697|467494094|FG003|Overall Study|Death|1|||
129873028|NCT01984697|467494095|FG004|Overall Study|Death|0|||
129873029|NCT01984697|467494091|FG000|Overall Study|Pregnancy|2|||
129873030|NCT01984697|467494092|FG001|Overall Study|Pregnancy|0|||
129873031|NCT01984697|467494093|FG002|Overall Study|Pregnancy|1|||
129873032|NCT01984697|467494094|FG003|Overall Study|Pregnancy|0|||
129873033|NCT01984697|467494095|FG004|Overall Study|Pregnancy|1|||
129873034|NCT00847405|467494096|FG000|First Intervention|Adverse Event|0|||
129873035|NCT00847405|467494097|FG001|First Intervention|Adverse Event|1|||
129873036|NCT00847405|467494096|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129873037|NCT00847405|467494097|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129873038|NCT00949715|467494099|FG000|Overall Study|Physician Decision|1|||
129873039|NCT00949715|467494100|FG001|Overall Study|Physician Decision|0|||
129873040|NCT00949715|467494099|FG000|Overall Study|Lost to Follow-up|1|||
129873041|NCT00949715|467494100|FG001|Overall Study|Lost to Follow-up|0|||
129873042|NCT00949715|467494099|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
129873043|NCT00949715|467494100|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
129873044|NCT01352585|467494101|FG000|Overall Study|Adverse Event|2|||
129873045|NCT01352585|467494102|FG001|Overall Study|Adverse Event|1|||
129873046|NCT01352585|467494101|FG000|Overall Study|Lost to Follow-up|1|||
129873047|NCT01352585|467494102|FG001|Overall Study|Lost to Follow-up|0|||
129873048|NCT01352585|467494101|FG000|Overall Study|Other|5|||
129873049|NCT01352585|467494102|FG001|Overall Study|Other|2|||
129873050|NCT05050578|467494105|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
129873051|NCT05050578|467494106|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
129984001|NCT03001076|467903828|FG001|Overall Study|Other|0|||
129873052|NCT05050578|467494105|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
129873053|NCT05050578|467494106|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
129873054|NCT05050578|467494105|FG000|Period 2, 30 Days|Protocol Violation|0|||
129873055|NCT05050578|467494106|FG001|Period 2, 30 Days|Protocol Violation|1|||
129873056|NCT02243280|467494107|FG000|Treated|Adverse Event|1|||
129873057|NCT02243280|467494108|FG001|Treated|Adverse Event|0|||
129873058|NCT02243280|467494109|FG002|Treated|Adverse Event|0|||
129873059|NCT02243280|467494110|FG003|Treated|Adverse Event|0|||
129873060|NCT02243280|467494111|FG004|Treated|Adverse Event|0|||
129873061|NCT02243280|467494112|FG005|Treated|Adverse Event|0|||
129873062|NCT02243280|467494113|FG006|Treated|Adverse Event|0|||
129873063|NCT02243280|467494114|FG007|Treated|Adverse Event|0|||
129873064|NCT02243280|467494115|FG008|Treated|Adverse Event|0|||
129873065|NCT02243280|467494116|FG009|Treated|Adverse Event|0|||
129984002|NCT03001076|467903827|FG000|Overall Study|Adverse Event|3|||
129873066|NCT02243280|467494117|FG010|Treated|Adverse Event|1|||
129873067|NCT02243280|467494107|FG000|Treated|Lost to Follow-up|0|||
129873068|NCT02243280|467494108|FG001|Treated|Lost to Follow-up|0|||
129873069|NCT02243280|467494109|FG002|Treated|Lost to Follow-up|0|||
129873070|NCT02243280|467494110|FG003|Treated|Lost to Follow-up|0|||
129873071|NCT02243280|467494111|FG004|Treated|Lost to Follow-up|0|||
129873072|NCT02243280|467494112|FG005|Treated|Lost to Follow-up|0|||
129873073|NCT02243280|467494113|FG006|Treated|Lost to Follow-up|0|||
129873074|NCT02243280|467494114|FG007|Treated|Lost to Follow-up|0|||
129873075|NCT02243280|467494115|FG008|Treated|Lost to Follow-up|1|||
129873076|NCT02243280|467494116|FG009|Treated|Lost to Follow-up|0|||
129873077|NCT02243280|467494117|FG010|Treated|Lost to Follow-up|2|||
129873078|NCT03928028|467494124|FG000|Overall Study|Physician Decision|9|||
129873079|NCT03928028|467494125|FG001|Overall Study|Physician Decision|6|||
129873080|NCT03928028|467494126|FG002|Overall Study|Physician Decision|3|||
129873081|NCT03928028|467494124|FG000|Overall Study|Withdrawal by Subject|12|||
129873082|NCT03928028|467494125|FG001|Overall Study|Withdrawal by Subject|3|||
129873083|NCT03928028|467494126|FG002|Overall Study|Withdrawal by Subject|3|||
129873084|NCT02710292|467494127|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
129873085|NCT02710292|467494128|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
129873086|NCT02710292|467494127|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
129873087|NCT02710292|467494128|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
129873088|NCT04525547|467494129|FG000|Overall Study|Not treated with Ofev|2|||
129873089|NCT04525547|467494129|FG000|Overall Study|Off-label use|2|||
129873090|NCT04525547|467494129|FG000|Overall Study|Lost to Follow-up|1|||
129873091|NCT03122119|467494130|FG000|Overall Study|Did not meet eligibility critria|1|||
129873092|NCT00800202|467494131|FG000|Overall Study|Adverse Event|7|||
129873093|NCT00800202|467494132|FG001|Overall Study|Adverse Event|6|||
129873094|NCT00800202|467494131|FG000|Overall Study|Death|1|||
129873095|NCT00800202|467494132|FG001|Overall Study|Death|0|||
129873096|NCT00800202|467494131|FG000|Overall Study|Other|5|||
129873097|NCT00800202|467494132|FG001|Overall Study|Other|0|||
129873098|NCT00800202|467494131|FG000|Overall Study|Disease Progression|54|||
129873099|NCT00800202|467494132|FG001|Overall Study|Disease Progression|18|||
129873100|NCT04425902|467494133|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
129873101|NCT04669600|467494143|FG000|Overall Study|Withdrawal by Subject|1|||
129873102|NCT04669600|467494143|FG000|Overall Study|Other|6|||
129873103|NCT00710606|467494146|FG000|Overall Study|Adverse Event|0|||
129873104|NCT00710606|467494147|FG001|Overall Study|Adverse Event|2|||
129873105|NCT00514683|467494152|FG000|Overall Study|Not treated|2|||
129873106|NCT00514683|467494153|FG001|Overall Study|Not treated|1|||
129873107|NCT00514683|467494154|FG002|Overall Study|Not treated|0|||
129873108|NCT00514683|467494155|FG003|Overall Study|Not treated|0|||
129873109|NCT00514683|467494156|FG004|Overall Study|Not treated|1|||
129873110|NCT00514683|467494152|FG000|Overall Study|Adverse Event|21|||
129873111|NCT00514683|467494153|FG001|Overall Study|Adverse Event|20|||
129873112|NCT00514683|467494154|FG002|Overall Study|Adverse Event|15|||
129873113|NCT00514683|467494155|FG003|Overall Study|Adverse Event|13|||
129873114|NCT00514683|467494156|FG004|Overall Study|Adverse Event|27|||
129873115|NCT00514683|467494152|FG000|Overall Study|Protocol Violation|1|||
129873116|NCT00514683|467494153|FG001|Overall Study|Protocol Violation|1|||
129873117|NCT00514683|467494154|FG002|Overall Study|Protocol Violation|0|||
129873118|NCT00514683|467494155|FG003|Overall Study|Protocol Violation|1|||
129873119|NCT00514683|467494156|FG004|Overall Study|Protocol Violation|0|||
129873120|NCT00514683|467494152|FG000|Overall Study|Withdrawal by Subject|2|||
129873121|NCT00514683|467494153|FG001|Overall Study|Withdrawal by Subject|2|||
129873122|NCT00514683|467494154|FG002|Overall Study|Withdrawal by Subject|1|||
129873123|NCT00514683|467494155|FG003|Overall Study|Withdrawal by Subject|0|||
129873124|NCT00514683|467494156|FG004|Overall Study|Withdrawal by Subject|4|||
129873125|NCT00514683|467494152|FG000|Overall Study|Reason other than listed above|0|||
129873126|NCT00514683|467494153|FG001|Overall Study|Reason other than listed above|1|||
129873127|NCT00514683|467494154|FG002|Overall Study|Reason other than listed above|2|||
129873128|NCT00514683|467494155|FG003|Overall Study|Reason other than listed above|0|||
129873129|NCT00514683|467494156|FG004|Overall Study|Reason other than listed above|1|||
129873130|NCT00335452|467494157|FG000|Overall Study|Death|156|||
129873131|NCT00335452|467494158|FG001|Overall Study|Death|144|||
129873132|NCT00335452|467494159|FG002|Overall Study|Death|158|||
129873133|NCT00335452|467494160|FG003|Overall Study|Death|129|||
129873134|NCT00335452|467494157|FG000|Overall Study|Lost to Follow-up|2|||
129873135|NCT00335452|467494158|FG001|Overall Study|Lost to Follow-up|3|||
129873136|NCT00335452|467494159|FG002|Overall Study|Lost to Follow-up|1|||
130095168|NCT00198107|468305433|FG000|Double-Blind Period|Lost to Follow-up|2|||
129873137|NCT00335452|467494160|FG003|Overall Study|Lost to Follow-up|2|||
129873138|NCT02736825|467494162|FG000|Overall Study|Lost to Follow-up|10|||
129873139|NCT02736825|467494163|FG001|Overall Study|Lost to Follow-up|11|||
129873140|NCT02736825|467494162|FG000|Overall Study|Early Termination|0|||
129873141|NCT02736825|467494163|FG001|Overall Study|Early Termination|1|||
129873142|NCT01564368|467494172|FG000|Overall Study|Ineligible|18|||
129873143|NCT01564368|467494172|FG000|Overall Study|Not Randomized in Parent study|116|||
129873144|NCT01564368|467494172|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
129873145|NCT01564368|467494172|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
129873146|NCT02901626|467494173|FG000|Overall Study|Lost to Follow-up|1|||
129873147|NCT02901626|467494174|FG001|Overall Study|Lost to Follow-up|1|||
129873148|NCT00331344|467494175|FG000|Phase I|Adverse Event|0|||
129873149|NCT00331344|467494176|FG001|Phase I|Adverse Event|0|||
129873150|NCT00331344|467494177|FG002|Phase I|Adverse Event|0|||
129873151|NCT00331344|467494178|FG003|Phase I|Adverse Event|1|||
129873152|NCT00331344|467494179|FG004|Phase I|Adverse Event|2|||
129873153|NCT00331344|467494180|FG005|Phase I|Adverse Event|2|||
129873154|NCT00331344|467494181|FG006|Phase I|Adverse Event|0|||
129873155|NCT00331344|467494182|FG007|Phase I|Adverse Event|1|||
129873156|NCT00331344|467494183|FG008|Phase I|Adverse Event|0|||
129873157|NCT00331344|467494175|FG000|Phase II|Death|0|||
129873158|NCT00331344|467494176|FG001|Phase II|Death|0|||
129873159|NCT00331344|467494177|FG002|Phase II|Death|0|||
129873160|NCT00331344|467494178|FG003|Phase II|Death|0|||
129873161|NCT00331344|467494179|FG004|Phase II|Death|0|||
129873162|NCT00331344|467494180|FG005|Phase II|Death|0|||
129873163|NCT00331344|467494181|FG006|Phase II|Death|0|||
129873164|NCT00331344|467494182|FG007|Phase II|Death|0|||
129873165|NCT00331344|467494183|FG008|Phase II|Death|4|||
129873166|NCT01373931|467494184|FG000|Lead-in Period|Adverse Event|2|||
129873167|NCT01373931|467494185|FG001|Lead-in Period|Adverse Event|0|||
129873168|NCT01373931|467494184|FG000|Period 1|Adverse Event|2|||
129873169|NCT01373931|467494185|FG001|Period 1|Adverse Event|0|||
129873170|NCT01373931|467494184|FG000|Period 1|Withdrawal by Subject|0|||
129873171|NCT01373931|467494185|FG001|Period 1|Withdrawal by Subject|2|||
130207595|NCT01764997|468718999|FG000|Run-in Period|Lack of Efficacy|5|||
130207596|NCT01764997|468719000|FG001|Run-in Period|Lack of Efficacy|0|||
130207597|NCT01764997|468719001|FG002|Run-in Period|Lack of Efficacy|0|||
130207598|NCT01764997|468719002|FG003|Run-in Period|Lack of Efficacy|0|||
130207599|NCT01764997|468719003|FG004|Run-in Period|Lack of Efficacy|0|||
130207600|NCT01764997|468718999|FG000|Run-in Period|Poor compliance to protocol|1|||
130207601|NCT01764997|468719000|FG001|Run-in Period|Poor compliance to protocol|0|||
130207602|NCT01764997|468719001|FG002|Run-in Period|Poor compliance to protocol|0|||
130207603|NCT01764997|468719002|FG003|Run-in Period|Poor compliance to protocol|0|||
130207604|NCT01764997|468719003|FG004|Run-in Period|Poor compliance to protocol|0|||
130207605|NCT01764997|468718999|FG000|Run-in Period|Other than specified above|17|||
130207606|NCT01764997|468719000|FG001|Run-in Period|Other than specified above|0|||
130207607|NCT01764997|468719001|FG002|Run-in Period|Other than specified above|0|||
130207608|NCT01764997|468719002|FG003|Run-in Period|Other than specified above|0|||
130207609|NCT01764997|468719003|FG004|Run-in Period|Other than specified above|0|||
130207610|NCT01764997|468718999|FG000|Study Drug Treatment Period|Adverse Event|0|||
130207611|NCT01764997|468719000|FG001|Study Drug Treatment Period|Adverse Event|1|||
130207612|NCT01764997|468719001|FG002|Study Drug Treatment Period|Adverse Event|0|||
130207613|NCT01764997|468719002|FG003|Study Drug Treatment Period|Adverse Event|0|||
130207614|NCT01764997|468719003|FG004|Study Drug Treatment Period|Adverse Event|24|||
130207615|NCT01764997|468718999|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
130318925|NCT02587520|469135337|FG008|Overall Study|Adverse Event|0|||
130318926|NCT02587520|469135338|FG009|Overall Study|Adverse Event|0|||
130318927|NCT02587520|469135339|FG010|Overall Study|Adverse Event|0|||
130318928|NCT02587520|469135340|FG011|Overall Study|Adverse Event|1|||
130318929|NCT02587520|469135341|FG012|Overall Study|Adverse Event|0|||
130318930|NCT02587520|469135342|FG013|Overall Study|Adverse Event|0|||
130318931|NCT02587520|469135343|FG014|Overall Study|Adverse Event|0|||
130318932|NCT02587520|469135344|FG015|Overall Study|Adverse Event|0|||
130318933|NCT02587520|469135345|FG016|Overall Study|Adverse Event|0|||
130318934|NCT02587520|469135346|FG017|Overall Study|Adverse Event|0|||
130318935|NCT02587520|469135329|FG000|Overall Study|Withdrawal by Subject|0|||
130318936|NCT02587520|469135330|FG001|Overall Study|Withdrawal by Subject|0|||
130318937|NCT02587520|469135331|FG002|Overall Study|Withdrawal by Subject|1|||
130318938|NCT02587520|469135332|FG003|Overall Study|Withdrawal by Subject|1|||
130318939|NCT02587520|469135333|FG004|Overall Study|Withdrawal by Subject|0|||
130318940|NCT02587520|469135334|FG005|Overall Study|Withdrawal by Subject|1|||
129984003|NCT03001076|467903828|FG001|Overall Study|Adverse Event|3|||
129984004|NCT03001076|467903827|FG000|Overall Study|Sponsor decision|1|||
130095169|NCT00198107|468305434|FG001|Double-Blind Period|Lost to Follow-up|1|||
130207616|NCT01764997|468719000|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
130207617|NCT01764997|468719001|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
130207618|NCT01764997|468719002|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
130318941|NCT02587520|469135335|FG006|Overall Study|Withdrawal by Subject|1|||
130318942|NCT02587520|469135336|FG007|Overall Study|Withdrawal by Subject|0|||
130318943|NCT02587520|469135337|FG008|Overall Study|Withdrawal by Subject|0|||
130318944|NCT02587520|469135338|FG009|Overall Study|Withdrawal by Subject|0|||
129873172|NCT04857034|467494186|FG000|Placebo-Controlled Period|Request to discontinue|2|||
129873173|NCT04857034|467494187|FG001|Placebo-Controlled Period|Request to discontinue|2|||
129873174|NCT04857034|467494188|FG002|Placebo-Controlled Period|Request to discontinue|0|||
129873175|NCT04857034|467494189|FG003|Placebo-Controlled Period|Request to discontinue|0|||
129873176|NCT04857034|467494190|FG004|Placebo-Controlled Period|Request to discontinue|0|||
129873177|NCT04857034|467494186|FG000|Placebo-Controlled Period|withdrew consent|1|||
130318945|NCT02587520|469135339|FG010|Overall Study|Withdrawal by Subject|0|||
130318946|NCT02587520|469135340|FG011|Overall Study|Withdrawal by Subject|0|||
130318947|NCT02587520|469135341|FG012|Overall Study|Withdrawal by Subject|0|||
130318948|NCT02587520|469135342|FG013|Overall Study|Withdrawal by Subject|1|||
130318949|NCT02587520|469135343|FG014|Overall Study|Withdrawal by Subject|0|||
130318950|NCT02587520|469135344|FG015|Overall Study|Withdrawal by Subject|0|||
130318951|NCT02587520|469135345|FG016|Overall Study|Withdrawal by Subject|0|||
130318952|NCT02587520|469135346|FG017|Overall Study|Withdrawal by Subject|0|||
130318953|NCT02587520|469135329|FG000|Overall Study|Lost to Follow-up|0|||
129873178|NCT04857034|467494187|FG001|Placebo-Controlled Period|withdrew consent|1|||
129873179|NCT04857034|467494188|FG002|Placebo-Controlled Period|withdrew consent|2|||
129873180|NCT04857034|467494189|FG003|Placebo-Controlled Period|withdrew consent|0|||
129873181|NCT04857034|467494190|FG004|Placebo-Controlled Period|withdrew consent|0|||
129873182|NCT04857034|467494186|FG000|Placebo-Controlled Period|Pregnancy|1|||
129873183|NCT04857034|467494187|FG001|Placebo-Controlled Period|Pregnancy|1|||
129984005|NCT03001076|467903828|FG001|Overall Study|Sponsor decision|0|||
129984006|NCT03001076|467903827|FG000|Overall Study|Lost to Follow-up|0|||
129984007|NCT03001076|467903828|FG001|Overall Study|Lost to Follow-up|2|||
129984008|NCT00948766|467903829|FG000|Core Study|Adverse Event|73|||
129984009|NCT00948766|467903830|FG001|Core Study|Adverse Event|51|||
129984010|NCT00948766|467903829|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
129984011|NCT00948766|467903830|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
129984012|NCT00948766|467903829|FG000|Core Study|Patient Withdrew Consent|27|||
129984013|NCT00948766|467903830|FG001|Core Study|Patient Withdrew Consent|46|||
129984014|NCT00948766|467903829|FG000|Core Study|Lost to Follow-up|3|||
129984015|NCT00948766|467903830|FG001|Core Study|Lost to Follow-up|2|||
129984016|NCT00948766|467903829|FG000|Core Study|Administrative Problems|2|||
129984017|NCT00948766|467903830|FG001|Core Study|Administrative Problems|2|||
129984018|NCT00948766|467903829|FG000|Core Study|Death|1|||
129984019|NCT00948766|467903830|FG001|Core Study|Death|1|||
129984020|NCT00948766|467903829|FG000|Core Study|Protocol Deviation|8|||
129984021|NCT00948766|467903830|FG001|Core Study|Protocol Deviation|10|||
129984022|NCT00948766|467903829|FG000|Extension Study|Adverse Event|43|||
129984023|NCT00948766|467903830|FG001|Extension Study|Adverse Event|0|||
129984024|NCT00948766|467903829|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
129984025|NCT00948766|467903830|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
129984026|NCT00948766|467903829|FG000|Extension Study|Study Drug No Longer Required|1|||
129984027|NCT00948766|467903830|FG001|Extension Study|Study Drug No Longer Required|0|||
129984028|NCT00948766|467903829|FG000|Extension Study|Patient Withdrew Consent|32|||
129984029|NCT00948766|467903830|FG001|Extension Study|Patient Withdrew Consent|0|||
129984030|NCT00948766|467903829|FG000|Extension Study|Lost to Follow-up|8|||
129984031|NCT00948766|467903830|FG001|Extension Study|Lost to Follow-up|0|||
129984032|NCT00948766|467903829|FG000|Extension Study|Administrative Problems|1|||
129984033|NCT00948766|467903830|FG001|Extension Study|Administrative Problems|0|||
129984034|NCT00948766|467903829|FG000|Extension Study|Death|4|||
129984035|NCT00948766|467903830|FG001|Extension Study|Death|0|||
129984036|NCT03189745|467903834|FG000|Overall Study|Conflict in work schedule of participant|1|||
129984037|NCT03189745|467903835|FG001|Overall Study|Conflict in work schedule of participant|1|||
129984038|NCT02729831|467903836|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
129984039|NCT02729831|467903837|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
129984040|NCT02729831|467903838|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
129984041|NCT02729831|467903839|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
129984042|NCT02729831|467903836|FG000|1 Week Post-visit|Lost to Follow-up|43|||
129984043|NCT02729831|467903837|FG001|1 Week Post-visit|Lost to Follow-up|40|||
129984044|NCT02729831|467903838|FG002|1 Week Post-visit|Lost to Follow-up|38|||
129984045|NCT02729831|467903839|FG003|1 Week Post-visit|Lost to Follow-up|36|||
129984046|NCT02729831|467903836|FG000|6 Month Follow-up|Lost to Follow-up|54|||
129984047|NCT02729831|467903837|FG001|6 Month Follow-up|Lost to Follow-up|51|||
129984048|NCT02729831|467903838|FG002|6 Month Follow-up|Lost to Follow-up|48|||
130318954|NCT02587520|469135330|FG001|Overall Study|Lost to Follow-up|2|||
130318955|NCT02587520|469135331|FG002|Overall Study|Lost to Follow-up|0|||
130318956|NCT02587520|469135332|FG003|Overall Study|Lost to Follow-up|2|||
130318957|NCT02587520|469135333|FG004|Overall Study|Lost to Follow-up|0|||
130318958|NCT02587520|469135334|FG005|Overall Study|Lost to Follow-up|1|||
130318959|NCT02587520|469135335|FG006|Overall Study|Lost to Follow-up|1|||
130318960|NCT02587520|469135336|FG007|Overall Study|Lost to Follow-up|1|||
130318961|NCT02587520|469135337|FG008|Overall Study|Lost to Follow-up|0|||
130318962|NCT02587520|469135338|FG009|Overall Study|Lost to Follow-up|2|||
129873184|NCT04857034|467494188|FG002|Placebo-Controlled Period|Pregnancy|0|||
129873185|NCT04857034|467494189|FG003|Placebo-Controlled Period|Pregnancy|0|||
129984049|NCT02729831|467903839|FG003|6 Month Follow-up|Lost to Follow-up|42|||
129984050|NCT02729831|467903836|FG000|6 Month Follow-up|Death|1|||
129984051|NCT02729831|467903837|FG001|6 Month Follow-up|Death|3|||
129984052|NCT02729831|467903838|FG002|6 Month Follow-up|Death|0|||
129984053|NCT02729831|467903839|FG003|6 Month Follow-up|Death|1|||
129984054|NCT01373151|467903840|FG000|Period 1|Lack of Efficacy|3|||
129984055|NCT01373151|467903841|FG001|Period 1|Lack of Efficacy|0|||
129984056|NCT01373151|467903842|FG002|Period 1|Lack of Efficacy|0|||
129984057|NCT01373151|467903843|FG003|Period 1|Lack of Efficacy|0|||
129984058|NCT01373151|467903844|FG004|Period 1|Lack of Efficacy|1|||
129984059|NCT01373151|467903845|FG005|Period 1|Lack of Efficacy|0|||
129984060|NCT01373151|467903846|FG006|Period 1|Lack of Efficacy|0|||
130318963|NCT02587520|469135339|FG010|Overall Study|Lost to Follow-up|2|||
130318964|NCT02587520|469135340|FG011|Overall Study|Lost to Follow-up|1|||
130318965|NCT02587520|469135341|FG012|Overall Study|Lost to Follow-up|0|||
130318966|NCT02587520|469135342|FG013|Overall Study|Lost to Follow-up|0|||
130318967|NCT02587520|469135343|FG014|Overall Study|Lost to Follow-up|0|||
130318968|NCT02587520|469135344|FG015|Overall Study|Lost to Follow-up|0|||
130318969|NCT02587520|469135345|FG016|Overall Study|Lost to Follow-up|0|||
129873186|NCT04857034|467494190|FG004|Placebo-Controlled Period|Pregnancy|0|||
129873187|NCT04857034|467494186|FG000|Placebo-Controlled Period|Ongoing study period|0|||
129873188|NCT04857034|467494187|FG001|Placebo-Controlled Period|Ongoing study period|1|||
129873189|NCT04857034|467494188|FG002|Placebo-Controlled Period|Ongoing study period|0|||
129873190|NCT04857034|467494189|FG003|Placebo-Controlled Period|Ongoing study period|0|||
129873191|NCT04857034|467494190|FG004|Placebo-Controlled Period|Ongoing study period|0|||
129873192|NCT04857034|467494186|FG000|Active Treatment Period|Lack of Efficacy|1|||
129873193|NCT04857034|467494187|FG001|Active Treatment Period|Lack of Efficacy|0|||
129873194|NCT04857034|467494188|FG002|Active Treatment Period|Lack of Efficacy|0|||
129873195|NCT04857034|467494189|FG003|Active Treatment Period|Lack of Efficacy|0|||
129873196|NCT04857034|467494190|FG004|Active Treatment Period|Lack of Efficacy|0|||
129873197|NCT04857034|467494186|FG000|Active Treatment Period|request to discontinue|0|||
129873198|NCT04857034|467494187|FG001|Active Treatment Period|request to discontinue|1|||
129873199|NCT04857034|467494188|FG002|Active Treatment Period|request to discontinue|0|||
129873200|NCT04857034|467494189|FG003|Active Treatment Period|request to discontinue|1|||
129873201|NCT04857034|467494190|FG004|Active Treatment Period|request to discontinue|0|||
129873202|NCT04857034|467494186|FG000|Active Treatment Period|administrative reason by sponsor|1|||
129873203|NCT04857034|467494187|FG001|Active Treatment Period|administrative reason by sponsor|5|||
129873204|NCT04857034|467494188|FG002|Active Treatment Period|administrative reason by sponsor|0|||
129873205|NCT04857034|467494189|FG003|Active Treatment Period|administrative reason by sponsor|2|||
129873206|NCT04857034|467494190|FG004|Active Treatment Period|administrative reason by sponsor|2|||
129873207|NCT04857034|467494186|FG000|Active Treatment Period|other reasons|1|||
129873208|NCT04857034|467494187|FG001|Active Treatment Period|other reasons|1|||
129873209|NCT04857034|467494188|FG002|Active Treatment Period|other reasons|0|||
129873210|NCT04857034|467494189|FG003|Active Treatment Period|other reasons|0|||
129873211|NCT04857034|467494190|FG004|Active Treatment Period|other reasons|1|||
129873212|NCT04857034|467494186|FG000|Active Treatment Period|Ongoing Study Period|2|||
129873213|NCT04857034|467494187|FG001|Active Treatment Period|Ongoing Study Period|4|||
129873214|NCT04857034|467494188|FG002|Active Treatment Period|Ongoing Study Period|0|||
129873215|NCT04857034|467494189|FG003|Active Treatment Period|Ongoing Study Period|1|||
129873216|NCT04857034|467494190|FG004|Active Treatment Period|Ongoing Study Period|0|||
129873217|NCT00659490|467494191|FG000|Overall Study|Lost to Follow-up|2|||
129873218|NCT00659490|467494192|FG001|Overall Study|Lost to Follow-up|0|||
129873219|NCT00659490|467494193|FG002|Overall Study|Lost to Follow-up|1|||
129873220|NCT05674890|467494198|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
129873221|NCT05674890|467494199|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
129873222|NCT05674890|467494198|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
129873223|NCT05674890|467494199|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
129873224|NCT05674890|467494198|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
129873225|NCT05674890|467494199|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
129873226|NCT00827541|467494200|FG000|Overall Study|Exitus|1|||
129873227|NCT00827541|467494201|FG001|Overall Study|Exitus|8|||
129873228|NCT00827541|467494200|FG000|Overall Study|Other|1|||
129873229|NCT00827541|467494201|FG001|Overall Study|Other|3|||
129873230|NCT00827541|467494200|FG000|Overall Study|Pathogen not susceptible|1|||
129984061|NCT01373151|467903840|FG000|Period 1|Adverse Event|0|||
129984062|NCT01373151|467903841|FG001|Period 1|Adverse Event|0|||
130318970|NCT02587520|469135346|FG017|Overall Study|Lost to Follow-up|0|||
130318971|NCT03924622|469135347|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
130318972|NCT03924622|469135348|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318973|NCT03924622|469135349|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318974|NCT03924622|469135350|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
130318975|NCT03924622|469135351|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318976|NCT03924622|469135352|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
130318977|NCT02412306|469135354|FG000|Overall Study|Lost to Follow-up|0|||
130318978|NCT02412306|469135355|FG001|Overall Study|Lost to Follow-up|1|||
130318979|NCT02412306|469135356|FG002|Overall Study|Lost to Follow-up|0|||
130318980|NCT02412306|469135357|FG003|Overall Study|Lost to Follow-up|0|||
130318981|NCT02412306|469135358|FG004|Overall Study|Lost to Follow-up|0|||
130318982|NCT02412306|469135354|FG000|Overall Study|Withdrawal by Subject|0|||
130318983|NCT02412306|469135355|FG001|Overall Study|Withdrawal by Subject|0|||
130318984|NCT02412306|469135356|FG002|Overall Study|Withdrawal by Subject|1|||
130318985|NCT02412306|469135357|FG003|Overall Study|Withdrawal by Subject|0|||
130318986|NCT02412306|469135358|FG004|Overall Study|Withdrawal by Subject|0|||
130318987|NCT02412306|469135354|FG000|Overall Study|Death|5|||
130318988|NCT02412306|469135355|FG001|Overall Study|Death|7|||
130318989|NCT02412306|469135356|FG002|Overall Study|Death|15|||
129984063|NCT01373151|467903842|FG002|Period 1|Adverse Event|1|||
129984064|NCT01373151|467903843|FG003|Period 1|Adverse Event|0|||
129984065|NCT01373151|467903844|FG004|Period 1|Adverse Event|4|||
129984066|NCT01373151|467903845|FG005|Period 1|Adverse Event|3|||
129984067|NCT01373151|467903846|FG006|Period 1|Adverse Event|0|||
129984068|NCT01373151|467903840|FG000|Period 1|Withdrawal by Subject|2|||
129984069|NCT01373151|467903841|FG001|Period 1|Withdrawal by Subject|0|||
129984070|NCT01373151|467903842|FG002|Period 1|Withdrawal by Subject|3|||
129984071|NCT01373151|467903843|FG003|Period 1|Withdrawal by Subject|1|||
129984072|NCT01373151|467903844|FG004|Period 1|Withdrawal by Subject|0|||
129984073|NCT01373151|467903845|FG005|Period 1|Withdrawal by Subject|1|||
129984074|NCT01373151|467903846|FG006|Period 1|Withdrawal by Subject|0|||
129984075|NCT01373151|467903840|FG000|Period 2|Lack of Efficacy|9|||
129984076|NCT01373151|467903841|FG001|Period 2|Lack of Efficacy|0|||
129984077|NCT01373151|467903842|FG002|Period 2|Lack of Efficacy|0|||
129984078|NCT01373151|467903843|FG003|Period 2|Lack of Efficacy|1|||
129984079|NCT01373151|467903844|FG004|Period 2|Lack of Efficacy|2|||
129984080|NCT01373151|467903845|FG005|Period 2|Lack of Efficacy|0|||
129984081|NCT01373151|467903846|FG006|Period 2|Lack of Efficacy|3|||
129984082|NCT01373151|467903840|FG000|Period 2|Adverse Event|0|||
129984083|NCT01373151|467903841|FG001|Period 2|Adverse Event|0|||
129984084|NCT01373151|467903842|FG002|Period 2|Adverse Event|3|||
129984085|NCT01373151|467903843|FG003|Period 2|Adverse Event|3|||
129984086|NCT01373151|467903844|FG004|Period 2|Adverse Event|0|||
129984087|NCT01373151|467903845|FG005|Period 2|Adverse Event|0|||
129984088|NCT01373151|467903846|FG006|Period 2|Adverse Event|1|||
129984089|NCT01373151|467903840|FG000|Period 2|subject request to discontinue|0|||
129984090|NCT01373151|467903841|FG001|Period 2|subject request to discontinue|1|||
129984091|NCT01373151|467903842|FG002|Period 2|subject request to discontinue|0|||
129984092|NCT01373151|467903843|FG003|Period 2|subject request to discontinue|0|||
129984093|NCT01373151|467903844|FG004|Period 2|subject request to discontinue|0|||
129984094|NCT01373151|467903845|FG005|Period 2|subject request to discontinue|0|||
129984095|NCT01373151|467903846|FG006|Period 2|subject request to discontinue|0|||
129984096|NCT01373151|467903840|FG000|Period 2|Withdrawal by Subject|0|||
129984097|NCT01373151|467903841|FG001|Period 2|Withdrawal by Subject|0|||
129984098|NCT01373151|467903842|FG002|Period 2|Withdrawal by Subject|0|||
129984099|NCT01373151|467903843|FG003|Period 2|Withdrawal by Subject|1|||
129984100|NCT01373151|467903844|FG004|Period 2|Withdrawal by Subject|0|||
129984101|NCT01373151|467903845|FG005|Period 2|Withdrawal by Subject|0|||
129984102|NCT01373151|467903846|FG006|Period 2|Withdrawal by Subject|0|||
129984103|NCT01373151|467903840|FG000|Period 2|Other|0|||
129984104|NCT01373151|467903841|FG001|Period 2|Other|0|||
129984105|NCT01373151|467903842|FG002|Period 2|Other|1|||
129984106|NCT01373151|467903843|FG003|Period 2|Other|0|||
129984107|NCT01373151|467903844|FG004|Period 2|Other|0|||
129984108|NCT01373151|467903845|FG005|Period 2|Other|0|||
129984109|NCT01373151|467903846|FG006|Period 2|Other|1|||
129984110|NCT03117998|467903847|FG000|Overall Study|Adverse Event|1|||
129984111|NCT03117998|467903848|FG001|Overall Study|Adverse Event|0|||
129984112|NCT03117998|467903849|FG002|Overall Study|Adverse Event|0|||
129984113|NCT03117998|467903850|FG003|Overall Study|Adverse Event|0|||
130318990|NCT02412306|469135357|FG003|Overall Study|Death|0|||
129984114|NCT03117998|467903851|FG004|Overall Study|Adverse Event|0|||
130095170|NCT00198107|468305435|FG002|Double-Blind Period|Lost to Follow-up|0|||
130318991|NCT02412306|469135358|FG004|Overall Study|Death|2|||
130318992|NCT05543265|469135366|FG000|Overall Study|Lost to Follow-up|3|||
130318993|NCT05543265|469135367|FG001|Overall Study|Lost to Follow-up|3|||
129984115|NCT03117998|467903852|FG005|Overall Study|Adverse Event|0|||
129984116|NCT03117998|467903847|FG000|Overall Study|Withdrawal by Subject|0|||
129984117|NCT03117998|467903848|FG001|Overall Study|Withdrawal by Subject|0|||
129984118|NCT03117998|467903849|FG002|Overall Study|Withdrawal by Subject|2|||
129984119|NCT03117998|467903850|FG003|Overall Study|Withdrawal by Subject|3|||
129984120|NCT03117998|467903851|FG004|Overall Study|Withdrawal by Subject|3|||
129984121|NCT03117998|467903852|FG005|Overall Study|Withdrawal by Subject|0|||
129984122|NCT03117998|467903847|FG000|Overall Study|Physician Decision|0|||
129984123|NCT03117998|467903848|FG001|Overall Study|Physician Decision|1|||
129984124|NCT03117998|467903849|FG002|Overall Study|Physician Decision|1|||
129984125|NCT03117998|467903850|FG003|Overall Study|Physician Decision|0|||
129984126|NCT03117998|467903851|FG004|Overall Study|Physician Decision|0|||
129984127|NCT03117998|467903852|FG005|Overall Study|Physician Decision|0|||
129984128|NCT03117998|467903847|FG000|Overall Study|Lost to Follow-up|0|||
129984129|NCT03117998|467903848|FG001|Overall Study|Lost to Follow-up|0|||
129984130|NCT03117998|467903849|FG002|Overall Study|Lost to Follow-up|0|||
130318994|NCT05543265|469135366|FG000|Overall Study|Withdrawal by Subject|0|||
130318995|NCT05543265|469135367|FG001|Overall Study|Withdrawal by Subject|1|||
130318996|NCT05316597|469135368|FG000|First Session|Withdrawal by Subject|0|||
130318997|NCT05316597|469135369|FG001|First Session|Withdrawal by Subject|1|||
130318998|NCT05316597|469135368|FG000|Washout Period|Lost to Follow-up|1|||
130318999|NCT05316597|469135369|FG001|Washout Period|Lost to Follow-up|2|||
130319000|NCT05316597|469135368|FG000|Washout Period|Physician Decision|1|||
130319001|NCT05316597|469135369|FG001|Washout Period|Physician Decision|1|||
130319002|NCT05316597|469135368|FG000|Washout Period|Excluded before second session|1|||
130319003|NCT05316597|469135369|FG001|Washout Period|Excluded before second session|1|||
130319004|NCT05316597|469135368|FG000|Washout Period|Withdrawal by Subject|0|||
130319005|NCT05316597|469135369|FG001|Washout Period|Withdrawal by Subject|4|||
130319006|NCT05526716|469135370|FG000|Overall Study|Death|1|||
129873231|NCT00827541|467494201|FG001|Overall Study|Pathogen not susceptible|0|||
129873232|NCT00827541|467494200|FG000|Overall Study|Lack of effectiveness|1|||
129873233|NCT00827541|467494201|FG001|Overall Study|Lack of effectiveness|0|||
129873234|NCT01649232|467494202|FG000|Overall Study|Physician Decision|2|||
129873235|NCT01649232|467494203|FG001|Overall Study|Physician Decision|0|||
129873236|NCT02228967|467494204|FG000|Overall Study|Lost to Follow-up|146|||
129873237|NCT02228967|467494205|FG001|Overall Study|Lost to Follow-up|142|||
129873238|NCT02228967|467494204|FG000|Overall Study|Withdrawal by Subject|13|||
129873239|NCT02228967|467494205|FG001|Overall Study|Withdrawal by Subject|18|||
129873240|NCT00520975|467494206|FG000|Overall Study|Disease progression|31|||
129873241|NCT00520975|467494207|FG001|Overall Study|Disease progression|23|||
129873242|NCT00520975|467494206|FG000|Overall Study|Adverse Event|7|||
129873243|NCT00520975|467494207|FG001|Overall Study|Adverse Event|10|||
129873244|NCT00520975|467494206|FG000|Overall Study|Death|0|||
129873245|NCT00520975|467494207|FG001|Overall Study|Death|2|||
129873246|NCT00520975|467494206|FG000|Overall Study|Withdrawal by Subject|3|||
129873247|NCT00520975|467494207|FG001|Overall Study|Withdrawal by Subject|5|||
129873248|NCT00520975|467494206|FG000|Overall Study|Other therapy|2|||
129873249|NCT00520975|467494207|FG001|Overall Study|Other therapy|4|||
129873250|NCT00520975|467494206|FG000|Overall Study|Other reasons|4|||
129873251|NCT00520975|467494207|FG001|Overall Study|Other reasons|2|||
129873252|NCT00520975|467494206|FG000|Overall Study|Not start protocol therapy|1|||
129873253|NCT00520975|467494207|FG001|Overall Study|Not start protocol therapy|2|||
129873254|NCT04810221|467494208|FG000|Overall Study|Physician Decision|3|||
129873255|NCT03642938|467494209|FG000|Overall Study|Withdrawal by Subject|0|||
129873256|NCT03642938|467494210|FG001|Overall Study|Withdrawal by Subject|0|||
129873257|NCT03642938|467494211|FG002|Overall Study|Withdrawal by Subject|0|||
129873258|NCT03642938|467494212|FG003|Overall Study|Withdrawal by Subject|1|||
129984131|NCT03117998|467903850|FG003|Overall Study|Lost to Follow-up|1|||
129984132|NCT03117998|467903851|FG004|Overall Study|Lost to Follow-up|4|||
129984133|NCT03117998|467903852|FG005|Overall Study|Lost to Follow-up|0|||
129984134|NCT03117998|467903847|FG000|Overall Study|Subject noncompliance|0|||
129984135|NCT03117998|467903848|FG001|Overall Study|Subject noncompliance|0|||
129984136|NCT03117998|467903849|FG002|Overall Study|Subject noncompliance|1|||
129984137|NCT03117998|467903850|FG003|Overall Study|Subject noncompliance|0|||
129984138|NCT03117998|467903851|FG004|Overall Study|Subject noncompliance|0|||
129984139|NCT03117998|467903852|FG005|Overall Study|Subject noncompliance|2|||
129984140|NCT03117998|467903847|FG000|Overall Study|Protocol Violation|0|||
129984141|NCT03117998|467903848|FG001|Overall Study|Protocol Violation|0|||
129984142|NCT03117998|467903849|FG002|Overall Study|Protocol Violation|0|||
129984143|NCT03117998|467903850|FG003|Overall Study|Protocol Violation|0|||
129984144|NCT03117998|467903851|FG004|Overall Study|Protocol Violation|0|||
129984145|NCT03117998|467903852|FG005|Overall Study|Protocol Violation|1|||
129984146|NCT00438672|467903853|FG000|Overall Study|Lost to Follow-up|7|||
129984147|NCT00438672|467903854|FG001|Overall Study|Lost to Follow-up|9|||
129984148|NCT01468181|467903858|FG000|Overall Study|Adverse Event|8|||
129984149|NCT01468181|467903859|FG001|Overall Study|Adverse Event|1|||
129984150|NCT01468181|467903860|FG002|Overall Study|Adverse Event|6|||
129984151|NCT01468181|467903861|FG003|Overall Study|Adverse Event|2|||
129873259|NCT00105235|467494213|FG000|Overall Study|Death|4|||
129873260|NCT00105235|467494213|FG000|Overall Study|Physician Decision|1|||
129873261|NCT00105235|467494213|FG000|Overall Study|Withdrawal by Subject|2|||
129873262|NCT01964326|467494214|FG000|Overall Study|Adverse Event|48|||
129873263|NCT01964326|467494214|FG000|Overall Study|Death|2|||
129873264|NCT01964326|467494214|FG000|Overall Study|Protocol Violation|4|||
129873265|NCT01964326|467494214|FG000|Overall Study|Lost to Follow-up|88|||
129873266|NCT01964326|467494214|FG000|Overall Study|Withdrawal by Subject|87|||
129873267|NCT01964326|467494214|FG000|Overall Study|Pregnancy|1|||
129984152|NCT01468181|467903862|FG004|Overall Study|Adverse Event|2|||
129984153|NCT01468181|467903858|FG000|Overall Study|Protocol Violation|2|||
129984154|NCT01468181|467903859|FG001|Overall Study|Protocol Violation|0|||
129984155|NCT01468181|467903860|FG002|Overall Study|Protocol Violation|1|||
129984156|NCT01468181|467903861|FG003|Overall Study|Protocol Violation|0|||
129984157|NCT01468181|467903862|FG004|Overall Study|Protocol Violation|1|||
129984158|NCT01468181|467903858|FG000|Overall Study|Physician Decision|0|||
129984159|NCT01468181|467903859|FG001|Overall Study|Physician Decision|0|||
130319007|NCT05526716|469135371|FG001|Overall Study|Death|2|||
129984160|NCT01468181|467903860|FG002|Overall Study|Physician Decision|0|||
129984161|NCT01468181|467903861|FG003|Overall Study|Physician Decision|1|||
129984162|NCT01468181|467903862|FG004|Overall Study|Physician Decision|1|||
129984163|NCT01468181|467903858|FG000|Overall Study|Lost to Follow-up|0|||
129984164|NCT01468181|467903859|FG001|Overall Study|Lost to Follow-up|0|||
129984165|NCT01468181|467903860|FG002|Overall Study|Lost to Follow-up|1|||
129984166|NCT01468181|467903861|FG003|Overall Study|Lost to Follow-up|0|||
129984167|NCT01468181|467903862|FG004|Overall Study|Lost to Follow-up|1|||
129984168|NCT01468181|467903858|FG000|Overall Study|Withdrawal by Subject|0|||
129984169|NCT01468181|467903859|FG001|Overall Study|Withdrawal by Subject|1|||
129984170|NCT01468181|467903860|FG002|Overall Study|Withdrawal by Subject|0|||
129984171|NCT01468181|467903861|FG003|Overall Study|Withdrawal by Subject|0|||
129984172|NCT01468181|467903862|FG004|Overall Study|Withdrawal by Subject|0|||
129984173|NCT04828837|467903863|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
129984174|NCT04828837|467903864|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
129984175|NCT04828837|467903863|FG000|Overall Study|Lost to Follow-up|2|||
129984176|NCT04828837|467903864|FG001|Overall Study|Lost to Follow-up|6|||
129984177|NCT04828837|467903863|FG000|Overall Study|Lack of Efficacy|1|||
130095171|NCT00198107|468305433|FG000|Double-Blind Period|Physician Decision|1|||
130319008|NCT05526716|469135370|FG000|Overall Study|Lost to Follow-up|17|||
130319009|NCT05526716|469135371|FG001|Overall Study|Lost to Follow-up|15|||
130319010|NCT05526716|469135370|FG000|Overall Study|Physician Decision|0|||
130319011|NCT05526716|469135371|FG001|Overall Study|Physician Decision|1|||
130319012|NCT05526716|469135370|FG000|Overall Study|Randomized by mistake without study treatment|0|||
130319013|NCT05526716|469135371|FG001|Overall Study|Randomized by mistake without study treatment|1|||
130319014|NCT05526716|469135370|FG000|Overall Study|Withdrawal by Subject|12|||
130319015|NCT05526716|469135371|FG001|Overall Study|Withdrawal by Subject|12|||
130319016|NCT05526716|469135370|FG000|Overall Study|Not reported|0|||
130319017|NCT05526716|469135371|FG001|Overall Study|Not reported|2|||
130319018|NCT04750824|469135375|FG000|Overall Study|Toxicity/intolerability|3|||
130319019|NCT04750824|469135376|FG001|Overall Study|Toxicity/intolerability|1|||
130319020|NCT04750824|469135375|FG000|Overall Study|Death|1|||
130319021|NCT04750824|469135376|FG001|Overall Study|Death|3|||
130319022|NCT04750824|469135375|FG000|Overall Study|Scheduled duration of therapy complete|1|||
130319023|NCT04750824|469135376|FG001|Overall Study|Scheduled duration of therapy complete|9|||
129873268|NCT01964326|467494214|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
129873269|NCT01964326|467494214|FG000|Overall Study|Physician Decision|55|||
130319024|NCT04750824|469135375|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
130319025|NCT04750824|469135376|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
130319026|NCT00807911|469135377|FG000|Overall Study|Withdrawal by Subject|12|||
129873270|NCT01964326|467494214|FG000|Overall Study|Investigator Discretion|1|||
129873271|NCT01964326|467494214|FG000|Overall Study|Other|9|||
129873272|NCT01964326|467494214|FG000|Overall Study|Did not meet eligibility criteria|1|||
129873273|NCT02347657|467494215|FG000|Overall Study|Physician Decision|0|||
129873274|NCT02347657|467494216|FG001|Overall Study|Physician Decision|1|||
129873275|NCT02347657|467494215|FG000|Overall Study|Adverse Event|8|||
129873276|NCT02347657|467494216|FG001|Overall Study|Adverse Event|4|||
129873277|NCT02347657|467494215|FG000|Overall Study|Withdrawal by Subject|6|||
129873278|NCT02347657|467494216|FG001|Overall Study|Withdrawal by Subject|7|||
129873279|NCT02347657|467494215|FG000|Overall Study|Randomized but not treated|1|||
129873280|NCT02347657|467494216|FG001|Overall Study|Randomized but not treated|0|||
129873281|NCT02347657|467494215|FG000|Overall Study|Other|3|||
129873282|NCT02347657|467494216|FG001|Overall Study|Other|3|||
129873283|NCT01995539|467494217|FG000|Overall Study|Screening Failure|1|||
129873284|NCT01995539|467494217|FG000|Overall Study|Withdrawal by Investigator|15|||
129873285|NCT01995539|467494217|FG000|Overall Study|Withdrawal by Subject|11|||
129873286|NCT01995539|467494217|FG000|Overall Study|Lost to Follow-up|5|||
129873287|NCT01995539|467494217|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
129873288|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
129873289|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
129873290|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
129873291|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
129873292|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
129873293|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
129873294|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
129873295|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
129873296|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
129873297|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
129984178|NCT04828837|467903864|FG001|Overall Study|Lack of Efficacy|0|||
129984179|NCT04828837|467903863|FG000|Overall Study|Admitted due to pneumothorax.|1|||
129984180|NCT04828837|467903864|FG001|Overall Study|Admitted due to pneumothorax.|0|||
129984181|NCT04828837|467903863|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
130319027|NCT00807911|469135378|FG001|Overall Study|Withdrawal by Subject|10|||
130319028|NCT00807911|469135377|FG000|Overall Study|Ineligible|0|||
130319029|NCT00807911|469135378|FG001|Overall Study|Ineligible|4|||
129984182|NCT04828837|467903864|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
129984183|NCT00545753|467903865|FG000|Overall Study|Withdrawal by Subject|0|||
129984184|NCT00545753|467903866|FG001|Overall Study|Withdrawal by Subject|1|||
129984185|NCT00545753|467903867|FG002|Overall Study|Withdrawal by Subject|10|||
129984186|NCT00545753|467903865|FG000|Overall Study|Lost to Follow-up|13|||
129984187|NCT00545753|467903866|FG001|Overall Study|Lost to Follow-up|3|||
129984188|NCT00545753|467903867|FG002|Overall Study|Lost to Follow-up|12|||
129984189|NCT00545753|467903865|FG000|Overall Study|Protocol Violation|3|||
129984190|NCT00545753|467903866|FG001|Overall Study|Protocol Violation|1|||
129984191|NCT00545753|467903867|FG002|Overall Study|Protocol Violation|4|||
129984192|NCT02297139|467903868|FG000|Overall Study|Disease progression|0|||
129984193|NCT02297139|467903869|FG001|Overall Study|Disease progression|1|||
129984194|NCT02297139|467903868|FG000|Overall Study|Study drug toxicity|0|||
129984195|NCT02297139|467903869|FG001|Overall Study|Study drug toxicity|4|||
129984196|NCT02297139|467903868|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129984197|NCT02297139|467903869|FG001|Overall Study|Participant request to discontinue study treatment|1|||
129984198|NCT02297139|467903868|FG000|Overall Study|Maximum clinical benefit|1|||
129984199|NCT02297139|467903869|FG001|Overall Study|Maximum clinical benefit|0|||
129984200|NCT02297139|467903868|FG000|Overall Study|Administrative reason by sponsor|0|||
129984201|NCT02297139|467903869|FG001|Overall Study|Administrative reason by sponsor|2|||
129984202|NCT02297139|467903868|FG000|Overall Study|Other reasons|0|||
129984203|NCT02297139|467903869|FG001|Overall Study|Other reasons|8|||
129984204|NCT01942785|467903870|FG000|Overall Study|Adverse Event|2|||
129984205|NCT01942785|467903870|FG000|Overall Study|Withdrawal by Subject|1|||
129984206|NCT01942785|467903870|FG000|Overall Study|Protocol Violation|1|||
129984207|NCT00552929|467903873|FG000|Overall Study|Lost to Follow-up|0|||
129984208|NCT00552929|467903874|FG001|Overall Study|Lost to Follow-up|0|||
129984209|NCT00552929|467903875|FG002|Overall Study|Lost to Follow-up|0|||
129984210|NCT00552929|467903876|FG003|Overall Study|Lost to Follow-up|0|||
129984211|NCT00552929|467903877|FG004|Overall Study|Lost to Follow-up|0|||
129984212|NCT00552929|467903878|FG005|Overall Study|Lost to Follow-up|0|||
129984213|NCT00552929|467903879|FG006|Overall Study|Lost to Follow-up|0|||
129984214|NCT00552929|467903880|FG007|Overall Study|Lost to Follow-up|0|||
129984215|NCT00552929|467903881|FG008|Overall Study|Lost to Follow-up|1|||
129984216|NCT00552929|467903882|FG009|Overall Study|Lost to Follow-up|0|||
129984217|NCT00552929|467903873|FG000|Overall Study|Not Eligible|0|||
129984218|NCT00552929|467903874|FG001|Overall Study|Not Eligible|0|||
129984219|NCT00552929|467903875|FG002|Overall Study|Not Eligible|0|||
129984220|NCT00552929|467903876|FG003|Overall Study|Not Eligible|0|||
129984221|NCT00552929|467903877|FG004|Overall Study|Not Eligible|0|||
129984222|NCT00552929|467903878|FG005|Overall Study|Not Eligible|1|||
129984223|NCT00552929|467903879|FG006|Overall Study|Not Eligible|0|||
129984224|NCT00552929|467903880|FG007|Overall Study|Not Eligible|0|||
130319030|NCT03547518|469135381|FG000|Overall Study|Lost to Follow-up|2|||
130319031|NCT03547518|469135382|FG001|Overall Study|Lost to Follow-up|0|||
130319032|NCT04349891|469135389|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
130319033|NCT04349891|469135390|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
130319034|NCT04349891|469135389|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
130319035|NCT04349891|469135390|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
130319036|NCT04349891|469135389|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
130319037|NCT04349891|469135390|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
130319038|NCT04349891|469135389|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
130319039|NCT04349891|469135390|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
130319040|NCT02927301|469135393|FG000|Overall Study|Death|39|||
130319041|NCT02927301|469135393|FG000|Overall Study|Lost to Follow-up|8|||
130319042|NCT02927301|469135393|FG000|Overall Study|Physician Decision|2|||
130319043|NCT02927301|469135393|FG000|Overall Study|Withdrawal by Subject|12|||
130319044|NCT02927301|469135393|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
130319045|NCT02201524|469135396|FG000|Overall Study|Adverse Event|0|||
130319046|NCT02201524|469135397|FG001|Overall Study|Adverse Event|2|||
130319047|NCT02201524|469135398|FG002|Overall Study|Adverse Event|1|||
130319048|NCT02201524|469135399|FG003|Overall Study|Adverse Event|0|||
130319049|NCT02201524|469135396|FG000|Overall Study|Insufficient clinical response|1|||
130319050|NCT02201524|469135397|FG001|Overall Study|Insufficient clinical response|0|||
130319051|NCT02201524|469135398|FG002|Overall Study|Insufficient clinical response|0|||
129984225|NCT00552929|467903881|FG008|Overall Study|Not Eligible|0|||
129984226|NCT00552929|467903882|FG009|Overall Study|Not Eligible|0|||
129984227|NCT01147536|467903886|FG000|Overall Study|Administrative study close|2|||
129984228|NCT01147536|467903886|FG000|Overall Study|Death|1|||
129984229|NCT04577001|467903887|FG000|Overall Study|Subject became ineligible|0|||
129984230|NCT04577001|467903888|FG001|Overall Study|Subject became ineligible|1|||
130319052|NCT02201524|469135399|FG003|Overall Study|Insufficient clinical response|0|||
130319053|NCT02201524|469135396|FG000|Overall Study|Lost to Follow-up|0|||
130319054|NCT02201524|469135397|FG001|Overall Study|Lost to Follow-up|0|||
129984231|NCT05110690|467903889|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
130319055|NCT02201524|469135398|FG002|Overall Study|Lost to Follow-up|2|||
129984232|NCT05110690|467903889|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
130319056|NCT02201524|469135399|FG003|Overall Study|Lost to Follow-up|0|||
130319057|NCT02201524|469135396|FG000|Overall Study|No longer meets eligibility criteria|0|||
130319058|NCT02201524|469135397|FG001|Overall Study|No longer meets eligibility criteria|0|||
130319059|NCT02201524|469135398|FG002|Overall Study|No longer meets eligibility criteria|0|||
130319060|NCT02201524|469135399|FG003|Overall Study|No longer meets eligibility criteria|2|||
130319061|NCT02201524|469135396|FG000|Overall Study|Protocol Violation|0|||
130319062|NCT02201524|469135397|FG001|Overall Study|Protocol Violation|0|||
130319063|NCT02201524|469135398|FG002|Overall Study|Protocol Violation|0|||
130319064|NCT02201524|469135399|FG003|Overall Study|Protocol Violation|1|||
130319065|NCT02201524|469135396|FG000|Overall Study|Withdrawal by Subject|0|||
130319066|NCT02201524|469135397|FG001|Overall Study|Withdrawal by Subject|0|||
130319067|NCT02201524|469135398|FG002|Overall Study|Withdrawal by Subject|1|||
129873298|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
129984233|NCT05110690|467903889|FG000|Completion of Intervention|Lost to Follow-up|1|||
129984234|NCT05110690|467903889|FG000|Completion of Intervention|Death|1|||
129984235|NCT05110690|467903889|FG000|Completion of Intervention|Withdrawal by Subject|2|||
129984236|NCT03973931|467903892|FG000|Overall Study|Lost to Follow-up|47|||
129984237|NCT03973931|467903893|FG001|Overall Study|Lost to Follow-up|63|||
129984238|NCT03973931|467903894|FG002|Overall Study|Lost to Follow-up|51|||
129984239|NCT03973931|467903895|FG003|Overall Study|Lost to Follow-up|54|||
129984240|NCT03973931|467903892|FG000|Overall Study|opted out|6|||
129984241|NCT03973931|467903893|FG001|Overall Study|opted out|5|||
129984242|NCT03973931|467903894|FG002|Overall Study|opted out|5|||
129984243|NCT03973931|467903895|FG003|Overall Study|opted out|1|||
129984244|NCT00925353|467903896|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
129984245|NCT03507777|467905426|FG000|Overall Study|Lost to Follow-up|5|||
129984246|NCT03507777|467905427|FG001|Overall Study|Lost to Follow-up|7|||
129984247|NCT03507777|467905426|FG000|Overall Study|Withdrawal by Subject|6|||
129984248|NCT03507777|467905427|FG001|Overall Study|Withdrawal by Subject|11|||
129984249|NCT03507777|467905426|FG000|Overall Study|Death|30|||
129984250|NCT03507777|467905427|FG001|Overall Study|Death|44|||
129984251|NCT03507777|467905426|FG000|Overall Study|Other Reasons|3|||
129984252|NCT03507777|467905427|FG001|Overall Study|Other Reasons|8|||
129984253|NCT01879722|467905428|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130319068|NCT02201524|469135399|FG003|Overall Study|Withdrawal by Subject|1|||
130319069|NCT02201524|469135396|FG000|Overall Study|Other|1|||
130319070|NCT02201524|469135397|FG001|Overall Study|Other|1|||
130319071|NCT02201524|469135398|FG002|Overall Study|Other|0|||
130319072|NCT02201524|469135399|FG003|Overall Study|Other|0|||
130319073|NCT02914639|469135401|FG000|Overall Study|Withdrawal by Subject|0|||
130319074|NCT02914639|469135402|FG001|Overall Study|Withdrawal by Subject|2|||
130319075|NCT01018030|469135403|FG000|Overall Study|Adverse Event|10|||
130319076|NCT01018030|469135404|FG001|Overall Study|Adverse Event|5|||
130319077|NCT01018030|469135405|FG002|Overall Study|Adverse Event|5|||
130319078|NCT01018030|469135403|FG000|Overall Study|Withdrawal by Subject|2|||
130319079|NCT01018030|469135404|FG001|Overall Study|Withdrawal by Subject|2|||
130319080|NCT01018030|469135405|FG002|Overall Study|Withdrawal by Subject|4|||
130319081|NCT01018030|469135403|FG000|Overall Study|Lost to Follow-up|2|||
130319082|NCT01018030|469135404|FG001|Overall Study|Lost to Follow-up|0|||
130319083|NCT01018030|469135405|FG002|Overall Study|Lost to Follow-up|3|||
130319084|NCT01018030|469135403|FG000|Overall Study|Protocol Violation|2|||
130319085|NCT01018030|469135404|FG001|Overall Study|Protocol Violation|1|||
130319086|NCT01018030|469135405|FG002|Overall Study|Protocol Violation|0|||
130319087|NCT01018030|469135403|FG000|Overall Study|Physician Decision|1|||
130319088|NCT01018030|469135404|FG001|Overall Study|Physician Decision|0|||
130319089|NCT01018030|469135405|FG002|Overall Study|Physician Decision|1|||
130319090|NCT01018030|469135403|FG000|Overall Study|Lack of Efficacy|1|||
130319091|NCT01018030|469135404|FG001|Overall Study|Lack of Efficacy|0|||
130319092|NCT01018030|469135405|FG002|Overall Study|Lack of Efficacy|0|||
130319093|NCT01018030|469135403|FG000|Overall Study|Did Not Receive Study Drug|1|||
130319094|NCT01018030|469135404|FG001|Overall Study|Did Not Receive Study Drug|3|||
130319095|NCT01018030|469135405|FG002|Overall Study|Did Not Receive Study Drug|0|||
130319096|NCT03617172|469135406|FG000|Overall Study|Lost to Follow-up|1|||
130319097|NCT03617172|469135407|FG001|Overall Study|Lost to Follow-up|0|||
129873299|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
129984254|NCT01879722|467905429|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129984255|NCT01879722|467905430|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129984256|NCT01879722|467905431|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129984257|NCT01879722|467905432|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
129984258|NCT01879722|467905433|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
129984259|NCT01879722|467905434|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
130110658|NCT01629693|468365823|FG001|Overall Study|Adverse Event|0|||
130319098|NCT00189540|469135408|FG000|Overall Study|Withdrawal by Subject|3|||
130319099|NCT00189540|469135409|FG001|Overall Study|Withdrawal by Subject|0|||
130319100|NCT00189540|469135408|FG000|Overall Study|Death|4|||
130319101|NCT00189540|469135409|FG001|Overall Study|Death|1|||
130319102|NCT01089504|469135410|FG000|Overall Study|Lost to Follow-up|1|||
130319103|NCT01089504|469135411|FG001|Overall Study|Lost to Follow-up|1|||
129984260|NCT01879722|467905435|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
129984261|NCT01879722|467905436|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
129984262|NCT01879722|467905437|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
129984263|NCT01879722|467905428|FG000|Overall Study|Voluntary Withdrawal|0|||
129984264|NCT01879722|467905429|FG001|Overall Study|Voluntary Withdrawal|0|||
129984265|NCT01879722|467905430|FG002|Overall Study|Voluntary Withdrawal|0|||
129984266|NCT01879722|467905431|FG003|Overall Study|Voluntary Withdrawal|0|||
129984267|NCT01879722|467905432|FG004|Overall Study|Voluntary Withdrawal|0|||
129984268|NCT01879722|467905433|FG005|Overall Study|Voluntary Withdrawal|0|||
129984269|NCT01879722|467905434|FG006|Overall Study|Voluntary Withdrawal|0|||
129984270|NCT01879722|467905435|FG007|Overall Study|Voluntary Withdrawal|0|||
129984271|NCT01879722|467905436|FG008|Overall Study|Voluntary Withdrawal|1|||
129984272|NCT01879722|467905437|FG009|Overall Study|Voluntary Withdrawal|0|||
129984273|NCT01253304|467905438|FG000|Overall Study|Adverse Event|0|||
129984274|NCT01253304|467905439|FG001|Overall Study|Adverse Event|0|||
129984275|NCT01253304|467905440|FG002|Overall Study|Adverse Event|0|||
129984276|NCT01253304|467905441|FG003|Overall Study|Adverse Event|1|||
129984277|NCT01327495|467905442|FG000|Overall Study|Adverse Event|2|||
129984278|NCT01327495|467905443|FG001|Overall Study|Adverse Event|1|||
129984279|NCT01327495|467905444|FG002|Overall Study|Adverse Event|1|||
129984280|NCT01327495|467905445|FG003|Overall Study|Adverse Event|0|||
129984281|NCT01327495|467905446|FG004|Overall Study|Adverse Event|0|||
129984282|NCT01327495|467905447|FG005|Overall Study|Adverse Event|2|||
129984283|NCT01327495|467905442|FG000|Overall Study|Withdrawal by Subject|0|||
129984284|NCT01327495|467905443|FG001|Overall Study|Withdrawal by Subject|1|||
129984285|NCT01327495|467905444|FG002|Overall Study|Withdrawal by Subject|1|||
129984286|NCT01327495|467905445|FG003|Overall Study|Withdrawal by Subject|0|||
129984287|NCT01327495|467905446|FG004|Overall Study|Withdrawal by Subject|1|||
129984288|NCT01327495|467905447|FG005|Overall Study|Withdrawal by Subject|0|||
129984289|NCT01327495|467905442|FG000|Overall Study|Physician Decision|0|||
129984290|NCT01327495|467905443|FG001|Overall Study|Physician Decision|0|||
129984291|NCT01327495|467905444|FG002|Overall Study|Physician Decision|0|||
129984292|NCT01327495|467905445|FG003|Overall Study|Physician Decision|0|||
129984293|NCT01327495|467905446|FG004|Overall Study|Physician Decision|2|||
129984294|NCT01327495|467905447|FG005|Overall Study|Physician Decision|0|||
129984295|NCT00006011|467905448|FG000|Overall Study|Disease progression|13|||
129984296|NCT00006011|467905449|FG001|Overall Study|Disease progression|6|||
130319104|NCT01089504|469135410|FG000|Overall Study|Withdrawal by Subject|2|||
130319105|NCT01089504|469135411|FG001|Overall Study|Withdrawal by Subject|0|||
129873300|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
129873301|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
129873302|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
129873303|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
129873304|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
129873305|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
129873306|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
129873307|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
129873308|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
129873309|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
129873310|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
129873311|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
129873312|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
129873313|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
129873314|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
129873315|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
129873316|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
129873317|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
129873318|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
129873319|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
129873320|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
129873321|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
129873322|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
129873323|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
129873324|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129873325|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
129873326|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
129873327|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
129873328|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
129984297|NCT00006011|467905450|FG002|Overall Study|Disease progression|26|||
129984298|NCT00006011|467905448|FG000|Overall Study|Refused further treatment|15|||
129984299|NCT00006011|467905449|FG001|Overall Study|Refused further treatment|13|||
129984300|NCT00006011|467905450|FG002|Overall Study|Refused further treatment|26|||
129984301|NCT00006011|467905448|FG000|Overall Study|Adverse Event|15|||
129873329|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129873330|NCT01059630|467494220|FG000|Overall Study|Death|100|||
129873331|NCT01059630|467494221|FG001|Overall Study|Death|84|||
129873332|NCT01059630|467494220|FG000|Overall Study|Lost to Follow-up|4|||
129873333|NCT01059630|467494221|FG001|Overall Study|Lost to Follow-up|1|||
129873334|NCT01059630|467494220|FG000|Overall Study|Physician Decision|2|||
129873335|NCT01059630|467494221|FG001|Overall Study|Physician Decision|4|||
129873336|NCT01059630|467494220|FG000|Overall Study|Withdrawal by Subject|21|||
129873337|NCT01059630|467494221|FG001|Overall Study|Withdrawal by Subject|14|||
129873338|NCT03351738|467494222|FG000|Overall Study|Withdrawal by Subject|0|||
129873339|NCT03351738|467494223|FG001|Overall Study|Withdrawal by Subject|1|||
129873340|NCT03351738|467494224|FG002|Overall Study|Withdrawal by Subject|0|||
129873341|NCT03351738|467494225|FG003|Overall Study|Withdrawal by Subject|1|||
129873342|NCT03351738|467494226|FG004|Overall Study|Withdrawal by Subject|0|||
129873343|NCT03351738|467494227|FG005|Overall Study|Withdrawal by Subject|0|||
129873344|NCT01375205|467494228|FG000|Overall Study|Lost to Follow-up|15|||
129984302|NCT00006011|467905449|FG001|Overall Study|Adverse Event|39|||
129984303|NCT00006011|467905450|FG002|Overall Study|Adverse Event|5|||
129984304|NCT00006011|467905448|FG000|Overall Study|Death|0|||
129984305|NCT00006011|467905449|FG001|Overall Study|Death|1|||
129873345|NCT01375205|467494229|FG001|Overall Study|Lost to Follow-up|12|||
129873346|NCT01375205|467494228|FG000|Overall Study|Withdrawal by Subject|6|||
129873347|NCT01375205|467494229|FG001|Overall Study|Withdrawal by Subject|1|||
129873348|NCT05687032|467494230|FG000|Treatment Phase|Adverse Event|13|||
129873349|NCT05687032|467494230|FG000|Treatment Phase|Death|1|||
129873350|NCT05687032|467494230|FG000|Treatment Phase|Physician Decision|3|||
129873351|NCT05687032|467494230|FG000|Treatment Phase|Progressive disease|9|||
129873352|NCT05687032|467494230|FG000|Treatment Phase|Withdrawal by Subject|5|||
129873353|NCT05687032|467494230|FG000|Follow-Up Phase|Death|16|||
129873354|NCT05687032|467494230|FG000|Follow-Up Phase|Ongoing|26|||
129873355|NCT05614089|467494231|FG000|Overall Study|Pregnancy|5|||
129873356|NCT05614089|467494232|FG001|Overall Study|Pregnancy|2|||
129873357|NCT05614089|467494231|FG000|Overall Study|Lost to Follow-up|5|||
129873358|NCT05614089|467494232|FG001|Overall Study|Lost to Follow-up|1|||
129873359|NCT05614089|467494231|FG000|Overall Study|Death|0|||
129873360|NCT05614089|467494232|FG001|Overall Study|Death|1|||
129873361|NCT05614089|467494231|FG000|Overall Study|Adverse Event|1|||
129873362|NCT05614089|467494232|FG001|Overall Study|Adverse Event|0|||
129873363|NCT00701038|467494244|FG000|Overall Study|study amended pilot group of patients|4|||
129873364|NCT00701038|467494245|FG001|Overall Study|study amended pilot group of patients|4|||
129873365|NCT01064297|467494248|FG000|Overall Study|Lost to Follow-up|791|||
129873366|NCT01064297|467494249|FG001|Overall Study|Lost to Follow-up|48|||
129873367|NCT01064297|467494250|FG002|Overall Study|Lost to Follow-up|133|||
129873368|NCT04058353|467494256|FG000|Overall Study|Adverse Event|2|||
129873369|NCT04058353|467494257|FG001|Overall Study|Adverse Event|1|||
129873370|NCT04058353|467494256|FG000|Overall Study|Physician Decision|1|||
129873371|NCT04058353|467494257|FG001|Overall Study|Physician Decision|0|||
129873372|NCT04058353|467494256|FG000|Overall Study|Other|1|||
129873373|NCT04058353|467494257|FG001|Overall Study|Other|0|||
129873374|NCT03444376|467494260|FG000|Part A|Disease relapse or Progression|1|||
129873375|NCT03444376|467494260|FG000|Part A|Withdrawal by Subject|2|||
129873376|NCT03444376|467494260|FG000|Part A|Adverse Event|1|||
129873377|NCT03444376|467494260|FG000|Part B|Disease relapse or Progression|18|||
129873378|NCT03444376|467494260|FG000|Part B|Withdrawal by Subject|2|||
129873379|NCT03444376|467494260|FG000|Part B|Adverse Event|2|||
129873380|NCT03444376|467494260|FG000|Part B|Physician Decision|1|||
129873381|NCT03444376|467494260|FG000|Part C|Disease relapse or Progression|43|||
129873382|NCT03444376|467494260|FG000|Part C|Withdrawal by Subject|5|||
129873383|NCT03444376|467494260|FG000|Part C|Adverse Event|2|||
129873384|NCT03444376|467494260|FG000|Part C|Physician Decision|2|||
129873385|NCT03444376|467494260|FG000|Part C|Death|1|||
129891086|NCT01723826|467559612|FG002|Overall Study|Withdrawal by Subject|27|||
129984306|NCT00006011|467905450|FG002|Overall Study|Death|2|||
129984307|NCT00006011|467905448|FG000|Overall Study|Other|4|||
129984308|NCT00006011|467905449|FG001|Overall Study|Other|2|||
129984309|NCT00006011|467905450|FG002|Overall Study|Other|5|||
129984310|NCT00006011|467905448|FG000|Overall Study|Ineligible|18|||
129984311|NCT00006011|467905449|FG001|Overall Study|Ineligible|16|||
129984312|NCT00006011|467905450|FG002|Overall Study|Ineligible|9|||
129984313|NCT03212989|467905452|FG000|Overall Study|Physician Decision|8|||
129984314|NCT03047395|467905455|FG000|Overall Study|Adverse Event|142|||
129984315|NCT03047395|467905455|FG000|Overall Study|Withdrawal by Subject|155|||
129891087|NCT01723826|467559613|FG003|Overall Study|Withdrawal by Subject|48|||
129891088|NCT02408549|467559616|FG000|Overall Study|Adverse Event|15|||
129891089|NCT02408549|467559616|FG000|Overall Study|Death|4|||
129891090|NCT02408549|467559616|FG000|Overall Study|Lack of Efficacy|17|||
129891091|NCT02408549|467559616|FG000|Overall Study|Protocol Violation|4|||
129891092|NCT02408549|467559616|FG000|Overall Study|Lost to Follow-up|6|||
129891093|NCT02408549|467559616|FG000|Overall Study|Consent withdrawn|30|||
129891094|NCT02408549|467559616|FG000|Overall Study|Neurology research program closing at site|1|||
129984316|NCT03047395|467905455|FG000|Overall Study|Lost to Follow-up|144|||
129873386|NCT03308825|467495596|FG000|Overall Study|Lost to Follow-up|2|||
129873387|NCT03308825|467495597|FG001|Overall Study|Lost to Follow-up|2|||
129873388|NCT03308825|467495598|FG002|Overall Study|Lost to Follow-up|1|||
129873389|NCT03308825|467495599|FG003|Overall Study|Lost to Follow-up|0|||
129873390|NCT03308825|467495596|FG000|Overall Study|Protocol Violation|0|||
129873391|NCT03308825|467495597|FG001|Overall Study|Protocol Violation|2|||
129873392|NCT03308825|467495598|FG002|Overall Study|Protocol Violation|0|||
129873393|NCT03308825|467495599|FG003|Overall Study|Protocol Violation|0|||
129873394|NCT00685945|467495600|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
129873395|NCT03183388|467495601|FG000|Overall Study|Lost to Follow-up|3|||
129873396|NCT03183388|467495602|FG001|Overall Study|Lost to Follow-up|5|||
129873397|NCT03183388|467495601|FG000|Overall Study|Physician Decision|1|||
130319106|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
130319107|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
130319108|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
130319109|NCT00062439|469135412|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
130319110|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Death|1|||
130319111|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Disease progression|2|||
129873398|NCT03183388|467495602|FG001|Overall Study|Physician Decision|4|||
129873399|NCT03183388|467495601|FG000|Overall Study|Withdrawal by Subject|4|||
129873400|NCT03183388|467495602|FG001|Overall Study|Withdrawal by Subject|1|||
129873401|NCT03183388|467495601|FG000|Overall Study|Moved|1|||
129873402|NCT03183388|467495602|FG001|Overall Study|Moved|0|||
129873403|NCT03183388|467495601|FG000|Overall Study|Met Exclusion Criteria|2|||
129873404|NCT03183388|467495602|FG001|Overall Study|Met Exclusion Criteria|2|||
129873405|NCT03183388|467495601|FG000|Overall Study|COVID Pandemic Related|2|||
129873406|NCT03183388|467495602|FG001|Overall Study|COVID Pandemic Related|4|||
129873407|NCT01728792|467495603|FG000|Overall Study|Withdrawal of Consent|1|||
129873408|NCT01728792|467495604|FG001|Overall Study|Withdrawal of Consent|1|||
129873409|NCT01728792|467495605|FG002|Overall Study|Withdrawal of Consent|0|||
129873410|NCT01728792|467495606|FG003|Overall Study|Withdrawal of Consent|1|||
129873411|NCT01728792|467495607|FG004|Overall Study|Withdrawal of Consent|0|||
129873412|NCT01728792|467495603|FG000|Overall Study|Lost to Follow-up|2|||
129873413|NCT01728792|467495604|FG001|Overall Study|Lost to Follow-up|1|||
129873414|NCT01728792|467495605|FG002|Overall Study|Lost to Follow-up|4|||
129873415|NCT01728792|467495606|FG003|Overall Study|Lost to Follow-up|2|||
129873416|NCT01728792|467495607|FG004|Overall Study|Lost to Follow-up|0|||
129873417|NCT04277455|467495610|FG000|Overall Study|Lost to Follow-up|1|||
129873418|NCT04737109|467495611|FG000|Study Treatment|Disease Progression|5|||
129873419|NCT04737109|467495612|FG001|Study Treatment|Disease Progression|0|||
129873420|NCT04737109|467495613|FG002|Study Treatment|Disease Progression|0|||
129873421|NCT04737109|467495614|FG003|Study Treatment|Disease Progression|0|||
129873422|NCT04737109|467495611|FG000|Study Treatment|Death on study|1|||
129873423|NCT04737109|467495612|FG001|Study Treatment|Death on study|0|||
129873424|NCT04737109|467495613|FG002|Study Treatment|Death on study|0|||
129873425|NCT04737109|467495614|FG003|Study Treatment|Death on study|0|||
129984317|NCT03047395|467905455|FG000|Overall Study|COVID-19 Infection|2|||
129984318|NCT03047395|467905455|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
129984319|NCT03047395|467905455|FG000|Overall Study|Other, Not Specified|117|||
129984320|NCT03484273|467905456|FG000|Overall Study|Equipment Malfunction|1|||
129984321|NCT03484273|467905456|FG000|Overall Study|Data excluded from analysis|1|||
129984322|NCT00560066|467905459|FG000|Overall Study|Death|2|||
129984323|NCT00560066|467905460|FG001|Overall Study|Death|1|||
129984324|NCT00560066|467905459|FG000|Overall Study|Withdrawal by Subject|0|||
129984325|NCT00560066|467905460|FG001|Overall Study|Withdrawal by Subject|3|||
129984326|NCT00560066|467905459|FG000|Overall Study|Lost to Follow-up|4|||
129984327|NCT00560066|467905460|FG001|Overall Study|Lost to Follow-up|10|||
129984328|NCT00560066|467905459|FG000|Overall Study|Protocol Violation|0|||
129984329|NCT00560066|467905460|FG001|Overall Study|Protocol Violation|1|||
129984330|NCT00560066|467905459|FG000|Overall Study|Administrative reason|0|||
129984331|NCT00560066|467905460|FG001|Overall Study|Administrative reason|5|||
129984332|NCT00560066|467905459|FG000|Overall Study|Missing primary reason|0|||
129984333|NCT00560066|467905460|FG001|Overall Study|Missing primary reason|2|||
129984334|NCT01258595|467905467|FG000|Overall Study|Lost to Follow-up|1|||
129873426|NCT01582789|467495619|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129873427|NCT01582789|467495620|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129873428|NCT02259517|467495621|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
129873429|NCT02259517|467495622|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
129984335|NCT01258595|467905468|FG001|Overall Study|Lost to Follow-up|0|||
129984336|NCT01258595|467905467|FG000|Overall Study|Withdrawal by Subject|0|||
129873430|NCT02259517|467495623|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
129984337|NCT01258595|467905468|FG001|Overall Study|Withdrawal by Subject|1|||
129873431|NCT02259517|467495621|FG000|Overall Study|Withdrawal by Subject|0|||
129873432|NCT02259517|467495622|FG001|Overall Study|Withdrawal by Subject|0|||
129873433|NCT02259517|467495623|FG002|Overall Study|Withdrawal by Subject|3|||
129873434|NCT02276066|467495624|FG000|Overall Study|Lost to Follow-up|21|||
129984338|NCT04738292|467905469|FG000|Overall Study|Death|1|||
129984339|NCT01056718|467905473|FG000|Overall Study|Withdrawal by Subject|2|||
129984340|NCT01056718|467905473|FG000|Overall Study|Ischemia on baseline stress test|1|||
129984341|NCT05086276|467905474|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
129984342|NCT05086276|467905475|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
129984343|NCT00895154|467905476|FG000|Overall Study|Lost to Follow-up|1|||
129984344|NCT00895154|467905477|FG001|Overall Study|Lost to Follow-up|1|||
129984345|NCT00895154|467905476|FG000|Overall Study|Withdrawal by Subject|0|||
129984346|NCT00895154|467905477|FG001|Overall Study|Withdrawal by Subject|1|||
129984347|NCT01993927|467905478|FG000|Overall Study|Case Report Forms Uncollected|18|||
129984348|NCT01993927|467905478|FG000|Overall Study|Protocol Violation|11|||
129984349|NCT00777088|467905479|FG000|Overall Study|PED Treatment not attempted|1|||
129984350|NCT00287690|467905480|FG000|Overall Study|Protocol Violation|20|||
129984351|NCT00287690|467905481|FG001|Overall Study|Protocol Violation|26|||
129984352|NCT05017103|467905483|FG000|Overall Study|Death|2|||
129984353|NCT01747551|467905484|FG000|Overall Study|Progressive Disease|24|||
129984354|NCT01747551|467905485|FG001|Overall Study|Progressive Disease|17|||
129984355|NCT01747551|467905484|FG000|Overall Study|Death|3|||
129984356|NCT01747551|467905485|FG001|Overall Study|Death|1|||
129984357|NCT01747551|467905484|FG000|Overall Study|Adverse Event|7|||
129984358|NCT01747551|467905485|FG001|Overall Study|Adverse Event|1|||
129984359|NCT01747551|467905484|FG000|Overall Study|Prolonged Treatment Delay|2|||
129984360|NCT01747551|467905485|FG001|Overall Study|Prolonged Treatment Delay|0|||
129984361|NCT01747551|467905484|FG000|Overall Study|Withdrawal by Subject|3|||
129984362|NCT01747551|467905485|FG001|Overall Study|Withdrawal by Subject|1|||
129984363|NCT01747551|467905484|FG000|Overall Study|Physician Decision|2|||
129984364|NCT01747551|467905485|FG001|Overall Study|Physician Decision|1|||
129984365|NCT01747551|467905484|FG000|Overall Study|Other|2|||
129984366|NCT01747551|467905485|FG001|Overall Study|Other|0|||
129984367|NCT01142115|467905486|FG000|First Intervention|Lack of Efficacy|1|||
129984368|NCT01142115|467905487|FG001|First Intervention|Lack of Efficacy|1|||
129984369|NCT01142115|467905486|FG000|First Intervention|Adverse Event|1|||
129984370|NCT01142115|467905487|FG001|First Intervention|Adverse Event|0|||
129984371|NCT03406078|467905488|FG000|Overall Study|Death|1|||
129984372|NCT03406078|467905489|FG001|Overall Study|Death|0|||
129984373|NCT03406078|467905488|FG000|Overall Study|Lost to Follow-up|0|||
129984374|NCT03406078|467905489|FG001|Overall Study|Lost to Follow-up|1|||
129984375|NCT03406078|467905488|FG000|Overall Study|Withdrawal by Subject|5|||
129984376|NCT03406078|467905489|FG001|Overall Study|Withdrawal by Subject|2|||
129984377|NCT02091206|467905490|FG000|Treatment Period|Adverse Event|0|||
129984378|NCT02091206|467905491|FG001|Treatment Period|Adverse Event|1|||
129984379|NCT02091206|467905492|FG002|Treatment Period|Adverse Event|0|||
129984380|NCT02091206|467905493|FG003|Treatment Period|Adverse Event|0|||
129984381|NCT02091206|467905490|FG000|Treatment Period|Met withdrawal criteria|0|||
129984382|NCT02091206|467905491|FG001|Treatment Period|Met withdrawal criteria|0|||
129984383|NCT02091206|467905492|FG002|Treatment Period|Met withdrawal criteria|1|||
129984384|NCT02091206|467905493|FG003|Treatment Period|Met withdrawal criteria|0|||
129984385|NCT02091206|467905490|FG000|Taper Period|Participant refused study drug|1|||
129984386|NCT02091206|467905491|FG001|Taper Period|Participant refused study drug|0|||
129984387|NCT02091206|467905492|FG002|Taper Period|Participant refused study drug|0|||
129984388|NCT02091206|467905493|FG003|Taper Period|Participant refused study drug|1|||
129984389|NCT02091206|467905490|FG000|Taper Period|Lost to Follow-up|0|||
129984390|NCT02091206|467905491|FG001|Taper Period|Lost to Follow-up|0|||
129984391|NCT02091206|467905492|FG002|Taper Period|Lost to Follow-up|0|||
129984392|NCT02091206|467905493|FG003|Taper Period|Lost to Follow-up|1|||
129984393|NCT00700778|467905494|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
129984394|NCT00350103|467905497|FG000|Overall Study|Adverse Event|12|||
129984395|NCT00350103|467905498|FG001|Overall Study|Adverse Event|29|||
129984396|NCT00350103|467905499|FG002|Overall Study|Adverse Event|17|||
129984397|NCT00350103|467905497|FG000|Overall Study|Lack of Efficacy|5|||
129984398|NCT00350103|467905498|FG001|Overall Study|Lack of Efficacy|1|||
129984399|NCT00350103|467905499|FG002|Overall Study|Lack of Efficacy|3|||
130095172|NCT00198107|468305434|FG001|Double-Blind Period|Physician Decision|0|||
129873435|NCT02276066|467495625|FG001|Overall Study|Lost to Follow-up|11|||
129984400|NCT00350103|467905497|FG000|Overall Study|Withdrawal by Subject|6|||
129873436|NCT01191840|467495633|FG000|Overall Study|withdrew consent|2|||
129984401|NCT00350103|467905498|FG001|Overall Study|Withdrawal by Subject|6|||
129984402|NCT00350103|467905499|FG002|Overall Study|Withdrawal by Subject|8|||
130095173|NCT00198107|468305435|FG002|Double-Blind Period|Physician Decision|0|||
130207619|NCT01764997|468719003|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
129873437|NCT01191840|467495634|FG001|Overall Study|withdrew consent|1|||
129984403|NCT00350103|467905497|FG000|Overall Study|Protocol Violation|0|||
129984404|NCT00350103|467905498|FG001|Overall Study|Protocol Violation|0|||
129984405|NCT00350103|467905499|FG002|Overall Study|Protocol Violation|1|||
129984406|NCT00350103|467905497|FG000|Overall Study|Unsatisfactory Compliance|2|||
129984407|NCT00350103|467905498|FG001|Overall Study|Unsatisfactory Compliance|2|||
129984408|NCT00350103|467905499|FG002|Overall Study|Unsatisfactory Compliance|1|||
129984409|NCT00350103|467905497|FG000|Overall Study|Investigator´s decision|1|||
129984410|NCT00350103|467905498|FG001|Overall Study|Investigator´s decision|1|||
129984411|NCT00350103|467905499|FG002|Overall Study|Investigator´s decision|0|||
129984412|NCT00350103|467905497|FG000|Overall Study|Exclusion criteria met|0|||
129984413|NCT00350103|467905498|FG001|Overall Study|Exclusion criteria met|0|||
129984414|NCT00350103|467905499|FG002|Overall Study|Exclusion criteria met|1|||
129984415|NCT00350103|467905497|FG000|Overall Study|Patient relocated|0|||
129984416|NCT00350103|467905498|FG001|Overall Study|Patient relocated|0|||
129984417|NCT00350103|467905499|FG002|Overall Study|Patient relocated|1|||
129984418|NCT00350103|467905497|FG000|Overall Study|Need for prohibited medication|1|||
129984419|NCT00350103|467905498|FG001|Overall Study|Need for prohibited medication|0|||
129984420|NCT00350103|467905499|FG002|Overall Study|Need for prohibited medication|0|||
129984421|NCT00350103|467905497|FG000|Overall Study|Personal reasons|0|||
129984422|NCT00350103|467905498|FG001|Overall Study|Personal reasons|0|||
129984423|NCT00350103|467905499|FG002|Overall Study|Personal reasons|1|||
129984424|NCT00350103|467905497|FG000|Overall Study|Patient stopped feeling pain|1|||
129984425|NCT00350103|467905498|FG001|Overall Study|Patient stopped feeling pain|0|||
129873438|NCT01191840|467495633|FG000|Overall Study|Subject discontinued treatment|1|||
129873439|NCT01191840|467495634|FG001|Overall Study|Subject discontinued treatment|2|||
129984426|NCT00350103|467905499|FG002|Overall Study|Patient stopped feeling pain|0|||
129984427|NCT00350103|467905497|FG000|Overall Study|PR greater than 250ms|0|||
129984428|NCT00350103|467905498|FG001|Overall Study|PR greater than 250ms|0|||
129984429|NCT00350103|467905499|FG002|Overall Study|PR greater than 250ms|1|||
129984430|NCT00350103|467905497|FG000|Overall Study|Wrong calculation of QT interval|0|||
129984431|NCT00350103|467905498|FG001|Overall Study|Wrong calculation of QT interval|0|||
129873440|NCT01191840|467495633|FG000|Overall Study|Lost to Follow-up|4|||
129873441|NCT01191840|467495634|FG001|Overall Study|Lost to Follow-up|6|||
129984432|NCT00350103|467905499|FG002|Overall Study|Wrong calculation of QT interval|1|||
129984433|NCT00350103|467905497|FG000|Overall Study|Sponsor mistake|1|||
129984434|NCT00350103|467905498|FG001|Overall Study|Sponsor mistake|0|||
129984435|NCT00350103|467905499|FG002|Overall Study|Sponsor mistake|0|||
129984436|NCT00350103|467905497|FG000|Overall Study|Randomization mistake|0|||
130095174|NCT00198107|468305433|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130095175|NCT00198107|468305434|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130095176|NCT00198107|468305435|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130095177|NCT00198107|468305433|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
129984437|NCT00350103|467905498|FG001|Overall Study|Randomization mistake|1|||
129984438|NCT00350103|467905499|FG002|Overall Study|Randomization mistake|1|||
129984439|NCT00350103|467905497|FG000|Overall Study|Sponsor´s decision|0|||
129984440|NCT00350103|467905498|FG001|Overall Study|Sponsor´s decision|1|||
130095178|NCT00198107|468305434|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
130095179|NCT00198107|468305435|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
130095180|NCT04001790|468305436|FG000|Overall Study|Withdrawal by Subject|1|||
130095181|NCT04001790|468305437|FG001|Overall Study|Withdrawal by Subject|2|||
130095182|NCT02706327|468305438|FG000|Overall Study|Lost to Follow-up|1|||
130095183|NCT02706327|468305439|FG001|Overall Study|Lost to Follow-up|1|||
130095184|NCT02706327|468305440|FG002|Overall Study|Lost to Follow-up|2|||
130207620|NCT01764997|468718999|FG000|Study Drug Treatment Period|Other than specified above|0|||
130207621|NCT01764997|468719000|FG001|Study Drug Treatment Period|Other than specified above|0|||
130207622|NCT01764997|468719001|FG002|Study Drug Treatment Period|Other than specified above|0|||
130207623|NCT01764997|468719002|FG003|Study Drug Treatment Period|Other than specified above|0|||
130207624|NCT01764997|468719003|FG004|Study Drug Treatment Period|Other than specified above|10|||
130207625|NCT04438499|468719012|FG000|Overall Study|Lack of Efficacy|3|||
130207626|NCT04918355|468719013|FG000|Overall Study|no qualifying health encounter|497|||
130207627|NCT04918355|468719014|FG001|Overall Study|no qualifying health encounter|192|||
130207628|NCT04918355|468719015|FG002|Overall Study|no qualifying health encounter|438|||
130207629|NCT04918355|468719016|FG003|Overall Study|no qualifying health encounter|424|||
130207630|NCT04683939|468719018|FG000|Overall Study|Study termination by the sponsor|0|||
130207631|NCT04683939|468719019|FG001|Overall Study|Study termination by the sponsor|1|||
130207632|NCT04683939|468719020|FG002|Overall Study|Study termination by the sponsor|2|||
130207633|NCT04683939|468719021|FG003|Overall Study|Study termination by the sponsor|2|||
130207634|NCT04683939|468719018|FG000|Overall Study|Death|1|||
130207635|NCT04683939|468719019|FG001|Overall Study|Death|1|||
130207636|NCT04683939|468719020|FG002|Overall Study|Death|2|||
130207637|NCT04683939|468719021|FG003|Overall Study|Death|1|||
130207638|NCT04683939|468719018|FG000|Overall Study|Withdrawal by Subject|1|||
129873442|NCT01191840|467495633|FG000|Overall Study|Non Staph Infection|4|||
130207639|NCT04683939|468719019|FG001|Overall Study|Withdrawal by Subject|0|||
130207640|NCT04683939|468719020|FG002|Overall Study|Withdrawal by Subject|0|||
130207641|NCT04683939|468719021|FG003|Overall Study|Withdrawal by Subject|0|||
130207642|NCT04683939|468719018|FG000|Overall Study|Physician Decision|1|||
130207643|NCT04683939|468719019|FG001|Overall Study|Physician Decision|0|||
130207644|NCT04683939|468719020|FG002|Overall Study|Physician Decision|0|||
130207645|NCT04683939|468719021|FG003|Overall Study|Physician Decision|0|||
130207646|NCT04683939|468719018|FG000|Overall Study|Lost to Follow-up|0|||
129984441|NCT00350103|467905499|FG002|Overall Study|Sponsor´s decision|0|||
129984442|NCT00350103|467905497|FG000|Overall Study|Lost, Reason unknown|1|||
129984443|NCT00350103|467905498|FG001|Overall Study|Lost, Reason unknown|1|||
129984444|NCT00350103|467905499|FG002|Overall Study|Lost, Reason unknown|0|||
129984445|NCT02712905|467905500|FG000|Monotherapy|Death|2|||
129984446|NCT02712905|467905501|FG001|Monotherapy|Death|5|||
129984447|NCT02712905|467905502|FG002|Monotherapy|Death|0|||
129984448|NCT02712905|467905503|FG003|Monotherapy|Death|3|||
129984449|NCT02712905|467905504|FG004|Monotherapy|Death|15|||
129984450|NCT02712905|467905505|FG005|Monotherapy|Death|1|||
129984451|NCT02712905|467905506|FG006|Monotherapy|Death|3|||
129984452|NCT02712905|467905507|FG007|Monotherapy|Death|3|||
129984453|NCT02712905|467905508|FG008|Monotherapy|Death|0|||
129984454|NCT02712905|467905509|FG009|Monotherapy|Death|27|||
129984455|NCT02712905|467905510|FG010|Monotherapy|Death|2|||
129984456|NCT02712905|467905511|FG011|Monotherapy|Death|5|||
129984457|NCT02712905|467905512|FG012|Monotherapy|Death|0|||
129984458|NCT02712905|467905513|FG013|Monotherapy|Death|0|||
129984459|NCT02712905|467905514|FG014|Monotherapy|Death|0|||
129984460|NCT02712905|467905515|FG015|Monotherapy|Death|0|||
129984461|NCT02712905|467905516|FG016|Monotherapy|Death|0|||
129984462|NCT02712905|467905517|FG017|Monotherapy|Death|0|||
129984463|NCT02712905|467905500|FG000|Monotherapy|Lost to Follow-up|0|||
129984464|NCT02712905|467905501|FG001|Monotherapy|Lost to Follow-up|1|||
129984465|NCT02712905|467905502|FG002|Monotherapy|Lost to Follow-up|0|||
129984466|NCT02712905|467905503|FG003|Monotherapy|Lost to Follow-up|1|||
129984467|NCT02712905|467905504|FG004|Monotherapy|Lost to Follow-up|0|||
129984468|NCT02712905|467905505|FG005|Monotherapy|Lost to Follow-up|0|||
129984469|NCT02712905|467905506|FG006|Monotherapy|Lost to Follow-up|0|||
129984470|NCT02712905|467905507|FG007|Monotherapy|Lost to Follow-up|0|||
129984471|NCT02712905|467905508|FG008|Monotherapy|Lost to Follow-up|0|||
129984472|NCT02712905|467905509|FG009|Monotherapy|Lost to Follow-up|2|||
129984473|NCT02712905|467905510|FG010|Monotherapy|Lost to Follow-up|0|||
129984474|NCT02712905|467905511|FG011|Monotherapy|Lost to Follow-up|0|||
129984475|NCT02712905|467905512|FG012|Monotherapy|Lost to Follow-up|0|||
129984476|NCT02712905|467905513|FG013|Monotherapy|Lost to Follow-up|0|||
129984477|NCT02712905|467905514|FG014|Monotherapy|Lost to Follow-up|0|||
129984478|NCT02712905|467905515|FG015|Monotherapy|Lost to Follow-up|0|||
129984479|NCT02712905|467905516|FG016|Monotherapy|Lost to Follow-up|0|||
129984480|NCT02712905|467905517|FG017|Monotherapy|Lost to Follow-up|0|||
129984481|NCT02712905|467905500|FG000|Monotherapy|Physician Decision|1|||
129984482|NCT02712905|467905501|FG001|Monotherapy|Physician Decision|0|||
129984483|NCT02712905|467905502|FG002|Monotherapy|Physician Decision|0|||
129984484|NCT02712905|467905503|FG003|Monotherapy|Physician Decision|1|||
129984485|NCT02712905|467905504|FG004|Monotherapy|Physician Decision|0|||
129984486|NCT02712905|467905505|FG005|Monotherapy|Physician Decision|0|||
129984487|NCT02712905|467905506|FG006|Monotherapy|Physician Decision|0|||
129984488|NCT02712905|467905507|FG007|Monotherapy|Physician Decision|0|||
129984489|NCT02712905|467905508|FG008|Monotherapy|Physician Decision|0|||
129984490|NCT02712905|467905509|FG009|Monotherapy|Physician Decision|1|||
129984491|NCT02712905|467905510|FG010|Monotherapy|Physician Decision|0|||
129984492|NCT02712905|467905511|FG011|Monotherapy|Physician Decision|0|||
129984493|NCT02712905|467905512|FG012|Monotherapy|Physician Decision|0|||
129984494|NCT02712905|467905513|FG013|Monotherapy|Physician Decision|0|||
129984495|NCT02712905|467905514|FG014|Monotherapy|Physician Decision|0|||
129984496|NCT02712905|467905515|FG015|Monotherapy|Physician Decision|0|||
129984497|NCT02712905|467905516|FG016|Monotherapy|Physician Decision|0|||
129984498|NCT02712905|467905517|FG017|Monotherapy|Physician Decision|0|||
129984499|NCT02712905|467905500|FG000|Monotherapy|Study Terminated by Sponsor|0|||
129984500|NCT02712905|467905501|FG001|Monotherapy|Study Terminated by Sponsor|0|||
129984501|NCT02712905|467905502|FG002|Monotherapy|Study Terminated by Sponsor|0|||
129984502|NCT02712905|467905503|FG003|Monotherapy|Study Terminated by Sponsor|0|||
129984503|NCT02712905|467905504|FG004|Monotherapy|Study Terminated by Sponsor|1|||
129984504|NCT02712905|467905505|FG005|Monotherapy|Study Terminated by Sponsor|0|||
129984505|NCT02712905|467905506|FG006|Monotherapy|Study Terminated by Sponsor|0|||
129984506|NCT02712905|467905507|FG007|Monotherapy|Study Terminated by Sponsor|0|||
129984507|NCT02712905|467905508|FG008|Monotherapy|Study Terminated by Sponsor|0|||
129984508|NCT02712905|467905509|FG009|Monotherapy|Study Terminated by Sponsor|2|||
129984509|NCT02712905|467905510|FG010|Monotherapy|Study Terminated by Sponsor|0|||
129984510|NCT02712905|467905511|FG011|Monotherapy|Study Terminated by Sponsor|0|||
129984511|NCT02712905|467905512|FG012|Monotherapy|Study Terminated by Sponsor|0|||
129984512|NCT02712905|467905513|FG013|Monotherapy|Study Terminated by Sponsor|0|||
129984513|NCT02712905|467905514|FG014|Monotherapy|Study Terminated by Sponsor|0|||
129984514|NCT02712905|467905515|FG015|Monotherapy|Study Terminated by Sponsor|0|||
129984515|NCT02712905|467905516|FG016|Monotherapy|Study Terminated by Sponsor|0|||
129984516|NCT02712905|467905517|FG017|Monotherapy|Study Terminated by Sponsor|0|||
129984517|NCT02712905|467905500|FG000|Monotherapy|Withdrawal by Subject|0|||
129984518|NCT02712905|467905501|FG001|Monotherapy|Withdrawal by Subject|0|||
129984519|NCT02712905|467905502|FG002|Monotherapy|Withdrawal by Subject|1|||
129984520|NCT02712905|467905503|FG003|Monotherapy|Withdrawal by Subject|0|||
129984521|NCT02712905|467905504|FG004|Monotherapy|Withdrawal by Subject|2|||
129984522|NCT02712905|467905505|FG005|Monotherapy|Withdrawal by Subject|0|||
129984523|NCT02712905|467905506|FG006|Monotherapy|Withdrawal by Subject|0|||
129984524|NCT02712905|467905507|FG007|Monotherapy|Withdrawal by Subject|0|||
129984525|NCT02712905|467905508|FG008|Monotherapy|Withdrawal by Subject|0|||
129984526|NCT02712905|467905509|FG009|Monotherapy|Withdrawal by Subject|4|||
129984527|NCT02712905|467905510|FG010|Monotherapy|Withdrawal by Subject|1|||
129984528|NCT02712905|467905511|FG011|Monotherapy|Withdrawal by Subject|2|||
129984529|NCT02712905|467905512|FG012|Monotherapy|Withdrawal by Subject|0|||
129984530|NCT02712905|467905513|FG013|Monotherapy|Withdrawal by Subject|0|||
129984531|NCT02712905|467905514|FG014|Monotherapy|Withdrawal by Subject|0|||
129984532|NCT02712905|467905515|FG015|Monotherapy|Withdrawal by Subject|0|||
129984533|NCT02712905|467905516|FG016|Monotherapy|Withdrawal by Subject|0|||
129984534|NCT02712905|467905517|FG017|Monotherapy|Withdrawal by Subject|0|||
129984535|NCT02712905|467905500|FG000|Monotherapy|Started New Cancer Drug|0|||
129984536|NCT02712905|467905501|FG001|Monotherapy|Started New Cancer Drug|0|||
129984537|NCT02712905|467905502|FG002|Monotherapy|Started New Cancer Drug|0|||
129984538|NCT02712905|467905503|FG003|Monotherapy|Started New Cancer Drug|0|||
129984539|NCT02712905|467905504|FG004|Monotherapy|Started New Cancer Drug|0|||
129984540|NCT02712905|467905505|FG005|Monotherapy|Started New Cancer Drug|1|||
129984541|NCT02712905|467905506|FG006|Monotherapy|Started New Cancer Drug|0|||
129984542|NCT02712905|467905507|FG007|Monotherapy|Started New Cancer Drug|0|||
129984543|NCT02712905|467905508|FG008|Monotherapy|Started New Cancer Drug|0|||
129984544|NCT02712905|467905509|FG009|Monotherapy|Started New Cancer Drug|0|||
129984545|NCT02712905|467905510|FG010|Monotherapy|Started New Cancer Drug|0|||
129984546|NCT02712905|467905511|FG011|Monotherapy|Started New Cancer Drug|0|||
129984547|NCT02712905|467905512|FG012|Monotherapy|Started New Cancer Drug|0|||
129984548|NCT02712905|467905513|FG013|Monotherapy|Started New Cancer Drug|0|||
129984549|NCT02712905|467905514|FG014|Monotherapy|Started New Cancer Drug|0|||
129984550|NCT02712905|467905515|FG015|Monotherapy|Started New Cancer Drug|0|||
129984551|NCT02712905|467905516|FG016|Monotherapy|Started New Cancer Drug|0|||
129984552|NCT02712905|467905517|FG017|Monotherapy|Started New Cancer Drug|0|||
129984553|NCT02712905|467905500|FG000|Monotherapy|Adverse Event|0|||
129984554|NCT02712905|467905501|FG001|Monotherapy|Adverse Event|0|||
129984555|NCT02712905|467905502|FG002|Monotherapy|Adverse Event|0|||
129984556|NCT02712905|467905503|FG003|Monotherapy|Adverse Event|0|||
129984557|NCT02712905|467905504|FG004|Monotherapy|Adverse Event|0|||
129984558|NCT02712905|467905505|FG005|Monotherapy|Adverse Event|0|||
129984559|NCT02712905|467905506|FG006|Monotherapy|Adverse Event|0|||
129984560|NCT02712905|467905507|FG007|Monotherapy|Adverse Event|0|||
129984561|NCT02712905|467905508|FG008|Monotherapy|Adverse Event|1|||
129984562|NCT02712905|467905509|FG009|Monotherapy|Adverse Event|0|||
129984563|NCT02712905|467905510|FG010|Monotherapy|Adverse Event|0|||
129984564|NCT02712905|467905511|FG011|Monotherapy|Adverse Event|0|||
129984565|NCT02712905|467905512|FG012|Monotherapy|Adverse Event|0|||
129984566|NCT02712905|467905513|FG013|Monotherapy|Adverse Event|0|||
129984567|NCT02712905|467905514|FG014|Monotherapy|Adverse Event|0|||
129984568|NCT02712905|467905515|FG015|Monotherapy|Adverse Event|0|||
129984569|NCT02712905|467905516|FG016|Monotherapy|Adverse Event|0|||
129984570|NCT02712905|467905517|FG017|Monotherapy|Adverse Event|0|||
129984571|NCT02712905|467905500|FG000|Combination Therapy|Death|0|||
129984572|NCT02712905|467905501|FG001|Combination Therapy|Death|0|||
129984573|NCT02712905|467905502|FG002|Combination Therapy|Death|0|||
129984574|NCT02712905|467905503|FG003|Combination Therapy|Death|0|||
129984575|NCT02712905|467905504|FG004|Combination Therapy|Death|0|||
129984576|NCT02712905|467905505|FG005|Combination Therapy|Death|0|||
129984577|NCT02712905|467905506|FG006|Combination Therapy|Death|0|||
129984578|NCT02712905|467905507|FG007|Combination Therapy|Death|0|||
129984579|NCT02712905|467905508|FG008|Combination Therapy|Death|0|||
129984580|NCT02712905|467905509|FG009|Combination Therapy|Death|0|||
129984581|NCT02712905|467905510|FG010|Combination Therapy|Death|0|||
129984582|NCT02712905|467905511|FG011|Combination Therapy|Death|0|||
129984583|NCT02712905|467905512|FG012|Combination Therapy|Death|5|||
129984584|NCT02712905|467905513|FG013|Combination Therapy|Death|6|||
129984585|NCT02712905|467905514|FG014|Combination Therapy|Death|1|||
129984586|NCT02712905|467905515|FG015|Combination Therapy|Death|3|||
129984587|NCT02712905|467905516|FG016|Combination Therapy|Death|1|||
129873443|NCT01191840|467495634|FG001|Overall Study|Non Staph Infection|3|||
129873444|NCT01191840|467495633|FG000|Overall Study|ineligible at enrollment|1|||
129873445|NCT01191840|467495634|FG001|Overall Study|ineligible at enrollment|0|||
129873446|NCT01191840|467495633|FG000|Overall Study|IRB approval lapse|0|||
129873447|NCT01191840|467495634|FG001|Overall Study|IRB approval lapse|2|||
129873448|NCT01191840|467495633|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
129984588|NCT02712905|467905517|FG017|Combination Therapy|Death|3|||
129984589|NCT02712905|467905500|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
129984590|NCT02712905|467905501|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
129984591|NCT02712905|467905502|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
129984592|NCT02712905|467905503|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
129984593|NCT02712905|467905504|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
129984594|NCT02712905|467905505|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
129984595|NCT02712905|467905506|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
129984596|NCT02712905|467905507|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
129984597|NCT02712905|467905508|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
129984598|NCT02712905|467905509|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
129984599|NCT02712905|467905510|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
129984600|NCT02712905|467905511|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
129984601|NCT02712905|467905512|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
129984602|NCT02712905|467905513|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
129984603|NCT02712905|467905514|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
129984604|NCT02712905|467905515|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
129984605|NCT02712905|467905516|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
129984606|NCT02712905|467905517|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
129984607|NCT02712905|467905500|FG000|Combination Therapy|Withdrawal by Subject|0|||
129984608|NCT02712905|467905501|FG001|Combination Therapy|Withdrawal by Subject|0|||
129984609|NCT02712905|467905502|FG002|Combination Therapy|Withdrawal by Subject|0|||
129984610|NCT02712905|467905503|FG003|Combination Therapy|Withdrawal by Subject|0|||
129984611|NCT02712905|467905504|FG004|Combination Therapy|Withdrawal by Subject|0|||
129984612|NCT02712905|467905505|FG005|Combination Therapy|Withdrawal by Subject|0|||
129984613|NCT02712905|467905506|FG006|Combination Therapy|Withdrawal by Subject|0|||
129984614|NCT02712905|467905507|FG007|Combination Therapy|Withdrawal by Subject|0|||
129984615|NCT02712905|467905508|FG008|Combination Therapy|Withdrawal by Subject|0|||
129984616|NCT02712905|467905509|FG009|Combination Therapy|Withdrawal by Subject|0|||
129984617|NCT02712905|467905510|FG010|Combination Therapy|Withdrawal by Subject|0|||
129984618|NCT02712905|467905511|FG011|Combination Therapy|Withdrawal by Subject|0|||
129984619|NCT02712905|467905512|FG012|Combination Therapy|Withdrawal by Subject|0|||
129984620|NCT02712905|467905513|FG013|Combination Therapy|Withdrawal by Subject|0|||
129984621|NCT02712905|467905514|FG014|Combination Therapy|Withdrawal by Subject|0|||
129984622|NCT02712905|467905515|FG015|Combination Therapy|Withdrawal by Subject|1|||
129984623|NCT02712905|467905516|FG016|Combination Therapy|Withdrawal by Subject|0|||
129984624|NCT02712905|467905517|FG017|Combination Therapy|Withdrawal by Subject|2|||
129984625|NCT02712905|467905500|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984626|NCT02712905|467905501|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984627|NCT02712905|467905502|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984628|NCT02712905|467905503|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984629|NCT02712905|467905504|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984630|NCT02712905|467905505|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984631|NCT02712905|467905506|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984632|NCT02712905|467905507|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984633|NCT02712905|467905508|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984634|NCT02712905|467905509|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984635|NCT02712905|467905510|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984636|NCT02712905|467905511|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984637|NCT02712905|467905512|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984638|NCT02712905|467905513|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984639|NCT02712905|467905514|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984640|NCT02712905|467905515|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
129984641|NCT02712905|467905516|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984642|NCT02712905|467905517|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984643|NCT00320528|467905518|FG000|Study Period II|Adverse Event|3|||
129984644|NCT00320528|467905519|FG001|Study Period II|Adverse Event|4|||
130207647|NCT04683939|468719019|FG001|Overall Study|Lost to Follow-up|1|||
130207648|NCT04683939|468719020|FG002|Overall Study|Lost to Follow-up|0|||
130207649|NCT04683939|468719021|FG003|Overall Study|Lost to Follow-up|0|||
130207650|NCT02000882|468720962|FG000|Overall Study|Adverse Event|3|||
130207651|NCT02000882|468720962|FG000|Overall Study|Physician Decision|2|||
130207652|NCT02000882|468720962|FG000|Overall Study|Withdrawal by Subject|1|||
130207653|NCT00549601|468720963|FG000|Randomized|Protocol Violation|0|||
130207654|NCT00549601|468720964|FG001|Randomized|Protocol Violation|0|||
129873449|NCT01191840|467495634|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
129873450|NCT01191840|467495633|FG000|Overall Study|Withdrawal by Subject|2|||
130207655|NCT00549601|468720965|FG002|Randomized|Protocol Violation|1|||
130207656|NCT00549601|468720963|FG000|Randomized|Withdrawal by Subject|0|||
130207657|NCT00549601|468720964|FG001|Randomized|Withdrawal by Subject|1|||
130207658|NCT00549601|468720965|FG002|Randomized|Withdrawal by Subject|1|||
130207659|NCT00549601|468720963|FG000|Received Study Drug|Adverse Event|2|||
130207660|NCT00549601|468720964|FG001|Received Study Drug|Adverse Event|5|||
130207661|NCT00549601|468720965|FG002|Received Study Drug|Adverse Event|1|||
130207662|NCT00549601|468720963|FG000|Received Study Drug|Death|0|||
129873451|NCT01191840|467495634|FG001|Overall Study|Withdrawal by Subject|0|||
129873452|NCT00790452|467495635|FG000|Overall Study|Drug supply issue|1|||
129984645|NCT00320528|467905520|FG002|Study Period II|Adverse Event|8|||
129984646|NCT00320528|467905518|FG000|Study Period II|Parent/Caregiver Decision|8|||
129984647|NCT00320528|467905519|FG001|Study Period II|Parent/Caregiver Decision|3|||
129984648|NCT00320528|467905520|FG002|Study Period II|Parent/Caregiver Decision|11|||
129984649|NCT00320528|467905518|FG000|Study Period II|Withdrawal by Subject|0|||
129984650|NCT00320528|467905519|FG001|Study Period II|Withdrawal by Subject|1|||
129984651|NCT00320528|467905520|FG002|Study Period II|Withdrawal by Subject|1|||
129984652|NCT00320528|467905518|FG000|Study Period II|Entry Criteria Exclusion|0|||
129984653|NCT00320528|467905519|FG001|Study Period II|Entry Criteria Exclusion|2|||
129984654|NCT00320528|467905520|FG002|Study Period II|Entry Criteria Exclusion|2|||
129984655|NCT00320528|467905518|FG000|Study Period III|Adverse Event|1|||
129984656|NCT00320528|467905519|FG001|Study Period III|Adverse Event|0|||
129984657|NCT00320528|467905520|FG002|Study Period III|Adverse Event|0|||
129984658|NCT00320528|467905518|FG000|Study Period III|Lost to Follow-up|1|||
129984659|NCT00320528|467905519|FG001|Study Period III|Lost to Follow-up|0|||
129984660|NCT00320528|467905520|FG002|Study Period III|Lost to Follow-up|0|||
129984661|NCT00320528|467905518|FG000|Study Period III|Withdrawal by Subject|1|||
129984662|NCT00320528|467905519|FG001|Study Period III|Withdrawal by Subject|1|||
129984663|NCT00320528|467905520|FG002|Study Period III|Withdrawal by Subject|2|||
129984664|NCT00320528|467905518|FG000|Study Period III|Lack of Efficacy|2|||
129984665|NCT00320528|467905519|FG001|Study Period III|Lack of Efficacy|0|||
129984666|NCT00320528|467905520|FG002|Study Period III|Lack of Efficacy|0|||
129984667|NCT00320528|467905518|FG000|Study Period III|Parent/Caregiver Decision|14|||
129984668|NCT00320528|467905519|FG001|Study Period III|Parent/Caregiver Decision|3|||
129984669|NCT00320528|467905520|FG002|Study Period III|Parent/Caregiver Decision|11|||
129984670|NCT00320528|467905518|FG000|Study Period III|Protocol Violation|0|||
129984671|NCT00320528|467905519|FG001|Study Period III|Protocol Violation|1|||
129984672|NCT00320528|467905520|FG002|Study Period III|Protocol Violation|0|||
129984673|NCT00320528|467905518|FG000|Study Period III|Physician Decision|0|||
129984674|NCT00320528|467905519|FG001|Study Period III|Physician Decision|1|||
129984675|NCT00320528|467905520|FG002|Study Period III|Physician Decision|2|||
129984676|NCT00320528|467905518|FG000|Study Period III|Sponsor Decision|0|||
130207663|NCT00549601|468720964|FG001|Received Study Drug|Death|1|||
130207664|NCT00549601|468720965|FG002|Received Study Drug|Death|0|||
130207665|NCT00549601|468720963|FG000|Received Study Drug|Lost to Follow-up|0|||
130207666|NCT00549601|468720964|FG001|Received Study Drug|Lost to Follow-up|1|||
130207667|NCT00549601|468720965|FG002|Received Study Drug|Lost to Follow-up|1|||
130207668|NCT00549601|468720963|FG000|Received Study Drug|Protocol Violation|3|||
130207669|NCT00549601|468720964|FG001|Received Study Drug|Protocol Violation|4|||
130207670|NCT00549601|468720965|FG002|Received Study Drug|Protocol Violation|1|||
130207671|NCT00549601|468720963|FG000|Received Study Drug|Withdrawal by Subject|2|||
130207672|NCT00549601|468720964|FG001|Received Study Drug|Withdrawal by Subject|0|||
130207673|NCT00549601|468720965|FG002|Received Study Drug|Withdrawal by Subject|1|||
130207674|NCT04643964|468720970|FG000|Overall Study|Lost to Follow-up|55|||
130207675|NCT04643964|468720971|FG001|Overall Study|Lost to Follow-up|59|||
130207676|NCT04643964|468720972|FG002|Overall Study|Lost to Follow-up|54|||
130207677|NCT04643964|468720973|FG003|Overall Study|Lost to Follow-up|129|||
130207678|NCT04643964|468720974|FG004|Overall Study|Lost to Follow-up|48|||
130207679|NCT04643964|468720970|FG000|Overall Study|Failed attention check|1|||
130207680|NCT04643964|468720971|FG001|Overall Study|Failed attention check|8|||
130207681|NCT04643964|468720972|FG002|Overall Study|Failed attention check|2|||
130207682|NCT04643964|468720973|FG003|Overall Study|Failed attention check|14|||
130207683|NCT04643964|468720974|FG004|Overall Study|Failed attention check|11|||
130207684|NCT05932225|468720975|FG000|Overall Study|Lost to Follow-up|0|||
130207685|NCT05932225|468720976|FG001|Overall Study|Lost to Follow-up|1|||
130207686|NCT05932225|468720977|FG002|Overall Study|Lost to Follow-up|0|||
130207687|NCT05932225|468720975|FG000|Overall Study|Withdrawal by Subject|1|||
130207688|NCT05932225|468720976|FG001|Overall Study|Withdrawal by Subject|0|||
130207689|NCT05932225|468720977|FG002|Overall Study|Withdrawal by Subject|0|||
130207690|NCT05932225|468720975|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
130207691|NCT05932225|468720976|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
130207692|NCT05932225|468720977|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
130207693|NCT02638129|468720978|FG000|Overall Study|Study terminated|28|||
130207694|NCT02638129|468720979|FG001|Overall Study|Study terminated|30|||
130207695|NCT02949908|468720980|FG000|Overall Study|Study termination|2|||
130207696|NCT01472939|468720981|FG000|Overall Study|Adverse Event|3|||
130207697|NCT01472939|468720982|FG001|Overall Study|Adverse Event|7|||
130207698|NCT01472939|468720983|FG002|Overall Study|Adverse Event|7|||
129984677|NCT00320528|467905519|FG001|Study Period III|Sponsor Decision|0|||
129984678|NCT00320528|467905520|FG002|Study Period III|Sponsor Decision|1|||
129984679|NCT00320528|467905518|FG000|Study Period III|Atomoxetine Commercially Available|68|||
129984680|NCT00320528|467905519|FG001|Study Period III|Atomoxetine Commercially Available|25|||
129984681|NCT00320528|467905520|FG002|Study Period III|Atomoxetine Commercially Available|90|||
129984682|NCT04664400|467905521|FG000|Overall Study|Withdrawal by Subject|2|||
130207699|NCT01472939|468720984|FG003|Overall Study|Adverse Event|14|||
130207700|NCT01472939|468720981|FG000|Overall Study|Lack of Efficacy|1|||
129984683|NCT01011153|467905526|FG000|Overall Study|Less than 78 cases completed|8|||
129984684|NCT01011153|467905527|FG001|Overall Study|Less than 78 cases completed|11|||
129984685|NCT01011153|467905528|FG002|Overall Study|Less than 78 cases completed|9|||
129984686|NCT03014479|467905529|FG000|Overall Study|Adverse Event|0|||
129984687|NCT03014479|467905530|FG001|Overall Study|Adverse Event|1|||
129984688|NCT03014479|467905529|FG000|Overall Study|Voluntary Withdrawal|0|||
129984689|NCT03014479|467905530|FG001|Overall Study|Voluntary Withdrawal|2|||
129984690|NCT03014479|467905529|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
129984691|NCT03014479|467905530|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
129984692|NCT01394978|467905536|FG000|Overall Study|Withdrawal by Subject|2|||
129984693|NCT01394978|467905537|FG001|Overall Study|Withdrawal by Subject|4|||
129984694|NCT01394978|467905536|FG000|Overall Study|Lost to Follow-up|13|||
130207701|NCT01472939|468720982|FG001|Overall Study|Lack of Efficacy|0|||
130207702|NCT01472939|468720983|FG002|Overall Study|Lack of Efficacy|0|||
130207703|NCT01472939|468720984|FG003|Overall Study|Lack of Efficacy|1|||
130095185|NCT04963231|468305443|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
130095186|NCT04963231|468305444|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
130095187|NCT04963231|468305445|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
130095188|NCT04963231|468305443|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
130095189|NCT04963231|468305444|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
130095190|NCT04963231|468305445|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
130095191|NCT04963231|468305443|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
130095192|NCT04963231|468305444|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
130095193|NCT04963231|468305445|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
130095194|NCT04963231|468305443|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
130095195|NCT04963231|468305444|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
130095196|NCT04963231|468305445|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
130095197|NCT04963231|468305443|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
130095198|NCT04963231|468305444|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
129873453|NCT00790452|467495636|FG001|Overall Study|Drug supply issue|0|||
129873454|NCT01802437|467495637|FG000|Overall Study|Lost to Follow-up|1|||
129873455|NCT01802437|467495638|FG001|Overall Study|Lost to Follow-up|0|||
129873456|NCT01802437|467495637|FG000|Overall Study|Withdrawal by Subject|3|||
129873457|NCT01802437|467495638|FG001|Overall Study|Withdrawal by Subject|4|||
129873458|NCT04082884|467495639|FG000|Overall Study|Withdrawal by Subject|1|||
130095199|NCT04963231|468305445|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
130095200|NCT04963231|468305443|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
130095201|NCT04963231|468305444|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
130095202|NCT04963231|468305445|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
130095203|NCT04963231|468305443|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
130095204|NCT04963231|468305444|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
130095205|NCT04963231|468305445|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
130095206|NCT01982942|468305446|FG000|Overall Study|Adverse Event|10|||
130095207|NCT01982942|468305447|FG001|Overall Study|Adverse Event|5|||
130095208|NCT01982942|468305446|FG000|Overall Study|Lost to Follow-up|4|||
130095209|NCT01982942|468305447|FG001|Overall Study|Lost to Follow-up|3|||
130095210|NCT01982942|468305446|FG000|Overall Study|Multiple sclerosis progression|3|||
130095211|NCT01982942|468305447|FG001|Overall Study|Multiple sclerosis progression|2|||
130095212|NCT01982942|468305446|FG000|Overall Study|Wanted to try therapy not permitted|1|||
130095213|NCT01982942|468305447|FG001|Overall Study|Wanted to try therapy not permitted|0|||
130095214|NCT01982942|468305446|FG000|Overall Study|Subject declined future visits|0|||
130095215|NCT01982942|468305447|FG001|Overall Study|Subject declined future visits|1|||
130095216|NCT01982942|468305446|FG000|Overall Study|Left geographical area|2|||
130095217|NCT01982942|468305447|FG001|Overall Study|Left geographical area|0|||
130095218|NCT01982942|468305446|FG000|Overall Study|Too many pills|1|||
130095219|NCT01982942|468305447|FG001|Overall Study|Too many pills|0|||
130095220|NCT01982942|468305446|FG000|Overall Study|MS Relapse|0|||
130095221|NCT01982942|468305447|FG001|Overall Study|MS Relapse|1|||
130095222|NCT01982942|468305446|FG000|Overall Study|Chose to join a stem cell trial|0|||
130095223|NCT01982942|468305447|FG001|Overall Study|Chose to join a stem cell trial|1|||
130095224|NCT01982942|468305446|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
130095225|NCT01982942|468305447|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
130095226|NCT03471507|468305448|FG000|Overall Study|Lost to Follow-up|1|||
129984695|NCT01394978|467905537|FG001|Overall Study|Lost to Follow-up|20|||
130095227|NCT03471507|468305449|FG001|Overall Study|Lost to Follow-up|3|||
130095228|NCT03471507|468305448|FG000|Overall Study|Physician Decision|0|||
130095229|NCT03471507|468305449|FG001|Overall Study|Physician Decision|1|||
130095230|NCT03471507|468305448|FG000|Overall Study|Withdrawal by Subject|2|||
130095231|NCT03471507|468305449|FG001|Overall Study|Withdrawal by Subject|1|||
129984696|NCT01394978|467905536|FG000|Overall Study|Death|6|||
129984697|NCT01394978|467905537|FG001|Overall Study|Death|7|||
130095232|NCT00750061|468305450|FG000|Overall Study|Adverse Event|2|||
130095233|NCT00750061|468305451|FG001|Overall Study|Adverse Event|0|||
130095234|NCT00750061|468305450|FG000|Overall Study|Withdrawal by Subject|0|||
130095235|NCT00750061|468305451|FG001|Overall Study|Withdrawal by Subject|1|||
130095236|NCT00750061|468305450|FG000|Overall Study|Physician Decision|0|||
130095237|NCT00750061|468305451|FG001|Overall Study|Physician Decision|1|||
130095238|NCT03417245|468305452|FG000|Overall Study|Adverse Event|1|||
130095239|NCT03417245|468305453|FG001|Overall Study|Adverse Event|0|||
130095240|NCT03417245|468305452|FG000|Overall Study|Protocol Violation|1|||
130095241|NCT03417245|468305453|FG001|Overall Study|Protocol Violation|0|||
130095242|NCT03417245|468305452|FG000|Overall Study|Withdrawal by Subject|1|||
130095243|NCT03417245|468305453|FG001|Overall Study|Withdrawal by Subject|1|||
130095244|NCT02708524|468305461|FG000|Overall Study|Adverse Event|0|||
130207704|NCT01472939|468720981|FG000|Overall Study|Lost to Follow-up|3|||
129873459|NCT00642902|467495647|FG000|Overall Study|Adverse Event|0|||
129873460|NCT00642902|467495648|FG001|Overall Study|Adverse Event|1|||
129873461|NCT00642902|467495649|FG002|Overall Study|Adverse Event|3|||
129873462|NCT00642902|467495650|FG003|Overall Study|Adverse Event|1|||
129873463|NCT00642902|467495647|FG000|Overall Study|Lost to Follow-up|1|||
129873464|NCT00642902|467495648|FG001|Overall Study|Lost to Follow-up|1|||
129873465|NCT00642902|467495649|FG002|Overall Study|Lost to Follow-up|0|||
129873466|NCT00642902|467495650|FG003|Overall Study|Lost to Follow-up|0|||
129873467|NCT00642902|467495647|FG000|Overall Study|Lack of Efficacy|0|||
129873468|NCT00642902|467495648|FG001|Overall Study|Lack of Efficacy|3|||
129873469|NCT00642902|467495649|FG002|Overall Study|Lack of Efficacy|3|||
129873470|NCT00642902|467495650|FG003|Overall Study|Lack of Efficacy|0|||
129873471|NCT00642902|467495647|FG000|Overall Study|Death|1|||
129873472|NCT00642902|467495648|FG001|Overall Study|Death|0|||
129873473|NCT00642902|467495649|FG002|Overall Study|Death|0|||
129873474|NCT00642902|467495650|FG003|Overall Study|Death|0|||
129873475|NCT00642902|467495647|FG000|Overall Study|Premature termination of clinical trial|37|||
129873476|NCT00642902|467495648|FG001|Overall Study|Premature termination of clinical trial|32|||
129873477|NCT00642902|467495649|FG002|Overall Study|Premature termination of clinical trial|35|||
129873478|NCT00642902|467495650|FG003|Overall Study|Premature termination of clinical trial|35|||
129873479|NCT00642902|467495647|FG000|Overall Study|Randomized, but not treated|0|||
129873480|NCT00642902|467495648|FG001|Overall Study|Randomized, but not treated|0|||
129873481|NCT00642902|467495649|FG002|Overall Study|Randomized, but not treated|1|||
129873482|NCT00642902|467495650|FG003|Overall Study|Randomized, but not treated|0|||
129873483|NCT00642902|467495647|FG000|Overall Study|Other|1|||
129873484|NCT00642902|467495648|FG001|Overall Study|Other|5|||
129873485|NCT00642902|467495649|FG002|Overall Study|Other|1|||
129873486|NCT00642902|467495650|FG003|Overall Study|Other|4|||
129873487|NCT03953898|467495651|FG000|Overall Study|Lack of Efficacy|8|||
129873488|NCT03953898|467495651|FG000|Overall Study|Death|3|||
129873489|NCT03953898|467495651|FG000|Overall Study|Withdrawal by Subject|2|||
129873490|NCT03953898|467495651|FG000|Overall Study|Adverse Event|1|||
129873491|NCT01538472|467495653|FG000|Overall Study|Disease Progression|3|||
129873492|NCT01538472|467495653|FG000|Overall Study|Death|1|||
129873493|NCT02309112|467495654|FG000|Overall Study|Withdrawal by Subject|1|||
129873494|NCT02309112|467495655|FG001|Overall Study|Withdrawal by Subject|0|||
129873495|NCT02309112|467495656|FG002|Overall Study|Withdrawal by Subject|1|||
129873496|NCT02309112|467495654|FG000|Overall Study|Lost to Follow-up|0|||
129873497|NCT02309112|467495655|FG001|Overall Study|Lost to Follow-up|1|||
129873498|NCT02309112|467495656|FG002|Overall Study|Lost to Follow-up|0|||
129873499|NCT01376323|467495658|FG000|Overall Study|Adverse Event|1|||
129873500|NCT01376323|467495659|FG001|Overall Study|Adverse Event|0|||
129873501|NCT01376323|467495660|FG002|Overall Study|Adverse Event|0|||
129873502|NCT01376323|467495661|FG003|Overall Study|Adverse Event|2|||
129873503|NCT01376323|467495662|FG004|Overall Study|Adverse Event|0|||
129873504|NCT01376323|467495658|FG000|Overall Study|Lost to Follow-up|0|||
129873505|NCT01376323|467495659|FG001|Overall Study|Lost to Follow-up|0|||
129873506|NCT01376323|467495660|FG002|Overall Study|Lost to Follow-up|0|||
129873507|NCT01376323|467495661|FG003|Overall Study|Lost to Follow-up|2|||
129873508|NCT01376323|467495662|FG004|Overall Study|Lost to Follow-up|0|||
129873509|NCT01376323|467495658|FG000|Overall Study|Physician Decision|1|||
129873510|NCT01376323|467495659|FG001|Overall Study|Physician Decision|0|||
129873511|NCT01376323|467495660|FG002|Overall Study|Physician Decision|2|||
129873512|NCT01376323|467495661|FG003|Overall Study|Physician Decision|1|||
130207705|NCT01472939|468720982|FG001|Overall Study|Lost to Follow-up|0|||
130207706|NCT01472939|468720983|FG002|Overall Study|Lost to Follow-up|2|||
130207707|NCT01472939|468720984|FG003|Overall Study|Lost to Follow-up|0|||
130095245|NCT02708524|468305462|FG001|Overall Study|Adverse Event|1|||
129873513|NCT01376323|467495662|FG004|Overall Study|Physician Decision|1|||
129873514|NCT01376323|467495658|FG000|Overall Study|Withdrawal by Subject|0|||
129873515|NCT01376323|467495659|FG001|Overall Study|Withdrawal by Subject|1|||
129873516|NCT01376323|467495660|FG002|Overall Study|Withdrawal by Subject|1|||
129873517|NCT01376323|467495661|FG003|Overall Study|Withdrawal by Subject|0|||
129873518|NCT01376323|467495662|FG004|Overall Study|Withdrawal by Subject|0|||
129873519|NCT04681729|467495663|FG000|Overall Study|Lack of Efficacy|2|||
129873520|NCT04681729|467495664|FG001|Overall Study|Lack of Efficacy|2|||
129873521|NCT04681729|467495663|FG000|Overall Study|Withdrawal by Subject|8|||
129873522|NCT04681729|467495664|FG001|Overall Study|Withdrawal by Subject|9|||
129873523|NCT00499863|467495666|FG000|Overall Study|Lack of Efficacy|21|||
129873524|NCT00499863|467495667|FG001|Overall Study|Lack of Efficacy|27|||
129873525|NCT00499863|467495666|FG000|Overall Study|Protocol Violation|12|||
129873526|NCT00499863|467495667|FG001|Overall Study|Protocol Violation|7|||
129873527|NCT00499863|467495666|FG000|Overall Study|Withdrawal by Subject|6|||
129873528|NCT00499863|467495667|FG001|Overall Study|Withdrawal by Subject|4|||
129873529|NCT00499863|467495666|FG000|Overall Study|Adverse Event|8|||
129873530|NCT00499863|467495667|FG001|Overall Study|Adverse Event|2|||
129873531|NCT00499863|467495666|FG000|Overall Study|Sponsor decision|2|||
129873532|NCT00499863|467495667|FG001|Overall Study|Sponsor decision|2|||
129873533|NCT00499863|467495666|FG000|Overall Study|Lost to Follow-up|1|||
129873534|NCT00499863|467495667|FG001|Overall Study|Lost to Follow-up|1|||
129873535|NCT03759834|467495668|FG000|Overall Study|Withdrawal by Subject|1|||
129873536|NCT05701995|467495669|FG000|Pre-Treatment|Randomization Error|1|||
129873537|NCT05701995|467495670|FG001|Pre-Treatment|Randomization Error|1|||
129873538|NCT05701995|467495669|FG000|Treatment|Withdrawal by Subject|8|||
129873539|NCT05701995|467495670|FG001|Treatment|Withdrawal by Subject|4|||
129873540|NCT05701995|467495669|FG000|Treatment|Lost to Follow-up|2|||
129873541|NCT05701995|467495670|FG001|Treatment|Lost to Follow-up|3|||
129873542|NCT05701995|467495669|FG000|Treatment|Adverse Event|3|||
129873543|NCT05701995|467495670|FG001|Treatment|Adverse Event|1|||
129873544|NCT05701995|467495669|FG000|Treatment|Other Reason|1|||
129873545|NCT05701995|467495670|FG001|Treatment|Other Reason|1|||
129873546|NCT05701995|467495669|FG000|Treatment|Death|1|||
129873547|NCT05701995|467495670|FG001|Treatment|Death|0|||
129873548|NCT05701995|467495669|FG000|Treatment|Physician Decision|0|||
129873549|NCT05701995|467495670|FG001|Treatment|Physician Decision|1|||
129873550|NCT00504426|467495671|FG000|Overall Study|Adverse Event|0|||
129873551|NCT00504426|467495672|FG001|Overall Study|Adverse Event|0|||
129873552|NCT00504426|467495673|FG002|Overall Study|Adverse Event|2|||
129873553|NCT00504426|467495674|FG003|Overall Study|Adverse Event|0|||
129873554|NCT00504426|467495671|FG000|Overall Study|Protocol Violation|1|||
129873555|NCT00504426|467495672|FG001|Overall Study|Protocol Violation|1|||
129873556|NCT00504426|467495673|FG002|Overall Study|Protocol Violation|2|||
129873557|NCT00504426|467495674|FG003|Overall Study|Protocol Violation|0|||
129873558|NCT00504426|467495671|FG000|Overall Study|Withdrawal by Subject|2|||
129873559|NCT00504426|467495672|FG001|Overall Study|Withdrawal by Subject|0|||
129873560|NCT00504426|467495673|FG002|Overall Study|Withdrawal by Subject|0|||
129873561|NCT00504426|467495674|FG003|Overall Study|Withdrawal by Subject|0|||
129873562|NCT00633464|467495676|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
129873563|NCT00633464|467495677|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
129873564|NCT00633464|467495676|FG000|Overall Study|Never Treated (Randomized in error)|0|||
129873565|NCT00633464|467495677|FG001|Overall Study|Never Treated (Randomized in error)|1|||
129873566|NCT02612064|467495678|FG000|Overall Study|Withdrawal by Subject|1|||
129873567|NCT02612064|467495679|FG001|Overall Study|Withdrawal by Subject|1|||
129873568|NCT02612064|467495678|FG000|Overall Study|Other|0|||
129873569|NCT02612064|467495679|FG001|Overall Study|Other|2|||
129873570|NCT01669798|467495680|FG000|Overall Study|Physician Decision|5|||
129873571|NCT00717860|467495682|FG000|Overall Study|Clinical adverse experience|5|||
129873572|NCT00717860|467495683|FG001|Overall Study|Clinical adverse experience|9|||
129873573|NCT00717860|467495682|FG000|Overall Study|Laboratory adverse experience|2|||
129873574|NCT00717860|467495683|FG001|Overall Study|Laboratory adverse experience|2|||
129873575|NCT00717860|467495682|FG000|Overall Study|Lack of Efficacy|7|||
129873576|NCT00717860|467495683|FG001|Overall Study|Lack of Efficacy|13|||
129873577|NCT00717860|467495682|FG000|Overall Study|Discontinued for other reason|6|||
129873578|NCT00717860|467495683|FG001|Overall Study|Discontinued for other reason|1|||
129873579|NCT00717860|467495682|FG000|Overall Study|Withdrew consent|7|||
129873580|NCT00717860|467495683|FG001|Overall Study|Withdrew consent|3|||
129873581|NCT00698646|467495684|FG000|Overall Study|Adverse Event|8|||
129873582|NCT00698646|467495685|FG001|Overall Study|Adverse Event|7|||
129873583|NCT00698646|467495686|FG002|Overall Study|Adverse Event|8|||
129873584|NCT00698646|467495684|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
129873585|NCT00698646|467495685|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
129873586|NCT00698646|467495686|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
129873587|NCT00698646|467495684|FG000|Overall Study|Protocol Deviation|6|||
130095246|NCT02708524|468305463|FG002|Overall Study|Adverse Event|0|||
129873588|NCT00698646|467495685|FG001|Overall Study|Protocol Deviation|2|||
129873589|NCT00698646|467495686|FG002|Overall Study|Protocol Deviation|3|||
129873590|NCT00698646|467495684|FG000|Overall Study|Withdrawal by Subject|10|||
129873591|NCT00698646|467495685|FG001|Overall Study|Withdrawal by Subject|11|||
129873592|NCT00698646|467495686|FG002|Overall Study|Withdrawal by Subject|8|||
129873593|NCT00698646|467495684|FG000|Overall Study|Lost to Follow-up|0|||
129873594|NCT00698646|467495685|FG001|Overall Study|Lost to Follow-up|0|||
129873595|NCT00698646|467495686|FG002|Overall Study|Lost to Follow-up|2|||
129873596|NCT00698646|467495684|FG000|Overall Study|Administrative problems|1|||
129873597|NCT00698646|467495685|FG001|Overall Study|Administrative problems|0|||
129873598|NCT00698646|467495686|FG002|Overall Study|Administrative problems|1|||
129873599|NCT00279201|467495687|FG000|Initiation|Death|1|||
129873600|NCT00279201|467495688|FG001|Initiation|Death|5|||
129873601|NCT00279201|467495689|FG002|Initiation|Death|0|||
129873602|NCT00279201|467495690|FG003|Initiation|Death|0|||
129873603|NCT00279201|467495691|FG004|Initiation|Death|0|||
129873604|NCT00279201|467495692|FG005|Initiation|Death|0|||
129873605|NCT00279201|467495687|FG000|Initiation|Adverse Event|6|||
129873606|NCT00279201|467495688|FG001|Initiation|Adverse Event|15|||
129873607|NCT00279201|467495689|FG002|Initiation|Adverse Event|0|||
129873608|NCT00279201|467495690|FG003|Initiation|Adverse Event|0|||
129873609|NCT00279201|467495691|FG004|Initiation|Adverse Event|0|||
129873610|NCT00279201|467495692|FG005|Initiation|Adverse Event|0|||
129873611|NCT00279201|467495687|FG000|Initiation|Lost to Follow-up|42|||
129873612|NCT00279201|467495688|FG001|Initiation|Lost to Follow-up|41|||
129873613|NCT00279201|467495689|FG002|Initiation|Lost to Follow-up|0|||
129873614|NCT00279201|467495690|FG003|Initiation|Lost to Follow-up|0|||
129873615|NCT00279201|467495691|FG004|Initiation|Lost to Follow-up|0|||
129873616|NCT00279201|467495692|FG005|Initiation|Lost to Follow-up|0|||
129873617|NCT00279201|467495687|FG000|Initiation|Entry Criteria Exclusion|7|||
129873618|NCT00279201|467495688|FG001|Initiation|Entry Criteria Exclusion|9|||
129873619|NCT00279201|467495689|FG002|Initiation|Entry Criteria Exclusion|0|||
129873620|NCT00279201|467495690|FG003|Initiation|Entry Criteria Exclusion|0|||
129873621|NCT00279201|467495691|FG004|Initiation|Entry Criteria Exclusion|0|||
129873622|NCT00279201|467495692|FG005|Initiation|Entry Criteria Exclusion|0|||
129873623|NCT00279201|467495687|FG000|Initiation|Protocol Violation|9|||
129873624|NCT00279201|467495688|FG001|Initiation|Protocol Violation|10|||
129873625|NCT00279201|467495689|FG002|Initiation|Protocol Violation|0|||
129873626|NCT00279201|467495690|FG003|Initiation|Protocol Violation|0|||
129873627|NCT00279201|467495691|FG004|Initiation|Protocol Violation|0|||
129873628|NCT00279201|467495692|FG005|Initiation|Protocol Violation|0|||
129873629|NCT00279201|467495687|FG000|Initiation|Withdrawal by Subject|35|||
129873630|NCT00279201|467495688|FG001|Initiation|Withdrawal by Subject|41|||
129873631|NCT00279201|467495689|FG002|Initiation|Withdrawal by Subject|0|||
129873632|NCT00279201|467495690|FG003|Initiation|Withdrawal by Subject|0|||
129873633|NCT00279201|467495691|FG004|Initiation|Withdrawal by Subject|0|||
129873634|NCT00279201|467495692|FG005|Initiation|Withdrawal by Subject|0|||
129873635|NCT00279201|467495687|FG000|Initiation|Physician Decision|15|||
129873636|NCT00279201|467495688|FG001|Initiation|Physician Decision|18|||
129873637|NCT00279201|467495689|FG002|Initiation|Physician Decision|0|||
129873638|NCT00279201|467495690|FG003|Initiation|Physician Decision|0|||
129873639|NCT00279201|467495691|FG004|Initiation|Physician Decision|0|||
129873640|NCT00279201|467495692|FG005|Initiation|Physician Decision|0|||
129873641|NCT00279201|467495687|FG000|Initiation|Sponsor Decision|13|||
129873642|NCT00279201|467495688|FG001|Initiation|Sponsor Decision|5|||
129873643|NCT00279201|467495689|FG002|Initiation|Sponsor Decision|0|||
129873644|NCT00279201|467495690|FG003|Initiation|Sponsor Decision|0|||
129873645|NCT00279201|467495691|FG004|Initiation|Sponsor Decision|0|||
129873646|NCT00279201|467495692|FG005|Initiation|Sponsor Decision|0|||
129873647|NCT00279201|467495687|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873648|NCT00279201|467495688|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
129873649|NCT00279201|467495689|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873650|NCT00279201|467495690|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873651|NCT00279201|467495691|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873652|NCT00279201|467495692|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873653|NCT00279201|467495687|FG000|Maintenance|Lack of Efficacy|32|||
129873654|NCT00279201|467495688|FG001|Maintenance|Lack of Efficacy|30|||
129873655|NCT00279201|467495689|FG002|Maintenance|Lack of Efficacy|0|||
129873656|NCT00279201|467495690|FG003|Maintenance|Lack of Efficacy|0|||
129873657|NCT00279201|467495691|FG004|Maintenance|Lack of Efficacy|0|||
129873658|NCT00279201|467495692|FG005|Maintenance|Lack of Efficacy|0|||
129873659|NCT00279201|467495687|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
129873660|NCT00279201|467495688|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
129873661|NCT00279201|467495689|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129873662|NCT00279201|467495690|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129873663|NCT00279201|467495691|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129873664|NCT00279201|467495692|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129984698|NCT01081132|467905538|FG000|Overall Study|Lack of Efficacy|25|||
129984699|NCT01081132|467905539|FG001|Overall Study|Lack of Efficacy|9|||
129873665|NCT00279201|467495687|FG000|Maintenance|Adverse Event|4|||
129873666|NCT00279201|467495688|FG001|Maintenance|Adverse Event|4|||
129873667|NCT00279201|467495689|FG002|Maintenance|Adverse Event|0|||
129873668|NCT00279201|467495690|FG003|Maintenance|Adverse Event|0|||
129873669|NCT00279201|467495691|FG004|Maintenance|Adverse Event|0|||
129873670|NCT00279201|467495692|FG005|Maintenance|Adverse Event|0|||
129873671|NCT00279201|467495687|FG000|Maintenance|Death|4|||
129873672|NCT00279201|467495688|FG001|Maintenance|Death|4|||
129873673|NCT00279201|467495689|FG002|Maintenance|Death|0|||
129873674|NCT00279201|467495690|FG003|Maintenance|Death|0|||
129873675|NCT00279201|467495691|FG004|Maintenance|Death|0|||
129984700|NCT01081132|467905538|FG000|Overall Study|Withdrawal by Subject|13|||
129984701|NCT01081132|467905539|FG001|Overall Study|Withdrawal by Subject|16|||
129984702|NCT01081132|467905538|FG000|Overall Study|Lost to Follow-up|4|||
129984703|NCT01081132|467905539|FG001|Overall Study|Lost to Follow-up|11|||
129984704|NCT01081132|467905538|FG000|Overall Study|Adverse Event|3|||
129984705|NCT01081132|467905539|FG001|Overall Study|Adverse Event|9|||
129984706|NCT01081132|467905538|FG000|Overall Study|Non Compliance|4|||
129873676|NCT00279201|467495692|FG005|Maintenance|Death|0|||
129873677|NCT00279201|467495687|FG000|Maintenance|Lost to Follow-up|17|||
129873678|NCT00279201|467495688|FG001|Maintenance|Lost to Follow-up|13|||
129873679|NCT00279201|467495689|FG002|Maintenance|Lost to Follow-up|0|||
129873680|NCT00279201|467495690|FG003|Maintenance|Lost to Follow-up|0|||
129984707|NCT01081132|467905539|FG001|Overall Study|Non Compliance|2|||
129984708|NCT01081132|467905538|FG000|Overall Study|Lack Of Compliance|0|||
129984709|NCT01081132|467905539|FG001|Overall Study|Lack Of Compliance|1|||
129984710|NCT01081132|467905538|FG000|Overall Study|Missed Visits|1|||
129984711|NCT01081132|467905539|FG001|Overall Study|Missed Visits|1|||
129873681|NCT00279201|467495691|FG004|Maintenance|Lost to Follow-up|0|||
129984712|NCT01081132|467905538|FG000|Overall Study|Stopped Taking Meds|2|||
129984713|NCT01081132|467905539|FG001|Overall Study|Stopped Taking Meds|0|||
129984714|NCT01081132|467905538|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
129984715|NCT01081132|467905539|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
129984716|NCT01081132|467905538|FG000|Overall Study|Declined Taper Phase|0|||
129984717|NCT01081132|467905539|FG001|Overall Study|Declined Taper Phase|1|||
129984718|NCT01081132|467905538|FG000|Overall Study|Protocol Violation|3|||
129984719|NCT01081132|467905539|FG001|Overall Study|Protocol Violation|1|||
129984720|NCT02019667|467905540|FG000|First Intervention (6 Months)|Adverse Event|0|||
129984721|NCT02019667|467905541|FG001|First Intervention (6 Months)|Adverse Event|1|||
129984722|NCT02019667|467905540|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
130095247|NCT02708524|468305464|FG003|Overall Study|Adverse Event|0|||
129873682|NCT00279201|467495692|FG005|Maintenance|Lost to Follow-up|0|||
129873683|NCT00279201|467495687|FG000|Maintenance|Entry Criteria Exclusion|1|||
129873684|NCT00279201|467495688|FG001|Maintenance|Entry Criteria Exclusion|4|||
129873685|NCT00279201|467495689|FG002|Maintenance|Entry Criteria Exclusion|0|||
129873686|NCT00279201|467495690|FG003|Maintenance|Entry Criteria Exclusion|0|||
129873687|NCT00279201|467495691|FG004|Maintenance|Entry Criteria Exclusion|0|||
129873688|NCT00279201|467495692|FG005|Maintenance|Entry Criteria Exclusion|0|||
129873689|NCT00279201|467495687|FG000|Maintenance|Protocol Violation|16|||
129873690|NCT00279201|467495688|FG001|Maintenance|Protocol Violation|24|||
129873691|NCT00279201|467495689|FG002|Maintenance|Protocol Violation|0|||
129873692|NCT00279201|467495690|FG003|Maintenance|Protocol Violation|0|||
129873693|NCT00279201|467495691|FG004|Maintenance|Protocol Violation|0|||
129873694|NCT00279201|467495692|FG005|Maintenance|Protocol Violation|0|||
129873695|NCT00279201|467495687|FG000|Maintenance|Withdrawal by Subject|18|||
129873696|NCT00279201|467495688|FG001|Maintenance|Withdrawal by Subject|18|||
129873697|NCT00279201|467495689|FG002|Maintenance|Withdrawal by Subject|0|||
129873698|NCT00279201|467495690|FG003|Maintenance|Withdrawal by Subject|0|||
129873699|NCT00279201|467495691|FG004|Maintenance|Withdrawal by Subject|0|||
129873700|NCT00279201|467495692|FG005|Maintenance|Withdrawal by Subject|0|||
129873701|NCT00279201|467495687|FG000|Maintenance|Physician Decision|9|||
129873702|NCT00279201|467495688|FG001|Maintenance|Physician Decision|9|||
129873703|NCT00279201|467495689|FG002|Maintenance|Physician Decision|0|||
129873704|NCT00279201|467495690|FG003|Maintenance|Physician Decision|0|||
129873705|NCT00279201|467495691|FG004|Maintenance|Physician Decision|0|||
129873706|NCT00279201|467495692|FG005|Maintenance|Physician Decision|0|||
129873707|NCT00279201|467495687|FG000|Maintenance|Sponsor Decision|4|||
129873708|NCT00279201|467495688|FG001|Maintenance|Sponsor Decision|0|||
129873709|NCT00279201|467495689|FG002|Maintenance|Sponsor Decision|0|||
129873710|NCT00279201|467495690|FG003|Maintenance|Sponsor Decision|0|||
129873711|NCT00279201|467495691|FG004|Maintenance|Sponsor Decision|0|||
129873712|NCT00279201|467495692|FG005|Maintenance|Sponsor Decision|0|||
129873713|NCT00279201|467495687|FG000|Maintenance|HbA1c>7.5%|123|||
129873714|NCT00279201|467495688|FG001|Maintenance|HbA1c>7.5%|126|||
129873715|NCT00279201|467495689|FG002|Maintenance|HbA1c>7.5%|0|||
129873716|NCT00279201|467495690|FG003|Maintenance|HbA1c>7.5%|0|||
129873717|NCT00279201|467495691|FG004|Maintenance|HbA1c>7.5%|0|||
129873718|NCT00279201|467495692|FG005|Maintenance|HbA1c>7.5%|0|||
129873719|NCT00279201|467495687|FG000|Intensification Addendum|Withdrawal by Subject|0|||
129873720|NCT00279201|467495688|FG001|Intensification Addendum|Withdrawal by Subject|0|||
129873721|NCT00279201|467495689|FG002|Intensification Addendum|Withdrawal by Subject|12|||
129873722|NCT00279201|467495690|FG003|Intensification Addendum|Withdrawal by Subject|14|||
129873723|NCT00279201|467495691|FG004|Intensification Addendum|Withdrawal by Subject|9|||
129873724|NCT00279201|467495692|FG005|Intensification Addendum|Withdrawal by Subject|18|||
129873725|NCT00279201|467495687|FG000|Intensification Addendum|Lost to Follow-up|0|||
129984723|NCT02019667|467905541|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
129984724|NCT02019667|467905540|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
129984725|NCT02019667|467905541|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
129984726|NCT02101385|467905544|FG000|Study Treatment|Disease Progression|9|||
130095248|NCT02708524|468305461|FG000|Overall Study|Lens Discomfort|1|||
129873726|NCT00279201|467495688|FG001|Intensification Addendum|Lost to Follow-up|0|||
129873727|NCT00279201|467495689|FG002|Intensification Addendum|Lost to Follow-up|4|||
129873728|NCT00279201|467495690|FG003|Intensification Addendum|Lost to Follow-up|6|||
129873729|NCT00279201|467495691|FG004|Intensification Addendum|Lost to Follow-up|7|||
129873730|NCT00279201|467495692|FG005|Intensification Addendum|Lost to Follow-up|7|||
129873731|NCT00279201|467495687|FG000|Intensification Addendum|Protocol Violation|0|||
129873732|NCT00279201|467495688|FG001|Intensification Addendum|Protocol Violation|0|||
129873733|NCT00279201|467495689|FG002|Intensification Addendum|Protocol Violation|2|||
129873734|NCT00279201|467495690|FG003|Intensification Addendum|Protocol Violation|2|||
129873735|NCT00279201|467495691|FG004|Intensification Addendum|Protocol Violation|6|||
129873736|NCT00279201|467495692|FG005|Intensification Addendum|Protocol Violation|6|||
129873737|NCT00279201|467495687|FG000|Intensification Addendum|Adverse Event|0|||
129873738|NCT00279201|467495688|FG001|Intensification Addendum|Adverse Event|0|||
129873739|NCT00279201|467495689|FG002|Intensification Addendum|Adverse Event|0|||
129873740|NCT00279201|467495690|FG003|Intensification Addendum|Adverse Event|4|||
129873741|NCT00279201|467495691|FG004|Intensification Addendum|Adverse Event|1|||
129873742|NCT00279201|467495692|FG005|Intensification Addendum|Adverse Event|3|||
129873743|NCT00279201|467495687|FG000|Intensification Addendum|Physician Decision|0|||
129873744|NCT00279201|467495688|FG001|Intensification Addendum|Physician Decision|0|||
129873745|NCT00279201|467495689|FG002|Intensification Addendum|Physician Decision|4|||
129873746|NCT00279201|467495690|FG003|Intensification Addendum|Physician Decision|1|||
129873747|NCT00279201|467495691|FG004|Intensification Addendum|Physician Decision|3|||
129873748|NCT00279201|467495692|FG005|Intensification Addendum|Physician Decision|2|||
129873749|NCT00279201|467495687|FG000|Intensification Addendum|Sponsor Decision|0|||
129873750|NCT00279201|467495688|FG001|Intensification Addendum|Sponsor Decision|0|||
129873751|NCT00279201|467495689|FG002|Intensification Addendum|Sponsor Decision|0|||
129873752|NCT00279201|467495690|FG003|Intensification Addendum|Sponsor Decision|0|||
129873753|NCT00279201|467495691|FG004|Intensification Addendum|Sponsor Decision|1|||
129873754|NCT00279201|467495692|FG005|Intensification Addendum|Sponsor Decision|1|||
129873755|NCT00279201|467495687|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
129873756|NCT00279201|467495688|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
129873757|NCT00279201|467495689|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
129873758|NCT00279201|467495690|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
129873759|NCT00279201|467495691|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
129873760|NCT00279201|467495692|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
129873761|NCT00279201|467495687|FG000|Intensification Addendum|Lack of Efficacy|0|||
129873762|NCT00279201|467495688|FG001|Intensification Addendum|Lack of Efficacy|0|||
129873763|NCT00279201|467495689|FG002|Intensification Addendum|Lack of Efficacy|0|||
129873764|NCT00279201|467495690|FG003|Intensification Addendum|Lack of Efficacy|1|||
129873765|NCT00279201|467495691|FG004|Intensification Addendum|Lack of Efficacy|1|||
129873766|NCT00279201|467495692|FG005|Intensification Addendum|Lack of Efficacy|0|||
129873767|NCT00279201|467495687|FG000|Intensification Addendum|Death|0|||
129873768|NCT00279201|467495688|FG001|Intensification Addendum|Death|0|||
129873769|NCT00279201|467495689|FG002|Intensification Addendum|Death|0|||
129873770|NCT00279201|467495690|FG003|Intensification Addendum|Death|0|||
129873771|NCT00279201|467495691|FG004|Intensification Addendum|Death|1|||
129873772|NCT00279201|467495692|FG005|Intensification Addendum|Death|0|||
129873773|NCT02390531|467495695|FG000|Overall Study|Death|0|||
129873774|NCT02390531|467495696|FG001|Overall Study|Death|2|||
129873775|NCT02390531|467495697|FG002|Overall Study|Death|0|||
129873776|NCT02390531|467495698|FG003|Overall Study|Death|1|||
129873777|NCT02390531|467495699|FG004|Overall Study|Death|0|||
129873778|NCT02390531|467495700|FG005|Overall Study|Death|0|||
129873779|NCT02390531|467495701|FG006|Overall Study|Death|0|||
129873780|NCT02390531|467495702|FG007|Overall Study|Death|1|||
129873781|NCT02390531|467495695|FG000|Overall Study|Protocol Violation|0|||
129873782|NCT02390531|467495696|FG001|Overall Study|Protocol Violation|0|||
129873783|NCT02390531|467495697|FG002|Overall Study|Protocol Violation|0|||
129873784|NCT02390531|467495698|FG003|Overall Study|Protocol Violation|0|||
129873785|NCT02390531|467495699|FG004|Overall Study|Protocol Violation|1|||
129873786|NCT02390531|467495700|FG005|Overall Study|Protocol Violation|0|||
129873787|NCT02390531|467495701|FG006|Overall Study|Protocol Violation|2|||
129873788|NCT02390531|467495702|FG007|Overall Study|Protocol Violation|0|||
129873789|NCT00511875|467495703|FG000|Overall Study|Lost to Follow-up|4|||
129873790|NCT00511875|467495704|FG001|Overall Study|Lost to Follow-up|0|||
129873791|NCT00511875|467495703|FG000|Overall Study|Missing variables|1|||
129873792|NCT00511875|467495704|FG001|Overall Study|Missing variables|0|||
129984727|NCT02101385|467905545|FG001|Study Treatment|Disease Progression|3|||
129873793|NCT00542880|467495705|FG000|Period 1|Eligibility criteria not fulfilled|2|||
129873794|NCT00542880|467495706|FG001|Period 1|Eligibility criteria not fulfilled|6|||
129873795|NCT00542880|467495705|FG000|Period 1|Adverse Event|2|||
129873796|NCT00542880|467495706|FG001|Period 1|Adverse Event|2|||
129873797|NCT00542880|467495705|FG000|Period 1|Development of study-specific criteria|1|||
129873798|NCT00542880|467495706|FG001|Period 1|Development of study-specific criteria|2|||
129873799|NCT00542880|467495705|FG000|Period 1|Withdrawal by Subject|1|||
129873800|NCT00542880|467495706|FG001|Period 1|Withdrawal by Subject|1|||
129873801|NCT00542880|467495705|FG000|Period 1|Protocol Violation|0|||
129873802|NCT00542880|467495706|FG001|Period 1|Protocol Violation|1|||
129873803|NCT00542880|467495705|FG000|Period 2|Adverse Event|5|||
129873804|NCT00542880|467495706|FG001|Period 2|Adverse Event|7|||
129873805|NCT00542880|467495705|FG000|Period 2|Eligibility not fulfilled|0|||
129873806|NCT00542880|467495706|FG001|Period 2|Eligibility not fulfilled|1|||
129873807|NCT00542880|467495705|FG000|Period 2|Discontinuation criteria|2|||
129873808|NCT00542880|467495706|FG001|Period 2|Discontinuation criteria|0|||
129873809|NCT00542880|467495705|FG000|Period 2|Severe non-compliance|0|||
129873810|NCT00542880|467495706|FG001|Period 2|Severe non-compliance|1|||
129873811|NCT00542880|467495705|FG000|Period 2|Other|0|||
129873812|NCT00542880|467495706|FG001|Period 2|Other|1|||
129873813|NCT00542880|467495705|FG000|Period 3|Adverse Event|0|||
129873814|NCT00542880|467495706|FG001|Period 3|Adverse Event|2|||
129873815|NCT00696384|467495707|FG000|Open Label Phase|Adverse Event|27|||
129873816|NCT00696384|467495708|FG001|Open Label Phase|Adverse Event|0|||
129873817|NCT00696384|467495709|FG002|Open Label Phase|Adverse Event|0|||
129873818|NCT00696384|467495707|FG000|Open Label Phase|Protocol Violation|18|||
129873819|NCT00696384|467495708|FG001|Open Label Phase|Protocol Violation|0|||
129873820|NCT00696384|467495709|FG002|Open Label Phase|Protocol Violation|0|||
129873821|NCT00696384|467495707|FG000|Open Label Phase|Lost to Follow-up|24|||
129873822|NCT00696384|467495708|FG001|Open Label Phase|Lost to Follow-up|0|||
129873823|NCT00696384|467495709|FG002|Open Label Phase|Lost to Follow-up|0|||
129873824|NCT00696384|467495707|FG000|Open Label Phase|Withdrawal by Subject|37|||
129873825|NCT00696384|467495708|FG001|Open Label Phase|Withdrawal by Subject|0|||
129873826|NCT00696384|467495709|FG002|Open Label Phase|Withdrawal by Subject|0|||
129873827|NCT00696384|467495707|FG000|Open Label Phase|Other|6|||
129873828|NCT00696384|467495708|FG001|Open Label Phase|Other|0|||
129873829|NCT00696384|467495709|FG002|Open Label Phase|Other|0|||
129873830|NCT00696384|467495707|FG000|Open Label Phase|Lack of Efficacy|3|||
129873831|NCT00696384|467495708|FG001|Open Label Phase|Lack of Efficacy|0|||
129873832|NCT00696384|467495709|FG002|Open Label Phase|Lack of Efficacy|0|||
129873833|NCT00696384|467495707|FG000|Open Label Phase|Physician Decision|4|||
129873834|NCT00696384|467495708|FG001|Open Label Phase|Physician Decision|0|||
129873835|NCT00696384|467495709|FG002|Open Label Phase|Physician Decision|0|||
129873836|NCT00696384|467495707|FG000|Double Blind Phase|Adverse Event|0|||
129873837|NCT00696384|467495708|FG001|Double Blind Phase|Adverse Event|2|||
129873838|NCT00696384|467495709|FG002|Double Blind Phase|Adverse Event|2|||
129873839|NCT00696384|467495707|FG000|Double Blind Phase|Lost to Follow-up|0|||
129873840|NCT00696384|467495708|FG001|Double Blind Phase|Lost to Follow-up|2|||
129873841|NCT00696384|467495709|FG002|Double Blind Phase|Lost to Follow-up|1|||
129873842|NCT00696384|467495707|FG000|Double Blind Phase|Withdrawal by Subject|0|||
129873843|NCT00696384|467495708|FG001|Double Blind Phase|Withdrawal by Subject|4|||
129873844|NCT00696384|467495709|FG002|Double Blind Phase|Withdrawal by Subject|3|||
129873845|NCT00696384|467495707|FG000|Double Blind Phase|Lack of Efficacy|0|||
129873846|NCT00696384|467495708|FG001|Double Blind Phase|Lack of Efficacy|1|||
129873847|NCT00696384|467495709|FG002|Double Blind Phase|Lack of Efficacy|0|||
129873848|NCT00696384|467495707|FG000|Double Blind Phase|Physician Decision|0|||
129873849|NCT00696384|467495708|FG001|Double Blind Phase|Physician Decision|2|||
129873850|NCT00696384|467495709|FG002|Double Blind Phase|Physician Decision|0|||
129873851|NCT01678131|467495710|FG000|Overall Study|Adverse Event|0|||
129873852|NCT01678131|467495711|FG001|Overall Study|Adverse Event|1|||
129873853|NCT01678131|467495712|FG002|Overall Study|Adverse Event|0|||
129873854|NCT01678131|467495710|FG000|Overall Study|Withdrawal by Subject|0|||
129873855|NCT01678131|467495711|FG001|Overall Study|Withdrawal by Subject|0|||
129873856|NCT01678131|467495712|FG002|Overall Study|Withdrawal by Subject|2|||
129873857|NCT02027402|467495714|FG000|Overall Study|Withdrawal by Subject|4|||
129873858|NCT02027402|467495715|FG001|Overall Study|Withdrawal by Subject|1|||
129873859|NCT00941798|467495719|FG000|Overall Study|Withdrawal by Subject|72|||
129873860|NCT00941798|467495720|FG001|Overall Study|Withdrawal by Subject|74|||
129873861|NCT00941798|467495719|FG000|Overall Study|Adverse Event|43|||
129873862|NCT00941798|467495720|FG001|Overall Study|Adverse Event|23|||
129873863|NCT00941798|467495719|FG000|Overall Study|Lost to Follow-up|29|||
129873864|NCT00941798|467495720|FG001|Overall Study|Lost to Follow-up|23|||
129873865|NCT00941798|467495719|FG000|Overall Study|Protocol Violation|17|||
129873866|NCT00941798|467495720|FG001|Overall Study|Protocol Violation|20|||
129873867|NCT00941798|467495719|FG000|Overall Study|Administrative problems|13|||
129873868|NCT00941798|467495720|FG001|Overall Study|Administrative problems|23|||
129873869|NCT00941798|467495719|FG000|Overall Study|Lack of Efficacy|10|||
129873870|NCT00941798|467495720|FG001|Overall Study|Lack of Efficacy|17|||
129873871|NCT00941798|467495719|FG000|Overall Study|Patient's inability to use device|6|||
129873872|NCT00941798|467495720|FG001|Overall Study|Patient's inability to use device|1|||
129873873|NCT00941798|467495719|FG000|Overall Study|Abnormal test procedure results|3|||
129873874|NCT00941798|467495720|FG001|Overall Study|Abnormal test procedure results|1|||
129873875|NCT00941798|467495719|FG000|Overall Study|Abnormal laboratory values|1|||
129873876|NCT00941798|467495720|FG001|Overall Study|Abnormal laboratory values|2|||
129873877|NCT00941798|467495719|FG000|Overall Study|Death|0|||
129873878|NCT00941798|467495720|FG001|Overall Study|Death|1|||
129891095|NCT02408549|467559616|FG000|Overall Study|Site closure|1|||
129984728|NCT02101385|467905544|FG000|Study Treatment|Alternative therapy|0|||
129984729|NCT02101385|467905545|FG001|Study Treatment|Alternative therapy|1|||
129873879|NCT04179721|467495723|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
129873880|NCT04179721|467495724|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
129873881|NCT04179721|467495723|FG000|Overall Study|Lost to Follow-up|0|||
129873882|NCT04179721|467495724|FG001|Overall Study|Lost to Follow-up|1|||
129873883|NCT00112580|467495725|FG000|Overall Study|Adverse Event|1|||
129873884|NCT00112580|467495726|FG001|Overall Study|Adverse Event|2|||
129873885|NCT00112580|467495725|FG000|Overall Study|Disease progression|5|||
129873886|NCT00112580|467495726|FG001|Overall Study|Disease progression|16|||
129873887|NCT00112580|467495725|FG000|Overall Study|Participant withdrew consent|2|||
129873888|NCT00112580|467495726|FG001|Overall Study|Participant withdrew consent|1|||
129873889|NCT05619003|467495727|FG000|Overall Study|Adverse Event|1|||
129873890|NCT01682213|467496610|FG000|Overall Study|Withdrawal by Subject|2|||
129873891|NCT00742079|467496611|FG000|Overall Study|Lost to Follow-up|0|||
129873892|NCT00742079|467496612|FG001|Overall Study|Lost to Follow-up|1|||
129873893|NCT01264380|467496613|FG000|Period C|Disease Progression|0|||
129873894|NCT01264380|467496614|FG001|Period C|Disease Progression|0|||
129873895|NCT01264380|467496615|FG002|Period C|Disease Progression|4|||
129873896|NCT01264380|467496613|FG000|Period C|Death|0|||
129873897|NCT01264380|467496614|FG001|Period C|Death|0|||
129873898|NCT01264380|467496615|FG002|Period C|Death|2|||
129873899|NCT01264380|467496613|FG000|Period C|Follow-up for survival status|0|||
129873900|NCT01264380|467496614|FG001|Period C|Follow-up for survival status|0|||
129873901|NCT01264380|467496615|FG002|Period C|Follow-up for survival status|6|||
129984730|NCT02101385|467905544|FG000|Study Treatment|No treatment, per protocol criteria|0|||
129984731|NCT02101385|467905545|FG001|Study Treatment|No treatment, per protocol criteria|4|||
129984732|NCT02101385|467905544|FG000|Study Treatment|Patient Non compliance|0|||
129984733|NCT02101385|467905545|FG001|Study Treatment|Patient Non compliance|2|||
129984734|NCT02101385|467905544|FG000|Study Treatment|Withdrawal by Subject|5|||
130095249|NCT02708524|468305462|FG001|Overall Study|Lens Discomfort|0|||
129873902|NCT01264380|467496613|FG000|Period C|Withdrawal by Subject|0|||
129873903|NCT01264380|467496614|FG001|Period C|Withdrawal by Subject|0|||
129873904|NCT01264380|467496615|FG002|Period C|Withdrawal by Subject|1|||
129873905|NCT01264380|467496613|FG000|Period C|Adverse Event|0|||
129873906|NCT01264380|467496614|FG001|Period C|Adverse Event|0|||
129873907|NCT01264380|467496615|FG002|Period C|Adverse Event|1|||
129873908|NCT01147822|467496616|FG000|Overall Study|Lost to Follow-up|14|||
129873909|NCT01147822|467496617|FG001|Overall Study|Lost to Follow-up|6|||
129873910|NCT01147822|467496616|FG000|Overall Study|Withdrawal by Subject|10|||
129873911|NCT01147822|467496617|FG001|Overall Study|Withdrawal by Subject|16|||
129873912|NCT01147822|467496616|FG000|Overall Study|Physician Decision|9|||
129873913|NCT01147822|467496617|FG001|Overall Study|Physician Decision|8|||
130095250|NCT02708524|468305463|FG002|Overall Study|Lens Discomfort|1|||
130095251|NCT02708524|468305464|FG003|Overall Study|Lens Discomfort|0|||
129873914|NCT01147822|467496616|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
130095252|NCT02708524|468305461|FG000|Overall Study|Lost to Follow-up|1|||
130095253|NCT02708524|468305462|FG001|Overall Study|Lost to Follow-up|1|||
130095254|NCT02708524|468305463|FG002|Overall Study|Lost to Follow-up|1|||
130095255|NCT02708524|468305464|FG003|Overall Study|Lost to Follow-up|0|||
130095256|NCT02708524|468305461|FG000|Overall Study|Protocol Violation|0|||
130095257|NCT02708524|468305462|FG001|Overall Study|Protocol Violation|1|||
130095258|NCT02708524|468305463|FG002|Overall Study|Protocol Violation|0|||
130207708|NCT01472939|468720981|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130207709|NCT01472939|468720982|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130207710|NCT01472939|468720983|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
130207711|NCT01472939|468720984|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
130207712|NCT01472939|468720981|FG000|Overall Study|Prohibited Medication|0|||
130207713|NCT01472939|468720982|FG001|Overall Study|Prohibited Medication|1|||
130207714|NCT01472939|468720983|FG002|Overall Study|Prohibited Medication|0|||
130207715|NCT01472939|468720984|FG003|Overall Study|Prohibited Medication|0|||
130207716|NCT01472939|468720981|FG000|Overall Study|Withdrawal By PI|1|||
130207717|NCT01472939|468720982|FG001|Overall Study|Withdrawal By PI|0|||
130207718|NCT01472939|468720983|FG002|Overall Study|Withdrawal By PI|0|||
130207719|NCT01472939|468720984|FG003|Overall Study|Withdrawal By PI|0|||
130207720|NCT01472939|468720981|FG000|Overall Study|Protocol Violation|3|||
130207721|NCT01472939|468720982|FG001|Overall Study|Protocol Violation|3|||
130207722|NCT01472939|468720983|FG002|Overall Study|Protocol Violation|0|||
130207723|NCT01472939|468720984|FG003|Overall Study|Protocol Violation|1|||
130207724|NCT01472939|468720981|FG000|Overall Study|Withdrawal by Subject|9|||
130207725|NCT01472939|468720982|FG001|Overall Study|Withdrawal by Subject|3|||
130207726|NCT01472939|468720983|FG002|Overall Study|Withdrawal by Subject|1|||
130207727|NCT01472939|468720984|FG003|Overall Study|Withdrawal by Subject|4|||
130207728|NCT00114738|468720985|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
129873915|NCT01147822|467496617|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
129984735|NCT02101385|467905545|FG001|Study Treatment|Withdrawal by Subject|2|||
130095259|NCT02708524|468305464|FG003|Overall Study|Protocol Violation|0|||
129873916|NCT01147822|467496616|FG000|Overall Study|Protocol Violation|1|||
129873917|NCT01147822|467496617|FG001|Overall Study|Protocol Violation|1|||
129873918|NCT01226511|467496618|FG000|Acute Treatment Period|Adverse Event|7|||
130207729|NCT00114738|468720986|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
130207730|NCT00114738|468720987|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
130207731|NCT00114738|468720985|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
130207732|NCT00114738|468720986|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
130207733|NCT00114738|468720987|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
130207734|NCT00114738|468720985|FG000|Screening for Randomization|Neuropathy|17|||
130207735|NCT00114738|468720986|FG001|Screening for Randomization|Neuropathy|0|||
130207736|NCT00114738|468720987|FG002|Screening for Randomization|Neuropathy|0|||
130207737|NCT00114738|468720985|FG000|Screening for Randomization|Progressive disease|2|||
130207738|NCT00114738|468720986|FG001|Screening for Randomization|Progressive disease|0|||
130207739|NCT00114738|468720987|FG002|Screening for Randomization|Progressive disease|0|||
130207740|NCT00114738|468720985|FG000|Screening for Randomization|CNS Hemorrhage|1|||
130207741|NCT00114738|468720986|FG001|Screening for Randomization|CNS Hemorrhage|0|||
130207742|NCT00114738|468720987|FG002|Screening for Randomization|CNS Hemorrhage|0|||
130207743|NCT00114738|468720985|FG000|Screening for Randomization|Other|1|||
130207744|NCT00114738|468720986|FG001|Screening for Randomization|Other|0|||
130207745|NCT00114738|468720987|FG002|Screening for Randomization|Other|0|||
130207746|NCT00388297|468720990|FG000|Overall Study|Lost to Follow-up|16|||
130207747|NCT00388297|468720991|FG001|Overall Study|Lost to Follow-up|12|||
130207748|NCT00388297|468720992|FG002|Overall Study|Lost to Follow-up|11|||
130207749|NCT00388297|468720993|FG003|Overall Study|Lost to Follow-up|8|||
130207750|NCT02607280|468720994|FG000|Overall Study|Adverse Event|4|||
130207751|NCT02607280|468720995|FG001|Overall Study|Adverse Event|0|||
130207752|NCT02607280|468720994|FG000|Overall Study|Decrease in CrCl <15|0|||
130207753|NCT02607280|468720995|FG001|Overall Study|Decrease in CrCl <15|1|||
130207754|NCT03435224|468721001|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
130207755|NCT04472026|468721002|FG000|Overall Study|Lost to Follow-up|5|||
130207756|NCT01777295|468721003|FG000|Overall Study|Withdrawal by Subject|2|||
130207757|NCT01777295|468721004|FG001|Overall Study|Withdrawal by Subject|2|||
130207758|NCT01777295|468721003|FG000|Overall Study|Pregnancy|0|||
130207759|NCT01777295|468721004|FG001|Overall Study|Pregnancy|1|||
130207760|NCT01777295|468721003|FG000|Overall Study|Personal problem|1|||
130207761|NCT01777295|468721004|FG001|Overall Study|Personal problem|0|||
130207762|NCT01777295|468721003|FG000|Overall Study|Investigator call for AEs check|1|||
130207763|NCT01777295|468721004|FG001|Overall Study|Investigator call for AEs check|0|||
130207764|NCT01069419|468721005|FG000|Overall Study|Adverse Event|233|||
130207765|NCT01069419|468721005|FG000|Overall Study|Lack of Efficacy|332|||
130207766|NCT01069419|468721005|FG000|Overall Study|Lost to Follow-up|49|||
130207767|NCT01069419|468721005|FG000|Overall Study|Remission of disease|11|||
130207768|NCT01069419|468721005|FG000|Overall Study|Withdrawal by Subject|34|||
130207769|NCT01069419|468721005|FG000|Overall Study|Other Reason|43|||
130207770|NCT01069419|468721005|FG000|Overall Study|Missing termination information|13|||
130207771|NCT04526574|468721006|FG000|Overall Study|Protocol Violation|3|||
130207772|NCT04526574|468721007|FG001|Overall Study|Protocol Violation|1|||
130207773|NCT04526574|468721006|FG000|Overall Study|Withdrawal by Subject|12|||
129984736|NCT02101385|467905544|FG000|Study Treatment|screen failure|1|||
129984737|NCT02101385|467905545|FG001|Study Treatment|screen failure|0|||
129984738|NCT02101385|467905544|FG000|Study Treatment|AE/Side Effects/Complications|8|||
129984739|NCT02101385|467905545|FG001|Study Treatment|AE/Side Effects/Complications|0|||
129984740|NCT02101385|467905544|FG000|Study Treatment|Lost to Follow-up|1|||
129984741|NCT02101385|467905545|FG001|Study Treatment|Lost to Follow-up|0|||
129984742|NCT02101385|467905544|FG000|Study Treatment|Disease Progression before treatment|1|||
129984743|NCT02101385|467905545|FG001|Study Treatment|Disease Progression before treatment|0|||
129984744|NCT02101385|467905544|FG000|Study Treatment|Death|1|||
129984745|NCT02101385|467905545|FG001|Study Treatment|Death|0|||
129984746|NCT02101385|467905544|FG000|Follow up|Lost to Follow-up|4|||
130207774|NCT04526574|468721007|FG001|Overall Study|Withdrawal by Subject|9|||
130207775|NCT04526574|468721006|FG000|Overall Study|Other|1|||
130207776|NCT04526574|468721007|FG001|Overall Study|Other|2|||
130207777|NCT04526574|468721006|FG000|Overall Study|Adverse Event|1|||
130207778|NCT04526574|468721007|FG001|Overall Study|Adverse Event|1|||
130207779|NCT04526574|468721006|FG000|Overall Study|Death|2|||
130207780|NCT04526574|468721007|FG001|Overall Study|Death|3|||
130207781|NCT04526574|468721006|FG000|Overall Study|Lost to Follow-up|9|||
129873919|NCT01226511|467496619|FG001|Acute Treatment Period|Adverse Event|6|||
129873920|NCT01226511|467496618|FG000|Acute Treatment Period|Lack of Efficacy|2|||
129873921|NCT01226511|467496619|FG001|Acute Treatment Period|Lack of Efficacy|1|||
129873922|NCT01226511|467496618|FG000|Acute Treatment Period|Lost to Follow-up|3|||
129873923|NCT01226511|467496619|FG001|Acute Treatment Period|Lost to Follow-up|6|||
129873924|NCT01226511|467496618|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
129873925|NCT01226511|467496619|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
129984747|NCT02101385|467905545|FG001|Follow up|Lost to Follow-up|9|||
129984748|NCT02101385|467905544|FG000|Follow up|Refused to follow up|5|||
129891096|NCT02408549|467559616|FG000|Overall Study|Pregnancy|1|||
130207782|NCT04526574|468721007|FG001|Overall Study|Lost to Follow-up|9|||
130207783|NCT04526574|468721006|FG000|Overall Study|No longer meets eligibility criteria|8|||
130207784|NCT04526574|468721007|FG001|Overall Study|No longer meets eligibility criteria|8|||
130207785|NCT02248974|468721010|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
130207786|NCT02248974|468721011|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
130207787|NCT02248974|468721010|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
130207788|NCT02248974|468721011|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
130207789|NCT02248974|468721010|FG000|1-Day Follow-Up|Enrolled in another study|1|||
130207790|NCT02248974|468721011|FG001|1-Day Follow-Up|Enrolled in another study|0|||
130207791|NCT02248974|468721010|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
130207792|NCT02248974|468721011|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
130207793|NCT02248974|468721010|FG000|1-Week Follow-Up|Enrolled in another study|1|||
130207794|NCT02248974|468721011|FG001|1-Week Follow-Up|Enrolled in another study|1|||
130207795|NCT02248974|468721010|FG000|1-Week Follow-Up|Transferred to another facility|1|||
130207796|NCT02248974|468721011|FG001|1-Week Follow-Up|Transferred to another facility|0|||
130207797|NCT02248974|468721010|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
130207798|NCT02248974|468721011|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
130207799|NCT02248974|468721010|FG000|1-Week Follow-Up|Death|1|||
130207800|NCT02248974|468721011|FG001|1-Week Follow-Up|Death|1|||
129984749|NCT02101385|467905545|FG001|Follow up|Refused to follow up|4|||
129984750|NCT02101385|467905544|FG000|Follow up|Death|21|||
129984751|NCT02101385|467905545|FG001|Follow up|Death|39|||
129984752|NCT02101385|467905544|FG000|Follow up|study completed|33|||
129984753|NCT02101385|467905545|FG001|Follow up|study completed|52|||
129984754|NCT02101385|467905544|FG000|Follow up|screen failure|2|||
129984755|NCT02101385|467905545|FG001|Follow up|screen failure|0|||
129984756|NCT02101385|467905544|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
129984757|NCT02101385|467905545|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
129984758|NCT02101385|467905544|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
129984759|NCT02101385|467905545|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
129984760|NCT02101385|467905544|FG000|Follow up|Withdrawal by Subject|2|||
129984761|NCT02101385|467905545|FG001|Follow up|Withdrawal by Subject|2|||
129984762|NCT02101385|467905544|FG000|Follow up|PI requested closure of site|0|||
129984763|NCT02101385|467905545|FG001|Follow up|PI requested closure of site|5|||
129984764|NCT02432196|467905546|FG000|Overall Study|Exit - did not receive study device|1|||
129984765|NCT02432196|467905546|FG000|Overall Study|Death|2|||
129984766|NCT02432196|467905546|FG000|Overall Study|Reoperation|3|||
129984767|NCT05038163|467905547|FG000|Stage 1|Did not complete survey|374|||
129984768|NCT05038163|467905548|FG001|Stage 1|Did not complete survey|0|||
129984769|NCT05038163|467905549|FG002|Stage 1|Did not complete survey|0|||
129984770|NCT05038163|467905550|FG003|Stage 1|Did not complete survey|0|||
129984771|NCT05038163|467905551|FG004|Stage 1|Did not complete survey|0|||
129984772|NCT05038163|467905552|FG005|Stage 1|Did not complete survey|0|||
130095260|NCT02708524|468305461|FG000|Overall Study|Withdrawal by Subject|1|||
130207801|NCT02248974|468721010|FG000|1-Week Follow-Up|Excluded because of age|0|||
130207802|NCT02248974|468721011|FG001|1-Week Follow-Up|Excluded because of age|1|||
130207803|NCT02248974|468721010|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
130207804|NCT02248974|468721011|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
130207805|NCT02248974|468721010|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
130207806|NCT02248974|468721011|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
130207807|NCT02248974|468721010|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
130207808|NCT02248974|468721011|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
130207809|NCT02248974|468721010|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
130207810|NCT02248974|468721011|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
130207811|NCT02248974|468721010|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
130207812|NCT02248974|468721011|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
130207813|NCT02332239|468721012|FG000|Overall Study|Lost to Follow-up|4|||
130207814|NCT02332239|468721013|FG001|Overall Study|Lost to Follow-up|6|||
130207815|NCT00115037|468721014|FG000|Phase1|Lost to Follow-up|16|||
130207816|NCT00115037|468721015|FG001|Phase1|Lost to Follow-up|23|||
130207817|NCT00115037|468721016|FG002|Phase1|Lost to Follow-up|0|||
130207818|NCT00115037|468721017|FG003|Phase1|Lost to Follow-up|0|||
130207819|NCT00115037|468721018|FG004|Phase1|Lost to Follow-up|0|||
130207820|NCT00115037|468721019|FG005|Phase1|Lost to Follow-up|0|||
130207821|NCT00115037|468721014|FG000|Phase1|Withdrawal by Subject|9|||
130207822|NCT00115037|468721015|FG001|Phase1|Withdrawal by Subject|4|||
130207823|NCT00115037|468721016|FG002|Phase1|Withdrawal by Subject|0|||
130207824|NCT00115037|468721017|FG003|Phase1|Withdrawal by Subject|0|||
130207825|NCT00115037|468721018|FG004|Phase1|Withdrawal by Subject|0|||
130207826|NCT00115037|468721019|FG005|Phase1|Withdrawal by Subject|0|||
130207827|NCT00115037|468721014|FG000|Phase2|Death|0|||
130207828|NCT00115037|468721015|FG001|Phase2|Death|0|||
129984773|NCT05038163|467905547|FG000|Stage 2|Did not complete Stage 2 survey|0|||
129984774|NCT05038163|467905548|FG001|Stage 2|Did not complete Stage 2 survey|29|||
129984775|NCT05038163|467905549|FG002|Stage 2|Did not complete Stage 2 survey|30|||
130207829|NCT00115037|468721016|FG002|Phase2|Death|1|||
130207830|NCT00115037|468721017|FG003|Phase2|Death|0|||
130207831|NCT00115037|468721018|FG004|Phase2|Death|0|||
130207832|NCT00115037|468721019|FG005|Phase2|Death|1|||
130207833|NCT00115037|468721014|FG000|Phase2|Withdrawal by Subject|0|||
130207834|NCT00115037|468721015|FG001|Phase2|Withdrawal by Subject|0|||
130207835|NCT00115037|468721016|FG002|Phase2|Withdrawal by Subject|2|||
130207836|NCT00115037|468721017|FG003|Phase2|Withdrawal by Subject|1|||
130207837|NCT00115037|468721018|FG004|Phase2|Withdrawal by Subject|2|||
130207838|NCT00115037|468721019|FG005|Phase2|Withdrawal by Subject|1|||
130207839|NCT00115037|468721014|FG000|Phase2|Lost to Follow-up|0|||
130207840|NCT00115037|468721015|FG001|Phase2|Lost to Follow-up|0|||
130207841|NCT00115037|468721016|FG002|Phase2|Lost to Follow-up|12|||
130207842|NCT00115037|468721017|FG003|Phase2|Lost to Follow-up|14|||
130207843|NCT00115037|468721018|FG004|Phase2|Lost to Follow-up|4|||
130207844|NCT00115037|468721019|FG005|Phase2|Lost to Follow-up|10|||
130207845|NCT00396877|468721020|FG000|Overall Study|Lost to Follow-up|2|||
130207846|NCT00396877|468721021|FG001|Overall Study|Lost to Follow-up|1|||
130207847|NCT00396877|468721020|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
130207848|NCT00396877|468721021|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
130207849|NCT00334802|468721022|FG000|Overall Study|Progressive Disease|2|||
130207850|NCT00334802|468721023|FG001|Overall Study|Progressive Disease|24|||
130207851|NCT00334802|468721022|FG000|Overall Study|Toxicity|1|||
130207852|NCT00334802|468721023|FG001|Overall Study|Toxicity|5|||
130207853|NCT00334802|468721022|FG000|Overall Study|Lack of Efficacy|1|||
130207854|NCT00334802|468721023|FG001|Overall Study|Lack of Efficacy|3|||
130207855|NCT00334802|468721022|FG000|Overall Study|Patient Condition Aggrevated|1|||
130207856|NCT00334802|468721023|FG001|Overall Study|Patient Condition Aggrevated|0|||
130207857|NCT00334802|468721022|FG000|Overall Study|Physician Decision|1|||
130207858|NCT00334802|468721023|FG001|Overall Study|Physician Decision|0|||
130207859|NCT00334802|468721022|FG000|Overall Study|Withdrawal by Subject|0|||
130207860|NCT00334802|468721023|FG001|Overall Study|Withdrawal by Subject|4|||
130207861|NCT00334802|468721022|FG000|Overall Study|Adverse Event|0|||
130207862|NCT00334802|468721023|FG001|Overall Study|Adverse Event|3|||
130207863|NCT00334802|468721022|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
130207864|NCT00334802|468721023|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
129873926|NCT01226511|467496618|FG000|Acute Treatment Period|Protocol Violation|5|||
129873927|NCT01226511|467496619|FG001|Acute Treatment Period|Protocol Violation|5|||
129873928|NCT01226511|467496618|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
129873929|NCT01226511|467496619|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
129873930|NCT01226511|467496618|FG000|Extension Treatment Period|Adverse Event|8|||
129873931|NCT01226511|467496619|FG001|Extension Treatment Period|Adverse Event|8|||
129873932|NCT01226511|467496618|FG000|Extension Treatment Period|Lack of Efficacy|3|||
129873933|NCT01226511|467496619|FG001|Extension Treatment Period|Lack of Efficacy|2|||
129873934|NCT01226511|467496618|FG000|Extension Treatment Period|Lost to Follow-up|4|||
129873935|NCT01226511|467496619|FG001|Extension Treatment Period|Lost to Follow-up|3|||
129873936|NCT01226511|467496618|FG000|Extension Treatment Period|Protocol Violation|2|||
129873937|NCT01226511|467496619|FG001|Extension Treatment Period|Protocol Violation|2|||
129873938|NCT01226511|467496618|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
129873939|NCT01226511|467496619|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
129873940|NCT01226511|467496618|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
129873941|NCT01226511|467496619|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
129873942|NCT01226511|467496618|FG000|Extension Treatment Period|Sponsor Decision|1|||
129873943|NCT01226511|467496619|FG001|Extension Treatment Period|Sponsor Decision|1|||
129873944|NCT01226511|467496618|FG000|Taper Period|Adverse Event|1|||
129873945|NCT01226511|467496619|FG001|Taper Period|Adverse Event|0|||
129873946|NCT01226511|467496618|FG000|Taper Period|Lost to Follow-up|2|||
129873947|NCT01226511|467496619|FG001|Taper Period|Lost to Follow-up|2|||
129873948|NCT01226511|467496618|FG000|Taper Period|Protocol Violation|1|||
129873949|NCT01226511|467496619|FG001|Taper Period|Protocol Violation|0|||
129873950|NCT01226511|467496618|FG000|Taper Period|Parent/Caregiver Decision|1|||
129873951|NCT01226511|467496619|FG001|Taper Period|Parent/Caregiver Decision|1|||
129873952|NCT01337986|467496620|FG000|Overall Study|Adverse Event|2|||
129873953|NCT01337986|467496621|FG001|Overall Study|Adverse Event|2|||
130207865|NCT03436199|468721024|FG000|Overall Study|Adverse Event|15|||
130207866|NCT03436199|468721025|FG001|Overall Study|Adverse Event|40|||
130207867|NCT03436199|468721026|FG002|Overall Study|Adverse Event|7|||
130207868|NCT03436199|468721024|FG000|Overall Study|Withdrawal by Subject|4|||
130207869|NCT03436199|468721025|FG001|Overall Study|Withdrawal by Subject|10|||
130207870|NCT03436199|468721026|FG002|Overall Study|Withdrawal by Subject|3|||
129873954|NCT01337986|467496620|FG000|Overall Study|Lost to Follow-up|1|||
129873955|NCT01337986|467496621|FG001|Overall Study|Lost to Follow-up|0|||
130207871|NCT03436199|468721024|FG000|Overall Study|Lost to Follow-up|1|||
130207872|NCT03436199|468721025|FG001|Overall Study|Lost to Follow-up|0|||
130207873|NCT03436199|468721026|FG002|Overall Study|Lost to Follow-up|2|||
130207874|NCT03436199|468721024|FG000|Overall Study|Protocol Violation|1|||
130207875|NCT03436199|468721025|FG001|Overall Study|Protocol Violation|1|||
130207876|NCT03436199|468721026|FG002|Overall Study|Protocol Violation|0|||
130207877|NCT03436199|468721024|FG000|Overall Study|Physician Decision|0|||
130207878|NCT03436199|468721025|FG001|Overall Study|Physician Decision|1|||
130207879|NCT03436199|468721026|FG002|Overall Study|Physician Decision|0|||
129873956|NCT01337986|467496620|FG000|Overall Study|Protocol Violation|0|||
129873957|NCT01337986|467496621|FG001|Overall Study|Protocol Violation|3|||
129873958|NCT01520402|467496622|FG000|Overall Study|Withdrawal by Subject|2|||
129873959|NCT01520402|467496622|FG000|Overall Study|Physician Decision|3|||
129873960|NCT01722162|467496624|FG000|Overall Study|Withdrawal by Subject|1|||
129873961|NCT01722162|467496625|FG001|Overall Study|Withdrawal by Subject|1|||
129873962|NCT01722162|467496624|FG000|Overall Study|Found ineligible|1|||
129873963|NCT01722162|467496625|FG001|Overall Study|Found ineligible|0|||
129873964|NCT01722162|467496624|FG000|Overall Study|Unrelated to study adverse event|2|||
129873965|NCT01722162|467496625|FG001|Overall Study|Unrelated to study adverse event|2|||
129873966|NCT01722162|467496624|FG000|Overall Study|Adverse Event|1|||
129873967|NCT01722162|467496625|FG001|Overall Study|Adverse Event|1|||
129873968|NCT01722162|467496624|FG000|Overall Study|Insurance denial post enrollment|0|||
129873969|NCT01722162|467496625|FG001|Overall Study|Insurance denial post enrollment|1|||
129873970|NCT01722162|467496624|FG000|Overall Study|Noncompliance|0|||
129873971|NCT01722162|467496625|FG001|Overall Study|Noncompliance|1|||
129873972|NCT03170375|467496626|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
129873973|NCT03170375|467496627|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
129873974|NCT03170375|467496628|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
129873975|NCT03170375|467496626|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
129873976|NCT03170375|467496627|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
129873977|NCT03170375|467496628|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
129873978|NCT00763958|467496629|FG000|Overall Study|did not meet final criteria|4|||
129873979|NCT00763958|467496630|FG001|Overall Study|did not meet final criteria|4|||
129873980|NCT00763958|467496629|FG000|Overall Study|Lost to Follow-up|10|||
129873981|NCT00763958|467496630|FG001|Overall Study|Lost to Follow-up|2|||
129873982|NCT00763958|467496629|FG000|Overall Study|Believed they were receiving placebo|0|||
129873983|NCT00763958|467496630|FG001|Overall Study|Believed they were receiving placebo|5|||
129873984|NCT02535364|467496633|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
129873985|NCT02535364|467496633|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
129873986|NCT02535364|467496633|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
129873987|NCT02535364|467496633|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
129873988|NCT02535364|467496633|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
129873989|NCT02535364|467496633|FG000|Part B Screening|Death|2|||
129873990|NCT02535364|467496633|FG000|Part B Screening|Physician Decision|1|||
129873991|NCT02535364|467496633|FG000|Part B Screening|Withdrawal by Subject|1|||
129873992|NCT02535364|467496633|FG000|Part B Screening|Adverse Event|1|||
129873993|NCT02535364|467496633|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
129873994|NCT02535364|467496633|FG000|Study Treatment|Death|1|||
129873995|NCT02535364|467496633|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
129873996|NCT02535364|467496633|FG000|12-Month Follow-up Period|Disease progression|22|||
129873997|NCT02535364|467496633|FG000|12-Month Follow-up Period|Death|5|||
129873998|NCT02535364|467496633|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
130207880|NCT03436199|468721024|FG000|Overall Study|Could not return to clinic|1|||
130207881|NCT03436199|468721025|FG001|Overall Study|Could not return to clinic|0|||
130207882|NCT03436199|468721026|FG002|Overall Study|Could not return to clinic|0|||
130207883|NCT03436199|468721024|FG000|Overall Study|Withdrawn per physician|0|||
130207884|NCT03436199|468721025|FG001|Overall Study|Withdrawn per physician|1|||
130207885|NCT03436199|468721026|FG002|Overall Study|Withdrawn per physician|0|||
130207886|NCT00085098|468721027|FG000|Overall Study|Withdrawal by Subject|0|||
130207887|NCT00085098|468721028|FG001|Overall Study|Withdrawal by Subject|1|||
130207888|NCT00085098|468721027|FG000|Overall Study|Ineligible|1|||
130207889|NCT00085098|468721028|FG001|Overall Study|Ineligible|1|||
130207890|NCT03515629|468721029|FG000|Overall Study|Death|0|||
130207891|NCT03515629|468721030|FG001|Overall Study|Death|1|||
130207892|NCT03515629|468721031|FG002|Overall Study|Death|1|||
130207893|NCT03515629|468721029|FG000|Overall Study|Progressive disease|0|||
130207894|NCT03515629|468721030|FG001|Overall Study|Progressive disease|1|||
129873999|NCT02535364|467496633|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
129874000|NCT02535364|467496633|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
129874001|NCT00571701|467496634|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
129874002|NCT00571701|467496635|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
129874003|NCT00571701|467496634|FG000|First Intervention 12 Months|Death|1|||
129874004|NCT00571701|467496635|FG001|First Intervention 12 Months|Death|0|||
129874005|NCT00571701|467496634|FG000|Second Intervention 12 Months|Adverse Event|0|||
129874006|NCT00571701|467496635|FG001|Second Intervention 12 Months|Adverse Event|1|||
129874007|NCT00571701|467496634|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
129874008|NCT00571701|467496635|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
130207895|NCT03515629|468721031|FG002|Overall Study|Progressive disease|0|||
130207896|NCT01886781|468721032|FG000|Overall Study|Protocol Violation|5|||
130207897|NCT01886781|468721033|FG001|Overall Study|Protocol Violation|0|||
129874009|NCT04766086|467496639|FG000|Overall Study|Lost to Follow-up|3|||
129874010|NCT04766086|467496640|FG001|Overall Study|Lost to Follow-up|5|||
129874011|NCT04766086|467496641|FG002|Overall Study|Lost to Follow-up|3|||
129874012|NCT04766086|467496639|FG000|Overall Study|Withdrawal by Subject|1|||
129874013|NCT04766086|467496640|FG001|Overall Study|Withdrawal by Subject|1|||
129874014|NCT04766086|467496641|FG002|Overall Study|Withdrawal by Subject|2|||
129874015|NCT04766086|467496639|FG000|Overall Study|Other|0|||
129874016|NCT04766086|467496640|FG001|Overall Study|Other|0|||
129874017|NCT04766086|467496641|FG002|Overall Study|Other|1|||
129874018|NCT03815019|467496642|FG000|Overall Study|Withdrawal by Subject|6|||
129874019|NCT03815019|467496643|FG001|Overall Study|Withdrawal by Subject|8|||
129874020|NCT01320943|467496644|FG000|Overall Study|Lost to Follow-up|1|||
129874021|NCT01320943|467496645|FG001|Overall Study|Lost to Follow-up|0|||
129874022|NCT01320943|467496644|FG000|Overall Study|Physician Decision|0|||
129874023|NCT01320943|467496645|FG001|Overall Study|Physician Decision|1|||
129874024|NCT01320943|467496644|FG000|Overall Study|Randomized but not Treated|0|||
129874025|NCT01320943|467496645|FG001|Overall Study|Randomized but not Treated|1|||
129874026|NCT03937219|467496646|FG000|Overall Study|Death|223|||
129874027|NCT03937219|467496647|FG001|Overall Study|Death|211|||
129874028|NCT03937219|467496646|FG000|Overall Study|Withdrawal by Subject|17|||
129874029|NCT03937219|467496647|FG001|Overall Study|Withdrawal by Subject|25|||
129874030|NCT03937219|467496646|FG000|Overall Study|Lost to Follow-up|3|||
129874031|NCT03937219|467496647|FG001|Overall Study|Lost to Follow-up|4|||
129874032|NCT00532155|467496648|FG000|Overall Study|Adverse Event|66|||
129874033|NCT00532155|467496649|FG001|Overall Study|Adverse Event|123|||
129874034|NCT00532155|467496648|FG000|Overall Study|Lack of Efficacy|332|||
129874035|NCT00532155|467496649|FG001|Overall Study|Lack of Efficacy|255|||
129874036|NCT00532155|467496648|FG000|Overall Study|Protocol Violation|1|||
129874037|NCT00532155|467496649|FG001|Overall Study|Protocol Violation|3|||
129874038|NCT00532155|467496648|FG000|Overall Study|Lost to Follow-up|2|||
129874039|NCT00532155|467496649|FG001|Overall Study|Lost to Follow-up|0|||
129874040|NCT00532155|467496648|FG000|Overall Study|Physician Decision|16|||
129874041|NCT00532155|467496649|FG001|Overall Study|Physician Decision|15|||
129874042|NCT00532155|467496648|FG000|Overall Study|Withdrawal by Subject|23|||
129874043|NCT00532155|467496649|FG001|Overall Study|Withdrawal by Subject|44|||
129874044|NCT00532155|467496648|FG000|Overall Study|Consent withdrawn|5|||
129874045|NCT00532155|467496649|FG001|Overall Study|Consent withdrawn|7|||
129874046|NCT00532155|467496648|FG000|Overall Study|Moved|1|||
129874047|NCT00532155|467496649|FG001|Overall Study|Moved|0|||
129874048|NCT00532155|467496648|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
129874049|NCT00532155|467496649|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
129874050|NCT00532155|467496648|FG000|Overall Study|Occurence of a second cancer|0|||
129874051|NCT00532155|467496649|FG001|Overall Study|Occurence of a second cancer|1|||
129874052|NCT00532155|467496648|FG000|Overall Study|Occurence of a secondary cancer|0|||
129874053|NCT00532155|467496649|FG001|Overall Study|Occurence of a secondary cancer|1|||
129874054|NCT00532155|467496648|FG000|Overall Study|Promotor ended study|1|||
129874055|NCT00532155|467496649|FG001|Overall Study|Promotor ended study|0|||
129874056|NCT00532155|467496648|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
129874057|NCT00532155|467496649|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
129874058|NCT00532155|467496648|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
129874059|NCT00532155|467496649|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
129874060|NCT00532155|467496648|FG000|Overall Study|Study stopped|1|||
129874061|NCT00532155|467496649|FG001|Overall Study|Study stopped|0|||
129874062|NCT00532155|467496648|FG000|Overall Study|Study terminated by sponsor|1|||
129874063|NCT00532155|467496649|FG001|Overall Study|Study terminated by sponsor|0|||
129874064|NCT00532155|467496648|FG000|Overall Study|Study termination stop further treatment|4|||
129874065|NCT00532155|467496649|FG001|Overall Study|Study termination stop further treatment|0|||
129874066|NCT00532155|467496648|FG000|Overall Study|Did not receive study medication|2|||
129874067|NCT00532155|467496649|FG001|Overall Study|Did not receive study medication|6|||
129874068|NCT03483038|467496650|FG000|Overall Study|Subjects still in follow-up|18|||
129874069|NCT02134925|467496651|FG000|Overall Study|Withdrawal by Subject|1|||
129874070|NCT02134925|467496652|FG001|Overall Study|Withdrawal by Subject|0|||
129874071|NCT02134925|467496651|FG000|Overall Study|Cancel|1|||
129874072|NCT02134925|467496652|FG001|Overall Study|Cancel|6|||
129874073|NCT04987762|467496653|FG000|Overall Study|Study was Terminated by Sponsor|103|||
129874074|NCT02158884|467496658|FG000|Baseline Assessment|Missed performance assessment|3|||
129874075|NCT02158884|467496658|FG000|Baseline Assessment|Missed SMFA|1|||
129874076|NCT02158884|467496658|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
129874077|NCT02158884|467496658|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
129874078|NCT02158884|467496658|FG000|6 Month Assessment|Missed SMFA|20|||
129874079|NCT02158884|467496658|FG000|12 Month Assessment|Missed SMFA|17|||
129874080|NCT03988166|467496661|FG000|Overall Study|Lost to Follow-up|2|||
129874081|NCT03988166|467496661|FG000|Overall Study|Death|1|||
129874082|NCT03248375|467496662|FG000|Overall Study|Lost to Follow-up|5|||
129874083|NCT00316173|467496667|FG000|Run-in Phase|Adverse Event|1|||
129874084|NCT00316173|467496668|FG001|Run-in Phase|Adverse Event|0|||
129874085|NCT00316173|467496667|FG000|Run-in Phase|Protocol Violation|1|||
129874086|NCT00316173|467496668|FG001|Run-in Phase|Protocol Violation|0|||
129874087|NCT00316173|467496667|FG000|Run-in Phase|Study Follow-up Stopped|5|||
129874088|NCT00316173|467496668|FG001|Run-in Phase|Study Follow-up Stopped|0|||
129874089|NCT00316173|467496667|FG000|Treatment Phase|Adverse Event|0|||
129874090|NCT00316173|467496668|FG001|Treatment Phase|Adverse Event|1|||
129874091|NCT00316173|467496667|FG000|Treatment Phase|Lack of Efficacy|0|||
129874092|NCT00316173|467496668|FG001|Treatment Phase|Lack of Efficacy|3|||
129874093|NCT00316173|467496667|FG000|Treatment Phase|Lost to Follow-up|0|||
129874094|NCT00316173|467496668|FG001|Treatment Phase|Lost to Follow-up|3|||
129874095|NCT00316173|467496667|FG000|Treatment Phase|Withdrawal by Subject|0|||
129874096|NCT00316173|467496668|FG001|Treatment Phase|Withdrawal by Subject|1|||
129874097|NCT00316173|467496667|FG000|Treatment Phase|Study Follow-up Stopped|0|||
129874098|NCT00316173|467496668|FG001|Treatment Phase|Study Follow-up Stopped|34|||
129874099|NCT03764072|467496669|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874100|NCT03764072|467496670|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874101|NCT03764072|467496671|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
129874102|NCT03764072|467496672|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874103|NCT03764072|467496673|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874104|NCT03764072|467496674|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874105|NCT03764072|467496669|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
129874106|NCT03764072|467496670|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
129874107|NCT03764072|467496671|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
129874108|NCT03764072|467496672|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
129874109|NCT03764072|467496673|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
129874110|NCT03764072|467496674|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
129874111|NCT03764072|467496669|FG000|Overall Study|Lost to Follow-up|0|||
129874112|NCT03764072|467496670|FG001|Overall Study|Lost to Follow-up|0|||
129874113|NCT03764072|467496671|FG002|Overall Study|Lost to Follow-up|0|||
129874114|NCT03764072|467496672|FG003|Overall Study|Lost to Follow-up|0|||
129874115|NCT03764072|467496673|FG004|Overall Study|Lost to Follow-up|1|||
129874116|NCT03764072|467496674|FG005|Overall Study|Lost to Follow-up|0|||
129874117|NCT00558064|467496675|FG000|Overall Study|Adverse Event|3|||
129874118|NCT00558064|467496676|FG001|Overall Study|Adverse Event|2|||
129874119|NCT00558064|467496675|FG000|Overall Study|Lack of Efficacy|0|||
129874120|NCT00558064|467496676|FG001|Overall Study|Lack of Efficacy|1|||
129874121|NCT00558064|467496675|FG000|Overall Study|Protocol Violation|1|||
129874122|NCT00558064|467496676|FG001|Overall Study|Protocol Violation|0|||
129874123|NCT00558064|467496675|FG000|Overall Study|Lost to Follow-up|0|||
129874124|NCT00558064|467496676|FG001|Overall Study|Lost to Follow-up|1|||
129874125|NCT00558064|467496675|FG000|Overall Study|Withdrawal by Subject|0|||
129874126|NCT00558064|467496676|FG001|Overall Study|Withdrawal by Subject|1|||
129874127|NCT00558064|467496675|FG000|Overall Study|No visit within allowance period|1|||
129874128|NCT00558064|467496676|FG001|Overall Study|No visit within allowance period|0|||
129874129|NCT00982930|467496679|FG000|Overall Study|Adverse Event|1|||
129874130|NCT00982930|467496679|FG000|Overall Study|Withdrawal by Subject|1|||
129874131|NCT00982930|467496679|FG000|Overall Study|Administrative Problems|2|||
129874132|NCT01489189|467496680|FG000|Overall Study|Withdrawal by Subject|20|||
129874133|NCT01489189|467496681|FG001|Overall Study|Withdrawal by Subject|23|||
129874134|NCT01489189|467496680|FG000|Overall Study|Death|10|||
129874135|NCT01489189|467496681|FG001|Overall Study|Death|8|||
129874136|NCT01489189|467496680|FG000|Overall Study|Missed Visit|1|||
129874137|NCT01489189|467496681|FG001|Overall Study|Missed Visit|4|||
129874138|NCT05597722|467496682|FG000|Overall Study|Study was terminated|6|||
129874139|NCT05597722|467496683|FG001|Overall Study|Study was terminated|1|||
129874140|NCT00404495|467496684|FG000|Overall Study|Death|37|||
129874141|NCT00404495|467496685|FG001|Overall Study|Death|11|||
129874142|NCT00404495|467496684|FG000|Overall Study|Lost to Follow-up|5|||
129874143|NCT00404495|467496685|FG001|Overall Study|Lost to Follow-up|0|||
129874144|NCT00404495|467496684|FG000|Overall Study|Other|1|||
129874145|NCT00404495|467496685|FG001|Overall Study|Other|0|||
129874146|NCT00404495|467496684|FG000|Overall Study|Withdrawal by Subject|1|||
129874147|NCT00404495|467496685|FG001|Overall Study|Withdrawal by Subject|0|||
129874148|NCT04108000|467496686|FG000|Overall Study|Death of patient|1|||
129874149|NCT04108000|467496687|FG001|Overall Study|Death of patient|0|||
129874150|NCT04108000|467496688|FG002|Overall Study|Death of patient|1|||
129874151|NCT04108000|467496689|FG003|Overall Study|Death of patient|0|||
129874152|NCT04108000|467496686|FG000|Overall Study|Withdrawal by Subject|2|||
129874153|NCT04108000|467496687|FG001|Overall Study|Withdrawal by Subject|2|||
129874154|NCT04108000|467496688|FG002|Overall Study|Withdrawal by Subject|0|||
129874155|NCT04108000|467496689|FG003|Overall Study|Withdrawal by Subject|0|||
129874156|NCT04108000|467496686|FG000|Overall Study|Death of surrogate partner|0|||
129874157|NCT04108000|467496687|FG001|Overall Study|Death of surrogate partner|1|||
129874158|NCT04108000|467496688|FG002|Overall Study|Death of surrogate partner|0|||
129874159|NCT04108000|467496689|FG003|Overall Study|Death of surrogate partner|1|||
129874160|NCT03750006|467496693|FG000|Overall Study|Withdrawal by Subject|8|||
129874161|NCT03750006|467496693|FG000|Overall Study|COVID PANDEMIC|11|||
129874162|NCT03881696|467496694|FG000|Overall Study|Adverse Event|2|||
129874163|NCT03881696|467496695|FG001|Overall Study|Adverse Event|0|||
129874164|NCT03881696|467496694|FG000|Overall Study|Withdrawal by Subject|2|||
129874165|NCT03881696|467496695|FG001|Overall Study|Withdrawal by Subject|0|||
129874166|NCT03881696|467496694|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
129874167|NCT03881696|467496695|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
129874168|NCT03881696|467496694|FG000|Overall Study|Failure to meet continuation criteria|1|||
129874169|NCT03881696|467496695|FG001|Overall Study|Failure to meet continuation criteria|0|||
129874170|NCT01679301|467497883|FG000|Screening Period|screen failure|3|||
129874171|NCT01679301|467497884|FG001|Screening Period|screen failure|0|||
129874172|NCT01679301|467497885|FG002|Screening Period|screen failure|0|||
129874173|NCT02026232|467497886|FG000|Overall Study|incomplete visit/missing data|3|||
129874174|NCT02026232|467497887|FG001|Overall Study|incomplete visit/missing data|2|||
129874175|NCT01529008|467497888|FG000|Bone Marrow Harvesting|Physician Decision|1|||
129874176|NCT01529008|467497889|FG001|Bone Marrow Harvesting|Physician Decision|1|||
129874177|NCT01529008|467497888|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
129874178|NCT01529008|467497889|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
129874179|NCT01529008|467497888|FG000|Treatment|Adverse Event|6|||
129874180|NCT01529008|467497889|FG001|Treatment|Adverse Event|0|||
129874181|NCT01529008|467497888|FG000|Treatment|Other|3|||
129874182|NCT01529008|467497889|FG001|Treatment|Other|1|||
129874183|NCT01529008|467497888|FG000|Efficacy Analysis|Protocol Violation|2|||
129874184|NCT01529008|467497889|FG001|Efficacy Analysis|Protocol Violation|0|||
129874185|NCT01529008|467497888|FG000|Efficacy Analysis|Physician Decision|0|||
129874186|NCT01529008|467497889|FG001|Efficacy Analysis|Physician Decision|1|||
129874187|NCT01529008|467497888|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
129874188|NCT01529008|467497889|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
129874189|NCT01382602|467497890|FG000|Overall Study|Protocol Violation|0|||
129874190|NCT01382602|467497891|FG001|Overall Study|Protocol Violation|3|||
129874191|NCT01382602|467497890|FG000|Overall Study|Withdrawal by Subject|0|||
129874192|NCT01382602|467497891|FG001|Overall Study|Withdrawal by Subject|1|||
129874193|NCT01392300|467497898|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
129874194|NCT01392300|467497899|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
129874195|NCT01392300|467497900|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
129874196|NCT01392300|467497898|FG000|Main Period (MP)|Withdrawal by Subject|5|||
129874197|NCT01392300|467497899|FG001|Main Period (MP)|Withdrawal by Subject|1|||
129874198|NCT01392300|467497900|FG002|Main Period (MP)|Withdrawal by Subject|0|||
129874199|NCT01392300|467497898|FG000|Main Period (MP)|Lost to Follow-up|3|||
129874200|NCT01392300|467497899|FG001|Main Period (MP)|Lost to Follow-up|3|||
129874201|NCT01392300|467497900|FG002|Main Period (MP)|Lost to Follow-up|0|||
129874202|NCT01392300|467497898|FG000|Main Period (MP)|Non-compliance|1|||
129874203|NCT01392300|467497899|FG001|Main Period (MP)|Non-compliance|0|||
129874204|NCT01392300|467497900|FG002|Main Period (MP)|Non-compliance|0|||
129874205|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
129874206|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
129874207|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
129874208|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
129874209|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
129874210|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
129874211|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
129874212|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
129874213|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
129874214|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Death|0|||
129874215|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Death|0|||
129874216|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Death|4|||
129874217|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
129874218|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
129874219|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
129874220|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
129874221|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
129874222|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
129874223|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
129874224|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
129874225|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
129874226|NCT05056870|467497905|FG000|Period 1|Site COVID-19 Related|3|||
129874227|NCT05056870|467497906|FG001|Period 1|Site COVID-19 Related|3|||
129874228|NCT05056870|467497905|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129874229|NCT05056870|467497906|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
129874230|NCT05056870|467497905|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
129874231|NCT05056870|467497906|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129874232|NCT05056870|467497905|FG000|Period 2|COVID-19 Related|1|||
129874233|NCT05056870|467497906|FG001|Period 2|COVID-19 Related|0|||
130207898|NCT01886781|468721032|FG000|Overall Study|Adverse Event|1|||
129874234|NCT05056870|467497905|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
129874235|NCT05056870|467497906|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
129874236|NCT00676130|467497909|FG000|Overall Study|Lost to Follow-up|0|||
129874237|NCT00676130|467497910|FG001|Overall Study|Lost to Follow-up|1|||
129874238|NCT00676130|467497909|FG000|Overall Study|Found ineligible|3|||
129874239|NCT00676130|467497910|FG001|Overall Study|Found ineligible|2|||
129874240|NCT00676130|467497909|FG000|Overall Study|Withdrawal by Subject|0|||
129874241|NCT00676130|467497910|FG001|Overall Study|Withdrawal by Subject|1|||
129874242|NCT01181726|467497911|FG000|First Intervention|Adverse Event|1|||
129874243|NCT01181726|467497912|FG001|First Intervention|Adverse Event|0|||
129874244|NCT00429663|467497916|FG000|Overall Study|Lost to Follow-up|24|||
129874245|NCT00429663|467497917|FG001|Overall Study|Lost to Follow-up|31|||
129874246|NCT00429663|467497916|FG000|Overall Study|Physician Decision|6|||
129874247|NCT00429663|467497917|FG001|Overall Study|Physician Decision|3|||
129874248|NCT00429663|467497916|FG000|Overall Study|Withdrawal by Subject|2|||
129874249|NCT00429663|467497917|FG001|Overall Study|Withdrawal by Subject|5|||
129874250|NCT00429663|467497916|FG000|Overall Study|Death|4|||
129874251|NCT00429663|467497917|FG001|Overall Study|Death|0|||
129874252|NCT03261271|467497923|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
129874253|NCT03261271|467497924|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
129874254|NCT01932697|467497925|FG000|Overall Study|Received a different amount of tx|1|||
129874255|NCT01932697|467497926|FG001|Overall Study|Received a different amount of tx|0|||
129874256|NCT01932697|467497925|FG000|Overall Study|Ineligible|1|||
129874257|NCT01932697|467497926|FG001|Overall Study|Ineligible|0|||
129874258|NCT01114204|467497927|FG000|Overall Study|Adverse Event|3|||
129874259|NCT01114204|467497928|FG001|Overall Study|Adverse Event|2|||
129874260|NCT01114204|467497927|FG000|Overall Study|Lost to Follow-up|1|||
129874261|NCT01114204|467497928|FG001|Overall Study|Lost to Follow-up|0|||
129874262|NCT01114204|467497927|FG000|Overall Study|Withdrawal by Subject|10|||
129874263|NCT01114204|467497928|FG001|Overall Study|Withdrawal by Subject|6|||
129874264|NCT01114204|467497927|FG000|Overall Study|Death|1|||
129874265|NCT01114204|467497928|FG001|Overall Study|Death|0|||
129874266|NCT01114204|467497927|FG000|Overall Study|Other-Personal reasons|2|||
129874267|NCT01114204|467497928|FG001|Overall Study|Other-Personal reasons|0|||
129874268|NCT01114204|467497927|FG000|Overall Study|Other-Medical monitor request|1|||
129874269|NCT01114204|467497928|FG001|Overall Study|Other-Medical monitor request|0|||
129874270|NCT01114204|467497927|FG000|Overall Study|Other-Participant request|2|||
129874271|NCT01114204|467497928|FG001|Overall Study|Other-Participant request|0|||
129874272|NCT01114204|467497927|FG000|Overall Study|Other-Protocol Violation|1|||
129874273|NCT01114204|467497928|FG001|Overall Study|Other-Protocol Violation|0|||
129874274|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
129874275|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
129874276|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
129874277|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
129874278|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
129874279|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
129874280|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
129874281|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
129874282|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
129874283|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
129874284|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
129874285|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
129874286|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129874287|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129874288|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129874289|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
129874290|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
129874291|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129874292|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129874293|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129874294|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Death|2|||
129874295|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Death|2|||
129874296|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Death|0|||
129874297|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Death|0|||
129874298|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Death|0|||
129874299|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
129874300|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
129874301|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
129874302|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
129874303|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
129874304|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874305|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
129874306|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874307|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874308|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874309|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
129874310|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
129874311|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
129874312|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
129874313|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
129874314|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
129874315|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874316|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874317|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874318|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874319|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
129874320|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874321|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874322|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874323|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874324|NCT03420781|467497929|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874325|NCT03420781|467497930|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874326|NCT03420781|467497931|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874327|NCT03420781|467497932|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
129874328|NCT03420781|467497933|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874329|NCT03420781|467497929|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874330|NCT03420781|467497930|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874331|NCT03420781|467497931|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874332|NCT03420781|467497932|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874333|NCT03420781|467497933|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
129874334|NCT03420781|467497929|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
129874335|NCT03420781|467497930|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
129874336|NCT03420781|467497931|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
129874337|NCT03420781|467497932|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
129874338|NCT03420781|467497933|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
129874339|NCT00246337|467497934|FG000|Overall Study|Lost to Follow-up|3|||
129874340|NCT00246337|467497935|FG001|Overall Study|Lost to Follow-up|0|||
129874341|NCT00246337|467497936|FG002|Overall Study|Lost to Follow-up|0|||
129874342|NCT00246337|467497937|FG003|Overall Study|Lost to Follow-up|0|||
129874343|NCT00246337|467497938|FG004|Overall Study|Lost to Follow-up|2|||
129874344|NCT00246337|467497939|FG005|Overall Study|Lost to Follow-up|2|||
129874345|NCT00246337|467497940|FG006|Overall Study|Lost to Follow-up|1|||
129874346|NCT00246337|467497941|FG007|Overall Study|Lost to Follow-up|2|||
129874347|NCT00246337|467497942|FG008|Overall Study|Lost to Follow-up|0|||
129874348|NCT00246337|467497934|FG000|Overall Study|Protocol Violation|1|||
129874349|NCT00246337|467497935|FG001|Overall Study|Protocol Violation|0|||
129874350|NCT00246337|467497936|FG002|Overall Study|Protocol Violation|0|||
129874351|NCT00246337|467497937|FG003|Overall Study|Protocol Violation|0|||
129874352|NCT00246337|467497938|FG004|Overall Study|Protocol Violation|1|||
129874353|NCT00246337|467497939|FG005|Overall Study|Protocol Violation|0|||
129874354|NCT00246337|467497940|FG006|Overall Study|Protocol Violation|1|||
129874355|NCT00246337|467497941|FG007|Overall Study|Protocol Violation|1|||
129874356|NCT00246337|467497942|FG008|Overall Study|Protocol Violation|0|||
129874357|NCT00246337|467497934|FG000|Overall Study|Withdrawal by Subject|2|||
129874358|NCT00246337|467497935|FG001|Overall Study|Withdrawal by Subject|0|||
129874359|NCT00246337|467497936|FG002|Overall Study|Withdrawal by Subject|0|||
129874360|NCT00246337|467497937|FG003|Overall Study|Withdrawal by Subject|0|||
129874361|NCT00246337|467497938|FG004|Overall Study|Withdrawal by Subject|0|||
129874362|NCT00246337|467497939|FG005|Overall Study|Withdrawal by Subject|0|||
129874363|NCT00246337|467497940|FG006|Overall Study|Withdrawal by Subject|1|||
129874364|NCT00246337|467497941|FG007|Overall Study|Withdrawal by Subject|1|||
129874365|NCT00246337|467497942|FG008|Overall Study|Withdrawal by Subject|0|||
129874366|NCT00246337|467497934|FG000|Overall Study|Lack of Qualifying Event|8|||
129874367|NCT00246337|467497935|FG001|Overall Study|Lack of Qualifying Event|2|||
129874368|NCT00246337|467497936|FG002|Overall Study|Lack of Qualifying Event|1|||
129874369|NCT00246337|467497937|FG003|Overall Study|Lack of Qualifying Event|1|||
129874370|NCT00246337|467497938|FG004|Overall Study|Lack of Qualifying Event|1|||
129874371|NCT00246337|467497939|FG005|Overall Study|Lack of Qualifying Event|3|||
129874372|NCT00246337|467497940|FG006|Overall Study|Lack of Qualifying Event|3|||
129874373|NCT00246337|467497941|FG007|Overall Study|Lack of Qualifying Event|2|||
129874374|NCT00246337|467497942|FG008|Overall Study|Lack of Qualifying Event|5|||
129874375|NCT00246337|467497934|FG000|Overall Study|Site Terminated|10|||
129874376|NCT00246337|467497935|FG001|Overall Study|Site Terminated|0|||
129874377|NCT00246337|467497936|FG002|Overall Study|Site Terminated|0|||
129874378|NCT00246337|467497937|FG003|Overall Study|Site Terminated|0|||
129874379|NCT00246337|467497938|FG004|Overall Study|Site Terminated|0|||
129874380|NCT00246337|467497939|FG005|Overall Study|Site Terminated|7|||
129874381|NCT00246337|467497940|FG006|Overall Study|Site Terminated|1|||
129874382|NCT00246337|467497941|FG007|Overall Study|Site Terminated|6|||
129874383|NCT00246337|467497942|FG008|Overall Study|Site Terminated|2|||
129874384|NCT00246337|467497934|FG000|Overall Study|Abnormal baseline lab values|7|||
129874385|NCT00246337|467497935|FG001|Overall Study|Abnormal baseline lab values|0|||
129874386|NCT00246337|467497936|FG002|Overall Study|Abnormal baseline lab values|2|||
129874387|NCT00246337|467497937|FG003|Overall Study|Abnormal baseline lab values|0|||
129874388|NCT00246337|467497938|FG004|Overall Study|Abnormal baseline lab values|0|||
129874389|NCT00246337|467497939|FG005|Overall Study|Abnormal baseline lab values|2|||
129874390|NCT00246337|467497940|FG006|Overall Study|Abnormal baseline lab values|2|||
129874391|NCT00246337|467497941|FG007|Overall Study|Abnormal baseline lab values|0|||
129874392|NCT00246337|467497942|FG008|Overall Study|Abnormal baseline lab values|4|||
129874393|NCT00246337|467497934|FG000|Overall Study|Overwhelmed|0|||
129874394|NCT00246337|467497935|FG001|Overall Study|Overwhelmed|0|||
129874395|NCT00246337|467497936|FG002|Overall Study|Overwhelmed|0|||
129874396|NCT00246337|467497937|FG003|Overall Study|Overwhelmed|0|||
129874397|NCT00246337|467497938|FG004|Overall Study|Overwhelmed|0|||
129874398|NCT00246337|467497939|FG005|Overall Study|Overwhelmed|1|||
129874399|NCT00246337|467497940|FG006|Overall Study|Overwhelmed|0|||
129874400|NCT00246337|467497941|FG007|Overall Study|Overwhelmed|0|||
130207899|NCT01886781|468721033|FG001|Overall Study|Adverse Event|0|||
129874401|NCT00246337|467497942|FG008|Overall Study|Overwhelmed|0|||
129874402|NCT00246337|467497934|FG000|Overall Study|Protocol Violator|1|||
129874403|NCT00246337|467497935|FG001|Overall Study|Protocol Violator|0|||
129874404|NCT00246337|467497936|FG002|Overall Study|Protocol Violator|0|||
129874405|NCT00246337|467497937|FG003|Overall Study|Protocol Violator|0|||
129874406|NCT00246337|467497938|FG004|Overall Study|Protocol Violator|0|||
129874407|NCT00246337|467497939|FG005|Overall Study|Protocol Violator|0|||
129874408|NCT00246337|467497940|FG006|Overall Study|Protocol Violator|0|||
129874409|NCT00246337|467497941|FG007|Overall Study|Protocol Violator|0|||
129874410|NCT00246337|467497942|FG008|Overall Study|Protocol Violator|0|||
129874411|NCT00246337|467497934|FG000|Overall Study|Reported as completing trial in error|0|||
129874412|NCT00246337|467497935|FG001|Overall Study|Reported as completing trial in error|0|||
129874413|NCT00246337|467497936|FG002|Overall Study|Reported as completing trial in error|0|||
129874414|NCT00246337|467497937|FG003|Overall Study|Reported as completing trial in error|0|||
129874415|NCT00246337|467497938|FG004|Overall Study|Reported as completing trial in error|0|||
129874416|NCT00246337|467497939|FG005|Overall Study|Reported as completing trial in error|0|||
129874417|NCT00246337|467497940|FG006|Overall Study|Reported as completing trial in error|0|||
129874418|NCT00246337|467497941|FG007|Overall Study|Reported as completing trial in error|1|||
129874419|NCT00246337|467497942|FG008|Overall Study|Reported as completing trial in error|0|||
129874420|NCT02696564|467497947|FG000|Overall Study|Death|1|||
129874421|NCT02696564|467497948|FG001|Overall Study|Death|2|||
129874422|NCT02696564|467497947|FG000|Overall Study|Withdrawal by Subject|3|||
129874423|NCT02696564|467497948|FG001|Overall Study|Withdrawal by Subject|2|||
129874424|NCT02696564|467497947|FG000|Overall Study|Lost to Follow-up|3|||
129874425|NCT02696564|467497948|FG001|Overall Study|Lost to Follow-up|3|||
129874426|NCT02696564|467497947|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
129874427|NCT02696564|467497948|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
129874428|NCT02696564|467497947|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
129874429|NCT02696564|467497948|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
129874430|NCT02696564|467497947|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
129874431|NCT02696564|467497948|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
129874432|NCT02696564|467497947|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
129874433|NCT02696564|467497948|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
129874434|NCT02696564|467497947|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
129874435|NCT02696564|467497948|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
129874436|NCT03124199|467497951|FG000|Overall Study|Lost to Follow-up|4|||
129874437|NCT03056534|467497964|FG000|Overall Study|Participant withdrew consent|8|||
129874438|NCT03056534|467497964|FG000|Overall Study|Participant not able to return|6|||
129874439|NCT03056534|467497964|FG000|Overall Study|Lost to Follow-up|37|||
129874440|NCT03056534|467497964|FG000|Overall Study|Investigator judgment|1|||
129874441|NCT03056534|467497964|FG000|Overall Study|Death|4|||
129874442|NCT03056534|467497964|FG000|Overall Study|Adverse Event|1|||
129874443|NCT03056534|467497964|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
129874444|NCT01313286|467497971|FG000|Period 1|Withdrawal by Subject|2|||
130319112|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
129874445|NCT01313286|467497972|FG001|Period 1|Withdrawal by Subject|0|||
129874446|NCT00654901|467497973|FG000|Overall Study|Lost to Follow-up|1|||
130207900|NCT01886781|468721032|FG000|Overall Study|Lost to Follow-up|5|||
130319113|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
129874447|NCT00654901|467497974|FG001|Overall Study|Lost to Follow-up|0|||
129874448|NCT00654901|467497975|FG002|Overall Study|Lost to Follow-up|1|||
129874449|NCT00654901|467497976|FG003|Overall Study|Lost to Follow-up|0|||
129874450|NCT00654901|467497973|FG000|Overall Study|Withdrawal by Subject|3|||
129874451|NCT00654901|467497974|FG001|Overall Study|Withdrawal by Subject|0|||
129874452|NCT00654901|467497975|FG002|Overall Study|Withdrawal by Subject|1|||
129874453|NCT00654901|467497976|FG003|Overall Study|Withdrawal by Subject|0|||
129874454|NCT04241094|467497984|FG000|Overall Study|Dropped out of treatment|4|||
129874455|NCT04241094|467497984|FG000|Overall Study|Ineligible after clinical assessment|2|||
129874456|NCT04241094|467497984|FG000|Overall Study|Lost to Follow-up|2|||
129874457|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
129874458|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
129874459|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
129874460|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
129874461|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
129874462|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
129874463|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
129874464|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
129874465|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
129874466|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
129874467|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
129874468|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
129874469|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
129874470|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
129874471|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
129874472|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
129874473|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
129874474|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
129874475|NCT04739761|467498000|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
129874476|NCT04739761|467498001|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
129874477|NCT04739761|467498000|FG000|Overall Study|By complete response from the participant|1|||
129874478|NCT04739761|467498001|FG001|Overall Study|By complete response from the participant|0|||
129874479|NCT04739761|467498000|FG000|Overall Study|Lost to Follow-up|3|||
129874480|NCT04739761|467498001|FG001|Overall Study|Lost to Follow-up|3|||
129874481|NCT04739761|467498000|FG000|Overall Study|Death|13|||
129874482|NCT04739761|467498001|FG001|Overall Study|Death|13|||
129874483|NCT04739761|467498000|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
129874484|NCT04739761|467498001|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
129874485|NCT04739761|467498000|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
129874486|NCT04739761|467498001|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
129874487|NCT04739761|467498000|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
129874488|NCT04739761|467498001|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
129874489|NCT04739761|467498000|FG000|Overall Study|Adverse Event|0|||
129874490|NCT04739761|467498001|FG001|Overall Study|Adverse Event|3|||
129874491|NCT04739761|467498000|FG000|Overall Study|Participant decision|1|||
129874492|NCT04739761|467498001|FG001|Overall Study|Participant decision|0|||
129874493|NCT04739761|467498000|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
129874494|NCT04739761|467498001|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
129874495|NCT04739761|467498000|FG000|Overall Study|Participant immediately started next line of treatment|1|||
129874496|NCT04739761|467498001|FG001|Overall Study|Participant immediately started next line of treatment|0|||
129874497|NCT04739761|467498000|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
129874498|NCT04739761|467498001|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
129874499|NCT04739761|467498000|FG000|Overall Study|Lack of clinical benefit|1|||
129874500|NCT04739761|467498001|FG001|Overall Study|Lack of clinical benefit|0|||
129874501|NCT04739761|467498000|FG000|Overall Study|Disease progression|5|||
129874502|NCT04739761|467498001|FG001|Overall Study|Disease progression|5|||
129874503|NCT04739761|467498000|FG000|Overall Study|Withdrawal by Subject|14|||
129874504|NCT04739761|467498001|FG001|Overall Study|Withdrawal by Subject|13|||
129874505|NCT04739761|467498000|FG000|Overall Study|Protocol Violation|1|||
129874506|NCT04739761|467498001|FG001|Overall Study|Protocol Violation|0|||
129874507|NCT04739761|467498000|FG000|Overall Study|Physician Decision|2|||
129874508|NCT04739761|467498001|FG001|Overall Study|Physician Decision|0|||
129874509|NCT01061333|467498003|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
129874510|NCT01061333|467498004|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
129874511|NCT02044848|467499460|FG000|Overall Study|Administrative Problems|2|||
129874512|NCT02044848|467499461|FG001|Overall Study|Administrative Problems|3|||
129874513|NCT01493960|467499462|FG000|Overall Study|Adverse Event|0|||
129874514|NCT01493960|467499463|FG001|Overall Study|Adverse Event|1|||
129874515|NCT01493960|467499462|FG000|Overall Study|Lack of Efficacy|15|||
129874516|NCT01493960|467499463|FG001|Overall Study|Lack of Efficacy|9|||
129874517|NCT01493960|467499462|FG000|Overall Study|Protocol Violation|3|||
129874518|NCT01493960|467499463|FG001|Overall Study|Protocol Violation|0|||
129874519|NCT01493960|467499462|FG000|Overall Study|Withdrawal by Subject|10|||
129874520|NCT01493960|467499463|FG001|Overall Study|Withdrawal by Subject|4|||
129874521|NCT01493960|467499462|FG000|Overall Study|Non-specified|4|||
129874522|NCT01493960|467499463|FG001|Overall Study|Non-specified|4|||
129874523|NCT01160484|467499470|FG000|Overall Study|Lack of Efficacy|9|||
129874524|NCT01160484|467499470|FG000|Overall Study|Adverse Event|6|||
129874525|NCT01160484|467499470|FG000|Overall Study|Withdrawal by Subject|2|||
129874526|NCT01160484|467499470|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
129874527|NCT00803101|467499471|FG000|Overall Study|Death / Serious Adverse Event|4|||
129874528|NCT00803101|467499472|FG001|Overall Study|Death / Serious Adverse Event|6|||
129874529|NCT00803101|467499471|FG000|Overall Study|Withdrawal by Subject|6|||
129874530|NCT00803101|467499472|FG001|Overall Study|Withdrawal by Subject|4|||
129874531|NCT00803101|467499471|FG000|Overall Study|Lost to Follow-up|2|||
129874532|NCT00803101|467499472|FG001|Overall Study|Lost to Follow-up|2|||
129874533|NCT00803101|467499471|FG000|Overall Study|Protocol Violation|1|||
129874534|NCT00803101|467499472|FG001|Overall Study|Protocol Violation|7|||
129874535|NCT00803101|467499471|FG000|Overall Study|Surgery finished outside protocol window|1|||
129874536|NCT00803101|467499472|FG001|Overall Study|Surgery finished outside protocol window|1|||
129874537|NCT00803101|467499471|FG000|Overall Study|Patient died outside SAE report period|1|||
129874538|NCT00803101|467499472|FG001|Overall Study|Patient died outside SAE report period|0|||
129874539|NCT00803101|467499471|FG000|Overall Study|Patient did not attend scheduled visit|2|||
129874540|NCT00803101|467499472|FG001|Overall Study|Patient did not attend scheduled visit|1|||
129874541|NCT00803101|467499471|FG000|Overall Study|Patient did not have surgery|1|||
129874542|NCT00803101|467499472|FG001|Overall Study|Patient did not have surgery|1|||
129874543|NCT01782742|467499473|FG000|Double-blind Treatment Phase|Adverse Event|1|||
129874544|NCT01782742|467499474|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129874545|NCT00332332|467499479|FG000|Overall Study|Adverse Event|13|||
129874546|NCT00332332|467499479|FG000|Overall Study|Death|1|||
129874547|NCT00332332|467499479|FG000|Overall Study|Withdrawal by Subject|8|||
129874548|NCT00332332|467499479|FG000|Overall Study|Physician Decision|1|||
129874549|NCT00332332|467499479|FG000|Overall Study|Lost to Follow-up|3|||
129874550|NCT00332332|467499479|FG000|Overall Study|Protocol deviation|4|||
129874551|NCT00332332|467499479|FG000|Overall Study|Noncompliance|2|||
129874552|NCT00332332|467499479|FG000|Overall Study|Disease progression|2|||
129874553|NCT00332332|467499479|FG000|Overall Study|Other|18|||
129874554|NCT00332332|467499479|FG000|Overall Study|Did not receive study treatment|16|||
129874555|NCT02790073|467499480|FG000|Overall Study|Death|1|||
129874556|NCT02790073|467499480|FG000|Overall Study|Withdrawal from HD|1|||
129874557|NCT02790073|467499480|FG000|Overall Study|Withdrawal by Subject|1|||
129874558|NCT00674570|467499487|FG000|Overall Study|Withdrawal by Subject|0|||
129874559|NCT00674570|467499488|FG001|Overall Study|Withdrawal by Subject|2|||
129874560|NCT00674570|467499489|FG002|Overall Study|Withdrawal by Subject|0|||
129874561|NCT03633929|467499490|FG000|Overall Study|Lost to Follow-up|1|||
129874562|NCT03633929|467499490|FG000|Overall Study|Did not login to software. Did not participate|3|||
129874563|NCT04461795|467499492|FG000|Overall Study|Lost to Follow-up|2|||
129874564|NCT04461795|467499492|FG000|Overall Study|Withdrawal by Subject|2|||
129874565|NCT04461795|467499492|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
129874566|NCT00185640|467499493|FG000|Overall Study|Not Eligible|4|||
129874567|NCT00185640|467499493|FG000|Overall Study|Withdrawal by Subject|3|||
129874568|NCT00185640|467499493|FG000|Overall Study|Death|138|||
129874569|NCT00058422|467499494|FG000|Overall Study|Not treated|2|||
129874570|NCT02287584|467499495|FG000|the Double-blind Phase|Adverse Event|17|||
129874571|NCT02287584|467499496|FG001|the Double-blind Phase|Adverse Event|17|||
129874572|NCT02287584|467499497|FG002|the Double-blind Phase|Adverse Event|12|||
129874573|NCT02287584|467499498|FG003|the Double-blind Phase|Adverse Event|0|||
129874574|NCT02287584|467499499|FG004|the Double-blind Phase|Adverse Event|0|||
129874575|NCT02287584|467499500|FG005|the Double-blind Phase|Adverse Event|0|||
129874576|NCT02287584|467499495|FG000|the Double-blind Phase|Lack of Efficacy|18|||
129874577|NCT02287584|467499496|FG001|the Double-blind Phase|Lack of Efficacy|8|||
129874578|NCT02287584|467499497|FG002|the Double-blind Phase|Lack of Efficacy|8|||
129874579|NCT02287584|467499498|FG003|the Double-blind Phase|Lack of Efficacy|0|||
129874580|NCT02287584|467499499|FG004|the Double-blind Phase|Lack of Efficacy|0|||
129874581|NCT02287584|467499500|FG005|the Double-blind Phase|Lack of Efficacy|0|||
129874582|NCT02287584|467499495|FG000|the Double-blind Phase|Lost to Follow-up|0|||
129874583|NCT02287584|467499496|FG001|the Double-blind Phase|Lost to Follow-up|1|||
129874584|NCT02287584|467499497|FG002|the Double-blind Phase|Lost to Follow-up|1|||
129874585|NCT02287584|467499498|FG003|the Double-blind Phase|Lost to Follow-up|0|||
129874586|NCT02287584|467499499|FG004|the Double-blind Phase|Lost to Follow-up|0|||
129874587|NCT02287584|467499500|FG005|the Double-blind Phase|Lost to Follow-up|0|||
130207901|NCT01886781|468721033|FG001|Overall Study|Lost to Follow-up|0|||
129874588|NCT02287584|467499495|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
129874589|NCT02287584|467499496|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
130207902|NCT01886781|468721032|FG000|Overall Study|Withdrawal by Subject|2|||
130207903|NCT01886781|468721033|FG001|Overall Study|Withdrawal by Subject|1|||
130207904|NCT01886781|468721032|FG000|Overall Study|Worsening of symptoms|1|||
129874590|NCT02287584|467499497|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
129874591|NCT02287584|467499498|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
129874592|NCT02287584|467499499|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
129874593|NCT02287584|467499500|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
129874594|NCT02287584|467499495|FG000|the Double-blind Phase|Pregnancy|0|||
129874595|NCT02287584|467499496|FG001|the Double-blind Phase|Pregnancy|1|||
129874596|NCT02287584|467499497|FG002|the Double-blind Phase|Pregnancy|0|||
129874597|NCT02287584|467499498|FG003|the Double-blind Phase|Pregnancy|0|||
129874598|NCT02287584|467499499|FG004|the Double-blind Phase|Pregnancy|0|||
129874599|NCT02287584|467499500|FG005|the Double-blind Phase|Pregnancy|0|||
129874600|NCT02287584|467499495|FG000|the Double-blind Phase|Protocol Violation|0|||
129874601|NCT02287584|467499496|FG001|the Double-blind Phase|Protocol Violation|3|||
129874602|NCT02287584|467499497|FG002|the Double-blind Phase|Protocol Violation|0|||
129874603|NCT02287584|467499498|FG003|the Double-blind Phase|Protocol Violation|0|||
129874604|NCT02287584|467499499|FG004|the Double-blind Phase|Protocol Violation|0|||
129874605|NCT02287584|467499500|FG005|the Double-blind Phase|Protocol Violation|0|||
129874606|NCT02287584|467499495|FG000|the Double-blind Phase|other reasons|0|||
129874607|NCT02287584|467499496|FG001|the Double-blind Phase|other reasons|0|||
129874608|NCT02287584|467499497|FG002|the Double-blind Phase|other reasons|1|||
129874609|NCT02287584|467499498|FG003|the Double-blind Phase|other reasons|0|||
129874610|NCT02287584|467499499|FG004|the Double-blind Phase|other reasons|0|||
129874611|NCT02287584|467499500|FG005|the Double-blind Phase|other reasons|0|||
129874612|NCT02287584|467499495|FG000|the Open-label Phase|Did not receive drug|0|||
129874613|NCT02287584|467499496|FG001|the Open-label Phase|Did not receive drug|0|||
129874614|NCT02287584|467499497|FG002|the Open-label Phase|Did not receive drug|0|||
129874615|NCT02287584|467499498|FG003|the Open-label Phase|Did not receive drug|7|||
129874616|NCT02287584|467499499|FG004|the Open-label Phase|Did not receive drug|6|||
129874617|NCT02287584|467499500|FG005|the Open-label Phase|Did not receive drug|4|||
129874618|NCT02287584|467499495|FG000|the Open-label Phase|Adverse Event|0|||
129874619|NCT02287584|467499496|FG001|the Open-label Phase|Adverse Event|0|||
129874620|NCT02287584|467499497|FG002|the Open-label Phase|Adverse Event|0|||
129874621|NCT02287584|467499498|FG003|the Open-label Phase|Adverse Event|15|||
129874622|NCT02287584|467499499|FG004|the Open-label Phase|Adverse Event|12|||
129874623|NCT02287584|467499500|FG005|the Open-label Phase|Adverse Event|16|||
129874624|NCT02287584|467499495|FG000|the Open-label Phase|Lack of Efficacy|0|||
129874625|NCT02287584|467499496|FG001|the Open-label Phase|Lack of Efficacy|0|||
129874626|NCT02287584|467499497|FG002|the Open-label Phase|Lack of Efficacy|0|||
129874627|NCT02287584|467499498|FG003|the Open-label Phase|Lack of Efficacy|8|||
129874628|NCT02287584|467499499|FG004|the Open-label Phase|Lack of Efficacy|3|||
129874629|NCT02287584|467499500|FG005|the Open-label Phase|Lack of Efficacy|7|||
129874630|NCT02287584|467499495|FG000|the Open-label Phase|Lost to Follow-up|0|||
129874631|NCT02287584|467499496|FG001|the Open-label Phase|Lost to Follow-up|0|||
129874632|NCT02287584|467499497|FG002|the Open-label Phase|Lost to Follow-up|0|||
129874633|NCT02287584|467499498|FG003|the Open-label Phase|Lost to Follow-up|4|||
129874634|NCT02287584|467499499|FG004|the Open-label Phase|Lost to Follow-up|1|||
129874635|NCT02287584|467499500|FG005|the Open-label Phase|Lost to Follow-up|2|||
129874636|NCT02287584|467499495|FG000|the Open-label Phase|Withdrawal by Subject|0|||
129874637|NCT02287584|467499496|FG001|the Open-label Phase|Withdrawal by Subject|0|||
129874638|NCT02287584|467499497|FG002|the Open-label Phase|Withdrawal by Subject|0|||
129874639|NCT02287584|467499498|FG003|the Open-label Phase|Withdrawal by Subject|18|||
129874640|NCT02287584|467499499|FG004|the Open-label Phase|Withdrawal by Subject|29|||
129874641|NCT02287584|467499500|FG005|the Open-label Phase|Withdrawal by Subject|21|||
129874642|NCT02287584|467499495|FG000|the Open-label Phase|non-compliance|0|||
129874643|NCT02287584|467499496|FG001|the Open-label Phase|non-compliance|0|||
129874644|NCT02287584|467499497|FG002|the Open-label Phase|non-compliance|0|||
129874645|NCT02287584|467499498|FG003|the Open-label Phase|non-compliance|2|||
129874646|NCT02287584|467499499|FG004|the Open-label Phase|non-compliance|5|||
129874647|NCT02287584|467499500|FG005|the Open-label Phase|non-compliance|1|||
129874648|NCT02287584|467499495|FG000|the Open-label Phase|other reasons|0|||
129874649|NCT02287584|467499496|FG001|the Open-label Phase|other reasons|0|||
129874650|NCT02287584|467499497|FG002|the Open-label Phase|other reasons|0|||
129874651|NCT02287584|467499498|FG003|the Open-label Phase|other reasons|3|||
129874652|NCT02287584|467499499|FG004|the Open-label Phase|other reasons|6|||
129874653|NCT02287584|467499500|FG005|the Open-label Phase|other reasons|6|||
129874654|NCT03430063|467499503|FG000|Overall Study|Adverse Event|0|||
129874655|NCT03430063|467499504|FG001|Overall Study|Adverse Event|1|||
129874656|NCT03430063|467499505|FG002|Overall Study|Adverse Event|0|||
129874657|NCT03430063|467499503|FG000|Overall Study|Death|3|||
129874658|NCT03430063|467499504|FG001|Overall Study|Death|2|||
129874659|NCT03430063|467499505|FG002|Overall Study|Death|3|||
129874660|NCT03430063|467499503|FG000|Overall Study|Lost to Follow-up|0|||
129874661|NCT03430063|467499504|FG001|Overall Study|Lost to Follow-up|1|||
129874662|NCT03430063|467499505|FG002|Overall Study|Lost to Follow-up|0|||
129874663|NCT03430063|467499503|FG000|Overall Study|Withdrawal by Subject|0|||
129874664|NCT03430063|467499504|FG001|Overall Study|Withdrawal by Subject|0|||
129874665|NCT03430063|467499505|FG002|Overall Study|Withdrawal by Subject|1|||
129874666|NCT03430063|467499503|FG000|Overall Study|Withdrawal of consent|3|||
129874667|NCT03430063|467499504|FG001|Overall Study|Withdrawal of consent|1|||
129874668|NCT03430063|467499505|FG002|Overall Study|Withdrawal of consent|2|||
129874669|NCT03430063|467499503|FG000|Overall Study|Progressive disease|1|||
129874670|NCT03430063|467499504|FG001|Overall Study|Progressive disease|2|||
129874671|NCT03430063|467499505|FG002|Overall Study|Progressive disease|1|||
129874672|NCT03430063|467499503|FG000|Overall Study|Other un-specified|1|||
129874673|NCT03430063|467499504|FG001|Overall Study|Other un-specified|1|||
129874674|NCT03430063|467499505|FG002|Overall Study|Other un-specified|0|||
129874675|NCT03430063|467499503|FG000|Overall Study|Randomized, but never treated|0|||
129874676|NCT03430063|467499504|FG001|Overall Study|Randomized, but never treated|0|||
129874677|NCT03430063|467499505|FG002|Overall Study|Randomized, but never treated|1|||
129874678|NCT02798211|467499506|FG000|Period 1|Adverse Event|1|||
129874679|NCT02798211|467499507|FG001|Period 1|Adverse Event|1|||
129874680|NCT02798211|467499508|FG002|Period 1|Adverse Event|0|||
129874681|NCT02798211|467499509|FG003|Period 1|Adverse Event|0|||
129874682|NCT02798211|467499510|FG004|Period 1|Adverse Event|0|||
129874683|NCT02798211|467499511|FG005|Period 1|Adverse Event|0|||
129874684|NCT02798211|467499506|FG000|Period 1|Lost to Follow-up|2|||
129874685|NCT02798211|467499507|FG001|Period 1|Lost to Follow-up|1|||
129874686|NCT02798211|467499508|FG002|Period 1|Lost to Follow-up|0|||
129874687|NCT02798211|467499509|FG003|Period 1|Lost to Follow-up|0|||
129874688|NCT02798211|467499510|FG004|Period 1|Lost to Follow-up|0|||
129874689|NCT02798211|467499511|FG005|Period 1|Lost to Follow-up|0|||
129874690|NCT02798211|467499506|FG000|Period 1|Protocol Violation|0|||
129874691|NCT02798211|467499507|FG001|Period 1|Protocol Violation|0|||
129874692|NCT02798211|467499508|FG002|Period 1|Protocol Violation|2|||
129874693|NCT02798211|467499509|FG003|Period 1|Protocol Violation|0|||
129874694|NCT02798211|467499510|FG004|Period 1|Protocol Violation|0|||
129874695|NCT02798211|467499511|FG005|Period 1|Protocol Violation|0|||
129874696|NCT02798211|467499506|FG000|Period 1|Withdrawal by Subject|1|||
129874697|NCT02798211|467499507|FG001|Period 1|Withdrawal by Subject|1|||
129874698|NCT02798211|467499508|FG002|Period 1|Withdrawal by Subject|0|||
129874699|NCT02798211|467499509|FG003|Period 1|Withdrawal by Subject|0|||
129874700|NCT02798211|467499510|FG004|Period 1|Withdrawal by Subject|0|||
129874701|NCT02798211|467499511|FG005|Period 1|Withdrawal by Subject|0|||
129874702|NCT02798211|467499506|FG000|Period 1|Death|0|||
129874703|NCT02798211|467499507|FG001|Period 1|Death|0|||
129874704|NCT02798211|467499508|FG002|Period 1|Death|1|||
129874705|NCT02798211|467499509|FG003|Period 1|Death|0|||
129874706|NCT02798211|467499510|FG004|Period 1|Death|0|||
129874707|NCT02798211|467499511|FG005|Period 1|Death|0|||
129874708|NCT02798211|467499506|FG000|Period 1|Withdrawal of Informed Consent|2|||
129874709|NCT02798211|467499507|FG001|Period 1|Withdrawal of Informed Consent|7|||
129874710|NCT02798211|467499508|FG002|Period 1|Withdrawal of Informed Consent|3|||
129874711|NCT02798211|467499509|FG003|Period 1|Withdrawal of Informed Consent|0|||
129874712|NCT02798211|467499510|FG004|Period 1|Withdrawal of Informed Consent|0|||
129874713|NCT02798211|467499511|FG005|Period 1|Withdrawal of Informed Consent|0|||
129874714|NCT02798211|467499506|FG000|Period 2|Withdrawal by Subject|2|||
129874715|NCT02798211|467499507|FG001|Period 2|Withdrawal by Subject|0|||
129874716|NCT02798211|467499508|FG002|Period 2|Withdrawal by Subject|0|||
129874717|NCT02798211|467499509|FG003|Period 2|Withdrawal by Subject|0|||
129874718|NCT02798211|467499510|FG004|Period 2|Withdrawal by Subject|2|||
129874719|NCT02798211|467499511|FG005|Period 2|Withdrawal by Subject|2|||
129874720|NCT02798211|467499506|FG000|Period 2|Adverse Event|5|||
129874721|NCT02798211|467499507|FG001|Period 2|Adverse Event|0|||
129874722|NCT02798211|467499508|FG002|Period 2|Adverse Event|0|||
129874723|NCT02798211|467499509|FG003|Period 2|Adverse Event|0|||
129874724|NCT02798211|467499510|FG004|Period 2|Adverse Event|1|||
129874725|NCT02798211|467499511|FG005|Period 2|Adverse Event|0|||
129874726|NCT02798211|467499506|FG000|Period 2|Lack of Efficacy|1|||
129874727|NCT02798211|467499507|FG001|Period 2|Lack of Efficacy|0|||
129874728|NCT02798211|467499508|FG002|Period 2|Lack of Efficacy|0|||
129874729|NCT02798211|467499509|FG003|Period 2|Lack of Efficacy|1|||
129874730|NCT02798211|467499510|FG004|Period 2|Lack of Efficacy|0|||
129874731|NCT02798211|467499511|FG005|Period 2|Lack of Efficacy|1|||
129874732|NCT02798211|467499506|FG000|Period 2|Lost to Follow-up|3|||
129874733|NCT02798211|467499507|FG001|Period 2|Lost to Follow-up|0|||
129874734|NCT02798211|467499508|FG002|Period 2|Lost to Follow-up|0|||
129874735|NCT02798211|467499509|FG003|Period 2|Lost to Follow-up|0|||
129874736|NCT02798211|467499510|FG004|Period 2|Lost to Follow-up|2|||
129874737|NCT02798211|467499511|FG005|Period 2|Lost to Follow-up|0|||
129874738|NCT02798211|467499506|FG000|Period 2|Physician Decision|1|||
129874739|NCT02798211|467499507|FG001|Period 2|Physician Decision|0|||
129874740|NCT02798211|467499508|FG002|Period 2|Physician Decision|0|||
129874741|NCT02798211|467499509|FG003|Period 2|Physician Decision|1|||
129874742|NCT02798211|467499510|FG004|Period 2|Physician Decision|1|||
129874743|NCT02798211|467499511|FG005|Period 2|Physician Decision|0|||
129874744|NCT02798211|467499506|FG000|Period 2|Pregnancy|0|||
129874745|NCT02798211|467499507|FG001|Period 2|Pregnancy|0|||
129874746|NCT02798211|467499508|FG002|Period 2|Pregnancy|0|||
129874747|NCT02798211|467499509|FG003|Period 2|Pregnancy|2|||
129874748|NCT02798211|467499510|FG004|Period 2|Pregnancy|0|||
129874749|NCT02798211|467499511|FG005|Period 2|Pregnancy|0|||
129874750|NCT02798211|467499506|FG000|Period 2|Technical problems|1|||
129874751|NCT02798211|467499507|FG001|Period 2|Technical problems|0|||
129874752|NCT02798211|467499508|FG002|Period 2|Technical problems|0|||
129874753|NCT02798211|467499509|FG003|Period 2|Technical problems|1|||
129874754|NCT02798211|467499510|FG004|Period 2|Technical problems|0|||
129874755|NCT02798211|467499511|FG005|Period 2|Technical problems|0|||
129874756|NCT02798211|467499506|FG000|Period 2|Withdrawal of Informed Consent|1|||
129874757|NCT02798211|467499507|FG001|Period 2|Withdrawal of Informed Consent|0|||
129874758|NCT02798211|467499508|FG002|Period 2|Withdrawal of Informed Consent|0|||
129874759|NCT02798211|467499509|FG003|Period 2|Withdrawal of Informed Consent|2|||
129874760|NCT02798211|467499510|FG004|Period 2|Withdrawal of Informed Consent|2|||
129874761|NCT02798211|467499511|FG005|Period 2|Withdrawal of Informed Consent|3|||
129874762|NCT01982435|467499512|FG000|Overall Study|Adverse Event|1|||
129874763|NCT01982435|467499513|FG001|Overall Study|Adverse Event|0|||
129874764|NCT05292534|467499514|FG000|Overall Study|Protocol Violation|3|||
129874765|NCT05292534|467499515|FG001|Overall Study|Protocol Violation|4|||
129874766|NCT05292534|467499514|FG000|Overall Study|Withdrawal by Subject|0|||
129874767|NCT05292534|467499515|FG001|Overall Study|Withdrawal by Subject|1|||
129874768|NCT03086018|467499517|FG000|Final Testing for End of Trial|Adverse Event|1|||
129874769|NCT03086018|467499517|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
129874770|NCT01892345|467499518|FG000|Overall Study|Adverse Event|0|||
129874771|NCT01892345|467499519|FG001|Overall Study|Adverse Event|2|||
129874772|NCT01892345|467499518|FG000|Overall Study|Death|1|||
129874773|NCT01892345|467499519|FG001|Overall Study|Death|0|||
129874774|NCT01892345|467499518|FG000|Overall Study|Lost to Follow-up|3|||
129874775|NCT01892345|467499519|FG001|Overall Study|Lost to Follow-up|0|||
129874776|NCT01892345|467499518|FG000|Overall Study|Withdrawal by Subject|12|||
129874777|NCT01892345|467499519|FG001|Overall Study|Withdrawal by Subject|1|||
129874778|NCT02748694|467499520|FG000|Overall Study|Voluntary Withdrawal|0|||
129874779|NCT02748694|467499521|FG001|Overall Study|Voluntary Withdrawal|0|||
129874780|NCT02748694|467499522|FG002|Overall Study|Voluntary Withdrawal|0|||
129874781|NCT02748694|467499523|FG003|Overall Study|Voluntary Withdrawal|0|||
129874782|NCT02748694|467499524|FG004|Overall Study|Voluntary Withdrawal|0|||
129874783|NCT02748694|467499525|FG005|Overall Study|Voluntary Withdrawal|0|||
129874784|NCT02748694|467499526|FG006|Overall Study|Voluntary Withdrawal|0|||
129874785|NCT02748694|467499527|FG007|Overall Study|Voluntary Withdrawal|0|||
129874786|NCT02748694|467499528|FG008|Overall Study|Voluntary Withdrawal|0|||
129874787|NCT02748694|467499529|FG009|Overall Study|Voluntary Withdrawal|0|||
129874788|NCT02748694|467499530|FG010|Overall Study|Voluntary Withdrawal|0|||
129874789|NCT02748694|467499531|FG011|Overall Study|Voluntary Withdrawal|0|||
129874790|NCT02748694|467499532|FG012|Overall Study|Voluntary Withdrawal|0|||
129874791|NCT02748694|467499533|FG013|Overall Study|Voluntary Withdrawal|0|||
129874792|NCT02748694|467499534|FG014|Overall Study|Voluntary Withdrawal|2|||
129874793|NCT01473381|467499535|FG000|Overall Study|Adverse Event|8|||
129874794|NCT01473381|467499536|FG001|Overall Study|Adverse Event|20|||
129874795|NCT01473381|467499537|FG002|Overall Study|Adverse Event|25|||
129874796|NCT01473381|467499538|FG003|Overall Study|Adverse Event|17|||
129874797|NCT01473381|467499535|FG000|Overall Study|Insufficient Therapeutic Response|10|||
129874798|NCT01473381|467499536|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129874799|NCT01473381|467499537|FG002|Overall Study|Insufficient Therapeutic Response|2|||
129874800|NCT01473381|467499538|FG003|Overall Study|Insufficient Therapeutic Response|3|||
129874801|NCT01473381|467499535|FG000|Overall Study|Protocol Violation|17|||
129874802|NCT01473381|467499536|FG001|Overall Study|Protocol Violation|23|||
129874803|NCT01473381|467499537|FG002|Overall Study|Protocol Violation|19|||
129874804|NCT01473381|467499538|FG003|Overall Study|Protocol Violation|17|||
129874805|NCT01473381|467499535|FG000|Overall Study|Withdrawal of Consent|20|||
129984776|NCT05038163|467905550|FG003|Stage 2|Did not complete Stage 2 survey|24|||
129984777|NCT05038163|467905551|FG004|Stage 2|Did not complete Stage 2 survey|21|||
129984778|NCT05038163|467905552|FG005|Stage 2|Did not complete Stage 2 survey|100|||
129984779|NCT01905150|467905553|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
129984780|NCT01905150|467905554|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
129984781|NCT03762200|467905559|FG000|Overall Study|Death|2|||
129984782|NCT02631577|467905560|FG000|Overall Study|Death|1|||
129984783|NCT02631577|467905561|FG001|Overall Study|Death|7|||
129984784|NCT02631577|467905560|FG000|Overall Study|Withdrawal by Subject|0|||
129984785|NCT02631577|467905561|FG001|Overall Study|Withdrawal by Subject|3|||
129984786|NCT01593787|467905562|FG000|Overall Study|Adverse Event|1|||
129874806|NCT01473381|467499536|FG001|Overall Study|Withdrawal of Consent|21|||
129874807|NCT01473381|467499537|FG002|Overall Study|Withdrawal of Consent|20|||
129984787|NCT01593787|467905563|FG001|Overall Study|Adverse Event|0|||
129874808|NCT01473381|467499538|FG003|Overall Study|Withdrawal of Consent|26|||
129984788|NCT01593787|467905564|FG002|Overall Study|Adverse Event|0|||
129874809|NCT01473381|467499535|FG000|Overall Study|Lost to Follow-up|25|||
129874810|NCT01473381|467499536|FG001|Overall Study|Lost to Follow-up|28|||
129874811|NCT01473381|467499537|FG002|Overall Study|Lost to Follow-up|35|||
129874812|NCT01473381|467499538|FG003|Overall Study|Lost to Follow-up|23|||
129874813|NCT01473381|467499535|FG000|Overall Study|Other Reasons|0|||
129874814|NCT01473381|467499536|FG001|Overall Study|Other Reasons|0|||
129874815|NCT01473381|467499537|FG002|Overall Study|Other Reasons|1|||
129874816|NCT01473381|467499538|FG003|Overall Study|Other Reasons|3|||
129874817|NCT04026165|467499542|FG000|Run-in Placebo Period|Enrollment Error|13|||
129874818|NCT04026165|467499543|FG001|Run-in Placebo Period|Enrollment Error|0|||
129874819|NCT04026165|467499544|FG002|Run-in Placebo Period|Enrollment Error|0|||
129874820|NCT04026165|467499545|FG003|Run-in Placebo Period|Enrollment Error|0|||
129874821|NCT04026165|467499542|FG000|Run-in Placebo Period|Run-in Failure|4|||
129874822|NCT04026165|467499543|FG001|Run-in Placebo Period|Run-in Failure|0|||
129874823|NCT04026165|467499544|FG002|Run-in Placebo Period|Run-in Failure|0|||
129874824|NCT04026165|467499545|FG003|Run-in Placebo Period|Run-in Failure|0|||
129874825|NCT04026165|467499542|FG000|Run-in Placebo Period|Protocol Violation|2|||
129874826|NCT04026165|467499543|FG001|Run-in Placebo Period|Protocol Violation|0|||
129874827|NCT04026165|467499544|FG002|Run-in Placebo Period|Protocol Violation|0|||
129874828|NCT04026165|467499545|FG003|Run-in Placebo Period|Protocol Violation|0|||
129874829|NCT04026165|467499542|FG000|Run-in Placebo Period|Withdrew Consent|2|||
129874830|NCT04026165|467499543|FG001|Run-in Placebo Period|Withdrew Consent|0|||
129874831|NCT04026165|467499544|FG002|Run-in Placebo Period|Withdrew Consent|0|||
129874832|NCT04026165|467499545|FG003|Run-in Placebo Period|Withdrew Consent|0|||
129874833|NCT04026165|467499542|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
129874834|NCT04026165|467499543|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
129874835|NCT04026165|467499544|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
129874836|NCT04026165|467499545|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
129874837|NCT04026165|467499542|FG000|Run-in SEL Period|Run-in Failure|0|||
129874838|NCT04026165|467499543|FG001|Run-in SEL Period|Run-in Failure|26|||
129874839|NCT04026165|467499544|FG002|Run-in SEL Period|Run-in Failure|0|||
129874840|NCT04026165|467499545|FG003|Run-in SEL Period|Run-in Failure|0|||
129874841|NCT04026165|467499542|FG000|Run-in SEL Period|Withdrew Consent|0|||
129874842|NCT04026165|467499543|FG001|Run-in SEL Period|Withdrew Consent|10|||
129874843|NCT04026165|467499544|FG002|Run-in SEL Period|Withdrew Consent|0|||
129874844|NCT04026165|467499545|FG003|Run-in SEL Period|Withdrew Consent|0|||
129874845|NCT04026165|467499542|FG000|Run-in SEL Period|Enrollment Error|0|||
129874846|NCT04026165|467499543|FG001|Run-in SEL Period|Enrollment Error|4|||
129874847|NCT04026165|467499544|FG002|Run-in SEL Period|Enrollment Error|0|||
129874848|NCT04026165|467499545|FG003|Run-in SEL Period|Enrollment Error|0|||
129874849|NCT04026165|467499542|FG000|Run-in SEL Period|Protocol Violation|0|||
129874850|NCT04026165|467499543|FG001|Run-in SEL Period|Protocol Violation|3|||
129874851|NCT04026165|467499544|FG002|Run-in SEL Period|Protocol Violation|0|||
129874852|NCT04026165|467499545|FG003|Run-in SEL Period|Protocol Violation|0|||
129874853|NCT04026165|467499542|FG000|Run-in SEL Period|Investigator's Discretion|0|||
129874854|NCT04026165|467499543|FG001|Run-in SEL Period|Investigator's Discretion|2|||
129874855|NCT04026165|467499544|FG002|Run-in SEL Period|Investigator's Discretion|0|||
129874856|NCT04026165|467499545|FG003|Run-in SEL Period|Investigator's Discretion|0|||
129874857|NCT04026165|467499542|FG000|Run-in SEL Period|Death|0|||
129874858|NCT04026165|467499543|FG001|Run-in SEL Period|Death|1|||
129874859|NCT04026165|467499544|FG002|Run-in SEL Period|Death|0|||
129874860|NCT04026165|467499545|FG003|Run-in SEL Period|Death|0|||
129874861|NCT04026165|467499542|FG000|Randomized Period|Withdrew Consent|0|||
129874862|NCT04026165|467499543|FG001|Randomized Period|Withdrew Consent|0|||
129874863|NCT04026165|467499544|FG002|Randomized Period|Withdrew Consent|5|||
129874864|NCT04026165|467499545|FG003|Randomized Period|Withdrew Consent|8|||
129874865|NCT04026165|467499542|FG000|Randomized Period|Death|0|||
129874866|NCT04026165|467499543|FG001|Randomized Period|Death|0|||
129874867|NCT04026165|467499544|FG002|Randomized Period|Death|5|||
129874868|NCT04026165|467499545|FG003|Randomized Period|Death|7|||
129874869|NCT04026165|467499542|FG000|Randomized Period|Investigator's Discretion|0|||
129874870|NCT04026165|467499543|FG001|Randomized Period|Investigator's Discretion|0|||
129874871|NCT04026165|467499544|FG002|Randomized Period|Investigator's Discretion|2|||
129874872|NCT04026165|467499545|FG003|Randomized Period|Investigator's Discretion|2|||
129874873|NCT04026165|467499542|FG000|Randomized Period|Lost to Follow-up|0|||
129874874|NCT04026165|467499543|FG001|Randomized Period|Lost to Follow-up|0|||
129874875|NCT04026165|467499544|FG002|Randomized Period|Lost to Follow-up|2|||
129874876|NCT04026165|467499545|FG003|Randomized Period|Lost to Follow-up|2|||
129874877|NCT02487810|467499546|FG000|Overall Study|Withdrawal by Subject|1|||
129874878|NCT02487810|467499547|FG001|Overall Study|Withdrawal by Subject|0|||
129874879|NCT01889186|467499548|FG000|Overall Study|Adverse event- not related to progression|18|||
129874880|NCT01889186|467499549|FG001|Overall Study|Adverse event- not related to progression|5|||
129874881|NCT01889186|467499548|FG000|Overall Study|Adverse event- related to progression|7|||
129874882|NCT01889186|467499549|FG001|Overall Study|Adverse event- related to progression|2|||
129874883|NCT01889186|467499548|FG000|Overall Study|COVID-19 logistical restrictions|1|||
129874884|NCT01889186|467499549|FG001|Overall Study|COVID-19 logistical restrictions|0|||
129874885|NCT01889186|467499548|FG000|Overall Study|Investigator request|1|||
129874886|NCT01889186|467499549|FG001|Overall Study|Investigator request|1|||
129874887|NCT01889186|467499548|FG000|Overall Study|Progressive disease- Richter's|12|||
129874888|NCT01889186|467499549|FG001|Overall Study|Progressive disease- Richter's|7|||
129874889|NCT01889186|467499548|FG000|Overall Study|Progressive disease per protocol|46|||
129874890|NCT01889186|467499549|FG001|Overall Study|Progressive disease per protocol|17|||
129874891|NCT01889186|467499548|FG000|Overall Study|Stem cell transplant|2|||
129874892|NCT01889186|467499549|FG001|Overall Study|Stem cell transplant|1|||
129874893|NCT01889186|467499548|FG000|Overall Study|Withdrew consent|2|||
129874894|NCT01889186|467499549|FG001|Overall Study|Withdrew consent|3|||
129874895|NCT01889186|467499548|FG000|Overall Study|Other, not specified|18|||
129874896|NCT01889186|467499549|FG001|Overall Study|Other, not specified|15|||
129874897|NCT00441701|467499552|FG000|Overall Study|Adverse Event|3|||
129874898|NCT00441701|467499553|FG001|Overall Study|Adverse Event|2|||
129874899|NCT00441701|467499554|FG002|Overall Study|Adverse Event|1|||
129874900|NCT00441701|467499555|FG003|Overall Study|Adverse Event|0|||
129874901|NCT00441701|467499556|FG004|Overall Study|Adverse Event|2|||
129874902|NCT00441701|467499557|FG005|Overall Study|Adverse Event|2|||
129874903|NCT00441701|467499558|FG006|Overall Study|Adverse Event|0|||
129874904|NCT00441701|467499559|FG007|Overall Study|Adverse Event|0|||
129874905|NCT00441701|467499560|FG008|Overall Study|Adverse Event|0|||
129874906|NCT00441701|467499561|FG009|Overall Study|Adverse Event|0|||
129874907|NCT00441701|467499552|FG000|Overall Study|Lack of Efficacy|2|||
129874908|NCT00441701|467499553|FG001|Overall Study|Lack of Efficacy|0|||
129874909|NCT00441701|467499554|FG002|Overall Study|Lack of Efficacy|2|||
129874910|NCT00441701|467499555|FG003|Overall Study|Lack of Efficacy|2|||
129874911|NCT00441701|467499556|FG004|Overall Study|Lack of Efficacy|0|||
129874912|NCT00441701|467499557|FG005|Overall Study|Lack of Efficacy|1|||
129874913|NCT00441701|467499558|FG006|Overall Study|Lack of Efficacy|0|||
129874914|NCT00441701|467499559|FG007|Overall Study|Lack of Efficacy|0|||
129874915|NCT00441701|467499560|FG008|Overall Study|Lack of Efficacy|0|||
129874916|NCT00441701|467499561|FG009|Overall Study|Lack of Efficacy|0|||
129874917|NCT00441701|467499552|FG000|Overall Study|Withdrawal by Subject|0|||
129874918|NCT00441701|467499553|FG001|Overall Study|Withdrawal by Subject|2|||
129874919|NCT00441701|467499554|FG002|Overall Study|Withdrawal by Subject|1|||
129874920|NCT00441701|467499555|FG003|Overall Study|Withdrawal by Subject|1|||
129874921|NCT00441701|467499556|FG004|Overall Study|Withdrawal by Subject|0|||
129874922|NCT00441701|467499557|FG005|Overall Study|Withdrawal by Subject|0|||
129874923|NCT00441701|467499558|FG006|Overall Study|Withdrawal by Subject|0|||
129874924|NCT00441701|467499559|FG007|Overall Study|Withdrawal by Subject|0|||
129874925|NCT00441701|467499560|FG008|Overall Study|Withdrawal by Subject|0|||
129874926|NCT00441701|467499561|FG009|Overall Study|Withdrawal by Subject|0|||
129874927|NCT00077064|467499562|FG000|Overall Study|Adverse Event|0|||
129874928|NCT00077064|467499563|FG001|Overall Study|Adverse Event|4|||
129874929|NCT00077064|467499562|FG000|Overall Study|Patient refusal|0|||
129874930|NCT00077064|467499563|FG001|Overall Study|Patient refusal|2|||
129874931|NCT04710927|467499564|FG000|Overall Study|Lost to Follow-up|7|||
129874932|NCT04710927|467499565|FG001|Overall Study|Lost to Follow-up|6|||
129874933|NCT04710927|467499566|FG002|Overall Study|Lost to Follow-up|5|||
129874934|NCT00621543|467499567|FG000|Overall Study|Lost to Follow-up|23|||
129874935|NCT02007434|467499569|FG000|Overall Study|Lost to Follow-up|0|||
129874936|NCT02007434|467499570|FG001|Overall Study|Lost to Follow-up|1|||
129874937|NCT02007434|467499571|FG002|Overall Study|Lost to Follow-up|0|||
129874938|NCT02007434|467499572|FG003|Overall Study|Lost to Follow-up|0|||
129874939|NCT02007434|467499573|FG004|Overall Study|Lost to Follow-up|0|||
129874940|NCT02007434|467499574|FG005|Overall Study|Lost to Follow-up|0|||
129874941|NCT02007434|467499575|FG006|Overall Study|Lost to Follow-up|0|||
129874942|NCT02007434|467499576|FG007|Overall Study|Lost to Follow-up|0|||
129874943|NCT02007434|467499569|FG000|Overall Study|Non-compliance|1|||
129874944|NCT02007434|467499570|FG001|Overall Study|Non-compliance|0|||
129874945|NCT02007434|467499571|FG002|Overall Study|Non-compliance|1|||
129874946|NCT02007434|467499572|FG003|Overall Study|Non-compliance|0|||
129874947|NCT02007434|467499573|FG004|Overall Study|Non-compliance|0|||
129874948|NCT02007434|467499574|FG005|Overall Study|Non-compliance|0|||
129874949|NCT02007434|467499575|FG006|Overall Study|Non-compliance|0|||
129874950|NCT02007434|467499576|FG007|Overall Study|Non-compliance|0|||
129874951|NCT01287611|467499577|FG000|Overall Study|Lost to Follow-up|29|||
129874952|NCT01287611|467499578|FG001|Overall Study|Lost to Follow-up|16|||
129874953|NCT01287611|467499577|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
129874954|NCT01287611|467499578|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
129874955|NCT02192970|467499581|FG000|Overall Study|Lost to Follow-up|6|||
129874956|NCT02192970|467499582|FG001|Overall Study|Lost to Follow-up|0|||
129874957|NCT04074590|467499583|FG000|Overall Study|Adverse Event|1|||
129874958|NCT04074590|467499584|FG001|Overall Study|Adverse Event|0|||
129874959|NCT04074590|467499583|FG000|Overall Study|Physician Decision|1|||
129874960|NCT04074590|467499584|FG001|Overall Study|Physician Decision|0|||
129874961|NCT04074590|467499583|FG000|Overall Study|Withdrawal by Subject|2|||
129874962|NCT04074590|467499584|FG001|Overall Study|Withdrawal by Subject|0|||
129874963|NCT00691132|467499585|FG000|Overall Study|Adverse Event|2|||
129874964|NCT00691132|467499586|FG001|Overall Study|Adverse Event|3|||
129874965|NCT00691132|467499585|FG000|Overall Study|Withdrawal by Subject|10|||
129874966|NCT00691132|467499586|FG001|Overall Study|Withdrawal by Subject|10|||
129874967|NCT03954743|467499587|FG000|Overall Study|Adverse Event|1|||
129874968|NCT03954743|467499588|FG001|Overall Study|Adverse Event|0|||
129874969|NCT03954743|467499587|FG000|Overall Study|Lost to Follow-up|6|||
129874970|NCT03954743|467499588|FG001|Overall Study|Lost to Follow-up|4|||
129874971|NCT03954743|467499587|FG000|Overall Study|Protocol Violation|1|||
129874972|NCT03954743|467499588|FG001|Overall Study|Protocol Violation|0|||
129874973|NCT03954743|467499587|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
129984789|NCT03981861|467905570|FG000|Overall Study|Withdrawal by Subject|3|||
129984790|NCT05618912|467905571|FG000|Overall Study|Lost to Follow-up|14|||
129984791|NCT05618912|467905572|FG001|Overall Study|Lost to Follow-up|19|||
129984792|NCT01022112|467905573|FG000|Overall Study|Adverse Event|1|||
129984793|NCT01022112|467905574|FG001|Overall Study|Adverse Event|2|||
129984794|NCT01022112|467905575|FG002|Overall Study|Adverse Event|0|||
129984795|NCT01022112|467905576|FG003|Overall Study|Adverse Event|1|||
129984796|NCT01022112|467905577|FG004|Overall Study|Adverse Event|0|||
129984797|NCT01022112|467905573|FG000|Overall Study|Lack of Efficacy|1|||
129984798|NCT01022112|467905574|FG001|Overall Study|Lack of Efficacy|0|||
129984799|NCT01022112|467905575|FG002|Overall Study|Lack of Efficacy|0|||
129984800|NCT01022112|467905576|FG003|Overall Study|Lack of Efficacy|0|||
129874974|NCT03954743|467499588|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
129874975|NCT03954743|467499587|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
129874976|NCT03954743|467499588|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129874977|NCT02387996|467499593|FG000|Overall Study|Disease Progression|167|||
129874978|NCT02387996|467499593|FG000|Overall Study|Study Drug Toxicity|31|||
129874979|NCT02387996|467499593|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
129874980|NCT02387996|467499593|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
129874981|NCT02387996|467499593|FG000|Overall Study|Subject Withdrew Consent|5|||
129874982|NCT02387996|467499593|FG000|Overall Study|Lost to Follow-up|1|||
129874983|NCT02387996|467499593|FG000|Overall Study|Poor/Non-Compliance|1|||
129874984|NCT02387996|467499593|FG000|Overall Study|Other Reasons|5|||
129874985|NCT02387996|467499593|FG000|Overall Study|Death|1|||
129874986|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
129874987|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
129874988|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
129874989|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
129984801|NCT01022112|467905577|FG004|Overall Study|Lack of Efficacy|1|||
129984802|NCT01022112|467905573|FG000|Overall Study|Physician Decision|0|||
129984803|NCT01022112|467905574|FG001|Overall Study|Physician Decision|0|||
129984804|NCT01022112|467905575|FG002|Overall Study|Physician Decision|1|||
129984805|NCT01022112|467905576|FG003|Overall Study|Physician Decision|0|||
129984806|NCT01022112|467905577|FG004|Overall Study|Physician Decision|1|||
129984807|NCT01022112|467905573|FG000|Overall Study|Withdrawal by Subject|0|||
129984808|NCT01022112|467905574|FG001|Overall Study|Withdrawal by Subject|1|||
129984809|NCT01022112|467905575|FG002|Overall Study|Withdrawal by Subject|2|||
129984810|NCT01022112|467905576|FG003|Overall Study|Withdrawal by Subject|2|||
129984811|NCT01022112|467905577|FG004|Overall Study|Withdrawal by Subject|1|||
129984812|NCT01022112|467905573|FG000|Overall Study|Fasting plasma glucose level increased|1|||
129984813|NCT01022112|467905574|FG001|Overall Study|Fasting plasma glucose level increased|0|||
129984814|NCT01022112|467905575|FG002|Overall Study|Fasting plasma glucose level increased|0|||
129984815|NCT01022112|467905576|FG003|Overall Study|Fasting plasma glucose level increased|0|||
129984816|NCT01022112|467905577|FG004|Overall Study|Fasting plasma glucose level increased|7|||
130052047|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130052048|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
130052049|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
130052050|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130052051|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130052052|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130052053|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
130052054|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
130052055|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
130052056|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130052057|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130052058|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130207905|NCT01886781|468721033|FG001|Overall Study|Worsening of symptoms|1|||
129874990|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
130052059|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
130052060|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
129984817|NCT00432666|467907405|FG000|Main Period|Adverse Event|1|||
129984818|NCT00432666|467907406|FG001|Main Period|Adverse Event|1|||
130207906|NCT00424021|468721034|FG000|NCT00046319 Study Period|Adverse Event|1|||
130207907|NCT00424021|468721035|FG001|NCT00046319 Study Period|Adverse Event|0|||
130207908|NCT00424021|468721036|FG002|NCT00046319 Study Period|Adverse Event|1|||
130207909|NCT00424021|468721037|FG003|NCT00046319 Study Period|Adverse Event|1|||
129984819|NCT00432666|467907405|FG000|Main Period|Consent Withdrawn|1|||
129984820|NCT00432666|467907406|FG001|Main Period|Consent Withdrawn|0|||
129984821|NCT00432666|467907405|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
129984822|NCT00432666|467907406|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
129984823|NCT00432666|467907405|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
129984824|NCT00432666|467907406|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
129984825|NCT00432666|467907405|FG000|Open-Label Extension Period|Adverse Event|5|||
129984826|NCT00432666|467907406|FG001|Open-Label Extension Period|Adverse Event|0|||
129984827|NCT00432666|467907405|FG000|Open-Label Extension Period|Consent withdrawn|10|||
129984828|NCT00432666|467907406|FG001|Open-Label Extension Period|Consent withdrawn|0|||
129984829|NCT00432666|467907405|FG000|Open-Label Extension Period|Physician Decision|3|||
129984830|NCT00432666|467907406|FG001|Open-Label Extension Period|Physician Decision|0|||
129984831|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
129984832|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
129984833|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
129984834|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
129984835|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
129984836|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
129984837|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
129984838|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
129984839|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
129984840|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
129984841|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
129984842|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
129984843|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
129984844|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
129984845|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
129984846|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
129984847|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
129984848|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
129984849|NCT02516332|467907409|FG000|Overall Study|Withdrawal by Subject|2|||
129984850|NCT02516332|467907410|FG001|Overall Study|Withdrawal by Subject|1|||
129984851|NCT02516332|467907411|FG002|Overall Study|Withdrawal by Subject|2|||
129984852|NCT03037931|467907412|FG000|Overall Study|Death|354|||
129984853|NCT03037931|467907413|FG001|Overall Study|Death|367|||
129984854|NCT03037931|467907412|FG000|Overall Study|Lost to Follow-up|7|||
129984855|NCT03037931|467907413|FG001|Overall Study|Lost to Follow-up|4|||
129984856|NCT03037931|467907412|FG000|Overall Study|Withdrawal by Subject|48|||
129984857|NCT03037931|467907413|FG001|Overall Study|Withdrawal by Subject|41|||
129984858|NCT00605215|467907414|FG000|Overall Study|Death|0|||
129984859|NCT00605215|467907415|FG001|Overall Study|Death|0|||
129984860|NCT00605215|467907416|FG002|Overall Study|Death|1|||
129984861|NCT00605215|467907414|FG000|Overall Study|Adverse Event|19|||
129984862|NCT00605215|467907415|FG001|Overall Study|Adverse Event|21|||
129984863|NCT00605215|467907416|FG002|Overall Study|Adverse Event|26|||
129984864|NCT00605215|467907414|FG000|Overall Study|Refusal to sign the re-consent form|8|||
129984865|NCT00605215|467907415|FG001|Overall Study|Refusal to sign the re-consent form|3|||
129984866|NCT00605215|467907416|FG002|Overall Study|Refusal to sign the re-consent form|3|||
129984867|NCT00605215|467907414|FG000|Overall Study|Withdrawal by Subject|39|||
129984868|NCT00605215|467907415|FG001|Overall Study|Withdrawal by Subject|37|||
129984869|NCT00605215|467907416|FG002|Overall Study|Withdrawal by Subject|27|||
129984870|NCT00605215|467907414|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
129984871|NCT00605215|467907415|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
129984872|NCT00605215|467907416|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
129984873|NCT00605215|467907414|FG000|Overall Study|Protocol Violation|3|||
129984874|NCT00605215|467907415|FG001|Overall Study|Protocol Violation|4|||
129984875|NCT00605215|467907416|FG002|Overall Study|Protocol Violation|1|||
129984876|NCT00605215|467907414|FG000|Overall Study|Pregnancy|8|||
129984877|NCT00605215|467907415|FG001|Overall Study|Pregnancy|5|||
129984878|NCT00605215|467907416|FG002|Overall Study|Pregnancy|4|||
129984879|NCT00605215|467907414|FG000|Overall Study|Lost to Follow-up|8|||
129984880|NCT00605215|467907415|FG001|Overall Study|Lost to Follow-up|5|||
129984881|NCT00605215|467907416|FG002|Overall Study|Lost to Follow-up|2|||
129984882|NCT00605215|467907414|FG000|Overall Study|Other than specified|0|||
129984883|NCT00605215|467907415|FG001|Overall Study|Other than specified|2|||
129984884|NCT00605215|467907416|FG002|Overall Study|Other than specified|1|||
129984885|NCT02914275|467907419|FG000|Overall Study|Lost to Follow-up|84|||
129984886|NCT02914275|467907420|FG001|Overall Study|Lost to Follow-up|29|||
129984887|NCT02914275|467907419|FG000|Overall Study|Withdrawal by Subject|26|||
129984888|NCT02914275|467907420|FG001|Overall Study|Withdrawal by Subject|10|||
129984889|NCT02914275|467907419|FG000|Overall Study|Protocol Violation|1|||
129984890|NCT02914275|467907420|FG001|Overall Study|Protocol Violation|1|||
129984891|NCT02914275|467907419|FG000|Overall Study|Physician Decision|3|||
129984892|NCT02914275|467907420|FG001|Overall Study|Physician Decision|1|||
129984893|NCT02914275|467907419|FG000|Overall Study|Other|4|||
129984894|NCT02914275|467907420|FG001|Overall Study|Other|1|||
129984895|NCT02914275|467907419|FG000|Overall Study|Excluded due to invalid informed consent|3|||
129984896|NCT02914275|467907420|FG001|Overall Study|Excluded due to invalid informed consent|0|||
129984897|NCT01302067|467907425|FG000|Overall Study|Death|0|||
129984898|NCT01302067|467907426|FG001|Overall Study|Death|0|||
129984899|NCT01302067|467907427|FG002|Overall Study|Death|1|||
129984900|NCT01302067|467907425|FG000|Overall Study|Physician Decision|9|||
129984901|NCT01302067|467907426|FG001|Overall Study|Physician Decision|5|||
129984902|NCT01302067|467907427|FG002|Overall Study|Physician Decision|14|||
129984903|NCT01302067|467907425|FG000|Overall Study|Lack of Efficacy|8|||
129984904|NCT01302067|467907426|FG001|Overall Study|Lack of Efficacy|4|||
129984905|NCT01302067|467907427|FG002|Overall Study|Lack of Efficacy|2|||
129984906|NCT01302067|467907425|FG000|Overall Study|Lost to Follow-up|9|||
129984907|NCT01302067|467907426|FG001|Overall Study|Lost to Follow-up|4|||
129984908|NCT01302067|467907427|FG002|Overall Study|Lost to Follow-up|15|||
129984909|NCT01302067|467907425|FG000|Overall Study|Withdrawal by Subject|13|||
129984910|NCT01302067|467907426|FG001|Overall Study|Withdrawal by Subject|6|||
129984911|NCT01302067|467907427|FG002|Overall Study|Withdrawal by Subject|10|||
129984912|NCT01302067|467907425|FG000|Overall Study|Other|1|||
129984913|NCT01302067|467907426|FG001|Overall Study|Other|1|||
129984914|NCT01302067|467907427|FG002|Overall Study|Other|3|||
129984915|NCT01302067|467907425|FG000|Overall Study|Protocol Violation|11|||
129984916|NCT01302067|467907426|FG001|Overall Study|Protocol Violation|0|||
129984917|NCT01302067|467907427|FG002|Overall Study|Protocol Violation|8|||
129984918|NCT01302067|467907425|FG000|Overall Study|Adverse Event|27|||
129984919|NCT01302067|467907426|FG001|Overall Study|Adverse Event|14|||
129984920|NCT01302067|467907427|FG002|Overall Study|Adverse Event|45|||
129984921|NCT02738203|467907429|FG000|Overall Study|Failed IUD Insertion|2|||
129984922|NCT02738203|467907430|FG001|Overall Study|Failed IUD Insertion|2|||
129984923|NCT02738203|467907429|FG000|Overall Study|Protocol Violation|0|||
129984924|NCT02738203|467907430|FG001|Overall Study|Protocol Violation|1|||
129984925|NCT03241927|467907431|FG000|Overall Study|study terminated|1|||
129984926|NCT03241927|467907432|FG001|Overall Study|study terminated|0|||
129984927|NCT02704754|467907433|FG000|Overall Study|Lost to Follow-up|1|||
129984928|NCT02704754|467907434|FG001|Overall Study|Lost to Follow-up|1|||
129984929|NCT02704754|467907433|FG000|Overall Study|Lack of Efficacy|1|||
129984930|NCT02704754|467907434|FG001|Overall Study|Lack of Efficacy|0|||
129984931|NCT02704754|467907433|FG000|Overall Study|Withdrawal by Subject|1|||
129984932|NCT02704754|467907434|FG001|Overall Study|Withdrawal by Subject|0|||
129984933|NCT00423943|467907435|FG000|Overall Study|Withdrawal by Subject|3|||
129984934|NCT00423943|467907436|FG001|Overall Study|Withdrawal by Subject|1|||
129984935|NCT02383056|467907440|FG000|Overall Study|Adverse Event|1|||
129984936|NCT02383056|467907441|FG001|Overall Study|Adverse Event|0|||
129984937|NCT02383056|467907440|FG000|Overall Study|Lost to Follow-up|0|||
129984938|NCT02383056|467907441|FG001|Overall Study|Lost to Follow-up|2|||
129984939|NCT04214600|467907442|FG000|Overall Study|Lost to Follow-up|9|||
129984940|NCT04214600|467907443|FG001|Overall Study|Lost to Follow-up|14|||
129984941|NCT03245151|467907448|FG000|Overall Study|Withdrawal by Subject|2|||
129984942|NCT03245151|467907449|FG001|Overall Study|Withdrawal by Subject|0|||
129984943|NCT03245151|467907450|FG002|Overall Study|Withdrawal by Subject|0|||
129984944|NCT03245151|467907451|FG003|Overall Study|Withdrawal by Subject|2|||
129984945|NCT03245151|467907452|FG004|Overall Study|Withdrawal by Subject|1|||
129984946|NCT03245151|467907448|FG000|Overall Study|Death|3|||
129984947|NCT03245151|467907449|FG001|Overall Study|Death|14|||
129984948|NCT03245151|467907450|FG002|Overall Study|Death|9|||
129984949|NCT03245151|467907451|FG003|Overall Study|Death|16|||
129984950|NCT03245151|467907452|FG004|Overall Study|Death|7|||
129984951|NCT03245151|467907448|FG000|Overall Study|Sponsor's decision|0|||
129984952|NCT03245151|467907449|FG001|Overall Study|Sponsor's decision|1|||
129984953|NCT03245151|467907450|FG002|Overall Study|Sponsor's decision|0|||
129984954|NCT03245151|467907451|FG003|Overall Study|Sponsor's decision|0|||
129984955|NCT03245151|467907452|FG004|Overall Study|Sponsor's decision|0|||
129984956|NCT02366468|467907453|FG000|Overall Study|Adverse Event|2|||
129984957|NCT02366468|467907454|FG001|Overall Study|Adverse Event|0|||
129984958|NCT02366468|467907453|FG000|Overall Study|Withdrawal by Subject|1|||
129984959|NCT02366468|467907454|FG001|Overall Study|Withdrawal by Subject|5|||
129984960|NCT02366468|467907453|FG000|Overall Study|Lost to Follow-up|2|||
129984961|NCT02366468|467907454|FG001|Overall Study|Lost to Follow-up|0|||
129984962|NCT02366468|467907453|FG000|Overall Study|Death|1|||
129984963|NCT02366468|467907454|FG001|Overall Study|Death|2|||
129984964|NCT02366468|467907453|FG000|Overall Study|Other|0|||
129984965|NCT02366468|467907454|FG001|Overall Study|Other|2|||
129984966|NCT04797650|467907455|FG000|Overall Study|Reason Not Specified|5|||
129984967|NCT04797650|467907456|FG001|Overall Study|Reason Not Specified|12|||
129984968|NCT04797650|467907457|FG002|Overall Study|Reason Not Specified|5|||
129984969|NCT04797650|467907455|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
129984970|NCT04797650|467907456|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
129984971|NCT04797650|467907457|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
129984972|NCT04797650|467907455|FG000|Overall Study|Lack of Efficacy|1|||
129984973|NCT04797650|467907456|FG001|Overall Study|Lack of Efficacy|0|||
129984974|NCT04797650|467907457|FG002|Overall Study|Lack of Efficacy|1|||
129984975|NCT04797650|467907455|FG000|Overall Study|Non-compliance with Study Drug|0|||
129984976|NCT04797650|467907456|FG001|Overall Study|Non-compliance with Study Drug|0|||
129984977|NCT04797650|467907457|FG002|Overall Study|Non-compliance with Study Drug|2|||
129984978|NCT04797650|467907455|FG000|Overall Study|Lost to Follow-up|4|||
129984979|NCT04797650|467907456|FG001|Overall Study|Lost to Follow-up|6|||
129984980|NCT04797650|467907457|FG002|Overall Study|Lost to Follow-up|1|||
129984981|NCT00657020|467907458|FG000|PERIOD 1|Adverse Event|0|||
129984982|NCT00657020|467907459|FG001|PERIOD 1|Adverse Event|1|||
129984983|NCT04772898|467907460|FG000|Overall Study|Withdrawal by Subject|0|||
129984984|NCT04772898|467907461|FG001|Overall Study|Withdrawal by Subject|1|||
129984985|NCT02947087|467907462|FG000|Overall Study|Withdrawal by Subject|3|||
129984986|NCT02947087|467907463|FG001|Overall Study|Withdrawal by Subject|2|||
129984987|NCT00434213|467907467|FG000|Overall Study|Adverse Event|12|||
129984988|NCT00434213|467907467|FG000|Overall Study|Lack of Efficacy|9|||
129984989|NCT00434213|467907467|FG000|Overall Study|Lost to Follow-up|14|||
129984990|NCT00434213|467907467|FG000|Overall Study|Withdrawal by Subject|7|||
129984991|NCT00434213|467907467|FG000|Overall Study|Protocol Violation|3|||
129984992|NCT00434213|467907467|FG000|Overall Study|Unable to comply with study visit window|2|||
129984993|NCT00434213|467907467|FG000|Overall Study|Application site reaction|1|||
129984994|NCT00434213|467907467|FG000|Overall Study|Non-compliant to study schedule|1|||
129984995|NCT00774930|467907471|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
129984996|NCT00774930|467907472|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
129984997|NCT00774930|467907471|FG000|DB Phase|Adverse Event|1|||
129984998|NCT00774930|467907472|FG001|DB Phase|Adverse Event|2|||
129984999|NCT00774930|467907471|FG000|DB Phase|Subject Decision|1|||
129985000|NCT00774930|467907472|FG001|DB Phase|Subject Decision|5|||
129985001|NCT00774930|467907471|FG000|DB Phase|Sponsor Decision|0|||
129985002|NCT00774930|467907472|FG001|DB Phase|Sponsor Decision|1|||
129985003|NCT00774930|467907471|FG000|DB Phase|Disease Progression|1|||
129985004|NCT00774930|467907472|FG001|DB Phase|Disease Progression|1|||
129985005|NCT00774930|467907471|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
129985006|NCT00774930|467907472|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
129985007|NCT00774930|467907471|FG000|IOL Phase|Adverse Event|1|||
129985008|NCT00774930|467907472|FG001|IOL Phase|Adverse Event|1|||
129985009|NCT00774930|467907471|FG000|IOL Phase|Subject Decision|4|||
129985010|NCT00774930|467907472|FG001|IOL Phase|Subject Decision|3|||
129985011|NCT00774930|467907471|FG000|IOL Phase|Physician Decision|3|||
129985012|NCT00774930|467907472|FG001|IOL Phase|Physician Decision|2|||
129985013|NCT00774930|467907471|FG000|IOL Phase|Sponsor Decision|1|||
129985014|NCT00774930|467907472|FG001|IOL Phase|Sponsor Decision|0|||
129985015|NCT00774930|467907471|FG000|IOL Phase|Disease Progression|2|||
129985016|NCT00774930|467907472|FG001|IOL Phase|Disease Progression|1|||
129985017|NCT00774930|467907471|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
129985018|NCT00774930|467907472|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
129985019|NCT00774930|467907471|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
129985020|NCT00774930|467907472|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
129985021|NCT00774930|467907471|FG000|IOL Phase|Other|1|||
129985022|NCT00774930|467907472|FG001|IOL Phase|Other|0|||
129985023|NCT00774930|467907471|FG000|IOL Phase|Brain radiation|0|||
129985024|NCT00774930|467907472|FG001|IOL Phase|Brain radiation|1|||
129985025|NCT00774930|467907471|FG000|LTOLE Phase|Adverse Event|7|||
129985026|NCT00774930|467907472|FG001|LTOLE Phase|Adverse Event|3|||
129985027|NCT00774930|467907471|FG000|LTOLE Phase|Subject decision|0|||
129985028|NCT00774930|467907472|FG001|LTOLE Phase|Subject decision|5|||
129985029|NCT00774930|467907471|FG000|LTOLE Phase|Physician Decision|4|||
129985030|NCT00774930|467907472|FG001|LTOLE Phase|Physician Decision|1|||
129985031|NCT00774930|467907471|FG000|LTOLE Phase|Sponsor decision|2|||
129985032|NCT00774930|467907472|FG001|LTOLE Phase|Sponsor decision|1|||
129985033|NCT00774930|467907471|FG000|LTOLE Phase|Disease Progression|2|||
129985034|NCT00774930|467907472|FG001|LTOLE Phase|Disease Progression|5|||
129985035|NCT00774930|467907471|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
129985036|NCT00774930|467907472|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
129985037|NCT00774930|467907471|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
129985038|NCT00774930|467907472|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
129985039|NCT00766363|467907473|FG000|Overall Study|Withdrawal by Subject|1|||
129985040|NCT00766363|467907474|FG001|Overall Study|Withdrawal by Subject|0|||
129985041|NCT00766363|467907475|FG002|Overall Study|Withdrawal by Subject|0|||
129985042|NCT00766363|467907476|FG003|Overall Study|Withdrawal by Subject|0|||
129985043|NCT00766363|467907473|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
129985044|NCT00766363|467907474|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
129985045|NCT00766363|467907475|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
129985046|NCT00766363|467907476|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
129985047|NCT03020576|467907481|FG000|Overall Study|Withdrawal by Subject|1|||
129985048|NCT03020576|467907482|FG001|Overall Study|Withdrawal by Subject|2|||
129985049|NCT01153321|467907483|FG000|Overall Study|Development of study withdrawal criteria|0|||
129985050|NCT01153321|467907484|FG001|Overall Study|Development of study withdrawal criteria|1|||
129985051|NCT01153321|467907483|FG000|Overall Study|Withdrawal by Subject|0|||
129985052|NCT01153321|467907484|FG001|Overall Study|Withdrawal by Subject|1|||
129985053|NCT01153321|467907483|FG000|Overall Study|Adverse Event|1|||
129985054|NCT01153321|467907484|FG001|Overall Study|Adverse Event|1|||
129985055|NCT01177800|467907486|FG000|Overall Study|Adverse Event|9|||
129985056|NCT01177800|467907487|FG001|Overall Study|Adverse Event|3|||
129985057|NCT01177800|467907486|FG000|Overall Study|Protocol Violation|0|||
129985058|NCT01177800|467907487|FG001|Overall Study|Protocol Violation|1|||
129985059|NCT01177800|467907486|FG000|Overall Study|Physician Decision|1|||
129985060|NCT01177800|467907487|FG001|Overall Study|Physician Decision|0|||
129985061|NCT01177800|467907486|FG000|Overall Study|Withdrawal of informed consent|0|||
129985062|NCT01177800|467907487|FG001|Overall Study|Withdrawal of informed consent|1|||
129985063|NCT03527550|467907488|FG000|Overall Study|Lost to Follow-up|4|||
129985064|NCT03527550|467907489|FG001|Overall Study|Lost to Follow-up|2|||
129985065|NCT03527550|467907488|FG000|Overall Study|Withdrawal by Subject|4|||
129985066|NCT03527550|467907489|FG001|Overall Study|Withdrawal by Subject|1|||
129985067|NCT03527550|467907488|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
129985068|NCT03527550|467907489|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
129985069|NCT00911937|467907490|FG000|Overall Study|Death|1|||
129985070|NCT00911937|467907491|FG001|Overall Study|Death|0|||
129985071|NCT00911937|467907490|FG000|Overall Study|Lost to Follow-up|8|||
129985072|NCT00911937|467907491|FG001|Overall Study|Lost to Follow-up|5|||
129985073|NCT00911937|467907490|FG000|Overall Study|Withdrawal by Subject|10|||
129985074|NCT00911937|467907491|FG001|Overall Study|Withdrawal by Subject|7|||
129985075|NCT00911937|467907490|FG000|Overall Study|Withdrawn due to pregnancy|1|||
129985076|NCT00911937|467907491|FG001|Overall Study|Withdrawn due to pregnancy|0|||
129985077|NCT00911937|467907490|FG000|Overall Study|Adverse Event|11|||
129985078|NCT00911937|467907491|FG001|Overall Study|Adverse Event|25|||
129985079|NCT00911937|467907490|FG000|Overall Study|Lack of Efficacy|11|||
129985080|NCT00911937|467907491|FG001|Overall Study|Lack of Efficacy|6|||
129985081|NCT00911937|467907490|FG000|Overall Study|Did not meet inclusion criteria|9|||
129985082|NCT00911937|467907491|FG001|Overall Study|Did not meet inclusion criteria|11|||
129985083|NCT00911937|467907490|FG000|Overall Study|Protocol Violation|14|||
129985084|NCT00911937|467907491|FG001|Overall Study|Protocol Violation|23|||
129985085|NCT00911937|467907490|FG000|Overall Study|Randomized but not treated|13|||
129985086|NCT00911937|467907491|FG001|Overall Study|Randomized but not treated|13|||
129985087|NCT00911937|467907490|FG000|Overall Study|Other|9|||
129985088|NCT00911937|467907491|FG001|Overall Study|Other|5|||
129985089|NCT01498679|467907495|FG000|Overall Study|Adverse Event|1|||
129985090|NCT01498679|467907496|FG001|Overall Study|Adverse Event|4|||
129985091|NCT01498679|467907495|FG000|Overall Study|Lack of Efficacy|72|||
129985092|NCT01498679|467907496|FG001|Overall Study|Lack of Efficacy|12|||
129985093|NCT01498679|467907495|FG000|Overall Study|Protocol Violation|4|||
129985094|NCT01498679|467907496|FG001|Overall Study|Protocol Violation|0|||
129985095|NCT01498679|467907495|FG000|Overall Study|Physician Decision|0|||
129985096|NCT01498679|467907496|FG001|Overall Study|Physician Decision|2|||
129985097|NCT01498679|467907495|FG000|Overall Study|Withdrawal by Subject|12|||
129985098|NCT01498679|467907496|FG001|Overall Study|Withdrawal by Subject|4|||
129985099|NCT01844687|467907498|FG000|Visit 1|Protocol Violation|3|||
129985100|NCT01844687|467907498|FG000|Visit 1|Lost to Follow-up|5|||
129985101|NCT01844687|467907498|FG000|Visit 2|Withdrawal by Subject|1|||
129985102|NCT01844687|467907498|FG000|Visit 2|Protocol Violation|1|||
129985103|NCT01844687|467907498|FG000|Visit 3|Lost to Follow-up|1|||
129985104|NCT01844687|467907498|FG000|Visit 3|Withdrawal by Subject|3|||
129985105|NCT01844687|467907498|FG000|Visit 3|child care problems|1|||
129985106|NCT01844687|467907498|FG000|Visit 4|Pregnancy|1|||
129985107|NCT01844687|467907498|FG000|Visit 4|Lost to Follow-up|1|||
129985108|NCT01844687|467907498|FG000|Visit 4|Withdrawal by Subject|2|||
129985109|NCT00635427|467907505|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985110|NCT00635427|467907506|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985111|NCT00635427|467907507|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
129985112|NCT00635427|467907508|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985113|NCT00635427|467907509|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985114|NCT00635427|467907505|FG000|Overall Study|Death|0|||
129985115|NCT00635427|467907506|FG001|Overall Study|Death|0|||
129985116|NCT00635427|467907507|FG002|Overall Study|Death|0|||
129985117|NCT00635427|467907508|FG003|Overall Study|Death|1|||
129985118|NCT00635427|467907509|FG004|Overall Study|Death|0|||
129985119|NCT00635427|467907505|FG000|Overall Study|Termination Of Study By Sponsor|12|||
129985120|NCT00635427|467907506|FG001|Overall Study|Termination Of Study By Sponsor|6|||
129985121|NCT00635427|467907507|FG002|Overall Study|Termination Of Study By Sponsor|10|||
129985122|NCT00635427|467907508|FG003|Overall Study|Termination Of Study By Sponsor|6|||
129985123|NCT00635427|467907509|FG004|Overall Study|Termination Of Study By Sponsor|6|||
129985124|NCT00635427|467907505|FG000|Overall Study|Withdrawal Of Consent|0|||
129985125|NCT00635427|467907506|FG001|Overall Study|Withdrawal Of Consent|0|||
129985126|NCT00635427|467907507|FG002|Overall Study|Withdrawal Of Consent|0|||
129985127|NCT00635427|467907508|FG003|Overall Study|Withdrawal Of Consent|2|||
129985128|NCT00635427|467907509|FG004|Overall Study|Withdrawal Of Consent|2|||
129985129|NCT02706899|467907515|FG000|Overall Study|Withdrawal by Subject|1|||
129985130|NCT02706899|467907516|FG001|Overall Study|Withdrawal by Subject|0|||
129985131|NCT02706899|467907515|FG000|Overall Study|Death|8|||
129985132|NCT02706899|467907516|FG001|Overall Study|Death|0|||
129985133|NCT02706899|467907515|FG000|Overall Study|Study Termination by Sponsor|4|||
129985134|NCT02706899|467907516|FG001|Overall Study|Study Termination by Sponsor|6|||
129985135|NCT00324675|467907517|FG000|Overall Study|Adverse Event|1|||
129985136|NCT00324675|467907518|FG001|Overall Study|Adverse Event|0|||
129985137|NCT00735475|467907519|FG000|Overall Study|Adverse Event|0|||
129985138|NCT00735475|467907520|FG001|Overall Study|Adverse Event|1|||
129985139|NCT00735475|467907519|FG000|Overall Study|Death|1|||
129985140|NCT00735475|467907520|FG001|Overall Study|Death|1|||
129985141|NCT00735475|467907519|FG000|Overall Study|Lost to Follow-up|3|||
129985142|NCT00735475|467907520|FG001|Overall Study|Lost to Follow-up|3|||
129985143|NCT00735475|467907519|FG000|Overall Study|Physician Decision|0|||
129985144|NCT00735475|467907520|FG001|Overall Study|Physician Decision|1|||
129985145|NCT00735475|467907519|FG000|Overall Study|Withdrawal by Subject|4|||
129985146|NCT00735475|467907520|FG001|Overall Study|Withdrawal by Subject|5|||
129985147|NCT02442336|467907522|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
129985148|NCT02442336|467907522|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
129985149|NCT02442336|467907522|FG000|Overall Study|Lost to Follow-up|11|||
129985150|NCT00844532|467907524|FG000|Overall Study|Death|16|||
129985151|NCT00844532|467907524|FG000|Overall Study|Withdrawal by Subject|16|||
129985152|NCT00844532|467907524|FG000|Overall Study|Lost to Follow-up|7|||
129985153|NCT01080716|467907525|FG000|Part 1|Physician Decision|1|||
129985154|NCT01080716|467907526|FG001|Part 1|Physician Decision|0|||
129985155|NCT01080716|467907527|FG002|Part 1|Physician Decision|0|||
129985156|NCT01080716|467907528|FG003|Part 1|Physician Decision|0|||
129985157|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
129985158|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
129985159|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
129985160|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|Death|7|||
129985161|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
129985162|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
129985163|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
129985164|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Death|5|||
129985165|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
129985166|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
129985167|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
129985168|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
129985169|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Death|3|||
129985170|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
129985171|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
129985172|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
129985173|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
129985174|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
129985175|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
129985176|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
129985177|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
129985178|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
129985179|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
129985180|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
129985181|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
129985182|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
129985183|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
129985184|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
129985185|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
129985186|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
129985187|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
129985188|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
129985189|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
129985190|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
129985191|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
129985192|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
129985193|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
129985194|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
129985195|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
129985196|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
129985197|NCT01237587|467907532|FG000|Taper Phase|Adverse Event|0|||
129985198|NCT01237587|467907533|FG001|Taper Phase|Adverse Event|2|||
129985199|NCT01237587|467907532|FG000|Taper Phase|Protocol Violation|2|||
129985200|NCT01237587|467907533|FG001|Taper Phase|Protocol Violation|0|||
129985201|NCT01237587|467907532|FG000|Taper Phase|Lack of Efficacy|2|||
129985202|NCT01237587|467907533|FG001|Taper Phase|Lack of Efficacy|5|||
129985203|NCT01237587|467907532|FG000|Taper Phase|Parent/Guardian Decision|0|||
129985204|NCT01237587|467907533|FG001|Taper Phase|Parent/Guardian Decision|2|||
129985205|NCT01237587|467907532|FG000|Taper Phase|Sponsor Decision|1|||
129985206|NCT01237587|467907533|FG001|Taper Phase|Sponsor Decision|0|||
129985207|NCT01237587|467907532|FG000|Taper Phase|Withdrawal by Subject|0|||
129985208|NCT01237587|467907533|FG001|Taper Phase|Withdrawal by Subject|1|||
129985209|NCT00633880|467907538|FG000|Open Label Titration|Lack of Efficacy|1|||
129985210|NCT00633880|467907539|FG001|Open Label Titration|Lack of Efficacy|0|||
129985211|NCT00633880|467907540|FG002|Open Label Titration|Lack of Efficacy|0|||
129985212|NCT00633880|467907538|FG000|Open Label Titration|Adverse Event|13|||
129985213|NCT00633880|467907539|FG001|Open Label Titration|Adverse Event|0|||
129985214|NCT00633880|467907540|FG002|Open Label Titration|Adverse Event|0|||
129985215|NCT00633880|467907538|FG000|Open Label Titration|Treatment Failure|55|||
129985216|NCT00633880|467907539|FG001|Open Label Titration|Treatment Failure|0|||
129985217|NCT00633880|467907540|FG002|Open Label Titration|Treatment Failure|0|||
129985218|NCT00633880|467907538|FG000|Open Label Titration|Protocol Violation|6|||
129985219|NCT00633880|467907539|FG001|Open Label Titration|Protocol Violation|0|||
129985220|NCT00633880|467907540|FG002|Open Label Titration|Protocol Violation|0|||
129985221|NCT00633880|467907538|FG000|Open Label Titration|Physician Decision|1|||
129985222|NCT00633880|467907539|FG001|Open Label Titration|Physician Decision|0|||
129985223|NCT00633880|467907540|FG002|Open Label Titration|Physician Decision|0|||
129985224|NCT00633880|467907538|FG000|Open Label Titration|Withdrawal by Subject|4|||
129985225|NCT00633880|467907539|FG001|Open Label Titration|Withdrawal by Subject|0|||
129985226|NCT00633880|467907540|FG002|Open Label Titration|Withdrawal by Subject|0|||
129985227|NCT03208036|467907541|FG000|Baseline Assessment|Withdrawal by Subject|1|||
129985228|NCT03208036|467907542|FG001|Baseline Assessment|Withdrawal by Subject|1|||
129985229|NCT03208036|467907541|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
129985230|NCT03208036|467907542|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
129985231|NCT03208036|467907541|FG000|Intervention|Withdrawal by Subject|3|||
129985232|NCT03208036|467907542|FG001|Intervention|Withdrawal by Subject|2|||
130207910|NCT00424021|468721034|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
130207911|NCT00424021|468721035|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
130207912|NCT00424021|468721036|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
130207913|NCT00424021|468721037|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
130207914|NCT00424021|468721034|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
130207915|NCT00424021|468721035|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
130207916|NCT00424021|468721036|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
130207917|NCT00424021|468721037|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
130207918|NCT00424021|468721034|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
130207919|NCT00424021|468721035|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
130207920|NCT00424021|468721036|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
130207921|NCT00424021|468721037|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
130207922|NCT00424021|468721034|FG000|AMB-220-E Study Period|Adverse Event|1|||
130207923|NCT00424021|468721035|FG001|AMB-220-E Study Period|Adverse Event|1|||
130207924|NCT00424021|468721036|FG002|AMB-220-E Study Period|Adverse Event|3|||
130207925|NCT00424021|468721037|FG003|AMB-220-E Study Period|Adverse Event|7|||
130207926|NCT00424021|468721034|FG000|AMB-220-E Study Period|Death|0|||
130207927|NCT00424021|468721035|FG001|AMB-220-E Study Period|Death|0|||
130207928|NCT00424021|468721036|FG002|AMB-220-E Study Period|Death|1|||
130207929|NCT00424021|468721037|FG003|AMB-220-E Study Period|Death|1|||
129985233|NCT03208036|467907541|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
129985234|NCT03208036|467907542|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
129985235|NCT01879553|467907544|FG000|Overall Study|Withdrawal by Subject|1|||
129985236|NCT01879553|467907545|FG001|Overall Study|Withdrawal by Subject|0|||
129985237|NCT00760474|467907554|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
129985238|NCT00760474|467907555|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
129985239|NCT00760474|467907554|FG000|Placebo Washout Period|Other|0|||
130207930|NCT00424021|468721034|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
130207931|NCT00424021|468721035|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
130207932|NCT00424021|468721036|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
130207933|NCT00424021|468721037|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
129985240|NCT00760474|467907555|FG001|Placebo Washout Period|Other|1|||
129985241|NCT00760474|467907554|FG000|Period 2 (P2)|Lost to Follow-up|1|||
129985242|NCT00760474|467907555|FG001|Period 2 (P2)|Lost to Follow-up|0|||
129985243|NCT00760474|467907554|FG000|Period 2 (P2)|Adverse Event|0|||
129985244|NCT00760474|467907555|FG001|Period 2 (P2)|Adverse Event|1|||
130207934|NCT00424021|468721034|FG000|AMB-220-E Study Period|Physician Decision|0|||
130207935|NCT00424021|468721035|FG001|AMB-220-E Study Period|Physician Decision|0|||
130207936|NCT00424021|468721036|FG002|AMB-220-E Study Period|Physician Decision|0|||
130207937|NCT00424021|468721037|FG003|AMB-220-E Study Period|Physician Decision|1|||
130207938|NCT03769194|468721038|FG000|Overall Study|Withdrawal by Subject|0|||
130207939|NCT03769194|468721039|FG001|Overall Study|Withdrawal by Subject|7|||
130207940|NCT03769194|468721040|FG002|Overall Study|Withdrawal by Subject|4|||
130207941|NCT03769194|468721041|FG003|Overall Study|Withdrawal by Subject|1|||
130207942|NCT03769194|468721038|FG000|Overall Study|moved from study area|0|||
130207943|NCT03769194|468721039|FG001|Overall Study|moved from study area|2|||
130207944|NCT03769194|468721040|FG002|Overall Study|moved from study area|1|||
130207945|NCT03769194|468721041|FG003|Overall Study|moved from study area|1|||
130207946|NCT03769194|468721038|FG000|Overall Study|Lost to Follow-up|3|||
130207947|NCT03769194|468721039|FG001|Overall Study|Lost to Follow-up|6|||
130207948|NCT03769194|468721040|FG002|Overall Study|Lost to Follow-up|3|||
130207949|NCT03769194|468721041|FG003|Overall Study|Lost to Follow-up|6|||
129985245|NCT02217501|467907561|FG000|Overall Study|Death|3|||
129985246|NCT02217501|467907562|FG001|Overall Study|Death|4|||
129985247|NCT00565851|467909190|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
129985248|NCT00565851|467909191|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
129985249|NCT00565851|467909192|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
129985250|NCT00565851|467909193|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
129985251|NCT00565851|467909194|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
129985252|NCT00565851|467909195|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
129985253|NCT00565851|467909196|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
129985254|NCT00565851|467909197|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
129985255|NCT00565851|467909190|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985256|NCT00565851|467909191|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
129985257|NCT00565851|467909192|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985258|NCT00565851|467909193|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
129985259|NCT00565851|467909194|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985260|NCT00565851|467909195|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
129985261|NCT00565851|467909196|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985262|NCT00565851|467909197|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
129985263|NCT00969709|467909202|FG000|Overall Study|Adverse Event|3|||
129985264|NCT00969709|467909203|FG001|Overall Study|Adverse Event|13|||
129985265|NCT00969709|467909204|FG002|Overall Study|Adverse Event|26|||
129985266|NCT00969709|467909205|FG003|Overall Study|Adverse Event|12|||
129985267|NCT00969709|467909202|FG000|Overall Study|Lack of Efficacy|7|||
129985268|NCT00969709|467909203|FG001|Overall Study|Lack of Efficacy|4|||
129985269|NCT00969709|467909204|FG002|Overall Study|Lack of Efficacy|1|||
129985270|NCT00969709|467909205|FG003|Overall Study|Lack of Efficacy|3|||
129985271|NCT00969709|467909202|FG000|Overall Study|Protocol Violation|9|||
129985272|NCT00969709|467909203|FG001|Overall Study|Protocol Violation|5|||
129985273|NCT00969709|467909204|FG002|Overall Study|Protocol Violation|9|||
129985274|NCT00969709|467909205|FG003|Overall Study|Protocol Violation|10|||
129985275|NCT00969709|467909202|FG000|Overall Study|Withdrawal by Subject|9|||
129985276|NCT00969709|467909203|FG001|Overall Study|Withdrawal by Subject|12|||
129985277|NCT00969709|467909204|FG002|Overall Study|Withdrawal by Subject|11|||
129985278|NCT00969709|467909205|FG003|Overall Study|Withdrawal by Subject|23|||
129985279|NCT00969709|467909202|FG000|Overall Study|Lost to Follow-up|10|||
129985280|NCT00969709|467909203|FG001|Overall Study|Lost to Follow-up|14|||
129985281|NCT00969709|467909204|FG002|Overall Study|Lost to Follow-up|8|||
129985282|NCT00969709|467909205|FG003|Overall Study|Lost to Follow-up|15|||
129985283|NCT00969709|467909202|FG000|Overall Study|Other reasons|0|||
129985284|NCT00969709|467909203|FG001|Overall Study|Other reasons|0|||
129985285|NCT00969709|467909204|FG002|Overall Study|Other reasons|3|||
129985286|NCT00969709|467909205|FG003|Overall Study|Other reasons|0|||
129985287|NCT03695237|467909206|FG000|Overall Study|Withdrawal by Subject|1|||
129985288|NCT03695237|467909207|FG001|Overall Study|Withdrawal by Subject|3|||
129985289|NCT03695237|467909206|FG000|Overall Study|Lost to Follow-up|1|||
129985290|NCT03695237|467909207|FG001|Overall Study|Lost to Follow-up|2|||
129985291|NCT03695237|467909206|FG000|Overall Study|Other, Not Specified|8|||
129985292|NCT03695237|467909207|FG001|Overall Study|Other, Not Specified|2|||
129985293|NCT01342341|467909210|FG000|Overall Study|Lost to Follow-up|4|||
129985294|NCT01342341|467909211|FG001|Overall Study|Lost to Follow-up|4|||
129985295|NCT01789567|467909212|FG000|Overall Study|Death|6|||
130207950|NCT03769194|468721038|FG000|Overall Study|other|1|||
130207951|NCT03769194|468721039|FG001|Overall Study|other|3|||
129985296|NCT00091169|467909213|FG000|Overall Study|Disease progression|3|||
129985297|NCT00091169|467909214|FG001|Overall Study|Disease progression|1|||
129985298|NCT00091169|467909213|FG000|Overall Study|Adverse Event|11|||
129985299|NCT00091169|467909214|FG001|Overall Study|Adverse Event|17|||
129985300|NCT00091169|467909213|FG000|Overall Study|Death|4|||
129985301|NCT00091169|467909214|FG001|Overall Study|Death|1|||
129985302|NCT00091169|467909213|FG000|Overall Study|Withdrawal by Subject|10|||
129985303|NCT00091169|467909214|FG001|Overall Study|Withdrawal by Subject|13|||
129985304|NCT00091169|467909213|FG000|Overall Study|Other|3|||
129985305|NCT00091169|467909214|FG001|Overall Study|Other|4|||
129985306|NCT00091169|467909213|FG000|Overall Study|Not start protocol therapy|26|||
129985307|NCT00091169|467909214|FG001|Overall Study|Not start protocol therapy|17|||
129985308|NCT00872989|467909215|FG000|Overall Study|Adverse Event|7|||
129985309|NCT00872989|467909216|FG001|Overall Study|Adverse Event|15|||
129985310|NCT00872989|467909215|FG000|Overall Study|Withdrawal by Subject|8|||
129985311|NCT00872989|467909216|FG001|Overall Study|Withdrawal by Subject|5|||
129985312|NCT00872989|467909215|FG000|Overall Study|Progression/relapse|47|||
129985313|NCT00872989|467909216|FG001|Overall Study|Progression/relapse|35|||
129985314|NCT00872989|467909215|FG000|Overall Study|Not protocol specified|3|||
129985315|NCT00872989|467909216|FG001|Overall Study|Not protocol specified|8|||
129985316|NCT00266227|467909219|FG000|Initial Treatment|Adverse Event|0|||
129985317|NCT00266227|467909220|FG001|Initial Treatment|Adverse Event|0|||
129985318|NCT00266227|467909221|FG002|Initial Treatment|Adverse Event|13|||
129985319|NCT00266227|467909219|FG000|Initial Treatment|Lost to Follow-up|0|||
129985320|NCT00266227|467909220|FG001|Initial Treatment|Lost to Follow-up|0|||
129985321|NCT00266227|467909221|FG002|Initial Treatment|Lost to Follow-up|6|||
129985322|NCT00266227|467909219|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
129985323|NCT00266227|467909220|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
129985324|NCT00266227|467909221|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
129985325|NCT00266227|467909219|FG000|Initial Treatment|Physician decision to withdraw|0|||
129985326|NCT00266227|467909220|FG001|Initial Treatment|Physician decision to withdraw|0|||
129985327|NCT00266227|467909221|FG002|Initial Treatment|Physician decision to withdraw|12|||
129985328|NCT00266227|467909219|FG000|Initial Treatment|Pregnancy|0|||
129985329|NCT00266227|467909220|FG001|Initial Treatment|Pregnancy|0|||
129985330|NCT00266227|467909221|FG002|Initial Treatment|Pregnancy|1|||
129985331|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Death|1|||
129985332|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Death|0|||
129985333|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Death|0|||
129985334|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
129985335|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
129985336|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
129985337|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
129985338|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
129985339|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
129985340|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
129985341|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
129985342|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
129985343|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
129985344|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
129985345|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
129985346|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
129985347|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
129985348|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
129985349|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Death|1|||
129985350|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Death|1|||
129985351|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Death|0|||
129985352|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
129985353|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
129985354|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
129985355|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
129985356|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
129985357|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
129985358|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
129985359|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
129985360|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
129985361|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
129985362|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
129985363|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
129985364|NCT03725085|467909226|FG000|Overall Study|Lost to Follow-up|2|||
129985365|NCT02245737|467909228|FG000|Overall Study|Adverse Event|23|||
129985366|NCT02245737|467909229|FG001|Overall Study|Adverse Event|26|||
129985367|NCT02245737|467909230|FG002|Overall Study|Adverse Event|33|||
129985368|NCT02245737|467909228|FG000|Overall Study|Condition Worsened|9|||
129985369|NCT02245737|467909229|FG001|Overall Study|Condition Worsened|10|||
129985370|NCT02245737|467909230|FG002|Overall Study|Condition Worsened|9|||
129985371|NCT02245737|467909228|FG000|Overall Study|Death|2|||
129985372|NCT02245737|467909229|FG001|Overall Study|Death|4|||
129985373|NCT02245737|467909230|FG002|Overall Study|Death|4|||
129985374|NCT02245737|467909228|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
129985375|NCT02245737|467909229|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
129985376|NCT02245737|467909230|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
129985377|NCT02245737|467909228|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
129985378|NCT02245737|467909229|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
129985379|NCT02245737|467909230|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
129985380|NCT02245737|467909228|FG000|Overall Study|Lost to Follow-up|2|||
129985381|NCT02245737|467909229|FG001|Overall Study|Lost to Follow-up|5|||
129985382|NCT02245737|467909230|FG002|Overall Study|Lost to Follow-up|4|||
129985383|NCT02245737|467909228|FG000|Overall Study|Other-determined by Investigator|9|||
129985384|NCT02245737|467909229|FG001|Overall Study|Other-determined by Investigator|10|||
129985385|NCT02245737|467909230|FG002|Overall Study|Other-determined by Investigator|10|||
129985386|NCT02245737|467909228|FG000|Overall Study|Physician Decision|6|||
129985387|NCT02245737|467909229|FG001|Overall Study|Physician Decision|3|||
129985388|NCT02245737|467909230|FG002|Overall Study|Physician Decision|6|||
129985389|NCT02245737|467909228|FG000|Overall Study|Protocol Violation|3|||
129985390|NCT02245737|467909229|FG001|Overall Study|Protocol Violation|2|||
129985391|NCT02245737|467909230|FG002|Overall Study|Protocol Violation|3|||
129985392|NCT02245737|467909228|FG000|Overall Study|Withdrawal by Subject|40|||
129985393|NCT02245737|467909229|FG001|Overall Study|Withdrawal by Subject|41|||
129985394|NCT02245737|467909230|FG002|Overall Study|Withdrawal by Subject|44|||
129985395|NCT02245737|467909228|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
129985396|NCT02245737|467909229|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
129985397|NCT02245737|467909230|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
129985398|NCT02245737|467909228|FG000|Overall Study|Sponsor Decision|445|||
129985399|NCT02245737|467909229|FG001|Overall Study|Sponsor Decision|430|||
129985400|NCT02245737|467909230|FG002|Overall Study|Sponsor Decision|432|||
129985401|NCT01552603|467909232|FG000|Overall Study|Physician Decision|1|||
129985402|NCT00446043|467909237|FG000|Overall Study|Adverse Event|9|||
129985403|NCT00446043|467909237|FG000|Overall Study|Withdrawal by Subject|70|||
129985404|NCT00446043|467909237|FG000|Overall Study|Protocol Violation|2|||
129985405|NCT00446043|467909237|FG000|Overall Study|Lost to Follow-up|42|||
129985406|NCT00446043|467909237|FG000|Overall Study|Pregnancy|2|||
129985407|NCT01983254|467909243|FG000|Overall Study|Death|6|||
129985408|NCT01983254|467909244|FG001|Overall Study|Death|6|||
129985409|NCT01983254|467909243|FG000|Overall Study|Lost to Follow-up|17|||
129985410|NCT01983254|467909244|FG001|Overall Study|Lost to Follow-up|16|||
129985411|NCT01983254|467909243|FG000|Overall Study|too ill|11|||
129985412|NCT01983254|467909244|FG001|Overall Study|too ill|8|||
129985413|NCT04988867|467909249|FG000|Overall Study|Study terminated by Sponsor|12|||
129985414|NCT04988867|467909249|FG000|Overall Study|Adverse Event|2|||
129985415|NCT04988867|467909249|FG000|Overall Study|Study drug noncompliance|1|||
129985416|NCT01699503|467909252|FG000|Overall Study|Death|31|||
129985417|NCT01699503|467909253|FG001|Overall Study|Death|40|||
129985418|NCT01699503|467909252|FG000|Overall Study|Withdrawal by Subject|65|||
129985419|NCT01699503|467909253|FG001|Overall Study|Withdrawal by Subject|57|||
129985420|NCT01699503|467909252|FG000|Overall Study|Lost to Follow-up|121|||
129985421|NCT01699503|467909253|FG001|Overall Study|Lost to Follow-up|117|||
129985422|NCT01699503|467909252|FG000|Overall Study|Excluded due to quality|783|||
129985423|NCT01699503|467909253|FG001|Overall Study|Excluded due to quality|791|||
129985424|NCT01631227|467909259|FG000|Overall Study|withdrawn consent|27|||
129985425|NCT01631227|467909260|FG001|Overall Study|withdrawn consent|21|||
129985426|NCT01631227|467909259|FG000|Overall Study|Adverse Event|1|||
129985427|NCT01631227|467909260|FG001|Overall Study|Adverse Event|0|||
129985428|NCT01631227|467909259|FG000|Overall Study|administrative|2|||
129985429|NCT01631227|467909260|FG001|Overall Study|administrative|1|||
129985430|NCT00768079|467909263|FG000|Overall Study|Lost to Follow-up|2|||
129985431|NCT00768079|467909264|FG001|Overall Study|Lost to Follow-up|0|||
129985432|NCT00768079|467909265|FG002|Overall Study|Lost to Follow-up|4|||
129985433|NCT00768079|467909263|FG000|Overall Study|Participant incarcerated|0|||
129985434|NCT00768079|467909264|FG001|Overall Study|Participant incarcerated|1|||
129985435|NCT00768079|467909265|FG002|Overall Study|Participant incarcerated|0|||
129985436|NCT01097707|467909266|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129985437|NCT01097707|467909267|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129985438|NCT01097707|467909268|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129985439|NCT01097707|467909269|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129985440|NCT01097707|467909270|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129985441|NCT01097707|467909266|FG000|Overall Study|Adverse Event|4|||
129985442|NCT01097707|467909267|FG001|Overall Study|Adverse Event|2|||
129985443|NCT01097707|467909268|FG002|Overall Study|Adverse Event|3|||
129985444|NCT01097707|467909269|FG003|Overall Study|Adverse Event|1|||
129985445|NCT01097707|467909270|FG004|Overall Study|Adverse Event|3|||
129985446|NCT01097707|467909266|FG000|Overall Study|Entry Criteria Not Met|2|||
129985447|NCT01097707|467909267|FG001|Overall Study|Entry Criteria Not Met|1|||
129985448|NCT01097707|467909268|FG002|Overall Study|Entry Criteria Not Met|1|||
129985449|NCT01097707|467909269|FG003|Overall Study|Entry Criteria Not Met|0|||
129985450|NCT01097707|467909270|FG004|Overall Study|Entry Criteria Not Met|1|||
129985451|NCT01097707|467909266|FG000|Overall Study|Lack of Efficacy|1|||
129985452|NCT01097707|467909267|FG001|Overall Study|Lack of Efficacy|0|||
129985453|NCT01097707|467909268|FG002|Overall Study|Lack of Efficacy|0|||
129985454|NCT01097707|467909269|FG003|Overall Study|Lack of Efficacy|1|||
129985455|NCT01097707|467909270|FG004|Overall Study|Lack of Efficacy|0|||
129985456|NCT01097707|467909266|FG000|Overall Study|Lost to Follow-up|1|||
129985457|NCT01097707|467909267|FG001|Overall Study|Lost to Follow-up|1|||
129985458|NCT01097707|467909268|FG002|Overall Study|Lost to Follow-up|2|||
129985459|NCT01097707|467909269|FG003|Overall Study|Lost to Follow-up|0|||
129985460|NCT01097707|467909270|FG004|Overall Study|Lost to Follow-up|3|||
129985461|NCT01097707|467909266|FG000|Overall Study|Protocol Violation|2|||
129985462|NCT01097707|467909267|FG001|Overall Study|Protocol Violation|2|||
129985463|NCT01097707|467909268|FG002|Overall Study|Protocol Violation|3|||
129985464|NCT01097707|467909269|FG003|Overall Study|Protocol Violation|2|||
129985465|NCT01097707|467909270|FG004|Overall Study|Protocol Violation|2|||
129985466|NCT01097707|467909266|FG000|Overall Study|Sponsor Decision|31|||
129985467|NCT01097707|467909267|FG001|Overall Study|Sponsor Decision|31|||
129985468|NCT01097707|467909268|FG002|Overall Study|Sponsor Decision|34|||
129985469|NCT01097707|467909269|FG003|Overall Study|Sponsor Decision|35|||
129985470|NCT01097707|467909270|FG004|Overall Study|Sponsor Decision|36|||
129985471|NCT01097707|467909266|FG000|Overall Study|Withdrawal by Subject|3|||
129985472|NCT01097707|467909267|FG001|Overall Study|Withdrawal by Subject|6|||
129985473|NCT01097707|467909268|FG002|Overall Study|Withdrawal by Subject|1|||
129985474|NCT01097707|467909269|FG003|Overall Study|Withdrawal by Subject|4|||
129985475|NCT01097707|467909270|FG004|Overall Study|Withdrawal by Subject|3|||
129985476|NCT01097707|467909266|FG000|Overall Study|Reason unknown|0|||
129985477|NCT01097707|467909267|FG001|Overall Study|Reason unknown|0|||
129985478|NCT01097707|467909268|FG002|Overall Study|Reason unknown|0|||
129985479|NCT01097707|467909269|FG003|Overall Study|Reason unknown|0|||
129985480|NCT01097707|467909270|FG004|Overall Study|Reason unknown|1|||
129985481|NCT02207569|467909272|FG000|1-Month|Death|6|||
129985482|NCT02207569|467909272|FG000|1-Month|Withdrawal by Subject|2|||
129985483|NCT02207569|467909272|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
129985484|NCT02207569|467909272|FG000|6-Month|Death|8|||
129985485|NCT02207569|467909272|FG000|6-Month|Withdrawal by Subject|2|||
129985486|NCT02207569|467909272|FG000|12-Month|Death|14|||
129985487|NCT02207569|467909272|FG000|12-Month|Withdrawal by Subject|2|||
129985488|NCT02207569|467909272|FG000|24-Month|Death|23|||
129985489|NCT02207569|467909272|FG000|24-Month|Withdrawal by Subject|3|||
129985490|NCT02207569|467909272|FG000|36-Month|Death|23|||
129985491|NCT02207569|467909272|FG000|36-Month|Withdrawal by Subject|4|||
129985492|NCT02207569|467909272|FG000|48-Month|Death|25|||
129985493|NCT02207569|467909272|FG000|48-Month|Withdrawal by Subject|2|||
129985494|NCT02207569|467909272|FG000|48-Month|Lost to Follow-up|4|||
129985495|NCT02207569|467909272|FG000|60-Month|Death|1|||
129985496|NCT02207569|467909272|FG000|60-Month|Lost to Follow-up|1|||
129985497|NCT02207569|467909272|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
129985498|NCT02207569|467909272|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
129985499|NCT01236534|467909273|FG000|Overall Study|Adverse Event|3|||
129985500|NCT01236534|467909274|FG001|Overall Study|Adverse Event|0|||
129985501|NCT05383508|467909283|FG000|Overall Study|Withdrawal by Subject|1|||
129985502|NCT05383508|467909284|FG001|Overall Study|Withdrawal by Subject|0|||
129985503|NCT05383508|467909285|FG002|Overall Study|Withdrawal by Subject|1|||
129985504|NCT05383508|467909286|FG003|Overall Study|Withdrawal by Subject|1|||
129985505|NCT05383508|467909287|FG004|Overall Study|Withdrawal by Subject|2|||
129985506|NCT05383508|467909288|FG005|Overall Study|Withdrawal by Subject|0|||
129985507|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
129985508|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
129985509|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
129985510|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
129985511|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
129985512|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
129985513|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
129985514|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
129985515|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
129985516|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
129985517|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
129985518|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
129985519|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
129985520|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
129985521|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
129985522|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
130207952|NCT03769194|468721040|FG002|Overall Study|other|0|||
129985523|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
129985524|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
129985525|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
129985526|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
129985527|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
129985528|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
129985529|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
129985530|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
129985531|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
129985532|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
129985533|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
129985534|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
129985535|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
129985536|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
129985537|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
129985538|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
129985539|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
129985540|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
129985541|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
129985542|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
129985543|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
129985544|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
129985545|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
130095261|NCT02708524|468305462|FG001|Overall Study|Withdrawal by Subject|1|||
130095262|NCT02708524|468305463|FG002|Overall Study|Withdrawal by Subject|0|||
130095263|NCT02708524|468305464|FG003|Overall Study|Withdrawal by Subject|0|||
130095264|NCT02708524|468305461|FG000|Overall Study|Dispensed incorrect study lens|0|||
130095265|NCT02708524|468305462|FG001|Overall Study|Dispensed incorrect study lens|1|||
130095266|NCT02708524|468305463|FG002|Overall Study|Dispensed incorrect study lens|1|||
130095267|NCT02708524|468305464|FG003|Overall Study|Dispensed incorrect study lens|0|||
130095268|NCT02708524|468305461|FG000|Overall Study|Did not wear lens at final visit|0|||
130095269|NCT02708524|468305462|FG001|Overall Study|Did not wear lens at final visit|1|||
130095270|NCT02708524|468305463|FG002|Overall Study|Did not wear lens at final visit|0|||
130095271|NCT02708524|468305464|FG003|Overall Study|Did not wear lens at final visit|0|||
130095272|NCT02708524|468305461|FG000|Overall Study|Subject lost study lens|1|||
130095273|NCT02708524|468305462|FG001|Overall Study|Subject lost study lens|0|||
130095274|NCT02708524|468305463|FG002|Overall Study|Subject lost study lens|0|||
130095275|NCT02708524|468305464|FG003|Overall Study|Subject lost study lens|0|||
130095276|NCT00229931|468305471|FG000|Overall Study|Death|1|||
130095277|NCT00229931|468305472|FG001|Overall Study|Death|0|||
130095278|NCT00229931|468305471|FG000|Overall Study|Lost to Follow-up|3|||
130095279|NCT00229931|468305472|FG001|Overall Study|Lost to Follow-up|2|||
130095280|NCT02992743|468305473|FG000|Overall Study|Withdrawal by Subject|1|||
130095281|NCT02992743|468305474|FG001|Overall Study|Withdrawal by Subject|1|||
130095282|NCT02992743|468305473|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
130095283|NCT02992743|468305474|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
130095284|NCT02992743|468305473|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
130095285|NCT02992743|468305474|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
130095286|NCT02992743|468305473|FG000|Overall Study|No measurable disease|1|||
130095287|NCT02992743|468305474|FG001|Overall Study|No measurable disease|0|||
130095288|NCT02992743|468305473|FG000|Overall Study|Lost to Follow-up|0|||
130095289|NCT02992743|468305474|FG001|Overall Study|Lost to Follow-up|1|||
130095290|NCT00761735|468305475|FG000|Overall Study|Lost to Follow-up|6|||
130095291|NCT00761735|468305475|FG000|Overall Study|Withdrawal by Subject|6|||
130095292|NCT00761735|468305475|FG000|Overall Study|Non-compliance with protocol|1|||
130095293|NCT00761735|468305475|FG000|Overall Study|Administrative|1|||
130095294|NCT03290131|468305476|FG000|Overall Study|Adverse Event|22|||
130095295|NCT03290131|468305477|FG001|Overall Study|Adverse Event|57|||
130095296|NCT03290131|468305478|FG002|Overall Study|Adverse Event|11|||
130095297|NCT03290131|468305476|FG000|Overall Study|Withdrawal by Subject|18|||
130095298|NCT03290131|468305477|FG001|Overall Study|Withdrawal by Subject|13|||
130095299|NCT03290131|468305478|FG002|Overall Study|Withdrawal by Subject|8|||
130095300|NCT03290131|468305476|FG000|Overall Study|MS Relapse|2|||
130095301|NCT03290131|468305477|FG001|Overall Study|MS Relapse|1|||
130095302|NCT03290131|468305478|FG002|Overall Study|MS Relapse|0|||
130095303|NCT03290131|468305476|FG000|Overall Study|Unknown reason|0|||
130095304|NCT03290131|468305477|FG001|Overall Study|Unknown reason|1|||
130095305|NCT03290131|468305478|FG002|Overall Study|Unknown reason|0|||
130095306|NCT00483574|468305479|FG000|Overall Study|Adverse Event|6|||
130095307|NCT00483574|468305480|FG001|Overall Study|Adverse Event|0|||
130095308|NCT00483574|468305479|FG000|Overall Study|Protocol Violation|28|||
130095309|NCT00483574|468305480|FG001|Overall Study|Protocol Violation|9|||
129985546|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
129985547|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
129985548|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
129985549|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
129985550|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
129985551|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
129985552|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
129985553|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
129985554|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
129985555|NCT02081417|467909294|FG000|Overall Study|Lost to Follow-up|26|||
129985556|NCT02081417|467909295|FG001|Overall Study|Lost to Follow-up|23|||
130207953|NCT03769194|468721041|FG003|Overall Study|other|1|||
130207954|NCT03597022|468721044|FG000|Overall Study|Premature termination of the study|7|||
130207955|NCT03597022|468721045|FG001|Overall Study|Premature termination of the study|7|||
130207956|NCT03597022|468721046|FG002|Overall Study|Premature termination of the study|8|||
130207957|NCT03597022|468721044|FG000|Overall Study|Serious adverse event|1|||
130207958|NCT03597022|468721045|FG001|Overall Study|Serious adverse event|1|||
130207959|NCT03597022|468721046|FG002|Overall Study|Serious adverse event|0|||
130207960|NCT01672294|468721048|FG000|Overall Study|Withdrawal by Subject|4|||
130207961|NCT01672294|468721049|FG001|Overall Study|Withdrawal by Subject|4|||
130207962|NCT01672294|468721050|FG002|Overall Study|Withdrawal by Subject|4|||
130207963|NCT01672294|468721051|FG003|Overall Study|Withdrawal by Subject|4|||
130207964|NCT01672294|468721048|FG000|Overall Study|Excluded by study|1|||
130207965|NCT01672294|468721049|FG001|Overall Study|Excluded by study|1|||
130207966|NCT01672294|468721050|FG002|Overall Study|Excluded by study|0|||
130207967|NCT01672294|468721051|FG003|Overall Study|Excluded by study|0|||
130207968|NCT01672294|468721048|FG000|Overall Study|Lost to Follow-up|1|||
130207969|NCT01672294|468721049|FG001|Overall Study|Lost to Follow-up|16|||
130207970|NCT01672294|468721050|FG002|Overall Study|Lost to Follow-up|7|||
130207971|NCT01672294|468721051|FG003|Overall Study|Lost to Follow-up|9|||
130207972|NCT03887117|468721052|FG000|Overall Study|Discontinued prematurely|0|||
130207973|NCT03887117|468721053|FG001|Overall Study|Discontinued prematurely|1|||
130207974|NCT03887117|468721054|FG002|Overall Study|Discontinued prematurely|1|||
130207975|NCT03887117|468721055|FG003|Overall Study|Discontinued prematurely|2|||
130207976|NCT01739764|468721056|FG000|Overall Study|Adverse Event|0|||
130207977|NCT01739764|468721057|FG001|Overall Study|Adverse Event|3|||
130207978|NCT01739764|468721058|FG002|Overall Study|Adverse Event|4|||
130207979|NCT01739764|468721056|FG000|Overall Study|Death|4|||
130207980|NCT01739764|468721057|FG001|Overall Study|Death|6|||
129985557|NCT02081417|467909294|FG000|Overall Study|Moved Away|1|||
130207981|NCT01739764|468721058|FG002|Overall Study|Death|38|||
130207982|NCT01739764|468721056|FG000|Overall Study|Lost to Follow-up|0|||
130207983|NCT01739764|468721057|FG001|Overall Study|Lost to Follow-up|0|||
130207984|NCT01739764|468721058|FG002|Overall Study|Lost to Follow-up|5|||
130207985|NCT01739764|468721056|FG000|Overall Study|Non-Compliance|0|||
130207986|NCT01739764|468721057|FG001|Overall Study|Non-Compliance|0|||
130207987|NCT01739764|468721058|FG002|Overall Study|Non-Compliance|1|||
130207988|NCT01739764|468721056|FG000|Overall Study|Multiple Reasons|3|||
130207989|NCT01739764|468721057|FG001|Overall Study|Multiple Reasons|2|||
130207990|NCT01739764|468721058|FG002|Overall Study|Multiple Reasons|3|||
130207991|NCT01739764|468721056|FG000|Overall Study|Physician Decision|2|||
130207992|NCT01739764|468721057|FG001|Overall Study|Physician Decision|2|||
130207993|NCT01739764|468721058|FG002|Overall Study|Physician Decision|4|||
130207994|NCT01739764|468721056|FG000|Overall Study|Progressive Disease|3|||
130207995|NCT01739764|468721057|FG001|Overall Study|Progressive Disease|5|||
130207996|NCT01739764|468721058|FG002|Overall Study|Progressive Disease|16|||
130207997|NCT01739764|468721056|FG000|Overall Study|Protocol Violation|0|||
130207998|NCT01739764|468721057|FG001|Overall Study|Protocol Violation|0|||
130207999|NCT01739764|468721058|FG002|Overall Study|Protocol Violation|2|||
130208000|NCT01739764|468721056|FG000|Overall Study|Study Terminated by Sponsor|8|||
130208001|NCT01739764|468721057|FG001|Overall Study|Study Terminated by Sponsor|13|||
130208002|NCT01739764|468721058|FG002|Overall Study|Study Terminated by Sponsor|26|||
130208003|NCT01739764|468721056|FG000|Overall Study|Withdrawal by Subject|6|||
130208004|NCT01739764|468721057|FG001|Overall Study|Withdrawal by Subject|5|||
130208005|NCT01739764|468721058|FG002|Overall Study|Withdrawal by Subject|27|||
130208006|NCT01389258|468721059|FG000|Overall Study|Lost to Follow-up|5|||
130208007|NCT00926536|468721060|FG000|Overall Study|Physician Decision|1|||
130208008|NCT00926536|468721061|FG001|Overall Study|Physician Decision|2|||
130208009|NCT03013985|468721062|FG000|Overall Study|Protocol Violation|2|||
130208010|NCT03013985|468721063|FG001|Overall Study|Protocol Violation|2|||
129985558|NCT02081417|467909295|FG001|Overall Study|Moved Away|2|||
130208011|NCT03013985|468721062|FG000|Overall Study|Withdrawal by Subject|14|||
129985559|NCT02081417|467909294|FG000|Overall Study|Incarcerated|2|||
130208012|NCT03013985|468721063|FG001|Overall Study|Withdrawal by Subject|17|||
130208013|NCT01080391|468721064|FG000|Overall Study|Randomized but not treated|7|||
130208014|NCT01080391|468721065|FG001|Overall Study|Randomized but not treated|4|||
130208015|NCT01534208|468721066|FG000|Overall Study|Lost to Follow-up|19|||
130095310|NCT00483574|468305479|FG000|Overall Study|Lost to Follow-up|16|||
130095311|NCT00483574|468305480|FG001|Overall Study|Lost to Follow-up|4|||
130095312|NCT00483574|468305479|FG000|Overall Study|Withdrawal by Subject|52|||
130095313|NCT00483574|468305480|FG001|Overall Study|Withdrawal by Subject|0|||
130095314|NCT00465101|468305481|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
130095315|NCT00465101|468305481|FG000|Overall Study|Change in health precluded follow up|4|||
130095316|NCT00465101|468305481|FG000|Overall Study|Did not meet study criteria|4|||
130095317|NCT00465101|468305481|FG000|Overall Study|Lost to Follow-up|5|||
129985560|NCT02081417|467909295|FG001|Overall Study|Incarcerated|2|||
129985561|NCT02081417|467909294|FG000|Overall Study|Death|4|||
129985562|NCT02081417|467909295|FG001|Overall Study|Death|3|||
129985563|NCT02081417|467909294|FG000|Overall Study|Withdrawal by Subject|4|||
129985564|NCT02081417|467909295|FG001|Overall Study|Withdrawal by Subject|0|||
129985565|NCT02081417|467909294|FG000|Overall Study|Admitted to Residential Treatment|2|||
129985566|NCT02081417|467909295|FG001|Overall Study|Admitted to Residential Treatment|0|||
130095318|NCT00465101|468305481|FG000|Overall Study|Other|6|||
130095319|NCT00465101|468305481|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
130095320|NCT00465101|468305481|FG000|Overall Study|Patient postponed procedure|1|||
130095321|NCT00465101|468305481|FG000|Overall Study|Site closed due to IRB expiration|1|||
130095322|NCT00465101|468305481|FG000|Overall Study|Unable to obtain IRB approval|1|||
130095323|NCT00465101|468305481|FG000|Overall Study|Death|3|||
130095324|NCT00465101|468305481|FG000|Overall Study|Withdrawal by Subject|25|||
130095325|NCT00465101|468305481|FG000|Overall Study|Physician Decision|1|||
130095326|NCT00465101|468305481|FG000|Overall Study|Withdrew consent prior to procedure|3|||
130095327|NCT03099096|468305482|FG000|Overall Study|Adverse Event|1|||
130095328|NCT03099096|468305482|FG000|Overall Study|Physician Decision|1|||
130095329|NCT00361504|468305485|FG000|Overall Study|Withdrawal by Subject|94|||
130095330|NCT00361504|468305486|FG001|Overall Study|Withdrawal by Subject|31|||
130095331|NCT00361504|468305485|FG000|Overall Study|Lost to Follow-up|40|||
130095332|NCT00361504|468305486|FG001|Overall Study|Lost to Follow-up|7|||
130095333|NCT00361504|468305485|FG000|Overall Study|Adverse Event|203|||
130208016|NCT01534208|468721067|FG001|Overall Study|Lost to Follow-up|14|||
129985567|NCT02081417|467909294|FG000|Overall Study|Did not start treatment|17|||
129985568|NCT02081417|467909295|FG001|Overall Study|Did not start treatment|21|||
129985569|NCT01157676|467909298|FG000|Randomization|Death|1|||
129985570|NCT01157676|467909299|FG001|Randomization|Death|1|||
129985571|NCT01157676|467909298|FG000|Randomization|unresectable|2|||
129985572|NCT01157676|467909299|FG001|Randomization|unresectable|3|||
129985573|NCT01157676|467909298|FG000|Randomization|Withdrawal by Subject|17|||
129985574|NCT01157676|467909299|FG001|Randomization|Withdrawal by Subject|13|||
129985575|NCT01157676|467909298|FG000|Randomization|Physician Decision|1|||
129985576|NCT01157676|467909299|FG001|Randomization|Physician Decision|0|||
129985577|NCT01157676|467909298|FG000|Surgery|underwent open cystectomy|0|||
129985578|NCT01157676|467909299|FG001|Surgery|underwent open cystectomy|4|||
129985579|NCT01157676|467909298|FG000|Surgery|converted to open procedure|0|||
129985580|NCT01157676|467909299|FG001|Surgery|converted to open procedure|5|||
129985581|NCT01157676|467909298|FG000|Surgery|underwent robotic cystectomy|1|||
129985582|NCT01157676|467909299|FG001|Surgery|underwent robotic cystectomy|0|||
129985583|NCT00468104|467909303|FG000|First Intervention|Protocol Violation|2|||
129985584|NCT00468104|467909304|FG001|First Intervention|Protocol Violation|1|||
129985585|NCT00468104|467909303|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
129985586|NCT00468104|467909304|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
129985587|NCT00468104|467909303|FG000|First Intervention|died within 3 weeks|1|||
129985588|NCT00468104|467909304|FG001|First Intervention|died within 3 weeks|0|||
129985589|NCT00468104|467909303|FG000|First Intervention|malposition/blocked chest tube tube|2|||
129985590|NCT00468104|467909304|FG001|First Intervention|malposition/blocked chest tube tube|0|||
129985591|NCT00468104|467909303|FG000|First Intervention|large lung mass with minimal effusion|1|||
129985592|NCT00468104|467909304|FG001|First Intervention|large lung mass with minimal effusion|0|||
129985593|NCT00468104|467909303|FG000|First Intervention|associated prolonged pneumothorax|1|||
129985594|NCT00468104|467909304|FG001|First Intervention|associated prolonged pneumothorax|0|||
129985595|NCT00468104|467909303|FG000|First Intervention|trapped lung|1|||
129985596|NCT00468104|467909304|FG001|First Intervention|trapped lung|0|||
129985597|NCT00468104|467909303|FG000|Second Intervention|Withdrawal by Subject|5|||
129985598|NCT00468104|467909304|FG001|Second Intervention|Withdrawal by Subject|2|||
129985599|NCT00468104|467909303|FG000|Second Intervention|discarded for malposition of chest tube|0|||
129985600|NCT00468104|467909304|FG001|Second Intervention|discarded for malposition of chest tube|2|||
129985601|NCT01263665|467909305|FG000|Overall Study|Withdrew Consent|1|||
129985602|NCT01263665|467909305|FG000|Overall Study|Lost to Follow-up|3|||
129985603|NCT01263665|467909305|FG000|Overall Study|Death|2|||
129985604|NCT01263665|467909305|FG000|Overall Study|Amputation above the ankle|1|||
130208017|NCT01534208|468721066|FG000|Overall Study|Withdrawal by Subject|6|||
129985605|NCT01263665|467909305|FG000|Overall Study|Surgical Bypass|2|||
129985606|NCT00381615|467909308|FG000|Overall Study|Withdrawal by Subject|1|||
129985607|NCT00381615|467909309|FG001|Overall Study|Withdrawal by Subject|3|||
129985608|NCT00381615|467909310|FG002|Overall Study|Withdrawal by Subject|0|||
129985609|NCT00381615|467909311|FG003|Overall Study|Withdrawal by Subject|1|||
129985610|NCT00381615|467909308|FG000|Overall Study|Lost to Follow-up|3|||
129985611|NCT00381615|467909309|FG001|Overall Study|Lost to Follow-up|2|||
129985612|NCT00381615|467909310|FG002|Overall Study|Lost to Follow-up|0|||
129985613|NCT00381615|467909311|FG003|Overall Study|Lost to Follow-up|1|||
129985614|NCT00381615|467909308|FG000|Overall Study|Protocol Violation|0|||
129985615|NCT00381615|467909309|FG001|Overall Study|Protocol Violation|0|||
129985616|NCT00381615|467909310|FG002|Overall Study|Protocol Violation|1|||
129985617|NCT00381615|467909311|FG003|Overall Study|Protocol Violation|0|||
129985618|NCT01801735|467909316|FG000|Overall Study|Adverse Event|79|||
129985619|NCT01801735|467909316|FG000|Overall Study|Lack of Efficacy|28|||
129985620|NCT01801735|467909316|FG000|Overall Study|Withdrawal by Subject|27|||
129985621|NCT01801735|467909316|FG000|Overall Study|Protocol Violation|25|||
129985622|NCT01801735|467909316|FG000|Overall Study|Lost to Follow-up|15|||
129985623|NCT01801735|467909316|FG000|Overall Study|Non-compliance with Trial Drug|13|||
129985624|NCT01801735|467909316|FG000|Overall Study|Physician Decision|3|||
129985625|NCT01801735|467909316|FG000|Overall Study|Death|1|||
129985626|NCT01801735|467909316|FG000|Overall Study|Other, including site closure|19|||
129985627|NCT01435616|467909317|FG000|Overall Study|Adverse Event|39|||
129985628|NCT01435616|467909318|FG001|Overall Study|Adverse Event|21|||
129985629|NCT01435616|467909317|FG000|Overall Study|Death|7|||
129985630|NCT01435616|467909318|FG001|Overall Study|Death|2|||
129985631|NCT01435616|467909317|FG000|Overall Study|Lost to Follow-up|22|||
129985632|NCT01435616|467909318|FG001|Overall Study|Lost to Follow-up|13|||
129985633|NCT01435616|467909317|FG000|Overall Study|Protocol Violation|16|||
129985634|NCT01435616|467909318|FG001|Overall Study|Protocol Violation|13|||
129985635|NCT01435616|467909317|FG000|Overall Study|Withdrawal by Subject|66|||
129985636|NCT01435616|467909318|FG001|Overall Study|Withdrawal by Subject|24|||
130095334|NCT00361504|468305486|FG001|Overall Study|Adverse Event|82|||
130095335|NCT00361504|468305485|FG000|Overall Study|Lack of Efficacy|72|||
130095336|NCT00361504|468305486|FG001|Overall Study|Lack of Efficacy|7|||
130095337|NCT00361504|468305485|FG000|Overall Study|Resolution of Pain|2|||
130095338|NCT00361504|468305486|FG001|Overall Study|Resolution of Pain|0|||
130095339|NCT00361504|468305485|FG000|Overall Study|Study medication non compliant|42|||
130095340|NCT00361504|468305486|FG001|Overall Study|Study medication non compliant|15|||
130095341|NCT00361504|468305485|FG000|Overall Study|All other|28|||
130095342|NCT00361504|468305486|FG001|Overall Study|All other|3|||
130095343|NCT00450814|468305491|FG000|Overall Study|Failed to complete the initial therapy|0|||
130095344|NCT00450814|468305492|FG001|Overall Study|Failed to complete the initial therapy|0|||
130095345|NCT00450814|468305493|FG002|Overall Study|Failed to complete the initial therapy|0|||
130095346|NCT00450814|468305494|FG003|Overall Study|Failed to complete the initial therapy|1|||
130095347|NCT00450814|468305495|FG004|Overall Study|Failed to complete the initial therapy|1|||
130095348|NCT00450814|468305496|FG005|Overall Study|Failed to complete the initial therapy|1|||
130095349|NCT00450814|468305497|FG006|Overall Study|Failed to complete the initial therapy|0|||
130095350|NCT00450814|468305498|FG007|Overall Study|Failed to complete the initial therapy|0|||
130095351|NCT00450814|468305499|FG008|Overall Study|Failed to complete the initial therapy|0|||
130095352|NCT00450814|468305500|FG009|Overall Study|Failed to complete the initial therapy|0|||
130095353|NCT00450814|468305501|FG010|Overall Study|Failed to complete the initial therapy|0|||
130095354|NCT00450814|468305491|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
130095355|NCT00450814|468305492|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
130095356|NCT00450814|468305493|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
130095357|NCT00450814|468305494|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
130095358|NCT00450814|468305495|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
130095359|NCT00450814|468305496|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
130095360|NCT00450814|468305497|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
130095361|NCT00450814|468305498|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
130095362|NCT00450814|468305499|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
130095363|NCT00450814|468305500|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
130095364|NCT00450814|468305501|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
130095365|NCT04145531|468305502|FG000|Part A|Adverse Event|2|||
130095366|NCT04145531|468305503|FG001|Part A|Adverse Event|12|||
130095367|NCT04145531|468305504|FG002|Part A|Adverse Event|6|||
130095368|NCT04145531|468305505|FG003|Part A|Adverse Event|0|||
130095369|NCT04145531|468305502|FG000|Part A|Death|1|||
130095370|NCT04145531|468305503|FG001|Part A|Death|2|||
130095371|NCT04145531|468305504|FG002|Part A|Death|0|||
130095372|NCT04145531|468305505|FG003|Part A|Death|0|||
130095373|NCT04145531|468305502|FG000|Part A|Physician Decision|2|||
130095374|NCT04145531|468305503|FG001|Part A|Physician Decision|5|||
130095375|NCT04145531|468305504|FG002|Part A|Physician Decision|2|||
130095376|NCT04145531|468305505|FG003|Part A|Physician Decision|0|||
130095377|NCT04145531|468305502|FG000|Part A|Progressive disease|0|||
130095378|NCT04145531|468305503|FG001|Part A|Progressive disease|2|||
130095379|NCT04145531|468305504|FG002|Part A|Progressive disease|1|||
130095380|NCT04145531|468305505|FG003|Part A|Progressive disease|0|||
130095381|NCT04145531|468305502|FG000|Part A|Protocol deviation|0|||
129985637|NCT01435616|467909317|FG000|Overall Study|Physician Decision|20|||
130095382|NCT04145531|468305503|FG001|Part A|Protocol deviation|0|||
130095383|NCT04145531|468305504|FG002|Part A|Protocol deviation|1|||
130095384|NCT04145531|468305505|FG003|Part A|Protocol deviation|0|||
130095385|NCT04145531|468305502|FG000|Part A|Withdrawal by parent or guardian|1|||
130095386|NCT04145531|468305503|FG001|Part A|Withdrawal by parent or guardian|0|||
130095387|NCT04145531|468305504|FG002|Part A|Withdrawal by parent or guardian|0|||
130095388|NCT04145531|468305505|FG003|Part A|Withdrawal by parent or guardian|0|||
130095389|NCT04145531|468305502|FG000|Part A|Withdrawal by participant|0|||
130095390|NCT04145531|468305503|FG001|Part A|Withdrawal by participant|0|||
130095391|NCT04145531|468305504|FG002|Part A|Withdrawal by participant|1|||
130095392|NCT04145531|468305505|FG003|Part A|Withdrawal by participant|0|||
130095393|NCT04145531|468305502|FG000|Part A|Other|0|||
130095394|NCT04145531|468305503|FG001|Part A|Other|0|||
130095395|NCT04145531|468305504|FG002|Part A|Other|1|||
130095396|NCT04145531|468305505|FG003|Part A|Other|0|||
130095397|NCT04145531|468305502|FG000|Part B|Adverse Event|0|||
130095398|NCT04145531|468305503|FG001|Part B|Adverse Event|0|||
130095399|NCT04145531|468305504|FG002|Part B|Adverse Event|0|||
130095400|NCT04145531|468305505|FG003|Part B|Adverse Event|21|||
130095401|NCT04145531|468305502|FG000|Part B|Physician Decision|0|||
130095402|NCT04145531|468305503|FG001|Part B|Physician Decision|0|||
130095403|NCT04145531|468305504|FG002|Part B|Physician Decision|0|||
130095404|NCT04145531|468305505|FG003|Part B|Physician Decision|7|||
130095405|NCT04145531|468305502|FG000|Part B|Progressive disease|0|||
130095406|NCT04145531|468305503|FG001|Part B|Progressive disease|0|||
130095407|NCT04145531|468305504|FG002|Part B|Progressive disease|0|||
130095408|NCT04145531|468305505|FG003|Part B|Progressive disease|1|||
130095409|NCT04145531|468305502|FG000|Part B|Recurrent disease|0|||
130095410|NCT04145531|468305503|FG001|Part B|Recurrent disease|0|||
130095411|NCT04145531|468305504|FG002|Part B|Recurrent disease|0|||
130095412|NCT04145531|468305505|FG003|Part B|Recurrent disease|1|||
130095413|NCT04145531|468305502|FG000|Part B|Withdrawal by parent or guardian|0|||
130208018|NCT01534208|468721067|FG001|Overall Study|Withdrawal by Subject|20|||
130208019|NCT01534208|468721066|FG000|Overall Study|Adverse Event|15|||
130208020|NCT01534208|468721067|FG001|Overall Study|Adverse Event|8|||
130208021|NCT01534208|468721066|FG000|Overall Study|Physician Decision|2|||
130208022|NCT01534208|468721067|FG001|Overall Study|Physician Decision|0|||
130208023|NCT01534208|468721066|FG000|Overall Study|Lack of Efficacy|0|||
130208024|NCT01534208|468721067|FG001|Overall Study|Lack of Efficacy|3|||
130208025|NCT01534208|468721066|FG000|Overall Study|Protocol Violation|2|||
130208026|NCT01534208|468721067|FG001|Overall Study|Protocol Violation|2|||
130208027|NCT01534208|468721066|FG000|Overall Study|Sponsor decision|4|||
130208028|NCT01534208|468721067|FG001|Overall Study|Sponsor decision|1|||
130208029|NCT01534208|468721066|FG000|Overall Study|Subject relocation|2|||
130208030|NCT01534208|468721067|FG001|Overall Study|Subject relocation|0|||
130208031|NCT01534208|468721066|FG000|Overall Study|Lab assessment|2|||
130208032|NCT01534208|468721067|FG001|Overall Study|Lab assessment|1|||
130208033|NCT01534208|468721066|FG000|Overall Study|Eligibility error|3|||
130208034|NCT01534208|468721067|FG001|Overall Study|Eligibility error|0|||
130208035|NCT01534208|468721066|FG000|Overall Study|PCP decision|1|||
130208036|NCT01534208|468721067|FG001|Overall Study|PCP decision|0|||
130208037|NCT01534208|468721066|FG000|Overall Study|Needed prohibited meds|1|||
130208038|NCT01534208|468721067|FG001|Overall Study|Needed prohibited meds|0|||
130208039|NCT01904903|468721068|FG000|Overall Study|Withdrawal by Subject|1|||
130208040|NCT01260584|468721069|FG000|Period 1|Protocol Violation|0|||
130208041|NCT01260584|468721070|FG001|Period 1|Protocol Violation|0|||
130208042|NCT01260584|468721071|FG002|Period 1|Protocol Violation|1|||
130208043|NCT01260584|468721072|FG003|Period 1|Protocol Violation|1|||
130208044|NCT01260584|468721069|FG000|Period 1|Adverse Event|0|||
130208045|NCT01260584|468721070|FG001|Period 1|Adverse Event|0|||
130208046|NCT01260584|468721071|FG002|Period 1|Adverse Event|1|||
130208047|NCT01260584|468721072|FG003|Period 1|Adverse Event|0|||
130208048|NCT01260584|468721069|FG000|Period 2|Protocol Violation|0|||
130208049|NCT01260584|468721070|FG001|Period 2|Protocol Violation|2|||
130208050|NCT01260584|468721071|FG002|Period 2|Protocol Violation|3|||
130208051|NCT01260584|468721072|FG003|Period 2|Protocol Violation|1|||
130095414|NCT04145531|468305503|FG001|Part B|Withdrawal by parent or guardian|0|||
130095415|NCT04145531|468305504|FG002|Part B|Withdrawal by parent or guardian|0|||
130095416|NCT04145531|468305505|FG003|Part B|Withdrawal by parent or guardian|3|||
130095417|NCT04145531|468305502|FG000|Part B|Withdrawal by participant|0|||
130095418|NCT04145531|468305503|FG001|Part B|Withdrawal by participant|0|||
130095419|NCT04145531|468305504|FG002|Part B|Withdrawal by participant|0|||
130095420|NCT04145531|468305505|FG003|Part B|Withdrawal by participant|1|||
130095421|NCT04145531|468305502|FG000|Part B|Other|0|||
130095422|NCT04145531|468305503|FG001|Part B|Other|0|||
130095423|NCT04145531|468305504|FG002|Part B|Other|0|||
130095424|NCT04145531|468305505|FG003|Part B|Other|1|||
130095425|NCT02067728|468305506|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
130208052|NCT01260584|468721069|FG000|Period 2|Adverse Event|1|||
130208053|NCT01260584|468721070|FG001|Period 2|Adverse Event|0|||
130208054|NCT01260584|468721071|FG002|Period 2|Adverse Event|2|||
130208055|NCT01260584|468721072|FG003|Period 2|Adverse Event|0|||
130208056|NCT01260584|468721069|FG000|Period 2|Withdrawal by Subject|0|||
130095426|NCT02067728|468305507|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
130095427|NCT02067728|468305506|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
130095428|NCT02067728|468305507|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
130095429|NCT02067728|468305506|FG000|6 Month Measurements|Unable to attend|114|||
130095430|NCT02067728|468305507|FG001|6 Month Measurements|Unable to attend|97|||
130095431|NCT03602976|468305511|FG000|Overall Study|Withdrawal by Subject|1|||
130095432|NCT04837807|468305512|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
130095433|NCT04837807|468305513|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
130095434|NCT04629534|468305514|FG000|Overall Study|Physician Decision|1|||
130095435|NCT04629534|468305515|FG001|Overall Study|Physician Decision|0|||
130095436|NCT04629534|468305514|FG000|Overall Study|Protocol Violation|0|||
130095437|NCT04629534|468305515|FG001|Overall Study|Protocol Violation|2|||
130095438|NCT03732534|468305516|FG000|Overall Study|Study terminated by Sponsor|6|||
130095439|NCT02190604|468305517|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095440|NCT02190604|468305518|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095441|NCT02190604|468305519|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095442|NCT02190604|468305520|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095443|NCT02190604|468305521|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095444|NCT02190604|468305522|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095445|NCT02190604|468305523|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095446|NCT02190604|468305524|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095447|NCT02190604|468305525|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095448|NCT02190604|468305526|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095449|NCT02190604|468305527|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095450|NCT02190604|468305528|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095451|NCT02190604|468305529|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095452|NCT02190604|468305530|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095453|NCT02190604|468305531|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
130095454|NCT02190604|468305532|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095455|NCT02190604|468305533|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095456|NCT02190604|468305534|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095457|NCT02190604|468305535|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
130095458|NCT02190604|468305517|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095459|NCT02190604|468305518|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095460|NCT02190604|468305519|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095461|NCT02190604|468305520|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095462|NCT02190604|468305521|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095463|NCT02190604|468305522|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095464|NCT02190604|468305523|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095465|NCT02190604|468305524|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095466|NCT02190604|468305525|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095467|NCT02190604|468305526|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095468|NCT02190604|468305527|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095469|NCT02190604|468305528|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095470|NCT02190604|468305529|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095471|NCT02190604|468305530|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
130095472|NCT02190604|468305531|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095473|NCT02190604|468305532|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095474|NCT02190604|468305533|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095475|NCT02190604|468305534|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095476|NCT02190604|468305535|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
130095477|NCT02797951|468305536|FG000|Overall Study|Adverse Event|4|||
130095478|NCT02797951|468305536|FG000|Overall Study|Death|1|||
130095479|NCT02797951|468305536|FG000|Overall Study|Lack of Efficacy|19|||
130095480|NCT02797951|468305536|FG000|Overall Study|Lost to Follow-up|4|||
130095481|NCT02797951|468305536|FG000|Overall Study|Physician Decision|6|||
130095482|NCT02797951|468305536|FG000|Overall Study|Withdrawal by Subject|15|||
130095483|NCT03735849|468305538|FG000|Overall Study|Lost to Follow-up|1|||
130095484|NCT03735849|468305539|FG001|Overall Study|Lost to Follow-up|0|||
130095485|NCT03735849|468305540|FG002|Overall Study|Lost to Follow-up|0|||
130095486|NCT03735849|468305538|FG000|Overall Study|Participant unable to adhere to visit|1|||
130095487|NCT03735849|468305539|FG001|Overall Study|Participant unable to adhere to visit|0|||
130095488|NCT03735849|468305540|FG002|Overall Study|Participant unable to adhere to visit|0|||
130095489|NCT03735849|468305538|FG000|Overall Study|Not Randomized|0|||
130095490|NCT03735849|468305539|FG001|Overall Study|Not Randomized|0|||
130095491|NCT03735849|468305540|FG002|Overall Study|Not Randomized|4|||
130095492|NCT04585906|468305543|FG000|Overall Study|Lost to Follow-up|8|||
130095493|NCT04585906|468305544|FG001|Overall Study|Lost to Follow-up|5|||
130095494|NCT01484691|468305551|FG000|Overall Study|Withdrawal by Subject|1|||
130095495|NCT01484691|468305552|FG001|Overall Study|Withdrawal by Subject|1|||
129874991|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
130095496|NCT01484691|468305553|FG002|Overall Study|Withdrawal by Subject|1|||
130095497|NCT01484691|468305551|FG000|Overall Study|Physician Decision|0|||
130095498|NCT01484691|468305552|FG001|Overall Study|Physician Decision|2|||
130095499|NCT01484691|468305553|FG002|Overall Study|Physician Decision|1|||
130095500|NCT04095039|468305558|FG000|Overall Study|Withdrawal by Subject|2|||
130095501|NCT04095039|468305559|FG001|Overall Study|Withdrawal by Subject|16|||
130095502|NCT04095039|468305558|FG000|Overall Study|Transplanted|21|||
130095503|NCT04095039|468305559|FG001|Overall Study|Transplanted|24|||
130095504|NCT04095039|468305558|FG000|Overall Study|Transferred to Non-study Facility|47|||
130095505|NCT04095039|468305559|FG001|Overall Study|Transferred to Non-study Facility|44|||
130095506|NCT04095039|468305558|FG000|Overall Study|Withdrawal from internvention target|0|||
130095507|NCT04095039|468305559|FG001|Overall Study|Withdrawal from internvention target|2|||
130095508|NCT04095039|468305558|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
130095509|NCT04095039|468305559|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
130095510|NCT04095039|468305558|FG000|Overall Study|Cacliphylaxis|0|||
130095511|NCT04095039|468305559|FG001|Overall Study|Cacliphylaxis|1|||
130095512|NCT04095039|468305558|FG000|Overall Study|Pregnancy|1|||
130095513|NCT04095039|468305559|FG001|Overall Study|Pregnancy|0|||
130095514|NCT03205605|468305560|FG000|Overall Study|Withdrawal by Subject|1|||
130095515|NCT03328325|468305561|FG000|Overall Study|Lost to Follow-up|4|||
130095516|NCT03328325|468305561|FG000|Overall Study|Physician Decision|1|||
130095517|NCT03328325|468305561|FG000|Overall Study|Withdrawal by Subject|3|||
130095518|NCT03328325|468305561|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
130095519|NCT00736840|468305563|FG000|Overall Study|Lost to Follow-up|13|||
130095520|NCT01990339|468305564|FG000|Overall Study|Data Not Available|49|||
130095521|NCT01990339|468305564|FG000|Overall Study|Voluntary Withdrawal|1402|||
130095522|NCT01990339|468305564|FG000|Overall Study|Lost to Follow-up|861|||
130095523|NCT01038609|468305565|FG000|Overall Study|Adverse Event|0|||
130095524|NCT01038609|468305566|FG001|Overall Study|Adverse Event|0|||
130095525|NCT01038609|468305567|FG002|Overall Study|Adverse Event|1|||
130095526|NCT01038609|468305568|FG003|Overall Study|Adverse Event|0|||
130095527|NCT01038609|468305569|FG004|Overall Study|Adverse Event|0|||
130095528|NCT01038609|468305565|FG000|Overall Study|Dosing Error|0|||
130095529|NCT01038609|468305566|FG001|Overall Study|Dosing Error|0|||
130095530|NCT01038609|468305567|FG002|Overall Study|Dosing Error|0|||
130095531|NCT01038609|468305568|FG003|Overall Study|Dosing Error|1|||
130095532|NCT01038609|468305569|FG004|Overall Study|Dosing Error|1|||
130095533|NCT01038609|468305565|FG000|Overall Study|Death in the Family|1|||
130095534|NCT01038609|468305566|FG001|Overall Study|Death in the Family|0|||
130095535|NCT01038609|468305567|FG002|Overall Study|Death in the Family|0|||
130095536|NCT01038609|468305568|FG003|Overall Study|Death in the Family|0|||
130095537|NCT01038609|468305569|FG004|Overall Study|Death in the Family|0|||
130095538|NCT01038609|468305565|FG000|Overall Study|Refusal of Blood Draws|0|||
130095539|NCT01038609|468305566|FG001|Overall Study|Refusal of Blood Draws|1|||
130095540|NCT01038609|468305567|FG002|Overall Study|Refusal of Blood Draws|0|||
130095541|NCT01038609|468305568|FG003|Overall Study|Refusal of Blood Draws|0|||
130095542|NCT01038609|468305569|FG004|Overall Study|Refusal of Blood Draws|0|||
130095543|NCT00412360|468305570|FG000|Overall Study|Lost to Follow-up|0|||
130095544|NCT00412360|468305571|FG001|Overall Study|Lost to Follow-up|1|||
130095545|NCT00412360|468305570|FG000|Overall Study|Not Transplanted|1|||
130095546|NCT00412360|468305571|FG001|Overall Study|Not Transplanted|2|||
130095547|NCT03655951|468305572|FG000|Overall Study|Lost to Follow-up|39|||
130095548|NCT03655951|468305573|FG001|Overall Study|Lost to Follow-up|20|||
130095549|NCT03655951|468305572|FG000|Overall Study|Withdrawal by Subject|0|||
130095550|NCT03655951|468305573|FG001|Overall Study|Withdrawal by Subject|1|||
130095551|NCT02811640|468305574|FG000|Overall Study|Technology malfunction|2|||
130095552|NCT02569996|468305581|FG000|Overall Study|Adverse Event|6|||
130095553|NCT02569996|468305581|FG000|Overall Study|Physician Decision|3|||
130095554|NCT02569996|468305581|FG000|Overall Study|Progression of the disease|18|||
130095555|NCT02569996|468305581|FG000|Overall Study|New anti-lymphoma treatment|1|||
130095556|NCT02569996|468305581|FG000|Overall Study|Non-compliance|9|||
130208057|NCT01260584|468721070|FG001|Period 2|Withdrawal by Subject|1|||
130208058|NCT01260584|468721071|FG002|Period 2|Withdrawal by Subject|0|||
130095557|NCT02569996|468305581|FG000|Overall Study|Withdrawal by Subject|5|||
130095558|NCT02569996|468305581|FG000|Overall Study|Lost to Follow-up|5|||
130095559|NCT02569996|468305581|FG000|Overall Study|Complete remission|7|||
130095560|NCT02569996|468305581|FG000|Overall Study|Unknown reason|1|||
130095561|NCT01397409|468305583|FG000|Stage 2|Adverse Event|0|||
130095562|NCT01397409|468305584|FG001|Stage 2|Adverse Event|0|||
130095563|NCT01397409|468305585|FG002|Stage 2|Adverse Event|0|||
130095564|NCT01397409|468305586|FG003|Stage 2|Adverse Event|0|||
130095565|NCT01397409|468305587|FG004|Stage 2|Adverse Event|6|||
130095566|NCT01397409|468305588|FG005|Stage 2|Adverse Event|3|||
130095567|NCT01397409|468305589|FG006|Stage 2|Adverse Event|0|||
130095568|NCT01397409|468305590|FG007|Stage 2|Adverse Event|0|||
130095569|NCT01397409|468305591|FG008|Stage 2|Adverse Event|0|||
130095570|NCT01397409|468305592|FG009|Stage 2|Adverse Event|0|||
130095571|NCT01397409|468305583|FG000|Stage 2|Personal Reasons|0|||
130095572|NCT01397409|468305584|FG001|Stage 2|Personal Reasons|0|||
130095573|NCT01397409|468305585|FG002|Stage 2|Personal Reasons|0|||
130095574|NCT01397409|468305586|FG003|Stage 2|Personal Reasons|0|||
130095575|NCT01397409|468305587|FG004|Stage 2|Personal Reasons|1|||
130095576|NCT01397409|468305588|FG005|Stage 2|Personal Reasons|0|||
130095577|NCT01397409|468305589|FG006|Stage 2|Personal Reasons|0|||
130095578|NCT01397409|468305590|FG007|Stage 2|Personal Reasons|0|||
130095579|NCT01397409|468305591|FG008|Stage 2|Personal Reasons|0|||
130095580|NCT01397409|468305592|FG009|Stage 2|Personal Reasons|0|||
130095581|NCT01397409|468305583|FG000|Stage 2|Other Miscellaneous Reasons|0|||
130095582|NCT01397409|468305584|FG001|Stage 2|Other Miscellaneous Reasons|0|||
130095583|NCT01397409|468305585|FG002|Stage 2|Other Miscellaneous Reasons|0|||
130095584|NCT01397409|468305586|FG003|Stage 2|Other Miscellaneous Reasons|0|||
130095585|NCT01397409|468305587|FG004|Stage 2|Other Miscellaneous Reasons|1|||
130095586|NCT01397409|468305588|FG005|Stage 2|Other Miscellaneous Reasons|1|||
130095587|NCT01397409|468305589|FG006|Stage 2|Other Miscellaneous Reasons|0|||
130095588|NCT01397409|468305590|FG007|Stage 2|Other Miscellaneous Reasons|0|||
130095589|NCT01397409|468305591|FG008|Stage 2|Other Miscellaneous Reasons|0|||
130095590|NCT01397409|468305592|FG009|Stage 2|Other Miscellaneous Reasons|0|||
130095591|NCT01397409|468305583|FG000|Stage 3|Adverse Event|0|||
130095592|NCT01397409|468305584|FG001|Stage 3|Adverse Event|0|||
130095593|NCT01397409|468305585|FG002|Stage 3|Adverse Event|0|||
130095594|NCT01397409|468305586|FG003|Stage 3|Adverse Event|0|||
130095595|NCT01397409|468305587|FG004|Stage 3|Adverse Event|0|||
130095596|NCT01397409|468305588|FG005|Stage 3|Adverse Event|0|||
130095597|NCT01397409|468305589|FG006|Stage 3|Adverse Event|0|||
130095598|NCT01397409|468305590|FG007|Stage 3|Adverse Event|1|||
130095599|NCT01397409|468305591|FG008|Stage 3|Adverse Event|0|||
130095600|NCT01397409|468305592|FG009|Stage 3|Adverse Event|0|||
130095601|NCT01397409|468305583|FG000|Stage 3|Other Miscellaneous Reasons|0|||
130095602|NCT01397409|468305584|FG001|Stage 3|Other Miscellaneous Reasons|0|||
130095603|NCT01397409|468305585|FG002|Stage 3|Other Miscellaneous Reasons|0|||
130095604|NCT01397409|468305586|FG003|Stage 3|Other Miscellaneous Reasons|0|||
130095605|NCT01397409|468305587|FG004|Stage 3|Other Miscellaneous Reasons|0|||
130095606|NCT01397409|468305588|FG005|Stage 3|Other Miscellaneous Reasons|0|||
130095607|NCT01397409|468305589|FG006|Stage 3|Other Miscellaneous Reasons|0|||
130095608|NCT01397409|468305590|FG007|Stage 3|Other Miscellaneous Reasons|1|||
130095609|NCT01397409|468305591|FG008|Stage 3|Other Miscellaneous Reasons|0|||
130095610|NCT01397409|468305592|FG009|Stage 3|Other Miscellaneous Reasons|0|||
130095611|NCT01207427|468305593|FG000|Double-blind Treatment Period|Adverse Event|0|||
130095612|NCT01207427|468305594|FG001|Double-blind Treatment Period|Adverse Event|1|||
130095613|NCT01207427|468305595|FG002|Double-blind Treatment Period|Adverse Event|0|||
130095614|NCT01207427|468305593|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130095615|NCT01207427|468305594|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130095616|NCT01207427|468305595|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130095617|NCT01207427|468305593|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130095618|NCT01207427|468305594|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130095619|NCT01207427|468305595|FG002|Double-blind Treatment Period|Protocol Violation|1|||
130095620|NCT01207427|468305593|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130095621|NCT01207427|468305594|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130095622|NCT01207427|468305595|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130095623|NCT02383966|468307442|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
130095624|NCT02383966|468307443|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
130095625|NCT02383966|468307442|FG000|Overall Study|Randomized, but not treated|1|||
130095626|NCT02383966|468307443|FG001|Overall Study|Randomized, but not treated|3|||
130095627|NCT02163759|468307444|FG000|Overall Study|Withdrawal by Subject|1|||
130095628|NCT02163759|468307445|FG001|Overall Study|Withdrawal by Subject|5|||
130095629|NCT02163759|468307446|FG002|Overall Study|Withdrawal by Subject|1|||
130095630|NCT02163759|468307444|FG000|Overall Study|Adverse Event|0|||
130095631|NCT02163759|468307445|FG001|Overall Study|Adverse Event|0|||
130095632|NCT02163759|468307446|FG002|Overall Study|Adverse Event|1|||
130095633|NCT02163759|468307444|FG000|Overall Study|Death|0|||
130095634|NCT02163759|468307445|FG001|Overall Study|Death|0|||
130095635|NCT02163759|468307446|FG002|Overall Study|Death|1|||
130095636|NCT00451191|468307458|FG000|Overall Study|withdrawal or received alternate tx|15|||
130095637|NCT00451191|468307459|FG001|Overall Study|withdrawal or received alternate tx|11|||
130095638|NCT03575806|468307471|FG000|Overall Study|Withdrawal by Subject|0|||
130095639|NCT03575806|468307472|FG001|Overall Study|Withdrawal by Subject|2|||
130095640|NCT03575806|468307471|FG000|Overall Study|Protocol Violation|0|||
130095641|NCT03575806|468307472|FG001|Overall Study|Protocol Violation|2|||
130095642|NCT00219349|468307473|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
130095643|NCT00219349|468307473|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
130095644|NCT00219349|468307473|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
130095645|NCT00219349|468307473|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
130095646|NCT02777554|468307475|FG000|Overall Study|Adverse Event|4|||
130095647|NCT02777554|468307476|FG001|Overall Study|Adverse Event|4|||
130095648|NCT02777554|468307477|FG002|Overall Study|Adverse Event|0|||
130095649|NCT02777554|468307478|FG003|Overall Study|Adverse Event|1|||
130095650|NCT02777554|468307479|FG004|Overall Study|Adverse Event|0|||
130095651|NCT02777554|468307480|FG005|Overall Study|Adverse Event|0|||
130095652|NCT02777554|468307475|FG000|Overall Study|Withdrawal by Subject|3|||
130095653|NCT02777554|468307476|FG001|Overall Study|Withdrawal by Subject|1|||
130095654|NCT02777554|468307477|FG002|Overall Study|Withdrawal by Subject|1|||
130095655|NCT02777554|468307478|FG003|Overall Study|Withdrawal by Subject|0|||
130095656|NCT02777554|468307479|FG004|Overall Study|Withdrawal by Subject|0|||
130095657|NCT02777554|468307480|FG005|Overall Study|Withdrawal by Subject|0|||
130095658|NCT02777554|468307475|FG000|Overall Study|Discharged early due to hurricane|22|||
130095659|NCT02777554|468307476|FG001|Overall Study|Discharged early due to hurricane|20|||
130095660|NCT02777554|468307477|FG002|Overall Study|Discharged early due to hurricane|0|||
130095661|NCT02777554|468307478|FG003|Overall Study|Discharged early due to hurricane|0|||
130095662|NCT02777554|468307479|FG004|Overall Study|Discharged early due to hurricane|0|||
130095663|NCT02777554|468307480|FG005|Overall Study|Discharged early due to hurricane|0|||
130095664|NCT02777554|468307475|FG000|Overall Study|Other - Miscellaneous|1|||
130095665|NCT02777554|468307476|FG001|Overall Study|Other - Miscellaneous|0|||
130095666|NCT02777554|468307477|FG002|Overall Study|Other - Miscellaneous|0|||
130095667|NCT02777554|468307478|FG003|Overall Study|Other - Miscellaneous|0|||
130095668|NCT02777554|468307479|FG004|Overall Study|Other - Miscellaneous|0|||
130095669|NCT02777554|468307480|FG005|Overall Study|Other - Miscellaneous|0|||
130095670|NCT00270205|468307481|FG000|Overall Study|Lost to Follow-up|1|||
130095671|NCT00270205|468307482|FG001|Overall Study|Lost to Follow-up|0|||
130095672|NCT00270205|468307483|FG002|Overall Study|Lost to Follow-up|0|||
130095673|NCT00270205|468307484|FG003|Overall Study|Lost to Follow-up|1|||
130095674|NCT00066573|468307485|FG000|Overall Study|Did not received protocol treatment|28|||
130095675|NCT00066573|468307486|FG001|Overall Study|Did not received protocol treatment|28|||
130095676|NCT00869362|468307487|FG000|Overall Study|Death|0|||
130095677|NCT00869362|468307488|FG001|Overall Study|Death|2|||
130095678|NCT00869362|468307487|FG000|Overall Study|Lost to Follow-up|1|||
130095679|NCT00869362|468307488|FG001|Overall Study|Lost to Follow-up|3|||
130095680|NCT01241591|468307489|FG000|Overall Study|Lack of Efficacy|5|||
130095681|NCT01241591|468307490|FG001|Overall Study|Lack of Efficacy|2|||
130095682|NCT01241591|468307491|FG002|Overall Study|Lack of Efficacy|2|||
130095683|NCT01241591|468307492|FG003|Overall Study|Lack of Efficacy|3|||
130095684|NCT01241591|468307489|FG000|Overall Study|Protocol Violation|5|||
130095685|NCT01241591|468307490|FG001|Overall Study|Protocol Violation|2|||
130095686|NCT01241591|468307491|FG002|Overall Study|Protocol Violation|3|||
130095687|NCT01241591|468307492|FG003|Overall Study|Protocol Violation|0|||
130095688|NCT01241591|468307489|FG000|Overall Study|Lost to Follow-up|1|||
130095689|NCT01241591|468307490|FG001|Overall Study|Lost to Follow-up|2|||
130095690|NCT01241591|468307491|FG002|Overall Study|Lost to Follow-up|2|||
130095691|NCT01241591|468307492|FG003|Overall Study|Lost to Follow-up|2|||
130095692|NCT01241591|468307489|FG000|Overall Study|Screen Failure|3|||
130095693|NCT01241591|468307490|FG001|Overall Study|Screen Failure|2|||
130095694|NCT01241591|468307491|FG002|Overall Study|Screen Failure|1|||
130095695|NCT01241591|468307492|FG003|Overall Study|Screen Failure|0|||
130095696|NCT01241591|468307489|FG000|Overall Study|Withdrawal by Subject|6|||
130095697|NCT01241591|468307490|FG001|Overall Study|Withdrawal by Subject|4|||
130095698|NCT01241591|468307491|FG002|Overall Study|Withdrawal by Subject|2|||
130095699|NCT01241591|468307492|FG003|Overall Study|Withdrawal by Subject|2|||
130095700|NCT01241591|468307489|FG000|Overall Study|Other|0|||
130095701|NCT01241591|468307490|FG001|Overall Study|Other|1|||
130095702|NCT01241591|468307491|FG002|Overall Study|Other|0|||
130095703|NCT01241591|468307492|FG003|Overall Study|Other|1|||
130095704|NCT01241591|468307489|FG000|Overall Study|Adverse Event|3|||
130095705|NCT01241591|468307490|FG001|Overall Study|Adverse Event|11|||
130095706|NCT01241591|468307491|FG002|Overall Study|Adverse Event|12|||
130095707|NCT01241591|468307492|FG003|Overall Study|Adverse Event|4|||
130095708|NCT01945034|468307493|FG000|Overall Study|Medication Error|0|||
130095709|NCT01945034|468307494|FG001|Overall Study|Medication Error|1|||
130095710|NCT01945034|468307495|FG002|Overall Study|Medication Error|0|||
130095711|NCT01945034|468307493|FG000|Overall Study|Withdrawal by Subject|0|||
130095712|NCT01945034|468307494|FG001|Overall Study|Withdrawal by Subject|3|||
130095713|NCT01945034|468307495|FG002|Overall Study|Withdrawal by Subject|1|||
130095714|NCT01945034|468307493|FG000|Overall Study|Other|0|||
130095715|NCT01945034|468307494|FG001|Overall Study|Other|1|||
130095716|NCT01945034|468307495|FG002|Overall Study|Other|3|||
130095717|NCT01945034|468307493|FG000|Overall Study|Lost to Follow-up|0|||
130095718|NCT01945034|468307494|FG001|Overall Study|Lost to Follow-up|0|||
130095719|NCT01945034|468307495|FG002|Overall Study|Lost to Follow-up|2|||
130095720|NCT01945034|468307493|FG000|Overall Study|Protocol Violation|1|||
130095721|NCT01945034|468307494|FG001|Overall Study|Protocol Violation|0|||
130208059|NCT01260584|468721072|FG003|Period 2|Withdrawal by Subject|0|||
130095722|NCT01945034|468307495|FG002|Overall Study|Protocol Violation|1|||
130095723|NCT02147132|468307496|FG000|Overall Study|Lost to Follow-up|1|||
130095724|NCT02147132|468307497|FG001|Overall Study|Lost to Follow-up|0|||
130095725|NCT02147132|468307498|FG002|Overall Study|Lost to Follow-up|0|||
130095726|NCT02147132|468307499|FG003|Overall Study|Lost to Follow-up|0|||
130095727|NCT02213666|468307500|FG000|Overall Study|Withdrawal by Subject|1|||
130095728|NCT03246152|468307504|FG000|Overall Study|Lost to Follow-up|2|||
130095729|NCT03246152|468307504|FG000|Overall Study|Protocol Violation|1|||
130095730|NCT01374516|468307505|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
130095731|NCT01374516|468307506|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
130095732|NCT01374516|468307505|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
130095733|NCT01374516|468307506|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
130095734|NCT01374516|468307505|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
130095735|NCT01374516|468307506|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
130095736|NCT01374516|468307505|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
130095737|NCT01374516|468307506|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
130095738|NCT01374516|468307505|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
130095739|NCT01374516|468307506|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
130095740|NCT01374516|468307505|FG000|Surveillance Expansion Period|Protocol Violation|386|||
130095741|NCT01374516|468307506|FG001|Surveillance Expansion Period|Protocol Violation|217|||
130095742|NCT01374516|468307505|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
130095743|NCT01374516|468307506|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
130095744|NCT01374516|468307505|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
130095745|NCT01374516|468307506|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
130095746|NCT01374516|468307505|FG000|Surveillance Expansion Period|Serious adverse event|20|||
130095747|NCT01374516|468307506|FG001|Surveillance Expansion Period|Serious adverse event|5|||
130095748|NCT03219372|468307507|FG000|Overall Study|Withdrawal by Subject|1|||
130095749|NCT03219372|468307508|FG001|Overall Study|Withdrawal by Subject|0|||
130095750|NCT00814502|468307512|FG000|Overall Study|Adverse Event|1|||
130095751|NCT00814502|468307513|FG001|Overall Study|Adverse Event|0|||
130095752|NCT00814502|468307512|FG000|Overall Study|Withdrawal by Subject|0|||
130095753|NCT00814502|468307513|FG001|Overall Study|Withdrawal by Subject|2|||
130095754|NCT01050998|468307517|FG000|Overall Study|Adverse Event|1|||
130095755|NCT01050998|468307518|FG001|Overall Study|Adverse Event|0|||
130095756|NCT01050998|468307519|FG002|Overall Study|Adverse Event|1|||
130095757|NCT01050998|468307520|FG003|Overall Study|Adverse Event|0|||
130095758|NCT01050998|468307521|FG004|Overall Study|Adverse Event|2|||
130095759|NCT01050998|468307517|FG000|Overall Study|Withdrawal by Subject|0|||
130095760|NCT01050998|468307518|FG001|Overall Study|Withdrawal by Subject|0|||
130095761|NCT01050998|468307519|FG002|Overall Study|Withdrawal by Subject|0|||
130095762|NCT01050998|468307520|FG003|Overall Study|Withdrawal by Subject|1|||
130095763|NCT01050998|468307521|FG004|Overall Study|Withdrawal by Subject|3|||
130095764|NCT01050998|468307517|FG000|Overall Study|Other|3|||
130095765|NCT01050998|468307518|FG001|Overall Study|Other|2|||
130095766|NCT01050998|468307519|FG002|Overall Study|Other|1|||
130095767|NCT01050998|468307520|FG003|Overall Study|Other|1|||
130095768|NCT01050998|468307521|FG004|Overall Study|Other|5|||
130095769|NCT01050998|468307517|FG000|Overall Study|Data integrity issues|0|||
130095770|NCT01050998|468307518|FG001|Overall Study|Data integrity issues|0|||
130095771|NCT01050998|468307519|FG002|Overall Study|Data integrity issues|1|||
130095772|NCT01050998|468307520|FG003|Overall Study|Data integrity issues|1|||
130095773|NCT01050998|468307521|FG004|Overall Study|Data integrity issues|4|||
130095774|NCT02219477|468307524|FG000|Overall Study|Adverse Event|0|||
130095775|NCT02219477|468307525|FG001|Overall Study|Adverse Event|1|||
130095776|NCT02219477|468307526|FG002|Overall Study|Adverse Event|1|||
130095777|NCT02219477|468307524|FG000|Overall Study|Withdrawal by Subject|0|||
130095778|NCT02219477|468307525|FG001|Overall Study|Withdrawal by Subject|1|||
130095779|NCT02219477|468307526|FG002|Overall Study|Withdrawal by Subject|0|||
130095780|NCT00234533|468307533|FG000|Overall Study|Withdrawal by Subject|6|||
130095781|NCT00234533|468307533|FG000|Overall Study|Adverse Event|2|||
130095782|NCT00234533|468307533|FG000|Overall Study|Enrolled but not treated|3|||
130095783|NCT00976989|468307534|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130095784|NCT00976989|468307535|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130095785|NCT00976989|468307536|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
130095786|NCT00976989|468307534|FG000|Overall Study|Death|5|||
130095787|NCT00976989|468307535|FG001|Overall Study|Death|7|||
130095788|NCT00976989|468307536|FG002|Overall Study|Death|10|||
130095789|NCT00976989|468307534|FG000|Overall Study|Refused Treatment|4|||
130095790|NCT00976989|468307535|FG001|Overall Study|Refused Treatment|3|||
130095791|NCT00976989|468307536|FG002|Overall Study|Refused Treatment|5|||
130095792|NCT00976989|468307534|FG000|Overall Study|Failure to Return|2|||
130095793|NCT00976989|468307535|FG001|Overall Study|Failure to Return|1|||
130095794|NCT00976989|468307536|FG002|Overall Study|Failure to Return|0|||
130095795|NCT00976989|468307534|FG000|Overall Study|Recurrence of Disease|0|||
130095796|NCT00976989|468307535|FG001|Overall Study|Recurrence of Disease|1|||
130095797|NCT00976989|468307536|FG002|Overall Study|Recurrence of Disease|0|||
130095798|NCT00976989|468307534|FG000|Overall Study|Other|1|||
130095799|NCT00976989|468307535|FG001|Overall Study|Other|0|||
130095800|NCT00976989|468307536|FG002|Overall Study|Other|1|||
130095801|NCT00752206|468307538|FG000|Overall Study|Disease progression|8|||
130095802|NCT00752206|468307539|FG001|Overall Study|Disease progression|11|||
130095803|NCT00752206|468307538|FG000|Overall Study|Pregnancy|1|||
130095804|NCT00752206|468307539|FG001|Overall Study|Pregnancy|0|||
130095805|NCT00678652|468307540|FG000|Overall Study|Protocol Violation|2|||
130095806|NCT00678652|468307541|FG001|Overall Study|Protocol Violation|0|||
130095807|NCT00678652|468307542|FG002|Overall Study|Protocol Violation|0|||
130095808|NCT00678652|468307543|FG003|Overall Study|Protocol Violation|0|||
130095809|NCT00678652|468307540|FG000|Overall Study|Pregnancy|0|||
130095810|NCT00678652|468307541|FG001|Overall Study|Pregnancy|0|||
130095811|NCT00678652|468307542|FG002|Overall Study|Pregnancy|1|||
130095812|NCT00678652|468307543|FG003|Overall Study|Pregnancy|0|||
130095813|NCT00678652|468307540|FG000|Overall Study|Relocation|1|||
130095814|NCT00678652|468307541|FG001|Overall Study|Relocation|0|||
130095815|NCT00678652|468307542|FG002|Overall Study|Relocation|0|||
130095816|NCT00678652|468307543|FG003|Overall Study|Relocation|0|||
130095817|NCT02396849|468307544|FG000|Overall Study|Lost to Follow-up|1|||
130095818|NCT02396849|468307545|FG001|Overall Study|Lost to Follow-up|1|||
130095819|NCT02396849|468307544|FG000|Overall Study|Did not tolerate intervention|1|||
130095820|NCT02396849|468307545|FG001|Overall Study|Did not tolerate intervention|1|||
130095821|NCT04794491|468307550|FG000|Overall Study|Adverse Event|1|||
130095822|NCT04794491|468307550|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
130095823|NCT04794491|468307550|FG000|Overall Study|Noncompliance With Study Intervention|1|||
130095824|NCT04794491|468307550|FG000|Overall Study|Withdrawal by Subject|2|||
130095825|NCT00931515|468307551|FG000|Overall Study|Lost to Follow-up|2|||
130095826|NCT00931515|468307552|FG001|Overall Study|Lost to Follow-up|5|||
130095827|NCT03759340|468307553|FG000|Overall Study|Adverse Event|2|||
130095828|NCT03759340|468307553|FG000|Overall Study|Lost to Follow-up|1|||
130095829|NCT03759340|468307553|FG000|Overall Study|Withdrawal by Subject|15|||
130095830|NCT03759340|468307553|FG000|Overall Study|Study Terminated by Sponsor|38|||
130095831|NCT00945815|468307554|FG000|Overall Study|Death|3|||
130095832|NCT00945815|468307554|FG000|Overall Study|Not protocol specified|1|||
130095833|NCT00945815|468307554|FG000|Overall Study|Ineligible|3|||
130095834|NCT00945815|468307554|FG000|Overall Study|Did not begin protocol therapy|1|||
130095835|NCT03289676|468307559|FG000|Overall Study|Withdrawal by Subject|2|||
130095836|NCT03289676|468307560|FG001|Overall Study|Withdrawal by Subject|0|||
130095837|NCT03289676|468307559|FG000|Overall Study|Protocol Violation|2|||
130095838|NCT03289676|468307560|FG001|Overall Study|Protocol Violation|0|||
130095839|NCT03289676|468307559|FG000|Overall Study|Lost to Follow-up|0|||
130095840|NCT03289676|468307560|FG001|Overall Study|Lost to Follow-up|1|||
130095841|NCT01314261|468307561|FG000|Overall Study|Adverse Event|1|||
130095842|NCT01314261|468307562|FG001|Overall Study|Adverse Event|0|||
130095843|NCT01314261|468307563|FG002|Overall Study|Adverse Event|0|||
130095844|NCT01314261|468307564|FG003|Overall Study|Adverse Event|0|||
130095845|NCT01314261|468307561|FG000|Overall Study|Withdrawal by Subject|0|||
130095846|NCT01314261|468307562|FG001|Overall Study|Withdrawal by Subject|3|||
130095847|NCT01314261|468307563|FG002|Overall Study|Withdrawal by Subject|1|||
130095848|NCT01314261|468307564|FG003|Overall Study|Withdrawal by Subject|0|||
130095849|NCT01314261|468307561|FG000|Overall Study|Lost to Follow-up|1|||
130095850|NCT01314261|468307562|FG001|Overall Study|Lost to Follow-up|0|||
130095851|NCT01314261|468307563|FG002|Overall Study|Lost to Follow-up|2|||
130095852|NCT01314261|468307564|FG003|Overall Study|Lost to Follow-up|2|||
130095853|NCT01314261|468307561|FG000|Overall Study|Virologic Failure|0|||
130095854|NCT01314261|468307562|FG001|Overall Study|Virologic Failure|1|||
130095855|NCT01314261|468307563|FG002|Overall Study|Virologic Failure|0|||
130095856|NCT01314261|468307564|FG003|Overall Study|Virologic Failure|1|||
130095857|NCT04524507|468307565|FG000|Overall Study|Lost to Follow-up|2|||
130095858|NCT04524507|468307566|FG001|Overall Study|Lost to Follow-up|4|||
130095859|NCT04524507|468307565|FG000|Overall Study|Withdrawal by Subject|2|||
130095860|NCT04524507|468307566|FG001|Overall Study|Withdrawal by Subject|9|||
130095861|NCT04524507|468307565|FG000|Overall Study|Death|2|||
130095862|NCT04524507|468307566|FG001|Overall Study|Death|10|||
130095863|NCT02711306|468307567|FG000|Overall Study|Withdrawal by Subject|2|||
130095864|NCT02711306|468307568|FG001|Overall Study|Withdrawal by Subject|2|||
130095865|NCT01383317|468307569|FG000|Overall Study|Lost to Follow-up|2|||
130095866|NCT01383317|468307570|FG001|Overall Study|Lost to Follow-up|1|||
130095867|NCT01383317|468307569|FG000|Overall Study|Death|1|||
130095868|NCT01383317|468307570|FG001|Overall Study|Death|0|||
130095869|NCT01383317|468307569|FG000|Overall Study|Adverse Event|0|||
130095870|NCT01383317|468307570|FG001|Overall Study|Adverse Event|1|||
130095871|NCT00422227|468307571|FG000|Overall Study|Adverse Event|3|||
130095872|NCT00422227|468307572|FG001|Overall Study|Adverse Event|8|||
130095873|NCT00422227|468307571|FG000|Overall Study|Lost to Follow-up|1|||
130095874|NCT00422227|468307572|FG001|Overall Study|Lost to Follow-up|3|||
130095875|NCT00422227|468307571|FG000|Overall Study|Withdrawal by Subject|0|||
130095876|NCT00422227|468307572|FG001|Overall Study|Withdrawal by Subject|4|||
130095877|NCT01790633|468307573|FG000|Overall Study|Protocol Violation|1|||
130095878|NCT01790633|468307574|FG001|Overall Study|Protocol Violation|2|||
130095879|NCT01790633|468307573|FG000|Overall Study|Did not have serology performed|47|||
130095880|NCT01790633|468307574|FG001|Overall Study|Did not have serology performed|0|||
130095881|NCT01790633|468307573|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
130095882|NCT01790633|468307574|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
130095883|NCT00157157|468307575|FG000|Overall Study|Withdrawal by Subject|6|||
130095884|NCT00157157|468307575|FG000|Overall Study|Physician Decision|1|||
130095885|NCT00157157|468307575|FG000|Overall Study|Lost to Follow-up|1|||
130095886|NCT00157157|468307575|FG000|Overall Study|Enrolled in another study|1|||
130095887|NCT00157157|468307575|FG000|Overall Study|Met exclusion criteria|1|||
130095888|NCT00157157|468307575|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
130095889|NCT02260804|468307582|FG000|Induction Study Period|Protocol Violation|2|||
130095890|NCT02260804|468307583|FG001|Induction Study Period|Protocol Violation|0|||
130095891|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
130095892|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
130095893|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
130095894|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
130095895|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
130095896|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
130095897|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
130095898|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
130095899|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
130095900|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
130095901|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
130095902|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
130095903|NCT02260804|468307582|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
130095904|NCT02260804|468307583|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
130095905|NCT02260804|468307582|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
130095906|NCT02260804|468307583|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
130095907|NCT02260804|468307582|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
130095908|NCT02260804|468307583|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
130095909|NCT02260804|468307582|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
130095910|NCT02260804|468307583|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
130095911|NCT01798056|468309096|FG000|Overall Study|Serious Adverse Event|13|||
130095912|NCT01798056|468309097|FG001|Overall Study|Serious Adverse Event|12|||
130095913|NCT01798056|468309096|FG000|Overall Study|Withdrawal by Subject|12|||
130095914|NCT01798056|468309097|FG001|Overall Study|Withdrawal by Subject|9|||
130095915|NCT01798056|468309096|FG000|Overall Study|Migrated/moved from study area|1|||
130095916|NCT01798056|468309097|FG001|Overall Study|Migrated/moved from study area|1|||
130095917|NCT01798056|468309096|FG000|Overall Study|Lost to Follow-up|1|||
130095918|NCT01798056|468309097|FG001|Overall Study|Lost to Follow-up|1|||
130095919|NCT01798056|468309096|FG000|Overall Study|Other|0|||
130095920|NCT01798056|468309097|FG001|Overall Study|Other|2|||
130095921|NCT02842736|468309100|FG000|Overall Study|Lost to Follow-up|13|||
130095922|NCT02842736|468309100|FG000|Overall Study|Intervention for menstrual bleeding|17|||
130095923|NCT02842736|468309100|FG000|Overall Study|Withdrawal by Subject|4|||
130095924|NCT02842736|468309100|FG000|Overall Study|Pregnancy|3|||
130095925|NCT02842736|468309100|FG000|Overall Study|Hysterectomy for fibroids|2|||
130095926|NCT02842736|468309100|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
130095927|NCT02842736|468309100|FG000|Overall Study|IUD: Mirena|1|||
130095928|NCT03323034|468309102|FG000|Overall Study|Lack of Efficacy|5|||
130095929|NCT03323034|468309103|FG001|Overall Study|Lack of Efficacy|5|||
130095930|NCT03323034|468309104|FG002|Overall Study|Lack of Efficacy|6|||
130095931|NCT03323034|468309105|FG003|Overall Study|Lack of Efficacy|5|||
130095932|NCT03323034|468309106|FG004|Overall Study|Lack of Efficacy|5|||
130095933|NCT03323034|468309102|FG000|Overall Study|Physician Decision|0|||
130095934|NCT03323034|468309103|FG001|Overall Study|Physician Decision|0|||
130095935|NCT03323034|468309104|FG002|Overall Study|Physician Decision|0|||
130095936|NCT03323034|468309105|FG003|Overall Study|Physician Decision|0|||
130095937|NCT03323034|468309106|FG004|Overall Study|Physician Decision|1|||
130095938|NCT03323034|468309102|FG000|Overall Study|Withdrawal by Subject|1|||
130095939|NCT03323034|468309103|FG001|Overall Study|Withdrawal by Subject|1|||
130095940|NCT03323034|468309104|FG002|Overall Study|Withdrawal by Subject|0|||
130095941|NCT03323034|468309105|FG003|Overall Study|Withdrawal by Subject|1|||
130095942|NCT03323034|468309106|FG004|Overall Study|Withdrawal by Subject|0|||
130095943|NCT02646566|468309107|FG000|Overall Study|Lost to Follow-up|5|||
130095944|NCT02646566|468309108|FG001|Overall Study|Lost to Follow-up|4|||
130095945|NCT02646566|468309109|FG002|Overall Study|Lost to Follow-up|5|||
130095946|NCT02646566|468309107|FG000|Overall Study|Treatment failure|1|||
130095947|NCT02646566|468309108|FG001|Overall Study|Treatment failure|0|||
130095948|NCT02646566|468309109|FG002|Overall Study|Treatment failure|0|||
130095949|NCT02815540|468309112|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
130095950|NCT02222246|468309113|FG000|Overall Study|No Emergency Department Visits|27|||
130095951|NCT02222246|468309114|FG001|Overall Study|No Emergency Department Visits|26|||
130095952|NCT02222246|468309113|FG000|Overall Study|Physician Decision|0|||
130095953|NCT02222246|468309114|FG001|Overall Study|Physician Decision|1|||
130095954|NCT02660489|468309115|FG000|Overall Study|Lost to Follow-up|1|||
130095955|NCT02660489|468309116|FG001|Overall Study|Lost to Follow-up|1|||
130095956|NCT02660489|468309115|FG000|Overall Study|Adverse Event|1|||
130095957|NCT02660489|468309116|FG001|Overall Study|Adverse Event|3|||
130095958|NCT02660489|468309115|FG000|Overall Study|no rhinovirus infection|4|||
130095959|NCT02660489|468309116|FG001|Overall Study|no rhinovirus infection|4|||
130095960|NCT02064231|468309117|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
130095961|NCT02064231|468309118|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
130095962|NCT02064231|468309119|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
130095963|NCT02064231|468309120|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
130095964|NCT02064231|468309117|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
130095965|NCT02064231|468309118|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
130095966|NCT02064231|468309119|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
130095967|NCT02064231|468309120|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
130095968|NCT02064231|468309117|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
130095969|NCT02064231|468309118|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
130095970|NCT02064231|468309119|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
130095971|NCT02064231|468309120|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
130095972|NCT02064231|468309117|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
130095973|NCT02064231|468309118|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
130095974|NCT02064231|468309119|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
130095975|NCT02064231|468309120|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
130095976|NCT04887922|468309121|FG000|1st Randomization|Decided not to have surgery|0|||
130095977|NCT04887922|468309122|FG001|1st Randomization|Decided not to have surgery|1|||
130095978|NCT04887922|468309123|FG002|1st Randomization|Decided not to have surgery|0|||
130095979|NCT04887922|468309124|FG003|1st Randomization|Decided not to have surgery|0|||
130095980|NCT04887922|468309125|FG004|1st Randomization|Decided not to have surgery|0|||
130095981|NCT02392078|468309126|FG000|Overall Study|Did not have procedure|32|||
130095982|NCT02392078|468309127|FG001|Overall Study|Did not have procedure|43|||
130095983|NCT02392078|468309128|FG002|Overall Study|Did not have procedure|20|||
130095984|NCT02392078|468309129|FG003|Overall Study|Did not have procedure|1|||
130095985|NCT02652793|468309132|FG000|Overall Study|Adverse Event|1|||
130095986|NCT02652793|468309132|FG000|Overall Study|Lost to Follow-up|2|||
130095987|NCT02652793|468309132|FG000|Overall Study|Withdrawal by Subject|1|||
130095988|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Adverse Event|4|||
130095989|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Adverse Event|3|||
130095990|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Adverse Event|0|||
130095991|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Adverse Event|0|||
130095992|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Death|24|||
130095993|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Death|9|||
130095994|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Death|0|||
130095995|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Death|0|||
130095996|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
130095997|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
130095998|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
130095999|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
130096000|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Physician Decision|4|||
130096001|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Physician Decision|1|||
130096002|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Physician Decision|0|||
130096003|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Physician Decision|0|||
130096004|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Progressive disease|1|||
130096005|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Progressive disease|0|||
130096006|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Progressive disease|0|||
130096007|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Progressive disease|0|||
130096008|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
130096009|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
130096010|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
130096011|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
130096012|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
130096013|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
130096014|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
130096015|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
130208060|NCT00586508|468721077|FG000|Overall Study|Progressive disease|52|||
130208061|NCT00586508|468721078|FG001|Overall Study|Progressive disease|8|||
130208062|NCT00586508|468721077|FG000|Overall Study|Death|0|||
130208063|NCT00586508|468721078|FG001|Overall Study|Death|1|||
130208064|NCT00586508|468721077|FG000|Overall Study|Adverse Event|12|||
130208065|NCT00586508|468721078|FG001|Overall Study|Adverse Event|4|||
130208066|NCT00586508|468721077|FG000|Overall Study|Withdrawal by Subject|4|||
130208067|NCT00586508|468721078|FG001|Overall Study|Withdrawal by Subject|0|||
130208068|NCT00561470|468721079|FG000|Overall Study|Adverse Event|74|||
130208069|NCT00561470|468721080|FG001|Overall Study|Adverse Event|163|||
130208070|NCT00561470|468721079|FG000|Overall Study|Disease progression|437|||
130208071|NCT00561470|468721080|FG001|Overall Study|Disease progression|305|||
130208072|NCT00561470|468721079|FG000|Overall Study|poor compliance to protocol|4|||
130208073|NCT00561470|468721080|FG001|Overall Study|poor compliance to protocol|4|||
130208074|NCT00561470|468721079|FG000|Overall Study|Lost to Follow-up|2|||
130208075|NCT00561470|468721080|FG001|Overall Study|Lost to Follow-up|0|||
130208076|NCT00561470|468721079|FG000|Overall Study|Physician Decision|21|||
130208077|NCT00561470|468721080|FG001|Overall Study|Physician Decision|20|||
130208078|NCT00561470|468721079|FG000|Overall Study|Consent Withdrawn|2|||
130208079|NCT00561470|468721080|FG001|Overall Study|Consent Withdrawn|6|||
130208080|NCT00561470|468721079|FG000|Overall Study|Subject request|43|||
130208081|NCT00561470|468721080|FG001|Overall Study|Subject request|77|||
130208082|NCT00561470|468721079|FG000|Overall Study|Metastatic surgery|10|||
130208083|NCT00561470|468721080|FG001|Overall Study|Metastatic surgery|12|||
130208084|NCT00561470|468721079|FG000|Overall Study|Unauthorized procedure|3|||
130208085|NCT00561470|468721080|FG001|Overall Study|Unauthorized procedure|1|||
130208086|NCT00561470|468721079|FG000|Overall Study|Randomized but not treated|5|||
130208087|NCT00561470|468721080|FG001|Overall Study|Randomized but not treated|5|||
130208088|NCT00561470|468721079|FG000|Overall Study|Missed visit window|1|||
130208089|NCT00561470|468721080|FG001|Overall Study|Missed visit window|4|||
130208090|NCT00561470|468721079|FG000|Overall Study|Planning surgery|1|||
130208091|NCT00561470|468721080|FG001|Overall Study|Planning surgery|1|||
130208092|NCT00561470|468721079|FG000|Overall Study|Ongoing Treatment|11|||
130208093|NCT00561470|468721080|FG001|Overall Study|Ongoing Treatment|14|||
130208094|NCT03434249|468721081|FG000|Overall Study|Adverse Event|1|||
130208095|NCT03434249|468721082|FG001|Overall Study|Adverse Event|0|||
130208096|NCT03434249|468721081|FG000|Overall Study|Lost to Follow-up|0|||
130208097|NCT03434249|468721082|FG001|Overall Study|Lost to Follow-up|1|||
130208098|NCT03434249|468721081|FG000|Overall Study|Non-compliance of family|2|||
130208099|NCT03434249|468721082|FG001|Overall Study|Non-compliance of family|1|||
130208100|NCT03434249|468721081|FG000|Overall Study|Difficulties in completing daily diary|2|||
130208101|NCT03434249|468721082|FG001|Overall Study|Difficulties in completing daily diary|1|||
130208102|NCT02918552|468721083|FG000|Overall Study|Failed Pharmacokinetics|1|||
130208103|NCT02918552|468721084|FG001|Overall Study|Failed Pharmacokinetics|0|||
130208104|NCT02918552|468721083|FG000|Overall Study|Withdrawal by Subject|0|||
130208105|NCT02918552|468721084|FG001|Overall Study|Withdrawal by Subject|1|||
130208106|NCT02918552|468721083|FG000|Overall Study|Lost to Follow-up|0|||
130208107|NCT02918552|468721084|FG001|Overall Study|Lost to Follow-up|1|||
130208108|NCT03325894|468721085|FG000|Overall Study|Adverse Event|2|||
130208109|NCT03325894|468721086|FG001|Overall Study|Adverse Event|3|||
130208110|NCT03325894|468721085|FG000|Overall Study|Protocol Violation|1|||
130208111|NCT03325894|468721086|FG001|Overall Study|Protocol Violation|2|||
130208112|NCT03325894|468721085|FG000|Overall Study|Withdrawal by Subject|10|||
130208113|NCT03325894|468721086|FG001|Overall Study|Withdrawal by Subject|6|||
130208114|NCT03325894|468721085|FG000|Overall Study|Lost to Follow-up|4|||
130208115|NCT03325894|468721086|FG001|Overall Study|Lost to Follow-up|9|||
130208116|NCT03325894|468721085|FG000|Overall Study|Lack of Efficacy|8|||
130208117|NCT03325894|468721086|FG001|Overall Study|Lack of Efficacy|14|||
130208118|NCT03325894|468721085|FG000|Overall Study|Study Terminated by Sponsor|38|||
130208119|NCT03325894|468721086|FG001|Overall Study|Study Terminated by Sponsor|43|||
130208120|NCT03325894|468721085|FG000|Overall Study|Other (Not received Treatment)|1|||
130208121|NCT03325894|468721086|FG001|Overall Study|Other (Not received Treatment)|0|||
130208122|NCT04395274|468721087|FG000|Overall Study|Lost to Follow-up|20|||
130208123|NCT04395274|468721088|FG001|Overall Study|Lost to Follow-up|11|||
130208124|NCT04395274|468721087|FG000|Overall Study|Withdrawal by Subject|13|||
130208125|NCT04395274|468721088|FG001|Overall Study|Withdrawal by Subject|10|||
130208126|NCT04395274|468721087|FG000|Overall Study|Moved Abroad|0|||
130208127|NCT04395274|468721088|FG001|Overall Study|Moved Abroad|1|||
130208128|NCT01001598|468721091|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
130208129|NCT01001598|468721091|FG000|Overall Study|Adverse Event|1|||
130208130|NCT02920177|468721096|FG000|Overall Study|Withdrawal by Subject|1|||
130208131|NCT02920177|468721097|FG001|Overall Study|Withdrawal by Subject|1|||
130208132|NCT02920177|468721096|FG000|Overall Study|Physician Decision|1|||
130208133|NCT02920177|468721097|FG001|Overall Study|Physician Decision|0|||
130208134|NCT02920177|468721096|FG000|Overall Study|Lost to Follow-up|0|||
130208135|NCT02920177|468721097|FG001|Overall Study|Lost to Follow-up|1|||
130208136|NCT02054910|468721098|FG000|Overall Study|Lost to Follow-up|4|||
130208137|NCT02054910|468721099|FG001|Overall Study|Lost to Follow-up|1|||
130208138|NCT01096589|468721101|FG000|Overall Study|Adverse Event|2|||
130208139|NCT01096589|468721102|FG001|Overall Study|Adverse Event|1|||
130208140|NCT01096589|468721103|FG002|Overall Study|Adverse Event|2|||
130208141|NCT01096589|468721104|FG003|Overall Study|Adverse Event|1|||
130208142|NCT01096589|468721101|FG000|Overall Study|Withdrawal by Subject|2|||
130208143|NCT01096589|468721102|FG001|Overall Study|Withdrawal by Subject|1|||
130208144|NCT01096589|468721103|FG002|Overall Study|Withdrawal by Subject|1|||
130208145|NCT01096589|468721104|FG003|Overall Study|Withdrawal by Subject|1|||
130096016|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
130208146|NCT01096589|468721101|FG000|Overall Study|Compliance with protocol|0|||
130096017|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
130096018|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
130096019|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
130208147|NCT01096589|468721102|FG001|Overall Study|Compliance with protocol|0|||
130208148|NCT01096589|468721103|FG002|Overall Study|Compliance with protocol|1|||
130208149|NCT01096589|468721104|FG003|Overall Study|Compliance with protocol|0|||
130208150|NCT01096589|468721101|FG000|Overall Study|found treatment exhausting|0|||
130208151|NCT01096589|468721102|FG001|Overall Study|found treatment exhausting|0|||
130208152|NCT01096589|468721103|FG002|Overall Study|found treatment exhausting|0|||
130208153|NCT01096589|468721104|FG003|Overall Study|found treatment exhausting|1|||
130208154|NCT03673345|468721105|FG000|Overall Study|Lost to Follow-up|1|||
130208155|NCT03673345|468721106|FG001|Overall Study|Lost to Follow-up|0|||
130208156|NCT03673345|468721107|FG002|Overall Study|Lost to Follow-up|3|||
130208157|NCT03673345|468721108|FG003|Overall Study|Lost to Follow-up|3|||
130208158|NCT03673345|468721109|FG004|Overall Study|Lost to Follow-up|2|||
130208159|NCT03673345|468721110|FG005|Overall Study|Lost to Follow-up|1|||
130208160|NCT03673345|468721111|FG006|Overall Study|Lost to Follow-up|0|||
130208161|NCT03673345|468721112|FG007|Overall Study|Lost to Follow-up|0|||
130208162|NCT03673345|468721105|FG000|Overall Study|Withdrawal by Subject|1|||
130208163|NCT03673345|468721106|FG001|Overall Study|Withdrawal by Subject|0|||
130208164|NCT03673345|468721107|FG002|Overall Study|Withdrawal by Subject|4|||
130208165|NCT03673345|468721108|FG003|Overall Study|Withdrawal by Subject|2|||
130208166|NCT03673345|468721109|FG004|Overall Study|Withdrawal by Subject|0|||
130208167|NCT03673345|468721110|FG005|Overall Study|Withdrawal by Subject|0|||
130208168|NCT03673345|468721111|FG006|Overall Study|Withdrawal by Subject|0|||
130208169|NCT03673345|468721112|FG007|Overall Study|Withdrawal by Subject|0|||
130208170|NCT03673345|468721105|FG000|Overall Study|Physician Decision|0|||
130208171|NCT03673345|468721106|FG001|Overall Study|Physician Decision|0|||
130208172|NCT03673345|468721107|FG002|Overall Study|Physician Decision|2|||
130096020|NCT04579666|468309133|FG000|RTP (Up to Week 52)|Other|2|||
130096021|NCT04579666|468309134|FG001|RTP (Up to Week 52)|Other|0|||
130096022|NCT04579666|468309135|FG002|RTP (Up to Week 52)|Other|0|||
130096023|NCT04579666|468309136|FG003|RTP (Up to Week 52)|Other|0|||
130208173|NCT03673345|468721108|FG003|Overall Study|Physician Decision|0|||
130208174|NCT03673345|468721109|FG004|Overall Study|Physician Decision|0|||
130208175|NCT03673345|468721110|FG005|Overall Study|Physician Decision|0|||
130208176|NCT03673345|468721111|FG006|Overall Study|Physician Decision|0|||
130208177|NCT03673345|468721112|FG007|Overall Study|Physician Decision|0|||
130208178|NCT01362244|468721113|FG000|Overall Study|Adverse Event|3|||
130208179|NCT01362244|468721114|FG001|Overall Study|Adverse Event|5|||
130208180|NCT01362244|468721113|FG000|Overall Study|Lack of Efficacy|5|||
130208181|NCT01362244|468721114|FG001|Overall Study|Lack of Efficacy|11|||
130208182|NCT01362244|468721113|FG000|Overall Study|Lost to Follow-up|0|||
130208183|NCT01362244|468721114|FG001|Overall Study|Lost to Follow-up|2|||
130208184|NCT01362244|468721113|FG000|Overall Study|Protocol Violation|5|||
130208185|NCT01362244|468721114|FG001|Overall Study|Protocol Violation|1|||
130208186|NCT01362244|468721113|FG000|Overall Study|Withdrawal by Subject|2|||
130208187|NCT01362244|468721114|FG001|Overall Study|Withdrawal by Subject|1|||
130208188|NCT01362244|468721113|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
130208189|NCT01362244|468721114|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
130208190|NCT01362244|468721113|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
130208191|NCT01362244|468721114|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
130316097|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
130316098|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
130316099|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
130316100|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
130316101|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
130316102|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
130316103|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
130316104|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
130316105|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
130316106|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
130096024|NCT04579666|468309133|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
130096025|NCT04579666|468309134|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
130096026|NCT04579666|468309135|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
130096027|NCT04579666|468309136|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
130096028|NCT04579666|468309133|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
130096029|NCT04579666|468309134|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
130096030|NCT04579666|468309135|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
130096031|NCT04579666|468309136|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
130096032|NCT04579666|468309133|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
130096033|NCT04579666|468309134|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
130096034|NCT04579666|468309135|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
130096035|NCT04579666|468309136|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
130096036|NCT04579666|468309133|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
130096037|NCT04579666|468309134|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
130096038|NCT04579666|468309135|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
130096039|NCT04579666|468309136|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
130096040|NCT04579666|468309133|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
130208192|NCT00908596|468722738|FG000|Overall Study|Other reasons|46|||
130208193|NCT00908596|468722739|FG001|Overall Study|Other reasons|6|||
130208194|NCT00908596|468722740|FG002|Overall Study|Other reasons|2|||
130208195|NCT00908596|468722741|FG003|Overall Study|Other reasons|0|||
130208196|NCT00908596|468722738|FG000|Overall Study|Lost to Follow-up|0|||
130208197|NCT00908596|468722739|FG001|Overall Study|Lost to Follow-up|1|||
130208198|NCT00908596|468722740|FG002|Overall Study|Lost to Follow-up|12|||
130208199|NCT00908596|468722741|FG003|Overall Study|Lost to Follow-up|4|||
130208200|NCT00908596|468722738|FG000|Overall Study|Death|0|||
130208201|NCT00908596|468722739|FG001|Overall Study|Death|5|||
130208202|NCT00908596|468722740|FG002|Overall Study|Death|57|||
130208203|NCT00908596|468722741|FG003|Overall Study|Death|32|||
130208204|NCT00908596|468722738|FG000|Overall Study|Protocol Violation|1|||
130208205|NCT00908596|468722739|FG001|Overall Study|Protocol Violation|0|||
130208206|NCT00908596|468722740|FG002|Overall Study|Protocol Violation|0|||
130208207|NCT00908596|468722741|FG003|Overall Study|Protocol Violation|0|||
130208208|NCT00908596|468722738|FG000|Overall Study|Withdrawal by Subject|0|||
130208209|NCT00908596|468722739|FG001|Overall Study|Withdrawal by Subject|1|||
130208210|NCT00908596|468722740|FG002|Overall Study|Withdrawal by Subject|3|||
130208211|NCT00908596|468722741|FG003|Overall Study|Withdrawal by Subject|1|||
130208212|NCT01709864|468722744|FG000|Overall Study|Physician Decision|0|||
130208213|NCT01709864|468722745|FG001|Overall Study|Physician Decision|1|||
130208214|NCT01709864|468722744|FG000|Overall Study|subject/guardian decision|5|||
130208215|NCT01709864|468722745|FG001|Overall Study|subject/guardian decision|6|||
130208216|NCT01709864|468722744|FG000|Overall Study|Lost to Follow-up|1|||
130208217|NCT01709864|468722745|FG001|Overall Study|Lost to Follow-up|0|||
130208218|NCT01709864|468722744|FG000|Overall Study|non-compliance with study treatment|1|||
130208219|NCT01709864|468722745|FG001|Overall Study|non-compliance with study treatment|1|||
130208220|NCT01709864|468722744|FG000|Overall Study|Adverse Event|0|||
130208221|NCT01709864|468722745|FG001|Overall Study|Adverse Event|2|||
130208222|NCT01709864|468722744|FG000|Overall Study|Death|0|||
130208223|NCT01709864|468722745|FG001|Overall Study|Death|1|||
130208224|NCT02661061|468722748|FG000|Overall Study|Lack of Efficacy|1|||
130208225|NCT02661061|468722749|FG001|Overall Study|Lack of Efficacy|1|||
130208226|NCT02661061|468722748|FG000|Overall Study|Withdrawal by Subject|1|||
130208227|NCT02661061|468722749|FG001|Overall Study|Withdrawal by Subject|1|||
130208228|NCT01492101|468722752|FG000|Overall Study|Death|323|||
130208229|NCT01492101|468722753|FG001|Overall Study|Death|322|||
130208230|NCT01492101|468722752|FG000|Overall Study|Withdrawal by Subject|14|||
130208231|NCT01492101|468722753|FG001|Overall Study|Withdrawal by Subject|18|||
130208232|NCT01492101|468722752|FG000|Overall Study|Lost to Follow-up|0|||
130208233|NCT01492101|468722753|FG001|Overall Study|Lost to Follow-up|2|||
130208234|NCT02696434|468722754|FG000|Overall Study|Adverse Event|3|||
130208235|NCT02696434|468722755|FG001|Overall Study|Adverse Event|1|||
130208236|NCT02696434|468722754|FG000|Overall Study|Lost to Follow-up|5|||
130208237|NCT02696434|468722755|FG001|Overall Study|Lost to Follow-up|4|||
130208238|NCT02696434|468722754|FG000|Overall Study|Withdrawal by Subject|14|||
130208239|NCT02696434|468722755|FG001|Overall Study|Withdrawal by Subject|12|||
130208240|NCT02696434|468722754|FG000|Overall Study|Physician Decision|0|||
130208241|NCT02696434|468722755|FG001|Overall Study|Physician Decision|1|||
130208242|NCT00316914|468722774|FG000|Overall Study|Withdrawal by Subject|5|||
130208243|NCT00316914|468722775|FG001|Overall Study|Withdrawal by Subject|3|||
130208244|NCT00316914|468722774|FG000|Overall Study|Adverse Event|8|||
130208245|NCT00316914|468722775|FG001|Overall Study|Adverse Event|7|||
130208246|NCT00316914|468722774|FG000|Overall Study|Other Problems|6|||
130208247|NCT00316914|468722775|FG001|Overall Study|Other Problems|11|||
130208248|NCT00316914|468722774|FG000|Overall Study|Missing end of treatment documentation|14|||
130208249|NCT00316914|468722775|FG001|Overall Study|Missing end of treatment documentation|15|||
130208250|NCT04105010|468722776|FG000|Overall Study|Death|3|||
130208251|NCT04105010|468722777|FG001|Overall Study|Death|1|||
130208252|NCT04105010|468722778|FG002|Overall Study|Death|1|||
130208253|NCT04105010|468722779|FG003|Overall Study|Death|54|||
130208254|NCT04105010|468722776|FG000|Overall Study|Lost to Follow-up|0|||
130208255|NCT04105010|468722777|FG001|Overall Study|Lost to Follow-up|0|||
130208256|NCT04105010|468722778|FG002|Overall Study|Lost to Follow-up|0|||
130208257|NCT04105010|468722779|FG003|Overall Study|Lost to Follow-up|4|||
130208258|NCT04105010|468722776|FG000|Overall Study|Withdrawal by Subject|8|||
130208259|NCT04105010|468722777|FG001|Overall Study|Withdrawal by Subject|1|||
130208260|NCT04105010|468722778|FG002|Overall Study|Withdrawal by Subject|1|||
130208261|NCT04105010|468722779|FG003|Overall Study|Withdrawal by Subject|4|||
130208262|NCT04105010|468722776|FG000|Overall Study|Other reason|4|||
130208263|NCT04105010|468722777|FG001|Overall Study|Other reason|7|||
130208264|NCT04105010|468722778|FG002|Overall Study|Other reason|0|||
130208265|NCT04105010|468722779|FG003|Overall Study|Other reason|19|||
130208266|NCT01675154|468722780|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130208267|NCT01675154|468722781|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
130208268|NCT01675154|468722782|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130208269|NCT01675154|468722783|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
130096041|NCT04579666|468309134|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
130096042|NCT04579666|468309135|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
130096043|NCT04579666|468309136|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
130096044|NCT05450198|468309137|FG000|Overall Study|Withdrawal by Subject|1|||
130096045|NCT05450198|468309138|FG001|Overall Study|Withdrawal by Subject|1|||
130096046|NCT05450198|468309139|FG002|Overall Study|Withdrawal by Subject|2|||
130096047|NCT05450198|468309140|FG003|Overall Study|Withdrawal by Subject|0|||
130096048|NCT05450198|468309137|FG000|Overall Study|Lost to Follow-up|1|||
130096049|NCT05450198|468309138|FG001|Overall Study|Lost to Follow-up|0|||
130096050|NCT05450198|468309139|FG002|Overall Study|Lost to Follow-up|2|||
130096051|NCT05450198|468309140|FG003|Overall Study|Lost to Follow-up|1|||
130096052|NCT02059265|468309141|FG000|Overall Study|Ineligible|4|||
130096053|NCT02985996|468309142|FG000|Overall Study|Withdrawal by Subject|0|||
130096054|NCT02985996|468309143|FG001|Overall Study|Withdrawal by Subject|0|||
130096055|NCT02985996|468309144|FG002|Overall Study|Withdrawal by Subject|1|||
130096056|NCT02985996|468309145|FG003|Overall Study|Withdrawal by Subject|0|||
130096057|NCT02985996|468309146|FG004|Overall Study|Withdrawal by Subject|0|||
130096058|NCT02985996|468309142|FG000|Overall Study|Protocol Violation|0|||
130096059|NCT02985996|468309143|FG001|Overall Study|Protocol Violation|1|||
130096060|NCT02985996|468309144|FG002|Overall Study|Protocol Violation|0|||
130096061|NCT02985996|468309145|FG003|Overall Study|Protocol Violation|0|||
130208270|NCT00427999|468722784|FG000|Overall Study|Adverse Event|6|||
130208271|NCT00427999|468722784|FG000|Overall Study|Abnormal laboratory values|1|||
130208272|NCT00427999|468722784|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
130096062|NCT02985996|468309146|FG004|Overall Study|Protocol Violation|0|||
130096063|NCT00401726|468309147|FG000|Overall Study|Adverse Event|34|||
130096064|NCT00401726|468309148|FG001|Overall Study|Adverse Event|45|||
130208273|NCT00427999|468722784|FG000|Overall Study|Protocol Violation|2|||
130208274|NCT00427999|468722784|FG000|Overall Study|Withdrawal by Subject|9|||
130208275|NCT00427999|468722784|FG000|Overall Study|Death|1|||
130208276|NCT02380859|468722785|FG000|Overall Study|Withdrawal by Subject|2|||
130208277|NCT02380859|468722786|FG001|Overall Study|Withdrawal by Subject|0|||
130208278|NCT02284568|468722787|FG000|Overall Study|Adverse Event|2|||
130208279|NCT02284568|468722788|FG001|Overall Study|Adverse Event|9|||
130208280|NCT02284568|468722789|FG002|Overall Study|Adverse Event|4|||
130208281|NCT02284568|468722787|FG000|Overall Study|Withdrawal by Subject|22|||
130208282|NCT02284568|468722788|FG001|Overall Study|Withdrawal by Subject|21|||
130208283|NCT02284568|468722789|FG002|Overall Study|Withdrawal by Subject|1|||
130208284|NCT02284568|468722787|FG000|Overall Study|Noncompliance with study drug admin|1|||
130208285|NCT02284568|468722788|FG001|Overall Study|Noncompliance with study drug admin|2|||
130208286|NCT02284568|468722789|FG002|Overall Study|Noncompliance with study drug admin|0|||
130208287|NCT02284568|468722787|FG000|Overall Study|Noncompliance|1|||
130208288|NCT02284568|468722788|FG001|Overall Study|Noncompliance|0|||
130208289|NCT02284568|468722789|FG002|Overall Study|Noncompliance|0|||
130208290|NCT02284568|468722787|FG000|Overall Study|Protocol Violation|0|||
130208291|NCT02284568|468722788|FG001|Overall Study|Protocol Violation|1|||
130208292|NCT02284568|468722789|FG002|Overall Study|Protocol Violation|0|||
130208293|NCT02284568|468722787|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
130208294|NCT02284568|468722788|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
130208295|NCT02284568|468722789|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
130208296|NCT02284568|468722787|FG000|Overall Study|Lost to Follow-up|0|||
130208297|NCT02284568|468722788|FG001|Overall Study|Lost to Follow-up|3|||
130208298|NCT02284568|468722789|FG002|Overall Study|Lost to Follow-up|0|||
130208299|NCT02284568|468722787|FG000|Overall Study|Lack of Efficacy|4|||
130208300|NCT02284568|468722788|FG001|Overall Study|Lack of Efficacy|7|||
130208301|NCT02284568|468722789|FG002|Overall Study|Lack of Efficacy|0|||
130208302|NCT02284568|468722787|FG000|Overall Study|Other|1|||
130208303|NCT02284568|468722788|FG001|Overall Study|Other|2|||
130208304|NCT02284568|468722789|FG002|Overall Study|Other|0|||
130208305|NCT02284568|468722787|FG000|Overall Study|Withdrew before taking study drug|0|||
130096065|NCT00401726|468309147|FG000|Overall Study|Death|0|||
130096066|NCT00401726|468309148|FG001|Overall Study|Death|3|||
130096067|NCT00401726|468309147|FG000|Overall Study|Sponsor Request|0|||
130096068|NCT00401726|468309148|FG001|Overall Study|Sponsor Request|1|||
130096069|NCT00401726|468309147|FG000|Overall Study|Physician Decision|3|||
130208306|NCT02284568|468722788|FG001|Overall Study|Withdrew before taking study drug|1|||
130208307|NCT02284568|468722789|FG002|Overall Study|Withdrew before taking study drug|0|||
130208308|NCT05323994|468722790|FG000|Overall Study|Protocol Violation|1|||
130208309|NCT01420679|468722796|FG000|Overall Study|Disease Progression|3|||
130208310|NCT01420679|468722797|FG001|Overall Study|Disease Progression|2|||
130208311|NCT01420679|468722796|FG000|Overall Study|Adverse Event|4|||
130208312|NCT01420679|468722797|FG001|Overall Study|Adverse Event|0|||
130208313|NCT01420679|468722796|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
130208314|NCT01420679|468722797|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
130096070|NCT00401726|468309148|FG001|Overall Study|Physician Decision|6|||
130208315|NCT01420679|468722796|FG000|Overall Study|Patient Decision|1|||
130208316|NCT01420679|468722797|FG001|Overall Study|Patient Decision|0|||
130208317|NCT01420679|468722796|FG000|Overall Study|Investigator Decision|1|||
130208318|NCT01420679|468722797|FG001|Overall Study|Investigator Decision|2|||
130319114|NCT00062439|469135412|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
130319115|NCT00062439|469135412|FG000|Surgery|Physician Decision|4|||
130319116|NCT00062439|469135412|FG000|Surgery|Death|1|||
130319117|NCT00062439|469135412|FG000|Surgery|Adverse Event|2|||
130319118|NCT00062439|469135412|FG000|Consolidation Chemotherapy|Adverse Event|2|||
130319119|NCT01924845|469135413|FG000|Overall Study|Adverse Event|3|||
130319120|NCT01924845|469135413|FG000|Overall Study|Withdrawal by Subject|2|||
130319121|NCT01924845|469135413|FG000|Overall Study|Protocol Violation|1|||
130319122|NCT00001832|469135417|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
130319123|NCT00001832|469135418|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
130319124|NCT00001832|469135419|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
130319125|NCT00001832|469135420|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
130319126|NCT00001832|469135421|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
130319127|NCT00001832|469135422|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
130319128|NCT00001832|469135423|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
130319129|NCT00001832|469135424|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
130319130|NCT00001832|469135425|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
130319131|NCT00001832|469135426|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
130319132|NCT00001832|469135427|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
130319133|NCT00001832|469135428|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
130319134|NCT00001832|469135429|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
130208319|NCT01420679|468722796|FG000|Overall Study|Sponsor Decision|3|||
130208320|NCT01420679|468722797|FG001|Overall Study|Sponsor Decision|3|||
130208321|NCT01420679|468722796|FG000|Overall Study|Other|1|||
130208322|NCT01420679|468722797|FG001|Overall Study|Other|0|||
130208323|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
130208324|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
130208325|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
130208326|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
130208327|NCT00943670|468722798|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
130208328|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
130208329|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
130208330|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
130208331|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
130208332|NCT00943670|468722798|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
130208333|NCT03956615|468722799|FG000|Overall Study|No multiple myeloma confirmed|2|||
130208334|NCT03956615|468722799|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
130208335|NCT03956615|468722799|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
130208336|NCT03956615|468722799|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
130208337|NCT03000530|468722808|FG000|Overall Study|Adverse Event|0|||
130208338|NCT03000530|468722809|FG001|Overall Study|Adverse Event|0|||
130208339|NCT03000530|468722810|FG002|Overall Study|Adverse Event|2|||
130208340|NCT03000530|468722808|FG000|Overall Study|Lost to Follow-up|0|||
130208341|NCT03000530|468722809|FG001|Overall Study|Lost to Follow-up|3|||
130208342|NCT03000530|468722810|FG002|Overall Study|Lost to Follow-up|1|||
130208343|NCT03000530|468722808|FG000|Overall Study|Withdrawal by Subject|0|||
130208344|NCT03000530|468722809|FG001|Overall Study|Withdrawal by Subject|2|||
130208345|NCT03000530|468722810|FG002|Overall Study|Withdrawal by Subject|1|||
130208346|NCT00312572|468722814|FG000|Overall Study|Adverse Event|10|||
130208347|NCT00312572|468722815|FG001|Overall Study|Adverse Event|16|||
130208348|NCT00312572|468722814|FG000|Overall Study|Lost to Follow-up|1|||
130208349|NCT00312572|468722815|FG001|Overall Study|Lost to Follow-up|1|||
130208350|NCT00312572|468722814|FG000|Overall Study|Administrative|4|||
130208351|NCT00312572|468722815|FG001|Overall Study|Administrative|2|||
130208352|NCT00312572|468722814|FG000|Overall Study|Lack of Efficacy|1|||
130208353|NCT00312572|468722815|FG001|Overall Study|Lack of Efficacy|2|||
130208354|NCT01430624|468722816|FG000|Overall Study|Lost to Follow-up|23|||
130208355|NCT01430624|468722817|FG001|Overall Study|Lost to Follow-up|29|||
130208356|NCT01430624|468722818|FG002|Overall Study|Lost to Follow-up|27|||
130208357|NCT01430624|468722816|FG000|Overall Study|technical or eligibility|5|||
130208358|NCT01430624|468722817|FG001|Overall Study|technical or eligibility|5|||
130208359|NCT01430624|468722818|FG002|Overall Study|technical or eligibility|2|||
130208360|NCT02614131|468722823|FG000|Overall Study|Withdrawal by Subject|1|||
130208361|NCT02614131|468722824|FG001|Overall Study|Withdrawal by Subject|0|||
130208362|NCT02614131|468722825|FG002|Overall Study|Withdrawal by Subject|0|||
130208363|NCT02614131|468722826|FG003|Overall Study|Withdrawal by Subject|0|||
130208364|NCT02614131|468722827|FG004|Overall Study|Withdrawal by Subject|0|||
130208365|NCT02614131|468722828|FG005|Overall Study|Withdrawal by Subject|0|||
130208366|NCT02614131|468722829|FG006|Overall Study|Withdrawal by Subject|0|||
130208367|NCT02614131|468722823|FG000|Overall Study|Adverse Event|0|||
130208368|NCT02614131|468722824|FG001|Overall Study|Adverse Event|0|||
130208369|NCT02614131|468722825|FG002|Overall Study|Adverse Event|0|||
130208370|NCT02614131|468722826|FG003|Overall Study|Adverse Event|0|||
130208371|NCT02614131|468722827|FG004|Overall Study|Adverse Event|0|||
130208372|NCT02614131|468722828|FG005|Overall Study|Adverse Event|0|||
130208373|NCT02614131|468722829|FG006|Overall Study|Adverse Event|1|||
130208374|NCT01285492|468722834|FG000|Overall Study|Adverse Event|11|||
130208375|NCT01285492|468722835|FG001|Overall Study|Adverse Event|0|||
130208376|NCT01285492|468722834|FG000|Overall Study|Protocol Violation|3|||
130208377|NCT01285492|468722835|FG001|Overall Study|Protocol Violation|0|||
130208378|NCT01285492|468722834|FG000|Overall Study|Withdrawal by Subject|2|||
130208379|NCT01285492|468722835|FG001|Overall Study|Withdrawal by Subject|1|||
130208380|NCT01285492|468722834|FG000|Overall Study|Death|1|||
130208381|NCT01285492|468722835|FG001|Overall Study|Death|0|||
130208382|NCT01797094|468722836|FG000|Overall Study|Adverse Event|1|||
130208383|NCT01797094|468722837|FG001|Overall Study|Adverse Event|1|||
130208384|NCT01797094|468722836|FG000|Overall Study|Personal Reasons|4|||
130208385|NCT01797094|468722837|FG001|Overall Study|Personal Reasons|0|||
130208386|NCT01797094|468722836|FG000|Overall Study|Protocol Violation|0|||
130208387|NCT01797094|468722837|FG001|Overall Study|Protocol Violation|1|||
130208388|NCT01797094|468722836|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130208389|NCT01797094|468722837|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130208390|NCT03217968|468722840|FG000|Overall Study|Withdrawal by Subject|4|||
130208391|NCT03217968|468722840|FG000|Overall Study|Lost to Follow-up|1|||
130208392|NCT03217968|468722840|FG000|Overall Study|Protocol Violation|6|||
130208393|NCT00634049|468722852|FG000|Overall Study|Never received study drug|1|||
130208394|NCT00634049|468722852|FG000|Overall Study|Died prior to receiving study drug|1|||
130208395|NCT00634049|468722852|FG000|Overall Study|Screening failure|1|||
130208396|NCT00314132|468722853|FG000|Overall Study|Lost to Follow-up|3|||
130208397|NCT00314132|468722854|FG001|Overall Study|Lost to Follow-up|13|||
130208398|NCT00314132|468722853|FG000|Overall Study|Withdrawal by Subject|3|||
130208399|NCT00314132|468722854|FG001|Overall Study|Withdrawal by Subject|5|||
130208400|NCT00314132|468722853|FG000|Overall Study|Adverse Event|1|||
130208401|NCT00314132|468722854|FG001|Overall Study|Adverse Event|0|||
130208402|NCT00314132|468722853|FG000|Overall Study|Physician Decision|1|||
130208403|NCT00314132|468722854|FG001|Overall Study|Physician Decision|0|||
130208404|NCT00045734|468722855|FG000|Overall Study|Protocol Violation|1|||
130208405|NCT03482167|468722856|FG000|Allocated to Intervention|Physician Decision|1|||
130208406|NCT03482167|468722857|FG001|Allocated to Intervention|Physician Decision|2|||
130208407|NCT03482167|468722856|FG000|Received Intervention|Adverse Event|3|||
130208408|NCT03482167|468722857|FG001|Received Intervention|Adverse Event|1|||
130208409|NCT03482167|468722856|FG000|Received Intervention|Physician Decision|1|||
130208410|NCT03482167|468722857|FG001|Received Intervention|Physician Decision|1|||
130208411|NCT03482167|468722856|FG000|Received Intervention|Withdrawal by Subject|1|||
130208412|NCT03482167|468722857|FG001|Received Intervention|Withdrawal by Subject|0|||
130208413|NCT05079230|468722868|FG000|Overall Study|Study Terminated by Sponsor|101|||
130208414|NCT05079230|468722869|FG001|Overall Study|Study Terminated by Sponsor|102|||
130208415|NCT05079230|468722868|FG000|Overall Study|Death|72|||
130208416|NCT05079230|468722869|FG001|Overall Study|Death|66|||
130208417|NCT05079230|468722868|FG000|Overall Study|Withdrew Consent|16|||
130208418|NCT05079230|468722869|FG001|Overall Study|Withdrew Consent|18|||
130208419|NCT05079230|468722868|FG000|Overall Study|Lost to Follow-up|0|||
130208420|NCT05079230|468722869|FG001|Overall Study|Lost to Follow-up|3|||
130208421|NCT01524783|468722870|FG000|Blinded Period|Adverse Event|64|||
130208422|NCT01524783|468722871|FG001|Blinded Period|Adverse Event|7|||
130208423|NCT01524783|468722872|FG002|Blinded Period|Adverse Event|0|||
130208424|NCT01524783|468722870|FG000|Blinded Period|Disease Progression|89|||
130208425|NCT01524783|468722871|FG001|Blinded Period|Disease Progression|75|||
130208426|NCT01524783|468722872|FG002|Blinded Period|Disease Progression|0|||
130208427|NCT01524783|468722870|FG000|Blinded Period|Withdrawal by Subject|19|||
130208428|NCT01524783|468722871|FG001|Blinded Period|Withdrawal by Subject|6|||
130208429|NCT01524783|468722872|FG002|Blinded Period|Withdrawal by Subject|0|||
130208430|NCT01524783|468722870|FG000|Blinded Period|Protocol deviation|2|||
130208431|NCT01524783|468722871|FG001|Blinded Period|Protocol deviation|1|||
130208432|NCT01524783|468722872|FG002|Blinded Period|Protocol deviation|0|||
130208433|NCT01524783|468722870|FG000|Blinded Period|Death|5|||
130208434|NCT01524783|468722871|FG001|Blinded Period|Death|2|||
130208435|NCT01524783|468722872|FG002|Blinded Period|Death|0|||
130208436|NCT01524783|468722870|FG000|Open-label Period|Disease progression|13|||
130208437|NCT01524783|468722871|FG001|Open-label Period|Disease progression|0|||
130208438|NCT01524783|468722872|FG002|Open-label Period|Disease progression|2|||
130208439|NCT01524783|468722870|FG000|Open-label Period|Administrative problems|5|||
130208440|NCT01524783|468722871|FG001|Open-label Period|Administrative problems|0|||
130208441|NCT01524783|468722872|FG002|Open-label Period|Administrative problems|2|||
130208442|NCT01524783|468722870|FG000|Open-label Period|Adverse Event|5|||
130208443|NCT01524783|468722871|FG001|Open-label Period|Adverse Event|0|||
130208444|NCT01524783|468722872|FG002|Open-label Period|Adverse Event|1|||
130208445|NCT01524783|468722870|FG000|Open-label Period|Withdrawal by Subject|2|||
130208446|NCT01524783|468722871|FG001|Open-label Period|Withdrawal by Subject|0|||
130208447|NCT01524783|468722872|FG002|Open-label Period|Withdrawal by Subject|1|||
130208448|NCT01524783|468722870|FG000|Open-label Period|Protocol deviation|1|||
130208449|NCT01524783|468722871|FG001|Open-label Period|Protocol deviation|0|||
130096071|NCT00401726|468309147|FG000|Overall Study|Lost to Follow-up|23|||
130096072|NCT00401726|468309148|FG001|Overall Study|Lost to Follow-up|20|||
130096073|NCT00401726|468309147|FG000|Overall Study|Protocol Violation|6|||
130096074|NCT00401726|468309148|FG001|Overall Study|Protocol Violation|3|||
130096075|NCT00401726|468309147|FG000|Overall Study|Withdrawal by Subject|18|||
130096076|NCT00401726|468309148|FG001|Overall Study|Withdrawal by Subject|24|||
130096077|NCT00401726|468309147|FG000|Overall Study|Lack of Efficacy|4|||
130096078|NCT00401726|468309148|FG001|Overall Study|Lack of Efficacy|6|||
130096079|NCT00401726|468309147|FG000|Overall Study|Protocol Deviation|9|||
130096080|NCT00401726|468309148|FG001|Overall Study|Protocol Deviation|4|||
130096081|NCT00442572|468309149|FG000|Overall Study|Relapse|8|||
130096082|NCT00442572|468309150|FG001|Overall Study|Relapse|1|||
130096083|NCT00442572|468309149|FG000|Overall Study|Lost to Follow-up|0|||
130096084|NCT00442572|468309150|FG001|Overall Study|Lost to Follow-up|1|||
130096085|NCT00442572|468309149|FG000|Overall Study|Withdrawal by Subject|0|||
130096086|NCT00442572|468309150|FG001|Overall Study|Withdrawal by Subject|1|||
130096087|NCT01901393|468309151|FG000|Overall Study|Adverse Event|1|||
130096088|NCT01901393|468309152|FG001|Overall Study|Adverse Event|0|||
130096089|NCT04246593|468309154|FG000|Overall Study|Withdrawal by Subject|14|||
130096090|NCT04246593|468309155|FG001|Overall Study|Withdrawal by Subject|13|||
130096091|NCT04246593|468309154|FG000|Overall Study|Lost to Follow-up|124|||
130096092|NCT04246593|468309155|FG001|Overall Study|Lost to Follow-up|71|||
130096093|NCT04246593|468309154|FG000|Overall Study|Moved out of area/became ineligible|3|||
130096094|NCT04246593|468309155|FG001|Overall Study|Moved out of area/became ineligible|1|||
130096095|NCT04246593|468309154|FG000|Overall Study|Reason unknown|4|||
130096096|NCT04246593|468309155|FG001|Overall Study|Reason unknown|2|||
130096097|NCT02369874|468309157|FG000|Overall Study|Lost to Follow-up|2|||
130096098|NCT02369874|468309158|FG001|Overall Study|Lost to Follow-up|2|||
130096099|NCT02369874|468309159|FG002|Overall Study|Lost to Follow-up|2|||
130208450|NCT01524783|468722872|FG002|Open-label Period|Protocol deviation|0|||
130208451|NCT05153148|468722875|FG000|Overall Study|Adverse Event|1|||
130208452|NCT05153148|468722876|FG001|Overall Study|Adverse Event|0|||
130208453|NCT05153148|468722877|FG002|Overall Study|Adverse Event|3|||
130208454|NCT05153148|468722878|FG003|Overall Study|Adverse Event|5|||
130208455|NCT05153148|468722875|FG000|Overall Study|Lost to Follow-up|1|||
130208456|NCT05153148|468722876|FG001|Overall Study|Lost to Follow-up|1|||
130208457|NCT05153148|468722877|FG002|Overall Study|Lost to Follow-up|2|||
130096100|NCT02369874|468309157|FG000|Overall Study|Withdrawal by Subject|7|||
130096101|NCT02369874|468309158|FG001|Overall Study|Withdrawal by Subject|9|||
130096102|NCT02369874|468309159|FG002|Overall Study|Withdrawal by Subject|27|||
130096103|NCT02369874|468309157|FG000|Overall Study|Miscellaneous|1|||
130096104|NCT02369874|468309158|FG001|Overall Study|Miscellaneous|1|||
130096105|NCT02369874|468309159|FG002|Overall Study|Miscellaneous|0|||
130096106|NCT02369874|468309157|FG000|Overall Study|On Treatment/Off Study|34|||
130096107|NCT02369874|468309158|FG001|Overall Study|On Treatment/Off Study|45|||
130096108|NCT02369874|468309159|FG002|Overall Study|On Treatment/Off Study|32|||
130096109|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
130096110|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
130096111|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
130096112|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
130096113|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
130096114|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Death|1|||
130096115|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Death|0|||
130096116|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Death|0|||
130096117|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Death|0|||
130096118|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Death|0|||
130096119|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
130096120|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
130096121|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
130096122|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
130096123|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
130096124|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
130096125|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
130208458|NCT05153148|468722878|FG003|Overall Study|Lost to Follow-up|0|||
130096126|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
130096127|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
130096128|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
130096129|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
130208459|NCT05153148|468722875|FG000|Overall Study|Withdrawal by Subject|6|||
130096130|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
130096131|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
130096132|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
130208460|NCT05153148|468722876|FG001|Overall Study|Withdrawal by Subject|8|||
130208461|NCT05153148|468722877|FG002|Overall Study|Withdrawal by Subject|6|||
130208462|NCT05153148|468722878|FG003|Overall Study|Withdrawal by Subject|8|||
130096133|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
130096134|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130096135|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
130096136|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
130096137|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130096138|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
130096139|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
130096140|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
130096141|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130096142|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130096143|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
130096144|NCT00634933|468309162|FG000|Part A: Baseline to Week 24|Other|1|||
130096145|NCT00634933|468309163|FG001|Part A: Baseline to Week 24|Other|8|||
130096146|NCT00634933|468309164|FG002|Part A: Baseline to Week 24|Other|5|||
130096147|NCT00634933|468309165|FG003|Part A: Baseline to Week 24|Other|0|||
130208463|NCT05153148|468722875|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130208464|NCT05153148|468722876|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130208465|NCT05153148|468722877|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
130208466|NCT05153148|468722878|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
130208467|NCT05153148|468722875|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130096148|NCT00634933|468309166|FG004|Part A: Baseline to Week 24|Other|0|||
130096149|NCT00634933|468309162|FG000|Between Part A and Part B|Physician Decision|0|||
130096150|NCT00634933|468309163|FG001|Between Part A and Part B|Physician Decision|1|||
130096151|NCT00634933|468309164|FG002|Between Part A and Part B|Physician Decision|0|||
130096152|NCT00634933|468309165|FG003|Between Part A and Part B|Physician Decision|0|||
130096153|NCT00634933|468309166|FG004|Between Part A and Part B|Physician Decision|0|||
130096154|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
130096155|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
130096156|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
130208468|NCT05153148|468722876|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130208469|NCT05153148|468722877|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
130208470|NCT05153148|468722878|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
130208471|NCT05153148|468722875|FG000|Overall Study|Reason not Specified|1|||
130208472|NCT05153148|468722876|FG001|Overall Study|Reason not Specified|1|||
130208473|NCT05153148|468722877|FG002|Overall Study|Reason not Specified|1|||
130208474|NCT05153148|468722878|FG003|Overall Study|Reason not Specified|1|||
130208475|NCT01712334|468722879|FG000|Treatment Period 1|Randomized in Error|0|||
130208476|NCT01712334|468722880|FG001|Treatment Period 1|Randomized in Error|2|||
130208477|NCT01732471|468722881|FG000|Overall Study|Withdrawal by Subject|1|||
130208478|NCT01253174|468722882|FG000|Period 1|Randomized but not treated|0|||
130208479|NCT01253174|468722883|FG001|Period 1|Randomized but not treated|1|||
130208480|NCT01253174|468722884|FG002|Period 1|Randomized but not treated|1|||
130208481|NCT01253174|468722885|FG003|Period 1|Randomized but not treated|0|||
130208482|NCT01253174|468722886|FG004|Period 1|Randomized but not treated|1|||
130208483|NCT01253174|468722887|FG005|Period 1|Randomized but not treated|0|||
130208484|NCT01253174|468722882|FG000|Period 2|Adverse Event|0|||
130208485|NCT01253174|468722883|FG001|Period 2|Adverse Event|0|||
130208486|NCT01253174|468722884|FG002|Period 2|Adverse Event|1|||
130208487|NCT01253174|468722885|FG003|Period 2|Adverse Event|0|||
130208488|NCT01253174|468722886|FG004|Period 2|Adverse Event|0|||
130208489|NCT01253174|468722887|FG005|Period 2|Adverse Event|0|||
130208490|NCT01253174|468722882|FG000|Period 3|Withdrawal by Subject|0|||
130208491|NCT01253174|468722883|FG001|Period 3|Withdrawal by Subject|1|||
130208492|NCT01253174|468722884|FG002|Period 3|Withdrawal by Subject|0|||
130208493|NCT01253174|468722885|FG003|Period 3|Withdrawal by Subject|0|||
130208494|NCT01253174|468722886|FG004|Period 3|Withdrawal by Subject|1|||
130208495|NCT01253174|468722887|FG005|Period 3|Withdrawal by Subject|0|||
130208496|NCT01253174|468722882|FG000|Period 3|Pregnancy|0|||
130208497|NCT01253174|468722883|FG001|Period 3|Pregnancy|0|||
130208498|NCT01253174|468722884|FG002|Period 3|Pregnancy|1|||
130208499|NCT01253174|468722885|FG003|Period 3|Pregnancy|0|||
130208500|NCT01253174|468722886|FG004|Period 3|Pregnancy|0|||
130208501|NCT01253174|468722887|FG005|Period 3|Pregnancy|0|||
130208502|NCT02267135|468722888|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
130208503|NCT02267135|468722889|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
130208504|NCT02267135|468722888|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
130208505|NCT02267135|468722889|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
130208506|NCT02267135|468722888|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
130208507|NCT02267135|468722889|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
130208508|NCT02267135|468722888|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
130208509|NCT02267135|468722889|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
130208510|NCT02267135|468722888|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
130208511|NCT02267135|468722889|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
130208512|NCT02892513|468722890|FG000|Overall Study|Withdrawal by Subject|0|||
130208513|NCT02892513|468722891|FG001|Overall Study|Withdrawal by Subject|1|||
130096157|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
130208514|NCT00900731|468722892|FG000|Overall Study|Adverse Event|31|||
130208515|NCT00900731|468722893|FG001|Overall Study|Adverse Event|27|||
130208516|NCT00900731|468722892|FG000|Overall Study|Withdrawal by Subject|8|||
130096158|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
130096159|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
130096160|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
130096161|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
130096162|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
130096163|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
130096164|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
130096165|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
130096166|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
130096167|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
130096168|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
130096169|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
130096170|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
130096171|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
130096172|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
130096173|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
130096174|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
130096175|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
130096176|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
130096177|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
130096178|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
130096179|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130096180|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
130096181|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
130096182|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130096183|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
130096184|NCT00634933|468309162|FG000|Part B: Week 24 to Week 52|Other|0|||
130096185|NCT00634933|468309163|FG001|Part B: Week 24 to Week 52|Other|0|||
130096186|NCT00634933|468309164|FG002|Part B: Week 24 to Week 52|Other|5|||
130096187|NCT00634933|468309165|FG003|Part B: Week 24 to Week 52|Other|0|||
130096188|NCT00634933|468309166|FG004|Part B: Week 24 to Week 52|Other|1|||
130096189|NCT02058849|468309167|FG000|Overall Study|Hospitalization|1|||
130096190|NCT02058849|468309168|FG001|Overall Study|Hospitalization|1|||
130208517|NCT00900731|468722893|FG001|Overall Study|Withdrawal by Subject|7|||
130208518|NCT00900731|468722892|FG000|Overall Study|Protocol Deviation|8|||
130208519|NCT00900731|468722893|FG001|Overall Study|Protocol Deviation|11|||
130208520|NCT00900731|468722892|FG000|Overall Study|Administrative Problems|5|||
130208521|NCT00900731|468722893|FG001|Overall Study|Administrative Problems|4|||
130208522|NCT00900731|468722892|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
130208523|NCT00900731|468722893|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130208524|NCT00900731|468722892|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
130208525|NCT00900731|468722893|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
130208526|NCT00900731|468722892|FG000|Overall Study|Lost to Follow-up|2|||
130208527|NCT00900731|468722893|FG001|Overall Study|Lost to Follow-up|3|||
130208528|NCT00900731|468722892|FG000|Overall Study|Lack of Efficacy|1|||
130208529|NCT00900731|468722893|FG001|Overall Study|Lack of Efficacy|3|||
130208530|NCT00900731|468722892|FG000|Overall Study|Death|0|||
130208531|NCT00900731|468722893|FG001|Overall Study|Death|2|||
130208532|NCT03806231|468722894|FG000|Overall Study|Physician Decision|1|||
130208533|NCT03806231|468722895|FG001|Overall Study|Physician Decision|0|||
130208534|NCT03806231|468722894|FG000|Overall Study|Withdrawal by Subject|1|||
130208535|NCT03806231|468722895|FG001|Overall Study|Withdrawal by Subject|0|||
130208536|NCT02919267|468722896|FG000|Overall Study|Protocol Violation|0|||
130208537|NCT02919267|468722897|FG001|Overall Study|Protocol Violation|3|||
130208538|NCT02919267|468722898|FG002|Overall Study|Protocol Violation|3|||
130208539|NCT02919267|468722899|FG003|Overall Study|Protocol Violation|4|||
130208540|NCT00628927|468722900|FG000|Overall Study|Problems performing blood draw|6|||
130208541|NCT00628927|468722901|FG001|Overall Study|Problems performing blood draw|0|||
130208542|NCT00628927|468722900|FG000|Overall Study|Lost to Follow-up|1|||
130208543|NCT00628927|468722901|FG001|Overall Study|Lost to Follow-up|0|||
130208544|NCT00628927|468722900|FG000|Overall Study|Equipment failure|1|||
130208545|NCT00628927|468722901|FG001|Overall Study|Equipment failure|0|||
130208546|NCT02093390|468722902|FG000|Overall Study|Withdrawal by Subject|0|||
130208547|NCT02093390|468722903|FG001|Overall Study|Withdrawal by Subject|1|||
130208548|NCT02437188|468725118|FG000|Overall Study|Randomized but did not receive surgery|4|||
130208549|NCT02437188|468725119|FG001|Overall Study|Randomized but did not receive surgery|8|||
130319135|NCT00001832|469135430|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
130208550|NCT02437188|468725118|FG000|Overall Study|Adverse Event|0|||
130208551|NCT02437188|468725119|FG001|Overall Study|Adverse Event|1|||
130208552|NCT01172808|468725120|FG000|Overall Study|Adverse Event|8|||
130096191|NCT02058849|468309167|FG000|Overall Study|Death|1|||
130096192|NCT02058849|468309168|FG001|Overall Study|Death|0|||
130096193|NCT02058849|468309167|FG000|Overall Study|Lost to Follow-up|1|||
130096194|NCT02058849|468309168|FG001|Overall Study|Lost to Follow-up|0|||
130096195|NCT02058849|468309167|FG000|Overall Study|Withdrawal by Subject|4|||
130096196|NCT02058849|468309168|FG001|Overall Study|Withdrawal by Subject|0|||
130096197|NCT01049360|468309169|FG000|Period 1|Adverse Event|0|||
130096198|NCT01049360|468309170|FG001|Period 1|Adverse Event|1|||
130096199|NCT01049360|468309171|FG002|Period 1|Adverse Event|0|||
130096200|NCT01049360|468309172|FG003|Period 1|Adverse Event|1|||
130096201|NCT01049360|468309173|FG004|Period 1|Adverse Event|0|||
130096202|NCT01049360|468309174|FG005|Period 1|Adverse Event|0|||
130096203|NCT01049360|468309175|FG006|Period 1|Adverse Event|0|||
130096204|NCT01049360|468309176|FG007|Period 1|Adverse Event|1|||
130096205|NCT01049360|468309177|FG008|Period 1|Adverse Event|0|||
130096206|NCT01049360|468309178|FG009|Period 1|Adverse Event|0|||
130096207|NCT01049360|468309179|FG010|Period 1|Adverse Event|0|||
130096208|NCT01049360|468309180|FG011|Period 1|Adverse Event|0|||
130096209|NCT01049360|468309181|FG012|Period 1|Adverse Event|1|||
130096210|NCT01049360|468309182|FG013|Period 1|Adverse Event|1|||
130096211|NCT01049360|468309183|FG014|Period 1|Adverse Event|0|||
130096212|NCT01049360|468309184|FG015|Period 1|Adverse Event|0|||
130096213|NCT01049360|468309185|FG016|Period 1|Adverse Event|1|||
130096214|NCT01049360|468309186|FG017|Period 1|Adverse Event|0|||
130096215|NCT01049360|468309187|FG018|Period 1|Adverse Event|1|||
130096216|NCT01049360|468309188|FG019|Period 1|Adverse Event|0|||
130096217|NCT01049360|468309169|FG000|Period 1|Did not meet inc/exc criteria|0|||
130096218|NCT01049360|468309170|FG001|Period 1|Did not meet inc/exc criteria|0|||
130096219|NCT01049360|468309171|FG002|Period 1|Did not meet inc/exc criteria|0|||
130096220|NCT01049360|468309172|FG003|Period 1|Did not meet inc/exc criteria|0|||
130096221|NCT01049360|468309173|FG004|Period 1|Did not meet inc/exc criteria|0|||
130096222|NCT01049360|468309174|FG005|Period 1|Did not meet inc/exc criteria|0|||
130208553|NCT01172808|468725121|FG001|Overall Study|Adverse Event|4|||
130208554|NCT01172808|468725122|FG002|Overall Study|Adverse Event|8|||
130208555|NCT01172808|468725123|FG003|Overall Study|Adverse Event|3|||
130208556|NCT01172808|468725120|FG000|Overall Study|Lack of Efficacy|1|||
130208557|NCT01172808|468725121|FG001|Overall Study|Lack of Efficacy|0|||
130208558|NCT01172808|468725122|FG002|Overall Study|Lack of Efficacy|0|||
130208559|NCT01172808|468725123|FG003|Overall Study|Lack of Efficacy|0|||
130208560|NCT01172808|468725120|FG000|Overall Study|Protocol Violation|2|||
130208561|NCT01172808|468725121|FG001|Overall Study|Protocol Violation|2|||
130208562|NCT01172808|468725122|FG002|Overall Study|Protocol Violation|2|||
130208563|NCT01172808|468725123|FG003|Overall Study|Protocol Violation|0|||
130208564|NCT01172808|468725120|FG000|Overall Study|Lost to Follow-up|0|||
130208565|NCT01172808|468725121|FG001|Overall Study|Lost to Follow-up|1|||
130208566|NCT01172808|468725122|FG002|Overall Study|Lost to Follow-up|1|||
130208567|NCT01172808|468725123|FG003|Overall Study|Lost to Follow-up|3|||
130208568|NCT01172808|468725120|FG000|Overall Study|Withdrawal by Subject|4|||
130208569|NCT01172808|468725121|FG001|Overall Study|Withdrawal by Subject|1|||
130208570|NCT01172808|468725122|FG002|Overall Study|Withdrawal by Subject|3|||
130208571|NCT01172808|468725123|FG003|Overall Study|Withdrawal by Subject|2|||
130208572|NCT01172808|468725120|FG000|Overall Study|Other|6|||
130208573|NCT01172808|468725121|FG001|Overall Study|Other|5|||
130208574|NCT01172808|468725122|FG002|Overall Study|Other|9|||
130208575|NCT01172808|468725123|FG003|Overall Study|Other|7|||
130208576|NCT03246061|468725124|FG000|Overall Study|Still in follow-up|15|||
130208577|NCT03246061|468725125|FG001|Overall Study|Still in follow-up|21|||
130208578|NCT01937715|468725126|FG000|Overall Study|Death|0|||
130208579|NCT01937715|468725127|FG001|Overall Study|Death|0|||
130208580|NCT01937715|468725128|FG002|Overall Study|Death|0|||
130208581|NCT01937715|468725129|FG003|Overall Study|Death|1|||
130208582|NCT01937715|468725130|FG004|Overall Study|Death|0|||
130208583|NCT01937715|468725126|FG000|Overall Study|Withdrawal by Subject|0|||
130208584|NCT01937715|468725127|FG001|Overall Study|Withdrawal by Subject|1|||
130208585|NCT01937715|468725128|FG002|Overall Study|Withdrawal by Subject|0|||
130208586|NCT01937715|468725129|FG003|Overall Study|Withdrawal by Subject|0|||
130096223|NCT01049360|468309175|FG006|Period 1|Did not meet inc/exc criteria|0|||
130096224|NCT01049360|468309176|FG007|Period 1|Did not meet inc/exc criteria|1|||
130096225|NCT01049360|468309177|FG008|Period 1|Did not meet inc/exc criteria|1|||
130208587|NCT01937715|468725130|FG004|Overall Study|Withdrawal by Subject|2|||
130208588|NCT01937715|468725126|FG000|Overall Study|Other|0|||
130208589|NCT01937715|468725127|FG001|Overall Study|Other|0|||
130096226|NCT01049360|468309178|FG009|Period 1|Did not meet inc/exc criteria|0|||
130096227|NCT01049360|468309179|FG010|Period 1|Did not meet inc/exc criteria|0|||
130096228|NCT01049360|468309180|FG011|Period 1|Did not meet inc/exc criteria|0|||
130208590|NCT01937715|468725128|FG002|Overall Study|Other|0|||
130208591|NCT01937715|468725129|FG003|Overall Study|Other|3|||
130208592|NCT01937715|468725130|FG004|Overall Study|Other|0|||
130208593|NCT02864316|468725131|FG000|Overall Study|Progressive Disease|2|||
130208594|NCT02864316|468725132|FG001|Overall Study|Progressive Disease|1|||
130208595|NCT02864316|468725131|FG000|Overall Study|Adverse Event|0|||
130208596|NCT02864316|468725132|FG001|Overall Study|Adverse Event|1|||
130096229|NCT01049360|468309181|FG012|Period 1|Did not meet inc/exc criteria|0|||
130096230|NCT01049360|468309182|FG013|Period 1|Did not meet inc/exc criteria|0|||
130096231|NCT01049360|468309183|FG014|Period 1|Did not meet inc/exc criteria|0|||
130096232|NCT01049360|468309184|FG015|Period 1|Did not meet inc/exc criteria|0|||
130096233|NCT01049360|468309185|FG016|Period 1|Did not meet inc/exc criteria|0|||
130096234|NCT01049360|468309186|FG017|Period 1|Did not meet inc/exc criteria|0|||
130096235|NCT01049360|468309187|FG018|Period 1|Did not meet inc/exc criteria|0|||
130096236|NCT01049360|468309188|FG019|Period 1|Did not meet inc/exc criteria|0|||
130096237|NCT01049360|468309169|FG000|Period 1|Withdrawal by Subject|0|||
130096238|NCT01049360|468309170|FG001|Period 1|Withdrawal by Subject|0|||
130096239|NCT01049360|468309171|FG002|Period 1|Withdrawal by Subject|0|||
130096240|NCT01049360|468309172|FG003|Period 1|Withdrawal by Subject|0|||
130096241|NCT01049360|468309173|FG004|Period 1|Withdrawal by Subject|0|||
130096242|NCT01049360|468309174|FG005|Period 1|Withdrawal by Subject|0|||
130096243|NCT01049360|468309175|FG006|Period 1|Withdrawal by Subject|0|||
130096244|NCT01049360|468309176|FG007|Period 1|Withdrawal by Subject|0|||
130096245|NCT01049360|468309177|FG008|Period 1|Withdrawal by Subject|1|||
130096246|NCT01049360|468309178|FG009|Period 1|Withdrawal by Subject|0|||
130096247|NCT01049360|468309179|FG010|Period 1|Withdrawal by Subject|1|||
130096248|NCT01049360|468309180|FG011|Period 1|Withdrawal by Subject|0|||
130096249|NCT01049360|468309181|FG012|Period 1|Withdrawal by Subject|1|||
130096250|NCT01049360|468309182|FG013|Period 1|Withdrawal by Subject|0|||
130096251|NCT01049360|468309183|FG014|Period 1|Withdrawal by Subject|0|||
130096252|NCT01049360|468309184|FG015|Period 1|Withdrawal by Subject|0|||
130096253|NCT01049360|468309185|FG016|Period 1|Withdrawal by Subject|0|||
130096254|NCT01049360|468309186|FG017|Period 1|Withdrawal by Subject|0|||
130096255|NCT01049360|468309187|FG018|Period 1|Withdrawal by Subject|0|||
130096256|NCT01049360|468309188|FG019|Period 1|Withdrawal by Subject|0|||
130096257|NCT01049360|468309169|FG000|Period 2|Protocol Violation|0|||
130096258|NCT01049360|468309170|FG001|Period 2|Protocol Violation|0|||
130096259|NCT01049360|468309171|FG002|Period 2|Protocol Violation|0|||
130096260|NCT01049360|468309172|FG003|Period 2|Protocol Violation|1|||
130096261|NCT01049360|468309173|FG004|Period 2|Protocol Violation|0|||
130096262|NCT01049360|468309174|FG005|Period 2|Protocol Violation|0|||
130096263|NCT01049360|468309175|FG006|Period 2|Protocol Violation|0|||
130096264|NCT01049360|468309176|FG007|Period 2|Protocol Violation|0|||
130096265|NCT01049360|468309177|FG008|Period 2|Protocol Violation|0|||
130096266|NCT01049360|468309178|FG009|Period 2|Protocol Violation|0|||
130096267|NCT01049360|468309179|FG010|Period 2|Protocol Violation|0|||
130096268|NCT01049360|468309180|FG011|Period 2|Protocol Violation|0|||
130096269|NCT01049360|468309181|FG012|Period 2|Protocol Violation|0|||
130096270|NCT01049360|468309182|FG013|Period 2|Protocol Violation|0|||
130096271|NCT01049360|468309183|FG014|Period 2|Protocol Violation|1|||
130096272|NCT01049360|468309184|FG015|Period 2|Protocol Violation|1|||
130096273|NCT01049360|468309185|FG016|Period 2|Protocol Violation|0|||
130096274|NCT01049360|468309186|FG017|Period 2|Protocol Violation|0|||
130096275|NCT01049360|468309187|FG018|Period 2|Protocol Violation|0|||
130096276|NCT01049360|468309188|FG019|Period 2|Protocol Violation|0|||
130096277|NCT01049360|468309169|FG000|Period 2|Adverse Event|0|||
130096278|NCT01049360|468309170|FG001|Period 2|Adverse Event|1|||
130096279|NCT01049360|468309171|FG002|Period 2|Adverse Event|0|||
130096280|NCT01049360|468309172|FG003|Period 2|Adverse Event|0|||
130096281|NCT01049360|468309173|FG004|Period 2|Adverse Event|0|||
130096282|NCT01049360|468309174|FG005|Period 2|Adverse Event|0|||
130096283|NCT01049360|468309175|FG006|Period 2|Adverse Event|0|||
130096284|NCT01049360|468309176|FG007|Period 2|Adverse Event|0|||
130096285|NCT01049360|468309177|FG008|Period 2|Adverse Event|1|||
130096286|NCT01049360|468309178|FG009|Period 2|Adverse Event|0|||
130096287|NCT01049360|468309179|FG010|Period 2|Adverse Event|0|||
130096288|NCT01049360|468309180|FG011|Period 2|Adverse Event|0|||
130096289|NCT01049360|468309181|FG012|Period 2|Adverse Event|0|||
130096290|NCT01049360|468309182|FG013|Period 2|Adverse Event|0|||
130096291|NCT01049360|468309183|FG014|Period 2|Adverse Event|0|||
130096292|NCT01049360|468309184|FG015|Period 2|Adverse Event|0|||
130096293|NCT01049360|468309185|FG016|Period 2|Adverse Event|0|||
130096294|NCT01049360|468309186|FG017|Period 2|Adverse Event|0|||
130096295|NCT01049360|468309187|FG018|Period 2|Adverse Event|0|||
130096296|NCT01049360|468309188|FG019|Period 2|Adverse Event|1|||
130096297|NCT01049360|468309169|FG000|Period 2|Withdrawal by Subject|0|||
130096298|NCT01049360|468309170|FG001|Period 2|Withdrawal by Subject|0|||
130096299|NCT01049360|468309171|FG002|Period 2|Withdrawal by Subject|0|||
130096300|NCT01049360|468309172|FG003|Period 2|Withdrawal by Subject|1|||
130096301|NCT01049360|468309173|FG004|Period 2|Withdrawal by Subject|0|||
130096302|NCT01049360|468309174|FG005|Period 2|Withdrawal by Subject|0|||
130096303|NCT01049360|468309175|FG006|Period 2|Withdrawal by Subject|0|||
130096304|NCT01049360|468309176|FG007|Period 2|Withdrawal by Subject|0|||
130096305|NCT01049360|468309177|FG008|Period 2|Withdrawal by Subject|0|||
130096306|NCT01049360|468309178|FG009|Period 2|Withdrawal by Subject|0|||
130096307|NCT01049360|468309179|FG010|Period 2|Withdrawal by Subject|0|||
130096308|NCT01049360|468309180|FG011|Period 2|Withdrawal by Subject|0|||
130096309|NCT01049360|468309181|FG012|Period 2|Withdrawal by Subject|0|||
130096310|NCT01049360|468309182|FG013|Period 2|Withdrawal by Subject|0|||
130096311|NCT01049360|468309183|FG014|Period 2|Withdrawal by Subject|1|||
130096312|NCT01049360|468309184|FG015|Period 2|Withdrawal by Subject|0|||
130096313|NCT01049360|468309185|FG016|Period 2|Withdrawal by Subject|0|||
130096314|NCT01049360|468309186|FG017|Period 2|Withdrawal by Subject|0|||
130096315|NCT01049360|468309187|FG018|Period 2|Withdrawal by Subject|0|||
130096316|NCT01049360|468309188|FG019|Period 2|Withdrawal by Subject|1|||
130096317|NCT01049360|468309169|FG000|Period 2|Lack of Efficacy|0|||
130096318|NCT01049360|468309170|FG001|Period 2|Lack of Efficacy|0|||
130096319|NCT01049360|468309171|FG002|Period 2|Lack of Efficacy|0|||
130096320|NCT01049360|468309172|FG003|Period 2|Lack of Efficacy|0|||
130096321|NCT01049360|468309173|FG004|Period 2|Lack of Efficacy|0|||
130096322|NCT01049360|468309174|FG005|Period 2|Lack of Efficacy|1|||
130096323|NCT01049360|468309175|FG006|Period 2|Lack of Efficacy|0|||
130096324|NCT01049360|468309176|FG007|Period 2|Lack of Efficacy|0|||
130096325|NCT01049360|468309177|FG008|Period 2|Lack of Efficacy|0|||
130096326|NCT01049360|468309178|FG009|Period 2|Lack of Efficacy|0|||
130096327|NCT01049360|468309179|FG010|Period 2|Lack of Efficacy|0|||
130096328|NCT01049360|468309180|FG011|Period 2|Lack of Efficacy|0|||
130096329|NCT01049360|468309181|FG012|Period 2|Lack of Efficacy|0|||
130096330|NCT01049360|468309182|FG013|Period 2|Lack of Efficacy|0|||
130096331|NCT01049360|468309183|FG014|Period 2|Lack of Efficacy|0|||
130096332|NCT01049360|468309184|FG015|Period 2|Lack of Efficacy|0|||
130096333|NCT01049360|468309185|FG016|Period 2|Lack of Efficacy|0|||
130096334|NCT01049360|468309186|FG017|Period 2|Lack of Efficacy|0|||
130096335|NCT01049360|468309187|FG018|Period 2|Lack of Efficacy|0|||
130096336|NCT01049360|468309188|FG019|Period 2|Lack of Efficacy|0|||
130096337|NCT01049360|468309169|FG000|Period 4|Protocol Violation|0|||
130096338|NCT01049360|468309170|FG001|Period 4|Protocol Violation|0|||
130096339|NCT01049360|468309171|FG002|Period 4|Protocol Violation|0|||
130096340|NCT01049360|468309172|FG003|Period 4|Protocol Violation|0|||
130096341|NCT01049360|468309173|FG004|Period 4|Protocol Violation|0|||
130096342|NCT01049360|468309174|FG005|Period 4|Protocol Violation|0|||
130096343|NCT01049360|468309175|FG006|Period 4|Protocol Violation|0|||
130096344|NCT01049360|468309176|FG007|Period 4|Protocol Violation|0|||
130096345|NCT01049360|468309177|FG008|Period 4|Protocol Violation|0|||
130096346|NCT01049360|468309178|FG009|Period 4|Protocol Violation|0|||
130096347|NCT01049360|468309179|FG010|Period 4|Protocol Violation|0|||
130096348|NCT01049360|468309180|FG011|Period 4|Protocol Violation|0|||
130096349|NCT01049360|468309181|FG012|Period 4|Protocol Violation|0|||
130096350|NCT01049360|468309182|FG013|Period 4|Protocol Violation|0|||
130096351|NCT01049360|468309183|FG014|Period 4|Protocol Violation|0|||
130096352|NCT01049360|468309184|FG015|Period 4|Protocol Violation|0|||
130096353|NCT01049360|468309185|FG016|Period 4|Protocol Violation|0|||
130096354|NCT01049360|468309186|FG017|Period 4|Protocol Violation|1|||
130096355|NCT01049360|468309187|FG018|Period 4|Protocol Violation|0|||
130096356|NCT01049360|468309188|FG019|Period 4|Protocol Violation|0|||
130096357|NCT01049360|468309169|FG000|Period 4|Withdrawal by Subject|0|||
130096358|NCT01049360|468309170|FG001|Period 4|Withdrawal by Subject|0|||
130096359|NCT01049360|468309171|FG002|Period 4|Withdrawal by Subject|0|||
130096360|NCT01049360|468309172|FG003|Period 4|Withdrawal by Subject|1|||
130096361|NCT01049360|468309173|FG004|Period 4|Withdrawal by Subject|0|||
130096362|NCT01049360|468309174|FG005|Period 4|Withdrawal by Subject|0|||
130096363|NCT01049360|468309175|FG006|Period 4|Withdrawal by Subject|0|||
130096364|NCT01049360|468309176|FG007|Period 4|Withdrawal by Subject|0|||
130096365|NCT01049360|468309177|FG008|Period 4|Withdrawal by Subject|0|||
130096366|NCT01049360|468309178|FG009|Period 4|Withdrawal by Subject|0|||
130096367|NCT01049360|468309179|FG010|Period 4|Withdrawal by Subject|0|||
130096368|NCT01049360|468309180|FG011|Period 4|Withdrawal by Subject|0|||
130096369|NCT01049360|468309181|FG012|Period 4|Withdrawal by Subject|0|||
130096370|NCT01049360|468309182|FG013|Period 4|Withdrawal by Subject|0|||
130096371|NCT01049360|468309183|FG014|Period 4|Withdrawal by Subject|0|||
130096372|NCT01049360|468309184|FG015|Period 4|Withdrawal by Subject|0|||
130096373|NCT01049360|468309185|FG016|Period 4|Withdrawal by Subject|0|||
130096374|NCT01049360|468309186|FG017|Period 4|Withdrawal by Subject|0|||
130096375|NCT01049360|468309187|FG018|Period 4|Withdrawal by Subject|0|||
130096376|NCT01049360|468309188|FG019|Period 4|Withdrawal by Subject|0|||
130096377|NCT01694849|468309189|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
130208597|NCT01887288|468725133|FG000|Overall Study|The study was terminated and the PI has|16|||
130208598|NCT03114657|468725137|FG000|Overall Study|Adverse Event|9|||
130096378|NCT01694849|468309190|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
130096379|NCT01694849|468309191|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
130096380|NCT01694849|468309189|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
130208599|NCT03114657|468725138|FG001|Overall Study|Adverse Event|6|||
130096381|NCT01694849|468309190|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
130096382|NCT01694849|468309191|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
130096383|NCT01694849|468309189|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
130096384|NCT01694849|468309190|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
130096385|NCT01694849|468309191|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
130096386|NCT01694849|468309189|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
130096387|NCT01694849|468309190|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
130096388|NCT01694849|468309191|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
130096389|NCT01694849|468309189|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
130096390|NCT01694849|468309190|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
130096391|NCT01694849|468309191|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
130096392|NCT01694849|468309189|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
130096393|NCT01694849|468309190|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
130096394|NCT01694849|468309191|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
130096395|NCT01694849|468309189|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
130096396|NCT01694849|468309190|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
130096397|NCT01694849|468309191|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
130096398|NCT01694849|468309189|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
130096399|NCT01694849|468309190|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
130096400|NCT01694849|468309191|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
130096401|NCT01012765|468309192|FG000|Treatment Period 1|Adverse Event|1|||
130096402|NCT01012765|468309193|FG001|Treatment Period 1|Adverse Event|0|||
130096403|NCT01012765|468309194|FG002|Treatment Period 1|Adverse Event|1|||
130096404|NCT01012765|468309195|FG003|Treatment Period 1|Adverse Event|0|||
130096405|NCT01012765|468309196|FG004|Treatment Period 1|Adverse Event|0|||
130096406|NCT01012765|468309197|FG005|Treatment Period 1|Adverse Event|0|||
130096407|NCT01012765|468309192|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130096408|NCT01012765|468309193|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130096409|NCT01012765|468309194|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130096410|NCT01012765|468309195|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130096411|NCT01012765|468309196|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130096412|NCT01012765|468309197|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130096413|NCT01012765|468309192|FG000|Treatment Period 1|Administrative problems|0|||
130096414|NCT01012765|468309193|FG001|Treatment Period 1|Administrative problems|0|||
130096415|NCT01012765|468309194|FG002|Treatment Period 1|Administrative problems|1|||
130096416|NCT01012765|468309195|FG003|Treatment Period 1|Administrative problems|1|||
130096417|NCT01012765|468309196|FG004|Treatment Period 1|Administrative problems|1|||
130096418|NCT01012765|468309197|FG005|Treatment Period 1|Administrative problems|0|||
130096419|NCT01012765|468309192|FG000|Treatment Period 1|Protocol Violation|0|||
130096420|NCT01012765|468309193|FG001|Treatment Period 1|Protocol Violation|0|||
130096421|NCT01012765|468309194|FG002|Treatment Period 1|Protocol Violation|0|||
130096422|NCT01012765|468309195|FG003|Treatment Period 1|Protocol Violation|2|||
130096423|NCT01012765|468309196|FG004|Treatment Period 1|Protocol Violation|1|||
130096424|NCT01012765|468309197|FG005|Treatment Period 1|Protocol Violation|0|||
130096425|NCT01012765|468309192|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130096426|NCT01012765|468309193|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130096427|NCT01012765|468309194|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130096428|NCT01012765|468309195|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130096429|NCT01012765|468309196|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
130096430|NCT01012765|468309197|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
130096431|NCT01012765|468309192|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130096432|NCT01012765|468309193|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130096433|NCT01012765|468309194|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130096434|NCT01012765|468309195|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130096435|NCT01012765|468309196|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130096436|NCT01012765|468309197|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130096437|NCT01012765|468309192|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
130096438|NCT01012765|468309193|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
130096439|NCT01012765|468309194|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
130096440|NCT01012765|468309195|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
130096441|NCT01012765|468309196|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
130096442|NCT01012765|468309197|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
130096443|NCT01012765|468309192|FG000|Treatment Period 2|Adverse Event|0|||
130096444|NCT01012765|468309193|FG001|Treatment Period 2|Adverse Event|1|||
130096445|NCT01012765|468309194|FG002|Treatment Period 2|Adverse Event|1|||
130096446|NCT01012765|468309195|FG003|Treatment Period 2|Adverse Event|0|||
130096447|NCT01012765|468309196|FG004|Treatment Period 2|Adverse Event|0|||
130096448|NCT01012765|468309197|FG005|Treatment Period 2|Adverse Event|0|||
130096449|NCT01012765|468309192|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130096450|NCT01012765|468309193|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
130096451|NCT01012765|468309194|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
130096452|NCT01012765|468309195|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130096453|NCT01012765|468309196|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130096454|NCT01012765|468309197|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
130096455|NCT01326312|468309198|FG000|Overall Study|Adverse Event|11|||
130096456|NCT01326312|468309199|FG001|Overall Study|Adverse Event|11|||
130096457|NCT01326312|468309200|FG002|Overall Study|Adverse Event|1|||
130096458|NCT01326312|468309198|FG000|Overall Study|Withdrawal by Subject|1|||
130096459|NCT01326312|468309199|FG001|Overall Study|Withdrawal by Subject|2|||
130096460|NCT01326312|468309200|FG002|Overall Study|Withdrawal by Subject|1|||
130096461|NCT01326312|468309198|FG000|Overall Study|Protocol Violation|0|||
130096462|NCT01326312|468309199|FG001|Overall Study|Protocol Violation|1|||
130096463|NCT01326312|468309200|FG002|Overall Study|Protocol Violation|0|||
130096464|NCT01326312|468309198|FG000|Overall Study|Lack of Efficacy|13|||
130096465|NCT01326312|468309199|FG001|Overall Study|Lack of Efficacy|7|||
130096466|NCT01326312|468309200|FG002|Overall Study|Lack of Efficacy|1|||
130096467|NCT01326312|468309198|FG000|Overall Study|Death|1|||
130096468|NCT01326312|468309199|FG001|Overall Study|Death|0|||
130096469|NCT01326312|468309200|FG002|Overall Study|Death|1|||
130096470|NCT01326312|468309198|FG000|Overall Study|progressive disease|0|||
130096471|NCT01326312|468309199|FG001|Overall Study|progressive disease|1|||
130096472|NCT01326312|468309200|FG002|Overall Study|progressive disease|1|||
130096473|NCT01326312|468309198|FG000|Overall Study|Study terminated by Sponsor|8|||
130096474|NCT01326312|468309199|FG001|Overall Study|Study terminated by Sponsor|32|||
130096475|NCT01326312|468309200|FG002|Overall Study|Study terminated by Sponsor|46|||
130096476|NCT01326312|468309198|FG000|Overall Study|Treatment arm terminated|19|||
130096477|NCT01326312|468309199|FG001|Overall Study|Treatment arm terminated|0|||
130096478|NCT01326312|468309200|FG002|Overall Study|Treatment arm terminated|0|||
130096479|NCT01326312|468309198|FG000|Overall Study|QTc > 500|0|||
130096480|NCT01326312|468309199|FG001|Overall Study|QTc > 500|1|||
130096481|NCT01326312|468309200|FG002|Overall Study|QTc > 500|0|||
130096482|NCT00499694|468309205|FG000|Overall Study|Patient never received treatment.|1|||
130096483|NCT02304484|468309206|FG000|Overall Study|Death|9|||
130096484|NCT02304484|468309206|FG000|Overall Study|Withdrawal by Subject|14|||
130096485|NCT02304484|468309206|FG000|Overall Study|Lost to Follow-up|2|||
130096486|NCT04338685|468309207|FG000|Overall Study|Death|3|||
130096487|NCT04338685|468309208|FG001|Overall Study|Death|4|||
130096488|NCT04338685|468309209|FG002|Overall Study|Death|2|||
130096489|NCT04338685|468309210|FG003|Overall Study|Death|4|||
130096490|NCT04338685|468309211|FG004|Overall Study|Death|4|||
130096491|NCT04338685|468309212|FG005|Overall Study|Death|8|||
130096492|NCT04338685|468309213|FG006|Overall Study|Death|1|||
130096493|NCT04338685|468309214|FG007|Overall Study|Death|0|||
130096494|NCT04338685|468309215|FG008|Overall Study|Death|0|||
130096495|NCT04338685|468309207|FG000|Overall Study|Study terminated by Sponsor|0|||
130096496|NCT04338685|468309208|FG001|Overall Study|Study terminated by Sponsor|0|||
130096497|NCT04338685|468309209|FG002|Overall Study|Study terminated by Sponsor|1|||
130096498|NCT04338685|468309210|FG003|Overall Study|Study terminated by Sponsor|4|||
130096499|NCT04338685|468309211|FG004|Overall Study|Study terminated by Sponsor|0|||
130096500|NCT04338685|468309212|FG005|Overall Study|Study terminated by Sponsor|5|||
130096501|NCT04338685|468309213|FG006|Overall Study|Study terminated by Sponsor|2|||
130096502|NCT04338685|468309214|FG007|Overall Study|Study terminated by Sponsor|4|||
130096503|NCT04338685|468309215|FG008|Overall Study|Study terminated by Sponsor|1|||
130096504|NCT04338685|468309207|FG000|Overall Study|Withdrawal by Subject|1|||
130096505|NCT04338685|468309208|FG001|Overall Study|Withdrawal by Subject|2|||
130096506|NCT04338685|468309209|FG002|Overall Study|Withdrawal by Subject|0|||
130096507|NCT04338685|468309210|FG003|Overall Study|Withdrawal by Subject|2|||
130096508|NCT04338685|468309211|FG004|Overall Study|Withdrawal by Subject|0|||
130096509|NCT04338685|468309212|FG005|Overall Study|Withdrawal by Subject|5|||
130096510|NCT04338685|468309213|FG006|Overall Study|Withdrawal by Subject|1|||
130096511|NCT04338685|468309214|FG007|Overall Study|Withdrawal by Subject|1|||
130096512|NCT04338685|468309215|FG008|Overall Study|Withdrawal by Subject|0|||
130096513|NCT02967055|468309216|FG000|Overall Study|Excluded|40|||
130096514|NCT02967055|468309216|FG000|Overall Study|Screen fail|3|||
130096515|NCT02967055|468309216|FG000|Overall Study|Lost to Follow-up|2|||
130096516|NCT02967055|468309216|FG000|Overall Study|Stopped due to side effects|3|||
130096517|NCT02967055|468309216|FG000|Overall Study|Stopped due to drug cost|1|||
130096518|NCT00145795|468309217|FG000|Overall Study|Adverse Event|1|||
130096519|NCT00145795|468309218|FG001|Overall Study|Adverse Event|0|||
130096520|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
130096521|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
130096522|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
130096523|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
130096524|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
130096525|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
130096526|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
130096527|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
130096528|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
130096529|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
130096530|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
130096531|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
130096532|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
130096533|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
130096534|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
130096535|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
130096536|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
130096537|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
130096538|NCT00570492|468309219|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
130096539|NCT00570492|468309220|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
130096540|NCT00570492|468309221|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
130096541|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130096542|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
130096543|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
130096544|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
130096545|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
130096546|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
130096547|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
130096548|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
130096549|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
130096550|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
130096551|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
130096552|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
130096553|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
130096554|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
130096555|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
130096556|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
130096557|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
130096558|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
130096559|NCT00570492|468309219|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
130096560|NCT00570492|468309220|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
130096561|NCT00570492|468309221|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
130096562|NCT00908375|468309222|FG000|Overall Study|Withdrawal by Subject|2|||
130096563|NCT00908375|468309223|FG001|Overall Study|Withdrawal by Subject|4|||
130096564|NCT00908375|468309222|FG000|Overall Study|Lost to Follow-up|8|||
130096565|NCT00908375|468309223|FG001|Overall Study|Lost to Follow-up|6|||
130096566|NCT03958045|468309226|FG000|Overall Study|Withdrawal by Subject|1|||
130096567|NCT02283411|468309227|FG000|Overall Study|Withdrawal by Subject|3|||
130096568|NCT02283411|468309227|FG000|Overall Study|Screen Failed|28|||
130096569|NCT01298323|468309229|FG000|Overall Study|Adverse Event|2|||
130096570|NCT01298323|468309230|FG001|Overall Study|Adverse Event|4|||
130096571|NCT01298323|468309229|FG000|Overall Study|Death|11|||
130096572|NCT01298323|468309230|FG001|Overall Study|Death|16|||
130096573|NCT01298323|468309229|FG000|Overall Study|Lost to Follow-up|1|||
130096574|NCT01298323|468309230|FG001|Overall Study|Lost to Follow-up|0|||
130096575|NCT01298323|468309229|FG000|Overall Study|Withdrawal by Subject|6|||
130096576|NCT01298323|468309230|FG001|Overall Study|Withdrawal by Subject|3|||
130096577|NCT01298323|468309229|FG000|Overall Study|Protocol Violation|1|||
130096578|NCT01298323|468309230|FG001|Overall Study|Protocol Violation|0|||
130096579|NCT01298323|468309229|FG000|Overall Study|Other|10|||
130096580|NCT01298323|468309230|FG001|Overall Study|Other|9|||
130096581|NCT01298323|468309229|FG000|Overall Study|Ongoing|55|||
130096582|NCT01298323|468309230|FG001|Overall Study|Ongoing|55|||
130096583|NCT01298323|468309229|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130096584|NCT01298323|468309230|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130096585|NCT04409262|468309232|FG000|Overall Study|Adverse Event|0|||
130096586|NCT04409262|468309233|FG001|Overall Study|Adverse Event|2|||
130096587|NCT04409262|468309232|FG000|Overall Study|Death|55|||
130096588|NCT04409262|468309233|FG001|Overall Study|Death|97|||
130096589|NCT04409262|468309232|FG000|Overall Study|Lost to Follow-up|12|||
130096590|NCT04409262|468309233|FG001|Overall Study|Lost to Follow-up|23|||
130096591|NCT04409262|468309232|FG000|Overall Study|Lack of Staff|0|||
130096592|NCT04409262|468309233|FG001|Overall Study|Lack of Staff|1|||
130096593|NCT04409262|468309232|FG000|Overall Study|Protocol Violation|3|||
130096594|NCT04409262|468309233|FG001|Overall Study|Protocol Violation|1|||
130096595|NCT04409262|468309232|FG000|Overall Study|Withdrawal by Subject|5|||
130096596|NCT04409262|468309233|FG001|Overall Study|Withdrawal by Subject|10|||
130096597|NCT02500732|468309234|FG000|Overall Study|Physician Decision|0|||
130096598|NCT02500732|468309235|FG001|Overall Study|Physician Decision|1|||
130096599|NCT02950831|468309236|FG000|Overall Study|Lost to Follow-up|1|||
130096600|NCT02950831|468309236|FG000|Overall Study|Withdrawal by Subject|3|||
130096601|NCT02950831|468309236|FG000|Overall Study|stimulation trail failure|5|||
130096602|NCT01965600|468309237|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
130096603|NCT01965600|468309238|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
130096604|NCT01965600|468309239|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
130096605|NCT01965600|468309240|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
130208600|NCT03114657|468725137|FG000|Overall Study|Death|4|||
130208601|NCT03114657|468725138|FG001|Overall Study|Death|0|||
129985638|NCT01435616|467909318|FG001|Overall Study|Physician Decision|7|||
130096606|NCT01965600|468309237|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
130096607|NCT01965600|468309238|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
130096608|NCT01965600|468309239|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
130096609|NCT01965600|468309240|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
130096610|NCT01965600|468309237|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
130096611|NCT01965600|468309238|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
130096612|NCT01965600|468309239|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
130096613|NCT01965600|468309240|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
130208602|NCT03114657|468725137|FG000|Overall Study|Multiple Reasons|1|||
129985639|NCT01435616|467909317|FG000|Overall Study|Sponsor Decision|1|||
129985640|NCT01435616|467909318|FG001|Overall Study|Sponsor Decision|0|||
129985641|NCT04860297|467909319|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
129985642|NCT04860297|467909320|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
129985643|NCT04860297|467909321|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
129985644|NCT04860297|467909322|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
129985645|NCT04860297|467909323|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
129985646|NCT04860297|467909324|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
129985647|NCT04860297|467909325|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
129985648|NCT04860297|467909326|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
129985649|NCT04860297|467909319|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
129985650|NCT04860297|467909320|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
129985651|NCT04860297|467909321|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
129985652|NCT04860297|467909322|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
129985653|NCT04860297|467909323|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
129985654|NCT04860297|467909324|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
129985655|NCT04860297|467909325|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
129985656|NCT04860297|467909326|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
129985657|NCT04860297|467909319|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
129985658|NCT04860297|467909320|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
129985659|NCT04860297|467909321|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
129985660|NCT04860297|467909322|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
129985661|NCT04860297|467909323|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
129985662|NCT04860297|467909324|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
129985663|NCT04860297|467909325|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
129985664|NCT04860297|467909326|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
129985665|NCT04860297|467909319|FG000|Part B (Booster Dose)|Other Than Specified|0|||
129985666|NCT04860297|467909320|FG001|Part B (Booster Dose)|Other Than Specified|0|||
129985667|NCT04860297|467909321|FG002|Part B (Booster Dose)|Other Than Specified|0|||
129985668|NCT04860297|467909322|FG003|Part B (Booster Dose)|Other Than Specified|0|||
129985669|NCT04860297|467909323|FG004|Part B (Booster Dose)|Other Than Specified|0|||
129985670|NCT04860297|467909324|FG005|Part B (Booster Dose)|Other Than Specified|1|||
129985671|NCT04860297|467909325|FG006|Part B (Booster Dose)|Other Than Specified|1|||
129985672|NCT04860297|467909326|FG007|Part B (Booster Dose)|Other Than Specified|0|||
129985673|NCT04860297|467909319|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985674|NCT04860297|467909320|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985675|NCT04860297|467909321|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985676|NCT04860297|467909322|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985677|NCT04860297|467909323|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985678|NCT04860297|467909324|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
129985679|NCT04860297|467909325|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985680|NCT04860297|467909326|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
129985681|NCT04860297|467909319|FG000|Part B (Booster Dose)|Death|0|||
129985682|NCT04860297|467909320|FG001|Part B (Booster Dose)|Death|0|||
129985683|NCT04860297|467909321|FG002|Part B (Booster Dose)|Death|0|||
129985684|NCT04860297|467909322|FG003|Part B (Booster Dose)|Death|0|||
129985685|NCT04860297|467909323|FG004|Part B (Booster Dose)|Death|1|||
129985686|NCT04860297|467909324|FG005|Part B (Booster Dose)|Death|2|||
129985687|NCT04860297|467909325|FG006|Part B (Booster Dose)|Death|1|||
129985688|NCT04860297|467909326|FG007|Part B (Booster Dose)|Death|0|||
129985689|NCT04860297|467909319|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
129985690|NCT04860297|467909320|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
129985691|NCT04860297|467909321|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
129985692|NCT04860297|467909322|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
129985693|NCT04860297|467909323|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
129985694|NCT04860297|467909324|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
129985695|NCT04860297|467909325|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
129985696|NCT04860297|467909326|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
130096614|NCT01965600|468309237|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
130096615|NCT01965600|468309238|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
130096616|NCT01965600|468309239|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
130096617|NCT01965600|468309240|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
130096618|NCT01965600|468309237|FG000|Second Intervention|Study terminated by Sponsor|0|||
130096619|NCT01965600|468309238|FG001|Second Intervention|Study terminated by Sponsor|0|||
130096620|NCT01965600|468309239|FG002|Second Intervention|Study terminated by Sponsor|2|||
130096621|NCT01965600|468309240|FG003|Second Intervention|Study terminated by Sponsor|2|||
130096622|NCT03418727|468309246|FG000|Overall Study|Adverse Event|1|||
130096623|NCT03418727|468309247|FG001|Overall Study|Adverse Event|2|||
130096624|NCT03418727|468309248|FG002|Overall Study|Adverse Event|0|||
130096625|NCT03418727|468309246|FG000|Overall Study|Withdrawal by Subject|0|||
130096626|NCT03418727|468309247|FG001|Overall Study|Withdrawal by Subject|0|||
130096627|NCT03418727|468309248|FG002|Overall Study|Withdrawal by Subject|2|||
130096628|NCT00686894|468309250|FG000|Overall Study|Relapse|2|||
130096629|NCT00686894|468309250|FG000|Overall Study|Protocol Violation|4|||
130110659|NCT01629693|468365822|FG000|Overall Study|Investigator decision|0|||
130110660|NCT01629693|468365823|FG001|Overall Study|Investigator decision|1|||
130110661|NCT01629693|468365822|FG000|Overall Study|Poor comfort of study lenses|0|||
130110662|NCT01629693|468365823|FG001|Overall Study|Poor comfort of study lenses|2|||
130110663|NCT01629693|468365822|FG000|Overall Study|Subject decision unrelated to AE|0|||
130110664|NCT01629693|468365823|FG001|Overall Study|Subject decision unrelated to AE|1|||
130110665|NCT01585831|468365830|FG000|Overall Study|Physician Decision|0|||
130110666|NCT01585831|468365831|FG001|Overall Study|Physician Decision|1|||
130110667|NCT01585831|468365830|FG000|Overall Study|Withdrawal by Subject|2|||
130110668|NCT01585831|468365831|FG001|Overall Study|Withdrawal by Subject|1|||
130110669|NCT03120520|468365832|FG000|Overall Study|Lost to Follow-up|1|||
130110670|NCT03120520|468365833|FG001|Overall Study|Lost to Follow-up|1|||
130110671|NCT03120520|468365834|FG002|Overall Study|Lost to Follow-up|1|||
130110672|NCT03120520|468365835|FG003|Overall Study|Lost to Follow-up|1|||
130110673|NCT03120520|468365832|FG000|Overall Study|Withdrawal by Subject|3|||
130110674|NCT03120520|468365833|FG001|Overall Study|Withdrawal by Subject|2|||
130110675|NCT03120520|468365834|FG002|Overall Study|Withdrawal by Subject|3|||
130110676|NCT03120520|468365835|FG003|Overall Study|Withdrawal by Subject|2|||
130110677|NCT03120520|468365832|FG000|Overall Study|Other|0|||
130110678|NCT03120520|468365833|FG001|Overall Study|Other|1|||
130110679|NCT03120520|468365834|FG002|Overall Study|Other|0|||
130110680|NCT03120520|468365835|FG003|Overall Study|Other|0|||
130110681|NCT04385199|468365836|FG000|Overall Study|Withdrawal by Subject|1|||
130110682|NCT04385199|468365837|FG001|Overall Study|Withdrawal by Subject|0|||
130110683|NCT02133352|468365841|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
130110684|NCT00579254|468365842|FG000|Overall Study|Lost to Follow-up|39|||
130110685|NCT00579254|468365842|FG000|Overall Study|Discontinued when study terminated|73|||
130110686|NCT02557672|468365843|FG000|Overall Study|Withdrawal by Subject|4|||
130110687|NCT02557672|468365844|FG001|Overall Study|Withdrawal by Subject|2|||
130110688|NCT03705169|468365845|FG000|Overall Study|Lost to Follow-up|0|||
130110689|NCT03705169|468365846|FG001|Overall Study|Lost to Follow-up|0|||
130110690|NCT03705169|468365847|FG002|Overall Study|Lost to Follow-up|0|||
130110691|NCT03705169|468365848|FG003|Overall Study|Lost to Follow-up|2|||
130110692|NCT03705169|468365849|FG004|Overall Study|Lost to Follow-up|0|||
130110693|NCT03705169|468365850|FG005|Overall Study|Lost to Follow-up|2|||
130110694|NCT03705169|468365851|FG006|Overall Study|Lost to Follow-up|1|||
130110695|NCT03705169|468365852|FG007|Overall Study|Lost to Follow-up|0|||
130110696|NCT03705169|468365853|FG008|Overall Study|Lost to Follow-up|0|||
130110697|NCT03705169|468365854|FG009|Overall Study|Lost to Follow-up|1|||
130110698|NCT03705169|468365845|FG000|Overall Study|Adverse Event|0|||
130110699|NCT03705169|468365846|FG001|Overall Study|Adverse Event|0|||
130110700|NCT03705169|468365847|FG002|Overall Study|Adverse Event|0|||
130110701|NCT03705169|468365848|FG003|Overall Study|Adverse Event|1|||
130110702|NCT03705169|468365849|FG004|Overall Study|Adverse Event|0|||
130110703|NCT03705169|468365850|FG005|Overall Study|Adverse Event|0|||
130110704|NCT03705169|468365851|FG006|Overall Study|Adverse Event|0|||
130110705|NCT03705169|468365852|FG007|Overall Study|Adverse Event|0|||
130110706|NCT03705169|468365853|FG008|Overall Study|Adverse Event|0|||
130110707|NCT03705169|468365854|FG009|Overall Study|Adverse Event|0|||
130110708|NCT03705169|468365845|FG000|Overall Study|Site Closure|0|||
130110709|NCT03705169|468365846|FG001|Overall Study|Site Closure|0|||
130110710|NCT03705169|468365847|FG002|Overall Study|Site Closure|0|||
130110711|NCT03705169|468365848|FG003|Overall Study|Site Closure|1|||
130110712|NCT03705169|468365849|FG004|Overall Study|Site Closure|0|||
130110713|NCT03705169|468365850|FG005|Overall Study|Site Closure|0|||
130110714|NCT03705169|468365851|FG006|Overall Study|Site Closure|0|||
130110715|NCT03705169|468365852|FG007|Overall Study|Site Closure|0|||
130110716|NCT03705169|468365853|FG008|Overall Study|Site Closure|0|||
130110717|NCT03705169|468365854|FG009|Overall Study|Site Closure|0|||
130110718|NCT03705169|468365845|FG000|Overall Study|Did not receive study treatment|0|||
130110719|NCT03705169|468365846|FG001|Overall Study|Did not receive study treatment|0|||
130096630|NCT02513732|468311049|FG000|Overall Study|Lost to Follow-up|11|||
130096631|NCT02513732|468311049|FG000|Overall Study|Death|9|||
130096632|NCT02513732|468311049|FG000|Overall Study|Changing hospital|2|||
130096633|NCT01740297|468311050|FG000|Overall Study|Withdrawal by Subject|4|||
130096634|NCT01740297|468311051|FG001|Overall Study|Withdrawal by Subject|16|||
130096635|NCT01740297|468311052|FG002|Overall Study|Withdrawal by Subject|17|||
130096636|NCT01740297|468311050|FG000|Overall Study|Death|8|||
130096637|NCT01740297|468311051|FG001|Overall Study|Death|46|||
130096638|NCT01740297|468311052|FG002|Overall Study|Death|40|||
130096639|NCT01740297|468311050|FG000|Overall Study|Lost to Follow-up|1|||
130096640|NCT01740297|468311051|FG001|Overall Study|Lost to Follow-up|2|||
130096641|NCT01740297|468311052|FG002|Overall Study|Lost to Follow-up|4|||
130096642|NCT00953017|468311060|FG000|Overall Study|DId not show up for colonoscopy|4|||
130096643|NCT00953017|468311061|FG001|Overall Study|DId not show up for colonoscopy|4|||
130096644|NCT00953017|468311062|FG002|Overall Study|DId not show up for colonoscopy|5|||
130096645|NCT00953017|468311063|FG003|Overall Study|DId not show up for colonoscopy|4|||
130096646|NCT00953017|468311060|FG000|Overall Study|Incomplete data|1|||
130096647|NCT00953017|468311061|FG001|Overall Study|Incomplete data|1|||
130096648|NCT00953017|468311062|FG002|Overall Study|Incomplete data|0|||
130096649|NCT00953017|468311063|FG003|Overall Study|Incomplete data|0|||
130096650|NCT00953017|468311060|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
130096651|NCT00953017|468311061|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
130096652|NCT00953017|468311062|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
130096653|NCT00953017|468311063|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
130096654|NCT00953017|468311060|FG000|Overall Study|Brown stool prior to procedure|0|||
130096655|NCT00953017|468311061|FG001|Overall Study|Brown stool prior to procedure|0|||
130096656|NCT00953017|468311062|FG002|Overall Study|Brown stool prior to procedure|1|||
130096657|NCT00953017|468311063|FG003|Overall Study|Brown stool prior to procedure|0|||
130096658|NCT00718809|468311066|FG000|Overall Study|Disease progression|9|||
130096659|NCT00718809|468311067|FG001|Overall Study|Disease progression|7|||
130096660|NCT00718809|468311066|FG000|Overall Study|Adverse Event|1|||
130096661|NCT00718809|468311067|FG001|Overall Study|Adverse Event|1|||
130096662|NCT00718809|468311066|FG000|Overall Study|Withdrawal by Subject|0|||
130096663|NCT00718809|468311067|FG001|Overall Study|Withdrawal by Subject|1|||
130096664|NCT00718809|468311066|FG000|Overall Study|Lost to Follow-up|1|||
130096665|NCT00718809|468311067|FG001|Overall Study|Lost to Follow-up|0|||
130096666|NCT00718809|468311066|FG000|Overall Study|Noncompliance|1|||
130096667|NCT00718809|468311067|FG001|Overall Study|Noncompliance|0|||
130096668|NCT00463385|468311068|FG000|Overall Study|Other|4|||
130096669|NCT00463385|468311069|FG001|Overall Study|Other|3|||
130096670|NCT00463385|468311070|FG002|Overall Study|Other|6|||
130096671|NCT00463385|468311071|FG003|Overall Study|Other|4|||
130096672|NCT00463385|468311068|FG000|Overall Study|Adverse Event|5|||
130096673|NCT00463385|468311069|FG001|Overall Study|Adverse Event|8|||
130096674|NCT00463385|468311070|FG002|Overall Study|Adverse Event|4|||
130096675|NCT00463385|468311071|FG003|Overall Study|Adverse Event|2|||
130096676|NCT00463385|468311068|FG000|Overall Study|Lack of Efficacy|6|||
130096677|NCT00463385|468311069|FG001|Overall Study|Lack of Efficacy|6|||
130096678|NCT00463385|468311070|FG002|Overall Study|Lack of Efficacy|7|||
130096679|NCT00463385|468311071|FG003|Overall Study|Lack of Efficacy|9|||
130096680|NCT00463385|468311068|FG000|Overall Study|Withdrawal by Subject|3|||
130096681|NCT00463385|468311069|FG001|Overall Study|Withdrawal by Subject|3|||
130096682|NCT00463385|468311070|FG002|Overall Study|Withdrawal by Subject|3|||
130096683|NCT00463385|468311071|FG003|Overall Study|Withdrawal by Subject|4|||
130096684|NCT00463385|468311068|FG000|Overall Study|Lost to Follow-up|0|||
130096685|NCT00463385|468311069|FG001|Overall Study|Lost to Follow-up|0|||
130096686|NCT00463385|468311070|FG002|Overall Study|Lost to Follow-up|0|||
130096687|NCT00463385|468311071|FG003|Overall Study|Lost to Follow-up|1|||
130096688|NCT00463385|468311068|FG000|Overall Study|Death|2|||
130096689|NCT00463385|468311069|FG001|Overall Study|Death|1|||
130096690|NCT00463385|468311070|FG002|Overall Study|Death|2|||
130096691|NCT00463385|468311071|FG003|Overall Study|Death|0|||
130096692|NCT00463385|468311068|FG000|Overall Study|Missing|2|||
130096693|NCT00463385|468311069|FG001|Overall Study|Missing|0|||
130096694|NCT00463385|468311070|FG002|Overall Study|Missing|0|||
130096695|NCT00463385|468311071|FG003|Overall Study|Missing|2|||
130096696|NCT00463385|468311068|FG000|Overall Study|1 participant received commercial drug|0|||
130096697|NCT00463385|468311069|FG001|Overall Study|1 participant received commercial drug|1|||
130096698|NCT00463385|468311070|FG002|Overall Study|1 participant received commercial drug|0|||
130096699|NCT00463385|468311071|FG003|Overall Study|1 participant received commercial drug|0|||
130096700|NCT00449761|468311072|FG000|Overall Study|Disease progression|12|||
130096701|NCT00449761|468311072|FG000|Overall Study|Death|5|||
130096702|NCT00449761|468311072|FG000|Overall Study|New cancer therapy|1|||
130096703|NCT00344968|468311075|FG000|Overall Study|Adverse Event|5|||
130096704|NCT00344968|468311076|FG001|Overall Study|Adverse Event|4|||
130096705|NCT00344968|468311077|FG002|Overall Study|Adverse Event|15|||
130096706|NCT00344968|468311075|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130096707|NCT00344968|468311076|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130208603|NCT03114657|468725138|FG001|Overall Study|Multiple Reasons|2|||
130208604|NCT03114657|468725137|FG000|Overall Study|Physician Decision|2|||
130208605|NCT03114657|468725138|FG001|Overall Study|Physician Decision|2|||
130208606|NCT03114657|468725137|FG000|Overall Study|Study Terminated By Sponsor|355|||
130208607|NCT03114657|468725138|FG001|Overall Study|Study Terminated By Sponsor|374|||
130208608|NCT03114657|468725137|FG000|Overall Study|Symptomatic Deterioration|0|||
130208609|NCT03114657|468725138|FG001|Overall Study|Symptomatic Deterioration|1|||
130208610|NCT03114657|468725137|FG000|Overall Study|Withdrawal by Subject|28|||
130208611|NCT03114657|468725138|FG001|Overall Study|Withdrawal by Subject|22|||
130208612|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
130208613|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
130208614|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
130208615|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
130208616|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
130208617|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
130208618|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
130208619|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
130208620|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
130208621|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
130208622|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
130208623|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
130208624|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Death|0|||
130208625|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Death|0|||
130096708|NCT00344968|468311077|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130096709|NCT00344968|468311075|FG000|Overall Study|Protocol Violation|2|||
130096710|NCT00344968|468311076|FG001|Overall Study|Protocol Violation|2|||
130096711|NCT00344968|468311077|FG002|Overall Study|Protocol Violation|5|||
130096712|NCT00344968|468311075|FG000|Overall Study|Withdrawal by Subject|14|||
130096713|NCT00344968|468311076|FG001|Overall Study|Withdrawal by Subject|31|||
130096714|NCT00344968|468311077|FG002|Overall Study|Withdrawal by Subject|27|||
130096715|NCT00344968|468311075|FG000|Overall Study|Lost to Follow-up|24|||
130096716|NCT00344968|468311076|FG001|Overall Study|Lost to Follow-up|37|||
130096717|NCT00344968|468311077|FG002|Overall Study|Lost to Follow-up|37|||
130096718|NCT00344968|468311075|FG000|Overall Study|Death|11|||
130096719|NCT00344968|468311076|FG001|Overall Study|Death|27|||
130096720|NCT00344968|468311077|FG002|Overall Study|Death|31|||
130096721|NCT00344968|468311075|FG000|Overall Study|Other|0|||
130096722|NCT00344968|468311076|FG001|Overall Study|Other|1|||
130096723|NCT00344968|468311077|FG002|Overall Study|Other|0|||
130096724|NCT03735680|468311078|FG000|Overall Study|Withdrawal by Subject|0|||
130096725|NCT03735680|468311079|FG001|Overall Study|Withdrawal by Subject|1|||
130096726|NCT03735680|468311080|FG002|Overall Study|Withdrawal by Subject|0|||
130096727|NCT03735680|468311081|FG003|Overall Study|Withdrawal by Subject|0|||
130096728|NCT03735680|468311082|FG004|Overall Study|Withdrawal by Subject|0|||
130096729|NCT03735680|468311083|FG005|Overall Study|Withdrawal by Subject|1|||
130096730|NCT03735680|468311078|FG000|Overall Study|Patient unable or unwilling to continue|0|||
130096731|NCT03735680|468311079|FG001|Overall Study|Patient unable or unwilling to continue|0|||
130096732|NCT03735680|468311080|FG002|Overall Study|Patient unable or unwilling to continue|1|||
130096733|NCT03735680|468311081|FG003|Overall Study|Patient unable or unwilling to continue|0|||
130096734|NCT03735680|468311082|FG004|Overall Study|Patient unable or unwilling to continue|0|||
130096735|NCT03735680|468311083|FG005|Overall Study|Patient unable or unwilling to continue|0|||
130096736|NCT01422876|468311085|FG000|Week 24|Lost to Follow-up|1|||
130096737|NCT01422876|468311086|FG001|Week 24|Lost to Follow-up|1|||
130096738|NCT01422876|468311087|FG002|Week 24|Lost to Follow-up|2|||
130096739|NCT01422876|468311088|FG003|Week 24|Lost to Follow-up|4|||
130096740|NCT01422876|468311089|FG004|Week 24|Lost to Follow-up|2|||
130096741|NCT01422876|468311090|FG005|Week 24|Lost to Follow-up|0|||
130096742|NCT01422876|468311091|FG006|Week 24|Lost to Follow-up|1|||
130096743|NCT01422876|468311092|FG007|Week 24|Lost to Follow-up|3|||
130096744|NCT01422876|468311093|FG008|Week 24|Lost to Follow-up|3|||
130096745|NCT01422876|468311094|FG009|Week 24|Lost to Follow-up|4|||
130096746|NCT01422876|468311085|FG000|Week 24|Consent withdrawn|5|||
130096747|NCT01422876|468311086|FG001|Week 24|Consent withdrawn|1|||
130096748|NCT01422876|468311087|FG002|Week 24|Consent withdrawn|3|||
130096749|NCT01422876|468311088|FG003|Week 24|Consent withdrawn|4|||
130096750|NCT01422876|468311089|FG004|Week 24|Consent withdrawn|5|||
130208626|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Death|1|||
130208627|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Death|0|||
130208628|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130208629|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
130208630|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130208631|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
130208632|NCT01179737|468725140|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
130208633|NCT01179737|468725141|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
130096751|NCT01422876|468311090|FG005|Week 24|Consent withdrawn|6|||
130096752|NCT01422876|468311091|FG006|Week 24|Consent withdrawn|5|||
130096753|NCT01422876|468311092|FG007|Week 24|Consent withdrawn|4|||
130096754|NCT01422876|468311093|FG008|Week 24|Consent withdrawn|3|||
130096755|NCT01422876|468311094|FG009|Week 24|Consent withdrawn|6|||
130096756|NCT01422876|468311085|FG000|Week 24|Death|0|||
130096757|NCT01422876|468311086|FG001|Week 24|Death|1|||
130096758|NCT01422876|468311087|FG002|Week 24|Death|0|||
130096759|NCT01422876|468311088|FG003|Week 24|Death|0|||
130096760|NCT01422876|468311089|FG004|Week 24|Death|0|||
130096761|NCT01422876|468311090|FG005|Week 24|Death|0|||
130096762|NCT01422876|468311091|FG006|Week 24|Death|0|||
130096763|NCT01422876|468311092|FG007|Week 24|Death|0|||
130096764|NCT01422876|468311093|FG008|Week 24|Death|0|||
130096765|NCT01422876|468311094|FG009|Week 24|Death|0|||
130096766|NCT01422876|468311085|FG000|Week 52|Lost to Follow-up|3|||
130096767|NCT01422876|468311086|FG001|Week 52|Lost to Follow-up|5|||
130096768|NCT01422876|468311087|FG002|Week 52|Lost to Follow-up|7|||
130096769|NCT01422876|468311088|FG003|Week 52|Lost to Follow-up|5|||
130096770|NCT01422876|468311089|FG004|Week 52|Lost to Follow-up|8|||
130096771|NCT01422876|468311090|FG005|Week 52|Lost to Follow-up|5|||
130096772|NCT01422876|468311091|FG006|Week 52|Lost to Follow-up|5|||
130096773|NCT01422876|468311092|FG007|Week 52|Lost to Follow-up|8|||
130096774|NCT01422876|468311093|FG008|Week 52|Lost to Follow-up|7|||
130096775|NCT01422876|468311094|FG009|Week 52|Lost to Follow-up|8|||
130096776|NCT01422876|468311085|FG000|Week 52|Consent withdrawn|9|||
130096777|NCT01422876|468311086|FG001|Week 52|Consent withdrawn|4|||
130096778|NCT01422876|468311087|FG002|Week 52|Consent withdrawn|6|||
130096779|NCT01422876|468311088|FG003|Week 52|Consent withdrawn|12|||
130096780|NCT01422876|468311089|FG004|Week 52|Consent withdrawn|7|||
130096781|NCT01422876|468311090|FG005|Week 52|Consent withdrawn|12|||
130096782|NCT01422876|468311091|FG006|Week 52|Consent withdrawn|10|||
130096783|NCT01422876|468311092|FG007|Week 52|Consent withdrawn|12|||
130096784|NCT01422876|468311093|FG008|Week 52|Consent withdrawn|13|||
130096785|NCT01422876|468311094|FG009|Week 52|Consent withdrawn|9|||
130096786|NCT01422876|468311085|FG000|Week 52|Death|0|||
130096787|NCT01422876|468311086|FG001|Week 52|Death|1|||
130096788|NCT01422876|468311087|FG002|Week 52|Death|0|||
130096789|NCT01422876|468311088|FG003|Week 52|Death|1|||
130096790|NCT01422876|468311089|FG004|Week 52|Death|0|||
130096791|NCT01422876|468311090|FG005|Week 52|Death|0|||
130096792|NCT01422876|468311091|FG006|Week 52|Death|1|||
130096793|NCT01422876|468311092|FG007|Week 52|Death|3|||
130096794|NCT01422876|468311093|FG008|Week 52|Death|1|||
130096795|NCT01422876|468311094|FG009|Week 52|Death|0|||
130096796|NCT00536991|468311106|FG000|Overall Study|Withdrawal by Subject|10|||
130096797|NCT00536991|468311106|FG000|Overall Study|Physician Decision|1|||
130096798|NCT00536991|468311106|FG000|Overall Study|patient ineligible|2|||
130096799|NCT00054639|468311107|FG000|Overall Study|Lack of Efficacy|1|||
130096800|NCT00054639|468311107|FG000|Overall Study|Physician Decision|1|||
130096801|NCT01600755|468311108|FG000|Overall Study|Withdrawal by Subject|6|||
130096802|NCT04621227|468311117|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
130096803|NCT04621227|468311117|FG000|Period 3 (29 Days)|Adverse Event|1|||
130096804|NCT04621227|468311117|FG000|Period 8 (2 Days)|Adverse Event|1|||
130096805|NCT01548573|468311118|FG000|Overall Study|Death|3|||
130096806|NCT01548573|468311118|FG000|Overall Study|Withdrawal by Subject|2|||
130096807|NCT01366846|468311121|FG000|Overall Study|Withdrawal by Subject|2|||
130096808|NCT01366846|468311122|FG001|Overall Study|Withdrawal by Subject|0|||
130096809|NCT01366846|468311123|FG002|Overall Study|Withdrawal by Subject|0|||
130096810|NCT01366846|468311124|FG003|Overall Study|Withdrawal by Subject|0|||
130096811|NCT01366846|468311121|FG000|Overall Study|Communication Difficulties|1|||
130096812|NCT01366846|468311122|FG001|Overall Study|Communication Difficulties|4|||
130096813|NCT01366846|468311123|FG002|Overall Study|Communication Difficulties|0|||
130096814|NCT01366846|468311124|FG003|Overall Study|Communication Difficulties|1|||
130096815|NCT01366846|468311121|FG000|Overall Study|Scheduling Conflicts|0|||
130096816|NCT01366846|468311122|FG001|Overall Study|Scheduling Conflicts|0|||
130096817|NCT01366846|468311123|FG002|Overall Study|Scheduling Conflicts|1|||
130096818|NCT01366846|468311124|FG003|Overall Study|Scheduling Conflicts|0|||
130096819|NCT00558831|468311125|FG000|Overall Study|Lost to Follow-up|1|||
130096820|NCT00447265|468311126|FG000|Overall Study|Physician Decision|1|||
130096821|NCT00447265|468311127|FG001|Overall Study|Physician Decision|0|||
130096822|NCT02204449|468311130|FG000|Overall Study|Lost to Follow-up|7|||
130096823|NCT02204449|468311131|FG001|Overall Study|Lost to Follow-up|9|||
130096824|NCT02204449|468311130|FG000|Overall Study|Death|0|||
130096825|NCT02204449|468311131|FG001|Overall Study|Death|1|||
130096826|NCT02204449|468311130|FG000|Overall Study|Withdrawal by Subject|0|||
130096827|NCT02204449|468311131|FG001|Overall Study|Withdrawal by Subject|1|||
130096828|NCT00503035|468311132|FG000|Overall Study|Lost to Follow-up|2|||
130096829|NCT00503035|468311132|FG000|Overall Study|Physician Decision|3|||
130096830|NCT00503035|468311132|FG000|Overall Study|Ineligible|15|||
130096831|NCT05028816|468311135|FG000|Overall Study|Lost to Follow-up|5|||
130096832|NCT05028816|468311136|FG001|Overall Study|Lost to Follow-up|3|||
130096833|NCT05028816|468311135|FG000|Overall Study|Withdrawal by Subject|4|||
130096834|NCT05028816|468311136|FG001|Overall Study|Withdrawal by Subject|1|||
130096835|NCT05028816|468311135|FG000|Overall Study|Physician Decision|1|||
130096836|NCT05028816|468311136|FG001|Overall Study|Physician Decision|0|||
130096837|NCT05064436|468311137|FG000|Overall Study|Other Reasons|1|||
130096838|NCT05064436|468311138|FG001|Overall Study|Other Reasons|0|||
130096839|NCT01711736|468311140|FG000|Overall Study|Lost to Follow-up|4|||
130096840|NCT01711736|468311141|FG001|Overall Study|Lost to Follow-up|1|||
130096841|NCT01711736|468311140|FG000|Overall Study|Withdrawal by Subject|6|||
130096842|NCT01711736|468311141|FG001|Overall Study|Withdrawal by Subject|6|||
130096843|NCT01711736|468311140|FG000|Overall Study|Migrated/moved from study area|2|||
130096844|NCT01711736|468311141|FG001|Overall Study|Migrated/moved from study area|1|||
130096845|NCT01342445|468311142|FG000|Overall Study|Experienced side effects|0|||
130096846|NCT01342445|468311143|FG001|Overall Study|Experienced side effects|2|||
130096847|NCT05299359|468311144|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
130096848|NCT05299359|468311145|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
130096849|NCT05299359|468311144|FG000|Main Part: Day 1 up to Day 366|Other|2|||
130096850|NCT05299359|468311145|FG001|Main Part: Day 1 up to Day 366|Other|0|||
130096851|NCT05299359|468311144|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
130096852|NCT05299359|468311145|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
130096853|NCT05299359|468311144|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
130096854|NCT05299359|468311145|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
130096855|NCT05299359|468311144|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
130096856|NCT05299359|468311145|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
130096857|NCT05299359|468311144|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
130096858|NCT05299359|468311145|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
130096859|NCT05299359|468311144|FG000|Extension Part: Day 1 to Day 366|Other|0|||
130096860|NCT05299359|468311145|FG001|Extension Part: Day 1 to Day 366|Other|1|||
130096861|NCT03868410|468311146|FG000|Overall Study|Physician Decision|0|||
130096862|NCT03868410|468311147|FG001|Overall Study|Physician Decision|1|||
130096863|NCT01059175|468311148|FG000|Overall Study|Death|17|||
130096864|NCT01059175|468311149|FG001|Overall Study|Death|17|||
130096865|NCT01059175|468311148|FG000|Overall Study|Adverse Event|4|||
130096866|NCT01059175|468311149|FG001|Overall Study|Adverse Event|2|||
130096867|NCT01059175|468311148|FG000|Overall Study|Lost to Follow-up|0|||
130096868|NCT01059175|468311149|FG001|Overall Study|Lost to Follow-up|1|||
130096869|NCT00643006|468311153|FG000|Overall Study|Lost to Follow-up|5|||
130096870|NCT00643006|468311154|FG001|Overall Study|Lost to Follow-up|4|||
130096871|NCT02506101|468311155|FG000|Overall Study|Transportation issues|1|||
130096872|NCT02506101|468311156|FG001|Overall Study|Transportation issues|0|||
130208634|NCT01179737|468725142|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
130208635|NCT01179737|468725143|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
130096873|NCT02506101|468311155|FG000|Overall Study|No enrollment and staff unavailability|1|||
130096874|NCT02506101|468311156|FG001|Overall Study|No enrollment and staff unavailability|0|||
130096875|NCT01151085|468311158|FG000|Overall Study|Lost to Follow-up|31|||
130096876|NCT01151085|468311158|FG000|Overall Study|Protocol Violation|25|||
130096877|NCT01308476|468311159|FG000|Overall Study|Lost to Follow-up|2|||
130096878|NCT01308476|468311160|FG001|Overall Study|Lost to Follow-up|2|||
130096879|NCT01308476|468311159|FG000|Overall Study|Other|1|||
130096880|NCT01308476|468311160|FG001|Overall Study|Other|0|||
130096881|NCT00812968|468311161|FG000|Overall Study|Relapse after erythroid response|6|||
130096882|NCT00812968|468311161|FG000|Overall Study|Disease progression|1|||
130096883|NCT00812968|468311161|FG000|Overall Study|No further treatment required|1|||
130096884|NCT00812968|468311161|FG000|Overall Study|Study closed due to marketing approval|3|||
130096885|NCT01243762|468311169|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130096886|NCT01243762|468311170|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
130096887|NCT01243762|468311171|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130096888|NCT01243762|468311172|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130096889|NCT01243762|468311173|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
130096890|NCT01243762|468311174|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
130096891|NCT01243762|468311175|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
130096892|NCT01243762|468311169|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130096893|NCT01243762|468311170|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
130096894|NCT01243762|468311171|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130096895|NCT01243762|468311172|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
130096896|NCT01243762|468311173|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130096897|NCT01243762|468311174|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130096898|NCT01243762|468311175|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
130096899|NCT01243762|468311169|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
130096900|NCT01243762|468311170|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
130096901|NCT01243762|468311171|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
130096902|NCT01243762|468311172|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
130096903|NCT01243762|468311173|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
130096904|NCT01243762|468311174|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
130096905|NCT01243762|468311175|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
130096906|NCT01243762|468311169|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130096907|NCT01243762|468311170|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
130096908|NCT01243762|468311171|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130096909|NCT01243762|468311172|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130096910|NCT01243762|468311173|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130096911|NCT01243762|468311174|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130096912|NCT01243762|468311175|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
130096913|NCT01243762|468311169|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130096914|NCT01243762|468311170|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
130096915|NCT01243762|468311171|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130096916|NCT01243762|468311172|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130096917|NCT01243762|468311173|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130096918|NCT01243762|468311174|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
130096919|NCT01243762|468311175|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
130096920|NCT01243762|468311169|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
130096921|NCT01243762|468311170|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
130096922|NCT01243762|468311171|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
130096923|NCT01243762|468311172|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
130096924|NCT01243762|468311173|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
130096925|NCT01243762|468311174|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
130096926|NCT01243762|468311175|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
130096927|NCT01243762|468311169|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130096928|NCT01243762|468311170|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
130096929|NCT01243762|468311171|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130096930|NCT01243762|468311172|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130096931|NCT01243762|468311173|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
130096932|NCT01243762|468311174|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130096933|NCT01243762|468311175|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
130096934|NCT01243762|468311169|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130096935|NCT01243762|468311170|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130096936|NCT01243762|468311171|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130096937|NCT01243762|468311172|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
130096938|NCT01243762|468311173|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
130096939|NCT01243762|468311174|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130096940|NCT01243762|468311175|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
130096941|NCT04196023|468311176|FG000|Overall Study|Withdrawal by Subject|0|||
130096942|NCT04196023|468311177|FG001|Overall Study|Withdrawal by Subject|1|||
130096943|NCT04196023|468311176|FG000|Overall Study|Adverse Event|3|||
130096944|NCT04196023|468311177|FG001|Overall Study|Adverse Event|1|||
130096945|NCT04196023|468311176|FG000|Overall Study|Lost to Follow-up|0|||
130096946|NCT04196023|468311177|FG001|Overall Study|Lost to Follow-up|1|||
130096947|NCT04359758|468311182|FG000|Overall Study|Protocol Violation|3|||
130096948|NCT04359758|468311183|FG001|Overall Study|Protocol Violation|2|||
130096949|NCT03358407|468311184|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096950|NCT03358407|468311185|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096951|NCT03358407|468311186|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
130096952|NCT03358407|468311187|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096953|NCT03358407|468311188|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096954|NCT03358407|468311189|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096955|NCT03358407|468311190|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096956|NCT03358407|468311191|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130208636|NCT01179737|468725140|FG000|Extension|The study was terminated|3|||
130208637|NCT01179737|468725141|FG001|Extension|The study was terminated|0|||
130208638|NCT01179737|468725142|FG002|Extension|The study was terminated|0|||
130208639|NCT01179737|468725143|FG003|Extension|The study was terminated|0|||
130208640|NCT01546038|468725144|FG000|Overall Study|Death|15|||
130208641|NCT01546038|468725145|FG001|Overall Study|Death|6|||
130208642|NCT01546038|468725146|FG002|Overall Study|Death|4|||
130208643|NCT01546038|468725147|FG003|Overall Study|Death|2|||
130208644|NCT01546038|468725148|FG004|Overall Study|Death|9|||
130208645|NCT01546038|468725149|FG005|Overall Study|Death|3|||
130208646|NCT01546038|468725150|FG006|Overall Study|Death|46|||
130208647|NCT01546038|468725151|FG007|Overall Study|Death|76|||
130208648|NCT01546038|468725152|FG008|Overall Study|Death|39|||
130208649|NCT01546038|468725144|FG000|Overall Study|Lost to Follow-up|0|||
130208650|NCT01546038|468725145|FG001|Overall Study|Lost to Follow-up|0|||
130208651|NCT01546038|468725146|FG002|Overall Study|Lost to Follow-up|0|||
130208652|NCT01546038|468725147|FG003|Overall Study|Lost to Follow-up|0|||
130208653|NCT01546038|468725148|FG004|Overall Study|Lost to Follow-up|1|||
130208654|NCT01546038|468725149|FG005|Overall Study|Lost to Follow-up|0|||
130208655|NCT01546038|468725150|FG006|Overall Study|Lost to Follow-up|2|||
130208656|NCT01546038|468725151|FG007|Overall Study|Lost to Follow-up|1|||
130208657|NCT01546038|468725152|FG008|Overall Study|Lost to Follow-up|0|||
130208658|NCT01546038|468725144|FG000|Overall Study|Withdrawal by Subject|1|||
130208659|NCT01546038|468725145|FG001|Overall Study|Withdrawal by Subject|0|||
130319136|NCT00001832|469135431|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
130208660|NCT01546038|468725146|FG002|Overall Study|Withdrawal by Subject|0|||
130208661|NCT01546038|468725147|FG003|Overall Study|Withdrawal by Subject|1|||
130208662|NCT01546038|468725148|FG004|Overall Study|Withdrawal by Subject|0|||
130208663|NCT01546038|468725149|FG005|Overall Study|Withdrawal by Subject|1|||
130208664|NCT01546038|468725150|FG006|Overall Study|Withdrawal by Subject|3|||
130208665|NCT01546038|468725151|FG007|Overall Study|Withdrawal by Subject|3|||
130208666|NCT01546038|468725152|FG008|Overall Study|Withdrawal by Subject|1|||
130208667|NCT01546038|468725144|FG000|Overall Study|: Randomized, not treated|0|||
130208668|NCT01546038|468725145|FG001|Overall Study|: Randomized, not treated|0|||
130208669|NCT01546038|468725146|FG002|Overall Study|: Randomized, not treated|0|||
130096957|NCT03358407|468311192|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096958|NCT03358407|468311193|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
130096959|NCT03358407|468311184|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096960|NCT03358407|468311185|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130208670|NCT01546038|468725147|FG003|Overall Study|: Randomized, not treated|0|||
130208671|NCT01546038|468725148|FG004|Overall Study|: Randomized, not treated|0|||
130208672|NCT01546038|468725149|FG005|Overall Study|: Randomized, not treated|0|||
130208673|NCT01546038|468725150|FG006|Overall Study|: Randomized, not treated|2|||
130208674|NCT01546038|468725151|FG007|Overall Study|: Randomized, not treated|4|||
130208675|NCT01546038|468725152|FG008|Overall Study|: Randomized, not treated|3|||
130208676|NCT04245202|468725153|FG000|Overall Study|Lack of Efficacy|10|||
130208677|NCT04245202|468725154|FG001|Overall Study|Lack of Efficacy|1|||
130208678|NCT02470403|468725155|FG000|Overall Study|Adverse Event|1|||
130208679|NCT02470403|468725156|FG001|Overall Study|Adverse Event|0|||
130208680|NCT02470403|468725157|FG002|Overall Study|Adverse Event|0|||
130208681|NCT02470403|468725158|FG003|Overall Study|Adverse Event|0|||
130208682|NCT02470403|468725159|FG004|Overall Study|Adverse Event|0|||
130208683|NCT02470403|468725155|FG000|Overall Study|Lost to Follow-up|0|||
130208684|NCT02470403|468725156|FG001|Overall Study|Lost to Follow-up|1|||
130208685|NCT02470403|468725157|FG002|Overall Study|Lost to Follow-up|0|||
130208686|NCT02470403|468725158|FG003|Overall Study|Lost to Follow-up|0|||
130208687|NCT02470403|468725159|FG004|Overall Study|Lost to Follow-up|0|||
130096961|NCT03358407|468311186|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096962|NCT03358407|468311187|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096963|NCT03358407|468311188|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130096964|NCT03358407|468311189|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096965|NCT03358407|468311190|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096966|NCT03358407|468311191|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096967|NCT03358407|468311192|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096968|NCT03358407|468311193|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130208688|NCT02470403|468725155|FG000|Overall Study|Subject/guardian decision|1|||
130208689|NCT02470403|468725156|FG001|Overall Study|Subject/guardian decision|0|||
130208690|NCT02470403|468725157|FG002|Overall Study|Subject/guardian decision|0|||
130096969|NCT03358407|468311184|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096970|NCT03358407|468311185|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096971|NCT03358407|468311186|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096972|NCT03358407|468311187|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096973|NCT03358407|468311188|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096974|NCT03358407|468311189|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
130096975|NCT03358407|468311190|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096976|NCT03358407|468311191|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
130096977|NCT03358407|468311192|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130096978|NCT03358407|468311193|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
130208691|NCT02470403|468725158|FG003|Overall Study|Subject/guardian decision|4|||
130208692|NCT02470403|468725159|FG004|Overall Study|Subject/guardian decision|0|||
130208693|NCT00717275|468725160|FG000|Overall Study|Premature study termination.|3|||
130208694|NCT03329248|468725163|FG000|Overall Study|Progressive Disease|6|||
130208695|NCT01254721|468725168|FG000|Overall Study|Lost to Follow-up|0|||
130208696|NCT01254721|468725169|FG001|Overall Study|Lost to Follow-up|4|||
130096979|NCT03358407|468311184|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096980|NCT03358407|468311185|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096981|NCT03358407|468311186|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096982|NCT03358407|468311187|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096983|NCT03358407|468311188|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096984|NCT03358407|468311189|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
130096985|NCT03358407|468311190|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130208697|NCT01254721|468725168|FG000|Overall Study|Lack of Efficacy|4|||
130208698|NCT01254721|468725169|FG001|Overall Study|Lack of Efficacy|2|||
129985697|NCT04811131|467909333|FG000|Overall Study|Adverse Event|0|||
130208699|NCT01254721|468725168|FG000|Overall Study|Death|0|||
130208700|NCT01254721|468725169|FG001|Overall Study|Death|1|||
130096986|NCT03358407|468311191|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
130096987|NCT03358407|468311192|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096988|NCT03358407|468311193|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
130096989|NCT03358407|468311184|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096990|NCT03358407|468311185|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096991|NCT03358407|468311186|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096992|NCT03358407|468311187|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096993|NCT03358407|468311188|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096994|NCT03358407|468311189|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130096995|NCT03358407|468311190|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
130096996|NCT03358407|468311191|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096997|NCT03358407|468311192|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096998|NCT03358407|468311193|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
130096999|NCT03358407|468311184|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097000|NCT03358407|468311185|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097001|NCT03358407|468311186|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097002|NCT03358407|468311187|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097003|NCT03358407|468311188|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097004|NCT03358407|468311189|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
130097005|NCT03358407|468311190|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
130097006|NCT03358407|468311191|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
130097007|NCT03358407|468311192|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097008|NCT03358407|468311193|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
130097009|NCT03605758|468311194|FG000|Overall Study|Lost to Follow-up|2|||
130097010|NCT03605758|468311195|FG001|Overall Study|Lost to Follow-up|1|||
130097011|NCT03605758|468311194|FG000|Overall Study|Illness|0|||
130097012|NCT03605758|468311195|FG001|Overall Study|Illness|1|||
130097013|NCT03605758|468311194|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
130097014|NCT03605758|468311195|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
130097015|NCT04753606|468311196|FG000|Overall Study|Adverse Event|1|||
130097016|NCT04753606|468311197|FG001|Overall Study|Adverse Event|0|||
130097017|NCT04753606|468311198|FG002|Overall Study|Adverse Event|0|||
130097018|NCT00489411|468311199|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
130097019|NCT00489411|468311200|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
130097020|NCT00489411|468311199|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
130097021|NCT00489411|468311200|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
130097022|NCT00489411|468311199|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
130097023|NCT00489411|468311200|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
130097024|NCT00489411|468311199|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
130097025|NCT00489411|468311200|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
130097026|NCT00489411|468311199|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
130097027|NCT00489411|468311200|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
130097028|NCT01283009|468311201|FG000|Overall Study|Death|83|||
130097029|NCT01283009|468311202|FG001|Overall Study|Death|78|||
130097030|NCT01283009|468311201|FG000|Overall Study|Study ended early|23|||
130208701|NCT01254721|468725168|FG000|Overall Study|technical problum|1|||
130208702|NCT01254721|468725169|FG001|Overall Study|technical problum|0|||
130208703|NCT01254721|468725168|FG000|Overall Study|Adverse Event|2|||
130208704|NCT01254721|468725169|FG001|Overall Study|Adverse Event|3|||
130208705|NCT01254721|468725168|FG000|Overall Study|Withdrawal by Subject|8|||
130208706|NCT01254721|468725169|FG001|Overall Study|Withdrawal by Subject|11|||
130208707|NCT01254721|468725168|FG000|Overall Study|Wrongly randomization|0|||
130208708|NCT01254721|468725169|FG001|Overall Study|Wrongly randomization|1|||
130208709|NCT00987402|468725170|FG000|Overall Study|Insufficient data entry|86|||
130208710|NCT00987402|468725171|FG001|Overall Study|Insufficient data entry|98|||
130097031|NCT01283009|468311202|FG001|Overall Study|Study ended early|26|||
130097032|NCT01283009|468311201|FG000|Overall Study|Withdrawal by Subject|10|||
130097033|NCT01283009|468311202|FG001|Overall Study|Withdrawal by Subject|8|||
130097034|NCT01283009|468311201|FG000|Overall Study|Physician Decision|1|||
130097035|NCT01283009|468311202|FG001|Overall Study|Physician Decision|1|||
130097036|NCT01283009|468311201|FG000|Overall Study|Lost to Follow-up|1|||
130097037|NCT01283009|468311202|FG001|Overall Study|Lost to Follow-up|0|||
130097038|NCT01283009|468311201|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
130097039|NCT01283009|468311202|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
130097040|NCT01748162|468311203|FG000|Overall Study|no additional croup episodes to evaluate|2|||
130097041|NCT01748162|468311204|FG001|Overall Study|no additional croup episodes to evaluate|2|||
130097042|NCT01748162|468311203|FG000|Overall Study|participant consented but did not begin|0|||
130208711|NCT01362517|468725172|FG000|Overall Study|Protocol Violation|1|||
130097043|NCT01748162|468311204|FG001|Overall Study|participant consented but did not begin|1|||
130097044|NCT01748162|468311203|FG000|Overall Study|reasons not available|3|||
130097045|NCT01748162|468311204|FG001|Overall Study|reasons not available|2|||
130097046|NCT03841331|468311205|FG000|Overall Study|Withdrawal by Subject|4|||
130208712|NCT01362517|468725172|FG000|Overall Study|Lost to Follow-up|1|||
130208713|NCT01121536|468725174|FG000|Overall Study|Adverse Event|63|||
130208714|NCT01121536|468725174|FG000|Overall Study|Lack of Efficacy|35|||
130208715|NCT01121536|468725174|FG000|Overall Study|Withdrawal by Subject|65|||
130208716|NCT01121536|468725174|FG000|Overall Study|Protocol Violation|20|||
130208717|NCT01121536|468725174|FG000|Overall Study|Noncompliance with study medication|12|||
130208718|NCT01121536|468725174|FG000|Overall Study|Noncompliance with study procedures|9|||
130208719|NCT01121536|468725174|FG000|Overall Study|Lost to Follow-up|39|||
130208720|NCT01121536|468725174|FG000|Overall Study|Other|118|||
130208721|NCT00568334|468725175|FG000|Overall Study|Withdrawal by Subject|0|||
130208722|NCT00568334|468725176|FG001|Overall Study|Withdrawal by Subject|1|||
130208723|NCT00568334|468725175|FG000|Overall Study|Lost to Follow-up|1|||
130208724|NCT00568334|468725176|FG001|Overall Study|Lost to Follow-up|0|||
130097047|NCT03841331|468311206|FG001|Overall Study|Withdrawal by Subject|9|||
130097048|NCT03841331|468311205|FG000|Overall Study|Lost to Follow-up|5|||
130097049|NCT03841331|468311206|FG001|Overall Study|Lost to Follow-up|1|||
130097050|NCT02743117|468311207|FG000|Overall Study|Lost to Follow-up|0|||
130097051|NCT02743117|468311208|FG001|Overall Study|Lost to Follow-up|1|||
130097052|NCT02743117|468311207|FG000|Overall Study|Other|1|||
130097053|NCT02743117|468311208|FG001|Overall Study|Other|0|||
130097054|NCT01207219|468311209|FG000|Overall Study|changed diagnosis during study period|5|||
130097055|NCT01207219|468311210|FG001|Overall Study|changed diagnosis during study period|3|||
130097056|NCT01207219|468311211|FG002|Overall Study|changed diagnosis during study period|1|||
130097057|NCT01207219|468311209|FG000|Overall Study|Lost to Follow-up|6|||
130097058|NCT01207219|468311210|FG001|Overall Study|Lost to Follow-up|8|||
130097059|NCT01207219|468311211|FG002|Overall Study|Lost to Follow-up|6|||
130097060|NCT03532048|468311218|FG000|Overall Study|Lost to Follow-up|12|||
130097061|NCT03532048|468311219|FG001|Overall Study|Lost to Follow-up|17|||
130097062|NCT03532048|468311218|FG000|Overall Study|Withdrawal by Subject|7|||
130097063|NCT03532048|468311219|FG001|Overall Study|Withdrawal by Subject|0|||
130097064|NCT01725217|468311222|FG000|Overall Study|Withdrawal by Subject|1|||
130097065|NCT01725217|468311223|FG001|Overall Study|Withdrawal by Subject|0|||
130097066|NCT01725217|468311224|FG002|Overall Study|Withdrawal by Subject|0|||
130097067|NCT00596466|468311229|FG000|Overall Study|Lack of Efficacy|5|||
130097068|NCT00596466|468311229|FG000|Overall Study|Adverse Event|4|||
130097069|NCT00596466|468311229|FG000|Overall Study|Withdrawal by Subject|2|||
130097070|NCT00596466|468311229|FG000|Overall Study|Protocol Violation|2|||
130097071|NCT00596466|468311229|FG000|Overall Study|Unpecified|2|||
130097072|NCT00596466|468311229|FG000|Overall Study|Enrolled, not treated|2|||
130097073|NCT01396434|468311233|FG000|Overall Study|Lost to Follow-up|1|||
130097074|NCT01396434|468311234|FG001|Overall Study|Lost to Follow-up|0|||
130097075|NCT01396434|468311235|FG002|Overall Study|Lost to Follow-up|0|||
130097076|NCT01396434|468311233|FG000|Overall Study|Other|10|||
130097077|NCT01396434|468311234|FG001|Overall Study|Other|0|||
130097078|NCT01396434|468311235|FG002|Overall Study|Other|0|||
130097079|NCT04678557|468311236|FG000|Overall Study|Withdrawal by Subject|1|||
130097080|NCT04678557|468311237|FG001|Overall Study|Withdrawal by Subject|0|||
130097081|NCT04678557|468311236|FG000|Overall Study|Lack of Efficacy|0|||
130097082|NCT04678557|468311237|FG001|Overall Study|Lack of Efficacy|13|||
130097083|NCT04678557|468311236|FG000|Overall Study|Safety Evaluation|0|||
130097084|NCT04678557|468311237|FG001|Overall Study|Safety Evaluation|1|||
130097085|NCT02207413|468311238|FG000|Overall Study|Withdrawal by Subject|1|||
130097086|NCT02207413|468311239|FG001|Overall Study|Withdrawal by Subject|0|||
130097087|NCT02207413|468311240|FG002|Overall Study|Withdrawal by Subject|0|||
130097088|NCT02207413|468311241|FG003|Overall Study|Withdrawal by Subject|0|||
130097089|NCT02207413|468311242|FG004|Overall Study|Withdrawal by Subject|3|||
130097090|NCT02207413|468311243|FG005|Overall Study|Withdrawal by Subject|7|||
130097091|NCT02207413|468311238|FG000|Overall Study|Lost to Follow-up|0|||
130097092|NCT02207413|468311239|FG001|Overall Study|Lost to Follow-up|0|||
130097093|NCT02207413|468311240|FG002|Overall Study|Lost to Follow-up|0|||
130097094|NCT02207413|468311241|FG003|Overall Study|Lost to Follow-up|1|||
130097095|NCT02207413|468311242|FG004|Overall Study|Lost to Follow-up|1|||
130097096|NCT02207413|468311243|FG005|Overall Study|Lost to Follow-up|5|||
130097097|NCT02207413|468311238|FG000|Overall Study|Adverse Event|0|||
130097098|NCT02207413|468311239|FG001|Overall Study|Adverse Event|0|||
130097099|NCT02207413|468311240|FG002|Overall Study|Adverse Event|0|||
130097100|NCT02207413|468311241|FG003|Overall Study|Adverse Event|0|||
130097101|NCT02207413|468311242|FG004|Overall Study|Adverse Event|2|||
130097102|NCT02207413|468311243|FG005|Overall Study|Adverse Event|1|||
130097103|NCT02207413|468311238|FG000|Overall Study|Migrated/moved from study area|0|||
130097104|NCT02207413|468311239|FG001|Overall Study|Migrated/moved from study area|0|||
130208725|NCT00306787|468725177|FG000|Overall Study|Discontinued without taking study drug|208|||
130208726|NCT00306787|468725178|FG001|Overall Study|Discontinued without taking study drug|215|||
130097105|NCT02207413|468311240|FG002|Overall Study|Migrated/moved from study area|0|||
130208727|NCT00306787|468725177|FG000|Overall Study|Adverse Event|1|||
130208728|NCT00306787|468725178|FG001|Overall Study|Adverse Event|1|||
130208729|NCT00306787|468725177|FG000|Overall Study|Lack of Efficacy|1|||
130208730|NCT00306787|468725178|FG001|Overall Study|Lack of Efficacy|0|||
130208731|NCT00306787|468725177|FG000|Overall Study|Protocol Violation|8|||
130208732|NCT00306787|468725178|FG001|Overall Study|Protocol Violation|10|||
130208733|NCT00306787|468725177|FG000|Overall Study|Withdrawal by Subject|2|||
130208734|NCT00306787|468725178|FG001|Overall Study|Withdrawal by Subject|9|||
130208735|NCT00306787|468725177|FG000|Overall Study|Lost to Follow-up|9|||
130208736|NCT00306787|468725178|FG001|Overall Study|Lost to Follow-up|6|||
130208737|NCT00306787|468725177|FG000|Overall Study|Administrative problems|4|||
130208738|NCT00306787|468725178|FG001|Overall Study|Administrative problems|0|||
130208739|NCT00306787|468725177|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130208740|NCT00306787|468725178|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130208741|NCT02273908|468725179|FG000|Overall Study|Adverse Event|16|||
130208742|NCT02273908|468725180|FG001|Overall Study|Adverse Event|0|||
130208743|NCT02273908|468725179|FG000|Overall Study|Lost to Follow-up|10|||
130208744|NCT02273908|468725180|FG001|Overall Study|Lost to Follow-up|1|||
130208745|NCT02273908|468725179|FG000|Overall Study|Did not meet entrance criteria|3|||
130208746|NCT02273908|468725180|FG001|Overall Study|Did not meet entrance criteria|2|||
130208747|NCT02273908|468725179|FG000|Overall Study|Withdrawal by Subject|4|||
130208748|NCT02273908|468725180|FG001|Overall Study|Withdrawal by Subject|2|||
130208749|NCT04908475|468725181|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
130208750|NCT04908475|468725182|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208751|NCT04908475|468725183|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208752|NCT04908475|468725184|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208753|NCT04908475|468725185|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208754|NCT04908475|468725186|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130208755|NCT04908475|468725181|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
130208756|NCT04908475|468725182|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208757|NCT04908475|468725183|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208758|NCT04908475|468725184|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208759|NCT04908475|468725185|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208760|NCT04908475|468725186|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
130208761|NCT04908475|468725181|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
130208762|NCT04908475|468725182|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208763|NCT04908475|468725183|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208764|NCT04908475|468725184|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208765|NCT04908475|468725185|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208766|NCT04908475|468725186|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
130208767|NCT04908475|468725181|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130208768|NCT04908475|468725182|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
130208769|NCT04908475|468725183|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
130208770|NCT04908475|468725184|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
130208771|NCT04908475|468725185|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130208772|NCT04908475|468725186|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130208773|NCT04908475|468725181|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
130208774|NCT04908475|468725182|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
130208775|NCT04908475|468725183|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
130208776|NCT04908475|468725184|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
130208777|NCT04908475|468725185|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
130208778|NCT04908475|468725186|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
130208779|NCT04908475|468725181|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
130208780|NCT04908475|468725182|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
130208781|NCT04908475|468725183|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
130208782|NCT04908475|468725184|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
130208783|NCT04908475|468725185|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
130208784|NCT04908475|468725186|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
130208785|NCT03913104|468725189|FG000|Overall Study|Lost to Follow-up|20|||
130208786|NCT03913104|468725189|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
130208787|NCT03913104|468725189|FG000|Overall Study|Withdrawal by Subject|2|||
130208788|NCT01074255|468725190|FG000|Overall Study|Did not receive EMEND|2|||
130208789|NCT01593254|468725191|FG000|Overall Study|Disease progression|2|||
130208790|NCT01593254|468725192|FG001|Overall Study|Disease progression|7|||
130208791|NCT01593254|468725191|FG000|Overall Study|Study drug toxicity|6|||
130208792|NCT01593254|468725192|FG001|Overall Study|Study drug toxicity|20|||
130208793|NCT01593254|468725191|FG000|Overall Study|Death|3|||
130208794|NCT01593254|468725192|FG001|Overall Study|Death|3|||
130208795|NCT01593254|468725191|FG000|Overall Study|AE unrelated to study drug|0|||
130208796|NCT01593254|468725192|FG001|Overall Study|AE unrelated to study drug|1|||
130208797|NCT01593254|468725191|FG000|Overall Study|participant request to discontinue study treatment|1|||
130208798|NCT01593254|468725192|FG001|Overall Study|participant request to discontinue study treatment|3|||
130208799|NCT01593254|468725191|FG000|Overall Study|participant withdrew consent|0|||
130208800|NCT01593254|468725192|FG001|Overall Study|participant withdrew consent|9|||
130208801|NCT01593254|468725191|FG000|Overall Study|lost to follow up|1|||
130208802|NCT01593254|468725192|FG001|Overall Study|lost to follow up|6|||
130208803|NCT01593254|468725191|FG000|Overall Study|maximum clinical benefit|1|||
130208804|NCT01593254|468725192|FG001|Overall Study|maximum clinical benefit|2|||
130208805|NCT01593254|468725191|FG000|Overall Study|Poor/non compliance|1|||
130208806|NCT01593254|468725192|FG001|Overall Study|Poor/non compliance|1|||
130208807|NCT01593254|468725191|FG000|Overall Study|Pregnancy|0|||
130208808|NCT01593254|468725192|FG001|Overall Study|Pregnancy|3|||
130208809|NCT01593254|468725191|FG000|Overall Study|participant no longer meets study criteria|1|||
130208810|NCT01593254|468725192|FG001|Overall Study|participant no longer meets study criteria|1|||
130208811|NCT01593254|468725191|FG000|Overall Study|Admin reason by sponsor|7|||
130208812|NCT01593254|468725192|FG001|Overall Study|Admin reason by sponsor|3|||
130208813|NCT01593254|468725191|FG000|Overall Study|Imatinib treatment failure|2|||
130208814|NCT01593254|468725192|FG001|Overall Study|Imatinib treatment failure|0|||
130208815|NCT01593254|468725191|FG000|Overall Study|Other Reasons|61|||
130208816|NCT01593254|468725192|FG001|Overall Study|Other Reasons|115|||
130208817|NCT01887678|468725193|FG000|Overall Study|Adverse Event|4|||
130208818|NCT01887678|468725194|FG001|Overall Study|Adverse Event|6|||
130208819|NCT01887678|468725193|FG000|Overall Study|Exceeded rescue medication dosage|4|||
130208820|NCT01887678|468725194|FG001|Overall Study|Exceeded rescue medication dosage|5|||
130208821|NCT01887678|468725193|FG000|Overall Study|Withdrawal of consent|3|||
130208822|NCT01887678|468725194|FG001|Overall Study|Withdrawal of consent|4|||
130208823|NCT01887678|468725193|FG000|Overall Study|Lost to Follow-up|4|||
130208824|NCT01887678|468725194|FG001|Overall Study|Lost to Follow-up|2|||
130208825|NCT01887678|468725193|FG000|Overall Study|Deterioration of clinical condition|0|||
130208826|NCT01887678|468725194|FG001|Overall Study|Deterioration of clinical condition|4|||
130208827|NCT01887678|468725193|FG000|Overall Study|Lack of Efficacy|1|||
130208828|NCT01887678|468725194|FG001|Overall Study|Lack of Efficacy|2|||
130208829|NCT01887678|468725193|FG000|Overall Study|Non-compliance|0|||
130208830|NCT01887678|468725194|FG001|Overall Study|Non-compliance|3|||
130208831|NCT01887678|468725193|FG000|Overall Study|Specified|1|||
130208832|NCT01887678|468725194|FG001|Overall Study|Specified|2|||
130208833|NCT00791492|468725195|FG000|Overall Study|Withdrawal by Subject|1|||
130208834|NCT00791492|468725196|FG001|Overall Study|Withdrawal by Subject|2|||
130208835|NCT00791492|468725195|FG000|Overall Study|Liver transplantation|5|||
130208836|NCT00791492|468725196|FG001|Overall Study|Liver transplantation|1|||
130208837|NCT00076999|468725197|FG000|Overall Study|Adverse Event|2|||
130208838|NCT00076999|468725198|FG001|Overall Study|Adverse Event|8|||
130208839|NCT00076999|468725199|FG002|Overall Study|Adverse Event|6|||
130208840|NCT00076999|468725200|FG003|Overall Study|Adverse Event|0|||
130208841|NCT00076999|468725201|FG004|Overall Study|Adverse Event|2|||
130208842|NCT00076999|468725197|FG000|Overall Study|Protocol Violation|0|||
130208843|NCT00076999|468725198|FG001|Overall Study|Protocol Violation|3|||
130208844|NCT00076999|468725199|FG002|Overall Study|Protocol Violation|4|||
130208845|NCT00076999|468725200|FG003|Overall Study|Protocol Violation|0|||
130208846|NCT00076999|468725201|FG004|Overall Study|Protocol Violation|9|||
130208847|NCT00076999|468725197|FG000|Overall Study|Lost to Follow-up|2|||
130208848|NCT00076999|468725198|FG001|Overall Study|Lost to Follow-up|1|||
130208849|NCT00076999|468725199|FG002|Overall Study|Lost to Follow-up|0|||
130208850|NCT00076999|468725200|FG003|Overall Study|Lost to Follow-up|0|||
130208851|NCT00076999|468725201|FG004|Overall Study|Lost to Follow-up|0|||
130208852|NCT00076999|468725197|FG000|Overall Study|Withdrawal by Subject|0|||
130208853|NCT00076999|468725198|FG001|Overall Study|Withdrawal by Subject|4|||
130208854|NCT00076999|468725199|FG002|Overall Study|Withdrawal by Subject|3|||
130208855|NCT00076999|468725200|FG003|Overall Study|Withdrawal by Subject|0|||
130208856|NCT00076999|468725201|FG004|Overall Study|Withdrawal by Subject|1|||
130208857|NCT00076999|468725197|FG000|Overall Study|Other reason (not specified)|8|||
130208858|NCT00076999|468725198|FG001|Overall Study|Other reason (not specified)|8|||
130208859|NCT00076999|468725199|FG002|Overall Study|Other reason (not specified)|4|||
130208860|NCT00076999|468725200|FG003|Overall Study|Other reason (not specified)|1|||
130208861|NCT00076999|468725201|FG004|Overall Study|Other reason (not specified)|13|||
130208862|NCT02603562|468725214|FG000|Overall Study|Lost to Follow-up|1|||
130208863|NCT01380691|468725229|FG000|Washout (7 Days)|Protocol Violation|0|||
130208864|NCT01380691|468725230|FG001|Washout (7 Days)|Protocol Violation|0|||
130208865|NCT01380691|468725231|FG002|Washout (7 Days)|Protocol Violation|0|||
130208866|NCT01380691|468725232|FG003|Washout (7 Days)|Protocol Violation|1|||
130208867|NCT01380691|468725229|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130319137|NCT00001832|469135417|FG000|Treatment Period|Death during treatment|0|||
130208868|NCT01380691|468725230|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
130208869|NCT01380691|468725231|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
130208870|NCT01380691|468725232|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
130208871|NCT01987232|468725233|FG000|Overall Study|Ongoing in Study|0|||
130208872|NCT01987232|468725234|FG001|Overall Study|Ongoing in Study|0|||
130208873|NCT01987232|468725235|FG002|Overall Study|Ongoing in Study|0|||
130208874|NCT01987232|468725236|FG003|Overall Study|Ongoing in Study|1|||
130208875|NCT01987232|468725237|FG004|Overall Study|Ongoing in Study|0|||
130208876|NCT00232596|468725244|FG000|6-Week Titration Phase|Adverse Event|6|||
130208877|NCT00232596|468725245|FG001|6-Week Titration Phase|Adverse Event|19|||
130208878|NCT00232596|468725244|FG000|6-Week Titration Phase|Failed to Return|2|||
130208879|NCT00232596|468725245|FG001|6-Week Titration Phase|Failed to Return|1|||
130208880|NCT00232596|468725244|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
130208881|NCT00232596|468725245|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
130208882|NCT00232596|468725244|FG000|6-Week Titration Phase|Protocol Violation|1|||
130208883|NCT00232596|468725245|FG001|6-Week Titration Phase|Protocol Violation|3|||
130208884|NCT00232596|468725244|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
130208885|NCT00232596|468725245|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
130208886|NCT00232596|468725244|FG000|6-Week Titration Phase|Other|3|||
130208887|NCT00232596|468725245|FG001|6-Week Titration Phase|Other|3|||
130208888|NCT00232596|468725244|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130208889|NCT00232596|468725245|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
130208890|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Adverse Event|7|||
130208891|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Adverse Event|22|||
130208892|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
130208893|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
130208894|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
130208895|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
130208896|NCT00232596|468725244|FG000|12-Week Maintenance Phase|Other|1|||
130208897|NCT00232596|468725245|FG001|12-Week Maintenance Phase|Other|3|||
130208898|NCT03426436|468725246|FG000|Overall Study|Incorrect lead placement|12|||
130208899|NCT03426436|468725246|FG000|Overall Study|Withdrawal by Subject|2|||
130208900|NCT03426436|468725246|FG000|Overall Study|Consent issue|1|||
130208901|NCT03426436|468725246|FG000|Overall Study|ECGs not saved|4|||
130208902|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
130208903|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208904|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208905|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208906|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
130208907|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
130208908|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
130208909|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208910|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208911|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208912|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
130208913|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208914|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208915|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208916|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208917|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208918|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208919|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
130208920|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208921|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208922|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208923|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
130208924|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
130208925|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
130208926|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
130208927|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
130208928|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
130208929|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
130208930|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
130208931|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
130208932|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
130208933|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
130208934|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
130208935|NCT00932698|468725247|FG000|Part 1 (Dose Escalation)|Other|0|||
130208936|NCT00932698|468725248|FG001|Part 1 (Dose Escalation)|Other|0|||
130208937|NCT00932698|468725249|FG002|Part 1 (Dose Escalation)|Other|1|||
130208938|NCT00932698|468725250|FG003|Part 1 (Dose Escalation)|Other|0|||
130208939|NCT00932698|468725251|FG004|Part 1 (Dose Escalation)|Other|0|||
130208940|NCT00932698|468725252|FG005|Part 1 (Dose Escalation)|Other|0|||
130208941|NCT00932698|468725253|FG006|Part 1 (Dose Escalation)|Other|1|||
130208942|NCT00932698|468725254|FG007|Part 1 (Dose Escalation)|Other|0|||
130208943|NCT00932698|468725255|FG008|Part 1 (Dose Escalation)|Other|0|||
130208944|NCT00932698|468725256|FG009|Part 1 (Dose Escalation)|Other|0|||
130208945|NCT00932698|468725257|FG010|Part 1 (Dose Escalation)|Other|0|||
130208946|NCT00932698|468725247|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208947|NCT00932698|468725248|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208948|NCT00932698|468725249|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208949|NCT00932698|468725250|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208950|NCT00932698|468725251|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208951|NCT00932698|468725252|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208952|NCT00932698|468725253|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
130208953|NCT00932698|468725254|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
130208954|NCT00932698|468725255|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
130208955|NCT00932698|468725256|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
130208956|NCT00932698|468725257|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
130208957|NCT00932698|468725247|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208958|NCT00932698|468725248|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208959|NCT00932698|468725249|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208960|NCT00932698|468725250|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208961|NCT00932698|468725251|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208962|NCT00932698|468725252|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208963|NCT00932698|468725253|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208964|NCT00932698|468725254|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
130208965|NCT00932698|468725255|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
130208966|NCT00932698|468725256|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
130208967|NCT00932698|468725257|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
130208968|NCT00932698|468725247|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
130208969|NCT00932698|468725248|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
130208970|NCT00932698|468725249|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
130208971|NCT00932698|468725250|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
130208972|NCT00932698|468725251|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
130208973|NCT00932698|468725252|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
130208974|NCT00932698|468725253|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
130208975|NCT00932698|468725254|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
130208976|NCT00932698|468725255|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
130208977|NCT00932698|468725256|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
130208978|NCT00932698|468725257|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
130208979|NCT00655681|468725258|FG000|Overall Study|Lost to Follow-up|1|||
130208980|NCT00655681|468725259|FG001|Overall Study|Lost to Follow-up|1|||
130208981|NCT02429310|468725260|FG000|Overall Study|Lost to Follow-up|1|||
130208982|NCT02429310|468725261|FG001|Overall Study|Lost to Follow-up|2|||
130208983|NCT02429310|468725260|FG000|Overall Study|Protocol Violation|1|||
130208984|NCT02429310|468725261|FG001|Overall Study|Protocol Violation|1|||
130208985|NCT00394433|468725262|FG000|Overall Study|Adverse Event|2|||
130208986|NCT00394433|468725262|FG000|Overall Study|Alternative Therapy|1|||
130208987|NCT01554176|468725263|FG000|Treatment Phase|Protocol Violation|1|||
130208988|NCT01554176|468725264|FG001|Treatment Phase|Protocol Violation|2|||
130208989|NCT01554176|468725265|FG002|Treatment Phase|Protocol Violation|0|||
130208990|NCT01554176|468725266|FG003|Treatment Phase|Protocol Violation|0|||
130208991|NCT01554176|468725267|FG004|Treatment Phase|Protocol Violation|0|||
130208992|NCT01554176|468725263|FG000|Treatment Phase|Physician Decision|1|||
130208993|NCT01554176|468725264|FG001|Treatment Phase|Physician Decision|1|||
130208994|NCT01554176|468725265|FG002|Treatment Phase|Physician Decision|0|||
130208995|NCT01554176|468725266|FG003|Treatment Phase|Physician Decision|0|||
130208996|NCT01554176|468725267|FG004|Treatment Phase|Physician Decision|0|||
130208997|NCT01554176|468725263|FG000|Treatment Phase|Lack of Efficacy|0|||
130208998|NCT01554176|468725264|FG001|Treatment Phase|Lack of Efficacy|1|||
130208999|NCT01554176|468725265|FG002|Treatment Phase|Lack of Efficacy|0|||
130209000|NCT01554176|468725266|FG003|Treatment Phase|Lack of Efficacy|0|||
130209001|NCT01554176|468725267|FG004|Treatment Phase|Lack of Efficacy|0|||
130209002|NCT01554176|468725263|FG000|Treatment Phase|Adverse event, non-fatal|1|||
130209003|NCT01554176|468725264|FG001|Treatment Phase|Adverse event, non-fatal|1|||
130319138|NCT00001832|469135418|FG001|Treatment Period|Death during treatment|0|||
130319139|NCT00001832|469135419|FG002|Treatment Period|Death during treatment|0|||
130319140|NCT00001832|469135420|FG003|Treatment Period|Death during treatment|0|||
130319141|NCT00001832|469135421|FG004|Treatment Period|Death during treatment|0|||
130319142|NCT00001832|469135422|FG005|Treatment Period|Death during treatment|1|||
130319143|NCT00001832|469135423|FG006|Treatment Period|Death during treatment|0|||
130319144|NCT00001832|469135424|FG007|Treatment Period|Death during treatment|0|||
130209004|NCT01554176|468725265|FG002|Treatment Phase|Adverse event, non-fatal|0|||
130209005|NCT01554176|468725266|FG003|Treatment Phase|Adverse event, non-fatal|0|||
130209006|NCT01554176|468725267|FG004|Treatment Phase|Adverse event, non-fatal|0|||
130209007|NCT01554176|468725263|FG000|Treatment Phase|Non-compliance with study drug|1|||
130209008|NCT01554176|468725264|FG001|Treatment Phase|Non-compliance with study drug|0|||
130209009|NCT01554176|468725265|FG002|Treatment Phase|Non-compliance with study drug|0|||
130209010|NCT01554176|468725266|FG003|Treatment Phase|Non-compliance with study drug|0|||
130209011|NCT01554176|468725267|FG004|Treatment Phase|Non-compliance with study drug|0|||
130209012|NCT01554176|468725263|FG000|Treatment Phase|Withdrawal by Subject|1|||
130319145|NCT00001832|469135425|FG008|Treatment Period|Death during treatment|0|||
130319146|NCT00001832|469135426|FG009|Treatment Period|Death during treatment|0|||
130319147|NCT00001832|469135427|FG010|Treatment Period|Death during treatment|0|||
130319148|NCT00001832|469135428|FG011|Treatment Period|Death during treatment|0|||
130319149|NCT00001832|469135429|FG012|Treatment Period|Death during treatment|0|||
130319150|NCT00001832|469135430|FG013|Treatment Period|Death during treatment|0|||
130319151|NCT00001832|469135431|FG014|Treatment Period|Death during treatment|0|||
130319152|NCT00001832|469135417|FG000|Treatment Period|Not treated|0|||
130319153|NCT00001832|469135418|FG001|Treatment Period|Not treated|0|||
130319154|NCT00001832|469135419|FG002|Treatment Period|Not treated|0|||
130319155|NCT00001832|469135420|FG003|Treatment Period|Not treated|0|||
130319156|NCT00001832|469135421|FG004|Treatment Period|Not treated|0|||
130319157|NCT00001832|469135422|FG005|Treatment Period|Not treated|0|||
130319158|NCT00001832|469135423|FG006|Treatment Period|Not treated|0|||
130319159|NCT00001832|469135424|FG007|Treatment Period|Not treated|1|||
130319160|NCT00001832|469135425|FG008|Treatment Period|Not treated|0|||
130319161|NCT00001832|469135426|FG009|Treatment Period|Not treated|0|||
130319162|NCT00001832|469135427|FG010|Treatment Period|Not treated|0|||
130319163|NCT00001832|469135428|FG011|Treatment Period|Not treated|0|||
130319164|NCT00001832|469135429|FG012|Treatment Period|Not treated|0|||
130319165|NCT00001832|469135430|FG013|Treatment Period|Not treated|0|||
130319166|NCT00001832|469135431|FG014|Treatment Period|Not treated|0|||
130319167|NCT02546609|469135432|FG000|Overall Study|Withdrawal by Subject|0|||
130319168|NCT02546609|469135433|FG001|Overall Study|Withdrawal by Subject|1|||
130319169|NCT02546609|469135434|FG002|Overall Study|Withdrawal by Subject|2|||
130319170|NCT02546609|469135432|FG000|Overall Study|Adverse Event|0|||
130319171|NCT02546609|469135433|FG001|Overall Study|Adverse Event|6|||
130319172|NCT02546609|469135434|FG002|Overall Study|Adverse Event|1|||
130319173|NCT02546609|469135432|FG000|Overall Study|Protocol Violation|0|||
130319174|NCT02546609|469135433|FG001|Overall Study|Protocol Violation|1|||
130319175|NCT02546609|469135434|FG002|Overall Study|Protocol Violation|1|||
130319176|NCT02546609|469135432|FG000|Overall Study|Lost to Follow-up|2|||
130319177|NCT02546609|469135433|FG001|Overall Study|Lost to Follow-up|3|||
130319178|NCT02546609|469135434|FG002|Overall Study|Lost to Follow-up|1|||
130319179|NCT02546609|469135432|FG000|Overall Study|travel or work schedule restriction|0|||
130319180|NCT02546609|469135433|FG001|Overall Study|travel or work schedule restriction|0|||
130319181|NCT02546609|469135434|FG002|Overall Study|travel or work schedule restriction|2|||
130319182|NCT00914849|469135435|FG000|Overall Study|Withdrawal by Subject|1|||
130319183|NCT00914849|469135436|FG001|Overall Study|Withdrawal by Subject|0|||
130319184|NCT00914849|469135435|FG000|Overall Study|Not eligible|0|||
130319185|NCT00914849|469135436|FG001|Overall Study|Not eligible|1|||
130319186|NCT05106959|469135437|FG000|Overall Study|Lost to Follow-up|1|||
130319187|NCT01292486|469135438|FG000|Overall Study|Protocol Violation|2|||
130319188|NCT01292486|469135438|FG000|Overall Study|Did not meet screening criteria|2|||
130319189|NCT01292486|469135438|FG000|Overall Study|Adverse Event|1|||
130319190|NCT01292486|469135438|FG000|Overall Study|Physician Decision|1|||
130319191|NCT04602390|469135439|FG000|Overall Study|Withdrawal by Subject|0|||
130319192|NCT04602390|469135440|FG001|Overall Study|Withdrawal by Subject|0|||
130319193|NCT04602390|469135441|FG002|Overall Study|Withdrawal by Subject|0|||
130319194|NCT04602390|469135442|FG003|Overall Study|Withdrawal by Subject|0|||
130319195|NCT04602390|469135443|FG004|Overall Study|Withdrawal by Subject|1|||
130319196|NCT04602390|469135444|FG005|Overall Study|Withdrawal by Subject|0|||
130319197|NCT04602390|469135439|FG000|Overall Study|Adverse Event|0|||
130319198|NCT04602390|469135440|FG001|Overall Study|Adverse Event|0|||
130319199|NCT04602390|469135441|FG002|Overall Study|Adverse Event|0|||
130319200|NCT04602390|469135442|FG003|Overall Study|Adverse Event|0|||
130319201|NCT04602390|469135443|FG004|Overall Study|Adverse Event|0|||
130319202|NCT04602390|469135444|FG005|Overall Study|Adverse Event|1|||
130319203|NCT01553084|469135445|FG000|Overall Study|Withdrawal by Subject|15|||
130319204|NCT01553084|469135446|FG001|Overall Study|Withdrawal by Subject|13|||
130319205|NCT01553084|469135447|FG002|Overall Study|Withdrawal by Subject|35|||
130319206|NCT03988400|469135448|FG000|Overall Study|Adverse Event|1|||
130319207|NCT03988400|469135449|FG001|Overall Study|Adverse Event|0|||
130319208|NCT03988400|469135448|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
130319209|NCT03988400|469135449|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
130319210|NCT03988400|469135448|FG000|Overall Study|Lost to Follow-up|0|||
130319211|NCT03988400|469135449|FG001|Overall Study|Lost to Follow-up|1|||
130319212|NCT04201431|469135451|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
130319213|NCT04201431|469135452|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
130319214|NCT04201431|469135453|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
130319215|NCT01546857|469135454|FG000|Overall Study|Withdrawal by Subject|2|||
130097106|NCT02207413|468311241|FG003|Overall Study|Migrated/moved from study area|0|||
130097107|NCT02207413|468311242|FG004|Overall Study|Migrated/moved from study area|1|||
130319216|NCT01546857|469135455|FG001|Overall Study|Withdrawal by Subject|3|||
130319217|NCT02358473|469135456|FG000|Overall Study|Disease Progession|6|||
130319218|NCT02358473|469135456|FG000|Overall Study|Adverse Event|3|||
130319219|NCT02358473|469135456|FG000|Overall Study|Withdrawal by Subject|2|||
130209013|NCT01554176|468725264|FG001|Treatment Phase|Withdrawal by Subject|0|||
130209014|NCT01554176|468725265|FG002|Treatment Phase|Withdrawal by Subject|0|||
130209015|NCT01554176|468725266|FG003|Treatment Phase|Withdrawal by Subject|0|||
130209016|NCT01554176|468725267|FG004|Treatment Phase|Withdrawal by Subject|0|||
130209017|NCT01554176|468725263|FG000|Treatment Phase|Lost to Follow-up|3|||
130209018|NCT01554176|468725264|FG001|Treatment Phase|Lost to Follow-up|0|||
130209019|NCT01554176|468725265|FG002|Treatment Phase|Lost to Follow-up|0|||
130209020|NCT01554176|468725266|FG003|Treatment Phase|Lost to Follow-up|0|||
130209021|NCT01554176|468725267|FG004|Treatment Phase|Lost to Follow-up|0|||
130209022|NCT01554176|468725263|FG000|Run-out Phase|Protocol Violation|0|||
130209023|NCT01554176|468725264|FG001|Run-out Phase|Protocol Violation|0|||
130209024|NCT01554176|468725265|FG002|Run-out Phase|Protocol Violation|0|||
130209025|NCT01554176|468725266|FG003|Run-out Phase|Protocol Violation|1|||
130209026|NCT01554176|468725267|FG004|Run-out Phase|Protocol Violation|0|||
130209027|NCT00386425|468725268|FG000|Overall Study|Physician Decision|3|||
130209028|NCT00386425|468725269|FG001|Overall Study|Physician Decision|0|||
130209029|NCT00386425|468725270|FG002|Overall Study|Physician Decision|0|||
130209030|NCT00386425|468725268|FG000|Overall Study|Withdrawal by Subject|0|||
130209031|NCT00386425|468725269|FG001|Overall Study|Withdrawal by Subject|1|||
130209032|NCT00386425|468725270|FG002|Overall Study|Withdrawal by Subject|0|||
130209033|NCT03053427|468725271|FG000|Overall Study|Adverse Event|4|||
130209034|NCT03053427|468725272|FG001|Overall Study|Adverse Event|4|||
130209035|NCT03053427|468725271|FG000|Overall Study|Lack of Efficacy|1|||
130209036|NCT03053427|468725272|FG001|Overall Study|Lack of Efficacy|3|||
130209037|NCT03053427|468725271|FG000|Overall Study|Lost to Follow-up|2|||
130209038|NCT03053427|468725272|FG001|Overall Study|Lost to Follow-up|2|||
130209039|NCT03053427|468725271|FG000|Overall Study|Worsening of the target disease|0|||
130209040|NCT03053427|468725272|FG001|Overall Study|Worsening of the target disease|1|||
130209041|NCT03053427|468725271|FG000|Overall Study|Protocol Deviation|3|||
130209042|NCT03053427|468725272|FG001|Overall Study|Protocol Deviation|3|||
130209043|NCT03053427|468725271|FG000|Overall Study|Withdrawal by Subject|3|||
130209044|NCT03053427|468725272|FG001|Overall Study|Withdrawal by Subject|2|||
130209045|NCT03053427|468725271|FG000|Overall Study|Miscellaneous|0|||
130209046|NCT03053427|468725272|FG001|Overall Study|Miscellaneous|1|||
130209047|NCT02172040|468725276|FG000|Overall Study|Adverse Event|0|||
130209048|NCT02172040|468725277|FG001|Overall Study|Adverse Event|2|||
130209049|NCT02172040|468725278|FG002|Overall Study|Adverse Event|0|||
130209050|NCT02172040|468725279|FG003|Overall Study|Adverse Event|0|||
130209051|NCT02172040|468725276|FG000|Overall Study|Protocol Violation|0|||
130209052|NCT02172040|468725277|FG001|Overall Study|Protocol Violation|1|||
130209053|NCT02172040|468725278|FG002|Overall Study|Protocol Violation|0|||
130209054|NCT02172040|468725279|FG003|Overall Study|Protocol Violation|0|||
130209055|NCT02172040|468725276|FG000|Overall Study|Withdrawal by Subject|0|||
130209056|NCT02172040|468725277|FG001|Overall Study|Withdrawal by Subject|0|||
130209057|NCT02172040|468725278|FG002|Overall Study|Withdrawal by Subject|1|||
130209058|NCT02172040|468725279|FG003|Overall Study|Withdrawal by Subject|0|||
130209059|NCT02172040|468725276|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
130209060|NCT02172040|468725277|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
130209061|NCT02172040|468725278|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
130209062|NCT02172040|468725279|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
130209063|NCT02172040|468725276|FG000|Overall Study|Family emergency abroad|0|||
130209064|NCT02172040|468725277|FG001|Overall Study|Family emergency abroad|0|||
130209065|NCT02172040|468725278|FG002|Overall Study|Family emergency abroad|0|||
130209066|NCT02172040|468725279|FG003|Overall Study|Family emergency abroad|1|||
130209067|NCT01324570|468725286|FG000|Overall Study|Adverse Event|4|||
130209068|NCT01324570|468725287|FG001|Overall Study|Adverse Event|7|||
130209069|NCT01324570|468725286|FG000|Overall Study|Withdrawal by Subject|0|||
130209070|NCT01324570|468725287|FG001|Overall Study|Withdrawal by Subject|3|||
130209071|NCT01324570|468725286|FG000|Overall Study|Lack of Efficacy|0|||
130209072|NCT01324570|468725287|FG001|Overall Study|Lack of Efficacy|1|||
130209073|NCT01324570|468725286|FG000|Overall Study|Confirmed or suspected diversion|0|||
130209074|NCT01324570|468725287|FG001|Overall Study|Confirmed or suspected diversion|1|||
130209075|NCT01324570|468725286|FG000|Overall Study|Administrative|0|||
130209076|NCT01324570|468725287|FG001|Overall Study|Administrative|2|||
130209077|NCT02607306|468725290|FG000|Overall Study|Adverse Event|8|||
130209078|NCT02607306|468725291|FG001|Overall Study|Adverse Event|6|||
130209079|NCT02607306|468725292|FG002|Overall Study|Adverse Event|6|||
130209080|NCT02607306|468725290|FG000|Overall Study|Unclassified|1|||
130209081|NCT02607306|468725291|FG001|Overall Study|Unclassified|4|||
130209082|NCT02607306|468725292|FG002|Overall Study|Unclassified|0|||
130209083|NCT02607306|468725290|FG000|Overall Study|Withdrawal by Subject|8|||
130209084|NCT02607306|468725291|FG001|Overall Study|Withdrawal by Subject|10|||
130209085|NCT02607306|468725292|FG002|Overall Study|Withdrawal by Subject|2|||
130209086|NCT02607306|468725290|FG000|Overall Study|Lack of Efficacy|0|||
130209087|NCT02607306|468725291|FG001|Overall Study|Lack of Efficacy|1|||
130209088|NCT02607306|468725292|FG002|Overall Study|Lack of Efficacy|1|||
130209089|NCT02607306|468725290|FG000|Overall Study|Protocol Violation|4|||
130209090|NCT02607306|468725291|FG001|Overall Study|Protocol Violation|2|||
130209091|NCT02607306|468725292|FG002|Overall Study|Protocol Violation|1|||
130209092|NCT00435019|468725296|FG000|Overall Study|Adverse Event|1|||
130209093|NCT00435019|468725297|FG001|Overall Study|Adverse Event|0|||
130209094|NCT00435019|468725296|FG000|Overall Study|Lack of Efficacy|1|||
130209095|NCT00435019|468725297|FG001|Overall Study|Lack of Efficacy|2|||
130209096|NCT00435019|468725296|FG000|Overall Study|Protocol Violation|3|||
130209097|NCT00435019|468725297|FG001|Overall Study|Protocol Violation|1|||
130209098|NCT00435019|468725296|FG000|Overall Study|Personal reasons for withdrawal|8|||
130209099|NCT00435019|468725297|FG001|Overall Study|Personal reasons for withdrawal|7|||
130209100|NCT01764659|468725303|FG000|Overall Study|Death|1|||
130209101|NCT01764659|468725303|FG000|Overall Study|Physician Decision|1|||
130209102|NCT01298141|468725304|FG000|Overall Study|Adverse Event|3|||
130209103|NCT01298141|468725304|FG000|Overall Study|Refusal of Required Study Procedures|1|||
130209104|NCT01298141|468725304|FG000|Overall Study|Withdrawal by Subject|6|||
130209105|NCT01298141|468725304|FG000|Overall Study|Termination of Study by the Investigator|5|||
130209106|NCT01298141|468725304|FG000|Overall Study|Other|5|||
130209107|NCT01298141|468725304|FG000|Overall Study|Lost to Follow-up|1|||
130209108|NCT01298141|468725304|FG000|Overall Study|Death|6|||
130209109|NCT01298141|468725304|FG000|Overall Study|Not treated|4|||
130209110|NCT01854879|468725308|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
130209111|NCT01854879|468725308|FG000|Overall Study|screen fail|3|||
130209112|NCT01854879|468725308|FG000|Overall Study|incomplete data set|1|||
130209113|NCT01698268|468727169|FG000|Overall Study|Physician Decision|2|||
130209114|NCT01698268|468727170|FG001|Overall Study|Physician Decision|1|||
130209115|NCT00298363|468727171|FG000|Overall Study|Lost to Follow-up|0|||
130209116|NCT00298363|468727172|FG001|Overall Study|Lost to Follow-up|0|||
130209117|NCT00298363|468727173|FG002|Overall Study|Lost to Follow-up|1|||
130209118|NCT00298363|468727171|FG000|Overall Study|Physician Decision|4|||
130209119|NCT00298363|468727172|FG001|Overall Study|Physician Decision|1|||
130209120|NCT00298363|468727173|FG002|Overall Study|Physician Decision|0|||
130209121|NCT00298363|468727171|FG000|Overall Study|Protocol Violation|1|||
130209122|NCT00298363|468727172|FG001|Overall Study|Protocol Violation|1|||
130209123|NCT00298363|468727173|FG002|Overall Study|Protocol Violation|0|||
130209124|NCT00298363|468727171|FG000|Overall Study|Withdrawal by Subject|5|||
130209125|NCT00298363|468727172|FG001|Overall Study|Withdrawal by Subject|1|||
130209126|NCT00298363|468727173|FG002|Overall Study|Withdrawal by Subject|3|||
130209127|NCT00298363|468727171|FG000|Overall Study|Adverse Event|5|||
130209128|NCT00298363|468727172|FG001|Overall Study|Adverse Event|2|||
130209129|NCT00298363|468727173|FG002|Overall Study|Adverse Event|2|||
130209130|NCT00298363|468727171|FG000|Overall Study|Lack of Efficacy|2|||
130209131|NCT00298363|468727172|FG001|Overall Study|Lack of Efficacy|3|||
130209132|NCT00298363|468727173|FG002|Overall Study|Lack of Efficacy|0|||
130209133|NCT04710368|468727174|FG000|Overall Study|Withdrawal by Subject|9|||
130209134|NCT04710368|468727174|FG000|Overall Study|Lost to Follow-up|4|||
130209135|NCT04710368|468727174|FG000|Overall Study|Death|2|||
130209136|NCT04710368|468727174|FG000|Overall Study|Patient preference|11|||
130209137|NCT04710368|468727174|FG000|Overall Study|Treatment discontinuation|1|||
130209138|NCT00135356|468727175|FG000|Overall Study|Adverse Event|6|||
130209139|NCT00135356|468727176|FG001|Overall Study|Adverse Event|2|||
130209140|NCT00135356|468727175|FG000|Overall Study|Lack of Efficacy|2|||
130209141|NCT00135356|468727176|FG001|Overall Study|Lack of Efficacy|0|||
130209142|NCT00135356|468727175|FG000|Overall Study|Lost to Follow-up|3|||
130209143|NCT00135356|468727176|FG001|Overall Study|Lost to Follow-up|1|||
130209144|NCT00135356|468727175|FG000|Overall Study|Surgery for abdominal fat|1|||
130209145|NCT00135356|468727176|FG001|Overall Study|Surgery for abdominal fat|0|||
130209146|NCT00135356|468727175|FG000|Overall Study|Change in antiviral regimen|0|||
130209147|NCT00135356|468727176|FG001|Overall Study|Change in antiviral regimen|1|||
130209148|NCT00135356|468727175|FG000|Overall Study|Poor/noncompliance|1|||
130209149|NCT00135356|468727176|FG001|Overall Study|Poor/noncompliance|1|||
130209150|NCT00135356|468727175|FG000|Overall Study|No longer meets study criteria|2|||
130209151|NCT00135356|468727176|FG001|Overall Study|No longer meets study criteria|0|||
130209152|NCT00135356|468727175|FG000|Overall Study|Withdrawal by Subject|2|||
130209153|NCT00135356|468727176|FG001|Overall Study|Withdrawal by Subject|4|||
130209154|NCT00153816|468727177|FG000|Overall Study|Death|6|||
130209155|NCT00153816|468727178|FG001|Overall Study|Death|5|||
130209156|NCT00153816|468727179|FG002|Overall Study|Death|4|||
130209157|NCT00153816|468727180|FG003|Overall Study|Death|6|||
130209158|NCT00153816|468727181|FG004|Overall Study|Death|0|||
130209159|NCT00153816|468727182|FG005|Overall Study|Death|2|||
130209160|NCT00153816|468727177|FG000|Overall Study|Lost to Follow-up|7|||
130209161|NCT00153816|468727178|FG001|Overall Study|Lost to Follow-up|8|||
130209162|NCT00153816|468727179|FG002|Overall Study|Lost to Follow-up|5|||
130209163|NCT00153816|468727180|FG003|Overall Study|Lost to Follow-up|8|||
130209164|NCT00153816|468727181|FG004|Overall Study|Lost to Follow-up|7|||
130209165|NCT00153816|468727182|FG005|Overall Study|Lost to Follow-up|9|||
130209166|NCT00153816|468727177|FG000|Overall Study|Withdrawal by Subject|9|||
130209167|NCT00153816|468727178|FG001|Overall Study|Withdrawal by Subject|9|||
130209168|NCT00153816|468727179|FG002|Overall Study|Withdrawal by Subject|9|||
130209169|NCT00153816|468727180|FG003|Overall Study|Withdrawal by Subject|4|||
130319220|NCT02358473|469135456|FG000|Overall Study|Physician Decision|2|||
130319221|NCT02240485|469135457|FG000|3 Months Post-admission|Lost to Follow-up|1|||
130319222|NCT02240485|469135458|FG001|3 Months Post-admission|Lost to Follow-up|5|||
130319223|NCT02240485|469135457|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
130319224|NCT02240485|469135458|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
130319225|NCT02240485|469135457|FG000|9 Months Post-admission|Lost to Follow-up|3|||
130319226|NCT02240485|469135458|FG001|9 Months Post-admission|Lost to Follow-up|1|||
130319227|NCT02240485|469135457|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
130319228|NCT02240485|469135458|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
130319229|NCT02240485|469135457|FG000|18 Months Post-admission|Lost to Follow-up|1|||
130319230|NCT02240485|469135458|FG001|18 Months Post-admission|Lost to Follow-up|1|||
130319231|NCT02240485|469135457|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
130319232|NCT02240485|469135458|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
130319233|NCT00953667|469135459|FG000|Overall Study|Lost to Follow-up|11|||
130319234|NCT00953667|469135459|FG000|Overall Study|Physician Decision|35|||
130319235|NCT00953667|469135459|FG000|Overall Study|Withdrawal by Subject|63|||
130319236|NCT00953667|469135459|FG000|Overall Study|Adverse Event|10|||
130319237|NCT00953667|469135459|FG000|Overall Study|poor venous access,unable to draw blood|4|||
130319238|NCT04819945|469135460|FG000|Overall Study|Lost to Follow-up|1|||
130319239|NCT00475670|469135461|FG000|Overall Study|Death|0|||
130319240|NCT00475670|469135462|FG001|Overall Study|Death|1|||
130319241|NCT00475670|469135461|FG000|Overall Study|Lack of Efficacy|3|||
130319242|NCT00475670|469135462|FG001|Overall Study|Lack of Efficacy|34|||
130319243|NCT00475670|469135461|FG000|Overall Study|Refused treatment|0|||
130319244|NCT00475670|469135462|FG001|Overall Study|Refused treatment|2|||
130319245|NCT00475670|469135461|FG000|Overall Study|Failure to Return|0|||
130319246|NCT00475670|469135462|FG001|Overall Study|Failure to Return|1|||
130319247|NCT00475670|469135461|FG000|Overall Study|Other|0|||
130319248|NCT00475670|469135462|FG001|Overall Study|Other|3|||
130319249|NCT04949191|469135463|FG000|Overall Study|Non-compliance with Study Drug|1|||
130319250|NCT04949191|469135464|FG001|Overall Study|Non-compliance with Study Drug|0|||
130319251|NCT04949191|469135465|FG002|Overall Study|Non-compliance with Study Drug|0|||
130319252|NCT04949191|469135466|FG003|Overall Study|Non-compliance with Study Drug|0|||
130319253|NCT04949191|469135463|FG000|Overall Study|Progressive Disease|0|||
130319254|NCT04949191|469135464|FG001|Overall Study|Progressive Disease|1|||
130319255|NCT04949191|469135465|FG002|Overall Study|Progressive Disease|0|||
130319256|NCT04949191|469135466|FG003|Overall Study|Progressive Disease|0|||
130319257|NCT04949191|469135463|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130319258|NCT04949191|469135464|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
130319259|NCT04949191|469135465|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130319260|NCT04949191|469135466|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
130319261|NCT04949191|469135463|FG000|Overall Study|Sponsor Terminated Study|0|||
130319262|NCT04949191|469135464|FG001|Overall Study|Sponsor Terminated Study|0|||
130319263|NCT04949191|469135465|FG002|Overall Study|Sponsor Terminated Study|1|||
130319264|NCT04949191|469135466|FG003|Overall Study|Sponsor Terminated Study|1|||
130319265|NCT02913482|469135467|FG000|Overall Study|Death|0|||
130319266|NCT02913482|469135468|FG001|Overall Study|Death|2|||
130319267|NCT02913482|469135469|FG002|Overall Study|Death|2|||
130319268|NCT02913482|469135467|FG000|Overall Study|Progressive Disease|1|||
130319269|NCT02913482|469135468|FG001|Overall Study|Progressive Disease|1|||
130319270|NCT02913482|469135469|FG002|Overall Study|Progressive Disease|1|||
130319271|NCT02913482|469135467|FG000|Overall Study|Reason not specified|0|||
130319272|NCT02913482|469135468|FG001|Overall Study|Reason not specified|0|||
130319273|NCT02913482|469135469|FG002|Overall Study|Reason not specified|1|||
130319274|NCT02913482|469135467|FG000|Overall Study|Withdrawal by Subject|0|||
130319275|NCT02913482|469135468|FG001|Overall Study|Withdrawal by Subject|1|||
130319276|NCT02913482|469135469|FG002|Overall Study|Withdrawal by Subject|1|||
130319277|NCT01046565|469135474|FG000|Overall Study|Adverse Event|2|||
130319278|NCT01046565|469135474|FG000|Overall Study|Withdrawal by Subject|7|||
130319279|NCT00918385|469135475|FG000|Monotherapy|Adverse Event|1|||
130319280|NCT00918385|469135476|FG001|Monotherapy|Adverse Event|6|||
130319281|NCT00918385|469135475|FG000|Monotherapy|Complicating illness|1|||
130319282|NCT00918385|469135476|FG001|Monotherapy|Complicating illness|0|||
130319283|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
130319284|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
130319285|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
130319286|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
130319287|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
130319288|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
130319289|NCT00918385|469135475|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
130319290|NCT00918385|469135476|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
130319291|NCT00771914|469135479|FG000|Overall Study|Physician Decision|0|||
130319292|NCT00771914|469135480|FG001|Overall Study|Physician Decision|0|||
130319293|NCT00771914|469135481|FG002|Overall Study|Physician Decision|0|||
130319294|NCT00771914|469135482|FG003|Overall Study|Physician Decision|1|||
130319295|NCT00771914|469135479|FG000|Overall Study|Lost to Follow-up|0|||
130319296|NCT00771914|469135480|FG001|Overall Study|Lost to Follow-up|0|||
130319297|NCT00771914|469135481|FG002|Overall Study|Lost to Follow-up|0|||
130319298|NCT00771914|469135482|FG003|Overall Study|Lost to Follow-up|1|||
130319299|NCT02978417|469135485|FG000|Overall Study|Lost to Follow-up|2|||
130319300|NCT02978417|469135486|FG001|Overall Study|Lost to Follow-up|2|||
130319301|NCT03416868|469135494|FG000|Overall Study|Withdrawal by Subject|2|||
130319302|NCT03416868|469135494|FG000|Overall Study|Lost to Follow-up|1|||
130319303|NCT01323582|469135495|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
130319304|NCT01323582|469135496|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
130319305|NCT01323582|469135495|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
130319306|NCT01323582|469135496|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
130319307|NCT01323582|469135495|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
130319308|NCT01323582|469135496|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
130319309|NCT00960375|469135499|FG000|Overall Study|Lost to Follow-up|20|||
130319310|NCT00960375|469135500|FG001|Overall Study|Lost to Follow-up|22|||
130319311|NCT03557970|469135501|FG000|Overall Study|Study closure|1|||
130319312|NCT03557970|469135502|FG001|Overall Study|Study closure|0|||
130319313|NCT03557970|469135501|FG000|Overall Study|Physician Decision|0|||
130319314|NCT03557970|469135502|FG001|Overall Study|Physician Decision|1|||
130319315|NCT03557970|469135501|FG000|Overall Study|Death|0|||
130319316|NCT03557970|469135502|FG001|Overall Study|Death|1|||
130319317|NCT00112736|469135503|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
130319318|NCT00112736|469135504|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
130319319|NCT01927497|469135505|FG000|Overall Study|Death|0|||
130319320|NCT01927497|469135506|FG001|Overall Study|Death|1|||
130319321|NCT01927497|469135505|FG000|Overall Study|Protocol Violation|2|||
130319322|NCT01927497|469135506|FG001|Overall Study|Protocol Violation|0|||
130319323|NCT03914417|469135507|FG000|Overall Study|Withdrawal by Subject|2|||
130319324|NCT03409796|469137459|FG000|Overall Study|Adverse Event|2|||
130319325|NCT03409796|469137460|FG001|Overall Study|Adverse Event|0|||
130319326|NCT03409796|469137459|FG000|Overall Study|Other|0|||
130319327|NCT03409796|469137460|FG001|Overall Study|Other|1|||
130319328|NCT00740220|469137461|FG000|Overall Study|screen failures (non-COPD patients)|9|||
130319329|NCT01602224|469137462|FG000|Overall Study|Adverse Event|0|||
130319330|NCT01602224|469137463|FG001|Overall Study|Adverse Event|1|||
130319331|NCT01602224|469137464|FG002|Overall Study|Adverse Event|0|||
130319332|NCT01602224|469137462|FG000|Overall Study|Investigator Decison|1|||
130319333|NCT01602224|469137463|FG001|Overall Study|Investigator Decison|0|||
130319334|NCT01602224|469137464|FG002|Overall Study|Investigator Decison|0|||
130319335|NCT01602224|469137462|FG000|Overall Study|Lost to Follow-up|0|||
130319336|NCT01602224|469137463|FG001|Overall Study|Lost to Follow-up|0|||
130319337|NCT01602224|469137464|FG002|Overall Study|Lost to Follow-up|1|||
130319338|NCT01602224|469137462|FG000|Overall Study|Protocol Violation|0|||
130319339|NCT01602224|469137463|FG001|Overall Study|Protocol Violation|1|||
130319340|NCT01602224|469137464|FG002|Overall Study|Protocol Violation|0|||
130319341|NCT01602224|469137462|FG000|Overall Study|Sponsor Decision|2|||
130319342|NCT01602224|469137463|FG001|Overall Study|Sponsor Decision|3|||
130319343|NCT01602224|469137464|FG002|Overall Study|Sponsor Decision|2|||
130319344|NCT01602224|469137462|FG000|Overall Study|Withdrawal by Subject|5|||
130319345|NCT01602224|469137463|FG001|Overall Study|Withdrawal by Subject|3|||
130319346|NCT01602224|469137464|FG002|Overall Study|Withdrawal by Subject|3|||
130319347|NCT01352117|469137465|FG000|Overall Study|Death|15|||
130319348|NCT01352117|469137466|FG001|Overall Study|Death|16|||
130319349|NCT01352117|469137465|FG000|Overall Study|Withdrawal by Subject|1|||
130319350|NCT01352117|469137466|FG001|Overall Study|Withdrawal by Subject|0|||
130319351|NCT01352117|469137465|FG000|Overall Study|Lost to Follow-up|2|||
130319352|NCT01352117|469137466|FG001|Overall Study|Lost to Follow-up|7|||
130319353|NCT01352117|469137465|FG000|Overall Study|Non-adherent to study requirements|1|||
130319354|NCT01352117|469137466|FG001|Overall Study|Non-adherent to study requirements|1|||
130319355|NCT01352117|469137465|FG000|Overall Study|Did not initiate study treatment|1|||
130319356|NCT01352117|469137466|FG001|Overall Study|Did not initiate study treatment|0|||
130319357|NCT01352117|469137465|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
130319358|NCT01352117|469137466|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
130319359|NCT00633477|469137467|FG000|Overall Study|Death|1|||
130319360|NCT00633477|469137468|FG001|Overall Study|Death|0|||
130319361|NCT00633477|469137467|FG000|Overall Study|Randomized but not treated|1|||
130319362|NCT00633477|469137468|FG001|Overall Study|Randomized but not treated|0|||
130319363|NCT00770653|469137472|FG000|Overall Study|Adverse Event|13|||
130319364|NCT00770653|469137473|FG001|Overall Study|Adverse Event|5|||
130319365|NCT00770653|469137472|FG000|Overall Study|Protocol Violation|8|||
130319366|NCT00770653|469137473|FG001|Overall Study|Protocol Violation|6|||
130319367|NCT00770653|469137472|FG000|Overall Study|Withdrawal by Subject|4|||
130319368|NCT00770653|469137473|FG001|Overall Study|Withdrawal by Subject|7|||
130319369|NCT00770653|469137472|FG000|Overall Study|Lack of Compliance|1|||
130319370|NCT00770653|469137473|FG001|Overall Study|Lack of Compliance|4|||
130319371|NCT00770653|469137472|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
130319372|NCT00770653|469137473|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
130319373|NCT00770653|469137472|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
130319374|NCT00770653|469137473|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
130319375|NCT00770653|469137472|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
130319376|NCT00770653|469137473|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
130319377|NCT00770653|469137472|FG000|Overall Study|Lost to Follow-up|1|||
130319378|NCT00770653|469137473|FG001|Overall Study|Lost to Follow-up|2|||
130319379|NCT00770653|469137472|FG000|Overall Study|Physician Decision|1|||
130319380|NCT00770653|469137473|FG001|Overall Study|Physician Decision|0|||
130319381|NCT04906499|469137479|FG000|Overall Study|Lack of time|1|||
130319382|NCT00179621|469137480|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
130319383|NCT00179621|469137481|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
130319384|NCT00179621|469137482|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
130319385|NCT00179621|469137483|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
130319386|NCT00179621|469137480|FG000|Double-Blind Period|Adverse Event|2|||
130319387|NCT00179621|469137481|FG001|Double-Blind Period|Adverse Event|7|||
130319388|NCT00179621|469137482|FG002|Double-Blind Period|Adverse Event|4|||
130319389|NCT00179621|469137483|FG003|Double-Blind Period|Adverse Event|0|||
130319390|NCT00179621|469137480|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130319391|NCT00179621|469137481|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130319392|NCT00179621|469137482|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130319393|NCT00179621|469137483|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130319394|NCT00179621|469137480|FG000|Double-Blind Period|Death|0|||
130319395|NCT00179621|469137481|FG001|Double-Blind Period|Death|1|||
130319396|NCT00179621|469137482|FG002|Double-Blind Period|Death|2|||
130319397|NCT00179621|469137483|FG003|Double-Blind Period|Death|0|||
130319398|NCT00179621|469137480|FG000|Double-Blind Period|Protocol Violation|1|||
130319399|NCT00179621|469137481|FG001|Double-Blind Period|Protocol Violation|0|||
130319400|NCT00179621|469137482|FG002|Double-Blind Period|Protocol Violation|0|||
130319401|NCT00179621|469137483|FG003|Double-Blind Period|Protocol Violation|0|||
130319402|NCT00179621|469137480|FG000|Double-Blind Period|Other|0|||
130319403|NCT00179621|469137481|FG001|Double-Blind Period|Other|2|||
130319404|NCT00179621|469137482|FG002|Double-Blind Period|Other|2|||
130319405|NCT00179621|469137483|FG003|Double-Blind Period|Other|0|||
130319406|NCT00179621|469137480|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
130319407|NCT00179621|469137481|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
130319408|NCT00179621|469137482|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
130319409|NCT00179621|469137483|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
130319410|NCT00179621|469137480|FG000|Open-Label Period|Adverse Event|0|||
130319411|NCT00179621|469137481|FG001|Open-Label Period|Adverse Event|6|||
130319412|NCT00179621|469137482|FG002|Open-Label Period|Adverse Event|5|||
130319413|NCT00179621|469137483|FG003|Open-Label Period|Adverse Event|6|||
130319414|NCT00179621|469137480|FG000|Open-Label Period|Withdrawal by Subject|0|||
130319415|NCT00179621|469137481|FG001|Open-Label Period|Withdrawal by Subject|2|||
130319416|NCT00179621|469137482|FG002|Open-Label Period|Withdrawal by Subject|2|||
130319417|NCT00179621|469137483|FG003|Open-Label Period|Withdrawal by Subject|2|||
130319418|NCT00179621|469137480|FG000|Open-Label Period|Death|0|||
130319419|NCT00179621|469137481|FG001|Open-Label Period|Death|0|||
130319420|NCT00179621|469137482|FG002|Open-Label Period|Death|1|||
130319421|NCT00179621|469137483|FG003|Open-Label Period|Death|2|||
130319422|NCT00179621|469137480|FG000|Open-Label Period|Other|0|||
130319423|NCT00179621|469137481|FG001|Open-Label Period|Other|1|||
130319424|NCT00179621|469137482|FG002|Open-Label Period|Other|1|||
130319425|NCT00179621|469137483|FG003|Open-Label Period|Other|2|||
130319426|NCT00262860|469137490|FG000|Overall Study|Adverse Event|2|||
130319427|NCT02891174|469137502|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
130319428|NCT02891174|469137503|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
130319429|NCT02891174|469137502|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
130319430|NCT02891174|469137503|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
130319431|NCT02891174|469137502|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
130319432|NCT02891174|469137503|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
130319433|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
130319434|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
130319435|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
130319436|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
130319437|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
130319438|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
130319439|NCT02891174|469137502|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
130319440|NCT02891174|469137503|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
130319441|NCT04124939|469137504|FG000|Overall Study|Lost to Follow-up|1|||
130319442|NCT04124939|469137505|FG001|Overall Study|Lost to Follow-up|3|||
130319443|NCT04235140|469137506|FG000|Overall Study|Adverse Event|2|||
130319444|NCT04235140|469137506|FG000|Overall Study|Lost to Follow-up|1|||
130319445|NCT04235140|469137506|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
130319446|NCT04235140|469137506|FG000|Overall Study|Commercial drug is available for participants|7|||
130319447|NCT00672555|469137508|FG000|Overall Study|Lost to Follow-up|4|||
130319448|NCT00672555|469137508|FG000|Overall Study|Did not want to answer questionnaire|2|||
130319449|NCT00419393|469137509|FG000|Overall Study|Adverse Event|5|||
130319450|NCT00419393|469137509|FG000|Overall Study|Protocol Violation|5|||
130319451|NCT00419393|469137509|FG000|Overall Study|Withdrawal by Subject|7|||
130319452|NCT00419393|469137509|FG000|Overall Study|Other: Sponsor request|3|||
130319453|NCT00419393|469137509|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
130319454|NCT00419393|469137509|FG000|Overall Study|Other: Site closure|1|||
130319455|NCT00419393|469137509|FG000|Overall Study|Other: Other health problems|1|||
130319456|NCT00419393|469137509|FG000|Overall Study|Other: Investigator decision|1|||
130319457|NCT04516746|469137512|FG000|Overall Study|Randomized but not Treated|51|||
130319458|NCT04516746|469137513|FG001|Overall Study|Randomized but not Treated|19|||
130319459|NCT04516746|469137512|FG000|Overall Study|Adverse Event|0|||
130319460|NCT04516746|469137513|FG001|Overall Study|Adverse Event|1|||
130319461|NCT04516746|469137512|FG000|Overall Study|Death|62|||
130319462|NCT04516746|469137513|FG001|Overall Study|Death|32|||
130319463|NCT04516746|469137512|FG000|Overall Study|Lost to Follow-up|3431|||
130319464|NCT04516746|469137513|FG001|Overall Study|Lost to Follow-up|1831|||
130319465|NCT04516746|469137512|FG000|Overall Study|Withdrawal by Subject|1946|||
130319466|NCT04516746|469137513|FG001|Overall Study|Withdrawal by Subject|1696|||
130319467|NCT04516746|469137512|FG000|Overall Study|Physician Decision|10|||
130319468|NCT04516746|469137513|FG001|Overall Study|Physician Decision|8|||
130209170|NCT00153816|468727181|FG004|Overall Study|Withdrawal by Subject|1|||
130209171|NCT00153816|468727182|FG005|Overall Study|Withdrawal by Subject|5|||
130209172|NCT00153816|468727177|FG000|Overall Study|Follow-up exam not done|8|||
130209173|NCT00153816|468727178|FG001|Overall Study|Follow-up exam not done|7|||
130209174|NCT00153816|468727179|FG002|Overall Study|Follow-up exam not done|11|||
130209175|NCT00153816|468727180|FG003|Overall Study|Follow-up exam not done|10|||
130209176|NCT00153816|468727181|FG004|Overall Study|Follow-up exam not done|8|||
130209177|NCT00153816|468727182|FG005|Overall Study|Follow-up exam not done|9|||
130209178|NCT00153816|468727177|FG000|Overall Study|Follow-up exam done, histology missing|2|||
130209179|NCT00153816|468727178|FG001|Overall Study|Follow-up exam done, histology missing|3|||
130209180|NCT00153816|468727179|FG002|Overall Study|Follow-up exam done, histology missing|3|||
130209181|NCT00153816|468727180|FG003|Overall Study|Follow-up exam done, histology missing|3|||
130209182|NCT00153816|468727181|FG004|Overall Study|Follow-up exam done, histology missing|1|||
130209183|NCT00153816|468727182|FG005|Overall Study|Follow-up exam done, histology missing|2|||
130209184|NCT01211483|468727189|FG000|Phase 1b|Death|6|||
130209185|NCT01211483|468727190|FG001|Phase 1b|Death|0|||
130209186|NCT01211483|468727191|FG002|Phase 1b|Death|0|||
130209187|NCT01211483|468727192|FG003|Phase 1b|Death|0|||
130209188|NCT01211483|468727189|FG000|Phase 1b|Withdrawal by Subject|1|||
130209189|NCT01211483|468727190|FG001|Phase 1b|Withdrawal by Subject|0|||
130209190|NCT01211483|468727191|FG002|Phase 1b|Withdrawal by Subject|0|||
130209191|NCT01211483|468727192|FG003|Phase 1b|Withdrawal by Subject|0|||
130209192|NCT01211483|468727189|FG000|Phase 2|Lost to Follow-up|0|||
130209193|NCT01211483|468727190|FG001|Phase 2|Lost to Follow-up|1|||
130209194|NCT01211483|468727191|FG002|Phase 2|Lost to Follow-up|1|||
130209195|NCT01211483|468727192|FG003|Phase 2|Lost to Follow-up|2|||
130209196|NCT01211483|468727189|FG000|Phase 2|Death|0|||
130209197|NCT01211483|468727190|FG001|Phase 2|Death|64|||
130209198|NCT01211483|468727191|FG002|Phase 2|Death|53|||
130209199|NCT01211483|468727192|FG003|Phase 2|Death|53|||
130209200|NCT01211483|468727189|FG000|Phase 2|Withdrawal by Subject|0|||
130209201|NCT01211483|468727190|FG001|Phase 2|Withdrawal by Subject|1|||
130209202|NCT01211483|468727191|FG002|Phase 2|Withdrawal by Subject|10|||
130209203|NCT01211483|468727192|FG003|Phase 2|Withdrawal by Subject|5|||
130209204|NCT01211483|468727189|FG000|Phase 2|Study terminated by Sponsor|0|||
130209205|NCT01211483|468727190|FG001|Phase 2|Study terminated by Sponsor|6|||
130209206|NCT01211483|468727191|FG002|Phase 2|Study terminated by Sponsor|8|||
130209207|NCT01211483|468727192|FG003|Phase 2|Study terminated by Sponsor|11|||
130209208|NCT00460265|468727193|FG000|Overall Study|Lost to Follow-up|14|||
130209209|NCT00460265|468727194|FG001|Overall Study|Lost to Follow-up|15|||
130209210|NCT00460265|468727193|FG000|Overall Study|Physician Decision|1|||
130209211|NCT00460265|468727194|FG001|Overall Study|Physician Decision|2|||
130209212|NCT00460265|468727193|FG000|Overall Study|Withdrawal by Subject|10|||
130319469|NCT04516746|469137512|FG000|Overall Study|Other|35|||
130319470|NCT04516746|469137513|FG001|Overall Study|Other|16|||
130209213|NCT00460265|468727194|FG001|Overall Study|Withdrawal by Subject|25|||
130209214|NCT00460265|468727193|FG000|Overall Study|Ongoing|60|||
130209215|NCT00460265|468727194|FG001|Overall Study|Ongoing|47|||
130209216|NCT02719353|468727195|FG000|First Intervention|Physician Decision|0|||
130209217|NCT02719353|468727196|FG001|First Intervention|Physician Decision|1|||
130209218|NCT01917344|468727198|FG000|Overall Study|Withdrawal by Subject|1|||
130209219|NCT00412217|468727199|FG000|Overall Study|Insufficient Data Available|8|||
130209220|NCT00412217|468727200|FG001|Overall Study|Insufficient Data Available|3|||
130209221|NCT00412217|468727199|FG000|Overall Study|Death|5|||
130209222|NCT00412217|468727200|FG001|Overall Study|Death|4|||
130209223|NCT00412217|468727199|FG000|Overall Study|Disease Progression|2|||
130319471|NCT01751061|469137514|FG000|Overall Study|Death|1|||
130319472|NCT01751061|469137515|FG001|Overall Study|Death|0|||
130319473|NCT01751061|469137514|FG000|Overall Study|patient death|5|||
130319474|NCT01751061|469137515|FG001|Overall Study|patient death|0|||
130319475|NCT01751061|469137514|FG000|Overall Study|Lost to Follow-up|40|||
130319476|NCT01751061|469137515|FG001|Overall Study|Lost to Follow-up|25|||
130319477|NCT01751061|469137514|FG000|Overall Study|patient regained decisional capacity|4|||
130319478|NCT01751061|469137515|FG001|Overall Study|patient regained decisional capacity|8|||
130319479|NCT01751061|469137514|FG000|Overall Study|Withdrawal by Subject|4|||
130319480|NCT01751061|469137515|FG001|Overall Study|Withdrawal by Subject|1|||
130319481|NCT01751061|469137514|FG000|Overall Study|Physician Decision|2|||
130319482|NCT01751061|469137515|FG001|Overall Study|Physician Decision|0|||
130319483|NCT00446849|469137519|FG000|Acute Phase|Lack of Efficacy|64|||
130319484|NCT00446849|469137519|FG000|Acute Phase|Protocol Violation|10|||
130319485|NCT00446849|469137519|FG000|Acute Phase|Consent withdrawn|4|||
130319486|NCT00446849|469137519|FG000|Acute Phase|Lost to Follow-up|2|||
130319487|NCT00446849|469137519|FG000|Acute Phase|Physician Decision|1|||
130319488|NCT00446849|469137519|FG000|Acute Phase|noncompliance|1|||
130319489|NCT00446849|469137519|FG000|Maintenance Phase|Lack of Efficacy|40|||
130319490|NCT00446849|469137519|FG000|Maintenance Phase|Protocol Violation|7|||
130319491|NCT00446849|469137519|FG000|Maintenance Phase|Adverse Event|6|||
130319492|NCT00446849|469137519|FG000|Maintenance Phase|Consent withdrawn|5|||
130319493|NCT00446849|469137519|FG000|Maintenance Phase|Lost to Follow-up|3|||
130319494|NCT00446849|469137519|FG000|Maintenance Phase|Pregnancy|1|||
130319495|NCT00446849|469137519|FG000|Maintenance Phase|noncompliance|2|||
130319496|NCT00446849|469137519|FG000|Maintenance Phase|prohibited medication use|2|||
130319497|NCT00446849|469137519|FG000|Maintenance Phase|antibiotic use|1|||
130319498|NCT00446849|469137519|FG000|Maintenance Phase|study closure|1|||
130319499|NCT00446849|469137519|FG000|Maintenance Phase|hydrocodone use|1|||
130319500|NCT00446849|469137519|FG000|Maintenance Phase|concomitant medication use|1|||
130319501|NCT01194830|469137522|FG000|Overall Study|Adverse Event|3|||
130319502|NCT01194830|469137523|FG001|Overall Study|Adverse Event|2|||
130319503|NCT01194830|469137522|FG000|Overall Study|Protocol Violation|5|||
130319504|NCT01194830|469137523|FG001|Overall Study|Protocol Violation|4|||
130319505|NCT01194830|469137522|FG000|Overall Study|Lost to Follow-up|9|||
130319506|NCT01194830|469137523|FG001|Overall Study|Lost to Follow-up|7|||
130319507|NCT01194830|469137522|FG000|Overall Study|Withdrawal by Subject|2|||
130319508|NCT01194830|469137523|FG001|Overall Study|Withdrawal by Subject|1|||
130319509|NCT01194830|469137522|FG000|Overall Study|Lack of Efficacy|1|||
130319510|NCT01194830|469137523|FG001|Overall Study|Lack of Efficacy|1|||
130319511|NCT01194830|469137522|FG000|Overall Study|Non-compliance issues|4|||
130319512|NCT01194830|469137523|FG001|Overall Study|Non-compliance issues|4|||
130319513|NCT01194830|469137522|FG000|Overall Study|Other Reason|12|||
130319514|NCT01194830|469137523|FG001|Overall Study|Other Reason|8|||
130319515|NCT03115359|469137524|FG000|Overall Study|Withdrawal by Subject|29|||
130319516|NCT03115359|469137525|FG001|Overall Study|Withdrawal by Subject|39|||
130319517|NCT03115359|469137524|FG000|Overall Study|Scheduling conflict|25|||
130319518|NCT03115359|469137525|FG001|Overall Study|Scheduling conflict|23|||
130319519|NCT03115359|469137524|FG000|Overall Study|Personal reasons including health|12|||
130319520|NCT03115359|469137525|FG001|Overall Study|Personal reasons including health|9|||
130319521|NCT03115359|469137524|FG000|Overall Study|Transportation barriers|3|||
130319522|NCT03115359|469137525|FG001|Overall Study|Transportation barriers|0|||
130319523|NCT03115359|469137524|FG000|Overall Study|No longer interested|5|||
130319524|NCT03115359|469137525|FG001|Overall Study|No longer interested|4|||
130319525|NCT03115359|469137524|FG000|Overall Study|No reason provided|45|||
130319526|NCT03115359|469137525|FG001|Overall Study|No reason provided|47|||
130319527|NCT01815918|469137528|FG000|Overall Study|Patient samples not analyzable|3|||
130319528|NCT01815918|469137529|FG001|Overall Study|Patient samples not analyzable|4|||
130319529|NCT01815918|469137528|FG000|Overall Study|Lack of Efficacy|15|||
130319530|NCT01815918|469137529|FG001|Overall Study|Lack of Efficacy|15|||
130319531|NCT03284710|469137532|FG000|Overall Study|Withdrawal by Subject|1|||
130319532|NCT03284710|469137533|FG001|Overall Study|Withdrawal by Subject|0|||
130319533|NCT03284710|469137534|FG002|Overall Study|Withdrawal by Subject|1|||
130319534|NCT03284710|469137535|FG003|Overall Study|Withdrawal by Subject|6|||
130319535|NCT03284710|469137532|FG000|Overall Study|Lost to Follow-up|3|||
130319536|NCT03284710|469137533|FG001|Overall Study|Lost to Follow-up|3|||
130319537|NCT03284710|469137534|FG002|Overall Study|Lost to Follow-up|1|||
130319538|NCT03284710|469137535|FG003|Overall Study|Lost to Follow-up|0|||
130319539|NCT03284710|469137532|FG000|Overall Study|Physician Decision|1|||
130319540|NCT03284710|469137533|FG001|Overall Study|Physician Decision|0|||
130319541|NCT03284710|469137534|FG002|Overall Study|Physician Decision|0|||
130319542|NCT03284710|469137535|FG003|Overall Study|Physician Decision|0|||
130319543|NCT03284710|469137532|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130319544|NCT03284710|469137533|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130319545|NCT03284710|469137534|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
130319546|NCT03284710|469137535|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
130319547|NCT03284710|469137532|FG000|Overall Study|HIV Infection|0|||
130319548|NCT03284710|469137533|FG001|Overall Study|HIV Infection|2|||
130319549|NCT03284710|469137534|FG002|Overall Study|HIV Infection|2|||
130319550|NCT03284710|469137535|FG003|Overall Study|HIV Infection|1|||
130319551|NCT02814916|469137542|FG000|Overall Study|Withdrawal of consent|0|||
130319552|NCT02814916|469137543|FG001|Overall Study|Withdrawal of consent|2|||
130319553|NCT02814916|469137544|FG002|Overall Study|Withdrawal of consent|0|||
130319554|NCT02814916|469137542|FG000|Overall Study|Lost to Follow-up|0|||
130319555|NCT02814916|469137543|FG001|Overall Study|Lost to Follow-up|1|||
130319556|NCT02814916|469137544|FG002|Overall Study|Lost to Follow-up|0|||
130319557|NCT02814916|469137542|FG000|Overall Study|Other, not specified|0|||
130319558|NCT02814916|469137543|FG001|Overall Study|Other, not specified|1|||
130319559|NCT02814916|469137544|FG002|Overall Study|Other, not specified|0|||
130319560|NCT01706458|469137552|FG000|Overall Study|Physician Decision|3|||
130319561|NCT01706458|469137553|FG001|Overall Study|Physician Decision|4|||
130319562|NCT02384551|469137557|FG000|Overall Study|Lost to Follow-up|13|||
130319563|NCT02384551|469137558|FG001|Overall Study|Lost to Follow-up|14|||
130319564|NCT02384551|469137559|FG002|Overall Study|Lost to Follow-up|14|||
130319565|NCT02384551|469137560|FG003|Overall Study|Lost to Follow-up|14|||
130319566|NCT04742556|469137563|FG000|Overall Study|Withdrawal by Subject|0|||
130319567|NCT04742556|469137564|FG001|Overall Study|Withdrawal by Subject|1|||
130319568|NCT04742556|469137565|FG002|Overall Study|Withdrawal by Subject|0|||
130319569|NCT04742556|469137563|FG000|Overall Study|Adverse Event|0|||
130319570|NCT04742556|469137564|FG001|Overall Study|Adverse Event|0|||
130319571|NCT04742556|469137565|FG002|Overall Study|Adverse Event|2|||
130319572|NCT04742556|469137563|FG000|Overall Study|Clinical disease progression|0|||
130319573|NCT04742556|469137564|FG001|Overall Study|Clinical disease progression|1|||
130319574|NCT04742556|469137565|FG002|Overall Study|Clinical disease progression|2|||
130319575|NCT04742556|469137563|FG000|Overall Study|Objective disease progression|3|||
130319576|NCT04742556|469137564|FG001|Overall Study|Objective disease progression|2|||
130319577|NCT04742556|469137565|FG002|Overall Study|Objective disease progression|4|||
130319578|NCT01903356|469137571|FG000|Overall Study|Lost to Follow-up|7|||
130319579|NCT01903356|469137571|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
130319580|NCT01903356|469137571|FG000|Overall Study|Violated the dosage and administration|3|||
130319581|NCT04196686|469137576|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
130319582|NCT04196686|469137577|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
130319583|NCT03448406|469137579|FG000|Overall Study|Noncompliance of scheduled visits|1|||
130319584|NCT03448406|469137580|FG001|Overall Study|Noncompliance of scheduled visits|2|||
130319585|NCT03448406|469137579|FG000|Overall Study|Withdrawal by Subject|1|||
130319586|NCT03448406|469137580|FG001|Overall Study|Withdrawal by Subject|2|||
130097108|NCT02207413|468311243|FG005|Overall Study|Migrated/moved from study area|0|||
130097109|NCT01302366|468312953|FG000|Overall Study|patient choice or noncompliance|5|||
130319587|NCT03448406|469137579|FG000|Overall Study|Protocol Violation|1|||
130319588|NCT03448406|469137580|FG001|Overall Study|Protocol Violation|0|||
130319589|NCT03448406|469137579|FG000|Overall Study|Adverse Event|8|||
130319590|NCT03448406|469137580|FG001|Overall Study|Adverse Event|9|||
130319591|NCT02542865|469137588|FG000|Overall Study|Identified as screen failure|1|||
130319592|NCT02542865|469137589|FG001|Overall Study|Identified as screen failure|0|||
130319593|NCT02542865|469137588|FG000|Overall Study|Withdrawal by Subject|16|||
130319594|NCT02542865|469137589|FG001|Overall Study|Withdrawal by Subject|0|||
130319595|NCT00083889|469137591|FG000|Overall Study|Adverse Event|76|||
130319596|NCT00083889|469137592|FG001|Overall Study|Adverse Event|86|||
130319597|NCT00083889|469137591|FG000|Overall Study|Protocol Violation|2|||
130319598|NCT00083889|469137592|FG001|Overall Study|Protocol Violation|2|||
130319599|NCT00083889|469137591|FG000|Overall Study|Withdrawal by Subject|22|||
130319600|NCT00083889|469137592|FG001|Overall Study|Withdrawal by Subject|24|||
130319601|NCT00083889|469137591|FG000|Overall Study|Lack of Efficacy|240|||
130319602|NCT00083889|469137592|FG001|Overall Study|Lack of Efficacy|219|||
130319603|NCT00083889|469137591|FG000|Overall Study|Decision of sponsor|32|||
130319604|NCT00083889|469137592|FG001|Overall Study|Decision of sponsor|4|||
130319605|NCT00083889|469137591|FG000|Overall Study|Randomized: did not take study drug|0|||
130319606|NCT00083889|469137592|FG001|Overall Study|Randomized: did not take study drug|15|||
130319607|NCT00083889|469137591|FG000|Overall Study|Completed on marketed sunitinub|3|||
130319608|NCT00083889|469137592|FG001|Overall Study|Completed on marketed sunitinub|0|||
130319609|NCT00083889|469137591|FG000|Overall Study|Crossover to SU011248|0|||
130319610|NCT00083889|469137592|FG001|Overall Study|Crossover to SU011248|25|||
130319611|NCT05135871|469137594|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
130319612|NCT05135871|469137595|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130319613|NCT05135871|469137596|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130319614|NCT05135871|469137597|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
130319615|NCT03836625|469137601|FG000|Overall Study|Lost to Follow-up|9|||
130319616|NCT03836625|469137602|FG001|Overall Study|Lost to Follow-up|9|||
130319617|NCT03836625|469137601|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
130319618|NCT03836625|469137602|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
130319619|NCT03836625|469137601|FG000|Overall Study|Death|0|||
130319620|NCT03836625|469137602|FG001|Overall Study|Death|1|||
130319621|NCT03836625|469137601|FG000|Overall Study|Refused follow-up|0|||
130319622|NCT03836625|469137602|FG001|Overall Study|Refused follow-up|1|||
130319623|NCT01247324|469137607|FG000|Overall Study|Death|6|||
130319624|NCT01247324|469137608|FG001|Overall Study|Death|10|||
130319625|NCT01247324|469137607|FG000|Overall Study|Physician Decision|2|||
130319626|NCT01247324|469137608|FG001|Overall Study|Physician Decision|3|||
130319627|NCT01247324|469137607|FG000|Overall Study|Non-compliance with study drug|3|||
130319628|NCT01247324|469137608|FG001|Overall Study|Non-compliance with study drug|0|||
130319629|NCT01247324|469137607|FG000|Overall Study|Lack of Efficacy|24|||
130319630|NCT01247324|469137608|FG001|Overall Study|Lack of Efficacy|14|||
130319631|NCT01247324|469137607|FG000|Overall Study|Non-compliance|3|||
130319632|NCT01247324|469137608|FG001|Overall Study|Non-compliance|2|||
130319633|NCT01247324|469137607|FG000|Overall Study|Pregnancy|5|||
130319634|NCT01247324|469137608|FG001|Overall Study|Pregnancy|10|||
130319635|NCT01247324|469137607|FG000|Overall Study|Protocol Violation|1|||
130319636|NCT01247324|469137608|FG001|Overall Study|Protocol Violation|1|||
130319637|NCT01247324|469137607|FG000|Overall Study|Reason not specified|42|||
130319638|NCT01247324|469137608|FG001|Overall Study|Reason not specified|32|||
130319639|NCT01247324|469137607|FG000|Overall Study|Consent withdrawn by participant|41|||
130319640|NCT01247324|469137608|FG001|Overall Study|Consent withdrawn by participant|56|||
130319641|NCT01247324|469137607|FG000|Overall Study|Adverse Event|49|||
130319642|NCT01247324|469137608|FG001|Overall Study|Adverse Event|35|||
130319643|NCT01247324|469137607|FG000|Overall Study|Lost to Follow-up|3|||
130319644|NCT01247324|469137608|FG001|Overall Study|Lost to Follow-up|6|||
130319645|NCT01247324|469137607|FG000|Overall Study|Study Terminated by Sponsor|4|||
130319646|NCT01247324|469137608|FG001|Overall Study|Study Terminated by Sponsor|1|||
130319647|NCT01247324|469137607|FG000|Overall Study|Missing|2|||
130319648|NCT01247324|469137608|FG001|Overall Study|Missing|1|||
130319649|NCT03035032|469139621|FG000|Overall Study|Adverse Event|2|||
130319650|NCT03035032|469139621|FG000|Overall Study|Death|9|||
130319651|NCT03035032|469139621|FG000|Overall Study|Lost to Follow-up|1|||
130319652|NCT03035032|469139621|FG000|Overall Study|Progressive Disease|22|||
130319653|NCT03035032|469139621|FG000|Overall Study|Protocol Violation|2|||
130319654|NCT03035032|469139621|FG000|Overall Study|Withdrawal by Subject|2|||
130319655|NCT03035032|469139621|FG000|Overall Study|Physician Decision|5|||
130319656|NCT00836589|469139622|FG000|Overall Study|Lost to Follow-up|246|||
130319657|NCT00836589|469139622|FG000|Overall Study|Death|429|||
130319658|NCT00836589|469139622|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
130319659|NCT02399215|469139644|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
130319660|NCT02399215|469139644|FG000|Overall Study|Withdrawal by Subject|1|||
130319661|NCT04529083|469139645|FG000|Overall Study|Withdrawal by Subject|3|||
130319662|NCT01176032|469139649|FG000|Overall Study|Adverse Event|1|||
130319663|NCT01176032|469139650|FG001|Overall Study|Adverse Event|0|||
130319664|NCT01176032|469139649|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130319665|NCT01176032|469139650|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130319666|NCT01176032|469139649|FG000|Overall Study|Protocol Violation|1|||
130319667|NCT01176032|469139650|FG001|Overall Study|Protocol Violation|0|||
130319668|NCT01176032|469139649|FG000|Overall Study|Informed consent withdrawn|3|||
130319669|NCT01176032|469139650|FG001|Overall Study|Informed consent withdrawn|0|||
130319670|NCT01176032|469139649|FG000|Overall Study|Other|1|||
130319671|NCT01176032|469139650|FG001|Overall Study|Other|0|||
130319672|NCT01469221|469139651|FG000|Double Blind Phase|Protocol Violation|1|||
130319673|NCT01469221|469139652|FG001|Double Blind Phase|Protocol Violation|0|||
130319674|NCT01469221|469139653|FG002|Double Blind Phase|Protocol Violation|0|||
130319675|NCT01469221|469139651|FG000|Double Blind Phase|Physician Decision|1|||
130319676|NCT01469221|469139652|FG001|Double Blind Phase|Physician Decision|1|||
130319677|NCT01469221|469139653|FG002|Double Blind Phase|Physician Decision|0|||
130319678|NCT01469221|469139651|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
130319679|NCT01469221|469139652|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
130319680|NCT01469221|469139653|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
130319681|NCT03186209|469139659|FG000|Overall Study|Withdrawal by Subject|11|||
130319682|NCT03186209|469139660|FG001|Overall Study|Withdrawal by Subject|22|||
130319683|NCT03186209|469139659|FG000|Overall Study|Pregnancy|1|||
130319684|NCT03186209|469139660|FG001|Overall Study|Pregnancy|0|||
130319685|NCT03186209|469139659|FG000|Overall Study|Adverse Event|4|||
130319686|NCT03186209|469139660|FG001|Overall Study|Adverse Event|0|||
130319687|NCT03186209|469139659|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
130319688|NCT03186209|469139660|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
130319689|NCT03186209|469139659|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
130319690|NCT03186209|469139660|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
130319691|NCT03186209|469139659|FG000|Overall Study|Fail to meet randomization criteria|0|||
130319692|NCT03186209|469139660|FG001|Overall Study|Fail to meet randomization criteria|1|||
130319693|NCT03186209|469139659|FG000|Overall Study|Lost to Follow-up|0|||
130319694|NCT03186209|469139660|FG001|Overall Study|Lost to Follow-up|1|||
130319695|NCT04739982|469139666|FG000|Overall Study|Lost to Follow-up|176|||
130319696|NCT04739982|469139667|FG001|Overall Study|Lost to Follow-up|65|||
130319697|NCT04739982|469139666|FG000|Overall Study|Withdrawal by Subject|19|||
130319698|NCT04739982|469139667|FG001|Overall Study|Withdrawal by Subject|0|||
130319699|NCT04739982|469139666|FG000|Overall Study|Protocol Violation|0|||
130319700|NCT04739982|469139667|FG001|Overall Study|Protocol Violation|5|||
130319701|NCT04079296|469139668|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130319702|NCT04079296|469139669|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130319703|NCT04079296|469139670|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
130319704|NCT04079296|469139671|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
130319705|NCT04079296|469139672|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
130319706|NCT04079296|469139668|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130319707|NCT04079296|469139669|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130319708|NCT04079296|469139670|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
130319709|NCT04079296|469139671|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
130319710|NCT04079296|469139672|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
130319711|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319712|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319713|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319714|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
130319715|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
130319716|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319717|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319718|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319719|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
130319720|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
130319721|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319722|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319723|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319724|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
130319725|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
130319726|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130319727|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130319728|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
130319729|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
130319730|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
130319731|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130319732|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130319733|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
130319734|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
130319735|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
130319736|NCT04079296|469139668|FG000|Dose Expansion Phase (168 Days)|Death|0|||
130319737|NCT04079296|469139669|FG001|Dose Expansion Phase (168 Days)|Death|0|||
130319738|NCT04079296|469139670|FG002|Dose Expansion Phase (168 Days)|Death|0|||
130319739|NCT04079296|469139671|FG003|Dose Expansion Phase (168 Days)|Death|1|||
130319740|NCT04079296|469139672|FG004|Dose Expansion Phase (168 Days)|Death|0|||
130319741|NCT01346358|469139685|FG000|Overall Study|Withdrawal by Subject|1|||
130319742|NCT01346358|469139686|FG001|Overall Study|Withdrawal by Subject|0|||
130319743|NCT01346358|469139687|FG002|Overall Study|Withdrawal by Subject|1|||
130319744|NCT01346358|469139688|FG003|Overall Study|Withdrawal by Subject|1|||
130319745|NCT01346358|469139689|FG004|Overall Study|Withdrawal by Subject|0|||
130319746|NCT01346358|469139690|FG005|Overall Study|Withdrawal by Subject|2|||
130319747|NCT01346358|469139691|FG006|Overall Study|Withdrawal by Subject|1|||
130319748|NCT01346358|469139692|FG007|Overall Study|Withdrawal by Subject|1|||
130319749|NCT01346358|469139693|FG008|Overall Study|Withdrawal by Subject|1|||
130319750|NCT01346358|469139685|FG000|Overall Study|Adverse Event|1|||
130319751|NCT01346358|469139686|FG001|Overall Study|Adverse Event|0|||
130319752|NCT01346358|469139687|FG002|Overall Study|Adverse Event|0|||
130319753|NCT01346358|469139688|FG003|Overall Study|Adverse Event|0|||
130319754|NCT01346358|469139689|FG004|Overall Study|Adverse Event|1|||
130319755|NCT01346358|469139690|FG005|Overall Study|Adverse Event|0|||
130319756|NCT01346358|469139691|FG006|Overall Study|Adverse Event|0|||
130319757|NCT01346358|469139692|FG007|Overall Study|Adverse Event|0|||
130319758|NCT01346358|469139693|FG008|Overall Study|Adverse Event|1|||
130319759|NCT01346358|469139685|FG000|Overall Study|Non-Compliance|0|||
130319760|NCT01346358|469139686|FG001|Overall Study|Non-Compliance|0|||
130319761|NCT01346358|469139687|FG002|Overall Study|Non-Compliance|0|||
130319762|NCT01346358|469139688|FG003|Overall Study|Non-Compliance|0|||
130319763|NCT01346358|469139689|FG004|Overall Study|Non-Compliance|0|||
130319764|NCT01346358|469139690|FG005|Overall Study|Non-Compliance|0|||
130319765|NCT01346358|469139691|FG006|Overall Study|Non-Compliance|0|||
130319766|NCT01346358|469139692|FG007|Overall Study|Non-Compliance|2|||
130319767|NCT01346358|469139693|FG008|Overall Study|Non-Compliance|0|||
130319768|NCT01346358|469139685|FG000|Overall Study|Physician Decision|0|||
130319769|NCT01346358|469139686|FG001|Overall Study|Physician Decision|1|||
130319770|NCT01346358|469139687|FG002|Overall Study|Physician Decision|0|||
130319771|NCT01346358|469139688|FG003|Overall Study|Physician Decision|0|||
130319772|NCT01346358|469139689|FG004|Overall Study|Physician Decision|0|||
130319773|NCT01346358|469139690|FG005|Overall Study|Physician Decision|0|||
130319774|NCT01346358|469139691|FG006|Overall Study|Physician Decision|0|||
130319775|NCT01346358|469139692|FG007|Overall Study|Physician Decision|1|||
130319776|NCT01346358|469139693|FG008|Overall Study|Physician Decision|1|||
130319777|NCT05058365|469139696|FG000|Overall Study|Migration|1|||
130319778|NCT05058365|469139697|FG001|Overall Study|Migration|1|||
130319779|NCT00702702|469139698|FG000|Overall Study|Study prematurely terminated|56|||
130319780|NCT04038359|469139699|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
130319781|NCT04038359|469139700|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
130319782|NCT04038359|469139699|FG000|Overall Study|Death|8|||
130319783|NCT04038359|469139700|FG001|Overall Study|Death|7|||
130319784|NCT04038359|469139699|FG000|Overall Study|Lost to Follow-up|3|||
130319785|NCT04038359|469139700|FG001|Overall Study|Lost to Follow-up|0|||
130319786|NCT04038359|469139699|FG000|Overall Study|Participant Moved|1|||
130319787|NCT04038359|469139700|FG001|Overall Study|Participant Moved|0|||
130319788|NCT04038359|469139699|FG000|Overall Study|Withdrawal by Subject|4|||
130319789|NCT04038359|469139700|FG001|Overall Study|Withdrawal by Subject|3|||
130319790|NCT04038359|469139699|FG000|Overall Study|Physician Decision|3|||
130319791|NCT04038359|469139700|FG001|Overall Study|Physician Decision|2|||
130319792|NCT04038359|469139699|FG000|Overall Study|Adverse Event|0|||
130319793|NCT04038359|469139700|FG001|Overall Study|Adverse Event|2|||
130319794|NCT04038359|469139699|FG000|Overall Study|Progressive Disease|0|||
130319795|NCT04038359|469139700|FG001|Overall Study|Progressive Disease|1|||
130319796|NCT02004236|469139701|FG000|Overall Study|Lack of Efficacy|0|||
130319797|NCT02004236|469139702|FG001|Overall Study|Lack of Efficacy|0|||
130319798|NCT02004236|469139703|FG002|Overall Study|Lack of Efficacy|16|||
130319799|NCT05121766|469139704|FG000|Overall Study|Covid reinfection|3|||
130319800|NCT05121766|469139705|FG001|Overall Study|Covid reinfection|0|||
130319801|NCT05121766|469139704|FG000|Overall Study|Withdrawal by Subject|3|||
130319802|NCT05121766|469139705|FG001|Overall Study|Withdrawal by Subject|1|||
130319803|NCT05121766|469139704|FG000|Overall Study|Adverse Event|2|||
130319804|NCT05121766|469139705|FG001|Overall Study|Adverse Event|4|||
130319805|NCT05121766|469139704|FG000|Overall Study|Lost to Follow-up|0|||
130319806|NCT05121766|469139705|FG001|Overall Study|Lost to Follow-up|1|||
130319807|NCT03259230|469139707|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
130319808|NCT03259230|469139708|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
130319809|NCT01033240|469139709|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
130319810|NCT01033240|469139710|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
130319811|NCT01033240|469139711|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
130319812|NCT01033240|469139709|FG000|Overall Study|Death|2|||
130319813|NCT01033240|469139710|FG001|Overall Study|Death|0|||
130319814|NCT01033240|469139711|FG002|Overall Study|Death|0|||
130319815|NCT01033240|469139709|FG000|Overall Study|Withdrew Consent|2|||
130319816|NCT01033240|469139710|FG001|Overall Study|Withdrew Consent|9|||
130319817|NCT01033240|469139711|FG002|Overall Study|Withdrew Consent|2|||
130319818|NCT01033240|469139709|FG000|Overall Study|Disease Progression|35|||
130319819|NCT01033240|469139710|FG001|Overall Study|Disease Progression|32|||
130319820|NCT01033240|469139711|FG002|Overall Study|Disease Progression|41|||
130319821|NCT01033240|469139709|FG000|Overall Study|Investigator Discretion|0|||
130319822|NCT01033240|469139710|FG001|Overall Study|Investigator Discretion|0|||
130319823|NCT01033240|469139711|FG002|Overall Study|Investigator Discretion|2|||
130319824|NCT01033240|469139709|FG000|Overall Study|Other|0|||
130319825|NCT01033240|469139710|FG001|Overall Study|Other|1|||
130319826|NCT01033240|469139711|FG002|Overall Study|Other|2|||
130319827|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
130319828|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
130319829|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
130319830|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
130319831|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
130319832|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
130319833|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
130319834|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
130319835|NCT02960217|469139713|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
130319836|NCT02960217|469139714|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
130319837|NCT02960217|469139713|FG000|Open-Label Extension Phase|Adverse Event|1|||
130319838|NCT02960217|469139714|FG001|Open-Label Extension Phase|Adverse Event|0|||
130319839|NCT02960217|469139713|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
130319840|NCT02960217|469139714|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
130319841|NCT02960217|469139713|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
130319842|NCT02960217|469139714|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
130319843|NCT02960217|469139713|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
130319844|NCT02960217|469139714|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
130319845|NCT00625131|469139715|FG000|Overall Study|Lost to Follow-up|3|||
130097110|NCT00467051|468312954|FG000|Overall Study|Adverse Event|2|||
130319846|NCT00625131|469139716|FG001|Overall Study|Lost to Follow-up|2|||
130319847|NCT00625131|469139717|FG002|Overall Study|Lost to Follow-up|0|||
130319848|NCT00625131|469139715|FG000|Overall Study|Withdrawal by Subject|1|||
130319849|NCT00625131|469139716|FG001|Overall Study|Withdrawal by Subject|0|||
130319850|NCT00625131|469139717|FG002|Overall Study|Withdrawal by Subject|5|||
130319851|NCT00918281|469139720|FG000|Overall Study|Physician Decision|29|||
130319852|NCT01743469|469139721|FG000|Active Treatment Phase|Adverse Event|10|||
130319853|NCT01743469|469139722|FG001|Active Treatment Phase|Adverse Event|5|||
130319854|NCT01743469|469139723|FG002|Active Treatment Phase|Adverse Event|8|||
130319855|NCT01743469|469139724|FG003|Active Treatment Phase|Adverse Event|1|||
130319856|NCT01743469|469139721|FG000|Active Treatment Phase|Disease Progression|40|||
130319857|NCT01743469|469139722|FG001|Active Treatment Phase|Disease Progression|47|||
130319858|NCT01743469|469139723|FG002|Active Treatment Phase|Disease Progression|30|||
130319859|NCT01743469|469139724|FG003|Active Treatment Phase|Disease Progression|20|||
130319860|NCT01743469|469139721|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
130319861|NCT01743469|469139722|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
130319862|NCT01743469|469139723|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
130319863|NCT01743469|469139724|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
130319864|NCT01743469|469139721|FG000|Active Treatment Phase|Missing|1|||
130319865|NCT01743469|469139722|FG001|Active Treatment Phase|Missing|0|||
130319866|NCT01743469|469139723|FG002|Active Treatment Phase|Missing|0|||
130319867|NCT01743469|469139724|FG003|Active Treatment Phase|Missing|0|||
130319868|NCT01743469|469139721|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
130319869|NCT01743469|469139722|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
130319870|NCT01743469|469139723|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
130319871|NCT01743469|469139724|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
130319872|NCT01743469|469139721|FG000|Follow-up Period - Post-Treatment|Death|43|||
130319873|NCT01743469|469139722|FG001|Follow-up Period - Post-Treatment|Death|47|||
130319874|NCT01743469|469139723|FG002|Follow-up Period - Post-Treatment|Death|22|||
130319875|NCT01743469|469139724|FG003|Follow-up Period - Post-Treatment|Death|16|||
130319876|NCT01743469|469139721|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
130319877|NCT01743469|469139722|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
130319878|NCT01743469|469139723|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
130319879|NCT01743469|469139724|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
130319880|NCT00317473|469139725|FG000|Overall Study|Withdrawal by Subject|2|||
130319881|NCT00317473|469139726|FG001|Overall Study|Withdrawal by Subject|1|||
130319882|NCT00317473|469139727|FG002|Overall Study|Withdrawal by Subject|2|||
130319883|NCT00317473|469139728|FG003|Overall Study|Withdrawal by Subject|1|||
130319884|NCT00317473|469139729|FG004|Overall Study|Withdrawal by Subject|3|||
130319885|NCT00317473|469139730|FG005|Overall Study|Withdrawal by Subject|1|||
130319886|NCT00317473|469139725|FG000|Overall Study|Relocation|1|||
130319887|NCT00317473|469139726|FG001|Overall Study|Relocation|0|||
130319888|NCT00317473|469139727|FG002|Overall Study|Relocation|1|||
130319889|NCT00317473|469139728|FG003|Overall Study|Relocation|1|||
130319890|NCT00317473|469139729|FG004|Overall Study|Relocation|5|||
130319891|NCT00317473|469139730|FG005|Overall Study|Relocation|2|||
130319892|NCT00317473|469139725|FG000|Overall Study|Death|1|||
130319893|NCT00317473|469139726|FG001|Overall Study|Death|0|||
130319894|NCT00317473|469139727|FG002|Overall Study|Death|0|||
130319895|NCT00317473|469139728|FG003|Overall Study|Death|0|||
130319896|NCT00317473|469139729|FG004|Overall Study|Death|0|||
130319897|NCT00317473|469139730|FG005|Overall Study|Death|0|||
130319898|NCT00317473|469139725|FG000|Overall Study|Other|0|||
130319899|NCT00317473|469139726|FG001|Overall Study|Other|2|||
130319900|NCT00317473|469139727|FG002|Overall Study|Other|0|||
130319901|NCT00317473|469139728|FG003|Overall Study|Other|0|||
130319902|NCT00317473|469139729|FG004|Overall Study|Other|0|||
130319903|NCT00317473|469139730|FG005|Overall Study|Other|0|||
130319904|NCT00388349|469139731|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
130319905|NCT00388349|469139732|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
130319906|NCT00168844|469139733|FG000|Overall Study|Adverse Event|31|||
130319907|NCT00168844|469139734|FG001|Overall Study|Adverse Event|32|||
130319908|NCT00168844|469139735|FG002|Overall Study|Adverse Event|48|||
130319909|NCT00168844|469139733|FG000|Overall Study|Lost to Follow-up|4|||
130319910|NCT00168844|469139734|FG001|Overall Study|Lost to Follow-up|5|||
130319911|NCT00168844|469139735|FG002|Overall Study|Lost to Follow-up|11|||
130319912|NCT00168844|469139733|FG000|Overall Study|Withdrawal by Subject|12|||
130319913|NCT00168844|469139734|FG001|Overall Study|Withdrawal by Subject|9|||
130319914|NCT00168844|469139735|FG002|Overall Study|Withdrawal by Subject|19|||
130319915|NCT00168844|469139733|FG000|Overall Study|Protocol Violation|2|||
130319916|NCT00168844|469139734|FG001|Overall Study|Protocol Violation|2|||
130319917|NCT00168844|469139735|FG002|Overall Study|Protocol Violation|4|||
130319918|NCT00168844|469139733|FG000|Overall Study|Other|6|||
130319919|NCT00168844|469139734|FG001|Overall Study|Other|7|||
130319920|NCT00168844|469139735|FG002|Overall Study|Other|9|||
130319921|NCT02138890|469139744|FG000|Overall Study|Adverse Event|1|||
130319922|NCT02138890|469139745|FG001|Overall Study|Adverse Event|0|||
130319923|NCT01446159|469139748|FG000|Overall Study|Withdrawal by Subject|1|||
130319924|NCT01446159|469139749|FG001|Overall Study|Withdrawal by Subject|0|||
130319925|NCT01446159|469139750|FG002|Overall Study|Withdrawal by Subject|14|||
130319926|NCT01446159|469139751|FG003|Overall Study|Withdrawal by Subject|11|||
130319927|NCT01446159|469139748|FG000|Overall Study|Lost to Follow-up|0|||
130319928|NCT01446159|469139749|FG001|Overall Study|Lost to Follow-up|0|||
130319929|NCT01446159|469139750|FG002|Overall Study|Lost to Follow-up|1|||
130319930|NCT01446159|469139751|FG003|Overall Study|Lost to Follow-up|2|||
130319931|NCT01446159|469139748|FG000|Overall Study|Death|2|||
130319932|NCT01446159|469139749|FG001|Overall Study|Death|3|||
130319933|NCT01446159|469139750|FG002|Overall Study|Death|43|||
130319934|NCT01446159|469139751|FG003|Overall Study|Death|36|||
130319935|NCT01446159|469139748|FG000|Overall Study|Other|0|||
130319936|NCT01446159|469139749|FG001|Overall Study|Other|0|||
130319937|NCT01446159|469139750|FG002|Overall Study|Other|13|||
130319938|NCT01446159|469139751|FG003|Overall Study|Other|13|||
130319939|NCT00537394|469139752|FG000|First Year of Follow-up|Death|7|||
130319940|NCT00537394|469139753|FG001|First Year of Follow-up|Death|0|||
130319941|NCT00537394|469139754|FG002|First Year of Follow-up|Death|0|||
130319942|NCT00537394|469139752|FG000|First Year of Follow-up|Severe debilitation|1|||
130319943|NCT00537394|469139753|FG001|First Year of Follow-up|Severe debilitation|0|||
130319944|NCT00537394|469139754|FG002|First Year of Follow-up|Severe debilitation|1|||
130319945|NCT00537394|469139752|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
130319946|NCT00537394|469139753|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
130319947|NCT00537394|469139754|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
130319948|NCT00537394|469139752|FG000|First Year of Follow-up|Lost to Follow-up|1|||
130319949|NCT00537394|469139753|FG001|First Year of Follow-up|Lost to Follow-up|5|||
130319950|NCT00537394|469139754|FG002|First Year of Follow-up|Lost to Follow-up|1|||
130319951|NCT00537394|469139752|FG000|2nd Year of Follow-up|Death|4|||
130319952|NCT00537394|469139753|FG001|2nd Year of Follow-up|Death|1|||
130319953|NCT00537394|469139754|FG002|2nd Year of Follow-up|Death|2|||
130319954|NCT00537394|469139752|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
130319955|NCT00537394|469139753|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
130319956|NCT00537394|469139754|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
130319957|NCT00537394|469139752|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
130319958|NCT00537394|469139753|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
130319959|NCT00537394|469139754|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
130319960|NCT00537394|469139752|FG000|2nd Year of Follow-up|Clinic site closure|1|||
130319961|NCT00537394|469139753|FG001|2nd Year of Follow-up|Clinic site closure|0|||
130319962|NCT00537394|469139754|FG002|2nd Year of Follow-up|Clinic site closure|0|||
130319963|NCT00685165|469139756|FG000|Washout Period of 14 Days|Adverse Event|1|||
130319964|NCT00685165|469139757|FG001|Washout Period of 14 Days|Adverse Event|0|||
130319965|NCT00795535|469139765|FG000|Overall Study|incomplete data and technical problems|20|||
130319966|NCT00556075|469139766|FG000|Overall Study|Lost to Follow-up|3|||
130319967|NCT00556075|469139767|FG001|Overall Study|Lost to Follow-up|0|||
130319968|NCT00556075|469139768|FG002|Overall Study|Lost to Follow-up|3|||
130319969|NCT00556075|469139766|FG000|Overall Study|Withdrawal by Subject|3|||
130319970|NCT00556075|469139767|FG001|Overall Study|Withdrawal by Subject|3|||
130319971|NCT00556075|469139768|FG002|Overall Study|Withdrawal by Subject|0|||
130319972|NCT00556075|469139766|FG000|Overall Study|Protocol Violation|1|||
130319973|NCT00556075|469139767|FG001|Overall Study|Protocol Violation|1|||
130319974|NCT00556075|469139768|FG002|Overall Study|Protocol Violation|3|||
130319975|NCT00556075|469139766|FG000|Overall Study|Not eligible|1|||
130319976|NCT00556075|469139767|FG001|Overall Study|Not eligible|1|||
130319977|NCT00556075|469139768|FG002|Overall Study|Not eligible|2|||
130319978|NCT00556075|469139766|FG000|Overall Study|Adverse Event|1|||
130319979|NCT00556075|469139767|FG001|Overall Study|Adverse Event|2|||
130319980|NCT00556075|469139768|FG002|Overall Study|Adverse Event|0|||
130319981|NCT00556075|469139766|FG000|Overall Study|Personal issues|4|||
130319982|NCT00556075|469139767|FG001|Overall Study|Personal issues|1|||
130319983|NCT00556075|469139768|FG002|Overall Study|Personal issues|0|||
130319984|NCT00556075|469139766|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
130319985|NCT00556075|469139767|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
130319986|NCT00556075|469139768|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
130319987|NCT02485691|469139769|FG000|Overall Study|Adverse Event|25|||
130319988|NCT02485691|469139770|FG001|Overall Study|Adverse Event|11|||
130319989|NCT02485691|469139769|FG000|Overall Study|Poor compliance to protocol|0|||
130319990|NCT02485691|469139770|FG001|Overall Study|Poor compliance to protocol|1|||
130319991|NCT02485691|469139769|FG000|Overall Study|Disease progression|57|||
130319992|NCT02485691|469139770|FG001|Overall Study|Disease progression|92|||
130319993|NCT02485691|469139769|FG000|Overall Study|Investigator's decision|23|||
130319994|NCT02485691|469139770|FG001|Overall Study|Investigator's decision|5|||
130319995|NCT02485691|469139769|FG000|Overall Study|Participant's request|13|||
130319996|NCT02485691|469139770|FG001|Overall Study|Participant's request|6|||
130319997|NCT02485691|469139769|FG000|Overall Study|Other reason|8|||
130319998|NCT02485691|469139770|FG001|Overall Study|Other reason|9|||
130319999|NCT02485691|469139769|FG000|Overall Study|Randomized and not treated|3|||
130320000|NCT02485691|469139770|FG001|Overall Study|Randomized and not treated|2|||
130320001|NCT01420861|469139771|FG000|Overall Study|Adverse Event|2|||
130320002|NCT01420861|469139771|FG000|Overall Study|Study terminated by Sponsor|7|||
130320003|NCT01420861|469139771|FG000|Overall Study|Screen failure|7|||
130320004|NCT01420861|469139771|FG000|Overall Study|Randomized not Treated|2|||
130320005|NCT04764162|469139772|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
130320006|NCT04764162|469139773|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
130097111|NCT00934661|468312955|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
130209224|NCT00412217|468727200|FG001|Overall Study|Disease Progression|3|||
130320007|NCT03361137|469139774|FG000|Overall Study|Reason not specified|1|||
130320008|NCT03361137|469139775|FG001|Overall Study|Reason not specified|0|||
130320009|NCT03361137|469139776|FG002|Overall Study|Reason not specified|0|||
130320010|NCT03361137|469139777|FG003|Overall Study|Reason not specified|0|||
130320011|NCT03361137|469139778|FG004|Overall Study|Reason not specified|0|||
130320012|NCT03413891|469139779|FG000|Overall Study|Lost to Follow-up|2|||
130320013|NCT03413891|469139780|FG001|Overall Study|Lost to Follow-up|1|||
130320014|NCT03413891|469139779|FG000|Overall Study|Protocol Violation|0|||
130320015|NCT03413891|469139780|FG001|Overall Study|Protocol Violation|1|||
130320016|NCT04905134|469139783|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
130320017|NCT04905134|469139783|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
130320018|NCT03009058|469139784|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
130320019|NCT05556265|469139785|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320020|NCT05556265|469139786|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
130320021|NCT05556265|469139787|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320022|NCT05556265|469139788|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320023|NCT05556265|469139789|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
130320024|NCT05556265|469139785|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320025|NCT05556265|469139786|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
130320026|NCT05556265|469139787|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320027|NCT05556265|469139788|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320028|NCT05556265|469139789|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
130320029|NCT05556265|469139785|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320030|NCT05556265|469139786|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
130320031|NCT05556265|469139787|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320032|NCT05556265|469139788|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320033|NCT05556265|469139789|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
130320034|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
130320035|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
130320036|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
130320037|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
130320038|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
130320039|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
130320040|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
130320041|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
130320042|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
130320043|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
130320044|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
130320045|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
130320046|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
130320047|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
130320048|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
130320049|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130320050|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
130320051|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130320052|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
130320053|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
130320054|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130320055|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130320056|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
130320057|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
130320058|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
130320059|NCT05556265|469139785|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130320060|NCT05556265|469139786|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130320061|NCT05556265|469139787|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
130320062|NCT05556265|469139788|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
130320063|NCT05556265|469139789|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
130320064|NCT01486966|469139792|FG000|Overall Study|Adverse Event|0|||
130320065|NCT01486966|469139793|FG001|Overall Study|Adverse Event|1|||
130320066|NCT01486966|469139792|FG000|Overall Study|Withdrawal by Subject|0|||
130320067|NCT01486966|469139793|FG001|Overall Study|Withdrawal by Subject|1|||
130320068|NCT02153086|469141810|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
130320069|NCT02153086|469141810|FG000|Overall Study|Other|2|||
130320070|NCT01317472|469141811|FG000|Overall Study|Withdrawal by Subject|1|||
130320071|NCT01317472|469141812|FG001|Overall Study|Withdrawal by Subject|0|||
130320072|NCT01317472|469141811|FG000|Overall Study|Unrelated hospitalization|1|||
130320073|NCT01317472|469141812|FG001|Overall Study|Unrelated hospitalization|0|||
130320074|NCT05546476|469141813|FG000|Period 1: Part A|Adverse Event|2|||
130320075|NCT05546476|469141814|FG001|Period 1: Part A|Adverse Event|0|||
130320076|NCT05546476|469141815|FG002|Period 1: Part A|Adverse Event|0|||
130320077|NCT05546476|469141816|FG003|Period 1: Part A|Adverse Event|1|||
130320078|NCT05546476|469141813|FG000|Period 1: Part A|Death|4|||
130320079|NCT05546476|469141814|FG001|Period 1: Part A|Death|4|||
130320080|NCT05546476|469141815|FG002|Period 1: Part A|Death|5|||
130320081|NCT05546476|469141816|FG003|Period 1: Part A|Death|6|||
130320082|NCT05546476|469141813|FG000|Period 1: Part A|Lack of Efficacy|0|||
130320083|NCT05546476|469141814|FG001|Period 1: Part A|Lack of Efficacy|0|||
130320084|NCT05546476|469141815|FG002|Period 1: Part A|Lack of Efficacy|0|||
130320085|NCT05546476|469141816|FG003|Period 1: Part A|Lack of Efficacy|1|||
130320086|NCT05546476|469141813|FG000|Period 1: Part A|Lost to Follow-up|0|||
130320087|NCT05546476|469141814|FG001|Period 1: Part A|Lost to Follow-up|0|||
130320088|NCT05546476|469141815|FG002|Period 1: Part A|Lost to Follow-up|0|||
130320089|NCT05546476|469141816|FG003|Period 1: Part A|Lost to Follow-up|1|||
130320090|NCT05546476|469141813|FG000|Period 1: Part A|Physician Decision|1|||
130320091|NCT05546476|469141814|FG001|Period 1: Part A|Physician Decision|0|||
130320092|NCT05546476|469141815|FG002|Period 1: Part A|Physician Decision|0|||
130320093|NCT05546476|469141816|FG003|Period 1: Part A|Physician Decision|0|||
130320094|NCT05546476|469141813|FG000|Period 1: Part A|Progressive disease|3|||
130320095|NCT05546476|469141814|FG001|Period 1: Part A|Progressive disease|5|||
130320096|NCT05546476|469141815|FG002|Period 1: Part A|Progressive disease|0|||
130320097|NCT05546476|469141816|FG003|Period 1: Part A|Progressive disease|1|||
130320098|NCT05546476|469141813|FG000|Period 1: Part A|Withdrawal by Subject|1|||
130320099|NCT05546476|469141814|FG001|Period 1: Part A|Withdrawal by Subject|1|||
130320100|NCT05546476|469141815|FG002|Period 1: Part A|Withdrawal by Subject|1|||
130320101|NCT05546476|469141816|FG003|Period 1: Part A|Withdrawal by Subject|2|||
130320102|NCT05546476|469141813|FG000|Period 1: Part A|Global deterioration of health status|2|||
130320103|NCT05546476|469141814|FG001|Period 1: Part A|Global deterioration of health status|2|||
130320104|NCT05546476|469141815|FG002|Period 1: Part A|Global deterioration of health status|1|||
130320105|NCT05546476|469141816|FG003|Period 1: Part A|Global deterioration of health status|4|||
130320106|NCT05546476|469141813|FG000|Period 1: Part A|Other: Unspecified|0|||
130320107|NCT05546476|469141814|FG001|Period 1: Part A|Other: Unspecified|2|||
130320108|NCT05546476|469141815|FG002|Period 1: Part A|Other: Unspecified|0|||
130320109|NCT05546476|469141816|FG003|Period 1: Part A|Other: Unspecified|0|||
130320110|NCT05546476|469141813|FG000|Period 2: Part B|Ongoing|26|||
130320111|NCT05546476|469141814|FG001|Period 2: Part B|Ongoing|27|||
130320112|NCT05546476|469141815|FG002|Period 2: Part B|Ongoing|35|||
130320113|NCT05546476|469141816|FG003|Period 2: Part B|Ongoing|29|||
130320114|NCT02953652|469141817|FG000|Overall Study|Adverse Event|18|||
130320115|NCT02953652|469141817|FG000|Overall Study|Withdrawal by Subject|6|||
130320116|NCT02953652|469141817|FG000|Overall Study|Protocol Violation|1|||
130320117|NCT02953652|469141817|FG000|Overall Study|Disease Progression|27|||
130320118|NCT00772538|469141818|FG000|Overall Study|Adverse Event|6|||
130320119|NCT00772538|469141819|FG001|Overall Study|Adverse Event|6|||
130320120|NCT00772538|469141818|FG000|Overall Study|Protocol Violation|3|||
130320121|NCT00772538|469141819|FG001|Overall Study|Protocol Violation|3|||
130320122|NCT00772538|469141818|FG000|Overall Study|Lost to Follow-up|1|||
130320123|NCT00772538|469141819|FG001|Overall Study|Lost to Follow-up|1|||
130320124|NCT00772538|469141818|FG000|Overall Study|Withdrawal by Subject|3|||
130320125|NCT00772538|469141819|FG001|Overall Study|Withdrawal by Subject|8|||
130320126|NCT00772538|469141818|FG000|Overall Study|Lack of Efficacy|0|||
130320127|NCT00772538|469141819|FG001|Overall Study|Lack of Efficacy|1|||
130320128|NCT00772538|469141818|FG000|Overall Study|Other|7|||
130320129|NCT00772538|469141819|FG001|Overall Study|Other|7|||
130320130|NCT00713609|469141822|FG000|Overall Study|Adverse Event|2|||
130320131|NCT00713609|469141823|FG001|Overall Study|Adverse Event|0|||
130320132|NCT00713609|469141824|FG002|Overall Study|Adverse Event|2|||
130320133|NCT00713609|469141825|FG003|Overall Study|Adverse Event|2|||
130320134|NCT00713609|469141826|FG004|Overall Study|Adverse Event|3|||
130320135|NCT00713609|469141827|FG005|Overall Study|Adverse Event|1|||
130320136|NCT00713609|469141822|FG000|Overall Study|Lost to Follow-up|5|||
130320137|NCT00713609|469141823|FG001|Overall Study|Lost to Follow-up|7|||
130320138|NCT00713609|469141824|FG002|Overall Study|Lost to Follow-up|5|||
130320139|NCT00713609|469141825|FG003|Overall Study|Lost to Follow-up|5|||
130320140|NCT00713609|469141826|FG004|Overall Study|Lost to Follow-up|7|||
130320141|NCT00713609|469141827|FG005|Overall Study|Lost to Follow-up|0|||
130320142|NCT00713609|469141822|FG000|Overall Study|Lack of Efficacy|1|||
130320143|NCT00713609|469141823|FG001|Overall Study|Lack of Efficacy|3|||
130320144|NCT00713609|469141824|FG002|Overall Study|Lack of Efficacy|0|||
130320145|NCT00713609|469141825|FG003|Overall Study|Lack of Efficacy|0|||
130320146|NCT00713609|469141826|FG004|Overall Study|Lack of Efficacy|1|||
130320147|NCT00713609|469141827|FG005|Overall Study|Lack of Efficacy|0|||
130320148|NCT00713609|469141822|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
130320149|NCT00713609|469141823|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
130320150|NCT00713609|469141824|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
130320151|NCT00713609|469141825|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
130320152|NCT00713609|469141826|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
130320153|NCT00713609|469141827|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
130320154|NCT00713609|469141822|FG000|Overall Study|Withdrawal by Subject|6|||
130320155|NCT00713609|469141823|FG001|Overall Study|Withdrawal by Subject|1|||
130320156|NCT00713609|469141824|FG002|Overall Study|Withdrawal by Subject|5|||
130320157|NCT00713609|469141825|FG003|Overall Study|Withdrawal by Subject|1|||
130320158|NCT00713609|469141826|FG004|Overall Study|Withdrawal by Subject|5|||
130320159|NCT00713609|469141827|FG005|Overall Study|Withdrawal by Subject|7|||
130320160|NCT00713609|469141822|FG000|Overall Study|Protocol Violation|6|||
130320161|NCT00713609|469141823|FG001|Overall Study|Protocol Violation|3|||
130320162|NCT00713609|469141824|FG002|Overall Study|Protocol Violation|1|||
130320163|NCT00713609|469141825|FG003|Overall Study|Protocol Violation|1|||
130320164|NCT00713609|469141826|FG004|Overall Study|Protocol Violation|2|||
130320165|NCT00713609|469141827|FG005|Overall Study|Protocol Violation|0|||
130320166|NCT03780452|469141831|FG000|Overall Study|Screening failure|2|||
130320167|NCT01001221|469141832|FG000|Overall Study|Adverse Event|1|||
130320168|NCT01001221|469141833|FG001|Overall Study|Adverse Event|2|||
130320169|NCT01001221|469141834|FG002|Overall Study|Adverse Event|0|||
130320170|NCT01001221|469141835|FG003|Overall Study|Adverse Event|2|||
130320171|NCT01001221|469141836|FG004|Overall Study|Adverse Event|0|||
130320172|NCT01001221|469141832|FG000|Overall Study|Disease progression|3|||
130320173|NCT01001221|469141833|FG001|Overall Study|Disease progression|2|||
130320174|NCT01001221|469141834|FG002|Overall Study|Disease progression|2|||
130320175|NCT01001221|469141835|FG003|Overall Study|Disease progression|4|||
129874992|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
129874993|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Physician Decision|4|||
129874994|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Physician Decision|1|||
129874995|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Physician Decision|3|||
129874996|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Physician Decision|0|||
129874997|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Physician Decision|0|||
129874998|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Physician Decision|1|||
129874999|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Physician Decision|0|||
129875000|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Other|0|||
129875001|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Other|1|||
129875002|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Other|0|||
129875003|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Other|0|||
129875004|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Other|0|||
129875005|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Other|0|||
129875006|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Other|0|||
129875007|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875008|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875009|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875010|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875011|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875012|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875013|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
129875014|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
129875015|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
129875016|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
129875017|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
129875018|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
129875019|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
129875020|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
129875021|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Pregnancy|0|||
129875022|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Pregnancy|0|||
129875023|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Pregnancy|1|||
129875024|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Pregnancy|0|||
129875025|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Pregnancy|0|||
130097112|NCT00934661|468312956|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
130320176|NCT01001221|469141836|FG004|Overall Study|Disease progression|0|||
130320177|NCT01001221|469141832|FG000|Overall Study|Other|1|||
130320178|NCT01001221|469141833|FG001|Overall Study|Other|1|||
130320179|NCT01001221|469141834|FG002|Overall Study|Other|0|||
129875026|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Pregnancy|0|||
129875027|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Pregnancy|0|||
129875028|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875029|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875030|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
130320180|NCT01001221|469141835|FG003|Overall Study|Other|0|||
130320181|NCT01001221|469141836|FG004|Overall Study|Other|0|||
130320182|NCT01001221|469141832|FG000|Overall Study|Not treated; protocol exclusion|0|||
130320183|NCT01001221|469141833|FG001|Overall Study|Not treated; protocol exclusion|0|||
130320184|NCT01001221|469141834|FG002|Overall Study|Not treated; protocol exclusion|1|||
130320185|NCT01001221|469141835|FG003|Overall Study|Not treated; protocol exclusion|0|||
130320186|NCT01001221|469141836|FG004|Overall Study|Not treated; protocol exclusion|0|||
130320187|NCT02388269|469141837|FG000|Overall Study|Adverse Event|2|||
130320188|NCT02388269|469141838|FG001|Overall Study|Adverse Event|0|||
129875031|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130320189|NCT02388269|469141839|FG002|Overall Study|Adverse Event|0|||
130320190|NCT02388269|469141837|FG000|Overall Study|Withdrawal by Subject|1|||
130320191|NCT02388269|469141838|FG001|Overall Study|Withdrawal by Subject|2|||
130320192|NCT02388269|469141839|FG002|Overall Study|Withdrawal by Subject|0|||
130320193|NCT02388269|469141837|FG000|Overall Study|less than 50% stimulations|1|||
130320194|NCT02388269|469141838|FG001|Overall Study|less than 50% stimulations|0|||
130320195|NCT02388269|469141839|FG002|Overall Study|less than 50% stimulations|0|||
130320196|NCT02388269|469141837|FG000|Overall Study|no diary data|3|||
130320197|NCT02388269|469141838|FG001|Overall Study|no diary data|0|||
130320198|NCT02388269|469141839|FG002|Overall Study|no diary data|0|||
130320199|NCT02388269|469141837|FG000|Overall Study|Protocol Violation|2|||
130320200|NCT02388269|469141838|FG001|Overall Study|Protocol Violation|0|||
130320201|NCT02388269|469141839|FG002|Overall Study|Protocol Violation|0|||
130320202|NCT02388269|469141837|FG000|Overall Study|Screen Failure|0|||
130320203|NCT02388269|469141838|FG001|Overall Study|Screen Failure|0|||
130320204|NCT02388269|469141839|FG002|Overall Study|Screen Failure|10|||
130320205|NCT01791244|469141841|FG000|Overall Study|Adverse Event|5|||
130320206|NCT01791244|469141842|FG001|Overall Study|Adverse Event|7|||
130320207|NCT01791244|469141841|FG000|Overall Study|Insufficient clinical response|10|||
130320208|NCT01791244|469141842|FG001|Overall Study|Insufficient clinical response|10|||
130320209|NCT01791244|469141841|FG000|Overall Study|Laboratory Abnormality|0|||
130320210|NCT01791244|469141842|FG001|Overall Study|Laboratory Abnormality|1|||
130320211|NCT01383928|469141843|FG000|Overall Study|Initiation of ASCT|2|||
130320212|NCT01383928|469141844|FG001|Overall Study|Initiation of ASCT|1|||
130320213|NCT01383928|469141845|FG002|Overall Study|Initiation of ASCT|18|||
130320214|NCT01383928|469141843|FG000|Overall Study|Adverse Event|1|||
130320215|NCT01383928|469141844|FG001|Overall Study|Adverse Event|2|||
130320216|NCT01383928|469141845|FG002|Overall Study|Adverse Event|8|||
130320217|NCT01383928|469141843|FG000|Overall Study|Other|1|||
130320218|NCT01383928|469141844|FG001|Overall Study|Other|3|||
130320219|NCT01383928|469141845|FG002|Overall Study|Other|4|||
130320220|NCT01383928|469141843|FG000|Overall Study|Progressive Disease|1|||
130320221|NCT01383928|469141844|FG001|Overall Study|Progressive Disease|1|||
130320222|NCT01383928|469141845|FG002|Overall Study|Progressive Disease|5|||
130320223|NCT01383928|469141843|FG000|Overall Study|Withdrawal by Subject|0|||
130320224|NCT01383928|469141844|FG001|Overall Study|Withdrawal by Subject|0|||
130320225|NCT01383928|469141845|FG002|Overall Study|Withdrawal by Subject|4|||
130320226|NCT01383928|469141843|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
130320227|NCT01383928|469141844|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130320228|NCT01383928|469141845|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
130320229|NCT01149096|469141847|FG000|Overall Study|Lost to Follow-up|0|||
130320230|NCT01149096|469141848|FG001|Overall Study|Lost to Follow-up|1|||
130320231|NCT03651765|469141850|FG000|Overall Study|Adverse Event|6|||
130320232|NCT03651765|469141850|FG000|Overall Study|Lack of Efficacy|18|||
130320233|NCT03651765|469141850|FG000|Overall Study|Lost to Follow-up|5|||
130320234|NCT03651765|469141850|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130320235|NCT03651765|469141850|FG000|Overall Study|Physician Decision|6|||
130320236|NCT03651765|469141850|FG000|Overall Study|Pregnancy|1|||
130320237|NCT03651765|469141850|FG000|Overall Study|Discontinued by Sponsor|40|||
130320238|NCT03651765|469141850|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
130320239|NCT03651765|469141850|FG000|Overall Study|Withdrawal by Subject|24|||
130320240|NCT03651765|469141850|FG000|Overall Study|Miscellaneous|6|||
130320241|NCT00703014|469141858|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
130320242|NCT00703014|469141859|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
130320243|NCT00703014|469141860|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320244|NCT00703014|469141861|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320245|NCT00703014|469141858|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320246|NCT00703014|469141859|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
130320247|NCT00703014|469141860|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
130320248|NCT00703014|469141861|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
130320249|NCT05468814|469141864|FG000|Overall Study|Lost to Follow-up|5|||
130320250|NCT05468814|469141865|FG001|Overall Study|Lost to Follow-up|6|||
130320251|NCT04716426|469141866|FG000|Overall Study|Vaccination|1|||
130320252|NCT04716426|469141867|FG001|Overall Study|Vaccination|1|||
130320253|NCT04716426|469141866|FG000|Overall Study|Contamination|1|||
130320254|NCT04716426|469141867|FG001|Overall Study|Contamination|0|||
130320255|NCT03668873|469141869|FG000|Overall Study|Lost to Follow-up|6|||
130320256|NCT03668873|469141870|FG001|Overall Study|Lost to Follow-up|3|||
130320257|NCT01521117|469141871|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
130320258|NCT01521117|469141872|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130320259|NCT01521117|469141871|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
130320260|NCT01521117|469141872|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
130209225|NCT00412217|468727199|FG000|Overall Study|Investigator Decision|1|||
130320261|NCT01521117|469141871|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130320262|NCT01521117|469141872|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
130320263|NCT00784563|469141873|FG000|Years 1 & 2|Withdrawal by Subject|3|||
130320264|NCT00784563|469141874|FG001|Years 1 & 2|Withdrawal by Subject|2|||
130320265|NCT00784563|469141875|FG002|Years 1 & 2|Withdrawal by Subject|0|||
130320266|NCT00784563|469141873|FG000|Years 1 & 2|Adverse Event|0|||
130320267|NCT00784563|469141874|FG001|Years 1 & 2|Adverse Event|3|||
130320268|NCT00784563|469141875|FG002|Years 1 & 2|Adverse Event|0|||
130320269|NCT00784563|469141873|FG000|Year 3|Withdrawal by Subject|0|||
130320270|NCT00784563|469141874|FG001|Year 3|Withdrawal by Subject|0|||
130320271|NCT00784563|469141875|FG002|Year 3|Withdrawal by Subject|2|||
130320272|NCT00784563|469141873|FG000|Year 3|Adverse Event|0|||
130320273|NCT00784563|469141874|FG001|Year 3|Adverse Event|0|||
130320274|NCT00784563|469141875|FG002|Year 3|Adverse Event|1|||
130097113|NCT00761462|468312960|FG000|Treatment|Subjects never received study medication|23|||
130097114|NCT00761462|468312961|FG001|Treatment|Subjects never received study medication|12|||
130097115|NCT00761462|468312960|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
130097116|NCT00761462|468312961|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
130097117|NCT00761462|468312960|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
130097118|NCT00761462|468312961|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
130097119|NCT00761462|468312960|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
130097120|NCT00761462|468312961|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
130097121|NCT01479777|468312962|FG000|Overall Study|Physician Decision|2|||
130097122|NCT01013207|468312966|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
130097123|NCT01541644|468312971|FG000|Overall Study|Withdrawal by Subject|3|||
130097124|NCT02389621|468312972|FG000|Treatment Period|Withdrawal by Subject|1|||
130097125|NCT02389621|468312973|FG001|Treatment Period|Withdrawal by Subject|1|||
130097126|NCT02389621|468312972|FG000|Posttreatment Period|Adverse Event|3|||
130097127|NCT02389621|468312973|FG001|Posttreatment Period|Adverse Event|1|||
130097128|NCT02389621|468312972|FG000|Posttreatment Period|Withdrawal by Subject|3|||
130097129|NCT02389621|468312973|FG001|Posttreatment Period|Withdrawal by Subject|2|||
130097130|NCT02389621|468312972|FG000|Posttreatment Period|Lost to Follow-up|1|||
130097131|NCT02389621|468312973|FG001|Posttreatment Period|Lost to Follow-up|1|||
130097132|NCT02389621|468312972|FG000|Posttreatment Period|Other - Miscellaneous|2|||
130097133|NCT02389621|468312973|FG001|Posttreatment Period|Other - Miscellaneous|0|||
130097134|NCT02957149|468312992|FG000|Overall Study|Withdrawal by Subject|5|||
130097135|NCT00003526|468312993|FG000|Overall Study|Not evaluable|6|||
130097136|NCT00505765|468312998|FG000|Overall Study|Withdrawal by Subject|1|||
130097137|NCT00505765|468312999|FG001|Overall Study|Withdrawal by Subject|0|||
130097138|NCT00505765|468313000|FG002|Overall Study|Withdrawal by Subject|0|||
130097139|NCT00505765|468312998|FG000|Overall Study|Adverse Event|1|||
130097140|NCT00505765|468312999|FG001|Overall Study|Adverse Event|2|||
130097141|NCT00505765|468313000|FG002|Overall Study|Adverse Event|0|||
130097142|NCT00505765|468312998|FG000|Overall Study|Noncompliance|0|||
130097143|NCT00505765|468312999|FG001|Overall Study|Noncompliance|1|||
130097144|NCT00505765|468313000|FG002|Overall Study|Noncompliance|3|||
130097145|NCT00779857|468313001|FG000|Overall Study|Death|1|||
130097146|NCT00779857|468313001|FG000|Overall Study|Withdrawal by Subject|3|||
130097147|NCT00779857|468313001|FG000|Overall Study|Missed Visit|2|||
130097148|NCT04640168|468313002|FG000|Overall Study|Withdrawal by Subject|8|||
130209226|NCT00412217|468727200|FG001|Overall Study|Investigator Decision|0|||
130209227|NCT00412217|468727199|FG000|Overall Study|Withdrawal by Subject|2|||
130097149|NCT04640168|468313003|FG001|Overall Study|Withdrawal by Subject|7|||
130097150|NCT04640168|468313002|FG000|Overall Study|Lost to Follow-up|1|||
130209228|NCT00412217|468727200|FG001|Overall Study|Withdrawal by Subject|0|||
130320275|NCT00374140|469141882|FG000|Overall Study|Lost to Follow-up|1|||
130097151|NCT04640168|468313003|FG001|Overall Study|Lost to Follow-up|0|||
130097152|NCT04640168|468313002|FG000|Overall Study|Enrolled but not treated|12|||
130097153|NCT04640168|468313003|FG001|Overall Study|Enrolled but not treated|12|||
130097154|NCT01453296|468313004|FG000|Treatment Period 1|Adverse Event|0|||
130097155|NCT01453296|468313005|FG001|Treatment Period 1|Adverse Event|1|||
130097156|NCT01453296|468313004|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
130097157|NCT01453296|468313005|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
130097158|NCT01453296|468313004|FG000|Treatment Period 2|Adverse Event|1|||
130097159|NCT01453296|468313005|FG001|Treatment Period 2|Adverse Event|0|||
130097160|NCT01453296|468313004|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130097161|NCT01453296|468313005|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130097162|NCT00620776|468313006|FG000|Overall Study|Did not receive treatment|3|||
130097163|NCT00620776|468313007|FG001|Overall Study|Did not receive treatment|5|||
130097164|NCT00620776|468313006|FG000|Overall Study|Adverse Event|2|||
130097165|NCT00620776|468313007|FG001|Overall Study|Adverse Event|3|||
130097166|NCT00620776|468313006|FG000|Overall Study|Lack of Efficacy|2|||
130097167|NCT00620776|468313007|FG001|Overall Study|Lack of Efficacy|1|||
130097168|NCT00620776|468313006|FG000|Overall Study|Lost to Follow-up|2|||
130097169|NCT00620776|468313007|FG001|Overall Study|Lost to Follow-up|5|||
130097170|NCT00620776|468313006|FG000|Overall Study|Withdrawal by Subject|3|||
130097171|NCT00620776|468313007|FG001|Overall Study|Withdrawal by Subject|2|||
130097172|NCT04366258|468313011|FG000|Baseline Assessments|Screen Failure|21|||
130097173|NCT04366258|468313011|FG000|Baseline Assessments|Early Termination|3|||
129875032|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
130097174|NCT00308555|468313012|FG000|Overall Study|Withdrawal by Subject|1|||
130097175|NCT00308555|468313013|FG001|Overall Study|Withdrawal by Subject|0|||
129875033|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875034|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875035|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
129875036|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875037|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
129875038|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875039|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875040|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
129875041|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
130097176|NCT00308555|468313012|FG000|Overall Study|Physician Decision|2|||
130097177|NCT00308555|468313013|FG001|Overall Study|Physician Decision|0|||
130097178|NCT00276458|468313018|FG000|Overall Study|Adverse Event|0|||
130097179|NCT00276458|468313019|FG001|Overall Study|Adverse Event|2|||
130097180|NCT00276458|468313018|FG000|Overall Study|Lost to Follow-up|2|||
130097181|NCT00276458|468313019|FG001|Overall Study|Lost to Follow-up|2|||
129875042|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Other|0|||
129875043|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Other|1|||
129875044|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Other|0|||
129875045|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Other|0|||
129875046|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Other|0|||
129875047|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Other|0|||
129875048|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Other|0|||
129875049|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
129875050|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130097182|NCT00276458|468313018|FG000|Overall Study|Protocol Violation|4|||
130097183|NCT00276458|468313019|FG001|Overall Study|Protocol Violation|3|||
130097184|NCT02940392|468313024|FG000|Overall Study|Lost to Follow-up|3|||
130097185|NCT02940392|468313024|FG000|Overall Study|Retreatment|3|||
130097186|NCT02940392|468313024|FG000|Overall Study|Death|2|||
130097187|NCT03205046|468313026|FG000|Overall Study|Death|10|||
130097188|NCT03205046|468313027|FG001|Overall Study|Death|6|||
130097189|NCT03205046|468313026|FG000|Overall Study|Withdrawal by Subject|1|||
130097190|NCT03205046|468313027|FG001|Overall Study|Withdrawal by Subject|2|||
130097191|NCT03205046|468313026|FG000|Overall Study|Lost to Follow-up|0|||
130097192|NCT03205046|468313027|FG001|Overall Study|Lost to Follow-up|1|||
130097193|NCT03205046|468313026|FG000|Overall Study|Study terminated by sponsor|2|||
130097194|NCT03205046|468313027|FG001|Overall Study|Study terminated by sponsor|1|||
130097195|NCT01023815|468313028|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
130097196|NCT01023815|468313029|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
130097197|NCT01023815|468313030|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
130097198|NCT01023815|468313031|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
130097199|NCT01023815|468313028|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
130097200|NCT01023815|468313029|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
130097201|NCT01023815|468313030|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
130097202|NCT01023815|468313031|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
130097203|NCT01023815|468313028|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
130097204|NCT01023815|468313029|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
130097205|NCT01023815|468313030|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
130097206|NCT01023815|468313031|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
130097207|NCT01023815|468313028|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
130097208|NCT01023815|468313029|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
130097209|NCT01023815|468313030|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
130097210|NCT01023815|468313031|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
130097211|NCT01023815|468313028|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
130097212|NCT01023815|468313029|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
130097213|NCT01023815|468313030|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
130097214|NCT01023815|468313031|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
130097215|NCT03253809|468313034|FG000|Overall Study|Unable to obtain study related data|14|||
130097216|NCT03992456|468313035|FG000|Overall Study|Withdrawal by Subject|1|||
130097217|NCT03992456|468313036|FG001|Overall Study|Withdrawal by Subject|0|||
129875051|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
129875052|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129875053|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
130097218|NCT03992456|468313035|FG000|Overall Study|Disease progression|4|||
130097219|NCT03992456|468313036|FG001|Overall Study|Disease progression|5|||
130097220|NCT03992456|468313035|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
130097221|NCT03992456|468313036|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
130097222|NCT00910000|468313040|FG000|Overall Study|Adverse Event|0|||
130097223|NCT00910000|468313041|FG001|Overall Study|Adverse Event|3|||
130097224|NCT00910000|468313042|FG002|Overall Study|Adverse Event|2|||
130097225|NCT00910000|468313043|FG003|Overall Study|Adverse Event|2|||
130097226|NCT00910000|468313044|FG004|Overall Study|Adverse Event|0|||
130097227|NCT00910000|468313045|FG005|Overall Study|Adverse Event|1|||
130097228|NCT00910000|468313040|FG000|Overall Study|Withdrawal by Subject|0|||
130097229|NCT00910000|468313041|FG001|Overall Study|Withdrawal by Subject|0|||
130097230|NCT00910000|468313042|FG002|Overall Study|Withdrawal by Subject|1|||
130097231|NCT00910000|468313043|FG003|Overall Study|Withdrawal by Subject|0|||
130097232|NCT00910000|468313044|FG004|Overall Study|Withdrawal by Subject|1|||
130097233|NCT00910000|468313045|FG005|Overall Study|Withdrawal by Subject|0|||
130097234|NCT01977625|468313046|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
130097235|NCT01977625|468313047|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130097236|NCT01977625|468313046|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130097237|NCT01977625|468313047|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130097238|NCT04113746|468313048|FG000|Overall Study|Lost to Follow-up|4|||
130097239|NCT04113746|468313049|FG001|Overall Study|Lost to Follow-up|4|||
130097240|NCT02594384|468313050|FG000|Overall Study|Disease Progression|3|||
130097241|NCT02594384|468313051|FG001|Overall Study|Disease Progression|7|||
130097242|NCT02594384|468313052|FG002|Overall Study|Disease Progression|0|||
130097243|NCT02594384|468313053|FG003|Overall Study|Disease Progression|2|||
130097244|NCT02594384|468313054|FG004|Overall Study|Disease Progression|2|||
130097245|NCT02594384|468313055|FG005|Overall Study|Disease Progression|12|||
130097246|NCT02594384|468313056|FG006|Overall Study|Disease Progression|5|||
130097247|NCT02594384|468313057|FG007|Overall Study|Disease Progression|5|||
130097248|NCT02594384|468313050|FG000|Overall Study|Adverse Event|0|||
130097249|NCT02594384|468313051|FG001|Overall Study|Adverse Event|1|||
130097250|NCT02594384|468313052|FG002|Overall Study|Adverse Event|4|||
130097251|NCT02594384|468313053|FG003|Overall Study|Adverse Event|1|||
130097252|NCT02594384|468313054|FG004|Overall Study|Adverse Event|0|||
130097253|NCT02594384|468313055|FG005|Overall Study|Adverse Event|6|||
130097254|NCT02594384|468313056|FG006|Overall Study|Adverse Event|1|||
130097255|NCT02594384|468313057|FG007|Overall Study|Adverse Event|1|||
130097256|NCT02594384|468313050|FG000|Overall Study|Withdrawal by Subject|0|||
130097257|NCT02594384|468313051|FG001|Overall Study|Withdrawal by Subject|0|||
130097258|NCT02594384|468313052|FG002|Overall Study|Withdrawal by Subject|0|||
130097259|NCT02594384|468313053|FG003|Overall Study|Withdrawal by Subject|1|||
130097260|NCT02594384|468313054|FG004|Overall Study|Withdrawal by Subject|0|||
130097261|NCT02594384|468313055|FG005|Overall Study|Withdrawal by Subject|0|||
130097262|NCT02594384|468313056|FG006|Overall Study|Withdrawal by Subject|0|||
130097263|NCT02594384|468313057|FG007|Overall Study|Withdrawal by Subject|1|||
130097264|NCT02594384|468313050|FG000|Overall Study|Physician Decision|0|||
130097265|NCT02594384|468313051|FG001|Overall Study|Physician Decision|0|||
130097266|NCT02594384|468313052|FG002|Overall Study|Physician Decision|0|||
130097267|NCT02594384|468313053|FG003|Overall Study|Physician Decision|0|||
130097268|NCT02594384|468313054|FG004|Overall Study|Physician Decision|0|||
130097269|NCT02594384|468313055|FG005|Overall Study|Physician Decision|1|||
130097270|NCT02594384|468313056|FG006|Overall Study|Physician Decision|2|||
130097271|NCT02594384|468313057|FG007|Overall Study|Physician Decision|0|||
130097272|NCT02594384|468313050|FG000|Overall Study|Progressive Leukocytosis|0|||
130097273|NCT02594384|468313051|FG001|Overall Study|Progressive Leukocytosis|0|||
130097274|NCT02594384|468313052|FG002|Overall Study|Progressive Leukocytosis|1|||
130097275|NCT02594384|468313053|FG003|Overall Study|Progressive Leukocytosis|0|||
130097276|NCT02594384|468313054|FG004|Overall Study|Progressive Leukocytosis|0|||
130097277|NCT02594384|468313055|FG005|Overall Study|Progressive Leukocytosis|0|||
130097278|NCT02594384|468313056|FG006|Overall Study|Progressive Leukocytosis|0|||
130097279|NCT02594384|468313057|FG007|Overall Study|Progressive Leukocytosis|0|||
130097280|NCT02594384|468313050|FG000|Overall Study|Lack of Efficacy|0|||
130097281|NCT02594384|468313051|FG001|Overall Study|Lack of Efficacy|0|||
130097282|NCT02594384|468313052|FG002|Overall Study|Lack of Efficacy|0|||
130097283|NCT02594384|468313053|FG003|Overall Study|Lack of Efficacy|0|||
130097284|NCT02594384|468313054|FG004|Overall Study|Lack of Efficacy|1|||
130097285|NCT02594384|468313055|FG005|Overall Study|Lack of Efficacy|0|||
130097286|NCT02594384|468313056|FG006|Overall Study|Lack of Efficacy|0|||
130209229|NCT00412217|468727199|FG000|Overall Study|Lost to Follow-up|1|||
130097287|NCT02594384|468313057|FG007|Overall Study|Lack of Efficacy|0|||
130097288|NCT02594384|468313050|FG000|Overall Study|Substantial noncompliance|0|||
130097289|NCT02594384|468313051|FG001|Overall Study|Substantial noncompliance|0|||
130097290|NCT02594384|468313052|FG002|Overall Study|Substantial noncompliance|0|||
130097291|NCT02594384|468313053|FG003|Overall Study|Substantial noncompliance|0|||
130097292|NCT02594384|468313054|FG004|Overall Study|Substantial noncompliance|0|||
130209230|NCT00412217|468727200|FG001|Overall Study|Lost to Follow-up|4|||
130209231|NCT00412217|468727199|FG000|Overall Study|Study Terminated by Sponsor|26|||
130209232|NCT00412217|468727200|FG001|Overall Study|Study Terminated by Sponsor|33|||
130209233|NCT00412217|468727199|FG000|Overall Study|Other|1|||
130209234|NCT00412217|468727200|FG001|Overall Study|Other|1|||
130209235|NCT01398410|468727202|FG000|Overall Study|Adverse Event|12|||
130209236|NCT01398410|468727203|FG001|Overall Study|Adverse Event|16|||
130209237|NCT01398410|468727202|FG000|Overall Study|Participants Choice|8|||
130209238|NCT01398410|468727203|FG001|Overall Study|Participants Choice|11|||
130209239|NCT01398410|468727202|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
130209240|NCT01398410|468727203|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
130209241|NCT01398410|468727202|FG000|Overall Study|Other|36|||
130209242|NCT01398410|468727203|FG001|Overall Study|Other|29|||
130209243|NCT03209518|468727206|FG000|Overall Study|Case Report Forms Uncollected|1|||
130209244|NCT03209518|468727206|FG000|Overall Study|Protocol Deviation|1|||
130209245|NCT00236899|468727207|FG000|Overall Study|Adverse Event (Study Related)|1|||
130209246|NCT00236899|468727208|FG001|Overall Study|Adverse Event (Study Related)|1|||
130209247|NCT00236899|468727209|FG002|Overall Study|Adverse Event (Study Related)|2|||
130209248|NCT00236899|468727210|FG003|Overall Study|Adverse Event (Study Related)|1|||
130209249|NCT00236899|468727207|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
130209250|NCT00236899|468727208|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
130209251|NCT00236899|468727209|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
130209252|NCT00236899|468727210|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
130209253|NCT00236899|468727207|FG000|Overall Study|Death (Study Disease)|1|||
130209254|NCT00236899|468727208|FG001|Overall Study|Death (Study Disease)|4|||
130209255|NCT00236899|468727209|FG002|Overall Study|Death (Study Disease)|0|||
130209256|NCT00236899|468727210|FG003|Overall Study|Death (Study Disease)|0|||
130209257|NCT00236899|468727207|FG000|Overall Study|Death (Not Study Related)|2|||
130209258|NCT00236899|468727208|FG001|Overall Study|Death (Not Study Related)|0|||
130209259|NCT00236899|468727209|FG002|Overall Study|Death (Not Study Related)|0|||
130209260|NCT00236899|468727210|FG003|Overall Study|Death (Not Study Related)|0|||
130209261|NCT00236899|468727207|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
130209262|NCT00236899|468727208|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
130209263|NCT00236899|468727209|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
130209264|NCT00236899|468727210|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
130209265|NCT00236899|468727207|FG000|Overall Study|Lost to Follow-up|0|||
130209266|NCT00236899|468727208|FG001|Overall Study|Lost to Follow-up|1|||
130209267|NCT00236899|468727209|FG002|Overall Study|Lost to Follow-up|0|||
130209268|NCT00236899|468727210|FG003|Overall Study|Lost to Follow-up|0|||
130209269|NCT00236899|468727207|FG000|Overall Study|Entry Criteria Exclusion|0|||
130209270|NCT00236899|468727208|FG001|Overall Study|Entry Criteria Exclusion|1|||
130209271|NCT00236899|468727209|FG002|Overall Study|Entry Criteria Exclusion|1|||
130209272|NCT00236899|468727210|FG003|Overall Study|Entry Criteria Exclusion|0|||
130209273|NCT00236899|468727207|FG000|Overall Study|Protocol Violation|1|||
130209274|NCT00236899|468727208|FG001|Overall Study|Protocol Violation|0|||
130209275|NCT00236899|468727209|FG002|Overall Study|Protocol Violation|0|||
130209276|NCT00236899|468727210|FG003|Overall Study|Protocol Violation|0|||
130209277|NCT00236899|468727207|FG000|Overall Study|Withdrawal by Subject|6|||
130209278|NCT00236899|468727208|FG001|Overall Study|Withdrawal by Subject|4|||
130209279|NCT00236899|468727209|FG002|Overall Study|Withdrawal by Subject|5|||
130209280|NCT00236899|468727210|FG003|Overall Study|Withdrawal by Subject|2|||
130209281|NCT00236899|468727207|FG000|Overall Study|Physician Decision|7|||
130209282|NCT00236899|468727208|FG001|Overall Study|Physician Decision|8|||
130209283|NCT00236899|468727209|FG002|Overall Study|Physician Decision|7|||
130209284|NCT00236899|468727210|FG003|Overall Study|Physician Decision|6|||
130209285|NCT00236899|468727207|FG000|Overall Study|Satisfactory Response|2|||
130209286|NCT00236899|468727208|FG001|Overall Study|Satisfactory Response|0|||
130209287|NCT00236899|468727209|FG002|Overall Study|Satisfactory Response|0|||
130209288|NCT00236899|468727210|FG003|Overall Study|Satisfactory Response|1|||
130209289|NCT00236899|468727207|FG000|Overall Study|Lack of Efficacy|18|||
130209290|NCT00236899|468727208|FG001|Overall Study|Lack of Efficacy|18|||
130209291|NCT00236899|468727209|FG002|Overall Study|Lack of Efficacy|25|||
130209292|NCT00236899|468727210|FG003|Overall Study|Lack of Efficacy|23|||
130209293|NCT03379792|468727211|FG000|Overall Study|Physician Decision|0|||
130209294|NCT03379792|468727212|FG001|Overall Study|Physician Decision|0|||
130209295|NCT03379792|468727213|FG002|Overall Study|Physician Decision|0|||
130209296|NCT03379792|468727214|FG003|Overall Study|Physician Decision|1|||
130209297|NCT03379792|468727215|FG004|Overall Study|Physician Decision|0|||
130209298|NCT03379792|468727216|FG005|Overall Study|Physician Decision|0|||
130209299|NCT03379792|468727211|FG000|Overall Study|Withdrawal by Subject|0|||
130209300|NCT03379792|468727212|FG001|Overall Study|Withdrawal by Subject|0|||
130209301|NCT03379792|468727213|FG002|Overall Study|Withdrawal by Subject|0|||
130209302|NCT03379792|468727214|FG003|Overall Study|Withdrawal by Subject|0|||
130209303|NCT03379792|468727215|FG004|Overall Study|Withdrawal by Subject|1|||
130209304|NCT03379792|468727216|FG005|Overall Study|Withdrawal by Subject|1|||
130209305|NCT02854605|468727219|FG000|Overall Study|Adverse Event|1|||
130209306|NCT02854605|468727220|FG001|Overall Study|Adverse Event|5|||
130209307|NCT02854605|468727221|FG002|Overall Study|Adverse Event|2|||
130209308|NCT02854605|468727219|FG000|Overall Study|Lost to Follow-up|0|||
130097293|NCT02594384|468313055|FG005|Overall Study|Substantial noncompliance|0|||
130097294|NCT02594384|468313056|FG006|Overall Study|Substantial noncompliance|1|||
130097295|NCT02594384|468313057|FG007|Overall Study|Substantial noncompliance|0|||
130097296|NCT04964960|468313060|FG000|Overall Study|Withdrawal by Subject|1|||
130097297|NCT02686749|468313061|FG000|Overall Study|terminated for poor enrollment|2|||
130097298|NCT02686749|468313062|FG001|Overall Study|terminated for poor enrollment|2|||
130097299|NCT05147311|468313065|FG000|Overall Study|Did not complete survey|2|||
130097300|NCT05147311|468313066|FG001|Overall Study|Did not complete survey|1|||
130097301|NCT05147311|468313065|FG000|Overall Study|Patient too sick|1|||
130097302|NCT05147311|468313066|FG001|Overall Study|Patient too sick|2|||
130097303|NCT05147311|468313065|FG000|Overall Study|Death|0|||
130097304|NCT05147311|468313066|FG001|Overall Study|Death|1|||
130097305|NCT05147311|468313065|FG000|Overall Study|Declined survey|1|||
130097306|NCT05147311|468313066|FG001|Overall Study|Declined survey|0|||
130097307|NCT01015118|468313068|FG000|Overall Study|Protocol Violation|5|||
129875054|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129875055|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129875056|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875057|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
129875058|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875059|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
129875060|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875061|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875062|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
130097308|NCT01015118|468313069|FG001|Overall Study|Protocol Violation|6|||
130209309|NCT02854605|468727220|FG001|Overall Study|Lost to Follow-up|2|||
130209310|NCT02854605|468727221|FG002|Overall Study|Lost to Follow-up|0|||
130097309|NCT01015118|468313068|FG000|Overall Study|Withdrawal by Subject|103|||
130097310|NCT01015118|468313069|FG001|Overall Study|Withdrawal by Subject|27|||
130209311|NCT02854605|468727219|FG000|Overall Study|Withdrew Consent|1|||
130209312|NCT02854605|468727220|FG001|Overall Study|Withdrew Consent|0|||
129985698|NCT04811131|467909334|FG001|Overall Study|Adverse Event|0|||
130097311|NCT01015118|468313068|FG000|Overall Study|Other Adverse Event (AE)|141|||
130097312|NCT01015118|468313069|FG001|Overall Study|Other Adverse Event (AE)|33|||
129875063|NCT02063828|467499611|FG000|Overall Study|Withdrawal by Subject|4|||
129875064|NCT02063828|467499612|FG001|Overall Study|Withdrawal by Subject|6|||
129875065|NCT02063828|467499613|FG002|Overall Study|Withdrawal by Subject|3|||
129875066|NCT02063828|467499611|FG000|Overall Study|Death|0|||
129875067|NCT02063828|467499612|FG001|Overall Study|Death|0|||
129875068|NCT02063828|467499613|FG002|Overall Study|Death|1|||
129875069|NCT00733980|467499616|FG000|Overall Study|Adverse Event|5|||
129875070|NCT00733980|467499617|FG001|Overall Study|Adverse Event|2|||
129875071|NCT00733980|467499616|FG000|Overall Study|Lack of Efficacy|0|||
129875072|NCT00733980|467499617|FG001|Overall Study|Lack of Efficacy|1|||
129875073|NCT00733980|467499616|FG000|Overall Study|Protocol Violation|2|||
129875074|NCT00733980|467499617|FG001|Overall Study|Protocol Violation|1|||
129875075|NCT00733980|467499616|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
129875076|NCT00733980|467499617|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
129875077|NCT00733980|467499616|FG000|Overall Study|Lost to Follow-up|6|||
129875078|NCT00733980|467499617|FG001|Overall Study|Lost to Follow-up|11|||
129875079|NCT00733980|467499616|FG000|Overall Study|Physician Decision|2|||
129875080|NCT00733980|467499617|FG001|Overall Study|Physician Decision|3|||
129875081|NCT00733980|467499616|FG000|Overall Study|Withdrawal by Subject|6|||
129875082|NCT00733980|467499617|FG001|Overall Study|Withdrawal by Subject|2|||
129875083|NCT02010632|467499618|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
129875084|NCT02010632|467499619|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
129875085|NCT06387472|467499623|FG000|Overall Study|Withdrawal by Subject|1|||
129875086|NCT06387472|467499623|FG000|Overall Study|Lost to Follow-up|2|||
129875087|NCT06387472|467499623|FG000|Overall Study|Physician Decision|1|||
129875088|NCT01679236|467501804|FG000|Overall Study|Lost to Follow-up|15|||
129875089|NCT01679236|467501805|FG001|Overall Study|Lost to Follow-up|15|||
129875090|NCT00975221|467501807|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
129875091|NCT00975221|467501808|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
129875092|NCT00975221|467501807|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
129875093|NCT00975221|467501808|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
129875094|NCT00975221|467501807|FG000|Titration Phase (Weeks 1-12)|Other|0|||
129875095|NCT00975221|467501808|FG001|Titration Phase (Weeks 1-12)|Other|1|||
129875096|NCT00975221|467501807|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
129875097|NCT00975221|467501808|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
129875098|NCT00975221|467501807|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
129875099|NCT00975221|467501808|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
129875100|NCT00975221|467501807|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
129875101|NCT00975221|467501808|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
129875102|NCT03935217|467501809|FG000|Overall Study|Adverse Event|1|||
129875103|NCT03935217|467501810|FG001|Overall Study|Adverse Event|0|||
129875104|NCT03935217|467501809|FG000|Overall Study|Lost to Follow-up|0|||
129875105|NCT03935217|467501810|FG001|Overall Study|Lost to Follow-up|1|||
129875106|NCT03935217|467501809|FG000|Overall Study|Withdrawal by Subject|0|||
129875107|NCT03935217|467501810|FG001|Overall Study|Withdrawal by Subject|2|||
129875108|NCT03559218|467501811|FG000|Overall Study|Withdrawal by Subject|1|||
129875109|NCT03559218|467501812|FG001|Overall Study|Withdrawal by Subject|0|||
129875110|NCT03237858|467501819|FG000|Overall Study|Death|19|||
129875111|NCT03237858|467501819|FG000|Overall Study|Withdrawal by Subject|37|||
129875112|NCT01862991|467501820|FG000|Overall Study|Lost to Follow-up|2|||
129875113|NCT01862991|467501821|FG001|Overall Study|Lost to Follow-up|1|||
129875114|NCT01862991|467501822|FG002|Overall Study|Lost to Follow-up|1|||
129875115|NCT01862991|467501820|FG000|Overall Study|Protocol Violation|1|||
129875116|NCT01862991|467501821|FG001|Overall Study|Protocol Violation|0|||
129875117|NCT01862991|467501822|FG002|Overall Study|Protocol Violation|0|||
130097313|NCT01015118|468313068|FG000|Overall Study|Worsening or AE of underlying disease|5|||
130097314|NCT01015118|468313069|FG001|Overall Study|Worsening or AE of underlying disease|4|||
130097315|NCT01015118|468313068|FG000|Overall Study|Progressive disease|364|||
130097316|NCT01015118|468313069|FG001|Overall Study|Progressive disease|229|||
130097317|NCT01015118|468313068|FG000|Overall Study|Not treated|9|||
130097318|NCT01015118|468313069|FG001|Overall Study|Not treated|5|||
130097319|NCT01015118|468313068|FG000|Overall Study|Other than stated above|42|||
130097320|NCT01015118|468313069|FG001|Overall Study|Other than stated above|23|||
130097321|NCT03522506|468313070|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130097322|NCT03522506|468313071|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130097323|NCT03522506|468313072|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130097324|NCT03522506|468313073|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130097325|NCT03522506|468313070|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129875118|NCT04858802|467501823|FG000|Overall Study|Lost to Follow-up|1|||
129875119|NCT04858802|467501824|FG001|Overall Study|Lost to Follow-up|1|||
129875120|NCT04858802|467501823|FG000|Overall Study|Withdrawal by Subject|1|||
130097326|NCT03522506|468313071|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130097327|NCT03522506|468313072|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130097328|NCT03522506|468313073|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
130097329|NCT04365387|468313075|FG000|Overall Study|Adverse Event|4|||
130097330|NCT04365387|468313076|FG001|Overall Study|Adverse Event|2|||
130097331|NCT04365387|468313075|FG000|Overall Study|Participants request|14|||
130097332|NCT04365387|468313076|FG001|Overall Study|Participants request|14|||
130097333|NCT04365387|468313075|FG000|Overall Study|Lost to Follow-up|8|||
130097334|NCT04365387|468313076|FG001|Overall Study|Lost to Follow-up|5|||
130097335|NCT04365387|468313075|FG000|Overall Study|Protocol deviation|3|||
130097336|NCT04365387|468313076|FG001|Overall Study|Protocol deviation|4|||
130097337|NCT04365387|468313075|FG000|Overall Study|Participant compliance with visit schedule|1|||
130097338|NCT04365387|468313076|FG001|Overall Study|Participant compliance with visit schedule|0|||
130097339|NCT04365387|468313075|FG000|Overall Study|Participant incarcerated|1|||
130097340|NCT04365387|468313076|FG001|Overall Study|Participant incarcerated|0|||
130097341|NCT04365387|468313075|FG000|Overall Study|Participant moved out of town (relocated)|0|||
130097342|NCT04365387|468313076|FG001|Overall Study|Participant moved out of town (relocated)|1|||
130097343|NCT04365387|468313075|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
130097344|NCT04365387|468313076|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
130097345|NCT04365387|468313075|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
130097346|NCT04365387|468313076|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
130097347|NCT00480077|468313077|FG000|Overall Study|Death|19|||
130097348|NCT00480077|468313078|FG001|Overall Study|Death|15|||
130097349|NCT00480077|468313077|FG000|Overall Study|early exit|12|||
130097350|NCT00480077|468313078|FG001|Overall Study|early exit|11|||
130097351|NCT04298229|468313083|FG000|Overall Study|Physician Decision|1|||
130097352|NCT04298229|468313084|FG001|Overall Study|Physician Decision|1|||
130097353|NCT04298229|468313083|FG000|Overall Study|Withdrawal by Subject|1|||
130097354|NCT04298229|468313084|FG001|Overall Study|Withdrawal by Subject|1|||
130097355|NCT04298229|468313083|FG000|Overall Study|Did not receive IV loop diuretics|2|||
130097356|NCT04298229|468313084|FG001|Overall Study|Did not receive IV loop diuretics|0|||
130097357|NCT00262119|468313086|FG000|Overall Study|Lost to Follow-up|38|||
130097358|NCT00262119|468313087|FG001|Overall Study|Lost to Follow-up|51|||
130097359|NCT00262119|468313088|FG002|Overall Study|Lost to Follow-up|42|||
130097360|NCT00262119|468313086|FG000|Overall Study|Death|20|||
130097361|NCT00262119|468313087|FG001|Overall Study|Death|19|||
130097362|NCT00262119|468313088|FG002|Overall Study|Death|16|||
130097363|NCT01683565|468313089|FG000|Overall Study|Lost to Follow-up|2|||
130097364|NCT01683565|468313090|FG001|Overall Study|Lost to Follow-up|0|||
130097365|NCT01683565|468313089|FG000|Overall Study|Discontinued Intervention|1|||
130097366|NCT01683565|468313090|FG001|Overall Study|Discontinued Intervention|1|||
130097367|NCT00071006|468313091|FG000|Overall Study|Lack of Efficacy|7|||
130097368|NCT00071006|468313091|FG000|Overall Study|Adverse Event|1|||
130097369|NCT00071006|468313091|FG000|Overall Study|Withdrawal by Subject|1|||
130097370|NCT00071006|468313091|FG000|Overall Study|Other|3|||
130097371|NCT00859313|468313092|FG000|Overall Study|Lack of Efficacy|2|||
130097372|NCT00859313|468313092|FG000|Overall Study|Adverse Event|1|||
130097373|NCT00859313|468313092|FG000|Overall Study|staff error|1|||
130097374|NCT05261126|468313093|FG000|Overall Study|Death|0|||
130097375|NCT05261126|468313094|FG001|Overall Study|Death|0|||
130097376|NCT05261126|468313095|FG002|Overall Study|Death|1|||
130097377|NCT05261126|468313096|FG003|Overall Study|Death|0|||
130097378|NCT05261126|468313097|FG004|Overall Study|Death|0|||
130097379|NCT05261126|468313093|FG000|Overall Study|Lost to Follow-up|0|||
130097380|NCT05261126|468313094|FG001|Overall Study|Lost to Follow-up|0|||
130097381|NCT05261126|468313095|FG002|Overall Study|Lost to Follow-up|0|||
130097382|NCT05261126|468313096|FG003|Overall Study|Lost to Follow-up|0|||
129875121|NCT04858802|467501824|FG001|Overall Study|Withdrawal by Subject|1|||
129875122|NCT01108458|467501825|FG000|Overall Study|Withdrawal by Subject|1|||
129875123|NCT04170686|467501826|FG000|Screening|Physician Decision|12|||
129875124|NCT04170686|467501827|FG001|Screening|Physician Decision|13|||
129875125|NCT04170686|467501826|FG000|Randomization and Treatment|Lost to Follow-up|26|||
129875126|NCT04170686|467501827|FG001|Randomization and Treatment|Lost to Follow-up|15|||
129875127|NCT03328143|467501828|FG000|Overall Study|Declined|3|||
129875128|NCT03328143|467501828|FG000|Overall Study|Required increased sedation|4|||
129875129|NCT03328143|467501828|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
129875130|NCT03328143|467501828|FG000|Overall Study|Surgery cancelled|1|||
129875131|NCT02305381|467501829|FG000|Overall Study|Unclassified|5|||
129875132|NCT02305381|467501830|FG001|Overall Study|Unclassified|5|||
129875133|NCT02305381|467501831|FG002|Overall Study|Unclassified|7|||
129875134|NCT02487498|467501835|FG000|Period: Period 1|Adverse Event|2|||
129875135|NCT02487498|467501836|FG001|Period: Period 1|Adverse Event|4|||
129875136|NCT02487498|467501835|FG000|Period: Period 1|Subject/guardian decision|2|||
129875137|NCT02487498|467501836|FG001|Period: Period 1|Subject/guardian decision|4|||
129875138|NCT02487498|467501835|FG000|Period: Period 1|Lost to Follow-up|0|||
130097383|NCT05261126|468313097|FG004|Overall Study|Lost to Follow-up|1|||
130097384|NCT05261126|468313093|FG000|Overall Study|Physician Decision|1|||
130097385|NCT05261126|468313094|FG001|Overall Study|Physician Decision|0|||
130097386|NCT05261126|468313095|FG002|Overall Study|Physician Decision|0|||
130097387|NCT05261126|468313096|FG003|Overall Study|Physician Decision|0|||
130097388|NCT05261126|468313097|FG004|Overall Study|Physician Decision|0|||
130097389|NCT05261126|468313093|FG000|Overall Study|Screen Failure|0|||
129875139|NCT02487498|467501836|FG001|Period: Period 1|Lost to Follow-up|2|||
129875140|NCT02487498|467501835|FG000|Period: Period 1|Lack of Efficacy|1|||
129875141|NCT02487498|467501836|FG001|Period: Period 1|Lack of Efficacy|0|||
129875142|NCT02487498|467501835|FG000|Period: Period 1|Physician Decision|0|||
129875143|NCT02487498|467501836|FG001|Period: Period 1|Physician Decision|1|||
129875144|NCT02487498|467501835|FG000|Period: Period 1|Protocol deviation|1|||
130097390|NCT05261126|468313094|FG001|Overall Study|Screen Failure|0|||
130097391|NCT05261126|468313095|FG002|Overall Study|Screen Failure|0|||
130097392|NCT05261126|468313096|FG003|Overall Study|Screen Failure|0|||
130097393|NCT05261126|468313097|FG004|Overall Study|Screen Failure|1|||
130097394|NCT05261126|468313093|FG000|Overall Study|Withdrawal by Subject|1|||
130097395|NCT05261126|468313094|FG001|Overall Study|Withdrawal by Subject|0|||
130097396|NCT05261126|468313095|FG002|Overall Study|Withdrawal by Subject|1|||
130097397|NCT05261126|468313096|FG003|Overall Study|Withdrawal by Subject|1|||
130097398|NCT05261126|468313097|FG004|Overall Study|Withdrawal by Subject|0|||
129875145|NCT02487498|467501836|FG001|Period: Period 1|Protocol deviation|0|||
130097399|NCT05261126|468313093|FG000|Overall Study|Not Recorded|0|||
130097400|NCT05261126|468313094|FG001|Overall Study|Not Recorded|0|||
130097401|NCT05261126|468313095|FG002|Overall Study|Not Recorded|0|||
130097402|NCT05261126|468313096|FG003|Overall Study|Not Recorded|1|||
130097403|NCT05261126|468313097|FG004|Overall Study|Not Recorded|0|||
130097404|NCT05570604|468313098|FG000|Overall Study|Lost to Follow-up|1|||
130097405|NCT05570604|468313099|FG001|Overall Study|Lost to Follow-up|5|||
130097406|NCT05570604|468313098|FG000|Overall Study|Illness|2|||
130097407|NCT05570604|468313099|FG001|Overall Study|Illness|2|||
130097408|NCT00145119|468313102|FG000|Overall Study|Death|45|||
130097409|NCT05437211|468313109|FG000|Overall Study|Patient's decision|1|||
130097410|NCT05437211|468313110|FG001|Overall Study|Patient's decision|1|||
130097411|NCT04410991|468313112|FG000|Overall Study|Poor compliance to protocol|5|||
130097412|NCT04410991|468313113|FG001|Overall Study|Poor compliance to protocol|4|||
130097413|NCT04410991|468313112|FG000|Overall Study|Withdrawal by Subject|59|||
130097414|NCT04410991|468313113|FG001|Overall Study|Withdrawal by Subject|55|||
130097415|NCT04410991|468313112|FG000|Overall Study|Other|10|||
130097416|NCT04410991|468313113|FG001|Overall Study|Other|4|||
130097417|NCT01463631|468313121|FG000|Overall Study|Withdrawal by Subject|0|||
130097418|NCT01463631|468313122|FG001|Overall Study|Withdrawal by Subject|0|||
130097419|NCT01463631|468313123|FG002|Overall Study|Withdrawal by Subject|0|||
130097420|NCT01463631|468313124|FG003|Overall Study|Withdrawal by Subject|1|||
130097421|NCT01463631|468313121|FG000|Overall Study|Death|0|||
130097422|NCT01463631|468313122|FG001|Overall Study|Death|0|||
130097423|NCT01463631|468313123|FG002|Overall Study|Death|1|||
130097424|NCT01463631|468313124|FG003|Overall Study|Death|0|||
130097425|NCT01463631|468313121|FG000|Overall Study|Progressive Disease|0|||
130097426|NCT01463631|468313122|FG001|Overall Study|Progressive Disease|0|||
130097427|NCT01463631|468313123|FG002|Overall Study|Progressive Disease|0|||
129875146|NCT02487498|467501835|FG000|Period: Washout|Subject/guardian decision|0|||
129875147|NCT02487498|467501836|FG001|Period: Washout|Subject/guardian decision|5|||
129875148|NCT02487498|467501835|FG000|Period: Washout|Lack of Efficacy|1|||
129875149|NCT02487498|467501836|FG001|Period: Washout|Lack of Efficacy|1|||
129875150|NCT02487498|467501835|FG000|Period: Washout|Physician Decision|1|||
129875151|NCT02487498|467501836|FG001|Period: Washout|Physician Decision|0|||
129875152|NCT02487498|467501835|FG000|Period: Washout|Non-compliance with study treatment|0|||
129875153|NCT02487498|467501836|FG001|Period: Washout|Non-compliance with study treatment|1|||
129875154|NCT02487498|467501835|FG000|Period: Period 2|Adverse Event|2|||
129875155|NCT02487498|467501836|FG001|Period: Period 2|Adverse Event|2|||
129875156|NCT02487498|467501835|FG000|Period: Period 2|Subject/guardian decision|2|||
129875157|NCT02487498|467501836|FG001|Period: Period 2|Subject/guardian decision|1|||
129875158|NCT02487498|467501835|FG000|Period: Period 2|Lost to Follow-up|1|||
129875159|NCT02487498|467501836|FG001|Period: Period 2|Lost to Follow-up|1|||
129875160|NCT02487498|467501835|FG000|Period: Period 2|Death|0|||
130097428|NCT01463631|468313124|FG003|Overall Study|Progressive Disease|5|||
130097429|NCT05966129|468313125|FG000|Overall Study|Death|1|||
130097430|NCT05966129|468313126|FG001|Overall Study|Death|2|||
130097431|NCT05966129|468313125|FG000|Overall Study|Lost to Follow-up|63|||
130097432|NCT05966129|468313126|FG001|Overall Study|Lost to Follow-up|66|||
130097433|NCT05966129|468313125|FG000|Overall Study|Protocol Violation|1|||
130097434|NCT05966129|468313126|FG001|Overall Study|Protocol Violation|0|||
130097435|NCT05966129|468313125|FG000|Overall Study|Withdrawal by Subject|26|||
130097436|NCT05966129|468313126|FG001|Overall Study|Withdrawal by Subject|25|||
130097437|NCT05966129|468313125|FG000|Overall Study|Surgery not completed|63|||
130097438|NCT05966129|468313126|FG001|Overall Study|Surgery not completed|69|||
130097439|NCT05966129|468313125|FG000|Overall Study|Surgery logistics issue|2|||
130097440|NCT05966129|468313126|FG001|Overall Study|Surgery logistics issue|1|||
130097441|NCT03145207|468313127|FG000|Overall Study|volunteer started taking allergy shots|1|||
129875161|NCT02487498|467501836|FG001|Period: Period 2|Death|1|||
129875162|NCT02487498|467501835|FG000|Period: Period 2|Physician Decision|1|||
129875163|NCT02487498|467501836|FG001|Period: Period 2|Physician Decision|0|||
129875164|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Adverse Event|0|||
130209313|NCT02854605|468727221|FG002|Overall Study|Withdrew Consent|1|||
130097442|NCT03145207|468313127|FG000|Overall Study|baseline blood pressure high|1|||
130097443|NCT03526549|468315181|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
130097444|NCT03526549|468315182|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
130097445|NCT03526549|468315181|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
130097446|NCT03526549|468315182|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
130097447|NCT03526549|468315181|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
130097448|NCT03526549|468315182|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
130097449|NCT03526549|468315181|FG000|Open-label Phase|Adverse Event|4|||
130097450|NCT03526549|468315182|FG001|Open-label Phase|Adverse Event|0|||
130097451|NCT03526549|468315181|FG000|Open-label Phase|Withdrawal by Subject|54|||
130097452|NCT03526549|468315182|FG001|Open-label Phase|Withdrawal by Subject|0|||
130097453|NCT03526549|468315181|FG000|Open-label Phase|Lost to Follow-up|35|||
130097454|NCT03526549|468315182|FG001|Open-label Phase|Lost to Follow-up|0|||
130097455|NCT03526549|468315181|FG000|Open-label Phase|Other than Specified|5|||
130097456|NCT03526549|468315182|FG001|Open-label Phase|Other than Specified|0|||
130097457|NCT05981365|468315189|FG000|Period 1|Adverse Event|1|||
130097458|NCT05981365|468315190|FG001|Period 1|Adverse Event|0|||
130097459|NCT04780776|468315191|FG000|Titration Week 1-5|Lost to Follow-up|2|||
130097460|NCT04780776|468315192|FG001|Titration Week 1-5|Lost to Follow-up|8|||
130097461|NCT04780776|468315191|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
130097462|NCT04780776|468315192|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
130097463|NCT04780776|468315191|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
130097464|NCT04780776|468315192|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
130097465|NCT03113760|468315193|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
130097466|NCT03113760|468315194|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
130097467|NCT03113760|468315195|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
130097468|NCT03113760|468315196|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
130097469|NCT03113760|468315193|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
130097470|NCT03113760|468315194|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
130097471|NCT03113760|468315195|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
130097472|NCT03113760|468315196|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
130097473|NCT03113760|468315193|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
130097474|NCT03113760|468315194|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
130097475|NCT03113760|468315195|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
130097476|NCT03113760|468315196|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
130097477|NCT03927989|468315197|FG000|Overall Study|Withdrawal by Subject|0|||
130097478|NCT03927989|468315198|FG001|Overall Study|Withdrawal by Subject|1|||
130097479|NCT03919669|468315200|FG000|Overall Study|Withdrawal by Subject|1|||
130097480|NCT03919669|468315201|FG001|Overall Study|Withdrawal by Subject|0|||
130097481|NCT03919669|468315202|FG002|Overall Study|Withdrawal by Subject|0|||
130097482|NCT03125382|468315203|FG000|Randomization|screening failure|1|||
130097483|NCT03125382|468315204|FG001|Randomization|screening failure|4|||
130097484|NCT03125382|468315205|FG002|Randomization|screening failure|2|||
130097485|NCT03125382|468315206|FG003|Randomization|screening failure|0|||
130097486|NCT03125382|468315203|FG000|Follow-up|Death|1|||
130097487|NCT03125382|468315204|FG001|Follow-up|Death|2|||
130097488|NCT03125382|468315205|FG002|Follow-up|Death|1|||
130097489|NCT03125382|468315206|FG003|Follow-up|Death|2|||
130097490|NCT03125382|468315203|FG000|Follow-up|Lost to Follow-up|1|||
130097491|NCT03125382|468315204|FG001|Follow-up|Lost to Follow-up|4|||
130097492|NCT03125382|468315205|FG002|Follow-up|Lost to Follow-up|3|||
130097493|NCT03125382|468315206|FG003|Follow-up|Lost to Follow-up|1|||
130097494|NCT02319642|468315207|FG000|Overall Study|Adverse Event|2|||
130097495|NCT02319642|468315208|FG001|Overall Study|Adverse Event|4|||
130097496|NCT02319642|468315207|FG000|Overall Study|Lack of Efficacy|1|||
130097497|NCT02319642|468315208|FG001|Overall Study|Lack of Efficacy|1|||
130097498|NCT02319642|468315207|FG000|Overall Study|Withdrawal by Subject|1|||
130097499|NCT02319642|468315208|FG001|Overall Study|Withdrawal by Subject|1|||
130097500|NCT04668066|468315209|FG000|Part 1: Treatment Phase|Adverse Event|0|||
130097501|NCT04668066|468315210|FG001|Part 1: Treatment Phase|Adverse Event|0|||
130097502|NCT04668066|468315211|FG002|Part 1: Treatment Phase|Adverse Event|0|||
130097503|NCT04668066|468315212|FG003|Part 1: Treatment Phase|Adverse Event|0|||
130097504|NCT04668066|468315213|FG004|Part 1: Treatment Phase|Adverse Event|0|||
130097505|NCT04668066|468315214|FG005|Part 1: Treatment Phase|Adverse Event|0|||
130097506|NCT04668066|468315215|FG006|Part 1: Treatment Phase|Adverse Event|0|||
130097507|NCT04668066|468315216|FG007|Part 1: Treatment Phase|Adverse Event|0|||
130097508|NCT04668066|468315217|FG008|Part 1: Treatment Phase|Adverse Event|0|||
130097509|NCT04668066|468315218|FG009|Part 1: Treatment Phase|Adverse Event|0|||
130097510|NCT04668066|468315219|FG010|Part 1: Treatment Phase|Adverse Event|0|||
130097511|NCT04668066|468315220|FG011|Part 1: Treatment Phase|Adverse Event|1|||
130097512|NCT04668066|468315221|FG012|Part 1: Treatment Phase|Adverse Event|1|||
130097513|NCT04668066|468315222|FG013|Part 1: Treatment Phase|Adverse Event|0|||
130097514|NCT04668066|468315223|FG014|Part 1: Treatment Phase|Adverse Event|0|||
130097515|NCT04668066|468315224|FG015|Part 1: Treatment Phase|Adverse Event|0|||
130320276|NCT00374140|469141882|FG000|Overall Study|Protocol Violation|1|||
130097516|NCT04668066|468315225|FG016|Part 1: Treatment Phase|Adverse Event|0|||
130097517|NCT04668066|468315226|FG017|Part 1: Treatment Phase|Adverse Event|0|||
130097518|NCT04668066|468315227|FG018|Part 1: Treatment Phase|Adverse Event|0|||
130097519|NCT04668066|468315209|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097520|NCT04668066|468315210|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097521|NCT04668066|468315211|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
130097522|NCT04668066|468315212|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097523|NCT04668066|468315213|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097524|NCT04668066|468315214|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097525|NCT04668066|468315215|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097526|NCT04668066|468315216|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097527|NCT04668066|468315217|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097528|NCT04668066|468315218|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097529|NCT04668066|468315219|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097530|NCT04668066|468315220|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097531|NCT04668066|468315221|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097532|NCT04668066|468315222|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097533|NCT04668066|468315223|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097534|NCT04668066|468315224|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097535|NCT04668066|468315225|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097536|NCT04668066|468315226|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097537|NCT04668066|468315227|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
130097538|NCT04668066|468315209|FG000|Part 1: Treatment Phase|Other|0|||
130097539|NCT04668066|468315210|FG001|Part 1: Treatment Phase|Other|0|||
130097540|NCT04668066|468315211|FG002|Part 1: Treatment Phase|Other|0|||
130097541|NCT04668066|468315212|FG003|Part 1: Treatment Phase|Other|0|||
130097542|NCT04668066|468315213|FG004|Part 1: Treatment Phase|Other|0|||
130097543|NCT04668066|468315214|FG005|Part 1: Treatment Phase|Other|0|||
130097544|NCT04668066|468315215|FG006|Part 1: Treatment Phase|Other|0|||
130209314|NCT02854605|468727219|FG000|Overall Study|Investigator's Discretion|1|||
130209315|NCT02854605|468727220|FG001|Overall Study|Investigator's Discretion|0|||
130209316|NCT02854605|468727221|FG002|Overall Study|Investigator's Discretion|0|||
130209317|NCT02854605|468727219|FG000|Overall Study|Protocol Violation|0|||
130209318|NCT02854605|468727220|FG001|Overall Study|Protocol Violation|0|||
130209319|NCT02854605|468727221|FG002|Overall Study|Protocol Violation|1|||
130209320|NCT01897571|468727224|FG000|Overall Study|Lost to Follow-up|3|||
130209321|NCT01897571|468727225|FG001|Overall Study|Lost to Follow-up|0|||
130209322|NCT01897571|468727226|FG002|Overall Study|Lost to Follow-up|0|||
130209323|NCT01897571|468727227|FG003|Overall Study|Lost to Follow-up|0|||
130209324|NCT01897571|468727228|FG004|Overall Study|Lost to Follow-up|2|||
130209325|NCT01897571|468727229|FG005|Overall Study|Lost to Follow-up|0|||
130209326|NCT01897571|468727230|FG006|Overall Study|Lost to Follow-up|0|||
130209327|NCT01897571|468727231|FG007|Overall Study|Lost to Follow-up|0|||
130209328|NCT01897571|468727232|FG008|Overall Study|Lost to Follow-up|1|||
130209329|NCT01897571|468727233|FG009|Overall Study|Lost to Follow-up|2|||
130209330|NCT01897571|468727234|FG010|Overall Study|Lost to Follow-up|4|||
130209331|NCT01897571|468727224|FG000|Overall Study|Withdrawal by Subject|0|||
130209332|NCT01897571|468727225|FG001|Overall Study|Withdrawal by Subject|0|||
130209333|NCT01897571|468727226|FG002|Overall Study|Withdrawal by Subject|0|||
130209334|NCT01897571|468727227|FG003|Overall Study|Withdrawal by Subject|0|||
130209335|NCT01897571|468727228|FG004|Overall Study|Withdrawal by Subject|0|||
130209336|NCT01897571|468727229|FG005|Overall Study|Withdrawal by Subject|0|||
130209337|NCT01897571|468727230|FG006|Overall Study|Withdrawal by Subject|0|||
130209338|NCT01897571|468727231|FG007|Overall Study|Withdrawal by Subject|1|||
130209339|NCT01897571|468727232|FG008|Overall Study|Withdrawal by Subject|4|||
130209340|NCT01897571|468727233|FG009|Overall Study|Withdrawal by Subject|3|||
130209341|NCT01897571|468727234|FG010|Overall Study|Withdrawal by Subject|1|||
130209342|NCT01897571|468727224|FG000|Overall Study|Other|1|||
130209343|NCT01897571|468727225|FG001|Overall Study|Other|0|||
130209344|NCT01897571|468727226|FG002|Overall Study|Other|0|||
130209345|NCT01897571|468727227|FG003|Overall Study|Other|3|||
130209346|NCT01897571|468727228|FG004|Overall Study|Other|3|||
130209347|NCT01897571|468727229|FG005|Overall Study|Other|4|||
130209348|NCT01897571|468727230|FG006|Overall Study|Other|7|||
130209349|NCT01897571|468727231|FG007|Overall Study|Other|0|||
130209350|NCT01897571|468727232|FG008|Overall Study|Other|0|||
130209351|NCT01897571|468727233|FG009|Overall Study|Other|0|||
130209352|NCT01897571|468727234|FG010|Overall Study|Other|0|||
130209353|NCT01897571|468727224|FG000|Overall Study|Enrolled in rollover study|0|||
130209354|NCT01897571|468727225|FG001|Overall Study|Enrolled in rollover study|0|||
130209355|NCT01897571|468727226|FG002|Overall Study|Enrolled in rollover study|0|||
130209356|NCT01897571|468727227|FG003|Overall Study|Enrolled in rollover study|0|||
130209357|NCT01897571|468727228|FG004|Overall Study|Enrolled in rollover study|0|||
130209358|NCT01897571|468727229|FG005|Overall Study|Enrolled in rollover study|0|||
130209359|NCT01897571|468727230|FG006|Overall Study|Enrolled in rollover study|0|||
130097545|NCT04668066|468315216|FG007|Part 1: Treatment Phase|Other|0|||
130097546|NCT04668066|468315217|FG008|Part 1: Treatment Phase|Other|0|||
130097547|NCT04668066|468315218|FG009|Part 1: Treatment Phase|Other|0|||
130209360|NCT01897571|468727231|FG007|Overall Study|Enrolled in rollover study|9|||
130097548|NCT04668066|468315219|FG010|Part 1: Treatment Phase|Other|0|||
130097549|NCT04668066|468315220|FG011|Part 1: Treatment Phase|Other|1|||
130097550|NCT04668066|468315221|FG012|Part 1: Treatment Phase|Other|0|||
130097551|NCT04668066|468315222|FG013|Part 1: Treatment Phase|Other|0|||
130097552|NCT04668066|468315223|FG014|Part 1: Treatment Phase|Other|0|||
130097553|NCT04668066|468315224|FG015|Part 1: Treatment Phase|Other|0|||
130097554|NCT04668066|468315225|FG016|Part 1: Treatment Phase|Other|0|||
130097555|NCT04668066|468315226|FG017|Part 1: Treatment Phase|Other|0|||
130097556|NCT04668066|468315227|FG018|Part 1: Treatment Phase|Other|0|||
130097557|NCT04668066|468315209|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097558|NCT04668066|468315210|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097559|NCT04668066|468315211|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097560|NCT04668066|468315212|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097561|NCT04668066|468315213|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097562|NCT04668066|468315214|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097563|NCT04668066|468315215|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097564|NCT04668066|468315216|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097565|NCT04668066|468315217|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097566|NCT04668066|468315218|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097567|NCT04668066|468315219|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097568|NCT04668066|468315220|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097569|NCT04668066|468315221|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
130097570|NCT04668066|468315222|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097571|NCT04668066|468315223|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097572|NCT04668066|468315224|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
130097573|NCT04668066|468315225|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097574|NCT04668066|468315226|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097575|NCT04668066|468315227|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
130097576|NCT04668066|468315209|FG000|Part 1: Follow-Up|Adverse Event|0|||
130097577|NCT04668066|468315210|FG001|Part 1: Follow-Up|Adverse Event|0|||
130097578|NCT04668066|468315211|FG002|Part 1: Follow-Up|Adverse Event|0|||
130097579|NCT04668066|468315212|FG003|Part 1: Follow-Up|Adverse Event|0|||
130097580|NCT04668066|468315213|FG004|Part 1: Follow-Up|Adverse Event|0|||
130097581|NCT04668066|468315214|FG005|Part 1: Follow-Up|Adverse Event|0|||
130097582|NCT04668066|468315215|FG006|Part 1: Follow-Up|Adverse Event|0|||
130097583|NCT04668066|468315216|FG007|Part 1: Follow-Up|Adverse Event|0|||
130097584|NCT04668066|468315217|FG008|Part 1: Follow-Up|Adverse Event|0|||
130097585|NCT04668066|468315218|FG009|Part 1: Follow-Up|Adverse Event|0|||
130097586|NCT04668066|468315219|FG010|Part 1: Follow-Up|Adverse Event|0|||
130097587|NCT04668066|468315220|FG011|Part 1: Follow-Up|Adverse Event|1|||
130097588|NCT04668066|468315221|FG012|Part 1: Follow-Up|Adverse Event|0|||
130097589|NCT04668066|468315222|FG013|Part 1: Follow-Up|Adverse Event|0|||
130097590|NCT04668066|468315223|FG014|Part 1: Follow-Up|Adverse Event|0|||
130097591|NCT04668066|468315224|FG015|Part 1: Follow-Up|Adverse Event|0|||
130097592|NCT04668066|468315225|FG016|Part 1: Follow-Up|Adverse Event|0|||
130097593|NCT04668066|468315226|FG017|Part 1: Follow-Up|Adverse Event|0|||
130097594|NCT04668066|468315227|FG018|Part 1: Follow-Up|Adverse Event|0|||
130097595|NCT04668066|468315209|FG000|Part 1: Follow-Up|Other|0|||
130097596|NCT04668066|468315210|FG001|Part 1: Follow-Up|Other|0|||
130097597|NCT04668066|468315211|FG002|Part 1: Follow-Up|Other|0|||
130097598|NCT04668066|468315212|FG003|Part 1: Follow-Up|Other|0|||
130097599|NCT04668066|468315213|FG004|Part 1: Follow-Up|Other|0|||
130097600|NCT04668066|468315214|FG005|Part 1: Follow-Up|Other|0|||
130097601|NCT04668066|468315215|FG006|Part 1: Follow-Up|Other|0|||
130097602|NCT04668066|468315216|FG007|Part 1: Follow-Up|Other|0|||
130097603|NCT04668066|468315217|FG008|Part 1: Follow-Up|Other|0|||
130097604|NCT04668066|468315218|FG009|Part 1: Follow-Up|Other|0|||
130097605|NCT04668066|468315219|FG010|Part 1: Follow-Up|Other|0|||
130097606|NCT04668066|468315220|FG011|Part 1: Follow-Up|Other|1|||
130097607|NCT04668066|468315221|FG012|Part 1: Follow-Up|Other|1|||
130097608|NCT04668066|468315222|FG013|Part 1: Follow-Up|Other|0|||
130097609|NCT04668066|468315223|FG014|Part 1: Follow-Up|Other|0|||
130097610|NCT04668066|468315224|FG015|Part 1: Follow-Up|Other|0|||
130097611|NCT04668066|468315225|FG016|Part 1: Follow-Up|Other|0|||
130097612|NCT04668066|468315226|FG017|Part 1: Follow-Up|Other|0|||
130097613|NCT04668066|468315227|FG018|Part 1: Follow-Up|Other|0|||
130097614|NCT04668066|468315209|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097615|NCT04668066|468315210|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097616|NCT04668066|468315211|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097617|NCT04668066|468315212|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097618|NCT04668066|468315213|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097619|NCT04668066|468315214|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097620|NCT04668066|468315215|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097621|NCT04668066|468315216|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097622|NCT04668066|468315217|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097623|NCT04668066|468315218|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097624|NCT04668066|468315219|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097625|NCT04668066|468315220|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097626|NCT04668066|468315221|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
130209361|NCT01897571|468727232|FG008|Overall Study|Enrolled in rollover study|7|||
130209362|NCT01897571|468727233|FG009|Overall Study|Enrolled in rollover study|9|||
130209363|NCT01897571|468727234|FG010|Overall Study|Enrolled in rollover study|1|||
130209364|NCT01897571|468727224|FG000|Overall Study|Death|2|||
130097627|NCT04668066|468315222|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097628|NCT04668066|468315223|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097629|NCT04668066|468315224|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
130097630|NCT04668066|468315225|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097631|NCT04668066|468315226|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097632|NCT04668066|468315227|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
130097633|NCT04668066|468315209|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097634|NCT04668066|468315210|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097635|NCT04668066|468315211|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097636|NCT04668066|468315212|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097637|NCT04668066|468315213|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097638|NCT04668066|468315214|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097639|NCT04668066|468315215|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097640|NCT04668066|468315216|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097641|NCT04668066|468315217|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097642|NCT04668066|468315218|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097643|NCT04668066|468315219|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130209365|NCT01897571|468727225|FG001|Overall Study|Death|2|||
130209366|NCT01897571|468727226|FG002|Overall Study|Death|3|||
130209367|NCT01897571|468727227|FG003|Overall Study|Death|6|||
130209368|NCT01897571|468727228|FG004|Overall Study|Death|7|||
130209369|NCT01897571|468727229|FG005|Overall Study|Death|9|||
130209370|NCT01897571|468727230|FG006|Overall Study|Death|5|||
130209371|NCT01897571|468727231|FG007|Overall Study|Death|22|||
130209372|NCT01897571|468727232|FG008|Overall Study|Death|23|||
130209373|NCT01897571|468727233|FG009|Overall Study|Death|129|||
130209374|NCT01897571|468727234|FG010|Overall Study|Death|59|||
130209375|NCT00089635|468727236|FG000|Overall Study|Adverse Event|2|||
130209376|NCT00089635|468727236|FG000|Overall Study|Death|17|||
130209377|NCT00089635|468727236|FG000|Overall Study|Disease Progression|12|||
130209378|NCT00089635|468727236|FG000|Overall Study|Lost to Follow-up|3|||
130209379|NCT00089635|468727236|FG000|Overall Study|Withdrawal by Subject|6|||
130209380|NCT00089635|468727236|FG000|Overall Study|Ineligibility determined|1|||
130209381|NCT00089635|468727236|FG000|Overall Study|Other|2|||
130209382|NCT02943785|468727238|FG000|Overall Study|Adverse Event|112|||
130209383|NCT02943785|468727239|FG001|Overall Study|Adverse Event|97|||
130209384|NCT02943785|468727238|FG000|Overall Study|Withdrawal by Subject|63|||
130209385|NCT02943785|468727239|FG001|Overall Study|Withdrawal by Subject|126|||
130209386|NCT02943785|468727238|FG000|Overall Study|Physician Decision|23|||
130209387|NCT02943785|468727239|FG001|Overall Study|Physician Decision|47|||
130209388|NCT02943785|468727238|FG000|Overall Study|Death|46|||
130209389|NCT02943785|468727239|FG001|Overall Study|Death|46|||
130209390|NCT02943785|468727238|FG000|Overall Study|Lost to Follow-up|1|||
130209391|NCT02943785|468727239|FG001|Overall Study|Lost to Follow-up|0|||
130209392|NCT02943785|468727238|FG000|Overall Study|Other|16|||
130209393|NCT02943785|468727239|FG001|Overall Study|Other|19|||
130209394|NCT02943785|468727238|FG000|Overall Study|Did not receive any study medication|21|||
130209395|NCT02943785|468727239|FG001|Overall Study|Did not receive any study medication|28|||
130209396|NCT00821015|468727242|FG000|Overall Study|Lost to Follow-up|12|||
130209397|NCT03170609|468727243|FG000|Overall Study|Death|0|||
130209398|NCT03170609|468727244|FG001|Overall Study|Death|0|||
130209399|NCT03170609|468727245|FG002|Overall Study|Death|1|||
130209400|NCT03170609|468727246|FG003|Overall Study|Death|0|||
130209401|NCT03170609|468727247|FG004|Overall Study|Death|0|||
130209402|NCT03170609|468727248|FG005|Overall Study|Death|0|||
130209403|NCT03170609|468727249|FG006|Overall Study|Death|0|||
130209404|NCT03170609|468727243|FG000|Overall Study|Withdrawal by Subject|1|||
130209405|NCT03170609|468727244|FG001|Overall Study|Withdrawal by Subject|2|||
130209406|NCT03170609|468727245|FG002|Overall Study|Withdrawal by Subject|0|||
130209407|NCT03170609|468727246|FG003|Overall Study|Withdrawal by Subject|0|||
130209408|NCT03170609|468727247|FG004|Overall Study|Withdrawal by Subject|0|||
130209409|NCT03170609|468727248|FG005|Overall Study|Withdrawal by Subject|0|||
130209410|NCT03170609|468727249|FG006|Overall Study|Withdrawal by Subject|1|||
130209411|NCT03170609|468727243|FG000|Overall Study|Lost to Follow-up|1|||
130209412|NCT03170609|468727244|FG001|Overall Study|Lost to Follow-up|0|||
130209413|NCT03170609|468727245|FG002|Overall Study|Lost to Follow-up|5|||
130209414|NCT03170609|468727246|FG003|Overall Study|Lost to Follow-up|2|||
130209415|NCT03170609|468727247|FG004|Overall Study|Lost to Follow-up|1|||
130209416|NCT03170609|468727248|FG005|Overall Study|Lost to Follow-up|1|||
130209417|NCT03170609|468727249|FG006|Overall Study|Lost to Follow-up|0|||
130209418|NCT03170609|468727243|FG000|Overall Study|Other|1|||
130097644|NCT04668066|468315220|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130209419|NCT03170609|468727244|FG001|Overall Study|Other|0|||
130209420|NCT03170609|468727245|FG002|Overall Study|Other|0|||
130209421|NCT03170609|468727246|FG003|Overall Study|Other|0|||
130209422|NCT03170609|468727247|FG004|Overall Study|Other|0|||
130097645|NCT04668066|468315221|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097646|NCT04668066|468315222|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097647|NCT04668066|468315223|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097648|NCT04668066|468315224|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097649|NCT04668066|468315225|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097650|NCT04668066|468315226|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
130097651|NCT04668066|468315227|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
130097652|NCT04668066|468315209|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097653|NCT04668066|468315210|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097654|NCT04668066|468315211|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097655|NCT04668066|468315212|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097656|NCT04668066|468315213|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097657|NCT04668066|468315214|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097658|NCT04668066|468315215|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097659|NCT04668066|468315216|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097660|NCT04668066|468315217|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097661|NCT04668066|468315218|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097662|NCT04668066|468315219|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097663|NCT04668066|468315220|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097664|NCT04668066|468315221|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097665|NCT04668066|468315222|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097666|NCT04668066|468315223|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097667|NCT04668066|468315224|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097668|NCT04668066|468315225|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097669|NCT04668066|468315226|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
130097670|NCT04668066|468315227|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
130097671|NCT04668066|468315209|FG000|Part 2: Treatment Phase|Other|0|||
130097672|NCT04668066|468315210|FG001|Part 2: Treatment Phase|Other|0|||
130097673|NCT04668066|468315211|FG002|Part 2: Treatment Phase|Other|0|||
130097674|NCT04668066|468315212|FG003|Part 2: Treatment Phase|Other|0|||
130097675|NCT04668066|468315213|FG004|Part 2: Treatment Phase|Other|0|||
130097676|NCT04668066|468315214|FG005|Part 2: Treatment Phase|Other|0|||
130097677|NCT04668066|468315215|FG006|Part 2: Treatment Phase|Other|0|||
130097678|NCT04668066|468315216|FG007|Part 2: Treatment Phase|Other|0|||
130097679|NCT04668066|468315217|FG008|Part 2: Treatment Phase|Other|0|||
130097680|NCT04668066|468315218|FG009|Part 2: Treatment Phase|Other|0|||
130097681|NCT04668066|468315219|FG010|Part 2: Treatment Phase|Other|0|||
130097682|NCT04668066|468315220|FG011|Part 2: Treatment Phase|Other|0|||
130097683|NCT04668066|468315221|FG012|Part 2: Treatment Phase|Other|0|||
130097684|NCT04668066|468315222|FG013|Part 2: Treatment Phase|Other|0|||
130097685|NCT04668066|468315223|FG014|Part 2: Treatment Phase|Other|0|||
130097686|NCT04668066|468315224|FG015|Part 2: Treatment Phase|Other|0|||
130097687|NCT04668066|468315225|FG016|Part 2: Treatment Phase|Other|0|||
130097688|NCT04668066|468315226|FG017|Part 2: Treatment Phase|Other|0|||
130097689|NCT04668066|468315227|FG018|Part 2: Treatment Phase|Other|1|||
130097690|NCT04668066|468315209|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097691|NCT04668066|468315210|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097692|NCT04668066|468315211|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097693|NCT04668066|468315212|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097694|NCT04668066|468315213|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097695|NCT04668066|468315214|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097696|NCT04668066|468315215|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097697|NCT04668066|468315216|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097698|NCT04668066|468315217|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097699|NCT04668066|468315218|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097700|NCT04668066|468315219|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097701|NCT04668066|468315220|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097702|NCT04668066|468315221|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097703|NCT04668066|468315222|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097704|NCT04668066|468315223|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097705|NCT04668066|468315224|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097706|NCT04668066|468315225|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097707|NCT04668066|468315226|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
130097708|NCT04668066|468315227|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
130097709|NCT04505592|468315228|FG000|Overall Study|Death|2|||
130097710|NCT04505592|468315229|FG001|Overall Study|Death|1|||
130097711|NCT03480243|468315234|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
130097712|NCT03480243|468315234|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
130097713|NCT02388906|468315242|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
130097714|NCT02388906|468315243|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130097715|NCT02388906|468315242|FG000|Treatment Period|Disease progression|121|||
130097716|NCT02388906|468315243|FG001|Treatment Period|Disease progression|100|||
130097717|NCT02388906|468315242|FG000|Treatment Period|Study drug toxicity|41|||
130097718|NCT02388906|468315243|FG001|Treatment Period|Study drug toxicity|208|||
130097719|NCT02388906|468315242|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
130209423|NCT03170609|468727248|FG005|Overall Study|Other|1|||
130097720|NCT02388906|468315243|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
130097721|NCT02388906|468315242|FG000|Treatment Period|Participant request to stop treatment|5|||
130097722|NCT02388906|468315243|FG001|Treatment Period|Participant request to stop treatment|9|||
130097723|NCT02388906|468315242|FG000|Treatment Period|Participant withdrew consent|2|||
130097724|NCT02388906|468315243|FG001|Treatment Period|Participant withdrew consent|3|||
130097725|NCT02388906|468315242|FG000|Treatment Period|Poor/non-compliance|0|||
130097726|NCT02388906|468315243|FG001|Treatment Period|Poor/non-compliance|1|||
130097727|NCT02388906|468315242|FG000|Treatment Period|Participant no longer meets study criteria|0|||
130097728|NCT02388906|468315243|FG001|Treatment Period|Participant no longer meets study criteria|1|||
130097729|NCT02388906|468315242|FG000|Treatment Period|Other reasons|3|||
130097730|NCT02388906|468315243|FG001|Treatment Period|Other reasons|3|||
130097731|NCT05770401|468315252|FG000|Overall Study|Lost to Follow-up|5|||
130097732|NCT05770401|468315253|FG001|Overall Study|Lost to Follow-up|4|||
130097733|NCT00402298|468315254|FG000|Overall Study|Withdrawal by Subject|1|||
130097734|NCT00402298|468315255|FG001|Overall Study|Withdrawal by Subject|0|||
130097735|NCT04784455|468315256|FG000|Overall Study|Death|4|||
130097736|NCT03901274|468315259|FG000|Overall Study|Lost to Follow-up|120|||
130097737|NCT03901274|468315260|FG001|Overall Study|Lost to Follow-up|124|||
130097738|NCT03901274|468315259|FG000|Overall Study|Withdrawal by Subject|0|||
130097739|NCT03901274|468315260|FG001|Overall Study|Withdrawal by Subject|6|||
130097740|NCT04527380|468315261|FG000|Overall Study|Lack of Efficacy|0|||
130097741|NCT04527380|468315262|FG001|Overall Study|Lack of Efficacy|1|||
130097742|NCT04527380|468315261|FG000|Overall Study|Withdrawal by Subject|1|||
130097743|NCT04527380|468315262|FG001|Overall Study|Withdrawal by Subject|0|||
130097744|NCT05048875|468315263|FG000|Overall Study|Withdrawal by Subject|1|||
130097745|NCT05048875|468315264|FG001|Overall Study|Withdrawal by Subject|0|||
130097746|NCT05048875|468315265|FG002|Overall Study|Withdrawal by Subject|0|||
130097747|NCT05048875|468315266|FG003|Overall Study|Withdrawal by Subject|0|||
130097748|NCT05048875|468315267|FG004|Overall Study|Withdrawal by Subject|0|||
130097749|NCT05048875|468315268|FG005|Overall Study|Withdrawal by Subject|0|||
130097750|NCT05048875|468315269|FG006|Overall Study|Withdrawal by Subject|0|||
130097751|NCT05048875|468315270|FG007|Overall Study|Withdrawal by Subject|0|||
130097752|NCT05048875|468315263|FG000|Overall Study|Adverse Event|0|||
130097753|NCT05048875|468315264|FG001|Overall Study|Adverse Event|0|||
130097754|NCT05048875|468315265|FG002|Overall Study|Adverse Event|0|||
130097755|NCT05048875|468315266|FG003|Overall Study|Adverse Event|1|||
130097756|NCT05048875|468315267|FG004|Overall Study|Adverse Event|0|||
130097757|NCT05048875|468315268|FG005|Overall Study|Adverse Event|0|||
130097758|NCT05048875|468315269|FG006|Overall Study|Adverse Event|0|||
130097759|NCT05048875|468315270|FG007|Overall Study|Adverse Event|0|||
130097760|NCT04411641|468315275|FG000|DB Period|Other|7|||
130097761|NCT04411641|468315276|FG001|DB Period|Other|27|||
130097762|NCT04411641|468315277|FG002|DB Period|Other|0|||
130097763|NCT04411641|468315278|FG003|DB Period|Other|0|||
130097764|NCT04411641|468315275|FG000|DB Period|Withdrawal by Subject|67|||
130097765|NCT04411641|468315276|FG001|DB Period|Withdrawal by Subject|122|||
130097766|NCT04411641|468315277|FG002|DB Period|Withdrawal by Subject|0|||
130097767|NCT04411641|468315278|FG003|DB Period|Withdrawal by Subject|0|||
130097768|NCT04411641|468315275|FG000|DB Period|Progressive disease|76|||
130097769|NCT04411641|468315276|FG001|DB Period|Progressive disease|116|||
130097770|NCT04411641|468315277|FG002|DB Period|Progressive disease|0|||
130097771|NCT04411641|468315278|FG003|DB Period|Progressive disease|0|||
130097772|NCT04411641|468315275|FG000|DB Period|Poor compliance to protocol|1|||
130097773|NCT04411641|468315276|FG001|DB Period|Poor compliance to protocol|5|||
130097774|NCT04411641|468315277|FG002|DB Period|Poor compliance to protocol|0|||
130097775|NCT04411641|468315278|FG003|DB Period|Poor compliance to protocol|0|||
130097776|NCT04411641|468315275|FG000|DB Period|Lack of Efficacy|19|||
130097777|NCT04411641|468315276|FG001|DB Period|Lack of Efficacy|19|||
130097778|NCT04411641|468315277|FG002|DB Period|Lack of Efficacy|0|||
130097779|NCT04411641|468315278|FG003|DB Period|Lack of Efficacy|0|||
130097780|NCT04411641|468315275|FG000|DB Period|Adverse Event|13|||
130097781|NCT04411641|468315276|FG001|DB Period|Adverse Event|29|||
130097782|NCT04411641|468315277|FG002|DB Period|Adverse Event|0|||
130097783|NCT04411641|468315278|FG003|DB Period|Adverse Event|0|||
130097784|NCT04411641|468315275|FG000|DB Period|Randomized and not treated|2|||
130097785|NCT04411641|468315276|FG001|DB Period|Randomized and not treated|2|||
130097786|NCT04411641|468315277|FG002|DB Period|Randomized and not treated|0|||
130097787|NCT04411641|468315278|FG003|DB Period|Randomized and not treated|0|||
130097788|NCT04411641|468315275|FG000|OL|Withdrawal by Subject|0|||
130097789|NCT04411641|468315276|FG001|OL|Withdrawal by Subject|0|||
130097790|NCT04411641|468315277|FG002|OL|Withdrawal by Subject|6|||
130097791|NCT04411641|468315278|FG003|OL|Withdrawal by Subject|17|||
130097792|NCT04411641|468315275|FG000|OL|Progressive disease|0|||
130097793|NCT04411641|468315276|FG001|OL|Progressive disease|0|||
130097794|NCT04411641|468315277|FG002|OL|Progressive disease|1|||
130097795|NCT04411641|468315278|FG003|OL|Progressive disease|2|||
130097796|NCT04411641|468315275|FG000|OL|Poor compliance to protocol|0|||
130097797|NCT04411641|468315276|FG001|OL|Poor compliance to protocol|0|||
130097798|NCT04411641|468315277|FG002|OL|Poor compliance to protocol|1|||
130209424|NCT03170609|468727249|FG006|Overall Study|Other|0|||
130209425|NCT01281956|468727250|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
130209426|NCT01281956|468727251|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
130209427|NCT01857102|468727264|FG000|Period 1|No longer meets Eligibility Criteria|0|||
130209428|NCT01857102|468727265|FG001|Period 1|No longer meets Eligibility Criteria|2|||
130209429|NCT01857102|468727264|FG000|Period 1|Lost to Follow-up|0|||
130209430|NCT01857102|468727265|FG001|Period 1|Lost to Follow-up|3|||
130209431|NCT01857102|468727264|FG000|Period 1|Unsatisfactory Lens Fit|1|||
130209432|NCT01857102|468727265|FG001|Period 1|Unsatisfactory Lens Fit|0|||
130097799|NCT04411641|468315278|FG003|OL|Poor compliance to protocol|0|||
130209433|NCT01857102|468727264|FG000|Period 1|Unsatisfactory Visual Response|1|||
130209434|NCT01857102|468727265|FG001|Period 1|Unsatisfactory Visual Response|0|||
130209435|NCT01857102|468727264|FG000|Period 1|Physician Decision|1|||
130209436|NCT01857102|468727265|FG001|Period 1|Physician Decision|0|||
130209437|NCT01857102|468727264|FG000|Period 2|Lens Discomfort|1|||
130209438|NCT01857102|468727265|FG001|Period 2|Lens Discomfort|0|||
130209439|NCT01857102|468727264|FG000|Period 2|Unsatisfactory Lens Fit|1|||
130209440|NCT01857102|468727265|FG001|Period 2|Unsatisfactory Lens Fit|0|||
130209441|NCT01490697|468727266|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
130209442|NCT01490697|468727267|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
130209443|NCT00090584|468727268|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
130209444|NCT00090584|468727269|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
130209445|NCT00090584|468727268|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
130209446|NCT00090584|468727269|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
130209447|NCT02117713|468727278|FG000|Week 48|Adverse Event|4|||
130209448|NCT02117713|468727278|FG000|Week 48|Withdrawal by caregiver|2|||
130097800|NCT04411641|468315275|FG000|OL|Adverse Event|0|||
130097801|NCT04411641|468315276|FG001|OL|Adverse Event|0|||
130097802|NCT04411641|468315277|FG002|OL|Adverse Event|1|||
130097803|NCT04411641|468315278|FG003|OL|Adverse Event|0|||
130097804|NCT04411641|468315275|FG000|OL|Other|0|||
130097805|NCT04411641|468315276|FG001|OL|Other|0|||
130097806|NCT04411641|468315277|FG002|OL|Other|0|||
130097807|NCT04411641|468315278|FG003|OL|Other|6|||
130097808|NCT03282123|468315283|FG000|Overall Study|Withdrawal by Subject|5|||
130097809|NCT00938366|468315286|FG000|Overall Study|Withdrawal by Subject|1|||
130097810|NCT00938366|468315287|FG001|Overall Study|Withdrawal by Subject|0|||
130097811|NCT01195662|468315288|FG000|Double Blind Treatment Period|Adverse Event|4|||
130097812|NCT01195662|468315289|FG001|Double Blind Treatment Period|Adverse Event|1|||
130097813|NCT01195662|468315290|FG002|Double Blind Treatment Period|Adverse Event|2|||
130097814|NCT01195662|468315288|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
130097815|NCT01195662|468315289|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
130097816|NCT01195662|468315290|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
130097817|NCT01195662|468315288|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
130097818|NCT01195662|468315289|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
130097819|NCT01195662|468315290|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
130097820|NCT01195662|468315288|FG000|Double Blind Treatment Period|Administrative reason|2|||
130097821|NCT01195662|468315289|FG001|Double Blind Treatment Period|Administrative reason|1|||
130097822|NCT01195662|468315290|FG002|Double Blind Treatment Period|Administrative reason|1|||
130097823|NCT01195662|468315288|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
130097824|NCT01195662|468315289|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
130097825|NCT01195662|468315290|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
130097826|NCT01195662|468315288|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
130097827|NCT01195662|468315289|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
130097828|NCT01195662|468315290|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
130097829|NCT01195662|468315288|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
130097830|NCT01195662|468315289|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130097831|NCT01195662|468315290|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130097832|NCT01195662|468315288|FG000|Double Blind Treatment Period|Non-specified|3|||
130097833|NCT01195662|468315289|FG001|Double Blind Treatment Period|Non-specified|0|||
130097834|NCT01195662|468315290|FG002|Double Blind Treatment Period|Non-specified|0|||
130097835|NCT01195662|468315288|FG000|Double Blind Treatment Period|Missing disposition information|0|||
130097836|NCT01195662|468315289|FG001|Double Blind Treatment Period|Missing disposition information|1|||
130097837|NCT01195662|468315290|FG002|Double Blind Treatment Period|Missing disposition information|1|||
130097838|NCT01195662|468315288|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
130097839|NCT01195662|468315289|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
130097840|NCT01195662|468315290|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
130097841|NCT01195662|468315288|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
130097842|NCT01195662|468315289|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
130209449|NCT02117713|468727278|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
130209450|NCT02117713|468727278|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
130209451|NCT02117713|468727278|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
130209452|NCT02117713|468727278|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
130097843|NCT01195662|468315290|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
130097844|NCT01215968|468315291|FG000|Overall Study|Adverse Event|0|||
130097845|NCT01215968|468315292|FG001|Overall Study|Adverse Event|2|||
130097846|NCT01215968|468315291|FG000|Overall Study|Protocol Violation|2|||
130097847|NCT01215968|468315292|FG001|Overall Study|Protocol Violation|4|||
130097848|NCT01215968|468315291|FG000|Overall Study|Not received study drug|0|||
130097849|NCT01215968|468315292|FG001|Overall Study|Not received study drug|1|||
130097850|NCT01250418|468315296|FG000|Overall Study|monitor data failure|1|||
130097851|NCT01250418|468315297|FG001|Overall Study|monitor data failure|1|||
130097852|NCT01761565|468315298|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
130097853|NCT05643573|468315300|FG000|Overall Study|Adverse Event|117|||
130097854|NCT05643573|468315301|FG001|Overall Study|Adverse Event|90|||
130097855|NCT05643573|468315300|FG000|Overall Study|Death|53|||
130097856|NCT05643573|468315301|FG001|Overall Study|Death|57|||
130097857|NCT05643573|468315300|FG000|Overall Study|Lost to Follow-up|6|||
130097858|NCT05643573|468315301|FG001|Overall Study|Lost to Follow-up|3|||
130097859|NCT05643573|468315300|FG000|Overall Study|Other|18|||
130097860|NCT05643573|468315301|FG001|Overall Study|Other|15|||
130097861|NCT05643573|468315300|FG000|Overall Study|Outcome event|64|||
130097862|NCT05643573|468315301|FG001|Overall Study|Outcome event|36|||
130097863|NCT05643573|468315300|FG000|Overall Study|Physician Decision|33|||
130097864|NCT05643573|468315301|FG001|Overall Study|Physician Decision|19|||
130097865|NCT05643573|468315300|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
130097866|NCT05643573|468315301|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
130097867|NCT05643573|468315300|FG000|Overall Study|Site terminated by sponsor|10|||
130097868|NCT05643573|468315301|FG001|Overall Study|Site terminated by sponsor|10|||
130097869|NCT05643573|468315300|FG000|Overall Study|Study terminated by sponsor|1|||
130097870|NCT05643573|468315301|FG001|Overall Study|Study terminated by sponsor|0|||
130097871|NCT05643573|468315300|FG000|Overall Study|Withdrawal by Subject|178|||
130097872|NCT05643573|468315301|FG001|Overall Study|Withdrawal by Subject|130|||
130097873|NCT05182840|468315302|FG000|Run-in Period|Not treated|0|||
130097874|NCT05182840|468315303|FG001|Run-in Period|Not treated|1|||
130097875|NCT05182840|468315304|FG002|Run-in Period|Not treated|0|||
130097876|NCT05182840|468315305|FG003|Run-in Period|Not treated|0|||
130097877|NCT05182840|468315306|FG004|Run-in Period|Not treated|0|||
130097878|NCT05182840|468315307|FG005|Run-in Period|Not treated|0|||
130097879|NCT05182840|468315308|FG006|Run-in Period|Not treated|0|||
130097880|NCT05182840|468315309|FG007|Run-in Period|Not treated|0|||
130097881|NCT05182840|468315310|FG008|Run-in Period|Not treated|0|||
130097882|NCT05182840|468315311|FG009|Run-in Period|Not treated|0|||
130097883|NCT05182840|468315302|FG000|Run-in Period|Other reason but not sponsor termination|14|||
130097884|NCT05182840|468315303|FG001|Run-in Period|Other reason but not sponsor termination|18|||
130097885|NCT05182840|468315304|FG002|Run-in Period|Other reason but not sponsor termination|0|||
130097886|NCT05182840|468315305|FG003|Run-in Period|Other reason but not sponsor termination|0|||
130097887|NCT05182840|468315306|FG004|Run-in Period|Other reason but not sponsor termination|0|||
130097888|NCT05182840|468315307|FG005|Run-in Period|Other reason but not sponsor termination|0|||
130097889|NCT05182840|468315308|FG006|Run-in Period|Other reason but not sponsor termination|0|||
130097890|NCT05182840|468315309|FG007|Run-in Period|Other reason but not sponsor termination|0|||
130097891|NCT05182840|468315310|FG008|Run-in Period|Other reason but not sponsor termination|0|||
130097892|NCT05182840|468315311|FG009|Run-in Period|Other reason but not sponsor termination|0|||
130097893|NCT05182840|468315302|FG000|Run-in Period|No reason available|2|||
130097894|NCT05182840|468315303|FG001|Run-in Period|No reason available|2|||
130097895|NCT05182840|468315304|FG002|Run-in Period|No reason available|0|||
130097896|NCT05182840|468315305|FG003|Run-in Period|No reason available|0|||
130097897|NCT05182840|468315306|FG004|Run-in Period|No reason available|0|||
130097898|NCT05182840|468315307|FG005|Run-in Period|No reason available|0|||
130097899|NCT05182840|468315308|FG006|Run-in Period|No reason available|0|||
130097900|NCT05182840|468315309|FG007|Run-in Period|No reason available|0|||
130097901|NCT05182840|468315310|FG008|Run-in Period|No reason available|0|||
130097902|NCT05182840|468315311|FG009|Run-in Period|No reason available|0|||
130097903|NCT05182840|468315302|FG000|Run-in Period|Burden of study procedures|2|||
130097904|NCT05182840|468315303|FG001|Run-in Period|Burden of study procedures|2|||
130209453|NCT02028169|468727280|FG000|Overall Study|Lost to Follow-up|21|||
130097905|NCT05182840|468315304|FG002|Run-in Period|Burden of study procedures|0|||
130097906|NCT05182840|468315305|FG003|Run-in Period|Burden of study procedures|0|||
130097907|NCT05182840|468315306|FG004|Run-in Period|Burden of study procedures|0|||
130097908|NCT05182840|468315307|FG005|Run-in Period|Burden of study procedures|0|||
130097909|NCT05182840|468315308|FG006|Run-in Period|Burden of study procedures|0|||
130097910|NCT05182840|468315309|FG007|Run-in Period|Burden of study procedures|0|||
130097911|NCT05182840|468315310|FG008|Run-in Period|Burden of study procedures|0|||
130097912|NCT05182840|468315311|FG009|Run-in Period|Burden of study procedures|0|||
130097913|NCT05182840|468315302|FG000|Run-in Period|Change of residence|1|||
130097914|NCT05182840|468315303|FG001|Run-in Period|Change of residence|0|||
130097915|NCT05182840|468315304|FG002|Run-in Period|Change of residence|0|||
130097916|NCT05182840|468315305|FG003|Run-in Period|Change of residence|0|||
130097917|NCT05182840|468315306|FG004|Run-in Period|Change of residence|0|||
130209454|NCT02028169|468727280|FG000|Overall Study|Lack of Efficacy|2|||
130209455|NCT02028169|468727280|FG000|Overall Study|Withdrawal by Subject|2|||
130209456|NCT02028169|468727280|FG000|Overall Study|Adverse Event|1|||
130209457|NCT02028169|468727280|FG000|Overall Study|Cessation of Drug|1|||
130209458|NCT02028169|468727280|FG000|Overall Study|Concomitant Medication Usage|1|||
130209459|NCT04907227|468727281|FG000|Overall Study|Death|12|||
130209460|NCT04907227|468727282|FG001|Overall Study|Death|8|||
130209461|NCT04907227|468727281|FG000|Overall Study|Withdrawal by Subject|2|||
130209462|NCT04907227|468727282|FG001|Overall Study|Withdrawal by Subject|2|||
130209463|NCT04907227|468727281|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
130209464|NCT04907227|468727282|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130209465|NCT04907227|468727281|FG000|Overall Study|Sponsor Decision|25|||
130209466|NCT04907227|468727282|FG001|Overall Study|Sponsor Decision|30|||
130209467|NCT04907227|468727281|FG000|Overall Study|Physician Decision|1|||
130209468|NCT04907227|468727282|FG001|Overall Study|Physician Decision|0|||
130209469|NCT02208050|468727283|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
130209470|NCT02208050|468727284|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
130209471|NCT00432276|468727286|FG000|Overall Study|Hyperglycemic Rescue|44|||
130209472|NCT00432276|468727287|FG001|Overall Study|Hyperglycemic Rescue|87|||
130209473|NCT00432276|468727286|FG000|Overall Study|Adverse Event|13|||
130209474|NCT00432276|468727287|FG001|Overall Study|Adverse Event|16|||
130209475|NCT00432276|468727286|FG000|Overall Study|Protocol Violation|25|||
130209476|NCT00432276|468727287|FG001|Overall Study|Protocol Violation|20|||
130209477|NCT00432276|468727286|FG000|Overall Study|Lost to Follow-up|6|||
130209478|NCT00432276|468727287|FG001|Overall Study|Lost to Follow-up|2|||
130209479|NCT00432276|468727286|FG000|Overall Study|Withdrawal by Subject|25|||
130209480|NCT00432276|468727287|FG001|Overall Study|Withdrawal by Subject|20|||
130209481|NCT00432276|468727286|FG000|Overall Study|Physician Decision|6|||
130209482|NCT00432276|468727287|FG001|Overall Study|Physician Decision|8|||
130209483|NCT00432276|468727286|FG000|Overall Study|Other|2|||
130209484|NCT00432276|468727287|FG001|Overall Study|Other|3|||
130209485|NCT00467961|468727288|FG000|Overall Study|Technical Failures|5|||
130209486|NCT00467961|468727288|FG000|Overall Study|Disease Progression|2|||
130209487|NCT05249127|468727289|FG000|Overall Study|Protocol Violation|13|||
130209488|NCT05249127|468727289|FG000|Overall Study|Physician Decision|4|||
130209489|NCT05249127|468727289|FG000|Overall Study|Withdrawal by Subject|2|||
130209490|NCT05249127|468727289|FG000|Overall Study|Participant Non-compliance|1|||
130209491|NCT02073565|468727291|FG000|Cohort A|Withdrawal by Subject|1|||
130209492|NCT02073565|468727292|FG001|Cohort A|Withdrawal by Subject|0|||
130209493|NCT02073565|468727291|FG000|Cohort B|Withdrawal by Subject|1|||
130209494|NCT02073565|468727292|FG001|Cohort B|Withdrawal by Subject|2|||
130209495|NCT02073565|468727291|FG000|Cohort C|Withdrawal by Subject|0|||
130209496|NCT02073565|468727292|FG001|Cohort C|Withdrawal by Subject|2|||
130209497|NCT02073565|468727291|FG000|Cohort C|Lost to Follow-up|0|||
130209498|NCT02073565|468727292|FG001|Cohort C|Lost to Follow-up|2|||
130209499|NCT03168919|468727295|FG000|Overall Study|Withdrawal by Subject|2|||
130209500|NCT01085136|468727296|FG000|Part A|Other Adverse event|223|||
130209501|NCT01085136|468727297|FG001|Part A|Other Adverse event|0|||
130097918|NCT05182840|468315307|FG005|Run-in Period|Change of residence|0|||
130097919|NCT05182840|468315308|FG006|Run-in Period|Change of residence|0|||
130097920|NCT05182840|468315309|FG007|Run-in Period|Change of residence|0|||
130097921|NCT05182840|468315310|FG008|Run-in Period|Change of residence|0|||
130097922|NCT05182840|468315311|FG009|Run-in Period|Change of residence|0|||
130097923|NCT05182840|468315302|FG000|Run-in Period|Adverse Event|5|||
130097924|NCT05182840|468315303|FG001|Run-in Period|Adverse Event|5|||
130209502|NCT01085136|468727298|FG002|Part A|Other Adverse event|0|||
130209503|NCT01085136|468727296|FG000|Part A|Protocol Violation|3|||
130209504|NCT01085136|468727297|FG001|Part A|Protocol Violation|0|||
130209505|NCT01085136|468727298|FG002|Part A|Protocol Violation|0|||
130209506|NCT01085136|468727296|FG000|Part A|Lost to Follow-up|3|||
130209507|NCT01085136|468727297|FG001|Part A|Lost to Follow-up|0|||
130209508|NCT01085136|468727298|FG002|Part A|Lost to Follow-up|0|||
130209509|NCT01085136|468727296|FG000|Part A|Refusal to continue trial medication|64|||
130209510|NCT01085136|468727297|FG001|Part A|Refusal to continue trial medication|0|||
130209511|NCT01085136|468727298|FG002|Part A|Refusal to continue trial medication|0|||
130209512|NCT01085136|468727296|FG000|Part A|Other reason not defined above|30|||
130209513|NCT01085136|468727297|FG001|Part A|Other reason not defined above|0|||
130209514|NCT01085136|468727298|FG002|Part A|Other reason not defined above|0|||
130209515|NCT01085136|468727296|FG000|Part B|Other AE|0|||
130209516|NCT01085136|468727297|FG001|Part B|Other AE|29|||
130209517|NCT01085136|468727298|FG002|Part B|Other AE|8|||
130209518|NCT01085136|468727296|FG000|Part B|Refusal to continue trial medication|0|||
130097925|NCT05182840|468315304|FG002|Run-in Period|Adverse Event|0|||
130097926|NCT05182840|468315305|FG003|Run-in Period|Adverse Event|0|||
130097927|NCT05182840|468315306|FG004|Run-in Period|Adverse Event|0|||
130209519|NCT01085136|468727297|FG001|Part B|Refusal to continue trial medication|12|||
130209520|NCT01085136|468727298|FG002|Part B|Refusal to continue trial medication|7|||
130097928|NCT05182840|468315307|FG005|Run-in Period|Adverse Event|0|||
130209521|NCT01085136|468727296|FG000|Part B|Not treated|0|||
130209522|NCT01085136|468727297|FG001|Part B|Not treated|4|||
130097929|NCT05182840|468315308|FG006|Run-in Period|Adverse Event|0|||
130097930|NCT05182840|468315309|FG007|Run-in Period|Adverse Event|0|||
130097931|NCT05182840|468315310|FG008|Run-in Period|Adverse Event|0|||
130097932|NCT05182840|468315311|FG009|Run-in Period|Adverse Event|0|||
130097933|NCT05182840|468315302|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
130097934|NCT05182840|468315303|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
130097935|NCT05182840|468315304|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097936|NCT05182840|468315305|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097937|NCT05182840|468315306|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097938|NCT05182840|468315307|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097939|NCT05182840|468315308|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097940|NCT05182840|468315309|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097941|NCT05182840|468315310|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097942|NCT05182840|468315311|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
130097943|NCT05182840|468315302|FG000|Treatment Period|Reason missing|0|||
130097944|NCT05182840|468315303|FG001|Treatment Period|Reason missing|0|||
130097945|NCT05182840|468315304|FG002|Treatment Period|Reason missing|1|||
130097946|NCT05182840|468315305|FG003|Treatment Period|Reason missing|0|||
130097947|NCT05182840|468315306|FG004|Treatment Period|Reason missing|0|||
130097948|NCT05182840|468315307|FG005|Treatment Period|Reason missing|0|||
130097949|NCT05182840|468315308|FG006|Treatment Period|Reason missing|0|||
130097950|NCT05182840|468315309|FG007|Treatment Period|Reason missing|0|||
130097951|NCT05182840|468315310|FG008|Treatment Period|Reason missing|0|||
130097952|NCT05182840|468315311|FG009|Treatment Period|Reason missing|0|||
130097953|NCT05182840|468315302|FG000|Treatment Period|Other but not sponsor termination|0|||
130097954|NCT05182840|468315303|FG001|Treatment Period|Other but not sponsor termination|0|||
130097955|NCT05182840|468315304|FG002|Treatment Period|Other but not sponsor termination|8|||
130097956|NCT05182840|468315305|FG003|Treatment Period|Other but not sponsor termination|6|||
130097957|NCT05182840|468315306|FG004|Treatment Period|Other but not sponsor termination|6|||
130097958|NCT05182840|468315307|FG005|Treatment Period|Other but not sponsor termination|7|||
130097959|NCT05182840|468315308|FG006|Treatment Period|Other but not sponsor termination|5|||
130097960|NCT05182840|468315309|FG007|Treatment Period|Other but not sponsor termination|8|||
130097961|NCT05182840|468315310|FG008|Treatment Period|Other but not sponsor termination|7|||
130097962|NCT05182840|468315311|FG009|Treatment Period|Other but not sponsor termination|2|||
130097963|NCT05182840|468315302|FG000|Treatment Period|Protocol deviation|0|||
130097964|NCT05182840|468315303|FG001|Treatment Period|Protocol deviation|0|||
130097965|NCT05182840|468315304|FG002|Treatment Period|Protocol deviation|0|||
130097966|NCT05182840|468315305|FG003|Treatment Period|Protocol deviation|0|||
130097967|NCT05182840|468315306|FG004|Treatment Period|Protocol deviation|0|||
130097968|NCT05182840|468315307|FG005|Treatment Period|Protocol deviation|0|||
130097969|NCT05182840|468315308|FG006|Treatment Period|Protocol deviation|0|||
130097970|NCT05182840|468315309|FG007|Treatment Period|Protocol deviation|0|||
130097971|NCT05182840|468315310|FG008|Treatment Period|Protocol deviation|1|||
130097972|NCT05182840|468315311|FG009|Treatment Period|Protocol deviation|0|||
130097973|NCT05182840|468315302|FG000|Treatment Period|No reason available|0|||
130097974|NCT05182840|468315303|FG001|Treatment Period|No reason available|0|||
130097975|NCT05182840|468315304|FG002|Treatment Period|No reason available|0|||
130097976|NCT05182840|468315305|FG003|Treatment Period|No reason available|1|||
130097977|NCT05182840|468315306|FG004|Treatment Period|No reason available|0|||
130097978|NCT05182840|468315307|FG005|Treatment Period|No reason available|2|||
130097979|NCT05182840|468315308|FG006|Treatment Period|No reason available|0|||
130097980|NCT05182840|468315309|FG007|Treatment Period|No reason available|1|||
130097981|NCT05182840|468315310|FG008|Treatment Period|No reason available|0|||
130097982|NCT05182840|468315311|FG009|Treatment Period|No reason available|0|||
130097983|NCT05182840|468315302|FG000|Treatment Period|Burden of study procedures|0|||
130097984|NCT05182840|468315303|FG001|Treatment Period|Burden of study procedures|0|||
130097985|NCT05182840|468315304|FG002|Treatment Period|Burden of study procedures|0|||
130097986|NCT05182840|468315305|FG003|Treatment Period|Burden of study procedures|0|||
130097987|NCT05182840|468315306|FG004|Treatment Period|Burden of study procedures|1|||
130097988|NCT05182840|468315307|FG005|Treatment Period|Burden of study procedures|0|||
130097989|NCT05182840|468315308|FG006|Treatment Period|Burden of study procedures|0|||
130097990|NCT05182840|468315309|FG007|Treatment Period|Burden of study procedures|0|||
130097991|NCT05182840|468315310|FG008|Treatment Period|Burden of study procedures|0|||
130097992|NCT05182840|468315311|FG009|Treatment Period|Burden of study procedures|0|||
130097993|NCT05182840|468315302|FG000|Treatment Period|Change of residence|0|||
130097994|NCT05182840|468315303|FG001|Treatment Period|Change of residence|0|||
130097995|NCT05182840|468315304|FG002|Treatment Period|Change of residence|0|||
130209523|NCT01085136|468727298|FG002|Part B|Not treated|8|||
130097996|NCT05182840|468315305|FG003|Treatment Period|Change of residence|0|||
130097997|NCT05182840|468315306|FG004|Treatment Period|Change of residence|0|||
130097998|NCT05182840|468315307|FG005|Treatment Period|Change of residence|1|||
130097999|NCT05182840|468315308|FG006|Treatment Period|Change of residence|0|||
130098000|NCT05182840|468315309|FG007|Treatment Period|Change of residence|0|||
130098001|NCT05182840|468315310|FG008|Treatment Period|Change of residence|0|||
130098002|NCT05182840|468315311|FG009|Treatment Period|Change of residence|0|||
130098003|NCT05182840|468315302|FG000|Treatment Period|Adverse Event|0|||
130098004|NCT05182840|468315303|FG001|Treatment Period|Adverse Event|0|||
130098005|NCT05182840|468315304|FG002|Treatment Period|Adverse Event|4|||
130098006|NCT05182840|468315305|FG003|Treatment Period|Adverse Event|16|||
130098007|NCT05182840|468315306|FG004|Treatment Period|Adverse Event|12|||
130098008|NCT05182840|468315307|FG005|Treatment Period|Adverse Event|6|||
130098009|NCT05182840|468315308|FG006|Treatment Period|Adverse Event|4|||
130098010|NCT05182840|468315309|FG007|Treatment Period|Adverse Event|8|||
130098011|NCT05182840|468315310|FG008|Treatment Period|Adverse Event|16|||
130098012|NCT05182840|468315311|FG009|Treatment Period|Adverse Event|5|||
130098013|NCT05182840|468315302|FG000|Treatment Period|Not treated with study drug|0|||
130098014|NCT05182840|468315303|FG001|Treatment Period|Not treated with study drug|0|||
130098015|NCT05182840|468315304|FG002|Treatment Period|Not treated with study drug|0|||
130098016|NCT05182840|468315305|FG003|Treatment Period|Not treated with study drug|1|||
130098017|NCT05182840|468315306|FG004|Treatment Period|Not treated with study drug|0|||
130098018|NCT05182840|468315307|FG005|Treatment Period|Not treated with study drug|0|||
130098019|NCT05182840|468315308|FG006|Treatment Period|Not treated with study drug|1|||
130098020|NCT05182840|468315309|FG007|Treatment Period|Not treated with study drug|1|||
130098021|NCT05182840|468315310|FG008|Treatment Period|Not treated with study drug|0|||
130098022|NCT05182840|468315311|FG009|Treatment Period|Not treated with study drug|0|||
130209524|NCT01085136|468727296|FG000|Part B|Other reason not defined above|0|||
130209525|NCT01085136|468727297|FG001|Part B|Other reason not defined above|6|||
130209526|NCT01085136|468727298|FG002|Part B|Other reason not defined above|3|||
130209527|NCT02678000|468727300|FG000|PART 2|Adverse Event|0|||
130209528|NCT02678000|468727301|FG001|PART 2|Adverse Event|0|||
130209529|NCT02678000|468727302|FG002|PART 2|Adverse Event|2|||
130209530|NCT02678000|468727303|FG003|PART 2|Adverse Event|1|||
130209531|NCT02678000|468727304|FG004|PART 2|Adverse Event|0|||
130209532|NCT02678000|468727300|FG000|PART 2|Withdrawal by Subject|0|||
130209533|NCT02678000|468727301|FG001|PART 2|Withdrawal by Subject|0|||
130209534|NCT02678000|468727302|FG002|PART 2|Withdrawal by Subject|1|||
130209535|NCT02678000|468727303|FG003|PART 2|Withdrawal by Subject|0|||
130209536|NCT02678000|468727304|FG004|PART 2|Withdrawal by Subject|0|||
130209537|NCT02360475|468727306|FG000|Overall Study|Lost to Follow-up|4|||
130209538|NCT02360475|468727307|FG001|Overall Study|Lost to Follow-up|12|||
130209539|NCT02360475|468727308|FG002|Overall Study|Lost to Follow-up|6|||
130209540|NCT02360475|468727309|FG003|Overall Study|Lost to Follow-up|4|||
130209541|NCT02360475|468727306|FG000|Overall Study|Withdrawal by Subject|0|||
130209542|NCT02360475|468727307|FG001|Overall Study|Withdrawal by Subject|1|||
130209543|NCT02360475|468727308|FG002|Overall Study|Withdrawal by Subject|2|||
130209544|NCT02360475|468727309|FG003|Overall Study|Withdrawal by Subject|0|||
130209545|NCT02360475|468727306|FG000|Overall Study|Migrated/moved from study area|0|||
130209546|NCT02360475|468727307|FG001|Overall Study|Migrated/moved from study area|0|||
130209547|NCT02360475|468727308|FG002|Overall Study|Migrated/moved from study area|0|||
130209548|NCT02360475|468727309|FG003|Overall Study|Migrated/moved from study area|1|||
130209549|NCT03759366|468727311|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
130209550|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
130209551|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
130209552|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
130209553|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
130209554|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
130209555|NCT03759366|468727311|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
130209556|NCT04226495|468727312|FG000|Overall Study|Withdrawal by Subject|3|||
130209557|NCT04226495|468727313|FG001|Overall Study|Withdrawal by Subject|3|||
130209558|NCT04226495|468727312|FG000|Overall Study|PI discretion|3|||
130209559|NCT04226495|468727313|FG001|Overall Study|PI discretion|4|||
130209560|NCT00539032|468727314|FG000|Overall Study|Withdrawal by Subject|2|||
130209561|NCT00539032|468727315|FG001|Overall Study|Withdrawal by Subject|1|||
130209562|NCT01210352|468727316|FG000|Overall Study|Adverse Event|0|||
130209563|NCT01210352|468727317|FG001|Overall Study|Adverse Event|0|||
130209564|NCT01210352|468727318|FG002|Overall Study|Adverse Event|0|||
130209565|NCT01210352|468727319|FG003|Overall Study|Adverse Event|0|||
130098023|NCT02161380|468315312|FG000|Overall Study|Lost to Follow-up|0|||
130209566|NCT01210352|468727320|FG004|Overall Study|Adverse Event|0|||
130209567|NCT01210352|468727321|FG005|Overall Study|Adverse Event|0|||
130098024|NCT02161380|468315313|FG001|Overall Study|Lost to Follow-up|1|||
130098025|NCT02161380|468315314|FG002|Overall Study|Lost to Follow-up|0|||
130098026|NCT02161380|468315315|FG003|Overall Study|Lost to Follow-up|0|||
130098027|NCT04768881|468315324|FG000|Overall Study|Completed Study Follow-up|0|||
130098028|NCT04768881|468315325|FG001|Overall Study|Completed Study Follow-up|2|||
130098029|NCT04768881|468315324|FG000|Overall Study|Death|3|||
130098030|NCT04768881|468315325|FG001|Overall Study|Death|2|||
130098031|NCT04768881|468315324|FG000|Overall Study|Study Terminated by Sponsor|2|||
130098032|NCT04768881|468315325|FG001|Overall Study|Study Terminated by Sponsor|2|||
130098033|NCT04768881|468315324|FG000|Overall Study|Withdrawal by Subject|2|||
130098034|NCT04768881|468315325|FG001|Overall Study|Withdrawal by Subject|0|||
130098035|NCT04768881|468315324|FG000|Overall Study|Other|2|||
130098036|NCT04768881|468315325|FG001|Overall Study|Other|0|||
130098037|NCT04089566|468315327|FG000|Overall Study|Death|0|||
130098038|NCT04089566|468315328|FG001|Overall Study|Death|6|||
130098039|NCT04089566|468315329|FG002|Overall Study|Death|10|||
130098040|NCT04089566|468315330|FG003|Overall Study|Death|0|||
130098041|NCT04089566|468315331|FG004|Overall Study|Death|0|||
130098042|NCT04089566|468315332|FG005|Overall Study|Death|0|||
130098043|NCT04089566|468315327|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
130098044|NCT04089566|468315328|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
130098045|NCT04089566|468315329|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
130098046|NCT04089566|468315330|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
130098047|NCT04089566|468315331|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
130098048|NCT04089566|468315332|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
130098049|NCT04089566|468315327|FG000|Overall Study|Reason not Specified|0|||
130098050|NCT04089566|468315328|FG001|Overall Study|Reason not Specified|4|||
130098051|NCT04089566|468315329|FG002|Overall Study|Reason not Specified|4|||
130098052|NCT04089566|468315330|FG003|Overall Study|Reason not Specified|1|||
130098053|NCT04089566|468315331|FG004|Overall Study|Reason not Specified|0|||
130098054|NCT04089566|468315332|FG005|Overall Study|Reason not Specified|0|||
130098055|NCT01958619|468315338|FG000|Overall Study|Protocol Violation|2|||
130098056|NCT01958619|468315339|FG001|Overall Study|Protocol Violation|0|||
130098057|NCT01958619|468315340|FG002|Overall Study|Protocol Violation|1|||
130098058|NCT01958619|468315341|FG003|Overall Study|Protocol Violation|0|||
130098059|NCT01003691|468315346|FG000|Overall Study|Adverse Event|0|||
130098060|NCT01003691|468315347|FG001|Overall Study|Adverse Event|0|||
130098061|NCT01003691|468315348|FG002|Overall Study|Adverse Event|0|||
130098062|NCT01003691|468315349|FG003|Overall Study|Adverse Event|1|||
130098063|NCT00167414|468315350|FG000|Overall Study|Death|10|||
130098064|NCT01875731|468315351|FG000|Overall Study|Fail to obtain lab sample|1|||
130098065|NCT01875731|468315352|FG001|Overall Study|Fail to obtain lab sample|0|||
130098066|NCT00157820|468315355|FG000|Randomized|Physician Decision|4|||
130098067|NCT00157820|468315356|FG001|Randomized|Physician Decision|2|||
130098068|NCT00157820|468315357|FG002|Randomized|Physician Decision|3|||
130098069|NCT00157820|468315355|FG000|Randomized|Withdrawal by Subject|1|||
130098070|NCT00157820|468315356|FG001|Randomized|Withdrawal by Subject|2|||
130098071|NCT00157820|468315357|FG002|Randomized|Withdrawal by Subject|3|||
130098072|NCT00157820|468315355|FG000|Randomized|Protocol Violation|2|||
130098073|NCT00157820|468315356|FG001|Randomized|Protocol Violation|1|||
130098074|NCT00157820|468315357|FG002|Randomized|Protocol Violation|2|||
130098075|NCT00157820|468315355|FG000|1st 8 Month|Death|7|||
130098076|NCT00157820|468315356|FG001|1st 8 Month|Death|8|||
130098077|NCT00157820|468315357|FG002|1st 8 Month|Death|3|||
130098078|NCT00157820|468315355|FG000|1st 8 Month|Lost to Follow-up|1|||
130098079|NCT00157820|468315356|FG001|1st 8 Month|Lost to Follow-up|2|||
130098080|NCT00157820|468315357|FG002|1st 8 Month|Lost to Follow-up|1|||
130098081|NCT00157820|468315355|FG000|1st 8 Month|Premature cross-over|0|||
130098082|NCT00157820|468315356|FG001|1st 8 Month|Premature cross-over|2|||
130098083|NCT00157820|468315357|FG002|1st 8 Month|Premature cross-over|2|||
130098084|NCT00157820|468315355|FG000|2nd 8 Months|Death|3|||
130098085|NCT00157820|468315356|FG001|2nd 8 Months|Death|1|||
130098086|NCT00157820|468315357|FG002|2nd 8 Months|Death|3|||
130098087|NCT00157820|468315355|FG000|2nd 8 Months|Lost to Follow-up|1|||
130098088|NCT00157820|468315356|FG001|2nd 8 Months|Lost to Follow-up|5|||
130098089|NCT00157820|468315357|FG002|2nd 8 Months|Lost to Follow-up|2|||
130098090|NCT00157820|468315355|FG000|2nd 8 Months|Premature cross-over|1|||
130098091|NCT00157820|468315356|FG001|2nd 8 Months|Premature cross-over|7|||
130098092|NCT00157820|468315357|FG002|2nd 8 Months|Premature cross-over|9|||
130098093|NCT00223990|468315360|FG000|Overall Study|Moved from area|2|||
130098094|NCT00223990|468315361|FG001|Overall Study|Moved from area|1|||
130098095|NCT00223990|468315360|FG000|Overall Study|Withdrawal by Subject|4|||
130098096|NCT00223990|468315361|FG001|Overall Study|Withdrawal by Subject|8|||
130098097|NCT00223990|468315360|FG000|Overall Study|Lost to Follow-up|1|||
130098098|NCT00223990|468315361|FG001|Overall Study|Lost to Follow-up|0|||
130098099|NCT00509223|468316658|FG000|Overall Study|Lost to Follow-up|1|||
130098100|NCT00509223|468316659|FG001|Overall Study|Lost to Follow-up|1|||
130098101|NCT00509223|468316658|FG000|Overall Study|Adverse Event|1|||
130098102|NCT00509223|468316659|FG001|Overall Study|Adverse Event|1|||
130098103|NCT00509223|468316658|FG000|Overall Study|Withdrawal by Subject|25|||
130098104|NCT00509223|468316659|FG001|Overall Study|Withdrawal by Subject|6|||
130098105|NCT00509223|468316658|FG000|Overall Study|Including: subject change of address|5|||
130098106|NCT00509223|468316659|FG001|Overall Study|Including: subject change of address|2|||
130098107|NCT00509223|468316658|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
130098108|NCT00509223|468316659|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
130098109|NCT00437294|468316663|FG000|Overall Study|Adverse Event|5|||
130098110|NCT00437294|468316664|FG001|Overall Study|Adverse Event|4|||
130098111|NCT00437294|468316663|FG000|Overall Study|Death|5|||
130098112|NCT00437294|468316664|FG001|Overall Study|Death|2|||
130098113|NCT00437294|468316663|FG000|Overall Study|Physician Decision|0|||
130098114|NCT00437294|468316664|FG001|Overall Study|Physician Decision|3|||
130098115|NCT00437294|468316663|FG000|Overall Study|Withdrawal by Subject|5|||
130098116|NCT00437294|468316664|FG001|Overall Study|Withdrawal by Subject|0|||
130098117|NCT00437294|468316663|FG000|Overall Study|Progressive Disease|19|||
130098118|NCT00437294|468316664|FG001|Overall Study|Progressive Disease|23|||
130098119|NCT00437294|468316663|FG000|Overall Study|Sponsor Decision|8|||
130098120|NCT00437294|468316664|FG001|Overall Study|Sponsor Decision|9|||
130098121|NCT00437294|468316663|FG000|Overall Study|Protocol Violation|0|||
130098122|NCT00437294|468316664|FG001|Overall Study|Protocol Violation|1|||
130098123|NCT00437294|468316663|FG000|Overall Study|Entry criteria not met|1|||
130098124|NCT00437294|468316664|FG001|Overall Study|Entry criteria not met|1|||
130098125|NCT01300741|468316671|FG000|Overall Study|Lens deposits|1|||
130098126|NCT01300741|468316671|FG000|Overall Study|Lost to Follow-up|1|||
130098127|NCT01300741|468316671|FG000|Overall Study|Discomfort|1|||
130098128|NCT01473602|468316672|FG000|Overall Study|Adverse Event|1|||
130098129|NCT01473602|468316673|FG001|Overall Study|Adverse Event|2|||
130098130|NCT01473602|468316672|FG000|Overall Study|Death|0|||
130098131|NCT01473602|468316673|FG001|Overall Study|Death|1|||
130098132|NCT01473602|468316672|FG000|Overall Study|Lost to Follow-up|1|||
130098133|NCT01473602|468316673|FG001|Overall Study|Lost to Follow-up|1|||
130098134|NCT01473602|468316672|FG000|Overall Study|Withdrawal by Subject|5|||
130098135|NCT01473602|468316673|FG001|Overall Study|Withdrawal by Subject|4|||
130098136|NCT01473602|468316672|FG000|Overall Study|Physician Decision|1|||
130098137|NCT01473602|468316673|FG001|Overall Study|Physician Decision|0|||
130098138|NCT01339273|468316675|FG000|Overall Study|Lost to Follow-up|8|||
130098139|NCT01339273|468316676|FG001|Overall Study|Lost to Follow-up|8|||
130098140|NCT00560573|468316677|FG000|Overall Study|Death|4|||
130098141|NCT00560573|468316678|FG001|Overall Study|Death|1|||
130098142|NCT00560573|468316679|FG002|Overall Study|Death|4|||
130098143|NCT00560573|468316680|FG003|Overall Study|Death|5|||
130098144|NCT00560573|468316681|FG004|Overall Study|Death|1|||
130098145|NCT00560573|468316682|FG005|Overall Study|Death|10|||
130098146|NCT00560573|468316677|FG000|Overall Study|Lost to Follow-up|0|||
130098147|NCT00560573|468316678|FG001|Overall Study|Lost to Follow-up|0|||
130098148|NCT00560573|468316679|FG002|Overall Study|Lost to Follow-up|0|||
130098149|NCT00560573|468316680|FG003|Overall Study|Lost to Follow-up|1|||
130098150|NCT00560573|468316681|FG004|Overall Study|Lost to Follow-up|1|||
130098151|NCT00560573|468316682|FG005|Overall Study|Lost to Follow-up|0|||
130098152|NCT00560573|468316677|FG000|Overall Study|Withdrawal by Subject|0|||
130098153|NCT00560573|468316678|FG001|Overall Study|Withdrawal by Subject|0|||
130098154|NCT00560573|468316679|FG002|Overall Study|Withdrawal by Subject|0|||
130098155|NCT00560573|468316680|FG003|Overall Study|Withdrawal by Subject|1|||
130098156|NCT00560573|468316681|FG004|Overall Study|Withdrawal by Subject|1|||
130098157|NCT00560573|468316682|FG005|Overall Study|Withdrawal by Subject|0|||
130098158|NCT00560573|468316677|FG000|Overall Study|Other|2|||
130098159|NCT00560573|468316678|FG001|Overall Study|Other|2|||
130098160|NCT00560573|468316679|FG002|Overall Study|Other|2|||
130098161|NCT00560573|468316680|FG003|Overall Study|Other|3|||
130098162|NCT00560573|468316681|FG004|Overall Study|Other|3|||
130098163|NCT00560573|468316682|FG005|Overall Study|Other|3|||
130098164|NCT00560573|468316677|FG000|Overall Study|Enrolled, not treated|0|||
130098165|NCT00560573|468316678|FG001|Overall Study|Enrolled, not treated|0|||
130098166|NCT00560573|468316679|FG002|Overall Study|Enrolled, not treated|0|||
130098167|NCT00560573|468316680|FG003|Overall Study|Enrolled, not treated|0|||
130098168|NCT00560573|468316681|FG004|Overall Study|Enrolled, not treated|1|||
130098169|NCT00560573|468316682|FG005|Overall Study|Enrolled, not treated|0|||
130098170|NCT00726882|468316683|FG000|Overall Study|Withdrawal by Subject|5|||
130098171|NCT00726882|468316683|FG000|Overall Study|Lost to Follow-up|7|||
130098172|NCT00726882|468316683|FG000|Overall Study|Other|10|||
130098173|NCT02526017|468316684|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098174|NCT02526017|468316685|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098175|NCT02526017|468316686|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098176|NCT02526017|468316687|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098177|NCT02526017|468316688|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
130098178|NCT02526017|468316689|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130209568|NCT01210352|468727322|FG006|Overall Study|Adverse Event|0|||
130209569|NCT01210352|468727323|FG007|Overall Study|Adverse Event|2|||
130209570|NCT01210352|468727324|FG008|Overall Study|Adverse Event|1|||
130209571|NCT01210352|468727316|FG000|Overall Study|Lack of Efficacy|0|||
130209572|NCT01210352|468727317|FG001|Overall Study|Lack of Efficacy|0|||
130209573|NCT01210352|468727318|FG002|Overall Study|Lack of Efficacy|0|||
130209574|NCT01210352|468727319|FG003|Overall Study|Lack of Efficacy|0|||
130209575|NCT01210352|468727320|FG004|Overall Study|Lack of Efficacy|0|||
130209576|NCT01210352|468727321|FG005|Overall Study|Lack of Efficacy|0|||
130209577|NCT01210352|468727322|FG006|Overall Study|Lack of Efficacy|1|||
130209578|NCT01210352|468727323|FG007|Overall Study|Lack of Efficacy|0|||
130209579|NCT01210352|468727324|FG008|Overall Study|Lack of Efficacy|0|||
130209580|NCT01210352|468727316|FG000|Overall Study|Physician Decision|0|||
130209581|NCT01210352|468727317|FG001|Overall Study|Physician Decision|0|||
130209582|NCT01210352|468727318|FG002|Overall Study|Physician Decision|0|||
130209583|NCT01210352|468727319|FG003|Overall Study|Physician Decision|0|||
130209584|NCT01210352|468727320|FG004|Overall Study|Physician Decision|0|||
130209585|NCT01210352|468727321|FG005|Overall Study|Physician Decision|0|||
130209586|NCT01210352|468727322|FG006|Overall Study|Physician Decision|0|||
130209587|NCT01210352|468727323|FG007|Overall Study|Physician Decision|1|||
130098179|NCT02526017|468316690|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098180|NCT02526017|468316691|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098181|NCT02526017|468316692|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
130098182|NCT02674568|468316697|FG000|Overall Study|Withdrawal by Subject|5|||
130209588|NCT01210352|468727324|FG008|Overall Study|Physician Decision|2|||
130209589|NCT01210352|468727316|FG000|Overall Study|Withdrawal by Subject|0|||
130209590|NCT01210352|468727317|FG001|Overall Study|Withdrawal by Subject|0|||
130209591|NCT01210352|468727318|FG002|Overall Study|Withdrawal by Subject|1|||
130209592|NCT01210352|468727319|FG003|Overall Study|Withdrawal by Subject|0|||
130209593|NCT01210352|468727320|FG004|Overall Study|Withdrawal by Subject|0|||
130209594|NCT01210352|468727321|FG005|Overall Study|Withdrawal by Subject|0|||
130209595|NCT01210352|468727322|FG006|Overall Study|Withdrawal by Subject|1|||
130209596|NCT01210352|468727323|FG007|Overall Study|Withdrawal by Subject|0|||
130209597|NCT01210352|468727324|FG008|Overall Study|Withdrawal by Subject|1|||
130209598|NCT01210352|468727316|FG000|Overall Study|Patient Discharged Early|0|||
130209599|NCT01210352|468727317|FG001|Overall Study|Patient Discharged Early|0|||
130209600|NCT01210352|468727318|FG002|Overall Study|Patient Discharged Early|1|||
130209601|NCT01210352|468727319|FG003|Overall Study|Patient Discharged Early|0|||
130209602|NCT01210352|468727320|FG004|Overall Study|Patient Discharged Early|0|||
130209603|NCT01210352|468727321|FG005|Overall Study|Patient Discharged Early|0|||
130209604|NCT01210352|468727322|FG006|Overall Study|Patient Discharged Early|0|||
130209605|NCT01210352|468727323|FG007|Overall Study|Patient Discharged Early|0|||
130209606|NCT01210352|468727324|FG008|Overall Study|Patient Discharged Early|0|||
130209607|NCT00422292|468727325|FG000|Overall Study|Serious adverse events|1|||
130209608|NCT00422292|468727326|FG001|Overall Study|Serious adverse events|4|||
130209609|NCT00422292|468727327|FG002|Overall Study|Serious adverse events|0|||
130209610|NCT00422292|468727328|FG003|Overall Study|Serious adverse events|0|||
130209611|NCT00422292|468727325|FG000|Overall Study|Adverse Event|1|||
130209612|NCT00422292|468727326|FG001|Overall Study|Adverse Event|0|||
130209613|NCT00422292|468727327|FG002|Overall Study|Adverse Event|1|||
130209614|NCT00422292|468727328|FG003|Overall Study|Adverse Event|0|||
130209615|NCT00422292|468727325|FG000|Overall Study|Protocol Violation|4|||
130209616|NCT00422292|468727326|FG001|Overall Study|Protocol Violation|25|||
130209617|NCT00422292|468727327|FG002|Overall Study|Protocol Violation|8|||
130209618|NCT00422292|468727328|FG003|Overall Study|Protocol Violation|5|||
130209619|NCT00422292|468727325|FG000|Overall Study|Lost to Follow-up|6|||
130209620|NCT00422292|468727326|FG001|Overall Study|Lost to Follow-up|12|||
130209621|NCT00422292|468727327|FG002|Overall Study|Lost to Follow-up|6|||
130209622|NCT00422292|468727328|FG003|Overall Study|Lost to Follow-up|6|||
130209623|NCT00422292|468727325|FG000|Overall Study|Withdrawal by Subject|6|||
130209624|NCT00422292|468727326|FG001|Overall Study|Withdrawal by Subject|25|||
130209625|NCT00422292|468727327|FG002|Overall Study|Withdrawal by Subject|7|||
130209626|NCT00422292|468727328|FG003|Overall Study|Withdrawal by Subject|13|||
130209627|NCT02440854|468727329|FG000|Overall Study|Relocation of patient|1|||
130209628|NCT02440854|468727329|FG000|Overall Study|Death|6|||
130209629|NCT02440854|468727329|FG000|Overall Study|Lost to Follow-up|10|||
130209630|NCT02440854|468727329|FG000|Overall Study|Afatinib discontinuation|46|||
130209631|NCT02440854|468727329|FG000|Overall Study|stopped study at earlier timepoint|14|||
130209632|NCT02440854|468727329|FG000|Overall Study|Study medication not received|1|||
130209633|NCT02440854|468727329|FG000|Overall Study|Violation of inclusion criteria|2|||
130209634|NCT03338569|468727330|FG000|Overall Study|Physician Decision|8|||
130209635|NCT03338569|468727331|FG001|Overall Study|Physician Decision|3|||
130209636|NCT03338569|468727330|FG000|Overall Study|Withdrawal by Subject|0|||
130209637|NCT03338569|468727331|FG001|Overall Study|Withdrawal by Subject|1|||
130209638|NCT03338569|468727330|FG000|Overall Study|Lost to Follow-up|0|||
130209639|NCT03338569|468727331|FG001|Overall Study|Lost to Follow-up|1|||
130209640|NCT02243046|468727332|FG000|Overall Study|Lost to Follow-up|1|||
130209641|NCT02243046|468727333|FG001|Overall Study|Lost to Follow-up|1|||
130209642|NCT02243046|468727334|FG002|Overall Study|Lost to Follow-up|4|||
130209643|NCT02669082|468727335|FG000|Overall Study|Adverse Event|1|||
130209644|NCT04852276|468727336|FG000|Overall Study|Death|2|||
130209645|NCT04852276|468727337|FG001|Overall Study|Death|0|||
130209646|NCT04852276|468727336|FG000|Overall Study|Lost to Follow-up|15|||
130209647|NCT04852276|468727337|FG001|Overall Study|Lost to Follow-up|9|||
130209648|NCT04852276|468727336|FG000|Overall Study|Withdrawal by Subject|26|||
130209649|NCT04852276|468727337|FG001|Overall Study|Withdrawal by Subject|6|||
130209650|NCT02824562|468729191|FG000|Overall Study|Lost to Follow-up|3|||
130209651|NCT02824562|468729192|FG001|Overall Study|Lost to Follow-up|4|||
130209652|NCT02824562|468729191|FG000|Overall Study|Death|0|||
130209653|NCT02824562|468729192|FG001|Overall Study|Death|1|||
130209654|NCT02168777|468729193|FG000|Overall Study|Withdrawal by Subject|1|||
130209655|NCT02168777|468729194|FG001|Overall Study|Withdrawal by Subject|0|||
130209656|NCT02168777|468729195|FG002|Overall Study|Withdrawal by Subject|2|||
130209657|NCT02168777|468729193|FG000|Overall Study|Adverse Event|1|||
130209658|NCT02168777|468729194|FG001|Overall Study|Adverse Event|0|||
130209659|NCT02168777|468729195|FG002|Overall Study|Adverse Event|1|||
130209660|NCT02168777|468729193|FG000|Overall Study|Disease recurrence|0|||
130209661|NCT02168777|468729194|FG001|Overall Study|Disease recurrence|0|||
130209662|NCT02168777|468729195|FG002|Overall Study|Disease recurrence|1|||
130209663|NCT02168777|468729193|FG000|Overall Study|Radiological disease progression|0|||
130209664|NCT02168777|468729194|FG001|Overall Study|Radiological disease progression|5|||
130209665|NCT02168777|468729195|FG002|Overall Study|Radiological disease progression|5|||
130209666|NCT02168777|468729193|FG000|Overall Study|Clinical disease progression|0|||
130209667|NCT02168777|468729194|FG001|Overall Study|Clinical disease progression|1|||
130209668|NCT02168777|468729195|FG002|Overall Study|Clinical disease progression|2|||
130209669|NCT02168777|468729193|FG000|Overall Study|Other reason|0|||
130209670|NCT02168777|468729194|FG001|Overall Study|Other reason|1|||
129985699|NCT04811131|467909335|FG002|Overall Study|Adverse Event|1|||
130209671|NCT02168777|468729195|FG002|Overall Study|Other reason|0|||
130209672|NCT05243563|468729196|FG000|Overall Study|Withdrawal by Subject|1|||
130209673|NCT05243563|468729197|FG001|Overall Study|Withdrawal by Subject|0|||
130209674|NCT05243563|468729196|FG000|Overall Study|Physician Decision|1|||
130209675|NCT05243563|468729197|FG001|Overall Study|Physician Decision|0|||
130209676|NCT02474355|468729201|FG000|Overall Study|Other|43|||
130209677|NCT02474355|468729201|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
130209678|NCT02474355|468729201|FG000|Overall Study|Lost to Follow-up|98|||
130209679|NCT02474355|468729201|FG000|Overall Study|Withdrawal by Subject|124|||
130209680|NCT02474355|468729201|FG000|Overall Study|Death|1361|||
130209681|NCT01066793|468729202|FG000|Overall Study|Death|4|||
130209682|NCT01066793|468729203|FG001|Overall Study|Death|1|||
130209683|NCT01066793|468729204|FG002|Overall Study|Death|1|||
130209684|NCT01066793|468729205|FG003|Overall Study|Death|0|||
130209685|NCT01066793|468729206|FG004|Overall Study|Death|0|||
130209686|NCT01066793|468729207|FG005|Overall Study|Death|0|||
130209687|NCT01066793|468729202|FG000|Overall Study|Lack of Efficacy|2|||
130209688|NCT01066793|468729203|FG001|Overall Study|Lack of Efficacy|1|||
130209689|NCT01066793|468729204|FG002|Overall Study|Lack of Efficacy|0|||
130209690|NCT01066793|468729205|FG003|Overall Study|Lack of Efficacy|0|||
130209691|NCT01066793|468729206|FG004|Overall Study|Lack of Efficacy|0|||
130209692|NCT01066793|468729207|FG005|Overall Study|Lack of Efficacy|0|||
130209693|NCT01066793|468729202|FG000|Overall Study|Lost to Follow-up|180|||
130209694|NCT01066793|468729203|FG001|Overall Study|Lost to Follow-up|39|||
130209695|NCT01066793|468729204|FG002|Overall Study|Lost to Follow-up|82|||
130209696|NCT01066793|468729205|FG003|Overall Study|Lost to Follow-up|16|||
130209697|NCT01066793|468729206|FG004|Overall Study|Lost to Follow-up|0|||
130209698|NCT01066793|468729207|FG005|Overall Study|Lost to Follow-up|1|||
130209699|NCT01066793|468729202|FG000|Overall Study|Physician Decision|3|||
130209700|NCT01066793|468729203|FG001|Overall Study|Physician Decision|0|||
130209701|NCT01066793|468729204|FG002|Overall Study|Physician Decision|0|||
130209702|NCT01066793|468729205|FG003|Overall Study|Physician Decision|0|||
130209703|NCT01066793|468729206|FG004|Overall Study|Physician Decision|0|||
130209704|NCT01066793|468729207|FG005|Overall Study|Physician Decision|0|||
130209705|NCT01066793|468729202|FG000|Overall Study|Protocol Violation|3|||
130209706|NCT01066793|468729203|FG001|Overall Study|Protocol Violation|2|||
130209707|NCT01066793|468729204|FG002|Overall Study|Protocol Violation|2|||
130209708|NCT01066793|468729205|FG003|Overall Study|Protocol Violation|0|||
130209709|NCT01066793|468729206|FG004|Overall Study|Protocol Violation|0|||
130209710|NCT01066793|468729207|FG005|Overall Study|Protocol Violation|0|||
130209711|NCT01066793|468729202|FG000|Overall Study|Withdrawal by Subject|7|||
130209712|NCT01066793|468729203|FG001|Overall Study|Withdrawal by Subject|4|||
130209713|NCT01066793|468729204|FG002|Overall Study|Withdrawal by Subject|1|||
130209714|NCT01066793|468729205|FG003|Overall Study|Withdrawal by Subject|0|||
130209715|NCT01066793|468729206|FG004|Overall Study|Withdrawal by Subject|0|||
130209716|NCT01066793|468729207|FG005|Overall Study|Withdrawal by Subject|0|||
130209717|NCT01066793|468729202|FG000|Overall Study|Early Termination|3|||
130209718|NCT01066793|468729203|FG001|Overall Study|Early Termination|0|||
130209719|NCT01066793|468729204|FG002|Overall Study|Early Termination|0|||
130209720|NCT01066793|468729205|FG003|Overall Study|Early Termination|0|||
130209721|NCT01066793|468729206|FG004|Overall Study|Early Termination|0|||
130209722|NCT01066793|468729207|FG005|Overall Study|Early Termination|0|||
130209723|NCT01066793|468729202|FG000|Overall Study|Lab test not done|7|||
130209724|NCT01066793|468729203|FG001|Overall Study|Lab test not done|0|||
130209725|NCT01066793|468729204|FG002|Overall Study|Lab test not done|0|||
130209726|NCT01066793|468729205|FG003|Overall Study|Lab test not done|1|||
130209727|NCT01066793|468729206|FG004|Overall Study|Lab test not done|0|||
130209728|NCT01066793|468729207|FG005|Overall Study|Lab test not done|0|||
130209729|NCT01066793|468729202|FG000|Overall Study|Miscellaneous|4|||
130209730|NCT01066793|468729203|FG001|Overall Study|Miscellaneous|5|||
130209731|NCT01066793|468729204|FG002|Overall Study|Miscellaneous|6|||
130209732|NCT01066793|468729205|FG003|Overall Study|Miscellaneous|0|||
130209733|NCT01066793|468729206|FG004|Overall Study|Miscellaneous|0|||
130209734|NCT01066793|468729207|FG005|Overall Study|Miscellaneous|0|||
130209735|NCT01066793|468729202|FG000|Overall Study|Non-responders|104|||
130209736|NCT01066793|468729203|FG001|Overall Study|Non-responders|5|||
130209737|NCT01066793|468729204|FG002|Overall Study|Non-responders|11|||
130209738|NCT01066793|468729205|FG003|Overall Study|Non-responders|25|||
130209739|NCT01066793|468729206|FG004|Overall Study|Non-responders|0|||
130209740|NCT01066793|468729207|FG005|Overall Study|Non-responders|0|||
130209741|NCT01066793|468729202|FG000|Overall Study|Other|15|||
130209742|NCT01066793|468729203|FG001|Overall Study|Other|5|||
130209743|NCT01066793|468729204|FG002|Overall Study|Other|6|||
130209744|NCT01066793|468729205|FG003|Overall Study|Other|2|||
130209745|NCT01066793|468729206|FG004|Overall Study|Other|0|||
130209746|NCT01066793|468729207|FG005|Overall Study|Other|0|||
130209747|NCT01066793|468729202|FG000|Overall Study|Relapse|20|||
130209748|NCT01066793|468729203|FG001|Overall Study|Relapse|8|||
130209749|NCT01066793|468729204|FG002|Overall Study|Relapse|2|||
130209750|NCT01066793|468729205|FG003|Overall Study|Relapse|3|||
130209751|NCT01066793|468729206|FG004|Overall Study|Relapse|0|||
130209752|NCT01066793|468729207|FG005|Overall Study|Relapse|0|||
130209753|NCT01066793|468729202|FG000|Overall Study|Result Not Available|1|||
130209754|NCT01066793|468729203|FG001|Overall Study|Result Not Available|0|||
129985700|NCT04811131|467909336|FG003|Overall Study|Adverse Event|0|||
130209755|NCT01066793|468729204|FG002|Overall Study|Result Not Available|0|||
130209756|NCT01066793|468729205|FG003|Overall Study|Result Not Available|0|||
130209757|NCT01066793|468729206|FG004|Overall Study|Result Not Available|0|||
130209758|NCT01066793|468729207|FG005|Overall Study|Result Not Available|0|||
130209759|NCT01066793|468729202|FG000|Overall Study|Treatment Interrupted|1|||
130209760|NCT01066793|468729203|FG001|Overall Study|Treatment Interrupted|1|||
130209761|NCT01066793|468729204|FG002|Overall Study|Treatment Interrupted|0|||
130209762|NCT01066793|468729205|FG003|Overall Study|Treatment Interrupted|0|||
130209763|NCT01066793|468729206|FG004|Overall Study|Treatment Interrupted|0|||
130209764|NCT01066793|468729207|FG005|Overall Study|Treatment Interrupted|0|||
130209765|NCT01066793|468729202|FG000|Overall Study|Treatment Never Started|18|||
130209766|NCT01066793|468729203|FG001|Overall Study|Treatment Never Started|5|||
130209767|NCT01066793|468729204|FG002|Overall Study|Treatment Never Started|4|||
130209768|NCT01066793|468729205|FG003|Overall Study|Treatment Never Started|1|||
130209769|NCT01066793|468729206|FG004|Overall Study|Treatment Never Started|0|||
130209770|NCT01066793|468729207|FG005|Overall Study|Treatment Never Started|0|||
130209771|NCT01066793|468729202|FG000|Overall Study|Treatment Stopped|2|||
130209772|NCT01066793|468729203|FG001|Overall Study|Treatment Stopped|1|||
130209773|NCT01066793|468729204|FG002|Overall Study|Treatment Stopped|0|||
130209774|NCT01066793|468729205|FG003|Overall Study|Treatment Stopped|1|||
130209775|NCT01066793|468729206|FG004|Overall Study|Treatment Stopped|0|||
130209776|NCT01066793|468729207|FG005|Overall Study|Treatment Stopped|0|||
130209777|NCT01911793|468729209|FG000|Overall Study|Physician Decision|1|||
129985701|NCT04811131|467909333|FG000|Overall Study|Lack of Efficacy|0|||
130209778|NCT01911793|468729210|FG001|Overall Study|Physician Decision|5|||
130209779|NCT03334422|468729211|FG000|Overall Study|Adverse Event|1|||
130209780|NCT03334422|468729212|FG001|Overall Study|Adverse Event|3|||
130209781|NCT03334422|468729213|FG002|Overall Study|Adverse Event|2|||
130098183|NCT02674568|468316697|FG000|Overall Study|Death|303|||
130098184|NCT02674568|468316697|FG000|Overall Study|Physician Decision|2|||
130098185|NCT02674568|468316697|FG000|Overall Study|Lost to Follow-up|9|||
130098186|NCT02674568|468316697|FG000|Overall Study|Other, Not Specified|20|||
130098187|NCT00968539|468316698|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
130098188|NCT00968539|468316699|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130098189|NCT00457249|468316700|FG000|Overall Study|Lost to Follow-up|3|||
130098190|NCT00457249|468316701|FG001|Overall Study|Lost to Follow-up|0|||
130098191|NCT00457249|468316700|FG000|Overall Study|Protocol Violation|4|||
130098192|NCT00457249|468316701|FG001|Overall Study|Protocol Violation|1|||
130098193|NCT00457249|468316700|FG000|Overall Study|Withdrawal by Subject|3|||
130098194|NCT00457249|468316701|FG001|Overall Study|Withdrawal by Subject|1|||
130098195|NCT00457249|468316700|FG000|Overall Study|Serious Adverse Events|2|||
130098196|NCT00457249|468316701|FG001|Overall Study|Serious Adverse Events|0|||
130098197|NCT00396318|468316702|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
130098198|NCT00326118|468316703|FG000|Active Phase|Withdrawal by Subject|4|||
130098199|NCT00326118|468316704|FG001|Active Phase|Withdrawal by Subject|1|||
130098200|NCT00938392|468316705|FG000|Overall Study|Adverse Event|0|||
130098201|NCT00938392|468316706|FG001|Overall Study|Adverse Event|1|||
130098202|NCT00938392|468316705|FG000|Overall Study|Withdrawal by Subject|0|||
130098203|NCT00938392|468316706|FG001|Overall Study|Withdrawal by Subject|1|||
130098204|NCT00938392|468316705|FG000|Overall Study|Lost to Follow-up|2|||
130098205|NCT00938392|468316706|FG001|Overall Study|Lost to Follow-up|2|||
130098206|NCT02916056|468316707|FG000|Overall Study|Adverse Event|6|||
130098207|NCT02916056|468316707|FG000|Overall Study|Lost to Follow-up|1|||
130098208|NCT02916056|468316707|FG000|Overall Study|Other|12|||
130098209|NCT02916056|468316707|FG000|Overall Study|Protocol Violation|1|||
130098210|NCT02916056|468316707|FG000|Overall Study|Withdrawal by Subject|8|||
130098211|NCT02916056|468316707|FG000|Overall Study|Study Terminated by Sponsor|269|||
130098212|NCT00290511|468316708|FG000|Overall Study|Adverse Event|1|||
130098213|NCT00290511|468316708|FG000|Overall Study|Death|1|||
130098214|NCT00290511|468316708|FG000|Overall Study|Physician Decision|1|||
130098215|NCT00290511|468316708|FG000|Overall Study|Withdrawal by Subject|1|||
130098216|NCT00124709|468316709|FG000|Overall Study|Randomized but did not take medication|3|||
130098217|NCT00124709|468316710|FG001|Overall Study|Randomized but did not take medication|1|||
130098218|NCT00124709|468316709|FG000|Overall Study|Adverse Event|3|||
130098219|NCT00124709|468316710|FG001|Overall Study|Adverse Event|0|||
130098220|NCT00124709|468316709|FG000|Overall Study|Lack of Efficacy|5|||
130098221|NCT00124709|468316710|FG001|Overall Study|Lack of Efficacy|10|||
130098222|NCT00124709|468316709|FG000|Overall Study|Protocol Violation|3|||
130098223|NCT00124709|468316710|FG001|Overall Study|Protocol Violation|5|||
130098224|NCT00124709|468316709|FG000|Overall Study|Withdrawal by Subject|127|||
130098225|NCT00124709|468316710|FG001|Overall Study|Withdrawal by Subject|136|||
130098226|NCT00124709|468316709|FG000|Overall Study|Lost to Follow-up|114|||
130098227|NCT00124709|468316710|FG001|Overall Study|Lost to Follow-up|120|||
130098228|NCT00122954|468316711|FG000|Overall Study|Withdrawal by Subject|2|||
130098229|NCT00122954|468316712|FG001|Overall Study|Withdrawal by Subject|2|||
130098230|NCT00122954|468316711|FG000|Overall Study|Protocol Violation|0|||
130098231|NCT00122954|468316712|FG001|Overall Study|Protocol Violation|1|||
130098232|NCT01728376|468316713|FG000|Overall Study|Adverse Event|1|||
130098233|NCT01728376|468316714|FG001|Overall Study|Adverse Event|1|||
130098234|NCT01728376|468316715|FG002|Overall Study|Adverse Event|1|||
130098235|NCT01728376|468316716|FG003|Overall Study|Adverse Event|1|||
130098236|NCT01728376|468316717|FG004|Overall Study|Adverse Event|1|||
130098237|NCT01728376|468316718|FG005|Overall Study|Adverse Event|0|||
130098238|NCT01728376|468316713|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
130098239|NCT01728376|468316714|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
130098240|NCT01728376|468316715|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
130098241|NCT01728376|468316716|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
130098242|NCT01728376|468316717|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
130098243|NCT01728376|468316718|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
130098244|NCT01728376|468316713|FG000|Overall Study|No relevant bacteria|2|||
130098245|NCT01728376|468316714|FG001|Overall Study|No relevant bacteria|0|||
130098246|NCT01728376|468316715|FG002|Overall Study|No relevant bacteria|0|||
130098247|NCT01728376|468316716|FG003|Overall Study|No relevant bacteria|0|||
130098248|NCT01728376|468316717|FG004|Overall Study|No relevant bacteria|1|||
130098249|NCT01728376|468316718|FG005|Overall Study|No relevant bacteria|1|||
130098250|NCT01728376|468316713|FG000|Overall Study|Did not receive treatment|0|||
130098251|NCT01728376|468316714|FG001|Overall Study|Did not receive treatment|1|||
130098252|NCT01728376|468316715|FG002|Overall Study|Did not receive treatment|0|||
130098253|NCT01728376|468316716|FG003|Overall Study|Did not receive treatment|0|||
130098254|NCT01728376|468316717|FG004|Overall Study|Did not receive treatment|0|||
130098255|NCT01728376|468316718|FG005|Overall Study|Did not receive treatment|0|||
130098256|NCT01728376|468316713|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130098257|NCT01728376|468316714|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130098258|NCT01728376|468316715|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130098259|NCT01728376|468316716|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
130098260|NCT01728376|468316717|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
130098261|NCT01728376|468316718|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
130098262|NCT04341727|468316728|FG000|Overall Study|Withdrawal by Subject|0|||
130098263|NCT04341727|468316729|FG001|Overall Study|Withdrawal by Subject|0|||
130098264|NCT04341727|468316730|FG002|Overall Study|Withdrawal by Subject|1|||
130098265|NCT04341727|468316731|FG003|Overall Study|Withdrawal by Subject|0|||
130098266|NCT04341727|468316728|FG000|Overall Study|Lost to Follow-up|0|||
130098267|NCT04341727|468316729|FG001|Overall Study|Lost to Follow-up|0|||
130098268|NCT04341727|468316730|FG002|Overall Study|Lost to Follow-up|0|||
130098269|NCT04341727|468316731|FG003|Overall Study|Lost to Follow-up|1|||
130098270|NCT05604521|468316732|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
130098271|NCT05604521|468316733|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
130098272|NCT05604521|468316732|FG000|Overall Study|Adverse Event|1|||
130098273|NCT05604521|468316733|FG001|Overall Study|Adverse Event|0|||
130098274|NCT01491737|468316739|FG000|Overall Study|Withdrawal by Subject|20|||
130098275|NCT01491737|468316740|FG001|Overall Study|Withdrawal by Subject|17|||
130098276|NCT01491737|468316739|FG000|Overall Study|Lost to Follow-up|2|||
130098277|NCT01491737|468316740|FG001|Overall Study|Lost to Follow-up|10|||
130098278|NCT01491737|468316739|FG000|Overall Study|Death|63|||
130098279|NCT01491737|468316740|FG001|Overall Study|Death|57|||
130098280|NCT01491737|468316739|FG000|Overall Study|Study Termination by Sponsor|36|||
130098281|NCT01491737|468316740|FG001|Overall Study|Study Termination by Sponsor|36|||
130098282|NCT01491737|468316739|FG000|Overall Study|Reason Not Specified|8|||
130098283|NCT01491737|468316740|FG001|Overall Study|Reason Not Specified|9|||
130098284|NCT01976663|468316741|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
130098285|NCT01976663|468316741|FG000|Overall Study|Personal Reasons|6|||
130098286|NCT01976663|468316741|FG000|Overall Study|Withdrawal by Subject|4|||
130098287|NCT01976663|468316741|FG000|Overall Study|Screen Failure|3|||
130098288|NCT01976663|468316741|FG000|Overall Study|Adverse Event|2|||
130098289|NCT01976663|468316741|FG000|Overall Study|Lost to Follow-up|3|||
130098290|NCT01817764|468316742|FG000|Overall Study|Adverse Event|7|||
130098291|NCT01817764|468316743|FG001|Overall Study|Adverse Event|10|||
130098292|NCT01817764|468316742|FG000|Overall Study|Lack of Efficacy|9|||
130098293|NCT01817764|468316743|FG001|Overall Study|Lack of Efficacy|7|||
130098294|NCT01817764|468316742|FG000|Overall Study|Protocol Violation|7|||
130098295|NCT01817764|468316743|FG001|Overall Study|Protocol Violation|5|||
130098296|NCT01817764|468316742|FG000|Overall Study|Lost to Follow-up|1|||
130098297|NCT01817764|468316743|FG001|Overall Study|Lost to Follow-up|4|||
130098298|NCT01817764|468316742|FG000|Overall Study|Withdrawal by Subject|10|||
130098299|NCT01817764|468316743|FG001|Overall Study|Withdrawal by Subject|12|||
130209782|NCT03334422|468729214|FG003|Overall Study|Adverse Event|2|||
130209783|NCT03334422|468729211|FG000|Overall Study|Lack of Efficacy|10|||
130209784|NCT03334422|468729212|FG001|Overall Study|Lack of Efficacy|2|||
130209785|NCT03334422|468729213|FG002|Overall Study|Lack of Efficacy|7|||
130209786|NCT03334422|468729214|FG003|Overall Study|Lack of Efficacy|3|||
130209787|NCT03334422|468729211|FG000|Overall Study|Withdrawal by Subject|8|||
130209788|NCT03334422|468729212|FG001|Overall Study|Withdrawal by Subject|3|||
130209789|NCT03334422|468729213|FG002|Overall Study|Withdrawal by Subject|1|||
130209790|NCT03334422|468729214|FG003|Overall Study|Withdrawal by Subject|0|||
130209791|NCT03334422|468729211|FG000|Overall Study|Lost to Follow-up|0|||
130209792|NCT03334422|468729212|FG001|Overall Study|Lost to Follow-up|0|||
130209793|NCT03334422|468729213|FG002|Overall Study|Lost to Follow-up|0|||
130209794|NCT03334422|468729214|FG003|Overall Study|Lost to Follow-up|1|||
130209795|NCT03334422|468729211|FG000|Overall Study|Inability to obtain laboratory samples|0|||
130209796|NCT03334422|468729212|FG001|Overall Study|Inability to obtain laboratory samples|1|||
130209797|NCT03334422|468729213|FG002|Overall Study|Inability to obtain laboratory samples|0|||
130209798|NCT03334422|468729214|FG003|Overall Study|Inability to obtain laboratory samples|0|||
130209799|NCT03334422|468729211|FG000|Overall Study|Pregnancy|0|||
130209800|NCT03334422|468729212|FG001|Overall Study|Pregnancy|1|||
130209801|NCT03334422|468729213|FG002|Overall Study|Pregnancy|0|||
130209802|NCT03334422|468729214|FG003|Overall Study|Pregnancy|0|||
130209803|NCT03774394|468729215|FG000|Overall Study|Withdrawal by Subject|2|||
130209804|NCT03774394|468729216|FG001|Overall Study|Withdrawal by Subject|0|||
130209805|NCT02697916|468729217|FG000|Overall Study|Death|357|||
130209806|NCT02697916|468729218|FG001|Overall Study|Death|315|||
130209807|NCT02697916|468729217|FG000|Overall Study|Withdrawal by Subject|221|||
130209808|NCT02697916|468729218|FG001|Overall Study|Withdrawal by Subject|393|||
130209809|NCT01313221|468729221|FG000|Overall Study|Protocol Violation|0|||
130209810|NCT01313221|468729222|FG001|Overall Study|Protocol Violation|1|||
130209811|NCT01313221|468729223|FG002|Overall Study|Protocol Violation|1|||
130209812|NCT01313221|468729221|FG000|Overall Study|Non-compliance|3|||
130209813|NCT01313221|468729222|FG001|Overall Study|Non-compliance|0|||
130209814|NCT01313221|468729223|FG002|Overall Study|Non-compliance|2|||
130209815|NCT01313221|468729221|FG000|Overall Study|Withdrawal by Subject|2|||
130209816|NCT01313221|468729222|FG001|Overall Study|Withdrawal by Subject|3|||
130209817|NCT01313221|468729223|FG002|Overall Study|Withdrawal by Subject|5|||
130209818|NCT01313221|468729221|FG000|Overall Study|Requirement for alternative therapy|0|||
130209819|NCT01313221|468729222|FG001|Overall Study|Requirement for alternative therapy|1|||
130209820|NCT01313221|468729223|FG002|Overall Study|Requirement for alternative therapy|1|||
130209821|NCT01313221|468729221|FG000|Overall Study|Lost to Follow-up|6|||
130209822|NCT01313221|468729222|FG001|Overall Study|Lost to Follow-up|3|||
130209823|NCT01313221|468729223|FG002|Overall Study|Lost to Follow-up|1|||
130209824|NCT01313221|468729221|FG000|Overall Study|Other|1|||
130209825|NCT01313221|468729222|FG001|Overall Study|Other|0|||
130209826|NCT01313221|468729223|FG002|Overall Study|Other|0|||
130209827|NCT01313221|468729221|FG000|Overall Study|Adverse Event|0|||
130209828|NCT01313221|468729222|FG001|Overall Study|Adverse Event|0|||
130209829|NCT01313221|468729223|FG002|Overall Study|Adverse Event|7|||
130209830|NCT01313221|468729221|FG000|Overall Study|Disease progression|0|||
130209831|NCT01313221|468729222|FG001|Overall Study|Disease progression|0|||
130209832|NCT01313221|468729223|FG002|Overall Study|Disease progression|2|||
130209833|NCT01313221|468729221|FG000|Overall Study|Physician Decision|0|||
130098300|NCT02255422|468316744|FG000|Overall Study|Withdrawal by Subject|0|||
130098301|NCT02255422|468316745|FG001|Overall Study|Withdrawal by Subject|0|||
130098302|NCT02255422|468316746|FG002|Overall Study|Withdrawal by Subject|0|||
130098303|NCT02255422|468316747|FG003|Overall Study|Withdrawal by Subject|0|||
130098304|NCT02255422|468316748|FG004|Overall Study|Withdrawal by Subject|0|||
130098305|NCT02255422|468316749|FG005|Overall Study|Withdrawal by Subject|0|||
130098306|NCT02255422|468316750|FG006|Overall Study|Withdrawal by Subject|2|||
130098307|NCT02255422|468316744|FG000|Overall Study|Lost to Follow-up|0|||
130098308|NCT02255422|468316745|FG001|Overall Study|Lost to Follow-up|0|||
130098309|NCT02255422|468316746|FG002|Overall Study|Lost to Follow-up|1|||
130098310|NCT02255422|468316747|FG003|Overall Study|Lost to Follow-up|0|||
130098311|NCT02255422|468316748|FG004|Overall Study|Lost to Follow-up|0|||
130098312|NCT02255422|468316749|FG005|Overall Study|Lost to Follow-up|0|||
130098313|NCT02255422|468316750|FG006|Overall Study|Lost to Follow-up|0|||
130098314|NCT02268214|468316755|FG000|Overall Study|Subject no longer meets study criteria|0|||
130098315|NCT02268214|468316756|FG001|Overall Study|Subject no longer meets study criteria|2|||
130098316|NCT02268214|468316757|FG002|Overall Study|Subject no longer meets study criteria|0|||
130098317|NCT02268214|468316755|FG000|Overall Study|Pregnancy|2|||
130098318|NCT02268214|468316756|FG001|Overall Study|Pregnancy|2|||
130098319|NCT02268214|468316757|FG002|Overall Study|Pregnancy|1|||
130098320|NCT02268214|468316755|FG000|Overall Study|Lost to Follow-up|3|||
130098321|NCT02268214|468316756|FG001|Overall Study|Lost to Follow-up|3|||
130098322|NCT02268214|468316757|FG002|Overall Study|Lost to Follow-up|4|||
130098323|NCT02268214|468316755|FG000|Overall Study|Lack of Efficacy|1|||
130098324|NCT02268214|468316756|FG001|Overall Study|Lack of Efficacy|0|||
130209834|NCT01313221|468729222|FG001|Overall Study|Physician Decision|0|||
130209835|NCT01313221|468729223|FG002|Overall Study|Physician Decision|2|||
130098325|NCT02268214|468316757|FG002|Overall Study|Lack of Efficacy|2|||
130098326|NCT02268214|468316755|FG000|Overall Study|Adverse Event|11|||
130098327|NCT02268214|468316756|FG001|Overall Study|Adverse Event|14|||
130098328|NCT02268214|468316757|FG002|Overall Study|Adverse Event|9|||
130098329|NCT02268214|468316755|FG000|Overall Study|Withdrawal by Subject|4|||
130098330|NCT02268214|468316756|FG001|Overall Study|Withdrawal by Subject|5|||
130098331|NCT02268214|468316757|FG002|Overall Study|Withdrawal by Subject|10|||
130098332|NCT02268214|468316755|FG000|Overall Study|Subject request to discontinue treatment|10|||
130098333|NCT02268214|468316756|FG001|Overall Study|Subject request to discontinue treatment|8|||
130098334|NCT02268214|468316757|FG002|Overall Study|Subject request to discontinue treatment|6|||
130098335|NCT02268214|468316755|FG000|Overall Study|Poor/non-compliance|2|||
130098336|NCT02268214|468316756|FG001|Overall Study|Poor/non-compliance|1|||
130098337|NCT02268214|468316757|FG002|Overall Study|Poor/non-compliance|2|||
130098338|NCT02268214|468316755|FG000|Overall Study|Other reasons|7|||
130098339|NCT02268214|468316756|FG001|Overall Study|Other reasons|3|||
130098340|NCT02268214|468316757|FG002|Overall Study|Other reasons|3|||
130098341|NCT02268214|468316755|FG000|Overall Study|Not entering long-term period|2|||
130098342|NCT02268214|468316756|FG001|Overall Study|Not entering long-term period|3|||
130098343|NCT02268214|468316757|FG002|Overall Study|Not entering long-term period|5|||
130098344|NCT04342390|468316760|FG000|Overall Study|Lost to Follow-up|3|||
130098345|NCT04342390|468316761|FG001|Overall Study|Lost to Follow-up|0|||
130098346|NCT01083121|468316771|FG000|Overall Study|Use of Humira outside the approved label|81|||
130098347|NCT05403502|468316772|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
130098348|NCT05403502|468316772|FG000|Humalog Lead-In Period|Physician Decision|2|||
130098349|NCT05403502|468316772|FG000|Humalog Lead-In Period|Protocol Violation|1|||
130098350|NCT05403502|468316772|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
130098351|NCT05403502|468316772|FG000|Lyumjev Treatment Period|Physician Decision|2|||
130098352|NCT01054443|468316773|FG000|Overall Study|Withdrawal by Subject|0|||
130098353|NCT01054443|468316774|FG001|Overall Study|Withdrawal by Subject|0|||
130098354|NCT01054443|468316775|FG002|Overall Study|Withdrawal by Subject|0|||
130098355|NCT01054443|468316776|FG003|Overall Study|Withdrawal by Subject|1|||
130098356|NCT00985114|468316777|FG000|Overall Study|Adverse Event|1|||
130098357|NCT00985114|468316778|FG001|Overall Study|Adverse Event|0|||
130098358|NCT00985114|468316777|FG000|Overall Study|Withdrawal by Subject|0|||
130098359|NCT00985114|468316778|FG001|Overall Study|Withdrawal by Subject|2|||
130098360|NCT01119118|468316779|FG000|Overall Study|Adverse Event|1|||
130098361|NCT01593761|468316783|FG000|Overall Study|Lost to Follow-up|1|||
130098362|NCT01593761|468316783|FG000|Overall Study|culture negative for MRSA at baseline|5|||
130098363|NCT01593761|468316783|FG000|Overall Study|positive for hepatitis C virus|1|||
130098364|NCT01593761|468316783|FG000|Overall Study|secondary cellulitis|1|||
130098365|NCT00563706|468319215|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
130098366|NCT00563706|468319216|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130098367|NCT00563706|468319217|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130098368|NCT00563706|468319218|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130098369|NCT00563706|468319219|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
130098370|NCT00563706|468319220|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
130098371|NCT00563706|468319221|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
130098372|NCT00563706|468319222|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
130098373|NCT00563706|468319223|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
130098374|NCT00563706|468319215|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130098375|NCT00563706|468319216|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
130098376|NCT00563706|468319217|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130098377|NCT00563706|468319218|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
130098378|NCT00563706|468319219|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
130098379|NCT00563706|468319220|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130098380|NCT00563706|468319221|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
130098381|NCT00563706|468319222|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
130098382|NCT00563706|468319223|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
130098383|NCT00563706|468319215|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
130098384|NCT00563706|468319216|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
130098385|NCT00563706|468319217|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
130098386|NCT00563706|468319218|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
130098387|NCT00563706|468319219|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
130098388|NCT00563706|468319220|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
130098389|NCT00563706|468319221|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
130098390|NCT00563706|468319222|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
130098391|NCT00563706|468319223|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
130098392|NCT00563706|468319215|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
130098393|NCT00563706|468319216|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130209836|NCT01313221|468729221|FG000|Overall Study|Pregnancy|0|||
130098394|NCT00563706|468319217|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130098395|NCT00563706|468319218|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130098396|NCT00563706|468319219|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130098397|NCT00563706|468319220|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130098398|NCT00563706|468319221|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130098399|NCT00563706|468319222|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
130098400|NCT00563706|468319223|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
130098401|NCT00563706|468319215|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098402|NCT00563706|468319216|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098403|NCT00563706|468319217|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098404|NCT00563706|468319218|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098405|NCT00563706|468319219|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098406|NCT00563706|468319220|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098407|NCT00563706|468319221|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
130098408|NCT00563706|468319222|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
130098409|NCT00563706|468319223|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
130098410|NCT04888377|468319224|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
130098411|NCT04888377|468319225|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
130098412|NCT04888377|468319224|FG000|Overall Study|Physician Decision|6|||
130098413|NCT04888377|468319225|FG001|Overall Study|Physician Decision|6|||
130098414|NCT04888377|468319224|FG000|Overall Study|Withdrawal by Subject|7|||
130098415|NCT04888377|468319225|FG001|Overall Study|Withdrawal by Subject|3|||
130098416|NCT00526162|468319226|FG000|Overall Study|Device not implanted|3|||
130098417|NCT05279807|468319227|FG000|Overall Study|Withdrawal by Subject|1|||
130098418|NCT05279807|468319228|FG001|Overall Study|Withdrawal by Subject|0|||
130098419|NCT05279807|468319227|FG000|Overall Study|Adverse Event|0|||
130098420|NCT05279807|468319228|FG001|Overall Study|Adverse Event|1|||
130098421|NCT05279807|468319227|FG000|Overall Study|Laboratory Abnormal Results|1|||
130098422|NCT05279807|468319228|FG001|Overall Study|Laboratory Abnormal Results|0|||
130098423|NCT05993299|468319229|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
130098424|NCT05993299|468319229|FG000|Overall Study|Ongoing|4|||
130098425|NCT03110107|468319230|FG000|Treatment Period|Disease Progression|3|||
130098426|NCT03110107|468319231|FG001|Treatment Period|Disease Progression|9|||
130098427|NCT03110107|468319232|FG002|Treatment Period|Disease Progression|8|||
130098428|NCT03110107|468319233|FG003|Treatment Period|Disease Progression|11|||
130098429|NCT03110107|468319234|FG004|Treatment Period|Disease Progression|8|||
130098430|NCT03110107|468319235|FG005|Treatment Period|Disease Progression|4|||
130098431|NCT03110107|468319236|FG006|Treatment Period|Disease Progression|6|||
130098432|NCT03110107|468319237|FG007|Treatment Period|Disease Progression|7|||
130098433|NCT03110107|468319238|FG008|Treatment Period|Disease Progression|2|||
130098434|NCT03110107|468319239|FG009|Treatment Period|Disease Progression|10|||
130098435|NCT03110107|468319240|FG010|Treatment Period|Disease Progression|5|||
130098436|NCT03110107|468319241|FG011|Treatment Period|Disease Progression|2|||
130098437|NCT03110107|468319242|FG012|Treatment Period|Disease Progression|0|||
130098438|NCT03110107|468319243|FG013|Treatment Period|Disease Progression|5|||
130098439|NCT03110107|468319244|FG014|Treatment Period|Disease Progression|14|||
130098440|NCT03110107|468319245|FG015|Treatment Period|Disease Progression|14|||
130098441|NCT03110107|468319246|FG016|Treatment Period|Disease Progression|4|||
130098442|NCT03110107|468319247|FG017|Treatment Period|Disease Progression|3|||
130098443|NCT03110107|468319248|FG018|Treatment Period|Disease Progression|16|||
130098444|NCT03110107|468319249|FG019|Treatment Period|Disease Progression|14|||
130098445|NCT03110107|468319250|FG020|Treatment Period|Disease Progression|12|||
130098446|NCT03110107|468319251|FG021|Treatment Period|Disease Progression|16|||
130098447|NCT03110107|468319252|FG022|Treatment Period|Disease Progression|18|||
130098448|NCT03110107|468319253|FG023|Treatment Period|Disease Progression|13|||
130098449|NCT03110107|468319254|FG024|Treatment Period|Disease Progression|16|||
130098450|NCT03110107|468319255|FG025|Treatment Period|Disease Progression|31|||
130098451|NCT03110107|468319230|FG000|Treatment Period|Study drug toxicity|1|||
130098452|NCT03110107|468319231|FG001|Treatment Period|Study drug toxicity|0|||
130098453|NCT03110107|468319232|FG002|Treatment Period|Study drug toxicity|1|||
130098454|NCT03110107|468319233|FG003|Treatment Period|Study drug toxicity|2|||
130098455|NCT03110107|468319234|FG004|Treatment Period|Study drug toxicity|0|||
130098456|NCT03110107|468319235|FG005|Treatment Period|Study drug toxicity|3|||
130098457|NCT03110107|468319236|FG006|Treatment Period|Study drug toxicity|1|||
130098458|NCT03110107|468319237|FG007|Treatment Period|Study drug toxicity|1|||
130098459|NCT03110107|468319238|FG008|Treatment Period|Study drug toxicity|3|||
130098460|NCT03110107|468319239|FG009|Treatment Period|Study drug toxicity|2|||
130098461|NCT03110107|468319240|FG010|Treatment Period|Study drug toxicity|0|||
130098462|NCT03110107|468319241|FG011|Treatment Period|Study drug toxicity|2|||
130098463|NCT03110107|468319242|FG012|Treatment Period|Study drug toxicity|0|||
130098464|NCT03110107|468319243|FG013|Treatment Period|Study drug toxicity|0|||
130098465|NCT03110107|468319244|FG014|Treatment Period|Study drug toxicity|2|||
130098466|NCT03110107|468319245|FG015|Treatment Period|Study drug toxicity|3|||
130098467|NCT03110107|468319246|FG016|Treatment Period|Study drug toxicity|3|||
130098468|NCT03110107|468319247|FG017|Treatment Period|Study drug toxicity|3|||
130098469|NCT03110107|468319248|FG018|Treatment Period|Study drug toxicity|1|||
130098470|NCT03110107|468319249|FG019|Treatment Period|Study drug toxicity|2|||
130098471|NCT03110107|468319250|FG020|Treatment Period|Study drug toxicity|2|||
130098472|NCT03110107|468319251|FG021|Treatment Period|Study drug toxicity|0|||
130209837|NCT01313221|468729222|FG001|Overall Study|Pregnancy|0|||
130209838|NCT01313221|468729223|FG002|Overall Study|Pregnancy|2|||
130209839|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130209840|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
130209841|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130209842|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
130209843|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130209844|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130209845|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
130209846|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
130209847|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
130209848|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130209849|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130209850|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
130209851|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
130209852|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
130209853|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
130209854|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
130209855|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130209856|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130209857|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
130209858|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
130209859|NCT00994214|468729224|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
130209860|NCT00994214|468729225|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
130209861|NCT00994214|468729226|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
130209862|NCT00994214|468729227|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
130209863|NCT01533688|468729231|FG000|Overall Study|Withdrawal by Subject|5|||
130209864|NCT01533688|468729232|FG001|Overall Study|Withdrawal by Subject|4|||
130209865|NCT01533688|468729233|FG002|Overall Study|Withdrawal by Subject|3|||
130209866|NCT01533688|468729231|FG000|Overall Study|Medically unstable|1|||
130209867|NCT01533688|468729232|FG001|Overall Study|Medically unstable|3|||
130209868|NCT01533688|468729233|FG002|Overall Study|Medically unstable|3|||
130209869|NCT01533688|468729231|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
130209870|NCT01533688|468729232|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
130209871|NCT01533688|468729233|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
130209872|NCT02509078|468729238|FG000|Overall Study|Protocol Violation|1|||
130209873|NCT02509078|468729239|FG001|Overall Study|Protocol Violation|1|||
130209874|NCT00253370|468729240|FG000|Overall Study|Adverse Event|18|||
130209875|NCT00253370|468729240|FG000|Overall Study|Disease progression|13|||
130209876|NCT00253370|468729240|FG000|Overall Study|Death|2|||
130209877|NCT00253370|468729240|FG000|Overall Study|Withdrawal by Subject|6|||
130209878|NCT00253370|468729240|FG000|Overall Study|Non-protocol therapy|1|||
130209879|NCT00253370|468729240|FG000|Overall Study|Physician Decision|1|||
130209880|NCT00253370|468729240|FG000|Overall Study|Protocol Violation|1|||
130209881|NCT00253370|468729240|FG000|Overall Study|Abdominal pain due to disease|1|||
130209882|NCT05916131|468729241|FG000|Overall Study|Lost to Follow-up|0|||
130209883|NCT05916131|468729242|FG001|Overall Study|Lost to Follow-up|0|||
130209884|NCT05916131|468729243|FG002|Overall Study|Lost to Follow-up|1|||
130209885|NCT05916131|468729244|FG003|Overall Study|Lost to Follow-up|0|||
130209886|NCT00904839|468729247|FG000|Overall Study|Adverse Event|0|||
130209887|NCT00904839|468729248|FG001|Overall Study|Adverse Event|5|||
130209888|NCT00904839|468729249|FG002|Overall Study|Adverse Event|4|||
130209889|NCT00904839|468729247|FG000|Overall Study|Protocol Violation|0|||
130209890|NCT00904839|468729248|FG001|Overall Study|Protocol Violation|1|||
130209891|NCT00904839|468729249|FG002|Overall Study|Protocol Violation|1|||
130209892|NCT00904839|468729247|FG000|Overall Study|Lost to Follow-up|0|||
130209893|NCT00904839|468729248|FG001|Overall Study|Lost to Follow-up|1|||
130209894|NCT00904839|468729249|FG002|Overall Study|Lost to Follow-up|2|||
130209895|NCT00904839|468729247|FG000|Overall Study|Withdrawal by Subject|0|||
130209896|NCT00904839|468729248|FG001|Overall Study|Withdrawal by Subject|2|||
130209897|NCT00904839|468729249|FG002|Overall Study|Withdrawal by Subject|0|||
130209898|NCT00904839|468729247|FG000|Overall Study|Not treated|1|||
130209899|NCT00904839|468729248|FG001|Overall Study|Not treated|0|||
130209900|NCT00904839|468729249|FG002|Overall Study|Not treated|1|||
130209901|NCT00904839|468729247|FG000|Overall Study|Other than above|0|||
130209902|NCT00904839|468729248|FG001|Overall Study|Other than above|9|||
130209903|NCT00904839|468729249|FG002|Overall Study|Other than above|7|||
130209904|NCT00553358|468729252|FG000|Overall Study|Randomized but did not receive treatment|3|||
130209905|NCT00553358|468729253|FG001|Overall Study|Randomized but did not receive treatment|3|||
130209906|NCT00553358|468729254|FG002|Overall Study|Randomized but did not receive treatment|1|||
130209907|NCT00553358|468729252|FG000|Overall Study|Lost to Follow-up|22|||
130209908|NCT00553358|468729253|FG001|Overall Study|Lost to Follow-up|26|||
130209909|NCT00553358|468729254|FG002|Overall Study|Lost to Follow-up|18|||
130209910|NCT00553358|468729252|FG000|Overall Study|Withdrew completely|23|||
130209911|NCT00553358|468729253|FG001|Overall Study|Withdrew completely|33|||
130209912|NCT00553358|468729254|FG002|Overall Study|Withdrew completely|34|||
130209913|NCT00553358|468729252|FG000|Overall Study|Died during clinical follow-up|25|||
130209914|NCT00553358|468729253|FG001|Overall Study|Died during clinical follow-up|29|||
130209915|NCT00553358|468729254|FG002|Overall Study|Died during clinical follow-up|32|||
130209916|NCT00553358|468729252|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
130209917|NCT00553358|468729253|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
130209918|NCT00553358|468729254|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
130209919|NCT00553358|468729252|FG000|Overall Study|Died after clinical follow-up ended|1|||
130209920|NCT00553358|468729253|FG001|Overall Study|Died after clinical follow-up ended|2|||
130209921|NCT00553358|468729254|FG002|Overall Study|Died after clinical follow-up ended|0|||
130209922|NCT00553358|468729252|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130209923|NCT00553358|468729253|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130209924|NCT00553358|468729254|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
130209925|NCT05268016|468729256|FG000|Overall Study|Unacceptable toxicity or AE|2|||
130209926|NCT05268016|468729257|FG001|Overall Study|Unacceptable toxicity or AE|2|||
130209927|NCT05268016|468729258|FG002|Overall Study|Unacceptable toxicity or AE|4|||
130209928|NCT05268016|468729259|FG003|Overall Study|Unacceptable toxicity or AE|3|||
130209929|NCT05268016|468729260|FG004|Overall Study|Unacceptable toxicity or AE|1|||
130209930|NCT05268016|468729256|FG000|Overall Study|Withdrawal by Subject|1|||
130209931|NCT05268016|468729257|FG001|Overall Study|Withdrawal by Subject|3|||
130209932|NCT05268016|468729258|FG002|Overall Study|Withdrawal by Subject|2|||
130209933|NCT05268016|468729259|FG003|Overall Study|Withdrawal by Subject|2|||
130209934|NCT05268016|468729260|FG004|Overall Study|Withdrawal by Subject|1|||
130209935|NCT05268016|468729256|FG000|Overall Study|Lost to Follow-up|4|||
130209936|NCT05268016|468729257|FG001|Overall Study|Lost to Follow-up|7|||
130209937|NCT05268016|468729258|FG002|Overall Study|Lost to Follow-up|1|||
130209938|NCT05268016|468729259|FG003|Overall Study|Lost to Follow-up|3|||
130209939|NCT05268016|468729260|FG004|Overall Study|Lost to Follow-up|5|||
130209940|NCT05268016|468729256|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
130209941|NCT05268016|468729257|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130209942|NCT05268016|468729258|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130209943|NCT05268016|468729259|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
130209944|NCT05268016|468729260|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
130209945|NCT05268016|468729256|FG000|Overall Study|Lack of Efficacy|0|||
130209946|NCT05268016|468729257|FG001|Overall Study|Lack of Efficacy|0|||
130209947|NCT05268016|468729258|FG002|Overall Study|Lack of Efficacy|0|||
130209948|NCT05268016|468729259|FG003|Overall Study|Lack of Efficacy|0|||
130209949|NCT05268016|468729260|FG004|Overall Study|Lack of Efficacy|4|||
130209950|NCT05268016|468729256|FG000|Overall Study|Physician Decision|0|||
130209951|NCT05268016|468729257|FG001|Overall Study|Physician Decision|0|||
130209952|NCT05268016|468729258|FG002|Overall Study|Physician Decision|0|||
130209953|NCT05268016|468729259|FG003|Overall Study|Physician Decision|1|||
130209954|NCT05268016|468729260|FG004|Overall Study|Physician Decision|0|||
130209955|NCT05268016|468729256|FG000|Overall Study|Other|1|||
130209956|NCT05268016|468729257|FG001|Overall Study|Other|0|||
130209957|NCT05268016|468729258|FG002|Overall Study|Other|1|||
130209958|NCT05268016|468729259|FG003|Overall Study|Other|2|||
130209959|NCT05268016|468729260|FG004|Overall Study|Other|0|||
130209960|NCT00404924|468729261|FG000|Overall Study|Adverse Event|75|||
130209961|NCT00404924|468729262|FG001|Overall Study|Adverse Event|16|||
130209962|NCT00404924|468729261|FG000|Overall Study|Condition under investigation worsened|475|||
130209963|NCT00404924|468729262|FG001|Overall Study|Condition under investigation worsened|264|||
130209964|NCT00404924|468729261|FG000|Overall Study|Lost to Follow-up|1|||
130209965|NCT00404924|468729262|FG001|Overall Study|Lost to Follow-up|1|||
130209966|NCT00404924|468729261|FG000|Overall Study|Withdrawal by Subject|26|||
130209967|NCT00404924|468729262|FG001|Overall Study|Withdrawal by Subject|13|||
130209968|NCT00404924|468729261|FG000|Overall Study|Other|25|||
130209969|NCT00404924|468729262|FG001|Overall Study|Other|11|||
130209970|NCT00404924|468729261|FG000|Overall Study|Randomised but not received treatment|1|||
130209971|NCT00404924|468729262|FG001|Overall Study|Randomised but not received treatment|1|||
130209972|NCT00187278|468729271|FG000|Overall Study|Protocol Violation|10|||
130209973|NCT00187278|468729272|FG001|Overall Study|Protocol Violation|13|||
130209974|NCT00803205|468729273|FG000|Overall Study|Adverse Event|7|||
130209975|NCT00803205|468729274|FG001|Overall Study|Adverse Event|2|||
130209976|NCT00803205|468729273|FG000|Overall Study|Lost to Follow-up|1|||
130209977|NCT00803205|468729274|FG001|Overall Study|Lost to Follow-up|0|||
130209978|NCT00803205|468729273|FG000|Overall Study|Withdrawal by Subject|9|||
130209979|NCT00803205|468729274|FG001|Overall Study|Withdrawal by Subject|9|||
130209980|NCT00803205|468729273|FG000|Overall Study|Physician Decision|1|||
130209981|NCT00803205|468729274|FG001|Overall Study|Physician Decision|0|||
130209982|NCT00803205|468729273|FG000|Overall Study|Protocol Violation|1|||
130209983|NCT00803205|468729274|FG001|Overall Study|Protocol Violation|1|||
130209984|NCT00803205|468729273|FG000|Overall Study|Medical Monitor Decision|1|||
130209985|NCT00803205|468729274|FG001|Overall Study|Medical Monitor Decision|0|||
130209986|NCT00803205|468729273|FG000|Overall Study|Acquired a Lung Infection|0|||
130209987|NCT00803205|468729274|FG001|Overall Study|Acquired a Lung Infection|1|||
130209988|NCT00803205|468729273|FG000|Overall Study|Sponsor Decision|0|||
130209989|NCT00803205|468729274|FG001|Overall Study|Sponsor Decision|1|||
130209990|NCT02735096|468729276|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
130209991|NCT00270231|468729277|FG000|First Intervention|Lost to Follow-up|1|||
130209992|NCT00270231|468729278|FG001|First Intervention|Lost to Follow-up|1|||
130209993|NCT00270231|468729277|FG000|Washout Period|Lost to Follow-up|1|||
130209994|NCT00270231|468729278|FG001|Washout Period|Lost to Follow-up|0|||
130209995|NCT00270231|468729277|FG000|Second Intervention|Lost to Follow-up|0|||
130209996|NCT00270231|468729278|FG001|Second Intervention|Lost to Follow-up|1|||
130209997|NCT00379808|468729279|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
130209998|NCT00379808|468729280|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
130209999|NCT04299048|468729285|FG000|Overall Study|Death|1|||
130210000|NCT04299048|468729285|FG000|Overall Study|Global deterioration of health status|2|||
130210001|NCT04299048|468729285|FG000|Overall Study|Enrolled and not treated|1|||
130210002|NCT00508157|468729288|FG000|Overall Study|Adverse Event|0|||
130210003|NCT00508157|468729289|FG001|Overall Study|Adverse Event|1|||
130210004|NCT00508157|468729288|FG000|Overall Study|Subject Withdrew Consent|1|||
130210005|NCT00508157|468729289|FG001|Overall Study|Subject Withdrew Consent|0|||
130210006|NCT00508157|468729288|FG000|Overall Study|Lost to Follow-up|1|||
130210007|NCT00508157|468729289|FG001|Overall Study|Lost to Follow-up|0|||
130210008|NCT00508157|468729288|FG000|Overall Study|Subject no longer met study criteria|0|||
130210009|NCT00508157|468729289|FG001|Overall Study|Subject no longer met study criteria|1|||
130210010|NCT00508157|468729288|FG000|Overall Study|Other known cause|0|||
130210011|NCT00508157|468729289|FG001|Overall Study|Other known cause|1|||
130210012|NCT02069093|468729290|FG000|Overall Study|Disease progression|14|||
130210013|NCT02069093|468729290|FG000|Overall Study|New cancer therapy|1|||
130210014|NCT02069093|468729290|FG000|Overall Study|Death|1|||
130210015|NCT02069093|468729290|FG000|Overall Study|Administrative problems|1|||
130210016|NCT02069093|468729290|FG000|Overall Study|Withdrawal by Subject|2|||
130210017|NCT02069093|468729290|FG000|Overall Study|Abnormal laboratory values|1|||
130210018|NCT02069093|468729290|FG000|Overall Study|Adverse Event|10|||
130210019|NCT03564795|468729291|FG000|Overall Study|Withdrawal by Subject|3|||
130210020|NCT03564795|468729291|FG000|Overall Study|Lost to Follow-up|6|||
130210021|NCT03564795|468729291|FG000|Overall Study|Physician Decision|2|||
130210022|NCT02906033|468729292|FG000|Baseline|Protocol Violation|37|||
130210023|NCT02906033|468729293|FG001|Baseline|Protocol Violation|33|||
130210024|NCT02906033|468729292|FG000|Follow-up|Lost to Follow-up|46|||
130210025|NCT02906033|468729293|FG001|Follow-up|Lost to Follow-up|62|||
130210026|NCT01333956|468729304|FG000|Overall Study|Lost to Follow-up|1|||
130210027|NCT01333956|468729305|FG001|Overall Study|Lost to Follow-up|2|||
130210028|NCT01333956|468729306|FG002|Overall Study|Lost to Follow-up|0|||
130210029|NCT01333956|468729307|FG003|Overall Study|Lost to Follow-up|1|||
130210030|NCT01333956|468729304|FG000|Overall Study|Unable to complete study procedure|1|||
130210031|NCT01333956|468729305|FG001|Overall Study|Unable to complete study procedure|0|||
130210032|NCT01333956|468729306|FG002|Overall Study|Unable to complete study procedure|0|||
130210033|NCT01333956|468729307|FG003|Overall Study|Unable to complete study procedure|1|||
130210034|NCT01333956|468729304|FG000|Overall Study|Withdrawal by Subject|0|||
130210035|NCT01333956|468729305|FG001|Overall Study|Withdrawal by Subject|2|||
130210036|NCT01333956|468729306|FG002|Overall Study|Withdrawal by Subject|1|||
130210037|NCT01333956|468729307|FG003|Overall Study|Withdrawal by Subject|0|||
130210038|NCT02240069|468729308|FG000|Overall Study|Withdrawal by Subject|5|||
130210039|NCT02240069|468729309|FG001|Overall Study|Withdrawal by Subject|5|||
130210040|NCT02240069|468729310|FG002|Overall Study|Withdrawal by Subject|2|||
130210041|NCT03723070|468729311|FG000|Overall Study|Lost to Follow-up|2|||
130210042|NCT03723070|468729311|FG000|Overall Study|Physician Decision|1|||
130210043|NCT03723070|468729311|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
130098473|NCT03110107|468319252|FG022|Treatment Period|Study drug toxicity|2|||
130098474|NCT03110107|468319253|FG023|Treatment Period|Study drug toxicity|6|||
130098475|NCT03110107|468319254|FG024|Treatment Period|Study drug toxicity|7|||
130098476|NCT03110107|468319255|FG025|Treatment Period|Study drug toxicity|6|||
130098477|NCT03110107|468319230|FG000|Treatment Period|Death|0|||
130098478|NCT03110107|468319231|FG001|Treatment Period|Death|0|||
130098479|NCT03110107|468319232|FG002|Treatment Period|Death|0|||
130098480|NCT03110107|468319233|FG003|Treatment Period|Death|0|||
130098481|NCT03110107|468319234|FG004|Treatment Period|Death|0|||
130098482|NCT03110107|468319235|FG005|Treatment Period|Death|0|||
130098483|NCT03110107|468319236|FG006|Treatment Period|Death|0|||
130098484|NCT03110107|468319237|FG007|Treatment Period|Death|0|||
130098485|NCT03110107|468319238|FG008|Treatment Period|Death|0|||
130098486|NCT03110107|468319239|FG009|Treatment Period|Death|0|||
130098487|NCT03110107|468319240|FG010|Treatment Period|Death|0|||
130098488|NCT03110107|468319241|FG011|Treatment Period|Death|0|||
130098489|NCT03110107|468319242|FG012|Treatment Period|Death|1|||
130098490|NCT03110107|468319243|FG013|Treatment Period|Death|0|||
130098491|NCT03110107|468319244|FG014|Treatment Period|Death|0|||
130098492|NCT03110107|468319245|FG015|Treatment Period|Death|0|||
130098493|NCT03110107|468319246|FG016|Treatment Period|Death|0|||
130098494|NCT03110107|468319247|FG017|Treatment Period|Death|0|||
130098495|NCT03110107|468319248|FG018|Treatment Period|Death|0|||
130098496|NCT03110107|468319249|FG019|Treatment Period|Death|0|||
130098497|NCT03110107|468319250|FG020|Treatment Period|Death|0|||
130098498|NCT03110107|468319251|FG021|Treatment Period|Death|0|||
130098499|NCT03110107|468319252|FG022|Treatment Period|Death|0|||
130098500|NCT03110107|468319253|FG023|Treatment Period|Death|0|||
130098501|NCT03110107|468319254|FG024|Treatment Period|Death|0|||
130098502|NCT03110107|468319255|FG025|Treatment Period|Death|0|||
130098503|NCT03110107|468319230|FG000|Treatment Period|Adverse Event|0|||
130098504|NCT03110107|468319231|FG001|Treatment Period|Adverse Event|0|||
130098505|NCT03110107|468319232|FG002|Treatment Period|Adverse Event|1|||
130098506|NCT03110107|468319233|FG003|Treatment Period|Adverse Event|0|||
130098507|NCT03110107|468319234|FG004|Treatment Period|Adverse Event|0|||
130098508|NCT03110107|468319235|FG005|Treatment Period|Adverse Event|2|||
130098509|NCT03110107|468319236|FG006|Treatment Period|Adverse Event|0|||
130098510|NCT03110107|468319237|FG007|Treatment Period|Adverse Event|2|||
130098511|NCT03110107|468319238|FG008|Treatment Period|Adverse Event|0|||
130098512|NCT03110107|468319239|FG009|Treatment Period|Adverse Event|1|||
130098513|NCT03110107|468319240|FG010|Treatment Period|Adverse Event|0|||
130098514|NCT03110107|468319241|FG011|Treatment Period|Adverse Event|0|||
130098515|NCT03110107|468319242|FG012|Treatment Period|Adverse Event|0|||
130098516|NCT03110107|468319243|FG013|Treatment Period|Adverse Event|0|||
130098517|NCT03110107|468319244|FG014|Treatment Period|Adverse Event|0|||
130098518|NCT03110107|468319245|FG015|Treatment Period|Adverse Event|2|||
130098519|NCT03110107|468319246|FG016|Treatment Period|Adverse Event|0|||
130098520|NCT03110107|468319247|FG017|Treatment Period|Adverse Event|1|||
130098521|NCT03110107|468319248|FG018|Treatment Period|Adverse Event|2|||
130098522|NCT03110107|468319249|FG019|Treatment Period|Adverse Event|1|||
130098523|NCT03110107|468319250|FG020|Treatment Period|Adverse Event|4|||
130098524|NCT03110107|468319251|FG021|Treatment Period|Adverse Event|2|||
130098525|NCT03110107|468319252|FG022|Treatment Period|Adverse Event|2|||
130098526|NCT03110107|468319253|FG023|Treatment Period|Adverse Event|2|||
130098527|NCT03110107|468319254|FG024|Treatment Period|Adverse Event|2|||
130098528|NCT03110107|468319255|FG025|Treatment Period|Adverse Event|4|||
130098529|NCT03110107|468319230|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
130098530|NCT03110107|468319231|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
130098531|NCT03110107|468319232|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
130098532|NCT03110107|468319233|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
130098533|NCT03110107|468319234|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
130098534|NCT03110107|468319235|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
130098535|NCT03110107|468319236|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
130098536|NCT03110107|468319237|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
130098537|NCT03110107|468319238|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
130098538|NCT03110107|468319239|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
130098539|NCT03110107|468319240|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
130098540|NCT03110107|468319241|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
130098541|NCT03110107|468319242|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
130098542|NCT03110107|468319243|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
130098543|NCT03110107|468319244|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
130098544|NCT03110107|468319245|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
130098545|NCT03110107|468319246|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
130210044|NCT00474786|468729312|FG000|Overall Study|Not Meeting Study Criteria|0|||
130210045|NCT00474786|468729313|FG001|Overall Study|Not Meeting Study Criteria|1|||
130210046|NCT00474786|468729312|FG000|Overall Study|Investigator Request|2|||
130210047|NCT00474786|468729313|FG001|Overall Study|Investigator Request|1|||
130210048|NCT00474786|468729312|FG000|Overall Study|Death|189|||
130210049|NCT00474786|468729313|FG001|Overall Study|Death|170|||
130210050|NCT00474786|468729312|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
130210051|NCT00474786|468729313|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
130210052|NCT00474786|468729312|FG000|Overall Study|Lost to Follow-up|4|||
130210053|NCT00474786|468729313|FG001|Overall Study|Lost to Follow-up|7|||
130210054|NCT00474786|468729312|FG000|Overall Study|Protocol Violation|2|||
130210055|NCT00474786|468729313|FG001|Overall Study|Protocol Violation|0|||
130210056|NCT00474786|468729312|FG000|Overall Study|Withdrawal by Subject|15|||
130210057|NCT00474786|468729313|FG001|Overall Study|Withdrawal by Subject|15|||
130210058|NCT00474786|468729312|FG000|Overall Study|Other|5|||
130210059|NCT00474786|468729313|FG001|Overall Study|Other|0|||
130210060|NCT03646305|468729316|FG000|Overall Study|Lost to Follow-up|4|||
130210061|NCT03646305|468729317|FG001|Overall Study|Lost to Follow-up|2|||
130210062|NCT03646305|468729318|FG002|Overall Study|Lost to Follow-up|2|||
130210063|NCT03646305|468729319|FG003|Overall Study|Lost to Follow-up|1|||
130210064|NCT03646305|468729316|FG000|Overall Study|Withdrawal by Subject|1|||
130210065|NCT03646305|468729317|FG001|Overall Study|Withdrawal by Subject|0|||
130210066|NCT03646305|468729318|FG002|Overall Study|Withdrawal by Subject|0|||
130210067|NCT03646305|468729319|FG003|Overall Study|Withdrawal by Subject|1|||
130210068|NCT03417024|468729320|FG000|Overall Study|Study Termination prior to follow-up|11|||
130210069|NCT03417024|468729320|FG000|Overall Study|Physician Decision|2|||
130210070|NCT02195427|468729321|FG000|Overall Study|Did not consent to study extension|13|||
130210071|NCT02195427|468729322|FG001|Overall Study|Did not consent to study extension|9|||
130210072|NCT02195427|468729321|FG000|Overall Study|Withdrawal by Subject|4|||
130210073|NCT02195427|468729322|FG001|Overall Study|Withdrawal by Subject|2|||
130210074|NCT02195427|468729321|FG000|Overall Study|Lost to Follow-up|0|||
130210075|NCT02195427|468729322|FG001|Overall Study|Lost to Follow-up|1|||
130210076|NCT02195427|468729321|FG000|Overall Study|Protocol Violation|7|||
130210077|NCT02195427|468729322|FG001|Overall Study|Protocol Violation|14|||
130210078|NCT02195427|468729321|FG000|Overall Study|Conditional re-treatment at W52|2|||
130210079|NCT02195427|468729322|FG001|Overall Study|Conditional re-treatment at W52|1|||
130210080|NCT02655419|468729323|FG000|Overall Study|Enrolled but not treated|1|||
130210081|NCT02655419|468729324|FG001|Overall Study|Enrolled but not treated|5|||
130210082|NCT02655419|468729323|FG000|Overall Study|Withdrawal by Subject|4|||
130210083|NCT02655419|468729324|FG001|Overall Study|Withdrawal by Subject|1|||
130210084|NCT02655419|468729323|FG000|Overall Study|Other|0|||
130210085|NCT02655419|468729324|FG001|Overall Study|Other|1|||
130210086|NCT00207727|468729325|FG000|Overall Study|Withdrawal by Subject|0|||
130210087|NCT00207727|468729326|FG001|Overall Study|Withdrawal by Subject|0|||
130210088|NCT00207727|468729327|FG002|Overall Study|Withdrawal by Subject|0|||
130210089|NCT00207727|468729328|FG003|Overall Study|Withdrawal by Subject|0|||
130210090|NCT00207727|468729329|FG004|Overall Study|Withdrawal by Subject|1|||
130210091|NCT00207727|468729325|FG000|Overall Study|Lost to Follow-up|0|||
130210092|NCT00207727|468729326|FG001|Overall Study|Lost to Follow-up|1|||
130210093|NCT00207727|468729327|FG002|Overall Study|Lost to Follow-up|0|||
130210094|NCT00207727|468729328|FG003|Overall Study|Lost to Follow-up|0|||
130210095|NCT00207727|468729329|FG004|Overall Study|Lost to Follow-up|0|||
130210096|NCT00207727|468729325|FG000|Overall Study|Other|38|||
130210097|NCT00207727|468729326|FG001|Overall Study|Other|41|||
130210098|NCT00207727|468729327|FG002|Overall Study|Other|41|||
130210099|NCT00207727|468729328|FG003|Overall Study|Other|37|||
130210100|NCT00207727|468729329|FG004|Overall Study|Other|33|||
130210101|NCT00463840|468729334|FG000|Overall Study|Disease progression|7|||
130210102|NCT00463840|468729334|FG000|Overall Study|Withdrawal by Subject|2|||
130210103|NCT00463840|468729334|FG000|Overall Study|Adverse Event|3|||
130210104|NCT01653327|468729335|FG000|Overall Study|Withdrawal by Subject|1|||
130210105|NCT04607980|468729336|FG000|Overall Study|Adverse Event|3|||
130210106|NCT04607980|468729337|FG001|Overall Study|Adverse Event|4|||
130210107|NCT04607980|468729336|FG000|Overall Study|Death|0|||
130210108|NCT04607980|468729337|FG001|Overall Study|Death|1|||
130210109|NCT04607980|468729336|FG000|Overall Study|Withdrawal by Subject|2|||
130210110|NCT04607980|468729337|FG001|Overall Study|Withdrawal by Subject|5|||
130210111|NCT04607980|468729336|FG000|Overall Study|Lost to Follow-up|4|||
130210112|NCT04607980|468729337|FG001|Overall Study|Lost to Follow-up|8|||
130210113|NCT04607980|468729336|FG000|Overall Study|Protocol Violation|0|||
130210114|NCT04607980|468729337|FG001|Overall Study|Protocol Violation|3|||
130210115|NCT04607980|468729336|FG000|Overall Study|Other|3|||
130210116|NCT04607980|468729337|FG001|Overall Study|Other|0|||
130210117|NCT04767529|468730688|FG000|Overall Study|Adverse Event|0|||
130210118|NCT04767529|468730689|FG001|Overall Study|Adverse Event|4|||
130210119|NCT04767529|468730690|FG002|Overall Study|Adverse Event|3|||
130210120|NCT04767529|468730688|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
130210121|NCT04767529|468730689|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
130210122|NCT04767529|468730690|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
130210123|NCT04767529|468730688|FG000|Overall Study|Required use of a prohibited medication|0|||
130210124|NCT04767529|468730689|FG001|Overall Study|Required use of a prohibited medication|1|||
130210125|NCT04767529|468730690|FG002|Overall Study|Required use of a prohibited medication|0|||
130210126|NCT04767529|468730688|FG000|Overall Study|Withdrawal by Subject|7|||
130210127|NCT04767529|468730689|FG001|Overall Study|Withdrawal by Subject|5|||
130210128|NCT04767529|468730690|FG002|Overall Study|Withdrawal by Subject|4|||
130210129|NCT04767529|468730688|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
130210130|NCT04767529|468730689|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
130210131|NCT04767529|468730690|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
130210132|NCT04767529|468730688|FG000|Overall Study|Lost to Follow-up|0|||
130210133|NCT04767529|468730689|FG001|Overall Study|Lost to Follow-up|2|||
130210134|NCT04767529|468730690|FG002|Overall Study|Lost to Follow-up|3|||
130210135|NCT01716520|468730691|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130210136|NCT01716520|468730692|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210137|NCT01716520|468730693|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210138|NCT01716520|468730694|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210139|NCT01716520|468730695|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210140|NCT01716520|468730696|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
130210141|NCT01716520|468730691|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210142|NCT01716520|468730692|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210143|NCT01716520|468730693|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
130210144|NCT01716520|468730694|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210145|NCT01716520|468730695|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210146|NCT01716520|468730696|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210147|NCT01716520|468730691|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210148|NCT01716520|468730692|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130210149|NCT01716520|468730693|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210150|NCT01716520|468730694|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210151|NCT01716520|468730695|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210152|NCT01716520|468730696|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130210153|NCT01716520|468730691|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210154|NCT01716520|468730692|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
130210155|NCT01716520|468730693|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210156|NCT01716520|468730694|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210157|NCT01716520|468730695|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210158|NCT01716520|468730696|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
130210159|NCT01716520|468730691|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210160|NCT01716520|468730692|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210161|NCT01716520|468730693|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210162|NCT01716520|468730694|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210163|NCT01716520|468730695|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130210164|NCT01716520|468730696|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
130210165|NCT01716520|468730691|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210166|NCT01716520|468730692|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210167|NCT01716520|468730693|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
130210168|NCT01716520|468730694|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210169|NCT01716520|468730695|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
130210170|NCT01716520|468730696|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
130210171|NCT01716520|468730691|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210172|NCT01716520|468730692|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210173|NCT01716520|468730693|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210174|NCT01716520|468730694|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210175|NCT01716520|468730695|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
130210176|NCT01716520|468730696|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
130210177|NCT01716520|468730691|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210178|NCT01716520|468730692|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210179|NCT01716520|468730693|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210180|NCT01716520|468730694|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210181|NCT01716520|468730695|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130210182|NCT01716520|468730696|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130210183|NCT01716520|468730691|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210184|NCT01716520|468730692|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210185|NCT01716520|468730693|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210186|NCT01716520|468730694|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
130210187|NCT01716520|468730695|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129985702|NCT04811131|467909334|FG001|Overall Study|Lack of Efficacy|0|||
129875165|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Adverse Event|0|||
129875166|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Adverse Event|0|||
129875167|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Adverse Event|0|||
129875168|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Adverse Event|0|||
129875169|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Adverse Event|1|||
129875170|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Adverse Event|0|||
129875171|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Adverse Event|1|||
129875172|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Adverse Event|0|||
129875173|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Adverse Event|0|||
129875174|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875175|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875176|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875177|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
129875178|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
129875179|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
129875180|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875181|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875182|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875183|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875184|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Physician Decision|0|||
129875185|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Physician Decision|0|||
129875186|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Physician Decision|0|||
129875187|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Physician Decision|0|||
129875188|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Physician Decision|0|||
129875189|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Physician Decision|0|||
129875190|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Physician Decision|1|||
129875191|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Physician Decision|0|||
129875192|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Physician Decision|0|||
129875193|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Physician Decision|0|||
129875194|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875195|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875196|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
129875197|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875198|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875199|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875200|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875201|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875202|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875203|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875204|NCT05044325|467501837|FG000|Part A:Treatment Period 2|Adverse Event|0|||
129875205|NCT05044325|467501838|FG001|Part A:Treatment Period 2|Adverse Event|1|||
129875206|NCT05044325|467501839|FG002|Part A:Treatment Period 2|Adverse Event|0|||
129875207|NCT05044325|467501840|FG003|Part A:Treatment Period 2|Adverse Event|0|||
129875208|NCT05044325|467501841|FG004|Part A:Treatment Period 2|Adverse Event|1|||
129875209|NCT05044325|467501842|FG005|Part A:Treatment Period 2|Adverse Event|1|||
129875210|NCT05044325|467501843|FG006|Part A:Treatment Period 2|Adverse Event|0|||
129875211|NCT05044325|467501844|FG007|Part A:Treatment Period 2|Adverse Event|0|||
129875212|NCT05044325|467501845|FG008|Part A:Treatment Period 2|Adverse Event|0|||
129875213|NCT05044325|467501846|FG009|Part A:Treatment Period 2|Adverse Event|0|||
129875214|NCT05044325|467501837|FG000|Part A:Treatment Period 2|Physician Decision|0|||
129875215|NCT05044325|467501838|FG001|Part A:Treatment Period 2|Physician Decision|0|||
129875216|NCT05044325|467501839|FG002|Part A:Treatment Period 2|Physician Decision|0|||
129875217|NCT05044325|467501840|FG003|Part A:Treatment Period 2|Physician Decision|0|||
129875218|NCT05044325|467501841|FG004|Part A:Treatment Period 2|Physician Decision|0|||
129875219|NCT05044325|467501842|FG005|Part A:Treatment Period 2|Physician Decision|1|||
129875220|NCT05044325|467501843|FG006|Part A:Treatment Period 2|Physician Decision|0|||
129875221|NCT05044325|467501844|FG007|Part A:Treatment Period 2|Physician Decision|0|||
129875222|NCT05044325|467501845|FG008|Part A:Treatment Period 2|Physician Decision|0|||
129875223|NCT05044325|467501846|FG009|Part A:Treatment Period 2|Physician Decision|0|||
129875224|NCT05044325|467501837|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875225|NCT05044325|467501838|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875226|NCT05044325|467501839|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875227|NCT05044325|467501840|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
129875228|NCT05044325|467501841|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
129875229|NCT05044325|467501842|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875230|NCT05044325|467501843|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
130098546|NCT03110107|468319247|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
130098547|NCT03110107|468319248|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
130098548|NCT03110107|468319249|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
130098549|NCT03110107|468319250|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
130098550|NCT03110107|468319251|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
130098551|NCT03110107|468319252|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
130098552|NCT03110107|468319253|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
130098553|NCT03110107|468319254|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
130098554|NCT03110107|468319255|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
130098555|NCT03110107|468319230|FG000|Treatment Period|Participant withdrew consent|0|||
130098556|NCT03110107|468319231|FG001|Treatment Period|Participant withdrew consent|0|||
130098557|NCT03110107|468319232|FG002|Treatment Period|Participant withdrew consent|1|||
130098558|NCT03110107|468319233|FG003|Treatment Period|Participant withdrew consent|0|||
130098559|NCT03110107|468319234|FG004|Treatment Period|Participant withdrew consent|4|||
130098560|NCT03110107|468319235|FG005|Treatment Period|Participant withdrew consent|3|||
130098561|NCT03110107|468319236|FG006|Treatment Period|Participant withdrew consent|0|||
130098562|NCT03110107|468319237|FG007|Treatment Period|Participant withdrew consent|0|||
130098563|NCT03110107|468319238|FG008|Treatment Period|Participant withdrew consent|0|||
130098564|NCT03110107|468319239|FG009|Treatment Period|Participant withdrew consent|1|||
130098565|NCT03110107|468319240|FG010|Treatment Period|Participant withdrew consent|0|||
130098566|NCT03110107|468319241|FG011|Treatment Period|Participant withdrew consent|0|||
130098567|NCT03110107|468319242|FG012|Treatment Period|Participant withdrew consent|0|||
130098568|NCT03110107|468319243|FG013|Treatment Period|Participant withdrew consent|0|||
130098569|NCT03110107|468319244|FG014|Treatment Period|Participant withdrew consent|0|||
130098570|NCT03110107|468319245|FG015|Treatment Period|Participant withdrew consent|0|||
130098571|NCT03110107|468319246|FG016|Treatment Period|Participant withdrew consent|0|||
130098572|NCT03110107|468319247|FG017|Treatment Period|Participant withdrew consent|0|||
130098573|NCT03110107|468319248|FG018|Treatment Period|Participant withdrew consent|0|||
130098574|NCT03110107|468319249|FG019|Treatment Period|Participant withdrew consent|1|||
130098575|NCT03110107|468319250|FG020|Treatment Period|Participant withdrew consent|0|||
130098576|NCT03110107|468319251|FG021|Treatment Period|Participant withdrew consent|2|||
130098577|NCT03110107|468319252|FG022|Treatment Period|Participant withdrew consent|0|||
130098578|NCT03110107|468319253|FG023|Treatment Period|Participant withdrew consent|0|||
130098579|NCT03110107|468319254|FG024|Treatment Period|Participant withdrew consent|0|||
130098580|NCT03110107|468319255|FG025|Treatment Period|Participant withdrew consent|2|||
130098581|NCT03110107|468319230|FG000|Treatment Period|Participants no longer meets study criteria|0|||
130098582|NCT03110107|468319231|FG001|Treatment Period|Participants no longer meets study criteria|0|||
130098583|NCT03110107|468319232|FG002|Treatment Period|Participants no longer meets study criteria|0|||
130098584|NCT03110107|468319233|FG003|Treatment Period|Participants no longer meets study criteria|0|||
130098585|NCT03110107|468319234|FG004|Treatment Period|Participants no longer meets study criteria|0|||
130098586|NCT03110107|468319235|FG005|Treatment Period|Participants no longer meets study criteria|0|||
130098587|NCT03110107|468319236|FG006|Treatment Period|Participants no longer meets study criteria|0|||
130098588|NCT03110107|468319237|FG007|Treatment Period|Participants no longer meets study criteria|0|||
130098589|NCT03110107|468319238|FG008|Treatment Period|Participants no longer meets study criteria|0|||
130098590|NCT03110107|468319239|FG009|Treatment Period|Participants no longer meets study criteria|0|||
130098591|NCT03110107|468319240|FG010|Treatment Period|Participants no longer meets study criteria|0|||
130098592|NCT03110107|468319241|FG011|Treatment Period|Participants no longer meets study criteria|0|||
130098593|NCT03110107|468319242|FG012|Treatment Period|Participants no longer meets study criteria|0|||
130098594|NCT03110107|468319243|FG013|Treatment Period|Participants no longer meets study criteria|0|||
130098595|NCT03110107|468319244|FG014|Treatment Period|Participants no longer meets study criteria|0|||
130098596|NCT03110107|468319245|FG015|Treatment Period|Participants no longer meets study criteria|0|||
130098597|NCT03110107|468319246|FG016|Treatment Period|Participants no longer meets study criteria|0|||
130098598|NCT03110107|468319247|FG017|Treatment Period|Participants no longer meets study criteria|0|||
130098599|NCT03110107|468319248|FG018|Treatment Period|Participants no longer meets study criteria|0|||
130098600|NCT03110107|468319249|FG019|Treatment Period|Participants no longer meets study criteria|0|||
130098601|NCT03110107|468319250|FG020|Treatment Period|Participants no longer meets study criteria|0|||
130098602|NCT03110107|468319251|FG021|Treatment Period|Participants no longer meets study criteria|0|||
130098603|NCT03110107|468319252|FG022|Treatment Period|Participants no longer meets study criteria|0|||
130098604|NCT03110107|468319253|FG023|Treatment Period|Participants no longer meets study criteria|1|||
130098605|NCT03110107|468319254|FG024|Treatment Period|Participants no longer meets study criteria|0|||
130098606|NCT03110107|468319255|FG025|Treatment Period|Participants no longer meets study criteria|0|||
130098607|NCT03110107|468319230|FG000|Treatment Period|Other Reasons|0|||
130098608|NCT03110107|468319231|FG001|Treatment Period|Other Reasons|0|||
130098609|NCT03110107|468319232|FG002|Treatment Period|Other Reasons|1|||
130098610|NCT03110107|468319233|FG003|Treatment Period|Other Reasons|1|||
130210188|NCT01716520|468730696|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
130210189|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130210190|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130210191|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130210192|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130210193|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
130210194|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
130210195|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
130210196|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210197|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210198|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210199|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210200|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
130210201|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210202|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210203|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210204|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210205|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
130210206|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
130210207|NCT01716520|468730691|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210208|NCT01716520|468730692|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
130210209|NCT01716520|468730693|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210210|NCT01716520|468730694|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210211|NCT01716520|468730695|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210212|NCT01716520|468730696|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
130210213|NCT01716520|468730691|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210214|NCT01716520|468730692|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210215|NCT01716520|468730693|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210216|NCT01716520|468730694|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210217|NCT01716520|468730695|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130210218|NCT01716520|468730696|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
130210219|NCT01716520|468730691|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210220|NCT01716520|468730692|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210221|NCT01716520|468730693|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
130210222|NCT01716520|468730694|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210223|NCT01716520|468730695|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210224|NCT01716520|468730696|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130210225|NCT01937884|468730700|FG000|Overall Study|Withdrawal by Subject|1|||
130210226|NCT01937884|468730701|FG001|Overall Study|Withdrawal by Subject|0|||
130210227|NCT00004088|468730702|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
130210228|NCT00004088|468730702|FG000|Overall Study|Withdrawal by Subject|1|||
130210229|NCT00004088|468730702|FG000|Overall Study|Protocol Violation|3|||
130210230|NCT00004088|468730702|FG000|Overall Study|Physician Decision|1|||
130210231|NCT02636699|468730709|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
130210232|NCT02636699|468730710|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
130210233|NCT02636699|468730711|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
130210234|NCT02636699|468730709|FG000|Screening Period|Withdrawal by Subject|0|||
130210235|NCT02636699|468730710|FG001|Screening Period|Withdrawal by Subject|0|||
130210236|NCT02636699|468730711|FG002|Screening Period|Withdrawal by Subject|23|||
130210237|NCT02636699|468730709|FG000|Screening Period|Adverse Event|0|||
130210238|NCT02636699|468730710|FG001|Screening Period|Adverse Event|0|||
130210239|NCT02636699|468730711|FG002|Screening Period|Adverse Event|1|||
130210240|NCT02636699|468730709|FG000|Screening Period|Other not specified|0|||
130210241|NCT02636699|468730710|FG001|Screening Period|Other not specified|0|||
130210242|NCT02636699|468730711|FG002|Screening Period|Other not specified|3|||
130210243|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
130210244|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
130210245|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
130210246|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
130210247|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
130210248|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
130210249|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
130210250|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
130210251|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
130210252|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
130210253|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
130210254|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
130210255|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
130210256|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
130210257|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
130210258|NCT02636699|468730709|FG000|Treatment and Follow-up Periods|Other|3|||
130210259|NCT02636699|468730710|FG001|Treatment and Follow-up Periods|Other|1|||
130210260|NCT02636699|468730711|FG002|Treatment and Follow-up Periods|Other|0|||
130210261|NCT00981058|468730714|FG000|Overall Study|Progressive Disease|38|||
130210262|NCT00981058|468730715|FG001|Overall Study|Progressive Disease|31|||
130210263|NCT00981058|468730714|FG000|Overall Study|Lost to Follow-up|3|||
130210264|NCT00981058|468730715|FG001|Overall Study|Lost to Follow-up|2|||
130210265|NCT00981058|468730714|FG000|Overall Study|Physician Decision|4|||
130210266|NCT00981058|468730715|FG001|Overall Study|Physician Decision|5|||
130210267|NCT00981058|468730714|FG000|Overall Study|Randomization Error|0|||
130210268|NCT00981058|468730715|FG001|Overall Study|Randomization Error|1|||
130210269|NCT00981058|468730714|FG000|Overall Study|Withdrawal by Subject|24|||
130210270|NCT00981058|468730715|FG001|Overall Study|Withdrawal by Subject|22|||
130210271|NCT02667587|468730716|FG000|Pre-Treatment|Not reported|1|||
130210272|NCT02667587|468730717|FG001|Pre-Treatment|Not reported|0|||
130210273|NCT02667587|468730716|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130210274|NCT02667587|468730717|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
130210275|NCT02667587|468730716|FG000|Pre-Treatment|Participant withdrew consent|0|||
130210276|NCT02667587|468730717|FG001|Pre-Treatment|Participant withdrew consent|1|||
130210277|NCT02667587|468730716|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130210278|NCT02667587|468730717|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
130210279|NCT02667587|468730716|FG000|End of Treatment|Disease Progression|193|||
130210280|NCT02667587|468730717|FG001|End of Treatment|Disease Progression|226|||
130210281|NCT02667587|468730716|FG000|End of Treatment|Study Drug Toxicity|75|||
130210282|NCT02667587|468730717|FG001|End of Treatment|Study Drug Toxicity|19|||
130210283|NCT02667587|468730716|FG000|End of Treatment|Death|2|||
130210284|NCT02667587|468730717|FG001|End of Treatment|Death|1|||
130210285|NCT02667587|468730716|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
130210286|NCT02667587|468730717|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
130210287|NCT02667587|468730716|FG000|End of Treatment|participant request to discontinue treatment|33|||
130210288|NCT02667587|468730717|FG001|End of Treatment|participant request to discontinue treatment|35|||
130210289|NCT02667587|468730716|FG000|End of Treatment|participant withdrew consent|5|||
130210290|NCT02667587|468730717|FG001|End of Treatment|participant withdrew consent|6|||
130210291|NCT02667587|468730716|FG000|End of Treatment|Lost to Follow-up|1|||
130210292|NCT02667587|468730717|FG001|End of Treatment|Lost to Follow-up|2|||
130210293|NCT02667587|468730716|FG000|End of Treatment|maximum clinical benefit|4|||
130210294|NCT02667587|468730717|FG001|End of Treatment|maximum clinical benefit|4|||
130210295|NCT02667587|468730716|FG000|End of Treatment|poor or non compliant|0|||
130210296|NCT02667587|468730717|FG001|End of Treatment|poor or non compliant|1|||
130210297|NCT02667587|468730716|FG000|End of Treatment|participant no longer meets study criteria|1|||
130210298|NCT02667587|468730717|FG001|End of Treatment|participant no longer meets study criteria|1|||
130210299|NCT02667587|468730716|FG000|End of Treatment|administrative reason by sponsor|1|||
130210300|NCT02667587|468730717|FG001|End of Treatment|administrative reason by sponsor|29|||
130210301|NCT02667587|468730716|FG000|End of Treatment|other reasonse|21|||
130210302|NCT02667587|468730717|FG001|End of Treatment|other reasonse|10|||
130210303|NCT02305446|468730724|FG000|Overall Study|Adverse Event|1|||
130210304|NCT01636947|468730725|FG000|Overall Study|Not Treated|2|||
130210305|NCT01636947|468730726|FG001|Overall Study|Not Treated|2|||
130210306|NCT01636947|468730725|FG000|Overall Study|Lost to Follow-up|4|||
130210307|NCT01636947|468730726|FG001|Overall Study|Lost to Follow-up|0|||
130210308|NCT01636947|468730725|FG000|Overall Study|Protocol Violation|1|||
130210309|NCT01636947|468730726|FG001|Overall Study|Protocol Violation|1|||
130210310|NCT01636947|468730725|FG000|Overall Study|Withdrawal by Subject|3|||
130210311|NCT01636947|468730726|FG001|Overall Study|Withdrawal by Subject|3|||
130210312|NCT01636947|468730725|FG000|Overall Study|Adverse Event|1|||
130210313|NCT01636947|468730726|FG001|Overall Study|Adverse Event|1|||
130210314|NCT01636947|468730725|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130210315|NCT01636947|468730726|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
130210316|NCT00957424|468730727|FG000|Overall Study|Lost to Follow-up|19|||
130210317|NCT00957424|468730727|FG000|Overall Study|Protocol Violation|3|||
130210318|NCT00957424|468730727|FG000|Overall Study|Withdrawal by Subject|1|||
130210319|NCT05182606|468730734|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
130210320|NCT01167634|468730737|FG000|Overall Study|Lost to Follow-up|1|||
130210321|NCT01167634|468730738|FG001|Overall Study|Lost to Follow-up|3|||
130210322|NCT01167634|468730739|FG002|Overall Study|Lost to Follow-up|3|||
130210323|NCT01167634|468730740|FG003|Overall Study|Lost to Follow-up|4|||
130210324|NCT01167634|468730737|FG000|Overall Study|Withdrawal by Subject|1|||
130210325|NCT01167634|468730738|FG001|Overall Study|Withdrawal by Subject|1|||
130210326|NCT01167634|468730739|FG002|Overall Study|Withdrawal by Subject|0|||
130210327|NCT01167634|468730740|FG003|Overall Study|Withdrawal by Subject|0|||
130210328|NCT00438256|468730741|FG000|Overall Study|Ineligible for Resection|2|||
130210329|NCT00438256|468730742|FG001|Overall Study|Ineligible for Resection|1|||
130210330|NCT00438256|468730743|FG002|Overall Study|Ineligible for Resection|1|||
130210331|NCT00438256|468730744|FG003|Overall Study|Ineligible for Resection|7|||
130210332|NCT00438256|468730741|FG000|Overall Study|Excluded final Diagnosis|0|||
130210333|NCT00438256|468730742|FG001|Overall Study|Excluded final Diagnosis|0|||
130210334|NCT00438256|468730743|FG002|Overall Study|Excluded final Diagnosis|0|||
130210335|NCT00438256|468730744|FG003|Overall Study|Excluded final Diagnosis|2|||
130210336|NCT01133288|468730745|FG000|Eligibility Assessment|met exclusion criteria|5|||
130210337|NCT01133288|468730745|FG000|Intervention Allocation|study terminated|2|||
130210338|NCT00369161|468730746|FG000|Overall Study|Adverse Event|15|||
130210339|NCT00369161|468730747|FG001|Overall Study|Adverse Event|13|||
130210340|NCT00369161|468730746|FG000|Overall Study|Abnormal laboratory value|0|||
130210341|NCT00369161|468730747|FG001|Overall Study|Abnormal laboratory value|1|||
130210342|NCT00369161|468730746|FG000|Overall Study|Lack of Efficacy|3|||
130210343|NCT00369161|468730747|FG001|Overall Study|Lack of Efficacy|1|||
130210344|NCT00369161|468730746|FG000|Overall Study|Protocol Violation|0|||
130210345|NCT00369161|468730747|FG001|Overall Study|Protocol Violation|2|||
130210346|NCT00369161|468730746|FG000|Overall Study|Withdrawal by Subject|2|||
130210347|NCT00369161|468730747|FG001|Overall Study|Withdrawal by Subject|3|||
130210348|NCT00369161|468730746|FG000|Overall Study|Death|1|||
130210349|NCT00369161|468730747|FG001|Overall Study|Death|2|||
130210350|NCT00369161|468730746|FG000|Overall Study|Graft loss|4|||
130210351|NCT00369161|468730747|FG001|Overall Study|Graft loss|0|||
130210352|NCT00369161|468730746|FG000|Overall Study|Administrative Problem|2|||
130210353|NCT00369161|468730747|FG001|Overall Study|Administrative Problem|2|||
130210354|NCT02147067|468730750|FG000|Overall Study|Withdrawal by Subject|2|||
130210355|NCT02147067|468730751|FG001|Overall Study|Withdrawal by Subject|2|||
130210356|NCT02603107|468730752|FG000|Randomized Phase|Withdrew consent|8|||
130210357|NCT02603107|468730753|FG001|Randomized Phase|Withdrew consent|15|||
130210358|NCT02603107|468730752|FG000|Randomized Phase|Lost to Follow-up|1|||
130210359|NCT02603107|468730753|FG001|Randomized Phase|Lost to Follow-up|3|||
130210360|NCT02603107|468730752|FG000|Randomized Phase|Adverse Event|2|||
130210361|NCT02603107|468730753|FG001|Randomized Phase|Adverse Event|0|||
130210362|NCT02603107|468730752|FG000|Randomized Phase|Death|1|||
130210363|NCT02603107|468730753|FG001|Randomized Phase|Death|1|||
130098611|NCT03110107|468319234|FG004|Treatment Period|Other Reasons|0|||
130098612|NCT03110107|468319235|FG005|Treatment Period|Other Reasons|1|||
130098613|NCT03110107|468319236|FG006|Treatment Period|Other Reasons|0|||
130098614|NCT03110107|468319237|FG007|Treatment Period|Other Reasons|0|||
130098615|NCT03110107|468319238|FG008|Treatment Period|Other Reasons|0|||
130098616|NCT03110107|468319239|FG009|Treatment Period|Other Reasons|0|||
130098617|NCT03110107|468319240|FG010|Treatment Period|Other Reasons|0|||
130098618|NCT03110107|468319241|FG011|Treatment Period|Other Reasons|0|||
130098619|NCT03110107|468319242|FG012|Treatment Period|Other Reasons|0|||
130098620|NCT03110107|468319243|FG013|Treatment Period|Other Reasons|0|||
130098621|NCT03110107|468319244|FG014|Treatment Period|Other Reasons|0|||
130098622|NCT03110107|468319245|FG015|Treatment Period|Other Reasons|0|||
130098623|NCT03110107|468319246|FG016|Treatment Period|Other Reasons|0|||
130098624|NCT03110107|468319247|FG017|Treatment Period|Other Reasons|0|||
130098625|NCT03110107|468319248|FG018|Treatment Period|Other Reasons|0|||
130098626|NCT03110107|468319249|FG019|Treatment Period|Other Reasons|0|||
130098627|NCT03110107|468319250|FG020|Treatment Period|Other Reasons|0|||
130098628|NCT03110107|468319251|FG021|Treatment Period|Other Reasons|0|||
130098629|NCT03110107|468319252|FG022|Treatment Period|Other Reasons|0|||
130098630|NCT03110107|468319253|FG023|Treatment Period|Other Reasons|0|||
130098631|NCT03110107|468319254|FG024|Treatment Period|Other Reasons|1|||
130098632|NCT03110107|468319255|FG025|Treatment Period|Other Reasons|0|||
130098633|NCT03586427|468319263|FG000|Overall Study|Lost to Follow-up|0|||
130098634|NCT03586427|468319264|FG001|Overall Study|Lost to Follow-up|3|||
130098635|NCT03586427|468319265|FG002|Overall Study|Lost to Follow-up|1|||
130098636|NCT03586427|468319266|FG003|Overall Study|Lost to Follow-up|3|||
130098637|NCT03586427|468319267|FG004|Overall Study|Lost to Follow-up|3|||
130098638|NCT03586427|468319263|FG000|Overall Study|Withdrawal by Subject|0|||
130098639|NCT03586427|468319264|FG001|Overall Study|Withdrawal by Subject|1|||
130098640|NCT03586427|468319265|FG002|Overall Study|Withdrawal by Subject|2|||
130098641|NCT03586427|468319266|FG003|Overall Study|Withdrawal by Subject|1|||
130098642|NCT03586427|468319267|FG004|Overall Study|Withdrawal by Subject|1|||
130098643|NCT03586427|468319263|FG000|Overall Study|Adverse Event|0|||
130098644|NCT03586427|468319264|FG001|Overall Study|Adverse Event|0|||
130098645|NCT03586427|468319265|FG002|Overall Study|Adverse Event|1|||
130098646|NCT03586427|468319266|FG003|Overall Study|Adverse Event|0|||
130098647|NCT03586427|468319267|FG004|Overall Study|Adverse Event|0|||
130210364|NCT02603107|468730752|FG000|Randomized Phase|Non-compliance with study drug|1|||
130210365|NCT02603107|468730753|FG001|Randomized Phase|Non-compliance with study drug|1|||
130210366|NCT02603107|468730752|FG000|Randomized Phase|Investigator's discretion|0|||
130210367|NCT02603107|468730753|FG001|Randomized Phase|Investigator's discretion|1|||
130210368|NCT02603107|468730752|FG000|Randomized Phase|Lack of Efficacy|1|||
130210369|NCT02603107|468730753|FG001|Randomized Phase|Lack of Efficacy|0|||
130210370|NCT02603107|468730752|FG000|Randomized Phase|Protocol Violation|1|||
130210371|NCT02603107|468730753|FG001|Randomized Phase|Protocol Violation|0|||
130210372|NCT02603107|468730752|FG000|Optional Extension Phase|Lost to Follow-up|3|||
130210373|NCT02603107|468730753|FG001|Optional Extension Phase|Lost to Follow-up|3|||
130210374|NCT02603107|468730752|FG000|Optional Extension Phase|Withdrew consent|3|||
130210375|NCT02603107|468730753|FG001|Optional Extension Phase|Withdrew consent|2|||
130210376|NCT02603107|468730752|FG000|Optional Extension Phase|Investigator's discretion|2|||
130210377|NCT02603107|468730753|FG001|Optional Extension Phase|Investigator's discretion|2|||
130210378|NCT02603107|468730752|FG000|Optional Extension Phase|Pregnancy|0|||
130210379|NCT02603107|468730753|FG001|Optional Extension Phase|Pregnancy|3|||
130210380|NCT02603107|468730752|FG000|Optional Extension Phase|Adverse Event|0|||
130210381|NCT02603107|468730753|FG001|Optional Extension Phase|Adverse Event|2|||
130210382|NCT02603107|468730752|FG000|Optional Extension Phase|Not treated in extension phase|0|||
130210383|NCT02603107|468730753|FG001|Optional Extension Phase|Not treated in extension phase|1|||
130210384|NCT02603107|468730752|FG000|Optional Extension Phase|Protocol Violation|1|||
130210385|NCT02603107|468730753|FG001|Optional Extension Phase|Protocol Violation|0|||
130210386|NCT01404949|468730754|FG000|Overall Study|Not Treated|1|||
130210387|NCT03411902|468730755|FG000|Overall Study|Lost to Follow-up|3|||
130210388|NCT03411902|468730756|FG001|Overall Study|Lost to Follow-up|0|||
130210389|NCT00419159|468730757|FG000|Overall Study|Adverse Event|7|||
130210390|NCT00419159|468730758|FG001|Overall Study|Adverse Event|15|||
130210391|NCT00419159|468730757|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130210392|NCT00419159|468730758|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130210393|NCT00419159|468730757|FG000|Overall Study|Subject's no longer requires study drug|0|||
130210394|NCT00419159|468730758|FG001|Overall Study|Subject's no longer requires study drug|1|||
130210395|NCT00419159|468730757|FG000|Overall Study|Protocol Violation|1|||
130210396|NCT00419159|468730758|FG001|Overall Study|Protocol Violation|0|||
130210397|NCT00419159|468730757|FG000|Overall Study|Withdrawal by Subject|10|||
130210398|NCT00419159|468730758|FG001|Overall Study|Withdrawal by Subject|3|||
130210399|NCT00419159|468730757|FG000|Overall Study|Lost to Follow-up|0|||
130210400|NCT00419159|468730758|FG001|Overall Study|Lost to Follow-up|1|||
130210401|NCT00419159|468730757|FG000|Overall Study|Death|2|||
130210402|NCT00419159|468730758|FG001|Overall Study|Death|2|||
130210403|NCT00419159|468730757|FG000|Overall Study|Disease progression|79|||
130210404|NCT00419159|468730758|FG001|Overall Study|Disease progression|76|||
130210405|NCT01017601|468730759|FG000|Overall Study|Disease Progression|12|||
130210406|NCT01017601|468730760|FG001|Overall Study|Disease Progression|12|||
130210407|NCT01017601|468730759|FG000|Overall Study|Withdrawal by Subject|0|||
130210408|NCT01017601|468730760|FG001|Overall Study|Withdrawal by Subject|1|||
130210409|NCT00574795|468730762|FG000|Infant Series|Withdrawal by Subject|2|||
130210410|NCT00574795|468730762|FG000|Infant Series|Protocol Violation|2|||
130210411|NCT00574795|468730762|FG000|Infant Series|Adverse Event|1|||
130210412|NCT00574795|468730762|FG000|After Infant Series|Withdrawal by Subject|1|||
130210413|NCT00574795|468730762|FG000|After Infant Series|Adverse Event|2|||
130210414|NCT00574795|468730762|FG000|Toddler Dose|Withdrawal by Subject|1|||
130210415|NCT02638259|468730763|FG000|Treatment Period 1|Adverse Event|1|||
130210416|NCT02638259|468730764|FG001|Treatment Period 1|Adverse Event|5|||
130210417|NCT02638259|468730763|FG000|Treatment Period 1|Death|0|||
130210418|NCT02638259|468730764|FG001|Treatment Period 1|Death|1|||
130210419|NCT02638259|468730763|FG000|Treatment Period 1|Lack of Efficacy|0|||
130210420|NCT02638259|468730764|FG001|Treatment Period 1|Lack of Efficacy|1|||
130210421|NCT02638259|468730763|FG000|Treatment Period 1|Protocol Violation|0|||
130210422|NCT02638259|468730764|FG001|Treatment Period 1|Protocol Violation|3|||
130210423|NCT02638259|468730763|FG000|Treatment Period 1|Withdrawal by Subject|4|||
130210424|NCT02638259|468730764|FG001|Treatment Period 1|Withdrawal by Subject|6|||
130210425|NCT02638259|468730763|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
130210426|NCT02638259|468730764|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
130210427|NCT02638259|468730763|FG000|Treatment Period 2|Adverse Event|5|||
130210428|NCT02638259|468730764|FG001|Treatment Period 2|Adverse Event|4|||
130210429|NCT02638259|468730763|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130210430|NCT02638259|468730764|FG001|Treatment Period 2|Withdrawal by Subject|7|||
130210431|NCT01706575|468730765|FG000|Overall Study|Participant Withdrew Consent|4|||
130210432|NCT01706575|468730765|FG000|Overall Study|Lost to Follow-up|2|||
130210433|NCT01706575|468730765|FG000|Overall Study|Started but not Treated|6|||
130210434|NCT01094782|468730766|FG000|Overall Study|Withdrawal by Subject|5|||
130210435|NCT01094782|468730767|FG001|Overall Study|Withdrawal by Subject|5|||
130210436|NCT01094782|468730768|FG002|Overall Study|Withdrawal by Subject|1|||
130210437|NCT01094782|468730769|FG003|Overall Study|Withdrawal by Subject|5|||
130210438|NCT01094782|468730770|FG004|Overall Study|Withdrawal by Subject|5|||
130210439|NCT01094782|468730771|FG005|Overall Study|Withdrawal by Subject|0|||
130210440|NCT01094782|468730766|FG000|Overall Study|Lost to Follow-up|1|||
130210441|NCT01094782|468730767|FG001|Overall Study|Lost to Follow-up|0|||
130210442|NCT01094782|468730768|FG002|Overall Study|Lost to Follow-up|0|||
130210443|NCT01094782|468730769|FG003|Overall Study|Lost to Follow-up|2|||
130210444|NCT01094782|468730770|FG004|Overall Study|Lost to Follow-up|1|||
130210445|NCT01094782|468730771|FG005|Overall Study|Lost to Follow-up|4|||
130210446|NCT01094782|468730766|FG000|Overall Study|Positive Drug Screen|2|||
130210447|NCT01094782|468730767|FG001|Overall Study|Positive Drug Screen|2|||
130210448|NCT01094782|468730768|FG002|Overall Study|Positive Drug Screen|1|||
130210449|NCT01094782|468730769|FG003|Overall Study|Positive Drug Screen|1|||
130210450|NCT01094782|468730770|FG004|Overall Study|Positive Drug Screen|3|||
130210451|NCT01094782|468730771|FG005|Overall Study|Positive Drug Screen|2|||
130210452|NCT01094782|468730766|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
130210453|NCT01094782|468730767|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
130210454|NCT01094782|468730768|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
130210455|NCT01094782|468730769|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
130210456|NCT01094782|468730770|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
130210457|NCT01094782|468730771|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
130210458|NCT01094782|468730766|FG000|Overall Study|Unable to Complete Questionnaires|0|||
130210459|NCT01094782|468730767|FG001|Overall Study|Unable to Complete Questionnaires|1|||
130210460|NCT01094782|468730768|FG002|Overall Study|Unable to Complete Questionnaires|0|||
130210461|NCT01094782|468730769|FG003|Overall Study|Unable to Complete Questionnaires|0|||
130210462|NCT01094782|468730770|FG004|Overall Study|Unable to Complete Questionnaires|0|||
130210463|NCT01094782|468730771|FG005|Overall Study|Unable to Complete Questionnaires|0|||
130210464|NCT01094782|468730766|FG000|Overall Study|Healthy Subject Had Pain|0|||
130210465|NCT01094782|468730767|FG001|Overall Study|Healthy Subject Had Pain|1|||
130210466|NCT01094782|468730768|FG002|Overall Study|Healthy Subject Had Pain|0|||
130210467|NCT01094782|468730769|FG003|Overall Study|Healthy Subject Had Pain|0|||
130210468|NCT01094782|468730770|FG004|Overall Study|Healthy Subject Had Pain|0|||
130210469|NCT01094782|468730771|FG005|Overall Study|Healthy Subject Had Pain|0|||
130210470|NCT01094782|468730766|FG000|Overall Study|Hypertension|0|||
130210471|NCT01094782|468730767|FG001|Overall Study|Hypertension|0|||
130210472|NCT01094782|468730768|FG002|Overall Study|Hypertension|1|||
130210473|NCT01094782|468730769|FG003|Overall Study|Hypertension|0|||
130210474|NCT01094782|468730770|FG004|Overall Study|Hypertension|0|||
130210475|NCT01094782|468730771|FG005|Overall Study|Hypertension|0|||
130210476|NCT01094782|468730766|FG000|Overall Study|Wrong Pain Condition|0|||
130210477|NCT01094782|468730767|FG001|Overall Study|Wrong Pain Condition|0|||
130210478|NCT01094782|468730768|FG002|Overall Study|Wrong Pain Condition|0|||
130210479|NCT01094782|468730769|FG003|Overall Study|Wrong Pain Condition|2|||
130210480|NCT01094782|468730770|FG004|Overall Study|Wrong Pain Condition|1|||
130210481|NCT01094782|468730771|FG005|Overall Study|Wrong Pain Condition|1|||
130210482|NCT01094782|468730766|FG000|Overall Study|Recent Interventional Injection|0|||
130210483|NCT01094782|468730767|FG001|Overall Study|Recent Interventional Injection|0|||
130210484|NCT01094782|468730768|FG002|Overall Study|Recent Interventional Injection|0|||
130210485|NCT01094782|468730769|FG003|Overall Study|Recent Interventional Injection|0|||
130210486|NCT01094782|468730770|FG004|Overall Study|Recent Interventional Injection|0|||
130210487|NCT01094782|468730771|FG005|Overall Study|Recent Interventional Injection|1|||
130210488|NCT01094782|468730766|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210489|NCT01094782|468730767|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210490|NCT01094782|468730768|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210491|NCT01094782|468730769|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210492|NCT01094782|468730770|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
130210493|NCT01094782|468730771|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
130210494|NCT01094782|468730766|FG000|Overall Study|Noncompliance With Study Schedule|0|||
130210495|NCT01094782|468730767|FG001|Overall Study|Noncompliance With Study Schedule|0|||
130210496|NCT01094782|468730768|FG002|Overall Study|Noncompliance With Study Schedule|0|||
130210497|NCT01094782|468730769|FG003|Overall Study|Noncompliance With Study Schedule|1|||
130210498|NCT01094782|468730770|FG004|Overall Study|Noncompliance With Study Schedule|0|||
130210499|NCT01094782|468730771|FG005|Overall Study|Noncompliance With Study Schedule|0|||
130210500|NCT00957905|468730772|FG000|Part B|Not Treated|0|||
130210501|NCT00957905|468730773|FG001|Part B|Not Treated|1|||
130210502|NCT00957905|468730772|FG000|Part B|Physician Decision|0|||
130210503|NCT00957905|468730773|FG001|Part B|Physician Decision|1|||
130210504|NCT00957905|468730772|FG000|Part B|Death|0|||
130210505|NCT00957905|468730773|FG001|Part B|Death|1|||
130210506|NCT00957905|468730772|FG000|Part B|Protocol Violation|0|||
130210507|NCT00957905|468730773|FG001|Part B|Protocol Violation|1|||
130210508|NCT02073656|468730790|FG000|Primary Study|Lost to Follow-up|6|||
130210509|NCT02073656|468730790|FG000|Primary Study|Death|1|||
130210510|NCT02073656|468730790|FG000|Primary Study|Withdrew Consent|1|||
130210511|NCT02536781|468730793|FG000|Overall Study|Lost to Follow-up|2|||
130210512|NCT02536781|468730794|FG001|Overall Study|Lost to Follow-up|0|||
130210513|NCT03423147|468730795|FG000|Overall Study|Lost to Follow-up|5|||
130210514|NCT03423147|468730796|FG001|Overall Study|Lost to Follow-up|8|||
130210515|NCT03423147|468730795|FG000|Overall Study|Withdrawal by Subject|1|||
130210516|NCT03423147|468730796|FG001|Overall Study|Withdrawal by Subject|0|||
130210517|NCT03423147|468730795|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
130210518|NCT03423147|468730796|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
130210519|NCT03423147|468730795|FG000|Overall Study|Age < 18|1|||
130210520|NCT03423147|468730796|FG001|Overall Study|Age < 18|0|||
130210521|NCT03423147|468730795|FG000|Overall Study|No Trial of Labor|0|||
130210522|NCT03423147|468730796|FG001|Overall Study|No Trial of Labor|1|||
130210523|NCT01048099|468730797|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
130210524|NCT01048099|468730797|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
130210525|NCT02258334|468730800|FG000|Overall Study|Adverse Event|1|||
130210526|NCT02258334|468730801|FG001|Overall Study|Adverse Event|0|||
130210527|NCT02258334|468730802|FG002|Overall Study|Adverse Event|0|||
130210528|NCT02258334|468730803|FG003|Overall Study|Adverse Event|0|||
130210529|NCT01969084|468730804|FG000|Overall Study|Adverse Event|0|||
130210530|NCT01969084|468730805|FG001|Overall Study|Adverse Event|1|||
130210531|NCT00862459|468730808|FG000|Overall Study|Lost to Follow-up|1|||
130210532|NCT00862459|468730809|FG001|Overall Study|Lost to Follow-up|2|||
130210533|NCT00862459|468730810|FG002|Overall Study|Lost to Follow-up|2|||
130210534|NCT00862459|468730808|FG000|Overall Study|Protocol Violation|1|||
130210535|NCT00862459|468730809|FG001|Overall Study|Protocol Violation|0|||
130210536|NCT00862459|468730810|FG002|Overall Study|Protocol Violation|0|||
130210537|NCT00862459|468730808|FG000|Overall Study|Withdrawal by Subject|1|||
130210538|NCT00862459|468730809|FG001|Overall Study|Withdrawal by Subject|1|||
130210539|NCT00862459|468730810|FG002|Overall Study|Withdrawal by Subject|3|||
130210540|NCT00862459|468730808|FG000|Overall Study|Adverse Event|0|||
130210541|NCT00862459|468730809|FG001|Overall Study|Adverse Event|1|||
130210542|NCT00862459|468730810|FG002|Overall Study|Adverse Event|0|||
130210543|NCT00862459|468730808|FG000|Overall Study|Personal reasons|1|||
130210544|NCT00862459|468730809|FG001|Overall Study|Personal reasons|0|||
130210545|NCT00862459|468730810|FG002|Overall Study|Personal reasons|0|||
130210546|NCT00862459|468730808|FG000|Overall Study|Operation|1|||
130210547|NCT00862459|468730809|FG001|Overall Study|Operation|1|||
130210548|NCT00862459|468730810|FG002|Overall Study|Operation|0|||
130210549|NCT00862459|468730808|FG000|Overall Study|Intravenous (IV) site problems|1|||
130210550|NCT00862459|468730809|FG001|Overall Study|Intravenous (IV) site problems|0|||
130210551|NCT00862459|468730810|FG002|Overall Study|Intravenous (IV) site problems|1|||
130210552|NCT00862459|468730808|FG000|Overall Study|Unable to hold still for imaging|0|||
130210553|NCT00862459|468730809|FG001|Overall Study|Unable to hold still for imaging|1|||
130210554|NCT00862459|468730810|FG002|Overall Study|Unable to hold still for imaging|0|||
130210555|NCT00862459|468730808|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
130210556|NCT00862459|468730809|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130210557|NCT00862459|468730810|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130210558|NCT00862459|468730808|FG000|Overall Study|Administrative problems|0|||
130210559|NCT00862459|468730809|FG001|Overall Study|Administrative problems|1|||
130210560|NCT00862459|468730810|FG002|Overall Study|Administrative problems|0|||
130210561|NCT04015518|468730815|FG000|Overall Study|Adverse Event|6|||
130210562|NCT04015518|468730816|FG001|Overall Study|Adverse Event|1|||
130210563|NCT04015518|468730817|FG002|Overall Study|Adverse Event|1|||
130210564|NCT04015518|468730818|FG003|Overall Study|Adverse Event|3|||
130210565|NCT04015518|468730819|FG004|Overall Study|Adverse Event|3|||
130210566|NCT04015518|468730815|FG000|Overall Study|Lack of Efficacy|1|||
130210567|NCT04015518|468730816|FG001|Overall Study|Lack of Efficacy|0|||
130210568|NCT04015518|468730817|FG002|Overall Study|Lack of Efficacy|1|||
130210569|NCT04015518|468730818|FG003|Overall Study|Lack of Efficacy|0|||
130210570|NCT04015518|468730819|FG004|Overall Study|Lack of Efficacy|4|||
130210571|NCT04015518|468730815|FG000|Overall Study|Lost to Follow-up|0|||
130210572|NCT04015518|468730816|FG001|Overall Study|Lost to Follow-up|0|||
130210573|NCT04015518|468730817|FG002|Overall Study|Lost to Follow-up|0|||
130210574|NCT04015518|468730818|FG003|Overall Study|Lost to Follow-up|0|||
130210575|NCT04015518|468730819|FG004|Overall Study|Lost to Follow-up|1|||
130210576|NCT04015518|468730815|FG000|Overall Study|Withdrawal by Subject|0|||
130210577|NCT04015518|468730816|FG001|Overall Study|Withdrawal by Subject|1|||
130210578|NCT04015518|468730817|FG002|Overall Study|Withdrawal by Subject|0|||
130210579|NCT04015518|468730818|FG003|Overall Study|Withdrawal by Subject|1|||
130210580|NCT04015518|468730819|FG004|Overall Study|Withdrawal by Subject|1|||
130210581|NCT04015518|468730815|FG000|Overall Study|Patient did not come for consecutive visits|0|||
130210582|NCT04015518|468730816|FG001|Overall Study|Patient did not come for consecutive visits|1|||
130210583|NCT04015518|468730817|FG002|Overall Study|Patient did not come for consecutive visits|0|||
130210584|NCT04015518|468730818|FG003|Overall Study|Patient did not come for consecutive visits|0|||
130210585|NCT04015518|468730819|FG004|Overall Study|Patient did not come for consecutive visits|0|||
130210586|NCT04015518|468730815|FG000|Overall Study|not willing to travel due to Covid-19|0|||
130210587|NCT04015518|468730816|FG001|Overall Study|not willing to travel due to Covid-19|0|||
130210588|NCT04015518|468730817|FG002|Overall Study|not willing to travel due to Covid-19|1|||
130210589|NCT04015518|468730818|FG003|Overall Study|not willing to travel due to Covid-19|0|||
130210590|NCT04015518|468730819|FG004|Overall Study|not willing to travel due to Covid-19|0|||
130210591|NCT04015518|468730815|FG000|Overall Study|Patient wants to discontinue treatment|0|||
130210592|NCT04015518|468730816|FG001|Overall Study|Patient wants to discontinue treatment|0|||
130210593|NCT04015518|468730817|FG002|Overall Study|Patient wants to discontinue treatment|0|||
130210594|NCT04015518|468730818|FG003|Overall Study|Patient wants to discontinue treatment|1|||
130210595|NCT04015518|468730819|FG004|Overall Study|Patient wants to discontinue treatment|0|||
129875231|NCT05044325|467501844|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875232|NCT05044325|467501845|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875233|NCT05044325|467501846|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875234|NCT00755222|467501847|FG000|Overall Study|Withdrawal by Subject|4|||
129875235|NCT00755222|467501848|FG001|Overall Study|Withdrawal by Subject|2|||
129875236|NCT00755222|467501847|FG000|Overall Study|Adverse Event|2|||
129875237|NCT00755222|467501848|FG001|Overall Study|Adverse Event|0|||
129875238|NCT00755222|467501847|FG000|Overall Study|Protocol Violation|2|||
129875239|NCT00755222|467501848|FG001|Overall Study|Protocol Violation|0|||
129875240|NCT02243202|467501849|FG000|Overall Study|Adverse Event|5|||
129875241|NCT02243202|467501850|FG001|Overall Study|Adverse Event|6|||
129875242|NCT02243202|467501851|FG002|Overall Study|Adverse Event|10|||
129875243|NCT02243202|467501852|FG003|Overall Study|Adverse Event|4|||
129875244|NCT02243202|467501849|FG000|Overall Study|Lost to Follow-up|9|||
129875245|NCT02243202|467501850|FG001|Overall Study|Lost to Follow-up|9|||
129875246|NCT02243202|467501851|FG002|Overall Study|Lost to Follow-up|14|||
129875247|NCT02243202|467501852|FG003|Overall Study|Lost to Follow-up|11|||
129875248|NCT02243202|467501849|FG000|Overall Study|Protocol Violation|3|||
129875249|NCT02243202|467501850|FG001|Overall Study|Protocol Violation|1|||
129875250|NCT02243202|467501851|FG002|Overall Study|Protocol Violation|2|||
129875251|NCT02243202|467501852|FG003|Overall Study|Protocol Violation|1|||
129875252|NCT02243202|467501849|FG000|Overall Study|Withdrawal by Subject|7|||
129875253|NCT02243202|467501850|FG001|Overall Study|Withdrawal by Subject|6|||
129875254|NCT02243202|467501851|FG002|Overall Study|Withdrawal by Subject|4|||
129875255|NCT02243202|467501852|FG003|Overall Study|Withdrawal by Subject|4|||
129875256|NCT02243202|467501849|FG000|Overall Study|Other|1|||
129875257|NCT02243202|467501850|FG001|Overall Study|Other|3|||
129875258|NCT02243202|467501851|FG002|Overall Study|Other|1|||
129875259|NCT02243202|467501852|FG003|Overall Study|Other|2|||
129875260|NCT02243202|467501849|FG000|Overall Study|Randomized but not received treatment|0|||
129875261|NCT02243202|467501850|FG001|Overall Study|Randomized but not received treatment|0|||
129875262|NCT02243202|467501851|FG002|Overall Study|Randomized but not received treatment|0|||
129875263|NCT02243202|467501852|FG003|Overall Study|Randomized but not received treatment|1|||
129875264|NCT02013388|467501859|FG000|Overall Study|work emergency|1|||
129875265|NCT02013388|467501860|FG001|Overall Study|work emergency|0|||
129875266|NCT02013388|467501861|FG002|Overall Study|work emergency|0|||
129875267|NCT02013388|467501862|FG003|Overall Study|work emergency|0|||
129875268|NCT02013388|467501863|FG004|Overall Study|work emergency|1|||
129875269|NCT02013388|467501864|FG005|Overall Study|work emergency|0|||
129875270|NCT02013388|467501865|FG006|Overall Study|work emergency|0|||
129875271|NCT02013388|467501866|FG007|Overall Study|work emergency|0|||
129875272|NCT04207840|467501867|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
129875273|NCT04207840|467501868|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
129875274|NCT04207840|467501869|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
129875275|NCT04207840|467501867|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
129875276|NCT04207840|467501868|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
129875277|NCT04207840|467501869|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
129875278|NCT03243422|467501870|FG000|Overall Study|Death|20|||
129875279|NCT03243422|467501871|FG001|Overall Study|Death|21|||
129875280|NCT03243422|467501870|FG000|Overall Study|Lost to Follow-up|9|||
129875281|NCT03243422|467501871|FG001|Overall Study|Lost to Follow-up|21|||
129875282|NCT03243422|467501870|FG000|Overall Study|Withdrawal by Subject|22|||
129875283|NCT03243422|467501871|FG001|Overall Study|Withdrawal by Subject|8|||
129875284|NCT02173054|467501872|FG000|Overall Study|lack of compliance|1|||
129875285|NCT02173054|467501873|FG001|Overall Study|lack of compliance|0|||
129875286|NCT02173054|467501874|FG002|Overall Study|lack of compliance|0|||
129875287|NCT02173054|467501872|FG000|Overall Study|Withdrawal by Subject|0|||
129875288|NCT02173054|467501873|FG001|Overall Study|Withdrawal by Subject|0|||
129875289|NCT02173054|467501874|FG002|Overall Study|Withdrawal by Subject|1|||
129875290|NCT00991341|467501881|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
129875291|NCT00991341|467501882|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
129875292|NCT00991341|467501881|FG000|Overall Study|Death|3|||
129875293|NCT00991341|467501882|FG001|Overall Study|Death|0|||
129875294|NCT00991341|467501881|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
129875295|NCT00991341|467501882|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
129875296|NCT00991341|467501881|FG000|Overall Study|Physician Decision|1|||
129875297|NCT00991341|467501882|FG001|Overall Study|Physician Decision|2|||
129875298|NCT00991341|467501881|FG000|Overall Study|Withdrawal by Subject|3|||
129985703|NCT04811131|467909335|FG002|Overall Study|Lack of Efficacy|0|||
129985704|NCT04811131|467909336|FG003|Overall Study|Lack of Efficacy|1|||
129985705|NCT04811131|467909333|FG000|Overall Study|Lost to Follow-up|0|||
129985706|NCT04811131|467909334|FG001|Overall Study|Lost to Follow-up|1|||
129985707|NCT04811131|467909335|FG002|Overall Study|Lost to Follow-up|0|||
129985708|NCT04811131|467909336|FG003|Overall Study|Lost to Follow-up|0|||
129985709|NCT04811131|467909333|FG000|Overall Study|Sponsor request|31|||
129985710|NCT04811131|467909334|FG001|Overall Study|Sponsor request|35|||
129985711|NCT04811131|467909335|FG002|Overall Study|Sponsor request|27|||
130210596|NCT04015518|468730815|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
130210597|NCT04015518|468730816|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
130210598|NCT04015518|468730817|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
130210599|NCT04015518|468730818|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
130210600|NCT04015518|468730819|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
130210601|NCT04015518|468730815|FG000|Overall Study|Pregnancy|0|||
130210602|NCT04015518|468730816|FG001|Overall Study|Pregnancy|0|||
130210603|NCT04015518|468730817|FG002|Overall Study|Pregnancy|0|||
130210604|NCT04015518|468730818|FG003|Overall Study|Pregnancy|0|||
130210605|NCT04015518|468730819|FG004|Overall Study|Pregnancy|1|||
130210606|NCT04015518|468730815|FG000|Overall Study|Personal reasons|1|||
130210607|NCT04015518|468730816|FG001|Overall Study|Personal reasons|0|||
130210608|NCT04015518|468730817|FG002|Overall Study|Personal reasons|0|||
130210609|NCT04015518|468730818|FG003|Overall Study|Personal reasons|0|||
130210610|NCT04015518|468730819|FG004|Overall Study|Personal reasons|1|||
130210611|NCT04015518|468730815|FG000|Overall Study|Withdrew consent|1|||
130210612|NCT04015518|468730816|FG001|Overall Study|Withdrew consent|0|||
130210613|NCT04015518|468730817|FG002|Overall Study|Withdrew consent|0|||
130210614|NCT04015518|468730818|FG003|Overall Study|Withdrew consent|0|||
130210615|NCT04015518|468730819|FG004|Overall Study|Withdrew consent|0|||
130210616|NCT04015518|468730815|FG000|Overall Study|Prostate carcinoma|1|||
130210617|NCT04015518|468730816|FG001|Overall Study|Prostate carcinoma|0|||
130210618|NCT04015518|468730817|FG002|Overall Study|Prostate carcinoma|0|||
130210619|NCT04015518|468730818|FG003|Overall Study|Prostate carcinoma|0|||
130210620|NCT04015518|468730819|FG004|Overall Study|Prostate carcinoma|0|||
130210621|NCT04015518|468730815|FG000|Overall Study|Could not keep appointments due to work|1|||
130210622|NCT04015518|468730816|FG001|Overall Study|Could not keep appointments due to work|0|||
130210623|NCT04015518|468730817|FG002|Overall Study|Could not keep appointments due to work|0|||
130210624|NCT04015518|468730818|FG003|Overall Study|Could not keep appointments due to work|0|||
130210625|NCT04015518|468730819|FG004|Overall Study|Could not keep appointments due to work|0|||
130210626|NCT00505661|468730820|FG000|Overall Study|Not Eligible|4|||
130210627|NCT01738191|468730821|FG000|Overall Study|Withdrawal by Subject|4|||
130210628|NCT01738191|468730822|FG001|Overall Study|Withdrawal by Subject|1|||
130210629|NCT02109445|468730825|FG000|Overall Study|Symptomatic deterioration|2|||
130210630|NCT02109445|468730825|FG000|Overall Study|Adverse Event|1|||
130210631|NCT03089853|468732398|FG000|Overall Study|Lost to Follow-up|2|||
130210632|NCT03089853|468732399|FG001|Overall Study|Lost to Follow-up|1|||
130210633|NCT02578940|468732400|FG000|Overall Study|Screening failure|5|||
130210634|NCT02578940|468732400|FG000|Overall Study|Lost to Follow-up|1|||
130210635|NCT04591015|468732403|FG000|Overall Study|Death|6|||
130210636|NCT04591015|468732404|FG001|Overall Study|Death|4|||
130210637|NCT04591015|468732403|FG000|Overall Study|Withdrawal by Subject|6|||
130210638|NCT04591015|468732404|FG001|Overall Study|Withdrawal by Subject|3|||
130210639|NCT04591015|468732403|FG000|Overall Study|Lost to Follow-up|16|||
130210640|NCT04591015|468732404|FG001|Overall Study|Lost to Follow-up|11|||
130210641|NCT02686814|468732405|FG000|Overall Study|Physician Decision|14|||
130210642|NCT02686814|468732405|FG000|Overall Study|Withdrawal by Subject|4|||
130210643|NCT02686814|468732405|FG000|Overall Study|Death|1|||
130210644|NCT00290693|468732406|FG000|Overall Study|Withdrawal by Subject|2|||
130210645|NCT02907619|468732407|FG000|Overall Study|Study terminated by sponsor|18|||
130210646|NCT02907619|468732408|FG001|Overall Study|Study terminated by sponsor|18|||
130210647|NCT02907619|468732409|FG002|Overall Study|Study terminated by sponsor|19|||
130210648|NCT02907619|468732407|FG000|Overall Study|Death|0|||
130210649|NCT02907619|468732408|FG001|Overall Study|Death|0|||
130210650|NCT02907619|468732409|FG002|Overall Study|Death|1|||
130210651|NCT02907619|468732407|FG000|Overall Study|Withdrawal by Subject|1|||
130210652|NCT02907619|468732408|FG001|Overall Study|Withdrawal by Subject|1|||
130210653|NCT02907619|468732409|FG002|Overall Study|Withdrawal by Subject|0|||
130210654|NCT02907619|468732407|FG000|Overall Study|Other|0|||
130210655|NCT02907619|468732408|FG001|Overall Study|Other|1|||
130210656|NCT02907619|468732409|FG002|Overall Study|Other|0|||
130210657|NCT01908582|468732410|FG000|Period 2|Physician Decision|1|||
130210658|NCT01908582|468732410|FG000|Period 2|Withdrawal by Subject|1|||
130210659|NCT03484403|468732412|FG000|Overall Study|Withdrawal by Subject|6|||
130210660|NCT03484403|468732413|FG001|Overall Study|Withdrawal by Subject|4|||
130210661|NCT02722746|468732427|FG000|Overall Study|Withdrawal by Subject|0|||
130210662|NCT02722746|468732428|FG001|Overall Study|Withdrawal by Subject|1|||
130210663|NCT02722746|468732429|FG002|Overall Study|Withdrawal by Subject|0|||
130210664|NCT02722746|468732427|FG000|Overall Study|Protocol Violation|8|||
130210665|NCT02722746|468732428|FG001|Overall Study|Protocol Violation|4|||
130210666|NCT02722746|468732429|FG002|Overall Study|Protocol Violation|6|||
130210667|NCT01134263|468732430|FG000|Overall Study|Serious adverse event|2|||
130210668|NCT01134263|468732431|FG001|Overall Study|Serious adverse event|1|||
130210669|NCT01134263|468732432|FG002|Overall Study|Serious adverse event|1|||
130210670|NCT01134263|468732433|FG003|Overall Study|Serious adverse event|1|||
130210671|NCT01134263|468732434|FG004|Overall Study|Serious adverse event|1|||
130210672|NCT01134263|468732430|FG000|Overall Study|Other adverse event|1|||
130210673|NCT01134263|468732431|FG001|Overall Study|Other adverse event|2|||
130210674|NCT01134263|468732432|FG002|Overall Study|Other adverse event|5|||
130210675|NCT01134263|468732433|FG003|Overall Study|Other adverse event|3|||
130210676|NCT01134263|468732434|FG004|Overall Study|Other adverse event|0|||
130210677|NCT01134263|468732430|FG000|Overall Study|Protocol Violation|8|||
130210678|NCT01134263|468732431|FG001|Overall Study|Protocol Violation|7|||
130210679|NCT01134263|468732432|FG002|Overall Study|Protocol Violation|2|||
130210680|NCT01134263|468732433|FG003|Overall Study|Protocol Violation|4|||
130210681|NCT01134263|468732434|FG004|Overall Study|Protocol Violation|2|||
130210682|NCT01134263|468732430|FG000|Overall Study|Lost to Follow-up|4|||
130210683|NCT01134263|468732431|FG001|Overall Study|Lost to Follow-up|3|||
130210684|NCT01134263|468732432|FG002|Overall Study|Lost to Follow-up|5|||
130210685|NCT01134263|468732433|FG003|Overall Study|Lost to Follow-up|3|||
130210686|NCT01134263|468732434|FG004|Overall Study|Lost to Follow-up|1|||
130210687|NCT01134263|468732430|FG000|Overall Study|Withdrawal by Subject|8|||
130210688|NCT01134263|468732431|FG001|Overall Study|Withdrawal by Subject|6|||
130210689|NCT01134263|468732432|FG002|Overall Study|Withdrawal by Subject|16|||
130210690|NCT01134263|468732433|FG003|Overall Study|Withdrawal by Subject|7|||
130210691|NCT01134263|468732434|FG004|Overall Study|Withdrawal by Subject|5|||
130210692|NCT01134263|468732430|FG000|Overall Study|Enrolled, but not treated|1|||
130210693|NCT01134263|468732431|FG001|Overall Study|Enrolled, but not treated|1|||
130210694|NCT01134263|468732432|FG002|Overall Study|Enrolled, but not treated|0|||
130210695|NCT01134263|468732433|FG003|Overall Study|Enrolled, but not treated|1|||
130210696|NCT01134263|468732434|FG004|Overall Study|Enrolled, but not treated|0|||
130210697|NCT01955109|468732440|FG000|Overall Study|Adverse Event|2|||
130210698|NCT01955109|468732441|FG001|Overall Study|Adverse Event|0|||
130210699|NCT01955109|468732440|FG000|Overall Study|Participant unwilling to continue|35|||
130210700|NCT01955109|468732441|FG001|Overall Study|Participant unwilling to continue|7|||
130210701|NCT01955109|468732440|FG000|Overall Study|Physician Decision|2|||
130210702|NCT01955109|468732441|FG001|Overall Study|Physician Decision|0|||
130210703|NCT01955109|468732440|FG000|Overall Study|Lost to Follow-up|3|||
130210704|NCT01955109|468732441|FG001|Overall Study|Lost to Follow-up|1|||
130210705|NCT01955109|468732440|FG000|Overall Study|Non-compliance|3|||
130210706|NCT01955109|468732441|FG001|Overall Study|Non-compliance|1|||
130210707|NCT00750919|468732452|FG000|Overall Study|Adverse Event|9|||
130210708|NCT00750919|468732452|FG000|Overall Study|Withdrawal by Subject|1|||
130210709|NCT00750919|468732452|FG000|Overall Study|Lack of Efficacy|8|||
130210710|NCT00750919|468732452|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
130210711|NCT00750919|468732452|FG000|Overall Study|Other|36|||
130210712|NCT02912455|468732458|FG000|Overall Study|Withdrawal by Subject|0|||
130210713|NCT02912455|468732459|FG001|Overall Study|Withdrawal by Subject|1|||
130210714|NCT02912455|468732458|FG000|Overall Study|Lack of Efficacy|0|||
130210715|NCT02912455|468732459|FG001|Overall Study|Lack of Efficacy|1|||
130210716|NCT02912455|468732458|FG000|Overall Study|Lost to Follow-up|2|||
130210717|NCT02912455|468732459|FG001|Overall Study|Lost to Follow-up|1|||
130210718|NCT01810783|468732464|FG000|Overall Study|Adverse Event|32|||
130210719|NCT01810783|468732464|FG000|Overall Study|Withdrawal by Subject|22|||
130210720|NCT01810783|468732464|FG000|Overall Study|Lack of Efficacy|12|||
130210721|NCT01810783|468732464|FG000|Overall Study|Lost to Follow-up|10|||
130210722|NCT01810783|468732464|FG000|Overall Study|Protocol Violation|5|||
130210723|NCT01810783|468732464|FG000|Overall Study|Non-compliance with IMP|4|||
130210724|NCT01810783|468732464|FG000|Overall Study|Adminstrative or other reason(s)|23|||
130210725|NCT01810783|468732464|FG000|Overall Study|Enrolled, not treated|1|||
130210726|NCT02134353|468732465|FG000|Overall Study|Adverse Event|10|||
130210727|NCT02134353|468732466|FG001|Overall Study|Adverse Event|6|||
130210728|NCT02134353|468732465|FG000|Overall Study|Lost to Follow-up|1|||
130210729|NCT02134353|468732466|FG001|Overall Study|Lost to Follow-up|1|||
130210730|NCT02134353|468732465|FG000|Overall Study|Lack of Efficacy|2|||
130210731|NCT02134353|468732466|FG001|Overall Study|Lack of Efficacy|1|||
130210732|NCT02134353|468732465|FG000|Overall Study|Withdrawal by Subject|12|||
130210733|NCT02134353|468732466|FG001|Overall Study|Withdrawal by Subject|13|||
130210734|NCT02134353|468732465|FG000|Overall Study|Death|0|||
130210735|NCT02134353|468732466|FG001|Overall Study|Death|1|||
130320277|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
130320278|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
130320279|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
130210736|NCT02134353|468732465|FG000|Overall Study|Pregnancy|0|||
130210737|NCT02134353|468732466|FG001|Overall Study|Pregnancy|1|||
130320280|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
130320281|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
130210738|NCT02134353|468732465|FG000|Overall Study|Relocation|1|||
130210739|NCT02134353|468732466|FG001|Overall Study|Relocation|0|||
130210740|NCT02134353|468732465|FG000|Overall Study|Other - Patient's Choice|0|||
130210741|NCT02134353|468732466|FG001|Overall Study|Other - Patient's Choice|1|||
130210742|NCT00477607|468732467|FG000|Overall Study|Lost to Follow-up|7|||
130210743|NCT00477607|468732468|FG001|Overall Study|Lost to Follow-up|7|||
130210744|NCT00358956|468732469|FG000|Overall Study|Adverse Event|3|||
130210745|NCT00358956|468732469|FG000|Overall Study|condition under investigation worsened|4|||
130210746|NCT00358956|468732469|FG000|Overall Study|Withdrawal by Subject|1|||
130210747|NCT04776018|468732470|FG000|Overall Study|Death|0|||
130210748|NCT04776018|468732471|FG001|Overall Study|Death|1|||
130210749|NCT04776018|468732472|FG002|Overall Study|Death|4|||
130210750|NCT04776018|468732473|FG003|Overall Study|Death|1|||
130210751|NCT04776018|468732474|FG004|Overall Study|Death|4|||
130210752|NCT04776018|468732475|FG005|Overall Study|Death|0|||
130210753|NCT04776018|468732476|FG006|Overall Study|Death|0|||
130210754|NCT04776018|468732470|FG000|Overall Study|Study terminated by sponsor|2|||
130210755|NCT04776018|468732471|FG001|Overall Study|Study terminated by sponsor|1|||
130210756|NCT04776018|468732472|FG002|Overall Study|Study terminated by sponsor|4|||
130210757|NCT04776018|468732473|FG003|Overall Study|Study terminated by sponsor|0|||
130210758|NCT04776018|468732474|FG004|Overall Study|Study terminated by sponsor|3|||
130210759|NCT04776018|468732475|FG005|Overall Study|Study terminated by sponsor|0|||
130210760|NCT04776018|468732476|FG006|Overall Study|Study terminated by sponsor|0|||
130210761|NCT04776018|468732470|FG000|Overall Study|Withdrawal by Subject|1|||
130210762|NCT04776018|468732471|FG001|Overall Study|Withdrawal by Subject|0|||
130210763|NCT04776018|468732472|FG002|Overall Study|Withdrawal by Subject|0|||
130210764|NCT04776018|468732473|FG003|Overall Study|Withdrawal by Subject|2|||
130210765|NCT04776018|468732474|FG004|Overall Study|Withdrawal by Subject|1|||
130210766|NCT04776018|468732475|FG005|Overall Study|Withdrawal by Subject|0|||
130210767|NCT04776018|468732476|FG006|Overall Study|Withdrawal by Subject|0|||
130210768|NCT04776018|468732470|FG000|Overall Study|Other|0|||
130210769|NCT04776018|468732471|FG001|Overall Study|Other|1|||
130210770|NCT04776018|468732472|FG002|Overall Study|Other|1|||
130210771|NCT04776018|468732473|FG003|Overall Study|Other|0|||
130210772|NCT04776018|468732474|FG004|Overall Study|Other|0|||
130210773|NCT04776018|468732475|FG005|Overall Study|Other|0|||
130210774|NCT04776018|468732476|FG006|Overall Study|Other|0|||
130210775|NCT04776018|468732470|FG000|Overall Study|Lost to Follow-up|0|||
130210776|NCT04776018|468732471|FG001|Overall Study|Lost to Follow-up|0|||
130210777|NCT04776018|468732472|FG002|Overall Study|Lost to Follow-up|1|||
130210778|NCT04776018|468732473|FG003|Overall Study|Lost to Follow-up|0|||
130210779|NCT04776018|468732474|FG004|Overall Study|Lost to Follow-up|0|||
130210780|NCT04776018|468732475|FG005|Overall Study|Lost to Follow-up|0|||
130210781|NCT04776018|468732476|FG006|Overall Study|Lost to Follow-up|0|||
130210782|NCT02908074|468732477|FG000|Overall Study|sponsor/ICON decision|0|||
130210783|NCT02908074|468732478|FG001|Overall Study|sponsor/ICON decision|0|||
130210784|NCT02908074|468732479|FG002|Overall Study|sponsor/ICON decision|1|||
130210785|NCT02908074|468732480|FG003|Overall Study|sponsor/ICON decision|0|||
130210786|NCT02908074|468732481|FG004|Overall Study|sponsor/ICON decision|0|||
130210787|NCT02908074|468732482|FG005|Overall Study|sponsor/ICON decision|0|||
130210788|NCT02908074|468732477|FG000|Overall Study|Protocol Violation|0|||
130210789|NCT02908074|468732478|FG001|Overall Study|Protocol Violation|1|||
130210790|NCT02908074|468732479|FG002|Overall Study|Protocol Violation|0|||
130210791|NCT02908074|468732480|FG003|Overall Study|Protocol Violation|0|||
130210792|NCT02908074|468732481|FG004|Overall Study|Protocol Violation|0|||
130210793|NCT02908074|468732482|FG005|Overall Study|Protocol Violation|0|||
130210794|NCT02908074|468732477|FG000|Overall Study|Adverse Event|5|||
130210795|NCT02908074|468732478|FG001|Overall Study|Adverse Event|2|||
130210796|NCT02908074|468732479|FG002|Overall Study|Adverse Event|0|||
130210797|NCT02908074|468732480|FG003|Overall Study|Adverse Event|0|||
130210798|NCT02908074|468732481|FG004|Overall Study|Adverse Event|1|||
130210799|NCT02908074|468732482|FG005|Overall Study|Adverse Event|0|||
130210800|NCT02908074|468732477|FG000|Overall Study|AESI|1|||
130210801|NCT02908074|468732478|FG001|Overall Study|AESI|0|||
130210802|NCT02908074|468732479|FG002|Overall Study|AESI|1|||
130210803|NCT02908074|468732480|FG003|Overall Study|AESI|0|||
130210804|NCT02908074|468732481|FG004|Overall Study|AESI|1|||
130210805|NCT02908074|468732482|FG005|Overall Study|AESI|0|||
130210806|NCT02908074|468732477|FG000|Overall Study|Discontinuation criteria per protocol|0|||
130210807|NCT02908074|468732478|FG001|Overall Study|Discontinuation criteria per protocol|0|||
130210808|NCT02908074|468732479|FG002|Overall Study|Discontinuation criteria per protocol|1|||
130210809|NCT02908074|468732480|FG003|Overall Study|Discontinuation criteria per protocol|0|||
130210810|NCT02908074|468732481|FG004|Overall Study|Discontinuation criteria per protocol|0|||
130210811|NCT02908074|468732482|FG005|Overall Study|Discontinuation criteria per protocol|1|||
130210812|NCT02908074|468732477|FG000|Overall Study|Withdrawal by Subject|3|||
130210813|NCT02908074|468732478|FG001|Overall Study|Withdrawal by Subject|2|||
130210814|NCT02908074|468732479|FG002|Overall Study|Withdrawal by Subject|2|||
130210815|NCT02908074|468732480|FG003|Overall Study|Withdrawal by Subject|2|||
130210816|NCT02908074|468732481|FG004|Overall Study|Withdrawal by Subject|2|||
130210817|NCT02908074|468732482|FG005|Overall Study|Withdrawal by Subject|2|||
130210818|NCT02908074|468732477|FG000|Overall Study|Lost to Follow-up|0|||
130210819|NCT02908074|468732478|FG001|Overall Study|Lost to Follow-up|1|||
130210820|NCT02908074|468732479|FG002|Overall Study|Lost to Follow-up|1|||
130210821|NCT02908074|468732480|FG003|Overall Study|Lost to Follow-up|1|||
130210822|NCT02908074|468732481|FG004|Overall Study|Lost to Follow-up|0|||
130210823|NCT02908074|468732482|FG005|Overall Study|Lost to Follow-up|1|||
130210824|NCT01900431|468732489|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
130210825|NCT01900431|468732490|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
130210826|NCT01900431|468732491|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
130210827|NCT01900431|468732489|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
130210828|NCT01900431|468732490|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
130210829|NCT01900431|468732491|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
130210830|NCT01900431|468732489|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
130210831|NCT01900431|468732490|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
130210832|NCT01900431|468732491|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
130210833|NCT01900431|468732489|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
130210834|NCT01900431|468732490|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
130210835|NCT01900431|468732491|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
130210836|NCT01900431|468732489|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
130210837|NCT01900431|468732490|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
130210838|NCT01900431|468732491|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
130210839|NCT01900431|468732489|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
130210840|NCT01900431|468732490|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
130210841|NCT01900431|468732491|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
130210842|NCT01900431|468732489|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
130210843|NCT01900431|468732490|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
130210844|NCT01900431|468732491|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
130210845|NCT01900431|468732489|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
130210846|NCT01900431|468732490|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
130210847|NCT01900431|468732491|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
130210848|NCT01900431|468732489|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
130210849|NCT01900431|468732490|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
130210850|NCT01900431|468732491|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
130210851|NCT03755518|468732492|FG000|Overall Study|Lack of Efficacy|10|||
130210852|NCT03755518|468732492|FG000|Overall Study|Adverse Event|7|||
130210853|NCT03755518|468732492|FG000|Overall Study|Study Terminated by Sponsor|5|||
130210854|NCT03755518|468732492|FG000|Overall Study|Death|1|||
130210855|NCT03755518|468732492|FG000|Overall Study|Withdrawal by Subject|3|||
130210856|NCT03755518|468732492|FG000|Overall Study|Progressive Disease|4|||
130210857|NCT03755518|468732492|FG000|Overall Study|Bone Marrow Transplant|4|||
130210858|NCT03755518|468732492|FG000|Overall Study|Physicians Decision|1|||
130210859|NCT03755518|468732492|FG000|Overall Study|Relapse|1|||
130210860|NCT03755518|468732492|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
130210861|NCT03755518|468732492|FG000|Overall Study|Withdrawal by PI|1|||
130210862|NCT03172364|468732493|FG000|Overall Study|Adverse Event|1|||
130210863|NCT03172364|468732494|FG001|Overall Study|Adverse Event|1|||
130210864|NCT03172364|468732493|FG000|Overall Study|Protocol Violation|1|||
130210865|NCT03172364|468732494|FG001|Overall Study|Protocol Violation|0|||
130210866|NCT02732327|468732495|FG000|Overall Study|Protocol Violation|0|||
130210867|NCT02732327|468732496|FG001|Overall Study|Protocol Violation|1|||
130210868|NCT04503668|468732497|FG000|Overall Study|Incomplete data|4|||
130210869|NCT04503668|468732498|FG001|Overall Study|Incomplete data|3|||
130210870|NCT04503668|468732497|FG000|Overall Study|Withdrawal by Subject|1|||
130210871|NCT04503668|468732498|FG001|Overall Study|Withdrawal by Subject|1|||
130210872|NCT04503668|468732497|FG000|Overall Study|Adverse Event|2|||
130210873|NCT04503668|468732498|FG001|Overall Study|Adverse Event|0|||
130210874|NCT00603382|468732499|FG000|Overall Study|Adverse Event|0|||
130210875|NCT00603382|468732500|FG001|Overall Study|Adverse Event|1|||
130210876|NCT00603382|468732501|FG002|Overall Study|Adverse Event|1|||
130210877|NCT00603382|468732502|FG003|Overall Study|Adverse Event|2|||
130210878|NCT00603382|468732503|FG004|Overall Study|Adverse Event|1|||
130210879|NCT00603382|468732504|FG005|Overall Study|Adverse Event|2|||
130210880|NCT00603382|468732499|FG000|Overall Study|Lack of Efficacy|14|||
130210881|NCT00603382|468732500|FG001|Overall Study|Lack of Efficacy|9|||
130210882|NCT00603382|468732501|FG002|Overall Study|Lack of Efficacy|3|||
130210883|NCT00603382|468732502|FG003|Overall Study|Lack of Efficacy|6|||
130210884|NCT00603382|468732503|FG004|Overall Study|Lack of Efficacy|6|||
130210885|NCT00603382|468732504|FG005|Overall Study|Lack of Efficacy|11|||
130210886|NCT00603382|468732499|FG000|Overall Study|Protocol Violation|1|||
130210887|NCT00603382|468732500|FG001|Overall Study|Protocol Violation|0|||
130210888|NCT00603382|468732501|FG002|Overall Study|Protocol Violation|1|||
130210889|NCT00603382|468732502|FG003|Overall Study|Protocol Violation|2|||
130210890|NCT00603382|468732503|FG004|Overall Study|Protocol Violation|1|||
130210891|NCT00603382|468732504|FG005|Overall Study|Protocol Violation|0|||
130210892|NCT00603382|468732499|FG000|Overall Study|Lost to Follow-up|0|||
130210893|NCT00603382|468732500|FG001|Overall Study|Lost to Follow-up|1|||
130210894|NCT00603382|468732501|FG002|Overall Study|Lost to Follow-up|1|||
130210895|NCT00603382|468732502|FG003|Overall Study|Lost to Follow-up|1|||
130210896|NCT00603382|468732503|FG004|Overall Study|Lost to Follow-up|0|||
130210897|NCT00603382|468732504|FG005|Overall Study|Lost to Follow-up|1|||
130210898|NCT00603382|468732499|FG000|Overall Study|Physician Decision|0|||
130210899|NCT00603382|468732500|FG001|Overall Study|Physician Decision|0|||
130210900|NCT00603382|468732501|FG002|Overall Study|Physician Decision|2|||
130210901|NCT00603382|468732502|FG003|Overall Study|Physician Decision|0|||
130210902|NCT00603382|468732503|FG004|Overall Study|Physician Decision|1|||
130210903|NCT00603382|468732504|FG005|Overall Study|Physician Decision|3|||
130210904|NCT00603382|468732499|FG000|Overall Study|Withdrawal by Subject|3|||
130210905|NCT00603382|468732500|FG001|Overall Study|Withdrawal by Subject|3|||
130210906|NCT00603382|468732501|FG002|Overall Study|Withdrawal by Subject|1|||
130210907|NCT00603382|468732502|FG003|Overall Study|Withdrawal by Subject|1|||
130210908|NCT00603382|468732503|FG004|Overall Study|Withdrawal by Subject|0|||
130210909|NCT00603382|468732504|FG005|Overall Study|Withdrawal by Subject|1|||
130210910|NCT03403621|468732505|FG000|Overall Study|Withdrawal by Subject|2|||
130210911|NCT03403621|468732506|FG001|Overall Study|Withdrawal by Subject|2|||
130210912|NCT00583102|468732507|FG000|Overall Study|Adverse Event|3|||
130210913|NCT03611582|468732510|FG000|Overall Study|Adverse Event|26|||
130210914|NCT03611582|468732511|FG001|Overall Study|Adverse Event|6|||
130210915|NCT03611582|468732510|FG000|Overall Study|Protocol Violation|0|||
130210916|NCT03611582|468732511|FG001|Overall Study|Protocol Violation|1|||
130210917|NCT03611582|468732510|FG000|Overall Study|Pregnancy|1|||
130210918|NCT03611582|468732511|FG001|Overall Study|Pregnancy|2|||
130210919|NCT03611582|468732510|FG000|Overall Study|Lack of Efficacy|0|||
130210920|NCT03611582|468732511|FG001|Overall Study|Lack of Efficacy|1|||
130210921|NCT03611582|468732510|FG000|Overall Study|At the discretion of the investigator|1|||
130210922|NCT03611582|468732511|FG001|Overall Study|At the discretion of the investigator|0|||
130210923|NCT03611582|468732510|FG000|Overall Study|Safety concern as judged by the investigator|1|||
130210924|NCT03611582|468732511|FG001|Overall Study|Safety concern as judged by the investigator|2|||
130210925|NCT03611582|468732510|FG000|Overall Study|Withdrawal by Subject|4|||
130210926|NCT03611582|468732511|FG001|Overall Study|Withdrawal by Subject|3|||
130210927|NCT03611582|468732510|FG000|Overall Study|Lost to Follow-up|18|||
130210928|NCT03611582|468732511|FG001|Overall Study|Lost to Follow-up|7|||
130210929|NCT03611582|468732510|FG000|Overall Study|other|17|||
130210930|NCT03611582|468732511|FG001|Overall Study|other|16|||
130210931|NCT01783821|468732512|FG000|Overall Study|Screen Failure|1|||
130210932|NCT01783821|468732513|FG001|Overall Study|Screen Failure|1|||
130210933|NCT02333383|468732516|FG000|Overall Study|Adalimumab discontinuation|21|||
130210934|NCT02333383|468732516|FG000|Overall Study|Lost to Follow-up|15|||
130210935|NCT02333383|468732516|FG000|Overall Study|Withdrawal by Subject|3|||
130210936|NCT02333383|468732516|FG000|Overall Study|Transfer to another hospital|2|||
130210937|NCT04459598|468732517|FG000|Overall Study|Adverse Event|1|||
130210938|NCT04459598|468732518|FG001|Overall Study|Adverse Event|1|||
130210939|NCT01907217|468732519|FG000|Overall Study|Withdrawal by Subject|0|||
130210940|NCT01907217|468732520|FG001|Overall Study|Withdrawal by Subject|2|||
130210941|NCT01078298|468732521|FG000|Overall Study|Lost to Follow-up|12|||
130210942|NCT01078298|468732522|FG001|Overall Study|Lost to Follow-up|13|||
130210943|NCT01078298|468732521|FG000|Overall Study|Withdrawal by Subject|31|||
130210944|NCT01078298|468732522|FG001|Overall Study|Withdrawal by Subject|33|||
130210945|NCT01078298|468732521|FG000|Overall Study|Protocol Violation|6|||
130210946|NCT01078298|468732522|FG001|Overall Study|Protocol Violation|6|||
130210947|NCT01078298|468732521|FG000|Overall Study|Adverse Event|6|||
130210948|NCT01078298|468732522|FG001|Overall Study|Adverse Event|5|||
130210949|NCT01078298|468732521|FG000|Overall Study|Death|2|||
130210950|NCT01078298|468732522|FG001|Overall Study|Death|0|||
130210951|NCT01078298|468732521|FG000|Overall Study|Did not meet entrance criteria|0|||
130210952|NCT01078298|468732522|FG001|Overall Study|Did not meet entrance criteria|1|||
130210953|NCT01078298|468732521|FG000|Overall Study|Other|24|||
130210954|NCT01078298|468732522|FG001|Overall Study|Other|32|||
130210955|NCT00866333|468732524|FG000|Overall Study|Withdrawal of consent|0|||
130210956|NCT00866333|468732525|FG001|Overall Study|Withdrawal of consent|1|||
130210957|NCT00866333|468732526|FG002|Overall Study|Withdrawal of consent|2|||
130210958|NCT00866333|468732524|FG000|Overall Study|Reason not Specified|3|||
130210959|NCT00866333|468732525|FG001|Overall Study|Reason not Specified|1|||
130210960|NCT00866333|468732526|FG002|Overall Study|Reason not Specified|1|||
130210961|NCT00866333|468732524|FG000|Overall Study|Study Terminated by Sponsor|2|||
130210962|NCT00866333|468732525|FG001|Overall Study|Study Terminated by Sponsor|5|||
130210963|NCT00866333|468732526|FG002|Overall Study|Study Terminated by Sponsor|9|||
130210964|NCT00350779|468732528|FG000|Overall Study|Adverse Event|4|||
130210965|NCT00350779|468732529|FG001|Overall Study|Adverse Event|2|||
130210966|NCT00350779|468732528|FG000|Overall Study|Lack of Efficacy|0|||
130210967|NCT00350779|468732529|FG001|Overall Study|Lack of Efficacy|4|||
130210968|NCT00350779|468732528|FG000|Overall Study|Lost to Follow-up|2|||
130210969|NCT00350779|468732529|FG001|Overall Study|Lost to Follow-up|0|||
130210970|NCT00350779|468732528|FG000|Overall Study|Physician Decision|2|||
130210971|NCT00350779|468732529|FG001|Overall Study|Physician Decision|4|||
130210972|NCT00350779|468732528|FG000|Overall Study|Protocol Violation|3|||
130210973|NCT00350779|468732529|FG001|Overall Study|Protocol Violation|1|||
130210974|NCT00350779|468732528|FG000|Overall Study|Withdrawal by Subject|9|||
130210975|NCT00350779|468732529|FG001|Overall Study|Withdrawal by Subject|8|||
130210976|NCT00350779|468732528|FG000|Overall Study|Patient Moved|2|||
130210977|NCT00350779|468732529|FG001|Overall Study|Patient Moved|1|||
129875299|NCT00991341|467501882|FG001|Overall Study|Withdrawal by Subject|4|||
129875300|NCT01330316|467501901|FG000|Overall Study|Adverse Event|2|||
129875301|NCT01330316|467501902|FG001|Overall Study|Adverse Event|2|||
129875302|NCT01330316|467501901|FG000|Overall Study|Lack of Efficacy|0|||
129875303|NCT01330316|467501902|FG001|Overall Study|Lack of Efficacy|10|||
129875304|NCT01330316|467501901|FG000|Overall Study|Lost to Follow-up|0|||
129875305|NCT01330316|467501902|FG001|Overall Study|Lost to Follow-up|1|||
129875306|NCT01330316|467501901|FG000|Overall Study|Withdrawal by Subject|0|||
129875307|NCT01330316|467501902|FG001|Overall Study|Withdrawal by Subject|1|||
129875308|NCT01330316|467501901|FG000|Overall Study|other than above|0|||
129875309|NCT01330316|467501902|FG001|Overall Study|other than above|1|||
129875310|NCT00215540|467501903|FG000|Overall Study|Withdrew from study medication|1|||
129875311|NCT00215540|467501904|FG001|Overall Study|Withdrew from study medication|0|||
129875312|NCT00215540|467501905|FG002|Overall Study|Withdrew from study medication|0|||
129875313|NCT03010462|467501906|FG000|Overall Study|Withdrawal by Subject|3|||
129875314|NCT03010462|467501907|FG001|Overall Study|Withdrawal by Subject|1|||
129875315|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
129875316|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
129875317|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
129875318|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
129875319|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
129875320|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
129875321|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
129875322|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
129875323|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
129875324|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
129875325|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
129875326|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
129875327|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
129875328|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
129875329|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
129875330|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
129875331|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129875332|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129875333|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129875334|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
129875335|NCT03145766|467501908|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
129875336|NCT03145766|467501909|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129875337|NCT03145766|467501910|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129875338|NCT03145766|467501911|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
129875339|NCT03145766|467501912|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129875340|NCT03145766|467501908|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
129875341|NCT03145766|467501909|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
129875342|NCT03145766|467501910|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
129875343|NCT03145766|467501911|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
129875344|NCT03145766|467501912|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
129875345|NCT03145766|467501908|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129875346|NCT03145766|467501909|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129875347|NCT03145766|467501910|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129875348|NCT03145766|467501911|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
129875349|NCT03145766|467501912|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
129875350|NCT02799472|467501916|FG000|Overall Study|Withdrawal by Subject|2|||
129875351|NCT02799472|467501917|FG001|Overall Study|Withdrawal by Subject|4|||
129875352|NCT02799472|467501916|FG000|Overall Study|Lack of Efficacy|2|||
129875353|NCT02799472|467501917|FG001|Overall Study|Lack of Efficacy|0|||
129875354|NCT02799472|467501916|FG000|Overall Study|Lost to Follow-up|0|||
129875355|NCT02799472|467501917|FG001|Overall Study|Lost to Follow-up|1|||
129875356|NCT02801669|467501918|FG000|Overall Study|Death|66|||
129875357|NCT02801669|467501919|FG001|Overall Study|Death|69|||
129875358|NCT02801669|467501918|FG000|Overall Study|Withdrawal by Subject|81|||
129875359|NCT02801669|467501919|FG001|Overall Study|Withdrawal by Subject|77|||
129875360|NCT02801669|467501918|FG000|Overall Study|Other|4|||
129875361|NCT02801669|467501919|FG001|Overall Study|Other|6|||
129875362|NCT01782872|467501923|FG000|Overall Study|Protocol Violation|0|||
129875363|NCT01782872|467501924|FG001|Overall Study|Protocol Violation|0|||
129875364|NCT01782872|467501925|FG002|Overall Study|Protocol Violation|0|||
129875365|NCT01782872|467501926|FG003|Overall Study|Protocol Violation|1|||
129875366|NCT01782872|467501923|FG000|Overall Study|Withdrawal by Subject|0|||
130210978|NCT00350779|468732528|FG000|Overall Study|Non-compliance with study procedures|0|||
130210979|NCT00350779|468732529|FG001|Overall Study|Non-compliance with study procedures|1|||
130210980|NCT02012959|468732530|FG000|Treatment Phase A|Adverse Event|2|||
130210981|NCT02012959|468732531|FG001|Treatment Phase A|Adverse Event|0|||
130210982|NCT02012959|468732532|FG002|Treatment Phase A|Adverse Event|0|||
130210983|NCT02012959|468732533|FG003|Treatment Phase A|Adverse Event|0|||
130210984|NCT02012959|468732534|FG004|Treatment Phase A|Adverse Event|0|||
130210985|NCT00642954|468733568|FG000|Overall Study|Progressive Disease|3|||
130210986|NCT00642954|468733569|FG001|Overall Study|Progressive Disease|3|||
130210987|NCT00642954|468733570|FG002|Overall Study|Progressive Disease|3|||
130210988|NCT00642954|468733571|FG003|Overall Study|Progressive Disease|3|||
130210989|NCT00642954|468733572|FG004|Overall Study|Progressive Disease|9|||
130210990|NCT00642954|468733568|FG000|Overall Study|Withdrawal by Subject|0|||
130210991|NCT00642954|468733569|FG001|Overall Study|Withdrawal by Subject|0|||
130210992|NCT00642954|468733570|FG002|Overall Study|Withdrawal by Subject|0|||
130210993|NCT00642954|468733571|FG003|Overall Study|Withdrawal by Subject|0|||
130210994|NCT00642954|468733572|FG004|Overall Study|Withdrawal by Subject|1|||
130210995|NCT00642954|468733568|FG000|Overall Study|Adverse Event|1|||
130210996|NCT00642954|468733569|FG001|Overall Study|Adverse Event|1|||
130210997|NCT00642954|468733570|FG002|Overall Study|Adverse Event|0|||
130210998|NCT00642954|468733571|FG003|Overall Study|Adverse Event|0|||
130210999|NCT00642954|468733572|FG004|Overall Study|Adverse Event|6|||
130211000|NCT00441363|468733573|FG000|Overall Study|Adverse Event|4|||
130211001|NCT00441363|468733574|FG001|Overall Study|Adverse Event|2|||
130211002|NCT00441363|468733573|FG000|Overall Study|Withdrawal by Subject|3|||
130211003|NCT00441363|468733574|FG001|Overall Study|Withdrawal by Subject|4|||
130211004|NCT00441363|468733573|FG000|Overall Study|Physician Decision|6|||
130211005|NCT00441363|468733574|FG001|Overall Study|Physician Decision|7|||
130211006|NCT00441363|468733573|FG000|Overall Study|Lost to Follow-up|2|||
130211007|NCT00441363|468733574|FG001|Overall Study|Lost to Follow-up|2|||
130211008|NCT00441363|468733573|FG000|Overall Study|Other|2|||
130211009|NCT00441363|468733574|FG001|Overall Study|Other|0|||
130211010|NCT01663857|468733577|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
130211011|NCT01663857|468733578|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
130211012|NCT01663857|468733579|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
130211013|NCT01663857|468733580|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
130211014|NCT01663857|468733577|FG000|Overall Study|Lost to Follow-up|0|||
130211015|NCT01663857|468733578|FG001|Overall Study|Lost to Follow-up|0|||
130211016|NCT01663857|468733579|FG002|Overall Study|Lost to Follow-up|3|||
130211017|NCT01663857|468733580|FG003|Overall Study|Lost to Follow-up|1|||
130211018|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
130211019|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
130211020|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
130211021|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
130211022|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
130211023|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
130211024|NCT04114656|468733581|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
130211025|NCT04114656|468733582|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
130211026|NCT04114656|468733581|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
130211027|NCT04114656|468733582|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
130211028|NCT03052920|468733583|FG000|Overall Study|Withdrawal by Subject|1|||
130211029|NCT03326518|468733589|FG000|Overall Study|Protocol Violation|1|||
130211030|NCT03326518|468733590|FG001|Overall Study|Protocol Violation|0|||
130211031|NCT03326518|468733591|FG002|Overall Study|Protocol Violation|0|||
130211032|NCT03326518|468733589|FG000|Overall Study|Withdrawal by Subject|1|||
130211033|NCT03326518|468733590|FG001|Overall Study|Withdrawal by Subject|0|||
130211034|NCT03326518|468733591|FG002|Overall Study|Withdrawal by Subject|0|||
130211035|NCT03326518|468733589|FG000|Overall Study|Lost to Follow-up|1|||
130211036|NCT03326518|468733590|FG001|Overall Study|Lost to Follow-up|0|||
130211037|NCT03326518|468733591|FG002|Overall Study|Lost to Follow-up|1|||
130211038|NCT01375374|468733594|FG000|Overall Study|Adverse Event|1|||
130211039|NCT02065518|468733595|FG000|Overall Study|Lost to Follow-up|3|||
130211040|NCT02065518|468733596|FG001|Overall Study|Lost to Follow-up|4|||
130211041|NCT02065518|468733597|FG002|Overall Study|Lost to Follow-up|0|||
130211042|NCT02065518|468733598|FG003|Overall Study|Lost to Follow-up|3|||
130211043|NCT02065518|468733595|FG000|Overall Study|Withdrawal by Subject|3|||
130211044|NCT02065518|468733596|FG001|Overall Study|Withdrawal by Subject|4|||
130211045|NCT02065518|468733597|FG002|Overall Study|Withdrawal by Subject|9|||
130211046|NCT02065518|468733598|FG003|Overall Study|Withdrawal by Subject|2|||
130211047|NCT04849416|468733599|FG000|Overall Study|Ongoing Treatment|12|||
130211048|NCT04849416|468733600|FG001|Overall Study|Ongoing Treatment|5|||
130211049|NCT04849416|468733601|FG002|Overall Study|Ongoing Treatment|3|||
130211050|NCT04849416|468733599|FG000|Overall Study|On Post-Treatment Follow-up|8|||
130211051|NCT04849416|468733600|FG001|Overall Study|On Post-Treatment Follow-up|9|||
130211052|NCT04849416|468733601|FG002|Overall Study|On Post-Treatment Follow-up|10|||
130211053|NCT04849416|468733599|FG000|Overall Study|Withdrawal by Subject|0|||
130211054|NCT04849416|468733600|FG001|Overall Study|Withdrawal by Subject|0|||
130211055|NCT04849416|468733601|FG002|Overall Study|Withdrawal by Subject|1|||
130211056|NCT04849416|468733599|FG000|Overall Study|Lost to Follow-up|1|||
130211057|NCT04849416|468733600|FG001|Overall Study|Lost to Follow-up|0|||
130211058|NCT04849416|468733601|FG002|Overall Study|Lost to Follow-up|0|||
130211059|NCT01038752|468733611|FG000|Overall Study|Tumor Progression|2|||
130211060|NCT01038752|468733612|FG001|Overall Study|Tumor Progression|2|||
130211061|NCT01038752|468733611|FG000|Overall Study|Lost to Follow-up|3|||
130211062|NCT01038752|468733612|FG001|Overall Study|Lost to Follow-up|3|||
130211063|NCT04165135|468733613|FG000|Overall Study|Protocol Violation|10|||
130211064|NCT04165135|468733613|FG000|Overall Study|Participants withdrawal of consent|5|||
130211065|NCT01618916|468733614|FG000|Overall Study|Adverse Event|1|||
130211066|NCT01618916|468733615|FG001|Overall Study|Adverse Event|0|||
130211067|NCT01618916|468733616|FG002|Overall Study|Adverse Event|0|||
130211068|NCT01618916|468733617|FG003|Overall Study|Adverse Event|0|||
130211069|NCT01618916|468733618|FG004|Overall Study|Adverse Event|0|||
130211070|NCT01618916|468733619|FG005|Overall Study|Adverse Event|0|||
130211071|NCT01618916|468733614|FG000|Overall Study|Withdrawal by Subject|0|||
130211072|NCT01618916|468733615|FG001|Overall Study|Withdrawal by Subject|1|||
130211073|NCT01618916|468733616|FG002|Overall Study|Withdrawal by Subject|1|||
130211074|NCT01618916|468733617|FG003|Overall Study|Withdrawal by Subject|0|||
130211075|NCT01618916|468733618|FG004|Overall Study|Withdrawal by Subject|1|||
130211076|NCT01618916|468733619|FG005|Overall Study|Withdrawal by Subject|0|||
130211077|NCT01618916|468733614|FG000|Overall Study|Lost to Follow-up|1|||
130211078|NCT01618916|468733615|FG001|Overall Study|Lost to Follow-up|0|||
130211079|NCT01618916|468733616|FG002|Overall Study|Lost to Follow-up|0|||
130211080|NCT01618916|468733617|FG003|Overall Study|Lost to Follow-up|2|||
130211081|NCT01618916|468733618|FG004|Overall Study|Lost to Follow-up|0|||
130211082|NCT01618916|468733619|FG005|Overall Study|Lost to Follow-up|0|||
130211083|NCT04521114|468733620|FG000|Overall Study|Lost to Follow-up|1|||
130211084|NCT04521114|468733621|FG001|Overall Study|Lost to Follow-up|2|||
130211085|NCT04521114|468733622|FG002|Overall Study|Lost to Follow-up|0|||
130211086|NCT04521114|468733620|FG000|Overall Study|Withdrawal by Subject|1|||
130211087|NCT04521114|468733621|FG001|Overall Study|Withdrawal by Subject|2|||
130211088|NCT04521114|468733622|FG002|Overall Study|Withdrawal by Subject|2|||
130211089|NCT04521114|468733620|FG000|Overall Study|Adverse Event|1|||
130211090|NCT04521114|468733621|FG001|Overall Study|Adverse Event|0|||
130211091|NCT04521114|468733622|FG002|Overall Study|Adverse Event|0|||
130211092|NCT04521114|468733620|FG000|Overall Study|Sponsor Wish|1|||
130211093|NCT04521114|468733621|FG001|Overall Study|Sponsor Wish|0|||
130211094|NCT04521114|468733622|FG002|Overall Study|Sponsor Wish|0|||
130211095|NCT04521114|468733620|FG000|Overall Study|Withdrawal of Consent|2|||
130211096|NCT04521114|468733621|FG001|Overall Study|Withdrawal of Consent|2|||
130211097|NCT04521114|468733622|FG002|Overall Study|Withdrawal of Consent|0|||
130211098|NCT01084538|468733630|FG000|Overall Study|Drug not available|30|||
130211099|NCT01084538|468733630|FG000|Overall Study|Adverse Event|9|||
130211100|NCT01084538|468733630|FG000|Overall Study|Kidney transplant|6|||
130211101|NCT01084538|468733630|FG000|Overall Study|Serious Adverse Event|3|||
130211102|NCT01084538|468733630|FG000|Overall Study|Lack of effectiveness|2|||
130211103|NCT01084538|468733630|FG000|Overall Study|Patient noncompliance|2|||
130211104|NCT01084538|468733630|FG000|Overall Study|Hyperphosphatemia|2|||
130211105|NCT01084538|468733630|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
130211106|NCT01084538|468733630|FG000|Overall Study|Change of residence|2|||
130211107|NCT01084538|468733630|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
130211108|NCT01084538|468733630|FG000|Overall Study|Reason unknown|8|||
130211109|NCT01625689|468733635|FG000|Overall Study|Migration|2|||
130211110|NCT01625689|468733636|FG001|Overall Study|Migration|1|||
130211111|NCT00106639|468733637|FG000|Overall Study|Adverse Event|3|||
130211112|NCT00106639|468733638|FG001|Overall Study|Adverse Event|4|||
130211113|NCT00106639|468733639|FG002|Overall Study|Adverse Event|1|||
130211114|NCT00106639|468733637|FG000|Overall Study|Protocol Violation|0|||
130211115|NCT00106639|468733638|FG001|Overall Study|Protocol Violation|1|||
130211116|NCT00106639|468733639|FG002|Overall Study|Protocol Violation|0|||
130211117|NCT00106639|468733637|FG000|Overall Study|Withdrawal by Subject|0|||
130211118|NCT00106639|468733638|FG001|Overall Study|Withdrawal by Subject|1|||
130211119|NCT00106639|468733639|FG002|Overall Study|Withdrawal by Subject|0|||
130211120|NCT00106639|468733637|FG000|Overall Study|Participant defaulted|0|||
130211121|NCT00106639|468733638|FG001|Overall Study|Participant defaulted|1|||
130211122|NCT00106639|468733639|FG002|Overall Study|Participant defaulted|1|||
130211123|NCT01210144|468733643|FG000|Overall Study|Lack of ovarian response|1|||
130211124|NCT01210144|468733644|FG001|Overall Study|Lack of ovarian response|0|||
130211125|NCT01210144|468733643|FG000|Overall Study|No fertilization|1|||
130211126|NCT01210144|468733644|FG001|Overall Study|No fertilization|0|||
130211127|NCT01210144|468733643|FG000|Overall Study|No transfer|1|||
130211128|NCT01210144|468733644|FG001|Overall Study|No transfer|0|||
130211129|NCT00494221|468733645|FG000|Overall Study|Death|15|||
130211130|NCT00494221|468733646|FG001|Overall Study|Death|9|||
130211131|NCT00494221|468733647|FG002|Overall Study|Death|14|||
130211132|NCT00494221|468733645|FG000|Overall Study|Withdrawal by Subject|1|||
130211133|NCT00494221|468733646|FG001|Overall Study|Withdrawal by Subject|2|||
130211134|NCT00494221|468733647|FG002|Overall Study|Withdrawal by Subject|0|||
130211135|NCT01714609|468733652|FG000|Overall Study|Protocol Violation|1|||
130211136|NCT01714609|468733653|FG001|Overall Study|Protocol Violation|0|||
130211137|NCT00630747|468733654|FG000|Overall Study|Death|1|||
130211138|NCT00630747|468733654|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
130211139|NCT00630747|468733654|FG000|Overall Study|Returned to country of origin|1|||
130211140|NCT02306694|468733657|FG000|Overall Study|Withdrawal by Subject|3|||
130211141|NCT02306694|468733657|FG000|Overall Study|Lost to Follow-up|1|||
130211142|NCT03782974|468733658|FG000|Overall Study|Withdrawal by Subject|7|||
130211143|NCT03782974|468733659|FG001|Overall Study|Withdrawal by Subject|7|||
130211144|NCT03782974|468733658|FG000|Overall Study|Pregnancy|1|||
130211145|NCT03782974|468733659|FG001|Overall Study|Pregnancy|0|||
130211146|NCT00395642|468733660|FG000|Overall Study|Death|4|||
130211147|NCT00395642|468733660|FG000|Overall Study|Lost to Follow-up|1|||
130211148|NCT00395642|468733660|FG000|Overall Study|Physician Decision|7|||
130211149|NCT00395642|468733660|FG000|Overall Study|Withdrawal by Subject|1|||
130211150|NCT00659776|468733670|FG000|Overall Study|Withdrawal by Subject|12|||
130211151|NCT00659776|468733671|FG001|Overall Study|Withdrawal by Subject|2|||
130211152|NCT00659776|468733672|FG002|Overall Study|Withdrawal by Subject|0|||
130211153|NCT01180049|468733673|FG000|Overall Study|Other|9|||
130211154|NCT01180049|468733674|FG001|Overall Study|Other|7|||
130211155|NCT01180049|468733673|FG000|Overall Study|Lost to Follow-up|8|||
130211156|NCT01180049|468733674|FG001|Overall Study|Lost to Follow-up|6|||
130211157|NCT01180049|468733673|FG000|Overall Study|Death|36|||
130211158|NCT01180049|468733674|FG001|Overall Study|Death|35|||
130211159|NCT01905592|468733677|FG000|Overall Study|Disease Progression|51|||
130211160|NCT01905592|468733678|FG001|Overall Study|Disease Progression|110|||
130211161|NCT01905592|468733677|FG000|Overall Study|Toxicity|1|||
130211162|NCT01905592|468733678|FG001|Overall Study|Toxicity|16|||
130211163|NCT01905592|468733677|FG000|Overall Study|Physician Decision|0|||
130211164|NCT01905592|468733678|FG001|Overall Study|Physician Decision|2|||
130211165|NCT01905592|468733677|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
130211166|NCT01905592|468733678|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
130211167|NCT01905592|468733677|FG000|Overall Study|Protocol Violation|0|||
130211168|NCT01905592|468733678|FG001|Overall Study|Protocol Violation|1|||
130211169|NCT01905592|468733677|FG000|Overall Study|Sponsor's decision|1|||
130211170|NCT01905592|468733678|FG001|Overall Study|Sponsor's decision|1|||
130211171|NCT01905592|468733677|FG000|Overall Study|Not treated|7|||
130211172|NCT01905592|468733678|FG001|Overall Study|Not treated|3|||
129875367|NCT01782872|467501924|FG001|Overall Study|Withdrawal by Subject|1|||
130211173|NCT01905592|468733677|FG000|Overall Study|Withdrawal by Subject|10|||
130211174|NCT01905592|468733678|FG001|Overall Study|Withdrawal by Subject|2|||
130211175|NCT03015194|468735477|FG000|Overall Study|Death|10|||
130211176|NCT03015194|468735477|FG000|Overall Study|Withdrawal by Subject|2|||
130211177|NCT00433017|468735479|FG000|Overall Study|Adverse Event|5|||
130211178|NCT00433017|468735480|FG001|Overall Study|Adverse Event|3|||
130211179|NCT00433017|468735479|FG000|Overall Study|Withdrawal by Subject|4|||
130211180|NCT00433017|468735480|FG001|Overall Study|Withdrawal by Subject|5|||
130211181|NCT00433017|468735479|FG000|Overall Study|Lost to Follow-up|3|||
130211182|NCT00433017|468735480|FG001|Overall Study|Lost to Follow-up|4|||
130211183|NCT00433017|468735479|FG000|Overall Study|Administrative problems|80|||
129985712|NCT04811131|467909336|FG003|Overall Study|Sponsor request|10|||
130098648|NCT03586427|468319263|FG000|Overall Study|Protocol Violation|0|||
129875368|NCT01782872|467501925|FG002|Overall Study|Withdrawal by Subject|0|||
129875369|NCT01782872|467501926|FG003|Overall Study|Withdrawal by Subject|0|||
130211184|NCT00433017|468735480|FG001|Overall Study|Administrative problems|86|||
130211185|NCT00433017|468735479|FG000|Overall Study|Protocol Violation|1|||
129875370|NCT03299686|467501937|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
129875371|NCT03299686|467501938|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
129875372|NCT03299686|467501937|FG000|Treatment Epoch|Physician Decision|1|||
129875373|NCT03299686|467501938|FG001|Treatment Epoch|Physician Decision|0|||
129875374|NCT03299686|467501937|FG000|Treatment Epoch|Adverse Event|8|||
129875375|NCT03299686|467501938|FG001|Treatment Epoch|Adverse Event|4|||
129875376|NCT03299686|467501937|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
130211186|NCT00433017|468735480|FG001|Overall Study|Protocol Violation|0|||
130211187|NCT00433017|468735479|FG000|Overall Study|Death|2|||
130211188|NCT00433017|468735480|FG001|Overall Study|Death|2|||
130211189|NCT00433017|468735479|FG000|Overall Study|Subject no longer requires study drug|1|||
130211190|NCT00433017|468735480|FG001|Overall Study|Subject no longer requires study drug|1|||
130211191|NCT01108237|468735483|FG000|Overall Study|No alignment data|2|||
130211192|NCT01108237|468735484|FG001|Overall Study|No alignment data|15|||
130211193|NCT01108237|468735483|FG000|Overall Study|Did not meet criteria for analysis|7|||
130211194|NCT01108237|468735484|FG001|Overall Study|Did not meet criteria for analysis|0|||
130211195|NCT00564278|468735486|FG000|Overall Study|Lost to Follow-up|35|||
130211196|NCT00564278|468735487|FG001|Overall Study|Lost to Follow-up|33|||
130211197|NCT00564278|468735486|FG000|Overall Study|Physician Decision|1|||
130211198|NCT00564278|468735487|FG001|Overall Study|Physician Decision|2|||
130211199|NCT00564278|468735486|FG000|Overall Study|Withdrawal by Subject|11|||
130211200|NCT00564278|468735487|FG001|Overall Study|Withdrawal by Subject|7|||
130211201|NCT06439095|468735488|FG000|Overall Study|Lost to Follow-up|2|||
130211202|NCT03341936|468735489|FG000|Overall Study|Ineligible|1|||
130211203|NCT03341936|468735489|FG000|Overall Study|Disease Progression|2|||
130211204|NCT03341936|468735489|FG000|Overall Study|Withdrew Consent|4|||
130211205|NCT03341936|468735489|FG000|Overall Study|Non-Compliance|1|||
130211206|NCT03341936|468735489|FG000|Overall Study|Physician Decision|1|||
130211207|NCT03341936|468735489|FG000|Overall Study|Withdrawal by Subject|1|||
130211208|NCT03341936|468735489|FG000|Overall Study|Other|1|||
130211209|NCT02368886|468735490|FG000|Overall Study|Cancel|1|||
130211210|NCT02368886|468735491|FG001|Overall Study|Cancel|1|||
130211211|NCT02368886|468735492|FG002|Overall Study|Cancel|1|||
130211212|NCT02368886|468735493|FG003|Overall Study|Cancel|3|||
130211213|NCT02368886|468735490|FG000|Overall Study|Ineligible|0|||
130211214|NCT02368886|468735491|FG001|Overall Study|Ineligible|0|||
130211215|NCT02368886|468735492|FG002|Overall Study|Ineligible|0|||
130211216|NCT02368886|468735493|FG003|Overall Study|Ineligible|1|||
130211217|NCT02131636|468735498|FG000|Overall Study|Personal Reasons|4|||
130211218|NCT02131636|468735499|FG001|Overall Study|Personal Reasons|4|||
130211219|NCT02131636|468735498|FG000|Overall Study|Lost to Follow-up|4|||
130211220|NCT02131636|468735499|FG001|Overall Study|Lost to Follow-up|0|||
130211221|NCT02131636|468735498|FG000|Overall Study|Adverse Event|4|||
130211222|NCT02131636|468735499|FG001|Overall Study|Adverse Event|1|||
130211223|NCT02173379|468735500|FG000|Overall Study|Lost to Follow-up|89|||
130211224|NCT02173379|468735501|FG001|Overall Study|Lost to Follow-up|81|||
130211225|NCT02173379|468735500|FG000|Overall Study|Withdrawal by Subject|24|||
130211226|NCT02173379|468735501|FG001|Overall Study|Withdrawal by Subject|29|||
130211227|NCT02173379|468735500|FG000|Overall Study|Physician Decision|8|||
130211228|NCT02173379|468735501|FG001|Overall Study|Physician Decision|8|||
130211229|NCT02173379|468735500|FG000|Overall Study|Death|75|||
130211230|NCT02173379|468735501|FG001|Overall Study|Death|72|||
130211231|NCT02173379|468735500|FG000|Overall Study|Other Reason|1|||
130211232|NCT02173379|468735501|FG001|Overall Study|Other Reason|0|||
130211233|NCT00715520|468735506|FG000|Overall Study|Screen failure|8|||
130211234|NCT00715520|468735507|FG001|Overall Study|Screen failure|1|||
130211235|NCT00715520|468735508|FG002|Overall Study|Screen failure|1|||
130211236|NCT00715520|468735506|FG000|Overall Study|Withdrawal by Subject|2|||
129875377|NCT03299686|467501938|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
129875378|NCT03745222|467501939|FG000|Overall Study|Withdrawal by Subject|0|||
129875379|NCT03745222|467501940|FG001|Overall Study|Withdrawal by Subject|1|||
130098649|NCT03586427|468319264|FG001|Overall Study|Protocol Violation|0|||
130320282|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
130320283|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
130320284|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
130320285|NCT04576988|469141883|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
130320286|NCT04576988|469141884|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
130320287|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
130320288|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
130320289|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
130320290|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
130320291|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
130320292|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
130320293|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Death|2|||
130320294|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Death|1|||
130320295|NCT04576988|469141883|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
130320296|NCT04576988|469141884|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
130320297|NCT00617734|469141885|FG000|Overall Study|Withdrew Consent|2|||
130320298|NCT00617734|469141886|FG001|Overall Study|Withdrew Consent|0|||
130320299|NCT00617734|469141885|FG000|Overall Study|Adverse Event|4|||
130320300|NCT00617734|469141886|FG001|Overall Study|Adverse Event|1|||
130320301|NCT00617734|469141885|FG000|Overall Study|Protocol Violation|1|||
130320302|NCT00617734|469141886|FG001|Overall Study|Protocol Violation|0|||
130320303|NCT00617734|469141885|FG000|Overall Study|Found Ineligible After Randomization|1|||
130320304|NCT00617734|469141886|FG001|Overall Study|Found Ineligible After Randomization|4|||
130320305|NCT00617734|469141885|FG000|Overall Study|Lost to Follow-up|0|||
130320306|NCT00617734|469141886|FG001|Overall Study|Lost to Follow-up|1|||
130320307|NCT01844765|469141887|FG000|Overall Study|Adverse Event|6|||
130320308|NCT01844765|469141888|FG001|Overall Study|Adverse Event|8|||
130320309|NCT01844765|469141887|FG000|Overall Study|Withdrawal by Subject|2|||
130320310|NCT01844765|469141888|FG001|Overall Study|Withdrawal by Subject|3|||
130320311|NCT01844765|469141887|FG000|Overall Study|Disease progression|1|||
130320312|NCT01844765|469141888|FG001|Overall Study|Disease progression|0|||
130320313|NCT01844765|469141887|FG000|Overall Study|Administrative problems|3|||
130320314|NCT01844765|469141888|FG001|Overall Study|Administrative problems|4|||
130320315|NCT01844765|469141887|FG000|Overall Study|Protocol deviation|2|||
130320316|NCT01844765|469141888|FG001|Overall Study|Protocol deviation|0|||
130320317|NCT01844765|469141887|FG000|Overall Study|Untreated|1|||
130320318|NCT01844765|469141888|FG001|Overall Study|Untreated|0|||
130320319|NCT03221556|469141890|FG000|Allocation|post-randomization exclusion|0|||
130320320|NCT03221556|469141891|FG001|Allocation|post-randomization exclusion|1|||
130320321|NCT03221556|469141890|FG000|Follow-Up|Withdrawal by Subject|0|||
130320322|NCT03221556|469141891|FG001|Follow-Up|Withdrawal by Subject|1|||
130320323|NCT00506350|469141892|FG000|Overall Study|Serious Adverse Event|1|||
130320324|NCT00506350|469141893|FG001|Overall Study|Serious Adverse Event|0|||
130320325|NCT00506350|469141894|FG002|Overall Study|Serious Adverse Event|0|||
130320326|NCT00506350|469141895|FG003|Overall Study|Serious Adverse Event|0|||
130320327|NCT00506350|469141896|FG004|Overall Study|Serious Adverse Event|0|||
130320328|NCT00506350|469141897|FG005|Overall Study|Serious Adverse Event|0|||
130320329|NCT00506350|469141898|FG006|Overall Study|Serious Adverse Event|0|||
130320330|NCT00506350|469141899|FG007|Overall Study|Serious Adverse Event|0|||
130320331|NCT00506350|469141900|FG008|Overall Study|Serious Adverse Event|0|||
130320332|NCT00506350|469141892|FG000|Overall Study|Adverse Event|0|||
130320333|NCT00506350|469141893|FG001|Overall Study|Adverse Event|0|||
130320334|NCT00506350|469141894|FG002|Overall Study|Adverse Event|0|||
130320335|NCT00506350|469141895|FG003|Overall Study|Adverse Event|0|||
130320336|NCT00506350|469141896|FG004|Overall Study|Adverse Event|0|||
130320337|NCT00506350|469141897|FG005|Overall Study|Adverse Event|0|||
130320338|NCT00506350|469141898|FG006|Overall Study|Adverse Event|0|||
130320339|NCT00506350|469141899|FG007|Overall Study|Adverse Event|1|||
130320340|NCT00506350|469141900|FG008|Overall Study|Adverse Event|1|||
130320341|NCT00506350|469141892|FG000|Overall Study|Protocol Violation|0|||
130320342|NCT00506350|469141893|FG001|Overall Study|Protocol Violation|0|||
130320343|NCT00506350|469141894|FG002|Overall Study|Protocol Violation|1|||
130320344|NCT00506350|469141895|FG003|Overall Study|Protocol Violation|0|||
130320345|NCT00506350|469141896|FG004|Overall Study|Protocol Violation|0|||
130320346|NCT00506350|469141897|FG005|Overall Study|Protocol Violation|0|||
130320347|NCT00506350|469141898|FG006|Overall Study|Protocol Violation|1|||
130320348|NCT00506350|469141899|FG007|Overall Study|Protocol Violation|0|||
130320349|NCT00506350|469141900|FG008|Overall Study|Protocol Violation|0|||
130320350|NCT00506350|469141892|FG000|Overall Study|Withdrawal by Subject|0|||
130320351|NCT00506350|469141893|FG001|Overall Study|Withdrawal by Subject|1|||
130320352|NCT00506350|469141894|FG002|Overall Study|Withdrawal by Subject|1|||
130320353|NCT00506350|469141895|FG003|Overall Study|Withdrawal by Subject|1|||
130320354|NCT00506350|469141896|FG004|Overall Study|Withdrawal by Subject|4|||
130320355|NCT00506350|469141897|FG005|Overall Study|Withdrawal by Subject|1|||
129875380|NCT03745222|467501941|FG002|Overall Study|Withdrawal by Subject|0|||
129875381|NCT02709005|467501942|FG000|Overall Study|Lost to Follow-up|1|||
129875382|NCT02709005|467501943|FG001|Overall Study|Lost to Follow-up|1|||
129875383|NCT02709005|467501942|FG000|Overall Study|Withdrawal by Subject|3|||
130211237|NCT00715520|468735507|FG001|Overall Study|Withdrawal by Subject|0|||
130211238|NCT00715520|468735508|FG002|Overall Study|Withdrawal by Subject|1|||
130211239|NCT02290925|468735510|FG000|First Period of Three Months|Lost to Follow-up|2|||
130211240|NCT02290925|468735511|FG001|First Period of Three Months|Lost to Follow-up|1|||
130211241|NCT02290925|468735510|FG000|First Period of Three Months|Death|1|||
130211242|NCT02290925|468735511|FG001|First Period of Three Months|Death|0|||
130211243|NCT02290925|468735510|FG000|First Period of Three Months|Insulin Started|1|||
130211244|NCT02290925|468735511|FG001|First Period of Three Months|Insulin Started|1|||
130211245|NCT02290925|468735510|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
130211246|NCT02290925|468735511|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
130211247|NCT02290925|468735510|FG000|Second Period of 3 Months|insulin started|0|||
130211248|NCT02290925|468735511|FG001|Second Period of 3 Months|insulin started|1|||
130211249|NCT04942210|468735512|FG000|Overall Study|Adverse Event|0|||
130211250|NCT04942210|468735513|FG001|Overall Study|Adverse Event|1|||
130211251|NCT04942210|468735512|FG000|Overall Study|Protocol Deviation|4|||
130211252|NCT04942210|468735513|FG001|Overall Study|Protocol Deviation|1|||
130211253|NCT04942210|468735512|FG000|Overall Study|Withdrawal by Subject|5|||
129875384|NCT02709005|467501943|FG001|Overall Study|Withdrawal by Subject|0|||
129875385|NCT01959347|467501944|FG000|Overall Study|Protocol Violation|9|||
129875386|NCT01959347|467501945|FG001|Overall Study|Protocol Violation|7|||
129875387|NCT01282801|467501946|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
129875388|NCT01282801|467501947|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
129875389|NCT01060553|467501948|FG000|Overall Study|Lost to Follow-up|3|||
129875390|NCT01060553|467501949|FG001|Overall Study|Lost to Follow-up|5|||
129875391|NCT01060553|467501948|FG000|Overall Study|Withdrawal by Subject|5|||
129875392|NCT01060553|467501949|FG001|Overall Study|Withdrawal by Subject|5|||
129875393|NCT01060553|467501948|FG000|Overall Study|Lack of Efficacy|1|||
129875394|NCT01060553|467501949|FG001|Overall Study|Lack of Efficacy|0|||
129875395|NCT04707196|467501951|FG000|Overall Study|Withdrawal by Subject|9|||
129875396|NCT04707196|467501952|FG001|Overall Study|Withdrawal by Subject|6|||
129875397|NCT04707196|467501951|FG000|Overall Study|Lost to Follow-up|1|||
129875398|NCT04707196|467501952|FG001|Overall Study|Lost to Follow-up|0|||
130211254|NCT04942210|468735513|FG001|Overall Study|Withdrawal by Subject|2|||
130211255|NCT04942210|468735512|FG000|Overall Study|Lost to Follow-up|16|||
130211256|NCT04942210|468735513|FG001|Overall Study|Lost to Follow-up|7|||
130211257|NCT04942210|468735512|FG000|Overall Study|Ongoing at the time of DBL date|60|||
130211258|NCT04942210|468735513|FG001|Overall Study|Ongoing at the time of DBL date|25|||
130211259|NCT04942210|468735512|FG000|Overall Study|Randomized but did not receive vaccination|3|||
130211260|NCT04942210|468735513|FG001|Overall Study|Randomized but did not receive vaccination|0|||
130211261|NCT05697627|468735514|FG000|Overall Study|Adverse Event|1|||
130211262|NCT02570750|468735515|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
130211263|NCT02570750|468735516|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
130211264|NCT02570750|468735515|FG000|Overall Study|Protocol deviation|4|||
130211265|NCT02570750|468735516|FG001|Overall Study|Protocol deviation|2|||
130211266|NCT02570750|468735515|FG000|Overall Study|Withdrawal by Subject|5|||
130211267|NCT02570750|468735516|FG001|Overall Study|Withdrawal by Subject|0|||
130211268|NCT02570750|468735515|FG000|Overall Study|Lost to Follow-up|2|||
130211269|NCT02570750|468735516|FG001|Overall Study|Lost to Follow-up|2|||
130211270|NCT02570750|468735515|FG000|Overall Study|Adverse Event|2|||
130211271|NCT02570750|468735516|FG001|Overall Study|Adverse Event|1|||
130211272|NCT04122625|468735517|FG000|Part A (up to 2.92 Years)|Death|2|||
130211273|NCT04122625|468735518|FG001|Part A (up to 2.92 Years)|Death|4|||
130211274|NCT04122625|468735519|FG002|Part A (up to 2.92 Years)|Death|0|||
130211275|NCT04122625|468735520|FG003|Part A (up to 2.92 Years)|Death|0|||
130211276|NCT04122625|468735521|FG004|Part A (up to 2.92 Years)|Death|0|||
130211277|NCT04122625|468735522|FG005|Part A (up to 2.92 Years)|Death|0|||
130211278|NCT04122625|468735517|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130211279|NCT04122625|468735518|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130211280|NCT04122625|468735519|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
130211281|NCT04122625|468735520|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
130211282|NCT04122625|468735521|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
130211283|NCT04122625|468735522|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
130211284|NCT04122625|468735517|FG000|Part B (up to 2.33 Years)|Death|0|||
130211285|NCT04122625|468735518|FG001|Part B (up to 2.33 Years)|Death|0|||
130211286|NCT04122625|468735519|FG002|Part B (up to 2.33 Years)|Death|5|||
130211287|NCT04122625|468735520|FG003|Part B (up to 2.33 Years)|Death|7|||
130211288|NCT04122625|468735521|FG004|Part B (up to 2.33 Years)|Death|6|||
130211289|NCT04122625|468735522|FG005|Part B (up to 2.33 Years)|Death|7|||
130211290|NCT01410240|468735523|FG000|Overall Study|Physician Decision|0|||
130211291|NCT01410240|468735524|FG001|Overall Study|Physician Decision|0|||
130211292|NCT01410240|468735525|FG002|Overall Study|Physician Decision|1|||
130211293|NCT01410240|468735523|FG000|Overall Study|Missed week 6 assessments|1|||
130211294|NCT01410240|468735524|FG001|Overall Study|Missed week 6 assessments|1|||
130211295|NCT01410240|468735525|FG002|Overall Study|Missed week 6 assessments|1|||
130211296|NCT02776670|468735526|FG000|Overall Study|Adverse Event|0|||
130211297|NCT02776670|468735527|FG001|Overall Study|Adverse Event|2|||
130211298|NCT02776670|468735526|FG000|Overall Study|Protocol Violation|0|||
130211299|NCT02776670|468735527|FG001|Overall Study|Protocol Violation|2|||
130211300|NCT02776670|468735526|FG000|Overall Study|Withdrawal by Subject|0|||
130211301|NCT02776670|468735527|FG001|Overall Study|Withdrawal by Subject|1|||
130211302|NCT02776670|468735526|FG000|Overall Study|Other - Reason not given|0|||
130211303|NCT02776670|468735527|FG001|Overall Study|Other - Reason not given|1|||
130211304|NCT02697591|468735530|FG000|Overall Study|Lost to Follow-up|0|||
130211305|NCT02697591|468735531|FG001|Overall Study|Lost to Follow-up|0|||
130211306|NCT02697591|468735532|FG002|Overall Study|Lost to Follow-up|0|||
130211307|NCT02697591|468735533|FG003|Overall Study|Lost to Follow-up|0|||
130211308|NCT02697591|468735534|FG004|Overall Study|Lost to Follow-up|0|||
130211309|NCT02697591|468735535|FG005|Overall Study|Lost to Follow-up|1|||
130211310|NCT02697591|468735536|FG006|Overall Study|Lost to Follow-up|1|||
130211311|NCT02697591|468735537|FG007|Overall Study|Lost to Follow-up|0|||
130211312|NCT02697591|468735538|FG008|Overall Study|Lost to Follow-up|0|||
130211313|NCT02697591|468735539|FG009|Overall Study|Lost to Follow-up|1|||
130211314|NCT02697591|468735530|FG000|Overall Study|Withdrawal by Subject|1|||
130211315|NCT02697591|468735531|FG001|Overall Study|Withdrawal by Subject|1|||
130211316|NCT02697591|468735532|FG002|Overall Study|Withdrawal by Subject|2|||
130211317|NCT02697591|468735533|FG003|Overall Study|Withdrawal by Subject|1|||
130211318|NCT02697591|468735534|FG004|Overall Study|Withdrawal by Subject|7|||
130211319|NCT02697591|468735535|FG005|Overall Study|Withdrawal by Subject|6|||
130211320|NCT02697591|468735536|FG006|Overall Study|Withdrawal by Subject|9|||
130211321|NCT02697591|468735537|FG007|Overall Study|Withdrawal by Subject|1|||
130211322|NCT02697591|468735538|FG008|Overall Study|Withdrawal by Subject|6|||
130211323|NCT02697591|468735539|FG009|Overall Study|Withdrawal by Subject|10|||
130211324|NCT02697591|468735530|FG000|Overall Study|Physician Decision|1|||
130211325|NCT02697591|468735531|FG001|Overall Study|Physician Decision|0|||
130211326|NCT02697591|468735532|FG002|Overall Study|Physician Decision|0|||
130211327|NCT02697591|468735533|FG003|Overall Study|Physician Decision|0|||
130211328|NCT02697591|468735534|FG004|Overall Study|Physician Decision|1|||
130211329|NCT02697591|468735535|FG005|Overall Study|Physician Decision|2|||
130211330|NCT02697591|468735536|FG006|Overall Study|Physician Decision|0|||
130211331|NCT02697591|468735537|FG007|Overall Study|Physician Decision|0|||
130211332|NCT02697591|468735538|FG008|Overall Study|Physician Decision|1|||
130211333|NCT02697591|468735539|FG009|Overall Study|Physician Decision|1|||
130211334|NCT02697591|468735530|FG000|Overall Study|Death|2|||
130211335|NCT02697591|468735531|FG001|Overall Study|Death|3|||
130211336|NCT02697591|468735532|FG002|Overall Study|Death|1|||
130211337|NCT02697591|468735533|FG003|Overall Study|Death|1|||
130211338|NCT02697591|468735534|FG004|Overall Study|Death|4|||
130211339|NCT02697591|468735535|FG005|Overall Study|Death|5|||
130211340|NCT02697591|468735536|FG006|Overall Study|Death|3|||
130211341|NCT02697591|468735537|FG007|Overall Study|Death|1|||
130211342|NCT02697591|468735538|FG008|Overall Study|Death|1|||
130211343|NCT02697591|468735539|FG009|Overall Study|Death|5|||
130211344|NCT02697591|468735530|FG000|Overall Study|Reason not Specified|0|||
130211345|NCT02697591|468735531|FG001|Overall Study|Reason not Specified|0|||
130211346|NCT02697591|468735532|FG002|Overall Study|Reason not Specified|0|||
130211347|NCT02697591|468735533|FG003|Overall Study|Reason not Specified|1|||
130211348|NCT02697591|468735534|FG004|Overall Study|Reason not Specified|1|||
130211349|NCT02697591|468735535|FG005|Overall Study|Reason not Specified|2|||
130211350|NCT02697591|468735536|FG006|Overall Study|Reason not Specified|3|||
130211351|NCT02697591|468735537|FG007|Overall Study|Reason not Specified|1|||
130211352|NCT02697591|468735538|FG008|Overall Study|Reason not Specified|1|||
130211353|NCT02697591|468735539|FG009|Overall Study|Reason not Specified|3|||
130211354|NCT04379700|468735544|FG000|Overall Study|Withdrawal by Subject|10|||
130211355|NCT04379700|468735544|FG000|Overall Study|Screen Fail|4|||
130211356|NCT04379700|468735544|FG000|Overall Study|Lost to Follow-up|3|||
130211357|NCT00592592|468735545|FG000|Overall Study|Patient found ineligible upon chart review|1|||
130211358|NCT00530790|468735546|FG000|Overall Study|Adverse Event|2|||
130211359|NCT00530790|468735546|FG000|Overall Study|Withdrawal by Subject|2|||
130211360|NCT00530790|468735546|FG000|Overall Study|Physician Decision|1|||
130211361|NCT05053035|468735547|FG000|Overall Study|Withdrawal by Subject|1|||
130211362|NCT05053035|468735548|FG001|Overall Study|Withdrawal by Subject|0|||
130211363|NCT00938587|468735551|FG000|Overall Study|Adverse Event|2|||
130211364|NCT00938587|468735552|FG001|Overall Study|Adverse Event|0|||
130211365|NCT00938587|468735553|FG002|Overall Study|Adverse Event|0|||
130211366|NCT00938587|468735554|FG003|Overall Study|Adverse Event|2|||
130211367|NCT00938587|468735551|FG000|Overall Study|Did not meet entrance criteria|0|||
130211368|NCT00938587|468735552|FG001|Overall Study|Did not meet entrance criteria|0|||
130211369|NCT00938587|468735553|FG002|Overall Study|Did not meet entrance criteria|1|||
130211370|NCT00938587|468735554|FG003|Overall Study|Did not meet entrance criteria|0|||
130211371|NCT00938587|468735551|FG000|Overall Study|Withdrawal by Subject|1|||
130211372|NCT00938587|468735552|FG001|Overall Study|Withdrawal by Subject|1|||
130211373|NCT00938587|468735553|FG002|Overall Study|Withdrawal by Subject|0|||
130211374|NCT00938587|468735554|FG003|Overall Study|Withdrawal by Subject|0|||
130211375|NCT02191046|468735558|FG000|Overall Study|low compliance|5|||
130211376|NCT02191046|468735559|FG001|Overall Study|low compliance|1|||
130211377|NCT00048997|468735562|FG000|Overall Study|Protocol Violation|7|||
130211378|NCT00048997|468735563|FG001|Overall Study|Protocol Violation|2|||
130211379|NCT00048997|468735562|FG000|Overall Study|Withdrawal by Subject|6|||
130211380|NCT00048997|468735563|FG001|Overall Study|Withdrawal by Subject|1|||
130211381|NCT02819440|468735564|FG000|Overall Study|Adverse Event|3|||
130211382|NCT02819440|468735565|FG001|Overall Study|Adverse Event|1|||
130211383|NCT02819440|468735564|FG000|Overall Study|Lost to Follow-up|1|||
130211384|NCT02819440|468735565|FG001|Overall Study|Lost to Follow-up|3|||
130211385|NCT02819440|468735564|FG000|Overall Study|Withdrawal by Subject|9|||
130211386|NCT02819440|468735565|FG001|Overall Study|Withdrawal by Subject|8|||
130211387|NCT00575510|468735568|FG000|Overall Study|Lost to Follow-up|4|||
130211388|NCT00575510|468735569|FG001|Overall Study|Lost to Follow-up|6|||
130211389|NCT00575510|468735570|FG002|Overall Study|Lost to Follow-up|9|||
130211390|NCT00575510|468735568|FG000|Overall Study|Withdrawal by Subject|1|||
130211391|NCT00575510|468735569|FG001|Overall Study|Withdrawal by Subject|0|||
130211392|NCT00575510|468735570|FG002|Overall Study|Withdrawal by Subject|0|||
130211393|NCT00575510|468735568|FG000|Overall Study|Clinic Called Patient|7|||
130211394|NCT00575510|468735569|FG001|Overall Study|Clinic Called Patient|7|||
130211395|NCT00575510|468735570|FG002|Overall Study|Clinic Called Patient|7|||
130211396|NCT00575510|468735568|FG000|Overall Study|Pregnancy|0|||
130211397|NCT00575510|468735569|FG001|Overall Study|Pregnancy|0|||
130211398|NCT00575510|468735570|FG002|Overall Study|Pregnancy|1|||
130211399|NCT02697734|468735575|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
130211400|NCT02697734|468735576|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
130211401|NCT02697734|468735575|FG000|Core Phase - up to Week 48|Adverse Event|1|||
130211402|NCT02697734|468735576|FG001|Core Phase - up to Week 48|Adverse Event|2|||
130211403|NCT02697734|468735575|FG000|Core Phase - up to Week 48|Physician Decision|1|||
130211404|NCT02697734|468735576|FG001|Core Phase - up to Week 48|Physician Decision|0|||
130211405|NCT02697734|468735575|FG000|Optional Extension Phase|Adverse Event|5|||
130211406|NCT02697734|468735576|FG001|Optional Extension Phase|Adverse Event|1|||
130211407|NCT02697734|468735575|FG000|Optional Extension Phase|Physician Decision|0|||
130211408|NCT02697734|468735576|FG001|Optional Extension Phase|Physician Decision|1|||
130211409|NCT02651688|468735577|FG000|Overall Study|Non-compliance|0|||
130211410|NCT02651688|468735578|FG001|Overall Study|Non-compliance|0|||
130211411|NCT02651688|468735579|FG002|Overall Study|Non-compliance|1|||
130211412|NCT02651688|468735577|FG000|Overall Study|Principal Investigator (PI) decision|0|||
130211413|NCT02651688|468735578|FG001|Overall Study|Principal Investigator (PI) decision|2|||
130211414|NCT02651688|468735579|FG002|Overall Study|Principal Investigator (PI) decision|0|||
130211415|NCT02651688|468735577|FG000|Overall Study|Lost to Follow-up|1|||
130211416|NCT02651688|468735578|FG001|Overall Study|Lost to Follow-up|3|||
130211417|NCT02651688|468735579|FG002|Overall Study|Lost to Follow-up|0|||
130211418|NCT02651688|468735577|FG000|Overall Study|Withdrawal by Subject|1|||
130211419|NCT02651688|468735578|FG001|Overall Study|Withdrawal by Subject|0|||
130211420|NCT02651688|468735579|FG002|Overall Study|Withdrawal by Subject|2|||
130211421|NCT00731731|468735580|FG000|Overall Study|Protocol Violation|0|||
130211422|NCT00731731|468735581|FG001|Overall Study|Protocol Violation|0|||
130211423|NCT00731731|468735582|FG002|Overall Study|Protocol Violation|1|||
130211424|NCT00731731|468735580|FG000|Overall Study|Cancel prior to treatment|0|||
130211425|NCT00731731|468735581|FG001|Overall Study|Cancel prior to treatment|0|||
130211426|NCT00731731|468735582|FG002|Overall Study|Cancel prior to treatment|2|||
130211427|NCT03970200|468735583|FG000|Overall Study|Death|2|||
130211428|NCT03970200|468735584|FG001|Overall Study|Death|2|||
130211429|NCT03970200|468735585|FG002|Overall Study|Death|1|||
130211430|NCT03970200|468735583|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
130211431|NCT03970200|468735584|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
130211432|NCT03970200|468735585|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
130211433|NCT01693185|468735586|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
130211434|NCT01693185|468735587|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
130211435|NCT01429441|468735588|FG000|Overall Study|Adverse Event|5|||
130211436|NCT01429441|468735589|FG001|Overall Study|Adverse Event|1|||
130211437|NCT01429441|468735588|FG000|Overall Study|Death|0|||
130211438|NCT01429441|468735589|FG001|Overall Study|Death|2|||
130211439|NCT01429441|468735588|FG000|Overall Study|Lost to Follow-up|5|||
130211440|NCT01429441|468735589|FG001|Overall Study|Lost to Follow-up|2|||
130211441|NCT01429441|468735588|FG000|Overall Study|Physician Decision|1|||
130211442|NCT01429441|468735589|FG001|Overall Study|Physician Decision|0|||
130211443|NCT01429441|468735588|FG000|Overall Study|Withdrawal by Subject|27|||
130211444|NCT01429441|468735589|FG001|Overall Study|Withdrawal by Subject|18|||
130211445|NCT02279745|468735590|FG000|Overall Study|Adverse Event|7|||
130211446|NCT02279745|468735590|FG000|Overall Study|Death|6|||
130211447|NCT02279745|468735590|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
130211448|NCT02279745|468735590|FG000|Overall Study|Withdrawal by Subject|2|||
130211449|NCT02279745|468735590|FG000|Overall Study|Pregnancy|1|||
130211450|NCT02279745|468735590|FG000|Overall Study|Study Non-compliance|1|||
130211451|NCT02279745|468735590|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
130211452|NCT00380718|468735591|FG000|Overall Study|Adverse Event|1|||
130211453|NCT00380718|468735591|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
130211454|NCT01606748|468735592|FG000|Overall Study|Adverse Event|1|||
130211455|NCT01606748|468735593|FG001|Overall Study|Adverse Event|0|||
130211456|NCT01606748|468735592|FG000|Overall Study|Progressive Disease|1|||
130211457|NCT01606748|468735593|FG001|Overall Study|Progressive Disease|0|||
130211458|NCT01606748|468735592|FG000|Overall Study|Withdrawal by Subject|1|||
130211459|NCT01606748|468735593|FG001|Overall Study|Withdrawal by Subject|0|||
130211460|NCT03742258|468735597|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
130211461|NCT03742258|468735598|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
130211462|NCT03742258|468735599|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
130211463|NCT03742258|468735597|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
130211464|NCT03742258|468735598|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
130211465|NCT03742258|468735599|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
130211466|NCT03742258|468735597|FG000|Survival Follow-Up|Still in Follow-up|0|||
130211467|NCT03742258|468735598|FG001|Survival Follow-Up|Still in Follow-up|0|||
130211468|NCT03742258|468735599|FG002|Survival Follow-Up|Still in Follow-up|2|||
130211469|NCT02083653|468735600|FG000|Overall Study|Randomized but not Treated|0|||
130211470|NCT02083653|468735601|FG001|Overall Study|Randomized but not Treated|2|||
130211471|NCT02083653|468735602|FG002|Overall Study|Randomized but not Treated|7|||
130211472|NCT02083653|468735600|FG000|Overall Study|Adverse Event|12|||
130211473|NCT02083653|468735601|FG001|Overall Study|Adverse Event|5|||
130211474|NCT02083653|468735602|FG002|Overall Study|Adverse Event|4|||
130320356|NCT00506350|469141898|FG006|Overall Study|Withdrawal by Subject|1|||
130320357|NCT00506350|469141899|FG007|Overall Study|Withdrawal by Subject|2|||
130320358|NCT00506350|469141900|FG008|Overall Study|Withdrawal by Subject|0|||
130320359|NCT00506350|469141892|FG000|Overall Study|Lost to Follow-up|1|||
130320360|NCT00506350|469141893|FG001|Overall Study|Lost to Follow-up|1|||
130320361|NCT00506350|469141894|FG002|Overall Study|Lost to Follow-up|1|||
130211475|NCT02083653|468735600|FG000|Overall Study|Lost to Follow-up|1|||
130211476|NCT02083653|468735601|FG001|Overall Study|Lost to Follow-up|0|||
130211477|NCT02083653|468735602|FG002|Overall Study|Lost to Follow-up|0|||
130211478|NCT02083653|468735600|FG000|Overall Study|Death|2|||
130211479|NCT02083653|468735601|FG001|Overall Study|Death|2|||
130211480|NCT02083653|468735602|FG002|Overall Study|Death|2|||
130211481|NCT02083653|468735600|FG000|Overall Study|Progressive Disease|65|||
130211482|NCT02083653|468735601|FG001|Overall Study|Progressive Disease|73|||
130211483|NCT02083653|468735602|FG002|Overall Study|Progressive Disease|63|||
130211484|NCT02083653|468735600|FG000|Overall Study|Withdrawal by Subject|2|||
130211485|NCT02083653|468735601|FG001|Overall Study|Withdrawal by Subject|1|||
130211486|NCT02083653|468735602|FG002|Overall Study|Withdrawal by Subject|2|||
130211487|NCT02083653|468735600|FG000|Overall Study|Other Events|0|||
130211488|NCT02083653|468735601|FG001|Overall Study|Other Events|2|||
130211489|NCT02083653|468735602|FG002|Overall Study|Other Events|2|||
130211490|NCT02083653|468735600|FG000|Overall Study|Reason Missing|0|||
130211491|NCT02083653|468735601|FG001|Overall Study|Reason Missing|0|||
130211492|NCT02083653|468735602|FG002|Overall Study|Reason Missing|4|||
130211493|NCT03084315|468735603|FG000|Overall Study|Lost to Follow-up|8|||
130211494|NCT03084315|468735604|FG001|Overall Study|Lost to Follow-up|7|||
130211495|NCT03084315|468735603|FG000|Overall Study|Withdrawal by Subject|2|||
130211496|NCT03084315|468735604|FG001|Overall Study|Withdrawal by Subject|2|||
130211497|NCT01952080|468735606|FG000|Overall Study|Withdrawal by Subject|0|||
130211498|NCT01952080|468735607|FG001|Overall Study|Withdrawal by Subject|0|||
130211499|NCT01952080|468735608|FG002|Overall Study|Withdrawal by Subject|0|||
130211500|NCT01952080|468735609|FG003|Overall Study|Withdrawal by Subject|1|||
130211501|NCT01952080|468735606|FG000|Overall Study|Protocol Non-compliance|0|||
130211502|NCT01952080|468735607|FG001|Overall Study|Protocol Non-compliance|1|||
130211503|NCT01952080|468735608|FG002|Overall Study|Protocol Non-compliance|0|||
130211504|NCT01952080|468735609|FG003|Overall Study|Protocol Non-compliance|0|||
130211505|NCT00564395|468735610|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
130211506|NCT00564395|468735611|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
130211507|NCT00564395|468735610|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
130211508|NCT00564395|468735611|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
130211509|NCT00594386|468735613|FG000|Overall Study|Major protocol violation|2|||
130211510|NCT00594386|468735613|FG000|Overall Study|Lack of Efficacy|12|||
130211511|NCT00594386|468735613|FG000|Overall Study|Adverse Event|68|||
130211512|NCT00594386|468735613|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
130211513|NCT00594386|468735613|FG000|Overall Study|Subject withdrew consent|35|||
130211514|NCT00594386|468735613|FG000|Overall Study|Study ended per sponsor|115|||
130211515|NCT00594386|468735613|FG000|Overall Study|Lost to Follow-up|6|||
130211516|NCT00594386|468735613|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
130211517|NCT00594386|468735613|FG000|Overall Study|Other: Subject moved to Seattle|1|||
130211518|NCT00594386|468735613|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
130211519|NCT00594386|468735613|FG000|Overall Study|Other: Study terminated per investigator|2|||
130211520|NCT00594386|468735613|FG000|Overall Study|Other: Sponsor closure of study|1|||
130211521|NCT00594386|468735613|FG000|Overall Study|Other: Site terminated participation|1|||
130211522|NCT00594386|468735613|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
130211523|NCT00594386|468735613|FG000|Overall Study|Other: Loss of drivers license|1|||
130211524|NCT00094536|468735614|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
130211525|NCT00094536|468735614|FG000|Treatment and Follow-up|Adverse Event|4|||
130211526|NCT00094536|468735614|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
130211527|NCT00094536|468735614|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
130211528|NCT00094536|468735614|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
130211529|NCT00094536|468735614|FG000|Treatment and Follow-up|Subject non-compliance|9|||
130211530|NCT00094536|468735614|FG000|Treatment and Follow-up|Unable to attend visits|1|||
130211531|NCT01687283|468737431|FG000|Overall Study|Adverse Event|11|||
130211532|NCT01687283|468737432|FG001|Overall Study|Adverse Event|4|||
130211533|NCT01687283|468737431|FG000|Overall Study|Lack of Efficacy|3|||
130211534|NCT01687283|468737432|FG001|Overall Study|Lack of Efficacy|1|||
130211535|NCT01687283|468737431|FG000|Overall Study|Protocol Violation|1|||
130211536|NCT01687283|468737432|FG001|Overall Study|Protocol Violation|3|||
130211537|NCT01687283|468737431|FG000|Overall Study|protocol defined stopping criteria|8|||
130211538|NCT01687283|468737432|FG001|Overall Study|protocol defined stopping criteria|10|||
130211539|NCT01687283|468737431|FG000|Overall Study|Lost to Follow-up|1|||
130211540|NCT01687283|468737432|FG001|Overall Study|Lost to Follow-up|1|||
130211541|NCT01687283|468737431|FG000|Overall Study|Investigator discretion|2|||
130211542|NCT01687283|468737432|FG001|Overall Study|Investigator discretion|0|||
130211543|NCT01687283|468737431|FG000|Overall Study|Withdrawal by Subject|9|||
130211544|NCT01687283|468737432|FG001|Overall Study|Withdrawal by Subject|8|||
130211545|NCT01744483|468737433|FG000|Overall Study|Death|9|||
130211546|NCT01744483|468737434|FG001|Overall Study|Death|4|||
130211547|NCT01744483|468737435|FG002|Overall Study|Death|11|||
130211548|NCT01744483|468737433|FG000|Overall Study|Lost to Follow-up|8|||
130211549|NCT01744483|468737434|FG001|Overall Study|Lost to Follow-up|9|||
130211550|NCT01744483|468737435|FG002|Overall Study|Lost to Follow-up|11|||
130211551|NCT01744483|468737433|FG000|Overall Study|Protocol Violation|1|||
130211552|NCT01744483|468737434|FG001|Overall Study|Protocol Violation|2|||
130211553|NCT01744483|468737435|FG002|Overall Study|Protocol Violation|1|||
130211554|NCT01744483|468737433|FG000|Overall Study|Withdrawal by Subject|4|||
130211555|NCT01744483|468737434|FG001|Overall Study|Withdrawal by Subject|6|||
130211556|NCT01744483|468737435|FG002|Overall Study|Withdrawal by Subject|2|||
130211557|NCT01744483|468737433|FG000|Overall Study|No ICU Admit|5|||
130211558|NCT01744483|468737434|FG001|Overall Study|No ICU Admit|1|||
130211559|NCT01744483|468737435|FG002|Overall Study|No ICU Admit|2|||
130211560|NCT01744483|468737433|FG000|Overall Study|Routed to OSH|2|||
130211561|NCT01744483|468737434|FG001|Overall Study|Routed to OSH|0|||
130211562|NCT01744483|468737435|FG002|Overall Study|Routed to OSH|1|||
130211563|NCT03041467|468737436|FG000|Overall Study|Death|46|||
130211564|NCT03041467|468737437|FG001|Overall Study|Death|39|||
130211565|NCT03041467|468737436|FG000|Overall Study|Withdrawal by Subject|36|||
130211566|NCT03041467|468737437|FG001|Overall Study|Withdrawal by Subject|37|||
130211567|NCT03041467|468737436|FG000|Overall Study|Lost to Follow-up|6|||
130211568|NCT03041467|468737437|FG001|Overall Study|Lost to Follow-up|8|||
130211569|NCT03041467|468737436|FG000|Overall Study|Declined consent for study extension|21|||
130211570|NCT03041467|468737437|FG001|Overall Study|Declined consent for study extension|33|||
130211571|NCT03041467|468737436|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
130211572|NCT03041467|468737437|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
130211573|NCT01190189|468737438|FG000|Overall Study|Lost to Follow-up|4|||
130211574|NCT01190189|468737438|FG000|Overall Study|Withdrawal by Subject|1|||
130211575|NCT01190189|468737438|FG000|Overall Study|Migrated/moved from study area|1|||
130211576|NCT02732015|468737439|FG000|Overall Study|Lost to Follow-up|0|||
130211577|NCT02732015|468737440|FG001|Overall Study|Lost to Follow-up|1|||
130211578|NCT01980628|468737441|FG000|Overall Study|Adverse Event|12|||
130211579|NCT01980628|468737441|FG000|Overall Study|Physician Decision|5|||
130211580|NCT01980628|468737441|FG000|Overall Study|Withdrawal by Subject|4|||
130211581|NCT01980628|468737441|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
130211582|NCT02469168|468737443|FG000|Overall Study|Trial closed|1|||
130211583|NCT02469168|468737444|FG001|Overall Study|Trial closed|0|||
130211584|NCT03959488|468737447|FG000|Season 1|Other|6|||
130211585|NCT03959488|468737448|FG001|Season 1|Other|7|||
130211586|NCT03959488|468737449|FG002|Season 1|Other|0|||
130211587|NCT03959488|468737450|FG003|Season 1|Other|0|||
130211588|NCT03959488|468737451|FG004|Season 1|Other|0|||
130211589|NCT03959488|468737447|FG000|Season 1|Withdrawal by parent/guardian|43|||
130211590|NCT03959488|468737448|FG001|Season 1|Withdrawal by parent/guardian|28|||
130211591|NCT03959488|468737449|FG002|Season 1|Withdrawal by parent/guardian|0|||
130211592|NCT03959488|468737450|FG003|Season 1|Withdrawal by parent/guardian|0|||
130211593|NCT03959488|468737451|FG004|Season 1|Withdrawal by parent/guardian|0|||
130211594|NCT03959488|468737447|FG000|Season 1|Due to COVID-19 pandemic|2|||
130211595|NCT03959488|468737448|FG001|Season 1|Due to COVID-19 pandemic|3|||
130211596|NCT03959488|468737449|FG002|Season 1|Due to COVID-19 pandemic|0|||
130211597|NCT03959488|468737450|FG003|Season 1|Due to COVID-19 pandemic|0|||
130211598|NCT03959488|468737451|FG004|Season 1|Due to COVID-19 pandemic|0|||
130211599|NCT03959488|468737447|FG000|Season 1|Lost to Follow-up|17|||
130211600|NCT03959488|468737448|FG001|Season 1|Lost to Follow-up|7|||
130211601|NCT03959488|468737449|FG002|Season 1|Lost to Follow-up|0|||
130211602|NCT03959488|468737450|FG003|Season 1|Lost to Follow-up|0|||
130211603|NCT03959488|468737451|FG004|Season 1|Lost to Follow-up|0|||
130211604|NCT03959488|468737447|FG000|Season 1|Death|5|||
130211605|NCT03959488|468737448|FG001|Season 1|Death|1|||
130211606|NCT03959488|468737449|FG002|Season 1|Death|0|||
130211607|NCT03959488|468737450|FG003|Season 1|Death|0|||
130211608|NCT03959488|468737451|FG004|Season 1|Death|0|||
130211609|NCT03959488|468737447|FG000|Season 2|Other|0|||
130211610|NCT03959488|468737448|FG001|Season 2|Other|0|||
130211611|NCT03959488|468737449|FG002|Season 2|Other|2|||
130211612|NCT03959488|468737450|FG003|Season 2|Other|0|||
130211613|NCT03959488|468737451|FG004|Season 2|Other|0|||
130211614|NCT03959488|468737447|FG000|Season 2|Withdrawal by parent/guardian|0|||
130211615|NCT03959488|468737448|FG001|Season 2|Withdrawal by parent/guardian|0|||
130211616|NCT03959488|468737449|FG002|Season 2|Withdrawal by parent/guardian|3|||
130211617|NCT03959488|468737450|FG003|Season 2|Withdrawal by parent/guardian|1|||
130211618|NCT03959488|468737451|FG004|Season 2|Withdrawal by parent/guardian|1|||
130211619|NCT03959488|468737447|FG000|Season 2|Lost to Follow-up|0|||
130211620|NCT03959488|468737448|FG001|Season 2|Lost to Follow-up|0|||
130211621|NCT03959488|468737449|FG002|Season 2|Lost to Follow-up|1|||
130211622|NCT03959488|468737450|FG003|Season 2|Lost to Follow-up|0|||
130211623|NCT03959488|468737451|FG004|Season 2|Lost to Follow-up|1|||
130211624|NCT01760447|468737452|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
130211625|NCT01760447|468737453|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
130211626|NCT01760447|468737454|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
130211627|NCT01760447|468737455|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
130211628|NCT01760447|468737452|FG000|Weeks 0-20|Withdrawal by Subject|2|||
130211629|NCT01760447|468737453|FG001|Weeks 0-20|Withdrawal by Subject|0|||
130211630|NCT01760447|468737454|FG002|Weeks 0-20|Withdrawal by Subject|1|||
130211631|NCT01760447|468737455|FG003|Weeks 0-20|Withdrawal by Subject|0|||
130211632|NCT01760447|468737452|FG000|Weeks 0-20|Lost to Follow-up|1|||
130211633|NCT01760447|468737453|FG001|Weeks 0-20|Lost to Follow-up|0|||
130211634|NCT01760447|468737454|FG002|Weeks 0-20|Lost to Follow-up|1|||
130211635|NCT01760447|468737455|FG003|Weeks 0-20|Lost to Follow-up|1|||
130211636|NCT01760447|468737452|FG000|Weeks 0-20|Randomized but not treated|0|||
130211637|NCT01760447|468737453|FG001|Weeks 0-20|Randomized but not treated|0|||
130211638|NCT01760447|468737454|FG002|Weeks 0-20|Randomized but not treated|2|||
130211639|NCT01760447|468737455|FG003|Weeks 0-20|Randomized but not treated|0|||
130211640|NCT01760447|468737452|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130211641|NCT01760447|468737453|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130211642|NCT01760447|468737454|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
130211643|NCT01760447|468737455|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
130211644|NCT01760447|468737452|FG000|Weeks 20-54|Withdrawal by Subject|2|||
130211645|NCT01760447|468737453|FG001|Weeks 20-54|Withdrawal by Subject|1|||
130211646|NCT01760447|468737454|FG002|Weeks 20-54|Withdrawal by Subject|1|||
130211647|NCT01760447|468737455|FG003|Weeks 20-54|Withdrawal by Subject|2|||
130211648|NCT01760447|468737452|FG000|Weeks 20-54|Lost to Follow-up|0|||
130211649|NCT01760447|468737453|FG001|Weeks 20-54|Lost to Follow-up|0|||
130211650|NCT01760447|468737454|FG002|Weeks 20-54|Lost to Follow-up|1|||
130211651|NCT01760447|468737455|FG003|Weeks 20-54|Lost to Follow-up|2|||
130211652|NCT00255840|468737458|FG000|Overall Study|Lost to Follow-up|10|||
130211653|NCT00255840|468737459|FG001|Overall Study|Lost to Follow-up|14|||
130211654|NCT00255840|468737458|FG000|Overall Study|Discontinued intervention|53|||
130211655|NCT00255840|468737459|FG001|Overall Study|Discontinued intervention|56|||
130211656|NCT04278924|468737461|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
130211657|NCT04278924|468737462|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
130211658|NCT04278924|468737463|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211659|NCT04278924|468737464|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
130211660|NCT04278924|468737465|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211661|NCT04278924|468737466|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211662|NCT04278924|468737467|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
130211663|NCT04278924|468737461|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211664|NCT04278924|468737462|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
130211665|NCT04278924|468737463|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211666|NCT04278924|468737464|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211667|NCT04278924|468737465|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211668|NCT04278924|468737466|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211669|NCT04278924|468737467|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
130211670|NCT06226649|468737468|FG000|Overall Study|Withdrawal by Subject|4|||
130211671|NCT06226649|468737469|FG001|Overall Study|Withdrawal by Subject|1|||
130211672|NCT04847232|468737470|FG000|Overall Study|Death|123|||
130211673|NCT04847232|468737471|FG001|Overall Study|Death|115|||
130211674|NCT04847232|468737470|FG000|Overall Study|Lost to Follow-up|3|||
130211675|NCT04847232|468737471|FG001|Overall Study|Lost to Follow-up|10|||
130211676|NCT04847232|468737470|FG000|Overall Study|Withdrawal by Subject|73|||
130211677|NCT04847232|468737471|FG001|Overall Study|Withdrawal by Subject|101|||
130211678|NCT04847232|468737470|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
130211679|NCT04847232|468737471|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
130211680|NCT00631163|468737472|FG000|Number of Participants in Year 1|Adverse Event|12|||
130211681|NCT00631163|468737472|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
130211682|NCT00631163|468737472|FG000|Number of Participants in Year 1|Death|6|||
130211683|NCT00631163|468737472|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
130211684|NCT00631163|468737472|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
130211685|NCT00631163|468737472|FG000|Number of Participants in Year 1|Administrative problems|6|||
130211686|NCT00631163|468737472|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
130211687|NCT00631163|468737472|FG000|Number of Participants in Year 2|Adverse Event|1|||
130211688|NCT00631163|468737472|FG000|Number of Participants in Year 2|Protocol Violation|1|||
130211689|NCT00631163|468737472|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
130211690|NCT04348500|468737475|FG000|Overall Study|Death|2|||
130211691|NCT04348500|468737476|FG001|Overall Study|Death|2|||
130211692|NCT04348500|468737475|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
130211693|NCT04348500|468737476|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
130211694|NCT03699540|468737477|FG000|Overall Study|Lost to Follow-up|1|||
130211695|NCT00624832|468737480|FG000|Overall Study|Adverse Event|0|||
130211696|NCT00624832|468737481|FG001|Overall Study|Adverse Event|1|||
130211697|NCT00624832|468737482|FG002|Overall Study|Adverse Event|0|||
130211698|NCT00624832|468737483|FG003|Overall Study|Adverse Event|1|||
130211699|NCT00624832|468737480|FG000|Overall Study|Abnormal Laboratory Value|2|||
130211700|NCT00624832|468737481|FG001|Overall Study|Abnormal Laboratory Value|0|||
130211701|NCT00624832|468737482|FG002|Overall Study|Abnormal Laboratory Value|0|||
130211702|NCT00624832|468737483|FG003|Overall Study|Abnormal Laboratory Value|0|||
130211703|NCT02700698|468737484|FG000|Overall Study|Withdrawal by Subject|1|||
130211704|NCT02700698|468737485|FG001|Overall Study|Withdrawal by Subject|0|||
130211705|NCT03517449|468737492|FG000|Overall Study|Death|184|||
130211706|NCT03517449|468737493|FG001|Overall Study|Death|236|||
130211707|NCT03517449|468737492|FG000|Overall Study|Lost to Follow-up|0|||
130211708|NCT03517449|468737493|FG001|Overall Study|Lost to Follow-up|2|||
130211709|NCT03517449|468737492|FG000|Overall Study|Withdrawal by Subject|7|||
130211710|NCT03517449|468737493|FG001|Overall Study|Withdrawal by Subject|26|||
130211711|NCT03517449|468737492|FG000|Overall Study|Participants Ongoing|220|||
130211712|NCT03517449|468737493|FG001|Overall Study|Participants Ongoing|152|||
130211713|NCT02005627|468737498|FG000|Overall Study|Lost to Follow-up|1|||
130211714|NCT02005627|468737499|FG001|Overall Study|Lost to Follow-up|2|||
130211715|NCT02005627|468737498|FG000|Overall Study|Withdrawal by Subject|1|||
130211716|NCT02005627|468737499|FG001|Overall Study|Withdrawal by Subject|2|||
130211717|NCT00548249|468737500|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
130211718|NCT00548249|468737501|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130211719|NCT00548249|468737502|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130211720|NCT00548249|468737503|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
130211721|NCT00548249|468737504|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
130211722|NCT00548249|468737500|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
130211723|NCT00548249|468737501|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
130211724|NCT00548249|468737502|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
130211725|NCT00548249|468737503|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
130211726|NCT00548249|468737504|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
130211727|NCT00548249|468737500|FG000|Overall Study|Protocol Violation|1|||
130211728|NCT00548249|468737501|FG001|Overall Study|Protocol Violation|1|||
130211729|NCT00548249|468737502|FG002|Overall Study|Protocol Violation|4|||
130211730|NCT00548249|468737503|FG003|Overall Study|Protocol Violation|0|||
130211731|NCT00548249|468737504|FG004|Overall Study|Protocol Violation|3|||
130211732|NCT00548249|468737500|FG000|Overall Study|Miscellaneous|2|||
130211733|NCT00548249|468737501|FG001|Overall Study|Miscellaneous|3|||
130211734|NCT00548249|468737502|FG002|Overall Study|Miscellaneous|2|||
130211735|NCT00548249|468737503|FG003|Overall Study|Miscellaneous|0|||
130211736|NCT00548249|468737504|FG004|Overall Study|Miscellaneous|2|||
130211737|NCT00548249|468737500|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
130211738|NCT00548249|468737501|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
130211739|NCT00548249|468737502|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
130211740|NCT00548249|468737503|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
130211741|NCT00548249|468737504|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
130211742|NCT00548249|468737500|FG000|Overall Study|Adverse Event|2|||
130211743|NCT00548249|468737501|FG001|Overall Study|Adverse Event|2|||
130211744|NCT00548249|468737502|FG002|Overall Study|Adverse Event|0|||
130211745|NCT00548249|468737503|FG003|Overall Study|Adverse Event|1|||
130211746|NCT00548249|468737504|FG004|Overall Study|Adverse Event|1|||
130211747|NCT00548249|468737500|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
130211748|NCT00548249|468737501|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
130211749|NCT00548249|468737502|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
130211750|NCT00548249|468737503|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
130211751|NCT00548249|468737504|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
130211752|NCT00548249|468737500|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
130211753|NCT00548249|468737501|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
130211754|NCT00548249|468737502|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
130211755|NCT00548249|468737503|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
130211756|NCT00548249|468737504|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
130211757|NCT00548249|468737500|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211758|NCT00548249|468737501|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211759|NCT00548249|468737502|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211760|NCT00548249|468737503|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
130211761|NCT00548249|468737504|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
130211762|NCT00548249|468737500|FG000|Overall Study|Prolonged hospitalization|0|||
130211763|NCT00548249|468737501|FG001|Overall Study|Prolonged hospitalization|0|||
130211764|NCT00548249|468737502|FG002|Overall Study|Prolonged hospitalization|2|||
130211765|NCT00548249|468737503|FG003|Overall Study|Prolonged hospitalization|1|||
130211766|NCT00548249|468737504|FG004|Overall Study|Prolonged hospitalization|0|||
130211767|NCT00548249|468737500|FG000|Overall Study|Withdrawal by Subject|2|||
130211768|NCT00548249|468737501|FG001|Overall Study|Withdrawal by Subject|0|||
130211769|NCT00548249|468737502|FG002|Overall Study|Withdrawal by Subject|0|||
130211770|NCT00548249|468737503|FG003|Overall Study|Withdrawal by Subject|0|||
130211771|NCT00548249|468737504|FG004|Overall Study|Withdrawal by Subject|0|||
130211772|NCT00548249|468737500|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130211773|NCT00548249|468737501|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
130211774|NCT00548249|468737502|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130211775|NCT00548249|468737503|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
130211776|NCT00548249|468737504|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
130211777|NCT00548249|468737500|FG000|Overall Study|Sponsor's request|0|||
130211778|NCT00548249|468737501|FG001|Overall Study|Sponsor's request|0|||
130211779|NCT00548249|468737502|FG002|Overall Study|Sponsor's request|0|||
130211780|NCT00548249|468737503|FG003|Overall Study|Sponsor's request|1|||
130211781|NCT00548249|468737504|FG004|Overall Study|Sponsor's request|0|||
130211782|NCT03003000|468737505|FG000|Overall Study|Adverse Event|1|||
130211783|NCT03003000|468737506|FG001|Overall Study|Adverse Event|2|||
130211784|NCT03003000|468737507|FG002|Overall Study|Adverse Event|3|||
130211785|NCT03003000|468737505|FG000|Overall Study|Lack of Efficacy|1|||
130211786|NCT03003000|468737506|FG001|Overall Study|Lack of Efficacy|0|||
130211787|NCT03003000|468737507|FG002|Overall Study|Lack of Efficacy|0|||
130211788|NCT03003000|468737505|FG000|Overall Study|Non-compliant with protocol|0|||
130211789|NCT03003000|468737506|FG001|Overall Study|Non-compliant with protocol|1|||
130211790|NCT03003000|468737507|FG002|Overall Study|Non-compliant with protocol|1|||
130211791|NCT03003000|468737505|FG000|Overall Study|Refused to continue medication|2|||
130211792|NCT03003000|468737506|FG001|Overall Study|Refused to continue medication|0|||
130211793|NCT03003000|468737507|FG002|Overall Study|Refused to continue medication|0|||
130211794|NCT03003000|468737505|FG000|Overall Study|Other than listed|1|||
130211795|NCT03003000|468737506|FG001|Overall Study|Other than listed|1|||
130211796|NCT03003000|468737507|FG002|Overall Study|Other than listed|1|||
130211797|NCT04933617|468737509|FG000|Dose Escalation|Early closure of study|0|||
130211798|NCT04933617|468737510|FG001|Dose Escalation|Early closure of study|3|||
130211799|NCT04933617|468737511|FG002|Dose Escalation|Early closure of study|0|||
130211800|NCT04933617|468737512|FG003|Dose Escalation|Early closure of study|0|||
130211801|NCT04933617|468737513|FG004|Dose Escalation|Early closure of study|0|||
130211802|NCT03760458|468737514|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
130211803|NCT03760458|468737515|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
130211804|NCT03760458|468737516|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130211805|NCT03760458|468737517|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130211806|NCT03760458|468737518|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
130211807|NCT02007278|468737532|FG000|Overall Study|Failure to comply with an eligibility|0|||
130211808|NCT02007278|468737533|FG001|Overall Study|Failure to comply with an eligibility|1|||
130211809|NCT02007278|468737532|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
130211810|NCT02007278|468737533|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
130211811|NCT02007278|468737532|FG000|Overall Study|Incorrect medication administration|1|||
130211812|NCT02007278|468737533|FG001|Overall Study|Incorrect medication administration|0|||
130211813|NCT02007278|468737532|FG000|Overall Study|Mis-randomization|1|||
130211814|NCT02007278|468737533|FG001|Overall Study|Mis-randomization|1|||
130211815|NCT00002525|468737534|FG000|Overall Study|Adverse Event|36|||
130211816|NCT00002525|468737535|FG001|Overall Study|Adverse Event|0|||
130211817|NCT00002525|468737534|FG000|Overall Study|Death|5|||
130211818|NCT00002525|468737535|FG001|Overall Study|Death|0|||
130211819|NCT00002525|468737534|FG000|Overall Study|Withdrawal by Subject|11|||
130211820|NCT00002525|468737535|FG001|Overall Study|Withdrawal by Subject|0|||
130211821|NCT00002525|468737534|FG000|Overall Study|Start non-protocol therapy|1|||
130211822|NCT00002525|468737535|FG001|Overall Study|Start non-protocol therapy|0|||
130211823|NCT00002525|468737534|FG000|Overall Study|Other complicating disease|1|||
130211824|NCT00002525|468737535|FG001|Overall Study|Other complicating disease|0|||
130211825|NCT00002525|468737534|FG000|Overall Study|Duke's A, B1, D disease|92|||
130211826|NCT00002525|468737535|FG001|Overall Study|Duke's A, B1, D disease|0|||
130211827|NCT00002525|468737534|FG000|Overall Study|Error|6|||
130211828|NCT00002525|468737535|FG001|Overall Study|Error|0|||
130211829|NCT00002525|468737534|FG000|Overall Study|Other|26|||
130211830|NCT00002525|468737535|FG001|Overall Study|Other|0|||
130211831|NCT00002525|468737534|FG000|Overall Study|Never start protocol therapy|8|||
130211832|NCT00002525|468737535|FG001|Overall Study|Never start protocol therapy|0|||
130211833|NCT02886884|468737536|FG000|Follow-up|Withdrawal by Subject|0|||
130211834|NCT02886884|468737537|FG001|Follow-up|Withdrawal by Subject|0|||
130211835|NCT02886884|468737538|FG002|Follow-up|Withdrawal by Subject|0|||
130211836|NCT02886884|468737539|FG003|Follow-up|Withdrawal by Subject|1|||
130211837|NCT03230838|468737540|FG000|Overall Study|Withdrawal by Subject|3|||
130211838|NCT03230838|468737541|FG001|Overall Study|Withdrawal by Subject|0|||
130211839|NCT03230838|468737540|FG000|Overall Study|Temperature excursion|1|||
130211840|NCT03230838|468737541|FG001|Overall Study|Temperature excursion|0|||
130211841|NCT00435188|468737547|FG000|Overall Study|Death|1|||
130211842|NCT00435188|468737548|FG001|Overall Study|Death|6|||
130211843|NCT00435188|468737547|FG000|Overall Study|Withdrawal by Subject|16|||
130211844|NCT00435188|468737548|FG001|Overall Study|Withdrawal by Subject|11|||
130211845|NCT00435188|468737547|FG000|Overall Study|Lost to Follow-up|5|||
130211846|NCT00435188|468737548|FG001|Overall Study|Lost to Follow-up|6|||
130211847|NCT01915771|468737549|FG000|Day 1|Withdrawal by Subject|1|||
130211848|NCT01915771|468737549|FG000|Day 15|Withdrawal by Subject|1|||
130211849|NCT03420222|468737552|FG000|Overall Study|Withdrawal by Subject|5|||
130211850|NCT03420222|468737553|FG001|Overall Study|Withdrawal by Subject|0|||
130211851|NCT03420222|468737552|FG000|Overall Study|Physician Decision|0|||
130211852|NCT03420222|468737553|FG001|Overall Study|Physician Decision|1|||
130211853|NCT02334384|468737554|FG000|Overall Study|Lost to Follow-up|1|||
130211854|NCT02334384|468737555|FG001|Overall Study|Lost to Follow-up|1|||
130211855|NCT00055497|468737556|FG000|Overall Study|Adverse Event|1|||
130211856|NCT00055497|468737557|FG001|Overall Study|Adverse Event|1|||
130211857|NCT00055497|468737558|FG002|Overall Study|Adverse Event|1|||
130211858|NCT00055497|468737559|FG003|Overall Study|Adverse Event|28|||
130211859|NCT00055497|468737556|FG000|Overall Study|Withdrawal by Subject|3|||
130211860|NCT00055497|468737557|FG001|Overall Study|Withdrawal by Subject|1|||
130211861|NCT00055497|468737558|FG002|Overall Study|Withdrawal by Subject|1|||
130211862|NCT00055497|468737559|FG003|Overall Study|Withdrawal by Subject|15|||
130211863|NCT00055497|468737556|FG000|Overall Study|Lost to Follow-up|0|||
130211864|NCT00055497|468737557|FG001|Overall Study|Lost to Follow-up|1|||
130211865|NCT00055497|468737558|FG002|Overall Study|Lost to Follow-up|0|||
130211866|NCT00055497|468737559|FG003|Overall Study|Lost to Follow-up|5|||
130211867|NCT00055497|468737556|FG000|Overall Study|Protocol Violation|0|||
130211868|NCT00055497|468737557|FG001|Overall Study|Protocol Violation|0|||
130211869|NCT00055497|468737558|FG002|Overall Study|Protocol Violation|0|||
130211870|NCT00055497|468737559|FG003|Overall Study|Protocol Violation|3|||
130211871|NCT00055497|468737556|FG000|Overall Study|Lack of Efficacy|1|||
130211872|NCT00055497|468737557|FG001|Overall Study|Lack of Efficacy|0|||
130211873|NCT00055497|468737558|FG002|Overall Study|Lack of Efficacy|0|||
130211874|NCT00055497|468737559|FG003|Overall Study|Lack of Efficacy|27|||
130211875|NCT00055497|468737556|FG000|Overall Study|Administrative Reasons|0|||
130211876|NCT00055497|468737557|FG001|Overall Study|Administrative Reasons|0|||
130211877|NCT00055497|468737558|FG002|Overall Study|Administrative Reasons|0|||
130211878|NCT00055497|468737559|FG003|Overall Study|Administrative Reasons|1|||
130211879|NCT00055497|468737556|FG000|Overall Study|Other|0|||
130211880|NCT00055497|468737557|FG001|Overall Study|Other|0|||
130211881|NCT00055497|468737558|FG002|Overall Study|Other|0|||
130211882|NCT00055497|468737559|FG003|Overall Study|Other|11|||
130211883|NCT00048165|468737560|FG000|Completed 6 Months Study|Administration/Other|8|||
130211884|NCT00048165|468737561|FG001|Completed 6 Months Study|Administration/Other|8|||
130211885|NCT00048165|468737560|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
130211886|NCT00048165|468737561|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
130211887|NCT00048165|468737560|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
130211888|NCT00048165|468737561|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
130211889|NCT00048165|468737560|FG000|Completed 6 Months Study|Death|12|||
130211890|NCT00048165|468737561|FG001|Completed 6 Months Study|Death|6|||
130211891|NCT00048165|468737560|FG000|Completed 6 Months Study|Insufficient therapy|1|||
130211892|NCT00048165|468737561|FG001|Completed 6 Months Study|Insufficient therapy|4|||
130211893|NCT00048165|468737560|FG000|Completed 6 Months Study|Other violation|4|||
130211894|NCT00048165|468737561|FG001|Completed 6 Months Study|Other violation|6|||
130211895|NCT00048165|468737560|FG000|Completed 6 Months Study|Refused treatment|5|||
130211896|NCT00048165|468737561|FG001|Completed 6 Months Study|Refused treatment|5|||
130211897|NCT00048165|468737560|FG000|Completed 6 Months Study|Violation criteria|0|||
130211898|NCT00048165|468737561|FG001|Completed 6 Months Study|Violation criteria|2|||
130211899|NCT00048165|468737560|FG000|Completed 6 Months Study|Did not receive study drug|6|||
130211900|NCT00048165|468737561|FG001|Completed 6 Months Study|Did not receive study drug|6|||
130211901|NCT00048165|468737560|FG000|Completed 12 Months Study|Administration/Other|0|||
130211902|NCT00048165|468737561|FG001|Completed 12 Months Study|Administration/Other|2|||
130211903|NCT00048165|468737560|FG000|Completed 12 Months Study|Death|2|||
130211904|NCT00048165|468737561|FG001|Completed 12 Months Study|Death|1|||
130211905|NCT00048165|468737560|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
130211906|NCT00048165|468737561|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
130211907|NCT02112877|468737562|FG000|Overall Study|Withdrawal by Subject|1|||
130211908|NCT02112877|468737563|FG001|Overall Study|Withdrawal by Subject|7|||
130211909|NCT02112877|468737562|FG000|Overall Study|Visit Missed|1|||
130211910|NCT02112877|468737563|FG001|Overall Study|Visit Missed|6|||
130211911|NCT00621517|468737574|FG000|Overall Study|Lost to Follow-up|3|||
130211912|NCT00621517|468737575|FG001|Overall Study|Lost to Follow-up|3|||
130211913|NCT00621517|468737574|FG000|Overall Study|Withdrawal by Subject|3|||
130211914|NCT00621517|468737575|FG001|Overall Study|Withdrawal by Subject|4|||
129875399|NCT04707196|467501951|FG000|Overall Study|Protocol Violation|4|||
129875400|NCT04707196|467501952|FG001|Overall Study|Protocol Violation|1|||
129875401|NCT04707196|467501951|FG000|Overall Study|Adverse Event|2|||
130211915|NCT00621517|468737574|FG000|Overall Study|Adverse Event|1|||
130211916|NCT00621517|468737575|FG001|Overall Study|Adverse Event|0|||
130211917|NCT00073008|468737576|FG000|Overall Study|Missing|6|||
130211918|NCT00073008|468737577|FG001|Overall Study|Missing|6|||
130211919|NCT00073008|468737576|FG000|Overall Study|Withdrawal by Subject|2|||
130211920|NCT00073008|468737577|FG001|Overall Study|Withdrawal by Subject|2|||
130211921|NCT00073008|468737576|FG000|Overall Study|Lost to Follow-up|1|||
130211922|NCT00073008|468737577|FG001|Overall Study|Lost to Follow-up|3|||
130211923|NCT00073008|468737576|FG000|Overall Study|Death|46|||
130211924|NCT00073008|468737577|FG001|Overall Study|Death|47|||
130211925|NCT00073008|468737576|FG000|Overall Study|"Other selected on Case Report Form"|7|||
130211926|NCT00073008|468737577|FG001|Overall Study|"Other selected on Case Report Form"|5|||
130211927|NCT02669667|468737578|FG000|Overall Study|Lost to Follow-up|0|||
130211928|NCT02669667|468737579|FG001|Overall Study|Lost to Follow-up|0|||
130211929|NCT02669667|468737580|FG002|Overall Study|Lost to Follow-up|0|||
130211930|NCT02669667|468737581|FG003|Overall Study|Lost to Follow-up|0|||
130211931|NCT02669667|468737582|FG004|Overall Study|Lost to Follow-up|0|||
130211932|NCT02669667|468737583|FG005|Overall Study|Lost to Follow-up|1|||
130211933|NCT02669667|468737584|FG006|Overall Study|Lost to Follow-up|0|||
130211934|NCT02839876|468737585|FG000|Overall Study|Protocol Violation|10|||
130211935|NCT02839876|468737586|FG001|Overall Study|Protocol Violation|11|||
130211936|NCT01156051|468737589|FG000|Overall Study|Lost to Follow-up|1|||
130211937|NCT01156051|468737590|FG001|Overall Study|Lost to Follow-up|0|||
130211938|NCT01156051|468737589|FG000|Overall Study|patient not compliant with protocol|0|||
130211939|NCT01156051|468737590|FG001|Overall Study|patient not compliant with protocol|1|||
130211940|NCT02071082|468737597|FG000|Overall Study|Enrolled and Never Treated|1|||
130211941|NCT02071082|468737598|FG001|Overall Study|Enrolled and Never Treated|1|||
130211942|NCT02071082|468737597|FG000|Overall Study|Adverse Event|0|||
130211943|NCT02071082|468737598|FG001|Overall Study|Adverse Event|1|||
130211944|NCT02071082|468737597|FG000|Overall Study|Withdrew Consent|0|||
130211945|NCT02071082|468737598|FG001|Overall Study|Withdrew Consent|4|||
130211946|NCT02071082|468737597|FG000|Overall Study|Lost to Follow-up|1|||
130211947|NCT02071082|468737598|FG001|Overall Study|Lost to Follow-up|1|||
130211948|NCT00958412|468737602|FG000|Overall Study|Study prematurely terminated|18|||
130211949|NCT02227368|468739383|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
130211950|NCT02227368|468739384|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
130211951|NCT02227368|468739383|FG000|Overall Study|Lost to Follow-up|1|||
130211952|NCT02227368|468739384|FG001|Overall Study|Lost to Follow-up|0|||
130211953|NCT02227368|468739383|FG000|Overall Study|Adverse Event|1|||
130211954|NCT02227368|468739384|FG001|Overall Study|Adverse Event|0|||
130211955|NCT02510820|468739388|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130211956|NCT02510820|468739389|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130211957|NCT02510820|468739388|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130211958|NCT02510820|468739389|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130211959|NCT03046056|468739390|FG000|Overall Study|Non-responder at Week 10|6|||
130211960|NCT03046056|468739391|FG001|Overall Study|Non-responder at Week 10|6|||
130211961|NCT03046056|468739392|FG002|Overall Study|Non-responder at Week 10|4|||
130211962|NCT03046056|468739390|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
130211963|NCT03046056|468739391|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
130211964|NCT03046056|468739392|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
130211965|NCT03046056|468739390|FG000|Overall Study|Adverse Event|1|||
130211966|NCT03046056|468739391|FG001|Overall Study|Adverse Event|5|||
130211967|NCT03046056|468739392|FG002|Overall Study|Adverse Event|0|||
130211968|NCT03046056|468739390|FG000|Overall Study|Non-compliance With Study Drug|0|||
130211969|NCT03046056|468739391|FG001|Overall Study|Non-compliance With Study Drug|0|||
130211970|NCT03046056|468739392|FG002|Overall Study|Non-compliance With Study Drug|2|||
130211971|NCT03046056|468739390|FG000|Overall Study|Protocol Violation|1|||
130211972|NCT03046056|468739391|FG001|Overall Study|Protocol Violation|1|||
130211973|NCT03046056|468739392|FG002|Overall Study|Protocol Violation|0|||
129875402|NCT04707196|467501952|FG001|Overall Study|Adverse Event|2|||
130211974|NCT03046056|468739390|FG000|Overall Study|Investigator's Discretion|0|||
130211975|NCT03046056|468739391|FG001|Overall Study|Investigator's Discretion|1|||
130211976|NCT03046056|468739392|FG002|Overall Study|Investigator's Discretion|0|||
130211977|NCT03046056|468739390|FG000|Overall Study|Withdrew Consent|1|||
130211978|NCT03046056|468739391|FG001|Overall Study|Withdrew Consent|0|||
130211979|NCT03046056|468739392|FG002|Overall Study|Withdrew Consent|0|||
130211980|NCT02913105|468739393|FG000|Overall Study|Adverse Event|11|||
130211981|NCT02913105|468739394|FG001|Overall Study|Adverse Event|0|||
130211982|NCT02913105|468739395|FG002|Overall Study|Adverse Event|4|||
130211983|NCT02913105|468739393|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130320362|NCT00506350|469141895|FG003|Overall Study|Lost to Follow-up|1|||
130211984|NCT02913105|468739394|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130211985|NCT02913105|468739395|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130211986|NCT02913105|468739393|FG000|Overall Study|Reason Not Specified|3|||
130211987|NCT02913105|468739394|FG001|Overall Study|Reason Not Specified|1|||
130211988|NCT02913105|468739395|FG002|Overall Study|Reason Not Specified|1|||
130211989|NCT02913105|468739393|FG000|Overall Study|Physician Decision|1|||
130211990|NCT02913105|468739394|FG001|Overall Study|Physician Decision|1|||
130211991|NCT02913105|468739395|FG002|Overall Study|Physician Decision|0|||
130211992|NCT02913105|468739393|FG000|Overall Study|Withdrawal by Subject|0|||
130211993|NCT02913105|468739394|FG001|Overall Study|Withdrawal by Subject|3|||
130211994|NCT02913105|468739395|FG002|Overall Study|Withdrawal by Subject|1|||
130211995|NCT01317004|468739396|FG000|Overall Study|Withdrawal by Subject|1|||
130211996|NCT01317004|468739397|FG001|Overall Study|Withdrawal by Subject|4|||
130211997|NCT01317004|468739396|FG000|Overall Study|Protocol Violation|0|||
130211998|NCT01317004|468739397|FG001|Overall Study|Protocol Violation|2|||
130211999|NCT01317004|468739396|FG000|Overall Study|Adverse Event|3|||
130212000|NCT01317004|468739397|FG001|Overall Study|Adverse Event|3|||
130212001|NCT01859949|468739403|FG000|Overall Study|Family Matters|0|||
130212002|NCT01859949|468739404|FG001|Overall Study|Family Matters|1|||
130212003|NCT01859949|468739403|FG000|Overall Study|Physician Decision|2|||
130212004|NCT01859949|468739404|FG001|Overall Study|Physician Decision|4|||
130212005|NCT01859949|468739403|FG000|Overall Study|Withdrawal by Subject|11|||
130212006|NCT01859949|468739404|FG001|Overall Study|Withdrawal by Subject|10|||
130212007|NCT01859949|468739403|FG000|Overall Study|Protocol Violation|1|||
130212008|NCT01859949|468739404|FG001|Overall Study|Protocol Violation|1|||
130212009|NCT01859949|468739403|FG000|Overall Study|Adverse Event|0|||
130212010|NCT01859949|468739404|FG001|Overall Study|Adverse Event|1|||
130212011|NCT01890759|468739405|FG000|Overall Study|Protocol Violation|0|||
130212012|NCT01890759|468739406|FG001|Overall Study|Protocol Violation|2|||
130212013|NCT01890759|468739405|FG000|Overall Study|Lost to Follow-up|0|||
130212014|NCT01890759|468739406|FG001|Overall Study|Lost to Follow-up|2|||
130212015|NCT01890759|468739405|FG000|Overall Study|Withdrawal by Subject|2|||
130212016|NCT01890759|468739406|FG001|Overall Study|Withdrawal by Subject|8|||
130212017|NCT01344759|468739407|FG000|Overall Study|Patients failed to reach sedation level|0|||
130212018|NCT01344759|468739408|FG001|Overall Study|Patients failed to reach sedation level|2|||
130212019|NCT01153009|468739409|FG000|Overall Study|Adverse Event|4|||
130212020|NCT01153009|468739410|FG001|Overall Study|Adverse Event|14|||
130212021|NCT01153009|468739411|FG002|Overall Study|Adverse Event|14|||
130212022|NCT01153009|468739412|FG003|Overall Study|Adverse Event|10|||
130212023|NCT01153009|468739409|FG000|Overall Study|Lack of Efficacy|9|||
130212024|NCT01153009|468739410|FG001|Overall Study|Lack of Efficacy|0|||
130212025|NCT01153009|468739411|FG002|Overall Study|Lack of Efficacy|2|||
130212026|NCT01153009|468739412|FG003|Overall Study|Lack of Efficacy|1|||
130212027|NCT01153009|468739409|FG000|Overall Study|Noncompliance with Study Medication|1|||
130212028|NCT01153009|468739410|FG001|Overall Study|Noncompliance with Study Medication|3|||
130212029|NCT01153009|468739411|FG002|Overall Study|Noncompliance with Study Medication|4|||
130212030|NCT01153009|468739412|FG003|Overall Study|Noncompliance with Study Medication|1|||
130212031|NCT01153009|468739409|FG000|Overall Study|Protocol Deviations|4|||
130212032|NCT01153009|468739410|FG001|Overall Study|Protocol Deviations|3|||
130212033|NCT01153009|468739411|FG002|Overall Study|Protocol Deviations|3|||
130212034|NCT01153009|468739412|FG003|Overall Study|Protocol Deviations|2|||
130212035|NCT01153009|468739409|FG000|Overall Study|Withdrawal of Consent|5|||
130212036|NCT01153009|468739410|FG001|Overall Study|Withdrawal of Consent|5|||
130212037|NCT01153009|468739411|FG002|Overall Study|Withdrawal of Consent|4|||
130212038|NCT01153009|468739412|FG003|Overall Study|Withdrawal of Consent|6|||
130212039|NCT01153009|468739409|FG000|Overall Study|Lost to Follow-up|8|||
130212040|NCT01153009|468739410|FG001|Overall Study|Lost to Follow-up|8|||
130212041|NCT01153009|468739411|FG002|Overall Study|Lost to Follow-up|11|||
130212042|NCT01153009|468739412|FG003|Overall Study|Lost to Follow-up|15|||
130212043|NCT01153009|468739409|FG000|Overall Study|Other|1|||
130212044|NCT01153009|468739410|FG001|Overall Study|Other|1|||
130212045|NCT01153009|468739411|FG002|Overall Study|Other|3|||
130212046|NCT01153009|468739412|FG003|Overall Study|Other|2|||
130212047|NCT04494425|468739417|FG000|Overall Study|Death|160|||
130212048|NCT04494425|468739418|FG001|Overall Study|Death|166|||
130212049|NCT04494425|468739417|FG000|Overall Study|Withdrawal by Subject|10|||
130212050|NCT04494425|468739418|FG001|Overall Study|Withdrawal by Subject|40|||
130212051|NCT04494425|468739417|FG000|Overall Study|Other|1|||
130212052|NCT04494425|468739418|FG001|Overall Study|Other|1|||
130212053|NCT04494425|468739417|FG000|Overall Study|Ongoing at the time of PCD|265|||
130212054|NCT04494425|468739418|FG001|Overall Study|Ongoing at the time of PCD|223|||
130212055|NCT01270321|468739420|FG000|Overall Study|Death|3|||
130212056|NCT01270321|468739421|FG001|Overall Study|Death|1|||
130212057|NCT01270321|468739422|FG002|Overall Study|Death|4|||
130212058|NCT01270321|468739420|FG000|Overall Study|Adverse Event|7|||
130212059|NCT01270321|468739421|FG001|Overall Study|Adverse Event|9|||
130212060|NCT01270321|468739422|FG002|Overall Study|Adverse Event|5|||
130212061|NCT04003623|468739426|FG000|Overall Study|Withdrawal by Subject|1|||
130212062|NCT04003623|468739427|FG001|Overall Study|Withdrawal by Subject|0|||
130212063|NCT00703326|468739429|FG000|Overall Study|Lost to Follow-up|47|||
130212064|NCT00703326|468739430|FG001|Overall Study|Lost to Follow-up|18|||
130212065|NCT00703326|468739429|FG000|Overall Study|Withdrawal by Subject|54|||
130212066|NCT00703326|468739430|FG001|Overall Study|Withdrawal by Subject|20|||
130212067|NCT00703326|468739429|FG000|Overall Study|Adverse Event|1|||
130212068|NCT00703326|468739430|FG001|Overall Study|Adverse Event|0|||
130212069|NCT01393106|468739433|FG000|Overall Study|Adverse Event|3|||
130212070|NCT01393106|468739433|FG000|Overall Study|Withdrawal by Subject|1|||
130212071|NCT01393106|468739433|FG000|Overall Study|Lack of Efficacy|1|||
130212072|NCT05437640|468739436|FG000|Washout (1 Week)|Adverse Event|1|||
130212073|NCT05437640|468739437|FG001|Washout (1 Week)|Adverse Event|0|||
130212074|NCT04228965|468739440|FG000|Overall Study|Lost to Follow-up|26|||
130212075|NCT04228965|468739441|FG001|Overall Study|Lost to Follow-up|11|||
130212076|NCT04228965|468739440|FG000|Overall Study|Withdrawal by Subject|18|||
130212077|NCT04228965|468739441|FG001|Overall Study|Withdrawal by Subject|5|||
130212078|NCT00734656|468739444|FG000|Lab Session 1|Withdrawal by Subject|2|||
130212079|NCT00734656|468739445|FG001|Lab Session 1|Withdrawal by Subject|0|||
130212080|NCT00734656|468739446|FG002|Lab Session 1|Withdrawal by Subject|0|||
130212081|NCT00734656|468739447|FG003|Lab Session 1|Withdrawal by Subject|0|||
130212082|NCT00734656|468739444|FG000|Washout 1|Withdrawal by Subject|1|||
130212083|NCT00734656|468739445|FG001|Washout 1|Withdrawal by Subject|5|||
130212084|NCT00734656|468739446|FG002|Washout 1|Withdrawal by Subject|2|||
130212085|NCT00734656|468739447|FG003|Washout 1|Withdrawal by Subject|3|||
130212086|NCT00734656|468739444|FG000|Lab Session 2|Withdrawal by Subject|1|||
130212087|NCT00734656|468739445|FG001|Lab Session 2|Withdrawal by Subject|0|||
130212088|NCT00734656|468739446|FG002|Lab Session 2|Withdrawal by Subject|0|||
130212089|NCT00734656|468739447|FG003|Lab Session 2|Withdrawal by Subject|1|||
130212090|NCT00734656|468739444|FG000|Washout 2|Withdrawal by Subject|1|||
130212091|NCT00734656|468739445|FG001|Washout 2|Withdrawal by Subject|1|||
130212092|NCT00734656|468739446|FG002|Washout 2|Withdrawal by Subject|1|||
130212093|NCT00734656|468739447|FG003|Washout 2|Withdrawal by Subject|0|||
130212094|NCT00734656|468739444|FG000|Washout 3|Withdrawal by Subject|1|||
130212095|NCT00734656|468739445|FG001|Washout 3|Withdrawal by Subject|0|||
130212096|NCT00734656|468739446|FG002|Washout 3|Withdrawal by Subject|0|||
130212097|NCT00734656|468739447|FG003|Washout 3|Withdrawal by Subject|1|||
130212098|NCT00734656|468739444|FG000|Lab Session 4|Withdrawal by Subject|0|||
130212099|NCT00734656|468739445|FG001|Lab Session 4|Withdrawal by Subject|0|||
130212100|NCT00734656|468739446|FG002|Lab Session 4|Withdrawal by Subject|0|||
130212101|NCT00734656|468739447|FG003|Lab Session 4|Withdrawal by Subject|1|||
130212102|NCT03214679|468739449|FG000|Overall Study|Lost to Follow-up|12|||
130212103|NCT03214679|468739450|FG001|Overall Study|Lost to Follow-up|14|||
130212104|NCT03214679|468739449|FG000|Overall Study|not eligible|2|||
130212105|NCT03214679|468739450|FG001|Overall Study|not eligible|0|||
130212106|NCT01754766|468739456|FG000|Overall Study|Personal reasons|1|||
130212107|NCT01754766|468739457|FG001|Overall Study|Personal reasons|1|||
130212108|NCT01754766|468739458|FG002|Overall Study|Personal reasons|0|||
130212109|NCT01709409|468739461|FG000|Overall Study|Protocol Violation|1|||
130212110|NCT01709409|468739462|FG001|Overall Study|Protocol Violation|0|||
130212111|NCT02412878|468739463|FG000|Overall Study|Withdrawal by Subject|19|||
130212112|NCT02412878|468739464|FG001|Overall Study|Withdrawal by Subject|10|||
130212113|NCT02412878|468739463|FG000|Overall Study|Lost to Follow-up|2|||
130212114|NCT02412878|468739464|FG001|Overall Study|Lost to Follow-up|3|||
130212115|NCT04571385|468739465|FG000|Overall Study|Participant non-compliance|1|||
130212116|NCT04571385|468739466|FG001|Overall Study|Participant non-compliance|0|||
130212117|NCT04571385|468739467|FG002|Overall Study|Participant non-compliance|0|||
130212118|NCT04571385|468739465|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
130212119|NCT04571385|468739466|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
130212120|NCT04571385|468739467|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
130212121|NCT04571385|468739465|FG000|Overall Study|Screen failure|0|||
130212122|NCT04571385|468739466|FG001|Overall Study|Screen failure|0|||
130212123|NCT04571385|468739467|FG002|Overall Study|Screen failure|1|||
130212124|NCT02263729|468739468|FG000|Overall Study|Lost to Follow-up|1|||
130212125|NCT02263729|468739469|FG001|Overall Study|Lost to Follow-up|1|||
130212126|NCT01212159|468739470|FG000|Overall Study|Withdrawal by Subject|12|||
130212127|NCT01212159|468739471|FG001|Overall Study|Withdrawal by Subject|12|||
130212128|NCT01306214|468739472|FG000|Overall Study|Death|0|||
130212129|NCT01306214|468739473|FG001|Overall Study|Death|0|||
130212130|NCT01306214|468739474|FG002|Overall Study|Death|1|||
130212131|NCT01306214|468739472|FG000|Overall Study|Lost to Follow-up|3|||
130212132|NCT01306214|468739473|FG001|Overall Study|Lost to Follow-up|5|||
130212133|NCT01306214|468739474|FG002|Overall Study|Lost to Follow-up|4|||
130212134|NCT01306214|468739472|FG000|Overall Study|Withdrawal by Subject|24|||
130212135|NCT01306214|468739473|FG001|Overall Study|Withdrawal by Subject|22|||
130212136|NCT01306214|468739474|FG002|Overall Study|Withdrawal by Subject|16|||
130212137|NCT01306214|468739472|FG000|Overall Study|Not treated|1|||
130212138|NCT01306214|468739473|FG001|Overall Study|Not treated|1|||
130212139|NCT01306214|468739474|FG002|Overall Study|Not treated|1|||
130212140|NCT01026818|468739475|FG000|Screening Period|Entry Criteria Not Met|105|||
130212141|NCT01026818|468739476|FG001|Screening Period|Entry Criteria Not Met|0|||
130212142|NCT01026818|468739477|FG002|Screening Period|Entry Criteria Not Met|0|||
130212143|NCT01026818|468739478|FG003|Screening Period|Entry Criteria Not Met|0|||
130212144|NCT01026818|468739475|FG000|Screening Period|Withdrawal by Subject|49|||
130212145|NCT01026818|468739476|FG001|Screening Period|Withdrawal by Subject|0|||
130212146|NCT01026818|468739477|FG002|Screening Period|Withdrawal by Subject|0|||
130212147|NCT01026818|468739478|FG003|Screening Period|Withdrawal by Subject|0|||
130212148|NCT01026818|468739475|FG000|Screening Period|Protocol Deviation|3|||
130212149|NCT01026818|468739476|FG001|Screening Period|Protocol Deviation|0|||
130212150|NCT01026818|468739477|FG002|Screening Period|Protocol Deviation|0|||
130212151|NCT01026818|468739478|FG003|Screening Period|Protocol Deviation|0|||
130212152|NCT01026818|468739475|FG000|Screening Period|Adverse Event|2|||
130212153|NCT01026818|468739476|FG001|Screening Period|Adverse Event|0|||
130212154|NCT01026818|468739477|FG002|Screening Period|Adverse Event|0|||
130212155|NCT01026818|468739478|FG003|Screening Period|Adverse Event|0|||
130212156|NCT01026818|468739475|FG000|Screening Period|Physician Decision|1|||
130212157|NCT01026818|468739476|FG001|Screening Period|Physician Decision|0|||
130212158|NCT01026818|468739477|FG002|Screening Period|Physician Decision|0|||
130212159|NCT01026818|468739478|FG003|Screening Period|Physician Decision|0|||
130212160|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
130212161|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
130212162|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
130212163|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
130212164|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
130212165|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
130212166|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
130212167|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
130212168|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
130212169|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
130212170|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
130212171|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
130212172|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
130212173|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
130212174|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
130212175|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
130212176|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
130212177|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
130212178|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
130212179|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
130212180|NCT01026818|468739475|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
130212181|NCT01026818|468739476|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
130212182|NCT01026818|468739477|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
130212183|NCT01026818|468739478|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
130212184|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
130212185|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
130212186|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
130212187|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
130212188|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
130212189|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
130212190|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
130212191|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
130212192|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130212193|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
130212194|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130212195|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
130212196|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
130212197|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
130212198|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
130212199|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
130212200|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
130212201|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
130212202|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
130212203|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
130212204|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130212205|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
130212206|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130212207|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
130212208|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
130212209|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
130212210|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
130212211|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
130212212|NCT01026818|468739475|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130212213|NCT01026818|468739476|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130212214|NCT01026818|468739477|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
130212215|NCT01026818|468739478|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
130212216|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130212217|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
130212218|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130212219|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
130212220|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130212221|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
130212222|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130212223|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
130212224|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
130212225|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
130212226|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
130212227|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
130212228|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
130212229|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
130212230|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
130212231|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
130212232|NCT01026818|468739475|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
130212233|NCT01026818|468739476|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
130212234|NCT01026818|468739477|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
130212235|NCT01026818|468739478|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
130212236|NCT01031004|468739479|FG000|Overall Study|Protocol Violation|0|||
130212237|NCT01031004|468739480|FG001|Overall Study|Protocol Violation|1|||
130212238|NCT01031004|468739479|FG000|Overall Study|Lost to Follow-up|1|||
130212239|NCT01031004|468739480|FG001|Overall Study|Lost to Follow-up|0|||
130212240|NCT01641471|468739481|FG000|Overall Study|Withdrawal by Subject|19|||
130212241|NCT01641471|468739482|FG001|Overall Study|Withdrawal by Subject|19|||
130212242|NCT01641471|468739481|FG000|Overall Study|Lost to Follow-up|2|||
130212243|NCT01641471|468739482|FG001|Overall Study|Lost to Follow-up|4|||
130212244|NCT01641471|468739481|FG000|Overall Study|Protocol Violation|2|||
130212245|NCT01641471|468739482|FG001|Overall Study|Protocol Violation|4|||
130212246|NCT04575584|468739486|FG000|Overall Study|Death|6|||
130212247|NCT04575584|468739487|FG001|Overall Study|Death|4|||
130212248|NCT04575584|468739488|FG002|Overall Study|Death|6|||
130212249|NCT04575584|468739489|FG003|Overall Study|Death|2|||
130212250|NCT04575584|468739490|FG004|Overall Study|Death|0|||
130212251|NCT04575584|468739491|FG005|Overall Study|Death|0|||
130212252|NCT04575584|468739486|FG000|Overall Study|Lost to Follow-up|1|||
130212253|NCT04575584|468739487|FG001|Overall Study|Lost to Follow-up|1|||
130212254|NCT04575584|468739488|FG002|Overall Study|Lost to Follow-up|1|||
130212255|NCT04575584|468739489|FG003|Overall Study|Lost to Follow-up|1|||
130212256|NCT04575584|468739490|FG004|Overall Study|Lost to Follow-up|0|||
130212257|NCT04575584|468739491|FG005|Overall Study|Lost to Follow-up|0|||
130212258|NCT04575584|468739486|FG000|Overall Study|Physician Decision|0|||
130212259|NCT04575584|468739487|FG001|Overall Study|Physician Decision|1|||
130212260|NCT04575584|468739488|FG002|Overall Study|Physician Decision|1|||
130212261|NCT04575584|468739489|FG003|Overall Study|Physician Decision|1|||
130212262|NCT04575584|468739490|FG004|Overall Study|Physician Decision|0|||
130212263|NCT04575584|468739491|FG005|Overall Study|Physician Decision|0|||
130212264|NCT04575584|468739486|FG000|Overall Study|Withdrawal by Subject|7|||
130212265|NCT04575584|468739487|FG001|Overall Study|Withdrawal by Subject|9|||
130212266|NCT04575584|468739488|FG002|Overall Study|Withdrawal by Subject|5|||
130212267|NCT04575584|468739489|FG003|Overall Study|Withdrawal by Subject|3|||
130212268|NCT04575584|468739490|FG004|Overall Study|Withdrawal by Subject|0|||
130212269|NCT04575584|468739491|FG005|Overall Study|Withdrawal by Subject|0|||
130212270|NCT04575584|468739486|FG000|Overall Study|Not recorded|0|||
130212271|NCT04575584|468739487|FG001|Overall Study|Not recorded|0|||
130212272|NCT04575584|468739488|FG002|Overall Study|Not recorded|0|||
130212273|NCT04575584|468739489|FG003|Overall Study|Not recorded|1|||
130212274|NCT04575584|468739490|FG004|Overall Study|Not recorded|0|||
130212275|NCT04575584|468739491|FG005|Overall Study|Not recorded|0|||
130212276|NCT03488563|468739492|FG000|Overall Study|Lost to Follow-up|7|||
130212277|NCT03488563|468739493|FG001|Overall Study|Lost to Follow-up|6|||
130212278|NCT03488563|468739494|FG002|Overall Study|Lost to Follow-up|7|||
130320363|NCT00506350|469141896|FG004|Overall Study|Lost to Follow-up|2|||
130212279|NCT03488563|468739492|FG000|Overall Study|Withdrawal by Subject|8|||
130212280|NCT03488563|468739493|FG001|Overall Study|Withdrawal by Subject|7|||
130212281|NCT03488563|468739494|FG002|Overall Study|Withdrawal by Subject|7|||
130212282|NCT03488563|468739492|FG000|Overall Study|Physician Decision|0|||
130212283|NCT03488563|468739493|FG001|Overall Study|Physician Decision|0|||
130212284|NCT03488563|468739494|FG002|Overall Study|Physician Decision|1|||
130212285|NCT03488563|468739492|FG000|Overall Study|Protocol Violation|3|||
130212286|NCT03488563|468739493|FG001|Overall Study|Protocol Violation|2|||
130212287|NCT03488563|468739494|FG002|Overall Study|Protocol Violation|6|||
130212288|NCT03488563|468739492|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
130212289|NCT03488563|468739493|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
130212290|NCT03488563|468739494|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
130212291|NCT03488563|468739492|FG000|Overall Study|Use of prohibited medication|2|||
130212292|NCT03488563|468739493|FG001|Overall Study|Use of prohibited medication|0|||
130212293|NCT03488563|468739494|FG002|Overall Study|Use of prohibited medication|0|||
130212294|NCT03488563|468739492|FG000|Overall Study|Adverse Event|1|||
130212295|NCT03488563|468739493|FG001|Overall Study|Adverse Event|0|||
130212296|NCT03488563|468739494|FG002|Overall Study|Adverse Event|1|||
130212297|NCT03488563|468739492|FG000|Overall Study|Subject returned for ET visit|0|||
130212298|NCT03488563|468739493|FG001|Overall Study|Subject returned for ET visit|1|||
130212299|NCT03488563|468739494|FG002|Overall Study|Subject returned for ET visit|0|||
130212300|NCT03488563|468739492|FG000|Overall Study|Sponsor's decision|0|||
130212301|NCT03488563|468739493|FG001|Overall Study|Sponsor's decision|0|||
130212302|NCT03488563|468739494|FG002|Overall Study|Sponsor's decision|1|||
130212303|NCT02769312|468739507|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
130212304|NCT02769312|468739508|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
130212305|NCT02769312|468739507|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
130212306|NCT02769312|468739508|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
130212307|NCT02769312|468739507|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
130212308|NCT02769312|468739508|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
130212309|NCT02769312|468739507|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
130212310|NCT02769312|468739508|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
130212311|NCT02769312|468739507|FG000|Follow-up|Lost to Follow-up|1|||
130212312|NCT02769312|468739508|FG001|Follow-up|Lost to Follow-up|1|||
130212313|NCT02815267|468739509|FG000|Double-Blind Phase|Adverse Event|0|||
130212314|NCT02815267|468739510|FG001|Double-Blind Phase|Adverse Event|3|||
130212315|NCT02815267|468739509|FG000|Double-Blind Phase|Lost to Follow-up|17|||
130212316|NCT02815267|468739510|FG001|Double-Blind Phase|Lost to Follow-up|9|||
130212317|NCT02815267|468739509|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
130212318|NCT02815267|468739510|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
130212319|NCT02815267|468739509|FG000|Double-Blind Phase|Protocol Violation|3|||
130212320|NCT02815267|468739510|FG001|Double-Blind Phase|Protocol Violation|2|||
130212321|NCT02815267|468739509|FG000|Double-Blind Phase|Site withdrawal|1|||
130212322|NCT02815267|468739510|FG001|Double-Blind Phase|Site withdrawal|6|||
130212323|NCT02815267|468739509|FG000|Double-Blind Phase|Received a disallowed medication|1|||
130212324|NCT02815267|468739510|FG001|Double-Blind Phase|Received a disallowed medication|1|||
130212325|NCT02815267|468739509|FG000|Open-Label Phase|Adverse Event|1|||
130212326|NCT02815267|468739510|FG001|Open-Label Phase|Adverse Event|1|||
130212327|NCT02815267|468739509|FG000|Open-Label Phase|Lost to Follow-up|23|||
130212328|NCT02815267|468739510|FG001|Open-Label Phase|Lost to Follow-up|9|||
130212329|NCT02815267|468739509|FG000|Open-Label Phase|Withdrawal by Subject|24|||
130212330|NCT02815267|468739510|FG001|Open-Label Phase|Withdrawal by Subject|13|||
130212331|NCT02815267|468739509|FG000|Open-Label Phase|Protocol Violation|0|||
130212332|NCT02815267|468739510|FG001|Open-Label Phase|Protocol Violation|1|||
130212333|NCT02815267|468739509|FG000|Open-Label Phase|Administrative|21|||
130212334|NCT02815267|468739510|FG001|Open-Label Phase|Administrative|12|||
130212335|NCT02815267|468739509|FG000|Open-Label Phase|Other|2|||
130212336|NCT02815267|468739510|FG001|Open-Label Phase|Other|5|||
130212337|NCT03594955|468739511|FG000|Overall Study|Adverse Event|1|||
130212338|NCT03594955|468739511|FG000|Overall Study|Progressive disease|5|||
130212339|NCT03594955|468739511|FG000|Overall Study|Sponsor's decision|1|||
130212340|NCT05600036|468739514|FG000|Overall Study|Adverse Event|0|||
130212341|NCT05600036|468739515|FG001|Overall Study|Adverse Event|2|||
130212342|NCT05600036|468739516|FG002|Overall Study|Adverse Event|1|||
130212343|NCT05600036|468739517|FG003|Overall Study|Adverse Event|0|||
130212344|NCT05600036|468739518|FG004|Overall Study|Adverse Event|1|||
130212345|NCT05600036|468739519|FG005|Overall Study|Adverse Event|0|||
130212346|NCT05600036|468739514|FG000|Overall Study|Lost to Follow-up|0|||
130212347|NCT05600036|468739515|FG001|Overall Study|Lost to Follow-up|2|||
130212348|NCT05600036|468739516|FG002|Overall Study|Lost to Follow-up|1|||
130212349|NCT05600036|468739517|FG003|Overall Study|Lost to Follow-up|1|||
130212350|NCT05600036|468739518|FG004|Overall Study|Lost to Follow-up|0|||
130212351|NCT05600036|468739519|FG005|Overall Study|Lost to Follow-up|0|||
130212352|NCT05600036|468739514|FG000|Overall Study|Protocol Violation|0|||
130212353|NCT05600036|468739515|FG001|Overall Study|Protocol Violation|0|||
130212354|NCT05600036|468739516|FG002|Overall Study|Protocol Violation|2|||
130212355|NCT05600036|468739517|FG003|Overall Study|Protocol Violation|0|||
130212356|NCT05600036|468739518|FG004|Overall Study|Protocol Violation|0|||
130212357|NCT05600036|468739519|FG005|Overall Study|Protocol Violation|0|||
130212358|NCT05600036|468739514|FG000|Overall Study|Withdrawal by Subject|0|||
130212359|NCT05600036|468739515|FG001|Overall Study|Withdrawal by Subject|1|||
130212360|NCT05600036|468739516|FG002|Overall Study|Withdrawal by Subject|2|||
130212361|NCT05600036|468739517|FG003|Overall Study|Withdrawal by Subject|0|||
130212362|NCT05600036|468739518|FG004|Overall Study|Withdrawal by Subject|3|||
130212363|NCT05600036|468739519|FG005|Overall Study|Withdrawal by Subject|5|||
130212364|NCT05600036|468739514|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212365|NCT05600036|468739515|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212366|NCT05600036|468739516|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212367|NCT05600036|468739517|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
130212368|NCT05600036|468739518|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212369|NCT05600036|468739519|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
130212370|NCT05600036|468739514|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212371|NCT05600036|468739515|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
130212372|NCT05600036|468739516|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212373|NCT05600036|468739517|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212374|NCT05600036|468739518|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212375|NCT05600036|468739519|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
130212376|NCT05600036|468739514|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212377|NCT05600036|468739515|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212378|NCT05600036|468739516|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212379|NCT05600036|468739517|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
130212380|NCT05600036|468739518|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212381|NCT05600036|468739519|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
130212382|NCT02714036|468739520|FG000|Overall Study|Adverse Event|9|||
130212383|NCT02714036|468739521|FG001|Overall Study|Adverse Event|2|||
130212384|NCT02714036|468739520|FG000|Overall Study|Withdrawal by Subject|3|||
130212385|NCT02714036|468739521|FG001|Overall Study|Withdrawal by Subject|2|||
130212386|NCT01006590|468739522|FG000|Overall Study|Adverse Event|2|||
130212387|NCT01006590|468739523|FG001|Overall Study|Adverse Event|3|||
130212388|NCT01006590|468739522|FG000|Overall Study|Death|1|||
130212389|NCT01006590|468739523|FG001|Overall Study|Death|1|||
130212390|NCT01006590|468739522|FG000|Overall Study|Lost to Follow-up|1|||
130212391|NCT01006590|468739523|FG001|Overall Study|Lost to Follow-up|1|||
130212392|NCT01006590|468739522|FG000|Overall Study|Protocol Violation|1|||
130212393|NCT01006590|468739523|FG001|Overall Study|Protocol Violation|0|||
130212394|NCT01006590|468739522|FG000|Overall Study|Withdrawal by Subject|4|||
130212395|NCT01006590|468739523|FG001|Overall Study|Withdrawal by Subject|2|||
130212396|NCT01006590|468739522|FG000|Overall Study|Study specific discontinuation criteria|16|||
130212397|NCT01006590|468739523|FG001|Overall Study|Study specific discontinuation criteria|23|||
130212398|NCT01006590|468739522|FG000|Overall Study|Other|3|||
130212399|NCT01006590|468739523|FG001|Overall Study|Other|2|||
130212400|NCT03332095|468739524|FG000|Overall Study|Lost to Follow-up|1|||
130212401|NCT03332095|468739525|FG001|Overall Study|Lost to Follow-up|0|||
130212402|NCT03332095|468739524|FG000|Overall Study|Pregnancy|0|||
130212403|NCT03332095|468739525|FG001|Overall Study|Pregnancy|1|||
130212404|NCT00703118|468739526|FG000|Overall Study|Adverse Event|1|||
130212405|NCT00703118|468739527|FG001|Overall Study|Adverse Event|2|||
130212406|NCT00703118|468739528|FG002|Overall Study|Adverse Event|2|||
130212407|NCT00703118|468739526|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
130212408|NCT00703118|468739527|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
130212409|NCT00703118|468739528|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
130212410|NCT00703118|468739526|FG000|Overall Study|Lost to Follow-up|6|||
130212411|NCT00703118|468739527|FG001|Overall Study|Lost to Follow-up|4|||
130212412|NCT00703118|468739528|FG002|Overall Study|Lost to Follow-up|4|||
130212413|NCT00703118|468739526|FG000|Overall Study|Withdrawal by Subject|8|||
130212414|NCT00703118|468739527|FG001|Overall Study|Withdrawal by Subject|7|||
130212415|NCT00703118|468739528|FG002|Overall Study|Withdrawal by Subject|13|||
130212416|NCT00703118|468739526|FG000|Overall Study|Other|0|||
130212417|NCT00703118|468739527|FG001|Overall Study|Other|0|||
130212418|NCT00703118|468739528|FG002|Overall Study|Other|1|||
130212419|NCT00431067|468739529|FG000|Overall Study|Other Adverse Event|9|||
130212420|NCT00431067|468739529|FG000|Overall Study|Progressive disease|30|||
130212421|NCT00431067|468739529|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
130212422|NCT00830518|468739539|FG000|Overall Study|Progressive Disease|18|||
130212423|NCT00830518|468739540|FG001|Overall Study|Progressive Disease|8|||
130212424|NCT00830518|468739539|FG000|Overall Study|Symptomatic Deterioration|4|||
130212425|NCT00830518|468739540|FG001|Overall Study|Symptomatic Deterioration|1|||
130212426|NCT00830518|468739539|FG000|Overall Study|Adverse Event|14|||
130212427|NCT00830518|468739540|FG001|Overall Study|Adverse Event|1|||
130212428|NCT00830518|468739539|FG000|Overall Study|Withdrawal by Patient|2|||
130212429|NCT00830518|468739540|FG001|Overall Study|Withdrawal by Patient|0|||
130212430|NCT00830518|468739539|FG000|Overall Study|Reason not Specified|8|||
130212431|NCT00830518|468739540|FG001|Overall Study|Reason not Specified|1|||
130212432|NCT02155322|468739545|FG000|Overall Study|Adverse Event|1|||
130212433|NCT02155322|468739545|FG000|Overall Study|Physician Decision|1|||
130212434|NCT02155322|468739545|FG000|Overall Study|Relapse/Recurrence|8|||
130212435|NCT02155322|468739545|FG000|Overall Study|Withdrawal by Subject|4|||
130212436|NCT03337048|468739549|FG000|Overall Study|Withdrawal by Subject|2|||
130212437|NCT03337048|468739550|FG001|Overall Study|Withdrawal by Subject|0|||
130212438|NCT03337048|468739551|FG002|Overall Study|Withdrawal by Subject|0|||
130212439|NCT02791438|468739552|FG000|Treatment Period|Adverse Event|1|||
130212440|NCT02791438|468739553|FG001|Treatment Period|Adverse Event|0|||
130212441|NCT02791438|468739552|FG000|Treatment Period|Withdrawal by Subject|0|||
130212442|NCT02791438|468739553|FG001|Treatment Period|Withdrawal by Subject|1|||
130212443|NCT02791438|468739552|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
130212444|NCT02791438|468739553|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
130212445|NCT00394771|468739554|FG000|Overall Study|Did not meet protocol requirements|1|||
130212446|NCT00394771|468739555|FG001|Overall Study|Did not meet protocol requirements|0|||
130212447|NCT00394771|468739556|FG002|Overall Study|Did not meet protocol requirements|2|||
130212448|NCT00394771|468739557|FG003|Overall Study|Did not meet protocol requirements|0|||
130212449|NCT00394771|468739554|FG000|Overall Study|Protocol Violation|2|||
130212450|NCT00394771|468739555|FG001|Overall Study|Protocol Violation|4|||
130212451|NCT00394771|468739556|FG002|Overall Study|Protocol Violation|9|||
130212452|NCT00394771|468739557|FG003|Overall Study|Protocol Violation|7|||
130212453|NCT00394771|468739554|FG000|Overall Study|Withdrawal by Subject|10|||
130212454|NCT00394771|468739555|FG001|Overall Study|Withdrawal by Subject|6|||
130212455|NCT00394771|468739556|FG002|Overall Study|Withdrawal by Subject|8|||
130212456|NCT00394771|468739557|FG003|Overall Study|Withdrawal by Subject|12|||
130212457|NCT00394771|468739554|FG000|Overall Study|Adverse Event|10|||
130212458|NCT00394771|468739555|FG001|Overall Study|Adverse Event|5|||
130212459|NCT00394771|468739556|FG002|Overall Study|Adverse Event|12|||
130212460|NCT00394771|468739557|FG003|Overall Study|Adverse Event|8|||
130212461|NCT00394771|468739554|FG000|Overall Study|Participant pregnant|0|||
130212462|NCT00394771|468739555|FG001|Overall Study|Participant pregnant|1|||
130212463|NCT00394771|468739556|FG002|Overall Study|Participant pregnant|2|||
130212464|NCT00394771|468739557|FG003|Overall Study|Participant pregnant|2|||
130212465|NCT00394771|468739554|FG000|Overall Study|Lost to Follow-up|15|||
130212466|NCT00394771|468739555|FG001|Overall Study|Lost to Follow-up|15|||
130212467|NCT00394771|468739556|FG002|Overall Study|Lost to Follow-up|13|||
130212468|NCT00394771|468739557|FG003|Overall Study|Lost to Follow-up|10|||
130212469|NCT00394771|468739554|FG000|Overall Study|Other|3|||
130212470|NCT00394771|468739555|FG001|Overall Study|Other|3|||
130212471|NCT00394771|468739556|FG002|Overall Study|Other|1|||
130212472|NCT00394771|468739557|FG003|Overall Study|Other|0|||
130212473|NCT00586898|468739562|FG000|Overall Study|Adverse Event|1|||
130212474|NCT00586898|468739562|FG000|Overall Study|Patiemt Non-compliance|1|||
130212475|NCT00586898|468739562|FG000|Overall Study|Evaluable for Toxicity Only|5|||
130212476|NCT02494401|468739564|FG000|Overall Study|Lost to Follow-up|22|||
130212477|NCT02494401|468739565|FG001|Overall Study|Lost to Follow-up|25|||
130212478|NCT02494401|468739564|FG000|Overall Study|Withdrawal by Subject|3|||
130212479|NCT02494401|468739565|FG001|Overall Study|Withdrawal by Subject|2|||
130212480|NCT00385827|468741115|FG000|Part 1|Adverse Event|1|||
130212481|NCT00385827|468741116|FG001|Part 1|Adverse Event|0|||
130212482|NCT00385827|468741117|FG002|Part 1|Adverse Event|0|||
130212483|NCT00385827|468741115|FG000|Part 1|Death|2|||
130212484|NCT00385827|468741116|FG001|Part 1|Death|0|||
130212485|NCT00385827|468741117|FG002|Part 1|Death|0|||
130212486|NCT00385827|468741115|FG000|Part 1|Lack of Efficacy|5|||
130212487|NCT00385827|468741116|FG001|Part 1|Lack of Efficacy|0|||
130212488|NCT00385827|468741117|FG002|Part 1|Lack of Efficacy|0|||
130212489|NCT00385827|468741115|FG000|Part 1|Other|1|||
130212490|NCT00385827|468741116|FG001|Part 1|Other|0|||
130212491|NCT00385827|468741117|FG002|Part 1|Other|0|||
130212492|NCT00385827|468741115|FG000|Part 2|Adverse Event|0|||
130212493|NCT00385827|468741116|FG001|Part 2|Adverse Event|6|||
130212494|NCT00385827|468741117|FG002|Part 2|Adverse Event|10|||
130212495|NCT00385827|468741115|FG000|Part 2|Death|0|||
130212496|NCT00385827|468741116|FG001|Part 2|Death|0|||
130212497|NCT00385827|468741117|FG002|Part 2|Death|2|||
130212498|NCT00385827|468741115|FG000|Part 2|Lack of Efficacy|0|||
130212499|NCT00385827|468741116|FG001|Part 2|Lack of Efficacy|14|||
130212500|NCT00385827|468741117|FG002|Part 2|Lack of Efficacy|13|||
130212501|NCT00385827|468741115|FG000|Part 2|Randomized but not treated|0|||
130212502|NCT00385827|468741116|FG001|Part 2|Randomized but not treated|2|||
130212503|NCT00385827|468741117|FG002|Part 2|Randomized but not treated|2|||
130212504|NCT00385827|468741115|FG000|Part 2|Other|0|||
130212505|NCT00385827|468741116|FG001|Part 2|Other|11|||
130212506|NCT00385827|468741117|FG002|Part 2|Other|21|||
130212507|NCT00410072|468741118|FG000|Day 1 to Week 48|Adverse Event|1|||
130212508|NCT00410072|468741119|FG001|Day 1 to Week 48|Adverse Event|2|||
130212509|NCT00410072|468741118|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
130212510|NCT00410072|468741119|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
130212511|NCT00410072|468741118|FG000|Day 1 to Week 48|Other|0|||
130212512|NCT00410072|468741119|FG001|Day 1 to Week 48|Other|1|||
130212513|NCT00410072|468741118|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
130212514|NCT00410072|468741119|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
130212515|NCT00410072|468741118|FG000|Day 1 to Week 48|Pregnancy|0|||
130212516|NCT00410072|468741119|FG001|Day 1 to Week 48|Pregnancy|2|||
130212517|NCT00410072|468741118|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
130212518|NCT00410072|468741119|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
130212519|NCT00410072|468741118|FG000|After Week 48 to Week 96|Adverse Event|1|||
130212520|NCT00410072|468741119|FG001|After Week 48 to Week 96|Adverse Event|2|||
130212521|NCT00410072|468741118|FG000|After Week 48 to Week 96|Death|0|||
130212522|NCT00410072|468741119|FG001|After Week 48 to Week 96|Death|1|||
130212523|NCT00410072|468741118|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
130212524|NCT00410072|468741119|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
130212525|NCT00410072|468741118|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
130212526|NCT00410072|468741119|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
130212527|NCT00410072|468741118|FG000|After Week 48 to Week 96|Other|2|||
130212528|NCT00410072|468741119|FG001|After Week 48 to Week 96|Other|0|||
130212529|NCT00410072|468741118|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
130212530|NCT00410072|468741119|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
130212531|NCT00410072|468741118|FG000|After Week 48 to Week 96|Pregnancy|0|||
130212532|NCT00410072|468741119|FG001|After Week 48 to Week 96|Pregnancy|2|||
130212533|NCT00410072|468741118|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
130212534|NCT00410072|468741119|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
130212535|NCT03307837|468741120|FG000|Overall Study|Withdrawal by Subject|0|||
130212536|NCT03307837|468741121|FG001|Overall Study|Withdrawal by Subject|0|||
130212537|NCT03307837|468741122|FG002|Overall Study|Withdrawal by Subject|1|||
130212538|NCT03307837|468741123|FG003|Overall Study|Withdrawal by Subject|0|||
130212539|NCT03307837|468741124|FG004|Overall Study|Withdrawal by Subject|0|||
130212540|NCT03307837|468741125|FG005|Overall Study|Withdrawal by Subject|1|||
130212541|NCT03307837|468741120|FG000|Overall Study|Lost to Follow-up|1|||
130212542|NCT03307837|468741121|FG001|Overall Study|Lost to Follow-up|1|||
130212543|NCT03307837|468741122|FG002|Overall Study|Lost to Follow-up|0|||
130212544|NCT03307837|468741123|FG003|Overall Study|Lost to Follow-up|0|||
130212545|NCT03307837|468741124|FG004|Overall Study|Lost to Follow-up|0|||
130212546|NCT03307837|468741125|FG005|Overall Study|Lost to Follow-up|1|||
130212547|NCT00904917|468741126|FG000|Overall Study|Lost to Follow-up|2|||
130212548|NCT00904917|468741127|FG001|Overall Study|Lost to Follow-up|2|||
130212549|NCT00904917|468741128|FG002|Overall Study|Lost to Follow-up|2|||
130212550|NCT00904917|468741129|FG003|Overall Study|Lost to Follow-up|2|||
130212551|NCT03915626|468741130|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
130212552|NCT02190721|468741138|FG000|Overall Study|Patient was out of the city|0|||
130212553|NCT02190721|468741139|FG001|Overall Study|Patient was out of the city|1|||
130212554|NCT02190721|468741140|FG002|Overall Study|Patient was out of the city|0|||
130212555|NCT05025332|468741142|FG000|Screening|Screen failure|12|||
130212556|NCT05025332|468741142|FG000|Treatment & Follow Up|Protocol Violation|1|||
130212557|NCT05025332|468741142|FG000|Treatment & Follow Up|Adverse Event|4|||
130212558|NCT01928199|468741143|FG000|Overall Study|Lost to Follow-up|2|||
130212559|NCT01928199|468741144|FG001|Overall Study|Lost to Follow-up|1|||
130212560|NCT01928199|468741143|FG000|Overall Study|Withdrawal by Subject|3|||
130212561|NCT01928199|468741144|FG001|Overall Study|Withdrawal by Subject|5|||
130212562|NCT01502956|468741145|FG000|Overall Study|Death|0|||
130212563|NCT01502956|468741146|FG001|Overall Study|Death|2|||
130212564|NCT01502956|468741145|FG000|Overall Study|Lost to Follow-up|14|||
130212565|NCT01502956|468741146|FG001|Overall Study|Lost to Follow-up|11|||
130212566|NCT01502956|468741145|FG000|Overall Study|Physician Decision|2|||
130212567|NCT01502956|468741146|FG001|Overall Study|Physician Decision|3|||
130212568|NCT01502956|468741145|FG000|Overall Study|Withdrawal by Subject|8|||
130212569|NCT01502956|468741146|FG001|Overall Study|Withdrawal by Subject|10|||
130212570|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
130212571|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
130212572|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
130212573|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
130212574|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
130212575|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
130212576|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
130212577|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
130212578|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
130212579|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
130212580|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
130212581|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
130212582|NCT02634801|468741149|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
130212583|NCT02634801|468741150|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
130212584|NCT02634801|468741151|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
130212585|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
130212586|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
130212587|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
130212588|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
130212589|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
130212590|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
130212591|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130212592|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130212593|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
130212594|NCT02634801|468741149|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
130212595|NCT02634801|468741150|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
130212596|NCT02634801|468741151|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
130212597|NCT02634801|468741149|FG000|Follow-up Period|Lost to Follow-up|3|||
130212598|NCT02634801|468741150|FG001|Follow-up Period|Lost to Follow-up|1|||
130212599|NCT02634801|468741151|FG002|Follow-up Period|Lost to Follow-up|2|||
130212600|NCT02634801|468741149|FG000|Follow-up Period|Physician Decision|0|||
130212601|NCT02634801|468741150|FG001|Follow-up Period|Physician Decision|0|||
130212602|NCT02634801|468741151|FG002|Follow-up Period|Physician Decision|1|||
130212603|NCT02634801|468741149|FG000|Follow-up Period|Withdrawal by Subject|1|||
130212604|NCT02634801|468741150|FG001|Follow-up Period|Withdrawal by Subject|2|||
130212605|NCT02634801|468741151|FG002|Follow-up Period|Withdrawal by Subject|5|||
130212606|NCT02634801|468741149|FG000|Follow-up Period|Adverse Event|1|||
130212607|NCT02634801|468741150|FG001|Follow-up Period|Adverse Event|5|||
130212608|NCT02634801|468741151|FG002|Follow-up Period|Adverse Event|0|||
130212609|NCT02626000|468741152|FG000|Overall Study|Decision by Sponsor|1|||
130212610|NCT02626000|468741152|FG000|Overall Study|Death|29|||
130212611|NCT03539484|468741153|FG000|Overall Study|Death|1|||
130212612|NCT03539484|468741154|FG001|Overall Study|Death|0|||
130212613|NCT03539484|468741155|FG002|Overall Study|Death|0|||
130212614|NCT03539484|468741156|FG003|Overall Study|Death|2|||
130212615|NCT03539484|468741157|FG004|Overall Study|Death|8|||
130212616|NCT03539484|468741158|FG005|Overall Study|Death|3|||
130212617|NCT03539484|468741159|FG006|Overall Study|Death|0|||
130212618|NCT03539484|468741153|FG000|Overall Study|Lost to Follow-up|0|||
130212619|NCT03539484|468741154|FG001|Overall Study|Lost to Follow-up|1|||
130212620|NCT03539484|468741155|FG002|Overall Study|Lost to Follow-up|0|||
130212621|NCT03539484|468741156|FG003|Overall Study|Lost to Follow-up|0|||
130212622|NCT03539484|468741157|FG004|Overall Study|Lost to Follow-up|1|||
130212623|NCT03539484|468741158|FG005|Overall Study|Lost to Follow-up|0|||
130212624|NCT03539484|468741159|FG006|Overall Study|Lost to Follow-up|0|||
130212625|NCT03539484|468741153|FG000|Overall Study|Withdrawal by Subject|0|||
130212626|NCT03539484|468741154|FG001|Overall Study|Withdrawal by Subject|0|||
130212627|NCT03539484|468741155|FG002|Overall Study|Withdrawal by Subject|0|||
130212628|NCT03539484|468741156|FG003|Overall Study|Withdrawal by Subject|0|||
130212629|NCT03539484|468741157|FG004|Overall Study|Withdrawal by Subject|2|||
130212630|NCT03539484|468741158|FG005|Overall Study|Withdrawal by Subject|0|||
130212631|NCT03539484|468741159|FG006|Overall Study|Withdrawal by Subject|1|||
130212632|NCT03539484|468741153|FG000|Overall Study|Study Terminated by Sponsor|0|||
130212633|NCT03539484|468741154|FG001|Overall Study|Study Terminated by Sponsor|0|||
130212634|NCT03539484|468741155|FG002|Overall Study|Study Terminated by Sponsor|1|||
130212635|NCT03539484|468741156|FG003|Overall Study|Study Terminated by Sponsor|1|||
130212636|NCT03539484|468741157|FG004|Overall Study|Study Terminated by Sponsor|2|||
130212637|NCT03539484|468741158|FG005|Overall Study|Study Terminated by Sponsor|2|||
130212638|NCT03539484|468741159|FG006|Overall Study|Study Terminated by Sponsor|1|||
130212639|NCT02476916|468741160|FG000|Core Period|Adverse Event|2|||
130212640|NCT02476916|468741161|FG001|Core Period|Adverse Event|2|||
130212641|NCT02476916|468741160|FG000|Core Period|Investigator decision|1|||
129985713|NCT04811131|467909333|FG000|Overall Study|Withdrawal by Subject|3|||
130212642|NCT02476916|468741161|FG001|Core Period|Investigator decision|1|||
130212643|NCT02476916|468741160|FG000|Core Period|Withdrawal by Subject|3|||
130212644|NCT02476916|468741161|FG001|Core Period|Withdrawal by Subject|0|||
130212645|NCT02476916|468741160|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
130212646|NCT02476916|468741161|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
130212647|NCT02476916|468741160|FG000|Extension Period|On Treatment|12|||
130212648|NCT02476916|468741161|FG001|Extension Period|On Treatment|17|||
130212649|NCT06010732|468741162|FG000|Crossover Period 1|Protocol Violation|0|||
130212650|NCT06010732|468741163|FG001|Crossover Period 1|Protocol Violation|0|||
130212651|NCT06010732|468741164|FG002|Crossover Period 1|Protocol Violation|1|||
130212652|NCT06010732|468741165|FG003|Crossover Period 1|Protocol Violation|0|||
130212653|NCT06010732|468741166|FG004|Crossover Period 1|Protocol Violation|1|||
130212654|NCT06010732|468741167|FG005|Crossover Period 1|Protocol Violation|0|||
130212655|NCT06010732|468741162|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212656|NCT06010732|468741163|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
130212657|NCT06010732|468741164|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212658|NCT06010732|468741165|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212659|NCT06010732|468741166|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212660|NCT06010732|468741167|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
130212661|NCT06010732|468741162|FG000|Crossover Period 2|Adverse Event|0|||
130212662|NCT06010732|468741163|FG001|Crossover Period 2|Adverse Event|1|||
130212663|NCT06010732|468741164|FG002|Crossover Period 2|Adverse Event|0|||
130212664|NCT06010732|468741165|FG003|Crossover Period 2|Adverse Event|0|||
130212665|NCT06010732|468741166|FG004|Crossover Period 2|Adverse Event|0|||
130212666|NCT06010732|468741167|FG005|Crossover Period 2|Adverse Event|0|||
130212667|NCT06010732|468741162|FG000|Crossover Period 2|broken denture|0|||
130212668|NCT06010732|468741163|FG001|Crossover Period 2|broken denture|0|||
130212669|NCT06010732|468741164|FG002|Crossover Period 2|broken denture|1|||
130212670|NCT06010732|468741165|FG003|Crossover Period 2|broken denture|0|||
130212671|NCT06010732|468741166|FG004|Crossover Period 2|broken denture|0|||
130212672|NCT06010732|468741167|FG005|Crossover Period 2|broken denture|0|||
130212673|NCT04401202|468741168|FG000|Overall Study|Lost to Follow-up|2|||
130212674|NCT04401202|468741169|FG001|Overall Study|Lost to Follow-up|2|||
130212675|NCT04401202|468741168|FG000|Overall Study|Adverse Event|0|||
130212676|NCT04401202|468741169|FG001|Overall Study|Adverse Event|1|||
130212677|NCT04401202|468741168|FG000|Overall Study|Hospitalized|4|||
130212678|NCT04401202|468741169|FG001|Overall Study|Hospitalized|1|||
130212679|NCT00329745|468741172|FG000|Overall Study|Protocol Violation|1|||
130212680|NCT00329745|468741173|FG001|Overall Study|Protocol Violation|0|||
130212681|NCT00329745|468741172|FG000|Overall Study|Withdrawal by Subject|0|||
130212682|NCT00329745|468741173|FG001|Overall Study|Withdrawal by Subject|1|||
130212683|NCT00329745|468741172|FG000|Overall Study|Lost to Follow-up|86|||
130212684|NCT00329745|468741173|FG001|Overall Study|Lost to Follow-up|101|||
130212685|NCT01597492|468741174|FG000|Overall Study|Withdrawal by Subject|1|||
130212686|NCT01597492|468741175|FG001|Overall Study|Withdrawal by Subject|2|||
130212687|NCT01597492|468741174|FG000|Overall Study|Adverse Event|3|||
130212688|NCT01597492|468741175|FG001|Overall Study|Adverse Event|0|||
130212689|NCT01597492|468741174|FG000|Overall Study|Lost to Follow-up|0|||
130212690|NCT01597492|468741175|FG001|Overall Study|Lost to Follow-up|2|||
130212691|NCT01597492|468741174|FG000|Overall Study|Other Reason|2|||
130212692|NCT01597492|468741175|FG001|Overall Study|Other Reason|0|||
130212693|NCT01939223|468741179|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
130212694|NCT01939223|468741180|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
130212695|NCT01939223|468741179|FG000|Overall Study|Disease recurrence (radiological)|1|||
130212696|NCT01939223|468741180|FG001|Overall Study|Disease recurrence (radiological)|3|||
130212697|NCT01939223|468741179|FG000|Overall Study|Study stopped by Sponsor|5|||
130212698|NCT01939223|468741180|FG001|Overall Study|Study stopped by Sponsor|7|||
130212699|NCT01939223|468741179|FG000|Overall Study|Withdrawal by Subject|6|||
130212700|NCT01939223|468741180|FG001|Overall Study|Withdrawal by Subject|0|||
130212701|NCT03624569|468741181|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130212702|NCT03624569|468741182|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130212703|NCT03624569|468741181|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
130212704|NCT03624569|468741182|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
130212705|NCT01557517|468741183|FG000|Overall Study|Death|1|||
130212706|NCT01557517|468741184|FG001|Overall Study|Death|0|||
130212707|NCT01557517|468741183|FG000|Overall Study|Refused further treatment|0|||
130212708|NCT01557517|468741184|FG001|Overall Study|Refused further treatment|2|||
130212709|NCT01557517|468741183|FG000|Overall Study|Adverse Event|0|||
130212710|NCT01557517|468741184|FG001|Overall Study|Adverse Event|2|||
130212711|NCT01557517|468741183|FG000|Overall Study|Pt declined before treatment started|1|||
130212712|NCT01557517|468741184|FG001|Overall Study|Pt declined before treatment started|0|||
130212713|NCT01204918|468741195|FG000|Overall Study|Withdrawal by Subject|4|||
130212714|NCT01204918|468741196|FG001|Overall Study|Withdrawal by Subject|10|||
130212715|NCT01204918|468741197|FG002|Overall Study|Withdrawal by Subject|5|||
130212716|NCT01853696|468741200|FG000|Overall Study|Withdrawal by Subject|1|||
130212717|NCT01853696|468741201|FG001|Overall Study|Withdrawal by Subject|1|||
130212718|NCT01853696|468741200|FG000|Overall Study|Lost to Follow-up|5|||
130212719|NCT01853696|468741201|FG001|Overall Study|Lost to Follow-up|4|||
130212720|NCT00849290|468741204|FG000|Overall Study|Adverse Event|3|||
130212721|NCT00849290|468741204|FG000|Overall Study|Death|14|||
130212722|NCT00849290|468741204|FG000|Overall Study|Withdrawal by Subject|11|||
130212723|NCT00849290|468741204|FG000|Overall Study|Lost to Follow-up|2|||
130212724|NCT00849290|468741204|FG000|Overall Study|Protocol Violation|5|||
130212725|NCT00849290|468741204|FG000|Overall Study|Disease Progression|20|||
130212726|NCT01119846|468741209|FG000|Overall Study|Adverse Event|1|||
130212727|NCT01119846|468741210|FG001|Overall Study|Adverse Event|0|||
130212728|NCT01119846|468741211|FG002|Overall Study|Adverse Event|6|||
130212729|NCT01119846|468741209|FG000|Overall Study|Physician Decision|1|||
130212730|NCT01119846|468741210|FG001|Overall Study|Physician Decision|0|||
130212731|NCT01119846|468741211|FG002|Overall Study|Physician Decision|0|||
130212732|NCT01119846|468741209|FG000|Overall Study|Protocol Violation|0|||
130212733|NCT01119846|468741210|FG001|Overall Study|Protocol Violation|0|||
130212734|NCT01119846|468741211|FG002|Overall Study|Protocol Violation|1|||
130212735|NCT01119846|468741209|FG000|Overall Study|Withdrawal by Subject|0|||
130212736|NCT01119846|468741210|FG001|Overall Study|Withdrawal by Subject|0|||
130212737|NCT01119846|468741211|FG002|Overall Study|Withdrawal by Subject|4|||
130212738|NCT03304184|468741216|FG000|Overall Study|Withdrawal by Subject|1|||
130212739|NCT03304184|468741217|FG001|Overall Study|Withdrawal by Subject|2|||
130212740|NCT01605825|468741222|FG000|Overall Study|Adverse Event|4|||
130212741|NCT01605825|468741223|FG001|Overall Study|Adverse Event|2|||
130212742|NCT01605825|468741222|FG000|Overall Study|Withdrawal by Subject|0|||
130212743|NCT01605825|468741223|FG001|Overall Study|Withdrawal by Subject|1|||
130212744|NCT01605825|468741222|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
130212745|NCT01605825|468741223|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
130212746|NCT01605825|468741222|FG000|Overall Study|Non-Compliance with Protocol|3|||
130212747|NCT01605825|468741223|FG001|Overall Study|Non-Compliance with Protocol|0|||
130212748|NCT03244618|468741228|FG000|Overall Study|Lost to Follow-up|3|||
130212749|NCT03244618|468741229|FG001|Overall Study|Lost to Follow-up|4|||
130212750|NCT03244618|468741228|FG000|Overall Study|Protocol Violation|4|||
130212751|NCT03244618|468741229|FG001|Overall Study|Protocol Violation|3|||
130212752|NCT03244618|468741228|FG000|Overall Study|Withdrawal by Subject|0|||
130212753|NCT03244618|468741229|FG001|Overall Study|Withdrawal by Subject|2|||
130212754|NCT00913770|468741231|FG000|Overall Study|Unable to contact|24|||
130212755|NCT00913770|468741232|FG001|Overall Study|Unable to contact|19|||
130212756|NCT00913770|468741233|FG002|Overall Study|Unable to contact|13|||
130212757|NCT00913770|468741231|FG000|Overall Study|Refused|11|||
130212758|NCT00913770|468741232|FG001|Overall Study|Refused|10|||
130212759|NCT00913770|468741233|FG002|Overall Study|Refused|8|||
130212760|NCT03816007|468741236|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
130212761|NCT03816007|468741237|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
130212762|NCT03816007|468741236|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
130212763|NCT03816007|468741237|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
130212764|NCT03816007|468741236|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
130212765|NCT03816007|468741237|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
130212766|NCT01926197|468741238|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
130212767|NCT01926197|468741239|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
130212768|NCT01926197|468741238|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
130212769|NCT01926197|468741239|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
130212770|NCT01428115|468741241|FG000|Overall Study|Lack of Efficacy|3|||
130212771|NCT01428115|468741241|FG000|Overall Study|Lost to Follow-up|10|||
130212772|NCT01428115|468741241|FG000|Overall Study|Pregnancy|1|||
130212773|NCT01428115|468741241|FG000|Overall Study|Protocol Violation|3|||
130212774|NCT01428115|468741241|FG000|Overall Study|Withdrawal by Subject|4|||
130212775|NCT02620384|468741242|FG000|Overall Study|Adverse Event|2|||
130212776|NCT02620384|468741243|FG001|Overall Study|Adverse Event|1|||
130212777|NCT02620384|468741242|FG000|Overall Study|Discharged prior to 2nd dose|2|||
130212778|NCT02620384|468741243|FG001|Overall Study|Discharged prior to 2nd dose|5|||
130212779|NCT02620384|468741242|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
130212780|NCT02620384|468741243|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
130212781|NCT02101359|468741244|FG000|Overall Study|Not included|23|||
130212782|NCT02101359|468741245|FG001|Overall Study|Not included|13|||
130212783|NCT02101359|468741244|FG000|Overall Study|Withdrawal by Subject|5|||
130212784|NCT02101359|468741245|FG001|Overall Study|Withdrawal by Subject|4|||
130212785|NCT02101359|468741244|FG000|Overall Study|Lost to Follow-up|1|||
130212786|NCT02101359|468741245|FG001|Overall Study|Lost to Follow-up|0|||
130212787|NCT02101359|468741244|FG000|Overall Study|Protocol Violation|0|||
130212788|NCT02101359|468741245|FG001|Overall Study|Protocol Violation|2|||
130212789|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
130212790|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212791|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212792|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
130212793|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
130212794|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
130212795|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
130212796|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212797|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212798|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212799|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212800|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212801|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212802|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
130212803|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212804|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130212805|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212806|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130212807|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212808|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212809|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
130212810|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212811|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212812|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212813|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212814|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212815|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212816|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
130212817|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
130212818|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212819|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212820|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212821|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212822|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212823|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212824|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212825|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212826|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212827|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212828|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212829|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212830|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
130212831|NCT01483599|468741247|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
130212832|NCT01483599|468741248|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
130212833|NCT01483599|468741249|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
130212834|NCT01483599|468741250|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
130212835|NCT01483599|468741251|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
130212836|NCT01483599|468741252|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
130212837|NCT01483599|468741253|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
130212838|NCT01483599|468741254|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
130212839|NCT01483599|468741255|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
130212840|NCT01483599|468741256|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
130212841|NCT01483599|468741257|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
130212842|NCT01483599|468741258|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
130212843|NCT01483599|468741259|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
130212844|NCT01483599|468741260|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
130212845|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
130212846|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
130212847|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
130212848|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
130212849|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
130212850|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
130212851|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
130212852|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
130212853|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
130212854|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
130212855|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
130212856|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
130212857|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
130212858|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
130212859|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212860|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212861|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212862|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212863|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212864|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212865|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212866|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212867|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212868|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212869|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212870|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
130212871|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212872|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
130212873|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212874|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212875|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212876|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212877|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212878|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212879|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212880|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212881|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130212882|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212883|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212884|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130212885|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
130212886|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
130212887|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212888|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212889|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212890|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212891|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212892|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212893|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212894|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212895|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
130212896|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212897|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
130212898|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212899|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
130212900|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
130212901|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212902|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212903|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212904|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212905|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212906|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212907|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212908|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212909|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
130212910|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212911|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212912|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
130212913|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
130212914|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
130212915|NCT01483599|468741247|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
130212916|NCT01483599|468741248|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
130212917|NCT01483599|468741249|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
130212918|NCT01483599|468741250|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
130212919|NCT01483599|468741251|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
130212920|NCT01483599|468741252|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
130212921|NCT01483599|468741253|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
130212922|NCT01483599|468741254|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
130212923|NCT01483599|468741255|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
130212924|NCT01483599|468741256|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
130212925|NCT01483599|468741257|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
130212926|NCT01483599|468741258|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
130212927|NCT01483599|468741259|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
130212928|NCT01483599|468741260|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
130212929|NCT00966355|468741261|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
130212930|NCT00966355|468741262|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
130212931|NCT00966355|468741263|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
130212932|NCT00966355|468741261|FG000|Overall Study|newly diagnosed advanced HCC|11|||
130212933|NCT00966355|468741262|FG001|Overall Study|newly diagnosed advanced HCC|12|||
130212934|NCT00966355|468741263|FG002|Overall Study|newly diagnosed advanced HCC|10|||
130212935|NCT00966355|468741261|FG000|Overall Study|Lost to Follow-up|5|||
130212936|NCT00966355|468741262|FG001|Overall Study|Lost to Follow-up|4|||
130212937|NCT00966355|468741263|FG002|Overall Study|Lost to Follow-up|3|||
130212938|NCT01421147|468742909|FG000|Treatment Period|Adverse Event|2|||
130212939|NCT01421147|468742910|FG001|Treatment Period|Adverse Event|3|||
130212940|NCT01421147|468742909|FG000|Treatment Period|Lost to Follow-up|2|||
130212941|NCT01421147|468742910|FG001|Treatment Period|Lost to Follow-up|1|||
130212942|NCT01421147|468742909|FG000|Treatment Period|Physician Decision|2|||
130212943|NCT01421147|468742910|FG001|Treatment Period|Physician Decision|2|||
130212944|NCT01421147|468742909|FG000|Treatment Period|Withdrawal by Subject|10|||
130212945|NCT01421147|468742910|FG001|Treatment Period|Withdrawal by Subject|5|||
130212946|NCT01421147|468742909|FG000|Extension Period|Adverse Event|0|||
130212947|NCT01421147|468742910|FG001|Extension Period|Adverse Event|2|||
130212948|NCT01421147|468742909|FG000|Extension Period|Death|0|||
130212949|NCT01421147|468742910|FG001|Extension Period|Death|1|||
130212950|NCT01421147|468742909|FG000|Extension Period|Lost to Follow-up|2|||
130212951|NCT01421147|468742910|FG001|Extension Period|Lost to Follow-up|5|||
130212952|NCT01421147|468742909|FG000|Extension Period|Physician Decision|1|||
130212953|NCT01421147|468742910|FG001|Extension Period|Physician Decision|0|||
130212954|NCT01421147|468742909|FG000|Extension Period|Withdrawal by Subject|5|||
130212955|NCT01421147|468742910|FG001|Extension Period|Withdrawal by Subject|3|||
130212956|NCT02155309|468742914|FG000|Overall Study|Protocol Violation|0|||
130212957|NCT02155309|468742915|FG001|Overall Study|Protocol Violation|0|||
130212958|NCT02155309|468742916|FG002|Overall Study|Protocol Violation|1|||
130212959|NCT04676152|468742917|FG000|Overall Study|screen fail|9|||
130212960|NCT00662311|468742929|FG000|Overall Study|Respiratory Infection|1|||
130212961|NCT00662311|468742930|FG001|Overall Study|Respiratory Infection|0|||
130212962|NCT00662311|468742931|FG002|Overall Study|Respiratory Infection|0|||
130212963|NCT01467271|468742932|FG000|Overall Study|Death|84|||
130212964|NCT01467271|468742932|FG000|Overall Study|Lost to Follow-up|83|||
130212965|NCT01467271|468742932|FG000|Overall Study|Retraction of patient's consent|21|||
130212966|NCT01467271|468742932|FG000|Overall Study|Other reason|14|||
130212967|NCT02335346|468742951|FG000|Overall Study|Adverse Event|11|||
130212968|NCT02335346|468742951|FG000|Overall Study|Withdrawal by Subject|1|||
130212969|NCT01548768|468742952|FG000|Overall Study|Withdrawal by Subject|0|||
130212970|NCT01548768|468742953|FG001|Overall Study|Withdrawal by Subject|2|||
130212971|NCT01548768|468742954|FG002|Overall Study|Withdrawal by Subject|1|||
130212972|NCT01548768|468742955|FG003|Overall Study|Withdrawal by Subject|0|||
130212973|NCT01548768|468742952|FG000|Overall Study|Physician Decision|1|||
130212974|NCT01548768|468742953|FG001|Overall Study|Physician Decision|0|||
130212975|NCT01548768|468742954|FG002|Overall Study|Physician Decision|0|||
130212976|NCT01548768|468742955|FG003|Overall Study|Physician Decision|0|||
130212977|NCT01548768|468742952|FG000|Overall Study|Adverse Event|0|||
130212978|NCT01548768|468742953|FG001|Overall Study|Adverse Event|0|||
130212979|NCT01548768|468742954|FG002|Overall Study|Adverse Event|0|||
130212980|NCT01548768|468742955|FG003|Overall Study|Adverse Event|1|||
130212981|NCT01548768|468742952|FG000|Overall Study|Non-Compliance|0|||
130212982|NCT01548768|468742953|FG001|Overall Study|Non-Compliance|0|||
130212983|NCT01548768|468742954|FG002|Overall Study|Non-Compliance|0|||
130212984|NCT01548768|468742955|FG003|Overall Study|Non-Compliance|3|||
130212985|NCT03300050|468742956|FG000|Overall Study|Lost to Follow-up|2|||
130212986|NCT03300050|468742957|FG001|Overall Study|Lost to Follow-up|1|||
130212987|NCT03300050|468742958|FG002|Overall Study|Lost to Follow-up|0|||
130212988|NCT03300050|468742959|FG003|Overall Study|Lost to Follow-up|0|||
130212989|NCT03300050|468742960|FG004|Overall Study|Lost to Follow-up|1|||
130212990|NCT03300050|468742956|FG000|Overall Study|Withdrawal by Subject|1|||
130212991|NCT03300050|468742957|FG001|Overall Study|Withdrawal by Subject|1|||
130212992|NCT03300050|468742958|FG002|Overall Study|Withdrawal by Subject|1|||
129875403|NCT04707196|467501951|FG000|Overall Study|Death|3|||
130212993|NCT03300050|468742959|FG003|Overall Study|Withdrawal by Subject|0|||
130212994|NCT03300050|468742960|FG004|Overall Study|Withdrawal by Subject|0|||
130212995|NCT03300050|468742956|FG000|Overall Study|Death|0|||
130212996|NCT03300050|468742957|FG001|Overall Study|Death|0|||
130212997|NCT03300050|468742958|FG002|Overall Study|Death|1|||
130212998|NCT03300050|468742959|FG003|Overall Study|Death|0|||
130212999|NCT03300050|468742960|FG004|Overall Study|Death|0|||
130213000|NCT03300050|468742956|FG000|Overall Study|Not Eligible at Randomization|0|||
130213001|NCT03300050|468742957|FG001|Overall Study|Not Eligible at Randomization|0|||
130213002|NCT03300050|468742958|FG002|Overall Study|Not Eligible at Randomization|1|||
130213003|NCT03300050|468742959|FG003|Overall Study|Not Eligible at Randomization|1|||
130213004|NCT03300050|468742960|FG004|Overall Study|Not Eligible at Randomization|0|||
130213005|NCT02178358|468742974|FG000|Overall Study|Withdrawal by Subject|0|||
130213006|NCT02178358|468742975|FG001|Overall Study|Withdrawal by Subject|2|||
130213007|NCT02178358|468742976|FG002|Overall Study|Withdrawal by Subject|2|||
130213008|NCT02178358|468742974|FG000|Overall Study|Lost to Follow-up|1|||
130213009|NCT02178358|468742975|FG001|Overall Study|Lost to Follow-up|0|||
130213010|NCT02178358|468742976|FG002|Overall Study|Lost to Follow-up|0|||
130213011|NCT01066663|468742977|FG000|Overall Study|Adverse Event|0|||
130213012|NCT01066663|468742978|FG001|Overall Study|Adverse Event|0|||
130213013|NCT01066663|468742979|FG002|Overall Study|Adverse Event|1|||
130213014|NCT02985021|468742980|FG000|Overall Study|Inability to comply with study procedures|1|||
130213015|NCT01090050|468742981|FG000|Overall Study|Lost to Follow-up|0|||
130213016|NCT01090050|468742982|FG001|Overall Study|Lost to Follow-up|1|||
130213017|NCT01090050|468742981|FG000|Overall Study|Lack of Efficacy|1|||
130213018|NCT01090050|468742982|FG001|Overall Study|Lack of Efficacy|5|||
130213019|NCT01090050|468742981|FG000|Overall Study|Physician Decision|0|||
130213020|NCT01090050|468742982|FG001|Overall Study|Physician Decision|1|||
130213021|NCT02232061|468742983|FG000|Overall Study|Administrative problems|1|||
130213022|NCT02232061|468742983|FG000|Overall Study|Withdrawal by Subject|1|||
130213023|NCT00560703|468742985|FG000|Overall Study|Adverse Event|0|||
130213024|NCT00560703|468742986|FG001|Overall Study|Adverse Event|2|||
130213025|NCT00560703|468742985|FG000|Overall Study|Protocol Violation|0|||
130213026|NCT00560703|468742986|FG001|Overall Study|Protocol Violation|2|||
130213027|NCT00560703|468742985|FG000|Overall Study|Withdrawal by Subject|0|||
130213028|NCT00560703|468742986|FG001|Overall Study|Withdrawal by Subject|1|||
130213029|NCT00560703|468742985|FG000|Overall Study|non-compliance|0|||
130213030|NCT00560703|468742986|FG001|Overall Study|non-compliance|1|||
130213031|NCT00790556|468742988|FG000|Treatment Period 1|Physician Decision|1|||
130213032|NCT00790556|468742989|FG001|Treatment Period 1|Physician Decision|0|||
130213033|NCT00790556|468742988|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130213034|NCT00790556|468742989|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130213035|NCT00339833|468742992|FG000|Overall Study|Withdrawal by Subject|1|||
130213036|NCT00339833|468742993|FG001|Overall Study|Withdrawal by Subject|2|||
130213037|NCT00339833|468742992|FG000|Overall Study|toothache|0|||
130213038|NCT00339833|468742993|FG001|Overall Study|toothache|1|||
130213039|NCT00339833|468742992|FG000|Overall Study|indigestion|0|||
130213040|NCT00339833|468742993|FG001|Overall Study|indigestion|1|||
130213041|NCT00339833|468742992|FG000|Overall Study|Chest pain|0|||
130213042|NCT00339833|468742993|FG001|Overall Study|Chest pain|1|||
130213043|NCT00339833|468742992|FG000|Overall Study|minor infection|0|||
130213044|NCT00339833|468742993|FG001|Overall Study|minor infection|1|||
130213045|NCT00339833|468742992|FG000|Overall Study|Poor venous access|2|||
130213046|NCT00339833|468742993|FG001|Overall Study|Poor venous access|2|||
130213047|NCT00339833|468742992|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
130213048|NCT00339833|468742993|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
130213049|NCT00339833|468742992|FG000|Overall Study|Error in data records|1|||
130213050|NCT00339833|468742993|FG001|Overall Study|Error in data records|0|||
130213051|NCT00482170|468742996|FG000|Overall Study|Adverse Event|5|||
130213052|NCT00482170|468742997|FG001|Overall Study|Adverse Event|14|||
130213053|NCT00482170|468742996|FG000|Overall Study|Withdrawal by Subject|6|||
130213054|NCT00482170|468742997|FG001|Overall Study|Withdrawal by Subject|1|||
130213055|NCT00482170|468742996|FG000|Overall Study|Protocol Violation|2|||
130213056|NCT00482170|468742997|FG001|Overall Study|Protocol Violation|3|||
130213057|NCT00482170|468742996|FG000|Overall Study|Lost to Follow-up|2|||
130213058|NCT00482170|468742997|FG001|Overall Study|Lost to Follow-up|0|||
130213059|NCT00482170|468742996|FG000|Overall Study|Unspecified reason|0|||
130213060|NCT00482170|468742997|FG001|Overall Study|Unspecified reason|2|||
130213061|NCT00162097|468742998|FG000|Overall Study|Participant no longer met study criteria|0|||
130213062|NCT00162097|468742999|FG001|Overall Study|Participant no longer met study criteria|0|||
130213063|NCT00162097|468743000|FG002|Overall Study|Participant no longer met study criteria|0|||
130213064|NCT00162097|468743001|FG003|Overall Study|Participant no longer met study criteria|1|||
130213065|NCT03585712|468743004|FG000|Treatment Period 1|Protocol Violation|1|||
130213066|NCT03585712|468743005|FG001|Treatment Period 1|Protocol Violation|0|||
130213067|NCT03585712|468743006|FG002|Treatment Period 1|Protocol Violation|0|||
130213068|NCT03585712|468743004|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
130213069|NCT03585712|468743005|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
130213070|NCT03585712|468743006|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
130213071|NCT03585712|468743004|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
130213072|NCT03585712|468743005|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
130213073|NCT03585712|468743006|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
130213074|NCT03585712|468743004|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
130213075|NCT03585712|468743005|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
130213076|NCT03585712|468743006|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
130213077|NCT03004924|468743013|FG000|Overall Study|Adverse Event|6|||
130213078|NCT03004924|468743014|FG001|Overall Study|Adverse Event|5|||
130213079|NCT03004924|468743015|FG002|Overall Study|Adverse Event|10|||
130213080|NCT03004924|468743013|FG000|Overall Study|Protocol Violation|4|||
130213081|NCT03004924|468743014|FG001|Overall Study|Protocol Violation|0|||
130213082|NCT03004924|468743015|FG002|Overall Study|Protocol Violation|1|||
130213083|NCT03004924|468743013|FG000|Overall Study|Withdrawal by Subject|5|||
130213084|NCT03004924|468743014|FG001|Overall Study|Withdrawal by Subject|3|||
130213085|NCT03004924|468743015|FG002|Overall Study|Withdrawal by Subject|5|||
130213086|NCT03004924|468743013|FG000|Overall Study|Lost to Follow-up|6|||
130213087|NCT03004924|468743014|FG001|Overall Study|Lost to Follow-up|1|||
130213088|NCT03004924|468743015|FG002|Overall Study|Lost to Follow-up|4|||
130213089|NCT03004924|468743013|FG000|Overall Study|Lack of Efficacy|2|||
130213090|NCT03004924|468743014|FG001|Overall Study|Lack of Efficacy|4|||
130213091|NCT03004924|468743015|FG002|Overall Study|Lack of Efficacy|2|||
130213092|NCT03004924|468743013|FG000|Overall Study|Physician Decision|1|||
130213093|NCT03004924|468743014|FG001|Overall Study|Physician Decision|0|||
130213094|NCT03004924|468743015|FG002|Overall Study|Physician Decision|1|||
130213095|NCT03004924|468743013|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130213096|NCT03004924|468743014|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130213097|NCT03004924|468743015|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130213098|NCT03004924|468743013|FG000|Overall Study|Screen Failure|1|||
130213099|NCT03004924|468743014|FG001|Overall Study|Screen Failure|0|||
130213100|NCT03004924|468743015|FG002|Overall Study|Screen Failure|0|||
130213101|NCT03004924|468743013|FG000|Overall Study|Pregnancy|0|||
130213102|NCT03004924|468743014|FG001|Overall Study|Pregnancy|1|||
130213103|NCT03004924|468743015|FG002|Overall Study|Pregnancy|0|||
130213104|NCT03004924|468743013|FG000|Overall Study|Terminated by Sponsor|0|||
130213105|NCT03004924|468743014|FG001|Overall Study|Terminated by Sponsor|0|||
130213106|NCT03004924|468743015|FG002|Overall Study|Terminated by Sponsor|1|||
130213107|NCT03004924|468743013|FG000|Overall Study|Missed Study Visit|0|||
130213108|NCT03004924|468743014|FG001|Overall Study|Missed Study Visit|0|||
130213109|NCT03004924|468743015|FG002|Overall Study|Missed Study Visit|2|||
130213110|NCT03004924|468743013|FG000|Overall Study|HSV1 Positive|1|||
130213111|NCT03004924|468743014|FG001|Overall Study|HSV1 Positive|0|||
130213112|NCT03004924|468743015|FG002|Overall Study|HSV1 Positive|0|||
130213113|NCT01280682|468743016|FG000|Overall Study|Lost to Follow-up|0|||
130213114|NCT01280682|468743017|FG001|Overall Study|Lost to Follow-up|6|||
130213115|NCT01280682|468743016|FG000|Overall Study|Withdrawal by Subject|0|||
130213116|NCT01280682|468743017|FG001|Overall Study|Withdrawal by Subject|7|||
130213117|NCT00269477|468743020|FG000|Overall Study|Protocol Violation|5|||
130213118|NCT00269477|468743021|FG001|Overall Study|Protocol Violation|5|||
130213119|NCT00269477|468743022|FG002|Overall Study|Protocol Violation|1|||
130213120|NCT00269477|468743023|FG003|Overall Study|Protocol Violation|0|||
130213121|NCT00269477|468743020|FG000|Overall Study|Missed post-vaccination blood draw|0|||
130213122|NCT00269477|468743021|FG001|Overall Study|Missed post-vaccination blood draw|1|||
130213123|NCT00269477|468743022|FG002|Overall Study|Missed post-vaccination blood draw|0|||
130213124|NCT00269477|468743023|FG003|Overall Study|Missed post-vaccination blood draw|0|||
130213125|NCT01964716|468743030|FG000|Overall Study|Withdrawal by Subject|2|||
130213126|NCT01964716|468743031|FG001|Overall Study|Withdrawal by Subject|3|||
130213127|NCT01964716|468743030|FG000|Overall Study|Lost to Follow-up|1|||
130213128|NCT01964716|468743031|FG001|Overall Study|Lost to Follow-up|2|||
130213129|NCT01964716|468743030|FG000|Overall Study|No longer met eligibility criteria|1|||
130213130|NCT01964716|468743031|FG001|Overall Study|No longer met eligibility criteria|1|||
130213131|NCT01964716|468743030|FG000|Overall Study|Death|1|||
130213132|NCT01964716|468743031|FG001|Overall Study|Death|0|||
130213133|NCT01464619|468743032|FG000|Overall Study|Lost to Follow-up|3|||
130213134|NCT01464619|468743033|FG001|Overall Study|Lost to Follow-up|4|||
130213135|NCT00080483|468743038|FG000|Overall Study|Lost to Follow-up|1|||
130213136|NCT00080483|468743039|FG001|Overall Study|Lost to Follow-up|1|||
130213137|NCT00080483|468743038|FG000|Overall Study|Physician Decision|1|||
130213138|NCT00080483|468743039|FG001|Overall Study|Physician Decision|1|||
130213139|NCT04527978|468743040|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
130213140|NCT04527978|468743041|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
130213141|NCT01370616|468743042|FG000|Overall Study|Adverse Event|11|||
130213142|NCT01370616|468743043|FG001|Overall Study|Adverse Event|16|||
130213143|NCT01370616|468743042|FG000|Overall Study|Death|1|||
130213144|NCT01370616|468743043|FG001|Overall Study|Death|0|||
130213145|NCT01370616|468743042|FG000|Overall Study|Lack of Efficacy|6|||
130213146|NCT01370616|468743043|FG001|Overall Study|Lack of Efficacy|2|||
130213147|NCT01370616|468743042|FG000|Overall Study|Lost to Follow-up|0|||
130213148|NCT01370616|468743043|FG001|Overall Study|Lost to Follow-up|3|||
130213149|NCT01370616|468743042|FG000|Overall Study|Physician Decision|6|||
130213150|NCT01370616|468743043|FG001|Overall Study|Physician Decision|6|||
130213151|NCT01370616|468743042|FG000|Overall Study|Progressive Disease|0|||
130213152|NCT01370616|468743043|FG001|Overall Study|Progressive Disease|1|||
130213153|NCT01370616|468743042|FG000|Overall Study|Recovery|1|||
130213154|NCT01370616|468743043|FG001|Overall Study|Recovery|0|||
130213155|NCT01370616|468743042|FG000|Overall Study|Technical Problems|3|||
130213156|NCT01370616|468743043|FG001|Overall Study|Technical Problems|5|||
130213157|NCT01370616|468743042|FG000|Overall Study|Withdrawal by Subject|34|||
130213158|NCT01370616|468743043|FG001|Overall Study|Withdrawal by Subject|34|||
130213159|NCT02324699|468743044|FG000|Overall Study|study terminated|1|||
130213160|NCT01578499|468743047|FG000|Overall Study|Reason not Specified|0|||
130213161|NCT01578499|468743048|FG001|Overall Study|Reason not Specified|1|||
130213162|NCT01578499|468743047|FG000|Overall Study|Lost to Follow-up|2|||
130213163|NCT01578499|468743048|FG001|Overall Study|Lost to Follow-up|1|||
130213164|NCT01578499|468743047|FG000|Overall Study|Withdrawal by Subject|10|||
130213165|NCT01578499|468743048|FG001|Overall Study|Withdrawal by Subject|16|||
130213166|NCT01578499|468743047|FG000|Overall Study|Death|20|||
130213167|NCT01578499|468743048|FG001|Overall Study|Death|25|||
130213168|NCT01578499|468743047|FG000|Overall Study|Died and End of Study Page not Completed|2|||
130213169|NCT01578499|468743048|FG001|Overall Study|Died and End of Study Page not Completed|0|||
130213170|NCT02670382|468743049|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
130213171|NCT02670382|468743050|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
130213172|NCT03469999|468743053|FG000|Overall Study|Lost to Follow-up|2|||
130213173|NCT01863732|468743054|FG000|Overall Study|Adverse Event|2|||
130213174|NCT01863732|468743055|FG001|Overall Study|Adverse Event|0|||
130213175|NCT01863732|468743056|FG002|Overall Study|Adverse Event|3|||
130213176|NCT01863732|468743057|FG003|Overall Study|Adverse Event|3|||
130213177|NCT01863732|468743054|FG000|Overall Study|Lack of Efficacy|1|||
130213178|NCT01863732|468743055|FG001|Overall Study|Lack of Efficacy|0|||
130213179|NCT01863732|468743056|FG002|Overall Study|Lack of Efficacy|2|||
130213180|NCT01863732|468743057|FG003|Overall Study|Lack of Efficacy|1|||
130213181|NCT01863732|468743054|FG000|Overall Study|Lost to Follow-up|2|||
130213182|NCT01863732|468743055|FG001|Overall Study|Lost to Follow-up|2|||
130213183|NCT01863732|468743056|FG002|Overall Study|Lost to Follow-up|1|||
130213184|NCT01863732|468743057|FG003|Overall Study|Lost to Follow-up|1|||
130213185|NCT01863732|468743054|FG000|Overall Study|Physician Decision|1|||
130213186|NCT01863732|468743055|FG001|Overall Study|Physician Decision|0|||
130213187|NCT01863732|468743056|FG002|Overall Study|Physician Decision|1|||
130213188|NCT01863732|468743057|FG003|Overall Study|Physician Decision|0|||
130213189|NCT01863732|468743054|FG000|Overall Study|Pregnancy|0|||
130213190|NCT01863732|468743055|FG001|Overall Study|Pregnancy|0|||
130213191|NCT01863732|468743056|FG002|Overall Study|Pregnancy|0|||
130213192|NCT01863732|468743057|FG003|Overall Study|Pregnancy|1|||
130213193|NCT01863732|468743054|FG000|Overall Study|Technical problems|0|||
130213194|NCT01863732|468743055|FG001|Overall Study|Technical problems|1|||
130213195|NCT01863732|468743056|FG002|Overall Study|Technical problems|1|||
130213196|NCT01863732|468743057|FG003|Overall Study|Technical problems|0|||
130213197|NCT01863732|468743054|FG000|Overall Study|Subject/guardian decision|6|||
130213198|NCT01863732|468743055|FG001|Overall Study|Subject/guardian decision|9|||
130213199|NCT01863732|468743056|FG002|Overall Study|Subject/guardian decision|3|||
130213200|NCT01863732|468743057|FG003|Overall Study|Subject/guardian decision|1|||
130213201|NCT01863732|468743054|FG000|Overall Study|Death|1|||
130213202|NCT01863732|468743055|FG001|Overall Study|Death|0|||
130213203|NCT01863732|468743056|FG002|Overall Study|Death|0|||
130213204|NCT01863732|468743057|FG003|Overall Study|Death|1|||
130213205|NCT00460746|468743058|FG000|Overall Study|Adverse Event|1|||
130213206|NCT00460746|468743058|FG000|Overall Study|Lost to Follow-up|1|||
130213207|NCT00636961|468743064|FG000|Period 1|Administrative problems|1|||
130213208|NCT00636961|468743065|FG001|Period 1|Administrative problems|1|||
130213209|NCT00636961|468743064|FG000|Period 2|Adverse Event|1|||
130213210|NCT00636961|468743065|FG001|Period 2|Adverse Event|0|||
130213211|NCT02223364|468743066|FG000|Overall Study|Protocol Violation|3|||
130213212|NCT02223364|468743067|FG001|Overall Study|Protocol Violation|0|||
130213213|NCT02223364|468743068|FG002|Overall Study|Protocol Violation|3|||
130213214|NCT02223364|468743066|FG000|Overall Study|subject expired before surgery|1|||
130213215|NCT02223364|468743067|FG001|Overall Study|subject expired before surgery|0|||
130213216|NCT02223364|468743068|FG002|Overall Study|subject expired before surgery|0|||
130213217|NCT02223364|468743066|FG000|Overall Study|Physician Decision|1|||
130213218|NCT02223364|468743067|FG001|Overall Study|Physician Decision|0|||
130213219|NCT02223364|468743068|FG002|Overall Study|Physician Decision|0|||
130213220|NCT00742027|468743069|FG000|Overall Study|Disease Progression|76|||
130213221|NCT00742027|468743069|FG000|Overall Study|New Cancer Therapy|19|||
130320364|NCT00506350|469141897|FG005|Overall Study|Lost to Follow-up|1|||
130213222|NCT00742027|468743069|FG000|Overall Study|Withdrawal by Subject|18|||
130213223|NCT00742027|468743069|FG000|Overall Study|Death|7|||
130213224|NCT00742027|468743069|FG000|Overall Study|Lost to Follow-up|4|||
130213225|NCT00742027|468743069|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
130213226|NCT00742027|468743069|FG000|Overall Study|Missing|2|||
130213227|NCT00742027|468743069|FG000|Overall Study|Administrative Problems|1|||
130213228|NCT00171158|468744560|FG000|Core Study|Death|27|||
130213229|NCT00171158|468744560|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
130213230|NCT00171158|468744560|FG000|Core Study|Protocol Violation|4|||
130213231|NCT00171158|468744560|FG000|Core Study|Administrative problems|1|||
130213232|NCT00171158|468744560|FG000|Core Study|Adverse event, non-fatal|21|||
130213233|NCT00171158|468744560|FG000|Core Study|Consent withdrawn by subject|6|||
130213234|NCT00171158|468744560|FG000|Core Study|No longer required drug (BMT)|14|||
130213235|NCT00171158|468744560|FG000|Core Study|Abnormal Laboratory Values|2|||
130213236|NCT00171158|468744560|FG000|Core Study|Lost to Follow-up|1|||
130213237|NCT00171158|468744560|FG000|E2 Extension|Other|7|||
130213238|NCT03536663|468744563|FG000|Endexo|Protocol Violation|1|||
130213239|NCT00762034|468744564|FG000|Induction Period|Protocol Violation|1|||
130213240|NCT00762034|468744565|FG001|Induction Period|Protocol Violation|2|||
130213241|NCT00762034|468744564|FG000|Induction Period|Entry Criterion Not Met|12|||
130213242|NCT00762034|468744565|FG001|Induction Period|Entry Criterion Not Met|11|||
130213243|NCT00762034|468744564|FG000|Induction Period|Adverse Event|27|||
130213244|NCT00762034|468744565|FG001|Induction Period|Adverse Event|38|||
130213245|NCT00762034|468744564|FG000|Induction Period|Lost to Follow-up|1|||
130213246|NCT00762034|468744565|FG001|Induction Period|Lost to Follow-up|1|||
130213247|NCT00762034|468744564|FG000|Induction Period|Progressive Disease|73|||
130213248|NCT00762034|468744565|FG001|Induction Period|Progressive Disease|55|||
130213249|NCT00762034|468744564|FG000|Induction Period|Physician Decision|21|||
130213250|NCT00762034|468744565|FG001|Induction Period|Physician Decision|20|||
130213251|NCT00762034|468744564|FG000|Induction Period|Withdrawal by Subject|15|||
130213252|NCT00762034|468744565|FG001|Induction Period|Withdrawal by Subject|19|||
130213253|NCT00762034|468744564|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
130213254|NCT00762034|468744565|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
130213255|NCT00762034|468744564|FG000|Induction Period|Deaths Due to Study Disease|9|||
130213256|NCT00762034|468744565|FG001|Induction Period|Deaths Due to Study Disease|9|||
130213257|NCT00762034|468744564|FG000|Maintenance Period|Protocol Violation|1|||
130213258|NCT00762034|468744565|FG001|Maintenance Period|Protocol Violation|3|||
130213259|NCT00762034|468744564|FG000|Maintenance Period|Entry Criterion Not Met|0|||
130213260|NCT00762034|468744565|FG001|Maintenance Period|Entry Criterion Not Met|2|||
130213261|NCT00762034|468744564|FG000|Maintenance Period|Adverse Event|42|||
130213262|NCT00762034|468744565|FG001|Maintenance Period|Adverse Event|26|||
130213263|NCT00762034|468744564|FG000|Maintenance Period|Progressive Disease|186|||
130213264|NCT00762034|468744565|FG001|Maintenance Period|Progressive Disease|224|||
130213265|NCT00762034|468744564|FG000|Maintenance Period|Physician Decision|25|||
130213266|NCT00762034|468744565|FG001|Maintenance Period|Physician Decision|20|||
130213267|NCT00762034|468744564|FG000|Maintenance Period|Withdrawal by Subject|34|||
130213268|NCT00762034|468744565|FG001|Maintenance Period|Withdrawal by Subject|14|||
130213269|NCT00762034|468744564|FG000|Maintenance Period|Death not due to study disease|2|||
130213270|NCT00762034|468744565|FG001|Maintenance Period|Death not due to study disease|5|||
130213271|NCT00762034|468744564|FG000|Maintenance Period|Death due to study disease|3|||
130213272|NCT00762034|468744565|FG001|Maintenance Period|Death due to study disease|3|||
130213273|NCT00762034|468744564|FG000|Maintenance Period|Other|1|||
130213274|NCT00762034|468744565|FG001|Maintenance Period|Other|1|||
130213275|NCT02442206|468744566|FG000|Period 1|Adverse Event|1|||
130213276|NCT02442206|468744567|FG001|Period 1|Adverse Event|1|||
130213277|NCT02442206|468744566|FG000|Period 1|withdrew consent|0|||
130213278|NCT02442206|468744567|FG001|Period 1|withdrew consent|1|||
130213279|NCT02442206|468744566|FG000|Period 1|COPD exacerbation|0|||
130213280|NCT02442206|468744567|FG001|Period 1|COPD exacerbation|1|||
130213281|NCT02442206|468744566|FG000|Period 2|Adverse Event|1|||
130213282|NCT02442206|468744567|FG001|Period 2|Adverse Event|0|||
130213283|NCT00497146|468744568|FG000|Treatment Period|Adverse Event|6|||
130213284|NCT00497146|468744569|FG001|Treatment Period|Adverse Event|2|||
130213285|NCT00497146|468744568|FG000|Treatment Period|Withdrawal by Subject|5|||
130213286|NCT00497146|468744569|FG001|Treatment Period|Withdrawal by Subject|9|||
130213287|NCT00497146|468744568|FG000|Treatment Period|Lost to Follow-up|1|||
130213288|NCT00497146|468744569|FG001|Treatment Period|Lost to Follow-up|3|||
130213289|NCT00497146|468744568|FG000|Treatment Period|Required dialysis|4|||
130213290|NCT00497146|468744569|FG001|Treatment Period|Required dialysis|1|||
130213291|NCT00497146|468744568|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
130213292|NCT00497146|468744569|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
130213293|NCT00497146|468744568|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
130213294|NCT00497146|468744569|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
130213295|NCT00497146|468744568|FG000|Treatment Period|Other Reason|2|||
130213296|NCT00497146|468744569|FG001|Treatment Period|Other Reason|3|||
130213297|NCT00497146|468744568|FG000|Long-term Follow-up Period|Adverse Event|2|||
130213298|NCT00497146|468744569|FG001|Long-term Follow-up Period|Adverse Event|2|||
130213299|NCT00497146|468744568|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
130213300|NCT00497146|468744569|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
130213301|NCT00497146|468744568|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
130213302|NCT00497146|468744569|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
130213303|NCT00497146|468744568|FG000|Long-term Follow-up Period|Other|0|||
130213304|NCT00497146|468744569|FG001|Long-term Follow-up Period|Other|1|||
130213305|NCT01471444|468744570|FG000|Overall Study|Physician Decision|3|||
130213306|NCT01471444|468744571|FG001|Overall Study|Physician Decision|2|||
130213307|NCT01471444|468744570|FG000|Overall Study|Withdrawal by Subject|0|||
130213308|NCT01471444|468744571|FG001|Overall Study|Withdrawal by Subject|1|||
130213309|NCT01299896|468744574|FG000|Overall Study|Withdrawal by Subject|1|||
130213310|NCT01299896|468744575|FG001|Overall Study|Withdrawal by Subject|7|||
130213311|NCT01299896|468744574|FG000|Overall Study|Lost to Follow-up|0|||
130213312|NCT01299896|468744575|FG001|Overall Study|Lost to Follow-up|11|||
130213313|NCT02107313|468744576|FG000|Overall Study|One participant did not do the FED cohor|0|||
130213314|NCT02107313|468744577|FG001|Overall Study|One participant did not do the FED cohor|1|||
130213315|NCT00582426|468744588|FG000|Overall Study|Lost to Follow-up|0|||
130213316|NCT00582426|468744589|FG001|Overall Study|Lost to Follow-up|2|||
130213317|NCT00582426|468744588|FG000|Overall Study|Adverse Event|4|||
130213318|NCT00582426|468744589|FG001|Overall Study|Adverse Event|2|||
130213319|NCT00582426|468744588|FG000|Overall Study|Protocol Violation|6|||
130213320|NCT00582426|468744589|FG001|Overall Study|Protocol Violation|2|||
130213321|NCT00582426|468744588|FG000|Overall Study|Death|4|||
130213322|NCT00582426|468744589|FG001|Overall Study|Death|3|||
130213323|NCT00582426|468744588|FG000|Overall Study|Withdrawal by Subject|3|||
130213324|NCT00582426|468744589|FG001|Overall Study|Withdrawal by Subject|2|||
130213325|NCT00582426|468744588|FG000|Overall Study|Disease Progression|2|||
130213326|NCT00582426|468744589|FG001|Overall Study|Disease Progression|2|||
130213327|NCT00582426|468744588|FG000|Overall Study|Use of illicit drugs|1|||
130213328|NCT00582426|468744589|FG001|Overall Study|Use of illicit drugs|0|||
130213329|NCT02164318|468744590|FG000|Overall Study|Withdrawal by Subject|0|||
130213330|NCT02164318|468744591|FG001|Overall Study|Withdrawal by Subject|1|||
130213331|NCT02164318|468744592|FG002|Overall Study|Withdrawal by Subject|0|||
130213332|NCT02164318|468744593|FG003|Overall Study|Withdrawal by Subject|1|||
130213333|NCT04126317|468744597|FG000|Overall Study|Adverse Event|0|||
130213334|NCT04126317|468744598|FG001|Overall Study|Adverse Event|1|||
130213335|NCT04126317|468744597|FG000|Overall Study|Withdrawal by Subject|4|||
130213336|NCT04126317|468744598|FG001|Overall Study|Withdrawal by Subject|1|||
130213337|NCT03297021|468744600|FG000|Overall Study|Incomplete/illegible data sheet|4|||
130213338|NCT03297021|468744601|FG001|Overall Study|Incomplete/illegible data sheet|2|||
130213339|NCT03297021|468744602|FG002|Overall Study|Incomplete/illegible data sheet|3|||
130213340|NCT03297021|468744600|FG000|Overall Study|Missing Post-Op Data|1|||
130213341|NCT03297021|468744601|FG001|Overall Study|Missing Post-Op Data|2|||
130213342|NCT03297021|468744602|FG002|Overall Study|Missing Post-Op Data|1|||
130213343|NCT00948922|468744604|FG000|Overall Study|Did not start study treatment|2|||
130213344|NCT00948922|468744605|FG001|Overall Study|Did not start study treatment|5|||
130213345|NCT00948922|468744606|FG002|Overall Study|Did not start study treatment|0|||
130213346|NCT00948922|468744604|FG000|Overall Study|Withdrawal by Subject|0|||
130213347|NCT00948922|468744605|FG001|Overall Study|Withdrawal by Subject|2|||
130213348|NCT00948922|468744606|FG002|Overall Study|Withdrawal by Subject|1|||
130213349|NCT00948922|468744604|FG000|Overall Study|Death|3|||
130213350|NCT00948922|468744605|FG001|Overall Study|Death|0|||
130213351|NCT00948922|468744606|FG002|Overall Study|Death|0|||
130213352|NCT00948922|468744604|FG000|Overall Study|Disease progression|0|||
130213353|NCT00948922|468744605|FG001|Overall Study|Disease progression|1|||
130213354|NCT00948922|468744606|FG002|Overall Study|Disease progression|0|||
130213355|NCT00948922|468744604|FG000|Overall Study|Insurance issues|1|||
130213356|NCT00948922|468744605|FG001|Overall Study|Insurance issues|0|||
130213357|NCT00948922|468744606|FG002|Overall Study|Insurance issues|0|||
130213358|NCT00948922|468744604|FG000|Overall Study|Transplant eligibility issues|2|||
130213359|NCT00948922|468744605|FG001|Overall Study|Transplant eligibility issues|3|||
130213360|NCT00948922|468744606|FG002|Overall Study|Transplant eligibility issues|0|||
130213361|NCT00948922|468744604|FG000|Overall Study|Not evaluable at time of analysis|0|||
130213362|NCT00948922|468744605|FG001|Overall Study|Not evaluable at time of analysis|3|||
130213363|NCT00948922|468744606|FG002|Overall Study|Not evaluable at time of analysis|0|||
130213364|NCT02095197|468744607|FG000|Overall Study|Lost to Follow-up|0|||
130213365|NCT02095197|468744608|FG001|Overall Study|Lost to Follow-up|3|||
130213366|NCT02829047|468744612|FG000|Overall Study|Withdrawal by Subject|1|||
130213367|NCT03077607|468744614|FG000|Period 1 (15 Days)|Adverse Event|1|||
130213368|NCT03077607|468744615|FG001|Period 1 (15 Days)|Adverse Event|0|||
130213369|NCT03077607|468744614|FG000|Period 1 (15 Days)|Death|1|||
130213370|NCT03077607|468744615|FG001|Period 1 (15 Days)|Death|0|||
129875404|NCT04707196|467501952|FG001|Overall Study|Death|1|||
130213371|NCT03077607|468744614|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
130213372|NCT03077607|468744615|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
130213373|NCT03077607|468744614|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
130320365|NCT00506350|469141898|FG006|Overall Study|Lost to Follow-up|0|||
130213374|NCT03077607|468744615|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
130213375|NCT01658904|468744617|FG000|Overall Study|Principal Investigator discretion|2|||
130213376|NCT01658904|468744618|FG001|Overall Study|Principal Investigator discretion|0|||
130213377|NCT01658904|468744619|FG002|Overall Study|Principal Investigator discretion|0|||
130213378|NCT01603394|468744629|FG000|Overall Study|Adverse Event|1|||
130213379|NCT04399538|468744631|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
130213380|NCT04399538|468744632|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
130213381|NCT04399538|468744633|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
130213382|NCT04399538|468744634|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
130213383|NCT04399538|468744635|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
130213384|NCT04399538|468744631|FG000|Double-Blind Treatment|Adverse Event|0|||
130213385|NCT04399538|468744632|FG001|Double-Blind Treatment|Adverse Event|0|||
130213386|NCT04399538|468744633|FG002|Double-Blind Treatment|Adverse Event|0|||
130213387|NCT04399538|468744634|FG003|Double-Blind Treatment|Adverse Event|0|||
130213388|NCT04399538|468744635|FG004|Double-Blind Treatment|Adverse Event|1|||
130213389|NCT04399538|468744631|FG000|Follow-Up|Adverse Event|0|||
130213390|NCT04399538|468744632|FG001|Follow-Up|Adverse Event|0|||
130213391|NCT04399538|468744633|FG002|Follow-Up|Adverse Event|0|||
130213392|NCT04399538|468744634|FG003|Follow-Up|Adverse Event|0|||
130213393|NCT04399538|468744635|FG004|Follow-Up|Adverse Event|1|||
130213394|NCT04399538|468744631|FG000|Follow-Up|Withdrawal by Subject|0|||
130213395|NCT04399538|468744632|FG001|Follow-Up|Withdrawal by Subject|0|||
130213396|NCT04399538|468744633|FG002|Follow-Up|Withdrawal by Subject|0|||
130213397|NCT04399538|468744634|FG003|Follow-Up|Withdrawal by Subject|2|||
130213398|NCT04399538|468744635|FG004|Follow-Up|Withdrawal by Subject|0|||
130213399|NCT01215435|468744636|FG000|Overall Study|Adverse Event|1|||
130213400|NCT01215435|468744637|FG001|Overall Study|Adverse Event|0|||
130213401|NCT01215435|468744636|FG000|Overall Study|Protocol Violation|2|||
130213402|NCT01215435|468744637|FG001|Overall Study|Protocol Violation|0|||
130213403|NCT01215435|468744636|FG000|Overall Study|Withdrawal Criteria|8|||
130213404|NCT01215435|468744637|FG001|Overall Study|Withdrawal Criteria|11|||
130213405|NCT01215435|468744636|FG000|Overall Study|Lost to Follow-up|3|||
130213406|NCT01215435|468744637|FG001|Overall Study|Lost to Follow-up|0|||
130213407|NCT01215435|468744636|FG000|Overall Study|Unclassified|5|||
130213408|NCT01215435|468744637|FG001|Overall Study|Unclassified|5|||
130213409|NCT00840034|468744638|FG000|Acute Treatment Phase|Adverse Event|6|||
130213410|NCT00840034|468744639|FG001|Acute Treatment Phase|Adverse Event|8|||
130213411|NCT00840034|468744638|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
130213412|NCT00840034|468744639|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
130213413|NCT00840034|468744638|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
130213414|NCT00840034|468744639|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
129875405|NCT04707196|467501951|FG000|Overall Study|Non-compliance with study drug|1|||
129875406|NCT04707196|467501952|FG001|Overall Study|Non-compliance with study drug|0|||
129875407|NCT04707196|467501951|FG000|Overall Study|Progressive disease|9|||
129875408|NCT04707196|467501952|FG001|Overall Study|Progressive disease|10|||
129875409|NCT01862796|467501953|FG000|Overall Study|Prohibited medications|0|||
129875410|NCT01862796|467501954|FG001|Overall Study|Prohibited medications|0|||
129875411|NCT01862796|467501955|FG002|Overall Study|Prohibited medications|1|||
129875412|NCT00728962|467501963|FG000|Implant Placement Surgery|Adverse Event|8|||
129875413|NCT00728962|467501963|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
129875414|NCT00728962|467501963|FG000|Implant Placement Surgery|Protocol Violation|1|||
129875415|NCT00728962|467501963|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
129875416|NCT00728962|467501963|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
129875417|NCT04954586|467501964|FG000|Overall Study|Withdrawal by Subject|5|||
129875418|NCT00779779|467501965|FG000|Overall Study|Adverse Event|1|||
129875419|NCT00779779|467501965|FG000|Overall Study|Protocol Violation|14|||
129875420|NCT00779779|467501965|FG000|Overall Study|Withdrawal by Subject|4|||
129875421|NCT00779779|467501965|FG000|Overall Study|Lost to Follow-up|5|||
129875422|NCT02552238|467501970|FG000|Overall Study|Withdrawal by Subject|2|||
129875423|NCT02552238|467501970|FG000|Overall Study|Adverse Event|2|||
129875424|NCT05158296|467501971|FG000|Overall Study|Sponsor Decision|2|||
129875425|NCT05158296|467501972|FG001|Overall Study|Sponsor Decision|3|||
129875426|NCT05158296|467501973|FG002|Overall Study|Sponsor Decision|2|||
129875427|NCT02036645|467501979|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875428|NCT02036645|467501980|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875429|NCT02036645|467501981|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875430|NCT02036645|467501982|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875431|NCT02036645|467501983|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875432|NCT02036645|467501984|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875433|NCT02036645|467501985|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
129875434|NCT02036645|467501986|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875435|NCT02036645|467501987|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
130213415|NCT00840034|468744638|FG000|Acute Treatment Phase|Physician Decision|0|||
130213416|NCT00840034|468744639|FG001|Acute Treatment Phase|Physician Decision|1|||
130213417|NCT00840034|468744638|FG000|Acute Treatment Phase|Protocol Violation|2|||
130213418|NCT00840034|468744639|FG001|Acute Treatment Phase|Protocol Violation|4|||
130213419|NCT00840034|468744638|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
130213420|NCT00840034|468744639|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
130213421|NCT00840034|468744638|FG000|Taper Phase|Adverse Event|1|||
130213422|NCT00840034|468744639|FG001|Taper Phase|Adverse Event|0|||
130213423|NCT00840034|468744638|FG000|Taper Phase|Lost to Follow-up|1|||
130213424|NCT00840034|468744639|FG001|Taper Phase|Lost to Follow-up|1|||
130213425|NCT00840034|468744638|FG000|Taper Phase|Withdrawal by Subject|1|||
130213426|NCT00840034|468744639|FG001|Taper Phase|Withdrawal by Subject|1|||
130213427|NCT02179749|468744652|FG000|Overall Study|Adverse Event|0|||
130213428|NCT02179749|468744653|FG001|Overall Study|Adverse Event|0|||
130213429|NCT02179749|468744654|FG002|Overall Study|Adverse Event|1|||
130213430|NCT02179749|468744652|FG000|Overall Study|Withdrawal by Subject|0|||
130213431|NCT02179749|468744653|FG001|Overall Study|Withdrawal by Subject|0|||
130213432|NCT02179749|468744654|FG002|Overall Study|Withdrawal by Subject|1|||
129875436|NCT02036645|467501988|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875437|NCT02036645|467501989|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875438|NCT02036645|467501990|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875439|NCT02036645|467501979|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875440|NCT02036645|467501980|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875441|NCT02036645|467501981|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875442|NCT02036645|467501982|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
129875443|NCT02036645|467501983|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
130213433|NCT02756364|468744655|FG000|Overall Study|Site Terminated by Sponsor|24|||
130213434|NCT02756364|468744656|FG001|Overall Study|Site Terminated by Sponsor|30|||
130213435|NCT02756364|468744657|FG002|Overall Study|Site Terminated by Sponsor|21|||
130213436|NCT02756364|468744655|FG000|Overall Study|Death|20|||
129875444|NCT02036645|467501984|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875445|NCT02036645|467501985|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875446|NCT02036645|467501986|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875447|NCT02036645|467501987|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875448|NCT02036645|467501988|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875449|NCT02036645|467501989|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875450|NCT02036645|467501990|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875451|NCT02404389|467501991|FG000|Overall Study|Adverse Event|1|||
130213437|NCT02756364|468744656|FG001|Overall Study|Death|15|||
129875452|NCT02404389|467501992|FG001|Overall Study|Adverse Event|0|||
130213438|NCT02756364|468744657|FG002|Overall Study|Death|18|||
130213439|NCT02756364|468744655|FG000|Overall Study|Withdrawal by Patient|2|||
130213440|NCT02756364|468744656|FG001|Overall Study|Withdrawal by Patient|1|||
130213441|NCT02756364|468744657|FG002|Overall Study|Withdrawal by Patient|8|||
130213442|NCT02756364|468744655|FG000|Overall Study|Lost to Follow-up|0|||
130213443|NCT02756364|468744656|FG001|Overall Study|Lost to Follow-up|1|||
130213444|NCT02756364|468744657|FG002|Overall Study|Lost to Follow-up|1|||
130213445|NCT00793546|468744658|FG000|Overall Study|Death|3|||
130213446|NCT00793546|468744659|FG001|Overall Study|Death|0|||
130213447|NCT00793546|468744658|FG000|Overall Study|Lost to Follow-up|1|||
130213448|NCT00793546|468744659|FG001|Overall Study|Lost to Follow-up|0|||
130213449|NCT00793546|468744658|FG000|Overall Study|Withdrawal by Subject|1|||
130213450|NCT00793546|468744659|FG001|Overall Study|Withdrawal by Subject|1|||
130213451|NCT00793546|468744658|FG000|Overall Study|Study Terminated by Sponsor|8|||
130213452|NCT00793546|468744659|FG001|Overall Study|Study Terminated by Sponsor|27|||
130213453|NCT00793546|468744658|FG000|Overall Study|Other|1|||
130213454|NCT00793546|468744659|FG001|Overall Study|Other|0|||
130213455|NCT01841567|468744660|FG000|Overall Study|Adverse Event|3|||
130213456|NCT01416155|468744661|FG000|Overall Study|Adverse Event|8|||
130213457|NCT01416155|468744661|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
130213458|NCT01416155|468744661|FG000|Overall Study|Withdrawal by Subject|33|||
130213459|NCT01416155|468744661|FG000|Overall Study|Investigator decision|8|||
130213460|NCT01416155|468744661|FG000|Overall Study|Other|7|||
130213461|NCT01573754|468744667|FG000|Overall Study|Noncompliance or remission not achieved|3|||
130213462|NCT01573754|468744668|FG001|Overall Study|Noncompliance or remission not achieved|15|||
130213463|NCT00829829|468744669|FG000|Overall Study|Protocol Violation|0|||
130213464|NCT00829829|468744670|FG001|Overall Study|Protocol Violation|3|||
130213465|NCT00829829|468744671|FG002|Overall Study|Protocol Violation|0|||
130213466|NCT00829829|468744669|FG000|Overall Study|Adverse Event|4|||
130213467|NCT00829829|468744670|FG001|Overall Study|Adverse Event|4|||
130213468|NCT00829829|468744671|FG002|Overall Study|Adverse Event|3|||
130213469|NCT00829829|468744669|FG000|Overall Study|Withdrawal by Subject|8|||
130213470|NCT00829829|468744670|FG001|Overall Study|Withdrawal by Subject|4|||
130213471|NCT00829829|468744671|FG002|Overall Study|Withdrawal by Subject|2|||
130213472|NCT00829829|468744669|FG000|Overall Study|Decision by the Sponsor|1|||
130213473|NCT00829829|468744670|FG001|Overall Study|Decision by the Sponsor|0|||
130213474|NCT00829829|468744671|FG002|Overall Study|Decision by the Sponsor|2|||
130213475|NCT00829829|468744669|FG000|Overall Study|Lost to Follow-up|7|||
130213476|NCT00829829|468744670|FG001|Overall Study|Lost to Follow-up|3|||
130213477|NCT00829829|468744671|FG002|Overall Study|Lost to Follow-up|3|||
130213478|NCT00829829|468744669|FG000|Overall Study|Other than specified above|2|||
130213479|NCT00829829|468744670|FG001|Overall Study|Other than specified above|2|||
130213480|NCT00829829|468744671|FG002|Overall Study|Other than specified above|1|||
130213481|NCT02984267|468744672|FG000|Overall Study|Protocol Violation|1|||
130213482|NCT02984267|468744673|FG001|Overall Study|Protocol Violation|0|||
130213483|NCT02984267|468744672|FG000|Overall Study|Withdrawal by Subject|0|||
130213484|NCT02984267|468744673|FG001|Overall Study|Withdrawal by Subject|1|||
130213485|NCT03597139|468744674|FG000|Overall Study|Adverse Event|3|||
130213486|NCT03597139|468744675|FG001|Overall Study|Adverse Event|0|||
130213487|NCT03597139|468744674|FG000|Overall Study|Protocol Non-compliance|1|||
130213488|NCT03597139|468744675|FG001|Overall Study|Protocol Non-compliance|0|||
130213489|NCT00520767|468744676|FG000|Overall Study|Death|2|||
130213490|NCT00382109|468744679|FG000|Overall Study|Adverse Event|3|||
130213491|NCT00382109|468744680|FG001|Overall Study|Adverse Event|0|||
130213492|NCT00382109|468744679|FG000|Overall Study|Physician Decision|6|||
130213493|NCT00382109|468744680|FG001|Overall Study|Physician Decision|1|||
130213494|NCT00382109|468744679|FG000|Overall Study|Withdrawal by Subject|1|||
130213495|NCT00382109|468744680|FG001|Overall Study|Withdrawal by Subject|0|||
130213496|NCT00382109|468744679|FG000|Overall Study|ineligible|2|||
130213497|NCT00382109|468744680|FG001|Overall Study|ineligible|0|||
130213498|NCT00382109|468744679|FG000|Overall Study|Other|0|||
130213499|NCT00382109|468744680|FG001|Overall Study|Other|2|||
130213500|NCT00382109|468744679|FG000|Overall Study|consent withdrawal|0|||
130213501|NCT00382109|468744680|FG001|Overall Study|consent withdrawal|1|||
130213502|NCT01249833|468744681|FG000|Overall Study|Lost to Follow-up|0|||
130213503|NCT01249833|468744682|FG001|Overall Study|Lost to Follow-up|1|||
130213504|NCT03796676|468744683|FG000|Overall Study|Adverse Event|2|||
130213505|NCT03796676|468744684|FG001|Overall Study|Adverse Event|1|||
129875453|NCT02404389|467501993|FG002|Overall Study|Adverse Event|1|||
129875454|NCT02404389|467501994|FG003|Overall Study|Adverse Event|0|||
129875455|NCT02404389|467501995|FG004|Overall Study|Adverse Event|2|||
129875456|NCT02404389|467501991|FG000|Overall Study|Subject/guardian decision|1|||
129875457|NCT02404389|467501992|FG001|Overall Study|Subject/guardian decision|0|||
129875458|NCT02404389|467501993|FG002|Overall Study|Subject/guardian decision|0|||
129875459|NCT02404389|467501994|FG003|Overall Study|Subject/guardian decision|1|||
129875460|NCT02404389|467501995|FG004|Overall Study|Subject/guardian decision|1|||
129875461|NCT00652938|467501999|FG000|Overall Study|Adverse Event|1|||
129875462|NCT00652938|467502000|FG001|Overall Study|Adverse Event|0|||
129875463|NCT00652938|467502001|FG002|Overall Study|Adverse Event|2|||
129875464|NCT00652938|467501999|FG000|Overall Study|Withdrawal by Subject|0|||
129875465|NCT00652938|467502000|FG001|Overall Study|Withdrawal by Subject|6|||
129875466|NCT00652938|467502001|FG002|Overall Study|Withdrawal by Subject|1|||
129875467|NCT00652938|467501999|FG000|Overall Study|Lost to Follow-up|0|||
129875468|NCT00652938|467502000|FG001|Overall Study|Lost to Follow-up|0|||
129875469|NCT00652938|467502001|FG002|Overall Study|Lost to Follow-up|2|||
129875470|NCT00652938|467501999|FG000|Overall Study|fear of blood sampling|0|||
129875471|NCT00652938|467502000|FG001|Overall Study|fear of blood sampling|1|||
129875472|NCT00652938|467502001|FG002|Overall Study|fear of blood sampling|0|||
129875473|NCT03324880|467502002|FG000|Overall Study|Adverse Event|0|||
129875474|NCT03324880|467502003|FG001|Overall Study|Adverse Event|2|||
129875475|NCT03324880|467502002|FG000|Overall Study|Withdrawal by Subject|2|||
129875476|NCT03324880|467502003|FG001|Overall Study|Withdrawal by Subject|2|||
129875477|NCT03324880|467502002|FG000|Overall Study|Lost to Follow-up|0|||
129875478|NCT03324880|467502003|FG001|Overall Study|Lost to Follow-up|1|||
129875479|NCT03324880|467502002|FG000|Overall Study|Product Recall|0|||
129875480|NCT03324880|467502003|FG001|Overall Study|Product Recall|1|||
129875481|NCT01412801|467502004|FG000|Overall Study|Death|0|||
129875482|NCT01412801|467502005|FG001|Overall Study|Death|1|||
129875483|NCT01412801|467502006|FG002|Overall Study|Death|0|||
129875484|NCT01412801|467502007|FG003|Overall Study|Death|4|||
129875485|NCT01412801|467502008|FG004|Overall Study|Death|2|||
129875486|NCT01412801|467502009|FG005|Overall Study|Death|2|||
129875487|NCT01412801|467502004|FG000|Overall Study|Lost to Follow-up|1|||
129875488|NCT01412801|467502005|FG001|Overall Study|Lost to Follow-up|2|||
129875489|NCT01412801|467502006|FG002|Overall Study|Lost to Follow-up|4|||
129875490|NCT01412801|467502007|FG003|Overall Study|Lost to Follow-up|0|||
129875491|NCT01412801|467502008|FG004|Overall Study|Lost to Follow-up|1|||
129875492|NCT01412801|467502009|FG005|Overall Study|Lost to Follow-up|1|||
129875493|NCT01412801|467502004|FG000|Overall Study|Withdrawal by Subject|3|||
130213506|NCT03796676|468744685|FG002|Overall Study|Adverse Event|2|||
130213507|NCT03796676|468744683|FG000|Overall Study|Lost to Follow-up|2|||
130213508|NCT03796676|468744684|FG001|Overall Study|Lost to Follow-up|1|||
130213509|NCT03796676|468744685|FG002|Overall Study|Lost to Follow-up|0|||
130213510|NCT03796676|468744683|FG000|Overall Study|Protocol Violation|0|||
130213511|NCT03796676|468744684|FG001|Overall Study|Protocol Violation|0|||
130213512|NCT03796676|468744685|FG002|Overall Study|Protocol Violation|1|||
130213513|NCT03796676|468744683|FG000|Overall Study|Withdrawal by Subject|1|||
130213514|NCT03796676|468744684|FG001|Overall Study|Withdrawal by Subject|1|||
130213515|NCT03796676|468744685|FG002|Overall Study|Withdrawal by Subject|0|||
130213516|NCT03796676|468744683|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
130213517|NCT03796676|468744684|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
130213518|NCT03796676|468744685|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
130213519|NCT00248833|468744689|FG000|Overall Study|Adverse Event|2|||
130213520|NCT00248833|468744690|FG001|Overall Study|Adverse Event|0|||
130213521|NCT00248833|468744691|FG002|Overall Study|Adverse Event|0|||
130213522|NCT00248833|468744689|FG000|Overall Study|Withdrawal by Subject|0|||
130213523|NCT00248833|468744690|FG001|Overall Study|Withdrawal by Subject|1|||
130213524|NCT00248833|468744691|FG002|Overall Study|Withdrawal by Subject|1|||
130213525|NCT00248833|468744689|FG000|Overall Study|Lost to Follow-up|1|||
130213526|NCT00248833|468744690|FG001|Overall Study|Lost to Follow-up|1|||
130213527|NCT00248833|468744691|FG002|Overall Study|Lost to Follow-up|1|||
130213528|NCT00248833|468744689|FG000|Overall Study|Other|0|||
130213529|NCT00248833|468744690|FG001|Overall Study|Other|1|||
129875494|NCT01412801|467502005|FG001|Overall Study|Withdrawal by Subject|2|||
129875495|NCT01412801|467502006|FG002|Overall Study|Withdrawal by Subject|1|||
129875496|NCT01412801|467502007|FG003|Overall Study|Withdrawal by Subject|0|||
130213530|NCT00248833|468744691|FG002|Overall Study|Other|0|||
130213531|NCT01900899|468744692|FG000|Overall Study|Withdrawal by Subject|7|||
129875497|NCT01412801|467502008|FG004|Overall Study|Withdrawal by Subject|0|||
129875498|NCT01412801|467502009|FG005|Overall Study|Withdrawal by Subject|0|||
129875499|NCT01412801|467502004|FG000|Overall Study|Relocated to another area|0|||
129875500|NCT01412801|467502005|FG001|Overall Study|Relocated to another area|0|||
129875501|NCT01412801|467502006|FG002|Overall Study|Relocated to another area|2|||
129875502|NCT01412801|467502007|FG003|Overall Study|Relocated to another area|0|||
129875503|NCT01412801|467502008|FG004|Overall Study|Relocated to another area|0|||
129875504|NCT01412801|467502009|FG005|Overall Study|Relocated to another area|0|||
129875505|NCT00116272|467502010|FG000|Overall Study|Lost to Follow-up|11|||
129875506|NCT00116272|467502011|FG001|Overall Study|Lost to Follow-up|6|||
129875507|NCT01547299|467502014|FG000|Overall Study|Withdrawal by Subject|2|||
129875508|NCT01547299|467502015|FG001|Overall Study|Withdrawal by Subject|2|||
129875509|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
129875510|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875511|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875512|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875513|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875514|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875515|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875516|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
129875517|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875518|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875519|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875520|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875521|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875522|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875523|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
129875524|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875525|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875526|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875527|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875528|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875529|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875530|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
129875531|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875532|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875533|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875534|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875535|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875536|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875537|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
129875538|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875539|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875540|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875541|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875542|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875543|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875544|NCT01576718|467502016|FG000|Treatment Period|Adverse Event|0|||
129875545|NCT01576718|467502017|FG001|Treatment Period|Adverse Event|1|||
129875546|NCT01576718|467502018|FG002|Treatment Period|Adverse Event|1|||
129875547|NCT01576718|467502019|FG003|Treatment Period|Adverse Event|1|||
129875548|NCT01576718|467502020|FG004|Treatment Period|Adverse Event|1|||
129875549|NCT01576718|467502021|FG005|Treatment Period|Adverse Event|1|||
129875550|NCT01576718|467502022|FG006|Treatment Period|Adverse Event|0|||
129875551|NCT01576718|467502016|FG000|Treatment Period|Withdrawal by Subject|0|||
129875552|NCT01576718|467502017|FG001|Treatment Period|Withdrawal by Subject|1|||
129875553|NCT01576718|467502018|FG002|Treatment Period|Withdrawal by Subject|1|||
129875554|NCT01576718|467502019|FG003|Treatment Period|Withdrawal by Subject|0|||
129875555|NCT01576718|467502020|FG004|Treatment Period|Withdrawal by Subject|2|||
129875556|NCT01576718|467502021|FG005|Treatment Period|Withdrawal by Subject|4|||
129875557|NCT01576718|467502022|FG006|Treatment Period|Withdrawal by Subject|2|||
129875558|NCT01576718|467502016|FG000|Treatment Period|Physician Decision|0|||
129875559|NCT01576718|467502017|FG001|Treatment Period|Physician Decision|1|||
129875560|NCT01576718|467502018|FG002|Treatment Period|Physician Decision|1|||
129875561|NCT01576718|467502019|FG003|Treatment Period|Physician Decision|1|||
129875562|NCT01576718|467502020|FG004|Treatment Period|Physician Decision|1|||
129875563|NCT01576718|467502021|FG005|Treatment Period|Physician Decision|0|||
129875564|NCT01576718|467502022|FG006|Treatment Period|Physician Decision|0|||
130098650|NCT03586427|468319265|FG002|Overall Study|Protocol Violation|1|||
129875565|NCT01576718|467502016|FG000|Treatment Period|Protocol Violation|0|||
129875566|NCT01576718|467502017|FG001|Treatment Period|Protocol Violation|5|||
129875567|NCT01576718|467502018|FG002|Treatment Period|Protocol Violation|4|||
129875568|NCT01576718|467502019|FG003|Treatment Period|Protocol Violation|10|||
129875569|NCT01576718|467502020|FG004|Treatment Period|Protocol Violation|6|||
129875570|NCT01576718|467502021|FG005|Treatment Period|Protocol Violation|8|||
130098651|NCT03586427|468319266|FG003|Overall Study|Protocol Violation|0|||
130098652|NCT03586427|468319267|FG004|Overall Study|Protocol Violation|1|||
130213532|NCT01900899|468744693|FG001|Overall Study|Withdrawal by Subject|1|||
130213533|NCT01900899|468744692|FG000|Overall Study|Migrated from study area|2|||
130213534|NCT01900899|468744693|FG001|Overall Study|Migrated from study area|0|||
130213535|NCT00723697|468744696|FG000|Overall Study|Physician questionnaires not received|2|||
130213536|NCT00723697|468744696|FG000|Overall Study|Missing Informed Consent Form|10|||
130213537|NCT00723697|468744696|FG000|Overall Study|Other exclusion criteria applied|6|||
130213538|NCT00467558|468744699|FG000|Overall Study|Lost to Follow-up|2|||
130213539|NCT00467558|468744700|FG001|Overall Study|Lost to Follow-up|0|||
130213540|NCT05188729|468744701|FG000|Overall Study|Withdrawal by Subject|0|||
130213541|NCT05188729|468744702|FG001|Overall Study|Withdrawal by Subject|0|||
130213542|NCT05188729|468744703|FG002|Overall Study|Withdrawal by Subject|0|||
130213543|NCT05188729|468744704|FG003|Overall Study|Withdrawal by Subject|0|||
130213544|NCT05188729|468744705|FG004|Overall Study|Withdrawal by Subject|0|||
130213545|NCT05188729|468744706|FG005|Overall Study|Withdrawal by Subject|0|||
130213546|NCT05188729|468744707|FG006|Overall Study|Withdrawal by Subject|0|||
130213547|NCT05188729|468744708|FG007|Overall Study|Withdrawal by Subject|0|||
130213548|NCT05188729|468744709|FG008|Overall Study|Withdrawal by Subject|0|||
130213549|NCT05188729|468744710|FG009|Overall Study|Withdrawal by Subject|1|||
130213550|NCT05188729|468744711|FG010|Overall Study|Withdrawal by Subject|0|||
130213551|NCT05188729|468744712|FG011|Overall Study|Withdrawal by Subject|0|||
130213552|NCT05188729|468744713|FG012|Overall Study|Withdrawal by Subject|0|||
130213553|NCT05188729|468744701|FG000|Overall Study|Lost to Follow-up|0|||
130213554|NCT05188729|468744702|FG001|Overall Study|Lost to Follow-up|0|||
130213555|NCT05188729|468744703|FG002|Overall Study|Lost to Follow-up|0|||
130213556|NCT05188729|468744704|FG003|Overall Study|Lost to Follow-up|0|||
130213557|NCT05188729|468744705|FG004|Overall Study|Lost to Follow-up|0|||
130213558|NCT05188729|468744706|FG005|Overall Study|Lost to Follow-up|0|||
130213559|NCT05188729|468744707|FG006|Overall Study|Lost to Follow-up|0|||
130320366|NCT00506350|469141899|FG007|Overall Study|Lost to Follow-up|0|||
130320367|NCT00506350|469141900|FG008|Overall Study|Lost to Follow-up|2|||
130320368|NCT00506350|469141892|FG000|Overall Study|Medical Reason|0|||
130320369|NCT00506350|469141893|FG001|Overall Study|Medical Reason|0|||
130320370|NCT00506350|469141894|FG002|Overall Study|Medical Reason|0|||
130320371|NCT00506350|469141895|FG003|Overall Study|Medical Reason|0|||
130320372|NCT00506350|469141896|FG004|Overall Study|Medical Reason|1|||
130320373|NCT00506350|469141897|FG005|Overall Study|Medical Reason|0|||
130320374|NCT00506350|469141898|FG006|Overall Study|Medical Reason|0|||
130320375|NCT00506350|469141899|FG007|Overall Study|Medical Reason|0|||
130320376|NCT00506350|469141900|FG008|Overall Study|Medical Reason|0|||
130320377|NCT00506350|469141892|FG000|Overall Study|Other|1|||
130320378|NCT00506350|469141893|FG001|Overall Study|Other|1|||
130320379|NCT00506350|469141894|FG002|Overall Study|Other|3|||
130320380|NCT00506350|469141895|FG003|Overall Study|Other|0|||
130320381|NCT00506350|469141896|FG004|Overall Study|Other|3|||
130320382|NCT00506350|469141897|FG005|Overall Study|Other|0|||
130320383|NCT00506350|469141898|FG006|Overall Study|Other|0|||
130320384|NCT00506350|469141899|FG007|Overall Study|Other|2|||
130320385|NCT00506350|469141900|FG008|Overall Study|Other|2|||
130320386|NCT01691794|469141901|FG000|Overall Study|Poor/Non-Compliance|1|||
130320387|NCT01691794|469141902|FG001|Overall Study|Poor/Non-Compliance|4|||
130320388|NCT01691794|469141903|FG002|Overall Study|Poor/Non-Compliance|1|||
130320389|NCT01691794|469141901|FG000|Overall Study|Death|0|||
130320390|NCT01691794|469141902|FG001|Overall Study|Death|0|||
130320391|NCT01691794|469141903|FG002|Overall Study|Death|1|||
130320392|NCT01691794|469141901|FG000|Overall Study|Lack of Efficacy|0|||
130320393|NCT01691794|469141902|FG001|Overall Study|Lack of Efficacy|7|||
130320394|NCT01691794|469141903|FG002|Overall Study|Lack of Efficacy|1|||
130320395|NCT01691794|469141901|FG000|Overall Study|Participant request to discontinue|0|||
130320396|NCT01691794|469141902|FG001|Overall Study|Participant request to discontinue|1|||
130320397|NCT01691794|469141903|FG002|Overall Study|Participant request to discontinue|0|||
130320398|NCT01691794|469141901|FG000|Overall Study|Adverse Event|0|||
130320399|NCT01691794|469141902|FG001|Overall Study|Adverse Event|1|||
130320400|NCT01691794|469141903|FG002|Overall Study|Adverse Event|1|||
130320401|NCT01691794|469141901|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
130320402|NCT01691794|469141902|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
130320403|NCT01691794|469141903|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
130320404|NCT01691794|469141901|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
130320405|NCT01691794|469141902|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
130320406|NCT01691794|469141903|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
130320407|NCT04972786|469141904|FG000|First Intervention (1 Day)|Adverse Event|1|||
130320408|NCT04972786|469141905|FG001|First Intervention (1 Day)|Adverse Event|0|||
130320409|NCT00844844|469141906|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
130320410|NCT00844844|469141906|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
130320411|NCT00844844|469141906|FG000|Extension Treatment Period|Adverse Event|2|||
130320412|NCT00844844|469141906|FG000|Post Treatment Period|Withdrawal by Subject|1|||
130320413|NCT03905096|469141907|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
130320414|NCT03905096|469141908|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
130320415|NCT02016781|469141910|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
129875571|NCT01576718|467502022|FG006|Treatment Period|Protocol Violation|12|||
129875572|NCT01576718|467502016|FG000|Treatment Period|Sponsor request|0|||
129875573|NCT01576718|467502017|FG001|Treatment Period|Sponsor request|1|||
129875574|NCT01576718|467502018|FG002|Treatment Period|Sponsor request|0|||
129875575|NCT01576718|467502019|FG003|Treatment Period|Sponsor request|0|||
129875576|NCT01576718|467502020|FG004|Treatment Period|Sponsor request|0|||
129875577|NCT01576718|467502021|FG005|Treatment Period|Sponsor request|1|||
129875578|NCT01576718|467502022|FG006|Treatment Period|Sponsor request|0|||
129875579|NCT01576718|467502016|FG000|Treatment Period|Met stopping criteria|0|||
129875580|NCT01576718|467502017|FG001|Treatment Period|Met stopping criteria|16|||
129875581|NCT01576718|467502018|FG002|Treatment Period|Met stopping criteria|13|||
129875582|NCT01576718|467502019|FG003|Treatment Period|Met stopping criteria|19|||
129875583|NCT01576718|467502020|FG004|Treatment Period|Met stopping criteria|16|||
129875584|NCT01576718|467502021|FG005|Treatment Period|Met stopping criteria|33|||
129875585|NCT01576718|467502022|FG006|Treatment Period|Met stopping criteria|15|||
129875586|NCT01576718|467502016|FG000|Treatment Period|Lost to Follow-up|0|||
129875587|NCT01576718|467502017|FG001|Treatment Period|Lost to Follow-up|0|||
129875588|NCT01576718|467502018|FG002|Treatment Period|Lost to Follow-up|0|||
129875589|NCT01576718|467502019|FG003|Treatment Period|Lost to Follow-up|0|||
129875590|NCT01576718|467502020|FG004|Treatment Period|Lost to Follow-up|1|||
129875591|NCT01576718|467502021|FG005|Treatment Period|Lost to Follow-up|0|||
129875592|NCT01576718|467502022|FG006|Treatment Period|Lost to Follow-up|0|||
129875593|NCT01576718|467502016|FG000|Treatment Period|Noncompliance to study medication|0|||
129875594|NCT01576718|467502017|FG001|Treatment Period|Noncompliance to study medication|0|||
129875595|NCT01576718|467502018|FG002|Treatment Period|Noncompliance to study medication|0|||
129875596|NCT01576718|467502019|FG003|Treatment Period|Noncompliance to study medication|0|||
129875597|NCT01576718|467502020|FG004|Treatment Period|Noncompliance to study medication|0|||
129875598|NCT01576718|467502021|FG005|Treatment Period|Noncompliance to study medication|1|||
129875599|NCT01576718|467502022|FG006|Treatment Period|Noncompliance to study medication|1|||
129875600|NCT00045708|467504063|FG000|Phase 1|early progressive disease|0|||
129875601|NCT00045708|467504064|FG001|Phase 1|early progressive disease|1|||
129875602|NCT00045708|467504065|FG002|Phase 1|early progressive disease|0|||
129875603|NCT00284141|467504066|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
129875604|NCT00284141|467504066|FG000|Overall Study|Adverse Event|19|||
129875605|NCT00284141|467504066|FG000|Overall Study|Participant's request|9|||
129875606|NCT00284141|467504066|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
129875607|NCT00284141|467504066|FG000|Overall Study|Clinical deterioration / death|2|||
129875608|NCT00284141|467504066|FG000|Overall Study|General decline|1|||
129875609|NCT00284141|467504066|FG000|Overall Study|Pneumonia|1|||
129875610|NCT00284141|467504066|FG000|Overall Study|Did not take study medication|2|||
129875611|NCT00284141|467504066|FG000|Overall Study|Ongoing treatment|2|||
129875612|NCT04382924|467504068|FG000|Overall Study|Death|2|||
129875613|NCT04382924|467504069|FG001|Overall Study|Death|5|||
129875614|NCT04382924|467504070|FG002|Overall Study|Death|4|||
129875615|NCT04382924|467504068|FG000|Overall Study|Protocol Violation|0|||
129875616|NCT04382924|467504069|FG001|Overall Study|Protocol Violation|1|||
129875617|NCT04382924|467504070|FG002|Overall Study|Protocol Violation|1|||
129875618|NCT04382924|467504068|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
129875619|NCT04382924|467504069|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
129875620|NCT04382924|467504070|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
129875621|NCT04382924|467504068|FG000|Overall Study|Withdrawal by Subject|6|||
129875622|NCT04382924|467504069|FG001|Overall Study|Withdrawal by Subject|3|||
129875623|NCT04382924|467504070|FG002|Overall Study|Withdrawal by Subject|6|||
129875624|NCT01559454|467504071|FG000|Overall Study|Lost to Follow-up|3|||
129875625|NCT01559454|467504072|FG001|Overall Study|Lost to Follow-up|2|||
129875626|NCT01559454|467504071|FG000|Overall Study|Withdrawal by Subject|0|||
129875627|NCT01559454|467504072|FG001|Overall Study|Withdrawal by Subject|1|||
129875628|NCT01559454|467504071|FG000|Overall Study|Physician Decision|0|||
129875629|NCT01559454|467504072|FG001|Overall Study|Physician Decision|1|||
129875630|NCT01559454|467504071|FG000|Overall Study|Protocol Violation|0|||
129875631|NCT01559454|467504072|FG001|Overall Study|Protocol Violation|1|||
129875632|NCT01559454|467504071|FG000|Overall Study|Lack of Efficacy|0|||
129875633|NCT01559454|467504072|FG001|Overall Study|Lack of Efficacy|1|||
129875634|NCT02207725|467504073|FG000|Overall Study|Did Not Receive Treatment|0|||
129875635|NCT02207725|467504074|FG001|Overall Study|Did Not Receive Treatment|1|||
129875636|NCT02207725|467504075|FG002|Overall Study|Did Not Receive Treatment|1|||
129875637|NCT02207725|467504076|FG003|Overall Study|Did Not Receive Treatment|1|||
129875638|NCT01966003|467504077|FG000|Overall Study|Death|43|||
129875639|NCT01966003|467504078|FG001|Overall Study|Death|36|||
129875640|NCT01966003|467504077|FG000|Overall Study|Protocol Violation|6|||
129875641|NCT01966003|467504078|FG001|Overall Study|Protocol Violation|4|||
129875642|NCT01966003|467504077|FG000|Overall Study|Lost to Follow-up|4|||
129875643|NCT01966003|467504078|FG001|Overall Study|Lost to Follow-up|3|||
129875644|NCT01966003|467504077|FG000|Overall Study|Physician Decision|12|||
129875645|NCT01966003|467504078|FG001|Overall Study|Physician Decision|13|||
129875646|NCT01966003|467504077|FG000|Overall Study|Withdrawal by Subject|29|||
130213560|NCT05188729|468744708|FG007|Overall Study|Lost to Follow-up|0|||
130213561|NCT05188729|468744709|FG008|Overall Study|Lost to Follow-up|0|||
130213562|NCT05188729|468744710|FG009|Overall Study|Lost to Follow-up|0|||
130213563|NCT05188729|468744711|FG010|Overall Study|Lost to Follow-up|1|||
130213564|NCT05188729|468744712|FG011|Overall Study|Lost to Follow-up|1|||
130213565|NCT05188729|468744713|FG012|Overall Study|Lost to Follow-up|0|||
130213566|NCT03084302|468746844|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
130213567|NCT03084302|468746844|FG000|Overall Study|No valid objective monitor data|6|||
130213568|NCT00929994|468746845|FG000|Overall Study|Withdrawal by Subject|1|||
130213569|NCT00929994|468746845|FG000|Overall Study|medical issue unrelated to intervention|4|||
130213570|NCT00929994|468746845|FG000|Overall Study|employment|1|||
130213571|NCT01214668|468746846|FG000|Overall Study|Adverse Event|0|||
130213572|NCT01214668|468746847|FG001|Overall Study|Adverse Event|1|||
130213573|NCT01214668|468746848|FG002|Overall Study|Adverse Event|0|||
130213574|NCT01214668|468746849|FG003|Overall Study|Adverse Event|2|||
130213575|NCT01214668|468746850|FG004|Overall Study|Adverse Event|1|||
130213576|NCT01214668|468746851|FG005|Overall Study|Adverse Event|1|||
130213577|NCT01214668|468746846|FG000|Overall Study|Death|0|||
130213578|NCT01214668|468746847|FG001|Overall Study|Death|0|||
130213579|NCT01214668|468746848|FG002|Overall Study|Death|1|||
130213580|NCT01214668|468746849|FG003|Overall Study|Death|0|||
130213581|NCT01214668|468746850|FG004|Overall Study|Death|0|||
130213582|NCT01214668|468746851|FG005|Overall Study|Death|0|||
130213583|NCT01214668|468746846|FG000|Overall Study|Progressive Disease|4|||
130213584|NCT01214668|468746847|FG001|Overall Study|Progressive Disease|2|||
130213585|NCT01214668|468746848|FG002|Overall Study|Progressive Disease|5|||
130213586|NCT01214668|468746849|FG003|Overall Study|Progressive Disease|4|||
130213587|NCT01214668|468746850|FG004|Overall Study|Progressive Disease|4|||
130213588|NCT01214668|468746851|FG005|Overall Study|Progressive Disease|5|||
130213589|NCT01214668|468746846|FG000|Overall Study|Withdrawal by Subject|0|||
130213590|NCT01214668|468746847|FG001|Overall Study|Withdrawal by Subject|0|||
130213591|NCT01214668|468746848|FG002|Overall Study|Withdrawal by Subject|0|||
130213592|NCT01214668|468746849|FG003|Overall Study|Withdrawal by Subject|0|||
130213593|NCT01214668|468746850|FG004|Overall Study|Withdrawal by Subject|1|||
130213594|NCT01214668|468746851|FG005|Overall Study|Withdrawal by Subject|0|||
130213595|NCT01964989|468746852|FG000|Overall Study|Protocol Violation|3|||
130213596|NCT01964989|468746853|FG001|Overall Study|Protocol Violation|4|||
130213597|NCT01964989|468746852|FG000|Overall Study|Administrative Reason|103|||
130213598|NCT01964989|468746853|FG001|Overall Study|Administrative Reason|95|||
130213599|NCT01964989|468746852|FG000|Overall Study|Adverse Event|0|||
130213600|NCT01964989|468746853|FG001|Overall Study|Adverse Event|1|||
130213601|NCT01964989|468746852|FG000|Overall Study|Death|1|||
130213602|NCT01964989|468746853|FG001|Overall Study|Death|3|||
130213603|NCT01964989|468746852|FG000|Overall Study|Withdrawal by Subject|156|||
130213604|NCT01964989|468746853|FG001|Overall Study|Withdrawal by Subject|160|||
130213605|NCT01964989|468746852|FG000|Overall Study|Lost to Follow-up|254|||
130213606|NCT01964989|468746853|FG001|Overall Study|Lost to Follow-up|232|||
130213607|NCT01964989|468746852|FG000|Overall Study|Other|267|||
130213608|NCT01964989|468746853|FG001|Overall Study|Other|252|||
130213609|NCT00424593|468746854|FG000|Acute Double-Blind Period|Adverse Event|16|||
130213610|NCT00424593|468746855|FG001|Acute Double-Blind Period|Adverse Event|7|||
130213611|NCT00424593|468746854|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
130213612|NCT00424593|468746855|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
130213613|NCT00424593|468746854|FG000|Acute Double-Blind Period|Protocol Violation|2|||
130213614|NCT00424593|468746855|FG001|Acute Double-Blind Period|Protocol Violation|2|||
130213615|NCT00424593|468746854|FG000|Acute Double-Blind Period|Physician Decision|1|||
130213616|NCT00424593|468746855|FG001|Acute Double-Blind Period|Physician Decision|2|||
130213617|NCT00424593|468746854|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
130213618|NCT00424593|468746855|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
130213619|NCT00424593|468746854|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
130213620|NCT00424593|468746855|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
130213621|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
130213622|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
130213623|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Adverse Event|18|||
130213624|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Adverse Event|0|||
130213625|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
130213626|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
130213627|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
130213628|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
130213629|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
130213630|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
130213631|NCT00424593|468746854|FG000|Dose-Blind Extension Period|Physician Decision|3|||
130213632|NCT00424593|468746855|FG001|Dose-Blind Extension Period|Physician Decision|0|||
130213633|NCT01796301|468746856|FG000|Overall Study|Withdrawal by Subject|15|||
129875647|NCT01966003|467504078|FG001|Overall Study|Withdrawal by Subject|19|||
129875648|NCT01966003|467504077|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
129875649|NCT01966003|467504078|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
129875650|NCT01966003|467504077|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
129875651|NCT01966003|467504078|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
129875652|NCT01966003|467504077|FG000|Overall Study|Other|1|||
129875653|NCT01966003|467504078|FG001|Overall Study|Other|1|||
129875654|NCT00615264|467504081|FG000|Overall Study|Withdrawal by Subject|17|||
129875655|NCT00615264|467504082|FG001|Overall Study|Withdrawal by Subject|19|||
129875656|NCT00615264|467504081|FG000|Overall Study|Lost to Follow-up|6|||
129875657|NCT00615264|467504082|FG001|Overall Study|Lost to Follow-up|13|||
129875658|NCT00615264|467504081|FG000|Overall Study|Adverse Event|8|||
129875659|NCT00615264|467504082|FG001|Overall Study|Adverse Event|5|||
129875660|NCT00615264|467504081|FG000|Overall Study|Death|1|||
129875661|NCT00615264|467504082|FG001|Overall Study|Death|1|||
129875662|NCT00615264|467504081|FG000|Overall Study|Protocol Violation|11|||
129875663|NCT00615264|467504082|FG001|Overall Study|Protocol Violation|7|||
129875664|NCT00615264|467504081|FG000|Overall Study|Not defined|7|||
129875665|NCT00615264|467504082|FG001|Overall Study|Not defined|4|||
129875666|NCT00615264|467504081|FG000|Overall Study|Dermal Hypersensitivity|0|||
129875667|NCT00615264|467504082|FG001|Overall Study|Dermal Hypersensitivity|3|||
129875668|NCT01492686|467504085|FG000|Double-blind Phase|Adverse Event|0|||
129875669|NCT01492686|467504086|FG001|Double-blind Phase|Adverse Event|2|||
129875670|NCT01492686|467504085|FG000|Double-blind Phase|Physician Decision|0|||
129875671|NCT01492686|467504086|FG001|Double-blind Phase|Physician Decision|1|||
129875672|NCT01492686|467504085|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129875673|NCT01492686|467504086|FG001|Double-blind Phase|Withdrawal by Subject|2|||
129875674|NCT01492686|467504085|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
129875675|NCT01492686|467504086|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
129875676|NCT01492686|467504085|FG000|Open-label Phase|Adverse Event|1|||
129875677|NCT01492686|467504086|FG001|Open-label Phase|Adverse Event|2|||
129875678|NCT01492686|467504085|FG000|Open-label Phase|Physician Decision|1|||
129875679|NCT01492686|467504086|FG001|Open-label Phase|Physician Decision|0|||
129875680|NCT01492686|467504085|FG000|Open-label Phase|Withdrawal by Subject|6|||
129875681|NCT01492686|467504086|FG001|Open-label Phase|Withdrawal by Subject|7|||
129875682|NCT01492686|467504085|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
129875683|NCT01492686|467504086|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
129875684|NCT02255357|467504096|FG000|Overall Study|Physician Decision|10|||
129875685|NCT02255357|467504097|FG001|Overall Study|Physician Decision|24|||
129875686|NCT00509236|467504098|FG000|Overall Study|Adverse Event|7|||
129875687|NCT00509236|467504099|FG001|Overall Study|Adverse Event|9|||
129875688|NCT00509236|467504098|FG000|Overall Study|Withdrawal by Subject|5|||
129875689|NCT00509236|467504099|FG001|Overall Study|Withdrawal by Subject|10|||
129875690|NCT00509236|467504098|FG000|Overall Study|Protocol Violation|3|||
129875691|NCT00509236|467504099|FG001|Overall Study|Protocol Violation|0|||
129875692|NCT00509236|467504098|FG000|Overall Study|Excluded Medication|1|||
129875693|NCT00509236|467504099|FG001|Overall Study|Excluded Medication|1|||
129875694|NCT00509236|467504098|FG000|Overall Study|Scheduled Kidney Transplant|1|||
129875695|NCT00509236|467504099|FG001|Overall Study|Scheduled Kidney Transplant|0|||
129875696|NCT00927355|467504100|FG000|Overall Study|Adverse Event|1|||
129875697|NCT00927355|467504101|FG001|Overall Study|Adverse Event|1|||
129875698|NCT00792103|467504102|FG000|Overall Study|Enrolled, not treated|15|||
129875699|NCT00792103|467504102|FG000|Overall Study|Lost to Follow-up|17|||
129875700|NCT00792103|467504102|FG000|Overall Study|Adverse Event|25|||
129875701|NCT00792103|467504102|FG000|Overall Study|Withdrawal by Subject|52|||
129875702|NCT00792103|467504102|FG000|Overall Study|Protocol Violation|10|||
129875703|NCT00792103|467504102|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
129875704|NCT01572389|467504104|FG000|Overall Study|Death|1|||
129875705|NCT01572389|467504105|FG001|Overall Study|Death|3|||
129875706|NCT01572389|467504104|FG000|Overall Study|Withdrawal by Subject|14|||
129875707|NCT01572389|467504105|FG001|Overall Study|Withdrawal by Subject|2|||
129875708|NCT01572389|467504104|FG000|Overall Study|Lost to Follow-up|25|||
129875709|NCT01572389|467504105|FG001|Overall Study|Lost to Follow-up|14|||
129875710|NCT01572389|467504104|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
129875711|NCT01572389|467504105|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
129875712|NCT01287520|467504106|FG000|Overall Study|Adverse Event|2|||
129875713|NCT01287520|467504107|FG001|Overall Study|Adverse Event|2|||
129875714|NCT01287520|467504108|FG002|Overall Study|Adverse Event|2|||
129875715|NCT01287520|467504109|FG003|Overall Study|Adverse Event|1|||
129875716|NCT01287520|467504110|FG004|Overall Study|Adverse Event|1|||
129875717|NCT01287520|467504111|FG005|Overall Study|Adverse Event|2|||
129875718|NCT01287520|467504112|FG006|Overall Study|Adverse Event|0|||
129875719|NCT01287520|467504113|FG007|Overall Study|Adverse Event|2|||
129875720|NCT01287520|467504114|FG008|Overall Study|Adverse Event|0|||
129875721|NCT01287520|467504106|FG000|Overall Study|Physician Decision|1|||
129875722|NCT01287520|467504107|FG001|Overall Study|Physician Decision|1|||
129875723|NCT01287520|467504108|FG002|Overall Study|Physician Decision|2|||
129875724|NCT01287520|467504109|FG003|Overall Study|Physician Decision|0|||
129875725|NCT01287520|467504110|FG004|Overall Study|Physician Decision|1|||
129875726|NCT01287520|467504111|FG005|Overall Study|Physician Decision|1|||
129875727|NCT01287520|467504112|FG006|Overall Study|Physician Decision|0|||
129875728|NCT01287520|467504113|FG007|Overall Study|Physician Decision|1|||
129875729|NCT01287520|467504114|FG008|Overall Study|Physician Decision|0|||
129875730|NCT01287520|467504106|FG000|Overall Study|Progressive disease|0|||
129875731|NCT01287520|467504107|FG001|Overall Study|Progressive disease|4|||
129875732|NCT01287520|467504108|FG002|Overall Study|Progressive disease|1|||
129875733|NCT01287520|467504109|FG003|Overall Study|Progressive disease|6|||
129875734|NCT01287520|467504110|FG004|Overall Study|Progressive disease|1|||
129875735|NCT01287520|467504111|FG005|Overall Study|Progressive disease|0|||
129875736|NCT01287520|467504112|FG006|Overall Study|Progressive disease|2|||
129875737|NCT01287520|467504113|FG007|Overall Study|Progressive disease|2|||
129875738|NCT01287520|467504114|FG008|Overall Study|Progressive disease|4|||
129875739|NCT01287520|467504106|FG000|Overall Study|Withdrawal by Subject|0|||
129875740|NCT01287520|467504107|FG001|Overall Study|Withdrawal by Subject|0|||
129875741|NCT01287520|467504108|FG002|Overall Study|Withdrawal by Subject|0|||
129875742|NCT01287520|467504109|FG003|Overall Study|Withdrawal by Subject|0|||
129875743|NCT01287520|467504110|FG004|Overall Study|Withdrawal by Subject|0|||
129875744|NCT01287520|467504111|FG005|Overall Study|Withdrawal by Subject|1|||
129875745|NCT01287520|467504112|FG006|Overall Study|Withdrawal by Subject|0|||
129875746|NCT01287520|467504113|FG007|Overall Study|Withdrawal by Subject|0|||
129875747|NCT01287520|467504114|FG008|Overall Study|Withdrawal by Subject|1|||
129875748|NCT03673462|467504115|FG000|Overall Study|Adverse Event|11|||
129875749|NCT03673462|467504116|FG001|Overall Study|Adverse Event|1|||
129875750|NCT03673462|467504115|FG000|Overall Study|Protocol Violation|25|||
129875751|NCT03673462|467504116|FG001|Overall Study|Protocol Violation|11|||
129875752|NCT03673462|467504115|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
129875753|NCT03673462|467504116|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
129875754|NCT03673462|467504115|FG000|Overall Study|Lost to Follow-up|102|||
129875755|NCT03673462|467504116|FG001|Overall Study|Lost to Follow-up|19|||
129875756|NCT02768662|467504117|FG000|Overall Study|Adverse Event|1|||
129875757|NCT02768662|467504117|FG000|Overall Study|Lost to Follow-up|4|||
129875758|NCT02768662|467504117|FG000|Overall Study|Withdrawal by Subject|3|||
129875759|NCT02768662|467504117|FG000|Overall Study|Study terminated by Sponsor|78|||
129875760|NCT01800201|467504118|FG000|Overall Study|Withdrawal by Subject|2|||
129875761|NCT01800201|467504119|FG001|Overall Study|Withdrawal by Subject|0|||
129875762|NCT01800201|467504118|FG000|Overall Study|patient privacy concerns|1|||
129875763|NCT01800201|467504119|FG001|Overall Study|patient privacy concerns|1|||
129875764|NCT01800201|467504118|FG000|Overall Study|did not want to use device|0|||
129875765|NCT01800201|467504119|FG001|Overall Study|did not want to use device|1|||
129875766|NCT01800201|467504118|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
129875767|NCT01800201|467504119|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
129875768|NCT05061537|467504125|FG000|Treatment Phase|Progressive disease|0|||
129875769|NCT05061537|467504126|FG001|Treatment Phase|Progressive disease|1|||
129875770|NCT05061537|467504127|FG002|Treatment Phase|Progressive disease|2|||
129875771|NCT05061537|467504128|FG003|Treatment Phase|Progressive disease|0|||
129875772|NCT05061537|467504129|FG004|Treatment Phase|Progressive disease|0|||
129875773|NCT05061537|467504125|FG000|Treatment Phase|Adverse Event|0|||
129875774|NCT05061537|467504126|FG001|Treatment Phase|Adverse Event|0|||
129875775|NCT05061537|467504127|FG002|Treatment Phase|Adverse Event|2|||
129875776|NCT05061537|467504128|FG003|Treatment Phase|Adverse Event|0|||
129875777|NCT05061537|467504129|FG004|Treatment Phase|Adverse Event|0|||
129875778|NCT05061537|467504125|FG000|Treatment Phase|Global deterioration of health status|0|||
129875779|NCT05061537|467504126|FG001|Treatment Phase|Global deterioration of health status|1|||
129875780|NCT05061537|467504127|FG002|Treatment Phase|Global deterioration of health status|0|||
129875781|NCT05061537|467504128|FG003|Treatment Phase|Global deterioration of health status|0|||
129875782|NCT05061537|467504129|FG004|Treatment Phase|Global deterioration of health status|0|||
129875783|NCT05061537|467504125|FG000|Follow up|Other|2|||
129875784|NCT05061537|467504126|FG001|Follow up|Other|0|||
129875785|NCT05061537|467504127|FG002|Follow up|Other|2|||
129875786|NCT05061537|467504128|FG003|Follow up|Other|0|||
129875787|NCT05061537|467504129|FG004|Follow up|Other|0|||
129875788|NCT05061537|467504125|FG000|Follow up|Study terminated by sponsor|0|||
129875789|NCT05061537|467504126|FG001|Follow up|Study terminated by sponsor|0|||
129875790|NCT05061537|467504127|FG002|Follow up|Study terminated by sponsor|2|||
129875791|NCT05061537|467504128|FG003|Follow up|Study terminated by sponsor|0|||
129875792|NCT05061537|467504129|FG004|Follow up|Study terminated by sponsor|0|||
129875793|NCT05061537|467504125|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
129875794|NCT05061537|467504126|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
129875795|NCT05061537|467504127|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
129875796|NCT05061537|467504128|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
129875797|NCT05061537|467504129|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
129875798|NCT05061537|467504125|FG000|Long-term Follow-up|Death|0|||
129875799|NCT05061537|467504126|FG001|Long-term Follow-up|Death|1|||
129875800|NCT05061537|467504127|FG002|Long-term Follow-up|Death|0|||
129875801|NCT05061537|467504128|FG003|Long-term Follow-up|Death|0|||
129875802|NCT05061537|467504129|FG004|Long-term Follow-up|Death|0|||
129875803|NCT03502616|467504130|FG000|Up to Week 16|Withdrawal by Subject|1|||
129875804|NCT03502616|467504131|FG001|Up to Week 16|Withdrawal by Subject|2|||
129875805|NCT03502616|467504130|FG000|Up to Week 16|Lost to Follow-up|0|||
129875806|NCT03502616|467504131|FG001|Up to Week 16|Lost to Follow-up|1|||
129875807|NCT03502616|467504130|FG000|Up to Week 16|Randomized, but not treated|1|||
129875808|NCT03502616|467504131|FG001|Up to Week 16|Randomized, but not treated|0|||
129875809|NCT03502616|467504130|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
129875810|NCT03502616|467504131|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
129875811|NCT03502616|467504130|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
129875812|NCT03502616|467504131|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
129875813|NCT03541044|467504144|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
129875814|NCT03541044|467504145|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
129875815|NCT03541044|467504144|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
129875816|NCT03541044|467504145|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
129875817|NCT01153269|467504146|FG000|Overall Study|Withdrawal by Subject|1|||
129875818|NCT01153269|467504146|FG000|Overall Study|Antiretroviral therapy break|1|||
129875819|NCT02635724|467504147|FG000|Overall Study|Withdrawal by Subject|0|||
129875820|NCT02635724|467504148|FG001|Overall Study|Withdrawal by Subject|1|||
129875821|NCT02635724|467504149|FG002|Overall Study|Withdrawal by Subject|0|||
129875822|NCT00860067|467504150|FG000|Overall Study|Lost to Follow-up|46|||
129875823|NCT00860067|467504151|FG001|Overall Study|Lost to Follow-up|9|||
129875824|NCT00860067|467504152|FG002|Overall Study|Lost to Follow-up|9|||
129875825|NCT00860067|467504150|FG000|Overall Study|Withdrawal by Subject|4|||
129875826|NCT00860067|467504151|FG001|Overall Study|Withdrawal by Subject|0|||
129875827|NCT00860067|467504152|FG002|Overall Study|Withdrawal by Subject|0|||
129875828|NCT00860067|467504150|FG000|Overall Study|Pregnancy|1|||
129875829|NCT00860067|467504151|FG001|Overall Study|Pregnancy|0|||
129875830|NCT00860067|467504152|FG002|Overall Study|Pregnancy|0|||
129875831|NCT02424591|467504157|FG000|Overall Study|Protocol Violation|2|||
129875832|NCT02424591|467504158|FG001|Overall Study|Protocol Violation|3|||
129875833|NCT01446796|467504159|FG000|Overall Study|Withdrawal by Subject|1|||
129875834|NCT01446796|467504160|FG001|Overall Study|Withdrawal by Subject|0|||
129875835|NCT01498822|467504161|FG000|Overall Study|Protocol Violation|8|||
129875836|NCT01498822|467504162|FG001|Overall Study|Protocol Violation|4|||
129875837|NCT01498822|467504161|FG000|Overall Study|Other Reason|5|||
129875838|NCT01498822|467504162|FG001|Overall Study|Other Reason|2|||
129875839|NCT01498822|467504161|FG000|Overall Study|Lack of Efficacy|7|||
129875840|NCT01498822|467504162|FG001|Overall Study|Lack of Efficacy|2|||
129875841|NCT01498822|467504161|FG000|Overall Study|AE, non-serious non-fatal|8|||
129875842|NCT01498822|467504162|FG001|Overall Study|AE, non-serious non-fatal|17|||
129875843|NCT01498822|467504161|FG000|Overall Study|SAE, non-fatal|2|||
129875844|NCT01498822|467504162|FG001|Overall Study|SAE, non-fatal|2|||
129875845|NCT01498822|467504161|FG000|Overall Study|Adverse Event, serious fatal|1|||
129875846|NCT01498822|467504162|FG001|Overall Study|Adverse Event, serious fatal|1|||
129875847|NCT01498822|467504161|FG000|Overall Study|Withdrawal by Subject|15|||
129875848|NCT01498822|467504162|FG001|Overall Study|Withdrawal by Subject|25|||
129875849|NCT01498822|467504161|FG000|Overall Study|Lost to Follow-up|8|||
129875850|NCT01498822|467504162|FG001|Overall Study|Lost to Follow-up|3|||
129875851|NCT01674621|467504163|FG000|Overall Study|Adverse Event|3|||
129875852|NCT01674621|467504164|FG001|Overall Study|Adverse Event|2|||
130320416|NCT02016781|469141911|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
129875853|NCT01674621|467504165|FG002|Overall Study|Adverse Event|5|||
129875854|NCT01674621|467504166|FG003|Overall Study|Adverse Event|5|||
129875855|NCT01674621|467504167|FG004|Overall Study|Adverse Event|1|||
129875856|NCT01674621|467504163|FG000|Overall Study|Inability to Complete Study Procedures|0|||
129875857|NCT01674621|467504164|FG001|Overall Study|Inability to Complete Study Procedures|0|||
129875858|NCT01674621|467504165|FG002|Overall Study|Inability to Complete Study Procedures|0|||
129875859|NCT01674621|467504166|FG003|Overall Study|Inability to Complete Study Procedures|0|||
129875860|NCT01674621|467504167|FG004|Overall Study|Inability to Complete Study Procedures|2|||
129875861|NCT01674621|467504163|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
130320417|NCT02016781|469141910|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
130320418|NCT02016781|469141911|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
130320419|NCT02016781|469141910|FG000|Final Database Lock|Withdrawal by Subject|2|||
129875862|NCT01674621|467504164|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129875863|NCT01674621|467504165|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129875864|NCT01674621|467504166|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
129875865|NCT01674621|467504167|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129875866|NCT01674621|467504163|FG000|Overall Study|Withdrawal by Subject|2|||
129875867|NCT01674621|467504164|FG001|Overall Study|Withdrawal by Subject|5|||
129875868|NCT01674621|467504165|FG002|Overall Study|Withdrawal by Subject|2|||
129875869|NCT01674621|467504166|FG003|Overall Study|Withdrawal by Subject|0|||
129875870|NCT01674621|467504167|FG004|Overall Study|Withdrawal by Subject|1|||
129875871|NCT01674621|467504163|FG000|Overall Study|Other than specified|0|||
129875872|NCT01674621|467504164|FG001|Overall Study|Other than specified|1|||
129875873|NCT01674621|467504165|FG002|Overall Study|Other than specified|0|||
129875874|NCT01674621|467504166|FG003|Overall Study|Other than specified|0|||
129875875|NCT01674621|467504167|FG004|Overall Study|Other than specified|2|||
129875876|NCT01148862|467504170|FG000|Second Intervention|Withdrawal by Subject|0|||
129875877|NCT01148862|467504171|FG001|Second Intervention|Withdrawal by Subject|2|||
129875878|NCT01597505|467504175|FG000|Overall Study|Physician Decision|5|||
129875879|NCT01597505|467504176|FG001|Overall Study|Physician Decision|0|||
129875880|NCT01597505|467504175|FG000|Overall Study|Adverse Event|19|||
129875881|NCT01597505|467504176|FG001|Overall Study|Adverse Event|7|||
129875882|NCT01597505|467504175|FG000|Overall Study|Lost to Follow-up|4|||
129875883|NCT01597505|467504176|FG001|Overall Study|Lost to Follow-up|2|||
129875884|NCT01597505|467504175|FG000|Overall Study|Withdrawal by Subject|10|||
129875885|NCT01597505|467504176|FG001|Overall Study|Withdrawal by Subject|18|||
129875886|NCT01597505|467504175|FG000|Overall Study|Other|5|||
129875887|NCT01597505|467504176|FG001|Overall Study|Other|6|||
129875888|NCT01597505|467504175|FG000|Overall Study|Missing|1|||
129875889|NCT01597505|467504176|FG001|Overall Study|Missing|0|||
129875890|NCT05454410|467504177|FG000|Overall Study|Withdrawal by Subject|0|||
129875891|NCT05454410|467504178|FG001|Overall Study|Withdrawal by Subject|0|||
129875892|NCT05454410|467504179|FG002|Overall Study|Withdrawal by Subject|1|||
129875893|NCT05454410|467504180|FG003|Overall Study|Withdrawal by Subject|1|||
129875894|NCT05004688|467504191|FG000|Overall Study|Protocol Violation|7|||
129875895|NCT05004688|467504191|FG000|Overall Study|Physician Decision|2|||
129875896|NCT05004688|467504191|FG000|Overall Study|Withdrawal by Subject|2|||
129875897|NCT00895622|467504192|FG000|Overall Study|Protocol Violation|5|||
129875898|NCT00895622|467504193|FG001|Overall Study|Protocol Violation|4|||
129875899|NCT00895622|467504194|FG002|Overall Study|Protocol Violation|4|||
129875900|NCT03724396|467504195|FG000|Overall Study|Lost to Follow-up|1|||
129875901|NCT03724396|467504196|FG001|Overall Study|Lost to Follow-up|1|||
129875902|NCT03724396|467504195|FG000|Overall Study|Withdrawal by Subject|1|||
129875903|NCT03724396|467504196|FG001|Overall Study|Withdrawal by Subject|0|||
129875904|NCT03879408|467504197|FG000|Overall Study|Lost to Follow-up|0|||
129875905|NCT03879408|467504198|FG001|Overall Study|Lost to Follow-up|3|||
129875906|NCT03879408|467504199|FG002|Overall Study|Lost to Follow-up|2|||
129875907|NCT03879408|467504200|FG003|Overall Study|Lost to Follow-up|1|||
129875908|NCT03879408|467504201|FG004|Overall Study|Lost to Follow-up|0|||
129875909|NCT03879408|467504197|FG000|Overall Study|Withdrawal by Subject|2|||
129875910|NCT03879408|467504198|FG001|Overall Study|Withdrawal by Subject|1|||
129875911|NCT03879408|467504199|FG002|Overall Study|Withdrawal by Subject|1|||
129875912|NCT03879408|467504200|FG003|Overall Study|Withdrawal by Subject|0|||
129875913|NCT03879408|467504201|FG004|Overall Study|Withdrawal by Subject|1|||
129875914|NCT01490125|467504202|FG000|Period I|Adverse Event|4|||
129875915|NCT01490125|467504203|FG001|Period I|Adverse Event|1|||
129875916|NCT01490125|467504204|FG002|Period I|Adverse Event|1|||
129875917|NCT01490125|467504205|FG003|Period I|Adverse Event|3|||
129875918|NCT01490125|467504206|FG004|Period I|Adverse Event|2|||
129875919|NCT01490125|467504207|FG005|Period I|Adverse Event|4|||
129875920|NCT01490125|467504202|FG000|Period I|Protocol Violation|1|||
129875921|NCT01490125|467504203|FG001|Period I|Protocol Violation|1|||
129875922|NCT01490125|467504204|FG002|Period I|Protocol Violation|1|||
129875923|NCT01490125|467504205|FG003|Period I|Protocol Violation|1|||
129875924|NCT01490125|467504206|FG004|Period I|Protocol Violation|0|||
129875925|NCT01490125|467504207|FG005|Period I|Protocol Violation|0|||
129875926|NCT01490125|467504202|FG000|Period I|Withdrawal by Subject|1|||
129875927|NCT01490125|467504203|FG001|Period I|Withdrawal by Subject|3|||
129875928|NCT01490125|467504204|FG002|Period I|Withdrawal by Subject|2|||
129875929|NCT01490125|467504205|FG003|Period I|Withdrawal by Subject|1|||
129875930|NCT01490125|467504206|FG004|Period I|Withdrawal by Subject|2|||
129875931|NCT01490125|467504207|FG005|Period I|Withdrawal by Subject|1|||
129875932|NCT01490125|467504202|FG000|Period II|Adverse Event|2|||
129875933|NCT01490125|467504203|FG001|Period II|Adverse Event|3|||
129875934|NCT01490125|467504204|FG002|Period II|Adverse Event|2|||
129875935|NCT01490125|467504205|FG003|Period II|Adverse Event|2|||
129875936|NCT01490125|467504206|FG004|Period II|Adverse Event|4|||
129875937|NCT01490125|467504207|FG005|Period II|Adverse Event|2|||
129875938|NCT01490125|467504202|FG000|Period II|Protocol Violation|0|||
129875939|NCT01490125|467504203|FG001|Period II|Protocol Violation|0|||
129875940|NCT01490125|467504204|FG002|Period II|Protocol Violation|1|||
129875941|NCT01490125|467504205|FG003|Period II|Protocol Violation|1|||
129875942|NCT01490125|467504206|FG004|Period II|Protocol Violation|0|||
129875943|NCT01490125|467504207|FG005|Period II|Protocol Violation|0|||
129875944|NCT01490125|467504202|FG000|Period II|Lost to Follow-up|0|||
129875945|NCT01490125|467504203|FG001|Period II|Lost to Follow-up|1|||
129875946|NCT01490125|467504204|FG002|Period II|Lost to Follow-up|0|||
129875947|NCT01490125|467504205|FG003|Period II|Lost to Follow-up|0|||
129875948|NCT01490125|467504206|FG004|Period II|Lost to Follow-up|0|||
129875949|NCT01490125|467504207|FG005|Period II|Lost to Follow-up|0|||
129875950|NCT01490125|467504202|FG000|Period II|Withdrawal by Subject|1|||
129875951|NCT01490125|467504203|FG001|Period II|Withdrawal by Subject|0|||
129875952|NCT01490125|467504204|FG002|Period II|Withdrawal by Subject|0|||
129875953|NCT01490125|467504205|FG003|Period II|Withdrawal by Subject|0|||
129875954|NCT01490125|467504206|FG004|Period II|Withdrawal by Subject|0|||
129875955|NCT01490125|467504207|FG005|Period II|Withdrawal by Subject|0|||
129875956|NCT01490125|467504202|FG000|Period III|Adverse Event|3|||
129875957|NCT01490125|467504203|FG001|Period III|Adverse Event|1|||
129875958|NCT01490125|467504204|FG002|Period III|Adverse Event|0|||
129875959|NCT01490125|467504205|FG003|Period III|Adverse Event|1|||
129875960|NCT01490125|467504206|FG004|Period III|Adverse Event|0|||
129875961|NCT01490125|467504207|FG005|Period III|Adverse Event|0|||
129875962|NCT01490125|467504202|FG000|Period III|Death|0|||
129875963|NCT01490125|467504203|FG001|Period III|Death|0|||
129875964|NCT01490125|467504204|FG002|Period III|Death|0|||
129875965|NCT01490125|467504205|FG003|Period III|Death|1|||
129875966|NCT01490125|467504206|FG004|Period III|Death|0|||
129875967|NCT01490125|467504207|FG005|Period III|Death|0|||
129875968|NCT01490125|467504202|FG000|Period III|Lack of Efficacy|0|||
129875969|NCT01490125|467504203|FG001|Period III|Lack of Efficacy|0|||
129875970|NCT01490125|467504204|FG002|Period III|Lack of Efficacy|0|||
129875971|NCT01490125|467504205|FG003|Period III|Lack of Efficacy|0|||
129875972|NCT01490125|467504206|FG004|Period III|Lack of Efficacy|1|||
129875973|NCT01490125|467504207|FG005|Period III|Lack of Efficacy|0|||
129875974|NCT02237508|467504209|FG000|Overall Study|Withdrawal by Subject|0|||
129875975|NCT02237508|467504210|FG001|Overall Study|Withdrawal by Subject|2|||
129875976|NCT02237508|467504211|FG002|Overall Study|Withdrawal by Subject|0|||
129875977|NCT02237508|467504212|FG003|Overall Study|Withdrawal by Subject|1|||
129875978|NCT02237508|467504213|FG004|Overall Study|Withdrawal by Subject|0|||
129875979|NCT02237508|467504214|FG005|Overall Study|Withdrawal by Subject|1|||
129875980|NCT02237508|467504215|FG006|Overall Study|Withdrawal by Subject|1|||
129875981|NCT02237508|467504216|FG007|Overall Study|Withdrawal by Subject|0|||
129875982|NCT02237508|467504217|FG008|Overall Study|Withdrawal by Subject|1|||
129875983|NCT02237508|467504218|FG009|Overall Study|Withdrawal by Subject|0|||
129875984|NCT02237508|467504209|FG000|Overall Study|Physician Decision|0|||
129875985|NCT02237508|467504210|FG001|Overall Study|Physician Decision|1|||
129875986|NCT02237508|467504211|FG002|Overall Study|Physician Decision|0|||
129875987|NCT02237508|467504212|FG003|Overall Study|Physician Decision|0|||
129875988|NCT02237508|467504213|FG004|Overall Study|Physician Decision|0|||
129875989|NCT02237508|467504214|FG005|Overall Study|Physician Decision|0|||
129875990|NCT02237508|467504215|FG006|Overall Study|Physician Decision|0|||
129875991|NCT02237508|467504216|FG007|Overall Study|Physician Decision|0|||
129875992|NCT02237508|467504217|FG008|Overall Study|Physician Decision|0|||
129875993|NCT02237508|467504218|FG009|Overall Study|Physician Decision|0|||
129875994|NCT02237508|467504209|FG000|Overall Study|Protocol Violation|0|||
129875995|NCT02237508|467504210|FG001|Overall Study|Protocol Violation|0|||
129875996|NCT02237508|467504211|FG002|Overall Study|Protocol Violation|1|||
129875997|NCT02237508|467504212|FG003|Overall Study|Protocol Violation|0|||
129875998|NCT02237508|467504213|FG004|Overall Study|Protocol Violation|0|||
129875999|NCT02237508|467504214|FG005|Overall Study|Protocol Violation|0|||
129876000|NCT02237508|467504215|FG006|Overall Study|Protocol Violation|0|||
129876001|NCT02237508|467504216|FG007|Overall Study|Protocol Violation|0|||
129876002|NCT02237508|467504217|FG008|Overall Study|Protocol Violation|0|||
129876003|NCT02237508|467504218|FG009|Overall Study|Protocol Violation|0|||
129876004|NCT04000594|467504219|FG000|Overall Study|Withdrawal by Subject|1|||
129876005|NCT04000594|467504220|FG001|Overall Study|Withdrawal by Subject|0|||
129876006|NCT04000594|467504221|FG002|Overall Study|Withdrawal by Subject|0|||
129876007|NCT04522180|467504222|FG000|Overall Study|Investigator judgement|3|||
129876008|NCT04522180|467504223|FG001|Overall Study|Investigator judgement|4|||
129876009|NCT04522180|467504222|FG000|Overall Study|Voluntary withdrawal|1|||
129876010|NCT04522180|467504223|FG001|Overall Study|Voluntary withdrawal|0|||
129876011|NCT04522180|467504222|FG000|Overall Study|Pregnancy|0|||
129876012|NCT04522180|467504223|FG001|Overall Study|Pregnancy|1|||
129876013|NCT04522180|467504222|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
129876014|NCT04522180|467504223|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
129876015|NCT04522180|467504222|FG000|Overall Study|Reason not specified|8|||
129876016|NCT04522180|467504223|FG001|Overall Study|Reason not specified|5|||
129876017|NCT05807919|467504224|FG000|Overall Study|Received antibiotics - excluded|0|||
129876018|NCT05807919|467504225|FG001|Overall Study|Received antibiotics - excluded|1|||
129876019|NCT05807919|467504224|FG000|Overall Study|Withdrawal by Subject|0|||
129876020|NCT05807919|467504225|FG001|Overall Study|Withdrawal by Subject|3|||
129876021|NCT05807919|467504224|FG000|Overall Study|Adverse Event|1|||
129876022|NCT05807919|467504225|FG001|Overall Study|Adverse Event|1|||
129876023|NCT01905046|467504226|FG000|Months 13-24|Withdrawal by Subject|10|||
129876024|NCT01905046|467504227|FG001|Months 13-24|Withdrawal by Subject|10|||
129876025|NCT01905046|467504226|FG000|Months 13-24|Adverse Event|3|||
129876026|NCT01905046|467504227|FG001|Months 13-24|Adverse Event|2|||
129876027|NCT01905046|467504226|FG000|Months 13-24|Protocol Violation|3|||
129876028|NCT01905046|467504227|FG001|Months 13-24|Protocol Violation|3|||
129876029|NCT01905046|467504226|FG000|Months 13-24|Physician Decision|1|||
129876030|NCT01905046|467504227|FG001|Months 13-24|Physician Decision|0|||
129876031|NCT03489057|467504232|FG000|Overall Study|Lost to Follow-up|16|||
129876032|NCT03489057|467504233|FG001|Overall Study|Lost to Follow-up|16|||
129876033|NCT03489057|467504234|FG002|Overall Study|Lost to Follow-up|14|||
129876034|NCT03489057|467504235|FG003|Overall Study|Lost to Follow-up|14|||
129876035|NCT03489057|467504232|FG000|Overall Study|Withdrawal by Subject|12|||
129876036|NCT03489057|467504233|FG001|Overall Study|Withdrawal by Subject|12|||
129876037|NCT03489057|467504234|FG002|Overall Study|Withdrawal by Subject|8|||
129876038|NCT03489057|467504235|FG003|Overall Study|Withdrawal by Subject|8|||
129876039|NCT03489057|467504232|FG000|Overall Study|Protocol Violation|7|||
129876040|NCT03489057|467504233|FG001|Overall Study|Protocol Violation|7|||
129876041|NCT03489057|467504234|FG002|Overall Study|Protocol Violation|2|||
129876042|NCT03489057|467504235|FG003|Overall Study|Protocol Violation|2|||
129876043|NCT01368900|467504238|FG000|Overall Study|Lost to Follow-up|7|||
129876044|NCT04027348|467504241|FG000|Overall Study|Adverse Event|2|||
129876045|NCT02487472|467504242|FG000|Overall Study|Did not complete telephonic interviews|9|||
129876046|NCT02487472|467504242|FG000|Overall Study|Other|2|||
129876047|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
129876048|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
129876049|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
129876050|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
129876051|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
129876052|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
129876053|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
129876054|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
129876055|NCT01552954|467504247|FG000|Overall Study|Adverse Event|1|||
129876056|NCT01552954|467504248|FG001|Overall Study|Adverse Event|2|||
129876057|NCT01552954|467504247|FG000|Overall Study|Lost to Follow-up|1|||
129876058|NCT01552954|467504248|FG001|Overall Study|Lost to Follow-up|1|||
129876059|NCT01552954|467504247|FG000|Overall Study|Withdrawal by Subject|1|||
129876060|NCT01552954|467504248|FG001|Overall Study|Withdrawal by Subject|1|||
129876061|NCT01552954|467504247|FG000|Overall Study|Protocol Violation|1|||
129876062|NCT01552954|467504248|FG001|Overall Study|Protocol Violation|2|||
129876063|NCT01552954|467504247|FG000|Overall Study|diagnosed DM|1|||
129876064|NCT01552954|467504248|FG001|Overall Study|diagnosed DM|0|||
129876065|NCT04843930|467504249|FG000|Randomization|Withdrawal by Subject|6|||
129876066|NCT04843930|467504250|FG001|Randomization|Withdrawal by Subject|6|||
129876067|NCT04843930|467504251|FG002|Randomization|Withdrawal by Subject|0|||
129876068|NCT04843930|467504252|FG003|Randomization|Withdrawal by Subject|0|||
129876069|NCT04843930|467504249|FG000|Week 6 Assessment|Adverse Event|3|||
129876070|NCT04843930|467504250|FG001|Week 6 Assessment|Adverse Event|0|||
129876071|NCT04843930|467504251|FG002|Week 6 Assessment|Adverse Event|0|||
129876072|NCT04843930|467504252|FG003|Week 6 Assessment|Adverse Event|0|||
129876073|NCT04843930|467504249|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
129876074|NCT04843930|467504250|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
129876075|NCT04843930|467504251|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
129876076|NCT04843930|467504252|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
129876077|NCT04843930|467504249|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
129876078|NCT04843930|467504250|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
129876079|NCT04843930|467504251|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
129876080|NCT04843930|467504252|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
129876081|NCT01931735|467504253|FG000|Randomized Phase|Lost to Follow-up|2|||
129876082|NCT01931735|467504254|FG001|Randomized Phase|Lost to Follow-up|2|||
129876083|NCT01931735|467504255|FG002|Randomized Phase|Lost to Follow-up|5|||
129876084|NCT01931735|467504256|FG003|Randomized Phase|Lost to Follow-up|0|||
129876085|NCT01931735|467504253|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
129876086|NCT01931735|467504254|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
129876087|NCT01931735|467504255|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
129876088|NCT01931735|467504256|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
129876089|NCT01931735|467504253|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
129876090|NCT01931735|467504254|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
129876091|NCT01931735|467504255|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
129876092|NCT01931735|467504256|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
129876093|NCT02719990|467504257|FG000|Overall Study|Physician Decision|2|||
129876094|NCT02719990|467504257|FG000|Overall Study|Withdrawal by Subject|2|||
129876095|NCT02719990|467504257|FG000|Overall Study|Study Terminated By Sponsor|32|||
129876096|NCT01833143|467504261|FG000|Overall Study|Not Treated|1|||
129876097|NCT03995784|467504262|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
129876098|NCT00369681|467506391|FG000|Overall Study|Death|1|||
129876099|NCT02991482|467506392|FG000|Overall Study|Disease progression|56|||
129876100|NCT02991482|467506393|FG001|Overall Study|Disease progression|47|||
129876101|NCT02991482|467506392|FG000|Overall Study|Death|4|||
129876102|NCT02991482|467506393|FG001|Overall Study|Death|4|||
129876103|NCT02991482|467506392|FG000|Overall Study|Adverse Event|1|||
129876104|NCT02991482|467506393|FG001|Overall Study|Adverse Event|6|||
129876105|NCT02991482|467506392|FG000|Overall Study|Patient decision|1|||
129876106|NCT02991482|467506393|FG001|Overall Study|Patient decision|1|||
129876107|NCT02991482|467506392|FG000|Overall Study|Physician Decision|0|||
129876108|NCT02991482|467506393|FG001|Overall Study|Physician Decision|6|||
129876109|NCT02991482|467506392|FG000|Overall Study|Clinical deterioration|1|||
129876110|NCT02991482|467506393|FG001|Overall Study|Clinical deterioration|0|||
129876111|NCT02991482|467506392|FG000|Overall Study|Patient feeling too unwell|1|||
129876112|NCT02991482|467506393|FG001|Overall Study|Patient feeling too unwell|0|||
129876113|NCT02991482|467506392|FG000|Overall Study|Worsening of performance status|0|||
129876114|NCT02991482|467506393|FG001|Overall Study|Worsening of performance status|1|||
129876115|NCT02991482|467506392|FG000|Overall Study|Death prior to study drug initiation|1|||
129876116|NCT02991482|467506393|FG001|Overall Study|Death prior to study drug initiation|0|||
129876117|NCT02991482|467506392|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
129876118|NCT02991482|467506393|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
129876119|NCT02396537|467506400|FG000|Overall Study|Protocol Violation|0|||
129876120|NCT02396537|467506401|FG001|Overall Study|Protocol Violation|1|||
129876121|NCT00871403|467506402|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
129876122|NCT00871403|467506403|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
129876123|NCT00871403|467506404|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
129876124|NCT00871403|467506402|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
129876125|NCT00871403|467506403|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
129876126|NCT00871403|467506404|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
129876127|NCT00871403|467506402|FG000|Combination Treatment Phase|Adverse Event|0|||
129876128|NCT00871403|467506403|FG001|Combination Treatment Phase|Adverse Event|17|||
129876129|NCT00871403|467506404|FG002|Combination Treatment Phase|Adverse Event|2|||
129876130|NCT00871403|467506402|FG000|Combination Treatment Phase|Disease Progression|0|||
129876131|NCT00871403|467506403|FG001|Combination Treatment Phase|Disease Progression|8|||
129876132|NCT00871403|467506404|FG002|Combination Treatment Phase|Disease Progression|5|||
129876133|NCT00871403|467506402|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
129876134|NCT00871403|467506403|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
129876135|NCT00871403|467506404|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
129876136|NCT00871403|467506402|FG000|Combination Treatment Phase|Physician Decision|0|||
129876137|NCT00871403|467506403|FG001|Combination Treatment Phase|Physician Decision|1|||
129876138|NCT00871403|467506404|FG002|Combination Treatment Phase|Physician Decision|3|||
129876139|NCT00871403|467506402|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
129876140|NCT00871403|467506403|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
129876141|NCT00871403|467506404|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
129876142|NCT00871403|467506402|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
129876143|NCT00871403|467506403|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
129876144|NCT00871403|467506404|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
129876145|NCT04887948|467506405|FG000|Overall Study|Death|1|||
129876146|NCT04887948|467506406|FG001|Overall Study|Death|0|||
129876147|NCT04887948|467506407|FG002|Overall Study|Death|0|||
129876148|NCT04887948|467506405|FG000|Overall Study|Lost to Follow-up|1|||
129876149|NCT04887948|467506406|FG001|Overall Study|Lost to Follow-up|0|||
129876150|NCT04887948|467506407|FG002|Overall Study|Lost to Follow-up|3|||
129876151|NCT04887948|467506405|FG000|Overall Study|Physician Decision|0|||
129876152|NCT04887948|467506406|FG001|Overall Study|Physician Decision|4|||
129876153|NCT04887948|467506407|FG002|Overall Study|Physician Decision|1|||
129876154|NCT04887948|467506405|FG000|Overall Study|Protocol Violation|1|||
129876155|NCT04887948|467506406|FG001|Overall Study|Protocol Violation|1|||
129876156|NCT04887948|467506407|FG002|Overall Study|Protocol Violation|0|||
129876157|NCT04887948|467506405|FG000|Overall Study|Withdrawal by Subject|0|||
129876158|NCT04887948|467506406|FG001|Overall Study|Withdrawal by Subject|6|||
129876159|NCT04887948|467506407|FG002|Overall Study|Withdrawal by Subject|1|||
129876160|NCT04887948|467506405|FG000|Overall Study|No longer met eligibility criteria|1|||
129876161|NCT04887948|467506406|FG001|Overall Study|No longer met eligibility criteria|2|||
129876162|NCT04887948|467506407|FG002|Overall Study|No longer met eligibility criteria|1|||
129876163|NCT04887948|467506405|FG000|Overall Study|Other|2|||
129876164|NCT04887948|467506406|FG001|Overall Study|Other|1|||
129876165|NCT04887948|467506407|FG002|Overall Study|Other|1|||
129876166|NCT00787319|467506411|FG000|Overall Study|Lost to Follow-up|2|||
129876167|NCT00787319|467506411|FG000|Overall Study|Withdrawal by Subject|15|||
129876168|NCT00787319|467506411|FG000|Overall Study|Adverse Event|3|||
129876169|NCT00787319|467506411|FG000|Overall Study|Objective progression or relapse|30|||
129876170|NCT00787319|467506411|FG000|Overall Study|Lack of Efficacy|1|||
129876171|NCT00787319|467506411|FG000|Overall Study|Budget exhausted/exceeded|1|||
129876172|NCT00787319|467506411|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
129876173|NCT00787319|467506411|FG000|Overall Study|No health insurance reimbursement|2|||
129876174|NCT00787319|467506411|FG000|Overall Study|Stabilized disease findings|3|||
129876175|NCT00787319|467506411|FG000|Overall Study|Inactive disease|5|||
129876176|NCT01932294|467506412|FG000|Overall Study|Death|43|||
129876177|NCT01932294|467506412|FG000|Overall Study|Lost to Follow-up|8|||
129876178|NCT01932294|467506412|FG000|Overall Study|VAD Implantation|20|||
129876179|NCT01932294|467506412|FG000|Overall Study|Heart Transplantation|16|||
129876180|NCT01932294|467506412|FG000|Overall Study|Transferred to other hospitals|12|||
129876181|NCT04415151|467506413|FG000|Overall Study|Death|1|||
129876182|NCT04415151|467506414|FG001|Overall Study|Death|1|||
129876183|NCT04415151|467506413|FG000|Overall Study|Withdrawal by Subject|1|||
130320420|NCT02016781|469141911|FG001|Final Database Lock|Withdrawal by Subject|1|||
130320421|NCT02016781|469141910|FG000|Final Database Lock|Lost to Follow-up|11|||
130320422|NCT02016781|469141911|FG001|Final Database Lock|Lost to Follow-up|4|||
130320423|NCT02016781|469141910|FG000|Final Database Lock|Missing data|0|||
130320424|NCT02016781|469141911|FG001|Final Database Lock|Missing data|3|||
130320425|NCT04886154|469141912|FG000|Overall Study|Adverse Event|0|||
130320426|NCT04886154|469141913|FG001|Overall Study|Adverse Event|0|||
130320427|NCT04886154|469141914|FG002|Overall Study|Adverse Event|0|||
130320428|NCT04886154|469141915|FG003|Overall Study|Adverse Event|0|||
130320429|NCT04886154|469141916|FG004|Overall Study|Adverse Event|1|||
130320430|NCT04886154|469141917|FG005|Overall Study|Adverse Event|0|||
130320431|NCT04886154|469141918|FG006|Overall Study|Adverse Event|0|||
130320432|NCT04886154|469141919|FG007|Overall Study|Adverse Event|1|||
130320433|NCT04886154|469141920|FG008|Overall Study|Adverse Event|1|||
130320434|NCT04886154|469141921|FG009|Overall Study|Adverse Event|0|||
130320435|NCT04886154|469141922|FG010|Overall Study|Adverse Event|0|||
130320436|NCT04886154|469141923|FG011|Overall Study|Adverse Event|1|||
130320437|NCT04886154|469141924|FG012|Overall Study|Adverse Event|0|||
130320438|NCT04886154|469141925|FG013|Overall Study|Adverse Event|0|||
130320439|NCT04886154|469141926|FG014|Overall Study|Adverse Event|3|||
130320440|NCT04886154|469141912|FG000|Overall Study|Lost to Follow-up|1|||
130320441|NCT04886154|469141913|FG001|Overall Study|Lost to Follow-up|0|||
130320442|NCT04886154|469141914|FG002|Overall Study|Lost to Follow-up|2|||
130320443|NCT04886154|469141915|FG003|Overall Study|Lost to Follow-up|0|||
130320444|NCT04886154|469141916|FG004|Overall Study|Lost to Follow-up|17|||
130320445|NCT04886154|469141917|FG005|Overall Study|Lost to Follow-up|7|||
130320446|NCT04886154|469141918|FG006|Overall Study|Lost to Follow-up|8|||
130320447|NCT04886154|469141919|FG007|Overall Study|Lost to Follow-up|7|||
130320448|NCT04886154|469141920|FG008|Overall Study|Lost to Follow-up|8|||
130320449|NCT04886154|469141921|FG009|Overall Study|Lost to Follow-up|0|||
130320450|NCT04886154|469141922|FG010|Overall Study|Lost to Follow-up|2|||
130320451|NCT04886154|469141923|FG011|Overall Study|Lost to Follow-up|0|||
130320452|NCT04886154|469141924|FG012|Overall Study|Lost to Follow-up|0|||
130320453|NCT04886154|469141925|FG013|Overall Study|Lost to Follow-up|0|||
130320454|NCT04886154|469141926|FG014|Overall Study|Lost to Follow-up|0|||
130320455|NCT04886154|469141912|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320456|NCT04886154|469141913|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320457|NCT04886154|469141914|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320458|NCT04886154|469141915|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320459|NCT04886154|469141916|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320460|NCT04886154|469141917|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129876184|NCT04415151|467506414|FG001|Overall Study|Withdrawal by Subject|0|||
129876185|NCT00638235|467506420|FG000|Overall Study|Lost to Follow-up|31|||
129876186|NCT00638235|467506421|FG001|Overall Study|Lost to Follow-up|3|||
129876187|NCT00638235|467506422|FG002|Overall Study|Lost to Follow-up|18|||
130320461|NCT04886154|469141918|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
130320462|NCT04886154|469141919|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320463|NCT04886154|469141920|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320464|NCT04886154|469141921|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320465|NCT04886154|469141922|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320466|NCT04886154|469141923|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320467|NCT04886154|469141924|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320468|NCT04886154|469141925|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320469|NCT04886154|469141926|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
130320470|NCT04886154|469141912|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320471|NCT04886154|469141913|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320472|NCT04886154|469141914|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320473|NCT04886154|469141915|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320474|NCT04886154|469141916|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130320475|NCT04886154|469141917|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320476|NCT04886154|469141918|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130320477|NCT04886154|469141919|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130320478|NCT04886154|469141920|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320479|NCT04886154|469141921|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129876188|NCT00638235|467506423|FG003|Overall Study|Lost to Follow-up|10|||
129876189|NCT00638235|467506424|FG004|Overall Study|Lost to Follow-up|13|||
129876190|NCT00638235|467506425|FG005|Overall Study|Lost to Follow-up|26|||
129876191|NCT00638235|467506426|FG006|Overall Study|Lost to Follow-up|0|||
129876192|NCT00638235|467506427|FG007|Overall Study|Lost to Follow-up|1|||
130320480|NCT04886154|469141922|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320481|NCT04886154|469141923|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320482|NCT04886154|469141924|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130320483|NCT04886154|469141925|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129876193|NCT00638235|467506428|FG008|Overall Study|Lost to Follow-up|18|||
129876194|NCT03505476|467506431|FG000|Overall Study|Physician Decision|18|||
129876195|NCT03505476|467506431|FG000|Overall Study|Device Malfunctioned|101|||
129876196|NCT03505476|467506431|FG000|Overall Study|Data Corrupt|6|||
129876197|NCT03505476|467506431|FG000|Overall Study|Device application insufficiant|3|||
129876198|NCT00659984|467506436|FG000|Overall Study|Adverse Event|1|||
129876199|NCT02228395|467506437|FG000|First Intervention Period|No longer willing to participate|1|||
129876200|NCT02228395|467506438|FG001|First Intervention Period|No longer willing to participate|0|||
129876201|NCT02228395|467506439|FG002|First Intervention Period|No longer willing to participate|0|||
129876202|NCT02228395|467506437|FG000|First Intervention Period|Unable to comply with study dates|0|||
129876203|NCT02228395|467506438|FG001|First Intervention Period|Unable to comply with study dates|1|||
129876204|NCT02228395|467506439|FG002|First Intervention Period|Unable to comply with study dates|1|||
129876205|NCT02569437|467506442|FG000|Overall Study|Lost to Follow-up|12|||
129876206|NCT02569437|467506443|FG001|Overall Study|Lost to Follow-up|14|||
129876207|NCT00985985|467506444|FG000|Overall Study|Adverse Event|4|||
129876208|NCT00985985|467506445|FG001|Overall Study|Adverse Event|2|||
129876209|NCT00985985|467506446|FG002|Overall Study|Adverse Event|2|||
129876210|NCT00985985|467506447|FG003|Overall Study|Adverse Event|2|||
129876211|NCT00985985|467506444|FG000|Overall Study|Lost to Follow-up|4|||
129876212|NCT00985985|467506445|FG001|Overall Study|Lost to Follow-up|11|||
129876213|NCT00985985|467506446|FG002|Overall Study|Lost to Follow-up|2|||
129876214|NCT00985985|467506447|FG003|Overall Study|Lost to Follow-up|3|||
129876215|NCT00985985|467506444|FG000|Overall Study|Protocol Violation|1|||
129876216|NCT00985985|467506445|FG001|Overall Study|Protocol Violation|2|||
129876217|NCT00985985|467506446|FG002|Overall Study|Protocol Violation|0|||
129876218|NCT00985985|467506447|FG003|Overall Study|Protocol Violation|1|||
129876219|NCT00985985|467506444|FG000|Overall Study|Lack of Efficacy|5|||
129876220|NCT00985985|467506445|FG001|Overall Study|Lack of Efficacy|6|||
129876221|NCT00985985|467506446|FG002|Overall Study|Lack of Efficacy|1|||
129876222|NCT00985985|467506447|FG003|Overall Study|Lack of Efficacy|3|||
129876223|NCT00985985|467506444|FG000|Overall Study|Withdrawal by Subject|4|||
129876224|NCT00985985|467506445|FG001|Overall Study|Withdrawal by Subject|2|||
129876225|NCT00985985|467506446|FG002|Overall Study|Withdrawal by Subject|2|||
129876226|NCT00985985|467506447|FG003|Overall Study|Withdrawal by Subject|2|||
129876227|NCT00985985|467506444|FG000|Overall Study|Other Reason|6|||
129876228|NCT00985985|467506445|FG001|Overall Study|Other Reason|1|||
129876229|NCT00985985|467506446|FG002|Overall Study|Other Reason|4|||
129876230|NCT00985985|467506447|FG003|Overall Study|Other Reason|2|||
129876231|NCT03587142|467506448|FG000|Overall Study|Lost to Follow-up|5|||
129876232|NCT03587142|467506449|FG001|Overall Study|Lost to Follow-up|3|||
129876233|NCT03587142|467506448|FG000|Overall Study|Did not complete the f4 visit|3|||
129876234|NCT03587142|467506449|FG001|Overall Study|Did not complete the f4 visit|7|||
129876235|NCT00708435|467506450|FG000|Overall Study|Death / Serious Adverse Event|10|||
129876236|NCT00708435|467506451|FG001|Overall Study|Death / Serious Adverse Event|5|||
129876237|NCT00708435|467506450|FG000|Overall Study|Lost to Follow-up|9|||
129876238|NCT00708435|467506451|FG001|Overall Study|Lost to Follow-up|4|||
129876239|NCT00708435|467506450|FG000|Overall Study|Withdrawal by Subject|3|||
129876240|NCT00708435|467506451|FG001|Overall Study|Withdrawal by Subject|7|||
129876241|NCT00708435|467506450|FG000|Overall Study|Adverse Event|1|||
129876242|NCT00708435|467506451|FG001|Overall Study|Adverse Event|0|||
129876243|NCT00708435|467506450|FG000|Overall Study|Protocol Violation|0|||
129876244|NCT00708435|467506451|FG001|Overall Study|Protocol Violation|1|||
129876245|NCT00708435|467506450|FG000|Overall Study|Intervention by primary care physician|1|||
129876246|NCT00708435|467506451|FG001|Overall Study|Intervention by primary care physician|0|||
129876247|NCT00708435|467506450|FG000|Overall Study|Refused hospitalization|1|||
129876248|NCT00708435|467506451|FG001|Overall Study|Refused hospitalization|0|||
129876249|NCT01691521|467506452|FG000|Overall Study|Adverse Event|4|||
129876250|NCT01691521|467506453|FG001|Overall Study|Adverse Event|0|||
129876251|NCT01691521|467506454|FG002|Overall Study|Adverse Event|1|||
129876252|NCT01691521|467506452|FG000|Overall Study|Lack of Efficacy|1|||
129876253|NCT01691521|467506453|FG001|Overall Study|Lack of Efficacy|1|||
129876254|NCT01691521|467506454|FG002|Overall Study|Lack of Efficacy|2|||
129876255|NCT01691521|467506452|FG000|Overall Study|Protocol Violation|0|||
129876256|NCT01691521|467506453|FG001|Overall Study|Protocol Violation|3|||
129876257|NCT01691521|467506454|FG002|Overall Study|Protocol Violation|0|||
129876258|NCT01691521|467506452|FG000|Overall Study|Lost to Follow-up|0|||
129876259|NCT01691521|467506453|FG001|Overall Study|Lost to Follow-up|2|||
129876260|NCT01691521|467506454|FG002|Overall Study|Lost to Follow-up|2|||
129876261|NCT01691521|467506452|FG000|Overall Study|Physician Decision|2|||
129876262|NCT01691521|467506453|FG001|Overall Study|Physician Decision|1|||
129876263|NCT01691521|467506454|FG002|Overall Study|Physician Decision|0|||
129876264|NCT01691521|467506452|FG000|Overall Study|Withdrawal by Subject|5|||
129876265|NCT01691521|467506453|FG001|Overall Study|Withdrawal by Subject|9|||
129876266|NCT01691521|467506454|FG002|Overall Study|Withdrawal by Subject|4|||
129876267|NCT00312702|467506458|FG000|Immunization Phase|Lost to Follow-up|0|||
129876268|NCT00312702|467506459|FG001|Immunization Phase|Lost to Follow-up|1|||
129876269|NCT00312702|467506460|FG002|Immunization Phase|Lost to Follow-up|0|||
129876270|NCT00770432|467506461|FG000|Overall Study|Other|4|||
129876271|NCT00770432|467506462|FG001|Overall Study|Other|6|||
129876272|NCT00770432|467506461|FG000|Overall Study|Non-compliance|0|||
129876273|NCT00770432|467506462|FG001|Overall Study|Non-compliance|1|||
129876274|NCT00988221|467506465|FG000|Part I|Adverse Event|0|||
129876275|NCT00988221|467506466|FG001|Part I|Adverse Event|1|||
129876276|NCT00988221|467506467|FG002|Part I|Adverse Event|2|||
129876277|NCT00988221|467506468|FG003|Part I|Adverse Event|0|||
129876278|NCT00988221|467506465|FG000|Part I|Insufficient Therapeutic Response|4|||
129876279|NCT00988221|467506466|FG001|Part I|Insufficient Therapeutic Response|6|||
129876280|NCT00988221|467506467|FG002|Part I|Insufficient Therapeutic Response|5|||
129876281|NCT00988221|467506468|FG003|Part I|Insufficient Therapeutic Response|0|||
129876282|NCT00988221|467506465|FG000|Part I|Refused Treatment|0|||
129876283|NCT00988221|467506466|FG001|Part I|Refused Treatment|2|||
129876284|NCT00988221|467506467|FG002|Part I|Refused Treatment|1|||
129876285|NCT00988221|467506468|FG003|Part I|Refused Treatment|0|||
129876286|NCT00988221|467506465|FG000|Part I|Lost to Follow-up|0|||
129876287|NCT00988221|467506466|FG001|Part I|Lost to Follow-up|1|||
129876288|NCT00988221|467506467|FG002|Part I|Lost to Follow-up|0|||
129876289|NCT00988221|467506468|FG003|Part I|Lost to Follow-up|0|||
129876290|NCT00988221|467506465|FG000|Part II|Adverse Event|1|||
129876291|NCT00988221|467506466|FG001|Part II|Adverse Event|0|||
129876292|NCT00988221|467506467|FG002|Part II|Adverse Event|0|||
129876293|NCT00988221|467506468|FG003|Part II|Adverse Event|1|||
129876294|NCT00988221|467506465|FG000|Part II|Withdrawal by Subject|0|||
129876295|NCT00988221|467506466|FG001|Part II|Withdrawal by Subject|0|||
129876296|NCT00988221|467506467|FG002|Part II|Withdrawal by Subject|2|||
129876297|NCT00988221|467506468|FG003|Part II|Withdrawal by Subject|2|||
129876298|NCT00988221|467506465|FG000|Part II|Reason not Specified|0|||
129876299|NCT00988221|467506466|FG001|Part II|Reason not Specified|0|||
129876300|NCT00988221|467506467|FG002|Part II|Reason not Specified|1|||
129876301|NCT00988221|467506468|FG003|Part II|Reason not Specified|0|||
129876302|NCT00988221|467506465|FG000|Part III|Adverse Event|1|||
129876303|NCT00988221|467506466|FG001|Part III|Adverse Event|0|||
129876304|NCT00988221|467506467|FG002|Part III|Adverse Event|1|||
129876305|NCT00988221|467506468|FG003|Part III|Adverse Event|0|||
129876306|NCT00988221|467506465|FG000|Part III|Insufficient Therapeutic Response|0|||
129876307|NCT00988221|467506466|FG001|Part III|Insufficient Therapeutic Response|1|||
129876308|NCT00988221|467506467|FG002|Part III|Insufficient Therapeutic Response|1|||
129876309|NCT00988221|467506468|FG003|Part III|Insufficient Therapeutic Response|0|||
129876310|NCT00988221|467506465|FG000|Part III|Refused Treatment|0|||
129876311|NCT00988221|467506466|FG001|Part III|Refused Treatment|0|||
129876312|NCT00988221|467506467|FG002|Part III|Refused Treatment|1|||
129876313|NCT00988221|467506468|FG003|Part III|Refused Treatment|0|||
129876314|NCT02756832|467506471|FG000|Overall Study|Lost for Observation after Baseline|6|||
129876315|NCT02756832|467506471|FG000|Overall Study|Lost for Observation|13|||
129876316|NCT02756832|467506471|FG000|Overall Study|Patient's Unwillingness|12|||
129876317|NCT02756832|467506471|FG000|Overall Study|Insufficient Efficacy|2|||
129876318|NCT02756832|467506471|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
129876319|NCT02756832|467506471|FG000|Overall Study|Reason not Specified|9|||
129876320|NCT02756832|467506471|FG000|Overall Study|Protocol Deviation|10|||
129876321|NCT01364597|467506472|FG000|Overall Study|Adverse Event|4|||
129876322|NCT01364597|467506473|FG001|Overall Study|Adverse Event|5|||
129876323|NCT01364597|467506474|FG002|Overall Study|Adverse Event|16|||
129876324|NCT01364597|467506475|FG003|Overall Study|Adverse Event|7|||
129876325|NCT01364597|467506472|FG000|Overall Study|Lack of Efficacy|4|||
129876326|NCT01364597|467506473|FG001|Overall Study|Lack of Efficacy|4|||
129876327|NCT01364597|467506474|FG002|Overall Study|Lack of Efficacy|23|||
129876328|NCT01364597|467506475|FG003|Overall Study|Lack of Efficacy|8|||
129876329|NCT01364597|467506472|FG000|Overall Study|Protocol Violation|0|||
129876330|NCT01364597|467506473|FG001|Overall Study|Protocol Violation|0|||
129876331|NCT01364597|467506474|FG002|Overall Study|Protocol Violation|2|||
129876332|NCT01364597|467506475|FG003|Overall Study|Protocol Violation|0|||
129876333|NCT01364597|467506472|FG000|Overall Study|Lost to Follow-up|0|||
129876334|NCT01364597|467506473|FG001|Overall Study|Lost to Follow-up|0|||
129876335|NCT01364597|467506474|FG002|Overall Study|Lost to Follow-up|5|||
129876336|NCT01364597|467506475|FG003|Overall Study|Lost to Follow-up|3|||
129876337|NCT01364597|467506472|FG000|Overall Study|Withdrawal by Subject|4|||
129876338|NCT01364597|467506473|FG001|Overall Study|Withdrawal by Subject|1|||
129876339|NCT01364597|467506474|FG002|Overall Study|Withdrawal by Subject|18|||
129876340|NCT01364597|467506475|FG003|Overall Study|Withdrawal by Subject|6|||
129876341|NCT01364597|467506472|FG000|Overall Study|Non compliance|1|||
129876342|NCT01364597|467506473|FG001|Overall Study|Non compliance|0|||
129876343|NCT01364597|467506474|FG002|Overall Study|Non compliance|1|||
129876344|NCT01364597|467506475|FG003|Overall Study|Non compliance|0|||
129876345|NCT01364597|467506472|FG000|Overall Study|Lack of compliance|1|||
129876346|NCT01364597|467506473|FG001|Overall Study|Lack of compliance|0|||
129876347|NCT01364597|467506474|FG002|Overall Study|Lack of compliance|0|||
129876348|NCT01364597|467506475|FG003|Overall Study|Lack of compliance|0|||
129876349|NCT01364597|467506472|FG000|Overall Study|End of treatment epilepsy|1|||
129876350|NCT01364597|467506473|FG001|Overall Study|End of treatment epilepsy|0|||
129876351|NCT01364597|467506474|FG002|Overall Study|End of treatment epilepsy|0|||
129876352|NCT01364597|467506475|FG003|Overall Study|End of treatment epilepsy|0|||
129876353|NCT01364597|467506472|FG000|Overall Study|No Seizures|1|||
129876354|NCT01364597|467506473|FG001|Overall Study|No Seizures|0|||
129876355|NCT01364597|467506474|FG002|Overall Study|No Seizures|0|||
129876356|NCT01364597|467506475|FG003|Overall Study|No Seizures|0|||
129876357|NCT01364597|467506472|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
129876358|NCT01364597|467506473|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
129876359|NCT01364597|467506474|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
129876360|NCT01364597|467506475|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
129876361|NCT01364597|467506472|FG000|Overall Study|Cure|1|||
129876362|NCT01364597|467506473|FG001|Overall Study|Cure|0|||
129876363|NCT01364597|467506474|FG002|Overall Study|Cure|0|||
129876364|NCT01364597|467506475|FG003|Overall Study|Cure|0|||
129876365|NCT01364597|467506472|FG000|Overall Study|Patient was moving|0|||
129876366|NCT01364597|467506473|FG001|Overall Study|Patient was moving|1|||
129876367|NCT01364597|467506474|FG002|Overall Study|Patient was moving|0|||
129876368|NCT01364597|467506475|FG003|Overall Study|Patient was moving|0|||
129876369|NCT01364597|467506472|FG000|Overall Study|Seizures resolved|0|||
129876370|NCT01364597|467506473|FG001|Overall Study|Seizures resolved|0|||
129876371|NCT01364597|467506474|FG002|Overall Study|Seizures resolved|1|||
129876372|NCT01364597|467506475|FG003|Overall Study|Seizures resolved|0|||
129876373|NCT01364597|467506472|FG000|Overall Study|Patient became seizure-free after surgery|0|||
129876374|NCT01364597|467506473|FG001|Overall Study|Patient became seizure-free after surgery|0|||
129876375|NCT01364597|467506474|FG002|Overall Study|Patient became seizure-free after surgery|1|||
129876376|NCT01364597|467506475|FG003|Overall Study|Patient became seizure-free after surgery|0|||
129876377|NCT01364597|467506472|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
129876378|NCT01364597|467506473|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
129876379|NCT01364597|467506474|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
129876380|NCT01364597|467506475|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
129876381|NCT01364597|467506472|FG000|Overall Study|Patient cured from Epilepsy|0|||
129876382|NCT01364597|467506473|FG001|Overall Study|Patient cured from Epilepsy|0|||
129876383|NCT01364597|467506474|FG002|Overall Study|Patient cured from Epilepsy|1|||
129876384|NCT01364597|467506475|FG003|Overall Study|Patient cured from Epilepsy|0|||
129876385|NCT01364597|467506472|FG000|Overall Study|Investigator decision|0|||
129876386|NCT01364597|467506473|FG001|Overall Study|Investigator decision|0|||
129876387|NCT01364597|467506474|FG002|Overall Study|Investigator decision|1|||
129876388|NCT01364597|467506475|FG003|Overall Study|Investigator decision|0|||
129876389|NCT01364597|467506472|FG000|Overall Study|Sponsor recommended discontinuation|0|||
129876390|NCT01364597|467506473|FG001|Overall Study|Sponsor recommended discontinuation|0|||
129876391|NCT01364597|467506474|FG002|Overall Study|Sponsor recommended discontinuation|0|||
129876392|NCT01364597|467506475|FG003|Overall Study|Sponsor recommended discontinuation|1|||
129876393|NCT01364597|467506472|FG000|Overall Study|Parents went abroad with the patient|0|||
129876394|NCT01364597|467506473|FG001|Overall Study|Parents went abroad with the patient|0|||
129876395|NCT01364597|467506474|FG002|Overall Study|Parents went abroad with the patient|1|||
129876396|NCT01364597|467506475|FG003|Overall Study|Parents went abroad with the patient|0|||
129876397|NCT01364597|467506472|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
129876398|NCT01364597|467506473|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
129876399|NCT01364597|467506474|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
129876400|NCT01364597|467506475|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
129876401|NCT01364597|467506472|FG000|Overall Study|BRV administration dropout|0|||
129876402|NCT01364597|467506473|FG001|Overall Study|BRV administration dropout|0|||
129876403|NCT01364597|467506474|FG002|Overall Study|BRV administration dropout|1|||
129876404|NCT01364597|467506475|FG003|Overall Study|BRV administration dropout|0|||
129876405|NCT01364597|467506472|FG000|Overall Study|Dropout|0|||
129876406|NCT01364597|467506473|FG001|Overall Study|Dropout|0|||
129876407|NCT01364597|467506474|FG002|Overall Study|Dropout|3|||
129876408|NCT01364597|467506475|FG003|Overall Study|Dropout|1|||
129876409|NCT01364597|467506472|FG000|Overall Study|Unreliable subject|0|||
129876410|NCT01364597|467506473|FG001|Overall Study|Unreliable subject|0|||
129876411|NCT01364597|467506474|FG002|Overall Study|Unreliable subject|0|||
129876412|NCT01364597|467506475|FG003|Overall Study|Unreliable subject|1|||
129876413|NCT01364597|467506472|FG000|Overall Study|Other|0|||
129876414|NCT01364597|467506473|FG001|Overall Study|Other|0|||
129876415|NCT01364597|467506474|FG002|Overall Study|Other|0|||
129876416|NCT01364597|467506475|FG003|Overall Study|Other|1|||
129876417|NCT03579290|467506485|FG000|Overall Study|Lost to Follow-up|9|||
129876418|NCT03131960|467506488|FG000|Overall Study|Adverse Event|0|||
129876419|NCT03131960|467506489|FG001|Overall Study|Adverse Event|1|||
129876420|NCT01781390|467506490|FG000|Overall Study|Withdrawal of Consent|0|||
129876421|NCT01781390|467506491|FG001|Overall Study|Withdrawal of Consent|3|||
129876422|NCT01781390|467506492|FG002|Overall Study|Withdrawal of Consent|1|||
129876423|NCT01781390|467506490|FG000|Overall Study|Lost to Follow-up|1|||
129876424|NCT01781390|467506491|FG001|Overall Study|Lost to Follow-up|1|||
129876425|NCT01781390|467506492|FG002|Overall Study|Lost to Follow-up|1|||
129876426|NCT01781390|467506490|FG000|Overall Study|Adverse Event|1|||
129876427|NCT01781390|467506491|FG001|Overall Study|Adverse Event|2|||
129876428|NCT01781390|467506492|FG002|Overall Study|Adverse Event|1|||
129876429|NCT01781390|467506490|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
129876430|NCT01781390|467506491|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
129876431|NCT01781390|467506492|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
129876432|NCT00622713|467506495|FG000|Overall Study|Adverse Event|35|||
129876433|NCT00622713|467506495|FG000|Overall Study|Administrative problems|4|||
129876434|NCT00622713|467506495|FG000|Overall Study|Withdrawal by Subject|11|||
129876435|NCT00622713|467506495|FG000|Overall Study|Lost to Follow-up|5|||
129876436|NCT00622713|467506495|FG000|Overall Study|Death|2|||
129876437|NCT00622713|467506495|FG000|Overall Study|Subject no longer required study drug|1|||
129876438|NCT00622713|467506495|FG000|Overall Study|Did not meet eligibility criteria|1|||
129876439|NCT04404478|467506499|FG000|Overall Study|Withdrawal by Subject|1|||
129876440|NCT04404478|467506500|FG001|Overall Study|Withdrawal by Subject|3|||
129876441|NCT03485911|467506501|FG000|Part 1|Perceived lack of efficacy|1|||
129876442|NCT03485911|467506502|FG001|Part 1|Perceived lack of efficacy|1|||
129876443|NCT03485911|467506503|FG002|Part 1|Perceived lack of efficacy|2|||
129876444|NCT03485911|467506504|FG003|Part 1|Perceived lack of efficacy|0|||
129876445|NCT03485911|467506501|FG000|Part 1|Subject withdrew consent|0|||
129876446|NCT03485911|467506502|FG001|Part 1|Subject withdrew consent|1|||
129876447|NCT03485911|467506503|FG002|Part 1|Subject withdrew consent|0|||
129876448|NCT03485911|467506504|FG003|Part 1|Subject withdrew consent|1|||
129876449|NCT03485911|467506501|FG000|Part 1|Lab abnormalities/AEs|3|||
129876450|NCT03485911|467506502|FG001|Part 1|Lab abnormalities/AEs|1|||
129876451|NCT03485911|467506503|FG002|Part 1|Lab abnormalities/AEs|1|||
129876452|NCT03485911|467506504|FG003|Part 1|Lab abnormalities/AEs|0|||
129876453|NCT03485911|467506501|FG000|Part 1|Withdrew Consent prior to dosing|0|||
129876454|NCT03485911|467506502|FG001|Part 1|Withdrew Consent prior to dosing|0|||
129876455|NCT03485911|467506503|FG002|Part 1|Withdrew Consent prior to dosing|0|||
129876456|NCT03485911|467506504|FG003|Part 1|Withdrew Consent prior to dosing|1|||
129876457|NCT03485911|467506501|FG000|Part 1|Other NOS|0|||
129876458|NCT03485911|467506502|FG001|Part 1|Other NOS|0|||
129876459|NCT03485911|467506503|FG002|Part 1|Other NOS|0|||
129876460|NCT03485911|467506504|FG003|Part 1|Other NOS|1|||
129876461|NCT03485911|467506501|FG000|Part 2|Perceived lack of efficacy|5|||
129876462|NCT03485911|467506502|FG001|Part 2|Perceived lack of efficacy|3|||
129876463|NCT03485911|467506503|FG002|Part 2|Perceived lack of efficacy|0|||
129876464|NCT03485911|467506504|FG003|Part 2|Perceived lack of efficacy|2|||
129876465|NCT03485911|467506501|FG000|Part 2|Subject withdrew consent|1|||
129876466|NCT03485911|467506502|FG001|Part 2|Subject withdrew consent|0|||
129876467|NCT03485911|467506503|FG002|Part 2|Subject withdrew consent|2|||
129876468|NCT03485911|467506504|FG003|Part 2|Subject withdrew consent|1|||
129876469|NCT03485911|467506501|FG000|Part 2|Lab abnormalities/AEs|1|||
129876470|NCT03485911|467506502|FG001|Part 2|Lab abnormalities/AEs|2|||
129876471|NCT03485911|467506503|FG002|Part 2|Lab abnormalities/AEs|0|||
130320484|NCT04886154|469141926|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129876472|NCT03485911|467506504|FG003|Part 2|Lab abnormalities/AEs|0|||
129876473|NCT03485911|467506501|FG000|Part 2|Other NOS|0|||
129876474|NCT03485911|467506502|FG001|Part 2|Other NOS|1|||
129876475|NCT03485911|467506503|FG002|Part 2|Other NOS|0|||
129876476|NCT03485911|467506504|FG003|Part 2|Other NOS|0|||
129876477|NCT03485911|467506501|FG000|Part 2|Intercurrent illness/new medical condition|1|||
129876478|NCT03485911|467506502|FG001|Part 2|Intercurrent illness/new medical condition|0|||
129876479|NCT03485911|467506503|FG002|Part 2|Intercurrent illness/new medical condition|0|||
129876480|NCT03485911|467506504|FG003|Part 2|Intercurrent illness/new medical condition|0|||
129876481|NCT03485911|467506501|FG000|Part 2|Investigator judgement|1|||
129876482|NCT03485911|467506502|FG001|Part 2|Investigator judgement|0|||
129876483|NCT03485911|467506503|FG002|Part 2|Investigator judgement|0|||
129876484|NCT03485911|467506504|FG003|Part 2|Investigator judgement|0|||
129876485|NCT03485911|467506501|FG000|Part 3|Perceived lack of efficacy|2|||
129876486|NCT03485911|467506502|FG001|Part 3|Perceived lack of efficacy|2|||
130320485|NCT04886154|469141912|FG000|Overall Study|Other, Not Specified|0|||
130320486|NCT04886154|469141913|FG001|Overall Study|Other, Not Specified|0|||
129876487|NCT03485911|467506503|FG002|Part 3|Perceived lack of efficacy|2|||
129876488|NCT03485911|467506504|FG003|Part 3|Perceived lack of efficacy|0|||
129876489|NCT03485911|467506501|FG000|Part 3|Subject withdrew consent|1|||
129876490|NCT03485911|467506502|FG001|Part 3|Subject withdrew consent|4|||
129876491|NCT03485911|467506503|FG002|Part 3|Subject withdrew consent|0|||
129876492|NCT03485911|467506504|FG003|Part 3|Subject withdrew consent|1|||
129876493|NCT03485911|467506501|FG000|Part 3|Lab abnormalities/AEs|1|||
129876494|NCT03485911|467506502|FG001|Part 3|Lab abnormalities/AEs|1|||
129876495|NCT03485911|467506503|FG002|Part 3|Lab abnormalities/AEs|0|||
129876496|NCT03485911|467506504|FG003|Part 3|Lab abnormalities/AEs|2|||
129876497|NCT03485911|467506501|FG000|Part 3|Other NOS|1|||
129876498|NCT03485911|467506502|FG001|Part 3|Other NOS|1|||
129876499|NCT03485911|467506503|FG002|Part 3|Other NOS|0|||
129876500|NCT03485911|467506504|FG003|Part 3|Other NOS|0|||
129876501|NCT03485911|467506501|FG000|Part 3|Intercurrent illness/new medical condition|0|||
129876502|NCT03485911|467506502|FG001|Part 3|Intercurrent illness/new medical condition|1|||
129876503|NCT03485911|467506503|FG002|Part 3|Intercurrent illness/new medical condition|1|||
129876504|NCT03485911|467506504|FG003|Part 3|Intercurrent illness/new medical condition|0|||
129876505|NCT03485911|467506501|FG000|Part 3|Sponsor discontinuation|1|||
129876506|NCT03485911|467506502|FG001|Part 3|Sponsor discontinuation|0|||
129876507|NCT03485911|467506503|FG002|Part 3|Sponsor discontinuation|0|||
129876508|NCT03485911|467506504|FG003|Part 3|Sponsor discontinuation|0|||
129876509|NCT03485911|467506501|FG000|Part 3|Berotralstat provided by alternative means|13|||
129876510|NCT03485911|467506502|FG001|Part 3|Berotralstat provided by alternative means|13|||
129876511|NCT03485911|467506503|FG002|Part 3|Berotralstat provided by alternative means|7|||
129876512|NCT03485911|467506504|FG003|Part 3|Berotralstat provided by alternative means|7|||
129876513|NCT00782496|467506509|FG000|Overall Study|Lost to Follow-up|14|||
129876514|NCT00782496|467506510|FG001|Overall Study|Lost to Follow-up|15|||
129876515|NCT00990340|467506513|FG000|First 14-day Treatment|Not Compliant|2|||
129876516|NCT00990340|467506514|FG001|First 14-day Treatment|Not Compliant|1|||
129876517|NCT00990340|467506513|FG000|First 14-day Treatment|Lost to Follow-up|2|||
129876518|NCT00990340|467506514|FG001|First 14-day Treatment|Lost to Follow-up|1|||
129876519|NCT00990340|467506513|FG000|First 14-day Treatment|Protocol Violation|2|||
129876520|NCT00990340|467506514|FG001|First 14-day Treatment|Protocol Violation|2|||
129876521|NCT01987817|467506516|FG000|Overall Study|Adverse Event|4|||
129876522|NCT01987817|467506517|FG001|Overall Study|Adverse Event|0|||
129876523|NCT01987817|467506516|FG000|Overall Study|Withdrawal by Subject|1|||
129876524|NCT01987817|467506517|FG001|Overall Study|Withdrawal by Subject|1|||
129876525|NCT01987817|467506516|FG000|Overall Study|Physician Decision|1|||
129876526|NCT01987817|467506517|FG001|Overall Study|Physician Decision|0|||
129876527|NCT02070484|467506518|FG000|Overall Study|Withdrawal by Subject|1|||
129876528|NCT02070484|467506519|FG001|Overall Study|Withdrawal by Subject|0|||
129876529|NCT00682643|467506520|FG000|Overall Study|Adverse Event|12|||
129876530|NCT00682643|467506521|FG001|Overall Study|Adverse Event|23|||
129876531|NCT00682643|467506520|FG000|Overall Study|Lack of Efficacy|2|||
129876532|NCT00682643|467506521|FG001|Overall Study|Lack of Efficacy|0|||
129876533|NCT00682643|467506520|FG000|Overall Study|Protocol Violation|38|||
129876534|NCT00682643|467506521|FG001|Overall Study|Protocol Violation|76|||
129876535|NCT00682643|467506520|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
129876536|NCT00682643|467506521|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
129876537|NCT00682643|467506520|FG000|Overall Study|Lost to Follow-up|1|||
129876538|NCT00682643|467506521|FG001|Overall Study|Lost to Follow-up|6|||
129876539|NCT00682643|467506520|FG000|Overall Study|Physician Decision|2|||
129876540|NCT00682643|467506521|FG001|Overall Study|Physician Decision|6|||
129876541|NCT00682643|467506520|FG000|Overall Study|Withdrawal by Subject|19|||
129876542|NCT00682643|467506521|FG001|Overall Study|Withdrawal by Subject|53|||
129876543|NCT00682643|467506520|FG000|Overall Study|Did Not Receive Study Drug|1|||
129876544|NCT00682643|467506521|FG001|Overall Study|Did Not Receive Study Drug|1|||
129876545|NCT01852058|467506524|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
129876546|NCT01852058|467506525|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876547|NCT01852058|467506526|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876548|NCT01852058|467506527|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876549|NCT01852058|467506528|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876550|NCT01852058|467506529|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876551|NCT01852058|467506530|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876552|NCT01852058|467506531|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876553|NCT01852058|467506532|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876554|NCT01852058|467506533|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876555|NCT01852058|467506534|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876556|NCT01852058|467506535|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876557|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876558|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876559|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876560|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876561|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
129876562|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876563|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876564|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876565|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876566|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876567|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876568|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876569|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876570|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
130320487|NCT04886154|469141914|FG002|Overall Study|Other, Not Specified|0|||
129876571|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876572|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876573|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
129876574|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
129876575|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876576|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876577|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876578|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876579|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876580|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876581|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876582|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876583|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876584|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876585|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
129876586|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876587|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876588|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876589|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876590|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876591|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876592|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876593|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876594|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876595|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876596|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876597|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
129876598|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
129876599|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876600|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876601|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876602|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876603|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876604|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876605|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876606|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876607|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876608|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
129876609|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876610|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876611|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876612|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876613|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876614|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876615|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876616|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876617|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876618|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876619|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876620|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876621|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
129876622|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
129876623|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876624|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876625|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876626|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876627|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876628|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876629|NCT01852058|467506524|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876630|NCT01852058|467506525|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876631|NCT01852058|467506526|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876632|NCT01852058|467506527|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876633|NCT01852058|467506528|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876634|NCT01852058|467506529|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876635|NCT01852058|467506530|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876636|NCT01852058|467506531|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
129876637|NCT01852058|467506532|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876638|NCT01852058|467506533|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876639|NCT01852058|467506534|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876640|NCT01852058|467506535|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876641|NCT01852058|467506524|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876642|NCT01852058|467506525|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876643|NCT01852058|467506526|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876644|NCT01852058|467506527|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876645|NCT01852058|467506528|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876646|NCT01852058|467506529|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876647|NCT01852058|467506530|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876648|NCT01852058|467506531|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876649|NCT01852058|467506532|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
129876650|NCT01852058|467506533|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876651|NCT01852058|467506534|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876652|NCT01852058|467506535|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876653|NCT00622180|467506536|FG000|Overall Study|Lost to Follow-up|1|||
129876654|NCT00622180|467506537|FG001|Overall Study|Lost to Follow-up|2|||
129876655|NCT01353222|467506540|FG000|Overall Study|Death|30|||
129876656|NCT01353222|467506541|FG001|Overall Study|Death|30|||
129876657|NCT01353222|467506540|FG000|Overall Study|Withdrawal by Subject|8|||
129876658|NCT01353222|467506541|FG001|Overall Study|Withdrawal by Subject|5|||
129876659|NCT01353222|467506540|FG000|Overall Study|Study Terminated|31|||
129876660|NCT01353222|467506541|FG001|Overall Study|Study Terminated|37|||
129876661|NCT01353222|467506540|FG000|Overall Study|Site closed research department|1|||
129876662|NCT01353222|467506541|FG001|Overall Study|Site closed research department|0|||
129876663|NCT02636270|467506542|FG000|Overall Study|Adverse Event|1|||
129876664|NCT02636270|467506543|FG001|Overall Study|Adverse Event|0|||
129876665|NCT02636270|467506544|FG002|Overall Study|Adverse Event|0|||
129876666|NCT02636270|467506542|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
129876667|NCT02636270|467506543|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
129876668|NCT02636270|467506544|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
129876669|NCT01119898|467506545|FG000|Overall Study|Adverse Event|4|||
129876670|NCT01119898|467506546|FG001|Overall Study|Adverse Event|5|||
129876671|NCT01119898|467506545|FG000|Overall Study|Withdrawal by Subject|1|||
129876672|NCT01119898|467506546|FG001|Overall Study|Withdrawal by Subject|4|||
129876673|NCT01119898|467506545|FG000|Overall Study|Lack of Efficacy|0|||
129876674|NCT01119898|467506546|FG001|Overall Study|Lack of Efficacy|2|||
129876675|NCT01119898|467506545|FG000|Overall Study|Protocol Violation|1|||
129876676|NCT01119898|467506546|FG001|Overall Study|Protocol Violation|1|||
129876677|NCT01119898|467506545|FG000|Overall Study|Medical procedure|1|||
129876678|NCT01119898|467506546|FG001|Overall Study|Medical procedure|0|||
129876679|NCT01119898|467506545|FG000|Overall Study|Randomized in error did not participate|1|||
129876680|NCT01119898|467506546|FG001|Overall Study|Randomized in error did not participate|0|||
129876681|NCT01806584|467506547|FG000|Overall Study|Adverse Event|2|||
129876682|NCT01806584|467506548|FG001|Overall Study|Adverse Event|1|||
129876683|NCT01806584|467506547|FG000|Overall Study|Death|1|||
129876684|NCT01806584|467506548|FG001|Overall Study|Death|0|||
129876685|NCT01806584|467506547|FG000|Overall Study|Lost to Follow-up|0|||
129876686|NCT01806584|467506548|FG001|Overall Study|Lost to Follow-up|2|||
129876687|NCT01806584|467506547|FG000|Overall Study|Study terminated by sponsor|9|||
129876688|NCT01806584|467506548|FG001|Overall Study|Study terminated by sponsor|14|||
129876689|NCT01806584|467506547|FG000|Overall Study|Withdrawal by Subject|1|||
129876690|NCT01806584|467506548|FG001|Overall Study|Withdrawal by Subject|1|||
129876691|NCT01806584|467506547|FG000|Overall Study|Other unspecified|1|||
129876692|NCT01806584|467506548|FG001|Overall Study|Other unspecified|0|||
129876693|NCT04398537|467506555|FG000|Overall Study|Physician Decision|10|||
129876694|NCT04398537|467506556|FG001|Overall Study|Physician Decision|15|||
129876695|NCT02202434|467509148|FG000|Overall Study|Death|70|||
129876696|NCT02202434|467509149|FG001|Overall Study|Death|39|||
129876697|NCT02202434|467509150|FG002|Overall Study|Death|13|||
129876698|NCT02202434|467509151|FG003|Overall Study|Death|27|||
129876699|NCT02202434|467509148|FG000|Overall Study|Lost to Follow-up|1|||
129876700|NCT02202434|467509149|FG001|Overall Study|Lost to Follow-up|1|||
129876701|NCT02202434|467509150|FG002|Overall Study|Lost to Follow-up|1|||
129876702|NCT02202434|467509151|FG003|Overall Study|Lost to Follow-up|0|||
129876703|NCT02202434|467509148|FG000|Overall Study|Physician Decision|2|||
129876704|NCT02202434|467509149|FG001|Overall Study|Physician Decision|3|||
130213634|NCT01796301|468746857|FG001|Overall Study|Withdrawal by Subject|15|||
130213635|NCT01796301|468746856|FG000|Overall Study|Lost to Follow-up|3|||
129876705|NCT02202434|467509150|FG002|Overall Study|Physician Decision|0|||
129876706|NCT02202434|467509151|FG003|Overall Study|Physician Decision|0|||
129876707|NCT02202434|467509148|FG000|Overall Study|Withdrawal by Subject|13|||
129876708|NCT02202434|467509149|FG001|Overall Study|Withdrawal by Subject|14|||
129876709|NCT02202434|467509150|FG002|Overall Study|Withdrawal by Subject|1|||
129876710|NCT02202434|467509151|FG003|Overall Study|Withdrawal by Subject|4|||
129876711|NCT02202434|467509148|FG000|Overall Study|Completed Study|1|||
129876712|NCT02202434|467509149|FG001|Overall Study|Completed Study|0|||
129876713|NCT02202434|467509150|FG002|Overall Study|Completed Study|0|||
129876714|NCT02202434|467509151|FG003|Overall Study|Completed Study|0|||
129876715|NCT02202434|467509148|FG000|Overall Study|Visit Missed|21|||
129876716|NCT02202434|467509149|FG001|Overall Study|Visit Missed|12|||
129876717|NCT02202434|467509150|FG002|Overall Study|Visit Missed|0|||
129876718|NCT02202434|467509151|FG003|Overall Study|Visit Missed|5|||
129876719|NCT02202434|467509148|FG000|Overall Study|Other|1|||
129876720|NCT02202434|467509149|FG001|Overall Study|Other|0|||
129876721|NCT02202434|467509150|FG002|Overall Study|Other|0|||
129876722|NCT02202434|467509151|FG003|Overall Study|Other|1|||
129876723|NCT03610737|467509154|FG000|Overall Study|Withdrawal by Subject|1|||
129876724|NCT03610737|467509155|FG001|Overall Study|Withdrawal by Subject|5|||
129876725|NCT03610737|467509154|FG000|Overall Study|Death|1|||
129876726|NCT03610737|467509155|FG001|Overall Study|Death|0|||
129876727|NCT03610737|467509154|FG000|Overall Study|Not treated|5|||
129876728|NCT03610737|467509155|FG001|Overall Study|Not treated|2|||
129876729|NCT03610737|467509154|FG000|Overall Study|Missed Visit|1|||
129876730|NCT03610737|467509155|FG001|Overall Study|Missed Visit|2|||
129876731|NCT02312856|467509157|FG000|Overall Study|Death|1|||
129876732|NCT02312856|467509157|FG000|Overall Study|Lost to Follow-up|3|||
129876733|NCT03075904|467509159|FG000|Overall Study|Physician Decision|3|||
129876734|NCT03075904|467509159|FG000|Overall Study|Need for Medication not Permitted|1|||
129876735|NCT04581200|467509160|FG000|Overall Study|Lost to Follow-up|6|||
129876736|NCT04581200|467509161|FG001|Overall Study|Lost to Follow-up|5|||
129876737|NCT03528174|467509162|FG000|Overall Study|Adverse Event|1|||
129876738|NCT03528174|467509162|FG000|Overall Study|sensors dislodged|1|||
129876739|NCT03002038|467509163|FG000|Overall Study|Adverse Event|3|||
129876740|NCT03002038|467509164|FG001|Overall Study|Adverse Event|1|||
129876741|NCT03002038|467509163|FG000|Overall Study|Withdrawal by Subject|8|||
129876742|NCT03002038|467509164|FG001|Overall Study|Withdrawal by Subject|4|||
129876743|NCT03002038|467509163|FG000|Overall Study|Immigration to another region|0|||
129876744|NCT03002038|467509164|FG001|Overall Study|Immigration to another region|2|||
129876745|NCT00979602|467509173|FG000|Overall Study|Serious Adverse Event|5|||
129876746|NCT00979602|467509174|FG001|Overall Study|Serious Adverse Event|3|||
129876747|NCT00979602|467509173|FG000|Overall Study|Protocol Violation|3|||
129876748|NCT00979602|467509174|FG001|Overall Study|Protocol Violation|0|||
129876749|NCT00979602|467509173|FG000|Overall Study|Withdrawal by Subject|31|||
129876750|NCT00979602|467509174|FG001|Overall Study|Withdrawal by Subject|25|||
129876751|NCT00979602|467509173|FG000|Overall Study|Lost to Follow-up|100|||
129876752|NCT00979602|467509174|FG001|Overall Study|Lost to Follow-up|96|||
129876753|NCT00979602|467509173|FG000|Overall Study|Migrated/moved from study area|3|||
129876754|NCT00979602|467509174|FG001|Overall Study|Migrated/moved from study area|6|||
129876755|NCT00979602|467509173|FG000|Overall Study|Others|3|||
129876756|NCT00979602|467509174|FG001|Overall Study|Others|3|||
129876757|NCT02904902|467509175|FG000|Overall Study|Withdrawal by Subject|1|||
129876758|NCT01719237|467509176|FG000|Overall Study|Physician Decision|0|||
129876759|NCT01719237|467509177|FG001|Overall Study|Physician Decision|1|||
129876760|NCT02712398|467509178|FG000|Overall Study|Withdrawal by Subject|6|||
129876761|NCT02712398|467509178|FG000|Overall Study|Lost to Follow-up|6|||
129876762|NCT02712398|467509178|FG000|Overall Study|Sponsor Decision|1|||
129876763|NCT02712398|467509178|FG000|Overall Study|Physician Decision|1|||
129876764|NCT02712398|467509178|FG000|Overall Study|Death|2|||
129876765|NCT02712398|467509178|FG000|Overall Study|Re-operation|21|||
129876766|NCT01216163|467509187|FG000|Overall Study|Withdrawal by Subject|1|||
129876767|NCT01216163|467509188|FG001|Overall Study|Withdrawal by Subject|1|||
129876768|NCT01216163|467509189|FG002|Overall Study|Withdrawal by Subject|0|||
129876769|NCT02914314|467509190|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129876770|NCT02914314|467509191|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129876771|NCT02914314|467509192|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129876772|NCT02914314|467509193|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
129876773|NCT02914314|467509190|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
129876774|NCT02914314|467509191|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
130213636|NCT01796301|468746857|FG001|Overall Study|Lost to Follow-up|3|||
130213637|NCT01796301|468746856|FG000|Overall Study|Death|0|||
130213638|NCT01796301|468746857|FG001|Overall Study|Death|1|||
130213639|NCT01796301|468746856|FG000|Overall Study|Decision by Sponsor|0|||
130213640|NCT01796301|468746857|FG001|Overall Study|Decision by Sponsor|1|||
130213641|NCT00667563|468746858|FG000|Overall Study|Protocol Violation|24|||
130213642|NCT02187029|468746860|FG000|Overall Study|Adverse Event|0|||
130213643|NCT02187029|468746861|FG001|Overall Study|Adverse Event|1|||
130213644|NCT02187029|468746862|FG002|Overall Study|Adverse Event|1|||
129876775|NCT02914314|467509192|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
129876776|NCT02914314|467509193|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
129876777|NCT02914314|467509190|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
130320488|NCT04886154|469141915|FG003|Overall Study|Other, Not Specified|0|||
130320489|NCT04886154|469141916|FG004|Overall Study|Other, Not Specified|11|||
130320490|NCT04886154|469141917|FG005|Overall Study|Other, Not Specified|8|||
130320491|NCT04886154|469141918|FG006|Overall Study|Other, Not Specified|9|||
130320492|NCT04886154|469141919|FG007|Overall Study|Other, Not Specified|10|||
130320493|NCT04886154|469141920|FG008|Overall Study|Other, Not Specified|6|||
130320494|NCT04886154|469141921|FG009|Overall Study|Other, Not Specified|1|||
130320495|NCT04886154|469141922|FG010|Overall Study|Other, Not Specified|1|||
130320496|NCT04886154|469141923|FG011|Overall Study|Other, Not Specified|2|||
130320497|NCT04886154|469141924|FG012|Overall Study|Other, Not Specified|1|||
130320498|NCT04886154|469141925|FG013|Overall Study|Other, Not Specified|2|||
130320499|NCT04886154|469141926|FG014|Overall Study|Other, Not Specified|3|||
130320500|NCT02336282|469141941|FG000|Overall Study|Unrelated illness|1|||
130320501|NCT02336282|469141941|FG000|Overall Study|Uncomfortable with technology|1|||
130320502|NCT02336282|469141941|FG000|Overall Study|Lost to Follow-up|1|||
130320503|NCT02336282|469141941|FG000|Overall Study|Not enough time to complete sessions|2|||
130320504|NCT03724942|469141943|FG000|Overall Study|Adverse Event|20|||
130320505|NCT03724942|469141944|FG001|Overall Study|Adverse Event|14|||
130213645|NCT02187029|468746863|FG003|Overall Study|Adverse Event|0|||
130213646|NCT02187029|468746860|FG000|Overall Study|Study Terminated by Sponsor|0|||
130213647|NCT02187029|468746861|FG001|Overall Study|Study Terminated by Sponsor|0|||
130213648|NCT02187029|468746862|FG002|Overall Study|Study Terminated by Sponsor|10|||
130213649|NCT02187029|468746863|FG003|Overall Study|Study Terminated by Sponsor|3|||
130213650|NCT02187029|468746860|FG000|Overall Study|Withdrawal by Subject|1|||
130213651|NCT02187029|468746861|FG001|Overall Study|Withdrawal by Subject|0|||
130213652|NCT02187029|468746862|FG002|Overall Study|Withdrawal by Subject|0|||
130213653|NCT02187029|468746863|FG003|Overall Study|Withdrawal by Subject|0|||
130213654|NCT03042910|468746864|FG000|Overall Study|Adverse Event|1|||
130213655|NCT03042910|468746864|FG000|Overall Study|Disease Progression|2|||
130213656|NCT03042910|468746864|FG000|Overall Study|Withdrawal by Subject|3|||
130213657|NCT03042910|468746864|FG000|Overall Study|Enrolled but not treated|1|||
129876778|NCT02914314|467509191|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129876779|NCT02914314|467509192|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
129876780|NCT02914314|467509193|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129876781|NCT02914314|467509190|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
129876782|NCT02914314|467509191|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
129876783|NCT02914314|467509192|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
129876784|NCT02914314|467509193|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
129876785|NCT02914314|467509190|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
129876786|NCT02914314|467509191|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130213658|NCT02756819|468746868|FG000|Overall Study|Lost for observation|23|||
130213659|NCT02756819|468746868|FG000|Overall Study|Patient's unwillingness|16|||
130213660|NCT02756819|468746868|FG000|Overall Study|Insufficient efficacy|2|||
130213661|NCT02756819|468746868|FG000|Overall Study|Adverse Event|2|||
130213662|NCT02756819|468746868|FG000|Overall Study|Reason not Specified|9|||
130213663|NCT01491841|468746870|FG000|Overall Study|Screen Failure|10|||
130213664|NCT01491841|468746870|FG000|Overall Study|Withdrawal by Subject|1|||
130213665|NCT02933528|468746871|FG000|Overall Study|Lost to Follow-up|2|||
130213666|NCT01301079|468746872|FG000|Overall Study|Lost to Follow-up|2|||
130213667|NCT01301079|468746873|FG001|Overall Study|Lost to Follow-up|2|||
130213668|NCT00264290|468746877|FG000|Intervention (8 Weeks)|Adverse Event|1|||
130213669|NCT00264290|468746878|FG001|Intervention (8 Weeks)|Adverse Event|0|||
130213670|NCT02496039|468746879|FG000|Overall Study|Adverse Event|3|||
130213671|NCT02496039|468746879|FG000|Overall Study|Protocol Violation|1|||
130213672|NCT04472494|468746880|FG000|Pre-treatment|Other reasons|2|||
130213673|NCT04472494|468746881|FG001|Pre-treatment|Other reasons|0|||
130213674|NCT04472494|468746880|FG000|Treatment|Death|5|||
130213675|NCT04472494|468746881|FG001|Treatment|Death|2|||
130213676|NCT04472494|468746880|FG000|Treatment|Hospital discharge|1|||
129876787|NCT02914314|467509192|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
129876788|NCT02914314|467509193|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
130213677|NCT04472494|468746881|FG001|Treatment|Hospital discharge|1|||
130213678|NCT00571103|468746882|FG000|Overall Study|Withdrawal by Subject|1|||
130213679|NCT00571103|468746882|FG000|Overall Study|Lost to Follow-up|1|||
130213680|NCT01308463|468746883|FG000|Overall Study|Study Discontinued|23|||
130213681|NCT01308463|468746883|FG000|Overall Study|Death|4|||
130213682|NCT01308463|468746883|FG000|Overall Study|Revision|2|||
130213683|NCT02784288|468746884|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
130213684|NCT02734862|468746885|FG000|Part A|Death|3|||
130213685|NCT02734862|468746886|FG001|Part A|Death|4|||
130213686|NCT02734862|468746887|FG002|Part A|Death|6|||
130320506|NCT03724942|469141943|FG000|Overall Study|Lack of Efficacy|0|||
130320507|NCT03724942|469141944|FG001|Overall Study|Lack of Efficacy|1|||
130213687|NCT02734862|468746885|FG000|Part A|Lost to Follow-up|2|||
130213688|NCT02734862|468746886|FG001|Part A|Lost to Follow-up|1|||
130213689|NCT02734862|468746887|FG002|Part A|Lost to Follow-up|1|||
130213690|NCT02734862|468746885|FG000|Part A|Withdrawal by Subject|1|||
130213691|NCT02734862|468746886|FG001|Part A|Withdrawal by Subject|1|||
130213692|NCT02734862|468746887|FG002|Part A|Withdrawal by Subject|2|||
130213693|NCT02734862|468746885|FG000|Part A|Physician Decision|2|||
130213694|NCT02734862|468746886|FG001|Part A|Physician Decision|0|||
130213695|NCT02734862|468746887|FG002|Part A|Physician Decision|1|||
130213696|NCT02734862|468746885|FG000|Part A|Adverse Event|2|||
130213697|NCT02734862|468746886|FG001|Part A|Adverse Event|0|||
130213698|NCT02734862|468746887|FG002|Part A|Adverse Event|1|||
130213699|NCT02734862|468746885|FG000|Part A|Noncompliance|1|||
130213700|NCT02734862|468746886|FG001|Part A|Noncompliance|1|||
130213701|NCT02734862|468746887|FG002|Part A|Noncompliance|0|||
130213702|NCT02734862|468746885|FG000|Part A|Other|1|||
130213703|NCT02734862|468746886|FG001|Part A|Other|1|||
130213704|NCT02734862|468746887|FG002|Part A|Other|3|||
130213705|NCT02734862|468746885|FG000|Part B|Death|8|||
130213706|NCT02734862|468746886|FG001|Part B|Death|3|||
130213707|NCT02734862|468746887|FG002|Part B|Death|5|||
130213708|NCT02734862|468746885|FG000|Part B|Lost to Follow-up|2|||
130213709|NCT02734862|468746886|FG001|Part B|Lost to Follow-up|2|||
130213710|NCT02734862|468746887|FG002|Part B|Lost to Follow-up|0|||
130213711|NCT02734862|468746885|FG000|Part B|Withdrawal by Subject|3|||
130213712|NCT02734862|468746886|FG001|Part B|Withdrawal by Subject|1|||
130213713|NCT02734862|468746887|FG002|Part B|Withdrawal by Subject|0|||
130213714|NCT02734862|468746885|FG000|Part B|Other|0|||
130213715|NCT02734862|468746886|FG001|Part B|Other|1|||
130213716|NCT02734862|468746887|FG002|Part B|Other|0|||
130213717|NCT02131233|468746888|FG000|Overall Study|Not Treated|2|||
130213718|NCT02131233|468746889|FG001|Overall Study|Not Treated|3|||
130213719|NCT02131233|468746888|FG000|Overall Study|Adverse Event|7|||
130213720|NCT02131233|468746889|FG001|Overall Study|Adverse Event|6|||
130213721|NCT02131233|468746888|FG000|Overall Study|Death|0|||
130213722|NCT02131233|468746889|FG001|Overall Study|Death|1|||
130213723|NCT02131233|468746888|FG000|Overall Study|Lack of Efficacy|6|||
130213724|NCT02131233|468746889|FG001|Overall Study|Lack of Efficacy|3|||
130213725|NCT02131233|468746888|FG000|Overall Study|Lost to Follow-up|14|||
130213726|NCT02131233|468746889|FG001|Overall Study|Lost to Follow-up|13|||
130213727|NCT02131233|468746888|FG000|Overall Study|Non-Compliance With Study Drug|8|||
130213728|NCT02131233|468746889|FG001|Overall Study|Non-Compliance With Study Drug|5|||
130213729|NCT02131233|468746888|FG000|Overall Study|Physician Decision|7|||
130213730|NCT02131233|468746889|FG001|Overall Study|Physician Decision|0|||
130213731|NCT02131233|468746888|FG000|Overall Study|Pregnancy|4|||
130213732|NCT02131233|468746889|FG001|Overall Study|Pregnancy|0|||
130320508|NCT03724942|469141943|FG000|Overall Study|Physician Decision|5|||
130320509|NCT03724942|469141944|FG001|Overall Study|Physician Decision|2|||
130320510|NCT03724942|469141943|FG000|Overall Study|Protocol Violation|1|||
130213733|NCT02131233|468746888|FG000|Overall Study|Withdrawal by Subject|18|||
130213734|NCT02131233|468746889|FG001|Overall Study|Withdrawal by Subject|11|||
130213735|NCT04399889|468746898|FG000|Overall Study|Death|5|||
130213736|NCT04399889|468746899|FG001|Overall Study|Death|1|||
130213737|NCT04399889|468746900|FG002|Overall Study|Death|1|||
130213738|NCT00217581|468746901|FG000|Overall Study|Withdrawal by Subject|1|||
130320511|NCT03724942|469141944|FG001|Overall Study|Protocol Violation|0|||
130320512|NCT03724942|469141943|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
130320513|NCT03724942|469141944|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
130320514|NCT03724942|469141943|FG000|Overall Study|Withdrawal by Legal Representative|3|||
130320515|NCT03724942|469141944|FG001|Overall Study|Withdrawal by Legal Representative|0|||
130320516|NCT00668148|469141958|FG000|Overall Study|Adverse Event|5|||
130320517|NCT00668148|469141958|FG000|Overall Study|Subject Non-compliance|1|||
129876789|NCT01859793|467509197|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
130320518|NCT00668148|469141958|FG000|Overall Study|Progressive Disease Before Treatment|2|||
129876790|NCT01859793|467509198|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
130320519|NCT00668148|469141958|FG000|Overall Study|Withdrawal of Consent|2|||
130320520|NCT04875975|469141961|FG000|Overall Study|Adverse Event|1|||
130320521|NCT04875975|469141962|FG001|Overall Study|Adverse Event|2|||
130213739|NCT01005901|468746902|FG000|Overall Study|Withdrawal by Subject|38|||
130213740|NCT01005901|468746903|FG001|Overall Study|Withdrawal by Subject|14|||
130213741|NCT01005901|468746902|FG000|Overall Study|Adverse Event|30|||
130213742|NCT01005901|468746903|FG001|Overall Study|Adverse Event|16|||
130213743|NCT01005901|468746902|FG000|Overall Study|Administrative problems|21|||
130213744|NCT01005901|468746903|FG001|Overall Study|Administrative problems|13|||
130213745|NCT01005901|468746902|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130213746|NCT01005901|468746903|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130213747|NCT01005901|468746902|FG000|Overall Study|Protocol Violation|4|||
130213748|NCT01005901|468746903|FG001|Overall Study|Protocol Violation|3|||
130213749|NCT01005901|468746902|FG000|Overall Study|Death|2|||
130213750|NCT01005901|468746903|FG001|Overall Study|Death|3|||
130213751|NCT01005901|468746902|FG000|Overall Study|Lost to Follow-up|1|||
130320522|NCT04875975|469141961|FG000|Overall Study|Lack of Efficacy|2|||
130320523|NCT04875975|469141962|FG001|Overall Study|Lack of Efficacy|2|||
130320524|NCT04875975|469141961|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
130320525|NCT04875975|469141962|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
130320526|NCT04875975|469141961|FG000|Overall Study|Relapse With Insults|0|||
130320527|NCT04875975|469141962|FG001|Overall Study|Relapse With Insults|1|||
130320528|NCT04875975|469141961|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
130320529|NCT04875975|469141962|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
130320530|NCT05472090|469141963|FG000|Overall Study|Adverse Event|2|||
130320531|NCT05472090|469141964|FG001|Overall Study|Adverse Event|3|||
130320532|NCT05472090|469141963|FG000|Overall Study|Lack of Efficacy|1|||
130320533|NCT05472090|469141964|FG001|Overall Study|Lack of Efficacy|0|||
130320534|NCT05472090|469141963|FG000|Overall Study|Physician Decision|1|||
130320535|NCT05472090|469141964|FG001|Overall Study|Physician Decision|0|||
130320536|NCT05472090|469141963|FG000|Overall Study|Withdrawal by Subject|2|||
130320537|NCT05472090|469141964|FG001|Overall Study|Withdrawal by Subject|0|||
130320538|NCT05472090|469141963|FG000|Overall Study|Lost to Follow-up|0|||
130320539|NCT05472090|469141964|FG001|Overall Study|Lost to Follow-up|3|||
130320540|NCT01350999|469141966|FG000|Overall Study|Adverse Event|4|||
130320541|NCT01350999|469141967|FG001|Overall Study|Adverse Event|9|||
130320542|NCT01350999|469141968|FG002|Overall Study|Adverse Event|10|||
130320543|NCT01350999|469141966|FG000|Overall Study|Voluntary withdrawal|3|||
130320544|NCT01350999|469141967|FG001|Overall Study|Voluntary withdrawal|4|||
130320545|NCT01350999|469141968|FG002|Overall Study|Voluntary withdrawal|6|||
130320546|NCT01350999|469141966|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
130320547|NCT01350999|469141967|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
130320548|NCT01350999|469141968|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
130320549|NCT01766050|469144021|FG000|Overall Study|Adverse Event|1|||
130320550|NCT01766050|469144021|FG000|Overall Study|Lost to Follow-up|1|||
130320551|NCT01766050|469144021|FG000|Overall Study|Withdrawal by Subject|2|||
130320552|NCT00089297|469144023|FG000|Overall Study|Adverse Event|9|||
130320553|NCT00089297|469144023|FG000|Overall Study|Death|1|||
130320554|NCT00089297|469144023|FG000|Overall Study|Withdrawal by Subject|12|||
130320555|NCT00089297|469144023|FG000|Overall Study|Disease progression|2|||
130320556|NCT00089297|469144023|FG000|Overall Study|Ineligible|11|||
130320557|NCT00089297|469144023|FG000|Overall Study|Secondary malignancy|1|||
130320558|NCT00089297|469144023|FG000|Overall Study|IRB approval not ready|1|||
130320559|NCT00089297|469144023|FG000|Overall Study|Non-compliance|1|||
130320560|NCT01910298|469144026|FG000|Overall Study|Adverse Event|1|||
130320561|NCT01910298|469144027|FG001|Overall Study|Adverse Event|0|||
130320562|NCT01910298|469144026|FG000|Overall Study|Withdrawal by Subject|2|||
130320563|NCT01910298|469144027|FG001|Overall Study|Withdrawal by Subject|7|||
130320564|NCT01910298|469144026|FG000|Overall Study|Protocol Deviation|0|||
130320565|NCT01910298|469144027|FG001|Overall Study|Protocol Deviation|5|||
130320566|NCT01910298|469144026|FG000|Overall Study|Lost to Follow-up|1|||
130320567|NCT01910298|469144027|FG001|Overall Study|Lost to Follow-up|1|||
130320568|NCT01910298|469144026|FG000|Overall Study|Study Terminated by Sponsor|1|||
130320569|NCT01910298|469144027|FG001|Overall Study|Study Terminated by Sponsor|17|||
130320570|NCT01910298|469144026|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130320571|NCT01910298|469144027|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130320572|NCT03037385|469144030|FG000|Overall Study|Adverse Event|0|||
130320573|NCT03037385|469144031|FG001|Overall Study|Adverse Event|0|||
130320574|NCT03037385|469144032|FG002|Overall Study|Adverse Event|1|||
130320575|NCT03037385|469144033|FG003|Overall Study|Adverse Event|0|||
130320576|NCT03037385|469144034|FG004|Overall Study|Adverse Event|0|||
130320577|NCT03037385|469144035|FG005|Overall Study|Adverse Event|0|||
130320578|NCT03037385|469144036|FG006|Overall Study|Adverse Event|0|||
130320579|NCT03037385|469144037|FG007|Overall Study|Adverse Event|0|||
130320580|NCT03037385|469144038|FG008|Overall Study|Adverse Event|0|||
130320581|NCT03037385|469144039|FG009|Overall Study|Adverse Event|6|||
130320582|NCT03037385|469144030|FG000|Overall Study|Death|1|||
130320583|NCT03037385|469144031|FG001|Overall Study|Death|4|||
130320584|NCT03037385|469144032|FG002|Overall Study|Death|2|||
130320585|NCT03037385|469144033|FG003|Overall Study|Death|2|||
130320586|NCT03037385|469144034|FG004|Overall Study|Death|5|||
130320587|NCT03037385|469144035|FG005|Overall Study|Death|2|||
130320588|NCT03037385|469144036|FG006|Overall Study|Death|1|||
130320589|NCT03037385|469144037|FG007|Overall Study|Death|4|||
130320590|NCT03037385|469144038|FG008|Overall Study|Death|3|||
130320591|NCT03037385|469144039|FG009|Overall Study|Death|240|||
130320592|NCT03037385|469144030|FG000|Overall Study|Initiation of Another Therapy|1|||
130320593|NCT03037385|469144031|FG001|Overall Study|Initiation of Another Therapy|0|||
130320594|NCT03037385|469144032|FG002|Overall Study|Initiation of Another Therapy|0|||
130320595|NCT03037385|469144033|FG003|Overall Study|Initiation of Another Therapy|0|||
130320596|NCT03037385|469144034|FG004|Overall Study|Initiation of Another Therapy|0|||
130320597|NCT03037385|469144035|FG005|Overall Study|Initiation of Another Therapy|0|||
130320598|NCT03037385|469144036|FG006|Overall Study|Initiation of Another Therapy|0|||
130320599|NCT03037385|469144037|FG007|Overall Study|Initiation of Another Therapy|1|||
130320600|NCT03037385|469144038|FG008|Overall Study|Initiation of Another Therapy|0|||
130320601|NCT03037385|469144039|FG009|Overall Study|Initiation of Another Therapy|2|||
130320602|NCT03037385|469144030|FG000|Overall Study|Lost to Follow-up|0|||
130320603|NCT03037385|469144031|FG001|Overall Study|Lost to Follow-up|0|||
130320604|NCT03037385|469144032|FG002|Overall Study|Lost to Follow-up|0|||
130320605|NCT03037385|469144033|FG003|Overall Study|Lost to Follow-up|0|||
130320606|NCT03037385|469144034|FG004|Overall Study|Lost to Follow-up|0|||
130320607|NCT03037385|469144035|FG005|Overall Study|Lost to Follow-up|1|||
130320608|NCT03037385|469144036|FG006|Overall Study|Lost to Follow-up|0|||
130320609|NCT03037385|469144037|FG007|Overall Study|Lost to Follow-up|0|||
130320610|NCT03037385|469144038|FG008|Overall Study|Lost to Follow-up|0|||
130320611|NCT03037385|469144039|FG009|Overall Study|Lost to Follow-up|16|||
130320612|NCT03037385|469144030|FG000|Overall Study|Physician Decision|0|||
130320613|NCT03037385|469144031|FG001|Overall Study|Physician Decision|0|||
130320614|NCT03037385|469144032|FG002|Overall Study|Physician Decision|0|||
130320615|NCT03037385|469144033|FG003|Overall Study|Physician Decision|0|||
130320616|NCT03037385|469144034|FG004|Overall Study|Physician Decision|0|||
130320617|NCT03037385|469144035|FG005|Overall Study|Physician Decision|0|||
130320618|NCT03037385|469144036|FG006|Overall Study|Physician Decision|0|||
130320619|NCT03037385|469144037|FG007|Overall Study|Physician Decision|0|||
130320620|NCT03037385|469144038|FG008|Overall Study|Physician Decision|0|||
130320621|NCT03037385|469144039|FG009|Overall Study|Physician Decision|1|||
130320622|NCT03037385|469144030|FG000|Overall Study|Progressive Disease|0|||
130320623|NCT03037385|469144031|FG001|Overall Study|Progressive Disease|1|||
130320624|NCT03037385|469144032|FG002|Overall Study|Progressive Disease|1|||
130320625|NCT03037385|469144033|FG003|Overall Study|Progressive Disease|5|||
130320626|NCT03037385|469144034|FG004|Overall Study|Progressive Disease|2|||
130320627|NCT03037385|469144035|FG005|Overall Study|Progressive Disease|0|||
130320628|NCT03037385|469144036|FG006|Overall Study|Progressive Disease|1|||
130320629|NCT03037385|469144037|FG007|Overall Study|Progressive Disease|0|||
130320630|NCT03037385|469144038|FG008|Overall Study|Progressive Disease|0|||
130320631|NCT03037385|469144039|FG009|Overall Study|Progressive Disease|30|||
130320632|NCT03037385|469144030|FG000|Overall Study|Withdrawal by Subject|0|||
130320633|NCT03037385|469144031|FG001|Overall Study|Withdrawal by Subject|0|||
130320634|NCT03037385|469144032|FG002|Overall Study|Withdrawal by Subject|1|||
130320635|NCT03037385|469144033|FG003|Overall Study|Withdrawal by Subject|2|||
130320636|NCT03037385|469144034|FG004|Overall Study|Withdrawal by Subject|1|||
130320637|NCT03037385|469144035|FG005|Overall Study|Withdrawal by Subject|3|||
130320638|NCT03037385|469144036|FG006|Overall Study|Withdrawal by Subject|0|||
130320639|NCT03037385|469144037|FG007|Overall Study|Withdrawal by Subject|0|||
130320640|NCT03037385|469144038|FG008|Overall Study|Withdrawal by Subject|0|||
130320641|NCT03037385|469144039|FG009|Overall Study|Withdrawal by Subject|52|||
130320642|NCT03037385|469144030|FG000|Overall Study|Reason Not Specified|0|||
130320643|NCT03037385|469144031|FG001|Overall Study|Reason Not Specified|1|||
130320644|NCT03037385|469144032|FG002|Overall Study|Reason Not Specified|0|||
130320645|NCT03037385|469144033|FG003|Overall Study|Reason Not Specified|4|||
130320646|NCT03037385|469144034|FG004|Overall Study|Reason Not Specified|3|||
130320647|NCT03037385|469144035|FG005|Overall Study|Reason Not Specified|6|||
130320648|NCT03037385|469144036|FG006|Overall Study|Reason Not Specified|2|||
130320649|NCT03037385|469144037|FG007|Overall Study|Reason Not Specified|0|||
130320650|NCT03037385|469144038|FG008|Overall Study|Reason Not Specified|1|||
130320651|NCT03037385|469144039|FG009|Overall Study|Reason Not Specified|181|||
130320652|NCT04515771|469144044|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
130320653|NCT04515771|469144045|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
130320654|NCT04515771|469144044|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
130320655|NCT04515771|469144045|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
130320656|NCT04515771|469144044|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
130320657|NCT04515771|469144045|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
130320658|NCT01021020|469144046|FG000|Period I|Protocol Violation|1|||
130320659|NCT01021020|469144046|FG000|Period I|Withdrawal by Subject|1|||
130320660|NCT01021020|469144046|FG000|14 Day Washout Period A|Physician Decision|1|||
130320661|NCT00948246|469144049|FG000|Overall Study|Lost to Follow-up|11|||
129876791|NCT01859793|467509197|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
129876792|NCT01859793|467509198|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
130320662|NCT00948246|469144049|FG000|Overall Study|Adverse Event|11|||
130320663|NCT00948246|469144049|FG000|Overall Study|Death|1|||
130320664|NCT00948246|469144049|FG000|Overall Study|Withdrawal by Subject|1|||
129876793|NCT01859793|467509197|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130320665|NCT03598036|469144052|FG000|Overall Study|Withdrawal by Subject|1|||
130320666|NCT03598036|469144053|FG001|Overall Study|Withdrawal by Subject|0|||
130320667|NCT04199351|469144054|FG000|Overall Study|Decision by sponsor|0|||
130320668|NCT04199351|469144055|FG001|Overall Study|Decision by sponsor|0|||
130320669|NCT04199351|469144056|FG002|Overall Study|Decision by sponsor|0|||
130320670|NCT04199351|469144057|FG003|Overall Study|Decision by sponsor|2|||
130320671|NCT04199351|469144058|FG004|Overall Study|Decision by sponsor|0|||
130320672|NCT04199351|469144059|FG005|Overall Study|Decision by sponsor|0|||
130320673|NCT04199351|469144060|FG006|Overall Study|Decision by sponsor|0|||
130320674|NCT04199351|469144061|FG007|Overall Study|Decision by sponsor|0|||
130320675|NCT04199351|469144062|FG008|Overall Study|Decision by sponsor|0|||
130320676|NCT04199351|469144063|FG009|Overall Study|Decision by sponsor|6|||
130320677|NCT04199351|469144054|FG000|Overall Study|Lost to Follow-up|0|||
130320678|NCT04199351|469144055|FG001|Overall Study|Lost to Follow-up|0|||
130320679|NCT04199351|469144056|FG002|Overall Study|Lost to Follow-up|1|||
130320680|NCT04199351|469144057|FG003|Overall Study|Lost to Follow-up|0|||
130320681|NCT04199351|469144058|FG004|Overall Study|Lost to Follow-up|0|||
130320682|NCT04199351|469144059|FG005|Overall Study|Lost to Follow-up|1|||
130320683|NCT04199351|469144060|FG006|Overall Study|Lost to Follow-up|0|||
130320684|NCT04199351|469144061|FG007|Overall Study|Lost to Follow-up|0|||
130320685|NCT04199351|469144062|FG008|Overall Study|Lost to Follow-up|0|||
130320686|NCT04199351|469144063|FG009|Overall Study|Lost to Follow-up|0|||
130320687|NCT04199351|469144054|FG000|Overall Study|Withdrawal by Subject|0|||
130320688|NCT04199351|469144055|FG001|Overall Study|Withdrawal by Subject|1|||
130320689|NCT04199351|469144056|FG002|Overall Study|Withdrawal by Subject|0|||
130320690|NCT04199351|469144057|FG003|Overall Study|Withdrawal by Subject|0|||
130320691|NCT04199351|469144058|FG004|Overall Study|Withdrawal by Subject|1|||
130320692|NCT04199351|469144059|FG005|Overall Study|Withdrawal by Subject|4|||
130320693|NCT04199351|469144060|FG006|Overall Study|Withdrawal by Subject|2|||
130320694|NCT04199351|469144061|FG007|Overall Study|Withdrawal by Subject|0|||
130320695|NCT04199351|469144062|FG008|Overall Study|Withdrawal by Subject|3|||
130320696|NCT04199351|469144063|FG009|Overall Study|Withdrawal by Subject|0|||
130320697|NCT01838694|469144064|FG000|Overall Study|Adverse Event|0|||
130320698|NCT01838694|469144065|FG001|Overall Study|Adverse Event|1|||
130320699|NCT03623243|469144066|FG000|Overall Study|Adverse Event|15|||
130320700|NCT03623243|469144066|FG000|Overall Study|Guardian Decision|1|||
130320701|NCT03623243|469144066|FG000|Overall Study|New Therapy for Study Indication|1|||
130320702|NCT03623243|469144066|FG000|Overall Study|Protocol Deviation|3|||
130320703|NCT03623243|469144066|FG000|Overall Study|Physician Decision|4|||
130320704|NCT03623243|469144066|FG000|Overall Study|Patient Decision|15|||
130320705|NCT02177695|469144070|FG000|ITT Analysis|Ineligible|5|||
130320706|NCT02177695|469144071|FG001|ITT Analysis|Ineligible|5|||
130320707|NCT02177695|469144070|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
130320708|NCT02177695|469144071|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
130320709|NCT02177695|469144070|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
130320710|NCT02177695|469144071|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
130320711|NCT02177695|469144070|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
130320712|NCT02177695|469144071|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
130320713|NCT00979901|469144072|FG000|Overall Study|Adverse Event|1|||
130320714|NCT00979901|469144073|FG001|Overall Study|Adverse Event|3|||
130320715|NCT00979901|469144074|FG002|Overall Study|Adverse Event|9|||
130320716|NCT00979901|469144075|FG003|Overall Study|Adverse Event|2|||
130320717|NCT00979901|469144072|FG000|Overall Study|Lack of Efficacy|8|||
130320718|NCT00979901|469144073|FG001|Overall Study|Lack of Efficacy|4|||
130320719|NCT00979901|469144074|FG002|Overall Study|Lack of Efficacy|9|||
130320720|NCT00979901|469144075|FG003|Overall Study|Lack of Efficacy|0|||
130320721|NCT00979901|469144072|FG000|Overall Study|Lost to Follow-up|1|||
130320722|NCT00979901|469144073|FG001|Overall Study|Lost to Follow-up|1|||
130320723|NCT00979901|469144074|FG002|Overall Study|Lost to Follow-up|2|||
130320724|NCT00979901|469144075|FG003|Overall Study|Lost to Follow-up|0|||
130320725|NCT00979901|469144072|FG000|Overall Study|Protocol Violation|2|||
130320726|NCT00979901|469144073|FG001|Overall Study|Protocol Violation|2|||
130320727|NCT00979901|469144074|FG002|Overall Study|Protocol Violation|7|||
130320728|NCT00979901|469144075|FG003|Overall Study|Protocol Violation|1|||
130320729|NCT00979901|469144072|FG000|Overall Study|Withdrawal by Subject|2|||
130320730|NCT00979901|469144073|FG001|Overall Study|Withdrawal by Subject|1|||
130320731|NCT00979901|469144074|FG002|Overall Study|Withdrawal by Subject|1|||
130320732|NCT00979901|469144075|FG003|Overall Study|Withdrawal by Subject|1|||
130320733|NCT00979901|469144072|FG000|Overall Study|Noncompliance|1|||
130320734|NCT00979901|469144073|FG001|Overall Study|Noncompliance|0|||
130320735|NCT00979901|469144074|FG002|Overall Study|Noncompliance|0|||
130320736|NCT00979901|469144075|FG003|Overall Study|Noncompliance|0|||
130320737|NCT00979901|469144072|FG000|Overall Study|out-of-state|1|||
130320738|NCT00979901|469144073|FG001|Overall Study|out-of-state|0|||
130320739|NCT00979901|469144074|FG002|Overall Study|out-of-state|0|||
130320740|NCT00979901|469144075|FG003|Overall Study|out-of-state|0|||
130320741|NCT00979901|469144072|FG000|Overall Study|vacation|1|||
130320742|NCT00979901|469144073|FG001|Overall Study|vacation|0|||
130320743|NCT00979901|469144074|FG002|Overall Study|vacation|0|||
130320744|NCT00979901|469144075|FG003|Overall Study|vacation|0|||
130320745|NCT00979901|469144072|FG000|Overall Study|elevated lab values pre-randomization|1|||
130320746|NCT00979901|469144073|FG001|Overall Study|elevated lab values pre-randomization|0|||
130320747|NCT00979901|469144074|FG002|Overall Study|elevated lab values pre-randomization|0|||
130320748|NCT00979901|469144075|FG003|Overall Study|elevated lab values pre-randomization|0|||
130320749|NCT00979901|469144072|FG000|Overall Study|Discontinued in Error|0|||
130320750|NCT00979901|469144073|FG001|Overall Study|Discontinued in Error|1|||
130320751|NCT00979901|469144074|FG002|Overall Study|Discontinued in Error|0|||
130320752|NCT00979901|469144075|FG003|Overall Study|Discontinued in Error|0|||
130320753|NCT00979901|469144072|FG000|Overall Study|Left Country|0|||
130320754|NCT00979901|469144073|FG001|Overall Study|Left Country|0|||
130320755|NCT00979901|469144074|FG002|Overall Study|Left Country|1|||
130320756|NCT00979901|469144075|FG003|Overall Study|Left Country|0|||
130320757|NCT00979901|469144072|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
130320758|NCT00979901|469144073|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
130320759|NCT00979901|469144074|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
130320760|NCT00979901|469144075|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
130320761|NCT02182895|469144086|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
130320762|NCT02182895|469144087|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
130320763|NCT00286468|469144088|FG000|Overall Study|Hyperglycemic Rescue|28|||
130320764|NCT00286468|469144089|FG001|Overall Study|Hyperglycemic Rescue|30|||
130320765|NCT00286468|469144090|FG002|Overall Study|Hyperglycemic Rescue|31|||
130320766|NCT00286468|469144088|FG000|Overall Study|Adverse Event|2|||
130320767|NCT00286468|469144089|FG001|Overall Study|Adverse Event|6|||
130320768|NCT00286468|469144090|FG002|Overall Study|Adverse Event|4|||
130320769|NCT00286468|469144088|FG000|Overall Study|Protocol Violation|0|||
130320770|NCT00286468|469144089|FG001|Overall Study|Protocol Violation|3|||
130320771|NCT00286468|469144090|FG002|Overall Study|Protocol Violation|1|||
130320772|NCT00286468|469144088|FG000|Overall Study|Lost to Follow-up|1|||
130320773|NCT00286468|469144089|FG001|Overall Study|Lost to Follow-up|1|||
130320774|NCT00286468|469144090|FG002|Overall Study|Lost to Follow-up|2|||
130320775|NCT00286468|469144088|FG000|Overall Study|Withdrawal by Subject|3|||
130320776|NCT00286468|469144089|FG001|Overall Study|Withdrawal by Subject|8|||
130320777|NCT00286468|469144090|FG002|Overall Study|Withdrawal by Subject|11|||
130320778|NCT00286468|469144088|FG000|Overall Study|Physician Decision|3|||
130320779|NCT00286468|469144089|FG001|Overall Study|Physician Decision|2|||
130320780|NCT00286468|469144090|FG002|Overall Study|Physician Decision|1|||
130320781|NCT03305666|469144091|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
130320782|NCT03305666|469144092|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
130320783|NCT02230410|469144094|FG000|Overall Study|Screen Failure|3|||
130320784|NCT02587221|469144099|FG000|Overall Study|Adverse Event|3|||
130320785|NCT02587221|469144100|FG001|Overall Study|Adverse Event|3|||
130320786|NCT02587221|469144099|FG000|Overall Study|Death|33|||
130320787|NCT02587221|469144100|FG001|Overall Study|Death|34|||
130320788|NCT02587221|469144099|FG000|Overall Study|Withdrawal by Subject|66|||
130320789|NCT02587221|469144100|FG001|Overall Study|Withdrawal by Subject|61|||
130320790|NCT02587221|469144099|FG000|Overall Study|Lost to Follow-up|21|||
130320791|NCT02587221|469144100|FG001|Overall Study|Lost to Follow-up|19|||
130320792|NCT02587221|469144099|FG000|Overall Study|Protocol Violation|6|||
130320793|NCT02587221|469144100|FG001|Overall Study|Protocol Violation|5|||
130320794|NCT02587221|469144099|FG000|Overall Study|Other Reason or Unspecified|2|||
130320795|NCT02587221|469144100|FG001|Overall Study|Other Reason or Unspecified|1|||
130320796|NCT02242942|469144105|FG000|Overall Study|Death|17|||
130320797|NCT02242942|469144106|FG001|Overall Study|Death|20|||
130320798|NCT02242942|469144107|FG002|Overall Study|Death|2|||
130320799|NCT02242942|469144105|FG000|Overall Study|Physician Decision|1|||
130320800|NCT02242942|469144106|FG001|Overall Study|Physician Decision|0|||
130320801|NCT02242942|469144107|FG002|Overall Study|Physician Decision|0|||
130320802|NCT02242942|469144105|FG000|Overall Study|Withdrawal by Subject|8|||
130320803|NCT02242942|469144106|FG001|Overall Study|Withdrawal by Subject|10|||
130320804|NCT02242942|469144107|FG002|Overall Study|Withdrawal by Subject|0|||
130320805|NCT02242942|469144105|FG000|Overall Study|On-going in Study|190|||
130320806|NCT02242942|469144106|FG001|Overall Study|On-going in Study|186|||
130320807|NCT02242942|469144107|FG002|Overall Study|On-going in Study|11|||
130320808|NCT00551759|469144108|FG000|Overall Study|Adverse Event|7|||
130320809|NCT00551759|469144108|FG000|Overall Study|Death|5|||
130320810|NCT00551759|469144108|FG000|Overall Study|Ineligible|1|||
130320811|NCT01451606|469144113|FG000|Overall Study|Withdrawal by Subject|4|||
130320812|NCT01451606|469144114|FG001|Overall Study|Withdrawal by Subject|3|||
130320813|NCT02163538|469144117|FG000|Overall Study|Protocol Violation|1|||
130320814|NCT02163538|469144118|FG001|Overall Study|Protocol Violation|0|||
130320815|NCT02163538|469144117|FG000|Overall Study|Physician Decision|0|||
130320816|NCT02163538|469144118|FG001|Overall Study|Physician Decision|1|||
130320817|NCT01283139|469144119|FG000|Overall Study|Lost to Follow-up|5|||
130320818|NCT01283139|469144120|FG001|Overall Study|Lost to Follow-up|2|||
130320819|NCT01283139|469144121|FG002|Overall Study|Lost to Follow-up|3|||
130320820|NCT01283139|469144122|FG003|Overall Study|Lost to Follow-up|1|||
130320821|NCT01283139|469144119|FG000|Overall Study|Withdrawal by Subject|8|||
130320822|NCT01283139|469144120|FG001|Overall Study|Withdrawal by Subject|8|||
130320823|NCT01283139|469144121|FG002|Overall Study|Withdrawal by Subject|6|||
130320824|NCT01283139|469144122|FG003|Overall Study|Withdrawal by Subject|8|||
130320825|NCT01283139|469144119|FG000|Overall Study|Death|2|||
130320826|NCT01283139|469144120|FG001|Overall Study|Death|0|||
130320827|NCT01283139|469144121|FG002|Overall Study|Death|2|||
130320828|NCT01283139|469144122|FG003|Overall Study|Death|2|||
130320829|NCT01283139|469144119|FG000|Overall Study|Lack of Efficacy|1|||
129876794|NCT01859793|467509198|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129876795|NCT01859793|467509197|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
129876796|NCT01859793|467509198|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
129876797|NCT01735396|467509202|FG000|Overall Study|not evaluable|1|||
129876798|NCT02002182|467509203|FG000|Overall Study|Withdraw from study|3|||
129876799|NCT02002182|467509204|FG001|Overall Study|Withdraw from study|1|||
129876800|NCT02002182|467509203|FG000|Overall Study|Health Reasons|1|||
129876801|NCT02002182|467509204|FG001|Overall Study|Health Reasons|0|||
130213752|NCT01005901|468746903|FG001|Overall Study|Lost to Follow-up|2|||
129876802|NCT02002182|467509203|FG000|Overall Study|Death|1|||
129876803|NCT02002182|467509204|FG001|Overall Study|Death|0|||
129876804|NCT04146896|467509205|FG000|Overall Study|Adverse Event|5|||
130213753|NCT01005901|468746902|FG000|Overall Study|Patient's inability to use the device|1|||
130213754|NCT01005901|468746903|FG001|Overall Study|Patient's inability to use the device|1|||
130213755|NCT01005901|468746902|FG000|Overall Study|No longer requires study drug|0|||
130213756|NCT01005901|468746903|FG001|Overall Study|No longer requires study drug|1|||
130213757|NCT00760487|468746904|FG000|Overall Study|Unilateral implantation|3|||
130213758|NCT06360588|468746905|FG000|Overall Study|Adverse Event|3|||
130213759|NCT06360588|468746905|FG000|Overall Study|Death|2|||
130213760|NCT06360588|468746905|FG000|Overall Study|Disease Progression|14|||
130213761|NCT06360588|468746905|FG000|Overall Study|Withdrawal by Subject|1|||
130213762|NCT06360588|468746905|FG000|Overall Study|Lack of Efficacy|1|||
130213763|NCT06360588|468746905|FG000|Overall Study|Ineligible|1|||
130213764|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
130213765|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
130213766|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
130213767|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
130213768|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
130213769|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
130213770|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
130213771|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
130213772|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
130213773|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
130213774|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
130213775|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
130213776|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
130213777|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
130213778|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
130213779|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
130213780|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130213781|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
130213782|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130213783|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
130213784|NCT02087943|468746906|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213785|NCT02087943|468746907|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
130213786|NCT02087943|468746908|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213787|NCT02087943|468746909|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213788|NCT02087943|468746910|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
130213789|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
130213790|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
130213791|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
130213792|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
130213793|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
130213794|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
130213795|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
130213796|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
130213797|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
130213798|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
130213799|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213800|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213801|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
130213802|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213803|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
130213804|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130213805|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129876805|NCT04146896|467509206|FG001|Overall Study|Adverse Event|8|||
129876806|NCT04146896|467509205|FG000|Overall Study|Lack of Efficacy|3|||
129876807|NCT04146896|467509206|FG001|Overall Study|Lack of Efficacy|2|||
129876808|NCT04146896|467509205|FG000|Overall Study|Lost to Follow-up|0|||
129876809|NCT04146896|467509206|FG001|Overall Study|Lost to Follow-up|1|||
129876810|NCT04146896|467509205|FG000|Overall Study|Non-compliance|5|||
129876811|NCT04146896|467509206|FG001|Overall Study|Non-compliance|4|||
129876812|NCT04146896|467509205|FG000|Overall Study|Withdrawal by Subject|3|||
130320830|NCT01283139|469144120|FG001|Overall Study|Lack of Efficacy|2|||
130320831|NCT01283139|469144121|FG002|Overall Study|Lack of Efficacy|2|||
130320832|NCT01283139|469144122|FG003|Overall Study|Lack of Efficacy|1|||
130320833|NCT01283139|469144119|FG000|Overall Study|Early termination due to AE/SAE|1|||
130320834|NCT01283139|469144120|FG001|Overall Study|Early termination due to AE/SAE|1|||
130320835|NCT01283139|469144121|FG002|Overall Study|Early termination due to AE/SAE|0|||
130320836|NCT01283139|469144122|FG003|Overall Study|Early termination due to AE/SAE|0|||
130320837|NCT01283139|469144119|FG000|Overall Study|Participant's refusal to continue|0|||
130320838|NCT01283139|469144120|FG001|Overall Study|Participant's refusal to continue|3|||
129876813|NCT04146896|467509206|FG001|Overall Study|Withdrawal by Subject|5|||
129876814|NCT04146896|467509205|FG000|Overall Study|Randomized in error|1|||
129876815|NCT04146896|467509206|FG001|Overall Study|Randomized in error|2|||
129876816|NCT04296890|467509207|FG000|Overall Study|Withdrawal by Subject|1|||
130320839|NCT01283139|469144121|FG002|Overall Study|Participant's refusal to continue|1|||
130320840|NCT01283139|469144122|FG003|Overall Study|Participant's refusal to continue|1|||
130320841|NCT01283139|469144119|FG000|Overall Study|Pregnancy|0|||
130320842|NCT01283139|469144120|FG001|Overall Study|Pregnancy|1|||
130320843|NCT01283139|469144121|FG002|Overall Study|Pregnancy|1|||
130320844|NCT01283139|469144122|FG003|Overall Study|Pregnancy|0|||
130320845|NCT01283139|469144119|FG000|Overall Study|Missed follow-up visit|0|||
130320846|NCT01283139|469144120|FG001|Overall Study|Missed follow-up visit|1|||
130320847|NCT01283139|469144121|FG002|Overall Study|Missed follow-up visit|2|||
130320848|NCT01283139|469144122|FG003|Overall Study|Missed follow-up visit|2|||
130320849|NCT01283139|469144119|FG000|Overall Study|Participant randomized in error|0|||
130320850|NCT01283139|469144120|FG001|Overall Study|Participant randomized in error|0|||
130320851|NCT01283139|469144121|FG002|Overall Study|Participant randomized in error|1|||
130320852|NCT01283139|469144122|FG003|Overall Study|Participant randomized in error|0|||
130320853|NCT00762164|469144123|FG000|Overall Study|Lost to Follow-up|1|||
130320854|NCT00762164|469144124|FG001|Overall Study|Lost to Follow-up|1|||
130320855|NCT00762164|469144123|FG000|Overall Study|Discontinued medication|2|||
130320856|NCT00762164|469144124|FG001|Overall Study|Discontinued medication|0|||
130320857|NCT00762164|469144123|FG000|Overall Study|Withdrawal by Subject|0|||
130320858|NCT00762164|469144124|FG001|Overall Study|Withdrawal by Subject|1|||
130320859|NCT02954536|469144125|FG000|Overall Study|Adverse Event|2|||
130320860|NCT02954536|469144125|FG000|Overall Study|Death|12|||
130320861|NCT00604565|469144133|FG000|Overall Study|Study terminated|0|||
130320862|NCT00604565|469144134|FG001|Overall Study|Study terminated|3|||
130320863|NCT04292535|469144136|FG000|Overall Study|Withdrawal by Subject|0|||
130320864|NCT04292535|469144137|FG001|Overall Study|Withdrawal by Subject|0|||
130320865|NCT04292535|469144138|FG002|Overall Study|Withdrawal by Subject|0|||
130320866|NCT04292535|469144139|FG003|Overall Study|Withdrawal by Subject|0|||
130320867|NCT04292535|469144140|FG004|Overall Study|Withdrawal by Subject|0|||
130320868|NCT04292535|469144141|FG005|Overall Study|Withdrawal by Subject|0|||
130320869|NCT04292535|469144142|FG006|Overall Study|Withdrawal by Subject|0|||
130320870|NCT04292535|469144143|FG007|Overall Study|Withdrawal by Subject|1|||
130320871|NCT04292535|469144144|FG008|Overall Study|Withdrawal by Subject|0|||
130320872|NCT04292535|469144145|FG009|Overall Study|Withdrawal by Subject|0|||
130320873|NCT04292535|469144146|FG010|Overall Study|Withdrawal by Subject|0|||
130320874|NCT04292535|469144147|FG011|Overall Study|Withdrawal by Subject|0|||
130320875|NCT04292535|469144148|FG012|Overall Study|Withdrawal by Subject|0|||
130320876|NCT04292535|469144149|FG013|Overall Study|Withdrawal by Subject|0|||
130320877|NCT04292535|469144136|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320878|NCT04292535|469144137|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129876817|NCT04296890|467509207|FG000|Overall Study|Death|62|||
129876818|NCT04296890|467509207|FG000|Overall Study|Lost to Follow-up|3|||
129876819|NCT04296890|467509207|FG000|Overall Study|Other than specified|2|||
130320879|NCT04292535|469144138|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320880|NCT04292535|469144139|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320881|NCT04292535|469144140|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129876820|NCT05400746|467509208|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
129876821|NCT05400746|467509209|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
129876822|NCT05400746|467509210|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
129876823|NCT02277743|467509215|FG000|Overall Study|Protocol Violation|1|||
130320882|NCT04292535|469144141|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320883|NCT04292535|469144142|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320884|NCT04292535|469144143|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130320885|NCT04292535|469144144|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320886|NCT04292535|469144145|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320887|NCT04292535|469144146|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320888|NCT04292535|469144147|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
130320889|NCT04292535|469144148|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130320890|NCT04292535|469144149|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
130320891|NCT04292535|469144136|FG000|Overall Study|Report of Dizziness|0|||
130320892|NCT04292535|469144137|FG001|Overall Study|Report of Dizziness|0|||
130320893|NCT04292535|469144138|FG002|Overall Study|Report of Dizziness|0|||
130320894|NCT04292535|469144139|FG003|Overall Study|Report of Dizziness|0|||
130320895|NCT04292535|469144140|FG004|Overall Study|Report of Dizziness|0|||
130320896|NCT04292535|469144141|FG005|Overall Study|Report of Dizziness|0|||
130320897|NCT04292535|469144142|FG006|Overall Study|Report of Dizziness|0|||
130320898|NCT04292535|469144143|FG007|Overall Study|Report of Dizziness|0|||
130320899|NCT04292535|469144144|FG008|Overall Study|Report of Dizziness|0|||
130320900|NCT04292535|469144145|FG009|Overall Study|Report of Dizziness|0|||
130320901|NCT04292535|469144146|FG010|Overall Study|Report of Dizziness|0|||
130320902|NCT04292535|469144147|FG011|Overall Study|Report of Dizziness|0|||
130320903|NCT04292535|469144148|FG012|Overall Study|Report of Dizziness|0|||
130320904|NCT04292535|469144149|FG013|Overall Study|Report of Dizziness|1|||
130320905|NCT04292535|469144136|FG000|Overall Study|Equipment Failure|0|||
130320906|NCT04292535|469144137|FG001|Overall Study|Equipment Failure|0|||
130320907|NCT04292535|469144138|FG002|Overall Study|Equipment Failure|0|||
130320908|NCT04292535|469144139|FG003|Overall Study|Equipment Failure|0|||
130320909|NCT04292535|469144140|FG004|Overall Study|Equipment Failure|0|||
130320910|NCT04292535|469144141|FG005|Overall Study|Equipment Failure|0|||
130320911|NCT04292535|469144142|FG006|Overall Study|Equipment Failure|0|||
130320912|NCT04292535|469144143|FG007|Overall Study|Equipment Failure|0|||
130320913|NCT04292535|469144144|FG008|Overall Study|Equipment Failure|0|||
130320914|NCT04292535|469144145|FG009|Overall Study|Equipment Failure|0|||
130320915|NCT04292535|469144146|FG010|Overall Study|Equipment Failure|0|||
130320916|NCT04292535|469144147|FG011|Overall Study|Equipment Failure|1|||
130320917|NCT04292535|469144148|FG012|Overall Study|Equipment Failure|0|||
130320918|NCT04292535|469144149|FG013|Overall Study|Equipment Failure|0|||
130320919|NCT00517296|469144150|FG000|Overall Study|Withdrawal by Subject|1|||
130320920|NCT00517296|469144151|FG001|Overall Study|Withdrawal by Subject|0|||
130320921|NCT04609319|469144153|FG000|Overall Study|Death|64|||
130320922|NCT04609319|469144154|FG001|Overall Study|Death|49|||
130320923|NCT04609319|469144155|FG002|Overall Study|Death|1|||
130320924|NCT04609319|469144153|FG000|Overall Study|Withdrawal of consent|15|||
130320925|NCT04609319|469144154|FG001|Overall Study|Withdrawal of consent|3|||
130320926|NCT04609319|469144155|FG002|Overall Study|Withdrawal of consent|0|||
130320927|NCT04609319|469144153|FG000|Overall Study|Lost to Follow-up|20|||
130320928|NCT04609319|469144154|FG001|Overall Study|Lost to Follow-up|33|||
130320929|NCT04609319|469144155|FG002|Overall Study|Lost to Follow-up|0|||
130320930|NCT04609319|469144153|FG000|Overall Study|Alive until end of follow-up|60|||
130320931|NCT04609319|469144154|FG001|Overall Study|Alive until end of follow-up|53|||
130320932|NCT04609319|469144155|FG002|Overall Study|Alive until end of follow-up|1|||
130320933|NCT01253291|469144156|FG000|Overall Study|Withdrawal by Subject|1|||
130320934|NCT01253291|469144157|FG001|Overall Study|Withdrawal by Subject|1|||
130320935|NCT01253291|469144158|FG002|Overall Study|Withdrawal by Subject|0|||
130320936|NCT01253291|469144159|FG003|Overall Study|Withdrawal by Subject|0|||
130320937|NCT01253291|469144160|FG004|Overall Study|Withdrawal by Subject|0|||
130320938|NCT01253291|469144156|FG000|Overall Study|Adverse Event|0|||
130320939|NCT01253291|469144157|FG001|Overall Study|Adverse Event|1|||
130320940|NCT01253291|469144158|FG002|Overall Study|Adverse Event|0|||
130320941|NCT01253291|469144159|FG003|Overall Study|Adverse Event|0|||
130320942|NCT01253291|469144160|FG004|Overall Study|Adverse Event|0|||
130320943|NCT01253291|469144156|FG000|Overall Study|Lack of Efficacy|1|||
130320944|NCT01253291|469144157|FG001|Overall Study|Lack of Efficacy|0|||
130320945|NCT01253291|469144158|FG002|Overall Study|Lack of Efficacy|0|||
130320946|NCT01253291|469144159|FG003|Overall Study|Lack of Efficacy|0|||
130320947|NCT01253291|469144160|FG004|Overall Study|Lack of Efficacy|0|||
130320948|NCT01253291|469144156|FG000|Overall Study|Physician Decision|2|||
130320949|NCT01253291|469144157|FG001|Overall Study|Physician Decision|0|||
130320950|NCT01253291|469144158|FG002|Overall Study|Physician Decision|0|||
130320951|NCT01253291|469144159|FG003|Overall Study|Physician Decision|0|||
130320952|NCT01253291|469144160|FG004|Overall Study|Physician Decision|2|||
130320953|NCT02234843|469144169|FG000|Overall Study|Death|1|||
130320954|NCT02234843|469144170|FG001|Overall Study|Death|0|||
130320955|NCT02234843|469144171|FG002|Overall Study|Death|0|||
130320956|NCT02234843|469144172|FG003|Overall Study|Death|0|||
130320957|NCT02234843|469144173|FG004|Overall Study|Death|0|||
130320958|NCT02234843|469144174|FG005|Overall Study|Death|0|||
130320959|NCT02234843|469144175|FG006|Overall Study|Death|0|||
130320960|NCT02234843|469144176|FG007|Overall Study|Death|0|||
130320961|NCT02234843|469144177|FG008|Overall Study|Death|0|||
130320962|NCT02234843|469144178|FG009|Overall Study|Death|0|||
130320963|NCT02234843|469144169|FG000|Overall Study|Protocol Violation|1|||
130320964|NCT02234843|469144170|FG001|Overall Study|Protocol Violation|0|||
130320965|NCT02234843|469144171|FG002|Overall Study|Protocol Violation|1|||
130320966|NCT02234843|469144172|FG003|Overall Study|Protocol Violation|0|||
130320967|NCT02234843|469144173|FG004|Overall Study|Protocol Violation|0|||
130320968|NCT02234843|469144174|FG005|Overall Study|Protocol Violation|0|||
130320969|NCT02234843|469144175|FG006|Overall Study|Protocol Violation|0|||
130320970|NCT02234843|469144176|FG007|Overall Study|Protocol Violation|0|||
130320971|NCT02234843|469144177|FG008|Overall Study|Protocol Violation|0|||
130320972|NCT02234843|469144178|FG009|Overall Study|Protocol Violation|0|||
130320973|NCT02234843|469144169|FG000|Overall Study|Efficacy outcome reached|2|||
130320974|NCT02234843|469144170|FG001|Overall Study|Efficacy outcome reached|0|||
130320975|NCT02234843|469144171|FG002|Overall Study|Efficacy outcome reached|0|||
130320976|NCT02234843|469144172|FG003|Overall Study|Efficacy outcome reached|0|||
130320977|NCT02234843|469144173|FG004|Overall Study|Efficacy outcome reached|0|||
130320978|NCT02234843|469144174|FG005|Overall Study|Efficacy outcome reached|2|||
130320979|NCT02234843|469144175|FG006|Overall Study|Efficacy outcome reached|0|||
130320980|NCT02234843|469144176|FG007|Overall Study|Efficacy outcome reached|0|||
130320981|NCT02234843|469144177|FG008|Overall Study|Efficacy outcome reached|0|||
130320982|NCT02234843|469144178|FG009|Overall Study|Efficacy outcome reached|0|||
130320983|NCT02234843|469144169|FG000|Overall Study|Patient convenience|2|||
130320984|NCT02234843|469144170|FG001|Overall Study|Patient convenience|0|||
130320985|NCT02234843|469144171|FG002|Overall Study|Patient convenience|0|||
130320986|NCT02234843|469144172|FG003|Overall Study|Patient convenience|0|||
130320987|NCT02234843|469144173|FG004|Overall Study|Patient convenience|0|||
130320988|NCT02234843|469144174|FG005|Overall Study|Patient convenience|1|||
130320989|NCT02234843|469144175|FG006|Overall Study|Patient convenience|0|||
130320990|NCT02234843|469144176|FG007|Overall Study|Patient convenience|0|||
130320991|NCT02234843|469144177|FG008|Overall Study|Patient convenience|0|||
130320992|NCT02234843|469144178|FG009|Overall Study|Patient convenience|0|||
130320993|NCT02234843|469144169|FG000|Overall Study|Withdrawal by Subject|5|||
130320994|NCT02234843|469144170|FG001|Overall Study|Withdrawal by Subject|1|||
130320995|NCT02234843|469144171|FG002|Overall Study|Withdrawal by Subject|1|||
130320996|NCT02234843|469144172|FG003|Overall Study|Withdrawal by Subject|0|||
130320997|NCT02234843|469144173|FG004|Overall Study|Withdrawal by Subject|0|||
130320998|NCT02234843|469144174|FG005|Overall Study|Withdrawal by Subject|7|||
130320999|NCT02234843|469144175|FG006|Overall Study|Withdrawal by Subject|0|||
130321000|NCT02234843|469144176|FG007|Overall Study|Withdrawal by Subject|0|||
130321001|NCT02234843|469144177|FG008|Overall Study|Withdrawal by Subject|0|||
130321002|NCT02234843|469144178|FG009|Overall Study|Withdrawal by Subject|0|||
130321003|NCT02234843|469144169|FG000|Overall Study|Recovery|1|||
130321004|NCT02234843|469144170|FG001|Overall Study|Recovery|0|||
130321005|NCT02234843|469144171|FG002|Overall Study|Recovery|0|||
130321006|NCT02234843|469144172|FG003|Overall Study|Recovery|0|||
130321007|NCT02234843|469144173|FG004|Overall Study|Recovery|0|||
130321008|NCT02234843|469144174|FG005|Overall Study|Recovery|0|||
130321009|NCT02234843|469144175|FG006|Overall Study|Recovery|0|||
130321010|NCT02234843|469144176|FG007|Overall Study|Recovery|0|||
130321011|NCT02234843|469144177|FG008|Overall Study|Recovery|0|||
130321012|NCT02234843|469144178|FG009|Overall Study|Recovery|0|||
130321013|NCT02234843|469144169|FG000|Overall Study|Other|0|||
130321014|NCT02234843|469144170|FG001|Overall Study|Other|2|||
130321015|NCT02234843|469144171|FG002|Overall Study|Other|0|||
130321016|NCT02234843|469144172|FG003|Overall Study|Other|1|||
130321017|NCT02234843|469144173|FG004|Overall Study|Other|0|||
130321018|NCT02234843|469144174|FG005|Overall Study|Other|1|||
130321019|NCT02234843|469144175|FG006|Overall Study|Other|0|||
130321020|NCT02234843|469144176|FG007|Overall Study|Other|1|||
130321021|NCT02234843|469144177|FG008|Overall Study|Other|0|||
130321022|NCT02234843|469144178|FG009|Overall Study|Other|0|||
130321023|NCT02234843|469144169|FG000|Overall Study|Physician Decision|4|||
130321024|NCT02234843|469144170|FG001|Overall Study|Physician Decision|1|||
130321025|NCT02234843|469144171|FG002|Overall Study|Physician Decision|0|||
130321026|NCT02234843|469144172|FG003|Overall Study|Physician Decision|1|||
130321027|NCT02234843|469144173|FG004|Overall Study|Physician Decision|0|||
130321028|NCT02234843|469144174|FG005|Overall Study|Physician Decision|0|||
130321029|NCT02234843|469144175|FG006|Overall Study|Physician Decision|0|||
130321030|NCT02234843|469144176|FG007|Overall Study|Physician Decision|1|||
130321031|NCT02234843|469144177|FG008|Overall Study|Physician Decision|0|||
130321032|NCT02234843|469144178|FG009|Overall Study|Physician Decision|0|||
130321033|NCT02234843|469144169|FG000|Overall Study|Adverse Event|5|||
130321034|NCT02234843|469144170|FG001|Overall Study|Adverse Event|1|||
130321035|NCT02234843|469144171|FG002|Overall Study|Adverse Event|1|||
130321036|NCT02234843|469144172|FG003|Overall Study|Adverse Event|3|||
130321037|NCT02234843|469144173|FG004|Overall Study|Adverse Event|2|||
130321038|NCT02234843|469144174|FG005|Overall Study|Adverse Event|1|||
130321039|NCT02234843|469144175|FG006|Overall Study|Adverse Event|0|||
130321040|NCT02234843|469144176|FG007|Overall Study|Adverse Event|0|||
130321041|NCT02234843|469144177|FG008|Overall Study|Adverse Event|1|||
130321042|NCT02234843|469144178|FG009|Overall Study|Adverse Event|0|||
130321043|NCT02234843|469144169|FG000|Overall Study|Non-compliance with study drug|1|||
130321044|NCT02234843|469144170|FG001|Overall Study|Non-compliance with study drug|0|||
130321045|NCT02234843|469144171|FG002|Overall Study|Non-compliance with study drug|0|||
130321046|NCT02234843|469144172|FG003|Overall Study|Non-compliance with study drug|0|||
130321047|NCT02234843|469144173|FG004|Overall Study|Non-compliance with study drug|0|||
130321048|NCT02234843|469144174|FG005|Overall Study|Non-compliance with study drug|1|||
130321049|NCT02234843|469144175|FG006|Overall Study|Non-compliance with study drug|1|||
130321050|NCT02234843|469144176|FG007|Overall Study|Non-compliance with study drug|0|||
130321051|NCT02234843|469144177|FG008|Overall Study|Non-compliance with study drug|0|||
130321052|NCT02234843|469144178|FG009|Overall Study|Non-compliance with study drug|0|||
130321053|NCT02234843|469144169|FG000|Overall Study|Lost to Follow-up|0|||
130321054|NCT02234843|469144170|FG001|Overall Study|Lost to Follow-up|1|||
130321055|NCT02234843|469144171|FG002|Overall Study|Lost to Follow-up|0|||
130321056|NCT02234843|469144172|FG003|Overall Study|Lost to Follow-up|0|||
130321057|NCT02234843|469144173|FG004|Overall Study|Lost to Follow-up|0|||
130321058|NCT02234843|469144174|FG005|Overall Study|Lost to Follow-up|0|||
130321059|NCT02234843|469144175|FG006|Overall Study|Lost to Follow-up|1|||
130321060|NCT02234843|469144176|FG007|Overall Study|Lost to Follow-up|0|||
130321061|NCT02234843|469144177|FG008|Overall Study|Lost to Follow-up|0|||
130321062|NCT02234843|469144178|FG009|Overall Study|Lost to Follow-up|0|||
130321063|NCT01607957|469144181|FG000|Overall Study|Not treated|1|||
130321064|NCT01607957|469144182|FG001|Overall Study|Not treated|1|||
130321065|NCT01607957|469144181|FG000|Overall Study|Death|367|||
130321066|NCT01607957|469144182|FG001|Overall Study|Death|211|||
130321067|NCT01607957|469144181|FG000|Overall Study|Lost to Follow-up|3|||
130321068|NCT01607957|469144182|FG001|Overall Study|Lost to Follow-up|3|||
130321069|NCT01607957|469144181|FG000|Overall Study|Participant refusal|1|||
130321070|NCT01607957|469144182|FG001|Overall Study|Participant refusal|0|||
130321071|NCT00945009|469144185|FG000|Overall Study|Lack of Efficacy|10|||
130321072|NCT00945009|469144186|FG001|Overall Study|Lack of Efficacy|0|||
130321073|NCT00945009|469144187|FG002|Overall Study|Lack of Efficacy|0|||
130321074|NCT00945009|469144185|FG000|Overall Study|Physician Decision|21|||
130321075|NCT00945009|469144186|FG001|Overall Study|Physician Decision|4|||
130321076|NCT00945009|469144187|FG002|Overall Study|Physician Decision|3|||
130321077|NCT00945009|469144185|FG000|Overall Study|Protocol Violation|6|||
130321078|NCT00945009|469144186|FG001|Overall Study|Protocol Violation|1|||
130321079|NCT00945009|469144187|FG002|Overall Study|Protocol Violation|0|||
130321080|NCT00945009|469144185|FG000|Overall Study|Withdrawal by Subject|1|||
130321081|NCT00945009|469144186|FG001|Overall Study|Withdrawal by Subject|0|||
130321082|NCT00945009|469144187|FG002|Overall Study|Withdrawal by Subject|0|||
130321083|NCT00945009|469144185|FG000|Overall Study|Ineligible|6|||
130321084|NCT00945009|469144186|FG001|Overall Study|Ineligible|1|||
130321085|NCT00945009|469144187|FG002|Overall Study|Ineligible|0|||
130321086|NCT00945009|469144185|FG000|Overall Study|Inevaluable|0|||
130321087|NCT00945009|469144186|FG001|Overall Study|Inevaluable|1|||
130321088|NCT00945009|469144187|FG002|Overall Study|Inevaluable|0|||
130321089|NCT00945009|469144185|FG000|Overall Study|Refusal of further protocol|1|||
130321090|NCT00945009|469144186|FG001|Overall Study|Refusal of further protocol|0|||
130321091|NCT00945009|469144187|FG002|Overall Study|Refusal of further protocol|0|||
130321092|NCT03919773|469144188|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
130321093|NCT03919773|469144189|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
130321094|NCT03919773|469144188|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
130321095|NCT03919773|469144189|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
130321096|NCT04659044|469144190|FG000|Induction|Physician Decision|1|||
130321097|NCT04659044|469144190|FG000|Induction|Adverse Event|2|||
130321098|NCT04966013|469144191|FG000|Overall Study|Withdrawal by Subject|0|||
130321099|NCT04966013|469144192|FG001|Overall Study|Withdrawal by Subject|2|||
130321100|NCT04966013|469144193|FG002|Overall Study|Withdrawal by Subject|1|||
130321101|NCT04966013|469144191|FG000|Overall Study|Adverse Event|2|||
130321102|NCT04966013|469144192|FG001|Overall Study|Adverse Event|1|||
130321103|NCT04966013|469144193|FG002|Overall Study|Adverse Event|1|||
130321104|NCT03518086|469144194|FG000|Overall Study|Adverse Event|23|||
130321105|NCT03518086|469144195|FG001|Overall Study|Adverse Event|15|||
130321106|NCT03518086|469144196|FG002|Overall Study|Adverse Event|3|||
130321107|NCT03518086|469144197|FG003|Overall Study|Adverse Event|2|||
130321108|NCT03518086|469144194|FG000|Overall Study|Withdrawal by Subject|8|||
129876824|NCT02277743|467509216|FG001|Overall Study|Protocol Violation|1|||
130321109|NCT03518086|469144195|FG001|Overall Study|Withdrawal by Subject|5|||
130321110|NCT03518086|469144196|FG002|Overall Study|Withdrawal by Subject|1|||
130321111|NCT03518086|469144197|FG003|Overall Study|Withdrawal by Subject|0|||
130321112|NCT03518086|469144194|FG000|Overall Study|Lack of Efficacy|5|||
129876825|NCT02277743|467509217|FG002|Overall Study|Protocol Violation|1|||
129876826|NCT02277743|467509215|FG000|Overall Study|Adverse Event|10|||
130321113|NCT03518086|469144195|FG001|Overall Study|Lack of Efficacy|5|||
130321114|NCT03518086|469144196|FG002|Overall Study|Lack of Efficacy|0|||
130321115|NCT03518086|469144197|FG003|Overall Study|Lack of Efficacy|2|||
130321116|NCT03518086|469144194|FG000|Overall Study|Protocol Violation|1|||
130321117|NCT03518086|469144195|FG001|Overall Study|Protocol Violation|5|||
129876827|NCT02277743|467509216|FG001|Overall Study|Adverse Event|6|||
130321118|NCT03518086|469144196|FG002|Overall Study|Protocol Violation|1|||
130321119|NCT03518086|469144197|FG003|Overall Study|Protocol Violation|3|||
130321120|NCT03518086|469144194|FG000|Overall Study|Lost to Follow-up|0|||
130321121|NCT03518086|469144195|FG001|Overall Study|Lost to Follow-up|3|||
130321122|NCT03518086|469144196|FG002|Overall Study|Lost to Follow-up|0|||
130321123|NCT03518086|469144197|FG003|Overall Study|Lost to Follow-up|0|||
130321124|NCT03518086|469144194|FG000|Overall Study|Insufficient Diary Data|0|||
130321125|NCT03518086|469144195|FG001|Overall Study|Insufficient Diary Data|2|||
130321126|NCT03518086|469144196|FG002|Overall Study|Insufficient Diary Data|0|||
130321127|NCT03518086|469144197|FG003|Overall Study|Insufficient Diary Data|0|||
130321128|NCT03518086|469144194|FG000|Overall Study|Non- compliance to Protocol|0|||
130321129|NCT03518086|469144195|FG001|Overall Study|Non- compliance to Protocol|1|||
130321130|NCT03518086|469144196|FG002|Overall Study|Non- compliance to Protocol|0|||
130321131|NCT03518086|469144197|FG003|Overall Study|Non- compliance to Protocol|0|||
130321132|NCT03518086|469144194|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
130321133|NCT03518086|469144195|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
130321134|NCT03518086|469144196|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
130321135|NCT03518086|469144197|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
130321136|NCT03518086|469144194|FG000|Overall Study|Site Terminated by Sponsor|0|||
130321137|NCT03518086|469144195|FG001|Overall Study|Site Terminated by Sponsor|1|||
130321138|NCT03518086|469144196|FG002|Overall Study|Site Terminated by Sponsor|0|||
130321139|NCT03518086|469144197|FG003|Overall Study|Site Terminated by Sponsor|0|||
130321140|NCT03518086|469144194|FG000|Overall Study|Pregnancy|0|||
130321141|NCT03518086|469144195|FG001|Overall Study|Pregnancy|0|||
130321142|NCT03518086|469144196|FG002|Overall Study|Pregnancy|0|||
130321143|NCT03518086|469144197|FG003|Overall Study|Pregnancy|2|||
130321144|NCT05967260|469144198|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
130321145|NCT05967260|469144199|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
130321146|NCT02994108|469145669|FG000|Intervention Messages|Withdrawal by Subject|2|||
130321147|NCT02994108|469145670|FG001|Intervention Messages|Withdrawal by Subject|0|||
130321148|NCT02994108|469145669|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
130321149|NCT02994108|469145670|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
130321150|NCT02994108|469145669|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
130321151|NCT02994108|469145670|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
130321152|NCT02994108|469145669|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
130321153|NCT02994108|469145670|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
130321154|NCT02081677|469145671|FG000|Overall Study|Adverse Event|0|||
130321155|NCT02081677|469145672|FG001|Overall Study|Adverse Event|0|||
130321156|NCT02081677|469145673|FG002|Overall Study|Adverse Event|1|||
130321157|NCT02081677|469145674|FG003|Overall Study|Adverse Event|0|||
130321158|NCT02081677|469145671|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130321159|NCT02081677|469145672|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130321160|NCT02081677|469145673|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
130321161|NCT02081677|469145674|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130321162|NCT02081677|469145671|FG000|Overall Study|Not comfortable with lens care system|1|||
130321163|NCT02081677|469145672|FG001|Overall Study|Not comfortable with lens care system|0|||
130321164|NCT02081677|469145673|FG002|Overall Study|Not comfortable with lens care system|0|||
130321165|NCT02081677|469145674|FG003|Overall Study|Not comfortable with lens care system|0|||
130321166|NCT02081677|469145671|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
130321167|NCT02081677|469145672|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
130321168|NCT02081677|469145673|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
130321169|NCT02081677|469145674|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
130321170|NCT01097668|469145675|FG000|Overall Study|Withdrawal by Subject|1|||
130321171|NCT01097668|469145676|FG001|Overall Study|Withdrawal by Subject|2|||
130321172|NCT01097668|469145675|FG000|Overall Study|Lost to Follow-up|1|||
130321173|NCT01097668|469145676|FG001|Overall Study|Lost to Follow-up|0|||
130321174|NCT04607668|469145681|FG000|Overall Study|Death|49|||
130321175|NCT04607668|469145682|FG001|Overall Study|Death|26|||
130321176|NCT04607668|469145681|FG000|Overall Study|Lost to Follow-up|3|||
130321177|NCT04607668|469145682|FG001|Overall Study|Lost to Follow-up|4|||
130321178|NCT04607668|469145681|FG000|Overall Study|Study terminated by Sponsor|92|||
130321179|NCT04607668|469145682|FG001|Overall Study|Study terminated by Sponsor|114|||
130321180|NCT04607668|469145681|FG000|Overall Study|Withdrawal by Subject|12|||
130321181|NCT04607668|469145682|FG001|Overall Study|Withdrawal by Subject|11|||
130321182|NCT04607668|469145681|FG000|Overall Study|Other, unspecified|8|||
129876828|NCT02277743|467509217|FG002|Overall Study|Adverse Event|6|||
129876829|NCT02277743|467509215|FG000|Overall Study|Lack of Efficacy|11|||
130321183|NCT04607668|469145682|FG001|Overall Study|Other, unspecified|7|||
130321184|NCT00474487|469145683|FG000|Overall Study|Withdrawal by Subject|6|||
130321185|NCT00474487|469145684|FG001|Overall Study|Withdrawal by Subject|0|||
130321186|NCT00474487|469145685|FG002|Overall Study|Withdrawal by Subject|0|||
130321187|NCT00474487|469145686|FG003|Overall Study|Withdrawal by Subject|0|||
130321188|NCT00474487|469145683|FG000|Overall Study|Lost to Follow-up|20|||
130321189|NCT00474487|469145684|FG001|Overall Study|Lost to Follow-up|1|||
130321190|NCT00474487|469145685|FG002|Overall Study|Lost to Follow-up|7|||
129876830|NCT02277743|467509216|FG001|Overall Study|Lack of Efficacy|4|||
130321191|NCT00474487|469145686|FG003|Overall Study|Lost to Follow-up|0|||
130321192|NCT00474487|469145683|FG000|Overall Study|Inappropriate enrollment|4|||
130321193|NCT00474487|469145684|FG001|Overall Study|Inappropriate enrollment|0|||
130321194|NCT00474487|469145685|FG002|Overall Study|Inappropriate enrollment|7|||
130321195|NCT00474487|469145686|FG003|Overall Study|Inappropriate enrollment|0|||
130321196|NCT00474487|469145683|FG000|Overall Study|Death|0|||
130321197|NCT00474487|469145684|FG001|Overall Study|Death|1|||
130321198|NCT00474487|469145685|FG002|Overall Study|Death|0|||
130321199|NCT00474487|469145686|FG003|Overall Study|Death|0|||
130321200|NCT01428258|469145687|FG000|Intervention 1|Withdrawal by Subject|2|||
130321201|NCT01428258|469145688|FG001|Intervention 1|Withdrawal by Subject|0|||
130321202|NCT02766023|469145689|FG000|Overall Study|Lost to Follow-up|23|||
130321203|NCT02766023|469145690|FG001|Overall Study|Lost to Follow-up|11|||
130321204|NCT02766023|469145689|FG000|Overall Study|Pregnancy|1|||
130321205|NCT02766023|469145690|FG001|Overall Study|Pregnancy|0|||
130321206|NCT02766023|469145689|FG000|Overall Study|Adverse Event|1|||
130321207|NCT02766023|469145690|FG001|Overall Study|Adverse Event|0|||
130321208|NCT02766023|469145689|FG000|Overall Study|Withdrawal by Subject|4|||
130321209|NCT02766023|469145690|FG001|Overall Study|Withdrawal by Subject|5|||
130321210|NCT02766023|469145689|FG000|Overall Study|Physician Decision|1|||
130321211|NCT02766023|469145690|FG001|Overall Study|Physician Decision|0|||
130321212|NCT02766023|469145689|FG000|Overall Study|Not Eligible at Enrollment|0|||
130321213|NCT02766023|469145690|FG001|Overall Study|Not Eligible at Enrollment|1|||
130321214|NCT01488045|469145691|FG000|Overall Study|Withdrawal by Subject|6|||
130321215|NCT01488045|469145692|FG001|Overall Study|Withdrawal by Subject|11|||
130321216|NCT01488045|469145691|FG000|Overall Study|Failure to present for colonoscopy|3|||
130321217|NCT01488045|469145692|FG001|Overall Study|Failure to present for colonoscopy|6|||
130321218|NCT01488045|469145691|FG000|Overall Study|Failure to report exclusion criteria|0|||
130321219|NCT01488045|469145692|FG001|Overall Study|Failure to report exclusion criteria|1|||
130321220|NCT05365217|469145694|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130321221|NCT05365217|469145695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130321222|NCT00656513|469145699|FG000|Overall Study|Protocol Violation|1|||
130321223|NCT00656513|469145700|FG001|Overall Study|Protocol Violation|0|||
130321224|NCT00656513|469145701|FG002|Overall Study|Protocol Violation|2|||
130321225|NCT00656513|469145699|FG000|Overall Study|Withdrawal by Subject|0|||
130321226|NCT00656513|469145700|FG001|Overall Study|Withdrawal by Subject|11|||
130321227|NCT00656513|469145701|FG002|Overall Study|Withdrawal by Subject|4|||
130321228|NCT00656513|469145699|FG000|Overall Study|Death|0|||
130321229|NCT00656513|469145700|FG001|Overall Study|Death|0|||
130321230|NCT00656513|469145701|FG002|Overall Study|Death|1|||
130321231|NCT00656513|469145699|FG000|Overall Study|Missing data|0|||
130321232|NCT00656513|469145700|FG001|Overall Study|Missing data|11|||
130321233|NCT00656513|469145701|FG002|Overall Study|Missing data|9|||
130321234|NCT00656513|469145699|FG000|Overall Study|Incomplete treatment|3|||
130321235|NCT00656513|469145700|FG001|Overall Study|Incomplete treatment|0|||
130321236|NCT00656513|469145701|FG002|Overall Study|Incomplete treatment|0|||
130321237|NCT00656513|469145699|FG000|Overall Study|Treatment completed outside of timeframe|0|||
130321238|NCT00656513|469145700|FG001|Overall Study|Treatment completed outside of timeframe|3|||
130321239|NCT00656513|469145701|FG002|Overall Study|Treatment completed outside of timeframe|1|||
130321240|NCT00656513|469145699|FG000|Overall Study|Missing baseline form|0|||
130321241|NCT00656513|469145700|FG001|Overall Study|Missing baseline form|5|||
130321242|NCT00656513|469145701|FG002|Overall Study|Missing baseline form|5|||
130321243|NCT03405792|469145702|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
130321244|NCT03405792|469145703|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
130321245|NCT03405792|469145702|FG000|Overall Study|o Did not receive pembrolizumab|1|||
130321246|NCT03405792|469145703|FG001|Overall Study|o Did not receive pembrolizumab|0|||
130321247|NCT03962491|469145704|FG000|Overall Study|Lost to Follow-up|4|||
130321248|NCT03962491|469145705|FG001|Overall Study|Lost to Follow-up|5|||
130321249|NCT03882021|469145708|FG000|Enrollment|Procedure aborted/cancelled|2|||
130321250|NCT03882021|469145708|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
130321251|NCT03882021|469145708|FG000|Enrollment to 3-Month|Death|1|||
130321252|NCT03882021|469145708|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
130321253|NCT03882021|469145708|FG000|Enrollment to 3-Month|Missed Visit|4|||
130321254|NCT03882021|469145708|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
130321255|NCT03882021|469145708|FG000|6-Month to 12-Month Visit|Death|1|||
129876831|NCT02277743|467509217|FG002|Overall Study|Lack of Efficacy|3|||
130321256|NCT03882021|469145708|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
130321257|NCT03796728|469145712|FG000|Overall Study|Lost to Follow-up|8|||
130321258|NCT03796728|469145712|FG000|Overall Study|Reason not Specified|16|||
130321259|NCT00333775|469145713|FG000|Overall Study|Death|144|||
130321260|NCT00333775|469145714|FG001|Overall Study|Death|149|||
130321261|NCT00333775|469145715|FG002|Overall Study|Death|143|||
130321262|NCT00333775|469145713|FG000|Overall Study|In Follow-up When Study Stopped|87|||
130321263|NCT00333775|469145714|FG001|Overall Study|In Follow-up When Study Stopped|92|||
130321264|NCT00333775|469145715|FG002|Overall Study|In Follow-up When Study Stopped|96|||
130321265|NCT00333775|469145713|FG000|Overall Study|Lost to Follow-up|10|||
130321266|NCT00333775|469145714|FG001|Overall Study|Lost to Follow-up|7|||
130321267|NCT00333775|469145715|FG002|Overall Study|Lost to Follow-up|8|||
130321268|NCT02476617|469145719|FG000|Overall Study|Adverse Event|1|||
130321269|NCT02476617|469145719|FG000|Overall Study|Lost to Follow-up|1|||
130321270|NCT03486912|469145720|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130321271|NCT03486912|469145721|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
130321272|NCT03486912|469145722|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130321273|NCT03486912|469145723|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
130321274|NCT03486912|469145720|FG000|Treatment Period|Withdrawal by Subject|3|||
130321275|NCT03486912|469145721|FG001|Treatment Period|Withdrawal by Subject|3|||
130321276|NCT03486912|469145722|FG002|Treatment Period|Withdrawal by Subject|3|||
130321277|NCT03486912|469145723|FG003|Treatment Period|Withdrawal by Subject|2|||
130321278|NCT03486912|469145720|FG000|Treatment Period|Other Reasons|0|||
130321279|NCT03486912|469145721|FG001|Treatment Period|Other Reasons|2|||
130321280|NCT03486912|469145722|FG002|Treatment Period|Other Reasons|1|||
130321281|NCT03486912|469145723|FG003|Treatment Period|Other Reasons|1|||
130321282|NCT03486912|469145720|FG000|Treatment Period|Adverse Event|0|||
130321283|NCT03486912|469145721|FG001|Treatment Period|Adverse Event|1|||
130321284|NCT03486912|469145722|FG002|Treatment Period|Adverse Event|1|||
130321285|NCT03486912|469145723|FG003|Treatment Period|Adverse Event|0|||
130321286|NCT03486912|469145720|FG000|Treatment Period|Lost to Follow-up|1|||
130321287|NCT03486912|469145721|FG001|Treatment Period|Lost to Follow-up|0|||
130321288|NCT03486912|469145722|FG002|Treatment Period|Lost to Follow-up|0|||
130321289|NCT03486912|469145723|FG003|Treatment Period|Lost to Follow-up|2|||
130321290|NCT02491684|469145724|FG000|Treatment Phase|Adverse Event|2|||
130321291|NCT02491684|469145725|FG001|Treatment Phase|Adverse Event|2|||
130321292|NCT02491684|469145724|FG000|Treatment Phase|Incorrect randomisation|1|||
130321293|NCT02491684|469145725|FG001|Treatment Phase|Incorrect randomisation|0|||
130321294|NCT02491684|469145724|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
130321295|NCT02491684|469145725|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
130321296|NCT01263769|469145728|FG000|Overall Study|Non-Compliant with treatment|1|||
130321297|NCT04842747|469145733|FG000|Overall Study|Withdrawal by Subject|6|||
130321298|NCT04842747|469145734|FG001|Overall Study|Withdrawal by Subject|2|||
130321299|NCT04842747|469145733|FG000|Overall Study|Lost to Follow-up|1|||
130321300|NCT04842747|469145734|FG001|Overall Study|Lost to Follow-up|2|||
130321301|NCT04842747|469145733|FG000|Overall Study|Physician Decision|1|||
130321302|NCT04842747|469145734|FG001|Overall Study|Physician Decision|0|||
130321303|NCT04842747|469145733|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
130321304|NCT04842747|469145734|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
130321305|NCT02559622|469145735|FG000|Overall Study|Progressive disease|0|||
130321306|NCT02559622|469145736|FG001|Overall Study|Progressive disease|1|||
130321307|NCT02559622|469145737|FG002|Overall Study|Progressive disease|0|||
130321308|NCT02559622|469145738|FG003|Overall Study|Progressive disease|0|||
130321309|NCT02559622|469145735|FG000|Overall Study|Adverse Event|0|||
130321310|NCT02559622|469145736|FG001|Overall Study|Adverse Event|2|||
130321311|NCT02559622|469145737|FG002|Overall Study|Adverse Event|2|||
130321312|NCT02559622|469145738|FG003|Overall Study|Adverse Event|2|||
130321313|NCT02559622|469145735|FG000|Overall Study|Patient/guardian decision|1|||
130321314|NCT02559622|469145736|FG001|Overall Study|Patient/guardian decision|2|||
130321315|NCT02559622|469145737|FG002|Overall Study|Patient/guardian decision|0|||
130321316|NCT02559622|469145738|FG003|Overall Study|Patient/guardian decision|1|||
130321317|NCT04011540|469145744|FG000|Overall Study|Lost to Follow-up|9|||
130321318|NCT04011540|469145745|FG001|Overall Study|Lost to Follow-up|6|||
130321319|NCT03019406|469145746|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
130321320|NCT03019406|469145747|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
130321321|NCT03019406|469145748|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
130321322|NCT03019406|469145749|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
130321323|NCT01339832|469145752|FG000|Overall Study|Lost to Follow-up|3|||
130321324|NCT01339832|469145752|FG000|Overall Study|Death|11|||
130321325|NCT00468169|469145753|FG000|Overall Study|Withdrawal by Subject|1|||
130321326|NCT00468169|469145754|FG001|Overall Study|Withdrawal by Subject|0|||
130321327|NCT00231816|469145755|FG000|Overall Study|Adverse Event|1|||
130321328|NCT00231816|469145756|FG001|Overall Study|Adverse Event|0|||
130321329|NCT00231816|469145755|FG000|Overall Study|Lost to Follow-up|8|||
129876832|NCT02277743|467509215|FG000|Overall Study|Other than specified above|18|||
129876833|NCT02277743|467509216|FG001|Overall Study|Other than specified above|5|||
129876834|NCT02277743|467509217|FG002|Overall Study|Other than specified above|16|||
129876835|NCT01224158|467509218|FG000|Overall Study|Withdrawal by Subject|1|||
130321330|NCT00231816|469145756|FG001|Overall Study|Lost to Follow-up|5|||
130321331|NCT00231816|469145755|FG000|Overall Study|Protocol Violation|2|||
130321332|NCT00231816|469145756|FG001|Overall Study|Protocol Violation|3|||
130321333|NCT00231816|469145755|FG000|Overall Study|Withdrawal by Subject|3|||
130321334|NCT00231816|469145756|FG001|Overall Study|Withdrawal by Subject|3|||
130321335|NCT00231816|469145755|FG000|Overall Study|Other|2|||
130321336|NCT00231816|469145756|FG001|Overall Study|Other|1|||
130321337|NCT01126749|469145761|FG000|Phase 1b|Other|0|||
130321338|NCT01126749|469145762|FG001|Phase 1b|Other|1|||
130321339|NCT01126749|469145763|FG002|Phase 1b|Other|0|||
130321340|NCT01126749|469145764|FG003|Phase 1b|Other|0|||
130321341|NCT01126749|469145761|FG000|Phase 1b|Withdrawal by Subject|0|||
130321342|NCT01126749|469145762|FG001|Phase 1b|Withdrawal by Subject|1|||
130321343|NCT01126749|469145763|FG002|Phase 1b|Withdrawal by Subject|0|||
130321344|NCT01126749|469145764|FG003|Phase 1b|Withdrawal by Subject|0|||
130321345|NCT01126749|469145761|FG000|Phase 1b|Death|3|||
130321346|NCT01126749|469145762|FG001|Phase 1b|Death|4|||
130321347|NCT01126749|469145763|FG002|Phase 1b|Death|0|||
130321348|NCT01126749|469145764|FG003|Phase 1b|Death|0|||
130321349|NCT01126749|469145761|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
130321350|NCT01126749|469145762|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
130321351|NCT01126749|469145763|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
130321352|NCT01126749|469145764|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
130321353|NCT01126749|469145761|FG000|Phase 2|Study Termination by Sponsor|0|||
130321354|NCT01126749|469145762|FG001|Phase 2|Study Termination by Sponsor|0|||
130321355|NCT01126749|469145763|FG002|Phase 2|Study Termination by Sponsor|12|||
130321356|NCT01126749|469145764|FG003|Phase 2|Study Termination by Sponsor|6|||
130321357|NCT01126749|469145761|FG000|Phase 2|Other|0|||
130321358|NCT01126749|469145762|FG001|Phase 2|Other|0|||
130321359|NCT01126749|469145763|FG002|Phase 2|Other|4|||
130321360|NCT01126749|469145764|FG003|Phase 2|Other|2|||
130321361|NCT01126749|469145761|FG000|Phase 2|Withdrawal by Subject|0|||
130321362|NCT01126749|469145762|FG001|Phase 2|Withdrawal by Subject|0|||
130321363|NCT01126749|469145763|FG002|Phase 2|Withdrawal by Subject|0|||
130321364|NCT01126749|469145764|FG003|Phase 2|Withdrawal by Subject|2|||
130321365|NCT01126749|469145761|FG000|Phase 2|Lost to Follow-up|0|||
130321366|NCT01126749|469145762|FG001|Phase 2|Lost to Follow-up|0|||
130321367|NCT01126749|469145763|FG002|Phase 2|Lost to Follow-up|0|||
130321368|NCT01126749|469145764|FG003|Phase 2|Lost to Follow-up|1|||
130321369|NCT01126749|469145761|FG000|Phase 2|Death|0|||
130321370|NCT01126749|469145762|FG001|Phase 2|Death|0|||
130321371|NCT01126749|469145763|FG002|Phase 2|Death|22|||
130321372|NCT01126749|469145764|FG003|Phase 2|Death|22|||
130321373|NCT01126749|469145761|FG000|Phase 2|Adverse Event|0|||
130321374|NCT01126749|469145762|FG001|Phase 2|Adverse Event|0|||
130321375|NCT01126749|469145763|FG002|Phase 2|Adverse Event|0|||
130321376|NCT01126749|469145764|FG003|Phase 2|Adverse Event|1|||
130321377|NCT02183675|469145766|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321378|NCT02183675|469145767|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321379|NCT02183675|469145768|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321380|NCT02183675|469145769|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321381|NCT02183675|469145770|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
130321382|NCT02183675|469145771|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
130321383|NCT01614249|469145776|FG000|Overall Study|Lost to Follow-up|11|||
130321384|NCT01614249|469145777|FG001|Overall Study|Lost to Follow-up|23|||
130321385|NCT05498649|469145778|FG000|Overall Study|Lost to Follow-up|1|||
130321386|NCT02946580|469145782|FG000|Overall Study|Withdrawal by Subject|1|||
130321387|NCT02946580|469145783|FG001|Overall Study|Withdrawal by Subject|2|||
130321388|NCT02946580|469145782|FG000|Overall Study|Adverse Event|0|||
130321389|NCT02946580|469145783|FG001|Overall Study|Adverse Event|2|||
130321390|NCT02946580|469145782|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
130321391|NCT02946580|469145783|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
130321392|NCT02761330|469145784|FG000|Treatment Week 1|Withdrawal by Subject|0|||
130321393|NCT02761330|469145785|FG001|Treatment Week 1|Withdrawal by Subject|0|||
130321394|NCT02761330|469145786|FG002|Treatment Week 1|Withdrawal by Subject|0|||
130321395|NCT02761330|469145787|FG003|Treatment Week 1|Withdrawal by Subject|1|||
130321396|NCT02761330|469145788|FG004|Treatment Week 1|Withdrawal by Subject|0|||
130321397|NCT02761330|469145789|FG005|Treatment Week 1|Withdrawal by Subject|1|||
130321398|NCT03043313|469145792|FG000|Overall Study|Withdrawal by Subject|5|||
130321399|NCT03043313|469145793|FG001|Overall Study|Withdrawal by Subject|1|||
130321400|NCT03043313|469145794|FG002|Overall Study|Withdrawal by Subject|1|||
130321401|NCT03043313|469145792|FG000|Overall Study|Lost to Follow-up|1|||
130321402|NCT03043313|469145793|FG001|Overall Study|Lost to Follow-up|1|||
130321403|NCT03043313|469145794|FG002|Overall Study|Lost to Follow-up|0|||
130321404|NCT03043313|469145792|FG000|Overall Study|Death|28|||
130321405|NCT03043313|469145793|FG001|Overall Study|Death|26|||
130321406|NCT03043313|469145794|FG002|Overall Study|Death|17|||
130321407|NCT03043313|469145792|FG000|Overall Study|Participation terminated by sponsor|11|||
130321408|NCT03043313|469145793|FG001|Overall Study|Participation terminated by sponsor|13|||
130321409|NCT03043313|469145794|FG002|Overall Study|Participation terminated by sponsor|13|||
130321410|NCT00980954|469145795|FG000|Overall Study|Protocol Violation|9|||
130321411|NCT00980954|469145796|FG001|Overall Study|Protocol Violation|15|||
130321412|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
130321413|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
130321414|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
130321415|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
130321416|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
130321417|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130321418|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130321419|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
130321420|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130321421|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
130321422|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130321423|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
130321424|NCT02657889|469145797|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130321425|NCT02657889|469145798|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
130321426|NCT02657889|469145799|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130321427|NCT02657889|469145800|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
130321428|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
130321429|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
130321430|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
130321431|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
130321432|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
130321433|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
130321434|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
130321435|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
130321436|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
130321437|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
130321438|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
130321439|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
130321440|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
130321441|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
130321442|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
130321443|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
129876836|NCT01224158|467509219|FG001|Overall Study|Withdrawal by Subject|0|||
129876837|NCT02055157|467509220|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
129876838|NCT02055157|467509221|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
129876839|NCT02055157|467509222|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
129876840|NCT02055157|467509223|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
129876841|NCT02055157|467509220|FG000|Initial 6 Months|Adverse Event|0|||
129876842|NCT02055157|467509221|FG001|Initial 6 Months|Adverse Event|0|||
129876843|NCT02055157|467509222|FG002|Initial 6 Months|Adverse Event|0|||
129876844|NCT02055157|467509223|FG003|Initial 6 Months|Adverse Event|1|||
129876845|NCT02055157|467509220|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
129876846|NCT02055157|467509221|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
129876847|NCT02055157|467509222|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
129876848|NCT02055157|467509223|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
129876849|NCT02055157|467509220|FG000|18-month Extension|Investigator decision|0|||
130098653|NCT03586427|468319263|FG000|Overall Study|Noncompliance with study drug|0|||
130098654|NCT03586427|468319264|FG001|Overall Study|Noncompliance with study drug|0|||
130098655|NCT03586427|468319265|FG002|Overall Study|Noncompliance with study drug|1|||
130098656|NCT03586427|468319266|FG003|Overall Study|Noncompliance with study drug|0|||
130098657|NCT03586427|468319267|FG004|Overall Study|Noncompliance with study drug|0|||
130098658|NCT00494234|468319268|FG000|Overall Study|Withdrawal by Subject|1|||
130098659|NCT00494234|468319269|FG001|Overall Study|Withdrawal by Subject|0|||
130098660|NCT00494234|468319268|FG000|Overall Study|Disease progression|11|||
130098661|NCT00494234|468319269|FG001|Overall Study|Disease progression|8|||
130098662|NCT00494234|468319268|FG000|Overall Study|Death|2|||
130098663|NCT00494234|468319269|FG001|Overall Study|Death|1|||
130098664|NCT03193996|468319270|FG000|Overall Study|Withdrawal by Subject|4|||
130098665|NCT03193996|468319270|FG000|Overall Study|Lost to Follow-up|4|||
130098666|NCT03193996|468319270|FG000|Overall Study|Physician Decision|2|||
130098667|NCT03193996|468319270|FG000|Overall Study|Pregnancy|1|||
130098668|NCT03193996|468319270|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
130098669|NCT03193996|468319270|FG000|Overall Study|Complicating disease|1|||
130098670|NCT00423137|468319271|FG000|Overall Study|Lost to Follow-up|0|||
130098671|NCT00423137|468319272|FG001|Overall Study|Lost to Follow-up|0|||
130098672|NCT00423137|468319273|FG002|Overall Study|Lost to Follow-up|1|||
130098673|NCT00423137|468319274|FG003|Overall Study|Lost to Follow-up|0|||
130098674|NCT00423137|468319271|FG000|Overall Study|Protocol Violation|0|||
130098675|NCT00423137|468319272|FG001|Overall Study|Protocol Violation|0|||
130098676|NCT00423137|468319273|FG002|Overall Study|Protocol Violation|0|||
130098677|NCT00423137|468319274|FG003|Overall Study|Protocol Violation|1|||
130098678|NCT00423137|468319271|FG000|Overall Study|Adverse Event Study disease worse|1|||
130098679|NCT00423137|468319272|FG001|Overall Study|Adverse Event Study disease worse|0|||
130098680|NCT00423137|468319273|FG002|Overall Study|Adverse Event Study disease worse|3|||
130098681|NCT00423137|468319274|FG003|Overall Study|Adverse Event Study disease worse|1|||
130098682|NCT00423137|468319271|FG000|Overall Study|Adverse Event Other|0|||
130321444|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
130321445|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
130321446|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
130321447|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
130321448|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130321449|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130321450|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
130321451|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
130321452|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
130321453|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
130321454|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
130321455|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
130321456|NCT02657889|469145797|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130321457|NCT02657889|469145798|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130321458|NCT02657889|469145799|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
130321459|NCT02657889|469145800|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
130321460|NCT01576341|469145801|FG000|Overall Study|Withdrawal by Subject|24|||
130321461|NCT01576341|469145801|FG000|Overall Study|Adverse Event|10|||
130321462|NCT01576341|469145801|FG000|Overall Study|Death|21|||
130321463|NCT01576341|469145801|FG000|Overall Study|Physician Decision|2|||
130321464|NCT01576341|469145801|FG000|Overall Study|Lost to Follow-up|2|||
130321465|NCT01576341|469145801|FG000|Overall Study|Kidney transplantation|10|||
130321466|NCT01576341|469145801|FG000|Overall Study|Protocol Violation|12|||
130321467|NCT01576341|469145801|FG000|Overall Study|Other|12|||
130321468|NCT03341299|469145802|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130321469|NCT03341299|469145803|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130321470|NCT03341299|469145804|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
130321471|NCT03341299|469145805|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
130321472|NCT00791934|469145807|FG000|Overall Study|Withdrawal by Subject|2|||
130321473|NCT00791934|469145807|FG000|Overall Study|Did not consent for extended follow-up|13|||
130321474|NCT02018562|469145809|FG000|Overall Study|Withdrawal by Subject|2|||
130321475|NCT02018562|469145810|FG001|Overall Study|Withdrawal by Subject|0|||
130321476|NCT02018562|469145809|FG000|Overall Study|Discharged prior to study completion|1|||
130321477|NCT02018562|469145810|FG001|Overall Study|Discharged prior to study completion|0|||
130321478|NCT05194124|469145811|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321479|NCT05194124|469145812|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321480|NCT05194124|469145813|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321481|NCT05194124|469145814|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
130321482|NCT05194124|469145815|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321483|NCT05194124|469145816|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
130321484|NCT05194124|469145817|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321485|NCT05194124|469145818|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321486|NCT05194124|469145819|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321487|NCT05194124|469145820|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
130321488|NCT05194124|469145811|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321489|NCT05194124|469145812|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321490|NCT05194124|469145813|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321491|NCT05194124|469145814|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321492|NCT05194124|469145815|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321493|NCT05194124|469145816|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321494|NCT05194124|469145817|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321495|NCT05194124|469145818|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321496|NCT05194124|469145819|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
130321497|NCT05194124|469145820|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
130321498|NCT03642873|469145821|FG000|Third Intervention (1 Day)|Screen failure|0|||
130321499|NCT03642873|469145822|FG001|Third Intervention (1 Day)|Screen failure|0|||
130321500|NCT03642873|469145823|FG002|Third Intervention (1 Day)|Screen failure|0|||
130321501|NCT03642873|469145824|FG003|Third Intervention (1 Day)|Screen failure|0|||
130321502|NCT03642873|469145825|FG004|Third Intervention (1 Day)|Screen failure|1|||
130321503|NCT03642873|469145826|FG005|Third Intervention (1 Day)|Screen failure|0|||
129876850|NCT02055157|467509221|FG001|18-month Extension|Investigator decision|1|||
129876851|NCT02055157|467509222|FG002|18-month Extension|Investigator decision|0|||
129876852|NCT02055157|467509223|FG003|18-month Extension|Investigator decision|0|||
129876853|NCT02055157|467509220|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
129876854|NCT02055157|467509221|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
130098683|NCT00423137|468319272|FG001|Overall Study|Adverse Event Other|0|||
130321504|NCT03589859|469145833|FG000|Overall Study|Withdrawal by Subject|0|||
130321505|NCT03589859|469145834|FG001|Overall Study|Withdrawal by Subject|6|||
130321506|NCT03253393|469145839|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
130321507|NCT03253393|469145840|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
130321508|NCT03253393|469145841|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
130321509|NCT00248625|469147507|FG000|Overall Study|Withdrawal by Subject|0|||
130321510|NCT00248625|469147508|FG001|Overall Study|Withdrawal by Subject|2|||
130321511|NCT02443688|469147511|FG000|Overall Study|Adverse Event|2|||
130321512|NCT02443688|469147512|FG001|Overall Study|Adverse Event|3|||
130321513|NCT02443688|469147513|FG002|Overall Study|Adverse Event|2|||
130321514|NCT02443688|469147511|FG000|Overall Study|Lost to Follow-up|1|||
130321515|NCT02443688|469147512|FG001|Overall Study|Lost to Follow-up|0|||
130321516|NCT02443688|469147513|FG002|Overall Study|Lost to Follow-up|0|||
130321517|NCT02443688|469147511|FG000|Overall Study|Physician Decision|3|||
130321518|NCT02443688|469147512|FG001|Overall Study|Physician Decision|0|||
130321519|NCT02443688|469147513|FG002|Overall Study|Physician Decision|1|||
130321520|NCT02443688|469147511|FG000|Overall Study|Pregnancy|0|||
130321521|NCT02443688|469147512|FG001|Overall Study|Pregnancy|0|||
130321522|NCT02443688|469147513|FG002|Overall Study|Pregnancy|1|||
130321523|NCT02443688|469147511|FG000|Overall Study|Withdrawal by Subject|3|||
130321524|NCT02443688|469147512|FG001|Overall Study|Withdrawal by Subject|3|||
130321525|NCT02443688|469147513|FG002|Overall Study|Withdrawal by Subject|4|||
130213806|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130213807|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
130213808|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
130213809|NCT02087943|468746906|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130213810|NCT02087943|468746907|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130213811|NCT02087943|468746908|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
130213812|NCT02087943|468746909|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
130213813|NCT02087943|468746910|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
130213814|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
130213815|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
130213816|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
130213817|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130213818|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130213819|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
130213820|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
130213821|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213822|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213823|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213824|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213825|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130213826|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
130213827|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
130213828|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130213829|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130213830|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130213831|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130321526|NCT02443688|469147511|FG000|Overall Study|Non-compliance with study drug|1|||
130321527|NCT02443688|469147512|FG001|Overall Study|Non-compliance with study drug|2|||
130321528|NCT02443688|469147513|FG002|Overall Study|Non-compliance with study drug|4|||
130321529|NCT02443688|469147511|FG000|Overall Study|Sponsor Request|2|||
130321530|NCT02443688|469147512|FG001|Overall Study|Sponsor Request|1|||
130321531|NCT02443688|469147513|FG002|Overall Study|Sponsor Request|0|||
130321532|NCT03182374|469147514|FG000|Overall Study|Lost to Follow-up|3|||
130321533|NCT03182374|469147515|FG001|Overall Study|Lost to Follow-up|2|||
130321534|NCT03182374|469147514|FG000|Overall Study|Lack of Efficacy|8|||
130321535|NCT03182374|469147515|FG001|Overall Study|Lack of Efficacy|14|||
130321536|NCT03182374|469147514|FG000|Overall Study|Withdrawal by Subject|1|||
130321537|NCT03182374|469147515|FG001|Overall Study|Withdrawal by Subject|1|||
130321538|NCT03182374|469147514|FG000|Overall Study|exit for non-compliance|1|||
130321539|NCT03182374|469147515|FG001|Overall Study|exit for non-compliance|1|||
129876855|NCT02055157|467509222|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
129876856|NCT02055157|467509223|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
129876857|NCT03976466|467509224|FG000|Overall Study|Lost to Follow-up|1|||
129876858|NCT03976466|467509225|FG001|Overall Study|Lost to Follow-up|3|||
129876859|NCT00733499|467509230|FG000|Pre-operative|Protocol Violation|0|||
129876860|NCT00733499|467509231|FG001|Pre-operative|Protocol Violation|1|||
129876861|NCT00733499|467509230|FG000|3 Months Follow-up|Death|1|||
129876862|NCT00733499|467509231|FG001|3 Months Follow-up|Death|2|||
129876863|NCT00733499|467509230|FG000|6 Months Follow-up|Death|0|||
129876864|NCT00733499|467509231|FG001|6 Months Follow-up|Death|2|||
129876865|NCT00733499|467509230|FG000|6 Months Follow-up|Adverse Event|0|||
129876866|NCT00733499|467509231|FG001|6 Months Follow-up|Adverse Event|1|||
129876867|NCT00733499|467509230|FG000|12 Months Follow-up|Death|2|||
129876868|NCT00733499|467509231|FG001|12 Months Follow-up|Death|1|||
129876869|NCT00733499|467509230|FG000|24 Months Follow-up|Death|0|||
129876870|NCT00733499|467509231|FG001|24 Months Follow-up|Death|1|||
129876871|NCT00733499|467509230|FG000|5 Year Followup|Adverse Event|2|||
129876872|NCT00733499|467509231|FG001|5 Year Followup|Adverse Event|2|||
129876873|NCT00733499|467509230|FG000|5 Year Followup|Non device related AE|0|||
129876874|NCT00733499|467509231|FG001|5 Year Followup|Non device related AE|1|||
129876875|NCT00733499|467509230|FG000|5 Year Followup|Revision of Study Implant|0|||
129876876|NCT00733499|467509231|FG001|5 Year Followup|Revision of Study Implant|1|||
129876877|NCT00733499|467509230|FG000|5 Year Followup|Lost to Follow-up|2|||
129876878|NCT00733499|467509231|FG001|5 Year Followup|Lost to Follow-up|0|||
129876879|NCT00733499|467509230|FG000|5 Year Followup|Death|13|||
129876880|NCT00733499|467509231|FG001|5 Year Followup|Death|19|||
129876881|NCT00733499|467509230|FG000|5 Year Followup|missing, unable to locate|0|||
129876882|NCT00733499|467509231|FG001|5 Year Followup|missing, unable to locate|1|||
129876883|NCT00733499|467509230|FG000|5 Year Followup|Withdrawal by Subject|4|||
129876884|NCT00733499|467509231|FG001|5 Year Followup|Withdrawal by Subject|1|||
129876885|NCT00733499|467509230|FG000|10 Year Followup|Death|9|||
129876886|NCT00733499|467509231|FG001|10 Year Followup|Death|7|||
129876887|NCT00733499|467509230|FG000|10 Year Followup|Adverse Event|3|||
129876888|NCT00733499|467509231|FG001|10 Year Followup|Adverse Event|3|||
129876889|NCT00733499|467509230|FG000|10 Year Followup|Lost to Follow-up|3|||
129876890|NCT00733499|467509231|FG001|10 Year Followup|Lost to Follow-up|2|||
129876891|NCT00733499|467509230|FG000|10 Year Followup|Withdrawal by Subject|5|||
129876892|NCT00733499|467509231|FG001|10 Year Followup|Withdrawal by Subject|5|||
129876893|NCT00733499|467509230|FG000|10 Year Followup|missing, unable to locate|0|||
129876894|NCT00733499|467509231|FG001|10 Year Followup|missing, unable to locate|2|||
129876895|NCT02739347|467509232|FG000|Overall Study|Adverse Event|3|||
129876896|NCT02739347|467509233|FG001|Overall Study|Adverse Event|0|||
129876897|NCT02739347|467509232|FG000|Overall Study|Protocol Violation|0|||
129876898|NCT02739347|467509233|FG001|Overall Study|Protocol Violation|1|||
129876899|NCT02739347|467509232|FG000|Overall Study|Lost to Follow-up|0|||
129876900|NCT02739347|467509233|FG001|Overall Study|Lost to Follow-up|2|||
129876901|NCT03929562|467509234|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
129876902|NCT03929562|467509235|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
129876903|NCT03929562|467509234|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
129876904|NCT03929562|467509235|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
129876905|NCT03929562|467509234|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
129876906|NCT03929562|467509235|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
130321540|NCT03182374|469147514|FG000|Overall Study|one subject was randomized but not treated|1|||
130321541|NCT03182374|469147515|FG001|Overall Study|one subject was randomized but not treated|0|||
130321542|NCT03182374|469147514|FG000|Overall Study|Other reasons|0|||
130321543|NCT03182374|469147515|FG001|Overall Study|Other reasons|3|||
129876907|NCT01778556|467509236|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
129876908|NCT01778556|467509237|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
129876909|NCT01778556|467509236|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129876910|NCT01778556|467509237|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
129876911|NCT01778556|467509236|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
129876912|NCT01778556|467509237|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
129876913|NCT01778556|467509236|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
129876914|NCT01778556|467509237|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
129876915|NCT01235403|467509241|FG000|Overall Study|Adverse Event|14|||
130321544|NCT03085095|469147516|FG000|Overall Study|Adverse Event|23|||
129876916|NCT01235403|467509241|FG000|Overall Study|Lost to Follow-up|2|||
129876917|NCT01235403|467509241|FG000|Overall Study|Withdrawal by Subject|4|||
129876918|NCT01235403|467509241|FG000|Overall Study|Lack of Efficacy|2|||
129876919|NCT01235403|467509241|FG000|Overall Study|Other reasons for premature termination|4|||
129876920|NCT02296190|467509242|FG000|Overall Study|Lost to Follow-up|0|||
129876921|NCT02296190|467509243|FG001|Overall Study|Lost to Follow-up|0|||
129876922|NCT02296190|467509244|FG002|Overall Study|Lost to Follow-up|0|||
129876923|NCT02296190|467509245|FG003|Overall Study|Lost to Follow-up|0|||
130321545|NCT03085095|469147517|FG001|Overall Study|Adverse Event|8|||
130321546|NCT03085095|469147516|FG000|Overall Study|Protocol Violation|0|||
130321547|NCT03085095|469147517|FG001|Overall Study|Protocol Violation|1|||
130321548|NCT03085095|469147516|FG000|Overall Study|Lost to Follow-up|2|||
130321549|NCT03085095|469147517|FG001|Overall Study|Lost to Follow-up|1|||
130321550|NCT03085095|469147516|FG000|Overall Study|Withdrawal by Subject|17|||
130321551|NCT03085095|469147517|FG001|Overall Study|Withdrawal by Subject|6|||
130321552|NCT03085095|469147516|FG000|Overall Study|Physician Decision|9|||
130321553|NCT03085095|469147517|FG001|Overall Study|Physician Decision|3|||
130321554|NCT03085095|469147516|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
130321555|NCT03085095|469147517|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
130321556|NCT03085095|469147516|FG000|Overall Study|Did not Receive Study Drug|2|||
130321557|NCT03085095|469147517|FG001|Overall Study|Did not Receive Study Drug|2|||
130321558|NCT03085095|469147516|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
130321559|NCT03085095|469147517|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
130321560|NCT00408317|469147518|FG000|First Intervention Period|Adverse Event|0|||
130321561|NCT00408317|469147519|FG001|First Intervention Period|Adverse Event|1|||
130321562|NCT00408317|469147518|FG000|Second Intervention Period|Adverse Event|2|||
130321563|NCT00408317|469147519|FG001|Second Intervention Period|Adverse Event|0|||
130321564|NCT00408317|469147518|FG000|Second Intervention Period|Protocol Violation|0|||
130321565|NCT00408317|469147519|FG001|Second Intervention Period|Protocol Violation|1|||
130321566|NCT00408317|469147518|FG000|Second Intervention Period|Withdrawal of consent|0|||
130321567|NCT00408317|469147519|FG001|Second Intervention Period|Withdrawal of consent|1|||
130321568|NCT03822117|469147520|FG000|Overall Study|Death|18|||
130321569|NCT03822117|469147521|FG001|Overall Study|Death|17|||
130321570|NCT03822117|469147522|FG002|Overall Study|Death|12|||
130321571|NCT03822117|469147523|FG003|Overall Study|Death|4|||
130321572|NCT03822117|469147520|FG000|Overall Study|Lost to Follow-up|1|||
130321573|NCT03822117|469147521|FG001|Overall Study|Lost to Follow-up|2|||
130321574|NCT03822117|469147522|FG002|Overall Study|Lost to Follow-up|3|||
130321575|NCT03822117|469147523|FG003|Overall Study|Lost to Follow-up|0|||
130321576|NCT03822117|469147520|FG000|Overall Study|Study Terminated by Sponsor|25|||
130321577|NCT03822117|469147521|FG001|Overall Study|Study Terminated by Sponsor|11|||
130321578|NCT03822117|469147522|FG002|Overall Study|Study Terminated by Sponsor|6|||
130321579|NCT03822117|469147523|FG003|Overall Study|Study Terminated by Sponsor|0|||
130321580|NCT03822117|469147520|FG000|Overall Study|Withdrawal by Subject|4|||
130321581|NCT03822117|469147521|FG001|Overall Study|Withdrawal by Subject|0|||
130321582|NCT03822117|469147522|FG002|Overall Study|Withdrawal by Subject|3|||
130321583|NCT03822117|469147523|FG003|Overall Study|Withdrawal by Subject|0|||
130321584|NCT03822117|469147520|FG000|Overall Study|Disease Progression|1|||
130321585|NCT03822117|469147521|FG001|Overall Study|Disease Progression|2|||
130321586|NCT03822117|469147522|FG002|Overall Study|Disease Progression|1|||
130321587|NCT03822117|469147523|FG003|Overall Study|Disease Progression|0|||
130321588|NCT03822117|469147520|FG000|Overall Study|Never Returned to Hospital|0|||
130321589|NCT03822117|469147521|FG001|Overall Study|Never Returned to Hospital|0|||
130321590|NCT03822117|469147522|FG002|Overall Study|Never Returned to Hospital|1|||
130321591|NCT03822117|469147523|FG003|Overall Study|Never Returned to Hospital|0|||
130321592|NCT01074502|469147524|FG000|Overall Study|Withdrawal by Subject|1|||
130321593|NCT03198715|469147525|FG000|Overall Study|Death|0|||
130321594|NCT03198715|469147526|FG001|Overall Study|Death|0|||
130321595|NCT03198715|469147527|FG002|Overall Study|Death|1|||
130321596|NCT03198715|469147528|FG003|Overall Study|Death|0|||
130321597|NCT03198715|469147529|FG004|Overall Study|Death|2|||
130321598|NCT03198715|469147525|FG000|Overall Study|Other|0|||
130321599|NCT03198715|469147526|FG001|Overall Study|Other|1|||
130321600|NCT03198715|469147527|FG002|Overall Study|Other|1|||
130321601|NCT03198715|469147528|FG003|Overall Study|Other|0|||
129876924|NCT02296190|467509246|FG004|Overall Study|Lost to Follow-up|1|||
130321602|NCT03198715|469147529|FG004|Overall Study|Other|0|||
130321603|NCT00616759|469147530|FG000|Overall Study|Physician Decision|2|||
130321604|NCT00616759|469147531|FG001|Overall Study|Physician Decision|0|||
130321605|NCT00616759|469147530|FG000|Overall Study|Withdrawal by Subject|1|||
130321606|NCT00616759|469147531|FG001|Overall Study|Withdrawal by Subject|2|||
130321607|NCT00726063|469147535|FG000|Overall Study|Adverse Event|9|||
130321608|NCT00726063|469147536|FG001|Overall Study|Adverse Event|7|||
130321609|NCT02007096|469147537|FG000|Overall Study|medication not available|2|||
130321610|NCT02007096|469147538|FG001|Overall Study|medication not available|0|||
130321611|NCT02007096|469147537|FG000|Overall Study|did not inject saline|0|||
130321612|NCT02007096|469147538|FG001|Overall Study|did not inject saline|3|||
129876925|NCT02296190|467509247|FG005|Overall Study|Lost to Follow-up|0|||
130321613|NCT02007096|469147537|FG000|Overall Study|did not follow postoperative protocol|8|||
130321614|NCT02007096|469147538|FG001|Overall Study|did not follow postoperative protocol|11|||
130321615|NCT02007096|469147537|FG000|Overall Study|converted to open surgery|1|||
130321616|NCT02007096|469147538|FG001|Overall Study|converted to open surgery|1|||
130321617|NCT02007096|469147537|FG000|Overall Study|no mesh placed|0|||
130321618|NCT02007096|469147538|FG001|Overall Study|no mesh placed|1|||
130321619|NCT05176314|469147540|FG000|Overall Study|Lost to Follow-up|2|||
130321620|NCT05176314|469147540|FG000|Overall Study|Physician Decision|1|||
130321621|NCT05176314|469147540|FG000|Overall Study|Adverse Event|1|||
130321622|NCT01231984|469147541|FG000|Study Period 1|Withdrawal by Subject|0|||
130321623|NCT01231984|469147542|FG001|Study Period 1|Withdrawal by Subject|0|||
130321624|NCT01231984|469147543|FG002|Study Period 1|Withdrawal by Subject|0|||
130321625|NCT01231984|469147544|FG003|Study Period 1|Withdrawal by Subject|1|||
130321626|NCT01231984|469147541|FG000|Study Period 1|Lost to Follow-up|1|||
130321627|NCT01231984|469147542|FG001|Study Period 1|Lost to Follow-up|1|||
130321628|NCT01231984|469147543|FG002|Study Period 1|Lost to Follow-up|1|||
130321629|NCT01231984|469147544|FG003|Study Period 1|Lost to Follow-up|0|||
130321630|NCT01231984|469147541|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321631|NCT01231984|469147542|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321632|NCT01231984|469147543|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321633|NCT01231984|469147544|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
130321634|NCT01231984|469147541|FG000|Study Period 1|Screen Failure|0|||
130321635|NCT01231984|469147542|FG001|Study Period 1|Screen Failure|0|||
130321636|NCT01231984|469147543|FG002|Study Period 1|Screen Failure|0|||
130321637|NCT01231984|469147544|FG003|Study Period 1|Screen Failure|1|||
130321638|NCT01231984|469147541|FG000|Study Period 1|Non-compliance with study requirements|5|||
130321639|NCT01231984|469147542|FG001|Study Period 1|Non-compliance with study requirements|0|||
130321640|NCT01231984|469147543|FG002|Study Period 1|Non-compliance with study requirements|2|||
130321641|NCT01231984|469147544|FG003|Study Period 1|Non-compliance with study requirements|1|||
130321642|NCT01231984|469147541|FG000|Study Period 1|Protocol Violation|3|||
130321643|NCT01231984|469147542|FG001|Study Period 1|Protocol Violation|4|||
130321644|NCT01231984|469147543|FG002|Study Period 1|Protocol Violation|2|||
130321645|NCT01231984|469147544|FG003|Study Period 1|Protocol Violation|3|||
130321646|NCT01231984|469147541|FG000|Study Period 1|Adverse Event|1|||
130321647|NCT01231984|469147542|FG001|Study Period 1|Adverse Event|0|||
130321648|NCT01231984|469147543|FG002|Study Period 1|Adverse Event|0|||
130321649|NCT01231984|469147544|FG003|Study Period 1|Adverse Event|0|||
130321650|NCT01231984|469147541|FG000|Study Period 1|Other|0|||
130321651|NCT01231984|469147542|FG001|Study Period 1|Other|0|||
130321652|NCT01231984|469147543|FG002|Study Period 1|Other|0|||
130321653|NCT01231984|469147544|FG003|Study Period 1|Other|1|||
130321654|NCT01231984|469147541|FG000|Study Period 2|Withdrawal by Subject|1|||
130321655|NCT01231984|469147542|FG001|Study Period 2|Withdrawal by Subject|1|||
130321656|NCT01231984|469147543|FG002|Study Period 2|Withdrawal by Subject|0|||
129876926|NCT02296190|467509242|FG000|Overall Study|Failure to induce PSVT|6|||
129876927|NCT02296190|467509243|FG001|Overall Study|Failure to induce PSVT|10|||
129876928|NCT02296190|467509244|FG002|Overall Study|Failure to induce PSVT|5|||
129876929|NCT02296190|467509245|FG003|Overall Study|Failure to induce PSVT|13|||
129876930|NCT02296190|467509246|FG004|Overall Study|Failure to induce PSVT|8|||
129876931|NCT02296190|467509247|FG005|Overall Study|Failure to induce PSVT|0|||
129876932|NCT02296190|467509242|FG000|Overall Study|Physician Decision|1|||
129876933|NCT02296190|467509243|FG001|Overall Study|Physician Decision|1|||
129876934|NCT02296190|467509244|FG002|Overall Study|Physician Decision|0|||
129876935|NCT02296190|467509245|FG003|Overall Study|Physician Decision|1|||
129876936|NCT02296190|467509246|FG004|Overall Study|Physician Decision|2|||
129876937|NCT02296190|467509247|FG005|Overall Study|Physician Decision|0|||
129876938|NCT02296190|467509242|FG000|Overall Study|Withdrawal by Subject|0|||
129876939|NCT02296190|467509243|FG001|Overall Study|Withdrawal by Subject|1|||
130321657|NCT01231984|469147544|FG003|Study Period 2|Withdrawal by Subject|0|||
130321658|NCT01231984|469147541|FG000|Study Period 2|Lost to Follow-up|1|||
130321659|NCT01231984|469147542|FG001|Study Period 2|Lost to Follow-up|0|||
130321660|NCT01231984|469147543|FG002|Study Period 2|Lost to Follow-up|0|||
129876940|NCT02296190|467509244|FG002|Overall Study|Withdrawal by Subject|0|||
130321661|NCT01231984|469147544|FG003|Study Period 2|Lost to Follow-up|3|||
130321662|NCT01231984|469147541|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
130321663|NCT01231984|469147542|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
130321664|NCT01231984|469147543|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
130321665|NCT01231984|469147544|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
130321666|NCT02923726|469147549|FG000|Overall Study|Death|196|||
130321667|NCT02923726|469147550|FG001|Overall Study|Death|175|||
130321668|NCT02923726|469147549|FG000|Overall Study|Withdrawal by Subject|337|||
130321669|NCT02923726|469147550|FG001|Overall Study|Withdrawal by Subject|307|||
129876941|NCT02296190|467509245|FG003|Overall Study|Withdrawal by Subject|0|||
129876942|NCT02296190|467509246|FG004|Overall Study|Withdrawal by Subject|0|||
129876943|NCT02296190|467509247|FG005|Overall Study|Withdrawal by Subject|0|||
129876944|NCT02296190|467509242|FG000|Overall Study|PSVT < 5 minutes|5|||
130321670|NCT01680341|469147553|FG000|Overall Study|Adverse Event|3|||
130321671|NCT01680341|469147554|FG001|Overall Study|Adverse Event|2|||
130321672|NCT01680341|469147553|FG000|Overall Study|Unclassified|18|||
130321673|NCT01680341|469147554|FG001|Overall Study|Unclassified|15|||
129876945|NCT02296190|467509243|FG001|Overall Study|PSVT < 5 minutes|6|||
129876946|NCT02296190|467509244|FG002|Overall Study|PSVT < 5 minutes|6|||
129876947|NCT02296190|467509245|FG003|Overall Study|PSVT < 5 minutes|6|||
129876948|NCT02296190|467509246|FG004|Overall Study|PSVT < 5 minutes|5|||
130321674|NCT00481832|469147555|FG000|Enrollment|Physician Decision|8|||
130321675|NCT00481832|469147555|FG000|Enrollment|Unable to collect enough stem cells|2|||
130321676|NCT00481832|469147555|FG000|Inter-transplant Period|Adverse Event|4|||
130321677|NCT00481832|469147555|FG000|Inter-transplant Period|Death|3|||
130321678|NCT00481832|469147555|FG000|Inter-transplant Period|Physician Decision|4|||
130321679|NCT00481832|469147555|FG000|Inter-transplant Period|Disease relapse|11|||
130321680|NCT00481832|469147555|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
130321681|NCT02558894|469147558|FG000|Overall Study|Death; any cause, entire study duration|28|||
130321682|NCT02558894|469147559|FG001|Overall Study|Death; any cause, entire study duration|31|||
130321683|NCT02558894|469147558|FG000|Overall Study|Withdrawal by Subject|2|||
130321684|NCT02558894|469147559|FG001|Overall Study|Withdrawal by Subject|1|||
130321685|NCT02558894|469147558|FG000|Overall Study|Closure of Part A|2|||
130321686|NCT02558894|469147559|FG001|Overall Study|Closure of Part A|1|||
130321687|NCT02992288|469147560|FG000|Overall Study|Adverse Event|8|||
130321688|NCT02992288|469147561|FG001|Overall Study|Adverse Event|2|||
130321689|NCT02992288|469147562|FG002|Overall Study|Adverse Event|2|||
130321690|NCT02992288|469147563|FG003|Overall Study|Adverse Event|2|||
130321691|NCT02992288|469147564|FG004|Overall Study|Adverse Event|2|||
129876949|NCT02296190|467509247|FG005|Overall Study|PSVT < 5 minutes|0|||
129876950|NCT02296190|467509242|FG000|Overall Study|Patient was given Propofol|0|||
129876951|NCT02296190|467509243|FG001|Overall Study|Patient was given Propofol|1|||
129876952|NCT02296190|467509244|FG002|Overall Study|Patient was given Propofol|0|||
129876953|NCT02296190|467509245|FG003|Overall Study|Patient was given Propofol|1|||
129876954|NCT02296190|467509246|FG004|Overall Study|Patient was given Propofol|0|||
129876955|NCT02296190|467509247|FG005|Overall Study|Patient was given Propofol|0|||
129876956|NCT02296190|467509242|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
129876957|NCT02296190|467509243|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
129876958|NCT02296190|467509244|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
129876959|NCT02296190|467509245|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
129876960|NCT02296190|467509246|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
129876961|NCT02296190|467509247|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
129876962|NCT02296190|467509242|FG000|Overall Study|Blood pressure <100 after sedation|0|||
129876963|NCT02296190|467509243|FG001|Overall Study|Blood pressure <100 after sedation|0|||
129876964|NCT02296190|467509244|FG002|Overall Study|Blood pressure <100 after sedation|0|||
129876965|NCT02296190|467509245|FG003|Overall Study|Blood pressure <100 after sedation|1|||
129876966|NCT02296190|467509246|FG004|Overall Study|Blood pressure <100 after sedation|0|||
129876967|NCT02296190|467509247|FG005|Overall Study|Blood pressure <100 after sedation|0|||
129876968|NCT02296190|467509242|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876969|NCT02296190|467509243|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
129876970|NCT02296190|467509244|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
129876971|NCT02296190|467509245|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876972|NCT02296190|467509246|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876973|NCT02296190|467509247|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876974|NCT02296190|467509242|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
129876975|NCT02296190|467509243|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
129876976|NCT02296190|467509244|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
129876977|NCT02296190|467509245|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
129876978|NCT02296190|467509246|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
129876979|NCT02296190|467509247|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
129876980|NCT02296190|467509242|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876981|NCT02296190|467509243|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
129876982|NCT02296190|467509244|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876983|NCT02296190|467509245|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876984|NCT02296190|467509246|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876985|NCT02296190|467509247|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876986|NCT02296190|467509242|FG000|Overall Study|Lab result not available in time|1|||
130321692|NCT02992288|469147565|FG005|Overall Study|Adverse Event|7|||
129876987|NCT02296190|467509243|FG001|Overall Study|Lab result not available in time|0|||
129876988|NCT02296190|467509244|FG002|Overall Study|Lab result not available in time|0|||
130321693|NCT02992288|469147560|FG000|Overall Study|Non-compliance with study drug|0|||
130321694|NCT02992288|469147561|FG001|Overall Study|Non-compliance with study drug|1|||
130321695|NCT02992288|469147562|FG002|Overall Study|Non-compliance with study drug|1|||
129876989|NCT02296190|467509245|FG003|Overall Study|Lab result not available in time|0|||
129876990|NCT02296190|467509246|FG004|Overall Study|Lab result not available in time|0|||
129876991|NCT02296190|467509247|FG005|Overall Study|Lab result not available in time|0|||
129876992|NCT03682705|467509248|FG000|Overall Study|Adverse Event|1|||
129876993|NCT03682705|467509249|FG001|Overall Study|Adverse Event|1|||
129876994|NCT03682705|467509250|FG002|Overall Study|Adverse Event|1|||
129876995|NCT03682705|467509251|FG003|Overall Study|Adverse Event|0|||
129876996|NCT03682705|467509252|FG004|Overall Study|Adverse Event|1|||
129876997|NCT03682705|467509253|FG005|Overall Study|Adverse Event|1|||
129876998|NCT03682705|467509248|FG000|Overall Study|Withdrawal by Subject|1|||
129876999|NCT03682705|467509249|FG001|Overall Study|Withdrawal by Subject|3|||
129877000|NCT03682705|467509250|FG002|Overall Study|Withdrawal by Subject|2|||
129877001|NCT03682705|467509251|FG003|Overall Study|Withdrawal by Subject|4|||
129877002|NCT03682705|467509252|FG004|Overall Study|Withdrawal by Subject|0|||
129877003|NCT03682705|467509253|FG005|Overall Study|Withdrawal by Subject|1|||
130321696|NCT02992288|469147563|FG003|Overall Study|Non-compliance with study drug|0|||
130321697|NCT02992288|469147564|FG004|Overall Study|Non-compliance with study drug|1|||
130321698|NCT02992288|469147565|FG005|Overall Study|Non-compliance with study drug|0|||
130321699|NCT02992288|469147560|FG000|Overall Study|Physician Decision|3|||
130321700|NCT02992288|469147561|FG001|Overall Study|Physician Decision|0|||
130321701|NCT02992288|469147562|FG002|Overall Study|Physician Decision|1|||
130321702|NCT02992288|469147563|FG003|Overall Study|Physician Decision|0|||
130321703|NCT02992288|469147564|FG004|Overall Study|Physician Decision|0|||
130321704|NCT02992288|469147565|FG005|Overall Study|Physician Decision|1|||
129877004|NCT03682705|467509248|FG000|Overall Study|Other, not specified|0|||
129877005|NCT03682705|467509249|FG001|Overall Study|Other, not specified|0|||
130321705|NCT02992288|469147560|FG000|Overall Study|Death|2|||
129877006|NCT03682705|467509250|FG002|Overall Study|Other, not specified|0|||
129877007|NCT03682705|467509251|FG003|Overall Study|Other, not specified|1|||
130321706|NCT02992288|469147561|FG001|Overall Study|Death|0|||
130321707|NCT02992288|469147562|FG002|Overall Study|Death|2|||
130321708|NCT02992288|469147563|FG003|Overall Study|Death|1|||
130321709|NCT02992288|469147564|FG004|Overall Study|Death|2|||
130321710|NCT02992288|469147565|FG005|Overall Study|Death|0|||
130321711|NCT02992288|469147560|FG000|Overall Study|Lost to Follow-up|0|||
130321712|NCT02992288|469147561|FG001|Overall Study|Lost to Follow-up|0|||
130321713|NCT02992288|469147562|FG002|Overall Study|Lost to Follow-up|0|||
130321714|NCT02992288|469147563|FG003|Overall Study|Lost to Follow-up|1|||
130321715|NCT02992288|469147564|FG004|Overall Study|Lost to Follow-up|0|||
130321716|NCT02992288|469147565|FG005|Overall Study|Lost to Follow-up|0|||
130321717|NCT02992288|469147560|FG000|Overall Study|Protocol Violation|0|||
130321718|NCT02992288|469147561|FG001|Overall Study|Protocol Violation|0|||
130321719|NCT02992288|469147562|FG002|Overall Study|Protocol Violation|0|||
130321720|NCT02992288|469147563|FG003|Overall Study|Protocol Violation|0|||
130321721|NCT02992288|469147564|FG004|Overall Study|Protocol Violation|0|||
129877008|NCT03682705|467509252|FG004|Overall Study|Other, not specified|2|||
129877009|NCT03682705|467509253|FG005|Overall Study|Other, not specified|0|||
129877010|NCT03682705|467509248|FG000|Overall Study|Lost to Follow-up|0|||
129877011|NCT03682705|467509249|FG001|Overall Study|Lost to Follow-up|0|||
130321722|NCT02992288|469147565|FG005|Overall Study|Protocol Violation|1|||
130321723|NCT02992288|469147560|FG000|Overall Study|Withdrawal by Subject|4|||
130321724|NCT02992288|469147561|FG001|Overall Study|Withdrawal by Subject|2|||
130321725|NCT02992288|469147562|FG002|Overall Study|Withdrawal by Subject|1|||
130321726|NCT02992288|469147563|FG003|Overall Study|Withdrawal by Subject|5|||
130321727|NCT02992288|469147564|FG004|Overall Study|Withdrawal by Subject|3|||
129877012|NCT03682705|467509250|FG002|Overall Study|Lost to Follow-up|0|||
129877013|NCT03682705|467509251|FG003|Overall Study|Lost to Follow-up|0|||
129877014|NCT03682705|467509252|FG004|Overall Study|Lost to Follow-up|3|||
129877015|NCT03682705|467509253|FG005|Overall Study|Lost to Follow-up|0|||
129877016|NCT00117156|467509255|FG000|Overall Study|Adverse Event|9|||
129877017|NCT00117156|467509255|FG000|Overall Study|Physician Decision|1|||
129877018|NCT00117156|467509255|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
129877019|NCT01919970|467509256|FG000|Overall Study|Withdrawal by Subject|3|||
129877020|NCT01919970|467509257|FG001|Overall Study|Withdrawal by Subject|0|||
129877021|NCT04043962|467509258|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
129877022|NCT04043962|467509258|FG000|Post-Treatment|Withdrawal by Subject|5|||
129877023|NCT04043962|467509258|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
129877024|NCT04615182|467509259|FG000|Overall Study|Re-transplanted|2|||
129877025|NCT04615182|467509259|FG000|Overall Study|Protocol Violation|6|||
130321728|NCT02992288|469147565|FG005|Overall Study|Withdrawal by Subject|4|||
130321729|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
130321730|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
130321731|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
129877026|NCT04615182|467509259|FG000|Overall Study|Death|6|||
129877027|NCT04615182|467509259|FG000|Overall Study|Death and protocol violation|1|||
130321732|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
130321733|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
130321734|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130321735|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130321736|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
129877028|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
129877029|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
129877030|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
129877031|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
129877032|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
129877033|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
130321737|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
130321738|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129877034|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
129877035|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
129877036|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
129877037|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
130321739|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
130321740|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
130321741|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
130321742|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
130321743|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
130321744|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Other|1|||
130321745|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Other|5|||
130321746|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Other|0|||
130321747|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Other|2|||
130321748|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Other|3|||
130321749|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
130321750|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
130321751|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
130321752|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
130321753|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
130321754|NCT02006472|469147569|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130321755|NCT02006472|469147570|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
130321756|NCT02006472|469147571|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130321757|NCT02006472|469147572|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
130321758|NCT02006472|469147573|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
130321759|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130321760|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
130321761|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
129877038|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
129877039|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
129877040|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
129877041|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
129877042|NCT01126060|467509263|FG000|Overall Study|Protocol Violation|0|||
129877043|NCT01126060|467509264|FG001|Overall Study|Protocol Violation|2|||
129877044|NCT01874145|467509265|FG000|Core Period|Non-compliance|1|||
129877045|NCT01874145|467509266|FG001|Core Period|Non-compliance|0|||
129877046|NCT01874145|467509265|FG000|Core Period|Protocol Violation|1|||
129877047|NCT01874145|467509266|FG001|Core Period|Protocol Violation|1|||
129877048|NCT01874145|467509265|FG000|Core Period|Physician Decision|1|||
129877049|NCT01874145|467509266|FG001|Core Period|Physician Decision|1|||
129877050|NCT01874145|467509265|FG000|Core Period|Adverse Event|0|||
129877051|NCT01874145|467509266|FG001|Core Period|Adverse Event|1|||
129877052|NCT01874145|467509265|FG000|Core Period|Withdrawal by Subject|0|||
129877053|NCT01874145|467509266|FG001|Core Period|Withdrawal by Subject|4|||
129877054|NCT01874145|467509265|FG000|Extension Period|Adverse Event|3|||
129877055|NCT01874145|467509266|FG001|Extension Period|Adverse Event|2|||
129877056|NCT01874145|467509265|FG000|Extension Period|Withdrawal by Subject|2|||
129877057|NCT01874145|467509266|FG001|Extension Period|Withdrawal by Subject|1|||
130321762|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130321763|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
130321764|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
130321765|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
130321766|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
130321767|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
129877058|NCT01874145|467509265|FG000|Extension Period|Lost to Follow-up|1|||
129877059|NCT01874145|467509266|FG001|Extension Period|Lost to Follow-up|1|||
129877060|NCT00402337|467509271|FG000|Overall Study|Adverse Event|0|||
130321768|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
130321769|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
130321770|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
130321771|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
129877061|NCT00402337|467509272|FG001|Overall Study|Adverse Event|2|||
129877062|NCT00402337|467509273|FG002|Overall Study|Adverse Event|2|||
130321772|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
130321773|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
129877063|NCT00402337|467509274|FG003|Overall Study|Adverse Event|3|||
129877064|NCT00402337|467509275|FG004|Overall Study|Adverse Event|2|||
130321774|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Other|0|||
130321775|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Other|1|||
130321776|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Other|0|||
130321777|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Other|1|||
130321778|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Other|0|||
130321779|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Not treated|0|||
130321780|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Not treated|0|||
130321781|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Not treated|2|||
130321782|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Not treated|0|||
130321783|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Not treated|0|||
130321784|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
130321785|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
130321786|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
130321787|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
130321788|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
130321789|NCT02006472|469147569|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
130321790|NCT02006472|469147570|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
130321791|NCT02006472|469147571|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
130321792|NCT02006472|469147572|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
130321793|NCT02006472|469147573|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
130321794|NCT00499486|469147574|FG000|Overall Study|Withdrawal by Subject|16|||
130321795|NCT00087152|469147575|FG000|Overall Study|Ineligible|6|||
130321796|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
130321797|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
130321798|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
130321799|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
130321800|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
130321801|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
130321802|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
130321803|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130321804|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130321805|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
130321806|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130321807|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130321808|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
130321809|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130321810|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
130321811|NCT01436149|469147577|FG000|Antidepressant Lead-in Phase|Other|119|||
130321812|NCT01436149|469147578|FG001|Antidepressant Lead-in Phase|Other|0|||
130321813|NCT01436149|469147579|FG002|Antidepressant Lead-in Phase|Other|0|||
130321814|NCT01436149|469147577|FG000|Randomized Phase|Adverse Event|9|||
130321815|NCT01436149|469147578|FG001|Randomized Phase|Adverse Event|10|||
130321816|NCT01436149|469147579|FG002|Randomized Phase|Adverse Event|11|||
130321817|NCT01436149|469147577|FG000|Randomized Phase|Protocol Violation|4|||
130321818|NCT01436149|469147578|FG001|Randomized Phase|Protocol Violation|5|||
130321819|NCT01436149|469147579|FG002|Randomized Phase|Protocol Violation|0|||
130321820|NCT01436149|469147577|FG000|Randomized Phase|Withdrawal by Subject|16|||
130321821|NCT01436149|469147578|FG001|Randomized Phase|Withdrawal by Subject|10|||
130321822|NCT01436149|469147579|FG002|Randomized Phase|Withdrawal by Subject|10|||
130321823|NCT01436149|469147577|FG000|Randomized Phase|Lost to Follow-up|34|||
130321824|NCT01436149|469147578|FG001|Randomized Phase|Lost to Follow-up|5|||
130321825|NCT01436149|469147579|FG002|Randomized Phase|Lost to Follow-up|6|||
130321826|NCT01436149|469147577|FG000|Randomized Phase|Lack of Efficacy|0|||
130321827|NCT01436149|469147578|FG001|Randomized Phase|Lack of Efficacy|0|||
130321828|NCT01436149|469147579|FG002|Randomized Phase|Lack of Efficacy|1|||
130321829|NCT01436149|469147577|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
130321830|NCT01436149|469147578|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
130321831|NCT01436149|469147579|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
130321832|NCT01436149|469147577|FG000|Randomized Phase|Other|12|||
130321833|NCT01436149|469147578|FG001|Randomized Phase|Other|5|||
130321834|NCT01436149|469147579|FG002|Randomized Phase|Other|11|||
130321835|NCT01643668|469147583|FG000|Overall Study|Death|1|||
130321836|NCT00322881|469147584|FG000|Overall Study|Death|2|||
130321837|NCT00322881|469147584|FG000|Overall Study|Adverse Event|1|||
130321838|NCT00322881|469147584|FG000|Overall Study|Disease Progression|2|||
130321839|NCT00561652|469147585|FG000|Overall Study|Withdrawal by Subject|0|||
130321840|NCT00561652|469147586|FG001|Overall Study|Withdrawal by Subject|1|||
130321841|NCT02285855|469147589|FG000|Overall Study|Withdrawal by Subject|2|||
130321842|NCT02285855|469147590|FG001|Overall Study|Withdrawal by Subject|1|||
130321843|NCT02718898|469147591|FG000|Blinded Treatment Period|Adverse Event|5|||
130321844|NCT02718898|469147592|FG001|Blinded Treatment Period|Adverse Event|1|||
130321845|NCT02718898|469147593|FG002|Blinded Treatment Period|Adverse Event|0|||
130321846|NCT02718898|469147594|FG003|Blinded Treatment Period|Adverse Event|0|||
130321847|NCT02718898|469147595|FG004|Blinded Treatment Period|Adverse Event|0|||
130321848|NCT02718898|469147596|FG005|Blinded Treatment Period|Adverse Event|0|||
130321849|NCT02718898|469147597|FG006|Blinded Treatment Period|Adverse Event|0|||
130321850|NCT02718898|469147591|FG000|Blinded Treatment Period|Physician Decision|1|||
130321851|NCT02718898|469147592|FG001|Blinded Treatment Period|Physician Decision|0|||
130321852|NCT02718898|469147593|FG002|Blinded Treatment Period|Physician Decision|0|||
130321853|NCT02718898|469147594|FG003|Blinded Treatment Period|Physician Decision|0|||
130321854|NCT02718898|469147595|FG004|Blinded Treatment Period|Physician Decision|0|||
130321855|NCT02718898|469147596|FG005|Blinded Treatment Period|Physician Decision|0|||
130321856|NCT02718898|469147597|FG006|Blinded Treatment Period|Physician Decision|0|||
130321857|NCT02718898|469147591|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
130321858|NCT02718898|469147592|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
130321859|NCT02718898|469147593|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
130321860|NCT02718898|469147594|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
130321861|NCT02718898|469147595|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
130321862|NCT02718898|469147596|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
130321863|NCT02718898|469147597|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
130321864|NCT02718898|469147591|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
130321865|NCT02718898|469147592|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
130321866|NCT02718898|469147593|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
130321867|NCT02718898|469147594|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
130321868|NCT02718898|469147595|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
130321869|NCT02718898|469147596|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
130321870|NCT02718898|469147597|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
130321871|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321872|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321873|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
130321874|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
130321875|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321876|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321877|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
130321878|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321879|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321880|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321881|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
130321882|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321883|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321884|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
130321885|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321886|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321887|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130321888|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
130321889|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321890|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321891|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130321892|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321893|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321894|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
130321895|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
130321896|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321897|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321898|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
130321899|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321900|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321901|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321902|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
130321903|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321904|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321905|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
130321906|NCT02718898|469147591|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321907|NCT02718898|469147592|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321908|NCT02718898|469147593|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321909|NCT02718898|469147594|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
130321910|NCT02718898|469147595|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129877065|NCT00402337|467509271|FG000|Overall Study|Noncompliance|0|||
129877066|NCT00402337|467509272|FG001|Overall Study|Noncompliance|0|||
130321911|NCT02718898|469147596|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129877067|NCT00402337|467509273|FG002|Overall Study|Noncompliance|0|||
130321912|NCT02718898|469147597|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
130321913|NCT02718898|469147591|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
130321914|NCT02718898|469147592|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
130321915|NCT02718898|469147593|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
130321916|NCT02718898|469147594|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
130321917|NCT02718898|469147595|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
130321918|NCT02718898|469147596|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
130321919|NCT02718898|469147597|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
130321920|NCT02718898|469147591|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321921|NCT02718898|469147592|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321922|NCT02718898|469147593|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321923|NCT02718898|469147594|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
130321924|NCT02718898|469147595|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
130321925|NCT02718898|469147596|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
130321926|NCT02718898|469147597|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
130321927|NCT02718898|469147591|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321928|NCT02718898|469147592|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321929|NCT02718898|469147593|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321930|NCT02718898|469147594|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321931|NCT02718898|469147595|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130321932|NCT02718898|469147596|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
130321933|NCT02718898|469147597|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
130321934|NCT04484961|469147598|FG000|Overall Study|Lost to Follow-up|9|||
130321935|NCT04484961|469147599|FG001|Overall Study|Lost to Follow-up|9|||
130321936|NCT01667900|469147600|FG000|Part B|Death|0|||
130321937|NCT01667900|469147601|FG001|Part B|Death|0|||
130321938|NCT01667900|469147602|FG002|Part B|Death|0|||
130321939|NCT01667900|469147603|FG003|Part B|Death|0|||
130321940|NCT01667900|469147604|FG004|Part B|Death|0|||
130321941|NCT01667900|469147605|FG005|Part B|Death|0|||
130321942|NCT01667900|469147606|FG006|Part B|Death|0|||
130321943|NCT01667900|469147607|FG007|Part B|Death|0|||
130321944|NCT01667900|469147608|FG008|Part B|Death|0|||
130321945|NCT01667900|469147609|FG009|Part B|Death|0|||
130321946|NCT01667900|469147610|FG010|Part B|Death|0|||
130321947|NCT01667900|469147611|FG011|Part B|Death|0|||
130321948|NCT01667900|469147612|FG012|Part B|Death|0|||
130321949|NCT01667900|469147613|FG013|Part B|Death|0|||
130321950|NCT01667900|469147614|FG014|Part B|Death|0|||
130321951|NCT01667900|469147615|FG015|Part B|Death|0|||
130321952|NCT01667900|469147616|FG016|Part B|Death|1|||
130321953|NCT01667900|469147617|FG017|Part B|Death|0|||
130321954|NCT01667900|469147618|FG018|Part B|Death|0|||
130321955|NCT01667900|469147619|FG019|Part B|Death|0|||
130321956|NCT00976274|469147621|FG000|Overall Study|Lost to Follow-up|5|||
130321957|NCT00976274|469147622|FG001|Overall Study|Lost to Follow-up|5|||
130321958|NCT00976274|469147621|FG000|Overall Study|Withdrawal by Subject|1|||
130321959|NCT00976274|469147622|FG001|Overall Study|Withdrawal by Subject|1|||
130321960|NCT00976274|469147621|FG000|Overall Study|Physician Decision|1|||
130321961|NCT00976274|469147622|FG001|Overall Study|Physician Decision|2|||
130321962|NCT00627393|469147625|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
130321963|NCT00627393|469147626|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
130321964|NCT00627393|469147625|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
130321965|NCT00627393|469147626|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
130321966|NCT00627393|469147625|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
130321967|NCT00627393|469147626|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
130321968|NCT00627393|469147625|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
130321969|NCT00627393|469147626|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
130321970|NCT00004563|469147627|FG000|Overall Study|Withdrawal by Subject|20|||
130321971|NCT00004563|469147628|FG001|Overall Study|Withdrawal by Subject|16|||
130321972|NCT00004563|469147627|FG000|Overall Study|Lack of Efficacy|3|||
130321973|NCT00004563|469147628|FG001|Overall Study|Lack of Efficacy|5|||
129877068|NCT00402337|467509274|FG003|Overall Study|Noncompliance|0|||
130321974|NCT00004563|469147627|FG000|Overall Study|Death|2|||
130321975|NCT00004563|469147628|FG001|Overall Study|Death|3|||
130321976|NCT03337308|469147629|FG000|Overall Study|Adverse Event|2|||
130321977|NCT03337308|469147630|FG001|Overall Study|Adverse Event|3|||
130321978|NCT03337308|469147631|FG002|Overall Study|Adverse Event|3|||
130321979|NCT03337308|469147632|FG003|Overall Study|Adverse Event|1|||
130321980|NCT03337308|469147629|FG000|Overall Study|Lost to Follow-up|1|||
130321981|NCT03337308|469147630|FG001|Overall Study|Lost to Follow-up|2|||
130321982|NCT03337308|469147631|FG002|Overall Study|Lost to Follow-up|0|||
129877069|NCT00402337|467509275|FG004|Overall Study|Noncompliance|2|||
130321983|NCT03337308|469147632|FG003|Overall Study|Lost to Follow-up|0|||
130321984|NCT03337308|469147629|FG000|Overall Study|Withdrawal by Subject|2|||
130321985|NCT03337308|469147630|FG001|Overall Study|Withdrawal by Subject|1|||
130321986|NCT03337308|469147631|FG002|Overall Study|Withdrawal by Subject|2|||
130321987|NCT03337308|469147632|FG003|Overall Study|Withdrawal by Subject|1|||
130321988|NCT03337308|469147629|FG000|Overall Study|Protocol Violation|0|||
129877070|NCT00402337|467509271|FG000|Overall Study|Withdrawal by Subject|5|||
129877071|NCT00402337|467509272|FG001|Overall Study|Withdrawal by Subject|3|||
129877072|NCT00402337|467509273|FG002|Overall Study|Withdrawal by Subject|1|||
129877073|NCT00402337|467509274|FG003|Overall Study|Withdrawal by Subject|6|||
129877074|NCT00402337|467509275|FG004|Overall Study|Withdrawal by Subject|4|||
129877075|NCT00402337|467509271|FG000|Overall Study|Lost to Follow-up|0|||
129877076|NCT00402337|467509272|FG001|Overall Study|Lost to Follow-up|0|||
129877077|NCT00402337|467509273|FG002|Overall Study|Lost to Follow-up|1|||
129877078|NCT00402337|467509274|FG003|Overall Study|Lost to Follow-up|2|||
129877079|NCT00402337|467509275|FG004|Overall Study|Lost to Follow-up|0|||
129877080|NCT00402337|467509271|FG000|Overall Study|Physician Decision|0|||
129877081|NCT00402337|467509272|FG001|Overall Study|Physician Decision|0|||
129877082|NCT00402337|467509273|FG002|Overall Study|Physician Decision|0|||
129877083|NCT00402337|467509274|FG003|Overall Study|Physician Decision|1|||
130321989|NCT03337308|469147630|FG001|Overall Study|Protocol Violation|1|||
130321990|NCT03337308|469147631|FG002|Overall Study|Protocol Violation|0|||
130321991|NCT03337308|469147632|FG003|Overall Study|Protocol Violation|0|||
130321992|NCT01056822|469147633|FG000|Overall Study|Adverse Event|0|||
130321993|NCT01056822|469147634|FG001|Overall Study|Adverse Event|1|||
130321994|NCT01056822|469147633|FG000|Overall Study|Protocol Violation|6|||
130321995|NCT01056822|469147634|FG001|Overall Study|Protocol Violation|5|||
130321996|NCT01056822|469147633|FG000|Overall Study|Withdrawal by Subject|1|||
130321997|NCT01056822|469147634|FG001|Overall Study|Withdrawal by Subject|1|||
130321998|NCT01056822|469147633|FG000|Overall Study|Lost to Follow-up|1|||
130321999|NCT01056822|469147634|FG001|Overall Study|Lost to Follow-up|0|||
130322000|NCT04528641|469147637|FG000|Overall Study|Withdrawal by Subject|0|||
130322001|NCT04528641|469147638|FG001|Overall Study|Withdrawal by Subject|0|||
130322002|NCT04528641|469147639|FG002|Overall Study|Withdrawal by Subject|0|||
130322003|NCT04528641|469147640|FG003|Overall Study|Withdrawal by Subject|1|||
130322004|NCT04528641|469147641|FG004|Overall Study|Withdrawal by Subject|0|||
130322005|NCT04528641|469147642|FG005|Overall Study|Withdrawal by Subject|1|||
130322006|NCT04366349|469147643|FG000|Overall Study|Withdrawal by Subject|1|||
130322007|NCT04366349|469147644|FG001|Overall Study|Withdrawal by Subject|0|||
130322008|NCT04366349|469147645|FG002|Overall Study|Withdrawal by Subject|0|||
130322009|NCT04366349|469147646|FG003|Overall Study|Withdrawal by Subject|0|||
130322010|NCT04366349|469147647|FG004|Overall Study|Withdrawal by Subject|0|||
130322011|NCT04366349|469147648|FG005|Overall Study|Withdrawal by Subject|0|||
130322012|NCT02783690|469147654|FG000|Overall Study|Withdrawal by Subject|3|||
130322013|NCT02783690|469147655|FG001|Overall Study|Withdrawal by Subject|3|||
130322014|NCT03474588|469147656|FG000|Overall Study|Withdrawal by Subject|4|||
130322015|NCT03474588|469147657|FG001|Overall Study|Withdrawal by Subject|3|||
130322016|NCT03474588|469147656|FG000|Overall Study|Death|0|||
130322017|NCT03474588|469147657|FG001|Overall Study|Death|1|||
130322018|NCT00626106|469147663|FG000|Overall Study|Withdrawal by Subject|2|||
130322019|NCT00626106|469147664|FG001|Overall Study|Withdrawal by Subject|1|||
130322020|NCT00626106|469147663|FG000|Overall Study|Lost to Follow-up|1|||
130322021|NCT00626106|469147664|FG001|Overall Study|Lost to Follow-up|4|||
130322022|NCT00626106|469147663|FG000|Overall Study|Death|64|||
130322023|NCT00626106|469147664|FG001|Overall Study|Death|19|||
130322024|NCT05417438|469147665|FG000|Overall Study|Withdrawal by Subject|3|||
130322025|NCT02702492|469147668|FG000|Overall Study|Disease progression|3|||
129877084|NCT00402337|467509275|FG004|Overall Study|Physician Decision|0|||
129877085|NCT00402337|467509271|FG000|Overall Study|Other Reason|0|||
129877086|NCT00402337|467509272|FG001|Overall Study|Other Reason|1|||
129877087|NCT00402337|467509273|FG002|Overall Study|Other Reason|0|||
129877088|NCT00402337|467509274|FG003|Overall Study|Other Reason|0|||
129877089|NCT00402337|467509275|FG004|Overall Study|Other Reason|0|||
129877090|NCT02178566|467509276|FG000|Overall Study|patient did not complete due to noncompliance|0|||
129877091|NCT02178566|467509277|FG001|Overall Study|patient did not complete due to noncompliance|1|||
129877092|NCT02658630|467509284|FG000|Overall Study|Withdrawal by Subject|4|||
129877093|NCT01521884|467509286|FG000|Overall Study|Non Responders|10|||
129877094|NCT01521884|467509286|FG000|Overall Study|Adverse Event|5|||
129877095|NCT01521884|467509286|FG000|Overall Study|Pregnancy|1|||
129877096|NCT01521884|467509286|FG000|Overall Study|Withdrawal by Subject|1|||
130322026|NCT02702492|469147669|FG001|Overall Study|Disease progression|3|||
130322027|NCT02702492|469147670|FG002|Overall Study|Disease progression|2|||
130322028|NCT02702492|469147671|FG003|Overall Study|Disease progression|4|||
130322029|NCT02702492|469147672|FG004|Overall Study|Disease progression|4|||
129877097|NCT01521884|467509286|FG000|Overall Study|Physician Decision|2|||
129877098|NCT01521884|467509286|FG000|Overall Study|Protocol Violation|3|||
129877099|NCT01521884|467509286|FG000|Overall Study|Participant non-eligible|1|||
129877100|NCT01521884|467509286|FG000|Overall Study|Lost to Follow-up|4|||
129877101|NCT02821819|467509287|FG000|Overall Study|Protocol Violation|1|||
130322030|NCT02702492|469147673|FG005|Overall Study|Disease progression|1|||
130322031|NCT02702492|469147674|FG006|Overall Study|Disease progression|2|||
130322032|NCT02702492|469147675|FG007|Overall Study|Disease progression|8|||
130322033|NCT02702492|469147676|FG008|Overall Study|Disease progression|5|||
130322034|NCT02702492|469147677|FG009|Overall Study|Disease progression|1|||
130322035|NCT02702492|469147678|FG010|Overall Study|Disease progression|0|||
130322036|NCT02702492|469147679|FG011|Overall Study|Disease progression|3|||
130322037|NCT02702492|469147680|FG012|Overall Study|Disease progression|2|||
130322038|NCT02702492|469147668|FG000|Overall Study|Clinical progression|0|||
130322039|NCT02702492|469147669|FG001|Overall Study|Clinical progression|0|||
130322040|NCT02702492|469147670|FG002|Overall Study|Clinical progression|2|||
130322041|NCT02702492|469147671|FG003|Overall Study|Clinical progression|1|||
130322042|NCT02702492|469147672|FG004|Overall Study|Clinical progression|0|||
130322043|NCT02702492|469147673|FG005|Overall Study|Clinical progression|2|||
130322044|NCT02702492|469147674|FG006|Overall Study|Clinical progression|1|||
130322045|NCT02702492|469147675|FG007|Overall Study|Clinical progression|4|||
130322046|NCT02702492|469147676|FG008|Overall Study|Clinical progression|0|||
130322047|NCT02702492|469147677|FG009|Overall Study|Clinical progression|0|||
130322048|NCT02702492|469147678|FG010|Overall Study|Clinical progression|1|||
130322049|NCT02702492|469147679|FG011|Overall Study|Clinical progression|2|||
130322050|NCT02702492|469147680|FG012|Overall Study|Clinical progression|0|||
130322051|NCT02702492|469147668|FG000|Overall Study|Adverse Event|0|||
130322052|NCT02702492|469147669|FG001|Overall Study|Adverse Event|0|||
130322053|NCT02702492|469147670|FG002|Overall Study|Adverse Event|1|||
130322054|NCT02702492|469147671|FG003|Overall Study|Adverse Event|2|||
130322055|NCT02702492|469147672|FG004|Overall Study|Adverse Event|1|||
130322056|NCT02702492|469147673|FG005|Overall Study|Adverse Event|0|||
130322057|NCT02702492|469147674|FG006|Overall Study|Adverse Event|1|||
130322058|NCT02702492|469147675|FG007|Overall Study|Adverse Event|0|||
130322059|NCT02702492|469147676|FG008|Overall Study|Adverse Event|2|||
130322060|NCT02702492|469147677|FG009|Overall Study|Adverse Event|0|||
130322061|NCT02702492|469147678|FG010|Overall Study|Adverse Event|0|||
130322062|NCT02702492|469147679|FG011|Overall Study|Adverse Event|0|||
130322063|NCT02702492|469147680|FG012|Overall Study|Adverse Event|1|||
130322064|NCT02702492|469147668|FG000|Overall Study|Other|0|||
130322065|NCT02702492|469147669|FG001|Overall Study|Other|0|||
130322066|NCT02702492|469147670|FG002|Overall Study|Other|0|||
130322067|NCT02702492|469147671|FG003|Overall Study|Other|0|||
130322068|NCT02702492|469147672|FG004|Overall Study|Other|0|||
130322069|NCT02702492|469147673|FG005|Overall Study|Other|0|||
130322070|NCT02702492|469147674|FG006|Overall Study|Other|0|||
130322071|NCT02702492|469147675|FG007|Overall Study|Other|0|||
130322072|NCT02702492|469147676|FG008|Overall Study|Other|0|||
130322073|NCT02702492|469147677|FG009|Overall Study|Other|0|||
130322074|NCT02702492|469147678|FG010|Overall Study|Other|0|||
130322075|NCT02702492|469147679|FG011|Overall Study|Other|0|||
130322076|NCT02702492|469147680|FG012|Overall Study|Other|1|||
130322077|NCT00781768|469149030|FG000|Overall Study|Not transplanted.|0|||
130322078|NCT00781768|469149031|FG001|Overall Study|Not transplanted.|2|||
130322079|NCT00079417|469149040|FG000|Overall Study|Physician Decision|2|||
130322080|NCT00079417|469149040|FG000|Overall Study|Ineligible|7|||
130322081|NCT02458313|469149041|FG000|Overall Study|Withdrawal by Subject|6|||
130322082|NCT02458313|469149042|FG001|Overall Study|Withdrawal by Subject|8|||
130322083|NCT02458313|469149041|FG000|Overall Study|Excluded for motion during MRI|1|||
130322084|NCT02458313|469149042|FG001|Overall Study|Excluded for motion during MRI|2|||
130322085|NCT00904969|469149043|FG000|Overall Study|Lost to Follow-up|4|||
130322086|NCT00904969|469149043|FG000|Overall Study|Withdrawal by Subject|3|||
130322087|NCT00904969|469149043|FG000|Overall Study|Additional Treatments|11|||
130322088|NCT00904969|469149043|FG000|Overall Study|Case Aborted; Subject Exited|1|||
130322089|NCT00199381|469149050|FG000|Overall Study|Withdrawal by Subject|38|||
130322090|NCT00199381|469149050|FG000|Overall Study|Adverse Event|73|||
130322091|NCT00199381|469149050|FG000|Overall Study|Protocol Violation|6|||
130322092|NCT00199381|469149050|FG000|Overall Study|Lack of Efficacy|27|||
130322093|NCT00199381|469149050|FG000|Overall Study|Not including due to early termination|37|||
130322094|NCT00199381|469149050|FG000|Overall Study|Study termination by Sponsor|323|||
130322095|NCT00385671|469149052|FG000|Overall Study|Adverse Event|14|||
130322096|NCT00385671|469149053|FG001|Overall Study|Adverse Event|27|||
130322097|NCT00385671|469149054|FG002|Overall Study|Adverse Event|18|||
129877102|NCT03565068|467509288|FG000|Overall Study|Protocol Violation|0|||
130322098|NCT00385671|469149052|FG000|Overall Study|Lack of Efficacy|5|||
130322099|NCT00385671|469149053|FG001|Overall Study|Lack of Efficacy|9|||
130322100|NCT00385671|469149054|FG002|Overall Study|Lack of Efficacy|5|||
130322101|NCT00385671|469149052|FG000|Overall Study|Lost to Follow-up|6|||
130322102|NCT00385671|469149053|FG001|Overall Study|Lost to Follow-up|6|||
130322103|NCT00385671|469149054|FG002|Overall Study|Lost to Follow-up|5|||
129877103|NCT03565068|467509289|FG001|Overall Study|Protocol Violation|0|||
130322104|NCT00385671|469149052|FG000|Overall Study|Physician Decision|2|||
130322105|NCT00385671|469149053|FG001|Overall Study|Physician Decision|1|||
130322106|NCT00385671|469149054|FG002|Overall Study|Physician Decision|2|||
130322107|NCT00385671|469149052|FG000|Overall Study|Protocol Violation|5|||
130322108|NCT00385671|469149053|FG001|Overall Study|Protocol Violation|2|||
130322109|NCT00385671|469149054|FG002|Overall Study|Protocol Violation|1|||
130322110|NCT00385671|469149052|FG000|Overall Study|Sponsor Decision|2|||
130322111|NCT00385671|469149053|FG001|Overall Study|Sponsor Decision|2|||
130322112|NCT00385671|469149054|FG002|Overall Study|Sponsor Decision|1|||
130322113|NCT00385671|469149052|FG000|Overall Study|Withdrawal by Subject|4|||
130322114|NCT00385671|469149053|FG001|Overall Study|Withdrawal by Subject|4|||
130322115|NCT00385671|469149054|FG002|Overall Study|Withdrawal by Subject|4|||
130322116|NCT00303069|469149055|FG000|Overall Study|Lost to Follow-up|1|||
130322117|NCT00303069|469149056|FG001|Overall Study|Lost to Follow-up|0|||
130322118|NCT00303069|469149057|FG002|Overall Study|Lost to Follow-up|0|||
130322119|NCT00303069|469149058|FG003|Overall Study|Lost to Follow-up|2|||
130322120|NCT00303069|469149055|FG000|Overall Study|subject moved|1|||
130322121|NCT00303069|469149056|FG001|Overall Study|subject moved|0|||
130322122|NCT00303069|469149057|FG002|Overall Study|subject moved|0|||
130322123|NCT00303069|469149058|FG003|Overall Study|subject moved|0|||
130322124|NCT00303069|469149055|FG000|Overall Study|Recruitment into Army Reserves|0|||
130322125|NCT00303069|469149056|FG001|Overall Study|Recruitment into Army Reserves|0|||
130322126|NCT00303069|469149057|FG002|Overall Study|Recruitment into Army Reserves|1|||
130322127|NCT00303069|469149058|FG003|Overall Study|Recruitment into Army Reserves|0|||
130322128|NCT00751296|469149059|FG000|Overall Study|Adverse Event|2|||
130322129|NCT01775501|469149060|FG000|Overall Study|Discontinued prior to treatment|1|||
130322130|NCT01280903|469149064|FG000|Overall Study|Lost to Follow-up|23|||
130322131|NCT01280903|469149065|FG001|Overall Study|Lost to Follow-up|16|||
130322132|NCT03453164|469149066|FG000|Overall Study|Lack of Efficacy|16|||
130322133|NCT03453164|469149066|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
130322134|NCT03007966|469149069|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
130322135|NCT03007966|469149070|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
130322136|NCT03459079|469149071|FG000|Overall Study|Adverse Event|4|||
130322137|NCT03459079|469149072|FG001|Overall Study|Adverse Event|2|||
130322138|NCT03459079|469149073|FG002|Overall Study|Adverse Event|0|||
130322139|NCT03459079|469149071|FG000|Overall Study|Withdrawal by Subject|2|||
130322140|NCT03459079|469149072|FG001|Overall Study|Withdrawal by Subject|2|||
130322141|NCT03459079|469149073|FG002|Overall Study|Withdrawal by Subject|0|||
130322142|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
130322143|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
130322144|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
130322145|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Death|9|||
130322146|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Death|0|||
130322147|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Death|0|||
130322148|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
130322149|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130322150|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
130322151|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
130322152|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
130322153|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
130322154|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Other|135|||
130322155|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Other|0|||
130322156|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Other|0|||
130322157|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
130322158|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
130322159|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
130322160|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
130322161|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
130322162|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
130322163|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
130322164|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
130322165|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
130322166|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Other|3|||
130322167|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Other|0|||
130322168|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Other|0|||
130322169|NCT02118584|469149075|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
130322170|NCT02118584|469149076|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130322171|NCT02118584|469149077|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
130322172|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130322173|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
130322174|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
130322175|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
130322176|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
130322177|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
130322178|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
130322179|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
130322180|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
130322181|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130322182|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
130322183|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
130322184|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
130322185|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
130322186|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129877104|NCT03565068|467509290|FG002|Overall Study|Protocol Violation|0|||
129877105|NCT03565068|467509291|FG003|Overall Study|Protocol Violation|0|||
129877106|NCT03565068|467509292|FG004|Overall Study|Protocol Violation|1|||
129877107|NCT03565068|467509293|FG005|Overall Study|Protocol Violation|0|||
129877108|NCT03565068|467509294|FG006|Overall Study|Protocol Violation|0|||
129877109|NCT03565068|467509295|FG007|Overall Study|Protocol Violation|1|||
129877110|NCT03565068|467509296|FG008|Overall Study|Protocol Violation|0|||
129877111|NCT03565068|467509288|FG000|Overall Study|Sponsor decision|0|||
129877112|NCT03565068|467509289|FG001|Overall Study|Sponsor decision|0|||
129877113|NCT03565068|467509290|FG002|Overall Study|Sponsor decision|0|||
129877114|NCT03565068|467509291|FG003|Overall Study|Sponsor decision|0|||
129877115|NCT03565068|467509292|FG004|Overall Study|Sponsor decision|1|||
130322187|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
130322188|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
130322189|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
130322190|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130322191|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
130322192|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
130322193|NCT02118584|469149075|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
130322194|NCT02118584|469149076|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
130322195|NCT02118584|469149077|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
130322196|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130322197|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
130322198|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130322199|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130322200|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130322201|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130322202|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130322203|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130322204|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
130322205|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130322206|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130322207|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130322208|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130322209|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130322210|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
130322211|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
130322212|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
130322213|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
130322214|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
130322215|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
130322216|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130322217|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
130322218|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130322219|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130322220|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130322221|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
130322222|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130322223|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
130322224|NCT04026113|469149081|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130322225|NCT04026113|469149082|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
130322226|NCT04026113|469149083|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130322227|NCT04026113|469149084|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130322228|NCT04026113|469149081|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
130322229|NCT04026113|469149082|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
129877116|NCT03565068|467509293|FG005|Overall Study|Sponsor decision|1|||
130322230|NCT04026113|469149083|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
129877117|NCT03565068|467509294|FG006|Overall Study|Sponsor decision|0|||
129877118|NCT03565068|467509295|FG007|Overall Study|Sponsor decision|0|||
129877119|NCT03565068|467509296|FG008|Overall Study|Sponsor decision|0|||
129877120|NCT03565068|467509288|FG000|Overall Study|Withdrawal by Subject|0|||
129877121|NCT03565068|467509289|FG001|Overall Study|Withdrawal by Subject|0|||
130213832|NCT01690299|468746912|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
130213833|NCT01690299|468746913|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
130213834|NCT01690299|468746914|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
130213835|NCT01690299|468746915|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130213836|NCT01690299|468746916|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130213837|NCT01690299|468746917|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
130213838|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130213839|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130213840|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
130213841|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
130213842|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
130213843|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
130213844|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130213845|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130213846|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
130213847|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
130213848|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
130213849|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
130213850|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213851|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213852|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213853|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
130213854|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
130213855|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
130213856|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130213857|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130213858|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
130213859|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
130213860|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
130213861|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
130213862|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130213863|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130213864|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
130213865|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
130213866|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
130213867|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
130213868|NCT01690299|468746912|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213869|NCT01690299|468746913|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213870|NCT01690299|468746914|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213871|NCT01690299|468746915|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213872|NCT01690299|468746916|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
130213873|NCT01690299|468746917|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
130213874|NCT03836209|468746918|FG000|Overall Study|Adverse Event|5|||
130213875|NCT03836209|468746919|FG001|Overall Study|Adverse Event|2|||
130213876|NCT03836209|468746918|FG000|Overall Study|Death|4|||
130213877|NCT03836209|468746919|FG001|Overall Study|Death|1|||
130213878|NCT03836209|468746918|FG000|Overall Study|Lack of Efficacy|7|||
130213879|NCT03836209|468746919|FG001|Overall Study|Lack of Efficacy|10|||
130213880|NCT03836209|468746918|FG000|Overall Study|Physician Decision|7|||
130213881|NCT03836209|468746919|FG001|Overall Study|Physician Decision|11|||
130213882|NCT03836209|468746918|FG000|Overall Study|Protocol Violation|0|||
130213883|NCT03836209|468746919|FG001|Overall Study|Protocol Violation|3|||
130213884|NCT03836209|468746918|FG000|Overall Study|Withdrawal by Subject|2|||
130213885|NCT03836209|468746919|FG001|Overall Study|Withdrawal by Subject|10|||
130213886|NCT03836209|468746918|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
130213887|NCT03836209|468746919|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
130213888|NCT03739710|468746920|FG000|Overall Study|Screen Failed|81|||
130213889|NCT01753115|468746921|FG000|Overall Study|Lost to Follow-up|3|||
130213890|NCT01753115|468746922|FG001|Overall Study|Lost to Follow-up|6|||
130213891|NCT01753115|468746923|FG002|Overall Study|Lost to Follow-up|8|||
130213892|NCT01753115|468746921|FG000|Overall Study|Withdrawal by Subject|6|||
130213893|NCT01753115|468746922|FG001|Overall Study|Withdrawal by Subject|5|||
130213894|NCT01753115|468746923|FG002|Overall Study|Withdrawal by Subject|6|||
130213895|NCT01753115|468746921|FG000|Overall Study|Subject non-compliant|3|||
130213896|NCT01753115|468746922|FG001|Overall Study|Subject non-compliant|3|||
130213897|NCT01753115|468746923|FG002|Overall Study|Subject non-compliant|0|||
130322231|NCT04026113|469149084|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
130322232|NCT04613362|469149085|FG000|3 Month Follow-up|Lost to Follow-up|1|||
130322233|NCT04613362|469149086|FG001|3 Month Follow-up|Lost to Follow-up|2|||
130322234|NCT04613362|469149085|FG000|6 Month Follow-up|Lost to Follow-up|0|||
130322235|NCT04613362|469149086|FG001|6 Month Follow-up|Lost to Follow-up|1|||
130322236|NCT02218372|469149087|FG000|Overall Study|Adverse Event|1|||
130322237|NCT02218372|469149088|FG001|Overall Study|Adverse Event|1|||
130322238|NCT02218372|469149087|FG000|Overall Study|Miscellaneous|2|||
130322239|NCT02218372|469149088|FG001|Overall Study|Miscellaneous|1|||
130322240|NCT02218372|469149087|FG000|Overall Study|Randomized but did not receive treatment|2|||
130322241|NCT02218372|469149088|FG001|Overall Study|Randomized but did not receive treatment|3|||
130322242|NCT02218372|469149087|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130322243|NCT02218372|469149088|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130322244|NCT00074711|469149097|FG000|Overall Study|Withdrawal by Subject|1|||
130322245|NCT00074711|469149098|FG001|Overall Study|Withdrawal by Subject|1|||
130322246|NCT00074711|469149097|FG000|Overall Study|Lost to Follow-up|10|||
130322247|NCT00074711|469149098|FG001|Overall Study|Lost to Follow-up|8|||
130322248|NCT00074711|469149097|FG000|Overall Study|Participant stopped study drug|4|||
130322249|NCT00074711|469149098|FG001|Overall Study|Participant stopped study drug|6|||
130322250|NCT00671658|469149099|FG000|Overall Study|Physician Decision|5|||
130322251|NCT01921205|469149100|FG000|Overall Study|Adverse Event|12|||
130322252|NCT01921205|469149101|FG001|Overall Study|Adverse Event|7|||
130322253|NCT01921205|469149100|FG000|Overall Study|Lack of Efficacy|1|||
130322254|NCT01921205|469149101|FG001|Overall Study|Lack of Efficacy|0|||
130322255|NCT01921205|469149100|FG000|Overall Study|Protocol Violation|1|||
130322256|NCT01921205|469149101|FG001|Overall Study|Protocol Violation|3|||
130322257|NCT01921205|469149100|FG000|Overall Study|Lost to Follow-up|1|||
130322258|NCT01921205|469149101|FG001|Overall Study|Lost to Follow-up|1|||
130322259|NCT01921205|469149100|FG000|Overall Study|Withdrawal by Subject|6|||
130322260|NCT01921205|469149101|FG001|Overall Study|Withdrawal by Subject|5|||
130322261|NCT01921205|469149100|FG000|Overall Study|Use Of Prohibited Medication|0|||
130322262|NCT01921205|469149101|FG001|Overall Study|Use Of Prohibited Medication|1|||
130322263|NCT01921205|469149100|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
130322264|NCT01921205|469149101|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
130322265|NCT01921205|469149100|FG000|Overall Study|Non Compliance Of The Parent|0|||
130322266|NCT01921205|469149101|FG001|Overall Study|Non Compliance Of The Parent|1|||
129877122|NCT03565068|467509290|FG002|Overall Study|Withdrawal by Subject|1|||
129877123|NCT03565068|467509291|FG003|Overall Study|Withdrawal by Subject|0|||
129877124|NCT03565068|467509292|FG004|Overall Study|Withdrawal by Subject|2|||
129877125|NCT03565068|467509293|FG005|Overall Study|Withdrawal by Subject|0|||
129877126|NCT03565068|467509294|FG006|Overall Study|Withdrawal by Subject|1|||
129877127|NCT03565068|467509295|FG007|Overall Study|Withdrawal by Subject|5|||
129877128|NCT03565068|467509296|FG008|Overall Study|Withdrawal by Subject|1|||
129877129|NCT03565068|467509288|FG000|Overall Study|Physician Decision|0|||
129877130|NCT03565068|467509289|FG001|Overall Study|Physician Decision|0|||
129877131|NCT03565068|467509290|FG002|Overall Study|Physician Decision|0|||
129877132|NCT03565068|467509291|FG003|Overall Study|Physician Decision|0|||
129877133|NCT03565068|467509292|FG004|Overall Study|Physician Decision|0|||
129877134|NCT03565068|467509293|FG005|Overall Study|Physician Decision|0|||
129877135|NCT03565068|467509294|FG006|Overall Study|Physician Decision|0|||
129877136|NCT03565068|467509295|FG007|Overall Study|Physician Decision|1|||
129877137|NCT03565068|467509296|FG008|Overall Study|Physician Decision|0|||
129877138|NCT03565068|467509288|FG000|Overall Study|Lost to Follow-up|0|||
129877139|NCT03565068|467509289|FG001|Overall Study|Lost to Follow-up|0|||
129877140|NCT03565068|467509290|FG002|Overall Study|Lost to Follow-up|0|||
129877141|NCT03565068|467509291|FG003|Overall Study|Lost to Follow-up|0|||
129877142|NCT03565068|467509292|FG004|Overall Study|Lost to Follow-up|0|||
129877143|NCT03565068|467509293|FG005|Overall Study|Lost to Follow-up|0|||
129877144|NCT03565068|467509294|FG006|Overall Study|Lost to Follow-up|0|||
129877145|NCT03565068|467509295|FG007|Overall Study|Lost to Follow-up|1|||
129877146|NCT03565068|467509296|FG008|Overall Study|Lost to Follow-up|0|||
129877147|NCT00085202|467509297|FG000|Overall Study|Still on therapy|2|||
129877148|NCT00085202|467509298|FG001|Overall Study|Still on therapy|0|||
129877149|NCT00085202|467509297|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
129877150|NCT00085202|467509298|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
129877151|NCT00085202|467509297|FG000|Overall Study|Excessive toxicity|6|||
130322267|NCT01921205|469149100|FG000|Overall Study|Non Compliance Of Child|0|||
130322268|NCT01921205|469149101|FG001|Overall Study|Non Compliance Of Child|1|||
130322269|NCT01527149|469149103|FG000|Overall Study|Death|2|||
130322270|NCT03125395|469149104|FG000|Overall Study|Adverse Event|2|||
130322271|NCT03125395|469149104|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130322272|NCT03125395|469149104|FG000|Overall Study|Physician Decision|2|||
130322273|NCT03125395|469149104|FG000|Overall Study|Commercial drug is available|5|||
129877152|NCT00085202|467509298|FG001|Overall Study|Excessive toxicity|5|||
129877153|NCT00085202|467509297|FG000|Overall Study|Non-specified|3|||
129877154|NCT00085202|467509298|FG001|Overall Study|Non-specified|5|||
129877155|NCT00085202|467509297|FG000|Overall Study|Withdrawal by Subject|2|||
129877156|NCT00085202|467509298|FG001|Overall Study|Withdrawal by Subject|1|||
129877157|NCT00085202|467509297|FG000|Overall Study|Physician Decision|4|||
129877158|NCT00085202|467509298|FG001|Overall Study|Physician Decision|1|||
129877159|NCT00085202|467509297|FG000|Overall Study|Progressive disease|1|||
129877160|NCT00085202|467509298|FG001|Overall Study|Progressive disease|11|||
129877161|NCT01435655|467509300|FG000|Overall Study|Death|2|||
129877162|NCT01435655|467509300|FG000|Overall Study|Other|1|||
129877163|NCT01436201|467509301|FG000|Overall Study|Adverse Event|2|||
129877164|NCT01436201|467509301|FG000|Overall Study|Withdrawal by Subject|1|||
129877165|NCT01436201|467509301|FG000|Overall Study|Protocol Violation|1|||
129877166|NCT00263328|467509302|FG000|Overall Study|Death|0|||
129877167|NCT00263328|467509303|FG001|Overall Study|Death|0|||
129877168|NCT00263328|467509304|FG002|Overall Study|Death|1|||
129877169|NCT00263328|467509302|FG000|Overall Study|Lost to Follow-up|1|||
129877170|NCT00263328|467509303|FG001|Overall Study|Lost to Follow-up|1|||
129877171|NCT00263328|467509304|FG002|Overall Study|Lost to Follow-up|0|||
129877172|NCT00263328|467509302|FG000|Overall Study|Withdrawal by Subject|3|||
129877173|NCT00263328|467509303|FG001|Overall Study|Withdrawal by Subject|0|||
129877174|NCT00263328|467509304|FG002|Overall Study|Withdrawal by Subject|1|||
129877175|NCT00263328|467509302|FG000|Overall Study|Other|3|||
129877176|NCT00263328|467509303|FG001|Overall Study|Other|0|||
129877177|NCT00263328|467509304|FG002|Overall Study|Other|1|||
129877178|NCT00263328|467509302|FG000|Overall Study|Adverse Event|1|||
129877179|NCT00263328|467509303|FG001|Overall Study|Adverse Event|1|||
129877180|NCT00263328|467509304|FG002|Overall Study|Adverse Event|4|||
129877181|NCT01301274|467509308|FG000|Overall Study|Physician Decision|2|||
129877182|NCT01301274|467509309|FG001|Overall Study|Physician Decision|1|||
129877183|NCT04512066|467509310|FG000|Double-blind Treatment Period|Adverse Event|6|||
129877184|NCT04512066|467509311|FG001|Double-blind Treatment Period|Adverse Event|4|||
129877185|NCT04512066|467509312|FG002|Double-blind Treatment Period|Adverse Event|5|||
129877186|NCT04512066|467509313|FG003|Double-blind Treatment Period|Adverse Event|1|||
129877187|NCT04512066|467509314|FG004|Double-blind Treatment Period|Adverse Event|0|||
129877188|NCT04512066|467509315|FG005|Double-blind Treatment Period|Adverse Event|0|||
129877189|NCT04512066|467509310|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
129877190|NCT04512066|467509311|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
129877191|NCT04512066|467509312|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
129877192|NCT04512066|467509313|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
130213898|NCT01753115|468746921|FG000|Overall Study|Used excluded drug|0|||
130213899|NCT01753115|468746922|FG001|Overall Study|Used excluded drug|1|||
130213900|NCT01753115|468746923|FG002|Overall Study|Used excluded drug|0|||
130213901|NCT01424241|468746926|FG000|Overall Study|Withdrawal by Subject|1|||
130213902|NCT01424241|468746926|FG000|Overall Study|Time constraints|2|||
130213903|NCT00496587|468746927|FG000|Overall Study|Adverse Event|2|||
130213904|NCT00496587|468746927|FG000|Overall Study|Progressive Disease|24|||
130213905|NCT00496587|468746927|FG000|Overall Study|Withdrawal by Subject|2|||
130213906|NCT00496587|468746927|FG000|Overall Study|Death|1|||
130213907|NCT00496587|468746927|FG000|Overall Study|Complications unrelated|2|||
130213908|NCT05259917|468746933|FG000|Overall Study|Protocol Violation|0|||
130213909|NCT05259917|468746934|FG001|Overall Study|Protocol Violation|0|||
130213910|NCT05259917|468746935|FG002|Overall Study|Protocol Violation|1|||
130213911|NCT05259917|468746936|FG003|Overall Study|Protocol Violation|0|||
130213912|NCT05259917|468746937|FG004|Overall Study|Protocol Violation|0|||
130213913|NCT05259917|468746938|FG005|Overall Study|Protocol Violation|0|||
130213914|NCT05259917|468746933|FG000|Overall Study|Lost to Follow-up|0|||
130213915|NCT05259917|468746934|FG001|Overall Study|Lost to Follow-up|0|||
130213916|NCT05259917|468746935|FG002|Overall Study|Lost to Follow-up|1|||
130213917|NCT05259917|468746936|FG003|Overall Study|Lost to Follow-up|0|||
130213918|NCT05259917|468746937|FG004|Overall Study|Lost to Follow-up|0|||
130213919|NCT05259917|468746938|FG005|Overall Study|Lost to Follow-up|1|||
130213920|NCT05259917|468746933|FG000|Overall Study|Physician Decision|0|||
130213921|NCT05259917|468746934|FG001|Overall Study|Physician Decision|1|||
130213922|NCT05259917|468746935|FG002|Overall Study|Physician Decision|0|||
130213923|NCT05259917|468746936|FG003|Overall Study|Physician Decision|0|||
130213924|NCT05259917|468746937|FG004|Overall Study|Physician Decision|0|||
130213925|NCT05259917|468746938|FG005|Overall Study|Physician Decision|0|||
130213926|NCT05259917|468746933|FG000|Overall Study|Withdrawal by Subject|0|||
130213927|NCT05259917|468746934|FG001|Overall Study|Withdrawal by Subject|1|||
130213928|NCT05259917|468746935|FG002|Overall Study|Withdrawal by Subject|0|||
130213929|NCT05259917|468746936|FG003|Overall Study|Withdrawal by Subject|0|||
129877193|NCT04512066|467509314|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
129877194|NCT04512066|467509315|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
129877195|NCT04512066|467509310|FG000|Double-blind Treatment Period|Physician Decision|1|||
130213930|NCT05259917|468746937|FG004|Overall Study|Withdrawal by Subject|1|||
130213931|NCT05259917|468746938|FG005|Overall Study|Withdrawal by Subject|1|||
129877196|NCT04512066|467509311|FG001|Double-blind Treatment Period|Physician Decision|0|||
129877197|NCT04512066|467509312|FG002|Double-blind Treatment Period|Physician Decision|1|||
130213932|NCT05259917|468746933|FG000|Overall Study|Trial Termination by Sponsor|7|||
130213933|NCT05259917|468746934|FG001|Overall Study|Trial Termination by Sponsor|2|||
130322274|NCT01780506|469149105|FG000|Double-Blind Phase|Randomized but not Treated|3|||
130322275|NCT01780506|469149106|FG001|Double-Blind Phase|Randomized but not Treated|2|||
130322276|NCT01780506|469149105|FG000|Double-Blind Phase|Adverse Event|4|||
130322277|NCT01780506|469149106|FG001|Double-Blind Phase|Adverse Event|14|||
130322278|NCT01780506|469149105|FG000|Double-Blind Phase|Death|1|||
130322279|NCT01780506|469149106|FG001|Double-Blind Phase|Death|2|||
130322280|NCT01780506|469149105|FG000|Double-Blind Phase|Pregnancy|2|||
130322281|NCT01780506|469149106|FG001|Double-Blind Phase|Pregnancy|1|||
130322282|NCT01780506|469149105|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130322283|NCT01780506|469149106|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130322284|NCT01780506|469149105|FG000|Double-Blind Phase|Investigator's Discretion|5|||
130322285|NCT01780506|469149106|FG001|Double-Blind Phase|Investigator's Discretion|2|||
130322286|NCT01780506|469149105|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
130322287|NCT01780506|469149106|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130322288|NCT01780506|469149105|FG000|Double-Blind Phase|Protocol Violation|4|||
130322289|NCT01780506|469149106|FG001|Double-Blind Phase|Protocol Violation|3|||
130322290|NCT01780506|469149105|FG000|Double-Blind Phase|Withdrew Consent|23|||
130322291|NCT01780506|469149106|FG001|Double-Blind Phase|Withdrew Consent|24|||
130322292|NCT01780506|469149105|FG000|Double-Blind Phase|Lost to Follow-up|23|||
130322293|NCT01780506|469149106|FG001|Double-Blind Phase|Lost to Follow-up|26|||
130322294|NCT01780506|469149105|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
130322295|NCT01780506|469149106|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
130322296|NCT05236270|469149107|FG000|Overall Study|Lost to Follow-up|3|||
130322297|NCT05236270|469149108|FG001|Overall Study|Lost to Follow-up|2|||
130322298|NCT05236270|469149109|FG002|Overall Study|Lost to Follow-up|0|||
130322299|NCT05236270|469149110|FG003|Overall Study|Lost to Follow-up|0|||
130322300|NCT05236270|469149111|FG004|Overall Study|Lost to Follow-up|2|||
130322301|NCT05236270|469149112|FG005|Overall Study|Lost to Follow-up|0|||
130322302|NCT05236270|469149113|FG006|Overall Study|Lost to Follow-up|1|||
130322303|NCT05236270|469149114|FG007|Overall Study|Lost to Follow-up|3|||
130322304|NCT01499940|469149115|FG000|Overall Study|Study was withdrawn before completion.|9|||
130322305|NCT03279081|469149117|FG000|Overall Study|Withdrawal by Subject|12|||
130322306|NCT03279081|469149118|FG001|Overall Study|Withdrawal by Subject|20|||
130322307|NCT03279081|469149117|FG000|Overall Study|Physician Decision|4|||
130322308|NCT03279081|469149118|FG001|Overall Study|Physician Decision|1|||
130322309|NCT03279081|469149117|FG000|Overall Study|Lost to Follow-up|8|||
130322310|NCT03279081|469149118|FG001|Overall Study|Lost to Follow-up|8|||
130322311|NCT03279081|469149117|FG000|Overall Study|Death|0|||
130322312|NCT03279081|469149118|FG001|Overall Study|Death|1|||
130322313|NCT03279081|469149117|FG000|Overall Study|Adverse Event|1|||
130322314|NCT03279081|469149118|FG001|Overall Study|Adverse Event|0|||
130322315|NCT03279081|469149117|FG000|Overall Study|Reason not Specified|14|||
130322316|NCT03279081|469149118|FG001|Overall Study|Reason not Specified|4|||
130322317|NCT03521570|469149119|FG000|Overall Study|Not eligible|11|||
130322318|NCT03253796|469149130|FG000|Period 1: Run-In|Adverse Event|4|||
130322319|NCT03253796|469149131|FG001|Period 1: Run-In|Adverse Event|0|||
130322320|NCT03253796|469149132|FG002|Period 1: Run-In|Adverse Event|0|||
130322321|NCT03253796|469149133|FG003|Period 1: Run-In|Adverse Event|0|||
130322322|NCT03253796|469149134|FG004|Period 1: Run-In|Adverse Event|0|||
130322323|NCT03253796|469149130|FG000|Period 1: Run-In|Lack of Efficacy|1|||
130322324|NCT03253796|469149131|FG001|Period 1: Run-In|Lack of Efficacy|0|||
130322325|NCT03253796|469149132|FG002|Period 1: Run-In|Lack of Efficacy|0|||
130322326|NCT03253796|469149133|FG003|Period 1: Run-In|Lack of Efficacy|0|||
130322327|NCT03253796|469149134|FG004|Period 1: Run-In|Lack of Efficacy|0|||
130322328|NCT03253796|469149130|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
130322329|NCT03253796|469149131|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
130322330|NCT03253796|469149132|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
130322331|NCT03253796|469149133|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
130322332|NCT03253796|469149134|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
130322333|NCT03253796|469149130|FG000|Period 1: Run-In|Protocol Violation|5|||
130322334|NCT03253796|469149131|FG001|Period 1: Run-In|Protocol Violation|0|||
130322335|NCT03253796|469149132|FG002|Period 1: Run-In|Protocol Violation|0|||
130322336|NCT03253796|469149133|FG003|Period 1: Run-In|Protocol Violation|0|||
130322337|NCT03253796|469149134|FG004|Period 1: Run-In|Protocol Violation|0|||
130322338|NCT03253796|469149130|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
130322339|NCT03253796|469149131|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
130322340|NCT03253796|469149132|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
130322341|NCT03253796|469149133|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
130322342|NCT03253796|469149134|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
130322343|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322344|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322345|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
130322346|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322347|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
130322348|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322349|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322350|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
130322351|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322352|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
130322353|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129877198|NCT04512066|467509313|FG003|Double-blind Treatment Period|Physician Decision|0|||
130213934|NCT05259917|468746935|FG002|Overall Study|Trial Termination by Sponsor|3|||
130213935|NCT05259917|468746936|FG003|Overall Study|Trial Termination by Sponsor|5|||
130213936|NCT05259917|468746937|FG004|Overall Study|Trial Termination by Sponsor|11|||
130213937|NCT05259917|468746938|FG005|Overall Study|Trial Termination by Sponsor|4|||
130213938|NCT05259917|468746933|FG000|Overall Study|Other|1|||
130213939|NCT05259917|468746934|FG001|Overall Study|Other|0|||
130213940|NCT05259917|468746935|FG002|Overall Study|Other|2|||
130213941|NCT05259917|468746936|FG003|Overall Study|Other|0|||
130213942|NCT05259917|468746937|FG004|Overall Study|Other|0|||
130213943|NCT05259917|468746938|FG005|Overall Study|Other|0|||
130213944|NCT02383355|468746941|FG000|Overall Study|Adverse Event|2|||
130213945|NCT02383355|468746942|FG001|Overall Study|Adverse Event|0|||
130213946|NCT01146561|468746944|FG000|Overall Study|Withdrawal by Subject|1|||
130213947|NCT01146561|468746944|FG000|Overall Study|Lost to Follow-up|1|||
130213948|NCT03628716|468746945|FG000|Overall Study|Adverse Event|1|||
130213949|NCT03628716|468746946|FG001|Overall Study|Adverse Event|1|||
130213950|NCT03628716|468746945|FG000|Overall Study|Death|1|||
130213951|NCT03628716|468746946|FG001|Overall Study|Death|0|||
130213952|NCT03628716|468746945|FG000|Overall Study|Lack of Efficacy|15|||
130213953|NCT03628716|468746946|FG001|Overall Study|Lack of Efficacy|20|||
130213954|NCT03628716|468746945|FG000|Overall Study|Withdrawal by Subject|1|||
130213955|NCT03628716|468746946|FG001|Overall Study|Withdrawal by Subject|2|||
130213956|NCT03628716|468746945|FG000|Overall Study|Study Terminated by Sponsor|1|||
130213957|NCT03628716|468746946|FG001|Overall Study|Study Terminated by Sponsor|0|||
130213958|NCT00856843|468746947|FG000|Overall Study|Withdrawal by Subject|1|||
130213959|NCT00856843|468746948|FG001|Overall Study|Withdrawal by Subject|5|||
130213960|NCT00856843|468746947|FG000|Overall Study|Lack of Efficacy|1|||
130213961|NCT00856843|468746948|FG001|Overall Study|Lack of Efficacy|0|||
130213962|NCT01994902|468746949|FG000|Test Period 1|Withdrawal by Subject|3|||
130213963|NCT01994902|468746950|FG001|Test Period 1|Withdrawal by Subject|0|||
130213964|NCT01994902|468746949|FG000|Test Period 1|device deficiency with adverse event|0|||
130213965|NCT01994902|468746950|FG001|Test Period 1|device deficiency with adverse event|1|||
130213966|NCT01994902|468746949|FG000|Test Period 1|Adverse Event|2|||
130213967|NCT01994902|468746950|FG001|Test Period 1|Adverse Event|1|||
130213968|NCT01994902|468746949|FG000|Test Period 1|Lack of Efficacy|0|||
130213969|NCT01994902|468746950|FG001|Test Period 1|Lack of Efficacy|1|||
130213970|NCT01994902|468746949|FG000|Test Period 1|bag too small|1|||
130213971|NCT01994902|468746950|FG001|Test Period 1|bag too small|0|||
130213972|NCT01994902|468746949|FG000|Test Period 2|Withdrawal by Subject|0|||
130213973|NCT01994902|468746950|FG001|Test Period 2|Withdrawal by Subject|2|||
130213974|NCT01994902|468746949|FG000|Test Period 2|Lack of Efficacy|0|||
130213975|NCT01994902|468746950|FG001|Test Period 2|Lack of Efficacy|1|||
130213976|NCT01994902|468746949|FG000|Test Period 2|Other|0|||
130213977|NCT01994902|468746950|FG001|Test Period 2|Other|3|||
130213978|NCT02717442|468746952|FG000|Overall Study|Study Terminated by Sponsor|31|||
130213979|NCT02717442|468746953|FG001|Overall Study|Study Terminated by Sponsor|29|||
130213980|NCT02717442|468746952|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
130213981|NCT02717442|468746953|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
130213982|NCT02717442|468746952|FG000|Overall Study|Other - Not Specified|2|||
130213983|NCT02717442|468746953|FG001|Overall Study|Other - Not Specified|0|||
130213984|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
130213985|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213986|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213987|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213988|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213989|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213990|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213991|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213992|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
130213993|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130213994|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
130213995|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
130213996|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
130213997|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130213998|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
130213999|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
129877199|NCT04512066|467509314|FG004|Double-blind Treatment Period|Physician Decision|0|||
130214000|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130322354|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130322355|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
130322356|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
130322357|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
130322358|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322359|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322360|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
129877200|NCT04512066|467509315|FG005|Double-blind Treatment Period|Physician Decision|0|||
129877201|NCT04512066|467509310|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129877202|NCT04512066|467509311|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
129877203|NCT04512066|467509312|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
129877204|NCT04512066|467509313|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
129877205|NCT04512066|467509314|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
129877206|NCT04512066|467509315|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
129877207|NCT04512066|467509310|FG000|Extension Period|Adverse Event|0|||
129877208|NCT04512066|467509311|FG001|Extension Period|Adverse Event|1|||
129877209|NCT04512066|467509312|FG002|Extension Period|Adverse Event|4|||
129877210|NCT04512066|467509313|FG003|Extension Period|Adverse Event|3|||
129877211|NCT04512066|467509314|FG004|Extension Period|Adverse Event|1|||
129877212|NCT04512066|467509315|FG005|Extension Period|Adverse Event|3|||
129877213|NCT04512066|467509310|FG000|Extension Period|Death|0|||
129877214|NCT04512066|467509311|FG001|Extension Period|Death|0|||
129877215|NCT04512066|467509312|FG002|Extension Period|Death|0|||
129877216|NCT04512066|467509313|FG003|Extension Period|Death|0|||
129877217|NCT04512066|467509314|FG004|Extension Period|Death|0|||
129877218|NCT04512066|467509315|FG005|Extension Period|Death|1|||
129877219|NCT04512066|467509310|FG000|Extension Period|Lack of Efficacy|0|||
129877220|NCT04512066|467509311|FG001|Extension Period|Lack of Efficacy|4|||
129877221|NCT04512066|467509312|FG002|Extension Period|Lack of Efficacy|4|||
129877222|NCT04512066|467509313|FG003|Extension Period|Lack of Efficacy|1|||
129877223|NCT04512066|467509314|FG004|Extension Period|Lack of Efficacy|3|||
129877224|NCT04512066|467509315|FG005|Extension Period|Lack of Efficacy|3|||
129877225|NCT04512066|467509310|FG000|Extension Period|Lost to Follow-up|0|||
129877226|NCT04512066|467509311|FG001|Extension Period|Lost to Follow-up|1|||
129877227|NCT04512066|467509312|FG002|Extension Period|Lost to Follow-up|5|||
129877228|NCT04512066|467509313|FG003|Extension Period|Lost to Follow-up|2|||
129877229|NCT04512066|467509314|FG004|Extension Period|Lost to Follow-up|3|||
129877230|NCT04512066|467509315|FG005|Extension Period|Lost to Follow-up|2|||
129877231|NCT04512066|467509310|FG000|Extension Period|Non-compliance with study drug|0|||
129877232|NCT04512066|467509311|FG001|Extension Period|Non-compliance with study drug|1|||
129877233|NCT04512066|467509312|FG002|Extension Period|Non-compliance with study drug|0|||
129877234|NCT04512066|467509313|FG003|Extension Period|Non-compliance with study drug|0|||
129877235|NCT04512066|467509314|FG004|Extension Period|Non-compliance with study drug|0|||
129877236|NCT04512066|467509315|FG005|Extension Period|Non-compliance with study drug|1|||
129877237|NCT04512066|467509310|FG000|Extension Period|Other|0|||
129877238|NCT04512066|467509311|FG001|Extension Period|Other|2|||
129877239|NCT04512066|467509312|FG002|Extension Period|Other|0|||
129877240|NCT04512066|467509313|FG003|Extension Period|Other|0|||
129877241|NCT04512066|467509314|FG004|Extension Period|Other|0|||
129877242|NCT04512066|467509315|FG005|Extension Period|Other|0|||
129877243|NCT04512066|467509310|FG000|Extension Period|Physician Decision|0|||
129877244|NCT04512066|467509311|FG001|Extension Period|Physician Decision|2|||
130322361|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322362|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
130322363|NCT03253796|469149130|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
130322364|NCT03253796|469149131|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
130322365|NCT03253796|469149132|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
130322366|NCT03253796|469149133|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
130322367|NCT03253796|469149134|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
129877245|NCT04512066|467509312|FG002|Extension Period|Physician Decision|0|||
129877246|NCT04512066|467509313|FG003|Extension Period|Physician Decision|1|||
129877247|NCT04512066|467509314|FG004|Extension Period|Physician Decision|1|||
129877248|NCT04512066|467509315|FG005|Extension Period|Physician Decision|0|||
129877249|NCT04512066|467509310|FG000|Extension Period|Withdrawal by Subject|0|||
129877250|NCT04512066|467509311|FG001|Extension Period|Withdrawal by Subject|3|||
129877251|NCT04512066|467509312|FG002|Extension Period|Withdrawal by Subject|7|||
129877252|NCT04512066|467509313|FG003|Extension Period|Withdrawal by Subject|11|||
129877253|NCT04512066|467509314|FG004|Extension Period|Withdrawal by Subject|8|||
129877254|NCT04512066|467509315|FG005|Extension Period|Withdrawal by Subject|4|||
129877255|NCT03520400|467509316|FG000|Overall Study|Physician Decision|15|||
129877256|NCT03520400|467509317|FG001|Overall Study|Physician Decision|7|||
129877257|NCT01654601|467509323|FG000|1st Administration|Withdrawal by Subject|2|||
129877258|NCT01654601|467509324|FG001|1st Administration|Withdrawal by Subject|0|||
129877259|NCT01654601|467509323|FG000|1st Administration|Protocol Violation|0|||
129877260|NCT01654601|467509324|FG001|1st Administration|Protocol Violation|2|||
129877261|NCT01654601|467509323|FG000|2nd Administration|Adverse Event|1|||
129877262|NCT01654601|467509324|FG001|2nd Administration|Adverse Event|0|||
129877263|NCT01654601|467509323|FG000|2nd Administration|Protocol Violation|0|||
129877264|NCT01654601|467509324|FG001|2nd Administration|Protocol Violation|1|||
129877265|NCT02272725|467509325|FG000|Overall Study|equipment malfunction|2|||
129877266|NCT02272725|467509326|FG001|Overall Study|equipment malfunction|0|||
129877267|NCT00597714|467510714|FG000|Overall Study|Death|56|||
129877268|NCT00597714|467510715|FG001|Overall Study|Death|46|||
129877269|NCT00597714|467510716|FG002|Overall Study|Death|0|||
129877270|NCT00597714|467510714|FG000|Overall Study|Recipient death|0|||
129877271|NCT00597714|467510715|FG001|Overall Study|Recipient death|0|||
129877272|NCT00597714|467510716|FG002|Overall Study|Recipient death|10|||
129877273|NCT01350141|467510717|FG000|Overall Study|Lost to Follow-up|1|||
129877274|NCT01350141|467510718|FG001|Overall Study|Lost to Follow-up|0|||
129877275|NCT01350141|467510719|FG002|Overall Study|Lost to Follow-up|1|||
129877276|NCT01350141|467510717|FG000|Overall Study|Withdrawal by Subject|1|||
129877277|NCT01350141|467510718|FG001|Overall Study|Withdrawal by Subject|0|||
129877278|NCT01350141|467510719|FG002|Overall Study|Withdrawal by Subject|0|||
129877279|NCT01350141|467510717|FG000|Overall Study|Randomized but not treated|1|||
129877280|NCT01350141|467510718|FG001|Overall Study|Randomized but not treated|0|||
129877281|NCT01350141|467510719|FG002|Overall Study|Randomized but not treated|0|||
129877282|NCT00519896|467510720|FG000|Overall Study|Protocol Violation|1|||
129877283|NCT00519896|467510720|FG000|Overall Study|Adverse Event|1|||
129877284|NCT01588990|467510721|FG000|Phase A|Withdrawal by Subject|5|||
129877285|NCT01588990|467510721|FG000|Phase A|Physician Decision|11|||
129877286|NCT01588990|467510721|FG000|Phase A|Other|14|||
129877287|NCT01588990|467510721|FG000|Phase A|Lost to Follow-up|1|||
129877288|NCT01588990|467510721|FG000|Phase A|Death|5|||
129877289|NCT01588990|467510721|FG000|Phase A|Adverse Event|28|||
129877290|NCT01588990|467510721|FG000|Phase A|Still on therapy at end of study|6|||
129877291|NCT01588990|467510721|FG000|Phase B|Adverse Event|2|||
129877292|NCT01588990|467510721|FG000|Phase B|Still on therapy at end of study|5|||
129877293|NCT01588990|467510721|FG000|Phase B|Withdrawal by Subject|3|||
129877294|NCT01588990|467510721|FG000|Phase B|Physician Decision|4|||
129877295|NCT01588990|467510721|FG000|Phase B|Other|2|||
129877296|NCT02367716|467510726|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
129877297|NCT00539643|467510727|FG000|Overall Study|Adverse Event|1|||
129877298|NCT00539643|467510728|FG001|Overall Study|Adverse Event|0|||
129877299|NCT00539643|467510727|FG000|Overall Study|Death|2|||
129877300|NCT00539643|467510728|FG001|Overall Study|Death|1|||
129877301|NCT00539643|467510727|FG000|Overall Study|Physician Decision|3|||
129877302|NCT00539643|467510728|FG001|Overall Study|Physician Decision|1|||
129877303|NCT00539643|467510727|FG000|Overall Study|Withdrawal by Subject|0|||
129877304|NCT00539643|467510728|FG001|Overall Study|Withdrawal by Subject|1|||
129877305|NCT01480596|467510733|FG000|Overall Study|Adverse Event|3|||
129877306|NCT01480596|467510734|FG001|Overall Study|Adverse Event|0|||
129877307|NCT01480596|467510733|FG000|Overall Study|MG exacerbation or change in medication|2|||
129877308|NCT01480596|467510734|FG001|Overall Study|MG exacerbation or change in medication|2|||
129877309|NCT04503096|467510735|FG000|Overall Study|Withdrawal by Subject|3|||
129877310|NCT02343003|467510736|FG000|Overall Study|Withdrawal by Subject|9|||
129877311|NCT02343003|467510737|FG001|Overall Study|Withdrawal by Subject|4|||
129877312|NCT02343003|467510736|FG000|Overall Study|Lost to Follow-up|5|||
129877313|NCT02343003|467510737|FG001|Overall Study|Lost to Follow-up|1|||
129877314|NCT02343003|467510736|FG000|Overall Study|Protocol Violation|1|||
129877315|NCT02343003|467510737|FG001|Overall Study|Protocol Violation|0|||
129877316|NCT02343003|467510736|FG000|Overall Study|Death|0|||
129877317|NCT02343003|467510737|FG001|Overall Study|Death|1|||
129877318|NCT02343003|467510736|FG000|Overall Study|exclusion criteria met|1|||
130214001|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
130214002|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
129877319|NCT02343003|467510737|FG001|Overall Study|exclusion criteria met|1|||
129877320|NCT02343003|467510736|FG000|Overall Study|terminated by sponsor|2|||
129877321|NCT02343003|467510737|FG001|Overall Study|terminated by sponsor|0|||
129877322|NCT02281760|467510739|FG000|Overall Study|Withdrawal by Subject|1|||
129877323|NCT01576367|467510744|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129877324|NCT01576367|467510744|FG000|Overall Study|Moved to commercial use after 6 months|1|||
129877325|NCT01453348|467510745|FG000|Overall Study|Death|0|||
129877326|NCT01453348|467510746|FG001|Overall Study|Death|0|||
129877327|NCT01453348|467510747|FG002|Overall Study|Death|1|||
129877328|NCT01453348|467510745|FG000|Overall Study|Withdrawal by Subject|0|||
129877329|NCT01453348|467510746|FG001|Overall Study|Withdrawal by Subject|1|||
130214003|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
129877330|NCT01453348|467510747|FG002|Overall Study|Withdrawal by Subject|0|||
129877331|NCT01453348|467510745|FG000|Overall Study|Protocol Violation|1|||
129877332|NCT01453348|467510746|FG001|Overall Study|Protocol Violation|0|||
129877333|NCT01453348|467510747|FG002|Overall Study|Protocol Violation|0|||
129877334|NCT04359771|467510752|FG000|Overall Study|Lack of Efficacy|2|||
129877335|NCT04359771|467510753|FG001|Overall Study|Lack of Efficacy|2|||
129877336|NCT03592277|467510754|FG000|Overall Study|Withdrawal by Subject|6|||
129877337|NCT03592277|467510755|FG001|Overall Study|Withdrawal by Subject|8|||
129877338|NCT00954733|467510756|FG000|Overall Study|blood gas machine did not work|1|||
129877339|NCT01462162|467510759|FG000|Overall Study|Adverse Event|5|||
129877340|NCT01462162|467510759|FG000|Overall Study|Lack of Efficacy|4|||
129877341|NCT01462162|467510759|FG000|Overall Study|Abnormal laboratory parameters|1|||
129877342|NCT01462162|467510759|FG000|Overall Study|Other|2|||
129877343|NCT01346514|467510760|FG000|Overall Study|Lost to Follow-up|19|||
129877344|NCT01346514|467510761|FG001|Overall Study|Lost to Follow-up|30|||
129877345|NCT01346514|467510760|FG000|Overall Study|Withdrawal by Subject|7|||
129877346|NCT01346514|467510761|FG001|Overall Study|Withdrawal by Subject|3|||
129877347|NCT01346514|467510760|FG000|Overall Study|Death|3|||
129877348|NCT01346514|467510761|FG001|Overall Study|Death|4|||
129877349|NCT00909480|467510762|FG000|Overall Study|Adverse Event|5|||
129877350|NCT00909480|467510763|FG001|Overall Study|Adverse Event|3|||
129877351|NCT00909480|467510762|FG000|Overall Study|Protocol Violation|6|||
129877352|NCT00909480|467510763|FG001|Overall Study|Protocol Violation|8|||
129877353|NCT00909480|467510762|FG000|Overall Study|Withdrawal criteria|9|||
129877354|NCT00909480|467510763|FG001|Overall Study|Withdrawal criteria|11|||
129877355|NCT00909480|467510762|FG000|Overall Study|Unclassified|18|||
129877356|NCT00909480|467510763|FG001|Overall Study|Unclassified|19|||
129877357|NCT01215357|467510767|FG000|Overall Study|Withdrawal by Subject|3|||
129877358|NCT01215357|467510767|FG000|Overall Study|Protocol Violation|9|||
129877359|NCT04772053|467510782|FG000|Overall Study|Physician Decision|2|||
129877360|NCT04772053|467510782|FG000|Overall Study|Withdrawal by Subject|3|||
129877361|NCT04772053|467510782|FG000|Overall Study|Study Terminated by Sponsor|1|||
129877362|NCT04599101|467510783|FG000|Overall Study|Lost to Follow-up|5|||
129877363|NCT04599101|467510784|FG001|Overall Study|Lost to Follow-up|5|||
129877364|NCT00098254|467510789|FG000|Overall Study|Adverse Event|2|||
129877365|NCT00098254|467510789|FG000|Overall Study|Death|1|||
129877366|NCT02118337|467510790|FG000|Overall Study|Other|1|||
129877367|NCT02118337|467510791|FG001|Overall Study|Other|0|||
129877368|NCT02118337|467510792|FG002|Overall Study|Other|0|||
129877369|NCT02118337|467510793|FG003|Overall Study|Other|0|||
129877370|NCT02118337|467510794|FG004|Overall Study|Other|2|||
129877371|NCT02118337|467510795|FG005|Overall Study|Other|3|||
129877372|NCT02118337|467510796|FG006|Overall Study|Other|1|||
129877373|NCT02118337|467510797|FG007|Overall Study|Other|28|||
129877374|NCT02118337|467510798|FG008|Overall Study|Other|15|||
129877375|NCT02118337|467510790|FG000|Overall Study|Lost to Follow-up|0|||
129877376|NCT02118337|467510791|FG001|Overall Study|Lost to Follow-up|0|||
129877377|NCT02118337|467510792|FG002|Overall Study|Lost to Follow-up|0|||
129877378|NCT02118337|467510793|FG003|Overall Study|Lost to Follow-up|0|||
129877379|NCT02118337|467510794|FG004|Overall Study|Lost to Follow-up|0|||
129877380|NCT02118337|467510795|FG005|Overall Study|Lost to Follow-up|0|||
129877381|NCT02118337|467510796|FG006|Overall Study|Lost to Follow-up|0|||
129877382|NCT02118337|467510797|FG007|Overall Study|Lost to Follow-up|1|||
129877383|NCT02118337|467510798|FG008|Overall Study|Lost to Follow-up|0|||
129877384|NCT02118337|467510790|FG000|Overall Study|Withdrawal by Subject|1|||
129877385|NCT02118337|467510791|FG001|Overall Study|Withdrawal by Subject|3|||
129877386|NCT02118337|467510792|FG002|Overall Study|Withdrawal by Subject|2|||
129877387|NCT02118337|467510793|FG003|Overall Study|Withdrawal by Subject|1|||
129877388|NCT02118337|467510794|FG004|Overall Study|Withdrawal by Subject|2|||
129877389|NCT02118337|467510795|FG005|Overall Study|Withdrawal by Subject|2|||
129877390|NCT02118337|467510796|FG006|Overall Study|Withdrawal by Subject|1|||
129877391|NCT02118337|467510797|FG007|Overall Study|Withdrawal by Subject|4|||
129877392|NCT02118337|467510798|FG008|Overall Study|Withdrawal by Subject|2|||
129877393|NCT02118337|467510790|FG000|Overall Study|Death|2|||
129877394|NCT02118337|467510791|FG001|Overall Study|Death|2|||
129877395|NCT02118337|467510792|FG002|Overall Study|Death|1|||
129877396|NCT02118337|467510793|FG003|Overall Study|Death|2|||
129877397|NCT02118337|467510794|FG004|Overall Study|Death|5|||
129877398|NCT02118337|467510795|FG005|Overall Study|Death|1|||
130322368|NCT03253796|469149130|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129877399|NCT02118337|467510796|FG006|Overall Study|Death|2|||
129877400|NCT02118337|467510797|FG007|Overall Study|Death|9|||
129877401|NCT02118337|467510798|FG008|Overall Study|Death|4|||
129877402|NCT03300570|467510804|FG000|Overall Study|Adverse Event|0|||
129877403|NCT03300570|467510805|FG001|Overall Study|Adverse Event|1|||
129877404|NCT03300570|467510804|FG000|Overall Study|Withdrawal by Subject|1|||
129877405|NCT03300570|467510805|FG001|Overall Study|Withdrawal by Subject|0|||
129877406|NCT03300570|467510804|FG000|Overall Study|Inadequate bowel prep|1|||
129877407|NCT03300570|467510805|FG001|Overall Study|Inadequate bowel prep|0|||
129877408|NCT03188120|467510806|FG000|Overall Study|Adverse Event|4|||
130322369|NCT03253796|469149131|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129877409|NCT03188120|467510806|FG000|Overall Study|Insufficient Effectiveness|8|||
129877410|NCT03188120|467510806|FG000|Overall Study|Improved|12|||
129877411|NCT03188120|467510806|FG000|Overall Study|Lost to Follow-up|7|||
129877412|NCT03188120|467510806|FG000|Overall Study|Other than specified|3|||
129877413|NCT03188120|467510806|FG000|Overall Study|No visit after the first visit|13|||
129877414|NCT02978443|467510808|FG000|Overall Study|Withdrawal by Subject|1|||
129877415|NCT02978443|467510808|FG000|Overall Study|Adverse Event|3|||
129877416|NCT02978443|467510808|FG000|Overall Study|Disease Progression on study|6|||
129877417|NCT02978443|467510808|FG000|Overall Study|Death|1|||
129877418|NCT02978443|467510808|FG000|Overall Study|Physician Decision|1|||
129877419|NCT02978443|467510808|FG000|Overall Study|Switch to alternative therapy|1|||
129877420|NCT02978443|467510808|FG000|Overall Study|Refused further treatment|1|||
129877421|NCT00717314|467510809|FG000|Overall Study|Adverse Event|3|||
129877422|NCT00717314|467510810|FG001|Overall Study|Adverse Event|2|||
129877423|NCT00717314|467510809|FG000|Overall Study|Protocol Violation|1|||
129877424|NCT00717314|467510810|FG001|Overall Study|Protocol Violation|0|||
129877425|NCT00717314|467510809|FG000|Overall Study|Lost to Follow-up|1|||
129877426|NCT00717314|467510810|FG001|Overall Study|Lost to Follow-up|5|||
129877427|NCT00717314|467510809|FG000|Overall Study|Withdrawal by Subject|1|||
129877428|NCT00717314|467510810|FG001|Overall Study|Withdrawal by Subject|3|||
129877429|NCT04631705|467510812|FG000|Overall Study|Withdrawal by Subject|0|||
129877430|NCT04631705|467510813|FG001|Overall Study|Withdrawal by Subject|0|||
129877431|NCT04631705|467510814|FG002|Overall Study|Withdrawal by Subject|0|||
129877432|NCT04631705|467510815|FG003|Overall Study|Withdrawal by Subject|0|||
129877433|NCT04631705|467510816|FG004|Overall Study|Withdrawal by Subject|0|||
129877434|NCT04631705|467510817|FG005|Overall Study|Withdrawal by Subject|0|||
129877435|NCT04631705|467510818|FG006|Overall Study|Withdrawal by Subject|1|||
129877436|NCT04631705|467510819|FG007|Overall Study|Withdrawal by Subject|0|||
129877437|NCT04631705|467510820|FG008|Overall Study|Withdrawal by Subject|0|||
129877438|NCT02130284|467510821|FG000|Overall Study|Withdrawal by Subject|3|||
129877439|NCT02130284|467510821|FG000|Overall Study|Subject Withdrew Consent|1|||
129877440|NCT02130284|467510821|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
129877441|NCT02130284|467510821|FG000|Overall Study|Subject was screened as backup for study|3|||
129877442|NCT02130284|467510821|FG000|Overall Study|Screen Failure|1|||
129877443|NCT03238300|467510825|FG000|Baseline (Before Intervention)|Physician Decision|0|||
129877444|NCT03238300|467510826|FG001|Baseline (Before Intervention)|Physician Decision|1|||
129877445|NCT03238300|467510825|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
129877446|NCT03238300|467510826|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
129877447|NCT03238300|467510825|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
129877448|NCT03238300|467510826|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
129877449|NCT03238300|467510825|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
129877450|NCT03238300|467510826|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
129877451|NCT00110890|467510832|FG000|Overall Study|Adverse Event|30|||
129877452|NCT00110890|467510833|FG001|Overall Study|Adverse Event|7|||
129877453|NCT00110890|467510832|FG000|Overall Study|Death|16|||
129877454|NCT00110890|467510833|FG001|Overall Study|Death|9|||
129877455|NCT00110890|467510832|FG000|Overall Study|Lost to Follow-up|3|||
129877456|NCT00110890|467510833|FG001|Overall Study|Lost to Follow-up|1|||
129877457|NCT00110890|467510832|FG000|Overall Study|Physician Decision|4|||
129877458|NCT00110890|467510833|FG001|Overall Study|Physician Decision|5|||
129877459|NCT00110890|467510832|FG000|Overall Study|Withdrawal by Subject|17|||
129877460|NCT00110890|467510833|FG001|Overall Study|Withdrawal by Subject|5|||
129877461|NCT00110890|467510832|FG000|Overall Study|Protocol Deviation|1|||
129877462|NCT00110890|467510833|FG001|Overall Study|Protocol Deviation|0|||
129877463|NCT00110890|467510832|FG000|Overall Study|Noncompliance|10|||
129877464|NCT00110890|467510833|FG001|Overall Study|Noncompliance|0|||
129877465|NCT00110890|467510832|FG000|Overall Study|Kidney Transplant|16|||
129877466|NCT00110890|467510833|FG001|Overall Study|Kidney Transplant|12|||
129877467|NCT00110890|467510832|FG000|Overall Study|Invest. Product Commercially Available|217|||
129877468|NCT00110890|467510833|FG001|Overall Study|Invest. Product Commercially Available|110|||
129877469|NCT00110890|467510832|FG000|Overall Study|Other|34|||
129877470|NCT00110890|467510833|FG001|Overall Study|Other|23|||
129877471|NCT00110890|467510832|FG000|Overall Study|Ineligibility determined|3|||
129877472|NCT00110890|467510833|FG001|Overall Study|Ineligibility determined|0|||
129877473|NCT00110890|467510832|FG000|Overall Study|Requirement for alternative therapy|0|||
129877474|NCT00110890|467510833|FG001|Overall Study|Requirement for alternative therapy|1|||
129877475|NCT00110890|467510832|FG000|Overall Study|Disease progression|0|||
129877476|NCT00110890|467510833|FG001|Overall Study|Disease progression|1|||
129877477|NCT00110890|467510832|FG000|Overall Study|Parathyroidectomy|0|||
129877478|NCT00110890|467510833|FG001|Overall Study|Parathyroidectomy|1|||
129877479|NCT00110890|467510832|FG000|Overall Study|Did not enter follow-up phase|10|||
129877480|NCT00110890|467510833|FG001|Overall Study|Did not enter follow-up phase|4|||
129877481|NCT01975220|467510834|FG000|Test Period 1|Not treated|0|||
129877482|NCT01975220|467510835|FG001|Test Period 1|Not treated|1|||
129877483|NCT01975220|467510836|FG002|Test Period 1|Not treated|0|||
129877484|NCT01975220|467510837|FG003|Test Period 1|Not treated|0|||
129877485|NCT01975220|467510838|FG004|Test Period 1|Not treated|0|||
129877486|NCT01975220|467510839|FG005|Test Period 1|Not treated|0|||
129877487|NCT02839343|467510840|FG000|Overall Study|Withdrawal by Subject|3|||
129877488|NCT02839343|467510841|FG001|Overall Study|Withdrawal by Subject|1|||
129877489|NCT02839343|467510840|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
129877490|NCT02839343|467510841|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
129877491|NCT02839343|467510840|FG000|Overall Study|Adverse Event|1|||
129877492|NCT02839343|467510841|FG001|Overall Study|Adverse Event|0|||
129877493|NCT00661661|467510842|FG000|Overall Study|Adverse Event|99|||
129877494|NCT00661661|467510843|FG001|Overall Study|Adverse Event|24|||
129877495|NCT00661661|467510842|FG000|Overall Study|Lack of Efficacy|3|||
129877496|NCT00661661|467510843|FG001|Overall Study|Lack of Efficacy|2|||
129877497|NCT00661661|467510842|FG000|Overall Study|Lost to Follow-up|0|||
129877498|NCT00661661|467510843|FG001|Overall Study|Lost to Follow-up|1|||
129877499|NCT00661661|467510842|FG000|Overall Study|Withdrawal by Subject|15|||
129877500|NCT00661661|467510843|FG001|Overall Study|Withdrawal by Subject|5|||
129877501|NCT00661661|467510842|FG000|Overall Study|Other|22|||
129877502|NCT00661661|467510843|FG001|Overall Study|Other|7|||
129877503|NCT00661661|467510842|FG000|Overall Study|Not assigned treatment|1|||
129877504|NCT00661661|467510843|FG001|Overall Study|Not assigned treatment|0|||
129877505|NCT01893827|467510844|FG000|Overall Study|Lost to Follow-up|19|||
129877506|NCT01893827|467510845|FG001|Overall Study|Lost to Follow-up|26|||
129877507|NCT00445679|467510848|FG000|Overall Study|Adverse Event|22|||
129877508|NCT00445679|467510849|FG001|Overall Study|Adverse Event|12|||
129877509|NCT00445679|467510850|FG002|Overall Study|Adverse Event|30|||
129877510|NCT00445679|467510851|FG003|Overall Study|Adverse Event|19|||
129877511|NCT00445679|467510848|FG000|Overall Study|Failed to return|1|||
129877512|NCT00445679|467510849|FG001|Overall Study|Failed to return|3|||
129877513|NCT00445679|467510850|FG002|Overall Study|Failed to return|2|||
129877514|NCT00445679|467510851|FG003|Overall Study|Failed to return|2|||
129877515|NCT00445679|467510848|FG000|Overall Study|Physician Decision|0|||
129877516|NCT00445679|467510849|FG001|Overall Study|Physician Decision|0|||
129877517|NCT00445679|467510850|FG002|Overall Study|Physician Decision|1|||
129877518|NCT00445679|467510851|FG003|Overall Study|Physician Decision|0|||
129877519|NCT00445679|467510848|FG000|Overall Study|Lost to Follow-up|10|||
129877520|NCT00445679|467510849|FG001|Overall Study|Lost to Follow-up|6|||
129877521|NCT00445679|467510850|FG002|Overall Study|Lost to Follow-up|6|||
129877522|NCT00445679|467510851|FG003|Overall Study|Lost to Follow-up|5|||
129877523|NCT00445679|467510848|FG000|Overall Study|Compliance|3|||
129877524|NCT00445679|467510849|FG001|Overall Study|Compliance|2|||
129877525|NCT00445679|467510850|FG002|Overall Study|Compliance|1|||
129877526|NCT00445679|467510851|FG003|Overall Study|Compliance|2|||
129877527|NCT00445679|467510848|FG000|Overall Study|Withdrawal of Informed Consent|0|||
129877528|NCT00445679|467510849|FG001|Overall Study|Withdrawal of Informed Consent|0|||
129877529|NCT00445679|467510850|FG002|Overall Study|Withdrawal of Informed Consent|1|||
129877530|NCT00445679|467510851|FG003|Overall Study|Withdrawal of Informed Consent|0|||
129877531|NCT00445679|467510848|FG000|Overall Study|Protocol Violation|2|||
129877532|NCT00445679|467510849|FG001|Overall Study|Protocol Violation|3|||
129877533|NCT00445679|467510850|FG002|Overall Study|Protocol Violation|3|||
129877534|NCT00445679|467510851|FG003|Overall Study|Protocol Violation|1|||
129877535|NCT00445679|467510848|FG000|Overall Study|Withdrawal by Subject|8|||
129877536|NCT00445679|467510849|FG001|Overall Study|Withdrawal by Subject|14|||
129877537|NCT00445679|467510850|FG002|Overall Study|Withdrawal by Subject|20|||
129877538|NCT00445679|467510851|FG003|Overall Study|Withdrawal by Subject|18|||
129877539|NCT00445679|467510848|FG000|Overall Study|Lack of Efficacy|2|||
129877540|NCT00445679|467510849|FG001|Overall Study|Lack of Efficacy|6|||
129877541|NCT00445679|467510850|FG002|Overall Study|Lack of Efficacy|2|||
129877542|NCT00445679|467510851|FG003|Overall Study|Lack of Efficacy|0|||
129877543|NCT03535337|467510855|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
129877544|NCT03535337|467510856|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
129877545|NCT03535337|467510857|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
129877546|NCT03535337|467510858|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
130214004|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
130214005|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
130214006|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
130214007|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
130214008|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
130214009|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
130214010|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
129877547|NCT03535337|467510859|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
129877548|NCT03535337|467510860|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
130214011|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
129877549|NCT03535337|467510861|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
129877550|NCT03535337|467510862|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
129877551|NCT03535337|467510863|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
129877552|NCT03535337|467510864|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
129877553|NCT02089230|467510865|FG000|Overall Study|Death|0|||
129877554|NCT02089230|467510866|FG001|Overall Study|Death|0|||
129877555|NCT02089230|467510867|FG002|Overall Study|Death|2|||
129877556|NCT02089230|467510865|FG000|Overall Study|Seeking Alternative Therapy|0|||
129877557|NCT02089230|467510866|FG001|Overall Study|Seeking Alternative Therapy|0|||
129877558|NCT02089230|467510867|FG002|Overall Study|Seeking Alternative Therapy|4|||
129877559|NCT02392611|467512668|FG000|Overall Study|Adverse Event|0|||
129877560|NCT02392611|467512669|FG001|Overall Study|Adverse Event|0|||
129877561|NCT02392611|467512670|FG002|Overall Study|Adverse Event|0|||
129877562|NCT02392611|467512671|FG003|Overall Study|Adverse Event|1|||
129877563|NCT02392611|467512672|FG004|Overall Study|Adverse Event|0|||
129877564|NCT02392611|467512673|FG005|Overall Study|Adverse Event|0|||
129877565|NCT02392611|467512674|FG006|Overall Study|Adverse Event|0|||
129877566|NCT02392611|467512675|FG007|Overall Study|Adverse Event|0|||
129877567|NCT02392611|467512676|FG008|Overall Study|Adverse Event|0|||
129877568|NCT02392611|467512668|FG000|Overall Study|Progressive disease|0|||
129877569|NCT02392611|467512669|FG001|Overall Study|Progressive disease|0|||
129877570|NCT02392611|467512670|FG002|Overall Study|Progressive disease|0|||
129877571|NCT02392611|467512671|FG003|Overall Study|Progressive disease|2|||
129877572|NCT02392611|467512672|FG004|Overall Study|Progressive disease|1|||
129877573|NCT02392611|467512673|FG005|Overall Study|Progressive disease|0|||
129877574|NCT02392611|467512674|FG006|Overall Study|Progressive disease|0|||
129877575|NCT02392611|467512675|FG007|Overall Study|Progressive disease|0|||
129877576|NCT02392611|467512676|FG008|Overall Study|Progressive disease|0|||
129877577|NCT02392611|467512668|FG000|Overall Study|Death|1|||
129877578|NCT02392611|467512669|FG001|Overall Study|Death|0|||
129877579|NCT02392611|467512670|FG002|Overall Study|Death|0|||
129877580|NCT02392611|467512671|FG003|Overall Study|Death|0|||
129877581|NCT02392611|467512672|FG004|Overall Study|Death|0|||
129877582|NCT02392611|467512673|FG005|Overall Study|Death|1|||
129877583|NCT02392611|467512674|FG006|Overall Study|Death|0|||
129877584|NCT02392611|467512675|FG007|Overall Study|Death|0|||
129877585|NCT02392611|467512676|FG008|Overall Study|Death|0|||
129877586|NCT02392611|467512668|FG000|Overall Study|Withdrawal by Subject|0|||
129877587|NCT02392611|467512669|FG001|Overall Study|Withdrawal by Subject|0|||
129877588|NCT02392611|467512670|FG002|Overall Study|Withdrawal by Subject|0|||
129877589|NCT02392611|467512671|FG003|Overall Study|Withdrawal by Subject|1|||
129877590|NCT02392611|467512672|FG004|Overall Study|Withdrawal by Subject|0|||
129877591|NCT02392611|467512673|FG005|Overall Study|Withdrawal by Subject|0|||
129877592|NCT02392611|467512674|FG006|Overall Study|Withdrawal by Subject|0|||
129877593|NCT02392611|467512675|FG007|Overall Study|Withdrawal by Subject|0|||
129877594|NCT02392611|467512676|FG008|Overall Study|Withdrawal by Subject|0|||
129877595|NCT02392611|467512668|FG000|Overall Study|Lost to Follow-up|0|||
129877596|NCT02392611|467512669|FG001|Overall Study|Lost to Follow-up|0|||
129877597|NCT02392611|467512670|FG002|Overall Study|Lost to Follow-up|0|||
129877598|NCT02392611|467512671|FG003|Overall Study|Lost to Follow-up|0|||
129877599|NCT02392611|467512672|FG004|Overall Study|Lost to Follow-up|0|||
129877600|NCT02392611|467512673|FG005|Overall Study|Lost to Follow-up|0|||
129877601|NCT02392611|467512674|FG006|Overall Study|Lost to Follow-up|1|||
129877602|NCT02392611|467512675|FG007|Overall Study|Lost to Follow-up|0|||
129877603|NCT02392611|467512676|FG008|Overall Study|Lost to Follow-up|0|||
129877604|NCT02392611|467512668|FG000|Overall Study|Enrolled, not treated|0|||
129877605|NCT02392611|467512669|FG001|Overall Study|Enrolled, not treated|0|||
129877606|NCT02392611|467512670|FG002|Overall Study|Enrolled, not treated|0|||
129877607|NCT02392611|467512671|FG003|Overall Study|Enrolled, not treated|2|||
129877608|NCT02392611|467512672|FG004|Overall Study|Enrolled, not treated|0|||
129877609|NCT02392611|467512673|FG005|Overall Study|Enrolled, not treated|0|||
129877610|NCT02392611|467512674|FG006|Overall Study|Enrolled, not treated|0|||
129877611|NCT02392611|467512675|FG007|Overall Study|Enrolled, not treated|0|||
129877612|NCT02392611|467512676|FG008|Overall Study|Enrolled, not treated|0|||
129877613|NCT03585296|467512692|FG000|Overall Study|Adverse Event|1|||
129877614|NCT03585296|467512692|FG000|Overall Study|Lost to Follow-up|2|||
129877615|NCT03585296|467512692|FG000|Overall Study|Withdrawal by Subject|2|||
129877616|NCT00462670|467512693|FG000|Overall Study|Adverse Event|3|||
129877617|NCT00462670|467512694|FG001|Overall Study|Adverse Event|5|||
129877618|NCT00462670|467512693|FG000|Overall Study|Lack of Efficacy|1|||
129877619|NCT00462670|467512694|FG001|Overall Study|Lack of Efficacy|0|||
129877620|NCT00462670|467512693|FG000|Overall Study|Protocol Violation|1|||
129877621|NCT00462670|467512694|FG001|Overall Study|Protocol Violation|0|||
129877622|NCT00462670|467512693|FG000|Overall Study|Resolution of signs and symptoms|0|||
129877623|NCT00462670|467512694|FG001|Overall Study|Resolution of signs and symptoms|2|||
129877624|NCT02110732|467512695|FG000|Overall Study|Physician Decision|5|||
129877625|NCT02110732|467512696|FG001|Overall Study|Physician Decision|2|||
129877626|NCT02110732|467512695|FG000|Overall Study|Lost to Follow-up|1|||
129877627|NCT02110732|467512696|FG001|Overall Study|Lost to Follow-up|1|||
129877628|NCT00633932|467512698|FG000|Overall Study|Adverse Event|1|||
129877629|NCT00633932|467512699|FG001|Overall Study|Adverse Event|3|||
129877630|NCT00633932|467512700|FG002|Overall Study|Adverse Event|4|||
129877631|NCT00633932|467512698|FG000|Overall Study|Withdrawal by Subject|3|||
129877632|NCT00633932|467512699|FG001|Overall Study|Withdrawal by Subject|9|||
129877633|NCT00633932|467512700|FG002|Overall Study|Withdrawal by Subject|1|||
129877634|NCT00633932|467512698|FG000|Overall Study|Lost to Follow-up|1|||
129877635|NCT00633932|467512699|FG001|Overall Study|Lost to Follow-up|0|||
129877636|NCT00633932|467512700|FG002|Overall Study|Lost to Follow-up|2|||
129877637|NCT00633932|467512698|FG000|Overall Study|Protocol Violation|5|||
129877638|NCT00633932|467512699|FG001|Overall Study|Protocol Violation|2|||
129877639|NCT00633932|467512700|FG002|Overall Study|Protocol Violation|3|||
129877640|NCT00633932|467512698|FG000|Overall Study|Physician Decision|0|||
129877641|NCT00633932|467512699|FG001|Overall Study|Physician Decision|0|||
129877642|NCT00633932|467512700|FG002|Overall Study|Physician Decision|1|||
129877643|NCT00633932|467512698|FG000|Overall Study|Doctor's judgement|1|||
129877644|NCT00633932|467512699|FG001|Overall Study|Doctor's judgement|0|||
129877645|NCT00633932|467512700|FG002|Overall Study|Doctor's judgement|0|||
129877646|NCT00633932|467512698|FG000|Overall Study|Moved Away|1|||
129877647|NCT00633932|467512699|FG001|Overall Study|Moved Away|0|||
129877648|NCT00633932|467512700|FG002|Overall Study|Moved Away|0|||
129877649|NCT00482274|467512701|FG000|Overall Study|Adverse Event|1|||
129877650|NCT04836858|467512702|FG000|Overall Study|Adverse Event|0|||
129877651|NCT04836858|467512703|FG001|Overall Study|Adverse Event|0|||
129877652|NCT04836858|467512704|FG002|Overall Study|Adverse Event|0|||
129877653|NCT04836858|467512705|FG003|Overall Study|Adverse Event|1|||
129877654|NCT04836858|467512702|FG000|Overall Study|Lost to Follow-up|1|||
129877655|NCT04836858|467512703|FG001|Overall Study|Lost to Follow-up|0|||
129877656|NCT04836858|467512704|FG002|Overall Study|Lost to Follow-up|0|||
129877657|NCT04836858|467512705|FG003|Overall Study|Lost to Follow-up|0|||
129877658|NCT04836858|467512702|FG000|Overall Study|Subject/Guardian decision|3|||
129877659|NCT04836858|467512703|FG001|Overall Study|Subject/Guardian decision|0|||
129877660|NCT04836858|467512704|FG002|Overall Study|Subject/Guardian decision|0|||
129877661|NCT04836858|467512705|FG003|Overall Study|Subject/Guardian decision|1|||
129877662|NCT04836858|467512702|FG000|Overall Study|Randomized but not treated|4|||
129877663|NCT04836858|467512703|FG001|Overall Study|Randomized but not treated|0|||
129877664|NCT04836858|467512704|FG002|Overall Study|Randomized but not treated|0|||
129877665|NCT04836858|467512705|FG003|Overall Study|Randomized but not treated|0|||
129877666|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
129877667|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
129877668|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Adverse Event|2|||
129877669|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Adverse Event|5|||
129877670|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
129877671|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
129877672|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
129877673|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
129877674|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Randomized by error|0|||
129877675|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Randomized by error|5|||
129877676|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
129877677|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
129877678|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
129877679|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
129877680|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Change of residence location|0|||
129877681|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Change of residence location|1|||
129877682|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
129877683|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
129877684|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
129877685|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
129877686|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
129877687|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
129877688|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
129877689|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
129877690|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
129877691|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
129877692|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Study site closure|1|||
129877693|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Study site closure|0|||
129877694|NCT00810082|467512710|FG000|Overall Study|Lost to Follow-up|0|||
129877695|NCT00810082|467512711|FG001|Overall Study|Lost to Follow-up|4|||
129877696|NCT02508532|467512714|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877697|NCT02508532|467512715|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877698|NCT02508532|467512716|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877699|NCT02508532|467512717|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
130322370|NCT03253796|469149132|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
130322371|NCT03253796|469149133|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129877700|NCT02508532|467512718|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877701|NCT02508532|467512719|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877702|NCT02508532|467512720|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
129877703|NCT02508532|467512721|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877704|NCT02508532|467512722|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877705|NCT02508532|467512714|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877706|NCT02508532|467512715|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877707|NCT02508532|467512716|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877708|NCT02508532|467512717|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877709|NCT02508532|467512718|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877710|NCT02508532|467512719|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877711|NCT02508532|467512720|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877712|NCT02508532|467512721|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
129877713|NCT02508532|467512722|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877714|NCT02508532|467512714|FG000|Part 2 - Treatment|Disease Progression|0|||
129877715|NCT02508532|467512715|FG001|Part 2 - Treatment|Disease Progression|0|||
129877716|NCT02508532|467512716|FG002|Part 2 - Treatment|Disease Progression|0|||
129877717|NCT02508532|467512717|FG003|Part 2 - Treatment|Disease Progression|0|||
129877718|NCT02508532|467512718|FG004|Part 2 - Treatment|Disease Progression|0|||
129877719|NCT02508532|467512719|FG005|Part 2 - Treatment|Disease Progression|0|||
129877720|NCT02508532|467512720|FG006|Part 2 - Treatment|Disease Progression|0|||
129877721|NCT02508532|467512721|FG007|Part 2 - Treatment|Disease Progression|0|||
129877722|NCT02508532|467512722|FG008|Part 2 - Treatment|Disease Progression|118|||
129877723|NCT02508532|467512714|FG000|Part 2 - Treatment|Adverse Event|0|||
129877724|NCT02508532|467512715|FG001|Part 2 - Treatment|Adverse Event|0|||
129877725|NCT02508532|467512716|FG002|Part 2 - Treatment|Adverse Event|0|||
129877726|NCT02508532|467512717|FG003|Part 2 - Treatment|Adverse Event|0|||
129877727|NCT02508532|467512718|FG004|Part 2 - Treatment|Adverse Event|0|||
129877728|NCT02508532|467512719|FG005|Part 2 - Treatment|Adverse Event|0|||
129877729|NCT02508532|467512720|FG006|Part 2 - Treatment|Adverse Event|0|||
129877730|NCT02508532|467512721|FG007|Part 2 - Treatment|Adverse Event|0|||
129877731|NCT02508532|467512722|FG008|Part 2 - Treatment|Adverse Event|49|||
129877732|NCT02508532|467512714|FG000|Part 2 - Treatment|Physician Decision|0|||
129877733|NCT02508532|467512715|FG001|Part 2 - Treatment|Physician Decision|0|||
129877734|NCT02508532|467512716|FG002|Part 2 - Treatment|Physician Decision|0|||
129877735|NCT02508532|467512717|FG003|Part 2 - Treatment|Physician Decision|0|||
129877736|NCT02508532|467512718|FG004|Part 2 - Treatment|Physician Decision|0|||
129877737|NCT02508532|467512719|FG005|Part 2 - Treatment|Physician Decision|0|||
129877738|NCT02508532|467512720|FG006|Part 2 - Treatment|Physician Decision|0|||
129877739|NCT02508532|467512721|FG007|Part 2 - Treatment|Physician Decision|0|||
129877740|NCT02508532|467512722|FG008|Part 2 - Treatment|Physician Decision|12|||
129877741|NCT02508532|467512714|FG000|Part 2 - Treatment|Administrative|0|||
129877742|NCT02508532|467512715|FG001|Part 2 - Treatment|Administrative|0|||
129877743|NCT02508532|467512716|FG002|Part 2 - Treatment|Administrative|0|||
129877744|NCT02508532|467512717|FG003|Part 2 - Treatment|Administrative|0|||
129877745|NCT02508532|467512718|FG004|Part 2 - Treatment|Administrative|0|||
129877746|NCT02508532|467512719|FG005|Part 2 - Treatment|Administrative|0|||
129877747|NCT02508532|467512720|FG006|Part 2 - Treatment|Administrative|0|||
129877748|NCT02508532|467512721|FG007|Part 2 - Treatment|Administrative|0|||
129877749|NCT02508532|467512722|FG008|Part 2 - Treatment|Administrative|3|||
129877750|NCT02508532|467512714|FG000|Part 2 - Treatment|Sponsor Decision|0|||
129877751|NCT02508532|467512715|FG001|Part 2 - Treatment|Sponsor Decision|0|||
129877752|NCT02508532|467512716|FG002|Part 2 - Treatment|Sponsor Decision|0|||
129877753|NCT02508532|467512717|FG003|Part 2 - Treatment|Sponsor Decision|0|||
129877754|NCT02508532|467512718|FG004|Part 2 - Treatment|Sponsor Decision|0|||
129877755|NCT02508532|467512719|FG005|Part 2 - Treatment|Sponsor Decision|0|||
129877756|NCT02508532|467512720|FG006|Part 2 - Treatment|Sponsor Decision|0|||
129877757|NCT02508532|467512721|FG007|Part 2 - Treatment|Sponsor Decision|0|||
129877758|NCT02508532|467512722|FG008|Part 2 - Treatment|Sponsor Decision|28|||
129877759|NCT02508532|467512714|FG000|Part 2 - Treatment|Death|0|||
129877760|NCT02508532|467512715|FG001|Part 2 - Treatment|Death|0|||
129877761|NCT02508532|467512716|FG002|Part 2 - Treatment|Death|0|||
129877762|NCT02508532|467512717|FG003|Part 2 - Treatment|Death|0|||
129877763|NCT02508532|467512718|FG004|Part 2 - Treatment|Death|0|||
129877764|NCT02508532|467512719|FG005|Part 2 - Treatment|Death|0|||
129877765|NCT02508532|467512720|FG006|Part 2 - Treatment|Death|0|||
129877766|NCT02508532|467512721|FG007|Part 2 - Treatment|Death|0|||
129877767|NCT02508532|467512722|FG008|Part 2 - Treatment|Death|1|||
129877768|NCT02508532|467512714|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
129877769|NCT02508532|467512715|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
129877770|NCT02508532|467512716|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
129877771|NCT02508532|467512717|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
129877772|NCT02508532|467512718|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
129877773|NCT02508532|467512719|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
129877774|NCT02508532|467512720|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
129877775|NCT02508532|467512721|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
129877776|NCT02508532|467512722|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
129877777|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
129877778|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877779|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877780|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
130098684|NCT00423137|468319273|FG002|Overall Study|Adverse Event Other|2|||
129877781|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877782|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877783|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877784|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
129877785|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
129877786|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
129877787|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877788|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
129877789|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877790|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877791|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877792|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877793|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877794|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
129877795|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Death|0|||
129877796|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Death|4|||
129877797|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Death|2|||
129877798|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Death|4|||
129877799|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Death|3|||
129877800|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Death|0|||
129877801|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Death|0|||
129877802|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Death|1|||
129877803|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Death|111|||
129877804|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
129877805|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
129877806|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
129877807|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877808|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877809|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877810|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877811|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877812|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
129877813|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877814|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877815|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877816|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877817|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877818|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877819|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877820|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877821|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
129877822|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877823|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877824|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
129877825|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877826|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
129877827|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877828|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877829|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877830|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
129877831|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877832|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877833|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877834|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877835|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877836|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877837|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877838|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877839|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
129877840|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
129877841|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
129877842|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
129877843|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
129877844|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
129877845|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
129877846|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
129877847|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
129877848|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
129877849|NCT03097861|467512723|FG000|Overall Study|Adverse Event|3|||
129877850|NCT03097861|467512724|FG001|Overall Study|Adverse Event|8|||
129877851|NCT03097861|467512725|FG002|Overall Study|Adverse Event|4|||
129877852|NCT03097861|467512723|FG000|Overall Study|Investigator Decision|0|||
129877853|NCT03097861|467512724|FG001|Overall Study|Investigator Decision|1|||
129877854|NCT03097861|467512725|FG002|Overall Study|Investigator Decision|0|||
129877855|NCT03097861|467512723|FG000|Overall Study|Lost to Follow-up|0|||
129877856|NCT03097861|467512724|FG001|Overall Study|Lost to Follow-up|7|||
129877857|NCT03097861|467512725|FG002|Overall Study|Lost to Follow-up|1|||
129877858|NCT03097861|467512723|FG000|Overall Study|Withdrawal by Subject|1|||
129877859|NCT03097861|467512724|FG001|Overall Study|Withdrawal by Subject|5|||
129877860|NCT03097861|467512725|FG002|Overall Study|Withdrawal by Subject|3|||
129877861|NCT03097861|467512723|FG000|Overall Study|Reason not provided|3|||
129877862|NCT03097861|467512724|FG001|Overall Study|Reason not provided|1|||
129877863|NCT03097861|467512725|FG002|Overall Study|Reason not provided|1|||
129877864|NCT05672680|467512726|FG000|Overall Study|Patient Did Not Complete the Form|5|||
129877865|NCT05672680|467512727|FG001|Overall Study|Patient Did Not Complete the Form|4|||
129877866|NCT05672680|467512726|FG000|Overall Study|Procedure Aborted|1|||
129877867|NCT05672680|467512727|FG001|Overall Study|Procedure Aborted|0|||
129877868|NCT00943306|467512728|FG000|Overall Study|Physician Decision|1|||
129877869|NCT00943306|467512728|FG000|Overall Study|Death|1|||
129877870|NCT00943306|467512728|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
129877871|NCT01395823|467512740|FG000|Overall Study|Death|4|||
129877872|NCT01395823|467512741|FG001|Overall Study|Death|4|||
129877873|NCT01395823|467512740|FG000|Overall Study|Physician Decision|3|||
129877874|NCT01395823|467512741|FG001|Overall Study|Physician Decision|1|||
129877875|NCT01395823|467512740|FG000|Overall Study|Lost to Follow-up|1|||
129877876|NCT01395823|467512741|FG001|Overall Study|Lost to Follow-up|0|||
129877877|NCT01395823|467512740|FG000|Overall Study|Transplant|1|||
129877878|NCT01395823|467512741|FG001|Overall Study|Transplant|0|||
129877879|NCT01395823|467512740|FG000|Overall Study|GI symptoms|1|||
129877880|NCT01395823|467512741|FG001|Overall Study|GI symptoms|0|||
129877881|NCT01395823|467512740|FG000|Overall Study|Withdrawal by Subject|5|||
129877882|NCT01395823|467512741|FG001|Overall Study|Withdrawal by Subject|4|||
129877883|NCT01036022|467512742|FG000|Overall Study|Adverse Event|1|||
129877884|NCT01036022|467512743|FG001|Overall Study|Adverse Event|3|||
129877885|NCT01036022|467512744|FG002|Overall Study|Adverse Event|2|||
129877886|NCT01036022|467512745|FG003|Overall Study|Adverse Event|1|||
129877887|NCT01036022|467512746|FG004|Overall Study|Adverse Event|0|||
129877888|NCT01036022|467512747|FG005|Overall Study|Adverse Event|2|||
129877889|NCT01036022|467512742|FG000|Overall Study|Lack of Efficacy|1|||
129877890|NCT01036022|467512743|FG001|Overall Study|Lack of Efficacy|1|||
129877891|NCT01036022|467512744|FG002|Overall Study|Lack of Efficacy|1|||
129877892|NCT01036022|467512745|FG003|Overall Study|Lack of Efficacy|0|||
129877893|NCT01036022|467512746|FG004|Overall Study|Lack of Efficacy|1|||
129877894|NCT01036022|467512747|FG005|Overall Study|Lack of Efficacy|1|||
129877895|NCT01036022|467512742|FG000|Overall Study|Physician Decision|0|||
129877896|NCT01036022|467512743|FG001|Overall Study|Physician Decision|0|||
129877897|NCT01036022|467512744|FG002|Overall Study|Physician Decision|1|||
129877898|NCT01036022|467512745|FG003|Overall Study|Physician Decision|0|||
129877899|NCT01036022|467512746|FG004|Overall Study|Physician Decision|0|||
129877900|NCT01036022|467512747|FG005|Overall Study|Physician Decision|0|||
129877901|NCT01036022|467512742|FG000|Overall Study|Withdrawal by Subject|0|||
129877902|NCT01036022|467512743|FG001|Overall Study|Withdrawal by Subject|0|||
129877903|NCT01036022|467512744|FG002|Overall Study|Withdrawal by Subject|0|||
129877904|NCT01036022|467512745|FG003|Overall Study|Withdrawal by Subject|1|||
129877905|NCT01036022|467512746|FG004|Overall Study|Withdrawal by Subject|2|||
129877906|NCT01036022|467512747|FG005|Overall Study|Withdrawal by Subject|0|||
129877907|NCT00576732|467512748|FG000|DOUBLE BLIND|Adverse Event|0|||
129877908|NCT00576732|467512749|FG001|DOUBLE BLIND|Adverse Event|0|||
129877909|NCT00576732|467512750|FG002|DOUBLE BLIND|Adverse Event|1|||
129877910|NCT00576732|467512751|FG003|DOUBLE BLIND|Adverse Event|0|||
129877911|NCT00576732|467512752|FG004|DOUBLE BLIND|Adverse Event|0|||
129877912|NCT00576732|467512753|FG005|DOUBLE BLIND|Adverse Event|0|||
129877913|NCT00576732|467512748|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
129877914|NCT00576732|467512749|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
129877915|NCT00576732|467512750|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
129877916|NCT00576732|467512751|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
129877917|NCT00576732|467512752|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
129877918|NCT00576732|467512753|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
129877919|NCT00576732|467512748|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
129877920|NCT00576732|467512749|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
129877921|NCT00576732|467512750|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
129877922|NCT00576732|467512751|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
129877923|NCT00576732|467512752|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
129877924|NCT00576732|467512753|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
129877925|NCT00576732|467512748|FG000|DOUBLE BLIND|OTHER|0|||
129877926|NCT00576732|467512749|FG001|DOUBLE BLIND|OTHER|2|||
129877927|NCT00576732|467512750|FG002|DOUBLE BLIND|OTHER|1|||
129877928|NCT00576732|467512751|FG003|DOUBLE BLIND|OTHER|0|||
129877929|NCT00576732|467512752|FG004|DOUBLE BLIND|OTHER|0|||
129877930|NCT00576732|467512753|FG005|DOUBLE BLIND|OTHER|0|||
129877931|NCT00576732|467512748|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
129877932|NCT00576732|467512749|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
129877933|NCT00576732|467512750|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
129877934|NCT00576732|467512751|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
129877935|NCT00576732|467512752|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
129877936|NCT00576732|467512753|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
129877937|NCT00576732|467512748|FG000|DOUBLE BLIND|Protocol Violation|1|||
129877938|NCT00576732|467512749|FG001|DOUBLE BLIND|Protocol Violation|0|||
129877939|NCT00576732|467512750|FG002|DOUBLE BLIND|Protocol Violation|0|||
129877940|NCT00576732|467512751|FG003|DOUBLE BLIND|Protocol Violation|0|||
129877941|NCT00576732|467512752|FG004|DOUBLE BLIND|Protocol Violation|0|||
129877942|NCT00576732|467512753|FG005|DOUBLE BLIND|Protocol Violation|0|||
129877943|NCT00576732|467512748|FG000|OPEN LABEL|Adverse Event|0|||
129877944|NCT00576732|467512749|FG001|OPEN LABEL|Adverse Event|0|||
129877945|NCT00576732|467512750|FG002|OPEN LABEL|Adverse Event|0|||
129877946|NCT00576732|467512751|FG003|OPEN LABEL|Adverse Event|4|||
129877947|NCT00576732|467512752|FG004|OPEN LABEL|Adverse Event|0|||
129877948|NCT00576732|467512753|FG005|OPEN LABEL|Adverse Event|1|||
129877949|NCT00576732|467512748|FG000|OPEN LABEL|Lost to Follow-up|0|||
129877950|NCT00576732|467512749|FG001|OPEN LABEL|Lost to Follow-up|0|||
129877951|NCT00576732|467512750|FG002|OPEN LABEL|Lost to Follow-up|0|||
129877952|NCT00576732|467512751|FG003|OPEN LABEL|Lost to Follow-up|2|||
129877953|NCT00576732|467512752|FG004|OPEN LABEL|Lost to Follow-up|1|||
129877954|NCT00576732|467512753|FG005|OPEN LABEL|Lost to Follow-up|1|||
129877955|NCT00576732|467512748|FG000|OPEN LABEL|Withdrawal by Subject|0|||
129877956|NCT00576732|467512749|FG001|OPEN LABEL|Withdrawal by Subject|0|||
129877957|NCT00576732|467512750|FG002|OPEN LABEL|Withdrawal by Subject|0|||
129877958|NCT00576732|467512751|FG003|OPEN LABEL|Withdrawal by Subject|1|||
129877959|NCT00576732|467512752|FG004|OPEN LABEL|Withdrawal by Subject|0|||
129877960|NCT00576732|467512753|FG005|OPEN LABEL|Withdrawal by Subject|1|||
129877961|NCT00576732|467512748|FG000|OPEN LABEL|OTHER|0|||
129877962|NCT00576732|467512749|FG001|OPEN LABEL|OTHER|0|||
129877963|NCT00576732|467512750|FG002|OPEN LABEL|OTHER|0|||
129877964|NCT00576732|467512751|FG003|OPEN LABEL|OTHER|0|||
129877965|NCT00576732|467512752|FG004|OPEN LABEL|OTHER|0|||
129877966|NCT00576732|467512753|FG005|OPEN LABEL|OTHER|2|||
129877967|NCT00576732|467512748|FG000|OPEN LABEL|Lack of Efficacy|0|||
129877968|NCT00576732|467512749|FG001|OPEN LABEL|Lack of Efficacy|0|||
129877969|NCT00576732|467512750|FG002|OPEN LABEL|Lack of Efficacy|0|||
129877970|NCT00576732|467512751|FG003|OPEN LABEL|Lack of Efficacy|2|||
129877971|NCT00576732|467512752|FG004|OPEN LABEL|Lack of Efficacy|2|||
129877972|NCT00576732|467512753|FG005|OPEN LABEL|Lack of Efficacy|3|||
129877973|NCT00576732|467512748|FG000|OPEN LABEL|Protocol Violation|0|||
129877974|NCT00576732|467512749|FG001|OPEN LABEL|Protocol Violation|0|||
129877975|NCT00576732|467512750|FG002|OPEN LABEL|Protocol Violation|0|||
129877976|NCT00576732|467512751|FG003|OPEN LABEL|Protocol Violation|2|||
129877977|NCT00576732|467512752|FG004|OPEN LABEL|Protocol Violation|1|||
129877978|NCT00576732|467512753|FG005|OPEN LABEL|Protocol Violation|0|||
130214012|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
130214013|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130214014|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130214015|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130214016|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130214017|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
130214018|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
130214019|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
130214020|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214021|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214022|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214023|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
130322372|NCT03253796|469149134|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
129877979|NCT05076149|467512757|FG000|Overall Study|Adverse Event|3|||
129877980|NCT05076149|467512758|FG001|Overall Study|Adverse Event|9|||
129877981|NCT05076149|467512757|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129877982|NCT05076149|467512758|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
129877983|NCT05076149|467512757|FG000|Overall Study|Lost to Follow-up|0|||
129877984|NCT05076149|467512758|FG001|Overall Study|Lost to Follow-up|1|||
129877985|NCT05076149|467512757|FG000|Overall Study|Commercial drug is available for participant|0|||
129877986|NCT05076149|467512758|FG001|Overall Study|Commercial drug is available for participant|1|||
129877987|NCT05076149|467512757|FG000|Overall Study|Other non compliance|1|||
129877988|NCT05076149|467512758|FG001|Overall Study|Other non compliance|1|||
129877989|NCT05076149|467512757|FG000|Overall Study|Physician Decision|0|||
129877990|NCT05076149|467512758|FG001|Overall Study|Physician Decision|1|||
129877991|NCT05076149|467512757|FG000|Overall Study|Other|5|||
129877992|NCT05076149|467512758|FG001|Overall Study|Other|4|||
129877993|NCT05096208|467512759|FG000|Overall Study|Lost to Follow-up|3|||
129877994|NCT05096208|467512760|FG001|Overall Study|Lost to Follow-up|5|||
129877995|NCT05096208|467512761|FG002|Overall Study|Lost to Follow-up|5|||
129877996|NCT05096208|467512762|FG003|Overall Study|Lost to Follow-up|2|||
129877997|NCT05096208|467512759|FG000|Overall Study|Withdrawal by Subject|0|||
129877998|NCT05096208|467512760|FG001|Overall Study|Withdrawal by Subject|1|||
129877999|NCT05096208|467512761|FG002|Overall Study|Withdrawal by Subject|2|||
129878000|NCT05096208|467512762|FG003|Overall Study|Withdrawal by Subject|3|||
129878001|NCT05096208|467512759|FG000|Overall Study|No longer met eligibility criteria|1|||
129878002|NCT05096208|467512760|FG001|Overall Study|No longer met eligibility criteria|0|||
129878003|NCT05096208|467512761|FG002|Overall Study|No longer met eligibility criteria|0|||
129878004|NCT05096208|467512762|FG003|Overall Study|No longer met eligibility criteria|0|||
129878005|NCT05096208|467512759|FG000|Overall Study|Other|0|||
129878006|NCT05096208|467512760|FG001|Overall Study|Other|0|||
129878007|NCT05096208|467512761|FG002|Overall Study|Other|1|||
129878008|NCT05096208|467512762|FG003|Overall Study|Other|0|||
129878009|NCT02087501|467512763|FG000|Overall Study|Death|7|||
129878010|NCT02087501|467512763|FG000|Overall Study|Open repair of aneurysm|1|||
129878011|NCT02087501|467512763|FG000|Overall Study|Lost to Follow-up|2|||
129878012|NCT00094328|467512764|FG000|Overall Study|Lost to Follow-up|1|||
129878013|NCT01483937|467512765|FG000|Overall Study|Withdrawal by Subject|4|||
129878014|NCT01483937|467512766|FG001|Overall Study|Withdrawal by Subject|3|||
129878015|NCT01875185|467512768|FG000|Overall Study|study was terminated|52|||
129878016|NCT01875185|467512769|FG001|Overall Study|study was terminated|48|||
129878017|NCT04838613|467512770|FG000|Overall Study|Withdrawal by Subject|3|||
129878018|NCT04838613|467512771|FG001|Overall Study|Withdrawal by Subject|6|||
129878019|NCT04838613|467512770|FG000|Overall Study|Protocol Deviation|3|||
129878020|NCT04838613|467512771|FG001|Overall Study|Protocol Deviation|2|||
129878021|NCT04838613|467512770|FG000|Overall Study|Technical Problems|0|||
129878022|NCT04838613|467512771|FG001|Overall Study|Technical Problems|5|||
129878023|NCT04838613|467512770|FG000|Overall Study|Physician Decision|2|||
129878024|NCT04838613|467512771|FG001|Overall Study|Physician Decision|0|||
129878025|NCT01686581|467512772|FG000|Overall Study|Side-effects or Health Problems|15|||
129878026|NCT01686581|467512772|FG000|Overall Study|Lack of Efficacy|90|||
129878027|NCT01686581|467512772|FG000|Overall Study|Participant Concerned about Risks|6|||
129878028|NCT01686581|467512772|FG000|Overall Study|Thinks Injections Too Painful|8|||
129878029|NCT01686581|467512772|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
129878030|NCT01686581|467512772|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
129878031|NCT01686581|467512772|FG000|Overall Study|Thinks it is Inconvenient|17|||
129878032|NCT01686581|467512772|FG000|Overall Study|Other Miscellaneous Reasons|36|||
129878033|NCT01686581|467512772|FG000|Overall Study|Reason Missing|1|||
129878034|NCT00399763|467512773|FG000|Overall Study|Lost to Follow-up|2|||
129878035|NCT00399763|467512774|FG001|Overall Study|Lost to Follow-up|3|||
129878036|NCT04182880|467512775|FG000|Overall Study|Pregnancy|1|||
129878037|NCT04182880|467512776|FG001|Overall Study|Pregnancy|0|||
129878038|NCT03389477|467512777|FG000|Step 1|Withdrawal by Subject|1|||
129878039|NCT03389477|467512778|FG001|Step 1|Withdrawal by Subject|0|||
129878040|NCT03389477|467512777|FG000|Step 2|Withdrawal by Subject|1|||
129878041|NCT03389477|467512778|FG001|Step 2|Withdrawal by Subject|2|||
129878042|NCT03389477|467512777|FG000|Step 2|Disease progression|1|||
129878043|NCT03389477|467512778|FG001|Step 2|Disease progression|0|||
129878044|NCT03389477|467512777|FG000|Step 2|Death|0|||
129878045|NCT03389477|467512778|FG001|Step 2|Death|1|||
129878046|NCT03389477|467512777|FG000|Step 2|Poor performance status and nutrition|0|||
129878047|NCT03389477|467512778|FG001|Step 2|Poor performance status and nutrition|1|||
129878048|NCT03389477|467512777|FG000|Step 3|Withdrawal after 3 cycles|0|||
129878049|NCT03389477|467512778|FG001|Step 3|Withdrawal after 3 cycles|1|||
129878050|NCT03389477|467512777|FG000|Step 3|Still receiving active treatment|4|||
129878051|NCT03389477|467512778|FG001|Step 3|Still receiving active treatment|0|||
129878052|NCT03389477|467512777|FG000|Step 3|Progressive disease after 2 cycles|1|||
129878053|NCT03389477|467512778|FG001|Step 3|Progressive disease after 2 cycles|0|||
129878054|NCT03403426|467512781|FG000|Overall Study|Death|1|||
129878055|NCT03403426|467512781|FG000|Overall Study|Lost to Follow-up|2|||
129878056|NCT03021668|467512782|FG000|Overall Study|Physician Decision|0|||
129878057|NCT03021668|467512783|FG001|Overall Study|Physician Decision|1|||
129878058|NCT00909428|467512784|FG000|Overall Study|Lost to Follow-up|13|||
129878059|NCT00909428|467512785|FG001|Overall Study|Lost to Follow-up|10|||
129878060|NCT00909428|467512786|FG002|Overall Study|Lost to Follow-up|9|||
129878061|NCT01122381|467512787|FG000|Overall Study|study terminated early|0|||
129878062|NCT01122381|467512788|FG001|Overall Study|study terminated early|1|||
129878063|NCT02217280|467512789|FG000|Overall Study|Withdrawal by Subject|2|||
129878064|NCT02217280|467512789|FG000|Overall Study|Post-consent sceen fail|2|||
129878065|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
129878066|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
129878067|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
130214024|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130098685|NCT00423137|468319274|FG003|Overall Study|Adverse Event Other|0|||
130322373|NCT01075243|469149138|FG000|Overall Study|Lost to Follow-up|5|||
129878068|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
129878069|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
129878070|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
129878071|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
129878072|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
129878073|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
129878074|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
129878075|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
129878076|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
129878077|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
129878078|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
129878079|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
129878080|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
129878081|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
129878082|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
129878083|NCT01933880|467512794|FG000|Overall Study|Withdrawal by Subject|5|||
129878084|NCT01933880|467512795|FG001|Overall Study|Withdrawal by Subject|0|||
129878085|NCT01933880|467512794|FG000|Overall Study|Lack of Efficacy|1|||
129878086|NCT01933880|467512795|FG001|Overall Study|Lack of Efficacy|0|||
129878087|NCT01933880|467512794|FG000|Overall Study|Concomitant medication Interference|0|||
129878088|NCT01933880|467512795|FG001|Overall Study|Concomitant medication Interference|1|||
129878089|NCT01933880|467512794|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
129878090|NCT01933880|467512795|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
129878091|NCT01933880|467512794|FG000|Overall Study|Other|4|||
129878092|NCT01933880|467512795|FG001|Overall Study|Other|0|||
129878093|NCT01933880|467512794|FG000|Overall Study|Protocol Violation|1|||
129878094|NCT01933880|467512795|FG001|Overall Study|Protocol Violation|0|||
129878095|NCT02395133|467512796|FG000|Overall Study|Adverse Event|4|||
129878096|NCT02395133|467512797|FG001|Overall Study|Adverse Event|1|||
129878097|NCT02395133|467512798|FG002|Overall Study|Adverse Event|3|||
129878098|NCT02395133|467512799|FG003|Overall Study|Adverse Event|0|||
129878099|NCT02395133|467512796|FG000|Overall Study|Lack of Efficacy|1|||
129878100|NCT02395133|467512797|FG001|Overall Study|Lack of Efficacy|0|||
129878101|NCT02395133|467512798|FG002|Overall Study|Lack of Efficacy|1|||
129878102|NCT02395133|467512799|FG003|Overall Study|Lack of Efficacy|1|||
129878103|NCT02395133|467512796|FG000|Overall Study|Protocol Violation|1|||
129878104|NCT02395133|467512797|FG001|Overall Study|Protocol Violation|1|||
129878105|NCT02395133|467512798|FG002|Overall Study|Protocol Violation|0|||
129878106|NCT02395133|467512799|FG003|Overall Study|Protocol Violation|3|||
129878107|NCT02395133|467512796|FG000|Overall Study|Lost to Follow-up|0|||
129878108|NCT02395133|467512797|FG001|Overall Study|Lost to Follow-up|1|||
129878109|NCT02395133|467512798|FG002|Overall Study|Lost to Follow-up|1|||
129878110|NCT02395133|467512799|FG003|Overall Study|Lost to Follow-up|0|||
129878111|NCT02395133|467512796|FG000|Overall Study|Pregnancy|0|||
129878112|NCT02395133|467512797|FG001|Overall Study|Pregnancy|0|||
129878113|NCT02395133|467512798|FG002|Overall Study|Pregnancy|3|||
129878114|NCT02395133|467512799|FG003|Overall Study|Pregnancy|0|||
129878115|NCT02395133|467512796|FG000|Overall Study|Consent withdrawn with no reason given|1|||
129878116|NCT02395133|467512797|FG001|Overall Study|Consent withdrawn with no reason given|3|||
129878117|NCT02395133|467512798|FG002|Overall Study|Consent withdrawn with no reason given|0|||
129878118|NCT02395133|467512799|FG003|Overall Study|Consent withdrawn with no reason given|2|||
129878119|NCT02395133|467512796|FG000|Overall Study|Consent withdrawn with personal reason|0|||
129878120|NCT02395133|467512797|FG001|Overall Study|Consent withdrawn with personal reason|1|||
129878121|NCT02395133|467512798|FG002|Overall Study|Consent withdrawn with personal reason|0|||
129878122|NCT02395133|467512799|FG003|Overall Study|Consent withdrawn with personal reason|3|||
129878123|NCT02395133|467512796|FG000|Overall Study|Sponsor decision|2|||
129878124|NCT02395133|467512797|FG001|Overall Study|Sponsor decision|0|||
129878125|NCT02395133|467512798|FG002|Overall Study|Sponsor decision|0|||
129878126|NCT02395133|467512799|FG003|Overall Study|Sponsor decision|1|||
129878127|NCT02395133|467512796|FG000|Overall Study|Other than specified above|5|||
129878128|NCT02395133|467512797|FG001|Overall Study|Other than specified above|2|||
129878129|NCT02395133|467512798|FG002|Overall Study|Other than specified above|2|||
129878130|NCT02395133|467512799|FG003|Overall Study|Other than specified above|4|||
129878131|NCT00962247|467512800|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
129878132|NCT00962247|467512800|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
129878133|NCT03474549|467512801|FG000|Overall Study|Death|31|||
129878134|NCT03474549|467512801|FG000|Overall Study|Lost to Follow-up|4|||
129878135|NCT03474549|467512801|FG000|Overall Study|Withdrawal by Subject|2|||
129878136|NCT00738101|467512806|FG000|Overall Study|Physician Decision|5|||
129878137|NCT00738101|467512806|FG000|Overall Study|Death|1|||
129878138|NCT00738101|467512806|FG000|Overall Study|Repeat enrollment|1|||
129878139|NCT00709059|467512813|FG000|Overall Study|Lost to Follow-up|34|||
129878140|NCT00709059|467512813|FG000|Overall Study|Withdrawal by Subject|19|||
129878141|NCT00709059|467512813|FG000|Overall Study|Physician Decision|7|||
129878142|NCT00709059|467512813|FG000|Overall Study|Disease complication|3|||
129878143|NCT00709059|467512813|FG000|Overall Study|Side effects|20|||
129878144|NCT00709059|467512813|FG000|Overall Study|Serious side effects|11|||
129878145|NCT01786330|467512814|FG000|Overall Study|Withdrawal by Subject|0|||
129878146|NCT01786330|467512815|FG001|Overall Study|Withdrawal by Subject|1|||
129878147|NCT01786330|467512814|FG000|Overall Study|Lost to Follow-up|0|||
129878148|NCT01786330|467512815|FG001|Overall Study|Lost to Follow-up|1|||
129878149|NCT01786330|467512814|FG000|Overall Study|Excluded intraoperatively|0|||
129878150|NCT01786330|467512815|FG001|Overall Study|Excluded intraoperatively|1|||
129878151|NCT01786330|467512814|FG000|Overall Study|Protocol Violation|1|||
129878152|NCT01786330|467512815|FG001|Overall Study|Protocol Violation|0|||
129878153|NCT02969525|467512820|FG000|Double-Blind Period|Adverse Event|0|||
130322374|NCT01075243|469149139|FG001|Overall Study|Lost to Follow-up|2|||
129878154|NCT02969525|467512821|FG001|Double-Blind Period|Adverse Event|0|||
129878155|NCT02969525|467512822|FG002|Double-Blind Period|Adverse Event|1|||
129878156|NCT02969525|467512823|FG003|Double-Blind Period|Adverse Event|1|||
129878157|NCT02969525|467512824|FG004|Double-Blind Period|Adverse Event|0|||
129878158|NCT02969525|467512825|FG005|Double-Blind Period|Adverse Event|0|||
129878159|NCT02969525|467512826|FG006|Double-Blind Period|Adverse Event|0|||
129878160|NCT02969525|467512827|FG007|Double-Blind Period|Adverse Event|0|||
129878161|NCT02969525|467512828|FG008|Double-Blind Period|Adverse Event|0|||
129878162|NCT02969525|467512829|FG009|Double-Blind Period|Adverse Event|0|||
129878163|NCT02969525|467512830|FG010|Double-Blind Period|Adverse Event|0|||
129878164|NCT02969525|467512831|FG011|Double-Blind Period|Adverse Event|0|||
129878165|NCT02969525|467512820|FG000|Double-Blind Period|LOW EGFR|0|||
129878166|NCT02969525|467512821|FG001|Double-Blind Period|LOW EGFR|0|||
129878167|NCT02969525|467512822|FG002|Double-Blind Period|LOW EGFR|0|||
129878168|NCT02969525|467512823|FG003|Double-Blind Period|LOW EGFR|1|||
129878169|NCT02969525|467512824|FG004|Double-Blind Period|LOW EGFR|0|||
129878170|NCT02969525|467512825|FG005|Double-Blind Period|LOW EGFR|0|||
129878171|NCT02969525|467512826|FG006|Double-Blind Period|LOW EGFR|0|||
129878172|NCT02969525|467512827|FG007|Double-Blind Period|LOW EGFR|0|||
129878173|NCT02969525|467512828|FG008|Double-Blind Period|LOW EGFR|0|||
129878174|NCT02969525|467512829|FG009|Double-Blind Period|LOW EGFR|0|||
129878175|NCT02969525|467512830|FG010|Double-Blind Period|LOW EGFR|0|||
129878176|NCT02969525|467512831|FG011|Double-Blind Period|LOW EGFR|0|||
129878177|NCT02969525|467512820|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
129878178|NCT02969525|467512821|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878179|NCT02969525|467512822|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878180|NCT02969525|467512823|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
129878181|NCT02969525|467512824|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878182|NCT02969525|467512825|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878183|NCT02969525|467512826|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878184|NCT02969525|467512827|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878185|NCT02969525|467512828|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878186|NCT02969525|467512829|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878187|NCT02969525|467512830|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878188|NCT02969525|467512831|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878189|NCT02969525|467512820|FG000|Dose-Blind Period|Adverse Event|0|||
129878190|NCT02969525|467512821|FG001|Dose-Blind Period|Adverse Event|0|||
129878191|NCT02969525|467512822|FG002|Dose-Blind Period|Adverse Event|0|||
129878192|NCT02969525|467512823|FG003|Dose-Blind Period|Adverse Event|0|||
129878193|NCT02969525|467512824|FG004|Dose-Blind Period|Adverse Event|0|||
129878194|NCT02969525|467512825|FG005|Dose-Blind Period|Adverse Event|0|||
129878195|NCT02969525|467512826|FG006|Dose-Blind Period|Adverse Event|0|||
129878196|NCT02969525|467512827|FG007|Dose-Blind Period|Adverse Event|0|||
129878197|NCT02969525|467512828|FG008|Dose-Blind Period|Adverse Event|0|||
129878198|NCT02969525|467512829|FG009|Dose-Blind Period|Adverse Event|1|||
129878199|NCT02969525|467512830|FG010|Dose-Blind Period|Adverse Event|1|||
129878200|NCT02969525|467512831|FG011|Dose-Blind Period|Adverse Event|1|||
129878201|NCT02969525|467512820|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
129878202|NCT02969525|467512821|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
129878203|NCT02969525|467512822|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
129878204|NCT02969525|467512823|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
129878205|NCT02969525|467512824|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
129878206|NCT02969525|467512825|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
129878207|NCT02969525|467512826|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
129878208|NCT02969525|467512827|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
129878209|NCT02969525|467512828|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
129878210|NCT02969525|467512829|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
129878211|NCT02969525|467512830|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
129878212|NCT02969525|467512831|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
130322375|NCT01075243|469149140|FG002|Overall Study|Lost to Follow-up|0|||
129878213|NCT02969525|467512820|FG000|Dose-Blind Period|Non-cooperating patient|0|||
129878214|NCT02969525|467512821|FG001|Dose-Blind Period|Non-cooperating patient|0|||
129878215|NCT02969525|467512822|FG002|Dose-Blind Period|Non-cooperating patient|0|||
129878216|NCT02969525|467512823|FG003|Dose-Blind Period|Non-cooperating patient|0|||
129878217|NCT02969525|467512824|FG004|Dose-Blind Period|Non-cooperating patient|0|||
129878218|NCT02969525|467512825|FG005|Dose-Blind Period|Non-cooperating patient|0|||
129878219|NCT02969525|467512826|FG006|Dose-Blind Period|Non-cooperating patient|0|||
129878220|NCT02969525|467512827|FG007|Dose-Blind Period|Non-cooperating patient|0|||
129878221|NCT02969525|467512828|FG008|Dose-Blind Period|Non-cooperating patient|0|||
129878222|NCT02969525|467512829|FG009|Dose-Blind Period|Non-cooperating patient|0|||
129878223|NCT02969525|467512830|FG010|Dose-Blind Period|Non-cooperating patient|0|||
129878224|NCT02969525|467512831|FG011|Dose-Blind Period|Non-cooperating patient|1|||
129878225|NCT02969525|467512820|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878226|NCT02969525|467512821|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878227|NCT02969525|467512822|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878228|NCT02969525|467512823|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878229|NCT02969525|467512824|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878230|NCT02969525|467512825|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878231|NCT02969525|467512826|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878232|NCT02969525|467512827|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878233|NCT02969525|467512828|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878234|NCT02969525|467512829|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878235|NCT02969525|467512830|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
129878236|NCT02969525|467512831|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878237|NCT02172625|467512832|FG000|Overall Study|Adverse Event|0|||
129878238|NCT02172625|467512833|FG001|Overall Study|Adverse Event|1|||
129878239|NCT02172625|467512832|FG000|Overall Study|Pregnancy|0|||
129878240|NCT02172625|467512833|FG001|Overall Study|Pregnancy|1|||
129878241|NCT02172625|467512832|FG000|Overall Study|car accident|0|||
129878242|NCT02172625|467512833|FG001|Overall Study|car accident|1|||
129878243|NCT03445065|467512834|FG000|Overall Study|Withdrawal by Subject|3|||
129878244|NCT03445065|467512835|FG001|Overall Study|Withdrawal by Subject|6|||
129878245|NCT03445065|467512836|FG002|Overall Study|Withdrawal by Subject|2|||
129878246|NCT03445065|467512837|FG003|Overall Study|Withdrawal by Subject|2|||
129878247|NCT03445065|467512834|FG000|Overall Study|Other|4|||
129878248|NCT03445065|467512835|FG001|Overall Study|Other|3|||
129878249|NCT03445065|467512836|FG002|Overall Study|Other|3|||
129878250|NCT03445065|467512837|FG003|Overall Study|Other|1|||
129878251|NCT03315130|467512838|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
129878252|NCT03315130|467512839|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
129878253|NCT03315130|467512840|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
129878254|NCT03315130|467512841|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
129878255|NCT03315130|467512838|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
129878256|NCT03315130|467512839|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
129878257|NCT03315130|467512840|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
129878258|NCT03315130|467512841|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
129878259|NCT03315130|467512838|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
129878260|NCT03315130|467512839|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
129878261|NCT03315130|467512840|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
129878262|NCT03315130|467512841|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
129878263|NCT03315130|467512838|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
129878264|NCT03315130|467512839|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
129878265|NCT03315130|467512840|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
129878266|NCT03315130|467512841|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
129878267|NCT03315130|467512838|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
129878268|NCT03315130|467512839|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
129878269|NCT03315130|467512840|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
129878270|NCT03315130|467512841|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
129878271|NCT03315130|467512838|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
129878272|NCT03315130|467512839|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
129878273|NCT03315130|467512840|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
129878274|NCT03315130|467512841|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
129878275|NCT00524030|467512842|FG000|Overall Study|Lack of Efficacy|10|||
129878276|NCT00524030|467512843|FG001|Overall Study|Lack of Efficacy|24|||
129878277|NCT00524030|467512842|FG000|Overall Study|Lost to Follow-up|0|||
129878278|NCT00524030|467512843|FG001|Overall Study|Lost to Follow-up|2|||
129878279|NCT00524030|467512842|FG000|Overall Study|Withdrawal by Subject|3|||
129878280|NCT00524030|467512843|FG001|Overall Study|Withdrawal by Subject|8|||
129878281|NCT00524030|467512842|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
129878282|NCT00524030|467512843|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
129878283|NCT00524030|467512842|FG000|Overall Study|Protocol Violation|0|||
129878284|NCT00524030|467512843|FG001|Overall Study|Protocol Violation|1|||
129878285|NCT00524030|467512842|FG000|Overall Study|Pregnancy|1|||
129878286|NCT00524030|467512843|FG001|Overall Study|Pregnancy|0|||
129878287|NCT00524030|467512842|FG000|Overall Study|Adverse Event|3|||
130322376|NCT01075243|469149138|FG000|Overall Study|Withdrawal by Subject|1|||
130322377|NCT01075243|469149139|FG001|Overall Study|Withdrawal by Subject|1|||
130322378|NCT01075243|469149140|FG002|Overall Study|Withdrawal by Subject|0|||
130322379|NCT03094416|469149143|FG000|Run-in|Screening failure|8|||
130322380|NCT03094416|469149143|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
130322381|NCT03094416|469149143|FG000|Run-in|Withdrawal by Subject|3|||
130322382|NCT03094416|469149143|FG000|Treatment Period|Withdrawal by Subject|2|||
130322383|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
130322384|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
130322385|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
130322386|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
130322387|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
130322388|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
130322389|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
130322390|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
130322391|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
130322392|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
130322393|NCT01668784|469149144|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
130322394|NCT01668784|469149145|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
130322395|NCT01668784|469149144|FG000|Treatment Period|Disease Progression|316|||
130322396|NCT01668784|469149145|FG001|Treatment Period|Disease Progression|293|||
130322397|NCT01668784|469149144|FG000|Treatment Period|Study Drug Toxicity|46|||
130322398|NCT01668784|469149145|FG001|Treatment Period|Study Drug Toxicity|53|||
130322399|NCT01668784|469149144|FG000|Treatment Period|Death|1|||
130322400|NCT01668784|469149145|FG001|Treatment Period|Death|1|||
130322401|NCT01668784|469149144|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
130322402|NCT01668784|469149145|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
130322403|NCT01668784|469149144|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
130322404|NCT01668784|469149145|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
130322405|NCT01668784|469149144|FG000|Treatment Period|Withdrawal by Subject|5|||
130322406|NCT01668784|469149145|FG001|Treatment Period|Withdrawal by Subject|3|||
130322407|NCT01668784|469149144|FG000|Treatment Period|Maximal Clinical Benefit|3|||
130322408|NCT01668784|469149145|FG001|Treatment Period|Maximal Clinical Benefit|3|||
130322409|NCT01668784|469149144|FG000|Treatment Period|Other|2|||
130322410|NCT01668784|469149145|FG001|Treatment Period|Other|8|||
130322411|NCT01668784|469149144|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
130322412|NCT01668784|469149145|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
130322413|NCT03804528|469149153|FG000|Overall Study|Time Commitment|18|||
130322414|NCT03804528|469149153|FG000|Overall Study|Health Reasons|5|||
130322415|NCT04607005|469149154|FG000|Overall Study|Adverse Event|0|||
130322416|NCT04607005|469149155|FG001|Overall Study|Adverse Event|1|||
130322417|NCT04607005|469149154|FG000|Overall Study|Lack of Efficacy|1|||
130322418|NCT04607005|469149155|FG001|Overall Study|Lack of Efficacy|6|||
130322419|NCT04607005|469149154|FG000|Overall Study|Withdrawal by Subject|4|||
130322420|NCT04607005|469149155|FG001|Overall Study|Withdrawal by Subject|9|||
130322421|NCT04607005|469149154|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
130322422|NCT04607005|469149155|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
130322423|NCT02331134|469149156|FG000|Overall Study|Withdrawal by Subject|1|||
130322424|NCT04825574|469149158|FG000|Overall Study|Commercial treatment became available|1|||
130322425|NCT04825574|469149158|FG000|Overall Study|Disease progression|1|||
130322426|NCT04272242|469149161|FG000|Overall Study|Withdrawal by Subject|3|||
130322427|NCT04272242|469149161|FG000|Overall Study|Lost to Follow-up|1|||
130322428|NCT04272242|469149161|FG000|Overall Study|Adverse Event|1|||
130322429|NCT04944992|469151267|FG000|Overall Study|Lost to Follow-up|1|||
130322430|NCT04944992|469151268|FG001|Overall Study|Lost to Follow-up|1|||
130322431|NCT04944992|469151267|FG000|Overall Study|Physician Decision|1|||
130322432|NCT04944992|469151268|FG001|Overall Study|Physician Decision|0|||
130322433|NCT04944992|469151267|FG000|Overall Study|Withdrawal by Subject|6|||
130322434|NCT04944992|469151268|FG001|Overall Study|Withdrawal by Subject|1|||
130322435|NCT01295814|469151269|FG000|Overall Study|Lack of Efficacy|0|||
130322436|NCT01295814|469151270|FG001|Overall Study|Lack of Efficacy|2|||
130322437|NCT01295814|469151269|FG000|Overall Study|Withdrawal by Subject|2|||
130322438|NCT01295814|469151270|FG001|Overall Study|Withdrawal by Subject|0|||
130322439|NCT03414983|469151271|FG000|Pre-Treatment|Other reasons|1|||
130322440|NCT03414983|469151272|FG001|Pre-Treatment|Other reasons|0|||
130322441|NCT03414983|469151271|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
130322442|NCT03414983|469151272|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
130322443|NCT03414983|469151271|FG000|Pre-Treatment|Participant withdrew consent|1|||
130322444|NCT03414983|469151272|FG001|Pre-Treatment|Participant withdrew consent|3|||
129878288|NCT00524030|467512843|FG001|Overall Study|Adverse Event|21|||
129878289|NCT00524030|467512842|FG000|Overall Study|Death|0|||
129878290|NCT00524030|467512843|FG001|Overall Study|Death|1|||
129878291|NCT00429494|467514277|FG000|Overall Study|Withdrawal by Subject|9|||
129878292|NCT00429494|467514277|FG000|Overall Study|Death|6|||
129878293|NCT00976703|467514278|FG000|Overall Study|Physician Decision|1|||
129878294|NCT00976703|467514279|FG001|Overall Study|Physician Decision|1|||
129878295|NCT00976703|467514278|FG000|Overall Study|ineligible for study|2|||
129878296|NCT00976703|467514279|FG001|Overall Study|ineligible for study|2|||
129878297|NCT03075501|467514282|FG000|Overall Study|Scheduling difficulties|15|||
129878298|NCT03075501|467514283|FG001|Overall Study|Scheduling difficulties|9|||
129878299|NCT00957931|467514286|FG000|Overall Study|Death|4|||
129878300|NCT00857805|467514287|FG000|Overall Study|Withdrawal by Subject|1|||
129878301|NCT00857805|467514288|FG001|Overall Study|Withdrawal by Subject|1|||
129878302|NCT04867785|467514289|FG000|Overall Study|Adverse Event|1|||
129878303|NCT04867785|467514290|FG001|Overall Study|Adverse Event|0|||
129878304|NCT04867785|467514291|FG002|Overall Study|Adverse Event|1|||
129878305|NCT04867785|467514292|FG003|Overall Study|Adverse Event|0|||
129878306|NCT04867785|467514293|FG004|Overall Study|Adverse Event|0|||
129878307|NCT04867785|467514294|FG005|Overall Study|Adverse Event|0|||
129878308|NCT04867785|467514295|FG006|Overall Study|Adverse Event|0|||
129878309|NCT04867785|467514296|FG007|Overall Study|Adverse Event|2|||
129878310|NCT04867785|467514289|FG000|Overall Study|Lost to Follow-up|4|||
129878311|NCT04867785|467514290|FG001|Overall Study|Lost to Follow-up|4|||
129878312|NCT04867785|467514291|FG002|Overall Study|Lost to Follow-up|3|||
129878313|NCT04867785|467514292|FG003|Overall Study|Lost to Follow-up|2|||
129878314|NCT04867785|467514293|FG004|Overall Study|Lost to Follow-up|0|||
129878315|NCT04867785|467514294|FG005|Overall Study|Lost to Follow-up|1|||
129878316|NCT04867785|467514295|FG006|Overall Study|Lost to Follow-up|0|||
129878317|NCT04867785|467514296|FG007|Overall Study|Lost to Follow-up|1|||
129878318|NCT04867785|467514289|FG000|Overall Study|Withdrawal by Subject|6|||
129878319|NCT04867785|467514290|FG001|Overall Study|Withdrawal by Subject|2|||
129878320|NCT04867785|467514291|FG002|Overall Study|Withdrawal by Subject|2|||
129878321|NCT04867785|467514292|FG003|Overall Study|Withdrawal by Subject|1|||
129878322|NCT04867785|467514293|FG004|Overall Study|Withdrawal by Subject|2|||
129878323|NCT04867785|467514294|FG005|Overall Study|Withdrawal by Subject|0|||
129878324|NCT04867785|467514295|FG006|Overall Study|Withdrawal by Subject|2|||
129878325|NCT04867785|467514296|FG007|Overall Study|Withdrawal by Subject|5|||
129878326|NCT04867785|467514289|FG000|Overall Study|Physician Decision|0|||
129878327|NCT04867785|467514290|FG001|Overall Study|Physician Decision|0|||
129878328|NCT04867785|467514291|FG002|Overall Study|Physician Decision|0|||
129878329|NCT04867785|467514292|FG003|Overall Study|Physician Decision|0|||
129878330|NCT04867785|467514293|FG004|Overall Study|Physician Decision|0|||
129878331|NCT04867785|467514294|FG005|Overall Study|Physician Decision|0|||
129878332|NCT04867785|467514295|FG006|Overall Study|Physician Decision|0|||
129878333|NCT04867785|467514296|FG007|Overall Study|Physician Decision|1|||
129878334|NCT04867785|467514289|FG000|Overall Study|Inadvertent Enrollment|0|||
129878335|NCT04867785|467514290|FG001|Overall Study|Inadvertent Enrollment|0|||
129878336|NCT04867785|467514291|FG002|Overall Study|Inadvertent Enrollment|0|||
129878337|NCT04867785|467514292|FG003|Overall Study|Inadvertent Enrollment|1|||
129878338|NCT04867785|467514293|FG004|Overall Study|Inadvertent Enrollment|1|||
129878339|NCT04867785|467514294|FG005|Overall Study|Inadvertent Enrollment|0|||
129878340|NCT04867785|467514295|FG006|Overall Study|Inadvertent Enrollment|0|||
129878341|NCT04867785|467514296|FG007|Overall Study|Inadvertent Enrollment|1|||
129878342|NCT04867785|467514289|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129878343|NCT04867785|467514290|FG001|Overall Study|Eligibility Criteria Not Met|0|||
129878344|NCT04867785|467514291|FG002|Overall Study|Eligibility Criteria Not Met|0|||
129878345|NCT04867785|467514292|FG003|Overall Study|Eligibility Criteria Not Met|0|||
129878346|NCT04867785|467514293|FG004|Overall Study|Eligibility Criteria Not Met|0|||
129878347|NCT04867785|467514294|FG005|Overall Study|Eligibility Criteria Not Met|0|||
129878348|NCT04867785|467514295|FG006|Overall Study|Eligibility Criteria Not Met|0|||
129878349|NCT04867785|467514296|FG007|Overall Study|Eligibility Criteria Not Met|1|||
129878350|NCT01289041|467514297|FG000|Overall Study|Adverse Event|24|||
129878351|NCT01289041|467514297|FG000|Overall Study|Physician Decision|1|||
129878352|NCT01289041|467514297|FG000|Overall Study|Progressive Disease|41|||
129878353|NCT01289041|467514297|FG000|Overall Study|Withdrawal by Subject|3|||
129878354|NCT01289041|467514297|FG000|Overall Study|Death|1|||
129878355|NCT01062763|467514298|FG000|Overall Study|Adverse Event|3|||
129878356|NCT01062763|467514299|FG001|Overall Study|Adverse Event|4|||
129878357|NCT02494921|467514301|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
129878358|NCT02494921|467514302|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
129878359|NCT02494921|467514303|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
129878360|NCT02494921|467514304|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
129878361|NCT02494921|467514305|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
129878362|NCT02494921|467514301|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
129878363|NCT02494921|467514302|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
129878364|NCT02494921|467514303|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
129878365|NCT02494921|467514304|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
129878366|NCT02494921|467514305|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
129878367|NCT02494921|467514301|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878368|NCT02494921|467514302|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878369|NCT02494921|467514303|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
129878370|NCT02494921|467514304|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878371|NCT02494921|467514305|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878372|NCT02714868|467514313|FG000|Overall Study|Withdrawal by Subject|3|||
129878373|NCT02714868|467514314|FG001|Overall Study|Withdrawal by Subject|0|||
129878374|NCT02714868|467514313|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
129878375|NCT02714868|467514314|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
129878376|NCT02714868|467514313|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
129878377|NCT02714868|467514314|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
129878378|NCT04399356|467514321|FG000|Overall Study|Lost to Follow-up|1|||
129878379|NCT04399356|467514322|FG001|Overall Study|Lost to Follow-up|1|||
129878380|NCT04399356|467514321|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
129878381|NCT04399356|467514322|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
129878382|NCT04399356|467514321|FG000|Overall Study|Withdrawal by Subject|1|||
129878383|NCT04399356|467514322|FG001|Overall Study|Withdrawal by Subject|0|||
129878384|NCT00154310|467514323|FG000|Overall Study|Adverse Event|19|||
129878385|NCT00154310|467514324|FG001|Overall Study|Adverse Event|9|||
129878386|NCT00154310|467514323|FG000|Overall Study|Lack of Efficacy|5|||
129878387|NCT00154310|467514324|FG001|Overall Study|Lack of Efficacy|4|||
129878388|NCT00154310|467514323|FG000|Overall Study|Protocol Violation|4|||
129878389|NCT00154310|467514324|FG001|Overall Study|Protocol Violation|2|||
129878390|NCT00154310|467514323|FG000|Overall Study|Withdrawal by Subject|9|||
129878391|NCT00154310|467514324|FG001|Overall Study|Withdrawal by Subject|3|||
129878392|NCT00154310|467514323|FG000|Overall Study|Lost to Follow-up|0|||
129878393|NCT00154310|467514324|FG001|Overall Study|Lost to Follow-up|8|||
129878394|NCT00154310|467514323|FG000|Overall Study|Administrative problems|0|||
129878395|NCT00154310|467514324|FG001|Overall Study|Administrative problems|1|||
129878396|NCT00154310|467514323|FG000|Overall Study|Death|0|||
129878397|NCT00154310|467514324|FG001|Overall Study|Death|1|||
129878398|NCT03447730|467514325|FG000|Overall Study|Adverse Event|0|||
129878399|NCT03447730|467514326|FG001|Overall Study|Adverse Event|2|||
129878400|NCT03447730|467514327|FG002|Overall Study|Adverse Event|0|||
129878401|NCT01834222|467514336|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
129878402|NCT04251065|467514337|FG000|Overall Study|Death|2|||
129878403|NCT04251065|467514337|FG000|Overall Study|Lack of Efficacy|3|||
129878404|NCT04251065|467514337|FG000|Overall Study|Death|1|||
129878405|NCT01054573|467514338|FG000|Overall Study|Adverse Event|1|||
129878406|NCT01054573|467514339|FG001|Overall Study|Adverse Event|0|||
129878407|NCT01054573|467514340|FG002|Overall Study|Adverse Event|1|||
129878408|NCT01054573|467514341|FG003|Overall Study|Adverse Event|1|||
129878409|NCT01054573|467514338|FG000|Overall Study|Lost to Follow-up|0|||
129878410|NCT01054573|467514339|FG001|Overall Study|Lost to Follow-up|2|||
129878411|NCT01054573|467514340|FG002|Overall Study|Lost to Follow-up|0|||
129878412|NCT01054573|467514341|FG003|Overall Study|Lost to Follow-up|0|||
129878413|NCT01054573|467514338|FG000|Overall Study|Withdrawal by Subject|0|||
129878414|NCT01054573|467514339|FG001|Overall Study|Withdrawal by Subject|2|||
129878415|NCT01054573|467514340|FG002|Overall Study|Withdrawal by Subject|2|||
129878416|NCT01054573|467514341|FG003|Overall Study|Withdrawal by Subject|1|||
129878417|NCT05266963|467514345|FG000|Drug Period A|Withdrawal by Subject|0|||
129878418|NCT05266963|467514346|FG001|Drug Period A|Withdrawal by Subject|1|||
129878419|NCT01725386|467514347|FG000|Overall Study|Death|84|||
129878420|NCT01725386|467514348|FG001|Overall Study|Death|40|||
129878421|NCT01725386|467514347|FG000|Overall Study|Lost to Follow-up|81|||
129878422|NCT01725386|467514348|FG001|Overall Study|Lost to Follow-up|6|||
129878423|NCT01725386|467514347|FG000|Overall Study|Withdrawal by Subject|10|||
129878424|NCT01725386|467514348|FG001|Overall Study|Withdrawal by Subject|0|||
129878425|NCT03812536|467514349|FG000|Overall Study|Protocol Violation|2|||
129878426|NCT03812536|467514350|FG001|Overall Study|Protocol Violation|0|||
129878427|NCT03812536|467514349|FG000|Overall Study|Withdrawal by Subject|1|||
129878428|NCT03812536|467514350|FG001|Overall Study|Withdrawal by Subject|1|||
129878429|NCT00152009|467514351|FG000|Overall Study|Adverse Event|9|||
129878430|NCT00152009|467514352|FG001|Overall Study|Adverse Event|13|||
129878431|NCT00152009|467514353|FG002|Overall Study|Adverse Event|20|||
129878432|NCT00152009|467514354|FG003|Overall Study|Adverse Event|1|||
129878433|NCT00152009|467514351|FG000|Overall Study|Protocol Violation|3|||
129878434|NCT00152009|467514352|FG001|Overall Study|Protocol Violation|0|||
129878435|NCT00152009|467514353|FG002|Overall Study|Protocol Violation|0|||
129878436|NCT00152009|467514354|FG003|Overall Study|Protocol Violation|1|||
129878437|NCT00152009|467514351|FG000|Overall Study|Withdrawal by Subject|2|||
129878438|NCT00152009|467514352|FG001|Overall Study|Withdrawal by Subject|3|||
129878439|NCT00152009|467514353|FG002|Overall Study|Withdrawal by Subject|4|||
129878440|NCT00152009|467514354|FG003|Overall Study|Withdrawal by Subject|9|||
129878441|NCT00152009|467514351|FG000|Overall Study|Lost to Follow-up|2|||
129878442|NCT00152009|467514352|FG001|Overall Study|Lost to Follow-up|4|||
129878443|NCT00152009|467514353|FG002|Overall Study|Lost to Follow-up|3|||
129878444|NCT00152009|467514354|FG003|Overall Study|Lost to Follow-up|3|||
129878445|NCT00152009|467514351|FG000|Overall Study|Lack of Efficacy|8|||
129878446|NCT00152009|467514352|FG001|Overall Study|Lack of Efficacy|6|||
129878447|NCT00152009|467514353|FG002|Overall Study|Lack of Efficacy|7|||
129878448|NCT00152009|467514354|FG003|Overall Study|Lack of Efficacy|15|||
129878449|NCT00152009|467514351|FG000|Overall Study|ECG abnormalities|2|||
129878450|NCT00152009|467514352|FG001|Overall Study|ECG abnormalities|2|||
129878451|NCT00152009|467514353|FG002|Overall Study|ECG abnormalities|2|||
129878452|NCT00152009|467514354|FG003|Overall Study|ECG abnormalities|1|||
129878453|NCT00152009|467514351|FG000|Overall Study|Sponsor's decision|3|||
129878454|NCT00152009|467514352|FG001|Overall Study|Sponsor's decision|3|||
129878455|NCT00152009|467514353|FG002|Overall Study|Sponsor's decision|1|||
129878456|NCT00152009|467514354|FG003|Overall Study|Sponsor's decision|3|||
129878457|NCT01306201|467514356|FG000|Overall Study|Arrhythmia|4|||
129878458|NCT01306201|467514356|FG000|Overall Study|Files could not be processed|3|||
129878459|NCT01306201|467514356|FG000|Overall Study|Files unreadable|3|||
129878460|NCT04702568|467514357|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
129878461|NCT04702568|467514358|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
129878462|NCT04702568|467514357|FG000|Overall Study|Pregnancy|1|||
129878463|NCT04702568|467514358|FG001|Overall Study|Pregnancy|0|||
129878464|NCT04702568|467514357|FG000|Overall Study|Bone marrow transplant|1|||
129878465|NCT04702568|467514358|FG001|Overall Study|Bone marrow transplant|0|||
129878466|NCT04702568|467514357|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
129878467|NCT04702568|467514358|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
129878468|NCT04702568|467514357|FG000|Overall Study|Withdrawal by Subject|0|||
129878469|NCT04702568|467514358|FG001|Overall Study|Withdrawal by Subject|2|||
129878470|NCT00393523|467514359|FG000|Overall Study|Lost to Follow-up|0|||
129878471|NCT00393523|467514360|FG001|Overall Study|Lost to Follow-up|0|||
129878472|NCT00393523|467514361|FG002|Overall Study|Lost to Follow-up|0|||
129878473|NCT00393523|467514362|FG003|Overall Study|Lost to Follow-up|2|||
129878474|NCT00393523|467514363|FG004|Overall Study|Lost to Follow-up|1|||
129878475|NCT00393523|467514359|FG000|Overall Study|Protocol Violation|6|||
129878476|NCT00393523|467514360|FG001|Overall Study|Protocol Violation|2|||
129878477|NCT00393523|467514361|FG002|Overall Study|Protocol Violation|0|||
129878478|NCT00393523|467514362|FG003|Overall Study|Protocol Violation|1|||
129878479|NCT00393523|467514363|FG004|Overall Study|Protocol Violation|0|||
129878480|NCT00393523|467514359|FG000|Overall Study|Withdrawal by Subject|6|||
129878481|NCT00393523|467514360|FG001|Overall Study|Withdrawal by Subject|7|||
129878482|NCT00393523|467514361|FG002|Overall Study|Withdrawal by Subject|2|||
129878483|NCT00393523|467514362|FG003|Overall Study|Withdrawal by Subject|3|||
129878484|NCT00393523|467514363|FG004|Overall Study|Withdrawal by Subject|0|||
129878485|NCT00393523|467514359|FG000|Overall Study|Difficulties in specimen collection|0|||
129878486|NCT00393523|467514360|FG001|Overall Study|Difficulties in specimen collection|0|||
129878487|NCT00393523|467514361|FG002|Overall Study|Difficulties in specimen collection|1|||
129878488|NCT00393523|467514362|FG003|Overall Study|Difficulties in specimen collection|0|||
129878489|NCT00393523|467514363|FG004|Overall Study|Difficulties in specimen collection|0|||
129878490|NCT00393523|467514359|FG000|Overall Study|Vaccine supply issue|0|||
129878491|NCT00393523|467514360|FG001|Overall Study|Vaccine supply issue|0|||
129878492|NCT00393523|467514361|FG002|Overall Study|Vaccine supply issue|1|||
129878493|NCT00393523|467514362|FG003|Overall Study|Vaccine supply issue|0|||
129878494|NCT00393523|467514363|FG004|Overall Study|Vaccine supply issue|0|||
129878495|NCT04091360|467514364|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878496|NCT04091360|467514365|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878497|NCT04091360|467514366|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878498|NCT04091360|467514367|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878499|NCT04091360|467514368|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878500|NCT04091360|467514369|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878501|NCT04091360|467514370|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878502|NCT04091360|467514371|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878503|NCT04091360|467514372|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
129878504|NCT04091360|467514373|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
129878505|NCT04091360|467514364|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878506|NCT04091360|467514365|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878507|NCT04091360|467514366|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878508|NCT04091360|467514367|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878509|NCT04091360|467514368|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878510|NCT04091360|467514369|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
130214025|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
130214026|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214027|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214028|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
130214029|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
130214030|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214031|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129878511|NCT04091360|467514370|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
129878512|NCT04091360|467514371|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
129878513|NCT04091360|467514372|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878514|NCT04091360|467514373|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878515|NCT04091360|467514364|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878516|NCT04091360|467514365|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878517|NCT04091360|467514366|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878518|NCT04091360|467514367|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878519|NCT04091360|467514368|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878520|NCT04091360|467514369|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878521|NCT04091360|467514370|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
129878522|NCT04091360|467514371|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878523|NCT04091360|467514372|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878524|NCT04091360|467514373|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
129878525|NCT00423852|467514374|FG000|Overall Study|Removed pior to the high-dose portion|3|||
129878526|NCT00572624|467514375|FG000|Overall Study|Lost to Follow-up|10|||
129878527|NCT00572624|467514376|FG001|Overall Study|Lost to Follow-up|4|||
129878528|NCT00572624|467514375|FG000|Overall Study|Wanted to do a different diet program|1|||
129878529|NCT00572624|467514376|FG001|Overall Study|Wanted to do a different diet program|0|||
129878530|NCT00572624|467514375|FG000|Overall Study|Medication change|1|||
129878531|NCT00572624|467514376|FG001|Overall Study|Medication change|0|||
129878532|NCT00572624|467514375|FG000|Overall Study|Started a new job-- no time for study|1|||
129878533|NCT00572624|467514376|FG001|Overall Study|Started a new job-- no time for study|0|||
129878534|NCT00572624|467514375|FG000|Overall Study|Admitted to being a smoker|1|||
129878535|NCT00572624|467514376|FG001|Overall Study|Admitted to being a smoker|0|||
129878536|NCT00572624|467514375|FG000|Overall Study|Refused to do the stress test|1|||
129878537|NCT00572624|467514376|FG001|Overall Study|Refused to do the stress test|0|||
129878538|NCT00572624|467514375|FG000|Overall Study|Problem with vascular access|1|||
129878539|NCT00572624|467514376|FG001|Overall Study|Problem with vascular access|0|||
129878540|NCT00572624|467514375|FG000|Overall Study|Health issues unrelated to the study|1|||
129878541|NCT00572624|467514376|FG001|Overall Study|Health issues unrelated to the study|0|||
129878542|NCT01515189|467514378|FG000|Induction|Disease Progression|109|||
129878543|NCT01515189|467514379|FG001|Induction|Disease Progression|155|||
129878544|NCT01515189|467514378|FG000|Induction|Study drug toxicity|86|||
129878545|NCT01515189|467514379|FG001|Induction|Study drug toxicity|36|||
129878546|NCT01515189|467514378|FG000|Induction|Death|24|||
129878547|NCT01515189|467514379|FG001|Induction|Death|17|||
129878548|NCT01515189|467514378|FG000|Induction|Adverse Event|14|||
129878549|NCT01515189|467514379|FG001|Induction|Adverse Event|9|||
129878550|NCT01515189|467514378|FG000|Induction|Withdrawal by Subject|3|||
129878551|NCT01515189|467514379|FG001|Induction|Withdrawal by Subject|9|||
129878552|NCT01515189|467514378|FG000|Induction|No longer meets study criteria|0|||
129878553|NCT01515189|467514379|FG001|Induction|No longer meets study criteria|2|||
129878554|NCT01515189|467514378|FG000|Induction|Lost to Follow-up|1|||
129878555|NCT01515189|467514379|FG001|Induction|Lost to Follow-up|0|||
129878556|NCT01515189|467514378|FG000|Induction|Other|0|||
129878557|NCT01515189|467514379|FG001|Induction|Other|4|||
129878558|NCT01515189|467514378|FG000|First Re-Induction Phase|Disease progression|6|||
129878559|NCT01515189|467514379|FG001|First Re-Induction Phase|Disease progression|14|||
129878560|NCT01515189|467514378|FG000|First Re-Induction Phase|Study drug toxicity|5|||
129878561|NCT01515189|467514379|FG001|First Re-Induction Phase|Study drug toxicity|0|||
129878562|NCT01515189|467514378|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
129878563|NCT01515189|467514379|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
129878564|NCT01515189|467514378|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
129878565|NCT01515189|467514379|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
129878566|NCT01515189|467514378|FG000|First Re-Induction Phase|Other|1|||
129878567|NCT01515189|467514379|FG001|First Re-Induction Phase|Other|0|||
129878568|NCT03787680|467514380|FG000|Overall Study|Physician Decision|2|||
129878569|NCT03787680|467514381|FG001|Overall Study|Physician Decision|3|||
129878570|NCT03787680|467514380|FG000|Overall Study|Adverse Event|7|||
129878571|NCT03787680|467514381|FG001|Overall Study|Adverse Event|3|||
129878572|NCT03787680|467514380|FG000|Overall Study|Withdrawal by Subject|2|||
129878573|NCT03787680|467514381|FG001|Overall Study|Withdrawal by Subject|1|||
129878574|NCT05458024|467514384|FG000|Overall Study|Withdrawal by Subject|1|||
129878575|NCT05458024|467514385|FG001|Overall Study|Withdrawal by Subject|1|||
129878576|NCT05229653|467514389|FG000|Overall Study|Lost to Follow-up|1|||
129878577|NCT05229653|467514390|FG001|Overall Study|Lost to Follow-up|0|||
129878578|NCT02667886|467514391|FG000|Dose Escalation (Part A)|Adverse Event|1|||
129878579|NCT02667886|467514392|FG001|Dose Escalation (Part A)|Adverse Event|3|||
129878580|NCT02667886|467514393|FG002|Dose Escalation (Part A)|Adverse Event|1|||
129878581|NCT02667886|467514394|FG003|Dose Escalation (Part A)|Adverse Event|0|||
129878582|NCT02667886|467514395|FG004|Dose Escalation (Part A)|Adverse Event|0|||
129878583|NCT02667886|467514391|FG000|Dose Escalation (Part A)|Disease Progression|1|||
129878584|NCT02667886|467514392|FG001|Dose Escalation (Part A)|Disease Progression|4|||
129878585|NCT02667886|467514393|FG002|Dose Escalation (Part A)|Disease Progression|3|||
129878586|NCT02667886|467514394|FG003|Dose Escalation (Part A)|Disease Progression|0|||
129878587|NCT02667886|467514395|FG004|Dose Escalation (Part A)|Disease Progression|0|||
129878588|NCT02667886|467514391|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878589|NCT02667886|467514392|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878590|NCT02667886|467514393|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
129878591|NCT02667886|467514394|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878592|NCT02667886|467514395|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878593|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Adverse Event|0|||
129878594|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Adverse Event|0|||
129878595|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Adverse Event|0|||
129878596|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Adverse Event|9|||
129878597|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Adverse Event|0|||
129878598|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878599|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878600|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878601|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
129878602|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878603|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Disease Progression|0|||
129878604|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Disease Progression|0|||
129878605|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Disease Progression|0|||
129878606|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Disease Progression|38|||
129878607|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Disease Progression|0|||
129878608|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878609|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878610|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878611|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
129878612|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878613|NCT02667886|467514391|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878614|NCT02667886|467514392|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878615|NCT02667886|467514393|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878616|NCT02667886|467514394|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878617|NCT02667886|467514395|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
129878618|NCT02667886|467514391|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
129878619|NCT02667886|467514392|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
129878620|NCT02667886|467514393|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
129878621|NCT02667886|467514394|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
129878622|NCT02667886|467514395|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
129878623|NCT00594217|467514396|FG000|Overall Study|Withdrawal by Subject|1|||
129878624|NCT00594217|467514397|FG001|Overall Study|Withdrawal by Subject|3|||
129878625|NCT00747123|467514398|FG000|Overall Study|Investigator's request|0|||
129878626|NCT00747123|467514399|FG001|Overall Study|Investigator's request|0|||
129878627|NCT00747123|467514400|FG002|Overall Study|Investigator's request|1|||
129878628|NCT00747123|467514401|FG003|Overall Study|Investigator's request|0|||
129878629|NCT00747123|467514398|FG000|Overall Study|Withdrew consent|0|||
129878630|NCT00747123|467514399|FG001|Overall Study|Withdrew consent|1|||
129878631|NCT00747123|467514400|FG002|Overall Study|Withdrew consent|0|||
129878632|NCT00747123|467514401|FG003|Overall Study|Withdrew consent|0|||
129878633|NCT00747123|467514398|FG000|Overall Study|Adverse Event|0|||
129878634|NCT00747123|467514399|FG001|Overall Study|Adverse Event|1|||
129878635|NCT00747123|467514400|FG002|Overall Study|Adverse Event|0|||
129878636|NCT00747123|467514401|FG003|Overall Study|Adverse Event|1|||
129878637|NCT03635489|467514402|FG000|Overall Study|Death|19|||
129878638|NCT03635489|467514403|FG001|Overall Study|Death|13|||
129878639|NCT03635489|467514402|FG000|Overall Study|Lost to Follow-up|1|||
129878640|NCT03635489|467514403|FG001|Overall Study|Lost to Follow-up|2|||
129878641|NCT03635489|467514402|FG000|Overall Study|Withdrawal by Subject|1|||
129878642|NCT03635489|467514403|FG001|Overall Study|Withdrawal by Subject|2|||
129878643|NCT03635489|467514402|FG000|Overall Study|Study Ended by Sponsor|28|||
129878644|NCT03635489|467514403|FG001|Overall Study|Study Ended by Sponsor|34|||
129878645|NCT01657266|467514407|FG000|Overall Study|Lost to Follow-up|2|||
129878646|NCT01657266|467514408|FG001|Overall Study|Lost to Follow-up|2|||
129878647|NCT01657266|467514407|FG000|Overall Study|Adverse Event|2|||
129878648|NCT01657266|467514408|FG001|Overall Study|Adverse Event|3|||
129878649|NCT01807650|467514409|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
129878650|NCT01807650|467514409|FG000|Overall Study|Adverse Event|5|||
129878651|NCT01807650|467514409|FG000|Overall Study|Other|2|||
129878652|NCT00736489|467514410|FG000|Period 1|Lost to Follow-up|1|||
129878653|NCT00736489|467514411|FG001|Period 1|Lost to Follow-up|0|||
129878654|NCT00736489|467514412|FG002|Period 1|Lost to Follow-up|0|||
129878655|NCT00736489|467514413|FG003|Period 1|Lost to Follow-up|0|||
129878656|NCT00736489|467514414|FG004|Period 1|Lost to Follow-up|0|||
129878657|NCT00736489|467514415|FG005|Period 1|Lost to Follow-up|0|||
129878658|NCT00736489|467514410|FG000|Period 1|Withdrawal by Subject|0|||
129878659|NCT00736489|467514411|FG001|Period 1|Withdrawal by Subject|0|||
129878660|NCT00736489|467514412|FG002|Period 1|Withdrawal by Subject|0|||
129878661|NCT00736489|467514413|FG003|Period 1|Withdrawal by Subject|0|||
129878662|NCT00736489|467514414|FG004|Period 1|Withdrawal by Subject|0|||
129878663|NCT00736489|467514415|FG005|Period 1|Withdrawal by Subject|1|||
129878664|NCT01125722|467514416|FG000|Overall Study|Withdrawal by Subject|2|||
129878665|NCT01125722|467514417|FG001|Overall Study|Withdrawal by Subject|1|||
129878666|NCT01125722|467514416|FG000|Overall Study|Lost to Follow-up|1|||
129878667|NCT01125722|467514417|FG001|Overall Study|Lost to Follow-up|0|||
129878668|NCT00118898|467514419|FG000|Overall Study|Death|6|||
129878669|NCT00118898|467514420|FG001|Overall Study|Death|11|||
129878670|NCT00118898|467514421|FG002|Overall Study|Death|6|||
129878671|NCT00118898|467514422|FG003|Overall Study|Death|8|||
129878672|NCT00118898|467514419|FG000|Overall Study|Lost to Follow-up|26|||
129878673|NCT00118898|467514420|FG001|Overall Study|Lost to Follow-up|34|||
129878674|NCT00118898|467514421|FG002|Overall Study|Lost to Follow-up|33|||
129878675|NCT00118898|467514422|FG003|Overall Study|Lost to Follow-up|33|||
129878676|NCT00118898|467514419|FG000|Overall Study|Withdrawal by Subject|10|||
129878677|NCT00118898|467514420|FG001|Overall Study|Withdrawal by Subject|5|||
129878678|NCT00118898|467514421|FG002|Overall Study|Withdrawal by Subject|8|||
129878679|NCT00118898|467514422|FG003|Overall Study|Withdrawal by Subject|8|||
129878680|NCT00118898|467514419|FG000|Overall Study|Site Closure|33|||
129878681|NCT00118898|467514420|FG001|Overall Study|Site Closure|31|||
129878682|NCT00118898|467514421|FG002|Overall Study|Site Closure|28|||
129878683|NCT00118898|467514422|FG003|Overall Study|Site Closure|37|||
129878684|NCT00118898|467514419|FG000|Overall Study|Severe debilitation|1|||
129878685|NCT00118898|467514420|FG001|Overall Study|Severe debilitation|4|||
129878686|NCT00118898|467514421|FG002|Overall Study|Severe debilitation|6|||
129878687|NCT00118898|467514422|FG003|Overall Study|Severe debilitation|4|||
129878688|NCT00118898|467514419|FG000|Overall Study|Not compliant with requirements|11|||
129878689|NCT00118898|467514420|FG001|Overall Study|Not compliant with requirements|13|||
129878690|NCT00118898|467514421|FG002|Overall Study|Not compliant with requirements|11|||
129878691|NCT00118898|467514422|FG003|Overall Study|Not compliant with requirements|11|||
129878692|NCT00118898|467514419|FG000|Overall Study|Not able to get to clinic|34|||
129878693|NCT00118898|467514420|FG001|Overall Study|Not able to get to clinic|43|||
129878694|NCT00118898|467514421|FG002|Overall Study|Not able to get to clinic|31|||
129878695|NCT00118898|467514422|FG003|Overall Study|Not able to get to clinic|40|||
129878696|NCT01816763|467515556|FG000|Overall Study|The main reason for an incomplete survey|4|||
129878697|NCT01816763|467515557|FG001|Overall Study|The main reason for an incomplete survey|15|||
129878698|NCT01816763|467515558|FG002|Overall Study|The main reason for an incomplete survey|11|||
129878699|NCT00311155|467515561|FG000|Overall Study|Adverse Event|21|||
129878700|NCT00311155|467515561|FG000|Overall Study|Withdrawal by Subject|17|||
129878701|NCT00311155|467515561|FG000|Overall Study|Did not meet entry criteria|55|||
129878702|NCT02243631|467515564|FG000|Overall Study|no synovial fluid on second aspirate|0|||
129878703|NCT02243631|467515565|FG001|Overall Study|no synovial fluid on second aspirate|1|||
129878704|NCT01785628|467515568|FG000|Overall Study|Lost to Follow-up|2|||
129878705|NCT01785628|467515569|FG001|Overall Study|Lost to Follow-up|3|||
129878706|NCT00840996|467515570|FG000|Overall Study|Withdrawal by Subject|1|||
129878707|NCT00840996|467515571|FG001|Overall Study|Withdrawal by Subject|0|||
129878708|NCT03285295|467515572|FG000|Alinity s HBsAg|Protocol Violation|11|||
129878709|NCT03285295|467515573|FG001|Alinity s HBsAg|Protocol Violation|0|||
129878710|NCT03285295|467515574|FG002|Alinity s HBsAg|Protocol Violation|0|||
129878711|NCT03285295|467515575|FG003|Alinity s HBsAg|Protocol Violation|0|||
129878712|NCT03285295|467515576|FG004|Alinity s HBsAg|Protocol Violation|0|||
129878713|NCT03285295|467515572|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
129878714|NCT03285295|467515573|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878715|NCT03285295|467515574|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878716|NCT03285295|467515575|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878717|NCT03285295|467515576|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878718|NCT03285295|467515572|FG000|Alinity s HBsAg|No Results Generated|74|||
129878719|NCT03285295|467515573|FG001|Alinity s HBsAg|No Results Generated|6|||
129878720|NCT03285295|467515574|FG002|Alinity s HBsAg|No Results Generated|0|||
129878721|NCT03285295|467515575|FG003|Alinity s HBsAg|No Results Generated|0|||
129878722|NCT03285295|467515576|FG004|Alinity s HBsAg|No Results Generated|0|||
129878723|NCT03285295|467515572|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
129878724|NCT03285295|467515573|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
129878725|NCT03285295|467515574|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
129878726|NCT03285295|467515575|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
129878727|NCT03285295|467515576|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
129878728|NCT03285295|467515572|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
129878729|NCT03285295|467515573|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878730|NCT03285295|467515574|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878731|NCT03285295|467515575|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878732|NCT03285295|467515576|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878733|NCT03285295|467515572|FG000|Alinity s HTLV I/II|No Results Generated|70|||
129878734|NCT03285295|467515573|FG001|Alinity s HTLV I/II|No Results Generated|0|||
129878735|NCT03285295|467515574|FG002|Alinity s HTLV I/II|No Results Generated|0|||
129878736|NCT03285295|467515575|FG003|Alinity s HTLV I/II|No Results Generated|0|||
129878737|NCT03285295|467515576|FG004|Alinity s HTLV I/II|No Results Generated|0|||
129878738|NCT03285295|467515572|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
129878739|NCT03285295|467515573|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878740|NCT03285295|467515574|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878741|NCT03285295|467515575|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878742|NCT03285295|467515576|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878743|NCT03285295|467515572|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
129878744|NCT03285295|467515573|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
129878745|NCT03285295|467515574|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
129878746|NCT03285295|467515575|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
130322445|NCT03414983|469151271|FG000|Treatment|Participant withdrew consent|4|||
130322446|NCT03414983|469151272|FG001|Treatment|Participant withdrew consent|3|||
130322447|NCT03414983|469151271|FG000|Treatment|Participant request to discontinue study treatment|8|||
130322448|NCT03414983|469151272|FG001|Treatment|Participant request to discontinue study treatment|10|||
130322449|NCT03414983|469151271|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
130322450|NCT03414983|469151272|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
130322451|NCT03414983|469151271|FG000|Treatment|Death|0|||
129878747|NCT03285295|467515576|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
129878748|NCT03285295|467515572|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
129878749|NCT03285295|467515573|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878750|NCT03285295|467515574|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878751|NCT03285295|467515575|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878752|NCT03285295|467515576|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878753|NCT03285295|467515572|FG000|Alinity s Anti-HCV|No Results Generated|71|||
129878754|NCT03285295|467515573|FG001|Alinity s Anti-HCV|No Results Generated|0|||
129878755|NCT03285295|467515574|FG002|Alinity s Anti-HCV|No Results Generated|0|||
129878756|NCT03285295|467515575|FG003|Alinity s Anti-HCV|No Results Generated|0|||
129878757|NCT03285295|467515576|FG004|Alinity s Anti-HCV|No Results Generated|0|||
129878758|NCT03285295|467515572|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
129878759|NCT03285295|467515573|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878760|NCT03285295|467515574|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878761|NCT03285295|467515575|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878762|NCT03285295|467515576|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878763|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
129878764|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878765|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878766|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878767|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878768|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
129878769|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878770|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878771|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878772|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878773|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
129878774|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878775|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878776|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878777|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878778|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
129878779|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878780|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878781|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878782|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878783|NCT03285295|467515572|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
129878784|NCT03285295|467515573|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
129878785|NCT03285295|467515574|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
129878786|NCT03285295|467515575|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
129878787|NCT03285295|467515576|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
129878788|NCT03285295|467515572|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
129878789|NCT03285295|467515573|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
129878790|NCT03285295|467515574|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
129878791|NCT03285295|467515575|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130322452|NCT03414983|469151272|FG001|Treatment|Death|1|||
130322453|NCT03414983|469151271|FG000|Treatment|Study Drug Toxicity|10|||
129878792|NCT03285295|467515576|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
130322454|NCT03414983|469151272|FG001|Treatment|Study Drug Toxicity|5|||
130098686|NCT00593385|468319276|FG000|Overall Study|Death|14|||
130322455|NCT03414983|469151271|FG000|Treatment|Disease Progression|75|||
129878793|NCT03285295|467515572|FG000|Alinity s Anti-HBc|No Results Generated|70|||
129878794|NCT03285295|467515573|FG001|Alinity s Anti-HBc|No Results Generated|0|||
129878795|NCT03285295|467515574|FG002|Alinity s Anti-HBc|No Results Generated|0|||
129878796|NCT03285295|467515575|FG003|Alinity s Anti-HBc|No Results Generated|0|||
129878797|NCT03285295|467515576|FG004|Alinity s Anti-HBc|No Results Generated|0|||
129878798|NCT03285295|467515572|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
129878799|NCT03285295|467515573|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878800|NCT03285295|467515574|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878801|NCT03285295|467515575|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878802|NCT03285295|467515576|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878803|NCT03285295|467515572|FG000|Alinity s Chagas|Protocol Violation|76|||
129878804|NCT03285295|467515573|FG001|Alinity s Chagas|Protocol Violation|0|||
129878805|NCT03285295|467515574|FG002|Alinity s Chagas|Protocol Violation|0|||
129878806|NCT03285295|467515575|FG003|Alinity s Chagas|Protocol Violation|0|||
129878807|NCT03285295|467515576|FG004|Alinity s Chagas|Protocol Violation|0|||
129878808|NCT03285295|467515572|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
129878809|NCT03285295|467515573|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
129878810|NCT03285295|467515574|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
129878811|NCT03285295|467515575|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
129878812|NCT03285295|467515576|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
129878813|NCT03285295|467515572|FG000|Alinity s Chagas|No Results Generated|105|||
129878814|NCT03285295|467515573|FG001|Alinity s Chagas|No Results Generated|0|||
129878815|NCT03285295|467515574|FG002|Alinity s Chagas|No Results Generated|0|||
129878816|NCT03285295|467515575|FG003|Alinity s Chagas|No Results Generated|0|||
129878817|NCT03285295|467515576|FG004|Alinity s Chagas|No Results Generated|0|||
129878818|NCT03285295|467515572|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
129878819|NCT03285295|467515573|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878820|NCT03285295|467515574|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878821|NCT03285295|467515575|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878822|NCT03285295|467515576|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878823|NCT02746575|467515577|FG000|Overall Study|Surgery cancelled or time chaned|13|||
129878824|NCT02746575|467515577|FG000|Overall Study|Received epidural|10|||
129878825|NCT02746575|467515577|FG000|Overall Study|Withdrawal by Subject|3|||
129878826|NCT02746575|467515577|FG000|Overall Study|Bradycardia/hypotension|9|||
129878827|NCT02746575|467515577|FG000|Overall Study|Study paused|8|||
129878828|NCT02746575|467515577|FG000|Overall Study|put on beta-blocker|3|||
129878829|NCT02746575|467515577|FG000|Overall Study|type of surgery|1|||
129878830|NCT02746575|467515577|FG000|Overall Study|typ of surgery|1|||
129878831|NCT02746575|467515577|FG000|Overall Study|PI unavailable|1|||
129878832|NCT02746575|467515577|FG000|Overall Study|Unknown history of CVA|1|||
129878833|NCT03239873|467515578|FG000|Overall Study|Lost to Follow-up|15|||
129878834|NCT03239873|467515579|FG001|Overall Study|Lost to Follow-up|16|||
129878835|NCT03239873|467515578|FG000|Overall Study|Physician Decision|1|||
129878836|NCT03239873|467515579|FG001|Overall Study|Physician Decision|0|||
129878837|NCT03239873|467515578|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
129878838|NCT03239873|467515579|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
129878839|NCT03239873|467515578|FG000|Overall Study|Withdrawal by Subject|2|||
129878840|NCT03239873|467515579|FG001|Overall Study|Withdrawal by Subject|0|||
129878841|NCT03239873|467515578|FG000|Overall Study|Contraindication to study medication|1|||
129878842|NCT03239873|467515579|FG001|Overall Study|Contraindication to study medication|0|||
129878843|NCT03239873|467515578|FG000|Overall Study|Protocol Violation|1|||
129878844|NCT03239873|467515579|FG001|Overall Study|Protocol Violation|0|||
129878845|NCT00605319|467515584|FG000|Overall Study|Adverse Event|6|||
129878846|NCT02670538|467515585|FG000|Overall Study|Withdrawal of Consent|8|||
129878847|NCT02670538|467515586|FG001|Overall Study|Withdrawal of Consent|6|||
129878848|NCT02670538|467515587|FG002|Overall Study|Withdrawal of Consent|5|||
129878849|NCT02670538|467515585|FG000|Overall Study|Lost to Follow-up|8|||
129878850|NCT02670538|467515586|FG001|Overall Study|Lost to Follow-up|12|||
129878851|NCT02670538|467515587|FG002|Overall Study|Lost to Follow-up|7|||
129878852|NCT02670538|467515585|FG000|Overall Study|Adverse Event|5|||
130322456|NCT03414983|469151272|FG001|Treatment|Disease Progression|29|||
130322457|NCT03414983|469151271|FG000|Treatment|Not reported|1|||
130322458|NCT03414983|469151272|FG001|Treatment|Not reported|0|||
130322459|NCT03414983|469151271|FG000|Treatment|Other reasons|3|||
129878853|NCT02670538|467515586|FG001|Overall Study|Adverse Event|5|||
129878854|NCT02670538|467515587|FG002|Overall Study|Adverse Event|11|||
130322460|NCT03414983|469151272|FG001|Treatment|Other reasons|2|||
130322461|NCT03414983|469151271|FG000|Treatment|Poor/non-compliance|2|||
130322462|NCT03414983|469151272|FG001|Treatment|Poor/non-compliance|0|||
129878855|NCT02670538|467515585|FG000|Overall Study|Lack of Efficacy|7|||
129878856|NCT02670538|467515586|FG001|Overall Study|Lack of Efficacy|1|||
129878857|NCT02670538|467515587|FG002|Overall Study|Lack of Efficacy|2|||
129878858|NCT02670538|467515585|FG000|Overall Study|Protocol Violation|3|||
129878859|NCT02670538|467515586|FG001|Overall Study|Protocol Violation|4|||
129878860|NCT02670538|467515587|FG002|Overall Study|Protocol Violation|1|||
129878861|NCT02670538|467515585|FG000|Overall Study|Noncompliance with Study Drug|1|||
129878862|NCT02670538|467515586|FG001|Overall Study|Noncompliance with Study Drug|3|||
129878863|NCT02670538|467515587|FG002|Overall Study|Noncompliance with Study Drug|2|||
129878864|NCT02670538|467515585|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129878865|NCT02670538|467515586|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129878866|NCT02670538|467515587|FG002|Overall Study|Other Miscellaneous Reasons|2|||
129878867|NCT01250119|467515588|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
129878868|NCT01250119|467515589|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
129878869|NCT01250119|467515588|FG000|Diagnostic Phase|Participants Not Tested|44|||
129878870|NCT01250119|467515589|FG001|Diagnostic Phase|Participants Not Tested|0|||
129878871|NCT01250119|467515588|FG000|Treatment Phase|Progressive Disease|0|||
129878872|NCT01250119|467515589|FG001|Treatment Phase|Progressive Disease|32|||
129878873|NCT01250119|467515588|FG000|Treatment Phase|Death|0|||
129878874|NCT01250119|467515589|FG001|Treatment Phase|Death|2|||
129878875|NCT01250119|467515588|FG000|Treatment Phase|Withdrawal by Subject|0|||
129878876|NCT01250119|467515589|FG001|Treatment Phase|Withdrawal by Subject|1|||
129878877|NCT01250119|467515588|FG000|Treatment Phase|Adverse Event|0|||
129878878|NCT01250119|467515589|FG001|Treatment Phase|Adverse Event|2|||
129878879|NCT01250119|467515588|FG000|Treatment Phase|Unknown reason|0|||
129878880|NCT01250119|467515589|FG001|Treatment Phase|Unknown reason|4|||
129878881|NCT02887989|467515590|FG000|Overall Study|Withdrawal by Subject|8|||
129878882|NCT02887989|467515591|FG001|Overall Study|Withdrawal by Subject|11|||
129878883|NCT02887989|467515590|FG000|Overall Study|Death|1|||
129878884|NCT02887989|467515591|FG001|Overall Study|Death|0|||
129878885|NCT05648357|467515595|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
129878886|NCT00255346|467515596|FG000|Overall Study|Adverse Event|1|||
129878887|NCT00255346|467515597|FG001|Overall Study|Adverse Event|0|||
129878888|NCT00255346|467515598|FG002|Overall Study|Adverse Event|0|||
129878889|NCT00255346|467515599|FG003|Overall Study|Adverse Event|0|||
129878890|NCT00255346|467515600|FG004|Overall Study|Adverse Event|0|||
129878891|NCT00674323|467515601|FG000|Overall Study|Adverse Event|0|||
129878892|NCT00674323|467515602|FG001|Overall Study|Adverse Event|1|||
129878893|NCT00674323|467515603|FG002|Overall Study|Adverse Event|0|||
129878894|NCT00674323|467515601|FG000|Overall Study|Protocol Violation|1|||
129878895|NCT00674323|467515602|FG001|Overall Study|Protocol Violation|0|||
129878896|NCT00674323|467515603|FG002|Overall Study|Protocol Violation|0|||
129878897|NCT02045433|467515610|FG000|Overall Study|Withdrawal by Subject|1|||
129878898|NCT00409786|467515611|FG000|Overall Study|Withdrawal by Subject|3|||
129878899|NCT01678820|467515612|FG000|Overall Study|Study Terminated by Sponsor|45|||
129878900|NCT01678820|467515613|FG001|Overall Study|Study Terminated by Sponsor|43|||
129878901|NCT01678820|467515614|FG002|Overall Study|Study Terminated by Sponsor|43|||
129878902|NCT01678820|467515612|FG000|Overall Study|Withdrawal by Subject|2|||
129878903|NCT01678820|467515613|FG001|Overall Study|Withdrawal by Subject|5|||
129878904|NCT01678820|467515614|FG002|Overall Study|Withdrawal by Subject|2|||
129878905|NCT01678820|467515612|FG000|Overall Study|Protocol Specified Criteria|2|||
129878906|NCT01678820|467515613|FG001|Overall Study|Protocol Specified Criteria|3|||
129878907|NCT01678820|467515614|FG002|Overall Study|Protocol Specified Criteria|1|||
129878908|NCT01678820|467515612|FG000|Overall Study|Adverse Event|2|||
129878909|NCT01678820|467515613|FG001|Overall Study|Adverse Event|2|||
129878910|NCT01678820|467515614|FG002|Overall Study|Adverse Event|2|||
129878911|NCT01678820|467515612|FG000|Overall Study|Lost to Follow-up|7|||
129878912|NCT01678820|467515613|FG001|Overall Study|Lost to Follow-up|2|||
129878913|NCT01678820|467515614|FG002|Overall Study|Lost to Follow-up|2|||
129878914|NCT01678820|467515612|FG000|Overall Study|Non-compliance with study drug|0|||
129878915|NCT01678820|467515613|FG001|Overall Study|Non-compliance with study drug|1|||
129878916|NCT01678820|467515614|FG002|Overall Study|Non-compliance with study drug|0|||
129878917|NCT01678820|467515612|FG000|Overall Study|Physician Decision|0|||
129878918|NCT01678820|467515613|FG001|Overall Study|Physician Decision|0|||
129878919|NCT01678820|467515614|FG002|Overall Study|Physician Decision|1|||
129878920|NCT01678820|467515612|FG000|Overall Study|Protocol Violation|4|||
129878921|NCT01678820|467515613|FG001|Overall Study|Protocol Violation|5|||
129878922|NCT01678820|467515614|FG002|Overall Study|Protocol Violation|4|||
129878923|NCT01678820|467515612|FG000|Overall Study|Not treated with double-blind study drug|0|||
129878924|NCT01678820|467515613|FG001|Overall Study|Not treated with double-blind study drug|2|||
129878925|NCT01678820|467515614|FG002|Overall Study|Not treated with double-blind study drug|2|||
129878926|NCT02306265|467515615|FG000|Overall Study|Withdrawal by Subject|1|||
129878927|NCT04488003|467515616|FG000|Assessed for Eligibility|Screen Failure|24|||
129878928|NCT04488003|467515617|FG001|Assessed for Eligibility|Screen Failure|0|||
129878929|NCT04488003|467515618|FG002|Assessed for Eligibility|Screen Failure|0|||
129878930|NCT04488003|467515616|FG000|Assessed for Eligibility|Adverse Event|1|||
129878931|NCT04488003|467515617|FG001|Assessed for Eligibility|Adverse Event|0|||
129878932|NCT04488003|467515618|FG002|Assessed for Eligibility|Adverse Event|0|||
129878933|NCT04488003|467515616|FG000|Assessed for Eligibility|Death|1|||
129878934|NCT04488003|467515617|FG001|Assessed for Eligibility|Death|0|||
129878935|NCT04488003|467515618|FG002|Assessed for Eligibility|Death|0|||
129878936|NCT04488003|467515616|FG000|Assessed for Eligibility|Physician Decision|1|||
129878937|NCT04488003|467515617|FG001|Assessed for Eligibility|Physician Decision|0|||
129878938|NCT04488003|467515618|FG002|Assessed for Eligibility|Physician Decision|0|||
129878939|NCT04488003|467515616|FG000|Allocated to Treatment|Progressive Disease|51|||
129878940|NCT04488003|467515617|FG001|Allocated to Treatment|Progressive Disease|0|||
129878941|NCT04488003|467515618|FG002|Allocated to Treatment|Progressive Disease|0|||
129878942|NCT04488003|467515616|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
129878943|NCT04488003|467515617|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
129878944|NCT04488003|467515618|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
129878945|NCT04488003|467515616|FG000|Allocated to Treatment|Adverse Event|6|||
129878946|NCT04488003|467515617|FG001|Allocated to Treatment|Adverse Event|0|||
129878947|NCT04488003|467515618|FG002|Allocated to Treatment|Adverse Event|0|||
129878948|NCT04488003|467515616|FG000|Allocated to Treatment|Other|5|||
129878949|NCT04488003|467515617|FG001|Allocated to Treatment|Other|0|||
129878950|NCT04488003|467515618|FG002|Allocated to Treatment|Other|0|||
129878951|NCT04488003|467515616|FG000|Allocated to Treatment|Physician Decision|4|||
129878952|NCT04488003|467515617|FG001|Allocated to Treatment|Physician Decision|0|||
129878953|NCT04488003|467515618|FG002|Allocated to Treatment|Physician Decision|0|||
129878954|NCT04488003|467515616|FG000|Allocated to Treatment|Death|4|||
129878955|NCT04488003|467515617|FG001|Allocated to Treatment|Death|0|||
129878956|NCT04488003|467515618|FG002|Allocated to Treatment|Death|0|||
129878957|NCT01350505|467515622|FG000|Overall Study|Lost to Follow-up|4|||
129878958|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
129878959|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
129878960|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
129878961|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
129878962|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
129878963|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
129878964|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
129878965|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
129878966|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
129878967|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
129878968|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
129878969|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
129878970|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
129878971|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
129878972|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
129878973|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
129878974|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
129878975|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
129878976|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
129878977|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
129878978|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
129878979|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
129878980|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
129878981|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
129878982|NCT02307513|467515627|FG000|Long-term Extension|Physician Decision|1|||
129878983|NCT02307513|467515628|FG001|Long-term Extension|Physician Decision|0|||
129878984|NCT00744263|467515629|FG000|Overall Study|Death|3006|||
129878985|NCT00744263|467515630|FG001|Overall Study|Death|3005|||
129878986|NCT00744263|467515629|FG000|Overall Study|Lost to Follow-up|2038|||
129878987|NCT00744263|467515630|FG001|Overall Study|Lost to Follow-up|2135|||
129878988|NCT00744263|467515629|FG000|Overall Study|Withdrawal by Subject|166|||
129878989|NCT00744263|467515630|FG001|Overall Study|Withdrawal by Subject|150|||
129878990|NCT00744263|467515629|FG000|Overall Study|Physician Decision|20|||
129878991|NCT00744263|467515630|FG001|Overall Study|Physician Decision|23|||
129878992|NCT00744263|467515629|FG000|Overall Study|Protocol Violation|3|||
129878993|NCT00744263|467515630|FG001|Overall Study|Protocol Violation|5|||
129878994|NCT00744263|467515629|FG000|Overall Study|Adverse Event|1|||
129878995|NCT00744263|467515630|FG001|Overall Study|Adverse Event|0|||
129878996|NCT00744263|467515629|FG000|Overall Study|Other|2|||
129878997|NCT00744263|467515630|FG001|Overall Study|Other|2|||
129878998|NCT02213328|467515634|FG000|Overall Study|Withdrawal by Subject|10|||
129878999|NCT02213328|467515634|FG000|Overall Study|Physician Decision|2|||
129879000|NCT02213328|467515634|FG000|Overall Study|Lost to Follow-up|16|||
129879001|NCT02487095|467515640|FG000|Dose Expansion|Unable to scan/restage participant|0|||
129879002|NCT02487095|467515641|FG001|Dose Expansion|Unable to scan/restage participant|0|||
129879003|NCT02487095|467515642|FG002|Dose Expansion|Unable to scan/restage participant|0|||
129879004|NCT02487095|467515643|FG003|Dose Expansion|Unable to scan/restage participant|0|||
129879005|NCT02487095|467515644|FG004|Dose Expansion|Unable to scan/restage participant|1|||
129879006|NCT05778526|467515647|FG000|Overall Study|Lost to Follow-up|0|||
129879007|NCT05778526|467515648|FG001|Overall Study|Lost to Follow-up|1|||
129879008|NCT05778526|467515649|FG002|Overall Study|Lost to Follow-up|3|||
129879009|NCT05778526|467515647|FG000|Overall Study|Protocol Violation|0|||
129879010|NCT05778526|467515648|FG001|Overall Study|Protocol Violation|0|||
129879011|NCT05778526|467515649|FG002|Overall Study|Protocol Violation|8|||
129879012|NCT03108157|467515650|FG000|Overall Study|Protocol Violation|15|||
129879013|NCT03108157|467515651|FG001|Overall Study|Protocol Violation|4|||
129879014|NCT01279343|467515654|FG000|Overall Study|Did not receive treatment|2|||
129879015|NCT01279343|467515655|FG001|Overall Study|Did not receive treatment|6|||
129879016|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129879017|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
129879018|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129879019|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129879020|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
129879021|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
129879022|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
129879023|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
129879024|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
129879025|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
129879026|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
129879027|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
129879028|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
129879029|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
129879030|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
129879031|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
129879032|NCT04534114|467515656|FG000|Main Treatment Period|Physician Decision|0|||
129879033|NCT04534114|467515657|FG001|Main Treatment Period|Physician Decision|0|||
129879034|NCT04534114|467515658|FG002|Main Treatment Period|Physician Decision|0|||
129879035|NCT04534114|467515659|FG003|Main Treatment Period|Physician Decision|1|||
129879036|NCT04534114|467515656|FG000|Main Treatment Period|Death|1|||
129879037|NCT04534114|467515657|FG001|Main Treatment Period|Death|0|||
129879038|NCT04534114|467515658|FG002|Main Treatment Period|Death|0|||
129879039|NCT04534114|467515659|FG003|Main Treatment Period|Death|1|||
129879040|NCT04534114|467515656|FG000|Main Treatment Period|Other reason|1|||
129879041|NCT04534114|467515657|FG001|Main Treatment Period|Other reason|1|||
129879042|NCT04534114|467515658|FG002|Main Treatment Period|Other reason|0|||
129879043|NCT04534114|467515659|FG003|Main Treatment Period|Other reason|0|||
129879044|NCT04534114|467515656|FG000|Main Treatment Period|Participant decision|1|||
129879045|NCT04534114|467515657|FG001|Main Treatment Period|Participant decision|3|||
129879046|NCT04534114|467515658|FG002|Main Treatment Period|Participant decision|3|||
129879047|NCT04534114|467515659|FG003|Main Treatment Period|Participant decision|1|||
129879048|NCT04534114|467515656|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
129879049|NCT04534114|467515657|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
129879050|NCT04534114|467515658|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
129879051|NCT04534114|467515659|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
129879052|NCT04534114|467515656|FG000|Main Treatment Period|Adverse Event|4|||
129879053|NCT04534114|467515657|FG001|Main Treatment Period|Adverse Event|2|||
129879054|NCT04534114|467515658|FG002|Main Treatment Period|Adverse Event|1|||
129879055|NCT04534114|467515659|FG003|Main Treatment Period|Adverse Event|2|||
129879056|NCT04534114|467515656|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
129879057|NCT04534114|467515657|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
129879058|NCT04534114|467515658|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
129879059|NCT04534114|467515659|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
129879060|NCT04534114|467515656|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
129879061|NCT04534114|467515657|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
129879062|NCT04534114|467515658|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
129879063|NCT04534114|467515659|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
129879064|NCT04534114|467515656|FG000|Extension Treatment Period|Other reason|0|||
129879065|NCT04534114|467515657|FG001|Extension Treatment Period|Other reason|1|||
129879066|NCT04534114|467515658|FG002|Extension Treatment Period|Other reason|0|||
129879067|NCT04534114|467515659|FG003|Extension Treatment Period|Other reason|0|||
129879068|NCT04534114|467515656|FG000|Extension Treatment Period|Death|0|||
129879069|NCT04534114|467515657|FG001|Extension Treatment Period|Death|0|||
129879070|NCT04534114|467515658|FG002|Extension Treatment Period|Death|1|||
129879071|NCT04534114|467515659|FG003|Extension Treatment Period|Death|2|||
129879072|NCT04534114|467515656|FG000|Extension Treatment Period|Adverse Event|0|||
129879073|NCT04534114|467515657|FG001|Extension Treatment Period|Adverse Event|1|||
129879074|NCT04534114|467515658|FG002|Extension Treatment Period|Adverse Event|0|||
129879075|NCT04534114|467515659|FG003|Extension Treatment Period|Adverse Event|1|||
129879076|NCT04534114|467515656|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
129879077|NCT04534114|467515657|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
129879078|NCT04534114|467515658|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
129879079|NCT04534114|467515659|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
129879080|NCT03287414|467515660|FG000|Treatment Epoch|Adverse Event|0|||
129879081|NCT03287414|467515661|FG001|Treatment Epoch|Adverse Event|1|||
129879082|NCT03287414|467515660|FG000|Treatment Epoch|Study terminated by sponsor|2|||
129879083|NCT03287414|467515661|FG001|Treatment Epoch|Study terminated by sponsor|2|||
129879084|NCT03287414|467515660|FG000|Treatment Epoch|Subject/Guardian decision|4|||
129879085|NCT03287414|467515661|FG001|Treatment Epoch|Subject/Guardian decision|0|||
129879086|NCT03287414|467515660|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
129879087|NCT03287414|467515661|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
129879088|NCT03287414|467515660|FG000|Treatment Epoch|Withdrawal by Subject|1|||
129879089|NCT03287414|467515661|FG001|Treatment Epoch|Withdrawal by Subject|0|||
129879090|NCT03287414|467515660|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
129879091|NCT03287414|467515661|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
129879092|NCT03287414|467515660|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
129879093|NCT03287414|467515661|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
129879094|NCT02759185|467515662|FG000|Stage 1|Adverse Event|0|||
129879095|NCT02759185|467515663|FG001|Stage 1|Adverse Event|1|||
129879096|NCT02759185|467515664|FG002|Stage 1|Adverse Event|3|||
129879097|NCT02759185|467515665|FG003|Stage 1|Adverse Event|0|||
129879098|NCT02759185|467515666|FG004|Stage 1|Adverse Event|0|||
129879099|NCT02759185|467515667|FG005|Stage 1|Adverse Event|0|||
129879100|NCT02759185|467515668|FG006|Stage 1|Adverse Event|0|||
129879101|NCT02759185|467515662|FG000|Stage 1|Withdrawal by Subject|1|||
129879102|NCT02759185|467515663|FG001|Stage 1|Withdrawal by Subject|0|||
129879103|NCT02759185|467515664|FG002|Stage 1|Withdrawal by Subject|0|||
129879104|NCT02759185|467515665|FG003|Stage 1|Withdrawal by Subject|0|||
129879105|NCT02759185|467515666|FG004|Stage 1|Withdrawal by Subject|0|||
129879106|NCT02759185|467515667|FG005|Stage 1|Withdrawal by Subject|0|||
129879107|NCT02759185|467515668|FG006|Stage 1|Withdrawal by Subject|0|||
129879108|NCT02759185|467515662|FG000|Stage 2|Adverse Event|0|||
129879109|NCT02759185|467515663|FG001|Stage 2|Adverse Event|0|||
129879110|NCT02759185|467515664|FG002|Stage 2|Adverse Event|0|||
129879111|NCT02759185|467515665|FG003|Stage 2|Adverse Event|0|||
129879112|NCT02759185|467515666|FG004|Stage 2|Adverse Event|1|||
129879113|NCT02759185|467515667|FG005|Stage 2|Adverse Event|2|||
129879114|NCT02759185|467515668|FG006|Stage 2|Adverse Event|0|||
129879115|NCT02759185|467515662|FG000|Stage 2|Withdrawal by Subject|0|||
129879116|NCT02759185|467515663|FG001|Stage 2|Withdrawal by Subject|0|||
129879117|NCT02759185|467515664|FG002|Stage 2|Withdrawal by Subject|0|||
129879118|NCT02759185|467515665|FG003|Stage 2|Withdrawal by Subject|0|||
129879119|NCT02759185|467515666|FG004|Stage 2|Withdrawal by Subject|1|||
129879120|NCT02759185|467515667|FG005|Stage 2|Withdrawal by Subject|1|||
129879121|NCT02759185|467515668|FG006|Stage 2|Withdrawal by Subject|1|||
129879122|NCT02613221|467515674|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
129879123|NCT02613221|467515674|FG000|Overall Study|Adverse Event|2|||
129879124|NCT02613221|467515674|FG000|Overall Study|Voluntary Discontinuation|1|||
129879125|NCT02613221|467515674|FG000|Overall Study|Delayed Treatment|1|||
129879126|NCT02613221|467515674|FG000|Overall Study|Enrolled but Not Treated|1|||
129879127|NCT01008475|467515677|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
129879128|NCT01008475|467515678|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
129879129|NCT01008475|467515679|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
129879130|NCT01008475|467515680|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
129879131|NCT01008475|467515681|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
129879132|NCT01008475|467515682|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
129879133|NCT01008475|467515683|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
129879134|NCT02668016|467515684|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
129879135|NCT02668016|467515684|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
129879136|NCT02668016|467515684|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
129879137|NCT02668016|467515684|FG000|Month 4|Withdrawal due to severe symptoms|1|||
129879138|NCT02668016|467515684|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
129879139|NCT02668016|467515684|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
129879140|NCT02668016|467515684|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
129879141|NCT02668016|467515684|FG000|Month 6|Withdrawal due to severe symptoms|2|||
129879142|NCT02668016|467515684|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
129879143|NCT02668016|467515684|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
129879144|NCT02668016|467515684|FG000|Month 8|Withdrawal due to severe symptoms|1|||
129879145|NCT02668016|467515684|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
129879146|NCT02668016|467515684|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
129879147|NCT02668016|467515684|FG000|Month 10|Withdrawal due to severe symptoms|1|||
129879148|NCT02668016|467515684|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
129879149|NCT02917941|467515686|FG000|Treatment Period|Adverse Event|11|||
129879150|NCT02917941|467515686|FG000|Treatment Period|Progressive Disease|11|||
129879151|NCT02917941|467515686|FG000|Treatment Period|Reason not Specified|2|||
129879152|NCT02917941|467515686|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
129879153|NCT02917941|467515686|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
129879154|NCT02946918|467515698|FG000|Overall Study|Patient unblinded himself|1|||
129879155|NCT02946918|467515699|FG001|Overall Study|Patient unblinded himself|0|||
129879156|NCT02946918|467515698|FG000|Overall Study|Physician Decision|0|||
129879157|NCT02946918|467515699|FG001|Overall Study|Physician Decision|2|||
129879158|NCT02946918|467515698|FG000|Overall Study|Ran out of study medication|0|||
129879159|NCT02946918|467515699|FG001|Overall Study|Ran out of study medication|1|||
129879160|NCT00069784|467515700|FG000|Overall Study|Adverse Event|105|||
129879161|NCT00069784|467515701|FG001|Overall Study|Adverse Event|0|||
129879162|NCT00069784|467515700|FG000|Overall Study|Withdrawal by Subject|1090|||
129879163|NCT00069784|467515701|FG001|Overall Study|Withdrawal by Subject|0|||
129879164|NCT00069784|467515700|FG000|Overall Study|Other|17|||
129879165|NCT00069784|467515701|FG001|Overall Study|Other|0|||
129879166|NCT01672853|467515706|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
129879167|NCT01672853|467515707|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
129879168|NCT01672853|467515708|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
129879169|NCT01672853|467515706|FG000|Overall Study|Pregnancy|0|||
129879170|NCT01672853|467515707|FG001|Overall Study|Pregnancy|1|||
129879171|NCT01672853|467515708|FG002|Overall Study|Pregnancy|0|||
129879172|NCT01672853|467515706|FG000|Overall Study|Investigator's Discretion|1|||
129879173|NCT01672853|467515707|FG001|Overall Study|Investigator's Discretion|0|||
129879174|NCT01672853|467515708|FG002|Overall Study|Investigator's Discretion|0|||
129879175|NCT01672853|467515706|FG000|Overall Study|Withdrew Consent|5|||
129879176|NCT01672853|467515707|FG001|Overall Study|Withdrew Consent|5|||
129879177|NCT01672853|467515708|FG002|Overall Study|Withdrew Consent|5|||
129879178|NCT01672853|467515706|FG000|Overall Study|Adverse Event|4|||
129879179|NCT01672853|467515707|FG001|Overall Study|Adverse Event|6|||
129879180|NCT01672853|467515708|FG002|Overall Study|Adverse Event|8|||
129879181|NCT01672853|467515706|FG000|Overall Study|Lost to Follow-up|0|||
129879182|NCT01672853|467515707|FG001|Overall Study|Lost to Follow-up|1|||
129879183|NCT01672853|467515708|FG002|Overall Study|Lost to Follow-up|0|||
129879184|NCT01672853|467515706|FG000|Overall Study|Randomized but Never Treated|0|||
129879185|NCT01672853|467515707|FG001|Overall Study|Randomized but Never Treated|0|||
129879186|NCT01672853|467515708|FG002|Overall Study|Randomized but Never Treated|1|||
129879187|NCT00663117|467517132|FG000|Overall Study|Lack of Efficacy|1|||
129879188|NCT00663117|467517133|FG001|Overall Study|Lack of Efficacy|0|||
129879189|NCT01992549|467517139|FG000|Overall Study|Lost to Follow-up|2|||
129879190|NCT01992549|467517139|FG000|Overall Study|Serious Adverse Event|1|||
129879191|NCT01992549|467517139|FG000|Overall Study|Product Switch to Extend Half Life|1|||
129879192|NCT01590771|467517140|FG000|Overall Study|Other Protocol Specified Criteria|5|||
129879193|NCT01590771|467517141|FG001|Overall Study|Other Protocol Specified Criteria|14|||
129879194|NCT01590771|467517140|FG000|Overall Study|Withdrawal by Subject|8|||
129879195|NCT01590771|467517141|FG001|Overall Study|Withdrawal by Subject|15|||
129879196|NCT01590771|467517140|FG000|Overall Study|Protocol Violation|1|||
129879197|NCT01590771|467517141|FG001|Overall Study|Protocol Violation|2|||
129879198|NCT01590771|467517140|FG000|Overall Study|Lost to Follow-up|1|||
129879199|NCT01590771|467517141|FG001|Overall Study|Lost to Follow-up|1|||
129879200|NCT01590771|467517140|FG000|Overall Study|Lack of Efficacy|1|||
129879201|NCT01590771|467517141|FG001|Overall Study|Lack of Efficacy|0|||
129879202|NCT01590771|467517140|FG000|Overall Study|Adverse Event|3|||
129879203|NCT01590771|467517141|FG001|Overall Study|Adverse Event|7|||
129879204|NCT00767104|467517147|FG000|Overall Study|Lost to Follow-up|1|||
129879205|NCT00767104|467517148|FG001|Overall Study|Lost to Follow-up|2|||
129879206|NCT01900054|467517156|FG000|Overall Study|Physician Decision|1|||
129879207|NCT01900054|467517156|FG000|Overall Study|Withdrawal by Subject|1|||
129879208|NCT01186328|467517157|FG000|Overall Study|Death|1|||
129879209|NCT01186328|467517158|FG001|Overall Study|Death|0|||
129879210|NCT01186328|467517159|FG002|Overall Study|Death|0|||
129879211|NCT03015116|467517164|FG000|Overall Study|Lost to Follow-up|3|||
129879212|NCT03015116|467517165|FG001|Overall Study|Lost to Follow-up|0|||
129879213|NCT03015116|467517166|FG002|Overall Study|Lost to Follow-up|2|||
129879214|NCT03015116|467517164|FG000|Overall Study|Withdrawal by Subject|3|||
129879215|NCT03015116|467517165|FG001|Overall Study|Withdrawal by Subject|1|||
129879216|NCT03015116|467517166|FG002|Overall Study|Withdrawal by Subject|0|||
129879217|NCT03015116|467517164|FG000|Overall Study|Subject has New Medical Status|1|||
129879218|NCT03015116|467517165|FG001|Overall Study|Subject has New Medical Status|0|||
129879219|NCT03015116|467517166|FG002|Overall Study|Subject has New Medical Status|0|||
129879220|NCT03015116|467517164|FG000|Overall Study|Physician Decision|0|||
129879221|NCT03015116|467517165|FG001|Overall Study|Physician Decision|1|||
129879222|NCT03015116|467517166|FG002|Overall Study|Physician Decision|0|||
129879223|NCT02200939|467517171|FG000|Overall Study|Participant withdrew consent|0|||
129879224|NCT02200939|467517172|FG001|Overall Study|Participant withdrew consent|1|||
129879225|NCT02200939|467517171|FG000|Overall Study|Lost to Follow-up|2|||
129879226|NCT02200939|467517172|FG001|Overall Study|Lost to Follow-up|9|||
129879227|NCT02200939|467517171|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
129879228|NCT02200939|467517172|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
129879229|NCT02762981|467517173|FG000|Overall Study|Adverse Event|2|||
129879230|NCT02762981|467517174|FG001|Overall Study|Adverse Event|3|||
129879231|NCT02762981|467517175|FG002|Overall Study|Adverse Event|1|||
129879232|NCT02762981|467517176|FG003|Overall Study|Adverse Event|1|||
129879233|NCT02762981|467517177|FG004|Overall Study|Adverse Event|3|||
129879234|NCT02762981|467517173|FG000|Overall Study|Physician Decision|0|||
129879235|NCT02762981|467517174|FG001|Overall Study|Physician Decision|1|||
129879236|NCT02762981|467517175|FG002|Overall Study|Physician Decision|0|||
129879237|NCT02762981|467517176|FG003|Overall Study|Physician Decision|0|||
129879238|NCT02762981|467517177|FG004|Overall Study|Physician Decision|1|||
129879239|NCT02762981|467517173|FG000|Overall Study|Disease progression|11|||
129879240|NCT02762981|467517174|FG001|Overall Study|Disease progression|23|||
129879241|NCT02762981|467517175|FG002|Overall Study|Disease progression|4|||
129879242|NCT02762981|467517176|FG003|Overall Study|Disease progression|10|||
129879243|NCT02762981|467517177|FG004|Overall Study|Disease progression|1|||
129879244|NCT02762981|467517173|FG000|Overall Study|Enrolled not treated|1|||
129879245|NCT02762981|467517174|FG001|Overall Study|Enrolled not treated|5|||
129879246|NCT02762981|467517175|FG002|Overall Study|Enrolled not treated|0|||
129879247|NCT02762981|467517176|FG003|Overall Study|Enrolled not treated|2|||
129879248|NCT02762981|467517177|FG004|Overall Study|Enrolled not treated|0|||
129879249|NCT02762981|467517173|FG000|Overall Study|Other|2|||
129879250|NCT02762981|467517174|FG001|Overall Study|Other|3|||
129879251|NCT02762981|467517175|FG002|Overall Study|Other|1|||
129879252|NCT02762981|467517176|FG003|Overall Study|Other|0|||
129879253|NCT02762981|467517177|FG004|Overall Study|Other|0|||
129879254|NCT02762981|467517173|FG000|Overall Study|Missing|1|||
129879255|NCT02762981|467517174|FG001|Overall Study|Missing|0|||
129879256|NCT02762981|467517175|FG002|Overall Study|Missing|0|||
129879257|NCT02762981|467517176|FG003|Overall Study|Missing|0|||
129879258|NCT02762981|467517177|FG004|Overall Study|Missing|0|||
129879259|NCT02762981|467517173|FG000|Overall Study|Withdrawal by Subject|0|||
129879260|NCT02762981|467517174|FG001|Overall Study|Withdrawal by Subject|5|||
129879261|NCT02762981|467517175|FG002|Overall Study|Withdrawal by Subject|1|||
129879262|NCT02762981|467517176|FG003|Overall Study|Withdrawal by Subject|3|||
129879263|NCT02762981|467517177|FG004|Overall Study|Withdrawal by Subject|0|||
129879264|NCT02176421|467517178|FG000|Overall Study|Lost to Follow-up|4|||
129879265|NCT02176421|467517178|FG000|Overall Study|Adverse Event|1|||
129879266|NCT00584805|467517181|FG000|Overall Study|No longer at risk of exposure|39|||
129879267|NCT00584805|467517181|FG000|Overall Study|Relocation|36|||
129879268|NCT00584805|467517181|FG000|Overall Study|Withdrawal by Subject|18|||
129879269|NCT00584805|467517181|FG000|Overall Study|Non-compliance|1|||
129879270|NCT00584805|467517181|FG000|Overall Study|Lost to follow up|3|||
129879271|NCT00584805|467517181|FG000|Overall Study|Screen failures|2|||
129879272|NCT02341456|467517185|FG000|Overall Study|Disease progression|2|||
129879273|NCT02341456|467517186|FG001|Overall Study|Disease progression|3|||
129879274|NCT02341456|467517187|FG002|Overall Study|Disease progression|1|||
129879275|NCT02341456|467517185|FG000|Overall Study|Death|1|||
129879276|NCT02341456|467517186|FG001|Overall Study|Death|1|||
129879277|NCT02341456|467517187|FG002|Overall Study|Death|1|||
129879278|NCT02341456|467517185|FG000|Overall Study|Withdrawal by Subject|0|||
129879279|NCT02341456|467517186|FG001|Overall Study|Withdrawal by Subject|1|||
129879280|NCT02341456|467517187|FG002|Overall Study|Withdrawal by Subject|1|||
129879281|NCT02341456|467517185|FG000|Overall Study|Moved to local access programme.|0|||
129879282|NCT02341456|467517186|FG001|Overall Study|Moved to local access programme.|1|||
129879283|NCT02341456|467517187|FG002|Overall Study|Moved to local access programme.|1|||
129879284|NCT02341456|467517185|FG000|Overall Study|Physician Decision|1|||
129879285|NCT02341456|467517186|FG001|Overall Study|Physician Decision|0|||
129879286|NCT02341456|467517187|FG002|Overall Study|Physician Decision|0|||
129879287|NCT01077362|467517188|FG000|Overall Study|Lack of Efficacy|13|||
129879288|NCT01077362|467517189|FG001|Overall Study|Lack of Efficacy|8|||
129879289|NCT01077362|467517190|FG002|Overall Study|Lack of Efficacy|10|||
129879290|NCT01077362|467517188|FG000|Overall Study|Lost to Follow-up|1|||
129879291|NCT01077362|467517189|FG001|Overall Study|Lost to Follow-up|0|||
129879292|NCT01077362|467517190|FG002|Overall Study|Lost to Follow-up|3|||
129879293|NCT01077362|467517188|FG000|Overall Study|Adverse Event|12|||
129879294|NCT01077362|467517189|FG001|Overall Study|Adverse Event|7|||
130322463|NCT03414983|469151271|FG000|Treatment|Maximum clinical benefit|5|||
129879295|NCT01077362|467517190|FG002|Overall Study|Adverse Event|4|||
129879296|NCT01077362|467517188|FG000|Overall Study|Withdrawal by Subject|5|||
129879297|NCT01077362|467517189|FG001|Overall Study|Withdrawal by Subject|3|||
129879298|NCT01077362|467517190|FG002|Overall Study|Withdrawal by Subject|5|||
129879299|NCT01077362|467517188|FG000|Overall Study|Other|0|||
129879300|NCT01077362|467517189|FG001|Overall Study|Other|1|||
129879301|NCT01077362|467517190|FG002|Overall Study|Other|2|||
129879302|NCT00301080|467517191|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
129879303|NCT00301080|467517192|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879304|NCT00301080|467517193|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879305|NCT00301080|467517194|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879306|NCT00301080|467517195|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879307|NCT01641926|467517196|FG000|Overall Study|Adverse Event|5|||
129879308|NCT01641926|467517197|FG001|Overall Study|Adverse Event|2|||
129879309|NCT01641926|467517198|FG002|Overall Study|Adverse Event|3|||
129879310|NCT01641926|467517199|FG003|Overall Study|Adverse Event|1|||
129879311|NCT01641926|467517196|FG000|Overall Study|Lost to Follow-up|2|||
129879312|NCT01641926|467517197|FG001|Overall Study|Lost to Follow-up|2|||
129879313|NCT01641926|467517198|FG002|Overall Study|Lost to Follow-up|1|||
129879314|NCT01641926|467517199|FG003|Overall Study|Lost to Follow-up|0|||
129879315|NCT01641926|467517196|FG000|Overall Study|Physician Decision|6|||
129879316|NCT01641926|467517197|FG001|Overall Study|Physician Decision|5|||
129879317|NCT01641926|467517198|FG002|Overall Study|Physician Decision|0|||
129879318|NCT01641926|467517199|FG003|Overall Study|Physician Decision|1|||
129879319|NCT01641926|467517196|FG000|Overall Study|Protocol Violation|1|||
129879320|NCT01641926|467517197|FG001|Overall Study|Protocol Violation|0|||
129879321|NCT01641926|467517198|FG002|Overall Study|Protocol Violation|0|||
129879322|NCT01641926|467517199|FG003|Overall Study|Protocol Violation|1|||
129879323|NCT01641926|467517196|FG000|Overall Study|Withdrawal by Subject|13|||
129879324|NCT01641926|467517197|FG001|Overall Study|Withdrawal by Subject|5|||
129879325|NCT01641926|467517198|FG002|Overall Study|Withdrawal by Subject|6|||
129879326|NCT01641926|467517199|FG003|Overall Study|Withdrawal by Subject|1|||
129879327|NCT01641926|467517196|FG000|Overall Study|Not Treated|1|||
129879328|NCT01641926|467517197|FG001|Overall Study|Not Treated|1|||
129879329|NCT01641926|467517198|FG002|Overall Study|Not Treated|1|||
129879330|NCT01641926|467517199|FG003|Overall Study|Not Treated|0|||
129879331|NCT02567825|467517206|FG000|Overall Study|No follow-up post-randomization|5|||
129879332|NCT02567825|467517207|FG001|Overall Study|No follow-up post-randomization|1|||
129879333|NCT02567825|467517206|FG000|Overall Study|Follow-up less than 23 months|16|||
129879334|NCT02567825|467517207|FG001|Overall Study|Follow-up less than 23 months|20|||
129879335|NCT01540565|467517209|FG000|Overall Study|Ineligible|2|||
129879336|NCT04145037|467517210|FG000|Overall Study|Study terminated|2|||
129879337|NCT04145037|467517211|FG001|Overall Study|Study terminated|0|||
129879338|NCT04145037|467517210|FG000|Overall Study|Withdrawal by Subject|1|||
129879339|NCT04145037|467517211|FG001|Overall Study|Withdrawal by Subject|0|||
129879340|NCT04145037|467517210|FG000|Overall Study|Lost to Follow-up|1|||
129879341|NCT04145037|467517211|FG001|Overall Study|Lost to Follow-up|0|||
129879342|NCT00130793|467517212|FG000|Overall Study|Lost to Follow-up|1|||
129879343|NCT00130793|467517213|FG001|Overall Study|Lost to Follow-up|4|||
129879344|NCT00130793|467517212|FG000|Overall Study|Withdrew consent|2|||
129879345|NCT00130793|467517213|FG001|Overall Study|Withdrew consent|0|||
129879346|NCT00453102|467517216|FG000|Overall Study|Withdrawal by Subject|2|||
129879347|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
129879348|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
129879349|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
129879350|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
129879351|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
129879352|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
129879353|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
129879354|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
129879355|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
129879356|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
129879357|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
129879358|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
129879359|NCT03500640|467517222|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
129879360|NCT03500640|467517223|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
129879361|NCT03500640|467517224|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
129879362|NCT03500640|467517222|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
129879363|NCT03500640|467517223|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
129879364|NCT03500640|467517224|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
129879365|NCT03500640|467517222|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
129879366|NCT03500640|467517223|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
129879367|NCT03500640|467517224|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
129879368|NCT03500640|467517222|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
129879369|NCT03500640|467517223|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
129879370|NCT03500640|467517224|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
129879371|NCT03500640|467517222|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
129879372|NCT03500640|467517223|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
129879373|NCT03500640|467517224|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
129879374|NCT03500640|467517222|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
129879375|NCT03500640|467517223|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
129879376|NCT03500640|467517224|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
129879377|NCT01650519|467517225|FG000|Overall Study|Withdrawal by Subject|1|||
129879378|NCT01650519|467517226|FG001|Overall Study|Withdrawal by Subject|0|||
129879379|NCT05067933|467517235|FG000|Overall Study|Withdrawal by Subject|2|||
129879380|NCT05067933|467517236|FG001|Overall Study|Withdrawal by Subject|0|||
129879381|NCT05067933|467517237|FG002|Overall Study|Withdrawal by Subject|0|||
129879382|NCT05067933|467517238|FG003|Overall Study|Withdrawal by Subject|0|||
129879383|NCT05067933|467517239|FG004|Overall Study|Withdrawal by Subject|0|||
129879384|NCT05067933|467517240|FG005|Overall Study|Withdrawal by Subject|0|||
129879385|NCT05067933|467517235|FG000|Overall Study|Lost to Follow-up|1|||
129879386|NCT05067933|467517236|FG001|Overall Study|Lost to Follow-up|1|||
129879387|NCT05067933|467517237|FG002|Overall Study|Lost to Follow-up|1|||
129879388|NCT05067933|467517238|FG003|Overall Study|Lost to Follow-up|2|||
129879389|NCT05067933|467517239|FG004|Overall Study|Lost to Follow-up|1|||
129879390|NCT05067933|467517240|FG005|Overall Study|Lost to Follow-up|0|||
129879391|NCT05067933|467517235|FG000|Overall Study|Miscellaneous|1|||
129879392|NCT05067933|467517236|FG001|Overall Study|Miscellaneous|0|||
129879393|NCT05067933|467517237|FG002|Overall Study|Miscellaneous|0|||
129879394|NCT05067933|467517238|FG003|Overall Study|Miscellaneous|0|||
129879395|NCT05067933|467517239|FG004|Overall Study|Miscellaneous|0|||
129879396|NCT05067933|467517240|FG005|Overall Study|Miscellaneous|0|||
129879397|NCT05067933|467517235|FG000|Overall Study|Death|0|||
129879398|NCT05067933|467517236|FG001|Overall Study|Death|0|||
129879399|NCT05067933|467517237|FG002|Overall Study|Death|0|||
129879400|NCT05067933|467517238|FG003|Overall Study|Death|1|||
129879401|NCT05067933|467517239|FG004|Overall Study|Death|0|||
129879402|NCT05067933|467517240|FG005|Overall Study|Death|0|||
129879403|NCT02234063|467517253|FG000|Overall Study|Lost to Follow-up|235|||
129879404|NCT02234063|467517254|FG001|Overall Study|Lost to Follow-up|42|||
129879405|NCT02234063|467517253|FG000|Overall Study|Withdrawal by Subject|20|||
129879406|NCT02234063|467517254|FG001|Overall Study|Withdrawal by Subject|1|||
129879407|NCT02669095|467517259|FG000|Overall Study|Adverse Event|1|||
129879408|NCT02669095|467517260|FG001|Overall Study|Adverse Event|0|||
129879409|NCT02669095|467517259|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129879410|NCT02669095|467517260|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129879411|NCT02669095|467517259|FG000|Overall Study|Torn Lens|0|||
129879412|NCT02669095|467517260|FG001|Overall Study|Torn Lens|1|||
129879413|NCT02669095|467517259|FG000|Overall Study|Visit 5 assessments not completed|0|||
129879414|NCT02669095|467517260|FG001|Overall Study|Visit 5 assessments not completed|1|||
129879415|NCT00926003|467517261|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
129879416|NCT00926003|467517262|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
129879417|NCT00926003|467517263|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
129879418|NCT00926003|467517261|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
129879419|NCT00926003|467517262|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
129879420|NCT00926003|467517263|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
129879421|NCT01396317|467517264|FG000|Overall Study|Adverse Event|1|||
129879422|NCT01396317|467517265|FG001|Overall Study|Adverse Event|0|||
129879423|NCT02294474|467517266|FG000|Overall Study|Adverse Event|7|||
129879424|NCT02294474|467517267|FG001|Overall Study|Adverse Event|7|||
129879425|NCT02294474|467517266|FG000|Overall Study|Lack of Efficacy|2|||
129879426|NCT02294474|467517267|FG001|Overall Study|Lack of Efficacy|1|||
129879427|NCT02294474|467517266|FG000|Overall Study|Protocol Violation|4|||
129879428|NCT02294474|467517267|FG001|Overall Study|Protocol Violation|2|||
129879429|NCT02294474|467517266|FG000|Overall Study|Other than specified above|12|||
129879430|NCT02294474|467517267|FG001|Overall Study|Other than specified above|12|||
129879431|NCT05200936|467517269|FG000|Overall Study|Withdrawal by Subject|2|||
129879432|NCT05200936|467517270|FG001|Overall Study|Withdrawal by Subject|2|||
129879433|NCT05200936|467517269|FG000|Overall Study|Lost to Follow-up|2|||
129879434|NCT05200936|467517270|FG001|Overall Study|Lost to Follow-up|0|||
129879435|NCT05200936|467517269|FG000|Overall Study|Pregnancy|0|||
129879436|NCT05200936|467517270|FG001|Overall Study|Pregnancy|1|||
129879437|NCT03443713|467517271|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
129879438|NCT03443713|467517272|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
129879439|NCT03443713|467517273|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
129879440|NCT02944656|467517275|FG000|Overall Study|No longer eligible|3|||
129879441|NCT02944656|467517276|FG001|Overall Study|No longer eligible|0|||
129879442|NCT02944656|467517275|FG000|Overall Study|Lost to Follow-up|7|||
129879443|NCT02944656|467517276|FG001|Overall Study|Lost to Follow-up|10|||
129879444|NCT05879198|467517279|FG000|Overall Study|Lost to Follow-up|1|||
129879445|NCT02073097|467517280|FG000|Overall Study|Adverse Event|0|||
129879446|NCT02073097|467517281|FG001|Overall Study|Adverse Event|0|||
129879447|NCT02073097|467517282|FG002|Overall Study|Adverse Event|0|||
129879448|NCT02073097|467517283|FG003|Overall Study|Adverse Event|0|||
129879449|NCT02073097|467517284|FG004|Overall Study|Adverse Event|0|||
129879450|NCT02073097|467517285|FG005|Overall Study|Adverse Event|0|||
129879451|NCT02073097|467517286|FG006|Overall Study|Adverse Event|0|||
129879452|NCT02073097|467517287|FG007|Overall Study|Adverse Event|2|||
129879453|NCT02073097|467517280|FG000|Overall Study|Withdrawal by Subject|0|||
129879454|NCT02073097|467517281|FG001|Overall Study|Withdrawal by Subject|0|||
129879455|NCT02073097|467517282|FG002|Overall Study|Withdrawal by Subject|0|||
129879456|NCT02073097|467517283|FG003|Overall Study|Withdrawal by Subject|0|||
129879457|NCT02073097|467517284|FG004|Overall Study|Withdrawal by Subject|0|||
129879458|NCT02073097|467517285|FG005|Overall Study|Withdrawal by Subject|0|||
130098687|NCT00593385|468319276|FG000|Overall Study|Lost to Follow-up|17|||
129879459|NCT02073097|467517286|FG006|Overall Study|Withdrawal by Subject|0|||
129879460|NCT02073097|467517287|FG007|Overall Study|Withdrawal by Subject|2|||
129879461|NCT02073097|467517280|FG000|Overall Study|Death|0|||
129879462|NCT02073097|467517281|FG001|Overall Study|Death|0|||
129879463|NCT02073097|467517282|FG002|Overall Study|Death|0|||
129879464|NCT02073097|467517283|FG003|Overall Study|Death|0|||
129879465|NCT02073097|467517284|FG004|Overall Study|Death|0|||
129879466|NCT02073097|467517285|FG005|Overall Study|Death|0|||
129879467|NCT02073097|467517286|FG006|Overall Study|Death|0|||
129879468|NCT02073097|467517287|FG007|Overall Study|Death|1|||
129879469|NCT02073097|467517280|FG000|Overall Study|Physician Decision|0|||
129879470|NCT02073097|467517281|FG001|Overall Study|Physician Decision|0|||
129879471|NCT02073097|467517282|FG002|Overall Study|Physician Decision|0|||
129879472|NCT02073097|467517283|FG003|Overall Study|Physician Decision|0|||
129879473|NCT02073097|467517284|FG004|Overall Study|Physician Decision|0|||
129879474|NCT02073097|467517285|FG005|Overall Study|Physician Decision|0|||
129879475|NCT02073097|467517286|FG006|Overall Study|Physician Decision|0|||
129879476|NCT02073097|467517287|FG007|Overall Study|Physician Decision|1|||
129879477|NCT02769065|467519315|FG000|Overall Study|Voluntary Withdrawal|1|||
129879478|NCT02769065|467519316|FG001|Overall Study|Voluntary Withdrawal|0|||
129879479|NCT02769065|467519317|FG002|Overall Study|Voluntary Withdrawal|0|||
129879480|NCT02769065|467519318|FG003|Overall Study|Voluntary Withdrawal|0|||
129879481|NCT02769065|467519319|FG004|Overall Study|Voluntary Withdrawal|0|||
129879482|NCT02769065|467519320|FG005|Overall Study|Voluntary Withdrawal|0|||
129879483|NCT02769065|467519321|FG006|Overall Study|Voluntary Withdrawal|0|||
129879484|NCT02769065|467519322|FG007|Overall Study|Voluntary Withdrawal|0|||
129879485|NCT02769065|467519323|FG008|Overall Study|Voluntary Withdrawal|0|||
129879486|NCT02769065|467519324|FG009|Overall Study|Voluntary Withdrawal|0|||
129879487|NCT02769065|467519325|FG010|Overall Study|Voluntary Withdrawal|0|||
129879488|NCT02769065|467519326|FG011|Overall Study|Voluntary Withdrawal|0|||
129879489|NCT02769065|467519327|FG012|Overall Study|Voluntary Withdrawal|0|||
129879490|NCT02769065|467519328|FG013|Overall Study|Voluntary Withdrawal|0|||
129879491|NCT02769065|467519329|FG014|Overall Study|Voluntary Withdrawal|0|||
129879492|NCT02769065|467519330|FG015|Overall Study|Voluntary Withdrawal|0|||
129879493|NCT02769065|467519331|FG016|Overall Study|Voluntary Withdrawal|0|||
129879494|NCT02769065|467519332|FG017|Overall Study|Voluntary Withdrawal|0|||
129879495|NCT02769065|467519333|FG018|Overall Study|Voluntary Withdrawal|0|||
129879496|NCT02769065|467519334|FG019|Overall Study|Voluntary Withdrawal|0|||
129879497|NCT02769065|467519335|FG020|Overall Study|Voluntary Withdrawal|0|||
129879498|NCT02769065|467519336|FG021|Overall Study|Voluntary Withdrawal|0|||
129879499|NCT02769065|467519337|FG022|Overall Study|Voluntary Withdrawal|0|||
129879500|NCT02769065|467519338|FG023|Overall Study|Voluntary Withdrawal|0|||
129879501|NCT02769065|467519339|FG024|Overall Study|Voluntary Withdrawal|0|||
129879502|NCT02769065|467519340|FG025|Overall Study|Voluntary Withdrawal|0|||
129879503|NCT02769065|467519341|FG026|Overall Study|Voluntary Withdrawal|0|||
129879504|NCT02769065|467519342|FG027|Overall Study|Voluntary Withdrawal|0|||
129879505|NCT02769065|467519343|FG028|Overall Study|Voluntary Withdrawal|0|||
129879506|NCT02769065|467519344|FG029|Overall Study|Voluntary Withdrawal|0|||
129879507|NCT02769065|467519315|FG000|Overall Study|Reason Not Specified|0|||
129879508|NCT02769065|467519316|FG001|Overall Study|Reason Not Specified|0|||
129879509|NCT02769065|467519317|FG002|Overall Study|Reason Not Specified|0|||
129879510|NCT02769065|467519318|FG003|Overall Study|Reason Not Specified|0|||
129879511|NCT02769065|467519319|FG004|Overall Study|Reason Not Specified|0|||
129879512|NCT02769065|467519320|FG005|Overall Study|Reason Not Specified|0|||
129879513|NCT02769065|467519321|FG006|Overall Study|Reason Not Specified|1|||
129879514|NCT02769065|467519322|FG007|Overall Study|Reason Not Specified|0|||
129879515|NCT02769065|467519323|FG008|Overall Study|Reason Not Specified|0|||
129879516|NCT02769065|467519324|FG009|Overall Study|Reason Not Specified|0|||
129879517|NCT02769065|467519325|FG010|Overall Study|Reason Not Specified|0|||
129879518|NCT02769065|467519326|FG011|Overall Study|Reason Not Specified|0|||
129879519|NCT02769065|467519327|FG012|Overall Study|Reason Not Specified|0|||
129879520|NCT02769065|467519328|FG013|Overall Study|Reason Not Specified|0|||
129879521|NCT02769065|467519329|FG014|Overall Study|Reason Not Specified|0|||
129879522|NCT02769065|467519330|FG015|Overall Study|Reason Not Specified|0|||
129879523|NCT02769065|467519331|FG016|Overall Study|Reason Not Specified|0|||
129879524|NCT02769065|467519332|FG017|Overall Study|Reason Not Specified|0|||
129879525|NCT02769065|467519333|FG018|Overall Study|Reason Not Specified|0|||
129879526|NCT02769065|467519334|FG019|Overall Study|Reason Not Specified|0|||
130098688|NCT00593385|468319276|FG000|Overall Study|Withdrawal by Subject|9|||
129879527|NCT02769065|467519335|FG020|Overall Study|Reason Not Specified|0|||
129879528|NCT02769065|467519336|FG021|Overall Study|Reason Not Specified|0|||
129879529|NCT02769065|467519337|FG022|Overall Study|Reason Not Specified|0|||
129879530|NCT02769065|467519338|FG023|Overall Study|Reason Not Specified|0|||
129879531|NCT02769065|467519339|FG024|Overall Study|Reason Not Specified|0|||
129879532|NCT02769065|467519340|FG025|Overall Study|Reason Not Specified|0|||
129879533|NCT02769065|467519341|FG026|Overall Study|Reason Not Specified|0|||
129879534|NCT02769065|467519342|FG027|Overall Study|Reason Not Specified|0|||
129879535|NCT02769065|467519343|FG028|Overall Study|Reason Not Specified|0|||
129879536|NCT02769065|467519344|FG029|Overall Study|Reason Not Specified|0|||
129879537|NCT02769065|467519315|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879538|NCT02769065|467519316|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879539|NCT02769065|467519317|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879540|NCT02769065|467519318|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879541|NCT02769065|467519319|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879542|NCT02769065|467519320|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879543|NCT02769065|467519321|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879544|NCT02769065|467519322|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879545|NCT02769065|467519323|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879546|NCT02769065|467519324|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879547|NCT02769065|467519325|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
129879548|NCT02769065|467519326|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879549|NCT02769065|467519327|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879550|NCT02769065|467519328|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879551|NCT02769065|467519329|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879552|NCT02769065|467519330|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879553|NCT02769065|467519331|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879554|NCT02769065|467519332|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879555|NCT02769065|467519333|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879556|NCT02769065|467519334|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879557|NCT02769065|467519335|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879558|NCT02769065|467519336|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879559|NCT02769065|467519337|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879560|NCT02769065|467519338|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879561|NCT02769065|467519339|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879562|NCT02769065|467519340|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879563|NCT02769065|467519341|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879564|NCT02769065|467519342|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879565|NCT02769065|467519343|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879566|NCT02769065|467519344|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879567|NCT02764775|467519347|FG000|Overall Study|Death|1|||
129879568|NCT02764775|467519347|FG000|Overall Study|Lost to Follow-up|2|||
129879569|NCT02764775|467519347|FG000|Overall Study|Withdrawal by Subject|3|||
129879570|NCT04022889|467519350|FG000|Stage 1: Period 1|Adverse Event|1|||
129879571|NCT04022889|467519351|FG001|Stage 1: Period 1|Adverse Event|0|||
129879572|NCT04022889|467519352|FG002|Stage 1: Period 1|Adverse Event|0|||
129879573|NCT04022889|467519350|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
129879574|NCT04022889|467519351|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
129879575|NCT04022889|467519352|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
129879576|NCT04022889|467519350|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
129879577|NCT04022889|467519351|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
129879578|NCT04022889|467519352|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
129879579|NCT04022889|467519350|FG000|Stage 2|Screen Failure|0|||
129879580|NCT04022889|467519351|FG001|Stage 2|Screen Failure|0|||
129879581|NCT04022889|467519352|FG002|Stage 2|Screen Failure|3|||
129879582|NCT04022889|467519350|FG000|Stage 2|Ineligible for apheresis donation|0|||
129879583|NCT04022889|467519351|FG001|Stage 2|Ineligible for apheresis donation|0|||
129879584|NCT04022889|467519352|FG002|Stage 2|Ineligible for apheresis donation|2|||
129879585|NCT04022889|467519350|FG000|Stage 2|Adverse Event|0|||
129879586|NCT04022889|467519351|FG001|Stage 2|Adverse Event|0|||
129879587|NCT04022889|467519352|FG002|Stage 2|Adverse Event|2|||
129879588|NCT04022889|467519350|FG000|Stage 2|Protocol Violation|0|||
129879589|NCT04022889|467519351|FG001|Stage 2|Protocol Violation|0|||
129879590|NCT04022889|467519352|FG002|Stage 2|Protocol Violation|1|||
130322464|NCT03414983|469151272|FG001|Treatment|Maximum clinical benefit|9|||
130322465|NCT03414983|469151271|FG000|Treatment|Lost to Follow-up|0|||
130322466|NCT03414983|469151272|FG001|Treatment|Lost to Follow-up|1|||
130322467|NCT03414983|469151271|FG000|Treatment|Administrative reasons by sponsor|1|||
130322468|NCT03414983|469151272|FG001|Treatment|Administrative reasons by sponsor|0|||
130322469|NCT00092417|469151273|FG000|Overall Study|Lost to Follow-up|2|||
129879591|NCT04022889|467519350|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
129879592|NCT04022889|467519351|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
129879593|NCT04022889|467519352|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
129879594|NCT02291432|467519355|FG000|Overall Study|Withdrawal by Subject|2|||
129879595|NCT02145078|467519356|FG000|Overall Study|Death|1|||
129879596|NCT02145078|467519356|FG000|Overall Study|Reason not given|3|||
129879597|NCT03327402|467519357|FG000|Overall Study|Withdrawal by Subject|1|||
129879598|NCT03327402|467519357|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
129879599|NCT02440594|467519361|FG000|Overall Study|Lost to Follow-up|34|||
130322470|NCT00092417|469151274|FG001|Overall Study|Lost to Follow-up|0|||
130322471|NCT00092417|469151273|FG000|Overall Study|Withdrawal by Subject|2|||
129879600|NCT02440594|467519362|FG001|Overall Study|Lost to Follow-up|33|||
129879601|NCT02440594|467519363|FG002|Overall Study|Lost to Follow-up|54|||
129879602|NCT02440594|467519364|FG003|Overall Study|Lost to Follow-up|47|||
129879603|NCT02440594|467519365|FG004|Overall Study|Lost to Follow-up|5|||
129879604|NCT02440594|467519366|FG005|Overall Study|Lost to Follow-up|4|||
129879605|NCT02440594|467519367|FG006|Overall Study|Lost to Follow-up|28|||
129879606|NCT02440594|467519368|FG007|Overall Study|Lost to Follow-up|48|||
129879607|NCT02440594|467519361|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
129879608|NCT02440594|467519362|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
129879609|NCT02440594|467519363|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
129879610|NCT02440594|467519364|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
129879611|NCT02440594|467519365|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
129879612|NCT02440594|467519366|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
129879613|NCT02440594|467519367|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
129879614|NCT02440594|467519368|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
129879615|NCT02440594|467519361|FG000|Overall Study|Withdrawal by Subject|81|||
129879616|NCT02440594|467519362|FG001|Overall Study|Withdrawal by Subject|67|||
129879617|NCT02440594|467519363|FG002|Overall Study|Withdrawal by Subject|59|||
129879618|NCT02440594|467519364|FG003|Overall Study|Withdrawal by Subject|38|||
129879619|NCT02440594|467519365|FG004|Overall Study|Withdrawal by Subject|2|||
129879620|NCT02440594|467519366|FG005|Overall Study|Withdrawal by Subject|2|||
129879621|NCT02440594|467519367|FG006|Overall Study|Withdrawal by Subject|7|||
129879622|NCT02440594|467519368|FG007|Overall Study|Withdrawal by Subject|7|||
129879623|NCT02440594|467519361|FG000|Overall Study|Administratively w/drawn|3|||
129879624|NCT02440594|467519362|FG001|Overall Study|Administratively w/drawn|2|||
129879625|NCT02440594|467519363|FG002|Overall Study|Administratively w/drawn|0|||
129879626|NCT02440594|467519364|FG003|Overall Study|Administratively w/drawn|0|||
129879627|NCT02440594|467519365|FG004|Overall Study|Administratively w/drawn|0|||
129879628|NCT02440594|467519366|FG005|Overall Study|Administratively w/drawn|0|||
129879629|NCT02440594|467519367|FG006|Overall Study|Administratively w/drawn|2|||
129879630|NCT02440594|467519368|FG007|Overall Study|Administratively w/drawn|1|||
129879631|NCT03810313|467519369|FG000|Overall Study|Study terminated by sponsor|164|||
129879632|NCT03810313|467519370|FG001|Overall Study|Study terminated by sponsor|159|||
129879633|NCT03810313|467519369|FG000|Overall Study|Subject decision|10|||
129879634|NCT03810313|467519370|FG001|Overall Study|Subject decision|11|||
129879635|NCT03810313|467519369|FG000|Overall Study|Lost to Follow-up|3|||
129879636|NCT03810313|467519370|FG001|Overall Study|Lost to Follow-up|3|||
129879637|NCT03810313|467519369|FG000|Overall Study|Adverse Event|2|||
129879638|NCT03810313|467519370|FG001|Overall Study|Adverse Event|1|||
129879639|NCT03810313|467519369|FG000|Overall Study|Death|2|||
129879640|NCT03810313|467519370|FG001|Overall Study|Death|1|||
129879641|NCT03810313|467519369|FG000|Overall Study|Physician Decision|0|||
129879642|NCT03810313|467519370|FG001|Overall Study|Physician Decision|1|||
129879643|NCT03029780|467519373|FG000|Overall Study|Disease Progression|20|||
129879644|NCT03029780|467519374|FG001|Overall Study|Disease Progression|22|||
129879645|NCT03029780|467519373|FG000|Overall Study|Study Drug Toxicity|15|||
129879646|NCT03029780|467519374|FG001|Overall Study|Study Drug Toxicity|11|||
129879647|NCT03029780|467519373|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129879648|NCT03029780|467519374|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129879649|NCT03029780|467519373|FG000|Overall Study|Participant request to discontinue study treatment|4|||
129879650|NCT03029780|467519374|FG001|Overall Study|Participant request to discontinue study treatment|1|||
129879651|NCT03029780|467519373|FG000|Overall Study|Maximum clinical benefit|1|||
129879652|NCT03029780|467519374|FG001|Overall Study|Maximum clinical benefit|0|||
129879653|NCT03029780|467519373|FG000|Overall Study|Participant no longer meets study criteria|0|||
129879654|NCT03029780|467519374|FG001|Overall Study|Participant no longer meets study criteria|1|||
129879655|NCT03029780|467519373|FG000|Overall Study|Other reasons|6|||
129879656|NCT03029780|467519374|FG001|Overall Study|Other reasons|6|||
129879657|NCT03029780|467519373|FG000|Overall Study|Not reported|1|||
129879658|NCT03029780|467519374|FG001|Overall Study|Not reported|1|||
129879659|NCT03029780|467519373|FG000|Overall Study|Death|2|||
129879660|NCT03029780|467519374|FG001|Overall Study|Death|6|||
129879661|NCT03066622|467519375|FG000|Overall Study|Lost to Follow-up|24|||
129879662|NCT03066622|467519376|FG001|Overall Study|Lost to Follow-up|25|||
129879663|NCT03066622|467519375|FG000|Overall Study|Withdrawal by Subject|2|||
129879664|NCT03066622|467519376|FG001|Overall Study|Withdrawal by Subject|1|||
130322472|NCT00092417|469151274|FG001|Overall Study|Withdrawal by Subject|1|||
129879665|NCT01111838|467519377|FG000|Overall Study|Patient Ineligible|2|||
129879666|NCT01111838|467519377|FG000|Overall Study|Not Treated|3|||
129879667|NCT01111838|467519377|FG000|Overall Study|Clinical deterioration|1|||
129879668|NCT01111838|467519377|FG000|Overall Study|Other Complicating Disease|1|||
129879669|NCT00641719|467519378|FG000|Overall Study|Lack of Efficacy|1|||
129879670|NCT00641719|467519379|FG001|Overall Study|Lack of Efficacy|2|||
129879671|NCT00641719|467519378|FG000|Overall Study|Adverse Event|24|||
129879672|NCT00641719|467519379|FG001|Overall Study|Adverse Event|29|||
129879673|NCT00641719|467519378|FG000|Overall Study|Withdrawal by Subject|4|||
129879674|NCT00641719|467519379|FG001|Overall Study|Withdrawal by Subject|4|||
129879675|NCT00641719|467519378|FG000|Overall Study|Reason Not Specified|1|||
129879676|NCT00641719|467519379|FG001|Overall Study|Reason Not Specified|2|||
129879677|NCT03303469|467519380|FG000|Overall Study|Lost to Follow-up|2|||
129879678|NCT04741802|467519382|FG000|Overall Study|Death|1|||
129879679|NCT04741802|467519382|FG000|Overall Study|Lost to Follow-up|11|||
129879680|NCT01785563|467519384|FG000|Overall Study|Physician Decision|10|||
129879681|NCT01785563|467519384|FG000|Overall Study|Withdrawal by Subject|1|||
129879682|NCT01785563|467519384|FG000|Overall Study|Protocol Violation|2|||
129879683|NCT01872910|467519385|FG000|Overall Study|Lost to Follow-up|2|||
129879684|NCT01872910|467519386|FG001|Overall Study|Lost to Follow-up|0|||
129879685|NCT01872910|467519387|FG002|Overall Study|Lost to Follow-up|2|||
129879686|NCT01872910|467519388|FG003|Overall Study|Lost to Follow-up|0|||
129879687|NCT01872910|467519389|FG004|Overall Study|Lost to Follow-up|0|||
129879688|NCT01872910|467519390|FG005|Overall Study|Lost to Follow-up|0|||
129879689|NCT01616771|467519391|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
129879690|NCT00100932|467519392|FG000|Overall Study|Adverse Event|11|||
129879691|NCT00100932|467519393|FG001|Overall Study|Adverse Event|2|||
129879692|NCT00100932|467519392|FG000|Overall Study|Withdrawal by Subject|6|||
129879693|NCT00100932|467519393|FG001|Overall Study|Withdrawal by Subject|0|||
129879694|NCT00100932|467519392|FG000|Overall Study|Progressive Disease|44|||
129879695|NCT00100932|467519393|FG001|Overall Study|Progressive Disease|18|||
129879696|NCT00100932|467519392|FG000|Overall Study|Physician Decision|7|||
129879697|NCT00100932|467519393|FG001|Overall Study|Physician Decision|5|||
129879698|NCT00100932|467519392|FG000|Overall Study|Other|5|||
129879699|NCT00100932|467519393|FG001|Overall Study|Other|2|||
129879700|NCT00744328|467519394|FG000|Overall Study|Lost to Follow-up|2|||
129879701|NCT00744328|467519395|FG001|Overall Study|Lost to Follow-up|5|||
129879702|NCT00744328|467519396|FG002|Overall Study|Lost to Follow-up|3|||
129879703|NCT00744328|467519394|FG000|Overall Study|Withdrawal by Subject|5|||
129879704|NCT00744328|467519395|FG001|Overall Study|Withdrawal by Subject|3|||
129879705|NCT00744328|467519396|FG002|Overall Study|Withdrawal by Subject|4|||
129879706|NCT00744328|467519394|FG000|Overall Study|Found ineligible after randomization|0|||
129879707|NCT00744328|467519395|FG001|Overall Study|Found ineligible after randomization|0|||
129879708|NCT00744328|467519396|FG002|Overall Study|Found ineligible after randomization|1|||
129879709|NCT02387216|467519401|FG000|Overall Study|Progressive disease|2|||
129879710|NCT02387216|467519402|FG001|Overall Study|Progressive disease|0|||
129879711|NCT02387216|467519401|FG000|Overall Study|Withdrawal by Subject|3|||
129879712|NCT02387216|467519402|FG001|Overall Study|Withdrawal by Subject|5|||
129879713|NCT02387216|467519401|FG000|Overall Study|Physician Decision|2|||
129879714|NCT02387216|467519402|FG001|Overall Study|Physician Decision|0|||
129879715|NCT02387216|467519401|FG000|Overall Study|Sponsor Decision|28|||
129879716|NCT02387216|467519402|FG001|Overall Study|Sponsor Decision|12|||
129879717|NCT02387216|467519401|FG000|Overall Study|Death|60|||
129879718|NCT02387216|467519402|FG001|Overall Study|Death|23|||
129879719|NCT02387216|467519401|FG000|Overall Study|Other|5|||
129879720|NCT02387216|467519402|FG001|Overall Study|Other|4|||
129879721|NCT02387216|467519401|FG000|Overall Study|Lost to Follow-up|0|||
129879722|NCT02387216|467519402|FG001|Overall Study|Lost to Follow-up|3|||
129879723|NCT04041440|467519403|FG000|Overall Study|Withdrawal by Subject|0|||
129879724|NCT04041440|467519404|FG001|Overall Study|Withdrawal by Subject|1|||
129879725|NCT04041440|467519403|FG000|Overall Study|Lost to Follow-up|0|||
129879726|NCT04041440|467519404|FG001|Overall Study|Lost to Follow-up|1|||
129879727|NCT02247804|467519409|FG000|Treatment Period 1|Adverse Event|9|||
129879728|NCT02247804|467519410|FG001|Treatment Period 1|Adverse Event|2|||
129879729|NCT02247804|467519411|FG002|Treatment Period 1|Adverse Event|0|||
129879730|NCT02247804|467519409|FG000|Treatment Period 1|Lack of Efficacy|0|||
129879731|NCT02247804|467519410|FG001|Treatment Period 1|Lack of Efficacy|0|||
129879732|NCT02247804|467519411|FG002|Treatment Period 1|Lack of Efficacy|2|||
129879733|NCT02247804|467519409|FG000|Treatment Period 1|Lost to Follow-up|1|||
129879734|NCT02247804|467519410|FG001|Treatment Period 1|Lost to Follow-up|0|||
129879735|NCT02247804|467519411|FG002|Treatment Period 1|Lost to Follow-up|2|||
129879736|NCT02247804|467519409|FG000|Treatment Period 1|Personal Reasons|7|||
129879737|NCT02247804|467519410|FG001|Treatment Period 1|Personal Reasons|1|||
130098689|NCT01471197|468319277|FG000|Overall Study|Disease Progression|4|||
130098690|NCT01471197|468319278|FG001|Overall Study|Disease Progression|2|||
129879738|NCT02247804|467519411|FG002|Treatment Period 1|Personal Reasons|2|||
129879739|NCT02247804|467519409|FG000|Treatment Period 1|Protocol Deviation|0|||
129879740|NCT02247804|467519410|FG001|Treatment Period 1|Protocol Deviation|0|||
129879741|NCT02247804|467519411|FG002|Treatment Period 1|Protocol Deviation|1|||
129879742|NCT02247804|467519409|FG000|Treatment Period 1|Randomized but not Treated|5|||
129879743|NCT02247804|467519410|FG001|Treatment Period 1|Randomized but not Treated|1|||
129879744|NCT02247804|467519411|FG002|Treatment Period 1|Randomized but not Treated|1|||
129879745|NCT02247804|467519409|FG000|Treatment Period 2|Adverse Event|6|||
129879746|NCT02247804|467519410|FG001|Treatment Period 2|Adverse Event|3|||
129879747|NCT02247804|467519411|FG002|Treatment Period 2|Adverse Event|3|||
129879748|NCT02247804|467519409|FG000|Treatment Period 2|Lack of Efficacy|0|||
129879749|NCT02247804|467519410|FG001|Treatment Period 2|Lack of Efficacy|0|||
129879750|NCT02247804|467519411|FG002|Treatment Period 2|Lack of Efficacy|1|||
129879751|NCT02247804|467519409|FG000|Treatment Period 2|Lost to Follow-up|0|||
129879752|NCT02247804|467519410|FG001|Treatment Period 2|Lost to Follow-up|1|||
129879753|NCT02247804|467519411|FG002|Treatment Period 2|Lost to Follow-up|1|||
129879754|NCT02247804|467519409|FG000|Treatment Period 2|Personal Reasons|2|||
129879755|NCT02247804|467519410|FG001|Treatment Period 2|Personal Reasons|1|||
129879756|NCT02247804|467519411|FG002|Treatment Period 2|Personal Reasons|1|||
129879757|NCT02247804|467519409|FG000|Treatment Period 2|Reason not Specified|0|||
129879758|NCT02247804|467519410|FG001|Treatment Period 2|Reason not Specified|0|||
129879759|NCT02247804|467519411|FG002|Treatment Period 2|Reason not Specified|2|||
129879760|NCT02247804|467519409|FG000|Treatment Period 3|Adverse Event|4|||
129879761|NCT02247804|467519410|FG001|Treatment Period 3|Adverse Event|3|||
129879762|NCT02247804|467519411|FG002|Treatment Period 3|Adverse Event|3|||
129879763|NCT02247804|467519409|FG000|Treatment Period 3|Lack of Efficacy|0|||
129879764|NCT02247804|467519410|FG001|Treatment Period 3|Lack of Efficacy|1|||
129879765|NCT02247804|467519411|FG002|Treatment Period 3|Lack of Efficacy|0|||
129879766|NCT02247804|467519409|FG000|Treatment Period 3|Lost to Follow-up|1|||
129879767|NCT02247804|467519410|FG001|Treatment Period 3|Lost to Follow-up|2|||
129879768|NCT02247804|467519411|FG002|Treatment Period 3|Lost to Follow-up|2|||
129879769|NCT02247804|467519409|FG000|Treatment Period 3|Personal Reasons|4|||
129879770|NCT02247804|467519410|FG001|Treatment Period 3|Personal Reasons|3|||
129879771|NCT02247804|467519411|FG002|Treatment Period 3|Personal Reasons|2|||
129879772|NCT02247804|467519409|FG000|Treatment Period 3|Reason not Specified|2|||
129879773|NCT02247804|467519410|FG001|Treatment Period 3|Reason not Specified|1|||
129879774|NCT02247804|467519411|FG002|Treatment Period 3|Reason not Specified|3|||
129879775|NCT02917265|467519412|FG000|Overall Study|Physician Decision|1|||
129879776|NCT02917265|467519413|FG001|Overall Study|Physician Decision|0|||
129879777|NCT02917265|467519412|FG000|Overall Study|Withdrawal by Subject|1|||
129879778|NCT02917265|467519413|FG001|Overall Study|Withdrawal by Subject|0|||
129879779|NCT00980005|467519414|FG000|Overall Study|Withdrawal by Subject|6|||
129879780|NCT00980005|467519415|FG001|Overall Study|Withdrawal by Subject|17|||
129879781|NCT00980005|467519414|FG000|Overall Study|Lost to Follow-up|37|||
130322473|NCT00092417|469151273|FG000|Overall Study|Other|1|||
129879782|NCT00980005|467519415|FG001|Overall Study|Lost to Follow-up|43|||
129879783|NCT00980005|467519414|FG000|Overall Study|Other|4|||
129879784|NCT00980005|467519415|FG001|Overall Study|Other|3|||
129879785|NCT00692406|467519416|FG000|Overall Study|PI dropped, bad data|57|||
129879786|NCT01617005|467519417|FG000|Overall Study|Pregnancy|1|||
129879787|NCT01617005|467519417|FG000|Overall Study|Lack of motivation for treatment|1|||
129879788|NCT05952297|467519422|FG000|Overall Study|Withdrawal by Subject|1|||
129879789|NCT05952297|467519423|FG001|Overall Study|Withdrawal by Subject|0|||
129879790|NCT00525265|467519426|FG000|Overall Study|Protocol Violation|1|||
129879791|NCT00525265|467519427|FG001|Overall Study|Protocol Violation|0|||
129879792|NCT03107377|467519428|FG000|Overall Study|Adverse Event|3|||
129879793|NCT03107377|467519429|FG001|Overall Study|Adverse Event|3|||
129879794|NCT03107377|467519428|FG000|Overall Study|Protocol Violation|9|||
129879795|NCT03107377|467519429|FG001|Overall Study|Protocol Violation|12|||
129879796|NCT03107377|467519428|FG000|Overall Study|Physician Decision|3|||
129879797|NCT03107377|467519429|FG001|Overall Study|Physician Decision|6|||
129879798|NCT03107377|467519428|FG000|Overall Study|Pregnancy|7|||
129879799|NCT03107377|467519429|FG001|Overall Study|Pregnancy|7|||
129879800|NCT03107377|467519428|FG000|Overall Study|Withdrawal by Subject|16|||
129879801|NCT03107377|467519429|FG001|Overall Study|Withdrawal by Subject|22|||
129879802|NCT03107377|467519428|FG000|Overall Study|Lost to Follow-up|37|||
129879803|NCT03107377|467519429|FG001|Overall Study|Lost to Follow-up|34|||
129879804|NCT03107377|467519428|FG000|Overall Study|Other reason not specified|16|||
129879805|NCT03107377|467519429|FG001|Overall Study|Other reason not specified|15|||
129879806|NCT00211237|467519430|FG000|Baseline|Withdrew|1|||
129879807|NCT00211237|467519431|FG001|Baseline|Withdrew|3|||
129879808|NCT00211237|467519432|FG002|Baseline|Withdrew|0|||
129879809|NCT00211237|467519430|FG000|Baseline|Refused random assignment|1|||
129879810|NCT00211237|467519431|FG001|Baseline|Refused random assignment|0|||
129879811|NCT00211237|467519432|FG002|Baseline|Refused random assignment|0|||
129879812|NCT00211237|467519430|FG000|1 Month|Death|2|||
129879813|NCT00211237|467519431|FG001|1 Month|Death|1|||
129879814|NCT00211237|467519432|FG002|1 Month|Death|0|||
129879815|NCT00211237|467519430|FG000|1 Month|Lost to Follow-up|0|||
129879816|NCT00211237|467519431|FG001|1 Month|Lost to Follow-up|2|||
129879817|NCT00211237|467519432|FG002|1 Month|Lost to Follow-up|0|||
129879818|NCT00211237|467519430|FG000|1 Month|Withdrew|0|||
129879819|NCT00211237|467519431|FG001|1 Month|Withdrew|4|||
129879820|NCT00211237|467519432|FG002|1 Month|Withdrew|0|||
129879821|NCT00211237|467519430|FG000|1 Month|Additional surgery needed|1|||
129879822|NCT00211237|467519431|FG001|1 Month|Additional surgery needed|0|||
129879823|NCT00211237|467519432|FG002|1 Month|Additional surgery needed|0|||
129879824|NCT00211237|467519430|FG000|1 Month|Non-medical problem|0|||
129879825|NCT00211237|467519431|FG001|1 Month|Non-medical problem|2|||
129879826|NCT00211237|467519432|FG002|1 Month|Non-medical problem|0|||
129879827|NCT00211237|467519430|FG000|3 Months|Death|7|||
129879828|NCT00211237|467519431|FG001|3 Months|Death|3|||
129879829|NCT00211237|467519432|FG002|3 Months|Death|0|||
129879830|NCT00211237|467519430|FG000|3 Months|Could not comply with protocol|1|||
129879831|NCT00211237|467519431|FG001|3 Months|Could not comply with protocol|0|||
129879832|NCT00211237|467519432|FG002|3 Months|Could not comply with protocol|0|||
129879833|NCT00211237|467519430|FG000|3 Months|Withdrew|0|||
129879834|NCT00211237|467519431|FG001|3 Months|Withdrew|1|||
129879835|NCT00211237|467519432|FG002|3 Months|Withdrew|0|||
129879836|NCT00211237|467519430|FG000|3 Months|Non-medical problem|0|||
129879837|NCT00211237|467519431|FG001|3 Months|Non-medical problem|0|||
129879838|NCT00211237|467519432|FG002|3 Months|Non-medical problem|1|||
129879839|NCT00211237|467519430|FG000|6 Months|Death|6|||
129879840|NCT00211237|467519431|FG001|6 Months|Death|0|||
129879841|NCT00211237|467519432|FG002|6 Months|Death|3|||
129879842|NCT00211237|467519430|FG000|6 Months|Lost to Follow-up|2|||
129879843|NCT00211237|467519431|FG001|6 Months|Lost to Follow-up|0|||
129879844|NCT00211237|467519432|FG002|6 Months|Lost to Follow-up|0|||
129879845|NCT00211237|467519430|FG000|6 Months|Could not comply with protocol|0|||
129879846|NCT00211237|467519431|FG001|6 Months|Could not comply with protocol|2|||
129879847|NCT00211237|467519432|FG002|6 Months|Could not comply with protocol|0|||
129879848|NCT00211237|467519430|FG000|12 Months|Death|8|||
129879849|NCT00211237|467519431|FG001|12 Months|Death|2|||
129879850|NCT00211237|467519432|FG002|12 Months|Death|3|||
129879851|NCT00211237|467519430|FG000|12 Months|Lost to Follow-up|1|||
129879852|NCT00211237|467519431|FG001|12 Months|Lost to Follow-up|0|||
129879853|NCT00211237|467519432|FG002|12 Months|Lost to Follow-up|1|||
129879854|NCT00211237|467519430|FG000|12 Months|Withdrew|0|||
129879855|NCT00211237|467519431|FG001|12 Months|Withdrew|0|||
129879856|NCT00211237|467519432|FG002|12 Months|Withdrew|1|||
129879857|NCT00211237|467519430|FG000|12 Months|unrelated medical problem|0|||
129879858|NCT00211237|467519431|FG001|12 Months|unrelated medical problem|0|||
129879859|NCT00211237|467519432|FG002|12 Months|unrelated medical problem|1|||
129879860|NCT04078035|467519433|FG000|Session 2|Lost to Follow-up|3|||
129879861|NCT04078035|467519434|FG001|Session 2|Lost to Follow-up|1|||
129879862|NCT04078035|467519433|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
129879863|NCT04078035|467519434|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
129879864|NCT01013792|467519437|FG000|Overall Study|Study suspended|2|||
129879865|NCT01013792|467519438|FG001|Overall Study|Study suspended|1|||
129879866|NCT01013792|467519437|FG000|Overall Study|Adverse Event|0|||
129879867|NCT01013792|467519438|FG001|Overall Study|Adverse Event|3|||
129879868|NCT01013792|467519437|FG000|Overall Study|Lost to Follow-up|0|||
129879869|NCT01013792|467519438|FG001|Overall Study|Lost to Follow-up|1|||
129879870|NCT02100722|467519439|FG000|Overall Study|Withdrawal pre-procedure|4|||
129879871|NCT02100722|467519440|FG001|Overall Study|Withdrawal pre-procedure|9|||
129879872|NCT02100722|467519439|FG000|Overall Study|Withdrawal post-procedure|0|||
129879873|NCT02100722|467519440|FG001|Overall Study|Withdrawal post-procedure|3|||
129879874|NCT02100722|467519439|FG000|Overall Study|Lost to Follow-up|2|||
129879875|NCT02100722|467519440|FG001|Overall Study|Lost to Follow-up|2|||
129879876|NCT02100722|467519439|FG000|Overall Study|Continuing on study|751|||
129879877|NCT02100722|467519440|FG001|Overall Study|Continuing on study|729|||
129879878|NCT02541383|467519444|FG000|Overall Study|Death|50|||
129879879|NCT02541383|467519445|FG001|Overall Study|Death|37|||
129879880|NCT02541383|467519446|FG002|Overall Study|Death|48|||
129879881|NCT02541383|467519447|FG003|Overall Study|Death|41|||
129879882|NCT02541383|467519448|FG004|Overall Study|Death|21|||
129879883|NCT02541383|467519449|FG005|Overall Study|Death|25|||
129879884|NCT02541383|467519444|FG000|Overall Study|Lost to Follow-up|5|||
129879885|NCT02541383|467519445|FG001|Overall Study|Lost to Follow-up|3|||
129879886|NCT02541383|467519446|FG002|Overall Study|Lost to Follow-up|1|||
129879887|NCT02541383|467519447|FG003|Overall Study|Lost to Follow-up|1|||
129879888|NCT02541383|467519448|FG004|Overall Study|Lost to Follow-up|3|||
129879889|NCT02541383|467519449|FG005|Overall Study|Lost to Follow-up|0|||
129879890|NCT02541383|467519444|FG000|Overall Study|Consent withdrawn|5|||
129879891|NCT02541383|467519445|FG001|Overall Study|Consent withdrawn|6|||
129879892|NCT02541383|467519446|FG002|Overall Study|Consent withdrawn|1|||
129879893|NCT02541383|467519447|FG003|Overall Study|Consent withdrawn|1|||
129879894|NCT02541383|467519448|FG004|Overall Study|Consent withdrawn|0|||
129879895|NCT02541383|467519449|FG005|Overall Study|Consent withdrawn|0|||
130322474|NCT00092417|469151274|FG001|Overall Study|Other|0|||
129879896|NCT02541383|467519444|FG000|Overall Study|Sponsor's decision|1|||
129879897|NCT02541383|467519445|FG001|Overall Study|Sponsor's decision|1|||
129879898|NCT02541383|467519446|FG002|Overall Study|Sponsor's decision|0|||
129879899|NCT02541383|467519447|FG003|Overall Study|Sponsor's decision|0|||
129879900|NCT02541383|467519448|FG004|Overall Study|Sponsor's decision|0|||
129879901|NCT02541383|467519449|FG005|Overall Study|Sponsor's decision|0|||
129879902|NCT05796518|467519452|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
129879903|NCT02954458|467519453|FG000|Overall Study|Adverse Event|0|||
129879904|NCT02954458|467519454|FG001|Overall Study|Adverse Event|0|||
129879905|NCT02954458|467519455|FG002|Overall Study|Adverse Event|0|||
129879906|NCT02954458|467519456|FG003|Overall Study|Adverse Event|1|||
129879907|NCT02954458|467519453|FG000|Overall Study|Withdrawal by Subject|0|||
129879908|NCT02954458|467519454|FG001|Overall Study|Withdrawal by Subject|0|||
129879909|NCT02954458|467519455|FG002|Overall Study|Withdrawal by Subject|0|||
129879910|NCT02954458|467519456|FG003|Overall Study|Withdrawal by Subject|1|||
129879911|NCT02954458|467519453|FG000|Overall Study|Physician Decision|0|||
129879912|NCT02954458|467519454|FG001|Overall Study|Physician Decision|0|||
129879913|NCT02954458|467519455|FG002|Overall Study|Physician Decision|1|||
129879914|NCT02954458|467519456|FG003|Overall Study|Physician Decision|1|||
129879915|NCT02954458|467519453|FG000|Overall Study|Lost to Follow-up|1|||
129879916|NCT02954458|467519454|FG001|Overall Study|Lost to Follow-up|0|||
129879917|NCT02954458|467519455|FG002|Overall Study|Lost to Follow-up|0|||
129879918|NCT02954458|467519456|FG003|Overall Study|Lost to Follow-up|1|||
129879919|NCT02954458|467519453|FG000|Overall Study|Death|0|||
129879920|NCT02954458|467519454|FG001|Overall Study|Death|0|||
129879921|NCT02954458|467519455|FG002|Overall Study|Death|0|||
129879922|NCT02954458|467519456|FG003|Overall Study|Death|1|||
129879923|NCT02954458|467519453|FG000|Overall Study|Other|0|||
129879924|NCT02954458|467519454|FG001|Overall Study|Other|0|||
129879925|NCT02954458|467519455|FG002|Overall Study|Other|0|||
129879926|NCT02954458|467519456|FG003|Overall Study|Other|7|||
129879927|NCT02690077|467519457|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
129879928|NCT02690077|467519458|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
129879929|NCT02690077|467519457|FG000|Overall Study|Withdrawal by Subject|0|||
129879930|NCT02690077|467519458|FG001|Overall Study|Withdrawal by Subject|5|||
129879931|NCT02690077|467519457|FG000|Overall Study|Excluded by IRB|0|||
129879932|NCT02690077|467519458|FG001|Overall Study|Excluded by IRB|2|||
129879933|NCT01845974|467519459|FG000|Overall Study|screen failure|1|||
129879934|NCT01845974|467519460|FG001|Overall Study|screen failure|0|||
129879935|NCT05408468|467519461|FG000|Overall Study|Lost to Follow-up|3|||
129879936|NCT05408468|467519462|FG001|Overall Study|Lost to Follow-up|1|||
129879937|NCT05408468|467519461|FG000|Overall Study|Physician Decision|1|||
129879938|NCT05408468|467519462|FG001|Overall Study|Physician Decision|0|||
129879939|NCT05408468|467519461|FG000|Overall Study|Overwhelmed by clinical situation|3|||
129879940|NCT05408468|467519462|FG001|Overall Study|Overwhelmed by clinical situation|0|||
129879941|NCT05408468|467519461|FG000|Overall Study|Personal illness precluding participation|1|||
129879942|NCT05408468|467519462|FG001|Overall Study|Personal illness precluding participation|0|||
129879943|NCT05408468|467519461|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
129879944|NCT05408468|467519462|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
129879945|NCT04186403|467519463|FG000|Overall Study|Adverse Event|1|||
129879946|NCT04186403|467519464|FG001|Overall Study|Adverse Event|8|||
129879947|NCT04186403|467519463|FG000|Overall Study|Lost to Follow-up|7|||
129879948|NCT04186403|467519464|FG001|Overall Study|Lost to Follow-up|3|||
129879949|NCT04186403|467519463|FG000|Overall Study|Physician Decision|1|||
129879950|NCT04186403|467519464|FG001|Overall Study|Physician Decision|0|||
129879951|NCT04186403|467519463|FG000|Overall Study|Withdrawal by Subject|7|||
129879952|NCT04186403|467519464|FG001|Overall Study|Withdrawal by Subject|8|||
129879953|NCT04186403|467519463|FG000|Overall Study|Other: Not Related to Covid-19|3|||
129879954|NCT04186403|467519464|FG001|Overall Study|Other: Not Related to Covid-19|0|||
129879955|NCT00405639|467519467|FG000|Overall Study|Withdrawal by Subject|1|||
129879956|NCT00405639|467519468|FG001|Overall Study|Withdrawal by Subject|0|||
129879957|NCT00405639|467519467|FG000|Overall Study|Adverse Event|1|||
129879958|NCT00405639|467519468|FG001|Overall Study|Adverse Event|0|||
129879959|NCT00405639|467519467|FG000|Overall Study|Seizure prior to receiving BNP|1|||
129879960|NCT00405639|467519468|FG001|Overall Study|Seizure prior to receiving BNP|0|||
129879961|NCT00612534|467519469|FG000|Overall Study|Adverse Event|0|||
129879962|NCT00612534|467519470|FG001|Overall Study|Adverse Event|4|||
129879963|NCT00612534|467519471|FG002|Overall Study|Adverse Event|2|||
129879964|NCT00612534|467519472|FG003|Overall Study|Adverse Event|1|||
129879965|NCT00612534|467519469|FG000|Overall Study|Lack of Efficacy|13|||
129879966|NCT00612534|467519470|FG001|Overall Study|Lack of Efficacy|12|||
129879967|NCT00612534|467519471|FG002|Overall Study|Lack of Efficacy|5|||
129879968|NCT00612534|467519472|FG003|Overall Study|Lack of Efficacy|16|||
129879969|NCT00612534|467519469|FG000|Overall Study|Other Reason|0|||
129879970|NCT00612534|467519470|FG001|Overall Study|Other Reason|1|||
129879971|NCT00612534|467519471|FG002|Overall Study|Other Reason|0|||
129879972|NCT00612534|467519472|FG003|Overall Study|Other Reason|0|||
129879973|NCT00265330|467519473|FG000|Overall Study|Adverse Event|41|||
129879974|NCT00265330|467519473|FG000|Overall Study|Lost to Follow-up|8|||
129879975|NCT00265330|467519473|FG000|Overall Study|Withdrawal by Subject|34|||
129879976|NCT00265330|467519473|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
129879977|NCT00265330|467519473|FG000|Overall Study|Lack of Efficacy|4|||
129879978|NCT00265330|467519473|FG000|Overall Study|Family Scheduling Conflicts|1|||
129879979|NCT00265330|467519473|FG000|Overall Study|Began Taking Formulary Geodon|1|||
129879980|NCT00265330|467519473|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
129879981|NCT00265330|467519473|FG000|Overall Study|Site Closed by Sponsor|1|||
129879982|NCT00265330|467519473|FG000|Overall Study|Principal Investigators Request|1|||
129879983|NCT00265330|467519473|FG000|Overall Study|Withdrew Consent|1|||
129879984|NCT00265330|467519473|FG000|Overall Study|Protocol Violation|1|||
129879985|NCT01065350|467519478|FG000|Overall Study|Received incorrect drug allocation|0|||
129879986|NCT01065350|467519479|FG001|Overall Study|Received incorrect drug allocation|1|||
129879987|NCT02716038|467519486|FG000|Overall Study|Not evaluable|1|||
129879988|NCT02716038|467519486|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
129879989|NCT02716038|467519486|FG000|Overall Study|Unresectable|3|||
129879990|NCT03573908|467519487|FG000|Treatment Period|Adverse Event|4|||
129879991|NCT03573908|467519488|FG001|Treatment Period|Adverse Event|9|||
129879992|NCT03573908|467519489|FG002|Treatment Period|Adverse Event|0|||
129879993|NCT03573908|467519490|FG003|Treatment Period|Adverse Event|0|||
129879994|NCT03573908|467519491|FG004|Treatment Period|Adverse Event|0|||
129879995|NCT03573908|467519487|FG000|Treatment Period|Protocol Violation|1|||
129879996|NCT03573908|467519488|FG001|Treatment Period|Protocol Violation|0|||
129879997|NCT03573908|467519489|FG002|Treatment Period|Protocol Violation|0|||
129879998|NCT03573908|467519490|FG003|Treatment Period|Protocol Violation|0|||
129879999|NCT03573908|467519491|FG004|Treatment Period|Protocol Violation|0|||
129880000|NCT03573908|467519487|FG000|Treatment Period|Withdrawal by Subject|7|||
129880001|NCT03573908|467519488|FG001|Treatment Period|Withdrawal by Subject|5|||
129880002|NCT03573908|467519489|FG002|Treatment Period|Withdrawal by Subject|0|||
129880003|NCT03573908|467519490|FG003|Treatment Period|Withdrawal by Subject|0|||
129880004|NCT03573908|467519491|FG004|Treatment Period|Withdrawal by Subject|0|||
129880005|NCT03573908|467519487|FG000|Treatment Period|Lost to Follow-up|7|||
129880006|NCT03573908|467519488|FG001|Treatment Period|Lost to Follow-up|6|||
129880007|NCT03573908|467519489|FG002|Treatment Period|Lost to Follow-up|0|||
129880008|NCT03573908|467519490|FG003|Treatment Period|Lost to Follow-up|0|||
129880009|NCT03573908|467519491|FG004|Treatment Period|Lost to Follow-up|0|||
129880010|NCT03573908|467519487|FG000|Treatment Period|Pregnancy|1|||
129880011|NCT03573908|467519488|FG001|Treatment Period|Pregnancy|0|||
129880012|NCT03573908|467519489|FG002|Treatment Period|Pregnancy|0|||
129880013|NCT03573908|467519490|FG003|Treatment Period|Pregnancy|0|||
129880014|NCT03573908|467519491|FG004|Treatment Period|Pregnancy|0|||
129880015|NCT03573908|467519487|FG000|Treatment Period|Other, Not Specified|4|||
129880016|NCT03573908|467519488|FG001|Treatment Period|Other, Not Specified|6|||
129880017|NCT03573908|467519489|FG002|Treatment Period|Other, Not Specified|0|||
129880018|NCT03573908|467519490|FG003|Treatment Period|Other, Not Specified|0|||
129880019|NCT03573908|467519491|FG004|Treatment Period|Other, Not Specified|0|||
129880020|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Adverse Event|0|||
129880021|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Adverse Event|0|||
129880022|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Adverse Event|3|||
129880023|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Adverse Event|0|||
129880024|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Adverse Event|0|||
129880025|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880026|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880027|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880028|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880029|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
129880030|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880031|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880032|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
129880033|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880034|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880035|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
129880036|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
129880037|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
129880038|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
129880039|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
129880040|NCT04006925|467519492|FG000|Overall Study|Side effects|2|||
129880041|NCT04006925|467519493|FG001|Overall Study|Side effects|0|||
129880042|NCT01555164|467519497|FG000|Overall Study|Adverse Event|5|||
129880043|NCT01555164|467519498|FG001|Overall Study|Adverse Event|7|||
129880044|NCT01555164|467519497|FG000|Overall Study|Hyperglycemia|0|||
129880045|NCT01555164|467519498|FG001|Overall Study|Hyperglycemia|1|||
129880046|NCT01555164|467519497|FG000|Overall Study|Investigator's Discretion|2|||
129880047|NCT01555164|467519498|FG001|Overall Study|Investigator's Discretion|2|||
130322475|NCT03780244|469151285|FG000|Overall Study|Lost to Follow-up|1|||
129880048|NCT01555164|467519497|FG000|Overall Study|Lost to Follow-up|4|||
129880049|NCT01555164|467519498|FG001|Overall Study|Lost to Follow-up|3|||
129880050|NCT01555164|467519497|FG000|Overall Study|Protocol Violation|9|||
129880051|NCT01555164|467519498|FG001|Overall Study|Protocol Violation|5|||
129880052|NCT01555164|467519497|FG000|Overall Study|Subject Non-compliance|14|||
129880053|NCT01555164|467519498|FG001|Overall Study|Subject Non-compliance|6|||
129880054|NCT01555164|467519497|FG000|Overall Study|Subject Withdrew Consent|6|||
129880055|NCT01555164|467519498|FG001|Overall Study|Subject Withdrew Consent|11|||
129880056|NCT01709305|467519503|FG000|Phase 1|Clinical Adverse Event|80|||
129880057|NCT01709305|467519504|FG001|Phase 1|Clinical Adverse Event|0|||
129880058|NCT01709305|467519505|FG002|Phase 1|Clinical Adverse Event|0|||
130322476|NCT03780244|469151286|FG001|Overall Study|Lost to Follow-up|0|||
130322477|NCT00804908|469151289|FG000|Overall Study|Other|115|||
129880059|NCT01709305|467519506|FG003|Phase 1|Clinical Adverse Event|0|||
129880060|NCT01709305|467519507|FG004|Phase 1|Clinical Adverse Event|0|||
129880061|NCT01709305|467519503|FG000|Phase 1|Death|2|||
129880062|NCT01709305|467519504|FG001|Phase 1|Death|0|||
129880063|NCT01709305|467519505|FG002|Phase 1|Death|0|||
129880064|NCT01709305|467519506|FG003|Phase 1|Death|0|||
129880065|NCT01709305|467519507|FG004|Phase 1|Death|0|||
129880066|NCT01709305|467519503|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
129880067|NCT01709305|467519504|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880068|NCT01709305|467519505|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880069|NCT01709305|467519506|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880070|NCT01709305|467519507|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880071|NCT01709305|467519503|FG000|Phase 1|Laboratory Adverse Event|16|||
129880072|NCT01709305|467519504|FG001|Phase 1|Laboratory Adverse Event|0|||
129880073|NCT01709305|467519505|FG002|Phase 1|Laboratory Adverse Event|0|||
129880074|NCT01709305|467519506|FG003|Phase 1|Laboratory Adverse Event|0|||
129880075|NCT01709305|467519507|FG004|Phase 1|Laboratory Adverse Event|0|||
129880076|NCT01709305|467519503|FG000|Phase 1|Lost to Follow-up|147|||
129880077|NCT01709305|467519504|FG001|Phase 1|Lost to Follow-up|0|||
129880078|NCT01709305|467519505|FG002|Phase 1|Lost to Follow-up|0|||
129880079|NCT01709305|467519506|FG003|Phase 1|Lost to Follow-up|0|||
129880080|NCT01709305|467519507|FG004|Phase 1|Lost to Follow-up|0|||
129880081|NCT01709305|467519503|FG000|Phase 1|Travel, moving, etc.|30|||
129880082|NCT01709305|467519504|FG001|Phase 1|Travel, moving, etc.|0|||
129880083|NCT01709305|467519505|FG002|Phase 1|Travel, moving, etc.|0|||
129880084|NCT01709305|467519506|FG003|Phase 1|Travel, moving, etc.|0|||
129880085|NCT01709305|467519507|FG004|Phase 1|Travel, moving, etc.|0|||
129880086|NCT01709305|467519503|FG000|Phase 1|Physician Decision|13|||
129880087|NCT01709305|467519504|FG001|Phase 1|Physician Decision|0|||
129880088|NCT01709305|467519505|FG002|Phase 1|Physician Decision|0|||
129880089|NCT01709305|467519506|FG003|Phase 1|Physician Decision|0|||
129880090|NCT01709305|467519507|FG004|Phase 1|Physician Decision|0|||
129880091|NCT01709305|467519503|FG000|Phase 1|Protocol Violation|118|||
129880092|NCT01709305|467519504|FG001|Phase 1|Protocol Violation|0|||
129880093|NCT01709305|467519505|FG002|Phase 1|Protocol Violation|0|||
129880094|NCT01709305|467519506|FG003|Phase 1|Protocol Violation|0|||
129880095|NCT01709305|467519507|FG004|Phase 1|Protocol Violation|0|||
129880096|NCT01709305|467519503|FG000|Phase 1|Withdrawal by Subject|218|||
129880097|NCT01709305|467519504|FG001|Phase 1|Withdrawal by Subject|0|||
129880098|NCT01709305|467519505|FG002|Phase 1|Withdrawal by Subject|0|||
129880099|NCT01709305|467519506|FG003|Phase 1|Withdrawal by Subject|0|||
129880100|NCT01709305|467519507|FG004|Phase 1|Withdrawal by Subject|0|||
129880101|NCT01709305|467519503|FG000|Phase 2|Clinical Adverse Event|0|||
129880102|NCT01709305|467519504|FG001|Phase 2|Clinical Adverse Event|10|||
129880103|NCT01709305|467519505|FG002|Phase 2|Clinical Adverse Event|10|||
129880104|NCT01709305|467519506|FG003|Phase 2|Clinical Adverse Event|6|||
129880105|NCT01709305|467519507|FG004|Phase 2|Clinical Adverse Event|11|||
129880106|NCT01709305|467519503|FG000|Phase 2|Death|0|||
129880107|NCT01709305|467519504|FG001|Phase 2|Death|0|||
129880108|NCT01709305|467519505|FG002|Phase 2|Death|1|||
129880109|NCT01709305|467519506|FG003|Phase 2|Death|0|||
129880110|NCT01709305|467519507|FG004|Phase 2|Death|0|||
129880111|NCT01709305|467519503|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880112|NCT01709305|467519504|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880113|NCT01709305|467519505|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880114|NCT01709305|467519506|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880115|NCT01709305|467519507|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
129880116|NCT01709305|467519503|FG000|Phase 2|Laboratory Adverse Event|0|||
129880117|NCT01709305|467519504|FG001|Phase 2|Laboratory Adverse Event|1|||
129880118|NCT01709305|467519505|FG002|Phase 2|Laboratory Adverse Event|0|||
129880119|NCT01709305|467519506|FG003|Phase 2|Laboratory Adverse Event|1|||
129880120|NCT01709305|467519507|FG004|Phase 2|Laboratory Adverse Event|1|||
129880121|NCT01709305|467519503|FG000|Phase 2|Lost to Follow-up|0|||
129880122|NCT01709305|467519504|FG001|Phase 2|Lost to Follow-up|10|||
129880123|NCT01709305|467519505|FG002|Phase 2|Lost to Follow-up|6|||
129880124|NCT01709305|467519506|FG003|Phase 2|Lost to Follow-up|9|||
129880125|NCT01709305|467519507|FG004|Phase 2|Lost to Follow-up|5|||
129880126|NCT01709305|467519503|FG000|Phase 2|Travel, moving, etc.|0|||
129880127|NCT01709305|467519504|FG001|Phase 2|Travel, moving, etc.|2|||
129880128|NCT01709305|467519505|FG002|Phase 2|Travel, moving, etc.|3|||
129880129|NCT01709305|467519506|FG003|Phase 2|Travel, moving, etc.|3|||
129880130|NCT01709305|467519507|FG004|Phase 2|Travel, moving, etc.|5|||
130322478|NCT00804908|469151290|FG001|Overall Study|Other|116|||
129880131|NCT01709305|467519503|FG000|Phase 2|Physician Decision|0|||
129880132|NCT01709305|467519504|FG001|Phase 2|Physician Decision|2|||
129880133|NCT01709305|467519505|FG002|Phase 2|Physician Decision|0|||
129880134|NCT01709305|467519506|FG003|Phase 2|Physician Decision|1|||
129880135|NCT01709305|467519507|FG004|Phase 2|Physician Decision|2|||
129880136|NCT01709305|467519503|FG000|Phase 2|Protocol Violation|0|||
129880137|NCT01709305|467519504|FG001|Phase 2|Protocol Violation|19|||
129880138|NCT01709305|467519505|FG002|Phase 2|Protocol Violation|19|||
129880139|NCT01709305|467519506|FG003|Phase 2|Protocol Violation|13|||
129880140|NCT01709305|467519507|FG004|Phase 2|Protocol Violation|9|||
129880141|NCT01709305|467519503|FG000|Phase 2|Withdrawal by Subject|0|||
129880142|NCT01709305|467519504|FG001|Phase 2|Withdrawal by Subject|8|||
129880143|NCT01709305|467519505|FG002|Phase 2|Withdrawal by Subject|6|||
129880144|NCT01709305|467519506|FG003|Phase 2|Withdrawal by Subject|15|||
129880145|NCT01709305|467519507|FG004|Phase 2|Withdrawal by Subject|12|||
129880146|NCT00171873|467519510|FG000|Overall Study|Withdrawal by Subject|4|||
129880147|NCT00171873|467519511|FG001|Overall Study|Withdrawal by Subject|2|||
129880148|NCT00171873|467519510|FG000|Overall Study|Adverse Event|5|||
129880149|NCT00171873|467519511|FG001|Overall Study|Adverse Event|0|||
129880150|NCT00171873|467519510|FG000|Overall Study|Switched to Octreotide|0|||
129880151|NCT00171873|467519511|FG001|Overall Study|Switched to Octreotide|1|||
129880152|NCT01382940|467521116|FG000|Overall Study|Adverse Event|19|||
129880153|NCT01382940|467521116|FG000|Overall Study|Lost to Follow-up|4|||
129880154|NCT01382940|467521116|FG000|Overall Study|Physician Decision|7|||
129880155|NCT01382940|467521116|FG000|Overall Study|Withdrawal by Subject|23|||
129880156|NCT01382940|467521116|FG000|Overall Study|Protocol Violation|20|||
129880157|NCT00976482|467521119|FG000|Overall Study|Death|208|||
129880158|NCT00976482|467521119|FG000|Overall Study|Withdrawal by Subject|45|||
129880159|NCT00976482|467521119|FG000|Overall Study|Center terminated|1|||
129880160|NCT00976482|467521119|FG000|Overall Study|Protocol Violation|5|||
129880161|NCT00720902|467521122|FG000|Overall Study|Withdrawal by Subject|1|||
129880162|NCT00720902|467521123|FG001|Overall Study|Withdrawal by Subject|0|||
129880163|NCT00720902|467521122|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
129880164|NCT00720902|467521123|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
129880165|NCT01486758|467521124|FG000|Overall Study|Lost to Follow-up|0|||
129880166|NCT01486758|467521125|FG001|Overall Study|Lost to Follow-up|1|||
129880167|NCT02254408|467521135|FG000|Overall Study|Randomized But Not Treated|1|||
129880168|NCT02254408|467521136|FG001|Overall Study|Randomized But Not Treated|3|||
129880169|NCT02254408|467521135|FG000|Overall Study|Adverse Event|1|||
129880170|NCT02254408|467521136|FG001|Overall Study|Adverse Event|0|||
129880171|NCT02254408|467521135|FG000|Overall Study|Death|2|||
129880172|NCT02254408|467521136|FG001|Overall Study|Death|3|||
129880173|NCT02254408|467521135|FG000|Overall Study|Investigator's Discretion|0|||
129880174|NCT02254408|467521136|FG001|Overall Study|Investigator's Discretion|1|||
129880175|NCT02254408|467521135|FG000|Overall Study|Withdrawal by Subject|3|||
129880176|NCT02254408|467521136|FG001|Overall Study|Withdrawal by Subject|3|||
129880177|NCT02254408|467521135|FG000|Overall Study|Lost to Follow-up|1|||
129880178|NCT02254408|467521136|FG001|Overall Study|Lost to Follow-up|0|||
129880179|NCT02914184|467521138|FG000|Overall Study|Lost to Follow-up|7|||
129880180|NCT02914184|467521139|FG001|Overall Study|Lost to Follow-up|10|||
129880181|NCT02914184|467521140|FG002|Overall Study|Lost to Follow-up|8|||
129880182|NCT02914184|467521141|FG003|Overall Study|Lost to Follow-up|7|||
129880183|NCT02914184|467521138|FG000|Overall Study|Withdrawal by Subject|4|||
129880184|NCT02914184|467521139|FG001|Overall Study|Withdrawal by Subject|2|||
129880185|NCT02914184|467521140|FG002|Overall Study|Withdrawal by Subject|7|||
129880186|NCT02914184|467521141|FG003|Overall Study|Withdrawal by Subject|3|||
129880187|NCT02914184|467521138|FG000|Overall Study|Other|1|||
129880188|NCT02914184|467521139|FG001|Overall Study|Other|0|||
129880189|NCT02914184|467521140|FG002|Overall Study|Other|0|||
129880190|NCT02914184|467521141|FG003|Overall Study|Other|0|||
129880191|NCT02914184|467521138|FG000|Overall Study|Migrated/moved from the study area|2|||
129880192|NCT02914184|467521139|FG001|Overall Study|Migrated/moved from the study area|1|||
129880193|NCT02914184|467521140|FG002|Overall Study|Migrated/moved from the study area|2|||
129880194|NCT02914184|467521141|FG003|Overall Study|Migrated/moved from the study area|1|||
129880195|NCT00798174|467521142|FG000|Overall Study|inability to implant azygos coil|3|||
129880196|NCT00798174|467521143|FG001|Overall Study|inability to implant azygos coil|3|||
129880197|NCT00798174|467521142|FG000|Overall Study|Inability to sedate for DFT testing|1|||
129880198|NCT00798174|467521143|FG001|Overall Study|Inability to sedate for DFT testing|0|||
129880199|NCT01478113|467521144|FG000|Overall Study|Withdrawal by Subject|0|||
129880200|NCT01478113|467521145|FG001|Overall Study|Withdrawal by Subject|1|||
129880201|NCT01478113|467521144|FG000|Overall Study|Physician Decision|1|||
129880202|NCT01478113|467521145|FG001|Overall Study|Physician Decision|0|||
129880203|NCT03093428|467521153|FG000|Overall Study|Not eligible for treatment|2|||
129880204|NCT03093428|467521154|FG001|Overall Study|Not eligible for treatment|1|||
129880205|NCT03093428|467521153|FG000|Overall Study|Progression|14|||
129880206|NCT03093428|467521154|FG001|Overall Study|Progression|4|||
129880207|NCT03093428|467521153|FG000|Overall Study|Death|1|||
129880208|NCT03093428|467521154|FG001|Overall Study|Death|0|||
129880209|NCT03093428|467521153|FG000|Overall Study|Adverse Event|1|||
129880210|NCT03093428|467521154|FG001|Overall Study|Adverse Event|0|||
129880211|NCT03093428|467521153|FG000|Overall Study|Withdrawal by Subject|1|||
129880212|NCT03093428|467521154|FG001|Overall Study|Withdrawal by Subject|1|||
129880213|NCT01642602|467521155|FG000|Overall Study|Adverse Event|2|||
129880214|NCT03377790|467521156|FG000|Overall Study|Withdrawal by Subject|1|||
129880215|NCT03377790|467521157|FG001|Overall Study|Withdrawal by Subject|0|||
129880216|NCT03377790|467521156|FG000|Overall Study|Adverse Event|1|||
129880217|NCT03377790|467521157|FG001|Overall Study|Adverse Event|0|||
129880218|NCT03377790|467521156|FG000|Overall Study|Lost to Follow-up|0|||
129880219|NCT03377790|467521157|FG001|Overall Study|Lost to Follow-up|2|||
129880220|NCT03377790|467521156|FG000|Overall Study|Randomized but not treated|1|||
129880221|NCT03377790|467521157|FG001|Overall Study|Randomized but not treated|0|||
129880222|NCT03377790|467521156|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
129880223|NCT03377790|467521157|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
129880224|NCT03101241|467521160|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
129880225|NCT03101241|467521161|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
129880226|NCT03101241|467521160|FG000|Overall Study|Participant withdrew consent|3|||
129880227|NCT03101241|467521161|FG001|Overall Study|Participant withdrew consent|1|||
129880228|NCT03101241|467521160|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
129880229|NCT03101241|467521161|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
129880230|NCT03101241|467521160|FG000|Overall Study|Lost to Follow-up|2|||
129880231|NCT03101241|467521161|FG001|Overall Study|Lost to Follow-up|0|||
129880232|NCT03101241|467521160|FG000|Overall Study|Lack of Efficacy|0|||
129880233|NCT03101241|467521161|FG001|Overall Study|Lack of Efficacy|1|||
129880234|NCT03101241|467521160|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
129880235|NCT03101241|467521161|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
129880236|NCT04498247|467521162|FG000|Overall Study|Lost to Follow-up|0|||
129880237|NCT04498247|467521163|FG001|Overall Study|Lost to Follow-up|0|||
129880238|NCT04498247|467521164|FG002|Overall Study|Lost to Follow-up|0|||
129880239|NCT04498247|467521165|FG003|Overall Study|Lost to Follow-up|1|||
129880240|NCT04498247|467521166|FG004|Overall Study|Lost to Follow-up|0|||
129880241|NCT04498247|467521167|FG005|Overall Study|Lost to Follow-up|0|||
129880242|NCT04498247|467521168|FG006|Overall Study|Lost to Follow-up|0|||
129880243|NCT04498247|467521169|FG007|Overall Study|Lost to Follow-up|0|||
129880244|NCT04498247|467521162|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
130322479|NCT00804908|469151291|FG002|Overall Study|Other|114|||
130322480|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
130322481|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
130322482|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
130322483|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
130322484|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
129880245|NCT04498247|467521163|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880246|NCT04498247|467521164|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880247|NCT04498247|467521165|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880248|NCT04498247|467521166|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880249|NCT04498247|467521167|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880250|NCT04498247|467521168|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880251|NCT04498247|467521169|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880252|NCT04498247|467521162|FG000|Overall Study|Withdrawal by Subject|0|||
129880253|NCT04498247|467521163|FG001|Overall Study|Withdrawal by Subject|8|||
129880254|NCT04498247|467521164|FG002|Overall Study|Withdrawal by Subject|0|||
129880255|NCT04498247|467521165|FG003|Overall Study|Withdrawal by Subject|7|||
129880256|NCT04498247|467521166|FG004|Overall Study|Withdrawal by Subject|0|||
129880257|NCT04498247|467521167|FG005|Overall Study|Withdrawal by Subject|0|||
129880258|NCT04498247|467521168|FG006|Overall Study|Withdrawal by Subject|1|||
129880259|NCT04498247|467521169|FG007|Overall Study|Withdrawal by Subject|0|||
129880260|NCT04498247|467521162|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880261|NCT04498247|467521163|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
129880262|NCT04498247|467521164|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880263|NCT04498247|467521165|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
129880264|NCT04498247|467521166|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880265|NCT04498247|467521167|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880266|NCT04498247|467521168|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
129880267|NCT04498247|467521169|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880268|NCT03469349|467521170|FG000|Overall Study|Withdrawal by Subject|1|||
129880269|NCT03469349|467521171|FG001|Overall Study|Withdrawal by Subject|3|||
129880270|NCT03469349|467521170|FG000|Overall Study|Progressive Disease|0|||
129880271|NCT03469349|467521171|FG001|Overall Study|Progressive Disease|1|||
129880272|NCT03469349|467521170|FG000|Overall Study|Lost to Follow-up|2|||
129880273|NCT03469349|467521171|FG001|Overall Study|Lost to Follow-up|2|||
129880274|NCT03469349|467521170|FG000|Overall Study|Adverse Event|2|||
129880275|NCT03469349|467521171|FG001|Overall Study|Adverse Event|4|||
129880276|NCT01381874|467521173|FG000|Overall Study|Lost to Follow-up|1|||
129880277|NCT01381874|467521174|FG001|Overall Study|Lost to Follow-up|1|||
129880278|NCT01381874|467521175|FG002|Overall Study|Lost to Follow-up|0|||
129880279|NCT01381874|467521173|FG000|Overall Study|Withdrawal by Subject|9|||
129880280|NCT01381874|467521174|FG001|Overall Study|Withdrawal by Subject|10|||
130322485|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
130322486|NCT03181932|469151292|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
130322487|NCT03181932|469151293|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
130322488|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
129880281|NCT01381874|467521175|FG002|Overall Study|Withdrawal by Subject|9|||
129880282|NCT01381874|467521173|FG000|Overall Study|Other|67|||
129880283|NCT01381874|467521174|FG001|Overall Study|Other|52|||
129880284|NCT01381874|467521175|FG002|Overall Study|Other|67|||
129880285|NCT01737996|467521176|FG000|Overall Study|Adverse Event|0|||
129880286|NCT01737996|467521177|FG001|Overall Study|Adverse Event|1|||
129880287|NCT01737996|467521178|FG002|Overall Study|Adverse Event|1|||
129880288|NCT01737996|467521176|FG000|Overall Study|Withdrawal by Subject|0|||
129880289|NCT01737996|467521177|FG001|Overall Study|Withdrawal by Subject|0|||
129880290|NCT01737996|467521178|FG002|Overall Study|Withdrawal by Subject|1|||
129880291|NCT00452413|467521179|FG000|Overall Study|Progressive Disease|4|||
129880292|NCT00452413|467521180|FG001|Overall Study|Progressive Disease|11|||
129880293|NCT00452413|467521181|FG002|Overall Study|Progressive Disease|30|||
129880294|NCT00452413|467521179|FG000|Overall Study|Withdrawal by Subject|0|||
129880295|NCT00452413|467521180|FG001|Overall Study|Withdrawal by Subject|1|||
129880296|NCT00452413|467521181|FG002|Overall Study|Withdrawal by Subject|4|||
129880297|NCT00452413|467521179|FG000|Overall Study|Adverse Event|0|||
129880298|NCT00452413|467521180|FG001|Overall Study|Adverse Event|0|||
129880299|NCT00452413|467521181|FG002|Overall Study|Adverse Event|5|||
129880300|NCT00452413|467521179|FG000|Overall Study|Physician Decision|0|||
129880301|NCT00452413|467521180|FG001|Overall Study|Physician Decision|0|||
129880302|NCT00452413|467521181|FG002|Overall Study|Physician Decision|4|||
129880303|NCT00452413|467521179|FG000|Overall Study|Death due to study disease|0|||
129880304|NCT00452413|467521180|FG001|Overall Study|Death due to study disease|0|||
129880305|NCT00452413|467521181|FG002|Overall Study|Death due to study disease|2|||
129880306|NCT00452413|467521179|FG000|Overall Study|Death due to adverse event (AE)|0|||
129880307|NCT00452413|467521180|FG001|Overall Study|Death due to adverse event (AE)|0|||
129880308|NCT00452413|467521181|FG002|Overall Study|Death due to adverse event (AE)|1|||
129880309|NCT00452413|467521179|FG000|Overall Study|On treatment|0|||
129880310|NCT00452413|467521180|FG001|Overall Study|On treatment|0|||
129880311|NCT00452413|467521181|FG002|Overall Study|On treatment|3|||
129880312|NCT01248962|467521182|FG000|Overall Study|Withdrawal by Subject|1|||
129880313|NCT01248962|467521183|FG001|Overall Study|Withdrawal by Subject|1|||
129880314|NCT01248962|467521182|FG000|Overall Study|Adverse Event|2|||
129880315|NCT01248962|467521183|FG001|Overall Study|Adverse Event|1|||
129880316|NCT01248962|467521182|FG000|Overall Study|Complete Response after 4 Cycles|1|||
129880317|NCT01248962|467521183|FG001|Overall Study|Complete Response after 4 Cycles|0|||
129880318|NCT01248962|467521182|FG000|Overall Study|Complete Response after 3 Cycles|0|||
129880319|NCT01248962|467521183|FG001|Overall Study|Complete Response after 3 Cycles|1|||
129880320|NCT01248962|467521182|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
129880321|NCT01248962|467521183|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
129880322|NCT03119610|467521185|FG000|Overall Study|Adverse Event|1|||
129880323|NCT03119610|467521186|FG001|Overall Study|Adverse Event|0|||
129880324|NCT03119610|467521185|FG000|Overall Study|Lost to Follow-up|0|||
129880325|NCT03119610|467521186|FG001|Overall Study|Lost to Follow-up|1|||
129880326|NCT00114634|467521187|FG000|Overall Study|failure to return forms|3|||
129880327|NCT03283696|467521188|FG000|Overall Study|Physician Decision|5|||
129880328|NCT03283696|467521189|FG001|Overall Study|Physician Decision|6|||
129880329|NCT03283696|467521188|FG000|Overall Study|Withdrawal by Subject|2|||
129880330|NCT03283696|467521189|FG001|Overall Study|Withdrawal by Subject|0|||
129880331|NCT00557622|467521193|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
129880332|NCT00557622|467521194|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
129880333|NCT00557622|467521193|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
129880334|NCT00557622|467521194|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
129880335|NCT00557622|467521193|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
129880336|NCT00557622|467521194|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
129880337|NCT01539863|467521195|FG000|Overall Study|Lost to Follow-up|5|||
129880338|NCT01539863|467521196|FG001|Overall Study|Lost to Follow-up|4|||
129880339|NCT02765490|467521199|FG000|Overall Study|Lost to Follow-up|1|||
129880340|NCT02765490|467521200|FG001|Overall Study|Lost to Follow-up|1|||
129880341|NCT02765490|467521199|FG000|Overall Study|Other|0|||
129880342|NCT02765490|467521200|FG001|Overall Study|Other|1|||
129880343|NCT02765490|467521199|FG000|Overall Study|Death|0|||
129880344|NCT02765490|467521200|FG001|Overall Study|Death|1|||
129880345|NCT01468922|467521201|FG000|Overall Study|Screening failure|0|||
129880346|NCT01468922|467521202|FG001|Overall Study|Screening failure|0|||
129880347|NCT01468922|467521203|FG002|Overall Study|Screening failure|0|||
129880348|NCT01468922|467521204|FG003|Overall Study|Screening failure|0|||
129880349|NCT01468922|467521205|FG004|Overall Study|Screening failure|0|||
129880350|NCT01468922|467521206|FG005|Overall Study|Screening failure|0|||
129880351|NCT01468922|467521207|FG006|Overall Study|Screening failure|0|||
129880352|NCT01468922|467521208|FG007|Overall Study|Screening failure|0|||
129880353|NCT01468922|467521209|FG008|Overall Study|Screening failure|1|||
129880354|NCT01468922|467521201|FG000|Overall Study|Per patient choice|1|||
129880355|NCT01468922|467521202|FG001|Overall Study|Per patient choice|0|||
129880356|NCT01468922|467521203|FG002|Overall Study|Per patient choice|0|||
129880357|NCT01468922|467521204|FG003|Overall Study|Per patient choice|0|||
129880358|NCT01468922|467521205|FG004|Overall Study|Per patient choice|0|||
129880359|NCT01468922|467521206|FG005|Overall Study|Per patient choice|0|||
129880360|NCT01468922|467521207|FG006|Overall Study|Per patient choice|0|||
129880361|NCT01468922|467521208|FG007|Overall Study|Per patient choice|0|||
129880362|NCT01468922|467521209|FG008|Overall Study|Per patient choice|0|||
129880363|NCT01468922|467521201|FG000|Overall Study|Switched to alternative treatment|1|||
129880364|NCT01468922|467521202|FG001|Overall Study|Switched to alternative treatment|0|||
129880365|NCT01468922|467521203|FG002|Overall Study|Switched to alternative treatment|0|||
129880366|NCT01468922|467521204|FG003|Overall Study|Switched to alternative treatment|0|||
129880367|NCT01468922|467521205|FG004|Overall Study|Switched to alternative treatment|1|||
129880368|NCT01468922|467521206|FG005|Overall Study|Switched to alternative treatment|0|||
129880369|NCT01468922|467521207|FG006|Overall Study|Switched to alternative treatment|0|||
129880370|NCT01468922|467521208|FG007|Overall Study|Switched to alternative treatment|0|||
129880371|NCT01468922|467521209|FG008|Overall Study|Switched to alternative treatment|0|||
129880372|NCT01468922|467521201|FG000|Overall Study|Enrolled on new protocol|0|||
129880373|NCT01468922|467521202|FG001|Overall Study|Enrolled on new protocol|0|||
129880374|NCT01468922|467521203|FG002|Overall Study|Enrolled on new protocol|0|||
129880375|NCT01468922|467521204|FG003|Overall Study|Enrolled on new protocol|0|||
129880376|NCT01468922|467521205|FG004|Overall Study|Enrolled on new protocol|1|||
129880377|NCT01468922|467521206|FG005|Overall Study|Enrolled on new protocol|0|||
129880378|NCT01468922|467521207|FG006|Overall Study|Enrolled on new protocol|0|||
129880379|NCT01468922|467521208|FG007|Overall Study|Enrolled on new protocol|0|||
129880380|NCT01468922|467521209|FG008|Overall Study|Enrolled on new protocol|0|||
129880381|NCT01468922|467521201|FG000|Overall Study|Adverse Event|0|||
129880382|NCT01468922|467521202|FG001|Overall Study|Adverse Event|0|||
129880383|NCT01468922|467521203|FG002|Overall Study|Adverse Event|0|||
129880384|NCT01468922|467521204|FG003|Overall Study|Adverse Event|0|||
129880385|NCT01468922|467521205|FG004|Overall Study|Adverse Event|0|||
129880386|NCT01468922|467521206|FG005|Overall Study|Adverse Event|0|||
129880387|NCT01468922|467521207|FG006|Overall Study|Adverse Event|0|||
129880388|NCT01468922|467521208|FG007|Overall Study|Adverse Event|1|||
129880389|NCT01468922|467521209|FG008|Overall Study|Adverse Event|0|||
129880390|NCT01468922|467521201|FG000|Overall Study|Infection of blood|0|||
129880391|NCT01468922|467521202|FG001|Overall Study|Infection of blood|0|||
129880392|NCT01468922|467521203|FG002|Overall Study|Infection of blood|0|||
129880393|NCT01468922|467521204|FG003|Overall Study|Infection of blood|0|||
129880394|NCT01468922|467521205|FG004|Overall Study|Infection of blood|0|||
129880395|NCT01468922|467521206|FG005|Overall Study|Infection of blood|0|||
129880396|NCT01468922|467521207|FG006|Overall Study|Infection of blood|0|||
129880397|NCT01468922|467521208|FG007|Overall Study|Infection of blood|1|||
129880398|NCT01468922|467521209|FG008|Overall Study|Infection of blood|0|||
129880399|NCT01468922|467521201|FG000|Overall Study|Patient choice - surgery|0|||
129880400|NCT01468922|467521202|FG001|Overall Study|Patient choice - surgery|0|||
129880401|NCT01468922|467521203|FG002|Overall Study|Patient choice - surgery|0|||
129880402|NCT01468922|467521204|FG003|Overall Study|Patient choice - surgery|0|||
129880403|NCT01468922|467521205|FG004|Overall Study|Patient choice - surgery|0|||
129880404|NCT01468922|467521206|FG005|Overall Study|Patient choice - surgery|0|||
129880405|NCT01468922|467521207|FG006|Overall Study|Patient choice - surgery|0|||
129880406|NCT01468922|467521208|FG007|Overall Study|Patient choice - surgery|1|||
129880407|NCT01468922|467521209|FG008|Overall Study|Patient choice - surgery|0|||
129880408|NCT01468922|467521201|FG000|Overall Study|Refused further treatment|0|||
129880409|NCT01468922|467521202|FG001|Overall Study|Refused further treatment|0|||
129880410|NCT01468922|467521203|FG002|Overall Study|Refused further treatment|0|||
129880411|NCT01468922|467521204|FG003|Overall Study|Refused further treatment|0|||
129880412|NCT01468922|467521205|FG004|Overall Study|Refused further treatment|0|||
129880413|NCT01468922|467521206|FG005|Overall Study|Refused further treatment|0|||
129880414|NCT01468922|467521207|FG006|Overall Study|Refused further treatment|0|||
129880415|NCT01468922|467521208|FG007|Overall Study|Refused further treatment|1|||
129880416|NCT01468922|467521209|FG008|Overall Study|Refused further treatment|0|||
129880417|NCT00007475|467521216|FG000|Overall Study|Withdrawal by Subject|1|||
129880418|NCT00007475|467521217|FG001|Overall Study|Withdrawal by Subject|0|||
129880419|NCT00007475|467521218|FG002|Overall Study|Withdrawal by Subject|0|||
129880420|NCT00007475|467521219|FG003|Overall Study|Withdrawal by Subject|0|||
129880421|NCT00007475|467521216|FG000|Overall Study|Adverse Event|3|||
129880422|NCT00007475|467521217|FG001|Overall Study|Adverse Event|0|||
129880423|NCT00007475|467521218|FG002|Overall Study|Adverse Event|0|||
129880424|NCT00007475|467521219|FG003|Overall Study|Adverse Event|0|||
129880425|NCT01719224|467521220|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
129880426|NCT01719224|467521221|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
129880427|NCT03000673|467521222|FG000|Overall Study|Withdrawal by Subject|1|||
129880428|NCT03000673|467521223|FG001|Overall Study|Withdrawal by Subject|0|||
129880429|NCT03000673|467521224|FG002|Overall Study|Withdrawal by Subject|0|||
129880430|NCT03000673|467521225|FG003|Overall Study|Withdrawal by Subject|0|||
129880431|NCT01121484|467521227|FG000|Overall Study|Adverse Event|12|||
129880432|NCT01121484|467521228|FG001|Overall Study|Adverse Event|5|||
129880433|NCT01121484|467521227|FG000|Overall Study|Lack of Efficacy|3|||
129880434|NCT01121484|467521228|FG001|Overall Study|Lack of Efficacy|11|||
129880435|NCT01121484|467521227|FG000|Overall Study|Lost to Follow-up|5|||
129880436|NCT01121484|467521228|FG001|Overall Study|Lost to Follow-up|9|||
129880437|NCT01121484|467521227|FG000|Overall Study|Physician Decision|0|||
129880438|NCT01121484|467521228|FG001|Overall Study|Physician Decision|3|||
129880439|NCT01121484|467521227|FG000|Overall Study|Protocol Violation|1|||
129880440|NCT01121484|467521228|FG001|Overall Study|Protocol Violation|0|||
129880441|NCT01121484|467521227|FG000|Overall Study|Withdrawal by Subject|8|||
129880442|NCT01121484|467521228|FG001|Overall Study|Withdrawal by Subject|7|||
129880443|NCT01121484|467521227|FG000|Overall Study|Discontinuation of study by sponsor|0|||
129880444|NCT01121484|467521228|FG001|Overall Study|Discontinuation of study by sponsor|1|||
129880445|NCT01121484|467521227|FG000|Overall Study|Other|3|||
129880446|NCT01121484|467521228|FG001|Overall Study|Other|3|||
129880447|NCT01121484|467521227|FG000|Overall Study|Randomized, not treated|1|||
129880448|NCT01121484|467521228|FG001|Overall Study|Randomized, not treated|4|||
129880449|NCT01512745|467521229|FG000|Overall Study|Adverse Event|22|||
129880450|NCT01512745|467521230|FG001|Overall Study|Adverse Event|3|||
129880451|NCT01512745|467521229|FG000|Overall Study|Death|9|||
129880452|NCT01512745|467521230|FG001|Overall Study|Death|13|||
129880453|NCT01512745|467521229|FG000|Overall Study|Withdrawal by Subject|2|||
129880454|NCT01512745|467521230|FG001|Overall Study|Withdrawal by Subject|2|||
129880455|NCT01512745|467521229|FG000|Overall Study|Lost to Follow-up|4|||
129880456|NCT01512745|467521230|FG001|Overall Study|Lost to Follow-up|0|||
129880457|NCT01512745|467521229|FG000|Overall Study|Lack of Efficacy|2|||
129880458|NCT01512745|467521230|FG001|Overall Study|Lack of Efficacy|2|||
129880459|NCT01512745|467521229|FG000|Overall Study|Protocol Violation|1|||
129880460|NCT01512745|467521230|FG001|Overall Study|Protocol Violation|0|||
129880461|NCT02357810|467521231|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
129880462|NCT02357810|467521231|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
129880463|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Adverse Event|5|||
129880464|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
129880465|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
129880466|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
129880467|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Death|1|||
129880468|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Physician Decision|1|||
129880469|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Other|1|||
129880470|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
129880471|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
129880472|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
129880473|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
129880474|NCT02357810|467521231|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
129880475|NCT02357810|467521231|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
129880476|NCT00936221|467521232|FG000|Overall Study|Withdrawal by Subject|1|||
129880477|NCT00936221|467521233|FG001|Overall Study|Withdrawal by Subject|1|||
129880478|NCT03820323|467521234|FG000|Overall Study|Lost to Follow-up|2|||
129880479|NCT03820323|467521235|FG001|Overall Study|Lost to Follow-up|1|||
129880480|NCT03820323|467521234|FG000|Overall Study|Missed 12-month visit|22|||
129880481|NCT03820323|467521235|FG001|Overall Study|Missed 12-month visit|14|||
129880482|NCT03820323|467521234|FG000|Overall Study|Death|2|||
129880483|NCT03820323|467521235|FG001|Overall Study|Death|1|||
129880484|NCT03820323|467521234|FG000|Overall Study|Transferred out|13|||
129880485|NCT03820323|467521235|FG001|Overall Study|Transferred out|11|||
129880486|NCT03820323|467521234|FG000|Overall Study|Terminated|0|||
129880487|NCT03820323|467521235|FG001|Overall Study|Terminated|3|||
129880488|NCT03820323|467521234|FG000|Overall Study|Withdrawal by Subject|1|||
129880489|NCT03820323|467521235|FG001|Overall Study|Withdrawal by Subject|6|||
129880490|NCT03151395|467521236|FG000|Overall Study|Adverse Event|2|||
129880491|NCT03151395|467521236|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
129880492|NCT03151395|467521236|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
129880493|NCT03151395|467521236|FG000|Overall Study|Unspecified reason|4|||
129880494|NCT00879996|467521237|FG000|Overall Study|Lost to Follow-up|7|||
129880495|NCT00879996|467521238|FG001|Overall Study|Lost to Follow-up|6|||
129880496|NCT00879996|467521237|FG000|Overall Study|non-compliance|6|||
129880497|NCT00879996|467521238|FG001|Overall Study|non-compliance|4|||
129880498|NCT00879996|467521237|FG000|Overall Study|Physician Decision|1|||
129880499|NCT00879996|467521238|FG001|Overall Study|Physician Decision|2|||
129880500|NCT00879996|467521237|FG000|Overall Study|psychiatric problem|0|||
129880501|NCT00879996|467521238|FG001|Overall Study|psychiatric problem|1|||
129880502|NCT00879996|467521237|FG000|Overall Study|put on parole|1|||
129880503|NCT00879996|467521238|FG001|Overall Study|put on parole|0|||
129880504|NCT02597933|467521243|FG000|Overall Study|Withdrawal by Subject|7|||
129880505|NCT02597933|467521244|FG001|Overall Study|Withdrawal by Subject|5|||
129880506|NCT02597933|467521243|FG000|Overall Study|Protocol Violation|2|||
129880507|NCT02597933|467521244|FG001|Overall Study|Protocol Violation|2|||
129880508|NCT02597933|467521243|FG000|Overall Study|Adverse Event|20|||
129880509|NCT02597933|467521244|FG001|Overall Study|Adverse Event|28|||
129880510|NCT02597933|467521243|FG000|Overall Study|Not treated|2|||
129880511|NCT02597933|467521244|FG001|Overall Study|Not treated|2|||
129880512|NCT02597933|467521243|FG000|Overall Study|Other than stated above|7|||
129880513|NCT02597933|467521244|FG001|Overall Study|Other than stated above|14|||
129880514|NCT02223754|467521247|FG000|Period 1|Adverse Event|1|||
129880515|NCT02223754|467521248|FG001|Period 1|Adverse Event|0|||
129880516|NCT02223754|467521247|FG000|Period 1|Lost to Follow-up|0|||
129880517|NCT02223754|467521248|FG001|Period 1|Lost to Follow-up|1|||
129880518|NCT02223754|467521247|FG000|Period 1|Protocol Violation|2|||
129880519|NCT02223754|467521248|FG001|Period 1|Protocol Violation|4|||
129880520|NCT02223754|467521247|FG000|Period 1|Withdrawal by Subject|0|||
129880521|NCT02223754|467521248|FG001|Period 1|Withdrawal by Subject|4|||
129880522|NCT02223754|467521247|FG000|Period 1|Test Article No Longer Available|1|||
129880523|NCT02223754|467521248|FG001|Period 1|Test Article No Longer Available|5|||
129880524|NCT02223754|467521247|FG000|Period 1|Unsatisfactory Visual Response|0|||
129880525|NCT02223754|467521248|FG001|Period 1|Unsatisfactory Visual Response|1|||
129880526|NCT02223754|467521247|FG000|Period 2|Adverse Event|0|||
129880527|NCT02223754|467521248|FG001|Period 2|Adverse Event|1|||
129880528|NCT02223754|467521247|FG000|Period 2|Protocol Violation|1|||
129880529|NCT02223754|467521248|FG001|Period 2|Protocol Violation|0|||
129880530|NCT02223754|467521247|FG000|Period 2|Lens Discomfort|1|||
129880531|NCT02223754|467521248|FG001|Period 2|Lens Discomfort|1|||
129880532|NCT02223754|467521247|FG000|Period 2|Lost to Follow-up|1|||
129880533|NCT02223754|467521248|FG001|Period 2|Lost to Follow-up|0|||
129880534|NCT02223754|467521247|FG000|Period 2|Test Article No Longer Available|0|||
129880535|NCT02223754|467521248|FG001|Period 2|Test Article No Longer Available|1|||
129880536|NCT04395183|467521249|FG000|Overall Study|Withdrawal by Subject|1|||
129880537|NCT04395183|467521250|FG001|Overall Study|Withdrawal by Subject|0|||
129880538|NCT04395183|467521251|FG002|Overall Study|Withdrawal by Subject|2|||
129880539|NCT04395183|467521252|FG003|Overall Study|Withdrawal by Subject|2|||
129880540|NCT00510458|467521256|FG000|Overall Study|5 year not evaluable/missed|21|||
129880541|NCT00510458|467521256|FG000|Overall Study|Death|1|||
129880542|NCT00510458|467521256|FG000|Overall Study|Terminated|14|||
129880543|NCT00510458|467521256|FG000|Overall Study|Lost to Follow-up|6|||
129880544|NCT00510458|467521256|FG000|Overall Study|Withdrawal by Subject|3|||
129880545|NCT00510458|467521256|FG000|Overall Study|Revision|2|||
129880546|NCT02569710|467521257|FG000|Overall Study|Adverse Event|1|||
129880547|NCT02569710|467521258|FG001|Overall Study|Adverse Event|0|||
129880548|NCT02569710|467521259|FG002|Overall Study|Adverse Event|0|||
129880549|NCT02569710|467521260|FG003|Overall Study|Adverse Event|0|||
129880550|NCT02569710|467521261|FG004|Overall Study|Adverse Event|0|||
129880551|NCT02569710|467521262|FG005|Overall Study|Adverse Event|0|||
129880552|NCT02569710|467521263|FG006|Overall Study|Adverse Event|0|||
129880553|NCT02569710|467521264|FG007|Overall Study|Adverse Event|0|||
129880554|NCT02569710|467521265|FG008|Overall Study|Adverse Event|0|||
129880555|NCT02569710|467521266|FG009|Overall Study|Adverse Event|0|||
129880556|NCT02569710|467521257|FG000|Overall Study|Lost to Follow-up|0|||
129880557|NCT02569710|467521258|FG001|Overall Study|Lost to Follow-up|0|||
129880558|NCT02569710|467521259|FG002|Overall Study|Lost to Follow-up|0|||
129880559|NCT02569710|467521260|FG003|Overall Study|Lost to Follow-up|0|||
129880560|NCT02569710|467521261|FG004|Overall Study|Lost to Follow-up|0|||
129880561|NCT02569710|467521262|FG005|Overall Study|Lost to Follow-up|0|||
129880562|NCT02569710|467521263|FG006|Overall Study|Lost to Follow-up|1|||
129880563|NCT02569710|467521264|FG007|Overall Study|Lost to Follow-up|0|||
129880564|NCT02569710|467521265|FG008|Overall Study|Lost to Follow-up|1|||
129880565|NCT02569710|467521266|FG009|Overall Study|Lost to Follow-up|0|||
129880566|NCT02569710|467521257|FG000|Overall Study|Virologic failure|0|||
129880567|NCT02569710|467521258|FG001|Overall Study|Virologic failure|0|||
129880568|NCT02569710|467521259|FG002|Overall Study|Virologic failure|0|||
129880569|NCT02569710|467521260|FG003|Overall Study|Virologic failure|0|||
129880570|NCT02569710|467521261|FG004|Overall Study|Virologic failure|1|||
129880571|NCT02569710|467521262|FG005|Overall Study|Virologic failure|0|||
129880572|NCT02569710|467521263|FG006|Overall Study|Virologic failure|1|||
129880573|NCT02569710|467521264|FG007|Overall Study|Virologic failure|0|||
129880574|NCT02569710|467521265|FG008|Overall Study|Virologic failure|0|||
130322489|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
129880575|NCT02569710|467521266|FG009|Overall Study|Virologic failure|0|||
130322490|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
129880576|NCT02569710|467521257|FG000|Overall Study|Withdrawal by Subject|0|||
129880577|NCT02569710|467521258|FG001|Overall Study|Withdrawal by Subject|0|||
129880578|NCT02569710|467521259|FG002|Overall Study|Withdrawal by Subject|0|||
129880579|NCT02569710|467521260|FG003|Overall Study|Withdrawal by Subject|0|||
129880580|NCT02569710|467521261|FG004|Overall Study|Withdrawal by Subject|0|||
129880581|NCT02569710|467521262|FG005|Overall Study|Withdrawal by Subject|1|||
129880582|NCT02569710|467521263|FG006|Overall Study|Withdrawal by Subject|0|||
129880583|NCT02569710|467521264|FG007|Overall Study|Withdrawal by Subject|0|||
129880584|NCT02569710|467521265|FG008|Overall Study|Withdrawal by Subject|0|||
129880585|NCT02569710|467521266|FG009|Overall Study|Withdrawal by Subject|0|||
129880586|NCT00539279|467521267|FG000|Treatment|Withdrawal by Subject|10|||
129880587|NCT00539279|467521268|FG001|Treatment|Withdrawal by Subject|8|||
129880588|NCT00539279|467521267|FG000|Treatment|Death|1|||
129880589|NCT00539279|467521268|FG001|Treatment|Death|0|||
129880590|NCT00539279|467521267|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
129880591|NCT00539279|467521268|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
129880592|NCT00539279|467521267|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
129880593|NCT00539279|467521268|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
129880594|NCT01338012|467521269|FG000|Overall Study|Death|4|||
129880595|NCT01338012|467521269|FG000|Overall Study|Study terminated|4|||
129880596|NCT02714205|467521270|FG000|Overall Study|Cannot tolerate medication|1|||
129880597|NCT02714205|467521271|FG001|Overall Study|Cannot tolerate medication|0|||
129880598|NCT02714205|467521270|FG000|Overall Study|Adverse Event|2|||
129880599|NCT02714205|467521271|FG001|Overall Study|Adverse Event|0|||
129880600|NCT02714205|467521270|FG000|Overall Study|Too busy|1|||
129880601|NCT02714205|467521271|FG001|Overall Study|Too busy|0|||
129880602|NCT02714205|467521270|FG000|Overall Study|Incomplete outcome data|0|||
129880603|NCT02714205|467521271|FG001|Overall Study|Incomplete outcome data|1|||
129880604|NCT01693692|467521272|FG000|Overall Study|Withdrawal by Subject|12|||
129880605|NCT01693692|467521273|FG001|Overall Study|Withdrawal by Subject|10|||
129880606|NCT01693692|467521274|FG002|Overall Study|Withdrawal by Subject|11|||
129880607|NCT01693692|467521272|FG000|Overall Study|Adverse Event|7|||
129880608|NCT01693692|467521273|FG001|Overall Study|Adverse Event|14|||
129880609|NCT01693692|467521274|FG002|Overall Study|Adverse Event|9|||
129880610|NCT01693692|467521272|FG000|Overall Study|Physician Decision|0|||
129880611|NCT01693692|467521273|FG001|Overall Study|Physician Decision|0|||
129880612|NCT01693692|467521274|FG002|Overall Study|Physician Decision|1|||
129880613|NCT01693692|467521272|FG000|Overall Study|Protocol Violation|5|||
129880614|NCT01693692|467521273|FG001|Overall Study|Protocol Violation|4|||
129880615|NCT01693692|467521274|FG002|Overall Study|Protocol Violation|6|||
129880616|NCT01693692|467521272|FG000|Overall Study|Lost to Follow-up|2|||
129880617|NCT01693692|467521273|FG001|Overall Study|Lost to Follow-up|2|||
129880618|NCT01693692|467521274|FG002|Overall Study|Lost to Follow-up|3|||
129880619|NCT01693692|467521272|FG000|Overall Study|Other|4|||
129880620|NCT01693692|467521273|FG001|Overall Study|Other|4|||
129880621|NCT01693692|467521274|FG002|Overall Study|Other|6|||
129880622|NCT04567693|467523154|FG000|Overall Study|Death|0|||
129880623|NCT04567693|467523155|FG001|Overall Study|Death|0|||
129880624|NCT04567693|467523156|FG002|Overall Study|Death|2|||
129880625|NCT04567693|467523154|FG000|Overall Study|Lost to Follow-up|1|||
129880626|NCT04567693|467523155|FG001|Overall Study|Lost to Follow-up|0|||
129880627|NCT04567693|467523156|FG002|Overall Study|Lost to Follow-up|2|||
129880628|NCT04567693|467523154|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
129880629|NCT04567693|467523155|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
129880630|NCT04567693|467523156|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
129880631|NCT04105972|467523163|FG000|Overall Study|Adverse Event|2|||
129880632|NCT04105972|467523164|FG001|Overall Study|Adverse Event|1|||
129880633|NCT00553202|467523165|FG000|Overall Study|Death|16|||
129880634|NCT00553202|467523165|FG000|Overall Study|Lost to Follow-up|1|||
129880635|NCT00553202|467523165|FG000|Overall Study|Physician Decision|28|||
129880636|NCT00553202|467523165|FG000|Overall Study|Withdrawal by Subject|1|||
129880637|NCT00553202|467523165|FG000|Overall Study|No donor identified|16|||
129880638|NCT00553202|467523165|FG000|Overall Study|Fails to meet organ function|6|||
129880639|NCT02593305|467523166|FG000|Post 1|Comparison only group. No intervention.|0|||
129880640|NCT02593305|467523167|FG001|Post 1|Comparison only group. No intervention.|0|||
129880641|NCT02593305|467523168|FG002|Post 1|Comparison only group. No intervention.|10|||
129880642|NCT01161472|467523169|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
129880643|NCT01161472|467523170|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129880644|NCT01161472|467523171|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129880645|NCT01161472|467523172|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129880646|NCT00768430|467523195|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
129880647|NCT00768430|467523196|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
129880648|NCT00041756|467523198|FG000|Overall Study|Adverse Event|4|||
129880649|NCT00041756|467523199|FG001|Overall Study|Adverse Event|10|||
129880650|NCT00041756|467523200|FG002|Overall Study|Adverse Event|6|||
129880651|NCT00041756|467523201|FG003|Overall Study|Adverse Event|11|||
129880652|NCT00041756|467523202|FG004|Overall Study|Adverse Event|34|||
129880653|NCT00041756|467523198|FG000|Overall Study|Protocol Violation|1|||
129880654|NCT00041756|467523199|FG001|Overall Study|Protocol Violation|1|||
129880655|NCT00041756|467523200|FG002|Overall Study|Protocol Violation|2|||
129880656|NCT00041756|467523201|FG003|Overall Study|Protocol Violation|2|||
129880657|NCT00041756|467523202|FG004|Overall Study|Protocol Violation|1|||
129880658|NCT00041756|467523198|FG000|Overall Study|Withdrawal by Subject|3|||
129880659|NCT00041756|467523199|FG001|Overall Study|Withdrawal by Subject|3|||
129880660|NCT00041756|467523200|FG002|Overall Study|Withdrawal by Subject|4|||
129880661|NCT00041756|467523201|FG003|Overall Study|Withdrawal by Subject|2|||
129880662|NCT00041756|467523202|FG004|Overall Study|Withdrawal by Subject|3|||
129880663|NCT00041756|467523198|FG000|Overall Study|Lost to Follow-up|0|||
129880664|NCT00041756|467523199|FG001|Overall Study|Lost to Follow-up|1|||
130322491|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
130322492|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
130322493|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
130322494|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
130322495|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
130322496|NCT03181932|469151292|FG000|Period 2 (Open-label Period)|Reason missing|2|||
130322497|NCT03181932|469151293|FG001|Period 2 (Open-label Period)|Reason missing|0|||
130322498|NCT02220920|469151295|FG000|Overall Study|Adverse Event|1|||
130322499|NCT02220920|469151296|FG001|Overall Study|Adverse Event|0|||
130322500|NCT02220920|469151295|FG000|Overall Study|Lack of Efficacy|0|||
129880665|NCT00041756|467523200|FG002|Overall Study|Lost to Follow-up|0|||
130322501|NCT02220920|469151296|FG001|Overall Study|Lack of Efficacy|1|||
130322502|NCT02220920|469151295|FG000|Overall Study|Withdrawal by Subject|1|||
130322503|NCT02220920|469151296|FG001|Overall Study|Withdrawal by Subject|0|||
130322504|NCT02220920|469151295|FG000|Overall Study|Conflict with the stopping criteria|1|||
130322505|NCT02220920|469151296|FG001|Overall Study|Conflict with the stopping criteria|2|||
130322506|NCT01112917|469151297|FG000|Overall Study|Death|2|||
130322507|NCT01112917|469151298|FG001|Overall Study|Death|11|||
130322508|NCT01112917|469151297|FG000|Overall Study|Lost to Follow-up|1|||
130322509|NCT01112917|469151298|FG001|Overall Study|Lost to Follow-up|1|||
130322510|NCT01112917|469151297|FG000|Overall Study|Withdrawal by Subject|1|||
130322511|NCT01112917|469151298|FG001|Overall Study|Withdrawal by Subject|3|||
130322512|NCT01112917|469151297|FG000|Overall Study|Unable to Convert Filter|3|||
130322513|NCT01112917|469151298|FG001|Overall Study|Unable to Convert Filter|0|||
130322514|NCT02177123|469151299|FG000|Overall Study|Lost to Follow-up|6|||
130322515|NCT02177123|469151299|FG000|Overall Study|Withdrawal by Subject|4|||
130322516|NCT02177123|469151299|FG000|Overall Study|Adverse Event|4|||
130322517|NCT02177123|469151299|FG000|Overall Study|Physician Decision|3|||
130322518|NCT02177123|469151299|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
130322519|NCT02177123|469151299|FG000|Overall Study|Excluded for medical reasons|2|||
130322520|NCT02177123|469151299|FG000|Overall Study|Death|1|||
130322521|NCT02177123|469151299|FG000|Overall Study|Other|1|||
130322522|NCT02177123|469151299|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
130322523|NCT06271993|469151306|FG000|Overall Study|Not reactive to histamine|5|||
130322524|NCT06271993|469151307|FG001|Overall Study|Not reactive to histamine|5|||
130322525|NCT06271993|469151308|FG002|Overall Study|Not reactive to histamine|5|||
130322526|NCT03103542|469151309|FG000|Overall Study|Physician Decision|2|||
130322527|NCT03103542|469151309|FG000|Overall Study|Adverse Event|2|||
130322528|NCT03103542|469151309|FG000|Overall Study|Other|2|||
130322529|NCT03103542|469151309|FG000|Overall Study|Withdrawal by Subject|1|||
130322530|NCT03566511|469151310|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
130322531|NCT03566511|469151311|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
130322532|NCT02939287|469151317|FG000|Overall Study|met exclusion criteria|1|||
130322533|NCT02939287|469151318|FG001|Overall Study|met exclusion criteria|1|||
130322534|NCT02939287|469151319|FG002|Overall Study|met exclusion criteria|1|||
130322535|NCT02939287|469151317|FG000|Overall Study|Did not complete survey|2|||
130322536|NCT02939287|469151318|FG001|Overall Study|Did not complete survey|2|||
130322537|NCT02939287|469151319|FG002|Overall Study|Did not complete survey|0|||
130322538|NCT02939287|469151317|FG000|Overall Study|Withdrawal by Subject|1|||
130322539|NCT02939287|469151318|FG001|Overall Study|Withdrawal by Subject|1|||
130322540|NCT02939287|469151319|FG002|Overall Study|Withdrawal by Subject|0|||
130322541|NCT00981656|469151320|FG000|Overall Study|Protocol Violation|1|||
130322542|NCT00981656|469151320|FG000|Overall Study|Did not start protocol treatment|2|||
130322543|NCT00687596|469151321|FG000|Overall Study|Adverse Event (AE)|10|||
130322544|NCT00687596|469151322|FG001|Overall Study|Adverse Event (AE)|3|||
130322545|NCT00687596|469151321|FG000|Overall Study|Radiological Disease Progression|6|||
129880666|NCT00041756|467523201|FG003|Overall Study|Lost to Follow-up|1|||
129880667|NCT00041756|467523202|FG004|Overall Study|Lost to Follow-up|0|||
129880668|NCT00041756|467523198|FG000|Overall Study|Unable to meet protocol criteria|0|||
129880669|NCT00041756|467523199|FG001|Overall Study|Unable to meet protocol criteria|0|||
129880670|NCT00041756|467523200|FG002|Overall Study|Unable to meet protocol criteria|1|||
129880671|NCT00041756|467523201|FG003|Overall Study|Unable to meet protocol criteria|0|||
129880672|NCT00041756|467523202|FG004|Overall Study|Unable to meet protocol criteria|1|||
129880673|NCT00041756|467523198|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
129880674|NCT00041756|467523199|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
129880675|NCT00041756|467523200|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
129880676|NCT00041756|467523201|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
130322546|NCT00687596|469151322|FG001|Overall Study|Radiological Disease Progression|2|||
130322547|NCT00687596|469151321|FG000|Overall Study|Clinical Disease Progression|1|||
129880677|NCT00041756|467523202|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
130322548|NCT00687596|469151322|FG001|Overall Study|Clinical Disease Progression|3|||
130322549|NCT00687596|469151321|FG000|Overall Study|Investigator Discretion|3|||
130322550|NCT00687596|469151322|FG001|Overall Study|Investigator Discretion|1|||
129880678|NCT03980184|467523203|FG000|Overall Study|Dropped out before treatment|2|||
129880679|NCT03980184|467523204|FG001|Overall Study|Dropped out before treatment|2|||
129880680|NCT03980184|467523203|FG000|Overall Study|Lost to Follow-up|11|||
129880681|NCT03980184|467523204|FG001|Overall Study|Lost to Follow-up|13|||
129880682|NCT00603265|467523205|FG000|Overall Study|Adverse Event|2|||
129880683|NCT00603265|467523206|FG001|Overall Study|Adverse Event|11|||
129880684|NCT00603265|467523207|FG002|Overall Study|Adverse Event|1|||
129880685|NCT00603265|467523205|FG000|Overall Study|Withdrawal by Subject|1|||
129880686|NCT00603265|467523206|FG001|Overall Study|Withdrawal by Subject|2|||
129880687|NCT00603265|467523207|FG002|Overall Study|Withdrawal by Subject|1|||
129880688|NCT00603265|467523205|FG000|Overall Study|Lack of Efficacy|3|||
129880689|NCT00603265|467523206|FG001|Overall Study|Lack of Efficacy|0|||
129880690|NCT00603265|467523207|FG002|Overall Study|Lack of Efficacy|3|||
129880691|NCT00603265|467523205|FG000|Overall Study|Lost to Follow-up|0|||
129880692|NCT00603265|467523206|FG001|Overall Study|Lost to Follow-up|1|||
129880693|NCT00603265|467523207|FG002|Overall Study|Lost to Follow-up|0|||
129880694|NCT00603265|467523205|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
129880695|NCT00603265|467523206|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
129880696|NCT00603265|467523207|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
129880697|NCT00603265|467523205|FG000|Overall Study|Participant Left Country, No Responses|0|||
129880698|NCT00603265|467523206|FG001|Overall Study|Participant Left Country, No Responses|1|||
129880699|NCT00603265|467523207|FG002|Overall Study|Participant Left Country, No Responses|0|||
129880700|NCT00603265|467523205|FG000|Overall Study|Protocol Violation|1|||
129880701|NCT00603265|467523206|FG001|Overall Study|Protocol Violation|0|||
129880702|NCT00603265|467523207|FG002|Overall Study|Protocol Violation|0|||
129880703|NCT02002884|467523209|FG000|Main Period (MP)|Other|0|||
129880704|NCT02002884|467523210|FG001|Main Period (MP)|Other|3|||
129880705|NCT02002884|467523211|FG002|Main Period (MP)|Other|3|||
129880706|NCT02002884|467523212|FG003|Main Period (MP)|Other|0|||
129880707|NCT02002884|467523209|FG000|Main Period (MP)|Adverse Event|0|||
129880708|NCT02002884|467523210|FG001|Main Period (MP)|Adverse Event|1|||
129880709|NCT02002884|467523211|FG002|Main Period (MP)|Adverse Event|1|||
129880710|NCT02002884|467523212|FG003|Main Period (MP)|Adverse Event|0|||
129880711|NCT02002884|467523209|FG000|Main Period (MP)|Withdrawal by Subject|6|||
129880712|NCT02002884|467523210|FG001|Main Period (MP)|Withdrawal by Subject|2|||
129880713|NCT02002884|467523211|FG002|Main Period (MP)|Withdrawal by Subject|2|||
129880714|NCT02002884|467523212|FG003|Main Period (MP)|Withdrawal by Subject|0|||
129880715|NCT02002884|467523209|FG000|Main Period (MP)|Lost to Follow-up|0|||
129880716|NCT02002884|467523210|FG001|Main Period (MP)|Lost to Follow-up|0|||
129880717|NCT02002884|467523211|FG002|Main Period (MP)|Lost to Follow-up|2|||
129880718|NCT02002884|467523212|FG003|Main Period (MP)|Lost to Follow-up|0|||
129880719|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Other|0|||
129880720|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Other|0|||
129880721|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Other|0|||
129880722|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Other|24|||
129880723|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
129880724|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
129880725|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
129880726|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
129880727|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
129880728|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
129880729|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
129880730|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
129880731|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
129880732|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
129880733|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
129880734|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
129880735|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
129880736|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
129880737|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
129880738|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
129880739|NCT02966002|467523213|FG000|Overall Study|Withdrawal by Subject|2|||
129880740|NCT02966002|467523213|FG000|Overall Study|Adverse Event|1|||
129880741|NCT02966002|467523213|FG000|Overall Study|Lost to Follow-up|1|||
129880742|NCT01112514|467523214|FG000|Overall Study|Lost to Follow-up|1|||
129880743|NCT01118455|467523215|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
129880744|NCT01118455|467523216|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
129880745|NCT02632786|467523227|FG000|Overall Study|Adverse Event|2|||
129880746|NCT02632786|467523228|FG001|Overall Study|Adverse Event|1|||
129880747|NCT02632786|467523227|FG000|Overall Study|Death|3|||
129880748|NCT02632786|467523228|FG001|Overall Study|Death|2|||
129880749|NCT02632786|467523227|FG000|Overall Study|Physician Decision|5|||
129880750|NCT02632786|467523228|FG001|Overall Study|Physician Decision|4|||
129880751|NCT02632786|467523227|FG000|Overall Study|Withdrawal by Subject|1|||
130322551|NCT00687596|469151321|FG000|Overall Study|Sponsor Terminated Study|6|||
129880752|NCT02632786|467523228|FG001|Overall Study|Withdrawal by Subject|0|||
129880753|NCT01928225|467523229|FG000|Overall Study|Pregnancy|1|||
129880754|NCT01928225|467523230|FG001|Overall Study|Pregnancy|0|||
129880755|NCT01928225|467523229|FG000|Overall Study|basaloid cervical cancer|1|||
129880756|NCT01928225|467523230|FG001|Overall Study|basaloid cervical cancer|0|||
129880757|NCT01928225|467523229|FG000|Overall Study|Lost to Follow-up|1|||
129880758|NCT01928225|467523230|FG001|Overall Study|Lost to Follow-up|3|||
129880759|NCT01454830|467523234|FG000|Overall Study|Withdrawal by Subject|4|||
130322552|NCT00687596|469151322|FG001|Overall Study|Sponsor Terminated Study|17|||
130322553|NCT03406780|469151323|FG000|Overall Study|Withdrawal by Subject|1|||
130322554|NCT03406780|469151324|FG001|Overall Study|Withdrawal by Subject|1|||
130322555|NCT03406780|469151323|FG000|Overall Study|Other|0|||
130322556|NCT03406780|469151324|FG001|Overall Study|Other|2|||
130322557|NCT03466658|469151327|FG000|Overall Study|Withdrawal by Subject|3|||
130322558|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322559|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130322560|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130322561|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322562|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322563|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
130322564|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
130322565|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322566|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322567|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322568|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322569|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322570|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
130322571|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
130322572|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322573|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322574|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322575|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
130322576|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322577|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322578|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
130322579|NCT00129402|469151328|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322580|NCT00129402|469151329|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322581|NCT00129402|469151330|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
130322582|NCT00129402|469151331|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322583|NCT00129402|469151332|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
130322584|NCT00129402|469151333|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322585|NCT00129402|469151334|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
130322586|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322587|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322588|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
130322589|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322590|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322591|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322592|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
130322593|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322594|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322595|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
130322596|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129880760|NCT01454830|467523235|FG001|Overall Study|Withdrawal by Subject|4|||
129880761|NCT01454830|467523234|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
129880762|NCT01454830|467523235|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
129880763|NCT01454830|467523234|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
129880764|NCT01454830|467523235|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
129880765|NCT01454830|467523234|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
129880766|NCT01454830|467523235|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
129880767|NCT01454830|467523234|FG000|Overall Study|Withdrawal - no polysomnography|3|||
129880768|NCT01454830|467523235|FG001|Overall Study|Withdrawal - no polysomnography|2|||
129880769|NCT00152763|467523236|FG000|Overall Study|Death|4|||
129880770|NCT00152763|467523237|FG001|Overall Study|Death|1|||
129880771|NCT00152763|467523238|FG002|Overall Study|Death|2|||
129880772|NCT00152763|467523239|FG003|Overall Study|Death|1|||
129880773|NCT00152763|467523236|FG000|Overall Study|Lost to Follow-up|6|||
129880774|NCT00152763|467523237|FG001|Overall Study|Lost to Follow-up|4|||
129880775|NCT00152763|467523238|FG002|Overall Study|Lost to Follow-up|2|||
129880776|NCT00152763|467523239|FG003|Overall Study|Lost to Follow-up|13|||
129880777|NCT00569803|467523242|FG000|Overall Study|Lost to Follow-up|1|||
129880778|NCT00569803|467523243|FG001|Overall Study|Lost to Follow-up|0|||
129880779|NCT00569803|467523244|FG002|Overall Study|Lost to Follow-up|0|||
129880780|NCT00569803|467523245|FG003|Overall Study|Lost to Follow-up|0|||
129880781|NCT00569803|467523246|FG004|Overall Study|Lost to Follow-up|0|||
129880782|NCT00569803|467523247|FG005|Overall Study|Lost to Follow-up|0|||
129880783|NCT00569803|467523248|FG006|Overall Study|Lost to Follow-up|0|||
129880784|NCT00569803|467523249|FG007|Overall Study|Lost to Follow-up|0|||
129880785|NCT00569803|467523242|FG000|Overall Study|injection syringe leaked during dosing|0|||
129880786|NCT00569803|467523243|FG001|Overall Study|injection syringe leaked during dosing|0|||
129880787|NCT00569803|467523244|FG002|Overall Study|injection syringe leaked during dosing|0|||
129880788|NCT00569803|467523245|FG003|Overall Study|injection syringe leaked during dosing|1|||
129880789|NCT00569803|467523246|FG004|Overall Study|injection syringe leaked during dosing|0|||
129880790|NCT00569803|467523247|FG005|Overall Study|injection syringe leaked during dosing|0|||
129880791|NCT00569803|467523248|FG006|Overall Study|injection syringe leaked during dosing|0|||
129880792|NCT00569803|467523249|FG007|Overall Study|injection syringe leaked during dosing|0|||
129880793|NCT00569803|467523242|FG000|Overall Study|Withdrawal by Subject|0|||
129880794|NCT00569803|467523243|FG001|Overall Study|Withdrawal by Subject|0|||
129880795|NCT00569803|467523244|FG002|Overall Study|Withdrawal by Subject|0|||
129880796|NCT00569803|467523245|FG003|Overall Study|Withdrawal by Subject|0|||
129880797|NCT00569803|467523246|FG004|Overall Study|Withdrawal by Subject|0|||
129880798|NCT00569803|467523247|FG005|Overall Study|Withdrawal by Subject|0|||
129880799|NCT00569803|467523248|FG006|Overall Study|Withdrawal by Subject|0|||
129880800|NCT00569803|467523249|FG007|Overall Study|Withdrawal by Subject|1|||
129880801|NCT01993823|467523250|FG000|Overall Study|Requested by the patient|6|||
129880802|NCT01993823|467523251|FG001|Overall Study|Requested by the patient|11|||
129880803|NCT01993823|467523250|FG000|Overall Study|Protocol Violation|0|||
129880804|NCT01993823|467523251|FG001|Overall Study|Protocol Violation|1|||
129880805|NCT01993823|467523250|FG000|Overall Study|Lost to Follow-up|1|||
129880806|NCT01993823|467523251|FG001|Overall Study|Lost to Follow-up|4|||
129880807|NCT01235975|467523254|FG000|Overall Study|Serious Adverse Event|0|||
129880808|NCT01235975|467523255|FG001|Overall Study|Serious Adverse Event|1|||
129880809|NCT01235975|467523254|FG000|Overall Study|Withdrawal by Subject|8|||
129880810|NCT01235975|467523255|FG001|Overall Study|Withdrawal by Subject|2|||
129880811|NCT01235975|467523254|FG000|Overall Study|Migrated/moved from study area|2|||
129880812|NCT01235975|467523255|FG001|Overall Study|Migrated/moved from study area|1|||
129880813|NCT01235975|467523254|FG000|Overall Study|Lost to Follow-up|7|||
129880814|NCT01235975|467523255|FG001|Overall Study|Lost to Follow-up|3|||
129880815|NCT00791921|467523256|FG000|Overall Study|Protocol planed|24|||
129880816|NCT00791921|467523257|FG001|Overall Study|Protocol planed|88|||
129880817|NCT00791921|467523256|FG000|Overall Study|Withdrawal by Subject|1|||
129880818|NCT00791921|467523257|FG001|Overall Study|Withdrawal by Subject|2|||
129880819|NCT00791921|467523256|FG000|Overall Study|Adverse Event|8|||
129880820|NCT00791921|467523257|FG001|Overall Study|Adverse Event|2|||
129880821|NCT00791921|467523256|FG000|Overall Study|Lack of Efficacy|0|||
129880822|NCT00791921|467523257|FG001|Overall Study|Lack of Efficacy|2|||
129880823|NCT00791921|467523256|FG000|Overall Study|Lack of study drug administration|1|||
129880824|NCT00791921|467523257|FG001|Overall Study|Lack of study drug administration|1|||
129880825|NCT00791921|467523256|FG000|Overall Study|Reason other than those above|0|||
129880826|NCT00791921|467523257|FG001|Overall Study|Reason other than those above|1|||
129880827|NCT00474175|467523259|FG000|Overall Study|Lack of Efficacy|0|||
129880828|NCT00474175|467523260|FG001|Overall Study|Lack of Efficacy|0|||
129880829|NCT00474175|467523261|FG002|Overall Study|Lack of Efficacy|1|||
129880830|NCT00474175|467523259|FG000|Overall Study|Withdrawal by Subject|0|||
129880831|NCT00474175|467523260|FG001|Overall Study|Withdrawal by Subject|1|||
129880832|NCT00474175|467523261|FG002|Overall Study|Withdrawal by Subject|1|||
129880833|NCT00474175|467523259|FG000|Overall Study|Ineligible|1|||
129880834|NCT00474175|467523260|FG001|Overall Study|Ineligible|3|||
129880835|NCT00474175|467523261|FG002|Overall Study|Ineligible|1|||
129880836|NCT00474175|467523259|FG000|Overall Study|Protocol Violation|0|||
129880837|NCT00474175|467523260|FG001|Overall Study|Protocol Violation|2|||
129880838|NCT00474175|467523261|FG002|Overall Study|Protocol Violation|1|||
129880839|NCT00474175|467523259|FG000|Overall Study|Administrative|0|||
129880840|NCT00474175|467523260|FG001|Overall Study|Administrative|1|||
129880841|NCT00474175|467523261|FG002|Overall Study|Administrative|0|||
129880842|NCT01460160|467523265|FG000|Treatment Phase|Lack of Efficacy|3|||
129880843|NCT01460160|467523265|FG000|Treatment Phase|Study Drug Toxicity|2|||
129880844|NCT01460160|467523265|FG000|Treatment Phase|Adverse Event|8|||
129880845|NCT01460160|467523265|FG000|Treatment Phase|Withdrawal by Subject|4|||
129880846|NCT01460160|467523265|FG000|Treatment Phase|Death|2|||
129880847|NCT01460160|467523265|FG000|Treatment Phase|Other reasons|9|||
129880848|NCT01460160|467523265|FG000|Follow-up Phase|Withdrawal by Subject|4|||
129880849|NCT01460160|467523265|FG000|Follow-up Phase|Death|14|||
129880850|NCT01460160|467523265|FG000|Follow-up Phase|Lost to Follow-up|7|||
129880851|NCT01460160|467523265|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
129880852|NCT01460160|467523265|FG000|Follow-up Phase|Other and not reported reasons|5|||
129880853|NCT02091739|467523267|FG000|MP: 16 Weeks|Adverse Event|1|||
129880854|NCT02091739|467523268|FG001|MP: 16 Weeks|Adverse Event|1|||
129880855|NCT02091739|467523269|FG002|MP: 16 Weeks|Adverse Event|1|||
129880856|NCT02091739|467523270|FG003|MP: 16 Weeks|Adverse Event|0|||
129880857|NCT02091739|467523271|FG004|MP: 16 Weeks|Adverse Event|0|||
129880858|NCT02091739|467523267|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
129880859|NCT02091739|467523268|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
129880860|NCT02091739|467523269|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
129880861|NCT02091739|467523270|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
129880862|NCT02091739|467523271|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
129880863|NCT02091739|467523267|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
129880864|NCT02091739|467523268|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
129880865|NCT02091739|467523269|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
129880866|NCT02091739|467523270|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
129880867|NCT02091739|467523271|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
129880868|NCT02091739|467523267|FG000|EP: 48 Weeks|Other|0|||
129880869|NCT02091739|467523268|FG001|EP: 48 Weeks|Other|0|||
129880870|NCT02091739|467523269|FG002|EP: 48 Weeks|Other|0|||
129880871|NCT02091739|467523270|FG003|EP: 48 Weeks|Other|1|||
129880872|NCT02091739|467523271|FG004|EP: 48 Weeks|Other|0|||
129880873|NCT02091739|467523267|FG000|EP: 48 Weeks|Death|0|||
129880874|NCT02091739|467523268|FG001|EP: 48 Weeks|Death|0|||
129880875|NCT02091739|467523269|FG002|EP: 48 Weeks|Death|0|||
129880876|NCT02091739|467523270|FG003|EP: 48 Weeks|Death|3|||
129880877|NCT02091739|467523271|FG004|EP: 48 Weeks|Death|2|||
129880878|NCT02091739|467523267|FG000|EP: 48 Weeks|Adverse Event|0|||
129880879|NCT02091739|467523268|FG001|EP: 48 Weeks|Adverse Event|0|||
129880880|NCT02091739|467523269|FG002|EP: 48 Weeks|Adverse Event|0|||
129880881|NCT02091739|467523270|FG003|EP: 48 Weeks|Adverse Event|2|||
129880882|NCT02091739|467523271|FG004|EP: 48 Weeks|Adverse Event|6|||
129880883|NCT02091739|467523267|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
129880884|NCT02091739|467523268|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
129880885|NCT02091739|467523269|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
129880886|NCT02091739|467523270|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
129880887|NCT02091739|467523271|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
129880888|NCT00192023|467523272|FG000|Period III - Double-Blind|Adverse Event|3|||
129880889|NCT00192023|467523273|FG001|Period III - Double-Blind|Adverse Event|0|||
129880890|NCT00192023|467523272|FG000|Period III - Double-Blind|Physician Decision|2|||
129880891|NCT00192023|467523273|FG001|Period III - Double-Blind|Physician Decision|0|||
129880892|NCT00192023|467523272|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
129880893|NCT00192023|467523273|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
129880894|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
129880895|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
129880896|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
129880897|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
129880898|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
129880899|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
129880900|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
129880901|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
129880902|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
129880903|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
129880904|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
129880905|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
129880906|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
129880907|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
129880908|NCT02086162|467523280|FG000|Overall Study|Withdrawal by Subject|4|||
129880909|NCT02086162|467523281|FG001|Overall Study|Withdrawal by Subject|4|||
129880910|NCT02086162|467523280|FG000|Overall Study|moved|1|||
129880911|NCT02086162|467523281|FG001|Overall Study|moved|1|||
129880912|NCT02086162|467523280|FG000|Overall Study|Lost to Follow-up|4|||
129880913|NCT02086162|467523281|FG001|Overall Study|Lost to Follow-up|2|||
129880914|NCT02086162|467523280|FG000|Overall Study|Death|1|||
129880915|NCT02086162|467523281|FG001|Overall Study|Death|0|||
129880916|NCT01027364|467523282|FG000|Overall Study|Adverse Event|1|||
129880917|NCT01027364|467523283|FG001|Overall Study|Adverse Event|0|||
129880918|NCT01027364|467523284|FG002|Overall Study|Adverse Event|1|||
129880919|NCT01027364|467523285|FG003|Overall Study|Adverse Event|0|||
129880920|NCT01027364|467523282|FG000|Overall Study|Lost to Follow-up|1|||
129880921|NCT01027364|467523283|FG001|Overall Study|Lost to Follow-up|0|||
129880922|NCT01027364|467523284|FG002|Overall Study|Lost to Follow-up|0|||
129880923|NCT01027364|467523285|FG003|Overall Study|Lost to Follow-up|0|||
129880924|NCT01027364|467523282|FG000|Overall Study|Protocol Violation|1|||
129880925|NCT01027364|467523283|FG001|Overall Study|Protocol Violation|0|||
129880926|NCT01027364|467523284|FG002|Overall Study|Protocol Violation|0|||
129880927|NCT01027364|467523285|FG003|Overall Study|Protocol Violation|1|||
129880928|NCT01027364|467523282|FG000|Overall Study|Withdrawal by Subject|1|||
129880929|NCT01027364|467523283|FG001|Overall Study|Withdrawal by Subject|2|||
129880930|NCT01027364|467523284|FG002|Overall Study|Withdrawal by Subject|0|||
129880931|NCT01027364|467523285|FG003|Overall Study|Withdrawal by Subject|0|||
129880932|NCT03662997|467523286|FG000|Overall Study|Adverse Event|0|||
129880933|NCT03662997|467523287|FG001|Overall Study|Adverse Event|2|||
129880934|NCT03662997|467523288|FG002|Overall Study|Adverse Event|0|||
129880935|NCT03662997|467523289|FG003|Overall Study|Adverse Event|0|||
129880936|NCT00675506|467523293|FG000|Overall Study|Lost to Follow-up|1|||
129880937|NCT00675506|467523294|FG001|Overall Study|Lost to Follow-up|5|||
129880938|NCT00675506|467523293|FG000|Overall Study|Lost interest|3|||
129880939|NCT00675506|467523294|FG001|Overall Study|Lost interest|5|||
129880940|NCT00675506|467523293|FG000|Overall Study|Elevated fasting glucose|2|||
129880941|NCT00675506|467523294|FG001|Overall Study|Elevated fasting glucose|1|||
129880942|NCT00675506|467523293|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
129880943|NCT00675506|467523294|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
129880944|NCT00675506|467523293|FG000|Overall Study|Elevated IGF-1|2|||
129880945|NCT00675506|467523294|FG001|Overall Study|Elevated IGF-1|0|||
129880946|NCT00675506|467523293|FG000|Overall Study|Hypersensitivity Reaction|1|||
129880947|NCT00675506|467523294|FG001|Overall Study|Hypersensitivity Reaction|0|||
129880948|NCT00675506|467523293|FG000|Overall Study|Disclosed history of cancer|1|||
129880949|NCT00675506|467523294|FG001|Overall Study|Disclosed history of cancer|0|||
129880950|NCT00675506|467523293|FG000|Overall Study|Declined participation|1|||
129880951|NCT00675506|467523294|FG001|Overall Study|Declined participation|0|||
129880952|NCT00675506|467523293|FG000|Overall Study|Schedule conflict|0|||
129880953|NCT00675506|467523294|FG001|Overall Study|Schedule conflict|1|||
129880954|NCT02912468|467523296|FG000|Overall Study|Adverse Event|3|||
129880955|NCT02912468|467523297|FG001|Overall Study|Adverse Event|2|||
129880956|NCT02912468|467523296|FG000|Overall Study|Withdrawal by Subject|6|||
129880957|NCT02912468|467523297|FG001|Overall Study|Withdrawal by Subject|2|||
129880958|NCT02912468|467523296|FG000|Overall Study|Randomized and not treated|0|||
129880959|NCT02912468|467523297|FG001|Overall Study|Randomized and not treated|1|||
129880960|NCT01320735|467523298|FG000|Overall Study|Adverse Event|3|||
129880961|NCT01320735|467523298|FG000|Overall Study|Withdrawal by Subject|3|||
129880962|NCT01320735|467523298|FG000|Overall Study|Lost to Follow-up|13|||
129880963|NCT01320735|467523298|FG000|Overall Study|Administrative Reason|6|||
129880964|NCT01320735|467523298|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
129880965|NCT01320735|467523298|FG000|Overall Study|Protocol Violation|1|||
129880966|NCT01320735|467523298|FG000|Overall Study|Other|1|||
129880967|NCT01320735|467523298|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
129880968|NCT01320735|467523298|FG000|Overall Study|Investigator Unable to be Contacted|17|||
129880969|NCT01913639|467523301|FG000|Overall Study|Not Eligible|3|||
129880970|NCT01225822|467523311|FG000|Overall Study|Adverse Event|13|||
129880971|NCT01225822|467523312|FG001|Overall Study|Adverse Event|31|||
129880972|NCT01225822|467523313|FG002|Overall Study|Adverse Event|18|||
129880973|NCT01225822|467523314|FG003|Overall Study|Adverse Event|23|||
129880974|NCT01225822|467523315|FG004|Overall Study|Adverse Event|14|||
129880975|NCT01225822|467523311|FG000|Overall Study|Protocol Violation|6|||
129880976|NCT01225822|467523312|FG001|Overall Study|Protocol Violation|8|||
129880977|NCT01225822|467523313|FG002|Overall Study|Protocol Violation|6|||
129880978|NCT01225822|467523314|FG003|Overall Study|Protocol Violation|7|||
129880979|NCT01225822|467523315|FG004|Overall Study|Protocol Violation|4|||
129880980|NCT01225822|467523311|FG000|Overall Study|Lost to Follow-up|0|||
129880981|NCT01225822|467523312|FG001|Overall Study|Lost to Follow-up|0|||
129880982|NCT01225822|467523313|FG002|Overall Study|Lost to Follow-up|0|||
129880983|NCT01225822|467523314|FG003|Overall Study|Lost to Follow-up|1|||
129880984|NCT01225822|467523315|FG004|Overall Study|Lost to Follow-up|0|||
129880985|NCT01225822|467523311|FG000|Overall Study|Withdrawal by Subject|6|||
129880986|NCT01225822|467523312|FG001|Overall Study|Withdrawal by Subject|7|||
129880987|NCT01225822|467523313|FG002|Overall Study|Withdrawal by Subject|7|||
129880988|NCT01225822|467523314|FG003|Overall Study|Withdrawal by Subject|11|||
129880989|NCT01225822|467523315|FG004|Overall Study|Withdrawal by Subject|6|||
129880990|NCT01225822|467523311|FG000|Overall Study|Other|13|||
129880991|NCT01225822|467523312|FG001|Overall Study|Other|10|||
129880992|NCT01225822|467523313|FG002|Overall Study|Other|7|||
129880993|NCT01225822|467523314|FG003|Overall Study|Other|10|||
129880994|NCT01225822|467523315|FG004|Overall Study|Other|7|||
129880995|NCT01290822|467523316|FG000|Overall Study|Withdrawal by Subject|1|||
129880996|NCT01290822|467523316|FG000|Overall Study|Physician Decision|10|||
129880997|NCT05644353|467523320|FG000|Overall Study|Physician Decision|1|||
129880998|NCT05644353|467523321|FG001|Overall Study|Physician Decision|0|||
129880999|NCT05644353|467523322|FG002|Overall Study|Physician Decision|0|||
129881000|NCT05644353|467523323|FG003|Overall Study|Physician Decision|0|||
129881001|NCT05644353|467523324|FG004|Overall Study|Physician Decision|0|||
129881002|NCT05644353|467523325|FG005|Overall Study|Physician Decision|0|||
129881003|NCT05644353|467523320|FG000|Overall Study|Protocol Violation|1|||
129881004|NCT05644353|467523321|FG001|Overall Study|Protocol Violation|0|||
129881005|NCT05644353|467523322|FG002|Overall Study|Protocol Violation|0|||
129881006|NCT05644353|467523323|FG003|Overall Study|Protocol Violation|0|||
129881007|NCT05644353|467523324|FG004|Overall Study|Protocol Violation|0|||
129881008|NCT05644353|467523325|FG005|Overall Study|Protocol Violation|0|||
129881009|NCT05644353|467523320|FG000|Overall Study|Withdrawal by Subject|0|||
130322597|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322598|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
130322599|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
130322600|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322601|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322602|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
130322603|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322604|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322605|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322606|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
130322607|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322608|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322609|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
130322610|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322611|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322612|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
130322613|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
130322614|NCT00129402|469151328|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322615|NCT00129402|469151329|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322616|NCT00129402|469151330|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
130322617|NCT00129402|469151331|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322618|NCT00129402|469151332|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322619|NCT00129402|469151333|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
130322620|NCT00129402|469151334|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
130322621|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322622|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322623|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322624|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322625|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322626|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
130322627|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
130322628|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322629|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322630|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322631|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322632|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322633|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
130322634|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
130322635|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129881010|NCT05644353|467523321|FG001|Overall Study|Withdrawal by Subject|2|||
130214032|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214033|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214034|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
130214035|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214036|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214037|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
130214038|NCT00528372|468746957|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
130214039|NCT00528372|468746958|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214040|NCT00528372|468746959|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214041|NCT00528372|468746960|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
130214042|NCT00528372|468746961|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214043|NCT00528372|468746962|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214044|NCT00528372|468746963|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214045|NCT00528372|468746964|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
130214046|NCT00528372|468746965|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
130214047|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
130214048|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
130214049|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
130214050|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129881011|NCT05644353|467523322|FG002|Overall Study|Withdrawal by Subject|0|||
130214051|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130322636|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322637|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322638|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322639|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322640|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
130322641|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
130322642|NCT00129402|469151328|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322643|NCT00129402|469151329|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322644|NCT00129402|469151330|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322645|NCT00129402|469151331|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322646|NCT00129402|469151332|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322647|NCT00129402|469151333|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
130322648|NCT00129402|469151334|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
130322649|NCT00456846|469151335|FG000|Overall Study|Adverse Event|2|||
130322650|NCT00456846|469151336|FG001|Overall Study|Adverse Event|15|||
130322651|NCT00456846|469151335|FG000|Overall Study|Physician Decision|11|||
130322652|NCT00456846|469151336|FG001|Overall Study|Physician Decision|6|||
130322653|NCT00456846|469151335|FG000|Overall Study|Protocol Deviation|2|||
130322654|NCT00456846|469151336|FG001|Overall Study|Protocol Deviation|0|||
130322655|NCT00456846|469151335|FG000|Overall Study|Participant Discretion|1|||
130322656|NCT00456846|469151336|FG001|Overall Study|Participant Discretion|5|||
130322657|NCT00456846|469151335|FG000|Overall Study|Other|0|||
130322658|NCT00456846|469151336|FG001|Overall Study|Other|2|||
130322659|NCT03044106|469151337|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
130322660|NCT03044106|469151338|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
130322661|NCT01748292|469151339|FG000|Overall Study|Adverse Event|2|||
130322662|NCT01748292|469151340|FG001|Overall Study|Adverse Event|4|||
130322663|NCT01748292|469151339|FG000|Overall Study|Lost to Follow-up|0|||
130322664|NCT01748292|469151340|FG001|Overall Study|Lost to Follow-up|3|||
130322665|NCT01748292|469151339|FG000|Overall Study|Death|0|||
130322666|NCT01748292|469151340|FG001|Overall Study|Death|3|||
130322667|NCT01748292|469151339|FG000|Overall Study|Withdrawal by Subject|0|||
130322668|NCT01748292|469151340|FG001|Overall Study|Withdrawal by Subject|2|||
130322669|NCT03379818|469151341|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
130322670|NCT03379818|469151342|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
130322671|NCT03379818|469151341|FG000|Overall Study|Withdrawal by Subject|2|||
130322672|NCT03379818|469151342|FG001|Overall Study|Withdrawal by Subject|3|||
130322673|NCT03379818|469151341|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
130322674|NCT03379818|469151342|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
130322675|NCT03199976|469151344|FG000|Overall Study|Lack of Efficacy|3|||
130322676|NCT03199976|469151345|FG001|Overall Study|Lack of Efficacy|6|||
130322677|NCT03199976|469151346|FG002|Overall Study|Lack of Efficacy|13|||
130322678|NCT03199976|469151344|FG000|Overall Study|Withdrawal by Subject|1|||
130322679|NCT03199976|469151345|FG001|Overall Study|Withdrawal by Subject|0|||
130322680|NCT03199976|469151346|FG002|Overall Study|Withdrawal by Subject|0|||
130322681|NCT03199976|469151344|FG000|Overall Study|Lost to Follow-up|0|||
130322682|NCT03199976|469151345|FG001|Overall Study|Lost to Follow-up|1|||
130322683|NCT03199976|469151346|FG002|Overall Study|Lost to Follow-up|1|||
130322684|NCT04030143|469151354|FG000|Overall Study|Adverse Event|5|||
130322685|NCT04030143|469151355|FG001|Overall Study|Adverse Event|10|||
130322686|NCT04030143|469151354|FG000|Overall Study|Lost to Follow-up|3|||
130322687|NCT04030143|469151355|FG001|Overall Study|Lost to Follow-up|7|||
130322688|NCT04030143|469151354|FG000|Overall Study|Protocol Deviation|2|||
130322689|NCT04030143|469151355|FG001|Overall Study|Protocol Deviation|2|||
130322690|NCT04030143|469151354|FG000|Overall Study|Withdrawal by Subject|16|||
130322691|NCT04030143|469151355|FG001|Overall Study|Withdrawal by Subject|18|||
130322692|NCT04030143|469151354|FG000|Overall Study|Physician Decision|1|||
130322693|NCT04030143|469151355|FG001|Overall Study|Physician Decision|1|||
130322694|NCT04030143|469151354|FG000|Overall Study|Due to Covid-19|2|||
130322695|NCT04030143|469151355|FG001|Overall Study|Due to Covid-19|3|||
130322696|NCT04030143|469151354|FG000|Overall Study|Not Due to Covid-19|1|||
130322697|NCT04030143|469151355|FG001|Overall Study|Not Due to Covid-19|1|||
130322698|NCT00412984|469151357|FG000|Overall Study|Death|331|||
130322699|NCT00412984|469151358|FG001|Overall Study|Death|349|||
130322700|NCT00412984|469151357|FG000|Overall Study|Adverse Event|679|||
130322701|NCT00412984|469151358|FG001|Overall Study|Adverse Event|738|||
130322702|NCT00412984|469151357|FG000|Overall Study|Withdrawal by Subject|921|||
130322703|NCT00412984|469151358|FG001|Overall Study|Withdrawal by Subject|989|||
130322704|NCT00412984|469151357|FG000|Overall Study|Lost to Follow-up|51|||
130322705|NCT00412984|469151358|FG001|Overall Study|Lost to Follow-up|39|||
130322706|NCT00412984|469151357|FG000|Overall Study|Poor/Noncompliance|57|||
130322707|NCT00412984|469151358|FG001|Overall Study|Poor/Noncompliance|77|||
130322708|NCT00412984|469151357|FG000|Overall Study|Pregnancy|1|||
130322709|NCT00412984|469151358|FG001|Overall Study|Pregnancy|0|||
130322710|NCT00412984|469151357|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
130322711|NCT00412984|469151358|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
130322712|NCT00412984|469151357|FG000|Overall Study|Administrative Reason by Sponsor|11|||
130322713|NCT00412984|469151358|FG001|Overall Study|Administrative Reason by Sponsor|8|||
130322714|NCT00412984|469151357|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
130322715|NCT00412984|469151358|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
130322716|NCT00412984|469151357|FG000|Overall Study|Other Reason|80|||
130322717|NCT00412984|469151358|FG001|Overall Study|Other Reason|92|||
130322718|NCT00412984|469151357|FG000|Overall Study|Not Reported|11|||
130322719|NCT00412984|469151358|FG001|Overall Study|Not Reported|12|||
130322720|NCT02383576|469151359|FG000|Overall Study|Death|53|||
130322721|NCT02383576|469151360|FG001|Overall Study|Death|33|||
130322722|NCT02383576|469151359|FG000|Overall Study|Lost to Follow-up|7|||
130322723|NCT02383576|469151360|FG001|Overall Study|Lost to Follow-up|1|||
130322724|NCT02383576|469151359|FG000|Overall Study|Withdrew Consent|1|||
130322725|NCT02383576|469151360|FG001|Overall Study|Withdrew Consent|6|||
130322726|NCT02383576|469151359|FG000|Overall Study|Investigator's Decision|0|||
130322727|NCT02383576|469151360|FG001|Overall Study|Investigator's Decision|1|||
130322728|NCT02383576|469151359|FG000|Overall Study|Administrative/Other|2|||
130322729|NCT02383576|469151360|FG001|Overall Study|Administrative/Other|4|||
130322730|NCT04218240|469151361|FG000|Overall Study|Withdrawal by Subject|6|||
130322731|NCT04218240|469151362|FG001|Overall Study|Withdrawal by Subject|0|||
130322732|NCT04218240|469151361|FG000|Overall Study|Lack of Efficacy|24|||
130322733|NCT04218240|469151362|FG001|Overall Study|Lack of Efficacy|19|||
130322734|NCT04218240|469151361|FG000|Overall Study|Physician Decision|0|||
130322735|NCT04218240|469151362|FG001|Overall Study|Physician Decision|1|||
130322736|NCT04218240|469151361|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
130322737|NCT04218240|469151362|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
130322738|NCT04914364|469151363|FG000|Overall Study|No longer eligible for study|1|||
130322739|NCT04914364|469151363|FG000|Overall Study|Lost to Follow-up|2|||
130322740|NCT04097678|469151364|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
130322741|NCT04097678|469151365|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
130322742|NCT03694678|469151366|FG000|Overall Study|Withdrawal by Subject|2|||
130322743|NCT03694678|469151367|FG001|Overall Study|Withdrawal by Subject|0|||
130322744|NCT03694678|469151366|FG000|Overall Study|Lost to Follow-up|2|||
130322745|NCT03694678|469151367|FG001|Overall Study|Lost to Follow-up|3|||
130322746|NCT02435212|469151368|FG000|Core Phase|Adverse Event|8|||
130322747|NCT02435212|469151369|FG001|Core Phase|Adverse Event|5|||
130322748|NCT02435212|469151368|FG000|Core Phase|Withdrawal by Subject|3|||
130322749|NCT02435212|469151369|FG001|Core Phase|Withdrawal by Subject|0|||
130322750|NCT02435212|469151368|FG000|Core Phase|Withdrawal by parent/guardian|9|||
130322751|NCT02435212|469151369|FG001|Core Phase|Withdrawal by parent/guardian|4|||
130322752|NCT02435212|469151368|FG000|Core Phase|Protocol Violation|1|||
130322753|NCT02435212|469151369|FG001|Core Phase|Protocol Violation|2|||
130322754|NCT02435212|469151368|FG000|Core Phase|Physician Decision|3|||
130322755|NCT02435212|469151369|FG001|Core Phase|Physician Decision|0|||
130322756|NCT02435212|469151368|FG000|Core Phase|Lost to Follow-up|0|||
130322757|NCT02435212|469151369|FG001|Core Phase|Lost to Follow-up|1|||
130322758|NCT02435212|469151368|FG000|Core Phase|Lack of Efficacy|0|||
130322759|NCT02435212|469151369|FG001|Core Phase|Lack of Efficacy|1|||
129881012|NCT05644353|467523323|FG003|Overall Study|Withdrawal by Subject|0|||
129881013|NCT05644353|467523324|FG004|Overall Study|Withdrawal by Subject|1|||
129881014|NCT05644353|467523325|FG005|Overall Study|Withdrawal by Subject|0|||
129881015|NCT05644353|467523320|FG000|Overall Study|Lost to Follow-up|0|||
129881016|NCT05644353|467523321|FG001|Overall Study|Lost to Follow-up|0|||
129881017|NCT05644353|467523322|FG002|Overall Study|Lost to Follow-up|1|||
129881018|NCT05644353|467523323|FG003|Overall Study|Lost to Follow-up|0|||
129881019|NCT05644353|467523324|FG004|Overall Study|Lost to Follow-up|0|||
129881020|NCT05644353|467523325|FG005|Overall Study|Lost to Follow-up|0|||
129881021|NCT03679767|467523326|FG000|Overall Study|Death|16|||
129881022|NCT03679767|467523327|FG001|Overall Study|Death|11|||
129881023|NCT03679767|467523328|FG002|Overall Study|Death|17|||
129881024|NCT03679767|467523329|FG003|Overall Study|Death|10|||
129881025|NCT03679767|467523326|FG000|Overall Study|Lost to Follow-up|1|||
129881026|NCT03679767|467523327|FG001|Overall Study|Lost to Follow-up|1|||
129881027|NCT03679767|467523328|FG002|Overall Study|Lost to Follow-up|1|||
129881028|NCT03679767|467523329|FG003|Overall Study|Lost to Follow-up|1|||
129881029|NCT03679767|467523326|FG000|Overall Study|Withdrawal by Subject|0|||
129881030|NCT03679767|467523327|FG001|Overall Study|Withdrawal by Subject|0|||
129881031|NCT03679767|467523328|FG002|Overall Study|Withdrawal by Subject|0|||
129881032|NCT03679767|467523329|FG003|Overall Study|Withdrawal by Subject|1|||
129881033|NCT03679767|467523326|FG000|Overall Study|Follow-up Completed|18|||
130322760|NCT02435212|469151368|FG000|Core Phase|Recovery|1|||
130322761|NCT02435212|469151369|FG001|Core Phase|Recovery|0|||
130322762|NCT02435212|469151368|FG000|Optional Extension Phase|Adverse Event|3|||
130322763|NCT02435212|469151369|FG001|Optional Extension Phase|Adverse Event|9|||
129881034|NCT03679767|467523327|FG001|Overall Study|Follow-up Completed|11|||
129881035|NCT03679767|467523328|FG002|Overall Study|Follow-up Completed|11|||
129881036|NCT03679767|467523329|FG003|Overall Study|Follow-up Completed|20|||
130322764|NCT02435212|469151368|FG000|Optional Extension Phase|Physician Decision|6|||
130322765|NCT02435212|469151369|FG001|Optional Extension Phase|Physician Decision|8|||
130322766|NCT02435212|469151368|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
130322767|NCT02435212|469151369|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
130322768|NCT02435212|469151368|FG000|Optional Extension Phase|Lack of Efficacy|2|||
130322769|NCT02435212|469151369|FG001|Optional Extension Phase|Lack of Efficacy|3|||
130322770|NCT02435212|469151368|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
130322771|NCT02435212|469151369|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
130322772|NCT02435212|469151368|FG000|Optional Extension Phase|Protocol Violation|0|||
130322773|NCT02435212|469151369|FG001|Optional Extension Phase|Protocol Violation|1|||
130322774|NCT02435212|469151368|FG000|Optional Extension Phase|Recovery|1|||
130322775|NCT02435212|469151369|FG001|Optional Extension Phase|Recovery|1|||
130322776|NCT02435212|469151368|FG000|Optional Extension Phase|Death|1|||
130322777|NCT02435212|469151369|FG001|Optional Extension Phase|Death|0|||
130322778|NCT02435212|469151368|FG000|Optional Extension Phase|Technical problems|2|||
130322779|NCT02435212|469151369|FG001|Optional Extension Phase|Technical problems|0|||
130322780|NCT05966142|469151379|FG000|Overall Study|Death|3|||
130322781|NCT05966142|469151380|FG001|Overall Study|Death|3|||
130322782|NCT05966142|469151379|FG000|Overall Study|Lost to Follow-up|55|||
130322783|NCT05966142|469151380|FG001|Overall Study|Lost to Follow-up|52|||
130322784|NCT05966142|469151379|FG000|Overall Study|Physician Decision|1|||
130322785|NCT05966142|469151380|FG001|Overall Study|Physician Decision|0|||
130322786|NCT05966142|469151379|FG000|Overall Study|Withdrawal by Subject|9|||
130322787|NCT05966142|469151380|FG001|Overall Study|Withdrawal by Subject|8|||
130322788|NCT05966142|469151379|FG000|Overall Study|Duplicate Enrollment|1|||
130322789|NCT05966142|469151380|FG001|Overall Study|Duplicate Enrollment|0|||
130322790|NCT05966142|469151379|FG000|Overall Study|Study Logistical Reason|1|||
130322791|NCT05966142|469151380|FG001|Overall Study|Study Logistical Reason|0|||
130322792|NCT05966142|469151379|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
130322793|NCT05966142|469151380|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
130322794|NCT04852302|469151386|FG000|Overall Study|Withdrawal by Subject|2|||
130322795|NCT04852302|469151386|FG000|Overall Study|Did not complete CALM therapy.|2|||
130322796|NCT04711850|469151387|FG000|Overall Study|Graft loss|2|||
130322797|NCT04711850|469151388|FG001|Overall Study|Graft loss|1|||
130322798|NCT04711850|469151387|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
130322799|NCT04711850|469151388|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
130322800|NCT04711850|469151387|FG000|Overall Study|Study terminated by sponsor|5|||
130322801|NCT04711850|469151388|FG001|Overall Study|Study terminated by sponsor|3|||
129881037|NCT03679767|467523326|FG000|Overall Study|Entered Hospice Care|0|||
129881038|NCT03679767|467523327|FG001|Overall Study|Entered Hospice Care|0|||
129881039|NCT03679767|467523328|FG002|Overall Study|Entered Hospice Care|0|||
129881040|NCT03679767|467523329|FG003|Overall Study|Entered Hospice Care|1|||
129881041|NCT03679767|467523326|FG000|Overall Study|Progressive Disease|0|||
129881042|NCT03679767|467523327|FG001|Overall Study|Progressive Disease|0|||
129881043|NCT03679767|467523328|FG002|Overall Study|Progressive Disease|0|||
129881044|NCT03679767|467523329|FG003|Overall Study|Progressive Disease|1|||
129881045|NCT01407354|467523330|FG000|First Intervention|Withdrawal by Subject|0|||
129881046|NCT01407354|467523331|FG001|First Intervention|Withdrawal by Subject|2|||
129881047|NCT01407354|467523330|FG000|First Intervention|Adverse Event|1|||
129881048|NCT01407354|467523331|FG001|First Intervention|Adverse Event|0|||
129881049|NCT01407354|467523330|FG000|First Intervention|Physician Decision|1|||
129881050|NCT01407354|467523331|FG001|First Intervention|Physician Decision|0|||
129881051|NCT02204579|467523332|FG000|Overall Study|Screen failures|2|||
129881052|NCT03556358|467523335|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
129881053|NCT03556358|467523336|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
129881054|NCT03556358|467523335|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
129881055|NCT03556358|467523336|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
129881056|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
129881057|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
129881058|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
129881059|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
130322802|NCT04711850|469151387|FG000|Overall Study|Sponsor decision|0|||
130322803|NCT04711850|469151388|FG001|Overall Study|Sponsor decision|2|||
130322804|NCT03267277|469151389|FG000|Overall Study|Withdrawal by Subject|1|||
130322805|NCT04849364|469151390|FG000|Overall Study|Eligibility criteria not meet|0|||
130322806|NCT04849364|469151391|FG001|Overall Study|Eligibility criteria not meet|1|||
129881060|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
129881061|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
130322807|NCT04849364|469151392|FG002|Overall Study|Eligibility criteria not meet|0|||
130322808|NCT04531176|469151403|FG000|Overall Study|Study was stopped early|24|||
130322809|NCT04531176|469151404|FG001|Overall Study|Study was stopped early|26|||
130322810|NCT04531176|469151405|FG002|Overall Study|Study was stopped early|24|||
130322811|NCT00528112|469151406|FG000|Treatment up to 3 Years|Adverse Event|313|||
130322812|NCT00528112|469151407|FG001|Treatment up to 3 Years|Adverse Event|278|||
130322813|NCT00528112|469151406|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
130322814|NCT00528112|469151407|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
130322815|NCT00528112|469151406|FG000|Treatment up to 3 Years|Protocol Violation|16|||
130322816|NCT00528112|469151407|FG001|Treatment up to 3 Years|Protocol Violation|16|||
130322817|NCT00528112|469151406|FG000|Treatment up to 3 Years|Death|0|||
130322818|NCT00528112|469151407|FG001|Treatment up to 3 Years|Death|1|||
130322819|NCT00528112|469151406|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
130322820|NCT00528112|469151407|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
130322821|NCT00528112|469151406|FG000|Treatment up to 3 Years|Pregnancy|9|||
130322822|NCT00528112|469151407|FG001|Treatment up to 3 Years|Pregnancy|10|||
130322823|NCT00528112|469151406|FG000|Treatment up to 3 Years|Other reasons|186|||
130322824|NCT00528112|469151407|FG001|Treatment up to 3 Years|Other reasons|186|||
130322825|NCT00528112|469151406|FG000|Extension Phase|Withdrawal by Subject|0|||
130322826|NCT00528112|469151407|FG001|Extension Phase|Withdrawal by Subject|3|||
130322827|NCT00528112|469151406|FG000|Extension Phase|Other reasons|0|||
130322828|NCT00528112|469151407|FG001|Extension Phase|Other reasons|100|||
130322829|NCT00528112|469151406|FG000|Extension Phase|Pregnancy|0|||
130322830|NCT00528112|469151407|FG001|Extension Phase|Pregnancy|3|||
130322831|NCT00528112|469151406|FG000|Extension Phase|Lost to Follow-up|0|||
130322832|NCT00528112|469151407|FG001|Extension Phase|Lost to Follow-up|12|||
130322833|NCT00528112|469151406|FG000|Extension Phase|Death|0|||
130322834|NCT00528112|469151407|FG001|Extension Phase|Death|1|||
130322835|NCT00528112|469151406|FG000|Extension Phase|Adverse Event|0|||
130322836|NCT00528112|469151407|FG001|Extension Phase|Adverse Event|36|||
130322837|NCT00528112|469151406|FG000|Extension Phase|Protocol Violation|0|||
130322838|NCT00528112|469151407|FG001|Extension Phase|Protocol Violation|2|||
130322839|NCT00894803|469151408|FG000|Overall Study|Death|20|||
130322840|NCT00894803|469151409|FG001|Overall Study|Death|4|||
130322841|NCT00894803|469151408|FG000|Overall Study|Lost to Follow-up|0|||
130322842|NCT00894803|469151409|FG001|Overall Study|Lost to Follow-up|1|||
130322843|NCT01345240|469151411|FG000|Overall Study|Adverse Event|3|||
130322844|NCT01345240|469151412|FG001|Overall Study|Adverse Event|5|||
130322845|NCT01345240|469151413|FG002|Overall Study|Adverse Event|4|||
130322846|NCT01345240|469151414|FG003|Overall Study|Adverse Event|2|||
130322847|NCT01345240|469151415|FG004|Overall Study|Adverse Event|1|||
130322848|NCT01345240|469151411|FG000|Overall Study|Lost to Follow-up|8|||
130322849|NCT01345240|469151412|FG001|Overall Study|Lost to Follow-up|9|||
130322850|NCT01345240|469151413|FG002|Overall Study|Lost to Follow-up|14|||
130322851|NCT01345240|469151414|FG003|Overall Study|Lost to Follow-up|7|||
130322852|NCT01345240|469151415|FG004|Overall Study|Lost to Follow-up|9|||
130322853|NCT01502293|469151416|FG000|Overall Study|Progressive Disease|20|||
130322854|NCT01502293|469151417|FG001|Overall Study|Progressive Disease|12|||
130322855|NCT01502293|469151418|FG002|Overall Study|Progressive Disease|2|||
130322856|NCT01502293|469151416|FG000|Overall Study|Withdrawal by Subject|3|||
130322857|NCT01502293|469151417|FG001|Overall Study|Withdrawal by Subject|3|||
130322858|NCT01502293|469151418|FG002|Overall Study|Withdrawal by Subject|1|||
130322859|NCT01502293|469151416|FG000|Overall Study|Adverse Event|0|||
130322860|NCT01502293|469151417|FG001|Overall Study|Adverse Event|2|||
130322861|NCT01502293|469151418|FG002|Overall Study|Adverse Event|0|||
130322862|NCT01502293|469151416|FG000|Overall Study|Reason Not Specified|2|||
130322863|NCT01502293|469151417|FG001|Overall Study|Reason Not Specified|0|||
130322864|NCT01502293|469151418|FG002|Overall Study|Reason Not Specified|0|||
130322865|NCT01502293|469151416|FG000|Overall Study|Physician Decision|0|||
130322866|NCT01502293|469151417|FG001|Overall Study|Physician Decision|0|||
130322867|NCT01502293|469151418|FG002|Overall Study|Physician Decision|1|||
130322868|NCT00774046|469151421|FG000|Screening|Not eligible|56|||
130322869|NCT00774046|469151421|FG000|Enrollment|Desired other therapy/refused|28|||
130322870|NCT00774046|469151421|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
130322871|NCT02246530|469151423|FG000|Overall Study|Lost to Follow-up|4|||
130322872|NCT02246530|469151424|FG001|Overall Study|Lost to Follow-up|0|||
130322873|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
130322874|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322875|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322876|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322877|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322878|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322879|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322880|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322881|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322882|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322883|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322884|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322885|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322886|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322887|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322888|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
130322889|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322890|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
130322891|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322892|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322893|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322894|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322895|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322896|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322897|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
130322898|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322899|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322900|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322901|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322902|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322903|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322904|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
130322905|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322906|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
130322907|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322908|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322909|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
130322910|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322911|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322912|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322913|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322914|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322915|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322916|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322917|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322918|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322919|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322920|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
130322921|NCT05138653|469151425|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322922|NCT05138653|469151426|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322923|NCT05138653|469151427|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322924|NCT05138653|469151428|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322925|NCT05138653|469151429|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322926|NCT05138653|469151430|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322927|NCT05138653|469151431|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
130322928|NCT05138653|469151432|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322929|NCT05138653|469151433|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322930|NCT05138653|469151434|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322931|NCT05138653|469151435|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322932|NCT05138653|469151436|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322933|NCT05138653|469151437|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322934|NCT05138653|469151438|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322935|NCT05138653|469151439|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322936|NCT05138653|469151440|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
130322937|NCT05138653|469151425|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322938|NCT05138653|469151426|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322939|NCT05138653|469151427|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322940|NCT05138653|469151428|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322941|NCT05138653|469151429|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322942|NCT05138653|469151430|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322943|NCT05138653|469151431|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322944|NCT05138653|469151432|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322945|NCT05138653|469151433|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322946|NCT05138653|469151434|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322947|NCT05138653|469151435|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129881062|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
129881063|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
130098691|NCT01471197|468319277|FG000|Overall Study|Death|1|||
130322948|NCT05138653|469151436|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322949|NCT05138653|469151437|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130322950|NCT05138653|469151438|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322951|NCT05138653|469151439|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
130322952|NCT05138653|469151440|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
130322953|NCT05138653|469151425|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322954|NCT05138653|469151426|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322955|NCT05138653|469151427|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322956|NCT05138653|469151428|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322957|NCT05138653|469151429|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322958|NCT05138653|469151430|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322959|NCT05138653|469151431|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322960|NCT05138653|469151432|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322961|NCT05138653|469151433|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322962|NCT05138653|469151434|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322963|NCT05138653|469151435|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322964|NCT05138653|469151436|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322965|NCT05138653|469151437|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322966|NCT05138653|469151438|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322967|NCT05138653|469151439|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
130322968|NCT05138653|469151440|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
130322969|NCT05138653|469151425|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322970|NCT05138653|469151426|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322971|NCT05138653|469151427|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322972|NCT05138653|469151428|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322973|NCT05138653|469151429|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322974|NCT05138653|469151430|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322975|NCT05138653|469151431|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322976|NCT05138653|469151432|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322977|NCT05138653|469151433|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322978|NCT05138653|469151434|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322979|NCT05138653|469151435|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322980|NCT05138653|469151436|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322981|NCT05138653|469151437|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322982|NCT05138653|469151438|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
130322983|NCT05138653|469151439|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322984|NCT05138653|469151440|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
130322985|NCT01824836|469151441|FG000|Overall Study|Adverse Event|48|||
130322986|NCT01824836|469151441|FG000|Overall Study|Withdrawal by Subject|63|||
130322987|NCT01824836|469151441|FG000|Overall Study|Other complicating disease|116|||
130322988|NCT01824836|469151441|FG000|Overall Study|Disease progression|5|||
130322989|NCT01824836|469151441|FG000|Overall Study|Alternative therapy|2|||
130322990|NCT01824836|469151441|FG000|Overall Study|Depression|1|||
130322991|NCT01824836|469151441|FG000|Overall Study|Non-compliance|3|||
130322992|NCT01824836|469151441|FG000|Overall Study|Patient regained ovarian function|3|||
130322993|NCT01824836|469151441|FG000|Overall Study|Lost to Follow-up|8|||
130322994|NCT01824836|469151441|FG000|Overall Study|Physician Decision|2|||
130322995|NCT01824836|469151441|FG000|Overall Study|Research office was closed|3|||
130322996|NCT01824836|469151441|FG000|Overall Study|Relocation|3|||
130322997|NCT01824836|469151441|FG000|Overall Study|Insurance-related issue|1|||
130322998|NCT01824836|469151441|FG000|Overall Study|Transportation issue|1|||
130322999|NCT01824836|469151441|FG000|Overall Study|Patient transferred care|1|||
130323000|NCT01824836|469151441|FG000|Overall Study|Unknown reasons|4|||
130323001|NCT01824836|469151441|FG000|Overall Study|Never started treatment|16|||
130323002|NCT02608684|469153504|FG000|Overall Study|Physician Decision|2|||
130323003|NCT02608684|469153504|FG000|Overall Study|Withdrawal by Subject|1|||
130323004|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129881064|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
129881065|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
129881066|NCT01351025|467523337|FG000|Week 0 - 20|Lost to Follow-up|2|||
129881067|NCT01351025|467523338|FG001|Week 0 - 20|Lost to Follow-up|1|||
129881068|NCT01351025|467523337|FG000|Week 0 - 20|Withdrawal by Subject|1|||
129881069|NCT01351025|467523338|FG001|Week 0 - 20|Withdrawal by Subject|0|||
129881070|NCT01351025|467523337|FG000|Week 24 - 44|Lost to Follow-up|0|||
129881071|NCT01351025|467523338|FG001|Week 24 - 44|Lost to Follow-up|2|||
129881072|NCT01351025|467523337|FG000|Week 24 - 44|Site closed|0|||
129881073|NCT01351025|467523338|FG001|Week 24 - 44|Site closed|1|||
129881074|NCT01351025|467523337|FG000|Week 24 - 44|unable to get to clinic|1|||
129881075|NCT01351025|467523338|FG001|Week 24 - 44|unable to get to clinic|1|||
129881076|NCT01861522|467523343|FG000|Overall Study|Adverse Event|1|||
129881077|NCT01861522|467523344|FG001|Overall Study|Adverse Event|0|||
129881078|NCT01861522|467523343|FG000|Overall Study|Withdrawal by Subject|2|||
129881079|NCT01861522|467523344|FG001|Overall Study|Withdrawal by Subject|0|||
129881080|NCT00550550|467523345|FG000|Overall Study|Adverse Event|13|||
129881081|NCT00550550|467523346|FG001|Overall Study|Adverse Event|5|||
129881082|NCT00550550|467523345|FG000|Overall Study|Treatment Failure|0|||
129881083|NCT00550550|467523346|FG001|Overall Study|Treatment Failure|1|||
129881084|NCT00550550|467523345|FG000|Overall Study|Lost to Follow-up|4|||
129881085|NCT00550550|467523346|FG001|Overall Study|Lost to Follow-up|0|||
129881086|NCT00550550|467523345|FG000|Overall Study|Withdrawal by Subject|10|||
129881087|NCT00550550|467523346|FG001|Overall Study|Withdrawal by Subject|8|||
129881088|NCT00550550|467523345|FG000|Overall Study|Protocol Violation|5|||
129881089|NCT00550550|467523346|FG001|Overall Study|Protocol Violation|14|||
129881090|NCT00550550|467523345|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
129881091|NCT00550550|467523346|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
129881092|NCT00550550|467523345|FG000|Overall Study|Randomized But Not Treated|1|||
129881093|NCT00550550|467523346|FG001|Overall Study|Randomized But Not Treated|0|||
129881094|NCT00381641|467523349|FG000|Overall Study|Withdrawal by Subject|0|||
129881095|NCT00381641|467523350|FG001|Overall Study|Withdrawal by Subject|2|||
129881096|NCT01598298|467523351|FG000|Overall Study|Not eligible|5|||
129881097|NCT01598298|467523352|FG001|Overall Study|Not eligible|5|||
129881098|NCT01598298|467523351|FG000|Overall Study|Adverse Event|21|||
129881099|NCT01598298|467523352|FG001|Overall Study|Adverse Event|19|||
129881100|NCT01598298|467523351|FG000|Overall Study|Progression/relapse|0|||
129881101|NCT01598298|467523352|FG001|Overall Study|Progression/relapse|2|||
129881102|NCT01598298|467523351|FG000|Overall Study|Withdrawal by Subject|10|||
129881103|NCT01598298|467523352|FG001|Overall Study|Withdrawal by Subject|15|||
129881104|NCT01598298|467523351|FG000|Overall Study|Other reason (not protocol specified)|4|||
129881105|NCT01598298|467523352|FG001|Overall Study|Other reason (not protocol specified)|0|||
129881106|NCT03813147|467523353|FG000|Overall Study|Lack of Efficacy|4|||
129881107|NCT03813147|467523354|FG001|Overall Study|Lack of Efficacy|4|||
129881108|NCT03813147|467523353|FG000|Overall Study|Physician Decision|2|||
129881109|NCT03813147|467523354|FG001|Overall Study|Physician Decision|1|||
129881110|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
129881111|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
129881112|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
129881113|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
129881114|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
129881115|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
129881116|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Death|0|||
129881117|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Death|1|||
130214052|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
130214053|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
129881118|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Adverse Event|11|||
129881119|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Adverse Event|11|||
129881120|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
129881121|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
129881122|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129881123|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129881124|NCT02936037|467524790|FG000|Open Label Extension|Adverse Event|0|||
129881125|NCT02936037|467524791|FG001|Open Label Extension|Adverse Event|3|||
129881126|NCT02936037|467524790|FG000|Open Label Extension|Other|0|||
129881127|NCT02936037|467524791|FG001|Open Label Extension|Other|3|||
129881128|NCT02936037|467524790|FG000|Open Label Extension|Withdrawal by Subject|0|||
129881129|NCT02936037|467524791|FG001|Open Label Extension|Withdrawal by Subject|4|||
129881130|NCT04666922|467524792|FG000|Overall Study|Withdrawal by Subject|1|||
129881131|NCT04666922|467524793|FG001|Overall Study|Withdrawal by Subject|0|||
129881132|NCT04666922|467524794|FG002|Overall Study|Withdrawal by Subject|0|||
129881133|NCT04666922|467524795|FG003|Overall Study|Withdrawal by Subject|0|||
129881134|NCT04666922|467524796|FG004|Overall Study|Withdrawal by Subject|0|||
129881135|NCT04666922|467524797|FG005|Overall Study|Withdrawal by Subject|0|||
129881136|NCT04666922|467524798|FG006|Overall Study|Withdrawal by Subject|0|||
129881137|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
129881138|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881139|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881140|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881141|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881142|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
129881143|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881144|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881145|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881146|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881147|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
129881148|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881149|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881150|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881151|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881152|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
129881153|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881154|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881155|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881156|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881157|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
129881158|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881159|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881160|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881161|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881162|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
129881163|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881164|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881165|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881166|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881167|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
129881168|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881169|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881170|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881171|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881172|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
129881173|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881174|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881175|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881176|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881177|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
129881178|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881179|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881180|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881181|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881182|NCT03722264|467524804|FG000|Overall Study|Physician Decision|3|||
129881183|NCT02959671|467524805|FG000|Overall Study|Adverse Event|2|||
129881184|NCT02959671|467524805|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
129881185|NCT03462706|467524806|FG000|Overall Study|Polyp was pedunculated|1|||
129881186|NCT03462706|467524807|FG001|Overall Study|Polyp was pedunculated|0|||
129881187|NCT03462706|467524808|FG002|Overall Study|Polyp was pedunculated|1|||
129881188|NCT03462706|467524809|FG003|Overall Study|Polyp was pedunculated|0|||
129881189|NCT03462706|467524806|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
129881190|NCT03462706|467524807|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
129881191|NCT03462706|467524808|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
129881192|NCT03462706|467524809|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
129881193|NCT04651114|467524816|FG000|Overall Study|Withdrawal by Subject|8|||
129881194|NCT01923896|467524821|FG000|Overall Study|Adverse Event|1|||
129881195|NCT01923896|467524822|FG001|Overall Study|Adverse Event|0|||
129881196|NCT00474929|467524827|FG000|Overall Study|Withdrawal by Subject|0|||
129881197|NCT00474929|467524828|FG001|Overall Study|Withdrawal by Subject|1|||
129881198|NCT00474929|467524829|FG002|Overall Study|Withdrawal by Subject|0|||
129881199|NCT00474929|467524830|FG003|Overall Study|Withdrawal by Subject|0|||
129881200|NCT00474929|467524831|FG004|Overall Study|Withdrawal by Subject|0|||
129881201|NCT00474929|467524827|FG000|Overall Study|Unrelated medical condition|0|||
129881202|NCT00474929|467524828|FG001|Overall Study|Unrelated medical condition|0|||
129881203|NCT00474929|467524829|FG002|Overall Study|Unrelated medical condition|1|||
129881204|NCT00474929|467524830|FG003|Overall Study|Unrelated medical condition|0|||
130323005|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
130323006|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130323007|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
130323008|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
130323009|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
130323010|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
129881205|NCT00474929|467524831|FG004|Overall Study|Unrelated medical condition|0|||
129881206|NCT00474929|467524827|FG000|Overall Study|Physician Decision|0|||
129881207|NCT00474929|467524828|FG001|Overall Study|Physician Decision|0|||
129881208|NCT00474929|467524829|FG002|Overall Study|Physician Decision|1|||
129881209|NCT00474929|467524830|FG003|Overall Study|Physician Decision|2|||
129881210|NCT00474929|467524831|FG004|Overall Study|Physician Decision|0|||
129881211|NCT03661996|467524834|FG000|Overall Study|Adverse Event|0|||
129881212|NCT03661996|467524835|FG001|Overall Study|Adverse Event|0|||
129881213|NCT03661996|467524836|FG002|Overall Study|Adverse Event|1|||
129881214|NCT03661996|467524837|FG003|Overall Study|Adverse Event|1|||
129881215|NCT03661996|467524838|FG004|Overall Study|Adverse Event|0|||
129881216|NCT03661996|467524834|FG000|Overall Study|Lost to Follow-up|5|||
129881217|NCT03661996|467524835|FG001|Overall Study|Lost to Follow-up|1|||
129881218|NCT03661996|467524836|FG002|Overall Study|Lost to Follow-up|2|||
129881219|NCT03661996|467524837|FG003|Overall Study|Lost to Follow-up|2|||
129881220|NCT03661996|467524838|FG004|Overall Study|Lost to Follow-up|6|||
129881221|NCT03661996|467524834|FG000|Overall Study|Physician Decision|1|||
129881222|NCT03661996|467524835|FG001|Overall Study|Physician Decision|1|||
129881223|NCT03661996|467524836|FG002|Overall Study|Physician Decision|1|||
129881224|NCT03661996|467524837|FG003|Overall Study|Physician Decision|2|||
129881225|NCT03661996|467524838|FG004|Overall Study|Physician Decision|0|||
129881226|NCT03661996|467524834|FG000|Overall Study|Protocol Violation|0|||
129881227|NCT03661996|467524835|FG001|Overall Study|Protocol Violation|0|||
129881228|NCT03661996|467524836|FG002|Overall Study|Protocol Violation|0|||
129881229|NCT03661996|467524837|FG003|Overall Study|Protocol Violation|0|||
129881230|NCT03661996|467524838|FG004|Overall Study|Protocol Violation|1|||
129881231|NCT03661996|467524834|FG000|Overall Study|Withdrawal by Subject|3|||
129881232|NCT03661996|467524835|FG001|Overall Study|Withdrawal by Subject|5|||
129881233|NCT03661996|467524836|FG002|Overall Study|Withdrawal by Subject|1|||
129881234|NCT03661996|467524837|FG003|Overall Study|Withdrawal by Subject|7|||
129881235|NCT03661996|467524838|FG004|Overall Study|Withdrawal by Subject|7|||
129881236|NCT03661996|467524834|FG000|Overall Study|Sponsors Decision|2|||
129881237|NCT03661996|467524835|FG001|Overall Study|Sponsors Decision|0|||
129881238|NCT03661996|467524836|FG002|Overall Study|Sponsors Decision|0|||
129881239|NCT03661996|467524837|FG003|Overall Study|Sponsors Decision|0|||
129881240|NCT03661996|467524838|FG004|Overall Study|Sponsors Decision|0|||
129881241|NCT03661996|467524834|FG000|Overall Study|Other|1|||
129881242|NCT03661996|467524835|FG001|Overall Study|Other|1|||
129881243|NCT03661996|467524836|FG002|Overall Study|Other|1|||
129881244|NCT03661996|467524837|FG003|Overall Study|Other|1|||
129881245|NCT03661996|467524838|FG004|Overall Study|Other|0|||
129881246|NCT00068380|467524839|FG000|Overall Study|Withdrawal by Subject|3|||
129881247|NCT00068380|467524839|FG000|Overall Study|Adverse Event|2|||
129881248|NCT01190215|467524840|FG000|Up to Month 6|Lost to Follow-up|2|||
129881249|NCT01190215|467524841|FG001|Up to Month 6|Lost to Follow-up|0|||
129881250|NCT00067990|467524858|FG000|Overall Study|Death|5|||
129881251|NCT00067990|467524859|FG001|Overall Study|Death|7|||
129881252|NCT00067990|467524858|FG000|Overall Study|ESRD, Non IF/TA|1|||
129881253|NCT00067990|467524859|FG001|Overall Study|ESRD, Non IF/TA|3|||
129881254|NCT00067990|467524858|FG000|Overall Study|Withdrawal by Subject|4|||
129881255|NCT00067990|467524859|FG001|Overall Study|Withdrawal by Subject|12|||
129881256|NCT01973491|467524860|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
129881257|NCT01973491|467524860|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
129881258|NCT01973491|467524860|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
129881259|NCT00422799|467524861|FG000|Overall Study|Withdrawal by Subject|6|||
129881260|NCT00422799|467524861|FG000|Overall Study|Adverse Event|7|||
129881261|NCT01965158|467524862|FG000|Overall Study|Adverse Event|14|||
129881262|NCT01965158|467524863|FG001|Overall Study|Adverse Event|5|||
129881263|NCT01965158|467524862|FG000|Overall Study|Withdrawal by Subject|16|||
129881264|NCT01965158|467524863|FG001|Overall Study|Withdrawal by Subject|24|||
129881265|NCT01965158|467524862|FG000|Overall Study|Lost to Follow-up|7|||
129881266|NCT01965158|467524863|FG001|Overall Study|Lost to Follow-up|5|||
129881267|NCT01965158|467524862|FG000|Overall Study|Protocol Violation|1|||
129881268|NCT01965158|467524863|FG001|Overall Study|Protocol Violation|1|||
129881269|NCT01965158|467524862|FG000|Overall Study|Other - Miscellaneous|3|||
129881270|NCT01965158|467524863|FG001|Overall Study|Other - Miscellaneous|0|||
129881271|NCT01619787|467524864|FG000|Overall Study|Lost to Follow-up|5|||
129881272|NCT03321006|467524867|FG000|Overall Study|Death|1|||
129881273|NCT03321006|467524868|FG001|Overall Study|Death|0|||
129881274|NCT03321006|467524867|FG000|Overall Study|Lack of Efficacy|1|||
129881275|NCT03321006|467524868|FG001|Overall Study|Lack of Efficacy|0|||
129881276|NCT03560258|467524869|FG000|Overall Study|Lost to Follow-up|3|||
129881277|NCT03560258|467524870|FG001|Overall Study|Lost to Follow-up|0|||
129881278|NCT03560258|467524871|FG002|Overall Study|Lost to Follow-up|0|||
129881279|NCT03560258|467524869|FG000|Overall Study|Protocol Violation|0|||
129881280|NCT03560258|467524870|FG001|Overall Study|Protocol Violation|1|||
129881281|NCT03560258|467524871|FG002|Overall Study|Protocol Violation|0|||
129881282|NCT03560258|467524869|FG000|Overall Study|Withdrawal by Subject|0|||
129881283|NCT03560258|467524870|FG001|Overall Study|Withdrawal by Subject|0|||
129881284|NCT03560258|467524871|FG002|Overall Study|Withdrawal by Subject|1|||
129881285|NCT02006121|467524872|FG000|Double Blind Phase|Adverse Event|6|||
129881286|NCT02006121|467524873|FG001|Double Blind Phase|Adverse Event|0|||
129881287|NCT02006121|467524872|FG000|Double Blind Phase|Lack of Efficacy|1|||
129881288|NCT02006121|467524873|FG001|Double Blind Phase|Lack of Efficacy|16|||
129881289|NCT02006121|467524872|FG000|Double Blind Phase|Withdrawal by Subject|3|||
129881290|NCT02006121|467524873|FG001|Double Blind Phase|Withdrawal by Subject|4|||
129881291|NCT02006121|467524872|FG000|Double Blind Phase|Non-compliance with study drug|1|||
129881292|NCT02006121|467524873|FG001|Double Blind Phase|Non-compliance with study drug|3|||
129881293|NCT02006121|467524872|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
129881294|NCT02006121|467524873|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
129881295|NCT02006121|467524872|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
129881296|NCT02006121|467524873|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
129881297|NCT02006121|467524872|FG000|Open Label Phase|Adverse Event|15|||
129881298|NCT02006121|467524873|FG001|Open Label Phase|Adverse Event|0|||
129881299|NCT02006121|467524872|FG000|Open Label Phase|Lack of Efficacy|2|||
129881300|NCT02006121|467524873|FG001|Open Label Phase|Lack of Efficacy|0|||
129881301|NCT02006121|467524872|FG000|Open Label Phase|Protocol Violation|2|||
129881302|NCT02006121|467524873|FG001|Open Label Phase|Protocol Violation|0|||
129881303|NCT02006121|467524872|FG000|Open Label Phase|Withdrawal by Subject|3|||
129881304|NCT02006121|467524873|FG001|Open Label Phase|Withdrawal by Subject|0|||
129881305|NCT02006121|467524872|FG000|Open Label Phase|Non-compliance with study drug|3|||
129881306|NCT02006121|467524873|FG001|Open Label Phase|Non-compliance with study drug|0|||
129881307|NCT00245856|467524889|FG000|Period Two|Withdrawal by Subject|0|||
129881308|NCT00245856|467524890|FG001|Period Two|Withdrawal by Subject|1|||
129881309|NCT01003184|467524891|FG000|Overall Study|Adverse Event|12|||
129881310|NCT01003184|467524892|FG001|Overall Study|Adverse Event|5|||
129881311|NCT01003184|467524891|FG000|Overall Study|Lost to Follow-up|1|||
129881312|NCT01003184|467524892|FG001|Overall Study|Lost to Follow-up|0|||
129881313|NCT01003184|467524891|FG000|Overall Study|Loss of glucose control|1|||
130323011|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
130323012|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130323013|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
129881314|NCT01003184|467524892|FG001|Overall Study|Loss of glucose control|1|||
129881315|NCT01003184|467524891|FG000|Overall Study|Protocol Violation|3|||
130323014|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
130323015|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129881316|NCT01003184|467524892|FG001|Overall Study|Protocol Violation|0|||
129881317|NCT01003184|467524891|FG000|Overall Study|Withdrawal by Subject|1|||
129881318|NCT01003184|467524892|FG001|Overall Study|Withdrawal by Subject|6|||
129881319|NCT01003184|467524891|FG000|Overall Study|Physician Decision|1|||
129881320|NCT01003184|467524892|FG001|Overall Study|Physician Decision|0|||
129881321|NCT02693834|467524894|FG000|Baseline Measurement|Withdrawal by Subject|1|||
129881322|NCT02693834|467524895|FG001|Baseline Measurement|Withdrawal by Subject|0|||
129881323|NCT02693834|467524894|FG000|Baseline Measurement|Adverse Event|1|||
129881324|NCT02693834|467524895|FG001|Baseline Measurement|Adverse Event|0|||
129881325|NCT02693834|467524894|FG000|Week 2 Practice|Adverse Event|0|||
129881326|NCT02693834|467524895|FG001|Week 2 Practice|Adverse Event|1|||
130323016|NCT01972217|469153505|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
130323017|NCT01972217|469153506|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
130323018|NCT01972217|469153507|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
130323019|NCT01972217|469153508|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
130323020|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Death|0|||
130323021|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Death|0|||
129881327|NCT04848662|467524896|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
129881328|NCT04848662|467524897|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
130098692|NCT01471197|468319278|FG001|Overall Study|Death|0|||
129881329|NCT01107743|467524906|FG000|Overall Study|Protocol Violation|46|||
129881330|NCT00308737|467524907|FG000|Overall Study|Adverse Event|104|||
129881331|NCT00308737|467524908|FG001|Overall Study|Adverse Event|9|||
129881332|NCT00308737|467524909|FG002|Overall Study|Adverse Event|0|||
129881333|NCT00308737|467524907|FG000|Overall Study|Death|4|||
129881334|NCT00308737|467524908|FG001|Overall Study|Death|3|||
129881335|NCT00308737|467524909|FG002|Overall Study|Death|0|||
129881336|NCT00308737|467524907|FG000|Overall Study|Lost to Follow-up|56|||
129881337|NCT00308737|467524908|FG001|Overall Study|Lost to Follow-up|80|||
130098693|NCT01471197|468319277|FG000|Overall Study|Study Drug Toxicity|1|||
129881338|NCT00308737|467524909|FG002|Overall Study|Lost to Follow-up|5|||
129881339|NCT00308737|467524907|FG000|Overall Study|Physician Decision|15|||
129881340|NCT00308737|467524908|FG001|Overall Study|Physician Decision|2|||
129881341|NCT00308737|467524909|FG002|Overall Study|Physician Decision|1|||
129881342|NCT00308737|467524907|FG000|Overall Study|Protocol Violation|34|||
129881343|NCT00308737|467524908|FG001|Overall Study|Protocol Violation|9|||
129881344|NCT00308737|467524909|FG002|Overall Study|Protocol Violation|5|||
129881345|NCT00308737|467524907|FG000|Overall Study|Withdrawal by Subject|218|||
129881346|NCT00308737|467524908|FG001|Overall Study|Withdrawal by Subject|166|||
129881347|NCT00308737|467524909|FG002|Overall Study|Withdrawal by Subject|18|||
129881348|NCT00308737|467524907|FG000|Overall Study|Various|32|||
129881349|NCT00308737|467524908|FG001|Overall Study|Various|20|||
129881350|NCT00308737|467524909|FG002|Overall Study|Various|8|||
129881351|NCT00089895|467524910|FG000|Overall Study|Consent Withdrawn|11|||
129881352|NCT00089895|467524911|FG001|Overall Study|Consent Withdrawn|14|||
129881353|NCT00089895|467524910|FG000|Overall Study|Technical reason|7|||
129881354|NCT00089895|467524911|FG001|Overall Study|Technical reason|2|||
129881355|NCT00089895|467524910|FG000|Overall Study|Surgery|0|||
129881356|NCT00089895|467524911|FG001|Overall Study|Surgery|1|||
129881357|NCT00089895|467524910|FG000|Overall Study|Bleeding|0|||
129881358|NCT00089895|467524911|FG001|Overall Study|Bleeding|2|||
129881359|NCT00089895|467524910|FG000|Overall Study|Physician Decision|3|||
129881360|NCT00089895|467524911|FG001|Overall Study|Physician Decision|7|||
129881361|NCT00089895|467524910|FG000|Overall Study|Exclusion criteria met|6|||
129881362|NCT00089895|467524911|FG001|Overall Study|Exclusion criteria met|6|||
129881363|NCT00089895|467524910|FG000|Overall Study|Not otherwise specified|4|||
129881364|NCT00089895|467524911|FG001|Overall Study|Not otherwise specified|8|||
129881365|NCT00089895|467524910|FG000|Overall Study|Missing|4|||
130214054|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
130214055|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
130214056|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
130214057|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
130214058|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
130214059|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130214060|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
130214061|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
130214062|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
130214063|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130214064|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
130214065|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
130214066|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
130214067|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
130214068|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
130214069|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
130214070|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
130214071|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
130214072|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
130214073|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
130214074|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
130214075|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
130214076|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130214077|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130214078|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
130214079|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
130214080|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
130214081|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
130214082|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
130214083|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214084|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214085|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214086|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214087|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129881366|NCT00089895|467524911|FG001|Overall Study|Missing|2|||
129881367|NCT01535274|467524912|FG000|Overall Study|Determined to be ineligible|0|||
129881368|NCT01535274|467524913|FG001|Overall Study|Determined to be ineligible|1|||
129881369|NCT01535274|467524912|FG000|Overall Study|Misallocated to propofol intervention|0|||
129881370|NCT01535274|467524913|FG001|Overall Study|Misallocated to propofol intervention|1|||
129881371|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
129881372|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
130098694|NCT01471197|468319278|FG001|Overall Study|Study Drug Toxicity|0|||
129881373|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
129881374|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
129881375|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
129881376|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
129881377|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
129881378|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
129881379|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
129881380|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
129881381|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
129881382|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
129881383|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881384|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881385|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881386|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881387|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
129881388|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881389|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
129881390|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881391|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881392|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881393|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881394|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
129881395|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881396|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881397|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881398|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
129881399|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
129881400|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881401|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
129881402|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
129881403|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
129881404|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
129881405|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
129881406|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
129881407|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
129881408|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
129881409|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
129881410|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
129881411|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
129881412|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
129881413|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881414|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
129881415|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881416|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881417|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881418|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881419|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
129881420|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
129881421|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
129881422|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
129881423|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
129881424|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
129881425|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
129881426|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881427|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
129881428|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881429|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881430|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881431|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
129881432|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
129881433|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
129881434|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
129881435|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
129881436|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
129881437|NCT00447954|467524927|FG000|Overall Study|Adverse Event|0|||
129881438|NCT00447954|467524928|FG001|Overall Study|Adverse Event|2|||
129881439|NCT00447954|467524929|FG002|Overall Study|Adverse Event|0|||
129881440|NCT00447954|467524927|FG000|Overall Study|Withdrawal by Subject|0|||
129881441|NCT00447954|467524928|FG001|Overall Study|Withdrawal by Subject|1|||
129881442|NCT00447954|467524929|FG002|Overall Study|Withdrawal by Subject|1|||
129881443|NCT00447954|467524927|FG000|Overall Study|Lost to Follow-up|0|||
129881444|NCT00447954|467524928|FG001|Overall Study|Lost to Follow-up|1|||
129881445|NCT00447954|467524929|FG002|Overall Study|Lost to Follow-up|0|||
129881446|NCT00447954|467524927|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
129881447|NCT00447954|467524928|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
129881448|NCT00447954|467524929|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
129881449|NCT00856661|467524930|FG000|Overall Study|Death|15|||
129881450|NCT00856661|467524931|FG001|Overall Study|Death|18|||
129881451|NCT00856661|467524930|FG000|Overall Study|Protocol Violation|2|||
129881452|NCT00856661|467524931|FG001|Overall Study|Protocol Violation|1|||
129881453|NCT00856661|467524930|FG000|Overall Study|Withdrawal by Subject|1|||
129881454|NCT00856661|467524931|FG001|Overall Study|Withdrawal by Subject|2|||
129881455|NCT00856661|467524930|FG000|Overall Study|Lost to Follow-up|1|||
129881456|NCT00856661|467524931|FG001|Overall Study|Lost to Follow-up|3|||
129881457|NCT00856661|467524930|FG000|Overall Study|Physician Judgement|8|||
129881458|NCT00856661|467524931|FG001|Overall Study|Physician Judgement|5|||
129881459|NCT02120664|467524932|FG000|Overall Study|Withdrawal by Subject|0|||
129881460|NCT02120664|467524933|FG001|Overall Study|Withdrawal by Subject|0|||
129881461|NCT02120664|467524934|FG002|Overall Study|Withdrawal by Subject|0|||
129881462|NCT02120664|467524935|FG003|Overall Study|Withdrawal by Subject|1|||
129881463|NCT02120664|467524936|FG004|Overall Study|Withdrawal by Subject|0|||
129881464|NCT03916744|467524937|FG000|Overall Study|Withdrawal by Subject|0|||
129881465|NCT03916744|467524938|FG001|Overall Study|Withdrawal by Subject|1|||
129881466|NCT03916744|467524939|FG002|Overall Study|Withdrawal by Subject|2|||
129881467|NCT04524598|467524940|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
129881468|NCT04524598|467524941|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
129881469|NCT04524598|467524942|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
129881470|NCT04524598|467524943|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
129881471|NCT04524598|467524944|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
129881472|NCT04524598|467524940|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
129881473|NCT04524598|467524941|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
129881474|NCT04524598|467524942|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881475|NCT04524598|467524943|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881476|NCT04524598|467524944|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881477|NCT04524598|467524940|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
129881478|NCT04524598|467524941|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
129881479|NCT04524598|467524942|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
129881480|NCT04524598|467524943|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
129881481|NCT04524598|467524944|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
129881482|NCT04524598|467524940|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
129881483|NCT04524598|467524941|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
129881484|NCT04524598|467524942|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
129881485|NCT04524598|467524943|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
129881486|NCT04524598|467524944|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
129881487|NCT04524598|467524940|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881488|NCT04524598|467524941|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881489|NCT04524598|467524942|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
129881490|NCT04524598|467524943|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
129881491|NCT04524598|467524944|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881492|NCT04524598|467524940|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
129881493|NCT04524598|467524941|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
129881494|NCT04524598|467524942|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
129881495|NCT04524598|467524943|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
129881496|NCT04524598|467524944|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
129881497|NCT04524598|467524940|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881498|NCT04524598|467524941|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881499|NCT04524598|467524942|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881500|NCT04524598|467524943|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881501|NCT04524598|467524944|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
129881502|NCT04152343|467524945|FG000|Overall Study|Transplanted|5|||
129881503|NCT04152343|467524945|FG000|Overall Study|Death|20|||
129881504|NCT04152343|467524945|FG000|Overall Study|Lost to Follow-up|3|||
129881505|NCT02090634|467524950|FG000|Overall Study|Lost to Follow-up|0|||
129881506|NCT02090634|467524951|FG001|Overall Study|Lost to Follow-up|1|||
129881507|NCT02090634|467524950|FG000|Overall Study|Death|0|||
129881508|NCT02090634|467524951|FG001|Overall Study|Death|1|||
129881509|NCT02090634|467524950|FG000|Overall Study|Protocol Violation|3|||
130323022|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Death|43|||
129881510|NCT02090634|467524951|FG001|Overall Study|Protocol Violation|1|||
129881511|NCT02090634|467524950|FG000|Overall Study|Adverse Event|2|||
129881512|NCT02090634|467524951|FG001|Overall Study|Adverse Event|0|||
129881513|NCT01965938|467524952|FG000|Overall Study|Withdrawal by Subject|1|||
129881514|NCT01965938|467524953|FG001|Overall Study|Withdrawal by Subject|0|||
129881515|NCT01164228|467524954|FG000|Overall Study|Progression|24|||
129881516|NCT01164228|467524955|FG001|Overall Study|Progression|25|||
129881517|NCT01164228|467524954|FG000|Overall Study|Adverse Event|13|||
129881518|NCT01164228|467524955|FG001|Overall Study|Adverse Event|7|||
129881519|NCT01164228|467524954|FG000|Overall Study|Death|1|||
129881520|NCT01164228|467524955|FG001|Overall Study|Death|1|||
129881521|NCT01164228|467524954|FG000|Overall Study|Withdrawal by Subject|2|||
129881522|NCT01164228|467524955|FG001|Overall Study|Withdrawal by Subject|0|||
129881523|NCT01164228|467524954|FG000|Overall Study|Physician Decision|1|||
129881524|NCT01164228|467524955|FG001|Overall Study|Physician Decision|2|||
129881525|NCT01164228|467524954|FG000|Overall Study|Symptomatic deterioration|1|||
129881526|NCT01164228|467524955|FG001|Overall Study|Symptomatic deterioration|0|||
129881527|NCT01164228|467524954|FG000|Overall Study|Never started treatment|1|||
129881528|NCT01164228|467524955|FG001|Overall Study|Never started treatment|3|||
129881529|NCT01164228|467524954|FG000|Overall Study|Ineligible|1|||
129881530|NCT01164228|467524955|FG001|Overall Study|Ineligible|0|||
129881531|NCT03757234|467524956|FG000|Overall Study|Adverse Event|0|||
129881532|NCT03757234|467524957|FG001|Overall Study|Adverse Event|0|||
129881533|NCT03757234|467524958|FG002|Overall Study|Adverse Event|0|||
129881534|NCT03757234|467524959|FG003|Overall Study|Adverse Event|0|||
129881535|NCT03757234|467524960|FG004|Overall Study|Adverse Event|1|||
129881536|NCT03757234|467524956|FG000|Overall Study|Lost to Follow-up|1|||
129881537|NCT03757234|467524957|FG001|Overall Study|Lost to Follow-up|0|||
129881538|NCT03757234|467524958|FG002|Overall Study|Lost to Follow-up|0|||
129881539|NCT03757234|467524959|FG003|Overall Study|Lost to Follow-up|0|||
129881540|NCT03757234|467524960|FG004|Overall Study|Lost to Follow-up|1|||
129881541|NCT03757234|467524956|FG000|Overall Study|Withdrawal by Subject|1|||
129881542|NCT03757234|467524957|FG001|Overall Study|Withdrawal by Subject|1|||
129881543|NCT03757234|467524958|FG002|Overall Study|Withdrawal by Subject|0|||
129881544|NCT03757234|467524959|FG003|Overall Study|Withdrawal by Subject|1|||
129881545|NCT03757234|467524960|FG004|Overall Study|Withdrawal by Subject|2|||
129881546|NCT03757234|467524956|FG000|Overall Study|Other|1|||
129881547|NCT03757234|467524957|FG001|Overall Study|Other|1|||
129881548|NCT03757234|467524958|FG002|Overall Study|Other|0|||
129881549|NCT03757234|467524959|FG003|Overall Study|Other|0|||
129881550|NCT03757234|467524960|FG004|Overall Study|Other|0|||
129881551|NCT01871558|467524963|FG000|Overall Study|Other reason|0|||
129881552|NCT01871558|467524964|FG001|Overall Study|Other reason|1|||
129881553|NCT01871558|467524963|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
129881554|NCT01871558|467524964|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
129881555|NCT01871558|467524963|FG000|Overall Study|Withdrawal by Subject|2|||
129881556|NCT01871558|467524964|FG001|Overall Study|Withdrawal by Subject|0|||
129881557|NCT01103960|467524970|FG000|Overall Study|Adverse Event|2|||
129881558|NCT01103960|467524971|FG001|Overall Study|Adverse Event|1|||
129881559|NCT01103960|467524970|FG000|Overall Study|Withdrawal by Subject|2|||
129881560|NCT01103960|467524971|FG001|Overall Study|Withdrawal by Subject|1|||
129881561|NCT01103960|467524970|FG000|Overall Study|Other|1|||
129881562|NCT01103960|467524971|FG001|Overall Study|Other|0|||
129881563|NCT04287868|467524978|FG000|Overall Study|Screening fail|1|||
129881564|NCT04287868|467524979|FG001|Overall Study|Screening fail|0|||
129881565|NCT02105636|467526945|FG000|Pre-Treatment|Disease Progression|1|||
129881566|NCT02105636|467526946|FG001|Pre-Treatment|Disease Progression|0|||
129881567|NCT02105636|467526945|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
130323023|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Death|44|||
130323024|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
130323025|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129881568|NCT02105636|467526946|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
130323026|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
129881569|NCT02105636|467526945|FG000|Pre-Treatment|Participant withdrew consent|0|||
129881570|NCT02105636|467526946|FG001|Pre-Treatment|Participant withdrew consent|6|||
129881571|NCT02105636|467526945|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129881572|NCT02105636|467526946|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
129881573|NCT02105636|467526945|FG000|Treatment|Study Drug Toxicity|14|||
129881574|NCT02105636|467526946|FG001|Treatment|Study Drug Toxicity|10|||
129881575|NCT02105636|467526945|FG000|Treatment|Adverse event unrelated to study drug|19|||
129881576|NCT02105636|467526946|FG001|Treatment|Adverse event unrelated to study drug|3|||
129881577|NCT02105636|467526945|FG000|Treatment|Participant request to discontinue study treatment|8|||
129881578|NCT02105636|467526946|FG001|Treatment|Participant request to discontinue study treatment|6|||
129881579|NCT02105636|467526945|FG000|Treatment|Participant withdrew consent|5|||
129881580|NCT02105636|467526946|FG001|Treatment|Participant withdrew consent|1|||
129881581|NCT02105636|467526945|FG000|Treatment|Lost to Follow-up|1|||
129881582|NCT02105636|467526946|FG001|Treatment|Lost to Follow-up|0|||
129881583|NCT02105636|467526945|FG000|Treatment|Maximum Clinical Benefit|1|||
129881584|NCT02105636|467526946|FG001|Treatment|Maximum Clinical Benefit|3|||
129881585|NCT02105636|467526945|FG000|Treatment|Poor/Non-compliance|0|||
129881586|NCT02105636|467526946|FG001|Treatment|Poor/Non-compliance|1|||
129881587|NCT02105636|467526945|FG000|Treatment|Participant no longer meets study criteria|1|||
129881588|NCT02105636|467526946|FG001|Treatment|Participant no longer meets study criteria|0|||
129881589|NCT02105636|467526945|FG000|Treatment|Other reasons|1|||
129881590|NCT02105636|467526946|FG001|Treatment|Other reasons|0|||
129881591|NCT02105636|467526945|FG000|Treatment|Disease Progression|185|||
129881592|NCT02105636|467526946|FG001|Treatment|Disease Progression|87|||
129881593|NCT00235443|467526948|FG000|Overall Study|Adverse Event|4|||
129881594|NCT00235443|467526949|FG001|Overall Study|Adverse Event|12|||
129881595|NCT00235443|467526950|FG002|Overall Study|Adverse Event|17|||
129881596|NCT00235443|467526951|FG003|Overall Study|Adverse Event|44|||
129881597|NCT00235443|467526952|FG004|Overall Study|Adverse Event|10|||
129881598|NCT00235443|467526953|FG005|Overall Study|Adverse Event|15|||
129881599|NCT00235443|467526948|FG000|Overall Study|Lack of Efficacy|0|||
129881600|NCT00235443|467526949|FG001|Overall Study|Lack of Efficacy|1|||
129881601|NCT00235443|467526950|FG002|Overall Study|Lack of Efficacy|5|||
129881602|NCT00235443|467526951|FG003|Overall Study|Lack of Efficacy|12|||
129881603|NCT00235443|467526952|FG004|Overall Study|Lack of Efficacy|2|||
129881604|NCT00235443|467526953|FG005|Overall Study|Lack of Efficacy|9|||
129881605|NCT00235443|467526948|FG000|Overall Study|Withdrawal by Subject|3|||
129881606|NCT00235443|467526949|FG001|Overall Study|Withdrawal by Subject|9|||
129881607|NCT00235443|467526950|FG002|Overall Study|Withdrawal by Subject|25|||
129881608|NCT00235443|467526951|FG003|Overall Study|Withdrawal by Subject|24|||
129881609|NCT00235443|467526952|FG004|Overall Study|Withdrawal by Subject|10|||
129881610|NCT00235443|467526953|FG005|Overall Study|Withdrawal by Subject|12|||
129881611|NCT00235443|467526948|FG000|Overall Study|Lost to Follow-up|0|||
129881612|NCT00235443|467526949|FG001|Overall Study|Lost to Follow-up|8|||
129881613|NCT00235443|467526950|FG002|Overall Study|Lost to Follow-up|6|||
129881614|NCT00235443|467526951|FG003|Overall Study|Lost to Follow-up|6|||
129881615|NCT00235443|467526952|FG004|Overall Study|Lost to Follow-up|4|||
129881616|NCT00235443|467526953|FG005|Overall Study|Lost to Follow-up|3|||
129881617|NCT00235443|467526948|FG000|Overall Study|Unsatisfactory compliance|0|||
129881618|NCT00235443|467526949|FG001|Overall Study|Unsatisfactory compliance|2|||
129881619|NCT00235443|467526950|FG002|Overall Study|Unsatisfactory compliance|3|||
129881620|NCT00235443|467526951|FG003|Overall Study|Unsatisfactory compliance|4|||
129881621|NCT00235443|467526952|FG004|Overall Study|Unsatisfactory compliance|1|||
129881622|NCT00235443|467526953|FG005|Overall Study|Unsatisfactory compliance|0|||
129881623|NCT00235443|467526948|FG000|Overall Study|Other reasons for premature termination|1|||
129881624|NCT00235443|467526949|FG001|Overall Study|Other reasons for premature termination|6|||
129881625|NCT00235443|467526950|FG002|Overall Study|Other reasons for premature termination|6|||
129881626|NCT00235443|467526951|FG003|Overall Study|Other reasons for premature termination|7|||
129881627|NCT00235443|467526952|FG004|Overall Study|Other reasons for premature termination|3|||
129881628|NCT00235443|467526953|FG005|Overall Study|Other reasons for premature termination|6|||
129881629|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
129881630|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
129881631|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
129881632|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
129881633|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
129881634|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
129881635|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
129881636|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
129881637|NCT01976364|467526958|FG000|Main Study (36 Months)|Adverse Event|63|||
129881638|NCT01976364|467526959|FG001|Main Study (36 Months)|Adverse Event|0|||
129881639|NCT01976364|467526960|FG002|Main Study (36 Months)|Adverse Event|0|||
129881640|NCT01976364|467526958|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
129881641|NCT01976364|467526959|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
129881642|NCT01976364|467526960|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
129881643|NCT01976364|467526958|FG000|Main Study (36 Months)|Other|13|||
129881644|NCT01976364|467526959|FG001|Main Study (36 Months)|Other|0|||
129881645|NCT01976364|467526960|FG002|Main Study (36 Months)|Other|0|||
129881646|NCT01976364|467526958|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
129881647|NCT01976364|467526959|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
129881648|NCT01976364|467526960|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
129881649|NCT01976364|467526958|FG000|Main Study (36 Months)|Medication error|1|||
129881650|NCT01976364|467526959|FG001|Main Study (36 Months)|Medication error|0|||
129881651|NCT01976364|467526960|FG002|Main Study (36 Months)|Medication error|0|||
129881652|NCT01976364|467526958|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
129881653|NCT01976364|467526959|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
129881654|NCT01976364|467526960|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
129881655|NCT01976364|467526958|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
129881656|NCT01976364|467526959|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
129881657|NCT01976364|467526960|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
129881658|NCT01976364|467526958|FG000|Main Study (36 Months)|Protocol Violation|13|||
129881659|NCT01976364|467526959|FG001|Main Study (36 Months)|Protocol Violation|0|||
129881660|NCT01976364|467526960|FG002|Main Study (36 Months)|Protocol Violation|0|||
129881661|NCT01976364|467526958|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
129881662|NCT01976364|467526959|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
129881663|NCT01976364|467526960|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
129881664|NCT01976364|467526958|FG000|Main Study (36 Months)|Death|5|||
129881665|NCT01976364|467526959|FG001|Main Study (36 Months)|Death|0|||
129881666|NCT01976364|467526960|FG002|Main Study (36 Months)|Death|0|||
129881667|NCT01976364|467526958|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
129881668|NCT01976364|467526959|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
129881669|NCT01976364|467526960|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
129881670|NCT01976364|467526958|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
129881671|NCT01976364|467526959|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
129881672|NCT01976364|467526960|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
129881673|NCT01976364|467526958|FG000|Sub-study (12 Months)|Protocol Violation|0|||
129881674|NCT01976364|467526959|FG001|Sub-study (12 Months)|Protocol Violation|1|||
129881675|NCT01976364|467526960|FG002|Sub-study (12 Months)|Protocol Violation|1|||
129881676|NCT01976364|467526958|FG000|Sub-study (12 Months)|Adverse Event|0|||
129881677|NCT01976364|467526959|FG001|Sub-study (12 Months)|Adverse Event|4|||
130323027|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129881678|NCT01976364|467526960|FG002|Sub-study (12 Months)|Adverse Event|3|||
129881679|NCT02318719|467526962|FG000|Double-blind Phase|Adverse Event|7|||
129881680|NCT02318719|467526963|FG001|Double-blind Phase|Adverse Event|6|||
129881681|NCT02318719|467526964|FG002|Double-blind Phase|Adverse Event|12|||
129881682|NCT02318719|467526965|FG003|Double-blind Phase|Adverse Event|4|||
129881683|NCT02318719|467526966|FG004|Double-blind Phase|Adverse Event|0|||
129881684|NCT02318719|467526962|FG000|Double-blind Phase|Lack of Efficacy|5|||
129881685|NCT02318719|467526963|FG001|Double-blind Phase|Lack of Efficacy|0|||
129881686|NCT02318719|467526964|FG002|Double-blind Phase|Lack of Efficacy|1|||
129881687|NCT02318719|467526965|FG003|Double-blind Phase|Lack of Efficacy|1|||
129881688|NCT02318719|467526966|FG004|Double-blind Phase|Lack of Efficacy|0|||
129881689|NCT02318719|467526962|FG000|Double-blind Phase|Protocol Violation|0|||
129881690|NCT02318719|467526963|FG001|Double-blind Phase|Protocol Violation|1|||
129881691|NCT02318719|467526964|FG002|Double-blind Phase|Protocol Violation|3|||
129881692|NCT02318719|467526965|FG003|Double-blind Phase|Protocol Violation|0|||
129881693|NCT02318719|467526966|FG004|Double-blind Phase|Protocol Violation|0|||
129881694|NCT02318719|467526962|FG000|Double-blind Phase|Withdrawal by Subject|25|||
129881695|NCT02318719|467526963|FG001|Double-blind Phase|Withdrawal by Subject|7|||
129881696|NCT02318719|467526964|FG002|Double-blind Phase|Withdrawal by Subject|9|||
129881697|NCT02318719|467526965|FG003|Double-blind Phase|Withdrawal by Subject|10|||
129881698|NCT02318719|467526966|FG004|Double-blind Phase|Withdrawal by Subject|0|||
129881699|NCT02318719|467526962|FG000|Double-blind Phase|Other|1|||
129881700|NCT02318719|467526963|FG001|Double-blind Phase|Other|2|||
129881701|NCT02318719|467526964|FG002|Double-blind Phase|Other|0|||
129881702|NCT02318719|467526965|FG003|Double-blind Phase|Other|0|||
129881703|NCT02318719|467526966|FG004|Double-blind Phase|Other|0|||
129881704|NCT02318719|467526962|FG000|Open-label Extension Phase|Adverse Event|0|||
129881705|NCT02318719|467526963|FG001|Open-label Extension Phase|Adverse Event|0|||
129881706|NCT02318719|467526964|FG002|Open-label Extension Phase|Adverse Event|0|||
129881707|NCT02318719|467526965|FG003|Open-label Extension Phase|Adverse Event|0|||
129881708|NCT02318719|467526966|FG004|Open-label Extension Phase|Adverse Event|15|||
129881709|NCT02318719|467526962|FG000|Open-label Extension Phase|Death|0|||
129881710|NCT02318719|467526963|FG001|Open-label Extension Phase|Death|0|||
129881711|NCT02318719|467526964|FG002|Open-label Extension Phase|Death|0|||
129881712|NCT02318719|467526965|FG003|Open-label Extension Phase|Death|0|||
129881713|NCT02318719|467526966|FG004|Open-label Extension Phase|Death|1|||
129881714|NCT02318719|467526962|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
129881715|NCT02318719|467526963|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
129881716|NCT02318719|467526964|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
129881717|NCT02318719|467526965|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
129881718|NCT02318719|467526966|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
129881719|NCT02318719|467526962|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
129881720|NCT02318719|467526963|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
129881721|NCT02318719|467526964|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
129881722|NCT02318719|467526965|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
129881723|NCT02318719|467526966|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
129881724|NCT02318719|467526962|FG000|Open-label Extension Phase|Other|0|||
129881725|NCT02318719|467526963|FG001|Open-label Extension Phase|Other|0|||
129881726|NCT02318719|467526964|FG002|Open-label Extension Phase|Other|0|||
129881727|NCT02318719|467526965|FG003|Open-label Extension Phase|Other|0|||
129881728|NCT02318719|467526966|FG004|Open-label Extension Phase|Other|7|||
129881729|NCT01868035|467526967|FG000|Overall Study|Lost to Follow-up|3|||
129881730|NCT01868035|467526967|FG000|Overall Study|Withdrawal by Subject|1|||
129881731|NCT01868035|467526967|FG000|Overall Study|Progressive Disease|2|||
129881732|NCT01868035|467526967|FG000|Overall Study|Non-compliance|1|||
129881733|NCT00432835|467526968|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
129881734|NCT00432835|467526969|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
129881735|NCT00423293|467526970|FG000|Overall Study|Ineligible / No protocol treatment|11|||
129881736|NCT01912222|467526971|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
129881737|NCT01912222|467526972|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
129881738|NCT01912222|467526973|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
129881739|NCT01912222|467526971|FG000|Part B: Treatment Period|Progressive disease|10|||
129881740|NCT01912222|467526972|FG001|Part B: Treatment Period|Progressive disease|12|||
129881741|NCT01912222|467526973|FG002|Part B: Treatment Period|Progressive disease|15|||
129881742|NCT01912222|467526971|FG000|Part B: Treatment Period|Adverse Event|1|||
129881743|NCT01912222|467526972|FG001|Part B: Treatment Period|Adverse Event|2|||
129881744|NCT01912222|467526973|FG002|Part B: Treatment Period|Adverse Event|3|||
129881745|NCT01912222|467526971|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
129881746|NCT01912222|467526972|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
129881747|NCT01912222|467526973|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
129881748|NCT03154359|467526974|FG000|Overall Study|Adverse Event|1|||
129881749|NCT03154359|467526974|FG000|Overall Study|Lack of Efficacy|2|||
129881750|NCT03154359|467526974|FG000|Overall Study|Lost to Follow-up|3|||
129881751|NCT03154359|467526974|FG000|Overall Study|Physician Decision|3|||
129881752|NCT03154359|467526974|FG000|Overall Study|Protocol Violation|4|||
129881753|NCT03154359|467526974|FG000|Overall Study|Withdrawal by Subject|5|||
129881754|NCT03154359|467526974|FG000|Overall Study|Disruption of study due to COVID-19|4|||
129881755|NCT00562978|467526975|FG000|Overall Study|Patient had imaging dose only|1|||
129881756|NCT00562978|467526976|FG001|Overall Study|Patient had imaging dose only|11|||
129881757|NCT00152971|467526978|FG000|Overall Study|Adverse Event|12|||
129881758|NCT00152971|467526979|FG001|Overall Study|Adverse Event|10|||
129881759|NCT00152971|467526980|FG002|Overall Study|Adverse Event|9|||
129881760|NCT00152971|467526978|FG000|Overall Study|Protocol Violation|10|||
129881761|NCT00152971|467526979|FG001|Overall Study|Protocol Violation|11|||
129881762|NCT00152971|467526980|FG002|Overall Study|Protocol Violation|8|||
129881763|NCT00152971|467526978|FG000|Overall Study|Lost to Follow-up|17|||
129881764|NCT00152971|467526979|FG001|Overall Study|Lost to Follow-up|14|||
129881765|NCT00152971|467526980|FG002|Overall Study|Lost to Follow-up|13|||
129881766|NCT00152971|467526978|FG000|Overall Study|Withdrawal by Subject|9|||
129881767|NCT00152971|467526979|FG001|Overall Study|Withdrawal by Subject|8|||
129881768|NCT00152971|467526980|FG002|Overall Study|Withdrawal by Subject|14|||
129881769|NCT00152971|467526978|FG000|Overall Study|Other|3|||
129881770|NCT00152971|467526979|FG001|Overall Study|Other|5|||
129881771|NCT00152971|467526980|FG002|Overall Study|Other|5|||
129881772|NCT00152971|467526978|FG000|Treatment|Adverse Event|49|||
129881773|NCT00152971|467526979|FG001|Treatment|Adverse Event|40|||
129881774|NCT00152971|467526980|FG002|Treatment|Adverse Event|54|||
129881775|NCT00152971|467526978|FG000|Treatment|Protocol Violation|8|||
129881776|NCT00152971|467526979|FG001|Treatment|Protocol Violation|6|||
129881777|NCT00152971|467526980|FG002|Treatment|Protocol Violation|10|||
129881778|NCT00152971|467526978|FG000|Treatment|Lost to Follow-up|1|||
129881779|NCT00152971|467526979|FG001|Treatment|Lost to Follow-up|2|||
129881780|NCT00152971|467526980|FG002|Treatment|Lost to Follow-up|1|||
129881781|NCT00152971|467526978|FG000|Treatment|Withdrawal by Subject|4|||
129881782|NCT00152971|467526979|FG001|Treatment|Withdrawal by Subject|4|||
129881783|NCT00152971|467526980|FG002|Treatment|Withdrawal by Subject|5|||
129881784|NCT00152971|467526978|FG000|Treatment|Other|9|||
129881785|NCT00152971|467526979|FG001|Treatment|Other|11|||
129881786|NCT00152971|467526980|FG002|Treatment|Other|10|||
129881787|NCT03125941|467526987|FG000|Overall Study|did not receive intervention|1|||
129881788|NCT03125941|467526988|FG001|Overall Study|did not receive intervention|2|||
129881789|NCT03853317|467526989|FG000|Overall Study|Progressive Disease|5|||
129881790|NCT03853317|467526989|FG000|Overall Study|Adverse Event|1|||
129881791|NCT03853317|467526989|FG000|Overall Study|Death|1|||
129881792|NCT03853317|467526989|FG000|Overall Study|other event|2|||
129881793|NCT00779584|467526990|FG000|Overall Study|Protocol Violation|0|||
129881794|NCT00779584|467526991|FG001|Overall Study|Protocol Violation|0|||
129881795|NCT00779584|467526992|FG002|Overall Study|Protocol Violation|0|||
129881796|NCT00779584|467526993|FG003|Overall Study|Protocol Violation|0|||
129881797|NCT00779584|467526994|FG004|Overall Study|Protocol Violation|0|||
129881798|NCT00779584|467526995|FG005|Overall Study|Protocol Violation|1|||
129881799|NCT00779584|467526996|FG006|Overall Study|Protocol Violation|0|||
129881800|NCT00779584|467526997|FG007|Overall Study|Protocol Violation|0|||
129881801|NCT00779584|467526998|FG008|Overall Study|Protocol Violation|0|||
129881802|NCT00779584|467526990|FG000|Overall Study|Withdrawal by Subject|1|||
129881803|NCT00779584|467526991|FG001|Overall Study|Withdrawal by Subject|1|||
129881804|NCT00779584|467526992|FG002|Overall Study|Withdrawal by Subject|2|||
129881805|NCT00779584|467526993|FG003|Overall Study|Withdrawal by Subject|0|||
129881806|NCT00779584|467526994|FG004|Overall Study|Withdrawal by Subject|0|||
129881807|NCT00779584|467526995|FG005|Overall Study|Withdrawal by Subject|2|||
130323028|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
130323029|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
130323030|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
130323031|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
130323032|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
130323033|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
130323034|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
130323035|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
130323036|NCT01972217|469153505|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130323037|NCT01972217|469153506|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130323038|NCT01972217|469153507|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
130323039|NCT01972217|469153508|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
130323040|NCT02318706|469153509|FG000|Double-blind Phase|Adverse Event|7|||
130323041|NCT02318706|469153510|FG001|Double-blind Phase|Adverse Event|4|||
130323042|NCT02318706|469153511|FG002|Double-blind Phase|Adverse Event|3|||
130323043|NCT02318706|469153512|FG003|Double-blind Phase|Adverse Event|10|||
130323044|NCT02318706|469153513|FG004|Double-blind Phase|Adverse Event|0|||
130323045|NCT02318706|469153509|FG000|Double-blind Phase|Lost to Follow-up|1|||
130323046|NCT02318706|469153510|FG001|Double-blind Phase|Lost to Follow-up|0|||
130323047|NCT02318706|469153511|FG002|Double-blind Phase|Lost to Follow-up|0|||
130323048|NCT02318706|469153512|FG003|Double-blind Phase|Lost to Follow-up|0|||
130323049|NCT02318706|469153513|FG004|Double-blind Phase|Lost to Follow-up|0|||
130323050|NCT02318706|469153509|FG000|Double-blind Phase|Protocol Violation|4|||
130323051|NCT02318706|469153510|FG001|Double-blind Phase|Protocol Violation|2|||
130323052|NCT02318706|469153511|FG002|Double-blind Phase|Protocol Violation|4|||
130323053|NCT02318706|469153512|FG003|Double-blind Phase|Protocol Violation|3|||
130323054|NCT02318706|469153513|FG004|Double-blind Phase|Protocol Violation|0|||
130323055|NCT02318706|469153509|FG000|Double-blind Phase|Withdrawal by Subject|9|||
130323056|NCT02318706|469153510|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130323057|NCT02318706|469153511|FG002|Double-blind Phase|Withdrawal by Subject|7|||
130323058|NCT02318706|469153512|FG003|Double-blind Phase|Withdrawal by Subject|10|||
130323059|NCT02318706|469153513|FG004|Double-blind Phase|Withdrawal by Subject|0|||
130323060|NCT02318706|469153509|FG000|Double-blind Phase|Other|4|||
130323061|NCT02318706|469153510|FG001|Double-blind Phase|Other|1|||
130323062|NCT02318706|469153511|FG002|Double-blind Phase|Other|2|||
130323063|NCT02318706|469153512|FG003|Double-blind Phase|Other|1|||
130323064|NCT02318706|469153513|FG004|Double-blind Phase|Other|0|||
130323065|NCT02318706|469153509|FG000|Double-blind Phase|Death|0|||
130323066|NCT02318706|469153510|FG001|Double-blind Phase|Death|0|||
130323067|NCT02318706|469153511|FG002|Double-blind Phase|Death|2|||
130323068|NCT02318706|469153512|FG003|Double-blind Phase|Death|0|||
130323069|NCT02318706|469153513|FG004|Double-blind Phase|Death|0|||
129881808|NCT00779584|467526996|FG006|Overall Study|Withdrawal by Subject|1|||
129881809|NCT00779584|467526997|FG007|Overall Study|Withdrawal by Subject|0|||
129881810|NCT00779584|467526998|FG008|Overall Study|Withdrawal by Subject|0|||
129881811|NCT00779584|467526990|FG000|Overall Study|Lost to Follow-up|0|||
129881812|NCT00779584|467526991|FG001|Overall Study|Lost to Follow-up|0|||
129881813|NCT00779584|467526992|FG002|Overall Study|Lost to Follow-up|0|||
129881814|NCT00779584|467526993|FG003|Overall Study|Lost to Follow-up|0|||
129881815|NCT00779584|467526994|FG004|Overall Study|Lost to Follow-up|1|||
129881816|NCT00779584|467526995|FG005|Overall Study|Lost to Follow-up|0|||
129881817|NCT00779584|467526996|FG006|Overall Study|Lost to Follow-up|0|||
129881818|NCT00779584|467526997|FG007|Overall Study|Lost to Follow-up|0|||
129881819|NCT00779584|467526998|FG008|Overall Study|Lost to Follow-up|0|||
129881820|NCT00779584|467526990|FG000|Overall Study|Progression of Disease|0|||
129881821|NCT00779584|467526991|FG001|Overall Study|Progression of Disease|1|||
129881822|NCT00779584|467526992|FG002|Overall Study|Progression of Disease|2|||
129881823|NCT00779584|467526993|FG003|Overall Study|Progression of Disease|6|||
129881824|NCT00779584|467526994|FG004|Overall Study|Progression of Disease|5|||
129881825|NCT00779584|467526995|FG005|Overall Study|Progression of Disease|1|||
129881826|NCT00779584|467526996|FG006|Overall Study|Progression of Disease|4|||
129881827|NCT00779584|467526997|FG007|Overall Study|Progression of Disease|2|||
129881828|NCT00779584|467526998|FG008|Overall Study|Progression of Disease|1|||
129881829|NCT00779584|467526990|FG000|Overall Study|Adverse Event|1|||
129881830|NCT00779584|467526991|FG001|Overall Study|Adverse Event|0|||
129881831|NCT00779584|467526992|FG002|Overall Study|Adverse Event|2|||
129881832|NCT00779584|467526993|FG003|Overall Study|Adverse Event|0|||
129881833|NCT00779584|467526994|FG004|Overall Study|Adverse Event|0|||
129881834|NCT00779584|467526995|FG005|Overall Study|Adverse Event|0|||
130098695|NCT00924313|468319284|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
130323070|NCT02318706|469153509|FG000|Open-label Extension Phase|Adverse Event|0|||
130323071|NCT02318706|469153510|FG001|Open-label Extension Phase|Adverse Event|0|||
130323072|NCT02318706|469153511|FG002|Open-label Extension Phase|Adverse Event|0|||
130323073|NCT02318706|469153512|FG003|Open-label Extension Phase|Adverse Event|0|||
130323074|NCT02318706|469153513|FG004|Open-label Extension Phase|Adverse Event|21|||
130323075|NCT02318706|469153509|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
129881835|NCT00779584|467526996|FG006|Overall Study|Adverse Event|2|||
129881836|NCT00779584|467526997|FG007|Overall Study|Adverse Event|1|||
129881837|NCT00779584|467526998|FG008|Overall Study|Adverse Event|1|||
129881838|NCT00779584|467526990|FG000|Overall Study|Symptomatic Deterioration|1|||
129881839|NCT00779584|467526991|FG001|Overall Study|Symptomatic Deterioration|1|||
129881840|NCT00779584|467526992|FG002|Overall Study|Symptomatic Deterioration|1|||
129881841|NCT00779584|467526993|FG003|Overall Study|Symptomatic Deterioration|0|||
129881842|NCT00779584|467526994|FG004|Overall Study|Symptomatic Deterioration|0|||
129881843|NCT00779584|467526995|FG005|Overall Study|Symptomatic Deterioration|1|||
129881844|NCT00779584|467526996|FG006|Overall Study|Symptomatic Deterioration|1|||
129881845|NCT00779584|467526997|FG007|Overall Study|Symptomatic Deterioration|0|||
129881846|NCT00779584|467526998|FG008|Overall Study|Symptomatic Deterioration|0|||
129881847|NCT00779584|467526990|FG000|Overall Study|Ongoing in Study|0|||
129881848|NCT00779584|467526991|FG001|Overall Study|Ongoing in Study|0|||
129881849|NCT00779584|467526992|FG002|Overall Study|Ongoing in Study|0|||
129881850|NCT00779584|467526993|FG003|Overall Study|Ongoing in Study|0|||
129881851|NCT00779584|467526994|FG004|Overall Study|Ongoing in Study|1|||
129881852|NCT00779584|467526995|FG005|Overall Study|Ongoing in Study|1|||
129881853|NCT00779584|467526996|FG006|Overall Study|Ongoing in Study|0|||
129881854|NCT00779584|467526997|FG007|Overall Study|Ongoing in Study|0|||
129881855|NCT00779584|467526998|FG008|Overall Study|Ongoing in Study|0|||
129881856|NCT00406419|467527001|FG000|Overall Study|Death|3|||
129881857|NCT00406419|467527002|FG001|Overall Study|Death|1|||
129881858|NCT00406419|467527003|FG002|Overall Study|Death|4|||
129881859|NCT00406419|467527001|FG000|Overall Study|Protocol Violation|6|||
129881860|NCT00406419|467527002|FG001|Overall Study|Protocol Violation|2|||
129881861|NCT00406419|467527003|FG002|Overall Study|Protocol Violation|5|||
129881862|NCT00406419|467527001|FG000|Overall Study|Study Terminated by Sponsor|260|||
129881863|NCT00406419|467527002|FG001|Overall Study|Study Terminated by Sponsor|288|||
129881864|NCT00406419|467527003|FG002|Overall Study|Study Terminated by Sponsor|282|||
129881865|NCT00406419|467527001|FG000|Overall Study|Withdrawal by Subject|17|||
129881866|NCT00406419|467527002|FG001|Overall Study|Withdrawal by Subject|24|||
129881867|NCT00406419|467527003|FG002|Overall Study|Withdrawal by Subject|26|||
129881868|NCT00406419|467527001|FG000|Overall Study|Lack of Efficacy|12|||
129881869|NCT00406419|467527002|FG001|Overall Study|Lack of Efficacy|1|||
129881870|NCT00406419|467527003|FG002|Overall Study|Lack of Efficacy|6|||
130214088|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214089|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
130214090|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214091|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
130214092|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214093|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214094|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214095|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214096|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
130214097|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
130214098|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214099|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214100|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
130214101|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214102|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130214103|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214104|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214105|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214106|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214107|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130214108|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
130214109|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
130214110|NCT00528372|468746957|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130214111|NCT00528372|468746958|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130214112|NCT00528372|468746959|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
130214113|NCT00528372|468746960|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
130214114|NCT00528372|468746961|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
129881871|NCT00406419|467527001|FG000|Overall Study|Non-Compliance with Study Drug|5|||
129881872|NCT00406419|467527002|FG001|Overall Study|Non-Compliance with Study Drug|6|||
129881873|NCT00406419|467527003|FG002|Overall Study|Non-Compliance with Study Drug|3|||
129881874|NCT00406419|467527001|FG000|Overall Study|Adverse Event|10|||
129881875|NCT00406419|467527002|FG001|Overall Study|Adverse Event|12|||
129881876|NCT00406419|467527003|FG002|Overall Study|Adverse Event|16|||
129881877|NCT00406419|467527001|FG000|Overall Study|Lost to Follow-up|11|||
129881878|NCT00406419|467527002|FG001|Overall Study|Lost to Follow-up|10|||
129881879|NCT00406419|467527003|FG002|Overall Study|Lost to Follow-up|5|||
129881880|NCT02878213|467527004|FG000|Overall Study|Withdrawal by Subject|2|||
129881881|NCT02878213|467527004|FG000|Overall Study|Adverse Event|1|||
129881882|NCT02494206|467527020|FG000|Overall Study|Adverse Event|1|||
129881883|NCT02494206|467527020|FG000|Overall Study|Disease Progression|1|||
129881884|NCT04986982|467527022|FG000|Overall Study|Withdrawal by Subject|3|||
129881885|NCT04986982|467527023|FG001|Overall Study|Withdrawal by Subject|1|||
129881886|NCT04986982|467527022|FG000|Overall Study|Lack of Efficacy|0|||
129881887|NCT04986982|467527023|FG001|Overall Study|Lack of Efficacy|2|||
129881888|NCT04986982|467527022|FG000|Overall Study|Ineligibility|3|||
129881889|NCT04986982|467527023|FG001|Overall Study|Ineligibility|0|||
129881890|NCT04986982|467527022|FG000|Overall Study|Adverse Event|4|||
129881891|NCT04986982|467527023|FG001|Overall Study|Adverse Event|4|||
129881892|NCT04986982|467527022|FG000|Overall Study|Lost to Follow-up|0|||
129881893|NCT04986982|467527023|FG001|Overall Study|Lost to Follow-up|1|||
129881894|NCT04986982|467527022|FG000|Overall Study|Sponsor's discretion|1|||
129881895|NCT04986982|467527023|FG001|Overall Study|Sponsor's discretion|0|||
129881896|NCT01155661|467527024|FG000|Overall Study|Adverse Event|101|||
129881897|NCT01155661|467527024|FG000|Overall Study|Death|1|||
129881898|NCT01155661|467527024|FG000|Overall Study|Lack of Efficacy|32|||
129881899|NCT01155661|467527024|FG000|Overall Study|Lost to Follow-up|22|||
129881900|NCT01155661|467527024|FG000|Overall Study|Physician Decision|3|||
129881901|NCT01155661|467527024|FG000|Overall Study|Protocol Violation|35|||
129881902|NCT01155661|467527024|FG000|Overall Study|Withdrawal by Subject|73|||
129881903|NCT01155661|467527024|FG000|Overall Study|Sponsor Decision|13|||
129881904|NCT01396395|467527028|FG000|Overall Study|Withdrawal by Subject|10|||
129881905|NCT01396395|467527029|FG001|Overall Study|Withdrawal by Subject|12|||
129881906|NCT01396395|467527028|FG000|Overall Study|Protocol Violation|3|||
129881907|NCT01396395|467527029|FG001|Overall Study|Protocol Violation|1|||
129881908|NCT01396395|467527028|FG000|Overall Study|Adverse Event|10|||
129881909|NCT01396395|467527029|FG001|Overall Study|Adverse Event|2|||
129881910|NCT01396395|467527028|FG000|Overall Study|Lost to Follow-up|17|||
129881911|NCT01396395|467527029|FG001|Overall Study|Lost to Follow-up|11|||
129881912|NCT01396395|467527028|FG000|Overall Study|Other|0|||
129881913|NCT01396395|467527029|FG001|Overall Study|Other|1|||
129881914|NCT00882921|467527032|FG000|Overall Study|Death|2|||
129881915|NCT00882921|467527032|FG000|Overall Study|Other|3|||
129881916|NCT00882921|467527032|FG000|Overall Study|Lost to Follow-up|2|||
129881917|NCT00882921|467527032|FG000|Overall Study|Termination By Investigator|3|||
129881918|NCT00882921|467527032|FG000|Overall Study|Withdrawal Of Consent|1|||
129881919|NCT01370005|467527033|FG000|Overall Study|Not treated|1|||
129881920|NCT01370005|467527034|FG001|Overall Study|Not treated|0|||
129881921|NCT01370005|467527035|FG002|Overall Study|Not treated|0|||
129881922|NCT01370005|467527033|FG000|Overall Study|Adverse Event|5|||
129881923|NCT01370005|467527034|FG001|Overall Study|Adverse Event|5|||
129881924|NCT01370005|467527035|FG002|Overall Study|Adverse Event|6|||
129881925|NCT01370005|467527033|FG000|Overall Study|Lack of Efficacy|1|||
129881926|NCT01370005|467527034|FG001|Overall Study|Lack of Efficacy|0|||
129881927|NCT01370005|467527035|FG002|Overall Study|Lack of Efficacy|0|||
129881928|NCT01370005|467527033|FG000|Overall Study|Non compliant with protocol|0|||
129881929|NCT01370005|467527034|FG001|Overall Study|Non compliant with protocol|1|||
129881930|NCT01370005|467527035|FG002|Overall Study|Non compliant with protocol|2|||
129881931|NCT01370005|467527033|FG000|Overall Study|Lost to Follow-up|1|||
129881932|NCT01370005|467527034|FG001|Overall Study|Lost to Follow-up|1|||
129881933|NCT01370005|467527035|FG002|Overall Study|Lost to Follow-up|1|||
129881934|NCT01370005|467527033|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
129881935|NCT01370005|467527034|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
129881936|NCT01370005|467527035|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
129881937|NCT01370005|467527033|FG000|Overall Study|Other reason not defined above|3|||
129881938|NCT01370005|467527034|FG001|Overall Study|Other reason not defined above|0|||
129881939|NCT01370005|467527035|FG002|Overall Study|Other reason not defined above|2|||
129881940|NCT02009696|467527036|FG000|Overall Study|Withdrawal by Subject|2|||
129881941|NCT02302066|467527037|FG000|Overall Study|Adverse Event|1|||
130323076|NCT02318706|469153510|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
129881942|NCT02302066|467527038|FG001|Overall Study|Adverse Event|1|||
129881943|NCT02302066|467527039|FG002|Overall Study|Adverse Event|3|||
129881944|NCT02302066|467527040|FG003|Overall Study|Adverse Event|0|||
129881945|NCT02302066|467527037|FG000|Overall Study|Lost to Follow-up|4|||
129881946|NCT02302066|467527038|FG001|Overall Study|Lost to Follow-up|5|||
129881947|NCT02302066|467527039|FG002|Overall Study|Lost to Follow-up|24|||
129881948|NCT02302066|467527040|FG003|Overall Study|Lost to Follow-up|7|||
129881949|NCT02302066|467527037|FG000|Overall Study|Withdrawal by Subject|25|||
129881950|NCT02302066|467527038|FG001|Overall Study|Withdrawal by Subject|58|||
129881951|NCT02302066|467527039|FG002|Overall Study|Withdrawal by Subject|124|||
129881952|NCT02302066|467527040|FG003|Overall Study|Withdrawal by Subject|33|||
129881953|NCT02302066|467527037|FG000|Overall Study|Pregnancy|2|||
129881954|NCT02302066|467527038|FG001|Overall Study|Pregnancy|10|||
129881955|NCT02302066|467527039|FG002|Overall Study|Pregnancy|12|||
129881956|NCT02302066|467527040|FG003|Overall Study|Pregnancy|0|||
129881957|NCT02302066|467527037|FG000|Overall Study|Reason Not Specified|1|||
129881958|NCT02302066|467527038|FG001|Overall Study|Reason Not Specified|1|||
129881959|NCT02302066|467527039|FG002|Overall Study|Reason Not Specified|9|||
129881960|NCT02302066|467527040|FG003|Overall Study|Reason Not Specified|1|||
129881961|NCT05490329|467527041|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
129881962|NCT05490329|467527042|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
129881963|NCT05490329|467527041|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
129881964|NCT05490329|467527042|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
129881965|NCT05490329|467527041|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
129881966|NCT05490329|467527042|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
129881967|NCT02460263|467527043|FG000|Transition Period|Withdrawal by Subject|1|||
129881968|NCT02460263|467527043|FG000|Transition Period|Death|1|||
129881969|NCT03176238|467527044|FG000|Overall Study|Unacceptable AEs|15|||
129881970|NCT03176238|467527045|FG001|Overall Study|Unacceptable AEs|8|||
129881971|NCT03176238|467527044|FG000|Overall Study|Abnormal lab value(s)|2|||
129881972|NCT03176238|467527045|FG001|Overall Study|Abnormal lab value(s)|0|||
130323077|NCT02318706|469153511|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
129881973|NCT03176238|467527044|FG000|Overall Study|Inter-current illness|0|||
129881974|NCT03176238|467527045|FG001|Overall Study|Inter-current illness|1|||
129881975|NCT03176238|467527044|FG000|Overall Study|Consent withdrawal|14|||
129881976|NCT03176238|467527045|FG001|Overall Study|Consent withdrawal|2|||
129881977|NCT03176238|467527044|FG000|Overall Study|Lost to Follow-up|3|||
129881978|NCT03176238|467527045|FG001|Overall Study|Lost to Follow-up|0|||
129881979|NCT03176238|467527044|FG000|Overall Study|Administrative problems|1|||
129881980|NCT03176238|467527045|FG001|Overall Study|Administrative problems|0|||
129881981|NCT03176238|467527044|FG000|Overall Study|Death|3|||
129881982|NCT03176238|467527045|FG001|Overall Study|Death|0|||
129881983|NCT03176238|467527044|FG000|Overall Study|Disease Progression|133|||
129881984|NCT03176238|467527045|FG001|Overall Study|Disease Progression|22|||
129881985|NCT03176238|467527044|FG000|Overall Study|Tx duration completed per EAP|0|||
129881986|NCT03176238|467527045|FG001|Overall Study|Tx duration completed per EAP|1|||
129881987|NCT03176238|467527044|FG000|Overall Study|Patient is switched to commercial drug|16|||
129881988|NCT03176238|467527045|FG001|Overall Study|Patient is switched to commercial drug|1|||
129881989|NCT03176238|467527044|FG000|Overall Study|Protocol Violation|1|||
129881990|NCT03176238|467527045|FG001|Overall Study|Protocol Violation|0|||
129881991|NCT03176238|467527044|FG000|Overall Study|Changes in the patient's condition|2|||
129881992|NCT03176238|467527045|FG001|Overall Study|Changes in the patient's condition|1|||
129881993|NCT03176238|467527044|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
129881994|NCT03176238|467527045|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
129881995|NCT02301156|467527046|FG000|Overall Study|Adverse Event|13|||
129881996|NCT02301156|467527047|FG001|Overall Study|Adverse Event|14|||
129881997|NCT02301156|467527046|FG000|Overall Study|Death|1|||
129881998|NCT02301156|467527047|FG001|Overall Study|Death|5|||
129881999|NCT02301156|467527046|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
129882000|NCT02301156|467527047|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
129882001|NCT02301156|467527046|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
129882002|NCT02301156|467527047|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
129882003|NCT02301156|467527046|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
130323078|NCT02318706|469153512|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
130323079|NCT02318706|469153513|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
130323080|NCT02318706|469153509|FG000|Open-label Extension Phase|Death|0|||
130323081|NCT02318706|469153510|FG001|Open-label Extension Phase|Death|0|||
130323082|NCT02318706|469153511|FG002|Open-label Extension Phase|Death|0|||
130323083|NCT02318706|469153512|FG003|Open-label Extension Phase|Death|0|||
130323084|NCT02318706|469153513|FG004|Open-label Extension Phase|Death|1|||
130323085|NCT02318706|469153509|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
130323086|NCT02318706|469153510|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130323087|NCT02318706|469153511|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
130323088|NCT02318706|469153512|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
130323089|NCT02318706|469153513|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
130323090|NCT00755183|469153516|FG000|Overall Study|Adverse Event|5|||
129882004|NCT02301156|467527047|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
129882005|NCT02301156|467527046|FG000|Overall Study|Reason not Specified|6|||
129882006|NCT02301156|467527047|FG001|Overall Study|Reason not Specified|3|||
129882007|NCT02638623|467527049|FG000|Overall Study|Surgery timing|5|||
129882008|NCT02638623|467527050|FG001|Overall Study|Surgery timing|6|||
129882009|NCT02638623|467527049|FG000|Overall Study|Not given intervention|2|||
129882010|NCT02638623|467527050|FG001|Overall Study|Not given intervention|0|||
129882011|NCT00886639|467527051|FG000|Overall Study|acute exacerbation|14|||
129882012|NCT00886639|467527051|FG000|Overall Study|non-compliance|2|||
130098696|NCT01012609|468319285|FG000|Overall Study|Withdrawal by Subject|1|||
130323091|NCT00755183|469153517|FG001|Overall Study|Adverse Event|2|||
130323092|NCT00755183|469153516|FG000|Overall Study|Protocol Violation|0|||
129882013|NCT03203694|467527052|FG000|Overall Study|Withdrawal by Subject|2|||
129882014|NCT03203694|467527053|FG001|Overall Study|Withdrawal by Subject|0|||
129882015|NCT03203694|467527054|FG002|Overall Study|Withdrawal by Subject|0|||
129882016|NCT03203694|467527055|FG003|Overall Study|Withdrawal by Subject|0|||
129882017|NCT03203694|467527056|FG004|Overall Study|Withdrawal by Subject|0|||
129882018|NCT03203694|467527057|FG005|Overall Study|Withdrawal by Subject|0|||
129882019|NCT02875834|467527058|FG000|Open-label Phase|Withdrawal by Subject|3|||
129882020|NCT02875834|467527059|FG001|Open-label Phase|Withdrawal by Subject|0|||
129882021|NCT02875834|467527060|FG002|Open-label Phase|Withdrawal by Subject|0|||
129882022|NCT02875834|467527061|FG003|Open-label Phase|Withdrawal by Subject|0|||
129882023|NCT02875834|467527058|FG000|Open-label Phase|(Not collected)|4|||
129882024|NCT02875834|467527059|FG001|Open-label Phase|(Not collected)|0|||
129882025|NCT02875834|467527060|FG002|Open-label Phase|(Not collected)|0|||
129882026|NCT02875834|467527061|FG003|Open-label Phase|(Not collected)|0|||
129882027|NCT02875834|467527058|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
129882028|NCT02875834|467527059|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
129882029|NCT02875834|467527060|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
129882030|NCT02875834|467527061|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
129882031|NCT02875834|467527058|FG000|Randomized Treatment Phase|Protocol Violation|0|||
129882032|NCT02875834|467527059|FG001|Randomized Treatment Phase|Protocol Violation|2|||
129882033|NCT02875834|467527060|FG002|Randomized Treatment Phase|Protocol Violation|0|||
129882034|NCT02875834|467527061|FG003|Randomized Treatment Phase|Protocol Violation|0|||
129882035|NCT02875834|467527058|FG000|Randomized Treatment Phase|(Not collected)|0|||
129882036|NCT02875834|467527059|FG001|Randomized Treatment Phase|(Not collected)|9|||
129882037|NCT02875834|467527060|FG002|Randomized Treatment Phase|(Not collected)|10|||
129882038|NCT02875834|467527061|FG003|Randomized Treatment Phase|(Not collected)|9|||
129882039|NCT01032044|467527062|FG000|Overall Study|Protocol Violation|14|||
130323093|NCT00755183|469153517|FG001|Overall Study|Protocol Violation|1|||
130323094|NCT00755183|469153516|FG000|Overall Study|Withdrawal by Subject|0|||
130323095|NCT00755183|469153517|FG001|Overall Study|Withdrawal by Subject|2|||
130323096|NCT00755183|469153516|FG000|Overall Study|Administrative|2|||
130323097|NCT00755183|469153517|FG001|Overall Study|Administrative|1|||
130323098|NCT00148317|469153518|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
130323099|NCT00148317|469153518|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
130323100|NCT00148317|469153518|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
130323101|NCT00992108|469153526|FG000|Overall Study|Lost to Follow-up|0|||
130323102|NCT00992108|469153527|FG001|Overall Study|Lost to Follow-up|1|||
129882040|NCT01032044|467527063|FG001|Overall Study|Protocol Violation|8|||
129882041|NCT01032044|467527062|FG000|Overall Study|Adverse Event|0|||
129882042|NCT01032044|467527063|FG001|Overall Study|Adverse Event|1|||
129882043|NCT01032044|467527062|FG000|Overall Study|Lost to Follow-up|11|||
129882044|NCT01032044|467527063|FG001|Overall Study|Lost to Follow-up|11|||
129882045|NCT03311230|467527064|FG000|Overall Study|Withdrawal by Subject|1|||
129882046|NCT03311230|467527065|FG001|Overall Study|Withdrawal by Subject|4|||
129882047|NCT03311230|467527066|FG002|Overall Study|Withdrawal by Subject|2|||
129882048|NCT03311230|467527067|FG003|Overall Study|Withdrawal by Subject|7|||
129882049|NCT03311230|467527064|FG000|Overall Study|Unrelated injury|0|||
129882050|NCT03311230|467527065|FG001|Overall Study|Unrelated injury|1|||
129882051|NCT03311230|467527066|FG002|Overall Study|Unrelated injury|0|||
129882052|NCT03311230|467527067|FG003|Overall Study|Unrelated injury|0|||
129882053|NCT03342053|467527068|FG000|Overall Study|Adverse Event|2|||
129882054|NCT03342053|467527069|FG001|Overall Study|Adverse Event|0|||
129882055|NCT03342053|467527068|FG000|Overall Study|Withdrawal by Subject|0|||
129882056|NCT03342053|467527069|FG001|Overall Study|Withdrawal by Subject|1|||
129882057|NCT01302938|467527070|FG000|Overall Study|Withdrawal by Subject|1|||
129882058|NCT01302938|467527071|FG001|Overall Study|Withdrawal by Subject|0|||
129882059|NCT01302938|467527070|FG000|Overall Study|Adverse Event|1|||
129882060|NCT01302938|467527071|FG001|Overall Study|Adverse Event|0|||
129882061|NCT01233609|467527072|FG000|Overall Study|Death|1|||
129882062|NCT01233609|467527073|FG001|Overall Study|Death|0|||
129882063|NCT01233609|467527072|FG000|Overall Study|Lost to Follow-up|3|||
129882064|NCT01233609|467527073|FG001|Overall Study|Lost to Follow-up|1|||
129882065|NCT01233609|467527072|FG000|Overall Study|Adverse Event|2|||
129882066|NCT01233609|467527073|FG001|Overall Study|Adverse Event|1|||
129882067|NCT01233609|467527072|FG000|Overall Study|Withdrawal by Subject|3|||
129882068|NCT01233609|467527073|FG001|Overall Study|Withdrawal by Subject|0|||
129882069|NCT02961374|467527074|FG000|Overall Study|Adverse Event|4|||
129882070|NCT00735644|467527075|FG000|Overall Study|Did not receive study vaccine|0|||
129882071|NCT00735644|467527076|FG001|Overall Study|Did not receive study vaccine|1|||
130323103|NCT04639245|469153528|FG000|Overall Study|Death|1|||
130323104|NCT01702311|469153529|FG000|Overall Study|Withdrawal by Subject|3|||
130323105|NCT01702311|469153530|FG001|Overall Study|Withdrawal by Subject|2|||
129882072|NCT00735644|467527077|FG002|Overall Study|Did not receive study vaccine|0|||
130323106|NCT01702311|469153529|FG000|Overall Study|Discharge less than 24 hours|10|||
129882073|NCT00735644|467527078|FG003|Overall Study|Did not receive study vaccine|0|||
129882074|NCT00735644|467527079|FG004|Overall Study|Did not receive study vaccine|0|||
130323107|NCT01702311|469153530|FG001|Overall Study|Discharge less than 24 hours|7|||
130323108|NCT01702311|469153529|FG000|Overall Study|Physician Decision|3|||
130323109|NCT01702311|469153530|FG001|Overall Study|Physician Decision|4|||
130323110|NCT04106557|469153534|FG000|Overall Study|Physician Decision|0|||
130323111|NCT04106557|469153535|FG001|Overall Study|Physician Decision|1|||
130323112|NCT04106557|469153536|FG002|Overall Study|Physician Decision|0|||
130323113|NCT04106557|469153534|FG000|Overall Study|Protocol Violation|0|||
130323114|NCT04106557|469153535|FG001|Overall Study|Protocol Violation|1|||
130323115|NCT04106557|469153536|FG002|Overall Study|Protocol Violation|0|||
130323116|NCT01209689|469153537|FG000|Overall Study|Insufficient Therapeutic Response|7|||
130323117|NCT01209689|469153538|FG001|Overall Study|Insufficient Therapeutic Response|2|||
130323118|NCT01209689|469153537|FG000|Overall Study|Refused Treatment|8|||
130323119|NCT01209689|469153538|FG001|Overall Study|Refused Treatment|3|||
130323120|NCT01209689|469153537|FG000|Overall Study|Adverse Event|4|||
130323121|NCT01209689|469153538|FG001|Overall Study|Adverse Event|0|||
130323122|NCT01209689|469153537|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130323123|NCT01209689|469153538|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130323124|NCT01209689|469153537|FG000|Overall Study|Failure to Return|3|||
130323125|NCT01209689|469153538|FG001|Overall Study|Failure to Return|0|||
129882075|NCT00735644|467527075|FG000|Overall Study|Withdrawal by Subject|0|||
129882076|NCT00735644|467527076|FG001|Overall Study|Withdrawal by Subject|1|||
129882077|NCT00735644|467527077|FG002|Overall Study|Withdrawal by Subject|1|||
129882078|NCT00735644|467527078|FG003|Overall Study|Withdrawal by Subject|1|||
129882079|NCT00735644|467527079|FG004|Overall Study|Withdrawal by Subject|0|||
129882080|NCT02041923|467527082|FG000|Overall Study|Lost to Follow-up|26|||
129882081|NCT02041923|467527083|FG001|Overall Study|Lost to Follow-up|30|||
129882082|NCT00874432|467527091|FG000|Overall Study|Withdrawal by Subject|1|||
129882083|NCT00874432|467527092|FG001|Overall Study|Withdrawal by Subject|0|||
129882084|NCT00874432|467527093|FG002|Overall Study|Withdrawal by Subject|0|||
129882085|NCT00874432|467527094|FG003|Overall Study|Withdrawal by Subject|0|||
129882086|NCT00874432|467527091|FG000|Overall Study|Physician Decision|1|||
129882087|NCT00874432|467527092|FG001|Overall Study|Physician Decision|0|||
129882088|NCT00874432|467527093|FG002|Overall Study|Physician Decision|0|||
129882089|NCT00874432|467527094|FG003|Overall Study|Physician Decision|0|||
129882090|NCT00874432|467527091|FG000|Overall Study|Other|1|||
129882091|NCT00874432|467527092|FG001|Overall Study|Other|2|||
129882092|NCT00874432|467527093|FG002|Overall Study|Other|8|||
129882093|NCT00874432|467527094|FG003|Overall Study|Other|3|||
129882094|NCT01518946|467527095|FG000|Open-label Phase|Other|4|||
129882095|NCT01518946|467527096|FG001|Open-label Phase|Other|0|||
129882096|NCT01518946|467527097|FG002|Open-label Phase|Other|0|||
129882097|NCT01518946|467527095|FG000|Randomized Phase (First Intervention)|Other|0|||
129882098|NCT01518946|467527096|FG001|Randomized Phase (First Intervention)|Other|1|||
129882099|NCT01518946|467527097|FG002|Randomized Phase (First Intervention)|Other|0|||
129882100|NCT00384059|467527098|FG000|Infant Series|Not consented|2|||
129882101|NCT00384059|467527099|FG001|Infant Series|Not consented|6|||
129882102|NCT00384059|467527098|FG000|Infant Series|Withdrawal by Subject|2|||
129882103|NCT00384059|467527099|FG001|Infant Series|Withdrawal by Subject|2|||
129882104|NCT00384059|467527098|FG000|Infant Series|Adverse Event|1|||
129882105|NCT00384059|467527099|FG001|Infant Series|Adverse Event|2|||
129882106|NCT00384059|467527098|FG000|Infant Series|Protocol Violation|1|||
129882107|NCT00384059|467527099|FG001|Infant Series|Protocol Violation|2|||
129882108|NCT00384059|467527098|FG000|Infant Series|Lost to Follow-up|0|||
129882109|NCT00384059|467527099|FG001|Infant Series|Lost to Follow-up|1|||
129882110|NCT00384059|467527098|FG000|After Infant Series|Protocol Violation|2|||
129882111|NCT00384059|467527099|FG001|After Infant Series|Protocol Violation|3|||
129882112|NCT00384059|467527098|FG000|After Infant Series|Withdrawal by Subject|2|||
129882113|NCT00384059|467527099|FG001|After Infant Series|Withdrawal by Subject|2|||
129882114|NCT00384059|467527098|FG000|After Infant Series|Failed to Return|0|||
129882115|NCT00384059|467527099|FG001|After Infant Series|Failed to Return|2|||
129882116|NCT00384059|467527098|FG000|After Infant Series|Adverse Event|0|||
129882117|NCT00384059|467527099|FG001|After Infant Series|Adverse Event|1|||
129882118|NCT00384059|467527098|FG000|After Infant Series|Physician Decision|0|||
129882119|NCT00384059|467527099|FG001|After Infant Series|Physician Decision|1|||
130098697|NCT01012609|468319286|FG001|Overall Study|Withdrawal by Subject|1|||
130323126|NCT01209689|469153537|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
130323127|NCT01209689|469153538|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
130323128|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129882120|NCT00384059|467527098|FG000|After Infant Series|Lost to Follow-up|0|||
129882121|NCT00384059|467527099|FG001|After Infant Series|Lost to Follow-up|1|||
129882122|NCT00384059|467527098|FG000|Toddler Dose|Lost to Follow-up|1|||
129882123|NCT00384059|467527099|FG001|Toddler Dose|Lost to Follow-up|1|||
129882124|NCT00384059|467527098|FG000|Toddler Dose|Failed to return|0|||
129882125|NCT00384059|467527099|FG001|Toddler Dose|Failed to return|1|||
129882126|NCT01167179|467528740|FG000|Overall Study|disease recurrence|4|||
130323129|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129882127|NCT01167179|467528741|FG001|Overall Study|disease recurrence|4|||
130323130|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
130323131|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
130323132|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130323133|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
130323134|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
130323135|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323136|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323137|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130323138|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
130323139|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
130323140|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323141|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
130323142|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130323143|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130323144|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
130323145|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
130323146|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130323147|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130323148|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130323149|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
130323150|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
130323151|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
130323152|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
130323153|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130323154|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130323155|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
130323156|NCT03175367|469153539|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323157|NCT03175367|469153540|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323158|NCT03175367|469153541|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130323159|NCT03175367|469153542|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323160|NCT03175367|469153543|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
130323161|NCT03175367|469153544|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323162|NCT03175367|469153545|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130323163|NCT03175367|469153539|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323164|NCT03175367|469153540|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323165|NCT03175367|469153541|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323166|NCT03175367|469153542|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323167|NCT03175367|469153543|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323168|NCT03175367|469153544|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
130323169|NCT03175367|469153545|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
130323170|NCT03175367|469153539|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323171|NCT03175367|469153540|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323172|NCT03175367|469153541|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323173|NCT03175367|469153542|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323174|NCT03175367|469153543|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130323175|NCT03175367|469153544|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
130323176|NCT03175367|469153545|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130323177|NCT02151058|469153547|FG000|Overall Study|Withdrawal by Subject|1|||
130323178|NCT02151058|469153548|FG001|Overall Study|Withdrawal by Subject|1|||
130323179|NCT02151058|469153549|FG002|Overall Study|Withdrawal by Subject|3|||
130323180|NCT02151058|469153547|FG000|Overall Study|Lost to Follow-up|1|||
130323181|NCT02151058|469153548|FG001|Overall Study|Lost to Follow-up|0|||
130323182|NCT02151058|469153549|FG002|Overall Study|Lost to Follow-up|2|||
130323183|NCT03829228|469153550|FG000|Overall Study|Protocol Violation|1|||
130323184|NCT03337477|469153551|FG000|Overall Study|not categorized into the listed ones|11|||
130323185|NCT03337477|469153552|FG001|Overall Study|not categorized into the listed ones|9|||
130323186|NCT03337477|469153551|FG000|Overall Study|Withdrawal by Subject|0|||
130323187|NCT03337477|469153552|FG001|Overall Study|Withdrawal by Subject|1|||
130323188|NCT03337477|469153551|FG000|Overall Study|Death|0|||
130323189|NCT03337477|469153552|FG001|Overall Study|Death|1|||
130323190|NCT03337477|469153551|FG000|Overall Study|Lost to Follow-up|0|||
130323191|NCT03337477|469153552|FG001|Overall Study|Lost to Follow-up|2|||
130323192|NCT01462370|469153559|FG000|Overall Study|Lack of Qualifying Event|1|||
130323193|NCT01462370|469153560|FG001|Overall Study|Lack of Qualifying Event|1|||
130323194|NCT01462370|469153559|FG000|Overall Study|Physician Decision|0|||
130323195|NCT01462370|469153560|FG001|Overall Study|Physician Decision|1|||
130323196|NCT01462370|469153559|FG000|Overall Study|Withdrawal by Subject|0|||
130323197|NCT01462370|469153560|FG001|Overall Study|Withdrawal by Subject|3|||
129882128|NCT01167179|467528740|FG000|Overall Study|Death|4|||
129882129|NCT01167179|467528741|FG001|Overall Study|Death|10|||
129882130|NCT01167179|467528740|FG000|Overall Study|Withdrawal by Subject|1|||
129882131|NCT01167179|467528741|FG001|Overall Study|Withdrawal by Subject|2|||
129882132|NCT01167179|467528740|FG000|Overall Study|diverse|6|||
129882133|NCT01167179|467528741|FG001|Overall Study|diverse|5|||
129882134|NCT02781506|467528742|FG000|Overall Study|Adverse Event|5|||
129882135|NCT01158378|467528743|FG000|Overall Study|Death|4|||
129882136|NCT01158378|467528744|FG001|Overall Study|Death|5|||
129882137|NCT01158378|467528743|FG000|Overall Study|Lost to Follow-up|2|||
129882138|NCT01158378|467528744|FG001|Overall Study|Lost to Follow-up|4|||
129882139|NCT01158378|467528743|FG000|Overall Study|Withdrawal by Subject|4|||
129882140|NCT01158378|467528744|FG001|Overall Study|Withdrawal by Subject|0|||
129882141|NCT03017235|467528745|FG000|Overall Study|Withdrawal by Subject|4|||
129882142|NCT03017235|467528746|FG001|Overall Study|Withdrawal by Subject|3|||
129882143|NCT03017235|467528745|FG000|Overall Study|Lost to Follow-up|2|||
129882144|NCT03017235|467528746|FG001|Overall Study|Lost to Follow-up|7|||
129882145|NCT03017235|467528745|FG000|Overall Study|Adverse Event|0|||
129882146|NCT03017235|467528746|FG001|Overall Study|Adverse Event|1|||
129882147|NCT03017235|467528745|FG000|Overall Study|Protocol Violation|2|||
129882148|NCT03017235|467528746|FG001|Overall Study|Protocol Violation|1|||
129882149|NCT03017235|467528745|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
129882150|NCT03017235|467528746|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
129882151|NCT02593539|467528750|FG000|Overall Study|Adverse Event|1|||
129882152|NCT00649389|467528751|FG000|Overall Study|Adverse Event|22|||
129882153|NCT00649389|467528752|FG001|Overall Study|Adverse Event|46|||
129882154|NCT00649389|467528753|FG002|Overall Study|Adverse Event|38|||
129882155|NCT00649389|467528754|FG003|Overall Study|Adverse Event|48|||
129882156|NCT00649389|467528751|FG000|Overall Study|Lost to Follow-up|15|||
129882157|NCT00649389|467528752|FG001|Overall Study|Lost to Follow-up|17|||
129882158|NCT00649389|467528753|FG002|Overall Study|Lost to Follow-up|21|||
129882159|NCT00649389|467528754|FG003|Overall Study|Lost to Follow-up|26|||
129882160|NCT00649389|467528751|FG000|Overall Study|Protocol Violation|11|||
129882161|NCT00649389|467528752|FG001|Overall Study|Protocol Violation|13|||
129882162|NCT00649389|467528753|FG002|Overall Study|Protocol Violation|9|||
129882163|NCT00649389|467528754|FG003|Overall Study|Protocol Violation|8|||
129882164|NCT00649389|467528751|FG000|Overall Study|Withdrawal by Subject|20|||
129882165|NCT00649389|467528752|FG001|Overall Study|Withdrawal by Subject|21|||
129882166|NCT00649389|467528753|FG002|Overall Study|Withdrawal by Subject|19|||
129882167|NCT00649389|467528754|FG003|Overall Study|Withdrawal by Subject|23|||
129882168|NCT00649389|467528751|FG000|Overall Study|Other|3|||
129882169|NCT00649389|467528752|FG001|Overall Study|Other|9|||
129882170|NCT00649389|467528753|FG002|Overall Study|Other|1|||
129882171|NCT00649389|467528754|FG003|Overall Study|Other|6|||
129882172|NCT01806740|467528755|FG000|Overall Study|Withdrawal by Subject|4|||
130214115|NCT00528372|468746962|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
130214116|NCT00528372|468746963|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
130214117|NCT00528372|468746964|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
130214118|NCT00528372|468746965|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
130214119|NCT02772809|468746968|FG000|Overall Study|not completed some tasks|6|||
130214120|NCT00534105|468746969|FG000|Overall Study|Lost to Follow-up|23|||
130214121|NCT00534105|468746970|FG001|Overall Study|Lost to Follow-up|39|||
130214122|NCT02774005|468746971|FG000|Overall Study|Adverse Event|8|||
130214123|NCT02774005|468746971|FG000|Overall Study|Withdrawal by Subject|23|||
130214124|NCT02774005|468746971|FG000|Overall Study|Lost to Follow-up|7|||
130214125|NCT02774005|468746971|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
130214126|NCT02774005|468746971|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
130214127|NCT02774005|468746971|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
130214128|NCT02774005|468746971|FG000|Overall Study|Death|1|||
130214129|NCT02774005|468746971|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
130214130|NCT02774005|468746971|FG000|Overall Study|Lack of compliance with study medication|4|||
130214131|NCT02774005|468746971|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
130214132|NCT02774005|468746971|FG000|Overall Study|another study|1|||
130323198|NCT00853307|469153561|FG000|Overall Study|Adverse Event|1|||
129882173|NCT01806740|467528755|FG000|Overall Study|Physician Decision|1|||
129882174|NCT01806740|467528755|FG000|Overall Study|Patient's refusal of treatment|1|||
129882175|NCT00592319|467528758|FG000|Overall Study|Lost to Follow-up|0|||
129882176|NCT00592319|467528759|FG001|Overall Study|Lost to Follow-up|3|||
129882177|NCT02757521|467528763|FG000|Overall Study|Adverse Event|1|||
129882178|NCT02757521|467528764|FG001|Overall Study|Adverse Event|0|||
129882179|NCT00003511|467528765|FG000|Overall Study|Not evaluable|4|||
129882180|NCT00312858|467528773|FG000|Overall Study|Adverse Event|0|||
129882181|NCT00312858|467528774|FG001|Overall Study|Adverse Event|1|||
129882182|NCT00312858|467528773|FG000|Overall Study|Lost to Follow-up|25|||
129882183|NCT00312858|467528774|FG001|Overall Study|Lost to Follow-up|42|||
129882184|NCT00312858|467528773|FG000|Overall Study|Protocol Violation|3|||
129882185|NCT00312858|467528774|FG001|Overall Study|Protocol Violation|8|||
130323199|NCT00853307|469153562|FG001|Overall Study|Adverse Event|2|||
130323200|NCT00853307|469153561|FG000|Overall Study|Withdrawal by Subject|1|||
130323201|NCT00853307|469153562|FG001|Overall Study|Withdrawal by Subject|2|||
130323202|NCT00853307|469153561|FG000|Overall Study|Reason Not Specified|0|||
129882186|NCT00312858|467528773|FG000|Overall Study|Withdraw by Participant|20|||
129882187|NCT00312858|467528774|FG001|Overall Study|Withdraw by Participant|20|||
129882188|NCT00312858|467528773|FG000|Overall Study|Participant Moved|11|||
129882189|NCT00312858|467528774|FG001|Overall Study|Participant Moved|10|||
129882190|NCT00312858|467528773|FG000|Overall Study|Other|9|||
129882191|NCT00312858|467528774|FG001|Overall Study|Other|12|||
129882192|NCT00802659|467528775|FG000|Overall Study|Physician Decision|0|||
129882193|NCT00802659|467528776|FG001|Overall Study|Physician Decision|1|||
129882194|NCT00802659|467528777|FG002|Overall Study|Physician Decision|0|||
129882195|NCT00802659|467528778|FG003|Overall Study|Physician Decision|0|||
129882196|NCT05340751|467528781|FG000|Overall Study|Physician Decision|3|||
129882197|NCT04399551|467528782|FG000|Overall Study|Adverse Event|15|||
129882198|NCT04399551|467528782|FG000|Overall Study|Withdrawal by Subject|6|||
129882199|NCT04399551|467528782|FG000|Overall Study|Physician Decision|3|||
129882200|NCT04399551|467528782|FG000|Overall Study|Lost to Follow-up|2|||
129882201|NCT04399551|467528782|FG000|Overall Study|Protocol Deviation|2|||
129882202|NCT01014975|467528783|FG000|Overall Study|Withdrawal by Subject|1|||
129882203|NCT01014975|467528784|FG001|Overall Study|Withdrawal by Subject|0|||
129882204|NCT01014975|467528785|FG002|Overall Study|Withdrawal by Subject|1|||
129882205|NCT01014975|467528783|FG000|Overall Study|Death|3|||
129882206|NCT01014975|467528784|FG001|Overall Study|Death|3|||
129882207|NCT01014975|467528785|FG002|Overall Study|Death|4|||
129882208|NCT01014975|467528783|FG000|Overall Study|Lost to Follow-up|0|||
129882209|NCT01014975|467528784|FG001|Overall Study|Lost to Follow-up|0|||
129882210|NCT01014975|467528785|FG002|Overall Study|Lost to Follow-up|1|||
129882211|NCT01336634|467528788|FG000|Overall Study|Study closed/terminated|5|||
129882212|NCT01336634|467528789|FG001|Overall Study|Study closed/terminated|6|||
129882213|NCT01336634|467528790|FG002|Overall Study|Study closed/terminated|6|||
129882214|NCT01336634|467528788|FG000|Overall Study|Lost to Follow-up|2|||
129882215|NCT01336634|467528789|FG001|Overall Study|Lost to Follow-up|1|||
129882216|NCT01336634|467528790|FG002|Overall Study|Lost to Follow-up|1|||
129882217|NCT01336634|467528788|FG000|Overall Study|Physician Decision|1|||
129882218|NCT01336634|467528789|FG001|Overall Study|Physician Decision|1|||
129882219|NCT01336634|467528790|FG002|Overall Study|Physician Decision|0|||
129882220|NCT01336634|467528788|FG000|Overall Study|Withdrawal by Subject|6|||
129882221|NCT01336634|467528789|FG001|Overall Study|Withdrawal by Subject|0|||
129882222|NCT01336634|467528790|FG002|Overall Study|Withdrawal by Subject|2|||
129882223|NCT02961881|467528791|FG000|Overall Study|Adverse Event|1|||
129882224|NCT02961881|467528792|FG001|Overall Study|Adverse Event|2|||
129882225|NCT02961881|467528793|FG002|Overall Study|Adverse Event|2|||
129882226|NCT02961881|467528794|FG003|Overall Study|Adverse Event|0|||
129882227|NCT02961881|467528795|FG004|Overall Study|Adverse Event|1|||
129882228|NCT02961881|467528791|FG000|Overall Study|Participant request|0|||
129882229|NCT02961881|467528792|FG001|Overall Study|Participant request|2|||
129882230|NCT02961881|467528793|FG002|Overall Study|Participant request|0|||
129882231|NCT02961881|467528794|FG003|Overall Study|Participant request|0|||
129882232|NCT02961881|467528795|FG004|Overall Study|Participant request|0|||
130323203|NCT00853307|469153562|FG001|Overall Study|Reason Not Specified|1|||
130323204|NCT00473564|469153563|FG000|Overall Study|robot surgery aborted in OR|23|||
130323205|NCT00674817|469153564|FG000|Period 1|Withdrawal by Subject|2|||
130323206|NCT00674817|469153564|FG000|Period 1|Protocol Violation|1|||
130323207|NCT00674817|469153564|FG000|Period 3|Adverse Event|1|||
130323208|NCT00674817|469153564|FG000|Period 3|Protocol Violation|1|||
130323209|NCT00674817|469153564|FG000|Period 4|Adverse Event|1|||
130323210|NCT00837434|469153566|FG000|Overall Study|Physician Decision|3|||
130323211|NCT00837434|469153567|FG001|Overall Study|Physician Decision|0|||
130323212|NCT00837434|469153566|FG000|Overall Study|Lost to Follow-up|1|||
130323213|NCT00837434|469153567|FG001|Overall Study|Lost to Follow-up|1|||
130323214|NCT00837434|469153566|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
130323215|NCT00837434|469153567|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
130323216|NCT00837434|469153566|FG000|Overall Study|Noncompliant|2|||
129882233|NCT02961881|467528791|FG000|Overall Study|Disease progression|1|||
129882234|NCT02961881|467528792|FG001|Overall Study|Disease progression|0|||
129882235|NCT02961881|467528793|FG002|Overall Study|Disease progression|1|||
129882236|NCT02961881|467528794|FG003|Overall Study|Disease progression|0|||
129882237|NCT02961881|467528795|FG004|Overall Study|Disease progression|0|||
129882238|NCT01863043|467528796|FG000|Overall Study|Death|6|||
129882239|NCT01863043|467528797|FG001|Overall Study|Death|1|||
129882240|NCT01863043|467528796|FG000|Overall Study|Withdrawal by Subject|0|||
129882241|NCT01863043|467528797|FG001|Overall Study|Withdrawal by Subject|2|||
129882242|NCT01863043|467528796|FG000|Overall Study|Adverse Event|7|||
129882243|NCT01863043|467528797|FG001|Overall Study|Adverse Event|8|||
130323217|NCT00837434|469153567|FG001|Overall Study|Noncompliant|0|||
130323218|NCT00837434|469153566|FG000|Overall Study|Baseline assessments not done in time|1|||
130323219|NCT00837434|469153567|FG001|Overall Study|Baseline assessments not done in time|0|||
130323220|NCT00837434|469153566|FG000|Overall Study|Unable to obtain study drug|1|||
130323221|NCT00837434|469153567|FG001|Overall Study|Unable to obtain study drug|0|||
130323222|NCT00459316|469153568|FG000|Steps 1 & 2|Other eligibility failure|1|||
130323223|NCT00459316|469153569|FG001|Steps 1 & 2|Other eligibility failure|1|||
130323224|NCT00459316|469153570|FG002|Steps 1 & 2|Other eligibility failure|0|||
130323225|NCT00459316|469153568|FG000|Steps 1 & 2|Death|1|||
130323226|NCT00459316|469153569|FG001|Steps 1 & 2|Death|1|||
130323227|NCT00459316|469153570|FG002|Steps 1 & 2|Death|0|||
130323228|NCT00459316|469153568|FG000|Steps 1 & 2|Not able to get to clinic|7|||
130323229|NCT00459316|469153569|FG001|Steps 1 & 2|Not able to get to clinic|4|||
130323230|NCT00459316|469153570|FG002|Steps 1 & 2|Not able to get to clinic|0|||
130323231|NCT00459316|469153568|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
130323232|NCT00459316|469153569|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
130323233|NCT00459316|469153570|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
130323234|NCT00459316|469153568|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
130323235|NCT00459316|469153569|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
130323236|NCT00459316|469153570|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
130323237|NCT00459316|469153568|FG000|Steps 1 & 2|Lost to Follow-up|5|||
130323238|NCT00459316|469153569|FG001|Steps 1 & 2|Lost to Follow-up|0|||
130323239|NCT00459316|469153570|FG002|Steps 1 & 2|Lost to Follow-up|2|||
130323240|NCT00459316|469153568|FG000|Step 3|Withdrawal by Subject|3|||
130323241|NCT00459316|469153569|FG001|Step 3|Withdrawal by Subject|0|||
130323242|NCT00459316|469153570|FG002|Step 3|Withdrawal by Subject|1|||
130323243|NCT01614886|469153571|FG000|Overall Study|Adverse Event|15|||
130323244|NCT01614886|469153572|FG001|Overall Study|Adverse Event|20|||
130323245|NCT01614886|469153571|FG000|Overall Study|Withdrawal by Subject|4|||
130323246|NCT01614886|469153572|FG001|Overall Study|Withdrawal by Subject|4|||
130323247|NCT01614886|469153571|FG000|Overall Study|Death|1|||
130323248|NCT01614886|469153572|FG001|Overall Study|Death|0|||
130323249|NCT01614886|469153571|FG000|Overall Study|Protocol deviation|0|||
130323250|NCT01614886|469153572|FG001|Overall Study|Protocol deviation|2|||
130323251|NCT01207414|469153574|FG000|Overall Study|Adverse Event|25|||
130323252|NCT01207414|469153575|FG001|Overall Study|Adverse Event|39|||
130323253|NCT01207414|469153574|FG000|Overall Study|Abnormal test procedure results|0|||
130323254|NCT01207414|469153575|FG001|Overall Study|Abnormal test procedure results|1|||
130323255|NCT01207414|469153574|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130323256|NCT01207414|469153575|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130323257|NCT01207414|469153574|FG000|Overall Study|Patient withdrew consent|14|||
130323258|NCT01207414|469153575|FG001|Overall Study|Patient withdrew consent|11|||
129882244|NCT01863043|467528796|FG000|Overall Study|exclusion criteria found after enrollment|0|||
129882245|NCT01863043|467528797|FG001|Overall Study|exclusion criteria found after enrollment|1|||
129882246|NCT01912781|467528798|FG000|Overall Study|Withdrawal by Subject|2|||
129882247|NCT01912781|467528799|FG001|Overall Study|Withdrawal by Subject|0|||
129882248|NCT00854295|467528802|FG000|Overall Study|Death|7|||
129882249|NCT00854295|467528803|FG001|Overall Study|Death|0|||
129882250|NCT00854295|467528804|FG002|Overall Study|Death|1|||
129882251|NCT00854295|467528805|FG003|Overall Study|Death|1|||
129882252|NCT00854295|467528802|FG000|Overall Study|Adverse Event|6|||
129882253|NCT00854295|467528803|FG001|Overall Study|Adverse Event|1|||
129882254|NCT00854295|467528804|FG002|Overall Study|Adverse Event|1|||
129882255|NCT00854295|467528805|FG003|Overall Study|Adverse Event|3|||
129882256|NCT00854295|467528802|FG000|Overall Study|Lost to Follow-up|18|||
129882257|NCT00854295|467528803|FG001|Overall Study|Lost to Follow-up|5|||
129882258|NCT00854295|467528804|FG002|Overall Study|Lost to Follow-up|21|||
129882259|NCT00854295|467528805|FG003|Overall Study|Lost to Follow-up|21|||
129882260|NCT00854295|467528802|FG000|Overall Study|Physician Decision|10|||
129882261|NCT00854295|467528803|FG001|Overall Study|Physician Decision|0|||
129882262|NCT00854295|467528804|FG002|Overall Study|Physician Decision|0|||
129882263|NCT00854295|467528805|FG003|Overall Study|Physician Decision|0|||
129882264|NCT04250337|467528806|FG000|Overall Study|Adverse Event|0|||
129882265|NCT04250337|467528807|FG001|Overall Study|Adverse Event|3|||
129882266|NCT04250337|467528806|FG000|Overall Study|Lack of Efficacy|1|||
129882267|NCT04250337|467528807|FG001|Overall Study|Lack of Efficacy|3|||
129882268|NCT04250337|467528806|FG000|Overall Study|Physician Decision|1|||
129882269|NCT04250337|467528807|FG001|Overall Study|Physician Decision|0|||
129882270|NCT04250337|467528806|FG000|Overall Study|Protocol Deviation|2|||
129882271|NCT04250337|467528807|FG001|Overall Study|Protocol Deviation|2|||
129882272|NCT04250337|467528806|FG000|Overall Study|Withdrawal by Subject|4|||
129882273|NCT04250337|467528807|FG001|Overall Study|Withdrawal by Subject|3|||
129882274|NCT05033743|467528813|FG000|Overall Study|Lost to Follow-up|1|||
129882275|NCT05033743|467528813|FG000|Overall Study|Protocol Violation|2|||
130323259|NCT01207414|469153574|FG000|Overall Study|Lost to Follow-up|15|||
130323260|NCT01207414|469153575|FG001|Overall Study|Lost to Follow-up|17|||
130323261|NCT01207414|469153574|FG000|Overall Study|Administrative problems|1|||
130323262|NCT01207414|469153575|FG001|Overall Study|Administrative problems|1|||
130323263|NCT01207414|469153574|FG000|Overall Study|Protocol deviation|12|||
130323264|NCT01207414|469153575|FG001|Overall Study|Protocol deviation|9|||
130323265|NCT01207414|469153574|FG000|Overall Study|Randomized in error|1|||
129882276|NCT05033743|467528813|FG000|Overall Study|Withdrawal by Subject|1|||
129882277|NCT04537897|467528814|FG000|Overall Study|Other than listed|0|||
129882278|NCT04537897|467528815|FG001|Overall Study|Other than listed|0|||
129882279|NCT04537897|467528816|FG002|Overall Study|Other than listed|0|||
129882280|NCT04537897|467528817|FG003|Overall Study|Other than listed|0|||
129882281|NCT04537897|467528818|FG004|Overall Study|Other than listed|0|||
129882282|NCT04537897|467528819|FG005|Overall Study|Other than listed|0|||
129882283|NCT04537897|467528820|FG006|Overall Study|Other than listed|1|||
129882284|NCT04537897|467528821|FG007|Overall Study|Other than listed|0|||
129882285|NCT04537897|467528822|FG008|Overall Study|Other than listed|0|||
129882286|NCT04537897|467528814|FG000|Overall Study|Adverse Event|0|||
129882287|NCT04537897|467528815|FG001|Overall Study|Adverse Event|0|||
129882288|NCT04537897|467528816|FG002|Overall Study|Adverse Event|0|||
129882289|NCT04537897|467528817|FG003|Overall Study|Adverse Event|1|||
129882290|NCT04537897|467528818|FG004|Overall Study|Adverse Event|0|||
129882291|NCT04537897|467528819|FG005|Overall Study|Adverse Event|0|||
129882292|NCT04537897|467528820|FG006|Overall Study|Adverse Event|0|||
129882293|NCT04537897|467528821|FG007|Overall Study|Adverse Event|0|||
129882294|NCT04537897|467528822|FG008|Overall Study|Adverse Event|0|||
129882295|NCT04537897|467528814|FG000|Overall Study|Withdrawal by Subject|0|||
129882296|NCT04537897|467528815|FG001|Overall Study|Withdrawal by Subject|1|||
129882297|NCT04537897|467528816|FG002|Overall Study|Withdrawal by Subject|0|||
129882298|NCT04537897|467528817|FG003|Overall Study|Withdrawal by Subject|0|||
129882299|NCT04537897|467528818|FG004|Overall Study|Withdrawal by Subject|0|||
129882300|NCT04537897|467528819|FG005|Overall Study|Withdrawal by Subject|0|||
129882301|NCT04537897|467528820|FG006|Overall Study|Withdrawal by Subject|0|||
129882302|NCT04537897|467528821|FG007|Overall Study|Withdrawal by Subject|0|||
129882303|NCT04537897|467528822|FG008|Overall Study|Withdrawal by Subject|0|||
129882304|NCT00197028|467528826|FG000|Overall Study|Adverse Event|2|||
129882305|NCT00197028|467528827|FG001|Overall Study|Adverse Event|2|||
129882306|NCT00197028|467528826|FG000|Overall Study|Protocol Violation|2|||
129882307|NCT00197028|467528827|FG001|Overall Study|Protocol Violation|1|||
129882308|NCT00197028|467528826|FG000|Overall Study|Withdrawal by Subject|8|||
129882309|NCT00197028|467528827|FG001|Overall Study|Withdrawal by Subject|12|||
129882310|NCT00197028|467528826|FG000|Overall Study|Lost to Follow-up|1|||
129882311|NCT00197028|467528827|FG001|Overall Study|Lost to Follow-up|0|||
129882312|NCT00197028|467528826|FG000|Overall Study|Other|3|||
129882313|NCT00197028|467528827|FG001|Overall Study|Other|6|||
129882314|NCT00885352|467528832|FG000|Overall Study|Adverse Event|2|||
129882315|NCT00885352|467528833|FG001|Overall Study|Adverse Event|3|||
129882316|NCT00885352|467528832|FG000|Overall Study|Lost to Follow-up|2|||
129882317|NCT00885352|467528833|FG001|Overall Study|Lost to Follow-up|2|||
129882318|NCT00885352|467528832|FG000|Overall Study|Physician Decision|0|||
129882319|NCT00885352|467528833|FG001|Overall Study|Physician Decision|3|||
129882320|NCT00885352|467528832|FG000|Overall Study|Protocol Violation|0|||
129882321|NCT00885352|467528833|FG001|Overall Study|Protocol Violation|2|||
129882322|NCT00885352|467528832|FG000|Overall Study|Withdrawal by Subject|1|||
129882323|NCT00885352|467528833|FG001|Overall Study|Withdrawal by Subject|5|||
129882324|NCT00885352|467528832|FG000|Overall Study|Contradiction to study medication|0|||
129882325|NCT00885352|467528833|FG001|Overall Study|Contradiction to study medication|2|||
129882326|NCT00885352|467528832|FG000|Overall Study|Excluded medication|2|||
129882327|NCT00885352|467528833|FG001|Overall Study|Excluded medication|2|||
129882328|NCT00885352|467528832|FG000|Overall Study|Lab abnormalities|1|||
129882329|NCT00885352|467528833|FG001|Overall Study|Lab abnormalities|1|||
129882330|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
129882331|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
129882332|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129882333|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
129882334|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
129882335|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
129882336|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
129882337|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
129882338|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
129882339|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
129882340|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
129882341|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
129882342|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
129882343|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
129882344|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
129882345|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
129882346|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
129882347|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
129882348|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
129882349|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
129882350|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
129882351|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
129882352|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
129882353|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
129882354|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
129882355|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
129882356|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
129882357|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
129882358|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
129882359|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
130323266|NCT01207414|469153575|FG001|Overall Study|Randomized in error|0|||
130323267|NCT03697252|469153578|FG000|Overall Study|Adverse Event|3|||
130323268|NCT03697252|469153579|FG001|Overall Study|Adverse Event|2|||
130323269|NCT03697252|469153578|FG000|Overall Study|Withdrawal by Subject|14|||
130323270|NCT03697252|469153579|FG001|Overall Study|Withdrawal by Subject|14|||
130323271|NCT03697252|469153578|FG000|Overall Study|Lost to Follow-up|0|||
130323272|NCT03697252|469153579|FG001|Overall Study|Lost to Follow-up|1|||
130323273|NCT03697252|469153578|FG000|Overall Study|Physician Decision|1|||
130323274|NCT03697252|469153579|FG001|Overall Study|Physician Decision|1|||
130323275|NCT03697252|469153578|FG000|Overall Study|Other|0|||
130323276|NCT03697252|469153579|FG001|Overall Study|Other|1|||
130323277|NCT02340026|469153580|FG000|Treatment Phase|Withdrawal by Subject|2|||
130323278|NCT02340026|469153581|FG001|Treatment Phase|Withdrawal by Subject|2|||
130323279|NCT02340026|469153580|FG000|Follow-up Phase|Lost to Follow-up|1|||
130323280|NCT02340026|469153581|FG001|Follow-up Phase|Lost to Follow-up|0|||
130323281|NCT02738801|469153593|FG000|Overall Study|Adverse Event|1|||
130323282|NCT02738801|469153594|FG001|Overall Study|Adverse Event|1|||
130323283|NCT02738801|469153593|FG000|Overall Study|Withdrawal by Subject|0|||
130323284|NCT02738801|469153594|FG001|Overall Study|Withdrawal by Subject|1|||
130323285|NCT00888134|469153609|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
130323286|NCT00888134|469153609|FG000|Follow-up|being followed for long-term survival|1|||
130323287|NCT01488890|469153612|FG000|Overall Study|Serious adverse event|2|||
130323288|NCT01488890|469153613|FG001|Overall Study|Serious adverse event|0|||
130323289|NCT01488890|469153614|FG002|Overall Study|Serious adverse event|0|||
130323290|NCT01488890|469153615|FG003|Overall Study|Serious adverse event|0|||
130323291|NCT01488890|469153612|FG000|Overall Study|Protocol Violation|3|||
130323292|NCT01488890|469153613|FG001|Overall Study|Protocol Violation|0|||
130323293|NCT01488890|469153614|FG002|Overall Study|Protocol Violation|4|||
130323294|NCT01488890|469153615|FG003|Overall Study|Protocol Violation|0|||
130323295|NCT01488890|469153612|FG000|Overall Study|Lost to Follow-up|13|||
130323296|NCT01488890|469153613|FG001|Overall Study|Lost to Follow-up|10|||
130323297|NCT01488890|469153614|FG002|Overall Study|Lost to Follow-up|20|||
130323298|NCT01488890|469153615|FG003|Overall Study|Lost to Follow-up|3|||
130323299|NCT01488890|469153612|FG000|Overall Study|Withdrawal by Subject|14|||
130323300|NCT01488890|469153613|FG001|Overall Study|Withdrawal by Subject|10|||
130323301|NCT01488890|469153614|FG002|Overall Study|Withdrawal by Subject|11|||
130323302|NCT01488890|469153615|FG003|Overall Study|Withdrawal by Subject|2|||
130323303|NCT05712460|469153616|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323304|NCT05712460|469153617|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323305|NCT05712460|469153618|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323306|NCT05712460|469153619|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323307|NCT05712460|469153620|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323308|NCT05712460|469153621|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323309|NCT05712460|469153622|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323310|NCT05712460|469153623|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
130323311|NCT05712460|469153624|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323312|NCT05712460|469153625|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323313|NCT05712460|469153626|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323314|NCT05712460|469153627|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
130323315|NCT00829426|469153632|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130323316|NCT00829426|469153633|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130323317|NCT05135767|469153636|FG000|Baseline|Lost to Follow-up|1|||
130323318|NCT05135767|469153637|FG001|Baseline|Lost to Follow-up|1|||
129882360|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
129882361|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
130323319|NCT05135767|469153636|FG000|Baseline|Withdrawal by Subject|0|||
130323320|NCT05135767|469153637|FG001|Baseline|Withdrawal by Subject|2|||
130323321|NCT05135767|469153636|FG000|Active Study Phase|Lost to Follow-up|2|||
130323322|NCT05135767|469153637|FG001|Active Study Phase|Lost to Follow-up|0|||
130323323|NCT02260934|469153643|FG000|Overall Study|Lost to Follow-up|2|||
129882362|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
130323324|NCT02260934|469153644|FG001|Overall Study|Lost to Follow-up|1|||
130323325|NCT02260934|469153643|FG000|Overall Study|Withdrawal by Subject|0|||
130323326|NCT02260934|469153644|FG001|Overall Study|Withdrawal by Subject|2|||
130323327|NCT02260934|469153643|FG000|Overall Study|Participant Relocated|1|||
130323328|NCT02260934|469153644|FG001|Overall Study|Participant Relocated|0|||
129882363|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
129882364|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
129882365|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
129882366|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
129882367|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
129882368|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
129882369|NCT00365378|467528834|FG000|Extension|Adverse Event|0|||
129882370|NCT00365378|467528835|FG001|Extension|Adverse Event|0|||
129882371|NCT00365378|467528836|FG002|Extension|Adverse Event|1|||
129882372|NCT00365378|467528834|FG000|Extension|Moved|0|||
129882373|NCT00365378|467528835|FG001|Extension|Moved|0|||
129882374|NCT00365378|467528836|FG002|Extension|Moved|8|||
129882375|NCT00365378|467528834|FG000|Extension|Lost to Follow-up|0|||
129882376|NCT00365378|467528835|FG001|Extension|Lost to Follow-up|0|||
129882377|NCT00365378|467528836|FG002|Extension|Lost to Follow-up|57|||
129882378|NCT00365378|467528834|FG000|Extension|Protocol Violation|0|||
129882379|NCT00365378|467528835|FG001|Extension|Protocol Violation|0|||
129882380|NCT00365378|467528836|FG002|Extension|Protocol Violation|2|||
129882381|NCT00365378|467528834|FG000|Extension|Withdrawal by Subject|0|||
129882382|NCT00365378|467528835|FG001|Extension|Withdrawal by Subject|0|||
129882383|NCT00365378|467528836|FG002|Extension|Withdrawal by Subject|98|||
129882384|NCT00365378|467528834|FG000|Extension|Other|0|||
129882385|NCT00365378|467528835|FG001|Extension|Other|0|||
129882386|NCT00365378|467528836|FG002|Extension|Other|31|||
129882387|NCT04161807|467528842|FG000|Overall Study|Withdrawal by Subject|2|||
129882388|NCT04161807|467528842|FG000|Overall Study|Performed only 1 treatment|2|||
129882389|NCT00669903|467528845|FG000|Overall Study|Adverse Event|0|||
129882390|NCT00669903|467528846|FG001|Overall Study|Adverse Event|1|||
129882391|NCT00669903|467528847|FG002|Overall Study|Adverse Event|3|||
129882392|NCT00669903|467528848|FG003|Overall Study|Adverse Event|1|||
129882393|NCT00669903|467528845|FG000|Overall Study|Withdrawal by Subject|0|||
129882394|NCT00669903|467528846|FG001|Overall Study|Withdrawal by Subject|2|||
129882395|NCT00669903|467528847|FG002|Overall Study|Withdrawal by Subject|2|||
129882396|NCT00669903|467528848|FG003|Overall Study|Withdrawal by Subject|2|||
129882397|NCT00669903|467528845|FG000|Overall Study|Lost to Follow-up|1|||
129882398|NCT00669903|467528846|FG001|Overall Study|Lost to Follow-up|1|||
129882399|NCT00669903|467528847|FG002|Overall Study|Lost to Follow-up|0|||
129882400|NCT00669903|467528848|FG003|Overall Study|Lost to Follow-up|1|||
129882401|NCT00669903|467528845|FG000|Overall Study|Protocol Violation|0|||
129882402|NCT00669903|467528846|FG001|Overall Study|Protocol Violation|1|||
129882403|NCT00669903|467528847|FG002|Overall Study|Protocol Violation|0|||
129882404|NCT00669903|467528848|FG003|Overall Study|Protocol Violation|0|||
129882405|NCT04789577|467528851|FG000|Overall Study|Withdrawal by Subject|1|||
129882406|NCT04789577|467528852|FG001|Overall Study|Withdrawal by Subject|1|||
130214133|NCT02774005|468746971|FG000|Overall Study|cardiologist imposed travel restriction|1|||
130214134|NCT03275389|468746975|FG000|Overall Study|Lost to Follow-up|10|||
129882407|NCT04789577|467528853|FG002|Overall Study|Withdrawal by Subject|1|||
129882408|NCT04789577|467528854|FG003|Overall Study|Withdrawal by Subject|3|||
129882409|NCT04789577|467528855|FG004|Overall Study|Withdrawal by Subject|1|||
129882410|NCT04789577|467528856|FG005|Overall Study|Withdrawal by Subject|7|||
129882411|NCT04789577|467528857|FG006|Overall Study|Withdrawal by Subject|1|||
130214135|NCT03275389|468746976|FG001|Overall Study|Lost to Follow-up|10|||
130214136|NCT03275389|468746977|FG002|Overall Study|Lost to Follow-up|19|||
130214137|NCT03275389|468746978|FG003|Overall Study|Lost to Follow-up|12|||
130214138|NCT03275389|468746979|FG004|Overall Study|Lost to Follow-up|11|||
130214139|NCT03275389|468746980|FG005|Overall Study|Lost to Follow-up|12|||
130214140|NCT03275389|468746981|FG006|Overall Study|Lost to Follow-up|21|||
130214141|NCT03275389|468746982|FG007|Overall Study|Lost to Follow-up|15|||
130214142|NCT03275389|468746983|FG008|Overall Study|Lost to Follow-up|12|||
130214143|NCT03275389|468746984|FG009|Overall Study|Lost to Follow-up|14|||
130214144|NCT03275389|468746975|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214145|NCT03275389|468746976|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214146|NCT03275389|468746977|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214147|NCT03275389|468746978|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214148|NCT03275389|468746979|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214149|NCT03275389|468746980|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
130214150|NCT03275389|468746981|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214151|NCT03275389|468746982|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214152|NCT03275389|468746983|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
130214153|NCT03275389|468746984|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
130214154|NCT03275389|468746975|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130214155|NCT03275389|468746976|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130214156|NCT03275389|468746977|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130214157|NCT03275389|468746978|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
129882412|NCT04789577|467528851|FG000|Overall Study|Lost to Follow-up|7|||
129882413|NCT04789577|467528852|FG001|Overall Study|Lost to Follow-up|12|||
129882414|NCT04789577|467528853|FG002|Overall Study|Lost to Follow-up|7|||
130323329|NCT02260934|469153643|FG000|Overall Study|Site error|0|||
129882415|NCT04789577|467528854|FG003|Overall Study|Lost to Follow-up|10|||
129882416|NCT04789577|467528855|FG004|Overall Study|Lost to Follow-up|8|||
129882417|NCT04789577|467528856|FG005|Overall Study|Lost to Follow-up|6|||
129882418|NCT04789577|467528857|FG006|Overall Study|Lost to Follow-up|10|||
129882419|NCT04789577|467528851|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
129882420|NCT04789577|467528852|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
129882421|NCT04789577|467528853|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
129882422|NCT04789577|467528854|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
129882423|NCT04789577|467528855|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
129882424|NCT04789577|467528856|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
129882425|NCT04789577|467528857|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
129882426|NCT04789577|467528851|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
129882427|NCT04789577|467528852|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
129882428|NCT04789577|467528853|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
129882429|NCT04789577|467528854|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
129882430|NCT04789577|467528855|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
129882431|NCT04789577|467528856|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
129882432|NCT04789577|467528857|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
130323330|NCT02260934|469153644|FG001|Overall Study|Site error|1|||
130323331|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
130323332|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
130323333|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
130323334|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
130323335|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
130323336|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
130323337|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
130323338|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
130323339|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
130323340|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
130323341|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
130323342|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
130323343|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
130323344|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
130323345|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
130323346|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
130323347|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
130323348|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
130323349|NCT03605667|469153647|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
130323350|NCT03605667|469153648|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
130323351|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
130323352|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
130323353|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Other|6|||
130323354|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Other|8|||
130323355|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
130323356|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
130323357|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
130323358|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
130323359|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
130323360|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
130323361|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
130323362|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
130323363|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
130323364|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
130323365|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
130323366|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
130323367|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Death|0|||
130323368|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Death|2|||
130323369|NCT03605667|469153647|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
130323370|NCT03605667|469153648|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
130323371|NCT03597347|469153651|FG000|Overall Study|Withdrawal by Subject|1|||
130323372|NCT03597347|469153652|FG001|Overall Study|Withdrawal by Subject|1|||
130323373|NCT03597347|469153653|FG002|Overall Study|Withdrawal by Subject|0|||
130323374|NCT03597347|469153651|FG000|Overall Study|Withdrawal due to Covid-19|3|||
130323375|NCT03597347|469153652|FG001|Overall Study|Withdrawal due to Covid-19|0|||
130323376|NCT03597347|469153653|FG002|Overall Study|Withdrawal due to Covid-19|0|||
130323377|NCT03597347|469153651|FG000|Overall Study|Sponsor decision to terminate study|3|||
130323378|NCT03597347|469153652|FG001|Overall Study|Sponsor decision to terminate study|2|||
129882433|NCT01827254|467528859|FG000|Overall Study|Death|10|||
129882434|NCT01827254|467528859|FG000|Overall Study|Case report form not completed|4|||
129882435|NCT01827254|467528859|FG000|Overall Study|Invalidated centre|3|||
129882436|NCT01827254|467528859|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
129882437|NCT01827254|467528859|FG000|Overall Study|Did not complete re-challenge|1|||
129882438|NCT01827254|467528859|FG000|Overall Study|Disease progression|36|||
129882439|NCT01827254|467528859|FG000|Overall Study|Intolerance to treatment|4|||
129882440|NCT01923389|467528867|FG000|Overall Study|Protocol Violation|1|||
129882441|NCT01923389|467528868|FG001|Overall Study|Protocol Violation|0|||
129882442|NCT03292146|467528874|FG000|Baseline to 12 Months|Relocation|1|||
129882443|NCT03292146|467528875|FG001|Baseline to 12 Months|Relocation|0|||
129882444|NCT03292146|467528874|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
129882445|NCT03292146|467528875|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
129882446|NCT03292146|467528874|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
129882447|NCT03292146|467528875|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
129882448|NCT03292146|467528874|FG000|12 Months to 24 Months|Planning pregnancy|2|||
129882449|NCT03292146|467528875|FG001|12 Months to 24 Months|Planning pregnancy|2|||
129882450|NCT03292146|467528874|FG000|12 Months to 24 Months|Personal reasons|1|||
129882451|NCT03292146|467528875|FG001|12 Months to 24 Months|Personal reasons|0|||
129882452|NCT03292146|467528874|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
129882453|NCT03292146|467528875|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
129882454|NCT00545363|467528878|FG000|Overall Study|Adverse Event|6|||
129882455|NCT00545363|467528879|FG001|Overall Study|Adverse Event|7|||
129882456|NCT00545363|467528878|FG000|Overall Study|Withdrawal by Subject|6|||
129882457|NCT00545363|467528879|FG001|Overall Study|Withdrawal by Subject|5|||
129882458|NCT00545363|467528878|FG000|Overall Study|Non-compliance|3|||
129882459|NCT00545363|467528879|FG001|Overall Study|Non-compliance|1|||
129882460|NCT00545363|467528878|FG000|Overall Study|Did not meet entry criteria|1|||
129882461|NCT00545363|467528879|FG001|Overall Study|Did not meet entry criteria|1|||
129882462|NCT00545363|467528878|FG000|Overall Study|Lost to Follow-up|2|||
129882463|NCT00545363|467528879|FG001|Overall Study|Lost to Follow-up|0|||
129882464|NCT00545363|467528878|FG000|Overall Study|Other|1|||
129882465|NCT00545363|467528879|FG001|Overall Study|Other|1|||
129882466|NCT00366301|467528880|FG000|Overall Study|Lost to Follow-up|4|||
129882467|NCT00366301|467528881|FG001|Overall Study|Lost to Follow-up|4|||
129882468|NCT00366301|467528882|FG002|Overall Study|Lost to Follow-up|3|||
129882469|NCT00366301|467528883|FG003|Overall Study|Lost to Follow-up|7|||
129882470|NCT00366301|467528880|FG000|Overall Study|Withdrawal by Subject|4|||
129882471|NCT00366301|467528881|FG001|Overall Study|Withdrawal by Subject|2|||
129882472|NCT00366301|467528882|FG002|Overall Study|Withdrawal by Subject|1|||
129882473|NCT00366301|467528883|FG003|Overall Study|Withdrawal by Subject|1|||
129882474|NCT01348776|467528888|FG000|Overall Study|Lost to Follow-up|3|||
129882475|NCT01463293|467528889|FG000|Overall Study|Lost to Follow-up|1|||
129882476|NCT01463293|467528890|FG001|Overall Study|Lost to Follow-up|4|||
129882477|NCT01463293|467528891|FG002|Overall Study|Lost to Follow-up|5|||
129882478|NCT01463293|467528889|FG000|Overall Study|Adverse Event|1|||
129882479|NCT01463293|467528890|FG001|Overall Study|Adverse Event|2|||
129882480|NCT01463293|467528891|FG002|Overall Study|Adverse Event|0|||
129882481|NCT01463293|467528889|FG000|Overall Study|Withdrawal by Subject|4|||
129882482|NCT01463293|467528890|FG001|Overall Study|Withdrawal by Subject|10|||
129882483|NCT01463293|467528891|FG002|Overall Study|Withdrawal by Subject|5|||
129882484|NCT01463293|467528889|FG000|Overall Study|Other|0|||
129882485|NCT01463293|467528890|FG001|Overall Study|Other|0|||
129882486|NCT01463293|467528891|FG002|Overall Study|Other|2|||
129882487|NCT00309608|467528892|FG000|Overall Study|Adverse Event|1|||
130214158|NCT03275389|468746979|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130214159|NCT03275389|468746980|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130214160|NCT03275389|468746981|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129882488|NCT00309608|467528893|FG001|Overall Study|Adverse Event|5|||
129882489|NCT00309608|467528894|FG002|Overall Study|Adverse Event|3|||
129882490|NCT00309608|467528895|FG003|Overall Study|Adverse Event|2|||
129882491|NCT00309608|467528896|FG004|Overall Study|Adverse Event|3|||
129882492|NCT00309608|467528892|FG000|Overall Study|Protocol Violation|2|||
129882493|NCT00309608|467528893|FG001|Overall Study|Protocol Violation|0|||
129882494|NCT00309608|467528894|FG002|Overall Study|Protocol Violation|0|||
129882495|NCT00309608|467528895|FG003|Overall Study|Protocol Violation|0|||
129882496|NCT00309608|467528896|FG004|Overall Study|Protocol Violation|0|||
129882497|NCT00309608|467528892|FG000|Overall Study|Lost to Follow-up|0|||
129882498|NCT00309608|467528893|FG001|Overall Study|Lost to Follow-up|0|||
130214161|NCT03275389|468746982|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
130214162|NCT03275389|468746983|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130214163|NCT03275389|468746984|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130214164|NCT03275389|468746975|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214165|NCT03275389|468746976|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130214166|NCT03275389|468746977|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214167|NCT03275389|468746978|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130214168|NCT03275389|468746979|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214169|NCT03275389|468746980|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129882499|NCT00309608|467528894|FG002|Overall Study|Lost to Follow-up|2|||
129882500|NCT00309608|467528895|FG003|Overall Study|Lost to Follow-up|0|||
130214170|NCT03275389|468746981|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130214171|NCT03275389|468746982|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214172|NCT03275389|468746983|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214173|NCT03275389|468746984|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130214174|NCT03275389|468746975|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214175|NCT03275389|468746976|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214176|NCT03275389|468746977|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130214177|NCT03275389|468746978|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214178|NCT03275389|468746979|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214179|NCT03275389|468746980|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214180|NCT03275389|468746981|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214181|NCT03275389|468746982|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214182|NCT03275389|468746983|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130214183|NCT03275389|468746984|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130214184|NCT03275389|468746975|FG000|Overall Study|Other|0|||
130214185|NCT03275389|468746976|FG001|Overall Study|Other|4|||
130214186|NCT03275389|468746977|FG002|Overall Study|Other|3|||
130214187|NCT03275389|468746978|FG003|Overall Study|Other|2|||
130214188|NCT03275389|468746979|FG004|Overall Study|Other|2|||
130214189|NCT03275389|468746980|FG005|Overall Study|Other|2|||
130214190|NCT03275389|468746981|FG006|Overall Study|Other|0|||
130214191|NCT03275389|468746982|FG007|Overall Study|Other|0|||
130214192|NCT03275389|468746983|FG008|Overall Study|Other|1|||
130214193|NCT03275389|468746984|FG009|Overall Study|Other|0|||
130214194|NCT00978341|468746985|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
130214195|NCT00978341|468746986|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
130214196|NCT00448812|468746987|FG000|Year 2|Missed visit but remained in study|4|||
130214197|NCT00448812|468746988|FG001|Year 2|Missed visit but remained in study|1|||
130214198|NCT00448812|468746987|FG000|Year 3|Withdrawal by Subject|1|||
130214199|NCT00448812|468746988|FG001|Year 3|Withdrawal by Subject|3|||
130214200|NCT00448812|468746987|FG000|Year 3|Lost to Follow-up|1|||
130214201|NCT00448812|468746988|FG001|Year 3|Lost to Follow-up|0|||
130214202|NCT00448812|468746987|FG000|Year 3|Missed visit but remained in study|2|||
130214203|NCT00448812|468746988|FG001|Year 3|Missed visit but remained in study|0|||
130214204|NCT00448812|468746987|FG000|Year 5|Missed visit but remained in study|1|||
130214205|NCT00448812|468746988|FG001|Year 5|Missed visit but remained in study|0|||
130214206|NCT03035916|468746989|FG000|Overall Study|Puncture failed|0|||
130214207|NCT03035916|468746990|FG001|Overall Study|Puncture failed|2|||
130214208|NCT03035916|468746991|FG002|Overall Study|Puncture failed|0|||
130214209|NCT03885999|468746992|FG000|Overall Study|Adverse Event|1|||
130214210|NCT02452554|468746993|FG000|Overall Study|Death|2|||
130214211|NCT02452554|468746994|FG001|Overall Study|Death|1|||
130214212|NCT02452554|468746995|FG002|Overall Study|Death|0|||
130214213|NCT02452554|468746996|FG003|Overall Study|Death|0|||
130214214|NCT02452554|468746997|FG004|Overall Study|Death|0|||
130214215|NCT02452554|468746998|FG005|Overall Study|Death|0|||
130214216|NCT02452554|468746993|FG000|Overall Study|Lack of Efficacy|13|||
130214217|NCT02452554|468746994|FG001|Overall Study|Lack of Efficacy|14|||
130214218|NCT02452554|468746995|FG002|Overall Study|Lack of Efficacy|9|||
130214219|NCT02452554|468746996|FG003|Overall Study|Lack of Efficacy|1|||
130214220|NCT02452554|468746997|FG004|Overall Study|Lack of Efficacy|5|||
130214221|NCT02452554|468746998|FG005|Overall Study|Lack of Efficacy|8|||
130214222|NCT02452554|468746993|FG000|Overall Study|Physician Decision|0|||
130214223|NCT02452554|468746994|FG001|Overall Study|Physician Decision|1|||
130214224|NCT02452554|468746995|FG002|Overall Study|Physician Decision|0|||
130214225|NCT02452554|468746996|FG003|Overall Study|Physician Decision|0|||
130214226|NCT02452554|468746997|FG004|Overall Study|Physician Decision|0|||
130214227|NCT02452554|468746998|FG005|Overall Study|Physician Decision|0|||
130214228|NCT02452554|468746993|FG000|Overall Study|Withdrawal by Subject|1|||
130214229|NCT02452554|468746994|FG001|Overall Study|Withdrawal by Subject|0|||
130214230|NCT02452554|468746995|FG002|Overall Study|Withdrawal by Subject|2|||
130214231|NCT02452554|468746996|FG003|Overall Study|Withdrawal by Subject|0|||
130214232|NCT02452554|468746997|FG004|Overall Study|Withdrawal by Subject|0|||
130214233|NCT02452554|468746998|FG005|Overall Study|Withdrawal by Subject|1|||
130214234|NCT02452554|468746993|FG000|Overall Study|Ineligible|0|||
130214235|NCT02452554|468746994|FG001|Overall Study|Ineligible|1|||
130214236|NCT02452554|468746995|FG002|Overall Study|Ineligible|0|||
130214237|NCT02452554|468746996|FG003|Overall Study|Ineligible|0|||
130214238|NCT02452554|468746997|FG004|Overall Study|Ineligible|0|||
130214239|NCT02452554|468746998|FG005|Overall Study|Ineligible|0|||
130214240|NCT02452554|468746993|FG000|Overall Study|Never Received Treatment|1|||
130214241|NCT02452554|468746994|FG001|Overall Study|Never Received Treatment|0|||
130214242|NCT02452554|468746995|FG002|Overall Study|Never Received Treatment|0|||
130214243|NCT02452554|468746996|FG003|Overall Study|Never Received Treatment|0|||
130214244|NCT02452554|468746997|FG004|Overall Study|Never Received Treatment|0|||
130214245|NCT02452554|468746998|FG005|Overall Study|Never Received Treatment|0|||
130323379|NCT03597347|469153653|FG002|Overall Study|Sponsor decision to terminate study|4|||
130323380|NCT00107653|469153654|FG000|Overall Study|Adverse Event|24|||
130323381|NCT00107653|469153655|FG001|Overall Study|Adverse Event|43|||
130323382|NCT00107653|469153654|FG000|Overall Study|Insufficient Therapeutic Response|25|||
130323383|NCT00107653|469153655|FG001|Overall Study|Insufficient Therapeutic Response|11|||
130323384|NCT00107653|469153654|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130323385|NCT00107653|469153655|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130323386|NCT00107653|469153654|FG000|Overall Study|Protocol Violation|1|||
130323387|NCT00107653|469153655|FG001|Overall Study|Protocol Violation|0|||
130323388|NCT00107653|469153654|FG000|Overall Study|Withdrawal by Subject|12|||
130323389|NCT00107653|469153655|FG001|Overall Study|Withdrawal by Subject|13|||
130323390|NCT00107653|469153654|FG000|Overall Study|Lost to Follow-up|13|||
130323391|NCT00107653|469153655|FG001|Overall Study|Lost to Follow-up|5|||
130323392|NCT00107653|469153654|FG000|Overall Study|Administrative Reasons|3|||
130323393|NCT00107653|469153655|FG001|Overall Study|Administrative Reasons|3|||
130323394|NCT02532517|469153659|FG000|Overall Study|Did not complete 24-Month visit|4|||
130323395|NCT02532517|469153659|FG000|Overall Study|Failed Angiographic eligibility|1|||
130323396|NCT02532517|469153659|FG000|Overall Study|Lost to Follow-up|4|||
130323397|NCT02532517|469153659|FG000|Overall Study|Withdrawal by Subject|4|||
130323398|NCT02532517|469153659|FG000|Overall Study|Death|4|||
130323399|NCT03312231|469153660|FG000|Overall Study|Lost to Follow-up|2|||
130323400|NCT03312231|469153661|FG001|Overall Study|Lost to Follow-up|6|||
130323401|NCT03312231|469153662|FG002|Overall Study|Lost to Follow-up|1|||
130323402|NCT03312231|469153663|FG003|Overall Study|Lost to Follow-up|3|||
130323403|NCT03312231|469153664|FG004|Overall Study|Lost to Follow-up|1|||
130323404|NCT03312231|469153660|FG000|Overall Study|Withdrawal by Subject|0|||
130323405|NCT03312231|469153661|FG001|Overall Study|Withdrawal by Subject|3|||
130323406|NCT03312231|469153662|FG002|Overall Study|Withdrawal by Subject|1|||
130323407|NCT03312231|469153663|FG003|Overall Study|Withdrawal by Subject|0|||
130323408|NCT03312231|469153664|FG004|Overall Study|Withdrawal by Subject|0|||
130323409|NCT03312231|469153660|FG000|Overall Study|Death|0|||
130323410|NCT03312231|469153661|FG001|Overall Study|Death|1|||
130323411|NCT03312231|469153662|FG002|Overall Study|Death|1|||
130323412|NCT03312231|469153663|FG003|Overall Study|Death|0|||
130323413|NCT03312231|469153664|FG004|Overall Study|Death|0|||
130323414|NCT03312231|469153660|FG000|Overall Study|Study Vaccination not Received|1|||
130323415|NCT03312231|469153661|FG001|Overall Study|Study Vaccination not Received|1|||
130323416|NCT03312231|469153662|FG002|Overall Study|Study Vaccination not Received|1|||
130323417|NCT03312231|469153663|FG003|Overall Study|Study Vaccination not Received|0|||
130323418|NCT03312231|469153664|FG004|Overall Study|Study Vaccination not Received|0|||
130323419|NCT03157830|469153665|FG000|Overall Study|Lost to Follow-up|1|||
130323420|NCT03157830|469153665|FG000|Overall Study|Withdrawal by Subject|1|||
130323421|NCT03694353|469153667|FG000|Overall Study|Withdrawal by Subject|1|||
130323422|NCT03694353|469153667|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
130323423|NCT05720897|469153668|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
130323424|NCT05720897|469153669|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
130323425|NCT00400179|469153670|FG000|Overall Study|Adverse Event|2|||
130323426|NCT00400179|469153671|FG001|Overall Study|Adverse Event|2|||
130323427|NCT00400179|469153670|FG000|Overall Study|Death|1|||
130323428|NCT00400179|469153671|FG001|Overall Study|Death|2|||
130323429|NCT00400179|469153670|FG000|Overall Study|Withdrew Consent|1|||
130323430|NCT00400179|469153671|FG001|Overall Study|Withdrew Consent|5|||
130323431|NCT00400179|469153670|FG000|Overall Study|Disease progression|1|||
130323432|NCT00400179|469153671|FG001|Overall Study|Disease progression|1|||
130323433|NCT00400179|469153670|FG000|Overall Study|Intercurrent illness|0|||
130323434|NCT00400179|469153671|FG001|Overall Study|Intercurrent illness|1|||
130323435|NCT00400179|469153670|FG000|Overall Study|Investigator judgment|0|||
130323436|NCT00400179|469153671|FG001|Overall Study|Investigator judgment|1|||
130323437|NCT00400179|469153670|FG000|Overall Study|Randomization error/patient ineligible|1|||
130323438|NCT00400179|469153671|FG001|Overall Study|Randomization error/patient ineligible|6|||
130323439|NCT04780061|469153672|FG000|Overall Study|Withdrawal by Subject|5|||
130323440|NCT04780061|469153673|FG001|Overall Study|Withdrawal by Subject|8|||
130323441|NCT04780061|469153672|FG000|Overall Study|Adverse Event|2|||
129882501|NCT00309608|467528896|FG004|Overall Study|Lost to Follow-up|1|||
129882502|NCT00309608|467528892|FG000|Overall Study|Withdrawal by Subject|1|||
130323442|NCT04780061|469153673|FG001|Overall Study|Adverse Event|2|||
130323443|NCT04780061|469153672|FG000|Overall Study|Lost to Follow-up|1|||
130323444|NCT04780061|469153673|FG001|Overall Study|Lost to Follow-up|5|||
130323445|NCT05523089|469153674|FG000|Overall Study|Withdrawal by Subject|1|||
130323446|NCT05523089|469153675|FG001|Overall Study|Withdrawal by Subject|0|||
130323447|NCT05523089|469153676|FG002|Overall Study|Withdrawal by Subject|0|||
130323448|NCT05523089|469153674|FG000|Overall Study|Lost to Follow-up|1|||
130323449|NCT05523089|469153675|FG001|Overall Study|Lost to Follow-up|0|||
130323450|NCT05523089|469153676|FG002|Overall Study|Lost to Follow-up|0|||
130323451|NCT02681523|469153677|FG000|Overall Study|Adverse Event|1|||
130323452|NCT02681523|469153677|FG000|Overall Study|Patient Non-compliance|1|||
129882503|NCT00309608|467528893|FG001|Overall Study|Withdrawal by Subject|4|||
129882504|NCT00309608|467528894|FG002|Overall Study|Withdrawal by Subject|2|||
129882505|NCT00309608|467528895|FG003|Overall Study|Withdrawal by Subject|0|||
129882506|NCT00309608|467528896|FG004|Overall Study|Withdrawal by Subject|0|||
129882507|NCT00309608|467528892|FG000|Overall Study|Other incl. Lack of efficacy|10|||
129882508|NCT00309608|467528893|FG001|Overall Study|Other incl. Lack of efficacy|4|||
129882509|NCT00309608|467528894|FG002|Overall Study|Other incl. Lack of efficacy|3|||
129882510|NCT00309608|467528895|FG003|Overall Study|Other incl. Lack of efficacy|4|||
129882511|NCT00309608|467528896|FG004|Overall Study|Other incl. Lack of efficacy|0|||
129882512|NCT00621296|467528903|FG000|Overall Study|Adverse Event|2|||
129882513|NCT00621296|467528903|FG000|Overall Study|Lack of Efficacy|1|||
129882514|NCT00621296|467528903|FG000|Overall Study|Physician Decision|7|||
129882515|NCT00621296|467528903|FG000|Overall Study|Unmatch Criteria|1|||
129882516|NCT00621296|467528903|FG000|Overall Study|Stopping Criteria|3|||
129882517|NCT02049710|467528904|FG000|Overall Study|Lost to Follow-up|319|||
130323453|NCT01456039|469155485|FG000|Phase 1 (First Step)|Disease Progression|1|||
130323454|NCT01456039|469155486|FG001|Phase 1 (First Step)|Disease Progression|1|||
130323455|NCT01456039|469155487|FG002|Phase 1 (First Step)|Disease Progression|0|||
129882518|NCT02049710|467528905|FG001|Overall Study|Lost to Follow-up|324|||
129882519|NCT00386308|467530423|FG000|Overall Study|Adverse Event|3|||
129882520|NCT00386308|467530424|FG001|Overall Study|Adverse Event|3|||
129882521|NCT00386308|467530423|FG000|Overall Study|Protocol Violation|2|||
129882522|NCT00386308|467530424|FG001|Overall Study|Protocol Violation|5|||
129882523|NCT00386308|467530423|FG000|Overall Study|Lack of Efficacy|0|||
129882524|NCT00386308|467530424|FG001|Overall Study|Lack of Efficacy|2|||
129882525|NCT00386308|467530423|FG000|Overall Study|Lost to Follow-up|10|||
129882526|NCT00386308|467530424|FG001|Overall Study|Lost to Follow-up|6|||
129882527|NCT00386308|467530423|FG000|Overall Study|Withdrawal by Subject|6|||
129882528|NCT00386308|467530424|FG001|Overall Study|Withdrawal by Subject|2|||
129882529|NCT00386308|467530423|FG000|Overall Study|Other Event|8|||
129882530|NCT00386308|467530424|FG001|Overall Study|Other Event|1|||
129882531|NCT02906683|467530425|FG000|Overall Study|Adverse Event|0|||
129882532|NCT02906683|467530426|FG001|Overall Study|Adverse Event|1|||
129882533|NCT02906683|467530427|FG002|Overall Study|Adverse Event|0|||
129882534|NCT02906683|467530425|FG000|Overall Study|Physician Decision|0|||
129882535|NCT02906683|467530426|FG001|Overall Study|Physician Decision|1|||
129882536|NCT02906683|467530427|FG002|Overall Study|Physician Decision|1|||
129882537|NCT02906683|467530425|FG000|Overall Study|Withdrawal by Subject|0|||
129882538|NCT02906683|467530426|FG001|Overall Study|Withdrawal by Subject|2|||
129882539|NCT02906683|467530427|FG002|Overall Study|Withdrawal by Subject|1|||
129882540|NCT02906683|467530425|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
129882541|NCT02906683|467530426|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
129882542|NCT02906683|467530427|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
129882543|NCT02906683|467530425|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
129882544|NCT02906683|467530426|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
129882545|NCT02906683|467530427|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
129882546|NCT01340482|467530428|FG000|Overall Study|Adverse Event|2|||
129882547|NCT01340482|467530429|FG001|Overall Study|Adverse Event|0|||
130098698|NCT03557775|468319287|FG000|Overall Study|Withdrawal by Subject|1|||
130098699|NCT03557775|468319288|FG001|Overall Study|Withdrawal by Subject|2|||
130323456|NCT01456039|469155485|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
130323457|NCT01456039|469155486|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
130323458|NCT01456039|469155487|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
130323459|NCT01456039|469155485|FG000|Phase 1 (First Step)|Adverse Event|0|||
130323460|NCT01456039|469155486|FG001|Phase 1 (First Step)|Adverse Event|3|||
130323461|NCT01456039|469155487|FG002|Phase 1 (First Step)|Adverse Event|0|||
130323462|NCT01456039|469155485|FG000|Phase 1 (First Step)|Other|0|||
130323463|NCT01456039|469155486|FG001|Phase 1 (First Step)|Other|1|||
130323464|NCT01456039|469155487|FG002|Phase 1 (First Step)|Other|0|||
130323465|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Disease Progression|0|||
130323466|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Disease Progression|0|||
130323467|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Disease Progression|17|||
130323468|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Adverse Event|0|||
130323469|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Adverse Event|0|||
130323470|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Adverse Event|10|||
129882548|NCT01340482|467530430|FG002|Overall Study|Adverse Event|0|||
129882549|NCT01282476|467530431|FG000|Overall Study|Death|11|||
129882550|NCT00437125|467530434|FG000|Overall Study|Adverse Event|12|||
129882551|NCT00437125|467530434|FG000|Overall Study|Death|1|||
129882552|NCT00437125|467530434|FG000|Overall Study|Clinical Relapse|1|||
129882553|NCT00437125|467530434|FG000|Overall Study|Lack of Efficacy|1|||
129882554|NCT00437125|467530434|FG000|Overall Study|Lost to Follow-up|1|||
129882555|NCT00437125|467530434|FG000|Overall Study|Withdrawal by Subject|13|||
129882556|NCT00437125|467530434|FG000|Overall Study|Withdrawal by Caregiver|2|||
130323471|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
129882557|NCT00437125|467530434|FG000|Overall Study|Physician Decision|1|||
129882558|NCT02248961|467530435|FG000|Overall Study|Adverse Event|1|||
129882559|NCT02248961|467530436|FG001|Overall Study|Adverse Event|0|||
129882560|NCT02248961|467530435|FG000|Overall Study|Withdrawal by Subject|1|||
129882561|NCT02248961|467530436|FG001|Overall Study|Withdrawal by Subject|2|||
129882562|NCT02248961|467530435|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
129882563|NCT02248961|467530436|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
129882564|NCT00453310|467530441|FG000|Overall Study|Progression of Disease|10|||
129882565|NCT01267825|467530442|FG000|Overall Study|study terminated. no data collected.|1|||
129882566|NCT01267825|467530443|FG001|Overall Study|study terminated. no data collected.|0|||
129882567|NCT00871351|467530446|FG000|Overall Study|Withdrawal by Subject|1|||
129882568|NCT00871351|467530447|FG001|Overall Study|Withdrawal by Subject|0|||
129882569|NCT00871351|467530448|FG002|Overall Study|Withdrawal by Subject|0|||
129882570|NCT00871351|467530446|FG000|Overall Study|Adverse Event|3|||
129882571|NCT00871351|467530447|FG001|Overall Study|Adverse Event|1|||
129882572|NCT00871351|467530448|FG002|Overall Study|Adverse Event|0|||
129882573|NCT00744237|467530449|FG000|Overall Study|Lack of Efficacy|1|||
129882574|NCT00744237|467530450|FG001|Overall Study|Lack of Efficacy|1|||
129882575|NCT00744237|467530451|FG002|Overall Study|Lack of Efficacy|0|||
129882576|NCT00744237|467530449|FG000|Overall Study|Withdrawal by Subject|9|||
129882577|NCT00744237|467530450|FG001|Overall Study|Withdrawal by Subject|5|||
129882578|NCT00744237|467530451|FG002|Overall Study|Withdrawal by Subject|3|||
129882579|NCT00744237|467530449|FG000|Overall Study|Lost to Follow-up|1|||
129882580|NCT00744237|467530450|FG001|Overall Study|Lost to Follow-up|1|||
129882581|NCT00744237|467530451|FG002|Overall Study|Lost to Follow-up|1|||
129882582|NCT00744237|467530449|FG000|Overall Study|Protocol Violation|3|||
129882583|NCT00744237|467530450|FG001|Overall Study|Protocol Violation|4|||
129882584|NCT00744237|467530451|FG002|Overall Study|Protocol Violation|3|||
129882585|NCT00744237|467530449|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
129882586|NCT00744237|467530450|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
129882587|NCT00744237|467530451|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
129882588|NCT00744237|467530449|FG000|Overall Study|Dosing Error|1|||
129882589|NCT00744237|467530450|FG001|Overall Study|Dosing Error|0|||
129882590|NCT00744237|467530451|FG002|Overall Study|Dosing Error|1|||
129882591|NCT00744237|467530449|FG000|Overall Study|Study Drug Error|1|||
129882592|NCT00744237|467530450|FG001|Overall Study|Study Drug Error|0|||
129882593|NCT00744237|467530451|FG002|Overall Study|Study Drug Error|0|||
129882594|NCT00744237|467530449|FG000|Overall Study|Prohibited Concomitant Medication|0|||
129882595|NCT00744237|467530450|FG001|Overall Study|Prohibited Concomitant Medication|0|||
129882596|NCT00744237|467530451|FG002|Overall Study|Prohibited Concomitant Medication|1|||
129882597|NCT00744237|467530449|FG000|Overall Study|Poor Compliance|0|||
129882598|NCT00744237|467530450|FG001|Overall Study|Poor Compliance|2|||
129882599|NCT00744237|467530451|FG002|Overall Study|Poor Compliance|0|||
129882600|NCT00744237|467530449|FG000|Overall Study|Administrative. Site Closed|1|||
129882601|NCT00744237|467530450|FG001|Overall Study|Administrative. Site Closed|1|||
129882602|NCT00744237|467530451|FG002|Overall Study|Administrative. Site Closed|1|||
129882603|NCT00744237|467530449|FG000|Overall Study|Adverse Event|9|||
129882604|NCT00744237|467530450|FG001|Overall Study|Adverse Event|13|||
129882605|NCT00744237|467530451|FG002|Overall Study|Adverse Event|5|||
129882606|NCT02791490|467530453|FG000|Overall Study|Lost to Follow-up|1|||
129882607|NCT02791490|467530454|FG001|Overall Study|Lost to Follow-up|2|||
129882608|NCT02791490|467530453|FG000|Overall Study|Withdrawal by Subject|2|||
129882609|NCT02791490|467530454|FG001|Overall Study|Withdrawal by Subject|6|||
129882610|NCT01984424|467530455|FG000|Overall Study|Withdrawal by Subject|3|||
129882611|NCT01984424|467530456|FG001|Overall Study|Withdrawal by Subject|5|||
129882612|NCT01984424|467530455|FG000|Overall Study|Sponsor Decision|0|||
129882613|NCT01984424|467530456|FG001|Overall Study|Sponsor Decision|1|||
129882614|NCT01984424|467530455|FG000|Overall Study|Lost to Follow-up|0|||
129882615|NCT01984424|467530456|FG001|Overall Study|Lost to Follow-up|1|||
129882616|NCT02802319|467530457|FG000|Overall Study|Physician Decision|2|||
129882617|NCT02802319|467530458|FG001|Overall Study|Physician Decision|1|||
129882618|NCT02802319|467530457|FG000|Overall Study|Lost to Follow-up|0|||
129882619|NCT02802319|467530458|FG001|Overall Study|Lost to Follow-up|4|||
129882620|NCT00077636|467530459|FG000|Overall Study|Refused Treatment|9|||
129882621|NCT00077636|467530460|FG001|Overall Study|Refused Treatment|31|||
129882622|NCT00077636|467530459|FG000|Overall Study|Admin|3|||
129882623|NCT00077636|467530460|FG001|Overall Study|Admin|3|||
129882624|NCT00077636|467530459|FG000|Overall Study|Withdrawal by Subject|2|||
129882625|NCT00077636|467530460|FG001|Overall Study|Withdrawal by Subject|2|||
129882626|NCT00077636|467530459|FG000|Overall Study|Adverse Event|17|||
129882627|NCT00077636|467530460|FG001|Overall Study|Adverse Event|34|||
129882628|NCT00077636|467530459|FG000|Overall Study|Protocol Violation|0|||
129882629|NCT00077636|467530460|FG001|Overall Study|Protocol Violation|2|||
129882630|NCT00077636|467530459|FG000|Overall Study|Lost to Follow-up|10|||
129882631|NCT00077636|467530460|FG001|Overall Study|Lost to Follow-up|18|||
129882632|NCT00077636|467530459|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
129882633|NCT00077636|467530460|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
130214246|NCT02749799|468746999|FG000|Overall Study|Adverse Event|2|||
129882634|NCT02032173|467530461|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
129882635|NCT03321513|467530464|FG000|Overall Study|Death|11|||
129882636|NCT03321513|467530465|FG001|Overall Study|Death|5|||
129882637|NCT03321513|467530464|FG000|Overall Study|Withdrawal by Subject|5|||
129882638|NCT03321513|467530465|FG001|Overall Study|Withdrawal by Subject|10|||
129882639|NCT03321513|467530464|FG000|Overall Study|Lost to Follow-up|10|||
129882640|NCT03321513|467530465|FG001|Overall Study|Lost to Follow-up|11|||
129882641|NCT01993017|467530466|FG000|Overall Study|Death|23|||
129882642|NCT01993017|467530467|FG001|Overall Study|Death|26|||
129882643|NCT01993017|467530468|FG002|Overall Study|Death|18|||
129882644|NCT01993017|467530466|FG000|Overall Study|Could not be contacted|43|||
129882645|NCT01993017|467530467|FG001|Overall Study|Could not be contacted|42|||
129882646|NCT01993017|467530468|FG002|Overall Study|Could not be contacted|38|||
129882647|NCT01993017|467530466|FG000|Overall Study|Dropped out|19|||
129882648|NCT01993017|467530467|FG001|Overall Study|Dropped out|6|||
129882649|NCT01993017|467530468|FG002|Overall Study|Dropped out|11|||
129882650|NCT01993017|467530466|FG000|Overall Study|Other reasons|17|||
129882651|NCT01993017|467530467|FG001|Overall Study|Other reasons|11|||
129882652|NCT01993017|467530468|FG002|Overall Study|Other reasons|7|||
129882653|NCT01993017|467530466|FG000|Overall Study|Ineligible after randomization|4|||
129882654|NCT01993017|467530467|FG001|Overall Study|Ineligible after randomization|5|||
129882655|NCT01993017|467530468|FG002|Overall Study|Ineligible after randomization|5|||
129882656|NCT01683994|467530471|FG000|Overall Study|Withdrawal by Subject|1|||
129882657|NCT01683994|467530472|FG001|Overall Study|Withdrawal by Subject|0|||
129882658|NCT01683994|467530473|FG002|Overall Study|Withdrawal by Subject|0|||
129882659|NCT01683994|467530474|FG003|Overall Study|Withdrawal by Subject|1|||
129882660|NCT01683994|467530475|FG004|Overall Study|Withdrawal by Subject|0|||
129882661|NCT01683994|467530471|FG000|Overall Study|Intercurrent illness|0|||
129882662|NCT01683994|467530472|FG001|Overall Study|Intercurrent illness|0|||
129882663|NCT01683994|467530473|FG002|Overall Study|Intercurrent illness|0|||
129882664|NCT01683994|467530474|FG003|Overall Study|Intercurrent illness|2|||
129882665|NCT01683994|467530475|FG004|Overall Study|Intercurrent illness|1|||
129882666|NCT00999661|467530477|FG000|Overall Study|Lost to Follow-up|59|||
129882667|NCT00999661|467530477|FG000|Overall Study|Adverse Event|1|||
129882668|NCT00999661|467530477|FG000|Overall Study|Withdrawal by Subject|1|||
129882669|NCT00999661|467530477|FG000|Overall Study|Not meeting eligibility criteria|9|||
129882670|NCT00917267|467530478|FG000|Overall Study|Adverse Event|15|||
129882671|NCT00917267|467530479|FG001|Overall Study|Adverse Event|36|||
129882672|NCT00917267|467530478|FG000|Overall Study|Physician Decision|2|||
129882673|NCT00917267|467530479|FG001|Overall Study|Physician Decision|4|||
129882674|NCT00917267|467530478|FG000|Overall Study|Protocol Violation|9|||
129882675|NCT00917267|467530479|FG001|Overall Study|Protocol Violation|18|||
129882676|NCT00917267|467530478|FG000|Overall Study|Withdrawal by Subject|5|||
129882677|NCT00917267|467530479|FG001|Overall Study|Withdrawal by Subject|12|||
129882678|NCT00917267|467530478|FG000|Overall Study|Lost to follow up|0|||
129882679|NCT00917267|467530479|FG001|Overall Study|Lost to follow up|2|||
129882680|NCT00917267|467530478|FG000|Overall Study|Entry Criteria Not Met|1|||
129882681|NCT00917267|467530479|FG001|Overall Study|Entry Criteria Not Met|0|||
130214247|NCT02749799|468746999|FG000|Overall Study|Lost to Follow-up|4|||
130214248|NCT02749799|468746999|FG000|Overall Study|Protocol Violation|1|||
130214249|NCT02749799|468746999|FG000|Overall Study|Withdrawal by Subject|1|||
130214250|NCT03749109|468747000|FG000|Overall Study|Adverse Event|2|||
130214251|NCT03749109|468747001|FG001|Overall Study|Adverse Event|0|||
130214252|NCT02636439|468747004|FG000|Overall Study|Adverse Event|2|||
130214253|NCT02636439|468747005|FG001|Overall Study|Adverse Event|2|||
130214254|NCT02636439|468747004|FG000|Overall Study|Lost to Follow-up|1|||
130214255|NCT02636439|468747005|FG001|Overall Study|Lost to Follow-up|0|||
130214256|NCT02636439|468747004|FG000|Overall Study|Non-compliance|1|||
130214257|NCT02636439|468747005|FG001|Overall Study|Non-compliance|1|||
130214258|NCT02636439|468747004|FG000|Overall Study|Personal reasons|2|||
130214259|NCT02636439|468747005|FG001|Overall Study|Personal reasons|0|||
130214260|NCT02075008|468748942|FG000|Overall Study|Technical problems|1|||
130214261|NCT02075008|468748942|FG000|Overall Study|Pregnancy|1|||
130214262|NCT02075008|468748942|FG000|Overall Study|Physician Decision|1|||
130214263|NCT02075008|468748942|FG000|Overall Study|Lost to Follow-up|1|||
129882682|NCT00917267|467530478|FG000|Overall Study|Sponsor Decision|5|||
129882683|NCT00917267|467530479|FG001|Overall Study|Sponsor Decision|5|||
129882684|NCT00917267|467530478|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
129882685|NCT00917267|467530479|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
129882686|NCT02960763|467530481|FG000|Step 1|Withdrawal by Subject|10|||
129882687|NCT02960763|467530482|FG001|Step 1|Withdrawal by Subject|8|||
129882688|NCT02960763|467530483|FG002|Step 1|Withdrawal by Subject|13|||
130214264|NCT02075008|468748942|FG000|Overall Study|Lack of Efficacy|1|||
130214265|NCT02075008|468748942|FG000|Overall Study|Death|1|||
130214266|NCT02075008|468748942|FG000|Overall Study|Adverse Event|5|||
130214267|NCT02075008|468748942|FG000|Overall Study|Withdrawal by Subject|6|||
130214268|NCT02075008|468748942|FG000|Overall Study|Study terminated by Sponsor|159|||
130214269|NCT00660595|468748943|FG000|Overall Study|Lost to Follow-up|0|||
130214270|NCT00660595|468748944|FG001|Overall Study|Lost to Follow-up|1|||
129882689|NCT02960763|467530484|FG003|Step 1|Withdrawal by Subject|0|||
129882690|NCT02960763|467530485|FG004|Step 1|Withdrawal by Subject|0|||
129882691|NCT02960763|467530481|FG000|Step 1|Lost to Follow-up|7|||
129882692|NCT02960763|467530482|FG001|Step 1|Lost to Follow-up|9|||
129882693|NCT02960763|467530483|FG002|Step 1|Lost to Follow-up|12|||
129882694|NCT02960763|467530484|FG003|Step 1|Lost to Follow-up|0|||
129882695|NCT02960763|467530485|FG004|Step 1|Lost to Follow-up|0|||
129882696|NCT02960763|467530481|FG000|Step 1|Death|1|||
129882697|NCT02960763|467530482|FG001|Step 1|Death|1|||
129882698|NCT02960763|467530483|FG002|Step 1|Death|1|||
129882699|NCT02960763|467530484|FG003|Step 1|Death|0|||
129882700|NCT02960763|467530485|FG004|Step 1|Death|0|||
129882701|NCT02960763|467530481|FG000|Step 1|Investigator discretion|1|||
129882702|NCT02960763|467530482|FG001|Step 1|Investigator discretion|0|||
129882703|NCT02960763|467530483|FG002|Step 1|Investigator discretion|1|||
129882704|NCT02960763|467530484|FG003|Step 1|Investigator discretion|0|||
129882705|NCT02960763|467530485|FG004|Step 1|Investigator discretion|0|||
129882706|NCT02960763|467530481|FG000|Step 1|Other|0|||
129882707|NCT02960763|467530482|FG001|Step 1|Other|0|||
129882708|NCT02960763|467530483|FG002|Step 1|Other|1|||
129882709|NCT02960763|467530484|FG003|Step 1|Other|0|||
129882710|NCT02960763|467530485|FG004|Step 1|Other|0|||
129882711|NCT02960763|467530481|FG000|Step 2|Withdrawal by Subject|0|||
129882712|NCT02960763|467530482|FG001|Step 2|Withdrawal by Subject|0|||
129882713|NCT02960763|467530483|FG002|Step 2|Withdrawal by Subject|0|||
129882714|NCT02960763|467530484|FG003|Step 2|Withdrawal by Subject|7|||
129882715|NCT02960763|467530485|FG004|Step 2|Withdrawal by Subject|3|||
129882716|NCT02960763|467530481|FG000|Step 2|Lost to Follow-up|0|||
129882717|NCT02960763|467530482|FG001|Step 2|Lost to Follow-up|0|||
129882718|NCT02960763|467530483|FG002|Step 2|Lost to Follow-up|0|||
129882719|NCT02960763|467530484|FG003|Step 2|Lost to Follow-up|4|||
129882720|NCT02960763|467530485|FG004|Step 2|Lost to Follow-up|1|||
129882721|NCT02960763|467530481|FG000|Step 2|Investigator discretion|0|||
129882722|NCT02960763|467530482|FG001|Step 2|Investigator discretion|0|||
129882723|NCT02960763|467530483|FG002|Step 2|Investigator discretion|0|||
129882724|NCT02960763|467530484|FG003|Step 2|Investigator discretion|0|||
129882725|NCT02960763|467530485|FG004|Step 2|Investigator discretion|1|||
129882726|NCT03638635|467530489|FG000|Initial Hospitalization|Study terminated prematurely|0|||
129882727|NCT03638635|467530490|FG001|Initial Hospitalization|Study terminated prematurely|1|||
129882728|NCT03638635|467530489|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
129882729|NCT03638635|467530490|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
129882730|NCT03638635|467530489|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
129882731|NCT03638635|467530490|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
129882732|NCT00289770|467530496|FG000|Year 15|Withdrawal by Subject|1|||
129882733|NCT00313911|467530501|FG000|Overall Study|Serious adverse event|6|||
129882734|NCT00313911|467530502|FG001|Overall Study|Serious adverse event|1|||
129882735|NCT00313911|467530501|FG000|Overall Study|Adverse Event|2|||
129882736|NCT00313911|467530502|FG001|Overall Study|Adverse Event|3|||
129882737|NCT00313911|467530501|FG000|Overall Study|Protocol Violation|19|||
129882738|NCT00313911|467530502|FG001|Overall Study|Protocol Violation|10|||
129882739|NCT00313911|467530501|FG000|Overall Study|Lost to Follow-up|27|||
129882740|NCT00313911|467530502|FG001|Overall Study|Lost to Follow-up|14|||
129882741|NCT00313911|467530501|FG000|Overall Study|Withdrawal by Subject|39|||
129882742|NCT00313911|467530502|FG001|Overall Study|Withdrawal by Subject|12|||
130214271|NCT00660595|468748943|FG000|Overall Study|Did not consent to participate in study|12|||
130214272|NCT00660595|468748944|FG001|Overall Study|Did not consent to participate in study|8|||
130214273|NCT00660595|468748943|FG000|Overall Study|Participant left hospital|1|||
130214274|NCT00660595|468748944|FG001|Overall Study|Participant left hospital|0|||
130214275|NCT00660595|468748943|FG000|Overall Study|Non Specified reasons|5|||
130214276|NCT00660595|468748944|FG001|Overall Study|Non Specified reasons|0|||
130214277|NCT05205005|468748945|FG000|Overall Study|Withdrawal by Subject|1|||
130214278|NCT05205005|468748946|FG001|Overall Study|Withdrawal by Subject|0|||
130214279|NCT05205005|468748945|FG000|Overall Study|Adverse Event|1|||
130214280|NCT05205005|468748946|FG001|Overall Study|Adverse Event|0|||
129882743|NCT00313911|467530501|FG000|Overall Study|Did not meet age criteria|1|||
129882744|NCT00313911|467530502|FG001|Overall Study|Did not meet age criteria|1|||
129882745|NCT01372605|467530505|FG000|Overall Study|Death|1|||
129882746|NCT01372605|467530506|FG001|Overall Study|Death|2|||
129882747|NCT01372605|467530505|FG000|Overall Study|Lost to Follow-up|2|||
129882748|NCT01372605|467530506|FG001|Overall Study|Lost to Follow-up|1|||
129882749|NCT01372605|467530505|FG000|Overall Study|Withdrawal by Subject|4|||
129882750|NCT01372605|467530506|FG001|Overall Study|Withdrawal by Subject|7|||
129882751|NCT01372605|467530505|FG000|Overall Study|Moved|3|||
129882752|NCT01372605|467530506|FG001|Overall Study|Moved|0|||
129882753|NCT01372605|467530505|FG000|Overall Study|Changed medical home|2|||
129882754|NCT01372605|467530506|FG001|Overall Study|Changed medical home|0|||
129882755|NCT00951509|467530507|FG000|Overall Study|Withdrawal by Subject|2|||
129882756|NCT00582491|467530508|FG000|Overall Study|Withdrawal by Subject|1|||
129882757|NCT00582491|467530509|FG001|Overall Study|Withdrawal by Subject|0|||
129882758|NCT01003639|467530510|FG000|Overall Study|Lost to Follow-up|6|||
129882759|NCT01003639|467530511|FG001|Overall Study|Lost to Follow-up|9|||
129882760|NCT01003639|467530510|FG000|Overall Study|Withdrawal by Subject|9|||
129882761|NCT01003639|467530511|FG001|Overall Study|Withdrawal by Subject|5|||
129882762|NCT01003639|467530510|FG000|Overall Study|Lack of Efficacy|1|||
129882763|NCT01003639|467530511|FG001|Overall Study|Lack of Efficacy|6|||
129882764|NCT01003639|467530510|FG000|Overall Study|Adverse Event|0|||
129882765|NCT01003639|467530511|FG001|Overall Study|Adverse Event|1|||
129882766|NCT01003639|467530510|FG000|Overall Study|Protocol Violation|0|||
129882767|NCT01003639|467530511|FG001|Overall Study|Protocol Violation|1|||
129882768|NCT01003639|467530510|FG000|Overall Study|Physician Decision|1|||
129882769|NCT01003639|467530511|FG001|Overall Study|Physician Decision|0|||
129882770|NCT04362137|467530515|FG000|Overall Study|Death|9|||
129882771|NCT04362137|467530516|FG001|Overall Study|Death|3|||
129882772|NCT04362137|467530515|FG000|Overall Study|Patient decision|6|||
129882773|NCT04362137|467530516|FG001|Overall Study|Patient decision|3|||
129882774|NCT04362137|467530515|FG000|Overall Study|Adverse Event|1|||
129882775|NCT04362137|467530516|FG001|Overall Study|Adverse Event|0|||
129882776|NCT04362137|467530515|FG000|Overall Study|Lost to Follow-up|1|||
129882777|NCT04362137|467530516|FG001|Overall Study|Lost to Follow-up|0|||
129882778|NCT04362137|467530515|FG000|Overall Study|Protocol deviation|1|||
129882779|NCT04362137|467530516|FG001|Overall Study|Protocol deviation|0|||
129882780|NCT03306043|467530520|FG000|Overall Study|Adverse Event|1|||
129882781|NCT03306043|467530520|FG000|Overall Study|Lost to Follow-up|1|||
129882782|NCT03306043|467530520|FG000|Overall Study|Withdrawal by Subject|2|||
129882783|NCT00785538|467530521|FG000|Treatment Period|Adverse Event|1|||
129882784|NCT00785538|467530522|FG001|Treatment Period|Adverse Event|2|||
129882785|NCT00785538|467530523|FG002|Treatment Period|Adverse Event|2|||
129882786|NCT00785538|467530524|FG003|Treatment Period|Adverse Event|0|||
129882787|NCT00785538|467530521|FG000|Treatment Period|Withdrawal by Subject|0|||
129882788|NCT00785538|467530522|FG001|Treatment Period|Withdrawal by Subject|0|||
129882789|NCT00785538|467530523|FG002|Treatment Period|Withdrawal by Subject|0|||
129882790|NCT00785538|467530524|FG003|Treatment Period|Withdrawal by Subject|1|||
129882791|NCT01799720|467530525|FG000|Overall Study|Withdrawal by Subject|3|||
129882792|NCT01799720|467530526|FG001|Overall Study|Withdrawal by Subject|0|||
129882793|NCT01799720|467530527|FG002|Overall Study|Withdrawal by Subject|0|||
129882794|NCT01799720|467530525|FG000|Overall Study|Protocol Violation|0|||
129882795|NCT01799720|467530526|FG001|Overall Study|Protocol Violation|1|||
129882796|NCT01799720|467530527|FG002|Overall Study|Protocol Violation|0|||
129882797|NCT01799720|467530525|FG000|Overall Study|Pregnancy|0|||
129882798|NCT01799720|467530526|FG001|Overall Study|Pregnancy|0|||
129882799|NCT01799720|467530527|FG002|Overall Study|Pregnancy|1|||
129882800|NCT04276090|467530528|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
129882801|NCT04276090|467530529|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
129882802|NCT01234649|467530530|FG000|Overall Study|Withdrawal by Subject|32|||
129882803|NCT01234649|467530531|FG001|Overall Study|Withdrawal by Subject|26|||
129882804|NCT01234649|467530530|FG000|Overall Study|Pregnancy|6|||
129882805|NCT01234649|467530531|FG001|Overall Study|Pregnancy|6|||
129882806|NCT01234649|467530530|FG000|Overall Study|intolerant to side effects|4|||
129882807|NCT01234649|467530531|FG001|Overall Study|intolerant to side effects|3|||
129882808|NCT01234649|467530530|FG000|Overall Study|Allergic reaction|1|||
129882809|NCT01234649|467530531|FG001|Overall Study|Allergic reaction|0|||
129882810|NCT01234649|467530530|FG000|Overall Study|Lack of Efficacy|0|||
129882811|NCT01234649|467530531|FG001|Overall Study|Lack of Efficacy|3|||
129882812|NCT00318149|467530534|FG000|Overall Study|Adverse Event|0|||
129882813|NCT00318149|467530535|FG001|Overall Study|Adverse Event|0|||
129882814|NCT00318149|467530536|FG002|Overall Study|Adverse Event|0|||
129882815|NCT00318149|467530537|FG003|Overall Study|Adverse Event|0|||
129882816|NCT00318149|467530538|FG004|Overall Study|Adverse Event|0|||
129882817|NCT00318149|467530539|FG005|Overall Study|Adverse Event|2|||
129882818|NCT00785707|467530545|FG000|Overall Study|Lost to Follow-up|7|||
129882819|NCT00105586|467530546|FG000|Overall Study|Adverse Event|4|||
129882820|NCT00105586|467530547|FG001|Overall Study|Adverse Event|3|||
129882821|NCT00105586|467530546|FG000|Overall Study|Physician Decision|13|||
129882822|NCT00105586|467530547|FG001|Overall Study|Physician Decision|13|||
129882823|NCT02306122|467530548|FG000|Initial Physician Randomization|Physician Decision|0|||
129882824|NCT02306122|467530549|FG001|Initial Physician Randomization|Physician Decision|0|||
129882825|NCT02306122|467530550|FG002|Initial Physician Randomization|Physician Decision|0|||
129882826|NCT02306122|467530551|FG003|Initial Physician Randomization|Physician Decision|0|||
129882827|NCT02306122|467530552|FG004|Initial Physician Randomization|Physician Decision|0|||
129882828|NCT02306122|467530553|FG005|Initial Physician Randomization|Physician Decision|0|||
129882829|NCT02306122|467530554|FG006|Initial Physician Randomization|Physician Decision|0|||
129882830|NCT02306122|467530555|FG007|Initial Physician Randomization|Physician Decision|0|||
129882831|NCT02306122|467530556|FG008|Initial Physician Randomization|Physician Decision|1|||
129882832|NCT02306122|467530557|FG009|Initial Physician Randomization|Physician Decision|0|||
129882833|NCT02306122|467530558|FG010|Initial Physician Randomization|Physician Decision|0|||
129882834|NCT02262260|467530561|FG000|Overall Study|Adverse Event|4|||
129882835|NCT02262260|467530562|FG001|Overall Study|Adverse Event|1|||
129882836|NCT02262260|467530561|FG000|Overall Study|Withdrawal of consent|4|||
129882837|NCT02262260|467530562|FG001|Overall Study|Withdrawal of consent|2|||
129882838|NCT02262260|467530561|FG000|Overall Study|Lost to Follow-up|1|||
129882839|NCT02262260|467530562|FG001|Overall Study|Lost to Follow-up|2|||
129882840|NCT02262260|467530561|FG000|Overall Study|Protocol deviation|2|||
129882841|NCT02262260|467530562|FG001|Overall Study|Protocol deviation|5|||
129882842|NCT01794117|467530564|FG000|Overall Study|Adverse Event|1|||
129882843|NCT01794117|467530565|FG001|Overall Study|Adverse Event|0|||
129882844|NCT01794117|467530566|FG002|Overall Study|Adverse Event|0|||
129882845|NCT01794117|467530567|FG003|Overall Study|Adverse Event|0|||
129882846|NCT01794117|467530564|FG000|Overall Study|Participant noncompliance|0|||
129882847|NCT01794117|467530565|FG001|Overall Study|Participant noncompliance|1|||
129882848|NCT01794117|467530566|FG002|Overall Study|Participant noncompliance|0|||
129882849|NCT01794117|467530567|FG003|Overall Study|Participant noncompliance|0|||
129882850|NCT01794117|467530564|FG000|Overall Study|Refused further treatment|0|||
129882851|NCT01794117|467530565|FG001|Overall Study|Refused further treatment|2|||
129882852|NCT01794117|467530566|FG002|Overall Study|Refused further treatment|0|||
129882853|NCT01794117|467530567|FG003|Overall Study|Refused further treatment|0|||
129882854|NCT03734991|467530568|FG000|Overall Study|Adverse Event|4|||
129882855|NCT03734991|467530569|FG001|Overall Study|Adverse Event|0|||
129882856|NCT03734991|467530568|FG000|Overall Study|Lost to Follow-up|4|||
129882857|NCT03734991|467530569|FG001|Overall Study|Lost to Follow-up|0|||
129882858|NCT03734991|467530568|FG000|Overall Study|Physician Decision|0|||
129882859|NCT03734991|467530569|FG001|Overall Study|Physician Decision|1|||
129882860|NCT03734991|467530568|FG000|Overall Study|Pregnancy|1|||
129882861|NCT03734991|467530569|FG001|Overall Study|Pregnancy|0|||
129882862|NCT03734991|467530568|FG000|Overall Study|Withdrawal by Subject|6|||
129882863|NCT03734991|467530569|FG001|Overall Study|Withdrawal by Subject|3|||
129882864|NCT03734991|467530568|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
129882865|NCT03734991|467530569|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
129882866|NCT03734991|467530568|FG000|Overall Study|Other|2|||
129882867|NCT03734991|467530569|FG001|Overall Study|Other|2|||
129882868|NCT02322814|467530572|FG000|Overall Study|Death|7|||
129882869|NCT02322814|467530573|FG001|Overall Study|Death|29|||
129882870|NCT02322814|467530574|FG002|Overall Study|Death|32|||
129882871|NCT02322814|467530575|FG003|Overall Study|Death|23|||
129882872|NCT02322814|467530576|FG004|Overall Study|Death|14|||
129882873|NCT02322814|467530572|FG000|Overall Study|Lost to Follow-up|1|||
129882874|NCT02322814|467530573|FG001|Overall Study|Lost to Follow-up|3|||
129882875|NCT02322814|467530574|FG002|Overall Study|Lost to Follow-up|3|||
129882876|NCT02322814|467530575|FG003|Overall Study|Lost to Follow-up|1|||
129882877|NCT02322814|467530576|FG004|Overall Study|Lost to Follow-up|0|||
129882878|NCT02322814|467530572|FG000|Overall Study|Various Reasons|2|||
129882879|NCT02322814|467530573|FG001|Overall Study|Various Reasons|0|||
129882880|NCT02322814|467530574|FG002|Overall Study|Various Reasons|1|||
129882881|NCT02322814|467530575|FG003|Overall Study|Various Reasons|1|||
129882882|NCT02322814|467530576|FG004|Overall Study|Various Reasons|0|||
129882883|NCT02322814|467530572|FG000|Overall Study|Progressive Disease|0|||
129882884|NCT02322814|467530573|FG001|Overall Study|Progressive Disease|0|||
129882885|NCT02322814|467530574|FG002|Overall Study|Progressive Disease|0|||
129882886|NCT02322814|467530575|FG003|Overall Study|Progressive Disease|1|||
129882887|NCT02322814|467530576|FG004|Overall Study|Progressive Disease|1|||
129882888|NCT02322814|467530572|FG000|Overall Study|Protocol Violation|1|||
129882889|NCT02322814|467530573|FG001|Overall Study|Protocol Violation|0|||
129882890|NCT02322814|467530574|FG002|Overall Study|Protocol Violation|0|||
129882891|NCT02322814|467530575|FG003|Overall Study|Protocol Violation|0|||
129882892|NCT02322814|467530576|FG004|Overall Study|Protocol Violation|0|||
129882893|NCT02322814|467530572|FG000|Overall Study|Study Terminated by Sponsor|0|||
129882894|NCT02322814|467530573|FG001|Overall Study|Study Terminated by Sponsor|7|||
129882895|NCT02322814|467530574|FG002|Overall Study|Study Terminated by Sponsor|9|||
129882896|NCT02322814|467530575|FG003|Overall Study|Study Terminated by Sponsor|5|||
129882897|NCT02322814|467530576|FG004|Overall Study|Study Terminated by Sponsor|13|||
129882898|NCT02322814|467530572|FG000|Overall Study|Withdrawal by Subject|5|||
129882899|NCT02322814|467530573|FG001|Overall Study|Withdrawal by Subject|4|||
129882900|NCT02322814|467530574|FG002|Overall Study|Withdrawal by Subject|2|||
129882901|NCT02322814|467530575|FG003|Overall Study|Withdrawal by Subject|1|||
129882902|NCT02322814|467530576|FG004|Overall Study|Withdrawal by Subject|3|||
129882903|NCT00591864|467530577|FG000|Overall Study|Incomplete Imaging|5|||
129882904|NCT02459093|467530578|FG000|Overall Study|Protocol Violation|6|||
129882905|NCT02459093|467530579|FG001|Overall Study|Protocol Violation|11|||
129882906|NCT02459093|467530578|FG000|Overall Study|Lost to Follow-up|6|||
129882907|NCT02459093|467530579|FG001|Overall Study|Lost to Follow-up|7|||
129882908|NCT00118092|467530580|FG000|Overall Study|Withdrawal by Subject|1|||
129882909|NCT00118092|467530580|FG000|Overall Study|Protocol Violation|1|||
129882910|NCT02736968|467530588|FG000|Overall Study|Lost to Follow-up|0|||
129882911|NCT02736968|467530589|FG001|Overall Study|Lost to Follow-up|0|||
129882912|NCT02736968|467530590|FG002|Overall Study|Lost to Follow-up|0|||
129882913|NCT02736968|467530591|FG003|Overall Study|Lost to Follow-up|0|||
129882914|NCT02736968|467530592|FG004|Overall Study|Lost to Follow-up|0|||
129882915|NCT02736968|467530593|FG005|Overall Study|Lost to Follow-up|0|||
129882916|NCT02736968|467530594|FG006|Overall Study|Lost to Follow-up|5|||
129882917|NCT02736968|467530595|FG007|Overall Study|Lost to Follow-up|2|||
129882918|NCT02736968|467530588|FG000|Overall Study|COVID-19 Pandemic|0|||
129882919|NCT02736968|467530589|FG001|Overall Study|COVID-19 Pandemic|0|||
129882920|NCT02736968|467530590|FG002|Overall Study|COVID-19 Pandemic|0|||
129882921|NCT02736968|467530591|FG003|Overall Study|COVID-19 Pandemic|0|||
129882922|NCT02736968|467530592|FG004|Overall Study|COVID-19 Pandemic|0|||
129882923|NCT02736968|467530593|FG005|Overall Study|COVID-19 Pandemic|0|||
129882924|NCT02736968|467530594|FG006|Overall Study|COVID-19 Pandemic|2|||
129882925|NCT02736968|467530595|FG007|Overall Study|COVID-19 Pandemic|0|||
129882926|NCT02736968|467530588|FG000|Overall Study|Withdrawal by Subject|0|||
129882927|NCT02736968|467530589|FG001|Overall Study|Withdrawal by Subject|0|||
129882928|NCT02736968|467530590|FG002|Overall Study|Withdrawal by Subject|0|||
129882929|NCT02736968|467530591|FG003|Overall Study|Withdrawal by Subject|0|||
129882930|NCT02736968|467530592|FG004|Overall Study|Withdrawal by Subject|0|||
129882931|NCT02736968|467530593|FG005|Overall Study|Withdrawal by Subject|0|||
129882932|NCT02736968|467530594|FG006|Overall Study|Withdrawal by Subject|1|||
129882933|NCT02736968|467530595|FG007|Overall Study|Withdrawal by Subject|0|||
129882934|NCT00147225|467530596|FG000|Overall Study|Withdrawal by Subject|1|||
129882935|NCT00147225|467530597|FG001|Overall Study|Withdrawal by Subject|0|||
129882936|NCT00147225|467530598|FG002|Overall Study|Withdrawal by Subject|1|||
129882937|NCT00147225|467530599|FG003|Overall Study|Withdrawal by Subject|0|||
129882938|NCT00147225|467530600|FG004|Overall Study|Withdrawal by Subject|0|||
129882939|NCT00147225|467530601|FG005|Overall Study|Withdrawal by Subject|1|||
129882940|NCT00147225|467530596|FG000|Overall Study|Adverse Event|0|||
129882941|NCT00147225|467530597|FG001|Overall Study|Adverse Event|0|||
129882942|NCT00147225|467530598|FG002|Overall Study|Adverse Event|1|||
129882943|NCT00147225|467530599|FG003|Overall Study|Adverse Event|1|||
129882944|NCT00147225|467530600|FG004|Overall Study|Adverse Event|0|||
129882945|NCT00147225|467530601|FG005|Overall Study|Adverse Event|0|||
129882946|NCT00147225|467530596|FG000|Overall Study|Screen Failure|0|||
129882947|NCT00147225|467530597|FG001|Overall Study|Screen Failure|0|||
129882948|NCT00147225|467530598|FG002|Overall Study|Screen Failure|0|||
129882949|NCT00147225|467530599|FG003|Overall Study|Screen Failure|0|||
129882950|NCT00147225|467530600|FG004|Overall Study|Screen Failure|1|||
129882951|NCT00147225|467530601|FG005|Overall Study|Screen Failure|0|||
129882952|NCT00147225|467530596|FG000|Overall Study|Chemotherapy Changed|0|||
129882953|NCT00147225|467530597|FG001|Overall Study|Chemotherapy Changed|0|||
129882954|NCT00147225|467530598|FG002|Overall Study|Chemotherapy Changed|0|||
129882955|NCT00147225|467530599|FG003|Overall Study|Chemotherapy Changed|0|||
129882956|NCT00147225|467530600|FG004|Overall Study|Chemotherapy Changed|0|||
129882957|NCT00147225|467530601|FG005|Overall Study|Chemotherapy Changed|1|||
129882958|NCT03713021|467530606|FG000|Overall Study|Did not have CT sim scan available|6|||
129882959|NCT03713021|467530606|FG000|Overall Study|Not eligible|4|||
129882960|NCT03713021|467530606|FG000|Overall Study|Issues with TraceIT markers|5|||
129882961|NCT03391960|467530607|FG000|Overall Study|Protocol Violation|0|||
129882962|NCT03391960|467530608|FG001|Overall Study|Protocol Violation|0|||
129882963|NCT03545113|467532268|FG000|Overall Study|Surgery Cancelled|1|||
129882964|NCT03545113|467532269|FG001|Overall Study|Surgery Cancelled|0|||
129882965|NCT03545113|467532268|FG000|Overall Study|Death|1|||
129882966|NCT03545113|467532269|FG001|Overall Study|Death|0|||
129882967|NCT03545113|467532268|FG000|Overall Study|Adverse Event|2|||
129882968|NCT03545113|467532269|FG001|Overall Study|Adverse Event|0|||
129882969|NCT03545113|467532268|FG000|Overall Study|Received different surgery|1|||
129882970|NCT03545113|467532269|FG001|Overall Study|Received different surgery|0|||
129882971|NCT01804673|467532270|FG000|Overall Study|Adverse Event|4|||
129882972|NCT01804673|467532270|FG000|Overall Study|Withdrawal by Subject|1|||
129882973|NCT01804673|467532270|FG000|Overall Study|Lack of Efficacy|9|||
129882974|NCT01804673|467532270|FG000|Overall Study|Change to Oral Therapy|37|||
129882975|NCT01804673|467532270|FG000|Overall Study|No Further Therapy Required|84|||
129882976|NCT01804673|467532270|FG000|Overall Study|Use of Prohibited Medication|1|||
129882977|NCT01804673|467532270|FG000|Overall Study|Other|4|||
129882978|NCT01533714|467532271|FG000|Overall Study|Adverse Event|0|||
129882979|NCT01533714|467532272|FG001|Overall Study|Adverse Event|1|||
129882980|NCT01533714|467532273|FG002|Overall Study|Adverse Event|2|||
129882981|NCT01533714|467532274|FG003|Overall Study|Adverse Event|2|||
129882982|NCT01533714|467532275|FG004|Overall Study|Adverse Event|2|||
129882983|NCT01533714|467532276|FG005|Overall Study|Adverse Event|1|||
129882984|NCT01533714|467532271|FG000|Overall Study|Lack of Efficacy|0|||
129882985|NCT01533714|467532272|FG001|Overall Study|Lack of Efficacy|0|||
129882986|NCT01533714|467532273|FG002|Overall Study|Lack of Efficacy|0|||
129882987|NCT01533714|467532274|FG003|Overall Study|Lack of Efficacy|0|||
129882988|NCT01533714|467532275|FG004|Overall Study|Lack of Efficacy|0|||
129882989|NCT01533714|467532276|FG005|Overall Study|Lack of Efficacy|1|||
129882990|NCT01533714|467532271|FG000|Overall Study|Withdrawal by Subject|0|||
129882991|NCT01533714|467532272|FG001|Overall Study|Withdrawal by Subject|1|||
129882992|NCT01533714|467532273|FG002|Overall Study|Withdrawal by Subject|0|||
129882993|NCT01533714|467532274|FG003|Overall Study|Withdrawal by Subject|1|||
129882994|NCT01533714|467532275|FG004|Overall Study|Withdrawal by Subject|1|||
129882995|NCT01533714|467532276|FG005|Overall Study|Withdrawal by Subject|0|||
129882996|NCT01533714|467532271|FG000|Overall Study|Exclusion criteria|0|||
129882997|NCT01533714|467532272|FG001|Overall Study|Exclusion criteria|1|||
129882998|NCT01533714|467532273|FG002|Overall Study|Exclusion criteria|0|||
129882999|NCT01533714|467532274|FG003|Overall Study|Exclusion criteria|0|||
129883000|NCT01533714|467532275|FG004|Overall Study|Exclusion criteria|0|||
129883001|NCT01533714|467532276|FG005|Overall Study|Exclusion criteria|0|||
129883002|NCT01533714|467532271|FG000|Overall Study|Positive for purified protein derivative|0|||
129883003|NCT01533714|467532272|FG001|Overall Study|Positive for purified protein derivative|0|||
129883004|NCT01533714|467532273|FG002|Overall Study|Positive for purified protein derivative|1|||
129883005|NCT01533714|467532274|FG003|Overall Study|Positive for purified protein derivative|0|||
129883006|NCT01533714|467532275|FG004|Overall Study|Positive for purified protein derivative|1|||
129883007|NCT01533714|467532276|FG005|Overall Study|Positive for purified protein derivative|0|||
129883008|NCT01533714|467532271|FG000|Overall Study|Withdrawal criteria|0|||
129883009|NCT01533714|467532272|FG001|Overall Study|Withdrawal criteria|0|||
129883010|NCT01533714|467532273|FG002|Overall Study|Withdrawal criteria|1|||
129883011|NCT01533714|467532274|FG003|Overall Study|Withdrawal criteria|0|||
129883012|NCT01533714|467532275|FG004|Overall Study|Withdrawal criteria|3|||
129883013|NCT01533714|467532276|FG005|Overall Study|Withdrawal criteria|1|||
129883014|NCT01533714|467532271|FG000|Overall Study|Ineligibility reason|0|||
129883015|NCT01533714|467532272|FG001|Overall Study|Ineligibility reason|0|||
129883016|NCT01533714|467532273|FG002|Overall Study|Ineligibility reason|0|||
129883017|NCT01533714|467532274|FG003|Overall Study|Ineligibility reason|1|||
129883018|NCT01533714|467532275|FG004|Overall Study|Ineligibility reason|0|||
129883019|NCT01533714|467532276|FG005|Overall Study|Ineligibility reason|0|||
129883020|NCT00251927|467532283|FG000|Overall Study|Adverse Event|3|||
129883021|NCT00251927|467532284|FG001|Overall Study|Adverse Event|15|||
129883022|NCT00251927|467532283|FG000|Overall Study|Lack of Efficacy|22|||
129883023|NCT00251927|467532284|FG001|Overall Study|Lack of Efficacy|16|||
129883024|NCT00251927|467532283|FG000|Overall Study|Lost to Follow-up|22|||
130214281|NCT01763203|468748953|FG000|Overall Study|Death|4|||
130214282|NCT01763203|468748954|FG001|Overall Study|Death|7|||
130214283|NCT01763203|468748953|FG000|Overall Study|Lost to Follow-up|12|||
130214284|NCT01763203|468748954|FG001|Overall Study|Lost to Follow-up|12|||
130214285|NCT01763203|468748953|FG000|Overall Study|Withdrawal by Subject|8|||
130214286|NCT01763203|468748954|FG001|Overall Study|Withdrawal by Subject|12|||
130214287|NCT01763203|468748953|FG000|Overall Study|Moved out of study region|7|||
130214288|NCT01763203|468748954|FG001|Overall Study|Moved out of study region|10|||
130214289|NCT01763203|468748953|FG000|Overall Study|Physician Decision|2|||
130214290|NCT01763203|468748954|FG001|Overall Study|Physician Decision|1|||
130214291|NCT02187861|468748955|FG000|Overall Study|Adverse Event|2|||
130214292|NCT02187861|468748956|FG001|Overall Study|Adverse Event|1|||
130214293|NCT02187861|468748957|FG002|Overall Study|Adverse Event|2|||
130214294|NCT02187861|468748958|FG003|Overall Study|Adverse Event|1|||
130214295|NCT02187861|468748955|FG000|Overall Study|Death|0|||
130214296|NCT02187861|468748956|FG001|Overall Study|Death|3|||
130214297|NCT02187861|468748957|FG002|Overall Study|Death|1|||
130214298|NCT02187861|468748958|FG003|Overall Study|Death|2|||
130214299|NCT02187861|468748955|FG000|Overall Study|Physician Decision|0|||
130214300|NCT02187861|468748956|FG001|Overall Study|Physician Decision|1|||
130214301|NCT02187861|468748957|FG002|Overall Study|Physician Decision|0|||
130214302|NCT02187861|468748958|FG003|Overall Study|Physician Decision|3|||
130214303|NCT02187861|468748955|FG000|Overall Study|Progressive Disease|4|||
130214304|NCT02187861|468748956|FG001|Overall Study|Progressive Disease|42|||
130214305|NCT02187861|468748957|FG002|Overall Study|Progressive Disease|19|||
130214306|NCT02187861|468748958|FG003|Overall Study|Progressive Disease|22|||
130214307|NCT02187861|468748955|FG000|Overall Study|Withdrawal by Subject|0|||
130214308|NCT02187861|468748956|FG001|Overall Study|Withdrawal by Subject|0|||
130214309|NCT02187861|468748957|FG002|Overall Study|Withdrawal by Subject|3|||
130214310|NCT02187861|468748958|FG003|Overall Study|Withdrawal by Subject|3|||
130214311|NCT02187861|468748955|FG000|Overall Study|Other|0|||
130214312|NCT02187861|468748956|FG001|Overall Study|Other|1|||
130214313|NCT02187861|468748957|FG002|Overall Study|Other|7|||
129883025|NCT00251927|467532284|FG001|Overall Study|Lost to Follow-up|8|||
129883026|NCT00251927|467532283|FG000|Overall Study|Protocol Violation|1|||
129883027|NCT00251927|467532284|FG001|Overall Study|Protocol Violation|2|||
129883028|NCT00251927|467532283|FG000|Overall Study|Pregnancy|2|||
129883029|NCT00251927|467532284|FG001|Overall Study|Pregnancy|0|||
129883030|NCT00251927|467532283|FG000|Overall Study|Withdrawal by Subject|40|||
129883031|NCT00251927|467532284|FG001|Overall Study|Withdrawal by Subject|25|||
129883032|NCT00251927|467532283|FG000|Overall Study|Study-specific discont. achieved|13|||
129883033|NCT00251927|467532284|FG001|Overall Study|Study-specific discont. achieved|2|||
130214314|NCT02187861|468748958|FG003|Overall Study|Other|1|||
130214315|NCT02757625|468748960|FG000|Overall Study|Investigator's discretion|0|||
130214316|NCT02757625|468748961|FG001|Overall Study|Investigator's discretion|0|||
130214317|NCT02757625|468748962|FG002|Overall Study|Investigator's discretion|1|||
130214318|NCT02757625|468748963|FG003|Overall Study|Investigator's discretion|0|||
129883034|NCT00251927|467532283|FG000|Overall Study|Study procedure non-compliance|5|||
129883035|NCT00251927|467532284|FG001|Overall Study|Study procedure non-compliance|6|||
129883036|NCT02222896|467532296|FG000|Abdomen|Did not qualify|34|||
129883037|NCT02222896|467532297|FG001|Abdomen|Did not qualify|10|||
129883038|NCT02222896|467532298|FG002|Abdomen|Did not qualify|32|||
129883039|NCT02222896|467532296|FG000|Groin|Did not qualify|43|||
129883040|NCT02222896|467532297|FG001|Groin|Did not qualify|9|||
129883041|NCT02222896|467532298|FG002|Groin|Did not qualify|40|||
129883042|NCT02226172|467532301|FG000|Overall Study|Participant refused further follow-up|4|||
129883043|NCT02226172|467532301|FG000|Overall Study|Other|5|||
129883044|NCT02226172|467532301|FG000|Overall Study|Death|1|||
129883045|NCT02226172|467532301|FG000|Overall Study|Study terminated by sponsor|1|||
129883046|NCT02226172|467532301|FG000|Overall Study|Adverse Event|6|||
129883047|NCT01865617|467532302|FG000|Overall Study|Death|27|||
129883048|NCT01865617|467532303|FG001|Overall Study|Death|3|||
129883049|NCT01865617|467532304|FG002|Overall Study|Death|1|||
129883050|NCT01865617|467532305|FG003|Overall Study|Death|1|||
129883051|NCT01865617|467532306|FG004|Overall Study|Death|5|||
129883052|NCT01865617|467532307|FG005|Overall Study|Death|1|||
129883053|NCT01865617|467532308|FG006|Overall Study|Death|11|||
129883054|NCT01865617|467532309|FG007|Overall Study|Death|1|||
129883055|NCT01865617|467532310|FG008|Overall Study|Death|11|||
129883056|NCT01865617|467532311|FG009|Overall Study|Death|3|||
129883057|NCT01865617|467532312|FG010|Overall Study|Death|32|||
129883058|NCT01865617|467532313|FG011|Overall Study|Death|6|||
129883059|NCT01865617|467532314|FG012|Overall Study|Death|13|||
129883060|NCT01865617|467532302|FG000|Overall Study|Lost to Follow-up|2|||
129883061|NCT01865617|467532303|FG001|Overall Study|Lost to Follow-up|0|||
129883062|NCT01865617|467532304|FG002|Overall Study|Lost to Follow-up|0|||
129883063|NCT01865617|467532305|FG003|Overall Study|Lost to Follow-up|0|||
129883064|NCT01865617|467532306|FG004|Overall Study|Lost to Follow-up|0|||
129883065|NCT01865617|467532307|FG005|Overall Study|Lost to Follow-up|0|||
129883066|NCT01865617|467532308|FG006|Overall Study|Lost to Follow-up|0|||
129883067|NCT01865617|467532309|FG007|Overall Study|Lost to Follow-up|0|||
129883068|NCT01865617|467532310|FG008|Overall Study|Lost to Follow-up|0|||
129883069|NCT01865617|467532311|FG009|Overall Study|Lost to Follow-up|0|||
129883070|NCT01865617|467532312|FG010|Overall Study|Lost to Follow-up|0|||
129883071|NCT01865617|467532313|FG011|Overall Study|Lost to Follow-up|0|||
129883072|NCT01865617|467532314|FG012|Overall Study|Lost to Follow-up|0|||
129883073|NCT01865617|467532302|FG000|Overall Study|Withdrawal by Subject|1|||
129883074|NCT01865617|467532303|FG001|Overall Study|Withdrawal by Subject|0|||
129883075|NCT01865617|467532304|FG002|Overall Study|Withdrawal by Subject|0|||
129883076|NCT01865617|467532305|FG003|Overall Study|Withdrawal by Subject|0|||
129883077|NCT01865617|467532306|FG004|Overall Study|Withdrawal by Subject|0|||
129883078|NCT01865617|467532307|FG005|Overall Study|Withdrawal by Subject|0|||
129883079|NCT01865617|467532308|FG006|Overall Study|Withdrawal by Subject|0|||
129883080|NCT01865617|467532309|FG007|Overall Study|Withdrawal by Subject|0|||
129883081|NCT01865617|467532310|FG008|Overall Study|Withdrawal by Subject|0|||
129883082|NCT01865617|467532311|FG009|Overall Study|Withdrawal by Subject|0|||
129883083|NCT01865617|467532312|FG010|Overall Study|Withdrawal by Subject|0|||
129883084|NCT01865617|467532313|FG011|Overall Study|Withdrawal by Subject|0|||
129883085|NCT01865617|467532314|FG012|Overall Study|Withdrawal by Subject|0|||
129883086|NCT01865617|467532302|FG000|Overall Study|Patient proceeded to new therapy|0|||
129883087|NCT01865617|467532303|FG001|Overall Study|Patient proceeded to new therapy|0|||
129883088|NCT01865617|467532304|FG002|Overall Study|Patient proceeded to new therapy|0|||
129883089|NCT01865617|467532305|FG003|Overall Study|Patient proceeded to new therapy|0|||
129883090|NCT01865617|467532306|FG004|Overall Study|Patient proceeded to new therapy|2|||
129883091|NCT01865617|467532307|FG005|Overall Study|Patient proceeded to new therapy|0|||
129883092|NCT01865617|467532308|FG006|Overall Study|Patient proceeded to new therapy|0|||
129883093|NCT01865617|467532309|FG007|Overall Study|Patient proceeded to new therapy|0|||
129883094|NCT01865617|467532310|FG008|Overall Study|Patient proceeded to new therapy|0|||
129883095|NCT01865617|467532311|FG009|Overall Study|Patient proceeded to new therapy|0|||
129883096|NCT01865617|467532312|FG010|Overall Study|Patient proceeded to new therapy|0|||
129883097|NCT01865617|467532313|FG011|Overall Study|Patient proceeded to new therapy|0|||
129883098|NCT01865617|467532314|FG012|Overall Study|Patient proceeded to new therapy|0|||
129883099|NCT01865617|467532302|FG000|Overall Study|Other|0|||
129883100|NCT01865617|467532303|FG001|Overall Study|Other|0|||
129883101|NCT01865617|467532304|FG002|Overall Study|Other|0|||
129883102|NCT01865617|467532305|FG003|Overall Study|Other|0|||
129883103|NCT01865617|467532306|FG004|Overall Study|Other|0|||
129883104|NCT01865617|467532307|FG005|Overall Study|Other|0|||
129883105|NCT01865617|467532308|FG006|Overall Study|Other|1|||
129883106|NCT01865617|467532309|FG007|Overall Study|Other|0|||
129883107|NCT01865617|467532310|FG008|Overall Study|Other|0|||
129883108|NCT01865617|467532311|FG009|Overall Study|Other|0|||
129883109|NCT01865617|467532312|FG010|Overall Study|Other|0|||
129883110|NCT01865617|467532313|FG011|Overall Study|Other|0|||
129883111|NCT01865617|467532314|FG012|Overall Study|Other|0|||
129883112|NCT00258440|467532318|FG000|Overall Study|Withdrawal by Subject|0|||
129883113|NCT00258440|467532319|FG001|Overall Study|Withdrawal by Subject|0|||
129883114|NCT00258440|467532320|FG002|Overall Study|Withdrawal by Subject|1|||
129883115|NCT00737061|467532321|FG000|Waiting Period|Lost to Follow-up|6|||
129883116|NCT00737061|467532321|FG000|Waiting Period|Withdrawal by Subject|1|||
129883117|NCT00737061|467532321|FG000|Waiting Period|Bilateral placement failure|34|||
129883118|NCT00737061|467532321|FG000|Waiting Period|Deemed patent following HSG|26|||
129883119|NCT00737061|467532321|FG000|Waiting Period|Alternative contraception failure|3|||
129883120|NCT00737061|467532321|FG000|Waiting Period|Elected surgical tubal ligation|5|||
129883121|NCT00737061|467532321|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
129883122|NCT00737061|467532321|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
129883123|NCT00737061|467532321|FG000|1 Year Wearing Period|Discontinued reilance|3|||
129883124|NCT00737061|467532321|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
129883125|NCT00439179|467532323|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
129883126|NCT00439179|467532324|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
129883127|NCT00439179|467532325|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
129883128|NCT00439179|467532326|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
129883129|NCT01844115|467532330|FG000|Overall Study|Adverse Event|4|||
129883130|NCT01844115|467532331|FG001|Overall Study|Adverse Event|22|||
129883131|NCT01844115|467532330|FG000|Overall Study|Lack of Efficacy|1|||
129883132|NCT01844115|467532331|FG001|Overall Study|Lack of Efficacy|4|||
129883133|NCT01844115|467532330|FG000|Overall Study|Protocol Violation|12|||
129883134|NCT01844115|467532331|FG001|Overall Study|Protocol Violation|10|||
129883135|NCT01844115|467532330|FG000|Overall Study|Withdrawal by Subject|11|||
129883136|NCT01844115|467532331|FG001|Overall Study|Withdrawal by Subject|11|||
129883137|NCT01844115|467532330|FG000|Overall Study|Lost to Follow-up|11|||
129883138|NCT01844115|467532331|FG001|Overall Study|Lost to Follow-up|10|||
129883139|NCT01844115|467532330|FG000|Overall Study|Pregnancy|0|||
129883140|NCT01844115|467532331|FG001|Overall Study|Pregnancy|1|||
129883141|NCT00758160|467532332|FG000|Overall Study|No Longer Requires Study Medication|4|||
129883142|NCT00758160|467532332|FG000|Overall Study|Administration Problems|3|||
129883143|NCT00758160|467532332|FG000|Overall Study|Adverse Event|15|||
129883144|NCT00758160|467532332|FG000|Overall Study|Lack of Efficacy|10|||
129883145|NCT00758160|467532332|FG000|Overall Study|Lost to Follow-up|14|||
129883146|NCT00758160|467532332|FG000|Overall Study|Protocol Violation|12|||
129883147|NCT00758160|467532332|FG000|Overall Study|Withdrawal by Subject|8|||
129883148|NCT01613027|467532333|FG000|Overall Study|Lost to Follow-up|5|||
129883149|NCT01613027|467532333|FG000|Overall Study|Switched Physician|1|||
129883150|NCT01613027|467532333|FG000|Overall Study|Lack of Efficacy|1|||
129883151|NCT01613027|467532333|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
129883152|NCT00993317|467532334|FG000|Overall Study|Adverse Event|2|||
129883153|NCT00993317|467532335|FG001|Overall Study|Adverse Event|4|||
129883154|NCT00993317|467532334|FG000|Overall Study|Lack of Efficacy|18|||
129883155|NCT00993317|467532335|FG001|Overall Study|Lack of Efficacy|18|||
129883156|NCT00993317|467532334|FG000|Overall Study|Withdrawal by Subject|0|||
129883157|NCT00993317|467532335|FG001|Overall Study|Withdrawal by Subject|2|||
129883158|NCT00993317|467532334|FG000|Overall Study|Investigator's opinion|0|||
129883159|NCT00993317|467532335|FG001|Overall Study|Investigator's opinion|1|||
129883160|NCT00993317|467532334|FG000|Overall Study|Early study termination at the site|1|||
129883161|NCT00993317|467532335|FG001|Overall Study|Early study termination at the site|0|||
129883162|NCT02153359|467532336|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
129883163|NCT02153359|467532337|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
129883164|NCT04422639|467532338|FG000|Overall Study|Death|1|||
129883165|NCT04422639|467532339|FG001|Overall Study|Death|0|||
129883166|NCT04422639|467532338|FG000|Overall Study|study closed prior to completion of FU visits|0|||
129883167|NCT04422639|467532339|FG001|Overall Study|study closed prior to completion of FU visits|2|||
129883168|NCT01964521|467532340|FG000|Overall Study|Lost to Follow-up|4|||
129883169|NCT01108510|467532341|FG000|Overall Study|Randomized but Not Treated|5|||
129883170|NCT01108510|467532342|FG001|Overall Study|Randomized but Not Treated|1|||
129883171|NCT01108510|467532341|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
129883172|NCT01108510|467532342|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
129883173|NCT01108510|467532341|FG000|Overall Study|Adverse Event|26|||
129883174|NCT01108510|467532342|FG001|Overall Study|Adverse Event|19|||
129883175|NCT01108510|467532341|FG000|Overall Study|Lost to Follow-up|20|||
129883176|NCT01108510|467532342|FG001|Overall Study|Lost to Follow-up|17|||
129883177|NCT01108510|467532341|FG000|Overall Study|Withdrew Consent|21|||
129883178|NCT01108510|467532342|FG001|Overall Study|Withdrew Consent|15|||
129883179|NCT01108510|467532341|FG000|Overall Study|Investigator's Discretion|12|||
129883180|NCT01108510|467532342|FG001|Overall Study|Investigator's Discretion|10|||
129883181|NCT01108510|467532341|FG000|Overall Study|Participant Noncompliance|5|||
129883182|NCT01108510|467532342|FG001|Overall Study|Participant Noncompliance|7|||
129883183|NCT01108510|467532341|FG000|Overall Study|Lack of Efficacy|3|||
129883184|NCT01108510|467532342|FG001|Overall Study|Lack of Efficacy|0|||
129883185|NCT01108510|467532341|FG000|Overall Study|Pregnancy|0|||
129883186|NCT01108510|467532342|FG001|Overall Study|Pregnancy|3|||
129883187|NCT01108510|467532341|FG000|Overall Study|Death|1|||
129883188|NCT01108510|467532342|FG001|Overall Study|Death|1|||
129883189|NCT02796963|467532343|FG000|Overall Study|Lost to Follow-up|89|||
130214319|NCT02757625|468748960|FG000|Overall Study|Adverse Event|0|||
130214320|NCT02757625|468748961|FG001|Overall Study|Adverse Event|0|||
130214321|NCT02757625|468748962|FG002|Overall Study|Adverse Event|1|||
130214322|NCT02757625|468748963|FG003|Overall Study|Adverse Event|0|||
130214323|NCT04854057|468748964|FG000|Overall Study|Adverse Event|0|||
129883190|NCT02796963|467532344|FG001|Overall Study|Lost to Follow-up|76|||
130214324|NCT04854057|468748965|FG001|Overall Study|Adverse Event|1|||
130214325|NCT03519919|468748966|FG000|Overall Study|Withdrawal by Subject|1|||
130214326|NCT03519919|468748966|FG000|Overall Study|Lack of Efficacy|1|||
130214327|NCT03519919|468748966|FG000|Overall Study|Screen Failure|1|||
130214328|NCT00645671|468748967|FG000|Overall Study|Protocol Violation|1|||
130214329|NCT00645671|468748968|FG001|Overall Study|Protocol Violation|0|||
130214330|NCT00645671|468748967|FG000|Overall Study|Withdrawal by Subject|0|||
130214331|NCT00645671|468748968|FG001|Overall Study|Withdrawal by Subject|4|||
130214332|NCT00645671|468748967|FG000|Overall Study|Adverse Event|0|||
130214333|NCT00645671|468748968|FG001|Overall Study|Adverse Event|1|||
130214334|NCT00645671|468748967|FG000|Overall Study|Physician Decision|0|||
130214335|NCT00645671|468748968|FG001|Overall Study|Physician Decision|1|||
130214336|NCT05114564|468748969|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
130214337|NCT05114564|468748970|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
130214338|NCT05114564|468748969|FG000|First Intervention|Adverse Event|0|||
130214339|NCT05114564|468748970|FG001|First Intervention|Adverse Event|1|||
130214340|NCT00493311|468748971|FG000|Overall Study|Need for rescue medication|2|||
130214341|NCT00493311|468748972|FG001|Overall Study|Need for rescue medication|2|||
130214342|NCT02779075|468748973|FG000|Overall Study|Withdrawal by Subject|1|||
130214343|NCT02779075|468748974|FG001|Overall Study|Withdrawal by Subject|3|||
130214344|NCT02779075|468748973|FG000|Overall Study|IV lost during 2nd study|1|||
130214345|NCT02779075|468748974|FG001|Overall Study|IV lost during 2nd study|0|||
130214346|NCT01951573|468748975|FG000|Washout Period|Adverse Event|0|||
130214347|NCT01951573|468748976|FG001|Washout Period|Adverse Event|1|||
130214348|NCT00707980|468748977|FG000|Overall Study|Adverse Event|49|||
130214349|NCT00707980|468748977|FG000|Overall Study|Lack of Efficacy|35|||
130214350|NCT00707980|468748977|FG000|Overall Study|Non-Compliance with Study Drug|28|||
130214351|NCT00707980|468748977|FG000|Overall Study|Protocol Deviations|19|||
130214352|NCT00707980|468748977|FG000|Overall Study|Withdrawal of Consent|81|||
130214353|NCT00707980|468748977|FG000|Overall Study|Lost to Follow-up|59|||
130214354|NCT00707980|468748977|FG000|Overall Study|Other|39|||
130214355|NCT01909973|468748978|FG000|Overall Study|Lost to Follow-up|1|||
130214356|NCT01909973|468748979|FG001|Overall Study|Lost to Follow-up|0|||
130214357|NCT00460239|468748980|FG000|Overall Study|Physician Decision|0|||
130214358|NCT00460239|468748981|FG001|Overall Study|Physician Decision|1|||
130214359|NCT00460239|468748982|FG002|Overall Study|Physician Decision|0|||
130214360|NCT00460239|468748983|FG003|Overall Study|Physician Decision|0|||
130214361|NCT00460239|468748984|FG004|Overall Study|Physician Decision|0|||
130214362|NCT00460239|468748985|FG005|Overall Study|Physician Decision|2|||
130214363|NCT00460239|468748986|FG006|Overall Study|Physician Decision|0|||
130214364|NCT00460239|468748987|FG007|Overall Study|Physician Decision|0|||
130214365|NCT00460239|468748988|FG008|Overall Study|Physician Decision|0|||
130214366|NCT00460239|468748980|FG000|Overall Study|Withdrawal by Subject|0|||
130214367|NCT00460239|468748981|FG001|Overall Study|Withdrawal by Subject|0|||
130214368|NCT00460239|468748982|FG002|Overall Study|Withdrawal by Subject|0|||
130214369|NCT00460239|468748983|FG003|Overall Study|Withdrawal by Subject|0|||
130214370|NCT00460239|468748984|FG004|Overall Study|Withdrawal by Subject|0|||
130214371|NCT00460239|468748985|FG005|Overall Study|Withdrawal by Subject|1|||
130214372|NCT00460239|468748986|FG006|Overall Study|Withdrawal by Subject|0|||
130214373|NCT00460239|468748987|FG007|Overall Study|Withdrawal by Subject|0|||
130214374|NCT00460239|468748988|FG008|Overall Study|Withdrawal by Subject|0|||
130214375|NCT04217317|468749016|FG000|Overall Study|Lack of Efficacy|4|||
130214376|NCT04217317|468749016|FG000|Overall Study|Physician Decision|1|||
130214377|NCT04313400|468749020|FG000|Overall Study|Withdrawal by Subject|0|||
130214378|NCT04313400|468749021|FG001|Overall Study|Withdrawal by Subject|0|||
130214379|NCT04313400|468749022|FG002|Overall Study|Withdrawal by Subject|0|||
130214380|NCT04313400|468749023|FG003|Overall Study|Withdrawal by Subject|0|||
129883191|NCT02796963|467532345|FG002|Overall Study|Lost to Follow-up|69|||
129883192|NCT02796963|467532346|FG003|Overall Study|Lost to Follow-up|72|||
129883193|NCT01258660|467532348|FG000|Overall Study|Adverse Event|2|||
129883194|NCT01258660|467532349|FG001|Overall Study|Adverse Event|4|||
129883195|NCT01258660|467532348|FG000|Overall Study|Withdrawal by Subject|3|||
129883196|NCT01258660|467532349|FG001|Overall Study|Withdrawal by Subject|0|||
130214381|NCT04313400|468749024|FG004|Overall Study|Withdrawal by Subject|0|||
130214382|NCT04313400|468749025|FG005|Overall Study|Withdrawal by Subject|4|||
130214383|NCT04313400|468749026|FG006|Overall Study|Withdrawal by Subject|1|||
130214384|NCT04313400|468749020|FG000|Overall Study|Adverse Event|0|||
130214385|NCT04313400|468749021|FG001|Overall Study|Adverse Event|0|||
130214386|NCT04313400|468749022|FG002|Overall Study|Adverse Event|0|||
130214387|NCT04313400|468749023|FG003|Overall Study|Adverse Event|0|||
130214388|NCT04313400|468749024|FG004|Overall Study|Adverse Event|0|||
129883197|NCT01258660|467532348|FG000|Overall Study|due to relocation|2|||
129883198|NCT01258660|467532349|FG001|Overall Study|due to relocation|0|||
129883199|NCT01258660|467532348|FG000|Overall Study|Protocol Violation|0|||
129883200|NCT01258660|467532349|FG001|Overall Study|Protocol Violation|1|||
129883201|NCT01258660|467532348|FG000|Overall Study|Invalid for primary analysis data set|4|||
129883202|NCT01258660|467532349|FG001|Overall Study|Invalid for primary analysis data set|6|||
129883203|NCT04192630|467532350|FG000|Overall Study|Discontinued before surgery|2|||
129883204|NCT04192630|467532351|FG001|Overall Study|Discontinued before surgery|0|||
129883205|NCT04192630|467532350|FG000|Overall Study|Discontinued after surgery|5|||
129883206|NCT04192630|467532351|FG001|Overall Study|Discontinued after surgery|3|||
129883207|NCT01193582|467532352|FG000|Vaccination Series|Withdrawal by Subject|11|||
129883208|NCT01193582|467532353|FG001|Vaccination Series|Withdrawal by Subject|13|||
129883209|NCT01193582|467532354|FG002|Vaccination Series|Withdrawal by Subject|8|||
129883210|NCT01193582|467532355|FG003|Vaccination Series|Withdrawal by Subject|3|||
129883211|NCT01193582|467532352|FG000|12 Month Follow-up|Death|0|||
129883212|NCT01193582|467532353|FG001|12 Month Follow-up|Death|0|||
129883213|NCT01193582|467532354|FG002|12 Month Follow-up|Death|1|||
129883214|NCT01193582|467532355|FG003|12 Month Follow-up|Death|0|||
129883215|NCT01193582|467532352|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
129883216|NCT01193582|467532353|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
129883217|NCT01193582|467532354|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
129883218|NCT01193582|467532355|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
129883219|NCT01425632|467532356|FG000|Overall Study|Adverse Event|0|||
129883220|NCT01425632|467532357|FG001|Overall Study|Adverse Event|1|||
129883221|NCT01425632|467532358|FG002|Overall Study|Adverse Event|1|||
130214389|NCT04313400|468749025|FG005|Overall Study|Adverse Event|1|||
130214390|NCT04313400|468749026|FG006|Overall Study|Adverse Event|0|||
130214391|NCT04313400|468749020|FG000|Overall Study|Lost to Follow-up|0|||
130214392|NCT04313400|468749021|FG001|Overall Study|Lost to Follow-up|0|||
130214393|NCT04313400|468749022|FG002|Overall Study|Lost to Follow-up|0|||
130214394|NCT04313400|468749023|FG003|Overall Study|Lost to Follow-up|0|||
130214395|NCT04313400|468749024|FG004|Overall Study|Lost to Follow-up|0|||
130214396|NCT04313400|468749025|FG005|Overall Study|Lost to Follow-up|1|||
130214397|NCT04313400|468749026|FG006|Overall Study|Lost to Follow-up|0|||
130214398|NCT00770913|468749029|FG000|Overall Study|Adverse Event|1|||
130214399|NCT00770913|468749030|FG001|Overall Study|Adverse Event|3|||
130214400|NCT00770913|468749031|FG002|Overall Study|Adverse Event|6|||
130214401|NCT00770913|468749029|FG000|Overall Study|Refusal to continue participation|6|||
130214402|NCT00770913|468749030|FG001|Overall Study|Refusal to continue participation|4|||
130214403|NCT00770913|468749031|FG002|Overall Study|Refusal to continue participation|5|||
130214404|NCT00770913|468749029|FG000|Overall Study|Physician Decision|0|||
130214405|NCT00770913|468749030|FG001|Overall Study|Physician Decision|1|||
130214406|NCT00770913|468749031|FG002|Overall Study|Physician Decision|1|||
130214407|NCT00770913|468749029|FG000|Overall Study|Protocol Violation|3|||
130214408|NCT00770913|468749030|FG001|Overall Study|Protocol Violation|0|||
130214409|NCT00770913|468749031|FG002|Overall Study|Protocol Violation|1|||
130214410|NCT00770913|468749029|FG000|Overall Study|Incorrect drug was allocated|1|||
130214411|NCT00770913|468749030|FG001|Overall Study|Incorrect drug was allocated|0|||
130214412|NCT00770913|468749031|FG002|Overall Study|Incorrect drug was allocated|0|||
130214413|NCT00359294|468749032|FG000|Overall Study|Progressive disease|1|||
130214414|NCT00359294|468749033|FG001|Overall Study|Progressive disease|1|||
130214415|NCT00359294|468749034|FG002|Overall Study|Progressive disease|2|||
130214416|NCT00359294|468749035|FG003|Overall Study|Progressive disease|3|||
130214417|NCT00359294|468749036|FG004|Overall Study|Progressive disease|2|||
130214418|NCT00359294|468749032|FG000|Overall Study|Withdrawal by Subject|0|||
130214419|NCT00359294|468749033|FG001|Overall Study|Withdrawal by Subject|0|||
130214420|NCT00359294|468749034|FG002|Overall Study|Withdrawal by Subject|0|||
130214421|NCT00359294|468749035|FG003|Overall Study|Withdrawal by Subject|0|||
130214422|NCT00359294|468749036|FG004|Overall Study|Withdrawal by Subject|1|||
130214423|NCT00359294|468749032|FG000|Overall Study|Not treated|0|||
130214424|NCT00359294|468749033|FG001|Overall Study|Not treated|0|||
130214425|NCT00359294|468749034|FG002|Overall Study|Not treated|0|||
130214426|NCT00359294|468749035|FG003|Overall Study|Not treated|1|||
130214427|NCT00359294|468749036|FG004|Overall Study|Not treated|0|||
130214428|NCT00359294|468749032|FG000|Overall Study|Physician Decision|0|||
130214429|NCT00359294|468749033|FG001|Overall Study|Physician Decision|0|||
130214430|NCT00359294|468749034|FG002|Overall Study|Physician Decision|1|||
130214431|NCT00359294|468749035|FG003|Overall Study|Physician Decision|0|||
130214432|NCT00359294|468749036|FG004|Overall Study|Physician Decision|0|||
129883222|NCT01425632|467532356|FG000|Overall Study|Physician Decision|1|||
129883223|NCT01425632|467532357|FG001|Overall Study|Physician Decision|0|||
129883224|NCT01425632|467532358|FG002|Overall Study|Physician Decision|0|||
130214433|NCT01808222|468749037|FG000|Overall Study|mpMR scan was not performed|1|||
130214434|NCT00524680|468749040|FG000|Overall Study|progression|0|||
130214435|NCT00524680|468749041|FG001|Overall Study|progression|0|||
129883225|NCT01425632|467532356|FG000|Overall Study|Protocol Violation|0|||
129883226|NCT01425632|467532357|FG001|Overall Study|Protocol Violation|0|||
129883227|NCT01425632|467532358|FG002|Overall Study|Protocol Violation|2|||
130214436|NCT00524680|468749042|FG002|Overall Study|progression|0|||
130214437|NCT00524680|468749043|FG003|Overall Study|progression|1|||
129883228|NCT01425632|467532356|FG000|Overall Study|Withdrawal by Subject|0|||
129883229|NCT01425632|467532357|FG001|Overall Study|Withdrawal by Subject|0|||
129883230|NCT01425632|467532358|FG002|Overall Study|Withdrawal by Subject|1|||
129883231|NCT01775930|467532365|FG000|Overall Study|Futility stopping boundary met|1|||
129883232|NCT01208415|467532368|FG000|Overall Study|Death|1|||
129883233|NCT01208415|467532368|FG000|Overall Study|Lost to Follow-up|2|||
129883234|NCT01208415|467532368|FG000|Overall Study|Withdrawal by Subject|3|||
129883235|NCT01208415|467532368|FG000|Overall Study|Device not placed|1|||
129883236|NCT01208415|467532368|FG000|Overall Study|Still be eligible for follow-up|33|||
129883237|NCT01115491|467532369|FG000|Overall Study|Death|22|||
129883238|NCT01115491|467532369|FG000|Overall Study|Adverse Event|3|||
129883239|NCT01115491|467532369|FG000|Overall Study|Lost to Follow-up|3|||
129883240|NCT01115491|467532369|FG000|Overall Study|Withdrawal by Subject|1|||
129883241|NCT01115491|467532369|FG000|Overall Study|Physician Decision|1|||
129883242|NCT04297241|467532370|FG000|Overall Study|Withdrawal by Subject|1|||
129883243|NCT04297241|467532370|FG000|Overall Study|Adverse Event|1|||
129883244|NCT04297241|467532370|FG000|Overall Study|Physician Decision|3|||
129883245|NCT03856996|467532374|FG000|Overall Study|Withdrawal by Subject|1|||
129883246|NCT03856996|467532375|FG001|Overall Study|Withdrawal by Subject|0|||
129883247|NCT03856996|467532374|FG000|Overall Study|Lost to Follow-up|0|||
129883248|NCT03856996|467532375|FG001|Overall Study|Lost to Follow-up|1|||
129883249|NCT03856996|467532374|FG000|Overall Study|Adverse Event|1|||
129883250|NCT03856996|467532375|FG001|Overall Study|Adverse Event|1|||
129883251|NCT03856996|467532374|FG000|Overall Study|Other|1|||
129883252|NCT03856996|467532375|FG001|Overall Study|Other|0|||
129883253|NCT02340520|467532378|FG000|Overall Study|Lost to Follow-up|1|||
129883254|NCT02340520|467532378|FG000|Overall Study|Patient did not take drug as specified|1|||
129883255|NCT02340520|467532378|FG000|Overall Study|Withdrawal by Subject|1|||
129883256|NCT01464255|467532379|FG000|Overall Study|unresolve corneal staining|0|||
129883257|NCT01464255|467532380|FG001|Overall Study|unresolve corneal staining|1|||
129883258|NCT01231503|467532381|FG000|Overall Study|Adverse Event|0|||
129883259|NCT01231503|467532382|FG001|Overall Study|Adverse Event|0|||
129883260|NCT01231503|467532383|FG002|Overall Study|Adverse Event|0|||
129883261|NCT01231503|467532384|FG003|Overall Study|Adverse Event|0|||
129883262|NCT01231503|467532385|FG004|Overall Study|Adverse Event|0|||
129883263|NCT01231503|467532386|FG005|Overall Study|Adverse Event|1|||
129883264|NCT01231503|467532387|FG006|Overall Study|Adverse Event|0|||
129883265|NCT01231503|467532388|FG007|Overall Study|Adverse Event|0|||
129883266|NCT01231503|467532381|FG000|Overall Study|Adverse event, serious fatal|0|||
129883267|NCT01231503|467532382|FG001|Overall Study|Adverse event, serious fatal|0|||
129883268|NCT01231503|467532383|FG002|Overall Study|Adverse event, serious fatal|1|||
129985714|NCT04811131|467909334|FG001|Overall Study|Withdrawal by Subject|1|||
129985715|NCT04811131|467909335|FG002|Overall Study|Withdrawal by Subject|3|||
129985716|NCT04811131|467909336|FG003|Overall Study|Withdrawal by Subject|1|||
129985717|NCT01528345|467909338|FG000|Overall Study|Adverse Event|10|||
129985718|NCT01528345|467909339|FG001|Overall Study|Adverse Event|1|||
129985719|NCT01528345|467909338|FG000|Overall Study|Death|1|||
129985720|NCT01528345|467909339|FG001|Overall Study|Death|1|||
129985721|NCT01528345|467909338|FG000|Overall Study|Non-compliance with study treatment|1|||
129985722|NCT01528345|467909339|FG001|Overall Study|Non-compliance with study treatment|0|||
129985723|NCT01528345|467909338|FG000|Overall Study|Progressive Disease|26|||
129985724|NCT01528345|467909339|FG001|Overall Study|Progressive Disease|40|||
129985725|NCT01528345|467909338|FG000|Overall Study|Study Terminated by Sponsor|4|||
129985726|NCT01528345|467909339|FG001|Overall Study|Study Terminated by Sponsor|8|||
129985727|NCT01528345|467909338|FG000|Overall Study|Subject/Guardian Decision|5|||
129985728|NCT01528345|467909339|FG001|Overall Study|Subject/Guardian Decision|0|||
129985729|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Death|1|||
129985730|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Death|1|||
129985731|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
129985732|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
129985733|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
129985734|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
129985735|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
129985736|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
129985737|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
129985738|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
129985739|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
129985740|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
129985741|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
129985742|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
129985743|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
129985744|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
129985745|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|Death|0|||
129883269|NCT01231503|467532384|FG003|Overall Study|Adverse event, serious fatal|1|||
129985746|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|Death|2|||
129985747|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
129985748|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
129985749|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
129985750|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
129985751|NCT03181789|467909343|FG000|Overall Study|Withdrawal by Subject|0|||
129985752|NCT03181789|467909344|FG001|Overall Study|Withdrawal by Subject|1|||
129985753|NCT03181789|467909345|FG002|Overall Study|Withdrawal by Subject|1|||
129985754|NCT03181789|467909346|FG003|Overall Study|Withdrawal by Subject|0|||
129985755|NCT03181789|467909343|FG000|Overall Study|Lost to Follow-up|7|||
129985756|NCT03181789|467909344|FG001|Overall Study|Lost to Follow-up|1|||
129985757|NCT03181789|467909345|FG002|Overall Study|Lost to Follow-up|0|||
129985758|NCT03181789|467909346|FG003|Overall Study|Lost to Follow-up|0|||
129985759|NCT03181789|467909343|FG000|Overall Study|Participant unable to adhere to visit|0|||
129985760|NCT03181789|467909344|FG001|Overall Study|Participant unable to adhere to visit|1|||
129985761|NCT03181789|467909345|FG002|Overall Study|Participant unable to adhere to visit|0|||
129985762|NCT03181789|467909346|FG003|Overall Study|Participant unable to adhere to visit|0|||
129985763|NCT01151410|467909347|FG000|Overall Study|Withdrawal by Subject|3|||
129985764|NCT01151410|467909348|FG001|Overall Study|Withdrawal by Subject|5|||
129985765|NCT01151410|467909347|FG000|Overall Study|Lost to Follow-up|3|||
129985766|NCT01151410|467909348|FG001|Overall Study|Lost to Follow-up|4|||
129985767|NCT01151410|467909347|FG000|Overall Study|Adverse Event|1|||
129985768|NCT01151410|467909348|FG001|Overall Study|Adverse Event|2|||
129985769|NCT01151410|467909347|FG000|Overall Study|Protocol deviation|2|||
129985770|NCT01151410|467909348|FG001|Overall Study|Protocol deviation|1|||
129985771|NCT01151410|467909347|FG000|Overall Study|Administrative problems|1|||
129985772|NCT01151410|467909348|FG001|Overall Study|Administrative problems|1|||
129985773|NCT01151410|467909347|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129985774|NCT01151410|467909348|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129985775|NCT01151410|467909347|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129985776|NCT01151410|467909348|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129985777|NCT02624791|467909349|FG000|Overall Study|Withdrawal by Subject|2|||
129985778|NCT02624791|467909350|FG001|Overall Study|Withdrawal by Subject|0|||
129985779|NCT02624791|467909351|FG002|Overall Study|Withdrawal by Subject|0|||
129985780|NCT02624791|467909352|FG003|Overall Study|Withdrawal by Subject|0|||
129985781|NCT02624791|467909353|FG004|Overall Study|Withdrawal by Subject|0|||
129985782|NCT02624791|467909354|FG005|Overall Study|Withdrawal by Subject|0|||
129985783|NCT00775463|467910716|FG000|Overall Study|Withdrawal by Subject|0|||
129985784|NCT00775463|467910717|FG001|Overall Study|Withdrawal by Subject|1|||
129985785|NCT00775463|467910716|FG000|Overall Study|Adverse Event|7|||
129985786|NCT00775463|467910717|FG001|Overall Study|Adverse Event|9|||
129985787|NCT00775463|467910716|FG000|Overall Study|Protocol Violation|2|||
129985788|NCT00775463|467910717|FG001|Overall Study|Protocol Violation|2|||
129985789|NCT00775463|467910716|FG000|Overall Study|Lost to Follow-up|1|||
129985790|NCT00775463|467910717|FG001|Overall Study|Lost to Follow-up|0|||
129985791|NCT00775463|467910716|FG000|Overall Study|Lack of Efficacy|1|||
129985792|NCT00775463|467910717|FG001|Overall Study|Lack of Efficacy|1|||
129985793|NCT01238900|467910718|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
129985794|NCT01238900|467910718|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
129985795|NCT03836716|467910719|FG000|Overall Study|Adverse Event|3|||
129985796|NCT03836716|467910719|FG000|Overall Study|Death|22|||
129985797|NCT03836716|467910719|FG000|Overall Study|Withdrawal by Subject|8|||
129985798|NCT03836716|467910719|FG000|Overall Study|Study terminated by sponsor|87|||
129985799|NCT01871805|467910729|FG000|Phase I|Death|7|||
129985800|NCT01871805|467910730|FG001|Phase I|Death|4|||
129985801|NCT01871805|467910731|FG002|Phase I|Death|6|||
129985802|NCT01871805|467910732|FG003|Phase I|Death|2|||
129985803|NCT01871805|467910733|FG004|Phase I|Death|9|||
129985804|NCT01871805|467910734|FG005|Phase I|Death|0|||
130214438|NCT00524680|468749040|FG000|Overall Study|Adverse Event|2|||
130214439|NCT00524680|468749041|FG001|Overall Study|Adverse Event|0|||
130214440|NCT00524680|468749042|FG002|Overall Study|Adverse Event|0|||
129883270|NCT01231503|467532385|FG004|Overall Study|Adverse event, serious fatal|0|||
129883271|NCT01231503|467532386|FG005|Overall Study|Adverse event, serious fatal|1|||
129883272|NCT01231503|467532387|FG006|Overall Study|Adverse event, serious fatal|0|||
129883273|NCT01231503|467532388|FG007|Overall Study|Adverse event, serious fatal|0|||
130214441|NCT00524680|468749043|FG003|Overall Study|Adverse Event|1|||
130214442|NCT00524680|468749040|FG000|Overall Study|Other|0|||
130214443|NCT00524680|468749041|FG001|Overall Study|Other|1|||
130214444|NCT00524680|468749042|FG002|Overall Study|Other|2|||
129883274|NCT01231503|467532381|FG000|Overall Study|Withdrawal by Subject|6|||
129883275|NCT01231503|467532382|FG001|Overall Study|Withdrawal by Subject|3|||
129883276|NCT01231503|467532383|FG002|Overall Study|Withdrawal by Subject|3|||
129883277|NCT01231503|467532384|FG003|Overall Study|Withdrawal by Subject|1|||
129883278|NCT01231503|467532385|FG004|Overall Study|Withdrawal by Subject|3|||
129883279|NCT01231503|467532386|FG005|Overall Study|Withdrawal by Subject|5|||
129883280|NCT01231503|467532387|FG006|Overall Study|Withdrawal by Subject|1|||
129883281|NCT01231503|467532388|FG007|Overall Study|Withdrawal by Subject|2|||
129883282|NCT01231503|467532381|FG000|Overall Study|Lost to Follow-up|8|||
129883283|NCT01231503|467532382|FG001|Overall Study|Lost to Follow-up|10|||
129883284|NCT01231503|467532383|FG002|Overall Study|Lost to Follow-up|8|||
129883285|NCT01231503|467532384|FG003|Overall Study|Lost to Follow-up|5|||
129883286|NCT01231503|467532385|FG004|Overall Study|Lost to Follow-up|7|||
129883287|NCT01231503|467532386|FG005|Overall Study|Lost to Follow-up|9|||
129883288|NCT01231503|467532387|FG006|Overall Study|Lost to Follow-up|6|||
129883289|NCT01231503|467532388|FG007|Overall Study|Lost to Follow-up|6|||
129883290|NCT01231503|467532381|FG000|Overall Study|Protocol Violation|0|||
129883291|NCT01231503|467532382|FG001|Overall Study|Protocol Violation|0|||
129883292|NCT01231503|467532383|FG002|Overall Study|Protocol Violation|0|||
129883293|NCT01231503|467532384|FG003|Overall Study|Protocol Violation|1|||
129883294|NCT01231503|467532385|FG004|Overall Study|Protocol Violation|0|||
129883295|NCT01231503|467532386|FG005|Overall Study|Protocol Violation|0|||
129883296|NCT01231503|467532387|FG006|Overall Study|Protocol Violation|0|||
129883297|NCT01231503|467532388|FG007|Overall Study|Protocol Violation|0|||
129883298|NCT01586338|467532389|FG000|Overall Study|Adverse Event|3|||
129883299|NCT01586338|467532389|FG000|Overall Study|Lost to Follow-up|1|||
129883300|NCT01586338|467532389|FG000|Overall Study|Withdrawal by participant|3|||
129883301|NCT01586338|467532389|FG000|Overall Study|Other|1|||
129883302|NCT00284089|467532390|FG000|Multiple Dose Phase|Adverse Event|1|||
129883303|NCT00284089|467532391|FG001|Multiple Dose Phase|Adverse Event|0|||
129883304|NCT00284089|467532392|FG002|Multiple Dose Phase|Adverse Event|1|||
129883305|NCT00284089|467532393|FG003|Multiple Dose Phase|Adverse Event|1|||
129883306|NCT00284089|467532390|FG000|Multiple Dose Phase|Protocol Violation|0|||
129883307|NCT00284089|467532391|FG001|Multiple Dose Phase|Protocol Violation|0|||
129883308|NCT00284089|467532392|FG002|Multiple Dose Phase|Protocol Violation|1|||
129883309|NCT00284089|467532393|FG003|Multiple Dose Phase|Protocol Violation|0|||
129883310|NCT00284089|467532390|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
129883311|NCT00284089|467532391|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
129883312|NCT00284089|467532392|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
129883313|NCT00284089|467532393|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
129883314|NCT00284089|467532390|FG000|Multiple Dose Phase|Death|0|||
129883315|NCT00284089|467532391|FG001|Multiple Dose Phase|Death|0|||
129883316|NCT00284089|467532392|FG002|Multiple Dose Phase|Death|1|||
129883317|NCT00284089|467532393|FG003|Multiple Dose Phase|Death|1|||
129883318|NCT00284089|467532390|FG000|Extension Phase|Adverse Event|0|||
129883319|NCT00284089|467532391|FG001|Extension Phase|Adverse Event|0|||
129883320|NCT00284089|467532392|FG002|Extension Phase|Adverse Event|2|||
129883321|NCT00284089|467532393|FG003|Extension Phase|Adverse Event|2|||
129883322|NCT00284089|467532390|FG000|Extension Phase|condition no longer requires study drug|2|||
129883323|NCT00284089|467532391|FG001|Extension Phase|condition no longer requires study drug|0|||
129883324|NCT00284089|467532392|FG002|Extension Phase|condition no longer requires study drug|2|||
129883325|NCT00284089|467532393|FG003|Extension Phase|condition no longer requires study drug|7|||
129883326|NCT00284089|467532390|FG000|Extension Phase|Protocol Violation|0|||
129883327|NCT00284089|467532391|FG001|Extension Phase|Protocol Violation|0|||
129883328|NCT00284089|467532392|FG002|Extension Phase|Protocol Violation|1|||
129883329|NCT00284089|467532393|FG003|Extension Phase|Protocol Violation|0|||
129883330|NCT00284089|467532390|FG000|Extension Phase|Withdrawal by Subject|0|||
129883331|NCT00284089|467532391|FG001|Extension Phase|Withdrawal by Subject|0|||
129883332|NCT00284089|467532392|FG002|Extension Phase|Withdrawal by Subject|1|||
129883333|NCT00284089|467532393|FG003|Extension Phase|Withdrawal by Subject|3|||
129883334|NCT00180713|467532396|FG000|Overall Study|Withdrawal by Subject|2|||
129883335|NCT00180713|467532397|FG001|Overall Study|Withdrawal by Subject|0|||
129883336|NCT00180713|467532396|FG000|Overall Study|Adverse Event|3|||
129883337|NCT00180713|467532397|FG001|Overall Study|Adverse Event|3|||
129985805|NCT01871805|467910729|FG000|Phase I|Alive in Survival Follow-up|0|||
129985806|NCT01871805|467910730|FG001|Phase I|Alive in Survival Follow-up|2|||
129985807|NCT01871805|467910731|FG002|Phase I|Alive in Survival Follow-up|4|||
129985808|NCT01871805|467910732|FG003|Phase I|Alive in Survival Follow-up|5|||
129985809|NCT01871805|467910733|FG004|Phase I|Alive in Survival Follow-up|4|||
129985810|NCT01871805|467910734|FG005|Phase I|Alive in Survival Follow-up|0|||
129985811|NCT01871805|467910729|FG000|Phase I|Lost to Follow-up|0|||
129883338|NCT02401308|467532402|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
129883339|NCT02401308|467532403|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
129883340|NCT02998021|467532404|FG000|Overall Study|Withdrawal by Subject|3|||
129883341|NCT02998021|467532405|FG001|Overall Study|Withdrawal by Subject|1|||
129883342|NCT02998021|467532404|FG000|Overall Study|unsafe home|0|||
129883343|NCT02998021|467532405|FG001|Overall Study|unsafe home|1|||
129883344|NCT00655551|467532406|FG000|All Periods Combined|Adverse Event|0|||
129883345|NCT00655551|467532407|FG001|All Periods Combined|Adverse Event|3|||
129883346|NCT00655551|467532408|FG002|All Periods Combined|Adverse Event|4|||
129883347|NCT00655551|467532406|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
129883348|NCT00655551|467532407|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
129883349|NCT00655551|467532408|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
129883350|NCT00655551|467532406|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
130323472|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
130323473|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
130323474|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
130323475|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
129985812|NCT01871805|467910730|FG001|Phase I|Lost to Follow-up|1|||
129985813|NCT01871805|467910731|FG002|Phase I|Lost to Follow-up|3|||
129985814|NCT01871805|467910732|FG003|Phase I|Lost to Follow-up|0|||
129985815|NCT01871805|467910733|FG004|Phase I|Lost to Follow-up|0|||
130323476|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
130323477|NCT01456039|469155485|FG000|Phase 2 (Second Step)|Other|0|||
130323478|NCT01456039|469155486|FG001|Phase 2 (Second Step)|Other|0|||
130323479|NCT01456039|469155487|FG002|Phase 2 (Second Step)|Other|1|||
130323480|NCT00335777|469155488|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
130323481|NCT00335777|469155488|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
130323482|NCT00335777|469155488|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
130323483|NCT00335777|469155488|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
130323484|NCT00335777|469155488|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
130323485|NCT00371150|469155491|FG000|Overall Study|Lost to Follow-up|3|||
130323486|NCT00371150|469155492|FG001|Overall Study|Lost to Follow-up|2|||
130323487|NCT00124943|469155495|FG000|Phase II|Adverse Event|0|||
130323488|NCT00124943|469155496|FG001|Phase II|Adverse Event|2|||
130323489|NCT00124943|469155497|FG002|Phase II|Adverse Event|0|||
130323490|NCT00124943|469155498|FG003|Phase II|Adverse Event|1|||
130323491|NCT00124943|469155495|FG000|Phase II|Protocol Violation|0|||
130323492|NCT00124943|469155496|FG001|Phase II|Protocol Violation|0|||
130323493|NCT00124943|469155497|FG002|Phase II|Protocol Violation|0|||
129985816|NCT01871805|467910734|FG005|Phase I|Lost to Follow-up|0|||
129985817|NCT01871805|467910729|FG000|Phase II|Death|0|||
129985818|NCT01871805|467910730|FG001|Phase II|Death|0|||
129985819|NCT01871805|467910731|FG002|Phase II|Death|0|||
129985820|NCT01871805|467910732|FG003|Phase II|Death|0|||
129985821|NCT01871805|467910733|FG004|Phase II|Death|0|||
129883351|NCT00655551|467532407|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
129883352|NCT00655551|467532408|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
129883353|NCT00655551|467532406|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
129883354|NCT00655551|467532407|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
130323494|NCT00124943|469155498|FG003|Phase II|Protocol Violation|1|||
130323495|NCT00124943|469155495|FG000|Phase II|Lost to Follow-up|0|||
130323496|NCT00124943|469155496|FG001|Phase II|Lost to Follow-up|0|||
130323497|NCT00124943|469155497|FG002|Phase II|Lost to Follow-up|0|||
130323498|NCT00124943|469155498|FG003|Phase II|Lost to Follow-up|1|||
129883355|NCT00655551|467532408|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
129883356|NCT01734434|467532409|FG000|Overall Study|Death Infant|3|||
129883357|NCT01734434|467532410|FG001|Overall Study|Death Infant|1|||
129883358|NCT01734434|467532411|FG002|Overall Study|Death Infant|17|||
129883359|NCT01734434|467532412|FG003|Overall Study|Death Infant|5|||
129883360|NCT01734434|467532409|FG000|Overall Study|Lost to Follow-up|2|||
129883361|NCT01734434|467532410|FG001|Overall Study|Lost to Follow-up|9|||
129883362|NCT01734434|467532411|FG002|Overall Study|Lost to Follow-up|67|||
129883363|NCT01734434|467532412|FG003|Overall Study|Lost to Follow-up|11|||
129883364|NCT01734434|467532409|FG000|Overall Study|No Live Birth|1|||
129883365|NCT01734434|467532410|FG001|Overall Study|No Live Birth|2|||
129883366|NCT01734434|467532411|FG002|Overall Study|No Live Birth|32|||
129883367|NCT01734434|467532412|FG003|Overall Study|No Live Birth|6|||
129883368|NCT01734434|467532409|FG000|Overall Study|Withdrawal by Subject|4|||
129985822|NCT01871805|467910734|FG005|Phase II|Death|45|||
129985823|NCT01871805|467910729|FG000|Phase II|Alive in Survival Follow-up|0|||
129985824|NCT01871805|467910730|FG001|Phase II|Alive in Survival Follow-up|0|||
129985825|NCT01871805|467910731|FG002|Phase II|Alive in Survival Follow-up|0|||
129985826|NCT01871805|467910732|FG003|Phase II|Alive in Survival Follow-up|0|||
129985827|NCT01871805|467910733|FG004|Phase II|Alive in Survival Follow-up|0|||
129985828|NCT01871805|467910734|FG005|Phase II|Alive in Survival Follow-up|29|||
129985829|NCT01871805|467910729|FG000|Phase II|Lost to Follow-up|0|||
129985830|NCT01871805|467910730|FG001|Phase II|Lost to Follow-up|0|||
129985831|NCT01871805|467910731|FG002|Phase II|Lost to Follow-up|0|||
129985832|NCT01871805|467910732|FG003|Phase II|Lost to Follow-up|0|||
129985833|NCT01871805|467910733|FG004|Phase II|Lost to Follow-up|0|||
129985834|NCT01871805|467910734|FG005|Phase II|Lost to Follow-up|13|||
129883369|NCT01734434|467532410|FG001|Overall Study|Withdrawal by Subject|0|||
129883370|NCT01734434|467532411|FG002|Overall Study|Withdrawal by Subject|8|||
129883371|NCT01734434|467532412|FG003|Overall Study|Withdrawal by Subject|1|||
129883372|NCT01734434|467532409|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
129985835|NCT01131182|467910735|FG000|Overall Study|Withdrawal by Subject|1|||
129985836|NCT01131182|467910736|FG001|Overall Study|Withdrawal by Subject|1|||
129985837|NCT01131182|467910735|FG000|Overall Study|Lost to Follow-up|14|||
129985838|NCT01131182|467910736|FG001|Overall Study|Lost to Follow-up|15|||
129985839|NCT01131182|467910735|FG000|Overall Study|Other Reason|1|||
129985840|NCT01131182|467910736|FG001|Overall Study|Other Reason|0|||
130323499|NCT00124943|469155495|FG000|Phase II|Withdrawal by Subject|0|||
129985841|NCT01146782|467910742|FG000|Screening Cohort|Screen Failure|187|||
129883373|NCT01734434|467532410|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
129883374|NCT01734434|467532411|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
129883375|NCT01734434|467532412|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
129883376|NCT01734434|467532409|FG000|Overall Study|Subject Not Reachable|0|||
129883377|NCT01734434|467532410|FG001|Overall Study|Subject Not Reachable|0|||
129883378|NCT01734434|467532411|FG002|Overall Study|Subject Not Reachable|1|||
129883379|NCT01734434|467532412|FG003|Overall Study|Subject Not Reachable|0|||
129883380|NCT01734434|467532409|FG000|Overall Study|Treatment Defaulter|0|||
129883381|NCT01734434|467532410|FG001|Overall Study|Treatment Defaulter|0|||
129883382|NCT01734434|467532411|FG002|Overall Study|Treatment Defaulter|1|||
129883383|NCT01734434|467532412|FG003|Overall Study|Treatment Defaulter|0|||
129883384|NCT01734434|467532409|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
129883385|NCT01734434|467532410|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
129985842|NCT01146782|467910742|FG000|Screening Cohort|Lost to Follow-up|4|||
129985843|NCT01146782|467910742|FG000|Screening Cohort|Physician Decision|1|||
129985844|NCT01146782|467910742|FG000|Screening Cohort|Withdrawal by Subject|29|||
129985845|NCT01146782|467910742|FG000|Safety Cohort|Screen Failure|61|||
129985846|NCT01146782|467910742|FG000|Safety Cohort|Withdrawal by Subject|4|||
129985847|NCT01146782|467910742|FG000|Safety Cohort|Control AHI <5|4|||
129985848|NCT01146782|467910742|FG000|Safety Cohort|TST <4 hrs|14|||
129985849|NCT01146782|467910742|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
129985850|NCT01146782|467910742|FG000|Primary Endpoint Cohort|Physician Decision|1|||
129985851|NCT02656329|467910744|FG000|Overall Study|Lost to Follow-up|2|||
129985852|NCT02656329|467910745|FG001|Overall Study|Lost to Follow-up|3|||
129985853|NCT02656329|467910744|FG000|Overall Study|Withdrawal by Subject|7|||
129985854|NCT02656329|467910745|FG001|Overall Study|Withdrawal by Subject|6|||
129985855|NCT02656329|467910744|FG000|Overall Study|Study termination by Sponsor|150|||
129985856|NCT02656329|467910745|FG001|Overall Study|Study termination by Sponsor|142|||
129985857|NCT02656329|467910744|FG000|Overall Study|Other than specified above|5|||
129985858|NCT02656329|467910745|FG001|Overall Study|Other than specified above|6|||
129985859|NCT01139580|467910746|FG000|Overall Study|Adverse Event|5|||
129985860|NCT01139580|467910747|FG001|Overall Study|Adverse Event|4|||
129985861|NCT01139580|467910746|FG000|Overall Study|Lost to Follow-up|9|||
129985862|NCT01139580|467910747|FG001|Overall Study|Lost to Follow-up|1|||
129985863|NCT01139580|467910746|FG000|Overall Study|Lack of Efficacy|0|||
129985864|NCT01139580|467910747|FG001|Overall Study|Lack of Efficacy|2|||
129985865|NCT01139580|467910746|FG000|Overall Study|Withdrawal by Subject|6|||
129985866|NCT01139580|467910747|FG001|Overall Study|Withdrawal by Subject|9|||
129985867|NCT01139580|467910746|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
129985868|NCT01139580|467910747|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
129985869|NCT01139580|467910746|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
129985870|NCT01139580|467910747|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
129985871|NCT01139580|467910746|FG000|Overall Study|Misrandomized|1|||
129985872|NCT01139580|467910747|FG001|Overall Study|Misrandomized|0|||
129985873|NCT01139580|467910746|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
129985874|NCT01139580|467910747|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
129985875|NCT01139580|467910746|FG000|Overall Study|Participant Randomization in Error|0|||
129985876|NCT01139580|467910747|FG001|Overall Study|Participant Randomization in Error|1|||
129985877|NCT00911768|467910748|FG000|Overall Study|Protocol Violation|5|||
129985878|NCT00911768|467910749|FG001|Overall Study|Protocol Violation|4|||
129985879|NCT00911768|467910748|FG000|Overall Study|Withdrawal by Subject|1|||
129985880|NCT00911768|467910749|FG001|Overall Study|Withdrawal by Subject|0|||
129985881|NCT02842151|467910754|FG000|Overall Study|Adverse Event|1|||
129985882|NCT02842151|467910754|FG000|Overall Study|Subject moved too far away|1|||
129985883|NCT00591851|467910755|FG000|Overall Study|Withdrawal by Subject|3|||
129985884|NCT00591851|467910755|FG000|Overall Study|Adverse Event|2|||
129985885|NCT00591851|467910755|FG000|Overall Study|Progressive Disease|1|||
129985886|NCT02559895|467910756|FG000|Overall Study|Adverse Event|3|||
129985887|NCT02559895|467910757|FG001|Overall Study|Adverse Event|3|||
129985888|NCT02559895|467910758|FG002|Overall Study|Adverse Event|2|||
129985889|NCT02559895|467910759|FG003|Overall Study|Adverse Event|1|||
129985890|NCT02559895|467910756|FG000|Overall Study|Lack of Efficacy|2|||
129985891|NCT02559895|467910757|FG001|Overall Study|Lack of Efficacy|3|||
129985892|NCT02559895|467910758|FG002|Overall Study|Lack of Efficacy|2|||
129985893|NCT02559895|467910759|FG003|Overall Study|Lack of Efficacy|8|||
129985894|NCT02559895|467910756|FG000|Overall Study|Lost to Follow-up|22|||
129985895|NCT02559895|467910757|FG001|Overall Study|Lost to Follow-up|16|||
129985896|NCT02559895|467910758|FG002|Overall Study|Lost to Follow-up|12|||
129985897|NCT02559895|467910759|FG003|Overall Study|Lost to Follow-up|17|||
129985898|NCT02559895|467910756|FG000|Overall Study|Physician Decision|1|||
129985899|NCT02559895|467910757|FG001|Overall Study|Physician Decision|1|||
129985900|NCT02559895|467910758|FG002|Overall Study|Physician Decision|3|||
129985901|NCT02559895|467910759|FG003|Overall Study|Physician Decision|0|||
129985902|NCT02559895|467910756|FG000|Overall Study|Withdrawal by Subject|16|||
129985903|NCT02559895|467910757|FG001|Overall Study|Withdrawal by Subject|9|||
129985904|NCT02559895|467910758|FG002|Overall Study|Withdrawal by Subject|20|||
129985905|NCT02559895|467910759|FG003|Overall Study|Withdrawal by Subject|9|||
129985906|NCT02559895|467910756|FG000|Overall Study|Study Burden|10|||
129985907|NCT02559895|467910757|FG001|Overall Study|Study Burden|16|||
129985908|NCT02559895|467910758|FG002|Overall Study|Study Burden|12|||
129985909|NCT02559895|467910759|FG003|Overall Study|Study Burden|22|||
129985910|NCT02559895|467910756|FG000|Overall Study|Other|1|||
129985911|NCT02559895|467910757|FG001|Overall Study|Other|5|||
129985912|NCT02559895|467910758|FG002|Overall Study|Other|3|||
129985913|NCT02559895|467910759|FG003|Overall Study|Other|3|||
129985914|NCT00515853|467910760|FG000|Overall Study|Lost to Follow-up|9|||
129985915|NCT00515853|467910761|FG001|Overall Study|Lost to Follow-up|13|||
129985916|NCT00515853|467910760|FG000|Overall Study|Withdrawal by Subject|6|||
129985917|NCT00515853|467910761|FG001|Overall Study|Withdrawal by Subject|4|||
129985918|NCT01262027|467910762|FG000|Overall Study|Adverse Event|1|||
129985919|NCT01262027|467910762|FG000|Overall Study|Withdrawal by Subject|3|||
129985920|NCT01262027|467910762|FG000|Overall Study|Protocol Violation|1|||
129985921|NCT00589121|467910766|FG000|Overall Study|Protocol Violation|2|||
129985922|NCT00589121|467910767|FG001|Overall Study|Protocol Violation|6|||
129985923|NCT00589121|467910766|FG000|Overall Study|No protocol treatment received|0|||
129985924|NCT00589121|467910767|FG001|Overall Study|No protocol treatment received|1|||
129985925|NCT00847808|467910769|FG000|Overall Study|Adverse Event|7|||
129985926|NCT00847808|467910769|FG000|Overall Study|Protocol Violation|1|||
129985927|NCT00847808|467910769|FG000|Overall Study|Lost to Follow-up|1|||
129985928|NCT00847808|467910769|FG000|Overall Study|Withdrawal by Subject|4|||
129985929|NCT00847808|467910769|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
129985930|NCT00847808|467910769|FG000|Overall Study|Participant Took Excluded Medication|1|||
129985931|NCT01758900|467910776|FG000|Overall Study|difficulty for further intubation|7|||
129985932|NCT01758900|467910777|FG001|Overall Study|difficulty for further intubation|8|||
129985933|NCT01892540|467910779|FG000|Overall Study|Did not complete PET/MRI|0|||
129985934|NCT01892540|467910780|FG001|Overall Study|Did not complete PET/MRI|0|||
129985935|NCT01892540|467910781|FG002|Overall Study|Did not complete PET/MRI|2|||
129985936|NCT01892540|467910779|FG000|Overall Study|Did not fit in scanner|0|||
129985937|NCT01892540|467910780|FG001|Overall Study|Did not fit in scanner|0|||
129985938|NCT01892540|467910781|FG002|Overall Study|Did not fit in scanner|1|||
129985939|NCT01370590|467910782|FG000|Period 1|Adverse Event|8|||
129985940|NCT01370590|467910783|FG001|Period 1|Adverse Event|4|||
129985941|NCT01370590|467910782|FG000|Period 1|Lost to Follow-up|2|||
129985942|NCT01370590|467910783|FG001|Period 1|Lost to Follow-up|2|||
129985943|NCT01370590|467910782|FG000|Period 1|Protocol Violation|2|||
129985944|NCT01370590|467910783|FG001|Period 1|Protocol Violation|2|||
129985945|NCT01370590|467910782|FG000|Period 1|Withdrawal by Subject|4|||
129985946|NCT01370590|467910783|FG001|Period 1|Withdrawal by Subject|2|||
129985947|NCT01370590|467910782|FG000|Period 1|Could not access randomization system|0|||
129985948|NCT01370590|467910783|FG001|Period 1|Could not access randomization system|1|||
130323500|NCT00124943|469155496|FG001|Phase II|Withdrawal by Subject|0|||
130323501|NCT00124943|469155497|FG002|Phase II|Withdrawal by Subject|0|||
130323502|NCT00124943|469155498|FG003|Phase II|Withdrawal by Subject|2|||
130323503|NCT00321620|469155499|FG000|Overall Study|Death|269|||
129985949|NCT01370590|467910782|FG000|Crossover Washout Period|Adverse Event|1|||
129985950|NCT01370590|467910783|FG001|Crossover Washout Period|Adverse Event|4|||
129985951|NCT01370590|467910782|FG000|Crossover Washout Period|Lost to Follow-up|2|||
130214445|NCT00524680|468749043|FG003|Overall Study|Other|3|||
130214446|NCT00524680|468749040|FG000|Overall Study|Withdrawal by Subject|1|||
130214447|NCT00524680|468749041|FG001|Overall Study|Withdrawal by Subject|0|||
130214448|NCT00524680|468749042|FG002|Overall Study|Withdrawal by Subject|1|||
130214449|NCT00524680|468749043|FG003|Overall Study|Withdrawal by Subject|1|||
130214450|NCT03124537|468749044|FG000|Overall Study|Lost to Follow-up|3|||
130214451|NCT03124537|468749045|FG001|Overall Study|Lost to Follow-up|5|||
130214452|NCT03124537|468749044|FG000|Overall Study|App Crash, Incomplete Data|7|||
130214453|NCT03124537|468749045|FG001|Overall Study|App Crash, Incomplete Data|8|||
130214454|NCT03681184|468749046|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
130214455|NCT03681184|468749047|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
130214456|NCT01607346|468749050|FG000|Overall Study|Adverse Event|3|||
130214457|NCT01098162|468749051|FG000|Overall Study|Adverse Event|37|||
130214458|NCT01098162|468749051|FG000|Overall Study|Lack of Efficacy|4|||
129985952|NCT01370590|467910783|FG001|Crossover Washout Period|Lost to Follow-up|0|||
129985953|NCT01370590|467910782|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
129985954|NCT01370590|467910783|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
129985955|NCT01370590|467910782|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
129985956|NCT01370590|467910783|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
130214459|NCT01098162|468749051|FG000|Overall Study|Wish of Patient|7|||
130214460|NCT01098162|468749051|FG000|Overall Study|Lost to Follow-up|9|||
130323504|NCT00321620|469155500|FG001|Overall Study|Death|294|||
129985957|NCT01370590|467910782|FG000|Period 2|Adverse Event|0|||
129985958|NCT01370590|467910783|FG001|Period 2|Adverse Event|1|||
129985959|NCT01370590|467910782|FG000|Period 2|Withdrawal by Subject|1|||
129985960|NCT01370590|467910783|FG001|Period 2|Withdrawal by Subject|1|||
129985961|NCT05172050|467910784|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
129985962|NCT05172050|467910785|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
129985963|NCT05172050|467910786|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
129985964|NCT05172050|467910784|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
129985965|NCT05172050|467910785|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
129985966|NCT05172050|467910786|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
129985967|NCT05172050|467910784|FG000|Overall Study|Other|2|||
129985968|NCT05172050|467910785|FG001|Overall Study|Other|2|||
129985969|NCT05172050|467910786|FG002|Overall Study|Other|1|||
129985970|NCT00867308|467910789|FG000|Overall Study|Death|1|||
129985971|NCT00867308|467910790|FG001|Overall Study|Death|0|||
129985972|NCT00867308|467910789|FG000|Overall Study|Adverse Event|1|||
130214461|NCT01098162|468749051|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
130214462|NCT01098162|468749051|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
130214463|NCT01098162|468749051|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
130214464|NCT01098162|468749051|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
130214465|NCT01098162|468749051|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
130214466|NCT01098162|468749051|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
130214467|NCT01098162|468749051|FG000|Overall Study|Other Reason|1|||
130214468|NCT01098162|468749051|FG000|Overall Study|Reason Unknown|26|||
130214469|NCT00625183|468749052|FG000|Overall Study|Disease Progression|1|||
130214470|NCT04318132|468749053|FG000|Overall Study|Protocol Violation|0|||
130214471|NCT04318132|468749054|FG001|Overall Study|Protocol Violation|0|||
130214472|NCT04318132|468749055|FG002|Overall Study|Protocol Violation|3|||
130214473|NCT04318132|468749056|FG003|Overall Study|Protocol Violation|0|||
130214474|NCT04424914|468749057|FG000|Overall Study|Other|0|||
130214475|NCT04424914|468749058|FG001|Overall Study|Other|0|||
130214476|NCT04424914|468749059|FG002|Overall Study|Other|28|||
130214477|NCT04424914|468749057|FG000|Overall Study|Withdrawal by Subject|3|||
130214478|NCT04424914|468749058|FG001|Overall Study|Withdrawal by Subject|0|||
130214479|NCT04424914|468749059|FG002|Overall Study|Withdrawal by Subject|0|||
130214480|NCT04424914|468749057|FG000|Overall Study|Study terminated by sponsor|23|||
130214481|NCT04424914|468749058|FG001|Overall Study|Study terminated by sponsor|7|||
130214482|NCT04424914|468749059|FG002|Overall Study|Study terminated by sponsor|0|||
130214483|NCT04424914|468749057|FG000|Overall Study|Lost to Follow-up|0|||
130214484|NCT04424914|468749058|FG001|Overall Study|Lost to Follow-up|0|||
130214485|NCT04424914|468749059|FG002|Overall Study|Lost to Follow-up|1|||
130214486|NCT04424914|468749057|FG000|Overall Study|Death|3|||
130214487|NCT04424914|468749058|FG001|Overall Study|Death|1|||
130214488|NCT04424914|468749059|FG002|Overall Study|Death|0|||
130214489|NCT01778751|468749064|FG000|Overall Study|Lost to Follow-up|1|||
130214490|NCT01778751|468749065|FG001|Overall Study|Lost to Follow-up|0|||
130214491|NCT01778751|468749064|FG000|Overall Study|Withdrawal by Subject|0|||
130214492|NCT01778751|468749065|FG001|Overall Study|Withdrawal by Subject|2|||
130214493|NCT01778751|468749064|FG000|Overall Study|Transfered care|1|||
130214494|NCT01778751|468749065|FG001|Overall Study|Transfered care|0|||
130214495|NCT02685072|468749073|FG000|Treatment Period|Lost to Follow-up|12|||
130214496|NCT02685072|468749074|FG001|Treatment Period|Lost to Follow-up|6|||
130214497|NCT02685072|468749073|FG000|Treatment Period|Withdrawal by Subject|1|||
130214498|NCT02685072|468749074|FG001|Treatment Period|Withdrawal by Subject|3|||
130214499|NCT02685072|468749073|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
130214500|NCT02685072|468749074|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
130214501|NCT02634710|468749075|FG000|Overall Study|Death|4|||
130214502|NCT02432144|468749079|FG000|Overall Study|Participant Non-Compliance|1|||
130214503|NCT01451554|468749080|FG000|Overall Study|Withdrawal by Subject|14|||
130214504|NCT01451554|468749081|FG001|Overall Study|Withdrawal by Subject|9|||
130214505|NCT01402986|468749082|FG000|Overall Study|Withdrawal by Subject|7|||
130214506|NCT01402986|468749083|FG001|Overall Study|Withdrawal by Subject|10|||
130214507|NCT01402986|468749084|FG002|Overall Study|Withdrawal by Subject|7|||
130214508|NCT01402986|468749085|FG003|Overall Study|Withdrawal by Subject|13|||
130214509|NCT01402986|468749082|FG000|Overall Study|Death|0|||
130214510|NCT01402986|468749083|FG001|Overall Study|Death|0|||
130214511|NCT01402986|468749084|FG002|Overall Study|Death|0|||
130214512|NCT01402986|468749085|FG003|Overall Study|Death|2|||
130214513|NCT01402986|468749082|FG000|Overall Study|Lost to Follow-up|0|||
130214514|NCT01402986|468749083|FG001|Overall Study|Lost to Follow-up|0|||
130214515|NCT01402986|468749084|FG002|Overall Study|Lost to Follow-up|0|||
130214516|NCT01402986|468749085|FG003|Overall Study|Lost to Follow-up|1|||
130214517|NCT01402986|468749082|FG000|Overall Study|Other|2|||
130214518|NCT01402986|468749083|FG001|Overall Study|Other|5|||
130214519|NCT01402986|468749084|FG002|Overall Study|Other|1|||
130214520|NCT01402986|468749085|FG003|Overall Study|Other|6|||
130214521|NCT02427802|468749086|FG000|Overall Study|Adverse Event|11|||
130214522|NCT02427802|468749087|FG001|Overall Study|Adverse Event|3|||
130214523|NCT02427802|468749088|FG002|Overall Study|Adverse Event|7|||
130214524|NCT02427802|468749086|FG000|Overall Study|Death|0|||
130214525|NCT02427802|468749087|FG001|Overall Study|Death|4|||
130214526|NCT02427802|468749088|FG002|Overall Study|Death|1|||
129985973|NCT00867308|467910790|FG001|Overall Study|Adverse Event|4|||
129985974|NCT00867308|467910789|FG000|Overall Study|Lack of Efficacy|6|||
129985975|NCT00867308|467910790|FG001|Overall Study|Lack of Efficacy|12|||
129985976|NCT00867308|467910789|FG000|Overall Study|Withdrawal by Subject|1|||
129985977|NCT00867308|467910790|FG001|Overall Study|Withdrawal by Subject|2|||
129985978|NCT00604825|467910791|FG000|Overall Study|Adverse Event|2|||
129985979|NCT00604825|467910792|FG001|Overall Study|Adverse Event|6|||
129985980|NCT00604825|467910793|FG002|Overall Study|Adverse Event|7|||
129985981|NCT00604825|467910794|FG003|Overall Study|Adverse Event|4|||
129985982|NCT00604825|467910791|FG000|Overall Study|Lost to Follow-up|0|||
129985983|NCT00604825|467910792|FG001|Overall Study|Lost to Follow-up|3|||
129985984|NCT00604825|467910793|FG002|Overall Study|Lost to Follow-up|1|||
129985985|NCT00604825|467910794|FG003|Overall Study|Lost to Follow-up|0|||
129985986|NCT00604825|467910791|FG000|Overall Study|Protocol Violation|0|||
129985987|NCT00604825|467910792|FG001|Overall Study|Protocol Violation|1|||
129985988|NCT00604825|467910793|FG002|Overall Study|Protocol Violation|0|||
129985989|NCT00604825|467910794|FG003|Overall Study|Protocol Violation|0|||
129985990|NCT00604825|467910791|FG000|Overall Study|Withdrawal by Subject|4|||
130214527|NCT02427802|468749086|FG000|Overall Study|Lost to Follow-up|13|||
130214528|NCT02427802|468749087|FG001|Overall Study|Lost to Follow-up|8|||
130214529|NCT02427802|468749088|FG002|Overall Study|Lost to Follow-up|8|||
130214530|NCT02427802|468749086|FG000|Overall Study|Physician Decision|4|||
130214531|NCT02427802|468749087|FG001|Overall Study|Physician Decision|2|||
130214532|NCT02427802|468749088|FG002|Overall Study|Physician Decision|4|||
130214533|NCT02427802|468749086|FG000|Overall Study|Withdrawal by Subject|10|||
130214534|NCT02427802|468749087|FG001|Overall Study|Withdrawal by Subject|5|||
130214535|NCT02427802|468749088|FG002|Overall Study|Withdrawal by Subject|11|||
130214536|NCT02427802|468749086|FG000|Overall Study|Protocol Violation|3|||
130214537|NCT02427802|468749087|FG001|Overall Study|Protocol Violation|1|||
130214538|NCT02427802|468749088|FG002|Overall Study|Protocol Violation|1|||
130214539|NCT02427802|468749086|FG000|Overall Study|protocol specific treatment unrelated|18|||
130214540|NCT02427802|468749087|FG001|Overall Study|protocol specific treatment unrelated|11|||
130214541|NCT02427802|468749088|FG002|Overall Study|protocol specific treatment unrelated|11|||
130214542|NCT01085084|468749089|FG000|Overall Study|Withdrawal by Subject|1|||
130214543|NCT01085084|468749090|FG001|Overall Study|Withdrawal by Subject|0|||
130214544|NCT01085084|468749091|FG002|Overall Study|Withdrawal by Subject|0|||
130214545|NCT01085084|468749089|FG000|Overall Study|Lost to Follow-up|2|||
130214546|NCT01085084|468749090|FG001|Overall Study|Lost to Follow-up|1|||
130214547|NCT01085084|468749091|FG002|Overall Study|Lost to Follow-up|1|||
130214548|NCT01085084|468749089|FG000|Overall Study|Adverse Event|4|||
130214549|NCT01085084|468749090|FG001|Overall Study|Adverse Event|3|||
130214550|NCT01085084|468749091|FG002|Overall Study|Adverse Event|6|||
130214551|NCT01085084|468749089|FG000|Overall Study|Treatment Failure|0|||
130214552|NCT01085084|468749090|FG001|Overall Study|Treatment Failure|1|||
130214553|NCT01085084|468749091|FG002|Overall Study|Treatment Failure|2|||
130214554|NCT02634983|468749092|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
130214555|NCT02634983|468749093|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
130214556|NCT02070978|468749094|FG000|Overall Study|Adverse Event|6|||
130214557|NCT02070978|468749095|FG001|Overall Study|Adverse Event|2|||
130214558|NCT02070978|468749096|FG002|Overall Study|Adverse Event|0|||
130214559|NCT02070978|468749094|FG000|Overall Study|Lost to Follow-up|1|||
130214560|NCT02070978|468749095|FG001|Overall Study|Lost to Follow-up|3|||
130214561|NCT02070978|468749096|FG002|Overall Study|Lost to Follow-up|4|||
130214562|NCT02070978|468749094|FG000|Overall Study|Withdrawal by Subject|3|||
130214563|NCT02070978|468749095|FG001|Overall Study|Withdrawal by Subject|5|||
130214564|NCT02070978|468749096|FG002|Overall Study|Withdrawal by Subject|3|||
130214565|NCT02070978|468749094|FG000|Overall Study|Protocol Violation|1|||
130214566|NCT02070978|468749095|FG001|Overall Study|Protocol Violation|0|||
130214567|NCT02070978|468749096|FG002|Overall Study|Protocol Violation|3|||
130214568|NCT02070978|468749094|FG000|Overall Study|Lack of Efficacy|0|||
130214569|NCT02070978|468749095|FG001|Overall Study|Lack of Efficacy|1|||
130214570|NCT02070978|468749096|FG002|Overall Study|Lack of Efficacy|0|||
130214571|NCT02070978|468749094|FG000|Overall Study|Death|0|||
130214572|NCT02070978|468749095|FG001|Overall Study|Death|0|||
130214573|NCT02070978|468749096|FG002|Overall Study|Death|2|||
130214574|NCT02070978|468749094|FG000|Overall Study|Un-specified|3|||
130214575|NCT02070978|468749095|FG001|Overall Study|Un-specified|2|||
130214576|NCT02070978|468749096|FG002|Overall Study|Un-specified|2|||
130214577|NCT02070978|468749094|FG000|Overall Study|Terminated by Sponsor|33|||
130214578|NCT02070978|468749095|FG001|Overall Study|Terminated by Sponsor|40|||
130214579|NCT02070978|468749096|FG002|Overall Study|Terminated by Sponsor|39|||
130214580|NCT03951753|468749097|FG000|Overall Study|Adverse Event|1|||
130214581|NCT03951753|468749098|FG001|Overall Study|Adverse Event|0|||
130214582|NCT03951753|468749099|FG002|Overall Study|Adverse Event|3|||
130214583|NCT03951753|468749097|FG000|Overall Study|Withdrawal by Subject|3|||
130214584|NCT03951753|468749098|FG001|Overall Study|Withdrawal by Subject|1|||
130214585|NCT03951753|468749099|FG002|Overall Study|Withdrawal by Subject|0|||
129985991|NCT00604825|467910792|FG001|Overall Study|Withdrawal by Subject|3|||
129985992|NCT00604825|467910793|FG002|Overall Study|Withdrawal by Subject|5|||
129985993|NCT00604825|467910794|FG003|Overall Study|Withdrawal by Subject|5|||
129985994|NCT00604825|467910791|FG000|Overall Study|Lack of Efficacy|3|||
129985995|NCT00604825|467910792|FG001|Overall Study|Lack of Efficacy|2|||
129985996|NCT00604825|467910793|FG002|Overall Study|Lack of Efficacy|1|||
129985997|NCT00604825|467910794|FG003|Overall Study|Lack of Efficacy|0|||
129985998|NCT00604825|467910791|FG000|Overall Study|Did not meet eligibility criteria|0|||
129985999|NCT00604825|467910792|FG001|Overall Study|Did not meet eligibility criteria|0|||
129986000|NCT00604825|467910793|FG002|Overall Study|Did not meet eligibility criteria|2|||
129986001|NCT00604825|467910794|FG003|Overall Study|Did not meet eligibility criteria|0|||
129986002|NCT00604825|467910791|FG000|Overall Study|Physician Decision|0|||
129986003|NCT00604825|467910792|FG001|Overall Study|Physician Decision|0|||
129986004|NCT00604825|467910793|FG002|Overall Study|Physician Decision|0|||
129986005|NCT00604825|467910794|FG003|Overall Study|Physician Decision|1|||
129986006|NCT00604825|467910791|FG000|Overall Study|Exclusion criterion met|0|||
129986007|NCT00604825|467910792|FG001|Overall Study|Exclusion criterion met|0|||
129986008|NCT00604825|467910793|FG002|Overall Study|Exclusion criterion met|0|||
129986009|NCT00604825|467910794|FG003|Overall Study|Exclusion criterion met|1|||
129986010|NCT04617275|467910795|FG000|Treatment Period|Adverse Event|1|||
129986011|NCT04617275|467910796|FG001|Treatment Period|Adverse Event|6|||
129986012|NCT04617275|467910797|FG002|Treatment Period|Adverse Event|4|||
129986013|NCT04617275|467910798|FG003|Treatment Period|Adverse Event|6|||
129986014|NCT04617275|467910799|FG004|Treatment Period|Adverse Event|7|||
129986015|NCT04617275|467910800|FG005|Treatment Period|Adverse Event|8|||
129986016|NCT04617275|467910801|FG006|Treatment Period|Adverse Event|0|||
129986017|NCT04617275|467910802|FG007|Treatment Period|Adverse Event|12|||
129986018|NCT04617275|467910795|FG000|Treatment Period|Lost to Follow-up|0|||
129986019|NCT04617275|467910796|FG001|Treatment Period|Lost to Follow-up|0|||
129986020|NCT04617275|467910797|FG002|Treatment Period|Lost to Follow-up|2|||
129986021|NCT04617275|467910798|FG003|Treatment Period|Lost to Follow-up|0|||
129986022|NCT04617275|467910799|FG004|Treatment Period|Lost to Follow-up|0|||
129986023|NCT04617275|467910800|FG005|Treatment Period|Lost to Follow-up|3|||
129986024|NCT04617275|467910801|FG006|Treatment Period|Lost to Follow-up|0|||
129986025|NCT04617275|467910802|FG007|Treatment Period|Lost to Follow-up|2|||
129986026|NCT04617275|467910795|FG000|Treatment Period|No longer meets eligibility criteria|0|||
129986027|NCT04617275|467910796|FG001|Treatment Period|No longer meets eligibility criteria|0|||
129986028|NCT04617275|467910797|FG002|Treatment Period|No longer meets eligibility criteria|0|||
129986029|NCT04617275|467910798|FG003|Treatment Period|No longer meets eligibility criteria|1|||
129986030|NCT04617275|467910799|FG004|Treatment Period|No longer meets eligibility criteria|0|||
129986031|NCT04617275|467910800|FG005|Treatment Period|No longer meets eligibility criteria|0|||
129986032|NCT04617275|467910801|FG006|Treatment Period|No longer meets eligibility criteria|0|||
129986033|NCT04617275|467910802|FG007|Treatment Period|No longer meets eligibility criteria|0|||
129986034|NCT04617275|467910795|FG000|Treatment Period|Other|0|||
129986035|NCT04617275|467910796|FG001|Treatment Period|Other|1|||
129986036|NCT04617275|467910797|FG002|Treatment Period|Other|0|||
129986037|NCT04617275|467910798|FG003|Treatment Period|Other|0|||
129986038|NCT04617275|467910799|FG004|Treatment Period|Other|0|||
129986039|NCT04617275|467910800|FG005|Treatment Period|Other|0|||
129986040|NCT04617275|467910801|FG006|Treatment Period|Other|0|||
129986041|NCT04617275|467910802|FG007|Treatment Period|Other|0|||
129986042|NCT04617275|467910795|FG000|Treatment Period|Withdrawal by Subject|2|||
129986043|NCT04617275|467910796|FG001|Treatment Period|Withdrawal by Subject|0|||
129986044|NCT04617275|467910797|FG002|Treatment Period|Withdrawal by Subject|0|||
129986045|NCT04617275|467910798|FG003|Treatment Period|Withdrawal by Subject|2|||
129986046|NCT04617275|467910799|FG004|Treatment Period|Withdrawal by Subject|2|||
129986047|NCT04617275|467910800|FG005|Treatment Period|Withdrawal by Subject|0|||
129986048|NCT04617275|467910801|FG006|Treatment Period|Withdrawal by Subject|1|||
129986049|NCT04617275|467910802|FG007|Treatment Period|Withdrawal by Subject|2|||
129986050|NCT04617275|467910795|FG000|Follow-up Period|Adverse Event|1|||
129986051|NCT04617275|467910796|FG001|Follow-up Period|Adverse Event|1|||
129986052|NCT04617275|467910797|FG002|Follow-up Period|Adverse Event|2|||
129986053|NCT04617275|467910798|FG003|Follow-up Period|Adverse Event|3|||
129986054|NCT04617275|467910799|FG004|Follow-up Period|Adverse Event|4|||
129986055|NCT04617275|467910800|FG005|Follow-up Period|Adverse Event|3|||
129986056|NCT04617275|467910801|FG006|Follow-up Period|Adverse Event|0|||
129986057|NCT04617275|467910802|FG007|Follow-up Period|Adverse Event|3|||
129986058|NCT04617275|467910795|FG000|Follow-up Period|Lost to Follow-up|0|||
129986059|NCT04617275|467910796|FG001|Follow-up Period|Lost to Follow-up|1|||
129986060|NCT04617275|467910797|FG002|Follow-up Period|Lost to Follow-up|2|||
129986061|NCT04617275|467910798|FG003|Follow-up Period|Lost to Follow-up|0|||
129986062|NCT04617275|467910799|FG004|Follow-up Period|Lost to Follow-up|0|||
129986063|NCT04617275|467910800|FG005|Follow-up Period|Lost to Follow-up|4|||
129986064|NCT04617275|467910801|FG006|Follow-up Period|Lost to Follow-up|0|||
129986065|NCT04617275|467910802|FG007|Follow-up Period|Lost to Follow-up|3|||
129986066|NCT04617275|467910795|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
130214586|NCT03951753|468749097|FG000|Overall Study|Lost to Follow-up|0|||
129986067|NCT04617275|467910796|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
129986068|NCT04617275|467910797|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
129986069|NCT04617275|467910798|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
129986070|NCT04617275|467910799|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
129986071|NCT04617275|467910800|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
129986072|NCT04617275|467910801|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
129986073|NCT04617275|467910802|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
129986074|NCT04617275|467910795|FG000|Follow-up Period|Other|0|||
129986075|NCT04617275|467910796|FG001|Follow-up Period|Other|1|||
129986076|NCT04617275|467910797|FG002|Follow-up Period|Other|0|||
129986077|NCT04617275|467910798|FG003|Follow-up Period|Other|0|||
129986078|NCT04617275|467910799|FG004|Follow-up Period|Other|0|||
129986079|NCT04617275|467910800|FG005|Follow-up Period|Other|0|||
129986080|NCT04617275|467910801|FG006|Follow-up Period|Other|0|||
129986081|NCT04617275|467910802|FG007|Follow-up Period|Other|0|||
129986082|NCT04617275|467910795|FG000|Follow-up Period|Withdrawal by Subject|2|||
129986083|NCT04617275|467910796|FG001|Follow-up Period|Withdrawal by Subject|0|||
129986084|NCT04617275|467910797|FG002|Follow-up Period|Withdrawal by Subject|0|||
129986085|NCT04617275|467910798|FG003|Follow-up Period|Withdrawal by Subject|2|||
129986086|NCT04617275|467910799|FG004|Follow-up Period|Withdrawal by Subject|2|||
129986087|NCT04617275|467910800|FG005|Follow-up Period|Withdrawal by Subject|0|||
129986088|NCT04617275|467910801|FG006|Follow-up Period|Withdrawal by Subject|1|||
129986089|NCT04617275|467910802|FG007|Follow-up Period|Withdrawal by Subject|2|||
129986090|NCT04927884|467910815|FG000|Overall Study|Progressive Disease|2|||
129986091|NCT05593445|467910816|FG000|12-Week DBVC Period|Adverse Event|1|||
129986092|NCT05593445|467910817|FG001|12-Week DBVC Period|Adverse Event|0|||
129986093|NCT05593445|467910818|FG002|12-Week DBVC Period|Adverse Event|0|||
129986094|NCT05593445|467910819|FG003|12-Week DBVC Period|Adverse Event|0|||
129986095|NCT05593445|467910816|FG000|12-Week DBVC Period|Physician Decision|0|||
129986096|NCT05593445|467910817|FG001|12-Week DBVC Period|Physician Decision|1|||
129986097|NCT05593445|467910818|FG002|12-Week DBVC Period|Physician Decision|0|||
129986098|NCT05593445|467910819|FG003|12-Week DBVC Period|Physician Decision|0|||
129986099|NCT05593445|467910816|FG000|12-Week DBVC Period|Protocol Violation|0|||
129986100|NCT05593445|467910817|FG001|12-Week DBVC Period|Protocol Violation|1|||
129986101|NCT05593445|467910818|FG002|12-Week DBVC Period|Protocol Violation|0|||
129986102|NCT05593445|467910819|FG003|12-Week DBVC Period|Protocol Violation|0|||
129986103|NCT05593445|467910816|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
129986104|NCT05593445|467910817|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
129986105|NCT05593445|467910818|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
129986106|NCT05593445|467910819|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
129986107|NCT05593445|467910816|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
129986108|NCT05593445|467910817|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
129986109|NCT05593445|467910818|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
129986110|NCT05593445|467910819|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
130098700|NCT03557775|468319289|FG002|Overall Study|Withdrawal by Subject|4|||
129986111|NCT05593445|467910816|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
129986112|NCT05593445|467910817|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
129986113|NCT05593445|467910818|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
129986114|NCT05593445|467910819|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
129986115|NCT05593445|467910816|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
129986116|NCT05593445|467910817|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
129986117|NCT05593445|467910818|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
129986118|NCT05593445|467910819|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
129986119|NCT05593445|467910816|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129986120|NCT05593445|467910817|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129986121|NCT05593445|467910818|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
129986122|NCT05593445|467910819|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129986123|NCT05559476|467910820|FG000|Overall Study|Adverse Event|2|||
130323505|NCT00321620|469155499|FG000|Overall Study|Withdrawal by Subject|164|||
130323506|NCT00321620|469155500|FG001|Overall Study|Withdrawal by Subject|147|||
129986124|NCT05559476|467910821|FG001|Overall Study|Adverse Event|0|||
129986125|NCT05559476|467910820|FG000|Overall Study|Lost to Follow-up|13|||
129986126|NCT05559476|467910821|FG001|Overall Study|Lost to Follow-up|12|||
129986127|NCT05559476|467910820|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
130323507|NCT00321620|469155499|FG000|Overall Study|Disease progression|113|||
130323508|NCT00321620|469155500|FG001|Overall Study|Disease progression|117|||
130323509|NCT00321620|469155499|FG000|Overall Study|Adverse Event|43|||
130323510|NCT00321620|469155500|FG001|Overall Study|Adverse Event|56|||
130323511|NCT00321620|469155499|FG000|Overall Study|Lost to Follow-up|13|||
130323512|NCT00321620|469155500|FG001|Overall Study|Lost to Follow-up|9|||
130323513|NCT00321620|469155499|FG000|Overall Study|Physician Decision|4|||
130323514|NCT00321620|469155500|FG001|Overall Study|Physician Decision|1|||
130323515|NCT00321620|469155499|FG000|Overall Study|Noncompliance|14|||
130323516|NCT00321620|469155500|FG001|Overall Study|Noncompliance|7|||
129986128|NCT05559476|467910821|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
129986129|NCT05559476|467910820|FG000|Overall Study|Other|0|||
130323517|NCT00321620|469155499|FG000|Overall Study|Protocol deviation|4|||
129986130|NCT05559476|467910821|FG001|Overall Study|Other|2|||
129986131|NCT00727311|467910822|FG000|Overall Study|Did not receive drug|316|||
129986132|NCT00727311|467910822|FG000|Overall Study|Missing end of therapy data|205|||
129986133|NCT00727311|467910822|FG000|Overall Study|Adverse Event|58|||
129986134|NCT00727311|467910822|FG000|Overall Study|Lack of Efficacy|242|||
129986135|NCT00727311|467910822|FG000|Overall Study|Lost to Follow-up|73|||
129986136|NCT00727311|467910822|FG000|Overall Study|Withdrawal by Subject|77|||
129986137|NCT00727311|467910822|FG000|Overall Study|Other|97|||
129986138|NCT00727311|467910822|FG000|Overall Study|Multiple reasons|39|||
129986139|NCT03647488|467912041|FG000|Overall Study|Progressive disease|10|||
129986140|NCT03647488|467912042|FG001|Overall Study|Progressive disease|0|||
129986141|NCT03647488|467912043|FG002|Overall Study|Progressive disease|0|||
129986142|NCT03647488|467912041|FG000|Overall Study|Adverse Event|5|||
129986143|NCT03647488|467912042|FG001|Overall Study|Adverse Event|0|||
129986144|NCT03647488|467912043|FG002|Overall Study|Adverse Event|0|||
129986145|NCT03647488|467912041|FG000|Overall Study|Clinical progression|2|||
129986146|NCT03647488|467912042|FG001|Overall Study|Clinical progression|0|||
129986147|NCT03647488|467912043|FG002|Overall Study|Clinical progression|0|||
129986148|NCT03647488|467912041|FG000|Overall Study|Participant refused to take investigational product|1|||
129986149|NCT03647488|467912042|FG001|Overall Study|Participant refused to take investigational product|0|||
129986150|NCT03647488|467912043|FG002|Overall Study|Participant refused to take investigational product|0|||
129986151|NCT03694275|467912044|FG000|Overall Study|Adverse Event|0|||
129986152|NCT03694275|467912045|FG001|Overall Study|Adverse Event|1|||
129986153|NCT03694275|467912044|FG000|Overall Study|Reason not Specified|0|||
129986154|NCT03694275|467912045|FG001|Overall Study|Reason not Specified|1|||
129986155|NCT03541174|467912046|FG000|Part 1 Double-Blind|Adverse Event|6|||
129986156|NCT03541174|467912047|FG001|Part 1 Double-Blind|Adverse Event|5|||
129986157|NCT03541174|467912048|FG002|Part 1 Double-Blind|Adverse Event|2|||
129986158|NCT03541174|467912049|FG003|Part 1 Double-Blind|Adverse Event|0|||
129986159|NCT03541174|467912050|FG004|Part 1 Double-Blind|Adverse Event|0|||
129986160|NCT03541174|467912051|FG005|Part 1 Double-Blind|Adverse Event|0|||
129986161|NCT03541174|467912046|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
129986162|NCT03541174|467912047|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
130323518|NCT00321620|469155500|FG001|Overall Study|Protocol deviation|3|||
130323519|NCT00321620|469155499|FG000|Overall Study|Ineligibility determined|2|||
130323520|NCT00321620|469155500|FG001|Overall Study|Ineligibility determined|3|||
130323521|NCT00321620|469155499|FG000|Overall Study|Participant request|75|||
130323522|NCT00321620|469155500|FG001|Overall Study|Participant request|52|||
130323523|NCT00321620|469155499|FG000|Overall Study|Other|42|||
130323524|NCT00321620|469155500|FG001|Overall Study|Other|33|||
130323525|NCT03304626|469155503|FG000|Overall Study|Adverse Event|1|||
130323526|NCT03304626|469155504|FG001|Overall Study|Adverse Event|0|||
130323527|NCT03304626|469155503|FG000|Overall Study|Lack of Efficacy|1|||
130323528|NCT03304626|469155504|FG001|Overall Study|Lack of Efficacy|1|||
130323529|NCT04385277|469155505|FG000|Overall Study|Physician Decision|2|||
130323530|NCT04385277|469155505|FG000|Overall Study|Ineligible|1|||
130323531|NCT04385277|469155505|FG000|Overall Study|Patient/Parent Refusal|2|||
130323532|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
130323533|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323534|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323535|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323536|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323537|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
130323538|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
129986163|NCT03541174|467912048|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
129986164|NCT03541174|467912049|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
129986165|NCT03541174|467912050|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
129986166|NCT03541174|467912051|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
129986167|NCT03541174|467912046|FG000|Part 1 Double-Blind|Other reasons|3|||
129986168|NCT03541174|467912047|FG001|Part 1 Double-Blind|Other reasons|2|||
129986169|NCT03541174|467912048|FG002|Part 1 Double-Blind|Other reasons|3|||
129986170|NCT03541174|467912049|FG003|Part 1 Double-Blind|Other reasons|0|||
129986171|NCT03541174|467912050|FG004|Part 1 Double-Blind|Other reasons|0|||
129986172|NCT03541174|467912051|FG005|Part 1 Double-Blind|Other reasons|0|||
129986173|NCT03541174|467912046|FG000|Part 2 Single-Blind|Adverse Event|0|||
129986174|NCT03541174|467912047|FG001|Part 2 Single-Blind|Adverse Event|0|||
129986175|NCT03541174|467912048|FG002|Part 2 Single-Blind|Adverse Event|0|||
129986176|NCT03541174|467912049|FG003|Part 2 Single-Blind|Adverse Event|25|||
129986177|NCT03541174|467912050|FG004|Part 2 Single-Blind|Adverse Event|0|||
129986178|NCT03541174|467912051|FG005|Part 2 Single-Blind|Adverse Event|0|||
129986179|NCT03541174|467912046|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
129986180|NCT03541174|467912047|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
129986181|NCT03541174|467912048|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
130323539|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323540|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
129986182|NCT03541174|467912049|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
129986183|NCT03541174|467912050|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
129986184|NCT03541174|467912051|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
129986185|NCT03541174|467912046|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
130214587|NCT03951753|468749098|FG001|Overall Study|Lost to Follow-up|0|||
130214588|NCT03951753|468749099|FG002|Overall Study|Lost to Follow-up|1|||
130214589|NCT03178851|468749100|FG000|Overall Study|Death|48|||
130214590|NCT03178851|468749101|FG001|Overall Study|Death|2|||
130214591|NCT03178851|468749102|FG002|Overall Study|Death|25|||
130214592|NCT03178851|468749100|FG000|Overall Study|Withdrawal by Subject|8|||
130214593|NCT03178851|468749101|FG001|Overall Study|Withdrawal by Subject|0|||
130214594|NCT03178851|468749102|FG002|Overall Study|Withdrawal by Subject|0|||
130214595|NCT03178851|468749100|FG000|Overall Study|Lost to Follow-up|5|||
130214596|NCT03178851|468749101|FG001|Overall Study|Lost to Follow-up|2|||
130214597|NCT03178851|468749102|FG002|Overall Study|Lost to Follow-up|0|||
130214598|NCT03178851|468749100|FG000|Overall Study|Adverse Event|0|||
130214599|NCT03178851|468749101|FG001|Overall Study|Adverse Event|0|||
130214600|NCT03178851|468749102|FG002|Overall Study|Adverse Event|1|||
130214601|NCT03178851|468749100|FG000|Overall Study|Study Termination by Sponsor|31|||
130214602|NCT03178851|468749101|FG001|Overall Study|Study Termination by Sponsor|7|||
130214603|NCT03178851|468749102|FG002|Overall Study|Study Termination by Sponsor|26|||
130214604|NCT02669043|468749107|FG000|Overall Study|Didn't meet I/E criteria|4|||
130214605|NCT02552888|468749110|FG000|Overall Study|Lost to Follow-up|1|||
130214606|NCT02552888|468749111|FG001|Overall Study|Lost to Follow-up|1|||
130214607|NCT00401193|468751584|FG000|Overall Study|Adverse Event|1|||
130214608|NCT00401193|468751585|FG001|Overall Study|Adverse Event|3|||
130214609|NCT00401193|468751586|FG002|Overall Study|Adverse Event|1|||
130214610|NCT00401193|468751584|FG000|Overall Study|Protocol Violation|3|||
130214611|NCT00401193|468751585|FG001|Overall Study|Protocol Violation|1|||
130214612|NCT00401193|468751586|FG002|Overall Study|Protocol Violation|1|||
130214613|NCT00401193|468751584|FG000|Overall Study|Lost to Follow-up|6|||
130214614|NCT00401193|468751585|FG001|Overall Study|Lost to Follow-up|5|||
130214615|NCT00401193|468751586|FG002|Overall Study|Lost to Follow-up|1|||
130214616|NCT00401193|468751584|FG000|Overall Study|Withdrawal by Subject|2|||
130214617|NCT00401193|468751585|FG001|Overall Study|Withdrawal by Subject|0|||
130214618|NCT00401193|468751586|FG002|Overall Study|Withdrawal by Subject|1|||
130214619|NCT00401193|468751584|FG000|Overall Study|Other Event|3|||
130214620|NCT00401193|468751585|FG001|Overall Study|Other Event|2|||
130214621|NCT00401193|468751586|FG002|Overall Study|Other Event|2|||
130214622|NCT00398216|468751587|FG000|Overall Study|Adverse Event|4|||
130214623|NCT00398216|468751588|FG001|Overall Study|Adverse Event|2|||
130214624|NCT00398216|468751589|FG002|Overall Study|Adverse Event|5|||
130214625|NCT00398216|468751590|FG003|Overall Study|Adverse Event|7|||
130214626|NCT00398216|468751591|FG004|Overall Study|Adverse Event|2|||
130214627|NCT00398216|468751587|FG000|Overall Study|Protocol Violation|2|||
130214628|NCT00398216|468751588|FG001|Overall Study|Protocol Violation|4|||
130214629|NCT00398216|468751589|FG002|Overall Study|Protocol Violation|5|||
130214630|NCT00398216|468751590|FG003|Overall Study|Protocol Violation|7|||
130214631|NCT00398216|468751591|FG004|Overall Study|Protocol Violation|5|||
130214632|NCT00398216|468751587|FG000|Overall Study|Lost to Follow-up|1|||
130214633|NCT00398216|468751588|FG001|Overall Study|Lost to Follow-up|6|||
130214634|NCT00398216|468751589|FG002|Overall Study|Lost to Follow-up|4|||
130214635|NCT00398216|468751590|FG003|Overall Study|Lost to Follow-up|4|||
130214636|NCT00398216|468751591|FG004|Overall Study|Lost to Follow-up|1|||
130214637|NCT00398216|468751587|FG000|Overall Study|Death|0|||
130214638|NCT00398216|468751588|FG001|Overall Study|Death|3|||
130214639|NCT00398216|468751589|FG002|Overall Study|Death|0|||
130214640|NCT00398216|468751590|FG003|Overall Study|Death|0|||
130214641|NCT00398216|468751591|FG004|Overall Study|Death|0|||
130214642|NCT00398216|468751587|FG000|Overall Study|Withdrawal by Subject|1|||
130214643|NCT00398216|468751588|FG001|Overall Study|Withdrawal by Subject|0|||
130214644|NCT00398216|468751589|FG002|Overall Study|Withdrawal by Subject|3|||
130214645|NCT00398216|468751590|FG003|Overall Study|Withdrawal by Subject|1|||
129986186|NCT03541174|467912047|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
130214646|NCT00398216|468751591|FG004|Overall Study|Withdrawal by Subject|2|||
130214647|NCT00398216|468751587|FG000|Overall Study|administrative reasons|3|||
130214648|NCT00398216|468751588|FG001|Overall Study|administrative reasons|4|||
130214649|NCT00398216|468751589|FG002|Overall Study|administrative reasons|4|||
130214650|NCT00398216|468751590|FG003|Overall Study|administrative reasons|3|||
130214651|NCT00398216|468751591|FG004|Overall Study|administrative reasons|3|||
130214652|NCT00398216|468751587|FG000|Overall Study|entrance criteria|0|||
130214653|NCT00398216|468751588|FG001|Overall Study|entrance criteria|0|||
130214654|NCT00398216|468751589|FG002|Overall Study|entrance criteria|0|||
130214655|NCT00398216|468751590|FG003|Overall Study|entrance criteria|0|||
130214656|NCT00398216|468751591|FG004|Overall Study|entrance criteria|2|||
130214657|NCT00376532|468751592|FG000|Overall Study|Lack sufficient blood sample|6|||
130214658|NCT00376532|468751593|FG001|Overall Study|Lack sufficient blood sample|6|||
130214659|NCT04227405|468751594|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
130214660|NCT04227405|468751595|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
129986187|NCT03541174|467912048|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
129986188|NCT03541174|467912049|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
129986189|NCT03541174|467912050|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
129986190|NCT03541174|467912051|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
129986191|NCT03541174|467912046|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
129986192|NCT03541174|467912047|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
129986193|NCT03541174|467912048|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
130323541|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323542|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
129986194|NCT03541174|467912049|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
129986195|NCT03541174|467912050|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
129986196|NCT03541174|467912051|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
129986197|NCT03541174|467912046|FG000|Part 2 Single-Blind|Death|0|||
129986198|NCT03541174|467912047|FG001|Part 2 Single-Blind|Death|0|||
129986199|NCT03541174|467912048|FG002|Part 2 Single-Blind|Death|0|||
129986200|NCT03541174|467912049|FG003|Part 2 Single-Blind|Death|5|||
129986201|NCT03541174|467912050|FG004|Part 2 Single-Blind|Death|0|||
129986202|NCT03541174|467912051|FG005|Part 2 Single-Blind|Death|0|||
129986203|NCT03541174|467912046|FG000|Part 2 Single-Blind|Pregnancy|0|||
129986204|NCT03541174|467912047|FG001|Part 2 Single-Blind|Pregnancy|0|||
129986205|NCT03541174|467912048|FG002|Part 2 Single-Blind|Pregnancy|0|||
129986206|NCT03541174|467912049|FG003|Part 2 Single-Blind|Pregnancy|1|||
129986207|NCT03541174|467912050|FG004|Part 2 Single-Blind|Pregnancy|0|||
129986208|NCT03541174|467912051|FG005|Part 2 Single-Blind|Pregnancy|0|||
129986209|NCT03541174|467912046|FG000|Part 2 Single-Blind|Other reasons|0|||
129986210|NCT03541174|467912047|FG001|Part 2 Single-Blind|Other reasons|0|||
129986211|NCT03541174|467912048|FG002|Part 2 Single-Blind|Other reasons|0|||
129986212|NCT03541174|467912049|FG003|Part 2 Single-Blind|Other reasons|32|||
129986213|NCT03541174|467912050|FG004|Part 2 Single-Blind|Other reasons|0|||
129986214|NCT03541174|467912051|FG005|Part 2 Single-Blind|Other reasons|0|||
129986215|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986216|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986217|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986218|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986219|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
129986220|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
129986221|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986222|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986223|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986224|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986225|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
129986226|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
129986227|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986228|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986229|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986230|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986231|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986232|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
129986233|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129986234|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129986235|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129986236|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
130323543|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323544|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323545|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
130323546|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323547|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323548|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
130323549|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323550|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129986237|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
129986238|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
129986239|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986240|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986241|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986242|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986243|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
129986244|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986245|NCT02217332|467912054|FG000|Overall Study|Adverse Event|3|||
129986246|NCT02217332|467912054|FG000|Overall Study|Dose interruption >1 month|1|||
129986247|NCT02217332|467912054|FG000|Overall Study|Protocol Violation (eligibility)|1|||
130323551|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
130323552|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
130323553|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323554|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323555|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323556|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129986248|NCT02217332|467912054|FG000|Overall Study|Withdrawal by Subject|1|||
129986249|NCT02217332|467912054|FG000|Overall Study|Lost to Follow-up|1|||
129986250|NCT02407990|467912055|FG000|Overall Study|Death|2|||
129986251|NCT02407990|467912056|FG001|Overall Study|Death|22|||
129986252|NCT02407990|467912057|FG002|Overall Study|Death|23|||
129986253|NCT02407990|467912058|FG003|Overall Study|Death|7|||
129986254|NCT02407990|467912059|FG004|Overall Study|Death|17|||
129986255|NCT02407990|467912060|FG005|Overall Study|Death|16|||
129986256|NCT02407990|467912061|FG006|Overall Study|Death|10|||
129986257|NCT02407990|467912062|FG007|Overall Study|Death|248|||
129986258|NCT02407990|467912055|FG000|Overall Study|Lost to Follow-up|0|||
129986259|NCT02407990|467912056|FG001|Overall Study|Lost to Follow-up|1|||
129986260|NCT02407990|467912057|FG002|Overall Study|Lost to Follow-up|0|||
129986261|NCT02407990|467912058|FG003|Overall Study|Lost to Follow-up|0|||
129986262|NCT02407990|467912059|FG004|Overall Study|Lost to Follow-up|0|||
129986263|NCT02407990|467912060|FG005|Overall Study|Lost to Follow-up|0|||
129986264|NCT02407990|467912061|FG006|Overall Study|Lost to Follow-up|0|||
129986265|NCT02407990|467912062|FG007|Overall Study|Lost to Follow-up|17|||
129986266|NCT02407990|467912055|FG000|Overall Study|Progressive Disease|0|||
129986267|NCT02407990|467912056|FG001|Overall Study|Progressive Disease|0|||
129986268|NCT02407990|467912057|FG002|Overall Study|Progressive Disease|0|||
129986269|NCT02407990|467912058|FG003|Overall Study|Progressive Disease|0|||
129986270|NCT02407990|467912059|FG004|Overall Study|Progressive Disease|0|||
129986271|NCT02407990|467912060|FG005|Overall Study|Progressive Disease|0|||
129986272|NCT02407990|467912061|FG006|Overall Study|Progressive Disease|0|||
129986273|NCT02407990|467912062|FG007|Overall Study|Progressive Disease|1|||
129986274|NCT02407990|467912055|FG000|Overall Study|Withdrawal by Subject|0|||
129986275|NCT02407990|467912056|FG001|Overall Study|Withdrawal by Subject|0|||
129986276|NCT02407990|467912057|FG002|Overall Study|Withdrawal by Subject|0|||
129986277|NCT02407990|467912058|FG003|Overall Study|Withdrawal by Subject|0|||
129986278|NCT02407990|467912059|FG004|Overall Study|Withdrawal by Subject|1|||
129986279|NCT02407990|467912060|FG005|Overall Study|Withdrawal by Subject|0|||
129986280|NCT02407990|467912061|FG006|Overall Study|Withdrawal by Subject|0|||
129986281|NCT02407990|467912062|FG007|Overall Study|Withdrawal by Subject|30|||
129986282|NCT02407990|467912055|FG000|Overall Study|Study Terminated by Sponsor|1|||
129986283|NCT02407990|467912056|FG001|Overall Study|Study Terminated by Sponsor|3|||
129986284|NCT02407990|467912057|FG002|Overall Study|Study Terminated by Sponsor|3|||
129986285|NCT02407990|467912058|FG003|Overall Study|Study Terminated by Sponsor|0|||
129986286|NCT02407990|467912059|FG004|Overall Study|Study Terminated by Sponsor|3|||
129986287|NCT02407990|467912060|FG005|Overall Study|Study Terminated by Sponsor|4|||
129986288|NCT02407990|467912061|FG006|Overall Study|Study Terminated by Sponsor|3|||
129986289|NCT02407990|467912062|FG007|Overall Study|Study Terminated by Sponsor|37|||
129986290|NCT02407990|467912055|FG000|Overall Study|Logistics|0|||
129986291|NCT02407990|467912056|FG001|Overall Study|Logistics|0|||
129986292|NCT02407990|467912057|FG002|Overall Study|Logistics|0|||
129986293|NCT02407990|467912058|FG003|Overall Study|Logistics|0|||
129986294|NCT02407990|467912059|FG004|Overall Study|Logistics|0|||
129986295|NCT02407990|467912060|FG005|Overall Study|Logistics|0|||
129986296|NCT02407990|467912061|FG006|Overall Study|Logistics|0|||
129986297|NCT02407990|467912062|FG007|Overall Study|Logistics|1|||
129986298|NCT02407990|467912055|FG000|Overall Study|Rolled into long-term extension study|0|||
129986299|NCT02407990|467912056|FG001|Overall Study|Rolled into long-term extension study|0|||
129986300|NCT02407990|467912057|FG002|Overall Study|Rolled into long-term extension study|0|||
129986301|NCT02407990|467912058|FG003|Overall Study|Rolled into long-term extension study|0|||
129986302|NCT02407990|467912059|FG004|Overall Study|Rolled into long-term extension study|0|||
129986303|NCT02407990|467912060|FG005|Overall Study|Rolled into long-term extension study|0|||
129986304|NCT02407990|467912061|FG006|Overall Study|Rolled into long-term extension study|0|||
129986305|NCT02407990|467912062|FG007|Overall Study|Rolled into long-term extension study|1|||
129986306|NCT00734097|467912063|FG000|Screening|Protocol Violation|12|||
129986307|NCT00734097|467912063|FG000|Screening|Withdrawal by Subject|5|||
129986308|NCT00734097|467912063|FG000|Screening|Lost to Follow-up|2|||
129986309|NCT00734097|467912063|FG000|Screening|Unconfirmed pregnancy|1|||
129986310|NCT00734097|467912063|FG000|Open Label|Lost to Follow-up|7|||
129986311|NCT00734097|467912063|FG000|Open Label|Withdrawal by Subject|5|||
129986312|NCT00734097|467912063|FG000|Open Label|Protocol Violation|4|||
129986313|NCT02233543|467912068|FG000|Period 1|Withdrawal by Subject|1|||
129986314|NCT02233543|467912069|FG001|Period 1|Withdrawal by Subject|0|||
130323557|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
129986315|NCT02233543|467912068|FG000|Period 1|Participants required other treatment.|2|||
129986316|NCT02233543|467912069|FG001|Period 1|Participants required other treatment.|3|||
129986317|NCT02233543|467912068|FG000|Period 2|Adverse Event|1|||
129986318|NCT02233543|467912069|FG001|Period 2|Adverse Event|0|||
129986319|NCT02233543|467912068|FG000|Period 2|Participant required other treatment.|0|||
129986320|NCT02233543|467912069|FG001|Period 2|Participant required other treatment.|1|||
129986321|NCT02233543|467912068|FG000|Period 2|COPD exacerbation|1|||
129986322|NCT02233543|467912069|FG001|Period 2|COPD exacerbation|0|||
129986323|NCT00603304|467912070|FG000|Overall Study|Lost to Follow-up|5|||
129986324|NCT00603304|467912071|FG001|Overall Study|Lost to Follow-up|7|||
129986325|NCT00603304|467912070|FG000|Overall Study|Withdrawal by Subject|8|||
129986326|NCT00603304|467912071|FG001|Overall Study|Withdrawal by Subject|5|||
129986327|NCT00603304|467912070|FG000|Overall Study|Protocol Violation|1|||
129986328|NCT00603304|467912071|FG001|Overall Study|Protocol Violation|0|||
129986329|NCT00603304|467912070|FG000|Overall Study|Adverse Event|4|||
129986330|NCT00603304|467912071|FG001|Overall Study|Adverse Event|2|||
129986331|NCT00603304|467912070|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
129986332|NCT00603304|467912071|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
129986333|NCT00603304|467912070|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
129986334|NCT00603304|467912071|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
129986335|NCT00603304|467912070|FG000|Overall Study|Exclusionary Medication|2|||
129986336|NCT00603304|467912071|FG001|Overall Study|Exclusionary Medication|3|||
129986337|NCT00603304|467912070|FG000|Overall Study|Non-Compliant|0|||
129986338|NCT00603304|467912071|FG001|Overall Study|Non-Compliant|1|||
129986339|NCT00603304|467912070|FG000|Overall Study|Moved Away|0|||
129986340|NCT00603304|467912071|FG001|Overall Study|Moved Away|2|||
129986341|NCT00603304|467912070|FG000|Overall Study|Other|2|||
129986342|NCT00603304|467912071|FG001|Overall Study|Other|0|||
129986343|NCT00603304|467912070|FG000|Overall Study|Patient Decision|2|||
129986344|NCT00603304|467912071|FG001|Overall Study|Patient Decision|0|||
129986345|NCT00616902|467912072|FG000|Overall Study|Termination of study|6|||
129986346|NCT00616902|467912073|FG001|Overall Study|Termination of study|6|||
129986347|NCT03573583|467912074|FG000|Overall Study|Lost to Follow-up|1|||
129986348|NCT03573583|467912075|FG001|Overall Study|Lost to Follow-up|0|||
129986349|NCT03573583|467912074|FG000|Overall Study|Withdrawal by Subject|1|||
129986350|NCT03573583|467912075|FG001|Overall Study|Withdrawal by Subject|1|||
129986351|NCT01227577|467912076|FG000|Overall Study|Protocol deviation|3|||
129986352|NCT01227577|467912076|FG000|Overall Study|Death|3|||
129986353|NCT01227577|467912076|FG000|Overall Study|Administrative problems|2|||
130098701|NCT03557775|468319287|FG000|Overall Study|Physician Decision|0|||
130098702|NCT03557775|468319288|FG001|Overall Study|Physician Decision|1|||
130098703|NCT03557775|468319289|FG002|Overall Study|Physician Decision|0|||
130098704|NCT00483119|468319290|FG000|Overall Study|Adverse Event|0|||
130098705|NCT00483119|468319291|FG001|Overall Study|Adverse Event|1|||
130098706|NCT00483119|468319290|FG000|Overall Study|Physician Decision|1|||
130098707|NCT00483119|468319291|FG001|Overall Study|Physician Decision|0|||
130098708|NCT03426995|468319292|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098709|NCT03426995|468319293|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098710|NCT03426995|468319294|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
130098711|NCT03426995|468319295|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130323558|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130323559|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
130098712|NCT03426995|468319296|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098713|NCT03426995|468319297|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098714|NCT03426995|468319298|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098715|NCT03426995|468319299|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130323560|NCT02903771|469155510|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
129986354|NCT01227577|467912076|FG000|Overall Study|Lost to Follow-up|1|||
129986355|NCT01227577|467912076|FG000|Overall Study|Withdrawal by Subject|4|||
129986356|NCT01227577|467912076|FG000|Overall Study|Lack of Efficacy|5|||
129986357|NCT01227577|467912076|FG000|Overall Study|Adverse Event|17|||
129986358|NCT00852540|467912077|FG000|Overall Study|Adverse Event|10|||
129986359|NCT00852540|467912078|FG001|Overall Study|Adverse Event|3|||
129986360|NCT00852540|467912077|FG000|Overall Study|Lack of Efficacy|15|||
129986361|NCT00852540|467912078|FG001|Overall Study|Lack of Efficacy|3|||
129986362|NCT00852540|467912077|FG000|Overall Study|Protocol Violation|1|||
129986363|NCT00852540|467912078|FG001|Overall Study|Protocol Violation|2|||
129986364|NCT00852540|467912077|FG000|Overall Study|Lost to Follow-up|2|||
129986365|NCT00852540|467912078|FG001|Overall Study|Lost to Follow-up|3|||
129986366|NCT00852540|467912077|FG000|Overall Study|Investigator Discretion|2|||
129986367|NCT00852540|467912078|FG001|Overall Study|Investigator Discretion|3|||
129986368|NCT00852540|467912077|FG000|Overall Study|Withdrawal by Subject|3|||
129986369|NCT00852540|467912078|FG001|Overall Study|Withdrawal by Subject|1|||
129986370|NCT00852540|467912077|FG000|Overall Study|Did Not Receive Study Drug|3|||
129986371|NCT00852540|467912078|FG001|Overall Study|Did Not Receive Study Drug|3|||
129986372|NCT01639495|467912079|FG000|Overall Study|Lost to Follow-up|6|||
129986373|NCT01639495|467912079|FG000|Overall Study|Consented but didn't have study catheter|4|||
129986374|NCT01639495|467912079|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
129986375|NCT01639495|467912079|FG000|Overall Study|No radiofrequency energy applied|2|||
129986376|NCT01119105|467912080|FG000|Overall Study|Withdrawal by Subject|1|||
129986377|NCT01119105|467912081|FG001|Overall Study|Withdrawal by Subject|1|||
129986378|NCT01119105|467912082|FG002|Overall Study|Withdrawal by Subject|1|||
129986379|NCT01119105|467912080|FG000|Overall Study|Lost to Follow-up|0|||
129986380|NCT01119105|467912081|FG001|Overall Study|Lost to Follow-up|2|||
130323561|NCT02903771|469155511|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323562|NCT02903771|469155512|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323563|NCT02903771|469155513|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323564|NCT02903771|469155514|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323565|NCT02903771|469155515|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
130323566|NCT02903771|469155516|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
130323567|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323568|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323569|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323570|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323571|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
130323572|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323573|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
130323574|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323575|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323576|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323577|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323578|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
130323579|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323580|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
130323581|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323582|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323583|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323584|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323585|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
130323586|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323587|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
130323588|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323589|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323590|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129986381|NCT01119105|467912082|FG002|Overall Study|Lost to Follow-up|5|||
129986382|NCT01119105|467912080|FG000|Overall Study|Adverse Event|1|||
130323591|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323592|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
130323593|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323594|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
130323595|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323596|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323597|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323598|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323599|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
130323600|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323601|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
130323602|NCT02903771|469155510|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323603|NCT02903771|469155511|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323604|NCT02903771|469155512|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323605|NCT02903771|469155513|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323606|NCT02903771|469155514|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
130323607|NCT02903771|469155515|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129986383|NCT01119105|467912081|FG001|Overall Study|Adverse Event|0|||
129986384|NCT01119105|467912082|FG002|Overall Study|Adverse Event|1|||
129986385|NCT01119105|467912080|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
129986386|NCT01119105|467912081|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
129986387|NCT01119105|467912082|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
130323608|NCT02903771|469155516|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
130323609|NCT03041038|469155540|FG000|Overall Study|Withdrawal by Subject|4|||
130323610|NCT03041038|469155541|FG001|Overall Study|Withdrawal by Subject|0|||
130323611|NCT03041038|469155540|FG000|Overall Study|Lost to Follow-up|1|||
130323612|NCT03041038|469155541|FG001|Overall Study|Lost to Follow-up|1|||
129986388|NCT01119105|467912080|FG000|Overall Study|Other|1|||
129986389|NCT01119105|467912081|FG001|Overall Study|Other|1|||
129986390|NCT01119105|467912082|FG002|Overall Study|Other|0|||
129986391|NCT01775475|467912083|FG000|Overall Study|Death|3|||
129986392|NCT01775475|467912084|FG001|Overall Study|Death|3|||
129986393|NCT00618618|467912085|FG000|Overall Study|Patient Request|0|||
129986394|NCT00618618|467912086|FG001|Overall Study|Patient Request|0|||
129986395|NCT00618618|467912087|FG002|Overall Study|Patient Request|2|||
129986396|NCT00618618|467912088|FG003|Overall Study|Patient Request|0|||
129986397|NCT00618618|467912085|FG000|Overall Study|Inability to Complete Study Procedures|0|||
129986398|NCT00618618|467912086|FG001|Overall Study|Inability to Complete Study Procedures|1|||
129986399|NCT00618618|467912087|FG002|Overall Study|Inability to Complete Study Procedures|0|||
129986400|NCT00618618|467912088|FG003|Overall Study|Inability to Complete Study Procedures|0|||
129986401|NCT00618618|467912085|FG000|Overall Study|Lost to Follow-up|3|||
129986402|NCT00618618|467912086|FG001|Overall Study|Lost to Follow-up|0|||
129986403|NCT00618618|467912087|FG002|Overall Study|Lost to Follow-up|0|||
129986404|NCT00618618|467912088|FG003|Overall Study|Lost to Follow-up|1|||
129986405|NCT00618618|467912085|FG000|Overall Study|Non-compliance|1|||
129986406|NCT00618618|467912086|FG001|Overall Study|Non-compliance|1|||
129986407|NCT00618618|467912087|FG002|Overall Study|Non-compliance|0|||
129986408|NCT00618618|467912088|FG003|Overall Study|Non-compliance|0|||
129986409|NCT00618618|467912085|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
129986410|NCT00618618|467912086|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
129986411|NCT00618618|467912087|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
129986412|NCT00618618|467912088|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
129986413|NCT00618618|467912085|FG000|Overall Study|Death|0|||
129986414|NCT00618618|467912086|FG001|Overall Study|Death|1|||
129986415|NCT00618618|467912087|FG002|Overall Study|Death|0|||
129986416|NCT00618618|467912088|FG003|Overall Study|Death|0|||
129986417|NCT02929329|467912089|FG000|Overall Study|Withdrawal by Subject|24|||
129986418|NCT02929329|467912090|FG001|Overall Study|Withdrawal by Subject|21|||
129986419|NCT02929329|467912089|FG000|Overall Study|Lost to Follow-up|26|||
129986420|NCT02929329|467912090|FG001|Overall Study|Lost to Follow-up|20|||
129986421|NCT02929329|467912089|FG000|Overall Study|Death|1054|||
129986422|NCT02929329|467912090|FG001|Overall Study|Death|1051|||
129986423|NCT01183234|467912091|FG000|First Intervention|Adverse Event|1|||
130214661|NCT04227405|468751594|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
130214662|NCT04227405|468751595|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
130214663|NCT04227405|468751594|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
130214664|NCT04227405|468751595|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
130214665|NCT02207400|468751596|FG000|Overall Study|Adverse Event|1|||
130214666|NCT02207400|468751597|FG001|Overall Study|Adverse Event|1|||
130214667|NCT02207400|468751596|FG000|Overall Study|Lost to Follow-up|6|||
130214668|NCT02207400|468751597|FG001|Overall Study|Lost to Follow-up|7|||
130214669|NCT02207400|468751596|FG000|Overall Study|Protocol Violation|1|||
130214670|NCT02207400|468751597|FG001|Overall Study|Protocol Violation|1|||
130214671|NCT02207400|468751596|FG000|Overall Study|Withdrawal by Subject|8|||
130214672|NCT02207400|468751597|FG001|Overall Study|Withdrawal by Subject|4|||
130214673|NCT02207400|468751596|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
130214674|NCT02207400|468751597|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
130214675|NCT02757352|468751600|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
130214676|NCT02757352|468751601|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214677|NCT02757352|468751602|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
130214678|NCT02757352|468751603|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214679|NCT02757352|468751604|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214680|NCT02757352|468751605|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214681|NCT02757352|468751606|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214682|NCT02757352|468751607|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214683|NCT02757352|468751608|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214684|NCT02757352|468751609|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
130214685|NCT02757352|468751600|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214686|NCT02757352|468751601|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214687|NCT02757352|468751602|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
130214688|NCT02757352|468751603|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214689|NCT02757352|468751604|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129986424|NCT01183234|467912092|FG001|First Intervention|Adverse Event|0|||
129986425|NCT00309959|467912101|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
129986426|NCT02937454|467912102|FG000|Overall Study|Adverse Event|0|||
129986427|NCT02937454|467912103|FG001|Overall Study|Adverse Event|1|||
129986428|NCT02937454|467912102|FG000|Overall Study|Death|98|||
129986429|NCT02937454|467912103|FG001|Overall Study|Death|95|||
129986430|NCT02937454|467912102|FG000|Overall Study|Lost to Follow-up|1|||
129986431|NCT02937454|467912103|FG001|Overall Study|Lost to Follow-up|1|||
129986432|NCT02937454|467912102|FG000|Overall Study|Physician Decision|0|||
129986433|NCT02937454|467912103|FG001|Overall Study|Physician Decision|1|||
129986434|NCT02937454|467912102|FG000|Overall Study|Protocol Violation|6|||
129986435|NCT02937454|467912103|FG001|Overall Study|Protocol Violation|10|||
129986436|NCT02937454|467912102|FG000|Overall Study|Withdrawal by Subject|27|||
129986437|NCT02937454|467912103|FG001|Overall Study|Withdrawal by Subject|15|||
129986438|NCT02937454|467912102|FG000|Overall Study|Other|8|||
129986439|NCT02937454|467912103|FG001|Overall Study|Other|5|||
129986440|NCT00037830|467912106|FG000|Overall Study|Adverse Event|2|||
129986441|NCT00037830|467912107|FG001|Overall Study|Adverse Event|0|||
129986442|NCT00037830|467912108|FG002|Overall Study|Adverse Event|0|||
129986443|NCT00037830|467912106|FG000|Overall Study|Withdrawal by Subject|4|||
129986444|NCT00037830|467912107|FG001|Overall Study|Withdrawal by Subject|5|||
129986445|NCT00037830|467912108|FG002|Overall Study|Withdrawal by Subject|1|||
129986446|NCT00037830|467912106|FG000|Overall Study|Protocol Violation|2|||
129986447|NCT00037830|467912107|FG001|Overall Study|Protocol Violation|2|||
129986448|NCT00037830|467912108|FG002|Overall Study|Protocol Violation|0|||
129986449|NCT00037830|467912106|FG000|Overall Study|Unrelated Medical Problem|2|||
129986450|NCT00037830|467912107|FG001|Overall Study|Unrelated Medical Problem|0|||
129986451|NCT00037830|467912108|FG002|Overall Study|Unrelated Medical Problem|0|||
129986452|NCT01004848|467912109|FG000|Overall Study|Lost to Follow-up|55|||
129986453|NCT01004848|467912110|FG001|Overall Study|Lost to Follow-up|45|||
129986454|NCT03292432|467912111|FG000|Overall Study|Lost to Follow-up|11|||
129986455|NCT03292432|467912112|FG001|Overall Study|Lost to Follow-up|8|||
129986456|NCT03292432|467912111|FG000|Overall Study|Death|2|||
129986457|NCT03292432|467912112|FG001|Overall Study|Death|1|||
129986458|NCT03292432|467912111|FG000|Overall Study|Withdrawal by Subject|1|||
130323613|NCT03041038|469155540|FG000|Overall Study|Protocol Violation|1|||
130323614|NCT03041038|469155541|FG001|Overall Study|Protocol Violation|1|||
130323615|NCT03331315|469155542|FG000|Overall Study|Physician Decision|18|||
130323616|NCT03331315|469155543|FG001|Overall Study|Physician Decision|14|||
130323617|NCT01709721|469155544|FG000|Open Label Phase|Withdrawal by Subject|0|||
130323618|NCT01709721|469155545|FG001|Open Label Phase|Withdrawal by Subject|0|||
130323619|NCT01709721|469155546|FG002|Open Label Phase|Withdrawal by Subject|5|||
130323620|NCT01709721|469155544|FG000|Open Label Phase|Adverse Event|0|||
130323621|NCT01709721|469155545|FG001|Open Label Phase|Adverse Event|0|||
130323622|NCT01709721|469155546|FG002|Open Label Phase|Adverse Event|8|||
130323623|NCT01709721|469155544|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
130323624|NCT01709721|469155545|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
130323625|NCT01709721|469155546|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
130323626|NCT01709721|469155544|FG000|Open Label Phase|Investigator Decision|0|||
130323627|NCT01709721|469155545|FG001|Open Label Phase|Investigator Decision|0|||
130323628|NCT01709721|469155546|FG002|Open Label Phase|Investigator Decision|1|||
130323629|NCT01709721|469155544|FG000|Open Label Phase|Sponsor Decision|0|||
130323630|NCT01709721|469155545|FG001|Open Label Phase|Sponsor Decision|0|||
130323631|NCT01709721|469155546|FG002|Open Label Phase|Sponsor Decision|2|||
130323632|NCT01709721|469155544|FG000|Open Label Phase|Protocol Violation|0|||
130323633|NCT01709721|469155545|FG001|Open Label Phase|Protocol Violation|0|||
130323634|NCT01709721|469155546|FG002|Open Label Phase|Protocol Violation|1|||
130323635|NCT01709721|469155544|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
130323636|NCT01709721|469155545|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
130323637|NCT01709721|469155546|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
130323638|NCT01709721|469155544|FG000|Open Label Phase|Inadequate Pain Control|0|||
130323639|NCT01709721|469155545|FG001|Open Label Phase|Inadequate Pain Control|0|||
130323640|NCT01709721|469155546|FG002|Open Label Phase|Inadequate Pain Control|37|||
130323641|NCT01709721|469155544|FG000|Open Label Phase|Other, Specify in text field in database|0|||
130323642|NCT01709721|469155545|FG001|Open Label Phase|Other, Specify in text field in database|0|||
130323643|NCT01709721|469155546|FG002|Open Label Phase|Other, Specify in text field in database|14|||
130323644|NCT01709721|469155544|FG000|Randomized Phase|Adverse Event|0|||
130323645|NCT01709721|469155545|FG001|Randomized Phase|Adverse Event|1|||
130323646|NCT01709721|469155546|FG002|Randomized Phase|Adverse Event|0|||
130323647|NCT01709721|469155544|FG000|Randomized Phase|Lost to Follow-up|1|||
130323648|NCT01709721|469155545|FG001|Randomized Phase|Lost to Follow-up|0|||
130323649|NCT01709721|469155546|FG002|Randomized Phase|Lost to Follow-up|0|||
130323650|NCT01709721|469155544|FG000|Randomized Phase|Inadequate Pain Control|1|||
130323651|NCT01709721|469155545|FG001|Randomized Phase|Inadequate Pain Control|2|||
130323652|NCT01709721|469155546|FG002|Randomized Phase|Inadequate Pain Control|0|||
129986459|NCT03292432|467912112|FG001|Overall Study|Withdrawal by Subject|2|||
129986460|NCT03292432|467912111|FG000|Overall Study|Site closed before any data collected|1|||
129986461|NCT03292432|467912112|FG001|Overall Study|Site closed before any data collected|0|||
129986462|NCT01014143|467912114|FG000|Second Intervention|Lost to Follow-up|2|||
129986463|NCT01014143|467912115|FG001|Second Intervention|Lost to Follow-up|0|||
129986464|NCT01014143|467912116|FG002|Second Intervention|Lost to Follow-up|0|||
130323653|NCT01709721|469155544|FG000|Randomized Phase|Other, Specify text field in database|1|||
130323654|NCT01709721|469155545|FG001|Randomized Phase|Other, Specify text field in database|3|||
130323655|NCT01709721|469155546|FG002|Randomized Phase|Other, Specify text field in database|0|||
130323656|NCT00360230|469155549|FG000|Overall Study|Withdrawal by Subject|1|||
130323657|NCT00360230|469155550|FG001|Overall Study|Withdrawal by Subject|1|||
130323658|NCT00360230|469155551|FG002|Overall Study|Withdrawal by Subject|0|||
130323659|NCT00360230|469155552|FG003|Overall Study|Withdrawal by Subject|1|||
129986465|NCT00495586|467912117|FG000|Overall Study|Withdrawal by Subject|4|||
129986466|NCT00495586|467912118|FG001|Overall Study|Withdrawal by Subject|4|||
129986467|NCT02038543|467912119|FG000|Overall Study|Screen Failure|0|||
129986468|NCT02038543|467912120|FG001|Overall Study|Screen Failure|0|||
129986469|NCT02038543|467912121|FG002|Overall Study|Screen Failure|0|||
129986470|NCT02038543|467912122|FG003|Overall Study|Screen Failure|1|||
129986471|NCT02038543|467912119|FG000|Overall Study|Withdrawal by Subject|0|||
129986472|NCT02038543|467912120|FG001|Overall Study|Withdrawal by Subject|0|||
129986473|NCT02038543|467912121|FG002|Overall Study|Withdrawal by Subject|0|||
129986474|NCT02038543|467912122|FG003|Overall Study|Withdrawal by Subject|1|||
129986475|NCT00158860|467912123|FG000|Overall Study|Adverse Event|3|||
129986476|NCT00158860|467912124|FG001|Overall Study|Adverse Event|6|||
129986477|NCT00158860|467912123|FG000|Overall Study|Lost to Follow-up|11|||
129986478|NCT00158860|467912124|FG001|Overall Study|Lost to Follow-up|17|||
129986479|NCT00158860|467912123|FG000|Overall Study|Protocol Violation|8|||
129986480|NCT00158860|467912124|FG001|Overall Study|Protocol Violation|23|||
129986481|NCT00158860|467912123|FG000|Overall Study|Withdrawal by Subject|7|||
129986482|NCT00158860|467912124|FG001|Overall Study|Withdrawal by Subject|17|||
129986483|NCT00158860|467912123|FG000|Overall Study|MOVING OUT OF STATE|1|||
129986484|NCT00158860|467912124|FG001|Overall Study|MOVING OUT OF STATE|0|||
129986485|NCT00158860|467912123|FG000|Overall Study|Pregnancy|3|||
129986486|NCT00158860|467912124|FG001|Overall Study|Pregnancy|3|||
129986487|NCT00158860|467912123|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
129986488|NCT00158860|467912124|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
129986489|NCT00158860|467912123|FG000|Overall Study|SPONSOR REQUEST|0|||
129986490|NCT00158860|467912124|FG001|Overall Study|SPONSOR REQUEST|1|||
129986491|NCT00158860|467912123|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
129986492|NCT00158860|467912124|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
129986493|NCT00158860|467912123|FG000|Overall Study|Closed per sponsor|0|||
129986494|NCT00158860|467912124|FG001|Overall Study|Closed per sponsor|1|||
129986495|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
129986496|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
129986497|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
129986498|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
129986499|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
129986500|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
129986501|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
129986502|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
129986503|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Death|0|||
129986504|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Death|1|||
129986505|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
129986506|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
129986507|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
129986508|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
129986509|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
129986510|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
129986511|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
129986512|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
129986513|NCT01029652|467912125|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
129986514|NCT01029652|467912126|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
129986515|NCT01029652|467912125|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
129986516|NCT01029652|467912126|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
129986517|NCT01029652|467912125|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
129986518|NCT01029652|467912126|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
129986519|NCT02095951|467912127|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
129986520|NCT02095951|467912128|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
129986521|NCT03618823|467912129|FG000|Overall Study|Lost to Follow-up|63|||
129986522|NCT03618823|467912130|FG001|Overall Study|Lost to Follow-up|61|||
129986523|NCT04638920|467912131|FG000|Overall Study|Withdrawal by Subject|5|||
129986524|NCT00964886|467912132|FG000|Overall Study|Lost to Follow-up|2|||
129986525|NCT00964886|467912133|FG001|Overall Study|Lost to Follow-up|2|||
129986526|NCT00964886|467912134|FG002|Overall Study|Lost to Follow-up|6|||
129986527|NCT00964886|467912135|FG003|Overall Study|Lost to Follow-up|4|||
129986528|NCT00964886|467912132|FG000|Overall Study|Withdrawal by Subject|6|||
129986529|NCT00964886|467912133|FG001|Overall Study|Withdrawal by Subject|2|||
129986530|NCT00964886|467912134|FG002|Overall Study|Withdrawal by Subject|5|||
129986531|NCT00964886|467912135|FG003|Overall Study|Withdrawal by Subject|3|||
129986532|NCT00964886|467912132|FG000|Overall Study|Adverse Event|3|||
129986533|NCT00964886|467912133|FG001|Overall Study|Adverse Event|1|||
129986534|NCT00964886|467912134|FG002|Overall Study|Adverse Event|5|||
129986535|NCT00964886|467912135|FG003|Overall Study|Adverse Event|2|||
129986536|NCT00964886|467912132|FG000|Overall Study|Protocol Violation|0|||
129986537|NCT00964886|467912133|FG001|Overall Study|Protocol Violation|2|||
129986538|NCT00964886|467912134|FG002|Overall Study|Protocol Violation|0|||
129986539|NCT00964886|467912135|FG003|Overall Study|Protocol Violation|0|||
129986540|NCT00523640|467912137|FG000|Overall Study|Death|1|||
129986541|NCT03775434|467912139|FG000|Overall Study|Adverse Event|2|||
129986542|NCT03775434|467912139|FG000|Overall Study|Withdrawal by Subject|1|||
129986543|NCT01859988|467912140|FG000|Overall Study|Withdrawal by Subject|6|||
129986544|NCT01859988|467912141|FG001|Overall Study|Withdrawal by Subject|3|||
129986545|NCT01859988|467912142|FG002|Overall Study|Withdrawal by Subject|4|||
129986546|NCT01859988|467912143|FG003|Overall Study|Withdrawal by Subject|3|||
129986547|NCT01859988|467912144|FG004|Overall Study|Withdrawal by Subject|2|||
129986548|NCT01859988|467912145|FG005|Overall Study|Withdrawal by Subject|2|||
129986549|NCT01859988|467912140|FG000|Overall Study|Lack of Efficacy|1|||
129986550|NCT01859988|467912141|FG001|Overall Study|Lack of Efficacy|1|||
129986551|NCT01859988|467912142|FG002|Overall Study|Lack of Efficacy|5|||
129986552|NCT01859988|467912143|FG003|Overall Study|Lack of Efficacy|0|||
129986553|NCT01859988|467912144|FG004|Overall Study|Lack of Efficacy|7|||
129986554|NCT01859988|467912145|FG005|Overall Study|Lack of Efficacy|9|||
129986555|NCT01859988|467912140|FG000|Overall Study|Physician Decision|1|||
129986556|NCT01859988|467912141|FG001|Overall Study|Physician Decision|3|||
129986557|NCT01859988|467912142|FG002|Overall Study|Physician Decision|1|||
129986558|NCT01859988|467912143|FG003|Overall Study|Physician Decision|3|||
129986559|NCT01859988|467912144|FG004|Overall Study|Physician Decision|4|||
129986560|NCT01859988|467912145|FG005|Overall Study|Physician Decision|1|||
129986561|NCT01859988|467912140|FG000|Overall Study|Adverse Event|2|||
129986562|NCT01859988|467912141|FG001|Overall Study|Adverse Event|1|||
129986563|NCT01859988|467912142|FG002|Overall Study|Adverse Event|3|||
129986564|NCT01859988|467912143|FG003|Overall Study|Adverse Event|1|||
129986565|NCT01859988|467912144|FG004|Overall Study|Adverse Event|2|||
129986566|NCT01859988|467912145|FG005|Overall Study|Adverse Event|2|||
129986567|NCT01859988|467912140|FG000|Overall Study|Lost to Follow-up|1|||
129986568|NCT01859988|467912141|FG001|Overall Study|Lost to Follow-up|2|||
129986569|NCT01859988|467912142|FG002|Overall Study|Lost to Follow-up|3|||
129986570|NCT01859988|467912143|FG003|Overall Study|Lost to Follow-up|0|||
129986571|NCT01859988|467912144|FG004|Overall Study|Lost to Follow-up|3|||
129986572|NCT01859988|467912145|FG005|Overall Study|Lost to Follow-up|2|||
129986573|NCT01859988|467912140|FG000|Overall Study|Protocol Violation|0|||
129986574|NCT01859988|467912141|FG001|Overall Study|Protocol Violation|0|||
129986575|NCT01859988|467912142|FG002|Overall Study|Protocol Violation|1|||
129986576|NCT01859988|467912143|FG003|Overall Study|Protocol Violation|0|||
129986577|NCT01859988|467912144|FG004|Overall Study|Protocol Violation|0|||
129986578|NCT01859988|467912145|FG005|Overall Study|Protocol Violation|0|||
129986579|NCT01859988|467912140|FG000|Overall Study|Other than specified above|0|||
129986580|NCT01859988|467912141|FG001|Overall Study|Other than specified above|2|||
129986581|NCT01859988|467912142|FG002|Overall Study|Other than specified above|11|||
129986582|NCT01859988|467912143|FG003|Overall Study|Other than specified above|3|||
129986583|NCT01859988|467912144|FG004|Overall Study|Other than specified above|5|||
129986584|NCT01859988|467912145|FG005|Overall Study|Other than specified above|3|||
129986585|NCT00468559|467912150|FG000|Open-label Treatment Phase|Adverse Event|5|||
129986586|NCT00468559|467912151|FG001|Open-label Treatment Phase|Adverse Event|0|||
129986587|NCT00468559|467912152|FG002|Open-label Treatment Phase|Adverse Event|0|||
129986588|NCT00468559|467912150|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
129986589|NCT00468559|467912151|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
129986590|NCT00468559|467912152|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
129986591|NCT00468559|467912150|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
129986592|NCT00468559|467912151|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
129986593|NCT00468559|467912152|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
129986594|NCT00468559|467912150|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
129986595|NCT00468559|467912151|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
129986596|NCT00468559|467912152|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
129986597|NCT00468559|467912150|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
129986598|NCT00468559|467912151|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
129986599|NCT00468559|467912152|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
129986600|NCT04602221|467912153|FG000|Overall Study|Discontinuation of trial treatment|0|||
129986601|NCT04602221|467912154|FG001|Overall Study|Discontinuation of trial treatment|0|||
129986602|NCT04602221|467912155|FG002|Overall Study|Discontinuation of trial treatment|1|||
129986603|NCT04602221|467912156|FG003|Overall Study|Discontinuation of trial treatment|0|||
129986604|NCT04602221|467912157|FG004|Overall Study|Discontinuation of trial treatment|0|||
129986605|NCT04602221|467912158|FG005|Overall Study|Discontinuation of trial treatment|0|||
129986606|NCT04602221|467912159|FG006|Overall Study|Discontinuation of trial treatment|0|||
129986607|NCT04602221|467912160|FG007|Overall Study|Discontinuation of trial treatment|0|||
129986608|NCT04602221|467912161|FG008|Overall Study|Discontinuation of trial treatment|0|||
129986609|NCT04602221|467912162|FG009|Overall Study|Discontinuation of trial treatment|0|||
129986610|NCT04602221|467912163|FG010|Overall Study|Discontinuation of trial treatment|0|||
129986611|NCT04602221|467912164|FG011|Overall Study|Discontinuation of trial treatment|0|||
129986612|NCT04602221|467912165|FG012|Overall Study|Discontinuation of trial treatment|0|||
129986613|NCT04602221|467912166|FG013|Overall Study|Discontinuation of trial treatment|0|||
129986614|NCT04602221|467912167|FG014|Overall Study|Discontinuation of trial treatment|0|||
129986615|NCT04602221|467912168|FG015|Overall Study|Discontinuation of trial treatment|0|||
129986616|NCT04602221|467912169|FG016|Overall Study|Discontinuation of trial treatment|0|||
129986617|NCT04602221|467912170|FG017|Overall Study|Discontinuation of trial treatment|0|||
129986618|NCT04602221|467912153|FG000|Overall Study|Other than listed|0|||
129986619|NCT04602221|467912154|FG001|Overall Study|Other than listed|0|||
129986620|NCT04602221|467912155|FG002|Overall Study|Other than listed|0|||
129986621|NCT04602221|467912156|FG003|Overall Study|Other than listed|0|||
129986622|NCT04602221|467912157|FG004|Overall Study|Other than listed|0|||
129986623|NCT04602221|467912158|FG005|Overall Study|Other than listed|0|||
129986624|NCT04602221|467912159|FG006|Overall Study|Other than listed|0|||
129986625|NCT04602221|467912160|FG007|Overall Study|Other than listed|0|||
129986626|NCT04602221|467912161|FG008|Overall Study|Other than listed|0|||
129986627|NCT04602221|467912162|FG009|Overall Study|Other than listed|0|||
129986628|NCT04602221|467912163|FG010|Overall Study|Other than listed|0|||
129986629|NCT04602221|467912164|FG011|Overall Study|Other than listed|0|||
129986630|NCT04602221|467912165|FG012|Overall Study|Other than listed|0|||
129986631|NCT04602221|467912166|FG013|Overall Study|Other than listed|0|||
129986632|NCT04602221|467912167|FG014|Overall Study|Other than listed|0|||
129986633|NCT04602221|467912168|FG015|Overall Study|Other than listed|1|||
129986634|NCT04602221|467912169|FG016|Overall Study|Other than listed|0|||
129986635|NCT04602221|467912170|FG017|Overall Study|Other than listed|1|||
129986636|NCT04602221|467912153|FG000|Overall Study|Withdrawal by Subject|0|||
129986637|NCT04602221|467912154|FG001|Overall Study|Withdrawal by Subject|0|||
129986638|NCT04602221|467912155|FG002|Overall Study|Withdrawal by Subject|0|||
129986639|NCT04602221|467912156|FG003|Overall Study|Withdrawal by Subject|0|||
129986640|NCT04602221|467912157|FG004|Overall Study|Withdrawal by Subject|0|||
129986641|NCT04602221|467912158|FG005|Overall Study|Withdrawal by Subject|0|||
129986642|NCT04602221|467912159|FG006|Overall Study|Withdrawal by Subject|0|||
129986643|NCT04602221|467912160|FG007|Overall Study|Withdrawal by Subject|0|||
129986644|NCT04602221|467912161|FG008|Overall Study|Withdrawal by Subject|0|||
129986645|NCT04602221|467912162|FG009|Overall Study|Withdrawal by Subject|0|||
129986646|NCT04602221|467912163|FG010|Overall Study|Withdrawal by Subject|0|||
130323660|NCT00360230|469155553|FG004|Overall Study|Withdrawal by Subject|1|||
130323661|NCT00360230|469155554|FG005|Overall Study|Withdrawal by Subject|1|||
130323662|NCT00360230|469155555|FG006|Overall Study|Withdrawal by Subject|0|||
130323663|NCT00360230|469155549|FG000|Overall Study|Migrated|4|||
130323664|NCT00360230|469155550|FG001|Overall Study|Migrated|1|||
130323665|NCT00360230|469155551|FG002|Overall Study|Migrated|3|||
130323666|NCT00360230|469155552|FG003|Overall Study|Migrated|1|||
129986647|NCT04602221|467912164|FG011|Overall Study|Withdrawal by Subject|0|||
129986648|NCT04602221|467912165|FG012|Overall Study|Withdrawal by Subject|1|||
129986649|NCT04602221|467912166|FG013|Overall Study|Withdrawal by Subject|0|||
129986650|NCT04602221|467912167|FG014|Overall Study|Withdrawal by Subject|0|||
129986651|NCT04602221|467912168|FG015|Overall Study|Withdrawal by Subject|0|||
129986652|NCT04602221|467912169|FG016|Overall Study|Withdrawal by Subject|0|||
129986653|NCT04602221|467912170|FG017|Overall Study|Withdrawal by Subject|0|||
129986654|NCT04602221|467912153|FG000|Overall Study|Lost to Follow-up|0|||
129986655|NCT04602221|467912154|FG001|Overall Study|Lost to Follow-up|0|||
129986656|NCT04602221|467912155|FG002|Overall Study|Lost to Follow-up|0|||
129986657|NCT04602221|467912156|FG003|Overall Study|Lost to Follow-up|0|||
129986658|NCT04602221|467912157|FG004|Overall Study|Lost to Follow-up|0|||
129986659|NCT04602221|467912158|FG005|Overall Study|Lost to Follow-up|1|||
129986660|NCT04602221|467912159|FG006|Overall Study|Lost to Follow-up|0|||
129986661|NCT04602221|467912160|FG007|Overall Study|Lost to Follow-up|0|||
129986662|NCT04602221|467912161|FG008|Overall Study|Lost to Follow-up|0|||
129986663|NCT04602221|467912162|FG009|Overall Study|Lost to Follow-up|0|||
130323667|NCT00360230|469155553|FG004|Overall Study|Migrated|4|||
130323668|NCT00360230|469155554|FG005|Overall Study|Migrated|1|||
130323669|NCT00360230|469155555|FG006|Overall Study|Migrated|1|||
130323670|NCT00360230|469155549|FG000|Overall Study|Other|1|||
129986664|NCT04602221|467912163|FG010|Overall Study|Lost to Follow-up|0|||
129986665|NCT04602221|467912164|FG011|Overall Study|Lost to Follow-up|0|||
129986666|NCT04602221|467912165|FG012|Overall Study|Lost to Follow-up|0|||
129986667|NCT04602221|467912166|FG013|Overall Study|Lost to Follow-up|0|||
129986668|NCT04602221|467912167|FG014|Overall Study|Lost to Follow-up|0|||
129986669|NCT04602221|467912168|FG015|Overall Study|Lost to Follow-up|0|||
129986670|NCT04602221|467912169|FG016|Overall Study|Lost to Follow-up|0|||
129986671|NCT04602221|467912170|FG017|Overall Study|Lost to Follow-up|0|||
130323671|NCT00360230|469155550|FG001|Overall Study|Other|0|||
129986672|NCT03538301|467912171|FG000|Overall Study|Adverse Event|1|||
129986673|NCT03538301|467912172|FG001|Overall Study|Adverse Event|4|||
130323672|NCT00360230|469155551|FG002|Overall Study|Other|0|||
130323673|NCT00360230|469155552|FG003|Overall Study|Other|0|||
129986674|NCT03538301|467912173|FG002|Overall Study|Adverse Event|4|||
129986675|NCT03538301|467912171|FG000|Overall Study|Death|1|||
129986676|NCT03538301|467912172|FG001|Overall Study|Death|1|||
129986677|NCT03538301|467912173|FG002|Overall Study|Death|0|||
129986678|NCT03538301|467912171|FG000|Overall Study|Physician Decision|0|||
130323674|NCT00360230|469155553|FG004|Overall Study|Other|0|||
130323675|NCT00360230|469155554|FG005|Overall Study|Other|0|||
130323676|NCT00360230|469155555|FG006|Overall Study|Other|0|||
130323677|NCT00360230|469155549|FG000|Overall Study|Protocol Violation|0|||
130323678|NCT00360230|469155550|FG001|Overall Study|Protocol Violation|0|||
130323679|NCT00360230|469155551|FG002|Overall Study|Protocol Violation|0|||
130323680|NCT00360230|469155552|FG003|Overall Study|Protocol Violation|0|||
130323681|NCT00360230|469155553|FG004|Overall Study|Protocol Violation|0|||
130323682|NCT00360230|469155554|FG005|Overall Study|Protocol Violation|1|||
130323683|NCT00360230|469155555|FG006|Overall Study|Protocol Violation|0|||
130323684|NCT00360230|469155549|FG000|Overall Study|Death|0|||
130323685|NCT00360230|469155550|FG001|Overall Study|Death|1|||
130323686|NCT00360230|469155551|FG002|Overall Study|Death|0|||
130323687|NCT00360230|469155552|FG003|Overall Study|Death|0|||
130323688|NCT00360230|469155553|FG004|Overall Study|Death|0|||
130323689|NCT00360230|469155554|FG005|Overall Study|Death|1|||
130323690|NCT00360230|469155555|FG006|Overall Study|Death|1|||
130323691|NCT00581308|469155556|FG000|Pre Discharge|Lost to Follow-up|1|||
130323692|NCT00581308|469155556|FG000|Pre Discharge|Device Removed|1|||
130323693|NCT00581308|469155556|FG000|Month 1|Lost to Follow-up|3|||
130323694|NCT00581308|469155556|FG000|Month 1|Withdrawal by Subject|2|||
130323695|NCT00581308|469155556|FG000|Month 1|Device Removed|2|||
130323696|NCT00581308|469155556|FG000|Month 1|Uknown|1|||
130323697|NCT00581308|469155556|FG000|Month 6|Lost to Follow-up|1|||
130323698|NCT00581308|469155556|FG000|Month 6|Withdrawal by Subject|2|||
130323699|NCT00581308|469155556|FG000|Month 12|Death|1|||
130323700|NCT00581308|469155556|FG000|Month 12|Lost to Follow-up|14|||
130323701|NCT00581308|469155556|FG000|Month 12|Withdrawal by Subject|3|||
130323702|NCT00581308|469155556|FG000|Month 12|Device Removed|1|||
130323703|NCT00581308|469155556|FG000|Month 12|Other|1|||
130323704|NCT03219723|469155557|FG000|Overall Study|Case Report Forms Uncollected|6|||
130323705|NCT03219723|469155557|FG000|Overall Study|Protocol Deviation|4|||
130323706|NCT01527370|469155560|FG000|Overall Study|Withdrawal by Subject|4|||
130323707|NCT01527370|469155560|FG000|Overall Study|Physician Decision|1|||
130323708|NCT01527370|469155560|FG000|Overall Study|Death|1|||
130323709|NCT02057250|469155561|FG000|AID Assessment Phase|Adverse Event|3|||
130323710|NCT02057250|469155562|FG001|AID Assessment Phase|Adverse Event|2|||
130323711|NCT02057250|469155563|FG002|AID Assessment Phase|Adverse Event|6|||
130323712|NCT02057250|469155564|FG003|AID Assessment Phase|Adverse Event|1|||
130323713|NCT02057250|469155565|FG004|AID Assessment Phase|Adverse Event|0|||
130323714|NCT02057250|469155561|FG000|AID Assessment Phase|Other than specified above|1|||
130323715|NCT02057250|469155562|FG001|AID Assessment Phase|Other than specified above|1|||
130323716|NCT02057250|469155563|FG002|AID Assessment Phase|Other than specified above|1|||
130323717|NCT02057250|469155564|FG003|AID Assessment Phase|Other than specified above|1|||
130323718|NCT02057250|469155565|FG004|AID Assessment Phase|Other than specified above|0|||
130323719|NCT02057250|469155561|FG000|Extension Phase|Adverse Event|0|||
130323720|NCT02057250|469155562|FG001|Extension Phase|Adverse Event|0|||
130323721|NCT02057250|469155563|FG002|Extension Phase|Adverse Event|0|||
130323722|NCT02057250|469155564|FG003|Extension Phase|Adverse Event|0|||
130323723|NCT02057250|469155565|FG004|Extension Phase|Adverse Event|15|||
130323724|NCT02057250|469155561|FG000|Extension Phase|Lack of Efficacy|0|||
130323725|NCT02057250|469155562|FG001|Extension Phase|Lack of Efficacy|0|||
130323726|NCT02057250|469155563|FG002|Extension Phase|Lack of Efficacy|0|||
130323727|NCT02057250|469155564|FG003|Extension Phase|Lack of Efficacy|0|||
130323728|NCT02057250|469155565|FG004|Extension Phase|Lack of Efficacy|10|||
130323729|NCT02057250|469155561|FG000|Extension Phase|Entered in this period but not treated|0|||
130323730|NCT02057250|469155562|FG001|Extension Phase|Entered in this period but not treated|0|||
130323731|NCT02057250|469155563|FG002|Extension Phase|Entered in this period but not treated|0|||
130323732|NCT02057250|469155564|FG003|Extension Phase|Entered in this period but not treated|0|||
130323733|NCT02057250|469155565|FG004|Extension Phase|Entered in this period but not treated|4|||
130323734|NCT02057250|469155561|FG000|Extension Phase|Other than specified above|0|||
130323735|NCT02057250|469155562|FG001|Extension Phase|Other than specified above|0|||
130323736|NCT02057250|469155563|FG002|Extension Phase|Other than specified above|0|||
130323737|NCT02057250|469155564|FG003|Extension Phase|Other than specified above|0|||
130323738|NCT02057250|469155565|FG004|Extension Phase|Other than specified above|7|||
130323739|NCT01435382|469155567|FG000|Overall Study|Lost to Follow-up|1|||
130323740|NCT01435382|469155568|FG001|Overall Study|Lost to Follow-up|0|||
130323741|NCT01435382|469155569|FG002|Overall Study|Lost to Follow-up|1|||
130323742|NCT01435382|469155570|FG003|Overall Study|Lost to Follow-up|0|||
130323743|NCT01435382|469155567|FG000|Overall Study|Withdrawal by Subject|0|||
130323744|NCT01435382|469155568|FG001|Overall Study|Withdrawal by Subject|2|||
130323745|NCT01435382|469155569|FG002|Overall Study|Withdrawal by Subject|0|||
130323746|NCT01435382|469155570|FG003|Overall Study|Withdrawal by Subject|1|||
130323747|NCT02435992|469155571|FG000|Overall Study|non compliance with protocol|2|||
130323748|NCT02435992|469155572|FG001|Overall Study|non compliance with protocol|0|||
130323749|NCT02435992|469155573|FG002|Overall Study|non compliance with protocol|1|||
130323750|NCT02435992|469155574|FG003|Overall Study|non compliance with protocol|0|||
130323751|NCT02435992|469155575|FG004|Overall Study|non compliance with protocol|0|||
130323752|NCT02435992|469155571|FG000|Overall Study|Adverse Event|11|||
130323753|NCT02435992|469155572|FG001|Overall Study|Adverse Event|6|||
129986679|NCT03538301|467912172|FG001|Overall Study|Physician Decision|1|||
129986680|NCT03538301|467912173|FG002|Overall Study|Physician Decision|0|||
129986681|NCT03538301|467912171|FG000|Overall Study|Protocol Violation|0|||
129986682|NCT03538301|467912172|FG001|Overall Study|Protocol Violation|0|||
129986683|NCT03538301|467912173|FG002|Overall Study|Protocol Violation|1|||
129986684|NCT03538301|467912171|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
129986685|NCT03538301|467912172|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
129986686|NCT03538301|467912173|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
129986687|NCT04540887|467912174|FG000|Overall Study|Withdrawal by Subject|2|||
129986688|NCT05180500|467912175|FG000|Overall Study|Adverse Event|1|||
129986689|NCT05180500|467912176|FG001|Overall Study|Adverse Event|0|||
129986690|NCT05180500|467912175|FG000|Overall Study|Withdrawal by Subject|2|||
129986691|NCT05180500|467912176|FG001|Overall Study|Withdrawal by Subject|0|||
129986692|NCT05917470|467912177|FG000|Overall Study|Progressive Disease|1|||
129986693|NCT05917470|467912178|FG001|Overall Study|Progressive Disease|1|||
129986694|NCT05917470|467912179|FG002|Overall Study|Progressive Disease|2|||
129986695|NCT05917470|467912180|FG003|Overall Study|Progressive Disease|3|||
129986696|NCT05917470|467912181|FG004|Overall Study|Progressive Disease|1|||
129986697|NCT05917470|467912182|FG005|Overall Study|Progressive Disease|1|||
129986698|NCT05917470|467912183|FG006|Overall Study|Progressive Disease|0|||
129986699|NCT05917470|467912184|FG007|Overall Study|Progressive Disease|0|||
129986700|NCT05917470|467912177|FG000|Overall Study|Withdrawal by Subject|0|||
129986701|NCT05917470|467912178|FG001|Overall Study|Withdrawal by Subject|0|||
129986702|NCT05917470|467912179|FG002|Overall Study|Withdrawal by Subject|1|||
129986703|NCT05917470|467912180|FG003|Overall Study|Withdrawal by Subject|0|||
129986704|NCT05917470|467912181|FG004|Overall Study|Withdrawal by Subject|0|||
129986705|NCT05917470|467912182|FG005|Overall Study|Withdrawal by Subject|0|||
129986706|NCT05917470|467912183|FG006|Overall Study|Withdrawal by Subject|0|||
129986707|NCT05917470|467912184|FG007|Overall Study|Withdrawal by Subject|0|||
129986708|NCT05917470|467912177|FG000|Overall Study|Sponsor Decision|0|||
129986709|NCT05917470|467912178|FG001|Overall Study|Sponsor Decision|0|||
129986710|NCT05917470|467912179|FG002|Overall Study|Sponsor Decision|1|||
129986711|NCT05917470|467912180|FG003|Overall Study|Sponsor Decision|0|||
129986712|NCT05917470|467912181|FG004|Overall Study|Sponsor Decision|2|||
129986713|NCT05917470|467912182|FG005|Overall Study|Sponsor Decision|1|||
129986714|NCT05917470|467912183|FG006|Overall Study|Sponsor Decision|3|||
129986715|NCT05917470|467912184|FG007|Overall Study|Sponsor Decision|3|||
129986716|NCT05917470|467912177|FG000|Overall Study|Adverse Event|0|||
129986717|NCT05917470|467912178|FG001|Overall Study|Adverse Event|0|||
129986718|NCT05917470|467912179|FG002|Overall Study|Adverse Event|0|||
129986719|NCT05917470|467912180|FG003|Overall Study|Adverse Event|0|||
129986720|NCT05917470|467912181|FG004|Overall Study|Adverse Event|0|||
129986721|NCT05917470|467912182|FG005|Overall Study|Adverse Event|1|||
129986722|NCT05917470|467912183|FG006|Overall Study|Adverse Event|0|||
129986723|NCT05917470|467912184|FG007|Overall Study|Adverse Event|0|||
129986724|NCT02317432|467912185|FG000|Overall Study|Death|4|||
129986725|NCT02317432|467912186|FG001|Overall Study|Death|1|||
129986726|NCT02317432|467912185|FG000|Overall Study|Lost to Follow-up|0|||
129986727|NCT02317432|467912186|FG001|Overall Study|Lost to Follow-up|5|||
129986728|NCT02317432|467912185|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
129986729|NCT02317432|467912186|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
129986730|NCT03992846|467912191|FG000|Overall Study|Adverse Event|8|||
129986731|NCT03992846|467912192|FG001|Overall Study|Adverse Event|6|||
129986732|NCT03992846|467912193|FG002|Overall Study|Adverse Event|3|||
129986733|NCT03992846|467912191|FG000|Overall Study|Lost to Follow-up|0|||
129986734|NCT03992846|467912192|FG001|Overall Study|Lost to Follow-up|1|||
129986735|NCT03992846|467912193|FG002|Overall Study|Lost to Follow-up|1|||
129986736|NCT03992846|467912191|FG000|Overall Study|Pregnancy|2|||
129986737|NCT03992846|467912192|FG001|Overall Study|Pregnancy|0|||
129986738|NCT03992846|467912193|FG002|Overall Study|Pregnancy|1|||
129986739|NCT03992846|467912191|FG000|Overall Study|Protocol Violation|1|||
129986740|NCT03992846|467912192|FG001|Overall Study|Protocol Violation|2|||
129986741|NCT03992846|467912193|FG002|Overall Study|Protocol Violation|0|||
129986742|NCT03992846|467912191|FG000|Overall Study|Withdrawal by Subject|8|||
129986743|NCT03992846|467912192|FG001|Overall Study|Withdrawal by Subject|10|||
129986744|NCT03992846|467912193|FG002|Overall Study|Withdrawal by Subject|20|||
129986745|NCT03992846|467912191|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
129986746|NCT03992846|467912192|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
129986747|NCT03992846|467912193|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
129986748|NCT04058366|467914002|FG000|Overall Study|Adverse Event|14|||
129986749|NCT04058366|467914002|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
129986750|NCT04058366|467914002|FG000|Overall Study|Commercial drug is available for participants|6|||
129986751|NCT04058366|467914002|FG000|Overall Study|Death|1|||
130323754|NCT02435992|469155573|FG002|Overall Study|Adverse Event|12|||
129986752|NCT04058366|467914002|FG000|Overall Study|Other non-compliance|2|||
129986753|NCT04058366|467914002|FG000|Overall Study|Other|6|||
129986754|NCT04343872|467914007|FG000|Overall Study|Lost to Follow-up|6|||
129986755|NCT04343872|467914008|FG001|Overall Study|Lost to Follow-up|3|||
129986756|NCT01850446|467914009|FG000|Overall Study|Lack of Efficacy|1|||
129986757|NCT01850446|467914010|FG001|Overall Study|Lack of Efficacy|0|||
129986758|NCT01850446|467914009|FG000|Overall Study|Withdrawal by Subject|4|||
129986759|NCT01850446|467914010|FG001|Overall Study|Withdrawal by Subject|0|||
129986760|NCT01850446|467914009|FG000|Overall Study|Protocol Violation|0|||
129986761|NCT01850446|467914010|FG001|Overall Study|Protocol Violation|2|||
129986762|NCT00759915|467914011|FG000|Overall Study|Withdrawal by Subject|1|||
129986763|NCT00759915|467914012|FG001|Overall Study|Withdrawal by Subject|0|||
129986764|NCT00759915|467914011|FG000|Overall Study|Adverse Event|0|||
129986765|NCT00759915|467914012|FG001|Overall Study|Adverse Event|1|||
129986766|NCT03730480|467914013|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
129986767|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
129986768|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
129986769|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
129986770|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
129986771|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
129986772|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
129986773|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
129986774|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
129986775|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
129986776|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
129986777|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
129986778|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
129986779|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
129986780|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
129986781|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
129986782|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
129986783|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
129986784|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
129986785|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
129986786|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
129986787|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
129986788|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
129986789|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
129986790|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
129986791|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
129986792|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
129986793|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
129986794|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
129986795|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
129986796|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
129986797|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
129986798|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
129986799|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
129986800|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
129986801|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
129986802|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
129986803|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
129986804|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
129986805|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
129986806|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
129986807|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
129986808|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
129986809|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
129986810|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
129986811|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
129986812|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
129986813|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
129986814|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
129986815|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
129986816|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
129986817|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
129986818|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
129986819|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
129986820|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
130323755|NCT02435992|469155574|FG003|Overall Study|Adverse Event|0|||
129986821|NCT00512317|467914017|FG000|Overall Study|Insufficient clinical response|36|||
129986822|NCT00512317|467914017|FG000|Overall Study|Withdrawal by Subject|23|||
129986823|NCT00512317|467914017|FG000|Overall Study|Sponsor closure of study|21|||
130323756|NCT02435992|469155575|FG004|Overall Study|Adverse Event|0|||
129986824|NCT00512317|467914017|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
129986825|NCT00512317|467914017|FG000|Overall Study|Adverse Event|13|||
129986826|NCT00512317|467914017|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
129986827|NCT00512317|467914017|FG000|Overall Study|Lost to Follow-up|2|||
129986828|NCT00512317|467914017|FG000|Overall Study|Other|2|||
129986829|NCT01813929|467914018|FG000|Overall Study|Withdrawal by Subject|0|||
129986830|NCT01813929|467914019|FG001|Overall Study|Withdrawal by Subject|1|||
129986831|NCT00007345|467914020|FG000|Overall Study|Refused further treatment|0|||
129986832|NCT00007345|467914021|FG001|Overall Study|Refused further treatment|7|||
130323757|NCT02435992|469155571|FG000|Overall Study|Lack of Efficacy|4|||
130323758|NCT02435992|469155572|FG001|Overall Study|Lack of Efficacy|10|||
130323759|NCT02435992|469155573|FG002|Overall Study|Lack of Efficacy|9|||
130323760|NCT02435992|469155574|FG003|Overall Study|Lack of Efficacy|0|||
130323761|NCT02435992|469155575|FG004|Overall Study|Lack of Efficacy|0|||
130323762|NCT02435992|469155571|FG000|Overall Study|Withdrawal by Subject|10|||
130323763|NCT02435992|469155572|FG001|Overall Study|Withdrawal by Subject|8|||
130323764|NCT02435992|469155573|FG002|Overall Study|Withdrawal by Subject|20|||
130323765|NCT02435992|469155574|FG003|Overall Study|Withdrawal by Subject|0|||
130323766|NCT02435992|469155575|FG004|Overall Study|Withdrawal by Subject|0|||
130323767|NCT02435992|469155571|FG000|Overall Study|Other Reason|1|||
130323768|NCT02435992|469155572|FG001|Overall Study|Other Reason|0|||
130323769|NCT02435992|469155573|FG002|Overall Study|Other Reason|0|||
130323770|NCT02435992|469155574|FG003|Overall Study|Other Reason|0|||
130323771|NCT02435992|469155575|FG004|Overall Study|Other Reason|0|||
130323772|NCT02435992|469155571|FG000|Overall Study|Physician Decision|0|||
130323773|NCT02435992|469155572|FG001|Overall Study|Physician Decision|0|||
130323774|NCT02435992|469155573|FG002|Overall Study|Physician Decision|1|||
130323775|NCT02435992|469155574|FG003|Overall Study|Physician Decision|0|||
130323776|NCT02435992|469155575|FG004|Overall Study|Physician Decision|0|||
130323777|NCT00260533|469155576|FG000|Overall Study|Other|3|||
130323778|NCT00260533|469155577|FG001|Overall Study|Other|3|||
130323779|NCT01761877|469155578|FG000|Overall Study|Adverse Event|7|||
130323780|NCT01761877|469155579|FG001|Overall Study|Adverse Event|0|||
130323781|NCT01761877|469155578|FG000|Overall Study|Withdrawal by Subject|6|||
130323782|NCT01761877|469155579|FG001|Overall Study|Withdrawal by Subject|4|||
130323783|NCT01761877|469155578|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
130323784|NCT01761877|469155579|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
130323785|NCT01761877|469155578|FG000|Overall Study|Death|0|||
130323786|NCT01761877|469155579|FG001|Overall Study|Death|1|||
130323787|NCT01761877|469155578|FG000|Overall Study|MRI intolerant|1|||
130323788|NCT01761877|469155579|FG001|Overall Study|MRI intolerant|6|||
130323789|NCT01310777|469155581|FG000|Overall Study|Adverse Event|23|||
130323790|NCT01310777|469155582|FG001|Overall Study|Adverse Event|1|||
130323791|NCT01310777|469155583|FG002|Overall Study|Adverse Event|15|||
130323792|NCT01310777|469155581|FG000|Overall Study|Lost to Follow-up|0|||
129883386|NCT01734434|467532411|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
129883387|NCT01734434|467532412|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
129883388|NCT01734434|467532409|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
129883389|NCT01734434|467532410|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
129883390|NCT01734434|467532411|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
129883391|NCT01734434|467532412|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
129883392|NCT01567865|467532417|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
129883393|NCT01567865|467532418|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
129986833|NCT00007345|467914020|FG000|Overall Study|Switched to alternative treatment|0|||
130323793|NCT01310777|469155582|FG001|Overall Study|Lost to Follow-up|4|||
130323794|NCT01310777|469155583|FG002|Overall Study|Lost to Follow-up|1|||
130323795|NCT01310777|469155581|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
130323796|NCT01310777|469155582|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
130323797|NCT01310777|469155583|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
130323798|NCT01310777|469155581|FG000|Overall Study|Inadequate Control of IOP|5|||
130323799|NCT01310777|469155582|FG001|Overall Study|Inadequate Control of IOP|7|||
130323800|NCT01310777|469155583|FG002|Overall Study|Inadequate Control of IOP|10|||
130323801|NCT01310777|469155581|FG000|Overall Study|Other|4|||
130323802|NCT01310777|469155582|FG001|Overall Study|Other|1|||
130323803|NCT01310777|469155583|FG002|Overall Study|Other|2|||
130323804|NCT02461758|469155585|FG000|Overall Study|Lost to Follow-up|0|||
130323805|NCT02461758|469155586|FG001|Overall Study|Lost to Follow-up|1|||
130323806|NCT02461758|469155587|FG002|Overall Study|Lost to Follow-up|1|||
130323807|NCT02461758|469155588|FG003|Overall Study|Lost to Follow-up|0|||
130323808|NCT01210313|469155594|FG000|Overall Study|Withdrawal by Subject|3|||
130323809|NCT01210313|469155594|FG000|Overall Study|Adverse Event|2|||
130323810|NCT01210313|469155594|FG000|Overall Study|Distant recurrence|4|||
129986834|NCT00007345|467914021|FG001|Overall Study|Switched to alternative treatment|3|||
129986835|NCT00007345|467914020|FG000|Overall Study|Intercurrent illness|1|||
129986836|NCT00007345|467914021|FG001|Overall Study|Intercurrent illness|0|||
129986837|NCT00007345|467914020|FG000|Overall Study|Death on study|1|||
129986838|NCT00007345|467914021|FG001|Overall Study|Death on study|1|||
129986839|NCT04433585|467914022|FG000|Overall Study|Withdrawal by Subject|15|||
129986840|NCT04433585|467914023|FG001|Overall Study|Withdrawal by Subject|3|||
129986841|NCT04433585|467914024|FG002|Overall Study|Withdrawal by Subject|15|||
129986842|NCT04433585|467914025|FG003|Overall Study|Withdrawal by Subject|6|||
129986843|NCT04433585|467914022|FG000|Overall Study|Adverse Event|10|||
129986844|NCT04433585|467914023|FG001|Overall Study|Adverse Event|4|||
129986845|NCT04433585|467914024|FG002|Overall Study|Adverse Event|1|||
129986846|NCT04433585|467914025|FG003|Overall Study|Adverse Event|0|||
129986847|NCT04433585|467914022|FG000|Overall Study|Due to the conflict in Ukraine|2|||
129986848|NCT04433585|467914023|FG001|Overall Study|Due to the conflict in Ukraine|1|||
129986849|NCT04433585|467914024|FG002|Overall Study|Due to the conflict in Ukraine|1|||
129986850|NCT04433585|467914025|FG003|Overall Study|Due to the conflict in Ukraine|2|||
129986851|NCT04433585|467914022|FG000|Overall Study|Physician Decision|1|||
129986852|NCT04433585|467914023|FG001|Overall Study|Physician Decision|2|||
129986853|NCT04433585|467914024|FG002|Overall Study|Physician Decision|0|||
129986854|NCT04433585|467914025|FG003|Overall Study|Physician Decision|0|||
129986855|NCT04433585|467914022|FG000|Overall Study|Lost to Follow-up|1|||
129986856|NCT04433585|467914023|FG001|Overall Study|Lost to Follow-up|1|||
129986857|NCT04433585|467914024|FG002|Overall Study|Lost to Follow-up|1|||
129986858|NCT04433585|467914025|FG003|Overall Study|Lost to Follow-up|0|||
129986859|NCT04433585|467914022|FG000|Overall Study|Lack of Efficacy|0|||
129986860|NCT04433585|467914023|FG001|Overall Study|Lack of Efficacy|1|||
129986861|NCT04433585|467914024|FG002|Overall Study|Lack of Efficacy|1|||
129986862|NCT04433585|467914025|FG003|Overall Study|Lack of Efficacy|1|||
129986863|NCT04433585|467914022|FG000|Overall Study|Death|0|||
129986864|NCT04433585|467914023|FG001|Overall Study|Death|1|||
129986865|NCT04433585|467914024|FG002|Overall Study|Death|0|||
129986866|NCT04433585|467914025|FG003|Overall Study|Death|0|||
129986867|NCT02074553|467914026|FG000|Intervention Period 1|Family Emergency|0|||
129986868|NCT02074553|467914027|FG001|Intervention Period 1|Family Emergency|0|||
129986869|NCT02074553|467914028|FG002|Intervention Period 1|Family Emergency|0|||
129986870|NCT02074553|467914029|FG003|Intervention Period 1|Family Emergency|1|||
129986871|NCT02074553|467914030|FG004|Intervention Period 1|Family Emergency|0|||
129986872|NCT02074553|467914031|FG005|Intervention Period 1|Family Emergency|0|||
129986873|NCT02074553|467914032|FG006|Intervention Period 1|Family Emergency|0|||
129986874|NCT02074553|467914033|FG007|Intervention Period 1|Family Emergency|0|||
129986875|NCT02074553|467914026|FG000|Washout Period 1|Adverse Event|1|||
129986876|NCT02074553|467914027|FG001|Washout Period 1|Adverse Event|0|||
129986877|NCT02074553|467914028|FG002|Washout Period 1|Adverse Event|0|||
129986878|NCT02074553|467914029|FG003|Washout Period 1|Adverse Event|0|||
129986879|NCT02074553|467914030|FG004|Washout Period 1|Adverse Event|0|||
129986880|NCT02074553|467914031|FG005|Washout Period 1|Adverse Event|0|||
129986881|NCT02074553|467914032|FG006|Washout Period 1|Adverse Event|0|||
129986882|NCT02074553|467914033|FG007|Washout Period 1|Adverse Event|0|||
129986883|NCT02074553|467914026|FG000|Washout Period 1|Physician Decision|0|||
129986884|NCT02074553|467914027|FG001|Washout Period 1|Physician Decision|0|||
129986885|NCT02074553|467914028|FG002|Washout Period 1|Physician Decision|0|||
129986886|NCT02074553|467914029|FG003|Washout Period 1|Physician Decision|1|||
129986887|NCT02074553|467914030|FG004|Washout Period 1|Physician Decision|0|||
129986888|NCT02074553|467914031|FG005|Washout Period 1|Physician Decision|0|||
129986889|NCT02074553|467914032|FG006|Washout Period 1|Physician Decision|0|||
129986890|NCT02074553|467914033|FG007|Washout Period 1|Physician Decision|0|||
129986891|NCT02074553|467914026|FG000|Washout Period 1|Other|0|||
129986892|NCT02074553|467914027|FG001|Washout Period 1|Other|0|||
129986893|NCT02074553|467914028|FG002|Washout Period 1|Other|0|||
129986894|NCT02074553|467914029|FG003|Washout Period 1|Other|0|||
130214690|NCT02757352|468751605|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214691|NCT02757352|468751606|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214692|NCT02757352|468751607|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214693|NCT02757352|468751608|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214694|NCT02757352|468751609|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
130214695|NCT02757352|468751600|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
130214696|NCT02757352|468751601|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
130214697|NCT02757352|468751602|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
130214698|NCT02757352|468751603|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129986895|NCT02074553|467914030|FG004|Washout Period 1|Other|0|||
129986896|NCT02074553|467914031|FG005|Washout Period 1|Other|1|||
129986897|NCT02074553|467914032|FG006|Washout Period 1|Other|0|||
129986898|NCT02074553|467914033|FG007|Washout Period 1|Other|0|||
129986899|NCT02074553|467914026|FG000|Washout Period 2|Adverse Event|0|||
129986900|NCT02074553|467914027|FG001|Washout Period 2|Adverse Event|0|||
129986901|NCT02074553|467914028|FG002|Washout Period 2|Adverse Event|0|||
130323811|NCT01210313|469155594|FG000|Overall Study|Non-compliance|7|||
130323812|NCT01710345|469155603|FG000|Overall Study|Adverse Event|0|||
130323813|NCT01710345|469155604|FG001|Overall Study|Adverse Event|2|||
130323814|NCT01710345|469155605|FG002|Overall Study|Adverse Event|0|||
130323815|NCT01710345|469155603|FG000|Overall Study|Lack of Efficacy|2|||
130323816|NCT01710345|469155604|FG001|Overall Study|Lack of Efficacy|3|||
130323817|NCT01710345|469155605|FG002|Overall Study|Lack of Efficacy|1|||
130323818|NCT01710345|469155603|FG000|Overall Study|Drug Dosing Error|1|||
130323819|NCT01710345|469155604|FG001|Overall Study|Drug Dosing Error|0|||
130323820|NCT01710345|469155605|FG002|Overall Study|Drug Dosing Error|0|||
130323821|NCT04298697|469155609|FG000|Overall Study|Lost to Follow-up|5|||
130323822|NCT04298697|469155610|FG001|Overall Study|Lost to Follow-up|5|||
130323823|NCT04298697|469155611|FG002|Overall Study|Lost to Follow-up|1|||
130323824|NCT04298697|469155612|FG003|Overall Study|Lost to Follow-up|0|||
130323825|NCT04298697|469155609|FG000|Overall Study|Withdrawal by Subject|0|||
130323826|NCT04298697|469155610|FG001|Overall Study|Withdrawal by Subject|3|||
130323827|NCT04298697|469155611|FG002|Overall Study|Withdrawal by Subject|2|||
130323828|NCT04298697|469155612|FG003|Overall Study|Withdrawal by Subject|3|||
130323829|NCT00449696|469155613|FG000|Overall Study|Other Treatment Required|6|||
130323830|NCT00449696|469155614|FG001|Overall Study|Other Treatment Required|1|||
130323831|NCT00449696|469155613|FG000|Overall Study|Withdrawal by Subject|5|||
130323832|NCT00449696|469155614|FG001|Overall Study|Withdrawal by Subject|5|||
130323833|NCT00449696|469155613|FG000|Overall Study|Lost to Follow-up|2|||
130323834|NCT00449696|469155614|FG001|Overall Study|Lost to Follow-up|3|||
130323835|NCT00449696|469155613|FG000|Overall Study|Others|7|||
130323836|NCT00449696|469155614|FG001|Overall Study|Others|0|||
130323837|NCT01903460|469155615|FG000|Overall Study|Adverse Event|0|||
130323838|NCT01903460|469155616|FG001|Overall Study|Adverse Event|0|||
130323839|NCT01903460|469155617|FG002|Overall Study|Adverse Event|0|||
130323840|NCT01903460|469155618|FG003|Overall Study|Adverse Event|1|||
130323841|NCT04973449|469155619|FG000|Overall Study|Withdrawal by Subject|3|||
130323842|NCT04973449|469155620|FG001|Overall Study|Withdrawal by Subject|3|||
130323843|NCT04973449|469155621|FG002|Overall Study|Withdrawal by Subject|2|||
130323844|NCT04973449|469155622|FG003|Overall Study|Withdrawal by Subject|5|||
130323845|NCT04973449|469155623|FG004|Overall Study|Withdrawal by Subject|5|||
130323846|NCT04973449|469155624|FG005|Overall Study|Withdrawal by Subject|4|||
130323847|NCT04973449|469155625|FG006|Overall Study|Withdrawal by Subject|7|||
129986902|NCT02074553|467914029|FG003|Washout Period 2|Adverse Event|0|||
129986903|NCT02074553|467914030|FG004|Washout Period 2|Adverse Event|0|||
129986904|NCT02074553|467914031|FG005|Washout Period 2|Adverse Event|0|||
129986905|NCT02074553|467914032|FG006|Washout Period 2|Adverse Event|1|||
129986906|NCT02074553|467914033|FG007|Washout Period 2|Adverse Event|0|||
129986907|NCT02074553|467914026|FG000|Washout Period 2|Physician Decision|0|||
129986908|NCT02074553|467914027|FG001|Washout Period 2|Physician Decision|0|||
129986909|NCT02074553|467914028|FG002|Washout Period 2|Physician Decision|0|||
129986910|NCT02074553|467914029|FG003|Washout Period 2|Physician Decision|0|||
129986911|NCT02074553|467914030|FG004|Washout Period 2|Physician Decision|0|||
129986912|NCT02074553|467914031|FG005|Washout Period 2|Physician Decision|1|||
129986913|NCT02074553|467914032|FG006|Washout Period 2|Physician Decision|0|||
129986914|NCT02074553|467914033|FG007|Washout Period 2|Physician Decision|0|||
129986915|NCT02074553|467914026|FG000|Washout Period 2|Lost to Follow-up|0|||
129986916|NCT02074553|467914027|FG001|Washout Period 2|Lost to Follow-up|0|||
129986917|NCT02074553|467914028|FG002|Washout Period 2|Lost to Follow-up|1|||
129986918|NCT02074553|467914029|FG003|Washout Period 2|Lost to Follow-up|0|||
129986919|NCT02074553|467914030|FG004|Washout Period 2|Lost to Follow-up|0|||
129986920|NCT02074553|467914031|FG005|Washout Period 2|Lost to Follow-up|0|||
129986921|NCT02074553|467914032|FG006|Washout Period 2|Lost to Follow-up|0|||
129986922|NCT02074553|467914033|FG007|Washout Period 2|Lost to Follow-up|0|||
129986923|NCT02074553|467914026|FG000|Washout Period 3|Physician Decision|0|||
129986924|NCT02074553|467914027|FG001|Washout Period 3|Physician Decision|0|||
129986925|NCT02074553|467914028|FG002|Washout Period 3|Physician Decision|0|||
129986926|NCT02074553|467914029|FG003|Washout Period 3|Physician Decision|0|||
129986927|NCT02074553|467914030|FG004|Washout Period 3|Physician Decision|0|||
129986928|NCT02074553|467914031|FG005|Washout Period 3|Physician Decision|0|||
129986929|NCT02074553|467914032|FG006|Washout Period 3|Physician Decision|0|||
129986930|NCT02074553|467914033|FG007|Washout Period 3|Physician Decision|1|||
129986931|NCT01658150|467914034|FG000|Overall Study|Withdrawal by Subject|1|||
129986932|NCT02342743|467914035|FG000|Baseline Period|Withdrawal by Subject|3|||
130323848|NCT04973449|469155626|FG007|Overall Study|Withdrawal by Subject|5|||
130323849|NCT04973449|469155619|FG000|Overall Study|Lost to Follow-up|15|||
130323850|NCT04973449|469155620|FG001|Overall Study|Lost to Follow-up|16|||
130323851|NCT04973449|469155621|FG002|Overall Study|Lost to Follow-up|16|||
130323852|NCT04973449|469155622|FG003|Overall Study|Lost to Follow-up|13|||
130323853|NCT04973449|469155623|FG004|Overall Study|Lost to Follow-up|5|||
130323854|NCT04973449|469155624|FG005|Overall Study|Lost to Follow-up|6|||
130323855|NCT04973449|469155625|FG006|Overall Study|Lost to Follow-up|10|||
129986933|NCT02342743|467914035|FG000|Baseline Period|Lost to Follow-up|2|||
130323856|NCT04973449|469155626|FG007|Overall Study|Lost to Follow-up|6|||
129986934|NCT02342743|467914035|FG000|Baseline Period|Change in prophylactic medication|3|||
129986935|NCT02342743|467914035|FG000|Baseline Period|Screening failure regarding baseline|7|||
129986936|NCT02342743|467914035|FG000|Treatment Period|Withdrawal by Subject|2|||
129986937|NCT02342743|467914035|FG000|Treatment Period|Lost to Follow-up|8|||
129986938|NCT02342743|467914035|FG000|Treatment Period|Change in prophylactic medication|1|||
129986939|NCT04875676|467914036|FG000|Overall Study|Lost to Follow-up|1|||
129986940|NCT04875676|467914037|FG001|Overall Study|Lost to Follow-up|0|||
129986941|NCT04875676|467914038|FG002|Overall Study|Lost to Follow-up|0|||
129986942|NCT04187989|467914039|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
129986943|NCT04187989|467914040|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
129986944|NCT04187989|467914039|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
129986945|NCT04187989|467914040|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
129986946|NCT03646656|467914041|FG000|Overall Study|Lost to Follow-up|1|||
129986947|NCT03646656|467914042|FG001|Overall Study|Lost to Follow-up|0|||
129986948|NCT03646656|467914041|FG000|Overall Study|Withdrawal by Subject|2|||
129986949|NCT03646656|467914042|FG001|Overall Study|Withdrawal by Subject|0|||
129986950|NCT03602066|467914043|FG000|Overall Study|Withdrawal by Subject|2|||
129986951|NCT03602066|467914044|FG001|Overall Study|Withdrawal by Subject|0|||
129986952|NCT03602066|467914043|FG000|Overall Study|Physician Decision|1|||
129986953|NCT03602066|467914044|FG001|Overall Study|Physician Decision|0|||
129986954|NCT00092495|467914045|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
129986955|NCT00092495|467914046|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
129986956|NCT00092495|467914047|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129986957|NCT00092495|467914048|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
129986958|NCT00092495|467914049|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129986959|NCT00092495|467914045|FG000|Base Study Vaccination Period|Extended|0|||
129986960|NCT00092495|467914046|FG001|Base Study Vaccination Period|Extended|0|||
129986961|NCT00092495|467914047|FG002|Base Study Vaccination Period|Extended|0|||
129986962|NCT00092495|467914048|FG003|Base Study Vaccination Period|Extended|1|||
129986963|NCT00092495|467914049|FG004|Base Study Vaccination Period|Extended|0|||
129986964|NCT00092495|467914045|FG000|Base Study Vaccination Period|*Clinical AE|1|||
129986965|NCT00092495|467914046|FG001|Base Study Vaccination Period|*Clinical AE|0|||
129986966|NCT00092495|467914047|FG002|Base Study Vaccination Period|*Clinical AE|1|||
129986967|NCT00092495|467914048|FG003|Base Study Vaccination Period|*Clinical AE|2|||
129986968|NCT00092495|467914049|FG004|Base Study Vaccination Period|*Clinical AE|0|||
129986969|NCT00092495|467914045|FG000|Base Study Vaccination Period|*Other reasons|1|||
129986970|NCT00092495|467914046|FG001|Base Study Vaccination Period|*Other reasons|0|||
129986971|NCT00092495|467914047|FG002|Base Study Vaccination Period|*Other reasons|0|||
129986972|NCT00092495|467914048|FG003|Base Study Vaccination Period|*Other reasons|1|||
129986973|NCT00092495|467914049|FG004|Base Study Vaccination Period|*Other reasons|0|||
129986974|NCT00092495|467914045|FG000|Base Study Vaccination Period|*Pregnancy|0|||
129986975|NCT00092495|467914046|FG001|Base Study Vaccination Period|*Pregnancy|2|||
129986976|NCT00092495|467914047|FG002|Base Study Vaccination Period|*Pregnancy|5|||
129986977|NCT00092495|467914048|FG003|Base Study Vaccination Period|*Pregnancy|7|||
129986978|NCT00092495|467914049|FG004|Base Study Vaccination Period|*Pregnancy|0|||
129986979|NCT00092495|467914045|FG000|Base Study Vaccination Period|Adverse Event|1|||
129986980|NCT00092495|467914046|FG001|Base Study Vaccination Period|Adverse Event|0|||
129986981|NCT00092495|467914047|FG002|Base Study Vaccination Period|Adverse Event|0|||
129986982|NCT00092495|467914048|FG003|Base Study Vaccination Period|Adverse Event|3|||
129986983|NCT00092495|467914049|FG004|Base Study Vaccination Period|Adverse Event|0|||
129986984|NCT00092495|467914045|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
129986985|NCT00092495|467914046|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
129986986|NCT00092495|467914047|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
129986987|NCT00092495|467914048|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
129986988|NCT00092495|467914049|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129986989|NCT00092495|467914045|FG000|Base Study Vaccination Period|Moved|3|||
129986990|NCT00092495|467914046|FG001|Base Study Vaccination Period|Moved|1|||
129986991|NCT00092495|467914047|FG002|Base Study Vaccination Period|Moved|2|||
129986992|NCT00092495|467914048|FG003|Base Study Vaccination Period|Moved|2|||
129986993|NCT00092495|467914049|FG004|Base Study Vaccination Period|Moved|0|||
129986994|NCT00092495|467914045|FG000|Base Study Vaccination Period|Other|1|||
129986995|NCT00092495|467914046|FG001|Base Study Vaccination Period|Other|1|||
129986996|NCT00092495|467914047|FG002|Base Study Vaccination Period|Other|0|||
129986997|NCT00092495|467914048|FG003|Base Study Vaccination Period|Other|2|||
129986998|NCT00092495|467914049|FG004|Base Study Vaccination Period|Other|0|||
129986999|NCT00092495|467914045|FG000|Base Study Vaccination Period|Pregnancy|2|||
129987000|NCT00092495|467914046|FG001|Base Study Vaccination Period|Pregnancy|0|||
129987001|NCT00092495|467914047|FG002|Base Study Vaccination Period|Pregnancy|0|||
129987002|NCT00092495|467914048|FG003|Base Study Vaccination Period|Pregnancy|0|||
129987003|NCT00092495|467914049|FG004|Base Study Vaccination Period|Pregnancy|0|||
129987004|NCT00092495|467914045|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
129987005|NCT00092495|467914046|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
129987006|NCT00092495|467914047|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
129987007|NCT00092495|467914048|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
129987008|NCT00092495|467914049|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
129987009|NCT00092495|467914045|FG000|Base Study Vaccination Period|Protocol Violation|1|||
129987010|NCT00092495|467914046|FG001|Base Study Vaccination Period|Protocol Violation|0|||
129987011|NCT00092495|467914047|FG002|Base Study Vaccination Period|Protocol Violation|0|||
129987012|NCT00092495|467914048|FG003|Base Study Vaccination Period|Protocol Violation|0|||
129987013|NCT00092495|467914049|FG004|Base Study Vaccination Period|Protocol Violation|0|||
129987014|NCT00092495|467914045|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
129987015|NCT00092495|467914046|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
129987016|NCT00092495|467914047|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
129987017|NCT00092495|467914048|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
129987018|NCT00092495|467914049|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129987019|NCT00092495|467914045|FG000|Base Study Follow-up Period|Extended|0|||
129987020|NCT00092495|467914046|FG001|Base Study Follow-up Period|Extended|0|||
129987021|NCT00092495|467914047|FG002|Base Study Follow-up Period|Extended|1|||
129987022|NCT00092495|467914048|FG003|Base Study Follow-up Period|Extended|2|||
129987023|NCT00092495|467914049|FG004|Base Study Follow-up Period|Extended|0|||
129987024|NCT00092495|467914045|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
129987025|NCT00092495|467914046|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
129987026|NCT00092495|467914047|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
129987027|NCT00092495|467914048|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
129987028|NCT00092495|467914049|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
129987029|NCT00092495|467914045|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
129987030|NCT00092495|467914046|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987031|NCT00092495|467914047|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987032|NCT00092495|467914048|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987033|NCT00092495|467914049|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987034|NCT00938470|467914056|FG000|Overall Study|Disease Progression|3|||
129987035|NCT00938470|467914057|FG001|Overall Study|Disease Progression|0|||
129987036|NCT00938470|467914056|FG000|Overall Study|Alternate Treatment|1|||
129987037|NCT00938470|467914057|FG001|Overall Study|Alternate Treatment|0|||
129987038|NCT00938470|467914056|FG000|Overall Study|Death|3|||
129987039|NCT00938470|467914057|FG001|Overall Study|Death|2|||
129987040|NCT00938470|467914056|FG000|Overall Study|Other Reason|0|||
129987041|NCT00938470|467914057|FG001|Overall Study|Other Reason|1|||
129987042|NCT01621568|467914059|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
129987043|NCT01621568|467914060|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
129987044|NCT01621568|467914059|FG000|Week 5-6 No Treatment|Death|1|||
129987045|NCT01621568|467914060|FG001|Week 5-6 No Treatment|Death|0|||
129987046|NCT02334423|467914061|FG000|Overall Study|Protocol Violation|10|||
129987047|NCT02334423|467914062|FG001|Overall Study|Protocol Violation|3|||
129987048|NCT02930226|467914063|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987049|NCT02930226|467914064|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987050|NCT02930226|467914065|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987051|NCT02930226|467914066|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987052|NCT02930226|467914067|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
129987053|NCT02930226|467914068|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987054|NCT00652327|467914069|FG000|Overall Study|Adverse Event|0|||
129987055|NCT00652327|467914070|FG001|Overall Study|Adverse Event|2|||
129987056|NCT00652327|467914069|FG000|Overall Study|Lost to Follow-up|0|||
129987057|NCT00652327|467914070|FG001|Overall Study|Lost to Follow-up|3|||
129987058|NCT01076647|467914071|FG000|Overall Study|Adverse Event|4|||
129987059|NCT01076647|467914072|FG001|Overall Study|Adverse Event|1|||
129987060|NCT01076647|467914071|FG000|Overall Study|Lack of Efficacy|0|||
129987061|NCT01076647|467914072|FG001|Overall Study|Lack of Efficacy|1|||
129987062|NCT01076647|467914071|FG000|Overall Study|Protocol Violation|7|||
129987063|NCT01076647|467914072|FG001|Overall Study|Protocol Violation|9|||
129987064|NCT01076647|467914071|FG000|Overall Study|Withdrawal criteria|2|||
129987065|NCT01076647|467914072|FG001|Overall Study|Withdrawal criteria|2|||
129987066|NCT01076647|467914071|FG000|Overall Study|Unclassified|12|||
129987067|NCT01076647|467914072|FG001|Overall Study|Unclassified|12|||
129987068|NCT00564889|467914078|FG000|Overall Study|Death|7|||
129987069|NCT00564889|467914078|FG000|Overall Study|Adverse Event|12|||
129987070|NCT00564889|467914078|FG000|Overall Study|Alternative treatment|3|||
129987071|NCT00564889|467914078|FG000|Overall Study|Disease progression|3|||
129987072|NCT00564889|467914078|FG000|Overall Study|Other, not specified|4|||
129987073|NCT03500159|467914079|FG000|Overall Study|Study Terminated|2|||
129987074|NCT03500159|467914080|FG001|Overall Study|Study Terminated|1|||
129987075|NCT02292927|467914085|FG000|Overall Study|Protocol Violation|13|||
129987076|NCT02292927|467914086|FG001|Overall Study|Protocol Violation|7|||
129987077|NCT00141219|467914090|FG000|Overall Study|Protocol violations|5|||
130323857|NCT04973449|469155619|FG000|Overall Study|Death|1|||
129987078|NCT00141219|467914091|FG001|Overall Study|Protocol violations|4|||
129987079|NCT00141219|467914090|FG000|Overall Study|Adverse Event|8|||
129987080|NCT00141219|467914091|FG001|Overall Study|Adverse Event|6|||
129987081|NCT00141219|467914090|FG000|Overall Study|Lack of Efficacy|5|||
129987082|NCT00141219|467914091|FG001|Overall Study|Lack of Efficacy|4|||
129987083|NCT00141219|467914090|FG000|Overall Study|Withdrawal by Subject|6|||
129987084|NCT00141219|467914091|FG001|Overall Study|Withdrawal by Subject|2|||
129987085|NCT02224690|467914092|FG000|Overall Study|Adverse Event|8|||
129987086|NCT02224690|467914093|FG001|Overall Study|Adverse Event|1|||
129987087|NCT02224690|467914092|FG000|Overall Study|Met Withdrawal Criteria|4|||
129987088|NCT02224690|467914093|FG001|Overall Study|Met Withdrawal Criteria|0|||
129987089|NCT02224690|467914092|FG000|Overall Study|Use of G-tube|1|||
129987090|NCT02224690|467914093|FG001|Overall Study|Use of G-tube|0|||
129987091|NCT02224690|467914092|FG000|Overall Study|Did not meet eligibility criteria|1|||
129987092|NCT02224690|467914093|FG001|Overall Study|Did not meet eligibility criteria|0|||
129987093|NCT00122460|467914095|FG000|Overall Study|investigational study phase ongoing|7|||
129987094|NCT00122460|467914096|FG001|Overall Study|investigational study phase ongoing|1|||
129987095|NCT02595073|467914097|FG000|Overall Study|Progressive Disease|0|||
129987096|NCT02595073|467914098|FG001|Overall Study|Progressive Disease|1|||
129987097|NCT02595073|467914097|FG000|Overall Study|Protocol Violation|2|||
129987098|NCT02595073|467914098|FG001|Overall Study|Protocol Violation|0|||
129987099|NCT02962960|467914099|FG000|Overall Study|Withdrawal by Subject|1|||
129987100|NCT02962960|467914100|FG001|Overall Study|Withdrawal by Subject|1|||
129987101|NCT02962960|467914101|FG002|Overall Study|Withdrawal by Subject|0|||
129987102|NCT02962960|467914099|FG000|Overall Study|Adverse Event|1|||
129987103|NCT02962960|467914100|FG001|Overall Study|Adverse Event|1|||
129987104|NCT02962960|467914101|FG002|Overall Study|Adverse Event|0|||
129987105|NCT02962960|467914099|FG000|Overall Study|Protocol Violation|1|||
129987106|NCT02962960|467914100|FG001|Overall Study|Protocol Violation|0|||
129987107|NCT02962960|467914101|FG002|Overall Study|Protocol Violation|0|||
129987108|NCT02424734|467914102|FG000|Overall Study|Treatment stopped to be discharged home|2|||
129987109|NCT02424734|467914103|FG001|Overall Study|Treatment stopped to be discharged home|2|||
129987110|NCT02424734|467914104|FG002|Overall Study|Treatment stopped to be discharged home|0|||
129987111|NCT00752557|467914105|FG000|Overall Study|Withdrawal by Subject|4|||
129987112|NCT00752557|467914106|FG001|Overall Study|Withdrawal by Subject|3|||
129987113|NCT00752557|467914107|FG002|Overall Study|Withdrawal by Subject|3|||
129987114|NCT00752557|467914105|FG000|Overall Study|Unspecified resaons|0|||
129987115|NCT00752557|467914106|FG001|Overall Study|Unspecified resaons|2|||
129987116|NCT00752557|467914107|FG002|Overall Study|Unspecified resaons|2|||
129987117|NCT00752557|467914105|FG000|Overall Study|Lost to Follow-up|1|||
129987118|NCT00752557|467914106|FG001|Overall Study|Lost to Follow-up|0|||
129987119|NCT00752557|467914107|FG002|Overall Study|Lost to Follow-up|1|||
129987120|NCT00470366|467914108|FG000|Overall Study|Adverse Event|3|||
129987121|NCT00470366|467914108|FG000|Overall Study|Poor compliance|1|||
129987122|NCT02996474|467914109|FG000|Overall Study|Physician Decision|5|||
129987123|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
129987124|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
129987125|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
129987126|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
129987127|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
129987128|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
129987129|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
129987130|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
129987131|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
129987132|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
129987133|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
129987134|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
129987135|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
129987136|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
129987137|NCT04493502|467914110|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
129987138|NCT04493502|467914111|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
129987139|NCT04493502|467914110|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
129987140|NCT04493502|467914111|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
129987141|NCT04493502|467914110|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
129987142|NCT04493502|467914111|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
129987143|NCT04493502|467914110|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
129987144|NCT04493502|467914111|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
129987145|NCT04493502|467914110|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
129987146|NCT04493502|467914111|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
129987147|NCT04493502|467914110|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
129987148|NCT04493502|467914111|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
129987149|NCT00540046|467914112|FG000|Overall Study|Lost to Follow-up|33|||
129987150|NCT00540046|467914113|FG001|Overall Study|Lost to Follow-up|23|||
129987151|NCT02891837|467914114|FG000|Overall Study|Lost to Follow-up|2|||
129987152|NCT02891837|467914115|FG001|Overall Study|Lost to Follow-up|0|||
129987153|NCT02891837|467914114|FG000|Overall Study|Withdrawal by Subject|1|||
129987154|NCT02891837|467914115|FG001|Overall Study|Withdrawal by Subject|0|||
129987155|NCT01021215|467914123|FG000|Overall Study|Lost to Follow-up|3|||
129987156|NCT01021215|467914124|FG001|Overall Study|Lost to Follow-up|0|||
129987157|NCT02751320|467914125|FG000|Overall Study|Adverse Event|2|||
129987158|NCT02751320|467914125|FG000|Overall Study|Withdrawal by Subject|1|||
129987159|NCT02549196|467914126|FG000|Overall Study|Protocol Violation|0|||
129987160|NCT02549196|467914127|FG001|Overall Study|Protocol Violation|0|||
129987161|NCT02549196|467914128|FG002|Overall Study|Protocol Violation|0|||
129987162|NCT02549196|467914129|FG003|Overall Study|Protocol Violation|1|||
129987163|NCT02549196|467914126|FG000|Overall Study|Withdrawal by Subject|1|||
129987164|NCT02549196|467914127|FG001|Overall Study|Withdrawal by Subject|0|||
129987165|NCT02549196|467914128|FG002|Overall Study|Withdrawal by Subject|1|||
129987166|NCT02549196|467914129|FG003|Overall Study|Withdrawal by Subject|0|||
129987167|NCT00185965|467914132|FG000|Overall Study|Adverse Event|0|||
129987168|NCT00185965|467914133|FG001|Overall Study|Adverse Event|1|||
129987169|NCT01103362|467914134|FG000|Overall Study|study terminated|596|||
129987170|NCT02533531|467914135|FG000|Overall Study|Device did not turn on|1|||
129987171|NCT02047903|467914136|FG000|Overall Study|Adverse Event|14|||
129987172|NCT02047903|467914136|FG000|Overall Study|Serious adverse event|10|||
129987173|NCT02047903|467914136|FG000|Overall Study|Withdrawal by Subject|16|||
129987174|NCT02047903|467914136|FG000|Overall Study|Lost to Follow-up|4|||
129987175|NCT02047903|467914136|FG000|Overall Study|Reason not listed|6|||
129987176|NCT02047903|467914136|FG000|Overall Study|Not Treated|9|||
129987177|NCT01011387|467914143|FG000|Overall Study|Withdrawal by Subject|3|||
129987178|NCT01011387|467914143|FG000|Overall Study|Adverse Event|2|||
129987179|NCT01011387|467914143|FG000|Overall Study|Protocol Violation|1|||
129987180|NCT01226095|467914144|FG000|Overall Study|Poor compliance|1|||
129987181|NCT02665338|467914146|FG000|Overall Study|Withdrawal by Subject|0|||
129987182|NCT02665338|467914147|FG001|Overall Study|Withdrawal by Subject|1|||
129987183|NCT05326815|467914151|FG000|Overall Study|Withdrawal by Subject|3|||
129987184|NCT05326815|467914151|FG000|Overall Study|Did not complete required labs|6|||
129987185|NCT05326815|467914151|FG000|Overall Study|Screen fail- abnormal labs|5|||
129987186|NCT03562975|467914152|FG000|Overall Study|Death|1|||
129987187|NCT03562975|467914152|FG000|Overall Study|Lost to Follow-up|1|||
129987188|NCT03562975|467914152|FG000|Overall Study|Withdrawal by Subject|1|||
129987189|NCT02545933|467914153|FG000|Overall Study|Adverse Event|3|||
129987190|NCT02545933|467914154|FG001|Overall Study|Adverse Event|0|||
129987191|NCT02545933|467914155|FG002|Overall Study|Adverse Event|0|||
129987192|NCT02545933|467914153|FG000|Overall Study|Withdrawal by Subject|2|||
129987193|NCT02545933|467914154|FG001|Overall Study|Withdrawal by Subject|3|||
129987194|NCT02545933|467914155|FG002|Overall Study|Withdrawal by Subject|3|||
129987195|NCT02545933|467914153|FG000|Overall Study|Protocol Violation|1|||
129987196|NCT02545933|467914154|FG001|Overall Study|Protocol Violation|0|||
129987197|NCT02545933|467914155|FG002|Overall Study|Protocol Violation|1|||
129987198|NCT00935818|467914158|FG000|Overall Study|Withdrawal by Subject|45|||
129987199|NCT00935818|467914159|FG001|Overall Study|Withdrawal by Subject|50|||
129987200|NCT00935818|467914158|FG000|Overall Study|Lost to Follow-up|40|||
129987201|NCT00935818|467914159|FG001|Overall Study|Lost to Follow-up|42|||
129987202|NCT00935818|467914158|FG000|Overall Study|Adverse Event|6|||
129987203|NCT00935818|467914159|FG001|Overall Study|Adverse Event|7|||
129987204|NCT00935818|467914158|FG000|Overall Study|Physician Decision|0|||
129987205|NCT00935818|467914159|FG001|Overall Study|Physician Decision|1|||
129987206|NCT00979134|467914160|FG000|Overall Study|Disease progression|18|||
129987207|NCT00979134|467914161|FG001|Overall Study|Disease progression|2|||
129987208|NCT00979134|467914162|FG002|Overall Study|Disease progression|5|||
129987209|NCT00979134|467914160|FG000|Overall Study|Adverse Event|0|||
129987210|NCT00979134|467914161|FG001|Overall Study|Adverse Event|0|||
129987211|NCT00979134|467914162|FG002|Overall Study|Adverse Event|2|||
129987212|NCT00979134|467914160|FG000|Overall Study|Withdrawal by Subject|1|||
129987213|NCT00979134|467914161|FG001|Overall Study|Withdrawal by Subject|1|||
129987214|NCT00979134|467914162|FG002|Overall Study|Withdrawal by Subject|2|||
129987215|NCT00979134|467914160|FG000|Overall Study|Lost to Follow-up|2|||
129987216|NCT00979134|467914161|FG001|Overall Study|Lost to Follow-up|2|||
129987217|NCT00979134|467914162|FG002|Overall Study|Lost to Follow-up|0|||
129987218|NCT00979134|467914160|FG000|Overall Study|Death|4|||
129987219|NCT00979134|467914161|FG001|Overall Study|Death|0|||
129987220|NCT00979134|467914162|FG002|Overall Study|Death|26|||
129987221|NCT00979134|467914160|FG000|Overall Study|Other|8|||
129987222|NCT00979134|467914161|FG001|Overall Study|Other|1|||
129987223|NCT00979134|467914162|FG002|Overall Study|Other|5|||
129987224|NCT01076192|467916797|FG000|Overall Study|Other|197|||
129987225|NCT01034176|467916798|FG000|Overall Study|Physician Decision|2|||
129987226|NCT01034176|467916799|FG001|Overall Study|Physician Decision|0|||
129987227|NCT01034176|467916798|FG000|Overall Study|Withdrawal by Subject|0|||
129987228|NCT01034176|467916799|FG001|Overall Study|Withdrawal by Subject|1|||
129987229|NCT01034176|467916798|FG000|Overall Study|Lost to Follow-up|0|||
129987230|NCT01034176|467916799|FG001|Overall Study|Lost to Follow-up|1|||
129987231|NCT00107120|467916803|FG000|Overall Study|Adverse Event|4|||
129987232|NCT00107120|467916804|FG001|Overall Study|Adverse Event|1|||
129987233|NCT00107120|467916803|FG000|Overall Study|Lack of Efficacy|5|||
129987234|NCT00107120|467916804|FG001|Overall Study|Lack of Efficacy|5|||
129987235|NCT00107120|467916803|FG000|Overall Study|Protocol Violation|3|||
129987236|NCT00107120|467916804|FG001|Overall Study|Protocol Violation|0|||
129987237|NCT00107120|467916803|FG000|Overall Study|Withdrawal by Subject|8|||
129987238|NCT00107120|467916804|FG001|Overall Study|Withdrawal by Subject|9|||
129987239|NCT00107120|467916803|FG000|Overall Study|Lost to Follow-up|8|||
129987240|NCT00107120|467916804|FG001|Overall Study|Lost to Follow-up|6|||
129987241|NCT00107120|467916803|FG000|Overall Study|Pregnancy|0|||
129987242|NCT00107120|467916804|FG001|Overall Study|Pregnancy|1|||
129987243|NCT00107120|467916803|FG000|Overall Study|moving away from site|1|||
129987244|NCT00107120|467916804|FG001|Overall Study|moving away from site|1|||
129987245|NCT00107120|467916803|FG000|Overall Study|death of parent|0|||
129987246|NCT00107120|467916804|FG001|Overall Study|death of parent|1|||
129987247|NCT01635920|467916805|FG000|Overall Study|Adverse Event|1|||
129987248|NCT01635920|467916806|FG001|Overall Study|Adverse Event|0|||
129987249|NCT01635920|467916805|FG000|Overall Study|Lost to Follow-up|0|||
129987250|NCT01635920|467916806|FG001|Overall Study|Lost to Follow-up|1|||
129987251|NCT01635920|467916805|FG000|Overall Study|Subject decision|2|||
129987252|NCT01635920|467916806|FG001|Overall Study|Subject decision|0|||
129987253|NCT00194987|467916807|FG000|Overall Study|Withdrawal by Subject|0|||
129987254|NCT00194987|467916808|FG001|Overall Study|Withdrawal by Subject|3|||
129987255|NCT01664598|467916809|FG000|Overall Study|Sponsor Decision|1|||
129987256|NCT01664598|467916809|FG000|Overall Study|Withdrawal of Informed Consent|4|||
129987257|NCT01664598|467916809|FG000|Overall Study|Adverse Event|1|||
129987258|NCT00686725|467916810|FG000|Overall Study|Adverse Event|1|||
129987259|NCT00686725|467916811|FG001|Overall Study|Adverse Event|1|||
129987260|NCT00686725|467916810|FG000|Overall Study|Progressive Disease|17|||
129987261|NCT00686725|467916811|FG001|Overall Study|Progressive Disease|23|||
129987262|NCT00686725|467916810|FG000|Overall Study|Lost to Follow-up|7|||
129987263|NCT00686725|467916811|FG001|Overall Study|Lost to Follow-up|5|||
129987264|NCT00686725|467916810|FG000|Overall Study|Death|6|||
129987265|NCT00686725|467916811|FG001|Overall Study|Death|3|||
129987266|NCT00686725|467916810|FG000|Overall Study|Withdrawal by Subject|13|||
129987267|NCT00686725|467916811|FG001|Overall Study|Withdrawal by Subject|4|||
129987268|NCT00686725|467916810|FG000|Overall Study|Protocol Violation|1|||
129987269|NCT00686725|467916811|FG001|Overall Study|Protocol Violation|3|||
129987270|NCT00686725|467916810|FG000|Overall Study|Other|1|||
129987271|NCT00686725|467916811|FG001|Overall Study|Other|3|||
129987272|NCT02630693|467916815|FG000|Overall Study|No receive treatment|0|||
129987273|NCT02630693|467916816|FG001|Overall Study|No receive treatment|1|||
129987274|NCT01639560|467916817|FG000|Overall Study|Withdrawal by Subject|9|||
129987275|NCT01639560|467916818|FG001|Overall Study|Withdrawal by Subject|14|||
129987276|NCT01639560|467916817|FG000|Overall Study|Lack of Efficacy|1|||
129987277|NCT01639560|467916818|FG001|Overall Study|Lack of Efficacy|2|||
129987278|NCT01639560|467916817|FG000|Overall Study|Lost to Follow-up|9|||
129987279|NCT01639560|467916818|FG001|Overall Study|Lost to Follow-up|11|||
129987280|NCT01639560|467916817|FG000|Overall Study|Adverse Event|0|||
129987281|NCT01639560|467916818|FG001|Overall Study|Adverse Event|2|||
129987282|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
129987283|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987284|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987285|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987286|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987287|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987288|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
129987289|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987290|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987291|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987292|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987293|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987294|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
129987295|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987296|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987297|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987298|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987299|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987300|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
129987301|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987302|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987303|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987304|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
130323858|NCT04973449|469155620|FG001|Overall Study|Death|0|||
129987305|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987306|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
129987307|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987308|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987309|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987310|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987311|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987312|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
129987313|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987314|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987315|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987316|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987317|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987318|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
129987319|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987320|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987321|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987322|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987323|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987324|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
129987325|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987326|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987327|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987328|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987329|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987330|NCT01160289|467916819|FG000|Post-Randomization Period|Adverse Event|0|||
129987331|NCT01160289|467916820|FG001|Post-Randomization Period|Adverse Event|4|||
129987332|NCT01160289|467916821|FG002|Post-Randomization Period|Adverse Event|4|||
129987333|NCT01160289|467916822|FG003|Post-Randomization Period|Adverse Event|2|||
129987334|NCT01160289|467916823|FG004|Post-Randomization Period|Adverse Event|0|||
129987335|NCT01160289|467916824|FG005|Post-Randomization Period|Adverse Event|0|||
129987336|NCT01160289|467916819|FG000|Post-Randomization Period|Death|0|||
129987337|NCT01160289|467916820|FG001|Post-Randomization Period|Death|0|||
129987338|NCT01160289|467916821|FG002|Post-Randomization Period|Death|0|||
129987339|NCT01160289|467916822|FG003|Post-Randomization Period|Death|1|||
129987340|NCT01160289|467916823|FG004|Post-Randomization Period|Death|0|||
129987341|NCT01160289|467916824|FG005|Post-Randomization Period|Death|0|||
129987342|NCT01160289|467916819|FG000|Post-Randomization Period|Lack of Efficacy|0|||
129987343|NCT01160289|467916820|FG001|Post-Randomization Period|Lack of Efficacy|1|||
129987344|NCT01160289|467916821|FG002|Post-Randomization Period|Lack of Efficacy|0|||
129987345|NCT01160289|467916822|FG003|Post-Randomization Period|Lack of Efficacy|3|||
129987346|NCT01160289|467916823|FG004|Post-Randomization Period|Lack of Efficacy|0|||
129987347|NCT01160289|467916824|FG005|Post-Randomization Period|Lack of Efficacy|0|||
129987348|NCT01160289|467916819|FG000|Post-Randomization Period|Lost to Follow-up|0|||
129987349|NCT01160289|467916820|FG001|Post-Randomization Period|Lost to Follow-up|3|||
129987350|NCT01160289|467916821|FG002|Post-Randomization Period|Lost to Follow-up|2|||
129987351|NCT01160289|467916822|FG003|Post-Randomization Period|Lost to Follow-up|5|||
129987352|NCT01160289|467916823|FG004|Post-Randomization Period|Lost to Follow-up|3|||
129987353|NCT01160289|467916824|FG005|Post-Randomization Period|Lost to Follow-up|4|||
129987354|NCT01160289|467916819|FG000|Post-Randomization Period|Physician Decision|0|||
129987355|NCT01160289|467916820|FG001|Post-Randomization Period|Physician Decision|0|||
129987356|NCT01160289|467916821|FG002|Post-Randomization Period|Physician Decision|1|||
129987357|NCT01160289|467916822|FG003|Post-Randomization Period|Physician Decision|0|||
129987358|NCT01160289|467916823|FG004|Post-Randomization Period|Physician Decision|0|||
129987359|NCT01160289|467916824|FG005|Post-Randomization Period|Physician Decision|0|||
129987360|NCT01160289|467916819|FG000|Post-Randomization Period|Protocol Violation|0|||
129987361|NCT01160289|467916820|FG001|Post-Randomization Period|Protocol Violation|4|||
129987362|NCT01160289|467916821|FG002|Post-Randomization Period|Protocol Violation|2|||
129987363|NCT01160289|467916822|FG003|Post-Randomization Period|Protocol Violation|0|||
129987364|NCT01160289|467916823|FG004|Post-Randomization Period|Protocol Violation|1|||
129987365|NCT01160289|467916824|FG005|Post-Randomization Period|Protocol Violation|3|||
129987366|NCT01160289|467916819|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
129987367|NCT01160289|467916820|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
129987368|NCT01160289|467916821|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
129987369|NCT01160289|467916822|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
129987370|NCT01160289|467916823|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
129987371|NCT01160289|467916824|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
129987372|NCT01160289|467916819|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
130323859|NCT04973449|469155621|FG002|Overall Study|Death|0|||
130323860|NCT04973449|469155622|FG003|Overall Study|Death|0|||
130323861|NCT04973449|469155623|FG004|Overall Study|Death|0|||
130323862|NCT04973449|469155624|FG005|Overall Study|Death|1|||
130323863|NCT04973449|469155625|FG006|Overall Study|Death|0|||
130323864|NCT04973449|469155626|FG007|Overall Study|Death|0|||
130323865|NCT04973449|469155619|FG000|Overall Study|Other|1|||
129987373|NCT01160289|467916820|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
129987374|NCT01160289|467916821|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
129987375|NCT01160289|467916822|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
129987376|NCT01160289|467916823|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
129987377|NCT01160289|467916824|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
129987378|NCT01160289|467916819|FG000|Post-Randomization Period|Sponsor Decision|0|||
129987379|NCT01160289|467916820|FG001|Post-Randomization Period|Sponsor Decision|1|||
129987380|NCT01160289|467916821|FG002|Post-Randomization Period|Sponsor Decision|0|||
129987381|NCT01160289|467916822|FG003|Post-Randomization Period|Sponsor Decision|0|||
129987382|NCT01160289|467916823|FG004|Post-Randomization Period|Sponsor Decision|0|||
129987383|NCT01160289|467916824|FG005|Post-Randomization Period|Sponsor Decision|0|||
129987384|NCT01156792|467916826|FG000|Overall Study|Adverse Event|1|||
129987385|NCT01156792|467916826|FG000|Overall Study|Lack of Efficacy|36|||
129987386|NCT01156792|467916826|FG000|Overall Study|Protocol Violation|6|||
129987387|NCT01156792|467916826|FG000|Overall Study|Lost to Follow-up|3|||
129987388|NCT01156792|467916826|FG000|Overall Study|Physician Decision|3|||
129987389|NCT01156792|467916826|FG000|Overall Study|Withdrawal by Subject|9|||
129987390|NCT01156792|467916826|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
129987391|NCT01474434|467916827|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
129987392|NCT01474434|467916828|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
129987393|NCT01474434|467916829|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
129987394|NCT01474434|467916830|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
129987395|NCT01474434|467916827|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
129987396|NCT01474434|467916828|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
129987397|NCT01474434|467916829|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
129987398|NCT01474434|467916830|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
129987399|NCT01474434|467916827|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
129987400|NCT01474434|467916828|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
129987401|NCT01474434|467916829|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
129987402|NCT01474434|467916830|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
129987403|NCT00993668|467916831|FG000|Single-Blind Period|Adverse Event|1|||
129987404|NCT00993668|467916832|FG001|Single-Blind Period|Adverse Event|1|||
129987405|NCT00993668|467916831|FG000|Single-Blind Period|Lack of Efficacy|0|||
129987406|NCT00993668|467916832|FG001|Single-Blind Period|Lack of Efficacy|1|||
129987407|NCT00993668|467916831|FG000|Single-Blind Period|Lost to Follow-up|3|||
129987408|NCT00993668|467916832|FG001|Single-Blind Period|Lost to Follow-up|1|||
129987409|NCT00993668|467916831|FG000|Open-Label Period|Adverse Event|9|||
129987410|NCT00993668|467916832|FG001|Open-Label Period|Adverse Event|8|||
129987411|NCT00993668|467916831|FG000|Open-Label Period|Lack of Efficacy|4|||
129987412|NCT00993668|467916832|FG001|Open-Label Period|Lack of Efficacy|3|||
129987413|NCT00993668|467916831|FG000|Open-Label Period|Withdrawal by Subject|4|||
129987414|NCT00993668|467916832|FG001|Open-Label Period|Withdrawal by Subject|3|||
129987415|NCT00993668|467916831|FG000|Open-Label Period|Lost to Follow-up|6|||
129987416|NCT00993668|467916832|FG001|Open-Label Period|Lost to Follow-up|1|||
129987417|NCT03606668|467916835|FG000|Overall Study|Screen Failure|1|||
129987418|NCT03606668|467916835|FG000|Overall Study|Lost to Follow-up|1|||
129987419|NCT02057523|467916839|FG000|Overall Study|Withdrawal by Subject|1|||
129987420|NCT02057523|467916839|FG000|Overall Study|Lack of Efficacy|1|||
129987421|NCT02399254|467916843|FG000|Overall Study|Physician Decision|2|||
129987422|NCT01656733|467916844|FG000|Overall Study|No permission to collect birth outcomes|0|||
129987423|NCT01656733|467916845|FG001|Overall Study|No permission to collect birth outcomes|1|||
129987424|NCT01656733|467916844|FG000|Overall Study|Delivery at another hospital|0|||
129987425|NCT01656733|467916845|FG001|Overall Study|Delivery at another hospital|2|||
129987426|NCT01656733|467916844|FG000|Overall Study|Spontaneous abortion|0|||
129987427|NCT01656733|467916845|FG001|Overall Study|Spontaneous abortion|1|||
129987428|NCT00682890|467916849|FG000|Overall Study|Lost to Follow-up|1|||
129987429|NCT00682890|467916850|FG001|Overall Study|Lost to Follow-up|1|||
129987430|NCT00682890|467916849|FG000|Overall Study|subject moved away|0|||
129987431|NCT00682890|467916850|FG001|Overall Study|subject moved away|1|||
129987432|NCT00682890|467916849|FG000|Overall Study|heavy menstrual bleeding|1|||
129987433|NCT00682890|467916850|FG001|Overall Study|heavy menstrual bleeding|0|||
129987434|NCT03545503|467916851|FG000|Overall Study|Protocol Violation|14|||
129987435|NCT03545503|467916852|FG001|Overall Study|Protocol Violation|16|||
129987436|NCT01506609|467916855|FG000|Overall Study|Adverse Event Related to Progression|0|||
129987437|NCT01506609|467916856|FG001|Overall Study|Adverse Event Related to Progression|0|||
130323866|NCT04973449|469155620|FG001|Overall Study|Other|1|||
130323867|NCT04973449|469155621|FG002|Overall Study|Other|2|||
129987438|NCT01506609|467916857|FG002|Overall Study|Adverse Event Related to Progression|0|||
129987439|NCT01506609|467916858|FG003|Overall Study|Adverse Event Related to Progression|3|||
129987440|NCT01506609|467916859|FG004|Overall Study|Adverse Event Related to Progression|7|||
129987441|NCT01506609|467916860|FG005|Overall Study|Adverse Event Related to Progression|3|||
129987442|NCT01506609|467916855|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
130323868|NCT04973449|469155622|FG003|Overall Study|Other|1|||
130323869|NCT04973449|469155623|FG004|Overall Study|Other|4|||
130323870|NCT04973449|469155624|FG005|Overall Study|Other|0|||
130323871|NCT04973449|469155625|FG006|Overall Study|Other|2|||
130323872|NCT04973449|469155626|FG007|Overall Study|Other|2|||
130323873|NCT00521079|469155627|FG000|Overall Study|Adverse Event|7|||
130323874|NCT00521079|469155628|FG001|Overall Study|Adverse Event|1|||
130323875|NCT00521079|469155627|FG000|Overall Study|Lost to Follow-up|2|||
130323876|NCT00521079|469155628|FG001|Overall Study|Lost to Follow-up|1|||
130323877|NCT00521079|469155627|FG000|Overall Study|Withdrawal by Subject|5|||
130323878|NCT00521079|469155628|FG001|Overall Study|Withdrawal by Subject|3|||
130323879|NCT01506596|469155630|FG000|Overall Study|ineligible pathology|1|||
130323880|NCT00888173|469155631|FG000|Overall Study|Wrong Primary|1|||
130323881|NCT00888173|469155631|FG000|Overall Study|Ineligible: required test not done|1|||
130323882|NCT00651742|469155645|FG000|Overall Study|Objective Disease Progression|22|||
130323883|NCT00651742|469155645|FG000|Overall Study|Toxicity|3|||
130323884|NCT00651742|469155645|FG000|Overall Study|Investigator Judgment|1|||
130323885|NCT00651742|469155645|FG000|Overall Study|Withdrawal of Consent|1|||
130323886|NCT00651742|469155645|FG000|Overall Study|Enrolled but not treated|1|||
130323887|NCT04050553|469155646|FG000|Period 1|Physician Decision|2|||
130323888|NCT04050553|469155647|FG001|Period 1|Physician Decision|2|||
130323889|NCT04050553|469155646|FG000|Period 1|Adverse Event|1|||
130323890|NCT04050553|469155647|FG001|Period 1|Adverse Event|1|||
130323891|NCT04050553|469155646|FG000|Period 1|Withdrawal by Subject|0|||
130323892|NCT04050553|469155647|FG001|Period 1|Withdrawal by Subject|1|||
130323893|NCT04050553|469155646|FG000|Wash-out|Adverse Event|0|||
130323894|NCT04050553|469155647|FG001|Wash-out|Adverse Event|1|||
130323895|NCT04050553|469155646|FG000|Wash-out|Withdrawal by Subject|0|||
130323896|NCT04050553|469155647|FG001|Wash-out|Withdrawal by Subject|1|||
130323897|NCT02638220|469155648|FG000|Overall Study|Lost to Follow-up|6|||
130323898|NCT02638220|469155648|FG000|Overall Study|Withdrawal by Subject|3|||
130323899|NCT02638220|469155648|FG000|Overall Study|Physician Decision|1|||
130323900|NCT02638220|469155648|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
130323901|NCT04323124|469155653|FG000|Overall Study|Adverse Event|0|||
130323902|NCT04323124|469155654|FG001|Overall Study|Adverse Event|0|||
130323903|NCT04323124|469155655|FG002|Overall Study|Adverse Event|0|||
130323904|NCT04323124|469155656|FG003|Overall Study|Adverse Event|0|||
130323905|NCT04323124|469155657|FG004|Overall Study|Adverse Event|0|||
130323906|NCT04323124|469155658|FG005|Overall Study|Adverse Event|1|||
130323907|NCT04323124|469155659|FG006|Overall Study|Adverse Event|0|||
130323908|NCT04323124|469155660|FG007|Overall Study|Adverse Event|1|||
130323909|NCT04323124|469155661|FG008|Overall Study|Adverse Event|1|||
130323910|NCT04323124|469155662|FG009|Overall Study|Adverse Event|0|||
130323911|NCT04323124|469155663|FG010|Overall Study|Adverse Event|0|||
130323912|NCT04323124|469155664|FG011|Overall Study|Adverse Event|0|||
130323913|NCT04323124|469155665|FG012|Overall Study|Adverse Event|0|||
130323914|NCT04323124|469155666|FG013|Overall Study|Adverse Event|0|||
130323915|NCT04323124|469155667|FG014|Overall Study|Adverse Event|0|||
130323916|NCT04323124|469155653|FG000|Overall Study|Other|0|||
130323917|NCT04323124|469155654|FG001|Overall Study|Other|0|||
130323918|NCT04323124|469155655|FG002|Overall Study|Other|0|||
130323919|NCT04323124|469155656|FG003|Overall Study|Other|0|||
129987443|NCT01506609|467916856|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
129987444|NCT01506609|467916857|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
129987445|NCT01506609|467916858|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
130323920|NCT04323124|469155657|FG004|Overall Study|Other|1|||
130323921|NCT04323124|469155658|FG005|Overall Study|Other|0|||
130323922|NCT04323124|469155659|FG006|Overall Study|Other|0|||
130323923|NCT04323124|469155660|FG007|Overall Study|Other|0|||
130323924|NCT04323124|469155661|FG008|Overall Study|Other|1|||
130323925|NCT04323124|469155662|FG009|Overall Study|Other|0|||
130323926|NCT04323124|469155663|FG010|Overall Study|Other|0|||
129987446|NCT01506609|467916859|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
129987447|NCT01506609|467916860|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
129987448|NCT01506609|467916855|FG000|Overall Study|Withdrawal by Subject|0|||
130323927|NCT04323124|469155664|FG011|Overall Study|Other|0|||
129987449|NCT01506609|467916856|FG001|Overall Study|Withdrawal by Subject|0|||
130323928|NCT04323124|469155665|FG012|Overall Study|Other|0|||
130323929|NCT04323124|469155666|FG013|Overall Study|Other|0|||
130323930|NCT04323124|469155667|FG014|Overall Study|Other|0|||
130323931|NCT04323124|469155653|FG000|Overall Study|Coming from a red zone (COVID)|0|||
130323932|NCT04323124|469155654|FG001|Overall Study|Coming from a red zone (COVID)|0|||
130323933|NCT04323124|469155655|FG002|Overall Study|Coming from a red zone (COVID)|0|||
130323934|NCT04323124|469155656|FG003|Overall Study|Coming from a red zone (COVID)|0|||
129987450|NCT01506609|467916857|FG002|Overall Study|Withdrawal by Subject|0|||
129987451|NCT01506609|467916858|FG003|Overall Study|Withdrawal by Subject|9|||
129987452|NCT01506609|467916859|FG004|Overall Study|Withdrawal by Subject|7|||
129987453|NCT01506609|467916860|FG005|Overall Study|Withdrawal by Subject|7|||
129987454|NCT01506609|467916855|FG000|Overall Study|Lost to Follow-up|0|||
129987455|NCT01506609|467916856|FG001|Overall Study|Lost to Follow-up|0|||
129987456|NCT01506609|467916857|FG002|Overall Study|Lost to Follow-up|0|||
129987457|NCT01506609|467916858|FG003|Overall Study|Lost to Follow-up|1|||
129987458|NCT01506609|467916859|FG004|Overall Study|Lost to Follow-up|2|||
129987459|NCT01506609|467916860|FG005|Overall Study|Lost to Follow-up|0|||
129987460|NCT01506609|467916855|FG000|Overall Study|Sponsor Discontinued Study|0|||
129987461|NCT01506609|467916856|FG001|Overall Study|Sponsor Discontinued Study|0|||
129987462|NCT01506609|467916857|FG002|Overall Study|Sponsor Discontinued Study|0|||
129987463|NCT01506609|467916858|FG003|Overall Study|Sponsor Discontinued Study|2|||
129987464|NCT01506609|467916859|FG004|Overall Study|Sponsor Discontinued Study|2|||
129987465|NCT01506609|467916860|FG005|Overall Study|Sponsor Discontinued Study|0|||
129987466|NCT01506609|467916855|FG000|Overall Study|Progressive Disease per Protocol|1|||
129987467|NCT01506609|467916856|FG001|Overall Study|Progressive Disease per Protocol|0|||
129987468|NCT01506609|467916857|FG002|Overall Study|Progressive Disease per Protocol|0|||
129987469|NCT01506609|467916858|FG003|Overall Study|Progressive Disease per Protocol|64|||
129987470|NCT01506609|467916859|FG004|Overall Study|Progressive Disease per Protocol|57|||
129987471|NCT01506609|467916860|FG005|Overall Study|Progressive Disease per Protocol|74|||
129987472|NCT01506609|467916855|FG000|Overall Study|Other, Not Specified|0|||
129987473|NCT01506609|467916856|FG001|Overall Study|Other, Not Specified|0|||
129987474|NCT01506609|467916857|FG002|Overall Study|Other, Not Specified|0|||
129987475|NCT01506609|467916858|FG003|Overall Study|Other, Not Specified|10|||
129987476|NCT01506609|467916859|FG004|Overall Study|Other, Not Specified|7|||
129987477|NCT01506609|467916860|FG005|Overall Study|Other, Not Specified|3|||
129987478|NCT01506609|467916855|FG000|Overall Study|Missing / Unknown Reason|1|||
129987479|NCT01506609|467916856|FG001|Overall Study|Missing / Unknown Reason|0|||
129987480|NCT01506609|467916857|FG002|Overall Study|Missing / Unknown Reason|1|||
129987481|NCT01506609|467916858|FG003|Overall Study|Missing / Unknown Reason|4|||
129987482|NCT01506609|467916859|FG004|Overall Study|Missing / Unknown Reason|4|||
129987483|NCT01506609|467916860|FG005|Overall Study|Missing / Unknown Reason|2|||
129987484|NCT01605019|467916861|FG000|Overall Study|pt did not meet transplant endpoint|3|||
129987485|NCT01605019|467916862|FG001|Overall Study|pt did not meet transplant endpoint|0|||
129987486|NCT00862719|467916863|FG000|Overall Study|Disease Progression|5|||
129987487|NCT00862719|467916864|FG001|Overall Study|Disease Progression|0|||
129987488|NCT00862719|467916865|FG002|Overall Study|Disease Progression|1|||
129987489|NCT00862719|467916866|FG003|Overall Study|Disease Progression|0|||
129987490|NCT00862719|467916863|FG000|Overall Study|Death|5|||
129987491|NCT00862719|467916864|FG001|Overall Study|Death|6|||
129987492|NCT00862719|467916865|FG002|Overall Study|Death|1|||
129987493|NCT00862719|467916866|FG003|Overall Study|Death|1|||
129987494|NCT00862719|467916863|FG000|Overall Study|Engraftment failure|0|||
129987495|NCT00862719|467916864|FG001|Overall Study|Engraftment failure|0|||
129987496|NCT00862719|467916865|FG002|Overall Study|Engraftment failure|1|||
129987497|NCT00862719|467916866|FG003|Overall Study|Engraftment failure|0|||
129987498|NCT00862719|467916863|FG000|Overall Study|Veno-Occlusive Disease|0|||
129987499|NCT00862719|467916864|FG001|Overall Study|Veno-Occlusive Disease|0|||
129987500|NCT00862719|467916865|FG002|Overall Study|Veno-Occlusive Disease|1|||
129987501|NCT00862719|467916866|FG003|Overall Study|Veno-Occlusive Disease|0|||
129987502|NCT00324116|467916867|FG000|Overall Study|Adverse Event|5|||
129987503|NCT00324116|467916867|FG000|Overall Study|Lack of Efficacy|17|||
129987504|NCT00324116|467916867|FG000|Overall Study|Withdrawal by Subject|5|||
129987505|NCT00324116|467916867|FG000|Overall Study|Other|5|||
129987506|NCT01737827|467916868|FG000|Overall Study|Adverse Event|3|||
129987507|NCT01737827|467916869|FG001|Overall Study|Adverse Event|6|||
129987508|NCT01737827|467916870|FG002|Overall Study|Adverse Event|0|||
129987509|NCT01737827|467916868|FG000|Overall Study|Lost to Follow-up|0|||
129987510|NCT01737827|467916869|FG001|Overall Study|Lost to Follow-up|1|||
129987511|NCT01737827|467916870|FG002|Overall Study|Lost to Follow-up|0|||
129987512|NCT01737827|467916868|FG000|Overall Study|Physician Decision|0|||
129987513|NCT01737827|467916869|FG001|Overall Study|Physician Decision|2|||
129987514|NCT01737827|467916870|FG002|Overall Study|Physician Decision|0|||
129987515|NCT01737827|467916868|FG000|Overall Study|Progressive Disease|5|||
129987516|NCT01737827|467916869|FG001|Overall Study|Progressive Disease|16|||
129987517|NCT01737827|467916870|FG002|Overall Study|Progressive Disease|2|||
129987518|NCT01737827|467916868|FG000|Overall Study|Study Terminated by Sponsor|0|||
129987519|NCT01737827|467916869|FG001|Overall Study|Study Terminated by Sponsor|1|||
129987520|NCT01737827|467916870|FG002|Overall Study|Study Terminated by Sponsor|0|||
129987521|NCT01737827|467916868|FG000|Overall Study|Subject/Guardian Decision|0|||
129987522|NCT01737827|467916869|FG001|Overall Study|Subject/Guardian Decision|2|||
129987523|NCT01737827|467916870|FG002|Overall Study|Subject/Guardian Decision|0|||
129987524|NCT01451827|467916871|FG000|Overall Study|Adverse Event|2|||
129987525|NCT01451827|467916872|FG001|Overall Study|Adverse Event|0|||
129987526|NCT01451827|467916873|FG002|Overall Study|Adverse Event|1|||
129987527|NCT01451827|467916874|FG003|Overall Study|Adverse Event|1|||
129987528|NCT01451827|467916871|FG000|Overall Study|Protocol deviation|1|||
129987529|NCT01451827|467916872|FG001|Overall Study|Protocol deviation|0|||
129987530|NCT01451827|467916873|FG002|Overall Study|Protocol deviation|0|||
129987531|NCT01451827|467916874|FG003|Overall Study|Protocol deviation|0|||
129987532|NCT01451827|467916871|FG000|Overall Study|Lost to Follow-up|0|||
129987533|NCT01451827|467916872|FG001|Overall Study|Lost to Follow-up|3|||
129987534|NCT01451827|467916873|FG002|Overall Study|Lost to Follow-up|0|||
129987535|NCT01451827|467916874|FG003|Overall Study|Lost to Follow-up|2|||
129987536|NCT01451827|467916871|FG000|Overall Study|Participant met withdrawal criteria|0|||
129987537|NCT01451827|467916872|FG001|Overall Study|Participant met withdrawal criteria|2|||
129987538|NCT01451827|467916873|FG002|Overall Study|Participant met withdrawal criteria|0|||
129987539|NCT01451827|467916874|FG003|Overall Study|Participant met withdrawal criteria|0|||
129987540|NCT01451827|467916871|FG000|Overall Study|Withdrawal by Subject|0|||
129987541|NCT01451827|467916872|FG001|Overall Study|Withdrawal by Subject|0|||
129987542|NCT01451827|467916873|FG002|Overall Study|Withdrawal by Subject|1|||
129987543|NCT01451827|467916874|FG003|Overall Study|Withdrawal by Subject|1|||
129987544|NCT02971761|467916875|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
129987545|NCT00116753|467916876|FG000|Overall Study|Adverse Event|16|||
129987546|NCT00116753|467916877|FG001|Overall Study|Adverse Event|10|||
129987547|NCT00116753|467916878|FG002|Overall Study|Adverse Event|7|||
129987548|NCT00116753|467916876|FG000|Overall Study|Withdrawal by Subject|11|||
129987549|NCT00116753|467916877|FG001|Overall Study|Withdrawal by Subject|12|||
129987550|NCT00116753|467916878|FG002|Overall Study|Withdrawal by Subject|8|||
129987551|NCT00116753|467916876|FG000|Overall Study|Lost to Follow-up|0|||
129987552|NCT00116753|467916877|FG001|Overall Study|Lost to Follow-up|2|||
129987553|NCT00116753|467916878|FG002|Overall Study|Lost to Follow-up|1|||
129987554|NCT00116753|467916876|FG000|Overall Study|Protocol Violation|0|||
129987555|NCT00116753|467916877|FG001|Overall Study|Protocol Violation|0|||
129987556|NCT00116753|467916878|FG002|Overall Study|Protocol Violation|1|||
129987557|NCT00116753|467916876|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
129987558|NCT00116753|467916877|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
129987559|NCT00116753|467916878|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
129987560|NCT00116753|467916876|FG000|Overall Study|Disease Progression|3|||
129987561|NCT00116753|467916877|FG001|Overall Study|Disease Progression|4|||
129987562|NCT00116753|467916878|FG002|Overall Study|Disease Progression|3|||
129987563|NCT00116753|467916876|FG000|Overall Study|Abnormal Echocardiogram|0|||
129987564|NCT00116753|467916877|FG001|Overall Study|Abnormal Echocardiogram|0|||
129987565|NCT00116753|467916878|FG002|Overall Study|Abnormal Echocardiogram|1|||
129987566|NCT00116753|467916876|FG000|Overall Study|Progressive Parkinson's Disease|1|||
129987567|NCT00116753|467916877|FG001|Overall Study|Progressive Parkinson's Disease|0|||
129987568|NCT00116753|467916878|FG002|Overall Study|Progressive Parkinson's Disease|0|||
129987569|NCT00116753|467916876|FG000|Overall Study|Dosing Error|0|||
129987570|NCT00116753|467916877|FG001|Overall Study|Dosing Error|1|||
129987571|NCT00116753|467916878|FG002|Overall Study|Dosing Error|0|||
129987572|NCT01642251|467916879|FG000|Overall Study|Progressive disease|0|||
129987573|NCT01642251|467916880|FG001|Overall Study|Progressive disease|0|||
129987574|NCT01642251|467916881|FG002|Overall Study|Progressive disease|3|||
129987575|NCT01642251|467916882|FG003|Overall Study|Progressive disease|3|||
129987576|NCT01642251|467916879|FG000|Overall Study|Adverse Event|0|||
129987577|NCT01642251|467916880|FG001|Overall Study|Adverse Event|0|||
129987578|NCT01642251|467916881|FG002|Overall Study|Adverse Event|5|||
129987579|NCT01642251|467916882|FG003|Overall Study|Adverse Event|4|||
129987580|NCT01642251|467916879|FG000|Overall Study|Death|0|||
129987581|NCT01642251|467916880|FG001|Overall Study|Death|0|||
129987582|NCT01642251|467916881|FG002|Overall Study|Death|1|||
129987583|NCT01642251|467916882|FG003|Overall Study|Death|3|||
129987584|NCT01642251|467916879|FG000|Overall Study|Withdrawal by Subject|0|||
129987585|NCT01642251|467916880|FG001|Overall Study|Withdrawal by Subject|0|||
129987586|NCT01642251|467916881|FG002|Overall Study|Withdrawal by Subject|1|||
129987587|NCT01642251|467916882|FG003|Overall Study|Withdrawal by Subject|3|||
129987588|NCT01642251|467916879|FG000|Overall Study|Alternative therapy|0|||
129987589|NCT01642251|467916880|FG001|Overall Study|Alternative therapy|0|||
129987590|NCT01642251|467916881|FG002|Overall Study|Alternative therapy|0|||
129987591|NCT01642251|467916882|FG003|Overall Study|Alternative therapy|2|||
129987592|NCT01642251|467916879|FG000|Overall Study|Other complicating disease|0|||
129987593|NCT01642251|467916880|FG001|Overall Study|Other complicating disease|0|||
129987594|NCT01642251|467916881|FG002|Overall Study|Other complicating disease|1|||
129987595|NCT01642251|467916882|FG003|Overall Study|Other complicating disease|0|||
129987596|NCT01642251|467916879|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
129987597|NCT01642251|467916880|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
129987598|NCT01642251|467916881|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
129987599|NCT01642251|467916882|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
129987600|NCT01445301|467916883|FG000|Overall Study|Adverse Event|15|||
129987601|NCT01445301|467916884|FG001|Overall Study|Adverse Event|25|||
129987602|NCT01445301|467916885|FG002|Overall Study|Adverse Event|4|||
129987603|NCT01445301|467916883|FG000|Overall Study|Lack of Efficacy|0|||
130323935|NCT04323124|469155657|FG004|Overall Study|Coming from a red zone (COVID)|1|||
130323936|NCT04323124|469155658|FG005|Overall Study|Coming from a red zone (COVID)|1|||
130323937|NCT04323124|469155659|FG006|Overall Study|Coming from a red zone (COVID)|0|||
130323938|NCT04323124|469155660|FG007|Overall Study|Coming from a red zone (COVID)|0|||
130323939|NCT04323124|469155661|FG008|Overall Study|Coming from a red zone (COVID)|0|||
130323940|NCT04323124|469155662|FG009|Overall Study|Coming from a red zone (COVID)|0|||
130323941|NCT04323124|469155663|FG010|Overall Study|Coming from a red zone (COVID)|0|||
130323942|NCT04323124|469155664|FG011|Overall Study|Coming from a red zone (COVID)|0|||
129987604|NCT01445301|467916884|FG001|Overall Study|Lack of Efficacy|1|||
129987605|NCT01445301|467916885|FG002|Overall Study|Lack of Efficacy|0|||
129987606|NCT01445301|467916883|FG000|Overall Study|Protocol Violation|1|||
129987607|NCT01445301|467916884|FG001|Overall Study|Protocol Violation|0|||
129987608|NCT01445301|467916885|FG002|Overall Study|Protocol Violation|0|||
129987609|NCT01445301|467916883|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
129987610|NCT01445301|467916884|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
129987611|NCT01445301|467916885|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
129987612|NCT01445301|467916883|FG000|Overall Study|Physician Decision|0|||
129987613|NCT01445301|467916884|FG001|Overall Study|Physician Decision|2|||
129987614|NCT01445301|467916885|FG002|Overall Study|Physician Decision|0|||
129987615|NCT01445301|467916883|FG000|Overall Study|Withdrawal by Subject|5|||
129987616|NCT01445301|467916884|FG001|Overall Study|Withdrawal by Subject|6|||
129987617|NCT01445301|467916885|FG002|Overall Study|Withdrawal by Subject|4|||
129987618|NCT01605916|467916890|FG000|Overall Study|Adverse Event|1|||
129987619|NCT01605916|467916891|FG001|Overall Study|Adverse Event|0|||
129987620|NCT01605916|467916892|FG002|Overall Study|Adverse Event|0|||
129987621|NCT01605916|467916893|FG003|Overall Study|Adverse Event|1|||
129987622|NCT01605916|467916894|FG004|Overall Study|Adverse Event|0|||
129987623|NCT01605916|467916890|FG000|Overall Study|Lack of Efficacy|2|||
129987624|NCT01605916|467916891|FG001|Overall Study|Lack of Efficacy|3|||
129987625|NCT01605916|467916892|FG002|Overall Study|Lack of Efficacy|3|||
129987626|NCT01605916|467916893|FG003|Overall Study|Lack of Efficacy|5|||
129987627|NCT01605916|467916894|FG004|Overall Study|Lack of Efficacy|4|||
129987628|NCT01605916|467916890|FG000|Overall Study|Withdrawal by Subject|1|||
129987629|NCT01605916|467916891|FG001|Overall Study|Withdrawal by Subject|1|||
129987630|NCT01605916|467916892|FG002|Overall Study|Withdrawal by Subject|0|||
129987631|NCT01605916|467916893|FG003|Overall Study|Withdrawal by Subject|0|||
129987632|NCT01605916|467916894|FG004|Overall Study|Withdrawal by Subject|2|||
129987633|NCT00296400|467916897|FG000|Overall Study|Adverse Event|7|||
129987634|NCT00296400|467916898|FG001|Overall Study|Adverse Event|7|||
129987635|NCT00296400|467916899|FG002|Overall Study|Adverse Event|7|||
129987636|NCT00296400|467916897|FG000|Overall Study|Withdrawal by Subject|5|||
129987637|NCT00296400|467916898|FG001|Overall Study|Withdrawal by Subject|6|||
129987638|NCT00296400|467916899|FG002|Overall Study|Withdrawal by Subject|2|||
129987639|NCT00296400|467916897|FG000|Overall Study|Incorrect enrollment|2|||
129987640|NCT00296400|467916898|FG001|Overall Study|Incorrect enrollment|0|||
129987641|NCT00296400|467916899|FG002|Overall Study|Incorrect enrollment|0|||
129987642|NCT00296400|467916897|FG000|Overall Study|Protocol Violation|1|||
129987643|NCT00296400|467916898|FG001|Overall Study|Protocol Violation|1|||
129987644|NCT00296400|467916899|FG002|Overall Study|Protocol Violation|1|||
129987645|NCT00296400|467916897|FG000|Overall Study|Lost to Follow-up|1|||
129987646|NCT00296400|467916898|FG001|Overall Study|Lost to Follow-up|1|||
129987647|NCT00296400|467916899|FG002|Overall Study|Lost to Follow-up|2|||
129987648|NCT00296400|467916897|FG000|Overall Study|Study specific discontinuation criteria|0|||
129987649|NCT00296400|467916898|FG001|Overall Study|Study specific discontinuation criteria|0|||
129987650|NCT00296400|467916899|FG002|Overall Study|Study specific discontinuation criteria|1|||
129987651|NCT00296400|467916897|FG000|Overall Study|Visit 10 was performed earlier|0|||
129987652|NCT00296400|467916898|FG001|Overall Study|Visit 10 was performed earlier|1|||
129987653|NCT00296400|467916899|FG002|Overall Study|Visit 10 was performed earlier|0|||
129987654|NCT00296400|467916897|FG000|Overall Study|Pregnancy|1|||
130323943|NCT04323124|469155665|FG012|Overall Study|Coming from a red zone (COVID)|0|||
130323944|NCT04323124|469155666|FG013|Overall Study|Coming from a red zone (COVID)|0|||
130323945|NCT04323124|469155667|FG014|Overall Study|Coming from a red zone (COVID)|0|||
129987655|NCT00296400|467916898|FG001|Overall Study|Pregnancy|2|||
129987656|NCT00296400|467916899|FG002|Overall Study|Pregnancy|0|||
130323946|NCT04323124|469155653|FG000|Overall Study|No longer meets eligibility criteria|0|||
129987657|NCT01014533|467916900|FG000|Overall Study|Protocol Violation|3|||
130323947|NCT04323124|469155654|FG001|Overall Study|No longer meets eligibility criteria|0|||
129987658|NCT01014533|467916901|FG001|Overall Study|Protocol Violation|2|||
129987659|NCT01014533|467916900|FG000|Overall Study|Withdrawal by Subject|2|||
129987660|NCT01014533|467916901|FG001|Overall Study|Withdrawal by Subject|0|||
129987661|NCT01014533|467916900|FG000|Overall Study|unable to come to appointment|0|||
129987662|NCT01014533|467916901|FG001|Overall Study|unable to come to appointment|3|||
129987663|NCT00412061|467916903|FG000|Double Blind Phase|Disease Progression|101|||
129987664|NCT00412061|467916904|FG001|Double Blind Phase|Disease Progression|154|||
129987665|NCT00412061|467916903|FG000|Double Blind Phase|Adverse Event|61|||
129987666|NCT00412061|467916904|FG001|Double Blind Phase|Adverse Event|16|||
129987667|NCT00412061|467916903|FG000|Double Blind Phase|Final Primary Analysis|26|||
129987668|NCT00412061|467916904|FG001|Double Blind Phase|Final Primary Analysis|14|||
129987669|NCT00412061|467916903|FG000|Double Blind Phase|Withdrawal by Subject|18|||
129987670|NCT00412061|467916904|FG001|Double Blind Phase|Withdrawal by Subject|20|||
129987671|NCT00412061|467916903|FG000|Double Blind Phase|Death|6|||
129987672|NCT00412061|467916904|FG001|Double Blind Phase|Death|3|||
129987673|NCT00412061|467916903|FG000|Double Blind Phase|Protocol Violation|3|||
129987674|NCT00412061|467916904|FG001|Double Blind Phase|Protocol Violation|4|||
129987675|NCT00412061|467916903|FG000|Double Blind Phase|New Cander Therapy|1|||
129987676|NCT00412061|467916904|FG001|Double Blind Phase|New Cander Therapy|1|||
129987677|NCT00412061|467916903|FG000|Double Blind Phase|Lost to Follow-up|0|||
129987678|NCT00412061|467916904|FG001|Double Blind Phase|Lost to Follow-up|1|||
129987679|NCT00412061|467916903|FG000|Open Label Phase|Disease Progression|0|||
129987680|NCT00412061|467916904|FG001|Open Label Phase|Disease Progression|86|||
129987681|NCT00412061|467916903|FG000|Open Label Phase|Adverse Event|0|||
129987682|NCT00412061|467916904|FG001|Open Label Phase|Adverse Event|46|||
129987683|NCT00412061|467916903|FG000|Open Label Phase|Withdrawal by Subject|0|||
129987684|NCT00412061|467916904|FG001|Open Label Phase|Withdrawal by Subject|15|||
129987685|NCT00412061|467916903|FG000|Open Label Phase|Administrative Problems|0|||
129987686|NCT00412061|467916904|FG001|Open Label Phase|Administrative Problems|13|||
129987687|NCT00412061|467916903|FG000|Open Label Phase|Death|0|||
129987688|NCT00412061|467916904|FG001|Open Label Phase|Death|7|||
129987689|NCT00412061|467916903|FG000|Open Label Phase|Lost to Follow-up|0|||
129987690|NCT00412061|467916904|FG001|Open Label Phase|Lost to Follow-up|2|||
129987691|NCT00412061|467916903|FG000|Open Label Phase|New Cancer Therapy|0|||
129987692|NCT00412061|467916904|FG001|Open Label Phase|New Cancer Therapy|1|||
129987693|NCT01942590|467916905|FG000|Overall Study|Withdrawal by Subject|0|||
129987694|NCT01942590|467916906|FG001|Overall Study|Withdrawal by Subject|1|||
129987695|NCT01942590|467916905|FG000|Overall Study|Adverse Event|1|||
129987696|NCT01942590|467916906|FG001|Overall Study|Adverse Event|0|||
129987697|NCT02433340|467916908|FG000|Overall Study|Adverse Event|0|||
129987698|NCT02433340|467916909|FG001|Overall Study|Adverse Event|0|||
129987699|NCT02433340|467916910|FG002|Overall Study|Adverse Event|1|||
129987700|NCT02433340|467916911|FG003|Overall Study|Adverse Event|0|||
129987701|NCT02433340|467916908|FG000|Overall Study|Withdrawal by Subject|1|||
129987702|NCT02433340|467916909|FG001|Overall Study|Withdrawal by Subject|0|||
129987703|NCT02433340|467916910|FG002|Overall Study|Withdrawal by Subject|1|||
129987704|NCT02433340|467916911|FG003|Overall Study|Withdrawal by Subject|2|||
129987705|NCT02433340|467916908|FG000|Overall Study|Lost to Follow-up|0|||
129987706|NCT02433340|467916909|FG001|Overall Study|Lost to Follow-up|1|||
129987707|NCT02433340|467916910|FG002|Overall Study|Lost to Follow-up|0|||
129987708|NCT02433340|467916911|FG003|Overall Study|Lost to Follow-up|0|||
129987709|NCT02433340|467916908|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
129987710|NCT02433340|467916909|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
129987711|NCT02433340|467916910|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
129987712|NCT02433340|467916911|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
129987713|NCT02433340|467916908|FG000|Overall Study|Other|0|||
129987714|NCT02433340|467916909|FG001|Overall Study|Other|1|||
129987715|NCT02433340|467916910|FG002|Overall Study|Other|0|||
129987716|NCT02433340|467916911|FG003|Overall Study|Other|0|||
129987717|NCT01178385|467916912|FG000|Overall Study|Withdrawal by Subject|2|||
129987718|NCT01178385|467916913|FG001|Overall Study|Withdrawal by Subject|0|||
129987719|NCT01688830|467916916|FG000|Overall Study|Lost to Follow-up|0|||
129987720|NCT01688830|467916917|FG001|Overall Study|Lost to Follow-up|0|||
129987721|NCT01688830|467916918|FG002|Overall Study|Lost to Follow-up|0|||
129987722|NCT01688830|467916919|FG003|Overall Study|Lost to Follow-up|0|||
129987723|NCT01688830|467916920|FG004|Overall Study|Lost to Follow-up|0|||
129987724|NCT01688830|467916921|FG005|Overall Study|Lost to Follow-up|0|||
129987725|NCT01688830|467916922|FG006|Overall Study|Lost to Follow-up|0|||
129987726|NCT01688830|467916923|FG007|Overall Study|Lost to Follow-up|0|||
129987727|NCT01688830|467916924|FG008|Overall Study|Lost to Follow-up|0|||
129987728|NCT01688830|467916925|FG009|Overall Study|Lost to Follow-up|0|||
129987729|NCT01688830|467916926|FG010|Overall Study|Lost to Follow-up|1|||
129987730|NCT01688830|467916927|FG011|Overall Study|Lost to Follow-up|0|||
129987731|NCT01688830|467916928|FG012|Overall Study|Lost to Follow-up|0|||
129987732|NCT01688830|467916929|FG013|Overall Study|Lost to Follow-up|0|||
129987733|NCT01688830|467916930|FG014|Overall Study|Lost to Follow-up|0|||
129987734|NCT01688830|467916931|FG015|Overall Study|Lost to Follow-up|0|||
129987735|NCT01688830|467916932|FG016|Overall Study|Lost to Follow-up|0|||
129987736|NCT01688830|467916933|FG017|Overall Study|Lost to Follow-up|0|||
129987737|NCT01688830|467916934|FG018|Overall Study|Lost to Follow-up|0|||
129987738|NCT01688830|467916935|FG019|Overall Study|Lost to Follow-up|0|||
129987739|NCT01688830|467916936|FG020|Overall Study|Lost to Follow-up|0|||
129987740|NCT04822597|467916937|FG000|Overall Study|Withdrawal by Subject|0|||
129987741|NCT04822597|467916938|FG001|Overall Study|Withdrawal by Subject|1|||
129987742|NCT04822597|467916939|FG002|Overall Study|Withdrawal by Subject|1|||
129987743|NCT04822597|467916940|FG003|Overall Study|Withdrawal by Subject|0|||
129987744|NCT04822597|467916937|FG000|Overall Study|Physician Decision|0|||
130323948|NCT04323124|469155655|FG002|Overall Study|No longer meets eligibility criteria|0|||
130323949|NCT04323124|469155656|FG003|Overall Study|No longer meets eligibility criteria|0|||
130323950|NCT04323124|469155657|FG004|Overall Study|No longer meets eligibility criteria|0|||
130323951|NCT04323124|469155658|FG005|Overall Study|No longer meets eligibility criteria|0|||
130323952|NCT04323124|469155659|FG006|Overall Study|No longer meets eligibility criteria|0|||
129987745|NCT04822597|467916938|FG001|Overall Study|Physician Decision|0|||
129987746|NCT04822597|467916939|FG002|Overall Study|Physician Decision|1|||
130323953|NCT04323124|469155660|FG007|Overall Study|No longer meets eligibility criteria|1|||
130323954|NCT04323124|469155661|FG008|Overall Study|No longer meets eligibility criteria|0|||
130323955|NCT04323124|469155662|FG009|Overall Study|No longer meets eligibility criteria|0|||
130323956|NCT04323124|469155663|FG010|Overall Study|No longer meets eligibility criteria|0|||
130323957|NCT04323124|469155664|FG011|Overall Study|No longer meets eligibility criteria|0|||
130323958|NCT04323124|469155665|FG012|Overall Study|No longer meets eligibility criteria|0|||
130323959|NCT04323124|469155666|FG013|Overall Study|No longer meets eligibility criteria|1|||
130323960|NCT04323124|469155667|FG014|Overall Study|No longer meets eligibility criteria|1|||
130323961|NCT04323124|469155653|FG000|Overall Study|Study terminated by sponsor|0|||
130323962|NCT04323124|469155654|FG001|Overall Study|Study terminated by sponsor|0|||
130323963|NCT04323124|469155655|FG002|Overall Study|Study terminated by sponsor|0|||
130323964|NCT04323124|469155656|FG003|Overall Study|Study terminated by sponsor|0|||
130323965|NCT04323124|469155657|FG004|Overall Study|Study terminated by sponsor|0|||
130323966|NCT04323124|469155658|FG005|Overall Study|Study terminated by sponsor|0|||
130323967|NCT04323124|469155659|FG006|Overall Study|Study terminated by sponsor|0|||
130323968|NCT04323124|469155660|FG007|Overall Study|Study terminated by sponsor|0|||
130323969|NCT04323124|469155661|FG008|Overall Study|Study terminated by sponsor|0|||
130323970|NCT04323124|469155662|FG009|Overall Study|Study terminated by sponsor|0|||
130323971|NCT04323124|469155663|FG010|Overall Study|Study terminated by sponsor|0|||
130323972|NCT04323124|469155664|FG011|Overall Study|Study terminated by sponsor|2|||
130323973|NCT04323124|469155665|FG012|Overall Study|Study terminated by sponsor|1|||
130323974|NCT04323124|469155666|FG013|Overall Study|Study terminated by sponsor|0|||
130323975|NCT04323124|469155667|FG014|Overall Study|Study terminated by sponsor|0|||
130323976|NCT00489307|469155668|FG000|Overall Study|Death|1|||
130323977|NCT00489307|469155669|FG001|Overall Study|Death|1|||
130323978|NCT00489307|469155668|FG000|Overall Study|Lost to Follow-up|2|||
130323979|NCT00489307|469155669|FG001|Overall Study|Lost to Follow-up|2|||
130323980|NCT00489307|469155668|FG000|Overall Study|Physician Decision|1|||
130323981|NCT00489307|469155669|FG001|Overall Study|Physician Decision|0|||
130323982|NCT00489307|469155668|FG000|Overall Study|Withdrawal by Subject|2|||
130323983|NCT00489307|469155669|FG001|Overall Study|Withdrawal by Subject|4|||
130323984|NCT00489307|469155668|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
130323985|NCT00489307|469155669|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
130323986|NCT00489307|469155668|FG000|Overall Study|Surgery after assignment|1|||
130323987|NCT00489307|469155669|FG001|Overall Study|Surgery after assignment|0|||
130323988|NCT00489307|469155668|FG000|Overall Study|Did not fill up the forms|2|||
130323989|NCT00489307|469155669|FG001|Overall Study|Did not fill up the forms|1|||
130323990|NCT00489307|469155668|FG000|Overall Study|Patient or family refusal|5|||
130323991|NCT00489307|469155669|FG001|Overall Study|Patient or family refusal|9|||
130323992|NCT03204188|469155672|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
130323993|NCT03204188|469155672|FG000|Immunotherapy Phase (1 Year)|Death|1|||
130323994|NCT03204188|469155672|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
130323995|NCT03204188|469155672|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
130323996|NCT01520506|469156991|FG000|Overall Study|Missed Visit|4|||
130323997|NCT01520506|469156991|FG000|Overall Study|Lost to Follow-up|1|||
130323998|NCT01520506|469156991|FG000|Overall Study|Withdrawal by Subject|1|||
130323999|NCT00425269|469156992|FG000|Overall Study|Pregnancy|5|||
130324000|NCT00425269|469156993|FG001|Overall Study|Pregnancy|7|||
130324001|NCT00425269|469156992|FG000|Overall Study|Lost to Follow-up|9|||
130324002|NCT00425269|469156993|FG001|Overall Study|Lost to Follow-up|9|||
130324003|NCT00425269|469156992|FG000|Overall Study|moved or medical reason|5|||
130324004|NCT00425269|469156993|FG001|Overall Study|moved or medical reason|4|||
130324005|NCT01084655|469156998|FG000|Overall Study|Radiographic disease progression|3|||
130324006|NCT01084655|469156999|FG001|Overall Study|Radiographic disease progression|2|||
130324007|NCT01084655|469157000|FG002|Overall Study|Radiographic disease progression|8|||
130324008|NCT01084655|469156998|FG000|Overall Study|Withdrawal by Subject|1|||
129987747|NCT04822597|467916940|FG003|Overall Study|Physician Decision|1|||
130324009|NCT01084655|469156999|FG001|Overall Study|Withdrawal by Subject|0|||
130324010|NCT01084655|469157000|FG002|Overall Study|Withdrawal by Subject|4|||
130324011|NCT01084655|469156998|FG000|Overall Study|Adverse Event|2|||
130324012|NCT01084655|469156999|FG001|Overall Study|Adverse Event|1|||
130324013|NCT01084655|469157000|FG002|Overall Study|Adverse Event|2|||
130324014|NCT01084655|469156998|FG000|Overall Study|Other|0|||
130324015|NCT01084655|469156999|FG001|Overall Study|Other|3|||
129987748|NCT04822597|467916937|FG000|Overall Study|Subject withdrawn after enrollment|0|||
130324016|NCT01084655|469157000|FG002|Overall Study|Other|2|||
129987749|NCT04822597|467916938|FG001|Overall Study|Subject withdrawn after enrollment|1|||
130324017|NCT01084655|469156998|FG000|Overall Study|Symptomatic deterioration|0|||
130324018|NCT01084655|469156999|FG001|Overall Study|Symptomatic deterioration|0|||
130324019|NCT01084655|469157000|FG002|Overall Study|Symptomatic deterioration|2|||
130324020|NCT01084655|469156998|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
130324021|NCT01084655|469156999|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
130324022|NCT01084655|469157000|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
130324023|NCT00535496|469157001|FG000|Overall Study|Lost to Follow-up|0|||
130324024|NCT00535496|469157002|FG001|Overall Study|Lost to Follow-up|1|||
130324025|NCT00535496|469157003|FG002|Overall Study|Lost to Follow-up|0|||
130324026|NCT00535496|469157004|FG003|Overall Study|Lost to Follow-up|0|||
130324027|NCT00535496|469157001|FG000|Overall Study|Not treated with sugammadex|0|||
130324028|NCT00535496|469157002|FG001|Overall Study|Not treated with sugammadex|1|||
130324029|NCT00535496|469157003|FG002|Overall Study|Not treated with sugammadex|0|||
130324030|NCT00535496|469157004|FG003|Overall Study|Not treated with sugammadex|0|||
130324031|NCT02326155|469157005|FG000|Overall Study|Adverse Event|21|||
130324032|NCT02326155|469157006|FG001|Overall Study|Adverse Event|5|||
130324033|NCT02326155|469157005|FG000|Overall Study|Death|3|||
130324034|NCT02326155|469157006|FG001|Overall Study|Death|0|||
130324035|NCT02326155|469157005|FG000|Overall Study|Lack of Efficacy|49|||
130324036|NCT02326155|469157006|FG001|Overall Study|Lack of Efficacy|5|||
130324037|NCT02326155|469157005|FG000|Overall Study|Lost to Follow-up|14|||
130324038|NCT02326155|469157006|FG001|Overall Study|Lost to Follow-up|3|||
130324039|NCT02326155|469157005|FG000|Overall Study|Protocol Violation|2|||
130324040|NCT02326155|469157006|FG001|Overall Study|Protocol Violation|0|||
130324041|NCT02326155|469157005|FG000|Overall Study|Withdrawal by Subject|34|||
130324042|NCT02326155|469157006|FG001|Overall Study|Withdrawal by Subject|11|||
130324043|NCT02326155|469157005|FG000|Overall Study|Disease progression|37|||
130324044|NCT02326155|469157006|FG001|Overall Study|Disease progression|4|||
130324045|NCT02326155|469157005|FG000|Overall Study|Study close|188|||
130324046|NCT02326155|469157006|FG001|Overall Study|Study close|21|||
130324047|NCT02326155|469157005|FG000|Overall Study|except for study close|46|||
130324048|NCT02326155|469157006|FG001|Overall Study|except for study close|13|||
130324049|NCT05024032|469157007|FG000|Overall Study|Withdrawal by Subject|0|||
130324050|NCT05024032|469157008|FG001|Overall Study|Withdrawal by Subject|3|||
130324051|NCT05024032|469157009|FG002|Overall Study|Withdrawal by Subject|4|||
130324052|NCT05024032|469157007|FG000|Overall Study|Adverse Event|0|||
130324053|NCT05024032|469157008|FG001|Overall Study|Adverse Event|1|||
130324054|NCT05024032|469157009|FG002|Overall Study|Adverse Event|0|||
130324055|NCT05024032|469157007|FG000|Overall Study|Protocol Deviation|1|||
130324056|NCT05024032|469157008|FG001|Overall Study|Protocol Deviation|0|||
130324057|NCT05024032|469157009|FG002|Overall Study|Protocol Deviation|0|||
130324058|NCT03714672|469157012|FG000|Overall Study|Adverse Event|0|||
130324059|NCT03714672|469157013|FG001|Overall Study|Adverse Event|0|||
130324060|NCT03714672|469157014|FG002|Overall Study|Adverse Event|3|||
130324061|NCT03714672|469157015|FG003|Overall Study|Adverse Event|0|||
130324062|NCT03714672|469157012|FG000|Overall Study|Physician Decision|0|||
129987750|NCT04822597|467916939|FG002|Overall Study|Subject withdrawn after enrollment|0|||
129987751|NCT04822597|467916940|FG003|Overall Study|Subject withdrawn after enrollment|1|||
129987752|NCT04822597|467916937|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
129987753|NCT04822597|467916938|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
129987754|NCT04822597|467916939|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
129987755|NCT04822597|467916940|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
129987756|NCT01285609|467916941|FG000|Randomized|Progressive Disease|41|||
129987757|NCT01285609|467916942|FG001|Randomized|Progressive Disease|61|||
129987758|NCT01285609|467916941|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
129987759|NCT01285609|467916942|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
129987760|NCT01285609|467916941|FG000|Randomized|Study Drug Toxicity|13|||
129987761|NCT01285609|467916942|FG001|Randomized|Study Drug Toxicity|14|||
129987762|NCT01285609|467916941|FG000|Randomized|Death|5|||
129987763|NCT01285609|467916942|FG001|Randomized|Death|7|||
129987764|NCT01285609|467916941|FG000|Randomized|Withdrawal by Subject|8|||
130324063|NCT03714672|469157013|FG001|Overall Study|Physician Decision|1|||
130324064|NCT03714672|469157014|FG002|Overall Study|Physician Decision|0|||
130324065|NCT03714672|469157015|FG003|Overall Study|Physician Decision|0|||
130324066|NCT03714672|469157012|FG000|Overall Study|Other Reason|1|||
130324067|NCT03714672|469157013|FG001|Overall Study|Other Reason|2|||
130324068|NCT03714672|469157014|FG002|Overall Study|Other Reason|1|||
129987765|NCT01285609|467916942|FG001|Randomized|Withdrawal by Subject|11|||
130324069|NCT03714672|469157015|FG003|Overall Study|Other Reason|1|||
130324070|NCT03714672|469157012|FG000|Overall Study|Lost to Follow-up|1|||
130324071|NCT03714672|469157013|FG001|Overall Study|Lost to Follow-up|1|||
130324072|NCT03714672|469157014|FG002|Overall Study|Lost to Follow-up|0|||
129987766|NCT01285609|467916941|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
129987767|NCT01285609|467916942|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
130324073|NCT03714672|469157015|FG003|Overall Study|Lost to Follow-up|0|||
130324074|NCT02345070|469157016|FG000|Overall Study|Adverse Event|12|||
130324075|NCT02345070|469157017|FG001|Overall Study|Adverse Event|8|||
130324076|NCT02345070|469157018|FG002|Overall Study|Adverse Event|16|||
130324077|NCT02345070|469157016|FG000|Overall Study|Poor compliance to protocol|2|||
130324078|NCT02345070|469157017|FG001|Overall Study|Poor compliance to protocol|0|||
130324079|NCT02345070|469157018|FG002|Overall Study|Poor compliance to protocol|0|||
130324080|NCT02345070|469157016|FG000|Overall Study|Other than specified above|6|||
130324081|NCT02345070|469157017|FG001|Overall Study|Other than specified above|3|||
130324082|NCT02345070|469157018|FG002|Overall Study|Other than specified above|7|||
130324083|NCT02379728|469157019|FG000|Overall Study|Lost to Follow-up|1|||
130324084|NCT02379728|469157020|FG001|Overall Study|Lost to Follow-up|0|||
130324085|NCT02379728|469157021|FG002|Overall Study|Lost to Follow-up|3|||
130324086|NCT02379728|469157022|FG003|Overall Study|Lost to Follow-up|0|||
130324087|NCT02379728|469157019|FG000|Overall Study|Withdrawal by Subject|5|||
130324088|NCT02379728|469157020|FG001|Overall Study|Withdrawal by Subject|0|||
130324089|NCT02379728|469157021|FG002|Overall Study|Withdrawal by Subject|5|||
130324090|NCT02379728|469157022|FG003|Overall Study|Withdrawal by Subject|3|||
130324091|NCT02379728|469157019|FG000|Overall Study|Protocol Violation|0|||
130324092|NCT02379728|469157020|FG001|Overall Study|Protocol Violation|0|||
130324093|NCT02379728|469157021|FG002|Overall Study|Protocol Violation|2|||
130324094|NCT02379728|469157022|FG003|Overall Study|Protocol Violation|0|||
130324095|NCT05101122|469157023|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
130324096|NCT05101122|469157023|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
130324097|NCT05101122|469157023|FG000|AD313 80/5|Withdrawal by Subject|1|||
129987768|NCT01285609|467916941|FG000|Randomized|Undisclosed Reasons|1|||
129987769|NCT01285609|467916942|FG001|Randomized|Undisclosed Reasons|0|||
129987770|NCT01285609|467916941|FG000|Randomized|Randomized but not Treated|4|||
129987771|NCT01285609|467916942|FG001|Randomized|Randomized but not Treated|4|||
129987772|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
129987773|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
129987774|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
129987775|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
129987776|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
129987777|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
129987778|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
129987779|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
129987780|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Death|11|||
129987781|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Death|3|||
130324098|NCT05101122|469157023|FG000|AD313 80/10|Physician Decision|1|||
130324099|NCT04945733|469157026|FG000|Overall Study|Physician Decision|1|||
130324100|NCT04945733|469157027|FG001|Overall Study|Physician Decision|3|||
130324101|NCT04945733|469157028|FG002|Overall Study|Physician Decision|0|||
130324102|NCT04945733|469157026|FG000|Overall Study|Withdrawal by Subject|3|||
130324103|NCT04945733|469157027|FG001|Overall Study|Withdrawal by Subject|3|||
129987782|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
129987783|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
129987784|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Not Reported|0|||
129987785|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Not Reported|2|||
130324104|NCT04945733|469157028|FG002|Overall Study|Withdrawal by Subject|0|||
129883394|NCT01567865|467532419|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
129883395|NCT01567865|467532420|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
129883396|NCT01567865|467532417|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
129883397|NCT01567865|467532418|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
129883398|NCT01567865|467532419|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
129883399|NCT01567865|467532420|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
129883400|NCT01051063|467532423|FG000|Overall Study|Death|2|||
129883401|NCT01051063|467532424|FG001|Overall Study|Death|2|||
129883402|NCT01051063|467532423|FG000|Overall Study|Withdrawal by Subject|1|||
129883403|NCT01051063|467532424|FG001|Overall Study|Withdrawal by Subject|1|||
129883404|NCT01051063|467532423|FG000|Overall Study|Termination of the study|5|||
129883405|NCT01051063|467532424|FG001|Overall Study|Termination of the study|0|||
129883406|NCT01051063|467532423|FG000|Overall Study|Moved from the study site area|1|||
129883407|NCT01051063|467532424|FG001|Overall Study|Moved from the study site area|0|||
129883408|NCT01051063|467532423|FG000|Overall Study|Other|1|||
129883409|NCT01051063|467532424|FG001|Overall Study|Other|0|||
129883410|NCT01051063|467532423|FG000|Overall Study|Lost to Follow-up|0|||
129987786|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
129987787|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
129987788|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
129883411|NCT01051063|467532424|FG001|Overall Study|Lost to Follow-up|1|||
129883412|NCT03857841|467532426|FG000|Overall Study|Death|1|||
129987789|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
130324105|NCT05660577|469157031|FG000|Overall Study|Discontinued|9|||
130324106|NCT03363841|469157034|FG000|Overall Study|Adverse Event|1|||
130324107|NCT03363841|469157034|FG000|Overall Study|Withdrawal by Subject|1|||
129883413|NCT03857841|467532427|FG001|Overall Study|Death|0|||
129883414|NCT03857841|467532428|FG002|Overall Study|Death|0|||
129883415|NCT03857841|467532429|FG003|Overall Study|Death|0|||
129987790|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
129987791|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
129987792|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
129987793|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
129987794|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
129987795|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
129987796|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
129987797|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
129987798|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
129987799|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
129987800|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
129987801|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
129987802|NCT01285609|467916941|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
129987803|NCT01285609|467916942|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
129987804|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
129987805|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
129987806|NCT03265938|467916952|FG000|Overall Study|Withdrawal by Subject|1|||
129987807|NCT03265938|467916952|FG000|Overall Study|Physician Decision|1|||
129987808|NCT03265938|467916952|FG000|Overall Study|friable mass|6|||
129987809|NCT02679508|467916953|FG000|Healing Phase|Protocol Violation|1|||
129987810|NCT02679508|467916954|FG001|Healing Phase|Protocol Violation|1|||
129987811|NCT02679508|467916953|FG000|Healing Phase|Lost to Follow-up|1|||
129987812|NCT02679508|467916954|FG001|Healing Phase|Lost to Follow-up|0|||
129987813|NCT02679508|467916953|FG000|Maintenance Phase|Adverse Event|12|||
129987814|NCT02679508|467916954|FG001|Maintenance Phase|Adverse Event|2|||
129987815|NCT02679508|467916953|FG000|Maintenance Phase|Lost to Follow-up|0|||
129987816|NCT02679508|467916954|FG001|Maintenance Phase|Lost to Follow-up|1|||
129987817|NCT02679508|467916953|FG000|Maintenance Phase|Withdrawal by Subject|15|||
129987818|NCT02679508|467916954|FG001|Maintenance Phase|Withdrawal by Subject|8|||
129987819|NCT02679508|467916953|FG000|Maintenance Phase|Other|5|||
129987820|NCT02679508|467916954|FG001|Maintenance Phase|Other|4|||
129987821|NCT03143166|467916955|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
129987822|NCT03616977|467916956|FG000|Period 1|Physician Decision|0|||
129987823|NCT03616977|467916957|FG001|Period 1|Physician Decision|1|||
129987824|NCT03616977|467916956|FG000|Period 3|Adverse Event|1|||
129987825|NCT03616977|467916957|FG001|Period 3|Adverse Event|1|||
129987826|NCT03683823|467916958|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
129987827|NCT03683823|467916959|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
129987828|NCT03683823|467916958|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
129987829|NCT03683823|467916959|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
129987830|NCT03683823|467916958|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
129987831|NCT03683823|467916959|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
129987832|NCT01323972|467916961|FG000|Overall Study|Withdrawal by Subject|1|||
129987833|NCT01323972|467916962|FG001|Overall Study|Withdrawal by Subject|0|||
129987834|NCT01323972|467916963|FG002|Overall Study|Withdrawal by Subject|1|||
129987835|NCT01323972|467916964|FG003|Overall Study|Withdrawal by Subject|0|||
129987836|NCT01323972|467916961|FG000|Overall Study|Migrated/moved from study area|1|||
129987837|NCT01323972|467916962|FG001|Overall Study|Migrated/moved from study area|2|||
129987838|NCT01323972|467916963|FG002|Overall Study|Migrated/moved from study area|0|||
129987839|NCT01323972|467916964|FG003|Overall Study|Migrated/moved from study area|0|||
129987840|NCT01323972|467916961|FG000|Overall Study|Lost to Follow-up|0|||
129987841|NCT01323972|467916962|FG001|Overall Study|Lost to Follow-up|1|||
129987842|NCT01323972|467916963|FG002|Overall Study|Lost to Follow-up|1|||
129987843|NCT01323972|467916964|FG003|Overall Study|Lost to Follow-up|1|||
129987844|NCT05000931|467916973|FG000|Overall Study|Lost to Follow-up|1|||
129987845|NCT00925132|467916974|FG000|Overall Study|Withdrawal by Subject|2|||
129987846|NCT00925132|467916975|FG001|Overall Study|Withdrawal by Subject|0|||
129987847|NCT00925132|467916976|FG002|Overall Study|Withdrawal by Subject|0|||
129987848|NCT00925132|467916977|FG003|Overall Study|Withdrawal by Subject|0|||
129987849|NCT00925132|467916978|FG004|Overall Study|Withdrawal by Subject|1|||
129987850|NCT00925132|467916974|FG000|Overall Study|Removed due to disease progression|0|||
129987851|NCT00925132|467916975|FG001|Overall Study|Removed due to disease progression|0|||
129987852|NCT00925132|467916976|FG002|Overall Study|Removed due to disease progression|0|||
129987853|NCT00925132|467916977|FG003|Overall Study|Removed due to disease progression|0|||
129987854|NCT00925132|467916978|FG004|Overall Study|Removed due to disease progression|4|||
129987855|NCT03141905|467916979|FG000|Overall Study|Death|3|||
129987856|NCT03141905|467916980|FG001|Overall Study|Death|2|||
129987857|NCT03141905|467916979|FG000|Overall Study|Withdrawal by Subject|1|||
129987858|NCT03141905|467916980|FG001|Overall Study|Withdrawal by Subject|0|||
129987859|NCT03141905|467916979|FG000|Overall Study|Lost to Follow-up|3|||
129987860|NCT03141905|467916980|FG001|Overall Study|Lost to Follow-up|7|||
129987861|NCT03141905|467916979|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
130324108|NCT03363841|469157034|FG000|Overall Study|Death|7|||
130324109|NCT03363841|469157034|FG000|Overall Study|Physician Decision|1|||
130324110|NCT00886379|469157037|FG000|Overall Study|Transferred Schools|0|||
130324111|NCT00886379|469157038|FG001|Overall Study|Transferred Schools|0|||
130324112|NCT00886379|469157039|FG002|Overall Study|Transferred Schools|2|||
130324113|NCT00886379|469157040|FG003|Overall Study|Transferred Schools|1|||
130324114|NCT00886379|469157041|FG004|Overall Study|Transferred Schools|1|||
130324115|NCT00886379|469157037|FG000|Overall Study|Final blood draw not obtained|3|||
130324116|NCT00886379|469157038|FG001|Overall Study|Final blood draw not obtained|3|||
130324117|NCT00886379|469157039|FG002|Overall Study|Final blood draw not obtained|4|||
130324118|NCT00886379|469157040|FG003|Overall Study|Final blood draw not obtained|2|||
130324119|NCT00886379|469157041|FG004|Overall Study|Final blood draw not obtained|2|||
130324120|NCT04558125|469157042|FG000|Overall Study|Death|1|||
130324121|NCT03137381|469157043|FG000|Overall Study|Adverse Event|3|||
130324122|NCT03137381|469157044|FG001|Overall Study|Adverse Event|0|||
130324123|NCT03137381|469157045|FG002|Overall Study|Adverse Event|2|||
130324124|NCT03137381|469157046|FG003|Overall Study|Adverse Event|0|||
130324125|NCT03137381|469157043|FG000|Overall Study|Lost to Follow-up|2|||
130324126|NCT03137381|469157044|FG001|Overall Study|Lost to Follow-up|1|||
130324127|NCT03137381|469157045|FG002|Overall Study|Lost to Follow-up|1|||
130324128|NCT03137381|469157046|FG003|Overall Study|Lost to Follow-up|0|||
130324129|NCT03137381|469157043|FG000|Overall Study|Protocol deviation|1|||
130324130|NCT03137381|469157044|FG001|Overall Study|Protocol deviation|1|||
130324131|NCT03137381|469157045|FG002|Overall Study|Protocol deviation|0|||
130324132|NCT03137381|469157046|FG003|Overall Study|Protocol deviation|1|||
130324133|NCT03137381|469157043|FG000|Overall Study|Withdrawal by Investigator|0|||
130324134|NCT03137381|469157044|FG001|Overall Study|Withdrawal by Investigator|1|||
130324135|NCT03137381|469157045|FG002|Overall Study|Withdrawal by Investigator|1|||
129987862|NCT03141905|467916980|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
129987863|NCT02502799|467918738|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
129987864|NCT02502799|467918739|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
129987865|NCT02502799|467918740|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
129987866|NCT02502799|467918741|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
129987867|NCT02502799|467918738|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
129987868|NCT02502799|467918739|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
129987869|NCT02502799|467918740|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
129987870|NCT02502799|467918741|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
129987871|NCT02502799|467918738|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
129987872|NCT02502799|467918739|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
129987873|NCT02502799|467918740|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
129987874|NCT02502799|467918741|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
129987875|NCT02502799|467918738|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
129987876|NCT02502799|467918739|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
129987877|NCT02502799|467918740|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
129987878|NCT02502799|467918741|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
129987879|NCT02502799|467918738|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
129987880|NCT02502799|467918739|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
129987881|NCT02502799|467918740|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
129987882|NCT02502799|467918741|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
129987883|NCT00055601|467918744|FG000|Overall Study|Protocol Violation|1|||
129987884|NCT00055601|467918745|FG001|Overall Study|Protocol Violation|1|||
129987885|NCT00055601|467918744|FG000|Overall Study|No protocol treatment received|1|||
129987886|NCT00055601|467918745|FG001|Overall Study|No protocol treatment received|1|||
129987887|NCT00117845|467918746|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
129987888|NCT01022268|467918748|FG000|Overall Study|Withdrawal by Subject|1|||
129987889|NCT01022268|467918749|FG001|Overall Study|Withdrawal by Subject|0|||
129987890|NCT01022268|467918748|FG000|Overall Study|Withdrawal by Subject|1|||
129987891|NCT01022268|467918749|FG001|Overall Study|Withdrawal by Subject|0|||
129987892|NCT05087979|467918750|FG000|Overall Study|Converted to general anesthesia|1|||
129987893|NCT05087979|467918751|FG001|Overall Study|Converted to general anesthesia|0|||
129987894|NCT02915302|467918752|FG000|Overall Study|Adverse Event|3|||
129987895|NCT02915302|467918753|FG001|Overall Study|Adverse Event|0|||
129987896|NCT02915302|467918752|FG000|Overall Study|Protocol Violation|20|||
129987897|NCT02915302|467918753|FG001|Overall Study|Protocol Violation|27|||
130324136|NCT03137381|469157046|FG003|Overall Study|Withdrawal by Investigator|0|||
129987898|NCT02915302|467918752|FG000|Overall Study|Lost to Follow-up|19|||
130324137|NCT03137381|469157043|FG000|Overall Study|Withdrawal by Subject|3|||
130324138|NCT03137381|469157044|FG001|Overall Study|Withdrawal by Subject|4|||
130324139|NCT03137381|469157045|FG002|Overall Study|Withdrawal by Subject|3|||
129987899|NCT02915302|467918753|FG001|Overall Study|Lost to Follow-up|22|||
129987900|NCT02915302|467918752|FG000|Overall Study|Withdrawal by Subject|22|||
130324140|NCT03137381|469157046|FG003|Overall Study|Withdrawal by Subject|0|||
130324141|NCT03137381|469157043|FG000|Overall Study|Pregnancy|0|||
130324142|NCT03137381|469157044|FG001|Overall Study|Pregnancy|0|||
130324143|NCT03137381|469157045|FG002|Overall Study|Pregnancy|1|||
130324144|NCT03137381|469157046|FG003|Overall Study|Pregnancy|0|||
130324145|NCT01980017|469157051|FG000|Overall Study|Lost to Follow-up|30|||
130324146|NCT01980017|469157052|FG001|Overall Study|Lost to Follow-up|21|||
130324147|NCT01980017|469157051|FG000|Overall Study|Death|0|||
130324148|NCT01980017|469157052|FG001|Overall Study|Death|1|||
130324149|NCT00910650|469157053|FG000|Overall Study|Death|2|||
130324150|NCT03367793|469157054|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324151|NCT03367793|469157055|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324152|NCT03367793|469157056|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
130324153|NCT03367793|469157057|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324154|NCT03367793|469157058|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324155|NCT03367793|469157059|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
130324156|NCT00423579|469157060|FG000|Overall Study|Lost to Follow-up|3|||
130324157|NCT00423579|469157061|FG001|Overall Study|Lost to Follow-up|0|||
130324158|NCT00423579|469157060|FG000|Overall Study|Protocol Violation|1|||
130324159|NCT00423579|469157061|FG001|Overall Study|Protocol Violation|3|||
130324160|NCT00423579|469157060|FG000|Overall Study|Diagnosis of diabetes|0|||
130324161|NCT00423579|469157061|FG001|Overall Study|Diagnosis of diabetes|1|||
130324162|NCT00106704|469157064|FG000|Overall Study|Adverse Event|10|||
130324163|NCT00106704|469157065|FG001|Overall Study|Adverse Event|7|||
130324164|NCT00106704|469157064|FG000|Overall Study|Death|2|||
129987901|NCT02915302|467918753|FG001|Overall Study|Withdrawal by Subject|29|||
129987902|NCT02915302|467918752|FG000|Overall Study|Other|1|||
129987903|NCT02915302|467918753|FG001|Overall Study|Other|0|||
129987904|NCT03207009|467918754|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
129987905|NCT02924428|467918755|FG000|Overall Study|Adverse Event|1|||
129987906|NCT02924428|467918756|FG001|Overall Study|Adverse Event|0|||
129987907|NCT02924428|467918755|FG000|Overall Study|Physician Decision|1|||
129987908|NCT02924428|467918756|FG001|Overall Study|Physician Decision|0|||
129987909|NCT02924428|467918755|FG000|Overall Study|Lost to Follow-up|2|||
129987910|NCT02924428|467918756|FG001|Overall Study|Lost to Follow-up|4|||
129987911|NCT02924428|467918755|FG000|Overall Study|Pregnancy|0|||
129987912|NCT02924428|467918756|FG001|Overall Study|Pregnancy|1|||
129987913|NCT02680002|467918757|FG000|Overall Study|Lost to Follow-up|5|||
129987914|NCT02680002|467918758|FG001|Overall Study|Lost to Follow-up|1|||
129987915|NCT02680002|467918759|FG002|Overall Study|Lost to Follow-up|4|||
129987916|NCT02680002|467918760|FG003|Overall Study|Lost to Follow-up|2|||
129987917|NCT02680002|467918761|FG004|Overall Study|Lost to Follow-up|0|||
129987918|NCT02680002|467918762|FG005|Overall Study|Lost to Follow-up|2|||
129987919|NCT02680002|467918757|FG000|Overall Study|Physician Decision|5|||
129987920|NCT02680002|467918758|FG001|Overall Study|Physician Decision|1|||
129987921|NCT02680002|467918759|FG002|Overall Study|Physician Decision|1|||
129987922|NCT02680002|467918760|FG003|Overall Study|Physician Decision|1|||
129987923|NCT02680002|467918761|FG004|Overall Study|Physician Decision|1|||
129987924|NCT02680002|467918762|FG005|Overall Study|Physician Decision|1|||
129987925|NCT02680002|467918757|FG000|Overall Study|Protocol Violation|1|||
129987926|NCT02680002|467918758|FG001|Overall Study|Protocol Violation|0|||
129987927|NCT02680002|467918759|FG002|Overall Study|Protocol Violation|1|||
129987928|NCT02680002|467918760|FG003|Overall Study|Protocol Violation|0|||
129987929|NCT02680002|467918761|FG004|Overall Study|Protocol Violation|1|||
129987930|NCT02680002|467918762|FG005|Overall Study|Protocol Violation|2|||
129987931|NCT02680002|467918757|FG000|Overall Study|Withdrawal by Subject|0|||
129987932|NCT02680002|467918758|FG001|Overall Study|Withdrawal by Subject|0|||
129987933|NCT02680002|467918759|FG002|Overall Study|Withdrawal by Subject|1|||
130324165|NCT00106704|469157065|FG001|Overall Study|Death|1|||
130324166|NCT00106704|469157064|FG000|Overall Study|Lack of Efficacy|67|||
129987934|NCT02680002|467918760|FG003|Overall Study|Withdrawal by Subject|0|||
129987935|NCT02680002|467918761|FG004|Overall Study|Withdrawal by Subject|2|||
129987936|NCT02680002|467918762|FG005|Overall Study|Withdrawal by Subject|2|||
129987937|NCT02680002|467918757|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
130324167|NCT00106704|469157065|FG001|Overall Study|Lack of Efficacy|69|||
130324168|NCT00106704|469157064|FG000|Overall Study|Lost to Follow-up|7|||
130324169|NCT00106704|469157065|FG001|Overall Study|Lost to Follow-up|3|||
130324170|NCT00106704|469157064|FG000|Overall Study|Pregnancy|1|||
130324171|NCT00106704|469157065|FG001|Overall Study|Pregnancy|0|||
130324172|NCT00106704|469157064|FG000|Overall Study|Protocol Violation|4|||
130324173|NCT00106704|469157065|FG001|Overall Study|Protocol Violation|7|||
130324174|NCT00106704|469157064|FG000|Overall Study|Withdrawal by Subject|14|||
130324175|NCT00106704|469157065|FG001|Overall Study|Withdrawal by Subject|21|||
129987938|NCT02680002|467918758|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
129987939|NCT02680002|467918759|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
129987940|NCT02680002|467918760|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
129987941|NCT02680002|467918761|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
129987942|NCT02680002|467918762|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
129987943|NCT02680002|467918757|FG000|Overall Study|Other|0|||
129987944|NCT02680002|467918758|FG001|Overall Study|Other|1|||
129987945|NCT02680002|467918759|FG002|Overall Study|Other|0|||
129987946|NCT02680002|467918760|FG003|Overall Study|Other|0|||
130324176|NCT00106704|469157064|FG000|Overall Study|Patient moved|1|||
130324177|NCT00106704|469157065|FG001|Overall Study|Patient moved|0|||
130324178|NCT00106704|469157064|FG000|Overall Study|Site terminated|0|||
130324179|NCT00106704|469157065|FG001|Overall Study|Site terminated|1|||
130324180|NCT00106704|469157064|FG000|Overall Study|Planned major surgery|1|||
130324181|NCT00106704|469157065|FG001|Overall Study|Planned major surgery|0|||
130324182|NCT00106704|469157064|FG000|Overall Study|Patient Received Glycemic Medication|22|||
130324183|NCT00106704|469157065|FG001|Overall Study|Patient Received Glycemic Medication|41|||
130324184|NCT00106704|469157064|FG000|Overall Study|Unable to re-enter US|1|||
130324185|NCT00106704|469157065|FG001|Overall Study|Unable to re-enter US|0|||
130324186|NCT00106704|469157064|FG000|Overall Study|Laboratory test|1|||
130324187|NCT00106704|469157065|FG001|Overall Study|Laboratory test|1|||
130324188|NCT02224560|469157066|FG000|Overall Study|Protocol Deviation|1|||
130324189|NCT02224560|469157067|FG001|Overall Study|Protocol Deviation|0|||
130324190|NCT02224560|469157068|FG002|Overall Study|Protocol Deviation|0|||
130324191|NCT02224560|469157066|FG000|Overall Study|Withdrawal by Subject|2|||
130324192|NCT02224560|469157067|FG001|Overall Study|Withdrawal by Subject|0|||
130324193|NCT02224560|469157068|FG002|Overall Study|Withdrawal by Subject|1|||
130324194|NCT02224560|469157066|FG000|Overall Study|Met Withdrawal Criteria|1|||
130324195|NCT02224560|469157067|FG001|Overall Study|Met Withdrawal Criteria|0|||
130324196|NCT02224560|469157068|FG002|Overall Study|Met Withdrawal Criteria|0|||
130324197|NCT02224560|469157066|FG000|Overall Study|Adverse Event|4|||
130324198|NCT02224560|469157067|FG001|Overall Study|Adverse Event|1|||
130324199|NCT02224560|469157068|FG002|Overall Study|Adverse Event|1|||
130324200|NCT02224560|469157066|FG000|Overall Study|Withdrawn by Investigator|1|||
130324201|NCT02224560|469157067|FG001|Overall Study|Withdrawn by Investigator|1|||
130324202|NCT02224560|469157068|FG002|Overall Study|Withdrawn by Investigator|0|||
130324203|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
130324204|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
130324205|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
130324206|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
130324207|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
130324208|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
130324209|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
130324210|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
130324211|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
130324212|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
130324213|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
130324214|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
130324215|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
130324216|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
130324217|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
130324218|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
130324219|NCT03773978|469157071|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
130324220|NCT03773978|469157072|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
130324221|NCT03773978|469157071|FG000|DBW Period|Adverse Event|2|||
130324222|NCT03773978|469157072|FG001|DBW Period|Adverse Event|2|||
130324223|NCT03773978|469157071|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
130324224|NCT03773978|469157072|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
130324225|NCT03773978|469157071|FG000|DBW Period|Withdrawal by Subject|2|||
130324226|NCT03773978|469157072|FG001|DBW Period|Withdrawal by Subject|1|||
130324227|NCT03773978|469157071|FG000|DBW Period|Due to epidemic or pandemic|5|||
130324228|NCT03773978|469157072|FG001|DBW Period|Due to epidemic or pandemic|6|||
130324229|NCT03773978|469157071|FG000|DBW Period|Study team decision|1|||
130324230|NCT03773978|469157072|FG001|DBW Period|Study team decision|0|||
130324231|NCT01033019|469157073|FG000|Overall Study|Withdrawal by Subject|1|||
130324232|NCT01033019|469157074|FG001|Overall Study|Withdrawal by Subject|0|||
130324233|NCT03224819|469157080|FG000|Overall Study|Withdrawal by Subject|0|||
130324234|NCT03224819|469157081|FG001|Overall Study|Withdrawal by Subject|0|||
130324235|NCT03224819|469157082|FG002|Overall Study|Withdrawal by Subject|0|||
130324236|NCT03224819|469157083|FG003|Overall Study|Withdrawal by Subject|0|||
130324237|NCT03224819|469157084|FG004|Overall Study|Withdrawal by Subject|0|||
130324238|NCT03224819|469157085|FG005|Overall Study|Withdrawal by Subject|0|||
130324239|NCT03224819|469157086|FG006|Overall Study|Withdrawal by Subject|0|||
130324240|NCT03224819|469157087|FG007|Overall Study|Withdrawal by Subject|0|||
130324241|NCT03224819|469157088|FG008|Overall Study|Withdrawal by Subject|0|||
130324242|NCT03224819|469157089|FG009|Overall Study|Withdrawal by Subject|0|||
130324243|NCT03224819|469157090|FG010|Overall Study|Withdrawal by Subject|0|||
130324244|NCT03224819|469157091|FG011|Overall Study|Withdrawal by Subject|0|||
130324245|NCT03224819|469157092|FG012|Overall Study|Withdrawal by Subject|1|||
129987947|NCT02680002|467918761|FG004|Overall Study|Other|1|||
129987948|NCT02680002|467918762|FG005|Overall Study|Other|0|||
130324246|NCT03224819|469157093|FG013|Overall Study|Withdrawal by Subject|0|||
130324247|NCT03224819|469157080|FG000|Overall Study|Sponsor Decision|0|||
130324248|NCT03224819|469157081|FG001|Overall Study|Sponsor Decision|0|||
130324249|NCT03224819|469157082|FG002|Overall Study|Sponsor Decision|0|||
130324250|NCT03224819|469157083|FG003|Overall Study|Sponsor Decision|1|||
130324251|NCT03224819|469157084|FG004|Overall Study|Sponsor Decision|1|||
130324252|NCT03224819|469157085|FG005|Overall Study|Sponsor Decision|2|||
130324253|NCT03224819|469157086|FG006|Overall Study|Sponsor Decision|1|||
130324254|NCT03224819|469157087|FG007|Overall Study|Sponsor Decision|1|||
130324255|NCT03224819|469157088|FG008|Overall Study|Sponsor Decision|1|||
130324256|NCT03224819|469157089|FG009|Overall Study|Sponsor Decision|2|||
130324257|NCT03224819|469157090|FG010|Overall Study|Sponsor Decision|1|||
130324258|NCT03224819|469157091|FG011|Overall Study|Sponsor Decision|1|||
130324259|NCT03224819|469157092|FG012|Overall Study|Sponsor Decision|1|||
130324260|NCT03224819|469157093|FG013|Overall Study|Sponsor Decision|0|||
130324261|NCT03224819|469157080|FG000|Overall Study|Lost to Follow-up|0|||
130324262|NCT03224819|469157081|FG001|Overall Study|Lost to Follow-up|0|||
130324263|NCT03224819|469157082|FG002|Overall Study|Lost to Follow-up|0|||
130324264|NCT03224819|469157083|FG003|Overall Study|Lost to Follow-up|0|||
130324265|NCT03224819|469157084|FG004|Overall Study|Lost to Follow-up|0|||
130324266|NCT03224819|469157085|FG005|Overall Study|Lost to Follow-up|0|||
130324267|NCT03224819|469157086|FG006|Overall Study|Lost to Follow-up|0|||
130324268|NCT03224819|469157087|FG007|Overall Study|Lost to Follow-up|0|||
130324269|NCT03224819|469157088|FG008|Overall Study|Lost to Follow-up|1|||
130324270|NCT03224819|469157089|FG009|Overall Study|Lost to Follow-up|0|||
130324271|NCT03224819|469157090|FG010|Overall Study|Lost to Follow-up|0|||
130324272|NCT03224819|469157091|FG011|Overall Study|Lost to Follow-up|0|||
130324273|NCT03224819|469157092|FG012|Overall Study|Lost to Follow-up|0|||
130324274|NCT03224819|469157093|FG013|Overall Study|Lost to Follow-up|0|||
130324275|NCT03224819|469157080|FG000|Overall Study|Death|0|||
130324276|NCT03224819|469157081|FG001|Overall Study|Death|1|||
130324277|NCT03224819|469157082|FG002|Overall Study|Death|0|||
130324278|NCT03224819|469157083|FG003|Overall Study|Death|0|||
130324279|NCT03224819|469157084|FG004|Overall Study|Death|0|||
130324280|NCT03224819|469157085|FG005|Overall Study|Death|0|||
130324281|NCT03224819|469157086|FG006|Overall Study|Death|0|||
130324282|NCT03224819|469157087|FG007|Overall Study|Death|1|||
130324283|NCT03224819|469157088|FG008|Overall Study|Death|0|||
130324284|NCT03224819|469157089|FG009|Overall Study|Death|0|||
130324285|NCT03224819|469157090|FG010|Overall Study|Death|0|||
130324286|NCT03224819|469157091|FG011|Overall Study|Death|1|||
130324287|NCT03224819|469157092|FG012|Overall Study|Death|0|||
130324288|NCT03224819|469157093|FG013|Overall Study|Death|0|||
130324289|NCT01535040|469157100|FG000|Overall Study|Physician Decision|0|||
130324290|NCT01535040|469157101|FG001|Overall Study|Physician Decision|1|||
130324291|NCT01535040|469157100|FG000|Overall Study|Withdrawal by Subject|13|||
130324292|NCT01535040|469157101|FG001|Overall Study|Withdrawal by Subject|10|||
130324293|NCT01535040|469157100|FG000|Overall Study|Never Started|9|||
130324294|NCT01535040|469157101|FG001|Overall Study|Never Started|4|||
130324295|NCT01535040|469157100|FG000|Overall Study|Toxicity|7|||
130324296|NCT01535040|469157101|FG001|Overall Study|Toxicity|5|||
130324297|NCT01535040|469157100|FG000|Overall Study|Multiple Reasons|1|||
130324298|NCT01535040|469157101|FG001|Overall Study|Multiple Reasons|1|||
130324299|NCT01074970|469157103|FG000|Overall Study|Never Treated|0|||
129987949|NCT02680002|467918757|FG000|Overall Study|Adverse Event|0|||
129987950|NCT02680002|467918758|FG001|Overall Study|Adverse Event|0|||
129987951|NCT02680002|467918759|FG002|Overall Study|Adverse Event|0|||
129987952|NCT02680002|467918760|FG003|Overall Study|Adverse Event|0|||
129987953|NCT02680002|467918761|FG004|Overall Study|Adverse Event|1|||
129987954|NCT02680002|467918762|FG005|Overall Study|Adverse Event|2|||
129987955|NCT03527173|467918765|FG000|Overall Study|Lost to Follow-up|4|||
129987956|NCT03527173|467918766|FG001|Overall Study|Lost to Follow-up|2|||
129987957|NCT03527173|467918765|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
129987958|NCT03527173|467918766|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
130324300|NCT01074970|469157104|FG001|Overall Study|Never Treated|0|||
130324301|NCT01074970|469157105|FG002|Overall Study|Never Treated|8|||
130324302|NCT01074970|469157106|FG003|Overall Study|Never Treated|1|||
130324303|NCT01074970|469157103|FG000|Overall Study|Adverse Event|1|||
130324304|NCT01074970|469157104|FG001|Overall Study|Adverse Event|0|||
130324305|NCT01074970|469157105|FG002|Overall Study|Adverse Event|4|||
130324306|NCT01074970|469157106|FG003|Overall Study|Adverse Event|3|||
130324307|NCT01074970|469157103|FG000|Overall Study|Disease progression during treatment|3|||
130324308|NCT01074970|469157104|FG001|Overall Study|Disease progression during treatment|1|||
130324309|NCT01074970|469157105|FG002|Overall Study|Disease progression during treatment|2|||
130324310|NCT01074970|469157106|FG003|Overall Study|Disease progression during treatment|9|||
130324311|NCT01074970|469157103|FG000|Overall Study|Lost to Follow-up|0|||
130324312|NCT01074970|469157104|FG001|Overall Study|Lost to Follow-up|0|||
130324313|NCT01074970|469157105|FG002|Overall Study|Lost to Follow-up|1|||
130324314|NCT01074970|469157106|FG003|Overall Study|Lost to Follow-up|0|||
129987959|NCT03527173|467918765|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130324315|NCT01074970|469157103|FG000|Overall Study|Withdrawal by Subject|0|||
130324316|NCT01074970|469157104|FG001|Overall Study|Withdrawal by Subject|0|||
130324317|NCT01074970|469157105|FG002|Overall Study|Withdrawal by Subject|6|||
129987960|NCT03527173|467918766|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
129987961|NCT03527173|467918765|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129987962|NCT03527173|467918766|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129987963|NCT01248780|467918771|FG000|Overall Study|Lack of Efficacy|2|||
129987964|NCT01248780|467918772|FG001|Overall Study|Lack of Efficacy|0|||
129987965|NCT01248780|467918771|FG000|Overall Study|Lost to Follow-up|0|||
129987966|NCT01248780|467918772|FG001|Overall Study|Lost to Follow-up|1|||
129987967|NCT01248780|467918771|FG000|Overall Study|Death|0|||
129987968|NCT01248780|467918772|FG001|Overall Study|Death|1|||
129987969|NCT01248780|467918771|FG000|Overall Study|Adverse Event|2|||
129987970|NCT01248780|467918772|FG001|Overall Study|Adverse Event|7|||
129987971|NCT01248780|467918771|FG000|Overall Study|Protocol Violation|1|||
129987972|NCT01248780|467918772|FG001|Overall Study|Protocol Violation|1|||
129987973|NCT01248780|467918771|FG000|Overall Study|Withdrawal by Subject|4|||
129987974|NCT01248780|467918772|FG001|Overall Study|Withdrawal by Subject|4|||
129987975|NCT01248780|467918771|FG000|Overall Study|Not treated|0|||
129987976|NCT01248780|467918772|FG001|Overall Study|Not treated|1|||
129987977|NCT02134977|467918773|FG000|Overall Study|Protocol Deviation|102|||
129987978|NCT04097301|467918774|FG000|Overall Study|Death|1|||
129987979|NCT04097301|467918774|FG000|Overall Study|Withdrawal by Subject|1|||
129987980|NCT04097301|467918774|FG000|Overall Study|Screening Failure|5|||
129987981|NCT01773291|467918775|FG000|Overall Study|Protocol Violation|1|||
129987982|NCT01773291|467918776|FG001|Overall Study|Protocol Violation|0|||
129987983|NCT01773291|467918777|FG002|Overall Study|Protocol Violation|0|||
129987984|NCT01773291|467918775|FG000|Overall Study|Withdrawal by Subject|0|||
129987985|NCT01773291|467918776|FG001|Overall Study|Withdrawal by Subject|0|||
129987986|NCT01773291|467918777|FG002|Overall Study|Withdrawal by Subject|1|||
129987987|NCT00203476|467918778|FG000|Overall Study|Lost to Follow-up|1|||
129987988|NCT00203476|467918779|FG001|Overall Study|Lost to Follow-up|0|||
129987989|NCT00203476|467918780|FG002|Overall Study|Lost to Follow-up|0|||
129987990|NCT00203476|467918778|FG000|Overall Study|Withdrawal by Subject|0|||
129987991|NCT00203476|467918779|FG001|Overall Study|Withdrawal by Subject|1|||
129987992|NCT00203476|467918780|FG002|Overall Study|Withdrawal by Subject|0|||
129987993|NCT01190514|467918781|FG000|First Intervention (Period 1)|Adverse Event|1|||
129987994|NCT01190514|467918782|FG001|First Intervention (Period 1)|Adverse Event|0|||
129987995|NCT01190514|467918783|FG002|First Intervention (Period 1)|Adverse Event|0|||
129987996|NCT01190514|467918784|FG003|First Intervention (Period 1)|Adverse Event|0|||
129987997|NCT01190514|467918781|FG000|Third Intervention (Period 3)|Adverse Event|1|||
129987998|NCT01190514|467918782|FG001|Third Intervention (Period 3)|Adverse Event|0|||
129987999|NCT01190514|467918783|FG002|Third Intervention (Period 3)|Adverse Event|0|||
129988000|NCT01190514|467918784|FG003|Third Intervention (Period 3)|Adverse Event|0|||
129988001|NCT03241225|467918785|FG000|Overall Study|Lost to Follow-up|2|||
129988002|NCT03241225|467918786|FG001|Overall Study|Lost to Follow-up|1|||
129988003|NCT03241225|467918785|FG000|Overall Study|Protocol Violation|4|||
129988004|NCT03241225|467918786|FG001|Overall Study|Protocol Violation|1|||
129988005|NCT03241225|467918785|FG000|Overall Study|Withdrawal by Subject|1|||
129988006|NCT03241225|467918786|FG001|Overall Study|Withdrawal by Subject|0|||
129988007|NCT01970345|467918791|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
129988008|NCT01970345|467918792|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
129988009|NCT01970345|467918791|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
129988010|NCT01970345|467918792|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
129988011|NCT03932812|467918799|FG000|Overall Study|Lost to Follow-up|12|||
129988012|NCT03932812|467918800|FG001|Overall Study|Lost to Follow-up|14|||
129988013|NCT03932812|467918799|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
129988014|NCT03932812|467918800|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
129988015|NCT02585232|467918805|FG000|Overall Study|Lost to Follow-up|8|||
129988016|NCT02585232|467918806|FG001|Overall Study|Lost to Follow-up|8|||
129988017|NCT02585232|467918805|FG000|Overall Study|Withdrawal by Subject|4|||
129988018|NCT02585232|467918806|FG001|Overall Study|Withdrawal by Subject|8|||
129988019|NCT03215810|467918807|FG000|Overall Study|Still responding to nivolumab|1|||
129988020|NCT03215810|467918807|FG000|Overall Study|Insufficient TIL growth|1|||
129988021|NCT03215810|467918807|FG000|Overall Study|Decline in performance status|1|||
129988022|NCT03215810|467918807|FG000|Overall Study|Withdrawal by Subject|1|||
129988023|NCT02313233|467918808|FG000|Overall Study|Withdrawal by Subject|1|||
129988024|NCT02313233|467918809|FG001|Overall Study|Withdrawal by Subject|2|||
129988025|NCT02313233|467918808|FG000|Overall Study|Administrative reason|1|||
129988026|NCT02313233|467918809|FG001|Overall Study|Administrative reason|1|||
129988027|NCT02679573|467918812|FG000|Overall Study|Adverse Event|13|||
129988028|NCT02679573|467918813|FG001|Overall Study|Adverse Event|6|||
129988029|NCT02679573|467918812|FG000|Overall Study|Lack of Efficacy|12|||
129988030|NCT02679573|467918813|FG001|Overall Study|Lack of Efficacy|15|||
129988031|NCT02679573|467918812|FG000|Overall Study|Could not complete required study visits|6|||
129988032|NCT02679573|467918813|FG001|Overall Study|Could not complete required study visits|2|||
129988033|NCT02679573|467918812|FG000|Overall Study|Withdrawal by Subject|2|||
129988034|NCT02679573|467918813|FG001|Overall Study|Withdrawal by Subject|9|||
130324318|NCT01074970|469157106|FG003|Overall Study|Withdrawal by Subject|4|||
130324319|NCT00734149|469157107|FG000|Overall Study|Withdrawal by Subject|1|||
130324320|NCT05430854|469157108|FG000|Overall Study|Trial terminated by Sponsor|39|||
130324321|NCT05430854|469157109|FG001|Overall Study|Trial terminated by Sponsor|50|||
130324322|NCT05430854|469157110|FG002|Overall Study|Trial terminated by Sponsor|46|||
130324323|NCT05430854|469157108|FG000|Overall Study|Withdrawal by Subject|0|||
130324324|NCT05430854|469157109|FG001|Overall Study|Withdrawal by Subject|3|||
130324325|NCT05430854|469157110|FG002|Overall Study|Withdrawal by Subject|0|||
130324326|NCT04314284|469157111|FG000|Overall Study|Withdrawal by Subject|4|||
130324327|NCT04314284|469157112|FG001|Overall Study|Withdrawal by Subject|7|||
130324328|NCT04314284|469157111|FG000|Overall Study|Consented but did not complete survey|0|||
130324329|NCT04314284|469157112|FG001|Overall Study|Consented but did not complete survey|6|||
130324330|NCT01652235|469157115|FG000|Overall Study|Death|9|||
130324331|NCT01652235|469157115|FG000|Overall Study|Lost to Follow-up|5|||
130324332|NCT01652235|469157115|FG000|Overall Study|Withdrawal by Subject|2|||
130324333|NCT02023086|469157118|FG000|Overall Study|Withdrawal by Subject|2|||
130324334|NCT02023086|469157119|FG001|Overall Study|Withdrawal by Subject|0|||
130324335|NCT03472885|469157120|FG000|24-Week Treatment Period|Adverse Event|1|||
130324336|NCT02201953|469157121|FG000|Overall Study|Randomized but Never Treated|1|||
130324337|NCT02201953|469157122|FG001|Overall Study|Randomized but Never Treated|5|||
130324338|NCT02201953|469157121|FG000|Overall Study|Lack of Efficacy|9|||
130324339|NCT02201953|469157122|FG001|Overall Study|Lack of Efficacy|30|||
130324340|NCT02201953|469157121|FG000|Overall Study|Lost to Follow-up|8|||
130324341|NCT02201953|469157122|FG001|Overall Study|Lost to Follow-up|8|||
130324342|NCT02201953|469157121|FG000|Overall Study|Withdrew Consent|2|||
130324343|NCT02201953|469157122|FG001|Overall Study|Withdrew Consent|5|||
130324344|NCT02201953|469157121|FG000|Overall Study|Adverse Event|0|||
130324345|NCT02201953|469157122|FG001|Overall Study|Adverse Event|5|||
130324346|NCT02201953|469157121|FG000|Overall Study|Death|0|||
130324347|NCT02201953|469157122|FG001|Overall Study|Death|3|||
130324348|NCT01615939|469158630|FG000|Overall Study|Lost to Follow-up|5|||
130324349|NCT01615939|469158631|FG001|Overall Study|Lost to Follow-up|0|||
130324350|NCT02892344|469158635|FG000|Overall Study|Protocol deviation|3|||
130324351|NCT02892344|469158636|FG001|Overall Study|Protocol deviation|4|||
130324352|NCT02892344|469158635|FG000|Overall Study|Adverse Event|1|||
130324353|NCT02892344|469158636|FG001|Overall Study|Adverse Event|8|||
130324354|NCT02892344|469158635|FG000|Overall Study|Lost to Follow-up|0|||
130324355|NCT02892344|469158636|FG001|Overall Study|Lost to Follow-up|1|||
130324356|NCT02892344|469158635|FG000|Overall Study|Non-compliance with study treatment|0|||
130324357|NCT02892344|469158636|FG001|Overall Study|Non-compliance with study treatment|1|||
130324358|NCT02892344|469158635|FG000|Overall Study|Physician Decision|0|||
130324359|NCT02892344|469158636|FG001|Overall Study|Physician Decision|2|||
130324360|NCT02892344|469158635|FG000|Overall Study|Subject/guardian decision|0|||
130324361|NCT02892344|469158636|FG001|Overall Study|Subject/guardian decision|4|||
130324362|NCT02892344|469158635|FG000|Overall Study|Technical problems|0|||
130324363|NCT02892344|469158636|FG001|Overall Study|Technical problems|1|||
130324364|NCT03591406|469158638|FG000|Overall Study|Adverse Event|5|||
130324365|NCT03591406|469158639|FG001|Overall Study|Adverse Event|3|||
130324366|NCT03591406|469158638|FG000|Overall Study|Protocol Violation|2|||
130324367|NCT03591406|469158639|FG001|Overall Study|Protocol Violation|1|||
130324368|NCT03591406|469158638|FG000|Overall Study|Withdrawal by Subject|0|||
130324369|NCT03591406|469158639|FG001|Overall Study|Withdrawal by Subject|5|||
130324370|NCT01083771|469158640|FG000|Overall Study|non-compliant|2|||
129988035|NCT02679573|467918812|FG000|Overall Study|Death|2|||
129988036|NCT02679573|467918813|FG001|Overall Study|Death|0|||
129988037|NCT02679573|467918812|FG000|Overall Study|Physician Decision|2|||
129988038|NCT02679573|467918813|FG001|Overall Study|Physician Decision|4|||
129988039|NCT02679573|467918812|FG000|Overall Study|Lost to Follow-up|0|||
129988040|NCT02679573|467918813|FG001|Overall Study|Lost to Follow-up|3|||
129988041|NCT01502631|467918814|FG000|Overall Study|Adverse Event|5|||
129988042|NCT01502631|467918815|FG001|Overall Study|Adverse Event|8|||
129988043|NCT01502631|467918814|FG000|Overall Study|Lost to Follow-up|2|||
130324371|NCT01083771|469158640|FG000|Overall Study|Withdrawal by Subject|3|||
130324372|NCT02066181|469158641|FG000|Overall Study|Withdrawal by Subject|1|||
130324373|NCT02066181|469158642|FG001|Overall Study|Withdrawal by Subject|1|||
130324374|NCT00939393|469158645|FG000|Overall Study|Withdrawal by Subject|1|||
130324375|NCT00939393|469158646|FG001|Overall Study|Withdrawal by Subject|0|||
130324376|NCT00939393|469158645|FG000|Overall Study|Lost to Follow-up|3|||
130324377|NCT00939393|469158646|FG001|Overall Study|Lost to Follow-up|0|||
130324378|NCT02851615|469158647|FG000|Overall Study|Cognitive Issue|1|||
130324379|NCT02851615|469158648|FG001|Overall Study|Cognitive Issue|0|||
130324380|NCT02851615|469158647|FG000|Overall Study|Lost to Follow-up|0|||
129988044|NCT01502631|467918815|FG001|Overall Study|Lost to Follow-up|2|||
129988045|NCT01502631|467918814|FG000|Overall Study|Participant withdrew consent|2|||
129988046|NCT01502631|467918815|FG001|Overall Study|Participant withdrew consent|4|||
129988047|NCT01502631|467918814|FG000|Overall Study|Participant non-compliant|1|||
130098716|NCT03426995|468319300|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130324381|NCT02851615|469158648|FG001|Overall Study|Lost to Follow-up|4|||
130324382|NCT01747876|469158658|FG000|Overall Study|Adverse Event|1|||
130324383|NCT01747876|469158659|FG001|Overall Study|Adverse Event|0|||
130324384|NCT01747876|469158660|FG002|Overall Study|Adverse Event|2|||
130324385|NCT01747876|469158658|FG000|Overall Study|Withdrawal by Subject|0|||
130324386|NCT01747876|469158659|FG001|Overall Study|Withdrawal by Subject|1|||
130324387|NCT01747876|469158660|FG002|Overall Study|Withdrawal by Subject|1|||
130324388|NCT01747876|469158658|FG000|Overall Study|Disease progression|4|||
130324389|NCT01747876|469158659|FG001|Overall Study|Disease progression|13|||
130324390|NCT01747876|469158660|FG002|Overall Study|Disease progression|8|||
130324391|NCT01747876|469158658|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
130324392|NCT01747876|469158659|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
130324393|NCT01747876|469158660|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
130324394|NCT03131219|469158663|FG000|Initial Evaluation Period|Adverse Event|2|||
130324395|NCT03131219|469158664|FG001|Initial Evaluation Period|Adverse Event|0|||
130324396|NCT03131219|469158663|FG000|Initial Evaluation Period|Protocol Violation|1|||
130324397|NCT03131219|469158664|FG001|Initial Evaluation Period|Protocol Violation|0|||
130324398|NCT03131219|469158663|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
130324399|NCT03131219|469158664|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
130324400|NCT03131219|469158663|FG000|Initial Evaluation Period|Physician Decision|1|||
130324401|NCT03131219|469158664|FG001|Initial Evaluation Period|Physician Decision|0|||
130324402|NCT03131219|469158663|FG000|Extension Period|Physician Decision|1|||
130324403|NCT03131219|469158664|FG001|Extension Period|Physician Decision|0|||
130324404|NCT01391546|469158667|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
130324405|NCT01391546|469158668|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
130324406|NCT02156076|469158669|FG000|Treatment Period|no longer meets study criteria|0|||
130324407|NCT02156076|469158670|FG001|Treatment Period|no longer meets study criteria|0|||
130324408|NCT02156076|469158671|FG002|Treatment Period|no longer meets study criteria|1|||
130324409|NCT02156076|469158672|FG003|Treatment Period|no longer meets study criteria|0|||
130324410|NCT02156076|469158669|FG000|Treatment Period|Poor/non-compliance|0|||
130324411|NCT02156076|469158670|FG001|Treatment Period|Poor/non-compliance|1|||
130324412|NCT02156076|469158671|FG002|Treatment Period|Poor/non-compliance|0|||
130324413|NCT02156076|469158672|FG003|Treatment Period|Poor/non-compliance|0|||
130324414|NCT02156076|469158669|FG000|Treatment Period|Lost to Follow-up|0|||
130324415|NCT02156076|469158670|FG001|Treatment Period|Lost to Follow-up|0|||
130324416|NCT02156076|469158671|FG002|Treatment Period|Lost to Follow-up|0|||
130324417|NCT02156076|469158672|FG003|Treatment Period|Lost to Follow-up|1|||
130324418|NCT02156076|469158669|FG000|Treatment Period|Withdrawal by Subject|0|||
130324419|NCT02156076|469158670|FG001|Treatment Period|Withdrawal by Subject|0|||
130324420|NCT02156076|469158671|FG002|Treatment Period|Withdrawal by Subject|1|||
130324421|NCT02156076|469158672|FG003|Treatment Period|Withdrawal by Subject|0|||
130324422|NCT02156076|469158669|FG000|Treatment Period|Subject request to discontinue treatment|0|||
130324423|NCT02156076|469158670|FG001|Treatment Period|Subject request to discontinue treatment|1|||
130324424|NCT02156076|469158671|FG002|Treatment Period|Subject request to discontinue treatment|0|||
130324425|NCT02156076|469158672|FG003|Treatment Period|Subject request to discontinue treatment|0|||
130324426|NCT02156076|469158669|FG000|Treatment Period|Adverse Event|0|||
130324427|NCT02156076|469158670|FG001|Treatment Period|Adverse Event|0|||
130324428|NCT02156076|469158671|FG002|Treatment Period|Adverse Event|0|||
130324429|NCT02156076|469158672|FG003|Treatment Period|Adverse Event|1|||
130324430|NCT02156076|469158669|FG000|Follow-up Period|Withdrawal by Subject|1|||
130324431|NCT02156076|469158670|FG001|Follow-up Period|Withdrawal by Subject|0|||
130324432|NCT02156076|469158671|FG002|Follow-up Period|Withdrawal by Subject|0|||
130324433|NCT02156076|469158672|FG003|Follow-up Period|Withdrawal by Subject|0|||
130324434|NCT00003475|469158673|FG000|Overall Study|Not evaluable|13|||
130324435|NCT01498068|469158677|FG000|Overall Study|Withdrawal by Subject|1|||
130324436|NCT01498068|469158678|FG001|Overall Study|Withdrawal by Subject|1|||
130324437|NCT01353898|469158680|FG000|Overall Study|Study site terminated|0|||
130324438|NCT01353898|469158681|FG001|Overall Study|Study site terminated|0|||
130324439|NCT01353898|469158682|FG002|Overall Study|Study site terminated|0|||
130324440|NCT01353898|469158683|FG003|Overall Study|Study site terminated|0|||
130324441|NCT01353898|469158684|FG004|Overall Study|Study site terminated|0|||
130324442|NCT01353898|469158685|FG005|Overall Study|Study site terminated|1|||
130324443|NCT03558737|469158686|FG000|Overall Study|Death|1|||
129883416|NCT03857841|467532426|FG000|Overall Study|Study Terminated by Sponsor|1|||
129883417|NCT03857841|467532427|FG001|Overall Study|Study Terminated by Sponsor|0|||
129883418|NCT03857841|467532428|FG002|Overall Study|Study Terminated by Sponsor|0|||
129883419|NCT03857841|467532429|FG003|Overall Study|Study Terminated by Sponsor|0|||
129883420|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883421|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
129883422|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
129883423|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883424|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883425|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883426|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883427|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
129988048|NCT01502631|467918815|FG001|Overall Study|Participant non-compliant|0|||
129988049|NCT01502631|467918814|FG000|Overall Study|Investigator's decision|0|||
129988050|NCT01502631|467918815|FG001|Overall Study|Investigator's decision|1|||
129988051|NCT01502631|467918814|FG000|Overall Study|Other|10|||
129988052|NCT01502631|467918815|FG001|Overall Study|Other|5|||
129988053|NCT01293487|467918816|FG000|Overall Study|Lost to Follow-up|0|||
129988054|NCT01293487|467918817|FG001|Overall Study|Lost to Follow-up|0|||
129988055|NCT01293487|467918818|FG002|Overall Study|Lost to Follow-up|0|||
129988056|NCT01293487|467918819|FG003|Overall Study|Lost to Follow-up|1|||
129988057|NCT01293487|467918820|FG004|Overall Study|Lost to Follow-up|0|||
129988058|NCT01293487|467918821|FG005|Overall Study|Lost to Follow-up|0|||
129988059|NCT01293487|467918822|FG006|Overall Study|Lost to Follow-up|0|||
129988060|NCT01293487|467918823|FG007|Overall Study|Lost to Follow-up|0|||
129988061|NCT01293487|467918816|FG000|Overall Study|Withdrawal by Subject|0|||
129988062|NCT01293487|467918817|FG001|Overall Study|Withdrawal by Subject|0|||
129988063|NCT01293487|467918818|FG002|Overall Study|Withdrawal by Subject|0|||
129988064|NCT01293487|467918819|FG003|Overall Study|Withdrawal by Subject|0|||
129988065|NCT01293487|467918820|FG004|Overall Study|Withdrawal by Subject|0|||
129988066|NCT01293487|467918821|FG005|Overall Study|Withdrawal by Subject|0|||
129988067|NCT01293487|467918822|FG006|Overall Study|Withdrawal by Subject|0|||
129988068|NCT01293487|467918823|FG007|Overall Study|Withdrawal by Subject|2|||
129988069|NCT00395460|467918824|FG000|Overall Study|Withdrawal by Subject|1|||
129988070|NCT00395460|467918825|FG001|Overall Study|Withdrawal by Subject|0|||
129988071|NCT04223830|467918832|FG000|Overall Study|Lost to Follow-up|9|||
129988072|NCT04223830|467918832|FG000|Overall Study|Adverse Event|1|||
129988073|NCT01806623|467918833|FG000|Overall Study|Withdrawal by Subject|1|||
129988074|NCT01806623|467918833|FG000|Overall Study|Adverse Event|1|||
129988075|NCT01806623|467918833|FG000|Overall Study|Did not meet the inclusion criteria|56|||
129988076|NCT01964924|467918834|FG000|Trametinib Monotherapy|Progression|19|||
130324444|NCT03558737|469158687|FG001|Overall Study|Death|1|||
130324445|NCT01318915|469158688|FG000|Overall Study|Lost to Follow-up|1|||
130324446|NCT00453206|469158690|FG000|Overall Study|Death|1|||
129988077|NCT01964924|467918835|FG001|Trametinib Monotherapy|Progression|0|||
129988078|NCT01153958|467918836|FG000|Overall Study|Study Terminated|36|||
129988079|NCT01153958|467918837|FG001|Overall Study|Study Terminated|32|||
129988080|NCT01034163|467918838|FG000|Overall Study|Treatment completed as per protocol|8|||
129988081|NCT01034163|467918839|FG001|Overall Study|Treatment completed as per protocol|7|||
130324447|NCT05386329|469158691|FG000|Overall Study|Lost to Follow-up|3|||
130324448|NCT03041181|469158693|FG000|Overall Study|Disease Progression|1|||
130324449|NCT03041181|469158694|FG001|Overall Study|Disease Progression|2|||
130324450|NCT03104868|469158695|FG000|6 Week Follow up|Lost to Follow-up|5|||
130324451|NCT03104868|469158696|FG001|6 Week Follow up|Lost to Follow-up|8|||
130324452|NCT03104868|469158695|FG000|6 Week Follow up|Death|1|||
130324453|NCT03104868|469158696|FG001|6 Week Follow up|Death|1|||
130324454|NCT03104868|469158695|FG000|6 Week Follow up|Withdrawal by Subject|7|||
130324455|NCT03104868|469158696|FG001|6 Week Follow up|Withdrawal by Subject|6|||
130324456|NCT03104868|469158695|FG000|6 Week Follow up|Completed Later Timepoint|24|||
130324457|NCT03104868|469158696|FG001|6 Week Follow up|Completed Later Timepoint|22|||
130324458|NCT03104868|469158695|FG000|6 Month Follow up|Lost to Follow-up|2|||
130324459|NCT03104868|469158696|FG001|6 Month Follow up|Lost to Follow-up|2|||
130324460|NCT03104868|469158695|FG000|6 Month Follow up|Death|0|||
130324461|NCT03104868|469158696|FG001|6 Month Follow up|Death|1|||
130324462|NCT03104868|469158695|FG000|6 Month Follow up|Completed Later Timepoint|22|||
130324463|NCT03104868|469158696|FG001|6 Month Follow up|Completed Later Timepoint|32|||
130324464|NCT03104868|469158695|FG000|12 Month Follow up|Lost to Follow-up|1|||
130324465|NCT03104868|469158696|FG001|12 Month Follow up|Lost to Follow-up|2|||
130324466|NCT03104868|469158695|FG000|12 Month Follow up|Death|0|||
130324467|NCT03104868|469158696|FG001|12 Month Follow up|Death|1|||
130324468|NCT03104868|469158695|FG000|12 Month Follow up|Withdrawal by Subject|0|||
130324469|NCT03104868|469158696|FG001|12 Month Follow up|Withdrawal by Subject|3|||
130324470|NCT03104868|469158695|FG000|12 Month Follow up|Completed Later Timepoint|32|||
130324471|NCT03104868|469158696|FG001|12 Month Follow up|Completed Later Timepoint|29|||
130324472|NCT03104868|469158695|FG000|18 Month Follow up|Lost to Follow-up|7|||
130324473|NCT03104868|469158696|FG001|18 Month Follow up|Lost to Follow-up|11|||
130324474|NCT03104868|469158695|FG000|18 Month Follow up|Death|2|||
130324475|NCT03104868|469158696|FG001|18 Month Follow up|Death|1|||
130324476|NCT03104868|469158695|FG000|18 Month Follow up|Withdrawal by Subject|1|||
130324477|NCT03104868|469158696|FG001|18 Month Follow up|Withdrawal by Subject|2|||
129988082|NCT01034163|467918838|FG000|Overall Study|Withdrawal by Subject|8|||
129988083|NCT01034163|467918839|FG001|Overall Study|Withdrawal by Subject|2|||
129988084|NCT01034163|467918838|FG000|Overall Study|Protocol deviation|1|||
129988085|NCT01034163|467918839|FG001|Overall Study|Protocol deviation|0|||
129988086|NCT01034163|467918838|FG000|Overall Study|Disease progression|3|||
129988087|NCT01034163|467918839|FG001|Overall Study|Disease progression|4|||
129988088|NCT01034163|467918838|FG000|Overall Study|Adverse Event|6|||
129988089|NCT01034163|467918839|FG001|Overall Study|Adverse Event|0|||
130324478|NCT03104868|469158695|FG000|18 Month Follow up|Graft Loss|1|||
130324479|NCT03104868|469158696|FG001|18 Month Follow up|Graft Loss|1|||
130324480|NCT03104868|469158695|FG000|18 Month Follow up|Completed Later Timepoint|19|||
130324481|NCT03104868|469158696|FG001|18 Month Follow up|Completed Later Timepoint|20|||
130324482|NCT03104868|469158695|FG000|24 Month Follow up|Lost to Follow-up|15|||
130324483|NCT03104868|469158696|FG001|24 Month Follow up|Lost to Follow-up|16|||
130324484|NCT03104868|469158695|FG000|24 Month Follow up|Death|3|||
130324485|NCT03104868|469158696|FG001|24 Month Follow up|Death|2|||
130324486|NCT03104868|469158695|FG000|24 Month Follow up|Withdrawal by Subject|1|||
130324487|NCT03104868|469158696|FG001|24 Month Follow up|Withdrawal by Subject|0|||
130324488|NCT03104868|469158695|FG000|24 Month Follow up|Graft Loss|2|||
130324489|NCT03104868|469158696|FG001|24 Month Follow up|Graft Loss|0|||
130324490|NCT03050801|469158699|FG000|Experiment 1|Lost to Follow-up|0|||
130324491|NCT03050801|469158700|FG001|Experiment 1|Lost to Follow-up|1|||
130324492|NCT03050801|469158701|FG002|Experiment 1|Lost to Follow-up|0|||
130324493|NCT03050801|469158702|FG003|Experiment 1|Lost to Follow-up|0|||
130324494|NCT03050801|469158703|FG004|Experiment 1|Lost to Follow-up|0|||
130324495|NCT03050801|469158704|FG005|Experiment 1|Lost to Follow-up|0|||
130324496|NCT03050801|469158699|FG000|Experiment 1|Physician Decision|0|||
130324497|NCT03050801|469158700|FG001|Experiment 1|Physician Decision|3|||
130324498|NCT03050801|469158701|FG002|Experiment 1|Physician Decision|0|||
130324499|NCT03050801|469158702|FG003|Experiment 1|Physician Decision|0|||
130324500|NCT03050801|469158703|FG004|Experiment 1|Physician Decision|0|||
130324501|NCT03050801|469158704|FG005|Experiment 1|Physician Decision|0|||
130324502|NCT03050801|469158699|FG000|Experiment 1|Change of experimental design|0|||
130324503|NCT03050801|469158700|FG001|Experiment 1|Change of experimental design|3|||
130324504|NCT03050801|469158701|FG002|Experiment 1|Change of experimental design|0|||
130324505|NCT03050801|469158702|FG003|Experiment 1|Change of experimental design|0|||
130324506|NCT03050801|469158703|FG004|Experiment 1|Change of experimental design|0|||
130324507|NCT03050801|469158704|FG005|Experiment 1|Change of experimental design|0|||
130324508|NCT03050801|469158699|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324509|NCT03050801|469158700|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324510|NCT03050801|469158701|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
130324511|NCT03050801|469158702|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324512|NCT03050801|469158703|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324513|NCT03050801|469158704|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
130324514|NCT03050801|469158699|FG000|Experiment 2|Lost to Follow-up|0|||
130324515|NCT03050801|469158700|FG001|Experiment 2|Lost to Follow-up|0|||
130324516|NCT03050801|469158701|FG002|Experiment 2|Lost to Follow-up|0|||
130324517|NCT03050801|469158702|FG003|Experiment 2|Lost to Follow-up|1|||
130324518|NCT03050801|469158703|FG004|Experiment 2|Lost to Follow-up|1|||
130324519|NCT03050801|469158704|FG005|Experiment 2|Lost to Follow-up|0|||
130324520|NCT03050801|469158699|FG000|Experiment 2|Physician Decision|0|||
130324521|NCT03050801|469158700|FG001|Experiment 2|Physician Decision|0|||
130324522|NCT03050801|469158701|FG002|Experiment 2|Physician Decision|0|||
130324523|NCT03050801|469158702|FG003|Experiment 2|Physician Decision|0|||
130324524|NCT03050801|469158703|FG004|Experiment 2|Physician Decision|1|||
130324525|NCT03050801|469158704|FG005|Experiment 2|Physician Decision|0|||
130324526|NCT03050801|469158699|FG000|Experiment 2|Pregnancy|0|||
130324527|NCT03050801|469158700|FG001|Experiment 2|Pregnancy|0|||
130324528|NCT03050801|469158701|FG002|Experiment 2|Pregnancy|0|||
130324529|NCT03050801|469158702|FG003|Experiment 2|Pregnancy|0|||
130324530|NCT03050801|469158703|FG004|Experiment 2|Pregnancy|1|||
130324531|NCT03050801|469158704|FG005|Experiment 2|Pregnancy|0|||
130324532|NCT03050801|469158699|FG000|Experiment 2|Withdrawal by Subject|0|||
130324533|NCT03050801|469158700|FG001|Experiment 2|Withdrawal by Subject|0|||
130324534|NCT03050801|469158701|FG002|Experiment 2|Withdrawal by Subject|0|||
130324535|NCT03050801|469158702|FG003|Experiment 2|Withdrawal by Subject|1|||
130324536|NCT03050801|469158703|FG004|Experiment 2|Withdrawal by Subject|0|||
130324537|NCT03050801|469158704|FG005|Experiment 2|Withdrawal by Subject|0|||
130324538|NCT03050801|469158699|FG000|Experiment 2|Poor data quality|0|||
130324539|NCT03050801|469158700|FG001|Experiment 2|Poor data quality|0|||
130324540|NCT03050801|469158701|FG002|Experiment 2|Poor data quality|0|||
130324541|NCT03050801|469158702|FG003|Experiment 2|Poor data quality|4|||
130324542|NCT03050801|469158703|FG004|Experiment 2|Poor data quality|1|||
130324543|NCT03050801|469158704|FG005|Experiment 2|Poor data quality|0|||
130324544|NCT03050801|469158699|FG000|Experiment 2|Discomfort during stimulation|0|||
129883428|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883429|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883430|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883431|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883432|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130324545|NCT03050801|469158700|FG001|Experiment 2|Discomfort during stimulation|0|||
130324546|NCT03050801|469158701|FG002|Experiment 2|Discomfort during stimulation|0|||
130324547|NCT03050801|469158702|FG003|Experiment 2|Discomfort during stimulation|0|||
130324548|NCT03050801|469158703|FG004|Experiment 2|Discomfort during stimulation|0|||
130324549|NCT03050801|469158704|FG005|Experiment 2|Discomfort during stimulation|2|||
130324550|NCT00005780|469158705|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
130324551|NCT03600909|469158706|FG000|Overall Study|Not treated|0|||
130324552|NCT03600909|469158707|FG001|Overall Study|Not treated|3|||
130324553|NCT03600909|469158708|FG002|Overall Study|Not treated|0|||
130324554|NCT02651675|469158709|FG000|Overall Study|Death|0|||
130324555|NCT02651675|469158710|FG001|Overall Study|Death|0|||
130324556|NCT02651675|469158711|FG002|Overall Study|Death|1|||
130324557|NCT03674411|469158712|FG000|Overall Study|Non-treatment|4|||
130324558|NCT04408989|469158713|FG000|Overall Study|Lost to Follow-up|0|||
130324559|NCT04408989|469158714|FG001|Overall Study|Lost to Follow-up|0|||
130324560|NCT04408989|469158715|FG002|Overall Study|Lost to Follow-up|1|||
130324561|NCT04408989|469158713|FG000|Overall Study|Withdrawal by Subject|0|||
130324562|NCT04408989|469158714|FG001|Overall Study|Withdrawal by Subject|0|||
130324563|NCT04408989|469158715|FG002|Overall Study|Withdrawal by Subject|2|||
130324564|NCT02694185|469158716|FG000|Overall Study|Withdrawal by Subject|45|||
130324565|NCT02694185|469158717|FG001|Overall Study|Withdrawal by Subject|0|||
130324566|NCT05082857|469158718|FG000|Overall Study|participants relocated and could not continue|2|||
130324567|NCT05082857|469158719|FG001|Overall Study|participants relocated and could not continue|1|||
130324568|NCT05082857|469158718|FG000|Overall Study|Lost to Follow-up|1|||
130324569|NCT05082857|469158719|FG001|Overall Study|Lost to Follow-up|3|||
130324570|NCT04363320|469158720|FG000|Overall Study|Lost to Follow-up|43|||
130324571|NCT04363320|469158721|FG001|Overall Study|Lost to Follow-up|42|||
130324572|NCT04363320|469158722|FG002|Overall Study|Lost to Follow-up|24|||
130324573|NCT04363320|469158723|FG003|Overall Study|Lost to Follow-up|29|||
130324574|NCT04363320|469158720|FG000|Overall Study|Death|0|||
130324575|NCT04363320|469158721|FG001|Overall Study|Death|0|||
130324576|NCT04363320|469158722|FG002|Overall Study|Death|1|||
130324577|NCT04363320|469158723|FG003|Overall Study|Death|0|||
130324578|NCT05632211|469158724|FG000|Overall Study|Withdrawal by Subject|2|||
130324579|NCT05632211|469158725|FG001|Overall Study|Withdrawal by Subject|0|||
130324580|NCT05632211|469158726|FG002|Overall Study|Withdrawal by Subject|2|||
130324581|NCT05632211|469158724|FG000|Overall Study|Other reasons|1|||
130324582|NCT05632211|469158725|FG001|Overall Study|Other reasons|1|||
130324583|NCT05632211|469158726|FG002|Overall Study|Other reasons|1|||
130324584|NCT04672239|469158727|FG000|Week 2 Survey|Failed survey check items|1|||
130324585|NCT04672239|469158728|FG001|Week 2 Survey|Failed survey check items|2|||
130324586|NCT04672239|469158729|FG002|Week 2 Survey|Failed survey check items|3|||
130324587|NCT04672239|469158727|FG000|Week 2 Survey|Partially completed survey|7|||
130324588|NCT04672239|469158728|FG001|Week 2 Survey|Partially completed survey|1|||
130324589|NCT04672239|469158729|FG002|Week 2 Survey|Partially completed survey|4|||
130324590|NCT04672239|469158727|FG000|Week 2 Survey|Withdrawal by Subject|0|||
130324591|NCT04672239|469158728|FG001|Week 2 Survey|Withdrawal by Subject|1|||
130324592|NCT04672239|469158729|FG002|Week 2 Survey|Withdrawal by Subject|0|||
130324593|NCT04672239|469158727|FG000|Week 2 Survey|Lost to Follow-up|3|||
130324594|NCT04672239|469158728|FG001|Week 2 Survey|Lost to Follow-up|2|||
130324595|NCT04672239|469158729|FG002|Week 2 Survey|Lost to Follow-up|5|||
130324596|NCT04672239|469158727|FG000|Week 6 Survey|Failed survey check items|2|||
130324597|NCT04672239|469158728|FG001|Week 6 Survey|Failed survey check items|2|||
130324598|NCT04672239|469158729|FG002|Week 6 Survey|Failed survey check items|2|||
130324599|NCT04672239|469158727|FG000|Week 6 Survey|Partially completed survey|3|||
130324600|NCT04672239|469158728|FG001|Week 6 Survey|Partially completed survey|3|||
130324601|NCT04672239|469158729|FG002|Week 6 Survey|Partially completed survey|2|||
130324602|NCT04672239|469158727|FG000|Week 6 Survey|Withdrawal by Subject|1|||
130324603|NCT04672239|469158728|FG001|Week 6 Survey|Withdrawal by Subject|1|||
130324604|NCT04672239|469158729|FG002|Week 6 Survey|Withdrawal by Subject|1|||
130324605|NCT04672239|469158727|FG000|Week 6 Survey|Withdrawn by PI|0|||
130324606|NCT04672239|469158728|FG001|Week 6 Survey|Withdrawn by PI|1|||
130324607|NCT04672239|469158729|FG002|Week 6 Survey|Withdrawn by PI|0|||
130324608|NCT04672239|469158727|FG000|Week 6 Survey|Lost to Follow-up|12|||
130324609|NCT04672239|469158728|FG001|Week 6 Survey|Lost to Follow-up|2|||
130324610|NCT04672239|469158729|FG002|Week 6 Survey|Lost to Follow-up|5|||
130324611|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
130324612|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
130324613|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
130324614|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
129883433|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883434|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
129883435|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
129883436|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
129883437|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129883438|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129883439|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130324615|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
129883440|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130324616|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
130324617|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
130324618|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
130324619|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
130324620|NCT04672239|469158727|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
130324621|NCT04672239|469158728|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
130324622|NCT04672239|469158729|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
130324623|NCT04672239|469158727|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
130324624|NCT04672239|469158728|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
130324625|NCT04672239|469158729|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
130324626|NCT04672239|469158727|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
130324627|NCT04672239|469158728|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
130324628|NCT04672239|469158729|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
130324629|NCT04672239|469158727|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
130324630|NCT04672239|469158728|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
130324631|NCT04672239|469158729|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
130324632|NCT04606134|469158730|FG000|Overall Study|Adverse Event|0|||
130324633|NCT04606134|469158731|FG001|Overall Study|Adverse Event|1|||
130324634|NCT01099267|469158733|FG000|MDS-003 Study|Adverse Event|37|||
130324635|NCT01099267|469158733|FG000|MDS-003 Study|Lack of Efficacy|52|||
130324636|NCT01099267|469158733|FG000|MDS-003 Study|Withdrawal by Subject|8|||
130324637|NCT01099267|469158733|FG000|MDS-003 Study|Lost to Follow-up|1|||
129883441|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883442|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
129883443|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
129883444|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883445|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883446|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883447|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883448|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883449|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883450|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
129883451|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883452|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883453|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883454|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883455|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
129883456|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
129883457|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
129883458|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883459|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883460|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883461|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883462|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
129883463|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
129883464|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883465|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883466|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883467|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883468|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883469|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883470|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883471|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883472|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883473|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883474|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883475|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
129883476|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883477|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883478|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883479|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
129883480|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883481|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
129883482|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129883483|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129883484|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129883485|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129883486|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
129883487|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
130324638|NCT01099267|469158733|FG000|MDS-003 Study|Death|11|||
129883488|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
129883489|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
130324639|NCT01099267|469158733|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
130324640|NCT01099267|469158733|FG000|MDS-003 Study|Disease Progression|7|||
130324641|NCT01099267|469158733|FG000|MDS-003 Study|Investigator Decision|2|||
130324642|NCT01099267|469158733|FG000|MDS-003 Study|Non-Compliance|2|||
130324643|NCT01099267|469158733|FG000|MDS-003 Study|Loss of Response|1|||
130324644|NCT01099267|469158733|FG000|MDS-003 Study|Secondary Malign Disease|1|||
130324645|NCT01838395|469158741|FG000|Overall Study|Withdrawal by Subject|0|||
130324646|NCT01838395|469158742|FG001|Overall Study|Withdrawal by Subject|0|||
130324647|NCT01838395|469158743|FG002|Overall Study|Withdrawal by Subject|0|||
130324648|NCT01838395|469158744|FG003|Overall Study|Withdrawal by Subject|0|||
130324649|NCT01838395|469158745|FG004|Overall Study|Withdrawal by Subject|1|||
130324650|NCT01838395|469158746|FG005|Overall Study|Withdrawal by Subject|0|||
130324651|NCT01838395|469158741|FG000|Overall Study|Death|0|||
130324652|NCT01838395|469158742|FG001|Overall Study|Death|0|||
130324653|NCT01838395|469158743|FG002|Overall Study|Death|1|||
130324654|NCT01838395|469158744|FG003|Overall Study|Death|0|||
130324655|NCT01838395|469158745|FG004|Overall Study|Death|0|||
130324656|NCT01838395|469158746|FG005|Overall Study|Death|0|||
130324657|NCT01838395|469158741|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324658|NCT01838395|469158742|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
130324659|NCT01838395|469158743|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324660|NCT01838395|469158744|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324661|NCT01838395|469158745|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324662|NCT01838395|469158746|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
130324663|NCT03866577|469158747|FG000|Overall Study|Protocol Violation|0|||
130324664|NCT03866577|469158748|FG001|Overall Study|Protocol Violation|0|||
130324665|NCT03866577|469158749|FG002|Overall Study|Protocol Violation|0|||
130324666|NCT03866577|469158750|FG003|Overall Study|Protocol Violation|0|||
130324667|NCT03866577|469158751|FG004|Overall Study|Protocol Violation|0|||
130324668|NCT03866577|469158752|FG005|Overall Study|Protocol Violation|0|||
130324669|NCT03866577|469158753|FG006|Overall Study|Protocol Violation|0|||
130324670|NCT03866577|469158754|FG007|Overall Study|Protocol Violation|0|||
130324671|NCT03866577|469158755|FG008|Overall Study|Protocol Violation|0|||
130324672|NCT03866577|469158756|FG009|Overall Study|Protocol Violation|0|||
130324673|NCT03866577|469158757|FG010|Overall Study|Protocol Violation|0|||
130324674|NCT03866577|469158758|FG011|Overall Study|Protocol Violation|1|||
130324675|NCT03866577|469158759|FG012|Overall Study|Protocol Violation|0|||
130324676|NCT03866577|469158747|FG000|Overall Study|Withdrawal by Subject|0|||
130324677|NCT03866577|469158748|FG001|Overall Study|Withdrawal by Subject|0|||
130324678|NCT03866577|469158749|FG002|Overall Study|Withdrawal by Subject|0|||
130324679|NCT03866577|469158750|FG003|Overall Study|Withdrawal by Subject|0|||
130324680|NCT03866577|469158751|FG004|Overall Study|Withdrawal by Subject|0|||
130324681|NCT03866577|469158752|FG005|Overall Study|Withdrawal by Subject|0|||
130324682|NCT03866577|469158753|FG006|Overall Study|Withdrawal by Subject|0|||
130324683|NCT03866577|469158754|FG007|Overall Study|Withdrawal by Subject|0|||
130324684|NCT03866577|469158755|FG008|Overall Study|Withdrawal by Subject|1|||
130324685|NCT03866577|469158756|FG009|Overall Study|Withdrawal by Subject|1|||
130324686|NCT03866577|469158757|FG010|Overall Study|Withdrawal by Subject|0|||
130324687|NCT03866577|469158758|FG011|Overall Study|Withdrawal by Subject|0|||
130324688|NCT03866577|469158759|FG012|Overall Study|Withdrawal by Subject|0|||
130324689|NCT03866577|469158747|FG000|Overall Study|Not qualified for IVIg infusion|0|||
130324690|NCT03866577|469158748|FG001|Overall Study|Not qualified for IVIg infusion|0|||
130324691|NCT03866577|469158749|FG002|Overall Study|Not qualified for IVIg infusion|0|||
130324692|NCT03866577|469158750|FG003|Overall Study|Not qualified for IVIg infusion|0|||
130324693|NCT03866577|469158751|FG004|Overall Study|Not qualified for IVIg infusion|0|||
130324694|NCT03866577|469158752|FG005|Overall Study|Not qualified for IVIg infusion|0|||
130324695|NCT03866577|469158753|FG006|Overall Study|Not qualified for IVIg infusion|0|||
130324696|NCT03866577|469158754|FG007|Overall Study|Not qualified for IVIg infusion|0|||
130324697|NCT03866577|469158755|FG008|Overall Study|Not qualified for IVIg infusion|0|||
130324698|NCT03866577|469158756|FG009|Overall Study|Not qualified for IVIg infusion|1|||
130324699|NCT03866577|469158757|FG010|Overall Study|Not qualified for IVIg infusion|0|||
130324700|NCT03866577|469158758|FG011|Overall Study|Not qualified for IVIg infusion|0|||
130324701|NCT03866577|469158759|FG012|Overall Study|Not qualified for IVIg infusion|0|||
130324702|NCT04825678|469158760|FG000|Overall Study|Decision by Sponsor|2|||
130324703|NCT04825678|469158761|FG001|Overall Study|Decision by Sponsor|3|||
130324704|NCT04825678|469158760|FG000|Overall Study|Withdrawal of Consent From Study|7|||
130324705|NCT04825678|469158761|FG001|Overall Study|Withdrawal of Consent From Study|9|||
130324706|NCT04825678|469158760|FG000|Overall Study|Lost to Follow-up|3|||
130324707|NCT04825678|469158761|FG001|Overall Study|Lost to Follow-up|4|||
130324708|NCT04825678|469158760|FG000|Overall Study|Never Received Investigational Product|1|||
130324709|NCT04825678|469158761|FG001|Overall Study|Never Received Investigational Product|1|||
130324710|NCT05530252|469158762|FG000|Overall Study|Lost to Follow-up|1|||
130324711|NCT05530252|469158763|FG001|Overall Study|Lost to Follow-up|1|||
130324712|NCT05530252|469158764|FG002|Overall Study|Lost to Follow-up|1|||
130324713|NCT03043794|469158770|FG000|Overall Study|Lost to Follow-up|1|||
129883490|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130214699|NCT02757352|468751604|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214700|NCT02757352|468751605|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214701|NCT02757352|468751606|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214702|NCT02757352|468751607|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214703|NCT02757352|468751608|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214704|NCT02757352|468751609|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
130214705|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214706|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
130214707|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214708|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214709|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214710|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214711|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214712|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214713|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214714|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
130214715|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214716|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130214717|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214718|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214719|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214720|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214721|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214722|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214723|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214724|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214725|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214726|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214727|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
130214728|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214729|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214730|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214731|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214732|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214733|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214734|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214735|NCT02757352|468751600|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
130214736|NCT02757352|468751601|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
130214737|NCT02757352|468751602|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
130214738|NCT02757352|468751603|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214739|NCT02757352|468751604|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214740|NCT02757352|468751605|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214741|NCT02757352|468751606|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214742|NCT02757352|468751607|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214743|NCT02757352|468751608|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214744|NCT02757352|468751609|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
130214745|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214746|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214747|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214748|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
130214749|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214750|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
130214751|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214752|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214753|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214754|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
130214755|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214756|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214757|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214758|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
129883491|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
130324714|NCT05565742|469158771|FG000|Overall Study|Withdrawal by Subject|0|||
130324715|NCT05565742|469158772|FG001|Overall Study|Withdrawal by Subject|0|||
130324716|NCT05565742|469158773|FG002|Overall Study|Withdrawal by Subject|2|||
130324717|NCT05565742|469158774|FG003|Overall Study|Withdrawal by Subject|2|||
130324718|NCT05565742|469158775|FG004|Overall Study|Withdrawal by Subject|2|||
130324719|NCT05565742|469158771|FG000|Overall Study|Death|1|||
130324720|NCT05565742|469158772|FG001|Overall Study|Death|0|||
130324721|NCT05565742|469158773|FG002|Overall Study|Death|0|||
130324722|NCT05565742|469158774|FG003|Overall Study|Death|0|||
129883492|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
129883493|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
129883494|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
129883495|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
129883496|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
129883497|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129883498|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129883499|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129883500|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
129988090|NCT01034163|467918838|FG000|Overall Study|Administrative problems|0|||
129988091|NCT01034163|467918839|FG001|Overall Study|Administrative problems|1|||
129988092|NCT01034163|467918838|FG000|Overall Study|Abnormal laboratory value|1|||
129988093|NCT01034163|467918839|FG001|Overall Study|Abnormal laboratory value|0|||
129988094|NCT00528645|467918840|FG000|Overall Study|Adverse Event|3|||
130214759|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130214760|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
130214761|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214762|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214763|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214764|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130214765|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214766|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214767|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214768|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214769|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
130214770|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214771|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214772|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214773|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214774|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
130214775|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214776|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214777|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214778|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214779|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214780|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
130214781|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214782|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214783|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214784|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
130214785|NCT02757352|468751600|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214786|NCT02757352|468751601|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214787|NCT02757352|468751602|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214788|NCT02757352|468751603|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
130214789|NCT02757352|468751604|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214790|NCT02757352|468751605|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
130214791|NCT02757352|468751606|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214792|NCT02757352|468751607|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214793|NCT02757352|468751608|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214794|NCT02757352|468751609|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130214795|NCT02757352|468751600|FG000|Follow-Up Period|Adverse Event|0|||
130214796|NCT02757352|468751601|FG001|Follow-Up Period|Adverse Event|0|||
130214797|NCT02757352|468751602|FG002|Follow-Up Period|Adverse Event|0|||
130214798|NCT02757352|468751603|FG003|Follow-Up Period|Adverse Event|0|||
130214799|NCT02757352|468751604|FG004|Follow-Up Period|Adverse Event|0|||
130214800|NCT02757352|468751605|FG005|Follow-Up Period|Adverse Event|0|||
130324723|NCT05565742|469158775|FG004|Overall Study|Death|0|||
130324724|NCT05565742|469158771|FG000|Overall Study|Participant Travelled Abroad|0|||
129988095|NCT02150343|467918841|FG000|Overall Study|Adverse Event|2|||
129988096|NCT02150343|467918842|FG001|Overall Study|Adverse Event|0|||
130324725|NCT05565742|469158772|FG001|Overall Study|Participant Travelled Abroad|0|||
130324726|NCT05565742|469158773|FG002|Overall Study|Participant Travelled Abroad|0|||
130324727|NCT05565742|469158774|FG003|Overall Study|Participant Travelled Abroad|0|||
130324728|NCT05565742|469158775|FG004|Overall Study|Participant Travelled Abroad|1|||
130324729|NCT04163341|469158776|FG000|Overall Study|Withdrawal by Subject|2|||
130324730|NCT04163341|469158777|FG001|Overall Study|Withdrawal by Subject|0|||
130324731|NCT04163341|469158776|FG000|Overall Study|Lost to Follow-up|3|||
130324732|NCT04163341|469158777|FG001|Overall Study|Lost to Follow-up|4|||
130324733|NCT02855125|469158778|FG000|Overall Study|Withdrawal by Subject|2|||
130324734|NCT02855125|469158779|FG001|Overall Study|Withdrawal by Subject|2|||
130324735|NCT02855125|469158778|FG000|Overall Study|Clinical Disease Progression|5|||
130324736|NCT02855125|469158779|FG001|Overall Study|Clinical Disease Progression|4|||
130324737|NCT02855125|469158778|FG000|Overall Study|Radiologic Disease Progression|36|||
130324738|NCT02855125|469158779|FG001|Overall Study|Radiologic Disease Progression|39|||
130324739|NCT02855125|469158778|FG000|Overall Study|Adverse Event|11|||
130324740|NCT02855125|469158779|FG001|Overall Study|Adverse Event|7|||
130324741|NCT02855125|469158778|FG000|Overall Study|Physician Decision|1|||
130324742|NCT02855125|469158779|FG001|Overall Study|Physician Decision|0|||
130324743|NCT02855125|469158778|FG000|Overall Study|On Treatment|9|||
130324744|NCT02855125|469158779|FG001|Overall Study|On Treatment|11|||
130324745|NCT02855125|469158778|FG000|Overall Study|Randomized but not treated|0|||
130324746|NCT02855125|469158779|FG001|Overall Study|Randomized but not treated|1|||
130324747|NCT04467905|469158780|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
130324748|NCT04467905|469158781|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
130324749|NCT04467905|469158782|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
130324750|NCT04467905|469158780|FG000|Overall Study|Conversion to SR|0|||
130324751|NCT04467905|469158781|FG001|Overall Study|Conversion to SR|0|||
130324752|NCT04467905|469158782|FG002|Overall Study|Conversion to SR|3|||
130324753|NCT04467905|469158780|FG000|Overall Study|Technical issue with Holter ECG|0|||
130324754|NCT04467905|469158781|FG001|Overall Study|Technical issue with Holter ECG|0|||
130324755|NCT04467905|469158782|FG002|Overall Study|Technical issue with Holter ECG|3|||
130324756|NCT04467905|469158780|FG000|Overall Study|Hemodynamic instability|0|||
130324757|NCT04467905|469158781|FG001|Overall Study|Hemodynamic instability|0|||
130324758|NCT04467905|469158782|FG002|Overall Study|Hemodynamic instability|1|||
130324759|NCT04467905|469158780|FG000|Overall Study|Site misinterpretation of protocol|0|||
130324760|NCT04467905|469158781|FG001|Overall Study|Site misinterpretation of protocol|0|||
130324761|NCT04467905|469158782|FG002|Overall Study|Site misinterpretation of protocol|1|||
130324762|NCT04586205|469158787|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
130324763|NCT04586205|469158788|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
129883501|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
129883502|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
129883503|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
129883504|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
129883505|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130324782|NCT01586364|469160689|FG000|Overall Study|Withdrawal by Subject|40|||
130324783|NCT01586364|469160689|FG000|Overall Study|Adverse Event|37|||
129883506|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130324784|NCT01586364|469160689|FG000|Overall Study|Lost to Follow-up|17|||
130324785|NCT01586364|469160689|FG000|Overall Study|Protocol Violation|16|||
130324786|NCT01586364|469160689|FG000|Overall Study|Lack of Efficacy|1|||
130324787|NCT01586364|469160689|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
130324788|NCT01586364|469160689|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
130324789|NCT01586364|469160689|FG000|Overall Study|Other-Site closure due to PI illness|1|||
130324790|NCT01586364|469160689|FG000|Overall Study|Other-PI discretion, site closing|2|||
129883507|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
130214801|NCT02757352|468751606|FG006|Follow-Up Period|Adverse Event|1|||
130214802|NCT02757352|468751607|FG007|Follow-Up Period|Adverse Event|0|||
130214803|NCT02757352|468751608|FG008|Follow-Up Period|Adverse Event|2|||
130214804|NCT02757352|468751609|FG009|Follow-Up Period|Adverse Event|0|||
130214805|NCT02757352|468751600|FG000|Follow-Up Period|Lost to Follow-up|0|||
130214806|NCT02757352|468751601|FG001|Follow-Up Period|Lost to Follow-up|0|||
130214807|NCT02757352|468751602|FG002|Follow-Up Period|Lost to Follow-up|0|||
130214808|NCT02757352|468751603|FG003|Follow-Up Period|Lost to Follow-up|0|||
130214809|NCT02757352|468751604|FG004|Follow-Up Period|Lost to Follow-up|0|||
130214810|NCT02757352|468751605|FG005|Follow-Up Period|Lost to Follow-up|0|||
130214811|NCT02757352|468751606|FG006|Follow-Up Period|Lost to Follow-up|0|||
130214812|NCT02757352|468751607|FG007|Follow-Up Period|Lost to Follow-up|0|||
130214813|NCT02757352|468751608|FG008|Follow-Up Period|Lost to Follow-up|1|||
130214814|NCT02757352|468751609|FG009|Follow-Up Period|Lost to Follow-up|0|||
130214815|NCT02757352|468751600|FG000|Follow-Up Period|Lack of Efficacy|0|||
130214816|NCT02757352|468751601|FG001|Follow-Up Period|Lack of Efficacy|0|||
130214817|NCT02757352|468751602|FG002|Follow-Up Period|Lack of Efficacy|0|||
130214818|NCT02757352|468751603|FG003|Follow-Up Period|Lack of Efficacy|0|||
130214819|NCT02757352|468751604|FG004|Follow-Up Period|Lack of Efficacy|0|||
130214820|NCT02757352|468751605|FG005|Follow-Up Period|Lack of Efficacy|0|||
130214821|NCT02757352|468751606|FG006|Follow-Up Period|Lack of Efficacy|0|||
130214822|NCT02757352|468751607|FG007|Follow-Up Period|Lack of Efficacy|0|||
130214823|NCT02757352|468751608|FG008|Follow-Up Period|Lack of Efficacy|1|||
130214824|NCT02757352|468751609|FG009|Follow-Up Period|Lack of Efficacy|1|||
130214825|NCT02757352|468751600|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130214826|NCT02757352|468751601|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130214827|NCT02757352|468751602|FG002|Follow-Up Period|Withdrawal by Subject|0|||
130214828|NCT02757352|468751603|FG003|Follow-Up Period|Withdrawal by Subject|0|||
130214829|NCT02757352|468751604|FG004|Follow-Up Period|Withdrawal by Subject|0|||
130214830|NCT02757352|468751605|FG005|Follow-Up Period|Withdrawal by Subject|0|||
130214831|NCT02757352|468751606|FG006|Follow-Up Period|Withdrawal by Subject|0|||
130214832|NCT02757352|468751607|FG007|Follow-Up Period|Withdrawal by Subject|1|||
130214833|NCT02757352|468751608|FG008|Follow-Up Period|Withdrawal by Subject|6|||
130214834|NCT02757352|468751609|FG009|Follow-Up Period|Withdrawal by Subject|2|||
130214835|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
130214836|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130214837|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130214838|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
130214839|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
130214840|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130214841|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130214842|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
130214843|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
130214844|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
130214845|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
130214846|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
130214847|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
130214848|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130214849|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130214850|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
130214851|NCT02362425|468751610|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
130214852|NCT02362425|468751611|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
130214853|NCT02362425|468751612|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
130214854|NCT02362425|468751613|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
130214855|NCT02362425|468751610|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130214856|NCT02362425|468751611|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130214857|NCT02362425|468751612|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
130214858|NCT02362425|468751613|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
130214859|NCT02362425|468751610|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130214860|NCT02362425|468751611|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130214861|NCT02362425|468751612|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
130214862|NCT02362425|468751613|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
130214863|NCT02362425|468751610|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130214864|NCT02362425|468751611|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130214865|NCT02362425|468751612|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
130214866|NCT02362425|468751613|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
130214867|NCT00802672|468751620|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
130214868|NCT00802672|468751621|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
130214869|NCT00802672|468751622|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
130214870|NCT00802672|468751620|FG000|Overall Study|Adverse Event|1|||
130214871|NCT00802672|468751621|FG001|Overall Study|Adverse Event|1|||
130324791|NCT01586364|469160689|FG000|Overall Study|Other-Not specified|1|||
130324792|NCT02121535|469160690|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
130324793|NCT02121535|469160691|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
130324794|NCT02121535|469160690|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
130324795|NCT02121535|469160691|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
130324796|NCT00091949|469160692|FG000|Overall Study|Withdrawal by Subject|117|||
130324797|NCT00091949|469160693|FG001|Overall Study|Withdrawal by Subject|110|||
130324798|NCT00091949|469160692|FG000|Overall Study|Lost to Follow-up|58|||
130324799|NCT00091949|469160693|FG001|Overall Study|Lost to Follow-up|41|||
130324800|NCT02083354|469160694|FG000|Overall Study|Withdrawal by Subject|9|||
130324801|NCT02083354|469160694|FG000|Overall Study|Lost to Follow-up|1|||
130324802|NCT02083354|469160694|FG000|Overall Study|Adverse Event|3|||
130324803|NCT02083354|469160694|FG000|Overall Study|Disease progression|46|||
130324804|NCT02083354|469160694|FG000|Overall Study|Study closed/terminated|5|||
130324805|NCT04328077|469160695|FG000|Overall Study|Lost to Follow-up|0|||
130324806|NCT04328077|469160696|FG001|Overall Study|Lost to Follow-up|1|||
130324807|NCT04328077|469160697|FG002|Overall Study|Lost to Follow-up|0|||
130324808|NCT04328077|469160698|FG003|Overall Study|Lost to Follow-up|0|||
130324809|NCT04328077|469160695|FG000|Overall Study|Withdrawal by Subject|0|||
130324810|NCT04328077|469160696|FG001|Overall Study|Withdrawal by Subject|1|||
130324811|NCT04328077|469160697|FG002|Overall Study|Withdrawal by Subject|1|||
130324812|NCT04328077|469160698|FG003|Overall Study|Withdrawal by Subject|3|||
130324813|NCT02419001|469160709|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
130324814|NCT02419001|469160710|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
130324815|NCT00313014|469160711|FG000|Overall Study|Withdrawal by Subject|11|||
130324816|NCT00313014|469160712|FG001|Overall Study|Withdrawal by Subject|7|||
130324817|NCT00313014|469160713|FG002|Overall Study|Withdrawal by Subject|5|||
130324818|NCT00313014|469160711|FG000|Overall Study|Adverse Event|14|||
130324819|NCT00313014|469160712|FG001|Overall Study|Adverse Event|29|||
130324820|NCT00313014|469160713|FG002|Overall Study|Adverse Event|16|||
130324821|NCT00313014|469160711|FG000|Overall Study|Lost to Follow-up|7|||
130324822|NCT00313014|469160712|FG001|Overall Study|Lost to Follow-up|6|||
130324823|NCT00313014|469160713|FG002|Overall Study|Lost to Follow-up|10|||
130324824|NCT00313014|469160711|FG000|Overall Study|Administrative|9|||
130324825|NCT00313014|469160712|FG001|Overall Study|Administrative|6|||
130324826|NCT00313014|469160713|FG002|Overall Study|Administrative|14|||
130324827|NCT00313014|469160711|FG000|Overall Study|Lack of Efficacy|52|||
130324828|NCT00313014|469160712|FG001|Overall Study|Lack of Efficacy|25|||
130324829|NCT00313014|469160713|FG002|Overall Study|Lack of Efficacy|16|||
130324830|NCT01198795|469160716|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
130324831|NCT01198795|469160716|FG000|Overall Study|Withdrawal by Subject|17|||
130324832|NCT01198795|469160716|FG000|Overall Study|Lost to Follow-up|15|||
130324833|NCT01198795|469160716|FG000|Overall Study|Adverse Event|9|||
130324834|NCT01198795|469160716|FG000|Overall Study|Lack of Efficacy|5|||
130324835|NCT01198795|469160716|FG000|Overall Study|Protocol Violation|2|||
130324836|NCT01198795|469160716|FG000|Overall Study|Other Reason|4|||
130324837|NCT00744497|469160717|FG000|Overall Study|Withdrawal by Subject|21|||
130324838|NCT00744497|469160718|FG001|Overall Study|Withdrawal by Subject|18|||
130324839|NCT00744497|469160717|FG000|Overall Study|Death|11|||
130324840|NCT00744497|469160718|FG001|Overall Study|Death|9|||
130324841|NCT00744497|469160717|FG000|Overall Study|Lost to Follow-up|4|||
130324842|NCT00744497|469160718|FG001|Overall Study|Lost to Follow-up|2|||
130324843|NCT00744497|469160717|FG000|Overall Study|Poor compliance/noncompliance|9|||
130324844|NCT00744497|469160718|FG001|Overall Study|Poor compliance/noncompliance|5|||
130324845|NCT00744497|469160717|FG000|Overall Study|No longer meets study criteria|7|||
130324846|NCT00744497|469160718|FG001|Overall Study|No longer meets study criteria|3|||
130324847|NCT00744497|469160717|FG000|Overall Study|Administrative Reason By Sponsor|25|||
130324848|NCT00744497|469160718|FG001|Overall Study|Administrative Reason By Sponsor|8|||
130324849|NCT00744497|469160717|FG000|Overall Study|Disease progression|312|||
130324850|NCT00744497|469160718|FG001|Overall Study|Disease progression|219|||
130324851|NCT00744497|469160717|FG000|Overall Study|Study drug toxicity|68|||
130324852|NCT00744497|469160718|FG001|Overall Study|Study drug toxicity|141|||
129883508|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
130324853|NCT00744497|469160717|FG000|Overall Study|Adverse event unrelated to study drug|78|||
130324854|NCT00744497|469160718|FG001|Overall Study|Adverse event unrelated to study drug|122|||
130324855|NCT00744497|469160717|FG000|Overall Study|Patient requested to stop study drug|65|||
130324856|NCT00744497|469160718|FG001|Overall Study|Patient requested to stop study drug|80|||
130324857|NCT00744497|469160717|FG000|Overall Study|Maximum clinical benefit|141|||
130324858|NCT00744497|469160718|FG001|Overall Study|Maximum clinical benefit|142|||
130324859|NCT00744497|469160717|FG000|Overall Study|Not defined|19|||
130324860|NCT00744497|469160718|FG001|Overall Study|Not defined|13|||
130324861|NCT04154904|469160753|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
130324862|NCT04154904|469160754|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
130324863|NCT04154904|469160755|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
130324864|NCT00936715|469160756|FG000|Overall Study|Investigators Discretion|1|||
130324865|NCT00936715|469160756|FG000|Overall Study|Protocol Violation|1|||
130324866|NCT00936715|469160756|FG000|Overall Study|Safety or Tolerability Reasons|4|||
130324867|NCT03819114|469160757|FG000|Overall Study|Protocol Violation|0|||
130324868|NCT03819114|469160758|FG001|Overall Study|Protocol Violation|1|||
130324869|NCT03819114|469160759|FG002|Overall Study|Protocol Violation|1|||
130324870|NCT03819114|469160760|FG003|Overall Study|Protocol Violation|0|||
130324871|NCT03819114|469160757|FG000|Overall Study|Lost to Follow-up|0|||
130324872|NCT03819114|469160758|FG001|Overall Study|Lost to Follow-up|0|||
130324873|NCT03819114|469160759|FG002|Overall Study|Lost to Follow-up|1|||
130324874|NCT03819114|469160760|FG003|Overall Study|Lost to Follow-up|0|||
130324875|NCT01744977|469160761|FG000|Overall Study|Withdrawal by Subject|1|||
130324876|NCT01744977|469160762|FG001|Overall Study|Withdrawal by Subject|2|||
130324877|NCT01744977|469160761|FG000|Overall Study|Death|2|||
130324878|NCT01744977|469160762|FG001|Overall Study|Death|3|||
130324879|NCT01744977|469160761|FG000|Overall Study|Lost to Follow-up|2|||
130324880|NCT01744977|469160762|FG001|Overall Study|Lost to Follow-up|0|||
130324881|NCT01744977|469160761|FG000|Overall Study|No longer meets inclusion|6|||
130324882|NCT01744977|469160762|FG001|Overall Study|No longer meets inclusion|0|||
130324883|NCT04225897|469160770|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324884|NCT04225897|469160771|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
130324885|NCT04225897|469160772|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324886|NCT04225897|469160773|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324887|NCT04225897|469160774|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324888|NCT04225897|469160775|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324889|NCT04225897|469160776|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324890|NCT04225897|469160777|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324891|NCT04225897|469160778|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324892|NCT04225897|469160779|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324893|NCT04225897|469160780|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324894|NCT04225897|469160781|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
130324895|NCT04225897|469160770|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324896|NCT04225897|469160771|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324897|NCT04225897|469160772|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
130324898|NCT04225897|469160773|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324899|NCT04225897|469160774|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324900|NCT04225897|469160775|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324901|NCT04225897|469160776|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324902|NCT04225897|469160777|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324903|NCT04225897|469160778|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324904|NCT04225897|469160779|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324905|NCT04225897|469160780|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324906|NCT04225897|469160781|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
130324907|NCT04225897|469160770|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324908|NCT04225897|469160771|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324909|NCT04225897|469160772|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
130324910|NCT04225897|469160773|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324911|NCT04225897|469160774|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324912|NCT04225897|469160775|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324913|NCT04225897|469160776|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324914|NCT04225897|469160777|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324915|NCT04225897|469160778|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324916|NCT04225897|469160779|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324917|NCT04225897|469160780|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324918|NCT04225897|469160781|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
130324919|NCT04225897|469160770|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324920|NCT04225897|469160771|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324921|NCT04225897|469160772|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130098717|NCT03426995|468319301|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130214872|NCT00802672|468751622|FG002|Overall Study|Adverse Event|1|||
130214873|NCT00802672|468751620|FG000|Overall Study|Protocol Violation|2|||
130214874|NCT00802672|468751621|FG001|Overall Study|Protocol Violation|1|||
130214875|NCT00802672|468751622|FG002|Overall Study|Protocol Violation|1|||
130214876|NCT00802672|468751620|FG000|Overall Study|Lost to Follow-up|5|||
130214877|NCT00802672|468751621|FG001|Overall Study|Lost to Follow-up|5|||
130214878|NCT00802672|468751622|FG002|Overall Study|Lost to Follow-up|3|||
130214879|NCT00802672|468751620|FG000|Overall Study|Withdrawal by Subject|1|||
130214880|NCT00802672|468751621|FG001|Overall Study|Withdrawal by Subject|1|||
130214881|NCT00802672|468751622|FG002|Overall Study|Withdrawal by Subject|2|||
130214882|NCT00802672|468751620|FG000|Overall Study|other|3|||
130214883|NCT00802672|468751621|FG001|Overall Study|other|1|||
130214884|NCT00802672|468751622|FG002|Overall Study|other|2|||
130324922|NCT04225897|469160773|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324923|NCT04225897|469160774|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324924|NCT04225897|469160775|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324925|NCT04225897|469160776|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324926|NCT04225897|469160777|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
130324927|NCT04225897|469160778|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324928|NCT04225897|469160779|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324929|NCT04225897|469160780|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324930|NCT04225897|469160781|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
130324931|NCT02703597|469160782|FG000|Assignment to Baseline|Lost to Follow-up|17|||
130324932|NCT02703597|469160783|FG001|Assignment to Baseline|Lost to Follow-up|16|||
130324933|NCT02703597|469160782|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
130324934|NCT02703597|469160783|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
130324935|NCT02703597|469160782|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
130324936|NCT02703597|469160783|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
130324937|NCT02703597|469160782|FG000|First Post-test to First Follow-up|Site drop out|0|||
130324938|NCT02703597|469160783|FG001|First Post-test to First Follow-up|Site drop out|58|||
130324939|NCT02703597|469160782|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
130324940|NCT02703597|469160783|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
130324941|NCT02703597|469160782|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
130324942|NCT02703597|469160783|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
130324943|NCT02703597|469160782|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
130324944|NCT02703597|469160783|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
130324945|NCT02131259|469160784|FG000|Overall Study|Progressive disease|751|||
130324946|NCT02131259|469160784|FG000|Overall Study|Adverse Event|341|||
130324947|NCT02131259|469160784|FG000|Overall Study|Lost to Follow-up|7|||
130324948|NCT02131259|469160784|FG000|Overall Study|Relocation|32|||
130324949|NCT02131259|469160784|FG000|Overall Study|Other|63|||
130324950|NCT02131259|469160784|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
130324951|NCT02131259|469160784|FG000|Overall Study|Progressive disease/relocation|1|||
130324952|NCT02131259|469160784|FG000|Overall Study|Progressive disease/other|2|||
130324953|NCT02131259|469160784|FG000|Overall Study|AE/lost to follow-up|1|||
130324954|NCT02131259|469160784|FG000|Overall Study|AE/other|1|||
130324955|NCT02131259|469160784|FG000|Overall Study|Progressive disease/AE/other|1|||
130324956|NCT02131259|469160784|FG000|Overall Study|Missing|3|||
130324957|NCT02796170|469160785|FG000|Overall Study|Lost to Follow-up|3|||
130324958|NCT02796170|469160786|FG001|Overall Study|Lost to Follow-up|0|||
130324959|NCT03818321|469160789|FG000|Overall Study|Withdrawal by Subject|1|||
130324960|NCT03818321|469160790|FG001|Overall Study|Withdrawal by Subject|2|||
130324961|NCT01867671|469160791|FG000|Overall Study|Adverse Event|5|||
130324962|NCT01867671|469160792|FG001|Overall Study|Adverse Event|3|||
130324963|NCT01867671|469160791|FG000|Overall Study|Anaphylaxis|0|||
130324964|NCT01867671|469160792|FG001|Overall Study|Anaphylaxis|1|||
130324965|NCT01867671|469160791|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
130214885|NCT01616758|468751624|FG000|Overall Study|Adverse Event|1|||
130214886|NCT01616758|468751624|FG000|Overall Study|Withdrawal by Subject|2|||
130214887|NCT01616758|468751624|FG000|Overall Study|Disease progression|18|||
130214888|NCT01616758|468751624|FG000|Overall Study|Study termination by Sponsor|1|||
130214889|NCT03026283|468751625|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
130214890|NCT03026283|468751626|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
130214891|NCT03026283|468751627|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
130214892|NCT03026283|468751628|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
130214893|NCT03026283|468751629|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
130214894|NCT03026283|468751630|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
130214895|NCT03026283|468751631|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
130214896|NCT03026283|468751632|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
130214897|NCT03026283|468751625|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
130214898|NCT03026283|468751626|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
130214899|NCT03026283|468751627|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
130214900|NCT03026283|468751628|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
130214901|NCT03026283|468751629|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
130214902|NCT03026283|468751630|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
130214903|NCT03026283|468751631|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
130214904|NCT03026283|468751632|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
130214905|NCT03026283|468751625|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214906|NCT03026283|468751626|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
130214907|NCT03026283|468751627|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214908|NCT03026283|468751628|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214909|NCT03026283|468751629|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130324966|NCT01867671|469160792|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
130324967|NCT01867671|469160791|FG000|Overall Study|Lost to Follow-up|0|||
130324968|NCT01867671|469160792|FG001|Overall Study|Lost to Follow-up|1|||
130324969|NCT01867671|469160791|FG000|Overall Study|Non-compliance with Study Drug|1|||
130324970|NCT01867671|469160792|FG001|Overall Study|Non-compliance with Study Drug|2|||
130324971|NCT01867671|469160791|FG000|Overall Study|Withdrawal by Subject|21|||
130324972|NCT01867671|469160792|FG001|Overall Study|Withdrawal by Subject|21|||
130324973|NCT01523366|469160793|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130324974|NCT01523366|469160794|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130324975|NCT01523366|469160793|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
130324976|NCT01523366|469160794|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
130324977|NCT04543279|469160799|FG000|Overall Study|Withdrawal by Subject|1|||
130324978|NCT04543279|469160800|FG001|Overall Study|Withdrawal by Subject|0|||
130324979|NCT04543279|469160799|FG000|Overall Study|Adverse Event|1|||
130324980|NCT04543279|469160800|FG001|Overall Study|Adverse Event|0|||
130324981|NCT04543279|469160799|FG000|Overall Study|Physician Decision|1|||
130324982|NCT04543279|469160800|FG001|Overall Study|Physician Decision|0|||
130324983|NCT05249582|469160804|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
130324984|NCT05249582|469160805|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
130324985|NCT05249582|469160804|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
130324986|NCT05249582|469160805|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
130324987|NCT05249582|469160804|FG000|Overall Study|Declined to use virtual reality headset|1|||
130324988|NCT05249582|469160805|FG001|Overall Study|Declined to use virtual reality headset|0|||
130324989|NCT03675126|469160806|FG000|Overall Study|Study Terminated by Sponsor|9|||
130324990|NCT03675126|469160806|FG000|Overall Study|Death|2|||
130324991|NCT03675126|469160806|FG000|Overall Study|Withdrawal by Subject|4|||
130324992|NCT00001959|469160807|FG000|Overall Study|newly diagnosed colon cancer|1|||
130324993|NCT00001959|469160807|FG000|Overall Study|disabling sedation|1|||
130324994|NCT00001959|469160807|FG000|Overall Study|non-compliance|1|||
130324995|NCT04189952|469160809|FG000|Follow-up Period|Death|1|||
130324996|NCT04189952|469160809|FG000|Follow-up Period|Withdrawal by Subject|1|||
130324997|NCT01052493|469160810|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
130324998|NCT01052493|469160811|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
130324999|NCT01052493|469160812|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
130325000|NCT00283296|469160814|FG000|Overall Study|in-home trial not completed|5|||
130325001|NCT02158442|469160817|FG000|Overall Study|Withdrawal by Subject|1|||
130325002|NCT02158442|469160818|FG001|Overall Study|Withdrawal by Subject|0|||
130325003|NCT02158442|469160817|FG000|Overall Study|Perfusion staff not available|1|||
130325004|NCT02158442|469160818|FG001|Overall Study|Perfusion staff not available|0|||
130325005|NCT00632229|469160826|FG000|Overall Study|Adverse Event|6|||
130325006|NCT00632229|469160827|FG001|Overall Study|Adverse Event|0|||
129988097|NCT02150343|467918843|FG002|Overall Study|Adverse Event|1|||
130214910|NCT03026283|468751630|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214911|NCT03026283|468751631|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214912|NCT03026283|468751632|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
130214913|NCT03026283|468751625|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214914|NCT03026283|468751626|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214915|NCT03026283|468751627|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
130214916|NCT03026283|468751628|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214917|NCT03026283|468751629|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214918|NCT03026283|468751630|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214919|NCT03026283|468751631|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214920|NCT03026283|468751632|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
130214921|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214922|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214923|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214924|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
130214925|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
130214926|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214927|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214928|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
130214929|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214930|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214931|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214932|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
130214933|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
130214934|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
130214935|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130214936|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
130325007|NCT00632229|469160826|FG000|Overall Study|Lost to Follow-up|0|||
130325008|NCT00632229|469160827|FG001|Overall Study|Lost to Follow-up|3|||
130325009|NCT00632229|469160826|FG000|Overall Study|Lack of Efficacy|0|||
130325010|NCT00632229|469160827|FG001|Overall Study|Lack of Efficacy|2|||
130325011|NCT00632229|469160826|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
129988098|NCT02150343|467918844|FG003|Overall Study|Adverse Event|1|||
129988099|NCT02150343|467918841|FG000|Overall Study|Withdrawal by Subject|13|||
129988100|NCT02150343|467918842|FG001|Overall Study|Withdrawal by Subject|10|||
129988101|NCT02150343|467918843|FG002|Overall Study|Withdrawal by Subject|9|||
129988102|NCT02150343|467918844|FG003|Overall Study|Withdrawal by Subject|4|||
129988103|NCT02150343|467918841|FG000|Overall Study|Lost to Follow-up|4|||
129988104|NCT02150343|467918842|FG001|Overall Study|Lost to Follow-up|4|||
129988105|NCT02150343|467918843|FG002|Overall Study|Lost to Follow-up|2|||
129988106|NCT02150343|467918844|FG003|Overall Study|Lost to Follow-up|3|||
129988107|NCT02150343|467918841|FG000|Overall Study|Other|2|||
129988108|NCT02150343|467918842|FG001|Overall Study|Other|6|||
129988109|NCT02150343|467918843|FG002|Overall Study|Other|0|||
129988110|NCT02150343|467918844|FG003|Overall Study|Other|2|||
129988111|NCT00190749|467918845|FG000|Overall Study|Lost to Follow-up|8|||
129988112|NCT00190749|467918846|FG001|Overall Study|Lost to Follow-up|11|||
129988113|NCT00190749|467918845|FG000|Overall Study|Withdrawal by Subject|10|||
129988114|NCT00190749|467918846|FG001|Overall Study|Withdrawal by Subject|6|||
129988115|NCT00190749|467918845|FG000|Overall Study|Protocol Violation|5|||
129988116|NCT00190749|467918846|FG001|Overall Study|Protocol Violation|4|||
129988117|NCT00190749|467918845|FG000|Overall Study|Adverse Event|0|||
130325012|NCT00632229|469160827|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
130325013|NCT00474812|469160834|FG000|Overall Study|Withdrawal by Subject|5|||
130325014|NCT00474812|469160834|FG000|Overall Study|No Initiation of treatment|2|||
130325015|NCT00737672|469160841|FG000|Overall Study|Graft Abandonment|48|||
130325016|NCT00737672|469160842|FG001|Overall Study|Graft Abandonment|56|||
130325017|NCT00737672|469160841|FG000|Overall Study|Death|23|||
130325018|NCT00737672|469160842|FG001|Overall Study|Death|22|||
130325019|NCT00737672|469160841|FG000|Overall Study|Withdrawal by Subject|1|||
130325020|NCT00737672|469160842|FG001|Overall Study|Withdrawal by Subject|2|||
130325021|NCT00737672|469160841|FG000|Overall Study|Lost to Follow-up|1|||
130325022|NCT00737672|469160842|FG001|Overall Study|Lost to Follow-up|0|||
130325023|NCT00737672|469160841|FG000|Overall Study|Miscellaneous|7|||
130325024|NCT00737672|469160842|FG001|Overall Study|Miscellaneous|1|||
130325025|NCT00737672|469160841|FG000|Overall Study|Physician Decision|0|||
130325026|NCT00737672|469160842|FG001|Overall Study|Physician Decision|2|||
130325027|NCT04123470|469160844|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
130325028|NCT04123470|469160845|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130325029|NCT04123470|469160844|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
130325030|NCT04123470|469160845|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
130325031|NCT04123470|469160844|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
130325032|NCT04123470|469160845|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
130325033|NCT04123470|469160844|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
130325034|NCT04123470|469160845|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
130325035|NCT05408429|469160857|FG000|Overall Study|Lost to Follow-up|1|||
130325036|NCT05408429|469160858|FG001|Overall Study|Lost to Follow-up|1|||
130325037|NCT05408429|469160859|FG002|Overall Study|Lost to Follow-up|0|||
130325038|NCT05408429|469160857|FG000|Overall Study|Withdrawal by Subject|5|||
130325039|NCT05408429|469160858|FG001|Overall Study|Withdrawal by Subject|0|||
130325040|NCT05408429|469160859|FG002|Overall Study|Withdrawal by Subject|1|||
130325041|NCT05972993|469160861|FG000|Overall Study|Lost to Follow-up|2|||
130325042|NCT05972993|469160862|FG001|Overall Study|Lost to Follow-up|0|||
130325043|NCT05972993|469160863|FG002|Overall Study|Lost to Follow-up|1|||
130325044|NCT05972993|469160864|FG003|Overall Study|Lost to Follow-up|0|||
130325045|NCT05972993|469160865|FG004|Overall Study|Lost to Follow-up|0|||
130325046|NCT05972993|469160866|FG005|Overall Study|Lost to Follow-up|0|||
130325047|NCT05972993|469160867|FG006|Overall Study|Lost to Follow-up|0|||
130325048|NCT05972993|469160868|FG007|Overall Study|Lost to Follow-up|2|||
130325049|NCT05972993|469160869|FG008|Overall Study|Lost to Follow-up|0|||
130325050|NCT03818256|469160872|FG000|Overall Study|Withdrawal by Subject|2|||
130325051|NCT03818256|469160873|FG001|Overall Study|Withdrawal by Subject|2|||
130325052|NCT03818256|469160872|FG000|Overall Study|Adverse Event|3|||
130325053|NCT03818256|469160873|FG001|Overall Study|Adverse Event|1|||
130325054|NCT03818256|469160872|FG000|Overall Study|Lost to Follow-up|0|||
130325055|NCT03818256|469160873|FG001|Overall Study|Lost to Follow-up|5|||
130325056|NCT03818256|469160872|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
130325057|NCT03818256|469160873|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
129988118|NCT00190749|467918846|FG001|Overall Study|Adverse Event|5|||
129988119|NCT00190749|467918845|FG000|Overall Study|Lack of Efficacy|2|||
130325058|NCT03818256|469160872|FG000|Overall Study|Not reporting for scheduled visits|1|||
129988120|NCT00190749|467918846|FG001|Overall Study|Lack of Efficacy|3|||
130325059|NCT03818256|469160873|FG001|Overall Study|Not reporting for scheduled visits|0|||
130325060|NCT03818256|469160872|FG000|Overall Study|Non-compliant with investigational product|1|||
130325061|NCT03818256|469160873|FG001|Overall Study|Non-compliant with investigational product|0|||
130325062|NCT00911170|469160874|FG000|Treatment Period|Randomized in error|1|||
130325063|NCT00911170|469160875|FG001|Treatment Period|Randomized in error|1|||
130325064|NCT00911170|469160874|FG000|Treatment Period|Ineligibility determined|1|||
130325065|NCT00911170|469160875|FG001|Treatment Period|Ineligibility determined|3|||
130325066|NCT00911170|469160874|FG000|Treatment Period|Protocol deviation|1|||
130325067|NCT00911170|469160875|FG001|Treatment Period|Protocol deviation|2|||
130325068|NCT00911170|469160874|FG000|Treatment Period|Adverse Event|9|||
130325069|NCT00911170|469160875|FG001|Treatment Period|Adverse Event|10|||
130325070|NCT00911170|469160874|FG000|Treatment Period|Withdrawal by Subject|4|||
130325071|NCT00911170|469160875|FG001|Treatment Period|Withdrawal by Subject|4|||
130325072|NCT00911170|469160874|FG000|Treatment Period|Disease progression|0|||
130325073|NCT00911170|469160875|FG001|Treatment Period|Disease progression|2|||
130325074|NCT00911170|469160874|FG000|Treatment Period|Physician Decision|5|||
130325075|NCT00911170|469160875|FG001|Treatment Period|Physician Decision|5|||
130325076|NCT00911170|469160874|FG000|Treatment Period|Lost to Follow-up|0|||
130325077|NCT00911170|469160875|FG001|Treatment Period|Lost to Follow-up|1|||
130325078|NCT00911170|469160874|FG000|Treatment Period|Death|6|||
130325079|NCT00911170|469160875|FG001|Treatment Period|Death|9|||
130325080|NCT00911170|469160874|FG000|Long Term Follow-Up|Continuing in study|274|||
130325081|NCT00911170|469160875|FG001|Long Term Follow-Up|Continuing in study|269|||
130325082|NCT00911170|469160874|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
130325083|NCT00911170|469160875|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
130325084|NCT00911170|469160874|FG000|Long Term Follow-Up|Physician Decision|5|||
130325085|NCT00911170|469160875|FG001|Long Term Follow-Up|Physician Decision|4|||
130325086|NCT00911170|469160874|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
130325087|NCT00911170|469160875|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
130325088|NCT00911170|469160874|FG000|Long Term Follow-Up|Death|116|||
130325089|NCT00911170|469160875|FG001|Long Term Follow-Up|Death|121|||
130325090|NCT02514083|469160876|FG000|Overall Study|Adverse Event|1|||
130325091|NCT04226742|469163656|FG000|Overall Study|Lost to Follow-up|16|||
130325092|NCT04226742|469163657|FG001|Overall Study|Lost to Follow-up|13|||
130325093|NCT04226742|469163656|FG000|Overall Study|Withdrawal by Subject|5|||
130325094|NCT04226742|469163657|FG001|Overall Study|Withdrawal by Subject|3|||
130325095|NCT02492763|469163658|FG000|Overall Study|Withdrawal by Subject|0|||
130325096|NCT02492763|469163659|FG001|Overall Study|Withdrawal by Subject|2|||
130325097|NCT02492763|469163660|FG002|Overall Study|Withdrawal by Subject|1|||
130325098|NCT02492763|469163661|FG003|Overall Study|Withdrawal by Subject|0|||
130325099|NCT02492763|469163658|FG000|Overall Study|Adverse Event|3|||
130325100|NCT02492763|469163659|FG001|Overall Study|Adverse Event|1|||
130325101|NCT02492763|469163660|FG002|Overall Study|Adverse Event|1|||
130325102|NCT02492763|469163661|FG003|Overall Study|Adverse Event|2|||
130325103|NCT02492763|469163658|FG000|Overall Study|Death|0|||
130325104|NCT02492763|469163659|FG001|Overall Study|Death|0|||
130325105|NCT02492763|469163660|FG002|Overall Study|Death|1|||
130325106|NCT02492763|469163661|FG003|Overall Study|Death|0|||
130325107|NCT02492763|469163658|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130325108|NCT02492763|469163659|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
130325109|NCT02492763|469163660|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130325110|NCT02492763|469163661|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
130325111|NCT02492763|469163658|FG000|Overall Study|Lost to Follow-up|0|||
130325112|NCT02492763|469163659|FG001|Overall Study|Lost to Follow-up|0|||
130325113|NCT02492763|469163660|FG002|Overall Study|Lost to Follow-up|1|||
130325114|NCT02492763|469163661|FG003|Overall Study|Lost to Follow-up|0|||
130325115|NCT02492763|469163658|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130325116|NCT02492763|469163659|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130325117|NCT02492763|469163660|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130325118|NCT02492763|469163661|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130325119|NCT02492763|469163658|FG000|Overall Study|Screen Failure|0|||
130325120|NCT02492763|469163659|FG001|Overall Study|Screen Failure|0|||
130325121|NCT02492763|469163660|FG002|Overall Study|Screen Failure|0|||
130325122|NCT02492763|469163661|FG003|Overall Study|Screen Failure|1|||
130325123|NCT02492763|469163658|FG000|Overall Study|Study Terminated by Sponsor|13|||
130325124|NCT02492763|469163659|FG001|Overall Study|Study Terminated by Sponsor|10|||
130325125|NCT02492763|469163660|FG002|Overall Study|Study Terminated by Sponsor|6|||
130325126|NCT02492763|469163661|FG003|Overall Study|Study Terminated by Sponsor|10|||
130325127|NCT01337960|469163662|FG000|Overall Study|Lost to Follow-up|1|||
130325128|NCT01337960|469163663|FG001|Overall Study|Lost to Follow-up|0|||
130325129|NCT01337960|469163664|FG002|Overall Study|Lost to Follow-up|0|||
130325130|NCT01337960|469163662|FG000|Overall Study|Withdrawal by Subject|1|||
130325131|NCT01337960|469163663|FG001|Overall Study|Withdrawal by Subject|0|||
130325132|NCT01337960|469163664|FG002|Overall Study|Withdrawal by Subject|0|||
130325133|NCT01772316|469163665|FG000|Overall Study|Serious adverse event|1|||
130325134|NCT01772316|469163665|FG000|Overall Study|Inform consent withdrawn|1|||
130325135|NCT01772316|469163665|FG000|Overall Study|Withdrawn by sponsor decision|5|||
130325136|NCT00914316|469163669|FG000|Phase 1|Physician Decision|4|||
130325137|NCT00914316|469163670|FG001|Phase 1|Physician Decision|0|||
130325138|NCT00914316|469163671|FG002|Phase 1|Physician Decision|1|||
129988121|NCT00190749|467918845|FG000|Overall Study|Reason Not Specified|0|||
129988122|NCT00190749|467918846|FG001|Overall Study|Reason Not Specified|2|||
129988123|NCT00190749|467918845|FG000|Overall Study|Sponsor Decision|1|||
129988124|NCT00190749|467918846|FG001|Overall Study|Sponsor Decision|0|||
129988125|NCT02729753|467918847|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
130325139|NCT00914316|469163672|FG003|Phase 1|Physician Decision|2|||
130325140|NCT00914316|469163669|FG000|Phase 1|Withdrawal by Subject|0|||
130325141|NCT00914316|469163670|FG001|Phase 1|Withdrawal by Subject|2|||
130325142|NCT00914316|469163671|FG002|Phase 1|Withdrawal by Subject|4|||
130325143|NCT00914316|469163672|FG003|Phase 1|Withdrawal by Subject|0|||
129988126|NCT02729753|467918848|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
130214937|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214938|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214939|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214940|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
130214941|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214942|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
130214943|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214944|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
130214945|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214946|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214947|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214948|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
130214949|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214950|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214951|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214952|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
130214953|NCT03026283|468751625|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214954|NCT03026283|468751626|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214955|NCT03026283|468751627|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214956|NCT03026283|468751628|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214957|NCT03026283|468751629|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
130214958|NCT03026283|468751630|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
130214959|NCT03026283|468751631|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214960|NCT03026283|468751632|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
130214961|NCT03782571|468751633|FG000|Period 1|Withdrawal by Subject|1|||
130214962|NCT03782571|468751634|FG001|Period 1|Withdrawal by Subject|0|||
130214963|NCT03782571|468751635|FG002|Period 1|Withdrawal by Subject|0|||
130214964|NCT03782571|468751636|FG003|Period 1|Withdrawal by Subject|0|||
130214965|NCT03782571|468751633|FG000|Period 3|Subject Unable to Attend V5|1|||
130214966|NCT03782571|468751634|FG001|Period 3|Subject Unable to Attend V5|0|||
130214967|NCT03782571|468751635|FG002|Period 3|Subject Unable to Attend V5|0|||
130214968|NCT03782571|468751636|FG003|Period 3|Subject Unable to Attend V5|0|||
130214969|NCT03782571|468751633|FG000|Period 3|Adverse Event|1|||
130214970|NCT03782571|468751634|FG001|Period 3|Adverse Event|0|||
130214971|NCT03782571|468751635|FG002|Period 3|Adverse Event|0|||
130214972|NCT03782571|468751636|FG003|Period 3|Adverse Event|0|||
130214973|NCT02090283|468751646|FG000|Overall Study|Withdrawal by Subject|6|||
130214974|NCT02090283|468751647|FG001|Overall Study|Withdrawal by Subject|6|||
130214975|NCT02090283|468751648|FG002|Overall Study|Withdrawal by Subject|6|||
130214976|NCT02090283|468751646|FG000|Overall Study|Sponsor Terminated Study|6|||
130214977|NCT02090283|468751647|FG001|Overall Study|Sponsor Terminated Study|6|||
130214978|NCT02090283|468751648|FG002|Overall Study|Sponsor Terminated Study|1|||
130214979|NCT02090283|468751646|FG000|Overall Study|Lost to Follow-up|2|||
130214980|NCT02090283|468751647|FG001|Overall Study|Lost to Follow-up|2|||
130214981|NCT02090283|468751648|FG002|Overall Study|Lost to Follow-up|3|||
130214982|NCT02090283|468751646|FG000|Overall Study|Adverse Event|1|||
130214983|NCT02090283|468751647|FG001|Overall Study|Adverse Event|1|||
130214984|NCT02090283|468751648|FG002|Overall Study|Adverse Event|0|||
130214985|NCT02090283|468751646|FG000|Overall Study|Protocol Violation|2|||
130214986|NCT02090283|468751647|FG001|Overall Study|Protocol Violation|0|||
130214987|NCT02090283|468751648|FG002|Overall Study|Protocol Violation|0|||
130214988|NCT01411319|468751656|FG000|Overall Study|Lost to Follow-up|1|||
130214989|NCT02499263|468751657|FG000|Overall Study|Lost to Follow-up|9|||
130325144|NCT00914316|469163669|FG000|Phase 1|Adverse Event|1|||
130325145|NCT00914316|469163670|FG001|Phase 1|Adverse Event|0|||
130214990|NCT02499263|468751657|FG000|Overall Study|Participant's withdrawal of consent|4|||
130214991|NCT02499263|468751657|FG000|Overall Study|Lack of Efficacy|22|||
130214992|NCT02499263|468751657|FG000|Overall Study|investigator's judgment|12|||
130214993|NCT02499263|468751657|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
130325146|NCT00914316|469163671|FG002|Phase 1|Adverse Event|0|||
130325147|NCT00914316|469163672|FG003|Phase 1|Adverse Event|0|||
130325148|NCT00914316|469163669|FG000|Phase 2|Withdrawal by Subject|1|||
130325149|NCT00914316|469163670|FG001|Phase 2|Withdrawal by Subject|0|||
130325150|NCT00914316|469163671|FG002|Phase 2|Withdrawal by Subject|1|||
130325151|NCT00914316|469163672|FG003|Phase 2|Withdrawal by Subject|0|||
130325152|NCT01759446|469163674|FG000|Overall Study|Protocol Violation|1|||
130325153|NCT01759446|469163675|FG001|Overall Study|Protocol Violation|0|||
130325154|NCT01759446|469163676|FG002|Overall Study|Protocol Violation|1|||
130325155|NCT01759446|469163677|FG003|Overall Study|Protocol Violation|0|||
130325156|NCT01759446|469163678|FG004|Overall Study|Protocol Violation|0|||
130325157|NCT01759446|469163674|FG000|Overall Study|Withdrawal by Subject|0|||
130325158|NCT01759446|469163675|FG001|Overall Study|Withdrawal by Subject|1|||
130325159|NCT01759446|469163676|FG002|Overall Study|Withdrawal by Subject|0|||
130325160|NCT01759446|469163677|FG003|Overall Study|Withdrawal by Subject|1|||
130325161|NCT01759446|469163678|FG004|Overall Study|Withdrawal by Subject|0|||
130325162|NCT01213472|469163686|FG000|Overall Study|Recurrence/Progressive disease|25|||
130325163|NCT01213472|469163686|FG000|Overall Study|Withdrawal by Subject|1|||
130325164|NCT01213472|469163686|FG000|Overall Study|Physician Decision|1|||
130325165|NCT02085460|469163687|FG000|Overall Study|Adverse Event|2|||
130325166|NCT02085460|469163688|FG001|Overall Study|Adverse Event|2|||
130325167|NCT02085460|469163689|FG002|Overall Study|Adverse Event|1|||
130325168|NCT02085460|469163687|FG000|Overall Study|Physician Decision|1|||
130325169|NCT02085460|469163688|FG001|Overall Study|Physician Decision|1|||
130325170|NCT02085460|469163689|FG002|Overall Study|Physician Decision|2|||
130325171|NCT02085460|469163687|FG000|Overall Study|Withdrawal by Subject|11|||
130325172|NCT02085460|469163688|FG001|Overall Study|Withdrawal by Subject|5|||
130325173|NCT02085460|469163689|FG002|Overall Study|Withdrawal by Subject|7|||
130325174|NCT01285323|469163690|FG000|Overall Study|Adverse Event|9|||
130325175|NCT01285323|469163691|FG001|Overall Study|Adverse Event|8|||
130325176|NCT01285323|469163690|FG000|Overall Study|Lack of Efficacy|4|||
130325177|NCT01285323|469163691|FG001|Overall Study|Lack of Efficacy|2|||
130325178|NCT01285323|469163690|FG000|Overall Study|Withdrawal by Subject|15|||
130325179|NCT01285323|469163691|FG001|Overall Study|Withdrawal by Subject|11|||
130325180|NCT01285323|469163690|FG000|Overall Study|Protocol Violation|1|||
130325181|NCT01285323|469163691|FG001|Overall Study|Protocol Violation|2|||
130325182|NCT01285323|469163690|FG000|Overall Study|Non-compliance with study procedures|2|||
130325183|NCT01285323|469163691|FG001|Overall Study|Non-compliance with study procedures|3|||
130325184|NCT01285323|469163690|FG000|Overall Study|Lost to Follow-up|1|||
130325185|NCT01285323|469163691|FG001|Overall Study|Lost to Follow-up|1|||
130325186|NCT01285323|469163690|FG000|Overall Study|Other|1|||
130325187|NCT01285323|469163691|FG001|Overall Study|Other|3|||
130325188|NCT00763035|469163692|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
130325189|NCT00763035|469163693|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
130325190|NCT00763035|469163692|FG000|First Intervention|Adverse Event|0|||
130325191|NCT00763035|469163693|FG001|First Intervention|Adverse Event|1|||
130325192|NCT00763035|469163692|FG000|Second Intervention|Adverse Event|1|||
130325193|NCT00763035|469163693|FG001|Second Intervention|Adverse Event|0|||
130325194|NCT00763035|469163692|FG000|Second Intervention|Physician Decision|2|||
130325195|NCT00763035|469163693|FG001|Second Intervention|Physician Decision|0|||
130325196|NCT02606643|469163694|FG000|Overall Study|did not meet inclusion criteria|1|||
130325197|NCT02606643|469163695|FG001|Overall Study|did not meet inclusion criteria|3|||
130325198|NCT04313244|469163701|FG000|Overall Study|Withdrawal of Consent|3|||
130325199|NCT04313244|469163702|FG001|Overall Study|Withdrawal of Consent|3|||
130325200|NCT04313244|469163701|FG000|Overall Study|Met Exclusion Criteria|1|||
130325201|NCT04313244|469163702|FG001|Overall Study|Met Exclusion Criteria|0|||
130325202|NCT04313244|469163701|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
130325203|NCT04313244|469163702|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
130325204|NCT01472289|469163705|FG000|Overall Study|Death|2|||
130325205|NCT00907335|469163706|FG000|Overall Study|Withdrawal by Subject|2|||
130325206|NCT00907335|469163707|FG001|Overall Study|Withdrawal by Subject|0|||
130325207|NCT00907335|469163706|FG000|Overall Study|Adverse Event|4|||
130325208|NCT00907335|469163707|FG001|Overall Study|Adverse Event|1|||
130325209|NCT00907335|469163706|FG000|Overall Study|Lost to Follow-up|2|||
130325210|NCT00907335|469163707|FG001|Overall Study|Lost to Follow-up|0|||
130325211|NCT03879772|469163708|FG000|Overall Study|Adverse Event|2|||
130325212|NCT03879772|469163709|FG001|Overall Study|Adverse Event|2|||
130325213|NCT03879772|469163710|FG002|Overall Study|Adverse Event|3|||
130325214|NCT03879772|469163711|FG003|Overall Study|Adverse Event|4|||
130325215|NCT03879772|469163712|FG004|Overall Study|Adverse Event|3|||
130325216|NCT03879772|469163708|FG000|Overall Study|Treatment Failure|1|||
130325217|NCT03879772|469163709|FG001|Overall Study|Treatment Failure|0|||
130325218|NCT03879772|469163710|FG002|Overall Study|Treatment Failure|0|||
130325219|NCT03879772|469163711|FG003|Overall Study|Treatment Failure|2|||
130325220|NCT03879772|469163712|FG004|Overall Study|Treatment Failure|1|||
130325221|NCT03879772|469163708|FG000|Overall Study|Lost to Follow-up|0|||
130325222|NCT03879772|469163709|FG001|Overall Study|Lost to Follow-up|0|||
130325223|NCT03879772|469163710|FG002|Overall Study|Lost to Follow-up|0|||
130325224|NCT03879772|469163711|FG003|Overall Study|Lost to Follow-up|0|||
129988127|NCT01090427|467918849|FG000|After Controlled Period|Death|0|||
129988128|NCT01090427|467918850|FG001|After Controlled Period|Death|0|||
129988129|NCT01090427|467918851|FG002|After Controlled Period|Death|0|||
129988130|NCT01090427|467918852|FG003|After Controlled Period|Death|0|||
129988131|NCT01090427|467918853|FG004|After Controlled Period|Death|0|||
129988132|NCT01090427|467918854|FG005|After Controlled Period|Death|1|||
129988133|NCT01090427|467918855|FG006|After Controlled Period|Death|0|||
129988134|NCT01090427|467918849|FG000|After Controlled Period|Lack of Efficacy|0|||
129988135|NCT01090427|467918850|FG001|After Controlled Period|Lack of Efficacy|0|||
129988136|NCT01090427|467918851|FG002|After Controlled Period|Lack of Efficacy|0|||
129988137|NCT01090427|467918852|FG003|After Controlled Period|Lack of Efficacy|0|||
129988138|NCT01090427|467918853|FG004|After Controlled Period|Lack of Efficacy|0|||
129988139|NCT01090427|467918854|FG005|After Controlled Period|Lack of Efficacy|3|||
129988140|NCT01090427|467918855|FG006|After Controlled Period|Lack of Efficacy|2|||
129988141|NCT01090427|467918849|FG000|After Controlled Period|Adverse Event|0|||
129988142|NCT01090427|467918850|FG001|After Controlled Period|Adverse Event|0|||
129988143|NCT01090427|467918851|FG002|After Controlled Period|Adverse Event|0|||
129988144|NCT01090427|467918852|FG003|After Controlled Period|Adverse Event|2|||
129988145|NCT01090427|467918853|FG004|After Controlled Period|Adverse Event|0|||
129988146|NCT01090427|467918854|FG005|After Controlled Period|Adverse Event|1|||
129988147|NCT01090427|467918855|FG006|After Controlled Period|Adverse Event|0|||
129988148|NCT01200589|467918856|FG000|Overall Study|Withdrawal by Subject|13|||
129988149|NCT01200589|467918857|FG001|Overall Study|Withdrawal by Subject|11|||
129988150|NCT01200589|467918856|FG000|Overall Study|Physician Decision|2|||
129988151|NCT01200589|467918857|FG001|Overall Study|Physician Decision|2|||
129988152|NCT01200589|467918856|FG000|Overall Study|Lost to Follow-up|5|||
129988153|NCT01200589|467918857|FG001|Overall Study|Lost to Follow-up|4|||
129988154|NCT01200589|467918856|FG000|Overall Study|Study terminated|170|||
129988155|NCT01200589|467918857|FG001|Overall Study|Study terminated|172|||
129988156|NCT01154010|467918858|FG000|Overall Study|Lost to Follow-up|0|||
129988157|NCT01154010|467918859|FG001|Overall Study|Lost to Follow-up|1|||
129988158|NCT00439231|467918860|FG000|Overall Study|Lack of Efficacy|28|||
129988159|NCT02689518|467918861|FG000|Overall Study|Withdrawal by Subject|3|||
129988160|NCT00825825|467918864|FG000|First Medication Period (14 Days)|Adverse Event|1|||
129988161|NCT00825825|467918865|FG001|First Medication Period (14 Days)|Adverse Event|0|||
129988162|NCT00825825|467918866|FG002|First Medication Period (14 Days)|Adverse Event|0|||
129988163|NCT00825825|467918867|FG003|First Medication Period (14 Days)|Adverse Event|0|||
129988164|NCT00825825|467918868|FG004|First Medication Period (14 Days)|Adverse Event|0|||
129988165|NCT00825825|467918869|FG005|First Medication Period (14 Days)|Adverse Event|1|||
129988166|NCT00825825|467918864|FG000|First Medication Period (14 Days)|Physician Decision|2|||
129988167|NCT00825825|467918865|FG001|First Medication Period (14 Days)|Physician Decision|0|||
129988168|NCT00825825|467918866|FG002|First Medication Period (14 Days)|Physician Decision|1|||
129988169|NCT00825825|467918867|FG003|First Medication Period (14 Days)|Physician Decision|0|||
129988170|NCT00825825|467918868|FG004|First Medication Period (14 Days)|Physician Decision|0|||
129988171|NCT00825825|467918869|FG005|First Medication Period (14 Days)|Physician Decision|1|||
129988172|NCT00825825|467918864|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
129988173|NCT00825825|467918865|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
129988174|NCT00825825|467918866|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
129988175|NCT00825825|467918867|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
129988176|NCT00825825|467918868|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
129988177|NCT00825825|467918869|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
129988178|NCT00825825|467918864|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
129988179|NCT00825825|467918865|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
129988180|NCT00825825|467918866|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
129988181|NCT00825825|467918867|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
129988182|NCT00825825|467918868|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
129988183|NCT00825825|467918869|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
129988184|NCT00825825|467918864|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
129988185|NCT00825825|467918865|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
129988186|NCT00825825|467918866|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
130325225|NCT03879772|469163712|FG004|Overall Study|Lost to Follow-up|1|||
129988187|NCT00825825|467918867|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
129988188|NCT00825825|467918868|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
129988189|NCT00825825|467918869|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
129988190|NCT00825825|467918864|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
130325226|NCT03879772|469163708|FG000|Overall Study|Withdrawal by Subject|0|||
129988191|NCT00825825|467918865|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
129988192|NCT00825825|467918866|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
129988193|NCT00825825|467918867|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
129988194|NCT00825825|467918868|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
129988195|NCT00825825|467918869|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
129988196|NCT00825825|467918864|FG000|Third Medication Period (14 Days)|poor data quality|0|||
130325227|NCT03879772|469163709|FG001|Overall Study|Withdrawal by Subject|1|||
130325228|NCT03879772|469163710|FG002|Overall Study|Withdrawal by Subject|3|||
130325229|NCT03879772|469163711|FG003|Overall Study|Withdrawal by Subject|1|||
130325230|NCT03879772|469163712|FG004|Overall Study|Withdrawal by Subject|1|||
130325231|NCT03879772|469163708|FG000|Overall Study|Protocol Violation|0|||
130325232|NCT03879772|469163709|FG001|Overall Study|Protocol Violation|0|||
130325233|NCT03879772|469163710|FG002|Overall Study|Protocol Violation|3|||
130325234|NCT03879772|469163711|FG003|Overall Study|Protocol Violation|1|||
130325235|NCT03879772|469163712|FG004|Overall Study|Protocol Violation|2|||
130325236|NCT03879772|469163708|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
130325237|NCT03879772|469163709|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
130325238|NCT03879772|469163710|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
130325239|NCT03879772|469163711|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
130325240|NCT03879772|469163712|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
130325241|NCT00930046|469163713|FG000|Overall Study|Wound catheter malfunctioned|1|||
130325242|NCT00930046|469163714|FG001|Overall Study|Wound catheter malfunctioned|2|||
130325243|NCT02161016|469163715|FG000|Overall Study|withdrawn by IRB|1|||
130325244|NCT02531802|469163716|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
130325245|NCT02531802|469163717|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
130325246|NCT02531802|469163718|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
130325247|NCT02531802|469163719|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
130325248|NCT02531802|469163720|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
130325249|NCT02531802|469163721|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
130325250|NCT02531802|469163722|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
130325251|NCT02531802|469163723|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
130325252|NCT02531802|469163724|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
130325253|NCT02531802|469163725|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
130325254|NCT02531802|469163726|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
130325255|NCT02531802|469163727|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
129988197|NCT00825825|467918865|FG001|Third Medication Period (14 Days)|poor data quality|1|||
129988198|NCT00825825|467918866|FG002|Third Medication Period (14 Days)|poor data quality|0|||
129988199|NCT00825825|467918867|FG003|Third Medication Period (14 Days)|poor data quality|0|||
130325256|NCT02531802|469163728|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
130325257|NCT02531802|469163729|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
130325258|NCT02531802|469163730|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
130325259|NCT02531802|469163731|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
130325260|NCT02531802|469163732|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
129988200|NCT00825825|467918868|FG004|Third Medication Period (14 Days)|poor data quality|0|||
129988201|NCT00825825|467918869|FG005|Third Medication Period (14 Days)|poor data quality|0|||
129988202|NCT01920854|467918872|FG000|Overall Study|Withdrawal by Subject|1|||
129988203|NCT01920854|467918873|FG001|Overall Study|Withdrawal by Subject|0|||
130214994|NCT02499263|468751657|FG000|Overall Study|Participant's decision|3|||
130214995|NCT02499263|468751657|FG000|Overall Study|Pregnancy|1|||
130214996|NCT01148459|468751676|FG000|Overall Study|Serious Adverse Event|5|||
130214997|NCT01148459|468751677|FG001|Overall Study|Serious Adverse Event|4|||
130214998|NCT01148459|468751676|FG000|Overall Study|Withdrawal by Subject|1|||
130214999|NCT01148459|468751677|FG001|Overall Study|Withdrawal by Subject|0|||
130215000|NCT01148459|468751676|FG000|Overall Study|Migrated/moved from study area|3|||
130215001|NCT01148459|468751677|FG001|Overall Study|Migrated/moved from study area|6|||
130215002|NCT01148459|468751676|FG000|Overall Study|Lost to Follow-up|2|||
130215003|NCT01148459|468751677|FG001|Overall Study|Lost to Follow-up|0|||
130215004|NCT01148459|468751676|FG000|Overall Study|Refusal|1|||
130215005|NCT01148459|468751677|FG001|Overall Study|Refusal|0|||
130215006|NCT01148459|468751676|FG000|Overall Study|Failure to comply with study procedures|0|||
130215007|NCT01148459|468751677|FG001|Overall Study|Failure to comply with study procedures|1|||
130215008|NCT00694356|468751678|FG000|Overall Study|Adverse Event|1|||
130215009|NCT00694356|468751679|FG001|Overall Study|Adverse Event|0|||
130215010|NCT00694356|468751680|FG002|Overall Study|Adverse Event|0|||
130215011|NCT00694356|468751678|FG000|Overall Study|Progressive Disease|2|||
130215012|NCT00694356|468751679|FG001|Overall Study|Progressive Disease|6|||
130215013|NCT00694356|468751680|FG002|Overall Study|Progressive Disease|6|||
130215014|NCT01152996|468751681|FG000|Overall Study|Withdrawal by Subject|142|||
130215015|NCT01152996|468751681|FG000|Overall Study|Adverse Event|115|||
130215016|NCT01152996|468751681|FG000|Overall Study|Lost to Follow-up|112|||
130215017|NCT01152996|468751681|FG000|Overall Study|Lack of Efficacy|68|||
130215018|NCT01152996|468751681|FG000|Overall Study|Noncompliance|41|||
130215019|NCT01152996|468751681|FG000|Overall Study|Other|36|||
130215020|NCT01152996|468751681|FG000|Overall Study|Protocol Violation|22|||
130215021|NCT01152996|468751681|FG000|Overall Study|Elevated liver enzymes|1|||
130215022|NCT02072941|468751682|FG000|Overall Study|Withdrawal by Subject|29|||
130215023|NCT02072941|468751683|FG001|Overall Study|Withdrawal by Subject|21|||
129883509|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
129883510|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
130215024|NCT02072941|468751682|FG000|Overall Study|Lost to Follow-up|4|||
130215025|NCT02072941|468751683|FG001|Overall Study|Lost to Follow-up|4|||
130215026|NCT02072941|468751682|FG000|Overall Study|Death|3|||
130215027|NCT02072941|468751683|FG001|Overall Study|Death|2|||
130215028|NCT02072941|468751682|FG000|Overall Study|Removed by Study Staff|2|||
130215029|NCT02072941|468751683|FG001|Overall Study|Removed by Study Staff|2|||
130215030|NCT03224624|468751693|FG000|Overall Study|Lost to Follow-up|9|||
130215031|NCT03224624|468751694|FG001|Overall Study|Lost to Follow-up|4|||
130215032|NCT03224624|468751693|FG000|Overall Study|Death|1|||
130215033|NCT03224624|468751694|FG001|Overall Study|Death|0|||
130215034|NCT01884545|468751695|FG000|Overall Study|Lost to Follow-up|6|||
130215035|NCT01884545|468751696|FG001|Overall Study|Lost to Follow-up|4|||
130215036|NCT01884545|468751697|FG002|Overall Study|Lost to Follow-up|9|||
130215037|NCT01884545|468751698|FG003|Overall Study|Lost to Follow-up|4|||
130215038|NCT01884545|468751695|FG000|Overall Study|Patient withdrawn|7|||
130215039|NCT01884545|468751696|FG001|Overall Study|Patient withdrawn|12|||
130215040|NCT01884545|468751697|FG002|Overall Study|Patient withdrawn|5|||
130215041|NCT01884545|468751698|FG003|Overall Study|Patient withdrawn|5|||
130215042|NCT01884545|468751695|FG000|Overall Study|Non-adherence|0|||
130215043|NCT01884545|468751696|FG001|Overall Study|Non-adherence|2|||
130215044|NCT01884545|468751697|FG002|Overall Study|Non-adherence|0|||
130215045|NCT01884545|468751698|FG003|Overall Study|Non-adherence|0|||
130215046|NCT02782377|468751699|FG000|Overall Study|Physician Decision|5|||
130215047|NCT02521792|468751700|FG000|Overall Study|Study Terminated|6|||
130215048|NCT01188668|468751701|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
130215049|NCT01188668|468751701|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
130215050|NCT01188668|468751701|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
130215051|NCT00303472|468751702|FG000|Treatment Period|Adverse Event|0|||
130215052|NCT00303472|468751703|FG001|Treatment Period|Adverse Event|0|||
130215053|NCT00303472|468751704|FG002|Treatment Period|Adverse Event|0|||
130215054|NCT00303472|468751705|FG003|Treatment Period|Adverse Event|0|||
130215055|NCT00303472|468751706|FG004|Treatment Period|Adverse Event|1|||
130215056|NCT00303472|468751707|FG005|Treatment Period|Adverse Event|0|||
130215057|NCT00303472|468751708|FG006|Treatment Period|Adverse Event|0|||
130215058|NCT00303472|468751702|FG000|Treatment Period|Death|0|||
130215059|NCT00303472|468751703|FG001|Treatment Period|Death|0|||
130215060|NCT00303472|468751704|FG002|Treatment Period|Death|0|||
130215061|NCT00303472|468751705|FG003|Treatment Period|Death|1|||
130215062|NCT00303472|468751706|FG004|Treatment Period|Death|0|||
130215063|NCT00303472|468751707|FG005|Treatment Period|Death|0|||
130215064|NCT00303472|468751708|FG006|Treatment Period|Death|1|||
130215065|NCT00303472|468751702|FG000|Treatment Period|Withdrawal by Subject|0|||
130215066|NCT00303472|468751703|FG001|Treatment Period|Withdrawal by Subject|0|||
130215067|NCT00303472|468751704|FG002|Treatment Period|Withdrawal by Subject|0|||
130215068|NCT00303472|468751705|FG003|Treatment Period|Withdrawal by Subject|1|||
130215069|NCT00303472|468751706|FG004|Treatment Period|Withdrawal by Subject|0|||
130215070|NCT00303472|468751707|FG005|Treatment Period|Withdrawal by Subject|1|||
130215071|NCT00303472|468751708|FG006|Treatment Period|Withdrawal by Subject|0|||
130215072|NCT00303472|468751702|FG000|Treatment Period|Other|0|||
130215073|NCT00303472|468751703|FG001|Treatment Period|Other|0|||
130215074|NCT00303472|468751704|FG002|Treatment Period|Other|0|||
130215075|NCT00303472|468751705|FG003|Treatment Period|Other|0|||
130215076|NCT00303472|468751706|FG004|Treatment Period|Other|1|||
130215077|NCT00303472|468751707|FG005|Treatment Period|Other|0|||
130215078|NCT00303472|468751708|FG006|Treatment Period|Other|1|||
130215079|NCT00303472|468751702|FG000|Treatment Period|Disease Progression (to AML)|0|||
130215080|NCT00303472|468751703|FG001|Treatment Period|Disease Progression (to AML)|0|||
130215081|NCT00303472|468751704|FG002|Treatment Period|Disease Progression (to AML)|0|||
130215082|NCT00303472|468751705|FG003|Treatment Period|Disease Progression (to AML)|0|||
130215083|NCT00303472|468751706|FG004|Treatment Period|Disease Progression (to AML)|1|||
130215084|NCT00303472|468751707|FG005|Treatment Period|Disease Progression (to AML)|0|||
130215085|NCT00303472|468751708|FG006|Treatment Period|Disease Progression (to AML)|0|||
130215086|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Adverse Event|1|||
130215087|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Adverse Event|0|||
130215088|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Adverse Event|1|||
130215089|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Adverse Event|0|||
130215090|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Adverse Event|0|||
130215091|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Adverse Event|0|||
130215092|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Adverse Event|0|||
130215093|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Death|2|||
130215094|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Death|0|||
130215095|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Death|1|||
130215096|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Death|0|||
130325261|NCT02531802|469163733|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
130325262|NCT02531802|469163734|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
130325263|NCT02531802|469163735|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
130325264|NCT02531802|469163736|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
130325265|NCT02531802|469163716|FG000|Received Vaccination 2|Physician Decision|0|||
130325266|NCT02531802|469163717|FG001|Received Vaccination 2|Physician Decision|0|||
130325267|NCT02531802|469163718|FG002|Received Vaccination 2|Physician Decision|0|||
130325268|NCT02531802|469163719|FG003|Received Vaccination 2|Physician Decision|0|||
130325269|NCT02531802|469163720|FG004|Received Vaccination 2|Physician Decision|0|||
130325270|NCT02531802|469163721|FG005|Received Vaccination 2|Physician Decision|1|||
130325271|NCT02531802|469163722|FG006|Received Vaccination 2|Physician Decision|0|||
130325272|NCT02531802|469163723|FG007|Received Vaccination 2|Physician Decision|0|||
130325273|NCT02531802|469163724|FG008|Received Vaccination 2|Physician Decision|0|||
130325274|NCT02531802|469163725|FG009|Received Vaccination 2|Physician Decision|2|||
130325275|NCT02531802|469163726|FG010|Received Vaccination 2|Physician Decision|0|||
130325276|NCT02531802|469163727|FG011|Received Vaccination 2|Physician Decision|0|||
130325277|NCT02531802|469163728|FG012|Received Vaccination 2|Physician Decision|0|||
130325278|NCT02531802|469163729|FG013|Received Vaccination 2|Physician Decision|1|||
130325279|NCT02531802|469163730|FG014|Received Vaccination 2|Physician Decision|0|||
130325280|NCT02531802|469163731|FG015|Received Vaccination 2|Physician Decision|0|||
130325281|NCT02531802|469163732|FG016|Received Vaccination 2|Physician Decision|0|||
130325282|NCT02531802|469163733|FG017|Received Vaccination 2|Physician Decision|1|||
130325283|NCT02531802|469163734|FG018|Received Vaccination 2|Physician Decision|0|||
130325284|NCT02531802|469163735|FG019|Received Vaccination 2|Physician Decision|0|||
130325285|NCT02531802|469163736|FG020|Received Vaccination 2|Physician Decision|0|||
130325286|NCT02531802|469163716|FG000|Received Vaccination 2|Adverse Event|0|||
130325287|NCT02531802|469163717|FG001|Received Vaccination 2|Adverse Event|0|||
130325288|NCT02531802|469163718|FG002|Received Vaccination 2|Adverse Event|0|||
130325289|NCT02531802|469163719|FG003|Received Vaccination 2|Adverse Event|0|||
130325290|NCT02531802|469163720|FG004|Received Vaccination 2|Adverse Event|0|||
130325291|NCT02531802|469163721|FG005|Received Vaccination 2|Adverse Event|2|||
130325292|NCT02531802|469163722|FG006|Received Vaccination 2|Adverse Event|0|||
130325293|NCT02531802|469163723|FG007|Received Vaccination 2|Adverse Event|0|||
130325294|NCT02531802|469163724|FG008|Received Vaccination 2|Adverse Event|0|||
130325295|NCT02531802|469163725|FG009|Received Vaccination 2|Adverse Event|0|||
130325296|NCT02531802|469163726|FG010|Received Vaccination 2|Adverse Event|0|||
130325297|NCT02531802|469163727|FG011|Received Vaccination 2|Adverse Event|0|||
130325298|NCT02531802|469163728|FG012|Received Vaccination 2|Adverse Event|0|||
130325299|NCT02531802|469163729|FG013|Received Vaccination 2|Adverse Event|0|||
130325300|NCT02531802|469163730|FG014|Received Vaccination 2|Adverse Event|0|||
130325301|NCT02531802|469163731|FG015|Received Vaccination 2|Adverse Event|0|||
130325302|NCT02531802|469163732|FG016|Received Vaccination 2|Adverse Event|0|||
130325303|NCT02531802|469163733|FG017|Received Vaccination 2|Adverse Event|2|||
130325304|NCT02531802|469163734|FG018|Received Vaccination 2|Adverse Event|1|||
130325305|NCT02531802|469163735|FG019|Received Vaccination 2|Adverse Event|0|||
130325306|NCT02531802|469163736|FG020|Received Vaccination 2|Adverse Event|1|||
130325307|NCT02531802|469163716|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130325308|NCT02531802|469163717|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130325309|NCT02531802|469163718|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
130325310|NCT02531802|469163719|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130325311|NCT02531802|469163720|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130325312|NCT02531802|469163721|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
130325313|NCT02531802|469163722|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
130325314|NCT02531802|469163723|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
130325315|NCT02531802|469163724|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
130325316|NCT02531802|469163725|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
130325317|NCT02531802|469163726|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
130325318|NCT02531802|469163727|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
130325319|NCT02531802|469163728|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
130325320|NCT02531802|469163729|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
130325321|NCT02531802|469163730|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
130325322|NCT02531802|469163731|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
130325323|NCT02531802|469163732|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
130325324|NCT02531802|469163733|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
130325325|NCT02531802|469163734|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
130325326|NCT02531802|469163735|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
130325327|NCT02531802|469163736|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
130325328|NCT03345784|469163739|FG000|Overall Study|Withdrawal by Subject|2|||
130325329|NCT03345784|469163740|FG001|Overall Study|Withdrawal by Subject|1|||
130325330|NCT04798196|469163741|FG000|Overall Study|Lost to Follow-up|3|||
129988204|NCT01920854|467918874|FG002|Overall Study|Withdrawal by Subject|0|||
129988205|NCT01920854|467918875|FG003|Overall Study|Withdrawal by Subject|0|||
129988206|NCT01920854|467918876|FG004|Overall Study|Withdrawal by Subject|1|||
130325331|NCT04798196|469163742|FG001|Overall Study|Lost to Follow-up|1|||
130325332|NCT04798196|469163743|FG002|Overall Study|Lost to Follow-up|3|||
130325333|NCT00728689|469163752|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
130325334|NCT00728689|469163753|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
130325335|NCT00929695|469163754|FG000|Overall Study|Death|2|||
130325336|NCT00929695|469163755|FG001|Overall Study|Death|1|||
130325337|NCT00929695|469163754|FG000|Overall Study|Withdrawal by Subject|0|||
130325338|NCT00929695|469163755|FG001|Overall Study|Withdrawal by Subject|2|||
130325339|NCT00929695|469163754|FG000|Overall Study|discharge home|4|||
130325340|NCT00929695|469163755|FG001|Overall Study|discharge home|3|||
130325341|NCT00929695|469163754|FG000|Overall Study|incorrect stratification|2|||
130325342|NCT00929695|469163755|FG001|Overall Study|incorrect stratification|0|||
130325343|NCT03216226|469163756|FG000|Overall Study|Adverse Event|3|||
130325344|NCT03216226|469163757|FG001|Overall Study|Adverse Event|0|||
130325345|NCT03216226|469163756|FG000|Overall Study|Protocol Violation|1|||
130325346|NCT03216226|469163757|FG001|Overall Study|Protocol Violation|3|||
130325347|NCT03216226|469163756|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
130325348|NCT03216226|469163757|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
130325349|NCT03216226|469163756|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
130325350|NCT03216226|469163757|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
130325351|NCT03216226|469163756|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
130325352|NCT03216226|469163757|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
130325353|NCT00887809|469163758|FG000|Overall Study|Patient Not Treated|3|||
130325354|NCT00887809|469163759|FG001|Overall Study|Patient Not Treated|0|||
130325355|NCT00887809|469163758|FG000|Overall Study|Death|1|||
130325356|NCT00887809|469163759|FG001|Overall Study|Death|0|||
130325357|NCT01352715|469163762|FG000|Overall Study|Death|3|||
130325358|NCT01352715|469163763|FG001|Overall Study|Death|3|||
130325359|NCT01352715|469163762|FG000|Overall Study|Lost to Follow-up|5|||
130325360|NCT01352715|469163763|FG001|Overall Study|Lost to Follow-up|7|||
130325361|NCT01352715|469163762|FG000|Overall Study|Withdrawal by Subject|4|||
130325362|NCT01352715|469163763|FG001|Overall Study|Withdrawal by Subject|8|||
130325363|NCT01352715|469163762|FG000|Overall Study|site closure|16|||
130325364|NCT01352715|469163763|FG001|Overall Study|site closure|15|||
130325365|NCT01352715|469163762|FG000|Overall Study|no final visit in closeout period|15|||
130325366|NCT01352715|469163763|FG001|Overall Study|no final visit in closeout period|12|||
130325367|NCT01352715|469163762|FG000|Overall Study|major ineligibility|2|||
130325368|NCT01352715|469163763|FG001|Overall Study|major ineligibility|1|||
130325369|NCT04596267|469163764|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
130325370|NCT04596267|469163765|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
130325371|NCT04596267|469163764|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
130325372|NCT04596267|469163765|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
130325373|NCT00071058|469163766|FG000|Overall Study|brain tumor-removed from study|1|||
130325374|NCT04109547|469163767|FG000|Overall Study|Withdrawal by Subject|3|||
130325375|NCT04109547|469163768|FG001|Overall Study|Withdrawal by Subject|2|||
130325376|NCT04109547|469163769|FG002|Overall Study|Withdrawal by Subject|6|||
130325377|NCT04109547|469163770|FG003|Overall Study|Withdrawal by Subject|6|||
130325378|NCT04109547|469163767|FG000|Overall Study|Lost to Follow-up|0|||
130325379|NCT04109547|469163768|FG001|Overall Study|Lost to Follow-up|0|||
130325380|NCT04109547|469163769|FG002|Overall Study|Lost to Follow-up|0|||
130325381|NCT04109547|469163770|FG003|Overall Study|Lost to Follow-up|1|||
130325382|NCT04109547|469163767|FG000|Overall Study|Physician Decision|1|||
130325383|NCT04109547|469163768|FG001|Overall Study|Physician Decision|2|||
130325384|NCT04109547|469163769|FG002|Overall Study|Physician Decision|0|||
130325385|NCT04109547|469163770|FG003|Overall Study|Physician Decision|0|||
130325386|NCT01550003|469163771|FG000|Overall Study|Adverse Event|0|||
130325387|NCT01550003|469163772|FG001|Overall Study|Adverse Event|9|||
130325388|NCT01550003|469163773|FG002|Overall Study|Adverse Event|15|||
130325389|NCT01550003|469163771|FG000|Overall Study|Lack of Efficacy|4|||
130325390|NCT01550003|469163772|FG001|Overall Study|Lack of Efficacy|11|||
130325391|NCT01550003|469163773|FG002|Overall Study|Lack of Efficacy|15|||
130325392|NCT01550003|469163771|FG000|Overall Study|Protocol Violation|0|||
130325393|NCT01550003|469163772|FG001|Overall Study|Protocol Violation|3|||
130325394|NCT01550003|469163773|FG002|Overall Study|Protocol Violation|2|||
130325395|NCT01550003|469163771|FG000|Overall Study|Lost to Follow-up|1|||
130325396|NCT01550003|469163772|FG001|Overall Study|Lost to Follow-up|4|||
130325397|NCT01550003|469163773|FG002|Overall Study|Lost to Follow-up|8|||
130325398|NCT01550003|469163771|FG000|Overall Study|Consent withdrawn|2|||
130325399|NCT01550003|469163772|FG001|Overall Study|Consent withdrawn|11|||
130325400|NCT01550003|469163773|FG002|Overall Study|Consent withdrawn|23|||
130325401|NCT01550003|469163771|FG000|Overall Study|Missing|1|||
130325402|NCT01550003|469163772|FG001|Overall Study|Missing|0|||
130325403|NCT01550003|469163773|FG002|Overall Study|Missing|2|||
130325404|NCT01550003|469163771|FG000|Overall Study|Study closure as announced by sponsor|7|||
130110720|NCT03705169|468365847|FG002|Overall Study|Did not receive study treatment|0|||
129988207|NCT01920854|467918877|FG005|Overall Study|Withdrawal by Subject|0|||
130215097|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Death|0|||
130215098|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Death|0|||
129988208|NCT01920854|467918878|FG006|Overall Study|Withdrawal by Subject|1|||
130215099|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Death|0|||
130215100|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215101|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215102|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215103|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
130215104|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215105|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215106|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
130215107|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Physician Decision|0|||
130215108|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Physician Decision|4|||
130215109|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Physician Decision|2|||
130215110|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Physician Decision|3|||
130215111|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Physician Decision|2|||
130215112|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Physician Decision|0|||
130215113|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Physician Decision|0|||
130215114|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130215115|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130215116|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130215117|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
130215118|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
130215119|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130215120|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
130215121|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Other|0|||
130215122|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Other|2|||
130215123|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Other|4|||
130215124|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Other|2|||
130215125|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Other|1|||
130215126|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Other|0|||
130215127|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Other|0|||
130215128|NCT00303472|468751702|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
130215129|NCT00303472|468751703|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215130|NCT00303472|468751704|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215131|NCT00303472|468751705|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215132|NCT00303472|468751706|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215133|NCT00303472|468751707|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
130215134|NCT00303472|468751708|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
130215135|NCT02937636|468751709|FG000|Overall Study|Other (Not specified)|3|||
130215136|NCT02937636|468751710|FG001|Overall Study|Other (Not specified)|2|||
130215137|NCT03383692|468751723|FG000|Overall Study|Progressive disease as per RECIST|3|||
130215138|NCT03383692|468751724|FG001|Overall Study|Progressive disease as per RECIST|3|||
130215139|NCT03383692|468751723|FG000|Overall Study|Clinical progression|0|||
130215140|NCT03383692|468751724|FG001|Overall Study|Clinical progression|1|||
130215141|NCT03383692|468751723|FG000|Overall Study|Adverse Event|3|||
130215142|NCT03383692|468751724|FG001|Overall Study|Adverse Event|0|||
130215143|NCT00893971|468751725|FG000|Overall Study|Physician Decision|3|||
130215144|NCT02453256|468751726|FG000|Double Blind Period|Death|1|||
130215145|NCT02453256|468751727|FG001|Double Blind Period|Death|1|||
130215146|NCT02453256|468751726|FG000|Double Blind Period|Adverse Event|3|||
130215147|NCT02453256|468751727|FG001|Double Blind Period|Adverse Event|2|||
130215148|NCT02453256|468751726|FG000|Double Blind Period|Withdrawal by Subject|9|||
130215149|NCT02453256|468751727|FG001|Double Blind Period|Withdrawal by Subject|5|||
130215150|NCT02453256|468751726|FG000|Double Blind Period|Other|0|||
130215151|NCT02453256|468751727|FG001|Double Blind Period|Other|1|||
130215152|NCT02453256|468751726|FG000|Open Label Period|Adverse Event|1|||
130215153|NCT02453256|468751727|FG001|Open Label Period|Adverse Event|3|||
130215154|NCT02453256|468751726|FG000|Open Label Period|Death|0|||
130215155|NCT02453256|468751727|FG001|Open Label Period|Death|1|||
130215156|NCT02453256|468751726|FG000|Open Label Period|Lost to Follow-up|1|||
130215157|NCT02453256|468751727|FG001|Open Label Period|Lost to Follow-up|0|||
130215158|NCT02453256|468751726|FG000|Open Label Period|Other|0|||
130215159|NCT02453256|468751727|FG001|Open Label Period|Other|2|||
130215160|NCT02453256|468751726|FG000|Open Label Period|Withdrawal by Subject|5|||
130215161|NCT02453256|468751727|FG001|Open Label Period|Withdrawal by Subject|1|||
130215162|NCT01366638|468751728|FG000|Overall Study|Withdrawal by Subject|0|||
130215163|NCT01366638|468751729|FG001|Overall Study|Withdrawal by Subject|0|||
130215164|NCT01366638|468751730|FG002|Overall Study|Withdrawal by Subject|6|||
130215165|NCT01366638|468751728|FG000|Overall Study|Other|1|||
130215166|NCT01366638|468751729|FG001|Overall Study|Other|0|||
130215167|NCT01366638|468751730|FG002|Overall Study|Other|0|||
130325405|NCT01550003|469163772|FG001|Overall Study|Study closure as announced by sponsor|6|||
130325406|NCT01550003|469163773|FG002|Overall Study|Study closure as announced by sponsor|24|||
130325407|NCT01550003|469163771|FG000|Overall Study|Protocol Noncompliance|1|||
130325408|NCT01550003|469163772|FG001|Overall Study|Protocol Noncompliance|0|||
130325409|NCT01550003|469163773|FG002|Overall Study|Protocol Noncompliance|0|||
130325410|NCT01550003|469163771|FG000|Overall Study|Study closure|0|||
130325411|NCT01550003|469163772|FG001|Overall Study|Study closure|1|||
130325412|NCT01550003|469163773|FG002|Overall Study|Study closure|1|||
130325413|NCT01550003|469163771|FG000|Overall Study|Patient reached adulthood|0|||
130325414|NCT01550003|469163772|FG001|Overall Study|Patient reached adulthood|1|||
130325415|NCT01550003|469163773|FG002|Overall Study|Patient reached adulthood|0|||
130325416|NCT01550003|469163771|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
130325417|NCT01550003|469163772|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
130325418|NCT01550003|469163773|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
130325419|NCT01550003|469163771|FG000|Overall Study|Sponsor's order|0|||
130325420|NCT01550003|469163772|FG001|Overall Study|Sponsor's order|3|||
130325421|NCT01550003|469163773|FG002|Overall Study|Sponsor's order|3|||
130325422|NCT01550003|469163771|FG000|Overall Study|Sponsor's decision|1|||
130325423|NCT01550003|469163772|FG001|Overall Study|Sponsor's decision|5|||
130325424|NCT01550003|469163773|FG002|Overall Study|Sponsor's decision|4|||
130325425|NCT01550003|469163771|FG000|Overall Study|Subject mother passed away|0|||
130325426|NCT01550003|469163772|FG001|Overall Study|Subject mother passed away|1|||
130325427|NCT01550003|469163773|FG002|Overall Study|Subject mother passed away|0|||
130325428|NCT01550003|469163771|FG000|Overall Study|Discontinuation|0|||
130325429|NCT01550003|469163772|FG001|Overall Study|Discontinuation|1|||
130325430|NCT01550003|469163773|FG002|Overall Study|Discontinuation|0|||
130325431|NCT01550003|469163771|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
130325432|NCT01550003|469163772|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
130325433|NCT01550003|469163773|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
130325434|NCT01550003|469163771|FG000|Overall Study|Site closure|0|||
130325435|NCT01550003|469163772|FG001|Overall Study|Site closure|2|||
130325436|NCT01550003|469163773|FG002|Overall Study|Site closure|0|||
130325437|NCT01550003|469163771|FG000|Overall Study|Pregnancy|0|||
130325438|NCT01550003|469163772|FG001|Overall Study|Pregnancy|1|||
130325439|NCT01550003|469163773|FG002|Overall Study|Pregnancy|0|||
130325440|NCT01550003|469163771|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
130325441|NCT01550003|469163772|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
130325442|NCT01550003|469163773|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
130325443|NCT01550003|469163771|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
130325444|NCT01550003|469163772|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
130325445|NCT01550003|469163773|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
130325446|NCT01550003|469163771|FG000|Overall Study|Switching to adult rheumatologist|0|||
130325447|NCT01550003|469163772|FG001|Overall Study|Switching to adult rheumatologist|0|||
130325448|NCT01550003|469163773|FG002|Overall Study|Switching to adult rheumatologist|1|||
130325449|NCT01550003|469163771|FG000|Overall Study|Patient transition to adult care|0|||
130325450|NCT01550003|469163772|FG001|Overall Study|Patient transition to adult care|0|||
130325451|NCT01550003|469163773|FG002|Overall Study|Patient transition to adult care|1|||
130325452|NCT01550003|469163771|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
130325453|NCT01550003|469163772|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
130325454|NCT01550003|469163773|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
130325455|NCT01550003|469163771|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
130325456|NCT01550003|469163772|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
130325457|NCT01550003|469163773|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
130325458|NCT01550003|469163771|FG000|Overall Study|Per Sponsor request|1|||
129988209|NCT00757783|467918879|FG000|Overall Study|Adverse Event|0|||
129988210|NCT00757783|467918880|FG001|Overall Study|Adverse Event|2|||
130325459|NCT01550003|469163772|FG001|Overall Study|Per Sponsor request|0|||
130325460|NCT01550003|469163773|FG002|Overall Study|Per Sponsor request|1|||
130325461|NCT01550003|469163771|FG000|Overall Study|Patient not compliance|0|||
130325462|NCT01550003|469163772|FG001|Overall Study|Patient not compliance|0|||
130325463|NCT01550003|469163773|FG002|Overall Study|Patient not compliance|1|||
130325464|NCT01550003|469163771|FG000|Overall Study|Non-compliance|0|||
130325465|NCT01550003|469163772|FG001|Overall Study|Non-compliance|0|||
130325466|NCT01550003|469163773|FG002|Overall Study|Non-compliance|1|||
130325467|NCT01550003|469163771|FG000|Overall Study|Study closed|0|||
130325468|NCT01550003|469163772|FG001|Overall Study|Study closed|1|||
130325469|NCT01550003|469163773|FG002|Overall Study|Study closed|0|||
130325470|NCT01550003|469163771|FG000|Overall Study|Transitioned to adult rheumatology|0|||
130325471|NCT01550003|469163772|FG001|Overall Study|Transitioned to adult rheumatology|0|||
129988211|NCT00757783|467918879|FG000|Overall Study|Lost to Follow-up|1|||
130325472|NCT01550003|469163773|FG002|Overall Study|Transitioned to adult rheumatology|1|||
129988212|NCT00757783|467918880|FG001|Overall Study|Lost to Follow-up|1|||
129988213|NCT00757783|467918879|FG000|Overall Study|Protocol Violation|1|||
130325473|NCT01656408|469163774|FG000|Overall Study|Adverse Event|0|||
130325474|NCT01656408|469163775|FG001|Overall Study|Adverse Event|0|||
130325475|NCT01656408|469163776|FG002|Overall Study|Adverse Event|1|||
130325476|NCT01656408|469163777|FG003|Overall Study|Adverse Event|0|||
130325477|NCT01656408|469163778|FG004|Overall Study|Adverse Event|0|||
130325478|NCT01656408|469163779|FG005|Overall Study|Adverse Event|1|||
130325479|NCT01656408|469163780|FG006|Overall Study|Adverse Event|1|||
130325480|NCT01656408|469163781|FG007|Overall Study|Adverse Event|0|||
130325481|NCT01656408|469163782|FG008|Overall Study|Adverse Event|1|||
130325482|NCT01656408|469163783|FG009|Overall Study|Adverse Event|0|||
130325483|NCT01656408|469163774|FG000|Overall Study|Physician Decision|1|||
130325484|NCT01656408|469163775|FG001|Overall Study|Physician Decision|0|||
130325485|NCT01656408|469163776|FG002|Overall Study|Physician Decision|1|||
130325486|NCT01656408|469163777|FG003|Overall Study|Physician Decision|0|||
130325487|NCT01656408|469163778|FG004|Overall Study|Physician Decision|1|||
130325488|NCT01656408|469163779|FG005|Overall Study|Physician Decision|1|||
130325489|NCT01656408|469163780|FG006|Overall Study|Physician Decision|0|||
130325490|NCT01656408|469163781|FG007|Overall Study|Physician Decision|1|||
130325491|NCT01656408|469163782|FG008|Overall Study|Physician Decision|1|||
130325492|NCT01656408|469163783|FG009|Overall Study|Physician Decision|3|||
130325493|NCT00871975|469163784|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
130325494|NCT00871975|469163784|FG000|Overall Study|Catheters could not be inserted|1|||
130325495|NCT00871975|469163784|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
130325496|NCT00871975|469163784|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
130325497|NCT00870740|469163785|FG000|Overall Study|Adverse Event|2|||
130325498|NCT00870740|469163786|FG001|Overall Study|Adverse Event|1|||
130325499|NCT00870740|469163787|FG002|Overall Study|Adverse Event|3|||
130325500|NCT00870740|469163788|FG003|Overall Study|Adverse Event|2|||
130325501|NCT00870740|469163789|FG004|Overall Study|Adverse Event|1|||
130325502|NCT00870740|469163790|FG005|Overall Study|Adverse Event|6|||
130325503|NCT00870740|469163785|FG000|Overall Study|Consent Withdrawn|6|||
130325504|NCT00870740|469163786|FG001|Overall Study|Consent Withdrawn|3|||
130325505|NCT00870740|469163787|FG002|Overall Study|Consent Withdrawn|4|||
130325506|NCT00870740|469163788|FG003|Overall Study|Consent Withdrawn|6|||
130325507|NCT00870740|469163789|FG004|Overall Study|Consent Withdrawn|6|||
130325508|NCT00870740|469163790|FG005|Overall Study|Consent Withdrawn|5|||
130325509|NCT00870740|469163785|FG000|Overall Study|Investigator Decision|2|||
130325510|NCT00870740|469163786|FG001|Overall Study|Investigator Decision|0|||
130325511|NCT00870740|469163787|FG002|Overall Study|Investigator Decision|1|||
130325512|NCT00870740|469163788|FG003|Overall Study|Investigator Decision|0|||
130325513|NCT00870740|469163789|FG004|Overall Study|Investigator Decision|0|||
130325514|NCT00870740|469163790|FG005|Overall Study|Investigator Decision|0|||
130325515|NCT00870740|469163785|FG000|Overall Study|Subject Non-compliance|0|||
130325516|NCT00870740|469163786|FG001|Overall Study|Subject Non-compliance|0|||
130325517|NCT00870740|469163787|FG002|Overall Study|Subject Non-compliance|0|||
130325518|NCT00870740|469163788|FG003|Overall Study|Subject Non-compliance|0|||
129988214|NCT00757783|467918880|FG001|Overall Study|Protocol Violation|0|||
129988215|NCT00757783|467918879|FG000|Overall Study|Withdrawal by Subject|2|||
129988216|NCT00757783|467918880|FG001|Overall Study|Withdrawal by Subject|1|||
129988217|NCT00757783|467918879|FG000|Overall Study|Other|1|||
129988218|NCT00757783|467918880|FG001|Overall Study|Other|2|||
129988219|NCT02008877|467918881|FG000|Overall Study|Inevaluable|0|||
129988220|NCT02008877|467918882|FG001|Overall Study|Inevaluable|1|||
129988221|NCT02008877|467918883|FG002|Overall Study|Inevaluable|0|||
129988222|NCT02412371|467918884|FG000|Overall Study|Withdrawal by Subject|0|||
129988223|NCT02412371|467918885|FG001|Overall Study|Withdrawal by Subject|2|||
130215168|NCT01237327|468751731|FG000|Overall Study|Protocol Violation: Core Study|1|||
130215169|NCT01237327|468751732|FG001|Overall Study|Protocol Violation: Core Study|0|||
130215170|NCT01237327|468751731|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
130215171|NCT01237327|468751732|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
130215172|NCT01237327|468751731|FG000|Overall Study|Progression of Disease: Core Study|18|||
130215173|NCT01237327|468751732|FG001|Overall Study|Progression of Disease: Core Study|22|||
130215174|NCT01237327|468751731|FG000|Overall Study|Progression of Disease: Extension Study|15|||
130215175|NCT01237327|468751732|FG001|Overall Study|Progression of Disease: Extension Study|13|||
130215176|NCT01237327|468751731|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
130215177|NCT01237327|468751732|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
130215178|NCT01237327|468751731|FG000|Overall Study|Withdrawal by Subject|1|||
130215179|NCT01237327|468751732|FG001|Overall Study|Withdrawal by Subject|3|||
130215180|NCT01237327|468751731|FG000|Overall Study|Lost to Follow-up|3|||
130215181|NCT01237327|468751732|FG001|Overall Study|Lost to Follow-up|0|||
130215182|NCT02483572|468751735|FG000|Overall Study|Withdrawal by Subject|1|||
130215183|NCT02483572|468751736|FG001|Overall Study|Withdrawal by Subject|0|||
130215184|NCT02483572|468751735|FG000|Overall Study|Lost to Follow-up|1|||
130325519|NCT00870740|469163789|FG004|Overall Study|Subject Non-compliance|0|||
130325520|NCT00870740|469163790|FG005|Overall Study|Subject Non-compliance|1|||
130325521|NCT00870740|469163785|FG000|Overall Study|Death|0|||
130325522|NCT00870740|469163786|FG001|Overall Study|Death|0|||
130325523|NCT00870740|469163787|FG002|Overall Study|Death|0|||
130325524|NCT00870740|469163788|FG003|Overall Study|Death|0|||
130325525|NCT00870740|469163789|FG004|Overall Study|Death|1|||
130325526|NCT00870740|469163790|FG005|Overall Study|Death|0|||
130325527|NCT00870740|469163785|FG000|Overall Study|Other|2|||
130325528|NCT00870740|469163786|FG001|Overall Study|Other|5|||
130325529|NCT00870740|469163787|FG002|Overall Study|Other|2|||
130325530|NCT00870740|469163788|FG003|Overall Study|Other|4|||
130325531|NCT00870740|469163789|FG004|Overall Study|Other|3|||
130325532|NCT00870740|469163790|FG005|Overall Study|Other|5|||
130325533|NCT03592186|469163791|FG000|Overall Study|Withdrawal by Subject|1|||
130325534|NCT03592186|469163792|FG001|Overall Study|Withdrawal by Subject|0|||
130325535|NCT03592186|469163791|FG000|Overall Study|Lost to Follow-up|16|||
130325536|NCT03592186|469163792|FG001|Overall Study|Lost to Follow-up|11|||
130325537|NCT00307801|469163795|FG000|Overall Study|Adverse Event|12|||
130325538|NCT00307801|469163796|FG001|Overall Study|Adverse Event|4|||
130325539|NCT00307801|469163795|FG000|Overall Study|Withdrawal by Subject|9|||
130325540|NCT00307801|469163796|FG001|Overall Study|Withdrawal by Subject|4|||
130325541|NCT00307801|469163795|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
130325542|NCT00307801|469163796|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
130325543|NCT00307801|469163795|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
130325544|NCT00307801|469163796|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
130325545|NCT00307801|469163795|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
130325546|NCT00307801|469163796|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
130325547|NCT00307801|469163795|FG000|Overall Study|Wrong Randomization|1|||
130325548|NCT00307801|469163796|FG001|Overall Study|Wrong Randomization|0|||
130325549|NCT00307801|469163795|FG000|Overall Study|Lack of Efficacy|0|||
130325550|NCT00307801|469163796|FG001|Overall Study|Lack of Efficacy|2|||
130325551|NCT00307801|469163795|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
130325552|NCT00307801|469163796|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
130325553|NCT00307801|469163795|FG000|Overall Study|Frustration with e-diary|1|||
130325554|NCT00307801|469163796|FG001|Overall Study|Frustration with e-diary|0|||
130325555|NCT00307801|469163795|FG000|Overall Study|Protocol Violation|3|||
130325556|NCT00307801|469163796|FG001|Overall Study|Protocol Violation|2|||
130325557|NCT00307801|469163795|FG000|Overall Study|No reason specified|2|||
130325558|NCT00307801|469163796|FG001|Overall Study|No reason specified|0|||
130325559|NCT00307801|469163795|FG000|Overall Study|Pregnancy|0|||
130325560|NCT00307801|469163796|FG001|Overall Study|Pregnancy|1|||
130325561|NCT00551642|469163799|FG000|Treatment Period|Protocol Deviation|6|||
130325562|NCT00551642|469163800|FG001|Treatment Period|Protocol Deviation|11|||
130325563|NCT00551642|469163799|FG000|Treatment Period|Delivery device failure|1|||
130325564|NCT00551642|469163800|FG001|Treatment Period|Delivery device failure|3|||
130325565|NCT00551642|469163799|FG000|Treatment Period|Physician Decision|0|||
130325566|NCT00551642|469163800|FG001|Treatment Period|Physician Decision|1|||
130325567|NCT00551642|469163799|FG000|Treatment Period|Death|33|||
130325568|NCT00551642|469163800|FG001|Treatment Period|Death|31|||
130325569|NCT00551642|469163799|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
130325570|NCT00551642|469163800|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
130325571|NCT00551642|469163799|FG000|Treatment Period|Adverse Event|15|||
130325572|NCT00551642|469163800|FG001|Treatment Period|Adverse Event|12|||
130325573|NCT00551642|469163799|FG000|Treatment Period|Withdrawal by Subject|2|||
130325574|NCT00551642|469163800|FG001|Treatment Period|Withdrawal by Subject|1|||
130325575|NCT03011099|469163804|FG000|Overall Study|Withdrawal by Subject|0|||
130325576|NCT03011099|469163805|FG001|Overall Study|Withdrawal by Subject|2|||
130325577|NCT02668653|469163808|FG000|Overall Study|Refractory disease|41|||
130325578|NCT02668653|469163809|FG001|Overall Study|Refractory disease|70|||
130325579|NCT02668653|469163808|FG000|Overall Study|Relapse|44|||
130325580|NCT02668653|469163809|FG001|Overall Study|Relapse|65|||
130325581|NCT02668653|469163808|FG000|Overall Study|Adverse Event|58|||
130325582|NCT02668653|469163809|FG001|Overall Study|Adverse Event|23|||
130325583|NCT02668653|469163808|FG000|Overall Study|Subject decision to stop study drug|25|||
130325584|NCT02668653|469163809|FG001|Overall Study|Subject decision to stop study drug|23|||
130325585|NCT02668653|469163808|FG000|Overall Study|Other reasons not specified|16|||
130325586|NCT02668653|469163809|FG001|Overall Study|Other reasons not specified|11|||
130325587|NCT02668653|469163808|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
130325588|NCT02668653|469163809|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
130325589|NCT02668653|469163808|FG000|Overall Study|Investigator decision|10|||
130325590|NCT02668653|469163809|FG001|Overall Study|Investigator decision|7|||
130325591|NCT02668653|469163808|FG000|Overall Study|Failure to meet continuation criteria|5|||
130325592|NCT02668653|469163809|FG001|Overall Study|Failure to meet continuation criteria|12|||
130325593|NCT02668653|469163808|FG000|Overall Study|Lost to Follow-up|1|||
130325594|NCT02668653|469163809|FG001|Overall Study|Lost to Follow-up|0|||
130325595|NCT02668653|469163808|FG000|Overall Study|Pregnancy|0|||
130325596|NCT02668653|469163809|FG001|Overall Study|Pregnancy|1|||
130325597|NCT02668653|469163808|FG000|Overall Study|Death|0|||
130325598|NCT02668653|469163809|FG001|Overall Study|Death|1|||
130325599|NCT01294553|469163810|FG000|Overall Study|Duplicated Participants|1|||
130325600|NCT01294553|469163810|FG000|Overall Study|Protocol Violation|268|||
130325601|NCT01217229|469163811|FG000|Overall Study|Adverse Event|1|||
130325602|NCT01217229|469163811|FG000|Overall Study|Disease progression, deterioration|2|||
130325603|NCT01217229|469163811|FG000|Overall Study|Disease progression, Cheson criteria|14|||
130325604|NCT01217229|469163811|FG000|Overall Study|Protocol Violation|1|||
130325605|NCT01217229|469163811|FG000|Overall Study|Disease progression not confirmed|2|||
130325606|NCT00926237|469163812|FG000|Overall Study|Withdrawal by Subject|2|||
130325607|NCT00926237|469163813|FG001|Overall Study|Withdrawal by Subject|1|||
130325608|NCT00577889|469163814|FG000|Overall Study|Withdrawal by Subject|1|||
130325609|NCT00577889|469163815|FG001|Overall Study|Withdrawal by Subject|0|||
130325610|NCT00577889|469163816|FG002|Overall Study|Withdrawal by Subject|0|||
130325611|NCT02667119|469163817|FG000|Overall Study|Lost to Follow-up|3|||
130325612|NCT02667119|469163818|FG001|Overall Study|Lost to Follow-up|0|||
130325613|NCT03783078|469163821|FG000|Overall Study|Death|31|||
130325614|NCT03783078|469163821|FG000|Overall Study|Sponsor Decision|23|||
130325615|NCT03783078|469163821|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130325616|NCT02059278|469163823|FG000|Overall Study|Adverse Event|1|||
130325617|NCT02059278|469163824|FG001|Overall Study|Adverse Event|1|||
130325618|NCT02059278|469163823|FG000|Overall Study|Lost to Follow-up|1|||
130325619|NCT02059278|469163824|FG001|Overall Study|Lost to Follow-up|0|||
130325620|NCT02059278|469163823|FG000|Overall Study|Withdrawal by Subject|0|||
130325621|NCT02059278|469163824|FG001|Overall Study|Withdrawal by Subject|3|||
130325622|NCT02059278|469163823|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
130325623|NCT02059278|469163824|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
130325624|NCT00541658|469163825|FG000|Overall Study|Adverse Event|28|||
130325625|NCT00541658|469163826|FG001|Overall Study|Adverse Event|37|||
130325626|NCT00541658|469163827|FG002|Overall Study|Adverse Event|25|||
130325627|NCT00541658|469163825|FG000|Overall Study|Physician Decision|0|||
130325628|NCT00541658|469163826|FG001|Overall Study|Physician Decision|0|||
130325629|NCT00541658|469163827|FG002|Overall Study|Physician Decision|4|||
130325630|NCT00541658|469163825|FG000|Overall Study|Lost to Follow-up|3|||
130325631|NCT00541658|469163826|FG001|Overall Study|Lost to Follow-up|3|||
130325632|NCT00541658|469163827|FG002|Overall Study|Lost to Follow-up|6|||
130215185|NCT02483572|468751736|FG001|Overall Study|Lost to Follow-up|0|||
130215186|NCT02483572|468751735|FG000|Overall Study|Physician Decision|0|||
130215187|NCT02483572|468751736|FG001|Overall Study|Physician Decision|1|||
130215188|NCT04811664|468751737|FG000|Overall Study|Lost to Follow-up|78|||
130215189|NCT04811664|468751738|FG001|Overall Study|Lost to Follow-up|125|||
130215190|NCT04811664|468751739|FG002|Overall Study|Lost to Follow-up|46|||
130215191|NCT04811664|468751737|FG000|Overall Study|Withdrawal by Subject|39|||
130215192|NCT04811664|468751738|FG001|Overall Study|Withdrawal by Subject|76|||
130215193|NCT04811664|468751739|FG002|Overall Study|Withdrawal by Subject|12|||
130215194|NCT04811664|468751737|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
130215195|NCT04811664|468751738|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
130215196|NCT04811664|468751739|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
130215197|NCT04811664|468751737|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
130215198|NCT04811664|468751738|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
130215199|NCT04811664|468751739|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
130215200|NCT04811664|468751737|FG000|Overall Study|Protocol Violation|0|||
130215201|NCT04811664|468751738|FG001|Overall Study|Protocol Violation|5|||
130215202|NCT04811664|468751739|FG002|Overall Study|Protocol Violation|11|||
130215203|NCT04811664|468751737|FG000|Overall Study|Study Terminated by Sponsor|4|||
130215204|NCT04811664|468751738|FG001|Overall Study|Study Terminated by Sponsor|3|||
130215205|NCT04811664|468751739|FG002|Overall Study|Study Terminated by Sponsor|34|||
130215206|NCT04811664|468751737|FG000|Overall Study|Early Study Closure|3|||
130215207|NCT04811664|468751738|FG001|Overall Study|Early Study Closure|7|||
130215208|NCT04811664|468751739|FG002|Overall Study|Early Study Closure|79|||
130215209|NCT04811664|468751737|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
130215210|NCT04811664|468751738|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
130215211|NCT04811664|468751739|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
130215212|NCT05052697|468751740|FG000|Substudy A|Lost to Follow-up|0|||
130215213|NCT05052697|468751741|FG001|Substudy A|Lost to Follow-up|0|||
130215214|NCT05052697|468751742|FG002|Substudy A|Lost to Follow-up|0|||
130215215|NCT05052697|468751743|FG003|Substudy A|Lost to Follow-up|0|||
130215216|NCT05052697|468751744|FG004|Substudy A|Lost to Follow-up|0|||
130215217|NCT05052697|468751745|FG005|Substudy A|Lost to Follow-up|1|||
130215218|NCT05052697|468751746|FG006|Substudy A|Lost to Follow-up|0|||
130215219|NCT05052697|468751747|FG007|Substudy A|Lost to Follow-up|0|||
130215220|NCT05052697|468751748|FG008|Substudy A|Lost to Follow-up|0|||
130215221|NCT05052697|468751749|FG009|Substudy A|Lost to Follow-up|0|||
130215222|NCT05052697|468751750|FG010|Substudy A|Lost to Follow-up|0|||
130215223|NCT05052697|468751751|FG011|Substudy A|Lost to Follow-up|0|||
130215224|NCT05052697|468751752|FG012|Substudy A|Lost to Follow-up|0|||
130215225|NCT05052697|468751753|FG013|Substudy A|Lost to Follow-up|0|||
130215226|NCT05052697|468751754|FG014|Substudy A|Lost to Follow-up|0|||
130215227|NCT05052697|468751755|FG015|Substudy A|Lost to Follow-up|2|||
130325633|NCT00541658|469163825|FG000|Overall Study|Protocol Violation|0|||
130325634|NCT00541658|469163826|FG001|Overall Study|Protocol Violation|1|||
130325635|NCT00541658|469163827|FG002|Overall Study|Protocol Violation|1|||
130325636|NCT00541658|469163825|FG000|Overall Study|Withdrawal by Subject|28|||
130325637|NCT00541658|469163826|FG001|Overall Study|Withdrawal by Subject|32|||
130325638|NCT00541658|469163827|FG002|Overall Study|Withdrawal by Subject|32|||
130325639|NCT00541658|469163825|FG000|Overall Study|Took No Study Drug|1|||
130325640|NCT00541658|469163826|FG001|Overall Study|Took No Study Drug|0|||
130325641|NCT00541658|469163827|FG002|Overall Study|Took No Study Drug|0|||
130325642|NCT04482647|469163833|FG000|Overall Study|Time constraints|2|||
130325643|NCT04482647|469163833|FG000|Overall Study|Health issues|1|||
130325644|NCT04482647|469163833|FG000|Overall Study|Death in the family|1|||
130325645|NCT04482647|469163833|FG000|Overall Study|Disliked the intervention|1|||
130325646|NCT04482647|469163833|FG000|Overall Study|No reasons specified|7|||
130325647|NCT02484391|469163834|FG000|Overall Study|Lack of Efficacy|15|||
130325648|NCT02484391|469163835|FG001|Overall Study|Lack of Efficacy|14|||
130325649|NCT02484391|469163836|FG002|Overall Study|Lack of Efficacy|3|||
130325650|NCT02484391|469163834|FG000|Overall Study|Lost to Follow-up|0|||
130325651|NCT02484391|469163835|FG001|Overall Study|Lost to Follow-up|0|||
130325652|NCT02484391|469163836|FG002|Overall Study|Lost to Follow-up|2|||
130325653|NCT02484391|469163834|FG000|Overall Study|Physician Decision|1|||
130325654|NCT02484391|469163835|FG001|Overall Study|Physician Decision|3|||
130325655|NCT02484391|469163836|FG002|Overall Study|Physician Decision|0|||
130325656|NCT02484391|469163834|FG000|Overall Study|Went to Transplant|5|||
130325657|NCT02484391|469163835|FG001|Overall Study|Went to Transplant|3|||
130325658|NCT02484391|469163836|FG002|Overall Study|Went to Transplant|2|||
130325659|NCT02594124|469163837|FG000|Overall Study|Adverse Event|0|||
129988224|NCT02412371|467918886|FG002|Overall Study|Withdrawal by Subject|0|||
130325660|NCT02594124|469163838|FG001|Overall Study|Adverse Event|5|||
130325661|NCT02594124|469163839|FG002|Overall Study|Adverse Event|8|||
130325662|NCT02594124|469163840|FG003|Overall Study|Adverse Event|1|||
130325663|NCT02594124|469163841|FG004|Overall Study|Adverse Event|0|||
130325664|NCT02594124|469163842|FG005|Overall Study|Adverse Event|0|||
130325665|NCT02594124|469163843|FG006|Overall Study|Adverse Event|2|||
130325666|NCT02594124|469163844|FG007|Overall Study|Adverse Event|2|||
130325667|NCT02594124|469163845|FG008|Overall Study|Adverse Event|0|||
130325668|NCT02594124|469163837|FG000|Overall Study|Withdrawal by Subject|2|||
130325669|NCT02594124|469163838|FG001|Overall Study|Withdrawal by Subject|3|||
130325670|NCT02594124|469163839|FG002|Overall Study|Withdrawal by Subject|5|||
130325671|NCT02594124|469163840|FG003|Overall Study|Withdrawal by Subject|1|||
130325672|NCT02594124|469163841|FG004|Overall Study|Withdrawal by Subject|8|||
130325673|NCT02594124|469163842|FG005|Overall Study|Withdrawal by Subject|4|||
130325674|NCT02594124|469163843|FG006|Overall Study|Withdrawal by Subject|13|||
130325675|NCT02594124|469163844|FG007|Overall Study|Withdrawal by Subject|19|||
130325676|NCT02594124|469163845|FG008|Overall Study|Withdrawal by Subject|0|||
130325677|NCT02594124|469163837|FG000|Overall Study|Physician Decision|0|||
130325678|NCT02594124|469163838|FG001|Overall Study|Physician Decision|2|||
130325679|NCT02594124|469163839|FG002|Overall Study|Physician Decision|0|||
130325680|NCT02594124|469163840|FG003|Overall Study|Physician Decision|0|||
130325681|NCT02594124|469163841|FG004|Overall Study|Physician Decision|0|||
130325682|NCT02594124|469163842|FG005|Overall Study|Physician Decision|0|||
130325683|NCT02594124|469163843|FG006|Overall Study|Physician Decision|0|||
130325684|NCT02594124|469163844|FG007|Overall Study|Physician Decision|1|||
130325685|NCT02594124|469163845|FG008|Overall Study|Physician Decision|0|||
130325686|NCT02594124|469163837|FG000|Overall Study|Commercial drug|0|||
130325687|NCT02594124|469163838|FG001|Overall Study|Commercial drug|1|||
130325688|NCT02594124|469163839|FG002|Overall Study|Commercial drug|6|||
129988225|NCT02412371|467918887|FG003|Overall Study|Withdrawal by Subject|1|||
130325689|NCT02594124|469163840|FG003|Overall Study|Commercial drug|3|||
130325690|NCT02594124|469163841|FG004|Overall Study|Commercial drug|0|||
130325691|NCT02594124|469163842|FG005|Overall Study|Commercial drug|0|||
130325692|NCT02594124|469163843|FG006|Overall Study|Commercial drug|7|||
130325693|NCT02594124|469163844|FG007|Overall Study|Commercial drug|11|||
129988226|NCT02412371|467918888|FG004|Overall Study|Withdrawal by Subject|1|||
130325694|NCT02594124|469163845|FG008|Overall Study|Commercial drug|2|||
130325695|NCT02594124|469163837|FG000|Overall Study|Reason Not Specified|1|||
130325696|NCT02594124|469163838|FG001|Overall Study|Reason Not Specified|3|||
130325697|NCT02594124|469163839|FG002|Overall Study|Reason Not Specified|4|||
130325698|NCT02594124|469163840|FG003|Overall Study|Reason Not Specified|0|||
130325699|NCT02594124|469163841|FG004|Overall Study|Reason Not Specified|0|||
130325700|NCT02594124|469163842|FG005|Overall Study|Reason Not Specified|1|||
130325701|NCT02594124|469163843|FG006|Overall Study|Reason Not Specified|1|||
130325702|NCT02594124|469163844|FG007|Overall Study|Reason Not Specified|6|||
130325703|NCT02594124|469163845|FG008|Overall Study|Reason Not Specified|1|||
130325704|NCT01899040|469163850|FG000|Overall Study|Randomized in error|0|||
130325705|NCT01899040|469163851|FG001|Overall Study|Randomized in error|1|||
130325706|NCT01899040|469163852|FG002|Overall Study|Randomized in error|1|||
130325707|NCT01899040|469163850|FG000|Overall Study|Adverse Event|3|||
130325708|NCT01899040|469163851|FG001|Overall Study|Adverse Event|1|||
130325709|NCT01899040|469163852|FG002|Overall Study|Adverse Event|2|||
130325710|NCT01899040|469163850|FG000|Overall Study|Unspecified reasons|4|||
130325711|NCT01899040|469163851|FG001|Overall Study|Unspecified reasons|4|||
130325712|NCT01899040|469163852|FG002|Overall Study|Unspecified reasons|0|||
130325713|NCT01899040|469163850|FG000|Overall Study|Compliance issues|1|||
130325714|NCT01899040|469163851|FG001|Overall Study|Compliance issues|2|||
130325715|NCT01899040|469163852|FG002|Overall Study|Compliance issues|0|||
130325716|NCT00905164|469163858|FG000|Period 1|Protocol Violation|0|||
130325717|NCT00905164|469163859|FG001|Period 1|Protocol Violation|1|||
130325718|NCT01256788|469165847|FG000|Overall Study|Lost to Follow-up|5|||
130325719|NCT01256788|469165848|FG001|Overall Study|Lost to Follow-up|8|||
130325720|NCT01256788|469165849|FG002|Overall Study|Lost to Follow-up|3|||
130325721|NCT03312634|469165850|FG000|Overall Study|Adverse Event|11|||
130325722|NCT03312634|469165851|FG001|Overall Study|Adverse Event|0|||
130325723|NCT03312634|469165850|FG000|Overall Study|Sponsor request|2|||
130325724|NCT03312634|469165851|FG001|Overall Study|Sponsor request|0|||
130325725|NCT03312634|469165850|FG000|Overall Study|Withdrawal by Subject|31|||
130325726|NCT03312634|469165851|FG001|Overall Study|Withdrawal by Subject|9|||
130325727|NCT03312634|469165850|FG000|Overall Study|Enrolled in an interventional study|0|||
130325728|NCT03312634|469165851|FG001|Overall Study|Enrolled in an interventional study|52|||
130325729|NCT03312634|469165850|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
130325730|NCT03312634|469165851|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
130325731|NCT03312634|469165850|FG000|Overall Study|Death|0|||
130325732|NCT03312634|469165851|FG001|Overall Study|Death|1|||
130325733|NCT03312634|469165850|FG000|Overall Study|Non-compliance|0|||
130325734|NCT03312634|469165851|FG001|Overall Study|Non-compliance|2|||
130325735|NCT03312634|469165850|FG000|Overall Study|Lost to Follow-up|0|||
130325736|NCT03312634|469165851|FG001|Overall Study|Lost to Follow-up|1|||
130325737|NCT03312634|469165850|FG000|Overall Study|Enrolled into non-interventional study|0|||
130325738|NCT03312634|469165851|FG001|Overall Study|Enrolled into non-interventional study|5|||
130325739|NCT03312634|469165850|FG000|Overall Study|Worsening clinical condition|0|||
130325740|NCT03312634|469165851|FG001|Overall Study|Worsening clinical condition|1|||
130325741|NCT03312634|469165850|FG000|Overall Study|Participant did not want to travel|0|||
130325742|NCT03312634|469165851|FG001|Overall Study|Participant did not want to travel|1|||
130325743|NCT03312634|469165850|FG000|Overall Study|Physician Decision|1|||
130325744|NCT03312634|469165851|FG001|Overall Study|Physician Decision|0|||
130325745|NCT03312634|469165850|FG000|Overall Study|Other|13|||
130325746|NCT03312634|469165851|FG001|Overall Study|Other|0|||
130325747|NCT05366738|469165852|FG000|Overall Study|Adverse Event|0|||
130325748|NCT05366738|469165853|FG001|Overall Study|Adverse Event|1|||
130325749|NCT05366738|469165854|FG002|Overall Study|Adverse Event|0|||
130325750|NCT00906204|469165857|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
130325751|NCT00906204|469165858|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
130325752|NCT00906204|469165857|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
130325753|NCT00906204|469165858|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
130325754|NCT00906204|469165857|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
130325755|NCT00906204|469165858|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
130325756|NCT00906204|469165857|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
130325757|NCT00906204|469165858|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
130325758|NCT00906204|469165857|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
130325759|NCT00906204|469165858|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
130325760|NCT05291520|469165859|FG000|Overall Study|Lost to Follow-up|0|||
130325761|NCT05291520|469165860|FG001|Overall Study|Lost to Follow-up|0|||
130325762|NCT05291520|469165861|FG002|Overall Study|Lost to Follow-up|1|||
130325763|NCT01347112|469165862|FG000|Overall Study|Withdrawal by Subject|1|||
130325764|NCT01347112|469165863|FG001|Overall Study|Withdrawal by Subject|7|||
130325765|NCT01347112|469165862|FG000|Overall Study|Lost to Follow-up|3|||
130325766|NCT01347112|469165863|FG001|Overall Study|Lost to Follow-up|5|||
129988227|NCT02412371|467918889|FG005|Overall Study|Withdrawal by Subject|0|||
129988228|NCT02412371|467918884|FG000|Overall Study|Sponsor Discontinued Study|1|||
129988229|NCT02412371|467918885|FG001|Overall Study|Sponsor Discontinued Study|4|||
129988230|NCT02412371|467918886|FG002|Overall Study|Sponsor Discontinued Study|6|||
129988231|NCT02412371|467918887|FG003|Overall Study|Sponsor Discontinued Study|4|||
129988232|NCT02412371|467918888|FG004|Overall Study|Sponsor Discontinued Study|5|||
129988233|NCT02412371|467918889|FG005|Overall Study|Sponsor Discontinued Study|0|||
129988234|NCT02412371|467918884|FG000|Overall Study|Death|4|||
129988235|NCT02412371|467918885|FG001|Overall Study|Death|2|||
130325767|NCT00696072|469165866|FG000|Overall Study|continuing active treatment|10|||
130325768|NCT00696072|469165867|FG001|Overall Study|continuing active treatment|13|||
130325769|NCT00696072|469165866|FG000|Overall Study|Adverse Event|10|||
130325770|NCT00696072|469165867|FG001|Overall Study|Adverse Event|6|||
130325771|NCT00696072|469165866|FG000|Overall Study|Patient Request|3|||
130325772|NCT00696072|469165867|FG001|Overall Study|Patient Request|7|||
130325773|NCT00696072|469165866|FG000|Overall Study|Investigator Request|1|||
130325774|NCT00696072|469165867|FG001|Overall Study|Investigator Request|4|||
130325775|NCT00696072|469165866|FG000|Overall Study|Sponsor Request|0|||
130325776|NCT00696072|469165867|FG001|Overall Study|Sponsor Request|1|||
130325777|NCT00696072|469165866|FG000|Overall Study|Disease Progression|32|||
130325778|NCT00696072|469165867|FG001|Overall Study|Disease Progression|30|||
130325779|NCT00696072|469165866|FG000|Overall Study|Non-specified|1|||
130325780|NCT00696072|469165867|FG001|Overall Study|Non-specified|2|||
130325781|NCT01597596|469165868|FG000|Overall Study|Study terminated by sponsor|1|||
130325782|NCT01597596|469165869|FG001|Overall Study|Study terminated by sponsor|0|||
130325783|NCT01597596|469165868|FG000|Overall Study|Physician Decision|0|||
130325784|NCT01597596|469165869|FG001|Overall Study|Physician Decision|1|||
130325785|NCT02141295|469165884|FG000|Overall Study|Adverse Event|1|||
130325786|NCT02141295|469165885|FG001|Overall Study|Adverse Event|18|||
130325787|NCT02141295|469165886|FG002|Overall Study|Adverse Event|11|||
130325788|NCT02141295|469165884|FG000|Overall Study|Physician Decision|2|||
130325789|NCT02141295|469165885|FG001|Overall Study|Physician Decision|19|||
130325790|NCT02141295|469165886|FG002|Overall Study|Physician Decision|14|||
130325791|NCT02141295|469165884|FG000|Overall Study|Study terminated by sponsor|0|||
130325792|NCT02141295|469165885|FG001|Overall Study|Study terminated by sponsor|6|||
130325793|NCT02141295|469165886|FG002|Overall Study|Study terminated by sponsor|6|||
130325794|NCT02141295|469165884|FG000|Overall Study|Non-compliance|0|||
130325795|NCT02141295|469165885|FG001|Overall Study|Non-compliance|1|||
130325796|NCT02141295|469165886|FG002|Overall Study|Non-compliance|0|||
130325797|NCT02141295|469165884|FG000|Overall Study|Progressive disease|3|||
130325798|NCT02141295|469165885|FG001|Overall Study|Progressive disease|32|||
130325799|NCT02141295|469165886|FG002|Overall Study|Progressive disease|50|||
130325800|NCT02141295|469165884|FG000|Overall Study|Reason not specified|0|||
130325801|NCT02141295|469165885|FG001|Overall Study|Reason not specified|9|||
130325802|NCT02141295|469165886|FG002|Overall Study|Reason not specified|10|||
130325803|NCT02141295|469165884|FG000|Overall Study|Withdrawal by Subject|0|||
130325804|NCT02141295|469165885|FG001|Overall Study|Withdrawal by Subject|9|||
130325805|NCT02141295|469165886|FG002|Overall Study|Withdrawal by Subject|4|||
130325806|NCT01710501|469165887|FG000|Overall Study|Lost to Follow-up|2|||
130325807|NCT01710501|469165888|FG001|Overall Study|Lost to Follow-up|0|||
130325808|NCT01710501|469165889|FG002|Overall Study|Lost to Follow-up|0|||
130325809|NCT02536976|469165890|FG000|Overall Study|Physician Decision|0|||
130325810|NCT02536976|469165891|FG001|Overall Study|Physician Decision|1|||
130325811|NCT01671319|469165894|FG000|Overall Study|Withdrawal by Subject|1|||
130325812|NCT01389596|469165895|FG000|Overall Study|Protocol Violation|3|||
130325813|NCT01389596|469165896|FG001|Overall Study|Protocol Violation|4|||
130325814|NCT01389596|469165897|FG002|Overall Study|Protocol Violation|3|||
130325815|NCT01389596|469165895|FG000|Overall Study|Withdrawal by Subject|1|||
130325816|NCT01389596|469165896|FG001|Overall Study|Withdrawal by Subject|2|||
130325817|NCT01389596|469165897|FG002|Overall Study|Withdrawal by Subject|2|||
130325818|NCT01389596|469165895|FG000|Overall Study|Insufficient Clinical Response|3|||
130325819|NCT01389596|469165896|FG001|Overall Study|Insufficient Clinical Response|4|||
130325820|NCT01389596|469165897|FG002|Overall Study|Insufficient Clinical Response|5|||
130325821|NCT01389596|469165895|FG000|Overall Study|Adverse Event|1|||
130325822|NCT01389596|469165896|FG001|Overall Study|Adverse Event|4|||
130325823|NCT01389596|469165897|FG002|Overall Study|Adverse Event|0|||
130325824|NCT01389596|469165895|FG000|Overall Study|Death|0|||
130325825|NCT01389596|469165896|FG001|Overall Study|Death|1|||
130325826|NCT01389596|469165897|FG002|Overall Study|Death|0|||
130325827|NCT01389596|469165895|FG000|Overall Study|Other Unspecified|2|||
130325828|NCT01389596|469165896|FG001|Overall Study|Other Unspecified|1|||
130325829|NCT01389596|469165897|FG002|Overall Study|Other Unspecified|0|||
130325830|NCT01709084|469165898|FG000|Overall Study|Lost to Follow-up|4|||
130325831|NCT01709084|469165899|FG001|Overall Study|Lost to Follow-up|7|||
130325832|NCT01709084|469165898|FG000|Overall Study|Withdrawal by Subject|2|||
130325833|NCT01709084|469165899|FG001|Overall Study|Withdrawal by Subject|2|||
130325834|NCT01709084|469165898|FG000|Overall Study|Adverse Event|5|||
129988236|NCT02412371|467918886|FG002|Overall Study|Death|1|||
130325835|NCT01709084|469165899|FG001|Overall Study|Adverse Event|0|||
130325836|NCT01709084|469165898|FG000|Overall Study|Other|5|||
130325837|NCT01709084|469165899|FG001|Overall Study|Other|3|||
130325838|NCT01709084|469165898|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
129988237|NCT02412371|467918887|FG003|Overall Study|Death|3|||
129988238|NCT02412371|467918888|FG004|Overall Study|Death|5|||
129988239|NCT02412371|467918889|FG005|Overall Study|Death|2|||
130325839|NCT01709084|469165899|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
130325840|NCT01709084|469165898|FG000|Overall Study|Not Treated|0|||
130325841|NCT01709084|469165899|FG001|Overall Study|Not Treated|2|||
130325842|NCT02144610|469165900|FG000|Overall Study|Physician Decision|1|||
130325843|NCT02144610|469165901|FG001|Overall Study|Physician Decision|0|||
130325844|NCT02144610|469165900|FG000|Overall Study|Withdrawal by Subject|1|||
130325845|NCT02144610|469165901|FG001|Overall Study|Withdrawal by Subject|5|||
130325846|NCT02144610|469165900|FG000|Overall Study|Death|2|||
130325847|NCT02144610|469165901|FG001|Overall Study|Death|2|||
130325848|NCT02144610|469165900|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
130325849|NCT02144610|469165901|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
130325850|NCT02144610|469165900|FG000|Overall Study|Other|0|||
130325851|NCT02144610|469165901|FG001|Overall Study|Other|1|||
130325852|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
130325853|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325854|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325855|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325856|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325857|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130215228|NCT05052697|468751756|FG016|Substudy A|Lost to Follow-up|0|||
130215229|NCT05052697|468751757|FG017|Substudy A|Lost to Follow-up|0|||
130215230|NCT05052697|468751758|FG018|Substudy A|Lost to Follow-up|0|||
130215231|NCT05052697|468751759|FG019|Substudy A|Lost to Follow-up|0|||
130215232|NCT05052697|468751760|FG020|Substudy A|Lost to Follow-up|0|||
130215233|NCT05052697|468751761|FG021|Substudy A|Lost to Follow-up|0|||
130215234|NCT05052697|468751762|FG022|Substudy A|Lost to Follow-up|0|||
130215235|NCT05052697|468751763|FG023|Substudy A|Lost to Follow-up|0|||
130215236|NCT05052697|468751764|FG024|Substudy A|Lost to Follow-up|0|||
130215237|NCT05052697|468751765|FG025|Substudy A|Lost to Follow-up|0|||
130215238|NCT05052697|468751766|FG026|Substudy A|Lost to Follow-up|0|||
130215239|NCT05052697|468751767|FG027|Substudy A|Lost to Follow-up|0|||
130215240|NCT05052697|468751768|FG028|Substudy A|Lost to Follow-up|0|||
130215241|NCT05052697|468751769|FG029|Substudy A|Lost to Follow-up|0|||
130215242|NCT05052697|468751770|FG030|Substudy A|Lost to Follow-up|0|||
130215243|NCT05052697|468751771|FG031|Substudy A|Lost to Follow-up|0|||
130215244|NCT05052697|468751772|FG032|Substudy A|Lost to Follow-up|0|||
130215245|NCT05052697|468751773|FG033|Substudy A|Lost to Follow-up|0|||
130215246|NCT05052697|468751740|FG000|Substudy A|No longer met eligibility criteria|0|||
130215247|NCT05052697|468751741|FG001|Substudy A|No longer met eligibility criteria|0|||
130215248|NCT05052697|468751742|FG002|Substudy A|No longer met eligibility criteria|0|||
130215249|NCT05052697|468751743|FG003|Substudy A|No longer met eligibility criteria|0|||
130215250|NCT05052697|468751744|FG004|Substudy A|No longer met eligibility criteria|0|||
130215251|NCT05052697|468751745|FG005|Substudy A|No longer met eligibility criteria|0|||
130215252|NCT05052697|468751746|FG006|Substudy A|No longer met eligibility criteria|0|||
130215253|NCT05052697|468751747|FG007|Substudy A|No longer met eligibility criteria|0|||
130215254|NCT05052697|468751748|FG008|Substudy A|No longer met eligibility criteria|0|||
130215255|NCT05052697|468751749|FG009|Substudy A|No longer met eligibility criteria|0|||
130215256|NCT05052697|468751750|FG010|Substudy A|No longer met eligibility criteria|0|||
130215257|NCT05052697|468751751|FG011|Substudy A|No longer met eligibility criteria|0|||
130215258|NCT05052697|468751752|FG012|Substudy A|No longer met eligibility criteria|0|||
130215259|NCT05052697|468751753|FG013|Substudy A|No longer met eligibility criteria|1|||
130215260|NCT05052697|468751754|FG014|Substudy A|No longer met eligibility criteria|0|||
130215261|NCT05052697|468751755|FG015|Substudy A|No longer met eligibility criteria|0|||
130215262|NCT05052697|468751756|FG016|Substudy A|No longer met eligibility criteria|0|||
130215263|NCT05052697|468751757|FG017|Substudy A|No longer met eligibility criteria|0|||
130215264|NCT05052697|468751758|FG018|Substudy A|No longer met eligibility criteria|0|||
130215265|NCT05052697|468751759|FG019|Substudy A|No longer met eligibility criteria|0|||
130215266|NCT05052697|468751760|FG020|Substudy A|No longer met eligibility criteria|0|||
130215267|NCT05052697|468751761|FG021|Substudy A|No longer met eligibility criteria|0|||
130215268|NCT05052697|468751762|FG022|Substudy A|No longer met eligibility criteria|0|||
130215269|NCT05052697|468751763|FG023|Substudy A|No longer met eligibility criteria|0|||
130215270|NCT05052697|468751764|FG024|Substudy A|No longer met eligibility criteria|0|||
130215271|NCT05052697|468751765|FG025|Substudy A|No longer met eligibility criteria|0|||
130215272|NCT05052697|468751766|FG026|Substudy A|No longer met eligibility criteria|0|||
130215273|NCT05052697|468751767|FG027|Substudy A|No longer met eligibility criteria|0|||
130215274|NCT05052697|468751768|FG028|Substudy A|No longer met eligibility criteria|0|||
130215275|NCT05052697|468751769|FG029|Substudy A|No longer met eligibility criteria|0|||
130215276|NCT05052697|468751770|FG030|Substudy A|No longer met eligibility criteria|0|||
130215277|NCT05052697|468751771|FG031|Substudy A|No longer met eligibility criteria|0|||
130215278|NCT05052697|468751772|FG032|Substudy A|No longer met eligibility criteria|0|||
130215279|NCT05052697|468751773|FG033|Substudy A|No longer met eligibility criteria|0|||
130215280|NCT05052697|468751740|FG000|Substudy A|Not vaccinated|0|||
130215281|NCT05052697|468751741|FG001|Substudy A|Not vaccinated|0|||
130215282|NCT05052697|468751742|FG002|Substudy A|Not vaccinated|0|||
130215283|NCT05052697|468751743|FG003|Substudy A|Not vaccinated|1|||
130215284|NCT05052697|468751744|FG004|Substudy A|Not vaccinated|0|||
130215285|NCT05052697|468751745|FG005|Substudy A|Not vaccinated|0|||
130215286|NCT05052697|468751746|FG006|Substudy A|Not vaccinated|0|||
130215287|NCT05052697|468751747|FG007|Substudy A|Not vaccinated|0|||
130215288|NCT05052697|468751748|FG008|Substudy A|Not vaccinated|1|||
130215289|NCT05052697|468751749|FG009|Substudy A|Not vaccinated|0|||
130215290|NCT05052697|468751750|FG010|Substudy A|Not vaccinated|0|||
130215291|NCT05052697|468751751|FG011|Substudy A|Not vaccinated|0|||
130215292|NCT05052697|468751752|FG012|Substudy A|Not vaccinated|0|||
130325858|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130325859|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
130325860|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325861|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325862|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325863|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325864|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325865|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
130325866|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
130325867|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325868|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325869|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325870|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325871|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325872|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130325873|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
130325874|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325875|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325876|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325877|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325878|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325879|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130325880|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
130325881|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325882|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325883|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325884|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325885|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325886|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
130325887|NCT01054885|469165902|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
130325888|NCT01054885|469165903|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325889|NCT01054885|469165904|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325890|NCT01054885|469165905|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325891|NCT01054885|469165906|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325892|NCT01054885|469165907|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325893|NCT01054885|469165908|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130325894|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130325895|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
130325896|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
130325897|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
130325898|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
130325899|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
130325900|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
130325901|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325902|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325903|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130325904|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
130325905|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325906|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
130325907|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130325908|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130325909|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
130325910|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
130325911|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
130325912|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
130325913|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
130325914|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
130325915|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130325916|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
130325917|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
130325918|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130325919|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130325920|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
129883511|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130215293|NCT05052697|468751753|FG013|Substudy A|Not vaccinated|0|||
130215294|NCT05052697|468751754|FG014|Substudy A|Not vaccinated|0|||
130215295|NCT05052697|468751755|FG015|Substudy A|Not vaccinated|0|||
130215296|NCT05052697|468751756|FG016|Substudy A|Not vaccinated|0|||
130215297|NCT05052697|468751757|FG017|Substudy A|Not vaccinated|0|||
130215298|NCT05052697|468751758|FG018|Substudy A|Not vaccinated|0|||
130215299|NCT05052697|468751759|FG019|Substudy A|Not vaccinated|0|||
130215300|NCT05052697|468751760|FG020|Substudy A|Not vaccinated|0|||
130215301|NCT05052697|468751761|FG021|Substudy A|Not vaccinated|0|||
130215302|NCT05052697|468751762|FG022|Substudy A|Not vaccinated|0|||
130215303|NCT05052697|468751763|FG023|Substudy A|Not vaccinated|0|||
130215304|NCT05052697|468751764|FG024|Substudy A|Not vaccinated|0|||
130215305|NCT05052697|468751765|FG025|Substudy A|Not vaccinated|0|||
130215306|NCT05052697|468751766|FG026|Substudy A|Not vaccinated|0|||
130215307|NCT05052697|468751767|FG027|Substudy A|Not vaccinated|0|||
130215308|NCT05052697|468751768|FG028|Substudy A|Not vaccinated|0|||
130215309|NCT05052697|468751769|FG029|Substudy A|Not vaccinated|0|||
130215310|NCT05052697|468751770|FG030|Substudy A|Not vaccinated|0|||
130215311|NCT05052697|468751771|FG031|Substudy A|Not vaccinated|0|||
130215312|NCT05052697|468751772|FG032|Substudy A|Not vaccinated|0|||
130215313|NCT05052697|468751773|FG033|Substudy A|Not vaccinated|0|||
130215314|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215315|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215316|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215317|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215318|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215319|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215320|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215321|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215322|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215323|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215324|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215325|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215326|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215327|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215328|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215329|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215330|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215331|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215332|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130215333|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130215334|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215335|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
130215336|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
130215337|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215338|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215339|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215340|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215341|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215342|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215343|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215344|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215345|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215346|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215347|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
130215348|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215349|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215350|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215351|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215352|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215353|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215354|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215355|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215356|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215357|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215358|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215359|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215360|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
130325921|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130325922|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
130325923|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130325924|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
130325925|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130325926|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
130325927|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
130325928|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
130325929|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325930|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325931|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
130325932|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325933|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325934|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
130325935|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
130325936|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130325937|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130325938|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130325939|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130325940|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130325941|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130325942|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130325943|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130325944|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
130325945|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130325946|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
130325947|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
130325948|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
130325949|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
130325950|NCT01054885|469165902|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130325951|NCT01054885|469165903|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
130325952|NCT01054885|469165904|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130325953|NCT01054885|469165905|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130325954|NCT01054885|469165906|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
130325955|NCT01054885|469165907|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130325956|NCT01054885|469165908|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
130325957|NCT00214201|469165910|FG000|Overall Study|Withdrawal by Subject|2|||
130325958|NCT00214201|469165911|FG001|Overall Study|Withdrawal by Subject|0|||
130325959|NCT00214201|469165910|FG000|Overall Study|Death|0|||
130325960|NCT00214201|469165911|FG001|Overall Study|Death|2|||
130325961|NCT01399372|469165915|FG000|Overall Study|Protocol Violation|3|||
130325962|NCT01399372|469165916|FG001|Overall Study|Protocol Violation|1|||
130325963|NCT01432730|469165917|FG000|Period 1|Adverse Event|2|||
130325964|NCT01432730|469165918|FG001|Period 1|Adverse Event|0|||
130325965|NCT01432730|469165917|FG000|Period 2|Adverse Event|0|||
130325966|NCT01432730|469165918|FG001|Period 2|Adverse Event|4|||
130325967|NCT01421719|469165923|FG000|Overall Study|Withdrawal by Subject|4|||
130325968|NCT01124006|469165924|FG000|Overall Study|Withdrawal by Subject|2|||
130325969|NCT01124006|469165925|FG001|Overall Study|Withdrawal by Subject|2|||
130325970|NCT01124006|469165926|FG002|Overall Study|Withdrawal by Subject|0|||
130325971|NCT01124006|469165924|FG000|Overall Study|Lost to Follow-up|1|||
130325972|NCT01124006|469165925|FG001|Overall Study|Lost to Follow-up|0|||
130325973|NCT01124006|469165926|FG002|Overall Study|Lost to Follow-up|1|||
130325974|NCT01124006|469165924|FG000|Overall Study|Other|0|||
130325975|NCT01124006|469165925|FG001|Overall Study|Other|0|||
130325976|NCT01124006|469165926|FG002|Overall Study|Other|1|||
130325977|NCT01712399|469165932|FG000|Overall Study|Lost to Follow-up|1|||
130325978|NCT01712399|469165932|FG000|Overall Study|Withdrawal by Subject|39|||
130325979|NCT01712399|469165932|FG000|Overall Study|Death|1|||
130325980|NCT01712399|469165932|FG000|Overall Study|Adverse Event|11|||
130325981|NCT01712399|469165932|FG000|Overall Study|Study closure|345|||
130325982|NCT01942837|469165933|FG000|Overall Study|Death|1|||
130325983|NCT01942837|469165933|FG000|Overall Study|Symptomatic or radiographic progression|49|||
130325984|NCT01942837|469165933|FG000|Overall Study|Adverse Event|6|||
129988240|NCT02412371|467918884|FG000|Overall Study|Other|2|||
129988241|NCT02412371|467918885|FG001|Overall Study|Other|1|||
130325985|NCT01942837|469165933|FG000|Overall Study|Physician Decision|3|||
130325986|NCT01942837|469165933|FG000|Overall Study|Withdrawal by Subject|2|||
130325987|NCT01942837|469165933|FG000|Overall Study|Intercurrent Illness|1|||
129988242|NCT02412371|467918886|FG002|Overall Study|Other|0|||
130325988|NCT01942837|469165933|FG000|Overall Study|On treatment|3|||
130325989|NCT01942837|469165933|FG000|Overall Study|Never initiate the treatment|2|||
130325990|NCT01298648|469165934|FG000|Overall Study|Withdrawal by Subject|2|||
130325991|NCT01298648|469165934|FG000|Overall Study|Lost to Follow-up|21|||
130325992|NCT01803607|469165939|FG000|Overall Study|Adverse Event|5|||
130325993|NCT01803607|469165940|FG001|Overall Study|Adverse Event|3|||
130325994|NCT01803607|469165939|FG000|Overall Study|Lack of Efficacy|0|||
130325995|NCT01803607|469165940|FG001|Overall Study|Lack of Efficacy|1|||
130325996|NCT01803607|469165939|FG000|Overall Study|Protocol Violation|3|||
130325997|NCT01803607|469165940|FG001|Overall Study|Protocol Violation|2|||
130325998|NCT01803607|469165939|FG000|Overall Study|Study terminated by sponsor|54|||
130325999|NCT01803607|469165940|FG001|Overall Study|Study terminated by sponsor|56|||
130326000|NCT01803607|469165939|FG000|Overall Study|Withdrawal by Subject|6|||
130326001|NCT01803607|469165940|FG001|Overall Study|Withdrawal by Subject|5|||
130326002|NCT02038933|469165952|FG000|Overall Study|Disease progression|104|||
130326003|NCT02038933|469165952|FG000|Overall Study|Study drug toxicity|6|||
130326004|NCT02038933|469165952|FG000|Overall Study|Adverse event unrelated to study drug|6|||
130326005|NCT02038933|469165952|FG000|Overall Study|Participant request to discontinue treatment|2|||
130326006|NCT02038933|469165952|FG000|Overall Study|Lost to Follow-up|1|||
130326007|NCT02038933|469165952|FG000|Overall Study|Other reasons|2|||
130326008|NCT03250273|469165953|FG000|Overall Study|Disease Progression|2|||
130326009|NCT03250273|469165954|FG001|Overall Study|Disease Progression|11|||
130326010|NCT03250273|469165953|FG000|Overall Study|Death|0|||
130326011|NCT03250273|469165954|FG001|Overall Study|Death|1|||
130326012|NCT01774721|469165957|FG000|Overall Study|Death|133|||
130326013|NCT01774721|469165958|FG001|Overall Study|Death|152|||
130326014|NCT01774721|469165957|FG000|Overall Study|Withdrawal by Subject|20|||
130326015|NCT01774721|469165958|FG001|Overall Study|Withdrawal by Subject|14|||
130326016|NCT01774721|469165957|FG000|Overall Study|Lost to Follow-up|6|||
130326017|NCT01774721|469165958|FG001|Overall Study|Lost to Follow-up|7|||
130326018|NCT01774721|469165957|FG000|Overall Study|Did not meet eligibility criteria|0|||
130326019|NCT01774721|469165958|FG001|Overall Study|Did not meet eligibility criteria|3|||
130326020|NCT01774721|469165957|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
130326021|NCT01774721|469165958|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
130326022|NCT01774721|469165957|FG000|Overall Study|Study terminated by sponsor|5|||
130326023|NCT01774721|469165958|FG001|Overall Study|Study terminated by sponsor|0|||
130326024|NCT01774721|469165957|FG000|Overall Study|Disease progression|5|||
130326025|NCT01774721|469165958|FG001|Overall Study|Disease progression|0|||
130326026|NCT02399163|469165960|FG000|Overall Study|Adverse Event|2|||
130326027|NCT02399163|469165960|FG000|Overall Study|Protocol Deviation|2|||
130326028|NCT02399163|469165960|FG000|Overall Study|Withdrawal by Participant|5|||
130326029|NCT04646044|469165962|FG000|Overall Study|Lost to Follow-up|0|||
130326030|NCT04646044|469165963|FG001|Overall Study|Lost to Follow-up|0|||
130326031|NCT04646044|469165964|FG002|Overall Study|Lost to Follow-up|1|||
130326032|NCT04646044|469165965|FG003|Overall Study|Lost to Follow-up|0|||
130326033|NCT04646044|469165962|FG000|Overall Study|Withdrawal by Subject|0|||
130326034|NCT04646044|469165963|FG001|Overall Study|Withdrawal by Subject|1|||
130326035|NCT04646044|469165964|FG002|Overall Study|Withdrawal by Subject|0|||
130326036|NCT04646044|469165965|FG003|Overall Study|Withdrawal by Subject|0|||
130326037|NCT01907854|469165966|FG000|Overall Study|Protocol Violation|1|||
130326038|NCT01907854|469165967|FG001|Overall Study|Protocol Violation|1|||
130326039|NCT01907854|469165966|FG000|Overall Study|Withdrawal by Subject|9|||
130326040|NCT01907854|469165967|FG001|Overall Study|Withdrawal by Subject|7|||
130326041|NCT01907854|469165966|FG000|Overall Study|Lost to Follow-up|2|||
130326042|NCT01907854|469165967|FG001|Overall Study|Lost to Follow-up|2|||
130326043|NCT01907854|469165966|FG000|Overall Study|Unclassified|4|||
130326044|NCT01907854|469165967|FG001|Overall Study|Unclassified|3|||
130326045|NCT02215252|469165968|FG000|Overall Study|Adverse Event|1|||
130326046|NCT02215252|469165969|FG001|Overall Study|Adverse Event|5|||
130326047|NCT02215252|469165970|FG002|Overall Study|Adverse Event|2|||
130326048|NCT02215252|469165968|FG000|Overall Study|Lost to Follow-up|0|||
130326049|NCT02215252|469165969|FG001|Overall Study|Lost to Follow-up|0|||
130326050|NCT02215252|469165970|FG002|Overall Study|Lost to Follow-up|1|||
130326051|NCT02215252|469165968|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
130326052|NCT02215252|469165969|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
130326053|NCT02215252|469165970|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
130326054|NCT02215252|469165968|FG000|Overall Study|Protocol Violation|0|||
130326055|NCT02215252|469165969|FG001|Overall Study|Protocol Violation|1|||
130326056|NCT02215252|469165970|FG002|Overall Study|Protocol Violation|0|||
130326057|NCT02215252|469165968|FG000|Overall Study|Withdrawal by Subject|1|||
130326058|NCT02215252|469165969|FG001|Overall Study|Withdrawal by Subject|0|||
129883512|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129883513|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129883514|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
129883515|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129883516|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
130326059|NCT02215252|469165970|FG002|Overall Study|Withdrawal by Subject|0|||
130326060|NCT02215252|469165968|FG000|Overall Study|Other|0|||
130326061|NCT02215252|469165969|FG001|Overall Study|Other|1|||
130326062|NCT02215252|469165970|FG002|Overall Study|Other|1|||
130326063|NCT02633306|469165971|FG000|Overall Study|Withdrawal by Subject|3|||
130326064|NCT03910244|469165972|FG000|Overall Study|Adverse Event|14|||
130326065|NCT03910244|469165973|FG001|Overall Study|Adverse Event|0|||
130326066|NCT03910244|469165972|FG000|Overall Study|Death|1|||
130326067|NCT03910244|469165973|FG001|Overall Study|Death|0|||
130326068|NCT03910244|469165972|FG000|Overall Study|Lost to Follow-up|0|||
130326069|NCT03910244|469165973|FG001|Overall Study|Lost to Follow-up|2|||
130326070|NCT03910244|469165972|FG000|Overall Study|Joint withdrawal decision|1|||
130326071|NCT03910244|469165973|FG001|Overall Study|Joint withdrawal decision|0|||
130326072|NCT03910244|469165972|FG000|Overall Study|Study Terminated by Sponsor|7|||
130326073|NCT03910244|469165973|FG001|Overall Study|Study Terminated by Sponsor|4|||
130326074|NCT03910244|469165972|FG000|Overall Study|Physician Decision|1|||
130326075|NCT03910244|469165973|FG001|Overall Study|Physician Decision|0|||
130326076|NCT03910244|469165972|FG000|Overall Study|Protocol Violation|1|||
130326077|NCT03910244|469165973|FG001|Overall Study|Protocol Violation|0|||
130326078|NCT03910244|469165972|FG000|Overall Study|Withdrawal by Subject|7|||
130326079|NCT03910244|469165973|FG001|Overall Study|Withdrawal by Subject|2|||
130326080|NCT00803569|469165975|FG000|Overall Study|Progressive Disease|3|||
130326081|NCT00803569|469165975|FG000|Overall Study|Noncompliance|1|||
130326082|NCT04004988|469165976|FG000|Period 1|Physician Decision|2|||
130326083|NCT04004988|469165977|FG001|Period 1|Physician Decision|0|||
130326084|NCT04004988|469165976|FG000|Period 1|Withdrawal by Subject|0|||
130326085|NCT04004988|469165977|FG001|Period 1|Withdrawal by Subject|1|||
130326086|NCT04004988|469165976|FG000|Period 1|Adverse Event|1|||
130326087|NCT04004988|469165977|FG001|Period 1|Adverse Event|2|||
130326088|NCT01598532|469165978|FG000|Overall Study|Lost to Follow-up|3|||
130326089|NCT01598532|469165978|FG000|Overall Study|Did not meet inclusion criteria|8|||
130326090|NCT00912808|469165979|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
130326091|NCT00912808|469165980|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
130326092|NCT00912808|469165979|FG000|Washout|Withdrawal by Subject|0|||
130326093|NCT00912808|469165980|FG001|Washout|Withdrawal by Subject|1|||
130326094|NCT00912808|469165979|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
130326095|NCT00912808|469165980|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
130326096|NCT00912808|469165979|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
130326097|NCT00912808|469165980|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130326098|NCT03873116|469165981|FG000|Part 1|Study drug discontinuation due to rash|0|||
130326099|NCT03873116|469165982|FG001|Part 1|Study drug discontinuation due to rash|0|||
130326100|NCT03873116|469165983|FG002|Part 1|Study drug discontinuation due to rash|0|||
130326101|NCT03873116|469165984|FG003|Part 1|Study drug discontinuation due to rash|0|||
130326102|NCT03873116|469165985|FG004|Part 1|Study drug discontinuation due to rash|0|||
130326103|NCT03873116|469165986|FG005|Part 1|Study drug discontinuation due to rash|1|||
130326104|NCT03873116|469165981|FG000|Part 2|Withdrawal by Subject|0|||
130326105|NCT03873116|469165982|FG001|Part 2|Withdrawal by Subject|0|||
130326106|NCT03873116|469165983|FG002|Part 2|Withdrawal by Subject|1|||
130326107|NCT03873116|469165984|FG003|Part 2|Withdrawal by Subject|0|||
130326108|NCT03873116|469165985|FG004|Part 2|Withdrawal by Subject|0|||
130326109|NCT03873116|469165986|FG005|Part 2|Withdrawal by Subject|0|||
130326110|NCT03873116|469165981|FG000|Part 2|Lab abnormality or AE|0|||
130326111|NCT03873116|469165982|FG001|Part 2|Lab abnormality or AE|0|||
130326112|NCT03873116|469165983|FG002|Part 2|Lab abnormality or AE|0|||
130326113|NCT03873116|469165984|FG003|Part 2|Lab abnormality or AE|0|||
130326114|NCT03873116|469165985|FG004|Part 2|Lab abnormality or AE|1|||
130326115|NCT03873116|469165986|FG005|Part 2|Lab abnormality or AE|0|||
130326116|NCT03873116|469165981|FG000|Part 3|Withdrawal by Subject|0|||
130326117|NCT03873116|469165982|FG001|Part 3|Withdrawal by Subject|0|||
130326118|NCT03873116|469165983|FG002|Part 3|Withdrawal by Subject|0|||
130326119|NCT03873116|469165984|FG003|Part 3|Withdrawal by Subject|0|||
130326120|NCT03873116|469165985|FG004|Part 3|Withdrawal by Subject|1|||
130326121|NCT03873116|469165986|FG005|Part 3|Withdrawal by Subject|0|||
130326122|NCT04682366|469165987|FG000|Overall Study|Lost to Follow-up|1|||
130326123|NCT04682366|469165988|FG001|Overall Study|Lost to Follow-up|1|||
130326124|NCT00702221|469165989|FG000|Overall Study|Adverse Event|4|||
130326125|NCT00702221|469165990|FG001|Overall Study|Adverse Event|3|||
130326126|NCT02000440|469165995|FG000|Overall Study|Adverse Event|3|||
130326127|NCT02000440|469165995|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
130326128|NCT03995368|469165996|FG000|Overall Study|Lost to Follow-up|1|||
130326129|NCT03995368|469165997|FG001|Overall Study|Lost to Follow-up|4|||
130326130|NCT03995368|469165998|FG002|Overall Study|Lost to Follow-up|1|||
130326131|NCT03995368|469165996|FG000|Overall Study|Did not meet inclusion criteria|1|||
130326132|NCT03995368|469165997|FG001|Overall Study|Did not meet inclusion criteria|6|||
130326133|NCT03995368|469165998|FG002|Overall Study|Did not meet inclusion criteria|3|||
130326134|NCT03995368|469165996|FG000|Overall Study|Withdrawal by Subject|0|||
129988243|NCT02412371|467918887|FG003|Overall Study|Other|0|||
130326135|NCT03995368|469165997|FG001|Overall Study|Withdrawal by Subject|1|||
129988244|NCT02412371|467918888|FG004|Overall Study|Other|1|||
129988245|NCT02412371|467918889|FG005|Overall Study|Other|3|||
129988246|NCT02053792|467918890|FG000|Overall Study|Physician Decision|0|||
129988247|NCT02053792|467918891|FG001|Overall Study|Physician Decision|1|||
129988248|NCT02053792|467918890|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
130215361|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215362|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215363|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215364|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215365|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
130215366|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215367|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215368|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215369|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215370|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215371|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215372|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215373|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215374|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215375|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215376|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215377|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215378|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215379|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215380|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215381|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
130215382|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215383|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215384|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215385|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215386|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215387|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215388|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215389|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215390|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215391|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215392|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215393|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215394|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215395|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215396|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215397|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215398|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215399|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215400|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215401|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
130215402|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215403|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215404|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215405|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215406|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215407|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215408|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215409|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215410|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215411|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215412|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215413|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215414|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215415|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
130215416|NCT05052697|468751740|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215417|NCT05052697|468751741|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215418|NCT05052697|468751742|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215419|NCT05052697|468751743|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215420|NCT05052697|468751744|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215421|NCT05052697|468751745|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130326136|NCT03995368|469165998|FG002|Overall Study|Withdrawal by Subject|1|||
130326137|NCT03755934|469165999|FG000|Overall Study|Adverse Event|4|||
130326138|NCT03755934|469166000|FG001|Overall Study|Adverse Event|1|||
129988249|NCT02053792|467918891|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
129988250|NCT02053792|467918890|FG000|Overall Study|Lack of Efficacy|1|||
130326139|NCT03755934|469166001|FG002|Overall Study|Adverse Event|1|||
130326140|NCT03755934|469166002|FG003|Overall Study|Adverse Event|3|||
130326141|NCT03755934|469165999|FG000|Overall Study|Physician Decision|2|||
130326142|NCT03755934|469166000|FG001|Overall Study|Physician Decision|0|||
130326143|NCT03755934|469166001|FG002|Overall Study|Physician Decision|0|||
130326144|NCT03755934|469166002|FG003|Overall Study|Physician Decision|1|||
130326145|NCT03755934|469165999|FG000|Overall Study|Withdrawal by Subject|5|||
130326146|NCT03755934|469166000|FG001|Overall Study|Withdrawal by Subject|0|||
130326147|NCT03755934|469166001|FG002|Overall Study|Withdrawal by Subject|0|||
130326148|NCT03755934|469166002|FG003|Overall Study|Withdrawal by Subject|1|||
130326149|NCT03755934|469165999|FG000|Overall Study|Other|3|||
130326150|NCT03755934|469166000|FG001|Overall Study|Other|1|||
130326151|NCT03755934|469166001|FG002|Overall Study|Other|3|||
130326152|NCT03755934|469166002|FG003|Overall Study|Other|1|||
130326153|NCT00361296|469166006|FG000|Overall Study|Physician Decision|1|||
130326154|NCT00361296|469166006|FG000|Overall Study|Lack of Efficacy|2|||
130326155|NCT00198822|469166007|FG000|Overall Study|Lost to Follow-up|14|||
130326156|NCT00198822|469166008|FG001|Overall Study|Lost to Follow-up|20|||
130326157|NCT00198822|469166009|FG002|Overall Study|Lost to Follow-up|21|||
130326158|NCT02420821|469166011|FG000|Overall Study|Lost to Follow-up|6|||
130326159|NCT02420821|469166012|FG001|Overall Study|Lost to Follow-up|6|||
130326160|NCT02420821|469166011|FG000|Overall Study|Non-compliance|0|||
130326161|NCT02420821|469166012|FG001|Overall Study|Non-compliance|2|||
130326162|NCT02420821|469166011|FG000|Overall Study|Physician Decision|6|||
130326163|NCT02420821|469166012|FG001|Overall Study|Physician Decision|2|||
130326164|NCT02420821|469166011|FG000|Overall Study|Withdrawal by Subject|32|||
130326165|NCT02420821|469166012|FG001|Overall Study|Withdrawal by Subject|25|||
130326166|NCT02420821|469166011|FG000|Overall Study|Death|270|||
130326167|NCT02420821|469166012|FG001|Overall Study|Death|263|||
130326168|NCT02420821|469166011|FG000|Overall Study|Study Terminated By Sponsor|145|||
130326169|NCT02420821|469166012|FG001|Overall Study|Study Terminated By Sponsor|149|||
130326170|NCT02420821|469166011|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
130326171|NCT02420821|469166012|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
130326172|NCT02420821|469166011|FG000|Overall Study|Adverse Event|0|||
130326173|NCT02420821|469166012|FG001|Overall Study|Adverse Event|1|||
130326174|NCT02420821|469166011|FG000|Overall Study|Protinuria|0|||
130326175|NCT02420821|469166012|FG001|Overall Study|Protinuria|1|||
130326176|NCT02420821|469166011|FG000|Overall Study|Progressive Disease|1|||
130326177|NCT02420821|469166012|FG001|Overall Study|Progressive Disease|1|||
130326178|NCT02420821|469166011|FG000|Overall Study|Disease Progression|0|||
130326179|NCT02420821|469166012|FG001|Overall Study|Disease Progression|1|||
130326180|NCT02420821|469166011|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
130326181|NCT02420821|469166012|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
130326182|NCT04322526|469166014|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
130326183|NCT04322526|469166015|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130326184|NCT04322526|469166014|FG000|Washout (1 Week)|Lost to Follow-up|1|||
130326185|NCT04322526|469166015|FG001|Washout (1 Week)|Lost to Follow-up|2|||
130326186|NCT00993967|469166016|FG000|Overall Study|Adverse Event|8|||
130326187|NCT00993967|469166016|FG000|Overall Study|Death|1|||
130326188|NCT00993967|469166016|FG000|Overall Study|Lost to Follow-up|14|||
130326189|NCT00993967|469166016|FG000|Overall Study|Withdrawal by Subject|36|||
130326190|NCT00993967|469166016|FG000|Overall Study|Protocol Violation|2|||
130326191|NCT02760498|469166017|FG000|Overall Study|Adverse Event|3|||
129988251|NCT02053792|467918891|FG001|Overall Study|Lack of Efficacy|0|||
129988252|NCT02053792|467918890|FG000|Overall Study|Adverse Event|1|||
129988253|NCT02053792|467918891|FG001|Overall Study|Adverse Event|0|||
129988254|NCT02053792|467918890|FG000|Overall Study|Withdrawal by Subject|2|||
129988255|NCT02053792|467918891|FG001|Overall Study|Withdrawal by Subject|2|||
129988256|NCT02053792|467918890|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
129988257|NCT02053792|467918891|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
129988258|NCT02053792|467918890|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
129988259|NCT02053792|467918891|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
129988260|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Death|0|||
129988261|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Death|0|||
129988262|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Death|0|||
129988263|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Death|1|||
129988264|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Death|2|||
129988265|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Death|1|||
129988266|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Death|1|||
130326192|NCT02760498|469166018|FG001|Overall Study|Adverse Event|3|||
130326193|NCT02760498|469166019|FG002|Overall Study|Adverse Event|1|||
130326194|NCT02760498|469166020|FG003|Overall Study|Adverse Event|1|||
130326195|NCT02760498|469166021|FG004|Overall Study|Adverse Event|0|||
130326196|NCT02760498|469166022|FG005|Overall Study|Adverse Event|6|||
130326197|NCT02760498|469166017|FG000|Overall Study|Death|7|||
130326198|NCT02760498|469166018|FG001|Overall Study|Death|5|||
130326199|NCT02760498|469166019|FG002|Overall Study|Death|5|||
130326200|NCT02760498|469166020|FG003|Overall Study|Death|7|||
130326201|NCT02760498|469166021|FG004|Overall Study|Death|0|||
130326202|NCT02760498|469166022|FG005|Overall Study|Death|23|||
130326203|NCT02760498|469166017|FG000|Overall Study|Lost to Follow-up|0|||
130326204|NCT02760498|469166018|FG001|Overall Study|Lost to Follow-up|0|||
130326205|NCT02760498|469166019|FG002|Overall Study|Lost to Follow-up|0|||
130326206|NCT02760498|469166020|FG003|Overall Study|Lost to Follow-up|0|||
130326207|NCT02760498|469166021|FG004|Overall Study|Lost to Follow-up|0|||
130326208|NCT02760498|469166022|FG005|Overall Study|Lost to Follow-up|3|||
130326209|NCT02760498|469166017|FG000|Overall Study|Non-compliance with study drug|0|||
130326210|NCT02760498|469166018|FG001|Overall Study|Non-compliance with study drug|2|||
130326211|NCT02760498|469166019|FG002|Overall Study|Non-compliance with study drug|0|||
130326212|NCT02760498|469166020|FG003|Overall Study|Non-compliance with study drug|0|||
130326213|NCT02760498|469166021|FG004|Overall Study|Non-compliance with study drug|0|||
130326214|NCT02760498|469166022|FG005|Overall Study|Non-compliance with study drug|0|||
130326215|NCT02760498|469166017|FG000|Overall Study|Participant decision|1|||
130326216|NCT02760498|469166018|FG001|Overall Study|Participant decision|4|||
130326217|NCT02760498|469166019|FG002|Overall Study|Participant decision|2|||
130326218|NCT02760498|469166020|FG003|Overall Study|Participant decision|2|||
130326219|NCT02760498|469166021|FG004|Overall Study|Participant decision|1|||
130326220|NCT02760498|469166022|FG005|Overall Study|Participant decision|6|||
130326221|NCT02760498|469166017|FG000|Overall Study|Sponsor decision|0|||
130326222|NCT02760498|469166018|FG001|Overall Study|Sponsor decision|0|||
130326223|NCT02760498|469166019|FG002|Overall Study|Sponsor decision|0|||
130326224|NCT02760498|469166020|FG003|Overall Study|Sponsor decision|3|||
130326225|NCT02760498|469166021|FG004|Overall Study|Sponsor decision|0|||
130326226|NCT02760498|469166022|FG005|Overall Study|Sponsor decision|0|||
130326227|NCT02760498|469166017|FG000|Overall Study|Physician Decision|3|||
130326228|NCT02760498|469166018|FG001|Overall Study|Physician Decision|4|||
130326229|NCT02760498|469166019|FG002|Overall Study|Physician Decision|1|||
130326230|NCT02760498|469166020|FG003|Overall Study|Physician Decision|4|||
130326231|NCT02760498|469166021|FG004|Overall Study|Physician Decision|0|||
130326232|NCT02760498|469166022|FG005|Overall Study|Physician Decision|2|||
130326233|NCT02760498|469166017|FG000|Overall Study|Disease progression|21|||
130326234|NCT02760498|469166018|FG001|Overall Study|Disease progression|19|||
130326235|NCT02760498|469166019|FG002|Overall Study|Disease progression|20|||
130326236|NCT02760498|469166020|FG003|Overall Study|Disease progression|18|||
130326237|NCT02760498|469166021|FG004|Overall Study|Disease progression|4|||
130326238|NCT02760498|469166022|FG005|Overall Study|Disease progression|55|||
130326239|NCT02760498|469166017|FG000|Overall Study|Withdrawal by Subject|4|||
130326240|NCT02760498|469166018|FG001|Overall Study|Withdrawal by Subject|7|||
130326241|NCT02760498|469166019|FG002|Overall Study|Withdrawal by Subject|5|||
130326242|NCT02760498|469166020|FG003|Overall Study|Withdrawal by Subject|1|||
130326243|NCT02760498|469166021|FG004|Overall Study|Withdrawal by Subject|0|||
130326244|NCT02760498|469166022|FG005|Overall Study|Withdrawal by Subject|6|||
130326245|NCT02760498|469166017|FG000|Overall Study|Other than specified|1|||
130326246|NCT02760498|469166018|FG001|Overall Study|Other than specified|6|||
130326247|NCT02760498|469166019|FG002|Overall Study|Other than specified|0|||
130326248|NCT02760498|469166020|FG003|Overall Study|Other than specified|3|||
130326249|NCT02760498|469166021|FG004|Overall Study|Other than specified|1|||
130326250|NCT02760498|469166022|FG005|Overall Study|Other than specified|0|||
130326251|NCT02760498|469166017|FG000|Overall Study|Not treated|0|||
130326252|NCT02760498|469166018|FG001|Overall Study|Not treated|0|||
130326253|NCT02760498|469166019|FG002|Overall Study|Not treated|0|||
130326254|NCT02760498|469166020|FG003|Overall Study|Not treated|0|||
130326255|NCT02760498|469166021|FG004|Overall Study|Not treated|0|||
129988267|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Death|2|||
129988268|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Death|4|||
129988269|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Death|1|||
129988270|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Death|0|||
129988271|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Death|0|||
129988272|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Death|1|||
130326256|NCT02760498|469166022|FG005|Overall Study|Not treated|2|||
130326257|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
130326258|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
130326259|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
130326260|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
130326261|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Adverse Event|2|||
130326262|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Adverse Event|5|||
130326263|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Adverse Event|1|||
130326264|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Adverse Event|2|||
130326265|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Death|13|||
130326266|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Death|17|||
130326267|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Death|1|||
130326268|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Death|0|||
130326269|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
130326270|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
130326271|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
130326272|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
130326273|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Disease Progression|2|||
130326274|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Disease Progression|0|||
130326275|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Disease Progression|0|||
130326276|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Disease Progression|0|||
130326277|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
130326278|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
130326279|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
130326280|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
130326281|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
130326282|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
130326283|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
130326284|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
130326285|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
130326286|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
130326287|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
130326288|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
130326289|NCT03955146|469166025|FG000|DB Period (48 Weeks)|Participant Decision|9|||
130326290|NCT03955146|469166026|FG001|DB Period (48 Weeks)|Participant Decision|12|||
130326291|NCT03955146|469166027|FG002|DB Period (48 Weeks)|Participant Decision|1|||
130326292|NCT03955146|469166028|FG003|DB Period (48 Weeks)|Participant Decision|1|||
130326293|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
130326294|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
130326295|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
129988273|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988274|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988275|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988276|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988277|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988278|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988279|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988280|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
129988281|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
130326296|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
130326297|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
130326298|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
129883517|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
129883518|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883519|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883520|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883521|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883522|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883523|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
129883524|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
129883525|NCT03884231|467534325|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
129883526|NCT03884231|467534325|FG000|Overall Study|Subject Withdrew Consent|1|||
129883527|NCT03884231|467534325|FG000|Overall Study|MRI Scan Not Performed|1|||
129883528|NCT01853254|467534326|FG000|Overall Study|Abnormal Laboratory Test|1|||
129883529|NCT01853254|467534326|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
129883530|NCT01853254|467534326|FG000|Overall Study|Death|1|||
129883531|NCT01853254|467534326|FG000|Overall Study|Failure to Return|43|||
129883532|NCT01853254|467534326|FG000|Overall Study|Insufficient Therapeutic Response|22|||
129883533|NCT01853254|467534326|FG000|Overall Study|Refusal of Treatment|1|||
129883534|NCT01853254|467534326|FG000|Overall Study|Other Protocol Violation|1|||
129883535|NCT01853254|467534326|FG000|Overall Study|Withdrawal of Consent|16|||
129883536|NCT01853254|467534326|FG000|Overall Study|Administrative/Other|16|||
129883537|NCT01017120|467534332|FG000|Overall Study|Adverse Event|9|||
129883538|NCT01017120|467534333|FG001|Overall Study|Adverse Event|0|||
129883539|NCT01017120|467534332|FG000|Overall Study|Lost to Follow-up|13|||
129883540|NCT01017120|467534333|FG001|Overall Study|Lost to Follow-up|11|||
129883541|NCT01017120|467534332|FG000|Overall Study|Lack of Efficacy|1|||
129883542|NCT01017120|467534333|FG001|Overall Study|Lack of Efficacy|0|||
129883543|NCT01017120|467534332|FG000|Overall Study|Withdrawal by Subject|39|||
129883544|NCT01017120|467534333|FG001|Overall Study|Withdrawal by Subject|21|||
129883545|NCT01017120|467534332|FG000|Overall Study|Pregnancy|1|||
129883546|NCT01017120|467534333|FG001|Overall Study|Pregnancy|1|||
129883547|NCT01017120|467534332|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129883548|NCT01017120|467534333|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130326299|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
130326300|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
130326301|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130326302|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
130326303|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130326304|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
130326305|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
130326306|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
130326307|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
130326308|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
130326309|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
130326310|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
130326311|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
130326312|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
130326313|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
130326314|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130326315|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130326316|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
130326317|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
130326318|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
130326319|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
130326320|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
130326321|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
130326322|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
130326323|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
130326324|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
130326325|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
129988282|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988283|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988284|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988285|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
129988286|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
130326326|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130326327|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130326328|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
130326329|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
130326330|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
130326331|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
130326332|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
130326333|NCT03955146|469166025|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
130326334|NCT03955146|469166026|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130326335|NCT03955146|469166027|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130326336|NCT03955146|469166028|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
130326337|NCT02002598|469166031|FG000|Dose Level 1|Withdrawal by Subject|1|||
130326338|NCT02002598|469166032|FG001|Dose Level 1|Withdrawal by Subject|0|||
130326339|NCT02002598|469166033|FG002|Dose Level 1|Withdrawal by Subject|0|||
130326340|NCT02002598|469166034|FG003|Dose Level 1|Withdrawal by Subject|0|||
130326341|NCT02002598|469166035|FG004|Dose Level 1|Withdrawal by Subject|0|||
129988287|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988288|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988289|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
129988290|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
129988291|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
129988292|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
129988293|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988294|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
129988295|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988296|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988297|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988298|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988299|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Other|0|||
129988300|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Other|0|||
129988301|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Other|0|||
129988302|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Other|0|||
129988303|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Other|0|||
129988304|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Other|0|||
129988305|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Other|0|||
129988306|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Other|1|||
129988307|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Other|0|||
129988308|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Other|1|||
129988309|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Other|0|||
129988310|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Other|0|||
129988311|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Other|0|||
129988312|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988313|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988314|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988315|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988316|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988317|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
129988318|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
129988319|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988320|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
129988321|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988322|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988323|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988324|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988325|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988326|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988327|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988328|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988329|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
129988330|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988331|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988332|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
129988333|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
129988334|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988335|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988336|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
129988337|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
129988338|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988339|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988340|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988341|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988342|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988343|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988344|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988345|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
129988346|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988347|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988348|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
129988349|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988350|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988351|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
129988352|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
129988353|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
129988354|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
129988355|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
129988356|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
129988357|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
129988358|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
129988359|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
129988360|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
129988361|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
129988362|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
130326342|NCT02628873|469166036|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
130326343|NCT02628873|469166037|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
130326344|NCT02628873|469166036|FG000|Second Test (1 Hour)|Physician Decision|1|||
130326345|NCT02628873|469166037|FG001|Second Test (1 Hour)|Physician Decision|0|||
130326346|NCT02195518|469166038|FG000|Overall Study|Adverse Event|1|||
130326347|NCT02195518|469166038|FG000|Overall Study|Protocol Violation|4|||
130326348|NCT02195518|469166038|FG000|Overall Study|Pregnancy|2|||
129988363|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
129988364|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
129988365|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
130215422|NCT05052697|468751746|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215423|NCT05052697|468751747|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215424|NCT05052697|468751748|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215425|NCT05052697|468751749|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215426|NCT05052697|468751750|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215427|NCT05052697|468751751|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215428|NCT05052697|468751752|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215429|NCT05052697|468751753|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215430|NCT05052697|468751754|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215431|NCT05052697|468751755|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215432|NCT05052697|468751756|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215433|NCT05052697|468751757|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130215434|NCT05052697|468751758|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215435|NCT05052697|468751759|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215436|NCT05052697|468751760|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215437|NCT05052697|468751761|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215438|NCT05052697|468751762|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215439|NCT05052697|468751763|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215440|NCT05052697|468751764|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215441|NCT05052697|468751765|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130215442|NCT05052697|468751766|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215443|NCT05052697|468751767|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
130215444|NCT05052697|468751768|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215445|NCT05052697|468751769|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215446|NCT05052697|468751770|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215447|NCT05052697|468751771|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215448|NCT05052697|468751772|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215449|NCT05052697|468751773|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
130215450|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215451|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215452|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215453|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215454|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215455|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215456|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215457|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215458|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215459|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215460|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215461|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215462|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215463|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215464|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215465|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215466|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215467|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215468|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215469|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215470|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215471|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215472|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215473|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215474|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215475|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215476|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215477|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215478|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
130215479|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
130215480|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130215481|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130215482|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
130215483|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129988366|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
129988367|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
129988368|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
129988369|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
129988370|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
129988371|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
129988372|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
129988373|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
129988374|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
129988375|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
129988376|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
129988377|NCT00812331|467920994|FG000|Overall Study|Adverse Event|1|||
129988378|NCT00812331|467920995|FG001|Overall Study|Adverse Event|0|||
129988379|NCT00812331|467920996|FG002|Overall Study|Adverse Event|0|||
129988380|NCT00812331|467920997|FG003|Overall Study|Adverse Event|0|||
129988381|NCT00812331|467920998|FG004|Overall Study|Adverse Event|0|||
129988382|NCT01506453|467920999|FG000|Overall Study|Withdrawal prior to treatment|0|||
129988383|NCT01506453|467921000|FG001|Overall Study|Withdrawal prior to treatment|2|||
129988384|NCT00910689|467921008|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
130326349|NCT02195518|469166038|FG000|Overall Study|Withdrawal by Subject|1|||
130326350|NCT02195518|469166038|FG000|Overall Study|Lost to Follow-up|1|||
130326351|NCT01281124|469167775|FG000|Overall Study|Death|1|||
130326352|NCT03038100|469167776|FG000|Overall Study|Death|289|||
130326353|NCT03038100|469167777|FG001|Overall Study|Death|272|||
130326354|NCT03038100|469167776|FG000|Overall Study|Lost to Follow-up|9|||
130326355|NCT03038100|469167777|FG001|Overall Study|Lost to Follow-up|10|||
129988385|NCT00910689|467921009|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
129988386|NCT00910689|467921010|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
130326356|NCT03038100|469167776|FG000|Overall Study|Protocol Deviation|1|||
129988387|NCT00910689|467921011|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
129988388|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
129988389|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
129988390|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
129988391|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
129988392|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
129988393|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
129988394|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
129988395|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
129988396|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
129988397|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
129988398|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
129988399|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
129988400|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
130326357|NCT03038100|469167777|FG001|Overall Study|Protocol Deviation|4|||
130326358|NCT03038100|469167776|FG000|Overall Study|Withdrawal by Subject|45|||
130326359|NCT03038100|469167777|FG001|Overall Study|Withdrawal by Subject|51|||
130326360|NCT03038100|469167776|FG000|Overall Study|Study Terminated By Sponsor|305|||
130326361|NCT03038100|469167777|FG001|Overall Study|Study Terminated By Sponsor|311|||
130326362|NCT03038100|469167776|FG000|Overall Study|Physician Decision|1|||
130326363|NCT03038100|469167777|FG001|Overall Study|Physician Decision|3|||
130326364|NCT02392624|469167778|FG000|Overall Study|Withdrawal by Subject|15|||
130326365|NCT02392624|469167779|FG001|Overall Study|Withdrawal by Subject|12|||
130326366|NCT02392624|469167780|FG002|Overall Study|Withdrawal by Subject|9|||
130326367|NCT02392624|469167778|FG000|Overall Study|Adverse Event|4|||
130326368|NCT02392624|469167779|FG001|Overall Study|Adverse Event|1|||
130326369|NCT02392624|469167780|FG002|Overall Study|Adverse Event|2|||
130326370|NCT02392624|469167778|FG000|Overall Study|Pregnancy|1|||
130326371|NCT02392624|469167779|FG001|Overall Study|Pregnancy|0|||
130326372|NCT02392624|469167780|FG002|Overall Study|Pregnancy|0|||
130326373|NCT02392624|469167778|FG000|Overall Study|Protocol Violation|0|||
129988401|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
129988402|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
129988403|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
129988404|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
129988405|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
129988406|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
129988407|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
130326374|NCT02392624|469167779|FG001|Overall Study|Protocol Violation|0|||
130326375|NCT02392624|469167780|FG002|Overall Study|Protocol Violation|1|||
130326376|NCT02392624|469167778|FG000|Overall Study|Sponsor/Investigator Decision|2|||
130326377|NCT02392624|469167779|FG001|Overall Study|Sponsor/Investigator Decision|1|||
130326378|NCT02392624|469167780|FG002|Overall Study|Sponsor/Investigator Decision|0|||
130326379|NCT02392624|469167778|FG000|Overall Study|Other|49|||
130326380|NCT02392624|469167779|FG001|Overall Study|Other|1|||
130326381|NCT02392624|469167780|FG002|Overall Study|Other|1|||
130326382|NCT00706238|469167781|FG000|Overall Study|Disease progression|4|||
130326383|NCT00706238|469167781|FG000|Overall Study|Other|1|||
130326384|NCT03841604|469167786|FG000|Overall Study|Withdrawal by Subject|3|||
130326385|NCT03841604|469167787|FG001|Overall Study|Withdrawal by Subject|1|||
130326386|NCT03841604|469167786|FG000|Overall Study|Adverse Event|4|||
130326387|NCT03841604|469167787|FG001|Overall Study|Adverse Event|2|||
130326388|NCT03841604|469167786|FG000|Overall Study|Physician Decision|1|||
130326389|NCT03841604|469167787|FG001|Overall Study|Physician Decision|0|||
130326390|NCT03877510|469167790|FG000|Overall Study|Death|6|||
130326391|NCT03877510|469167790|FG000|Overall Study|Lost to Follow-up|2|||
130326392|NCT03877510|469167790|FG000|Overall Study|Non-compliance with study drug|2|||
130326393|NCT03877510|469167790|FG000|Overall Study|Lack of Efficacy|14|||
130326394|NCT03877510|469167790|FG000|Overall Study|Adverse Event|20|||
130326395|NCT03877510|469167790|FG000|Overall Study|Withdrawal by Subject|22|||
130326396|NCT03877510|469167790|FG000|Overall Study|Miscellaneous|1|||
130326397|NCT01417377|469167791|FG000|Overall Study|Lost to Follow-up|12|||
130326398|NCT01417377|469167791|FG000|Overall Study|Enrolled, but not treated|1|||
130326399|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
130326400|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
130326401|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
130326402|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
130326403|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
130326404|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
130326405|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
130326406|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
130326407|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
130326408|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
130326409|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
130326410|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
130326411|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
130326412|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
130326413|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
130326414|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
130326415|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
130326416|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
130326417|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
130326418|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
130326419|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
130326420|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
130326421|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
130326422|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
130326423|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
130326424|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
130326425|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
130326426|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
130326427|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326428|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326429|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326430|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326431|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326432|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326433|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
130326434|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326435|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326436|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326437|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129883549|NCT01017120|467534332|FG000|Overall Study|Relocated Out of Town|0|||
129883550|NCT01017120|467534333|FG001|Overall Study|Relocated Out of Town|2|||
129883551|NCT01017120|467534332|FG000|Overall Study|Protocol Violation|1|||
129883552|NCT01017120|467534333|FG001|Overall Study|Protocol Violation|0|||
129883553|NCT01017120|467534332|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
129883554|NCT01017120|467534333|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
129883555|NCT01087723|467534334|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
129883556|NCT01087723|467534335|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
129883557|NCT01087723|467534334|FG000|Overall Study|Withdrawal by Subject|10|||
129988408|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
130326438|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326439|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129883558|NCT01087723|467534335|FG001|Overall Study|Withdrawal by Subject|13|||
130326440|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
130326441|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Transplant|0|||
130326442|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Transplant|1|||
129883559|NCT01087723|467534334|FG000|Overall Study|Physician Decision|2|||
129988409|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
129988410|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
129988411|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
129988412|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
129988413|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
129988414|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
129988415|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
129988416|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
129988417|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
129988418|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
129988419|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
129988420|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
129988421|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
129988422|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
129988423|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
129988424|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
129988425|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
129988426|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
129988427|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
129988428|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
129988429|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
130215484|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129988430|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
129988431|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
130215485|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215486|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215487|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215488|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215489|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215490|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215491|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215492|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215493|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215494|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215495|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215496|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215497|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215498|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215499|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215500|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215501|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215502|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215503|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215504|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215505|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215506|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215507|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215508|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215509|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215510|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215511|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215512|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
130215513|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
130215514|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
130215515|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
130215516|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
130215517|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
130215518|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215519|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215520|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215521|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215522|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215523|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215524|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215525|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215526|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215527|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130326443|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Transplant|0|||
130326444|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Transplant|0|||
130326445|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Transplant|0|||
130326446|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Transplant|1|||
130326447|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Transplant|0|||
130326448|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Transplant|0|||
129988432|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
129988433|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
129988434|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
129988435|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
129988436|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
129988437|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
129988438|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
129988439|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
129988440|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
129988441|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
129988442|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
129988443|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
130326449|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Transplant|0|||
130326450|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Transplant|0|||
130326451|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Transplant|0|||
130326452|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Transplant|0|||
130326453|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Transplant|0|||
130326454|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Transplant|0|||
129883560|NCT01087723|467534335|FG001|Overall Study|Physician Decision|0|||
129883561|NCT01087723|467534334|FG000|Overall Study|Lost to Follow-up|1|||
129883562|NCT01087723|467534335|FG001|Overall Study|Lost to Follow-up|4|||
129883563|NCT01087723|467534334|FG000|Overall Study|Reason Not Specified|1|||
129883564|NCT01087723|467534335|FG001|Overall Study|Reason Not Specified|2|||
129883565|NCT00806624|467534336|FG000|Overall Study|Adverse Event|2|||
129883566|NCT00806624|467534337|FG001|Overall Study|Adverse Event|8|||
129883567|NCT00806624|467534338|FG002|Overall Study|Adverse Event|0|||
129883568|NCT00806624|467534336|FG000|Overall Study|Death|0|||
129883569|NCT00806624|467534337|FG001|Overall Study|Death|1|||
129883570|NCT00806624|467534338|FG002|Overall Study|Death|1|||
129883571|NCT00806624|467534336|FG000|Overall Study|Lost to Follow-up|1|||
129883572|NCT00806624|467534337|FG001|Overall Study|Lost to Follow-up|0|||
129883573|NCT00806624|467534338|FG002|Overall Study|Lost to Follow-up|1|||
129883574|NCT00806624|467534336|FG000|Overall Study|Withdrawal by Subject|6|||
129883575|NCT00806624|467534337|FG001|Overall Study|Withdrawal by Subject|3|||
129883576|NCT00806624|467534338|FG002|Overall Study|Withdrawal by Subject|3|||
129883577|NCT00806624|467534336|FG000|Overall Study|discontinued before start of treatment|0|||
129883578|NCT00806624|467534337|FG001|Overall Study|discontinued before start of treatment|0|||
129883579|NCT00806624|467534338|FG002|Overall Study|discontinued before start of treatment|1|||
129883580|NCT01702428|467534340|FG000|Overall Study|Adverse Event|2|||
129883581|NCT01702428|467534341|FG001|Overall Study|Adverse Event|0|||
129883582|NCT01702428|467534342|FG002|Overall Study|Adverse Event|0|||
129883583|NCT01702428|467534343|FG003|Overall Study|Adverse Event|0|||
129883584|NCT01702428|467534340|FG000|Overall Study|Lost to Follow-up|33|||
129883585|NCT01702428|467534341|FG001|Overall Study|Lost to Follow-up|41|||
129883586|NCT01702428|467534342|FG002|Overall Study|Lost to Follow-up|37|||
129883587|NCT01702428|467534343|FG003|Overall Study|Lost to Follow-up|44|||
129883588|NCT01702428|467534340|FG000|Overall Study|Parents cannot assist to site|1|||
129883589|NCT01702428|467534341|FG001|Overall Study|Parents cannot assist to site|0|||
129883590|NCT01702428|467534342|FG002|Overall Study|Parents cannot assist to site|1|||
129883591|NCT01702428|467534343|FG003|Overall Study|Parents cannot assist to site|0|||
129883592|NCT01702428|467534340|FG000|Overall Study|Lost Coverage|0|||
129883593|NCT01702428|467534341|FG001|Overall Study|Lost Coverage|0|||
129883594|NCT01702428|467534342|FG002|Overall Study|Lost Coverage|0|||
129883595|NCT01702428|467534343|FG003|Overall Study|Lost Coverage|1|||
129883596|NCT01702428|467534340|FG000|Overall Study|Lost Health Plan|3|||
129883597|NCT01702428|467534341|FG001|Overall Study|Lost Health Plan|5|||
129883598|NCT01702428|467534342|FG002|Overall Study|Lost Health Plan|0|||
129883599|NCT01702428|467534343|FG003|Overall Study|Lost Health Plan|2|||
129883600|NCT01702428|467534340|FG000|Overall Study|Mother transferred care|0|||
129883601|NCT01702428|467534341|FG001|Overall Study|Mother transferred care|1|||
129883602|NCT01702428|467534342|FG002|Overall Study|Mother transferred care|0|||
129883603|NCT01702428|467534343|FG003|Overall Study|Mother transferred care|0|||
129883604|NCT01702428|467534340|FG000|Overall Study|Parents too busy|1|||
129883605|NCT01702428|467534341|FG001|Overall Study|Parents too busy|0|||
129883606|NCT01702428|467534342|FG002|Overall Study|Parents too busy|0|||
129883607|NCT01702428|467534343|FG003|Overall Study|Parents too busy|0|||
129883608|NCT01702428|467534340|FG000|Overall Study|Protocol Violation|3|||
130326455|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
130326456|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
129883609|NCT01702428|467534341|FG001|Overall Study|Protocol Violation|0|||
129988444|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
129988445|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
129988446|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
129988447|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
129988448|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
129988449|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
129988450|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
129988451|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
129988452|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
129988453|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
129988454|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
129988455|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
129988456|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
129988457|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
129988458|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
129988459|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
129988460|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
129988461|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
129988462|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
129988463|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
129988464|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
129988465|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
129988466|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
129988467|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
129988468|NCT00484289|467921017|FG000|Long Term Phase|Adverse Event|1|||
129988469|NCT00484289|467921018|FG001|Long Term Phase|Adverse Event|17|||
129883610|NCT01702428|467534342|FG002|Overall Study|Protocol Violation|1|||
129883611|NCT01702428|467534343|FG003|Overall Study|Protocol Violation|0|||
129883612|NCT01702428|467534340|FG000|Overall Study|Withdrawal by Subject|21|||
129883613|NCT01702428|467534341|FG001|Overall Study|Withdrawal by Subject|23|||
129883614|NCT01702428|467534342|FG002|Overall Study|Withdrawal by Subject|14|||
129883615|NCT01702428|467534343|FG003|Overall Study|Withdrawal by Subject|10|||
129883616|NCT00154063|467534346|FG000|Overall Study|Adverse Event|4|||
129883617|NCT00154063|467534347|FG001|Overall Study|Adverse Event|8|||
129883618|NCT00154063|467534346|FG000|Overall Study|Protocol Violation|1|||
129883619|NCT00154063|467534347|FG001|Overall Study|Protocol Violation|1|||
129883620|NCT00154063|467534346|FG000|Overall Study|Investigator or Sponsor Request|0|||
129883621|NCT00154063|467534347|FG001|Overall Study|Investigator or Sponsor Request|1|||
129883622|NCT00154063|467534346|FG000|Overall Study|Withdrawal by Subject|4|||
129883623|NCT00154063|467534347|FG001|Overall Study|Withdrawal by Subject|9|||
129883624|NCT00154063|467534346|FG000|Overall Study|Other|3|||
129883625|NCT00154063|467534347|FG001|Overall Study|Other|3|||
129883626|NCT02091869|467534348|FG000|Overall Study|Withdrawal by Subject|0|||
129883627|NCT02091869|467534349|FG001|Overall Study|Withdrawal by Subject|3|||
129883628|NCT00451217|467534358|FG000|Overall Study|Lost to Follow-up|0|||
129883629|NCT00451217|467534359|FG001|Overall Study|Lost to Follow-up|1|||
129883630|NCT00451217|467534360|FG002|Overall Study|Lost to Follow-up|1|||
129883631|NCT00451217|467534361|FG003|Overall Study|Lost to Follow-up|1|||
129883632|NCT00451217|467534358|FG000|Overall Study|Withdrawal by Subject|1|||
129883633|NCT00451217|467534359|FG001|Overall Study|Withdrawal by Subject|0|||
129883634|NCT00451217|467534360|FG002|Overall Study|Withdrawal by Subject|0|||
129883635|NCT00451217|467534361|FG003|Overall Study|Withdrawal by Subject|0|||
129883636|NCT00451217|467534358|FG000|Overall Study|Not Treated|1|||
129883637|NCT00451217|467534359|FG001|Overall Study|Not Treated|1|||
129883638|NCT00451217|467534360|FG002|Overall Study|Not Treated|3|||
129883639|NCT00451217|467534361|FG003|Overall Study|Not Treated|4|||
129883640|NCT00467142|467534363|FG000|Overall Study|Withdrawal by Subject|1|||
129883641|NCT00467142|467534363|FG000|Overall Study|Adverse Event|1|||
129883642|NCT00467142|467534363|FG000|Overall Study|Protocol Violation|1|||
129883643|NCT02406261|467534364|FG000|Period 1|Lost to Follow-up|2|||
129883644|NCT02406261|467534365|FG001|Period 1|Lost to Follow-up|0|||
129883645|NCT02406261|467534364|FG000|Period 1|Adverse Event|1|||
129883646|NCT02406261|467534365|FG001|Period 1|Adverse Event|0|||
129883647|NCT02406261|467534364|FG000|Period 2|Physician Decision|0|||
129883648|NCT02406261|467534365|FG001|Period 2|Physician Decision|1|||
129883649|NCT02406261|467534364|FG000|Period 2|Protocol Violation|0|||
129883650|NCT02406261|467534365|FG001|Period 2|Protocol Violation|1|||
129883651|NCT02406261|467534364|FG000|Period 2|Withdrawal by Subject|0|||
129883652|NCT02406261|467534365|FG001|Period 2|Withdrawal by Subject|1|||
129883653|NCT02761629|467534372|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
129883654|NCT02761629|467534373|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
129883655|NCT02761629|467534372|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129883656|NCT02761629|467534373|FG001|Overall Study|Insufficient Therapeutic Response|7|||
130326457|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
130326458|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
130326459|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
130326460|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
130326461|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
130326462|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
130326463|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
130326464|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
130326465|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
130326466|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
130326467|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
130326468|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
130326469|NCT02113982|469167792|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
130326470|NCT02113982|469167793|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
130326471|NCT02113982|469167794|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
130326472|NCT02113982|469167795|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
130326473|NCT02113982|469167796|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
130326474|NCT02113982|469167797|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
130326475|NCT02113982|469167798|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
130326476|NCT02113982|469167799|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
130326477|NCT02113982|469167800|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
130326478|NCT02113982|469167801|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
130326479|NCT02113982|469167802|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
130326480|NCT02113982|469167803|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
130326481|NCT02113982|469167804|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
130326482|NCT02113982|469167805|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
130326483|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
130326484|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
130326485|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
130326486|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
130326487|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
130326488|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
130326489|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
130326490|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
130326491|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
130326492|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
130326493|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
130326494|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
130326495|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
130326496|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
130326497|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
130326498|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
130326499|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
130326500|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
130326501|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
130326502|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
130326503|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
130326504|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
130326505|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
129883657|NCT02761629|467534372|FG000|Overall Study|Failure to Return|2|||
129883658|NCT02761629|467534373|FG001|Overall Study|Failure to Return|4|||
129883659|NCT02761629|467534372|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
129883660|NCT02761629|467534373|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
129883661|NCT02761629|467534372|FG000|Overall Study|Protocol Violation|2|||
129883662|NCT02761629|467534373|FG001|Overall Study|Protocol Violation|2|||
129883663|NCT02761629|467534372|FG000|Overall Study|Withdrawal by Subject|0|||
129883664|NCT02761629|467534373|FG001|Overall Study|Withdrawal by Subject|3|||
129883665|NCT02761629|467534372|FG000|Overall Study|Other|0|||
129883666|NCT02761629|467534373|FG001|Overall Study|Other|2|||
129883667|NCT02761629|467534372|FG000|Overall Study|Lost to Follow-up|4|||
129883668|NCT02761629|467534373|FG001|Overall Study|Lost to Follow-up|1|||
129883669|NCT02761629|467534372|FG000|Overall Study|Randomized But Not Treated|8|||
129883670|NCT02761629|467534373|FG001|Overall Study|Randomized But Not Treated|4|||
129883671|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
129883672|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
129883673|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
129988470|NCT00484289|467921019|FG002|Long Term Phase|Adverse Event|5|||
129883674|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
130326506|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
130326507|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
130326508|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
130326509|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
130326510|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
129988471|NCT00484289|467921017|FG000|Long Term Phase|Withdrawal by Subject|0|||
129988472|NCT00484289|467921018|FG001|Long Term Phase|Withdrawal by Subject|7|||
129988473|NCT00484289|467921019|FG002|Long Term Phase|Withdrawal by Subject|6|||
129988474|NCT00484289|467921017|FG000|Long Term Phase|Inadequate response|2|||
129988475|NCT00484289|467921018|FG001|Long Term Phase|Inadequate response|7|||
129988476|NCT00484289|467921019|FG002|Long Term Phase|Inadequate response|4|||
129988477|NCT00484289|467921017|FG000|Long Term Phase|Other Reason|0|||
129988478|NCT00484289|467921018|FG001|Long Term Phase|Other Reason|5|||
129988479|NCT00484289|467921019|FG002|Long Term Phase|Other Reason|1|||
129988480|NCT00484289|467921017|FG000|Post Marketing Phase|Adverse Event|0|||
129988481|NCT00484289|467921018|FG001|Post Marketing Phase|Adverse Event|1|||
129988482|NCT00484289|467921019|FG002|Post Marketing Phase|Adverse Event|0|||
129988483|NCT02349425|467921020|FG000|Period 1|Adverse Event|1|||
129988484|NCT02349425|467921021|FG001|Period 1|Adverse Event|1|||
129988485|NCT02349425|467921022|FG002|Period 1|Adverse Event|0|||
129988486|NCT02349425|467921023|FG003|Period 1|Adverse Event|0|||
129988487|NCT02349425|467921020|FG000|Period 2|Adverse Event|0|||
129988488|NCT02349425|467921021|FG001|Period 2|Adverse Event|1|||
129988489|NCT02349425|467921022|FG002|Period 2|Adverse Event|1|||
129988490|NCT02349425|467921023|FG003|Period 2|Adverse Event|0|||
129988491|NCT03064035|467921028|FG000|Overall Study|Did not receive allocated intervention|4|||
129988492|NCT03064035|467921029|FG001|Overall Study|Did not receive allocated intervention|2|||
129988493|NCT03064035|467921028|FG000|Overall Study|Lost to Follow-up|1|||
129988494|NCT03064035|467921029|FG001|Overall Study|Lost to Follow-up|1|||
129988495|NCT03103763|467921030|FG000|Overall Study|Death|15|||
129988496|NCT03103763|467921031|FG001|Overall Study|Death|5|||
129988497|NCT03103763|467921032|FG002|Overall Study|Death|5|||
129988498|NCT03103763|467921030|FG000|Overall Study|Withdrawal by Subject|0|||
129988499|NCT03103763|467921031|FG001|Overall Study|Withdrawal by Subject|3|||
129988500|NCT03103763|467921032|FG002|Overall Study|Withdrawal by Subject|2|||
129988501|NCT01143038|467921033|FG000|Overall Study|Withdrawal by Subject|4|||
129988502|NCT01143038|467921033|FG000|Overall Study|Requirement for alternative therapy|5|||
129988503|NCT01143038|467921033|FG000|Overall Study|Adverse Event|3|||
129988504|NCT01143038|467921033|FG000|Overall Study|Lost to Follow-up|2|||
129988505|NCT01143038|467921033|FG000|Overall Study|Protocol Deviation|1|||
129988506|NCT01143038|467921033|FG000|Overall Study|Death|1|||
129988507|NCT01346475|467921037|FG000|First Intervention|Lost to Follow-up|4|||
129988508|NCT01346475|467921038|FG001|First Intervention|Lost to Follow-up|3|||
129988509|NCT04279392|467921039|FG000|Overall Study|Physician Decision|1|||
129988510|NCT04279392|467921040|FG001|Overall Study|Physician Decision|0|||
129988511|NCT01171807|467921041|FG000|Overall Study|Treatment failure|2|||
129988512|NCT01171807|467921042|FG001|Overall Study|Treatment failure|4|||
129988513|NCT01171807|467921041|FG000|Overall Study|Non compliance|1|||
129988514|NCT01171807|467921042|FG001|Overall Study|Non compliance|0|||
129988515|NCT01171807|467921041|FG000|Overall Study|Lost to Follow-up|3|||
129988516|NCT01171807|467921042|FG001|Overall Study|Lost to Follow-up|0|||
129988517|NCT04101318|467921049|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
129988518|NCT04101318|467921050|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
129988519|NCT04101318|467921049|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
129988520|NCT04101318|467921050|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
129988521|NCT04101318|467921049|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
129988522|NCT04101318|467921050|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
129988523|NCT00558259|467921051|FG000|Overall Study|Adverse Event|50|||
129988524|NCT00558259|467921052|FG001|Overall Study|Adverse Event|81|||
129988525|NCT00558259|467921051|FG000|Overall Study|Protocol Violation|9|||
129988526|NCT00558259|467921052|FG001|Overall Study|Protocol Violation|5|||
129988527|NCT00558259|467921051|FG000|Overall Study|Withdrawal by Subject|12|||
129988528|NCT00558259|467921052|FG001|Overall Study|Withdrawal by Subject|13|||
129988529|NCT04289051|467921053|FG000|Overall Study|Lost to Follow-up|0|||
129988530|NCT04289051|467921054|FG001|Overall Study|Lost to Follow-up|0|||
129988531|NCT04289051|467921055|FG002|Overall Study|Lost to Follow-up|2|||
129988532|NCT01901341|467921056|FG000|Overall Study|Adverse Event|4|||
129988533|NCT01901341|467921057|FG001|Overall Study|Adverse Event|2|||
129988534|NCT01901341|467921056|FG000|Overall Study|Lack of Efficacy|0|||
129988535|NCT01901341|467921057|FG001|Overall Study|Lack of Efficacy|2|||
129988536|NCT01901341|467921056|FG000|Overall Study|Lost to Follow-up|0|||
129988537|NCT01901341|467921057|FG001|Overall Study|Lost to Follow-up|1|||
129988538|NCT01901341|467921056|FG000|Overall Study|Protocol Violation|2|||
129988539|NCT01901341|467921057|FG001|Overall Study|Protocol Violation|0|||
129988540|NCT01901341|467921056|FG000|Overall Study|Study Terminated by Sponsor|13|||
129988541|NCT01901341|467921057|FG001|Overall Study|Study Terminated by Sponsor|15|||
129988542|NCT01901341|467921056|FG000|Overall Study|Withdrawal by Subject|1|||
129988543|NCT01901341|467921057|FG001|Overall Study|Withdrawal by Subject|1|||
129988544|NCT02966301|467921058|FG000|Overall Study|Death|2|||
129988545|NCT02966301|467921058|FG000|Overall Study|Withdrawal by Subject|1|||
129988546|NCT00370331|467921060|FG000|Overall Study|Adverse Event|4|||
129988547|NCT00370331|467921061|FG001|Overall Study|Adverse Event|13|||
129988548|NCT00370331|467921060|FG000|Overall Study|Withdrawal by Subject|2|||
130326511|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326512|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326513|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326514|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326515|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326516|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326517|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326518|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
130326519|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326520|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
130326521|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
130326522|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326523|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326524|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
130326525|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326526|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326527|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326528|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326529|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326530|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326531|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326532|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
130326533|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326534|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
130326535|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326536|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326537|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326538|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
130326539|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326540|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326541|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326542|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326543|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326544|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326545|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326546|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
130326547|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326548|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326549|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326550|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326551|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326552|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
130326553|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Transplant|0|||
130326554|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Transplant|0|||
130326555|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Transplant|0|||
130326556|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Transplant|0|||
130326557|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Transplant|0|||
130326558|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Transplant|0|||
130326559|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Transplant|0|||
130326560|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Transplant|0|||
130326561|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Transplant|0|||
130326562|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Transplant|4|||
130326563|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Transplant|2|||
130326564|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Transplant|0|||
130326565|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Transplant|0|||
130326566|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Transplant|0|||
130326567|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
129988549|NCT00370331|467921061|FG001|Overall Study|Withdrawal by Subject|4|||
129988550|NCT00370331|467921060|FG000|Overall Study|Lost to Follow-up|0|||
129988551|NCT00370331|467921061|FG001|Overall Study|Lost to Follow-up|3|||
129988552|NCT00370331|467921060|FG000|Overall Study|Lack of Efficacy|0|||
129988553|NCT00370331|467921061|FG001|Overall Study|Lack of Efficacy|1|||
129988554|NCT00370331|467921060|FG000|Overall Study|Non-compliance|0|||
130326568|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
130326569|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
130326570|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
130326571|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
130326572|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
130326573|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
129988555|NCT00370331|467921061|FG001|Overall Study|Non-compliance|1|||
129988556|NCT00370331|467921060|FG000|Overall Study|Protocol Violation|1|||
130326574|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
130326575|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
130326576|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
130326577|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
130326578|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
130326579|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
130326580|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
130326581|NCT02113982|469167792|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
130326582|NCT02113982|469167793|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
130326583|NCT02113982|469167794|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
130326584|NCT02113982|469167795|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
130326585|NCT02113982|469167796|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
130326586|NCT02113982|469167797|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
130326587|NCT02113982|469167798|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
130326588|NCT02113982|469167799|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
130326589|NCT02113982|469167800|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
130326590|NCT02113982|469167801|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
130326591|NCT02113982|469167802|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
130326592|NCT02113982|469167803|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
130326593|NCT02113982|469167804|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
130326594|NCT02113982|469167805|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
130326595|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326596|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326597|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326598|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326599|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326600|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326601|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326602|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326603|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326604|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326605|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326606|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
130326607|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326608|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
130326609|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326610|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326611|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326612|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326613|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326614|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326615|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326616|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326617|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326618|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326619|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326620|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
130326621|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326622|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
130326623|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326624|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326625|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326626|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326627|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326628|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326629|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326630|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326631|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326632|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326633|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326634|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
130326635|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326636|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
130326637|NCT02113982|469167792|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
129988557|NCT00370331|467921061|FG001|Overall Study|Protocol Violation|1|||
129988558|NCT01874431|467921062|FG000|Overall Study|Physician Decision|0|||
130326638|NCT02113982|469167793|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
130326639|NCT02113982|469167794|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
130326640|NCT02113982|469167795|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
130326641|NCT02113982|469167796|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
130326642|NCT02113982|469167797|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
130326643|NCT02113982|469167798|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
129988559|NCT01874431|467921063|FG001|Overall Study|Physician Decision|0|||
129988560|NCT01874431|467921064|FG002|Overall Study|Physician Decision|1|||
130326644|NCT02113982|469167799|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
130326645|NCT02113982|469167800|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
130326646|NCT02113982|469167801|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
130326647|NCT02113982|469167802|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
130326648|NCT02113982|469167803|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
130326649|NCT02113982|469167804|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
130326650|NCT02113982|469167805|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
130326651|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326652|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326653|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326654|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326655|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129988561|NCT01874431|467921065|FG003|Overall Study|Physician Decision|0|||
129988562|NCT01874431|467921066|FG004|Overall Study|Physician Decision|0|||
129988563|NCT01874431|467921067|FG005|Overall Study|Physician Decision|0|||
129988564|NCT01874431|467921068|FG006|Overall Study|Physician Decision|0|||
129988565|NCT01874431|467921069|FG007|Overall Study|Physician Decision|0|||
129988566|NCT01874431|467921062|FG000|Overall Study|Adverse Event|5|||
129988567|NCT01874431|467921063|FG001|Overall Study|Adverse Event|4|||
129988568|NCT01874431|467921064|FG002|Overall Study|Adverse Event|6|||
129988569|NCT01874431|467921065|FG003|Overall Study|Adverse Event|5|||
129988570|NCT01874431|467921066|FG004|Overall Study|Adverse Event|2|||
129988571|NCT01874431|467921067|FG005|Overall Study|Adverse Event|8|||
129988572|NCT01874431|467921068|FG006|Overall Study|Adverse Event|2|||
129988573|NCT01874431|467921069|FG007|Overall Study|Adverse Event|3|||
129988574|NCT01874431|467921062|FG000|Overall Study|Protocol Violation|1|||
129988575|NCT01874431|467921063|FG001|Overall Study|Protocol Violation|1|||
129988576|NCT01874431|467921064|FG002|Overall Study|Protocol Violation|1|||
129988577|NCT01874431|467921065|FG003|Overall Study|Protocol Violation|0|||
129988578|NCT01874431|467921066|FG004|Overall Study|Protocol Violation|3|||
129988579|NCT01874431|467921067|FG005|Overall Study|Protocol Violation|2|||
129988580|NCT01874431|467921068|FG006|Overall Study|Protocol Violation|1|||
129988581|NCT01874431|467921069|FG007|Overall Study|Protocol Violation|1|||
129988582|NCT01874431|467921062|FG000|Overall Study|Non-compliance|0|||
129988583|NCT01874431|467921063|FG001|Overall Study|Non-compliance|0|||
129988584|NCT01874431|467921064|FG002|Overall Study|Non-compliance|0|||
129988585|NCT01874431|467921065|FG003|Overall Study|Non-compliance|0|||
129988586|NCT01874431|467921066|FG004|Overall Study|Non-compliance|1|||
129988587|NCT01874431|467921067|FG005|Overall Study|Non-compliance|0|||
129988588|NCT01874431|467921068|FG006|Overall Study|Non-compliance|1|||
129988589|NCT01874431|467921069|FG007|Overall Study|Non-compliance|0|||
129988590|NCT01874431|467921062|FG000|Overall Study|Logistical difficulties|0|||
129988591|NCT01874431|467921063|FG001|Overall Study|Logistical difficulties|0|||
129988592|NCT01874431|467921064|FG002|Overall Study|Logistical difficulties|0|||
129988593|NCT01874431|467921065|FG003|Overall Study|Logistical difficulties|0|||
129988594|NCT01874431|467921066|FG004|Overall Study|Logistical difficulties|0|||
129988595|NCT01874431|467921067|FG005|Overall Study|Logistical difficulties|0|||
129988596|NCT01874431|467921068|FG006|Overall Study|Logistical difficulties|1|||
129988597|NCT01874431|467921069|FG007|Overall Study|Logistical difficulties|0|||
129988598|NCT01874431|467921062|FG000|Overall Study|Withdrawal by Subject|0|||
129988599|NCT01874431|467921063|FG001|Overall Study|Withdrawal by Subject|0|||
129988600|NCT01874431|467921064|FG002|Overall Study|Withdrawal by Subject|1|||
129988601|NCT01874431|467921065|FG003|Overall Study|Withdrawal by Subject|2|||
129988602|NCT01874431|467921066|FG004|Overall Study|Withdrawal by Subject|1|||
129988603|NCT01874431|467921067|FG005|Overall Study|Withdrawal by Subject|1|||
129988604|NCT01874431|467921068|FG006|Overall Study|Withdrawal by Subject|3|||
129988605|NCT01874431|467921069|FG007|Overall Study|Withdrawal by Subject|0|||
129988606|NCT01874431|467921062|FG000|Overall Study|Sponsor decision|0|||
129988607|NCT01874431|467921063|FG001|Overall Study|Sponsor decision|0|||
129988608|NCT01874431|467921064|FG002|Overall Study|Sponsor decision|0|||
129988609|NCT01874431|467921065|FG003|Overall Study|Sponsor decision|0|||
129988610|NCT01874431|467921066|FG004|Overall Study|Sponsor decision|1|||
130326656|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326657|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326658|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326659|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129988611|NCT01874431|467921067|FG005|Overall Study|Sponsor decision|0|||
129988612|NCT01874431|467921068|FG006|Overall Study|Sponsor decision|0|||
129988613|NCT01874431|467921069|FG007|Overall Study|Sponsor decision|0|||
130326660|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326661|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326662|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
130326663|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
129988614|NCT01874431|467921062|FG000|Overall Study|Lost to Follow-up|0|||
129988615|NCT01874431|467921063|FG001|Overall Study|Lost to Follow-up|0|||
129988616|NCT01874431|467921064|FG002|Overall Study|Lost to Follow-up|1|||
129988617|NCT01874431|467921065|FG003|Overall Study|Lost to Follow-up|0|||
130326664|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129988618|NCT01874431|467921066|FG004|Overall Study|Lost to Follow-up|0|||
129988619|NCT01874431|467921067|FG005|Overall Study|Lost to Follow-up|0|||
129988620|NCT01874431|467921068|FG006|Overall Study|Lost to Follow-up|0|||
129988621|NCT01874431|467921069|FG007|Overall Study|Lost to Follow-up|0|||
129988622|NCT01981473|467921070|FG000|Overall Study|Incorrect diagnosis of RA|0|||
129988623|NCT01981473|467921071|FG001|Overall Study|Incorrect diagnosis of RA|0|||
129988624|NCT01981473|467921072|FG002|Overall Study|Incorrect diagnosis of RA|1|||
129988625|NCT01981473|467921070|FG000|Overall Study|Received treatment for < 6 months|0|||
129988626|NCT01981473|467921071|FG001|Overall Study|Received treatment for < 6 months|0|||
129988627|NCT01981473|467921072|FG002|Overall Study|Received treatment for < 6 months|1|||
129988628|NCT01981473|467921070|FG000|Overall Study|Received treatment for >24 months|2|||
129988629|NCT01981473|467921071|FG001|Overall Study|Received treatment for >24 months|0|||
130326665|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326666|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326667|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326668|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326669|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326670|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326671|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326672|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326673|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326674|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326675|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326676|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
130326677|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
130326678|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
130326679|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326680|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326681|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326682|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326683|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326684|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326685|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326686|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326687|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326688|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326689|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326690|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
130326691|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
130326692|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
130326693|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326694|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326695|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326696|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326697|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326698|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326699|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326700|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326701|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326702|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326703|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326704|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
130326705|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
130326706|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
130326707|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326708|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326709|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326710|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326711|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326712|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326713|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326714|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326715|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326716|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326717|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129988630|NCT01981473|467921072|FG002|Overall Study|Received treatment for >24 months|6|||
129988631|NCT00545051|467921076|FG000|Overall Study|Adverse Event|7|||
130326718|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326719|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
130326720|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
130326721|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326722|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326723|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326724|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326725|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326726|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326727|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326728|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326729|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326730|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326731|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326732|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326733|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
130326734|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
130326735|NCT02113982|469167792|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326736|NCT02113982|469167793|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326737|NCT02113982|469167794|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326738|NCT02113982|469167795|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326739|NCT02113982|469167796|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326740|NCT02113982|469167797|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326741|NCT02113982|469167798|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326742|NCT02113982|469167799|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326743|NCT02113982|469167800|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326744|NCT02113982|469167801|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326745|NCT02113982|469167802|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326746|NCT02113982|469167803|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326747|NCT02113982|469167804|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
130326748|NCT02113982|469167805|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
130326749|NCT02085161|469167807|FG000|Overall Study|Not Treated|1|||
130326750|NCT02085161|469167808|FG001|Overall Study|Not Treated|0|||
130326751|NCT02085161|469167809|FG002|Overall Study|Not Treated|0|||
130326752|NCT02085161|469167810|FG003|Overall Study|Not Treated|0|||
130326753|NCT02085161|469167807|FG000|Overall Study|Adverse Event|8|||
130326754|NCT02085161|469167808|FG001|Overall Study|Adverse Event|5|||
130326755|NCT02085161|469167809|FG002|Overall Study|Adverse Event|4|||
130326756|NCT02085161|469167810|FG003|Overall Study|Adverse Event|5|||
130326757|NCT02085161|469167807|FG000|Overall Study|Protocol Violation|0|||
130326758|NCT02085161|469167808|FG001|Overall Study|Protocol Violation|1|||
130326759|NCT02085161|469167809|FG002|Overall Study|Protocol Violation|0|||
130326760|NCT02085161|469167810|FG003|Overall Study|Protocol Violation|1|||
130326761|NCT02085161|469167807|FG000|Overall Study|Withdrawal by Subject|2|||
130326762|NCT02085161|469167808|FG001|Overall Study|Withdrawal by Subject|4|||
130326763|NCT02085161|469167809|FG002|Overall Study|Withdrawal by Subject|0|||
130326764|NCT02085161|469167810|FG003|Overall Study|Withdrawal by Subject|3|||
130326765|NCT02085161|469167807|FG000|Overall Study|Other Reason|1|||
130326766|NCT02085161|469167808|FG001|Overall Study|Other Reason|0|||
130326767|NCT02085161|469167809|FG002|Overall Study|Other Reason|1|||
130326768|NCT02085161|469167810|FG003|Overall Study|Other Reason|1|||
130326769|NCT01936870|469167813|FG000|Overall Study|No Visit After Treatment|176|||
130326770|NCT01936870|469167813|FG000|Overall Study|Protocol Violation|12|||
130326771|NCT01936870|469167813|FG000|Overall Study|No Drug Administration|1|||
130326772|NCT00628108|469167824|FG000|Overall Study|Adverse Event|0|||
130326773|NCT00628108|469167825|FG001|Overall Study|Adverse Event|3|||
130326774|NCT00628108|469167824|FG000|Overall Study|Withdrawal by Subject|1|||
130326775|NCT00628108|469167825|FG001|Overall Study|Withdrawal by Subject|0|||
130326776|NCT03848832|469167826|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
130326777|NCT03848832|469167827|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
130326778|NCT03848832|469167828|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
129988632|NCT00545051|467921077|FG001|Overall Study|Adverse Event|3|||
130326779|NCT03848832|469167826|FG000|Overall Study|Withdrawal by Subject|0|||
129988633|NCT00545051|467921076|FG000|Overall Study|Death|1|||
129988634|NCT00545051|467921077|FG001|Overall Study|Death|0|||
130326780|NCT03848832|469167827|FG001|Overall Study|Withdrawal by Subject|0|||
129988635|NCT00545051|467921076|FG000|Overall Study|Violation of inclusion/exclusion|0|||
129988636|NCT00545051|467921077|FG001|Overall Study|Violation of inclusion/exclusion|2|||
130326781|NCT03848832|469167828|FG002|Overall Study|Withdrawal by Subject|1|||
130326782|NCT03848832|469167826|FG000|Overall Study|Withdrawal (Covid-19)|0|||
130326783|NCT03848832|469167827|FG001|Overall Study|Withdrawal (Covid-19)|2|||
129988637|NCT00545051|467921076|FG000|Overall Study|Protocol Violation|1|||
130326784|NCT03848832|469167828|FG002|Overall Study|Withdrawal (Covid-19)|0|||
130326785|NCT03848832|469167826|FG000|Overall Study|Physician Decision|2|||
130326786|NCT03848832|469167827|FG001|Overall Study|Physician Decision|1|||
130326787|NCT03848832|469167828|FG002|Overall Study|Physician Decision|3|||
130326788|NCT03848832|469167826|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
130326789|NCT03848832|469167827|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
130326790|NCT03848832|469167828|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
130326791|NCT03848832|469167826|FG000|Overall Study|Adverse Event|1|||
130326792|NCT03848832|469167827|FG001|Overall Study|Adverse Event|0|||
130326793|NCT03848832|469167828|FG002|Overall Study|Adverse Event|0|||
130326794|NCT01760733|469167829|FG000|Waiting List|Death|18|||
130326795|NCT01760733|469167829|FG000|Waiting List|Removed from waiting list|41|||
130326796|NCT01760733|469167829|FG000|Waiting List|Not received a transplant yet|13|||
130326797|NCT01760733|469167829|FG000|Transplanted|Not reached 10 years post transplant|184|||
130326798|NCT01760733|469167829|FG000|Transplanted|Death|26|||
130326799|NCT01760733|469167829|FG000|Transplanted|Graft loss|7|||
130326800|NCT02404025|469167831|FG000|Overall Study|Adverse Event|1|||
130326801|NCT02404025|469167831|FG000|Overall Study|Lack of Efficacy|3|||
130326802|NCT03938259|469167833|FG000|Overall Study|unable to establish baseline for ventilation|1|||
130326803|NCT03938259|469167834|FG001|Overall Study|unable to establish baseline for ventilation|1|||
130326804|NCT01746901|469167837|FG000|Naloxone Challenge Phase|Adverse Event|2|||
130326805|NCT01746901|469167838|FG001|Naloxone Challenge Phase|Adverse Event|0|||
130326806|NCT01746901|469167839|FG002|Naloxone Challenge Phase|Adverse Event|0|||
130326807|NCT01746901|469167840|FG003|Naloxone Challenge Phase|Adverse Event|0|||
130326808|NCT01746901|469167841|FG004|Naloxone Challenge Phase|Adverse Event|0|||
130326809|NCT01746901|469167842|FG005|Naloxone Challenge Phase|Adverse Event|0|||
130326810|NCT01746901|469167843|FG006|Naloxone Challenge Phase|Adverse Event|0|||
130326811|NCT01746901|469167844|FG007|Naloxone Challenge Phase|Adverse Event|0|||
130326812|NCT01746901|469167845|FG008|Naloxone Challenge Phase|Adverse Event|0|||
130326813|NCT01746901|469167837|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
130326814|NCT01746901|469167838|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326815|NCT01746901|469167839|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326816|NCT01746901|469167840|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326817|NCT01746901|469167841|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326818|NCT01746901|469167842|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326819|NCT01746901|469167843|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326820|NCT01746901|469167844|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326821|NCT01746901|469167845|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
130326822|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326823|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
130326824|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326825|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326826|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326827|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326828|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326829|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326830|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130326831|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326832|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
130326833|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
130326834|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129883675|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
129883676|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
129883677|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
129883678|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
129883679|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
129883680|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
129883681|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
130326835|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326836|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326837|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326838|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326839|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
130326840|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326841|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
130326842|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
130326843|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326844|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326845|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326846|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326847|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326848|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
130326849|NCT01746901|469167837|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326850|NCT01746901|469167838|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
130326851|NCT01746901|469167839|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
130326852|NCT01746901|469167840|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326853|NCT01746901|469167841|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326854|NCT01746901|469167842|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326855|NCT01746901|469167843|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326856|NCT01746901|469167844|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326857|NCT01746901|469167845|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130326858|NCT01746901|469167837|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
130326859|NCT01746901|469167838|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
130326860|NCT01746901|469167839|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
129988638|NCT00545051|467921077|FG001|Overall Study|Protocol Violation|0|||
129988639|NCT00545051|467921076|FG000|Overall Study|Withdrawal by Subject|0|||
129988640|NCT00545051|467921077|FG001|Overall Study|Withdrawal by Subject|1|||
129988641|NCT00545051|467921076|FG000|Overall Study|Administrative reasons|0|||
129988642|NCT00545051|467921077|FG001|Overall Study|Administrative reasons|1|||
129988643|NCT01888900|467921078|FG000|Overall Study|failed treatment|0|||
129988644|NCT01888900|467921079|FG001|Overall Study|failed treatment|2|||
129988645|NCT03271021|467921083|FG000|Overall Study|Adverse Event|3|||
129988646|NCT03271021|467921084|FG001|Overall Study|Adverse Event|2|||
129988647|NCT03271021|467921083|FG000|Overall Study|Withdrawal by Subject|36|||
129988648|NCT03271021|467921084|FG001|Overall Study|Withdrawal by Subject|53|||
129988649|NCT03271021|467921083|FG000|Overall Study|Lost to Follow-up|34|||
129988650|NCT03271021|467921084|FG001|Overall Study|Lost to Follow-up|39|||
129988651|NCT03271021|467921083|FG000|Overall Study|Protocol Violation|6|||
129988652|NCT03271021|467921084|FG001|Overall Study|Protocol Violation|4|||
129988653|NCT03271021|467921083|FG000|Overall Study|Abnormal Lab Results|1|||
129988654|NCT03271021|467921084|FG001|Overall Study|Abnormal Lab Results|0|||
129988655|NCT03271021|467921083|FG000|Overall Study|Miscellaneous|9|||
129988656|NCT03271021|467921084|FG001|Overall Study|Miscellaneous|8|||
129988657|NCT02257567|467921091|FG000|Overall Study|Adverse Event|0|||
129988658|NCT02257567|467921092|FG001|Overall Study|Adverse Event|0|||
129988659|NCT02257567|467921093|FG002|Overall Study|Adverse Event|0|||
129988660|NCT02257567|467921094|FG003|Overall Study|Adverse Event|1|||
129988661|NCT02257567|467921095|FG004|Overall Study|Adverse Event|1|||
129988662|NCT02257567|467921096|FG005|Overall Study|Adverse Event|0|||
129988663|NCT02257567|467921097|FG006|Overall Study|Adverse Event|0|||
129988664|NCT02257567|467921098|FG007|Overall Study|Adverse Event|0|||
129988665|NCT02257567|467921099|FG008|Overall Study|Adverse Event|1|||
129988666|NCT02257567|467921100|FG009|Overall Study|Adverse Event|0|||
129988667|NCT02257567|467921101|FG010|Overall Study|Adverse Event|0|||
129988668|NCT02257567|467921091|FG000|Overall Study|Death|2|||
129988669|NCT02257567|467921092|FG001|Overall Study|Death|2|||
129988670|NCT02257567|467921093|FG002|Overall Study|Death|2|||
129988671|NCT02257567|467921094|FG003|Overall Study|Death|4|||
129988672|NCT02257567|467921095|FG004|Overall Study|Death|15|||
129988673|NCT02257567|467921096|FG005|Overall Study|Death|11|||
129988674|NCT02257567|467921097|FG006|Overall Study|Death|26|||
129988675|NCT02257567|467921098|FG007|Overall Study|Death|30|||
129988676|NCT02257567|467921099|FG008|Overall Study|Death|2|||
129988677|NCT02257567|467921100|FG009|Overall Study|Death|18|||
129988678|NCT02257567|467921101|FG010|Overall Study|Death|65|||
129988679|NCT02257567|467921091|FG000|Overall Study|Lost to Follow-up|0|||
129988680|NCT02257567|467921092|FG001|Overall Study|Lost to Follow-up|0|||
129988681|NCT02257567|467921093|FG002|Overall Study|Lost to Follow-up|0|||
129988682|NCT02257567|467921094|FG003|Overall Study|Lost to Follow-up|0|||
129988683|NCT02257567|467921095|FG004|Overall Study|Lost to Follow-up|2|||
129988684|NCT02257567|467921096|FG005|Overall Study|Lost to Follow-up|2|||
129988685|NCT02257567|467921097|FG006|Overall Study|Lost to Follow-up|0|||
129988686|NCT02257567|467921098|FG007|Overall Study|Lost to Follow-up|0|||
129988687|NCT02257567|467921099|FG008|Overall Study|Lost to Follow-up|0|||
129988688|NCT02257567|467921100|FG009|Overall Study|Lost to Follow-up|1|||
129988689|NCT02257567|467921101|FG010|Overall Study|Lost to Follow-up|1|||
130326861|NCT01746901|469167840|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
129988690|NCT02257567|467921091|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988691|NCT02257567|467921092|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988692|NCT02257567|467921093|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130326862|NCT01746901|469167841|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
129988693|NCT02257567|467921094|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988694|NCT02257567|467921095|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
130326863|NCT01746901|469167842|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
130326864|NCT01746901|469167843|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
130326865|NCT01746901|469167844|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
130326866|NCT01746901|469167845|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
130326867|NCT01746901|469167837|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326868|NCT01746901|469167838|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326869|NCT01746901|469167839|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326870|NCT01746901|469167840|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326871|NCT01746901|469167841|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326872|NCT01746901|469167842|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326873|NCT01746901|469167843|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326874|NCT01746901|469167844|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
130326875|NCT01746901|469167845|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
130326876|NCT01746901|469167837|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326877|NCT01746901|469167838|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326878|NCT01746901|469167839|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326879|NCT01746901|469167840|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326880|NCT01746901|469167841|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326881|NCT01746901|469167842|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
130326882|NCT01746901|469167843|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
130326883|NCT01746901|469167844|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326884|NCT01746901|469167845|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
130326885|NCT01746901|469167837|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326886|NCT01746901|469167838|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326887|NCT01746901|469167839|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326888|NCT01746901|469167840|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
130326889|NCT01746901|469167841|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326890|NCT01746901|469167842|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326891|NCT01746901|469167843|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326892|NCT01746901|469167844|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326893|NCT01746901|469167845|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
130326894|NCT01746901|469167837|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326895|NCT01746901|469167838|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326896|NCT01746901|469167839|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326897|NCT01746901|469167840|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326898|NCT01746901|469167841|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326899|NCT01746901|469167842|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
130326900|NCT01746901|469167843|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326901|NCT01746901|469167844|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
130326902|NCT01746901|469167845|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
130326903|NCT01746901|469167837|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326904|NCT01746901|469167838|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326905|NCT01746901|469167839|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326906|NCT01746901|469167840|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326907|NCT01746901|469167841|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326908|NCT01746901|469167842|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326909|NCT01746901|469167843|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
130326910|NCT01746901|469167844|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
130326911|NCT01746901|469167845|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
130326912|NCT03594110|469167849|FG000|Interventional Part|Participant concerned about study treatment|23|||
130326913|NCT03594110|469167850|FG001|Interventional Part|Participant concerned about study treatment|28|||
130326914|NCT03594110|469167849|FG000|Interventional Part|Doctor advice|38|||
130326915|NCT03594110|469167850|FG001|Interventional Part|Doctor advice|40|||
130326916|NCT03594110|469167849|FG000|Interventional Part|Participants' wish|89|||
130326917|NCT03594110|469167850|FG001|Interventional Part|Participants' wish|68|||
130326918|NCT03594110|469167849|FG000|Interventional Part|Adverse event-non-fatal events|119|||
130326919|NCT03594110|469167850|FG001|Interventional Part|Adverse event-non-fatal events|116|||
130326920|NCT03594110|469167849|FG000|Interventional Part|Study drug stopped, reason missing|336|||
130326921|NCT03594110|469167850|FG001|Interventional Part|Study drug stopped, reason missing|294|||
130326922|NCT03594110|469167849|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
130326923|NCT03594110|469167850|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
130326924|NCT03594110|469167849|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
130326925|NCT03594110|469167850|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
130326926|NCT03594110|469167849|FG000|Interventional Part|Contraindicated drug started|32|||
130326927|NCT03594110|469167850|FG001|Interventional Part|Contraindicated drug started|18|||
130326928|NCT03594110|469167849|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
130326929|NCT03594110|469167850|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
130326930|NCT03594110|469167849|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
130326931|NCT03594110|469167850|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
130326932|NCT03594110|469167849|FG000|Non-interventional Part|Withdrawal by Subject|3|||
130326933|NCT03594110|469167850|FG001|Non-interventional Part|Withdrawal by Subject|4|||
130326934|NCT03594110|469167849|FG000|Non-interventional Part|Lost to Follow-up|45|||
130326935|NCT03594110|469167850|FG001|Non-interventional Part|Lost to Follow-up|41|||
130326936|NCT05029362|469167851|FG000|Overall Study|Lost to Follow-up|9|||
130326937|NCT00684021|469167857|FG000|Overall Study|MRI Contraindicated|1|||
130326938|NCT00684021|469167858|FG001|Overall Study|MRI Contraindicated|1|||
130326939|NCT00684021|469167859|FG002|Overall Study|MRI Contraindicated|1|||
130326940|NCT00684021|469167860|FG003|Overall Study|MRI Contraindicated|0|||
130326941|NCT00684021|469167857|FG000|Overall Study|MRI not performed|0|||
130326942|NCT00684021|469167858|FG001|Overall Study|MRI not performed|1|||
130326943|NCT00684021|469167859|FG002|Overall Study|MRI not performed|1|||
130326944|NCT00684021|469167860|FG003|Overall Study|MRI not performed|2|||
130326945|NCT00684021|469167857|FG000|Overall Study|Death|1|||
130326946|NCT00684021|469167858|FG001|Overall Study|Death|0|||
130326947|NCT00684021|469167859|FG002|Overall Study|Death|0|||
130326948|NCT00684021|469167860|FG003|Overall Study|Death|0|||
130326949|NCT04041414|469167861|FG000|Overall Study|Lost to Follow-up|1|||
130326950|NCT04041414|469167862|FG001|Overall Study|Lost to Follow-up|2|||
130326951|NCT02900378|469167863|FG000|Randomization (Visit 2)|Adverse Event|14|||
130326952|NCT02900378|469167864|FG001|Randomization (Visit 2)|Adverse Event|11|||
130326953|NCT02900378|469167863|FG000|Randomization (Visit 2)|Death|1|||
130326954|NCT02900378|469167864|FG001|Randomization (Visit 2)|Death|4|||
130326955|NCT02900378|469167863|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
130326956|NCT02900378|469167864|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
130326957|NCT02900378|469167863|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
130326958|NCT02900378|469167864|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
130326959|NCT02900378|469167863|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
130326960|NCT02900378|469167864|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
130326961|NCT02900378|469167863|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
130326962|NCT02900378|469167864|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
130326963|NCT02900378|469167863|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
130326964|NCT02900378|469167864|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
130326965|NCT01690143|469167868|FG000|Overall Study|Withdrawal by Subject|1|||
130326966|NCT01409707|469167877|FG000|Overall Study|Withdrawal by Subject|5|||
130326967|NCT01409707|469167878|FG001|Overall Study|Withdrawal by Subject|17|||
130326968|NCT01409707|469167879|FG002|Overall Study|Withdrawal by Subject|16|||
130326969|NCT01658436|469167880|FG000|Overall Study|Adverse Event|6|||
130326970|NCT01658436|469167881|FG001|Overall Study|Adverse Event|5|||
130326971|NCT01658436|469167880|FG000|Overall Study|Physician Decision|1|||
130326972|NCT01658436|469167881|FG001|Overall Study|Physician Decision|0|||
130326973|NCT01658436|469167880|FG000|Overall Study|Progressive disease|12|||
130326974|NCT01658436|469167881|FG001|Overall Study|Progressive disease|4|||
130326975|NCT01658436|469167880|FG000|Overall Study|Study terminated by sponsor|0|||
130326976|NCT01658436|469167881|FG001|Overall Study|Study terminated by sponsor|1|||
130326977|NCT01658436|469167880|FG000|Overall Study|Subject/guardian decision|0|||
130326978|NCT01658436|469167881|FG001|Overall Study|Subject/guardian decision|1|||
130326979|NCT01658436|469167880|FG000|Overall Study|Death|1|||
130326980|NCT01658436|469167881|FG001|Overall Study|Death|0|||
130326981|NCT00686712|469167882|FG000|Overall Study|Protocol Violation|8|||
130326982|NCT00686712|469167883|FG001|Overall Study|Protocol Violation|8|||
130326983|NCT00686712|469167884|FG002|Overall Study|Protocol Violation|10|||
130326984|NCT00686712|469167882|FG000|Overall Study|Lost to Follow-up|1|||
130326985|NCT00686712|469167883|FG001|Overall Study|Lost to Follow-up|2|||
130326986|NCT00686712|469167884|FG002|Overall Study|Lost to Follow-up|3|||
130326987|NCT00686712|469167882|FG000|Overall Study|Adverse Event|1|||
130326988|NCT00686712|469167883|FG001|Overall Study|Adverse Event|1|||
130326989|NCT00686712|469167884|FG002|Overall Study|Adverse Event|0|||
130326990|NCT03987503|469167885|FG000|Overall Study|Lost to Follow-up|20|||
130326991|NCT03987503|469167885|FG000|Overall Study|Withdrawal by Subject|2|||
130326992|NCT01929317|469167886|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
130326993|NCT01929317|469167887|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
130326994|NCT01929317|469167886|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
130326995|NCT01929317|469167887|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
130326996|NCT01929317|469167886|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
130326997|NCT01929317|469167887|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
129988695|NCT02257567|467921096|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
130326998|NCT01929317|469167886|FG000|Long-term Phase|Adverse Event|5|||
130326999|NCT01929317|469167887|FG001|Long-term Phase|Adverse Event|1|||
130327000|NCT01929317|469167886|FG000|Long-term Phase|Physician Decision|3|||
130327001|NCT01929317|469167887|FG001|Long-term Phase|Physician Decision|0|||
129988696|NCT02257567|467921097|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
129988697|NCT02257567|467921098|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988698|NCT02257567|467921099|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988699|NCT02257567|467921100|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988700|NCT02257567|467921101|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988701|NCT02257567|467921091|FG000|Overall Study|Physician Decision|0|||
129988702|NCT02257567|467921092|FG001|Overall Study|Physician Decision|0|||
129988703|NCT02257567|467921093|FG002|Overall Study|Physician Decision|0|||
129988704|NCT02257567|467921094|FG003|Overall Study|Physician Decision|0|||
129988705|NCT02257567|467921095|FG004|Overall Study|Physician Decision|0|||
129988706|NCT02257567|467921096|FG005|Overall Study|Physician Decision|0|||
129988707|NCT02257567|467921097|FG006|Overall Study|Physician Decision|0|||
129988708|NCT02257567|467921098|FG007|Overall Study|Physician Decision|2|||
129988709|NCT02257567|467921099|FG008|Overall Study|Physician Decision|0|||
129988710|NCT02257567|467921100|FG009|Overall Study|Physician Decision|1|||
129988711|NCT02257567|467921101|FG010|Overall Study|Physician Decision|0|||
129988712|NCT02257567|467921091|FG000|Overall Study|Withdrawal by Subject|0|||
129988713|NCT02257567|467921092|FG001|Overall Study|Withdrawal by Subject|0|||
129988714|NCT02257567|467921093|FG002|Overall Study|Withdrawal by Subject|2|||
129988715|NCT02257567|467921094|FG003|Overall Study|Withdrawal by Subject|0|||
129988716|NCT02257567|467921095|FG004|Overall Study|Withdrawal by Subject|0|||
129988717|NCT02257567|467921096|FG005|Overall Study|Withdrawal by Subject|6|||
129988718|NCT02257567|467921097|FG006|Overall Study|Withdrawal by Subject|6|||
129988719|NCT02257567|467921098|FG007|Overall Study|Withdrawal by Subject|6|||
129988720|NCT02257567|467921099|FG008|Overall Study|Withdrawal by Subject|1|||
129988721|NCT02257567|467921100|FG009|Overall Study|Withdrawal by Subject|1|||
129988722|NCT02257567|467921101|FG010|Overall Study|Withdrawal by Subject|10|||
129988723|NCT01065844|467921108|FG000|Overall Study|Adverse Event|5|||
129988724|NCT00577473|467921111|FG000|Overall Study|Protocol Violation|1|||
129988725|NCT00577473|467921112|FG001|Overall Study|Protocol Violation|4|||
129988726|NCT00577473|467921111|FG000|Overall Study|Adverse Event|8|||
129988727|NCT00577473|467921112|FG001|Overall Study|Adverse Event|5|||
129988728|NCT00577473|467921111|FG000|Overall Study|Withdrawal by Subject|2|||
129988729|NCT00577473|467921112|FG001|Overall Study|Withdrawal by Subject|6|||
129988730|NCT00577473|467921111|FG000|Overall Study|Physician Decision|2|||
129988731|NCT00577473|467921112|FG001|Overall Study|Physician Decision|2|||
129988732|NCT00577473|467921111|FG000|Overall Study|Lack of Efficacy|8|||
129988733|NCT00577473|467921112|FG001|Overall Study|Lack of Efficacy|7|||
129988734|NCT02884908|467921115|FG000|Overall Study|Lost to Follow-up|13|||
129988735|NCT02884908|467921116|FG001|Overall Study|Lost to Follow-up|18|||
129988736|NCT02084056|467921127|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
129988737|NCT02084056|467921128|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129988738|NCT02084056|467921129|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129988739|NCT02084056|467921130|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129988740|NCT02084056|467921127|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
129988741|NCT02084056|467921128|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129988742|NCT02084056|467921129|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129988743|NCT02084056|467921130|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129988744|NCT02413333|467921132|FG000|Period 1|Adverse Event|1|||
129988745|NCT02413333|467921133|FG001|Period 1|Adverse Event|0|||
129988746|NCT02413333|467921132|FG000|Period 1|Reason Not Specified|0|||
129988747|NCT02413333|467921133|FG001|Period 1|Reason Not Specified|1|||
129988748|NCT02413333|467921132|FG000|Period 2|Protocol Deviation|1|||
129988749|NCT02413333|467921133|FG001|Period 2|Protocol Deviation|0|||
129988750|NCT00709852|467921134|FG000|Period 1|Adverse Event|2|||
129988751|NCT00709852|467921135|FG001|Period 1|Adverse Event|0|||
129988752|NCT00709852|467921134|FG000|Period 1|Withdrawal by Subject|4|||
129988753|NCT00709852|467921135|FG001|Period 1|Withdrawal by Subject|2|||
129988754|NCT00709852|467921134|FG000|Period 1|Protocol Violation|1|||
129988755|NCT00709852|467921135|FG001|Period 1|Protocol Violation|0|||
129988756|NCT00709852|467921134|FG000|Period 1|Defective scanner|0|||
129988757|NCT00709852|467921135|FG001|Period 1|Defective scanner|1|||
129988758|NCT00709852|467921134|FG000|Period 1|Lost to Follow-up|1|||
129988759|NCT00709852|467921135|FG001|Period 1|Lost to Follow-up|0|||
129988760|NCT00709852|467921134|FG000|Period 2|Protocol Violation|4|||
129988761|NCT00709852|467921135|FG001|Period 2|Protocol Violation|1|||
129988762|NCT00709852|467921134|FG000|Period 2|Adverse Event|1|||
129988763|NCT00709852|467921135|FG001|Period 2|Adverse Event|1|||
129988764|NCT00709852|467921134|FG000|Period 2|Lost to Follow-up|1|||
129988765|NCT00709852|467921135|FG001|Period 2|Lost to Follow-up|0|||
129988766|NCT00709852|467921134|FG000|Period 2|No 72-hour follow-up|3|||
129988767|NCT00709852|467921135|FG001|Period 2|No 72-hour follow-up|0|||
129988768|NCT02951767|467921136|FG000|Overall Study|Study Terminated By Sponsor|9|||
130327002|NCT01929317|469167886|FG000|Long-term Phase|Withdrawal by Subject|4|||
130327003|NCT01929317|469167887|FG001|Long-term Phase|Withdrawal by Subject|0|||
130327004|NCT01929317|469167886|FG000|Long-term Phase|Protocol Violation|1|||
130327005|NCT01929317|469167887|FG001|Long-term Phase|Protocol Violation|0|||
130327006|NCT01929317|469167886|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
130327007|NCT01929317|469167887|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
130327008|NCT01929317|469167886|FG000|Long-term Phase|Study Closed/Terminated|5|||
130327009|NCT01929317|469167887|FG001|Long-term Phase|Study Closed/Terminated|3|||
130327010|NCT01523756|469167888|FG000|Baseline Period|Adverse Event|0|||
130327011|NCT01523756|469167889|FG001|Baseline Period|Adverse Event|1|||
130327012|NCT01523756|469167888|FG000|Test Period 1|Adverse Event|1|||
130327013|NCT01523756|469167889|FG001|Test Period 1|Adverse Event|0|||
130327014|NCT01523756|469167888|FG000|Test Period 2|Withdrawal by Subject|0|||
130327015|NCT01523756|469167889|FG001|Test Period 2|Withdrawal by Subject|1|||
130327016|NCT00515619|469167890|FG000|Overall Study|Adverse Event|34|||
130327017|NCT00515619|469167890|FG000|Overall Study|Lack of Efficacy|92|||
130327018|NCT00515619|469167890|FG000|Overall Study|Withdrawal by Subject|66|||
130327019|NCT00515619|469167890|FG000|Overall Study|Protocol Violation|3|||
130327020|NCT00515619|469167890|FG000|Overall Study|Lost to Follow-up|4|||
130327021|NCT00515619|469167890|FG000|Overall Study|Unsatisfactory compliance|6|||
130327022|NCT00515619|469167890|FG000|Overall Study|Other: Site discontinuing trials|2|||
130327023|NCT00515619|469167890|FG000|Overall Study|Other: Subject cannot attend visits|2|||
130327024|NCT00515619|469167890|FG000|Overall Study|Other: Subject required surgery|1|||
130327025|NCT00515619|469167890|FG000|Overall Study|Other: Subject moved to another country|1|||
129988769|NCT02951767|467921136|FG000|Overall Study|Withdrawal by Subject|11|||
130327026|NCT00515619|469167890|FG000|Overall Study|Other: Investigator decision|1|||
130327027|NCT00515619|469167890|FG000|Overall Study|Other: Subject became pregnant|1|||
130327028|NCT00515619|469167890|FG000|Overall Study|Other: Request from sponsor|1|||
130327029|NCT00515619|469167890|FG000|Overall Study|Other: Drug available on license|1|||
130327030|NCT00515619|469167890|FG000|Overall Study|Other: Subject interested in other AED|1|||
130327031|NCT01467960|469167891|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130327032|NCT01467960|469167892|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130327033|NCT01467960|469167893|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
130327034|NCT01467960|469167894|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130327035|NCT01467960|469167895|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130327036|NCT01467960|469167896|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
130327037|NCT01588522|469167897|FG000|Overall Study|Withdrawal by Subject|1|||
130327038|NCT01588522|469167898|FG001|Overall Study|Withdrawal by Subject|5|||
130327039|NCT01588522|469167899|FG002|Overall Study|Withdrawal by Subject|3|||
130327040|NCT01588522|469167900|FG003|Overall Study|Withdrawal by Subject|1|||
130327041|NCT01588522|469167901|FG004|Overall Study|Withdrawal by Subject|2|||
130327042|NCT01588522|469167902|FG005|Overall Study|Withdrawal by Subject|0|||
129988770|NCT02951767|467921136|FG000|Overall Study|Death|96|||
129988771|NCT02951767|467921136|FG000|Overall Study|Lost to Follow-up|2|||
129988772|NCT02951767|467921136|FG000|Overall Study|Physician Decision|1|||
129988773|NCT01048671|467921137|FG000|Overall Study|Protocol Violation|0|||
129988774|NCT01048671|467921138|FG001|Overall Study|Protocol Violation|1|||
129988775|NCT01048671|467921139|FG002|Overall Study|Protocol Violation|1|||
129988776|NCT03814187|467921140|FG000|Overall Study|Sponsor's Administrative Decision|0|||
129988777|NCT03814187|467921141|FG001|Overall Study|Sponsor's Administrative Decision|0|||
129988778|NCT03814187|467921142|FG002|Overall Study|Sponsor's Administrative Decision|272|||
129988779|NCT03814187|467921140|FG000|Overall Study|Death|80|||
129988780|NCT03814187|467921141|FG001|Overall Study|Death|81|||
129988781|NCT03814187|467921142|FG002|Overall Study|Death|4|||
129988782|NCT03814187|467921140|FG000|Overall Study|Withdrew Consent|77|||
129988783|NCT03814187|467921141|FG001|Overall Study|Withdrew Consent|78|||
129988784|NCT03814187|467921142|FG002|Overall Study|Withdrew Consent|2|||
129988785|NCT03814187|467921140|FG000|Overall Study|Lost to Follow-up|47|||
129988786|NCT03814187|467921141|FG001|Overall Study|Lost to Follow-up|52|||
129988787|NCT03814187|467921142|FG002|Overall Study|Lost to Follow-up|1|||
129988788|NCT03814187|467921140|FG000|Overall Study|Adverse Event|22|||
129988789|NCT03814187|467921141|FG001|Overall Study|Adverse Event|23|||
129988790|NCT03814187|467921142|FG002|Overall Study|Adverse Event|0|||
129988791|NCT03814187|467921140|FG000|Overall Study|Physician Decision|7|||
130327043|NCT01588522|469167897|FG000|Overall Study|Lack of Efficacy|0|||
129988792|NCT03814187|467921141|FG001|Overall Study|Physician Decision|4|||
129988793|NCT03814187|467921142|FG002|Overall Study|Physician Decision|2|||
129988794|NCT03814187|467921140|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
129988795|NCT03814187|467921141|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
130327044|NCT01588522|469167898|FG001|Overall Study|Lack of Efficacy|0|||
130327045|NCT01588522|469167899|FG002|Overall Study|Lack of Efficacy|0|||
130327046|NCT01588522|469167900|FG003|Overall Study|Lack of Efficacy|0|||
130327047|NCT01588522|469167901|FG004|Overall Study|Lack of Efficacy|1|||
130327048|NCT01588522|469167902|FG005|Overall Study|Lack of Efficacy|0|||
130327049|NCT01588522|469167897|FG000|Overall Study|Adverse Event|0|||
130327050|NCT01588522|469167898|FG001|Overall Study|Adverse Event|0|||
130327051|NCT01588522|469167899|FG002|Overall Study|Adverse Event|0|||
130215528|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215529|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215530|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215531|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215532|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215533|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215534|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215535|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215536|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215537|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215538|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215539|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215540|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215541|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215542|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215543|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215544|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215545|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215546|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215547|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215548|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215549|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215550|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
130215551|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
130215552|NCT05052697|468751740|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215553|NCT05052697|468751741|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215554|NCT05052697|468751742|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215555|NCT05052697|468751743|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215556|NCT05052697|468751744|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215557|NCT05052697|468751745|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215558|NCT05052697|468751746|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215559|NCT05052697|468751747|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215560|NCT05052697|468751748|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215561|NCT05052697|468751749|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215562|NCT05052697|468751750|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215563|NCT05052697|468751751|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215564|NCT05052697|468751752|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215565|NCT05052697|468751753|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215566|NCT05052697|468751754|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215567|NCT05052697|468751755|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215568|NCT05052697|468751756|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215569|NCT05052697|468751757|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215570|NCT05052697|468751758|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215571|NCT05052697|468751759|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215572|NCT05052697|468751760|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215573|NCT05052697|468751761|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215574|NCT05052697|468751762|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215575|NCT05052697|468751763|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215576|NCT05052697|468751764|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215577|NCT05052697|468751765|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215578|NCT05052697|468751766|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215579|NCT05052697|468751767|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215580|NCT05052697|468751768|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
130215581|NCT05052697|468751769|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
130215582|NCT05052697|468751770|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
130215583|NCT05052697|468751771|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215584|NCT05052697|468751772|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215585|NCT05052697|468751773|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
130215586|NCT01289574|468751774|FG000|Overall Study|Lack of Efficacy|4|||
130215587|NCT01289574|468751775|FG001|Overall Study|Lack of Efficacy|0|||
130215588|NCT01289574|468751776|FG002|Overall Study|Lack of Efficacy|1|||
130215589|NCT01289574|468751774|FG000|Overall Study|Lost to Follow-up|2|||
130215590|NCT01289574|468751775|FG001|Overall Study|Lost to Follow-up|0|||
130215591|NCT01289574|468751776|FG002|Overall Study|Lost to Follow-up|1|||
130215592|NCT01289574|468751774|FG000|Overall Study|Withdrawal by Subject|1|||
130215593|NCT01289574|468751775|FG001|Overall Study|Withdrawal by Subject|1|||
130215594|NCT01289574|468751776|FG002|Overall Study|Withdrawal by Subject|1|||
130327052|NCT01588522|469167900|FG003|Overall Study|Adverse Event|1|||
130327053|NCT01588522|469167901|FG004|Overall Study|Adverse Event|0|||
130327054|NCT01588522|469167902|FG005|Overall Study|Adverse Event|0|||
130327055|NCT01588522|469167897|FG000|Overall Study|Grade 2 alopecia|1|||
130327056|NCT01588522|469167898|FG001|Overall Study|Grade 2 alopecia|0|||
130327057|NCT01588522|469167899|FG002|Overall Study|Grade 2 alopecia|0|||
130327058|NCT01588522|469167900|FG003|Overall Study|Grade 2 alopecia|0|||
130327059|NCT01588522|469167901|FG004|Overall Study|Grade 2 alopecia|0|||
130327060|NCT01588522|469167902|FG005|Overall Study|Grade 2 alopecia|0|||
130327061|NCT01588522|469167897|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
130327062|NCT01588522|469167898|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
130327063|NCT01588522|469167899|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
130327064|NCT01588522|469167900|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
130327065|NCT01588522|469167901|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
130327066|NCT01588522|469167902|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
130327067|NCT01588522|469167897|FG000|Overall Study|Taken off taxane-based regimen|0|||
130327068|NCT01588522|469167898|FG001|Overall Study|Taken off taxane-based regimen|0|||
130327069|NCT01588522|469167899|FG002|Overall Study|Taken off taxane-based regimen|0|||
130327070|NCT01588522|469167900|FG003|Overall Study|Taken off taxane-based regimen|1|||
130327071|NCT01588522|469167901|FG004|Overall Study|Taken off taxane-based regimen|0|||
130327072|NCT01588522|469167902|FG005|Overall Study|Taken off taxane-based regimen|0|||
130327073|NCT01588522|469167897|FG000|Overall Study|Did not initiate chemotherapy|0|||
130327074|NCT01588522|469167898|FG001|Overall Study|Did not initiate chemotherapy|0|||
130327075|NCT01588522|469167899|FG002|Overall Study|Did not initiate chemotherapy|0|||
130327076|NCT01588522|469167900|FG003|Overall Study|Did not initiate chemotherapy|0|||
129988796|NCT03814187|467921142|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
130327077|NCT01588522|469167901|FG004|Overall Study|Did not initiate chemotherapy|1|||
130327078|NCT01588522|469167902|FG005|Overall Study|Did not initiate chemotherapy|0|||
130327079|NCT04949490|469167905|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327080|NCT04949490|469167906|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327081|NCT04949490|469167907|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327082|NCT04949490|469167908|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
130327083|NCT04949490|469167909|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327084|NCT04949490|469167910|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
130327085|NCT04949490|469167905|FG000|Group A and Group B|Withdrawal by Subject|0|||
130327086|NCT04949490|469167906|FG001|Group A and Group B|Withdrawal by Subject|0|||
130327087|NCT04949490|469167907|FG002|Group A and Group B|Withdrawal by Subject|1|||
130327088|NCT04949490|469167908|FG003|Group A and Group B|Withdrawal by Subject|0|||
130327089|NCT04949490|469167909|FG004|Group A and Group B|Withdrawal by Subject|0|||
130327090|NCT04949490|469167910|FG005|Group A and Group B|Withdrawal by Subject|0|||
130327091|NCT04949490|469167905|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327092|NCT04949490|469167906|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327093|NCT04949490|469167907|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327094|NCT04949490|469167908|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327095|NCT04949490|469167909|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
130327096|NCT04949490|469167910|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
130327097|NCT04949490|469167905|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327098|NCT04949490|469167906|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327099|NCT04949490|469167907|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327100|NCT04949490|469167908|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129988797|NCT03814187|467921140|FG000|Overall Study|Other reasons|34|||
129988798|NCT03814187|467921141|FG001|Overall Study|Other reasons|40|||
129988799|NCT03814187|467921142|FG002|Overall Study|Other reasons|2|||
129988800|NCT00196976|467921143|FG000|Primary Study|Migrated from study area|0|||
129988801|NCT00196976|467921144|FG001|Primary Study|Migrated from study area|0|||
129988802|NCT00196976|467921145|FG002|Primary Study|Migrated from study area|0|||
129988803|NCT00196976|467921146|FG003|Primary Study|Migrated from study area|0|||
129988804|NCT00196976|467921147|FG004|Primary Study|Migrated from study area|0|||
129988805|NCT00196976|467921148|FG005|Primary Study|Migrated from study area|0|||
129988806|NCT00196976|467921149|FG006|Primary Study|Migrated from study area|0|||
129988807|NCT00196976|467921150|FG007|Primary Study|Migrated from study area|1|||
129988808|NCT00196976|467921151|FG008|Primary Study|Migrated from study area|0|||
129988809|NCT00196976|467921152|FG009|Primary Study|Migrated from study area|0|||
129988810|NCT00196976|467921153|FG010|Primary Study|Migrated from study area|0|||
129988811|NCT00196976|467921154|FG011|Primary Study|Migrated from study area|0|||
129988812|NCT00196976|467921155|FG012|Primary Study|Migrated from study area|0|||
129988813|NCT00196976|467921156|FG013|Primary Study|Migrated from study area|0|||
129988814|NCT00196976|467921143|FG000|Primary Study|Protocol Violation|0|||
129988815|NCT00196976|467921144|FG001|Primary Study|Protocol Violation|1|||
130327101|NCT04949490|469167909|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
130327102|NCT04949490|469167910|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
130327103|NCT02017405|469167911|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327104|NCT02017405|469167912|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327105|NCT02017405|469167913|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327106|NCT02017405|469167914|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327107|NCT02017405|469167915|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
130327108|NCT02017405|469167916|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
130327109|NCT02017405|469167911|FG000|Open-label Phase|Adverse Event|1|||
130327110|NCT02017405|469167912|FG001|Open-label Phase|Adverse Event|1|||
130327111|NCT02017405|469167913|FG002|Open-label Phase|Adverse Event|0|||
130327112|NCT02017405|469167914|FG003|Open-label Phase|Adverse Event|0|||
130327113|NCT02017405|469167915|FG004|Open-label Phase|Adverse Event|0|||
130327114|NCT02017405|469167916|FG005|Open-label Phase|Adverse Event|0|||
130327115|NCT02864394|469167918|FG000|Overall Study|Death|184|||
130327116|NCT02864394|469167919|FG001|Overall Study|Death|189|||
130327117|NCT02864394|469167918|FG000|Overall Study|Lost to Follow-up|0|||
130327118|NCT02864394|469167919|FG001|Overall Study|Lost to Follow-up|2|||
130327119|NCT02864394|469167918|FG000|Overall Study|Sponsor Decision|26|||
130327120|NCT02864394|469167919|FG001|Overall Study|Sponsor Decision|11|||
130327121|NCT02864394|469167918|FG000|Overall Study|Withdrawal by Subject|3|||
130327122|NCT02864394|469167919|FG001|Overall Study|Withdrawal by Subject|10|||
130327123|NCT04730804|469167924|FG000|Overall Study|Physician Decision|0|||
130327124|NCT04730804|469167925|FG001|Overall Study|Physician Decision|0|||
130327125|NCT04730804|469167926|FG002|Overall Study|Physician Decision|0|||
130327126|NCT04730804|469167927|FG003|Overall Study|Physician Decision|0|||
130327127|NCT04730804|469167928|FG004|Overall Study|Physician Decision|0|||
130327128|NCT04730804|469167929|FG005|Overall Study|Physician Decision|1|||
130327129|NCT04730804|469167924|FG000|Overall Study|Withdrawal by Subject|0|||
130327130|NCT04730804|469167925|FG001|Overall Study|Withdrawal by Subject|0|||
130327131|NCT04730804|469167926|FG002|Overall Study|Withdrawal by Subject|0|||
130327132|NCT04730804|469167927|FG003|Overall Study|Withdrawal by Subject|0|||
130327133|NCT04730804|469167928|FG004|Overall Study|Withdrawal by Subject|1|||
130327134|NCT04730804|469167929|FG005|Overall Study|Withdrawal by Subject|2|||
130327135|NCT00554216|469169479|FG000|Overall Study|Lost to Follow-up|92|||
130327136|NCT00554216|469169480|FG001|Overall Study|Lost to Follow-up|31|||
130327137|NCT00554216|469169481|FG002|Overall Study|Lost to Follow-up|63|||
130327138|NCT00554216|469169479|FG000|Overall Study|Adverse Event|16|||
130327139|NCT00554216|469169480|FG001|Overall Study|Adverse Event|16|||
130327140|NCT00554216|469169481|FG002|Overall Study|Adverse Event|36|||
130327141|NCT00554216|469169479|FG000|Overall Study|Withdrawal by Subject|92|||
130327142|NCT00554216|469169480|FG001|Overall Study|Withdrawal by Subject|31|||
130327143|NCT00554216|469169481|FG002|Overall Study|Withdrawal by Subject|43|||
130327144|NCT00554216|469169479|FG000|Overall Study|Non compliance|10|||
130327145|NCT00554216|469169480|FG001|Overall Study|Non compliance|4|||
130327146|NCT00554216|469169481|FG002|Overall Study|Non compliance|5|||
130327147|NCT00554216|469169479|FG000|Overall Study|Pregnancy|2|||
130327148|NCT00554216|469169480|FG001|Overall Study|Pregnancy|1|||
130327149|NCT00554216|469169481|FG002|Overall Study|Pregnancy|14|||
130327150|NCT00554216|469169479|FG000|Overall Study|Restricted med|3|||
130327151|NCT00554216|469169480|FG001|Overall Study|Restricted med|1|||
130327152|NCT00554216|469169481|FG002|Overall Study|Restricted med|1|||
130327153|NCT00554216|469169479|FG000|Overall Study|Other|12|||
130327154|NCT00554216|469169480|FG001|Overall Study|Other|7|||
130327155|NCT00554216|469169481|FG002|Overall Study|Other|10|||
130327156|NCT00554216|469169479|FG000|Overall Study|Lack of Efficacy|15|||
130327157|NCT00554216|469169480|FG001|Overall Study|Lack of Efficacy|3|||
130327158|NCT00554216|469169481|FG002|Overall Study|Lack of Efficacy|0|||
130327159|NCT00463567|469169488|FG000|Overall Study|Adverse Event|29|||
130327160|NCT00463567|469169489|FG001|Overall Study|Adverse Event|26|||
130327161|NCT00463567|469169490|FG002|Overall Study|Adverse Event|17|||
130327162|NCT00463567|469169491|FG003|Overall Study|Adverse Event|46|||
129988816|NCT00196976|467921145|FG002|Primary Study|Protocol Violation|1|||
129988817|NCT00196976|467921146|FG003|Primary Study|Protocol Violation|0|||
130327163|NCT00463567|469169492|FG004|Overall Study|Adverse Event|10|||
129988818|NCT00196976|467921147|FG004|Primary Study|Protocol Violation|0|||
130327164|NCT00463567|469169493|FG005|Overall Study|Adverse Event|10|||
129988819|NCT00196976|467921148|FG005|Primary Study|Protocol Violation|0|||
130327165|NCT00463567|469169494|FG006|Overall Study|Adverse Event|4|||
130327166|NCT00463567|469169488|FG000|Overall Study|Withdrawal by Subject|29|||
130327167|NCT00463567|469169489|FG001|Overall Study|Withdrawal by Subject|22|||
130327168|NCT00463567|469169490|FG002|Overall Study|Withdrawal by Subject|20|||
130327169|NCT00463567|469169491|FG003|Overall Study|Withdrawal by Subject|37|||
129988820|NCT00196976|467921149|FG006|Primary Study|Protocol Violation|0|||
129988821|NCT00196976|467921150|FG007|Primary Study|Protocol Violation|0|||
130327170|NCT00463567|469169492|FG004|Overall Study|Withdrawal by Subject|6|||
130327171|NCT00463567|469169493|FG005|Overall Study|Withdrawal by Subject|5|||
130327172|NCT00463567|469169494|FG006|Overall Study|Withdrawal by Subject|1|||
130327173|NCT00463567|469169488|FG000|Overall Study|Protocol Deviation|13|||
129988822|NCT00196976|467921151|FG008|Primary Study|Protocol Violation|0|||
130327174|NCT00463567|469169489|FG001|Overall Study|Protocol Deviation|9|||
130327175|NCT00463567|469169490|FG002|Overall Study|Protocol Deviation|14|||
130327176|NCT00463567|469169491|FG003|Overall Study|Protocol Deviation|11|||
130327177|NCT00463567|469169492|FG004|Overall Study|Protocol Deviation|1|||
130327178|NCT00463567|469169493|FG005|Overall Study|Protocol Deviation|1|||
130327179|NCT00463567|469169494|FG006|Overall Study|Protocol Deviation|2|||
130327180|NCT00463567|469169488|FG000|Overall Study|Lost to Follow-up|12|||
130327181|NCT00463567|469169489|FG001|Overall Study|Lost to Follow-up|6|||
130327182|NCT00463567|469169490|FG002|Overall Study|Lost to Follow-up|13|||
130327183|NCT00463567|469169491|FG003|Overall Study|Lost to Follow-up|8|||
130327184|NCT00463567|469169492|FG004|Overall Study|Lost to Follow-up|1|||
130327185|NCT00463567|469169493|FG005|Overall Study|Lost to Follow-up|1|||
130327186|NCT00463567|469169494|FG006|Overall Study|Lost to Follow-up|1|||
130327187|NCT00463567|469169488|FG000|Overall Study|Administrative problems|5|||
130327188|NCT00463567|469169489|FG001|Overall Study|Administrative problems|3|||
130327189|NCT00463567|469169490|FG002|Overall Study|Administrative problems|6|||
130327190|NCT00463567|469169491|FG003|Overall Study|Administrative problems|9|||
130327191|NCT00463567|469169492|FG004|Overall Study|Administrative problems|3|||
130327192|NCT00463567|469169493|FG005|Overall Study|Administrative problems|2|||
130327193|NCT00463567|469169494|FG006|Overall Study|Administrative problems|2|||
130327194|NCT00463567|469169488|FG000|Overall Study|Lack of Efficacy|4|||
130327195|NCT00463567|469169489|FG001|Overall Study|Lack of Efficacy|9|||
130327196|NCT00463567|469169490|FG002|Overall Study|Lack of Efficacy|9|||
130327197|NCT00463567|469169491|FG003|Overall Study|Lack of Efficacy|17|||
130327198|NCT00463567|469169492|FG004|Overall Study|Lack of Efficacy|1|||
130327199|NCT00463567|469169493|FG005|Overall Study|Lack of Efficacy|0|||
130327200|NCT00463567|469169494|FG006|Overall Study|Lack of Efficacy|1|||
130327201|NCT00463567|469169488|FG000|Overall Study|Abnormal lab value(s)|1|||
130327202|NCT00463567|469169489|FG001|Overall Study|Abnormal lab value(s)|1|||
130327203|NCT00463567|469169490|FG002|Overall Study|Abnormal lab value(s)|2|||
130327204|NCT00463567|469169491|FG003|Overall Study|Abnormal lab value(s)|1|||
130327205|NCT00463567|469169492|FG004|Overall Study|Abnormal lab value(s)|1|||
130327206|NCT00463567|469169493|FG005|Overall Study|Abnormal lab value(s)|0|||
130327207|NCT00463567|469169494|FG006|Overall Study|Abnormal lab value(s)|0|||
130327208|NCT00463567|469169488|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130327209|NCT00463567|469169489|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130327210|NCT00463567|469169490|FG002|Overall Study|Abnormal test procedure result(s)|6|||
130327211|NCT00463567|469169491|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130327212|NCT00463567|469169492|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130327213|NCT00463567|469169493|FG005|Overall Study|Abnormal test procedure result(s)|2|||
130327214|NCT00463567|469169494|FG006|Overall Study|Abnormal test procedure result(s)|0|||
130327215|NCT00463567|469169488|FG000|Overall Study|Death|1|||
130327216|NCT00463567|469169489|FG001|Overall Study|Death|0|||
130327217|NCT00463567|469169490|FG002|Overall Study|Death|2|||
130327218|NCT00463567|469169491|FG003|Overall Study|Death|0|||
130327219|NCT00463567|469169492|FG004|Overall Study|Death|0|||
130327220|NCT00463567|469169493|FG005|Overall Study|Death|0|||
130327221|NCT00463567|469169494|FG006|Overall Study|Death|0|||
130327222|NCT01524796|469169496|FG000|Overall Study|Adverse Event|13|||
130327223|NCT01524796|469169496|FG000|Overall Study|Lack of Efficacy|3|||
130327224|NCT01524796|469169496|FG000|Overall Study|Lost to Follow-up|1|||
130327225|NCT01524796|469169496|FG000|Overall Study|The price|1|||
130327226|NCT01524796|469169496|FG000|Overall Study|Withdrawal by Subject|4|||
130327227|NCT01524796|469169496|FG000|Overall Study|Move|1|||
130327228|NCT01524796|469169496|FG000|Overall Study|Deterioration of pains|1|||
130327229|NCT01524796|469169496|FG000|Overall Study|Gall stone surgery|1|||
130327230|NCT01524796|469169496|FG000|Overall Study|Nervous about confidentiality|1|||
129988823|NCT00196976|467921152|FG009|Primary Study|Protocol Violation|0|||
129988824|NCT00196976|467921153|FG010|Primary Study|Protocol Violation|0|||
129988825|NCT00196976|467921154|FG011|Primary Study|Protocol Violation|0|||
129988826|NCT00196976|467921155|FG012|Primary Study|Protocol Violation|0|||
130327231|NCT01524796|469169496|FG000|Overall Study|Switch to carbamazapine|1|||
130327232|NCT01524796|469169496|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
130327233|NCT00956007|469169499|FG000|Overall Study|Protocol Violation|27|||
130327234|NCT00956007|469169500|FG001|Overall Study|Protocol Violation|23|||
130327235|NCT03774576|469169501|FG000|Period 2|Adverse Event|1|||
130327236|NCT00927953|469169502|FG000|Overall Study|Death|2|||
130327237|NCT00927953|469169503|FG001|Overall Study|Death|1|||
130327238|NCT01249261|469169516|FG000|Overall Study|Withdrawal by Subject|1|||
130327239|NCT01249261|469169517|FG001|Overall Study|Withdrawal by Subject|0|||
130327240|NCT00482053|469169521|FG000|Inter-treatment Period|Disease progression|1|||
129988827|NCT00196976|467921156|FG013|Primary Study|Protocol Violation|0|||
129988828|NCT00196976|467921143|FG000|Primary Study|Withdrawal by Subject|1|||
130215595|NCT01289574|468751774|FG000|Overall Study|Adverse Event|0|||
130327241|NCT01055197|469169527|FG000|Overall Study|Protocol Violation|7|||
130327242|NCT01055197|469169528|FG001|Overall Study|Protocol Violation|2|||
130327243|NCT01055197|469169527|FG000|Overall Study|Withdrawal by Subject|2|||
130327244|NCT01055197|469169528|FG001|Overall Study|Withdrawal by Subject|0|||
130327245|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
130327246|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
130327247|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
130327248|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
130327249|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
130327250|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
130327251|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
130327252|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
130327253|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
130327254|NCT00538902|469169529|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130327255|NCT00538902|469169530|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130327256|NCT00538902|469169531|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
130327257|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
130327258|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
130327259|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
130327260|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
130327261|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
130327262|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
130327263|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
130327264|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
130327265|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
130327266|NCT00538902|469169529|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
130327267|NCT00538902|469169530|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
130327268|NCT00538902|469169531|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
130327269|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
130327270|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
130327271|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
130327272|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130327273|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130327274|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130327275|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130327276|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130327277|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
130327278|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130327279|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130327280|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
130327281|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
130327282|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
130327283|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
130327284|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
130327285|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
130327286|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
130327287|NCT03739203|469169532|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
130327288|NCT03739203|469169533|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
130327289|NCT03739203|469169534|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
130327290|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
130327291|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
130327292|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
130327293|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
130327294|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
130327295|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
130327296|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
130327297|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
130327298|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
130327299|NCT03739203|469169532|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
130327300|NCT03739203|469169533|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
130327301|NCT03739203|469169534|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
130327302|NCT01967940|469169535|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
130327303|NCT01967940|469169536|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
130327304|NCT01967940|469169537|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
130327305|NCT01967940|469169538|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
130327306|NCT01967940|469169535|FG000|Part 2|Adverse Event|0|||
129988829|NCT00196976|467921144|FG001|Primary Study|Withdrawal by Subject|0|||
130327307|NCT01967940|469169536|FG001|Part 2|Adverse Event|0|||
130327308|NCT01967940|469169537|FG002|Part 2|Adverse Event|0|||
130327309|NCT01967940|469169538|FG003|Part 2|Adverse Event|1|||
130327310|NCT01967940|469169535|FG000|Part 2|Unknown Reason|0|||
130327311|NCT01967940|469169536|FG001|Part 2|Unknown Reason|0|||
130327312|NCT01967940|469169537|FG002|Part 2|Unknown Reason|0|||
130327313|NCT01967940|469169538|FG003|Part 2|Unknown Reason|1|||
130327314|NCT01663103|469169539|FG000|Overall Study|Withdrawal by Subject|1|||
130327315|NCT01663103|469169540|FG001|Overall Study|Withdrawal by Subject|2|||
130327316|NCT01663103|469169539|FG000|Overall Study|Adverse Event|1|||
130327317|NCT01663103|469169540|FG001|Overall Study|Adverse Event|0|||
130327318|NCT01663103|469169539|FG000|Overall Study|dog bite|1|||
130327319|NCT01663103|469169540|FG001|Overall Study|dog bite|0|||
130327320|NCT03113487|469169545|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
130327321|NCT03777982|469169546|FG000|Overall Study|Physician Decision|0|||
130327322|NCT03777982|469169547|FG001|Overall Study|Physician Decision|1|||
130327323|NCT00391586|469169551|FG000|Overall Study|Progressive disease|13|||
130327324|NCT00391586|469169551|FG000|Overall Study|Adverse Event|5|||
130327325|NCT00391586|469169551|FG000|Overall Study|Physician Decision|2|||
130327326|NCT00391586|469169551|FG000|Overall Study|Death|4|||
130327327|NCT00904982|469169552|FG000|Overall Study|Withdrawal by Subject|2|||
130327328|NCT00904982|469169553|FG001|Overall Study|Withdrawal by Subject|0|||
130327329|NCT00904982|469169554|FG002|Overall Study|Withdrawal by Subject|0|||
130327330|NCT00904982|469169555|FG003|Overall Study|Withdrawal by Subject|0|||
130327331|NCT02072668|469169556|FG000|Second Intervention|Lost to Follow-up|1|||
130327332|NCT02072668|469169557|FG001|Second Intervention|Lost to Follow-up|0|||
130327333|NCT03058146|469169558|FG000|Overall Study|Withdrawal by Subject|4|||
130327334|NCT03058146|469169559|FG001|Overall Study|Withdrawal by Subject|1|||
130327335|NCT03058146|469169558|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
130327336|NCT03058146|469169559|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
130327337|NCT00771758|469169564|FG000|Overall Study|Adverse Event|2|||
130327338|NCT00771758|469169565|FG001|Overall Study|Adverse Event|8|||
130327339|NCT00771758|469169566|FG002|Overall Study|Adverse Event|1|||
130327340|NCT00771758|469169564|FG000|Overall Study|Lack of Efficacy|0|||
130327341|NCT00771758|469169565|FG001|Overall Study|Lack of Efficacy|2|||
130327342|NCT00771758|469169566|FG002|Overall Study|Lack of Efficacy|1|||
130327343|NCT00771758|469169564|FG000|Overall Study|Lost to Follow-up|1|||
130327344|NCT00771758|469169565|FG001|Overall Study|Lost to Follow-up|0|||
130327345|NCT00771758|469169566|FG002|Overall Study|Lost to Follow-up|0|||
130327346|NCT00771758|469169564|FG000|Overall Study|Protocol Violation|1|||
130327347|NCT00771758|469169565|FG001|Overall Study|Protocol Violation|0|||
130327348|NCT00771758|469169566|FG002|Overall Study|Protocol Violation|0|||
130327349|NCT00771758|469169564|FG000|Overall Study|Withdrawal by Subject|1|||
130327350|NCT00771758|469169565|FG001|Overall Study|Withdrawal by Subject|0|||
130327351|NCT00771758|469169566|FG002|Overall Study|Withdrawal by Subject|0|||
130327352|NCT00771758|469169564|FG000|Overall Study|Other|3|||
130327353|NCT00771758|469169565|FG001|Overall Study|Other|2|||
130327354|NCT00771758|469169566|FG002|Overall Study|Other|0|||
130327355|NCT03067077|469169567|FG000|Overall Study|Did not receive surgery|4|||
130327356|NCT03067077|469169568|FG001|Overall Study|Did not receive surgery|5|||
130327357|NCT03067077|469169567|FG000|Overall Study|Lost to Follow-up|3|||
130327358|NCT03067077|469169568|FG001|Overall Study|Lost to Follow-up|2|||
130327359|NCT00935584|469169571|FG000|Overall Study|Withdrawal by Subject|9|||
130327360|NCT00935584|469169572|FG001|Overall Study|Withdrawal by Subject|0|||
130327361|NCT00935584|469169571|FG000|Overall Study|Death|3|||
130327362|NCT00935584|469169572|FG001|Overall Study|Death|0|||
130327363|NCT00935584|469169571|FG000|Overall Study|Lost to Follow-up|8|||
130327364|NCT00935584|469169572|FG001|Overall Study|Lost to Follow-up|0|||
130327365|NCT00935584|469169571|FG000|Overall Study|No show|9|||
130327366|NCT00935584|469169572|FG001|Overall Study|No show|0|||
130327367|NCT00935584|469169571|FG000|Overall Study|Relocated|3|||
130327368|NCT00935584|469169572|FG001|Overall Study|Relocated|0|||
130327369|NCT00935584|469169571|FG000|Overall Study|Patient changed provider|3|||
130327370|NCT00935584|469169572|FG001|Overall Study|Patient changed provider|0|||
130327371|NCT00935584|469169571|FG000|Overall Study|Provider dropped out of study|14|||
130327372|NCT00935584|469169572|FG001|Overall Study|Provider dropped out of study|4|||
130327373|NCT00687193|469169573|FG000|Overall Study|Adverse Event|0|||
130327374|NCT00687193|469169574|FG001|Overall Study|Adverse Event|1|||
130327375|NCT00687193|469169575|FG002|Overall Study|Adverse Event|2|||
130327376|NCT00687193|469169576|FG003|Overall Study|Adverse Event|3|||
130327377|NCT00687193|469169577|FG004|Overall Study|Adverse Event|0|||
130327378|NCT00687193|469169578|FG005|Overall Study|Adverse Event|2|||
130215596|NCT01289574|468751775|FG001|Overall Study|Adverse Event|1|||
130327379|NCT00687193|469169573|FG000|Overall Study|Lack of Efficacy|1|||
130327380|NCT00687193|469169574|FG001|Overall Study|Lack of Efficacy|1|||
130327381|NCT00687193|469169575|FG002|Overall Study|Lack of Efficacy|0|||
130327382|NCT00687193|469169576|FG003|Overall Study|Lack of Efficacy|0|||
130327383|NCT00687193|469169577|FG004|Overall Study|Lack of Efficacy|0|||
130327384|NCT00687193|469169578|FG005|Overall Study|Lack of Efficacy|2|||
130327385|NCT00687193|469169573|FG000|Overall Study|Protocol Violation|1|||
130327386|NCT00687193|469169574|FG001|Overall Study|Protocol Violation|2|||
130327387|NCT00687193|469169575|FG002|Overall Study|Protocol Violation|0|||
130327388|NCT00687193|469169576|FG003|Overall Study|Protocol Violation|1|||
130327389|NCT00687193|469169577|FG004|Overall Study|Protocol Violation|2|||
130327390|NCT00687193|469169578|FG005|Overall Study|Protocol Violation|0|||
129988830|NCT00196976|467921145|FG002|Primary Study|Withdrawal by Subject|1|||
130327391|NCT04986904|469169579|FG000|Overall Study|Lost to Follow-up|11|||
130327392|NCT04986904|469169579|FG000|Overall Study|Withdrawal by Subject|1|||
130327393|NCT03435211|469169580|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
130327394|NCT03863080|469169581|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130327395|NCT03863080|469169582|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130327396|NCT03863080|469169583|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
130327397|NCT03863080|469169584|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
130327398|NCT03863080|469169581|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130327399|NCT03863080|469169582|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130327400|NCT03863080|469169583|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
130327401|NCT03863080|469169584|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
130327402|NCT03863080|469169581|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130327403|NCT03863080|469169582|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130327404|NCT03863080|469169583|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
130327405|NCT03863080|469169584|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
130327406|NCT01342211|469169585|FG000|Overall Study|Lost to Follow-up|0|||
130327407|NCT01342211|469169586|FG001|Overall Study|Lost to Follow-up|0|||
130327408|NCT01342211|469169587|FG002|Overall Study|Lost to Follow-up|0|||
130327409|NCT01342211|469169588|FG003|Overall Study|Lost to Follow-up|1|||
130327410|NCT01342211|469169589|FG004|Overall Study|Lost to Follow-up|0|||
130327411|NCT01342211|469169585|FG000|Overall Study|Adverse Event|0|||
130327412|NCT01342211|469169586|FG001|Overall Study|Adverse Event|0|||
130327413|NCT01342211|469169587|FG002|Overall Study|Adverse Event|0|||
130327414|NCT01342211|469169588|FG003|Overall Study|Adverse Event|0|||
130327415|NCT01342211|469169589|FG004|Overall Study|Adverse Event|1|||
130327416|NCT01342211|469169585|FG000|Overall Study|Withdrawal by Subject|0|||
130327417|NCT01342211|469169586|FG001|Overall Study|Withdrawal by Subject|0|||
130327418|NCT01342211|469169587|FG002|Overall Study|Withdrawal by Subject|0|||
130327419|NCT01342211|469169588|FG003|Overall Study|Withdrawal by Subject|1|||
130327420|NCT01342211|469169589|FG004|Overall Study|Withdrawal by Subject|0|||
130327421|NCT01342211|469169585|FG000|Overall Study|Randomized, but not Treated|0|||
130327422|NCT01342211|469169586|FG001|Overall Study|Randomized, but not Treated|2|||
130327423|NCT01342211|469169587|FG002|Overall Study|Randomized, but not Treated|0|||
130327424|NCT01342211|469169588|FG003|Overall Study|Randomized, but not Treated|0|||
130327425|NCT01342211|469169589|FG004|Overall Study|Randomized, but not Treated|1|||
130327426|NCT01648751|469169607|FG000|Overall Study|Withdrawal by Subject|2|||
130327427|NCT01648751|469169608|FG001|Overall Study|Withdrawal by Subject|3|||
130327428|NCT05673876|469169611|FG000|Overall Study|Death|3|||
130327429|NCT05673876|469169612|FG001|Overall Study|Death|1|||
130327430|NCT05673876|469169611|FG000|Overall Study|Study Terminated by Sponsor|0|||
130327431|NCT05673876|469169612|FG001|Overall Study|Study Terminated by Sponsor|1|||
130327432|NCT05673876|469169611|FG000|Overall Study|Physician Decision|0|||
130327433|NCT05673876|469169612|FG001|Overall Study|Physician Decision|1|||
130327434|NCT03205423|469169615|FG000|Overall Study|Personal|1|||
130327435|NCT03205423|469169616|FG001|Overall Study|Personal|1|||
130327436|NCT03205423|469169615|FG000|Overall Study|Physician Decision|0|||
130327437|NCT03205423|469169616|FG001|Overall Study|Physician Decision|2|||
130327438|NCT02749422|469169619|FG000|Overall Study|Lost to Follow-up|0|||
130327439|NCT02749422|469169620|FG001|Overall Study|Lost to Follow-up|2|||
130327440|NCT02749422|469169619|FG000|Overall Study|Ineligible|0|||
130327441|NCT02749422|469169620|FG001|Overall Study|Ineligible|1|||
130327442|NCT05786651|469169623|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
130327443|NCT04390763|469169624|FG000|Safety run-in Part|Adverse Event|4|||
130327444|NCT04390763|469169625|FG001|Safety run-in Part|Adverse Event|0|||
130327445|NCT04390763|469169626|FG002|Safety run-in Part|Adverse Event|0|||
130327446|NCT04390763|469169627|FG003|Safety run-in Part|Adverse Event|0|||
130327447|NCT04390763|469169624|FG000|Safety run-in Part|Physician Decision|1|||
130327448|NCT04390763|469169625|FG001|Safety run-in Part|Physician Decision|0|||
130327449|NCT04390763|469169626|FG002|Safety run-in Part|Physician Decision|0|||
129988831|NCT00196976|467921146|FG003|Primary Study|Withdrawal by Subject|1|||
129988832|NCT00196976|467921147|FG004|Primary Study|Withdrawal by Subject|2|||
129988833|NCT00196976|467921148|FG005|Primary Study|Withdrawal by Subject|1|||
130327450|NCT04390763|469169627|FG003|Safety run-in Part|Physician Decision|0|||
130327451|NCT04390763|469169624|FG000|Safety run-in Part|Progressive Disease|6|||
130327452|NCT04390763|469169625|FG001|Safety run-in Part|Progressive Disease|0|||
130327453|NCT04390763|469169626|FG002|Safety run-in Part|Progressive Disease|0|||
130327454|NCT04390763|469169627|FG003|Safety run-in Part|Progressive Disease|0|||
130327455|NCT04390763|469169624|FG000|Randomized Part|Adverse Event|0|||
130327456|NCT04390763|469169625|FG001|Randomized Part|Adverse Event|11|||
129988834|NCT00196976|467921149|FG006|Primary Study|Withdrawal by Subject|0|||
130327457|NCT04390763|469169626|FG002|Randomized Part|Adverse Event|5|||
130327458|NCT04390763|469169627|FG003|Randomized Part|Adverse Event|5|||
130327459|NCT04390763|469169624|FG000|Randomized Part|Death|0|||
130327460|NCT04390763|469169625|FG001|Randomized Part|Death|3|||
130327461|NCT04390763|469169626|FG002|Randomized Part|Death|4|||
130327462|NCT04390763|469169627|FG003|Randomized Part|Death|2|||
130327463|NCT04390763|469169624|FG000|Randomized Part|Physician Decision|0|||
130327464|NCT04390763|469169625|FG001|Randomized Part|Physician Decision|2|||
130327465|NCT04390763|469169626|FG002|Randomized Part|Physician Decision|2|||
130327466|NCT04390763|469169627|FG003|Randomized Part|Physician Decision|9|||
130327467|NCT04390763|469169624|FG000|Randomized Part|Progressive Disease|0|||
129988835|NCT00196976|467921150|FG007|Primary Study|Withdrawal by Subject|0|||
129988836|NCT00196976|467921151|FG008|Primary Study|Withdrawal by Subject|0|||
129988837|NCT00196976|467921152|FG009|Primary Study|Withdrawal by Subject|1|||
129988838|NCT00196976|467921153|FG010|Primary Study|Withdrawal by Subject|0|||
129988839|NCT00196976|467921154|FG011|Primary Study|Withdrawal by Subject|0|||
129988840|NCT00196976|467921155|FG012|Primary Study|Withdrawal by Subject|0|||
130327468|NCT04390763|469169625|FG001|Randomized Part|Progressive Disease|24|||
130327469|NCT04390763|469169626|FG002|Randomized Part|Progressive Disease|31|||
130327470|NCT04390763|469169627|FG003|Randomized Part|Progressive Disease|23|||
130327471|NCT04390763|469169624|FG000|Randomized Part|Study terminated by sponsor|0|||
130327472|NCT04390763|469169625|FG001|Randomized Part|Study terminated by sponsor|1|||
130327473|NCT04390763|469169626|FG002|Randomized Part|Study terminated by sponsor|0|||
130327474|NCT04390763|469169627|FG003|Randomized Part|Study terminated by sponsor|0|||
130327475|NCT04390763|469169624|FG000|Randomized Part|Participant Decision|0|||
130327476|NCT04390763|469169625|FG001|Randomized Part|Participant Decision|5|||
130327477|NCT04390763|469169626|FG002|Randomized Part|Participant Decision|7|||
130327478|NCT04390763|469169627|FG003|Randomized Part|Participant Decision|6|||
130327479|NCT04390763|469169624|FG000|Randomized Part|Not treated|0|||
130327480|NCT04390763|469169625|FG001|Randomized Part|Not treated|4|||
130327481|NCT04390763|469169626|FG002|Randomized Part|Not treated|2|||
130327482|NCT04390763|469169627|FG003|Randomized Part|Not treated|7|||
130327483|NCT04721977|469169633|FG000|Overall Study|Death|15|||
130327484|NCT04721977|469169633|FG000|Overall Study|Ongoing|51|||
130327485|NCT00777153|469171533|FG000|Overall Study|Lost to Follow-up|1|||
130327486|NCT00777153|469171534|FG001|Overall Study|Lost to Follow-up|1|||
130327487|NCT00777153|469171535|FG002|Overall Study|Lost to Follow-up|0|||
130327488|NCT00777153|469171533|FG000|Overall Study|Death|85|||
130327489|NCT00777153|469171534|FG001|Overall Study|Death|73|||
130327490|NCT00777153|469171535|FG002|Overall Study|Death|33|||
130327491|NCT00777153|469171533|FG000|Overall Study|Withdrawal by Subject|3|||
130327492|NCT00777153|469171534|FG001|Overall Study|Withdrawal by Subject|4|||
130327493|NCT00777153|469171535|FG002|Overall Study|Withdrawal by Subject|3|||
129988841|NCT00196976|467921156|FG013|Primary Study|Withdrawal by Subject|0|||
129988842|NCT00196976|467921143|FG000|Primary Study|Lost to Follow-up|0|||
129988843|NCT00196976|467921144|FG001|Primary Study|Lost to Follow-up|0|||
129988844|NCT00196976|467921145|FG002|Primary Study|Lost to Follow-up|0|||
129988845|NCT00196976|467921146|FG003|Primary Study|Lost to Follow-up|0|||
129988846|NCT00196976|467921147|FG004|Primary Study|Lost to Follow-up|1|||
129988847|NCT00196976|467921148|FG005|Primary Study|Lost to Follow-up|1|||
129988848|NCT00196976|467921149|FG006|Primary Study|Lost to Follow-up|0|||
129988849|NCT00196976|467921150|FG007|Primary Study|Lost to Follow-up|2|||
129988850|NCT00196976|467921151|FG008|Primary Study|Lost to Follow-up|0|||
129988851|NCT00196976|467921152|FG009|Primary Study|Lost to Follow-up|0|||
129988852|NCT00196976|467921153|FG010|Primary Study|Lost to Follow-up|0|||
129988853|NCT00196976|467921154|FG011|Primary Study|Lost to Follow-up|0|||
129988854|NCT00196976|467921155|FG012|Primary Study|Lost to Follow-up|0|||
129988855|NCT00196976|467921156|FG013|Primary Study|Lost to Follow-up|0|||
129988856|NCT00196976|467921143|FG000|Primary Study|Other|0|||
129988857|NCT00196976|467921144|FG001|Primary Study|Other|0|||
129988858|NCT00196976|467921145|FG002|Primary Study|Other|2|||
130215597|NCT01289574|468751776|FG002|Overall Study|Adverse Event|0|||
130215598|NCT01289574|468751774|FG000|Overall Study|Subject wanted alternate treatment|0|||
130215599|NCT01289574|468751775|FG001|Overall Study|Subject wanted alternate treatment|1|||
130327494|NCT00777153|469171533|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
130327495|NCT00777153|469171534|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
130327496|NCT00777153|469171535|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
130327497|NCT02079246|469171537|FG000|OLEX|Withdrawal before treatment|1|||
130327498|NCT02079246|469171538|FG001|OLEX|Withdrawal before treatment|0|||
130327499|NCT02079246|469171537|FG000|OLEX|Death|11|||
130327500|NCT02079246|469171538|FG001|OLEX|Death|0|||
129988859|NCT00196976|467921146|FG003|Primary Study|Other|0|||
129988860|NCT00196976|467921147|FG004|Primary Study|Other|0|||
129988861|NCT00196976|467921148|FG005|Primary Study|Other|0|||
129988862|NCT00196976|467921149|FG006|Primary Study|Other|0|||
129988863|NCT00196976|467921150|FG007|Primary Study|Other|0|||
130215600|NCT01289574|468751776|FG002|Overall Study|Subject wanted alternate treatment|0|||
130215601|NCT00262002|468751777|FG000|Overall Study|Adverse Event|2|||
130327501|NCT02079246|469171537|FG000|OLEX|Adverse Event|66|||
130327502|NCT02079246|469171538|FG001|OLEX|Adverse Event|0|||
130327503|NCT02079246|469171537|FG000|OLEX|Withdrawal by Subject|60|||
130327504|NCT02079246|469171538|FG001|OLEX|Withdrawal by Subject|0|||
130327505|NCT02079246|469171537|FG000|OLEX|Lost to Follow-up|6|||
130327506|NCT02079246|469171538|FG001|OLEX|Lost to Follow-up|0|||
129988864|NCT00196976|467921151|FG008|Primary Study|Other|0|||
129988865|NCT00196976|467921152|FG009|Primary Study|Other|0|||
129988866|NCT00196976|467921153|FG010|Primary Study|Other|0|||
129988867|NCT00196976|467921154|FG011|Primary Study|Other|0|||
130327507|NCT02079246|469171537|FG000|OLEX|Protocol Violation|6|||
130327508|NCT02079246|469171538|FG001|OLEX|Protocol Violation|0|||
130327509|NCT02079246|469171537|FG000|OLEX|Lack of Efficacy|3|||
130327510|NCT02079246|469171538|FG001|OLEX|Lack of Efficacy|0|||
130327511|NCT02079246|469171537|FG000|OLEX|Results of the lead-in studies|58|||
130327512|NCT02079246|469171538|FG001|OLEX|Results of the lead-in studies|0|||
130327513|NCT02079246|469171537|FG000|OLEX|Other: Disallowed medication|8|||
130327514|NCT02079246|469171538|FG001|OLEX|Other: Disallowed medication|0|||
130327515|NCT02079246|469171537|FG000|OLEX|Other: Insufficient compliance|2|||
130327516|NCT02079246|469171538|FG001|OLEX|Other: Insufficient compliance|0|||
130327517|NCT02079246|469171537|FG000|OLEX|Other: Caregiver unavailable|3|||
130327518|NCT02079246|469171538|FG001|OLEX|Other: Caregiver unavailable|0|||
130327519|NCT02079246|469171537|FG000|OLEX|Other: Coordinator decision|1|||
130327520|NCT02079246|469171538|FG001|OLEX|Other: Coordinator decision|0|||
130327521|NCT02079246|469171537|FG000|OLEX|Other: Worsening of condition|1|||
130327522|NCT02079246|469171538|FG001|OLEX|Other: Worsening of condition|0|||
130327523|NCT02079246|469171537|FG000|OLEX|Other: Moved to nursing home|1|||
130327524|NCT02079246|469171538|FG001|OLEX|Other: Moved to nursing home|0|||
130327525|NCT02079246|469171537|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
130327526|NCT02079246|469171538|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
130327527|NCT02079246|469171537|FG000|OLEX-MEM|Adverse Event|0|||
130327528|NCT02079246|469171538|FG001|OLEX-MEM|Adverse Event|6|||
130327529|NCT02079246|469171537|FG000|OLEX-MEM|Withdrawal by Subject|0|||
130327530|NCT02079246|469171538|FG001|OLEX-MEM|Withdrawal by Subject|7|||
130327531|NCT02079246|469171537|FG000|OLEX-MEM|Protocol Violation|0|||
130327532|NCT02079246|469171538|FG001|OLEX-MEM|Protocol Violation|2|||
130327533|NCT02079246|469171537|FG000|OLEX-MEM|Lost to Follow-up|0|||
130327534|NCT02079246|469171538|FG001|OLEX-MEM|Lost to Follow-up|1|||
130327535|NCT02079246|469171537|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
130327536|NCT02079246|469171538|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
130327537|NCT03077412|469171539|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
130327538|NCT03077412|469171540|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
130327539|NCT03077412|469171541|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
130327540|NCT03077412|469171539|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
130327541|NCT03077412|469171540|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
130327542|NCT03077412|469171541|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
130327543|NCT03077412|469171539|FG000|Overall Study|Adverse Event|1|||
130327544|NCT03077412|469171540|FG001|Overall Study|Adverse Event|2|||
130327545|NCT03077412|469171541|FG002|Overall Study|Adverse Event|2|||
130327546|NCT03077412|469171539|FG000|Overall Study|Investigator's Discretion|0|||
130327547|NCT03077412|469171540|FG001|Overall Study|Investigator's Discretion|1|||
129988868|NCT00196976|467921155|FG012|Primary Study|Other|0|||
129988869|NCT00196976|467921156|FG013|Primary Study|Other|0|||
129988870|NCT00196976|467921143|FG000|Booster Study|Withdrawal by Subject|0|||
129988871|NCT00196976|467921144|FG001|Booster Study|Withdrawal by Subject|0|||
129988872|NCT00196976|467921145|FG002|Booster Study|Withdrawal by Subject|0|||
129988873|NCT00196976|467921146|FG003|Booster Study|Withdrawal by Subject|0|||
129988874|NCT00196976|467921147|FG004|Booster Study|Withdrawal by Subject|0|||
129988875|NCT00196976|467921148|FG005|Booster Study|Withdrawal by Subject|0|||
129988876|NCT00196976|467921149|FG006|Booster Study|Withdrawal by Subject|0|||
129988877|NCT00196976|467921150|FG007|Booster Study|Withdrawal by Subject|0|||
129988878|NCT00196976|467921151|FG008|Booster Study|Withdrawal by Subject|0|||
129988879|NCT00196976|467921152|FG009|Booster Study|Withdrawal by Subject|0|||
129988880|NCT00196976|467921153|FG010|Booster Study|Withdrawal by Subject|1|||
129988881|NCT00196976|467921154|FG011|Booster Study|Withdrawal by Subject|0|||
129988882|NCT00196976|467921155|FG012|Booster Study|Withdrawal by Subject|0|||
129988883|NCT00196976|467921156|FG013|Booster Study|Withdrawal by Subject|0|||
130327548|NCT03077412|469171541|FG002|Overall Study|Investigator's Discretion|1|||
130327549|NCT03077412|469171539|FG000|Overall Study|Withdrew Consent|0|||
130327550|NCT03077412|469171540|FG001|Overall Study|Withdrew Consent|2|||
129988884|NCT00196976|467921143|FG000|Booster Study|Lost to Follow-up|0|||
129988885|NCT00196976|467921144|FG001|Booster Study|Lost to Follow-up|0|||
129988886|NCT00196976|467921145|FG002|Booster Study|Lost to Follow-up|0|||
129988887|NCT00196976|467921146|FG003|Booster Study|Lost to Follow-up|0|||
129988888|NCT00196976|467921147|FG004|Booster Study|Lost to Follow-up|0|||
129988889|NCT00196976|467921148|FG005|Booster Study|Lost to Follow-up|0|||
130327551|NCT03077412|469171541|FG002|Overall Study|Withdrew Consent|0|||
130327552|NCT02266888|469171542|FG000|Overall Study|Death|2|||
130327553|NCT02266888|469171543|FG001|Overall Study|Death|2|||
130327554|NCT02266888|469171544|FG002|Overall Study|Death|4|||
130327555|NCT02266888|469171545|FG003|Overall Study|Death|2|||
130327556|NCT02266888|469171542|FG000|Overall Study|Physician Decision|0|||
130327557|NCT02266888|469171543|FG001|Overall Study|Physician Decision|1|||
129988890|NCT00196976|467921149|FG006|Booster Study|Lost to Follow-up|0|||
129988891|NCT00196976|467921150|FG007|Booster Study|Lost to Follow-up|0|||
129988892|NCT00196976|467921151|FG008|Booster Study|Lost to Follow-up|0|||
129988893|NCT00196976|467921152|FG009|Booster Study|Lost to Follow-up|0|||
129988894|NCT00196976|467921153|FG010|Booster Study|Lost to Follow-up|1|||
129988895|NCT00196976|467921154|FG011|Booster Study|Lost to Follow-up|2|||
129988896|NCT00196976|467921155|FG012|Booster Study|Lost to Follow-up|0|||
129988897|NCT00196976|467921156|FG013|Booster Study|Lost to Follow-up|0|||
129988898|NCT01049217|467921164|FG000|Overall Study|Adverse Event|2|||
129988899|NCT01049217|467921165|FG001|Overall Study|Adverse Event|1|||
129988900|NCT01049217|467921164|FG000|Overall Study|Lack of Efficacy|1|||
129988901|NCT01049217|467921165|FG001|Overall Study|Lack of Efficacy|1|||
129988902|NCT01049217|467921164|FG000|Overall Study|Lost to Follow-up|3|||
129988903|NCT01049217|467921165|FG001|Overall Study|Lost to Follow-up|8|||
129988904|NCT01049217|467921164|FG000|Overall Study|Withdrawal by Subject|4|||
129988905|NCT01049217|467921165|FG001|Overall Study|Withdrawal by Subject|3|||
129988906|NCT01049217|467921164|FG000|Overall Study|Protocol Violation|1|||
129988907|NCT01049217|467921165|FG001|Overall Study|Protocol Violation|3|||
129988908|NCT01049217|467921164|FG000|Overall Study|Pregnancy|1|||
129988909|NCT01049217|467921165|FG001|Overall Study|Pregnancy|0|||
129988910|NCT01049217|467921164|FG000|Overall Study|Study Terminated by Sponsor|43|||
129988911|NCT01049217|467921165|FG001|Overall Study|Study Terminated by Sponsor|43|||
129988912|NCT01049217|467921164|FG000|Overall Study|Other|1|||
129988913|NCT01049217|467921165|FG001|Overall Study|Other|2|||
130327558|NCT02266888|469171544|FG002|Overall Study|Physician Decision|2|||
130327559|NCT02266888|469171545|FG003|Overall Study|Physician Decision|2|||
130327560|NCT02266888|469171542|FG000|Overall Study|Study Terminated|5|||
130327561|NCT02266888|469171543|FG001|Overall Study|Study Terminated|1|||
130327562|NCT02266888|469171544|FG002|Overall Study|Study Terminated|0|||
130327563|NCT02266888|469171545|FG003|Overall Study|Study Terminated|0|||
130327564|NCT02266888|469171542|FG000|Overall Study|No Longer Eligible|0|||
130327565|NCT02266888|469171543|FG001|Overall Study|No Longer Eligible|0|||
130327566|NCT02266888|469171544|FG002|Overall Study|No Longer Eligible|0|||
130327567|NCT02266888|469171545|FG003|Overall Study|No Longer Eligible|2|||
130327568|NCT02266888|469171542|FG000|Overall Study|Randomization Closed|0|||
130327569|NCT02266888|469171543|FG001|Overall Study|Randomization Closed|0|||
130327570|NCT02266888|469171544|FG002|Overall Study|Randomization Closed|4|||
130327571|NCT02266888|469171545|FG003|Overall Study|Randomization Closed|0|||
130327572|NCT02266888|469171542|FG000|Overall Study|Personnel unavailable at transplant|0|||
130327573|NCT02266888|469171543|FG001|Overall Study|Personnel unavailable at transplant|0|||
130327574|NCT02266888|469171544|FG002|Overall Study|Personnel unavailable at transplant|0|||
130327575|NCT02266888|469171545|FG003|Overall Study|Personnel unavailable at transplant|1|||
130327576|NCT02266888|469171542|FG000|Overall Study|Transfer of care|0|||
130327577|NCT02266888|469171543|FG001|Overall Study|Transfer of care|0|||
130327578|NCT02266888|469171544|FG002|Overall Study|Transfer of care|1|||
130327579|NCT02266888|469171545|FG003|Overall Study|Transfer of care|0|||
130327580|NCT02351856|469171546|FG000|Overall Study|Adverse Event|2|||
130327581|NCT02351856|469171546|FG000|Overall Study|Physician Decision|5|||
130327582|NCT02351856|469171546|FG000|Overall Study|Study terminated by sponsor|1|||
130327583|NCT01458392|469171547|FG000|Overall Study|Death|2|||
130327584|NCT01458392|469171548|FG001|Overall Study|Death|11|||
130327585|NCT01458392|469171549|FG002|Overall Study|Death|22|||
130327586|NCT01458392|469171547|FG000|Overall Study|At the discretion of the sponsor|0|||
130327587|NCT01458392|469171548|FG001|Overall Study|At the discretion of the sponsor|2|||
130327588|NCT01458392|469171549|FG002|Overall Study|At the discretion of the sponsor|7|||
130327589|NCT01458392|469171547|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
130327590|NCT01458392|469171548|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
130327591|NCT01458392|469171549|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
130327592|NCT01193244|469171552|FG000|Overall Study|Withdrawal by Subject|79|||
130327593|NCT01193244|469171553|FG001|Overall Study|Withdrawal by Subject|97|||
130327594|NCT01193244|469171552|FG000|Overall Study|Other|303|||
130327595|NCT01193244|469171553|FG001|Overall Study|Other|278|||
130327596|NCT01193244|469171552|FG000|Overall Study|Lost to Follow-up|6|||
130327597|NCT01193244|469171553|FG001|Overall Study|Lost to Follow-up|15|||
129988914|NCT01049217|467921164|FG000|Overall Study|Randomized but not Treated|0|||
129988915|NCT01049217|467921165|FG001|Overall Study|Randomized but not Treated|2|||
129988916|NCT00903682|467921166|FG000|Overall Study|Adverse Event|6|||
129988917|NCT00903682|467921167|FG001|Overall Study|Adverse Event|13|||
130327598|NCT03763877|469171563|FG000|Overall Study|Withdrawal by Subject|3|||
130327599|NCT03763877|469171564|FG001|Overall Study|Withdrawal by Subject|1|||
130327600|NCT03763877|469171565|FG002|Overall Study|Withdrawal by Subject|3|||
130327601|NCT03763877|469171566|FG003|Overall Study|Withdrawal by Subject|4|||
130327602|NCT03763877|469171563|FG000|Overall Study|Adverse Event|1|||
130327603|NCT03763877|469171564|FG001|Overall Study|Adverse Event|1|||
129988918|NCT00903682|467921166|FG000|Overall Study|Lost to Follow-up|1|||
129988919|NCT00903682|467921167|FG001|Overall Study|Lost to Follow-up|0|||
129988920|NCT00903682|467921166|FG000|Overall Study|Withdrawal by Subject|5|||
129988921|NCT00903682|467921167|FG001|Overall Study|Withdrawal by Subject|0|||
130327604|NCT03763877|469171565|FG002|Overall Study|Adverse Event|3|||
130327605|NCT03763877|469171566|FG003|Overall Study|Adverse Event|1|||
130327606|NCT03763877|469171563|FG000|Overall Study|Protocol Violation|1|||
130327607|NCT03763877|469171564|FG001|Overall Study|Protocol Violation|1|||
130327608|NCT03763877|469171565|FG002|Overall Study|Protocol Violation|0|||
130327609|NCT03763877|469171566|FG003|Overall Study|Protocol Violation|0|||
130327610|NCT03763877|469171563|FG000|Overall Study|Lost to Follow-up|0|||
130327611|NCT03763877|469171564|FG001|Overall Study|Lost to Follow-up|1|||
130327612|NCT03763877|469171565|FG002|Overall Study|Lost to Follow-up|1|||
130327613|NCT03763877|469171566|FG003|Overall Study|Lost to Follow-up|0|||
130327614|NCT03040336|469171567|FG000|Overall Study|Death|1|||
130327615|NCT03040336|469171568|FG001|Overall Study|Death|0|||
130327616|NCT03040336|469171567|FG000|Overall Study|Withdrawal by Subject|2|||
130327617|NCT03040336|469171568|FG001|Overall Study|Withdrawal by Subject|3|||
130327618|NCT00068692|469171573|FG000|Step 1: Registration|Disese progression/relapse|5|||
130327619|NCT00068692|469171574|FG001|Step 1: Registration|Disese progression/relapse|0|||
130327620|NCT00068692|469171575|FG002|Step 1: Registration|Disese progression/relapse|0|||
130327621|NCT00068692|469171576|FG003|Step 1: Registration|Disese progression/relapse|0|||
130327622|NCT00068692|469171577|FG004|Step 1: Registration|Disese progression/relapse|0|||
130327623|NCT00068692|469171578|FG005|Step 1: Registration|Disese progression/relapse|0|||
130327624|NCT00068692|469171579|FG006|Step 1: Registration|Disese progression/relapse|0|||
130327625|NCT00068692|469171580|FG007|Step 1: Registration|Disese progression/relapse|0|||
130327626|NCT00068692|469171573|FG000|Step 1: Registration|Adverse Event|7|||
130327627|NCT00068692|469171574|FG001|Step 1: Registration|Adverse Event|0|||
130327628|NCT00068692|469171575|FG002|Step 1: Registration|Adverse Event|0|||
130327629|NCT00068692|469171576|FG003|Step 1: Registration|Adverse Event|0|||
130327630|NCT00068692|469171577|FG004|Step 1: Registration|Adverse Event|0|||
130327631|NCT00068692|469171578|FG005|Step 1: Registration|Adverse Event|0|||
130327632|NCT00068692|469171579|FG006|Step 1: Registration|Adverse Event|0|||
130327633|NCT00068692|469171580|FG007|Step 1: Registration|Adverse Event|0|||
130327634|NCT00068692|469171573|FG000|Step 1: Registration|Death|1|||
130327635|NCT00068692|469171574|FG001|Step 1: Registration|Death|0|||
130327636|NCT00068692|469171575|FG002|Step 1: Registration|Death|0|||
130327637|NCT00068692|469171576|FG003|Step 1: Registration|Death|0|||
130327638|NCT00068692|469171577|FG004|Step 1: Registration|Death|0|||
130327639|NCT00068692|469171578|FG005|Step 1: Registration|Death|0|||
130327640|NCT00068692|469171579|FG006|Step 1: Registration|Death|0|||
130327641|NCT00068692|469171580|FG007|Step 1: Registration|Death|0|||
130327642|NCT00068692|469171573|FG000|Step 1: Registration|Withdrawal by Subject|11|||
130327643|NCT00068692|469171574|FG001|Step 1: Registration|Withdrawal by Subject|0|||
130327644|NCT00068692|469171575|FG002|Step 1: Registration|Withdrawal by Subject|0|||
130327645|NCT00068692|469171576|FG003|Step 1: Registration|Withdrawal by Subject|0|||
130327646|NCT00068692|469171577|FG004|Step 1: Registration|Withdrawal by Subject|0|||
130327647|NCT00068692|469171578|FG005|Step 1: Registration|Withdrawal by Subject|0|||
130327648|NCT00068692|469171579|FG006|Step 1: Registration|Withdrawal by Subject|0|||
130327649|NCT00068692|469171580|FG007|Step 1: Registration|Withdrawal by Subject|0|||
130327650|NCT00068692|469171573|FG000|Step 1: Registration|Alternative therapy|2|||
130327651|NCT00068692|469171574|FG001|Step 1: Registration|Alternative therapy|0|||
130327652|NCT00068692|469171575|FG002|Step 1: Registration|Alternative therapy|0|||
130327653|NCT00068692|469171576|FG003|Step 1: Registration|Alternative therapy|0|||
130327654|NCT00068692|469171577|FG004|Step 1: Registration|Alternative therapy|0|||
130327655|NCT00068692|469171578|FG005|Step 1: Registration|Alternative therapy|0|||
130327656|NCT00068692|469171579|FG006|Step 1: Registration|Alternative therapy|0|||
130327657|NCT00068692|469171580|FG007|Step 1: Registration|Alternative therapy|0|||
130327658|NCT00068692|469171573|FG000|Step 1: Registration|Complicating disease|2|||
130327659|NCT00068692|469171574|FG001|Step 1: Registration|Complicating disease|0|||
130327660|NCT00068692|469171575|FG002|Step 1: Registration|Complicating disease|0|||
130327661|NCT00068692|469171576|FG003|Step 1: Registration|Complicating disease|0|||
130327662|NCT00068692|469171577|FG004|Step 1: Registration|Complicating disease|0|||
130327663|NCT00068692|469171578|FG005|Step 1: Registration|Complicating disease|0|||
130327664|NCT00068692|469171579|FG006|Step 1: Registration|Complicating disease|0|||
130327665|NCT00068692|469171580|FG007|Step 1: Registration|Complicating disease|0|||
130327666|NCT00068692|469171573|FG000|Step 1: Registration|Protocol Violation|1|||
130327667|NCT00068692|469171574|FG001|Step 1: Registration|Protocol Violation|0|||
130327668|NCT00068692|469171575|FG002|Step 1: Registration|Protocol Violation|0|||
130327669|NCT00068692|469171576|FG003|Step 1: Registration|Protocol Violation|0|||
130327670|NCT00068692|469171577|FG004|Step 1: Registration|Protocol Violation|0|||
130327671|NCT00068692|469171578|FG005|Step 1: Registration|Protocol Violation|0|||
130327672|NCT00068692|469171579|FG006|Step 1: Registration|Protocol Violation|0|||
130327673|NCT00068692|469171580|FG007|Step 1: Registration|Protocol Violation|0|||
130327674|NCT00068692|469171573|FG000|Step 1: Registration|Not eligible|6|||
130327675|NCT00068692|469171574|FG001|Step 1: Registration|Not eligible|0|||
130327676|NCT00068692|469171575|FG002|Step 1: Registration|Not eligible|0|||
130327677|NCT00068692|469171576|FG003|Step 1: Registration|Not eligible|0|||
130327678|NCT00068692|469171577|FG004|Step 1: Registration|Not eligible|0|||
130327679|NCT00068692|469171578|FG005|Step 1: Registration|Not eligible|0|||
130327680|NCT00068692|469171579|FG006|Step 1: Registration|Not eligible|0|||
130327681|NCT00068692|469171580|FG007|Step 1: Registration|Not eligible|0|||
130327682|NCT00068692|469171573|FG000|Step 1: Registration|Other|2|||
130327683|NCT00068692|469171574|FG001|Step 1: Registration|Other|0|||
130327684|NCT00068692|469171575|FG002|Step 1: Registration|Other|0|||
130327685|NCT00068692|469171576|FG003|Step 1: Registration|Other|0|||
130327686|NCT00068692|469171577|FG004|Step 1: Registration|Other|0|||
130327687|NCT00068692|469171578|FG005|Step 1: Registration|Other|0|||
130327688|NCT00068692|469171579|FG006|Step 1: Registration|Other|0|||
130327689|NCT00068692|469171580|FG007|Step 1: Registration|Other|0|||
130327690|NCT00068692|469171573|FG000|Step 1: Registration|Not start protocol therapy|3|||
130327691|NCT00068692|469171574|FG001|Step 1: Registration|Not start protocol therapy|0|||
130327692|NCT00068692|469171575|FG002|Step 1: Registration|Not start protocol therapy|0|||
130327693|NCT00068692|469171576|FG003|Step 1: Registration|Not start protocol therapy|0|||
130327694|NCT00068692|469171577|FG004|Step 1: Registration|Not start protocol therapy|0|||
130327695|NCT00068692|469171578|FG005|Step 1: Registration|Not start protocol therapy|0|||
130327696|NCT00068692|469171579|FG006|Step 1: Registration|Not start protocol therapy|0|||
130327697|NCT00068692|469171580|FG007|Step 1: Registration|Not start protocol therapy|0|||
130327698|NCT00068692|469171573|FG000|Step 1: Registration|Registered but not randomized|0|||
130327699|NCT00068692|469171574|FG001|Step 1: Registration|Registered but not randomized|1|||
130327700|NCT00068692|469171575|FG002|Step 1: Registration|Registered but not randomized|0|||
130327701|NCT00068692|469171576|FG003|Step 1: Registration|Registered but not randomized|0|||
130327702|NCT00068692|469171577|FG004|Step 1: Registration|Registered but not randomized|0|||
130327703|NCT00068692|469171578|FG005|Step 1: Registration|Registered but not randomized|0|||
130327704|NCT00068692|469171579|FG006|Step 1: Registration|Registered but not randomized|0|||
130327705|NCT00068692|469171580|FG007|Step 1: Registration|Registered but not randomized|0|||
130327706|NCT00068692|469171573|FG000|Step 2: Randomization|Disesae progression/replase|0|||
130327707|NCT00068692|469171574|FG001|Step 2: Randomization|Disesae progression/replase|0|||
130327708|NCT00068692|469171575|FG002|Step 2: Randomization|Disesae progression/replase|1|||
130327709|NCT00068692|469171576|FG003|Step 2: Randomization|Disesae progression/replase|1|||
130327710|NCT00068692|469171577|FG004|Step 2: Randomization|Disesae progression/replase|0|||
130327711|NCT00068692|469171578|FG005|Step 2: Randomization|Disesae progression/replase|0|||
130327712|NCT00068692|469171579|FG006|Step 2: Randomization|Disesae progression/replase|0|||
130327713|NCT00068692|469171580|FG007|Step 2: Randomization|Disesae progression/replase|0|||
130327714|NCT00068692|469171573|FG000|Step 2: Randomization|Adverse Event|0|||
130327715|NCT00068692|469171574|FG001|Step 2: Randomization|Adverse Event|0|||
130327716|NCT00068692|469171575|FG002|Step 2: Randomization|Adverse Event|4|||
130327717|NCT00068692|469171576|FG003|Step 2: Randomization|Adverse Event|2|||
130327718|NCT00068692|469171577|FG004|Step 2: Randomization|Adverse Event|2|||
130327719|NCT00068692|469171578|FG005|Step 2: Randomization|Adverse Event|3|||
130327720|NCT00068692|469171579|FG006|Step 2: Randomization|Adverse Event|4|||
130327721|NCT00068692|469171580|FG007|Step 2: Randomization|Adverse Event|4|||
130327722|NCT00068692|469171573|FG000|Step 2: Randomization|Death|0|||
130327723|NCT00068692|469171574|FG001|Step 2: Randomization|Death|0|||
130327724|NCT00068692|469171575|FG002|Step 2: Randomization|Death|0|||
130327725|NCT00068692|469171576|FG003|Step 2: Randomization|Death|0|||
130327726|NCT00068692|469171577|FG004|Step 2: Randomization|Death|1|||
130327727|NCT00068692|469171578|FG005|Step 2: Randomization|Death|0|||
130327728|NCT00068692|469171579|FG006|Step 2: Randomization|Death|0|||
130327729|NCT00068692|469171580|FG007|Step 2: Randomization|Death|1|||
130327730|NCT00068692|469171573|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
130327731|NCT00068692|469171574|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
130327732|NCT00068692|469171575|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
130327733|NCT00068692|469171576|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
130215602|NCT00262002|468751778|FG001|Overall Study|Adverse Event|1|||
130215603|NCT00262002|468751779|FG002|Overall Study|Adverse Event|0|||
130215604|NCT00262002|468751780|FG003|Overall Study|Adverse Event|0|||
130215605|NCT00262002|468751781|FG004|Overall Study|Adverse Event|0|||
130215606|NCT00262002|468751782|FG005|Overall Study|Adverse Event|1|||
130215607|NCT00262002|468751783|FG006|Overall Study|Adverse Event|0|||
130215608|NCT00262002|468751777|FG000|Overall Study|Withdrawal by Subject|4|||
130215609|NCT00262002|468751778|FG001|Overall Study|Withdrawal by Subject|2|||
130327734|NCT00068692|469171577|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
130327735|NCT00068692|469171578|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
130327736|NCT00068692|469171579|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
130327737|NCT00068692|469171580|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
130327738|NCT00068692|469171573|FG000|Step 2: Randomization|alternative therapy|0|||
130327739|NCT00068692|469171574|FG001|Step 2: Randomization|alternative therapy|0|||
130327740|NCT00068692|469171575|FG002|Step 2: Randomization|alternative therapy|0|||
130327741|NCT00068692|469171576|FG003|Step 2: Randomization|alternative therapy|1|||
130327742|NCT00068692|469171577|FG004|Step 2: Randomization|alternative therapy|1|||
130327743|NCT00068692|469171578|FG005|Step 2: Randomization|alternative therapy|0|||
130327744|NCT00068692|469171579|FG006|Step 2: Randomization|alternative therapy|0|||
130327745|NCT00068692|469171580|FG007|Step 2: Randomization|alternative therapy|0|||
130327746|NCT00068692|469171573|FG000|Step 2: Randomization|Physician Decision|0|||
130327747|NCT00068692|469171574|FG001|Step 2: Randomization|Physician Decision|0|||
130327748|NCT00068692|469171575|FG002|Step 2: Randomization|Physician Decision|0|||
130327749|NCT00068692|469171576|FG003|Step 2: Randomization|Physician Decision|1|||
130327750|NCT00068692|469171577|FG004|Step 2: Randomization|Physician Decision|1|||
130327751|NCT00068692|469171578|FG005|Step 2: Randomization|Physician Decision|0|||
130327752|NCT00068692|469171579|FG006|Step 2: Randomization|Physician Decision|0|||
130327753|NCT00068692|469171580|FG007|Step 2: Randomization|Physician Decision|0|||
130327754|NCT00068692|469171573|FG000|Step 2: Randomization|Other|0|||
130327755|NCT00068692|469171574|FG001|Step 2: Randomization|Other|0|||
130327756|NCT00068692|469171575|FG002|Step 2: Randomization|Other|0|||
130327757|NCT00068692|469171576|FG003|Step 2: Randomization|Other|1|||
130327758|NCT00068692|469171577|FG004|Step 2: Randomization|Other|0|||
130327759|NCT00068692|469171578|FG005|Step 2: Randomization|Other|1|||
130327760|NCT00068692|469171579|FG006|Step 2: Randomization|Other|0|||
130327761|NCT00068692|469171580|FG007|Step 2: Randomization|Other|0|||
130327762|NCT00068692|469171573|FG000|Step 2: Randomization|never start protocol therapy|0|||
130327763|NCT00068692|469171574|FG001|Step 2: Randomization|never start protocol therapy|0|||
130327764|NCT00068692|469171575|FG002|Step 2: Randomization|never start protocol therapy|1|||
130327765|NCT00068692|469171576|FG003|Step 2: Randomization|never start protocol therapy|0|||
130327766|NCT00068692|469171577|FG004|Step 2: Randomization|never start protocol therapy|1|||
130327767|NCT00068692|469171578|FG005|Step 2: Randomization|never start protocol therapy|0|||
130327768|NCT00068692|469171579|FG006|Step 2: Randomization|never start protocol therapy|0|||
130327769|NCT00068692|469171580|FG007|Step 2: Randomization|never start protocol therapy|0|||
130327770|NCT00248040|469171585|FG000|Overall Study|transplantectomy|2|||
130327771|NCT00248040|469171586|FG001|Overall Study|transplantectomy|1|||
130327772|NCT00248040|469171587|FG002|Overall Study|transplantectomy|3|||
130327773|NCT00248040|469171585|FG000|Overall Study|transplant cancelled post treat start|1|||
129988922|NCT00903682|467921166|FG000|Overall Study|Pregnancy|0|||
129988923|NCT00903682|467921167|FG001|Overall Study|Pregnancy|1|||
129988924|NCT00903682|467921166|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
129988925|NCT00903682|467921167|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
129988926|NCT00903682|467921166|FG000|Overall Study|Subject Non-Compliant|1|||
129988927|NCT00903682|467921167|FG001|Overall Study|Subject Non-Compliant|0|||
129988928|NCT00903682|467921166|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
129988929|NCT00903682|467921167|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
129988930|NCT00903682|467921166|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
129988931|NCT00903682|467921167|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
129988932|NCT02495792|467921168|FG000|Overall Study|Lost to Follow-up|5|||
129988933|NCT02495792|467921169|FG001|Overall Study|Lost to Follow-up|9|||
129988934|NCT02495792|467921168|FG000|Overall Study|Protocol Violation|32|||
129988935|NCT02495792|467921169|FG001|Overall Study|Protocol Violation|31|||
129988936|NCT01028027|467921170|FG000|Overall Study|Lost to Follow-up|4|||
129988937|NCT01028027|467921171|FG001|Overall Study|Lost to Follow-up|1|||
129988938|NCT01028027|467921170|FG000|Overall Study|Withdrawal by Subject|5|||
129988939|NCT01028027|467921171|FG001|Overall Study|Withdrawal by Subject|3|||
129988940|NCT01028027|467921170|FG000|Overall Study|Adverse Event|4|||
129988941|NCT01028027|467921171|FG001|Overall Study|Adverse Event|7|||
129988942|NCT01028027|467921170|FG000|Overall Study|Protocol Violation|3|||
129988943|NCT01028027|467921171|FG001|Overall Study|Protocol Violation|1|||
129988944|NCT01028027|467921170|FG000|Overall Study|Lack of Efficacy|0|||
129988945|NCT01028027|467921171|FG001|Overall Study|Lack of Efficacy|1|||
129988946|NCT00153062|467923208|FG000|Overall Study|Death|360|||
129988947|NCT00153062|467923209|FG001|Overall Study|Death|352|||
129988948|NCT00153062|467923210|FG002|Overall Study|Death|369|||
129988949|NCT00153062|467923211|FG003|Overall Study|Death|365|||
129988950|NCT00153062|467923208|FG000|Overall Study|Withdrawal by Subject|14|||
129988951|NCT00153062|467923209|FG001|Overall Study|Withdrawal by Subject|30|||
129988952|NCT00153062|467923210|FG002|Overall Study|Withdrawal by Subject|27|||
129988953|NCT00153062|467923211|FG003|Overall Study|Withdrawal by Subject|28|||
129988954|NCT00153062|467923208|FG000|Overall Study|Lost to Follow-up|12|||
129988955|NCT00153062|467923209|FG001|Overall Study|Lost to Follow-up|20|||
129988956|NCT00153062|467923210|FG002|Overall Study|Lost to Follow-up|15|||
129988957|NCT00153062|467923211|FG003|Overall Study|Lost to Follow-up|16|||
129988958|NCT00153062|467923208|FG000|Overall Study|Adverse Event|0|||
129988959|NCT00153062|467923209|FG001|Overall Study|Adverse Event|1|||
129988960|NCT00153062|467923210|FG002|Overall Study|Adverse Event|1|||
129988961|NCT00153062|467923211|FG003|Overall Study|Adverse Event|0|||
129988962|NCT00153062|467923208|FG000|Overall Study|Protocol Violation|0|||
129988963|NCT00153062|467923209|FG001|Overall Study|Protocol Violation|2|||
129988964|NCT00153062|467923210|FG002|Overall Study|Protocol Violation|1|||
129988965|NCT00153062|467923211|FG003|Overall Study|Protocol Violation|1|||
130327774|NCT00248040|469171586|FG001|Overall Study|transplant cancelled post treat start|0|||
130327775|NCT00248040|469171587|FG002|Overall Study|transplant cancelled post treat start|0|||
130327776|NCT00248040|469171585|FG000|Overall Study|Death|0|||
130327777|NCT00248040|469171586|FG001|Overall Study|Death|0|||
130327778|NCT00248040|469171587|FG002|Overall Study|Death|1|||
130327779|NCT00711191|469171593|FG000|Overall Study|Adverse Event|1|||
129988966|NCT00153062|467923208|FG000|Overall Study|No disposition data available|1|||
130327780|NCT00711191|469171594|FG001|Overall Study|Adverse Event|1|||
130327781|NCT00711191|469171595|FG002|Overall Study|Adverse Event|2|||
130327782|NCT00711191|469171593|FG000|Overall Study|Objective progression or relapse|2|||
130327783|NCT00711191|469171594|FG001|Overall Study|Objective progression or relapse|3|||
130327784|NCT00711191|469171595|FG002|Overall Study|Objective progression or relapse|7|||
130327785|NCT00711191|469171593|FG000|Overall Study|Withdrawal by Subject|0|||
130327786|NCT00711191|469171594|FG001|Overall Study|Withdrawal by Subject|1|||
130327787|NCT00711191|469171595|FG002|Overall Study|Withdrawal by Subject|3|||
130327788|NCT00602472|469171596|FG000|Overall Study|Adverse Event|5|||
130327789|NCT00602472|469171597|FG001|Overall Study|Adverse Event|23|||
130327790|NCT00602472|469171596|FG000|Overall Study|Protocol Violation|4|||
130327791|NCT00602472|469171597|FG001|Overall Study|Protocol Violation|19|||
130327792|NCT00602472|469171596|FG000|Overall Study|Withdrawal by Subject|8|||
130327793|NCT00602472|469171597|FG001|Overall Study|Withdrawal by Subject|14|||
130327794|NCT00602472|469171596|FG000|Overall Study|Other incl. lack of efficacy|4|||
130327795|NCT00602472|469171597|FG001|Overall Study|Other incl. lack of efficacy|2|||
130327796|NCT03038880|469171598|FG000|Overall Study|Death|1|||
130327797|NCT03038880|469171599|FG001|Overall Study|Death|2|||
130327798|NCT03038880|469171600|FG002|Overall Study|Death|0|||
130327799|NCT03038880|469171598|FG000|Overall Study|Physician Decision|2|||
130327800|NCT03038880|469171599|FG001|Overall Study|Physician Decision|1|||
130327801|NCT03038880|469171600|FG002|Overall Study|Physician Decision|0|||
130327802|NCT01002339|469171601|FG000|Overall Study|Withdrawal by Subject|0|||
130327803|NCT01002339|469171602|FG001|Overall Study|Withdrawal by Subject|1|||
130327804|NCT01002339|469171603|FG002|Overall Study|Withdrawal by Subject|0|||
130327805|NCT01002339|469171601|FG000|Overall Study|Incorrect treatment assignment|0|||
130327806|NCT01002339|469171602|FG001|Overall Study|Incorrect treatment assignment|0|||
130327807|NCT01002339|469171603|FG002|Overall Study|Incorrect treatment assignment|1|||
130327808|NCT01002339|469171601|FG000|Overall Study|Protocol Violation|0|||
130327809|NCT01002339|469171602|FG001|Overall Study|Protocol Violation|0|||
130327810|NCT01002339|469171603|FG002|Overall Study|Protocol Violation|2|||
130327811|NCT01002339|469171601|FG000|Overall Study|Lung cancer detected before transplant|0|||
130327812|NCT01002339|469171602|FG001|Overall Study|Lung cancer detected before transplant|0|||
130327813|NCT01002339|469171603|FG002|Overall Study|Lung cancer detected before transplant|1|||
130327814|NCT01002339|469171601|FG000|Overall Study|Randomized. Not transplanted|0|||
130327815|NCT01002339|469171602|FG001|Overall Study|Randomized. Not transplanted|0|||
130327816|NCT01002339|469171603|FG002|Overall Study|Randomized. Not transplanted|1|||
130327817|NCT02118961|469171604|FG000|Overall Study|Withdrawal by Subject|1|||
130327818|NCT02118961|469171605|FG001|Overall Study|Withdrawal by Subject|0|||
130327819|NCT00790842|469171606|FG000|Dose Level 1|Adverse Event|1|||
130327820|NCT00790842|469171607|FG001|Dose Level 1|Adverse Event|0|||
130327821|NCT00790842|469171608|FG002|Dose Level 1|Adverse Event|0|||
130327822|NCT00790842|469171609|FG003|Dose Level 1|Adverse Event|2|||
130327823|NCT00790842|469171610|FG004|Dose Level 1|Adverse Event|0|||
130327824|NCT00790842|469171611|FG005|Dose Level 1|Adverse Event|0|||
130327825|NCT00790842|469171612|FG006|Dose Level 1|Adverse Event|0|||
130327826|NCT00790842|469171613|FG007|Dose Level 1|Adverse Event|1|||
130327827|NCT00790842|469171614|FG008|Dose Level 1|Adverse Event|0|||
130327828|NCT00790842|469171615|FG009|Dose Level 1|Adverse Event|0|||
129988967|NCT00153062|467923209|FG001|Overall Study|No disposition data available|1|||
129988968|NCT00153062|467923210|FG002|Overall Study|No disposition data available|1|||
129988969|NCT00153062|467923211|FG003|Overall Study|No disposition data available|1|||
129988970|NCT00153062|467923208|FG000|Overall Study|Other|0|||
129988971|NCT00153062|467923209|FG001|Overall Study|Other|0|||
129988972|NCT00153062|467923210|FG002|Overall Study|Other|1|||
129988973|NCT00153062|467923211|FG003|Overall Study|Other|0|||
129988974|NCT00275262|467923218|FG000|Overall Study|Adverse Event|2|||
129988975|NCT00275262|467923219|FG001|Overall Study|Adverse Event|0|||
129988976|NCT00275262|467923218|FG000|Overall Study|Disease progression|2|||
129988977|NCT00275262|467923219|FG001|Overall Study|Disease progression|5|||
129988978|NCT00275262|467923218|FG000|Overall Study|Lost to Follow-up|0|||
129988979|NCT00275262|467923219|FG001|Overall Study|Lost to Follow-up|2|||
129988980|NCT00275262|467923218|FG000|Overall Study|Protocol Violation|0|||
129988981|NCT00275262|467923219|FG001|Overall Study|Protocol Violation|2|||
129988982|NCT00275262|467923218|FG000|Overall Study|Death|1|||
129988983|NCT00275262|467923219|FG001|Overall Study|Death|0|||
130327829|NCT00790842|469171616|FG010|Dose Level 1|Adverse Event|0|||
129988984|NCT00275262|467923218|FG000|Overall Study|Started Chemotherapy|1|||
129988985|NCT00275262|467923219|FG001|Overall Study|Started Chemotherapy|0|||
130327830|NCT00790842|469171606|FG000|Dose Level 1|Physician Decision|1|||
130327831|NCT00790842|469171607|FG001|Dose Level 1|Physician Decision|0|||
130327832|NCT00790842|469171608|FG002|Dose Level 1|Physician Decision|0|||
130327833|NCT00790842|469171609|FG003|Dose Level 1|Physician Decision|0|||
129988986|NCT01589237|467923232|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
130327834|NCT00790842|469171610|FG004|Dose Level 1|Physician Decision|0|||
130327835|NCT00790842|469171611|FG005|Dose Level 1|Physician Decision|0|||
130327836|NCT00790842|469171612|FG006|Dose Level 1|Physician Decision|0|||
130327837|NCT00790842|469171613|FG007|Dose Level 1|Physician Decision|1|||
130327838|NCT00790842|469171614|FG008|Dose Level 1|Physician Decision|0|||
130327839|NCT00790842|469171615|FG009|Dose Level 1|Physician Decision|0|||
130327840|NCT00790842|469171616|FG010|Dose Level 1|Physician Decision|0|||
130327841|NCT00790842|469171606|FG000|Dose Level 1|Withdrawal by Subject|1|||
130327842|NCT00790842|469171607|FG001|Dose Level 1|Withdrawal by Subject|0|||
130327843|NCT00790842|469171608|FG002|Dose Level 1|Withdrawal by Subject|0|||
130327844|NCT00790842|469171609|FG003|Dose Level 1|Withdrawal by Subject|0|||
130327845|NCT00790842|469171610|FG004|Dose Level 1|Withdrawal by Subject|0|||
130327846|NCT00790842|469171611|FG005|Dose Level 1|Withdrawal by Subject|0|||
130327847|NCT00790842|469171612|FG006|Dose Level 1|Withdrawal by Subject|0|||
130327848|NCT00790842|469171613|FG007|Dose Level 1|Withdrawal by Subject|0|||
130327849|NCT00790842|469171614|FG008|Dose Level 1|Withdrawal by Subject|0|||
130327850|NCT00790842|469171615|FG009|Dose Level 1|Withdrawal by Subject|0|||
130327851|NCT00790842|469171616|FG010|Dose Level 1|Withdrawal by Subject|0|||
130327852|NCT00790842|469171606|FG000|Dose Level 2|Death|0|||
130327853|NCT00790842|469171607|FG001|Dose Level 2|Death|1|||
130327854|NCT00790842|469171608|FG002|Dose Level 2|Death|0|||
130327855|NCT00790842|469171609|FG003|Dose Level 2|Death|0|||
130327856|NCT00790842|469171610|FG004|Dose Level 2|Death|1|||
130327857|NCT00790842|469171611|FG005|Dose Level 2|Death|0|||
130327858|NCT00790842|469171612|FG006|Dose Level 2|Death|0|||
130327859|NCT00790842|469171613|FG007|Dose Level 2|Death|0|||
130327860|NCT00790842|469171614|FG008|Dose Level 2|Death|0|||
130327861|NCT00790842|469171615|FG009|Dose Level 2|Death|0|||
130327862|NCT00790842|469171616|FG010|Dose Level 2|Death|0|||
130327863|NCT00790842|469171606|FG000|Dose Level 2|Physician Decision|0|||
130327864|NCT00790842|469171607|FG001|Dose Level 2|Physician Decision|1|||
130327865|NCT00790842|469171608|FG002|Dose Level 2|Physician Decision|0|||
130327866|NCT00790842|469171609|FG003|Dose Level 2|Physician Decision|0|||
130327867|NCT00790842|469171610|FG004|Dose Level 2|Physician Decision|0|||
130327868|NCT00790842|469171611|FG005|Dose Level 2|Physician Decision|0|||
130327869|NCT00790842|469171612|FG006|Dose Level 2|Physician Decision|0|||
130327870|NCT00790842|469171613|FG007|Dose Level 2|Physician Decision|0|||
130327871|NCT00790842|469171614|FG008|Dose Level 2|Physician Decision|0|||
130327872|NCT00790842|469171615|FG009|Dose Level 2|Physician Decision|0|||
130327873|NCT00790842|469171616|FG010|Dose Level 2|Physician Decision|0|||
130327874|NCT00790842|469171606|FG000|Dose Level 2|Withdrawal by Subject|0|||
130327875|NCT00790842|469171607|FG001|Dose Level 2|Withdrawal by Subject|1|||
130327876|NCT00790842|469171608|FG002|Dose Level 2|Withdrawal by Subject|0|||
130327877|NCT00790842|469171609|FG003|Dose Level 2|Withdrawal by Subject|0|||
130327878|NCT00790842|469171610|FG004|Dose Level 2|Withdrawal by Subject|0|||
130327879|NCT00790842|469171611|FG005|Dose Level 2|Withdrawal by Subject|0|||
130327880|NCT00790842|469171612|FG006|Dose Level 2|Withdrawal by Subject|0|||
130327881|NCT00790842|469171613|FG007|Dose Level 2|Withdrawal by Subject|0|||
130327882|NCT00790842|469171614|FG008|Dose Level 2|Withdrawal by Subject|0|||
130327883|NCT00790842|469171615|FG009|Dose Level 2|Withdrawal by Subject|0|||
129988987|NCT01589237|467923233|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
129988988|NCT01589237|467923234|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
129988989|NCT01589237|467923235|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
129988990|NCT01589237|467923232|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129988991|NCT01589237|467923233|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
129988992|NCT01589237|467923234|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129988993|NCT01589237|467923235|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129988994|NCT01589237|467923232|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
129988995|NCT01589237|467923233|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
129988996|NCT01589237|467923234|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
129988997|NCT01589237|467923235|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
129988998|NCT01589237|467923232|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
129988999|NCT01589237|467923233|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
129989000|NCT01589237|467923234|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
129989001|NCT01589237|467923235|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
129989002|NCT02594163|467923236|FG000|Treatment Period|Progressive disease|2|||
130327884|NCT00790842|469171616|FG010|Dose Level 2|Withdrawal by Subject|0|||
130327885|NCT00790842|469171606|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327886|NCT00790842|469171607|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327887|NCT00790842|469171608|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327888|NCT00790842|469171609|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327889|NCT00790842|469171610|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327890|NCT00790842|469171611|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327891|NCT00790842|469171612|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327892|NCT00790842|469171613|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327893|NCT00790842|469171614|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
130327894|NCT00790842|469171615|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327895|NCT00790842|469171616|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
130327896|NCT00790842|469171606|FG000|Dose Level 3|Adverse Event|0|||
130327897|NCT00790842|469171607|FG001|Dose Level 3|Adverse Event|0|||
130327898|NCT00790842|469171608|FG002|Dose Level 3|Adverse Event|1|||
130327899|NCT00790842|469171609|FG003|Dose Level 3|Adverse Event|0|||
130327900|NCT00790842|469171610|FG004|Dose Level 3|Adverse Event|0|||
130327901|NCT00790842|469171611|FG005|Dose Level 3|Adverse Event|0|||
130327902|NCT00790842|469171612|FG006|Dose Level 3|Adverse Event|0|||
130327903|NCT00790842|469171613|FG007|Dose Level 3|Adverse Event|0|||
130327904|NCT00790842|469171614|FG008|Dose Level 3|Adverse Event|0|||
130327905|NCT00790842|469171615|FG009|Dose Level 3|Adverse Event|0|||
130327906|NCT00790842|469171616|FG010|Dose Level 3|Adverse Event|0|||
130327907|NCT00790842|469171606|FG000|Dose Level 3|Withdrawal by Subject|0|||
130327908|NCT00790842|469171607|FG001|Dose Level 3|Withdrawal by Subject|0|||
130327909|NCT00790842|469171608|FG002|Dose Level 3|Withdrawal by Subject|3|||
130327910|NCT00790842|469171609|FG003|Dose Level 3|Withdrawal by Subject|0|||
130327911|NCT00790842|469171610|FG004|Dose Level 3|Withdrawal by Subject|0|||
130327912|NCT00790842|469171611|FG005|Dose Level 3|Withdrawal by Subject|0|||
130327913|NCT00790842|469171612|FG006|Dose Level 3|Withdrawal by Subject|0|||
130327914|NCT00790842|469171613|FG007|Dose Level 3|Withdrawal by Subject|0|||
130327915|NCT00790842|469171614|FG008|Dose Level 3|Withdrawal by Subject|0|||
130327916|NCT00790842|469171615|FG009|Dose Level 3|Withdrawal by Subject|2|||
130327917|NCT00790842|469171616|FG010|Dose Level 3|Withdrawal by Subject|0|||
130327918|NCT00790842|469171606|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327919|NCT00790842|469171607|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327920|NCT00790842|469171608|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327921|NCT00790842|469171609|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327922|NCT00790842|469171610|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327923|NCT00790842|469171611|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
130327924|NCT00790842|469171612|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129883682|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
129883683|NCT03632434|467534377|FG000|Overall Study|Withdrawal by Subject|2|||
129883684|NCT01751113|467534380|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883685|NCT01751113|467534381|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883686|NCT01751113|467534382|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883687|NCT01751113|467534383|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
129883688|NCT01751113|467534384|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
129883689|NCT01751113|467534385|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883690|NCT01751113|467534380|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883691|NCT01751113|467534381|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883692|NCT01751113|467534382|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883693|NCT01751113|467534383|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883694|NCT01751113|467534384|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883695|NCT01751113|467534385|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
129883696|NCT01551303|467534387|FG000|Overall Study|failed awareness check on vision test|4|||
129883697|NCT01551303|467534388|FG001|Overall Study|failed awareness check on vision test|7|||
129883698|NCT02743793|467534398|FG000|Overall Study|Death|1|||
129883699|NCT02743793|467534399|FG001|Overall Study|Death|1|||
129883700|NCT02743793|467534398|FG000|Overall Study|Withdrawal by Subject|0|||
129883701|NCT02743793|467534399|FG001|Overall Study|Withdrawal by Subject|1|||
129883702|NCT02743793|467534398|FG000|Overall Study|Screen Failure|4|||
129883703|NCT02743793|467534399|FG001|Overall Study|Screen Failure|0|||
129883704|NCT02743793|467534398|FG000|Overall Study|No Primary Care Physician|0|||
129883705|NCT02743793|467534399|FG001|Overall Study|No Primary Care Physician|1|||
129883706|NCT02743793|467534398|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
129883707|NCT02743793|467534399|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
129883708|NCT02743793|467534398|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
129883709|NCT02743793|467534399|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
129883710|NCT01146574|467534404|FG000|Overall Study|Death|0|||
129883711|NCT01146574|467534405|FG001|Overall Study|Death|1|||
129883712|NCT01146574|467534406|FG002|Overall Study|Death|1|||
129883713|NCT01146574|467534407|FG003|Overall Study|Death|0|||
129883714|NCT01146574|467534408|FG004|Overall Study|Death|0|||
129883715|NCT01146574|467534409|FG005|Overall Study|Death|0|||
129883716|NCT01146574|467534410|FG006|Overall Study|Death|0|||
130215610|NCT00262002|468751779|FG002|Overall Study|Withdrawal by Subject|0|||
130327925|NCT00790842|469171613|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327926|NCT00790842|469171614|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327927|NCT00790842|469171615|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129883717|NCT01146574|467534404|FG000|Overall Study|Other reasons|0|||
129883718|NCT01146574|467534405|FG001|Overall Study|Other reasons|0|||
129883719|NCT01146574|467534406|FG002|Overall Study|Other reasons|3|||
129883720|NCT01146574|467534407|FG003|Overall Study|Other reasons|0|||
130327928|NCT00790842|469171616|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
130327929|NCT00790842|469171606|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327930|NCT00790842|469171607|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327931|NCT00790842|469171608|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
130327932|NCT00790842|469171609|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327933|NCT00790842|469171610|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327934|NCT00790842|469171611|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327935|NCT00790842|469171612|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327936|NCT00790842|469171613|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327937|NCT00790842|469171614|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327938|NCT00790842|469171615|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327939|NCT00790842|469171616|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
130327940|NCT00790842|469171606|FG000|Dose Level 4|Adverse Event|0|||
130327941|NCT00790842|469171607|FG001|Dose Level 4|Adverse Event|0|||
130327942|NCT00790842|469171608|FG002|Dose Level 4|Adverse Event|0|||
130327943|NCT00790842|469171609|FG003|Dose Level 4|Adverse Event|0|||
130327944|NCT00790842|469171610|FG004|Dose Level 4|Adverse Event|0|||
130327945|NCT00790842|469171611|FG005|Dose Level 4|Adverse Event|0|||
130327946|NCT00790842|469171612|FG006|Dose Level 4|Adverse Event|1|||
130327947|NCT00790842|469171613|FG007|Dose Level 4|Adverse Event|0|||
130327948|NCT00790842|469171614|FG008|Dose Level 4|Adverse Event|0|||
130327949|NCT00790842|469171615|FG009|Dose Level 4|Adverse Event|0|||
130327950|NCT00790842|469171616|FG010|Dose Level 4|Adverse Event|0|||
130327951|NCT00790842|469171606|FG000|Dose Level 4|Physician Decision|0|||
130327952|NCT00790842|469171607|FG001|Dose Level 4|Physician Decision|0|||
130327953|NCT00790842|469171608|FG002|Dose Level 4|Physician Decision|0|||
130327954|NCT00790842|469171609|FG003|Dose Level 4|Physician Decision|0|||
130327955|NCT00790842|469171610|FG004|Dose Level 4|Physician Decision|0|||
130327956|NCT00790842|469171611|FG005|Dose Level 4|Physician Decision|0|||
130327957|NCT00790842|469171612|FG006|Dose Level 4|Physician Decision|1|||
130327958|NCT00790842|469171613|FG007|Dose Level 4|Physician Decision|0|||
130327959|NCT00790842|469171614|FG008|Dose Level 4|Physician Decision|0|||
130327960|NCT00790842|469171615|FG009|Dose Level 4|Physician Decision|0|||
130327961|NCT00790842|469171616|FG010|Dose Level 4|Physician Decision|1|||
130327962|NCT00790842|469171606|FG000|Dose Level 4|Withdrawal by Subject|0|||
130327963|NCT00790842|469171607|FG001|Dose Level 4|Withdrawal by Subject|0|||
130327964|NCT00790842|469171608|FG002|Dose Level 4|Withdrawal by Subject|0|||
130327965|NCT00790842|469171609|FG003|Dose Level 4|Withdrawal by Subject|0|||
130327966|NCT00790842|469171610|FG004|Dose Level 4|Withdrawal by Subject|0|||
130327967|NCT00790842|469171611|FG005|Dose Level 4|Withdrawal by Subject|0|||
130327968|NCT00790842|469171612|FG006|Dose Level 4|Withdrawal by Subject|0|||
130327969|NCT00790842|469171613|FG007|Dose Level 4|Withdrawal by Subject|0|||
130327970|NCT00790842|469171614|FG008|Dose Level 4|Withdrawal by Subject|0|||
130327971|NCT00790842|469171615|FG009|Dose Level 4|Withdrawal by Subject|0|||
130327972|NCT00790842|469171616|FG010|Dose Level 4|Withdrawal by Subject|1|||
130327973|NCT00790842|469171606|FG000|Expansion Cohort|Adverse Event|0|||
130327974|NCT00790842|469171607|FG001|Expansion Cohort|Adverse Event|0|||
130327975|NCT00790842|469171608|FG002|Expansion Cohort|Adverse Event|0|||
130327976|NCT00790842|469171609|FG003|Expansion Cohort|Adverse Event|0|||
130327977|NCT00790842|469171610|FG004|Expansion Cohort|Adverse Event|0|||
130327978|NCT00790842|469171611|FG005|Expansion Cohort|Adverse Event|0|||
130327979|NCT00790842|469171612|FG006|Expansion Cohort|Adverse Event|1|||
130327980|NCT00790842|469171613|FG007|Expansion Cohort|Adverse Event|0|||
130327981|NCT00790842|469171614|FG008|Expansion Cohort|Adverse Event|0|||
130327982|NCT00790842|469171615|FG009|Expansion Cohort|Adverse Event|0|||
130327983|NCT00790842|469171616|FG010|Expansion Cohort|Adverse Event|0|||
130327984|NCT00790842|469171606|FG000|Expansion Cohort|Death|0|||
130327985|NCT00790842|469171607|FG001|Expansion Cohort|Death|0|||
130327986|NCT00790842|469171608|FG002|Expansion Cohort|Death|2|||
130327987|NCT00790842|469171609|FG003|Expansion Cohort|Death|0|||
130327988|NCT00790842|469171610|FG004|Expansion Cohort|Death|0|||
130327989|NCT00790842|469171611|FG005|Expansion Cohort|Death|0|||
130327990|NCT00790842|469171612|FG006|Expansion Cohort|Death|0|||
130327991|NCT00790842|469171613|FG007|Expansion Cohort|Death|0|||
130327992|NCT00790842|469171614|FG008|Expansion Cohort|Death|0|||
130327993|NCT00790842|469171615|FG009|Expansion Cohort|Death|0|||
130327994|NCT00790842|469171616|FG010|Expansion Cohort|Death|0|||
130327995|NCT00790842|469171606|FG000|Expansion Cohort|Physician Decision|0|||
130327996|NCT00790842|469171607|FG001|Expansion Cohort|Physician Decision|0|||
130327997|NCT00790842|469171608|FG002|Expansion Cohort|Physician Decision|1|||
130327998|NCT00790842|469171609|FG003|Expansion Cohort|Physician Decision|0|||
130327999|NCT00790842|469171610|FG004|Expansion Cohort|Physician Decision|0|||
130328000|NCT00790842|469171611|FG005|Expansion Cohort|Physician Decision|0|||
130328001|NCT00790842|469171612|FG006|Expansion Cohort|Physician Decision|0|||
130328002|NCT00790842|469171613|FG007|Expansion Cohort|Physician Decision|0|||
130328003|NCT00790842|469171614|FG008|Expansion Cohort|Physician Decision|0|||
130328004|NCT00790842|469171615|FG009|Expansion Cohort|Physician Decision|0|||
130328005|NCT00790842|469171616|FG010|Expansion Cohort|Physician Decision|0|||
130328006|NCT00790842|469171606|FG000|Expansion Cohort|Withdrawal by Subject|0|||
130328007|NCT00790842|469171607|FG001|Expansion Cohort|Withdrawal by Subject|0|||
130328008|NCT00790842|469171608|FG002|Expansion Cohort|Withdrawal by Subject|3|||
130328009|NCT00790842|469171609|FG003|Expansion Cohort|Withdrawal by Subject|0|||
130328010|NCT00790842|469171610|FG004|Expansion Cohort|Withdrawal by Subject|0|||
130328011|NCT00790842|469171611|FG005|Expansion Cohort|Withdrawal by Subject|0|||
130328012|NCT00790842|469171612|FG006|Expansion Cohort|Withdrawal by Subject|0|||
130328013|NCT00790842|469171613|FG007|Expansion Cohort|Withdrawal by Subject|0|||
130328014|NCT00790842|469171614|FG008|Expansion Cohort|Withdrawal by Subject|0|||
130328015|NCT00790842|469171615|FG009|Expansion Cohort|Withdrawal by Subject|0|||
130328016|NCT00790842|469171616|FG010|Expansion Cohort|Withdrawal by Subject|0|||
130328017|NCT00790842|469171606|FG000|Expansion Cohort|Study Closure|0|||
130328018|NCT00790842|469171607|FG001|Expansion Cohort|Study Closure|0|||
130328019|NCT00790842|469171608|FG002|Expansion Cohort|Study Closure|1|||
130328020|NCT00790842|469171609|FG003|Expansion Cohort|Study Closure|0|||
130328021|NCT00790842|469171610|FG004|Expansion Cohort|Study Closure|0|||
130328022|NCT00790842|469171611|FG005|Expansion Cohort|Study Closure|0|||
130328023|NCT00790842|469171612|FG006|Expansion Cohort|Study Closure|0|||
130328024|NCT00790842|469171613|FG007|Expansion Cohort|Study Closure|0|||
130328025|NCT00790842|469171614|FG008|Expansion Cohort|Study Closure|0|||
130328026|NCT00790842|469171615|FG009|Expansion Cohort|Study Closure|0|||
130328027|NCT00790842|469171616|FG010|Expansion Cohort|Study Closure|0|||
130328028|NCT00419952|469171617|FG000|Overall Study|Adverse Event|8|||
130328029|NCT00419952|469171618|FG001|Overall Study|Adverse Event|10|||
130328030|NCT00419952|469171617|FG000|Overall Study|Withdrawal by Subject|44|||
130328031|NCT00419952|469171618|FG001|Overall Study|Withdrawal by Subject|43|||
130328032|NCT00419952|469171617|FG000|Overall Study|Lost to Follow-up|43|||
130328033|NCT00419952|469171618|FG001|Overall Study|Lost to Follow-up|34|||
130328034|NCT00419952|469171617|FG000|Overall Study|Protocol Violation|32|||
130328035|NCT00419952|469171618|FG001|Overall Study|Protocol Violation|24|||
130328036|NCT00419952|469171617|FG000|Overall Study|Pregnancy|4|||
130328037|NCT00419952|469171618|FG001|Overall Study|Pregnancy|2|||
130328038|NCT00419952|469171617|FG000|Overall Study|Physician Decision|1|||
130328039|NCT00419952|469171618|FG001|Overall Study|Physician Decision|3|||
130328040|NCT00419952|469171617|FG000|Overall Study|Incorrectly enrolled|10|||
130328041|NCT00419952|469171618|FG001|Overall Study|Incorrectly enrolled|3|||
130328042|NCT00419952|469171617|FG000|Overall Study|Intake of prohibited medication|2|||
130328043|NCT00419952|469171618|FG001|Overall Study|Intake of prohibited medication|2|||
130328044|NCT00419952|469171617|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
130328045|NCT00419952|469171618|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
130328046|NCT00419952|469171617|FG000|Overall Study|Diary or medication non-compliance|2|||
130328047|NCT00419952|469171618|FG001|Overall Study|Diary or medication non-compliance|4|||
130328048|NCT00419952|469171617|FG000|Overall Study|Abnormal ECG|1|||
130328049|NCT00419952|469171618|FG001|Overall Study|Abnormal ECG|0|||
130328050|NCT03126591|469171619|FG000|Overall Study|Death|6|||
130328051|NCT03126591|469171620|FG001|Overall Study|Death|3|||
130328052|NCT03126591|469171621|FG002|Overall Study|Death|17|||
130328053|NCT03126591|469171619|FG000|Overall Study|Progressive Disease|0|||
130328054|NCT03126591|469171620|FG001|Overall Study|Progressive Disease|1|||
130328055|NCT03126591|469171621|FG002|Overall Study|Progressive Disease|2|||
130328056|NCT03126591|469171619|FG000|Overall Study|Terminated by Sponsor|0|||
129989003|NCT02594163|467923237|FG001|Treatment Period|Progressive disease|3|||
129989004|NCT02594163|467923236|FG000|Treatment Period|Adverse Event|1|||
129989005|NCT02594163|467923237|FG001|Treatment Period|Adverse Event|5|||
130328057|NCT03126591|469171620|FG001|Overall Study|Terminated by Sponsor|1|||
130328058|NCT03126591|469171621|FG002|Overall Study|Terminated by Sponsor|4|||
130328059|NCT03126591|469171619|FG000|Overall Study|Withdrawal by Subject|1|||
130328060|NCT03126591|469171620|FG001|Overall Study|Withdrawal by Subject|1|||
130328061|NCT03126591|469171621|FG002|Overall Study|Withdrawal by Subject|4|||
130328062|NCT02158546|469171622|FG000|Overall Study|Physician Decision|0|||
130328063|NCT02158546|469171623|FG001|Overall Study|Physician Decision|1|||
130328064|NCT02158546|469171624|FG002|Overall Study|Physician Decision|0|||
130328065|NCT02158546|469171625|FG003|Overall Study|Physician Decision|0|||
130328066|NCT02158546|469171622|FG000|Overall Study|Non-compliance|0|||
130328067|NCT02158546|469171623|FG001|Overall Study|Non-compliance|1|||
130328068|NCT02158546|469171624|FG002|Overall Study|Non-compliance|0|||
130328069|NCT02158546|469171625|FG003|Overall Study|Non-compliance|1|||
129989006|NCT02594163|467923236|FG000|Treatment Period|Physician Decision|1|||
130328070|NCT02158546|469171622|FG000|Overall Study|Failure to meet eligibility criteria|0|||
130215611|NCT00262002|468751780|FG003|Overall Study|Withdrawal by Subject|1|||
130328071|NCT02158546|469171623|FG001|Overall Study|Failure to meet eligibility criteria|1|||
130328072|NCT02158546|469171624|FG002|Overall Study|Failure to meet eligibility criteria|0|||
130328073|NCT02158546|469171625|FG003|Overall Study|Failure to meet eligibility criteria|0|||
130328074|NCT02158546|469171622|FG000|Overall Study|Lack of Efficacy|1|||
130328075|NCT02158546|469171623|FG001|Overall Study|Lack of Efficacy|1|||
130328076|NCT02158546|469171624|FG002|Overall Study|Lack of Efficacy|0|||
130328077|NCT02158546|469171625|FG003|Overall Study|Lack of Efficacy|0|||
130328078|NCT02158546|469171622|FG000|Overall Study|Adverse Event|2|||
130328079|NCT02158546|469171623|FG001|Overall Study|Adverse Event|2|||
129989007|NCT02594163|467923237|FG001|Treatment Period|Physician Decision|3|||
129989008|NCT02594163|467923236|FG000|Treatment Period|Study termination by sponsor|2|||
129989009|NCT02594163|467923237|FG001|Treatment Period|Study termination by sponsor|1|||
129989010|NCT02594163|467923236|FG000|Treatment Period|Other, Non-AE|1|||
129989011|NCT02594163|467923237|FG001|Treatment Period|Other, Non-AE|0|||
129989012|NCT02594163|467923236|FG000|Follow-up Period|Withdrawal by Subject|0|||
129989013|NCT02594163|467923237|FG001|Follow-up Period|Withdrawal by Subject|1|||
129989014|NCT02594163|467923236|FG000|Follow-up Period|Study Termination by Sponsor|6|||
129989015|NCT02594163|467923237|FG001|Follow-up Period|Study Termination by Sponsor|4|||
129989016|NCT02594163|467923236|FG000|Follow-up Period|Lost to Follow-up|1|||
129989017|NCT02594163|467923237|FG001|Follow-up Period|Lost to Follow-up|0|||
129989018|NCT02594163|467923236|FG000|Follow-up Period|Death|2|||
129989019|NCT02594163|467923237|FG001|Follow-up Period|Death|5|||
129989020|NCT02594163|467923236|FG000|Follow-up Period|Adverse Event|0|||
129989021|NCT02594163|467923237|FG001|Follow-up Period|Adverse Event|1|||
129989022|NCT02594163|467923236|FG000|Follow-up Period|Progressive Disease|2|||
129989023|NCT02594163|467923237|FG001|Follow-up Period|Progressive Disease|0|||
129989024|NCT02594163|467923236|FG000|Follow-up Period|Physician Decision|0|||
129989025|NCT02594163|467923237|FG001|Follow-up Period|Physician Decision|1|||
129989026|NCT01290029|467923240|FG000|Overall Study|Other|2|||
129989027|NCT00189488|467923241|FG000|Overall Study|Ineligibility determined|1|||
129989028|NCT00189488|467923242|FG001|Overall Study|Ineligibility determined|0|||
129989029|NCT00189488|467923241|FG000|Overall Study|Protocol deviation|2|||
129989030|NCT00189488|467923242|FG001|Overall Study|Protocol deviation|1|||
129989031|NCT00189488|467923241|FG000|Overall Study|Adverse Event|2|||
129989032|NCT00189488|467923242|FG001|Overall Study|Adverse Event|1|||
129989033|NCT00189488|467923241|FG000|Overall Study|Withdrawal by Subject|2|||
129989034|NCT00189488|467923242|FG001|Overall Study|Withdrawal by Subject|6|||
129989035|NCT00189488|467923241|FG000|Overall Study|Disease progression|2|||
129989036|NCT00189488|467923242|FG001|Overall Study|Disease progression|4|||
129989037|NCT00189488|467923241|FG000|Overall Study|Administrative Decision|0|||
129989038|NCT00189488|467923242|FG001|Overall Study|Administrative Decision|2|||
129989039|NCT00189488|467923241|FG000|Overall Study|Death|5|||
129989040|NCT00189488|467923242|FG001|Overall Study|Death|8|||
129989041|NCT00189488|467923241|FG000|Overall Study|Other|1|||
129989042|NCT00189488|467923242|FG001|Overall Study|Other|0|||
129989043|NCT01877837|467923243|FG000|Overall Study|Lost to Follow-up|1|||
129989044|NCT01877837|467923243|FG000|Overall Study|Ineligible|4|||
129989045|NCT00645801|467923245|FG000|Overall Study|unclear if patient took all the medication.|1|||
129989046|NCT00645801|467923246|FG001|Overall Study|unclear if patient took all the medication.|0|||
129989047|NCT00645801|467923245|FG000|Overall Study|Lost to Follow-up|19|||
129989048|NCT00645801|467923246|FG001|Overall Study|Lost to Follow-up|15|||
129989049|NCT00705679|467923247|FG000|Overall Study|Adverse Event|1|||
129989050|NCT00705679|467923248|FG001|Overall Study|Adverse Event|1|||
129989051|NCT00705679|467923249|FG002|Overall Study|Adverse Event|0|||
129989052|NCT00705679|467923250|FG003|Overall Study|Adverse Event|0|||
130328080|NCT02158546|469171624|FG002|Overall Study|Adverse Event|0|||
130328081|NCT02158546|469171625|FG003|Overall Study|Adverse Event|0|||
130328082|NCT02158546|469171622|FG000|Overall Study|Withdrawal by Subject|6|||
130328083|NCT02158546|469171623|FG001|Overall Study|Withdrawal by Subject|2|||
130328084|NCT02158546|469171624|FG002|Overall Study|Withdrawal by Subject|1|||
130328085|NCT02158546|469171625|FG003|Overall Study|Withdrawal by Subject|0|||
130328086|NCT02158546|469171622|FG000|Overall Study|Lost to Follow-up|5|||
130328087|NCT02158546|469171623|FG001|Overall Study|Lost to Follow-up|4|||
130328088|NCT02158546|469171624|FG002|Overall Study|Lost to Follow-up|0|||
130328089|NCT02158546|469171625|FG003|Overall Study|Lost to Follow-up|1|||
130328090|NCT02158546|469171622|FG000|Overall Study|Site Excluded|5|||
130328091|NCT02158546|469171623|FG001|Overall Study|Site Excluded|5|||
130328092|NCT02158546|469171624|FG002|Overall Study|Site Excluded|3|||
130328093|NCT02158546|469171625|FG003|Overall Study|Site Excluded|4|||
130328094|NCT02351817|469171626|FG000|Period 1|Adverse Event|1|||
130328095|NCT02351817|469171627|FG001|Period 1|Adverse Event|2|||
129989053|NCT00705679|467923251|FG004|Overall Study|Adverse Event|0|||
129989054|NCT00705679|467923247|FG000|Overall Study|Death|0|||
129989055|NCT00705679|467923248|FG001|Overall Study|Death|0|||
129989056|NCT00705679|467923249|FG002|Overall Study|Death|3|||
129989057|NCT00705679|467923250|FG003|Overall Study|Death|2|||
129989058|NCT00705679|467923251|FG004|Overall Study|Death|1|||
129989059|NCT00705679|467923247|FG000|Overall Study|Lost to Follow-up|32|||
129989060|NCT00705679|467923248|FG001|Overall Study|Lost to Follow-up|60|||
129989061|NCT00705679|467923249|FG002|Overall Study|Lost to Follow-up|44|||
129989062|NCT00705679|467923250|FG003|Overall Study|Lost to Follow-up|30|||
129989063|NCT00705679|467923251|FG004|Overall Study|Lost to Follow-up|35|||
129989064|NCT00705679|467923247|FG000|Overall Study|Physician Decision|0|||
129989065|NCT00705679|467923248|FG001|Overall Study|Physician Decision|1|||
130328096|NCT02351817|469171626|FG000|Period 1|Lack of Efficacy|0|||
130328097|NCT02351817|469171627|FG001|Period 1|Lack of Efficacy|1|||
130328098|NCT02351817|469171626|FG000|Period 2|Adverse Event|0|||
130328099|NCT02351817|469171627|FG001|Period 2|Adverse Event|2|||
129989066|NCT00705679|467923249|FG002|Overall Study|Physician Decision|0|||
129989067|NCT00705679|467923250|FG003|Overall Study|Physician Decision|1|||
129989068|NCT00705679|467923251|FG004|Overall Study|Physician Decision|0|||
129989069|NCT00705679|467923247|FG000|Overall Study|Withdrawal by Subject|32|||
129989070|NCT00705679|467923248|FG001|Overall Study|Withdrawal by Subject|77|||
129989071|NCT00705679|467923249|FG002|Overall Study|Withdrawal by Subject|68|||
129989072|NCT00705679|467923250|FG003|Overall Study|Withdrawal by Subject|47|||
129989073|NCT00705679|467923251|FG004|Overall Study|Withdrawal by Subject|33|||
129989074|NCT00932113|467923252|FG000|Overall Study|Lost to Follow-up|1|||
129989075|NCT00932113|467923253|FG001|Overall Study|Lost to Follow-up|0|||
129989076|NCT01403610|467923254|FG000|Overall Study|Withdrawal by Subject|2|||
129989077|NCT01403610|467923255|FG001|Overall Study|Withdrawal by Subject|0|||
129989078|NCT01403610|467923256|FG002|Overall Study|Withdrawal by Subject|0|||
129989079|NCT01403610|467923257|FG003|Overall Study|Withdrawal by Subject|0|||
129989080|NCT01403610|467923254|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
129989081|NCT01403610|467923255|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
129989082|NCT01403610|467923256|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
129989083|NCT01403610|467923257|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
129989084|NCT02874924|467923258|FG000|Overall Study|Adverse Event|2|||
129989085|NCT02874924|467923259|FG001|Overall Study|Adverse Event|0|||
129989086|NCT02874924|467923260|FG002|Overall Study|Adverse Event|0|||
129989087|NCT02874924|467923258|FG000|Overall Study|Withdrawal by Subject|1|||
129989088|NCT02874924|467923259|FG001|Overall Study|Withdrawal by Subject|0|||
129989089|NCT02874924|467923260|FG002|Overall Study|Withdrawal by Subject|0|||
129989090|NCT02029846|467923265|FG000|Overall Study|n=1 each arm|1|||
129989091|NCT02029846|467923266|FG001|Overall Study|n=1 each arm|1|||
129989092|NCT00822172|467923270|FG000|Overall Study|Adverse Event|10|||
129989093|NCT00822172|467923271|FG001|Overall Study|Adverse Event|12|||
129989094|NCT00822172|467923270|FG000|Overall Study|Death|1|||
129989095|NCT00822172|467923271|FG001|Overall Study|Death|0|||
129989096|NCT00822172|467923270|FG000|Overall Study|Lost to Follow-up|3|||
129989097|NCT00822172|467923271|FG001|Overall Study|Lost to Follow-up|1|||
129989098|NCT00822172|467923270|FG000|Overall Study|Withdrawal by Subject|1|||
129989099|NCT00822172|467923271|FG001|Overall Study|Withdrawal by Subject|4|||
129989100|NCT00822172|467923270|FG000|Overall Study|site closed|0|||
129989101|NCT00822172|467923271|FG001|Overall Study|site closed|1|||
129989102|NCT00822172|467923270|FG000|Overall Study|Other|0|||
129989103|NCT00822172|467923271|FG001|Overall Study|Other|1|||
129989104|NCT00700258|467923272|FG000|Overall Study|Premature discontinuation of documentation|136|||
129989105|NCT00700258|467923272|FG000|Overall Study|Type of study end not documented|1|||
129989106|NCT00700258|467923272|FG000|Overall Study|Lost to Follow-up|81|||
129989107|NCT00700258|467923272|FG000|Overall Study|Premature discontinuation of therapy|1013|||
129989108|NCT00738582|467923275|FG000|Combination Therapy|Completed Combination Therapy|1|||
129989109|NCT00738582|467923276|FG001|Combination Therapy|Completed Combination Therapy|0|||
129989110|NCT00738582|467923275|FG000|Combination Therapy|Physician Decision|1|||
129989111|NCT00738582|467923276|FG001|Combination Therapy|Physician Decision|0|||
129989112|NCT00738582|467923275|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
129989113|NCT00738582|467923276|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
129989114|NCT00738582|467923275|FG000|Combination Therapy|Other|5|||
129989115|NCT00738582|467923276|FG001|Combination Therapy|Other|0|||
129989116|NCT00738582|467923275|FG000|Combination Therapy|Adverse Event|16|||
129989117|NCT00738582|467923276|FG001|Combination Therapy|Adverse Event|0|||
129989118|NCT00738582|467923275|FG000|Combination Therapy|Progressive Disease|9|||
129989119|NCT00738582|467923276|FG001|Combination Therapy|Progressive Disease|0|||
129989120|NCT00738582|467923275|FG000|Maintenance Therapy|Other|0|||
129989121|NCT00738582|467923276|FG001|Maintenance Therapy|Other|2|||
129989122|NCT00738582|467923275|FG000|Maintenance Therapy|Adverse Event|0|||
129989123|NCT00738582|467923276|FG001|Maintenance Therapy|Adverse Event|6|||
129989124|NCT00738582|467923275|FG000|Maintenance Therapy|Progressive Disease|0|||
129989125|NCT00738582|467923276|FG001|Maintenance Therapy|Progressive Disease|47|||
129989126|NCT00738582|467923275|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
129989127|NCT00738582|467923276|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
129989128|NCT00642772|467923277|FG000|Overall Study|Lost to Follow-up|3|||
129989129|NCT00642772|467923277|FG000|Overall Study|Withdrawal by Subject|7|||
129989130|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
129989131|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
129989132|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
129989133|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
129989134|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
129989135|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
129989136|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
129989137|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
129989138|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
129989139|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
129989140|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
130328100|NCT02351817|469171626|FG000|Period 2|Protocol Violation|1|||
130328101|NCT02351817|469171627|FG001|Period 2|Protocol Violation|0|||
130328102|NCT02488915|469171630|FG000|Overall Study|Death|21|||
130328103|NCT02488915|469171630|FG000|Overall Study|Lost to Follow-up|4|||
130328104|NCT02488915|469171630|FG000|Overall Study|Withdrawal by Subject|1|||
130328105|NCT02976038|469171631|FG000|Overall Study|Physician Decision|22|||
130328106|NCT02976038|469171631|FG000|Overall Study|Withdrawal by Subject|3|||
130328107|NCT02976038|469171631|FG000|Overall Study|Lost to Follow-up|2|||
130328108|NCT02976038|469171631|FG000|Overall Study|Adverse Event|1|||
130328109|NCT01046396|469171632|FG000|Overall Study|Withdrawal by Subject|5|||
130328110|NCT01208207|469171633|FG000|Part I|Adverse Event|19|||
130328111|NCT01208207|469171634|FG001|Part I|Adverse Event|2|||
129989141|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
129989142|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
129989143|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
129989144|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
129989145|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
129989146|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
130328112|NCT01208207|469171635|FG002|Part I|Adverse Event|6|||
130328113|NCT01208207|469171636|FG003|Part I|Adverse Event|0|||
130328114|NCT01208207|469171637|FG004|Part I|Adverse Event|0|||
130328115|NCT01208207|469171638|FG005|Part I|Adverse Event|0|||
130328116|NCT01208207|469171639|FG006|Part I|Adverse Event|0|||
130328117|NCT01208207|469171633|FG000|Part I|Lack of Efficacy|21|||
130328118|NCT01208207|469171634|FG001|Part I|Lack of Efficacy|3|||
130328119|NCT01208207|469171635|FG002|Part I|Lack of Efficacy|2|||
130328120|NCT01208207|469171636|FG003|Part I|Lack of Efficacy|0|||
130328121|NCT01208207|469171637|FG004|Part I|Lack of Efficacy|0|||
129989147|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
129989148|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
129989149|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
129989150|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
129989151|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
129989152|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
129989153|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
129989154|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
129989155|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
129989156|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
129989157|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
129989158|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
129989159|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
129989160|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
129989161|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
129989162|NCT00903006|467923280|FG000|Overall Study|Withdrawal by Subject|2|||
129989163|NCT00903006|467923281|FG001|Overall Study|Withdrawal by Subject|0|||
129989164|NCT00903006|467923282|FG002|Overall Study|Withdrawal by Subject|0|||
129989165|NCT00903006|467923283|FG003|Overall Study|Withdrawal by Subject|0|||
129989166|NCT00903006|467923280|FG000|Overall Study|Progressive Disease|0|||
129989167|NCT00903006|467923281|FG001|Overall Study|Progressive Disease|3|||
129989168|NCT00903006|467923282|FG002|Overall Study|Progressive Disease|1|||
129989169|NCT00903006|467923283|FG003|Overall Study|Progressive Disease|0|||
129989170|NCT01383499|467923284|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
129989171|NCT01383499|467923285|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129989172|NCT01383499|467923286|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130328122|NCT01208207|469171638|FG005|Part I|Lack of Efficacy|0|||
130328123|NCT01208207|469171639|FG006|Part I|Lack of Efficacy|0|||
130328124|NCT01208207|469171633|FG000|Part I|Lost to Follow-up|6|||
130328125|NCT01208207|469171634|FG001|Part I|Lost to Follow-up|1|||
130328126|NCT01208207|469171635|FG002|Part I|Lost to Follow-up|0|||
130328127|NCT01208207|469171636|FG003|Part I|Lost to Follow-up|0|||
130328128|NCT01208207|469171637|FG004|Part I|Lost to Follow-up|0|||
130328129|NCT01208207|469171638|FG005|Part I|Lost to Follow-up|0|||
130328130|NCT01208207|469171639|FG006|Part I|Lost to Follow-up|0|||
130328131|NCT01208207|469171633|FG000|Part I|Non-Compliance With Study Drug|1|||
129989173|NCT01383499|467923287|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129989174|NCT04275089|467923290|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
129989175|NCT01079663|467923291|FG000|Overall Study|Adverse Event|0|||
129989176|NCT01079663|467923292|FG001|Overall Study|Adverse Event|2|||
130328132|NCT01208207|469171634|FG001|Part I|Non-Compliance With Study Drug|0|||
130328133|NCT01208207|469171635|FG002|Part I|Non-Compliance With Study Drug|1|||
130328134|NCT01208207|469171636|FG003|Part I|Non-Compliance With Study Drug|0|||
130328135|NCT01208207|469171637|FG004|Part I|Non-Compliance With Study Drug|0|||
130328136|NCT01208207|469171638|FG005|Part I|Non-Compliance With Study Drug|0|||
130328137|NCT01208207|469171639|FG006|Part I|Non-Compliance With Study Drug|0|||
130328138|NCT01208207|469171633|FG000|Part I|Physician Decision|0|||
130328139|NCT01208207|469171634|FG001|Part I|Physician Decision|1|||
130328140|NCT01208207|469171635|FG002|Part I|Physician Decision|0|||
129989177|NCT01079663|467923291|FG000|Overall Study|Protocol Violation|0|||
129989178|NCT01079663|467923292|FG001|Overall Study|Protocol Violation|2|||
129989179|NCT00297232|467923293|FG000|Overall Study|Lack of Efficacy|7|||
129989180|NCT00297232|467923293|FG000|Overall Study|Lost to Follow-up|10|||
129989181|NCT00297232|467923293|FG000|Overall Study|Adverse Event|63|||
129989182|NCT00297232|467923293|FG000|Overall Study|Voluntary Withdrawal|120|||
129989183|NCT00297232|467923293|FG000|Overall Study|Subject was Noncompliant|9|||
129989184|NCT00297232|467923293|FG000|Overall Study|Death|9|||
129989185|NCT00297232|467923293|FG000|Overall Study|Anti-natalizumab Positive|8|||
129989186|NCT00297232|467923293|FG000|Overall Study|Switched to Commercial Tysabri|22|||
129989187|NCT00297232|467923293|FG000|Overall Study|Disease Progression|8|||
129989188|NCT00297232|467923293|FG000|Overall Study|Fear of PML|10|||
129989189|NCT00297232|467923293|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
129989190|NCT00297232|467923293|FG000|Overall Study|Miscellaneous|5|||
129989191|NCT00297232|467923293|FG000|Overall Study|Sponsor Decision|34|||
129989192|NCT00297232|467923293|FG000|Overall Study|Subject Relocated|7|||
129989193|NCT00297232|467923293|FG000|Overall Study|Subject Withdrew Consent|37|||
129989194|NCT00297232|467923293|FG000|Overall Study|Persistently Positive Antibodies|11|||
129989195|NCT00297232|467923293|FG000|Overall Study|Investigator Withdrew From Program|19|||
129989196|NCT00297232|467923293|FG000|Overall Study|Did Not Enroll to Week 264|34|||
129989197|NCT00297232|467923293|FG000|Overall Study|Did Not Enroll to Week 480|17|||
129989198|NCT00297232|467923293|FG000|Overall Study|No data available after Week 264|161|||
129989199|NCT00297232|467923293|FG000|Overall Study|Other|1|||
129989200|NCT03038438|467923294|FG000|Overall Study|Death|3|||
129989201|NCT03038438|467923294|FG000|Overall Study|Lost to Follow-up|8|||
129989202|NCT03038438|467923294|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
129989203|NCT03038438|467923294|FG000|Overall Study|Withdrawal by Subject|5|||
129989204|NCT03038438|467923294|FG000|Overall Study|No 36-Month Follow-Up|18|||
129989205|NCT03625895|467923297|FG000|Overall Study|Protocol Violation|585|||
129989206|NCT02476279|467923298|FG000|Overall Study|Lost to Follow-up|1|||
129989207|NCT02476279|467923299|FG001|Overall Study|Lost to Follow-up|1|||
129989208|NCT01236339|467923304|FG000|Overall Study|Termination of study by sponsor|11|||
129989209|NCT01236339|467923305|FG001|Overall Study|Termination of study by sponsor|13|||
129989210|NCT02054741|467923306|FG000|Overall Study|Protocol Violation|13|||
129989211|NCT02054741|467923307|FG001|Overall Study|Protocol Violation|2|||
129989212|NCT02054741|467923306|FG000|Overall Study|Withdrawal by Subject|10|||
129989213|NCT02054741|467923307|FG001|Overall Study|Withdrawal by Subject|5|||
129989214|NCT02054741|467923306|FG000|Overall Study|Death|94|||
129989215|NCT02054741|467923307|FG001|Overall Study|Death|90|||
129989216|NCT02054741|467923306|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
129989217|NCT02054741|467923307|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
129989218|NCT01945060|467923308|FG000|Overall Study|Lost to follow up|1|||
129989219|NCT01945060|467923309|FG001|Overall Study|Lost to follow up|0|||
129989220|NCT01945060|467923308|FG000|Overall Study|Distress related to IV access|0|||
129989221|NCT01945060|467923309|FG001|Overall Study|Distress related to IV access|1|||
129989222|NCT00402597|467923310|FG000|Overall Study|Death|15|||
129989223|NCT00402597|467923311|FG001|Overall Study|Death|7|||
129989224|NCT00402597|467923312|FG002|Overall Study|Death|6|||
129989225|NCT00402597|467923313|FG003|Overall Study|Death|4|||
129989226|NCT00402597|467923314|FG004|Overall Study|Death|6|||
129989227|NCT00402597|467923310|FG000|Overall Study|Adverse Event|81|||
129989228|NCT00402597|467923311|FG001|Overall Study|Adverse Event|18|||
129989229|NCT00402597|467923312|FG002|Overall Study|Adverse Event|106|||
129989230|NCT00402597|467923313|FG003|Overall Study|Adverse Event|39|||
129989231|NCT00402597|467923314|FG004|Overall Study|Adverse Event|71|||
129989232|NCT00402597|467923310|FG000|Overall Study|Lost to Follow-up|8|||
129989233|NCT00402597|467923311|FG001|Overall Study|Lost to Follow-up|1|||
129989234|NCT00402597|467923312|FG002|Overall Study|Lost to Follow-up|8|||
129989235|NCT00402597|467923313|FG003|Overall Study|Lost to Follow-up|2|||
129989236|NCT00402597|467923314|FG004|Overall Study|Lost to Follow-up|3|||
129989237|NCT00402597|467923310|FG000|Overall Study|Withdrawal by Subject|57|||
129989238|NCT00402597|467923311|FG001|Overall Study|Withdrawal by Subject|16|||
129989239|NCT00402597|467923312|FG002|Overall Study|Withdrawal by Subject|65|||
129989240|NCT00402597|467923313|FG003|Overall Study|Withdrawal by Subject|15|||
129989241|NCT00402597|467923314|FG004|Overall Study|Withdrawal by Subject|24|||
129989242|NCT00402597|467923310|FG000|Overall Study|reason not specified|30|||
129989243|NCT00402597|467923311|FG001|Overall Study|reason not specified|4|||
129989244|NCT00402597|467923312|FG002|Overall Study|reason not specified|27|||
129989245|NCT00402597|467923313|FG003|Overall Study|reason not specified|14|||
129989246|NCT00402597|467923314|FG004|Overall Study|reason not specified|20|||
129989247|NCT02319525|467923316|FG000|Overall Study|Withdrawal by Subject|2|||
129989248|NCT02319525|467923317|FG001|Overall Study|Withdrawal by Subject|1|||
129989249|NCT00938860|467923318|FG000|Overall Study|Adverse Event|2|||
129989250|NCT00938860|467923319|FG001|Overall Study|Adverse Event|1|||
129989251|NCT00938860|467923318|FG000|Overall Study|Abnormal laboratory values|2|||
129989252|NCT00938860|467923319|FG001|Overall Study|Abnormal laboratory values|2|||
129989253|NCT00938860|467923318|FG000|Overall Study|Withdrawal by Subject|11|||
129989254|NCT00938860|467923319|FG001|Overall Study|Withdrawal by Subject|8|||
129989255|NCT00938860|467923318|FG000|Overall Study|Lost to Follow-up|4|||
129989256|NCT00938860|467923319|FG001|Overall Study|Lost to Follow-up|4|||
129989257|NCT00938860|467923318|FG000|Overall Study|Administration problems|2|||
129989258|NCT00938860|467923319|FG001|Overall Study|Administration problems|0|||
129989259|NCT00938860|467923318|FG000|Overall Study|Death|1|||
129989260|NCT00938860|467923319|FG001|Overall Study|Death|1|||
129989261|NCT00938860|467923318|FG000|Overall Study|Protocol Violation|3|||
130328141|NCT01208207|469171636|FG003|Part I|Physician Decision|0|||
130328142|NCT01208207|469171637|FG004|Part I|Physician Decision|0|||
130328143|NCT01208207|469171638|FG005|Part I|Physician Decision|0|||
130328144|NCT01208207|469171639|FG006|Part I|Physician Decision|0|||
130328145|NCT01208207|469171633|FG000|Part I|Progressive Disease|1|||
129989262|NCT00938860|467923319|FG001|Overall Study|Protocol Violation|1|||
129989263|NCT00577577|467923321|FG000|Overall Study|Adverse Event|3|||
129989264|NCT00577577|467923322|FG001|Overall Study|Adverse Event|2|||
129989265|NCT00577577|467923321|FG000|Overall Study|Lost to Follow-up|1|||
129989266|NCT00577577|467923322|FG001|Overall Study|Lost to Follow-up|0|||
129989267|NCT00577577|467923321|FG000|Overall Study|Protocol Violation|0|||
129989268|NCT00577577|467923322|FG001|Overall Study|Protocol Violation|3|||
129989269|NCT00577577|467923321|FG000|Overall Study|Transportation|1|||
129989270|NCT00577577|467923322|FG001|Overall Study|Transportation|0|||
129989271|NCT00232544|467923327|FG000|Overall Study|Lost to Follow-up|20|||
129989272|NCT00232544|467923328|FG001|Overall Study|Lost to Follow-up|15|||
129989273|NCT00986973|467923332|FG000|Overall Study|Withdrawn by study team|1|||
129989274|NCT01465347|467923333|FG000|Overall Study|Withdrawal by Subject|1|||
129989275|NCT01465347|467923334|FG001|Overall Study|Withdrawal by Subject|1|||
129989276|NCT01465347|467923333|FG000|Overall Study|Physician Decision|0|||
129989277|NCT01465347|467923334|FG001|Overall Study|Physician Decision|1|||
129989278|NCT01465347|467923333|FG000|Overall Study|Admitted to hospice|0|||
129989279|NCT01465347|467923334|FG001|Overall Study|Admitted to hospice|1|||
129989280|NCT01590082|467923335|FG000|Overall Study|Withdrawal by Subject|1|||
129989281|NCT01590082|467923336|FG001|Overall Study|Withdrawal by Subject|0|||
129989282|NCT01590082|467923335|FG000|Overall Study|Ineligible|1|||
129989283|NCT01590082|467923336|FG001|Overall Study|Ineligible|0|||
129989284|NCT02414932|467923337|FG000|Overall Study|Withdrawal by Subject|2|||
129989285|NCT02414932|467923338|FG001|Overall Study|Withdrawal by Subject|3|||
129989286|NCT02414932|467923337|FG000|Overall Study|Adverse Event|1|||
129989287|NCT02414932|467923338|FG001|Overall Study|Adverse Event|0|||
129989288|NCT01210664|467923340|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129989289|NCT01210664|467923341|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129989290|NCT01210664|467923342|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
130328146|NCT01208207|469171634|FG001|Part I|Progressive Disease|0|||
129989291|NCT01210664|467923343|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129989292|NCT01210664|467923340|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989293|NCT01210664|467923341|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989294|NCT01210664|467923342|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
129989295|NCT01210664|467923343|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989296|NCT01210664|467923340|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989297|NCT01210664|467923341|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989298|NCT01210664|467923342|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
130328147|NCT01208207|469171635|FG002|Part I|Progressive Disease|0|||
130328148|NCT01208207|469171636|FG003|Part I|Progressive Disease|0|||
130328149|NCT01208207|469171637|FG004|Part I|Progressive Disease|0|||
130328150|NCT01208207|469171638|FG005|Part I|Progressive Disease|0|||
130328151|NCT01208207|469171639|FG006|Part I|Progressive Disease|0|||
130328152|NCT01208207|469171633|FG000|Part I|Protocol Violation|8|||
130328153|NCT01208207|469171634|FG001|Part I|Protocol Violation|0|||
130328154|NCT01208207|469171635|FG002|Part I|Protocol Violation|2|||
130328155|NCT01208207|469171636|FG003|Part I|Protocol Violation|0|||
130328156|NCT01208207|469171637|FG004|Part I|Protocol Violation|0|||
130328157|NCT01208207|469171638|FG005|Part I|Protocol Violation|0|||
130328158|NCT01208207|469171639|FG006|Part I|Protocol Violation|0|||
130328159|NCT01208207|469171633|FG000|Part I|Withdrawal by Subject|14|||
130328160|NCT01208207|469171634|FG001|Part I|Withdrawal by Subject|4|||
130328161|NCT01208207|469171635|FG002|Part I|Withdrawal by Subject|4|||
130328162|NCT01208207|469171636|FG003|Part I|Withdrawal by Subject|0|||
130328163|NCT01208207|469171637|FG004|Part I|Withdrawal by Subject|0|||
130328164|NCT01208207|469171638|FG005|Part I|Withdrawal by Subject|0|||
130328165|NCT01208207|469171639|FG006|Part I|Withdrawal by Subject|0|||
129989299|NCT01210664|467923343|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
129989300|NCT01853644|467923344|FG000|Registration and Treatment Start|Did not start treatment|1|||
129989301|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
130328166|NCT01208207|469171633|FG000|Part II|Withdrawal by Subject|0|||
130328167|NCT01208207|469171634|FG001|Part II|Withdrawal by Subject|0|||
130328168|NCT01208207|469171635|FG002|Part II|Withdrawal by Subject|0|||
130328169|NCT01208207|469171636|FG003|Part II|Withdrawal by Subject|10|||
130328170|NCT01208207|469171637|FG004|Part II|Withdrawal by Subject|9|||
129989302|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
129989303|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
129989304|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
129989305|NCT01853644|467923344|FG000|Continued Treatment After First Response|Adverse Event|2|||
129989306|NCT01853644|467923344|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
129989307|NCT02891408|467923345|FG000|Overall Study|Lost to Follow-up|0|||
129989308|NCT02891408|467923346|FG001|Overall Study|Lost to Follow-up|0|||
129989309|NCT02891408|467923347|FG002|Overall Study|Lost to Follow-up|1|||
129989310|NCT02891408|467923348|FG003|Overall Study|Lost to Follow-up|0|||
129989311|NCT02891408|467923349|FG004|Overall Study|Lost to Follow-up|0|||
129989312|NCT02891408|467923350|FG005|Overall Study|Lost to Follow-up|0|||
129989313|NCT02891408|467923351|FG006|Overall Study|Lost to Follow-up|0|||
129989314|NCT01054170|467923352|FG000|Overall Study|Protocol Violation|1|||
129989315|NCT01054170|467923353|FG001|Overall Study|Protocol Violation|0|||
129989316|NCT01054170|467923352|FG000|Overall Study|Withdrawal by Subject|3|||
129989317|NCT01054170|467923353|FG001|Overall Study|Withdrawal by Subject|2|||
129989318|NCT01054170|467923352|FG000|Overall Study|Adverse Event|0|||
129989319|NCT01054170|467923353|FG001|Overall Study|Adverse Event|4|||
129989320|NCT01442779|467923354|FG000|Overall Study|Withdrawal by Subject|3|||
129989321|NCT01442779|467923354|FG000|Overall Study|Death|3|||
129989322|NCT01442779|467923354|FG000|Overall Study|Non-compliance|1|||
129989323|NCT05249829|467923355|FG000|Overall Study|Participant Relocation|0|||
129989324|NCT05249829|467923356|FG001|Overall Study|Participant Relocation|1|||
129989325|NCT05249829|467923357|FG002|Overall Study|Participant Relocation|2|||
129989326|NCT05249829|467923358|FG003|Overall Study|Participant Relocation|2|||
129989327|NCT05249829|467923355|FG000|Overall Study|Withdrawal by Subject|9|||
129989328|NCT05249829|467923356|FG001|Overall Study|Withdrawal by Subject|17|||
129989329|NCT05249829|467923357|FG002|Overall Study|Withdrawal by Subject|40|||
129989330|NCT05249829|467923358|FG003|Overall Study|Withdrawal by Subject|35|||
129989331|NCT05249829|467923355|FG000|Overall Study|Physician Decision|1|||
129989332|NCT05249829|467923356|FG001|Overall Study|Physician Decision|0|||
129989333|NCT05249829|467923357|FG002|Overall Study|Physician Decision|0|||
129989334|NCT05249829|467923358|FG003|Overall Study|Physician Decision|0|||
129989335|NCT05249829|467923355|FG000|Overall Study|Lost to Follow-up|16|||
129989336|NCT05249829|467923356|FG001|Overall Study|Lost to Follow-up|16|||
129989337|NCT05249829|467923357|FG002|Overall Study|Lost to Follow-up|57|||
129989338|NCT05249829|467923358|FG003|Overall Study|Lost to Follow-up|60|||
129989339|NCT05249829|467923355|FG000|Overall Study|Adverse Event|2|||
129989340|NCT05249829|467923356|FG001|Overall Study|Adverse Event|2|||
129989341|NCT05249829|467923357|FG002|Overall Study|Adverse Event|2|||
129989342|NCT05249829|467923358|FG003|Overall Study|Adverse Event|2|||
129989343|NCT05249829|467923355|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
129989344|NCT05249829|467923356|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
129989345|NCT05249829|467923357|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
129989346|NCT05249829|467923358|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
129989347|NCT05249829|467923355|FG000|Overall Study|Protocol Violation|2|||
129989348|NCT05249829|467923356|FG001|Overall Study|Protocol Violation|0|||
129989349|NCT05249829|467923357|FG002|Overall Study|Protocol Violation|5|||
129989350|NCT05249829|467923358|FG003|Overall Study|Protocol Violation|3|||
129989351|NCT05249829|467923355|FG000|Overall Study|Death|0|||
129989352|NCT05249829|467923356|FG001|Overall Study|Death|1|||
129989353|NCT05249829|467923357|FG002|Overall Study|Death|2|||
129989354|NCT05249829|467923358|FG003|Overall Study|Death|4|||
129989355|NCT00513604|467923359|FG000|Overall Study|Not treated|2|||
129989356|NCT00513604|467923360|FG001|Overall Study|Not treated|0|||
129989357|NCT00513604|467923361|FG002|Overall Study|Not treated|1|||
129989358|NCT00513604|467923362|FG003|Overall Study|Not treated|0|||
129989359|NCT00513604|467923363|FG004|Overall Study|Not treated|0|||
129989360|NCT00513604|467923359|FG000|Overall Study|Death during treatment|0|||
129989361|NCT00513604|467923360|FG001|Overall Study|Death during treatment|3|||
129989362|NCT00513604|467923361|FG002|Overall Study|Death during treatment|2|||
129989363|NCT00513604|467923362|FG003|Overall Study|Death during treatment|0|||
129989364|NCT00513604|467923363|FG004|Overall Study|Death during treatment|0|||
129989365|NCT01535560|467923365|FG000|Overall Study|Adverse Event|12|||
129989366|NCT01535560|467923366|FG001|Overall Study|Adverse Event|7|||
129989367|NCT01535560|467923365|FG000|Overall Study|Lost to Follow-up|1|||
129989368|NCT01535560|467923366|FG001|Overall Study|Lost to Follow-up|3|||
129989369|NCT01535560|467923365|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
129989370|NCT01535560|467923366|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
129989371|NCT01535560|467923365|FG000|Overall Study|Treatment Failure|21|||
129989372|NCT01535560|467923366|FG001|Overall Study|Treatment Failure|83|||
129989373|NCT01535560|467923365|FG000|Overall Study|Other|0|||
129989374|NCT01535560|467923366|FG001|Overall Study|Other|1|||
129989375|NCT01535560|467923365|FG000|Overall Study|Randomized in Error|0|||
129989376|NCT01535560|467923366|FG001|Overall Study|Randomized in Error|1|||
129989377|NCT02009761|467923367|FG000|Overall Study|Adverse Event|4|||
129989378|NCT02842827|467923368|FG000|Overall Study|Adverse Event|0|||
129989379|NCT02842827|467923369|FG001|Overall Study|Adverse Event|1|||
129989380|NCT02842827|467923370|FG002|Overall Study|Adverse Event|0|||
129989381|NCT02842827|467923371|FG003|Overall Study|Adverse Event|1|||
129989382|NCT02842827|467923372|FG004|Overall Study|Adverse Event|0|||
129989383|NCT02842827|467923373|FG005|Overall Study|Adverse Event|1|||
129989384|NCT02842827|467923374|FG006|Overall Study|Adverse Event|0|||
129989385|NCT02842827|467923375|FG007|Overall Study|Adverse Event|0|||
129989386|NCT02842827|467923368|FG000|Overall Study|Death|1|||
129989387|NCT02842827|467923369|FG001|Overall Study|Death|0|||
129989388|NCT02842827|467923370|FG002|Overall Study|Death|2|||
129989389|NCT02842827|467923371|FG003|Overall Study|Death|3|||
129989390|NCT02842827|467923372|FG004|Overall Study|Death|2|||
129989391|NCT02842827|467923373|FG005|Overall Study|Death|1|||
129989392|NCT02842827|467923374|FG006|Overall Study|Death|0|||
129989393|NCT02842827|467923375|FG007|Overall Study|Death|4|||
129989394|NCT02842827|467923368|FG000|Overall Study|Physician Decision|1|||
129989395|NCT02842827|467923369|FG001|Overall Study|Physician Decision|3|||
129989396|NCT02842827|467923370|FG002|Overall Study|Physician Decision|0|||
129989397|NCT02842827|467923371|FG003|Overall Study|Physician Decision|0|||
129989398|NCT02842827|467923372|FG004|Overall Study|Physician Decision|1|||
129989399|NCT02842827|467923373|FG005|Overall Study|Physician Decision|4|||
129989400|NCT02842827|467923374|FG006|Overall Study|Physician Decision|2|||
129989401|NCT02842827|467923375|FG007|Overall Study|Physician Decision|1|||
129989402|NCT02842827|467923368|FG000|Overall Study|Protocol Defined Disease Progression|0|||
129989403|NCT02842827|467923369|FG001|Overall Study|Protocol Defined Disease Progression|0|||
129989404|NCT02842827|467923370|FG002|Overall Study|Protocol Defined Disease Progression|0|||
129989405|NCT02842827|467923371|FG003|Overall Study|Protocol Defined Disease Progression|0|||
129989406|NCT02842827|467923372|FG004|Overall Study|Protocol Defined Disease Progression|0|||
129989407|NCT02842827|467923373|FG005|Overall Study|Protocol Defined Disease Progression|1|||
129989408|NCT02842827|467923374|FG006|Overall Study|Protocol Defined Disease Progression|0|||
129989409|NCT02842827|467923375|FG007|Overall Study|Protocol Defined Disease Progression|0|||
129989410|NCT02842827|467923368|FG000|Overall Study|Participant Withdrawal of Consent|1|||
129989411|NCT02842827|467923369|FG001|Overall Study|Participant Withdrawal of Consent|2|||
129989412|NCT02842827|467923370|FG002|Overall Study|Participant Withdrawal of Consent|2|||
129989413|NCT02842827|467923371|FG003|Overall Study|Participant Withdrawal of Consent|2|||
129989414|NCT02842827|467923372|FG004|Overall Study|Participant Withdrawal of Consent|2|||
129989415|NCT02842827|467923373|FG005|Overall Study|Participant Withdrawal of Consent|1|||
129989416|NCT02842827|467923374|FG006|Overall Study|Participant Withdrawal of Consent|2|||
129989417|NCT02842827|467923375|FG007|Overall Study|Participant Withdrawal of Consent|1|||
129989418|NCT02372136|467923376|FG000|Overall Study|Death|3|||
129989419|NCT02372136|467923377|FG001|Overall Study|Death|1|||
129989420|NCT00985946|467923378|FG000|Overall Study|Lost to Follow-up|6|||
129989421|NCT00985946|467923378|FG000|Overall Study|Withdrawal by Subject|1|||
129989422|NCT02471833|467923379|FG000|Overall Study|Lost to Follow-up|1|||
129989423|NCT02471833|467923380|FG001|Overall Study|Lost to Follow-up|0|||
129989424|NCT02471833|467923381|FG002|Overall Study|Lost to Follow-up|0|||
129989425|NCT02471833|467923379|FG000|Overall Study|Withdrawal by Subject|2|||
129989426|NCT02471833|467923380|FG001|Overall Study|Withdrawal by Subject|1|||
129989427|NCT02471833|467923381|FG002|Overall Study|Withdrawal by Subject|5|||
129989428|NCT02673515|467923385|FG000|Overall Study|Lack of motivation|2|||
129989429|NCT02673515|467923386|FG001|Overall Study|Lack of motivation|1|||
129989430|NCT03965351|467923388|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129989431|NCT03965351|467923389|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
129989432|NCT03965351|467923388|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
129989433|NCT03965351|467923389|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
129989434|NCT00490724|467923390|FG000|Period I|Physician Decision|0|||
129989435|NCT00490724|467923391|FG001|Period I|Physician Decision|0|||
129989436|NCT00490724|467923392|FG002|Period I|Physician Decision|1|||
129989437|NCT00490724|467923390|FG000|Period II|Treatment Discontinuation|3|||
129989438|NCT00490724|467923391|FG001|Period II|Treatment Discontinuation|1|||
129989439|NCT00490724|467923392|FG002|Period II|Treatment Discontinuation|3|||
129989440|NCT00994682|467923393|FG000|Double Bilnd|Withdrawal by Subject|5|||
129989441|NCT00994682|467923394|FG001|Double Bilnd|Withdrawal by Subject|6|||
129989442|NCT00994682|467923393|FG000|Double Bilnd|Lost to Follow-up|3|||
129989443|NCT00994682|467923394|FG001|Double Bilnd|Lost to Follow-up|3|||
129989444|NCT00994682|467923393|FG000|Double Bilnd|Adverse Event|1|||
129989445|NCT00994682|467923394|FG001|Double Bilnd|Adverse Event|0|||
129989446|NCT00994682|467923393|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
129989447|NCT00994682|467923394|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
129989448|NCT00994682|467923393|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
129989449|NCT00994682|467923394|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
129989450|NCT00994682|467923393|FG000|Pioglitazone Open Label|Physician Decision|6|||
129989451|NCT00994682|467923394|FG001|Pioglitazone Open Label|Physician Decision|1|||
129989452|NCT00896051|467925412|FG000|Overall Study|Adverse Event|2|||
129989453|NCT00896051|467925413|FG001|Overall Study|Adverse Event|1|||
129989454|NCT00896051|467925412|FG000|Overall Study|Lost to Follow-up|3|||
129989455|NCT00896051|467925413|FG001|Overall Study|Lost to Follow-up|2|||
129989456|NCT00896051|467925412|FG000|Overall Study|Withdrawal by Subject|3|||
129989457|NCT00896051|467925413|FG001|Overall Study|Withdrawal by Subject|2|||
129989458|NCT00896051|467925412|FG000|Overall Study|Subject noncompliant|1|||
129989459|NCT00896051|467925413|FG001|Overall Study|Subject noncompliant|3|||
129989460|NCT00896051|467925412|FG000|Overall Study|Other|1|||
129989461|NCT00896051|467925413|FG001|Overall Study|Other|1|||
129989462|NCT02935452|467925414|FG000|Overall Study|work and life commintment|3|||
129989463|NCT02935452|467925415|FG001|Overall Study|work and life commintment|1|||
129989464|NCT00876928|467925416|FG000|Overall Study|Lost to Follow-up|2|||
129989465|NCT00876928|467925417|FG001|Overall Study|Lost to Follow-up|5|||
129989466|NCT00876928|467925416|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
129989467|NCT00876928|467925417|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
129989468|NCT02336178|467925423|FG000|Overall Study|Lost to Follow-up|1|||
129989469|NCT02336178|467925423|FG000|Overall Study|Protocol Violation|1|||
129989470|NCT02336178|467925423|FG000|Overall Study|Withdrawal by Subject|1|||
129989471|NCT02336178|467925423|FG000|Overall Study|Other|1|||
129989472|NCT00618982|467925424|FG000|Overall Study|Adverse Event|23|||
129989473|NCT00618982|467925424|FG000|Overall Study|Withdrawal by Subject|1|||
129989474|NCT00618982|467925424|FG000|Overall Study|Protocol Violation|1|||
129989475|NCT00618982|467925424|FG000|Overall Study|ongoing, still treated with study med.|25|||
129989476|NCT01776541|467925427|FG000|Overall Study|Administrative Reason|6|||
129989477|NCT01776541|467925428|FG001|Overall Study|Administrative Reason|2|||
129989478|NCT01776541|467925427|FG000|Overall Study|Death|4|||
130328171|NCT01208207|469171638|FG005|Part II|Withdrawal by Subject|3|||
130328172|NCT01208207|469171639|FG006|Part II|Withdrawal by Subject|5|||
130328173|NCT01208207|469171633|FG000|Part II|Adverse Event|0|||
130328174|NCT01208207|469171634|FG001|Part II|Adverse Event|0|||
130328175|NCT01208207|469171635|FG002|Part II|Adverse Event|0|||
130328176|NCT01208207|469171636|FG003|Part II|Adverse Event|5|||
130328177|NCT01208207|469171637|FG004|Part II|Adverse Event|9|||
130328178|NCT01208207|469171638|FG005|Part II|Adverse Event|4|||
130328179|NCT01208207|469171639|FG006|Part II|Adverse Event|2|||
130328180|NCT01208207|469171633|FG000|Part II|Lack of Efficacy|0|||
130328181|NCT01208207|469171634|FG001|Part II|Lack of Efficacy|0|||
130328182|NCT01208207|469171635|FG002|Part II|Lack of Efficacy|0|||
130328183|NCT01208207|469171636|FG003|Part II|Lack of Efficacy|6|||
130328184|NCT01208207|469171637|FG004|Part II|Lack of Efficacy|4|||
130328185|NCT01208207|469171638|FG005|Part II|Lack of Efficacy|3|||
130328186|NCT01208207|469171639|FG006|Part II|Lack of Efficacy|3|||
130328187|NCT01208207|469171633|FG000|Part II|Lost to Follow-up|0|||
130328188|NCT01208207|469171634|FG001|Part II|Lost to Follow-up|0|||
130328189|NCT01208207|469171635|FG002|Part II|Lost to Follow-up|0|||
130328190|NCT01208207|469171636|FG003|Part II|Lost to Follow-up|4|||
130328191|NCT01208207|469171637|FG004|Part II|Lost to Follow-up|0|||
130328192|NCT01208207|469171638|FG005|Part II|Lost to Follow-up|2|||
130328193|NCT01208207|469171639|FG006|Part II|Lost to Follow-up|1|||
130328194|NCT01208207|469171633|FG000|Part II|Non-Compliance With Study Drug|0|||
130328195|NCT01208207|469171634|FG001|Part II|Non-Compliance With Study Drug|0|||
130328196|NCT01208207|469171635|FG002|Part II|Non-Compliance With Study Drug|0|||
130328197|NCT01208207|469171636|FG003|Part II|Non-Compliance With Study Drug|4|||
130328198|NCT01208207|469171637|FG004|Part II|Non-Compliance With Study Drug|1|||
130328199|NCT01208207|469171638|FG005|Part II|Non-Compliance With Study Drug|1|||
130328200|NCT01208207|469171639|FG006|Part II|Non-Compliance With Study Drug|0|||
130328201|NCT01208207|469171633|FG000|Part II|Physician Decision|0|||
130328202|NCT01208207|469171634|FG001|Part II|Physician Decision|0|||
130328203|NCT01208207|469171635|FG002|Part II|Physician Decision|0|||
130328204|NCT01208207|469171636|FG003|Part II|Physician Decision|1|||
130328205|NCT01208207|469171637|FG004|Part II|Physician Decision|0|||
130328206|NCT01208207|469171638|FG005|Part II|Physician Decision|2|||
130328207|NCT01208207|469171639|FG006|Part II|Physician Decision|0|||
130328208|NCT01208207|469171633|FG000|Part II|Protocol Violation|0|||
130328209|NCT01208207|469171634|FG001|Part II|Protocol Violation|0|||
130328210|NCT01208207|469171635|FG002|Part II|Protocol Violation|0|||
130328211|NCT01208207|469171636|FG003|Part II|Protocol Violation|1|||
129989479|NCT01776541|467925428|FG001|Overall Study|Death|0|||
129989480|NCT01776541|467925427|FG000|Overall Study|Lost to Follow-up|27|||
129989481|NCT01776541|467925428|FG001|Overall Study|Lost to Follow-up|48|||
130328212|NCT01208207|469171637|FG004|Part II|Protocol Violation|0|||
130328213|NCT01208207|469171638|FG005|Part II|Protocol Violation|0|||
129989482|NCT01776541|467925427|FG000|Overall Study|Unclassified|5|||
129989483|NCT01776541|467925428|FG001|Overall Study|Unclassified|4|||
129989484|NCT01776541|467925427|FG000|Overall Study|Protocol Violation|2|||
130328214|NCT01208207|469171639|FG006|Part II|Protocol Violation|0|||
130328215|NCT01208207|469171633|FG000|Part II|Technical Problems|0|||
130328216|NCT01208207|469171634|FG001|Part II|Technical Problems|0|||
130328217|NCT01208207|469171635|FG002|Part II|Technical Problems|0|||
130328218|NCT01208207|469171636|FG003|Part II|Technical Problems|1|||
130328219|NCT01208207|469171637|FG004|Part II|Technical Problems|0|||
130328220|NCT01208207|469171638|FG005|Part II|Technical Problems|1|||
130328221|NCT01208207|469171639|FG006|Part II|Technical Problems|0|||
130328222|NCT00724698|469171640|FG000|Overall Study|Adverse Event|9|||
130328223|NCT00724698|469171640|FG000|Overall Study|Failure of Therapy|4|||
130328224|NCT00724698|469171640|FG000|Overall Study|Poor Compliance|16|||
130328225|NCT00724698|469171640|FG000|Overall Study|Lost to Follow-up|36|||
130328226|NCT00724698|469171640|FG000|Overall Study|No Info|25|||
130328227|NCT02177032|469171643|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
130328228|NCT02177032|469171644|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
129989485|NCT01776541|467925428|FG001|Overall Study|Protocol Violation|1|||
130328229|NCT02177032|469171645|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
130328230|NCT02177032|469171646|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
130328231|NCT02177032|469171643|FG000|Overall Study|Lost to Follow-up|0|||
130328232|NCT02177032|469171644|FG001|Overall Study|Lost to Follow-up|2|||
130328233|NCT02177032|469171645|FG002|Overall Study|Lost to Follow-up|0|||
130328234|NCT02177032|469171646|FG003|Overall Study|Lost to Follow-up|0|||
130328235|NCT02177032|469171643|FG000|Overall Study|OTHER|2|||
130328236|NCT02177032|469171644|FG001|Overall Study|OTHER|0|||
130328237|NCT02177032|469171645|FG002|Overall Study|OTHER|1|||
130328238|NCT02177032|469171646|FG003|Overall Study|OTHER|0|||
130328239|NCT02177032|469171643|FG000|Overall Study|Withdrawal by Subject|1|||
130328240|NCT02177032|469171644|FG001|Overall Study|Withdrawal by Subject|0|||
130328241|NCT02177032|469171645|FG002|Overall Study|Withdrawal by Subject|1|||
130328242|NCT02177032|469171646|FG003|Overall Study|Withdrawal by Subject|0|||
130328243|NCT00665652|469171647|FG000|Overall Study|Adverse Event|4|||
130328244|NCT00665652|469171647|FG000|Overall Study|Death|1|||
130328245|NCT00665652|469171647|FG000|Overall Study|No longer met inclusion criteria.|1|||
130328246|NCT02556177|469171650|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
130328247|NCT02556177|469171651|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
130328248|NCT00389610|469171658|FG000|Overall Study|Disease Progression|0|||
130328249|NCT00389610|469171659|FG001|Overall Study|Disease Progression|19|||
130328250|NCT00389610|469171658|FG000|Overall Study|Death|0|||
130328251|NCT00389610|469171659|FG001|Overall Study|Death|1|||
130328252|NCT00389610|469171658|FG000|Overall Study|Physician Decision|0|||
130328253|NCT00389610|469171659|FG001|Overall Study|Physician Decision|1|||
130328254|NCT00389610|469171658|FG000|Overall Study|Withdrawal by Subject|0|||
130328255|NCT00389610|469171659|FG001|Overall Study|Withdrawal by Subject|1|||
130328256|NCT03131570|469171660|FG000|Overall Study|Adverse Event|1|||
130328257|NCT03131570|469171661|FG001|Overall Study|Adverse Event|0|||
130328258|NCT00830440|469171662|FG000|Overall Study|Protocol Violation|1|||
130328259|NCT00830440|469171663|FG001|Overall Study|Protocol Violation|0|||
130328260|NCT00830440|469171662|FG000|Overall Study|Withdrawal by Subject|1|||
130328261|NCT00830440|469171663|FG001|Overall Study|Withdrawal by Subject|0|||
130328262|NCT00830440|469171662|FG000|Overall Study|unsuccessful procedure|4|||
130328263|NCT00830440|469171663|FG001|Overall Study|unsuccessful procedure|0|||
130328264|NCT00830440|469171662|FG000|Overall Study|Adverse Event|2|||
130328265|NCT00830440|469171663|FG001|Overall Study|Adverse Event|0|||
129989486|NCT01776541|467925427|FG000|Overall Study|Withdrawal by Subject|12|||
129989487|NCT01776541|467925428|FG001|Overall Study|Withdrawal by Subject|20|||
129989488|NCT00156819|467925429|FG000|Overall Study|Lost to Follow-up|1|||
129989489|NCT00156819|467925430|FG001|Overall Study|Lost to Follow-up|1|||
129989490|NCT00156819|467925431|FG002|Overall Study|Lost to Follow-up|3|||
129989491|NCT02090959|467925432|FG000|Overall Study|Withdrawal by Subject|10|||
129989492|NCT02090959|467925432|FG000|Overall Study|Adverse Event|1|||
129989493|NCT02090959|467925432|FG000|Overall Study|Investigator decision|2|||
129989494|NCT02090959|467925432|FG000|Overall Study|Study termination|6|||
129989495|NCT02090959|467925432|FG000|Overall Study|Enrolled but not treated|1|||
129989496|NCT02090959|467925432|FG000|Overall Study|Transfer for compassionate use medicine|4|||
129989497|NCT02090959|467925432|FG000|Overall Study|Move to medical need program|3|||
129989498|NCT02090959|467925432|FG000|Overall Study|Entered in to other study|34|||
129989499|NCT02090959|467925432|FG000|Overall Study|Switched to commercial supply|88|||
129989500|NCT02090959|467925432|FG000|Overall Study|Other than specified|2|||
129989501|NCT00522873|467925435|FG000|Overall Study|Adverse Event|41|||
130328266|NCT00942604|469171669|FG000|Overall Study|Protocol Violation|1|||
130328267|NCT00942604|469171670|FG001|Overall Study|Protocol Violation|1|||
130328268|NCT00942604|469171669|FG000|Overall Study|Adverse Event|0|||
130328269|NCT00942604|469171670|FG001|Overall Study|Adverse Event|1|||
130328270|NCT00942604|469171669|FG000|Overall Study|Withdrawal by Subject|0|||
130328271|NCT00942604|469171670|FG001|Overall Study|Withdrawal by Subject|1|||
130328272|NCT00942604|469171669|FG000|Overall Study|Patient relocation|1|||
130328273|NCT00942604|469171670|FG001|Overall Study|Patient relocation|1|||
130328274|NCT01188343|469171671|FG000|Overall Study|Not vaccinated|0|||
130328275|NCT01188343|469171672|FG001|Overall Study|Not vaccinated|2|||
129989502|NCT00522873|467925436|FG001|Overall Study|Adverse Event|26|||
129989503|NCT00522873|467925435|FG000|Overall Study|Withdrawal by Subject|20|||
129989504|NCT00522873|467925436|FG001|Overall Study|Withdrawal by Subject|9|||
129989505|NCT00522873|467925435|FG000|Overall Study|Protocol Violation|14|||
129989506|NCT00522873|467925436|FG001|Overall Study|Protocol Violation|4|||
129989507|NCT00522873|467925435|FG000|Overall Study|Lost to Follow-up|11|||
130328276|NCT01188343|469171673|FG002|Overall Study|Not vaccinated|1|||
130328277|NCT01188343|469171671|FG000|Overall Study|Withdrawal by Subject|1|||
130328278|NCT01188343|469171672|FG001|Overall Study|Withdrawal by Subject|24|||
129883721|NCT01146574|467534408|FG004|Overall Study|Other reasons|0|||
129883722|NCT01146574|467534409|FG005|Overall Study|Other reasons|0|||
129883723|NCT01146574|467534410|FG006|Overall Study|Other reasons|0|||
129883724|NCT01146574|467534404|FG000|Overall Study|Kidney transplant|0|||
129883725|NCT01146574|467534405|FG001|Overall Study|Kidney transplant|0|||
129883726|NCT01146574|467534406|FG002|Overall Study|Kidney transplant|1|||
129883727|NCT01146574|467534407|FG003|Overall Study|Kidney transplant|1|||
129883728|NCT01146574|467534408|FG004|Overall Study|Kidney transplant|0|||
129883729|NCT01146574|467534409|FG005|Overall Study|Kidney transplant|0|||
129883730|NCT01146574|467534410|FG006|Overall Study|Kidney transplant|0|||
129883731|NCT01146574|467534404|FG000|Overall Study|Withdrew consent|0|||
129883732|NCT01146574|467534405|FG001|Overall Study|Withdrew consent|0|||
129883733|NCT01146574|467534406|FG002|Overall Study|Withdrew consent|1|||
129883734|NCT01146574|467534407|FG003|Overall Study|Withdrew consent|1|||
129883735|NCT01146574|467534408|FG004|Overall Study|Withdrew consent|2|||
129883736|NCT01146574|467534409|FG005|Overall Study|Withdrew consent|1|||
129883737|NCT01146574|467534410|FG006|Overall Study|Withdrew consent|1|||
129883738|NCT03051659|467534411|FG000|Treatment Period|Withdrawal by Subject|0|||
129883739|NCT03051659|467534412|FG001|Treatment Period|Withdrawal by Subject|2|||
129883740|NCT03051659|467534411|FG000|Survival Follow-up|Lost to Follow-up|23|||
129883741|NCT03051659|467534412|FG001|Survival Follow-up|Lost to Follow-up|22|||
129883742|NCT01076088|467534413|FG000|Overall Study|Adverse Event|1|||
129883743|NCT01076088|467534414|FG001|Overall Study|Adverse Event|6|||
129883744|NCT01076088|467534415|FG002|Overall Study|Adverse Event|3|||
129883745|NCT01076088|467534416|FG003|Overall Study|Adverse Event|2|||
129883746|NCT01076088|467534417|FG004|Overall Study|Adverse Event|3|||
129883747|NCT01076088|467534418|FG005|Overall Study|Adverse Event|3|||
129883748|NCT01076088|467534413|FG000|Overall Study|Lost to Follow-up|1|||
129883749|NCT01076088|467534414|FG001|Overall Study|Lost to Follow-up|1|||
129883750|NCT01076088|467534415|FG002|Overall Study|Lost to Follow-up|0|||
129883751|NCT01076088|467534416|FG003|Overall Study|Lost to Follow-up|1|||
129883752|NCT01076088|467534417|FG004|Overall Study|Lost to Follow-up|1|||
129883753|NCT01076088|467534418|FG005|Overall Study|Lost to Follow-up|2|||
129883754|NCT01076088|467534413|FG000|Overall Study|Non-compliance with study drug|0|||
129883755|NCT01076088|467534414|FG001|Overall Study|Non-compliance with study drug|0|||
129883756|NCT01076088|467534415|FG002|Overall Study|Non-compliance with study drug|0|||
129883757|NCT01076088|467534416|FG003|Overall Study|Non-compliance with study drug|1|||
129883758|NCT01076088|467534417|FG004|Overall Study|Non-compliance with study drug|0|||
129883759|NCT01076088|467534418|FG005|Overall Study|Non-compliance with study drug|0|||
129883760|NCT01076088|467534413|FG000|Overall Study|Physician Decision|1|||
129883761|NCT01076088|467534414|FG001|Overall Study|Physician Decision|3|||
129883762|NCT01076088|467534415|FG002|Overall Study|Physician Decision|0|||
129883763|NCT01076088|467534416|FG003|Overall Study|Physician Decision|1|||
129883764|NCT01076088|467534417|FG004|Overall Study|Physician Decision|1|||
129883765|NCT01076088|467534418|FG005|Overall Study|Physician Decision|0|||
129883766|NCT01076088|467534413|FG000|Overall Study|Withdrawal by Subject|8|||
129883767|NCT01076088|467534414|FG001|Overall Study|Withdrawal by Subject|8|||
129883768|NCT01076088|467534415|FG002|Overall Study|Withdrawal by Subject|14|||
129883769|NCT01076088|467534416|FG003|Overall Study|Withdrawal by Subject|10|||
129883770|NCT01076088|467534417|FG004|Overall Study|Withdrawal by Subject|11|||
129883771|NCT01076088|467534418|FG005|Overall Study|Withdrawal by Subject|17|||
129883772|NCT01076088|467534413|FG000|Overall Study|Other protocol specified criteria|0|||
129883773|NCT01076088|467534414|FG001|Overall Study|Other protocol specified criteria|0|||
129883774|NCT01076088|467534415|FG002|Overall Study|Other protocol specified criteria|0|||
129883775|NCT01076088|467534416|FG003|Overall Study|Other protocol specified criteria|0|||
129883776|NCT01076088|467534417|FG004|Overall Study|Other protocol specified criteria|0|||
129883777|NCT01076088|467534418|FG005|Overall Study|Other protocol specified criteria|1|||
129883778|NCT00786474|467534419|FG000|Overall Study|Death|5|||
129883779|NCT00786474|467534420|FG001|Overall Study|Death|4|||
129883780|NCT00786474|467534419|FG000|Overall Study|Withdrawal by Subject|23|||
129883781|NCT00786474|467534420|FG001|Overall Study|Withdrawal by Subject|31|||
129883782|NCT00786474|467534419|FG000|Overall Study|Lost to Follow-up|3|||
129883783|NCT00786474|467534420|FG001|Overall Study|Lost to Follow-up|3|||
129883784|NCT00786474|467534419|FG000|Overall Study|Physician Decision|2|||
129883785|NCT00786474|467534420|FG001|Overall Study|Physician Decision|1|||
129883786|NCT00786474|467534419|FG000|Overall Study|Other|4|||
129883787|NCT00786474|467534420|FG001|Overall Study|Other|4|||
129883788|NCT03053492|467534421|FG000|Overall Study|Adverse Event|1|||
129883789|NCT03053492|467534422|FG001|Overall Study|Adverse Event|1|||
129883790|NCT03053492|467534421|FG000|Overall Study|Withdrawal by Subject|7|||
129883791|NCT03053492|467534422|FG001|Overall Study|Withdrawal by Subject|5|||
129883792|NCT01868074|467534423|FG000|Overall Study|Lost to Follow-up|3|||
129883793|NCT01868074|467534424|FG001|Overall Study|Lost to Follow-up|2|||
129883794|NCT01868074|467534423|FG000|Overall Study|Withdrawal by Subject|4|||
129883795|NCT01868074|467534424|FG001|Overall Study|Withdrawal by Subject|2|||
129883796|NCT01544491|467534425|FG000|Overall Study|Withdrawal by Subject|3|||
129883797|NCT01544491|467534426|FG001|Overall Study|Withdrawal by Subject|2|||
129883798|NCT01544491|467534425|FG000|Overall Study|Lost to Follow-up|0|||
129989508|NCT00522873|467925436|FG001|Overall Study|Lost to Follow-up|3|||
129989509|NCT00522873|467925435|FG000|Overall Study|Personal Reasons|8|||
129989510|NCT00522873|467925436|FG001|Overall Study|Personal Reasons|1|||
129989511|NCT00522873|467925435|FG000|Overall Study|Medication Errors|1|||
129989512|NCT00522873|467925436|FG001|Overall Study|Medication Errors|1|||
129989513|NCT00522873|467925435|FG000|Overall Study|Never Received Medication|1|||
129989514|NCT00522873|467925436|FG001|Overall Study|Never Received Medication|0|||
129989515|NCT01052103|467925438|FG000|Overall Study|Adverse Event|10|||
130328279|NCT01188343|469171673|FG002|Overall Study|Withdrawal by Subject|0|||
130328280|NCT01143246|469171674|FG000|Overall Study|Adverse Event|24|||
130328281|NCT01143246|469171675|FG001|Overall Study|Adverse Event|28|||
130328282|NCT01143246|469171674|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
129883799|NCT01544491|467534426|FG001|Overall Study|Lost to Follow-up|1|||
129883800|NCT01544491|467534425|FG000|Overall Study|administrative problems|2|||
129883801|NCT01544491|467534426|FG001|Overall Study|administrative problems|0|||
129883802|NCT00967018|467534427|FG000|Overall Study|Adverse Event|2|||
129883803|NCT00967018|467534427|FG000|Overall Study|Physician Decision|7|||
129883804|NCT00967018|467534427|FG000|Overall Study|Lost to Follow-up|2|||
129883805|NCT00967018|467534427|FG000|Overall Study|Withdrawal by Subject|1|||
129883806|NCT00967018|467534427|FG000|Overall Study|Miscellaneous Reasons|9|||
129883807|NCT04642469|467534433|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
129883808|NCT04642469|467534434|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
129883809|NCT04642469|467534433|FG000|Overall Study|Death|1|||
129883810|NCT04642469|467534434|FG001|Overall Study|Death|2|||
129883811|NCT04642469|467534433|FG000|Overall Study|Study/site closed following amendment 1|11|||
129883812|NCT04642469|467534434|FG001|Overall Study|Study/site closed following amendment 1|11|||
129883813|NCT04642469|467534433|FG000|Overall Study|Other|1|||
129883814|NCT04642469|467534434|FG001|Overall Study|Other|1|||
129883815|NCT04642469|467534433|FG000|Overall Study|Withdrawal by Subject|1|||
129883816|NCT04642469|467534434|FG001|Overall Study|Withdrawal by Subject|0|||
129883817|NCT01461993|467534435|FG000|Overall Study|Withdrawal by Subject|60|||
129883818|NCT01461993|467534436|FG001|Overall Study|Withdrawal by Subject|53|||
129883819|NCT01461993|467534437|FG002|Overall Study|Withdrawal by Subject|16|||
129883820|NCT01461993|467534435|FG000|Overall Study|Lost to Follow-up|44|||
129883821|NCT01461993|467534436|FG001|Overall Study|Lost to Follow-up|48|||
129883822|NCT01461993|467534437|FG002|Overall Study|Lost to Follow-up|22|||
129883823|NCT01461993|467534435|FG000|Overall Study|Protocol Violation|10|||
129883824|NCT01461993|467534436|FG001|Overall Study|Protocol Violation|9|||
129883825|NCT01461993|467534437|FG002|Overall Study|Protocol Violation|7|||
129883826|NCT01461993|467534435|FG000|Overall Study|Adverse Event|9|||
129883827|NCT01461993|467534436|FG001|Overall Study|Adverse Event|11|||
129883828|NCT01461993|467534437|FG002|Overall Study|Adverse Event|3|||
129883829|NCT01461993|467534435|FG000|Overall Study|No longer met eligibility criteria|13|||
129883830|NCT01461993|467534436|FG001|Overall Study|No longer met eligibility criteria|18|||
129883831|NCT01461993|467534437|FG002|Overall Study|No longer met eligibility criteria|10|||
129883832|NCT01461993|467534435|FG000|Overall Study|Did not meet entrance criteria|2|||
129883833|NCT01461993|467534436|FG001|Overall Study|Did not meet entrance criteria|3|||
129883834|NCT01461993|467534437|FG002|Overall Study|Did not meet entrance criteria|0|||
129883835|NCT01461993|467534435|FG000|Overall Study|Other|13|||
129883836|NCT01461993|467534436|FG001|Overall Study|Other|15|||
129883837|NCT01461993|467534437|FG002|Overall Study|Other|6|||
129883838|NCT00680056|467534439|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
129883839|NCT00680056|467534440|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
129883840|NCT00680056|467534439|FG000|Second Intervention|Protocol Violation|3|||
129883841|NCT00680056|467534440|FG001|Second Intervention|Protocol Violation|1|||
129883842|NCT02733042|467534441|FG000|Overall Study|Adverse Event|1|||
129883843|NCT02733042|467534442|FG001|Overall Study|Adverse Event|0|||
129883844|NCT02733042|467534443|FG002|Overall Study|Adverse Event|1|||
129883845|NCT02733042|467534444|FG003|Overall Study|Adverse Event|1|||
129883846|NCT02733042|467534445|FG004|Overall Study|Adverse Event|0|||
129883847|NCT02733042|467534446|FG005|Overall Study|Adverse Event|0|||
129883848|NCT02733042|467534447|FG006|Overall Study|Adverse Event|0|||
129883849|NCT02733042|467534448|FG007|Overall Study|Adverse Event|0|||
129883850|NCT02733042|467534449|FG008|Overall Study|Adverse Event|0|||
129883851|NCT02733042|467534450|FG009|Overall Study|Adverse Event|0|||
129883852|NCT02733042|467534451|FG010|Overall Study|Adverse Event|2|||
129883853|NCT02733042|467534452|FG011|Overall Study|Adverse Event|2|||
129883854|NCT02733042|467534453|FG012|Overall Study|Adverse Event|0|||
129883855|NCT02733042|467534454|FG013|Overall Study|Adverse Event|2|||
129883856|NCT02733042|467534455|FG014|Overall Study|Adverse Event|0|||
129883857|NCT02733042|467534456|FG015|Overall Study|Adverse Event|0|||
129883858|NCT02733042|467534457|FG016|Overall Study|Adverse Event|0|||
129883859|NCT02733042|467534458|FG017|Overall Study|Adverse Event|1|||
129883860|NCT02733042|467534459|FG018|Overall Study|Adverse Event|0|||
129883861|NCT02733042|467534441|FG000|Overall Study|Progressive Disease|2|||
129883862|NCT02733042|467534442|FG001|Overall Study|Progressive Disease|1|||
129883863|NCT02733042|467534443|FG002|Overall Study|Progressive Disease|3|||
130328283|NCT01143246|469171675|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
129989516|NCT01052103|467925439|FG001|Overall Study|Adverse Event|6|||
129989517|NCT01052103|467925438|FG000|Overall Study|Entry Criteria Not Met|3|||
129989518|NCT01052103|467925439|FG001|Overall Study|Entry Criteria Not Met|1|||
129989519|NCT01052103|467925438|FG000|Overall Study|Lost to Follow-up|3|||
129989520|NCT01052103|467925439|FG001|Overall Study|Lost to Follow-up|5|||
129989521|NCT01052103|467925438|FG000|Overall Study|Protocol Violation|10|||
129989522|NCT01052103|467925439|FG001|Overall Study|Protocol Violation|4|||
129989523|NCT01052103|467925438|FG000|Overall Study|Scheduling conflict|2|||
129989524|NCT01052103|467925439|FG001|Overall Study|Scheduling conflict|1|||
129989525|NCT01052103|467925438|FG000|Overall Study|Sponsor Decision|2|||
129989526|NCT01052103|467925439|FG001|Overall Study|Sponsor Decision|0|||
129989527|NCT01052103|467925438|FG000|Overall Study|Withdrawal by Subject|3|||
129989528|NCT01052103|467925439|FG001|Overall Study|Withdrawal by Subject|6|||
129989529|NCT01052103|467925438|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129989530|NCT01052103|467925439|FG001|Overall Study|Perceived Lack of Efficacy|0|||
129989531|NCT00799513|467925443|FG000|Overall Study|Physician Decision|1|||
129989532|NCT00799513|467925443|FG000|Overall Study|Adverse Event|1|||
129989533|NCT05398237|467925446|FG000|Overall Study|Withdrawal by Subject|1|||
129989534|NCT00666679|467925447|FG000|First Intervention|Lost to Follow-up|1|||
129989535|NCT00666679|467925448|FG001|First Intervention|Lost to Follow-up|0|||
129989536|NCT00666679|467925447|FG000|First Intervention|Protocol Violation|1|||
129989537|NCT00666679|467925448|FG001|First Intervention|Protocol Violation|0|||
129989538|NCT00666679|467925447|FG000|First Intervention|Withdrawal by Subject|1|||
129989539|NCT00666679|467925448|FG001|First Intervention|Withdrawal by Subject|0|||
129989540|NCT00666679|467925447|FG000|First Intervention|Randomized did not start treatment|1|||
129989541|NCT00666679|467925448|FG001|First Intervention|Randomized did not start treatment|1|||
129989542|NCT00666679|467925447|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
129989543|NCT00666679|467925448|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
129989544|NCT00666679|467925447|FG000|Washout Period of 1 Week|Protocol Violation|0|||
129989545|NCT00666679|467925448|FG001|Washout Period of 1 Week|Protocol Violation|1|||
129989546|NCT00666679|467925447|FG000|Second Intervention|Adverse Event|1|||
129989547|NCT00666679|467925448|FG001|Second Intervention|Adverse Event|0|||
129989548|NCT00666679|467925447|FG000|Second Intervention|Death|0|||
129989549|NCT00666679|467925448|FG001|Second Intervention|Death|1|||
129989550|NCT05062759|467925454|FG000|Overall Study|Death|0|||
129989551|NCT05062759|467925455|FG001|Overall Study|Death|1|||
129989552|NCT05062759|467925454|FG000|Overall Study|Lost to Follow-up|1|||
129989553|NCT05062759|467925455|FG001|Overall Study|Lost to Follow-up|0|||
129989554|NCT01248065|467925456|FG000|Overall Study|Lost to Follow-up|3|||
129989555|NCT01248065|467925457|FG001|Overall Study|Lost to Follow-up|5|||
129989556|NCT01248065|467925456|FG000|Overall Study|Withdrawal by Subject|14|||
129989557|NCT01248065|467925457|FG001|Overall Study|Withdrawal by Subject|11|||
129989558|NCT01248065|467925456|FG000|Overall Study|Adverse Event|3|||
129989559|NCT01248065|467925457|FG001|Overall Study|Adverse Event|0|||
129989560|NCT01248065|467925456|FG000|Overall Study|Third treatment failure event|3|||
129989561|NCT01248065|467925457|FG001|Overall Study|Third treatment failure event|1|||
129989562|NCT01248065|467925456|FG000|Overall Study|Other|3|||
129989563|NCT01248065|467925457|FG001|Overall Study|Other|5|||
129989564|NCT02781844|467925461|FG000|Treatment Period 1|Adverse Event|0|||
129989565|NCT02781844|467925462|FG001|Treatment Period 1|Adverse Event|0|||
129989566|NCT02781844|467925463|FG002|Treatment Period 1|Adverse Event|0|||
129989567|NCT02781844|467925464|FG003|Treatment Period 1|Adverse Event|0|||
129989568|NCT02781844|467925465|FG004|Treatment Period 1|Adverse Event|0|||
129989569|NCT02781844|467925466|FG005|Treatment Period 1|Adverse Event|1|||
129989570|NCT02781844|467925467|FG006|Treatment Period 1|Adverse Event|0|||
129989571|NCT02781844|467925468|FG007|Treatment Period 1|Adverse Event|0|||
129989572|NCT02518490|467925471|FG000|Overall Study|Withdrawal by Subject|1|||
129989573|NCT02518490|467925472|FG001|Overall Study|Withdrawal by Subject|1|||
129989574|NCT03010176|467925475|FG000|Overall Study|Death|21|||
129989575|NCT03010176|467925476|FG001|Overall Study|Death|35|||
129989576|NCT03010176|467925477|FG002|Overall Study|Death|19|||
129989577|NCT03010176|467925478|FG003|Overall Study|Death|19|||
129989578|NCT03010176|467925479|FG004|Overall Study|Death|14|||
129989579|NCT03010176|467925480|FG005|Overall Study|Death|0|||
129989580|NCT03010176|467925475|FG000|Overall Study|Lost to Follow-up|0|||
129989581|NCT03010176|467925476|FG001|Overall Study|Lost to Follow-up|0|||
129989582|NCT03010176|467925477|FG002|Overall Study|Lost to Follow-up|0|||
129989583|NCT03010176|467925478|FG003|Overall Study|Lost to Follow-up|0|||
129989584|NCT03010176|467925479|FG004|Overall Study|Lost to Follow-up|1|||
129989585|NCT03010176|467925480|FG005|Overall Study|Lost to Follow-up|0|||
129989586|NCT03010176|467925475|FG000|Overall Study|Physician Decision|0|||
129989587|NCT03010176|467925476|FG001|Overall Study|Physician Decision|4|||
129989588|NCT03010176|467925477|FG002|Overall Study|Physician Decision|0|||
129989589|NCT03010176|467925478|FG003|Overall Study|Physician Decision|1|||
129989590|NCT03010176|467925479|FG004|Overall Study|Physician Decision|0|||
129989591|NCT03010176|467925480|FG005|Overall Study|Physician Decision|0|||
129989592|NCT03010176|467925475|FG000|Overall Study|Sponsor Decision|0|||
129989593|NCT03010176|467925476|FG001|Overall Study|Sponsor Decision|4|||
129989594|NCT03010176|467925477|FG002|Overall Study|Sponsor Decision|4|||
129989595|NCT03010176|467925478|FG003|Overall Study|Sponsor Decision|1|||
129989596|NCT03010176|467925479|FG004|Overall Study|Sponsor Decision|6|||
129989597|NCT03010176|467925480|FG005|Overall Study|Sponsor Decision|0|||
129989598|NCT03010176|467925475|FG000|Overall Study|Withdrawal by Subject|11|||
129989599|NCT03010176|467925476|FG001|Overall Study|Withdrawal by Subject|9|||
129989600|NCT03010176|467925477|FG002|Overall Study|Withdrawal by Subject|3|||
129989601|NCT03010176|467925478|FG003|Overall Study|Withdrawal by Subject|0|||
129989602|NCT03010176|467925479|FG004|Overall Study|Withdrawal by Subject|4|||
129989603|NCT03010176|467925480|FG005|Overall Study|Withdrawal by Subject|0|||
129989604|NCT04256629|467925481|FG000|Overall Study|Adverse Event|0|||
129989605|NCT04256629|467925482|FG001|Overall Study|Adverse Event|0|||
129989606|NCT04256629|467925483|FG002|Overall Study|Adverse Event|0|||
129989607|NCT04256629|467925484|FG003|Overall Study|Adverse Event|0|||
129989608|NCT04256629|467925485|FG004|Overall Study|Adverse Event|0|||
129989609|NCT04256629|467925486|FG005|Overall Study|Adverse Event|1|||
129989610|NCT04256629|467925481|FG000|Overall Study|Protocol Violation|0|||
129989611|NCT04256629|467925482|FG001|Overall Study|Protocol Violation|1|||
129989612|NCT04256629|467925483|FG002|Overall Study|Protocol Violation|0|||
129989613|NCT04256629|467925484|FG003|Overall Study|Protocol Violation|0|||
130328284|NCT01143246|469171674|FG000|Overall Study|Lost to Follow-up|0|||
130328285|NCT01143246|469171675|FG001|Overall Study|Lost to Follow-up|1|||
130328286|NCT01143246|469171674|FG000|Overall Study|Death|16|||
130328287|NCT01143246|469171675|FG001|Overall Study|Death|15|||
130328288|NCT01143246|469171674|FG000|Overall Study|Reason not Specified|3|||
130328289|NCT01143246|469171675|FG001|Overall Study|Reason not Specified|5|||
130328290|NCT05567783|469171676|FG000|Overall Study|Death|2|||
130328291|NCT05567783|469171677|FG001|Overall Study|Death|3|||
130328292|NCT05567783|469171678|FG002|Overall Study|Death|0|||
130328293|NCT05567783|469171676|FG000|Overall Study|Lost to Follow-up|25|||
130328294|NCT05567783|469171677|FG001|Overall Study|Lost to Follow-up|19|||
130328295|NCT05567783|469171678|FG002|Overall Study|Lost to Follow-up|17|||
130328296|NCT05567783|469171676|FG000|Overall Study|Physician Decision|10|||
130328297|NCT05567783|469171677|FG001|Overall Study|Physician Decision|7|||
130328298|NCT05567783|469171678|FG002|Overall Study|Physician Decision|9|||
130328299|NCT05567783|469171676|FG000|Overall Study|Study Terminated by Sponsor|924|||
130328300|NCT05567783|469171677|FG001|Overall Study|Study Terminated by Sponsor|937|||
130328301|NCT05567783|469171678|FG002|Overall Study|Study Terminated by Sponsor|941|||
130328302|NCT05567783|469171676|FG000|Overall Study|Withdrawal by Subject|23|||
130328303|NCT05567783|469171677|FG001|Overall Study|Withdrawal by Subject|27|||
129989614|NCT04256629|467925485|FG004|Overall Study|Protocol Violation|0|||
129989615|NCT04256629|467925486|FG005|Overall Study|Protocol Violation|0|||
129989616|NCT00321373|467925487|FG000|Overall Study|Adverse Event|0|||
129989617|NCT00321373|467925488|FG001|Overall Study|Adverse Event|0|||
129989618|NCT00321373|467925489|FG002|Overall Study|Adverse Event|1|||
129989619|NCT00321373|467925487|FG000|Overall Study|Lost to Follow-up|1|||
129989620|NCT00321373|467925488|FG001|Overall Study|Lost to Follow-up|0|||
129989621|NCT00321373|467925489|FG002|Overall Study|Lost to Follow-up|1|||
129989622|NCT00321373|467925487|FG000|Overall Study|Withdrawal by Subject|1|||
129989623|NCT00321373|467925488|FG001|Overall Study|Withdrawal by Subject|0|||
129989624|NCT00321373|467925489|FG002|Overall Study|Withdrawal by Subject|0|||
129989625|NCT00321373|467925487|FG000|Overall Study|Other|0|||
129989626|NCT00321373|467925488|FG001|Overall Study|Other|0|||
129989627|NCT00321373|467925489|FG002|Overall Study|Other|1|||
129989628|NCT01774487|467925490|FG000|Overall Study|Did not tolerate taste|4|||
129989629|NCT01774487|467925491|FG001|Overall Study|Did not tolerate taste|4|||
129989630|NCT00346632|467925492|FG000|Overall Study|Progressive Disease|2|||
129989631|NCT00346632|467925493|FG001|Overall Study|Progressive Disease|2|||
129989632|NCT00346632|467925494|FG002|Overall Study|Progressive Disease|4|||
129989633|NCT00346632|467925495|FG003|Overall Study|Progressive Disease|3|||
129989634|NCT00346632|467925496|FG004|Overall Study|Progressive Disease|3|||
129989635|NCT00346632|467925497|FG005|Overall Study|Progressive Disease|1|||
130328304|NCT05567783|469171678|FG002|Overall Study|Withdrawal by Subject|24|||
129989636|NCT00346632|467925498|FG006|Overall Study|Progressive Disease|2|||
129989637|NCT00346632|467925499|FG007|Overall Study|Progressive Disease|2|||
129989638|NCT00346632|467925500|FG008|Overall Study|Progressive Disease|2|||
129989639|NCT00346632|467925501|FG009|Overall Study|Progressive Disease|2|||
130328305|NCT05567783|469171676|FG000|Overall Study|Incarcerated|1|||
130328306|NCT05567783|469171677|FG001|Overall Study|Incarcerated|0|||
129989640|NCT00346632|467925492|FG000|Overall Study|Adverse Event|0|||
129989641|NCT00346632|467925493|FG001|Overall Study|Adverse Event|0|||
129989642|NCT00346632|467925494|FG002|Overall Study|Adverse Event|0|||
130328307|NCT05567783|469171678|FG002|Overall Study|Incarcerated|0|||
130328308|NCT05567783|469171676|FG000|Overall Study|Participant randomized in error|4|||
130328309|NCT05567783|469171677|FG001|Overall Study|Participant randomized in error|2|||
130328310|NCT05567783|469171678|FG002|Overall Study|Participant randomized in error|2|||
129989643|NCT00346632|467925495|FG003|Overall Study|Adverse Event|0|||
129989644|NCT00346632|467925496|FG004|Overall Study|Adverse Event|1|||
129989645|NCT00346632|467925497|FG005|Overall Study|Adverse Event|1|||
129989646|NCT00346632|467925498|FG006|Overall Study|Adverse Event|1|||
129989647|NCT00346632|467925499|FG007|Overall Study|Adverse Event|0|||
130328311|NCT03944577|469171684|FG000|Overall Study|Adverse Event|3|||
130328312|NCT04119414|469171685|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
130328313|NCT01352793|469171689|FG000|Overall Study|Lost to Follow-up|289|||
130328314|NCT01352793|469171690|FG001|Overall Study|Lost to Follow-up|125|||
130328315|NCT01352793|469171689|FG000|Overall Study|Withdrawal by Subject|120|||
130328316|NCT01352793|469171690|FG001|Overall Study|Withdrawal by Subject|55|||
130328317|NCT01352793|469171689|FG000|Overall Study|Protocol Violation|44|||
130328318|NCT01352793|469171690|FG001|Overall Study|Protocol Violation|23|||
130328319|NCT01352793|469171689|FG000|Overall Study|Adverse Event|44|||
130328320|NCT01352793|469171690|FG001|Overall Study|Adverse Event|10|||
130328321|NCT01352793|469171689|FG000|Overall Study|Physician Decision|1|||
130328322|NCT01352793|469171690|FG001|Overall Study|Physician Decision|0|||
130328323|NCT01352793|469171689|FG000|Overall Study|Pregnancy|26|||
130328324|NCT01352793|469171690|FG001|Overall Study|Pregnancy|8|||
130328325|NCT01352793|469171689|FG000|Overall Study|Other|25|||
130328326|NCT01352793|469171690|FG001|Overall Study|Other|7|||
130328327|NCT01352793|469171689|FG000|Overall Study|Medication error|2|||
130328328|NCT01352793|469171690|FG001|Overall Study|Medication error|2|||
130328329|NCT01352793|469171689|FG000|Overall Study|Death|1|||
130328330|NCT01352793|469171690|FG001|Overall Study|Death|0|||
130328331|NCT01352793|469171689|FG000|Overall Study|Randomized but not vaccinated|8|||
130328332|NCT01352793|469171690|FG001|Overall Study|Randomized but not vaccinated|0|||
130328333|NCT01352793|469171689|FG000|Overall Study|No longer meets eligibility criteria|25|||
130328334|NCT01352793|469171690|FG001|Overall Study|No longer meets eligibility criteria|15|||
130328335|NCT01716234|469171695|FG000|Overall Study|Protocol Violation|0|||
130328336|NCT01716234|469171696|FG001|Overall Study|Protocol Violation|0|||
130328337|NCT01716234|469171697|FG002|Overall Study|Protocol Violation|0|||
130328338|NCT01716234|469171698|FG003|Overall Study|Protocol Violation|1|||
130328339|NCT01716234|469171699|FG004|Overall Study|Protocol Violation|1|||
130328340|NCT01716234|469171700|FG005|Overall Study|Protocol Violation|1|||
130328341|NCT01716234|469171701|FG006|Overall Study|Protocol Violation|0|||
130328342|NCT01716234|469171695|FG000|Overall Study|Lack of Efficacy|0|||
130328343|NCT01716234|469171696|FG001|Overall Study|Lack of Efficacy|0|||
130328344|NCT01716234|469171697|FG002|Overall Study|Lack of Efficacy|0|||
130328345|NCT01716234|469171698|FG003|Overall Study|Lack of Efficacy|1|||
130328346|NCT01716234|469171699|FG004|Overall Study|Lack of Efficacy|0|||
130328347|NCT01716234|469171700|FG005|Overall Study|Lack of Efficacy|0|||
130328348|NCT01716234|469171701|FG006|Overall Study|Lack of Efficacy|0|||
130328349|NCT01716234|469171695|FG000|Overall Study|Did not meet protocol eligibility|0|||
130328350|NCT01716234|469171696|FG001|Overall Study|Did not meet protocol eligibility|0|||
130328351|NCT01716234|469171697|FG002|Overall Study|Did not meet protocol eligibility|1|||
130328352|NCT01716234|469171698|FG003|Overall Study|Did not meet protocol eligibility|0|||
130328353|NCT01716234|469171699|FG004|Overall Study|Did not meet protocol eligibility|0|||
130328354|NCT01716234|469171700|FG005|Overall Study|Did not meet protocol eligibility|4|||
130328355|NCT01716234|469171701|FG006|Overall Study|Did not meet protocol eligibility|0|||
130328356|NCT01716234|469171695|FG000|Overall Study|Adverse Event|7|||
130328357|NCT01716234|469171696|FG001|Overall Study|Adverse Event|10|||
130328358|NCT01716234|469171697|FG002|Overall Study|Adverse Event|2|||
130328359|NCT01716234|469171698|FG003|Overall Study|Adverse Event|8|||
130328360|NCT01716234|469171699|FG004|Overall Study|Adverse Event|3|||
130328361|NCT01716234|469171700|FG005|Overall Study|Adverse Event|6|||
130328362|NCT01716234|469171701|FG006|Overall Study|Adverse Event|0|||
130328363|NCT01716234|469171695|FG000|Overall Study|Withdrawal by Subject|3|||
130328364|NCT01716234|469171696|FG001|Overall Study|Withdrawal by Subject|0|||
130328365|NCT01716234|469171697|FG002|Overall Study|Withdrawal by Subject|2|||
130328366|NCT01716234|469171698|FG003|Overall Study|Withdrawal by Subject|2|||
130328367|NCT01716234|469171699|FG004|Overall Study|Withdrawal by Subject|1|||
130328368|NCT01716234|469171700|FG005|Overall Study|Withdrawal by Subject|3|||
130328369|NCT01716234|469171701|FG006|Overall Study|Withdrawal by Subject|0|||
129989648|NCT00346632|467925500|FG008|Overall Study|Adverse Event|0|||
129989649|NCT00346632|467925501|FG009|Overall Study|Adverse Event|0|||
129989650|NCT00346632|467925492|FG000|Overall Study|Death|0|||
129989651|NCT00346632|467925493|FG001|Overall Study|Death|0|||
129989652|NCT00346632|467925494|FG002|Overall Study|Death|1|||
130328370|NCT03326713|469171703|FG000|Overall Study|Death|2|||
130328371|NCT03326713|469171704|FG001|Overall Study|Death|1|||
130328372|NCT03326713|469171705|FG002|Overall Study|Death|0|||
129989653|NCT00346632|467925495|FG003|Overall Study|Death|0|||
129989654|NCT00346632|467925496|FG004|Overall Study|Death|0|||
129989655|NCT00346632|467925497|FG005|Overall Study|Death|0|||
129989656|NCT00346632|467925498|FG006|Overall Study|Death|0|||
129989657|NCT00346632|467925499|FG007|Overall Study|Death|0|||
129989658|NCT00346632|467925500|FG008|Overall Study|Death|0|||
129989659|NCT00346632|467925501|FG009|Overall Study|Death|0|||
130328373|NCT03326713|469171703|FG000|Overall Study|Lost to Follow-up|20|||
130328374|NCT03326713|469171704|FG001|Overall Study|Lost to Follow-up|21|||
130328375|NCT03326713|469171705|FG002|Overall Study|Lost to Follow-up|33|||
130328376|NCT03326713|469171703|FG000|Overall Study|Withdrawal by Subject|1|||
130328377|NCT03326713|469171704|FG001|Overall Study|Withdrawal by Subject|2|||
129989660|NCT00346632|467925492|FG000|Overall Study|Protocol Violation|0|||
129989661|NCT00346632|467925493|FG001|Overall Study|Protocol Violation|0|||
129989662|NCT00346632|467925494|FG002|Overall Study|Protocol Violation|0|||
129989663|NCT00346632|467925495|FG003|Overall Study|Protocol Violation|0|||
130328378|NCT03326713|469171705|FG002|Overall Study|Withdrawal by Subject|11|||
130328379|NCT03326713|469171703|FG000|Overall Study|Found Ineligible|11|||
130328380|NCT03326713|469171704|FG001|Overall Study|Found Ineligible|11|||
130328381|NCT03326713|469171705|FG002|Overall Study|Found Ineligible|8|||
130328382|NCT01394016|469171708|FG000|Overall Study|Progressive Disease|2|||
130328383|NCT01394016|469171709|FG001|Overall Study|Progressive Disease|0|||
130328384|NCT01394016|469171710|FG002|Overall Study|Progressive Disease|0|||
130328385|NCT01394016|469171711|FG003|Overall Study|Progressive Disease|0|||
130328386|NCT01394016|469171712|FG004|Overall Study|Progressive Disease|0|||
130328387|NCT01394016|469171713|FG005|Overall Study|Progressive Disease|0|||
130328388|NCT01394016|469171714|FG006|Overall Study|Progressive Disease|0|||
130328389|NCT01394016|469171715|FG007|Overall Study|Progressive Disease|0|||
130328390|NCT01394016|469171716|FG008|Overall Study|Progressive Disease|0|||
130328391|NCT01394016|469171717|FG009|Overall Study|Progressive Disease|0|||
130328392|NCT01394016|469171718|FG010|Overall Study|Progressive Disease|0|||
130328393|NCT01394016|469171719|FG011|Overall Study|Progressive Disease|0|||
130328394|NCT01394016|469171720|FG012|Overall Study|Progressive Disease|0|||
130328395|NCT01394016|469171721|FG013|Overall Study|Progressive Disease|0|||
130328396|NCT01394016|469171722|FG014|Overall Study|Progressive Disease|0|||
130328397|NCT01394016|469171723|FG015|Overall Study|Progressive Disease|0|||
130328398|NCT01394016|469171724|FG016|Overall Study|Progressive Disease|0|||
130328399|NCT01394016|469171725|FG017|Overall Study|Progressive Disease|0|||
130328400|NCT01394016|469171726|FG018|Overall Study|Progressive Disease|0|||
130328401|NCT01394016|469171708|FG000|Overall Study|Withdrawal by Subject|0|||
130328402|NCT01394016|469171709|FG001|Overall Study|Withdrawal by Subject|0|||
130328403|NCT01394016|469171710|FG002|Overall Study|Withdrawal by Subject|0|||
130328404|NCT01394016|469171711|FG003|Overall Study|Withdrawal by Subject|0|||
130328405|NCT01394016|469171712|FG004|Overall Study|Withdrawal by Subject|0|||
130328406|NCT01394016|469171713|FG005|Overall Study|Withdrawal by Subject|0|||
130328407|NCT01394016|469171714|FG006|Overall Study|Withdrawal by Subject|0|||
130328408|NCT01394016|469171715|FG007|Overall Study|Withdrawal by Subject|1|||
130328409|NCT01394016|469171716|FG008|Overall Study|Withdrawal by Subject|1|||
130328410|NCT01394016|469171717|FG009|Overall Study|Withdrawal by Subject|1|||
130328411|NCT01394016|469171718|FG010|Overall Study|Withdrawal by Subject|4|||
130328412|NCT01394016|469171719|FG011|Overall Study|Withdrawal by Subject|0|||
130328413|NCT01394016|469171720|FG012|Overall Study|Withdrawal by Subject|0|||
130328414|NCT01394016|469171721|FG013|Overall Study|Withdrawal by Subject|3|||
130328415|NCT01394016|469171722|FG014|Overall Study|Withdrawal by Subject|1|||
130328416|NCT01394016|469171723|FG015|Overall Study|Withdrawal by Subject|3|||
130328417|NCT01394016|469171724|FG016|Overall Study|Withdrawal by Subject|1|||
129989664|NCT00346632|467925496|FG004|Overall Study|Protocol Violation|0|||
129989665|NCT00346632|467925497|FG005|Overall Study|Protocol Violation|0|||
130328418|NCT01394016|469171725|FG017|Overall Study|Withdrawal by Subject|1|||
130328419|NCT01394016|469171726|FG018|Overall Study|Withdrawal by Subject|2|||
130328420|NCT01394016|469171708|FG000|Overall Study|Adverse Event|0|||
130328421|NCT01394016|469171709|FG001|Overall Study|Adverse Event|0|||
130328422|NCT01394016|469171710|FG002|Overall Study|Adverse Event|0|||
130328423|NCT01394016|469171711|FG003|Overall Study|Adverse Event|0|||
130328424|NCT01394016|469171712|FG004|Overall Study|Adverse Event|0|||
130328425|NCT01394016|469171713|FG005|Overall Study|Adverse Event|0|||
129989666|NCT00346632|467925498|FG006|Overall Study|Protocol Violation|1|||
129989667|NCT00346632|467925499|FG007|Overall Study|Protocol Violation|0|||
129989668|NCT00346632|467925500|FG008|Overall Study|Protocol Violation|0|||
129989669|NCT00346632|467925501|FG009|Overall Study|Protocol Violation|0|||
129989670|NCT00346632|467925492|FG000|Overall Study|Withdrawal by Subject|0|||
129989671|NCT00346632|467925493|FG001|Overall Study|Withdrawal by Subject|0|||
130328426|NCT01394016|469171714|FG006|Overall Study|Adverse Event|0|||
129989672|NCT00346632|467925494|FG002|Overall Study|Withdrawal by Subject|0|||
129989673|NCT00346632|467925495|FG003|Overall Study|Withdrawal by Subject|0|||
129989674|NCT00346632|467925496|FG004|Overall Study|Withdrawal by Subject|0|||
130215612|NCT00262002|468751781|FG004|Overall Study|Withdrawal by Subject|2|||
130215613|NCT00262002|468751782|FG005|Overall Study|Withdrawal by Subject|2|||
130328427|NCT01394016|469171715|FG007|Overall Study|Adverse Event|0|||
130328428|NCT01394016|469171716|FG008|Overall Study|Adverse Event|0|||
130328429|NCT01394016|469171717|FG009|Overall Study|Adverse Event|1|||
130328430|NCT01394016|469171718|FG010|Overall Study|Adverse Event|0|||
130328431|NCT01394016|469171719|FG011|Overall Study|Adverse Event|0|||
130328432|NCT01394016|469171720|FG012|Overall Study|Adverse Event|0|||
130328433|NCT01394016|469171721|FG013|Overall Study|Adverse Event|0|||
129989675|NCT00346632|467925497|FG005|Overall Study|Withdrawal by Subject|0|||
129989676|NCT00346632|467925498|FG006|Overall Study|Withdrawal by Subject|1|||
129989677|NCT00346632|467925499|FG007|Overall Study|Withdrawal by Subject|0|||
130215614|NCT00262002|468751783|FG006|Overall Study|Withdrawal by Subject|2|||
130328434|NCT01394016|469171722|FG014|Overall Study|Adverse Event|0|||
130328435|NCT01394016|469171723|FG015|Overall Study|Adverse Event|0|||
129989678|NCT00346632|467925500|FG008|Overall Study|Withdrawal by Subject|0|||
129989679|NCT00346632|467925501|FG009|Overall Study|Withdrawal by Subject|0|||
129989680|NCT00346632|467925492|FG000|Overall Study|Switched to alternative treatment|0|||
129989681|NCT00346632|467925493|FG001|Overall Study|Switched to alternative treatment|0|||
129989682|NCT00346632|467925494|FG002|Overall Study|Switched to alternative treatment|1|||
129989683|NCT00346632|467925495|FG003|Overall Study|Switched to alternative treatment|0|||
129989684|NCT00346632|467925496|FG004|Overall Study|Switched to alternative treatment|0|||
129989685|NCT00346632|467925497|FG005|Overall Study|Switched to alternative treatment|0|||
129989686|NCT00346632|467925498|FG006|Overall Study|Switched to alternative treatment|0|||
129989687|NCT00346632|467925499|FG007|Overall Study|Switched to alternative treatment|0|||
129989688|NCT00346632|467925500|FG008|Overall Study|Switched to alternative treatment|0|||
129989689|NCT00346632|467925501|FG009|Overall Study|Switched to alternative treatment|0|||
129989690|NCT00346632|467925492|FG000|Overall Study|Not Stated|1|||
129989691|NCT00346632|467925493|FG001|Overall Study|Not Stated|1|||
129989692|NCT00346632|467925494|FG002|Overall Study|Not Stated|0|||
129989693|NCT00346632|467925495|FG003|Overall Study|Not Stated|0|||
129989694|NCT00346632|467925496|FG004|Overall Study|Not Stated|0|||
129989695|NCT00346632|467925497|FG005|Overall Study|Not Stated|0|||
129989696|NCT00346632|467925498|FG006|Overall Study|Not Stated|0|||
129989697|NCT00346632|467925499|FG007|Overall Study|Not Stated|2|||
130215615|NCT00262002|468751777|FG000|Overall Study|Lost to Follow-up|2|||
130328436|NCT01394016|469171724|FG016|Overall Study|Adverse Event|1|||
130328437|NCT01394016|469171725|FG017|Overall Study|Adverse Event|1|||
130328438|NCT01394016|469171726|FG018|Overall Study|Adverse Event|0|||
130328439|NCT01394016|469171708|FG000|Overall Study|Sponsor Decision|0|||
130328440|NCT01394016|469171709|FG001|Overall Study|Sponsor Decision|0|||
130328441|NCT01394016|469171710|FG002|Overall Study|Sponsor Decision|0|||
130328442|NCT01394016|469171711|FG003|Overall Study|Sponsor Decision|0|||
130328443|NCT01394016|469171712|FG004|Overall Study|Sponsor Decision|0|||
130328444|NCT01394016|469171713|FG005|Overall Study|Sponsor Decision|0|||
130328445|NCT01394016|469171714|FG006|Overall Study|Sponsor Decision|0|||
130328446|NCT01394016|469171715|FG007|Overall Study|Sponsor Decision|0|||
130328447|NCT01394016|469171716|FG008|Overall Study|Sponsor Decision|0|||
130328448|NCT01394016|469171717|FG009|Overall Study|Sponsor Decision|0|||
130328449|NCT01394016|469171718|FG010|Overall Study|Sponsor Decision|0|||
130328450|NCT01394016|469171719|FG011|Overall Study|Sponsor Decision|0|||
130328451|NCT01394016|469171720|FG012|Overall Study|Sponsor Decision|1|||
130328452|NCT01394016|469171721|FG013|Overall Study|Sponsor Decision|0|||
130328453|NCT01394016|469171722|FG014|Overall Study|Sponsor Decision|0|||
130328454|NCT01394016|469171723|FG015|Overall Study|Sponsor Decision|0|||
130328455|NCT01394016|469171724|FG016|Overall Study|Sponsor Decision|0|||
130328456|NCT01394016|469171725|FG017|Overall Study|Sponsor Decision|0|||
130328457|NCT01394016|469171726|FG018|Overall Study|Sponsor Decision|0|||
130328458|NCT01394016|469171708|FG000|Overall Study|Lost to Follow-up|0|||
130328459|NCT01394016|469171709|FG001|Overall Study|Lost to Follow-up|0|||
130328460|NCT01394016|469171710|FG002|Overall Study|Lost to Follow-up|0|||
130328461|NCT01394016|469171711|FG003|Overall Study|Lost to Follow-up|0|||
130328462|NCT01394016|469171712|FG004|Overall Study|Lost to Follow-up|0|||
130328463|NCT01394016|469171713|FG005|Overall Study|Lost to Follow-up|0|||
130328464|NCT01394016|469171714|FG006|Overall Study|Lost to Follow-up|0|||
130328465|NCT01394016|469171715|FG007|Overall Study|Lost to Follow-up|0|||
130328466|NCT01394016|469171716|FG008|Overall Study|Lost to Follow-up|0|||
130328467|NCT01394016|469171717|FG009|Overall Study|Lost to Follow-up|0|||
130328468|NCT01394016|469171718|FG010|Overall Study|Lost to Follow-up|0|||
130328469|NCT01394016|469171719|FG011|Overall Study|Lost to Follow-up|0|||
130328470|NCT01394016|469171720|FG012|Overall Study|Lost to Follow-up|0|||
130328471|NCT01394016|469171721|FG013|Overall Study|Lost to Follow-up|0|||
130328472|NCT01394016|469171722|FG014|Overall Study|Lost to Follow-up|0|||
130328473|NCT01394016|469171723|FG015|Overall Study|Lost to Follow-up|0|||
130328474|NCT01394016|469171724|FG016|Overall Study|Lost to Follow-up|0|||
130328475|NCT01394016|469171725|FG017|Overall Study|Lost to Follow-up|0|||
130328476|NCT01394016|469171726|FG018|Overall Study|Lost to Follow-up|1|||
130328477|NCT03534804|469171727|FG000|Overall Study|Withdrawal by Subject|1|||
130328478|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
130328479|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
130328480|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
130328481|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
130328482|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
130328483|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
130328484|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
130328485|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
129989698|NCT00346632|467925500|FG008|Overall Study|Not Stated|2|||
129989699|NCT00346632|467925501|FG009|Overall Study|Not Stated|1|||
129989700|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
129989701|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
129989702|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
130328486|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
130328487|NCT00174187|469171728|FG000|Period 1 (up to 3 Years)|Other|0|||
130328488|NCT00174187|469171729|FG001|Period 1 (up to 3 Years)|Other|1|||
129989703|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
129989704|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
129989705|NCT00918580|467925502|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
129989706|NCT00918580|467925502|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
129989707|NCT00946101|467925503|FG000|Overall Study|Lost to Follow-up|2|||
129989708|NCT00946101|467925504|FG001|Overall Study|Lost to Follow-up|1|||
129989709|NCT00946101|467925503|FG000|Overall Study|Withdrawal of consent|2|||
129989710|NCT00946101|467925504|FG001|Overall Study|Withdrawal of consent|0|||
129989711|NCT00946101|467925503|FG000|Overall Study|Physician Decision|0|||
129989712|NCT00946101|467925504|FG001|Overall Study|Physician Decision|1|||
129989713|NCT00552240|467925508|FG000|Overall Study|Adverse Event|9|||
129989714|NCT00552240|467925509|FG001|Overall Study|Adverse Event|9|||
129989715|NCT00552240|467925508|FG000|Overall Study|Protocol Violation|1|||
129989716|NCT00552240|467925509|FG001|Overall Study|Protocol Violation|1|||
129989717|NCT00552240|467925508|FG000|Overall Study|Lost to Follow-up|5|||
129989718|NCT00552240|467925509|FG001|Overall Study|Lost to Follow-up|6|||
129989719|NCT00552240|467925508|FG000|Overall Study|Withdrawal by Subject|2|||
129989720|NCT00552240|467925509|FG001|Overall Study|Withdrawal by Subject|2|||
129989721|NCT00552240|467925508|FG000|Overall Study|Lack of Efficacy|6|||
129989722|NCT00552240|467925509|FG001|Overall Study|Lack of Efficacy|0|||
129989723|NCT00552240|467925508|FG000|Overall Study|Other|1|||
129989724|NCT00552240|467925509|FG001|Overall Study|Other|0|||
130328489|NCT00174187|469171730|FG002|Period 1 (up to 3 Years)|Other|0|||
130328490|NCT00174187|469171728|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
130328491|NCT00174187|469171729|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
130328492|NCT00174187|469171730|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
130328493|NCT00174187|469171728|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
130328494|NCT00174187|469171729|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
130328495|NCT00174187|469171730|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
130328496|NCT00174187|469171728|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
130328497|NCT00174187|469171729|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
130328498|NCT00174187|469171730|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
130328499|NCT00174187|469171728|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
130328500|NCT00174187|469171729|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
130328501|NCT00174187|469171730|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
130328502|NCT00174187|469171728|FG000|Period 2 (After 3 Years)|Other|0|||
130328503|NCT00174187|469171729|FG001|Period 2 (After 3 Years)|Other|0|||
130328504|NCT00174187|469171730|FG002|Period 2 (After 3 Years)|Other|5|||
130328505|NCT00759941|469171731|FG000|Overall Study|Use of medication|1|||
130328506|NCT00759941|469171732|FG001|Overall Study|Use of medication|0|||
130328507|NCT00759941|469171731|FG000|Overall Study|Adverse Event|1|||
130328508|NCT00759941|469171732|FG001|Overall Study|Adverse Event|0|||
130328509|NCT00759941|469171731|FG000|Overall Study|Exited in error by site|1|||
130328510|NCT00759941|469171732|FG001|Overall Study|Exited in error by site|1|||
130328511|NCT06078124|469171733|FG000|Overall Study|Lost to Follow-up|14|||
130328512|NCT06078124|469171734|FG001|Overall Study|Lost to Follow-up|14|||
130328513|NCT01198977|469171735|FG000|Overall Study|Lost to Follow-up|1|||
130328514|NCT01198977|469171736|FG001|Overall Study|Lost to Follow-up|0|||
130328515|NCT01285557|469171737|FG000|Overall Study|Death|173|||
130328516|NCT01285557|469171738|FG001|Overall Study|Death|90|||
130328517|NCT01285557|469171737|FG000|Overall Study|Lost to Follow-up|6|||
130328518|NCT01285557|469171738|FG001|Overall Study|Lost to Follow-up|2|||
130328519|NCT01285557|469171737|FG000|Overall Study|Withdrew Consent|6|||
130328520|NCT01285557|469171738|FG001|Overall Study|Withdrew Consent|1|||
130328521|NCT01285557|469171737|FG000|Overall Study|Sponsor Study Termination|23|||
130328522|NCT01285557|469171738|FG001|Overall Study|Sponsor Study Termination|13|||
130328523|NCT01285557|469171737|FG000|Overall Study|Randomized but not treated|1|||
130328524|NCT01285557|469171738|FG001|Overall Study|Randomized but not treated|1|||
130328525|NCT01285557|469171737|FG000|Overall Study|Study follow-up ongoing|28|||
130328526|NCT01285557|469171738|FG001|Overall Study|Study follow-up ongoing|14|||
130328527|NCT01285557|469171737|FG000|Overall Study|Sponsor Decision|2|||
130328528|NCT01285557|469171738|FG001|Overall Study|Sponsor Decision|1|||
130328529|NCT03467750|469171739|FG000|Overall Study|Surgery canceled|1|||
130328530|NCT03467750|469171740|FG001|Overall Study|Surgery canceled|0|||
130328531|NCT03467750|469171739|FG000|Overall Study|Protocol Violation|1|||
130328532|NCT03467750|469171740|FG001|Overall Study|Protocol Violation|1|||
130328533|NCT03467750|469171739|FG000|Overall Study|Withdrawal by Subject|0|||
130328534|NCT03467750|469171740|FG001|Overall Study|Withdrawal by Subject|1|||
130328535|NCT04922216|469171743|FG000|Overall Study|Withdrawal by Subject|0|||
130328536|NCT04922216|469171744|FG001|Overall Study|Withdrawal by Subject|1|||
129989725|NCT02783768|467925511|FG000|Overall Study|Lost to Follow-up|1|||
129989726|NCT02783768|467925512|FG001|Overall Study|Lost to Follow-up|0|||
129989727|NCT01323647|467925513|FG000|Overall Study|Migrated/moved from study area|2|||
129989728|NCT01323647|467925514|FG001|Overall Study|Migrated/moved from study area|0|||
129989729|NCT01323647|467925513|FG000|Overall Study|Withdrawal by Subject|5|||
130328537|NCT04922216|469171745|FG002|Overall Study|Withdrawal by Subject|0|||
130328538|NCT04922216|469171746|FG003|Overall Study|Withdrawal by Subject|0|||
130328539|NCT04922216|469171747|FG004|Overall Study|Withdrawal by Subject|0|||
130328540|NCT04922216|469171748|FG005|Overall Study|Withdrawal by Subject|0|||
130328541|NCT04922216|469171749|FG006|Overall Study|Withdrawal by Subject|0|||
130328542|NCT04922216|469171750|FG007|Overall Study|Withdrawal by Subject|2|||
130328543|NCT04922216|469171751|FG008|Overall Study|Withdrawal by Subject|0|||
130328544|NCT04922216|469171752|FG009|Overall Study|Withdrawal by Subject|0|||
130328545|NCT04922216|469171753|FG010|Overall Study|Withdrawal by Subject|0|||
130328546|NCT04922216|469171754|FG011|Overall Study|Withdrawal by Subject|0|||
130328547|NCT04922216|469171755|FG012|Overall Study|Withdrawal by Subject|1|||
130328548|NCT04922216|469171756|FG013|Overall Study|Withdrawal by Subject|1|||
130328549|NCT04922216|469171757|FG014|Overall Study|Withdrawal by Subject|1|||
130328550|NCT04922216|469171758|FG015|Overall Study|Withdrawal by Subject|0|||
130328551|NCT04922216|469171759|FG016|Overall Study|Withdrawal by Subject|0|||
130328552|NCT04922216|469171760|FG017|Overall Study|Withdrawal by Subject|1|||
130328553|NCT04922216|469171761|FG018|Overall Study|Withdrawal by Subject|1|||
130328554|NCT04922216|469171762|FG019|Overall Study|Withdrawal by Subject|1|||
130328555|NCT04922216|469171763|FG020|Overall Study|Withdrawal by Subject|1|||
130328556|NCT04922216|469171764|FG021|Overall Study|Withdrawal by Subject|0|||
130328557|NCT04922216|469171765|FG022|Overall Study|Withdrawal by Subject|0|||
130328558|NCT04922216|469171766|FG023|Overall Study|Withdrawal by Subject|2|||
130328559|NCT04922216|469171767|FG024|Overall Study|Withdrawal by Subject|0|||
130328560|NCT04922216|469171768|FG025|Overall Study|Withdrawal by Subject|0|||
130328561|NCT04922216|469171769|FG026|Overall Study|Withdrawal by Subject|1|||
130328562|NCT04922216|469171770|FG027|Overall Study|Withdrawal by Subject|0|||
130328563|NCT04922216|469171771|FG028|Overall Study|Withdrawal by Subject|0|||
130328564|NCT04922216|469171772|FG029|Overall Study|Withdrawal by Subject|0|||
130328565|NCT04922216|469171773|FG030|Overall Study|Withdrawal by Subject|1|||
130328566|NCT04922216|469171774|FG031|Overall Study|Withdrawal by Subject|0|||
130328567|NCT04922216|469171743|FG000|Overall Study|Lost to Follow-up|1|||
130328568|NCT04922216|469171744|FG001|Overall Study|Lost to Follow-up|0|||
130328569|NCT04922216|469171745|FG002|Overall Study|Lost to Follow-up|2|||
130328570|NCT04922216|469171746|FG003|Overall Study|Lost to Follow-up|0|||
130328571|NCT04922216|469171747|FG004|Overall Study|Lost to Follow-up|0|||
130328572|NCT04922216|469171748|FG005|Overall Study|Lost to Follow-up|2|||
130328573|NCT04922216|469171749|FG006|Overall Study|Lost to Follow-up|0|||
130328574|NCT04922216|469171750|FG007|Overall Study|Lost to Follow-up|1|||
130328575|NCT04922216|469171751|FG008|Overall Study|Lost to Follow-up|1|||
130328576|NCT04922216|469171752|FG009|Overall Study|Lost to Follow-up|2|||
130328577|NCT04922216|469171753|FG010|Overall Study|Lost to Follow-up|2|||
130328578|NCT04922216|469171754|FG011|Overall Study|Lost to Follow-up|1|||
130328579|NCT04922216|469171755|FG012|Overall Study|Lost to Follow-up|1|||
130328580|NCT04922216|469171756|FG013|Overall Study|Lost to Follow-up|0|||
130328581|NCT04922216|469171757|FG014|Overall Study|Lost to Follow-up|1|||
130328582|NCT04922216|469171758|FG015|Overall Study|Lost to Follow-up|0|||
130328583|NCT04922216|469171759|FG016|Overall Study|Lost to Follow-up|0|||
130328584|NCT04922216|469171760|FG017|Overall Study|Lost to Follow-up|2|||
130328585|NCT04922216|469171761|FG018|Overall Study|Lost to Follow-up|1|||
130328586|NCT04922216|469171762|FG019|Overall Study|Lost to Follow-up|0|||
130328587|NCT04922216|469171763|FG020|Overall Study|Lost to Follow-up|1|||
130328588|NCT04922216|469171764|FG021|Overall Study|Lost to Follow-up|0|||
130328589|NCT04922216|469171765|FG022|Overall Study|Lost to Follow-up|2|||
130328590|NCT04922216|469171766|FG023|Overall Study|Lost to Follow-up|1|||
130328591|NCT04922216|469171767|FG024|Overall Study|Lost to Follow-up|0|||
130328592|NCT04922216|469171768|FG025|Overall Study|Lost to Follow-up|2|||
130328593|NCT04922216|469171769|FG026|Overall Study|Lost to Follow-up|0|||
129989730|NCT01323647|467925514|FG001|Overall Study|Withdrawal by Subject|0|||
129989731|NCT01323647|467925513|FG000|Overall Study|Lost to Follow-up|2|||
129989732|NCT01323647|467925514|FG001|Overall Study|Lost to Follow-up|0|||
129989733|NCT00598273|467925515|FG000|Overall Study|Adverse Event|4|||
129989734|NCT00598273|467925516|FG001|Overall Study|Adverse Event|5|||
129989735|NCT00598273|467925517|FG002|Overall Study|Adverse Event|2|||
129989736|NCT00598273|467925515|FG000|Overall Study|Death|6|||
130328594|NCT04922216|469171770|FG027|Overall Study|Lost to Follow-up|0|||
130328595|NCT04922216|469171771|FG028|Overall Study|Lost to Follow-up|1|||
130328596|NCT04922216|469171772|FG029|Overall Study|Lost to Follow-up|0|||
130328597|NCT04922216|469171773|FG030|Overall Study|Lost to Follow-up|2|||
130328598|NCT04922216|469171774|FG031|Overall Study|Lost to Follow-up|1|||
130328599|NCT04145349|469173325|FG000|Overall Study|Withdrawal by Subject|3|||
129989737|NCT00598273|467925516|FG001|Overall Study|Death|12|||
129989738|NCT00598273|467925517|FG002|Overall Study|Death|8|||
129989739|NCT00598273|467925515|FG000|Overall Study|Lost to Follow-up|8|||
129989740|NCT00598273|467925516|FG001|Overall Study|Lost to Follow-up|3|||
130328600|NCT04145349|469173326|FG001|Overall Study|Withdrawal by Subject|0|||
130328601|NCT04145349|469173325|FG000|Overall Study|Lost to Follow-up|0|||
130328602|NCT04145349|469173326|FG001|Overall Study|Lost to Follow-up|1|||
130328603|NCT04145349|469173325|FG000|Overall Study|On study treatment (Ongoing)|0|||
130328604|NCT04145349|469173326|FG001|Overall Study|On study treatment (Ongoing)|1|||
130328605|NCT01148979|469173336|FG000|Overall Study|Lost to Follow-up|0|||
130328606|NCT01148979|469173337|FG001|Overall Study|Lost to Follow-up|1|||
130328607|NCT01646125|469173338|FG000|Overall Study|Untreated|2|||
130328608|NCT01646125|469173339|FG001|Overall Study|Untreated|5|||
130328609|NCT01646125|469173338|FG000|Overall Study|Adverse Event|2|||
130328610|NCT01646125|469173339|FG001|Overall Study|Adverse Event|1|||
130328611|NCT01646125|469173338|FG000|Overall Study|Death|1|||
130328612|NCT01646125|469173339|FG001|Overall Study|Death|1|||
130328613|NCT01646125|469173338|FG000|Overall Study|Physician Decision|1|||
130328614|NCT01646125|469173339|FG001|Overall Study|Physician Decision|3|||
130328615|NCT01646125|469173338|FG000|Overall Study|Progressive disease|22|||
130328616|NCT01646125|469173339|FG001|Overall Study|Progressive disease|16|||
130328617|NCT01646125|469173338|FG000|Overall Study|Study terminated by sponsor|2|||
130328618|NCT01646125|469173339|FG001|Overall Study|Study terminated by sponsor|1|||
130328619|NCT01646125|469173338|FG000|Overall Study|Subject/Guardian decision|1|||
130328620|NCT01646125|469173339|FG001|Overall Study|Subject/Guardian decision|1|||
130328621|NCT00775190|469173340|FG000|Overall Study|Lost to Follow-up|2|||
130328622|NCT00775190|469173341|FG001|Overall Study|Lost to Follow-up|3|||
130328623|NCT00775190|469173340|FG000|Overall Study|Withdrawal by Subject|1|||
130328624|NCT00775190|469173341|FG001|Overall Study|Withdrawal by Subject|2|||
130328625|NCT00775190|469173340|FG000|Overall Study|Protocol Violation|1|||
130328626|NCT00775190|469173341|FG001|Overall Study|Protocol Violation|0|||
130328627|NCT04610281|469173346|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
130328628|NCT04610281|469173347|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
130328629|NCT00918255|469173349|FG000|Overall Study|Adverse Event|1|||
130328630|NCT00918255|469173350|FG001|Overall Study|Adverse Event|0|||
130328631|NCT00918255|469173351|FG002|Overall Study|Adverse Event|0|||
130328632|NCT00918255|469173349|FG000|Overall Study|Withdrawal by Subject|1|||
130328633|NCT00918255|469173350|FG001|Overall Study|Withdrawal by Subject|0|||
130328634|NCT00918255|469173351|FG002|Overall Study|Withdrawal by Subject|2|||
130328635|NCT00918255|469173349|FG000|Overall Study|Lack of Efficacy|1|||
130328636|NCT00918255|469173350|FG001|Overall Study|Lack of Efficacy|0|||
130328637|NCT00918255|469173351|FG002|Overall Study|Lack of Efficacy|0|||
130328638|NCT00918255|469173349|FG000|Overall Study|Lost to Follow-up|1|||
130328639|NCT00918255|469173350|FG001|Overall Study|Lost to Follow-up|0|||
130328640|NCT00918255|469173351|FG002|Overall Study|Lost to Follow-up|2|||
130328641|NCT00918255|469173349|FG000|Overall Study|Exceeded allowed number of interventions|0|||
130328642|NCT00918255|469173350|FG001|Overall Study|Exceeded allowed number of interventions|0|||
130328643|NCT00918255|469173351|FG002|Overall Study|Exceeded allowed number of interventions|1|||
130328644|NCT00918255|469173349|FG000|Overall Study|Non-compliance|1|||
129989741|NCT00598273|467925517|FG002|Overall Study|Lost to Follow-up|5|||
129989742|NCT00598273|467925515|FG000|Overall Study|Physician Decision|0|||
129989743|NCT00598273|467925516|FG001|Overall Study|Physician Decision|0|||
129989744|NCT00598273|467925517|FG002|Overall Study|Physician Decision|1|||
129989745|NCT00598273|467925515|FG000|Overall Study|Withdrawal by Subject|12|||
129989746|NCT00598273|467925516|FG001|Overall Study|Withdrawal by Subject|10|||
129989747|NCT00598273|467925517|FG002|Overall Study|Withdrawal by Subject|10|||
129989748|NCT00598273|467925515|FG000|Overall Study|Noncompliance|3|||
129989749|NCT00598273|467925516|FG001|Overall Study|Noncompliance|2|||
129989750|NCT00598273|467925517|FG002|Overall Study|Noncompliance|3|||
129989751|NCT00598273|467925515|FG000|Overall Study|Relocation|0|||
129989752|NCT00598273|467925516|FG001|Overall Study|Relocation|2|||
129989753|NCT00598273|467925517|FG002|Overall Study|Relocation|4|||
129989754|NCT00598273|467925515|FG000|Overall Study|Renal transplant|1|||
129989755|NCT00598273|467925516|FG001|Overall Study|Renal transplant|0|||
129989756|NCT00598273|467925517|FG002|Overall Study|Renal transplant|1|||
129989757|NCT00598273|467925515|FG000|Overall Study|Site elected to close|1|||
129989758|NCT00598273|467925516|FG001|Overall Study|Site elected to close|0|||
129989759|NCT00598273|467925517|FG002|Overall Study|Site elected to close|0|||
129989760|NCT00598273|467925515|FG000|Overall Study|Started dialysis|6|||
129989761|NCT00598273|467925516|FG001|Overall Study|Started dialysis|4|||
129989762|NCT00598273|467925517|FG002|Overall Study|Started dialysis|5|||
130215616|NCT00262002|468751778|FG001|Overall Study|Lost to Follow-up|0|||
129989763|NCT00906945|467925518|FG000|Overall Study|Found to be not eligible|0|||
129989764|NCT00906945|467925519|FG001|Overall Study|Found to be not eligible|0|||
130215617|NCT00262002|468751779|FG002|Overall Study|Lost to Follow-up|0|||
129989765|NCT00906945|467925520|FG002|Overall Study|Found to be not eligible|0|||
130215618|NCT00262002|468751780|FG003|Overall Study|Lost to Follow-up|2|||
130328645|NCT00918255|469173350|FG001|Overall Study|Non-compliance|0|||
130328646|NCT00918255|469173351|FG002|Overall Study|Non-compliance|0|||
130328647|NCT00918255|469173349|FG000|Overall Study|Investigator discretion|1|||
130328648|NCT00918255|469173350|FG001|Overall Study|Investigator discretion|0|||
130328649|NCT00918255|469173351|FG002|Overall Study|Investigator discretion|0|||
130328650|NCT03557034|469173352|FG000|Overall Study|Withdrawal by Subject|1|||
130328651|NCT03557034|469173353|FG001|Overall Study|Withdrawal by Subject|0|||
130328652|NCT00719472|469173354|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
129989766|NCT00906945|467925521|FG003|Overall Study|Found to be not eligible|1|||
129989767|NCT00906945|467925522|FG004|Overall Study|Found to be not eligible|1|||
129989768|NCT00906945|467925523|FG005|Overall Study|Found to be not eligible|1|||
129989769|NCT00906945|467925518|FG000|Overall Study|Physician Decision|0|||
129989770|NCT00906945|467925519|FG001|Overall Study|Physician Decision|0|||
129989771|NCT00906945|467925520|FG002|Overall Study|Physician Decision|0|||
129989772|NCT00906945|467925521|FG003|Overall Study|Physician Decision|0|||
129989773|NCT00906945|467925522|FG004|Overall Study|Physician Decision|0|||
129989774|NCT00906945|467925523|FG005|Overall Study|Physician Decision|1|||
129989775|NCT00609765|467925531|FG000|Overall Study|Study ended prior to 12 months|1|||
129989776|NCT00943111|467925538|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
129989777|NCT00943111|467925539|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
129989778|NCT00943111|467925540|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
129989779|NCT00943111|467925538|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
129989780|NCT00943111|467925539|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
129989781|NCT00943111|467925540|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
129989782|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
129989783|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
129989784|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
129989785|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
129989786|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
129989787|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
129989788|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
129989789|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
129989790|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
129989791|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
129989792|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
129989793|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
129989794|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
129989795|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
129989796|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
129989797|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
129989798|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
129989799|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
129989800|NCT01796548|467925541|FG000|Overall Study|Lost to Follow-up|1|||
129989801|NCT01796548|467925541|FG000|Overall Study|Other|2|||
129989802|NCT02859324|467925542|FG000|Overall Study|Death|4|||
129989803|NCT02859324|467925543|FG001|Overall Study|Death|6|||
129989804|NCT02859324|467925544|FG002|Overall Study|Death|5|||
129989805|NCT02859324|467925542|FG000|Overall Study|Other reasons|3|||
129989806|NCT02859324|467925543|FG001|Overall Study|Other reasons|3|||
129989807|NCT02859324|467925544|FG002|Overall Study|Other reasons|0|||
129989808|NCT00790751|467925547|FG000|Overall Study|Protocol non-compliance|16|||
129989809|NCT00790751|467925548|FG001|Overall Study|Protocol non-compliance|16|||
129989810|NCT00790751|467925549|FG002|Overall Study|Protocol non-compliance|10|||
129989811|NCT00790751|467925550|FG003|Overall Study|Protocol non-compliance|11|||
129989812|NCT00790751|467925547|FG000|Overall Study|Lost to Follow-up|4|||
129989813|NCT00790751|467925548|FG001|Overall Study|Lost to Follow-up|9|||
129989814|NCT00790751|467925549|FG002|Overall Study|Lost to Follow-up|4|||
129989815|NCT00790751|467925550|FG003|Overall Study|Lost to Follow-up|5|||
129989816|NCT00790751|467925547|FG000|Overall Study|Adverse Event|5|||
129989817|NCT00790751|467925548|FG001|Overall Study|Adverse Event|3|||
129989818|NCT00790751|467925549|FG002|Overall Study|Adverse Event|5|||
129989819|NCT00790751|467925550|FG003|Overall Study|Adverse Event|4|||
129989820|NCT00790751|467925547|FG000|Overall Study|Requirement for restricted medication|0|||
129989821|NCT00790751|467925548|FG001|Overall Study|Requirement for restricted medication|2|||
129989822|NCT00790751|467925549|FG002|Overall Study|Requirement for restricted medication|0|||
129989823|NCT00790751|467925550|FG003|Overall Study|Requirement for restricted medication|0|||
129989824|NCT00790751|467925547|FG000|Overall Study|Death|0|||
129989825|NCT00790751|467925548|FG001|Overall Study|Death|0|||
129989826|NCT00790751|467925549|FG002|Overall Study|Death|1|||
129989827|NCT00790751|467925550|FG003|Overall Study|Death|0|||
129989828|NCT00790751|467925547|FG000|Overall Study|Physician Decision|0|||
129989829|NCT00790751|467925548|FG001|Overall Study|Physician Decision|0|||
129989830|NCT00790751|467925549|FG002|Overall Study|Physician Decision|0|||
129989831|NCT00790751|467925550|FG003|Overall Study|Physician Decision|1|||
129989832|NCT04227704|467925554|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
129989833|NCT04227704|467925555|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
129989834|NCT04227704|467925556|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
129989835|NCT04227704|467925554|FG000|Overall Study|due to C/S being cancelled|1|||
129989836|NCT04227704|467925555|FG001|Overall Study|due to C/S being cancelled|0|||
129989837|NCT04227704|467925556|FG002|Overall Study|due to C/S being cancelled|0|||
129989838|NCT03432260|467925563|FG000|Overall Study|Lost to Follow-up|1|||
129989839|NCT03432260|467925564|FG001|Overall Study|Lost to Follow-up|1|||
129989840|NCT03432260|467925565|FG002|Overall Study|Lost to Follow-up|0|||
129989841|NCT03432260|467925566|FG003|Overall Study|Lost to Follow-up|0|||
129989842|NCT03432260|467925567|FG004|Overall Study|Lost to Follow-up|1|||
129989843|NCT01775124|467925569|FG000|Core Period|Disease Progression|0|||
129989844|NCT01775124|467925570|FG001|Core Period|Disease Progression|1|||
129989845|NCT01775124|467925569|FG000|Core Period|Physician Decision|1|||
129989846|NCT01775124|467925570|FG001|Core Period|Physician Decision|1|||
129989847|NCT01775124|467925569|FG000|Core Period|Death|0|||
129989848|NCT01775124|467925570|FG001|Core Period|Death|1|||
129989849|NCT01775124|467925569|FG000|Core Period|Administrative problems|1|||
129989850|NCT01775124|467925570|FG001|Core Period|Administrative problems|0|||
129989851|NCT01775124|467925569|FG000|Core Period|Withdrawal by Subject|4|||
129989852|NCT01775124|467925570|FG001|Core Period|Withdrawal by Subject|2|||
129989853|NCT01775124|467925569|FG000|Core Period|Adverse Event|5|||
129989854|NCT01775124|467925570|FG001|Core Period|Adverse Event|5|||
129989855|NCT01775124|467925569|FG000|Extension Period|Adverse Event|3|||
129989856|NCT01775124|467925570|FG001|Extension Period|Adverse Event|2|||
129989857|NCT01775124|467925569|FG000|Extension Period|Physician Decision|0|||
129989858|NCT01775124|467925570|FG001|Extension Period|Physician Decision|2|||
129989859|NCT01775124|467925569|FG000|Extension Period|Administrative problems|0|||
129989860|NCT01775124|467925570|FG001|Extension Period|Administrative problems|1|||
129989861|NCT01775124|467925569|FG000|Extension Period|Lost to Follow-up|0|||
129989862|NCT01775124|467925570|FG001|Extension Period|Lost to Follow-up|1|||
129989863|NCT01775124|467925569|FG000|Extension Period|Withdrawal by Subject|9|||
129989864|NCT01775124|467925570|FG001|Extension Period|Withdrawal by Subject|12|||
129989865|NCT00112047|467925571|FG000|Randomized Phase|Lost to Follow-up|26|||
129989866|NCT00112047|467925572|FG001|Randomized Phase|Lost to Follow-up|33|||
129989867|NCT00112047|467925571|FG000|Randomized Phase|Adverse Event|10|||
129989868|NCT00112047|467925572|FG001|Randomized Phase|Adverse Event|10|||
129989869|NCT00112047|467925571|FG000|Randomized Phase|Withrawal of consent|10|||
129989870|NCT00112047|467925572|FG001|Randomized Phase|Withrawal of consent|18|||
130328653|NCT00719472|469173354|FG000|Enrolled in Study|Subject decision to withdraw|8|||
130328654|NCT00719472|469173354|FG000|Enrolled in Study|Various Reasons|17|||
130328655|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
130328656|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Death|5|||
130328657|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
129989871|NCT00112047|467925571|FG000|Randomized Phase|Sub-optimal virological response|3|||
129989872|NCT00112047|467925572|FG001|Randomized Phase|Sub-optimal virological response|13|||
129989873|NCT00112047|467925571|FG000|Randomized Phase|Noncompliance|8|||
129989874|NCT00112047|467925572|FG001|Randomized Phase|Noncompliance|4|||
129989875|NCT00112047|467925571|FG000|Randomized Phase|Protocol Violation|2|||
129989876|NCT00112047|467925572|FG001|Randomized Phase|Protocol Violation|0|||
129989877|NCT00112047|467925571|FG000|Randomized Phase|Pregnancy|3|||
129989878|NCT00112047|467925572|FG001|Randomized Phase|Pregnancy|1|||
129989879|NCT00112047|467925571|FG000|Randomized Phase|Death|1|||
129989880|NCT00112047|467925572|FG001|Randomized Phase|Death|3|||
129989881|NCT00112047|467925571|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
129989882|NCT00112047|467925572|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
129989883|NCT00112047|467925571|FG000|Randomized Phase|Inability to swallow pills|0|||
129989884|NCT00112047|467925572|FG001|Randomized Phase|Inability to swallow pills|1|||
129989885|NCT00112047|467925571|FG000|Randomized Phase|Incarceration|3|||
129989886|NCT00112047|467925572|FG001|Randomized Phase|Incarceration|2|||
129989887|NCT00112047|467925571|FG000|Randomized Phase|Moved out of State|0|||
129989888|NCT00112047|467925572|FG001|Randomized Phase|Moved out of State|1|||
129989889|NCT00112047|467925571|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
129989890|NCT00112047|467925572|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
129989891|NCT00112047|467925571|FG000|Randomized Phase|High Hepatitis B DNA|0|||
129989892|NCT00112047|467925572|FG001|Randomized Phase|High Hepatitis B DNA|1|||
129989893|NCT00112047|467925571|FG000|Atripla Phase|Adverse Event|2|||
129989894|NCT00112047|467925572|FG001|Atripla Phase|Adverse Event|1|||
129989895|NCT00112047|467925571|FG000|Atripla Phase|Lost to Follow-up|5|||
129989896|NCT00112047|467925572|FG001|Atripla Phase|Lost to Follow-up|7|||
129989897|NCT00112047|467925571|FG000|Atripla Phase|Pregnancy|0|||
129989898|NCT00112047|467925572|FG001|Atripla Phase|Pregnancy|1|||
129989899|NCT00112047|467925571|FG000|Atripla Phase|Death|0|||
129989900|NCT00112047|467925572|FG001|Atripla Phase|Death|2|||
129989901|NCT00112047|467925571|FG000|Atripla Phase|Withdrew consent|7|||
129989902|NCT00112047|467925572|FG001|Atripla Phase|Withdrew consent|7|||
130215619|NCT00262002|468751781|FG004|Overall Study|Lost to Follow-up|0|||
129989903|NCT00112047|467925571|FG000|Atripla Phase|Sub-optimal virological response|0|||
130328658|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
129989904|NCT00112047|467925572|FG001|Atripla Phase|Sub-optimal virological response|1|||
129989905|NCT00112047|467925571|FG000|Atripla Phase|Non-compliance|1|||
129989906|NCT00112047|467925572|FG001|Atripla Phase|Non-compliance|0|||
130215620|NCT00262002|468751782|FG005|Overall Study|Lost to Follow-up|1|||
129989907|NCT00112047|467925571|FG000|Atripla Phase|Other|3|||
129989908|NCT00112047|467925572|FG001|Atripla Phase|Other|1|||
129989909|NCT01307579|467925573|FG000|Overall Study|Death|3|||
129989910|NCT01307579|467925574|FG001|Overall Study|Death|6|||
130215621|NCT00262002|468751783|FG006|Overall Study|Lost to Follow-up|0|||
130215622|NCT00262002|468751777|FG000|Overall Study|Inapropriate enrollment|0|||
130215623|NCT00262002|468751778|FG001|Overall Study|Inapropriate enrollment|1|||
130215624|NCT00262002|468751779|FG002|Overall Study|Inapropriate enrollment|0|||
130215625|NCT00262002|468751780|FG003|Overall Study|Inapropriate enrollment|0|||
130215626|NCT00262002|468751781|FG004|Overall Study|Inapropriate enrollment|0|||
130215627|NCT00262002|468751782|FG005|Overall Study|Inapropriate enrollment|0|||
130215628|NCT00262002|468751783|FG006|Overall Study|Inapropriate enrollment|0|||
130215629|NCT00262002|468751777|FG000|Overall Study|Protocol Violation|3|||
130215630|NCT00262002|468751778|FG001|Overall Study|Protocol Violation|2|||
130215631|NCT00262002|468751779|FG002|Overall Study|Protocol Violation|0|||
130215632|NCT00262002|468751780|FG003|Overall Study|Protocol Violation|2|||
130215633|NCT00262002|468751781|FG004|Overall Study|Protocol Violation|5|||
130215634|NCT00262002|468751782|FG005|Overall Study|Protocol Violation|3|||
130215635|NCT00262002|468751783|FG006|Overall Study|Protocol Violation|2|||
130215636|NCT00262002|468751777|FG000|Overall Study|Unable to classify|0|||
130215637|NCT00262002|468751778|FG001|Overall Study|Unable to classify|0|||
130215638|NCT00262002|468751779|FG002|Overall Study|Unable to classify|0|||
130215639|NCT00262002|468751780|FG003|Overall Study|Unable to classify|0|||
130215640|NCT00262002|468751781|FG004|Overall Study|Unable to classify|0|||
130215641|NCT00262002|468751782|FG005|Overall Study|Unable to classify|0|||
130215642|NCT00262002|468751783|FG006|Overall Study|Unable to classify|2|||
130215643|NCT01790516|468751784|FG000|Overall Study|Physician Decision|1|||
130215644|NCT01790516|468751785|FG001|Overall Study|Physician Decision|0|||
130215645|NCT01554163|468751786|FG000|Overall Study|Adverse Event|3|||
130215646|NCT01554163|468751787|FG001|Overall Study|Adverse Event|0|||
130215647|NCT01554163|468751786|FG000|Overall Study|Lack of Efficacy|1|||
130215648|NCT01554163|468751787|FG001|Overall Study|Lack of Efficacy|0|||
130215649|NCT01554163|468751786|FG000|Overall Study|Lost to Follow-up|1|||
130215650|NCT01554163|468751787|FG001|Overall Study|Lost to Follow-up|0|||
130215651|NCT01554163|468751786|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130215652|NCT01554163|468751787|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130215653|NCT01554163|468751786|FG000|Overall Study|Protocol Violation|0|||
130215654|NCT01554163|468751787|FG001|Overall Study|Protocol Violation|4|||
130215655|NCT01554163|468751786|FG000|Overall Study|Withdrawal by Subject|1|||
130215656|NCT01554163|468751787|FG001|Overall Study|Withdrawal by Subject|5|||
130215657|NCT01554163|468751786|FG000|Overall Study|Not Treated|1|||
130215658|NCT01554163|468751787|FG001|Overall Study|Not Treated|0|||
130215659|NCT02226120|468751788|FG000|Overall Study|Adverse Event|60|||
130215660|NCT02226120|468751788|FG000|Overall Study|Death|172|||
130215661|NCT02226120|468751788|FG000|Overall Study|Study terminated by sponsor|1|||
130215662|NCT02226120|468751788|FG000|Overall Study|Technical problems|4|||
130215663|NCT02226120|468751788|FG000|Overall Study|Lost to Follow-up|13|||
130215664|NCT02226120|468751788|FG000|Overall Study|Physician Decision|21|||
130215665|NCT02226120|468751788|FG000|Overall Study|Withdrawal by parent/guardian|36|||
130215666|NCT02226120|468751788|FG000|Overall Study|Non-compliance with study drug|10|||
130215667|NCT02226120|468751788|FG000|Overall Study|Protocol deviation|1|||
130215668|NCT02226120|468751788|FG000|Overall Study|missing treatment disposition pages|2|||
130215669|NCT03034135|468751789|FG000|Overall Study|Withdrawal by Subject|2|||
130215670|NCT01972464|468751793|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
130215671|NCT01972464|468751794|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
130215672|NCT01972464|468751793|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
130215673|NCT01972464|468751794|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
130215674|NCT01972464|468751793|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
130215675|NCT01972464|468751794|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
130215676|NCT01972464|468751793|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
130215677|NCT01972464|468751794|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
130215678|NCT02526160|468753819|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
130215679|NCT02526160|468753820|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
130215680|NCT02526160|468753819|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
130215681|NCT02526160|468753820|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
130215682|NCT02526160|468753819|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
130215683|NCT02526160|468753820|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
130215684|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Death|0|||
130215685|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Death|1|||
130215686|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
130215687|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
130215688|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
130215689|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
130215690|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
129989911|NCT01307579|467925573|FG000|Overall Study|Physician Decision|26|||
129989912|NCT01307579|467925574|FG001|Overall Study|Physician Decision|29|||
129989913|NCT01307579|467925573|FG000|Overall Study|Withdrawal by Subject|7|||
129989914|NCT01307579|467925574|FG001|Overall Study|Withdrawal by Subject|3|||
129989915|NCT01307579|467925573|FG000|Overall Study|Institutional diagnosis of IFD|21|||
129989916|NCT01307579|467925574|FG001|Overall Study|Institutional diagnosis of IFD|36|||
130328659|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
130328660|NCT00719472|469173354|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
130328661|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
130328662|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Death|6|||
130328663|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Disease progression|3|||
130328664|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
130328665|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
130328666|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
130328667|NCT00719472|469173354|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
130328668|NCT01244893|469173355|FG000|Baseline|Protocol Violation|0|||
130328669|NCT01244893|469173356|FG001|Baseline|Protocol Violation|1|||
130328670|NCT01244893|469173355|FG000|1-Week Follow Up|Lost to Follow-up|1|||
130328671|NCT01244893|469173356|FG001|1-Week Follow Up|Lost to Follow-up|0|||
130328672|NCT00357552|469173357|FG000|Screening|Did not meet eligibility criteria|84|||
130328673|NCT00357552|469173357|FG000|Weeks 0 to 24|Death|1|||
130328674|NCT00357552|469173357|FG000|Weeks 24 to 104|Death|3|||
130328675|NCT00357552|469173357|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
130328676|NCT00882557|469173360|FG000|Overall Study|Withdrawal by Subject|1|||
130328677|NCT00882557|469173361|FG001|Overall Study|Withdrawal by Subject|0|||
130328678|NCT00882557|469173360|FG000|Overall Study|Trouble with Vein Access|1|||
130328679|NCT00882557|469173361|FG001|Overall Study|Trouble with Vein Access|0|||
130328680|NCT00882557|469173360|FG000|Overall Study|Randomized Not Treated|0|||
130328681|NCT00882557|469173361|FG001|Overall Study|Randomized Not Treated|1|||
130328682|NCT02803580|469173366|FG000|Overall Study|Death|13|||
130328683|NCT02803580|469173366|FG000|Overall Study|Lost to Follow-up|19|||
130328684|NCT02803580|469173366|FG000|Overall Study|Withdrawal by Subject|3|||
130328685|NCT02803580|469173366|FG000|Overall Study|Inclusion in clinical trial|1|||
130328686|NCT02054104|469173371|FG000|Overall Study|Did not want to continue due to college classes|1|||
130328687|NCT02054104|469173372|FG001|Overall Study|Did not want to continue due to college classes|0|||
130328688|NCT02054104|469173371|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
130328689|NCT02054104|469173372|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
130328690|NCT02054104|469173371|FG000|Overall Study|No evidence of immunologic response|2|||
130328691|NCT02054104|469173372|FG001|Overall Study|No evidence of immunologic response|2|||
130328692|NCT02054104|469173371|FG000|Overall Study|Disease Progression On Study|4|||
130328693|NCT02054104|469173372|FG001|Overall Study|Disease Progression On Study|5|||
130328694|NCT02054104|469173371|FG000|Overall Study|Diagnosis of lymphoma|0|||
130328695|NCT02054104|469173372|FG001|Overall Study|Diagnosis of lymphoma|1|||
130328696|NCT02054104|469173371|FG000|Overall Study|Inconclusive response|0|||
130328697|NCT02054104|469173372|FG001|Overall Study|Inconclusive response|1|||
130328698|NCT00084136|469173373|FG000|PI Comparison|Death|10|||
130328699|NCT00084136|469173374|FG001|PI Comparison|Death|9|||
130328700|NCT00084136|469173375|FG002|PI Comparison|Death|0|||
130328701|NCT00084136|469173373|FG000|PI Comparison|Lost to Follow-up|11|||
130328702|NCT00084136|469173374|FG001|PI Comparison|Lost to Follow-up|8|||
130328703|NCT00084136|469173375|FG002|PI Comparison|Lost to Follow-up|0|||
130328704|NCT00084136|469173373|FG000|PI Comparison|Withdrawal by Subject|33|||
130328705|NCT00084136|469173374|FG001|PI Comparison|Withdrawal by Subject|30|||
130328706|NCT00084136|469173375|FG002|PI Comparison|Withdrawal by Subject|0|||
130328707|NCT00084136|469173373|FG000|PI Comparison|Clinic site closed|1|||
130328708|NCT00084136|469173374|FG001|PI Comparison|Clinic site closed|0|||
130328709|NCT00084136|469173375|FG002|PI Comparison|Clinic site closed|0|||
130328710|NCT00084136|469173373|FG000|NRTI Comparison|Death|20|||
130328711|NCT00084136|469173374|FG001|NRTI Comparison|Death|0|||
130328712|NCT00084136|469173375|FG002|NRTI Comparison|Death|18|||
130328713|NCT00084136|469173373|FG000|NRTI Comparison|Lost to Follow-up|14|||
130328714|NCT00084136|469173374|FG001|NRTI Comparison|Lost to Follow-up|0|||
129989917|NCT01307579|467925573|FG000|Overall Study|Begin conditioning for HSCT|42|||
130328715|NCT00084136|469173375|FG002|NRTI Comparison|Lost to Follow-up|12|||
130328716|NCT00084136|469173373|FG000|NRTI Comparison|Withdrawal by Subject|54|||
130328717|NCT00084136|469173374|FG001|NRTI Comparison|Withdrawal by Subject|0|||
130328718|NCT00084136|469173375|FG002|NRTI Comparison|Withdrawal by Subject|38|||
130328719|NCT00084136|469173373|FG000|NRTI Comparison|Clinic site closed|12|||
130328720|NCT00084136|469173374|FG001|NRTI Comparison|Clinic site closed|0|||
130328721|NCT00084136|469173375|FG002|NRTI Comparison|Clinic site closed|14|||
130328722|NCT00084136|469173373|FG000|NRTI Comparison|Not reason above|1|||
129989918|NCT01307579|467925574|FG001|Overall Study|Begin conditioning for HSCT|44|||
129989919|NCT01307579|467925573|FG000|Overall Study|Refractory or relapsed AML|38|||
130328723|NCT00084136|469173374|FG001|NRTI Comparison|Not reason above|0|||
130328724|NCT00084136|469173375|FG002|NRTI Comparison|Not reason above|0|||
130328725|NCT00836693|469173378|FG000|Overall Study|Adverse Event|4|||
130328726|NCT00836693|469173379|FG001|Overall Study|Adverse Event|1|||
130328727|NCT00836693|469173378|FG000|Overall Study|Sponsor Decision|0|||
130328728|NCT00836693|469173379|FG001|Overall Study|Sponsor Decision|1|||
130328729|NCT00836693|469173378|FG000|Overall Study|Physician Decision|2|||
130328730|NCT00836693|469173379|FG001|Overall Study|Physician Decision|0|||
130328731|NCT00836693|469173378|FG000|Overall Study|Withdrawal by Subject|9|||
130328732|NCT00836693|469173379|FG001|Overall Study|Withdrawal by Subject|4|||
130328733|NCT00836693|469173378|FG000|Overall Study|Protocol Violation|1|||
130328734|NCT00836693|469173379|FG001|Overall Study|Protocol Violation|0|||
130328735|NCT00836693|469173378|FG000|Overall Study|Lost to Follow-up|1|||
130328736|NCT00836693|469173379|FG001|Overall Study|Lost to Follow-up|0|||
130328737|NCT02612779|469173380|FG000|Overall Study|Administrative reason by sponsor|4|||
130328738|NCT02612779|469173381|FG001|Overall Study|Administrative reason by sponsor|1|||
130328739|NCT02612779|469173380|FG000|Overall Study|No longer meet study criteria|0|||
130328740|NCT02612779|469173381|FG001|Overall Study|No longer meet study criteria|1|||
130328741|NCT02612779|469173380|FG000|Overall Study|Disease progression|29|||
130328742|NCT02612779|469173381|FG001|Overall Study|Disease progression|2|||
130328743|NCT02612779|469173380|FG000|Overall Study|Study drug toxicity|10|||
129989920|NCT01307579|467925574|FG001|Overall Study|Refractory or relapsed AML|23|||
129989921|NCT01307579|467925573|FG000|Overall Study|Ineligible|3|||
129989922|NCT01307579|467925574|FG001|Overall Study|Ineligible|4|||
129989923|NCT00031551|467927520|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
129989924|NCT00031551|467927521|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
129989925|NCT00409773|467927522|FG000|Overall Study|Adverse Event|3|||
129989926|NCT00409773|467927523|FG001|Overall Study|Adverse Event|4|||
129989927|NCT00409773|467927524|FG002|Overall Study|Adverse Event|4|||
129989928|NCT00409773|467927525|FG003|Overall Study|Adverse Event|2|||
129989929|NCT00409773|467927526|FG004|Overall Study|Adverse Event|6|||
129989930|NCT00409773|467927522|FG000|Overall Study|Lost to Follow-up|6|||
129989931|NCT00409773|467927523|FG001|Overall Study|Lost to Follow-up|1|||
129989932|NCT00409773|467927524|FG002|Overall Study|Lost to Follow-up|2|||
129989933|NCT00409773|467927525|FG003|Overall Study|Lost to Follow-up|3|||
129989934|NCT00409773|467927526|FG004|Overall Study|Lost to Follow-up|1|||
129989935|NCT00409773|467927522|FG000|Overall Study|Physician Decision|0|||
129989936|NCT00409773|467927523|FG001|Overall Study|Physician Decision|0|||
129989937|NCT00409773|467927524|FG002|Overall Study|Physician Decision|0|||
129989938|NCT00409773|467927525|FG003|Overall Study|Physician Decision|2|||
129989939|NCT00409773|467927526|FG004|Overall Study|Physician Decision|0|||
129989940|NCT00409773|467927522|FG000|Overall Study|Protocol Violation|0|||
129989941|NCT00409773|467927523|FG001|Overall Study|Protocol Violation|2|||
129989942|NCT00409773|467927524|FG002|Overall Study|Protocol Violation|3|||
129989943|NCT00409773|467927525|FG003|Overall Study|Protocol Violation|3|||
129989944|NCT00409773|467927526|FG004|Overall Study|Protocol Violation|1|||
129989945|NCT00409773|467927522|FG000|Overall Study|Withdrawal by Subject|0|||
129989946|NCT00409773|467927523|FG001|Overall Study|Withdrawal by Subject|0|||
129989947|NCT00409773|467927524|FG002|Overall Study|Withdrawal by Subject|0|||
129989948|NCT00409773|467927525|FG003|Overall Study|Withdrawal by Subject|2|||
129989949|NCT00409773|467927526|FG004|Overall Study|Withdrawal by Subject|1|||
129989950|NCT00409773|467927522|FG000|Overall Study|Lack of Eligibility|0|||
129989951|NCT00409773|467927523|FG001|Overall Study|Lack of Eligibility|0|||
129989952|NCT00409773|467927524|FG002|Overall Study|Lack of Eligibility|0|||
129989953|NCT00409773|467927525|FG003|Overall Study|Lack of Eligibility|0|||
129989954|NCT00409773|467927526|FG004|Overall Study|Lack of Eligibility|1|||
129989955|NCT02359877|467927527|FG000|Overall Study|Withdrawal by Subject|1|||
129989956|NCT02359877|467927528|FG001|Overall Study|Withdrawal by Subject|0|||
129989957|NCT02359877|467927529|FG002|Overall Study|Withdrawal by Subject|0|||
129989958|NCT02359877|467927530|FG003|Overall Study|Withdrawal by Subject|2|||
129989959|NCT02359877|467927527|FG000|Overall Study|Adverse Event|0|||
129989960|NCT02359877|467927528|FG001|Overall Study|Adverse Event|0|||
130328744|NCT02612779|469173381|FG001|Overall Study|Study drug toxicity|1|||
130328745|NCT02612779|469173380|FG000|Overall Study|Death|1|||
130328746|NCT02612779|469173381|FG001|Overall Study|Death|0|||
130328747|NCT02612779|469173380|FG000|Overall Study|Adverse event unrelated to study drug|5|||
130328748|NCT02612779|469173381|FG001|Overall Study|Adverse event unrelated to study drug|0|||
129989961|NCT02359877|467927529|FG002|Overall Study|Adverse Event|0|||
129989962|NCT02359877|467927530|FG003|Overall Study|Adverse Event|1|||
130328749|NCT02612779|469173380|FG000|Overall Study|Participant withdrew consent|4|||
130328750|NCT02612779|469173381|FG001|Overall Study|Participant withdrew consent|0|||
130328751|NCT02612779|469173380|FG000|Overall Study|Lost to Follow-up|1|||
129989963|NCT01919814|467927531|FG000|Overall Study|Adverse Event|1|||
129989964|NCT01919814|467927532|FG001|Overall Study|Adverse Event|0|||
129989965|NCT01919814|467927531|FG000|Overall Study|Protocol Violation|1|||
129989966|NCT01919814|467927532|FG001|Overall Study|Protocol Violation|0|||
130328752|NCT02612779|469173381|FG001|Overall Study|Lost to Follow-up|0|||
130328753|NCT02612779|469173380|FG000|Overall Study|Maximum clinical benefit|10|||
130328754|NCT02612779|469173381|FG001|Overall Study|Maximum clinical benefit|1|||
129989967|NCT01919814|467927531|FG000|Overall Study|Withdrawal by Subject|1|||
130215691|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
130328755|NCT02612779|469173380|FG000|Overall Study|Other reasons|4|||
130328756|NCT02612779|469173381|FG001|Overall Study|Other reasons|0|||
130328757|NCT01657019|469173382|FG000|Overall Study|Withdrawal by Subject|65|||
130328758|NCT01657019|469173382|FG000|Overall Study|Adverse Event|55|||
130328759|NCT01657019|469173382|FG000|Overall Study|Lost to Follow-up|48|||
130328760|NCT01657019|469173382|FG000|Overall Study|Protocol Violation|6|||
130328761|NCT01657019|469173382|FG000|Overall Study|Lack of Efficacy|3|||
130328762|NCT01657019|469173382|FG000|Overall Study|Other|58|||
130328763|NCT01750229|469173385|FG000|Randomized Crossover Phase|Adverse Event|1|||
130328764|NCT01750229|469173385|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
130328765|NCT01750229|469173385|FG000|Long-term Follow-up Phase|Adverse Event|2|||
130328766|NCT01750229|469173385|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
130328767|NCT02346721|469173386|FG000|Overall Study|Withdrew Consent|3|||
130328768|NCT02346721|469173386|FG000|Overall Study|Lack of Efficacy|1|||
130328769|NCT03809104|469173387|FG000|Overall Study|Withdrawal by Subject|3|||
130328770|NCT02968004|469173388|FG000|Main Study Phase|Adverse Event|1|||
130328771|NCT02968004|469173389|FG001|Main Study Phase|Adverse Event|0|||
129989968|NCT01919814|467927532|FG001|Overall Study|Withdrawal by Subject|0|||
129989969|NCT02164383|467927533|FG000|Overall Study|Lost to Follow-up|1|||
129989970|NCT02164383|467927534|FG001|Overall Study|Lost to Follow-up|0|||
129989971|NCT02831387|467927536|FG000|Overall Study|Withdrawal by Subject|1|||
129989972|NCT02831387|467927537|FG001|Overall Study|Withdrawal by Subject|1|||
129989973|NCT02831387|467927536|FG000|Overall Study|Discontinued due to stock recovery|0|||
129989974|NCT02831387|467927537|FG001|Overall Study|Discontinued due to stock recovery|1|||
129989975|NCT00192647|467927538|FG000|Overall Study|Death|1|||
129989976|NCT00192647|467927539|FG001|Overall Study|Death|1|||
129989977|NCT00192647|467927538|FG000|Overall Study|Adverse Event|35|||
129989978|NCT00192647|467927539|FG001|Overall Study|Adverse Event|29|||
129989979|NCT00192647|467927538|FG000|Overall Study|Laboratory Test Abnormality|4|||
129989980|NCT00192647|467927539|FG001|Overall Study|Laboratory Test Abnormality|2|||
129989981|NCT00192647|467927538|FG000|Overall Study|Insufficient Therapeutic Response|53|||
129989982|NCT00192647|467927539|FG001|Overall Study|Insufficient Therapeutic Response|83|||
129989983|NCT00192647|467927538|FG000|Overall Study|Entry Criteria Violation|6|||
129989984|NCT00192647|467927539|FG001|Overall Study|Entry Criteria Violation|6|||
129989985|NCT00192647|467927538|FG000|Overall Study|Protocol Violation|3|||
129989986|NCT00192647|467927539|FG001|Overall Study|Protocol Violation|1|||
129989987|NCT00192647|467927538|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
129989988|NCT00192647|467927539|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
129989989|NCT00192647|467927538|FG000|Overall Study|Failure to Return|11|||
129989990|NCT00192647|467927539|FG001|Overall Study|Failure to Return|13|||
129989991|NCT00192647|467927538|FG000|Overall Study|Other/Administrative|5|||
129989992|NCT00192647|467927539|FG001|Overall Study|Other/Administrative|3|||
129989993|NCT01828073|467927540|FG000|Overall Study|Lost to Follow-up|1|||
129989994|NCT01828073|467927541|FG001|Overall Study|Lost to Follow-up|2|||
129989995|NCT00690443|467927542|FG000|Overall Study|Adverse Event|1|||
129989996|NCT00690443|467927543|FG001|Overall Study|Adverse Event|2|||
129989997|NCT01350336|467927544|FG000|Overall Study|Lost to Follow-up|31|||
129989998|NCT01350336|467927544|FG000|Overall Study|Withdrawal by Subject|14|||
129989999|NCT01350336|467927544|FG000|Overall Study|Physician Decision|8|||
129990000|NCT01350336|467927544|FG000|Overall Study|Death|4|||
129990001|NCT02079610|467927545|FG000|Overall Study|Withdrawal by Subject|1|||
129990002|NCT02079610|467927546|FG001|Overall Study|Withdrawal by Subject|1|||
129990003|NCT01111474|467927547|FG000|Overall Study|Lost to Follow-up|12|||
129990004|NCT01016977|467927548|FG000|Overall Study|Lost to Follow-up|1|||
129990005|NCT01016977|467927549|FG001|Overall Study|Lost to Follow-up|0|||
129990006|NCT01016977|467927548|FG000|Overall Study|Withdrawal by Subject|2|||
129990007|NCT01016977|467927549|FG001|Overall Study|Withdrawal by Subject|2|||
129990008|NCT00477334|467927550|FG000|Overall Study|Discontinued prior to taking study drug|106|||
129990009|NCT00477334|467927551|FG001|Overall Study|Discontinued prior to taking study drug|53|||
129990010|NCT00477334|467927550|FG000|Overall Study|Adverse Event|1|||
129990011|NCT00477334|467927551|FG001|Overall Study|Adverse Event|2|||
129990012|NCT00477334|467927550|FG000|Overall Study|Withdrawal by Subject|2|||
129990013|NCT00477334|467927551|FG001|Overall Study|Withdrawal by Subject|1|||
130328772|NCT02968004|469173388|FG000|Main Study Phase|Withdrawal by Subject|0|||
130328773|NCT02968004|469173389|FG001|Main Study Phase|Withdrawal by Subject|1|||
130328774|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
129990014|NCT00477334|467927550|FG000|Overall Study|Lost to Follow-up|15|||
129990015|NCT00477334|467927551|FG001|Overall Study|Lost to Follow-up|4|||
129990016|NCT00477334|467927550|FG000|Overall Study|Administrative Problems|39|||
129990017|NCT00477334|467927551|FG001|Overall Study|Administrative Problems|15|||
129990018|NCT00477334|467927550|FG000|Overall Study|Protocol Violation|7|||
129990019|NCT00477334|467927551|FG001|Overall Study|Protocol Violation|1|||
129990020|NCT03587974|467927552|FG000|Overall Study|caregiver demented, care recipient died|3|||
130328775|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
129990021|NCT03587974|467927553|FG001|Overall Study|caregiver demented, care recipient died|3|||
129990022|NCT03587974|467927552|FG000|Overall Study|Withdrawal by Subject|2|||
129990023|NCT03587974|467927553|FG001|Overall Study|Withdrawal by Subject|1|||
129990024|NCT02354508|467927555|FG000|Period 1: Core Phase|Adverse Event|1|||
129990025|NCT02354508|467927556|FG001|Period 1: Core Phase|Adverse Event|1|||
129990026|NCT02354508|467927557|FG002|Period 1: Core Phase|Adverse Event|2|||
129990027|NCT02354508|467927555|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
129990028|NCT02354508|467927556|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
129990029|NCT02354508|467927557|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
129990030|NCT02354508|467927555|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
129990031|NCT02354508|467927556|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
130328776|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
130328777|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
130328778|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
130328779|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
130328780|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
130328781|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
130328782|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
130328783|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
130328784|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
130328785|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
130328786|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
130328787|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
130328788|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
130328789|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
130328790|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
130328791|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
130328792|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
130328793|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
130328794|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
130328795|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
130328796|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
130328797|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
130328798|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
130328799|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
130328800|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
130328801|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
130328802|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
130328803|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
130328804|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
130328805|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
130328806|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
130328807|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
130328808|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
130328809|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
130328810|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
130328811|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
130328812|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
130328813|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
130328814|NCT02968004|469173388|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
130328815|NCT02968004|469173389|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
130328816|NCT00885170|469173400|FG000|Overall Study|Adverse Event|12|||
130328817|NCT00885170|469173401|FG001|Overall Study|Adverse Event|4|||
130328818|NCT00885170|469173400|FG000|Overall Study|Excessive bone loss|6|||
130328819|NCT00885170|469173401|FG001|Overall Study|Excessive bone loss|3|||
130328820|NCT00885170|469173400|FG000|Overall Study|Lost to Follow-up|2|||
130328821|NCT00885170|469173401|FG001|Overall Study|Lost to Follow-up|1|||
130328822|NCT00885170|469173400|FG000|Overall Study|Physician Decision|2|||
130328823|NCT00885170|469173401|FG001|Overall Study|Physician Decision|1|||
130328824|NCT00885170|469173400|FG000|Overall Study|Protocol Violation|3|||
130328825|NCT00885170|469173401|FG001|Overall Study|Protocol Violation|1|||
130328826|NCT00885170|469173400|FG000|Overall Study|Withdrawal by Subject|13|||
130328827|NCT00885170|469173401|FG001|Overall Study|Withdrawal by Subject|13|||
130328828|NCT03771664|469173402|FG000|Overall Study|Adverse Event|1|||
130328829|NCT03771664|469173403|FG001|Overall Study|Adverse Event|0|||
129990032|NCT02354508|467927557|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
129990033|NCT02354508|467927555|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
129990034|NCT02354508|467927556|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
129990035|NCT02354508|467927557|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
129990036|NCT02354508|467927555|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
130328830|NCT03771664|469173402|FG000|Overall Study|Lost to Follow-up|1|||
130328831|NCT03771664|469173403|FG001|Overall Study|Lost to Follow-up|0|||
129990037|NCT02354508|467927556|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
129990038|NCT02354508|467927557|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
129990039|NCT02354508|467927555|FG000|Period 2: Extension Phase|Physician Decision|5|||
129990040|NCT02354508|467927556|FG001|Period 2: Extension Phase|Physician Decision|0|||
129990041|NCT02354508|467927557|FG002|Period 2: Extension Phase|Physician Decision|1|||
129990042|NCT02354508|467927555|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
129990043|NCT02354508|467927556|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
129990044|NCT02354508|467927557|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
129990045|NCT02354508|467927555|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
129990046|NCT02354508|467927556|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
129990047|NCT02354508|467927557|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
129990048|NCT02354508|467927555|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
129990049|NCT02354508|467927556|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
129990050|NCT02354508|467927557|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
129990051|NCT04447846|467927558|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
129990052|NCT00461032|467927561|FG000|Overall Study|Adverse Event|5|||
129990053|NCT00461032|467927562|FG001|Overall Study|Adverse Event|6|||
129990054|NCT00461032|467927561|FG000|Overall Study|Lack of Efficacy|5|||
129990055|NCT00461032|467927562|FG001|Overall Study|Lack of Efficacy|1|||
129990056|NCT00461032|467927561|FG000|Overall Study|Lost to Follow-up|7|||
129990057|NCT00461032|467927562|FG001|Overall Study|Lost to Follow-up|12|||
129990058|NCT00461032|467927561|FG000|Overall Study|Protocol Violation|4|||
129990059|NCT00461032|467927562|FG001|Overall Study|Protocol Violation|4|||
129990060|NCT00461032|467927561|FG000|Overall Study|Withdrawal by Subject|7|||
129990061|NCT00461032|467927562|FG001|Overall Study|Withdrawal by Subject|15|||
129990062|NCT00461032|467927561|FG000|Overall Study|Patient Moved or Relocated|2|||
129990063|NCT00461032|467927562|FG001|Overall Study|Patient Moved or Relocated|1|||
129990064|NCT00461032|467927561|FG000|Overall Study|Other|7|||
129990065|NCT00461032|467927562|FG001|Overall Study|Other|5|||
129990066|NCT03486457|467927563|FG000|Up to Month 3|Adverse Event|2|||
129990067|NCT03486457|467927564|FG001|Up to Month 3|Adverse Event|5|||
129990068|NCT03486457|467927563|FG000|Up to Month 3|Lack of Efficacy|1|||
129990069|NCT03486457|467927564|FG001|Up to Month 3|Lack of Efficacy|0|||
129990070|NCT03486457|467927563|FG000|Up to Month 3|Withdrawal by Subject|1|||
129990071|NCT03486457|467927564|FG001|Up to Month 3|Withdrawal by Subject|0|||
129990072|NCT03486457|467927563|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
129990073|NCT03486457|467927564|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
129990074|NCT03486457|467927563|FG000|Up to Month 3|Other|1|||
129990075|NCT03486457|467927564|FG001|Up to Month 3|Other|0|||
129990076|NCT03486457|467927563|FG000|Month 3 to Month 6|Adverse Event|2|||
129990077|NCT03486457|467927564|FG001|Month 3 to Month 6|Adverse Event|0|||
129990078|NCT03486457|467927563|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
129990079|NCT03486457|467927564|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
129990080|NCT03486457|467927563|FG000|Month 3 to Month 6|Pregnancy|0|||
129990081|NCT03486457|467927564|FG001|Month 3 to Month 6|Pregnancy|1|||
129990082|NCT03486457|467927563|FG000|Month 3 to Month 6|Other|1|||
129990083|NCT03486457|467927564|FG001|Month 3 to Month 6|Other|0|||
129990084|NCT00372229|467927565|FG000|Study Phase|Graft loss|0|||
129990085|NCT00372229|467927566|FG001|Study Phase|Graft loss|3|||
129990086|NCT00372229|467927565|FG000|Study Phase|Protocol Violation|3|||
129990087|NCT00372229|467927566|FG001|Study Phase|Protocol Violation|4|||
129990088|NCT00372229|467927565|FG000|Study Phase|Consent withdrawn|16|||
129990089|NCT00372229|467927566|FG001|Study Phase|Consent withdrawn|14|||
129990090|NCT00372229|467927565|FG000|Study Phase|Refused treatment/did not cooperate|3|||
129990091|NCT00372229|467927566|FG001|Study Phase|Refused treatment/did not cooperate|1|||
129990092|NCT00372229|467927565|FG000|Study Phase|Death|3|||
129990093|NCT00372229|467927566|FG001|Study Phase|Death|2|||
129990094|NCT00372229|467927565|FG000|Study Phase|Reason not specified|3|||
129990095|NCT00372229|467927566|FG001|Study Phase|Reason not specified|2|||
130215692|NCT02526160|468753819|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
130215693|NCT02526160|468753820|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
130215694|NCT01048944|468753823|FG000|Overall Study|Protocol Violation|8|||
130215695|NCT01048944|468753824|FG001|Overall Study|Protocol Violation|10|||
130215696|NCT01048944|468753825|FG002|Overall Study|Protocol Violation|10|||
129990096|NCT00372229|467927565|FG000|Study Phase|Lost to Follow-up|3|||
129990097|NCT00372229|467927566|FG001|Study Phase|Lost to Follow-up|3|||
129990098|NCT00372229|467927565|FG000|Follow-Up Phase|Graft loss|8|||
129990099|NCT00372229|467927566|FG001|Follow-Up Phase|Graft loss|7|||
129990100|NCT00372229|467927565|FG000|Follow-Up Phase|Consent withdrawn|13|||
129990101|NCT00372229|467927566|FG001|Follow-Up Phase|Consent withdrawn|19|||
129990102|NCT00372229|467927565|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
129990103|NCT00372229|467927566|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
129990104|NCT00372229|467927565|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
130215697|NCT01048944|468753826|FG003|Overall Study|Protocol Violation|2|||
130215698|NCT01844817|468753827|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
130215699|NCT01844817|468753828|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
130328832|NCT03771664|469173402|FG000|Overall Study|Withdrawal by Participant|1|||
130328833|NCT03771664|469173403|FG001|Overall Study|Withdrawal by Participant|4|||
130328834|NCT03771664|469173402|FG000|Overall Study|Randomized but not Treated|0|||
130328835|NCT03771664|469173403|FG001|Overall Study|Randomized but not Treated|1|||
130328836|NCT00561925|469173404|FG000|14 Day Lead-In Period|Adverse Event|38|||
130328837|NCT00561925|469173405|FG001|14 Day Lead-In Period|Adverse Event|0|||
130328838|NCT00561925|469173406|FG002|14 Day Lead-In Period|Adverse Event|0|||
130328839|NCT00561925|469173407|FG003|14 Day Lead-In Period|Adverse Event|0|||
130328840|NCT00561925|469173408|FG004|14 Day Lead-In Period|Adverse Event|0|||
130328841|NCT00561925|469173404|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
130328842|NCT00561925|469173405|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328843|NCT00561925|469173406|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328844|NCT00561925|469173407|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328845|NCT00561925|469173408|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
130328846|NCT00561925|469173404|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
130328847|NCT00561925|469173405|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
130328848|NCT00561925|469173406|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
130328849|NCT00561925|469173407|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
130328850|NCT00561925|469173408|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
130328851|NCT00561925|469173404|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
130328852|NCT00561925|469173405|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328853|NCT00561925|469173406|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328854|NCT00561925|469173407|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328855|NCT00561925|469173408|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
130328856|NCT00561925|469173404|FG000|14 Day Lead-In Period|Other|5|||
130328857|NCT00561925|469173405|FG001|14 Day Lead-In Period|Other|0|||
130328858|NCT00561925|469173406|FG002|14 Day Lead-In Period|Other|0|||
130328859|NCT00561925|469173407|FG003|14 Day Lead-In Period|Other|0|||
130328860|NCT00561925|469173408|FG004|14 Day Lead-In Period|Other|0|||
130328861|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
130328862|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
130328863|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
130328864|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
130328865|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
130328866|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130328867|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
130328868|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
130328869|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130328870|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
130328871|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130328872|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
130328873|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
130328874|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130328875|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
130328876|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130328877|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
130328878|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
130328879|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130328880|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
130328881|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130328882|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
130328883|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
130328884|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130328885|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
130328886|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
130328887|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
130328888|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
130328889|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
130328890|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
130328891|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Death|0|||
130328892|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Death|6|||
130328893|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Death|3|||
130328894|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Death|0|||
130328895|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Death|0|||
130328896|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328897|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
130328898|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328899|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328900|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
130328901|NCT00561925|469173404|FG000|144-week Double-blind, Double-dummy|Other|0|||
129990105|NCT00372229|467927566|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
129990106|NCT00372229|467927565|FG000|Follow-Up Phase|Death|9|||
129990107|NCT00372229|467927566|FG001|Follow-Up Phase|Death|12|||
130328902|NCT00561925|469173405|FG001|144-week Double-blind, Double-dummy|Other|8|||
130328903|NCT00561925|469173406|FG002|144-week Double-blind, Double-dummy|Other|11|||
130328904|NCT00561925|469173407|FG003|144-week Double-blind, Double-dummy|Other|0|||
130328905|NCT00561925|469173408|FG004|144-week Double-blind, Double-dummy|Other|0|||
130328906|NCT00561925|469173404|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
130328907|NCT00561925|469173405|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
130328908|NCT00561925|469173406|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
130328909|NCT00561925|469173407|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
130328910|NCT00561925|469173408|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
130328911|NCT00891904|469173409|FG000|Overall Study|Death|1|||
130328912|NCT00891904|469173409|FG000|Overall Study|Adverse Event|1|||
130328913|NCT05021978|469173410|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
130328914|NCT05021978|469173411|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130328915|NCT05021978|469173412|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130328916|NCT05021978|469173413|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
130328917|NCT05021978|469173410|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130328918|NCT05021978|469173411|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
130328919|NCT05021978|469173412|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130328920|NCT05021978|469173413|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
130328921|NCT03096288|469173415|FG000|Overall Study|Withdrawal by Subject|0|||
130328922|NCT03096288|469173416|FG001|Overall Study|Withdrawal by Subject|1|||
130328923|NCT03096288|469173417|FG002|Overall Study|Withdrawal by Subject|0|||
130328924|NCT03096288|469173418|FG003|Overall Study|Withdrawal by Subject|1|||
130328925|NCT04639258|469173423|FG000|Overall Study|Screen failure|5|||
130328926|NCT04639258|469173423|FG000|Overall Study|Physician Decision|2|||
130328927|NCT04639258|469173423|FG000|Overall Study|Early study termination|3|||
130328928|NCT04639258|469173423|FG000|Overall Study|Withdrawal by Subject|1|||
130328929|NCT02819804|469173425|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
130328930|NCT01782378|469173426|FG000|First Series|Lost to Follow-up|7|||
130328931|NCT01782378|469173427|FG001|First Series|Lost to Follow-up|8|||
130328932|NCT01782378|469173426|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
130328933|NCT01782378|469173427|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
130328934|NCT01782378|469173426|FG000|Second Series|Lost to Follow-up|8|||
130328935|NCT01782378|469173427|FG001|Second Series|Lost to Follow-up|7|||
130328936|NCT01782378|469173426|FG000|Second Series|Did not choose to complete S2 Optional|18|||
130328937|NCT01782378|469173427|FG001|Second Series|Did not choose to complete S2 Optional|0|||
130328938|NCT03815929|469173430|FG000|Overall Study|Lost to Follow-up|2|||
130328939|NCT03815929|469173431|FG001|Overall Study|Lost to Follow-up|1|||
130328940|NCT03815929|469173432|FG002|Overall Study|Lost to Follow-up|0|||
130328941|NCT03815929|469173430|FG000|Overall Study|Physician Decision|2|||
130328942|NCT03815929|469173431|FG001|Overall Study|Physician Decision|2|||
130328943|NCT03815929|469173432|FG002|Overall Study|Physician Decision|0|||
130328944|NCT03815929|469173430|FG000|Overall Study|Withdrawal by Subject|0|||
130328945|NCT03815929|469173431|FG001|Overall Study|Withdrawal by Subject|0|||
130328946|NCT03815929|469173432|FG002|Overall Study|Withdrawal by Subject|1|||
130328947|NCT02205736|469173433|FG000|Overall Study|Lost to Follow-up|106|||
130328948|NCT05615922|469173439|FG000|Overall Study|Lost to Follow-up|1|||
130328949|NCT03173248|469173443|FG000|Overall Study|Death|28|||
130328950|NCT03173248|469173444|FG001|Overall Study|Death|46|||
130328951|NCT03173248|469173443|FG000|Overall Study|Lost to Follow-up|0|||
130328952|NCT03173248|469173444|FG001|Overall Study|Lost to Follow-up|1|||
130328953|NCT03173248|469173443|FG000|Overall Study|Withdrawal by Subject|6|||
130328954|NCT03173248|469173444|FG001|Overall Study|Withdrawal by Subject|4|||
130328955|NCT03173248|469173443|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
130328956|NCT03173248|469173444|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
130328957|NCT02991768|469173446|FG000|Overall Study|Physician Decision|4|||
130328958|NCT04500158|469173449|FG000|Overall Study|Physician Decision|17|||
130328959|NCT04500158|469173450|FG001|Overall Study|Physician Decision|11|||
130328960|NCT02807402|469173453|FG000|Overall Study|Failure to Return|1|||
129990108|NCT00372229|467927565|FG000|Follow-Up Phase|Administrative|1|||
130328961|NCT02807402|469173453|FG000|Overall Study|Death|3|||
130328962|NCT02807402|469173453|FG000|Overall Study|Other|2|||
130328963|NCT04801420|469173455|FG000|Overall Study|Other|1|||
130328964|NCT04801420|469173456|FG001|Overall Study|Other|2|||
130328965|NCT04801420|469173457|FG002|Overall Study|Other|1|||
130328966|NCT04801420|469173455|FG000|Overall Study|Lost to Follow-up|7|||
130328967|NCT04801420|469173456|FG001|Overall Study|Lost to Follow-up|9|||
130328968|NCT04801420|469173457|FG002|Overall Study|Lost to Follow-up|10|||
130328969|NCT04801420|469173455|FG000|Overall Study|Moved from study area|0|||
130328970|NCT04801420|469173456|FG001|Overall Study|Moved from study area|1|||
130328971|NCT04801420|469173457|FG002|Overall Study|Moved from study area|1|||
130328972|NCT04801420|469173455|FG000|Overall Study|Withdrawal by Subject|5|||
129990109|NCT00372229|467927566|FG001|Follow-Up Phase|Administrative|0|||
130328973|NCT04801420|469173456|FG001|Overall Study|Withdrawal by Subject|1|||
130328974|NCT04801420|469173457|FG002|Overall Study|Withdrawal by Subject|4|||
130328975|NCT04801420|469173455|FG000|Overall Study|Individual stopping criteria reached|0|||
130328976|NCT04801420|469173456|FG001|Overall Study|Individual stopping criteria reached|1|||
130328977|NCT04801420|469173457|FG002|Overall Study|Individual stopping criteria reached|0|||
130328978|NCT04801420|469173455|FG000|Overall Study|Ongoing in the study|195|||
130328979|NCT04801420|469173456|FG001|Overall Study|Ongoing in the study|195|||
130328980|NCT04801420|469173457|FG002|Overall Study|Ongoing in the study|192|||
130328981|NCT04774094|469173458|FG000|Overall Study|Other|2|||
130328982|NCT04774094|469173458|FG000|Overall Study|Withdrawal by Subject|9|||
130328983|NCT04774094|469173458|FG000|Overall Study|Lost to Follow-up|7|||
130328984|NCT04774094|469173458|FG000|Overall Study|Lack of Efficacy|5|||
130328985|NCT04774094|469173458|FG000|Overall Study|Death|17|||
130328986|NCT04774094|469173458|FG000|Overall Study|Adverse Event|4|||
130328987|NCT01376804|469175312|FG000|Treatment Period|Withdrawal by Subject|1|||
130328988|NCT01376804|469175312|FG000|Treatment Period|Adverse Event|6|||
130328989|NCT01376804|469175312|FG000|Treatment Period|Patient did not receive study drug|1|||
129990110|NCT00372229|467927565|FG000|Follow-Up Phase|Reason not specified|2|||
129990111|NCT00372229|467927566|FG001|Follow-Up Phase|Reason not specified|3|||
129990112|NCT00372229|467927565|FG000|Follow-Up Phase|Lost to Follow-up|12|||
129990113|NCT00372229|467927566|FG001|Follow-Up Phase|Lost to Follow-up|10|||
129990114|NCT01878214|467927567|FG000|Overall Study|Withdrawal by Subject|18|||
129990115|NCT01878214|467927568|FG001|Overall Study|Withdrawal by Subject|7|||
129990116|NCT01878214|467927567|FG000|Overall Study|Death|0|||
129990117|NCT01878214|467927568|FG001|Overall Study|Death|1|||
130328990|NCT01357850|469175313|FG000|Overall Study|Lost to Follow-up|1|||
130328991|NCT01357850|469175314|FG001|Overall Study|Lost to Follow-up|0|||
130328992|NCT01357850|469175315|FG002|Overall Study|Lost to Follow-up|0|||
130328993|NCT01357850|469175316|FG003|Overall Study|Lost to Follow-up|0|||
129990118|NCT01878214|467927567|FG000|Overall Study|Lost to Follow-up|35|||
129990119|NCT01878214|467927568|FG001|Overall Study|Lost to Follow-up|36|||
129990120|NCT00093808|467927571|FG000|Overall Study|Cancel participation before receiving tx|1|||
129990121|NCT00093808|467927571|FG000|Overall Study|Protocol Violation|1|||
129990122|NCT00871780|467927572|FG000|Overall Study|Enrolled But Not Treated|6|||
129990123|NCT00871780|467927572|FG000|Overall Study|Withdrawal by Subject|9|||
129990124|NCT00871780|467927572|FG000|Overall Study|Adverse Event|6|||
129990125|NCT00871780|467927572|FG000|Overall Study|Voluntary Discontinuation|4|||
129990126|NCT00871780|467927572|FG000|Overall Study|Death|1|||
129990127|NCT00871780|467927572|FG000|Overall Study|Physician Decision|1|||
129990128|NCT03406260|467927573|FG000|Period 1|Adverse Event|0|||
129990129|NCT03406260|467927574|FG001|Period 1|Adverse Event|0|||
129990130|NCT03406260|467927575|FG002|Period 1|Adverse Event|0|||
129990131|NCT03406260|467927576|FG003|Period 1|Adverse Event|0|||
129990132|NCT03406260|467927577|FG004|Period 1|Adverse Event|1|||
129990133|NCT03406260|467927578|FG005|Period 1|Adverse Event|0|||
129990134|NCT02647866|467927579|FG000|Overall Study|Adverse Event|0|||
129990135|NCT02647866|467927580|FG001|Overall Study|Adverse Event|0|||
129990136|NCT02647866|467927581|FG002|Overall Study|Adverse Event|2|||
129990137|NCT02647866|467927582|FG003|Overall Study|Adverse Event|2|||
129990138|NCT02647866|467927583|FG004|Overall Study|Adverse Event|1|||
129990139|NCT02647866|467927579|FG000|Overall Study|Disease Worsening|3|||
129990140|NCT02647866|467927580|FG001|Overall Study|Disease Worsening|1|||
129990141|NCT02647866|467927581|FG002|Overall Study|Disease Worsening|0|||
129990142|NCT02647866|467927582|FG003|Overall Study|Disease Worsening|0|||
129990143|NCT02647866|467927583|FG004|Overall Study|Disease Worsening|1|||
129990144|NCT02647866|467927579|FG000|Overall Study|Withdrawal by Subject|1|||
129990145|NCT02647866|467927580|FG001|Overall Study|Withdrawal by Subject|1|||
129990146|NCT02647866|467927581|FG002|Overall Study|Withdrawal by Subject|2|||
129990147|NCT02647866|467927582|FG003|Overall Study|Withdrawal by Subject|4|||
130328994|NCT00753506|469175319|FG000|Overall Study|Withdrawal by Subject|4|||
130328995|NCT00753506|469175320|FG001|Overall Study|Withdrawal by Subject|1|||
130328996|NCT00753506|469175319|FG000|Overall Study|Lost to Follow-up|2|||
130328997|NCT00753506|469175320|FG001|Overall Study|Lost to Follow-up|0|||
130328998|NCT00753506|469175319|FG000|Overall Study|Other reason|1|||
129990148|NCT02647866|467927583|FG004|Overall Study|Withdrawal by Subject|4|||
129990149|NCT02647866|467927579|FG000|Overall Study|Physician Decision|0|||
129990150|NCT02647866|467927580|FG001|Overall Study|Physician Decision|1|||
129990151|NCT02647866|467927581|FG002|Overall Study|Physician Decision|1|||
129990152|NCT02647866|467927582|FG003|Overall Study|Physician Decision|0|||
129990153|NCT02647866|467927583|FG004|Overall Study|Physician Decision|2|||
129990154|NCT02647866|467927579|FG000|Overall Study|Death|0|||
129990155|NCT02647866|467927580|FG001|Overall Study|Death|1|||
129990156|NCT02647866|467927581|FG002|Overall Study|Death|0|||
129990157|NCT02647866|467927582|FG003|Overall Study|Death|0|||
129990158|NCT02647866|467927583|FG004|Overall Study|Death|0|||
130328999|NCT00753506|469175320|FG001|Overall Study|Other reason|1|||
130329000|NCT01600716|469175321|FG000|Overall Study|Other Reasons|3|||
130329001|NCT01600716|469175322|FG001|Overall Study|Other Reasons|1|||
130329002|NCT01600716|469175321|FG000|Overall Study|Personal Reasons|0|||
130329003|NCT01600716|469175322|FG001|Overall Study|Personal Reasons|2|||
130329004|NCT01600716|469175321|FG000|Overall Study|Lost to Follow-up|0|||
130329005|NCT01600716|469175322|FG001|Overall Study|Lost to Follow-up|2|||
130329006|NCT01600716|469175321|FG000|Overall Study|Pregnancy|1|||
130329007|NCT01600716|469175322|FG001|Overall Study|Pregnancy|0|||
130329008|NCT01600716|469175321|FG000|Overall Study|Lack of Efficacy|2|||
130329009|NCT01600716|469175322|FG001|Overall Study|Lack of Efficacy|1|||
130329010|NCT01600716|469175321|FG000|Overall Study|Adverse Event|1|||
130329011|NCT01600716|469175322|FG001|Overall Study|Adverse Event|1|||
130329012|NCT03926611|469175326|FG000|Overall Study|Adverse Event|0|||
130329013|NCT03926611|469175327|FG001|Overall Study|Adverse Event|0|||
130329014|NCT03926611|469175328|FG002|Overall Study|Adverse Event|0|||
130329015|NCT03926611|469175329|FG003|Overall Study|Adverse Event|3|||
130329016|NCT03926611|469175330|FG004|Overall Study|Adverse Event|1|||
130329017|NCT03926611|469175331|FG005|Overall Study|Adverse Event|3|||
130329018|NCT03926611|469175332|FG006|Overall Study|Adverse Event|0|||
130329019|NCT03926611|469175326|FG000|Overall Study|Lack of Efficacy|1|||
130329020|NCT03926611|469175327|FG001|Overall Study|Lack of Efficacy|2|||
130329021|NCT03926611|469175328|FG002|Overall Study|Lack of Efficacy|0|||
130329022|NCT03926611|469175329|FG003|Overall Study|Lack of Efficacy|0|||
130329023|NCT03926611|469175330|FG004|Overall Study|Lack of Efficacy|1|||
130329024|NCT03926611|469175331|FG005|Overall Study|Lack of Efficacy|0|||
130329025|NCT03926611|469175332|FG006|Overall Study|Lack of Efficacy|1|||
130329026|NCT03926611|469175326|FG000|Overall Study|Physician Decision|0|||
130329027|NCT03926611|469175327|FG001|Overall Study|Physician Decision|0|||
130329028|NCT03926611|469175328|FG002|Overall Study|Physician Decision|0|||
130329029|NCT03926611|469175329|FG003|Overall Study|Physician Decision|0|||
130329030|NCT03926611|469175330|FG004|Overall Study|Physician Decision|0|||
130329031|NCT03926611|469175331|FG005|Overall Study|Physician Decision|1|||
130329032|NCT03926611|469175332|FG006|Overall Study|Physician Decision|0|||
130329033|NCT03926611|469175326|FG000|Overall Study|Protocol Violation|1|||
130329034|NCT03926611|469175327|FG001|Overall Study|Protocol Violation|0|||
130329035|NCT03926611|469175328|FG002|Overall Study|Protocol Violation|0|||
130329036|NCT03926611|469175329|FG003|Overall Study|Protocol Violation|1|||
130329037|NCT03926611|469175330|FG004|Overall Study|Protocol Violation|1|||
130329038|NCT03926611|469175331|FG005|Overall Study|Protocol Violation|1|||
130329039|NCT03926611|469175332|FG006|Overall Study|Protocol Violation|1|||
130329040|NCT03926611|469175326|FG000|Overall Study|Technical problems|0|||
130329041|NCT03926611|469175327|FG001|Overall Study|Technical problems|0|||
130329042|NCT03926611|469175328|FG002|Overall Study|Technical problems|0|||
130329043|NCT03926611|469175329|FG003|Overall Study|Technical problems|0|||
130329044|NCT03926611|469175330|FG004|Overall Study|Technical problems|0|||
130329045|NCT03926611|469175331|FG005|Overall Study|Technical problems|1|||
130329046|NCT03926611|469175332|FG006|Overall Study|Technical problems|0|||
130329047|NCT03926611|469175326|FG000|Overall Study|Withdrawal by Subject|1|||
130329048|NCT03926611|469175327|FG001|Overall Study|Withdrawal by Subject|1|||
130329049|NCT03926611|469175328|FG002|Overall Study|Withdrawal by Subject|1|||
130329050|NCT03926611|469175329|FG003|Overall Study|Withdrawal by Subject|0|||
130329051|NCT03926611|469175330|FG004|Overall Study|Withdrawal by Subject|0|||
130329052|NCT03926611|469175331|FG005|Overall Study|Withdrawal by Subject|1|||
130329053|NCT03926611|469175332|FG006|Overall Study|Withdrawal by Subject|3|||
130329054|NCT03926611|469175326|FG000|Overall Study|Covid-19 pandemic|0|||
130329055|NCT03926611|469175327|FG001|Overall Study|Covid-19 pandemic|0|||
130329056|NCT03926611|469175328|FG002|Overall Study|Covid-19 pandemic|1|||
130329057|NCT03926611|469175329|FG003|Overall Study|Covid-19 pandemic|0|||
130329058|NCT03926611|469175330|FG004|Overall Study|Covid-19 pandemic|1|||
130329059|NCT03926611|469175331|FG005|Overall Study|Covid-19 pandemic|2|||
130329060|NCT03926611|469175332|FG006|Overall Study|Covid-19 pandemic|0|||
130329061|NCT02230670|469175335|FG000|Overall Study|Adverse Event|1|||
130329062|NCT02230670|469175336|FG001|Overall Study|Adverse Event|2|||
130329063|NCT02230670|469175335|FG000|Overall Study|Withdrawal by Subject|2|||
130329064|NCT02230670|469175336|FG001|Overall Study|Withdrawal by Subject|2|||
130329065|NCT02230670|469175335|FG000|Overall Study|Physician Decision|0|||
130329066|NCT02230670|469175336|FG001|Overall Study|Physician Decision|1|||
130329067|NCT02230670|469175335|FG000|Overall Study|Protocol Violation|0|||
130329068|NCT02230670|469175336|FG001|Overall Study|Protocol Violation|1|||
130329069|NCT02230670|469175335|FG000|Overall Study|Progression to Child-Pugh C|1|||
130329070|NCT02230670|469175336|FG001|Overall Study|Progression to Child-Pugh C|2|||
130329071|NCT03722238|469175337|FG000|Overall Study|Protocol Violation|1|||
130329072|NCT03722238|469175338|FG001|Overall Study|Protocol Violation|0|||
130329073|NCT03722238|469175337|FG000|Overall Study|Physician Decision|1|||
130329074|NCT03722238|469175338|FG001|Overall Study|Physician Decision|0|||
130329075|NCT03722238|469175337|FG000|Overall Study|Death|1|||
130329076|NCT03722238|469175338|FG001|Overall Study|Death|0|||
129883864|NCT02733042|467534444|FG003|Overall Study|Progressive Disease|1|||
129883865|NCT02733042|467534445|FG004|Overall Study|Progressive Disease|2|||
129883866|NCT02733042|467534446|FG005|Overall Study|Progressive Disease|3|||
129883867|NCT02733042|467534447|FG006|Overall Study|Progressive Disease|0|||
130329077|NCT03722238|469175337|FG000|Overall Study|Lost to Follow-up|6|||
130329078|NCT03722238|469175338|FG001|Overall Study|Lost to Follow-up|0|||
130329079|NCT03722238|469175337|FG000|Overall Study|Partial missing data|44|||
129990159|NCT02647866|467927579|FG000|Overall Study|Subject moved to different country|1|||
129990160|NCT02647866|467927580|FG001|Overall Study|Subject moved to different country|0|||
129990161|NCT02647866|467927581|FG002|Overall Study|Subject moved to different country|0|||
129990162|NCT02647866|467927582|FG003|Overall Study|Subject moved to different country|0|||
129990163|NCT02647866|467927583|FG004|Overall Study|Subject moved to different country|0|||
129990164|NCT00069108|467927587|FG000|Overall Study|Withdrawal by Subject|5|||
129990165|NCT00069108|467927588|FG001|Overall Study|Withdrawal by Subject|9|||
129990166|NCT00069108|467927587|FG000|Overall Study|Adverse Event|64|||
129990167|NCT00069108|467927588|FG001|Overall Study|Adverse Event|42|||
129990168|NCT00069108|467927587|FG000|Overall Study|Death|6|||
129990169|NCT00069108|467927588|FG001|Overall Study|Death|6|||
129990170|NCT00069108|467927587|FG000|Overall Study|Administration|15|||
129990171|NCT00069108|467927588|FG001|Overall Study|Administration|4|||
129990172|NCT00069108|467927587|FG000|Overall Study|Insufficient therapy|117|||
129990173|NCT00069108|467927588|FG001|Overall Study|Insufficient therapy|144|||
129990174|NCT00069108|467927587|FG000|Overall Study|Violation criteria|1|||
129990175|NCT00069108|467927588|FG001|Overall Study|Violation criteria|4|||
129990176|NCT00069108|467927587|FG000|Overall Study|Refused treatment|5|||
129990177|NCT00069108|467927588|FG001|Overall Study|Refused treatment|10|||
129990178|NCT01415531|467927589|FG000|Overall Study|Adverse Event|7|||
129990179|NCT01415531|467927590|FG001|Overall Study|Adverse Event|10|||
129990180|NCT01415531|467927589|FG000|Overall Study|Lack of Efficacy|3|||
129990181|NCT01415531|467927590|FG001|Overall Study|Lack of Efficacy|2|||
129990182|NCT01415531|467927589|FG000|Overall Study|Protocol Violation|0|||
129990183|NCT01415531|467927590|FG001|Overall Study|Protocol Violation|1|||
129990184|NCT01415531|467927589|FG000|Overall Study|Withdrawal by Subject|5|||
129990185|NCT01415531|467927590|FG001|Overall Study|Withdrawal by Subject|4|||
129990186|NCT01415531|467927589|FG000|Overall Study|Lost to Follow-up|6|||
129990187|NCT01415531|467927590|FG001|Overall Study|Lost to Follow-up|14|||
129990188|NCT01415531|467927589|FG000|Overall Study|Lack of Compliance|1|||
129990189|NCT01415531|467927590|FG001|Overall Study|Lack of Compliance|4|||
129990190|NCT01415531|467927589|FG000|Overall Study|Other Reasons|3|||
129990191|NCT01415531|467927590|FG001|Overall Study|Other Reasons|2|||
129990192|NCT00262951|467927591|FG000|Overall Study|Progressive disease/relapse|3|||
129990193|NCT00262951|467927591|FG000|Overall Study|Adverse Event|7|||
129990194|NCT00262951|467927591|FG000|Overall Study|Death|1|||
129990195|NCT00262951|467927591|FG000|Overall Study|Withdrawal by Subject|1|||
129990196|NCT00262951|467927591|FG000|Overall Study|Alternative treatment|3|||
129990197|NCT00262951|467927591|FG000|Overall Study|Off treatment for other disease|1|||
129990198|NCT00394082|467927594|FG000|Overall Study|Unacceptable toxicity|15|||
129990199|NCT00394082|467927594|FG000|Overall Study|Adverse Event|4|||
129990200|NCT00394082|467927594|FG000|Overall Study|Physician Decision|4|||
129990201|NCT00394082|467927594|FG000|Overall Study|Withdrawal by Subject|2|||
129990202|NCT00394082|467927594|FG000|Overall Study|Other|1|||
129990203|NCT02325557|467927596|FG000|Overall Study|Progressive disease|1|||
129990204|NCT02325557|467927597|FG001|Overall Study|Progressive disease|0|||
129990205|NCT02325557|467927598|FG002|Overall Study|Progressive disease|0|||
129990206|NCT02325557|467927599|FG003|Overall Study|Progressive disease|0|||
129990207|NCT02325557|467927596|FG000|Overall Study|Withdrawal by Subject|4|||
129990208|NCT02325557|467927597|FG001|Overall Study|Withdrawal by Subject|0|||
129990209|NCT02325557|467927598|FG002|Overall Study|Withdrawal by Subject|0|||
129990210|NCT02325557|467927599|FG003|Overall Study|Withdrawal by Subject|15|||
129990211|NCT02325557|467927596|FG000|Overall Study|Death|5|||
129990212|NCT02325557|467927597|FG001|Overall Study|Death|1|||
130329080|NCT03722238|469175338|FG001|Overall Study|Partial missing data|1|||
130329081|NCT03722238|469175337|FG000|Overall Study|Withdrawal by Subject|2|||
130329082|NCT03722238|469175338|FG001|Overall Study|Withdrawal by Subject|0|||
130329083|NCT03722238|469175337|FG000|Overall Study|Other|4|||
130329084|NCT03722238|469175338|FG001|Overall Study|Other|0|||
130329085|NCT03722238|469175337|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
130329086|NCT03722238|469175338|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
130329087|NCT03722238|469175337|FG000|Overall Study|Did not meet risk classification group criteria|90|||
130329088|NCT03722238|469175338|FG001|Overall Study|Did not meet risk classification group criteria|0|||
130329089|NCT03722238|469175337|FG000|Overall Study|Did not sign consent|17|||
130329090|NCT03722238|469175338|FG001|Overall Study|Did not sign consent|0|||
130329091|NCT03722238|469175337|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
130329092|NCT03722238|469175338|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
130329093|NCT03722238|469175337|FG000|Overall Study|Not willing to purchase study medication|142|||
129990213|NCT02325557|467927598|FG002|Overall Study|Death|1|||
129990214|NCT02325557|467927599|FG003|Overall Study|Death|16|||
129990215|NCT02325557|467927596|FG000|Overall Study|Lost to Follow-up|0|||
129990216|NCT02325557|467927597|FG001|Overall Study|Lost to Follow-up|0|||
130329094|NCT03722238|469175338|FG001|Overall Study|Not willing to purchase study medication|0|||
129990217|NCT02325557|467927598|FG002|Overall Study|Lost to Follow-up|1|||
129990218|NCT02325557|467927599|FG003|Overall Study|Lost to Follow-up|1|||
129990219|NCT02325557|467927596|FG000|Overall Study|Other|0|||
130215700|NCT01844817|468753827|FG000|Treatment|Progressive Disease|27|||
130215701|NCT01844817|468753828|FG001|Treatment|Progressive Disease|36|||
130215702|NCT01844817|468753827|FG000|Treatment|Adverse Event|17|||
130215703|NCT01844817|468753828|FG001|Treatment|Adverse Event|9|||
130215704|NCT01844817|468753827|FG000|Treatment|Withdrawal by Subject|10|||
130215705|NCT01844817|468753828|FG001|Treatment|Withdrawal by Subject|6|||
130215706|NCT01844817|468753827|FG000|Treatment|Death|10|||
130215707|NCT01844817|468753828|FG001|Treatment|Death|8|||
130215708|NCT01844817|468753827|FG000|Treatment|Lost to Follow-up|0|||
130215709|NCT01844817|468753828|FG001|Treatment|Lost to Follow-up|1|||
130215710|NCT01844817|468753827|FG000|Treatment|Other|0|||
130215711|NCT01844817|468753828|FG001|Treatment|Other|3|||
130215712|NCT01133704|468753829|FG000|Overall Study|Death|44|||
130215713|NCT01133704|468753830|FG001|Overall Study|Death|26|||
130215714|NCT01133704|468753829|FG000|Overall Study|Patient refused to continue|4|||
130215715|NCT01133704|468753830|FG001|Overall Study|Patient refused to continue|0|||
130215716|NCT01133704|468753829|FG000|Overall Study|Study Closure|1|||
130215717|NCT01133704|468753830|FG001|Overall Study|Study Closure|0|||
130215718|NCT03396822|468753833|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
130215719|NCT03396822|468753833|FG000|Overall Study|Physician Decision|1|||
130215720|NCT04985942|468753834|FG000|Overall Study|Adverse Event|14|||
130215721|NCT04985942|468753835|FG001|Overall Study|Adverse Event|2|||
130215722|NCT04985942|468753834|FG000|Overall Study|Lack of Efficacy|0|||
130215723|NCT04985942|468753835|FG001|Overall Study|Lack of Efficacy|3|||
130215724|NCT04985942|468753834|FG000|Overall Study|Lost to Follow-up|1|||
130215725|NCT04985942|468753835|FG001|Overall Study|Lost to Follow-up|1|||
130215726|NCT04985942|468753834|FG000|Overall Study|Protocol Violation|1|||
130215727|NCT04985942|468753835|FG001|Overall Study|Protocol Violation|1|||
130215728|NCT04985942|468753834|FG000|Overall Study|Withdrawal by Subject|5|||
130215729|NCT04985942|468753835|FG001|Overall Study|Withdrawal by Subject|4|||
130215730|NCT03630705|468753836|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
130215731|NCT03630705|468753837|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
130215732|NCT03630705|468753838|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130215733|NCT03630705|468753839|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130215734|NCT03630705|468753836|FG000|Overall Study|Lost to Follow-up|1|||
130215735|NCT03630705|468753837|FG001|Overall Study|Lost to Follow-up|2|||
130215736|NCT03630705|468753838|FG002|Overall Study|Lost to Follow-up|0|||
130215737|NCT03630705|468753839|FG003|Overall Study|Lost to Follow-up|0|||
130215738|NCT02849704|468753841|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
130215739|NCT02849704|468753842|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
130215740|NCT02849704|468753841|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
130215741|NCT02849704|468753842|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
130215742|NCT02849704|468753841|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
130215743|NCT02849704|468753842|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
130215744|NCT03638466|468753845|FG000|Overall Study|Early Termination|0|||
130215745|NCT03638466|468753846|FG001|Overall Study|Early Termination|1|||
130215746|NCT02576977|468753847|FG000|Overall Study|Adverse Event|13|||
130215747|NCT02576977|468753848|FG001|Overall Study|Adverse Event|2|||
130215748|NCT02576977|468753847|FG000|Overall Study|Death|73|||
130215749|NCT02576977|468753848|FG001|Overall Study|Death|60|||
130215750|NCT02576977|468753847|FG000|Overall Study|Screen failure|1|||
130215751|NCT02576977|468753848|FG001|Overall Study|Screen failure|0|||
130215752|NCT02576977|468753847|FG000|Overall Study|Study Terminated at Selected Sites|27|||
130215753|NCT02576977|468753848|FG001|Overall Study|Study Terminated at Selected Sites|50|||
130215754|NCT02576977|468753847|FG000|Overall Study|Withdrawal by Subject|11|||
130215755|NCT02576977|468753848|FG001|Overall Study|Withdrawal by Subject|11|||
130215756|NCT02576977|468753847|FG000|Overall Study|Final Disposition Unknown|0|||
130215757|NCT02576977|468753848|FG001|Overall Study|Final Disposition Unknown|1|||
130215758|NCT02576977|468753847|FG000|Overall Study|Lost to Follow-up|1|||
130215759|NCT02576977|468753848|FG001|Overall Study|Lost to Follow-up|0|||
130215760|NCT02576977|468753847|FG000|Overall Study|Progressive Disease|0|||
130215761|NCT02576977|468753848|FG001|Overall Study|Progressive Disease|1|||
130215762|NCT03251482|468753849|FG000|Overall Study|Withdrawal by Subject|0|||
130215763|NCT03251482|468753850|FG001|Overall Study|Withdrawal by Subject|1|||
130215764|NCT03251482|468753851|FG002|Overall Study|Withdrawal by Subject|0|||
130215765|NCT03251482|468753852|FG003|Overall Study|Withdrawal by Subject|0|||
130215766|NCT03251482|468753853|FG004|Overall Study|Withdrawal by Subject|0|||
130215767|NCT02447328|468753856|FG000|Overall Study|Withdrawal by Subject|1|||
130215768|NCT01128400|468753857|FG000|Overall Study|Lost to Follow-up|1|||
130215769|NCT01128400|468753858|FG001|Overall Study|Lost to Follow-up|0|||
130215770|NCT01128400|468753859|FG002|Overall Study|Lost to Follow-up|1|||
130215771|NCT01128400|468753857|FG000|Overall Study|Screening failure|1|||
130215772|NCT01128400|468753858|FG001|Overall Study|Screening failure|0|||
130215773|NCT01128400|468753859|FG002|Overall Study|Screening failure|0|||
130215774|NCT01128400|468753857|FG000|Overall Study|were not invited to participate on taste|0|||
130215775|NCT01128400|468753858|FG001|Overall Study|were not invited to participate on taste|0|||
130215776|NCT01128400|468753859|FG002|Overall Study|were not invited to participate on taste|15|||
130215777|NCT01128400|468753857|FG000|Overall Study|Excluded due to sinus problems|0|||
130215778|NCT01128400|468753858|FG001|Overall Study|Excluded due to sinus problems|1|||
130215779|NCT01128400|468753859|FG002|Overall Study|Excluded due to sinus problems|0|||
130215780|NCT00314808|468753865|FG000|Overall Study|Disease Progression without AE|4|||
130215781|NCT00314808|468753865|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
130215782|NCT04304508|468753866|FG000|Overall Study|Subject Decision|29|||
130215783|NCT04304508|468753867|FG001|Overall Study|Subject Decision|39|||
130215784|NCT04304508|468753868|FG002|Overall Study|Subject Decision|37|||
130215785|NCT04304508|468753869|FG003|Overall Study|Subject Decision|48|||
130215786|NCT04304508|468753866|FG000|Overall Study|Death|6|||
130215787|NCT04304508|468753867|FG001|Overall Study|Death|1|||
130215788|NCT04304508|468753868|FG002|Overall Study|Death|8|||
130215789|NCT04304508|468753869|FG003|Overall Study|Death|5|||
130215790|NCT04304508|468753866|FG000|Overall Study|Non-compliance With Study Drug|3|||
130215791|NCT04304508|468753867|FG001|Overall Study|Non-compliance With Study Drug|1|||
130215792|NCT04304508|468753868|FG002|Overall Study|Non-compliance With Study Drug|2|||
130215793|NCT04304508|468753869|FG003|Overall Study|Non-compliance With Study Drug|0|||
130215794|NCT04304508|468753866|FG000|Overall Study|Switching To Other Therapy|1|||
130215795|NCT04304508|468753867|FG001|Overall Study|Switching To Other Therapy|1|||
130215796|NCT04304508|468753868|FG002|Overall Study|Switching To Other Therapy|1|||
130215797|NCT04304508|468753869|FG003|Overall Study|Switching To Other Therapy|2|||
130215798|NCT04304508|468753866|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
130215799|NCT04304508|468753867|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
130215800|NCT04304508|468753868|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
130215801|NCT04304508|468753869|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
130215802|NCT04304508|468753866|FG000|Overall Study|Withdrawal by Subject|7|||
130215803|NCT04304508|468753867|FG001|Overall Study|Withdrawal by Subject|5|||
130215804|NCT04304508|468753868|FG002|Overall Study|Withdrawal by Subject|11|||
130215805|NCT04304508|468753869|FG003|Overall Study|Withdrawal by Subject|6|||
130215806|NCT04304508|468753866|FG000|Overall Study|Logistical Difficulties|2|||
130215807|NCT04304508|468753867|FG001|Overall Study|Logistical Difficulties|2|||
130215808|NCT04304508|468753868|FG002|Overall Study|Logistical Difficulties|3|||
130215809|NCT04304508|468753869|FG003|Overall Study|Logistical Difficulties|2|||
130215810|NCT04304508|468753866|FG000|Overall Study|Missing Information|1|||
130215811|NCT04304508|468753867|FG001|Overall Study|Missing Information|2|||
130215812|NCT04304508|468753868|FG002|Overall Study|Missing Information|1|||
130215813|NCT04304508|468753869|FG003|Overall Study|Missing Information|3|||
130215814|NCT04304508|468753866|FG000|Overall Study|Other|7|||
130215815|NCT04304508|468753867|FG001|Overall Study|Other|6|||
130215816|NCT04304508|468753868|FG002|Overall Study|Other|5|||
130215817|NCT04304508|468753869|FG003|Overall Study|Other|4|||
130215818|NCT04304508|468753866|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
130215819|NCT04304508|468753867|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130215820|NCT04304508|468753868|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130215821|NCT04304508|468753869|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
130215822|NCT04304508|468753866|FG000|Overall Study|Physician Decision|3|||
130215823|NCT04304508|468753867|FG001|Overall Study|Physician Decision|4|||
130215824|NCT04304508|468753868|FG002|Overall Study|Physician Decision|9|||
130215825|NCT04304508|468753869|FG003|Overall Study|Physician Decision|7|||
130215826|NCT04304508|468753866|FG000|Overall Study|Study drug never administered|10|||
130215827|NCT04304508|468753867|FG001|Overall Study|Study drug never administered|4|||
130215828|NCT04304508|468753868|FG002|Overall Study|Study drug never administered|4|||
130215829|NCT04304508|468753869|FG003|Overall Study|Study drug never administered|4|||
130215830|NCT04304508|468753866|FG000|Overall Study|Adverse Event|49|||
130215831|NCT04304508|468753867|FG001|Overall Study|Adverse Event|50|||
130215832|NCT04304508|468753868|FG002|Overall Study|Adverse Event|51|||
130215833|NCT04304508|468753869|FG003|Overall Study|Adverse Event|56|||
130215834|NCT04304508|468753866|FG000|Overall Study|Lost to Follow-up|1|||
130215835|NCT04304508|468753867|FG001|Overall Study|Lost to Follow-up|5|||
130215836|NCT04304508|468753868|FG002|Overall Study|Lost to Follow-up|2|||
130215837|NCT04304508|468753869|FG003|Overall Study|Lost to Follow-up|3|||
130215838|NCT02688764|468753870|FG000|Overall Study|Adverse Event|3|||
130215839|NCT02688764|468753871|FG001|Overall Study|Adverse Event|3|||
130215840|NCT02688764|468753870|FG000|Overall Study|AE/Kidney transplant|1|||
130215841|NCT02688764|468753871|FG001|Overall Study|AE/Kidney transplant|0|||
130215842|NCT02688764|468753870|FG000|Overall Study|AE/Lack of efficacy|1|||
130215843|NCT02688764|468753871|FG001|Overall Study|AE/Lack of efficacy|0|||
130215844|NCT02688764|468753870|FG000|Overall Study|AE/Non-compl.|1|||
130215845|NCT02688764|468753871|FG001|Overall Study|AE/Non-compl.|0|||
130215846|NCT02688764|468753870|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
130215847|NCT02688764|468753871|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
130215848|NCT02688764|468753870|FG000|Overall Study|AE/Other|0|||
130215849|NCT02688764|468753871|FG001|Overall Study|AE/Other|1|||
130215850|NCT02688764|468753870|FG000|Overall Study|AE/Physician decision|1|||
130215851|NCT02688764|468753871|FG001|Overall Study|AE/Physician decision|0|||
130215852|NCT02688764|468753870|FG000|Overall Study|AE/Withd. parent|3|||
129990220|NCT02325557|467927597|FG001|Overall Study|Other|0|||
129990221|NCT02325557|467927598|FG002|Overall Study|Other|0|||
129990222|NCT02325557|467927599|FG003|Overall Study|Other|5|||
129990223|NCT02344004|467927600|FG000|Overall Study|Adverse Event|11|||
129990224|NCT02344004|467927601|FG001|Overall Study|Adverse Event|1|||
129990225|NCT02344004|467927600|FG000|Overall Study|Death|9|||
129990226|NCT02344004|467927601|FG001|Overall Study|Death|7|||
129990227|NCT02344004|467927600|FG000|Overall Study|Physician Decision|4|||
129990228|NCT02344004|467927601|FG001|Overall Study|Physician Decision|1|||
130329095|NCT03722238|469175337|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
130329096|NCT03722238|469175338|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
130329097|NCT02004093|469175339|FG000|Overall Study|Death|2|||
130329098|NCT02004093|469175340|FG001|Overall Study|Death|1|||
130329099|NCT02004093|469175339|FG000|Overall Study|Lack of Efficacy|66|||
130329100|NCT02004093|469175340|FG001|Overall Study|Lack of Efficacy|62|||
130329101|NCT02004093|469175339|FG000|Overall Study|Protocol Violation|0|||
130329102|NCT02004093|469175340|FG001|Overall Study|Protocol Violation|1|||
130329103|NCT02004093|469175339|FG000|Overall Study|Lost to Follow-up|0|||
130329104|NCT02004093|469175340|FG001|Overall Study|Lost to Follow-up|1|||
130329105|NCT02004093|469175339|FG000|Overall Study|Withdrawal by Subject|3|||
130329106|NCT02004093|469175340|FG001|Overall Study|Withdrawal by Subject|7|||
130329107|NCT02004093|469175339|FG000|Overall Study|Other|3|||
130329108|NCT02004093|469175340|FG001|Overall Study|Other|1|||
130329109|NCT01411891|469175341|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
130329110|NCT01411891|469175342|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
130329111|NCT00414596|469175343|FG000|Overall Study|Protocol Violation|2|||
130329112|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Adverse Event|9|||
130329113|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Adverse Event|3|||
130329114|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Death|7|||
130329115|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Death|7|||
130329116|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
130329117|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
130329118|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Physician Decision|1|||
130329119|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Physician Decision|0|||
130329120|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
130329121|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
130329122|NCT02558296|469175344|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
130329123|NCT02558296|469175345|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
130329124|NCT02558296|469175344|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
130329125|NCT02558296|469175345|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
130329126|NCT02558296|469175344|FG000|Completed the Study|Adverse Event|14|||
130329127|NCT02558296|469175345|FG001|Completed the Study|Adverse Event|5|||
130329128|NCT02558296|469175344|FG000|Completed the Study|Death|39|||
130329129|NCT02558296|469175345|FG001|Completed the Study|Death|25|||
130329130|NCT02558296|469175344|FG000|Completed the Study|Lost to Follow-up|31|||
130329131|NCT02558296|469175345|FG001|Completed the Study|Lost to Follow-up|23|||
130329132|NCT02558296|469175344|FG000|Completed the Study|Physician Decision|6|||
130329133|NCT02558296|469175345|FG001|Completed the Study|Physician Decision|0|||
130329134|NCT02558296|469175344|FG000|Completed the Study|Protocol Violation|2|||
130329135|NCT02558296|469175345|FG001|Completed the Study|Protocol Violation|1|||
130329136|NCT02558296|469175344|FG000|Completed the Study|Withdrawal by Subject|53|||
130329137|NCT02558296|469175345|FG001|Completed the Study|Withdrawal by Subject|31|||
130329138|NCT02558296|469175344|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
130329139|NCT02558296|469175345|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
130329140|NCT00297258|469175346|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
130329141|NCT00297258|469175346|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
130329142|NCT00297258|469175346|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
130329143|NCT00297258|469175346|FG000|Overall Study|Intercurrent Illness|3|||
130329144|NCT00297258|469175346|FG000|Overall Study|Intercurrent Death|2|||
130329145|NCT00297258|469175346|FG000|Overall Study|Deteriorization of General Condition|1|||
130329146|NCT00297258|469175346|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
130329147|NCT00297258|469175346|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
130329148|NCT00297258|469175346|FG000|Overall Study|Switch to Commercial Treatment|1|||
130329149|NCT00297258|469175346|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
130329150|NCT00346697|469175349|FG000|Overall Study|Lost to Follow-up|0|||
130329151|NCT00346697|469175350|FG001|Overall Study|Lost to Follow-up|1|||
130329152|NCT00734539|469175351|FG000|Main Study|Death|33|||
130329153|NCT00734539|469175352|FG001|Main Study|Death|32|||
130329154|NCT00734539|469175351|FG000|Main Study|Physician Decision|2|||
129990229|NCT02344004|467927600|FG000|Overall Study|Withdrawal by Subject|22|||
129990230|NCT02344004|467927601|FG001|Overall Study|Withdrawal by Subject|5|||
129990231|NCT02344004|467927600|FG000|Overall Study|Rescue Medication|2|||
129990232|NCT02344004|467927601|FG001|Overall Study|Rescue Medication|0|||
130329155|NCT00734539|469175352|FG001|Main Study|Physician Decision|0|||
129990233|NCT02344004|467927600|FG000|Overall Study|Other Not Specified|12|||
129990234|NCT02344004|467927601|FG001|Overall Study|Other Not Specified|0|||
130329156|NCT00734539|469175351|FG000|Main Study|Withdrawal by Subject|1|||
130329157|NCT00734539|469175352|FG001|Main Study|Withdrawal by Subject|3|||
130329158|NCT00734539|469175351|FG000|Main Study|Enrolled in error; ineligible|1|||
130329159|NCT00734539|469175352|FG001|Main Study|Enrolled in error; ineligible|0|||
130329160|NCT02504151|469175357|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
130329161|NCT02504151|469175358|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
130329162|NCT02504151|469175357|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
130329163|NCT02504151|469175358|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
130329164|NCT02504151|469175357|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130329165|NCT02504151|469175358|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130329166|NCT02504151|469175357|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
130329167|NCT02504151|469175358|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
130329168|NCT05038982|469175359|FG000|Overall Study|Withdrawal by Subject|0|||
130329169|NCT05038982|469175360|FG001|Overall Study|Withdrawal by Subject|2|||
130329170|NCT02557139|469175366|FG000|Overall Study|Significant liver elevation|1|||
130329171|NCT02557139|469175367|FG001|Overall Study|Significant liver elevation|0|||
130329172|NCT02557139|469175368|FG002|Overall Study|Significant liver elevation|1|||
130329173|NCT02557139|469175366|FG000|Overall Study|Withdrawal by Subject|1|||
130329174|NCT02557139|469175367|FG001|Overall Study|Withdrawal by Subject|0|||
130329175|NCT02557139|469175368|FG002|Overall Study|Withdrawal by Subject|0|||
130329176|NCT02557139|469175366|FG000|Overall Study|Illness of prohibited medication|0|||
130329177|NCT02557139|469175367|FG001|Overall Study|Illness of prohibited medication|0|||
130329178|NCT02557139|469175368|FG002|Overall Study|Illness of prohibited medication|1|||
130329179|NCT01454102|469175369|FG000|Overall Study|Continuing in the treatment period|0|||
130329180|NCT01454102|469175370|FG001|Overall Study|Continuing in the treatment period|0|||
130329181|NCT01454102|469175371|FG002|Overall Study|Continuing in the treatment period|0|||
130329182|NCT01454102|469175372|FG003|Overall Study|Continuing in the treatment period|0|||
130329183|NCT01454102|469175373|FG004|Overall Study|Continuing in the treatment period|3|||
130329184|NCT01454102|469175374|FG005|Overall Study|Continuing in the treatment period|3|||
130329185|NCT01454102|469175375|FG006|Overall Study|Continuing in the treatment period|2|||
130329186|NCT01454102|469175376|FG007|Overall Study|Continuing in the treatment period|0|||
130329187|NCT01454102|469175377|FG008|Overall Study|Continuing in the treatment period|1|||
130329188|NCT01454102|469175378|FG009|Overall Study|Continuing in the treatment period|0|||
130329189|NCT01454102|469175379|FG010|Overall Study|Continuing in the treatment period|0|||
130329190|NCT01454102|469175380|FG011|Overall Study|Continuing in the treatment period|4|||
129990235|NCT02344004|467927600|FG000|Overall Study|Protocol Violation|1|||
129990236|NCT02344004|467927601|FG001|Overall Study|Protocol Violation|0|||
129990237|NCT03881553|467927609|FG000|Overall Study|Discharged prior to participation|1|||
129990238|NCT03881553|467927610|FG001|Overall Study|Discharged prior to participation|1|||
129990239|NCT03881553|467927611|FG002|Overall Study|Discharged prior to participation|0|||
129990240|NCT03881553|467927609|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
129990241|NCT03881553|467927610|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
129990242|NCT03881553|467927611|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
129990243|NCT00336895|467927615|FG000|Overall Study|diarrhea|1|||
129990244|NCT00336895|467927615|FG000|Overall Study|nausea and upset stomach|1|||
129990245|NCT00336895|467927615|FG000|Overall Study|Physician Decision|1|||
129990246|NCT00336895|467927615|FG000|Overall Study|screen failed|1|||
129990247|NCT02481947|467927616|FG000|Overall Study|Withdrawal by Subject|24|||
129990248|NCT02481947|467927617|FG001|Overall Study|Withdrawal by Subject|10|||
129990249|NCT02481947|467927616|FG000|Overall Study|Lost to Follow-up|11|||
129990250|NCT02481947|467927617|FG001|Overall Study|Lost to Follow-up|5|||
129990251|NCT02481947|467927616|FG000|Overall Study|Adverse Event|6|||
129990252|NCT02481947|467927617|FG001|Overall Study|Adverse Event|11|||
129990253|NCT02481947|467927616|FG000|Overall Study|Physician Decision|4|||
129990254|NCT02481947|467927617|FG001|Overall Study|Physician Decision|5|||
129990255|NCT02481947|467927616|FG000|Overall Study|Protocol Violation|1|||
129990256|NCT02481947|467927617|FG001|Overall Study|Protocol Violation|5|||
129990257|NCT03426605|467927618|FG000|Overall Study|AML relapse or progression|2|||
129990258|NCT03426605|467927619|FG001|Overall Study|AML relapse or progression|1|||
129990259|NCT03426605|467927620|FG002|Overall Study|AML relapse or progression|2|||
129990260|NCT03426605|467927621|FG003|Overall Study|AML relapse or progression|2|||
130329191|NCT01454102|469175381|FG012|Overall Study|Continuing in the treatment period|7|||
130329192|NCT01454102|469175382|FG013|Overall Study|Continuing in the treatment period|4|||
130329193|NCT01454102|469175383|FG014|Overall Study|Continuing in the treatment period|3|||
129990261|NCT03426605|467927618|FG000|Overall Study|Treatment failure|3|||
129990262|NCT03426605|467927619|FG001|Overall Study|Treatment failure|2|||
129990263|NCT03426605|467927620|FG002|Overall Study|Treatment failure|0|||
129990264|NCT03426605|467927621|FG003|Overall Study|Treatment failure|0|||
129990265|NCT03426605|467927618|FG000|Overall Study|Adverse Event|1|||
130215853|NCT02688764|468753871|FG001|Overall Study|AE/Withd. parent|0|||
129990266|NCT03426605|467927619|FG001|Overall Study|Adverse Event|0|||
129990267|NCT03426605|467927620|FG002|Overall Study|Adverse Event|1|||
129990268|NCT03426605|467927621|FG003|Overall Study|Adverse Event|1|||
129990269|NCT03426605|467927618|FG000|Overall Study|Withdrawal by Subject|0|||
129990270|NCT03426605|467927619|FG001|Overall Study|Withdrawal by Subject|0|||
129990271|NCT03426605|467927620|FG002|Overall Study|Withdrawal by Subject|1|||
129990272|NCT03426605|467927621|FG003|Overall Study|Withdrawal by Subject|1|||
129990273|NCT01815138|467927622|FG000|Overall Study|Withdrawal by Subject|0|||
129990274|NCT01815138|467927623|FG001|Overall Study|Withdrawal by Subject|1|||
129990275|NCT01815138|467927622|FG000|Overall Study|Physician Decision|8|||
129990276|NCT01815138|467927623|FG001|Overall Study|Physician Decision|5|||
129990277|NCT03426267|467927624|FG000|Overall Study|Physician Decision|1|||
129990278|NCT03426267|467927625|FG001|Overall Study|Physician Decision|4|||
129990279|NCT03426267|467927624|FG000|Overall Study|Lost to Follow-up|1|||
129990280|NCT03426267|467927625|FG001|Overall Study|Lost to Follow-up|0|||
129990281|NCT03426267|467927624|FG000|Overall Study|Withdrawal by Subject|4|||
129990282|NCT03426267|467927625|FG001|Overall Study|Withdrawal by Subject|10|||
129990283|NCT03426267|467927624|FG000|Overall Study|Protocol Violation|1|||
129990284|NCT03426267|467927625|FG001|Overall Study|Protocol Violation|3|||
129990285|NCT03426267|467927624|FG000|Overall Study|Adverse Event|9|||
129990286|NCT03426267|467927625|FG001|Overall Study|Adverse Event|27|||
129990287|NCT03426267|467927624|FG000|Overall Study|Prohibited Treatment Intake|2|||
129990288|NCT03426267|467927625|FG001|Overall Study|Prohibited Treatment Intake|3|||
129990289|NCT03426267|467927624|FG000|Overall Study|Lack of Efficacy|0|||
129990290|NCT03426267|467927625|FG001|Overall Study|Lack of Efficacy|25|||
129990291|NCT03426267|467927624|FG000|Overall Study|other|3|||
129990292|NCT03426267|467927625|FG001|Overall Study|other|0|||
129990293|NCT02649946|467927626|FG000|Overall Study|Withdrawal by Subject|1|||
129990294|NCT02649946|467927627|FG001|Overall Study|Withdrawal by Subject|1|||
129990295|NCT02649946|467927626|FG000|Overall Study|Death|7|||
129990296|NCT02649946|467927627|FG001|Overall Study|Death|9|||
129990297|NCT02649946|467927626|FG000|Overall Study|Physician Decision|1|||
129990298|NCT02649946|467927627|FG001|Overall Study|Physician Decision|0|||
129990299|NCT02649946|467927626|FG000|Overall Study|Lost to Follow-up|2|||
129990300|NCT02649946|467927627|FG001|Overall Study|Lost to Follow-up|1|||
129990301|NCT02649946|467927626|FG000|Overall Study|Erroneously enrolled|1|||
129990302|NCT02649946|467927627|FG001|Overall Study|Erroneously enrolled|0|||
129990303|NCT02649946|467927626|FG000|Overall Study|Missed 6-month follow-up visit|0|||
129990304|NCT02649946|467927627|FG001|Overall Study|Missed 6-month follow-up visit|4|||
129990305|NCT00950950|467927628|FG000|Overall Study|Adverse Event|1|||
129990306|NCT00950950|467927629|FG001|Overall Study|Adverse Event|0|||
129990307|NCT00950950|467927628|FG000|Overall Study|Withdrawal by Subject|0|||
129990308|NCT00950950|467927629|FG001|Overall Study|Withdrawal by Subject|1|||
129990309|NCT01047293|467927635|FG000|Overall Study|DLT criteria not fulfilled|1|||
129990310|NCT01047293|467927636|FG001|Overall Study|DLT criteria not fulfilled|1|||
129990311|NCT01047293|467927637|FG002|Overall Study|DLT criteria not fulfilled|0|||
130329194|NCT01454102|469175384|FG015|Overall Study|Continuing in the treatment period|1|||
130329195|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
130329196|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
130329197|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
130329198|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
130329199|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
130329200|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
130329201|NCT02592798|469175390|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
130329202|NCT02592798|469175391|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
130329203|NCT02592798|469175390|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
130329204|NCT02592798|469175391|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
130329205|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
130329206|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
130329207|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
130329208|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
130329209|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
129990312|NCT01047293|467927638|FG003|Overall Study|DLT criteria not fulfilled|0|||
130329210|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
129990313|NCT02054520|467927639|FG000|Overall Study|Adverse Event|1|||
129990314|NCT02054520|467927640|FG001|Overall Study|Adverse Event|4|||
130329211|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
129990315|NCT02054520|467927641|FG002|Overall Study|Adverse Event|2|||
129990316|NCT02054520|467927642|FG003|Overall Study|Adverse Event|1|||
129990317|NCT02054520|467927643|FG004|Overall Study|Adverse Event|1|||
129990318|NCT02054520|467927644|FG005|Overall Study|Adverse Event|0|||
129990319|NCT02054520|467927639|FG000|Overall Study|Lack of Efficacy|7|||
129990320|NCT02054520|467927640|FG001|Overall Study|Lack of Efficacy|0|||
129990321|NCT02054520|467927641|FG002|Overall Study|Lack of Efficacy|2|||
129990322|NCT02054520|467927642|FG003|Overall Study|Lack of Efficacy|1|||
129990323|NCT02054520|467927643|FG004|Overall Study|Lack of Efficacy|3|||
129990324|NCT02054520|467927644|FG005|Overall Study|Lack of Efficacy|2|||
129990325|NCT02054520|467927639|FG000|Overall Study|Withdrawal by Subject|1|||
129990326|NCT02054520|467927640|FG001|Overall Study|Withdrawal by Subject|0|||
129990327|NCT02054520|467927641|FG002|Overall Study|Withdrawal by Subject|0|||
129990328|NCT02054520|467927642|FG003|Overall Study|Withdrawal by Subject|2|||
129990329|NCT02054520|467927643|FG004|Overall Study|Withdrawal by Subject|1|||
129990330|NCT02054520|467927644|FG005|Overall Study|Withdrawal by Subject|0|||
129990331|NCT02054520|467927639|FG000|Overall Study|Physician Decision|0|||
129990332|NCT02054520|467927640|FG001|Overall Study|Physician Decision|1|||
129990333|NCT02054520|467927641|FG002|Overall Study|Physician Decision|0|||
129990334|NCT02054520|467927642|FG003|Overall Study|Physician Decision|1|||
129990335|NCT02054520|467927643|FG004|Overall Study|Physician Decision|0|||
129990336|NCT02054520|467927644|FG005|Overall Study|Physician Decision|1|||
129990337|NCT02054520|467927639|FG000|Overall Study|Study terminated by Sponsor|0|||
129990338|NCT02054520|467927640|FG001|Overall Study|Study terminated by Sponsor|0|||
129990339|NCT02054520|467927641|FG002|Overall Study|Study terminated by Sponsor|2|||
129990340|NCT02054520|467927642|FG003|Overall Study|Study terminated by Sponsor|1|||
129990341|NCT02054520|467927643|FG004|Overall Study|Study terminated by Sponsor|0|||
129990342|NCT02054520|467927644|FG005|Overall Study|Study terminated by Sponsor|0|||
129990343|NCT01272804|467927645|FG000|Overall Study|Adverse Event|1|||
129990344|NCT01272804|467927646|FG001|Overall Study|Adverse Event|0|||
129990345|NCT01272804|467927647|FG002|Overall Study|Adverse Event|0|||
129990346|NCT01272804|467927648|FG003|Overall Study|Adverse Event|0|||
129990347|NCT01272804|467927649|FG004|Overall Study|Adverse Event|2|||
129990348|NCT01272804|467927650|FG005|Overall Study|Adverse Event|1|||
129990349|NCT02318797|467927651|FG000|Overall Study|Death|3|||
129990350|NCT02318797|467927652|FG001|Overall Study|Death|6|||
129990351|NCT02318797|467927651|FG000|Overall Study|Lost to Follow-up|85|||
130329212|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
130329213|NCT02592798|469175390|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
130329214|NCT02592798|469175391|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
130329215|NCT02592798|469175390|FG000|Transition From DB2 to OLE|Other reasons|1|||
130329216|NCT02592798|469175391|FG001|Transition From DB2 to OLE|Other reasons|0|||
130329217|NCT02592798|469175390|FG000|Open Label Period (OLE)|Other reasons|0|||
130329218|NCT02592798|469175391|FG001|Open Label Period (OLE)|Other reasons|2|||
130329219|NCT02592798|469175390|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
130329220|NCT02592798|469175391|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
130329221|NCT02592798|469175390|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
130329222|NCT02592798|469175391|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
130329223|NCT02592798|469175390|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
130329224|NCT02592798|469175391|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
130329225|NCT02592798|469175390|FG000|Open Label Period (OLE)|Adverse Event|0|||
130329226|NCT02592798|469175391|FG001|Open Label Period (OLE)|Adverse Event|1|||
130329227|NCT00705016|469175392|FG000|Overall Study|Adverse Event|6|||
130329228|NCT00705016|469175393|FG001|Overall Study|Adverse Event|11|||
130329229|NCT00705016|469175394|FG002|Overall Study|Adverse Event|10|||
130329230|NCT00705016|469175392|FG000|Overall Study|Death|5|||
130329231|NCT00705016|469175393|FG001|Overall Study|Death|7|||
130329232|NCT00705016|469175394|FG002|Overall Study|Death|5|||
130329233|NCT00705016|469175392|FG000|Overall Study|Protocol Violation|0|||
130329234|NCT00705016|469175393|FG001|Overall Study|Protocol Violation|1|||
130329235|NCT00705016|469175394|FG002|Overall Study|Protocol Violation|1|||
130329236|NCT00705016|469175392|FG000|Overall Study|Withdrawal by Subject|4|||
130329237|NCT00705016|469175393|FG001|Overall Study|Withdrawal by Subject|3|||
130329238|NCT00705016|469175394|FG002|Overall Study|Withdrawal by Subject|2|||
130329239|NCT00705016|469175392|FG000|Overall Study|Progressive Disease|33|||
130329240|NCT00705016|469175393|FG001|Overall Study|Progressive Disease|29|||
130329241|NCT00705016|469175394|FG002|Overall Study|Progressive Disease|33|||
130329242|NCT00705016|469175392|FG000|Overall Study|Symptomatic Deterioration|3|||
130329243|NCT00705016|469175393|FG001|Overall Study|Symptomatic Deterioration|1|||
130329244|NCT00705016|469175394|FG002|Overall Study|Symptomatic Deterioration|1|||
130329245|NCT00705016|469175392|FG000|Overall Study|Other|9|||
130329246|NCT00705016|469175393|FG001|Overall Study|Other|6|||
130329247|NCT00705016|469175394|FG002|Overall Study|Other|6|||
130329248|NCT03853109|469175397|FG000|Overall Study|Withdrawal by Subject|0|||
129990352|NCT02318797|467927652|FG001|Overall Study|Lost to Follow-up|96|||
129990353|NCT02308020|467927655|FG000|Overall Study|Lost to Follow-up|1|||
129990354|NCT02308020|467927656|FG001|Overall Study|Lost to Follow-up|7|||
129990355|NCT02308020|467927657|FG002|Overall Study|Lost to Follow-up|0|||
129990356|NCT02308020|467927658|FG003|Overall Study|Lost to Follow-up|0|||
129990357|NCT02308020|467927659|FG004|Overall Study|Lost to Follow-up|1|||
129990358|NCT02308020|467927660|FG005|Overall Study|Lost to Follow-up|2|||
129990359|NCT02308020|467927655|FG000|Overall Study|Sponsor Decision|0|||
130329249|NCT03853109|469175398|FG001|Overall Study|Withdrawal by Subject|0|||
130329250|NCT03853109|469175399|FG002|Overall Study|Withdrawal by Subject|1|||
130329251|NCT03853109|469175400|FG003|Overall Study|Withdrawal by Subject|2|||
130329252|NCT03853109|469175401|FG004|Overall Study|Withdrawal by Subject|1|||
130329253|NCT03853109|469175402|FG005|Overall Study|Withdrawal by Subject|4|||
129990360|NCT02308020|467927656|FG001|Overall Study|Sponsor Decision|8|||
129990361|NCT02308020|467927657|FG002|Overall Study|Sponsor Decision|0|||
129990362|NCT02308020|467927658|FG003|Overall Study|Sponsor Decision|2|||
129990363|NCT02308020|467927659|FG004|Overall Study|Sponsor Decision|2|||
129990364|NCT02308020|467927660|FG005|Overall Study|Sponsor Decision|1|||
129990365|NCT02308020|467927655|FG000|Overall Study|Withdrawal by Subject|3|||
130329254|NCT03853109|469175403|FG006|Overall Study|Withdrawal by Subject|5|||
130329255|NCT03853109|469175404|FG007|Overall Study|Withdrawal by Subject|3|||
130329256|NCT03853109|469175397|FG000|Overall Study|Decision by Sponsor|0|||
130329257|NCT03853109|469175398|FG001|Overall Study|Decision by Sponsor|0|||
130329258|NCT03853109|469175399|FG002|Overall Study|Decision by Sponsor|1|||
130329259|NCT03853109|469175400|FG003|Overall Study|Decision by Sponsor|0|||
130329260|NCT03853109|469175401|FG004|Overall Study|Decision by Sponsor|1|||
130329261|NCT03853109|469175402|FG005|Overall Study|Decision by Sponsor|1|||
130329262|NCT03853109|469175403|FG006|Overall Study|Decision by Sponsor|10|||
130329263|NCT03853109|469175404|FG007|Overall Study|Decision by Sponsor|2|||
130329264|NCT03853109|469175397|FG000|Overall Study|Lost to Follow-up|0|||
130329265|NCT03853109|469175398|FG001|Overall Study|Lost to Follow-up|0|||
130329266|NCT03853109|469175399|FG002|Overall Study|Lost to Follow-up|0|||
130329267|NCT03853109|469175400|FG003|Overall Study|Lost to Follow-up|0|||
130329268|NCT03853109|469175401|FG004|Overall Study|Lost to Follow-up|1|||
130329269|NCT03853109|469175402|FG005|Overall Study|Lost to Follow-up|3|||
130329270|NCT03853109|469175403|FG006|Overall Study|Lost to Follow-up|0|||
130329271|NCT03853109|469175404|FG007|Overall Study|Lost to Follow-up|0|||
130329272|NCT03853109|469175397|FG000|Overall Study|Death|2|||
130329273|NCT03853109|469175398|FG001|Overall Study|Death|5|||
130329274|NCT03853109|469175399|FG002|Overall Study|Death|8|||
130329275|NCT03853109|469175400|FG003|Overall Study|Death|10|||
130329276|NCT03853109|469175401|FG004|Overall Study|Death|3|||
130329277|NCT03853109|469175402|FG005|Overall Study|Death|20|||
130329278|NCT03853109|469175403|FG006|Overall Study|Death|10|||
129990366|NCT02308020|467927656|FG001|Overall Study|Withdrawal by Subject|5|||
129990367|NCT02308020|467927657|FG002|Overall Study|Withdrawal by Subject|3|||
129990368|NCT02308020|467927658|FG003|Overall Study|Withdrawal by Subject|2|||
129990369|NCT02308020|467927659|FG004|Overall Study|Withdrawal by Subject|1|||
129990370|NCT02308020|467927660|FG005|Overall Study|Withdrawal by Subject|2|||
129990371|NCT03333837|467927661|FG000|Overall Study|Adverse Event|2|||
129990372|NCT03333837|467927662|FG001|Overall Study|Adverse Event|1|||
129990373|NCT03333837|467927663|FG002|Overall Study|Adverse Event|1|||
129990374|NCT03333837|467927664|FG003|Overall Study|Adverse Event|1|||
129990375|NCT03333837|467927665|FG004|Overall Study|Adverse Event|0|||
129990376|NCT03333837|467927661|FG000|Overall Study|Caregiver withdrew|0|||
129990377|NCT03333837|467927662|FG001|Overall Study|Caregiver withdrew|2|||
129990378|NCT03333837|467927663|FG002|Overall Study|Caregiver withdrew|1|||
129990379|NCT03333837|467927664|FG003|Overall Study|Caregiver withdrew|0|||
129990380|NCT03333837|467927665|FG004|Overall Study|Caregiver withdrew|0|||
129990381|NCT03333837|467927661|FG000|Overall Study|Withdrawal by Subject|0|||
129990382|NCT03333837|467927662|FG001|Overall Study|Withdrawal by Subject|0|||
129990383|NCT03333837|467927663|FG002|Overall Study|Withdrawal by Subject|1|||
129990384|NCT03333837|467927664|FG003|Overall Study|Withdrawal by Subject|1|||
129990385|NCT03333837|467927665|FG004|Overall Study|Withdrawal by Subject|3|||
129990386|NCT03333837|467927661|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990387|NCT03333837|467927662|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990388|NCT03333837|467927663|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
129990389|NCT03333837|467927664|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990390|NCT03333837|467927665|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990391|NCT04217590|467927666|FG000|Overall Study|Other|1|||
129990392|NCT04217590|467927667|FG001|Overall Study|Other|1|||
129990393|NCT04217590|467927666|FG000|Overall Study|Withdrawal by Subject|3|||
129990394|NCT04217590|467927667|FG001|Overall Study|Withdrawal by Subject|1|||
129990395|NCT04217590|467927666|FG000|Overall Study|Death|0|||
129990396|NCT04217590|467927667|FG001|Overall Study|Death|1|||
130329279|NCT03853109|469175404|FG007|Overall Study|Death|5|||
129990397|NCT02232243|467927668|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
129990398|NCT02232243|467927669|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
129990399|NCT02232243|467927670|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
130329280|NCT01721044|469175409|FG000|Treatment Period|Adverse Event|7|||
130329281|NCT01721044|469175410|FG001|Treatment Period|Adverse Event|7|||
130329282|NCT01721044|469175411|FG002|Treatment Period|Adverse Event|10|||
129990400|NCT00704405|467927671|FG000|Overall Study (NC Population)|Adverse Event|1|||
129990401|NCT00704405|467927672|FG001|Overall Study (NC Population)|Adverse Event|0|||
129990402|NCT00704405|467927673|FG002|Overall Study (NC Population)|Adverse Event|0|||
129990403|NCT00704405|467927674|FG003|Overall Study (NC Population)|Adverse Event|0|||
130329283|NCT01721044|469175409|FG000|Treatment Period|Death|0|||
130329284|NCT01721044|469175410|FG001|Treatment Period|Death|0|||
130329285|NCT01721044|469175411|FG002|Treatment Period|Death|1|||
130329286|NCT01721044|469175409|FG000|Treatment Period|Lack of Efficacy|16|||
129990404|NCT00704405|467927675|FG004|Overall Study (NC Population)|Adverse Event|0|||
129990405|NCT00704405|467927671|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
129990406|NCT00704405|467927672|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
129990407|NCT00704405|467927673|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
129990408|NCT00704405|467927674|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
129990409|NCT00704405|467927675|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
129990410|NCT00704405|467927671|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990411|NCT00704405|467927672|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
129990412|NCT00704405|467927673|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990413|NCT00704405|467927674|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990414|NCT00704405|467927675|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990415|NCT00704405|467927671|FG000|Overall Study (NC Population)|Other|0|||
129990416|NCT00704405|467927672|FG001|Overall Study (NC Population)|Other|0|||
129990417|NCT00704405|467927673|FG002|Overall Study (NC Population)|Other|0|||
129990418|NCT00704405|467927674|FG003|Overall Study (NC Population)|Other|0|||
129990419|NCT00704405|467927675|FG004|Overall Study (NC Population)|Other|1|||
129990420|NCT00704405|467927671|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
129990421|NCT00704405|467927672|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
129990422|NCT00704405|467927673|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
129990423|NCT00704405|467927674|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
129990424|NCT00704405|467927675|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
129990425|NCT00704405|467927671|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
129990426|NCT00704405|467927672|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
129990427|NCT00704405|467927673|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
129990428|NCT00704405|467927674|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
129990429|NCT00704405|467927675|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
129990430|NCT01395888|467927676|FG000|2-week Run-in Period|Adverse Event|2|||
129990431|NCT01395888|467927677|FG001|2-week Run-in Period|Adverse Event|0|||
129990432|NCT01395888|467927678|FG002|2-week Run-in Period|Adverse Event|0|||
129990433|NCT01395888|467927676|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
129990434|NCT01395888|467927677|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
129990435|NCT01395888|467927678|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
129990436|NCT01395888|467927676|FG000|2-week Run-in Period|Lost to Follow-up|1|||
129990437|NCT01395888|467927677|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129990438|NCT01395888|467927678|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129990439|NCT01395888|467927676|FG000|2-week Run-in Period|Protocol Violation|2|||
129990440|NCT01395888|467927677|FG001|2-week Run-in Period|Protocol Violation|0|||
129990441|NCT01395888|467927678|FG002|2-week Run-in Period|Protocol Violation|0|||
129990442|NCT01395888|467927676|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
129990443|NCT01395888|467927677|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129990444|NCT01395888|467927678|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129990445|NCT01395888|467927676|FG000|Treatment Period (TP)|Adverse Event|0|||
129990446|NCT01395888|467927677|FG001|Treatment Period (TP)|Adverse Event|7|||
129990447|NCT01395888|467927678|FG002|Treatment Period (TP)|Adverse Event|6|||
129990448|NCT01395888|467927676|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
129990449|NCT01395888|467927677|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
129990450|NCT01395888|467927678|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
129990451|NCT01395888|467927676|FG000|Treatment Period (TP)|Protocol Violation|0|||
129990452|NCT01395888|467927677|FG001|Treatment Period (TP)|Protocol Violation|1|||
129990453|NCT01395888|467927678|FG002|Treatment Period (TP)|Protocol Violation|5|||
129990454|NCT01395888|467927676|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
129990455|NCT01395888|467927677|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
129990456|NCT01395888|467927678|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
129990457|NCT01395888|467927676|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
129990458|NCT01395888|467927677|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
129990459|NCT01395888|467927678|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
130215854|NCT02688764|468753870|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
130215855|NCT02688764|468753871|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
130215856|NCT02688764|468753870|FG000|Overall Study|AE/Withd. subject|1|||
130215857|NCT02688764|468753871|FG001|Overall Study|AE/Withd. subject|0|||
130215858|NCT02688764|468753870|FG000|Overall Study|Kidney transplant|10|||
130215859|NCT02688764|468753871|FG001|Overall Study|Kidney transplant|4|||
130215860|NCT02688764|468753870|FG000|Overall Study|Lack of Efficacy|3|||
130215861|NCT02688764|468753871|FG001|Overall Study|Lack of Efficacy|2|||
130215862|NCT02688764|468753870|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
130215863|NCT02688764|468753871|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
130215864|NCT02688764|468753870|FG000|Overall Study|Non-compliance with study drug|4|||
130215865|NCT02688764|468753871|FG001|Overall Study|Non-compliance with study drug|0|||
130215866|NCT02688764|468753870|FG000|Overall Study|Non-compl./Physician decision|2|||
130215867|NCT02688764|468753871|FG001|Overall Study|Non-compl./Physician decision|0|||
130215868|NCT02688764|468753870|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
129990460|NCT03218397|467927679|FG000|Overall Study|Prior positive blood culture|8|||
129990461|NCT03218397|467927680|FG001|Overall Study|Prior positive blood culture|13|||
129990462|NCT03218397|467927679|FG000|Overall Study|Comfort care|8|||
129990463|NCT03218397|467927680|FG001|Overall Study|Comfort care|5|||
130329287|NCT01721044|469175410|FG001|Treatment Period|Lack of Efficacy|4|||
130329288|NCT01721044|469175411|FG002|Treatment Period|Lack of Efficacy|4|||
130329289|NCT01721044|469175409|FG000|Treatment Period|Lost to Follow-up|0|||
130329290|NCT01721044|469175410|FG001|Treatment Period|Lost to Follow-up|0|||
130329291|NCT01721044|469175411|FG002|Treatment Period|Lost to Follow-up|1|||
130329292|NCT01721044|469175409|FG000|Treatment Period|Physician Decision|1|||
130329293|NCT01721044|469175410|FG001|Treatment Period|Physician Decision|0|||
130329294|NCT01721044|469175411|FG002|Treatment Period|Physician Decision|2|||
130329295|NCT01721044|469175409|FG000|Treatment Period|Protocol Violation|1|||
130329296|NCT01721044|469175410|FG001|Treatment Period|Protocol Violation|0|||
130329297|NCT01721044|469175411|FG002|Treatment Period|Protocol Violation|0|||
129990464|NCT03218397|467927679|FG000|Overall Study|Comfort care and positive blood culture|1|||
129990465|NCT03218397|467927680|FG001|Overall Study|Comfort care and positive blood culture|0|||
129990466|NCT03218397|467927679|FG000|Overall Study|Comfort care and mixed culture|0|||
129990467|NCT03218397|467927680|FG001|Overall Study|Comfort care and mixed culture|1|||
129990468|NCT03218397|467927679|FG000|Overall Study|Mixed culture|2|||
129990469|NCT03218397|467927680|FG001|Overall Study|Mixed culture|2|||
129990470|NCT03218397|467927679|FG000|Overall Study|Inaccessible hospital records|2|||
129990471|NCT03218397|467927680|FG001|Overall Study|Inaccessible hospital records|5|||
129990472|NCT03218397|467927679|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
129990473|NCT03218397|467927680|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
129990474|NCT03218397|467927679|FG000|Overall Study|Randomized during laboratory off hours|2|||
129990475|NCT03218397|467927680|FG001|Overall Study|Randomized during laboratory off hours|1|||
129990476|NCT01946438|467927681|FG000|Overall Study|Adverse Event|0|||
129990477|NCT01946438|467927682|FG001|Overall Study|Adverse Event|0|||
129990478|NCT01946438|467927683|FG002|Overall Study|Adverse Event|0|||
129990479|NCT01946438|467927684|FG003|Overall Study|Adverse Event|1|||
129990480|NCT01946438|467927681|FG000|Overall Study|Serious Adverse event|1|||
129990481|NCT01946438|467927682|FG001|Overall Study|Serious Adverse event|0|||
129990482|NCT01946438|467927683|FG002|Overall Study|Serious Adverse event|0|||
130329298|NCT01721044|469175409|FG000|Treatment Period|Withdrawal by Subject|7|||
130329299|NCT01721044|469175410|FG001|Treatment Period|Withdrawal by Subject|6|||
130329300|NCT01721044|469175411|FG002|Treatment Period|Withdrawal by Subject|1|||
130329301|NCT04032093|469175414|FG000|Overall Study|Lost to Follow-up|7|||
130329302|NCT04032093|469175415|FG001|Overall Study|Lost to Follow-up|7|||
130329303|NCT04032093|469175416|FG002|Overall Study|Lost to Follow-up|6|||
130329304|NCT04032093|469175417|FG003|Overall Study|Lost to Follow-up|10|||
130329305|NCT04032093|469175418|FG004|Overall Study|Lost to Follow-up|13|||
130329306|NCT04032093|469175419|FG005|Overall Study|Lost to Follow-up|7|||
130329307|NCT04032093|469175420|FG006|Overall Study|Lost to Follow-up|7|||
130329308|NCT04032093|469175421|FG007|Overall Study|Lost to Follow-up|5|||
130329309|NCT04032093|469175422|FG008|Overall Study|Lost to Follow-up|9|||
130329310|NCT04032093|469175423|FG009|Overall Study|Lost to Follow-up|12|||
130329311|NCT04032093|469175414|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329312|NCT04032093|469175415|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329313|NCT04032093|469175416|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329314|NCT04032093|469175417|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
130329315|NCT04032093|469175418|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
130329316|NCT04032093|469175419|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329317|NCT04032093|469175420|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329318|NCT04032093|469175421|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130329319|NCT04032093|469175422|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
130329320|NCT04032093|469175423|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
130329321|NCT04032093|469175414|FG000|Overall Study|Other|1|||
130329322|NCT04032093|469175415|FG001|Overall Study|Other|0|||
130329323|NCT04032093|469175416|FG002|Overall Study|Other|0|||
130329324|NCT04032093|469175417|FG003|Overall Study|Other|1|||
130329325|NCT04032093|469175418|FG004|Overall Study|Other|1|||
130329326|NCT04032093|469175419|FG005|Overall Study|Other|0|||
130329327|NCT04032093|469175420|FG006|Overall Study|Other|0|||
130329328|NCT04032093|469175421|FG007|Overall Study|Other|0|||
130329329|NCT04032093|469175422|FG008|Overall Study|Other|0|||
130329330|NCT04032093|469175423|FG009|Overall Study|Other|1|||
130329331|NCT04032093|469175414|FG000|Overall Study|Withdrawal by Subject|1|||
130329332|NCT04032093|469175415|FG001|Overall Study|Withdrawal by Subject|3|||
130329333|NCT04032093|469175416|FG002|Overall Study|Withdrawal by Subject|2|||
130329334|NCT04032093|469175417|FG003|Overall Study|Withdrawal by Subject|2|||
130329335|NCT04032093|469175418|FG004|Overall Study|Withdrawal by Subject|3|||
129990483|NCT01946438|467927684|FG003|Overall Study|Serious Adverse event|0|||
129990484|NCT01946438|467927681|FG000|Overall Study|Protocol Violation|0|||
129990485|NCT01946438|467927682|FG001|Overall Study|Protocol Violation|0|||
129990486|NCT01946438|467927683|FG002|Overall Study|Protocol Violation|1|||
129990487|NCT01946438|467927684|FG003|Overall Study|Protocol Violation|0|||
129990488|NCT01946438|467927681|FG000|Overall Study|Withdrawal by Subject|1|||
129990489|NCT01946438|467927682|FG001|Overall Study|Withdrawal by Subject|0|||
129990490|NCT01946438|467927683|FG002|Overall Study|Withdrawal by Subject|0|||
129990491|NCT01946438|467927684|FG003|Overall Study|Withdrawal by Subject|0|||
129990492|NCT03169101|467927685|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
129990493|NCT03169101|467927686|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
129990494|NCT03169101|467927687|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
129990495|NCT03169101|467927688|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
129990496|NCT02641496|467927689|FG000|Overall Study|Lost to Follow-up|13|||
129990497|NCT02641496|467927690|FG001|Overall Study|Lost to Follow-up|12|||
129990498|NCT02641496|467927689|FG000|Overall Study|Withdrawal by Subject|1|||
129990499|NCT02641496|467927690|FG001|Overall Study|Withdrawal by Subject|0|||
129990500|NCT02523599|467927691|FG000|Overall Study|Adverse Event|1|||
129990501|NCT02523599|467927692|FG001|Overall Study|Adverse Event|0|||
129990502|NCT02523599|467927691|FG000|Overall Study|Physician Decision|1|||
129990503|NCT02523599|467927692|FG001|Overall Study|Physician Decision|0|||
129990504|NCT02523599|467927691|FG000|Overall Study|Lost to Follow-up|4|||
129990505|NCT02523599|467927692|FG001|Overall Study|Lost to Follow-up|1|||
129990506|NCT02523599|467927691|FG000|Overall Study|Did not return for Day 30 visit|2|||
129990507|NCT02523599|467927692|FG001|Overall Study|Did not return for Day 30 visit|0|||
129990508|NCT00346268|467929749|FG000|Overall Study|Adverse Event|1|||
129990509|NCT00346268|467929750|FG001|Overall Study|Adverse Event|0|||
129990510|NCT00346268|467929749|FG000|Overall Study|Protocol Violation|1|||
129990511|NCT00346268|467929750|FG001|Overall Study|Protocol Violation|0|||
129990512|NCT00346268|467929749|FG000|Overall Study|Participant refused|0|||
129990513|NCT00346268|467929750|FG001|Overall Study|Participant refused|3|||
129990514|NCT01036763|467929751|FG000|Overall Study|Adverse Event|25|||
129990515|NCT01036763|467929751|FG000|Overall Study|Lost to Follow-up|28|||
129990516|NCT01036763|467929751|FG000|Overall Study|Other reason (not specified)|40|||
129990517|NCT00743275|467929752|FG000|Overall Study|Protocol Violation|0|||
129990518|NCT00743275|467929753|FG001|Overall Study|Protocol Violation|1|||
129990519|NCT01672723|467929754|FG000|First Intervention|Adverse Event|3|||
129990520|NCT01672723|467929755|FG001|First Intervention|Adverse Event|0|||
129990521|NCT02502097|467929765|FG000|Period 1|Adverse Event|0|||
129990522|NCT02502097|467929766|FG001|Period 1|Adverse Event|0|||
129990523|NCT02502097|467929767|FG002|Period 1|Adverse Event|1|||
130329336|NCT04032093|469175419|FG005|Overall Study|Withdrawal by Subject|0|||
130329337|NCT04032093|469175420|FG006|Overall Study|Withdrawal by Subject|0|||
130329338|NCT04032093|469175421|FG007|Overall Study|Withdrawal by Subject|0|||
130329339|NCT04032093|469175422|FG008|Overall Study|Withdrawal by Subject|0|||
130329340|NCT04032093|469175423|FG009|Overall Study|Withdrawal by Subject|0|||
130329341|NCT04032093|469175414|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130329342|NCT04032093|469175415|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130329343|NCT04032093|469175416|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130329344|NCT04032093|469175417|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130329345|NCT04032093|469175418|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130329346|NCT04032093|469175419|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130329347|NCT04032093|469175420|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
130329348|NCT04032093|469175421|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
130329349|NCT04032093|469175422|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
130329350|NCT04032093|469175423|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
130329351|NCT04032093|469175414|FG000|Overall Study|Adverse Event|0|||
130329352|NCT04032093|469175415|FG001|Overall Study|Adverse Event|0|||
130329353|NCT04032093|469175416|FG002|Overall Study|Adverse Event|0|||
130329354|NCT04032093|469175417|FG003|Overall Study|Adverse Event|0|||
130329355|NCT04032093|469175418|FG004|Overall Study|Adverse Event|0|||
130329356|NCT04032093|469175419|FG005|Overall Study|Adverse Event|0|||
130329357|NCT04032093|469175420|FG006|Overall Study|Adverse Event|0|||
130329358|NCT04032093|469175421|FG007|Overall Study|Adverse Event|0|||
129990524|NCT02502097|467929768|FG003|Period 1|Adverse Event|0|||
130329359|NCT04032093|469175422|FG008|Overall Study|Adverse Event|0|||
130329360|NCT04032093|469175423|FG009|Overall Study|Adverse Event|1|||
129990525|NCT02502097|467929765|FG000|Wash Out Period|Adverse Event|0|||
129990526|NCT02502097|467929766|FG001|Wash Out Period|Adverse Event|1|||
129990527|NCT02502097|467929767|FG002|Wash Out Period|Adverse Event|1|||
129990528|NCT02502097|467929768|FG003|Wash Out Period|Adverse Event|1|||
129990529|NCT02502097|467929765|FG000|Period 2|Adverse Event|0|||
130329361|NCT04032093|469175414|FG000|Overall Study|Physician Decision|0|||
130329362|NCT04032093|469175415|FG001|Overall Study|Physician Decision|0|||
129990530|NCT02502097|467929766|FG001|Period 2|Adverse Event|0|||
129990531|NCT02502097|467929767|FG002|Period 2|Adverse Event|1|||
129990532|NCT02502097|467929768|FG003|Period 2|Adverse Event|0|||
129990533|NCT02186223|467929769|FG000|Overall Study|Not eligible for device placement|6|||
129990534|NCT02186223|467929769|FG000|Overall Study|Unable to obtain femoral access|3|||
130329363|NCT04032093|469175416|FG002|Overall Study|Physician Decision|0|||
129990535|NCT02186223|467929769|FG000|Overall Study|Death|3|||
129990536|NCT02186223|467929769|FG000|Overall Study|Device in place less than 48 hours|9|||
130329364|NCT04032093|469175417|FG003|Overall Study|Physician Decision|0|||
130329365|NCT04032093|469175418|FG004|Overall Study|Physician Decision|0|||
130329366|NCT04032093|469175419|FG005|Overall Study|Physician Decision|1|||
130329367|NCT04032093|469175420|FG006|Overall Study|Physician Decision|0|||
130329368|NCT04032093|469175421|FG007|Overall Study|Physician Decision|0|||
130329369|NCT04032093|469175422|FG008|Overall Study|Physician Decision|0|||
130329370|NCT04032093|469175423|FG009|Overall Study|Physician Decision|0|||
129990537|NCT01201317|467929770|FG000|Overall Study|Withdrawal by Subject|5|||
129990538|NCT01201317|467929771|FG001|Overall Study|Withdrawal by Subject|0|||
129990539|NCT01201317|467929772|FG002|Overall Study|Withdrawal by Subject|3|||
129990540|NCT01201317|467929770|FG000|Overall Study|Adverse Event|2|||
129990541|NCT01201317|467929771|FG001|Overall Study|Adverse Event|2|||
129990542|NCT01201317|467929772|FG002|Overall Study|Adverse Event|2|||
129990543|NCT01201317|467929770|FG000|Overall Study|Screen failure|1|||
129990544|NCT01201317|467929771|FG001|Overall Study|Screen failure|1|||
129990545|NCT01201317|467929772|FG002|Overall Study|Screen failure|0|||
129990546|NCT01201317|467929770|FG000|Overall Study|Protocol Violation|0|||
129990547|NCT01201317|467929771|FG001|Overall Study|Protocol Violation|1|||
129990548|NCT01201317|467929772|FG002|Overall Study|Protocol Violation|1|||
129990549|NCT01201317|467929770|FG000|Overall Study|Death|0|||
129990550|NCT01201317|467929771|FG001|Overall Study|Death|1|||
129990551|NCT01201317|467929772|FG002|Overall Study|Death|0|||
129990552|NCT01201317|467929770|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129990553|NCT01201317|467929771|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129990554|NCT01201317|467929772|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129990555|NCT01201317|467929770|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
129990556|NCT01201317|467929771|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
129990557|NCT01201317|467929772|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
129990558|NCT01201317|467929770|FG000|Overall Study|Decrease in renal function|0|||
129990559|NCT01201317|467929771|FG001|Overall Study|Decrease in renal function|1|||
129990560|NCT01201317|467929772|FG002|Overall Study|Decrease in renal function|0|||
129990561|NCT01201317|467929770|FG000|Overall Study|Lack of Efficacy|1|||
129990562|NCT01201317|467929771|FG001|Overall Study|Lack of Efficacy|0|||
129990563|NCT01201317|467929772|FG002|Overall Study|Lack of Efficacy|0|||
129990564|NCT01201317|467929770|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
129990565|NCT01201317|467929771|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
129990566|NCT01201317|467929772|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
129990567|NCT00252733|467929773|FG000|Overall Study|Withdrawal by Subject|73|||
129990568|NCT00252733|467929774|FG001|Overall Study|Withdrawal by Subject|67|||
129990569|NCT00252733|467929773|FG000|Overall Study|Death|7|||
129990570|NCT00252733|467929774|FG001|Overall Study|Death|5|||
129990571|NCT00252733|467929773|FG000|Overall Study|Lost to Follow-up|12|||
129990572|NCT00252733|467929774|FG001|Overall Study|Lost to Follow-up|6|||
129990573|NCT00252733|467929773|FG000|Overall Study|Multiple Reasons|14|||
129990574|NCT00252733|467929774|FG001|Overall Study|Multiple Reasons|14|||
129990575|NCT01491672|467929775|FG000|Overall Study|Lost to Follow-up|0|||
129990576|NCT01491672|467929776|FG001|Overall Study|Lost to Follow-up|4|||
129990577|NCT01491672|467929777|FG002|Overall Study|Lost to Follow-up|1|||
129990578|NCT01491672|467929775|FG000|Overall Study|Withdrawal by Subject|6|||
129990579|NCT01491672|467929776|FG001|Overall Study|Withdrawal by Subject|7|||
129990580|NCT01491672|467929777|FG002|Overall Study|Withdrawal by Subject|0|||
129990581|NCT01491672|467929775|FG000|Overall Study|Adverse Event|8|||
129990582|NCT01491672|467929776|FG001|Overall Study|Adverse Event|10|||
129990583|NCT01491672|467929777|FG002|Overall Study|Adverse Event|4|||
129990584|NCT01491672|467929775|FG000|Overall Study|Disease progression|42|||
129990585|NCT01491672|467929776|FG001|Overall Study|Disease progression|34|||
129990586|NCT01491672|467929777|FG002|Overall Study|Disease progression|6|||
129990587|NCT01491672|467929775|FG000|Overall Study|Protocol deviation|0|||
129990588|NCT01491672|467929776|FG001|Overall Study|Protocol deviation|1|||
129990589|NCT01491672|467929777|FG002|Overall Study|Protocol deviation|0|||
129990590|NCT01491672|467929775|FG000|Overall Study|Death|0|||
130329371|NCT01654302|469175430|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
130329372|NCT01654302|469175431|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
130329373|NCT03133793|469175435|FG000|Overall Study|Withdrawal by Subject|0|||
129990591|NCT01491672|467929776|FG001|Overall Study|Death|4|||
129990592|NCT01491672|467929777|FG002|Overall Study|Death|0|||
130329374|NCT03133793|469175436|FG001|Overall Study|Withdrawal by Subject|4|||
129990593|NCT03310268|467929781|FG000|Overall Study|(Not specified)|1|||
129990594|NCT03310268|467929782|FG001|Overall Study|(Not specified)|5|||
129990595|NCT03310268|467929783|FG002|Overall Study|(Not specified)|0|||
130329375|NCT03133793|469175437|FG002|Overall Study|Withdrawal by Subject|2|||
130329376|NCT03133793|469175438|FG003|Overall Study|Withdrawal by Subject|4|||
129990596|NCT00706433|467929786|FG000|Overall Study|Lost to Follow-up|3|||
130329377|NCT03133793|469175435|FG000|Overall Study|Lost to Follow-up|1|||
130329378|NCT03133793|469175436|FG001|Overall Study|Lost to Follow-up|0|||
129990597|NCT00706433|467929787|FG001|Overall Study|Lost to Follow-up|1|||
129990598|NCT00706433|467929788|FG002|Overall Study|Lost to Follow-up|6|||
129990599|NCT00706433|467929789|FG003|Overall Study|Lost to Follow-up|0|||
130329379|NCT03133793|469175437|FG002|Overall Study|Lost to Follow-up|2|||
130329380|NCT03133793|469175438|FG003|Overall Study|Lost to Follow-up|0|||
130329381|NCT03133793|469175435|FG000|Overall Study|Death|0|||
130329382|NCT03133793|469175436|FG001|Overall Study|Death|0|||
130329383|NCT03133793|469175437|FG002|Overall Study|Death|0|||
130329384|NCT03133793|469175438|FG003|Overall Study|Death|1|||
130329385|NCT02839200|469175439|FG000|Overall Study|Withdrawal by Subject|2|||
130329386|NCT02839200|469175440|FG001|Overall Study|Withdrawal by Subject|0|||
130329387|NCT02839200|469175441|FG002|Overall Study|Withdrawal by Subject|1|||
130329388|NCT02839200|469175442|FG003|Overall Study|Withdrawal by Subject|0|||
130329389|NCT02839200|469175443|FG004|Overall Study|Withdrawal by Subject|0|||
130329390|NCT02839200|469175444|FG005|Overall Study|Withdrawal by Subject|1|||
130329391|NCT02839200|469175439|FG000|Overall Study|Lost to Follow-up|2|||
130329392|NCT02839200|469175440|FG001|Overall Study|Lost to Follow-up|0|||
130329393|NCT02839200|469175441|FG002|Overall Study|Lost to Follow-up|0|||
130329394|NCT02839200|469175442|FG003|Overall Study|Lost to Follow-up|0|||
130329395|NCT02839200|469175443|FG004|Overall Study|Lost to Follow-up|1|||
130329396|NCT02839200|469175444|FG005|Overall Study|Lost to Follow-up|0|||
130329397|NCT02839200|469175439|FG000|Overall Study|Adverse Event|0|||
130329398|NCT02839200|469175440|FG001|Overall Study|Adverse Event|0|||
130329399|NCT02839200|469175441|FG002|Overall Study|Adverse Event|0|||
130329400|NCT02839200|469175442|FG003|Overall Study|Adverse Event|0|||
130329401|NCT02839200|469175443|FG004|Overall Study|Adverse Event|1|||
130329402|NCT02839200|469175444|FG005|Overall Study|Adverse Event|0|||
130329403|NCT02839200|469175439|FG000|Overall Study|Randomized in error|0|||
130329404|NCT02839200|469175440|FG001|Overall Study|Randomized in error|1|||
130329405|NCT02839200|469175441|FG002|Overall Study|Randomized in error|0|||
130329406|NCT02839200|469175442|FG003|Overall Study|Randomized in error|0|||
129990600|NCT00706433|467929786|FG000|Overall Study|Withdrawal by Subject|1|||
129990601|NCT00706433|467929787|FG001|Overall Study|Withdrawal by Subject|2|||
129990602|NCT00706433|467929788|FG002|Overall Study|Withdrawal by Subject|3|||
129990603|NCT00706433|467929789|FG003|Overall Study|Withdrawal by Subject|1|||
129990604|NCT00706433|467929786|FG000|Overall Study|Adverse Event|0|||
129990605|NCT00706433|467929787|FG001|Overall Study|Adverse Event|0|||
129990606|NCT00706433|467929788|FG002|Overall Study|Adverse Event|1|||
129990607|NCT00706433|467929789|FG003|Overall Study|Adverse Event|0|||
129990608|NCT00706433|467929786|FG000|Overall Study|Protocol Violation|1|||
129990609|NCT00706433|467929787|FG001|Overall Study|Protocol Violation|0|||
129990610|NCT00706433|467929788|FG002|Overall Study|Protocol Violation|0|||
129990611|NCT00706433|467929789|FG003|Overall Study|Protocol Violation|0|||
129990612|NCT00706433|467929786|FG000|Overall Study|new job|0|||
129990613|NCT00706433|467929787|FG001|Overall Study|new job|0|||
129990614|NCT00706433|467929788|FG002|Overall Study|new job|0|||
129990615|NCT00706433|467929789|FG003|Overall Study|new job|1|||
129990616|NCT01236365|467929790|FG000|Overall Study|Lost to Follow-up|0|||
129990617|NCT01236365|467929791|FG001|Overall Study|Lost to Follow-up|2|||
129990618|NCT01236365|467929790|FG000|Overall Study|Moved Out of State|1|||
129990619|NCT01236365|467929791|FG001|Overall Study|Moved Out of State|0|||
129990620|NCT01236365|467929790|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
129990621|NCT01236365|467929791|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
129990622|NCT00717067|467929792|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990623|NCT00717067|467929793|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990624|NCT00717067|467929794|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
129990625|NCT00717067|467929795|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990626|NCT00717067|467929796|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990627|NCT02808143|467929797|FG000|Maintenance Phase|Disease recurrence|1|||
129990628|NCT02808143|467929798|FG001|Maintenance Phase|Disease recurrence|3|||
130098718|NCT03426995|468319302|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098719|NCT03426995|468319303|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098720|NCT03426995|468319304|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098721|NCT03426995|468319305|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130329407|NCT02839200|469175443|FG004|Overall Study|Randomized in error|0|||
130329408|NCT02839200|469175444|FG005|Overall Study|Randomized in error|0|||
130329409|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
130098722|NCT03426995|468319306|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098723|NCT03426995|468319307|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098724|NCT03426995|468319308|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098725|NCT03426995|468319309|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130329410|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
130329411|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
129990629|NCT02808143|467929797|FG000|Maintenance Phase|Disease progression|1|||
130329412|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
130329413|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
129990630|NCT02808143|467929798|FG001|Maintenance Phase|Disease progression|2|||
130329414|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
130329415|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
130329416|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
130329417|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
130329418|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
130329419|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
130329420|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
130329421|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
130329422|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
130329423|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
130329424|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
130329425|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
130329426|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
130329427|NCT02952820|469175445|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130329428|NCT02952820|469175446|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130329429|NCT02952820|469175447|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
130329430|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
130329431|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
130329432|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
130329433|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
130329434|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
130329435|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
130329436|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
130329437|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
130329438|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
130329439|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
130329440|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
130329441|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
130329442|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
130329443|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
130329444|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
130329445|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
130329446|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
130329447|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
130329448|NCT02952820|469175445|FG000|Active Treatment Period (6 Months)|Not treated|0|||
130329449|NCT02952820|469175446|FG001|Active Treatment Period (6 Months)|Not treated|0|||
130329450|NCT02952820|469175447|FG002|Active Treatment Period (6 Months)|Not treated|1|||
130329451|NCT04139018|469175448|FG000|Overall Study|Screen fail|1|||
130329452|NCT04139018|469175449|FG001|Overall Study|Screen fail|0|||
130329453|NCT04139018|469175448|FG000|Overall Study|Withdrawal by Subject|2|||
130329454|NCT04139018|469175449|FG001|Overall Study|Withdrawal by Subject|0|||
130329455|NCT04139018|469175448|FG000|Overall Study|Lost to Follow-up|0|||
130329456|NCT04139018|469175449|FG001|Overall Study|Lost to Follow-up|1|||
130329457|NCT03486834|469175451|FG000|Overall Study|Withdrawal by Subject|46|||
130329458|NCT03486834|469175452|FG001|Overall Study|Withdrawal by Subject|46|||
130329459|NCT03486834|469175453|FG002|Overall Study|Withdrawal by Subject|52|||
130329460|NCT03486834|469175451|FG000|Overall Study|Adverse Event|8|||
130329461|NCT03486834|469175452|FG001|Overall Study|Adverse Event|7|||
130329462|NCT03486834|469175453|FG002|Overall Study|Adverse Event|0|||
130329463|NCT03486834|469175451|FG000|Overall Study|Lost to Follow-up|41|||
130329464|NCT03486834|469175452|FG001|Overall Study|Lost to Follow-up|24|||
130329465|NCT03486834|469175453|FG002|Overall Study|Lost to Follow-up|39|||
130329466|NCT03486834|469175451|FG000|Overall Study|Non-compliance with Study Drug|2|||
130329467|NCT03486834|469175452|FG001|Overall Study|Non-compliance with Study Drug|2|||
130329468|NCT03486834|469175453|FG002|Overall Study|Non-compliance with Study Drug|0|||
130329469|NCT03486834|469175451|FG000|Overall Study|Physician Decision|5|||
130329470|NCT03486834|469175452|FG001|Overall Study|Physician Decision|2|||
130329471|NCT03486834|469175453|FG002|Overall Study|Physician Decision|3|||
130329472|NCT03486834|469175451|FG000|Overall Study|Pregnancy|10|||
130329473|NCT03486834|469175452|FG001|Overall Study|Pregnancy|12|||
130329474|NCT03486834|469175453|FG002|Overall Study|Pregnancy|12|||
130329475|NCT03486834|469175451|FG000|Overall Study|Protocol Deviation|2|||
130329476|NCT03486834|469175452|FG001|Overall Study|Protocol Deviation|3|||
130329477|NCT03486834|469175453|FG002|Overall Study|Protocol Deviation|3|||
130329478|NCT03486834|469175451|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130329479|NCT03486834|469175452|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130329480|NCT03486834|469175453|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130329481|NCT03486834|469175451|FG000|Overall Study|Randomized but not treated|4|||
130329482|NCT03486834|469175452|FG001|Overall Study|Randomized but not treated|4|||
130329483|NCT03486834|469175453|FG002|Overall Study|Randomized but not treated|1|||
130329484|NCT04476797|469175454|FG000|Overall Study|Withdrawal by Subject|1|||
130329485|NCT04476797|469175455|FG001|Overall Study|Withdrawal by Subject|0|||
129990631|NCT02808143|467929797|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
129990632|NCT02808143|467929798|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
129990633|NCT02808143|467929797|FG000|Survival Follow-Up|Disease recurrence|0|||
129990634|NCT02808143|467929798|FG001|Survival Follow-Up|Disease recurrence|2|||
129990635|NCT02808143|467929797|FG000|Survival Follow-Up|Adverse Event|0|||
129990636|NCT02808143|467929798|FG001|Survival Follow-Up|Adverse Event|1|||
129990637|NCT02808143|467929797|FG000|Survival Follow-Up|Death|1|||
129990638|NCT02808143|467929798|FG001|Survival Follow-Up|Death|0|||
129990639|NCT04964388|467929799|FG000|Overall Study|Lost to Follow-up|3|||
129990640|NCT04964388|467929800|FG001|Overall Study|Lost to Follow-up|2|||
129990641|NCT01689337|467929801|FG000|Overall Study|Study Discontinuation|1|||
129990642|NCT02208999|467929807|FG000|Overall Study|Lost to Follow-up|1|||
129990643|NCT00319839|467929808|FG000|Overall Study|Adverse Event|5|||
129990644|NCT00319839|467929808|FG000|Overall Study|Withdrawal by Subject|1|||
129990645|NCT01577745|467929809|FG000|Overall Study|Withdrawal by Subject|0|||
129990646|NCT01577745|467929810|FG001|Overall Study|Withdrawal by Subject|1|||
129990647|NCT01577745|467929811|FG002|Overall Study|Withdrawal by Subject|0|||
129990648|NCT01577745|467929812|FG003|Overall Study|Withdrawal by Subject|3|||
129990649|NCT01577745|467929813|FG004|Overall Study|Withdrawal by Subject|2|||
129990650|NCT01577745|467929814|FG005|Overall Study|Withdrawal by Subject|0|||
129990651|NCT01577745|467929809|FG000|Overall Study|Death|3|||
129990652|NCT01577745|467929810|FG001|Overall Study|Death|2|||
129990653|NCT01577745|467929811|FG002|Overall Study|Death|2|||
129990654|NCT01577745|467929812|FG003|Overall Study|Death|1|||
129990655|NCT01577745|467929813|FG004|Overall Study|Death|1|||
129990656|NCT01577745|467929814|FG005|Overall Study|Death|3|||
129990657|NCT01577745|467929809|FG000|Overall Study|Physician Decision|0|||
129990658|NCT01577745|467929810|FG001|Overall Study|Physician Decision|0|||
129990659|NCT01577745|467929811|FG002|Overall Study|Physician Decision|0|||
129990660|NCT01577745|467929812|FG003|Overall Study|Physician Decision|1|||
129990661|NCT01577745|467929813|FG004|Overall Study|Physician Decision|1|||
129990662|NCT01577745|467929814|FG005|Overall Study|Physician Decision|0|||
129990663|NCT01577745|467929809|FG000|Overall Study|Lost to Follow-up|0|||
129990664|NCT01577745|467929810|FG001|Overall Study|Lost to Follow-up|0|||
129990665|NCT01577745|467929811|FG002|Overall Study|Lost to Follow-up|0|||
129990666|NCT01577745|467929812|FG003|Overall Study|Lost to Follow-up|0|||
129990667|NCT01577745|467929813|FG004|Overall Study|Lost to Follow-up|0|||
129990668|NCT01577745|467929814|FG005|Overall Study|Lost to Follow-up|1|||
129990669|NCT01577745|467929809|FG000|Overall Study|Alternative Therapy|0|||
129990670|NCT01577745|467929810|FG001|Overall Study|Alternative Therapy|0|||
129990671|NCT01577745|467929811|FG002|Overall Study|Alternative Therapy|0|||
129990672|NCT01577745|467929812|FG003|Overall Study|Alternative Therapy|1|||
129990673|NCT01577745|467929813|FG004|Overall Study|Alternative Therapy|1|||
129990674|NCT01577745|467929814|FG005|Overall Study|Alternative Therapy|0|||
129990675|NCT02483585|467929815|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
129990676|NCT02483585|467929816|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
129990677|NCT02483585|467929815|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
129990678|NCT02483585|467929816|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
129990679|NCT02483585|467929815|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
129990680|NCT02483585|467929816|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
129990681|NCT02483585|467929815|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
129990682|NCT02483585|467929816|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
129990683|NCT02483585|467929815|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
129990684|NCT02483585|467929816|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
129990685|NCT02483585|467929815|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
129990686|NCT02483585|467929816|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
129990687|NCT02483585|467929815|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
129990688|NCT02483585|467929816|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
129990689|NCT00825916|467929818|FG000|Overall Study|Lost to Follow-up|4|||
129990690|NCT00825916|467929819|FG001|Overall Study|Lost to Follow-up|2|||
129990691|NCT00825916|467929820|FG002|Overall Study|Lost to Follow-up|1|||
129990692|NCT01324440|467929824|FG000|Overall Study|Subject moved|0|||
129990693|NCT01324440|467929825|FG001|Overall Study|Subject moved|1|||
129990694|NCT00903630|467929826|FG000|Phase 2|Adverse Event|0|||
129990695|NCT00903630|467929827|FG001|Phase 2|Adverse Event|0|||
129990696|NCT00903630|467929828|FG002|Phase 2|Adverse Event|1|||
129990697|NCT01136772|467929831|FG000|Overall Study|Adverse Event|15|||
129990698|NCT01136772|467929832|FG001|Overall Study|Adverse Event|14|||
129990699|NCT01136772|467929831|FG000|Overall Study|Lack of Efficacy|42|||
129990700|NCT01136772|467929832|FG001|Overall Study|Lack of Efficacy|39|||
129990701|NCT01136772|467929831|FG000|Overall Study|Administrative|14|||
129990702|NCT01136772|467929832|FG001|Overall Study|Administrative|12|||
129990703|NCT01136772|467929831|FG000|Overall Study|Withdrawal by Subject|33|||
129990704|NCT01136772|467929832|FG001|Overall Study|Withdrawal by Subject|36|||
129990705|NCT01136772|467929831|FG000|Overall Study|Did not receive injection|10|||
129990706|NCT01136772|467929832|FG001|Overall Study|Did not receive injection|7|||
129990707|NCT01136772|467929831|FG000|Overall Study|Did not follow up after first injection|2|||
129990708|NCT01136772|467929832|FG001|Overall Study|Did not follow up after first injection|2|||
129990709|NCT01602562|467929833|FG000|Overall Study|Adverse Event|3|||
129990710|NCT01602562|467929834|FG001|Overall Study|Adverse Event|1|||
130329486|NCT04476797|469175456|FG002|Overall Study|Withdrawal by Subject|0|||
130329487|NCT04476797|469175454|FG000|Overall Study|Death|0|||
130329488|NCT04476797|469175455|FG001|Overall Study|Death|1|||
129990711|NCT01602562|467929833|FG000|Overall Study|Physician Decision|1|||
129990712|NCT01602562|467929834|FG001|Overall Study|Physician Decision|1|||
130329489|NCT04476797|469175456|FG002|Overall Study|Death|2|||
130329490|NCT04476797|469175454|FG000|Overall Study|Sponsor Terminated Study|0|||
130329491|NCT04476797|469175455|FG001|Overall Study|Sponsor Terminated Study|18|||
130329492|NCT04476797|469175456|FG002|Overall Study|Sponsor Terminated Study|17|||
130329493|NCT03614156|469175473|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
130329494|NCT03614156|469175474|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130329495|NCT03614156|469175475|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130329496|NCT03614156|469175476|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
130329497|NCT03614156|469175473|FG000|Open-Label Treatment Period|Adverse Event|7|||
130329498|NCT03614156|469175474|FG001|Open-Label Treatment Period|Adverse Event|0|||
130329499|NCT03614156|469175475|FG002|Open-Label Treatment Period|Adverse Event|0|||
130329500|NCT03614156|469175476|FG003|Open-Label Treatment Period|Adverse Event|0|||
130329501|NCT03614156|469175473|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
130329502|NCT03614156|469175474|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130329503|NCT03614156|469175475|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130329504|NCT03614156|469175476|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
130329505|NCT03614156|469175473|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
130329506|NCT03614156|469175474|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130329507|NCT03614156|469175475|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
130329508|NCT03614156|469175476|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
130329509|NCT03614156|469175473|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
130329510|NCT03614156|469175474|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
130329511|NCT03614156|469175475|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
130329512|NCT03614156|469175476|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
130329513|NCT03614156|469175473|FG000|Open-Label Treatment Period|Protocol Violation|2|||
130329514|NCT03614156|469175474|FG001|Open-Label Treatment Period|Protocol Violation|0|||
130329515|NCT03614156|469175475|FG002|Open-Label Treatment Period|Protocol Violation|0|||
130329516|NCT03614156|469175476|FG003|Open-Label Treatment Period|Protocol Violation|0|||
130329517|NCT03614156|469175473|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
130329518|NCT03614156|469175474|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
130329519|NCT03614156|469175475|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
130329520|NCT03614156|469175476|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
130329521|NCT03614156|469175473|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
130329522|NCT03614156|469175474|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
130329523|NCT03614156|469175475|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
130329524|NCT03614156|469175476|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
130329525|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
130329526|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
130329527|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
130329528|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
130329529|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130329530|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
130329531|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130329532|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130329533|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130329534|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
130329535|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
130329536|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
130329537|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
130329538|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130329539|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130329540|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
130329541|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
130329542|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
129990713|NCT01602562|467929833|FG000|Overall Study|Withdrawal by Subject|1|||
130329543|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
130329544|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
129990714|NCT01602562|467929834|FG001|Overall Study|Withdrawal by Subject|1|||
129990715|NCT01959516|467929835|FG000|Epoch 1|Adverse Event|4|||
129990716|NCT01959516|467929836|FG001|Epoch 1|Adverse Event|1|||
129990717|NCT01959516|467929835|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
130329545|NCT03614156|469175473|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129990718|NCT01959516|467929836|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
129990719|NCT01959516|467929835|FG000|Epoch 1|Subject withdrew consent|3|||
129990720|NCT01959516|467929836|FG001|Epoch 1|Subject withdrew consent|2|||
129990721|NCT01959516|467929835|FG000|Epoch 1|Administrative problems|1|||
129990722|NCT01959516|467929836|FG001|Epoch 1|Administrative problems|0|||
129990723|NCT01959516|467929835|FG000|Epoch 1|Use of prohibited treatment|1|||
129990724|NCT01959516|467929836|FG001|Epoch 1|Use of prohibited treatment|0|||
129990725|NCT01959516|467929835|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
129990726|NCT01959516|467929836|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
130329546|NCT03614156|469175474|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
130329547|NCT03614156|469175475|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130329548|NCT03614156|469175476|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
130329549|NCT03614156|469175473|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
130329550|NCT03614156|469175474|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130329551|NCT03614156|469175475|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130329552|NCT03614156|469175476|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
130329553|NCT03614156|469175473|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
130329554|NCT03614156|469175474|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
130329555|NCT03614156|469175475|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
130329556|NCT03614156|469175476|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
130329557|NCT03614156|469175473|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
130329558|NCT03614156|469175474|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
130329559|NCT03614156|469175475|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
130329560|NCT03614156|469175476|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
130329561|NCT04287517|469175481|FG000|Overall Study|Withdrawal by Subject|1|||
130329562|NCT04287517|469175482|FG001|Overall Study|Withdrawal by Subject|1|||
130329563|NCT03070964|469175483|FG000|Overall Study|Progressive disease|8|||
130329564|NCT03070964|469175483|FG000|Overall Study|Treatment-unrelated adverse event|2|||
130329565|NCT03070964|469175483|FG000|Overall Study|Never treated|1|||
130329566|NCT03070964|469175483|FG000|Overall Study|Physician Decision|1|||
130329567|NCT03070964|469175483|FG000|Overall Study|Withdrawal by Subject|1|||
130329568|NCT03070964|469175483|FG000|Overall Study|Adverse Event|1|||
130329569|NCT01094119|469175484|FG000|Overall Study|Lack of Efficacy|2|||
130329570|NCT01094119|469175485|FG001|Overall Study|Lack of Efficacy|4|||
130329571|NCT00834093|469175488|FG000|Overall Study|Progressive Disease|3|||
130329572|NCT00834093|469175488|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
130329573|NCT02745119|469175489|FG000|Overall Study|Adverse Event|1|||
130329574|NCT02745119|469175490|FG001|Overall Study|Adverse Event|0|||
130329575|NCT02745119|469175491|FG002|Overall Study|Adverse Event|1|||
130329576|NCT02745119|469175492|FG003|Overall Study|Adverse Event|3|||
130329577|NCT02745119|469175489|FG000|Overall Study|Death|3|||
130329578|NCT02745119|469175490|FG001|Overall Study|Death|3|||
130329579|NCT02745119|469175491|FG002|Overall Study|Death|0|||
130329580|NCT02745119|469175492|FG003|Overall Study|Death|4|||
130329581|NCT02745119|469175489|FG000|Overall Study|Lost to Follow-up|0|||
130329582|NCT02745119|469175490|FG001|Overall Study|Lost to Follow-up|0|||
130329583|NCT02745119|469175491|FG002|Overall Study|Lost to Follow-up|0|||
130329584|NCT02745119|469175492|FG003|Overall Study|Lost to Follow-up|1|||
130329585|NCT02745119|469175489|FG000|Overall Study|Protocol Deviation|0|||
130329586|NCT02745119|469175490|FG001|Overall Study|Protocol Deviation|0|||
130329587|NCT02745119|469175491|FG002|Overall Study|Protocol Deviation|0|||
130329588|NCT02745119|469175492|FG003|Overall Study|Protocol Deviation|1|||
130329589|NCT02745119|469175489|FG000|Overall Study|Withdrawal by Subject|7|||
130329590|NCT02745119|469175490|FG001|Overall Study|Withdrawal by Subject|15|||
130329591|NCT02745119|469175491|FG002|Overall Study|Withdrawal by Subject|8|||
130329592|NCT02745119|469175492|FG003|Overall Study|Withdrawal by Subject|14|||
130329593|NCT02745119|469175489|FG000|Overall Study|Study Terminated by Sponsor|134|||
130329594|NCT02745119|469175490|FG001|Overall Study|Study Terminated by Sponsor|252|||
130329595|NCT02745119|469175491|FG002|Overall Study|Study Terminated by Sponsor|135|||
130329596|NCT02745119|469175492|FG003|Overall Study|Study Terminated by Sponsor|251|||
129990727|NCT01959516|467929835|FG000|Epoch 1|Protocol deviation|0|||
129990728|NCT01959516|467929836|FG001|Epoch 1|Protocol deviation|1|||
130329597|NCT02745119|469175489|FG000|Overall Study|Physician Decision|0|||
130329598|NCT02745119|469175490|FG001|Overall Study|Physician Decision|2|||
130329599|NCT02745119|469175491|FG002|Overall Study|Physician Decision|2|||
129990729|NCT01959516|467929835|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
130329600|NCT02745119|469175492|FG003|Overall Study|Physician Decision|2|||
130329601|NCT02745119|469175489|FG000|Overall Study|Reason Not Specified|0|||
130329602|NCT02745119|469175490|FG001|Overall Study|Reason Not Specified|2|||
129990730|NCT01959516|467929836|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
130329603|NCT02745119|469175491|FG002|Overall Study|Reason Not Specified|0|||
130329604|NCT02745119|469175492|FG003|Overall Study|Reason Not Specified|1|||
130329605|NCT01587924|469175493|FG000|Overall Study|Adverse Event|0|||
130329606|NCT01587924|469175494|FG001|Overall Study|Adverse Event|2|||
130329607|NCT01587924|469175495|FG002|Overall Study|Adverse Event|0|||
129990731|NCT01959516|467929835|FG000|Epoch 2|Subject withdrew consent|1|||
129990732|NCT01959516|467929836|FG001|Epoch 2|Subject withdrew consent|0|||
129990733|NCT01959516|467929835|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
129990734|NCT01959516|467929836|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
129990735|NCT01477333|467929837|FG000|Overall Study|Adverse Event|1|||
129990736|NCT01477333|467929837|FG000|Overall Study|Withdrawal by Subject|1|||
129990737|NCT01477333|467929837|FG000|Overall Study|Clinical Deterioration|1|||
129990738|NCT00928746|467929838|FG000|Overall Study|Adverse Event|2|||
129990739|NCT00928746|467929838|FG000|Overall Study|Protocol Violation|1|||
129990740|NCT00928746|467929838|FG000|Overall Study|Withdrawal by Subject|1|||
129990741|NCT00928746|467929838|FG000|Overall Study|Other|2|||
129990742|NCT02004353|467929844|FG000|Overall Study|Voluntary participation|1334|||
129990743|NCT02581631|467929845|FG000|Overall Study|Disease progression|29|||
129990744|NCT02581631|467929846|FG001|Overall Study|Disease progression|19|||
129990745|NCT02581631|467929847|FG002|Overall Study|Disease progression|13|||
129990746|NCT02581631|467929848|FG003|Overall Study|Disease progression|5|||
130329608|NCT01587924|469175496|FG003|Overall Study|Adverse Event|0|||
130329609|NCT01587924|469175493|FG000|Overall Study|Protocol Violation|2|||
130329610|NCT01587924|469175494|FG001|Overall Study|Protocol Violation|1|||
130329611|NCT01587924|469175495|FG002|Overall Study|Protocol Violation|2|||
130329612|NCT01587924|469175496|FG003|Overall Study|Protocol Violation|1|||
130329613|NCT01587924|469175493|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
130329614|NCT01587924|469175494|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
130329615|NCT01587924|469175495|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
130329616|NCT01587924|469175496|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
130329617|NCT01587924|469175493|FG000|Overall Study|Withdrawal by Subject|0|||
130329618|NCT01587924|469175494|FG001|Overall Study|Withdrawal by Subject|1|||
130329619|NCT01587924|469175495|FG002|Overall Study|Withdrawal by Subject|1|||
130329620|NCT01587924|469175496|FG003|Overall Study|Withdrawal by Subject|0|||
130329621|NCT00432172|469175497|FG000|Overall Study|Physician Decision|0|||
130329622|NCT00432172|469175498|FG001|Overall Study|Physician Decision|0|||
130329623|NCT00432172|469175499|FG002|Overall Study|Physician Decision|2|||
130329624|NCT00432172|469175500|FG003|Overall Study|Physician Decision|0|||
130329625|NCT00432172|469175497|FG000|Overall Study|Adverse Event|4|||
130329626|NCT00432172|469175498|FG001|Overall Study|Adverse Event|2|||
130329627|NCT00432172|469175499|FG002|Overall Study|Adverse Event|4|||
130329628|NCT00432172|469175500|FG003|Overall Study|Adverse Event|3|||
130329629|NCT00432172|469175497|FG000|Overall Study|Disease progression|0|||
130329630|NCT00432172|469175498|FG001|Overall Study|Disease progression|2|||
130329631|NCT00432172|469175499|FG002|Overall Study|Disease progression|5|||
130329632|NCT00432172|469175500|FG003|Overall Study|Disease progression|1|||
130329633|NCT00432172|469175497|FG000|Overall Study|Withdrawal by Subject|0|||
130329634|NCT00432172|469175498|FG001|Overall Study|Withdrawal by Subject|1|||
130329635|NCT00432172|469175499|FG002|Overall Study|Withdrawal by Subject|0|||
130329636|NCT00432172|469175500|FG003|Overall Study|Withdrawal by Subject|2|||
130329637|NCT00432172|469175497|FG000|Overall Study|No treatment received|2|||
130329638|NCT00432172|469175498|FG001|Overall Study|No treatment received|2|||
130329639|NCT00432172|469175499|FG002|Overall Study|No treatment received|0|||
130329640|NCT00432172|469175500|FG003|Overall Study|No treatment received|1|||
130329641|NCT02425943|469175501|FG000|Overall Study|Adverse Event|3|||
130329642|NCT02425943|469175502|FG001|Overall Study|Adverse Event|1|||
130329643|NCT02425943|469175501|FG000|Overall Study|Lost to Follow-up|59|||
130329644|NCT02425943|469175502|FG001|Overall Study|Lost to Follow-up|37|||
130329645|NCT02425943|469175501|FG000|Overall Study|Protocol Violation|4|||
130329646|NCT02425943|469175502|FG001|Overall Study|Protocol Violation|1|||
130329647|NCT02425943|469175501|FG000|Overall Study|Withdrawal by Subject|64|||
130329648|NCT02425943|469175502|FG001|Overall Study|Withdrawal by Subject|31|||
130329649|NCT02425943|469175501|FG000|Overall Study|Other|6|||
130329650|NCT02425943|469175502|FG001|Overall Study|Other|0|||
130329651|NCT03313037|469175509|FG000|Overall Study|Protocol Violation|4|||
130329652|NCT03313037|469175510|FG001|Overall Study|Protocol Violation|1|||
130329653|NCT03313037|469175509|FG000|Overall Study|Other|1|||
129990747|NCT02581631|467929849|FG004|Overall Study|Disease progression|8|||
129990748|NCT02581631|467929845|FG000|Overall Study|Study drug toxicity|4|||
129990749|NCT02581631|467929846|FG001|Overall Study|Study drug toxicity|6|||
129990750|NCT02581631|467929847|FG002|Overall Study|Study drug toxicity|7|||
129990751|NCT02581631|467929848|FG003|Overall Study|Study drug toxicity|0|||
129990752|NCT02581631|467929849|FG004|Overall Study|Study drug toxicity|3|||
129990753|NCT02581631|467929845|FG000|Overall Study|AE unrelated to study drug|3|||
130329654|NCT03313037|469175510|FG001|Overall Study|Other|1|||
130329655|NCT03313037|469175509|FG000|Overall Study|Withdrawal by Subject|4|||
130329656|NCT03313037|469175510|FG001|Overall Study|Withdrawal by Subject|3|||
130329657|NCT03313037|469175509|FG000|Overall Study|No longer meets eligibility criteria|1|||
130329658|NCT03313037|469175510|FG001|Overall Study|No longer meets eligibility criteria|7|||
130329659|NCT03313037|469175509|FG000|Overall Study|Lost to Follow-up|9|||
129990754|NCT02581631|467929846|FG001|Overall Study|AE unrelated to study drug|1|||
129990755|NCT02581631|467929847|FG002|Overall Study|AE unrelated to study drug|1|||
129990756|NCT02581631|467929848|FG003|Overall Study|AE unrelated to study drug|0|||
129990757|NCT02581631|467929849|FG004|Overall Study|AE unrelated to study drug|2|||
129990758|NCT02581631|467929845|FG000|Overall Study|Request to discontinue|1|||
129990759|NCT02581631|467929846|FG001|Overall Study|Request to discontinue|0|||
129990760|NCT02581631|467929847|FG002|Overall Study|Request to discontinue|3|||
129990761|NCT02581631|467929848|FG003|Overall Study|Request to discontinue|0|||
129990762|NCT02581631|467929849|FG004|Overall Study|Request to discontinue|1|||
130329660|NCT03313037|469175510|FG001|Overall Study|Lost to Follow-up|8|||
130329661|NCT03313037|469175509|FG000|Overall Study|Randomized but not treated|1|||
130329662|NCT03313037|469175510|FG001|Overall Study|Randomized but not treated|0|||
130329663|NCT02379091|469175511|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130329664|NCT02379091|469175512|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130329665|NCT02379091|469175513|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130329666|NCT02379091|469175514|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129990763|NCT02581631|467929845|FG000|Overall Study|participant withdrew consent|3|||
130329667|NCT02379091|469175511|FG000|Overall Study|Principal Investigator Discretion|0|||
130329668|NCT02379091|469175512|FG001|Overall Study|Principal Investigator Discretion|1|||
130329669|NCT02379091|469175513|FG002|Overall Study|Principal Investigator Discretion|0|||
130329670|NCT02379091|469175514|FG003|Overall Study|Principal Investigator Discretion|0|||
130329671|NCT02379091|469175511|FG000|Overall Study|Lost to Follow-up|0|||
130329672|NCT02379091|469175512|FG001|Overall Study|Lost to Follow-up|0|||
130329673|NCT02379091|469175513|FG002|Overall Study|Lost to Follow-up|0|||
130329674|NCT02379091|469175514|FG003|Overall Study|Lost to Follow-up|1|||
130329675|NCT02379091|469175511|FG000|Overall Study|Voluntary Withdrawal|2|||
130329676|NCT02379091|469175512|FG001|Overall Study|Voluntary Withdrawal|5|||
130329677|NCT02379091|469175513|FG002|Overall Study|Voluntary Withdrawal|2|||
130329678|NCT02379091|469175514|FG003|Overall Study|Voluntary Withdrawal|4|||
129990764|NCT02581631|467929846|FG001|Overall Study|participant withdrew consent|0|||
130329679|NCT02379091|469175511|FG000|Overall Study|Study Termination|7|||
130329680|NCT02379091|469175512|FG001|Overall Study|Study Termination|2|||
130329681|NCT02379091|469175513|FG002|Overall Study|Study Termination|5|||
130329682|NCT02379091|469175514|FG003|Overall Study|Study Termination|8|||
130329683|NCT02379091|469175511|FG000|Overall Study|Lack of Efficacy|3|||
130329684|NCT02379091|469175512|FG001|Overall Study|Lack of Efficacy|0|||
130329685|NCT02379091|469175513|FG002|Overall Study|Lack of Efficacy|0|||
130329686|NCT02379091|469175514|FG003|Overall Study|Lack of Efficacy|0|||
130329687|NCT04161157|469175518|FG000|Overall Study|Lost to Follow-up|4|||
130329688|NCT04161157|469175518|FG000|Overall Study|Death|3|||
130329689|NCT04161157|469175518|FG000|Overall Study|Ineligible|2|||
130329690|NCT04161157|469175518|FG000|Overall Study|Withdrawal by Subject|4|||
130329691|NCT03278249|469175523|FG000|Overall Study|Withdrawal by Subject|2|||
130329692|NCT03278249|469175523|FG000|Overall Study|Lost to Follow-up|1|||
130329693|NCT04988477|469175524|FG000|Overall Study|Death|1|||
130329694|NCT04988477|469175525|FG001|Overall Study|Death|0|||
130329695|NCT04988477|469175526|FG002|Overall Study|Death|0|||
130329696|NCT04988477|469175524|FG000|Overall Study|Lost to Follow-up|5|||
130329697|NCT04988477|469175525|FG001|Overall Study|Lost to Follow-up|2|||
130329698|NCT04988477|469175526|FG002|Overall Study|Lost to Follow-up|0|||
130329699|NCT04988477|469175524|FG000|Overall Study|Withdrawal by Subject|2|||
130329700|NCT04988477|469175525|FG001|Overall Study|Withdrawal by Subject|0|||
130329701|NCT04988477|469175526|FG002|Overall Study|Withdrawal by Subject|0|||
130329702|NCT01354899|469176885|FG000|Overall Study|discharge from the hospital|2|||
130329703|NCT01354899|469176885|FG000|Overall Study|Protocol Violation|1|||
130329704|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
130329705|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
129990765|NCT02581631|467929847|FG002|Overall Study|participant withdrew consent|1|||
129990766|NCT02581631|467929848|FG003|Overall Study|participant withdrew consent|0|||
129990767|NCT02581631|467929849|FG004|Overall Study|participant withdrew consent|0|||
129990768|NCT02581631|467929845|FG000|Overall Study|Maximum clinical benefit|1|||
129990769|NCT02581631|467929846|FG001|Overall Study|Maximum clinical benefit|7|||
129990770|NCT02581631|467929847|FG002|Overall Study|Maximum clinical benefit|1|||
129990771|NCT02581631|467929848|FG003|Overall Study|Maximum clinical benefit|3|||
129990772|NCT02581631|467929849|FG004|Overall Study|Maximum clinical benefit|13|||
129990773|NCT02581631|467929845|FG000|Overall Study|Other Reasons|1|||
129990774|NCT02581631|467929846|FG001|Overall Study|Other Reasons|0|||
130329706|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Patient requirement|20|||
130329707|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Death|5|||
130329708|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Change of therapy|6|||
130329709|NCT01071798|469176886|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
130329710|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
130329711|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
130329712|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
130329713|NCT01071798|469176886|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
130329714|NCT00641667|469176887|FG000|Overall Study|Withdrawal by Subject|1|||
129990775|NCT02581631|467929847|FG002|Overall Study|Other Reasons|2|||
130329715|NCT00641667|469176887|FG000|Overall Study|Adverse Event|1|||
129990776|NCT02581631|467929848|FG003|Overall Study|Other Reasons|2|||
130329716|NCT00641667|469176887|FG000|Overall Study|Physician Decision|1|||
130329717|NCT00641667|469176887|FG000|Overall Study|Worsening of underlying disease|3|||
130329718|NCT03349034|469176888|FG000|Overall Study|catheters dislodged during transport|2|||
130329719|NCT03349034|469176889|FG001|Overall Study|catheters dislodged during transport|0|||
130329720|NCT03349034|469176888|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
130329721|NCT03349034|469176889|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
130329722|NCT03349034|469176888|FG000|Overall Study|soft tissue flap used|1|||
130329723|NCT03349034|469176889|FG001|Overall Study|soft tissue flap used|0|||
130329724|NCT03349034|469176888|FG000|Overall Study|Other|0|||
130329725|NCT03349034|469176889|FG001|Overall Study|Other|1|||
130329726|NCT00865566|469176890|FG000|Overall Study|Death|1|||
130329727|NCT00865566|469176891|FG001|Overall Study|Death|11|||
130329728|NCT00865566|469176890|FG000|Overall Study|Lost to Follow-up|314|||
130329729|NCT00865566|469176891|FG001|Overall Study|Lost to Follow-up|315|||
130329730|NCT00865566|469176890|FG000|Overall Study|Withdrawal by Subject|45|||
130329731|NCT00865566|469176891|FG001|Overall Study|Withdrawal by Subject|65|||
130329732|NCT00865566|469176890|FG000|Overall Study|Physician Decision|0|||
130329733|NCT00865566|469176891|FG001|Overall Study|Physician Decision|1|||
130329734|NCT00865566|469176890|FG000|Overall Study|Participant relocated|78|||
130329735|NCT00865566|469176891|FG001|Overall Study|Participant relocated|107|||
130329736|NCT00865566|469176890|FG000|Overall Study|Participant unable to adhere|27|||
130329737|NCT00865566|469176891|FG001|Overall Study|Participant unable to adhere|42|||
130329738|NCT00865566|469176890|FG000|Overall Study|Other; N=245 due to early study closure|154|||
130329739|NCT00865566|469176891|FG001|Overall Study|Other; N=245 due to early study closure|139|||
130329740|NCT00865566|469176890|FG000|Overall Study|HIV infection|5|||
130329741|NCT00865566|469176891|FG001|Overall Study|HIV infection|7|||
130329742|NCT00815659|469176892|FG000|Overall Study|Adverse Event|9|||
130329743|NCT00815659|469176892|FG000|Overall Study|Withdrawal by Subject|9|||
130329744|NCT00815659|469176892|FG000|Overall Study|Lost to Follow-up|4|||
130329745|NCT00815659|469176892|FG000|Overall Study|Protocol Violation|1|||
130329746|NCT03847896|469176893|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329747|NCT03847896|469176894|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329748|NCT03847896|469176895|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
130329749|NCT03847896|469176896|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329750|NCT03847896|469176897|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
130329751|NCT03847896|469176893|FG000|Overall Study|Withdrawal by Subject|2|||
130329752|NCT03847896|469176894|FG001|Overall Study|Withdrawal by Subject|10|||
130329753|NCT03847896|469176895|FG002|Overall Study|Withdrawal by Subject|5|||
130329754|NCT03847896|469176896|FG003|Overall Study|Withdrawal by Subject|9|||
129990777|NCT02581631|467929849|FG004|Overall Study|Other Reasons|3|||
129990778|NCT02581631|467929845|FG000|Overall Study|Poor/Non-Compliance|0|||
129990779|NCT02581631|467929846|FG001|Overall Study|Poor/Non-Compliance|0|||
129990780|NCT02581631|467929847|FG002|Overall Study|Poor/Non-Compliance|1|||
130329755|NCT03847896|469176897|FG004|Overall Study|Withdrawal by Subject|8|||
130329756|NCT03847896|469176893|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130329757|NCT03847896|469176894|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130329758|NCT03847896|469176895|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130329759|NCT03847896|469176896|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130329760|NCT03847896|469176897|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130329761|NCT03847896|469176893|FG000|Overall Study|Adverse Event|2|||
130329762|NCT03847896|469176894|FG001|Overall Study|Adverse Event|1|||
130329763|NCT03847896|469176895|FG002|Overall Study|Adverse Event|3|||
129990781|NCT02581631|467929848|FG003|Overall Study|Poor/Non-Compliance|0|||
129990782|NCT02581631|467929849|FG004|Overall Study|Poor/Non-Compliance|0|||
129990783|NCT00819390|467929850|FG000|Overall Study|Lost to Follow-up|1|||
129990784|NCT00819390|467929851|FG001|Overall Study|Lost to Follow-up|1|||
129990785|NCT00819390|467929852|FG002|Overall Study|Lost to Follow-up|0|||
129990786|NCT00819390|467929853|FG003|Overall Study|Lost to Follow-up|0|||
129990787|NCT00819390|467929850|FG000|Overall Study|Withdrawal by Subject|2|||
129990788|NCT00819390|467929851|FG001|Overall Study|Withdrawal by Subject|0|||
129990789|NCT00819390|467929852|FG002|Overall Study|Withdrawal by Subject|0|||
130329764|NCT03847896|469176896|FG003|Overall Study|Adverse Event|2|||
130329765|NCT03847896|469176897|FG004|Overall Study|Adverse Event|4|||
130329766|NCT03847896|469176893|FG000|Overall Study|A severe exacerbation event|0|||
130329767|NCT03847896|469176894|FG001|Overall Study|A severe exacerbation event|0|||
130329768|NCT03847896|469176895|FG002|Overall Study|A severe exacerbation event|0|||
130329769|NCT03847896|469176896|FG003|Overall Study|A severe exacerbation event|0|||
130329770|NCT03847896|469176897|FG004|Overall Study|A severe exacerbation event|3|||
130329771|NCT03847896|469176893|FG000|Overall Study|Protocol Violation|0|||
130329772|NCT03847896|469176894|FG001|Overall Study|Protocol Violation|2|||
130329773|NCT03847896|469176895|FG002|Overall Study|Protocol Violation|1|||
129990790|NCT00819390|467929853|FG003|Overall Study|Withdrawal by Subject|0|||
129990791|NCT00819390|467929850|FG000|Overall Study|Adverse Event|0|||
129990792|NCT00819390|467929851|FG001|Overall Study|Adverse Event|0|||
130329774|NCT03847896|469176896|FG003|Overall Study|Protocol Violation|0|||
130329775|NCT03847896|469176897|FG004|Overall Study|Protocol Violation|2|||
130329776|NCT03847896|469176893|FG000|Overall Study|Lost to Follow-up|0|||
130329777|NCT03847896|469176894|FG001|Overall Study|Lost to Follow-up|0|||
130329778|NCT03847896|469176895|FG002|Overall Study|Lost to Follow-up|0|||
130329779|NCT03847896|469176896|FG003|Overall Study|Lost to Follow-up|1|||
130329780|NCT03847896|469176897|FG004|Overall Study|Lost to Follow-up|0|||
130329781|NCT03847896|469176893|FG000|Overall Study|Condition under investigation worsened|0|||
130329782|NCT03847896|469176894|FG001|Overall Study|Condition under investigation worsened|0|||
130329783|NCT03847896|469176895|FG002|Overall Study|Condition under investigation worsened|0|||
130329784|NCT03847896|469176896|FG003|Overall Study|Condition under investigation worsened|1|||
130329785|NCT03847896|469176897|FG004|Overall Study|Condition under investigation worsened|1|||
130329786|NCT03847896|469176893|FG000|Overall Study|Lack of Efficacy|0|||
130329787|NCT03847896|469176894|FG001|Overall Study|Lack of Efficacy|0|||
130329788|NCT03847896|469176895|FG002|Overall Study|Lack of Efficacy|0|||
130329789|NCT03847896|469176896|FG003|Overall Study|Lack of Efficacy|2|||
130329790|NCT03847896|469176897|FG004|Overall Study|Lack of Efficacy|2|||
130329791|NCT03847896|469176893|FG000|Overall Study|Other reasons|3|||
130329792|NCT03847896|469176894|FG001|Overall Study|Other reasons|3|||
130329793|NCT03847896|469176895|FG002|Overall Study|Other reasons|1|||
130329794|NCT03847896|469176896|FG003|Overall Study|Other reasons|2|||
130329795|NCT03847896|469176897|FG004|Overall Study|Other reasons|1|||
130329796|NCT02395471|469176898|FG000|Overall Study|Lost to Follow-up|2|||
129990793|NCT00819390|467929852|FG002|Overall Study|Adverse Event|1|||
129990794|NCT00819390|467929853|FG003|Overall Study|Adverse Event|0|||
129990795|NCT03801915|467929861|FG000|Overall Study|Screen failure|0|||
129990796|NCT03801915|467929862|FG001|Overall Study|Screen failure|0|||
129990797|NCT03801915|467929863|FG002|Overall Study|Screen failure|1|||
129990798|NCT03801915|467929861|FG000|Overall Study|Ineligible|1|||
130329797|NCT02395471|469176899|FG001|Overall Study|Lost to Follow-up|0|||
130329798|NCT02395471|469176898|FG000|Overall Study|Withdrawal by Subject|2|||
129990799|NCT03801915|467929862|FG001|Overall Study|Ineligible|0|||
129990800|NCT03801915|467929863|FG002|Overall Study|Ineligible|0|||
129990801|NCT03801915|467929861|FG000|Overall Study|Physician Decision|2|||
129990802|NCT03801915|467929862|FG001|Overall Study|Physician Decision|1|||
129990803|NCT03801915|467929863|FG002|Overall Study|Physician Decision|0|||
129990804|NCT01211288|467929864|FG000|Overall Study|Lost to Follow-up|1|||
129990805|NCT01211288|467929865|FG001|Overall Study|Lost to Follow-up|1|||
129990806|NCT01270971|467929866|FG000|Overall Study|Withdrawal by Subject|24|||
129990807|NCT01270971|467929867|FG001|Overall Study|Withdrawal by Subject|11|||
129990808|NCT01270971|467929866|FG000|Overall Study|Lost to Follow-up|18|||
129990809|NCT01270971|467929867|FG001|Overall Study|Lost to Follow-up|5|||
129990810|NCT01270971|467929866|FG000|Overall Study|Adverse Event|1|||
129990811|NCT01270971|467929867|FG001|Overall Study|Adverse Event|2|||
129990812|NCT01270971|467929866|FG000|Overall Study|Non compliance|2|||
129990813|NCT01270971|467929867|FG001|Overall Study|Non compliance|2|||
129990814|NCT01270971|467929866|FG000|Overall Study|Non-specific|7|||
129990815|NCT01270971|467929867|FG001|Overall Study|Non-specific|3|||
129990816|NCT02003573|467929881|FG000|Overall Study|Progressive disease|2|||
129990817|NCT02003573|467929882|FG001|Overall Study|Progressive disease|0|||
129990818|NCT02003573|467929883|FG002|Overall Study|Progressive disease|1|||
129990819|NCT02003573|467929881|FG000|Overall Study|Other Adverse event|0|||
129990820|NCT02003573|467929882|FG001|Overall Study|Other Adverse event|1|||
129990821|NCT02003573|467929883|FG002|Overall Study|Other Adverse event|1|||
129990822|NCT02003573|467929881|FG000|Overall Study|Refuse to take trial medication|0|||
129990823|NCT02003573|467929882|FG001|Overall Study|Refuse to take trial medication|1|||
129990824|NCT02003573|467929883|FG002|Overall Study|Refuse to take trial medication|1|||
129990825|NCT02003573|467929881|FG000|Overall Study|Other than specified|1|||
129990826|NCT02003573|467929882|FG001|Overall Study|Other than specified|2|||
129990827|NCT02003573|467929883|FG002|Overall Study|Other than specified|3|||
129990828|NCT02112708|467929886|FG000|Baseline|Physician Decision|16|||
129990829|NCT02112708|467929887|FG001|Baseline|Physician Decision|11|||
130329799|NCT02395471|469176899|FG001|Overall Study|Withdrawal by Subject|1|||
129990830|NCT02112708|467929886|FG000|Baseline|Lost to Follow-up|12|||
129990831|NCT02112708|467929887|FG001|Baseline|Lost to Follow-up|0|||
129990832|NCT02112708|467929886|FG000|4 Month|Death|0|||
129990833|NCT02112708|467929887|FG001|4 Month|Death|1|||
129990834|NCT02112708|467929886|FG000|4 Month|Withdrawal by Subject|12|||
129990835|NCT02112708|467929887|FG001|4 Month|Withdrawal by Subject|0|||
129990836|NCT00928018|467929892|FG000|Overall Study|Withdrawal by Subject|1|||
129990837|NCT00928018|467929893|FG001|Overall Study|Withdrawal by Subject|0|||
129990838|NCT00126503|467929894|FG000|Overall Study|disease progression|23|||
130329800|NCT02395471|469176898|FG000|Overall Study|Physician Decision|1|||
130329801|NCT02395471|469176899|FG001|Overall Study|Physician Decision|0|||
130329802|NCT02395471|469176898|FG000|Overall Study|Protocol Violation|0|||
130329803|NCT02395471|469176899|FG001|Overall Study|Protocol Violation|1|||
129990839|NCT00126503|467929895|FG001|Overall Study|disease progression|14|||
129990840|NCT00126503|467929894|FG000|Overall Study|Withdrawal by Subject|0|||
129990841|NCT00126503|467929895|FG001|Overall Study|Withdrawal by Subject|1|||
129990842|NCT00126503|467929894|FG000|Overall Study|alternative therapy|1|||
129990843|NCT00126503|467929895|FG001|Overall Study|alternative therapy|1|||
129990844|NCT00126503|467929894|FG000|Overall Study|other complicating disease|4|||
129990845|NCT00126503|467929895|FG001|Overall Study|other complicating disease|1|||
129990846|NCT00126503|467929894|FG000|Overall Study|Death|3|||
129990847|NCT00126503|467929895|FG001|Overall Study|Death|0|||
129990848|NCT00126503|467929894|FG000|Overall Study|Adverse Event|13|||
129990849|NCT00126503|467929895|FG001|Overall Study|Adverse Event|3|||
129990850|NCT00126503|467929894|FG000|Overall Study|non-compliant|1|||
129990851|NCT00126503|467929895|FG001|Overall Study|non-compliant|0|||
129990852|NCT00126503|467929894|FG000|Overall Study|Physician Decision|2|||
129990853|NCT00126503|467929895|FG001|Overall Study|Physician Decision|1|||
129990854|NCT02457559|467929896|FG000|Overall Study|Progressive Disease|1|||
129990855|NCT02457559|467929897|FG001|Overall Study|Progressive Disease|2|||
130329804|NCT02395471|469176898|FG000|Overall Study|Failure to swollow sponge twice|1|||
130329805|NCT02395471|469176899|FG001|Overall Study|Failure to swollow sponge twice|0|||
130329806|NCT02395471|469176898|FG000|Overall Study|Patient did not return for procedure|0|||
130329807|NCT02395471|469176899|FG001|Overall Study|Patient did not return for procedure|1|||
130329808|NCT02395471|469176898|FG000|Overall Study|Subject not eligible|1|||
129990856|NCT02457559|467929898|FG002|Overall Study|Progressive Disease|3|||
129990857|NCT02457559|467929899|FG003|Overall Study|Progressive Disease|0|||
129990858|NCT02457559|467929900|FG004|Overall Study|Progressive Disease|0|||
129990859|NCT02457559|467929901|FG005|Overall Study|Progressive Disease|2|||
129990860|NCT02457559|467929902|FG006|Overall Study|Progressive Disease|1|||
130329809|NCT02395471|469176899|FG001|Overall Study|Subject not eligible|0|||
130329810|NCT02978781|469176900|FG000|Part A|Adverse Event|1|||
130329811|NCT02978781|469176901|FG001|Part A|Adverse Event|1|||
130329812|NCT02978781|469176902|FG002|Part A|Adverse Event|0|||
130329813|NCT02978781|469176903|FG003|Part A|Adverse Event|0|||
130329814|NCT02978781|469176904|FG004|Part A|Adverse Event|0|||
130329815|NCT02978781|469176900|FG000|Part A|Withdrawal by Subject|0|||
130329816|NCT02978781|469176901|FG001|Part A|Withdrawal by Subject|1|||
130329817|NCT02978781|469176902|FG002|Part A|Withdrawal by Subject|0|||
130329818|NCT02978781|469176903|FG003|Part A|Withdrawal by Subject|0|||
130329819|NCT02978781|469176904|FG004|Part A|Withdrawal by Subject|0|||
130329820|NCT02978781|469176900|FG000|Part B|Withdrawal by Subject|0|||
130329821|NCT02978781|469176901|FG001|Part B|Withdrawal by Subject|0|||
130329822|NCT02978781|469176902|FG002|Part B|Withdrawal by Subject|0|||
130329823|NCT02978781|469176903|FG003|Part B|Withdrawal by Subject|1|||
130329824|NCT02978781|469176904|FG004|Part B|Withdrawal by Subject|0|||
130329825|NCT02978781|469176900|FG000|Part C|Adverse Event|0|||
130329826|NCT02978781|469176901|FG001|Part C|Adverse Event|0|||
130329827|NCT02978781|469176902|FG002|Part C|Adverse Event|0|||
130329828|NCT02978781|469176903|FG003|Part C|Adverse Event|0|||
130329829|NCT02978781|469176904|FG004|Part C|Adverse Event|2|||
130329830|NCT02978781|469176900|FG000|Part C|Withdrawal by Subject|0|||
130329831|NCT02978781|469176901|FG001|Part C|Withdrawal by Subject|0|||
130329832|NCT02978781|469176902|FG002|Part C|Withdrawal by Subject|0|||
130329833|NCT02978781|469176903|FG003|Part C|Withdrawal by Subject|0|||
130329834|NCT02978781|469176904|FG004|Part C|Withdrawal by Subject|1|||
130329835|NCT02978781|469176900|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329836|NCT02978781|469176901|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329837|NCT02978781|469176902|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329838|NCT02978781|469176903|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
130329839|NCT02978781|469176904|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
130329840|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
130329841|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
130329842|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Adverse Event|31|||
130329843|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Adverse Event|21|||
130329844|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
130329845|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
130329846|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
130329847|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
130329848|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
130329849|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
130329850|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
130329851|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
130329852|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Administrative problems|3|||
130329853|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Administrative problems|3|||
130329854|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Death|5|||
129990861|NCT02457559|467929903|FG007|Overall Study|Progressive Disease|0|||
129990862|NCT02457559|467929904|FG008|Overall Study|Progressive Disease|1|||
129990863|NCT02457559|467929905|FG009|Overall Study|Progressive Disease|1|||
129990864|NCT02457559|467929906|FG010|Overall Study|Progressive Disease|1|||
129990865|NCT02457559|467929896|FG000|Overall Study|Investigator's Discretion|0|||
130329855|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Death|8|||
129990866|NCT02457559|467929897|FG001|Overall Study|Investigator's Discretion|0|||
129990867|NCT02457559|467929898|FG002|Overall Study|Investigator's Discretion|2|||
129990868|NCT02457559|467929899|FG003|Overall Study|Investigator's Discretion|0|||
129990869|NCT02457559|467929900|FG004|Overall Study|Investigator's Discretion|1|||
129990870|NCT02457559|467929901|FG005|Overall Study|Investigator's Discretion|0|||
129990871|NCT02457559|467929902|FG006|Overall Study|Investigator's Discretion|1|||
129990872|NCT02457559|467929903|FG007|Overall Study|Investigator's Discretion|0|||
129990873|NCT02457559|467929904|FG008|Overall Study|Investigator's Discretion|1|||
130329856|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Disease progression|139|||
130329857|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Disease progression|119|||
130329858|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
130329859|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
130329860|NCT00785785|469176905|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
130329861|NCT00785785|469176906|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
130329862|NCT00785785|469176905|FG000|Optional Extension Phase|Adverse Event|4|||
130329863|NCT00785785|469176906|FG001|Optional Extension Phase|Adverse Event|5|||
130329864|NCT00785785|469176905|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
130329865|NCT00785785|469176906|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
130329866|NCT00785785|469176905|FG000|Optional Extension Phase|Lost to Follow-up|1|||
130329867|NCT00785785|469176906|FG001|Optional Extension Phase|Lost to Follow-up|0|||
130329868|NCT00785785|469176905|FG000|Optional Extension Phase|Administrative problems|2|||
130329869|NCT00785785|469176906|FG001|Optional Extension Phase|Administrative problems|0|||
130329870|NCT00785785|469176905|FG000|Optional Extension Phase|Death|1|||
130329871|NCT00785785|469176906|FG001|Optional Extension Phase|Death|5|||
130329872|NCT00785785|469176905|FG000|Optional Extension Phase|Disease progression|22|||
130329873|NCT00785785|469176906|FG001|Optional Extension Phase|Disease progression|70|||
130329874|NCT00785785|469176905|FG000|Optional Extension Phase|Protocol deviation|0|||
130329875|NCT00785785|469176906|FG001|Optional Extension Phase|Protocol deviation|2|||
130329876|NCT00785785|469176905|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
130329877|NCT00785785|469176906|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
130329878|NCT02453321|469176907|FG000|Overall Study|Weakness|1|||
130329879|NCT02453321|469176908|FG001|Overall Study|Weakness|1|||
130329880|NCT02453321|469176909|FG002|Overall Study|Weakness|2|||
130329881|NCT02453321|469176907|FG000|Overall Study|Deep Venous Thrombosis|0|||
130329882|NCT02453321|469176908|FG001|Overall Study|Deep Venous Thrombosis|1|||
130329883|NCT02453321|469176909|FG002|Overall Study|Deep Venous Thrombosis|0|||
130329884|NCT00521404|469176910|FG000|Overall Study|Adverse Event|13|||
130329885|NCT00521404|469176910|FG000|Overall Study|Disease Progression|33|||
130329886|NCT00521404|469176910|FG000|Overall Study|Investigator decision|5|||
130329887|NCT00521404|469176910|FG000|Overall Study|Withdrawal of consent|3|||
130329888|NCT00521404|469176910|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
130329889|NCT00521404|469176910|FG000|Overall Study|Other|7|||
129990874|NCT02457559|467929905|FG009|Overall Study|Investigator's Discretion|0|||
129990875|NCT02457559|467929906|FG010|Overall Study|Investigator's Discretion|1|||
129990876|NCT02457559|467929896|FG000|Overall Study|Adverse Event|0|||
129990877|NCT02457559|467929897|FG001|Overall Study|Adverse Event|1|||
130329890|NCT02282605|469176913|FG000|Overall Study|negative SA result on Day -1|3|||
130329891|NCT02282605|469176914|FG001|Overall Study|negative SA result on Day -1|0|||
130329892|NCT02282605|469176915|FG002|Overall Study|negative SA result on Day -1|0|||
130329893|NCT03584789|469176918|FG000|Overall Study|refused EHR permission|19|||
130329894|NCT03584789|469176919|FG001|Overall Study|refused EHR permission|28|||
130329895|NCT03584789|469176920|FG002|Overall Study|refused EHR permission|23|||
130329896|NCT03584789|469176918|FG000|Overall Study|patients tied to a provider who retired|0|||
130329897|NCT03584789|469176919|FG001|Overall Study|patients tied to a provider who retired|0|||
130329898|NCT03584789|469176920|FG002|Overall Study|patients tied to a provider who retired|3|||
130329899|NCT02035267|469176921|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
130329900|NCT02035267|469176922|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
130329901|NCT02035267|469176923|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
130329902|NCT02035267|469176924|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
130329903|NCT02035267|469176921|FG000|Overall Study|Adverse Event|0|||
130329904|NCT02035267|469176922|FG001|Overall Study|Adverse Event|0|||
130329905|NCT02035267|469176923|FG002|Overall Study|Adverse Event|1|||
130329906|NCT02035267|469176924|FG003|Overall Study|Adverse Event|0|||
129990878|NCT02457559|467929898|FG002|Overall Study|Adverse Event|2|||
129990879|NCT02457559|467929899|FG003|Overall Study|Adverse Event|0|||
129990880|NCT02457559|467929900|FG004|Overall Study|Adverse Event|0|||
130329907|NCT02035267|469176921|FG000|Overall Study|Lost to Follow-up|0|||
130329908|NCT02035267|469176922|FG001|Overall Study|Lost to Follow-up|0|||
130329909|NCT02035267|469176923|FG002|Overall Study|Lost to Follow-up|0|||
130329910|NCT02035267|469176924|FG003|Overall Study|Lost to Follow-up|1|||
130329911|NCT02035267|469176921|FG000|Overall Study|Other unspecified|0|||
129990881|NCT02457559|467929901|FG005|Overall Study|Adverse Event|0|||
129990882|NCT02457559|467929902|FG006|Overall Study|Adverse Event|0|||
129990883|NCT02457559|467929903|FG007|Overall Study|Adverse Event|0|||
129990884|NCT02457559|467929904|FG008|Overall Study|Adverse Event|0|||
130329912|NCT02035267|469176922|FG001|Overall Study|Other unspecified|1|||
130329913|NCT02035267|469176923|FG002|Overall Study|Other unspecified|0|||
130329914|NCT02035267|469176924|FG003|Overall Study|Other unspecified|0|||
130329915|NCT00823615|469176933|FG000|Period 2|Lost to Follow-up|2|||
130329916|NCT00823615|469176934|FG001|Period 2|Lost to Follow-up|0|||
130329917|NCT00823615|469176933|FG000|Period 2|Time/Job Conflict|1|||
130329918|NCT00823615|469176934|FG001|Period 2|Time/Job Conflict|2|||
130329919|NCT00098813|469176935|FG000|Overall Study|Death|8|||
130329920|NCT00098813|469176935|FG000|Overall Study|Protocol Violation|1|||
130329921|NCT00098813|469176935|FG000|Overall Study|Withdrawal by Subject|7|||
130329922|NCT00098813|469176935|FG000|Overall Study|Progression of Disease|1|||
130329923|NCT00098813|469176935|FG000|Overall Study|Other complicating disease|1|||
130329924|NCT00098813|469176935|FG000|Overall Study|Reversal of RAI resistance|1|||
130329925|NCT00892099|469176937|FG000|Overall Study|Death|1|||
130329926|NCT00892099|469176938|FG001|Overall Study|Death|0|||
130329927|NCT00892099|469176939|FG002|Overall Study|Death|1|||
130329928|NCT00892099|469176937|FG000|Overall Study|Adverse Event|1|||
130329929|NCT00892099|469176938|FG001|Overall Study|Adverse Event|0|||
130329930|NCT00892099|469176939|FG002|Overall Study|Adverse Event|0|||
130329931|NCT00892099|469176937|FG000|Overall Study|replocated|1|||
130329932|NCT00892099|469176938|FG001|Overall Study|replocated|0|||
130329933|NCT00892099|469176939|FG002|Overall Study|replocated|2|||
130329934|NCT00892099|469176937|FG000|Overall Study|Prolonged hospitalization|1|||
130329935|NCT00892099|469176938|FG001|Overall Study|Prolonged hospitalization|0|||
130329936|NCT00892099|469176939|FG002|Overall Study|Prolonged hospitalization|1|||
130329937|NCT00892099|469176937|FG000|Overall Study|no further details|1|||
130329938|NCT00892099|469176938|FG001|Overall Study|no further details|0|||
130329939|NCT00892099|469176939|FG002|Overall Study|no further details|1|||
130329940|NCT00892099|469176937|FG000|Overall Study|kidney function recovered|0|||
130329941|NCT00892099|469176938|FG001|Overall Study|kidney function recovered|1|||
130329942|NCT00892099|469176939|FG002|Overall Study|kidney function recovered|0|||
130329943|NCT00892099|469176937|FG000|Overall Study|investigator decision|0|||
130329944|NCT00892099|469176938|FG001|Overall Study|investigator decision|0|||
130329945|NCT00892099|469176939|FG002|Overall Study|investigator decision|1|||
130329946|NCT00892099|469176937|FG000|Overall Study|Lost to Follow-up|0|||
130329947|NCT00892099|469176938|FG001|Overall Study|Lost to Follow-up|0|||
130329948|NCT00892099|469176939|FG002|Overall Study|Lost to Follow-up|1|||
130329949|NCT04396639|469176940|FG000|Overall Study|Withdrawal by Subject|1|||
130329950|NCT04396639|469176940|FG000|Overall Study|Other|1|||
130329951|NCT01532986|469176941|FG000|Overall Study|Death|9|||
130329952|NCT01532986|469176942|FG001|Overall Study|Death|9|||
130329953|NCT01532986|469176941|FG000|Overall Study|Withdrawal by Subject|7|||
130329954|NCT01532986|469176942|FG001|Overall Study|Withdrawal by Subject|10|||
130329955|NCT01532986|469176941|FG000|Overall Study|Physician Decision|7|||
130329956|NCT01532986|469176942|FG001|Overall Study|Physician Decision|5|||
130329957|NCT00043979|469176943|FG000|Period 1|recipient with progressive disease|7|||
130329958|NCT00043979|469176944|FG001|Period 1|recipient with progressive disease|4|||
130329959|NCT00043979|469176945|FG002|Period 1|recipient with progressive disease|3|||
130329960|NCT00658359|469176948|FG000|Overall Study|Death|3|||
130329961|NCT00658359|469176949|FG001|Overall Study|Death|1|||
130329962|NCT00658359|469176950|FG002|Overall Study|Death|2|||
130329963|NCT00658359|469176948|FG000|Overall Study|Adverse Event|13|||
130329964|NCT00658359|469176949|FG001|Overall Study|Adverse Event|6|||
130329965|NCT00658359|469176950|FG002|Overall Study|Adverse Event|9|||
130329966|NCT00658359|469176948|FG000|Overall Study|Protocol Violation|1|||
130329967|NCT00658359|469176949|FG001|Overall Study|Protocol Violation|0|||
130329968|NCT00658359|469176950|FG002|Overall Study|Protocol Violation|0|||
130329969|NCT00658359|469176948|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
130329970|NCT00658359|469176949|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
130329971|NCT00658359|469176950|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
130329972|NCT00658359|469176948|FG000|Overall Study|Withdrawal by Subject|7|||
130329973|NCT00658359|469176949|FG001|Overall Study|Withdrawal by Subject|4|||
130329974|NCT00658359|469176950|FG002|Overall Study|Withdrawal by Subject|2|||
130329975|NCT00658359|469176948|FG000|Overall Study|Lost to Follow-up|2|||
130329976|NCT00658359|469176949|FG001|Overall Study|Lost to Follow-up|2|||
129990885|NCT02457559|467929905|FG009|Overall Study|Adverse Event|0|||
129990886|NCT02457559|467929906|FG010|Overall Study|Adverse Event|0|||
130329977|NCT00658359|469176950|FG002|Overall Study|Lost to Follow-up|4|||
130329978|NCT00658359|469176948|FG000|Overall Study|Lack of Efficacy|0|||
130329979|NCT00658359|469176949|FG001|Overall Study|Lack of Efficacy|1|||
130329980|NCT00658359|469176950|FG002|Overall Study|Lack of Efficacy|0|||
130329981|NCT02754440|469176951|FG000|Overall Study|Protocol Violation|3|||
130329982|NCT02754440|469176952|FG001|Overall Study|Protocol Violation|2|||
130329983|NCT02754440|469176953|FG002|Overall Study|Protocol Violation|2|||
130329984|NCT02754440|469176954|FG003|Overall Study|Protocol Violation|6|||
130329985|NCT02754440|469176951|FG000|Overall Study|Adverse Event|3|||
130329986|NCT02754440|469176952|FG001|Overall Study|Adverse Event|1|||
130329987|NCT02754440|469176953|FG002|Overall Study|Adverse Event|0|||
130329988|NCT02754440|469176954|FG003|Overall Study|Adverse Event|9|||
129990887|NCT02457559|467929896|FG000|Overall Study|Reason not Specified|1|||
129990888|NCT02457559|467929897|FG001|Overall Study|Reason not Specified|0|||
129990889|NCT02457559|467929898|FG002|Overall Study|Reason not Specified|0|||
129990890|NCT02457559|467929899|FG003|Overall Study|Reason not Specified|0|||
129990891|NCT02457559|467929900|FG004|Overall Study|Reason not Specified|0|||
129990892|NCT02457559|467929901|FG005|Overall Study|Reason not Specified|0|||
129990893|NCT02457559|467929902|FG006|Overall Study|Reason not Specified|0|||
129990894|NCT02457559|467929903|FG007|Overall Study|Reason not Specified|0|||
130329989|NCT02754440|469176951|FG000|Overall Study|Withdrawal by Subject|0|||
130329990|NCT02754440|469176952|FG001|Overall Study|Withdrawal by Subject|0|||
130329991|NCT02754440|469176953|FG002|Overall Study|Withdrawal by Subject|0|||
130329992|NCT02754440|469176954|FG003|Overall Study|Withdrawal by Subject|1|||
130329993|NCT02754440|469176951|FG000|Overall Study|Equipment failure|0|||
130329994|NCT02754440|469176952|FG001|Overall Study|Equipment failure|5|||
130329995|NCT02754440|469176953|FG002|Overall Study|Equipment failure|5|||
130329996|NCT02754440|469176954|FG003|Overall Study|Equipment failure|7|||
130329997|NCT02754440|469176951|FG000|Overall Study|Subject issues not resulting in AE|0|||
129990895|NCT02457559|467929904|FG008|Overall Study|Reason not Specified|0|||
129990896|NCT02457559|467929905|FG009|Overall Study|Reason not Specified|2|||
129990897|NCT02457559|467929906|FG010|Overall Study|Reason not Specified|0|||
129990898|NCT02457559|467929896|FG000|Overall Study|Death|0|||
129990899|NCT02457559|467929897|FG001|Overall Study|Death|0|||
129990900|NCT02457559|467929898|FG002|Overall Study|Death|0|||
129990901|NCT02457559|467929899|FG003|Overall Study|Death|0|||
129990902|NCT02457559|467929900|FG004|Overall Study|Death|0|||
129990903|NCT02457559|467929901|FG005|Overall Study|Death|0|||
129990904|NCT02457559|467929902|FG006|Overall Study|Death|0|||
129990905|NCT02457559|467929903|FG007|Overall Study|Death|0|||
130329998|NCT02754440|469176952|FG001|Overall Study|Subject issues not resulting in AE|0|||
130329999|NCT02754440|469176953|FG002|Overall Study|Subject issues not resulting in AE|0|||
130330000|NCT02754440|469176954|FG003|Overall Study|Subject issues not resulting in AE|12|||
130330001|NCT01189032|469176957|FG000|Overall Study|Adverse Event|1|||
130330002|NCT01189032|469176958|FG001|Overall Study|Adverse Event|3|||
130330003|NCT01189032|469176959|FG002|Overall Study|Adverse Event|4|||
130330004|NCT01189032|469176957|FG000|Overall Study|Lack of Efficacy|2|||
130330005|NCT01189032|469176958|FG001|Overall Study|Lack of Efficacy|3|||
130330006|NCT01189032|469176959|FG002|Overall Study|Lack of Efficacy|0|||
130330007|NCT01189032|469176957|FG000|Overall Study|Withdrawal by Subject|1|||
130330008|NCT01189032|469176958|FG001|Overall Study|Withdrawal by Subject|0|||
130330009|NCT01189032|469176959|FG002|Overall Study|Withdrawal by Subject|1|||
130330010|NCT01189032|469176957|FG000|Overall Study|Protocol Violation|1|||
130330011|NCT01189032|469176958|FG001|Overall Study|Protocol Violation|1|||
130330012|NCT01189032|469176959|FG002|Overall Study|Protocol Violation|1|||
130330013|NCT03388164|469176964|FG000|Overall Study|Withdrawal by Subject|3|||
130330014|NCT03388164|469176965|FG001|Overall Study|Withdrawal by Subject|1|||
130330015|NCT05375760|469176968|FG000|Overall Study|Adverse Event|1|||
130330016|NCT05375760|469176969|FG001|Overall Study|Adverse Event|0|||
130330017|NCT05375760|469176968|FG000|Overall Study|Death|0|||
130330018|NCT05375760|469176969|FG001|Overall Study|Death|1|||
130330019|NCT05375760|469176968|FG000|Overall Study|Lost to Follow-up|6|||
130330020|NCT05375760|469176969|FG001|Overall Study|Lost to Follow-up|6|||
130330021|NCT05375760|469176968|FG000|Overall Study|Withdrawal by Subject|17|||
130330022|NCT05375760|469176969|FG001|Overall Study|Withdrawal by Subject|19|||
130330023|NCT05375760|469176968|FG000|Overall Study|Dosing halted by FDA|96|||
130330024|NCT05375760|469176969|FG001|Overall Study|Dosing halted by FDA|100|||
130330025|NCT05375760|469176968|FG000|Overall Study|Not compliant with study visit|2|||
130330026|NCT05375760|469176969|FG001|Overall Study|Not compliant with study visit|0|||
130330027|NCT05375760|469176968|FG000|Overall Study|Physician Decision|1|||
130330028|NCT05375760|469176969|FG001|Overall Study|Physician Decision|0|||
130330029|NCT05375760|469176968|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
130330030|NCT05375760|469176969|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
130330031|NCT05375760|469176968|FG000|Overall Study|Participant moved|1|||
129990906|NCT02457559|467929904|FG008|Overall Study|Death|1|||
129990907|NCT02457559|467929905|FG009|Overall Study|Death|1|||
129990908|NCT02457559|467929906|FG010|Overall Study|Death|0|||
130330032|NCT05375760|469176969|FG001|Overall Study|Participant moved|0|||
129990909|NCT00998335|467929909|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
129990910|NCT00998335|467929910|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
129990911|NCT02374671|467929911|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
129990912|NCT02374671|467929912|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
130330033|NCT00363480|469176970|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
130330034|NCT00363480|469176970|FG000|Overall Study|Adverse Event|4|||
130330035|NCT00363480|469176970|FG000|Overall Study|Lost to Follow-up|5|||
130330036|NCT00363480|469176970|FG000|Overall Study|Withdrawal by Subject|5|||
130330037|NCT00363480|469176970|FG000|Overall Study|Non-compliance of subject|1|||
130330038|NCT00363480|469176970|FG000|Overall Study|Participant discontinued on its own|1|||
130330039|NCT01457703|469176971|FG000|Overall Study|Screen Failure|5|||
130330040|NCT01457703|469176972|FG001|Overall Study|Screen Failure|7|||
130330041|NCT01457703|469176971|FG000|Overall Study|Withdrawal by Subject|1|||
130330042|NCT01457703|469176972|FG001|Overall Study|Withdrawal by Subject|4|||
130330043|NCT00949702|469176973|FG000|Overall Study|Death|40|||
130330044|NCT00949702|469176973|FG000|Overall Study|Disease progression|7|||
130330045|NCT00949702|469176973|FG000|Overall Study|Withdrawal of consent|1|||
130330046|NCT06042855|469176976|FG000|Overall Study|No Receipt of Study Drug|48|||
130330047|NCT06042855|469176977|FG001|Overall Study|No Receipt of Study Drug|57|||
130330048|NCT06042855|469176976|FG000|Overall Study|Administratively Withdrawn|59|||
130330049|NCT06042855|469176977|FG001|Overall Study|Administratively Withdrawn|59|||
130330050|NCT02129699|469176982|FG000|Overall Study|Did not start treatment|3|||
130330051|NCT02129699|469176983|FG001|Overall Study|Did not start treatment|2|||
130330052|NCT00525161|469176986|FG000|Overall Study|Adverse Event|1|||
130330053|NCT01076361|469176990|FG000|Overall Study|22 leads were excluded from analysis|21|||
130330054|NCT02447003|469176991|FG000|Overall Study|Other|0|||
130330055|NCT02447003|469176992|FG001|Overall Study|Other|4|||
130330056|NCT02447003|469176991|FG000|Overall Study|Site discontinued|0|||
130330057|NCT02447003|469176992|FG001|Overall Study|Site discontinued|2|||
130330058|NCT02447003|469176991|FG000|Overall Study|Physician Decision|0|||
130330059|NCT02447003|469176992|FG001|Overall Study|Physician Decision|1|||
130330060|NCT02447003|469176991|FG000|Overall Study|Withdrawal by Subject|4|||
130330061|NCT02447003|469176992|FG001|Overall Study|Withdrawal by Subject|3|||
130330062|NCT02447003|469176991|FG000|Overall Study|Sponsor Decision|6|||
130330063|NCT02447003|469176992|FG001|Overall Study|Sponsor Decision|11|||
130330064|NCT02447003|469176991|FG000|Overall Study|Progressive Disease|1|||
130330065|NCT02447003|469176992|FG001|Overall Study|Progressive Disease|0|||
130330066|NCT02447003|469176991|FG000|Overall Study|Lost to Follow-up|5|||
130330067|NCT02447003|469176992|FG001|Overall Study|Lost to Follow-up|0|||
130330068|NCT02447003|469176991|FG000|Overall Study|Death|154|||
130330069|NCT02447003|469176992|FG001|Overall Study|Death|63|||
130330070|NCT03848728|469176993|FG000|Overall Study|Death|16|||
130330071|NCT03848728|469176994|FG001|Overall Study|Death|13|||
130330072|NCT03848728|469176993|FG000|Overall Study|Outmigrated to non-study community|98|||
130330073|NCT03848728|469176994|FG001|Overall Study|Outmigrated to non-study community|106|||
130330074|NCT03848728|469176993|FG000|Overall Study|Transfered to non-study clinic|32|||
130330075|NCT03848728|469176994|FG001|Overall Study|Transfered to non-study clinic|48|||
130330076|NCT03848728|469176993|FG000|Overall Study|Withdrawal by Subject|1|||
130330077|NCT03848728|469176994|FG001|Overall Study|Withdrawal by Subject|0|||
130330078|NCT00630838|469176997|FG000|Overall Study|Death|0|||
130330079|NCT00630838|469176998|FG001|Overall Study|Death|1|||
130330080|NCT00630838|469176997|FG000|Overall Study|Lost to Follow-up|0|||
130330081|NCT00630838|469176998|FG001|Overall Study|Lost to Follow-up|1|||
130330082|NCT01108185|469176999|FG000|Overall Study|Non-compliance|15|||
130330083|NCT01108185|469176999|FG000|Overall Study|Lost to Follow-up|12|||
130330084|NCT02581410|469177000|FG000|Vaccination Phase|Adverse Event|2|||
130330085|NCT02581410|469177001|FG001|Vaccination Phase|Adverse Event|1|||
130330086|NCT02581410|469177000|FG000|Vaccination Phase|Withdrawal by Subject|0|||
129990913|NCT02374671|467929913|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
129990914|NCT02374671|467929911|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
129990915|NCT02374671|467929912|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
129990916|NCT02374671|467929913|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
129990917|NCT02374671|467929911|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
129990918|NCT02374671|467929912|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
129990919|NCT02374671|467929913|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
129990920|NCT02374671|467929911|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
129990921|NCT02374671|467929912|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
129990922|NCT02374671|467929913|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
129990923|NCT02374671|467929911|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
129990924|NCT02374671|467929912|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
129990925|NCT02374671|467929913|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
130330087|NCT02581410|469177001|FG001|Vaccination Phase|Withdrawal by Subject|1|||
130330088|NCT02581410|469177000|FG000|Vaccination Phase|Migrated/moved from study area|0|||
130330089|NCT02581410|469177001|FG001|Vaccination Phase|Migrated/moved from study area|1|||
130330090|NCT02581410|469177000|FG000|End of Study Phase|Adverse Event|4|||
129990926|NCT03866473|467929916|FG000|Phase 1|Death|1|||
129990927|NCT03866473|467929917|FG001|Phase 1|Death|0|||
129990928|NCT03866473|467929916|FG000|Phase 2|Death|0|||
129990929|NCT03866473|467929917|FG001|Phase 2|Death|2|||
130330091|NCT02581410|469177001|FG001|End of Study Phase|Adverse Event|3|||
129990930|NCT03866473|467929916|FG000|Phase 2|Dropped|1|||
130330092|NCT02581410|469177000|FG000|End of Study Phase|Withdrawal by Subject|1|||
130330093|NCT02581410|469177001|FG001|End of Study Phase|Withdrawal by Subject|2|||
130330094|NCT02581410|469177000|FG000|End of Study Phase|Migrated/moved from study area|0|||
130330095|NCT02581410|469177001|FG001|End of Study Phase|Migrated/moved from study area|3|||
130330096|NCT02581410|469177000|FG000|End of Study Phase|Lost to Follow-up|0|||
130330097|NCT02581410|469177001|FG001|End of Study Phase|Lost to Follow-up|2|||
130330098|NCT02581410|469177000|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
130330099|NCT02581410|469177001|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
130330100|NCT00670748|469177004|FG000|Overall Study|Death during treatment|1|||
130330101|NCT00670748|469177005|FG001|Overall Study|Death during treatment|1|||
130330102|NCT00670748|469177006|FG002|Overall Study|Death during treatment|1|||
130330103|NCT00670748|469177007|FG003|Overall Study|Death during treatment|0|||
130330104|NCT00670748|469177004|FG000|Overall Study|Not off study|2|||
130330105|NCT00670748|469177005|FG001|Overall Study|Not off study|1|||
130330106|NCT00670748|469177006|FG002|Overall Study|Not off study|1|||
130330107|NCT00670748|469177007|FG003|Overall Study|Not off study|1|||
130330108|NCT06083506|469177012|FG000|Overall Study|Physician Decision|2|||
130330109|NCT06083506|469177012|FG000|Overall Study|Lack of Efficacy|1|||
130330110|NCT03529422|469177013|FG000|Overall Study|Withdrawal by Subject|1|||
130330111|NCT03529422|469177013|FG000|Overall Study|Protocol Violation|1|||
130330112|NCT03529422|469177013|FG000|Overall Study|Disease progression|2|||
130330113|NCT02000115|469177014|FG000|Overall Study|Death|56|||
130330114|NCT02000115|469177015|FG001|Overall Study|Death|45|||
130330115|NCT02000115|469177016|FG002|Overall Study|Death|0|||
130330116|NCT02000115|469177017|FG003|Overall Study|Death|0|||
130330117|NCT02000115|469177014|FG000|Overall Study|Missed Visit|6|||
130330118|NCT02000115|469177015|FG001|Overall Study|Missed Visit|8|||
130330119|NCT02000115|469177016|FG002|Overall Study|Missed Visit|1|||
130330120|NCT02000115|469177017|FG003|Overall Study|Missed Visit|0|||
130330121|NCT02000115|469177014|FG000|Overall Study|Protocol Violation|2|||
130330122|NCT02000115|469177015|FG001|Overall Study|Protocol Violation|1|||
130330123|NCT02000115|469177016|FG002|Overall Study|Protocol Violation|0|||
130330124|NCT02000115|469177017|FG003|Overall Study|Protocol Violation|0|||
130330125|NCT02000115|469177014|FG000|Overall Study|Physician Decision|2|||
130330126|NCT02000115|469177015|FG001|Overall Study|Physician Decision|0|||
130330127|NCT02000115|469177016|FG002|Overall Study|Physician Decision|0|||
130330128|NCT02000115|469177017|FG003|Overall Study|Physician Decision|0|||
130330129|NCT02000115|469177014|FG000|Overall Study|Withdrawal by Subject|11|||
130330130|NCT02000115|469177015|FG001|Overall Study|Withdrawal by Subject|11|||
130330131|NCT02000115|469177016|FG002|Overall Study|Withdrawal by Subject|0|||
130330132|NCT02000115|469177017|FG003|Overall Study|Withdrawal by Subject|0|||
129990931|NCT03866473|467929917|FG001|Phase 2|Dropped|1|||
129990932|NCT03866473|467929916|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
130330133|NCT02000115|469177014|FG000|Overall Study|Lost to Follow-up|0|||
130330134|NCT02000115|469177015|FG001|Overall Study|Lost to Follow-up|1|||
130330135|NCT02000115|469177016|FG002|Overall Study|Lost to Follow-up|0|||
129990933|NCT03866473|467929917|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
129990934|NCT03110185|467929918|FG000|Overall Study|Death|0|||
129990935|NCT03110185|467929919|FG001|Overall Study|Death|1|||
129990936|NCT03110185|467929918|FG000|Overall Study|Withdrawal by Subject|2|||
129990937|NCT03110185|467929919|FG001|Overall Study|Withdrawal by Subject|7|||
129990938|NCT03110185|467929918|FG000|Overall Study|Time Constraints|0|||
129990939|NCT03110185|467929919|FG001|Overall Study|Time Constraints|6|||
129990940|NCT03110185|467929918|FG000|Overall Study|Conflict with care|5|||
129990941|NCT03110185|467929919|FG001|Overall Study|Conflict with care|12|||
129990942|NCT03110185|467929918|FG000|Overall Study|Protocol Violation|1|||
129990943|NCT03110185|467929919|FG001|Overall Study|Protocol Violation|4|||
129990944|NCT03110185|467929918|FG000|Overall Study|MRI Incompatible|2|||
129990945|NCT03110185|467929919|FG001|Overall Study|MRI Incompatible|0|||
129990946|NCT03110185|467929918|FG000|Overall Study|Patient Refusal|0|||
129990947|NCT03110185|467929919|FG001|Overall Study|Patient Refusal|1|||
129990948|NCT05330312|467929922|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
129990949|NCT05330312|467929923|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
129990950|NCT05330312|467929924|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
129990951|NCT05330312|467929922|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
129990952|NCT05330312|467929923|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
129990953|NCT05330312|467929924|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
129990954|NCT05330312|467929922|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
129990955|NCT05330312|467929923|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
129990956|NCT05330312|467929924|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
129990957|NCT05330312|467929922|FG000|Pivotal Investigation - Part 2|Death|1|||
129990958|NCT05330312|467929923|FG001|Pivotal Investigation - Part 2|Death|4|||
130330136|NCT02000115|469177017|FG003|Overall Study|Lost to Follow-up|0|||
130330137|NCT02000115|469177014|FG000|Overall Study|Non-compliance|2|||
130330138|NCT02000115|469177015|FG001|Overall Study|Non-compliance|1|||
130330139|NCT02000115|469177016|FG002|Overall Study|Non-compliance|0|||
129990959|NCT05330312|467929924|FG002|Pivotal Investigation - Part 2|Death|0|||
129990960|NCT01078454|467929927|FG000|Overall Study|Adverse Event|1|||
129990961|NCT01078454|467929928|FG001|Overall Study|Adverse Event|1|||
130330140|NCT02000115|469177017|FG003|Overall Study|Non-compliance|0|||
130330141|NCT02000115|469177014|FG000|Overall Study|Withdrawn on day of randomization|0|||
130330142|NCT02000115|469177015|FG001|Overall Study|Withdrawn on day of randomization|1|||
130330143|NCT02000115|469177016|FG002|Overall Study|Withdrawn on day of randomization|0|||
129990962|NCT01078454|467929927|FG000|Overall Study|Death|0|||
129990963|NCT01078454|467929928|FG001|Overall Study|Death|1|||
129990964|NCT00824161|467931360|FG000|Overall Study|Withdrawal by Subject|1|||
129990965|NCT00824161|467931360|FG000|Overall Study|Screen Failure|1|||
129990966|NCT04882995|467931361|FG000|Overall Study|Withdrawal by Subject|1|||
129990967|NCT04882995|467931362|FG001|Overall Study|Withdrawal by Subject|2|||
129990968|NCT04882995|467931361|FG000|Overall Study|Protocol Violation|4|||
129990969|NCT04882995|467931362|FG001|Overall Study|Protocol Violation|4|||
129990970|NCT04882995|467931361|FG000|Overall Study|Surgery postponed due to COVID|1|||
129990971|NCT04882995|467931362|FG001|Overall Study|Surgery postponed due to COVID|1|||
129990972|NCT02572882|467931363|FG000|Overall Study|Withdrawal by Subject|1|||
129990973|NCT02572882|467931363|FG000|Overall Study|Participant received kidney transplant|1|||
130330144|NCT02000115|469177017|FG003|Overall Study|Withdrawn on day of randomization|0|||
130330145|NCT02000115|469177014|FG000|Overall Study|Still on Study|0|||
130330146|NCT02000115|469177015|FG001|Overall Study|Still on Study|0|||
129990974|NCT04371198|467931367|FG000|Overall Study|inadequate sample|4|||
129990975|NCT03536143|467931368|FG000|Overall Study|Early termination, Sponsor decision|1|||
129990976|NCT01174160|467931369|FG000|Overall Study|Adverse Event|1|||
129990977|NCT01174160|467931370|FG001|Overall Study|Adverse Event|0|||
129990978|NCT01174160|467931369|FG000|Overall Study|Lost to Follow-up|1|||
129990979|NCT01174160|467931370|FG001|Overall Study|Lost to Follow-up|0|||
129990980|NCT01174160|467931369|FG000|Overall Study|Physician Decision|1|||
129990981|NCT01174160|467931370|FG001|Overall Study|Physician Decision|0|||
129990982|NCT01174160|467931369|FG000|Overall Study|Protocol Violation|4|||
129990983|NCT01174160|467931370|FG001|Overall Study|Protocol Violation|6|||
129990984|NCT01174160|467931369|FG000|Overall Study|Withdrawal by Subject|1|||
129990985|NCT01174160|467931370|FG001|Overall Study|Withdrawal by Subject|0|||
129990986|NCT04754477|467931371|FG000|Overall Study|Withdrawal by Subject|1|||
129990987|NCT01590017|467931372|FG000|Overall Study|Adverse Event|1|||
129990988|NCT01590017|467931372|FG000|Overall Study|Withdrawal by Subject|1|||
129990989|NCT01590017|467931372|FG000|Overall Study|Lack of Efficacy|1|||
129990990|NCT01590017|467931372|FG000|Overall Study|Physician Decision|1|||
129990991|NCT01347762|467931373|FG000|Overall Study|Lost to Follow-up|0|||
129990992|NCT01347762|467931374|FG001|Overall Study|Lost to Follow-up|1|||
129990993|NCT01347762|467931375|FG002|Overall Study|Lost to Follow-up|6|||
129990994|NCT01347762|467931376|FG003|Overall Study|Lost to Follow-up|5|||
129990995|NCT01347762|467931373|FG000|Overall Study|Withdrawal by Subject|4|||
129990996|NCT01347762|467931374|FG001|Overall Study|Withdrawal by Subject|1|||
129990997|NCT01347762|467931375|FG002|Overall Study|Withdrawal by Subject|3|||
129990998|NCT01347762|467931376|FG003|Overall Study|Withdrawal by Subject|3|||
129990999|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
129991000|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991001|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991002|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991003|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991004|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991005|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
129991006|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991007|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991008|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991009|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991010|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991011|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991012|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
129991013|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991014|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130330147|NCT02000115|469177016|FG002|Overall Study|Still on Study|0|||
130330148|NCT02000115|469177017|FG003|Overall Study|Still on Study|53|||
129991015|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991016|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991017|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Other|4|||
129991018|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Other|3|||
129991019|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Other|0|||
130330149|NCT05006573|469177018|FG000|Double-blind Treatment Period|Physician Decision|2|||
130330150|NCT05006573|469177019|FG001|Double-blind Treatment Period|Physician Decision|0|||
130330151|NCT05006573|469177018|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
129991020|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Other|0|||
130330152|NCT05006573|469177019|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
130330153|NCT05006573|469177018|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129991021|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Other|0|||
129991022|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Other|0|||
129991023|NCT02527343|467931377|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991024|NCT02527343|467931378|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991025|NCT02527343|467931379|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
129991026|NCT02527343|467931380|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991027|NCT02527343|467931381|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991028|NCT02527343|467931382|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991029|NCT02527343|467931377|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991030|NCT02527343|467931378|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991031|NCT02527343|467931379|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991032|NCT02527343|467931380|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
129991033|NCT02527343|467931381|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991034|NCT02527343|467931382|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991035|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991036|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991037|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991038|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991039|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
129991040|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991041|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991042|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991043|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991044|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991045|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
129991046|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
129991047|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129991048|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129991049|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
130330154|NCT05006573|469177019|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130330155|NCT05006573|469177018|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130330156|NCT05006573|469177019|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130330157|NCT05006573|469177018|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
130330158|NCT05006573|469177019|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
130330159|NCT05006573|469177018|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
130330160|NCT05006573|469177019|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
130330161|NCT03493464|469177024|FG000|Overall Study|Surgery not performed|1|||
130330162|NCT05462756|469178379|FG000|Treatment Period|Adverse Event|3|||
130330163|NCT05462756|469178380|FG001|Treatment Period|Adverse Event|0|||
130330164|NCT05462756|469178379|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
130330165|NCT05462756|469178380|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
130330166|NCT05462756|469178379|FG000|Treatment Period|Death|0|||
130330167|NCT05462756|469178380|FG001|Treatment Period|Death|1|||
130330168|NCT05462756|469178379|FG000|Treatment Period|Lost to Follow-up|2|||
130330169|NCT05462756|469178380|FG001|Treatment Period|Lost to Follow-up|1|||
130330170|NCT05462756|469178379|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
130330171|NCT05462756|469178380|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
130330172|NCT05462756|469178379|FG000|Treatment Period|Physician Decision|2|||
130330173|NCT05462756|469178380|FG001|Treatment Period|Physician Decision|0|||
130330174|NCT05462756|469178379|FG000|Treatment Period|Protocol Violation|0|||
130330175|NCT05462756|469178380|FG001|Treatment Period|Protocol Violation|1|||
130330176|NCT05462756|469178379|FG000|Treatment Period|Withdrawal by Subject|5|||
130330177|NCT05462756|469178380|FG001|Treatment Period|Withdrawal by Subject|12|||
130330178|NCT05462756|469178379|FG000|Follow-Up Period|Adverse Event|1|||
130330179|NCT05462756|469178380|FG001|Follow-Up Period|Adverse Event|0|||
130330180|NCT05462756|469178379|FG000|Follow-Up Period|Death|1|||
130330181|NCT05462756|469178380|FG001|Follow-Up Period|Death|0|||
130330182|NCT05462756|469178379|FG000|Follow-Up Period|Lost to Follow-up|3|||
130330183|NCT05462756|469178380|FG001|Follow-Up Period|Lost to Follow-up|1|||
130330184|NCT05462756|469178379|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130330185|NCT05462756|469178380|FG001|Follow-Up Period|Withdrawal by Subject|4|||
130330186|NCT00990704|469178381|FG000|Overall Study|Adverse Event|1|||
130330187|NCT00990704|469178382|FG001|Overall Study|Adverse Event|1|||
130330188|NCT00990704|469178381|FG000|Overall Study|Physician Decision|0|||
130330189|NCT00990704|469178382|FG001|Overall Study|Physician Decision|1|||
130330190|NCT04040933|469178383|FG000|Overall Study|Protocol Violation|1|||
130330191|NCT04040933|469178383|FG000|Overall Study|Withdrawal by Subject|2|||
130330192|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
130330193|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
130330194|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
130330195|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
130330196|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
129991050|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129991051|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
130330197|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
130330198|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
130330199|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
130330200|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
130330201|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
130330202|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
130330203|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
130330204|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
130330205|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
130330206|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
130330207|NCT01235741|469178387|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
130330208|NCT01235741|469178388|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
130330209|NCT01235741|469178389|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
130330210|NCT01235741|469178387|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
130330211|NCT01235741|469178388|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
130330212|NCT01235741|469178389|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
130330213|NCT01235741|469178387|FG000|Randomized to Treatment|Adverse Event|0|||
130330214|NCT01235741|469178388|FG001|Randomized to Treatment|Adverse Event|1|||
130330215|NCT01235741|469178389|FG002|Randomized to Treatment|Adverse Event|1|||
130330216|NCT01235741|469178387|FG000|Randomized to Treatment|Sponsor terminated study|0|||
130330217|NCT01235741|469178388|FG001|Randomized to Treatment|Sponsor terminated study|35|||
130330218|NCT01235741|469178389|FG002|Randomized to Treatment|Sponsor terminated study|34|||
130330219|NCT01235741|469178387|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
130330220|NCT01235741|469178388|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
130330221|NCT01235741|469178389|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
130330222|NCT01235741|469178387|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
130330223|NCT01235741|469178388|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
130330224|NCT01235741|469178389|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
130330225|NCT01235741|469178387|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
130330226|NCT01235741|469178388|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
130330227|NCT01235741|469178389|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
130330228|NCT00904033|469178394|FG000|Overall Study|Withdrawal by Subject|1|||
130330229|NCT00904033|469178395|FG001|Overall Study|Withdrawal by Subject|1|||
130330230|NCT00904033|469178396|FG002|Overall Study|Withdrawal by Subject|0|||
130330231|NCT00904033|469178397|FG003|Overall Study|Withdrawal by Subject|0|||
130330232|NCT00904033|469178394|FG000|Overall Study|Physician Decision|0|||
130330233|NCT00904033|469178395|FG001|Overall Study|Physician Decision|0|||
130330234|NCT00904033|469178396|FG002|Overall Study|Physician Decision|1|||
130330235|NCT00904033|469178397|FG003|Overall Study|Physician Decision|0|||
130330236|NCT00904033|469178394|FG000|Overall Study|Unable to obtain final blood draw|0|||
130330237|NCT00904033|469178395|FG001|Overall Study|Unable to obtain final blood draw|0|||
130330238|NCT00904033|469178396|FG002|Overall Study|Unable to obtain final blood draw|0|||
130330239|NCT00904033|469178397|FG003|Overall Study|Unable to obtain final blood draw|2|||
130330240|NCT01177397|469178398|FG000|Overall Study|Protocol Violation|0|||
130330241|NCT01177397|469178399|FG001|Overall Study|Protocol Violation|0|||
130330242|NCT01177397|469178400|FG002|Overall Study|Protocol Violation|0|||
130330243|NCT01177397|469178401|FG003|Overall Study|Protocol Violation|0|||
130330244|NCT01177397|469178402|FG004|Overall Study|Protocol Violation|0|||
129991052|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
129991053|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991054|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991055|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991056|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991057|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
129991058|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
129991059|NCT02527343|467931377|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991060|NCT02527343|467931378|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991061|NCT02527343|467931379|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991062|NCT02527343|467931380|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991063|NCT02527343|467931381|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
129991064|NCT02527343|467931382|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
130330245|NCT01177397|469178403|FG005|Overall Study|Protocol Violation|1|||
130330246|NCT01177397|469178404|FG006|Overall Study|Protocol Violation|0|||
130330247|NCT01177397|469178405|FG007|Overall Study|Protocol Violation|0|||
130330248|NCT01177397|469178406|FG008|Overall Study|Protocol Violation|0|||
130330249|NCT01177397|469178407|FG009|Overall Study|Protocol Violation|0|||
130330250|NCT01177397|469178408|FG010|Overall Study|Protocol Violation|0|||
130330251|NCT01177397|469178409|FG011|Overall Study|Protocol Violation|0|||
129991065|NCT02527343|467931377|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991066|NCT02527343|467931378|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991067|NCT02527343|467931379|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
130330252|NCT01177397|469178398|FG000|Overall Study|Lost to Follow-up|0|||
130330253|NCT01177397|469178399|FG001|Overall Study|Lost to Follow-up|0|||
130330254|NCT01177397|469178400|FG002|Overall Study|Lost to Follow-up|0|||
130330255|NCT01177397|469178401|FG003|Overall Study|Lost to Follow-up|0|||
130330256|NCT01177397|469178402|FG004|Overall Study|Lost to Follow-up|1|||
130330257|NCT01177397|469178403|FG005|Overall Study|Lost to Follow-up|0|||
130330258|NCT01177397|469178404|FG006|Overall Study|Lost to Follow-up|0|||
130330259|NCT01177397|469178405|FG007|Overall Study|Lost to Follow-up|2|||
130330260|NCT01177397|469178406|FG008|Overall Study|Lost to Follow-up|0|||
130330261|NCT01177397|469178407|FG009|Overall Study|Lost to Follow-up|0|||
130330262|NCT01177397|469178408|FG010|Overall Study|Lost to Follow-up|0|||
130330263|NCT01177397|469178409|FG011|Overall Study|Lost to Follow-up|0|||
130330264|NCT01177397|469178398|FG000|Overall Study|Death|0|||
130330265|NCT01177397|469178399|FG001|Overall Study|Death|0|||
130330266|NCT01177397|469178400|FG002|Overall Study|Death|1|||
130330267|NCT01177397|469178401|FG003|Overall Study|Death|1|||
130330268|NCT01177397|469178402|FG004|Overall Study|Death|0|||
130330269|NCT01177397|469178403|FG005|Overall Study|Death|0|||
130330270|NCT01177397|469178404|FG006|Overall Study|Death|0|||
130330271|NCT01177397|469178405|FG007|Overall Study|Death|5|||
130330272|NCT01177397|469178406|FG008|Overall Study|Death|2|||
130330273|NCT01177397|469178407|FG009|Overall Study|Death|1|||
130330274|NCT01177397|469178408|FG010|Overall Study|Death|0|||
130330275|NCT01177397|469178409|FG011|Overall Study|Death|0|||
130330276|NCT01177397|469178398|FG000|Overall Study|Withdrawal by Subject|0|||
130330277|NCT01177397|469178399|FG001|Overall Study|Withdrawal by Subject|0|||
130330278|NCT01177397|469178400|FG002|Overall Study|Withdrawal by Subject|1|||
130330279|NCT01177397|469178401|FG003|Overall Study|Withdrawal by Subject|1|||
130330280|NCT01177397|469178402|FG004|Overall Study|Withdrawal by Subject|1|||
130330281|NCT01177397|469178403|FG005|Overall Study|Withdrawal by Subject|2|||
130330282|NCT01177397|469178404|FG006|Overall Study|Withdrawal by Subject|0|||
130330283|NCT01177397|469178405|FG007|Overall Study|Withdrawal by Subject|5|||
130330284|NCT01177397|469178406|FG008|Overall Study|Withdrawal by Subject|9|||
130330285|NCT01177397|469178407|FG009|Overall Study|Withdrawal by Subject|1|||
130330286|NCT01177397|469178408|FG010|Overall Study|Withdrawal by Subject|1|||
130330287|NCT01177397|469178409|FG011|Overall Study|Withdrawal by Subject|0|||
130330288|NCT01177397|469178398|FG000|Overall Study|Adverse Event|0|||
130330289|NCT01177397|469178399|FG001|Overall Study|Adverse Event|0|||
130330290|NCT01177397|469178400|FG002|Overall Study|Adverse Event|1|||
129991068|NCT02527343|467931380|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991069|NCT02527343|467931381|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
129991070|NCT02527343|467931382|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991071|NCT02527343|467931377|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
129991072|NCT02527343|467931378|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
129991073|NCT02527343|467931379|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
130330291|NCT01177397|469178401|FG003|Overall Study|Adverse Event|2|||
130330292|NCT01177397|469178402|FG004|Overall Study|Adverse Event|0|||
130330293|NCT01177397|469178403|FG005|Overall Study|Adverse Event|12|||
130330294|NCT01177397|469178404|FG006|Overall Study|Adverse Event|1|||
130330295|NCT01177397|469178405|FG007|Overall Study|Adverse Event|14|||
130330296|NCT01177397|469178406|FG008|Overall Study|Adverse Event|8|||
130330297|NCT01177397|469178407|FG009|Overall Study|Adverse Event|6|||
130330298|NCT01177397|469178408|FG010|Overall Study|Adverse Event|3|||
130330299|NCT01177397|469178409|FG011|Overall Study|Adverse Event|7|||
130330300|NCT01177397|469178398|FG000|Overall Study|Disease progression|1|||
130330301|NCT01177397|469178399|FG001|Overall Study|Disease progression|2|||
130330302|NCT01177397|469178400|FG002|Overall Study|Disease progression|5|||
130330303|NCT01177397|469178401|FG003|Overall Study|Disease progression|5|||
130330304|NCT01177397|469178402|FG004|Overall Study|Disease progression|4|||
130330305|NCT01177397|469178403|FG005|Overall Study|Disease progression|10|||
130330306|NCT01177397|469178404|FG006|Overall Study|Disease progression|10|||
130330307|NCT01177397|469178405|FG007|Overall Study|Disease progression|21|||
130330308|NCT01177397|469178406|FG008|Overall Study|Disease progression|18|||
130330309|NCT01177397|469178407|FG009|Overall Study|Disease progression|12|||
130330310|NCT01177397|469178408|FG010|Overall Study|Disease progression|10|||
130330311|NCT01177397|469178409|FG011|Overall Study|Disease progression|8|||
130330312|NCT01177397|469178398|FG000|Overall Study|Other reasons|0|||
130330313|NCT01177397|469178399|FG001|Overall Study|Other reasons|0|||
130330314|NCT01177397|469178400|FG002|Overall Study|Other reasons|1|||
130330315|NCT01177397|469178401|FG003|Overall Study|Other reasons|0|||
129991074|NCT02527343|467931380|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
129991075|NCT02527343|467931381|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
130330316|NCT01177397|469178402|FG004|Overall Study|Other reasons|1|||
130330317|NCT01177397|469178403|FG005|Overall Study|Other reasons|1|||
130330318|NCT01177397|469178404|FG006|Overall Study|Other reasons|2|||
130330319|NCT01177397|469178405|FG007|Overall Study|Other reasons|6|||
129991076|NCT02527343|467931382|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
130330320|NCT01177397|469178406|FG008|Overall Study|Other reasons|10|||
130330321|NCT01177397|469178407|FG009|Overall Study|Other reasons|8|||
130330322|NCT01177397|469178408|FG010|Overall Study|Other reasons|0|||
130330323|NCT01177397|469178409|FG011|Overall Study|Other reasons|2|||
130330324|NCT00118417|469178410|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
130330325|NCT00118417|469178411|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
129991077|NCT00701220|467931383|FG000|Overall Study|Withdrawal by Subject|0|||
129991078|NCT00701220|467931384|FG001|Overall Study|Withdrawal by Subject|2|||
129991079|NCT00701220|467931383|FG000|Overall Study|Protocol Violation|2|||
129991080|NCT00701220|467931384|FG001|Overall Study|Protocol Violation|0|||
129991081|NCT03235284|467931385|FG000|Overall Study|Adverse Event|1|||
129991082|NCT03235284|467931386|FG001|Overall Study|Adverse Event|2|||
129991083|NCT03235284|467931387|FG002|Overall Study|Adverse Event|1|||
129991084|NCT00440999|467931390|FG000|Overall Study|Adverse Event|0|||
129991085|NCT00440999|467931391|FG001|Overall Study|Adverse Event|2|||
129991086|NCT00440999|467931390|FG000|Overall Study|Lack of Efficacy|6|||
129991087|NCT00440999|467931391|FG001|Overall Study|Lack of Efficacy|7|||
129991088|NCT00440999|467931390|FG000|Overall Study|Lost to Follow-up|19|||
129991089|NCT00440999|467931391|FG001|Overall Study|Lost to Follow-up|12|||
129991090|NCT00440999|467931390|FG000|Overall Study|Protocol Violation|1|||
129991091|NCT00440999|467931391|FG001|Overall Study|Protocol Violation|0|||
129991092|NCT00440999|467931390|FG000|Overall Study|Withdrawal by Subject|2|||
129991093|NCT00440999|467931391|FG001|Overall Study|Withdrawal by Subject|5|||
129991094|NCT00440999|467931390|FG000|Overall Study|Subjets missed the visit|1|||
129991095|NCT00440999|467931391|FG001|Overall Study|Subjets missed the visit|0|||
129991096|NCT00440999|467931390|FG000|Overall Study|Mixed infection at entry|1|||
129991097|NCT00440999|467931391|FG001|Overall Study|Mixed infection at entry|0|||
129991098|NCT00440999|467931390|FG000|Overall Study|P. falciparum malaria|5|||
129991099|NCT00440999|467931391|FG001|Overall Study|P. falciparum malaria|14|||
129991100|NCT00440999|467931390|FG000|Overall Study|Subj left hosp without inform staff|0|||
129991101|NCT00440999|467931391|FG001|Overall Study|Subj left hosp without inform staff|1|||
129991102|NCT04745026|467931392|FG000|Overall Study|Physician Decision|1|||
129991103|NCT04745026|467931393|FG001|Overall Study|Physician Decision|0|||
129991104|NCT04745026|467931392|FG000|Overall Study|Adverse Event|2|||
129991105|NCT04745026|467931393|FG001|Overall Study|Adverse Event|2|||
129991106|NCT04745026|467931392|FG000|Overall Study|Protocol Violation|1|||
129991107|NCT04745026|467931393|FG001|Overall Study|Protocol Violation|3|||
129991108|NCT04745026|467931392|FG000|Overall Study|Lost to Follow-up|4|||
129991109|NCT04745026|467931393|FG001|Overall Study|Lost to Follow-up|3|||
129991110|NCT04745026|467931392|FG000|Overall Study|Withdrawal by Subject|5|||
129991111|NCT04745026|467931393|FG001|Overall Study|Withdrawal by Subject|5|||
129991112|NCT05041101|467931394|FG000|Overall Study|Adverse Event|1|||
129991113|NCT05041101|467931395|FG001|Overall Study|Adverse Event|0|||
129991114|NCT05041101|467931396|FG002|Overall Study|Adverse Event|0|||
129991115|NCT05041101|467931394|FG000|Overall Study|Diease Progression|5|||
129991116|NCT05041101|467931395|FG001|Overall Study|Diease Progression|0|||
129991117|NCT05041101|467931396|FG002|Overall Study|Diease Progression|0|||
129991118|NCT01205152|467931397|FG000|Overall Study|Death|1|||
129991119|NCT04426851|467931398|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
129991120|NCT04426851|467931399|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
129991121|NCT04426851|467931398|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
129991122|NCT04426851|467931399|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
129991123|NCT00249002|467931400|FG000|Overall Study|Adverse Event|2|||
129991124|NCT00249002|467931400|FG000|Overall Study|Study cancellation|3|||
129991125|NCT00249002|467931400|FG000|Overall Study|Other|2|||
129991126|NCT03256851|467931401|FG000|Overall Study|Withdrawal by Subject|1|||
129991127|NCT03256851|467931402|FG001|Overall Study|Withdrawal by Subject|0|||
129991128|NCT00986674|467931403|FG000|Overall Study|Lack of Efficacy|28|||
129991129|NCT00986674|467931404|FG001|Overall Study|Lack of Efficacy|25|||
130330326|NCT00118417|469178410|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
130330327|NCT00118417|469178411|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
130330328|NCT00118417|469178410|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
130330329|NCT00118417|469178411|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
130330330|NCT00118417|469178410|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
130330331|NCT00118417|469178411|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
130330332|NCT00118417|469178410|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
129991130|NCT00986674|467931405|FG002|Overall Study|Lack of Efficacy|23|||
129991131|NCT00986674|467931403|FG000|Overall Study|Adverse Event|4|||
129991132|NCT00986674|467931404|FG001|Overall Study|Adverse Event|8|||
129991133|NCT00986674|467931405|FG002|Overall Study|Adverse Event|9|||
129991134|NCT00986674|467931403|FG000|Overall Study|Death|5|||
129991135|NCT00986674|467931404|FG001|Overall Study|Death|0|||
129991136|NCT00986674|467931405|FG002|Overall Study|Death|4|||
129991137|NCT00986674|467931403|FG000|Overall Study|Withdrawal by Subject|6|||
129991138|NCT00986674|467931404|FG001|Overall Study|Withdrawal by Subject|2|||
129991139|NCT00986674|467931405|FG002|Overall Study|Withdrawal by Subject|1|||
129991140|NCT00986674|467931403|FG000|Overall Study|alternative therapy|0|||
130330333|NCT00118417|469178411|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
129991141|NCT00986674|467931404|FG001|Overall Study|alternative therapy|0|||
129991142|NCT00986674|467931405|FG002|Overall Study|alternative therapy|1|||
129991143|NCT00986674|467931403|FG000|Overall Study|not start protocol therapy|4|||
130330334|NCT01383356|469178412|FG000|Period 1|Adverse Event|5|||
130330335|NCT01383356|469178413|FG001|Period 1|Adverse Event|3|||
130330336|NCT01383356|469178412|FG000|Period 1|Non-compliance|3|||
130330337|NCT01383356|469178413|FG001|Period 1|Non-compliance|0|||
130330338|NCT01383356|469178412|FG000|Period 1|Out of Range Mid-study-Test|0|||
130330339|NCT01383356|469178413|FG001|Period 1|Out of Range Mid-study-Test|1|||
130330340|NCT01383356|469178412|FG000|Period 1|Personal|0|||
130330341|NCT01383356|469178413|FG001|Period 1|Personal|2|||
130330342|NCT00998296|469178414|FG000|Overall Study|Progressive disease|0|||
130330343|NCT00998296|469178415|FG001|Overall Study|Progressive disease|1|||
130330344|NCT00998296|469178416|FG002|Overall Study|Progressive disease|0|||
130330345|NCT00998296|469178417|FG003|Overall Study|Progressive disease|0|||
130330346|NCT00998296|469178418|FG004|Overall Study|Progressive disease|0|||
130330347|NCT00998296|469178419|FG005|Overall Study|Progressive disease|0|||
130330348|NCT00998296|469178420|FG006|Overall Study|Progressive disease|1|||
130330349|NCT00998296|469178421|FG007|Overall Study|Progressive disease|0|||
130330350|NCT00998296|469178422|FG008|Overall Study|Progressive disease|0|||
130330351|NCT00998296|469178423|FG009|Overall Study|Progressive disease|14|||
130330352|NCT00998296|469178424|FG010|Overall Study|Progressive disease|5|||
130330353|NCT00998296|469178414|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330354|NCT00998296|469178415|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330355|NCT00998296|469178416|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330356|NCT00998296|469178417|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330357|NCT00998296|469178418|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
130330358|NCT00998296|469178419|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330359|NCT00998296|469178420|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330360|NCT00998296|469178421|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
130330361|NCT00998296|469178422|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
130330362|NCT00998296|469178423|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330363|NCT00998296|469178424|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
130330364|NCT00998296|469178414|FG000|Overall Study|Other adverse event|0|||
130330365|NCT00998296|469178415|FG001|Overall Study|Other adverse event|0|||
130330366|NCT00998296|469178416|FG002|Overall Study|Other adverse event|0|||
130330367|NCT00998296|469178417|FG003|Overall Study|Other adverse event|0|||
130330368|NCT00998296|469178418|FG004|Overall Study|Other adverse event|1|||
130330369|NCT00998296|469178419|FG005|Overall Study|Other adverse event|0|||
130330370|NCT00998296|469178420|FG006|Overall Study|Other adverse event|0|||
130330371|NCT00998296|469178421|FG007|Overall Study|Other adverse event|0|||
130330372|NCT00998296|469178422|FG008|Overall Study|Other adverse event|0|||
130330373|NCT00998296|469178423|FG009|Overall Study|Other adverse event|1|||
130330374|NCT00998296|469178424|FG010|Overall Study|Other adverse event|2|||
130330375|NCT00998296|469178414|FG000|Overall Study|Refused to continue taking trial med.|0|||
130330376|NCT00998296|469178415|FG001|Overall Study|Refused to continue taking trial med.|0|||
130330377|NCT00998296|469178416|FG002|Overall Study|Refused to continue taking trial med.|0|||
130330378|NCT00998296|469178417|FG003|Overall Study|Refused to continue taking trial med.|0|||
130330379|NCT00998296|469178418|FG004|Overall Study|Refused to continue taking trial med.|0|||
130330380|NCT00998296|469178419|FG005|Overall Study|Refused to continue taking trial med.|0|||
130330381|NCT00998296|469178420|FG006|Overall Study|Refused to continue taking trial med.|0|||
130330382|NCT00998296|469178421|FG007|Overall Study|Refused to continue taking trial med.|0|||
130330383|NCT00998296|469178422|FG008|Overall Study|Refused to continue taking trial med.|0|||
130330384|NCT00998296|469178423|FG009|Overall Study|Refused to continue taking trial med.|2|||
130330385|NCT00998296|469178424|FG010|Overall Study|Refused to continue taking trial med.|0|||
130330386|NCT00998296|469178414|FG000|Overall Study|Reason other than those specified above|0|||
130330387|NCT00998296|469178415|FG001|Overall Study|Reason other than those specified above|0|||
130330388|NCT00998296|469178416|FG002|Overall Study|Reason other than those specified above|0|||
130330389|NCT00998296|469178417|FG003|Overall Study|Reason other than those specified above|0|||
130330390|NCT00998296|469178418|FG004|Overall Study|Reason other than those specified above|0|||
130330391|NCT00998296|469178419|FG005|Overall Study|Reason other than those specified above|0|||
130330392|NCT00998296|469178420|FG006|Overall Study|Reason other than those specified above|0|||
130330393|NCT00998296|469178421|FG007|Overall Study|Reason other than those specified above|0|||
130330394|NCT00998296|469178422|FG008|Overall Study|Reason other than those specified above|0|||
130330395|NCT00998296|469178423|FG009|Overall Study|Reason other than those specified above|1|||
130330396|NCT00998296|469178424|FG010|Overall Study|Reason other than those specified above|0|||
130330397|NCT01544335|469178427|FG000|Overall Study|Lost to Follow-up|27|||
130330398|NCT01544335|469178427|FG000|Overall Study|Death|4|||
130330399|NCT01544335|469178427|FG000|Overall Study|Disease progression|3|||
130330400|NCT01544335|469178427|FG000|Overall Study|Baseline Measurements not Available|19|||
129883868|NCT02733042|467534448|FG007|Overall Study|Progressive Disease|3|||
129883869|NCT02733042|467534449|FG008|Overall Study|Progressive Disease|3|||
129883870|NCT02733042|467534450|FG009|Overall Study|Progressive Disease|2|||
129883871|NCT02733042|467534451|FG010|Overall Study|Progressive Disease|2|||
129883872|NCT02733042|467534452|FG011|Overall Study|Progressive Disease|2|||
129883873|NCT02733042|467534453|FG012|Overall Study|Progressive Disease|8|||
130330401|NCT03219528|469178428|FG000|Overall Study|Lost to Follow-up|5|||
130330402|NCT03219528|469178429|FG001|Overall Study|Lost to Follow-up|4|||
130330403|NCT03219528|469178428|FG000|Overall Study|Withdrawal by Subject|4|||
130330404|NCT03219528|469178429|FG001|Overall Study|Withdrawal by Subject|4|||
130330405|NCT02120898|469178432|FG000|Overall Study|Withdrawal by Subject|4|||
130330406|NCT02120898|469178433|FG001|Overall Study|Withdrawal by Subject|2|||
130330407|NCT02120898|469178434|FG002|Overall Study|Withdrawal by Subject|2|||
130330408|NCT02120898|469178432|FG000|Overall Study|Non-compliance with study drug|3|||
130330409|NCT02120898|469178433|FG001|Overall Study|Non-compliance with study drug|0|||
130330410|NCT02120898|469178434|FG002|Overall Study|Non-compliance with study drug|0|||
130330411|NCT02120898|469178432|FG000|Overall Study|Adverse Event|1|||
130330412|NCT02120898|469178433|FG001|Overall Study|Adverse Event|2|||
130330413|NCT02120898|469178434|FG002|Overall Study|Adverse Event|1|||
130330414|NCT02120898|469178432|FG000|Overall Study|Protocol Violation|1|||
130330415|NCT02120898|469178433|FG001|Overall Study|Protocol Violation|2|||
130330416|NCT02120898|469178434|FG002|Overall Study|Protocol Violation|0|||
130330417|NCT02120898|469178432|FG000|Overall Study|Lost to Follow-up|0|||
130330418|NCT02120898|469178433|FG001|Overall Study|Lost to Follow-up|0|||
130330419|NCT02120898|469178434|FG002|Overall Study|Lost to Follow-up|1|||
130330420|NCT04085289|469178435|FG000|Overall Study|Withdrawal by Subject|0|||
130330421|NCT04085289|469178436|FG001|Overall Study|Withdrawal by Subject|0|||
130330422|NCT04085289|469178437|FG002|Overall Study|Withdrawal by Subject|1|||
130330423|NCT02919995|469178440|FG000|Overall Study|Adverse Event|0|||
130330424|NCT02919995|469178441|FG001|Overall Study|Adverse Event|0|||
130330425|NCT02919995|469178442|FG002|Overall Study|Adverse Event|0|||
130330426|NCT02919995|469178443|FG003|Overall Study|Adverse Event|0|||
130330427|NCT02919995|469178444|FG004|Overall Study|Adverse Event|0|||
130330428|NCT02919995|469178445|FG005|Overall Study|Adverse Event|1|||
130330429|NCT02560558|469178447|FG000|Overall Study|Adverse Event|1|||
130330430|NCT02560558|469178448|FG001|Overall Study|Adverse Event|0|||
130330431|NCT02560558|469178447|FG000|Overall Study|Death|0|||
130330432|NCT02560558|469178448|FG001|Overall Study|Death|2|||
130330433|NCT02560558|469178447|FG000|Overall Study|Lost to Follow-up|0|||
130330434|NCT02560558|469178448|FG001|Overall Study|Lost to Follow-up|4|||
130330435|NCT02560558|469178447|FG000|Overall Study|Protocol Violation|3|||
130330436|NCT02560558|469178448|FG001|Overall Study|Protocol Violation|0|||
130330437|NCT02560558|469178447|FG000|Overall Study|Withdrawal by Subject|3|||
130330438|NCT02560558|469178448|FG001|Overall Study|Withdrawal by Subject|0|||
130330439|NCT02454517|469178455|FG000|Overall Study|Withdrawal by Subject|3|||
129991144|NCT00986674|467931404|FG001|Overall Study|not start protocol therapy|3|||
129991145|NCT00986674|467931405|FG002|Overall Study|not start protocol therapy|1|||
129991146|NCT00986674|467931403|FG000|Overall Study|unknown/not specify|0|||
129991147|NCT00986674|467931404|FG001|Overall Study|unknown/not specify|7|||
129991148|NCT00986674|467931405|FG002|Overall Study|unknown/not specify|9|||
129991149|NCT02128542|467931406|FG000|Overall Study|Lost to Follow-up|3|||
129991150|NCT02128542|467931407|FG001|Overall Study|Lost to Follow-up|0|||
129991151|NCT02128542|467931406|FG000|Overall Study|Withdrew Consent|1|||
129991152|NCT02128542|467931407|FG001|Overall Study|Withdrew Consent|0|||
129991153|NCT01778023|467931408|FG000|Overall Study|Withdrawal by Subject|0|||
129991154|NCT01778023|467931409|FG001|Overall Study|Withdrawal by Subject|3|||
130330440|NCT02454517|469178456|FG001|Overall Study|Withdrawal by Subject|0|||
130330441|NCT02454517|469178455|FG000|Overall Study|Lost to Follow-up|4|||
130330442|NCT02454517|469178456|FG001|Overall Study|Lost to Follow-up|7|||
130330443|NCT02454517|469178455|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
130330444|NCT02454517|469178456|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
130330445|NCT00473382|469178457|FG000|Core Study|Adverse Event|3|||
130330446|NCT00473382|469178458|FG001|Core Study|Adverse Event|1|||
130330447|NCT00473382|469178459|FG002|Core Study|Adverse Event|1|||
129991155|NCT01990560|467931410|FG000|Overall Study|Withdrawal by Subject|1|||
129991156|NCT01098097|467931411|FG000|Overall Study|Adverse Event|17|||
129991157|NCT01098097|467931411|FG000|Overall Study|Lost to Follow-up|18|||
129991158|NCT01098097|467931411|FG000|Overall Study|Status unknown|16|||
129991159|NCT01098097|467931411|FG000|Overall Study|No reason reported|31|||
129991160|NCT00966277|467931414|FG000|Overall Study|Withdrawal by Subject|3|||
130330448|NCT00473382|469178457|FG000|Core Study|Death|3|||
130330449|NCT00473382|469178458|FG001|Core Study|Death|5|||
130330450|NCT00473382|469178459|FG002|Core Study|Death|10|||
130330451|NCT00473382|469178457|FG000|Core Study|Lost to Follow-up|3|||
130330452|NCT00473382|469178458|FG001|Core Study|Lost to Follow-up|3|||
130330453|NCT00473382|469178459|FG002|Core Study|Lost to Follow-up|3|||
130330454|NCT00473382|469178457|FG000|Core Study|Physician Decision|1|||
130330455|NCT00473382|469178458|FG001|Core Study|Physician Decision|2|||
130330456|NCT00473382|469178459|FG002|Core Study|Physician Decision|2|||
130330457|NCT00473382|469178457|FG000|Core Study|Subject non-compliance|5|||
130330458|NCT00473382|469178458|FG001|Core Study|Subject non-compliance|2|||
130330459|NCT00473382|469178459|FG002|Core Study|Subject non-compliance|1|||
130330460|NCT00473382|469178457|FG000|Core Study|Subject needed other treatment|1|||
130330461|NCT00473382|469178458|FG001|Core Study|Subject needed other treatment|3|||
130330462|NCT00473382|469178459|FG002|Core Study|Subject needed other treatment|2|||
130330463|NCT00473382|469178457|FG000|Core Study|Subject's decision|12|||
130330464|NCT00473382|469178458|FG001|Core Study|Subject's decision|11|||
130330465|NCT00473382|469178459|FG002|Core Study|Subject's decision|10|||
130330466|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
130330467|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
130330468|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
130330469|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Death|1|||
130330470|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Death|3|||
130330471|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Death|3|||
130330472|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130330473|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
130330474|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130330475|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
130330476|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
130330477|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
130330478|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
130330479|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
130330480|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
130330481|NCT00473382|469178457|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
130330482|NCT00473382|469178458|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
130330483|NCT00473382|469178459|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
130330484|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
130330485|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
130330486|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
130330487|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Death|1|||
130330488|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Death|7|||
130330489|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Death|4|||
130330490|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
130330491|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
130330492|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
130330493|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
130330494|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
130330495|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
130330496|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
130330497|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
130330498|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
130330499|NCT00473382|469178457|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
130330500|NCT00473382|469178458|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
130330501|NCT00473382|469178459|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
130330502|NCT01134055|469178460|FG000|Overall Study|Adverse Event|5|||
130330503|NCT01134055|469178461|FG001|Overall Study|Adverse Event|2|||
130330504|NCT01134055|469178462|FG002|Overall Study|Adverse Event|2|||
130330505|NCT01134055|469178463|FG003|Overall Study|Adverse Event|2|||
130330506|NCT01134055|469178464|FG004|Overall Study|Adverse Event|5|||
130330507|NCT01134055|469178465|FG005|Overall Study|Adverse Event|7|||
130330508|NCT01134055|469178466|FG006|Overall Study|Adverse Event|2|||
130330509|NCT01134055|469178460|FG000|Overall Study|Lost to Follow-up|0|||
130330510|NCT01134055|469178461|FG001|Overall Study|Lost to Follow-up|1|||
130330511|NCT01134055|469178462|FG002|Overall Study|Lost to Follow-up|0|||
130330512|NCT01134055|469178463|FG003|Overall Study|Lost to Follow-up|1|||
130330513|NCT01134055|469178464|FG004|Overall Study|Lost to Follow-up|0|||
130330514|NCT01134055|469178465|FG005|Overall Study|Lost to Follow-up|0|||
130330515|NCT01134055|469178466|FG006|Overall Study|Lost to Follow-up|0|||
130330516|NCT01134055|469178460|FG000|Overall Study|Withdrawal by Subject|3|||
130330517|NCT01134055|469178461|FG001|Overall Study|Withdrawal by Subject|3|||
130330518|NCT01134055|469178462|FG002|Overall Study|Withdrawal by Subject|1|||
130330519|NCT01134055|469178463|FG003|Overall Study|Withdrawal by Subject|2|||
130330520|NCT01134055|469178464|FG004|Overall Study|Withdrawal by Subject|0|||
130330521|NCT01134055|469178465|FG005|Overall Study|Withdrawal by Subject|0|||
130330522|NCT01134055|469178466|FG006|Overall Study|Withdrawal by Subject|8|||
130330523|NCT01134055|469178460|FG000|Overall Study|Protocol Violation|0|||
130330524|NCT01134055|469178461|FG001|Overall Study|Protocol Violation|0|||
130330525|NCT01134055|469178462|FG002|Overall Study|Protocol Violation|0|||
130330526|NCT01134055|469178463|FG003|Overall Study|Protocol Violation|1|||
130330527|NCT01134055|469178464|FG004|Overall Study|Protocol Violation|1|||
130330528|NCT01134055|469178465|FG005|Overall Study|Protocol Violation|0|||
130330529|NCT01134055|469178466|FG006|Overall Study|Protocol Violation|0|||
130330530|NCT01134055|469178460|FG000|Overall Study|Physician Decision|0|||
130330531|NCT01134055|469178461|FG001|Overall Study|Physician Decision|0|||
130330532|NCT01134055|469178462|FG002|Overall Study|Physician Decision|0|||
129991161|NCT00966277|467931415|FG001|Overall Study|Withdrawal by Subject|0|||
129991162|NCT00966277|467931414|FG000|Overall Study|Ineligible|1|||
129991163|NCT00966277|467931415|FG001|Overall Study|Ineligible|3|||
129991164|NCT00966277|467931414|FG000|Overall Study|Treatment Plan Changed|0|||
129991165|NCT00966277|467931415|FG001|Overall Study|Treatment Plan Changed|1|||
129991166|NCT01488487|467931416|FG000|Overall Study|Adverse Event|6|||
129991167|NCT01488487|467931416|FG000|Overall Study|Death|1|||
129991168|NCT01488487|467931416|FG000|Overall Study|Withdrawal by Subject|2|||
129991169|NCT01588496|467931420|FG000|Overall Study|Withdrawal by Subject|0|||
129991170|NCT01588496|467931421|FG001|Overall Study|Withdrawal by Subject|1|||
129991171|NCT01588496|467931422|FG002|Overall Study|Withdrawal by Subject|0|||
129991172|NCT01551212|467931423|FG000|Overall Study|Graft loss/Retransplantation|0|||
129991173|NCT01551212|467931424|FG001|Overall Study|Graft loss/Retransplantation|1|||
129991174|NCT01551212|467931423|FG000|Overall Study|Administrative problems|1|||
129991175|NCT01551212|467931424|FG001|Overall Study|Administrative problems|2|||
129991176|NCT01551212|467931423|FG000|Overall Study|Lost to Follow-up|0|||
129991177|NCT01551212|467931424|FG001|Overall Study|Lost to Follow-up|1|||
129991178|NCT01551212|467931423|FG000|Overall Study|Protocol Violation|0|||
129991179|NCT01551212|467931424|FG001|Overall Study|Protocol Violation|1|||
129991180|NCT01551212|467931423|FG000|Overall Study|Withdrawal by Subject|0|||
129991181|NCT01551212|467931424|FG001|Overall Study|Withdrawal by Subject|7|||
129991182|NCT01551212|467931423|FG000|Overall Study|Death|2|||
130330533|NCT01134055|469178463|FG003|Overall Study|Physician Decision|0|||
130330534|NCT01134055|469178464|FG004|Overall Study|Physician Decision|0|||
130330535|NCT01134055|469178465|FG005|Overall Study|Physician Decision|0|||
130330536|NCT01134055|469178466|FG006|Overall Study|Physician Decision|1|||
130330537|NCT00275509|469178467|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
130330538|NCT00275509|469178468|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
130330539|NCT00594815|469178469|FG000|Overall Study|Never Treated|3|||
130330540|NCT00594815|469178469|FG000|Overall Study|Withdrawal by Subject|2|||
130330541|NCT00594815|469178469|FG000|Overall Study|Toxicity|4|||
130330542|NCT00131248|469178470|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
130330543|NCT00131248|469178471|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
130330544|NCT03023397|469178472|FG000|Run-In|Failed screening allergen challenge|1|||
130330545|NCT03023397|469178473|FG001|Run-In|Failed screening allergen challenge|0|||
130330546|NCT03023397|469178474|FG002|Run-In|Failed screening allergen challenge|0|||
130330547|NCT03023397|469178472|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
130330548|NCT03023397|469178473|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
130330549|NCT03023397|469178474|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
130330550|NCT01146795|469178478|FG000|Overall Study|Withdrawal by Subject|4|||
130330551|NCT01146795|469178478|FG000|Overall Study|Adverse Event|6|||
130330552|NCT01146795|469178478|FG000|Overall Study|Still in treatment at study closure|10|||
130330553|NCT01599637|469178486|FG000|Overall Study|administrative problems|0|||
130330554|NCT01599637|469178487|FG001|Overall Study|administrative problems|2|||
130330555|NCT01599637|469178488|FG002|Overall Study|administrative problems|0|||
130330556|NCT01599637|469178486|FG000|Overall Study|Adverse Event|1|||
130330557|NCT01599637|469178487|FG001|Overall Study|Adverse Event|0|||
130330558|NCT01599637|469178488|FG002|Overall Study|Adverse Event|0|||
130330559|NCT02721966|469178489|FG000|Overall Study|Protocol Violation|1|||
130330560|NCT02721966|469178490|FG001|Overall Study|Protocol Violation|0|||
130215869|NCT02688764|468753871|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
130215870|NCT02688764|468753870|FG000|Overall Study|Non-compl./Withd. subject|0|||
130215871|NCT02688764|468753871|FG001|Overall Study|Non-compl./Withd. subject|2|||
130215872|NCT02688764|468753870|FG000|Overall Study|Phosphorus level outside safe range|0|||
130215873|NCT02688764|468753871|FG001|Overall Study|Phosphorus level outside safe range|1|||
130215874|NCT02688764|468753870|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
130215875|NCT02688764|468753871|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
130330561|NCT02721966|469178491|FG002|Overall Study|Protocol Violation|0|||
130330562|NCT02721966|469178492|FG003|Overall Study|Protocol Violation|0|||
130330563|NCT02721966|469178493|FG004|Overall Study|Protocol Violation|0|||
130330564|NCT02721966|469178489|FG000|Overall Study|Withdrawal by Subject|9|||
130330565|NCT02721966|469178490|FG001|Overall Study|Withdrawal by Subject|2|||
130330566|NCT02721966|469178491|FG002|Overall Study|Withdrawal by Subject|3|||
130330567|NCT02721966|469178492|FG003|Overall Study|Withdrawal by Subject|7|||
130330568|NCT02721966|469178493|FG004|Overall Study|Withdrawal by Subject|0|||
129991183|NCT01551212|467931424|FG001|Overall Study|Death|4|||
130215876|NCT02688764|468753870|FG000|Overall Study|Study drug taste/Withd. parent|1|||
129991184|NCT01551212|467931423|FG000|Overall Study|Never Received Study Treatment|2|||
129991185|NCT01551212|467931424|FG001|Overall Study|Never Received Study Treatment|4|||
129991186|NCT00705523|467931425|FG000|Overall Study|Lost to Follow-up|2|||
129991187|NCT00705523|467931426|FG001|Overall Study|Lost to Follow-up|3|||
129991188|NCT01013285|467931427|FG000|Overall Study|Death|48|||
129991189|NCT01013285|467931428|FG001|Overall Study|Death|89|||
130330569|NCT02721966|469178489|FG000|Overall Study|Adverse Event|4|||
130330570|NCT02721966|469178490|FG001|Overall Study|Adverse Event|4|||
129991190|NCT01242800|467931431|FG000|Overall Study|Patient refusal|0|||
129991191|NCT01242800|467931432|FG001|Overall Study|Patient refusal|10|||
130330571|NCT02721966|469178491|FG002|Overall Study|Adverse Event|3|||
130330572|NCT02721966|469178492|FG003|Overall Study|Adverse Event|0|||
129991192|NCT01242800|467931431|FG000|Overall Study|Physician Decision|0|||
129991193|NCT01242800|467931432|FG001|Overall Study|Physician Decision|1|||
129991194|NCT01242800|467931431|FG000|Overall Study|Disease progression|0|||
130330573|NCT02721966|469178493|FG004|Overall Study|Adverse Event|0|||
130330574|NCT02721966|469178489|FG000|Overall Study|Death|1|||
130330575|NCT02721966|469178490|FG001|Overall Study|Death|0|||
130330576|NCT02721966|469178491|FG002|Overall Study|Death|0|||
129991195|NCT01242800|467931432|FG001|Overall Study|Disease progression|3|||
129991196|NCT01242800|467931431|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
129991197|NCT01242800|467931432|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
129991198|NCT01242800|467931431|FG000|Overall Study|Reasons not reported|0|||
129991199|NCT01242800|467931432|FG001|Overall Study|Reasons not reported|4|||
129991200|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
129991201|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
130330577|NCT02721966|469178492|FG003|Overall Study|Death|0|||
130330578|NCT02721966|469178493|FG004|Overall Study|Death|0|||
130330579|NCT02721966|469178489|FG000|Overall Study|Lack of Efficacy|7|||
130330580|NCT02721966|469178490|FG001|Overall Study|Lack of Efficacy|4|||
130330581|NCT02721966|469178491|FG002|Overall Study|Lack of Efficacy|0|||
130330582|NCT02721966|469178492|FG003|Overall Study|Lack of Efficacy|0|||
130330583|NCT02721966|469178493|FG004|Overall Study|Lack of Efficacy|0|||
130330584|NCT02721966|469178489|FG000|Overall Study|Lost to Follow-up|0|||
129991202|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
129991203|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
129991204|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
129991205|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
129991206|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
129991207|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
130330585|NCT02721966|469178490|FG001|Overall Study|Lost to Follow-up|0|||
130330586|NCT02721966|469178491|FG002|Overall Study|Lost to Follow-up|3|||
130330587|NCT02721966|469178492|FG003|Overall Study|Lost to Follow-up|0|||
130330588|NCT02721966|469178493|FG004|Overall Study|Lost to Follow-up|0|||
130330589|NCT02721966|469178489|FG000|Overall Study|Physician Decision|1|||
130330590|NCT02721966|469178490|FG001|Overall Study|Physician Decision|1|||
130330591|NCT02721966|469178491|FG002|Overall Study|Physician Decision|0|||
130330592|NCT02721966|469178492|FG003|Overall Study|Physician Decision|0|||
130330593|NCT02721966|469178493|FG004|Overall Study|Physician Decision|0|||
130330594|NCT02721966|469178489|FG000|Overall Study|Pregnancy|1|||
130330595|NCT02721966|469178490|FG001|Overall Study|Pregnancy|0|||
130330596|NCT02721966|469178491|FG002|Overall Study|Pregnancy|0|||
130330597|NCT02721966|469178492|FG003|Overall Study|Pregnancy|0|||
130330598|NCT02721966|469178493|FG004|Overall Study|Pregnancy|0|||
130330599|NCT02721966|469178489|FG000|Overall Study|Did not continue to period 2|5|||
130330600|NCT02721966|469178490|FG001|Overall Study|Did not continue to period 2|12|||
130330601|NCT02721966|469178491|FG002|Overall Study|Did not continue to period 2|0|||
130330602|NCT02721966|469178492|FG003|Overall Study|Did not continue to period 2|0|||
130330603|NCT02721966|469178493|FG004|Overall Study|Did not continue to period 2|5|||
130330604|NCT03857867|469178494|FG000|Overall Study|Physician Decision|1|||
130330605|NCT02157883|469178495|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
130330606|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
130330607|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
130330608|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
130330609|NCT02157883|469178495|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
130330610|NCT01106248|469178497|FG000|Overall Study|Adverse Event|1|||
130330611|NCT01106248|469178497|FG000|Overall Study|Administrative|2|||
129991208|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
129991209|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
129991210|NCT00953745|467931433|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
129991211|NCT00953745|467931434|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
129991212|NCT02640157|467931438|FG000|Overall Study|Adverse Event|2|||
129991213|NCT02640157|467931439|FG001|Overall Study|Adverse Event|2|||
129991214|NCT02640157|467931440|FG002|Overall Study|Adverse Event|1|||
130330612|NCT00357903|469178498|FG000|Overall Study|Adverse Event|87|||
130330613|NCT00357903|469178499|FG001|Overall Study|Adverse Event|4|||
130330614|NCT00357903|469178498|FG000|Overall Study|Death|33|||
130330615|NCT00357903|469178499|FG001|Overall Study|Death|0|||
130330616|NCT00357903|469178498|FG000|Overall Study|Lost to Follow-up|23|||
130330617|NCT00357903|469178499|FG001|Overall Study|Lost to Follow-up|4|||
130330618|NCT00357903|469178498|FG000|Overall Study|Physician Decision|39|||
130330619|NCT00357903|469178499|FG001|Overall Study|Physician Decision|5|||
130330620|NCT00357903|469178498|FG000|Overall Study|Withdrawal by Subject|57|||
130330621|NCT00357903|469178499|FG001|Overall Study|Withdrawal by Subject|7|||
130330622|NCT00357903|469178498|FG000|Overall Study|Completed month 12 only|0|||
130330623|NCT00357903|469178499|FG001|Overall Study|Completed month 12 only|1|||
130330624|NCT00357903|469178498|FG000|Overall Study|Protocol issues|14|||
130330625|NCT00357903|469178499|FG001|Overall Study|Protocol issues|3|||
130330626|NCT00357903|469178498|FG000|Overall Study|Response status|61|||
130330627|NCT00357903|469178499|FG001|Overall Study|Response status|9|||
130330628|NCT00357903|469178498|FG000|Overall Study|Other|49|||
130330629|NCT00357903|469178499|FG001|Overall Study|Other|10|||
130330630|NCT00606593|469178500|FG000|Overall Study|Adverse Event|0|||
130330631|NCT00606593|469178501|FG001|Overall Study|Adverse Event|0|||
130330632|NCT00606593|469178502|FG002|Overall Study|Adverse Event|0|||
130330633|NCT00606593|469178503|FG003|Overall Study|Adverse Event|1|||
130330634|NCT00606593|469178504|FG004|Overall Study|Adverse Event|1|||
130330635|NCT00606593|469178505|FG005|Overall Study|Adverse Event|0|||
130330636|NCT00606593|469178506|FG006|Overall Study|Adverse Event|1|||
130330637|NCT00606593|469178507|FG007|Overall Study|Adverse Event|2|||
130330638|NCT00606593|469178508|FG008|Overall Study|Adverse Event|1|||
130330639|NCT00606593|469178509|FG009|Overall Study|Adverse Event|0|||
130330640|NCT00606593|469178500|FG000|Overall Study|Withdrawal of consent|1|||
130330641|NCT00606593|469178501|FG001|Overall Study|Withdrawal of consent|0|||
130330642|NCT00606593|469178502|FG002|Overall Study|Withdrawal of consent|1|||
130330643|NCT00606593|469178503|FG003|Overall Study|Withdrawal of consent|0|||
130330644|NCT00606593|469178504|FG004|Overall Study|Withdrawal of consent|0|||
130330645|NCT00606593|469178505|FG005|Overall Study|Withdrawal of consent|0|||
130330646|NCT00606593|469178506|FG006|Overall Study|Withdrawal of consent|0|||
130330647|NCT00606593|469178507|FG007|Overall Study|Withdrawal of consent|0|||
130330648|NCT00606593|469178508|FG008|Overall Study|Withdrawal of consent|0|||
130330649|NCT00606593|469178509|FG009|Overall Study|Withdrawal of consent|0|||
130330650|NCT00606593|469178500|FG000|Overall Study|Administrative/Other|0|||
130330651|NCT00606593|469178501|FG001|Overall Study|Administrative/Other|0|||
130330652|NCT00606593|469178502|FG002|Overall Study|Administrative/Other|1|||
130330653|NCT00606593|469178503|FG003|Overall Study|Administrative/Other|0|||
130330654|NCT00606593|469178504|FG004|Overall Study|Administrative/Other|0|||
130330655|NCT00606593|469178505|FG005|Overall Study|Administrative/Other|0|||
130330656|NCT00606593|469178506|FG006|Overall Study|Administrative/Other|0|||
130330657|NCT00606593|469178507|FG007|Overall Study|Administrative/Other|0|||
130330658|NCT00606593|469178508|FG008|Overall Study|Administrative/Other|0|||
130330659|NCT00606593|469178509|FG009|Overall Study|Administrative/Other|0|||
130330660|NCT03181529|469178510|FG000|Overall Study|Withdrawal by Subject|1|||
130330661|NCT03181529|469178511|FG001|Overall Study|Withdrawal by Subject|1|||
130330662|NCT03181529|469178510|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
130330663|NCT03181529|469178511|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
130330664|NCT02374450|469178512|FG000|Overall Study|Protocol Violation|0|||
130330665|NCT02374450|469178513|FG001|Overall Study|Protocol Violation|1|||
130330666|NCT02374450|469178514|FG002|Overall Study|Protocol Violation|0|||
130330667|NCT02374450|469178512|FG000|Overall Study|Withdrawal by Subject|91|||
130330668|NCT02374450|469178513|FG001|Overall Study|Withdrawal by Subject|110|||
130330669|NCT02374450|469178514|FG002|Overall Study|Withdrawal by Subject|4|||
130330670|NCT02374450|469178512|FG000|Overall Study|Lost to Follow-up|168|||
130330671|NCT02374450|469178513|FG001|Overall Study|Lost to Follow-up|194|||
130330672|NCT02374450|469178514|FG002|Overall Study|Lost to Follow-up|138|||
130330673|NCT02374450|469178512|FG000|Overall Study|Death|173|||
130330674|NCT02374450|469178513|FG001|Overall Study|Death|185|||
130330675|NCT02374450|469178514|FG002|Overall Study|Death|81|||
130330676|NCT02374450|469178512|FG000|Overall Study|Migrated from the study area|538|||
130330677|NCT02374450|469178513|FG001|Overall Study|Migrated from the study area|648|||
130330678|NCT02374450|469178514|FG002|Overall Study|Migrated from the study area|181|||
130330679|NCT02374450|469178512|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
130330680|NCT02374450|469178513|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
130330681|NCT02374450|469178514|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
130330682|NCT02374450|469178512|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
130330683|NCT02374450|469178513|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
130330684|NCT02374450|469178514|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
130330685|NCT02374450|469178512|FG000|Overall Study|Other|0|||
130330686|NCT02374450|469178513|FG001|Overall Study|Other|21|||
130330687|NCT02374450|469178514|FG002|Overall Study|Other|79|||
130330688|NCT01442103|469180122|FG000|Overall Study|Lost to Follow-up|2|||
130330689|NCT02202759|469180123|FG000|Overall Study|Study Terminated by Sponsor|3|||
130330690|NCT02202759|469180124|FG001|Overall Study|Study Terminated by Sponsor|3|||
130330691|NCT02202759|469180125|FG002|Overall Study|Study Terminated by Sponsor|3|||
130330692|NCT02202759|469180123|FG000|Overall Study|Withdrawal by Subject|2|||
130330693|NCT02202759|469180124|FG001|Overall Study|Withdrawal by Subject|1|||
130330694|NCT02202759|469180125|FG002|Overall Study|Withdrawal by Subject|1|||
130330695|NCT02202759|469180123|FG000|Overall Study|Reason not Specified|4|||
130330696|NCT02202759|469180124|FG001|Overall Study|Reason not Specified|11|||
130330697|NCT02202759|469180125|FG002|Overall Study|Reason not Specified|10|||
130330698|NCT01987453|469180126|FG000|Overall Study|Death|0|||
130330699|NCT01987453|469180127|FG001|Overall Study|Death|0|||
130330700|NCT01987453|469180128|FG002|Overall Study|Death|1|||
130330701|NCT01987453|469180126|FG000|Overall Study|Lack of Efficacy|1|||
130330702|NCT01987453|469180127|FG001|Overall Study|Lack of Efficacy|12|||
130330703|NCT01987453|469180128|FG002|Overall Study|Lack of Efficacy|0|||
130330704|NCT01590888|469180130|FG000|Overall Study|Adverse Event|3|||
130330705|NCT01590888|469180131|FG001|Overall Study|Adverse Event|0|||
130330706|NCT01590888|469180132|FG002|Overall Study|Adverse Event|1|||
130330707|NCT01590888|469180130|FG000|Overall Study|Lost to Follow-up|1|||
130330708|NCT01590888|469180131|FG001|Overall Study|Lost to Follow-up|0|||
130330709|NCT01590888|469180132|FG002|Overall Study|Lost to Follow-up|0|||
130330710|NCT04953728|469180133|FG000|Overall Study|Withdrawal by Subject|3|||
130330711|NCT04953728|469180133|FG000|Overall Study|Physician Decision|1|||
130330712|NCT02105662|469180134|FG000|Overall Study|Lost to Follow-up|5|||
130330713|NCT02105662|469180134|FG000|Overall Study|Withdrawal by Subject|1|||
130330714|NCT02331277|469180137|FG000|Overall Study|Withdrawal by Subject|1|||
130330715|NCT02331277|469180138|FG001|Overall Study|Withdrawal by Subject|0|||
130330716|NCT03978117|469180139|FG000|Overall Study|Non-Compliance|26|||
130330717|NCT03978117|469180140|FG001|Overall Study|Non-Compliance|26|||
130330718|NCT03978117|469180139|FG000|Overall Study|Lost to Follow-up|4|||
130330719|NCT03978117|469180140|FG001|Overall Study|Lost to Follow-up|4|||
130330720|NCT01528969|469180147|FG000|Overall Study|absent from the school at baseline|2|||
130330721|NCT01528969|469180148|FG001|Overall Study|absent from the school at baseline|0|||
130330722|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
130330723|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
130330724|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
130330725|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130330726|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130330727|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130330728|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
130330729|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
130330730|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130330731|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
130330732|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
130330733|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
130330734|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
130330735|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
130330736|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
130330737|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130330738|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130330739|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130330740|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130330741|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130330742|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130330743|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
130330744|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129991215|NCT02640157|467931438|FG000|Overall Study|Withdrew consent|2|||
129991216|NCT02640157|467931439|FG001|Overall Study|Withdrew consent|0|||
129991217|NCT02640157|467931440|FG002|Overall Study|Withdrew consent|2|||
129991218|NCT02640157|467931438|FG000|Overall Study|Lost to Follow-up|9|||
129991219|NCT02640157|467931439|FG001|Overall Study|Lost to Follow-up|2|||
129991220|NCT02640157|467931440|FG002|Overall Study|Lost to Follow-up|7|||
129991221|NCT02640157|467931438|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
129991222|NCT02640157|467931439|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
129991223|NCT02640157|467931440|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
129991224|NCT01679405|467931442|FG000|Overall Study|Death|2|||
129991225|NCT01679405|467931443|FG001|Overall Study|Death|5|||
129991226|NCT04677179|467931444|FG000|Induction Treatment Period|Adverse Event|1|||
129991227|NCT04677179|467931445|FG001|Induction Treatment Period|Adverse Event|0|||
129991228|NCT04677179|467931446|FG002|Induction Treatment Period|Adverse Event|0|||
130330745|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130330746|NCT01106690|469180149|FG000|Core Period: Baseline to Week 26|Other|10|||
130330747|NCT01106690|469180150|FG001|Core Period: Baseline to Week 26|Other|2|||
130330748|NCT01106690|469180151|FG002|Core Period: Baseline to Week 26|Other|6|||
130330749|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130215877|NCT02688764|468753871|FG001|Overall Study|Study drug taste/Withd. parent|0|||
130330750|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130330751|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129991229|NCT04677179|467931447|FG003|Induction Treatment Period|Adverse Event|0|||
129991230|NCT04677179|467931448|FG004|Induction Treatment Period|Adverse Event|0|||
129991231|NCT04677179|467931449|FG005|Induction Treatment Period|Adverse Event|0|||
129991232|NCT04677179|467931450|FG006|Induction Treatment Period|Adverse Event|0|||
129991233|NCT04677179|467931451|FG007|Induction Treatment Period|Adverse Event|0|||
129991234|NCT04677179|467931452|FG008|Induction Treatment Period|Adverse Event|0|||
129991235|NCT04677179|467931453|FG009|Induction Treatment Period|Adverse Event|0|||
129991236|NCT04677179|467931444|FG000|Induction Treatment Period|Physician Decision|1|||
129991237|NCT04677179|467931445|FG001|Induction Treatment Period|Physician Decision|0|||
129991238|NCT04677179|467931446|FG002|Induction Treatment Period|Physician Decision|1|||
129991239|NCT04677179|467931447|FG003|Induction Treatment Period|Physician Decision|0|||
129991240|NCT04677179|467931448|FG004|Induction Treatment Period|Physician Decision|0|||
129991241|NCT04677179|467931449|FG005|Induction Treatment Period|Physician Decision|0|||
129991242|NCT04677179|467931450|FG006|Induction Treatment Period|Physician Decision|0|||
129991243|NCT04677179|467931451|FG007|Induction Treatment Period|Physician Decision|0|||
129991244|NCT04677179|467931452|FG008|Induction Treatment Period|Physician Decision|0|||
129991245|NCT04677179|467931453|FG009|Induction Treatment Period|Physician Decision|0|||
129991246|NCT04677179|467931444|FG000|Induction Treatment Period|Protocol Violation|0|||
129991247|NCT04677179|467931445|FG001|Induction Treatment Period|Protocol Violation|1|||
129991248|NCT04677179|467931446|FG002|Induction Treatment Period|Protocol Violation|0|||
129991249|NCT04677179|467931447|FG003|Induction Treatment Period|Protocol Violation|0|||
129991250|NCT04677179|467931448|FG004|Induction Treatment Period|Protocol Violation|0|||
129991251|NCT04677179|467931449|FG005|Induction Treatment Period|Protocol Violation|0|||
129991252|NCT04677179|467931450|FG006|Induction Treatment Period|Protocol Violation|0|||
129991253|NCT04677179|467931451|FG007|Induction Treatment Period|Protocol Violation|0|||
129991254|NCT04677179|467931452|FG008|Induction Treatment Period|Protocol Violation|0|||
129991255|NCT04677179|467931453|FG009|Induction Treatment Period|Protocol Violation|0|||
129991256|NCT04677179|467931444|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
129991257|NCT04677179|467931445|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
129991258|NCT04677179|467931446|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
129991259|NCT04677179|467931447|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
129991260|NCT04677179|467931448|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
129991261|NCT04677179|467931449|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
129991262|NCT04677179|467931450|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
129991263|NCT04677179|467931451|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
129991264|NCT04677179|467931452|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
129991265|NCT04677179|467931453|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
129991266|NCT04677179|467931444|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
129991267|NCT04677179|467931445|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
129991268|NCT04677179|467931446|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
129991269|NCT04677179|467931447|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
129991270|NCT04677179|467931448|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
129991271|NCT04677179|467931449|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
129991272|NCT04677179|467931450|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
129991273|NCT04677179|467931451|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
129991274|NCT04677179|467931452|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
129991275|NCT04677179|467931453|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
129991276|NCT04677179|467931444|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
129991277|NCT04677179|467931445|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
129991278|NCT04677179|467931446|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
129991279|NCT04677179|467931447|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
129991280|NCT04677179|467931448|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
129991281|NCT04677179|467931449|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
129991282|NCT04677179|467931450|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
129991283|NCT04677179|467931451|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
129991284|NCT04677179|467931452|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
129991285|NCT04677179|467931453|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
129991286|NCT04677179|467931444|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991287|NCT04677179|467931445|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991288|NCT04677179|467931446|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991289|NCT04677179|467931447|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
129991290|NCT04677179|467931448|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
130330752|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130330753|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130330754|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129991291|NCT04677179|467931449|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991292|NCT04677179|467931450|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991293|NCT04677179|467931451|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991294|NCT04677179|467931452|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991295|NCT04677179|467931453|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991296|NCT04677179|467931444|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991297|NCT04677179|467931445|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991298|NCT04677179|467931446|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991299|NCT04677179|467931447|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
129991300|NCT04677179|467931448|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
129991301|NCT04677179|467931449|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
129991302|NCT04677179|467931450|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991303|NCT04677179|467931451|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991304|NCT04677179|467931452|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991305|NCT04677179|467931453|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991306|NCT04677179|467931444|FG000|Extension Treatment Period|Lack of Efficacy|0|||
129991307|NCT04677179|467931445|FG001|Extension Treatment Period|Lack of Efficacy|0|||
130330755|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130330756|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130330757|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130330758|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130330759|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130330760|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
129991308|NCT04677179|467931446|FG002|Extension Treatment Period|Lack of Efficacy|0|||
129991309|NCT04677179|467931447|FG003|Extension Treatment Period|Lack of Efficacy|0|||
129991310|NCT04677179|467931448|FG004|Extension Treatment Period|Lack of Efficacy|0|||
129991311|NCT04677179|467931449|FG005|Extension Treatment Period|Lack of Efficacy|0|||
129991312|NCT04677179|467931450|FG006|Extension Treatment Period|Lack of Efficacy|6|||
129991313|NCT04677179|467931451|FG007|Extension Treatment Period|Lack of Efficacy|0|||
129991314|NCT04677179|467931452|FG008|Extension Treatment Period|Lack of Efficacy|0|||
129991315|NCT04677179|467931453|FG009|Extension Treatment Period|Lack of Efficacy|0|||
130330761|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130330762|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130330763|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130330764|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Other|8|||
130330765|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Other|3|||
130330766|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130330767|NCT01106690|469180149|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130330768|NCT01106690|469180150|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130330769|NCT01106690|469180151|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130330770|NCT04614974|469180157|FG000|Overall Study|Lost to Follow-up|14|||
130330771|NCT04614974|469180158|FG001|Overall Study|Lost to Follow-up|11|||
130330772|NCT01635153|469180159|FG000|Overall Study|Lost to Follow-up|40|||
130330773|NCT01635153|469180160|FG001|Overall Study|Lost to Follow-up|43|||
130330774|NCT01263197|469180172|FG000|First Intervention (Period 1)|Adverse Event|0|||
130330775|NCT01263197|469180173|FG001|First Intervention (Period 1)|Adverse Event|0|||
130330776|NCT01263197|469180174|FG002|First Intervention (Period 1)|Adverse Event|0|||
130330777|NCT01263197|469180175|FG003|First Intervention (Period 1)|Adverse Event|0|||
130330778|NCT01263197|469180176|FG004|First Intervention (Period 1)|Adverse Event|0|||
130330779|NCT01263197|469180177|FG005|First Intervention (Period 1)|Adverse Event|1|||
130330780|NCT01263197|469180172|FG000|Washout Period 1|Protocol Violation|0|||
130330781|NCT01263197|469180173|FG001|Washout Period 1|Protocol Violation|0|||
130330782|NCT01263197|469180174|FG002|Washout Period 1|Protocol Violation|0|||
130330783|NCT01263197|469180175|FG003|Washout Period 1|Protocol Violation|0|||
130330784|NCT01263197|469180176|FG004|Washout Period 1|Protocol Violation|1|||
130330785|NCT01263197|469180177|FG005|Washout Period 1|Protocol Violation|0|||
130330786|NCT01263197|469180172|FG000|Washout Period 2|Physician Decision|0|||
130330787|NCT01263197|469180173|FG001|Washout Period 2|Physician Decision|0|||
130330788|NCT01263197|469180174|FG002|Washout Period 2|Physician Decision|0|||
130330789|NCT01263197|469180175|FG003|Washout Period 2|Physician Decision|0|||
130330790|NCT01263197|469180176|FG004|Washout Period 2|Physician Decision|0|||
130330791|NCT01263197|469180177|FG005|Washout Period 2|Physician Decision|1|||
130330792|NCT01263197|469180172|FG000|Washout Period 2|Protocol Violation|0|||
130330793|NCT01263197|469180173|FG001|Washout Period 2|Protocol Violation|0|||
130330794|NCT01263197|469180174|FG002|Washout Period 2|Protocol Violation|0|||
130330795|NCT01263197|469180175|FG003|Washout Period 2|Protocol Violation|1|||
130330796|NCT01263197|469180176|FG004|Washout Period 2|Protocol Violation|0|||
130330797|NCT01263197|469180177|FG005|Washout Period 2|Protocol Violation|0|||
130330798|NCT01263197|469180172|FG000|Third Intervention (Period 3)|Adverse Event|0|||
130330799|NCT01263197|469180173|FG001|Third Intervention (Period 3)|Adverse Event|1|||
129991316|NCT04677179|467931444|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
129991317|NCT04677179|467931445|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130215878|NCT02688764|468753870|FG000|Overall Study|Subject moving out|2|||
130330800|NCT01263197|469180174|FG002|Third Intervention (Period 3)|Adverse Event|0|||
130330801|NCT01263197|469180175|FG003|Third Intervention (Period 3)|Adverse Event|0|||
129991318|NCT04677179|467931446|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129991319|NCT04677179|467931447|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
129991320|NCT04677179|467931448|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
129991321|NCT04677179|467931449|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
129991322|NCT04677179|467931450|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
129991323|NCT04677179|467931451|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
129991324|NCT04677179|467931452|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
129991325|NCT04677179|467931453|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
129991326|NCT04677179|467931444|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
129991327|NCT04677179|467931445|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
129991328|NCT04677179|467931446|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
129991329|NCT04677179|467931447|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
129991330|NCT04677179|467931448|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
129991331|NCT04677179|467931449|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
129991332|NCT04677179|467931450|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
129991333|NCT04677179|467931451|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
129991334|NCT04677179|467931452|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
130330802|NCT01263197|469180176|FG004|Third Intervention (Period 3)|Adverse Event|0|||
130330803|NCT01263197|469180177|FG005|Third Intervention (Period 3)|Adverse Event|0|||
130330804|NCT02892448|469180178|FG000|Overall Study|Screening failure|2|||
130330805|NCT02892448|469180179|FG001|Overall Study|Screening failure|2|||
130330806|NCT02892448|469180180|FG002|Overall Study|Screening failure|1|||
129991335|NCT04677179|467931453|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
129991336|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
129991337|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
129991338|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
129991339|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
129991340|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
129991341|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
129991342|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
129991343|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
129991344|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
129991345|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
129991346|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991347|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991348|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991349|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991350|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991351|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991352|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991353|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
129991354|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
129991355|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991356|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991357|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991358|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991359|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991360|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991361|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991362|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991363|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
129991364|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991365|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991366|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991367|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991368|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991369|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991370|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991371|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991372|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991373|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
129991374|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
130330807|NCT00499083|469180181|FG000|Overall Study|Not evaluable|3|||
130330808|NCT00686686|469180182|FG000|Overall Study|Non-compliance|1|||
130330809|NCT00686686|469180182|FG000|Overall Study|Adverse Event|2|||
129991375|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991376|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991377|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
130215879|NCT02688764|468753871|FG001|Overall Study|Subject moving out|0|||
129991378|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991379|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991380|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991381|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991382|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991383|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
129991384|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
129991385|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
129991386|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
129991387|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
129991388|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
129991389|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
129991390|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
129991391|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
129991392|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
129991393|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
129991394|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
129991395|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
129991396|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
129991397|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
129991398|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
129991399|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
129991400|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
129991401|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
129991402|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
129991403|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
129991404|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
129991405|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
129991406|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
129991407|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
129991408|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
129991409|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
129991410|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
129991411|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
129991412|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
129991413|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
129991414|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Death|1|||
129991415|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Death|1|||
129991416|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
129991417|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
129991418|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
129991419|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
129991420|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
129991421|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
130215880|NCT02688764|468753870|FG000|Overall Study|Subject taken off dialysis|1|||
130215881|NCT02688764|468753871|FG001|Overall Study|Subject taken off dialysis|0|||
130215882|NCT02688764|468753870|FG000|Overall Study|Withdrawal by parent|3|||
130215883|NCT02688764|468753871|FG001|Overall Study|Withdrawal by parent|0|||
130215884|NCT02113007|468753872|FG000|Overall Study|Progressive disease|2|||
130215885|NCT00885378|468753873|FG000|Overall Study|Lack of Efficacy|2|||
129991422|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
129991423|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
129991424|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
129991425|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
129991426|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
129991427|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
129991428|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
129991429|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
129991430|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Death|1|||
129991431|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Death|0|||
129991432|NCT03075410|467931458|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
129991433|NCT03075410|467931459|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
130215886|NCT00885378|468753874|FG001|Overall Study|Lack of Efficacy|2|||
130215887|NCT00885378|468753873|FG000|Overall Study|Withdrawal by Subject|1|||
130215888|NCT00885378|468753874|FG001|Overall Study|Withdrawal by Subject|2|||
130215889|NCT00885378|468753873|FG000|Overall Study|Lost to Follow-up|1|||
130215890|NCT00885378|468753874|FG001|Overall Study|Lost to Follow-up|2|||
129991434|NCT03075410|467931460|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
129991435|NCT03075410|467931461|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991436|NCT03075410|467931462|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991437|NCT03075410|467931463|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991438|NCT03075410|467931464|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991439|NCT03075410|467931465|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991440|NCT03075410|467931466|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991441|NCT03075410|467931458|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
129991442|NCT03075410|467931459|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991443|NCT03075410|467931460|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991444|NCT03075410|467931461|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991445|NCT03075410|467931462|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991446|NCT03075410|467931463|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991447|NCT03075410|467931464|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991448|NCT03075410|467931465|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991449|NCT03075410|467931466|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991450|NCT01427751|467931467|FG000|Overall Study|Adverse Event|18|||
129991451|NCT01427751|467931468|FG001|Overall Study|Adverse Event|2|||
129991452|NCT01427751|467931467|FG000|Overall Study|No further treatment benefit expected|5|||
129991453|NCT01427751|467931468|FG001|Overall Study|No further treatment benefit expected|1|||
129991454|NCT01427751|467931467|FG000|Overall Study|Lost to Follow-up|3|||
129991455|NCT01427751|467931468|FG001|Overall Study|Lost to Follow-up|1|||
129991456|NCT01427751|467931467|FG000|Overall Study|Withdrawal of consent|2|||
129991457|NCT01427751|467931468|FG001|Overall Study|Withdrawal of consent|2|||
129991458|NCT01427751|467931467|FG000|Overall Study|Protocol Violation|6|||
129991459|NCT01427751|467931468|FG001|Overall Study|Protocol Violation|4|||
129991460|NCT01427751|467931467|FG000|Overall Study|Death|2|||
129991461|NCT01427751|467931468|FG001|Overall Study|Death|0|||
129991462|NCT01427751|467931467|FG000|Overall Study|Other miscellaneous reasons|6|||
129991463|NCT01427751|467931468|FG001|Overall Study|Other miscellaneous reasons|4|||
129991464|NCT03534284|467931479|FG000|Overall Study|Death|2|||
129991465|NCT03534284|467931480|FG001|Overall Study|Death|3|||
129991466|NCT03534284|467931481|FG002|Overall Study|Death|3|||
129991467|NCT03534284|467931479|FG000|Overall Study|Withdrawal by Subject|5|||
129991468|NCT03534284|467931480|FG001|Overall Study|Withdrawal by Subject|0|||
129991469|NCT03534284|467931481|FG002|Overall Study|Withdrawal by Subject|0|||
129991470|NCT04737187|467931482|FG000|Overall Study|Switched to marketed drug|32|||
129991471|NCT04737187|467931483|FG001|Overall Study|Switched to marketed drug|4|||
129991472|NCT04737187|467931482|FG000|Overall Study|Radiological Progressive Disease|145|||
129991473|NCT04737187|467931483|FG001|Overall Study|Radiological Progressive Disease|146|||
129991474|NCT04737187|467931482|FG000|Overall Study|Clinical Progressive Disease|20|||
129991475|NCT04737187|467931483|FG001|Overall Study|Clinical Progressive Disease|20|||
129991476|NCT04737187|467931482|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
129991477|NCT04737187|467931483|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
129991478|NCT04737187|467931482|FG000|Overall Study|Adverse Event|16|||
129991479|NCT04737187|467931483|FG001|Overall Study|Adverse Event|16|||
129991480|NCT04737187|467931482|FG000|Overall Study|Physician Decision|2|||
129991481|NCT04737187|467931483|FG001|Overall Study|Physician Decision|0|||
129991482|NCT04737187|467931482|FG000|Overall Study|Withdrawal by Subject|5|||
129991483|NCT04737187|467931483|FG001|Overall Study|Withdrawal by Subject|8|||
129991484|NCT03756129|467931484|FG000|Overall Study|Adverse Event|1|||
129991485|NCT03756129|467931485|FG001|Overall Study|Adverse Event|1|||
129991486|NCT03756129|467931486|FG002|Overall Study|Adverse Event|0|||
129991487|NCT03756129|467931487|FG003|Overall Study|Adverse Event|2|||
129991488|NCT03756129|467931488|FG004|Overall Study|Adverse Event|0|||
129991489|NCT03756129|467931489|FG005|Overall Study|Adverse Event|0|||
129991490|NCT03756129|467931484|FG000|Overall Study|Withdrawal by Subject|2|||
129991491|NCT03756129|467931485|FG001|Overall Study|Withdrawal by Subject|1|||
129991492|NCT03756129|467931486|FG002|Overall Study|Withdrawal by Subject|3|||
129991493|NCT03756129|467931487|FG003|Overall Study|Withdrawal by Subject|1|||
129991494|NCT03756129|467931488|FG004|Overall Study|Withdrawal by Subject|1|||
129991495|NCT03756129|467931489|FG005|Overall Study|Withdrawal by Subject|3|||
129991496|NCT03756129|467931484|FG000|Overall Study|Lost to Follow-up|0|||
129991497|NCT03756129|467931485|FG001|Overall Study|Lost to Follow-up|0|||
129991498|NCT03756129|467931486|FG002|Overall Study|Lost to Follow-up|0|||
129991499|NCT03756129|467931487|FG003|Overall Study|Lost to Follow-up|0|||
129991500|NCT03756129|467931488|FG004|Overall Study|Lost to Follow-up|0|||
129991501|NCT03756129|467931489|FG005|Overall Study|Lost to Follow-up|1|||
129991502|NCT03756129|467931484|FG000|Overall Study|Physician Decision|0|||
129991503|NCT03756129|467931485|FG001|Overall Study|Physician Decision|0|||
129991504|NCT03756129|467931486|FG002|Overall Study|Physician Decision|0|||
129991505|NCT03756129|467931487|FG003|Overall Study|Physician Decision|0|||
129991506|NCT03756129|467931488|FG004|Overall Study|Physician Decision|0|||
129991507|NCT03756129|467931489|FG005|Overall Study|Physician Decision|1|||
129991508|NCT03035201|467931490|FG000|Overall Study|Death|9|||
129991509|NCT03035201|467931491|FG001|Overall Study|Death|12|||
129991510|NCT03035201|467931492|FG002|Overall Study|Death|9|||
129991511|NCT03035201|467931493|FG003|Overall Study|Death|10|||
129991512|NCT03035201|467931490|FG000|Overall Study|Withdrawal by Subject|51|||
129991513|NCT03035201|467931491|FG001|Overall Study|Withdrawal by Subject|49|||
129991514|NCT03035201|467931492|FG002|Overall Study|Withdrawal by Subject|37|||
129991515|NCT03035201|467931493|FG003|Overall Study|Withdrawal by Subject|46|||
129991516|NCT03035201|467931490|FG000|Overall Study|Lost to Follow-up|67|||
129991517|NCT03035201|467931491|FG001|Overall Study|Lost to Follow-up|51|||
129991518|NCT03035201|467931492|FG002|Overall Study|Lost to Follow-up|64|||
129991519|NCT03035201|467931493|FG003|Overall Study|Lost to Follow-up|69|||
129991520|NCT03319849|467931494|FG000|Overall Study|Adverse Event|1|||
129991521|NCT03319849|467931495|FG001|Overall Study|Adverse Event|0|||
129991522|NCT03319849|467931494|FG000|Overall Study|Physician Decision|0|||
129991523|NCT03319849|467931495|FG001|Overall Study|Physician Decision|1|||
129991524|NCT03319849|467931494|FG000|Overall Study|Withdrawal by Subject|0|||
129991525|NCT03319849|467931495|FG001|Overall Study|Withdrawal by Subject|1|||
129991526|NCT03319849|467931494|FG000|Overall Study|COVID-19|0|||
129991527|NCT03319849|467931495|FG001|Overall Study|COVID-19|1|||
129991528|NCT03319849|467931494|FG000|Overall Study|Other|1|||
129991529|NCT03319849|467931495|FG001|Overall Study|Other|2|||
129991530|NCT03319849|467931494|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
129991531|NCT03319849|467931495|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
129991532|NCT03319849|467931494|FG000|Overall Study|Lost to Follow-up|0|||
129991533|NCT03319849|467931495|FG001|Overall Study|Lost to Follow-up|2|||
129991534|NCT03727438|467931501|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
129991535|NCT03727438|467931502|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
129991536|NCT03727438|467931501|FG000|Intervention Period|Excluded (health)|1|||
129991537|NCT03727438|467931502|FG001|Intervention Period|Excluded (health)|0|||
129991538|NCT03727438|467931501|FG000|Intervention Period|Withdrawal by Subject|3|||
129991539|NCT03727438|467931502|FG001|Intervention Period|Withdrawal by Subject|1|||
129991540|NCT03727438|467931501|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
129991541|NCT03727438|467931502|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
129991542|NCT03727438|467931501|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
129991543|NCT03727438|467931502|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
129991544|NCT03727438|467931501|FG000|8 Week Assessment|Withdrawal by Subject|6|||
129991545|NCT03727438|467931502|FG001|8 Week Assessment|Withdrawal by Subject|1|||
129991546|NCT03727438|467931501|FG000|6 mo Assessment|did not complete assessment|10|||
129991547|NCT03727438|467931502|FG001|6 mo Assessment|did not complete assessment|11|||
129991557|NCT05195489|467934060|FG000|Overall Study|Lost to Follow-up|1|||
129991558|NCT05195489|467934061|FG001|Overall Study|Lost to Follow-up|0|||
129991559|NCT05195489|467934060|FG000|Overall Study|Protocol Violation|0|||
129991560|NCT05195489|467934061|FG001|Overall Study|Protocol Violation|2|||
129991561|NCT05195489|467934060|FG000|Overall Study|Withdrawal by Subject|1|||
129991562|NCT05195489|467934061|FG001|Overall Study|Withdrawal by Subject|1|||
129991563|NCT05195489|467934060|FG000|Overall Study|Removed|0|||
129991564|NCT05195489|467934061|FG001|Overall Study|Removed|1|||
129991565|NCT04812548|467934062|FG000|Overall Study|Adverse Event|2|||
129991566|NCT04812548|467934063|FG001|Overall Study|Adverse Event|7|||
129991567|NCT04812548|467934062|FG000|Overall Study|HSCT Planned|2|||
129991568|NCT04812548|467934063|FG001|Overall Study|HSCT Planned|3|||
129991569|NCT04812548|467934062|FG000|Overall Study|Progressive Disease|0|||
129991570|NCT04812548|467934063|FG001|Overall Study|Progressive Disease|2|||
129991571|NCT04812548|467934062|FG000|Overall Study|Death|0|||
129991572|NCT04812548|467934063|FG001|Overall Study|Death|1|||
129991573|NCT04812548|467934062|FG000|Overall Study|Post Study Access to Treatment|0|||
129991574|NCT04812548|467934063|FG001|Overall Study|Post Study Access to Treatment|1|||
129991575|NCT04812548|467934062|FG000|Overall Study|Withdrawal by Subject|0|||
129991576|NCT04812548|467934063|FG001|Overall Study|Withdrawal by Subject|1|||
129991577|NCT04812548|467934062|FG000|Overall Study|Physician Decision|1|||
130330810|NCT00686686|469180182|FG000|Overall Study|Lost to Follow-up|3|||
129991578|NCT04812548|467934063|FG001|Overall Study|Physician Decision|0|||
129991579|NCT03184870|467934066|FG000|Initial Treatment|Death|6|||
129991580|NCT03184870|467934067|FG001|Initial Treatment|Death|6|||
130330811|NCT01012440|469180183|FG000|Overall Study|Withdrawal by Subject|2|||
129991581|NCT03184870|467934068|FG002|Initial Treatment|Death|8|||
129991582|NCT03184870|467934069|FG003|Initial Treatment|Death|8|||
129991583|NCT03184870|467934070|FG004|Initial Treatment|Death|6|||
129991584|NCT03184870|467934071|FG005|Initial Treatment|Death|6|||
129991585|NCT03184870|467934072|FG006|Initial Treatment|Death|6|||
129991586|NCT03184870|467934073|FG007|Initial Treatment|Death|7|||
129991587|NCT03184870|467934074|FG008|Initial Treatment|Death|1|||
129991588|NCT03184870|467934075|FG009|Initial Treatment|Death|2|||
129991589|NCT03184870|467934076|FG010|Initial Treatment|Death|26|||
129991590|NCT03184870|467934077|FG011|Initial Treatment|Death|28|||
129991591|NCT03184870|467934078|FG012|Initial Treatment|Death|10|||
129991592|NCT03184870|467934079|FG013|Initial Treatment|Death|33|||
129991593|NCT03184870|467934080|FG014|Initial Treatment|Death|34|||
129991594|NCT03184870|467934081|FG015|Initial Treatment|Death|26|||
129991595|NCT03184870|467934082|FG016|Initial Treatment|Death|20|||
129991596|NCT03184870|467934083|FG017|Initial Treatment|Death|18|||
129991597|NCT03184870|467934066|FG000|Initial Treatment|Other Reasons|2|||
129991598|NCT03184870|467934067|FG001|Initial Treatment|Other Reasons|2|||
129991599|NCT03184870|467934068|FG002|Initial Treatment|Other Reasons|0|||
129991600|NCT03184870|467934069|FG003|Initial Treatment|Other Reasons|1|||
129991601|NCT03184870|467934070|FG004|Initial Treatment|Other Reasons|0|||
129991602|NCT03184870|467934071|FG005|Initial Treatment|Other Reasons|0|||
129991603|NCT03184870|467934072|FG006|Initial Treatment|Other Reasons|0|||
129991604|NCT03184870|467934073|FG007|Initial Treatment|Other Reasons|2|||
129991605|NCT03184870|467934074|FG008|Initial Treatment|Other Reasons|0|||
129991606|NCT03184870|467934075|FG009|Initial Treatment|Other Reasons|0|||
129991607|NCT03184870|467934076|FG010|Initial Treatment|Other Reasons|4|||
129991608|NCT03184870|467934077|FG011|Initial Treatment|Other Reasons|2|||
129991609|NCT03184870|467934078|FG012|Initial Treatment|Other Reasons|2|||
129991610|NCT03184870|467934079|FG013|Initial Treatment|Other Reasons|0|||
129991611|NCT03184870|467934080|FG014|Initial Treatment|Other Reasons|0|||
129991612|NCT03184870|467934081|FG015|Initial Treatment|Other Reasons|1|||
129991613|NCT03184870|467934082|FG016|Initial Treatment|Other Reasons|0|||
129991614|NCT03184870|467934083|FG017|Initial Treatment|Other Reasons|2|||
129991615|NCT03184870|467934066|FG000|Initial Treatment|Lost to Follow-up|2|||
129991616|NCT03184870|467934067|FG001|Initial Treatment|Lost to Follow-up|0|||
129991617|NCT03184870|467934068|FG002|Initial Treatment|Lost to Follow-up|0|||
129991618|NCT03184870|467934069|FG003|Initial Treatment|Lost to Follow-up|1|||
129991619|NCT03184870|467934070|FG004|Initial Treatment|Lost to Follow-up|1|||
129991620|NCT03184870|467934071|FG005|Initial Treatment|Lost to Follow-up|1|||
129991621|NCT03184870|467934072|FG006|Initial Treatment|Lost to Follow-up|0|||
129991622|NCT03184870|467934073|FG007|Initial Treatment|Lost to Follow-up|2|||
129991623|NCT03184870|467934074|FG008|Initial Treatment|Lost to Follow-up|0|||
129991624|NCT03184870|467934075|FG009|Initial Treatment|Lost to Follow-up|0|||
129991625|NCT03184870|467934076|FG010|Initial Treatment|Lost to Follow-up|2|||
129991626|NCT03184870|467934077|FG011|Initial Treatment|Lost to Follow-up|0|||
129991627|NCT03184870|467934078|FG012|Initial Treatment|Lost to Follow-up|2|||
129991628|NCT03184870|467934079|FG013|Initial Treatment|Lost to Follow-up|2|||
129991629|NCT03184870|467934080|FG014|Initial Treatment|Lost to Follow-up|0|||
129991630|NCT03184870|467934081|FG015|Initial Treatment|Lost to Follow-up|0|||
129991631|NCT03184870|467934082|FG016|Initial Treatment|Lost to Follow-up|2|||
129991632|NCT03184870|467934083|FG017|Initial Treatment|Lost to Follow-up|2|||
129991633|NCT03184870|467934066|FG000|Initial Treatment|Withdrawal by Subject|0|||
129991634|NCT03184870|467934067|FG001|Initial Treatment|Withdrawal by Subject|0|||
129991635|NCT03184870|467934068|FG002|Initial Treatment|Withdrawal by Subject|2|||
129991636|NCT03184870|467934069|FG003|Initial Treatment|Withdrawal by Subject|1|||
129991637|NCT03184870|467934070|FG004|Initial Treatment|Withdrawal by Subject|1|||
129991638|NCT03184870|467934071|FG005|Initial Treatment|Withdrawal by Subject|0|||
129991639|NCT03184870|467934072|FG006|Initial Treatment|Withdrawal by Subject|1|||
129991640|NCT03184870|467934073|FG007|Initial Treatment|Withdrawal by Subject|0|||
129991641|NCT03184870|467934074|FG008|Initial Treatment|Withdrawal by Subject|0|||
129991642|NCT03184870|467934075|FG009|Initial Treatment|Withdrawal by Subject|0|||
129991643|NCT03184870|467934076|FG010|Initial Treatment|Withdrawal by Subject|0|||
129991644|NCT03184870|467934077|FG011|Initial Treatment|Withdrawal by Subject|2|||
129991645|NCT03184870|467934078|FG012|Initial Treatment|Withdrawal by Subject|3|||
130330812|NCT01254422|469180187|FG000|Overall Study|Protocol Violation|1|||
130330813|NCT01254422|469180188|FG001|Overall Study|Protocol Violation|0|||
129991646|NCT03184870|467934079|FG013|Initial Treatment|Withdrawal by Subject|0|||
129991647|NCT03184870|467934080|FG014|Initial Treatment|Withdrawal by Subject|1|||
129991648|NCT03184870|467934081|FG015|Initial Treatment|Withdrawal by Subject|5|||
129991649|NCT03184870|467934082|FG016|Initial Treatment|Withdrawal by Subject|2|||
129991650|NCT03184870|467934083|FG017|Initial Treatment|Withdrawal by Subject|2|||
130330814|NCT01254422|469180187|FG000|Overall Study|Adverse Event|1|||
129991651|NCT03184870|467934066|FG000|Initial Treatment|Moved to crossover treatment|0|||
129991652|NCT03184870|467934067|FG001|Initial Treatment|Moved to crossover treatment|0|||
129991653|NCT03184870|467934068|FG002|Initial Treatment|Moved to crossover treatment|0|||
129991654|NCT03184870|467934069|FG003|Initial Treatment|Moved to crossover treatment|0|||
129991655|NCT03184870|467934070|FG004|Initial Treatment|Moved to crossover treatment|0|||
129991656|NCT03184870|467934071|FG005|Initial Treatment|Moved to crossover treatment|0|||
130330815|NCT01254422|469180188|FG001|Overall Study|Adverse Event|0|||
129991657|NCT03184870|467934072|FG006|Initial Treatment|Moved to crossover treatment|0|||
129991658|NCT03184870|467934073|FG007|Initial Treatment|Moved to crossover treatment|0|||
129991659|NCT03184870|467934074|FG008|Initial Treatment|Moved to crossover treatment|0|||
129991660|NCT03184870|467934075|FG009|Initial Treatment|Moved to crossover treatment|0|||
129991661|NCT03184870|467934076|FG010|Initial Treatment|Moved to crossover treatment|0|||
129991662|NCT03184870|467934077|FG011|Initial Treatment|Moved to crossover treatment|0|||
129991663|NCT03184870|467934078|FG012|Initial Treatment|Moved to crossover treatment|9|||
129991664|NCT03184870|467934079|FG013|Initial Treatment|Moved to crossover treatment|0|||
129991665|NCT03184870|467934080|FG014|Initial Treatment|Moved to crossover treatment|0|||
129991666|NCT03184870|467934081|FG015|Initial Treatment|Moved to crossover treatment|0|||
129991667|NCT03184870|467934082|FG016|Initial Treatment|Moved to crossover treatment|0|||
129991668|NCT03184870|467934083|FG017|Initial Treatment|Moved to crossover treatment|0|||
129991669|NCT03184870|467934066|FG000|Crossover Treatment|Other reasons|0|||
129991670|NCT03184870|467934067|FG001|Crossover Treatment|Other reasons|0|||
129991671|NCT03184870|467934068|FG002|Crossover Treatment|Other reasons|0|||
129991672|NCT03184870|467934069|FG003|Crossover Treatment|Other reasons|0|||
129991673|NCT03184870|467934070|FG004|Crossover Treatment|Other reasons|0|||
129991674|NCT03184870|467934071|FG005|Crossover Treatment|Other reasons|0|||
129991675|NCT03184870|467934072|FG006|Crossover Treatment|Other reasons|0|||
129991676|NCT03184870|467934073|FG007|Crossover Treatment|Other reasons|0|||
129991677|NCT03184870|467934074|FG008|Crossover Treatment|Other reasons|0|||
129991678|NCT03184870|467934075|FG009|Crossover Treatment|Other reasons|0|||
129991679|NCT03184870|467934076|FG010|Crossover Treatment|Other reasons|0|||
129991680|NCT03184870|467934077|FG011|Crossover Treatment|Other reasons|0|||
129991681|NCT03184870|467934078|FG012|Crossover Treatment|Other reasons|0|||
129991682|NCT03184870|467934079|FG013|Crossover Treatment|Other reasons|0|||
129991683|NCT03184870|467934080|FG014|Crossover Treatment|Other reasons|0|||
129991684|NCT03184870|467934081|FG015|Crossover Treatment|Other reasons|0|||
129991685|NCT03184870|467934082|FG016|Crossover Treatment|Other reasons|0|||
129991686|NCT03184870|467934083|FG017|Crossover Treatment|Other reasons|2|||
129991687|NCT03184870|467934066|FG000|Crossover Treatment|Death|0|||
129991688|NCT03184870|467934067|FG001|Crossover Treatment|Death|0|||
129991689|NCT03184870|467934068|FG002|Crossover Treatment|Death|0|||
129991690|NCT03184870|467934069|FG003|Crossover Treatment|Death|0|||
129991691|NCT03184870|467934070|FG004|Crossover Treatment|Death|0|||
129991692|NCT03184870|467934071|FG005|Crossover Treatment|Death|0|||
129991693|NCT03184870|467934072|FG006|Crossover Treatment|Death|0|||
129991694|NCT03184870|467934073|FG007|Crossover Treatment|Death|0|||
129991695|NCT03184870|467934074|FG008|Crossover Treatment|Death|0|||
129991696|NCT03184870|467934075|FG009|Crossover Treatment|Death|0|||
129991697|NCT03184870|467934076|FG010|Crossover Treatment|Death|0|||
129991698|NCT03184870|467934077|FG011|Crossover Treatment|Death|0|||
129991699|NCT03184870|467934078|FG012|Crossover Treatment|Death|0|||
129991700|NCT03184870|467934079|FG013|Crossover Treatment|Death|0|||
129991701|NCT03184870|467934080|FG014|Crossover Treatment|Death|0|||
129991702|NCT03184870|467934081|FG015|Crossover Treatment|Death|0|||
129991703|NCT03184870|467934082|FG016|Crossover Treatment|Death|0|||
129991704|NCT03184870|467934083|FG017|Crossover Treatment|Death|7|||
129991713|NCT03786783|467934087|FG000|Overall Study|Death|1|||
129991714|NCT03786783|467934087|FG000|Overall Study|Physician Decision|6|||
129991715|NCT03786783|467934087|FG000|Overall Study|Withdrawal by Subject|2|||
129991716|NCT03786783|467934087|FG000|Overall Study|Disease Progression|7|||
129991717|NCT03786783|467934087|FG000|Overall Study|Patient/Parent Refusal|4|||
129991718|NCT04363801|467934091|FG000|Overall Study|Death|18|||
130330816|NCT01254422|469180187|FG000|Overall Study|Serious adverse event|0|||
130330817|NCT01254422|469180188|FG001|Overall Study|Serious adverse event|1|||
129991719|NCT04363801|467934092|FG001|Overall Study|Death|14|||
129991720|NCT04363801|467934093|FG002|Overall Study|Death|16|||
129991721|NCT04363801|467934094|FG003|Overall Study|Death|48|||
129991722|NCT04363801|467934095|FG004|Overall Study|Death|38|||
129991723|NCT04363801|467934091|FG000|Overall Study|Withdrawal by Subject|1|||
129991724|NCT04363801|467934092|FG001|Overall Study|Withdrawal by Subject|6|||
129991725|NCT04363801|467934093|FG002|Overall Study|Withdrawal by Subject|1|||
129991726|NCT04363801|467934094|FG003|Overall Study|Withdrawal by Subject|4|||
130330818|NCT01254422|469180187|FG000|Overall Study|Lost to Follow-up|1|||
129991727|NCT04363801|467934095|FG004|Overall Study|Withdrawal by Subject|14|||
129991728|NCT04363801|467934091|FG000|Overall Study|Sponsor Decision|6|||
129991729|NCT04363801|467934092|FG001|Overall Study|Sponsor Decision|4|||
129991730|NCT04363801|467934093|FG002|Overall Study|Sponsor Decision|10|||
129991731|NCT04363801|467934094|FG003|Overall Study|Sponsor Decision|33|||
129991732|NCT04363801|467934095|FG004|Overall Study|Sponsor Decision|32|||
129991733|NCT04363801|467934091|FG000|Overall Study|Lost to Follow-up|0|||
129991734|NCT04363801|467934092|FG001|Overall Study|Lost to Follow-up|0|||
129991735|NCT04363801|467934093|FG002|Overall Study|Lost to Follow-up|1|||
129991736|NCT04363801|467934094|FG003|Overall Study|Lost to Follow-up|0|||
129991737|NCT04363801|467934095|FG004|Overall Study|Lost to Follow-up|1|||
129991738|NCT06336603|467934098|FG000|Overall Study|Withdrawal by Subject|1|||
129991739|NCT06336603|467934098|FG000|Overall Study|Lost to Follow-up|2|||
129991753|NCT04776148|467934104|FG000|Overall Study|Death|249|||
129991754|NCT04776148|467934105|FG001|Overall Study|Death|260|||
129991755|NCT04776148|467934104|FG000|Overall Study|Lost to Follow-up|0|||
129991756|NCT04776148|467934105|FG001|Overall Study|Lost to Follow-up|1|||
129991757|NCT04776148|467934104|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129991758|NCT04776148|467934105|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129991759|NCT04776148|467934104|FG000|Overall Study|Withdrawal by Subject|3|||
129991760|NCT04776148|467934105|FG001|Overall Study|Withdrawal by Subject|4|||
129991761|NCT04776148|467934104|FG000|Overall Study|Sponsor Decision|30|||
129991762|NCT04776148|467934105|FG001|Overall Study|Sponsor Decision|15|||
129991763|NCT02563522|467934106|FG000|Overall Study|Adverse Event|2|||
129991764|NCT02563522|467934107|FG001|Overall Study|Adverse Event|3|||
129991765|NCT02563522|467934106|FG000|Overall Study|Lost to Follow-up|1|||
129991766|NCT02563522|467934107|FG001|Overall Study|Lost to Follow-up|0|||
129991767|NCT02563522|467934106|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
129991768|NCT02563522|467934107|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
129991769|NCT05754333|467934108|FG000|Overall Study|Miscellaneous|3|||
129991770|NCT05754333|467934109|FG001|Overall Study|Miscellaneous|0|||
129991771|NCT05754333|467934110|FG002|Overall Study|Miscellaneous|0|||
129991772|NCT05754333|467934111|FG003|Overall Study|Miscellaneous|0|||
129991773|NCT05754333|467934108|FG000|Overall Study|Lost to Follow-up|2|||
129991774|NCT05754333|467934109|FG001|Overall Study|Lost to Follow-up|1|||
129991775|NCT05754333|467934110|FG002|Overall Study|Lost to Follow-up|0|||
129991776|NCT05754333|467934111|FG003|Overall Study|Lost to Follow-up|1|||
129991777|NCT04874415|467934112|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991778|NCT04874415|467934113|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991779|NCT04874415|467934114|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991780|NCT04874415|467934115|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991781|NCT04874415|467934116|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991782|NCT04874415|467934117|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991783|NCT04874415|467934118|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991784|NCT04874415|467934119|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991785|NCT04874415|467934120|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
129991786|NCT04874415|467934121|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991787|NCT04874415|467934122|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991788|NCT04874415|467934123|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991789|NCT04874415|467934124|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991790|NCT04874415|467934125|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991791|NCT04874415|467934126|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
129991792|NCT04874415|467934127|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991793|NCT04874415|467934112|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991794|NCT04874415|467934113|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991795|NCT04874415|467934114|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991796|NCT04874415|467934115|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991797|NCT04874415|467934116|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991798|NCT04874415|467934117|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991799|NCT04874415|467934118|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991800|NCT04874415|467934119|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991801|NCT04874415|467934120|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991802|NCT04874415|467934121|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
129991803|NCT04874415|467934122|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991804|NCT04874415|467934123|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991805|NCT04874415|467934124|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991806|NCT04874415|467934125|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
130330819|NCT01254422|469180188|FG001|Overall Study|Lost to Follow-up|0|||
130330820|NCT00643162|469180189|FG000|Overall Study|Withdrawal by Subject|1|||
130330821|NCT00643162|469180190|FG001|Overall Study|Withdrawal by Subject|1|||
130330822|NCT02691507|469180191|FG000|Overall Study|Missed Visit 3|0|||
130330823|NCT02691507|469180192|FG001|Overall Study|Missed Visit 3|1|||
129991807|NCT04874415|467934126|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991808|NCT04874415|467934127|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991809|NCT04874415|467934112|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991810|NCT04874415|467934113|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991811|NCT04874415|467934114|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991812|NCT04874415|467934115|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991813|NCT04874415|467934116|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
129991814|NCT04874415|467934117|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991815|NCT04874415|467934118|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991816|NCT04874415|467934119|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991817|NCT04874415|467934120|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991818|NCT04874415|467934121|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991819|NCT04874415|467934122|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991820|NCT04874415|467934123|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991821|NCT04874415|467934124|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991822|NCT04874415|467934125|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991823|NCT04874415|467934126|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991824|NCT04874415|467934127|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991825|NCT01312857|467934128|FG000|Overall Study|Adverse Event|1|||
129991826|NCT01312857|467934129|FG001|Overall Study|Adverse Event|1|||
129991827|NCT01312857|467934128|FG000|Overall Study|Lost to Follow-up|2|||
129991828|NCT01312857|467934129|FG001|Overall Study|Lost to Follow-up|0|||
129991829|NCT01312857|467934128|FG000|Overall Study|Physician Decision|3|||
129991830|NCT01312857|467934129|FG001|Overall Study|Physician Decision|0|||
129991831|NCT01312857|467934128|FG000|Overall Study|Withdrawal by Subject|2|||
129991832|NCT01312857|467934129|FG001|Overall Study|Withdrawal by Subject|0|||
129991840|NCT01382706|467934133|FG000|Overall Study|Adverse Event|1|||
129991841|NCT01382706|467934133|FG000|Overall Study|Withdrawal by Subject|1|||
129991842|NCT05559099|467934134|FG000|Overall Study|Death|5|||
129991843|NCT05559099|467934135|FG001|Overall Study|Death|4|||
129991844|NCT05559099|467934134|FG000|Overall Study|Lost to Follow-up|0|||
129991845|NCT05559099|467934135|FG001|Overall Study|Lost to Follow-up|2|||
129991846|NCT05559099|467934134|FG000|Overall Study|Adverse Event|1|||
129991847|NCT05559099|467934135|FG001|Overall Study|Adverse Event|1|||
129991848|NCT04018092|467934136|FG000|Overall Study|Withdrawal by Subject|1|||
129991849|NCT04018092|467934137|FG001|Overall Study|Withdrawal by Subject|1|||
129991850|NCT04018092|467934136|FG000|Overall Study|Withdrawal by Subject|1|||
129991851|NCT04018092|467934137|FG001|Overall Study|Withdrawal by Subject|1|||
129991864|NCT05218499|467934140|FG000|Overall Study|Not treated|1|||
129991865|NCT05218499|467934141|FG001|Overall Study|Not treated|1|||
129991866|NCT05218499|467934142|FG002|Overall Study|Not treated|8|||
129991867|NCT05218499|467934140|FG000|Overall Study|Death|2|||
129991868|NCT05218499|467934141|FG001|Overall Study|Death|0|||
129991869|NCT05218499|467934142|FG002|Overall Study|Death|0|||
129991870|NCT05218499|467934140|FG000|Overall Study|Other than listed|3|||
129991871|NCT05218499|467934141|FG001|Overall Study|Other than listed|7|||
129991872|NCT05218499|467934142|FG002|Overall Study|Other than listed|10|||
130330824|NCT00541385|469180193|FG000|Overall Study|Adverse Event|6|||
130330825|NCT00541385|469180194|FG001|Overall Study|Adverse Event|3|||
130330826|NCT00541385|469180193|FG000|Overall Study|Withdrawal by Subject|2|||
129991873|NCT05218499|467934140|FG000|Overall Study|Protocol deviation|5|||
129991874|NCT05218499|467934141|FG001|Overall Study|Protocol deviation|6|||
129991875|NCT05218499|467934142|FG002|Overall Study|Protocol deviation|4|||
129991876|NCT05218499|467934140|FG000|Overall Study|Technical problems|0|||
129991877|NCT05218499|467934141|FG001|Overall Study|Technical problems|1|||
129991878|NCT05218499|467934142|FG002|Overall Study|Technical problems|0|||
129991879|NCT05218499|467934140|FG000|Overall Study|Burden of trial procedures|0|||
129991880|NCT05218499|467934141|FG001|Overall Study|Burden of trial procedures|1|||
129991881|NCT05218499|467934142|FG002|Overall Study|Burden of trial procedures|2|||
129991882|NCT05218499|467934140|FG000|Overall Study|Clinical disease progression|6|||
129991883|NCT05218499|467934141|FG001|Overall Study|Clinical disease progression|6|||
129991884|NCT05218499|467934142|FG002|Overall Study|Clinical disease progression|11|||
129991885|NCT05218499|467934140|FG000|Overall Study|Objective disease progression|44|||
129991886|NCT05218499|467934141|FG001|Overall Study|Objective disease progression|61|||
129991887|NCT05218499|467934142|FG002|Overall Study|Objective disease progression|42|||
129991888|NCT05218499|467934140|FG000|Overall Study|Adverse Event|11|||
129991889|NCT05218499|467934141|FG001|Overall Study|Adverse Event|36|||
129991890|NCT05218499|467934142|FG002|Overall Study|Adverse Event|9|||
129991891|NCT05218499|467934140|FG000|Overall Study|On treatment at time of snapshot|18|||
129991892|NCT05218499|467934141|FG001|Overall Study|On treatment at time of snapshot|29|||
129991893|NCT05218499|467934142|FG002|Overall Study|On treatment at time of snapshot|0|||
129991894|NCT04055090|467934143|FG000|Overall Study|screen failure|1|||
129991895|NCT04055090|467934144|FG001|Overall Study|screen failure|0|||
129991896|NCT04055090|467934143|FG000|Overall Study|Withdrawal by Subject|1|||
129991897|NCT04055090|467934144|FG001|Overall Study|Withdrawal by Subject|0|||
129991898|NCT04572841|467934148|FG000|Overall Study|Adverse Event|1|||
129991899|NCT04572841|467934149|FG001|Overall Study|Adverse Event|1|||
129991900|NCT04572841|467934148|FG000|Overall Study|Withdrawal by Subject|2|||
129991901|NCT04572841|467934149|FG001|Overall Study|Withdrawal by Subject|1|||
129991902|NCT06469242|467934150|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
129991903|NCT06469242|467934151|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
129991904|NCT06469242|467934150|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
129991905|NCT06469242|467934151|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
129991912|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
129991913|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
129991914|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
129991915|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
129991916|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
129991917|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
129991918|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
129991919|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
130098726|NCT03426995|468319310|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
130098727|NCT03426995|468319292|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098728|NCT03426995|468319293|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098729|NCT03426995|468319294|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098730|NCT03426995|468319295|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098731|NCT03426995|468319296|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098732|NCT03426995|468319297|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
130330827|NCT00541385|469180194|FG001|Overall Study|Withdrawal by Subject|2|||
129991920|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991921|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991922|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991923|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
129991924|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991925|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991926|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991927|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991928|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991929|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991930|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
129991931|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991932|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991933|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
130098733|NCT03426995|468319298|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129991934|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991935|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991936|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
129991937|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
129991938|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991939|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991940|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991941|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129991942|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991943|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991944|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991945|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129991946|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129991947|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991948|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991949|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991950|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991951|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
129991952|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991953|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991954|NCT04494256|467934158|FG000|Part 2: Open Label Period|Death|0|||
129991955|NCT04494256|467934159|FG001|Part 2: Open Label Period|Death|0|||
129991956|NCT04494256|467934160|FG002|Part 2: Open Label Period|Death|0|||
129991957|NCT04494256|467934161|FG003|Part 2: Open Label Period|Death|0|||
129991958|NCT04494256|467934162|FG004|Part 2: Open Label Period|Death|0|||
129991959|NCT04494256|467934163|FG005|Part 2: Open Label Period|Death|4|||
129991960|NCT04494256|467934164|FG006|Part 2: Open Label Period|Death|2|||
129991961|NCT04494256|467934158|FG000|Part 2: Open Label Period|Adverse Event|0|||
129991962|NCT04494256|467934159|FG001|Part 2: Open Label Period|Adverse Event|0|||
129991963|NCT04494256|467934160|FG002|Part 2: Open Label Period|Adverse Event|0|||
129991964|NCT04494256|467934161|FG003|Part 2: Open Label Period|Adverse Event|0|||
129991965|NCT04494256|467934162|FG004|Part 2: Open Label Period|Adverse Event|0|||
129991966|NCT04494256|467934163|FG005|Part 2: Open Label Period|Adverse Event|0|||
129991967|NCT04494256|467934164|FG006|Part 2: Open Label Period|Adverse Event|2|||
129991968|NCT04494256|467934158|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991969|NCT04494256|467934159|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991970|NCT04494256|467934160|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991971|NCT04494256|467934161|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991972|NCT04494256|467934162|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991973|NCT04494256|467934163|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
129991974|NCT04494256|467934164|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
129991975|NCT04494256|467934158|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130215891|NCT00885378|468753873|FG000|Overall Study|Poor/Noncompliance|2|||
130215892|NCT00885378|468753874|FG001|Overall Study|Poor/Noncompliance|2|||
130330828|NCT00541385|469180193|FG000|Overall Study|Lost to Follow-up|6|||
130330829|NCT00541385|469180194|FG001|Overall Study|Lost to Follow-up|1|||
130330830|NCT00541385|469180193|FG000|Overall Study|Parasite reappearance/malaria|67|||
130330831|NCT00541385|469180194|FG001|Overall Study|Parasite reappearance/malaria|32|||
130330832|NCT04139798|469180196|FG000|Overall Study|Withdrawal by Subject|6|||
130330833|NCT04139798|469180197|FG001|Overall Study|Withdrawal by Subject|5|||
130330834|NCT04139798|469180196|FG000|Overall Study|Lost to Follow-up|2|||
130330835|NCT04139798|469180197|FG001|Overall Study|Lost to Follow-up|5|||
130330836|NCT04139798|469180196|FG000|Overall Study|Discontinued|4|||
130330837|NCT04139798|469180197|FG001|Overall Study|Discontinued|2|||
130330838|NCT04139798|469180196|FG000|Overall Study|Adverse Event|1|||
130330839|NCT04139798|469180197|FG001|Overall Study|Adverse Event|3|||
130330840|NCT04139798|469180196|FG000|Overall Study|Protocol Violation|1|||
130330841|NCT04139798|469180197|FG001|Overall Study|Protocol Violation|0|||
130330842|NCT03155841|469180198|FG000|Overall Study|Protocol Violation|3|||
130330843|NCT03155841|469180199|FG001|Overall Study|Protocol Violation|4|||
130330844|NCT02699749|469180202|FG000|Overall Study|Other|0|||
130330845|NCT02699749|469180203|FG001|Overall Study|Other|0|||
130330846|NCT02699749|469180204|FG002|Overall Study|Other|2|||
130330847|NCT02699749|469180205|FG003|Overall Study|Other|0|||
130330848|NCT02699749|469180206|FG004|Overall Study|Other|0|||
130330849|NCT02699749|469180207|FG005|Overall Study|Other|1|||
130330850|NCT02699749|469180208|FG006|Overall Study|Other|1|||
130330851|NCT02699749|469180209|FG007|Overall Study|Other|0|||
130330852|NCT02699749|469180210|FG008|Overall Study|Other|0|||
130330853|NCT02699749|469180211|FG009|Overall Study|Other|0|||
130330854|NCT02699749|469180212|FG010|Overall Study|Other|1|||
130330855|NCT02699749|469180213|FG011|Overall Study|Other|0|||
130330856|NCT02699749|469180214|FG012|Overall Study|Other|0|||
130330857|NCT02699749|469180215|FG013|Overall Study|Other|0|||
130330858|NCT02699749|469180202|FG000|Overall Study|Progressive Disease|3|||
130330859|NCT02699749|469180203|FG001|Overall Study|Progressive Disease|3|||
130330860|NCT02699749|469180204|FG002|Overall Study|Progressive Disease|14|||
130330861|NCT02699749|469180205|FG003|Overall Study|Progressive Disease|3|||
130330862|NCT02699749|469180206|FG004|Overall Study|Progressive Disease|3|||
130330863|NCT02699749|469180207|FG005|Overall Study|Progressive Disease|7|||
130330864|NCT02699749|469180208|FG006|Overall Study|Progressive Disease|5|||
130330865|NCT02699749|469180209|FG007|Overall Study|Progressive Disease|5|||
130330866|NCT02699749|469180210|FG008|Overall Study|Progressive Disease|6|||
130330867|NCT02699749|469180211|FG009|Overall Study|Progressive Disease|6|||
130330868|NCT02699749|469180212|FG010|Overall Study|Progressive Disease|5|||
130330869|NCT02699749|469180213|FG011|Overall Study|Progressive Disease|4|||
130330870|NCT02699749|469180214|FG012|Overall Study|Progressive Disease|3|||
130330871|NCT02699749|469180215|FG013|Overall Study|Progressive Disease|5|||
130330872|NCT02699749|469180202|FG000|Overall Study|Death|0|||
130330873|NCT02699749|469180203|FG001|Overall Study|Death|0|||
130330874|NCT02699749|469180204|FG002|Overall Study|Death|0|||
130330875|NCT02699749|469180205|FG003|Overall Study|Death|0|||
130330876|NCT02699749|469180206|FG004|Overall Study|Death|0|||
130330877|NCT02699749|469180207|FG005|Overall Study|Death|0|||
130330878|NCT02699749|469180208|FG006|Overall Study|Death|0|||
130330879|NCT02699749|469180209|FG007|Overall Study|Death|0|||
130330880|NCT02699749|469180210|FG008|Overall Study|Death|0|||
130330881|NCT02699749|469180211|FG009|Overall Study|Death|0|||
130330882|NCT02699749|469180212|FG010|Overall Study|Death|0|||
130330883|NCT02699749|469180213|FG011|Overall Study|Death|0|||
130330884|NCT02699749|469180214|FG012|Overall Study|Death|0|||
130330885|NCT02699749|469180215|FG013|Overall Study|Death|1|||
130330886|NCT02699749|469180202|FG000|Overall Study|Lost to Follow-up|0|||
130330887|NCT02699749|469180203|FG001|Overall Study|Lost to Follow-up|0|||
130330888|NCT02699749|469180204|FG002|Overall Study|Lost to Follow-up|0|||
130330889|NCT02699749|469180205|FG003|Overall Study|Lost to Follow-up|0|||
130330890|NCT02699749|469180206|FG004|Overall Study|Lost to Follow-up|0|||
130330891|NCT02699749|469180207|FG005|Overall Study|Lost to Follow-up|1|||
130330892|NCT02699749|469180208|FG006|Overall Study|Lost to Follow-up|0|||
130330893|NCT02699749|469180209|FG007|Overall Study|Lost to Follow-up|1|||
130330894|NCT02699749|469180210|FG008|Overall Study|Lost to Follow-up|0|||
130330895|NCT02699749|469180211|FG009|Overall Study|Lost to Follow-up|0|||
130330896|NCT02699749|469180212|FG010|Overall Study|Lost to Follow-up|0|||
130330897|NCT02699749|469180213|FG011|Overall Study|Lost to Follow-up|0|||
130330898|NCT02699749|469180214|FG012|Overall Study|Lost to Follow-up|0|||
130330899|NCT02699749|469180215|FG013|Overall Study|Lost to Follow-up|0|||
130330900|NCT00888940|469180217|FG000|Overall Study|Adverse Event|12|||
130330901|NCT00888940|469180218|FG001|Overall Study|Adverse Event|3|||
130330902|NCT00888940|469180217|FG000|Overall Study|Lost to Follow-up|5|||
130330903|NCT00888940|469180218|FG001|Overall Study|Lost to Follow-up|5|||
130330904|NCT00888940|469180217|FG000|Overall Study|Randomized Not Treated|11|||
130330905|NCT00888940|469180218|FG001|Overall Study|Randomized Not Treated|13|||
130330906|NCT01578486|469180219|FG000|Overall Study|Physician Decision|3|||
130330907|NCT01578486|469180219|FG000|Overall Study|Withdrawal by Subject|2|||
130330908|NCT02536963|469180220|FG000|Overall Study|Withdrawal by Subject|18|||
130330909|NCT02668393|469180222|FG000|Overall Study|Progressive disease|6|||
130330910|NCT02668393|469180223|FG001|Overall Study|Progressive disease|3|||
130330911|NCT02668393|469180222|FG000|Overall Study|Adverse Event|0|||
130330912|NCT02668393|469180223|FG001|Overall Study|Adverse Event|2|||
130330913|NCT02668393|469180222|FG000|Overall Study|Withdrawal from the trial|0|||
130330914|NCT02668393|469180223|FG001|Overall Study|Withdrawal from the trial|1|||
130330915|NCT02668393|469180222|FG000|Overall Study|Lack of benefit and side effects|1|||
130330916|NCT02668393|469180223|FG001|Overall Study|Lack of benefit and side effects|0|||
130215893|NCT00885378|468753873|FG000|Overall Study|Protocol Violation|2|||
130215894|NCT00885378|468753874|FG001|Overall Study|Protocol Violation|0|||
130330917|NCT02141204|469180224|FG000|Overall Study|Lost to Follow-up|2|||
130330918|NCT02141204|469180225|FG001|Overall Study|Lost to Follow-up|1|||
130330919|NCT02141204|469180224|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
130330920|NCT02141204|469180225|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
130330921|NCT02141204|469180224|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
130330922|NCT02141204|469180225|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
130330923|NCT02141204|469180224|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
130330924|NCT02141204|469180225|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
130330925|NCT00607373|469180226|FG000|Treatment Period|Adverse Event|0|||
130330926|NCT00607373|469180227|FG001|Treatment Period|Adverse Event|4|||
130330927|NCT00607373|469180226|FG000|Treatment Period|Physician Decision|0|||
130330928|NCT00607373|469180227|FG001|Treatment Period|Physician Decision|1|||
130330929|NCT00607373|469180226|FG000|Treatment Period|Withdrawal by Subject|0|||
130330930|NCT00607373|469180227|FG001|Treatment Period|Withdrawal by Subject|1|||
130330931|NCT00607373|469180226|FG000|Follow-up Period|Other|0|||
130330932|NCT00607373|469180227|FG001|Follow-up Period|Other|1|||
130330933|NCT00607373|469180226|FG000|Follow-up Period|Protocol Violation|0|||
130330934|NCT00607373|469180227|FG001|Follow-up Period|Protocol Violation|1|||
130330935|NCT00607373|469180226|FG000|Follow-up Period|Withdrawal by Subject|1|||
130330936|NCT00607373|469180227|FG001|Follow-up Period|Withdrawal by Subject|3|||
130330937|NCT02170077|469180228|FG000|Overall Study|Withdrawal by Subject|3|||
130330938|NCT02170077|469180229|FG001|Overall Study|Withdrawal by Subject|4|||
130330939|NCT02170077|469180230|FG002|Overall Study|Withdrawal by Subject|2|||
130330940|NCT02170077|469180228|FG000|Overall Study|Adverse Event|4|||
130330941|NCT02170077|469180229|FG001|Overall Study|Adverse Event|4|||
130330942|NCT02170077|469180230|FG002|Overall Study|Adverse Event|4|||
130330943|NCT02170077|469180228|FG000|Overall Study|Lost to Follow-up|0|||
130330944|NCT02170077|469180229|FG001|Overall Study|Lost to Follow-up|1|||
130330945|NCT02170077|469180230|FG002|Overall Study|Lost to Follow-up|0|||
130330946|NCT02170077|469180228|FG000|Overall Study|Exclusion criteria|2|||
130330947|NCT02170077|469180229|FG001|Overall Study|Exclusion criteria|2|||
130330948|NCT02170077|469180230|FG002|Overall Study|Exclusion criteria|5|||
130330949|NCT02170077|469180228|FG000|Overall Study|Exacerbation of seizures|0|||
130330950|NCT02170077|469180229|FG001|Overall Study|Exacerbation of seizures|2|||
130330951|NCT02170077|469180230|FG002|Overall Study|Exacerbation of seizures|1|||
130330952|NCT01780974|469180233|FG000|Overall Study|Death|1|||
130330953|NCT01780974|469180234|FG001|Overall Study|Death|0|||
130330954|NCT01780974|469180233|FG000|Overall Study|Adverse Event|1|||
130330955|NCT01780974|469180234|FG001|Overall Study|Adverse Event|3|||
130330956|NCT01724346|469180235|FG000|Overall Study|Death|42|||
130330957|NCT01724346|469180236|FG001|Overall Study|Death|42|||
130330958|NCT01724346|469180235|FG000|Overall Study|Lost to Follow-up|5|||
130330959|NCT01724346|469180236|FG001|Overall Study|Lost to Follow-up|1|||
130330960|NCT01724346|469180235|FG000|Overall Study|Withdrawal by Subject|27|||
130330961|NCT01724346|469180236|FG001|Overall Study|Withdrawal by Subject|19|||
130330962|NCT01724346|469180235|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
130330963|NCT01724346|469180236|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
130330964|NCT00787644|469180237|FG000|Overall Study|Lost to Follow-up|1|||
130330965|NCT00787644|469180238|FG001|Overall Study|Lost to Follow-up|1|||
130330966|NCT00787644|469180237|FG000|Overall Study|Withdrawal by Subject|1|||
130330967|NCT00787644|469180238|FG001|Overall Study|Withdrawal by Subject|1|||
130330968|NCT01642589|469180242|FG000|Overall Study|Withdrawal by Subject|1|||
130330969|NCT01642589|469180243|FG001|Overall Study|Withdrawal by Subject|1|||
130330970|NCT02876601|469180248|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130330971|NCT02876601|469180249|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130330972|NCT02876601|469180250|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
130330973|NCT02876601|469180251|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
130330974|NCT00256997|469180254|FG000|Overall Study|Protocol Violation|1|||
130330975|NCT00256997|469180255|FG001|Overall Study|Protocol Violation|4|||
130330976|NCT00256997|469180254|FG000|Overall Study|Lack of Efficacy|1|||
130330977|NCT00256997|469180255|FG001|Overall Study|Lack of Efficacy|4|||
130330978|NCT00256997|469180254|FG000|Overall Study|Death|2|||
130330979|NCT00256997|469180255|FG001|Overall Study|Death|0|||
130330980|NCT00256997|469180254|FG000|Overall Study|Adverse Event|4|||
130330981|NCT00256997|469180255|FG001|Overall Study|Adverse Event|0|||
130330982|NCT00256997|469180254|FG000|Overall Study|Lost to Follow-up|3|||
130330983|NCT00256997|469180255|FG001|Overall Study|Lost to Follow-up|5|||
130330984|NCT00256997|469180254|FG000|Overall Study|Withdrawal by Subject|13|||
130330985|NCT00256997|469180255|FG001|Overall Study|Withdrawal by Subject|3|||
130330986|NCT00256997|469180254|FG000|Overall Study|Started but not treated|2|||
130330987|NCT00256997|469180255|FG001|Overall Study|Started but not treated|0|||
130330988|NCT00256997|469180254|FG000|Overall Study|Other|5|||
130330989|NCT00256997|469180255|FG001|Overall Study|Other|8|||
130330990|NCT00256997|469180254|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
130330991|NCT00256997|469180255|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
130330992|NCT00256997|469180254|FG000|Overall Study|Participant Non-compliant|3|||
130215895|NCT04750278|468753875|FG000|Overall Study|Death|9|||
130330993|NCT00256997|469180255|FG001|Overall Study|Participant Non-compliant|6|||
130330994|NCT00256997|469180254|FG000|Overall Study|Investigator Withdrew Participant|2|||
130330995|NCT00256997|469180255|FG001|Overall Study|Investigator Withdrew Participant|1|||
130330996|NCT00354432|469180256|FG000|Overall Study|Adverse Event|3|||
130330997|NCT00354432|469180257|FG001|Overall Study|Adverse Event|1|||
130330998|NCT00354432|469180258|FG002|Overall Study|Adverse Event|5|||
130330999|NCT00354432|469180259|FG003|Overall Study|Adverse Event|5|||
130331000|NCT00354432|469180256|FG000|Overall Study|Off/Toxicity|3|||
130331001|NCT00354432|469180257|FG001|Overall Study|Off/Toxicity|7|||
130331002|NCT00354432|469180258|FG002|Overall Study|Off/Toxicity|5|||
130331003|NCT00354432|469180259|FG003|Overall Study|Off/Toxicity|5|||
130331004|NCT02736578|469180260|FG000|Overall Study|Adverse Event|1|||
130331005|NCT02736578|469180261|FG001|Overall Study|Adverse Event|0|||
130331006|NCT04163016|469180264|FG000|Enrollment|Adverse Event|1|||
130331007|NCT04163016|469180265|FG001|Enrollment|Adverse Event|0|||
130331008|NCT04163016|469180266|FG002|Enrollment|Adverse Event|0|||
130331009|NCT04163016|469180267|FG003|Enrollment|Adverse Event|0|||
130331010|NCT04163016|469180264|FG000|Treatment|Adverse Event|0|||
130331011|NCT04163016|469180265|FG001|Treatment|Adverse Event|1|||
130331012|NCT04163016|469180266|FG002|Treatment|Adverse Event|0|||
130331013|NCT04163016|469180267|FG003|Treatment|Adverse Event|0|||
130331014|NCT04163016|469180264|FG000|Treatment|Withdrawal by Subject|0|||
130331015|NCT04163016|469180265|FG001|Treatment|Withdrawal by Subject|2|||
130331016|NCT04163016|469180266|FG002|Treatment|Withdrawal by Subject|0|||
130331017|NCT04163016|469180267|FG003|Treatment|Withdrawal by Subject|0|||
130331018|NCT04163016|469180264|FG000|Treatment|Indeterminate TB-test|0|||
130331019|NCT04163016|469180265|FG001|Treatment|Indeterminate TB-test|0|||
130331020|NCT04163016|469180266|FG002|Treatment|Indeterminate TB-test|0|||
130331021|NCT04163016|469180267|FG003|Treatment|Indeterminate TB-test|1|||
130331022|NCT04163016|469180264|FG000|Treatment|Participant did not want to continue in study|0|||
130331023|NCT04163016|469180265|FG001|Treatment|Participant did not want to continue in study|0|||
130331024|NCT04163016|469180266|FG002|Treatment|Participant did not want to continue in study|0|||
130331025|NCT04163016|469180267|FG003|Treatment|Participant did not want to continue in study|1|||
130331026|NCT01967238|469180268|FG000|Overall Study|Adverse Event|1|||
130331027|NCT01967238|469180269|FG001|Overall Study|Adverse Event|1|||
130331028|NCT01967238|469180270|FG002|Overall Study|Adverse Event|0|||
130331029|NCT01967238|469180268|FG000|Overall Study|Lost to Follow-up|1|||
130331030|NCT01967238|469180269|FG001|Overall Study|Lost to Follow-up|0|||
130331031|NCT01967238|469180270|FG002|Overall Study|Lost to Follow-up|1|||
130331032|NCT01967238|469180268|FG000|Overall Study|Withdrawal by Subject|0|||
130331033|NCT01967238|469180269|FG001|Overall Study|Withdrawal by Subject|0|||
130331034|NCT01967238|469180270|FG002|Overall Study|Withdrawal by Subject|1|||
130331035|NCT05232682|469180271|FG000|Overall Study|Lost to Follow-up|2|||
130331036|NCT03387085|469180272|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
130331037|NCT02015637|469181454|FG000|Overall Study|Lost to Follow-up|3|||
130331038|NCT02015637|469181455|FG001|Overall Study|Lost to Follow-up|5|||
130331039|NCT02015637|469181454|FG000|Overall Study|Adverse Event|3|||
130052157|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
130331040|NCT02015637|469181455|FG001|Overall Study|Adverse Event|0|||
130331041|NCT02015637|469181454|FG000|Overall Study|Did not take study drug|2|||
130331042|NCT02015637|469181455|FG001|Overall Study|Did not take study drug|0|||
130331043|NCT02223858|469181458|FG000|Overall Study|Death|1|||
130331044|NCT02223858|469181459|FG001|Overall Study|Death|1|||
130331045|NCT02223858|469181458|FG000|Overall Study|Lost to Follow-up|6|||
130331046|NCT02223858|469181459|FG001|Overall Study|Lost to Follow-up|11|||
130331047|NCT02223858|469181458|FG000|Overall Study|Withdrawal by Subject|8|||
130331048|NCT02223858|469181459|FG001|Overall Study|Withdrawal by Subject|5|||
130331049|NCT02223858|469181458|FG000|Overall Study|Refused|9|||
130331050|NCT02223858|469181459|FG001|Overall Study|Refused|9|||
130331051|NCT04455815|469181460|FG000|Randomisation Phase|Adverse Event|1|||
130331052|NCT04455815|469181461|FG001|Randomisation Phase|Adverse Event|0|||
130331053|NCT04455815|469181460|FG000|Treatment Phase|Adverse Event|0|||
130331054|NCT04455815|469181461|FG001|Treatment Phase|Adverse Event|1|||
130331055|NCT04455815|469181460|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
130331056|NCT04455815|469181461|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
130331057|NCT04455815|469181460|FG000|Treatment Phase|Withdrawal by Subject|1|||
130331058|NCT04455815|469181461|FG001|Treatment Phase|Withdrawal by Subject|1|||
130331059|NCT02106390|469181462|FG000|Overall Study|Withdrawal by Subject|15|||
130331060|NCT02106390|469181463|FG001|Overall Study|Withdrawal by Subject|16|||
130331061|NCT02106390|469181464|FG002|Overall Study|Withdrawal by Subject|15|||
130331062|NCT02106390|469181462|FG000|Overall Study|Lost to Follow-up|25|||
130331063|NCT02106390|469181463|FG001|Overall Study|Lost to Follow-up|20|||
130331064|NCT02106390|469181464|FG002|Overall Study|Lost to Follow-up|13|||
130331065|NCT02106390|469181462|FG000|Overall Study|Other: Administrative Reason|8|||
130331066|NCT02106390|469181463|FG001|Overall Study|Other: Administrative Reason|5|||
130331067|NCT02106390|469181464|FG002|Overall Study|Other: Administrative Reason|12|||
130331068|NCT02106390|469181462|FG000|Overall Study|Other: Unspecified|1|||
130331069|NCT02106390|469181463|FG001|Overall Study|Other: Unspecified|4|||
130331070|NCT02106390|469181464|FG002|Overall Study|Other: Unspecified|2|||
130331071|NCT02106390|469181462|FG000|Overall Study|Adverse Event|0|||
130331072|NCT02106390|469181463|FG001|Overall Study|Adverse Event|2|||
130331073|NCT02106390|469181464|FG002|Overall Study|Adverse Event|1|||
130331074|NCT02106390|469181462|FG000|Overall Study|Protocol Violation|0|||
130331075|NCT02106390|469181463|FG001|Overall Study|Protocol Violation|1|||
130331076|NCT02106390|469181464|FG002|Overall Study|Protocol Violation|0|||
130331077|NCT03198507|469181465|FG000|Overall Study|Withdrawal by Subject|1|||
130331078|NCT03198507|469181466|FG001|Overall Study|Withdrawal by Subject|0|||
130331079|NCT00241839|469181469|FG000|Overall Study|Withdrawal by Subject|18|||
130331080|NCT00241839|469181470|FG001|Overall Study|Withdrawal by Subject|17|||
130331081|NCT00241839|469181469|FG000|Overall Study|Adverse Event|1|||
130331082|NCT00241839|469181470|FG001|Overall Study|Adverse Event|1|||
130331083|NCT00831181|469181471|FG000|Overall Study|Adverse Event|12|||
130331084|NCT02863419|469181472|FG000|Overall Study|Lost to Follow-up|0|||
130331085|NCT02863419|469181473|FG001|Overall Study|Lost to Follow-up|1|||
130331086|NCT02863419|469181474|FG002|Overall Study|Lost to Follow-up|4|||
130331087|NCT02863419|469181472|FG000|Overall Study|Withdrawal by Subject|5|||
130331088|NCT02863419|469181473|FG001|Overall Study|Withdrawal by Subject|5|||
130331089|NCT02863419|469181474|FG002|Overall Study|Withdrawal by Subject|3|||
130331090|NCT02863419|469181472|FG000|Overall Study|Died|3|||
130331091|NCT02863419|469181473|FG001|Overall Study|Died|4|||
130331092|NCT02863419|469181474|FG002|Overall Study|Died|1|||
130331093|NCT00196313|469181477|FG000|Overall Study|Protocol Violation|2|||
130331094|NCT00196313|469181478|FG001|Overall Study|Protocol Violation|3|||
130331095|NCT00196313|469181477|FG000|Overall Study|Withdrawal by Subject|3|||
130331096|NCT00196313|469181478|FG001|Overall Study|Withdrawal by Subject|1|||
130331097|NCT00196313|469181477|FG000|Overall Study|Adverse Event|3|||
130331098|NCT00196313|469181478|FG001|Overall Study|Adverse Event|1|||
130331099|NCT00196313|469181477|FG000|Overall Study|Subject Pregnant|1|||
130331100|NCT00196313|469181478|FG001|Overall Study|Subject Pregnant|1|||
130331101|NCT00196313|469181477|FG000|Overall Study|Lost to Follow-up|2|||
130331102|NCT00196313|469181478|FG001|Overall Study|Lost to Follow-up|2|||
130331103|NCT02577718|469181479|FG000|Overall Study|Death|6|||
130331104|NCT02577718|469181479|FG000|Overall Study|Withdrawal by Subject|2|||
130331105|NCT01967576|469181480|FG000|Overall Study|Withdrawal by Subject|3|||
130331106|NCT01967576|469181480|FG000|Overall Study|Progressed/Removed from treatment|1|||
130331107|NCT01967576|469181480|FG000|Overall Study|Study closing at site|1|||
130331108|NCT01967576|469181480|FG000|Overall Study|Adverse Event|1|||
130331109|NCT01967576|469181480|FG000|Overall Study|Refused further treatment|1|||
130331110|NCT03196349|469181481|FG000|Overall Study|Did not receive study drug|0|||
130331111|NCT03196349|469181482|FG001|Overall Study|Did not receive study drug|1|||
130331112|NCT03196349|469181483|FG002|Overall Study|Did not receive study drug|2|||
130331113|NCT03196349|469181481|FG000|Overall Study|No data entered|2|||
130331114|NCT03196349|469181482|FG001|Overall Study|No data entered|4|||
130331115|NCT03196349|469181483|FG002|Overall Study|No data entered|0|||
130331116|NCT03196349|469181481|FG000|Overall Study|Study Terminated early|15|||
130331117|NCT03196349|469181482|FG001|Overall Study|Study Terminated early|9|||
130331118|NCT03196349|469181483|FG002|Overall Study|Study Terminated early|11|||
130331119|NCT03967444|469181484|FG000|Overall Study|Lost to Follow-up|1|||
130331120|NCT03967444|469181485|FG001|Overall Study|Lost to Follow-up|2|||
130331121|NCT01821118|469181492|FG000|Overall Study|Death|0|||
130331122|NCT01821118|469181493|FG001|Overall Study|Death|1|||
130331123|NCT01605799|469181494|FG000|Overall Study|Withdrawal by Subject|2|||
130331124|NCT01605799|469181495|FG001|Overall Study|Withdrawal by Subject|1|||
130331125|NCT00345358|469181496|FG000|Primary Vaccination Phase|Other|0|||
130331126|NCT00345358|469181497|FG001|Primary Vaccination Phase|Other|1|||
130331127|NCT00345358|469181498|FG002|Primary Vaccination Phase|Other|1|||
130331128|NCT00345358|469181499|FG003|Primary Vaccination Phase|Other|0|||
130331129|NCT00345358|469181496|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
130331130|NCT00345358|469181497|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
130331131|NCT00345358|469181498|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
130331132|NCT00345358|469181499|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
130331133|NCT00345358|469181496|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
130331134|NCT00345358|469181497|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
130331135|NCT00345358|469181498|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
130331136|NCT00345358|469181499|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
130331137|NCT00345358|469181496|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
130331138|NCT00345358|469181497|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
130331139|NCT00345358|469181498|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
130331140|NCT00345358|469181499|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
130331141|NCT00345358|469181496|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
130331142|NCT00345358|469181497|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130331143|NCT00345358|469181498|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
130331144|NCT00345358|469181499|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
130331145|NCT00345358|469181496|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
130331146|NCT00345358|469181497|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
130331147|NCT00345358|469181498|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
130331148|NCT00345358|469181499|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
130331149|NCT00477386|469181500|FG000|Overall Study|Adverse Event|4|||
130331150|NCT00477386|469181501|FG001|Overall Study|Adverse Event|8|||
130215896|NCT04750278|468753876|FG001|Overall Study|Death|10|||
130331151|NCT00477386|469181500|FG000|Overall Study|Disease progression, relapse|3|||
130331152|NCT00477386|469181501|FG001|Overall Study|Disease progression, relapse|4|||
130331153|NCT00477386|469181500|FG000|Overall Study|Disease progression, refractory|1|||
130331154|NCT00477386|469181501|FG001|Overall Study|Disease progression, refractory|3|||
130331155|NCT00477386|469181500|FG000|Overall Study|Other|1|||
130215897|NCT04750278|468753877|FG002|Overall Study|Death|10|||
130331156|NCT00477386|469181501|FG001|Overall Study|Other|2|||
130331157|NCT00477386|469181500|FG000|Overall Study|Physician Decision|1|||
130331158|NCT00477386|469181501|FG001|Overall Study|Physician Decision|0|||
130331159|NCT00477386|469181500|FG000|Overall Study|Withdrawal by Subject|1|||
130331160|NCT00477386|469181501|FG001|Overall Study|Withdrawal by Subject|0|||
130331161|NCT02207088|469181502|FG000|Overall Study|Adverse Event|2|||
130331162|NCT01812252|469181503|FG000|Overall Study|Persistent Disease|1|||
130331163|NCT01812252|469181504|FG001|Overall Study|Persistent Disease|0|||
130331164|NCT01812252|469181503|FG000|Overall Study|Not transplanted|11|||
130331165|NCT01812252|469181504|FG001|Overall Study|Not transplanted|11|||
130331166|NCT01812252|469181503|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
130331167|NCT01812252|469181504|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
130331168|NCT01812252|469181503|FG000|Overall Study|Withdrawal by Subject|1|||
130331169|NCT01812252|469181504|FG001|Overall Study|Withdrawal by Subject|1|||
130331170|NCT01812252|469181503|FG000|Overall Study|Screen Failure|1|||
130331171|NCT01812252|469181504|FG001|Overall Study|Screen Failure|0|||
130331172|NCT02284243|469181505|FG000|Overall Study|Lack of Efficacy|3|||
130331173|NCT02284243|469181506|FG001|Overall Study|Lack of Efficacy|3|||
130331174|NCT02284243|469181505|FG000|Overall Study|Adverse Event|1|||
130331175|NCT02284243|469181506|FG001|Overall Study|Adverse Event|0|||
130331176|NCT04269889|469181508|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
130331177|NCT04634253|469181509|FG000|Overall Study|Adverse Event|1|||
130331178|NCT04634253|469181510|FG001|Overall Study|Adverse Event|1|||
130331179|NCT04634253|469181511|FG002|Overall Study|Adverse Event|0|||
130331180|NCT04634253|469181509|FG000|Overall Study|Physician Decision|0|||
130331181|NCT04634253|469181510|FG001|Overall Study|Physician Decision|1|||
130331182|NCT04634253|469181511|FG002|Overall Study|Physician Decision|0|||
130331183|NCT04634253|469181509|FG000|Overall Study|Withdrawal by Subject|1|||
130331184|NCT04634253|469181510|FG001|Overall Study|Withdrawal by Subject|0|||
130331185|NCT04634253|469181511|FG002|Overall Study|Withdrawal by Subject|3|||
130331186|NCT01499355|469181512|FG000|Run-In Period|Study Termination|15|||
130331187|NCT01499355|469181513|FG001|Run-In Period|Study Termination|0|||
130331188|NCT01499355|469181514|FG002|Run-In Period|Study Termination|0|||
130331189|NCT01499355|469181515|FG003|Run-In Period|Study Termination|0|||
130331190|NCT01499355|469181512|FG000|Run-In Period|Other|3|||
130331191|NCT01499355|469181513|FG001|Run-In Period|Other|0|||
130331192|NCT01499355|469181514|FG002|Run-In Period|Other|0|||
130331193|NCT01499355|469181515|FG003|Run-In Period|Other|0|||
130331194|NCT01499355|469181512|FG000|Run-In Period|Death|2|||
130331195|NCT01499355|469181513|FG001|Run-In Period|Death|0|||
130331196|NCT01499355|469181514|FG002|Run-In Period|Death|0|||
130331197|NCT01499355|469181515|FG003|Run-In Period|Death|0|||
130331198|NCT01499355|469181512|FG000|Run-In Period|Investigator Decision|2|||
130331199|NCT01499355|469181513|FG001|Run-In Period|Investigator Decision|0|||
130331200|NCT01499355|469181514|FG002|Run-In Period|Investigator Decision|0|||
130331201|NCT01499355|469181515|FG003|Run-In Period|Investigator Decision|0|||
130331202|NCT01499355|469181512|FG000|Run-In Period|Consent Withdrawn|1|||
130331203|NCT01499355|469181513|FG001|Run-In Period|Consent Withdrawn|0|||
130331204|NCT01499355|469181514|FG002|Run-In Period|Consent Withdrawn|0|||
130331205|NCT01499355|469181515|FG003|Run-In Period|Consent Withdrawn|0|||
130331206|NCT01499355|469181512|FG000|Run-In Period|Adverse Event|8|||
130331207|NCT01499355|469181513|FG001|Run-In Period|Adverse Event|0|||
130331208|NCT01499355|469181514|FG002|Run-In Period|Adverse Event|0|||
130331209|NCT01499355|469181515|FG003|Run-In Period|Adverse Event|0|||
130331210|NCT01499355|469181512|FG000|Double-Blind Period|Adverse Event|0|||
130331211|NCT01499355|469181513|FG001|Double-Blind Period|Adverse Event|2|||
130331212|NCT01499355|469181514|FG002|Double-Blind Period|Adverse Event|3|||
130331213|NCT01499355|469181515|FG003|Double-Blind Period|Adverse Event|2|||
130331214|NCT01499355|469181512|FG000|Double-Blind Period|Study Termination|0|||
130331215|NCT01499355|469181513|FG001|Double-Blind Period|Study Termination|18|||
130331216|NCT01499355|469181514|FG002|Double-Blind Period|Study Termination|16|||
130331217|NCT01499355|469181515|FG003|Double-Blind Period|Study Termination|14|||
130331218|NCT01499355|469181512|FG000|Double-Blind Period|Other|0|||
130331219|NCT01499355|469181513|FG001|Double-Blind Period|Other|1|||
130331220|NCT01499355|469181514|FG002|Double-Blind Period|Other|2|||
130331221|NCT01499355|469181515|FG003|Double-Blind Period|Other|2|||
130331222|NCT01499355|469181512|FG000|Double-Blind Period|Death|0|||
130331223|NCT01499355|469181513|FG001|Double-Blind Period|Death|1|||
130331224|NCT01499355|469181514|FG002|Double-Blind Period|Death|0|||
130331225|NCT01499355|469181515|FG003|Double-Blind Period|Death|0|||
130331226|NCT01499355|469181512|FG000|Double-Blind Period|Investigator Decision|0|||
130331227|NCT01499355|469181513|FG001|Double-Blind Period|Investigator Decision|0|||
130331228|NCT01499355|469181514|FG002|Double-Blind Period|Investigator Decision|3|||
130331229|NCT01499355|469181515|FG003|Double-Blind Period|Investigator Decision|3|||
130331230|NCT01499355|469181512|FG000|Double-Blind Period|Consent Withdrawn|0|||
130331231|NCT01499355|469181513|FG001|Double-Blind Period|Consent Withdrawn|0|||
130331232|NCT01499355|469181514|FG002|Double-Blind Period|Consent Withdrawn|1|||
130331233|NCT01499355|469181515|FG003|Double-Blind Period|Consent Withdrawn|2|||
130331234|NCT01499355|469181512|FG000|Double-Blind Period|Lost to Follow-up|0|||
130331235|NCT01499355|469181513|FG001|Double-Blind Period|Lost to Follow-up|1|||
130331236|NCT01499355|469181514|FG002|Double-Blind Period|Lost to Follow-up|0|||
130331237|NCT01499355|469181515|FG003|Double-Blind Period|Lost to Follow-up|0|||
130331238|NCT01526733|469181516|FG000|Phase 1|Protocol Violation|1|||
130331239|NCT01526733|469181517|FG001|Phase 1|Protocol Violation|0|||
130331240|NCT01526733|469181516|FG000|Phase 1|Withdrawal by Subject|1|||
130331241|NCT01526733|469181517|FG001|Phase 1|Withdrawal by Subject|1|||
130331242|NCT01310075|469181518|FG000|Overall Study|Lost to Follow-up|1|||
130331243|NCT01310075|469181519|FG001|Overall Study|Lost to Follow-up|0|||
130331244|NCT01310075|469181518|FG000|Overall Study|Physician Decision|10|||
130331245|NCT01310075|469181519|FG001|Overall Study|Physician Decision|7|||
130331246|NCT01310075|469181518|FG000|Overall Study|Protocol Violation|2|||
130331247|NCT01310075|469181519|FG001|Overall Study|Protocol Violation|2|||
130331248|NCT01310075|469181518|FG000|Overall Study|Withdrawal by Subject|1|||
130331249|NCT01310075|469181519|FG001|Overall Study|Withdrawal by Subject|1|||
130331250|NCT02395081|469181520|FG000|Overall Study|Withdrawal by Subject|1|||
130331251|NCT02395081|469181521|FG001|Overall Study|Withdrawal by Subject|1|||
130331252|NCT02395081|469181522|FG002|Overall Study|Withdrawal by Subject|0|||
130331253|NCT02395081|469181520|FG000|Overall Study|Moved where blood couldn't be collected|4|||
130331254|NCT02395081|469181521|FG001|Overall Study|Moved where blood couldn't be collected|1|||
130331255|NCT02395081|469181522|FG002|Overall Study|Moved where blood couldn't be collected|3|||
130331256|NCT02395081|469181520|FG000|Overall Study|Fetal Loss|2|||
130331257|NCT02395081|469181521|FG001|Overall Study|Fetal Loss|3|||
130331258|NCT02395081|469181522|FG002|Overall Study|Fetal Loss|1|||
130331259|NCT02991040|469181523|FG000|Overall Study|Withdrawal by Subject|2|||
130331260|NCT02991040|469181523|FG000|Overall Study|Lost to Follow-up|2|||
130331261|NCT01869764|469181524|FG000|Overall Study|Withdrawal by Subject|0|||
130331262|NCT01869764|469181525|FG001|Overall Study|Withdrawal by Subject|2|||
130331263|NCT01286480|469181526|FG000|Overall Study|Withdrawal by Subject|5|||
130331264|NCT01286480|469181527|FG001|Overall Study|Withdrawal by Subject|3|||
130331265|NCT01626872|469181528|FG000|Overall Study|Physician Decision|13|||
130331266|NCT01626872|469181529|FG001|Overall Study|Physician Decision|9|||
130331267|NCT01626872|469181530|FG002|Overall Study|Physician Decision|6|||
130331268|NCT01626872|469181528|FG000|Overall Study|Withdrawal by Subject|19|||
130331269|NCT01626872|469181529|FG001|Overall Study|Withdrawal by Subject|27|||
130331270|NCT01626872|469181530|FG002|Overall Study|Withdrawal by Subject|8|||
130331271|NCT01626872|469181528|FG000|Overall Study|Adverse Event (including Death)|20|||
130331272|NCT01626872|469181529|FG001|Overall Study|Adverse Event (including Death)|28|||
130331273|NCT01626872|469181530|FG002|Overall Study|Adverse Event (including Death)|8|||
130331274|NCT01626872|469181528|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
130331275|NCT01626872|469181529|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
130331276|NCT01626872|469181530|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
130331277|NCT00960999|469181531|FG000|Overall Study|Withdrawal by Subject|1|||
130331278|NCT00960999|469181532|FG001|Overall Study|Withdrawal by Subject|0|||
130331279|NCT00960999|469181531|FG000|Overall Study|Protocol Violation|5|||
130331280|NCT00960999|469181532|FG001|Overall Study|Protocol Violation|2|||
130331281|NCT00960999|469181531|FG000|Overall Study|RT dose constraints not met|2|||
130331282|NCT00960999|469181532|FG001|Overall Study|RT dose constraints not met|0|||
130331283|NCT01696188|469181533|FG000|Overall Study|Protocol Violation|1|||
130331284|NCT01696188|469181534|FG001|Overall Study|Protocol Violation|1|||
130331285|NCT01918306|469181535|FG000|Overall Study|progresive disease|4|||
130331286|NCT01918306|469181536|FG001|Overall Study|progresive disease|0|||
130331287|NCT01918306|469181537|FG002|Overall Study|progresive disease|1|||
130331288|NCT01918306|469181538|FG003|Overall Study|progresive disease|1|||
130331289|NCT01918306|469181535|FG000|Overall Study|Withdrawal by Subject|0|||
130331290|NCT01918306|469181536|FG001|Overall Study|Withdrawal by Subject|0|||
130331291|NCT01918306|469181537|FG002|Overall Study|Withdrawal by Subject|0|||
130331292|NCT01918306|469181538|FG003|Overall Study|Withdrawal by Subject|2|||
130331293|NCT01918306|469181535|FG000|Overall Study|neutropenia|1|||
130331294|NCT01918306|469181536|FG001|Overall Study|neutropenia|0|||
130331295|NCT01918306|469181537|FG002|Overall Study|neutropenia|0|||
130331296|NCT01918306|469181538|FG003|Overall Study|neutropenia|0|||
130331297|NCT01918306|469181535|FG000|Overall Study|Lack of Efficacy|1|||
130331298|NCT01918306|469181536|FG001|Overall Study|Lack of Efficacy|0|||
130215898|NCT04750278|468753875|FG000|Overall Study|Withdrawal by Subject|4|||
130215899|NCT04750278|468753876|FG001|Overall Study|Withdrawal by Subject|1|||
130215900|NCT04750278|468753877|FG002|Overall Study|Withdrawal by Subject|2|||
130215901|NCT04750278|468753875|FG000|Overall Study|Lost to Follow-up|1|||
130331299|NCT01918306|469181537|FG002|Overall Study|Lack of Efficacy|0|||
130331300|NCT01918306|469181538|FG003|Overall Study|Lack of Efficacy|0|||
130331301|NCT01918306|469181535|FG000|Overall Study|progress disease, crossover|0|||
130331302|NCT01918306|469181536|FG001|Overall Study|progress disease, crossover|0|||
130331303|NCT01918306|469181537|FG002|Overall Study|progress disease, crossover|1|||
130331304|NCT01918306|469181538|FG003|Overall Study|progress disease, crossover|0|||
130331305|NCT01958164|469181540|FG000|Overall Study|Adverse Event|0|||
130331306|NCT01958164|469181541|FG001|Overall Study|Adverse Event|2|||
130215902|NCT04750278|468753876|FG001|Overall Study|Lost to Follow-up|1|||
130331307|NCT01958164|469181540|FG000|Overall Study|Lost to Follow-up|2|||
130331308|NCT01958164|469181541|FG001|Overall Study|Lost to Follow-up|3|||
130331309|NCT02963506|469181542|FG000|Double-Blind Period|Adverse Event|0|||
130331310|NCT02963506|469181543|FG001|Double-Blind Period|Adverse Event|0|||
130331311|NCT02963506|469181544|FG002|Double-Blind Period|Adverse Event|1|||
130215903|NCT04750278|468753877|FG002|Overall Study|Lost to Follow-up|1|||
130331312|NCT02963506|469181545|FG003|Double-Blind Period|Adverse Event|0|||
130331313|NCT02963506|469181546|FG004|Double-Blind Period|Adverse Event|0|||
130331314|NCT02963506|469181547|FG005|Double-Blind Period|Adverse Event|0|||
130331315|NCT02963506|469181548|FG006|Double-Blind Period|Adverse Event|0|||
130331316|NCT02963506|469181549|FG007|Double-Blind Period|Adverse Event|0|||
130331317|NCT02963506|469181550|FG008|Double-Blind Period|Adverse Event|0|||
130331318|NCT02963506|469181551|FG009|Double-Blind Period|Adverse Event|0|||
130331319|NCT02963506|469181552|FG010|Double-Blind Period|Adverse Event|0|||
130331320|NCT02963506|469181553|FG011|Double-Blind Period|Adverse Event|0|||
130331321|NCT02963506|469181554|FG012|Double-Blind Period|Adverse Event|0|||
130331322|NCT02963506|469181542|FG000|Double-Blind Period|Death|0|||
130331323|NCT02963506|469181543|FG001|Double-Blind Period|Death|0|||
130331324|NCT02963506|469181544|FG002|Double-Blind Period|Death|0|||
130331325|NCT02963506|469181545|FG003|Double-Blind Period|Death|1|||
130331326|NCT02963506|469181546|FG004|Double-Blind Period|Death|0|||
130331327|NCT02963506|469181547|FG005|Double-Blind Period|Death|0|||
130331328|NCT02963506|469181548|FG006|Double-Blind Period|Death|0|||
130331329|NCT02963506|469181549|FG007|Double-Blind Period|Death|0|||
130331330|NCT02963506|469181550|FG008|Double-Blind Period|Death|0|||
130331331|NCT02963506|469181551|FG009|Double-Blind Period|Death|0|||
130331332|NCT02963506|469181552|FG010|Double-Blind Period|Death|0|||
130331333|NCT02963506|469181553|FG011|Double-Blind Period|Death|0|||
130331334|NCT02963506|469181554|FG012|Double-Blind Period|Death|0|||
130331335|NCT02963506|469181542|FG000|Double-Blind Period|Lost to Follow-up|0|||
130331336|NCT02963506|469181543|FG001|Double-Blind Period|Lost to Follow-up|1|||
130331337|NCT02963506|469181544|FG002|Double-Blind Period|Lost to Follow-up|0|||
130331338|NCT02963506|469181545|FG003|Double-Blind Period|Lost to Follow-up|0|||
130331339|NCT02963506|469181546|FG004|Double-Blind Period|Lost to Follow-up|0|||
130331340|NCT02963506|469181547|FG005|Double-Blind Period|Lost to Follow-up|0|||
130331341|NCT02963506|469181548|FG006|Double-Blind Period|Lost to Follow-up|0|||
130331342|NCT02963506|469181549|FG007|Double-Blind Period|Lost to Follow-up|0|||
130331343|NCT02963506|469181550|FG008|Double-Blind Period|Lost to Follow-up|0|||
130331344|NCT02963506|469181551|FG009|Double-Blind Period|Lost to Follow-up|0|||
130331345|NCT02963506|469181552|FG010|Double-Blind Period|Lost to Follow-up|0|||
130331346|NCT02963506|469181553|FG011|Double-Blind Period|Lost to Follow-up|0|||
130331347|NCT02963506|469181554|FG012|Double-Blind Period|Lost to Follow-up|0|||
130331348|NCT02963506|469181542|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130331349|NCT02963506|469181543|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130331350|NCT02963506|469181544|FG002|Double-Blind Period|Withdrawal by Subject|1|||
130331351|NCT02963506|469181545|FG003|Double-Blind Period|Withdrawal by Subject|1|||
130331352|NCT02963506|469181546|FG004|Double-Blind Period|Withdrawal by Subject|0|||
130331353|NCT02963506|469181547|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130331354|NCT02963506|469181548|FG006|Double-Blind Period|Withdrawal by Subject|0|||
130331355|NCT02963506|469181549|FG007|Double-Blind Period|Withdrawal by Subject|0|||
130331356|NCT02963506|469181550|FG008|Double-Blind Period|Withdrawal by Subject|0|||
130331357|NCT02963506|469181551|FG009|Double-Blind Period|Withdrawal by Subject|0|||
130331358|NCT02963506|469181552|FG010|Double-Blind Period|Withdrawal by Subject|0|||
130331359|NCT02963506|469181553|FG011|Double-Blind Period|Withdrawal by Subject|0|||
130331360|NCT02963506|469181554|FG012|Double-Blind Period|Withdrawal by Subject|0|||
130331361|NCT02963506|469181542|FG000|Double-Blind Period|No compliance|0|||
130331362|NCT02963506|469181543|FG001|Double-Blind Period|No compliance|1|||
130331363|NCT02963506|469181544|FG002|Double-Blind Period|No compliance|0|||
130331364|NCT02963506|469181545|FG003|Double-Blind Period|No compliance|0|||
130331365|NCT02963506|469181546|FG004|Double-Blind Period|No compliance|0|||
130331366|NCT02963506|469181547|FG005|Double-Blind Period|No compliance|0|||
130331367|NCT02963506|469181548|FG006|Double-Blind Period|No compliance|0|||
130331368|NCT02963506|469181549|FG007|Double-Blind Period|No compliance|0|||
130331369|NCT02963506|469181550|FG008|Double-Blind Period|No compliance|0|||
130331370|NCT02963506|469181551|FG009|Double-Blind Period|No compliance|0|||
130331371|NCT02963506|469181552|FG010|Double-Blind Period|No compliance|0|||
130331372|NCT02963506|469181553|FG011|Double-Blind Period|No compliance|0|||
130331373|NCT02963506|469181554|FG012|Double-Blind Period|No compliance|0|||
130331374|NCT02963506|469181542|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331375|NCT02963506|469181543|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
130331376|NCT02963506|469181544|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331377|NCT02963506|469181545|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331378|NCT02963506|469181546|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331379|NCT02963506|469181547|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331380|NCT02963506|469181548|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331381|NCT02963506|469181549|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331382|NCT02963506|469181550|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331383|NCT02963506|469181551|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331384|NCT02963506|469181552|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331385|NCT02963506|469181553|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331386|NCT02963506|469181554|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
130331387|NCT02963506|469181542|FG000|Dose-Blind Period|Adverse Event|0|||
130331388|NCT02963506|469181543|FG001|Dose-Blind Period|Adverse Event|0|||
130331389|NCT02963506|469181544|FG002|Dose-Blind Period|Adverse Event|0|||
130331390|NCT02963506|469181545|FG003|Dose-Blind Period|Adverse Event|0|||
130331391|NCT02963506|469181546|FG004|Dose-Blind Period|Adverse Event|0|||
130331392|NCT02963506|469181547|FG005|Dose-Blind Period|Adverse Event|1|||
130331393|NCT02963506|469181548|FG006|Dose-Blind Period|Adverse Event|3|||
130331394|NCT02963506|469181549|FG007|Dose-Blind Period|Adverse Event|2|||
130331395|NCT02963506|469181550|FG008|Dose-Blind Period|Adverse Event|2|||
130331396|NCT02963506|469181551|FG009|Dose-Blind Period|Adverse Event|2|||
130331397|NCT02963506|469181552|FG010|Dose-Blind Period|Adverse Event|1|||
130331398|NCT02963506|469181553|FG011|Dose-Blind Period|Adverse Event|1|||
130331399|NCT02963506|469181554|FG012|Dose-Blind Period|Adverse Event|6|||
130331400|NCT02963506|469181542|FG000|Dose-Blind Period|Lack of Efficacy|0|||
130331401|NCT02963506|469181543|FG001|Dose-Blind Period|Lack of Efficacy|0|||
130331402|NCT02963506|469181544|FG002|Dose-Blind Period|Lack of Efficacy|0|||
130331403|NCT02963506|469181545|FG003|Dose-Blind Period|Lack of Efficacy|0|||
130331404|NCT02963506|469181546|FG004|Dose-Blind Period|Lack of Efficacy|0|||
130331405|NCT02963506|469181547|FG005|Dose-Blind Period|Lack of Efficacy|0|||
130331406|NCT02963506|469181548|FG006|Dose-Blind Period|Lack of Efficacy|0|||
130331407|NCT02963506|469181549|FG007|Dose-Blind Period|Lack of Efficacy|1|||
129991976|NCT04494256|467934159|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991977|NCT04494256|467934160|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
130331408|NCT02963506|469181550|FG008|Dose-Blind Period|Lack of Efficacy|0|||
130331409|NCT02963506|469181551|FG009|Dose-Blind Period|Lack of Efficacy|1|||
130331410|NCT02963506|469181552|FG010|Dose-Blind Period|Lack of Efficacy|0|||
130331411|NCT02963506|469181553|FG011|Dose-Blind Period|Lack of Efficacy|0|||
130331412|NCT02963506|469181554|FG012|Dose-Blind Period|Lack of Efficacy|0|||
130331413|NCT02963506|469181542|FG000|Dose-Blind Period|Lost to Follow-up|0|||
130331414|NCT02963506|469181543|FG001|Dose-Blind Period|Lost to Follow-up|0|||
130331415|NCT02963506|469181544|FG002|Dose-Blind Period|Lost to Follow-up|0|||
130331416|NCT02963506|469181545|FG003|Dose-Blind Period|Lost to Follow-up|0|||
129991978|NCT04494256|467934161|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991979|NCT04494256|467934162|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991980|NCT04494256|467934163|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991981|NCT04494256|467934164|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
129991982|NCT04494256|467934158|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991983|NCT04494256|467934159|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991984|NCT04494256|467934160|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991985|NCT04494256|467934161|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991986|NCT04494256|467934162|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991987|NCT04494256|467934163|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
129991988|NCT04494256|467934164|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
129991989|NCT04494256|467934158|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991990|NCT04494256|467934159|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991991|NCT04494256|467934160|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991992|NCT04494256|467934161|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991993|NCT04494256|467934162|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991994|NCT04494256|467934163|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
129991995|NCT04494256|467934164|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
129991996|NCT04494256|467934158|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129991997|NCT04494256|467934159|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129991998|NCT04494256|467934160|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129991999|NCT04494256|467934161|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129992000|NCT04494256|467934162|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129992001|NCT04494256|467934163|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
129992002|NCT04494256|467934164|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
129992003|NCT02513303|467934165|FG000|Overall Study|Withdrawal by Subject|9|||
129992004|NCT02513303|467934166|FG001|Overall Study|Withdrawal by Subject|7|||
129992005|NCT02513303|467934167|FG002|Overall Study|Withdrawal by Subject|2|||
129992006|NCT02513303|467934165|FG000|Overall Study|Lost to Follow-up|2|||
129992007|NCT02513303|467934166|FG001|Overall Study|Lost to Follow-up|4|||
129992008|NCT02513303|467934167|FG002|Overall Study|Lost to Follow-up|0|||
129992009|NCT02513303|467934165|FG000|Overall Study|Adverse Event|0|||
129992010|NCT02513303|467934166|FG001|Overall Study|Adverse Event|1|||
129992011|NCT02513303|467934167|FG002|Overall Study|Adverse Event|0|||
130331417|NCT02963506|469181546|FG004|Dose-Blind Period|Lost to Follow-up|0|||
130331418|NCT02963506|469181547|FG005|Dose-Blind Period|Lost to Follow-up|1|||
130331419|NCT02963506|469181548|FG006|Dose-Blind Period|Lost to Follow-up|0|||
130331420|NCT02963506|469181549|FG007|Dose-Blind Period|Lost to Follow-up|0|||
130331421|NCT02963506|469181550|FG008|Dose-Blind Period|Lost to Follow-up|1|||
130331422|NCT02963506|469181551|FG009|Dose-Blind Period|Lost to Follow-up|0|||
130331423|NCT02963506|469181552|FG010|Dose-Blind Period|Lost to Follow-up|0|||
130331424|NCT02963506|469181553|FG011|Dose-Blind Period|Lost to Follow-up|1|||
129992012|NCT02513303|467934165|FG000|Overall Study|Physician Decision|1|||
129992013|NCT02513303|467934166|FG001|Overall Study|Physician Decision|1|||
129992014|NCT02513303|467934167|FG002|Overall Study|Physician Decision|0|||
129992015|NCT02513303|467934165|FG000|Overall Study|Death|8|||
129992016|NCT02513303|467934166|FG001|Overall Study|Death|4|||
129992017|NCT02513303|467934167|FG002|Overall Study|Death|2|||
129992018|NCT06338462|467934174|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
130331425|NCT02963506|469181554|FG012|Dose-Blind Period|Lost to Follow-up|0|||
130331426|NCT02963506|469181542|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
130331427|NCT02963506|469181543|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
130331428|NCT02963506|469181544|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
130331429|NCT02963506|469181545|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
130331430|NCT02963506|469181546|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
130331431|NCT02963506|469181547|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
130331432|NCT02963506|469181548|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
130331433|NCT02963506|469181549|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
130331434|NCT02963506|469181550|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
130331435|NCT02963506|469181551|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
130331436|NCT02963506|469181552|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
130331437|NCT02963506|469181553|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
130331438|NCT02963506|469181554|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
130331439|NCT02963506|469181542|FG000|Dose-Blind Period|Sponsor decision|0|||
130331440|NCT02963506|469181543|FG001|Dose-Blind Period|Sponsor decision|0|||
130331441|NCT02963506|469181544|FG002|Dose-Blind Period|Sponsor decision|0|||
130331442|NCT02963506|469181545|FG003|Dose-Blind Period|Sponsor decision|0|||
130331443|NCT02963506|469181546|FG004|Dose-Blind Period|Sponsor decision|0|||
130331444|NCT02963506|469181547|FG005|Dose-Blind Period|Sponsor decision|1|||
130331445|NCT02963506|469181548|FG006|Dose-Blind Period|Sponsor decision|0|||
130331446|NCT02963506|469181549|FG007|Dose-Blind Period|Sponsor decision|0|||
130331447|NCT02963506|469181550|FG008|Dose-Blind Period|Sponsor decision|0|||
130331448|NCT02963506|469181551|FG009|Dose-Blind Period|Sponsor decision|0|||
130331449|NCT02963506|469181552|FG010|Dose-Blind Period|Sponsor decision|0|||
130331450|NCT02963506|469181553|FG011|Dose-Blind Period|Sponsor decision|0|||
130331451|NCT02963506|469181554|FG012|Dose-Blind Period|Sponsor decision|0|||
130331452|NCT02963506|469181542|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331453|NCT02963506|469181543|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331454|NCT02963506|469181544|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331455|NCT02963506|469181545|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331456|NCT02963506|469181546|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331457|NCT02963506|469181547|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331458|NCT02963506|469181548|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331459|NCT02963506|469181549|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331460|NCT02963506|469181550|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331461|NCT02963506|469181551|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331462|NCT02963506|469181552|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331463|NCT02963506|469181553|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
130331464|NCT02963506|469181554|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
130331465|NCT00828204|469181557|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
130331466|NCT00828204|469181558|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
130331467|NCT00828204|469181557|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
130331468|NCT00828204|469181558|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
130331469|NCT00828204|469181557|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
130331470|NCT00828204|469181558|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
130331471|NCT00828204|469181557|FG000|Main Study: After Study Restart|Adverse Event|0|||
130331472|NCT00828204|469181558|FG001|Main Study: After Study Restart|Adverse Event|2|||
130331473|NCT00828204|469181557|FG000|Main Study: After Study Restart|Noncompliance|0|||
130331474|NCT00828204|469181558|FG001|Main Study: After Study Restart|Noncompliance|1|||
130331475|NCT00828204|469181557|FG000|Extension Study|Lost to Follow-up|0|||
130331476|NCT00828204|469181558|FG001|Extension Study|Lost to Follow-up|1|||
130331477|NCT00828204|469181557|FG000|Extension Study|Physician Decision|0|||
130331478|NCT00828204|469181558|FG001|Extension Study|Physician Decision|2|||
130331479|NCT00750438|469181561|FG000|Overall Study|Protocol Violation|4|||
130331480|NCT00750438|469181562|FG001|Overall Study|Protocol Violation|1|||
130331481|NCT00750438|469181561|FG000|Overall Study|Physician Decision|2|||
130331482|NCT00750438|469181562|FG001|Overall Study|Physician Decision|2|||
130331483|NCT00750438|469181561|FG000|Overall Study|Withdrawal by Subject|1|||
130331484|NCT00750438|469181562|FG001|Overall Study|Withdrawal by Subject|1|||
130331485|NCT00928408|469181567|FG000|Overall Study|Other|2|||
130331486|NCT00928408|469181567|FG000|Overall Study|Withdrawal by Subject|4|||
130331487|NCT00928408|469181567|FG000|Overall Study|Death|5|||
130331488|NCT00928408|469181567|FG000|Overall Study|Lost to Follow-up|12|||
130331489|NCT00536744|469181568|FG000|Overall Study|Adverse Event|13|||
130331490|NCT00536744|469181569|FG001|Overall Study|Adverse Event|10|||
130331491|NCT00536744|469181568|FG000|Overall Study|Death|2|||
130331492|NCT00536744|469181569|FG001|Overall Study|Death|1|||
130331493|NCT00536744|469181568|FG000|Overall Study|Physician Decision|3|||
130331494|NCT00536744|469181569|FG001|Overall Study|Physician Decision|1|||
130331495|NCT00536744|469181568|FG000|Overall Study|Lost to Follow-up|3|||
130331496|NCT00536744|469181569|FG001|Overall Study|Lost to Follow-up|5|||
130331497|NCT00536744|469181568|FG000|Overall Study|Withdrawal by Subject|7|||
130331498|NCT00536744|469181569|FG001|Overall Study|Withdrawal by Subject|8|||
130331499|NCT00536744|469181568|FG000|Overall Study|PI tried alternative treatment|1|||
130331500|NCT00536744|469181569|FG001|Overall Study|PI tried alternative treatment|3|||
130331501|NCT02827877|469181570|FG000|Overall Study|Withdrawal by Subject|1|||
130331502|NCT00145158|469183369|FG000|Overall Study|premature withdrawal|2|||
130331503|NCT00145158|469183370|FG001|Overall Study|premature withdrawal|3|||
130331504|NCT03252925|469183371|FG000|Overall Study|Withdrawal by Subject|1|||
130331505|NCT03252925|469183372|FG001|Overall Study|Withdrawal by Subject|0|||
130331506|NCT03252925|469183371|FG000|Overall Study|Protocol Violation|6|||
130331507|NCT03252925|469183372|FG001|Overall Study|Protocol Violation|0|||
130331508|NCT03252925|469183371|FG000|Overall Study|Adverse Event|1|||
130331509|NCT03252925|469183372|FG001|Overall Study|Adverse Event|0|||
130331510|NCT03252925|469183371|FG000|Overall Study|Lost to Follow-up|6|||
130331511|NCT03252925|469183372|FG001|Overall Study|Lost to Follow-up|6|||
130331512|NCT00499616|469183373|FG000|Overall Study|Death|1|||
130331513|NCT00499616|469183374|FG001|Overall Study|Death|5|||
130331514|NCT00499616|469183375|FG002|Overall Study|Death|3|||
130331515|NCT00499616|469183376|FG003|Overall Study|Death|1|||
130331516|NCT00499616|469183373|FG000|Overall Study|Lack of Efficacy|5|||
130331517|NCT00499616|469183374|FG001|Overall Study|Lack of Efficacy|0|||
130331518|NCT00499616|469183375|FG002|Overall Study|Lack of Efficacy|19|||
130331519|NCT00499616|469183376|FG003|Overall Study|Lack of Efficacy|0|||
130331520|NCT00499616|469183373|FG000|Overall Study|Lost to Follow-up|0|||
130331521|NCT00499616|469183374|FG001|Overall Study|Lost to Follow-up|0|||
130331522|NCT00499616|469183375|FG002|Overall Study|Lost to Follow-up|1|||
130331523|NCT00499616|469183376|FG003|Overall Study|Lost to Follow-up|0|||
130331524|NCT00499616|469183373|FG000|Overall Study|Physician Decision|6|||
130331525|NCT00499616|469183374|FG001|Overall Study|Physician Decision|16|||
130331526|NCT00499616|469183375|FG002|Overall Study|Physician Decision|9|||
130331527|NCT00499616|469183376|FG003|Overall Study|Physician Decision|0|||
130331528|NCT00499616|469183373|FG000|Overall Study|Withdrawal by Subject|1|||
130331529|NCT00499616|469183374|FG001|Overall Study|Withdrawal by Subject|0|||
130331530|NCT00499616|469183375|FG002|Overall Study|Withdrawal by Subject|1|||
130331531|NCT00499616|469183376|FG003|Overall Study|Withdrawal by Subject|0|||
130331532|NCT00499616|469183373|FG000|Overall Study|Ineligible|1|||
130331533|NCT00499616|469183374|FG001|Overall Study|Ineligible|2|||
130331534|NCT00499616|469183375|FG002|Overall Study|Ineligible|0|||
130331535|NCT00499616|469183376|FG003|Overall Study|Ineligible|15|||
130331536|NCT00499616|469183373|FG000|Overall Study|Not evaluable|0|||
130331537|NCT00499616|469183374|FG001|Overall Study|Not evaluable|0|||
130331538|NCT00499616|469183375|FG002|Overall Study|Not evaluable|0|||
130331539|NCT00499616|469183376|FG003|Overall Study|Not evaluable|41|||
130331540|NCT00499616|469183373|FG000|Overall Study|Patient/Parent Refusal|1|||
130331541|NCT00499616|469183374|FG001|Overall Study|Patient/Parent Refusal|5|||
130331542|NCT00499616|469183375|FG002|Overall Study|Patient/Parent Refusal|3|||
130331543|NCT00499616|469183376|FG003|Overall Study|Patient/Parent Refusal|0|||
130331544|NCT00123422|469183377|FG000|Overall Study|Physician Decision|2|||
130331545|NCT00123422|469183378|FG001|Overall Study|Physician Decision|2|||
130331546|NCT00123422|469183379|FG002|Overall Study|Physician Decision|6|||
130331547|NCT00123422|469183377|FG000|Overall Study|Withdrawal by Subject|1|||
130331548|NCT00123422|469183378|FG001|Overall Study|Withdrawal by Subject|2|||
130331549|NCT00123422|469183379|FG002|Overall Study|Withdrawal by Subject|2|||
130331550|NCT00123422|469183377|FG000|Overall Study|Lost to Follow-up|1|||
130331551|NCT00123422|469183378|FG001|Overall Study|Lost to Follow-up|2|||
130331552|NCT00123422|469183379|FG002|Overall Study|Lost to Follow-up|2|||
130331553|NCT04555616|469183380|FG000|Overall Study|Death|1|||
130331554|NCT04555616|469183381|FG001|Overall Study|Death|0|||
130331555|NCT04555616|469183382|FG002|Overall Study|Death|1|||
130331556|NCT04555616|469183380|FG000|Overall Study|Withdrawal by Subject|2|||
130331557|NCT04555616|469183381|FG001|Overall Study|Withdrawal by Subject|1|||
130331558|NCT04555616|469183382|FG002|Overall Study|Withdrawal by Subject|0|||
130331559|NCT01938716|469183385|FG000|Overall Study|Physician Decision|2|||
130331560|NCT01938716|469183385|FG000|Overall Study|Withdrawal by Subject|2|||
130331561|NCT01358721|469183386|FG000|Overall Study|Withdrawal by Subject|0|||
130331562|NCT01358721|469183387|FG001|Overall Study|Withdrawal by Subject|0|||
130331563|NCT01358721|469183388|FG002|Overall Study|Withdrawal by Subject|0|||
130331564|NCT01358721|469183389|FG003|Overall Study|Withdrawal by Subject|1|||
130331565|NCT01358721|469183386|FG000|Overall Study|Death|0|||
130331566|NCT01358721|469183387|FG001|Overall Study|Death|2|||
130331567|NCT01358721|469183388|FG002|Overall Study|Death|0|||
130331568|NCT01358721|469183389|FG003|Overall Study|Death|0|||
130331569|NCT01358721|469183386|FG000|Overall Study|Study Drug Toxicity|1|||
130331570|NCT01358721|469183387|FG001|Overall Study|Study Drug Toxicity|3|||
130331571|NCT01358721|469183388|FG002|Overall Study|Study Drug Toxicity|4|||
130331572|NCT01358721|469183389|FG003|Overall Study|Study Drug Toxicity|5|||
130331573|NCT01358721|469183386|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
130215904|NCT04750278|468753875|FG000|Overall Study|Pregnancy|1|||
130215905|NCT04750278|468753876|FG001|Overall Study|Pregnancy|0|||
130215906|NCT04750278|468753877|FG002|Overall Study|Pregnancy|0|||
130215907|NCT04750278|468753875|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
130215908|NCT04750278|468753876|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
130215909|NCT04750278|468753877|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
130215910|NCT04750278|468753875|FG000|Overall Study|Non-compliance|0|||
130215911|NCT04750278|468753876|FG001|Overall Study|Non-compliance|0|||
130215912|NCT04750278|468753877|FG002|Overall Study|Non-compliance|1|||
130215913|NCT04750278|468753875|FG000|Overall Study|Transfer to Outside Facility|0|||
130215914|NCT04750278|468753876|FG001|Overall Study|Transfer to Outside Facility|2|||
130215915|NCT04750278|468753877|FG002|Overall Study|Transfer to Outside Facility|1|||
130215916|NCT04750278|468753875|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
130215917|NCT04750278|468753876|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
130215918|NCT04750278|468753877|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
130215919|NCT04750278|468753875|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
130215920|NCT04750278|468753876|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
130215921|NCT04750278|468753877|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
130215922|NCT02579382|468753880|FG000|Main Study Phase|Lost to Follow-up|0|||
130215923|NCT02579382|468753881|FG001|Main Study Phase|Lost to Follow-up|0|||
130215924|NCT02579382|468753882|FG002|Main Study Phase|Lost to Follow-up|2|||
130215925|NCT02579382|468753883|FG003|Main Study Phase|Lost to Follow-up|0|||
130215926|NCT02579382|468753880|FG000|Main Study Phase|Withdrew Consent|0|||
130215927|NCT02579382|468753881|FG001|Main Study Phase|Withdrew Consent|0|||
130215928|NCT02579382|468753882|FG002|Main Study Phase|Withdrew Consent|0|||
130215929|NCT02579382|468753883|FG003|Main Study Phase|Withdrew Consent|2|||
130215930|NCT02579382|468753880|FG000|Main Study Phase|Lack of Efficacy|0|||
130215931|NCT02579382|468753881|FG001|Main Study Phase|Lack of Efficacy|0|||
130215932|NCT02579382|468753882|FG002|Main Study Phase|Lack of Efficacy|0|||
130215933|NCT02579382|468753883|FG003|Main Study Phase|Lack of Efficacy|1|||
130215934|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
130215935|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
130215936|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
130215937|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
130215938|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
130215939|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
130215940|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
130215941|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
130215942|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
130215943|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130215944|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130215945|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
130215946|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130331574|NCT01358721|469183387|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
130331575|NCT01358721|469183388|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
130331576|NCT01358721|469183389|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
130215947|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
130331577|NCT01358721|469183386|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130331578|NCT01358721|469183387|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130331579|NCT01358721|469183388|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130331580|NCT01358721|469183389|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
130331581|NCT01358721|469183386|FG000|Overall Study|Adverse Event related to study drug|1|||
130331582|NCT01358721|469183387|FG001|Overall Study|Adverse Event related to study drug|0|||
130331583|NCT01358721|469183388|FG002|Overall Study|Adverse Event related to study drug|0|||
130331584|NCT01358721|469183389|FG003|Overall Study|Adverse Event related to study drug|1|||
130331585|NCT01358721|469183386|FG000|Overall Study|Disease Progression|19|||
130331586|NCT01358721|469183387|FG001|Overall Study|Disease Progression|15|||
130331587|NCT01358721|469183388|FG002|Overall Study|Disease Progression|17|||
130331588|NCT01358721|469183389|FG003|Overall Study|Disease Progression|15|||
130331589|NCT01358721|469183386|FG000|Overall Study|Out of State/Unmet Criteria|0|||
130331590|NCT01358721|469183387|FG001|Overall Study|Out of State/Unmet Criteria|0|||
130331591|NCT01358721|469183388|FG002|Overall Study|Out of State/Unmet Criteria|1|||
130331592|NCT01358721|469183389|FG003|Overall Study|Out of State/Unmet Criteria|0|||
130331593|NCT01908803|469183390|FG000|Overall Study|Adverse Event|1|||
130331594|NCT01908803|469183391|FG001|Overall Study|Adverse Event|0|||
130331595|NCT01908803|469183390|FG000|Overall Study|Physician Decision|0|||
130331596|NCT01908803|469183391|FG001|Overall Study|Physician Decision|1|||
130331597|NCT01908803|469183390|FG000|Overall Study|Withdrawal by Subject|1|||
130215948|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130215949|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
130215950|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130215951|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
130215952|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130215953|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
130215954|NCT02579382|468753880|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130215955|NCT02579382|468753881|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
130215956|NCT02579382|468753882|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130215957|NCT02579382|468753883|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
130215958|NCT01775787|468753884|FG000|First 7-10 Days|Adverse Event|0|||
130215959|NCT01775787|468753885|FG001|First 7-10 Days|Adverse Event|1|||
130215960|NCT01775787|468753884|FG000|First 7-10 Days|family emergency|0|||
130215961|NCT01775787|468753885|FG001|First 7-10 Days|family emergency|1|||
130215962|NCT01775787|468753884|FG000|First 7-10 Days|time commitment|0|||
130215963|NCT01775787|468753885|FG001|First 7-10 Days|time commitment|2|||
130215964|NCT01775787|468753884|FG000|First 7-10 Days|concerns with using IV|1|||
130215965|NCT01775787|468753885|FG001|First 7-10 Days|concerns with using IV|2|||
130215966|NCT01775787|468753884|FG000|Second 7-10 Days|time commitment|0|||
130215967|NCT01775787|468753885|FG001|Second 7-10 Days|time commitment|1|||
130215968|NCT01775787|468753884|FG000|Second 7-10 Days|concerns with using IV|0|||
130215969|NCT01775787|468753885|FG001|Second 7-10 Days|concerns with using IV|1|||
130215970|NCT04076319|468753895|FG000|Overall Study|Withdrawal by Subject|2|||
130215971|NCT04076319|468753896|FG001|Overall Study|Withdrawal by Subject|0|||
130215972|NCT04076319|468753895|FG000|Overall Study|Death|1|||
130215973|NCT04076319|468753896|FG001|Overall Study|Death|0|||
130215974|NCT01054222|468753897|FG000|Overall Study|Lack of Efficacy|1|||
130215975|NCT01054222|468753897|FG000|Overall Study|Lost to Follow-up|4|||
130215976|NCT01054222|468753897|FG000|Overall Study|Withdrawal by Subject|6|||
130215977|NCT00824655|468753898|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
130215978|NCT00824655|468753899|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
130215979|NCT00824655|468753898|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
130215980|NCT00824655|468753899|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
130215981|NCT03252145|468753900|FG000|Overall Study|Withdrawal by Subject|1|||
130215982|NCT03252145|468753901|FG001|Overall Study|Withdrawal by Subject|0|||
130215983|NCT03252145|468753900|FG000|Overall Study|Complicating Disease|1|||
130215984|NCT03252145|468753901|FG001|Overall Study|Complicating Disease|2|||
130215985|NCT03504189|468753902|FG000|Overall Study|Withdrawal by Subject|1|||
130215986|NCT03504189|468753902|FG000|Overall Study|Screening Failure|1|||
130215987|NCT03504189|468753902|FG000|Overall Study|Device Failure|2|||
130215988|NCT03091738|468753903|FG000|Overall Study|Adverse Event|1|||
130215989|NCT03091738|468753903|FG000|Overall Study|Lost to Follow-up|1|||
130215990|NCT04336475|468753904|FG000|Overall Study|pain|1|||
130215991|NCT04336475|468753905|FG001|Overall Study|pain|0|||
130215992|NCT04336475|468753904|FG000|Overall Study|upper respiratory infection|1|||
130215993|NCT04336475|468753905|FG001|Overall Study|upper respiratory infection|0|||
130215994|NCT04336475|468753904|FG000|Overall Study|Lost to Follow-up|0|||
130215995|NCT04336475|468753905|FG001|Overall Study|Lost to Follow-up|2|||
130215996|NCT00199849|468753918|FG000|Overall Study|Unrelated illness or complication|0|||
130215997|NCT00199849|468753919|FG001|Overall Study|Unrelated illness or complication|1|||
130215998|NCT00199849|468753920|FG002|Overall Study|Unrelated illness or complication|0|||
130331598|NCT01908803|469183391|FG001|Overall Study|Withdrawal by Subject|0|||
130331599|NCT01908803|469183390|FG000|Overall Study|Randomization Error|1|||
130215999|NCT00199849|468753918|FG000|Overall Study|Progressive disease requiring intervention|0|||
130216000|NCT00199849|468753919|FG001|Overall Study|Progressive disease requiring intervention|0|||
130331600|NCT01908803|469183391|FG001|Overall Study|Randomization Error|0|||
130331601|NCT01908803|469183390|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
130331602|NCT01908803|469183391|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
130331603|NCT00867815|469183392|FG000|Overall Study|Lost to Follow-up|1|||
130331604|NCT00001213|469183393|FG000|Overall Study|Death|18|||
130331605|NCT01554241|469183394|FG000|Overall Study|Death|3|||
130331606|NCT01554241|469183395|FG001|Overall Study|Death|1|||
130331607|NCT01554241|469183396|FG002|Overall Study|Death|1|||
130331608|NCT01554241|469183397|FG003|Overall Study|Death|0|||
130331609|NCT01554241|469183394|FG000|Overall Study|protocol specified renal stone|0|||
130331610|NCT01554241|469183395|FG001|Overall Study|protocol specified renal stone|0|||
130331611|NCT01554241|469183396|FG002|Overall Study|protocol specified renal stone|0|||
130331612|NCT01554241|469183397|FG003|Overall Study|protocol specified renal stone|1|||
130331613|NCT01554241|469183394|FG000|Overall Study|protocol specified change in eGFR|0|||
130331614|NCT01554241|469183395|FG001|Overall Study|protocol specified change in eGFR|0|||
130331615|NCT01554241|469183396|FG002|Overall Study|protocol specified change in eGFR|1|||
130331616|NCT01554241|469183397|FG003|Overall Study|protocol specified change in eGFR|0|||
130331617|NCT01554241|469183394|FG000|Overall Study|Withdrawal by Subject|0|||
130331618|NCT01554241|469183395|FG001|Overall Study|Withdrawal by Subject|0|||
130331619|NCT01554241|469183396|FG002|Overall Study|Withdrawal by Subject|2|||
130331620|NCT01554241|469183397|FG003|Overall Study|Withdrawal by Subject|0|||
130331621|NCT00372593|469183404|FG000|Overall Study|Adverse Event|43|||
130331622|NCT00372593|469183405|FG001|Overall Study|Adverse Event|45|||
130331623|NCT00372593|469183406|FG002|Overall Study|Adverse Event|0|||
130331624|NCT00372593|469183404|FG000|Overall Study|Death|16|||
130331625|NCT00372593|469183405|FG001|Overall Study|Death|20|||
130331626|NCT00372593|469183406|FG002|Overall Study|Death|1|||
130331627|NCT00372593|469183404|FG000|Overall Study|Lack of Efficacy|82|||
130331628|NCT00372593|469183405|FG001|Overall Study|Lack of Efficacy|71|||
130331629|NCT00372593|469183406|FG002|Overall Study|Lack of Efficacy|2|||
130331630|NCT00372593|469183404|FG000|Overall Study|Lost to Follow-up|1|||
130331631|NCT00372593|469183405|FG001|Overall Study|Lost to Follow-up|0|||
130331632|NCT00372593|469183406|FG002|Overall Study|Lost to Follow-up|0|||
130331633|NCT00372593|469183404|FG000|Overall Study|Physician Decision|42|||
130331634|NCT00372593|469183405|FG001|Overall Study|Physician Decision|41|||
130331635|NCT00372593|469183406|FG002|Overall Study|Physician Decision|0|||
130331636|NCT00372593|469183404|FG000|Overall Study|Ineligible|20|||
130331637|NCT00372593|469183405|FG001|Overall Study|Ineligible|21|||
130331638|NCT00372593|469183406|FG002|Overall Study|Ineligible|1|||
130331639|NCT00433004|469183407|FG000|Overall Study|Lost to Follow-up|5|||
130331640|NCT00433004|469183408|FG001|Overall Study|Lost to Follow-up|7|||
130331641|NCT03534180|469183409|FG000|Overall Study|Withdrawal by Subject|1|||
130331642|NCT00220636|469183410|FG000|Overall Study|Withdrawal by Subject|4|||
130331643|NCT00330967|469183411|FG000|Overall Study|Withdrawal by Subject|0|||
130331644|NCT00330967|469183412|FG001|Overall Study|Withdrawal by Subject|5|||
130331645|NCT00330967|469183411|FG000|Overall Study|Physician Decision|0|||
130331646|NCT00330967|469183412|FG001|Overall Study|Physician Decision|9|||
130331647|NCT00790088|469183415|FG000|Overall Study|Protocol Violation|11|||
130331648|NCT00790088|469183415|FG000|Overall Study|Withdrawal by Subject|17|||
130331649|NCT00790088|469183415|FG000|Overall Study|Lost to Follow-up|7|||
130331650|NCT00790088|469183415|FG000|Overall Study|Physician Decision|4|||
130331651|NCT05661409|469183416|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
130331652|NCT05661409|469183417|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
130331653|NCT05661409|469183418|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
130331654|NCT05661409|469183419|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
130331655|NCT05661409|469183420|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
130331656|NCT05661409|469183421|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
130331657|NCT05661409|469183416|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
130331658|NCT05661409|469183417|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
130331659|NCT05661409|469183418|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
130331660|NCT05661409|469183419|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
130331661|NCT05661409|469183420|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
130331662|NCT05661409|469183421|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
130331663|NCT05661409|469183416|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130331664|NCT05661409|469183417|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130331665|NCT05661409|469183418|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
130331666|NCT05661409|469183419|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
130331667|NCT05661409|469183420|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
130331668|NCT05661409|469183421|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
130331669|NCT05661409|469183416|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331670|NCT05661409|469183417|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331671|NCT05661409|469183418|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331672|NCT05661409|469183419|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331673|NCT05661409|469183420|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
130331674|NCT05661409|469183421|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
130331675|NCT05661409|469183416|FG000|Overall Study|Miscommu-nication about administration|0|||
130331676|NCT05661409|469183417|FG001|Overall Study|Miscommu-nication about administration|0|||
130331677|NCT05661409|469183418|FG002|Overall Study|Miscommu-nication about administration|0|||
130331678|NCT05661409|469183419|FG003|Overall Study|Miscommu-nication about administration|0|||
130331679|NCT05661409|469183420|FG004|Overall Study|Miscommu-nication about administration|0|||
130331680|NCT05661409|469183421|FG005|Overall Study|Miscommu-nication about administration|1|||
130331681|NCT04439136|469183422|FG000|Overall Study|Ineligible|1|||
130331682|NCT04439136|469183422|FG000|Overall Study|Never Started Treatment|2|||
130331683|NCT04439136|469183422|FG000|Overall Study|Adverse Event|4|||
130331684|NCT04439136|469183422|FG000|Overall Study|Death|3|||
130331685|NCT04439136|469183422|FG000|Overall Study|Disease Progression|27|||
130331686|NCT04439136|469183422|FG000|Overall Study|Alternative Therapy|1|||
130331687|NCT04439136|469183422|FG000|Overall Study|Increased Tumor Burden|1|||
130331688|NCT04439136|469183422|FG000|Overall Study|Symptomatic Detrioration|1|||
130331689|NCT02578706|469183425|FG000|Overall Study|Withdrawal by Subject|1|||
130331690|NCT02578706|469183426|FG001|Overall Study|Withdrawal by Subject|0|||
130331691|NCT02578706|469183427|FG002|Overall Study|Withdrawal by Subject|0|||
130331692|NCT02578706|469183425|FG000|Overall Study|Lost to Follow-up|0|||
130331693|NCT02578706|469183426|FG001|Overall Study|Lost to Follow-up|4|||
130331694|NCT02578706|469183427|FG002|Overall Study|Lost to Follow-up|0|||
130331695|NCT02578706|469183425|FG000|Overall Study|Physician Decision|0|||
130331696|NCT02578706|469183426|FG001|Overall Study|Physician Decision|1|||
130331697|NCT02578706|469183427|FG002|Overall Study|Physician Decision|0|||
130331698|NCT01662102|469183432|FG000|Overall Study|Sponsor's decision|1|||
130331699|NCT01662102|469183433|FG001|Overall Study|Sponsor's decision|0|||
130331700|NCT01995838|469183436|FG000|Overall Study|Lost to Follow-up|0|||
130331701|NCT01995838|469183437|FG001|Overall Study|Lost to Follow-up|1|||
130331702|NCT01995838|469183438|FG002|Overall Study|Lost to Follow-up|0|||
130331703|NCT01995838|469183439|FG003|Overall Study|Lost to Follow-up|0|||
130331704|NCT01995838|469183440|FG004|Overall Study|Lost to Follow-up|0|||
130331705|NCT01995838|469183441|FG005|Overall Study|Lost to Follow-up|0|||
130331706|NCT01995838|469183442|FG006|Overall Study|Lost to Follow-up|1|||
130331707|NCT01995838|469183436|FG000|Overall Study|Participant choice|2|||
130331708|NCT01995838|469183437|FG001|Overall Study|Participant choice|0|||
130331709|NCT01995838|469183438|FG002|Overall Study|Participant choice|0|||
130331710|NCT01995838|469183439|FG003|Overall Study|Participant choice|0|||
130331711|NCT01995838|469183440|FG004|Overall Study|Participant choice|0|||
130331712|NCT01995838|469183441|FG005|Overall Study|Participant choice|1|||
130331713|NCT01995838|469183442|FG006|Overall Study|Participant choice|1|||
130331714|NCT01995838|469183436|FG000|Overall Study|Adverse Event|0|||
130331715|NCT01995838|469183437|FG001|Overall Study|Adverse Event|0|||
130331716|NCT01995838|469183438|FG002|Overall Study|Adverse Event|0|||
130331717|NCT01995838|469183439|FG003|Overall Study|Adverse Event|0|||
130331718|NCT01995838|469183440|FG004|Overall Study|Adverse Event|0|||
130331719|NCT01995838|469183441|FG005|Overall Study|Adverse Event|0|||
130331720|NCT01995838|469183442|FG006|Overall Study|Adverse Event|1|||
130331721|NCT01995838|469183436|FG000|Overall Study|Withdrawal by Subject|0|||
130331722|NCT01995838|469183437|FG001|Overall Study|Withdrawal by Subject|0|||
130331723|NCT01995838|469183438|FG002|Overall Study|Withdrawal by Subject|0|||
130331724|NCT01995838|469183439|FG003|Overall Study|Withdrawal by Subject|0|||
130331725|NCT01995838|469183440|FG004|Overall Study|Withdrawal by Subject|1|||
130331726|NCT01995838|469183441|FG005|Overall Study|Withdrawal by Subject|0|||
130331727|NCT01995838|469183442|FG006|Overall Study|Withdrawal by Subject|0|||
130331728|NCT01995838|469183436|FG000|Overall Study|Other|3|||
130331729|NCT01995838|469183437|FG001|Overall Study|Other|1|||
130331730|NCT01995838|469183438|FG002|Overall Study|Other|0|||
130331731|NCT01995838|469183439|FG003|Overall Study|Other|2|||
130331732|NCT01995838|469183440|FG004|Overall Study|Other|1|||
130331733|NCT01995838|469183441|FG005|Overall Study|Other|1|||
130331734|NCT01995838|469183442|FG006|Overall Study|Other|2|||
130331735|NCT00380367|469183445|FG000|Overall Study|Lost to Follow-up|1|||
130331736|NCT00380367|469183445|FG000|Overall Study|Withdrawal by Subject|1|||
130331737|NCT00439517|469183453|FG000|Overall Study|Subject on treatment|1|||
130331738|NCT00439517|469183454|FG001|Overall Study|Subject on treatment|0|||
130331739|NCT00439517|469183453|FG000|Overall Study|Subject in survival follow-up|1|||
130331740|NCT00439517|469183454|FG001|Overall Study|Subject in survival follow-up|0|||
130331741|NCT01519921|469183464|FG000|Overall Study|Adverse Event|10|||
130331742|NCT01519921|469183465|FG001|Overall Study|Adverse Event|9|||
130331743|NCT01519921|469183464|FG000|Overall Study|Lack of Efficacy|4|||
130331744|NCT01519921|469183465|FG001|Overall Study|Lack of Efficacy|3|||
130331745|NCT01519921|469183464|FG000|Overall Study|Withdrawal by Subject|3|||
130331746|NCT01519921|469183465|FG001|Overall Study|Withdrawal by Subject|0|||
130331747|NCT01519921|469183464|FG000|Overall Study|Lost to Follow-up|2|||
130331748|NCT01519921|469183465|FG001|Overall Study|Lost to Follow-up|1|||
130331749|NCT01519921|469183464|FG000|Overall Study|Treatment refusal|2|||
130331750|NCT01519921|469183465|FG001|Overall Study|Treatment refusal|1|||
130331751|NCT01519921|469183464|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
130331752|NCT01519921|469183465|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
130331753|NCT00060840|469183468|FG000|Overall Study|Change in surgical plan|2|||
130331754|NCT00060840|469183469|FG001|Overall Study|Change in surgical plan|6|||
130331755|NCT00060840|469183468|FG000|Overall Study|Death|0|||
130331756|NCT00060840|469183469|FG001|Overall Study|Death|1|||
130331757|NCT00060840|469183468|FG000|Overall Study|Withdrawal by Subject|0|||
130331758|NCT00060840|469183469|FG001|Overall Study|Withdrawal by Subject|1|||
130331759|NCT00060840|469183468|FG000|Overall Study|Subinvestigator unavailable|0|||
130331760|NCT00060840|469183469|FG001|Overall Study|Subinvestigator unavailable|1|||
130331761|NCT00060840|469183468|FG000|Overall Study|Physician Decision|1|||
130331762|NCT00060840|469183469|FG001|Overall Study|Physician Decision|0|||
130331763|NCT00060840|469183468|FG000|Overall Study|Other|1|||
130331764|NCT00060840|469183469|FG001|Overall Study|Other|0|||
130331765|NCT01216189|469183474|FG000|Overall Study|Lost to Follow-up|21|||
130331766|NCT01216189|469183475|FG001|Overall Study|Lost to Follow-up|3|||
130331767|NCT01216189|469183474|FG000|Overall Study|Death|4|||
130331768|NCT01216189|469183475|FG001|Overall Study|Death|2|||
130331769|NCT00125164|469183476|FG000|Overall Study|Adverse Event|0|||
130331770|NCT00125164|469183477|FG001|Overall Study|Adverse Event|0|||
130331771|NCT00125164|469183478|FG002|Overall Study|Adverse Event|2|||
130331772|NCT00125164|469183479|FG003|Overall Study|Adverse Event|4|||
130331773|NCT00125164|469183476|FG000|Overall Study|Lost to Follow-up|0|||
130331774|NCT00125164|469183477|FG001|Overall Study|Lost to Follow-up|0|||
130331775|NCT00125164|469183478|FG002|Overall Study|Lost to Follow-up|1|||
130331776|NCT00125164|469183479|FG003|Overall Study|Lost to Follow-up|1|||
130331777|NCT00125164|469183476|FG000|Overall Study|Withdrawal by Subject|2|||
130331778|NCT00125164|469183477|FG001|Overall Study|Withdrawal by Subject|0|||
130331779|NCT00125164|469183478|FG002|Overall Study|Withdrawal by Subject|1|||
130331780|NCT00125164|469183479|FG003|Overall Study|Withdrawal by Subject|1|||
130331781|NCT01339052|469183480|FG000|Overall Study|Disease progression|13|||
130331782|NCT01339052|469183481|FG001|Overall Study|Disease progression|46|||
130331783|NCT01339052|469183480|FG000|Overall Study|Adverse Event|1|||
130331784|NCT01339052|469183481|FG001|Overall Study|Adverse Event|1|||
130331785|NCT01339052|469183480|FG000|Overall Study|Withdrawal by Subject|0|||
130331786|NCT01339052|469183481|FG001|Overall Study|Withdrawal by Subject|3|||
130331787|NCT01339052|469183480|FG000|Overall Study|Physician Decision|1|||
130331788|NCT01339052|469183481|FG001|Overall Study|Physician Decision|0|||
130331789|NCT02637037|469183482|FG000|Overall Study|Positive drug screen at admission|1|||
130331790|NCT02637037|469183483|FG001|Overall Study|Positive drug screen at admission|0|||
130331791|NCT02637037|469183482|FG000|Overall Study|Withdrawal by Subject|2|||
130331792|NCT02637037|469183483|FG001|Overall Study|Withdrawal by Subject|1|||
130331793|NCT02637037|469183482|FG000|Overall Study|Adverse Event|1|||
130331794|NCT02637037|469183483|FG001|Overall Study|Adverse Event|0|||
130331795|NCT01469377|469183486|FG000|Overall Study|Protocol Deviation|7|||
130331796|NCT01469377|469183487|FG001|Overall Study|Protocol Deviation|10|||
130331797|NCT01469377|469183488|FG002|Overall Study|Protocol Deviation|10|||
130331798|NCT01469377|469183486|FG000|Overall Study|Lost to Follow-up|3|||
130331799|NCT01469377|469183487|FG001|Overall Study|Lost to Follow-up|2|||
130331800|NCT01469377|469183488|FG002|Overall Study|Lost to Follow-up|5|||
130331801|NCT01469377|469183486|FG000|Overall Study|Withdrawal of Consent|12|||
130331802|NCT01469377|469183487|FG001|Overall Study|Withdrawal of Consent|14|||
130331803|NCT01469377|469183488|FG002|Overall Study|Withdrawal of Consent|15|||
130331804|NCT01469377|469183486|FG000|Overall Study|Adverse Event|8|||
130331805|NCT01469377|469183487|FG001|Overall Study|Adverse Event|18|||
130331806|NCT01469377|469183488|FG002|Overall Study|Adverse Event|36|||
130331807|NCT01469377|469183486|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130331808|NCT01469377|469183487|FG001|Overall Study|Insufficient Therapeutic Response|4|||
130331809|NCT01469377|469183488|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130331810|NCT01469377|469183486|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130331811|NCT01469377|469183487|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130331812|NCT01469377|469183488|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130331813|NCT01733680|469183489|FG000|Overall Study|Withdrawal by Subject|0|||
130331814|NCT01733680|469183490|FG001|Overall Study|Withdrawal by Subject|1|||
130331815|NCT04308291|469183497|FG000|Run-In Phase|Withdrawal by Subject|4|||
130331816|NCT04308291|469183497|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
130331817|NCT04308291|469183497|FG000|Study Phase 6-M|Physician Decision|2|||
129883874|NCT02733042|467534454|FG013|Overall Study|Progressive Disease|1|||
130331818|NCT04308291|469183497|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
130331819|NCT04308291|469183497|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
130331820|NCT04308291|469183497|FG000|Study Phase 12-M|Physician Decision|2|||
130331821|NCT04308291|469183497|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
130331822|NCT02565108|469183498|FG000|Overall Study|Adverse Event|1|||
130331823|NCT02565108|469183499|FG001|Overall Study|Adverse Event|0|||
130331824|NCT02565108|469183498|FG000|Overall Study|Withdrew Consent|1|||
130331825|NCT02565108|469183499|FG001|Overall Study|Withdrew Consent|0|||
130331826|NCT02453711|469183500|FG000|Overall Study|Withdrawal by Subject|5|||
130331827|NCT02453711|469183501|FG001|Overall Study|Withdrawal by Subject|4|||
130331828|NCT02453711|469183502|FG002|Overall Study|Withdrawal by Subject|6|||
130331829|NCT02453711|469183503|FG003|Overall Study|Withdrawal by Subject|4|||
130331830|NCT02453711|469183504|FG004|Overall Study|Withdrawal by Subject|1|||
130331831|NCT02453711|469183505|FG005|Overall Study|Withdrawal by Subject|1|||
130331832|NCT02453711|469183506|FG006|Overall Study|Withdrawal by Subject|0|||
130331833|NCT02453711|469183507|FG007|Overall Study|Withdrawal by Subject|1|||
130331834|NCT02453711|469183508|FG008|Overall Study|Withdrawal by Subject|7|||
130331835|NCT02453711|469183500|FG000|Overall Study|Lost to Follow-up|5|||
130331836|NCT02453711|469183501|FG001|Overall Study|Lost to Follow-up|3|||
130331837|NCT02453711|469183502|FG002|Overall Study|Lost to Follow-up|2|||
130331838|NCT02453711|469183503|FG003|Overall Study|Lost to Follow-up|3|||
130331839|NCT02453711|469183504|FG004|Overall Study|Lost to Follow-up|1|||
130331840|NCT02453711|469183505|FG005|Overall Study|Lost to Follow-up|5|||
130331841|NCT02453711|469183506|FG006|Overall Study|Lost to Follow-up|2|||
130331842|NCT02453711|469183507|FG007|Overall Study|Lost to Follow-up|6|||
130331843|NCT02453711|469183508|FG008|Overall Study|Lost to Follow-up|6|||
130331844|NCT02453711|469183500|FG000|Overall Study|Death|0|||
130331845|NCT02453711|469183501|FG001|Overall Study|Death|0|||
130331846|NCT02453711|469183502|FG002|Overall Study|Death|0|||
130331847|NCT02453711|469183503|FG003|Overall Study|Death|0|||
130331848|NCT02453711|469183504|FG004|Overall Study|Death|0|||
130331849|NCT02453711|469183505|FG005|Overall Study|Death|0|||
130331850|NCT02453711|469183506|FG006|Overall Study|Death|1|||
130331851|NCT02453711|469183507|FG007|Overall Study|Death|0|||
130331852|NCT02453711|469183508|FG008|Overall Study|Death|0|||
130331853|NCT02453711|469183500|FG000|Overall Study|Unclassified|1|||
130331854|NCT02453711|469183501|FG001|Overall Study|Unclassified|0|||
130331855|NCT02453711|469183502|FG002|Overall Study|Unclassified|1|||
130331856|NCT02453711|469183503|FG003|Overall Study|Unclassified|0|||
130331857|NCT02453711|469183504|FG004|Overall Study|Unclassified|0|||
130331858|NCT02453711|469183505|FG005|Overall Study|Unclassified|0|||
130331859|NCT02453711|469183506|FG006|Overall Study|Unclassified|0|||
130331860|NCT02453711|469183507|FG007|Overall Study|Unclassified|0|||
130331861|NCT02453711|469183508|FG008|Overall Study|Unclassified|0|||
130331862|NCT01273519|469183509|FG000|Overall Study|Adverse Event|3|||
130331863|NCT01273519|469183510|FG001|Overall Study|Adverse Event|0|||
130331864|NCT01273519|469183511|FG002|Overall Study|Adverse Event|0|||
130331865|NCT01273519|469183509|FG000|Overall Study|Lost to Follow-up|2|||
130331866|NCT01273519|469183510|FG001|Overall Study|Lost to Follow-up|1|||
130331867|NCT01273519|469183511|FG002|Overall Study|Lost to Follow-up|3|||
130331868|NCT01273519|469183509|FG000|Overall Study|Lack of Efficacy|8|||
130331869|NCT01273519|469183510|FG001|Overall Study|Lack of Efficacy|3|||
130331870|NCT01273519|469183511|FG002|Overall Study|Lack of Efficacy|4|||
130331871|NCT01273519|469183509|FG000|Overall Study|Other|6|||
130331872|NCT01273519|469183510|FG001|Overall Study|Other|1|||
130331873|NCT01273519|469183511|FG002|Overall Study|Other|1|||
130331874|NCT02302339|469183512|FG000|Overall Study|Lost to Follow-up|1|||
130331875|NCT02302339|469183513|FG001|Overall Study|Lost to Follow-up|0|||
130331876|NCT02302339|469183514|FG002|Overall Study|Lost to Follow-up|0|||
130331877|NCT02302339|469183515|FG003|Overall Study|Lost to Follow-up|0|||
130331878|NCT02302339|469183512|FG000|Overall Study|Withdrawal by Subject|0|||
130331879|NCT02302339|469183513|FG001|Overall Study|Withdrawal by Subject|2|||
130331880|NCT02302339|469183514|FG002|Overall Study|Withdrawal by Subject|1|||
130331881|NCT02302339|469183515|FG003|Overall Study|Withdrawal by Subject|0|||
130331882|NCT02908672|469183516|FG000|Run-in Period|Death|12|||
130331883|NCT02908672|469183517|FG001|Run-in Period|Death|10|||
130331884|NCT02908672|469183518|FG002|Run-in Period|Death|0|||
130331885|NCT02908672|469183519|FG003|Run-in Period|Death|0|||
130331886|NCT02908672|469183516|FG000|Run-in Period|Lost to Follow-up|1|||
130331887|NCT02908672|469183517|FG001|Run-in Period|Lost to Follow-up|1|||
130331888|NCT02908672|469183518|FG002|Run-in Period|Lost to Follow-up|0|||
130331889|NCT02908672|469183519|FG003|Run-in Period|Lost to Follow-up|0|||
130216001|NCT00199849|468753920|FG002|Overall Study|Progressive disease requiring intervention|1|||
130331890|NCT02908672|469183516|FG000|Run-in Period|Reason Not Specified|2|||
130331891|NCT02908672|469183517|FG001|Run-in Period|Reason Not Specified|0|||
130331892|NCT02908672|469183518|FG002|Run-in Period|Reason Not Specified|0|||
130331893|NCT02908672|469183519|FG003|Run-in Period|Reason Not Specified|0|||
130331894|NCT02908672|469183516|FG000|Run-in Period|Protocol Violation|1|||
130331895|NCT02908672|469183517|FG001|Run-in Period|Protocol Violation|1|||
130331896|NCT02908672|469183518|FG002|Run-in Period|Protocol Violation|0|||
130331897|NCT02908672|469183519|FG003|Run-in Period|Protocol Violation|0|||
130331898|NCT02908672|469183516|FG000|Run-in Period|Study Ended by Sponsor|5|||
130331899|NCT02908672|469183517|FG001|Run-in Period|Study Ended by Sponsor|1|||
130331900|NCT02908672|469183518|FG002|Run-in Period|Study Ended by Sponsor|0|||
130331901|NCT02908672|469183519|FG003|Run-in Period|Study Ended by Sponsor|0|||
130331902|NCT02908672|469183516|FG000|Run-in Period|Withdrawal by Subject|3|||
130331903|NCT02908672|469183517|FG001|Run-in Period|Withdrawal by Subject|9|||
130331904|NCT02908672|469183518|FG002|Run-in Period|Withdrawal by Subject|0|||
130331905|NCT02908672|469183519|FG003|Run-in Period|Withdrawal by Subject|0|||
130331906|NCT02908672|469183516|FG000|Triple Combination Period|Death|0|||
130331907|NCT02908672|469183517|FG001|Triple Combination Period|Death|0|||
130331908|NCT02908672|469183518|FG002|Triple Combination Period|Death|150|||
130331909|NCT02908672|469183519|FG003|Triple Combination Period|Death|127|||
130331910|NCT02908672|469183516|FG000|Triple Combination Period|Lost to Follow-up|0|||
130331911|NCT02908672|469183517|FG001|Triple Combination Period|Lost to Follow-up|0|||
130331912|NCT02908672|469183518|FG002|Triple Combination Period|Lost to Follow-up|6|||
130331913|NCT02908672|469183519|FG003|Triple Combination Period|Lost to Follow-up|8|||
130331914|NCT02908672|469183516|FG000|Triple Combination Period|Reason Not Specified|0|||
130331915|NCT02908672|469183517|FG001|Triple Combination Period|Reason Not Specified|0|||
130331916|NCT02908672|469183518|FG002|Triple Combination Period|Reason Not Specified|0|||
130331917|NCT02908672|469183519|FG003|Triple Combination Period|Reason Not Specified|1|||
130331918|NCT02908672|469183516|FG000|Triple Combination Period|Physician Decision|0|||
130331919|NCT02908672|469183517|FG001|Triple Combination Period|Physician Decision|0|||
130331920|NCT02908672|469183518|FG002|Triple Combination Period|Physician Decision|1|||
130331921|NCT02908672|469183519|FG003|Triple Combination Period|Physician Decision|1|||
130331922|NCT02908672|469183516|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
130331923|NCT02908672|469183517|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
130331924|NCT02908672|469183518|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
130331925|NCT02908672|469183519|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
130331926|NCT02908672|469183516|FG000|Triple Combination Period|Withdrawal by Subject|0|||
130331927|NCT02908672|469183517|FG001|Triple Combination Period|Withdrawal by Subject|0|||
130331928|NCT02908672|469183518|FG002|Triple Combination Period|Withdrawal by Subject|13|||
130331929|NCT02908672|469183519|FG003|Triple Combination Period|Withdrawal by Subject|16|||
130331930|NCT01185080|469183520|FG000|Overall Study|Adverse Event|1|||
130331931|NCT01185080|469183521|FG001|Overall Study|Adverse Event|1|||
130331932|NCT01185080|469183522|FG002|Overall Study|Adverse Event|0|||
130331933|NCT01185080|469183520|FG000|Overall Study|Personal reasons|0|||
130331934|NCT01185080|469183521|FG001|Overall Study|Personal reasons|0|||
130331935|NCT01185080|469183522|FG002|Overall Study|Personal reasons|1|||
130331936|NCT01104311|469183523|FG000|Overall Study|Withdrawal by Subject|6|||
130331937|NCT01104311|469183524|FG001|Overall Study|Withdrawal by Subject|6|||
130331938|NCT01104311|469183523|FG000|Overall Study|Protocol Violation|0|||
130331939|NCT01104311|469183524|FG001|Overall Study|Protocol Violation|1|||
130331940|NCT01104311|469183523|FG000|Overall Study|Physician Decision|2|||
130331941|NCT01104311|469183524|FG001|Overall Study|Physician Decision|2|||
130331942|NCT01104311|469183523|FG000|Overall Study|low compliance|1|||
130331943|NCT01104311|469183524|FG001|Overall Study|low compliance|1|||
130331944|NCT01104311|469183523|FG000|Overall Study|Adverse Event|1|||
130331945|NCT01104311|469183524|FG001|Overall Study|Adverse Event|2|||
130331946|NCT01705509|469184941|FG000|Inclusion CPET|Screen Failure|5|||
130331947|NCT01705509|469184941|FG000|Inclusion CPET|Withdrawal by Subject|2|||
130331948|NCT01705509|469184941|FG000|CPET w/ Ranexa|Screen Failure|2|||
130331949|NCT01227018|469184942|FG000|Overall Study|Disease progression|9|||
130331950|NCT01227018|469184942|FG000|Overall Study|Toxicity|2|||
130331951|NCT01227018|469184942|FG000|Overall Study|Withdrew after beginning treatment|4|||
130331952|NCT01413204|469184945|FG000|Overall Study|Adverse Event|1|||
130331953|NCT01413204|469184946|FG001|Overall Study|Adverse Event|2|||
130331954|NCT01413204|469184947|FG002|Overall Study|Adverse Event|2|||
130331955|NCT01413204|469184945|FG000|Overall Study|Physician Decision|3|||
130331956|NCT01413204|469184946|FG001|Overall Study|Physician Decision|0|||
130331957|NCT01413204|469184947|FG002|Overall Study|Physician Decision|2|||
130331958|NCT01413204|469184945|FG000|Overall Study|Withdrawal by Subject|1|||
130331959|NCT01413204|469184946|FG001|Overall Study|Withdrawal by Subject|4|||
130331960|NCT01413204|469184947|FG002|Overall Study|Withdrawal by Subject|4|||
130331961|NCT01413204|469184945|FG000|Overall Study|Clearly not eligible for the study|0|||
130331962|NCT01413204|469184946|FG001|Overall Study|Clearly not eligible for the study|0|||
130331963|NCT01413204|469184947|FG002|Overall Study|Clearly not eligible for the study|1|||
130331964|NCT01413204|469184945|FG000|Overall Study|Fasting plasma glucose level increased|1|||
130331965|NCT01413204|469184946|FG001|Overall Study|Fasting plasma glucose level increased|0|||
130331966|NCT01413204|469184947|FG002|Overall Study|Fasting plasma glucose level increased|10|||
130331967|NCT01039376|469184948|FG000|Overall Study|Lost to Follow-up|5|||
130331968|NCT01039376|469184949|FG001|Overall Study|Lost to Follow-up|12|||
130331969|NCT01039376|469184948|FG000|Overall Study|Physician Decision|15|||
130331970|NCT01039376|469184949|FG001|Overall Study|Physician Decision|10|||
130331971|NCT01039376|469184948|FG000|Overall Study|Withdrawal by Subject|20|||
130331972|NCT01039376|469184949|FG001|Overall Study|Withdrawal by Subject|32|||
130331973|NCT01039376|469184948|FG000|Overall Study|Study terminated by Sponsor|90|||
130331974|NCT01039376|469184949|FG001|Overall Study|Study terminated by Sponsor|72|||
130331975|NCT00753649|469184950|FG000|Overall Study|Migrated/moved from study area|1|||
130331976|NCT00753649|469184951|FG001|Overall Study|Migrated/moved from study area|0|||
130331977|NCT00753649|469184950|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
130331978|NCT00753649|469184951|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
130331979|NCT00753649|469184950|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
130331980|NCT00753649|469184951|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
130331981|NCT00753649|469184950|FG000|Overall Study|Protocol Violation|2|||
130331982|NCT00753649|469184951|FG001|Overall Study|Protocol Violation|0|||
130331983|NCT01255436|469184954|FG000|Overall Study|Lost to Follow-up|178|||
130331984|NCT01255436|469184955|FG001|Overall Study|Lost to Follow-up|191|||
130331985|NCT01255436|469184954|FG000|Overall Study|Death, stroke, or MI|4|||
130331986|NCT01255436|469184955|FG001|Overall Study|Death, stroke, or MI|3|||
130331987|NCT04816669|469184956|FG000|Part 1|Adverse Event|1|||
130331988|NCT04816669|469184957|FG001|Part 1|Adverse Event|1|||
130331989|NCT04816669|469184958|FG002|Part 1|Adverse Event|0|||
130331990|NCT04816669|469184959|FG003|Part 1|Adverse Event|0|||
130331991|NCT04816669|469184956|FG000|Part 1|Lost to Follow-up|2|||
130331992|NCT04816669|469184957|FG001|Part 1|Lost to Follow-up|2|||
130331993|NCT04816669|469184958|FG002|Part 1|Lost to Follow-up|0|||
130331994|NCT04816669|469184959|FG003|Part 1|Lost to Follow-up|0|||
130331995|NCT04816669|469184956|FG000|Part 1|Protocol Violation|0|||
130331996|NCT04816669|469184957|FG001|Part 1|Protocol Violation|1|||
130331997|NCT04816669|469184958|FG002|Part 1|Protocol Violation|0|||
130331998|NCT04816669|469184959|FG003|Part 1|Protocol Violation|0|||
130331999|NCT04816669|469184956|FG000|Part 1|Withdrawal by Subject|1|||
130332000|NCT04816669|469184957|FG001|Part 1|Withdrawal by Subject|2|||
130332001|NCT04816669|469184958|FG002|Part 1|Withdrawal by Subject|0|||
130332002|NCT04816669|469184959|FG003|Part 1|Withdrawal by Subject|0|||
130332003|NCT04816669|469184956|FG000|Part 2|Other|0|||
130332004|NCT04816669|469184957|FG001|Part 2|Other|0|||
130332005|NCT04816669|469184958|FG002|Part 2|Other|1|||
130332006|NCT04816669|469184959|FG003|Part 2|Other|0|||
130332007|NCT04816669|469184956|FG000|Part 2|Withdrawal by Subject|0|||
130332008|NCT04816669|469184957|FG001|Part 2|Withdrawal by Subject|0|||
130332009|NCT04816669|469184958|FG002|Part 2|Withdrawal by Subject|0|||
130332010|NCT04816669|469184959|FG003|Part 2|Withdrawal by Subject|1|||
130332011|NCT04816669|469184956|FG000|Part 2|Lost to Follow-up|0|||
130332012|NCT04816669|469184957|FG001|Part 2|Lost to Follow-up|0|||
130332013|NCT04816669|469184958|FG002|Part 2|Lost to Follow-up|1|||
130332014|NCT04816669|469184959|FG003|Part 2|Lost to Follow-up|0|||
130332015|NCT01229267|469184960|FG000|Overall Study|Adverse Event|4|||
130332016|NCT01229267|469184961|FG001|Overall Study|Adverse Event|6|||
130332017|NCT01229267|469184962|FG002|Overall Study|Adverse Event|3|||
130332018|NCT01229267|469184963|FG003|Overall Study|Adverse Event|2|||
130332019|NCT01229267|469184964|FG004|Overall Study|Adverse Event|10|||
130332020|NCT01229267|469184960|FG000|Overall Study|Death|40|||
130332021|NCT01229267|469184961|FG001|Overall Study|Death|37|||
130332022|NCT01229267|469184962|FG002|Overall Study|Death|35|||
130332023|NCT01229267|469184963|FG003|Overall Study|Death|13|||
130332024|NCT01229267|469184964|FG004|Overall Study|Death|103|||
130332025|NCT01229267|469184960|FG000|Overall Study|Withdrawal by Subject|23|||
130332026|NCT01229267|469184961|FG001|Overall Study|Withdrawal by Subject|22|||
130332027|NCT01229267|469184962|FG002|Overall Study|Withdrawal by Subject|32|||
130332028|NCT01229267|469184963|FG003|Overall Study|Withdrawal by Subject|14|||
130332029|NCT01229267|469184964|FG004|Overall Study|Withdrawal by Subject|59|||
130332030|NCT01229267|469184960|FG000|Overall Study|Protocol Violation|0|||
130332031|NCT01229267|469184961|FG001|Overall Study|Protocol Violation|1|||
130332032|NCT01229267|469184962|FG002|Overall Study|Protocol Violation|0|||
130332033|NCT01229267|469184963|FG003|Overall Study|Protocol Violation|0|||
130332034|NCT01229267|469184964|FG004|Overall Study|Protocol Violation|0|||
130332035|NCT01229267|469184960|FG000|Overall Study|Progressive disease|0|||
130332036|NCT01229267|469184961|FG001|Overall Study|Progressive disease|0|||
130332037|NCT01229267|469184962|FG002|Overall Study|Progressive disease|0|||
130332038|NCT01229267|469184963|FG003|Overall Study|Progressive disease|0|||
130332039|NCT01229267|469184964|FG004|Overall Study|Progressive disease|1|||
130332040|NCT01229267|469184960|FG000|Overall Study|Physician Decision|8|||
130332041|NCT01229267|469184961|FG001|Overall Study|Physician Decision|11|||
130332042|NCT01229267|469184962|FG002|Overall Study|Physician Decision|8|||
130332043|NCT01229267|469184963|FG003|Overall Study|Physician Decision|3|||
130332044|NCT01229267|469184964|FG004|Overall Study|Physician Decision|25|||
130332045|NCT01229267|469184960|FG000|Overall Study|Lost to Follow-up|6|||
130332046|NCT01229267|469184961|FG001|Overall Study|Lost to Follow-up|5|||
130332047|NCT01229267|469184962|FG002|Overall Study|Lost to Follow-up|8|||
130332048|NCT01229267|469184963|FG003|Overall Study|Lost to Follow-up|3|||
130332049|NCT01229267|469184964|FG004|Overall Study|Lost to Follow-up|22|||
130332050|NCT01864603|469184976|FG000|Stage 2|DSMB design modification|86056|||
130332051|NCT01864603|469184977|FG001|Stage 2|DSMB design modification|92558|||
130332052|NCT02446899|469184978|FG000|Overall Study|Adverse Event|4|||
130332053|NCT02446899|469184979|FG001|Overall Study|Adverse Event|7|||
130332054|NCT02446899|469184978|FG000|Overall Study|Condition Under Investigation Worsened|1|||
130332055|NCT02446899|469184979|FG001|Overall Study|Condition Under Investigation Worsened|4|||
130332056|NCT02446899|469184978|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
130332057|NCT02446899|469184979|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
130332058|NCT02446899|469184978|FG000|Overall Study|Lack of Efficacy|2|||
130332059|NCT02446899|469184979|FG001|Overall Study|Lack of Efficacy|8|||
130332060|NCT02446899|469184978|FG000|Overall Study|Lost to Follow-up|1|||
130332061|NCT02446899|469184979|FG001|Overall Study|Lost to Follow-up|3|||
130332062|NCT02446899|469184978|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130332063|NCT02446899|469184979|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
130332064|NCT02446899|469184978|FG000|Overall Study|Withdrawal by Subject|11|||
130332065|NCT02446899|469184979|FG001|Overall Study|Withdrawal by Subject|19|||
130332066|NCT02446899|469184978|FG000|Overall Study|Miscellaneous|5|||
130332067|NCT02446899|469184979|FG001|Overall Study|Miscellaneous|4|||
130332068|NCT02446899|469184978|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130332069|NCT02446899|469184979|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130332070|NCT04050202|469184980|FG000|Overall Study|Lost to Follow-up|2|||
130332071|NCT01499277|469184985|FG000|Overall Study|Adverse Event|3|||
130332072|NCT01499277|469184986|FG001|Overall Study|Adverse Event|6|||
130332073|NCT01499277|469184985|FG000|Overall Study|Death|3|||
130332074|NCT01499277|469184986|FG001|Overall Study|Death|2|||
130332075|NCT01499277|469184985|FG000|Overall Study|Lost to Follow-up|15|||
130332076|NCT01499277|469184986|FG001|Overall Study|Lost to Follow-up|8|||
130332077|NCT01499277|469184985|FG000|Overall Study|Protocol Violation|2|||
130332078|NCT01499277|469184986|FG001|Overall Study|Protocol Violation|3|||
130332079|NCT01499277|469184985|FG000|Overall Study|Withdrawal by Subject|16|||
130332080|NCT01499277|469184986|FG001|Overall Study|Withdrawal by Subject|6|||
130332081|NCT01499277|469184985|FG000|Overall Study|Lack of therapeutic response and other|8|||
130332082|NCT01499277|469184986|FG001|Overall Study|Lack of therapeutic response and other|7|||
130332083|NCT02974543|469184987|FG000|Overall Study|Withdrawal by Subject|1|||
130332084|NCT02974543|469184988|FG001|Overall Study|Withdrawal by Subject|0|||
130332085|NCT00742235|469184989|FG000|Overall Study|Lost to Follow-up|0|||
130332086|NCT00742235|469184990|FG001|Overall Study|Lost to Follow-up|31|||
130332087|NCT01237899|469184991|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
130332088|NCT01237899|469184992|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
130332089|NCT01237899|469184993|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
130332090|NCT01237899|469184994|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
130332091|NCT01237899|469184995|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
130332092|NCT01237899|469184996|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
130332093|NCT01237899|469184997|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
130332094|NCT01237899|469184998|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
130332095|NCT01237899|469184999|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
130332096|NCT01237899|469185000|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
130332097|NCT01237899|469185001|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
130332098|NCT02141438|469185003|FG000|Overall Study|Death|1308|||
130332099|NCT02141438|469185003|FG000|Overall Study|Lost to Follow-up|84|||
130332100|NCT02141438|469185003|FG000|Overall Study|Withdrawal by Subject|52|||
130332101|NCT02141438|469185003|FG000|Overall Study|Physician Decision|1|||
130332102|NCT02141438|469185003|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
130332103|NCT04329806|469185004|FG000|Overall Study|Physician Decision|3|||
130216002|NCT00199849|468753918|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
130216003|NCT00199849|468753919|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
130216004|NCT00199849|468753920|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
130216005|NCT04727528|468753921|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
130216006|NCT04727528|468753922|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
130216007|NCT04727528|468753921|FG000|Open-label Period|Randomized who did not receive treatment|1|||
130216008|NCT04727528|468753922|FG001|Open-label Period|Randomized who did not receive treatment|0|||
130216009|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130216010|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Adverse Event|1|||
130216011|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Death|0|||
130216012|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Death|1|||
130216013|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
130216014|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
130216015|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
130216016|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
130216017|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Physician Decision|0|||
130216018|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Physician Decision|1|||
130216019|NCT04727528|468753921|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
130216020|NCT04727528|468753922|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130216021|NCT01763827|468753929|FG000|Overall Study|Withdrawal by Subject|1|||
130216022|NCT01763827|468753930|FG001|Overall Study|Withdrawal by Subject|0|||
130216023|NCT01763827|468753931|FG002|Overall Study|Withdrawal by Subject|0|||
130216024|NCT01763827|468753932|FG003|Overall Study|Withdrawal by Subject|0|||
130216025|NCT01763827|468753933|FG004|Overall Study|Withdrawal by Subject|2|||
130216026|NCT01763827|468753934|FG005|Overall Study|Withdrawal by Subject|0|||
130216027|NCT01763827|468753929|FG000|Overall Study|Decision by sponsor|2|||
130332104|NCT04329806|469185005|FG001|Overall Study|Physician Decision|4|||
130332105|NCT02636595|469185008|FG000|Overall Study|Lost to Follow-up|1|||
130332106|NCT02636595|469185008|FG000|Overall Study|Other|1|||
130332107|NCT04730271|469185009|FG000|Overall Study|Adverse Event|0|||
130332108|NCT04730271|469185010|FG001|Overall Study|Adverse Event|2|||
130332109|NCT04730271|469185009|FG000|Overall Study|Withdrawal by Subject|1|||
130332110|NCT04730271|469185010|FG001|Overall Study|Withdrawal by Subject|1|||
130332111|NCT04730271|469185009|FG000|Overall Study|Protocol Violation|7|||
130332112|NCT04730271|469185010|FG001|Overall Study|Protocol Violation|13|||
130332113|NCT04730271|469185009|FG000|Overall Study|Lost to Follow-up|3|||
130332114|NCT04730271|469185010|FG001|Overall Study|Lost to Follow-up|3|||
130332115|NCT04730271|469185009|FG000|Overall Study|Death|1|||
130332116|NCT04730271|469185010|FG001|Overall Study|Death|0|||
130332117|NCT05782179|469185013|FG000|Overall Study|Adverse Event|0|||
130332118|NCT05782179|469185014|FG001|Overall Study|Adverse Event|0|||
130332119|NCT05782179|469185015|FG002|Overall Study|Adverse Event|2|||
130332120|NCT05782179|469185016|FG003|Overall Study|Adverse Event|0|||
130332121|NCT05782179|469185017|FG004|Overall Study|Adverse Event|0|||
130332122|NCT05782179|469185018|FG005|Overall Study|Adverse Event|0|||
130332123|NCT03682770|469185021|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332124|NCT03682770|469185022|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
130332125|NCT03682770|469185023|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332126|NCT03682770|469185024|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332127|NCT03682770|469185025|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332128|NCT03682770|469185026|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332129|NCT03682770|469185027|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
130332130|NCT03682770|469185021|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
130332131|NCT03682770|469185022|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
130332132|NCT03682770|469185023|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332133|NCT03682770|469185024|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332134|NCT03682770|469185025|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332135|NCT03682770|469185026|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332136|NCT03682770|469185027|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
130332137|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332138|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332139|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
130332140|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
130332141|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332142|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332143|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
130332144|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332145|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332146|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332147|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
130332148|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332149|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332150|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
130332151|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332152|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332153|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
130332154|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
130332155|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332156|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332157|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
130332158|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332159|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332160|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
130332161|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332162|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332163|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332164|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
130332165|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332166|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332167|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
130332168|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332169|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332170|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332171|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
130332172|NCT03682770|469185021|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332173|NCT03682770|469185022|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332174|NCT03682770|469185023|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332175|NCT03682770|469185024|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
130332176|NCT03682770|469185025|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332177|NCT03682770|469185026|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332178|NCT03682770|469185027|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
130332179|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332180|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332181|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332182|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
130332183|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
130332184|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
130332185|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
130332186|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332187|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332188|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332189|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332190|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
130332191|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332192|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
130332193|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332194|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332195|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332196|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332197|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332198|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
130332199|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
130332200|NCT03682770|469185021|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332201|NCT03682770|469185022|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332202|NCT03682770|469185023|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332203|NCT03682770|469185024|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332204|NCT03682770|469185025|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
130332205|NCT03682770|469185026|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
130332206|NCT03682770|469185027|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
130332207|NCT02362282|469185028|FG000|Overall Study|Withdrawal by Subject|1|||
130332208|NCT02362282|469185029|FG001|Overall Study|Withdrawal by Subject|0|||
130332209|NCT01470326|469185030|FG000|Overall Study|Protocol Violation|32|||
130332210|NCT01470326|469185030|FG000|Overall Study|No Drug Administration Information|2|||
130332211|NCT01470326|469185030|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
130332212|NCT01166282|469185031|FG000|Open-label Period|Adverse Event|0|||
130332213|NCT01166282|469185032|FG001|Open-label Period|Adverse Event|0|||
130332214|NCT01166282|469185033|FG002|Open-label Period|Adverse Event|6|||
130332215|NCT01166282|469185031|FG000|Open-label Period|Withdrawal by Subject|0|||
130332216|NCT01166282|469185032|FG001|Open-label Period|Withdrawal by Subject|0|||
130332217|NCT01166282|469185033|FG002|Open-label Period|Withdrawal by Subject|4|||
130332218|NCT01166282|469185031|FG000|Open-label Period|Lack of Efficacy|0|||
130332219|NCT01166282|469185032|FG001|Open-label Period|Lack of Efficacy|0|||
130332220|NCT01166282|469185033|FG002|Open-label Period|Lack of Efficacy|2|||
130332221|NCT01166282|469185031|FG000|Open-label Period|Remission|0|||
130332222|NCT01166282|469185032|FG001|Open-label Period|Remission|0|||
130332223|NCT01166282|469185033|FG002|Open-label Period|Remission|4|||
130332224|NCT01166282|469185031|FG000|Open-label Period|Irregular Compliance|0|||
130332225|NCT01166282|469185032|FG001|Open-label Period|Irregular Compliance|0|||
130332226|NCT01166282|469185033|FG002|Open-label Period|Irregular Compliance|1|||
130332227|NCT02194985|469185038|FG000|Overall Study|Adverse Event|1|||
130332228|NCT02194985|469185038|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
130332229|NCT02194985|469185038|FG000|Overall Study|Physician Decision|4|||
130332230|NCT02194985|469185038|FG000|Overall Study|Lost to Follow-up|1|||
130332231|NCT02194985|469185038|FG000|Overall Study|Withdrawal by Subject|2|||
130332232|NCT00392769|469185041|FG000|Overall Study|Clinical Deterioration|9|||
130332233|NCT00392769|469185041|FG000|Overall Study|Adverse Event|1|||
130332234|NCT02561832|469185042|FG000|Overall Study|Withdrawal by Subject|1|||
130332235|NCT02561832|469185043|FG001|Overall Study|Withdrawal by Subject|1|||
130332236|NCT02561832|469185042|FG000|Overall Study|Adverse Event|3|||
130332237|NCT02561832|469185043|FG001|Overall Study|Adverse Event|0|||
130332238|NCT02561832|469185042|FG000|Overall Study|Disease progression|3|||
130332239|NCT02561832|469185043|FG001|Overall Study|Disease progression|3|||
130332240|NCT02304367|469185044|FG000|Overall Study|Lack of Response to Bruosumab|1|||
130332241|NCT02304367|469185044|FG000|Overall Study|Sponsor Decision|3|||
130332242|NCT02304367|469185044|FG000|Overall Study|Death|2|||
130332243|NCT02304367|469185044|FG000|Overall Study|Physician Decision|1|||
130332244|NCT02304367|469185044|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
130332245|NCT00318643|469185045|FG000|Overall Study|Adverse Event|0|||
130332246|NCT00318643|469185046|FG001|Overall Study|Adverse Event|0|||
130332247|NCT00318643|469185047|FG002|Overall Study|Adverse Event|0|||
130332248|NCT00318643|469185048|FG003|Overall Study|Adverse Event|0|||
130332249|NCT00318643|469185049|FG004|Overall Study|Adverse Event|1|||
130332250|NCT00318643|469185045|FG000|Overall Study|Participant's Decision|0|||
130332251|NCT00318643|469185046|FG001|Overall Study|Participant's Decision|0|||
130332252|NCT00318643|469185047|FG002|Overall Study|Participant's Decision|0|||
130332253|NCT00318643|469185048|FG003|Overall Study|Participant's Decision|0|||
130332254|NCT00318643|469185049|FG004|Overall Study|Participant's Decision|1|||
130332255|NCT00318643|469185045|FG000|Overall Study|Investigator's Decision|0|||
130332256|NCT00318643|469185046|FG001|Overall Study|Investigator's Decision|0|||
130332257|NCT00318643|469185047|FG002|Overall Study|Investigator's Decision|0|||
130332258|NCT00318643|469185048|FG003|Overall Study|Investigator's Decision|0|||
130332259|NCT00318643|469185049|FG004|Overall Study|Investigator's Decision|1|||
130332260|NCT04411667|469185052|FG000|Overall Study|Physician Decision|1|||
130332261|NCT04411667|469185053|FG001|Overall Study|Physician Decision|0|||
130332262|NCT00067002|469185054|FG000|Overall Study|Early Death|1|||
130332263|NCT00067002|469185055|FG001|Overall Study|Early Death|2|||
130332264|NCT00067002|469185054|FG000|Overall Study|Delayed|1|||
130332265|NCT00067002|469185055|FG001|Overall Study|Delayed|1|||
130332266|NCT00067002|469185054|FG000|Overall Study|Graft Failure|5|||
130332267|NCT00067002|469185055|FG001|Overall Study|Graft Failure|6|||
130332268|NCT01354314|469185060|FG000|Overall Study|Lost to Follow-up|1|||
130332269|NCT01354314|469185061|FG001|Overall Study|Lost to Follow-up|0|||
130332270|NCT01354314|469185062|FG002|Overall Study|Lost to Follow-up|1|||
130332271|NCT01354314|469185063|FG003|Overall Study|Lost to Follow-up|1|||
130332272|NCT01354314|469185060|FG000|Overall Study|Withdrawal by Subject|0|||
130332273|NCT01354314|469185061|FG001|Overall Study|Withdrawal by Subject|0|||
130332274|NCT01354314|469185062|FG002|Overall Study|Withdrawal by Subject|1|||
130332275|NCT01354314|469185063|FG003|Overall Study|Withdrawal by Subject|0|||
130332276|NCT01354314|469185060|FG000|Overall Study|Adverse Event|0|||
130332277|NCT01354314|469185061|FG001|Overall Study|Adverse Event|0|||
130332278|NCT01354314|469185062|FG002|Overall Study|Adverse Event|0|||
130332279|NCT01354314|469185063|FG003|Overall Study|Adverse Event|1|||
130332280|NCT01354314|469185060|FG000|Overall Study|Protocol Violation|1|||
130332281|NCT01354314|469185061|FG001|Overall Study|Protocol Violation|1|||
130332282|NCT01354314|469185062|FG002|Overall Study|Protocol Violation|0|||
130332283|NCT01354314|469185063|FG003|Overall Study|Protocol Violation|0|||
130332284|NCT01354314|469185060|FG000|Overall Study|Less than 90% Adherence|4|||
130332285|NCT01354314|469185061|FG001|Overall Study|Less than 90% Adherence|2|||
130332286|NCT01354314|469185062|FG002|Overall Study|Less than 90% Adherence|6|||
130332287|NCT01354314|469185063|FG003|Overall Study|Less than 90% Adherence|4|||
130332288|NCT00714870|469185065|FG000|Overall Study|Lost to Follow-up|22|||
130332289|NCT00714870|469185066|FG001|Overall Study|Lost to Follow-up|5|||
130332290|NCT00714870|469185065|FG000|Overall Study|patient unable to come b/c back pain|1|||
130332291|NCT00714870|469185066|FG001|Overall Study|patient unable to come b/c back pain|0|||
130332292|NCT00714870|469185065|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
130332293|NCT00714870|469185066|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
130332294|NCT03399552|469185067|FG000|Overall Study|No evidence of disease|1|||
130332295|NCT03399552|469185067|FG000|Overall Study|Unevaluable|1|||
130332296|NCT02357368|469185068|FG000|Overall Study|Lost to Follow-up|0|||
130332297|NCT02357368|469185069|FG001|Overall Study|Lost to Follow-up|0|||
130332298|NCT02357368|469185070|FG002|Overall Study|Lost to Follow-up|0|||
130332299|NCT02357368|469185071|FG003|Overall Study|Lost to Follow-up|1|||
130332300|NCT02357368|469185068|FG000|Overall Study|Pregnancy|3|||
130332301|NCT02357368|469185069|FG001|Overall Study|Pregnancy|2|||
130332302|NCT02357368|469185070|FG002|Overall Study|Pregnancy|0|||
130332303|NCT02357368|469185071|FG003|Overall Study|Pregnancy|0|||
130332304|NCT02357368|469185068|FG000|Overall Study|Withdrawal by Subject|3|||
130332305|NCT02357368|469185069|FG001|Overall Study|Withdrawal by Subject|1|||
130332306|NCT02357368|469185070|FG002|Overall Study|Withdrawal by Subject|1|||
130332307|NCT02357368|469185071|FG003|Overall Study|Withdrawal by Subject|2|||
130332308|NCT02377817|469185072|FG000|Overall Study|Transportation/childcare barriers.|2|||
130332309|NCT02377817|469185073|FG001|Overall Study|Transportation/childcare barriers.|0|||
130332310|NCT02377817|469185072|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
130332311|NCT02377817|469185073|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
130332312|NCT03895840|469185074|FG000|Overall Study|Withdrawal by Subject|21|||
130332313|NCT01931566|469185075|FG000|Overall Study|Randomized But Not Treated|6|||
130332314|NCT01931566|469185076|FG001|Overall Study|Randomized But Not Treated|9|||
130332315|NCT01931566|469185077|FG002|Overall Study|Randomized But Not Treated|14|||
130332316|NCT01931566|469185075|FG000|Overall Study|Adverse Event|37|||
130332317|NCT01931566|469185076|FG001|Overall Study|Adverse Event|167|||
130332318|NCT01931566|469185077|FG002|Overall Study|Adverse Event|132|||
130332319|NCT01931566|469185075|FG000|Overall Study|Major Protocol Deviation|5|||
130332320|NCT01931566|469185076|FG001|Overall Study|Major Protocol Deviation|14|||
130332321|NCT01931566|469185077|FG002|Overall Study|Major Protocol Deviation|21|||
130332322|NCT01931566|469185075|FG000|Overall Study|Lost to Follow-up|3|||
130332323|NCT01931566|469185076|FG001|Overall Study|Lost to Follow-up|26|||
130332324|NCT01931566|469185077|FG002|Overall Study|Lost to Follow-up|23|||
130332325|NCT01931566|469185075|FG000|Overall Study|Voluntary Withdrawal|78|||
130332326|NCT01931566|469185076|FG001|Overall Study|Voluntary Withdrawal|245|||
130332327|NCT01931566|469185077|FG002|Overall Study|Voluntary Withdrawal|225|||
130332328|NCT01931566|469185075|FG000|Overall Study|Study Termination|289|||
130332329|NCT01931566|469185076|FG001|Overall Study|Study Termination|968|||
130332330|NCT01931566|469185077|FG002|Overall Study|Study Termination|1037|||
130332331|NCT01931566|469185075|FG000|Overall Study|Reason Not Specified|11|||
130332332|NCT01931566|469185076|FG001|Overall Study|Reason Not Specified|47|||
130332333|NCT01931566|469185077|FG002|Overall Study|Reason Not Specified|53|||
130332334|NCT01931566|469185075|FG000|Overall Study|Missing|0|||
130332335|NCT01931566|469185076|FG001|Overall Study|Missing|0|||
130332336|NCT01931566|469185077|FG002|Overall Study|Missing|1|||
130332337|NCT00760617|469185081|FG000|Overall Study|Adverse Event|5|||
130332338|NCT00760617|469185082|FG001|Overall Study|Adverse Event|2|||
130332339|NCT00760617|469185083|FG002|Overall Study|Adverse Event|0|||
130332340|NCT00760617|469185081|FG000|Overall Study|Lost to Follow-up|0|||
130332341|NCT00760617|469185082|FG001|Overall Study|Lost to Follow-up|0|||
130332342|NCT00760617|469185083|FG002|Overall Study|Lost to Follow-up|5|||
130332343|NCT04625101|469185084|FG000|Overall Study|Withdrawal by Subject|0|||
130332344|NCT04625101|469185085|FG001|Overall Study|Withdrawal by Subject|1|||
130332345|NCT04625101|469185084|FG000|Overall Study|Protocol Deviation|1|||
130332346|NCT04625101|469185085|FG001|Overall Study|Protocol Deviation|0|||
130332347|NCT02817464|469185086|FG000|Overall Study|Lost to Follow-up|1|||
130332348|NCT02817464|469185087|FG001|Overall Study|Lost to Follow-up|0|||
130332349|NCT02817464|469185086|FG000|Overall Study|Discontinued early due to personal decision|1|||
130332350|NCT02817464|469185087|FG001|Overall Study|Discontinued early due to personal decision|1|||
130332351|NCT03207763|469186613|FG000|Overall Study|Lost to Follow-up|1|||
130332352|NCT03207763|469186614|FG001|Overall Study|Lost to Follow-up|0|||
130332353|NCT02605122|469186615|FG000|Overall Study|Withdrawal by Subject|4|||
130332354|NCT02605122|469186616|FG001|Overall Study|Withdrawal by Subject|1|||
130332355|NCT02605122|469186615|FG000|Overall Study|Lost to Follow-up|1|||
130332356|NCT02605122|469186616|FG001|Overall Study|Lost to Follow-up|1|||
130332357|NCT00684060|469186617|FG000|Overall Study|Lost to Follow-up|1|||
130332358|NCT00684060|469186618|FG001|Overall Study|Lost to Follow-up|0|||
130332359|NCT00684060|469186617|FG000|Overall Study|New stenosis identified|1|||
130332360|NCT00684060|469186618|FG001|Overall Study|New stenosis identified|0|||
130332361|NCT00684060|469186617|FG000|Overall Study|Unable to collect MRI|1|||
130332362|NCT00684060|469186618|FG001|Overall Study|Unable to collect MRI|2|||
130332363|NCT00684060|469186617|FG000|Overall Study|Death|0|||
130332364|NCT00684060|469186618|FG001|Overall Study|Death|1|||
130332365|NCT00702715|469186623|FG000|Overall Study|Lost to Follow-up|1|||
130332366|NCT00702715|469186624|FG001|Overall Study|Lost to Follow-up|0|||
130332367|NCT03751657|469186625|FG000|Overall Study|Physician Decision|0|||
130332368|NCT03751657|469186626|FG001|Overall Study|Physician Decision|1|||
130332369|NCT03751657|469186625|FG000|Overall Study|Withdrawal by Subject|1|||
130332370|NCT03751657|469186626|FG001|Overall Study|Withdrawal by Subject|1|||
130332371|NCT03751657|469186625|FG000|Overall Study|Lost to Follow-up|2|||
130332372|NCT03751657|469186626|FG001|Overall Study|Lost to Follow-up|1|||
130332373|NCT00807001|469186634|FG000|Overall Study|Non-compliance|0|||
130332374|NCT00807001|469186635|FG001|Overall Study|Non-compliance|1|||
130332375|NCT00807001|469186636|FG002|Overall Study|Non-compliance|0|||
130332376|NCT00807001|469186637|FG003|Overall Study|Non-compliance|0|||
130332377|NCT00807001|469186638|FG004|Overall Study|Non-compliance|0|||
130332378|NCT00854113|469186640|FG000|Overall Study|Adverse Event|0|||
130332379|NCT00854113|469186641|FG001|Overall Study|Adverse Event|0|||
130332380|NCT00854113|469186642|FG002|Overall Study|Adverse Event|0|||
130332381|NCT00854113|469186643|FG003|Overall Study|Adverse Event|0|||
130332382|NCT00854113|469186644|FG004|Overall Study|Adverse Event|0|||
130332383|NCT00854113|469186645|FG005|Overall Study|Adverse Event|0|||
130332384|NCT00854113|469186646|FG006|Overall Study|Adverse Event|0|||
130332385|NCT00854113|469186647|FG007|Overall Study|Adverse Event|2|||
130332386|NCT00854113|469186648|FG008|Overall Study|Adverse Event|0|||
130332387|NCT00854113|469186649|FG009|Overall Study|Adverse Event|0|||
130332388|NCT00854113|469186650|FG010|Overall Study|Adverse Event|0|||
130332389|NCT00854113|469186640|FG000|Overall Study|Withdrawal by Subject|0|||
130332390|NCT00854113|469186641|FG001|Overall Study|Withdrawal by Subject|0|||
130332391|NCT00854113|469186642|FG002|Overall Study|Withdrawal by Subject|0|||
130332392|NCT00854113|469186643|FG003|Overall Study|Withdrawal by Subject|0|||
130332393|NCT00854113|469186644|FG004|Overall Study|Withdrawal by Subject|0|||
130332394|NCT00854113|469186645|FG005|Overall Study|Withdrawal by Subject|0|||
130332395|NCT00854113|469186646|FG006|Overall Study|Withdrawal by Subject|0|||
130332396|NCT00854113|469186647|FG007|Overall Study|Withdrawal by Subject|1|||
130332397|NCT00854113|469186648|FG008|Overall Study|Withdrawal by Subject|1|||
130332398|NCT00854113|469186649|FG009|Overall Study|Withdrawal by Subject|0|||
130332399|NCT00854113|469186650|FG010|Overall Study|Withdrawal by Subject|0|||
130332400|NCT02273596|469186654|FG000|24-Week Treatment Period|Adverse Event|3|||
130332401|NCT02273596|469186654|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
130332402|NCT02273596|469186654|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
130332403|NCT02273596|469186654|FG000|24-Week Treatment Period|Physician Decision|1|||
130332404|NCT02273596|469186654|FG000|24-Week Treatment Period|Protocol Deviation|1|||
130332405|NCT02273596|469186654|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
130332406|NCT02273596|469186654|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
130332407|NCT02273596|469186654|FG000|Extension Period|Lost to Follow-up|1|||
130332408|NCT02273596|469186654|FG000|Extension Period|Protocol Deviation|1|||
130332409|NCT02604160|469186655|FG000|Overall Study|Protocol Violation|0|||
130332410|NCT02604160|469186656|FG001|Overall Study|Protocol Violation|1|||
130332411|NCT02604160|469186655|FG000|Overall Study|Physician Decision|0|||
130332412|NCT02604160|469186656|FG001|Overall Study|Physician Decision|1|||
130332413|NCT01596062|469186657|FG000|Overall Study|Adverse Event|1|||
130332414|NCT01596062|469186658|FG001|Overall Study|Adverse Event|0|||
130332415|NCT01596062|469186659|FG002|Overall Study|Adverse Event|2|||
130332416|NCT01596062|469186657|FG000|Overall Study|Lack of Efficacy|0|||
130332417|NCT01596062|469186658|FG001|Overall Study|Lack of Efficacy|0|||
130332418|NCT01596062|469186659|FG002|Overall Study|Lack of Efficacy|1|||
130332419|NCT02139592|469186660|FG000|Overall Study|Case Report Forms Uncollected|8|||
130332420|NCT02687191|469186661|FG000|Overall Study|Death|0|||
130332421|NCT02687191|469186662|FG001|Overall Study|Death|1|||
130332422|NCT02687191|469186663|FG002|Overall Study|Death|1|||
130332423|NCT02687191|469186664|FG003|Overall Study|Death|0|||
130332424|NCT02687191|469186665|FG004|Overall Study|Death|1|||
130332425|NCT02687191|469186666|FG005|Overall Study|Death|1|||
130332426|NCT02687191|469186661|FG000|Overall Study|Withdrawal by Subject|0|||
130332427|NCT02687191|469186662|FG001|Overall Study|Withdrawal by Subject|0|||
130332428|NCT02687191|469186663|FG002|Overall Study|Withdrawal by Subject|0|||
130332429|NCT02687191|469186664|FG003|Overall Study|Withdrawal by Subject|1|||
130332430|NCT02687191|469186665|FG004|Overall Study|Withdrawal by Subject|0|||
130332431|NCT02687191|469186666|FG005|Overall Study|Withdrawal by Subject|0|||
130332432|NCT03180840|469186667|FG000|Overall Study|Withdrawal by Subject|1|||
130332433|NCT01788358|469186668|FG000|Overall Study|Other|11|||
130332434|NCT01788358|469186668|FG000|Overall Study|Logistical difficulties|1|||
130332435|NCT01788358|469186668|FG000|Overall Study|Lost to Follow-up|5|||
130332436|NCT01788358|469186668|FG000|Overall Study|Protocol Violation|3|||
130332437|NCT01788358|469186668|FG000|Overall Study|Withdrawal by Subject|26|||
130332438|NCT01788358|469186668|FG000|Overall Study|Lack of Efficacy|1|||
130332439|NCT01788358|469186668|FG000|Overall Study|Adverse Event|51|||
130332440|NCT02736890|469186671|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
130332441|NCT02736890|469186672|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
130332442|NCT02736890|469186671|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
130332443|NCT02736890|469186672|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
130332444|NCT02904954|469186673|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
130332445|NCT02904954|469186674|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
130332446|NCT02904954|469186673|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
130332447|NCT02904954|469186674|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
130332448|NCT02904954|469186673|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
130332449|NCT02904954|469186674|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
130332450|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Recurrence|2|||
130332451|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Recurrence|0|||
130332452|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Adverse Event|2|||
130332453|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Adverse Event|6|||
130332454|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Participant wishes|12|||
130332455|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Participant wishes|7|||
130332456|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Physician Decision|2|||
130332457|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Physician Decision|1|||
130332458|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
130332459|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
130332460|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Death|0|||
130332461|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Death|1|||
130332462|NCT02904954|469186673|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
130332463|NCT02904954|469186674|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
130332464|NCT05097963|469186675|FG000|Overall Study|Protocol Violation|13|||
130332465|NCT05097963|469186675|FG000|Overall Study|Withdrawal by Subject|21|||
130332466|NCT02873702|469186678|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
130332467|NCT02873702|469186679|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
130332468|NCT02873702|469186680|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
130332469|NCT02873702|469186681|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
130332470|NCT02873702|469186678|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130332471|NCT02873702|469186679|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
130332472|NCT02873702|469186680|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130332473|NCT02873702|469186681|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
130332474|NCT02873702|469186678|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
130332475|NCT02873702|469186679|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
130332476|NCT02873702|469186680|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
130332477|NCT02873702|469186681|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
130332478|NCT02873702|469186678|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
130332479|NCT02873702|469186679|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
130332480|NCT02873702|469186680|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
130332481|NCT02873702|469186681|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
130332482|NCT02873702|469186678|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
130332483|NCT02873702|469186679|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
130332484|NCT02873702|469186680|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
130332485|NCT02873702|469186681|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
130332486|NCT02948634|469186685|FG000|Overall Study|Lack of efficacy and study suspended|10|||
130216028|NCT01763827|468753930|FG001|Overall Study|Decision by sponsor|0|||
130216029|NCT01763827|468753931|FG002|Overall Study|Decision by sponsor|3|||
130216030|NCT01763827|468753932|FG003|Overall Study|Decision by sponsor|0|||
130216031|NCT01763827|468753933|FG004|Overall Study|Decision by sponsor|2|||
130216032|NCT01763827|468753934|FG005|Overall Study|Decision by sponsor|1|||
130216033|NCT01763827|468753929|FG000|Overall Study|Lost to Follow-up|0|||
130216034|NCT01763827|468753930|FG001|Overall Study|Lost to Follow-up|1|||
130216035|NCT01763827|468753931|FG002|Overall Study|Lost to Follow-up|1|||
130216036|NCT01763827|468753932|FG003|Overall Study|Lost to Follow-up|1|||
130216037|NCT01763827|468753933|FG004|Overall Study|Lost to Follow-up|2|||
130216038|NCT01763827|468753934|FG005|Overall Study|Lost to Follow-up|1|||
130216039|NCT02906579|468753939|FG000|Overall Study|Adverse Event|1|||
130216040|NCT02906579|468753939|FG000|Overall Study|Physician Decision|1|||
130216041|NCT01826981|468753940|FG000|Overall Study|Lack of Efficacy|0|||
130216042|NCT01826981|468753941|FG001|Overall Study|Lack of Efficacy|1|||
130216043|NCT01826981|468753942|FG002|Overall Study|Lack of Efficacy|0|||
130216044|NCT01826981|468753943|FG003|Overall Study|Lack of Efficacy|0|||
130216045|NCT01826981|468753944|FG004|Overall Study|Lack of Efficacy|5|||
130216046|NCT01826981|468753945|FG005|Overall Study|Lack of Efficacy|0|||
130216047|NCT01826981|468753946|FG006|Overall Study|Lack of Efficacy|0|||
130216048|NCT01826981|468753947|FG007|Overall Study|Lack of Efficacy|8|||
130216049|NCT01826981|468753948|FG008|Overall Study|Lack of Efficacy|7|||
130216050|NCT01826981|468753949|FG009|Overall Study|Lack of Efficacy|0|||
130216051|NCT01826981|468753950|FG010|Overall Study|Lack of Efficacy|1|||
130216052|NCT01826981|468753951|FG011|Overall Study|Lack of Efficacy|0|||
130216053|NCT01826981|468753952|FG012|Overall Study|Lack of Efficacy|0|||
130216054|NCT01826981|468753953|FG013|Overall Study|Lack of Efficacy|3|||
130216055|NCT01826981|468753954|FG014|Overall Study|Lack of Efficacy|0|||
130216056|NCT01826981|468753940|FG000|Overall Study|Lost to Follow-up|0|||
130216057|NCT01826981|468753941|FG001|Overall Study|Lost to Follow-up|0|||
130216058|NCT01826981|468753942|FG002|Overall Study|Lost to Follow-up|0|||
130216059|NCT01826981|468753943|FG003|Overall Study|Lost to Follow-up|0|||
130216060|NCT01826981|468753944|FG004|Overall Study|Lost to Follow-up|1|||
130216061|NCT01826981|468753945|FG005|Overall Study|Lost to Follow-up|1|||
130216062|NCT01826981|468753946|FG006|Overall Study|Lost to Follow-up|0|||
130216063|NCT01826981|468753947|FG007|Overall Study|Lost to Follow-up|1|||
130216064|NCT01826981|468753948|FG008|Overall Study|Lost to Follow-up|0|||
130216065|NCT01826981|468753949|FG009|Overall Study|Lost to Follow-up|1|||
130216066|NCT01826981|468753950|FG010|Overall Study|Lost to Follow-up|1|||
130216067|NCT01826981|468753951|FG011|Overall Study|Lost to Follow-up|1|||
130216068|NCT01826981|468753952|FG012|Overall Study|Lost to Follow-up|1|||
130216069|NCT01826981|468753953|FG013|Overall Study|Lost to Follow-up|0|||
130216070|NCT01826981|468753954|FG014|Overall Study|Lost to Follow-up|0|||
130216071|NCT01826981|468753940|FG000|Overall Study|Withdrew Consent|0|||
130216072|NCT01826981|468753941|FG001|Overall Study|Withdrew Consent|0|||
130216073|NCT01826981|468753942|FG002|Overall Study|Withdrew Consent|0|||
130216074|NCT01826981|468753943|FG003|Overall Study|Withdrew Consent|0|||
130216075|NCT01826981|468753944|FG004|Overall Study|Withdrew Consent|0|||
130216076|NCT01826981|468753945|FG005|Overall Study|Withdrew Consent|0|||
130216077|NCT01826981|468753946|FG006|Overall Study|Withdrew Consent|1|||
130216078|NCT01826981|468753947|FG007|Overall Study|Withdrew Consent|1|||
130216079|NCT01826981|468753948|FG008|Overall Study|Withdrew Consent|0|||
130332487|NCT02948634|469186686|FG001|Overall Study|Lack of efficacy and study suspended|2|||
129883875|NCT02733042|467534455|FG014|Overall Study|Progressive Disease|4|||
130216080|NCT01826981|468753949|FG009|Overall Study|Withdrew Consent|0|||
130216081|NCT01826981|468753950|FG010|Overall Study|Withdrew Consent|0|||
130216082|NCT01826981|468753951|FG011|Overall Study|Withdrew Consent|1|||
130216083|NCT01826981|468753952|FG012|Overall Study|Withdrew Consent|0|||
130216084|NCT01826981|468753953|FG013|Overall Study|Withdrew Consent|1|||
130216085|NCT01826981|468753954|FG014|Overall Study|Withdrew Consent|0|||
130216086|NCT01826981|468753940|FG000|Overall Study|Adverse Event|0|||
130216087|NCT01826981|468753941|FG001|Overall Study|Adverse Event|0|||
130216088|NCT01826981|468753942|FG002|Overall Study|Adverse Event|0|||
130216089|NCT01826981|468753943|FG003|Overall Study|Adverse Event|0|||
130216090|NCT01826981|468753944|FG004|Overall Study|Adverse Event|1|||
130216091|NCT01826981|468753945|FG005|Overall Study|Adverse Event|0|||
130216092|NCT01826981|468753946|FG006|Overall Study|Adverse Event|0|||
130216093|NCT01826981|468753947|FG007|Overall Study|Adverse Event|0|||
130216094|NCT01826981|468753948|FG008|Overall Study|Adverse Event|0|||
130332488|NCT03830892|469186691|FG000|Overall Study|Physician Decision|2|||
130332489|NCT03830892|469186692|FG001|Overall Study|Physician Decision|3|||
130332490|NCT03830892|469186691|FG000|Overall Study|Study terminated due to COVID|4|||
130332491|NCT03830892|469186692|FG001|Overall Study|Study terminated due to COVID|0|||
130332492|NCT03830892|469186691|FG000|Overall Study|Protocol Violation|0|||
130332493|NCT03830892|469186692|FG001|Overall Study|Protocol Violation|1|||
130332494|NCT03830892|469186691|FG000|Overall Study|Withdrawal by Subject|0|||
130332495|NCT03830892|469186692|FG001|Overall Study|Withdrawal by Subject|2|||
130332496|NCT01262989|469186695|FG000|Period 1|Lost to Follow-up|1|||
130332497|NCT01262989|469186696|FG001|Period 1|Lost to Follow-up|1|||
130332498|NCT01262989|469186695|FG000|Period 1|Intercurrent disease|0|||
130332499|NCT01262989|469186696|FG001|Period 1|Intercurrent disease|1|||
130332500|NCT01262989|469186695|FG000|Period 1|Positive answer for exclusion criteria|0|||
130332501|NCT01262989|469186696|FG001|Period 1|Positive answer for exclusion criteria|1|||
130332502|NCT01262989|469186695|FG000|Period 2|Intercurrent disease|0|||
130332503|NCT01262989|469186696|FG001|Period 2|Intercurrent disease|1|||
130332504|NCT03599089|469186697|FG000|Overall Study|Lost to Follow-up|1|||
130332505|NCT03599089|469186698|FG001|Overall Study|Lost to Follow-up|0|||
130332506|NCT03599089|469186699|FG002|Overall Study|Lost to Follow-up|0|||
130332507|NCT03599089|469186700|FG003|Overall Study|Lost to Follow-up|0|||
130332508|NCT03599089|469186697|FG000|Overall Study|Withdrawal by Subject|2|||
130332509|NCT03599089|469186698|FG001|Overall Study|Withdrawal by Subject|1|||
130332510|NCT03599089|469186699|FG002|Overall Study|Withdrawal by Subject|0|||
130332511|NCT03599089|469186700|FG003|Overall Study|Withdrawal by Subject|0|||
130332512|NCT03599089|469186697|FG000|Overall Study|Lack of Efficacy|0|||
130332513|NCT03599089|469186698|FG001|Overall Study|Lack of Efficacy|0|||
130332514|NCT03599089|469186699|FG002|Overall Study|Lack of Efficacy|1|||
130332515|NCT03599089|469186700|FG003|Overall Study|Lack of Efficacy|2|||
130332516|NCT03214666|469186701|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332517|NCT03214666|469186702|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332518|NCT03214666|469186703|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332519|NCT03214666|469186704|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332520|NCT03214666|469186705|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
130332521|NCT03214666|469186706|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
130332522|NCT00470275|469186707|FG000|Overall Study|Death|1|||
130332523|NCT00470275|469186707|FG000|Overall Study|Lack of Efficacy|7|||
130332524|NCT00470275|469186707|FG000|Overall Study|Withdrawal by Subject|2|||
130332525|NCT03048578|469186708|FG000|Overall Study|Withdrawal by Subject|5|||
130332526|NCT03048578|469186709|FG001|Overall Study|Withdrawal by Subject|6|||
130332527|NCT03048578|469186708|FG000|Overall Study|Lost to Follow-up|22|||
130332528|NCT03048578|469186709|FG001|Overall Study|Lost to Follow-up|10|||
130332529|NCT03048578|469186708|FG000|Overall Study|Adverse Event|1|||
130332530|NCT03048578|469186709|FG001|Overall Study|Adverse Event|2|||
130332531|NCT03048578|469186708|FG000|Overall Study|Terminated|3|||
130332532|NCT03048578|469186709|FG001|Overall Study|Terminated|2|||
130332533|NCT00526071|469186710|FG000|Overall Study|Adverse Event|1|||
130332534|NCT00526071|469186710|FG000|Overall Study|Withdrawal by Subject|1|||
130332535|NCT00526071|469186710|FG000|Overall Study|Lack of Response to Study Drug|4|||
130332536|NCT02500797|469186715|FG000|Overall Study|Cancel (rapid disease progression)|0|||
130332537|NCT02500797|469186716|FG001|Overall Study|Cancel (rapid disease progression)|0|||
130332538|NCT02500797|469186717|FG002|Overall Study|Cancel (rapid disease progression)|0|||
130332539|NCT02500797|469186718|FG003|Overall Study|Cancel (rapid disease progression)|0|||
130332540|NCT02500797|469186719|FG004|Overall Study|Cancel (rapid disease progression)|1|||
130332541|NCT02500797|469186720|FG005|Overall Study|Cancel (rapid disease progression)|1|||
130332542|NCT02500797|469186721|FG006|Overall Study|Cancel (rapid disease progression)|0|||
130332543|NCT02500797|469186722|FG007|Overall Study|Cancel (rapid disease progression)|0|||
130332544|NCT02500797|469186715|FG000|Overall Study|Withdrawal by Subject|1|||
130332545|NCT02500797|469186716|FG001|Overall Study|Withdrawal by Subject|0|||
130332546|NCT02500797|469186717|FG002|Overall Study|Withdrawal by Subject|0|||
130332547|NCT02500797|469186718|FG003|Overall Study|Withdrawal by Subject|0|||
130332548|NCT02500797|469186719|FG004|Overall Study|Withdrawal by Subject|0|||
130332549|NCT02500797|469186720|FG005|Overall Study|Withdrawal by Subject|0|||
130332550|NCT02500797|469186721|FG006|Overall Study|Withdrawal by Subject|0|||
130332551|NCT02500797|469186722|FG007|Overall Study|Withdrawal by Subject|0|||
130332552|NCT01415882|469186725|FG000|Overall Study|Ineligible|1|||
130332553|NCT01415882|469186726|FG001|Overall Study|Ineligible|0|||
130332554|NCT01415882|469186727|FG002|Overall Study|Ineligible|0|||
130332555|NCT01415882|469186728|FG003|Overall Study|Ineligible|3|||
130332556|NCT01415882|469186729|FG004|Overall Study|Ineligible|0|||
130332557|NCT01415882|469186725|FG000|Overall Study|Withdrawal by Subject|0|||
130332558|NCT01415882|469186726|FG001|Overall Study|Withdrawal by Subject|1|||
130332559|NCT01415882|469186727|FG002|Overall Study|Withdrawal by Subject|0|||
130332560|NCT01415882|469186728|FG003|Overall Study|Withdrawal by Subject|1|||
130332561|NCT01415882|469186729|FG004|Overall Study|Withdrawal by Subject|0|||
130332562|NCT00357006|469186730|FG000|Overall Study|Lost to Follow-up|1|||
130332563|NCT00357006|469186731|FG001|Overall Study|Lost to Follow-up|2|||
130332564|NCT00357006|469186732|FG002|Overall Study|Lost to Follow-up|1|||
130332565|NCT00357006|469186730|FG000|Overall Study|Withdrawal by Subject|1|||
130332566|NCT00357006|469186731|FG001|Overall Study|Withdrawal by Subject|3|||
130332567|NCT00357006|469186732|FG002|Overall Study|Withdrawal by Subject|2|||
130332568|NCT00976560|469186733|FG000|Overall Study|Adverse Event|5|||
130332569|NCT00976560|469186734|FG001|Overall Study|Adverse Event|5|||
130332570|NCT00976560|469186733|FG000|Overall Study|Lack of Efficacy|3|||
130332571|NCT00976560|469186734|FG001|Overall Study|Lack of Efficacy|5|||
130332572|NCT00976560|469186733|FG000|Overall Study|Protocol Violation|1|||
130332573|NCT00976560|469186734|FG001|Overall Study|Protocol Violation|0|||
130332574|NCT00976560|469186733|FG000|Overall Study|Lost to Follow-up|1|||
130332575|NCT00976560|469186734|FG001|Overall Study|Lost to Follow-up|0|||
130332576|NCT00976560|469186733|FG000|Overall Study|Physician Decision|2|||
130332577|NCT00976560|469186734|FG001|Overall Study|Physician Decision|0|||
130332578|NCT00976560|469186733|FG000|Overall Study|Withdrawal by Subject|2|||
130332579|NCT00976560|469186734|FG001|Overall Study|Withdrawal by Subject|3|||
130332580|NCT03710161|469186735|FG000|Overall Study|Study halted due to COVID pandemic|3|||
130332581|NCT03710161|469186736|FG001|Overall Study|Study halted due to COVID pandemic|2|||
130332582|NCT03339219|469186744|FG000|Overall Study|Death|12|||
130332583|NCT03339219|469186744|FG000|Overall Study|Site Terminated by Sponsor|22|||
130332584|NCT03339219|469186744|FG000|Overall Study|Withdrawal by Subject|1|||
130332585|NCT01932437|469186746|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332586|NCT01932437|469186747|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332587|NCT01932437|469186748|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332588|NCT01932437|469186749|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332589|NCT01932437|469186750|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
130332590|NCT01932437|469186751|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
130332591|NCT00074490|469186752|FG000|Overall Study|Progressive malignancy|0|||
130332592|NCT00074490|469186753|FG001|Overall Study|Progressive malignancy|7|||
130332593|NCT00074490|469186754|FG002|Overall Study|Progressive malignancy|0|||
130332594|NCT00074490|469186755|FG003|Overall Study|Progressive malignancy|0|||
130332595|NCT00074490|469186756|FG004|Overall Study|Progressive malignancy|3|||
130332596|NCT00074490|469186757|FG005|Overall Study|Progressive malignancy|0|||
130332597|NCT00467753|469186763|FG000|Overall Study|Lost to Follow-up|1|||
130332598|NCT00467753|469186764|FG001|Overall Study|Lost to Follow-up|2|||
130332599|NCT00467753|469186763|FG000|Overall Study|Adverse Event|2|||
130332600|NCT00467753|469186764|FG001|Overall Study|Adverse Event|0|||
130332601|NCT02175030|469186765|FG000|Overall Study|Failed screen after consent|7|||
130332602|NCT02175030|469186766|FG001|Overall Study|Failed screen after consent|6|||
130332603|NCT02175030|469186765|FG000|Overall Study|Failed IUD Insertion|20|||
130332604|NCT02175030|469186766|FG001|Overall Study|Failed IUD Insertion|21|||
130332605|NCT02175030|469186765|FG000|Overall Study|Physician Decision|1|||
130332606|NCT02175030|469186766|FG001|Overall Study|Physician Decision|1|||
130332607|NCT02175030|469186765|FG000|Overall Study|Lost to Follow-up|6|||
130332608|NCT02175030|469186766|FG001|Overall Study|Lost to Follow-up|6|||
130332609|NCT02175030|469186765|FG000|Overall Study|Withdrawal by Subject|1|||
130332610|NCT02175030|469186766|FG001|Overall Study|Withdrawal by Subject|4|||
130332611|NCT03695367|469186769|FG000|Overall Study|Missed the Day 28 visit.|1|||
130332612|NCT03695367|469186770|FG001|Overall Study|Missed the Day 28 visit.|0|||
130332613|NCT03695367|469186769|FG000|Overall Study|Lost to Follow-up|0|||
130332614|NCT03695367|469186770|FG001|Overall Study|Lost to Follow-up|1|||
130332615|NCT03695367|469186769|FG000|Overall Study|Withdrawal by Subject|0|||
130332616|NCT03695367|469186770|FG001|Overall Study|Withdrawal by Subject|1|||
130332617|NCT03695367|469186769|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
130332618|NCT03695367|469186770|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
130332619|NCT01077050|469188497|FG000|Overall Study|Subjects signed ICF could not be located|1|||
130332620|NCT01077050|469188497|FG000|Overall Study|Screen failure|8|||
130332621|NCT03894813|469188498|FG000|Overall Study|Adverse Event|1|||
130332622|NCT03894813|469188499|FG001|Overall Study|Adverse Event|1|||
130332623|NCT03894813|469188498|FG000|Overall Study|Lack of Efficacy|3|||
130332624|NCT03894813|469188499|FG001|Overall Study|Lack of Efficacy|3|||
130332625|NCT03894813|469188498|FG000|Overall Study|Lost to Follow-up|1|||
130332626|NCT03894813|469188499|FG001|Overall Study|Lost to Follow-up|0|||
130332627|NCT03894813|469188498|FG000|Overall Study|Pregnancy|2|||
130332628|NCT03894813|469188499|FG001|Overall Study|Pregnancy|1|||
130332629|NCT03894813|469188498|FG000|Overall Study|Protocol Violation|3|||
130332630|NCT03894813|469188499|FG001|Overall Study|Protocol Violation|7|||
130332631|NCT03894813|469188498|FG000|Overall Study|Withdrawal by Subject|1|||
130332632|NCT03894813|469188499|FG001|Overall Study|Withdrawal by Subject|3|||
130332633|NCT03894813|469188498|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
130332634|NCT03894813|469188499|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
130332635|NCT03773796|469188500|FG000|Overall Study|Adverse Event|1|||
130332636|NCT03773796|469188500|FG000|Overall Study|Withdrawal by Subject|1|||
130332637|NCT03773796|469188500|FG000|Overall Study|Lack of Efficacy|1|||
130332638|NCT03805659|469188501|FG000|Overall Study|Withdrawal by Subject|0|||
130332639|NCT03805659|469188502|FG001|Overall Study|Withdrawal by Subject|1|||
130332640|NCT01250145|469188504|FG000|Overall Study|Adverse Event|2|||
130332641|NCT01250145|469188505|FG001|Overall Study|Adverse Event|1|||
130332642|NCT01250145|469188504|FG000|Overall Study|Withdrawal by Subject|0|||
130332643|NCT01250145|469188505|FG001|Overall Study|Withdrawal by Subject|4|||
130332644|NCT01069900|469188508|FG000|Overall Study|Technical problems|0|||
130332645|NCT01069900|469188509|FG001|Overall Study|Technical problems|1|||
130332646|NCT01069900|469188508|FG000|Overall Study|Lost to Follow-up|7|||
130332647|NCT01069900|469188509|FG001|Overall Study|Lost to Follow-up|1|||
130332648|NCT01069900|469188508|FG000|Overall Study|Withdrawal by Subject|6|||
130332649|NCT01069900|469188509|FG001|Overall Study|Withdrawal by Subject|1|||
130332650|NCT01069900|469188508|FG000|Overall Study|Protocol Violation|4|||
130332651|NCT01069900|469188509|FG001|Overall Study|Protocol Violation|1|||
130332652|NCT01069900|469188508|FG000|Overall Study|Insufficient Therapeutic effect|1|||
130332653|NCT01069900|469188509|FG001|Overall Study|Insufficient Therapeutic effect|0|||
130332654|NCT01675544|469188510|FG000|Overall Study|Withdrawal by Subject|2|||
130332655|NCT03675321|469188512|FG000|Overall Study|Lack of Efficacy|2|||
130332656|NCT03675321|469188513|FG001|Overall Study|Lack of Efficacy|2|||
130332657|NCT03675321|469188512|FG000|Overall Study|Withdrawal by Subject|1|||
130332658|NCT03675321|469188513|FG001|Overall Study|Withdrawal by Subject|3|||
130332659|NCT01491607|469188517|FG000|Overall Study|Lost to Follow-up|7|||
130332660|NCT01491607|469188517|FG000|Overall Study|Withdrawal by Subject|3|||
130332661|NCT01317277|469188518|FG000|Overall Study|Lost to Follow-up|3|||
130332662|NCT01317277|469188519|FG001|Overall Study|Lost to Follow-up|1|||
130332663|NCT01317277|469188518|FG000|Overall Study|Lost MEMS|1|||
130332664|NCT01317277|469188519|FG001|Overall Study|Lost MEMS|1|||
130332665|NCT01317277|469188518|FG000|Overall Study|Unable to comply with intervention|1|||
130332666|NCT01317277|469188519|FG001|Overall Study|Unable to comply with intervention|0|||
130332667|NCT01317277|469188518|FG000|Overall Study|Withdrawal by Subject|1|||
130332668|NCT01317277|469188519|FG001|Overall Study|Withdrawal by Subject|0|||
130332669|NCT01317277|469188518|FG000|Overall Study|Adverse Event|1|||
130332670|NCT01317277|469188519|FG001|Overall Study|Adverse Event|0|||
130332671|NCT00774566|469188520|FG000|Overall Study|Protocol Violation|18|||
130332672|NCT00774566|469188521|FG001|Overall Study|Protocol Violation|15|||
130332673|NCT02999672|469188528|FG000|Overall Study|Death|0|||
130332674|NCT02999672|469188529|FG001|Overall Study|Death|1|||
130332675|NCT02999672|469188528|FG000|Overall Study|Study Terminated by Sponsor|0|||
130332676|NCT02999672|469188529|FG001|Overall Study|Study Terminated by Sponsor|1|||
130332677|NCT02999672|469188528|FG000|Overall Study|Progressive Disease|9|||
130332678|NCT02999672|469188529|FG001|Overall Study|Progressive Disease|5|||
130332679|NCT02999672|469188528|FG000|Overall Study|Adverse Event|4|||
130332680|NCT02999672|469188529|FG001|Overall Study|Adverse Event|0|||
130332681|NCT03565497|469188530|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
130332682|NCT03565497|469188531|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
130332683|NCT03565497|469188532|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
130332684|NCT03565497|469188530|FG000|Overall Study|Lost to Follow-up|1|||
130332685|NCT03565497|469188531|FG001|Overall Study|Lost to Follow-up|1|||
130332686|NCT03565497|469188532|FG002|Overall Study|Lost to Follow-up|2|||
130332687|NCT03565497|469188530|FG000|Overall Study|Withdrawal by Subject|1|||
130332688|NCT03565497|469188531|FG001|Overall Study|Withdrawal by Subject|1|||
130332689|NCT03565497|469188532|FG002|Overall Study|Withdrawal by Subject|1|||
130332690|NCT01075685|469188533|FG000|Overall Study|Protocol Violation|9|||
130332691|NCT01075685|469188534|FG001|Overall Study|Protocol Violation|1|||
130332692|NCT01075685|469188533|FG000|Overall Study|Withdrawal by Subject|20|||
130332693|NCT01075685|469188534|FG001|Overall Study|Withdrawal by Subject|5|||
130332694|NCT01075685|469188533|FG000|Overall Study|Lost to Follow-up|563|||
130332695|NCT01075685|469188534|FG001|Overall Study|Lost to Follow-up|220|||
130332696|NCT02858362|469188537|FG000|Overall Study|Protocol Violation|0|||
130332697|NCT02858362|469188538|FG001|Overall Study|Protocol Violation|1|||
130332698|NCT02858362|469188539|FG002|Overall Study|Protocol Violation|0|||
130332699|NCT02858362|469188537|FG000|Overall Study|Withdrawal by Subject|1|||
130332700|NCT02858362|469188538|FG001|Overall Study|Withdrawal by Subject|0|||
130332701|NCT02858362|469188539|FG002|Overall Study|Withdrawal by Subject|0|||
130332702|NCT02858362|469188537|FG000|Overall Study|Early Study Termination|0|||
130332703|NCT02858362|469188538|FG001|Overall Study|Early Study Termination|0|||
130332704|NCT02858362|469188539|FG002|Overall Study|Early Study Termination|3|||
130332705|NCT02858362|469188537|FG000|Overall Study|Lost to Follow-up|1|||
130332706|NCT02858362|469188538|FG001|Overall Study|Lost to Follow-up|0|||
130332707|NCT02858362|469188539|FG002|Overall Study|Lost to Follow-up|0|||
130332708|NCT02813577|469188541|FG000|Overall Study|Study terminated|4|||
130332709|NCT01301027|469188542|FG000|Overall Study|Physician Decision|2|||
130332710|NCT01301027|469188543|FG001|Overall Study|Physician Decision|0|||
130332711|NCT01301027|469188542|FG000|Overall Study|Withdrawal by Subject|2|||
130332712|NCT01301027|469188543|FG001|Overall Study|Withdrawal by Subject|3|||
130332713|NCT01301027|469188542|FG000|Overall Study|Adverse Event|0|||
130332714|NCT01301027|469188543|FG001|Overall Study|Adverse Event|2|||
130332715|NCT01301027|469188542|FG000|Overall Study|Fracture|1|||
130332716|NCT01301027|469188543|FG001|Overall Study|Fracture|3|||
130332717|NCT01301027|469188542|FG000|Overall Study|Transplant|0|||
130332718|NCT01301027|469188543|FG001|Overall Study|Transplant|2|||
130332719|NCT01301027|469188542|FG000|Overall Study|Volume Overload|3|||
130332720|NCT01301027|469188543|FG001|Overall Study|Volume Overload|0|||
130332721|NCT02023697|469188544|FG000|Treatment Period|Radiological progression|13|||
130332722|NCT02023697|469188545|FG001|Treatment Period|Radiological progression|17|||
130332723|NCT02023697|469188546|FG002|Treatment Period|Radiological progression|26|||
130332724|NCT02023697|469188544|FG000|Treatment Period|Never Treated|5|||
130332725|NCT02023697|469188545|FG001|Treatment Period|Never Treated|6|||
130332726|NCT02023697|469188546|FG002|Treatment Period|Never Treated|10|||
130332727|NCT02023697|469188544|FG000|Treatment Period|Adverse Event|13|||
130332728|NCT02023697|469188545|FG001|Treatment Period|Adverse Event|25|||
130332729|NCT02023697|469188546|FG002|Treatment Period|Adverse Event|23|||
130332730|NCT02023697|469188544|FG000|Treatment Period|Logistical difficulties|1|||
130332731|NCT02023697|469188545|FG001|Treatment Period|Logistical difficulties|1|||
130332732|NCT02023697|469188546|FG002|Treatment Period|Logistical difficulties|1|||
130332733|NCT02023697|469188544|FG000|Treatment Period|Clinical progression|10|||
130332734|NCT02023697|469188545|FG001|Treatment Period|Clinical progression|8|||
130332735|NCT02023697|469188546|FG002|Treatment Period|Clinical progression|28|||
130332736|NCT02023697|469188544|FG000|Treatment Period|Withdrawal by Subject|4|||
130332737|NCT02023697|469188545|FG001|Treatment Period|Withdrawal by Subject|5|||
130332738|NCT02023697|469188546|FG002|Treatment Period|Withdrawal by Subject|13|||
130332739|NCT02023697|469188544|FG000|Treatment Period|Safety outcome reached|0|||
130332740|NCT02023697|469188545|FG001|Treatment Period|Safety outcome reached|1|||
130332741|NCT02023697|469188546|FG002|Treatment Period|Safety outcome reached|0|||
130332742|NCT02023697|469188544|FG000|Treatment Period|Physician Decision|0|||
130332743|NCT02023697|469188545|FG001|Treatment Period|Physician Decision|0|||
130332744|NCT02023697|469188546|FG002|Treatment Period|Physician Decision|1|||
130332745|NCT02023697|469188544|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
130332746|NCT02023697|469188545|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
130332747|NCT02023697|469188546|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
130332748|NCT02023697|469188544|FG000|Active Follow-up Period|Lost to Follow-up|1|||
130332749|NCT02023697|469188545|FG001|Active Follow-up Period|Lost to Follow-up|1|||
130332750|NCT02023697|469188546|FG002|Active Follow-up Period|Lost to Follow-up|1|||
130332751|NCT02023697|469188544|FG000|Active Follow-up Period|Deterioration of general condition|1|||
130332752|NCT02023697|469188545|FG001|Active Follow-up Period|Deterioration of general condition|1|||
130332753|NCT02023697|469188546|FG002|Active Follow-up Period|Deterioration of general condition|1|||
130332754|NCT02023697|469188544|FG000|Active Follow-up Period|Other unspecified|2|||
130332755|NCT02023697|469188545|FG001|Active Follow-up Period|Other unspecified|0|||
130332756|NCT02023697|469188546|FG002|Active Follow-up Period|Other unspecified|1|||
130332757|NCT02023697|469188544|FG000|Active Follow-up Period|Clinical progression|0|||
130332758|NCT02023697|469188545|FG001|Active Follow-up Period|Clinical progression|2|||
130332759|NCT02023697|469188546|FG002|Active Follow-up Period|Clinical progression|1|||
130332760|NCT02023697|469188544|FG000|Active Follow-up Period|Radiological progression|0|||
130332761|NCT02023697|469188545|FG001|Active Follow-up Period|Radiological progression|0|||
130332762|NCT02023697|469188546|FG002|Active Follow-up Period|Radiological progression|1|||
130332763|NCT02023697|469188544|FG000|Active Follow-up Period|Death|83|||
130332764|NCT02023697|469188545|FG001|Active Follow-up Period|Death|82|||
130332765|NCT02023697|469188546|FG002|Active Follow-up Period|Death|87|||
130332766|NCT02023697|469188544|FG000|Long-term Follow-up Period|Death|9|||
130332767|NCT02023697|469188545|FG001|Long-term Follow-up Period|Death|6|||
130332768|NCT02023697|469188546|FG002|Long-term Follow-up Period|Death|4|||
130332769|NCT02023697|469188544|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
130332770|NCT02023697|469188545|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
130332771|NCT02023697|469188546|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
130332772|NCT02023697|469188544|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
130332773|NCT02023697|469188545|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
130332774|NCT02023697|469188546|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
130332775|NCT02023697|469188544|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
130332776|NCT02023697|469188545|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
130332777|NCT02023697|469188546|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
130332778|NCT02023697|469188544|FG000|Long-term Follow-up Period|Technical problems|0|||
130332779|NCT02023697|469188545|FG001|Long-term Follow-up Period|Technical problems|0|||
130332780|NCT02023697|469188546|FG002|Long-term Follow-up Period|Technical problems|1|||
130332781|NCT02023697|469188544|FG000|Long-term Follow-up Period|Other unspecified|6|||
130332782|NCT02023697|469188545|FG001|Long-term Follow-up Period|Other unspecified|3|||
130332783|NCT02023697|469188546|FG002|Long-term Follow-up Period|Other unspecified|5|||
130332784|NCT00845897|469188547|FG000|Overall Study|Lost to Follow-up|1|||
130332785|NCT00845897|469188548|FG001|Overall Study|Lost to Follow-up|1|||
130332786|NCT00845897|469188549|FG002|Overall Study|Lost to Follow-up|0|||
130332787|NCT00845897|469188547|FG000|Overall Study|Withdrawal by Subject|0|||
130332788|NCT00845897|469188548|FG001|Overall Study|Withdrawal by Subject|3|||
130332789|NCT00845897|469188549|FG002|Overall Study|Withdrawal by Subject|2|||
130332790|NCT00845897|469188547|FG000|Overall Study|Ulcer did not heal|1|||
130332791|NCT00845897|469188548|FG001|Overall Study|Ulcer did not heal|0|||
130332792|NCT00845897|469188549|FG002|Overall Study|Ulcer did not heal|1|||
130332793|NCT00845897|469188547|FG000|Overall Study|Too ill to participate|0|||
130332794|NCT00845897|469188548|FG001|Overall Study|Too ill to participate|1|||
130332795|NCT00845897|469188549|FG002|Overall Study|Too ill to participate|0|||
130332796|NCT02722499|469188550|FG000|Overall Study|Lost to Follow-up|2|||
130332797|NCT02722499|469188551|FG001|Overall Study|Lost to Follow-up|0|||
130332798|NCT02722499|469188552|FG002|Overall Study|Lost to Follow-up|1|||
130332799|NCT03566485|469188562|FG000|Overall Study|Disease progression|5|||
130332800|NCT03566485|469188563|FG001|Overall Study|Disease progression|4|||
130332801|NCT03566485|469188562|FG000|Overall Study|Clinical progression|0|||
130332802|NCT03566485|469188563|FG001|Overall Study|Clinical progression|1|||
130332803|NCT03566485|469188562|FG000|Overall Study|Toxicity|0|||
130332804|NCT03566485|469188563|FG001|Overall Study|Toxicity|2|||
130332805|NCT04999852|469188564|FG000|Overall Study|Withdrawal by Subject|11|||
130332806|NCT04999852|469188565|FG001|Overall Study|Withdrawal by Subject|1|||
130332807|NCT04999852|469188564|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
130332808|NCT04999852|469188565|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
130332813|NCT03610269|469188569|FG000|Overall Study|Physician Decision|10|||
130332814|NCT03610269|469188569|FG000|Overall Study|Protocol Violation|1|||
130332815|NCT03610269|469188569|FG000|Overall Study|Unable to draw blood|1|||
130332816|NCT03610269|469188569|FG000|Overall Study|Screen fail|4|||
130332817|NCT00478023|469188570|FG000|Overall Study|Adverse Event|11|||
130332818|NCT00478023|469188571|FG001|Overall Study|Adverse Event|7|||
130332819|NCT00478023|469188572|FG002|Overall Study|Adverse Event|8|||
130332820|NCT00478023|469188573|FG003|Overall Study|Adverse Event|14|||
130332821|NCT00478023|469188574|FG004|Overall Study|Adverse Event|6|||
130332822|NCT00478023|469188570|FG000|Overall Study|Death|1|||
130332823|NCT00478023|469188571|FG001|Overall Study|Death|0|||
130332824|NCT00478023|469188572|FG002|Overall Study|Death|0|||
130332825|NCT00478023|469188573|FG003|Overall Study|Death|0|||
130332826|NCT00478023|469188574|FG004|Overall Study|Death|0|||
130332827|NCT00478023|469188570|FG000|Overall Study|Lack of Efficacy|11|||
130332828|NCT00478023|469188571|FG001|Overall Study|Lack of Efficacy|10|||
130332829|NCT00478023|469188572|FG002|Overall Study|Lack of Efficacy|4|||
130332830|NCT00478023|469188573|FG003|Overall Study|Lack of Efficacy|5|||
130332831|NCT00478023|469188574|FG004|Overall Study|Lack of Efficacy|41|||
130332832|NCT00478023|469188570|FG000|Overall Study|Lost to Follow-up|3|||
130332833|NCT00478023|469188571|FG001|Overall Study|Lost to Follow-up|1|||
130332834|NCT00478023|469188572|FG002|Overall Study|Lost to Follow-up|1|||
130332835|NCT00478023|469188573|FG003|Overall Study|Lost to Follow-up|1|||
130332836|NCT00478023|469188574|FG004|Overall Study|Lost to Follow-up|0|||
130332837|NCT00478023|469188570|FG000|Overall Study|Withdrawal by Subject|2|||
130332838|NCT00478023|469188571|FG001|Overall Study|Withdrawal by Subject|3|||
130332839|NCT00478023|469188572|FG002|Overall Study|Withdrawal by Subject|2|||
130332840|NCT00478023|469188573|FG003|Overall Study|Withdrawal by Subject|4|||
130332841|NCT00478023|469188574|FG004|Overall Study|Withdrawal by Subject|5|||
130332842|NCT00478023|469188570|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
130332843|NCT00478023|469188571|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
130332844|NCT00478023|469188572|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
130332845|NCT00478023|469188573|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
130332846|NCT00478023|469188574|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
130332847|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
130332848|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
130332849|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
130332850|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
130332851|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332852|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332853|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332854|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332855|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332856|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332857|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
130332858|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332859|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332860|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332861|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
130332862|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
130332863|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
130332864|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
130332865|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332866|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332867|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332868|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
130332869|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332870|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
130332871|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332872|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332873|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332874|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
130332875|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
130332876|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
130332877|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
130332878|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
130332879|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
130332880|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
130332881|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
130332882|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
130332883|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332884|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332885|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332886|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332887|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332888|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332889|NCT05019521|469188576|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332890|NCT05019521|469188577|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332891|NCT05019521|469188578|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332892|NCT05019521|469188579|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
130332893|NCT05019521|469188580|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332894|NCT05019521|469188581|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332895|NCT05019521|469188582|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332896|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
130332897|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
130332898|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
130332899|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332900|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332901|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
130332902|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
130332903|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332904|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
130332905|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332906|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332907|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332908|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
130332909|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
130332910|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
130332911|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332912|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332913|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
130332914|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
130332915|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
130332916|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
130332917|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332918|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
130332919|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
130332920|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332921|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332922|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332923|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
130332924|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332925|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
130332926|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
130332927|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332928|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
130332929|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332930|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
130332931|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332932|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332933|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332934|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332935|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332936|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
130332937|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
130332938|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332939|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
130332940|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
130332941|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332942|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332943|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
130332944|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
130332945|NCT05019521|469188576|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
130332946|NCT05019521|469188577|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
130332947|NCT05019521|469188578|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
130332948|NCT05019521|469188579|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
130332949|NCT05019521|469188580|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
130332950|NCT05019521|469188581|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
130332951|NCT05019521|469188582|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
130332952|NCT00611026|469188583|FG000|Randomized to Double-blind Treatment|Not treated|2|||
130332953|NCT00611026|469188584|FG001|Randomized to Double-blind Treatment|Not treated|1|||
130332954|NCT00611026|469188585|FG002|Randomized to Double-blind Treatment|Not treated|3|||
130332955|NCT00611026|469188583|FG000|Double-blind Treatment Period|Death|1|||
130332956|NCT00611026|469188584|FG001|Double-blind Treatment Period|Death|0|||
130332957|NCT00611026|469188585|FG002|Double-blind Treatment Period|Death|0|||
130332958|NCT00611026|469188583|FG000|Double-blind Treatment Period|Adverse Event|9|||
130332959|NCT00611026|469188584|FG001|Double-blind Treatment Period|Adverse Event|28|||
130332960|NCT00611026|469188585|FG002|Double-blind Treatment Period|Adverse Event|46|||
130332961|NCT00611026|469188583|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
130332962|NCT00611026|469188584|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
130332963|NCT00611026|469188585|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
130332964|NCT00611026|469188583|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
130332965|NCT00611026|469188584|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
130332966|NCT00611026|469188585|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
130332967|NCT00611026|469188583|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
130332968|NCT00611026|469188584|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
130332969|NCT00611026|469188585|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
130332970|NCT00611026|469188583|FG000|Double-blind Treatment Period|Other|13|||
130332971|NCT00611026|469188584|FG001|Double-blind Treatment Period|Other|20|||
130332972|NCT00611026|469188585|FG002|Double-blind Treatment Period|Other|18|||
130332973|NCT01147874|469188587|FG000|Overall Study|Adverse Event|5|||
130332974|NCT01147874|469188587|FG000|Overall Study|Investigator's Request|1|||
130332975|NCT01147874|469188587|FG000|Overall Study|Lost to Follow-up|25|||
130332976|NCT01147874|469188587|FG000|Overall Study|Other|5|||
130332977|NCT01147874|469188587|FG000|Overall Study|Protocol Violation|5|||
130332978|NCT01147874|469188587|FG000|Overall Study|Sponsor's Decision|2|||
130332979|NCT01147874|469188587|FG000|Overall Study|Withdrawal by Subject|24|||
130332980|NCT02533453|469188595|FG000|Overall Study|Adverse Event|6|||
130332981|NCT02533453|469188595|FG000|Overall Study|Protocol Violation|1|||
130332982|NCT02533453|469188595|FG000|Overall Study|Withdrawal by Subject|2|||
130332983|NCT00885534|469188596|FG000|Overall Study|Patient deemed ineligible|1|||
130332984|NCT04292899|469188598|FG000|Overall Study|Death|21|||
130332985|NCT04292899|469188599|FG001|Overall Study|Death|28|||
130332986|NCT04292899|469188600|FG002|Overall Study|Death|188|||
130332987|NCT04292899|469188601|FG003|Overall Study|Death|371|||
130332988|NCT04292899|469188598|FG000|Overall Study|Lost to Follow-up|8|||
130332989|NCT04292899|469188599|FG001|Overall Study|Lost to Follow-up|4|||
130332990|NCT04292899|469188600|FG002|Overall Study|Lost to Follow-up|22|||
130332991|NCT04292899|469188601|FG003|Overall Study|Lost to Follow-up|235|||
130332992|NCT04292899|469188598|FG000|Overall Study|Withdrew consent|1|||
130332993|NCT04292899|469188599|FG001|Overall Study|Withdrew consent|0|||
130332994|NCT04292899|469188600|FG002|Overall Study|Withdrew consent|11|||
130332995|NCT04292899|469188601|FG003|Overall Study|Withdrew consent|32|||
130332996|NCT04292899|469188598|FG000|Overall Study|Adverse Event|2|||
130332997|NCT04292899|469188599|FG001|Overall Study|Adverse Event|1|||
130332998|NCT04292899|469188600|FG002|Overall Study|Adverse Event|2|||
130332999|NCT04292899|469188601|FG003|Overall Study|Adverse Event|2|||
130333000|NCT04292899|469188598|FG000|Overall Study|Investigator's Discretion|0|||
130333001|NCT04292899|469188599|FG001|Overall Study|Investigator's Discretion|0|||
130333002|NCT04292899|469188600|FG002|Overall Study|Investigator's Discretion|0|||
130333003|NCT04292899|469188601|FG003|Overall Study|Investigator's Discretion|3|||
130333004|NCT04292899|469188598|FG000|Overall Study|Non-compliance With Study Drug|0|||
130333005|NCT04292899|469188599|FG001|Overall Study|Non-compliance With Study Drug|0|||
130333006|NCT04292899|469188600|FG002|Overall Study|Non-compliance With Study Drug|0|||
130333007|NCT04292899|469188601|FG003|Overall Study|Non-compliance With Study Drug|1|||
130333008|NCT04292899|469188598|FG000|Overall Study|Protocol Violation|0|||
130333009|NCT04292899|469188599|FG001|Overall Study|Protocol Violation|0|||
130333010|NCT04292899|469188600|FG002|Overall Study|Protocol Violation|0|||
130333011|NCT04292899|469188601|FG003|Overall Study|Protocol Violation|1|||
130333012|NCT01209325|469188607|FG000|Overall Study|Lost to Follow-up|24|||
130333013|NCT01209325|469188607|FG000|Overall Study|Adverse Event|1|||
130333014|NCT01209325|469188607|FG000|Overall Study|Relocated|3|||
130333015|NCT01209325|469188607|FG000|Overall Study|Refusal after starting therapy|8|||
130333016|NCT01209325|469188607|FG000|Overall Study|Protocol Violation|4|||
130333017|NCT01209325|469188607|FG000|Overall Study|Refusal prior to therapy|1|||
130333018|NCT01209325|469188607|FG000|Overall Study|Incarceration|2|||
130333019|NCT00396253|469188608|FG000|Overall Study|Protocol Violation|1|||
130333020|NCT00396253|469188608|FG000|Overall Study|Withdrawal by Subject|7|||
130333021|NCT00396253|469188608|FG000|Overall Study|Death|3|||
130333022|NCT00396253|469188608|FG000|Overall Study|Physician Decision|1|||
130333023|NCT00396253|469188608|FG000|Overall Study|Change in eligibility status|1|||
130333024|NCT05340478|469188612|FG000|Overall Study|Scheduling Issues|10|||
130333025|NCT05340478|469188613|FG001|Overall Study|Scheduling Issues|4|||
130333026|NCT05340478|469188612|FG000|Overall Study|Neither member of dyad started treatment|2|||
130333027|NCT05340478|469188613|FG001|Overall Study|Neither member of dyad started treatment|2|||
130333028|NCT05340478|469188612|FG000|Overall Study|Withdrawn from study|2|||
130333029|NCT05340478|469188613|FG001|Overall Study|Withdrawn from study|2|||
130333030|NCT05340478|469188612|FG000|Overall Study|Lost to Follow-up|1|||
130333031|NCT05340478|469188613|FG001|Overall Study|Lost to Follow-up|4|||
130333032|NCT02506244|469188614|FG000|Overall Study|Did not undergo active monitoring|458|||
130333033|NCT02506244|469188615|FG001|Overall Study|Did not undergo active monitoring|459|||
130333034|NCT02506244|469188616|FG002|Overall Study|Did not undergo active monitoring|0|||
130333035|NCT00314795|469188617|FG000|Overall Study|Adverse Event|8|||
130333036|NCT00314795|469188617|FG000|Overall Study|Death|4|||
130333037|NCT00314795|469188617|FG000|Overall Study|Reason not Specified|3|||
130333038|NCT00314795|469188617|FG000|Overall Study|Renal Transplant|3|||
130333039|NCT00314795|469188617|FG000|Overall Study|Participants Withdrew Consent|2|||
130333040|NCT02116205|469188621|FG000|Overall Study|Withdrawal by Subject|2|||
130333041|NCT02116205|469188622|FG001|Overall Study|Withdrawal by Subject|4|||
130333042|NCT02116205|469188623|FG002|Overall Study|Withdrawal by Subject|1|||
130333043|NCT02116205|469188624|FG003|Overall Study|Withdrawal by Subject|3|||
130333044|NCT02116205|469188621|FG000|Overall Study|Lost to Follow-up|0|||
130333045|NCT02116205|469188622|FG001|Overall Study|Lost to Follow-up|2|||
130333046|NCT02116205|469188623|FG002|Overall Study|Lost to Follow-up|1|||
130333047|NCT02116205|469188624|FG003|Overall Study|Lost to Follow-up|2|||
130333048|NCT02116205|469188621|FG000|Overall Study|Physician Decision|0|||
130333049|NCT02116205|469188622|FG001|Overall Study|Physician Decision|1|||
130333050|NCT02116205|469188623|FG002|Overall Study|Physician Decision|1|||
130333051|NCT02116205|469188624|FG003|Overall Study|Physician Decision|1|||
130333052|NCT02116205|469188621|FG000|Overall Study|Exclusion criteria|0|||
130333053|NCT02116205|469188622|FG001|Overall Study|Exclusion criteria|0|||
130333054|NCT02116205|469188623|FG002|Overall Study|Exclusion criteria|1|||
130333055|NCT02116205|469188624|FG003|Overall Study|Exclusion criteria|0|||
130333056|NCT02541604|469188625|FG000|Overall Study|Death|6|||
130333057|NCT02541604|469188626|FG001|Overall Study|Death|5|||
130333058|NCT02541604|469188627|FG002|Overall Study|Death|7|||
130333059|NCT02541604|469188628|FG003|Overall Study|Death|2|||
130333060|NCT02541604|469188629|FG004|Overall Study|Death|9|||
130333061|NCT02541604|469188630|FG005|Overall Study|Death|8|||
130333062|NCT02541604|469188631|FG006|Overall Study|Death|9|||
130333063|NCT02541604|469188632|FG007|Overall Study|Death|9|||
130333064|NCT02541604|469188633|FG008|Overall Study|Death|3|||
130333065|NCT02541604|469188634|FG009|Overall Study|Death|4|||
130333066|NCT02541604|469188635|FG010|Overall Study|Death|2|||
130333067|NCT02541604|469188636|FG011|Overall Study|Death|3|||
130333068|NCT02541604|469188625|FG000|Overall Study|Lost to Follow-up|2|||
130333069|NCT02541604|469188626|FG001|Overall Study|Lost to Follow-up|0|||
130333070|NCT02541604|469188627|FG002|Overall Study|Lost to Follow-up|1|||
130333071|NCT02541604|469188628|FG003|Overall Study|Lost to Follow-up|0|||
130333072|NCT02541604|469188629|FG004|Overall Study|Lost to Follow-up|0|||
130333073|NCT02541604|469188630|FG005|Overall Study|Lost to Follow-up|1|||
130333074|NCT02541604|469188631|FG006|Overall Study|Lost to Follow-up|1|||
130333075|NCT02541604|469188632|FG007|Overall Study|Lost to Follow-up|0|||
130333076|NCT02541604|469188633|FG008|Overall Study|Lost to Follow-up|0|||
130333077|NCT02541604|469188634|FG009|Overall Study|Lost to Follow-up|0|||
130333078|NCT02541604|469188635|FG010|Overall Study|Lost to Follow-up|0|||
130333079|NCT02541604|469188636|FG011|Overall Study|Lost to Follow-up|0|||
130333080|NCT02541604|469188625|FG000|Overall Study|Withdrawal by Subject|2|||
130333081|NCT02541604|469188626|FG001|Overall Study|Withdrawal by Subject|0|||
130333082|NCT02541604|469188627|FG002|Overall Study|Withdrawal by Subject|1|||
130333083|NCT02541604|469188628|FG003|Overall Study|Withdrawal by Subject|0|||
130333084|NCT02541604|469188629|FG004|Overall Study|Withdrawal by Subject|1|||
130333085|NCT02541604|469188630|FG005|Overall Study|Withdrawal by Subject|1|||
130333086|NCT02541604|469188631|FG006|Overall Study|Withdrawal by Subject|0|||
130333087|NCT02541604|469188632|FG007|Overall Study|Withdrawal by Subject|0|||
130333088|NCT02541604|469188633|FG008|Overall Study|Withdrawal by Subject|1|||
130333089|NCT02541604|469188634|FG009|Overall Study|Withdrawal by Subject|0|||
130333090|NCT02541604|469188635|FG010|Overall Study|Withdrawal by Subject|0|||
130333091|NCT02541604|469188636|FG011|Overall Study|Withdrawal by Subject|0|||
130333092|NCT02541604|469188625|FG000|Overall Study|Study Terminated by Sponsor|1|||
130333093|NCT02541604|469188626|FG001|Overall Study|Study Terminated by Sponsor|4|||
130333094|NCT02541604|469188627|FG002|Overall Study|Study Terminated by Sponsor|2|||
130333095|NCT02541604|469188628|FG003|Overall Study|Study Terminated by Sponsor|1|||
130333096|NCT02541604|469188629|FG004|Overall Study|Study Terminated by Sponsor|0|||
130333097|NCT02541604|469188630|FG005|Overall Study|Study Terminated by Sponsor|0|||
130333098|NCT02541604|469188631|FG006|Overall Study|Study Terminated by Sponsor|0|||
130333099|NCT02541604|469188632|FG007|Overall Study|Study Terminated by Sponsor|0|||
129992041|NCT02427464|467934183|FG000|Overall Study|Adverse Event|6|||
130333100|NCT02541604|469188633|FG008|Overall Study|Study Terminated by Sponsor|0|||
130333101|NCT02541604|469188634|FG009|Overall Study|Study Terminated by Sponsor|0|||
130333102|NCT02541604|469188635|FG010|Overall Study|Study Terminated by Sponsor|0|||
130333103|NCT02541604|469188636|FG011|Overall Study|Study Terminated by Sponsor|0|||
130333104|NCT02541604|469188625|FG000|Overall Study|Medical condition may jeopardize safety|0|||
130333105|NCT02541604|469188626|FG001|Overall Study|Medical condition may jeopardize safety|0|||
130333106|NCT02541604|469188627|FG002|Overall Study|Medical condition may jeopardize safety|0|||
130333107|NCT02541604|469188628|FG003|Overall Study|Medical condition may jeopardize safety|0|||
130333108|NCT02541604|469188629|FG004|Overall Study|Medical condition may jeopardize safety|0|||
130333109|NCT02541604|469188630|FG005|Overall Study|Medical condition may jeopardize safety|0|||
130333110|NCT02541604|469188631|FG006|Overall Study|Medical condition may jeopardize safety|0|||
130333111|NCT02541604|469188632|FG007|Overall Study|Medical condition may jeopardize safety|1|||
130333112|NCT02541604|469188633|FG008|Overall Study|Medical condition may jeopardize safety|0|||
130333113|NCT02541604|469188634|FG009|Overall Study|Medical condition may jeopardize safety|0|||
130333114|NCT02541604|469188635|FG010|Overall Study|Medical condition may jeopardize safety|0|||
130333115|NCT02541604|469188636|FG011|Overall Study|Medical condition may jeopardize safety|0|||
130333116|NCT02752165|469188643|FG000|Overall Study|Withdrawal by Subject|6|||
130333117|NCT02752165|469188644|FG001|Overall Study|Withdrawal by Subject|6|||
130333118|NCT02752165|469188643|FG000|Overall Study|Protocol Violation|6|||
130333119|NCT02752165|469188644|FG001|Overall Study|Protocol Violation|5|||
130333120|NCT02752165|469188643|FG000|Overall Study|Lost to Follow-up|33|||
130333121|NCT02752165|469188644|FG001|Overall Study|Lost to Follow-up|38|||
130333122|NCT01704599|469188646|FG000|Overall Study|Adverse Event|1|||
130333123|NCT02840461|469188647|FG000|Overall Study|Adverse Event|1|||
130333124|NCT02840461|469188648|FG001|Overall Study|Adverse Event|5|||
130333125|NCT02840461|469188649|FG002|Overall Study|Adverse Event|3|||
130333126|NCT02840461|469188647|FG000|Overall Study|Lost to Follow-up|10|||
130333127|NCT02840461|469188648|FG001|Overall Study|Lost to Follow-up|7|||
130333128|NCT02840461|469188649|FG002|Overall Study|Lost to Follow-up|6|||
130333129|NCT02840461|469188647|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
130333130|NCT02840461|469188648|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
130333131|NCT02840461|469188649|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
130333132|NCT02840461|469188647|FG000|Overall Study|Protocol Violation|2|||
130333133|NCT02840461|469188648|FG001|Overall Study|Protocol Violation|3|||
129992042|NCT02427464|467934184|FG001|Overall Study|Adverse Event|1|||
129992043|NCT02427464|467934183|FG000|Overall Study|Lost to Follow-up|16|||
130333134|NCT02840461|469188649|FG002|Overall Study|Protocol Violation|1|||
130333135|NCT02840461|469188647|FG000|Overall Study|Withdrawal by Subject|10|||
130333136|NCT02840461|469188648|FG001|Overall Study|Withdrawal by Subject|6|||
130333137|NCT02840461|469188649|FG002|Overall Study|Withdrawal by Subject|2|||
130333138|NCT02840461|469188647|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
130333139|NCT02840461|469188648|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
130333140|NCT02840461|469188649|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
130333141|NCT01737502|469188652|FG000|Phase I|Disease progression|2|||
129992044|NCT02427464|467934184|FG001|Overall Study|Lost to Follow-up|5|||
130333142|NCT01737502|469188653|FG001|Phase I|Disease progression|3|||
130333143|NCT01737502|469188652|FG000|Phase I|Complicating disease|1|||
130333144|NCT01737502|469188653|FG001|Phase I|Complicating disease|0|||
130333145|NCT01737502|469188652|FG000|Phase II|Adverse Event|0|||
130333146|NCT01737502|469188653|FG001|Phase II|Adverse Event|3|||
130333147|NCT01737502|469188652|FG000|Phase II|Disease progression|0|||
130333148|NCT01737502|469188653|FG001|Phase II|Disease progression|18|||
130333149|NCT01737502|469188652|FG000|Phase II|Death|0|||
130333150|NCT01737502|469188653|FG001|Phase II|Death|1|||
130333151|NCT01737502|469188652|FG000|Phase II|Transition to hospice care|0|||
130333152|NCT01737502|469188653|FG001|Phase II|Transition to hospice care|1|||
130333153|NCT04672655|469188654|FG000|Overall Study|Lost to Follow-up|12|||
130333154|NCT04672655|469188655|FG001|Overall Study|Lost to Follow-up|17|||
130333155|NCT04672655|469188654|FG000|Overall Study|Withdrawal by Subject|1|||
130333156|NCT04672655|469188655|FG001|Overall Study|Withdrawal by Subject|0|||
130333157|NCT04672655|469188654|FG000|Overall Study|Withdrawal by Study|1|||
130333158|NCT04672655|469188655|FG001|Overall Study|Withdrawal by Study|0|||
130333159|NCT00494676|469188656|FG000|Allocation|Withdrawal by Subject|2|||
130333160|NCT00494676|469188657|FG001|Allocation|Withdrawal by Subject|4|||
130333161|NCT00494676|469188656|FG000|First Intervention|Withdrawal by Subject|1|||
130333162|NCT00494676|469188657|FG001|First Intervention|Withdrawal by Subject|3|||
130333163|NCT00494676|469188656|FG000|Second Intervention|Withdrawal by Subject|1|||
130333164|NCT00494676|469188657|FG001|Second Intervention|Withdrawal by Subject|1|||
130333165|NCT05767749|469188661|FG000|Overall Study|Withdrawal by Subject|0|||
130333166|NCT05767749|469188662|FG001|Overall Study|Withdrawal by Subject|0|||
130333167|NCT05767749|469188663|FG002|Overall Study|Withdrawal by Subject|2|||
130333168|NCT05767749|469188664|FG003|Overall Study|Withdrawal by Subject|2|||
130333169|NCT05767749|469188665|FG004|Overall Study|Withdrawal by Subject|2|||
130333170|NCT05767749|469188666|FG005|Overall Study|Withdrawal by Subject|2|||
130333171|NCT02067676|469189680|FG000|Overall Study|Withdrawal by Subject|1|||
130333172|NCT02067676|469189681|FG001|Overall Study|Withdrawal by Subject|0|||
130333173|NCT02067676|469189682|FG002|Overall Study|Withdrawal by Subject|0|||
130333174|NCT02067676|469189683|FG003|Overall Study|Withdrawal by Subject|0|||
130333175|NCT02067676|469189684|FG004|Overall Study|Withdrawal by Subject|0|||
130333176|NCT02067676|469189685|FG005|Overall Study|Withdrawal by Subject|0|||
130333177|NCT00996333|469189686|FG000|Overall Study|Screen failure|1|||
130333178|NCT00996333|469189686|FG000|Overall Study|Withdrawal by Subject|1|||
130333179|NCT00996333|469189686|FG000|Overall Study|Death|4|||
130333180|NCT00996333|469189686|FG000|Overall Study|Adverse Event|1|||
129992045|NCT02427464|467934183|FG000|Overall Study|Physician Decision|2|||
129992046|NCT02427464|467934184|FG001|Overall Study|Physician Decision|0|||
129992047|NCT02427464|467934183|FG000|Overall Study|Withdrawal by Subject|10|||
129992048|NCT02427464|467934184|FG001|Overall Study|Withdrawal by Subject|8|||
129992049|NCT02427464|467934183|FG000|Overall Study|Noncompliance|16|||
129992050|NCT02427464|467934184|FG001|Overall Study|Noncompliance|10|||
130333181|NCT00996333|469189686|FG000|Overall Study|Physician Decision|1|||
130333182|NCT00996333|469189686|FG000|Overall Study|Other|5|||
130333183|NCT04939415|469189694|FG000|Overall Study|Withdrawal by Subject|1|||
130333184|NCT04939415|469189695|FG001|Overall Study|Withdrawal by Subject|3|||
130333185|NCT04939415|469189694|FG000|Overall Study|Lost to Follow-up|0|||
130333186|NCT04939415|469189695|FG001|Overall Study|Lost to Follow-up|2|||
130333187|NCT00369265|469189696|FG000|Overall Study|Study terminated|4|||
130333188|NCT00369265|469189697|FG001|Overall Study|Study terminated|7|||
130333189|NCT00068419|469189700|FG000|Overall Study|Adverse Event|3|||
130333190|NCT00068419|469189700|FG000|Overall Study|Lack of Efficacy|24|||
130333191|NCT00068419|469189700|FG000|Overall Study|Lost to Follow-up|1|||
130333192|NCT00068419|469189700|FG000|Overall Study|Physician Decision|7|||
130333193|NCT00068419|469189700|FG000|Overall Study|Withdrawal by Subject|14|||
130333194|NCT00068419|469189700|FG000|Overall Study|Ineligible|11|||
130333195|NCT00092443|469189701|FG000|Overall Study|Adverse Event|9|||
130333196|NCT00092443|469189702|FG001|Overall Study|Adverse Event|13|||
130333197|NCT00092443|469189701|FG000|Overall Study|Lost to Follow-up|7|||
130333198|NCT00092443|469189702|FG001|Overall Study|Lost to Follow-up|3|||
130333199|NCT00092443|469189701|FG000|Overall Study|Protocol Violation|11|||
130333200|NCT00092443|469189702|FG001|Overall Study|Protocol Violation|9|||
130333201|NCT00092443|469189701|FG000|Overall Study|Withdrawal by Subject|9|||
130333202|NCT00092443|469189702|FG001|Overall Study|Withdrawal by Subject|11|||
130333203|NCT00092443|469189701|FG000|Overall Study|Moved|5|||
130333204|NCT00092443|469189702|FG001|Overall Study|Moved|5|||
130333205|NCT00092443|469189701|FG000|Overall Study|Other|17|||
130333206|NCT00092443|469189702|FG001|Overall Study|Other|13|||
130333207|NCT01160822|469189703|FG000|Overall Study|Adverse Event|0|||
130333208|NCT01160822|469189704|FG001|Overall Study|Adverse Event|0|||
130333209|NCT01160822|469189705|FG002|Overall Study|Adverse Event|0|||
130333210|NCT01160822|469189706|FG003|Overall Study|Adverse Event|0|||
130333211|NCT01160822|469189707|FG004|Overall Study|Adverse Event|1|||
130333212|NCT01160822|469189708|FG005|Overall Study|Adverse Event|2|||
130333213|NCT01160822|469189709|FG006|Overall Study|Adverse Event|5|||
130333214|NCT01160822|469189703|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130333215|NCT01160822|469189704|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130333216|NCT01160822|469189705|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130333217|NCT01160822|469189706|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130333218|NCT01160822|469189707|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
130333219|NCT01160822|469189708|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
130333220|NCT01160822|469189709|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
130333221|NCT01160822|469189703|FG000|Overall Study|Withdrawal by Subject|0|||
130333222|NCT01160822|469189704|FG001|Overall Study|Withdrawal by Subject|0|||
130333223|NCT01160822|469189705|FG002|Overall Study|Withdrawal by Subject|0|||
130333224|NCT01160822|469189706|FG003|Overall Study|Withdrawal by Subject|0|||
130333225|NCT01160822|469189707|FG004|Overall Study|Withdrawal by Subject|0|||
130333226|NCT01160822|469189708|FG005|Overall Study|Withdrawal by Subject|0|||
130333227|NCT01160822|469189709|FG006|Overall Study|Withdrawal by Subject|1|||
130333228|NCT01160822|469189703|FG000|Overall Study|Lost to Follow-up|0|||
130333229|NCT01160822|469189704|FG001|Overall Study|Lost to Follow-up|0|||
130333230|NCT01160822|469189705|FG002|Overall Study|Lost to Follow-up|0|||
130333231|NCT01160822|469189706|FG003|Overall Study|Lost to Follow-up|0|||
130333232|NCT01160822|469189707|FG004|Overall Study|Lost to Follow-up|1|||
130333233|NCT01160822|469189708|FG005|Overall Study|Lost to Follow-up|0|||
130333234|NCT01160822|469189709|FG006|Overall Study|Lost to Follow-up|0|||
130333235|NCT01160822|469189703|FG000|Overall Study|Administrative problems|0|||
130333236|NCT01160822|469189704|FG001|Overall Study|Administrative problems|0|||
130333237|NCT01160822|469189705|FG002|Overall Study|Administrative problems|0|||
130333238|NCT01160822|469189706|FG003|Overall Study|Administrative problems|0|||
130333239|NCT01160822|469189707|FG004|Overall Study|Administrative problems|1|||
130333240|NCT01160822|469189708|FG005|Overall Study|Administrative problems|0|||
130333241|NCT01160822|469189709|FG006|Overall Study|Administrative problems|0|||
130333242|NCT01160822|469189703|FG000|Overall Study|Protocol deviation|0|||
130333243|NCT01160822|469189704|FG001|Overall Study|Protocol deviation|0|||
130333244|NCT01160822|469189705|FG002|Overall Study|Protocol deviation|0|||
130333245|NCT01160822|469189706|FG003|Overall Study|Protocol deviation|0|||
130333246|NCT01160822|469189707|FG004|Overall Study|Protocol deviation|2|||
130333247|NCT01160822|469189708|FG005|Overall Study|Protocol deviation|0|||
130333248|NCT01160822|469189709|FG006|Overall Study|Protocol deviation|0|||
130333249|NCT04717336|469189714|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
130333250|NCT04717336|469189715|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
130333251|NCT04717336|469189714|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
130333252|NCT04717336|469189715|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
130333253|NCT01500720|469189722|FG000|Overall Study|Randomized But Not Treated|1|||
130333254|NCT01500720|469189723|FG001|Overall Study|Randomized But Not Treated|1|||
130333255|NCT01500720|469189722|FG000|Overall Study|Other|4|||
130333256|NCT01500720|469189723|FG001|Overall Study|Other|8|||
130333257|NCT02527421|469189724|FG000|Overall Study|Withdrawal by Subject|1|||
130333258|NCT02527421|469189725|FG001|Overall Study|Withdrawal by Subject|0|||
130333259|NCT00806819|469189726|FG000|Overall Study|progressive disease (modified RECIST )|217|||
130333260|NCT00806819|469189727|FG001|Overall Study|progressive disease (modified RECIST )|216|||
130333261|NCT00806819|469189726|FG000|Overall Study|Worsening or AE of underlying disease|18|||
130333262|NCT00806819|469189727|FG001|Overall Study|Worsening or AE of underlying disease|25|||
130333263|NCT00806819|469189726|FG000|Overall Study|Other AE|38|||
130333264|NCT00806819|469189727|FG001|Overall Study|Other AE|40|||
130333265|NCT00806819|469189726|FG000|Overall Study|Protocol Violation|9|||
130333266|NCT00806819|469189727|FG001|Overall Study|Protocol Violation|4|||
130333267|NCT00806819|469189726|FG000|Overall Study|Lost to Follow-up|1|||
130333268|NCT00806819|469189727|FG001|Overall Study|Lost to Follow-up|0|||
130333269|NCT00806819|469189726|FG000|Overall Study|Withdrawal by Subject|32|||
130333270|NCT00806819|469189727|FG001|Overall Study|Withdrawal by Subject|29|||
130333271|NCT00806819|469189726|FG000|Overall Study|Not treated|6|||
130333272|NCT00806819|469189727|FG001|Overall Study|Not treated|3|||
130333273|NCT00806819|469189726|FG000|Overall Study|Reasons other than stated above|25|||
130333274|NCT00806819|469189727|FG001|Overall Study|Reasons other than stated above|41|||
130333275|NCT01615029|469189733|FG000|Overall Study|Adverse Event|0|||
130333276|NCT01615029|469189734|FG001|Overall Study|Adverse Event|0|||
130333277|NCT01615029|469189735|FG002|Overall Study|Adverse Event|0|||
130333278|NCT01615029|469189736|FG003|Overall Study|Adverse Event|0|||
130333279|NCT01615029|469189737|FG004|Overall Study|Adverse Event|1|||
130333280|NCT01615029|469189733|FG000|Overall Study|Death|0|||
130333281|NCT01615029|469189734|FG001|Overall Study|Death|0|||
130333282|NCT01615029|469189735|FG002|Overall Study|Death|0|||
130333283|NCT01615029|469189736|FG003|Overall Study|Death|0|||
130333284|NCT01615029|469189737|FG004|Overall Study|Death|1|||
130333285|NCT01615029|469189733|FG000|Overall Study|Lost to Follow-up|0|||
130333286|NCT01615029|469189734|FG001|Overall Study|Lost to Follow-up|0|||
130333287|NCT01615029|469189735|FG002|Overall Study|Lost to Follow-up|0|||
130333288|NCT01615029|469189736|FG003|Overall Study|Lost to Follow-up|0|||
130333289|NCT01615029|469189737|FG004|Overall Study|Lost to Follow-up|1|||
130333290|NCT01615029|469189733|FG000|Overall Study|Progressive disease|2|||
130333291|NCT01615029|469189734|FG001|Overall Study|Progressive disease|1|||
130333292|NCT01615029|469189735|FG002|Overall Study|Progressive disease|1|||
130333293|NCT01615029|469189736|FG003|Overall Study|Progressive disease|1|||
130333294|NCT01615029|469189737|FG004|Overall Study|Progressive disease|5|||
130333295|NCT01615029|469189733|FG000|Overall Study|Physician Decision|0|||
130333296|NCT01615029|469189734|FG001|Overall Study|Physician Decision|0|||
130333297|NCT01615029|469189735|FG002|Overall Study|Physician Decision|0|||
130333298|NCT01615029|469189736|FG003|Overall Study|Physician Decision|0|||
130333299|NCT01615029|469189737|FG004|Overall Study|Physician Decision|1|||
130333300|NCT01615029|469189733|FG000|Overall Study|Ongoing|1|||
130333301|NCT01615029|469189734|FG001|Overall Study|Ongoing|2|||
130333302|NCT01615029|469189735|FG002|Overall Study|Ongoing|3|||
130333303|NCT01615029|469189736|FG003|Overall Study|Ongoing|2|||
130333304|NCT01615029|469189737|FG004|Overall Study|Ongoing|23|||
130333305|NCT00802945|469189743|FG000|Overall Study|Death|27|||
130333306|NCT00802945|469189744|FG001|Overall Study|Death|23|||
130333307|NCT00802945|469189743|FG000|Overall Study|Terminated by sponsor|8|||
130333308|NCT00802945|469189744|FG001|Overall Study|Terminated by sponsor|12|||
130333309|NCT03843541|469189745|FG000|Overall Study|Adverse Event|4|||
130333310|NCT03843541|469189746|FG001|Overall Study|Adverse Event|2|||
130333311|NCT03843541|469189747|FG002|Overall Study|Adverse Event|3|||
130333312|NCT03843541|469189745|FG000|Overall Study|Death|1|||
130333313|NCT03843541|469189746|FG001|Overall Study|Death|0|||
130333314|NCT03843541|469189747|FG002|Overall Study|Death|0|||
130333315|NCT03843541|469189745|FG000|Overall Study|Lack of adherence to study medication|0|||
130333316|NCT03843541|469189746|FG001|Overall Study|Lack of adherence to study medication|0|||
130333317|NCT03843541|469189747|FG002|Overall Study|Lack of adherence to study medication|1|||
130333318|NCT03843541|469189745|FG000|Overall Study|Physician Decision|1|||
130333319|NCT03843541|469189746|FG001|Overall Study|Physician Decision|2|||
130333320|NCT03843541|469189747|FG002|Overall Study|Physician Decision|2|||
130333321|NCT03843541|469189745|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
130333322|NCT03843541|469189746|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
130333323|NCT03843541|469189747|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
130333324|NCT03843541|469189745|FG000|Overall Study|Withdrawal by Subject|6|||
130333325|NCT03843541|469189746|FG001|Overall Study|Withdrawal by Subject|9|||
130333326|NCT03843541|469189747|FG002|Overall Study|Withdrawal by Subject|7|||
130333327|NCT03843541|469189745|FG000|Overall Study|Administration of rescue mucolytic|0|||
130333328|NCT03843541|469189746|FG001|Overall Study|Administration of rescue mucolytic|0|||
130333329|NCT03843541|469189747|FG002|Overall Study|Administration of rescue mucolytic|1|||
130333330|NCT03843541|469189745|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
130333331|NCT03843541|469189746|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
130333332|NCT03843541|469189747|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
130333333|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130333334|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
130333335|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130333336|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
130333337|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130333338|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
130333339|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130333340|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
130333341|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
130333342|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
130333343|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
130333344|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
130333345|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
130333346|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
130333347|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
130333348|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
130333349|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130333350|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
130333351|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130333352|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
130333353|NCT05307692|469189751|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
130333354|NCT05307692|469189752|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
130333355|NCT05307692|469189753|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
130333356|NCT05307692|469189754|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
130333357|NCT05307692|469189751|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130333358|NCT05307692|469189752|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130333359|NCT05307692|469189753|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
130333360|NCT05307692|469189754|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
130333361|NCT05307692|469189751|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130333362|NCT05307692|469189752|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130333363|NCT05307692|469189753|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
130333364|NCT05307692|469189754|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
130333365|NCT02003924|469189757|FG000|Double-blind Phase|Lost to Follow-up|2|||
130333366|NCT02003924|469189758|FG001|Double-blind Phase|Lost to Follow-up|1|||
130333367|NCT02003924|469189759|FG002|Double-blind Phase|Lost to Follow-up|0|||
130333368|NCT02003924|469189757|FG000|Double-blind Phase|Protocol Violation|1|||
130333369|NCT02003924|469189758|FG001|Double-blind Phase|Protocol Violation|2|||
130333370|NCT02003924|469189759|FG002|Double-blind Phase|Protocol Violation|0|||
130333371|NCT02003924|469189757|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
130333372|NCT02003924|469189758|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
130333373|NCT02003924|469189759|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
130333374|NCT02003924|469189757|FG000|Double-blind Phase|Disease Progression|229|||
130333375|NCT02003924|469189758|FG001|Double-blind Phase|Disease Progression|247|||
130333376|NCT02003924|469189759|FG002|Double-blind Phase|Disease Progression|0|||
130333377|NCT02003924|469189757|FG000|Double-blind Phase|Adverse Event|120|||
130333378|NCT02003924|469189758|FG001|Double-blind Phase|Adverse Event|31|||
130333379|NCT02003924|469189759|FG002|Double-blind Phase|Adverse Event|0|||
130333380|NCT02003924|469189757|FG000|Double-blind Phase|Randomized But not Treated|3|||
130333381|NCT02003924|469189758|FG001|Double-blind Phase|Randomized But not Treated|3|||
130333382|NCT02003924|469189759|FG002|Double-blind Phase|Randomized But not Treated|0|||
130333383|NCT02003924|469189757|FG000|Double-blind Phase|Other|29|||
130333384|NCT02003924|469189758|FG001|Double-blind Phase|Other|50|||
130333385|NCT02003924|469189759|FG002|Double-blind Phase|Other|0|||
130333386|NCT02003924|469189757|FG000|Open-label Phase|Lost to Follow-up|0|||
130333387|NCT02003924|469189758|FG001|Open-label Phase|Lost to Follow-up|0|||
130333388|NCT02003924|469189759|FG002|Open-label Phase|Lost to Follow-up|1|||
130333389|NCT02003924|469189757|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
130333390|NCT02003924|469189758|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
130333391|NCT02003924|469189759|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
130333392|NCT02003924|469189757|FG000|Open-label Phase|Disease Progression|59|||
130333393|NCT02003924|469189758|FG001|Open-label Phase|Disease Progression|0|||
130333394|NCT02003924|469189759|FG002|Open-label Phase|Disease Progression|5|||
130333395|NCT02003924|469189757|FG000|Open-label Phase|Adverse Event|25|||
130333396|NCT02003924|469189758|FG001|Open-label Phase|Adverse Event|0|||
130333397|NCT02003924|469189759|FG002|Open-label Phase|Adverse Event|10|||
130333398|NCT02003924|469189757|FG000|Open-label Phase|Other|7|||
130333399|NCT02003924|469189758|FG001|Open-label Phase|Other|0|||
130333400|NCT02003924|469189759|FG002|Open-label Phase|Other|0|||
130333401|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Death|288|||
130333402|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Death|174|||
130333403|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Death|4|||
130333404|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
130333405|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
130333406|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
130333407|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
130333408|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
130333409|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
130333410|NCT02003924|469189757|FG000|Long-term Follow-up Phase|Other|5|||
130333411|NCT02003924|469189758|FG001|Long-term Follow-up Phase|Other|2|||
130333412|NCT02003924|469189759|FG002|Long-term Follow-up Phase|Other|1|||
130333413|NCT00560352|469189764|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130333414|NCT00560352|469189765|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130333415|NCT00560352|469189766|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130333416|NCT00560352|469189764|FG000|Overall Study|Study drug toxicity|3|||
130333417|NCT00560352|469189765|FG001|Overall Study|Study drug toxicity|0|||
130333418|NCT00560352|469189766|FG002|Overall Study|Study drug toxicity|1|||
130333419|NCT00560352|469189764|FG000|Overall Study|Disease progression|0|||
130333420|NCT00560352|469189765|FG001|Overall Study|Disease progression|1|||
130333421|NCT00560352|469189766|FG002|Overall Study|Disease progression|1|||
130333422|NCT00560352|469189764|FG000|Overall Study|Withdrawal by Subject|1|||
130333423|NCT00560352|469189765|FG001|Overall Study|Withdrawal by Subject|1|||
130333424|NCT00560352|469189766|FG002|Overall Study|Withdrawal by Subject|1|||
130333425|NCT00560352|469189764|FG000|Overall Study|Maximum clinical benefit|1|||
130333426|NCT00560352|469189765|FG001|Overall Study|Maximum clinical benefit|0|||
130333427|NCT00560352|469189766|FG002|Overall Study|Maximum clinical benefit|0|||
130333428|NCT04434937|469189767|FG000|Overall Study|Death|4|||
130333429|NCT04434937|469189767|FG000|Overall Study|Withdrawal by Subject|1|||
130333430|NCT04434937|469189767|FG000|Overall Study|Transitioned to Rollover Study|19|||
130333431|NCT04434937|469189767|FG000|Overall Study|Progressive Disease|18|||
130333432|NCT04695977|469189772|FG000|Overall Study|Sponsor Decision|9|||
130333433|NCT04695977|469189773|FG001|Overall Study|Sponsor Decision|4|||
130333434|NCT04695977|469189772|FG000|Overall Study|Death|2|||
130333435|NCT04695977|469189773|FG001|Overall Study|Death|5|||
130333436|NCT03083873|469191815|FG000|Overall Study|Death|6|||
130333437|NCT03083873|469191816|FG001|Overall Study|Death|15|||
130333438|NCT03083873|469191817|FG002|Overall Study|Death|13|||
130333439|NCT03083873|469191818|FG003|Overall Study|Death|9|||
130333440|NCT03083873|469191819|FG004|Overall Study|Death|0|||
130333441|NCT03083873|469191815|FG000|Overall Study|Sponsor Terminated Study|0|||
130333442|NCT03083873|469191816|FG001|Overall Study|Sponsor Terminated Study|1|||
130333443|NCT03083873|469191817|FG002|Overall Study|Sponsor Terminated Study|2|||
130333444|NCT03083873|469191818|FG003|Overall Study|Sponsor Terminated Study|3|||
130333445|NCT03083873|469191819|FG004|Overall Study|Sponsor Terminated Study|0|||
130333446|NCT03083873|469191815|FG000|Overall Study|Lost to Follow-up|0|||
130333447|NCT03083873|469191816|FG001|Overall Study|Lost to Follow-up|1|||
130333448|NCT03083873|469191817|FG002|Overall Study|Lost to Follow-up|1|||
130333449|NCT03083873|469191818|FG003|Overall Study|Lost to Follow-up|0|||
130333450|NCT03083873|469191819|FG004|Overall Study|Lost to Follow-up|0|||
130333451|NCT03083873|469191815|FG000|Overall Study|Withdrawal by Subject|2|||
130333452|NCT03083873|469191816|FG001|Overall Study|Withdrawal by Subject|0|||
130333453|NCT03083873|469191817|FG002|Overall Study|Withdrawal by Subject|0|||
130333454|NCT03083873|469191818|FG003|Overall Study|Withdrawal by Subject|0|||
130333455|NCT03083873|469191819|FG004|Overall Study|Withdrawal by Subject|0|||
130333456|NCT03083873|469191815|FG000|Overall Study|Did Not Receive TIL|2|||
130333457|NCT03083873|469191816|FG001|Overall Study|Did Not Receive TIL|5|||
130333458|NCT03083873|469191817|FG002|Overall Study|Did Not Receive TIL|3|||
130333459|NCT03083873|469191818|FG003|Overall Study|Did Not Receive TIL|1|||
130333460|NCT03083873|469191819|FG004|Overall Study|Did Not Receive TIL|0|||
130333461|NCT01677377|469191820|FG000|Overall Study|Protocol Violation|1|||
130333462|NCT01677377|469191821|FG001|Overall Study|Protocol Violation|0|||
130333463|NCT01677377|469191822|FG002|Overall Study|Protocol Violation|0|||
130333464|NCT01677377|469191820|FG000|Overall Study|Lost to Follow-up|0|||
130333465|NCT01677377|469191821|FG001|Overall Study|Lost to Follow-up|1|||
130333466|NCT01677377|469191822|FG002|Overall Study|Lost to Follow-up|1|||
130333467|NCT01677377|469191820|FG000|Overall Study|Withdrawal by Subject|0|||
130333468|NCT01677377|469191821|FG001|Overall Study|Withdrawal by Subject|0|||
130333469|NCT01677377|469191822|FG002|Overall Study|Withdrawal by Subject|3|||
130333470|NCT01677377|469191820|FG000|Overall Study|Lack of Efficacy|0|||
130333471|NCT01677377|469191821|FG001|Overall Study|Lack of Efficacy|0|||
130333472|NCT01677377|469191822|FG002|Overall Study|Lack of Efficacy|1|||
130333473|NCT01677377|469191820|FG000|Overall Study|Pregnancy|0|||
130333474|NCT01677377|469191821|FG001|Overall Study|Pregnancy|0|||
130333475|NCT01677377|469191822|FG002|Overall Study|Pregnancy|1|||
130333476|NCT02656693|469191836|FG000|Overall Study|Pregnancy|1|||
130333477|NCT02656693|469191837|FG001|Overall Study|Pregnancy|1|||
130333478|NCT02656693|469191838|FG002|Overall Study|Pregnancy|1|||
130333479|NCT02656693|469191836|FG000|Overall Study|Bariatric surgery|0|||
130333480|NCT02656693|469191837|FG001|Overall Study|Bariatric surgery|1|||
130333481|NCT02656693|469191838|FG002|Overall Study|Bariatric surgery|2|||
130333482|NCT02269267|469191840|FG000|Overall Study|Death|5|||
130333483|NCT00796419|469191842|FG000|Overall Study|Death|0|||
130333484|NCT00796419|469191843|FG001|Overall Study|Death|1|||
130333515|NCT01193257|469191852|FG000|Overall Study|Death|202|||
130333516|NCT01193257|469191853|FG001|Overall Study|Death|391|||
130333517|NCT01193257|469191852|FG000|Overall Study|Study termination by sponsor|0|||
130333518|NCT01193257|469191853|FG001|Overall Study|Study termination by sponsor|3|||
130333519|NCT01193257|469191852|FG000|Overall Study|Withdrawal by Subject|26|||
130333520|NCT01193257|469191853|FG001|Overall Study|Withdrawal by Subject|86|||
130333521|NCT01193257|469191852|FG000|Overall Study|Lost to Follow-up|2|||
130333522|NCT01193257|469191853|FG001|Overall Study|Lost to Follow-up|3|||
130333523|NCT01193257|469191852|FG000|Overall Study|Unblinded due to futility|135|||
130333524|NCT01193257|469191853|FG001|Overall Study|Unblinded due to futility|251|||
130333525|NCT01027273|469191856|FG000|Overall Study|Lost to Follow-up|57|||
130333526|NCT01027273|469191857|FG001|Overall Study|Lost to Follow-up|31|||
130333527|NCT01027273|469191856|FG000|Overall Study|Death|2|||
130333528|NCT01027273|469191857|FG001|Overall Study|Death|2|||
130333529|NCT00337675|469191859|FG000|Overall Study|Adverse Event|10|||
130333530|NCT00337675|469191860|FG001|Overall Study|Adverse Event|9|||
130333531|NCT00337675|469191861|FG002|Overall Study|Adverse Event|19|||
130333532|NCT00337675|469191859|FG000|Overall Study|Lack of Efficacy|10|||
130333533|NCT00337675|469191860|FG001|Overall Study|Lack of Efficacy|7|||
130333534|NCT00337675|469191861|FG002|Overall Study|Lack of Efficacy|9|||
130333535|NCT00337675|469191859|FG000|Overall Study|Lost to Follow-up|22|||
130333536|NCT00337675|469191860|FG001|Overall Study|Lost to Follow-up|19|||
130333537|NCT00337675|469191861|FG002|Overall Study|Lost to Follow-up|17|||
130333538|NCT00337675|469191859|FG000|Overall Study|Physician Decision|9|||
130333539|NCT00337675|469191860|FG001|Overall Study|Physician Decision|17|||
130333540|NCT00337675|469191861|FG002|Overall Study|Physician Decision|14|||
130333541|NCT00337675|469191859|FG000|Overall Study|Protocol Violation|21|||
130333542|NCT00337675|469191860|FG001|Overall Study|Protocol Violation|24|||
130333543|NCT00337675|469191861|FG002|Overall Study|Protocol Violation|19|||
130333544|NCT00337675|469191859|FG000|Overall Study|Withdrawal by Subject|25|||
130333545|NCT00337675|469191860|FG001|Overall Study|Withdrawal by Subject|25|||
130333546|NCT00337675|469191861|FG002|Overall Study|Withdrawal by Subject|19|||
130333547|NCT00337675|469191859|FG000|Overall Study|Progressive Disease|0|||
130333548|NCT00337675|469191860|FG001|Overall Study|Progressive Disease|2|||
130333549|NCT00337675|469191861|FG002|Overall Study|Progressive Disease|0|||
130333550|NCT00337675|469191859|FG000|Overall Study|Trial Terminated|0|||
130333551|NCT00337675|469191860|FG001|Overall Study|Trial Terminated|0|||
130333552|NCT00337675|469191861|FG002|Overall Study|Trial Terminated|2|||
130333553|NCT06170242|469191862|FG000|Overall Study|Lost to Follow-up|0|||
130333554|NCT06170242|469191863|FG001|Overall Study|Lost to Follow-up|0|||
130333555|NCT06170242|469191864|FG002|Overall Study|Lost to Follow-up|1|||
130333556|NCT06170242|469191865|FG003|Overall Study|Lost to Follow-up|1|||
130333557|NCT02586207|469191873|FG000|Overall Study|Physician Decision|1|||
130333558|NCT02586207|469191873|FG000|Overall Study|Withdrawal by Subject|1|||
130333559|NCT00441064|469191874|FG000|Overall Study|Adverse Event|1|||
130333560|NCT00441064|469191875|FG001|Overall Study|Adverse Event|0|||
130333561|NCT00441064|469191874|FG000|Overall Study|Abnormal laboratory values|0|||
130333562|NCT00441064|469191875|FG001|Overall Study|Abnormal laboratory values|2|||
130333563|NCT00441064|469191874|FG000|Overall Study|Abnormal test procedure results|0|||
130333564|NCT00441064|469191875|FG001|Overall Study|Abnormal test procedure results|1|||
130333565|NCT00441064|469191874|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130333566|NCT00441064|469191875|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130333567|NCT00441064|469191874|FG000|Overall Study|Protocol Deviation|3|||
130333568|NCT00441064|469191875|FG001|Overall Study|Protocol Deviation|2|||
130333569|NCT00441064|469191874|FG000|Overall Study|Patient withdrew consent|5|||
130333570|NCT00441064|469191875|FG001|Overall Study|Patient withdrew consent|2|||
130333571|NCT03962504|469191876|FG000|Overall Study|Other|11|||
130333572|NCT03962504|469191877|FG001|Overall Study|Other|32|||
130333573|NCT03776812|469191878|FG000|Overall Study|Death|53|||
130333574|NCT03776812|469191879|FG001|Overall Study|Death|49|||
130333575|NCT03776812|469191880|FG002|Overall Study|Death|56|||
130333576|NCT03776812|469191878|FG000|Overall Study|Withdrawal by Subject|1|||
130333577|NCT03776812|469191879|FG001|Overall Study|Withdrawal by Subject|7|||
130333578|NCT03776812|469191880|FG002|Overall Study|Withdrawal by Subject|2|||
130333579|NCT03776812|469191878|FG000|Overall Study|Lost to Follow-up|1|||
130333580|NCT03776812|469191879|FG001|Overall Study|Lost to Follow-up|1|||
130333581|NCT03776812|469191880|FG002|Overall Study|Lost to Follow-up|0|||
130333582|NCT03776812|469191878|FG000|Overall Study|Did not enter long-term follow-up|3|||
130333583|NCT03776812|469191879|FG001|Overall Study|Did not enter long-term follow-up|3|||
130333584|NCT03776812|469191880|FG002|Overall Study|Did not enter long-term follow-up|2|||
130333585|NCT00048074|469191883|FG000|Overall Study|Adverse Event|46|||
130333586|NCT00048074|469191884|FG001|Overall Study|Adverse Event|41|||
130333587|NCT00048074|469191885|FG002|Overall Study|Adverse Event|53|||
130333588|NCT00048074|469191883|FG000|Overall Study|Death|3|||
130333589|NCT00048074|469191884|FG001|Overall Study|Death|3|||
130333590|NCT00048074|469191885|FG002|Overall Study|Death|2|||
130333591|NCT00048074|469191883|FG000|Overall Study|Lost to Follow-up|2|||
130333592|NCT00048074|469191884|FG001|Overall Study|Lost to Follow-up|6|||
130333593|NCT00048074|469191885|FG002|Overall Study|Lost to Follow-up|6|||
130333594|NCT00048074|469191883|FG000|Overall Study|Withdrawal by Subject|28|||
130333595|NCT00048074|469191884|FG001|Overall Study|Withdrawal by Subject|30|||
130333596|NCT00048074|469191885|FG002|Overall Study|Withdrawal by Subject|35|||
130333597|NCT00048074|469191883|FG000|Overall Study|Protocol Violation|1|||
130333598|NCT00048074|469191884|FG001|Overall Study|Protocol Violation|3|||
130333599|NCT00048074|469191885|FG002|Overall Study|Protocol Violation|0|||
130333600|NCT00048074|469191883|FG000|Overall Study|Study participation was terminated|0|||
130333601|NCT00048074|469191884|FG001|Overall Study|Study participation was terminated|1|||
130333602|NCT00048074|469191885|FG002|Overall Study|Study participation was terminated|0|||
130333603|NCT00048074|469191883|FG000|Overall Study|Husband ill|0|||
130333604|NCT00048074|469191884|FG001|Overall Study|Husband ill|1|||
130333605|NCT00048074|469191885|FG002|Overall Study|Husband ill|0|||
130333606|NCT00048074|469191883|FG000|Overall Study|Poor compliance|0|||
130333607|NCT00048074|469191884|FG001|Overall Study|Poor compliance|1|||
130333608|NCT00048074|469191885|FG002|Overall Study|Poor compliance|0|||
130333609|NCT00048074|469191883|FG000|Overall Study|Out of station|0|||
130333610|NCT00048074|469191884|FG001|Overall Study|Out of station|1|||
130333611|NCT00048074|469191885|FG002|Overall Study|Out of station|1|||
130333612|NCT00048074|469191883|FG000|Overall Study|Social reasons|1|||
130333613|NCT00048074|469191884|FG001|Overall Study|Social reasons|0|||
130333614|NCT00048074|469191885|FG002|Overall Study|Social reasons|0|||
130333615|NCT02873377|469191886|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
130333616|NCT02873377|469191887|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
130333617|NCT02873377|469191886|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
130333618|NCT02873377|469191887|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
130333619|NCT01032889|469191897|FG000|Overall Study|Adverse Event|2|||
130333620|NCT01032889|469191898|FG001|Overall Study|Adverse Event|2|||
130333621|NCT01032889|469191899|FG002|Overall Study|Adverse Event|0|||
130333622|NCT01032889|469191897|FG000|Overall Study|Withdrawal of Consent|1|||
130333623|NCT01032889|469191898|FG001|Overall Study|Withdrawal of Consent|2|||
130333624|NCT01032889|469191899|FG002|Overall Study|Withdrawal of Consent|1|||
130333625|NCT01032889|469191897|FG000|Overall Study|Patient Request|0|||
130333626|NCT01032889|469191898|FG001|Overall Study|Patient Request|1|||
130333627|NCT01032889|469191899|FG002|Overall Study|Patient Request|0|||
130333628|NCT01032889|469191897|FG000|Overall Study|Lost to Follow-up|1|||
130333629|NCT01032889|469191898|FG001|Overall Study|Lost to Follow-up|1|||
130333630|NCT01032889|469191899|FG002|Overall Study|Lost to Follow-up|0|||
130333631|NCT01032889|469191897|FG000|Overall Study|Lack of Submental Fat|2|||
130333632|NCT01032889|469191898|FG001|Overall Study|Lack of Submental Fat|8|||
130333633|NCT01032889|469191899|FG002|Overall Study|Lack of Submental Fat|1|||
130333634|NCT01032889|469191897|FG000|Overall Study|Miscellaneous Reasons|2|||
130333635|NCT01032889|469191898|FG001|Overall Study|Miscellaneous Reasons|1|||
130333636|NCT01032889|469191899|FG002|Overall Study|Miscellaneous Reasons|1|||
130333637|NCT02039843|469191900|FG000|Randomization and Observation Period|Adverse Event|2|||
130333638|NCT02039843|469191901|FG001|Randomization and Observation Period|Adverse Event|0|||
130333639|NCT02039843|469191900|FG000|Randomization and Observation Period|Death|1|||
130333640|NCT02039843|469191901|FG001|Randomization and Observation Period|Death|0|||
130333641|NCT02039843|469191900|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
130333642|NCT02039843|469191901|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
130333643|NCT02039843|469191900|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
130333644|NCT02039843|469191901|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
130333645|NCT02039843|469191900|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
130333646|NCT02039843|469191901|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
130333647|NCT02039843|469191900|FG000|Pairing With a Study Dog|Death|1|||
130333648|NCT02039843|469191901|FG001|Pairing With a Study Dog|Death|0|||
130333649|NCT02039843|469191900|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
130333650|NCT02039843|469191901|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
130333651|NCT02039843|469191900|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
130333652|NCT02039843|469191901|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
130333653|NCT02039843|469191900|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
130333654|NCT02039843|469191901|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
130333655|NCT02624986|469191905|FG000|Overall Study|Death|0|||
130333656|NCT02624986|469191906|FG001|Overall Study|Death|1|||
130333657|NCT02624986|469191907|FG002|Overall Study|Death|2|||
130333658|NCT02624986|469191908|FG003|Overall Study|Death|2|||
130333659|NCT02624986|469191909|FG004|Overall Study|Death|2|||
130333660|NCT02624986|469191910|FG005|Overall Study|Death|0|||
130333661|NCT02624986|469191911|FG006|Overall Study|Death|0|||
130333662|NCT02624986|469191912|FG007|Overall Study|Death|1|||
130333663|NCT02624986|469191905|FG000|Overall Study|Study Terminated by Sponsor|1|||
130333664|NCT02624986|469191906|FG001|Overall Study|Study Terminated by Sponsor|1|||
130333665|NCT02624986|469191907|FG002|Overall Study|Study Terminated by Sponsor|0|||
130333666|NCT02624986|469191908|FG003|Overall Study|Study Terminated by Sponsor|1|||
130333667|NCT02624986|469191909|FG004|Overall Study|Study Terminated by Sponsor|2|||
130333668|NCT02624986|469191910|FG005|Overall Study|Study Terminated by Sponsor|2|||
130333669|NCT02624986|469191911|FG006|Overall Study|Study Terminated by Sponsor|4|||
130333670|NCT02624986|469191912|FG007|Overall Study|Study Terminated by Sponsor|3|||
130333671|NCT02624986|469191905|FG000|Overall Study|Progressive Disease|0|||
130333672|NCT02624986|469191906|FG001|Overall Study|Progressive Disease|1|||
130333673|NCT02624986|469191907|FG002|Overall Study|Progressive Disease|0|||
130333674|NCT02624986|469191908|FG003|Overall Study|Progressive Disease|0|||
130333675|NCT02624986|469191909|FG004|Overall Study|Progressive Disease|0|||
130333676|NCT02624986|469191910|FG005|Overall Study|Progressive Disease|0|||
130333677|NCT02624986|469191911|FG006|Overall Study|Progressive Disease|0|||
130333678|NCT02624986|469191912|FG007|Overall Study|Progressive Disease|0|||
130333679|NCT02624986|469191905|FG000|Overall Study|Protocol Violation|1|||
130333680|NCT02624986|469191906|FG001|Overall Study|Protocol Violation|0|||
130333681|NCT02624986|469191907|FG002|Overall Study|Protocol Violation|0|||
130333682|NCT02624986|469191908|FG003|Overall Study|Protocol Violation|0|||
130333683|NCT02624986|469191909|FG004|Overall Study|Protocol Violation|0|||
130333684|NCT02624986|469191910|FG005|Overall Study|Protocol Violation|0|||
130333685|NCT02624986|469191911|FG006|Overall Study|Protocol Violation|0|||
130333686|NCT02624986|469191912|FG007|Overall Study|Protocol Violation|0|||
130333687|NCT02624986|469191905|FG000|Overall Study|Withdrawal by Subject|0|||
130333688|NCT02624986|469191906|FG001|Overall Study|Withdrawal by Subject|0|||
130333689|NCT02624986|469191907|FG002|Overall Study|Withdrawal by Subject|0|||
130333690|NCT02624986|469191908|FG003|Overall Study|Withdrawal by Subject|0|||
130333691|NCT02624986|469191909|FG004|Overall Study|Withdrawal by Subject|0|||
130333692|NCT02624986|469191910|FG005|Overall Study|Withdrawal by Subject|0|||
130333693|NCT02624986|469191911|FG006|Overall Study|Withdrawal by Subject|0|||
130333694|NCT02624986|469191912|FG007|Overall Study|Withdrawal by Subject|1|||
130333695|NCT00740857|469191914|FG000|Overall Study|Withdrawal by Subject|1|||
130333696|NCT00740857|469191915|FG001|Overall Study|Withdrawal by Subject|0|||
130333697|NCT00740857|469191916|FG002|Overall Study|Withdrawal by Subject|0|||
130333698|NCT03532451|469191920|FG000|Overall Study|Withdrawal by Subject|0|||
130333699|NCT03532451|469191921|FG001|Overall Study|Withdrawal by Subject|1|||
130333700|NCT03532451|469191920|FG000|Overall Study|Did not undergo surgery|1|||
130333701|NCT03532451|469191921|FG001|Overall Study|Did not undergo surgery|1|||
130333702|NCT00912197|469191922|FG000|Overall Study|Withdrawal by Subject|3|||
130333703|NCT00912197|469191923|FG001|Overall Study|Withdrawal by Subject|3|||
130333704|NCT01326104|469191929|FG000|Overall Study|progressed prior to vaccine|0|||
130333705|NCT01326104|469191930|FG001|Overall Study|progressed prior to vaccine|2|||
130333706|NCT01326104|469191929|FG000|Overall Study|unable to make vaccine|0|||
130333707|NCT01326104|469191930|FG001|Overall Study|unable to make vaccine|2|||
130333708|NCT01287741|469191931|FG000|Overall Study|Withdrawal by Subject|35|||
130333709|NCT01287741|469191932|FG001|Overall Study|Withdrawal by Subject|38|||
130333710|NCT01287741|469191931|FG000|Overall Study|Protocol Violation|2|||
130333711|NCT01287741|469191932|FG001|Overall Study|Protocol Violation|0|||
130333712|NCT01287741|469191931|FG000|Overall Study|Physician Decision|15|||
130333713|NCT01287741|469191932|FG001|Overall Study|Physician Decision|23|||
130333714|NCT01287741|469191931|FG000|Overall Study|Non-compliance|8|||
130333715|NCT01287741|469191932|FG001|Overall Study|Non-compliance|6|||
130333716|NCT01287741|469191931|FG000|Overall Study|Lost to Follow-up|10|||
129992101|NCT03816332|467934192|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
129992102|NCT03816332|467934192|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
129992103|NCT04689828|467934195|FG000|Overall Study|Subject decision|5|||
129992104|NCT04689828|467934196|FG001|Overall Study|Subject decision|5|||
129992105|NCT04689828|467934195|FG000|Overall Study|Adverse Event|12|||
129992106|NCT04689828|467934196|FG001|Overall Study|Adverse Event|12|||
129992107|NCT04689828|467934195|FG000|Overall Study|Physician Decision|24|||
129992108|NCT04689828|467934196|FG001|Overall Study|Physician Decision|32|||
129992109|NCT04689828|467934195|FG000|Overall Study|Progressive disease|54|||
130333717|NCT01287741|469191932|FG001|Overall Study|Lost to Follow-up|8|||
130333718|NCT01287741|469191931|FG000|Overall Study|Death|32|||
130333719|NCT01287741|469191932|FG001|Overall Study|Death|44|||
130333720|NCT01287741|469191931|FG000|Overall Study|Adverse Event|4|||
130333721|NCT01287741|469191932|FG001|Overall Study|Adverse Event|6|||
130333722|NCT01287741|469191931|FG000|Overall Study|Study terminated by Sponsor|307|||
130333723|NCT01287741|469191932|FG001|Overall Study|Study terminated by Sponsor|315|||
130333724|NCT01287741|469191931|FG000|Overall Study|Progressive disease|190|||
130333725|NCT01287741|469191932|FG001|Overall Study|Progressive disease|166|||
130333726|NCT01287741|469191931|FG000|Overall Study|Reason not specified|23|||
130333727|NCT01287741|469191932|FG001|Overall Study|Reason not specified|9|||
130333728|NCT04421027|469191933|FG000|Treatment Period|Adverse Event|5|||
130333729|NCT04421027|469191934|FG001|Treatment Period|Adverse Event|3|||
130333730|NCT04421027|469191935|FG002|Treatment Period|Adverse Event|0|||
130333731|NCT04421027|469191936|FG003|Treatment Period|Adverse Event|0|||
130333732|NCT04421027|469191933|FG000|Treatment Period|Death|98|||
130333733|NCT04421027|469191934|FG001|Treatment Period|Death|61|||
130333734|NCT04421027|469191935|FG002|Treatment Period|Death|0|||
130333735|NCT04421027|469191936|FG003|Treatment Period|Death|0|||
130333736|NCT04421027|469191933|FG000|Treatment Period|Lost to Follow-up|22|||
130333737|NCT04421027|469191934|FG001|Treatment Period|Lost to Follow-up|20|||
130333738|NCT04421027|469191935|FG002|Treatment Period|Lost to Follow-up|0|||
130333739|NCT04421027|469191936|FG003|Treatment Period|Lost to Follow-up|0|||
130333740|NCT04421027|469191933|FG000|Treatment Period|Other-Unknown|15|||
130333741|NCT04421027|469191934|FG001|Treatment Period|Other-Unknown|9|||
130333742|NCT04421027|469191935|FG002|Treatment Period|Other-Unknown|0|||
130333743|NCT04421027|469191936|FG003|Treatment Period|Other-Unknown|0|||
130333744|NCT04421027|469191933|FG000|Treatment Period|Physician Decision|1|||
130333745|NCT04421027|469191934|FG001|Treatment Period|Physician Decision|1|||
130333746|NCT04421027|469191935|FG002|Treatment Period|Physician Decision|0|||
130333747|NCT04421027|469191936|FG003|Treatment Period|Physician Decision|0|||
130333748|NCT04421027|469191933|FG000|Treatment Period|Withdrawal by Subject|7|||
130333749|NCT04421027|469191934|FG001|Treatment Period|Withdrawal by Subject|12|||
130333750|NCT04421027|469191935|FG002|Treatment Period|Withdrawal by Subject|0|||
130333751|NCT04421027|469191936|FG003|Treatment Period|Withdrawal by Subject|0|||
130333752|NCT04421027|469191933|FG000|Treatment Period|Randomized Not Dosed|9|||
130333753|NCT04421027|469191934|FG001|Treatment Period|Randomized Not Dosed|14|||
130333754|NCT04421027|469191935|FG002|Treatment Period|Randomized Not Dosed|0|||
130333755|NCT04421027|469191936|FG003|Treatment Period|Randomized Not Dosed|0|||
130333756|NCT04421027|469191933|FG000|Follow-Up Period|Adverse Event|0|||
130333757|NCT04421027|469191934|FG001|Follow-Up Period|Adverse Event|0|||
130333758|NCT04421027|469191935|FG002|Follow-Up Period|Adverse Event|0|||
130333759|NCT04421027|469191936|FG003|Follow-Up Period|Adverse Event|3|||
130333760|NCT04421027|469191933|FG000|Follow-Up Period|Death|0|||
130333761|NCT04421027|469191934|FG001|Follow-Up Period|Death|0|||
130333762|NCT04421027|469191935|FG002|Follow-Up Period|Death|16|||
130333763|NCT04421027|469191936|FG003|Follow-Up Period|Death|17|||
130333764|NCT04421027|469191933|FG000|Follow-Up Period|Lost to Follow-up|0|||
130333765|NCT04421027|469191934|FG001|Follow-Up Period|Lost to Follow-up|0|||
130333766|NCT04421027|469191935|FG002|Follow-Up Period|Lost to Follow-up|7|||
130333767|NCT04421027|469191936|FG003|Follow-Up Period|Lost to Follow-up|7|||
129992110|NCT04689828|467934196|FG001|Overall Study|Progressive disease|173|||
129992111|NCT04689828|467934195|FG000|Overall Study|Death|0|||
130333768|NCT04421027|469191933|FG000|Follow-Up Period|Protocol Deviation|0|||
130333769|NCT04421027|469191934|FG001|Follow-Up Period|Protocol Deviation|0|||
130333770|NCT04421027|469191935|FG002|Follow-Up Period|Protocol Deviation|1|||
130333771|NCT04421027|469191936|FG003|Follow-Up Period|Protocol Deviation|0|||
130333772|NCT04421027|469191933|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130333773|NCT04421027|469191934|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130333774|NCT04421027|469191935|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
130333775|NCT04421027|469191936|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
130333776|NCT04421027|469191933|FG000|Follow-Up Period|Left message, participant did not call back|0|||
130333777|NCT04421027|469191934|FG001|Follow-Up Period|Left message, participant did not call back|0|||
130333778|NCT04421027|469191935|FG002|Follow-Up Period|Left message, participant did not call back|0|||
130333779|NCT04421027|469191936|FG003|Follow-Up Period|Left message, participant did not call back|1|||
130333780|NCT04421027|469191933|FG000|Follow-Up Period|Participant died|0|||
130333781|NCT04421027|469191934|FG001|Follow-Up Period|Participant died|0|||
130333782|NCT04421027|469191935|FG002|Follow-Up Period|Participant died|0|||
130333783|NCT04421027|469191936|FG003|Follow-Up Period|Participant died|1|||
130333784|NCT04421027|469191933|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130333785|NCT04421027|469191934|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130333786|NCT04421027|469191935|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
130333787|NCT04421027|469191936|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
130333788|NCT02930018|469191946|FG000|Overall Study|Lost to Follow-up|1|||
130333789|NCT02930018|469191947|FG001|Overall Study|Lost to Follow-up|1|||
130333790|NCT02930018|469191946|FG000|Overall Study|Withdrawal by Subject|5|||
130333791|NCT02930018|469191947|FG001|Overall Study|Withdrawal by Subject|2|||
130333792|NCT03892967|469191948|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
130333793|NCT03892967|469191949|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
130333794|NCT03892967|469191950|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
130333795|NCT03892967|469191951|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
130333796|NCT03892967|469191952|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
130333797|NCT03892967|469191948|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
130333798|NCT03892967|469191949|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
130333799|NCT03892967|469191950|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
130333800|NCT03892967|469191951|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
130333801|NCT03892967|469191952|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
130333802|NCT03892967|469191948|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
130333803|NCT03892967|469191949|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
130333804|NCT03892967|469191950|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
130333805|NCT03892967|469191951|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
130333806|NCT03892967|469191952|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
130333807|NCT03892967|469191948|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
130333808|NCT03892967|469191949|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
130333809|NCT03892967|469191950|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
130333810|NCT03892967|469191951|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
130333811|NCT03892967|469191952|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
130333812|NCT03892967|469191948|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
130333813|NCT03892967|469191949|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
130333814|NCT03892967|469191950|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
130333815|NCT03892967|469191951|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
130333816|NCT03892967|469191952|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
130333817|NCT03892967|469191948|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
130333818|NCT03892967|469191949|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
129992112|NCT04689828|467934196|FG001|Overall Study|Death|1|||
129992113|NCT04689828|467934195|FG000|Overall Study|Lost to Follow-up|1|||
129992114|NCT04689828|467934196|FG001|Overall Study|Lost to Follow-up|0|||
129992115|NCT04689828|467934195|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
129992116|NCT04689828|467934196|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
129992117|NCT04689828|467934195|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
129992118|NCT04689828|467934196|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
130333819|NCT03892967|469191950|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
130333820|NCT03892967|469191951|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
130333821|NCT03892967|469191952|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
130333822|NCT00114517|469191956|FG000|Overall Study|Adverse Event|6|||
130333823|NCT00114517|469191957|FG001|Overall Study|Adverse Event|1|||
130333824|NCT00114517|469191958|FG002|Overall Study|Adverse Event|6|||
130333825|NCT00114517|469191959|FG003|Overall Study|Adverse Event|3|||
130333826|NCT00114517|469191956|FG000|Overall Study|Lost to Follow-up|2|||
130333827|NCT00114517|469191957|FG001|Overall Study|Lost to Follow-up|2|||
129992119|NCT04689828|467934195|FG000|Overall Study|Participants not treated|7|||
129992120|NCT04689828|467934196|FG001|Overall Study|Participants not treated|2|||
129992121|NCT05182125|467934199|FG000|Overall Study|Withdrawal by Subject|0|||
129992122|NCT05182125|467934200|FG001|Overall Study|Withdrawal by Subject|0|||
130333828|NCT00114517|469191958|FG002|Overall Study|Lost to Follow-up|2|||
130333829|NCT00114517|469191959|FG003|Overall Study|Lost to Follow-up|1|||
130333830|NCT00114517|469191956|FG000|Overall Study|Too busy|3|||
130333831|NCT00114517|469191957|FG001|Overall Study|Too busy|1|||
130333832|NCT00114517|469191958|FG002|Overall Study|Too busy|1|||
130333833|NCT00114517|469191959|FG003|Overall Study|Too busy|2|||
130333834|NCT00114517|469191956|FG000|Overall Study|Moved from area|0|||
130333835|NCT00114517|469191957|FG001|Overall Study|Moved from area|3|||
130333836|NCT00114517|469191958|FG002|Overall Study|Moved from area|2|||
130333837|NCT00114517|469191959|FG003|Overall Study|Moved from area|1|||
130333838|NCT00114517|469191956|FG000|Overall Study|Did not want estradiol|1|||
130333839|NCT00114517|469191957|FG001|Overall Study|Did not want estradiol|1|||
130333840|NCT00114517|469191958|FG002|Overall Study|Did not want estradiol|0|||
130333841|NCT00114517|469191959|FG003|Overall Study|Did not want estradiol|0|||
130333842|NCT00114517|469191956|FG000|Overall Study|Armed-services duty|0|||
130333843|NCT00114517|469191957|FG001|Overall Study|Armed-services duty|1|||
130333844|NCT00114517|469191958|FG002|Overall Study|Armed-services duty|0|||
130333845|NCT00114517|469191959|FG003|Overall Study|Armed-services duty|1|||
130333846|NCT00114517|469191956|FG000|Overall Study|Competing family issue|0|||
130333847|NCT00114517|469191957|FG001|Overall Study|Competing family issue|1|||
130333848|NCT00114517|469191958|FG002|Overall Study|Competing family issue|0|||
130333849|NCT00114517|469191959|FG003|Overall Study|Competing family issue|1|||
130333850|NCT00114517|469191956|FG000|Overall Study|Physician Decision|0|||
130333851|NCT00114517|469191957|FG001|Overall Study|Physician Decision|1|||
129992123|NCT05182125|467934201|FG002|Overall Study|Withdrawal by Subject|0|||
129992124|NCT05182125|467934202|FG003|Overall Study|Withdrawal by Subject|0|||
129992125|NCT05182125|467934203|FG004|Overall Study|Withdrawal by Subject|2|||
130333852|NCT00114517|469191958|FG002|Overall Study|Physician Decision|0|||
130333853|NCT00114517|469191959|FG003|Overall Study|Physician Decision|0|||
130333854|NCT00114517|469191956|FG000|Overall Study|Lost interest|0|||
130333855|NCT00114517|469191957|FG001|Overall Study|Lost interest|0|||
130333856|NCT00114517|469191958|FG002|Overall Study|Lost interest|1|||
130333857|NCT00114517|469191959|FG003|Overall Study|Lost interest|0|||
130333858|NCT00114517|469191956|FG000|Overall Study|Weight increase|0|||
130333859|NCT00114517|469191957|FG001|Overall Study|Weight increase|0|||
130333860|NCT00114517|469191958|FG002|Overall Study|Weight increase|1|||
129992126|NCT05182125|467934204|FG005|Overall Study|Withdrawal by Subject|0|||
129992127|NCT05182125|467934199|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992128|NCT05182125|467934200|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992129|NCT05182125|467934201|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992130|NCT05182125|467934202|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
129992131|NCT05182125|467934203|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992132|NCT05182125|467934204|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992133|NCT05182125|467934199|FG000|Overall Study|Death|0|||
129992134|NCT05182125|467934200|FG001|Overall Study|Death|0|||
129992135|NCT05182125|467934201|FG002|Overall Study|Death|0|||
130333861|NCT00114517|469191959|FG003|Overall Study|Weight increase|0|||
130333862|NCT00114517|469191956|FG000|Overall Study|Concern about blood clots|0|||
130333863|NCT00114517|469191957|FG001|Overall Study|Concern about blood clots|0|||
129992136|NCT05182125|467934202|FG003|Overall Study|Death|0|||
130333864|NCT00114517|469191958|FG002|Overall Study|Concern about blood clots|1|||
130333865|NCT00114517|469191959|FG003|Overall Study|Concern about blood clots|0|||
130333866|NCT00114517|469191956|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130333867|NCT00114517|469191957|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
130333868|NCT00114517|469191958|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129992137|NCT05182125|467934203|FG004|Overall Study|Death|1|||
129992138|NCT05182125|467934204|FG005|Overall Study|Death|0|||
130333869|NCT00114517|469191959|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
130333870|NCT03474965|469191960|FG000|Overall Study|Pregnancy|1|||
130333871|NCT03474965|469191961|FG001|Overall Study|Pregnancy|0|||
130333872|NCT03474965|469191962|FG002|Overall Study|Pregnancy|0|||
130333873|NCT03474965|469191963|FG003|Overall Study|Pregnancy|0|||
130333874|NCT03474965|469191960|FG000|Overall Study|Lost to Follow-up|0|||
130333875|NCT03474965|469191961|FG001|Overall Study|Lost to Follow-up|0|||
130333876|NCT03474965|469191962|FG002|Overall Study|Lost to Follow-up|1|||
130333877|NCT03474965|469191963|FG003|Overall Study|Lost to Follow-up|0|||
130333878|NCT03474965|469191960|FG000|Overall Study|Death|1|||
130333879|NCT03474965|469191961|FG001|Overall Study|Death|0|||
130333880|NCT03474965|469191962|FG002|Overall Study|Death|0|||
130333881|NCT03474965|469191963|FG003|Overall Study|Death|0|||
130333882|NCT03474965|469191960|FG000|Overall Study|Adverse Event|1|||
130333883|NCT03474965|469191961|FG001|Overall Study|Adverse Event|0|||
130333884|NCT03474965|469191962|FG002|Overall Study|Adverse Event|0|||
130333885|NCT03474965|469191963|FG003|Overall Study|Adverse Event|1|||
130333886|NCT03474965|469191960|FG000|Overall Study|Physician Decision|3|||
130333887|NCT03474965|469191961|FG001|Overall Study|Physician Decision|1|||
130333888|NCT03474965|469191962|FG002|Overall Study|Physician Decision|2|||
130333889|NCT03474965|469191963|FG003|Overall Study|Physician Decision|0|||
130333890|NCT03474965|469191960|FG000|Overall Study|Participant Decision|7|||
130333891|NCT03474965|469191961|FG001|Overall Study|Participant Decision|0|||
130333892|NCT03474965|469191962|FG002|Overall Study|Participant Decision|1|||
130333893|NCT03474965|469191963|FG003|Overall Study|Participant Decision|0|||
130333894|NCT03474965|469191960|FG000|Overall Study|Guardian Decision|4|||
130333895|NCT03474965|469191961|FG001|Overall Study|Guardian Decision|2|||
130333896|NCT03474965|469191962|FG002|Overall Study|Guardian Decision|7|||
130333897|NCT03474965|469191963|FG003|Overall Study|Guardian Decision|2|||
130333898|NCT02255435|469193024|FG000|Overall Study|Patient's Limited Time Availability|0|||
130333899|NCT02255435|469193025|FG001|Overall Study|Patient's Limited Time Availability|0|||
130333900|NCT02255435|469193026|FG002|Overall Study|Patient's Limited Time Availability|0|||
130333901|NCT02255435|469193027|FG003|Overall Study|Patient's Limited Time Availability|0|||
130333902|NCT02255435|469193028|FG004|Overall Study|Patient's Limited Time Availability|0|||
130333903|NCT02255435|469193029|FG005|Overall Study|Patient's Limited Time Availability|0|||
130333904|NCT02255435|469193030|FG006|Overall Study|Patient's Limited Time Availability|0|||
130333905|NCT02255435|469193031|FG007|Overall Study|Patient's Limited Time Availability|1|||
130333906|NCT02255435|469193032|FG008|Overall Study|Patient's Limited Time Availability|0|||
130333907|NCT02255435|469193033|FG009|Overall Study|Patient's Limited Time Availability|0|||
130333908|NCT02255435|469193024|FG000|Overall Study|Withdrawal by Subject|0|||
130333909|NCT02255435|469193025|FG001|Overall Study|Withdrawal by Subject|0|||
130333910|NCT02255435|469193026|FG002|Overall Study|Withdrawal by Subject|0|||
130333911|NCT02255435|469193027|FG003|Overall Study|Withdrawal by Subject|0|||
130333912|NCT02255435|469193028|FG004|Overall Study|Withdrawal by Subject|0|||
130333913|NCT02255435|469193029|FG005|Overall Study|Withdrawal by Subject|0|||
130333914|NCT02255435|469193030|FG006|Overall Study|Withdrawal by Subject|0|||
130333915|NCT02255435|469193031|FG007|Overall Study|Withdrawal by Subject|0|||
130333916|NCT02255435|469193032|FG008|Overall Study|Withdrawal by Subject|1|||
130333917|NCT02255435|469193033|FG009|Overall Study|Withdrawal by Subject|4|||
130333918|NCT02255435|469193024|FG000|Overall Study|Administrative reasons|0|||
130333919|NCT02255435|469193025|FG001|Overall Study|Administrative reasons|0|||
130333920|NCT02255435|469193026|FG002|Overall Study|Administrative reasons|0|||
129992152|NCT03164564|467934215|FG000|Overall Study|Death|3|||
129992153|NCT03164564|467934216|FG001|Overall Study|Death|0|||
130333921|NCT02255435|469193027|FG003|Overall Study|Administrative reasons|0|||
130333922|NCT02255435|469193028|FG004|Overall Study|Administrative reasons|0|||
130333923|NCT02255435|469193029|FG005|Overall Study|Administrative reasons|0|||
130333924|NCT02255435|469193030|FG006|Overall Study|Administrative reasons|0|||
130333925|NCT02255435|469193031|FG007|Overall Study|Administrative reasons|0|||
130333926|NCT02255435|469193032|FG008|Overall Study|Administrative reasons|0|||
130333927|NCT02255435|469193033|FG009|Overall Study|Administrative reasons|2|||
130333928|NCT03656562|469193034|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
130333929|NCT03656562|469193035|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
130333930|NCT03656562|469193036|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
130333931|NCT03656562|469193037|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
130333932|NCT03656562|469193034|FG000|Overall Study|Physician Decision|1|||
130333933|NCT03656562|469193035|FG001|Overall Study|Physician Decision|2|||
130333934|NCT03656562|469193036|FG002|Overall Study|Physician Decision|0|||
130333935|NCT03656562|469193037|FG003|Overall Study|Physician Decision|0|||
130333936|NCT03656562|469193034|FG000|Overall Study|Subject Decision|3|||
130333937|NCT03656562|469193035|FG001|Overall Study|Subject Decision|5|||
130333938|NCT03656562|469193036|FG002|Overall Study|Subject Decision|0|||
130333939|NCT03656562|469193037|FG003|Overall Study|Subject Decision|2|||
130333940|NCT04269265|469193038|FG000|Overall Study|Physician Decision|1|||
130333941|NCT04269265|469193038|FG000|Overall Study|Withdrawal by Subject|1|||
130333942|NCT04269265|469193038|FG000|Overall Study|Overenrolled (sample size reached)|4|||
130333943|NCT04838626|469193039|FG000|Overall Study|Adverse Event|2|||
130333944|NCT04838626|469193039|FG000|Overall Study|Physician Decision|6|||
130333945|NCT04838626|469193039|FG000|Overall Study|Protocol Violation|3|||
130333946|NCT04838626|469193039|FG000|Overall Study|Withdrawal by Subject|9|||
130333947|NCT04838626|469193039|FG000|Overall Study|Technical Problems|2|||
130333948|NCT02867384|469193040|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
130333949|NCT02867384|469193041|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
130333950|NCT02867384|469193042|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
130333951|NCT02867384|469193040|FG000|Overall Study|Progression/ Relapse|15|||
130333952|NCT02867384|469193041|FG001|Overall Study|Progression/ Relapse|19|||
130333953|NCT02867384|469193042|FG002|Overall Study|Progression/ Relapse|0|||
130333954|NCT02867384|469193040|FG000|Overall Study|Adverse Event|13|||
130333955|NCT02867384|469193041|FG001|Overall Study|Adverse Event|1|||
130333956|NCT02867384|469193042|FG002|Overall Study|Adverse Event|0|||
130333957|NCT02867384|469193040|FG000|Overall Study|Withdrawal by Subject|6|||
130333958|NCT02867384|469193041|FG001|Overall Study|Withdrawal by Subject|5|||
130333959|NCT02867384|469193042|FG002|Overall Study|Withdrawal by Subject|0|||
130333960|NCT02867384|469193040|FG000|Overall Study|Physician Decision|1|||
130333961|NCT02867384|469193041|FG001|Overall Study|Physician Decision|2|||
130333962|NCT02867384|469193042|FG002|Overall Study|Physician Decision|0|||
130333963|NCT02867384|469193040|FG000|Overall Study|Patient compliance|1|||
130333964|NCT02867384|469193041|FG001|Overall Study|Patient compliance|0|||
130333965|NCT02867384|469193042|FG002|Overall Study|Patient compliance|0|||
130333966|NCT02867384|469193040|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
130333967|NCT02867384|469193041|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
130333968|NCT02867384|469193042|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
130333969|NCT02867384|469193040|FG000|Overall Study|Never start treatment|3|||
130333970|NCT02867384|469193041|FG001|Overall Study|Never start treatment|0|||
130333971|NCT02867384|469193042|FG002|Overall Study|Never start treatment|0|||
130333972|NCT03901469|469193046|FG000|Overall Study|Radiographic Progression|4|||
130333973|NCT03901469|469193047|FG001|Overall Study|Radiographic Progression|6|||
130333974|NCT03901469|469193048|FG002|Overall Study|Radiographic Progression|3|||
130333975|NCT03901469|469193049|FG003|Overall Study|Radiographic Progression|30|||
130333976|NCT03901469|469193050|FG004|Overall Study|Radiographic Progression|7|||
130333977|NCT03901469|469193051|FG005|Overall Study|Radiographic Progression|2|||
130333978|NCT03901469|469193052|FG006|Overall Study|Radiographic Progression|11|||
130333979|NCT03901469|469193046|FG000|Overall Study|Clinical Progression|0|||
130333980|NCT03901469|469193047|FG001|Overall Study|Clinical Progression|2|||
130333981|NCT03901469|469193048|FG002|Overall Study|Clinical Progression|0|||
130333982|NCT03901469|469193049|FG003|Overall Study|Clinical Progression|7|||
130333983|NCT03901469|469193050|FG004|Overall Study|Clinical Progression|6|||
130333984|NCT03901469|469193051|FG005|Overall Study|Clinical Progression|0|||
130333985|NCT03901469|469193052|FG006|Overall Study|Clinical Progression|2|||
130333986|NCT03901469|469193046|FG000|Overall Study|Adverse Event|1|||
130333987|NCT03901469|469193047|FG001|Overall Study|Adverse Event|0|||
130333988|NCT03901469|469193048|FG002|Overall Study|Adverse Event|0|||
130333989|NCT03901469|469193049|FG003|Overall Study|Adverse Event|0|||
130333990|NCT03901469|469193050|FG004|Overall Study|Adverse Event|0|||
130333991|NCT03901469|469193051|FG005|Overall Study|Adverse Event|0|||
130333992|NCT03901469|469193052|FG006|Overall Study|Adverse Event|9|||
130333993|NCT03901469|469193046|FG000|Overall Study|Physician Decision|0|||
130333994|NCT03901469|469193047|FG001|Overall Study|Physician Decision|0|||
130333995|NCT03901469|469193048|FG002|Overall Study|Physician Decision|0|||
130333996|NCT03901469|469193049|FG003|Overall Study|Physician Decision|1|||
130333997|NCT03901469|469193050|FG004|Overall Study|Physician Decision|0|||
130333998|NCT03901469|469193051|FG005|Overall Study|Physician Decision|0|||
130333999|NCT03901469|469193052|FG006|Overall Study|Physician Decision|0|||
130334000|NCT03901469|469193046|FG000|Overall Study|Withdrawal by Subject|0|||
130334001|NCT03901469|469193047|FG001|Overall Study|Withdrawal by Subject|0|||
130334002|NCT03901469|469193048|FG002|Overall Study|Withdrawal by Subject|0|||
130334003|NCT03901469|469193049|FG003|Overall Study|Withdrawal by Subject|0|||
130334004|NCT03901469|469193050|FG004|Overall Study|Withdrawal by Subject|2|||
130334005|NCT03901469|469193051|FG005|Overall Study|Withdrawal by Subject|0|||
130334006|NCT03901469|469193052|FG006|Overall Study|Withdrawal by Subject|8|||
130334007|NCT03901469|469193046|FG000|Overall Study|Death|0|||
130334008|NCT03901469|469193047|FG001|Overall Study|Death|0|||
130334009|NCT03901469|469193048|FG002|Overall Study|Death|0|||
130334010|NCT03901469|469193049|FG003|Overall Study|Death|3|||
130334011|NCT03901469|469193050|FG004|Overall Study|Death|5|||
130334012|NCT03901469|469193051|FG005|Overall Study|Death|0|||
130334013|NCT03901469|469193052|FG006|Overall Study|Death|1|||
130334014|NCT03901469|469193046|FG000|Overall Study|Termination of study by sponsor|0|||
130334015|NCT03901469|469193047|FG001|Overall Study|Termination of study by sponsor|0|||
130334016|NCT03901469|469193048|FG002|Overall Study|Termination of study by sponsor|0|||
130334017|NCT03901469|469193049|FG003|Overall Study|Termination of study by sponsor|0|||
130334018|NCT03901469|469193050|FG004|Overall Study|Termination of study by sponsor|1|||
130334019|NCT03901469|469193051|FG005|Overall Study|Termination of study by sponsor|1|||
130334020|NCT03901469|469193052|FG006|Overall Study|Termination of study by sponsor|0|||
130334021|NCT03901469|469193046|FG000|Overall Study|Not Reported|1|||
130334022|NCT03901469|469193047|FG001|Overall Study|Not Reported|0|||
130334023|NCT03901469|469193048|FG002|Overall Study|Not Reported|0|||
129992154|NCT03164564|467934215|FG000|Overall Study|Withdrawal by Subject|20|||
129992155|NCT03164564|467934216|FG001|Overall Study|Withdrawal by Subject|15|||
129992156|NCT03164564|467934215|FG000|Overall Study|Lost to Follow-up|2|||
129992157|NCT03164564|467934216|FG001|Overall Study|Lost to Follow-up|0|||
129992158|NCT03164564|467934215|FG000|Overall Study|Physician Decision|0|||
129992159|NCT03164564|467934216|FG001|Overall Study|Physician Decision|1|||
130334024|NCT03901469|469193049|FG003|Overall Study|Not Reported|1|||
130334025|NCT03901469|469193050|FG004|Overall Study|Not Reported|0|||
130334026|NCT03901469|469193051|FG005|Overall Study|Not Reported|0|||
130334027|NCT03901469|469193052|FG006|Overall Study|Not Reported|1|||
129992160|NCT03164564|467934215|FG000|Overall Study|Adverse Event|0|||
129992161|NCT03164564|467934216|FG001|Overall Study|Adverse Event|1|||
129992162|NCT03164564|467934215|FG000|Overall Study|Ongoing|1586|||
130334028|NCT03738228|469193056|FG000|Overall Study|Never received study treatment|2|||
130334029|NCT03738228|469193057|FG001|Overall Study|Never received study treatment|2|||
130334030|NCT04896073|469193058|FG000|Overall Study|Screen failure|0|||
129992163|NCT03164564|467934216|FG001|Overall Study|Ongoing|1586|||
129992164|NCT03464097|467934217|FG000|Overall Study|Withdrawal by Subject|15|||
129992165|NCT03464097|467934218|FG001|Overall Study|Withdrawal by Subject|13|||
129992166|NCT03464097|467934219|FG002|Overall Study|Withdrawal by Subject|11|||
129992167|NCT03464097|467934217|FG000|Overall Study|Study terminated by sponsor|47|||
129992168|NCT03464097|467934218|FG001|Overall Study|Study terminated by sponsor|44|||
129992169|NCT03464097|467934219|FG002|Overall Study|Study terminated by sponsor|40|||
129992170|NCT03464097|467934217|FG000|Overall Study|Pregnancy|0|||
130334031|NCT04896073|469193059|FG001|Overall Study|Screen failure|2|||
130334032|NCT04896073|469193058|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130334033|NCT04896073|469193059|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
130334034|NCT01385176|469193060|FG000|Randomization Phase|Death|1|||
130334035|NCT01385176|469193061|FG001|Randomization Phase|Death|2|||
130334036|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Death|1|||
130334037|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Death|2|||
130334038|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Physician Decision|0|||
130334039|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Physician Decision|1|||
130334040|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
130334041|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
130334042|NCT01385176|469193060|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
130334043|NCT01385176|469193061|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
130334044|NCT02306161|469193062|FG000|Overall Study|Death|1|||
130334045|NCT02306161|469193063|FG001|Overall Study|Death|3|||
130334046|NCT02306161|469193062|FG000|Overall Study|Lack of Efficacy|20|||
130334047|NCT02306161|469193063|FG001|Overall Study|Lack of Efficacy|43|||
130334048|NCT02306161|469193062|FG000|Overall Study|Physician Decision|30|||
130334049|NCT02306161|469193063|FG001|Overall Study|Physician Decision|18|||
130334050|NCT02306161|469193062|FG000|Overall Study|Withdrawal by Subject|4|||
130334051|NCT02306161|469193063|FG001|Overall Study|Withdrawal by Subject|0|||
130334052|NCT02306161|469193062|FG000|Overall Study|Ineligible|9|||
129992171|NCT03464097|467934218|FG001|Overall Study|Pregnancy|1|||
130334053|NCT02306161|469193063|FG001|Overall Study|Ineligible|5|||
130334054|NCT04995419|469193064|FG000|Overall Study|Withdrawal by Subject|3|||
130334055|NCT04995419|469193064|FG000|Overall Study|Progressive Disease|19|||
130334056|NCT04995419|469193064|FG000|Overall Study|Adverse Event|2|||
130334057|NCT04995419|469193064|FG000|Overall Study|Ongoing|16|||
130334058|NCT03306173|469193065|FG000|Overall Study|Lost to Follow-up|16|||
130334059|NCT03306173|469193066|FG001|Overall Study|Lost to Follow-up|23|||
130334060|NCT03306173|469193065|FG000|Overall Study|Withdrawal by Subject|4|||
129992172|NCT03464097|467934219|FG002|Overall Study|Pregnancy|0|||
129992173|NCT03464097|467934217|FG000|Overall Study|Other reasons|5|||
130334061|NCT03306173|469193066|FG001|Overall Study|Withdrawal by Subject|3|||
130334062|NCT03306173|469193065|FG000|Overall Study|Discontinued|4|||
129992174|NCT03464097|467934218|FG001|Overall Study|Other reasons|12|||
129992175|NCT03464097|467934219|FG002|Overall Study|Other reasons|14|||
129992176|NCT03464097|467934217|FG000|Overall Study|Lost to Follow-up|0|||
129992177|NCT03464097|467934218|FG001|Overall Study|Lost to Follow-up|1|||
129992178|NCT03464097|467934219|FG002|Overall Study|Lost to Follow-up|1|||
129992179|NCT03464097|467934217|FG000|Overall Study|Lack of Efficacy|11|||
130334063|NCT03306173|469193066|FG001|Overall Study|Discontinued|4|||
130334064|NCT04758637|469193067|FG000|Overall Study|Lost to Follow-up|0|||
129992180|NCT03464097|467934218|FG001|Overall Study|Lack of Efficacy|18|||
129992181|NCT03464097|467934219|FG002|Overall Study|Lack of Efficacy|30|||
130334065|NCT04758637|469193068|FG001|Overall Study|Lost to Follow-up|1|||
130334066|NCT04758637|469193069|FG002|Overall Study|Lost to Follow-up|0|||
130334067|NCT04758637|469193070|FG003|Overall Study|Lost to Follow-up|0|||
130334068|NCT05064358|469193076|FG000|Overall Study|Death|23|||
130334069|NCT05064358|469193077|FG001|Overall Study|Death|23|||
130334070|NCT05064358|469193078|FG002|Overall Study|Death|25|||
130334071|NCT05064358|469193079|FG003|Overall Study|Death|21|||
130334072|NCT05064358|469193080|FG004|Overall Study|Death|5|||
130334073|NCT05064358|469193076|FG000|Overall Study|Lost to Follow-up|1|||
130334074|NCT05064358|469193077|FG001|Overall Study|Lost to Follow-up|2|||
130334075|NCT05064358|469193078|FG002|Overall Study|Lost to Follow-up|0|||
130334076|NCT05064358|469193079|FG003|Overall Study|Lost to Follow-up|2|||
130334077|NCT05064358|469193080|FG004|Overall Study|Lost to Follow-up|0|||
130334078|NCT05064358|469193076|FG000|Overall Study|Physician Decision|1|||
130334079|NCT05064358|469193077|FG001|Overall Study|Physician Decision|1|||
130334080|NCT05064358|469193078|FG002|Overall Study|Physician Decision|2|||
130334081|NCT05064358|469193079|FG003|Overall Study|Physician Decision|0|||
130334082|NCT05064358|469193080|FG004|Overall Study|Physician Decision|0|||
130334083|NCT05064358|469193076|FG000|Overall Study|Withdrawal by Subject|4|||
130334084|NCT05064358|469193077|FG001|Overall Study|Withdrawal by Subject|5|||
130334085|NCT05064358|469193078|FG002|Overall Study|Withdrawal by Subject|3|||
130334086|NCT05064358|469193079|FG003|Overall Study|Withdrawal by Subject|6|||
130334087|NCT05064358|469193080|FG004|Overall Study|Withdrawal by Subject|3|||
130334088|NCT05064358|469193076|FG000|Overall Study|Ongoing at the time of analysis|1|||
130334089|NCT05064358|469193077|FG001|Overall Study|Ongoing at the time of analysis|2|||
130334090|NCT05064358|469193078|FG002|Overall Study|Ongoing at the time of analysis|2|||
130334091|NCT05064358|469193079|FG003|Overall Study|Ongoing at the time of analysis|2|||
130334092|NCT05064358|469193080|FG004|Overall Study|Ongoing at the time of analysis|2|||
130334093|NCT04976192|469193081|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334094|NCT04976192|469193082|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
130334095|NCT04976192|469193083|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334096|NCT04976192|469193084|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334097|NCT04976192|469193085|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334098|NCT04976192|469193086|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334099|NCT04976192|469193087|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334100|NCT04976192|469193088|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334101|NCT04976192|469193089|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334102|NCT04976192|469193090|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
130334103|NCT04976192|469193081|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
130334104|NCT04976192|469193082|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130334105|NCT04976192|469193083|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
130334106|NCT04976192|469193084|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130334107|NCT04976192|469193085|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334108|NCT04976192|469193086|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334109|NCT04976192|469193087|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334110|NCT04976192|469193088|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334111|NCT04976192|469193089|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334112|NCT04976192|469193090|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334113|NCT04976192|469193081|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
130334114|NCT04976192|469193082|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334115|NCT04976192|469193083|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
130334116|NCT04976192|469193084|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334117|NCT04976192|469193085|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334118|NCT04976192|469193086|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334119|NCT04976192|469193087|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334120|NCT04976192|469193088|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129992182|NCT03464097|467934217|FG000|Overall Study|Death|1|||
129992183|NCT03464097|467934218|FG001|Overall Study|Death|0|||
130334121|NCT04976192|469193089|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334122|NCT04976192|469193090|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
130334123|NCT04976192|469193081|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334124|NCT04976192|469193082|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334125|NCT04976192|469193083|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334126|NCT04976192|469193084|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130334127|NCT04976192|469193085|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
130334128|NCT04976192|469193086|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130334129|NCT04976192|469193087|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130334130|NCT04976192|469193088|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130334131|NCT04976192|469193089|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
130334132|NCT04976192|469193090|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130334133|NCT04976192|469193081|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334134|NCT04976192|469193082|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334135|NCT04976192|469193083|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334136|NCT04976192|469193084|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334137|NCT04976192|469193085|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
130334138|NCT04976192|469193086|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129992184|NCT03464097|467934219|FG002|Overall Study|Death|0|||
130334139|NCT04976192|469193087|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334140|NCT04976192|469193088|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129992185|NCT03464097|467934217|FG000|Overall Study|Adverse Event|13|||
130334141|NCT04976192|469193089|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334142|NCT04976192|469193090|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
130334143|NCT04976192|469193081|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334144|NCT04976192|469193082|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334145|NCT04976192|469193083|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334146|NCT04976192|469193084|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334147|NCT04976192|469193085|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334148|NCT04976192|469193086|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130334149|NCT04976192|469193087|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334150|NCT04976192|469193088|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334151|NCT04976192|469193089|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130334152|NCT04976192|469193090|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129992186|NCT03464097|467934218|FG001|Overall Study|Adverse Event|6|||
129992187|NCT03464097|467934219|FG002|Overall Study|Adverse Event|8|||
130334153|NCT02621151|469193091|FG000|Overall Study|Not eligible for trial|6|||
130334154|NCT04073225|469193092|FG000|Overall Study|Lost to Follow-up|4|||
130334155|NCT04073225|469193093|FG001|Overall Study|Lost to Follow-up|3|||
130334156|NCT02253316|469193103|FG000|Consolidation|Progression|4|||
130334157|NCT02253316|469193104|FG001|Consolidation|Progression|0|||
130334158|NCT02253316|469193105|FG002|Consolidation|Progression|0|||
130334159|NCT02253316|469193103|FG000|Consolidation|Non-Compliance|1|||
130334160|NCT02253316|469193104|FG001|Consolidation|Non-Compliance|0|||
130334161|NCT02253316|469193105|FG002|Consolidation|Non-Compliance|0|||
130334162|NCT02253316|469193103|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
130334163|NCT02253316|469193104|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
130334164|NCT02253316|469193105|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
130334165|NCT02253316|469193103|FG000|Consolidation|Secondary Malignancy|2|||
130334166|NCT02253316|469193104|FG001|Consolidation|Secondary Malignancy|0|||
130334167|NCT02253316|469193105|FG002|Consolidation|Secondary Malignancy|0|||
130334168|NCT02253316|469193103|FG000|Consolidation|Adverse Event|7|||
130334169|NCT02253316|469193104|FG001|Consolidation|Adverse Event|0|||
130334170|NCT02253316|469193105|FG002|Consolidation|Adverse Event|0|||
130334171|NCT02253316|469193103|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
130334172|NCT02253316|469193104|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
130334173|NCT02253316|469193105|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
130334174|NCT02253316|469193103|FG000|Maintenance|Physician Decision|0|||
130334175|NCT02253316|469193104|FG001|Maintenance|Physician Decision|7|||
130334176|NCT02253316|469193105|FG002|Maintenance|Physician Decision|16|||
129992210|NCT05445843|467934230|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
129992211|NCT05445843|467934231|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
129992212|NCT05445843|467934230|FG000|Overall Study|Progressive disease|17|||
129992213|NCT05445843|467934231|FG001|Overall Study|Progressive disease|9|||
129992214|NCT05445843|467934230|FG000|Overall Study|Physician Decision|16|||
129992215|NCT05445843|467934231|FG001|Overall Study|Physician Decision|4|||
129992216|NCT05445843|467934230|FG000|Overall Study|Death|6|||
129992217|NCT05445843|467934231|FG001|Overall Study|Death|3|||
129992218|NCT05445843|467934230|FG000|Overall Study|Subject decision|6|||
129992219|NCT05445843|467934231|FG001|Overall Study|Subject decision|2|||
129992220|NCT05445843|467934230|FG000|Overall Study|Adverse Event|2|||
129992221|NCT05445843|467934231|FG001|Overall Study|Adverse Event|0|||
129992222|NCT04469270|467934232|FG000|Overall Study|Adverse Event|2|||
129992223|NCT04469270|467934233|FG001|Overall Study|Adverse Event|0|||
130334177|NCT02253316|469193103|FG000|Maintenance|Non-Compliance|0|||
130334178|NCT02253316|469193104|FG001|Maintenance|Non-Compliance|1|||
129992224|NCT04469270|467934232|FG000|Overall Study|Lost to Follow-up|4|||
129992225|NCT04469270|467934233|FG001|Overall Study|Lost to Follow-up|3|||
129992226|NCT04469270|467934232|FG000|Overall Study|Withdrawal by Subject|7|||
129992227|NCT04469270|467934233|FG001|Overall Study|Withdrawal by Subject|3|||
129992228|NCT04469270|467934232|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
129992229|NCT04469270|467934233|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
129992230|NCT04469270|467934232|FG000|Overall Study|missing|1|||
129992231|NCT04469270|467934233|FG001|Overall Study|missing|0|||
129992244|NCT04576455|467934239|FG000|Overall Study|Ongoing in the Study|48|||
129992245|NCT04576455|467934240|FG001|Overall Study|Ongoing in the Study|58|||
129992246|NCT04576455|467934239|FG000|Overall Study|Death|83|||
129992247|NCT04576455|467934240|FG001|Overall Study|Death|77|||
129992248|NCT04576455|467934239|FG000|Overall Study|Lost to Follow-up|4|||
129992249|NCT04576455|467934240|FG001|Overall Study|Lost to Follow-up|5|||
129992250|NCT04576455|467934239|FG000|Overall Study|Withdrawal by Subject|16|||
129992251|NCT04576455|467934240|FG001|Overall Study|Withdrawal by Subject|12|||
129992252|NCT02186847|467934241|FG000|Overall Study|Protocol Violation|3|||
129992253|NCT02186847|467934242|FG001|Overall Study|Protocol Violation|0|||
130334179|NCT02253316|469193105|FG002|Maintenance|Non-Compliance|1|||
130334180|NCT02253316|469193103|FG000|Maintenance|Secondary Malignancy|0|||
130334181|NCT02253316|469193104|FG001|Maintenance|Secondary Malignancy|2|||
130334182|NCT02253316|469193105|FG002|Maintenance|Secondary Malignancy|6|||
130334183|NCT02253316|469193103|FG000|Maintenance|Adverse Event|0|||
129992262|NCT02254278|467934245|FG000|Overall Study|Protocol Violation|1|||
129992263|NCT02254278|467934246|FG001|Overall Study|Protocol Violation|1|||
129992264|NCT05774197|467934247|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
130334184|NCT02253316|469193104|FG001|Maintenance|Adverse Event|8|||
130334185|NCT02253316|469193105|FG002|Maintenance|Adverse Event|12|||
130334186|NCT02253316|469193103|FG000|Maintenance|Still receiving active treatment|0|||
130334187|NCT02253316|469193104|FG001|Maintenance|Still receiving active treatment|4|||
130334188|NCT02253316|469193105|FG002|Maintenance|Still receiving active treatment|0|||
130334189|NCT00124306|469193109|FG000|Overall Study|Adverse Event|7|||
130334190|NCT00124306|469193110|FG001|Overall Study|Adverse Event|2|||
130334191|NCT00124306|469193109|FG000|Overall Study|Lost to Follow-up|10|||
130334192|NCT00124306|469193110|FG001|Overall Study|Lost to Follow-up|6|||
130334193|NCT00124306|469193109|FG000|Overall Study|Lack of Efficacy|3|||
130334194|NCT00124306|469193110|FG001|Overall Study|Lack of Efficacy|6|||
130334195|NCT00124306|469193109|FG000|Overall Study|Personal constraints|0|||
130334196|NCT00124306|469193110|FG001|Overall Study|Personal constraints|2|||
130334197|NCT00124306|469193109|FG000|Overall Study|Use of unacceptable medication|1|||
130334198|NCT00124306|469193110|FG001|Overall Study|Use of unacceptable medication|0|||
129992277|NCT04647253|467934254|FG000|Overall Study|Death ≤ 365 Days|16|||
129992278|NCT04647253|467934255|FG001|Overall Study|Death ≤ 365 Days|7|||
129992279|NCT04647253|467934254|FG000|Overall Study|Physician Decision|0|||
129992280|NCT04647253|467934255|FG001|Overall Study|Physician Decision|1|||
129992281|NCT04647253|467934254|FG000|Overall Study|Withdrawal by Subject|7|||
129992282|NCT04647253|467934255|FG001|Overall Study|Withdrawal by Subject|2|||
129992283|NCT04647253|467934254|FG000|Overall Study|Missed 12-Month Visit|9|||
129992284|NCT04647253|467934255|FG001|Overall Study|Missed 12-Month Visit|7|||
129992285|NCT04647253|467934254|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
129992286|NCT04647253|467934255|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
129992287|NCT06729606|467934260|FG000|Overall Study|Adverse Event|0|||
129992288|NCT06729606|467934261|FG001|Overall Study|Adverse Event|2|||
129992289|NCT06729606|467934260|FG000|Overall Study|Death|1|||
129992290|NCT06729606|467934261|FG001|Overall Study|Death|0|||
129992291|NCT06729606|467934260|FG000|Overall Study|Physician Decision|0|||
129992292|NCT06729606|467934261|FG001|Overall Study|Physician Decision|1|||
129992293|NCT06729606|467934260|FG000|Overall Study|Withdrawal by Subject|2|||
129992294|NCT06729606|467934261|FG001|Overall Study|Withdrawal by Subject|4|||
129992301|NCT04873232|467934264|FG000|Overall Study|Lost to Follow-up|1|||
129992302|NCT04873232|467934265|FG001|Overall Study|Lost to Follow-up|4|||
129992303|NCT04873232|467934264|FG000|Overall Study|Withdrawal by Subject|1|||
129992304|NCT04873232|467934265|FG001|Overall Study|Withdrawal by Subject|0|||
129992305|NCT05437510|467934266|FG000|Overall Study|Adverse Event|2|||
129992306|NCT05437510|467934267|FG001|Overall Study|Adverse Event|1|||
129992307|NCT05437510|467934266|FG000|Overall Study|Protocol Deviation|1|||
129992308|NCT05437510|467934267|FG001|Overall Study|Protocol Deviation|6|||
129992309|NCT05437510|467934266|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
129992310|NCT05437510|467934267|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
129992311|NCT05437510|467934266|FG000|Overall Study|Lost to Follow-up|265|||
129992312|NCT05437510|467934267|FG001|Overall Study|Lost to Follow-up|358|||
129992313|NCT05959629|467934709|FG000|Overall Study|partially necrotic/technical issues|2|||
129992314|NCT05959629|467934710|FG001|Overall Study|partially necrotic/technical issues|2|||
129992315|NCT03573401|467934711|FG000|Overall Study|Withdrawal by Subject|2|||
129992316|NCT03573401|467934712|FG001|Overall Study|Withdrawal by Subject|0|||
129992317|NCT03573401|467934711|FG000|Overall Study|Subject non-compliance with study schedule|1|||
129992318|NCT03573401|467934712|FG001|Overall Study|Subject non-compliance with study schedule|0|||
129992319|NCT03573401|467934711|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
129992320|NCT03573401|467934712|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
129992321|NCT03573401|467934711|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
129992322|NCT03573401|467934712|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
130334199|NCT00124306|469193109|FG000|Overall Study|Abnormal lab result|0|||
130334200|NCT00124306|469193110|FG001|Overall Study|Abnormal lab result|1|||
130334201|NCT00124306|469193109|FG000|Overall Study|Other|2|||
130052061|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
130052062|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Other|0|||
130052063|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Other|0|||
130052064|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Other|0|||
130052065|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Other|0|||
130052066|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Other|3|||
130052067|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Other|3|||
130052068|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
130052069|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
130334202|NCT00124306|469193110|FG001|Overall Study|Other|0|||
130334203|NCT02112916|469193111|FG000|Overall Study|Adverse Event|6|||
130334204|NCT02112916|469193112|FG001|Overall Study|Adverse Event|9|||
130334205|NCT02112916|469193113|FG002|Overall Study|Adverse Event|3|||
130334206|NCT02112916|469193114|FG003|Overall Study|Adverse Event|2|||
130334207|NCT02112916|469193111|FG000|Overall Study|Death|9|||
130334208|NCT02112916|469193112|FG001|Overall Study|Death|9|||
130334209|NCT02112916|469193113|FG002|Overall Study|Death|3|||
130334210|NCT02112916|469193114|FG003|Overall Study|Death|4|||
130334211|NCT02112916|469193111|FG000|Overall Study|Lost to Follow-up|1|||
130334212|NCT02112916|469193112|FG001|Overall Study|Lost to Follow-up|0|||
130334213|NCT02112916|469193113|FG002|Overall Study|Lost to Follow-up|0|||
130334214|NCT02112916|469193114|FG003|Overall Study|Lost to Follow-up|0|||
130334215|NCT02112916|469193111|FG000|Overall Study|Physician Decision|94|||
130334216|NCT02112916|469193112|FG001|Overall Study|Physician Decision|72|||
130334217|NCT02112916|469193113|FG002|Overall Study|Physician Decision|24|||
130334218|NCT02112916|469193114|FG003|Overall Study|Physician Decision|15|||
130334219|NCT02112916|469193111|FG000|Overall Study|Withdrawal by Subject|5|||
130334220|NCT02112916|469193112|FG001|Overall Study|Withdrawal by Subject|3|||
130334221|NCT02112916|469193113|FG002|Overall Study|Withdrawal by Subject|1|||
130334222|NCT02112916|469193114|FG003|Overall Study|Withdrawal by Subject|1|||
130334223|NCT02112916|469193111|FG000|Overall Study|Ineligible|4|||
130334224|NCT02112916|469193112|FG001|Overall Study|Ineligible|8|||
130334225|NCT02112916|469193113|FG002|Overall Study|Ineligible|3|||
130334226|NCT02112916|469193114|FG003|Overall Study|Ineligible|8|||
130334227|NCT02112916|469193111|FG000|Overall Study|Inevaluable|6|||
130334228|NCT02112916|469193112|FG001|Overall Study|Inevaluable|4|||
130334229|NCT02112916|469193113|FG002|Overall Study|Inevaluable|5|||
130334230|NCT02112916|469193114|FG003|Overall Study|Inevaluable|5|||
130334231|NCT02112916|469193111|FG000|Overall Study|Refusal of further protocol therapy|19|||
130334232|NCT02112916|469193112|FG001|Overall Study|Refusal of further protocol therapy|16|||
130334233|NCT02112916|469193113|FG002|Overall Study|Refusal of further protocol therapy|1|||
130334234|NCT02112916|469193114|FG003|Overall Study|Refusal of further protocol therapy|7|||
130334235|NCT02112916|469193111|FG000|Overall Study|Development of SMN|1|||
130334236|NCT02112916|469193112|FG001|Overall Study|Development of SMN|0|||
130334237|NCT02112916|469193113|FG002|Overall Study|Development of SMN|0|||
130052070|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
130052071|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
130052072|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
130334238|NCT02112916|469193114|FG003|Overall Study|Development of SMN|1|||
130334239|NCT02112916|469193111|FG000|Overall Study|Relapse/Progression|10|||
130334240|NCT02112916|469193112|FG001|Overall Study|Relapse/Progression|18|||
130334241|NCT02112916|469193113|FG002|Overall Study|Relapse/Progression|15|||
130334242|NCT02112916|469193114|FG003|Overall Study|Relapse/Progression|2|||
130334243|NCT02112916|469193111|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
130334244|NCT02112916|469193112|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
129992351|NCT03938545|467936153|FG000|Overall Study|Lost to Follow-up|0|||
129992352|NCT03938545|467936154|FG001|Overall Study|Lost to Follow-up|0|||
129992353|NCT03938545|467936155|FG002|Overall Study|Lost to Follow-up|0|||
129992354|NCT03938545|467936156|FG003|Overall Study|Lost to Follow-up|1|||
129992355|NCT03938545|467936153|FG000|Overall Study|Non-compliance with study drug|0|||
129992356|NCT03938545|467936154|FG001|Overall Study|Non-compliance with study drug|0|||
129992357|NCT03938545|467936155|FG002|Overall Study|Non-compliance with study drug|1|||
129992358|NCT03938545|467936156|FG003|Overall Study|Non-compliance with study drug|0|||
129992359|NCT03938545|467936153|FG000|Overall Study|Pregnancy|1|||
129992360|NCT03938545|467936154|FG001|Overall Study|Pregnancy|0|||
129992361|NCT03938545|467936155|FG002|Overall Study|Pregnancy|0|||
129992362|NCT03938545|467936156|FG003|Overall Study|Pregnancy|0|||
129992363|NCT03938545|467936153|FG000|Overall Study|Study terminated by sponsor|6|||
129992364|NCT03938545|467936154|FG001|Overall Study|Study terminated by sponsor|4|||
129992365|NCT03938545|467936155|FG002|Overall Study|Study terminated by sponsor|2|||
129992366|NCT03938545|467936156|FG003|Overall Study|Study terminated by sponsor|4|||
129992367|NCT03938545|467936153|FG000|Overall Study|Withdrawal by Subject|0|||
129992368|NCT03938545|467936154|FG001|Overall Study|Withdrawal by Subject|1|||
129992369|NCT03938545|467936155|FG002|Overall Study|Withdrawal by Subject|0|||
129992370|NCT03938545|467936156|FG003|Overall Study|Withdrawal by Subject|0|||
129992371|NCT03938545|467936153|FG000|Overall Study|Adverse Event|1|||
129992372|NCT03938545|467936154|FG001|Overall Study|Adverse Event|0|||
129992373|NCT03938545|467936155|FG002|Overall Study|Adverse Event|0|||
129992374|NCT03938545|467936156|FG003|Overall Study|Adverse Event|0|||
129992375|NCT01060540|467936157|FG000|Overall Study|Withdrawal by Subject|10|||
129992376|NCT01060540|467936158|FG001|Overall Study|Withdrawal by Subject|20|||
129992377|NCT01060540|467936157|FG000|Overall Study|Lost to Follow-up|52|||
129992378|NCT01060540|467936158|FG001|Overall Study|Lost to Follow-up|43|||
129992379|NCT01060540|467936157|FG000|Overall Study|Death|2|||
129992380|NCT01060540|467936158|FG001|Overall Study|Death|1|||
129992381|NCT01060540|467936157|FG000|Overall Study|Physician Decision|0|||
129992382|NCT01060540|467936158|FG001|Overall Study|Physician Decision|1|||
129992383|NCT01222507|467936159|FG000|Overall Study|Physician Decision|1|||
129992384|NCT01222507|467936159|FG000|Overall Study|Withdrawal by Subject|1|||
129992385|NCT02647320|467936160|FG000|Overall Study|Adverse Event|0|||
129992386|NCT02647320|467936161|FG001|Overall Study|Adverse Event|1|||
129992387|NCT02647320|467936162|FG002|Overall Study|Adverse Event|3|||
129992388|NCT02647320|467936163|FG003|Overall Study|Adverse Event|2|||
129992389|NCT02647320|467936164|FG004|Overall Study|Adverse Event|1|||
129992390|NCT02647320|467936160|FG000|Overall Study|Protocol Violation|0|||
129992391|NCT02647320|467936161|FG001|Overall Study|Protocol Violation|0|||
129992392|NCT02647320|467936162|FG002|Overall Study|Protocol Violation|3|||
129992393|NCT02647320|467936163|FG003|Overall Study|Protocol Violation|0|||
129992394|NCT02647320|467936164|FG004|Overall Study|Protocol Violation|0|||
129992395|NCT02647320|467936160|FG000|Overall Study|Withdrawal by Subject|7|||
129992396|NCT02647320|467936161|FG001|Overall Study|Withdrawal by Subject|4|||
129992397|NCT02647320|467936162|FG002|Overall Study|Withdrawal by Subject|2|||
129992398|NCT02647320|467936163|FG003|Overall Study|Withdrawal by Subject|2|||
129992399|NCT02647320|467936164|FG004|Overall Study|Withdrawal by Subject|7|||
129992400|NCT02647320|467936160|FG000|Overall Study|Persistent hyperglycemia|0|||
129992401|NCT02647320|467936161|FG001|Overall Study|Persistent hyperglycemia|1|||
129992402|NCT02647320|467936162|FG002|Overall Study|Persistent hyperglycemia|1|||
129992403|NCT02647320|467936163|FG003|Overall Study|Persistent hyperglycemia|1|||
129992404|NCT02647320|467936164|FG004|Overall Study|Persistent hyperglycemia|1|||
129992405|NCT02647320|467936160|FG000|Overall Study|Study terminated by sponsor|1|||
129992406|NCT02647320|467936161|FG001|Overall Study|Study terminated by sponsor|1|||
129992407|NCT02647320|467936162|FG002|Overall Study|Study terminated by sponsor|1|||
129992408|NCT02647320|467936163|FG003|Overall Study|Study terminated by sponsor|1|||
129992409|NCT02647320|467936164|FG004|Overall Study|Study terminated by sponsor|2|||
129992410|NCT02647320|467936160|FG000|Overall Study|Reason not provided|0|||
129992411|NCT02647320|467936161|FG001|Overall Study|Reason not provided|0|||
129992412|NCT02647320|467936162|FG002|Overall Study|Reason not provided|1|||
129992413|NCT02647320|467936163|FG003|Overall Study|Reason not provided|0|||
129992414|NCT02647320|467936164|FG004|Overall Study|Reason not provided|2|||
129992415|NCT02647320|467936160|FG000|Overall Study|Lost to Follow-up|1|||
129992416|NCT02647320|467936161|FG001|Overall Study|Lost to Follow-up|1|||
129992417|NCT02647320|467936162|FG002|Overall Study|Lost to Follow-up|0|||
129992418|NCT02647320|467936163|FG003|Overall Study|Lost to Follow-up|0|||
129992419|NCT02647320|467936164|FG004|Overall Study|Lost to Follow-up|0|||
129992420|NCT02647320|467936160|FG000|Overall Study|Develop anemia|1|||
129992421|NCT02647320|467936161|FG001|Overall Study|Develop anemia|0|||
129992422|NCT02647320|467936162|FG002|Overall Study|Develop anemia|0|||
129992423|NCT02647320|467936163|FG003|Overall Study|Develop anemia|0|||
129992424|NCT02647320|467936164|FG004|Overall Study|Develop anemia|0|||
129992425|NCT02647320|467936160|FG000|Overall Study|Lack of Efficacy|0|||
129992426|NCT02647320|467936161|FG001|Overall Study|Lack of Efficacy|0|||
129992427|NCT02647320|467936162|FG002|Overall Study|Lack of Efficacy|0|||
129992428|NCT02647320|467936163|FG003|Overall Study|Lack of Efficacy|1|||
129992429|NCT02647320|467936164|FG004|Overall Study|Lack of Efficacy|0|||
130334245|NCT02112916|469193113|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
130334246|NCT02112916|469193114|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
130334247|NCT02112916|469193111|FG000|Overall Study|Still on Therapy|44|||
130334248|NCT02112916|469193112|FG001|Overall Study|Still on Therapy|47|||
130334249|NCT02112916|469193113|FG002|Overall Study|Still on Therapy|3|||
130334250|NCT02112916|469193114|FG003|Overall Study|Still on Therapy|2|||
130334251|NCT02112916|469193111|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
130334252|NCT02112916|469193112|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
130334253|NCT02112916|469193113|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
130334254|NCT02112916|469193114|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
130334255|NCT02112916|469193111|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
130334256|NCT02112916|469193112|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
130334257|NCT02112916|469193113|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
130334258|NCT02112916|469193114|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
130334259|NCT04238819|469193115|FG000|Overall Study|Ongoing Treatment|0|||
130334260|NCT04238819|469193116|FG001|Overall Study|Ongoing Treatment|0|||
130334261|NCT04238819|469193117|FG002|Overall Study|Ongoing Treatment|0|||
130334262|NCT04238819|469193118|FG003|Overall Study|Ongoing Treatment|0|||
130334263|NCT04238819|469193119|FG004|Overall Study|Ongoing Treatment|1|||
130334264|NCT04238819|469193120|FG005|Overall Study|Ongoing Treatment|4|||
130334265|NCT04238819|469193121|FG006|Overall Study|Ongoing Treatment|0|||
130334266|NCT04238819|469193115|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
130334267|NCT04238819|469193116|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
130334268|NCT04238819|469193117|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
130334269|NCT04238819|469193118|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
130334270|NCT04238819|469193119|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
130334271|NCT04238819|469193120|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
130334272|NCT04238819|469193121|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
130334273|NCT03568461|469193122|FG000|Overall Study|Death|7|||
130334274|NCT03568461|469193122|FG000|Overall Study|Physician Decision|5|||
130334275|NCT03568461|469193122|FG000|Overall Study|Subject decision|5|||
130334276|NCT03568461|469193122|FG000|Overall Study|Lost to Follow-up|1|||
130334277|NCT05109234|469193123|FG000|Overall Study|Adverse Event|2|||
129992430|NCT02647320|467936160|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
129992431|NCT02647320|467936161|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
130334278|NCT05109234|469193124|FG001|Overall Study|Adverse Event|2|||
130334279|NCT05109234|469193123|FG000|Overall Study|Lack of Efficacy|5|||
130334280|NCT05109234|469193124|FG001|Overall Study|Lack of Efficacy|0|||
130334281|NCT05109234|469193123|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
130334282|NCT05109234|469193124|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
130334283|NCT05109234|469193123|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
130334284|NCT05109234|469193124|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
130334285|NCT05109234|469193123|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
130334286|NCT05109234|469193124|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
130334287|NCT05109234|469193123|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
130334288|NCT05109234|469193124|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
130334289|NCT02355184|469193125|FG000|Overall Study|Lost to Follow-up|2|||
130334290|NCT02355184|469193125|FG000|Overall Study|Study Terminated|10|||
130334291|NCT00539864|469193760|FG000|Overall Study|Lost to Follow-up|0|||
130334292|NCT00539864|469193761|FG001|Overall Study|Lost to Follow-up|1|||
130334293|NCT00539864|469193760|FG000|Overall Study|Withdrawal by Subject|1|||
130334294|NCT00539864|469193761|FG001|Overall Study|Withdrawal by Subject|1|||
130334295|NCT00943072|469193764|FG000|Overall Study|Adverse Event|0|||
130334296|NCT00943072|469193765|FG001|Overall Study|Adverse Event|3|||
130334297|NCT00943072|469193764|FG000|Overall Study|Death|0|||
130334298|NCT00943072|469193765|FG001|Overall Study|Death|2|||
130216095|NCT01826981|468753949|FG009|Overall Study|Adverse Event|0|||
130216096|NCT01826981|468753950|FG010|Overall Study|Adverse Event|0|||
130216097|NCT01826981|468753951|FG011|Overall Study|Adverse Event|0|||
130216098|NCT01826981|468753952|FG012|Overall Study|Adverse Event|0|||
130216099|NCT01826981|468753953|FG013|Overall Study|Adverse Event|0|||
130334299|NCT00943072|469193764|FG000|Overall Study|Withdrawal by Subject|3|||
130334300|NCT00943072|469193765|FG001|Overall Study|Withdrawal by Subject|1|||
130334301|NCT00943072|469193764|FG000|Overall Study|Protocol Violation|0|||
130216100|NCT01826981|468753954|FG014|Overall Study|Adverse Event|0|||
130216101|NCT01826981|468753940|FG000|Overall Study|Upper G-I Haemorrhage|0|||
130216102|NCT01826981|468753941|FG001|Overall Study|Upper G-I Haemorrhage|0|||
130334302|NCT00943072|469193765|FG001|Overall Study|Protocol Violation|1|||
130334303|NCT00943072|469193764|FG000|Overall Study|Lost to Follow-up|1|||
130334304|NCT00943072|469193765|FG001|Overall Study|Lost to Follow-up|2|||
130334305|NCT00943072|469193764|FG000|Overall Study|Lack of Efficacy|0|||
130334306|NCT00943072|469193765|FG001|Overall Study|Lack of Efficacy|4|||
130334307|NCT00943072|469193764|FG000|Overall Study|Other|1|||
130334308|NCT00943072|469193765|FG001|Overall Study|Other|1|||
130216103|NCT01826981|468753942|FG002|Overall Study|Upper G-I Haemorrhage|0|||
130216104|NCT01826981|468753943|FG003|Overall Study|Upper G-I Haemorrhage|0|||
130216105|NCT01826981|468753944|FG004|Overall Study|Upper G-I Haemorrhage|0|||
130216106|NCT01826981|468753945|FG005|Overall Study|Upper G-I Haemorrhage|0|||
130216107|NCT01826981|468753946|FG006|Overall Study|Upper G-I Haemorrhage|0|||
130216108|NCT01826981|468753947|FG007|Overall Study|Upper G-I Haemorrhage|0|||
130216109|NCT01826981|468753948|FG008|Overall Study|Upper G-I Haemorrhage|0|||
130216110|NCT01826981|468753949|FG009|Overall Study|Upper G-I Haemorrhage|0|||
130216111|NCT01826981|468753950|FG010|Overall Study|Upper G-I Haemorrhage|0|||
130216112|NCT01826981|468753951|FG011|Overall Study|Upper G-I Haemorrhage|0|||
130216113|NCT01826981|468753952|FG012|Overall Study|Upper G-I Haemorrhage|0|||
130216114|NCT01826981|468753953|FG013|Overall Study|Upper G-I Haemorrhage|1|||
130216115|NCT01826981|468753954|FG014|Overall Study|Upper G-I Haemorrhage|0|||
130216116|NCT01826981|468753940|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
129992432|NCT02647320|467936162|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
129992433|NCT02647320|467936163|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
129992434|NCT02647320|467936164|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
129992435|NCT00596427|467936168|FG000|Overall Study|Withdrawal by Subject|2|||
129992436|NCT00596427|467936169|FG001|Overall Study|Withdrawal by Subject|2|||
129992437|NCT00596427|467936168|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
129992438|NCT00596427|467936169|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
129992439|NCT00596427|467936168|FG000|Overall Study|Protocol Violation|1|||
129992440|NCT00596427|467936169|FG001|Overall Study|Protocol Violation|0|||
129992441|NCT00320541|467936170|FG000|Overall Study|Adverse Event|21|||
129992442|NCT00320541|467936171|FG001|Overall Study|Adverse Event|19|||
129992443|NCT00320541|467936170|FG000|Overall Study|Protocol Violation|0|||
129992444|NCT00320541|467936171|FG001|Overall Study|Protocol Violation|1|||
129992445|NCT00320541|467936170|FG000|Overall Study|Withdrawal by Subject|12|||
129992446|NCT00320541|467936171|FG001|Overall Study|Withdrawal by Subject|16|||
129992447|NCT00320541|467936170|FG000|Overall Study|Physician Decision|9|||
129992448|NCT00320541|467936171|FG001|Overall Study|Physician Decision|13|||
129992449|NCT00320541|467936170|FG000|Overall Study|Other|3|||
129992450|NCT00320541|467936171|FG001|Overall Study|Other|4|||
130098734|NCT03426995|468319299|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098735|NCT03426995|468319300|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098736|NCT03426995|468319301|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098737|NCT03426995|468319302|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098738|NCT03426995|468319303|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129992451|NCT00320541|467936170|FG000|Overall Study|Sponsor Decision|2|||
129992452|NCT00320541|467936171|FG001|Overall Study|Sponsor Decision|1|||
129992453|NCT00320541|467936170|FG000|Overall Study|Death due to Study Disease|1|||
129992454|NCT00320541|467936171|FG001|Overall Study|Death due to Study Disease|3|||
129992455|NCT00320541|467936170|FG000|Overall Study|Death due to Adverse Event(s)|1|||
129992456|NCT00320541|467936171|FG001|Overall Study|Death due to Adverse Event(s)|0|||
129992457|NCT00320541|467936170|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
129992458|NCT00320541|467936171|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
129992459|NCT03057977|467936174|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
129992460|NCT03057977|467936175|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
129992461|NCT03057977|467936174|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
129992462|NCT03057977|467936175|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
129992463|NCT03057977|467936174|FG000|Discontinuation From Treatment|Protocol Violation|6|||
129992464|NCT03057977|467936175|FG001|Discontinuation From Treatment|Protocol Violation|5|||
129992465|NCT03057977|467936174|FG000|Discontinuation From Treatment|Not treated|4|||
129992466|NCT03057977|467936175|FG001|Discontinuation From Treatment|Not treated|0|||
129992467|NCT03057977|467936174|FG000|Discontinuation From Treatment|Adverse Event|343|||
129992468|NCT03057977|467936175|FG001|Discontinuation From Treatment|Adverse Event|337|||
129992469|NCT03057977|467936174|FG000|Discontinuation From Treatment|Reason Unknown|0|||
129992470|NCT03057977|467936175|FG001|Discontinuation From Treatment|Reason Unknown|1|||
129992471|NCT03057977|467936174|FG000|Discontinuation From Treatment|Personal Reasons|1|||
129992472|NCT03057977|467936175|FG001|Discontinuation From Treatment|Personal Reasons|1|||
129992473|NCT03057977|467936174|FG000|Discontinuation From Treatment|Unblinded medication|1|||
129992474|NCT03057977|467936175|FG001|Discontinuation From Treatment|Unblinded medication|0|||
129992475|NCT03057977|467936174|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
129992476|NCT03057977|467936175|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
129992477|NCT03057977|467936174|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
129992478|NCT03057977|467936175|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
129992479|NCT03057977|467936174|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
129992480|NCT03057977|467936175|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
130098739|NCT03426995|468319304|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130216117|NCT01826981|468753941|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216118|NCT01826981|468753942|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
129992481|NCT03057977|467936174|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
129992482|NCT03057977|467936175|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
129992483|NCT03057977|467936174|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
129992484|NCT03057977|467936175|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
129992485|NCT03057977|467936174|FG000|Discontinuation From Treatment|Not attending study visit|3|||
129992486|NCT03057977|467936175|FG001|Discontinuation From Treatment|Not attending study visit|10|||
129992487|NCT03057977|467936174|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
129992488|NCT03057977|467936175|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
129992489|NCT03057977|467936174|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
129992490|NCT03057977|467936175|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
129992491|NCT03057977|467936174|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
129992492|NCT03057977|467936175|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
129992493|NCT03057977|467936174|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
129992494|NCT03057977|467936175|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
129992495|NCT03057977|467936174|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
129992496|NCT03057977|467936175|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
129992497|NCT02401867|467936176|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
129992498|NCT02401867|467936176|FG000|Analysis|Cervical assay could not be conducted|9|||
129992499|NCT01650246|467936177|FG000|Overall Study|Adverse Event|23|||
129992500|NCT01650246|467936177|FG000|Overall Study|Protocol Violation|5|||
129992501|NCT01650246|467936177|FG000|Overall Study|Sponsor terminated study|53|||
129992502|NCT01650246|467936177|FG000|Overall Study|Lost to Follow-up|5|||
129992503|NCT01650246|467936177|FG000|Overall Study|Withdrawal by Subject|26|||
129992504|NCT01650246|467936177|FG000|Overall Study|Death|1|||
129992505|NCT01650246|467936177|FG000|Overall Study|Lack of Efficacy|30|||
129992506|NCT00953407|467936178|FG000|Overall Study|Failed inclusion criteria|1|||
129992507|NCT00953407|467936179|FG001|Overall Study|Failed inclusion criteria|1|||
129992508|NCT00953407|467936180|FG002|Overall Study|Failed inclusion criteria|1|||
129992509|NCT00953407|467936181|FG003|Overall Study|Failed inclusion criteria|1|||
129992510|NCT00953407|467936182|FG004|Overall Study|Failed inclusion criteria|1|||
129992511|NCT00953407|467936178|FG000|Overall Study|Lost to Follow-up|0|||
129992512|NCT00953407|467936179|FG001|Overall Study|Lost to Follow-up|0|||
129992513|NCT00953407|467936180|FG002|Overall Study|Lost to Follow-up|0|||
129992514|NCT00953407|467936181|FG003|Overall Study|Lost to Follow-up|1|||
129992515|NCT00953407|467936182|FG004|Overall Study|Lost to Follow-up|0|||
129992516|NCT03435497|467936184|FG000|Overall Study|Lost to Follow-up|1|||
129992517|NCT03435497|467936185|FG001|Overall Study|Lost to Follow-up|0|||
129992518|NCT03435497|467936184|FG000|Overall Study|Death|1|||
129992519|NCT03435497|467936185|FG001|Overall Study|Death|0|||
129992520|NCT03435497|467936184|FG000|Overall Study|Withdrawal by Subject|0|||
129992521|NCT03435497|467936185|FG001|Overall Study|Withdrawal by Subject|4|||
129992522|NCT03435497|467936184|FG000|Overall Study|Wrong survey administered|0|||
129992523|NCT03435497|467936185|FG001|Overall Study|Wrong survey administered|2|||
129992524|NCT02795429|467936186|FG000|Overall Study|Adverse Event|1|||
129992525|NCT02795429|467936187|FG001|Overall Study|Adverse Event|2|||
129992526|NCT02795429|467936188|FG002|Overall Study|Adverse Event|1|||
129992527|NCT02795429|467936189|FG003|Overall Study|Adverse Event|2|||
129992528|NCT02795429|467936190|FG004|Overall Study|Adverse Event|1|||
129992529|NCT02795429|467936186|FG000|Overall Study|Death|1|||
129992530|NCT02795429|467936187|FG001|Overall Study|Death|0|||
129992531|NCT02795429|467936188|FG002|Overall Study|Death|1|||
129992532|NCT02795429|467936189|FG003|Overall Study|Death|2|||
129992533|NCT02795429|467936190|FG004|Overall Study|Death|1|||
129992534|NCT02795429|467936186|FG000|Overall Study|Physician Decision|0|||
129992535|NCT02795429|467936187|FG001|Overall Study|Physician Decision|0|||
129992536|NCT02795429|467936188|FG002|Overall Study|Physician Decision|2|||
130334309|NCT03887702|469193768|FG000|Overall Study|Study terminated|0|||
130334310|NCT03887702|469193769|FG001|Overall Study|Study terminated|0|||
129992537|NCT02795429|467936189|FG003|Overall Study|Physician Decision|1|||
129992538|NCT02795429|467936190|FG004|Overall Study|Physician Decision|5|||
129992539|NCT02795429|467936186|FG000|Overall Study|Progressive disease|3|||
129992540|NCT02795429|467936187|FG001|Overall Study|Progressive disease|7|||
129992541|NCT02795429|467936188|FG002|Overall Study|Progressive disease|6|||
129992542|NCT02795429|467936189|FG003|Overall Study|Progressive disease|26|||
129992543|NCT02795429|467936190|FG004|Overall Study|Progressive disease|20|||
129992544|NCT02795429|467936186|FG000|Overall Study|Subject/guardian decision|1|||
129992545|NCT02795429|467936187|FG001|Overall Study|Subject/guardian decision|1|||
129992546|NCT02795429|467936188|FG002|Overall Study|Subject/guardian decision|1|||
129992547|NCT02795429|467936189|FG003|Overall Study|Subject/guardian decision|1|||
129992548|NCT02795429|467936190|FG004|Overall Study|Subject/guardian decision|3|||
130334311|NCT03887702|469193770|FG002|Overall Study|Study terminated|2|||
130334312|NCT03887702|469193771|FG003|Overall Study|Study terminated|2|||
129992549|NCT00701779|467936191|FG000|Overall Study|Adverse Event|6|||
129992550|NCT00701779|467936191|FG000|Overall Study|Lost to Follow-up|1|||
130334313|NCT01088048|469193777|FG000|Overall Study|Adverse Event|7|||
130334314|NCT01088048|469193778|FG001|Overall Study|Adverse Event|9|||
129992551|NCT00701779|467936191|FG000|Overall Study|Withdrawal by Subject|2|||
129992552|NCT01640054|467936194|FG000|Overall Study|Study-specific disc criteria|1|||
129992553|NCT01640054|467936194|FG000|Overall Study|Lack of Efficacy|3|||
129992554|NCT01640054|467936194|FG000|Overall Study|Adverse Event|2|||
129992555|NCT05220254|467936196|FG000|Overall Study|Withdrawal by Subject|4|||
129992556|NCT05220254|467936196|FG000|Overall Study|Removed due to ineligibility|1|||
129992557|NCT05220254|467936196|FG000|Overall Study|Lost to Follow-up|7|||
129992558|NCT01557283|467936197|FG000|Overall Study|Lost to Follow-up|7|||
129992559|NCT01557283|467936197|FG000|Overall Study|Non-responder|19|||
129992560|NCT01557283|467936197|FG000|Overall Study|Adverse Event|7|||
129992561|NCT01557283|467936197|FG000|Overall Study|Lack of Efficacy|1|||
129992562|NCT01557283|467936197|FG000|Overall Study|Non-compliance|1|||
129992563|NCT01557283|467936197|FG000|Overall Study|Withdrawal by Subject|1|||
129992564|NCT01557283|467936197|FG000|Overall Study|Participant's weight too high for dose|1|||
129992565|NCT01557283|467936197|FG000|Overall Study|Worsening of psoriasis|1|||
129992566|NCT01557283|467936197|FG000|Overall Study|Other|6|||
129992567|NCT03645057|467936198|FG000|Randomization to Baseline|Lost to Follow-up|1|||
129992568|NCT03645057|467936199|FG001|Randomization to Baseline|Lost to Follow-up|0|||
129992569|NCT03645057|467936200|FG002|Randomization to Baseline|Lost to Follow-up|1|||
129992570|NCT03645057|467936201|FG003|Randomization to Baseline|Lost to Follow-up|0|||
129992571|NCT03645057|467936198|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
129992572|NCT03645057|467936199|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
129992573|NCT03645057|467936200|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
129992574|NCT03645057|467936201|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
129992575|NCT03645057|467936198|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
129992576|NCT03645057|467936199|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
129992577|NCT03645057|467936200|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
129992578|NCT03645057|467936201|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
129992579|NCT03645057|467936198|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
129992580|NCT03645057|467936199|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
129992581|NCT03645057|467936200|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
129992582|NCT03645057|467936201|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
129992583|NCT01873495|467936202|FG000|Overall Study|Withdrawal by Subject|1|||
129992584|NCT01873495|467936202|FG000|Overall Study|Physician Decision|3|||
129992585|NCT01873495|467936202|FG000|Overall Study|Adverse Event|1|||
129992586|NCT01873495|467936202|FG000|Overall Study|Removed for Transplantation|1|||
129992587|NCT01873495|467936202|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
129992588|NCT01206777|467936203|FG000|Overall Study|Death|1|||
129992589|NCT01206777|467936203|FG000|Overall Study|Adverse Event|1|||
129992590|NCT02080221|467936204|FG000|Overall Study|Withdrawal by Subject|1|||
129992591|NCT02080221|467936204|FG000|Overall Study|Clinical Progression of Disease|1|||
129992592|NCT00250679|467936209|FG000|Overall Study|Adverse Event|12|||
129992593|NCT00250679|467936210|FG001|Overall Study|Adverse Event|15|||
129992594|NCT00250679|467936211|FG002|Overall Study|Adverse Event|16|||
129992595|NCT00250679|467936209|FG000|Overall Study|Protocol Violation|2|||
129992596|NCT00250679|467936210|FG001|Overall Study|Protocol Violation|4|||
129992597|NCT00250679|467936211|FG002|Overall Study|Protocol Violation|3|||
129992598|NCT00250679|467936209|FG000|Overall Study|Withdrawal by Subject|15|||
129992599|NCT00250679|467936210|FG001|Overall Study|Withdrawal by Subject|18|||
129992600|NCT00250679|467936211|FG002|Overall Study|Withdrawal by Subject|15|||
129992601|NCT00250679|467936209|FG000|Overall Study|Lost to Follow-up|3|||
129992602|NCT00250679|467936210|FG001|Overall Study|Lost to Follow-up|4|||
129992603|NCT00250679|467936211|FG002|Overall Study|Lost to Follow-up|2|||
129992604|NCT00250679|467936209|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
129992605|NCT00250679|467936210|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
129992606|NCT00250679|467936211|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
129992607|NCT00250679|467936209|FG000|Overall Study|Lack of Efficacy|0|||
129992608|NCT00250679|467936210|FG001|Overall Study|Lack of Efficacy|1|||
129992609|NCT00250679|467936211|FG002|Overall Study|Lack of Efficacy|3|||
129992610|NCT00250679|467936209|FG000|Overall Study|Technical Holter issues|1|||
129992611|NCT00250679|467936210|FG001|Overall Study|Technical Holter issues|0|||
129992612|NCT00250679|467936211|FG002|Overall Study|Technical Holter issues|2|||
129992613|NCT00250679|467936209|FG000|Overall Study|Moved|1|||
129992614|NCT00250679|467936210|FG001|Overall Study|Moved|1|||
129992615|NCT00250679|467936211|FG002|Overall Study|Moved|0|||
129992616|NCT00250679|467936209|FG000|Overall Study|Non-compliance|1|||
129992617|NCT00250679|467936210|FG001|Overall Study|Non-compliance|1|||
129992618|NCT00250679|467936211|FG002|Overall Study|Non-compliance|0|||
129992619|NCT00250679|467936209|FG000|Overall Study|various single events: hip surgery,diary|3|||
129992620|NCT00250679|467936210|FG001|Overall Study|various single events: hip surgery,diary|1|||
129992621|NCT00250679|467936211|FG002|Overall Study|various single events: hip surgery,diary|1|||
129992622|NCT00448279|467936213|FG000|Overall Study|Lost to Follow-up|2|||
129992623|NCT00448279|467936214|FG001|Overall Study|Lost to Follow-up|2|||
129992624|NCT00448279|467936213|FG000|Overall Study|Adverse Event|1|||
129992625|NCT00448279|467936214|FG001|Overall Study|Adverse Event|1|||
129992626|NCT00448279|467936213|FG000|Overall Study|Disease progression|16|||
130334315|NCT01088048|469193779|FG002|Overall Study|Adverse Event|7|||
130334316|NCT01088048|469193780|FG003|Overall Study|Adverse Event|5|||
130334317|NCT01088048|469193781|FG004|Overall Study|Adverse Event|6|||
130334318|NCT01088048|469193782|FG005|Overall Study|Adverse Event|3|||
129992627|NCT00448279|467936214|FG001|Overall Study|Disease progression|18|||
129992628|NCT00448279|467936213|FG000|Overall Study|Withdrawal by Subject|4|||
130334319|NCT01088048|469193783|FG006|Overall Study|Adverse Event|3|||
130334320|NCT01088048|469193784|FG007|Overall Study|Adverse Event|0|||
130334321|NCT01088048|469193785|FG008|Overall Study|Adverse Event|2|||
130334322|NCT01088048|469193786|FG009|Overall Study|Adverse Event|2|||
130334323|NCT01088048|469193777|FG000|Overall Study|Withdrew Consent|1|||
130334324|NCT01088048|469193778|FG001|Overall Study|Withdrew Consent|1|||
130334325|NCT01088048|469193779|FG002|Overall Study|Withdrew Consent|1|||
130334326|NCT01088048|469193780|FG003|Overall Study|Withdrew Consent|1|||
130334327|NCT01088048|469193781|FG004|Overall Study|Withdrew Consent|2|||
130334328|NCT01088048|469193782|FG005|Overall Study|Withdrew Consent|1|||
130334329|NCT01088048|469193783|FG006|Overall Study|Withdrew Consent|0|||
130334330|NCT01088048|469193784|FG007|Overall Study|Withdrew Consent|2|||
130334331|NCT01088048|469193785|FG008|Overall Study|Withdrew Consent|2|||
130334332|NCT01088048|469193786|FG009|Overall Study|Withdrew Consent|1|||
130334333|NCT01088048|469193777|FG000|Overall Study|Concomitant Medication Prohibited|1|||
130334334|NCT01088048|469193778|FG001|Overall Study|Concomitant Medication Prohibited|0|||
130334335|NCT01088048|469193779|FG002|Overall Study|Concomitant Medication Prohibited|0|||
130334336|NCT01088048|469193780|FG003|Overall Study|Concomitant Medication Prohibited|0|||
130334337|NCT01088048|469193781|FG004|Overall Study|Concomitant Medication Prohibited|0|||
130334338|NCT01088048|469193782|FG005|Overall Study|Concomitant Medication Prohibited|0|||
130334339|NCT01088048|469193783|FG006|Overall Study|Concomitant Medication Prohibited|0|||
129992629|NCT00448279|467936214|FG001|Overall Study|Withdrawal by Subject|3|||
130334340|NCT01088048|469193784|FG007|Overall Study|Concomitant Medication Prohibited|0|||
130334341|NCT01088048|469193785|FG008|Overall Study|Concomitant Medication Prohibited|0|||
130334342|NCT01088048|469193786|FG009|Overall Study|Concomitant Medication Prohibited|0|||
130334343|NCT01088048|469193777|FG000|Overall Study|Investigator Request|2|||
129992630|NCT00448279|467936213|FG000|Overall Study|Other|6|||
129992631|NCT00448279|467936214|FG001|Overall Study|Other|4|||
129992632|NCT00448279|467936213|FG000|Overall Study|Protocol Violation|0|||
129992633|NCT00448279|467936214|FG001|Overall Study|Protocol Violation|1|||
129992634|NCT03907410|467936215|FG000|Overall Study|Lost to Follow-up|4|||
129992635|NCT03907410|467936216|FG001|Overall Study|Lost to Follow-up|1|||
129992636|NCT03907410|467936217|FG002|Overall Study|Lost to Follow-up|1|||
129992637|NCT03907410|467936215|FG000|Overall Study|Lost to follow-up and research burden|0|||
129992638|NCT03907410|467936216|FG001|Overall Study|Lost to follow-up and research burden|0|||
129992639|NCT03907410|467936217|FG002|Overall Study|Lost to follow-up and research burden|1|||
129992640|NCT03718533|467936218|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
129992641|NCT03718533|467936218|FG000|Overall Study|Protocol deviation|1|||
129992642|NCT03718533|467936218|FG000|Overall Study|Disease progression|1|||
129992643|NCT03718533|467936218|FG000|Overall Study|Relapse|1|||
129992644|NCT03718533|467936218|FG000|Overall Study|Physician Decision|2|||
129992645|NCT03718533|467936218|FG000|Overall Study|Physician Decision and Adverse Event|1|||
129992646|NCT01853137|467936221|FG000|Overall Study|Lost to Follow-up|4|||
129992647|NCT01853137|467936222|FG001|Overall Study|Lost to Follow-up|1|||
129992648|NCT01037244|467936223|FG000|Overall Study|Adverse Event|3|||
129992649|NCT01037244|467936224|FG001|Overall Study|Adverse Event|2|||
129992650|NCT01037244|467936225|FG002|Overall Study|Adverse Event|6|||
129992651|NCT01037244|467936226|FG003|Overall Study|Adverse Event|3|||
129992652|NCT01037244|467936223|FG000|Overall Study|Lack of Efficacy|1|||
129992653|NCT01037244|467936224|FG001|Overall Study|Lack of Efficacy|1|||
129992654|NCT01037244|467936225|FG002|Overall Study|Lack of Efficacy|0|||
129992655|NCT01037244|467936226|FG003|Overall Study|Lack of Efficacy|1|||
129992656|NCT01037244|467936223|FG000|Overall Study|Lost to Follow-up|3|||
129992657|NCT01037244|467936224|FG001|Overall Study|Lost to Follow-up|3|||
129992658|NCT01037244|467936225|FG002|Overall Study|Lost to Follow-up|4|||
129992659|NCT01037244|467936226|FG003|Overall Study|Lost to Follow-up|4|||
129992660|NCT01037244|467936223|FG000|Overall Study|Withdrawal by Subject|1|||
129992661|NCT01037244|467936224|FG001|Overall Study|Withdrawal by Subject|5|||
129992662|NCT01037244|467936225|FG002|Overall Study|Withdrawal by Subject|3|||
129992663|NCT01037244|467936226|FG003|Overall Study|Withdrawal by Subject|5|||
129992664|NCT01037244|467936223|FG000|Overall Study|Partner Withdrew Consent|2|||
129992665|NCT01037244|467936224|FG001|Overall Study|Partner Withdrew Consent|1|||
130216119|NCT01826981|468753943|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
130334344|NCT01088048|469193778|FG001|Overall Study|Investigator Request|2|||
130334345|NCT01088048|469193779|FG002|Overall Study|Investigator Request|0|||
130334346|NCT01088048|469193780|FG003|Overall Study|Investigator Request|0|||
130334347|NCT01088048|469193781|FG004|Overall Study|Investigator Request|3|||
130334348|NCT01088048|469193782|FG005|Overall Study|Investigator Request|1|||
130334349|NCT01088048|469193783|FG006|Overall Study|Investigator Request|1|||
130334350|NCT01088048|469193784|FG007|Overall Study|Investigator Request|0|||
130334351|NCT01088048|469193785|FG008|Overall Study|Investigator Request|0|||
129992666|NCT01037244|467936225|FG002|Overall Study|Partner Withdrew Consent|0|||
129992667|NCT01037244|467936226|FG003|Overall Study|Partner Withdrew Consent|0|||
129992668|NCT01037244|467936223|FG000|Overall Study|Various|3|||
129992669|NCT01037244|467936224|FG001|Overall Study|Various|2|||
129992670|NCT01037244|467936225|FG002|Overall Study|Various|1|||
129992671|NCT01037244|467936226|FG003|Overall Study|Various|1|||
129992672|NCT01411215|467936227|FG000|Overall Study|Adverse Event|1|||
129992673|NCT01411215|467936228|FG001|Overall Study|Adverse Event|2|||
129992674|NCT01411215|467936227|FG000|Overall Study|Lack of Efficacy|2|||
129992675|NCT01411215|467936228|FG001|Overall Study|Lack of Efficacy|4|||
129992676|NCT01411215|467936227|FG000|Overall Study|Lost to Follow-up|12|||
129992677|NCT01411215|467936228|FG001|Overall Study|Lost to Follow-up|18|||
129992678|NCT01411215|467936227|FG000|Overall Study|Did not meet entrance criteria|0|||
129992679|NCT01411215|467936228|FG001|Overall Study|Did not meet entrance criteria|1|||
129992680|NCT01411215|467936227|FG000|Overall Study|Study terminated by sponsor|2|||
129992681|NCT01411215|467936228|FG001|Overall Study|Study terminated by sponsor|15|||
129992682|NCT01411215|467936227|FG000|Overall Study|Protocol Violation|3|||
129992683|NCT01411215|467936228|FG001|Overall Study|Protocol Violation|5|||
129992684|NCT01411215|467936227|FG000|Overall Study|Withdrawal by Subject|34|||
129992685|NCT01411215|467936228|FG001|Overall Study|Withdrawal by Subject|21|||
129992686|NCT01411215|467936227|FG000|Overall Study|Other|12|||
129992687|NCT01411215|467936228|FG001|Overall Study|Other|17|||
129992688|NCT01411215|467936227|FG000|Overall Study|Screen failure|0|||
129992689|NCT01411215|467936228|FG001|Overall Study|Screen failure|1|||
129992690|NCT00848926|467936229|FG000|Treatment Period|Progressive disease|45|||
129992691|NCT00848926|467936229|FG000|Treatment Period|Adverse Event|20|||
129992692|NCT00848926|467936229|FG000|Treatment Period|Physician Decision|12|||
129992693|NCT00848926|467936229|FG000|Treatment Period|Withdrawal by Subject|7|||
129992694|NCT00848926|467936229|FG000|Follow-up Period|Lost to Follow-up|7|||
129992695|NCT00848926|467936229|FG000|Follow-up Period|Withdrawal by Subject|3|||
129992696|NCT00848926|467936229|FG000|Follow-up Period|Other|2|||
129992697|NCT04025580|467936230|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
129992698|NCT04025580|467936231|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
129992699|NCT04025580|467936232|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
129992700|NCT04507126|467936233|FG000|Overall Study|Withdrawal by Subject|1|||
129992701|NCT04507126|467936233|FG000|Overall Study|Protocol Violation|2|||
129992702|NCT04507126|467936233|FG000|Overall Study|Physician Decision|1|||
129992703|NCT02924064|467936234|FG000|Overall Study|Adverse Event|2|||
129992704|NCT02924064|467936235|FG001|Overall Study|Adverse Event|2|||
129992705|NCT02924064|467936234|FG000|Overall Study|Lost to Follow-up|0|||
129992706|NCT02924064|467936235|FG001|Overall Study|Lost to Follow-up|2|||
129992707|NCT02924064|467936234|FG000|Overall Study|Physician Decision|0|||
129992708|NCT02924064|467936235|FG001|Overall Study|Physician Decision|2|||
129992709|NCT02924064|467936234|FG000|Overall Study|Protocol Violation|1|||
129992710|NCT02924064|467936235|FG001|Overall Study|Protocol Violation|3|||
129992711|NCT02924064|467936234|FG000|Overall Study|Withdrawal by Subject|4|||
129992712|NCT02924064|467936235|FG001|Overall Study|Withdrawal by Subject|5|||
129992713|NCT02924064|467936234|FG000|Overall Study|Other|17|||
129992714|NCT02924064|467936235|FG001|Overall Study|Other|29|||
129992715|NCT01249274|467936238|FG000|Overall Study|Lost to Follow-up|3|||
129992716|NCT01249274|467936239|FG001|Overall Study|Lost to Follow-up|4|||
129992717|NCT01249274|467936238|FG000|Overall Study|Received inpatient substance treatment|1|||
129992718|NCT01249274|467936239|FG001|Overall Study|Received inpatient substance treatment|2|||
129992719|NCT00138671|467936240|FG000|Overall Study|Death|0|||
129992720|NCT00138671|467936241|FG001|Overall Study|Death|3|||
129992721|NCT00138671|467936240|FG000|Overall Study|Adverse Event|6|||
129992722|NCT00138671|467936241|FG001|Overall Study|Adverse Event|3|||
129992723|NCT00138671|467936240|FG000|Overall Study|Lost to Follow-up|1|||
129992724|NCT00138671|467936241|FG001|Overall Study|Lost to Follow-up|2|||
129992725|NCT00138671|467936240|FG000|Overall Study|Withdrawal by Subject|3|||
129992726|NCT00138671|467936241|FG001|Overall Study|Withdrawal by Subject|5|||
129992727|NCT00138671|467936240|FG000|Overall Study|Other|3|||
129992728|NCT00138671|467936241|FG001|Overall Study|Other|3|||
129992729|NCT01952054|467936242|FG000|Overall Study|Physician Decision|1|||
129992730|NCT01100034|467936243|FG000|Overall Study|Lost to Follow-up|11|||
129992731|NCT01100034|467936243|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
129992732|NCT01100034|467936243|FG000|Overall Study|Withdrawal by Subject|4|||
129992733|NCT01100034|467936243|FG000|Overall Study|Sponsor decision|21|||
129992734|NCT01100034|467936243|FG000|Overall Study|Participated in another clinical trial|1|||
129992735|NCT01100034|467936243|FG000|Overall Study|Participants moved to another hospital|4|||
129992736|NCT01100034|467936243|FG000|Overall Study|Site closed due to non-responsiveness|1|||
129992737|NCT01831856|467936244|FG000|Overall Study|Adverse Event|5|||
129992738|NCT01831856|467936245|FG001|Overall Study|Adverse Event|8|||
129992739|NCT01831856|467936244|FG000|Overall Study|Lack of Efficacy|13|||
129992740|NCT01831856|467936245|FG001|Overall Study|Lack of Efficacy|11|||
129992741|NCT01831856|467936244|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
129992742|NCT01831856|467936245|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
129992743|NCT01498653|467936246|FG000|Overall Study|Adverse Event|2|||
129992744|NCT01498653|467936247|FG001|Overall Study|Adverse Event|2|||
129992745|NCT01498653|467936246|FG000|Overall Study|Lack of Efficacy|12|||
129992746|NCT01498653|467936247|FG001|Overall Study|Lack of Efficacy|26|||
129992747|NCT01498653|467936246|FG000|Overall Study|Protocol Violation|0|||
129992748|NCT01498653|467936247|FG001|Overall Study|Protocol Violation|4|||
129992749|NCT01498653|467936246|FG000|Overall Study|Lost to Follow-up|1|||
129992750|NCT01498653|467936247|FG001|Overall Study|Lost to Follow-up|0|||
129992751|NCT01498653|467936246|FG000|Overall Study|Physician Decision|2|||
129992752|NCT01498653|467936247|FG001|Overall Study|Physician Decision|0|||
129992753|NCT01498653|467936246|FG000|Overall Study|Withdrawal by Subject|2|||
129992754|NCT01498653|467936247|FG001|Overall Study|Withdrawal by Subject|3|||
129992755|NCT05208866|467936248|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
129992756|NCT02070588|467936249|FG000|Overall Study|Withdrawal by Subject|29|||
129992757|NCT02070588|467936250|FG001|Overall Study|Withdrawal by Subject|1|||
129992758|NCT02070588|467936251|FG002|Overall Study|Withdrawal by Subject|0|||
129992759|NCT02070588|467936249|FG000|Overall Study|Writhdrawal due to early termination|9|||
129992760|NCT02070588|467936250|FG001|Overall Study|Writhdrawal due to early termination|0|||
129992761|NCT02070588|467936251|FG002|Overall Study|Writhdrawal due to early termination|0|||
129992762|NCT02070588|467936249|FG000|Overall Study|Adverse Event|1|||
129992763|NCT02070588|467936250|FG001|Overall Study|Adverse Event|0|||
129992764|NCT02070588|467936251|FG002|Overall Study|Adverse Event|0|||
129992765|NCT02216357|467936253|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
129992766|NCT02216357|467936254|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
129992767|NCT00836095|467936256|FG000|Overall Study|Physician Decision|0|||
129992768|NCT00836095|467936257|FG001|Overall Study|Physician Decision|3|||
129992769|NCT04620811|467936260|FG000|Overall Study|Withdrawal by Subject|18|||
129992770|NCT04620811|467936261|FG001|Overall Study|Withdrawal by Subject|15|||
129992771|NCT04620811|467936260|FG000|Overall Study|Adverse Event|6|||
129992772|NCT04620811|467936261|FG001|Overall Study|Adverse Event|11|||
129992773|NCT04620811|467936260|FG000|Overall Study|Lost to Follow-up|4|||
129992774|NCT04620811|467936261|FG001|Overall Study|Lost to Follow-up|8|||
129992775|NCT04620811|467936260|FG000|Overall Study|Physician Decision|1|||
129992776|NCT04620811|467936261|FG001|Overall Study|Physician Decision|4|||
129992777|NCT04620811|467936260|FG000|Overall Study|Sponsor Decision|0|||
129992778|NCT04620811|467936261|FG001|Overall Study|Sponsor Decision|1|||
129992779|NCT04620811|467936260|FG000|Overall Study|Elevation of ALT or AST|1|||
129992780|NCT04620811|467936261|FG001|Overall Study|Elevation of ALT or AST|0|||
129992781|NCT04620811|467936260|FG000|Overall Study|Other|3|||
129992782|NCT04620811|467936261|FG001|Overall Study|Other|5|||
129992783|NCT01078675|467936262|FG000|Overall Study|Withdrawal by Subject|7|||
129992784|NCT01078675|467936263|FG001|Overall Study|Withdrawal by Subject|3|||
129992785|NCT01078675|467936262|FG000|Overall Study|Protocol Violation|56|||
129992786|NCT01078675|467936263|FG001|Overall Study|Protocol Violation|0|||
129992787|NCT01078675|467936262|FG000|Overall Study|Provided in CRF for specific reasons|2|||
129992788|NCT01078675|467936263|FG001|Overall Study|Provided in CRF for specific reasons|3|||
129992789|NCT01078675|467936262|FG000|Overall Study|Adverse Event|3|||
129992790|NCT01078675|467936263|FG001|Overall Study|Adverse Event|0|||
129992791|NCT01759368|467936266|FG000|Overall Study|Lost to Follow-up|1|||
129992792|NCT01759368|467936267|FG001|Overall Study|Lost to Follow-up|0|||
129992793|NCT01191268|467936268|FG000|Overall Study|Withdrawal by Subject|19|||
129992794|NCT01191268|467936269|FG001|Overall Study|Withdrawal by Subject|25|||
129992795|NCT01191268|467936270|FG002|Overall Study|Withdrawal by Subject|21|||
129992796|NCT01191268|467936268|FG000|Overall Study|Adverse Event|21|||
129992797|NCT01191268|467936269|FG001|Overall Study|Adverse Event|13|||
129992798|NCT01191268|467936270|FG002|Overall Study|Adverse Event|8|||
129992799|NCT01191268|467936268|FG000|Overall Study|Physician Decision|6|||
129992800|NCT01191268|467936269|FG001|Overall Study|Physician Decision|8|||
129992801|NCT01191268|467936270|FG002|Overall Study|Physician Decision|9|||
129992802|NCT01191268|467936268|FG000|Overall Study|Lost to Follow-up|8|||
129992803|NCT01191268|467936269|FG001|Overall Study|Lost to Follow-up|5|||
129992804|NCT01191268|467936270|FG002|Overall Study|Lost to Follow-up|9|||
130216120|NCT01826981|468753944|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
129992805|NCT01191268|467936268|FG000|Overall Study|Entry Criteria Not Met|3|||
129992806|NCT01191268|467936269|FG001|Overall Study|Entry Criteria Not Met|1|||
129992807|NCT01191268|467936270|FG002|Overall Study|Entry Criteria Not Met|1|||
129992808|NCT01191268|467936268|FG000|Overall Study|Death|0|||
129992809|NCT01191268|467936269|FG001|Overall Study|Death|1|||
129992810|NCT01191268|467936270|FG002|Overall Study|Death|3|||
129992811|NCT01191268|467936268|FG000|Overall Study|Protocol Violation|1|||
129992812|NCT01191268|467936269|FG001|Overall Study|Protocol Violation|0|||
129992813|NCT01191268|467936270|FG002|Overall Study|Protocol Violation|1|||
129992814|NCT01191268|467936268|FG000|Overall Study|Sponsor Decision|0|||
129992815|NCT01191268|467936269|FG001|Overall Study|Sponsor Decision|2|||
129992816|NCT01191268|467936270|FG002|Overall Study|Sponsor Decision|0|||
129992817|NCT02294227|467936273|FG000|Overall Study|Death|0|||
129992818|NCT02294227|467936274|FG001|Overall Study|Death|0|||
130216121|NCT01826981|468753945|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
129992819|NCT02294227|467936275|FG002|Overall Study|Death|1|||
129992820|NCT02294227|467936273|FG000|Overall Study|Subject/Guardian Decision|6|||
129992821|NCT02294227|467936274|FG001|Overall Study|Subject/Guardian Decision|3|||
129992822|NCT02294227|467936275|FG002|Overall Study|Subject/Guardian Decision|7|||
129992823|NCT02294227|467936273|FG000|Overall Study|Physician Decision|1|||
129992824|NCT02294227|467936274|FG001|Overall Study|Physician Decision|2|||
129992825|NCT02294227|467936275|FG002|Overall Study|Physician Decision|1|||
129992826|NCT02294227|467936273|FG000|Overall Study|Lost to Follow-up|1|||
129992827|NCT02294227|467936274|FG001|Overall Study|Lost to Follow-up|0|||
129992828|NCT02294227|467936275|FG002|Overall Study|Lost to Follow-up|0|||
129992829|NCT02294227|467936273|FG000|Overall Study|Lack of Efficacy|11|||
129992830|NCT02294227|467936274|FG001|Overall Study|Lack of Efficacy|12|||
129992831|NCT02294227|467936275|FG002|Overall Study|Lack of Efficacy|8|||
129992832|NCT02294227|467936273|FG000|Overall Study|Adverse Event|6|||
129992833|NCT02294227|467936274|FG001|Overall Study|Adverse Event|8|||
129992834|NCT02294227|467936275|FG002|Overall Study|Adverse Event|2|||
129992835|NCT01768637|467936278|FG000|Overall Study|Lost to Follow-up|2|||
129992836|NCT01768637|467936279|FG001|Overall Study|Lost to Follow-up|7|||
129992837|NCT01768637|467936278|FG000|Overall Study|Difficult blood draw|1|||
129992838|NCT01768637|467936279|FG001|Overall Study|Difficult blood draw|0|||
129992839|NCT00887432|467936280|FG000|Overall Study|Start Excluded Therapy|3|||
129992840|NCT00887432|467936281|FG001|Overall Study|Start Excluded Therapy|0|||
129992841|NCT00887432|467936280|FG000|Overall Study|Did not complete treatment|6|||
129992842|NCT00887432|467936281|FG001|Overall Study|Did not complete treatment|8|||
129992843|NCT00887432|467936280|FG000|Overall Study|Protocol Violation|2|||
129992844|NCT00887432|467936281|FG001|Overall Study|Protocol Violation|3|||
129992845|NCT00887432|467936280|FG000|Overall Study|Withdrawal by Subject|3|||
129992846|NCT00887432|467936281|FG001|Overall Study|Withdrawal by Subject|2|||
129992847|NCT00887432|467936280|FG000|Overall Study|Lost to Follow-up|1|||
129992848|NCT00887432|467936281|FG001|Overall Study|Lost to Follow-up|0|||
129992849|NCT00887432|467936280|FG000|Overall Study|No reason provided|0|||
129992850|NCT00887432|467936281|FG001|Overall Study|No reason provided|1|||
129992851|NCT00899548|467936282|FG000|Overall Study|Physician Decision|3|||
129992852|NCT01636960|467936283|FG000|Induction Phase|Adverse Event|2|||
129992853|NCT01636960|467936283|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
129992854|NCT01636960|467936283|FG000|Maintenance Phase|Adverse Event|3|||
129992855|NCT01636960|467936283|FG000|Maintenance Phase|Progressive disease|1|||
129992856|NCT01209780|467936284|FG000|Overall Study|Adverse Event|0|||
129992857|NCT01209780|467936285|FG001|Overall Study|Adverse Event|1|||
129992858|NCT01209780|467936286|FG002|Overall Study|Adverse Event|0|||
129992859|NCT01209780|467936287|FG003|Overall Study|Adverse Event|0|||
129992860|NCT01209780|467936288|FG004|Overall Study|Adverse Event|0|||
129992861|NCT01209780|467936284|FG000|Overall Study|Withdrawal by Subject|9|||
129992862|NCT01209780|467936285|FG001|Overall Study|Withdrawal by Subject|2|||
129992863|NCT01209780|467936286|FG002|Overall Study|Withdrawal by Subject|1|||
129992864|NCT01209780|467936287|FG003|Overall Study|Withdrawal by Subject|1|||
129992865|NCT01209780|467936288|FG004|Overall Study|Withdrawal by Subject|0|||
129992866|NCT01209780|467936284|FG000|Overall Study|Lost to Follow-up|17|||
129992867|NCT01209780|467936285|FG001|Overall Study|Lost to Follow-up|12|||
129992868|NCT01209780|467936286|FG002|Overall Study|Lost to Follow-up|3|||
129992869|NCT01209780|467936287|FG003|Overall Study|Lost to Follow-up|9|||
129992870|NCT01209780|467936288|FG004|Overall Study|Lost to Follow-up|4|||
129992871|NCT01209780|467936284|FG000|Overall Study|Protocol Violation|0|||
129992872|NCT01209780|467936285|FG001|Overall Study|Protocol Violation|1|||
129992873|NCT01209780|467936286|FG002|Overall Study|Protocol Violation|0|||
129992874|NCT01209780|467936287|FG003|Overall Study|Protocol Violation|0|||
129992875|NCT01209780|467936288|FG004|Overall Study|Protocol Violation|0|||
129992876|NCT01209780|467936284|FG000|Overall Study|Inappropriate enrollment|0|||
129992877|NCT01209780|467936285|FG001|Overall Study|Inappropriate enrollment|2|||
129992878|NCT01209780|467936286|FG002|Overall Study|Inappropriate enrollment|0|||
129992879|NCT01209780|467936287|FG003|Overall Study|Inappropriate enrollment|0|||
129992880|NCT01209780|467936288|FG004|Overall Study|Inappropriate enrollment|1|||
129992881|NCT00511472|467936289|FG000|Overall Study|Clinical Adverse Event|1|||
129992882|NCT00511472|467936290|FG001|Overall Study|Clinical Adverse Event|2|||
129992883|NCT00511472|467936289|FG000|Overall Study|Laboratory Adverse Event|0|||
129992884|NCT00511472|467936290|FG001|Overall Study|Laboratory Adverse Event|2|||
129992885|NCT00511472|467936289|FG000|Overall Study|Not reported|2|||
129992886|NCT00511472|467936290|FG001|Overall Study|Not reported|2|||
129992887|NCT02709096|467936291|FG000|Overall Study|non-compliance|1|||
129992888|NCT02709096|467936292|FG001|Overall Study|non-compliance|1|||
129992889|NCT00505284|467936293|FG000|Overall Study|Adverse Event|3|||
129992890|NCT00505284|467936294|FG001|Overall Study|Adverse Event|7|||
129992891|NCT00505284|467936295|FG002|Overall Study|Adverse Event|9|||
129992892|NCT00505284|467936296|FG003|Overall Study|Adverse Event|14|||
129992893|NCT00505284|467936297|FG004|Overall Study|Adverse Event|22|||
129992894|NCT00505284|467936293|FG000|Overall Study|Protocol Violation|0|||
129992895|NCT00505284|467936294|FG001|Overall Study|Protocol Violation|1|||
129992896|NCT00505284|467936295|FG002|Overall Study|Protocol Violation|1|||
129992897|NCT00505284|467936296|FG003|Overall Study|Protocol Violation|0|||
129992898|NCT00505284|467936297|FG004|Overall Study|Protocol Violation|0|||
129992899|NCT00505284|467936293|FG000|Overall Study|Withdrawal by Subject|2|||
129992900|NCT00505284|467936294|FG001|Overall Study|Withdrawal by Subject|6|||
129992901|NCT00505284|467936295|FG002|Overall Study|Withdrawal by Subject|1|||
129992902|NCT00505284|467936296|FG003|Overall Study|Withdrawal by Subject|0|||
129992903|NCT00505284|467936297|FG004|Overall Study|Withdrawal by Subject|6|||
129992904|NCT00505284|467936293|FG000|Overall Study|Lack of Efficacy|0|||
129992905|NCT00505284|467936294|FG001|Overall Study|Lack of Efficacy|1|||
129992906|NCT00505284|467936295|FG002|Overall Study|Lack of Efficacy|1|||
129992907|NCT00505284|467936296|FG003|Overall Study|Lack of Efficacy|1|||
129992908|NCT00505284|467936297|FG004|Overall Study|Lack of Efficacy|1|||
129992909|NCT00505284|467936293|FG000|Overall Study|Physician Decision|0|||
129992910|NCT00505284|467936294|FG001|Overall Study|Physician Decision|1|||
129992911|NCT00505284|467936295|FG002|Overall Study|Physician Decision|0|||
129992912|NCT00505284|467936296|FG003|Overall Study|Physician Decision|0|||
129992913|NCT00505284|467936297|FG004|Overall Study|Physician Decision|0|||
129992914|NCT00505284|467936293|FG000|Overall Study|Other|5|||
129992915|NCT00505284|467936294|FG001|Overall Study|Other|0|||
129992916|NCT00505284|467936295|FG002|Overall Study|Other|0|||
129992917|NCT00505284|467936296|FG003|Overall Study|Other|4|||
129992918|NCT00505284|467936297|FG004|Overall Study|Other|4|||
129992919|NCT00731120|467936298|FG000|Overall Study|Adverse Event|7|||
129992920|NCT00731120|467936299|FG001|Overall Study|Adverse Event|6|||
129992921|NCT00731120|467936300|FG002|Overall Study|Adverse Event|8|||
129992922|NCT00731120|467936298|FG000|Overall Study|Lack of Efficacy|4|||
129992923|NCT00731120|467936299|FG001|Overall Study|Lack of Efficacy|5|||
129992924|NCT00731120|467936300|FG002|Overall Study|Lack of Efficacy|4|||
129992925|NCT00731120|467936298|FG000|Overall Study|Noncompliance with Study Drug|3|||
129992926|NCT00731120|467936299|FG001|Overall Study|Noncompliance with Study Drug|3|||
129992927|NCT00731120|467936300|FG002|Overall Study|Noncompliance with Study Drug|1|||
129992928|NCT00731120|467936298|FG000|Overall Study|Protocol Deviations|1|||
129992929|NCT00731120|467936299|FG001|Overall Study|Protocol Deviations|6|||
129992930|NCT00731120|467936300|FG002|Overall Study|Protocol Deviations|1|||
129992931|NCT00731120|467936298|FG000|Overall Study|Withdrawal of Consent|13|||
129992932|NCT00731120|467936299|FG001|Overall Study|Withdrawal of Consent|8|||
129992933|NCT00731120|467936300|FG002|Overall Study|Withdrawal of Consent|4|||
129992934|NCT00731120|467936298|FG000|Overall Study|Lost to Follow-up|10|||
129992935|NCT00731120|467936299|FG001|Overall Study|Lost to Follow-up|15|||
129992936|NCT00731120|467936300|FG002|Overall Study|Lost to Follow-up|17|||
129992937|NCT00731120|467936298|FG000|Overall Study|Other|4|||
129992938|NCT00731120|467936299|FG001|Overall Study|Other|0|||
129992939|NCT00731120|467936300|FG002|Overall Study|Other|1|||
129992940|NCT01575028|467936301|FG000|Overall Study|Physician Decision|0|||
129992941|NCT01575028|467936302|FG001|Overall Study|Physician Decision|1|||
129992942|NCT01386788|467937700|FG000|Overall Study|Lost to Follow-up|2|||
129992943|NCT02986334|467937701|FG000|Overall Study|Withdrawal by Subject|0|||
129992944|NCT02986334|467937702|FG001|Overall Study|Withdrawal by Subject|1|||
129992945|NCT02986334|467937703|FG002|Overall Study|Withdrawal by Subject|2|||
129992946|NCT02986334|467937701|FG000|Overall Study|Lost to Follow-up|1|||
129992947|NCT02986334|467937702|FG001|Overall Study|Lost to Follow-up|2|||
129992948|NCT02986334|467937703|FG002|Overall Study|Lost to Follow-up|1|||
129992949|NCT02986334|467937701|FG000|Overall Study|Adverse Event|0|||
129992950|NCT02986334|467937702|FG001|Overall Study|Adverse Event|2|||
129992951|NCT02986334|467937703|FG002|Overall Study|Adverse Event|1|||
129992952|NCT02986334|467937701|FG000|Overall Study|non compliance in phone ratings|2|||
129992953|NCT02986334|467937702|FG001|Overall Study|non compliance in phone ratings|1|||
129992954|NCT02986334|467937703|FG002|Overall Study|non compliance in phone ratings|2|||
129992955|NCT02986334|467937701|FG000|Overall Study|undisclosed comorbidities|0|||
129992956|NCT02986334|467937702|FG001|Overall Study|undisclosed comorbidities|1|||
129992957|NCT02986334|467937703|FG002|Overall Study|undisclosed comorbidities|1|||
129992958|NCT00120406|467937704|FG000|Overall Study|Death|9|||
129992959|NCT00120406|467937705|FG001|Overall Study|Death|4|||
129992960|NCT00120406|467937704|FG000|Overall Study|Withdrawal by Subject|5|||
129992961|NCT00120406|467937705|FG001|Overall Study|Withdrawal by Subject|7|||
129992962|NCT00120406|467937704|FG000|Overall Study|Lost to Follow-up|5|||
129992963|NCT00120406|467937705|FG001|Overall Study|Lost to Follow-up|2|||
129992964|NCT00120406|467937704|FG000|Overall Study|received non-study stent|0|||
129992965|NCT00120406|467937705|FG001|Overall Study|received non-study stent|2|||
129992966|NCT00120406|467937704|FG000|Overall Study|patient moved but has not withdrawn|0|||
129992967|NCT00120406|467937705|FG001|Overall Study|patient moved but has not withdrawn|1|||
129992968|NCT01295034|467937706|FG000|Overall Study|Lost to Follow-up|5|||
129992969|NCT01295034|467937707|FG001|Overall Study|Lost to Follow-up|5|||
129992970|NCT01313637|467937710|FG000|Overall Study|Adverse Event|17|||
129992971|NCT01313637|467937711|FG001|Overall Study|Adverse Event|24|||
129992972|NCT01313637|467937712|FG002|Overall Study|Adverse Event|25|||
129992973|NCT01313637|467937713|FG003|Overall Study|Adverse Event|18|||
129992974|NCT01313637|467937710|FG000|Overall Study|Lack of Efficacy|44|||
129992975|NCT01313637|467937711|FG001|Overall Study|Lack of Efficacy|38|||
129992976|NCT01313637|467937712|FG002|Overall Study|Lack of Efficacy|37|||
129992977|NCT01313637|467937713|FG003|Overall Study|Lack of Efficacy|24|||
130334352|NCT01088048|469193786|FG009|Overall Study|Investigator Request|0|||
130334353|NCT01088048|469193777|FG000|Overall Study|Patient Non-compliance|0|||
130334354|NCT01088048|469193778|FG001|Overall Study|Patient Non-compliance|1|||
130334355|NCT01088048|469193779|FG002|Overall Study|Patient Non-compliance|0|||
130334356|NCT01088048|469193780|FG003|Overall Study|Patient Non-compliance|0|||
130334357|NCT01088048|469193781|FG004|Overall Study|Patient Non-compliance|0|||
130334358|NCT01088048|469193782|FG005|Overall Study|Patient Non-compliance|0|||
130334359|NCT01088048|469193783|FG006|Overall Study|Patient Non-compliance|0|||
130334360|NCT01088048|469193784|FG007|Overall Study|Patient Non-compliance|0|||
130334361|NCT01088048|469193785|FG008|Overall Study|Patient Non-compliance|0|||
130334362|NCT01088048|469193786|FG009|Overall Study|Patient Non-compliance|0|||
130334363|NCT01088048|469193777|FG000|Overall Study|Disease Progression|7|||
130334364|NCT01088048|469193778|FG001|Overall Study|Disease Progression|4|||
130334365|NCT01088048|469193779|FG002|Overall Study|Disease Progression|3|||
130334366|NCT01088048|469193780|FG003|Overall Study|Disease Progression|5|||
130334367|NCT01088048|469193781|FG004|Overall Study|Disease Progression|3|||
130334368|NCT01088048|469193782|FG005|Overall Study|Disease Progression|3|||
130334369|NCT01088048|469193783|FG006|Overall Study|Disease Progression|2|||
130334370|NCT01088048|469193784|FG007|Overall Study|Disease Progression|1|||
130334371|NCT01088048|469193785|FG008|Overall Study|Disease Progression|0|||
129992978|NCT01313637|467937710|FG000|Overall Study|Protocol Violation|4|||
129992979|NCT01313637|467937711|FG001|Overall Study|Protocol Violation|3|||
129992980|NCT01313637|467937712|FG002|Overall Study|Protocol Violation|11|||
129992981|NCT01313637|467937713|FG003|Overall Study|Protocol Violation|5|||
129992982|NCT01313637|467937710|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
129992983|NCT01313637|467937711|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
129992984|NCT01313637|467937712|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
129992985|NCT01313637|467937713|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
129992986|NCT01313637|467937710|FG000|Overall Study|Lost to Follow-up|0|||
129992987|NCT01313637|467937711|FG001|Overall Study|Lost to Follow-up|2|||
129992988|NCT01313637|467937712|FG002|Overall Study|Lost to Follow-up|1|||
129992989|NCT01313637|467937713|FG003|Overall Study|Lost to Follow-up|3|||
129992990|NCT01313637|467937710|FG000|Overall Study|Withdrawal by Subject|11|||
129992991|NCT01313637|467937711|FG001|Overall Study|Withdrawal by Subject|13|||
129992992|NCT01313637|467937712|FG002|Overall Study|Withdrawal by Subject|18|||
129992993|NCT01313637|467937713|FG003|Overall Study|Withdrawal by Subject|15|||
129992994|NCT04218084|467937715|FG000|Overall Study|Adverse Event|7|||
129992995|NCT04218084|467937716|FG001|Overall Study|Adverse Event|2|||
129992996|NCT04218084|467937715|FG000|Overall Study|Withdrawal of Consent|4|||
129992997|NCT04218084|467937716|FG001|Overall Study|Withdrawal of Consent|5|||
129992998|NCT04218084|467937715|FG000|Overall Study|Physician Decision|1|||
129992999|NCT04218084|467937716|FG001|Overall Study|Physician Decision|1|||
129993000|NCT04218084|467937715|FG000|Overall Study|Lost to Follow-up|1|||
129993001|NCT04218084|467937716|FG001|Overall Study|Lost to Follow-up|1|||
129993002|NCT04218084|467937715|FG000|Overall Study|Non-compliance with study drug|1|||
129993003|NCT04218084|467937716|FG001|Overall Study|Non-compliance with study drug|1|||
129993004|NCT04218084|467937715|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
129993005|NCT04218084|467937716|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
129993006|NCT04218084|467937715|FG000|Overall Study|Other|0|||
129993007|NCT04218084|467937716|FG001|Overall Study|Other|1|||
129993008|NCT04218084|467937715|FG000|Overall Study|Ongoing at data cut-off date|62|||
129993009|NCT04218084|467937716|FG001|Overall Study|Ongoing at data cut-off date|58|||
129993010|NCT05580588|467937717|FG000|Overall Study|Lack of Efficacy|12|||
129993011|NCT00211185|467937720|FG000|Overall Study|Death|2|||
129993012|NCT00211185|467937720|FG000|Overall Study|Disease progression|7|||
129993013|NCT00211185|467937720|FG000|Overall Study|Withdrawal by Subject|6|||
129993014|NCT00211185|467937720|FG000|Overall Study|Physician Decision|5|||
129993015|NCT00712673|467937721|FG000|Overall Study|Adverse Event|3|||
129993016|NCT00712673|467937722|FG001|Overall Study|Adverse Event|3|||
129993017|NCT00712673|467937723|FG002|Overall Study|Adverse Event|21|||
129993018|NCT00712673|467937724|FG003|Overall Study|Adverse Event|26|||
129993019|NCT00712673|467937721|FG000|Overall Study|Lack of Efficacy|2|||
129993020|NCT00712673|467937722|FG001|Overall Study|Lack of Efficacy|8|||
129993021|NCT00712673|467937723|FG002|Overall Study|Lack of Efficacy|8|||
129993022|NCT00712673|467937724|FG003|Overall Study|Lack of Efficacy|6|||
129993023|NCT00712673|467937721|FG000|Overall Study|Poor Compliance to Protocol|3|||
129993024|NCT00712673|467937722|FG001|Overall Study|Poor Compliance to Protocol|3|||
129993025|NCT00712673|467937723|FG002|Overall Study|Poor Compliance to Protocol|4|||
130216122|NCT01826981|468753946|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
129993026|NCT00712673|467937724|FG003|Overall Study|Poor Compliance to Protocol|16|||
129993027|NCT00712673|467937721|FG000|Overall Study|Lost to Follow-up|1|||
130216123|NCT01826981|468753947|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
130334372|NCT01088048|469193786|FG009|Overall Study|Disease Progression|0|||
130334373|NCT01088048|469193777|FG000|Overall Study|Death|1|||
130334374|NCT01088048|469193778|FG001|Overall Study|Death|5|||
130334375|NCT01088048|469193779|FG002|Overall Study|Death|3|||
130334376|NCT01088048|469193780|FG003|Overall Study|Death|3|||
130334377|NCT01088048|469193781|FG004|Overall Study|Death|1|||
129993028|NCT00712673|467937722|FG001|Overall Study|Lost to Follow-up|0|||
129993029|NCT00712673|467937723|FG002|Overall Study|Lost to Follow-up|2|||
129993030|NCT00712673|467937724|FG003|Overall Study|Lost to Follow-up|0|||
129993031|NCT00712673|467937721|FG000|Overall Study|Withdrawal by Subject|6|||
129993032|NCT00712673|467937722|FG001|Overall Study|Withdrawal by Subject|7|||
129993033|NCT00712673|467937723|FG002|Overall Study|Withdrawal by Subject|15|||
129993034|NCT00712673|467937724|FG003|Overall Study|Withdrawal by Subject|20|||
129993035|NCT00712673|467937721|FG000|Overall Study|Familial and Personal Reasons|5|||
129993036|NCT00712673|467937722|FG001|Overall Study|Familial and Personal Reasons|0|||
129993037|NCT00712673|467937723|FG002|Overall Study|Familial and Personal Reasons|5|||
129993038|NCT00712673|467937724|FG003|Overall Study|Familial and Personal Reasons|2|||
129993039|NCT00712673|467937721|FG000|Overall Study|Investigator's Decision|1|||
129993040|NCT00712673|467937722|FG001|Overall Study|Investigator's Decision|0|||
129993041|NCT00712673|467937723|FG002|Overall Study|Investigator's Decision|0|||
129993042|NCT00712673|467937724|FG003|Overall Study|Investigator's Decision|0|||
129993043|NCT00712673|467937721|FG000|Overall Study|Protocol Violation|0|||
129993044|NCT00712673|467937722|FG001|Overall Study|Protocol Violation|0|||
129993045|NCT00712673|467937723|FG002|Overall Study|Protocol Violation|2|||
129993046|NCT00712673|467937724|FG003|Overall Study|Protocol Violation|0|||
129993047|NCT03603028|467937725|FG000|Overall Study|Withdrawal by Subject|1|||
129993048|NCT00842985|467937730|FG000|Screening|Did not meet entrance requirements|27|||
129993049|NCT00842985|467937730|FG000|First Intervention|Withdrawal by Subject|3|||
129993050|NCT00842985|467937730|FG000|First Intervention|Protocol Violation|3|||
129993051|NCT00842985|467937730|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
129993052|NCT00842985|467937730|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
129993053|NCT01000636|467937731|FG000|Overall Study|Withdrawal by Subject|1|||
129993054|NCT01000636|467937731|FG000|Overall Study|Adverse Event|1|||
129993055|NCT03451162|467937732|FG000|Overall Study|Lost to Follow-up|1|||
129993056|NCT03451162|467937733|FG001|Overall Study|Lost to Follow-up|0|||
129993057|NCT03451162|467937734|FG002|Overall Study|Lost to Follow-up|0|||
129993058|NCT03451162|467937735|FG003|Overall Study|Lost to Follow-up|0|||
129993059|NCT03451162|467937736|FG004|Overall Study|Lost to Follow-up|0|||
129993060|NCT03451162|467937732|FG000|Overall Study|Physician Decision|0|||
129993061|NCT03451162|467937733|FG001|Overall Study|Physician Decision|1|||
129993062|NCT03451162|467937734|FG002|Overall Study|Physician Decision|0|||
129993063|NCT03451162|467937735|FG003|Overall Study|Physician Decision|0|||
129993064|NCT03451162|467937736|FG004|Overall Study|Physician Decision|0|||
129993065|NCT03451162|467937732|FG000|Overall Study|Withdrawal by Subject|1|||
129993066|NCT03451162|467937733|FG001|Overall Study|Withdrawal by Subject|1|||
129993067|NCT03451162|467937734|FG002|Overall Study|Withdrawal by Subject|0|||
129993068|NCT03451162|467937735|FG003|Overall Study|Withdrawal by Subject|0|||
129993069|NCT03451162|467937736|FG004|Overall Study|Withdrawal by Subject|0|||
129993070|NCT03305731|467937737|FG000|Overall Study|Protocol Violation|1|||
129993071|NCT03658668|467937738|FG000|Overall Study|Time Commitment|1|||
129993072|NCT03658668|467937739|FG001|Overall Study|Time Commitment|1|||
129993073|NCT01127139|467937740|FG000|Overall Study|Adverse Event|40|||
129993074|NCT01127139|467937740|FG000|Overall Study|Incompliance|12|||
129993075|NCT01127139|467937740|FG000|Overall Study|Lack of Efficacy|4|||
129993076|NCT01127139|467937740|FG000|Overall Study|Reason not specified|1|||
129993077|NCT04964414|467937744|FG000|Overall Study|Lost to Follow-up|10|||
129993078|NCT04964414|467937745|FG001|Overall Study|Lost to Follow-up|8|||
129993079|NCT04964414|467937744|FG000|Overall Study|Withdrawal by Subject|1|||
129993080|NCT04964414|467937745|FG001|Overall Study|Withdrawal by Subject|1|||
129993081|NCT01718353|467937746|FG000|Overall Study|Lost to Follow-up|0|||
129993082|NCT01718353|467937747|FG001|Overall Study|Lost to Follow-up|1|||
129993083|NCT01718353|467937746|FG000|Overall Study|Principal Investigator's Decision|10|||
129993084|NCT01718353|467937747|FG001|Overall Study|Principal Investigator's Decision|4|||
129993085|NCT01718353|467937746|FG000|Overall Study|Randomized but not treated|2|||
129993086|NCT01718353|467937747|FG001|Overall Study|Randomized but not treated|0|||
129993087|NCT00455325|467937748|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
129993088|NCT00455325|467937749|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
130334378|NCT01088048|469193782|FG005|Overall Study|Death|3|||
130334379|NCT01088048|469193783|FG006|Overall Study|Death|0|||
129993089|NCT00455325|467937750|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
129993090|NCT00455325|467937751|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
129993091|NCT00455325|467937748|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
129993092|NCT00455325|467937749|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
129993093|NCT00455325|467937750|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
129993094|NCT00455325|467937751|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
129993095|NCT00455325|467937748|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
129993096|NCT00455325|467937749|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
129993097|NCT00455325|467937750|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
129993098|NCT00455325|467937751|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
129993099|NCT00455325|467937748|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
129993100|NCT00455325|467937749|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
129993101|NCT00455325|467937750|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
129993102|NCT00455325|467937751|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
129993103|NCT00455325|467937748|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
129993104|NCT00455325|467937749|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
129993105|NCT00455325|467937750|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
129993106|NCT00455325|467937751|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
129993107|NCT00455325|467937748|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
129993108|NCT00455325|467937749|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
129993109|NCT00455325|467937750|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
129993110|NCT00455325|467937751|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
129993111|NCT00455325|467937748|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
129993112|NCT00455325|467937749|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
129993113|NCT00455325|467937750|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
129993114|NCT00455325|467937751|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
129993115|NCT02745392|467937760|FG000|Overall Study|Lost to Follow-up|0|||
129993116|NCT02745392|467937761|FG001|Overall Study|Lost to Follow-up|1|||
129993117|NCT02745392|467937762|FG002|Overall Study|Lost to Follow-up|0|||
129993118|NCT02745392|467937763|FG003|Overall Study|Lost to Follow-up|0|||
129993119|NCT01691768|467937764|FG000|Overall Study|Death|0|||
129993120|NCT01691768|467937765|FG001|Overall Study|Death|2|||
129993121|NCT01691768|467937764|FG000|Overall Study|Lost to Follow-up|4|||
129993122|NCT01691768|467937765|FG001|Overall Study|Lost to Follow-up|3|||
129993123|NCT01691768|467937764|FG000|Overall Study|Withdrawal by Subject|10|||
129993124|NCT01691768|467937765|FG001|Overall Study|Withdrawal by Subject|9|||
129993125|NCT01691768|467937764|FG000|Overall Study|Relocated|0|||
129993126|NCT01691768|467937765|FG001|Overall Study|Relocated|1|||
129993127|NCT01691768|467937764|FG000|Overall Study|Investigator decision|1|||
129993128|NCT01691768|467937765|FG001|Overall Study|Investigator decision|1|||
129993129|NCT01959334|467937766|FG000|Second Dose|Adverse Event|1|||
129993130|NCT01959334|467937767|FG001|Second Dose|Adverse Event|0|||
129993131|NCT01959334|467937766|FG000|Third Dose|Adverse Event|0|||
129993132|NCT01959334|467937767|FG001|Third Dose|Adverse Event|1|||
129993133|NCT04781387|467937768|FG000|Overall Study|Withdrawal by Subject|1|||
129993134|NCT04781387|467937769|FG001|Overall Study|Withdrawal by Subject|0|||
129993135|NCT04781387|467937770|FG002|Overall Study|Withdrawal by Subject|1|||
129993136|NCT04781387|467937768|FG000|Overall Study|Lost to Follow-up|1|||
129993137|NCT04781387|467937769|FG001|Overall Study|Lost to Follow-up|0|||
129993138|NCT04781387|467937770|FG002|Overall Study|Lost to Follow-up|0|||
129993139|NCT01275131|467937778|FG000|Period 1|Withdrawal by Subject|1|||
129993140|NCT01275131|467937779|FG001|Period 1|Withdrawal by Subject|0|||
129993141|NCT01275131|467937780|FG002|Period 1|Withdrawal by Subject|3|||
129993142|NCT01275131|467937781|FG003|Period 1|Withdrawal by Subject|2|||
129993143|NCT01275131|467937778|FG000|Period 1|Physician Decision|1|||
129993144|NCT01275131|467937779|FG001|Period 1|Physician Decision|0|||
129993145|NCT01275131|467937780|FG002|Period 1|Physician Decision|0|||
129993146|NCT01275131|467937781|FG003|Period 1|Physician Decision|0|||
129993147|NCT01275131|467937778|FG000|Period 2 (Crossover)|Adverse Event|0|||
129993148|NCT01275131|467937779|FG001|Period 2 (Crossover)|Adverse Event|1|||
129993149|NCT01275131|467937780|FG002|Period 2 (Crossover)|Adverse Event|0|||
129993150|NCT01275131|467937781|FG003|Period 2 (Crossover)|Adverse Event|0|||
129993151|NCT01275131|467937778|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
129993152|NCT01275131|467937779|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
129993153|NCT01275131|467937780|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
129993154|NCT01275131|467937781|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
129993155|NCT02434939|467937785|FG000|Overall Study|Lack of Efficacy|34|||
129993156|NCT02434939|467937786|FG001|Overall Study|Lack of Efficacy|48|||
129993157|NCT02434939|467937785|FG000|Overall Study|Withdrawal by Subject|3|||
129993158|NCT02434939|467937786|FG001|Overall Study|Withdrawal by Subject|0|||
129993159|NCT02434939|467937785|FG000|Overall Study|Adverse Event|0|||
130334380|NCT01088048|469193784|FG007|Overall Study|Death|0|||
130334381|NCT01088048|469193785|FG008|Overall Study|Death|3|||
130334382|NCT01088048|469193786|FG009|Overall Study|Death|1|||
130334383|NCT01088048|469193777|FG000|Overall Study|Other|3|||
130334384|NCT01088048|469193778|FG001|Overall Study|Other|5|||
130334385|NCT01088048|469193779|FG002|Overall Study|Other|0|||
130334386|NCT01088048|469193780|FG003|Overall Study|Other|0|||
130334387|NCT01088048|469193781|FG004|Overall Study|Other|2|||
130334388|NCT01088048|469193782|FG005|Overall Study|Other|0|||
129993160|NCT02434939|467937786|FG001|Overall Study|Adverse Event|1|||
129993161|NCT00069238|467937789|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
129993162|NCT00069238|467937790|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
129993163|NCT00069238|467937791|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
130334389|NCT01088048|469193783|FG006|Overall Study|Other|0|||
130334390|NCT01088048|469193784|FG007|Overall Study|Other|2|||
130334391|NCT01088048|469193785|FG008|Overall Study|Other|0|||
129993164|NCT00069238|467937789|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
129993165|NCT00069238|467937790|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
130334392|NCT01088048|469193786|FG009|Overall Study|Other|0|||
130334393|NCT02563067|469193788|FG000|Overall Study|Subject/guardian decision|14|||
130334394|NCT02563067|469193789|FG001|Overall Study|Subject/guardian decision|20|||
130334395|NCT02563067|469193790|FG002|Overall Study|Subject/guardian decision|16|||
130334396|NCT02563067|469193788|FG000|Overall Study|Physician Decision|0|||
130334397|NCT02563067|469193789|FG001|Overall Study|Physician Decision|1|||
130334398|NCT02563067|469193790|FG002|Overall Study|Physician Decision|3|||
130334399|NCT02563067|469193788|FG000|Overall Study|Lost to Follow-up|1|||
130334400|NCT02563067|469193789|FG001|Overall Study|Lost to Follow-up|2|||
130334401|NCT02563067|469193790|FG002|Overall Study|Lost to Follow-up|0|||
129883876|NCT02733042|467534456|FG015|Overall Study|Progressive Disease|7|||
129883877|NCT02733042|467534457|FG016|Overall Study|Progressive Disease|2|||
129883878|NCT02733042|467534458|FG017|Overall Study|Progressive Disease|3|||
129883879|NCT02733042|467534459|FG018|Overall Study|Progressive Disease|4|||
129883880|NCT02733042|467534441|FG000|Overall Study|Withdrawal by Subject|0|||
129883881|NCT02733042|467534442|FG001|Overall Study|Withdrawal by Subject|1|||
129883882|NCT02733042|467534443|FG002|Overall Study|Withdrawal by Subject|2|||
129883883|NCT02733042|467534444|FG003|Overall Study|Withdrawal by Subject|1|||
129883884|NCT02733042|467534445|FG004|Overall Study|Withdrawal by Subject|1|||
129883885|NCT02733042|467534446|FG005|Overall Study|Withdrawal by Subject|0|||
129883886|NCT02733042|467534447|FG006|Overall Study|Withdrawal by Subject|0|||
129883887|NCT02733042|467534448|FG007|Overall Study|Withdrawal by Subject|0|||
129883888|NCT02733042|467534449|FG008|Overall Study|Withdrawal by Subject|1|||
129883889|NCT02733042|467534450|FG009|Overall Study|Withdrawal by Subject|1|||
129883890|NCT02733042|467534451|FG010|Overall Study|Withdrawal by Subject|0|||
129883891|NCT02733042|467534452|FG011|Overall Study|Withdrawal by Subject|2|||
129883892|NCT02733042|467534453|FG012|Overall Study|Withdrawal by Subject|1|||
129883893|NCT02733042|467534454|FG013|Overall Study|Withdrawal by Subject|1|||
129883894|NCT02733042|467534455|FG014|Overall Study|Withdrawal by Subject|0|||
129883895|NCT02733042|467534456|FG015|Overall Study|Withdrawal by Subject|0|||
129883896|NCT02733042|467534457|FG016|Overall Study|Withdrawal by Subject|0|||
129883897|NCT02733042|467534458|FG017|Overall Study|Withdrawal by Subject|0|||
129883898|NCT02733042|467534459|FG018|Overall Study|Withdrawal by Subject|0|||
129883899|NCT02733042|467534441|FG000|Overall Study|Other Reasons|0|||
129883900|NCT02733042|467534442|FG001|Overall Study|Other Reasons|0|||
129883901|NCT02733042|467534443|FG002|Overall Study|Other Reasons|1|||
129883902|NCT02733042|467534444|FG003|Overall Study|Other Reasons|0|||
129883903|NCT02733042|467534445|FG004|Overall Study|Other Reasons|0|||
129883904|NCT02733042|467534446|FG005|Overall Study|Other Reasons|0|||
129883905|NCT02733042|467534447|FG006|Overall Study|Other Reasons|0|||
129883906|NCT02733042|467534448|FG007|Overall Study|Other Reasons|0|||
129883907|NCT02733042|467534449|FG008|Overall Study|Other Reasons|0|||
129883908|NCT02733042|467534450|FG009|Overall Study|Other Reasons|1|||
129883909|NCT02733042|467534451|FG010|Overall Study|Other Reasons|1|||
129883910|NCT02733042|467534452|FG011|Overall Study|Other Reasons|0|||
129883911|NCT02733042|467534453|FG012|Overall Study|Other Reasons|0|||
129883912|NCT02733042|467534454|FG013|Overall Study|Other Reasons|0|||
129883913|NCT02733042|467534455|FG014|Overall Study|Other Reasons|0|||
129883914|NCT02733042|467534456|FG015|Overall Study|Other Reasons|1|||
129883915|NCT02733042|467534457|FG016|Overall Study|Other Reasons|0|||
129883916|NCT02733042|467534458|FG017|Overall Study|Other Reasons|1|||
129883917|NCT02733042|467534459|FG018|Overall Study|Other Reasons|0|||
129883918|NCT02733042|467534441|FG000|Overall Study|Death|0|||
129883919|NCT02733042|467534442|FG001|Overall Study|Death|0|||
129883920|NCT02733042|467534443|FG002|Overall Study|Death|0|||
129883921|NCT02733042|467534444|FG003|Overall Study|Death|0|||
129883922|NCT02733042|467534445|FG004|Overall Study|Death|0|||
129883923|NCT02733042|467534446|FG005|Overall Study|Death|0|||
129883924|NCT02733042|467534447|FG006|Overall Study|Death|1|||
129883925|NCT02733042|467534448|FG007|Overall Study|Death|0|||
129883926|NCT02733042|467534449|FG008|Overall Study|Death|1|||
129883927|NCT02733042|467534450|FG009|Overall Study|Death|0|||
129883928|NCT02733042|467534451|FG010|Overall Study|Death|1|||
129883929|NCT02733042|467534452|FG011|Overall Study|Death|0|||
129883930|NCT02733042|467534453|FG012|Overall Study|Death|0|||
129883931|NCT02733042|467534454|FG013|Overall Study|Death|0|||
129883932|NCT02733042|467534455|FG014|Overall Study|Death|1|||
129883933|NCT02733042|467534456|FG015|Overall Study|Death|2|||
129883934|NCT02733042|467534457|FG016|Overall Study|Death|0|||
130334402|NCT02563067|469193788|FG000|Overall Study|Technical problems|0|||
129883935|NCT02733042|467534458|FG017|Overall Study|Death|0|||
129883936|NCT02733042|467534459|FG018|Overall Study|Death|0|||
129883937|NCT00219141|467534461|FG000|Overall Study|Adverse Event|4|||
129883938|NCT00219141|467534462|FG001|Overall Study|Adverse Event|10|||
129883939|NCT00219141|467534463|FG002|Overall Study|Adverse Event|5|||
129883940|NCT00219141|467534461|FG000|Overall Study|Lack of Efficacy|3|||
129883941|NCT00219141|467534462|FG001|Overall Study|Lack of Efficacy|2|||
129883942|NCT00219141|467534463|FG002|Overall Study|Lack of Efficacy|0|||
129883943|NCT00219141|467534461|FG000|Overall Study|Administrative problems|0|||
129883944|NCT00219141|467534462|FG001|Overall Study|Administrative problems|1|||
129883945|NCT00219141|467534463|FG002|Overall Study|Administrative problems|0|||
129883946|NCT00219141|467534461|FG000|Overall Study|Lost to Follow-up|2|||
130334403|NCT02563067|469193789|FG001|Overall Study|Technical problems|1|||
129993166|NCT00069238|467937791|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
129993167|NCT00069238|467937789|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
129993168|NCT00069238|467937790|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
129993169|NCT00069238|467937791|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
129993170|NCT01001832|467937792|FG000|Short-term Period|Adverse Event|2|||
129993171|NCT01001832|467937793|FG001|Short-term Period|Adverse Event|3|||
129993172|NCT01001832|467937792|FG000|Long-term Period|Adverse Event|2|||
129993173|NCT01001832|467937793|FG001|Long-term Period|Adverse Event|1|||
129993174|NCT01001832|467937792|FG000|Long-term Period|Withdrawal by Subject|1|||
129993175|NCT01001832|467937793|FG001|Long-term Period|Withdrawal by Subject|0|||
129993176|NCT01001832|467937792|FG000|Long-term Period|Lack of Efficacy|0|||
129993177|NCT01001832|467937793|FG001|Long-term Period|Lack of Efficacy|2|||
129993178|NCT01001832|467937792|FG000|Long-term Period|Other|1|||
129993179|NCT01001832|467937793|FG001|Long-term Period|Other|2|||
129993180|NCT01001832|467937792|FG000|Follow-up Period|Withdrawal by Subject|1|||
129993181|NCT01001832|467937793|FG001|Follow-up Period|Withdrawal by Subject|0|||
129993182|NCT01001832|467937792|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
129993183|NCT01001832|467937793|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
129993184|NCT01001832|467937792|FG000|Follow-up Period|Other|2|||
129993185|NCT01001832|467937793|FG001|Follow-up Period|Other|1|||
129993186|NCT00710021|467937800|FG000|Overall Study|Lost to Follow-up|1|||
129993187|NCT00710021|467937801|FG001|Overall Study|Lost to Follow-up|0|||
129993188|NCT00710021|467937802|FG002|Overall Study|Lost to Follow-up|0|||
129993189|NCT00710021|467937800|FG000|Overall Study|Subject's Decision|0|||
129993190|NCT00710021|467937801|FG001|Overall Study|Subject's Decision|1|||
129993191|NCT00710021|467937802|FG002|Overall Study|Subject's Decision|0|||
129993192|NCT00710021|467937800|FG000|Overall Study|Subject misrandomized|0|||
129993193|NCT00710021|467937801|FG001|Overall Study|Subject misrandomized|1|||
129993194|NCT00710021|467937802|FG002|Overall Study|Subject misrandomized|1|||
129993195|NCT00710021|467937800|FG000|Overall Study|Physician Decision|0|||
129993196|NCT00710021|467937801|FG001|Overall Study|Physician Decision|1|||
129993197|NCT00710021|467937802|FG002|Overall Study|Physician Decision|0|||
129993198|NCT00529958|467937803|FG000|2-Year Follow-up|Lost to Follow-up|1|||
129993199|NCT00529958|467937804|FG001|2-Year Follow-up|Lost to Follow-up|2|||
129993200|NCT00529958|467937805|FG002|2-Year Follow-up|Lost to Follow-up|2|||
129993201|NCT00529958|467937803|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
129993202|NCT00529958|467937804|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
129993203|NCT00529958|467937805|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
129993204|NCT00529958|467937803|FG000|5-Year Follow-up|Lost to Follow-up|2|||
129993205|NCT00529958|467937804|FG001|5-Year Follow-up|Lost to Follow-up|3|||
129993206|NCT00529958|467937805|FG002|5-Year Follow-up|Lost to Follow-up|1|||
129993207|NCT00529958|467937803|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
129993208|NCT00529958|467937804|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
129993209|NCT00529958|467937805|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
129993210|NCT03316300|467937806|FG000|Overall Study|Withdrawal by Subject|3|||
129993211|NCT03316300|467937807|FG001|Overall Study|Withdrawal by Subject|2|||
129993212|NCT03316300|467937806|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
129993213|NCT03316300|467937807|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
129993214|NCT03316300|467937806|FG000|Overall Study|Adverse Event|1|||
129993215|NCT03316300|467937807|FG001|Overall Study|Adverse Event|0|||
129993216|NCT03316300|467937806|FG000|Overall Study|COVID-19|0|||
129993217|NCT03316300|467937807|FG001|Overall Study|COVID-19|1|||
129993218|NCT01315353|467937808|FG000|Overall Study|Death|2|||
129993219|NCT01315353|467937809|FG001|Overall Study|Death|1|||
129993220|NCT01315353|467937810|FG002|Overall Study|Death|0|||
129993221|NCT01315353|467937808|FG000|Overall Study|Withdrawal by Subject|2|||
129993222|NCT01315353|467937809|FG001|Overall Study|Withdrawal by Subject|6|||
129993223|NCT01315353|467937810|FG002|Overall Study|Withdrawal by Subject|1|||
129993224|NCT01315353|467937808|FG000|Overall Study|Lost to Follow-up|13|||
129993225|NCT01315353|467937809|FG001|Overall Study|Lost to Follow-up|6|||
129993226|NCT01315353|467937810|FG002|Overall Study|Lost to Follow-up|6|||
129993227|NCT01315353|467937808|FG000|Overall Study|Unwilling to adhere to requirements|5|||
129993228|NCT01315353|467937809|FG001|Overall Study|Unwilling to adhere to requirements|5|||
129993229|NCT01315353|467937810|FG002|Overall Study|Unwilling to adhere to requirements|4|||
129993230|NCT01315353|467937808|FG000|Overall Study|Site closing|7|||
129993231|NCT01315353|467937809|FG001|Overall Study|Site closing|4|||
129993232|NCT01315353|467937810|FG002|Overall Study|Site closing|0|||
129993233|NCT01315353|467937808|FG000|Overall Study|Taken off study by site in error|0|||
129993234|NCT01315353|467937809|FG001|Overall Study|Taken off study by site in error|1|||
129993235|NCT01315353|467937810|FG002|Overall Study|Taken off study by site in error|0|||
129993236|NCT01315353|467937808|FG000|Overall Study|Inadvertent randomization/assignment|0|||
129993237|NCT01315353|467937809|FG001|Overall Study|Inadvertent randomization/assignment|0|||
129993238|NCT01315353|467937810|FG002|Overall Study|Inadvertent randomization/assignment|2|||
129993239|NCT03567434|467937811|FG000|Overall Study|Lost to Follow-up|1|||
129993240|NCT03567434|467937812|FG001|Overall Study|Lost to Follow-up|3|||
129993241|NCT01050790|467937814|FG000|Overall Study|Adverse Event|1|||
129993242|NCT03705832|467937815|FG000|Overall Study|Physician Decision|0|||
129993243|NCT03705832|467937816|FG001|Overall Study|Physician Decision|1|||
129993244|NCT03705832|467937815|FG000|Overall Study|Withdrawal by Subject|1|||
129993245|NCT03705832|467937816|FG001|Overall Study|Withdrawal by Subject|0|||
129993246|NCT01880528|467937817|FG000|Overall Study|Other|1|||
129993247|NCT01880528|467937818|FG001|Overall Study|Other|1|||
129993248|NCT01439360|467937819|FG000|Overall Study|Adverse Event|4|||
129993249|NCT01439360|467937820|FG001|Overall Study|Adverse Event|16|||
129993250|NCT01439360|467937819|FG000|Overall Study|Lost to Follow-up|43|||
129993251|NCT01439360|467937820|FG001|Overall Study|Lost to Follow-up|58|||
129993252|NCT01439360|467937819|FG000|Overall Study|Others|10|||
129993253|NCT01439360|467937820|FG001|Overall Study|Others|5|||
129993254|NCT01439360|467937819|FG000|Overall Study|Protocol Violation|1|||
129993255|NCT01439360|467937820|FG001|Overall Study|Protocol Violation|0|||
129993256|NCT01439360|467937819|FG000|Overall Study|Withdrawal by Subject|140|||
129993257|NCT01439360|467937820|FG001|Overall Study|Withdrawal by Subject|129|||
129993258|NCT01328717|467938955|FG000|Overall Study|Adverse Event|1|||
129993259|NCT03440320|467938956|FG000|Overall Study|Withdrawal by Subject|0|||
129993260|NCT03440320|467938957|FG001|Overall Study|Withdrawal by Subject|1|||
129993261|NCT01912456|467938958|FG000|Period 1|Physician Decision|0|||
129993262|NCT01912456|467938959|FG001|Period 1|Physician Decision|0|||
129993263|NCT01912456|467938960|FG002|Period 1|Physician Decision|1|||
129993264|NCT01912456|467938961|FG003|Period 1|Physician Decision|0|||
129993265|NCT01912456|467938958|FG000|Period 1|non-compliance|1|||
129993266|NCT01912456|467938959|FG001|Period 1|non-compliance|0|||
129993267|NCT01912456|467938960|FG002|Period 1|non-compliance|0|||
129993268|NCT01912456|467938961|FG003|Period 1|non-compliance|1|||
129993269|NCT01912456|467938958|FG000|Period 1|Adverse Event|1|||
129993270|NCT01912456|467938959|FG001|Period 1|Adverse Event|0|||
129993271|NCT01912456|467938960|FG002|Period 1|Adverse Event|0|||
129993272|NCT01912456|467938961|FG003|Period 1|Adverse Event|1|||
129993273|NCT01912456|467938958|FG000|Period 1|Withdrawal by Subject|0|||
129993274|NCT01912456|467938959|FG001|Period 1|Withdrawal by Subject|1|||
129993275|NCT01912456|467938960|FG002|Period 1|Withdrawal by Subject|1|||
129993276|NCT01912456|467938961|FG003|Period 1|Withdrawal by Subject|1|||
129993277|NCT01912456|467938958|FG000|Period 2|Lack of Efficacy|0|||
129993278|NCT01912456|467938959|FG001|Period 2|Lack of Efficacy|2|||
129993279|NCT01912456|467938960|FG002|Period 2|Lack of Efficacy|0|||
129993280|NCT01912456|467938961|FG003|Period 2|Lack of Efficacy|0|||
129993281|NCT01912456|467938958|FG000|Period 2|Adverse Event|0|||
129993282|NCT01912456|467938959|FG001|Period 2|Adverse Event|0|||
129993283|NCT01912456|467938960|FG002|Period 2|Adverse Event|0|||
129993284|NCT01912456|467938961|FG003|Period 2|Adverse Event|1|||
129993285|NCT01201343|467938962|FG000|Overall Study|Adverse Event|6|||
129993286|NCT01201343|467938962|FG000|Overall Study|Withdrawal by Subject|5|||
129993287|NCT01201343|467938962|FG000|Overall Study|Lost to Follow-up|2|||
129993288|NCT01201343|467938962|FG000|Overall Study|Lack of Efficacy|2|||
129993289|NCT01201343|467938962|FG000|Overall Study|Participant wrongly included in trial|1|||
129993290|NCT01201343|467938962|FG000|Overall Study|Randomized, not treated|3|||
129993291|NCT00001962|467938965|FG000|Overall Study|Lack of Efficacy|18|||
129993292|NCT00001962|467938965|FG000|Overall Study|Lack of Accrual|6|||
129993293|NCT00001962|467938965|FG000|Overall Study|Death|1|||
129993294|NCT00001962|467938965|FG000|Overall Study|Lost to Follow-up|2|||
129993295|NCT00001962|467938965|FG000|Overall Study|Adverse Event|1|||
129993296|NCT01440374|467938966|FG000|Part 1: Open-label Phase|Adverse Event|5|||
129993297|NCT01440374|467938967|FG001|Part 1: Open-label Phase|Adverse Event|0|||
129993298|NCT01440374|467938968|FG002|Part 1: Open-label Phase|Adverse Event|0|||
129993299|NCT01440374|467938969|FG003|Part 1: Open-label Phase|Adverse Event|0|||
129993300|NCT01440374|467938966|FG000|Part 1: Open-label Phase|Physician Decision|1|||
129993301|NCT01440374|467938967|FG001|Part 1: Open-label Phase|Physician Decision|0|||
129993302|NCT01440374|467938968|FG002|Part 1: Open-label Phase|Physician Decision|0|||
129993303|NCT01440374|467938969|FG003|Part 1: Open-label Phase|Physician Decision|0|||
129993304|NCT01440374|467938966|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
129993305|NCT01440374|467938967|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
129993306|NCT01440374|467938968|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
129993307|NCT01440374|467938969|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
129993308|NCT01440374|467938966|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
129993309|NCT01440374|467938967|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
129993310|NCT01440374|467938968|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
129993311|NCT01440374|467938969|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
129993312|NCT01440374|467938966|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
129993313|NCT01440374|467938967|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
129993314|NCT01440374|467938968|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
129993315|NCT01440374|467938969|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
129993316|NCT01440374|467938966|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
129993317|NCT01440374|467938967|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
129993318|NCT01440374|467938968|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
129993319|NCT01440374|467938969|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
129993320|NCT01440374|467938966|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
129883947|NCT00219141|467534462|FG001|Overall Study|Lost to Follow-up|4|||
129883948|NCT00219141|467534463|FG002|Overall Study|Lost to Follow-up|1|||
129883949|NCT00219141|467534461|FG000|Overall Study|Protocol Violation|3|||
129883950|NCT00219141|467534462|FG001|Overall Study|Protocol Violation|1|||
129883951|NCT00219141|467534463|FG002|Overall Study|Protocol Violation|1|||
129883952|NCT00219141|467534461|FG000|Overall Study|Withdrawal by Subject|1|||
129883953|NCT00219141|467534462|FG001|Overall Study|Withdrawal by Subject|3|||
129883954|NCT00219141|467534463|FG002|Overall Study|Withdrawal by Subject|5|||
129993321|NCT01440374|467938967|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
129993322|NCT01440374|467938968|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
129993323|NCT01440374|467938969|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
129993324|NCT01440374|467938966|FG000|Part 2; Double-blind Phase|Not treated|0|||
130334404|NCT02563067|469193790|FG002|Overall Study|Technical problems|0|||
130334405|NCT02563067|469193788|FG000|Overall Study|Lack of Efficacy|1|||
130334406|NCT02563067|469193789|FG001|Overall Study|Lack of Efficacy|0|||
130334407|NCT02563067|469193790|FG002|Overall Study|Lack of Efficacy|0|||
130334408|NCT02563067|469193788|FG000|Overall Study|Death|0|||
130334409|NCT02563067|469193789|FG001|Overall Study|Death|1|||
130334410|NCT02563067|469193790|FG002|Overall Study|Death|1|||
130334411|NCT02563067|469193788|FG000|Overall Study|Adverse Event|2|||
130334412|NCT02563067|469193789|FG001|Overall Study|Adverse Event|1|||
130334413|NCT02563067|469193790|FG002|Overall Study|Adverse Event|0|||
130334414|NCT02563067|469193788|FG000|Overall Study|Death post Treatment/safety period|1|||
130334415|NCT02563067|469193789|FG001|Overall Study|Death post Treatment/safety period|0|||
130334416|NCT02563067|469193790|FG002|Overall Study|Death post Treatment/safety period|0|||
130334417|NCT03544333|469193800|FG000|Overall Study|Withdrawal by Subject|1|||
130334418|NCT03544333|469193801|FG001|Overall Study|Withdrawal by Subject|0|||
130334419|NCT01039519|469193805|FG000|Treatment|Progressive disease|20|||
130334420|NCT01039519|469193805|FG000|Treatment|Treatment failure|2|||
130334421|NCT01039519|469193805|FG000|Treatment|Adverse Event|3|||
130334422|NCT01039519|469193805|FG000|Treatment|Physician Decision|2|||
130334423|NCT01039519|469193805|FG000|Survival Follow-up|Death|23|||
130334424|NCT01039519|469193805|FG000|Survival Follow-up|Sponsor decision|4|||
129993325|NCT01440374|467938967|FG001|Part 2; Double-blind Phase|Not treated|0|||
129993326|NCT01440374|467938968|FG002|Part 2; Double-blind Phase|Not treated|1|||
129993327|NCT01440374|467938969|FG003|Part 2; Double-blind Phase|Not treated|0|||
129993328|NCT01440374|467938966|FG000|Part 3: Extension|Withdrawal by Subject|0|||
129993329|NCT01440374|467938967|FG001|Part 3: Extension|Withdrawal by Subject|0|||
129993330|NCT01440374|467938968|FG002|Part 3: Extension|Withdrawal by Subject|0|||
129993331|NCT01440374|467938969|FG003|Part 3: Extension|Withdrawal by Subject|5|||
129993332|NCT01440374|467938966|FG000|Part 3: Extension|Adverse Event|0|||
129993333|NCT01440374|467938967|FG001|Part 3: Extension|Adverse Event|0|||
129993334|NCT01440374|467938968|FG002|Part 3: Extension|Adverse Event|0|||
129993335|NCT01440374|467938969|FG003|Part 3: Extension|Adverse Event|13|||
129993336|NCT01440374|467938966|FG000|Part 3: Extension|Physician Decision|0|||
129993337|NCT01440374|467938967|FG001|Part 3: Extension|Physician Decision|0|||
129993338|NCT01440374|467938968|FG002|Part 3: Extension|Physician Decision|0|||
129993339|NCT01440374|467938969|FG003|Part 3: Extension|Physician Decision|14|||
129993340|NCT01177722|467938978|FG000|Overall Study|Serious Adverse Event|0|||
129993341|NCT01177722|467938979|FG001|Overall Study|Serious Adverse Event|0|||
129993342|NCT01177722|467938980|FG002|Overall Study|Serious Adverse Event|1|||
129993343|NCT01177722|467938981|FG003|Overall Study|Serious Adverse Event|0|||
129993344|NCT01177722|467938978|FG000|Overall Study|Protocol Violation|0|||
129993345|NCT01177722|467938979|FG001|Overall Study|Protocol Violation|0|||
129993346|NCT01177722|467938980|FG002|Overall Study|Protocol Violation|1|||
129993347|NCT01177722|467938981|FG003|Overall Study|Protocol Violation|0|||
129993348|NCT01177722|467938978|FG000|Overall Study|Lost to Follow-up|3|||
129993349|NCT01177722|467938979|FG001|Overall Study|Lost to Follow-up|4|||
129993350|NCT01177722|467938980|FG002|Overall Study|Lost to Follow-up|3|||
129993351|NCT01177722|467938981|FG003|Overall Study|Lost to Follow-up|1|||
129993352|NCT01177722|467938978|FG000|Overall Study|Withdrawal by Subject|10|||
129993353|NCT01177722|467938979|FG001|Overall Study|Withdrawal by Subject|6|||
130334425|NCT01330108|469193808|FG000|Overall Study|Withdrawal by Subject|4|||
130334426|NCT00485134|469193809|FG000|Overall Study|Lost to Follow-up|1|||
130334427|NCT00485134|469193810|FG001|Overall Study|Lost to Follow-up|0|||
130334428|NCT00485134|469193811|FG002|Overall Study|Lost to Follow-up|0|||
130334429|NCT00485134|469193812|FG003|Overall Study|Lost to Follow-up|0|||
129993354|NCT01177722|467938980|FG002|Overall Study|Withdrawal by Subject|4|||
129993355|NCT01177722|467938981|FG003|Overall Study|Withdrawal by Subject|6|||
129993356|NCT04281004|467938994|FG000|Overall Study|Physician Decision|1|||
129993357|NCT04281004|467938995|FG001|Overall Study|Physician Decision|0|||
129993358|NCT03628898|467938996|FG000|Overall Study|Device deficiency|1|||
129883955|NCT00219141|467534461|FG000|Overall Study|Condition no longer requires study drug|1|||
129883956|NCT00219141|467534462|FG001|Overall Study|Condition no longer requires study drug|0|||
129993359|NCT03442985|467938997|FG000|Overall Study|Sponsor Request|55|||
130334430|NCT00485134|469193813|FG004|Overall Study|Lost to Follow-up|0|||
130334431|NCT00485134|469193814|FG005|Overall Study|Lost to Follow-up|0|||
130334432|NCT00485134|469193815|FG006|Overall Study|Lost to Follow-up|0|||
129993360|NCT03442985|467938998|FG001|Overall Study|Sponsor Request|60|||
129993361|NCT03442985|467938999|FG002|Overall Study|Sponsor Request|54|||
129993362|NCT03442985|467938997|FG000|Overall Study|Lost to Follow-up|5|||
129993363|NCT03442985|467938998|FG001|Overall Study|Lost to Follow-up|2|||
129993364|NCT03442985|467938999|FG002|Overall Study|Lost to Follow-up|7|||
129993365|NCT03442985|467938997|FG000|Overall Study|Withdrawal by Subject|2|||
129993366|NCT03442985|467938998|FG001|Overall Study|Withdrawal by Subject|3|||
129993367|NCT03442985|467938999|FG002|Overall Study|Withdrawal by Subject|4|||
129993368|NCT03442985|467938997|FG000|Overall Study|Adverse Event|0|||
129993369|NCT03442985|467938998|FG001|Overall Study|Adverse Event|1|||
129993370|NCT03442985|467938999|FG002|Overall Study|Adverse Event|0|||
129993371|NCT01217957|467939000|FG000|Phase 1|Withdrawal by Patient|1|||
129993372|NCT01217957|467939001|FG001|Phase 1|Withdrawal by Patient|0|||
129993373|NCT01217957|467939002|FG002|Phase 1|Withdrawal by Patient|1|||
129993374|NCT01217957|467939003|FG003|Phase 1|Withdrawal by Patient|1|||
129993375|NCT01217957|467939004|FG004|Phase 1|Withdrawal by Patient|0|||
129993376|NCT01217957|467939000|FG000|Phase 2|Withdrawal by Patient|0|||
129993377|NCT01217957|467939001|FG001|Phase 2|Withdrawal by Patient|0|||
129993378|NCT01217957|467939002|FG002|Phase 2|Withdrawal by Patient|0|||
129993379|NCT01217957|467939003|FG003|Phase 2|Withdrawal by Patient|0|||
129993380|NCT01217957|467939004|FG004|Phase 2|Withdrawal by Patient|1|||
129993381|NCT01716117|467939010|FG000|Overall Study|Death|5|||
129993382|NCT01716117|467939011|FG001|Overall Study|Death|2|||
129993383|NCT01716117|467939010|FG000|Overall Study|Withdrawal by Subject|2|||
129993384|NCT01716117|467939011|FG001|Overall Study|Withdrawal by Subject|0|||
129993385|NCT00762970|467939015|FG000|Overall Study|Withdrawal by Subject|7|||
129993386|NCT00762970|467939016|FG001|Overall Study|Withdrawal by Subject|4|||
129993387|NCT00762970|467939017|FG002|Overall Study|Withdrawal by Subject|0|||
129993388|NCT00762970|467939015|FG000|Overall Study|Protocol Violation|3|||
129993389|NCT00762970|467939016|FG001|Overall Study|Protocol Violation|1|||
129993390|NCT00762970|467939017|FG002|Overall Study|Protocol Violation|1|||
129993391|NCT00762970|467939015|FG000|Overall Study|Lost to Follow-up|1|||
129993392|NCT00762970|467939016|FG001|Overall Study|Lost to Follow-up|2|||
129993393|NCT00762970|467939017|FG002|Overall Study|Lost to Follow-up|0|||
129993394|NCT00762970|467939015|FG000|Overall Study|Difficulty of handling lens|1|||
129993395|NCT00762970|467939016|FG001|Overall Study|Difficulty of handling lens|2|||
129993396|NCT00762970|467939017|FG002|Overall Study|Difficulty of handling lens|0|||
129993397|NCT03864146|467939018|FG000|Overall Study|Lost to Follow-up|14|||
129993398|NCT03864146|467939019|FG001|Overall Study|Lost to Follow-up|23|||
129993399|NCT03864146|467939018|FG000|Overall Study|Withdrawal by Subject|3|||
129993400|NCT03864146|467939019|FG001|Overall Study|Withdrawal by Subject|2|||
129993401|NCT00690820|467939023|FG000|Period 1|Withdrawal by Subject|0|||
129993402|NCT00690820|467939024|FG001|Period 1|Withdrawal by Subject|1|||
129993403|NCT01768117|467939026|FG000|Overall Study|Lost to Follow-up|1|||
129993404|NCT01768117|467939026|FG000|Overall Study|Withdrawal by Subject|2|||
129993405|NCT01768117|467939026|FG000|Overall Study|Protocol Violation|3|||
129993406|NCT01580969|467939029|FG000|Overall Study|Physician Decision|3|||
129993407|NCT01580969|467939030|FG001|Overall Study|Physician Decision|0|||
129993408|NCT01580969|467939031|FG002|Overall Study|Physician Decision|0|||
129993409|NCT01079741|467939037|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129993410|NCT01079741|467939038|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
129993411|NCT01079741|467939039|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129993412|NCT01079741|467939040|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129993413|NCT01079741|467939041|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129993414|NCT01079741|467939037|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129993415|NCT01079741|467939038|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129993416|NCT01079741|467939039|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129993417|NCT01079741|467939040|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129993418|NCT01079741|467939041|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
129993419|NCT00446992|467939042|FG000|Overall Study|Adverse Event|11|||
129993420|NCT00446992|467939042|FG000|Overall Study|Lost to Follow-up|5|||
129993421|NCT02076178|467939043|FG000|Oral Phase|Adverse Event|0|||
129993422|NCT02076178|467939044|FG001|Oral Phase|Adverse Event|7|||
129993423|NCT02076178|467939043|FG000|Oral Phase|Withdrawal by Subject|0|||
129993424|NCT02076178|467939044|FG001|Oral Phase|Withdrawal by Subject|4|||
129993425|NCT02076178|467939043|FG000|Oral Phase|Physician Decision|0|||
129993426|NCT02076178|467939044|FG001|Oral Phase|Physician Decision|1|||
129993427|NCT02076178|467939043|FG000|Injection Phase|Protocol defined stopping criteria|1|||
129993428|NCT02076178|467939044|FG001|Injection Phase|Protocol defined stopping criteria|0|||
129993429|NCT02076178|467939043|FG000|Injection Phase|Withdrawal by Subject|0|||
129993430|NCT02076178|467939044|FG001|Injection Phase|Withdrawal by Subject|3|||
129993431|NCT02076178|467939043|FG000|Injection Phase|Physician Decision|0|||
129993432|NCT02076178|467939044|FG001|Injection Phase|Physician Decision|3|||
129993433|NCT02076178|467939043|FG000|Injection Phase|Lost to Follow-up|0|||
129993434|NCT02076178|467939044|FG001|Injection Phase|Lost to Follow-up|1|||
129993435|NCT03021954|467939049|FG000|Overall Study|Lost to Follow-up|10|||
129993436|NCT03021954|467939050|FG001|Overall Study|Lost to Follow-up|43|||
130334433|NCT00485134|469193816|FG007|Overall Study|Lost to Follow-up|0|||
129993437|NCT03021954|467939049|FG000|Overall Study|Subjects had avulsion trauma|4|||
129993438|NCT03021954|467939050|FG001|Overall Study|Subjects had avulsion trauma|1|||
129993439|NCT01536015|467939055|FG000|Overall Study|Adverse Event|1|||
129993440|NCT01536015|467939056|FG001|Overall Study|Adverse Event|4|||
129993441|NCT01536015|467939055|FG000|Overall Study|Lost to Follow-up|0|||
129993442|NCT01536015|467939056|FG001|Overall Study|Lost to Follow-up|1|||
129993443|NCT01536015|467939055|FG000|Overall Study|Inclusion Criterion not met|2|||
129993444|NCT01536015|467939056|FG001|Overall Study|Inclusion Criterion not met|0|||
129993445|NCT01536015|467939055|FG000|Overall Study|Study closure|5|||
129993446|NCT01536015|467939056|FG001|Overall Study|Study closure|5|||
129993447|NCT03581825|467939058|FG000|Period 1|Lens Discomfort|1|||
129993448|NCT03581825|467939059|FG001|Period 1|Lens Discomfort|0|||
129993449|NCT03581825|467939058|FG000|Period 2|Unsatisfactory Vision to Test|0|||
129993450|NCT03581825|467939059|FG001|Period 2|Unsatisfactory Vision to Test|1|||
129993451|NCT01668667|467939060|FG000|Overall Study|Adverse Event|3|||
129993452|NCT01668667|467939061|FG001|Overall Study|Adverse Event|6|||
129993453|NCT01668667|467939062|FG002|Overall Study|Adverse Event|4|||
129993454|NCT01668667|467939063|FG003|Overall Study|Adverse Event|4|||
129993455|NCT01668667|467939060|FG000|Overall Study|Lack of Efficacy|3|||
129993456|NCT01668667|467939061|FG001|Overall Study|Lack of Efficacy|2|||
129993457|NCT01668667|467939062|FG002|Overall Study|Lack of Efficacy|2|||
129993458|NCT01668667|467939063|FG003|Overall Study|Lack of Efficacy|3|||
129993459|NCT01668667|467939060|FG000|Overall Study|Protocol Violation|6|||
129993460|NCT01668667|467939061|FG001|Overall Study|Protocol Violation|10|||
129993461|NCT01668667|467939062|FG002|Overall Study|Protocol Violation|12|||
129993462|NCT01668667|467939063|FG003|Overall Study|Protocol Violation|5|||
129993463|NCT01668667|467939060|FG000|Overall Study|Lost to Follow-up|9|||
129993464|NCT01668667|467939061|FG001|Overall Study|Lost to Follow-up|4|||
129993465|NCT01668667|467939062|FG002|Overall Study|Lost to Follow-up|7|||
129993466|NCT01668667|467939063|FG003|Overall Study|Lost to Follow-up|6|||
129993467|NCT01668667|467939060|FG000|Overall Study|Physician Decision|3|||
129993468|NCT01668667|467939061|FG001|Overall Study|Physician Decision|0|||
129993469|NCT01668667|467939062|FG002|Overall Study|Physician Decision|1|||
129993470|NCT01668667|467939063|FG003|Overall Study|Physician Decision|0|||
129993471|NCT01668667|467939060|FG000|Overall Study|Withdrawal by Subject|7|||
129993472|NCT01668667|467939061|FG001|Overall Study|Withdrawal by Subject|4|||
129993473|NCT01668667|467939062|FG002|Overall Study|Withdrawal by Subject|5|||
129993474|NCT01668667|467939063|FG003|Overall Study|Withdrawal by Subject|5|||
129993475|NCT00511901|467939064|FG000|Overall Study|Withdrawal by Subject|1|||
129993476|NCT00511901|467939065|FG001|Overall Study|Withdrawal by Subject|3|||
129993477|NCT02447172|467939066|FG000|Overall Study|Adverse Event|11|||
129993478|NCT02447172|467939067|FG001|Overall Study|Adverse Event|8|||
129993479|NCT02447172|467939068|FG002|Overall Study|Adverse Event|7|||
129993480|NCT02447172|467939066|FG000|Overall Study|Death|3|||
129993481|NCT02447172|467939067|FG001|Overall Study|Death|1|||
129993482|NCT02447172|467939068|FG002|Overall Study|Death|0|||
129993483|NCT02447172|467939066|FG000|Overall Study|Protocol Violation|2|||
129993484|NCT02447172|467939067|FG001|Overall Study|Protocol Violation|1|||
129993485|NCT02447172|467939068|FG002|Overall Study|Protocol Violation|2|||
129993486|NCT02447172|467939066|FG000|Overall Study|Lost to Follow-up|7|||
129993487|NCT02447172|467939067|FG001|Overall Study|Lost to Follow-up|4|||
129993488|NCT02447172|467939068|FG002|Overall Study|Lost to Follow-up|4|||
129993489|NCT02447172|467939066|FG000|Overall Study|Withdrawal by Subject|5|||
129993490|NCT02447172|467939067|FG001|Overall Study|Withdrawal by Subject|1|||
129993491|NCT02447172|467939068|FG002|Overall Study|Withdrawal by Subject|3|||
129993492|NCT02447172|467939066|FG000|Overall Study|protocol specific treatment unrelated|3|||
129993493|NCT02447172|467939067|FG001|Overall Study|protocol specific treatment unrelated|0|||
129993494|NCT02447172|467939068|FG002|Overall Study|protocol specific treatment unrelated|2|||
129993495|NCT03343301|467939069|FG000|Overall Study|Withdrawal by Subject|1|||
129993496|NCT03343301|467939070|FG001|Overall Study|Withdrawal by Subject|1|||
129993497|NCT03343301|467939069|FG000|Overall Study|Death|0|||
129993498|NCT03343301|467939070|FG001|Overall Study|Death|2|||
129993499|NCT03343301|467939069|FG000|Overall Study|Other|0|||
129993500|NCT03343301|467939070|FG001|Overall Study|Other|6|||
129993501|NCT03343301|467939069|FG000|Overall Study|Missing|2|||
129993502|NCT03343301|467939070|FG001|Overall Study|Missing|0|||
129993503|NCT02881957|467939083|FG000|Overall Study|Comfort care|0|||
130334434|NCT00485134|469193809|FG000|Overall Study|Withdrawal by Subject|0|||
129993504|NCT02881957|467939084|FG001|Overall Study|Comfort care|1|||
129993505|NCT02881957|467939083|FG000|Overall Study|Concurrent trial enrollment|0|||
129993506|NCT02881957|467939084|FG001|Overall Study|Concurrent trial enrollment|1|||
130334435|NCT00485134|469193810|FG001|Overall Study|Withdrawal by Subject|1|||
129993507|NCT02881957|467939083|FG000|Overall Study|Discharged within 48 hours|0|||
129993508|NCT02881957|467939084|FG001|Overall Study|Discharged within 48 hours|1|||
129993509|NCT02881957|467939083|FG000|Overall Study|Withdrawal by Subject|2|||
129993510|NCT02881957|467939084|FG001|Overall Study|Withdrawal by Subject|1|||
129993511|NCT02881957|467939083|FG000|Overall Study|Protocol Violation|1|||
129993512|NCT02881957|467939084|FG001|Overall Study|Protocol Violation|0|||
129993513|NCT00345293|467939085|FG000|Overall Study|Unable to access line for sample|1|||
129993514|NCT00345293|467939086|FG001|Overall Study|Unable to access line for sample|0|||
129993515|NCT00345293|467939085|FG000|Overall Study|Withdrawal by Subject|1|||
129993516|NCT00345293|467939086|FG001|Overall Study|Withdrawal by Subject|0|||
129993517|NCT02390245|467939087|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
129993518|NCT02390245|467939088|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
129993519|NCT02390245|467939089|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
129993520|NCT02390245|467939087|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
129993521|NCT02390245|467939088|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
129993522|NCT02390245|467939089|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
129993523|NCT01786174|467940987|FG000|Overall Study|Discontinued Study Drug|2|||
129993524|NCT01786174|467940988|FG001|Overall Study|Discontinued Study Drug|0|||
129993525|NCT01620255|467940989|FG000|Overall Study|Withdrawal by Subject|4|||
129993526|NCT01620255|467940990|FG001|Overall Study|Withdrawal by Subject|1|||
129993527|NCT01620255|467940991|FG002|Overall Study|Withdrawal by Subject|1|||
129993528|NCT01620255|467940992|FG003|Overall Study|Withdrawal by Subject|2|||
129993529|NCT01620255|467940993|FG004|Overall Study|Withdrawal by Subject|4|||
129993530|NCT01620255|467940989|FG000|Overall Study|Participant underwent fecal transplant|0|||
129993531|NCT01620255|467940990|FG001|Overall Study|Participant underwent fecal transplant|0|||
129993532|NCT01620255|467940991|FG002|Overall Study|Participant underwent fecal transplant|1|||
129993533|NCT01620255|467940992|FG003|Overall Study|Participant underwent fecal transplant|0|||
129993534|NCT01620255|467940993|FG004|Overall Study|Participant underwent fecal transplant|0|||
129993535|NCT01620255|467940989|FG000|Overall Study|Non-compliance|0|||
129993536|NCT01620255|467940990|FG001|Overall Study|Non-compliance|1|||
129993537|NCT01620255|467940991|FG002|Overall Study|Non-compliance|0|||
129993538|NCT01620255|467940992|FG003|Overall Study|Non-compliance|0|||
129993539|NCT01620255|467940993|FG004|Overall Study|Non-compliance|0|||
129993540|NCT01620255|467940989|FG000|Overall Study|Adverse Event|0|||
129993541|NCT01620255|467940990|FG001|Overall Study|Adverse Event|4|||
129993542|NCT01620255|467940991|FG002|Overall Study|Adverse Event|0|||
129993543|NCT01620255|467940992|FG003|Overall Study|Adverse Event|1|||
129993544|NCT01620255|467940993|FG004|Overall Study|Adverse Event|1|||
129993545|NCT01620255|467940989|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
129993546|NCT01620255|467940990|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
129993547|NCT01620255|467940991|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
129993548|NCT01620255|467940992|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
129993549|NCT01620255|467940993|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
129993550|NCT01155375|467941002|FG000|Overall Study|Adverse Event|1|||
129993551|NCT01155375|467941003|FG001|Overall Study|Adverse Event|0|||
129993552|NCT01480674|467941007|FG000|Overall Study|Death|23|||
129993553|NCT01480674|467941007|FG000|Overall Study|Lost to Follow-up|2|||
129993554|NCT01480674|467941007|FG000|Overall Study|visit not done|10|||
129993555|NCT03818204|467941008|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993556|NCT03818204|467941009|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993557|NCT03818204|467941010|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993558|NCT03818204|467941011|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993559|NCT03818204|467941012|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
129993560|NCT03818204|467941013|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993561|NCT03818204|467941014|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993562|NCT03818204|467941015|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993563|NCT03818204|467941016|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993564|NCT03818204|467941017|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993565|NCT03818204|467941018|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993566|NCT03818204|467941019|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993567|NCT03818204|467941020|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993568|NCT03818204|467941021|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
129993569|NCT03818204|467941022|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993570|NCT03818204|467941023|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993571|NCT03818204|467941024|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993572|NCT03818204|467941025|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993573|NCT03818204|467941026|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129993574|NCT03818204|467941008|FG000|Overall Study|Physician Decision|0|||
129993575|NCT03818204|467941009|FG001|Overall Study|Physician Decision|0|||
129993576|NCT03818204|467941010|FG002|Overall Study|Physician Decision|0|||
129993577|NCT03818204|467941011|FG003|Overall Study|Physician Decision|0|||
129993578|NCT03818204|467941012|FG004|Overall Study|Physician Decision|0|||
129993579|NCT03818204|467941013|FG005|Overall Study|Physician Decision|0|||
129993580|NCT03818204|467941014|FG006|Overall Study|Physician Decision|0|||
129993581|NCT03818204|467941015|FG007|Overall Study|Physician Decision|0|||
129993582|NCT03818204|467941016|FG008|Overall Study|Physician Decision|0|||
129993583|NCT03818204|467941017|FG009|Overall Study|Physician Decision|0|||
129993584|NCT03818204|467941018|FG010|Overall Study|Physician Decision|0|||
129993585|NCT03818204|467941019|FG011|Overall Study|Physician Decision|0|||
129993586|NCT03818204|467941020|FG012|Overall Study|Physician Decision|0|||
129993587|NCT03818204|467941021|FG013|Overall Study|Physician Decision|0|||
129993588|NCT03818204|467941022|FG014|Overall Study|Physician Decision|1|||
129993589|NCT03818204|467941023|FG015|Overall Study|Physician Decision|0|||
129993590|NCT03818204|467941024|FG016|Overall Study|Physician Decision|0|||
129993591|NCT03818204|467941025|FG017|Overall Study|Physician Decision|0|||
129993592|NCT03818204|467941026|FG018|Overall Study|Physician Decision|0|||
129993593|NCT00887250|467941027|FG000|Overall Study|Adverse Event|3|||
129993594|NCT00887250|467941028|FG001|Overall Study|Adverse Event|0|||
129993595|NCT00887250|467941029|FG002|Overall Study|Adverse Event|7|||
129993596|NCT00887250|467941027|FG000|Overall Study|Lack of Efficacy|9|||
129993597|NCT00887250|467941028|FG001|Overall Study|Lack of Efficacy|6|||
129993598|NCT00887250|467941029|FG002|Overall Study|Lack of Efficacy|1|||
129993599|NCT00887250|467941027|FG000|Overall Study|Lost to Follow-up|2|||
129993600|NCT00887250|467941028|FG001|Overall Study|Lost to Follow-up|3|||
129993601|NCT00887250|467941029|FG002|Overall Study|Lost to Follow-up|1|||
129993602|NCT00887250|467941027|FG000|Overall Study|Protocol Violation|2|||
129993603|NCT00887250|467941028|FG001|Overall Study|Protocol Violation|2|||
129993604|NCT00887250|467941029|FG002|Overall Study|Protocol Violation|1|||
129993605|NCT00887250|467941027|FG000|Overall Study|Withdrawal by Subject|2|||
129993606|NCT00887250|467941028|FG001|Overall Study|Withdrawal by Subject|1|||
129993607|NCT00887250|467941029|FG002|Overall Study|Withdrawal by Subject|2|||
129993608|NCT00887250|467941027|FG000|Overall Study|Patient uncooperative|0|||
129993609|NCT00887250|467941028|FG001|Overall Study|Patient uncooperative|0|||
129993610|NCT00887250|467941029|FG002|Overall Study|Patient uncooperative|1|||
129993611|NCT01933113|467941030|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
129993612|NCT00879762|467941031|FG000|Overall Study|Lost to Follow-up|3|||
129993613|NCT00879762|467941032|FG001|Overall Study|Lost to Follow-up|1|||
129993614|NCT04981366|467941033|FG000|Overall Study|Withdrawal by Subject|5|||
129993615|NCT04981366|467941034|FG001|Overall Study|Withdrawal by Subject|4|||
129993616|NCT04981366|467941035|FG002|Overall Study|Withdrawal by Subject|8|||
129993617|NCT04981366|467941033|FG000|Overall Study|Health issues unrelated to the trial|1|||
129993618|NCT04981366|467941034|FG001|Overall Study|Health issues unrelated to the trial|2|||
129993619|NCT04981366|467941035|FG002|Overall Study|Health issues unrelated to the trial|0|||
129993620|NCT00881608|467941036|FG000|Overall Study|Study prematurely terminated|11|||
129993621|NCT03214094|467941037|FG000|Overall Study|Case Report Forms Uncollected|14|||
129993622|NCT03214094|467941037|FG000|Overall Study|Protocol Deviation|46|||
129993623|NCT00795951|467941043|FG000|Overall Study|Lost to Follow-up|1|||
129993624|NCT00795951|467941043|FG000|Overall Study|Withdrawal by Subject|1|||
129993625|NCT00846391|467941044|FG000|Overall Study|Physician Decision|0|||
129993626|NCT00846391|467941045|FG001|Overall Study|Physician Decision|0|||
129993627|NCT00846391|467941046|FG002|Overall Study|Physician Decision|1|||
129993628|NCT00846391|467941044|FG000|Overall Study|Study Terminated by Sponsor|1|||
129993629|NCT00846391|467941045|FG001|Overall Study|Study Terminated by Sponsor|2|||
129993630|NCT00846391|467941046|FG002|Overall Study|Study Terminated by Sponsor|2|||
129993631|NCT04634825|467941048|FG000|Overall Study|Death|10|||
129993632|NCT04634825|467941049|FG001|Overall Study|Death|3|||
129993633|NCT04634825|467941048|FG000|Overall Study|Lost to Follow-up|1|||
129993634|NCT04634825|467941049|FG001|Overall Study|Lost to Follow-up|0|||
129993635|NCT04634825|467941048|FG000|Overall Study|Study terminated by sponsor|35|||
129993636|NCT04634825|467941049|FG001|Overall Study|Study terminated by sponsor|11|||
129993637|NCT04634825|467941048|FG000|Overall Study|Withdrawal by Subject|2|||
129993638|NCT04634825|467941049|FG001|Overall Study|Withdrawal by Subject|0|||
129993639|NCT01337115|467941056|FG000|Overall Study|Protocol Violation|2|||
129993640|NCT01337115|467941057|FG001|Overall Study|Protocol Violation|0|||
129993641|NCT00551460|467941063|FG000|Overall Study|Adverse Event|1|||
129993642|NCT00551460|467941063|FG000|Overall Study|Withdrawal by Subject|1|||
129993643|NCT00551460|467941063|FG000|Overall Study|Physician Decision|1|||
129993644|NCT00551460|467941063|FG000|Overall Study|Death|7|||
129993645|NCT00551460|467941063|FG000|Overall Study|Ineligible|4|||
129993646|NCT00551460|467941063|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
129993647|NCT01745848|467941064|FG000|Overall Study|Adverse Event|6|||
129993648|NCT00679627|467941065|FG000|Overall Study|Death|41|||
129993649|NCT00679627|467941066|FG001|Overall Study|Death|29|||
129993650|NCT00679627|467941065|FG000|Overall Study|Adverse Event|43|||
129993651|NCT00679627|467941066|FG001|Overall Study|Adverse Event|53|||
129993652|NCT00679627|467941065|FG000|Overall Study|Withdrawal by Subject|168|||
129993653|NCT00679627|467941066|FG001|Overall Study|Withdrawal by Subject|172|||
129993654|NCT00679627|467941065|FG000|Overall Study|Lost to Follow-up|22|||
129993655|NCT00679627|467941066|FG001|Overall Study|Lost to Follow-up|26|||
129993656|NCT00679627|467941065|FG000|Overall Study|Early Study Closure|425|||
129993657|NCT00679627|467941066|FG001|Overall Study|Early Study Closure|405|||
129993658|NCT00448123|467941067|FG000|Overall Study|Lost to Follow-up|9|||
129993659|NCT00448123|467941068|FG001|Overall Study|Lost to Follow-up|6|||
129993660|NCT00448123|467941067|FG000|Overall Study|Physician Decision|6|||
129993661|NCT00448123|467941068|FG001|Overall Study|Physician Decision|6|||
129993662|NCT02027623|467941070|FG000|Overall Study|Lost to Follow-up|3|||
129993663|NCT02027623|467941071|FG001|Overall Study|Lost to Follow-up|3|||
129993664|NCT02027623|467941070|FG000|Overall Study|Withdrawal by Subject|6|||
129993665|NCT02027623|467941071|FG001|Overall Study|Withdrawal by Subject|9|||
129993666|NCT01886378|467941072|FG000|Overall Study|Adverse Event|1|||
129993667|NCT01886378|467941072|FG000|Overall Study|Withdrawal by Subject|4|||
129993668|NCT00406653|467941077|FG000|Induction Period|Adverse Event|1|||
129993669|NCT00406653|467941078|FG001|Induction Period|Adverse Event|10|||
129993670|NCT00406653|467941079|FG002|Induction Period|Adverse Event|4|||
129993671|NCT00406653|467941080|FG003|Induction Period|Adverse Event|11|||
129993672|NCT00406653|467941081|FG004|Induction Period|Adverse Event|0|||
129993673|NCT00406653|467941082|FG005|Induction Period|Adverse Event|0|||
129993674|NCT00406653|467941083|FG006|Induction Period|Adverse Event|0|||
129993675|NCT00406653|467941077|FG000|Induction Period|Lack of Efficacy|11|||
129993676|NCT00406653|467941078|FG001|Induction Period|Lack of Efficacy|14|||
129993677|NCT00406653|467941079|FG002|Induction Period|Lack of Efficacy|8|||
129993678|NCT00406653|467941080|FG003|Induction Period|Lack of Efficacy|10|||
129993679|NCT00406653|467941081|FG004|Induction Period|Lack of Efficacy|0|||
129993680|NCT00406653|467941082|FG005|Induction Period|Lack of Efficacy|0|||
129993681|NCT00406653|467941083|FG006|Induction Period|Lack of Efficacy|0|||
129993682|NCT00406653|467941077|FG000|Induction Period|Lost to Follow-up|0|||
129993683|NCT00406653|467941078|FG001|Induction Period|Lost to Follow-up|2|||
129993684|NCT00406653|467941079|FG002|Induction Period|Lost to Follow-up|0|||
129993685|NCT00406653|467941080|FG003|Induction Period|Lost to Follow-up|0|||
129993686|NCT00406653|467941081|FG004|Induction Period|Lost to Follow-up|0|||
129993687|NCT00406653|467941082|FG005|Induction Period|Lost to Follow-up|0|||
129993688|NCT00406653|467941083|FG006|Induction Period|Lost to Follow-up|0|||
129993689|NCT00406653|467941077|FG000|Induction Period|Withdrawal of Consent|2|||
129993690|NCT00406653|467941078|FG001|Induction Period|Withdrawal of Consent|5|||
129993691|NCT00406653|467941079|FG002|Induction Period|Withdrawal of Consent|1|||
129993692|NCT00406653|467941080|FG003|Induction Period|Withdrawal of Consent|2|||
129993693|NCT00406653|467941081|FG004|Induction Period|Withdrawal of Consent|0|||
129993694|NCT00406653|467941082|FG005|Induction Period|Withdrawal of Consent|0|||
129993695|NCT00406653|467941083|FG006|Induction Period|Withdrawal of Consent|0|||
129993696|NCT00406653|467941077|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
129993697|NCT00406653|467941078|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
129993698|NCT00406653|467941079|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
129993699|NCT00406653|467941080|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
129993700|NCT00406653|467941081|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
129993701|NCT00406653|467941082|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
129993702|NCT00406653|467941083|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
129993703|NCT00406653|467941077|FG000|Induction Period|Pregnancy|1|||
129993704|NCT00406653|467941078|FG001|Induction Period|Pregnancy|0|||
129993705|NCT00406653|467941079|FG002|Induction Period|Pregnancy|0|||
129993706|NCT00406653|467941080|FG003|Induction Period|Pregnancy|0|||
129993707|NCT00406653|467941081|FG004|Induction Period|Pregnancy|0|||
129993708|NCT00406653|467941082|FG005|Induction Period|Pregnancy|0|||
129993709|NCT00406653|467941083|FG006|Induction Period|Pregnancy|0|||
129993710|NCT00406653|467941077|FG000|Induction Period|Declined participation but followup done|0|||
129993711|NCT00406653|467941078|FG001|Induction Period|Declined participation but followup done|2|||
129993712|NCT00406653|467941079|FG002|Induction Period|Declined participation but followup done|1|||
129993713|NCT00406653|467941080|FG003|Induction Period|Declined participation but followup done|1|||
129993714|NCT00406653|467941081|FG004|Induction Period|Declined participation but followup done|0|||
129993715|NCT00406653|467941082|FG005|Induction Period|Declined participation but followup done|0|||
129993716|NCT00406653|467941083|FG006|Induction Period|Declined participation but followup done|0|||
129993717|NCT00406653|467941077|FG000|Induction Period|Given prohibited drug|0|||
129993718|NCT00406653|467941078|FG001|Induction Period|Given prohibited drug|1|||
129993719|NCT00406653|467941079|FG002|Induction Period|Given prohibited drug|2|||
129993720|NCT00406653|467941080|FG003|Induction Period|Given prohibited drug|0|||
129993721|NCT00406653|467941081|FG004|Induction Period|Given prohibited drug|0|||
129993722|NCT00406653|467941082|FG005|Induction Period|Given prohibited drug|0|||
129993723|NCT00406653|467941083|FG006|Induction Period|Given prohibited drug|0|||
129993724|NCT00406653|467941077|FG000|Induction Period|Incarcerated|0|||
129993725|NCT00406653|467941078|FG001|Induction Period|Incarcerated|0|||
129993726|NCT00406653|467941079|FG002|Induction Period|Incarcerated|1|||
129993727|NCT00406653|467941080|FG003|Induction Period|Incarcerated|0|||
129993728|NCT00406653|467941081|FG004|Induction Period|Incarcerated|0|||
129993729|NCT00406653|467941082|FG005|Induction Period|Incarcerated|0|||
129993730|NCT00406653|467941083|FG006|Induction Period|Incarcerated|0|||
129993731|NCT00406653|467941077|FG000|Induction Period|Patient relocated|0|||
129993732|NCT00406653|467941078|FG001|Induction Period|Patient relocated|0|||
129993733|NCT00406653|467941079|FG002|Induction Period|Patient relocated|1|||
129993734|NCT00406653|467941080|FG003|Induction Period|Patient relocated|0|||
129993735|NCT00406653|467941081|FG004|Induction Period|Patient relocated|0|||
129993736|NCT00406653|467941082|FG005|Induction Period|Patient relocated|0|||
129993737|NCT00406653|467941083|FG006|Induction Period|Patient relocated|0|||
129993738|NCT00406653|467941077|FG000|Maintenance Period|Adverse Event|0|||
129993739|NCT00406653|467941078|FG001|Maintenance Period|Adverse Event|0|||
129993740|NCT00406653|467941079|FG002|Maintenance Period|Adverse Event|0|||
129993741|NCT00406653|467941080|FG003|Maintenance Period|Adverse Event|0|||
129993742|NCT00406653|467941081|FG004|Maintenance Period|Adverse Event|1|||
129993743|NCT00406653|467941082|FG005|Maintenance Period|Adverse Event|1|||
129993744|NCT00406653|467941083|FG006|Maintenance Period|Adverse Event|0|||
129993745|NCT00406653|467941077|FG000|Maintenance Period|Lack of Efficacy|0|||
129993746|NCT00406653|467941078|FG001|Maintenance Period|Lack of Efficacy|0|||
129993747|NCT00406653|467941079|FG002|Maintenance Period|Lack of Efficacy|0|||
129993748|NCT00406653|467941080|FG003|Maintenance Period|Lack of Efficacy|0|||
129993749|NCT00406653|467941081|FG004|Maintenance Period|Lack of Efficacy|20|||
129993750|NCT00406653|467941082|FG005|Maintenance Period|Lack of Efficacy|26|||
129993751|NCT00406653|467941083|FG006|Maintenance Period|Lack of Efficacy|0|||
129993752|NCT00406653|467941077|FG000|Maintenance Period|Lost to Follow-up|0|||
129993753|NCT00406653|467941078|FG001|Maintenance Period|Lost to Follow-up|0|||
129993754|NCT00406653|467941079|FG002|Maintenance Period|Lost to Follow-up|0|||
129993755|NCT00406653|467941080|FG003|Maintenance Period|Lost to Follow-up|0|||
129993756|NCT00406653|467941081|FG004|Maintenance Period|Lost to Follow-up|2|||
129993757|NCT00406653|467941082|FG005|Maintenance Period|Lost to Follow-up|1|||
129993758|NCT00406653|467941083|FG006|Maintenance Period|Lost to Follow-up|0|||
129993759|NCT00406653|467941077|FG000|Maintenance Period|Withdrawal of Consent|0|||
129993760|NCT00406653|467941078|FG001|Maintenance Period|Withdrawal of Consent|0|||
129993761|NCT00406653|467941079|FG002|Maintenance Period|Withdrawal of Consent|0|||
129993762|NCT00406653|467941080|FG003|Maintenance Period|Withdrawal of Consent|0|||
129993763|NCT00406653|467941081|FG004|Maintenance Period|Withdrawal of Consent|2|||
129993764|NCT00406653|467941082|FG005|Maintenance Period|Withdrawal of Consent|0|||
129993765|NCT00406653|467941083|FG006|Maintenance Period|Withdrawal of Consent|0|||
129993766|NCT00406653|467941077|FG000|Maintenance Period|Pregnancy|0|||
129993767|NCT00406653|467941078|FG001|Maintenance Period|Pregnancy|0|||
129993768|NCT00406653|467941079|FG002|Maintenance Period|Pregnancy|0|||
129993769|NCT00406653|467941080|FG003|Maintenance Period|Pregnancy|0|||
129993770|NCT00406653|467941081|FG004|Maintenance Period|Pregnancy|0|||
129993771|NCT00406653|467941082|FG005|Maintenance Period|Pregnancy|1|||
129993772|NCT00406653|467941083|FG006|Maintenance Period|Pregnancy|0|||
129993773|NCT00406653|467941077|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
129993774|NCT00406653|467941078|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
129993775|NCT00406653|467941079|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
129993776|NCT00406653|467941080|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
129993777|NCT00406653|467941081|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
129993778|NCT00406653|467941082|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
129993779|NCT00406653|467941083|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
129993780|NCT00406653|467941077|FG000|Maintenance Period|Error in disease score evaluation|0|||
129993781|NCT00406653|467941078|FG001|Maintenance Period|Error in disease score evaluation|0|||
129993782|NCT00406653|467941079|FG002|Maintenance Period|Error in disease score evaluation|0|||
129993783|NCT00406653|467941080|FG003|Maintenance Period|Error in disease score evaluation|0|||
129993784|NCT00406653|467941081|FG004|Maintenance Period|Error in disease score evaluation|1|||
129993785|NCT00406653|467941082|FG005|Maintenance Period|Error in disease score evaluation|0|||
129993786|NCT00406653|467941083|FG006|Maintenance Period|Error in disease score evaluation|0|||
129993787|NCT00406653|467941077|FG000|Open-Label Period|Death|0|||
129993788|NCT00406653|467941078|FG001|Open-Label Period|Death|0|||
129993789|NCT00406653|467941079|FG002|Open-Label Period|Death|0|||
129993790|NCT00406653|467941080|FG003|Open-Label Period|Death|0|||
129993791|NCT00406653|467941081|FG004|Open-Label Period|Death|0|||
129993792|NCT00406653|467941082|FG005|Open-Label Period|Death|0|||
129993793|NCT00406653|467941083|FG006|Open-Label Period|Death|1|||
129993794|NCT00406653|467941077|FG000|Open-Label Period|Adverse Event|0|||
129993795|NCT00406653|467941078|FG001|Open-Label Period|Adverse Event|0|||
129993796|NCT00406653|467941079|FG002|Open-Label Period|Adverse Event|0|||
129993797|NCT00406653|467941080|FG003|Open-Label Period|Adverse Event|0|||
129993798|NCT00406653|467941081|FG004|Open-Label Period|Adverse Event|0|||
129993799|NCT00406653|467941082|FG005|Open-Label Period|Adverse Event|0|||
129993800|NCT00406653|467941083|FG006|Open-Label Period|Adverse Event|18|||
129993801|NCT00406653|467941077|FG000|Open-Label Period|Lack of Efficacy|0|||
129993802|NCT00406653|467941078|FG001|Open-Label Period|Lack of Efficacy|0|||
129993803|NCT00406653|467941079|FG002|Open-Label Period|Lack of Efficacy|0|||
129993804|NCT00406653|467941080|FG003|Open-Label Period|Lack of Efficacy|0|||
129993805|NCT00406653|467941081|FG004|Open-Label Period|Lack of Efficacy|0|||
129993806|NCT00406653|467941082|FG005|Open-Label Period|Lack of Efficacy|0|||
129993807|NCT00406653|467941083|FG006|Open-Label Period|Lack of Efficacy|160|||
129993808|NCT00406653|467941077|FG000|Open-Label Period|Lost to Follow-up|0|||
129993809|NCT00406653|467941078|FG001|Open-Label Period|Lost to Follow-up|0|||
129993810|NCT00406653|467941079|FG002|Open-Label Period|Lost to Follow-up|0|||
129993811|NCT00406653|467941080|FG003|Open-Label Period|Lost to Follow-up|0|||
129993812|NCT00406653|467941081|FG004|Open-Label Period|Lost to Follow-up|0|||
129993813|NCT00406653|467941082|FG005|Open-Label Period|Lost to Follow-up|0|||
129993814|NCT00406653|467941083|FG006|Open-Label Period|Lost to Follow-up|6|||
129993815|NCT00406653|467941077|FG000|Open-Label Period|Withdrawal of Consent|0|||
129993816|NCT00406653|467941078|FG001|Open-Label Period|Withdrawal of Consent|0|||
129993817|NCT00406653|467941079|FG002|Open-Label Period|Withdrawal of Consent|0|||
129993818|NCT00406653|467941080|FG003|Open-Label Period|Withdrawal of Consent|0|||
129993819|NCT00406653|467941081|FG004|Open-Label Period|Withdrawal of Consent|0|||
129993820|NCT00406653|467941082|FG005|Open-Label Period|Withdrawal of Consent|0|||
129993821|NCT00406653|467941083|FG006|Open-Label Period|Withdrawal of Consent|11|||
129993822|NCT00406653|467941077|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129993823|NCT00406653|467941078|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129993824|NCT00406653|467941079|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129993825|NCT00406653|467941080|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129993826|NCT00406653|467941081|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129993827|NCT00406653|467941082|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129993828|NCT00406653|467941083|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
129993829|NCT00406653|467941077|FG000|Open-Label Period|Pregnancy|0|||
129993830|NCT00406653|467941078|FG001|Open-Label Period|Pregnancy|0|||
129993831|NCT00406653|467941079|FG002|Open-Label Period|Pregnancy|0|||
129993832|NCT00406653|467941080|FG003|Open-Label Period|Pregnancy|0|||
129993833|NCT00406653|467941081|FG004|Open-Label Period|Pregnancy|0|||
129993834|NCT00406653|467941082|FG005|Open-Label Period|Pregnancy|0|||
129993835|NCT00406653|467941083|FG006|Open-Label Period|Pregnancy|2|||
129993836|NCT00406653|467941077|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
129993837|NCT00406653|467941078|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
129993838|NCT00406653|467941079|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
129993839|NCT00406653|467941080|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
129993840|NCT00406653|467941081|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
129993841|NCT00406653|467941082|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
129993842|NCT00406653|467941083|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
129993843|NCT00406653|467941077|FG000|Open-Label Period|Declined participation but followup done|0|||
129993844|NCT00406653|467941078|FG001|Open-Label Period|Declined participation but followup done|0|||
129993845|NCT00406653|467941079|FG002|Open-Label Period|Declined participation but followup done|0|||
129993846|NCT00406653|467941080|FG003|Open-Label Period|Declined participation but followup done|0|||
129993847|NCT00406653|467941081|FG004|Open-Label Period|Declined participation but followup done|0|||
129993848|NCT00406653|467941082|FG005|Open-Label Period|Declined participation but followup done|0|||
129993849|NCT00406653|467941083|FG006|Open-Label Period|Declined participation but followup done|8|||
129993850|NCT00406653|467941077|FG000|Open-Label Period|Discontinued by Sponsor|0|||
129993851|NCT00406653|467941078|FG001|Open-Label Period|Discontinued by Sponsor|0|||
129993852|NCT00406653|467941079|FG002|Open-Label Period|Discontinued by Sponsor|0|||
129993853|NCT00406653|467941080|FG003|Open-Label Period|Discontinued by Sponsor|0|||
129993854|NCT00406653|467941081|FG004|Open-Label Period|Discontinued by Sponsor|0|||
129993855|NCT00406653|467941082|FG005|Open-Label Period|Discontinued by Sponsor|0|||
129993856|NCT00406653|467941083|FG006|Open-Label Period|Discontinued by Sponsor|1|||
129993857|NCT00406653|467941077|FG000|Open-Label Period|Refused followup|0|||
129993858|NCT00406653|467941078|FG001|Open-Label Period|Refused followup|0|||
129993859|NCT00406653|467941079|FG002|Open-Label Period|Refused followup|0|||
129993860|NCT00406653|467941080|FG003|Open-Label Period|Refused followup|0|||
129993861|NCT00406653|467941081|FG004|Open-Label Period|Refused followup|0|||
129993862|NCT00406653|467941082|FG005|Open-Label Period|Refused followup|0|||
129993863|NCT00406653|467941083|FG006|Open-Label Period|Refused followup|1|||
129993864|NCT00818649|467941084|FG000|Overall Study|Declining performance status|2|||
129993865|NCT00818649|467941084|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
129993866|NCT00818649|467941084|FG000|Overall Study|Adverse Event|1|||
129993867|NCT03513588|467941085|FG000|Overall Study|Lost to Follow-up|0|||
129993868|NCT03513588|467941086|FG001|Overall Study|Lost to Follow-up|1|||
129993869|NCT03513588|467941087|FG002|Overall Study|Lost to Follow-up|1|||
129993870|NCT03513588|467941085|FG000|Overall Study|Study dosing paused by sponsor|1|||
129993871|NCT03513588|467941086|FG001|Overall Study|Study dosing paused by sponsor|1|||
129993872|NCT03513588|467941087|FG002|Overall Study|Study dosing paused by sponsor|0|||
129993873|NCT03513588|467941085|FG000|Overall Study|Death|0|||
129993874|NCT03513588|467941086|FG001|Overall Study|Death|0|||
129993875|NCT03513588|467941087|FG002|Overall Study|Death|1|||
129993876|NCT00940108|467941088|FG000|Overall Study|Adverse Event|2|||
129993877|NCT00940108|467941089|FG001|Overall Study|Adverse Event|4|||
129993878|NCT00940108|467941090|FG002|Overall Study|Adverse Event|0|||
129993879|NCT00940108|467941091|FG003|Overall Study|Adverse Event|2|||
129993880|NCT00940108|467941088|FG000|Overall Study|Withdrew Consent|2|||
129993881|NCT00940108|467941089|FG001|Overall Study|Withdrew Consent|1|||
129993882|NCT00940108|467941090|FG002|Overall Study|Withdrew Consent|0|||
129993883|NCT00940108|467941091|FG003|Overall Study|Withdrew Consent|1|||
129993884|NCT00940108|467941088|FG000|Overall Study|Dose 2 contraindicated|1|||
129993885|NCT00940108|467941089|FG001|Overall Study|Dose 2 contraindicated|1|||
129993886|NCT00940108|467941090|FG002|Overall Study|Dose 2 contraindicated|0|||
129993887|NCT00940108|467941091|FG003|Overall Study|Dose 2 contraindicated|1|||
129993888|NCT00940108|467941088|FG000|Overall Study|Declined further vaccination|0|||
129993889|NCT00940108|467941089|FG001|Overall Study|Declined further vaccination|1|||
129993890|NCT00940108|467941090|FG002|Overall Study|Declined further vaccination|3|||
129993891|NCT00940108|467941091|FG003|Overall Study|Declined further vaccination|0|||
129993892|NCT00940108|467941088|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
129993893|NCT00940108|467941089|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
129993894|NCT00940108|467941090|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
129993895|NCT00940108|467941091|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
129993896|NCT00940108|467941088|FG000|Overall Study|Viral illness after Dose 1|0|||
129993897|NCT00940108|467941089|FG001|Overall Study|Viral illness after Dose 1|1|||
129993898|NCT00940108|467941090|FG002|Overall Study|Viral illness after Dose 1|0|||
129993899|NCT00940108|467941091|FG003|Overall Study|Viral illness after Dose 1|0|||
129993900|NCT00940108|467941088|FG000|Overall Study|Diagnosed with H1N1|0|||
129993901|NCT00940108|467941089|FG001|Overall Study|Diagnosed with H1N1|0|||
129993902|NCT00940108|467941090|FG002|Overall Study|Diagnosed with H1N1|0|||
129993903|NCT00940108|467941091|FG003|Overall Study|Diagnosed with H1N1|1|||
129993904|NCT02075541|467941095|FG000|Overall Study|Serious Adverse Event|1|||
129993905|NCT02075541|467941096|FG001|Overall Study|Serious Adverse Event|4|||
129993906|NCT02075541|467941095|FG000|Overall Study|Protocol Violation|1|||
129993907|NCT02075541|467941096|FG001|Overall Study|Protocol Violation|0|||
129993908|NCT02075541|467941095|FG000|Overall Study|Withdrawal by Subject|1|||
129993909|NCT02075541|467941096|FG001|Overall Study|Withdrawal by Subject|3|||
129993910|NCT02075541|467941095|FG000|Overall Study|Sponsor study termination|0|||
129993911|NCT02075541|467941096|FG001|Overall Study|Sponsor study termination|1|||
129993912|NCT02075541|467941095|FG000|Overall Study|Other- unable to perform study procedure|1|||
129993913|NCT02075541|467941096|FG001|Overall Study|Other- unable to perform study procedure|0|||
129993914|NCT01142596|467941098|FG000|Overall Study|Withdrawal by Subject|9|||
129993915|NCT01142596|467941099|FG001|Overall Study|Withdrawal by Subject|35|||
129993916|NCT01142596|467941098|FG000|Overall Study|Adverse Event|8|||
129993917|NCT01142596|467941099|FG001|Overall Study|Adverse Event|35|||
129993918|NCT01142596|467941098|FG000|Overall Study|Lack of Efficacy|5|||
129993919|NCT01142596|467941099|FG001|Overall Study|Lack of Efficacy|9|||
129993920|NCT01142596|467941098|FG000|Overall Study|Lost to Follow-up|2|||
129993921|NCT01142596|467941099|FG001|Overall Study|Lost to Follow-up|3|||
129993922|NCT01142596|467941098|FG000|Overall Study|Other reason (not specified)|5|||
129993923|NCT01142596|467941099|FG001|Overall Study|Other reason (not specified)|4|||
129993924|NCT01013597|467941100|FG000|Overall Study|Withdrawal by Subject|1|||
129993925|NCT00427895|467941101|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993926|NCT00427895|467941102|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993927|NCT00427895|467941103|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993928|NCT00427895|467941104|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
129993929|NCT00427895|467941105|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993930|NCT00427895|467941106|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993931|NCT00427895|467941107|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993932|NCT00427895|467941108|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129993933|NCT00427895|467941101|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993934|NCT00427895|467941102|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993935|NCT00427895|467941103|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993936|NCT00427895|467941104|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993937|NCT00427895|467941105|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993938|NCT00427895|467941106|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993939|NCT00427895|467941107|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129993940|NCT00427895|467941108|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
129993941|NCT00427895|467941101|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993942|NCT00427895|467941102|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993943|NCT00427895|467941103|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993944|NCT00427895|467941104|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993945|NCT00427895|467941105|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993946|NCT00427895|467941106|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993947|NCT00427895|467941107|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
129993948|NCT00427895|467941108|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
129993949|NCT00427895|467941101|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
129993950|NCT00427895|467941102|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
129993951|NCT00427895|467941103|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
129993952|NCT00427895|467941104|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
129993953|NCT00427895|467941105|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
129993954|NCT00427895|467941106|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
129993955|NCT00427895|467941107|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
129993956|NCT00427895|467941108|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
129993957|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129993958|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
129993959|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
129993960|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
129993961|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129993962|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129993963|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129993964|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129993965|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
129993966|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129993967|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
129993968|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
129993969|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129993970|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129993971|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129993972|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129993973|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
129993974|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
129993975|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129993976|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129993977|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129993978|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129993979|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129993980|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129993981|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
129993982|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
129993983|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
129993984|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
129993985|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129993986|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129993987|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129993988|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129993989|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993990|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993991|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993992|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
129993993|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993994|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993995|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993996|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129993997|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
129993998|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
129993999|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
129994000|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
129994001|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129994002|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129994003|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129994004|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129994005|NCT00427895|467941101|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129994006|NCT00427895|467941102|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129994007|NCT00427895|467941103|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
129994008|NCT00427895|467941104|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
129994009|NCT00427895|467941105|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129994010|NCT00427895|467941106|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129994011|NCT00427895|467941107|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129994012|NCT00427895|467941108|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129994013|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129994014|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
129994015|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
129994016|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
129994017|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129994018|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129994019|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129994020|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129994021|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
129994022|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
130216124|NCT01826981|468753948|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
129994023|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129994024|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
129994025|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129994026|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129994027|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129994028|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129994029|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
129994030|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
129994031|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
129994032|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
129994033|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129994034|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129994035|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129994036|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129994037|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994038|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
129994039|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994040|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994041|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994042|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994043|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994044|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129994045|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Death|1|||
129994046|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Death|0|||
129994047|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Death|0|||
129994048|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Death|0|||
129994049|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Death|0|||
129994050|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Death|0|||
129994051|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Death|0|||
129994052|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Death|0|||
129994053|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129994054|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129994055|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
129994056|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
129994057|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129994058|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129994059|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129994060|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129994061|NCT00427895|467941101|FG000|Vax 1/Year 1 Follow-up|Other|0|||
129994062|NCT00427895|467941102|FG001|Vax 1/Year 1 Follow-up|Other|0|||
129994063|NCT00427895|467941103|FG002|Vax 1/Year 1 Follow-up|Other|0|||
129994064|NCT00427895|467941104|FG003|Vax 1/Year 1 Follow-up|Other|2|||
129994065|NCT00427895|467941105|FG004|Vax 1/Year 1 Follow-up|Other|0|||
129994066|NCT00427895|467941106|FG005|Vax 1/Year 1 Follow-up|Other|0|||
129994067|NCT00427895|467941107|FG006|Vax 1/Year 1 Follow-up|Other|0|||
129994068|NCT00427895|467941108|FG007|Vax 1/Year 1 Follow-up|Other|0|||
129994069|NCT00427895|467941101|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
129994070|NCT00427895|467941102|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
129994071|NCT00427895|467941103|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
129994072|NCT00427895|467941104|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
129994073|NCT00427895|467941105|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129994074|NCT00427895|467941106|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129994075|NCT00427895|467941107|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129994076|NCT00427895|467941108|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129994077|NCT00585195|467941111|FG000|Overall Study|Adverse Event|0|||
129994078|NCT00585195|467941112|FG001|Overall Study|Adverse Event|0|||
129994079|NCT00585195|467941113|FG002|Overall Study|Adverse Event|0|||
129994080|NCT00585195|467941114|FG003|Overall Study|Adverse Event|0|||
129994081|NCT00585195|467941115|FG004|Overall Study|Adverse Event|2|||
129994082|NCT00585195|467941116|FG005|Overall Study|Adverse Event|1|||
129994083|NCT00585195|467941117|FG006|Overall Study|Adverse Event|0|||
129994084|NCT00585195|467941118|FG007|Overall Study|Adverse Event|1|||
129994085|NCT00585195|467941119|FG008|Overall Study|Adverse Event|0|||
129994086|NCT00585195|467941120|FG009|Overall Study|Adverse Event|0|||
129994087|NCT00585195|467941121|FG010|Overall Study|Adverse Event|3|||
129994088|NCT00585195|467941122|FG011|Overall Study|Adverse Event|0|||
130334436|NCT00485134|469193811|FG002|Overall Study|Withdrawal by Subject|0|||
129994089|NCT00585195|467941123|FG012|Overall Study|Adverse Event|8|||
129994090|NCT00585195|467941124|FG013|Overall Study|Adverse Event|6|||
129994091|NCT00585195|467941125|FG014|Overall Study|Adverse Event|4|||
129994092|NCT00585195|467941126|FG015|Overall Study|Adverse Event|1|||
129994093|NCT00585195|467941127|FG016|Overall Study|Adverse Event|14|||
129994094|NCT00585195|467941128|FG017|Overall Study|Adverse Event|9|||
129994095|NCT00585195|467941129|FG018|Overall Study|Adverse Event|2|||
129994096|NCT00585195|467941130|FG019|Overall Study|Adverse Event|3|||
129994097|NCT00585195|467941131|FG020|Overall Study|Adverse Event|1|||
129994098|NCT00585195|467941111|FG000|Overall Study|Progressive Disease|2|||
129994099|NCT00585195|467941112|FG001|Overall Study|Progressive Disease|2|||
129994100|NCT00585195|467941113|FG002|Overall Study|Progressive Disease|5|||
129994101|NCT00585195|467941114|FG003|Overall Study|Progressive Disease|4|||
129994102|NCT00585195|467941115|FG004|Overall Study|Progressive Disease|6|||
129994103|NCT00585195|467941116|FG005|Overall Study|Progressive Disease|4|||
129994104|NCT00585195|467941117|FG006|Overall Study|Progressive Disease|6|||
129994105|NCT00585195|467941118|FG007|Overall Study|Progressive Disease|3|||
129994106|NCT00585195|467941119|FG008|Overall Study|Progressive Disease|0|||
129994107|NCT00585195|467941120|FG009|Overall Study|Progressive Disease|5|||
129994108|NCT00585195|467941121|FG010|Overall Study|Progressive Disease|2|||
129994109|NCT00585195|467941122|FG011|Overall Study|Progressive Disease|25|||
129994110|NCT00585195|467941123|FG012|Overall Study|Progressive Disease|29|||
129994111|NCT00585195|467941124|FG013|Overall Study|Progressive Disease|26|||
129994112|NCT00585195|467941125|FG014|Overall Study|Progressive Disease|21|||
129994113|NCT00585195|467941126|FG015|Overall Study|Progressive Disease|12|||
129994114|NCT00585195|467941127|FG016|Overall Study|Progressive Disease|94|||
129994115|NCT00585195|467941128|FG017|Overall Study|Progressive Disease|42|||
129994116|NCT00585195|467941129|FG018|Overall Study|Progressive Disease|4|||
129994117|NCT00585195|467941130|FG019|Overall Study|Progressive Disease|9|||
129994118|NCT00585195|467941131|FG020|Overall Study|Progressive Disease|8|||
129994119|NCT00585195|467941111|FG000|Overall Study|Withdrawal by Subject|1|||
129994120|NCT00585195|467941112|FG001|Overall Study|Withdrawal by Subject|1|||
129994121|NCT00585195|467941113|FG002|Overall Study|Withdrawal by Subject|2|||
129994122|NCT00585195|467941114|FG003|Overall Study|Withdrawal by Subject|2|||
129994123|NCT00585195|467941115|FG004|Overall Study|Withdrawal by Subject|0|||
129994124|NCT00585195|467941116|FG005|Overall Study|Withdrawal by Subject|0|||
129994125|NCT00585195|467941117|FG006|Overall Study|Withdrawal by Subject|0|||
129994126|NCT00585195|467941118|FG007|Overall Study|Withdrawal by Subject|1|||
129994127|NCT00585195|467941119|FG008|Overall Study|Withdrawal by Subject|0|||
129994128|NCT00585195|467941120|FG009|Overall Study|Withdrawal by Subject|0|||
129994129|NCT00585195|467941121|FG010|Overall Study|Withdrawal by Subject|3|||
129994130|NCT00585195|467941122|FG011|Overall Study|Withdrawal by Subject|8|||
129994131|NCT00585195|467941123|FG012|Overall Study|Withdrawal by Subject|15|||
129994132|NCT00585195|467941124|FG013|Overall Study|Withdrawal by Subject|0|||
129994133|NCT00585195|467941125|FG014|Overall Study|Withdrawal by Subject|3|||
129994134|NCT00585195|467941126|FG015|Overall Study|Withdrawal by Subject|0|||
129994135|NCT00585195|467941127|FG016|Overall Study|Withdrawal by Subject|7|||
129994136|NCT00585195|467941128|FG017|Overall Study|Withdrawal by Subject|1|||
129994137|NCT00585195|467941129|FG018|Overall Study|Withdrawal by Subject|2|||
129994138|NCT00585195|467941130|FG019|Overall Study|Withdrawal by Subject|2|||
129994139|NCT00585195|467941131|FG020|Overall Study|Withdrawal by Subject|0|||
129994140|NCT00585195|467941111|FG000|Overall Study|Other|0|||
129994141|NCT00585195|467941112|FG001|Overall Study|Other|1|||
129994142|NCT00585195|467941113|FG002|Overall Study|Other|1|||
129994143|NCT00585195|467941114|FG003|Overall Study|Other|1|||
129994144|NCT00585195|467941115|FG004|Overall Study|Other|0|||
129994145|NCT00585195|467941116|FG005|Overall Study|Other|1|||
129994146|NCT00585195|467941117|FG006|Overall Study|Other|0|||
129994147|NCT00585195|467941118|FG007|Overall Study|Other|0|||
129994148|NCT00585195|467941119|FG008|Overall Study|Other|2|||
129994149|NCT00585195|467941120|FG009|Overall Study|Other|1|||
129994150|NCT00585195|467941121|FG010|Overall Study|Other|0|||
129994151|NCT00585195|467941122|FG011|Overall Study|Other|19|||
129994152|NCT00585195|467941123|FG012|Overall Study|Other|24|||
129994153|NCT00585195|467941124|FG013|Overall Study|Other|7|||
129994154|NCT00585195|467941125|FG014|Overall Study|Other|11|||
129994155|NCT00585195|467941126|FG015|Overall Study|Other|3|||
129994156|NCT00585195|467941127|FG016|Overall Study|Other|28|||
129994157|NCT00585195|467941128|FG017|Overall Study|Other|12|||
129994158|NCT00585195|467941129|FG018|Overall Study|Other|10|||
129994159|NCT00585195|467941130|FG019|Overall Study|Other|4|||
129994160|NCT00585195|467941131|FG020|Overall Study|Other|2|||
129994161|NCT00585195|467941111|FG000|Overall Study|Randomized not treated|0|||
129994162|NCT00585195|467941112|FG001|Overall Study|Randomized not treated|0|||
129994163|NCT00585195|467941113|FG002|Overall Study|Randomized not treated|1|||
129994164|NCT00585195|467941114|FG003|Overall Study|Randomized not treated|0|||
129994165|NCT00585195|467941115|FG004|Overall Study|Randomized not treated|1|||
129994166|NCT00585195|467941116|FG005|Overall Study|Randomized not treated|0|||
129994167|NCT00585195|467941117|FG006|Overall Study|Randomized not treated|1|||
129994168|NCT00585195|467941118|FG007|Overall Study|Randomized not treated|0|||
129994169|NCT00585195|467941119|FG008|Overall Study|Randomized not treated|0|||
129994170|NCT00585195|467941120|FG009|Overall Study|Randomized not treated|0|||
129994171|NCT00585195|467941121|FG010|Overall Study|Randomized not treated|2|||
129994172|NCT00585195|467941122|FG011|Overall Study|Randomized not treated|0|||
129994173|NCT00585195|467941123|FG012|Overall Study|Randomized not treated|0|||
129994174|NCT00585195|467941124|FG013|Overall Study|Randomized not treated|0|||
129994175|NCT00585195|467941125|FG014|Overall Study|Randomized not treated|0|||
129994176|NCT00585195|467941126|FG015|Overall Study|Randomized not treated|1|||
129994177|NCT00585195|467941127|FG016|Overall Study|Randomized not treated|0|||
129994178|NCT00585195|467941128|FG017|Overall Study|Randomized not treated|1|||
129994179|NCT00585195|467941129|FG018|Overall Study|Randomized not treated|3|||
129994180|NCT00585195|467941130|FG019|Overall Study|Randomized not treated|0|||
129994181|NCT00585195|467941131|FG020|Overall Study|Randomized not treated|2|||
129994182|NCT00585195|467941111|FG000|Overall Study|Death|0|||
129994183|NCT00585195|467941112|FG001|Overall Study|Death|0|||
129994184|NCT00585195|467941113|FG002|Overall Study|Death|0|||
129994185|NCT00585195|467941114|FG003|Overall Study|Death|0|||
129994186|NCT00585195|467941115|FG004|Overall Study|Death|0|||
129994187|NCT00585195|467941116|FG005|Overall Study|Death|0|||
129994188|NCT00585195|467941117|FG006|Overall Study|Death|0|||
129994189|NCT00585195|467941118|FG007|Overall Study|Death|0|||
129994190|NCT00585195|467941119|FG008|Overall Study|Death|1|||
129994191|NCT00585195|467941120|FG009|Overall Study|Death|0|||
129994192|NCT00585195|467941121|FG010|Overall Study|Death|1|||
129994193|NCT00585195|467941122|FG011|Overall Study|Death|1|||
129994194|NCT00585195|467941123|FG012|Overall Study|Death|7|||
129994195|NCT00585195|467941124|FG013|Overall Study|Death|2|||
129994196|NCT00585195|467941125|FG014|Overall Study|Death|8|||
129994197|NCT00585195|467941126|FG015|Overall Study|Death|2|||
129994198|NCT00585195|467941127|FG016|Overall Study|Death|11|||
129994199|NCT00585195|467941128|FG017|Overall Study|Death|0|||
129994200|NCT00585195|467941129|FG018|Overall Study|Death|0|||
129994201|NCT00585195|467941130|FG019|Overall Study|Death|0|||
129994202|NCT00585195|467941131|FG020|Overall Study|Death|1|||
129994203|NCT00585195|467941111|FG000|Overall Study|Lost to Follow-up|0|||
129994204|NCT00585195|467941112|FG001|Overall Study|Lost to Follow-up|0|||
129994205|NCT00585195|467941113|FG002|Overall Study|Lost to Follow-up|0|||
129994206|NCT00585195|467941114|FG003|Overall Study|Lost to Follow-up|0|||
129994207|NCT00585195|467941115|FG004|Overall Study|Lost to Follow-up|0|||
129994208|NCT00585195|467941116|FG005|Overall Study|Lost to Follow-up|0|||
129994209|NCT00585195|467941117|FG006|Overall Study|Lost to Follow-up|0|||
129994210|NCT00585195|467941118|FG007|Overall Study|Lost to Follow-up|0|||
129994211|NCT00585195|467941119|FG008|Overall Study|Lost to Follow-up|0|||
129994212|NCT00585195|467941120|FG009|Overall Study|Lost to Follow-up|0|||
129994213|NCT00585195|467941121|FG010|Overall Study|Lost to Follow-up|0|||
129994214|NCT00585195|467941122|FG011|Overall Study|Lost to Follow-up|0|||
129994215|NCT00585195|467941123|FG012|Overall Study|Lost to Follow-up|1|||
129994216|NCT00585195|467941124|FG013|Overall Study|Lost to Follow-up|0|||
129994217|NCT00585195|467941125|FG014|Overall Study|Lost to Follow-up|0|||
129994218|NCT00585195|467941126|FG015|Overall Study|Lost to Follow-up|0|||
129994219|NCT00585195|467941127|FG016|Overall Study|Lost to Follow-up|0|||
129994220|NCT00585195|467941128|FG017|Overall Study|Lost to Follow-up|2|||
129994221|NCT00585195|467941129|FG018|Overall Study|Lost to Follow-up|0|||
129994222|NCT00585195|467941130|FG019|Overall Study|Lost to Follow-up|0|||
129994223|NCT00585195|467941131|FG020|Overall Study|Lost to Follow-up|0|||
129994224|NCT00585195|467941111|FG000|Overall Study|Site Terminated by Sponsor|0|||
129994225|NCT00585195|467941112|FG001|Overall Study|Site Terminated by Sponsor|0|||
129994226|NCT00585195|467941113|FG002|Overall Study|Site Terminated by Sponsor|0|||
129994227|NCT00585195|467941114|FG003|Overall Study|Site Terminated by Sponsor|0|||
130334437|NCT00485134|469193812|FG003|Overall Study|Withdrawal by Subject|0|||
130334438|NCT00485134|469193813|FG004|Overall Study|Withdrawal by Subject|0|||
130334439|NCT00485134|469193814|FG005|Overall Study|Withdrawal by Subject|0|||
130334440|NCT00485134|469193815|FG006|Overall Study|Withdrawal by Subject|0|||
130334441|NCT00485134|469193816|FG007|Overall Study|Withdrawal by Subject|0|||
129883957|NCT00219141|467534463|FG002|Overall Study|Condition no longer requires study drug|0|||
129883958|NCT01088529|467534464|FG000|Overall Study|Did not receive study treatment|0|||
129883959|NCT01088529|467534465|FG001|Overall Study|Did not receive study treatment|1|||
129883960|NCT02838628|467534467|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
129883961|NCT02838628|467534468|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
129883962|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Adverse Event|1|||
129883963|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Adverse Event|0|||
129883964|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Non-compliance|0|||
129883965|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Non-compliance|1|||
129883966|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
129883967|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
129883968|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Other un-specified|1|||
129883969|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Other un-specified|1|||
129883970|NCT01821898|467534469|FG000|Overall Study|Withdrawal by Subject|2|||
129883971|NCT01821898|467534470|FG001|Overall Study|Withdrawal by Subject|1|||
129883972|NCT02066532|467534475|FG000|Phase II|Withdrawal by Subject|1|||
129883973|NCT02066532|467534476|FG001|Phase II|Withdrawal by Subject|0|||
129883974|NCT02066532|467534477|FG002|Phase II|Withdrawal by Subject|0|||
129883975|NCT02066532|467534478|FG003|Phase II|Withdrawal by Subject|0|||
129883976|NCT00337662|467534479|FG000|Study Period II|Lost to Follow-up|0|||
129883977|NCT00337662|467534480|FG001|Study Period II|Lost to Follow-up|0|||
129883978|NCT00337662|467534481|FG002|Study Period II|Lost to Follow-up|0|||
129883979|NCT00337662|467534482|FG003|Study Period II|Lost to Follow-up|35|||
129883980|NCT00337662|467534479|FG000|Study Period II|Withdrawal by Subject|0|||
129883981|NCT00337662|467534480|FG001|Study Period II|Withdrawal by Subject|0|||
129994228|NCT00585195|467941115|FG004|Overall Study|Site Terminated by Sponsor|0|||
129994229|NCT00585195|467941116|FG005|Overall Study|Site Terminated by Sponsor|0|||
129994230|NCT00585195|467941117|FG006|Overall Study|Site Terminated by Sponsor|0|||
129994231|NCT00585195|467941118|FG007|Overall Study|Site Terminated by Sponsor|0|||
129994232|NCT00585195|467941119|FG008|Overall Study|Site Terminated by Sponsor|0|||
129994233|NCT00585195|467941120|FG009|Overall Study|Site Terminated by Sponsor|0|||
129994234|NCT00585195|467941121|FG010|Overall Study|Site Terminated by Sponsor|0|||
129994235|NCT00585195|467941122|FG011|Overall Study|Site Terminated by Sponsor|0|||
129994236|NCT00585195|467941123|FG012|Overall Study|Site Terminated by Sponsor|1|||
129994237|NCT00585195|467941124|FG013|Overall Study|Site Terminated by Sponsor|0|||
129994238|NCT00585195|467941125|FG014|Overall Study|Site Terminated by Sponsor|0|||
129994239|NCT00585195|467941126|FG015|Overall Study|Site Terminated by Sponsor|0|||
129994240|NCT00585195|467941127|FG016|Overall Study|Site Terminated by Sponsor|0|||
129994241|NCT00585195|467941128|FG017|Overall Study|Site Terminated by Sponsor|0|||
129994242|NCT00585195|467941129|FG018|Overall Study|Site Terminated by Sponsor|0|||
129994243|NCT00585195|467941130|FG019|Overall Study|Site Terminated by Sponsor|0|||
129994244|NCT00585195|467941131|FG020|Overall Study|Site Terminated by Sponsor|0|||
129994245|NCT00585195|467941111|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
129994246|NCT00585195|467941112|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
129994247|NCT00585195|467941113|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
129994248|NCT00585195|467941114|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
129994249|NCT00585195|467941115|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
129994250|NCT00585195|467941116|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
129994251|NCT00585195|467941117|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
129994252|NCT00585195|467941118|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
129994253|NCT00585195|467941119|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
129994254|NCT00585195|467941120|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
129994255|NCT00585195|467941121|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
129994256|NCT00585195|467941122|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
129994257|NCT00585195|467941123|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
129994258|NCT00585195|467941124|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
129994259|NCT00585195|467941125|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
129994260|NCT00585195|467941126|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
129994261|NCT00585195|467941127|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
129994262|NCT00585195|467941128|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
129994263|NCT00585195|467941129|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
129994264|NCT00585195|467941130|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
129994265|NCT00585195|467941131|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
129994266|NCT02796560|467941132|FG000|Overall Study|Adverse Event|2|||
129994267|NCT02796560|467941133|FG001|Overall Study|Adverse Event|0|||
129994268|NCT02796560|467941132|FG000|Overall Study|Withdrawal by Subject|2|||
129994269|NCT02796560|467941133|FG001|Overall Study|Withdrawal by Subject|2|||
129994270|NCT02533570|467941135|FG000|Overall Study|Adverse Event|0|||
129994271|NCT02533570|467941136|FG001|Overall Study|Adverse Event|1|||
129994272|NCT02533570|467941137|FG002|Overall Study|Adverse Event|1|||
129994273|NCT00423930|467941138|FG000|Overall Study|Withdrawal by Subject|2|||
129994274|NCT04002401|467941139|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
129994275|NCT04002401|467941139|FG000|Overall Study|Death|10|||
129994276|NCT04002401|467941139|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
129994277|NCT04002401|467941139|FG000|Overall Study|Enrolled but Never Treated|1|||
129994278|NCT04002401|467941139|FG000|Overall Study|Lost to Follow-up|1|||
129994279|NCT02656823|467941140|FG000|Overall Study|Adverse Event|3|||
129994280|NCT02656823|467941140|FG000|Overall Study|Lost to Follow-up|2|||
129994281|NCT01009580|467941145|FG000|Overall Study|Adverse Event|4|||
129994282|NCT01009580|467941146|FG001|Overall Study|Adverse Event|4|||
129994283|NCT01009580|467941145|FG000|Overall Study|Lack of Efficacy|0|||
129994284|NCT01009580|467941146|FG001|Overall Study|Lack of Efficacy|1|||
129994285|NCT01009580|467941145|FG000|Overall Study|Protocol Violation|2|||
129994286|NCT01009580|467941146|FG001|Overall Study|Protocol Violation|3|||
129994287|NCT01009580|467941145|FG000|Overall Study|Withdrawal Criteria|4|||
129994288|NCT01009580|467941146|FG001|Overall Study|Withdrawal Criteria|6|||
129994289|NCT01009580|467941145|FG000|Overall Study|Unclassified|17|||
129994290|NCT01009580|467941146|FG001|Overall Study|Unclassified|21|||
129883982|NCT00337662|467534481|FG002|Study Period II|Withdrawal by Subject|0|||
129883983|NCT00337662|467534482|FG003|Study Period II|Withdrawal by Subject|20|||
129883984|NCT00337662|467534479|FG000|Study Period II|Adverse Event|0|||
129883985|NCT00337662|467534480|FG001|Study Period II|Adverse Event|0|||
129883986|NCT00337662|467534481|FG002|Study Period II|Adverse Event|0|||
129883987|NCT00337662|467534482|FG003|Study Period II|Adverse Event|16|||
129883988|NCT00337662|467534479|FG000|Study Period II|Physician Decision|0|||
129883989|NCT00337662|467534480|FG001|Study Period II|Physician Decision|0|||
129883990|NCT00337662|467534481|FG002|Study Period II|Physician Decision|0|||
129883991|NCT00337662|467534482|FG003|Study Period II|Physician Decision|13|||
129883992|NCT00337662|467534479|FG000|Study Period II|Entry Criteria Not Met|0|||
129883993|NCT00337662|467534480|FG001|Study Period II|Entry Criteria Not Met|0|||
129883994|NCT00337662|467534481|FG002|Study Period II|Entry Criteria Not Met|0|||
129883995|NCT00337662|467534482|FG003|Study Period II|Entry Criteria Not Met|6|||
129883996|NCT00337662|467534479|FG000|Study Period II|Protocol Violation|0|||
129883997|NCT00337662|467534480|FG001|Study Period II|Protocol Violation|0|||
129883998|NCT00337662|467534481|FG002|Study Period II|Protocol Violation|0|||
129883999|NCT00337662|467534482|FG003|Study Period II|Protocol Violation|6|||
129884000|NCT00337662|467534479|FG000|Study Period II|Lack of Efficacy|0|||
129884001|NCT00337662|467534480|FG001|Study Period II|Lack of Efficacy|0|||
129884002|NCT00337662|467534481|FG002|Study Period II|Lack of Efficacy|0|||
129884003|NCT00337662|467534482|FG003|Study Period II|Lack of Efficacy|7|||
129884004|NCT00337662|467534479|FG000|Study Period II|Sponsor Decision|0|||
129884005|NCT00337662|467534480|FG001|Study Period II|Sponsor Decision|0|||
129884006|NCT00337662|467534481|FG002|Study Period II|Sponsor Decision|0|||
129884007|NCT00337662|467534482|FG003|Study Period II|Sponsor Decision|2|||
129884008|NCT00337662|467534479|FG000|Study Period II|Parent/Caregiver Decision|0|||
129884009|NCT00337662|467534480|FG001|Study Period II|Parent/Caregiver Decision|0|||
129884010|NCT00337662|467534481|FG002|Study Period II|Parent/Caregiver Decision|0|||
129884011|NCT00337662|467534482|FG003|Study Period II|Parent/Caregiver Decision|1|||
129884012|NCT00337662|467534479|FG000|Study Period III|Lost to Follow-up|14|||
129884013|NCT00337662|467534480|FG001|Study Period III|Lost to Follow-up|16|||
129884014|NCT00337662|467534481|FG002|Study Period III|Lost to Follow-up|14|||
129884015|NCT00337662|467534482|FG003|Study Period III|Lost to Follow-up|0|||
129884016|NCT00337662|467534479|FG000|Study Period III|Withdrawal by Subject|18|||
129884017|NCT00337662|467534480|FG001|Study Period III|Withdrawal by Subject|14|||
129884018|NCT00337662|467534481|FG002|Study Period III|Withdrawal by Subject|12|||
129884019|NCT00337662|467534482|FG003|Study Period III|Withdrawal by Subject|0|||
129884020|NCT00337662|467534479|FG000|Study Period III|Adverse Event|9|||
129884021|NCT00337662|467534480|FG001|Study Period III|Adverse Event|10|||
129884022|NCT00337662|467534481|FG002|Study Period III|Adverse Event|8|||
129884023|NCT00337662|467534482|FG003|Study Period III|Adverse Event|0|||
129884024|NCT00337662|467534479|FG000|Study Period III|Protocol Violation|3|||
129884025|NCT00337662|467534480|FG001|Study Period III|Protocol Violation|8|||
129884026|NCT00337662|467534481|FG002|Study Period III|Protocol Violation|2|||
129884027|NCT00337662|467534482|FG003|Study Period III|Protocol Violation|0|||
129884028|NCT00337662|467534479|FG000|Study Period III|Physician Decision|6|||
129884029|NCT00337662|467534480|FG001|Study Period III|Physician Decision|5|||
129884030|NCT00337662|467534481|FG002|Study Period III|Physician Decision|0|||
129884031|NCT00337662|467534482|FG003|Study Period III|Physician Decision|0|||
129884032|NCT00337662|467534479|FG000|Study Period III|Entry Criteria Not Met|4|||
129884033|NCT00337662|467534480|FG001|Study Period III|Entry Criteria Not Met|1|||
129884034|NCT00337662|467534481|FG002|Study Period III|Entry Criteria Not Met|3|||
129884035|NCT00337662|467534482|FG003|Study Period III|Entry Criteria Not Met|0|||
129884036|NCT00337662|467534479|FG000|Study Period III|Lack of Efficacy|4|||
129884037|NCT00337662|467534480|FG001|Study Period III|Lack of Efficacy|4|||
129884038|NCT00337662|467534481|FG002|Study Period III|Lack of Efficacy|2|||
129884039|NCT00337662|467534482|FG003|Study Period III|Lack of Efficacy|0|||
129884040|NCT00337662|467534479|FG000|Study Period III|Parent/Caregiver Decision|0|||
129884041|NCT00337662|467534480|FG001|Study Period III|Parent/Caregiver Decision|0|||
129884042|NCT00337662|467534481|FG002|Study Period III|Parent/Caregiver Decision|2|||
129884043|NCT00337662|467534482|FG003|Study Period III|Parent/Caregiver Decision|0|||
129884044|NCT00337662|467534479|FG000|Study Period III|Sponsor Decision|1|||
129884045|NCT00337662|467534480|FG001|Study Period III|Sponsor Decision|0|||
129884046|NCT00337662|467534481|FG002|Study Period III|Sponsor Decision|1|||
129884047|NCT00337662|467534482|FG003|Study Period III|Sponsor Decision|0|||
129884048|NCT00337662|467534479|FG000|Study Period III|Clinical Relapse|1|||
129884049|NCT00337662|467534480|FG001|Study Period III|Clinical Relapse|0|||
129884050|NCT00337662|467534481|FG002|Study Period III|Clinical Relapse|0|||
129884051|NCT00337662|467534482|FG003|Study Period III|Clinical Relapse|0|||
129884052|NCT01265823|467534483|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
129884053|NCT01265823|467534483|FG000|Overall Study|Failure to Return|4|||
129884054|NCT01265823|467534483|FG000|Overall Study|Protocol Violation|1|||
129884055|NCT01265823|467534483|FG000|Overall Study|Participant Request|1|||
129884056|NCT03691948|467534485|FG000|Overall Study|Lost to Follow-up|1|||
129884057|NCT03691948|467534486|FG001|Overall Study|Lost to Follow-up|3|||
129884058|NCT01018563|467534491|FG000|Overall Study|Termination of the study by Sponsor|2|||
129884059|NCT01018563|467534492|FG001|Overall Study|Termination of the study by Sponsor|1|||
129884060|NCT02344537|467534495|FG000|Overall Study|Protocol Violation|1|||
129884061|NCT02344537|467534496|FG001|Overall Study|Protocol Violation|1|||
129884062|NCT02344537|467534495|FG000|Overall Study|Subject started another treatment after wk 6|1|||
129884063|NCT02344537|467534496|FG001|Overall Study|Subject started another treatment after wk 6|0|||
129884064|NCT02344537|467534495|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
129884065|NCT02344537|467534496|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
129884066|NCT00960752|467534498|FG000|Overall Study|Adverse Event|0|||
129884067|NCT00960752|467534499|FG001|Overall Study|Adverse Event|0|||
129994291|NCT05269355|467941150|FG000|Overall Study|Progressive Disease|104|||
129994292|NCT05269355|467941151|FG001|Overall Study|Progressive Disease|68|||
129994293|NCT05269355|467941150|FG000|Overall Study|Study Terminated by Sponsor|87|||
129994294|NCT05269355|467941151|FG001|Overall Study|Study Terminated by Sponsor|29|||
129994295|NCT05269355|467941150|FG000|Overall Study|Adverse Event|15|||
129994296|NCT05269355|467941151|FG001|Overall Study|Adverse Event|8|||
129994297|NCT05269355|467941150|FG000|Overall Study|Withdrawal by Subject|18|||
129994298|NCT05269355|467941151|FG001|Overall Study|Withdrawal by Subject|5|||
129994299|NCT05269355|467941150|FG000|Overall Study|Physician Decision|6|||
129994300|NCT05269355|467941151|FG001|Overall Study|Physician Decision|4|||
129994301|NCT05269355|467941150|FG000|Overall Study|Death|3|||
129994302|NCT05269355|467941151|FG001|Overall Study|Death|5|||
129994303|NCT05269355|467941150|FG000|Overall Study|Other Than Specified|5|||
129994304|NCT05269355|467941151|FG001|Overall Study|Other Than Specified|1|||
129994305|NCT05269355|467941150|FG000|Overall Study|Randomized But Not Treated|1|||
129994306|NCT05269355|467941151|FG001|Overall Study|Randomized But Not Treated|0|||
129994307|NCT00081497|467941152|FG000|Overall Study|Adverse Event|2|||
129994308|NCT00081497|467941153|FG001|Overall Study|Adverse Event|0|||
129994309|NCT00081497|467941152|FG000|Overall Study|Death|0|||
129994310|NCT00081497|467941153|FG001|Overall Study|Death|1|||
129994311|NCT00081497|467941152|FG000|Overall Study|Withdrawal by Subject|1|||
129994312|NCT00081497|467941153|FG001|Overall Study|Withdrawal by Subject|0|||
129994313|NCT00081497|467941152|FG000|Overall Study|Non-compliance|0|||
129994314|NCT00081497|467941153|FG001|Overall Study|Non-compliance|1|||
129994315|NCT00959647|467941155|FG000|Overall Study|Adverse Event|2|||
129994316|NCT00959647|467941155|FG000|Overall Study|Progressive disease|6|||
129994317|NCT00959647|467941155|FG000|Overall Study|Study terminated by sponsor|4|||
129994318|NCT00959647|467941155|FG000|Overall Study|Withdrawal by Subject|7|||
129994319|NCT00655486|467942734|FG000|Overall Study|Adverse Event|10|||
129994320|NCT00655486|467942734|FG000|Overall Study|Lack of Efficacy|8|||
129994321|NCT00655486|467942734|FG000|Overall Study|Withdrawal by Subject|4|||
129994322|NCT00655486|467942734|FG000|Overall Study|Protocol Violation|1|||
129994323|NCT00655486|467942734|FG000|Overall Study|Unsatisfactory compliance|2|||
129994324|NCT00655486|467942734|FG000|Overall Study|Other: Pregnancy|1|||
129994325|NCT00655486|467942734|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
129994326|NCT00655486|467942734|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
129994327|NCT02768870|467942745|FG000|Overall Study|Death|1|||
129994328|NCT02768870|467942745|FG000|Overall Study|Reoperation|6|||
129994329|NCT02768870|467942745|FG000|Overall Study|Lost to Follow-up|1|||
129994330|NCT02768870|467942745|FG000|Overall Study|Exit|4|||
129994331|NCT03401229|467942746|FG000|Overall Study|Lost to Follow-up|2|||
129994332|NCT03401229|467942747|FG001|Overall Study|Lost to Follow-up|1|||
129994333|NCT03401229|467942746|FG000|Overall Study|Other|1|||
129994334|NCT03401229|467942747|FG001|Overall Study|Other|3|||
129994335|NCT03401229|467942746|FG000|Overall Study|Adverse Event|8|||
129994336|NCT03401229|467942747|FG001|Overall Study|Adverse Event|6|||
129994337|NCT03401229|467942746|FG000|Overall Study|Withdrawal by Subject|29|||
129994338|NCT03401229|467942747|FG001|Overall Study|Withdrawal by Subject|26|||
129994339|NCT03401229|467942746|FG000|Overall Study|COVID-19|0|||
129994340|NCT03401229|467942747|FG001|Overall Study|COVID-19|1|||
129994341|NCT02963610|467942748|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
129994342|NCT01774110|467942749|FG000|Overall Study|Lost to Follow-up|7|||
129994343|NCT01122862|467942750|FG000|Period 1|Protocol Violation|0|||
129994344|NCT01122862|467942751|FG001|Period 1|Protocol Violation|1|||
129994345|NCT01122862|467942752|FG002|Period 1|Protocol Violation|0|||
129994346|NCT01122862|467942750|FG000|Period 2|Adverse Event|0|||
129994347|NCT01122862|467942751|FG001|Period 2|Adverse Event|0|||
129994348|NCT01122862|467942752|FG002|Period 2|Adverse Event|1|||
129994349|NCT00640016|467942753|FG000|Overall Study|Withdrawal by Subject|0|||
129994350|NCT00640016|467942754|FG001|Overall Study|Withdrawal by Subject|1|||
129994351|NCT00640016|467942755|FG002|Overall Study|Withdrawal by Subject|0|||
129994352|NCT00640016|467942756|FG003|Overall Study|Withdrawal by Subject|0|||
129994353|NCT00640016|467942753|FG000|Overall Study|Study termination|2|||
129994354|NCT00640016|467942754|FG001|Overall Study|Study termination|1|||
129994355|NCT00640016|467942755|FG002|Overall Study|Study termination|3|||
129994356|NCT00640016|467942756|FG003|Overall Study|Study termination|2|||
130334442|NCT00485134|469193809|FG000|Overall Study|Change in health status|0|||
130334443|NCT00485134|469193810|FG001|Overall Study|Change in health status|1|||
129994357|NCT00640016|467942753|FG000|Overall Study|Adverse Event|0|||
129994358|NCT00640016|467942754|FG001|Overall Study|Adverse Event|0|||
129994359|NCT00640016|467942755|FG002|Overall Study|Adverse Event|0|||
129994360|NCT00640016|467942756|FG003|Overall Study|Adverse Event|1|||
129994361|NCT02699983|467942759|FG000|Overall Study|Withdrawal by Subject|1|||
129994362|NCT02699983|467942760|FG001|Overall Study|Withdrawal by Subject|0|||
129994363|NCT03575143|467942761|FG000|Overall Study|Lost to Follow-up|0|||
129994364|NCT03575143|467942762|FG001|Overall Study|Lost to Follow-up|0|||
129994365|NCT03575143|467942763|FG002|Overall Study|Lost to Follow-up|4|||
129994366|NCT03575143|467942761|FG000|Overall Study|Withdrawal by Subject|0|||
129994367|NCT03575143|467942762|FG001|Overall Study|Withdrawal by Subject|0|||
129994368|NCT03575143|467942763|FG002|Overall Study|Withdrawal by Subject|5|||
129994369|NCT03575143|467942761|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
129994370|NCT03575143|467942762|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
129994371|NCT03575143|467942763|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
129994372|NCT01287065|467942766|FG000|Treatment Period 1|Adverse Event|0|||
129994373|NCT01287065|467942767|FG001|Treatment Period 1|Adverse Event|0|||
129994374|NCT01287065|467942768|FG002|Treatment Period 1|Adverse Event|0|||
129994375|NCT01287065|467942769|FG003|Treatment Period 1|Adverse Event|0|||
129994376|NCT01287065|467942770|FG004|Treatment Period 1|Adverse Event|1|||
129994377|NCT01287065|467942771|FG005|Treatment Period 1|Adverse Event|0|||
129994378|NCT01287065|467942766|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129994379|NCT01287065|467942767|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129994380|NCT01287065|467942768|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129994381|NCT01287065|467942769|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129994382|NCT01287065|467942770|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129994383|NCT01287065|467942771|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129994384|NCT02875977|467942772|FG000|Overall Study|Lost to Follow-up|42|||
129994385|NCT02875977|467942773|FG001|Overall Study|Lost to Follow-up|29|||
129994386|NCT01259726|467942774|FG000|Overall Study|Death|1|||
129994387|NCT01259726|467942775|FG001|Overall Study|Death|0|||
129994388|NCT01259726|467942776|FG002|Overall Study|Death|0|||
129994389|NCT01259726|467942777|FG003|Overall Study|Death|0|||
129994390|NCT01259726|467942774|FG000|Overall Study|Physician Decision|2|||
129994391|NCT01259726|467942775|FG001|Overall Study|Physician Decision|0|||
129994392|NCT01259726|467942776|FG002|Overall Study|Physician Decision|1|||
129994393|NCT01259726|467942777|FG003|Overall Study|Physician Decision|1|||
129994394|NCT01259726|467942774|FG000|Overall Study|Withdrawal by Subject|1|||
129994395|NCT01259726|467942775|FG001|Overall Study|Withdrawal by Subject|3|||
129994396|NCT01259726|467942776|FG002|Overall Study|Withdrawal by Subject|2|||
129994397|NCT01259726|467942777|FG003|Overall Study|Withdrawal by Subject|1|||
129994398|NCT01259726|467942774|FG000|Overall Study|Lost to Follow-up|1|||
129994399|NCT01259726|467942775|FG001|Overall Study|Lost to Follow-up|1|||
129994400|NCT01259726|467942776|FG002|Overall Study|Lost to Follow-up|1|||
129994401|NCT01259726|467942777|FG003|Overall Study|Lost to Follow-up|3|||
129994402|NCT03421431|467942785|FG000|Overall Study|Adverse Event|2|||
129994403|NCT03421431|467942786|FG001|Overall Study|Adverse Event|1|||
129994404|NCT03421431|467942787|FG002|Overall Study|Adverse Event|12|||
129994405|NCT03421431|467942785|FG000|Overall Study|Lost to Follow-up|1|||
129994406|NCT03421431|467942786|FG001|Overall Study|Lost to Follow-up|1|||
129994407|NCT03421431|467942787|FG002|Overall Study|Lost to Follow-up|1|||
129994408|NCT03421431|467942785|FG000|Overall Study|Withdrawal by Subject|3|||
129994409|NCT03421431|467942786|FG001|Overall Study|Withdrawal by Subject|2|||
129994410|NCT03421431|467942787|FG002|Overall Study|Withdrawal by Subject|1|||
129994411|NCT03421431|467942785|FG000|Overall Study|Protocol Violation|0|||
129994412|NCT03421431|467942786|FG001|Overall Study|Protocol Violation|1|||
129994413|NCT03421431|467942787|FG002|Overall Study|Protocol Violation|0|||
129994414|NCT03421431|467942785|FG000|Overall Study|Participant met Stopping Rules|0|||
129994415|NCT03421431|467942786|FG001|Overall Study|Participant met Stopping Rules|1|||
129994416|NCT03421431|467942787|FG002|Overall Study|Participant met Stopping Rules|0|||
129994417|NCT00141726|467942791|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
129994418|NCT00235326|467942796|FG000|Overall Study|Lost to Follow-up|746|||
129994419|NCT00235326|467942797|FG001|Overall Study|Lost to Follow-up|1400|||
129994420|NCT01790126|467942798|FG000|Overall Study|PSA Progression|12|||
129994421|NCT01790126|467942799|FG001|Overall Study|PSA Progression|16|||
129994422|NCT01790126|467942800|FG002|Overall Study|PSA Progression|16|||
129994423|NCT01790126|467942798|FG000|Overall Study|Other|5|||
129994424|NCT01790126|467942799|FG001|Overall Study|Other|4|||
129994425|NCT01790126|467942800|FG002|Overall Study|Other|8|||
129994426|NCT01790126|467942798|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
129994427|NCT01790126|467942799|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
129994428|NCT01790126|467942800|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
129994429|NCT01790126|467942798|FG000|Overall Study|Withdrawal by Physician|1|||
129994430|NCT01790126|467942799|FG001|Overall Study|Withdrawal by Physician|1|||
129994431|NCT01790126|467942800|FG002|Overall Study|Withdrawal by Physician|2|||
129994432|NCT01790126|467942798|FG000|Overall Study|Withdrawal by Subject|3|||
129994433|NCT01790126|467942799|FG001|Overall Study|Withdrawal by Subject|1|||
129994434|NCT01790126|467942800|FG002|Overall Study|Withdrawal by Subject|2|||
129994435|NCT01790126|467942798|FG000|Overall Study|Lost to Follow-up|1|||
129994436|NCT01790126|467942799|FG001|Overall Study|Lost to Follow-up|0|||
129994437|NCT01790126|467942800|FG002|Overall Study|Lost to Follow-up|1|||
129994438|NCT01790126|467942798|FG000|Overall Study|Adverse Event|0|||
129994439|NCT01790126|467942799|FG001|Overall Study|Adverse Event|2|||
129994440|NCT01790126|467942800|FG002|Overall Study|Adverse Event|0|||
129994441|NCT01790126|467942798|FG000|Overall Study|Death|2|||
129994442|NCT01790126|467942799|FG001|Overall Study|Death|0|||
129994443|NCT01790126|467942800|FG002|Overall Study|Death|0|||
129994444|NCT01790126|467942798|FG000|Overall Study|Radiographic Progression|3|||
129994445|NCT01790126|467942799|FG001|Overall Study|Radiographic Progression|1|||
129994446|NCT01790126|467942800|FG002|Overall Study|Radiographic Progression|0|||
129994447|NCT01128738|467942801|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
129994448|NCT01128738|467942802|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
129994449|NCT01128738|467942801|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
129994450|NCT01128738|467942802|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
129994451|NCT01128738|467942801|FG000|Second TP|Lost to Follow-up|0|||
129994452|NCT01128738|467942802|FG001|Second TP|Lost to Follow-up|1|||
129994453|NCT01128738|467942801|FG000|Second TP|Withdrawal by Subject|0|||
129994454|NCT01128738|467942802|FG001|Second TP|Withdrawal by Subject|2|||
129994455|NCT01178671|467942803|FG000|Overall Study|Adverse Event|4|||
129994456|NCT01178671|467942804|FG001|Overall Study|Adverse Event|6|||
129994457|NCT01178671|467942803|FG000|Overall Study|Protocol Violation|1|||
129994458|NCT01178671|467942804|FG001|Overall Study|Protocol Violation|1|||
129994459|NCT01178671|467942803|FG000|Overall Study|Lack of Efficacy|0|||
129994460|NCT01178671|467942804|FG001|Overall Study|Lack of Efficacy|1|||
129994461|NCT01178671|467942803|FG000|Overall Study|Lost to Follow-up|3|||
129994462|NCT01178671|467942804|FG001|Overall Study|Lost to Follow-up|1|||
129994463|NCT01178671|467942803|FG000|Overall Study|Physician Decision|4|||
129994464|NCT01178671|467942804|FG001|Overall Study|Physician Decision|6|||
129994465|NCT02435966|467942805|FG000|Overall Study|Withdrawal by Subject|0|||
129994466|NCT02435966|467942806|FG001|Overall Study|Withdrawal by Subject|1|||
129994467|NCT02435966|467942807|FG002|Overall Study|Withdrawal by Subject|0|||
129994468|NCT01211197|467942811|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129994469|NCT01211197|467942812|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129994470|NCT01211197|467942813|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129994471|NCT01211197|467942814|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129994472|NCT01211197|467942815|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129994473|NCT01211197|467942816|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129994474|NCT01211197|467942811|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
129994475|NCT01211197|467942812|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
129994476|NCT01211197|467942813|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
129994477|NCT01211197|467942814|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
129994478|NCT01211197|467942815|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
129994479|NCT01211197|467942816|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
129994480|NCT01054846|467942817|FG000|Overall Study|Lost to Follow-up|76|||
129994481|NCT01054846|467942818|FG001|Overall Study|Lost to Follow-up|17|||
129994482|NCT02446886|467942819|FG000|Overall Study|Adverse Event|1|||
129994483|NCT02446886|467942820|FG001|Overall Study|Adverse Event|3|||
129994484|NCT02446886|467942819|FG000|Overall Study|Withdrawal by Subject|1|||
129994485|NCT02446886|467942820|FG001|Overall Study|Withdrawal by Subject|1|||
129994486|NCT00928447|467942821|FG000|Overall Study|Withdrawal by Subject|1|||
129994487|NCT00928447|467942821|FG000|Overall Study|Investigator's decision|1|||
129994488|NCT01259284|467942822|FG000|Overall Study|Study Termination|2|||
129994489|NCT01259284|467942823|FG001|Overall Study|Study Termination|0|||
129994490|NCT01259284|467942824|FG002|Overall Study|Study Termination|0|||
129994491|NCT01971203|467942825|FG000|Overall Study|Protocol Violation|3|||
129994492|NCT01971203|467942826|FG001|Overall Study|Protocol Violation|2|||
129994493|NCT01971203|467942825|FG000|Overall Study|Withdrawal by Subject|5|||
129994494|NCT01971203|467942826|FG001|Overall Study|Withdrawal by Subject|6|||
129994495|NCT01971203|467942825|FG000|Overall Study|Adverse Event|1|||
129994496|NCT01971203|467942826|FG001|Overall Study|Adverse Event|0|||
129994497|NCT00807235|467942827|FG000|Overall Study|Adverse Event|1|||
129994498|NCT00807235|467942828|FG001|Overall Study|Adverse Event|0|||
129994499|NCT01765179|467942829|FG000|Overall Study|Adverse Event|3|||
129994500|NCT01765179|467942829|FG000|Overall Study|Lost to Follow-up|5|||
129994501|NCT01765179|467942829|FG000|Overall Study|Non-compliance with study drug|2|||
130334444|NCT00485134|469193811|FG002|Overall Study|Change in health status|2|||
130334445|NCT00485134|469193812|FG003|Overall Study|Change in health status|1|||
130334446|NCT00485134|469193813|FG004|Overall Study|Change in health status|0|||
130334447|NCT00485134|469193814|FG005|Overall Study|Change in health status|1|||
130334448|NCT00485134|469193815|FG006|Overall Study|Change in health status|0|||
130334449|NCT00485134|469193816|FG007|Overall Study|Change in health status|0|||
130334450|NCT00485134|469193809|FG000|Overall Study|Withdrew for adverse event|0|||
130334451|NCT00485134|469193810|FG001|Overall Study|Withdrew for adverse event|0|||
130334452|NCT00485134|469193811|FG002|Overall Study|Withdrew for adverse event|1|||
129994502|NCT01765179|467942829|FG000|Overall Study|Protocol Violation|1|||
129994503|NCT01765179|467942829|FG000|Overall Study|Withdrawal by Subject|8|||
129994504|NCT01765179|467942829|FG000|Overall Study|Hematocrit >54%|3|||
129994505|NCT01765179|467942829|FG000|Overall Study|prohibited med|1|||
129994506|NCT01765179|467942829|FG000|Overall Study|Out of country unable to finish study|1|||
129994507|NCT01765179|467942829|FG000|Overall Study|lack of venous access|1|||
129994508|NCT01765179|467942829|FG000|Overall Study|work conflict|1|||
129994509|NCT01765179|467942829|FG000|Overall Study|Ca elevated 10.6|1|||
129994510|NCT02988622|467942830|FG000|Overall Study|Lost to Follow-up|17|||
129994511|NCT00178126|467942831|FG000|Overall Study|Lost to Follow-up|21|||
130334453|NCT00485134|469193812|FG003|Overall Study|Withdrew for adverse event|0|||
129994512|NCT00178126|467942832|FG001|Overall Study|Lost to Follow-up|21|||
129994513|NCT00178126|467942831|FG000|Overall Study|did not receive intervention|4|||
129994514|NCT00178126|467942832|FG001|Overall Study|did not receive intervention|6|||
129994515|NCT03562247|467942836|FG000|Overall Study|Lost to Follow-up|3|||
129994516|NCT03562247|467942837|FG001|Overall Study|Lost to Follow-up|1|||
129994517|NCT03562247|467942838|FG002|Overall Study|Lost to Follow-up|1|||
129994518|NCT01204398|467942839|FG000|Overall Study|Adverse Event|1|||
129994519|NCT00983931|467942840|FG000|14 Day Washout Period|Physician Decision|1|||
129994520|NCT01281969|467942843|FG000|Overall Study|not randomized didn't meet criteria|0|||
129994521|NCT01281969|467942844|FG001|Overall Study|not randomized didn't meet criteria|0|||
129994522|NCT01281969|467942845|FG002|Overall Study|not randomized didn't meet criteria|7|||
129994523|NCT01281969|467942843|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
129994524|NCT01281969|467942844|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
129994525|NCT01281969|467942845|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
129994526|NCT01281969|467942843|FG000|Overall Study|not randomized, child consent not given|0|||
129994527|NCT01281969|467942844|FG001|Overall Study|not randomized, child consent not given|0|||
129994528|NCT01281969|467942845|FG002|Overall Study|not randomized, child consent not given|2|||
129994529|NCT01201265|467942850|FG000|Overall Study|Death|14|||
129994530|NCT01201265|467942850|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129994531|NCT01201265|467942850|FG000|Overall Study|Lost to Follow-up|10|||
129994532|NCT01201265|467942850|FG000|Overall Study|Withdrawal by Subject|7|||
129994533|NCT01201265|467942850|FG000|Overall Study|Disease Progression|4|||
129994534|NCT04640077|467942851|FG000|Period 1|Withdrawal by Subject|4|||
129994535|NCT04640077|467942852|FG001|Period 1|Withdrawal by Subject|5|||
129994536|NCT04640077|467942853|FG002|Period 1|Withdrawal by Subject|0|||
129994537|NCT04640077|467942851|FG000|Period 1|Adverse Event|1|||
129994538|NCT04640077|467942852|FG001|Period 1|Adverse Event|1|||
129994539|NCT04640077|467942853|FG002|Period 1|Adverse Event|0|||
129994540|NCT04640077|467942851|FG000|Period 1|Screen Failure|2|||
129994541|NCT04640077|467942852|FG001|Period 1|Screen Failure|0|||
129994542|NCT04640077|467942853|FG002|Period 1|Screen Failure|0|||
129994543|NCT04640077|467942851|FG000|Period 2|Withdrawal by Subject|0|||
129994544|NCT04640077|467942852|FG001|Period 2|Withdrawal by Subject|0|||
129994545|NCT04640077|467942853|FG002|Period 2|Withdrawal by Subject|18|||
129994546|NCT04640077|467942851|FG000|Period 2|Adverse Event|0|||
129994547|NCT04640077|467942852|FG001|Period 2|Adverse Event|0|||
129994548|NCT04640077|467942853|FG002|Period 2|Adverse Event|6|||
129994549|NCT04640077|467942851|FG000|Period 2|Lost to Follow-up|0|||
129994550|NCT04640077|467942852|FG001|Period 2|Lost to Follow-up|0|||
129994551|NCT04640077|467942853|FG002|Period 2|Lost to Follow-up|2|||
129994552|NCT04640077|467942851|FG000|Period 2|Death|0|||
129994553|NCT04640077|467942852|FG001|Period 2|Death|0|||
129994554|NCT04640077|467942853|FG002|Period 2|Death|2|||
129994555|NCT04640077|467942851|FG000|Period 2|Progressive Disease|0|||
129994556|NCT04640077|467942852|FG001|Period 2|Progressive Disease|0|||
129994557|NCT04640077|467942853|FG002|Period 2|Progressive Disease|1|||
129994558|NCT04640077|467942851|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
129994559|NCT04640077|467942852|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
129994560|NCT04640077|467942853|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
129994561|NCT01257425|467942854|FG000|Overall Study|Lack of Efficacy|3|||
129994562|NCT01257425|467942855|FG001|Overall Study|Lack of Efficacy|3|||
129994563|NCT01257425|467942854|FG000|Overall Study|Adverse Event|1|||
129994564|NCT01257425|467942855|FG001|Overall Study|Adverse Event|1|||
129994565|NCT01257425|467942854|FG000|Overall Study|Protocol Violation|1|||
129994566|NCT01257425|467942855|FG001|Overall Study|Protocol Violation|1|||
129994567|NCT01257425|467942854|FG000|Overall Study|Withdrawal by Subject|0|||
129994568|NCT01257425|467942855|FG001|Overall Study|Withdrawal by Subject|1|||
129994569|NCT01257425|467942854|FG000|Overall Study|Death|1|||
129994570|NCT01257425|467942855|FG001|Overall Study|Death|0|||
129994571|NCT01182194|467942856|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
129994572|NCT01182194|467942857|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
129994573|NCT00368992|467942859|FG000|Overall Study|Ineligible|5|||
129994574|NCT00368992|467942859|FG000|Overall Study|Refused treatment|3|||
129994575|NCT00368992|467942859|FG000|Overall Study|Lack of Efficacy|63|||
129994576|NCT00368992|467942859|FG000|Overall Study|Adverse Event|26|||
129994577|NCT00368992|467942859|FG000|Overall Study|Death|4|||
129994578|NCT00368992|467942859|FG000|Overall Study|Other|9|||
129994579|NCT02668185|467942860|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
129994580|NCT02668185|467942861|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
129994581|NCT02668185|467942860|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
129994582|NCT02668185|467942861|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
129994583|NCT02668185|467942860|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
129994584|NCT02668185|467942861|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
129994585|NCT02668185|467942860|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
129994586|NCT02668185|467942861|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
129994587|NCT00723021|467942866|FG000|Intervention Period 4|Adverse Event|0|||
129994588|NCT00723021|467942867|FG001|Intervention Period 4|Adverse Event|0|||
129994589|NCT00723021|467942868|FG002|Intervention Period 4|Adverse Event|0|||
130334454|NCT00485134|469193813|FG004|Overall Study|Withdrew for adverse event|0|||
130334455|NCT00485134|469193814|FG005|Overall Study|Withdrew for adverse event|0|||
130334456|NCT00485134|469193815|FG006|Overall Study|Withdrew for adverse event|0|||
130334457|NCT00485134|469193816|FG007|Overall Study|Withdrew for adverse event|0|||
130334458|NCT00485134|469193809|FG000|Overall Study|Positive drug test|0|||
130334459|NCT00485134|469193810|FG001|Overall Study|Positive drug test|0|||
130334460|NCT00485134|469193811|FG002|Overall Study|Positive drug test|0|||
130334461|NCT00485134|469193812|FG003|Overall Study|Positive drug test|0|||
130334462|NCT00485134|469193813|FG004|Overall Study|Positive drug test|2|||
130334463|NCT00485134|469193814|FG005|Overall Study|Positive drug test|1|||
130334464|NCT00485134|469193815|FG006|Overall Study|Positive drug test|0|||
130334465|NCT00485134|469193816|FG007|Overall Study|Positive drug test|0|||
130334466|NCT00485134|469193809|FG000|Overall Study|Non-compliance|0|||
129884068|NCT00960752|467534500|FG002|Overall Study|Adverse Event|1|||
129884069|NCT00960752|467534498|FG000|Overall Study|Progression|0|||
129884070|NCT00960752|467534499|FG001|Overall Study|Progression|0|||
129884071|NCT00960752|467534500|FG002|Overall Study|Progression|1|||
129884072|NCT02180438|467534506|FG000|Overall Study|Lost to Follow-up|1|||
129884073|NCT00514046|467534511|FG000|Overall Study|transferred to another protocol|2|||
129884074|NCT00514046|467534512|FG001|Overall Study|transferred to another protocol|1|||
129884075|NCT00514046|467534513|FG002|Overall Study|transferred to another protocol|3|||
129884076|NCT00514046|467534514|FG003|Overall Study|transferred to another protocol|0|||
129884077|NCT00514046|467534515|FG004|Overall Study|transferred to another protocol|1|||
129884078|NCT00514046|467534516|FG005|Overall Study|transferred to another protocol|0|||
129884079|NCT00514046|467534517|FG006|Overall Study|transferred to another protocol|0|||
129884080|NCT00514046|467534518|FG007|Overall Study|transferred to another protocol|0|||
129884081|NCT00514046|467534519|FG008|Overall Study|transferred to another protocol|0|||
129884082|NCT00514046|467534511|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
129884083|NCT00514046|467534512|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
129884084|NCT00514046|467534513|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
129884085|NCT00514046|467534514|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
129884086|NCT00514046|467534515|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
129884087|NCT00514046|467534516|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
129884088|NCT00514046|467534517|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
129884089|NCT00514046|467534518|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
129884090|NCT00514046|467534519|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
129884091|NCT00514046|467534511|FG000|Overall Study|Disease progression on study|0|||
129884092|NCT00514046|467534512|FG001|Overall Study|Disease progression on study|0|||
129884093|NCT00514046|467534513|FG002|Overall Study|Disease progression on study|2|||
129884094|NCT00514046|467534514|FG003|Overall Study|Disease progression on study|0|||
129884095|NCT00514046|467534515|FG004|Overall Study|Disease progression on study|0|||
129884096|NCT00514046|467534516|FG005|Overall Study|Disease progression on study|1|||
129884097|NCT00514046|467534517|FG006|Overall Study|Disease progression on study|0|||
129884098|NCT00514046|467534518|FG007|Overall Study|Disease progression on study|0|||
129884099|NCT00514046|467534519|FG008|Overall Study|Disease progression on study|0|||
129884100|NCT00383240|467534521|FG000|Overall Study|Adverse Event|4|||
129884101|NCT00383240|467534522|FG001|Overall Study|Adverse Event|6|||
129884102|NCT00383240|467534523|FG002|Overall Study|Adverse Event|9|||
129884103|NCT00383240|467534524|FG003|Overall Study|Adverse Event|7|||
129884104|NCT00383240|467534521|FG000|Overall Study|Treatment Failure|8|||
129884105|NCT00383240|467534522|FG001|Overall Study|Treatment Failure|13|||
129884106|NCT00383240|467534523|FG002|Overall Study|Treatment Failure|47|||
129884107|NCT00383240|467534524|FG003|Overall Study|Treatment Failure|46|||
129884108|NCT00383240|467534521|FG000|Overall Study|Lost to Follow-up|3|||
129884109|NCT00383240|467534522|FG001|Overall Study|Lost to Follow-up|0|||
129884110|NCT00383240|467534523|FG002|Overall Study|Lost to Follow-up|0|||
129884111|NCT00383240|467534524|FG003|Overall Study|Lost to Follow-up|2|||
129884112|NCT00383240|467534521|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
129884113|NCT00383240|467534522|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
129884114|NCT00383240|467534523|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
129884115|NCT00383240|467534524|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
129884116|NCT00383240|467534521|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
129884117|NCT00383240|467534522|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
129884118|NCT00383240|467534523|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
129884119|NCT00383240|467534524|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
129884120|NCT00383240|467534521|FG000|Overall Study|Protocol Violation|4|||
129884121|NCT00383240|467534522|FG001|Overall Study|Protocol Violation|5|||
129884122|NCT00383240|467534523|FG002|Overall Study|Protocol Violation|9|||
129884123|NCT00383240|467534524|FG003|Overall Study|Protocol Violation|6|||
129884124|NCT00383240|467534521|FG000|Overall Study|Did not meet protocol eligibility|9|||
129884125|NCT00383240|467534522|FG001|Overall Study|Did not meet protocol eligibility|4|||
130334467|NCT00485134|469193810|FG001|Overall Study|Non-compliance|0|||
130334468|NCT00485134|469193811|FG002|Overall Study|Non-compliance|0|||
130334469|NCT00485134|469193812|FG003|Overall Study|Non-compliance|0|||
129994590|NCT00723021|467942869|FG003|Intervention Period 4|Adverse Event|0|||
129994591|NCT00723021|467942870|FG004|Intervention Period 4|Adverse Event|1|||
129994592|NCT00770341|467942872|FG000|Overall Study|Did not meet eligibility criteria|1|||
129994593|NCT00770341|467942873|FG001|Overall Study|Did not meet eligibility criteria|0|||
129994594|NCT00770341|467942874|FG002|Overall Study|Did not meet eligibility criteria|0|||
129994595|NCT00770341|467942872|FG000|Overall Study|Withdrawal by Subject|0|||
129994596|NCT00770341|467942873|FG001|Overall Study|Withdrawal by Subject|1|||
129994597|NCT00770341|467942874|FG002|Overall Study|Withdrawal by Subject|0|||
129994598|NCT00770341|467942872|FG000|Overall Study|Clinical Adverse Event|3|||
129994599|NCT00770341|467942873|FG001|Overall Study|Clinical Adverse Event|1|||
129994600|NCT00770341|467942874|FG002|Overall Study|Clinical Adverse Event|2|||
129994601|NCT00770341|467942872|FG000|Overall Study|Laboratory adverse event|3|||
129994602|NCT00770341|467942873|FG001|Overall Study|Laboratory adverse event|3|||
129994603|NCT00770341|467942874|FG002|Overall Study|Laboratory adverse event|0|||
129994604|NCT00770341|467942872|FG000|Overall Study|Lack of Efficacy|3|||
129994605|NCT00770341|467942873|FG001|Overall Study|Lack of Efficacy|0|||
129994606|NCT00770341|467942874|FG002|Overall Study|Lack of Efficacy|1|||
129994607|NCT00770341|467942872|FG000|Overall Study|Other|1|||
129994608|NCT00770341|467942873|FG001|Overall Study|Other|0|||
129994609|NCT00770341|467942874|FG002|Overall Study|Other|0|||
129994610|NCT00770341|467942872|FG000|Overall Study|Not treated|1|||
129994611|NCT00770341|467942873|FG001|Overall Study|Not treated|0|||
129994612|NCT00770341|467942874|FG002|Overall Study|Not treated|0|||
129994613|NCT00960531|467942880|FG000|Overall Study|Lack of Efficacy|1|||
129994614|NCT00960531|467942881|FG001|Overall Study|Lack of Efficacy|0|||
129994615|NCT00960531|467942882|FG002|Overall Study|Lack of Efficacy|0|||
129994616|NCT00960531|467942883|FG003|Overall Study|Lack of Efficacy|0|||
129994617|NCT00960531|467942884|FG004|Overall Study|Lack of Efficacy|0|||
129994618|NCT00960531|467942885|FG005|Overall Study|Lack of Efficacy|0|||
129994619|NCT00960531|467942886|FG006|Overall Study|Lack of Efficacy|0|||
129994620|NCT00960531|467942887|FG007|Overall Study|Lack of Efficacy|0|||
129994621|NCT00960531|467942888|FG008|Overall Study|Lack of Efficacy|0|||
129994622|NCT00960531|467942889|FG009|Overall Study|Lack of Efficacy|0|||
129994623|NCT00960531|467942880|FG000|Overall Study|Withdrawal by Subject|1|||
129994624|NCT00960531|467942881|FG001|Overall Study|Withdrawal by Subject|0|||
129994625|NCT00960531|467942882|FG002|Overall Study|Withdrawal by Subject|5|||
129994626|NCT00960531|467942883|FG003|Overall Study|Withdrawal by Subject|2|||
129994627|NCT00960531|467942884|FG004|Overall Study|Withdrawal by Subject|0|||
129994628|NCT00960531|467942885|FG005|Overall Study|Withdrawal by Subject|0|||
129994629|NCT00960531|467942886|FG006|Overall Study|Withdrawal by Subject|2|||
129994630|NCT00960531|467942887|FG007|Overall Study|Withdrawal by Subject|0|||
129994631|NCT00960531|467942888|FG008|Overall Study|Withdrawal by Subject|1|||
129994632|NCT00960531|467942889|FG009|Overall Study|Withdrawal by Subject|0|||
129994633|NCT00960531|467942880|FG000|Overall Study|Caregiver Request|2|||
129994634|NCT00960531|467942881|FG001|Overall Study|Caregiver Request|0|||
129994635|NCT00960531|467942882|FG002|Overall Study|Caregiver Request|6|||
129994636|NCT00960531|467942883|FG003|Overall Study|Caregiver Request|5|||
129994637|NCT00960531|467942884|FG004|Overall Study|Caregiver Request|0|||
129994638|NCT00960531|467942885|FG005|Overall Study|Caregiver Request|2|||
129994639|NCT00960531|467942886|FG006|Overall Study|Caregiver Request|3|||
129994640|NCT00960531|467942887|FG007|Overall Study|Caregiver Request|1|||
129994641|NCT00960531|467942888|FG008|Overall Study|Caregiver Request|3|||
129994642|NCT00960531|467942889|FG009|Overall Study|Caregiver Request|0|||
129994643|NCT00960531|467942880|FG000|Overall Study|Investigator Request|0|||
129994644|NCT00960531|467942881|FG001|Overall Study|Investigator Request|0|||
129994645|NCT00960531|467942882|FG002|Overall Study|Investigator Request|1|||
129994646|NCT00960531|467942883|FG003|Overall Study|Investigator Request|0|||
129994647|NCT00960531|467942884|FG004|Overall Study|Investigator Request|0|||
129994648|NCT00960531|467942885|FG005|Overall Study|Investigator Request|0|||
129994649|NCT00960531|467942886|FG006|Overall Study|Investigator Request|0|||
129994650|NCT00960531|467942887|FG007|Overall Study|Investigator Request|0|||
129994651|NCT00960531|467942888|FG008|Overall Study|Investigator Request|0|||
129994652|NCT00960531|467942889|FG009|Overall Study|Investigator Request|0|||
129994653|NCT00960531|467942880|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
129994654|NCT00960531|467942881|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129994655|NCT00960531|467942882|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
129994656|NCT00960531|467942883|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129994657|NCT00960531|467942884|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
129994658|NCT00960531|467942885|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
129994659|NCT00960531|467942886|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
129994660|NCT00960531|467942887|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
129994661|NCT00960531|467942888|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
129994662|NCT00960531|467942889|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
129994663|NCT00960531|467942880|FG000|Overall Study|Lost to Follow-up|0|||
129994664|NCT00960531|467942881|FG001|Overall Study|Lost to Follow-up|0|||
129994665|NCT00960531|467942882|FG002|Overall Study|Lost to Follow-up|1|||
129994666|NCT00960531|467942883|FG003|Overall Study|Lost to Follow-up|0|||
129994667|NCT00960531|467942884|FG004|Overall Study|Lost to Follow-up|0|||
129994668|NCT00960531|467942885|FG005|Overall Study|Lost to Follow-up|0|||
129994669|NCT00960531|467942886|FG006|Overall Study|Lost to Follow-up|1|||
129994670|NCT00960531|467942887|FG007|Overall Study|Lost to Follow-up|0|||
129994671|NCT00960531|467942888|FG008|Overall Study|Lost to Follow-up|0|||
129994672|NCT00960531|467942889|FG009|Overall Study|Lost to Follow-up|0|||
129994673|NCT00960531|467942880|FG000|Overall Study|Failed to Return|2|||
129994674|NCT00960531|467942881|FG001|Overall Study|Failed to Return|0|||
129994675|NCT00960531|467942882|FG002|Overall Study|Failed to Return|0|||
129994676|NCT00960531|467942883|FG003|Overall Study|Failed to Return|0|||
129994677|NCT00960531|467942884|FG004|Overall Study|Failed to Return|0|||
129994678|NCT00960531|467942885|FG005|Overall Study|Failed to Return|0|||
129994679|NCT00960531|467942886|FG006|Overall Study|Failed to Return|0|||
129994680|NCT00960531|467942887|FG007|Overall Study|Failed to Return|2|||
129994681|NCT00960531|467942888|FG008|Overall Study|Failed to Return|0|||
129994682|NCT00960531|467942889|FG009|Overall Study|Failed to Return|0|||
129994683|NCT00960531|467942880|FG000|Overall Study|Adverse Event (AE)|2|||
129994684|NCT00960531|467942881|FG001|Overall Study|Adverse Event (AE)|0|||
129994685|NCT00960531|467942882|FG002|Overall Study|Adverse Event (AE)|0|||
129994686|NCT00960531|467942883|FG003|Overall Study|Adverse Event (AE)|0|||
129994687|NCT00960531|467942884|FG004|Overall Study|Adverse Event (AE)|0|||
129994688|NCT00960531|467942885|FG005|Overall Study|Adverse Event (AE)|1|||
129994689|NCT00960531|467942886|FG006|Overall Study|Adverse Event (AE)|2|||
129994690|NCT00960531|467942887|FG007|Overall Study|Adverse Event (AE)|0|||
129994691|NCT00960531|467942888|FG008|Overall Study|Adverse Event (AE)|2|||
129994692|NCT00960531|467942889|FG009|Overall Study|Adverse Event (AE)|0|||
129994693|NCT00960531|467942880|FG000|Overall Study|Reason not Specified|2|||
129994694|NCT00960531|467942881|FG001|Overall Study|Reason not Specified|1|||
129994695|NCT00960531|467942882|FG002|Overall Study|Reason not Specified|13|||
129994696|NCT00960531|467942883|FG003|Overall Study|Reason not Specified|1|||
129994697|NCT00960531|467942884|FG004|Overall Study|Reason not Specified|2|||
129994698|NCT00960531|467942885|FG005|Overall Study|Reason not Specified|0|||
129994699|NCT00960531|467942886|FG006|Overall Study|Reason not Specified|16|||
129994700|NCT00960531|467942887|FG007|Overall Study|Reason not Specified|0|||
129994701|NCT00960531|467942888|FG008|Overall Study|Reason not Specified|8|||
129994702|NCT00960531|467942889|FG009|Overall Study|Reason not Specified|1|||
129994703|NCT01163916|467942892|FG000|Overall Study|Withdrawal by Subject|2|||
129994704|NCT01163916|467942893|FG001|Overall Study|Withdrawal by Subject|0|||
129994705|NCT01163916|467942894|FG002|Overall Study|Withdrawal by Subject|2|||
129994706|NCT01163916|467942892|FG000|Overall Study|Adverse Event|2|||
129994707|NCT01163916|467942893|FG001|Overall Study|Adverse Event|0|||
129994708|NCT01163916|467942894|FG002|Overall Study|Adverse Event|1|||
129994709|NCT01163916|467942892|FG000|Overall Study|Lack of Efficacy|2|||
129994710|NCT01163916|467942893|FG001|Overall Study|Lack of Efficacy|0|||
129994711|NCT01163916|467942894|FG002|Overall Study|Lack of Efficacy|1|||
129994712|NCT01163916|467942892|FG000|Overall Study|Other|24|||
129994713|NCT01163916|467942893|FG001|Overall Study|Other|4|||
129994714|NCT01163916|467942894|FG002|Overall Study|Other|16|||
129994715|NCT00883051|467942895|FG000|Overall Study|Lost to Follow-up|0|||
129994716|NCT00883051|467942896|FG001|Overall Study|Lost to Follow-up|0|||
129994717|NCT00883051|467942897|FG002|Overall Study|Lost to Follow-up|0|||
129994718|NCT00883051|467942898|FG003|Overall Study|Lost to Follow-up|0|||
129994719|NCT00883051|467942899|FG004|Overall Study|Lost to Follow-up|1|||
129994720|NCT00883051|467942895|FG000|Overall Study|Did not use study medication|24|||
129994721|NCT00883051|467942896|FG001|Overall Study|Did not use study medication|22|||
129994722|NCT00883051|467942897|FG002|Overall Study|Did not use study medication|29|||
129994723|NCT00883051|467942898|FG003|Overall Study|Did not use study medication|29|||
129994724|NCT00883051|467942899|FG004|Overall Study|Did not use study medication|17|||
129994725|NCT02337751|467942900|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
129994726|NCT02337751|467942901|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
129994727|NCT02337751|467942900|FG000|Overall Study|Voluntary Withdrawal|6|||
129994728|NCT02337751|467942901|FG001|Overall Study|Voluntary Withdrawal|8|||
129994729|NCT02337751|467942900|FG000|Overall Study|Lack of Efficacy|2|||
129994730|NCT02337751|467942901|FG001|Overall Study|Lack of Efficacy|5|||
129994731|NCT02337751|467942900|FG000|Overall Study|Investigator's Judgement|1|||
129994732|NCT02337751|467942901|FG001|Overall Study|Investigator's Judgement|0|||
129994733|NCT01910181|467942908|FG000|Overall Study|Death|37|||
129994734|NCT01910181|467942908|FG000|Overall Study|Lost to Follow-up|3|||
129994735|NCT01910181|467942908|FG000|Overall Study|Study Terminated by Sponsor|6|||
129994736|NCT01340196|467944943|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
130216125|NCT01826981|468753949|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
129994737|NCT00171704|467944946|FG000|Overall Study|Adverse Event|24|||
129994738|NCT00171704|467944947|FG001|Overall Study|Adverse Event|33|||
129994739|NCT00171704|467944946|FG000|Overall Study|Disease Progression|14|||
129994740|NCT00171704|467944947|FG001|Overall Study|Disease Progression|9|||
129994741|NCT00171704|467944946|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
129994742|NCT00171704|467944947|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
129994743|NCT00171704|467944946|FG000|Overall Study|Administrative Problems|2|||
129994744|NCT00171704|467944947|FG001|Overall Study|Administrative Problems|1|||
129994745|NCT00171704|467944946|FG000|Overall Study|Death|2|||
129994746|NCT00171704|467944947|FG001|Overall Study|Death|2|||
129994747|NCT00171704|467944946|FG000|Overall Study|Withdrawal by Subject|1|||
129994748|NCT00171704|467944947|FG001|Overall Study|Withdrawal by Subject|3|||
129994749|NCT00171704|467944946|FG000|Overall Study|Protocol Violation|0|||
129994750|NCT00171704|467944947|FG001|Overall Study|Protocol Violation|1|||
129994751|NCT02141984|467944948|FG000|Overall Study|Lack of Efficacy|2|||
129994752|NCT00816400|467944952|FG000|Overall Study|Death|2|||
129994753|NCT00816400|467944953|FG001|Overall Study|Death|3|||
129994754|NCT00816400|467944954|FG002|Overall Study|Death|3|||
129994755|NCT00816400|467944955|FG003|Overall Study|Death|3|||
129994756|NCT00816400|467944956|FG004|Overall Study|Death|2|||
129994757|NCT00816400|467944957|FG005|Overall Study|Death|3|||
129994758|NCT00816400|467944958|FG006|Overall Study|Death|2|||
129994759|NCT00816400|467944959|FG007|Overall Study|Death|5|||
129994760|NCT00816400|467944960|FG008|Overall Study|Death|6|||
129994761|NCT00816400|467944952|FG000|Overall Study|In hospice care at the end of the study|0|||
129994762|NCT00816400|467944953|FG001|Overall Study|In hospice care at the end of the study|0|||
129994763|NCT00816400|467944954|FG002|Overall Study|In hospice care at the end of the study|2|||
129994764|NCT00816400|467944955|FG003|Overall Study|In hospice care at the end of the study|0|||
129994765|NCT00816400|467944956|FG004|Overall Study|In hospice care at the end of the study|0|||
129994766|NCT00816400|467944957|FG005|Overall Study|In hospice care at the end of the study|0|||
129994767|NCT00816400|467944958|FG006|Overall Study|In hospice care at the end of the study|0|||
129994768|NCT00816400|467944959|FG007|Overall Study|In hospice care at the end of the study|0|||
129994769|NCT00816400|467944960|FG008|Overall Study|In hospice care at the end of the study|0|||
129994770|NCT00081770|467944961|FG000|Overall Study|Adverse Event|130|||
129994771|NCT00081770|467944962|FG001|Overall Study|Adverse Event|98|||
129994772|NCT00081770|467944963|FG002|Overall Study|Adverse Event|136|||
129994773|NCT00081770|467944961|FG000|Overall Study|Lack of Efficacy|262|||
129994774|NCT00081770|467944962|FG001|Overall Study|Lack of Efficacy|357|||
129994775|NCT00081770|467944963|FG002|Overall Study|Lack of Efficacy|211|||
129994776|NCT00081770|467944961|FG000|Overall Study|Lost to Follow-up|45|||
129994777|NCT00081770|467944962|FG001|Overall Study|Lost to Follow-up|34|||
129994778|NCT00081770|467944963|FG002|Overall Study|Lost to Follow-up|45|||
129994779|NCT00081770|467944961|FG000|Overall Study|Protocol Violation|15|||
129994780|NCT00081770|467944962|FG001|Overall Study|Protocol Violation|10|||
129994781|NCT00081770|467944963|FG002|Overall Study|Protocol Violation|10|||
129994782|NCT00081770|467944961|FG000|Overall Study|Withdrawal by Subject|45|||
129994783|NCT00081770|467944962|FG001|Overall Study|Withdrawal by Subject|40|||
129994784|NCT00081770|467944963|FG002|Overall Study|Withdrawal by Subject|42|||
129994785|NCT00081770|467944961|FG000|Overall Study|Did not meet protocol eligibility|2|||
129994786|NCT00081770|467944962|FG001|Overall Study|Did not meet protocol eligibility|0|||
129994787|NCT00081770|467944963|FG002|Overall Study|Did not meet protocol eligibility|3|||
129994788|NCT00081770|467944961|FG000|Overall Study|Administrative|1|||
129994789|NCT00081770|467944962|FG001|Overall Study|Administrative|0|||
129994790|NCT00081770|467944963|FG002|Overall Study|Administrative|1|||
129994791|NCT00081770|467944961|FG000|Overall Study|Other|2|||
129994792|NCT00081770|467944962|FG001|Overall Study|Other|7|||
129994793|NCT00081770|467944963|FG002|Overall Study|Other|8|||
129994794|NCT00601419|467944964|FG000|Overall Study|Lost to Follow-up|3|||
129994795|NCT00601419|467944964|FG000|Overall Study|Missed Visits|1|||
129994796|NCT01614197|467944965|FG000|Overall Study|Withdrawal by Subject|0|||
129994797|NCT01614197|467944966|FG001|Overall Study|Withdrawal by Subject|1|||
129994798|NCT01614197|467944967|FG002|Overall Study|Withdrawal by Subject|0|||
129994799|NCT01614197|467944968|FG003|Overall Study|Withdrawal by Subject|0|||
129994800|NCT02245672|467944969|FG000|Overall Study|Adverse Event|4|||
129994801|NCT02245672|467944970|FG001|Overall Study|Adverse Event|4|||
130334470|NCT00485134|469193813|FG004|Overall Study|Non-compliance|1|||
130334471|NCT00485134|469193814|FG005|Overall Study|Non-compliance|2|||
130334472|NCT00485134|469193815|FG006|Overall Study|Non-compliance|2|||
130334473|NCT00485134|469193816|FG007|Overall Study|Non-compliance|0|||
129994802|NCT02245672|467944971|FG002|Overall Study|Adverse Event|4|||
129994803|NCT02245672|467944969|FG000|Overall Study|Lost to Follow-up|3|||
129994804|NCT02245672|467944970|FG001|Overall Study|Lost to Follow-up|5|||
129994805|NCT02245672|467944971|FG002|Overall Study|Lost to Follow-up|1|||
129994806|NCT02245672|467944969|FG000|Overall Study|Withdrawal by Subject|6|||
129994807|NCT02245672|467944970|FG001|Overall Study|Withdrawal by Subject|3|||
129994808|NCT02245672|467944971|FG002|Overall Study|Withdrawal by Subject|0|||
129994809|NCT02245672|467944969|FG000|Overall Study|Randomized in error (not treated)|0|||
129994810|NCT02245672|467944970|FG001|Overall Study|Randomized in error (not treated)|1|||
129994811|NCT02245672|467944971|FG002|Overall Study|Randomized in error (not treated)|0|||
129994812|NCT00971932|467944972|FG000|Overall Study|Withdrawal by Subject|1|||
129994813|NCT00971932|467944972|FG000|Overall Study|Investigator's decision|2|||
129994814|NCT00971932|467944972|FG000|Overall Study|Ongoing|4|||
129994815|NCT01765192|467944975|FG000|Treatment Period 1|Adverse Event|0|||
129994816|NCT01765192|467944976|FG001|Treatment Period 1|Adverse Event|1|||
129994817|NCT01765192|467944975|FG000|Washout Period|Voluntary Withdrawal|1|||
130334474|NCT00485134|469193809|FG000|Overall Study|Unable to comply with study schedule|0|||
130334475|NCT00485134|469193810|FG001|Overall Study|Unable to comply with study schedule|0|||
130334476|NCT00485134|469193811|FG002|Overall Study|Unable to comply with study schedule|0|||
130334477|NCT00485134|469193812|FG003|Overall Study|Unable to comply with study schedule|0|||
130334478|NCT00485134|469193813|FG004|Overall Study|Unable to comply with study schedule|0|||
130334479|NCT00485134|469193814|FG005|Overall Study|Unable to comply with study schedule|0|||
130334480|NCT00485134|469193815|FG006|Overall Study|Unable to comply with study schedule|0|||
130334481|NCT00485134|469193816|FG007|Overall Study|Unable to comply with study schedule|1|||
129884126|NCT00383240|467534523|FG002|Overall Study|Did not meet protocol eligibility|9|||
129884127|NCT00383240|467534524|FG003|Overall Study|Did not meet protocol eligibility|3|||
129884128|NCT00383240|467534521|FG000|Overall Study|Administrative|1|||
129884129|NCT00383240|467534522|FG001|Overall Study|Administrative|1|||
129884130|NCT00383240|467534523|FG002|Overall Study|Administrative|0|||
129884131|NCT00383240|467534524|FG003|Overall Study|Administrative|0|||
129884132|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
129884133|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
129884134|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
129884135|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
129884136|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
129884137|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
129884138|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
129884139|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
129884140|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
129884141|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
129884142|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
129884143|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
129884144|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
129884145|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
129884146|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
129884147|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
129884148|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
129884149|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
129884150|NCT02023879|467534528|FG000|Extension Open Label Treatment|Adverse Event|1|||
129884151|NCT02023879|467534529|FG001|Extension Open Label Treatment|Adverse Event|7|||
129884152|NCT02023879|467534530|FG002|Extension Open Label Treatment|Adverse Event|3|||
129884153|NCT02023879|467534528|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
129884154|NCT02023879|467534529|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
129884155|NCT02023879|467534530|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
129884156|NCT02023879|467534528|FG000|Extension Open Label Treatment|Participant moved|1|||
129884157|NCT02023879|467534529|FG001|Extension Open Label Treatment|Participant moved|2|||
129884158|NCT02023879|467534530|FG002|Extension Open Label Treatment|Participant moved|0|||
129884159|NCT02023879|467534528|FG000|Extension Open Label Treatment|Other than specified above|2|||
129884160|NCT02023879|467534529|FG001|Extension Open Label Treatment|Other than specified above|7|||
129884161|NCT02023879|467534530|FG002|Extension Open Label Treatment|Other than specified above|2|||
129884162|NCT02924389|467534531|FG000|Overall Study|Lost to Follow-up|1|||
129884163|NCT02924389|467534532|FG001|Overall Study|Lost to Follow-up|0|||
129884164|NCT02924389|467534531|FG000|Overall Study|Physician Decision|2|||
129884165|NCT02924389|467534532|FG001|Overall Study|Physician Decision|0|||
129884166|NCT02924389|467534531|FG000|Overall Study|Withdrawal by Subject|3|||
129884167|NCT02924389|467534532|FG001|Overall Study|Withdrawal by Subject|0|||
129884168|NCT02924389|467534531|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
129884169|NCT02924389|467534532|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
129884170|NCT01091428|467536277|FG000|Phase 1|Progressive Disease|24|||
129884171|NCT01091428|467536278|FG001|Phase 1|Progressive Disease|8|||
129884172|NCT01091428|467536279|FG002|Phase 1|Progressive Disease|0|||
129884173|NCT01091428|467536280|FG003|Phase 1|Progressive Disease|0|||
129884174|NCT01091428|467536277|FG000|Phase 1|Symptomatic Deterioration|3|||
129884175|NCT01091428|467536278|FG001|Phase 1|Symptomatic Deterioration|2|||
129884176|NCT01091428|467536279|FG002|Phase 1|Symptomatic Deterioration|0|||
129884177|NCT01091428|467536280|FG003|Phase 1|Symptomatic Deterioration|0|||
129884178|NCT01091428|467536277|FG000|Phase 1|Adverse Event|2|||
129884179|NCT01091428|467536278|FG001|Phase 1|Adverse Event|0|||
129884180|NCT01091428|467536279|FG002|Phase 1|Adverse Event|0|||
129884181|NCT01091428|467536280|FG003|Phase 1|Adverse Event|0|||
129884182|NCT01091428|467536277|FG000|Phase 1|Withdrawal by Subject|7|||
129884183|NCT01091428|467536278|FG001|Phase 1|Withdrawal by Subject|0|||
129884184|NCT01091428|467536279|FG002|Phase 1|Withdrawal by Subject|0|||
129884185|NCT01091428|467536280|FG003|Phase 1|Withdrawal by Subject|0|||
129884186|NCT01091428|467536277|FG000|Phase 1|Reason not specified|0|||
130334482|NCT00485134|469193809|FG000|Overall Study|Pregnancy|0|||
130334483|NCT00485134|469193810|FG001|Overall Study|Pregnancy|0|||
130334484|NCT00485134|469193811|FG002|Overall Study|Pregnancy|0|||
130334485|NCT00485134|469193812|FG003|Overall Study|Pregnancy|0|||
130334486|NCT00485134|469193813|FG004|Overall Study|Pregnancy|0|||
130334487|NCT00485134|469193814|FG005|Overall Study|Pregnancy|0|||
130334488|NCT00485134|469193815|FG006|Overall Study|Pregnancy|1|||
130334489|NCT00485134|469193816|FG007|Overall Study|Pregnancy|0|||
130334490|NCT04294680|469193817|FG000|Overall Study|Withdrawal by Subject|2|||
130334491|NCT04294680|469193818|FG001|Overall Study|Withdrawal by Subject|1|||
130334492|NCT04294680|469193817|FG000|Overall Study|Follow-up visits completed outside of window|1|||
130334493|NCT04294680|469193818|FG001|Overall Study|Follow-up visits completed outside of window|0|||
130334494|NCT04027608|469193819|FG000|Overall Study|Withdrawal by Subject|13|||
130334495|NCT04027608|469193820|FG001|Overall Study|Withdrawal by Subject|2|||
130334496|NCT04027608|469193819|FG000|Overall Study|Protocol Violation|2|||
130334497|NCT04027608|469193820|FG001|Overall Study|Protocol Violation|1|||
130334498|NCT04027608|469193819|FG000|Overall Study|Physician Decision|1|||
130334499|NCT04027608|469193820|FG001|Overall Study|Physician Decision|0|||
130334500|NCT04027608|469193819|FG000|Overall Study|Lost to Follow-up|20|||
130334501|NCT04027608|469193820|FG001|Overall Study|Lost to Follow-up|4|||
130334502|NCT00993148|469193823|FG000|Overall Study|Lost to Follow-up|2|||
130334503|NCT00993148|469193823|FG000|Overall Study|never initiated treatment|1|||
130334504|NCT05564052|469193824|FG000|Overall Study|Withdrawal by Subject|0|||
130334505|NCT05564052|469193825|FG001|Overall Study|Withdrawal by Subject|0|||
130334506|NCT05564052|469193826|FG002|Overall Study|Withdrawal by Subject|0|||
130334507|NCT05564052|469193827|FG003|Overall Study|Withdrawal by Subject|1|||
130334508|NCT03978624|469193828|FG000|Overall Study|Protocol Violation|1|||
130334509|NCT03978624|469193829|FG001|Overall Study|Protocol Violation|0|||
130334510|NCT00924027|469193832|FG000|Overall Study|Lost to Further Follow-Up|4|||
130334511|NCT00924027|469193833|FG001|Overall Study|Lost to Further Follow-Up|0|||
130334512|NCT00924027|469193834|FG002|Overall Study|Lost to Further Follow-Up|0|||
130334513|NCT00924027|469193835|FG003|Overall Study|Lost to Further Follow-Up|0|||
130334514|NCT00924027|469193832|FG000|Overall Study|Physician Decision|1|||
130334515|NCT00924027|469193833|FG001|Overall Study|Physician Decision|0|||
130334516|NCT00924027|469193834|FG002|Overall Study|Physician Decision|0|||
130334517|NCT00924027|469193835|FG003|Overall Study|Physician Decision|1|||
130334518|NCT00924027|469193832|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
130334519|NCT00924027|469193833|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
130334520|NCT00924027|469193834|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
130334521|NCT00924027|469193835|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
130334522|NCT00924027|469193832|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
130334523|NCT00924027|469193833|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
130334524|NCT00924027|469193834|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
130334525|NCT00924027|469193835|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
130334526|NCT00924027|469193832|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
130334527|NCT00924027|469193833|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
130334528|NCT00924027|469193834|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
130334529|NCT00924027|469193835|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
130334530|NCT04193189|469193836|FG000|Overall Study|Lost to Follow-up|9|||
130334531|NCT04193189|469193837|FG001|Overall Study|Lost to Follow-up|7|||
130334532|NCT04193189|469193838|FG002|Overall Study|Lost to Follow-up|9|||
130334533|NCT04193189|469193839|FG003|Overall Study|Lost to Follow-up|0|||
130334534|NCT04193189|469193836|FG000|Overall Study|Withdrawal by Subject|1|||
130334535|NCT04193189|469193837|FG001|Overall Study|Withdrawal by Subject|2|||
130334536|NCT04193189|469193838|FG002|Overall Study|Withdrawal by Subject|2|||
130334537|NCT04193189|469193839|FG003|Overall Study|Withdrawal by Subject|0|||
130334538|NCT04193189|469193836|FG000|Overall Study|Death|1|||
130334539|NCT04193189|469193837|FG001|Overall Study|Death|1|||
130334540|NCT04193189|469193838|FG002|Overall Study|Death|0|||
130334541|NCT04193189|469193839|FG003|Overall Study|Death|0|||
130334542|NCT04193189|469193836|FG000|Overall Study|Protocol Violation|0|||
130334543|NCT04193189|469193837|FG001|Overall Study|Protocol Violation|0|||
130334544|NCT04193189|469193838|FG002|Overall Study|Protocol Violation|0|||
130334545|NCT04193189|469193839|FG003|Overall Study|Protocol Violation|1|||
130334546|NCT02840799|469195474|FG000|Phase 1|Physician Decision|1|||
130334547|NCT02840799|469195475|FG001|Phase 1|Physician Decision|3|||
130334548|NCT02840799|469195474|FG000|Phase 1|Withdrawal by Subject|4|||
130334549|NCT02840799|469195475|FG001|Phase 1|Withdrawal by Subject|0|||
130334550|NCT02840799|469195474|FG000|Phase 2 (Crossover)|Adverse Event|0|||
130334551|NCT02840799|469195475|FG001|Phase 2 (Crossover)|Adverse Event|1|||
130334552|NCT02840799|469195474|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
130334553|NCT02840799|469195475|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
130334554|NCT02565784|469195476|FG000|First Treatment|Adverse Event|1|||
130334555|NCT02565784|469195476|FG000|First Treatment|Withdrawal by Subject|1|||
130334556|NCT02565784|469195476|FG000|Second Treatment|Withdrawal by Subject|2|||
130334557|NCT00552188|469195482|FG000|Overall Study|Adverse Event|0|||
130334558|NCT00552188|469195483|FG001|Overall Study|Adverse Event|2|||
129994818|NCT01765192|467944976|FG001|Washout Period|Voluntary Withdrawal|1|||
129994819|NCT01765192|467944975|FG000|Washout Period|Reason not specified|1|||
129994820|NCT01765192|467944976|FG001|Washout Period|Reason not specified|0|||
129994821|NCT01765192|467944975|FG000|Treatment Period 2|Reason not specified|0|||
129994822|NCT01765192|467944976|FG001|Treatment Period 2|Reason not specified|2|||
129994823|NCT01765192|467944975|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
129994824|NCT01765192|467944976|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
129994825|NCT00876694|467944981|FG000|Overall Study|Adverse Event|10|||
129994826|NCT00876694|467944982|FG001|Overall Study|Adverse Event|7|||
129994827|NCT00876694|467944981|FG000|Overall Study|Subject withdrew consent|6|||
129994828|NCT00876694|467944982|FG001|Overall Study|Subject withdrew consent|4|||
129994829|NCT00876694|467944981|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129994830|NCT00876694|467944982|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129994831|NCT00876694|467944981|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129994832|NCT00876694|467944982|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129994833|NCT00876694|467944981|FG000|Overall Study|Administrative problems|1|||
129994834|NCT00876694|467944982|FG001|Overall Study|Administrative problems|1|||
129994835|NCT00876694|467944981|FG000|Overall Study|Death|1|||
129994836|NCT00876694|467944982|FG001|Overall Study|Death|0|||
129994837|NCT00288509|467944983|FG000|Treatment Cycle 1|Adverse Event|1|||
129994838|NCT00288509|467944983|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
129994839|NCT00288509|467944983|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
129994840|NCT00288509|467944983|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
129994841|NCT00288509|467944983|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
129994842|NCT00288509|467944983|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
129994843|NCT00288509|467944983|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
129994844|NCT00288509|467944983|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
129994845|NCT00288509|467944983|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
129994846|NCT00288509|467944983|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
129994847|NCT00288509|467944983|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
129994848|NCT00288509|467944983|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
129994849|NCT00288509|467944983|FG000|Treatment Cycle 4|Physician Decision|4|||
129994850|NCT00288509|467944983|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
129994851|NCT02349451|467944988|FG000|Overall Study|Withdrawal by Subject|0|||
129994852|NCT02349451|467944989|FG001|Overall Study|Withdrawal by Subject|1|||
129994853|NCT02349451|467944990|FG002|Overall Study|Withdrawal by Subject|2|||
129994854|NCT02349451|467944991|FG003|Overall Study|Withdrawal by Subject|1|||
129994855|NCT05116046|467944994|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129994856|NCT05116046|467944995|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129994857|NCT05116046|467944996|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129994858|NCT05116046|467944994|FG000|Overall Study|Study terminated by sponsor|14|||
129994859|NCT05116046|467944995|FG001|Overall Study|Study terminated by sponsor|16|||
129994860|NCT05116046|467944996|FG002|Overall Study|Study terminated by sponsor|1|||
129994861|NCT02683941|467944997|FG000|Double-blind Phase|Adverse Event|0|||
129994862|NCT02683941|467944998|FG001|Double-blind Phase|Adverse Event|1|||
129994863|NCT02683941|467944997|FG000|Double-blind Phase|Withdrawal by Subject|4|||
129994864|NCT02683941|467944998|FG001|Double-blind Phase|Withdrawal by Subject|2|||
129994865|NCT02683941|467944997|FG000|Double-blind Phase|Lost to Follow-up|1|||
129994866|NCT02683941|467944998|FG001|Double-blind Phase|Lost to Follow-up|0|||
129994867|NCT02683941|467944997|FG000|Double-blind Phase|Disease Progression|5|||
129994868|NCT02683941|467944998|FG001|Double-blind Phase|Disease Progression|2|||
129994869|NCT02683941|467944997|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
129994870|NCT02683941|467944998|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
129994871|NCT02683941|467944997|FG000|Open-label Treatment Phase|Disease Progression|1|||
129994872|NCT02683941|467944998|FG001|Open-label Treatment Phase|Disease Progression|2|||
129994873|NCT02683941|467944997|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
129994874|NCT02683941|467944998|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
129994875|NCT02683941|467944997|FG000|Open-label Treatment Phase|Other|1|||
129994876|NCT02683941|467944998|FG001|Open-label Treatment Phase|Other|0|||
129994877|NCT02683941|467944997|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
129994878|NCT02683941|467944998|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
129994879|NCT02683941|467944997|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
129994880|NCT02683941|467944998|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
129994881|NCT02683941|467944997|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
129994882|NCT02683941|467944998|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
130334559|NCT00552188|469195482|FG000|Overall Study|Lost to Follow-up|2|||
130334560|NCT00552188|469195483|FG001|Overall Study|Lost to Follow-up|1|||
129994883|NCT02683941|467944997|FG000|Open-label Follow-up Phase|Other|8|||
129994884|NCT02683941|467944998|FG001|Open-label Follow-up Phase|Other|1|||
129994885|NCT00261846|467944999|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
129994886|NCT00261846|467945000|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
129994887|NCT00261846|467945001|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
129994888|NCT00261846|467945002|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
130334561|NCT00552188|469195482|FG000|Overall Study|Withdrawal of consent|0|||
130334562|NCT00552188|469195483|FG001|Overall Study|Withdrawal of consent|1|||
130334563|NCT00552188|469195482|FG000|Overall Study|Subject returned to home country|0|||
130334564|NCT00552188|469195483|FG001|Overall Study|Subject returned to home country|1|||
130334565|NCT00476008|469195493|FG000|Overall Study|Adverse Event|4|||
130334566|NCT00476008|469195494|FG001|Overall Study|Adverse Event|4|||
130334567|NCT00476008|469195493|FG000|Overall Study|Placebo concerns|2|||
130334568|NCT00476008|469195494|FG001|Overall Study|Placebo concerns|2|||
130334569|NCT00476008|469195493|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
130334570|NCT00476008|469195494|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
130334571|NCT00476008|469195493|FG000|Overall Study|Withdrawal by Subject|0|||
130334572|NCT00476008|469195494|FG001|Overall Study|Withdrawal by Subject|1|||
129994889|NCT00261846|467945003|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994890|NCT00261846|467945004|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994891|NCT00261846|467945005|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994892|NCT00261846|467945006|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994893|NCT00261846|467945007|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994894|NCT00261846|467945008|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994895|NCT00261846|467945009|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994896|NCT00261846|467945010|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129994897|NCT00261846|467944999|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994898|NCT00261846|467945000|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994899|NCT00261846|467945001|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994900|NCT00261846|467945002|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
129994901|NCT00261846|467945003|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994902|NCT00261846|467945004|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994903|NCT00261846|467945005|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994904|NCT00261846|467945006|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994905|NCT00261846|467945007|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
129994906|NCT00261846|467945008|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994907|NCT00261846|467945009|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994908|NCT00261846|467945010|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129994909|NCT00261846|467944999|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129994910|NCT00261846|467945000|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129994911|NCT00261846|467945001|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129994912|NCT00261846|467945002|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
129994913|NCT00261846|467945003|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
129994914|NCT00261846|467945004|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
129994915|NCT00261846|467945005|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
129994916|NCT00261846|467945006|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
129994917|NCT00261846|467945007|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129994918|NCT00261846|467945008|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
129994919|NCT00261846|467945009|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129994920|NCT00261846|467945010|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129994921|NCT00261846|467944999|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129994922|NCT00261846|467945000|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129994923|NCT00261846|467945001|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129994924|NCT00261846|467945002|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
129994925|NCT00261846|467945003|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129994926|NCT00261846|467945004|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129994927|NCT00261846|467945005|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129994928|NCT00261846|467945006|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129994929|NCT00261846|467945007|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
129994930|NCT00261846|467945008|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129994931|NCT00261846|467945009|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129994932|NCT00261846|467945010|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129994933|NCT00261846|467944999|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
129994934|NCT00261846|467945000|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
129994935|NCT00261846|467945001|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
130334573|NCT00476008|469195493|FG000|Overall Study|Death|1|||
130334574|NCT00476008|469195494|FG001|Overall Study|Death|0|||
130334575|NCT01168219|469195498|FG000|Overall Study|off study before starting treatment|2|||
130334576|NCT01168219|469195498|FG000|Overall Study|withdrew before transplant|1|||
130334577|NCT01168219|469195498|FG000|Overall Study|ineligible due to CML|2|||
130334578|NCT00792571|469195499|FG000|Overall Study|Death|1|||
130334579|NCT00792571|469195499|FG000|Overall Study|Adverse Event|4|||
129994936|NCT00261846|467945002|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
129994937|NCT00261846|467945003|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
129994938|NCT00261846|467945004|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
130334580|NCT00792571|469195499|FG000|Overall Study|Withdrawal by Subject|1|||
129994939|NCT00261846|467945005|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
129994940|NCT00261846|467945006|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
130334581|NCT00792571|469195499|FG000|Overall Study|Other|4|||
130334582|NCT02600819|469195500|FG000|GEN Phase|Adverse Event|2|||
130334583|NCT02600819|469195501|FG001|GEN Phase|Adverse Event|0|||
130334584|NCT02600819|469195500|FG000|GEN Phase|Death|2|||
130334585|NCT02600819|469195501|FG001|GEN Phase|Death|0|||
130334586|NCT02600819|469195500|FG000|GEN Phase|Investigator's Discretion|4|||
130334587|NCT02600819|469195501|FG001|GEN Phase|Investigator's Discretion|0|||
130334588|NCT02600819|469195500|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
130334589|NCT02600819|469195501|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
130334590|NCT02600819|469195500|FG000|GEN Phase|Withdrew Consent|5|||
130334591|NCT02600819|469195501|FG001|GEN Phase|Withdrew Consent|0|||
130334592|NCT02600819|469195500|FG000|GEN Phase|Lost to Follow-up|2|||
130334593|NCT02600819|469195501|FG001|GEN Phase|Lost to Follow-up|0|||
130334594|NCT01621802|469195503|FG000|Overall Study|Protocol Violation|0|||
129994941|NCT00261846|467945007|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
129994942|NCT00261846|467945008|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
129994943|NCT00261846|467945009|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
129994944|NCT00261846|467945010|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
129994945|NCT00261846|467944999|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
129994946|NCT00261846|467945000|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
129994947|NCT00261846|467945001|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
129994948|NCT00261846|467945002|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
129994949|NCT00261846|467945003|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
129994950|NCT00261846|467945004|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
129994951|NCT00261846|467945005|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
129994952|NCT00261846|467945006|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
129994953|NCT00261846|467945007|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
129994954|NCT00261846|467945008|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
129994955|NCT00261846|467945009|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
129994956|NCT00261846|467945010|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
129994957|NCT00261846|467944999|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
129994958|NCT00261846|467945000|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
129994959|NCT00261846|467945001|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
129994960|NCT00261846|467945002|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
129994961|NCT00261846|467945003|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
129994962|NCT00261846|467945004|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
129994963|NCT00261846|467945005|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
129994964|NCT00261846|467945006|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
129994965|NCT00261846|467945007|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
129994966|NCT00261846|467945008|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
129994967|NCT00261846|467945009|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
129994968|NCT00261846|467945010|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
129994969|NCT00325039|467945011|FG000|Overall Study|Lost to Follow-up|18|||
129994970|NCT00325039|467945012|FG001|Overall Study|Lost to Follow-up|14|||
129994971|NCT01009203|467945013|FG000|Overall Study|Withdrawal by Subject|1|||
129994972|NCT01009203|467945013|FG000|Overall Study|Adverse Event|5|||
129994973|NCT01009203|467945013|FG000|Overall Study|Treatment-unrelated death|1|||
129994974|NCT00892723|467945014|FG000|Overall Study|Lost to Follow-up|1|||
129994975|NCT00892723|467945015|FG001|Overall Study|Lost to Follow-up|3|||
129994976|NCT00892723|467945016|FG002|Overall Study|Lost to Follow-up|1|||
129994977|NCT00892723|467945014|FG000|Overall Study|Withdrawal by Subject|1|||
129994978|NCT00892723|467945015|FG001|Overall Study|Withdrawal by Subject|1|||
129994979|NCT00892723|467945016|FG002|Overall Study|Withdrawal by Subject|1|||
129994980|NCT02974088|467945017|FG000|Overall Study|Lost to Follow-up|0|||
129994981|NCT02974088|467945018|FG001|Overall Study|Lost to Follow-up|2|||
129994982|NCT02974088|467945017|FG000|Overall Study|Adverse Event|0|||
129994983|NCT02974088|467945018|FG001|Overall Study|Adverse Event|1|||
129994984|NCT00150969|467945019|FG000|24 Month Main Study|Adverse Event|3|||
129994985|NCT00150969|467945020|FG001|24 Month Main Study|Adverse Event|4|||
129994986|NCT00150969|467945019|FG000|24 Month Main Study|Death|1|||
129994987|NCT00150969|467945020|FG001|24 Month Main Study|Death|1|||
129994988|NCT00150969|467945019|FG000|24 Month Main Study|Lack of Efficacy|1|||
129994989|NCT00150969|467945020|FG001|24 Month Main Study|Lack of Efficacy|8|||
129994990|NCT00150969|467945019|FG000|24 Month Main Study|Lost to Follow-up|3|||
129994991|NCT00150969|467945020|FG001|24 Month Main Study|Lost to Follow-up|2|||
129994992|NCT00150969|467945019|FG000|24 Month Main Study|Protocol Violation|4|||
129994993|NCT00150969|467945020|FG001|24 Month Main Study|Protocol Violation|2|||
129994994|NCT00150969|467945019|FG000|24 Month Main Study|Withdrawal by Subject|7|||
129994995|NCT00150969|467945020|FG001|24 Month Main Study|Withdrawal by Subject|4|||
129994996|NCT00150969|467945019|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
129994997|NCT00150969|467945020|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
129994998|NCT00150969|467945019|FG000|24-48 Month Extension|Lack of Efficacy|0|||
129994999|NCT00150969|467945020|FG001|24-48 Month Extension|Lack of Efficacy|1|||
130334595|NCT01621802|469195504|FG001|Overall Study|Protocol Violation|0|||
130334596|NCT01621802|469195505|FG002|Overall Study|Protocol Violation|0|||
130334597|NCT01621802|469195506|FG003|Overall Study|Protocol Violation|0|||
129995000|NCT00150969|467945019|FG000|24-48 Month Extension|Adverse Event|1|||
129995001|NCT00150969|467945020|FG001|24-48 Month Extension|Adverse Event|3|||
129995002|NCT00150969|467945019|FG000|24-48 Month Extension|Other Reason|81|||
129995003|NCT00150969|467945020|FG001|24-48 Month Extension|Other Reason|91|||
129995004|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
129995005|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
129995006|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
129995007|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
129995008|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
129995009|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
129995010|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
129995011|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
129995012|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
129995013|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
129995014|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
129995015|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
129995016|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
129995017|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
129995018|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
129995019|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
129995020|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
129995021|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
129995022|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
129995023|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
129995024|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
129995025|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
129995026|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
129995027|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
129995028|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
129995029|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
129995030|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
129995031|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
129995032|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
129995033|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
129995034|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Other|10|||
129995035|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Other|7|||
129995036|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Other|8|||
129995037|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Other|8|||
129995038|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Other|0|||
129995039|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
129995040|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
129995041|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
129995042|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
129995043|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
129995044|NCT00615836|467945021|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
129995045|NCT00615836|467945022|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129995046|NCT00615836|467945023|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129995047|NCT00615836|467945024|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129995048|NCT00615836|467945025|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129995049|NCT01313689|467945026|FG000|24-Week Randomization 1|Adverse Event|10|||
129995050|NCT01313689|467945027|FG001|24-Week Randomization 1|Adverse Event|5|||
129995051|NCT01313689|467945028|FG002|24-Week Randomization 1|Adverse Event|0|||
129995052|NCT01313689|467945029|FG003|24-Week Randomization 1|Adverse Event|0|||
129995053|NCT01313689|467945030|FG004|24-Week Randomization 1|Adverse Event|0|||
129995054|NCT01313689|467945026|FG000|24-Week Randomization 1|Physician Decision|4|||
130334598|NCT01621802|469195507|FG004|Overall Study|Protocol Violation|0|||
130334599|NCT01621802|469195508|FG005|Overall Study|Protocol Violation|1|||
130334600|NCT01621802|469195503|FG000|Overall Study|Withdrawal by Subject|8|||
130334601|NCT01621802|469195504|FG001|Overall Study|Withdrawal by Subject|4|||
130334602|NCT01621802|469195505|FG002|Overall Study|Withdrawal by Subject|4|||
130334603|NCT01621802|469195506|FG003|Overall Study|Withdrawal by Subject|2|||
130334604|NCT01621802|469195507|FG004|Overall Study|Withdrawal by Subject|2|||
130334605|NCT01621802|469195508|FG005|Overall Study|Withdrawal by Subject|0|||
129995055|NCT01313689|467945027|FG001|24-Week Randomization 1|Physician Decision|5|||
129995056|NCT01313689|467945028|FG002|24-Week Randomization 1|Physician Decision|0|||
129995057|NCT01313689|467945029|FG003|24-Week Randomization 1|Physician Decision|0|||
129995058|NCT01313689|467945030|FG004|24-Week Randomization 1|Physician Decision|0|||
130334606|NCT01621802|469195503|FG000|Overall Study|Migrated/moved from study area|0|||
130334607|NCT01621802|469195504|FG001|Overall Study|Migrated/moved from study area|0|||
129995059|NCT01313689|467945026|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
129995060|NCT01313689|467945027|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
129995061|NCT01313689|467945028|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
129995062|NCT01313689|467945029|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
129995063|NCT01313689|467945030|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
129995064|NCT01313689|467945026|FG000|24-Week Randomization 2|Adverse Event|0|||
129995065|NCT01313689|467945027|FG001|24-Week Randomization 2|Adverse Event|0|||
129995066|NCT01313689|467945028|FG002|24-Week Randomization 2|Adverse Event|2|||
129995067|NCT01313689|467945029|FG003|24-Week Randomization 2|Adverse Event|0|||
129995068|NCT01313689|467945030|FG004|24-Week Randomization 2|Adverse Event|8|||
129995069|NCT01313689|467945026|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
129995070|NCT01313689|467945027|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
129995071|NCT01313689|467945028|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
129995072|NCT01313689|467945029|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
129995073|NCT01313689|467945030|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
129995074|NCT01313689|467945026|FG000|24-Week Randomization 2|Physician Decision|0|||
129995075|NCT01313689|467945027|FG001|24-Week Randomization 2|Physician Decision|0|||
129995076|NCT01313689|467945028|FG002|24-Week Randomization 2|Physician Decision|0|||
129995077|NCT01313689|467945029|FG003|24-Week Randomization 2|Physician Decision|0|||
129995078|NCT01313689|467945030|FG004|24-Week Randomization 2|Physician Decision|4|||
129995079|NCT00687973|467945031|FG000|Overall Study|Adverse Event|18|||
129995080|NCT00687973|467945032|FG001|Overall Study|Adverse Event|28|||
129995081|NCT00687973|467945031|FG000|Overall Study|Lack of Efficacy|2|||
129995082|NCT00687973|467945032|FG001|Overall Study|Lack of Efficacy|3|||
129995083|NCT00687973|467945031|FG000|Overall Study|Protocol Violation|1|||
129995084|NCT00687973|467945032|FG001|Overall Study|Protocol Violation|2|||
129995085|NCT00687973|467945031|FG000|Overall Study|Administrative Reasons|0|||
129995086|NCT00687973|467945032|FG001|Overall Study|Administrative Reasons|2|||
129995087|NCT00687973|467945031|FG000|Overall Study|Withdrawal by Subject|3|||
129995088|NCT00687973|467945032|FG001|Overall Study|Withdrawal by Subject|3|||
129995089|NCT01007448|467945033|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
129995090|NCT01007448|467945034|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
129995091|NCT01007448|467945033|FG000|Overall Study|Staph Skin Infection Flare|1|||
129995092|NCT01007448|467945034|FG001|Overall Study|Staph Skin Infection Flare|0|||
129995093|NCT01007448|467945033|FG000|Overall Study|Participant Leaving the Country|1|||
129995094|NCT01007448|467945034|FG001|Overall Study|Participant Leaving the Country|0|||
129995095|NCT01007448|467945033|FG000|Overall Study|Participant Given Prohibited Medication|1|||
129995096|NCT01007448|467945034|FG001|Overall Study|Participant Given Prohibited Medication|0|||
129995097|NCT01007448|467945033|FG000|Overall Study|Progressive Disease|1|||
129995098|NCT01007448|467945034|FG001|Overall Study|Progressive Disease|2|||
129995099|NCT01007448|467945033|FG000|Overall Study|Lack of Efficacy|2|||
129995100|NCT01007448|467945034|FG001|Overall Study|Lack of Efficacy|0|||
129995101|NCT01007448|467945033|FG000|Overall Study|Withdrawal by Subject|2|||
129995102|NCT01007448|467945034|FG001|Overall Study|Withdrawal by Subject|3|||
129995103|NCT01007448|467945033|FG000|Overall Study|Adverse Event|1|||
129995104|NCT01007448|467945034|FG001|Overall Study|Adverse Event|4|||
129995105|NCT02121834|467945036|FG000|Overall Study|Protocol Violation|0|||
129995106|NCT02121834|467945037|FG001|Overall Study|Protocol Violation|1|||
129995107|NCT02121834|467945038|FG002|Overall Study|Protocol Violation|0|||
130334608|NCT01621802|469195505|FG002|Overall Study|Migrated/moved from study area|2|||
129995108|NCT02121834|467945039|FG003|Overall Study|Protocol Violation|0|||
129995109|NCT02121834|467945040|FG004|Overall Study|Protocol Violation|0|||
129995110|NCT02121834|467945041|FG005|Overall Study|Protocol Violation|0|||
129995111|NCT02121834|467945042|FG006|Overall Study|Protocol Violation|0|||
129995112|NCT02121834|467945036|FG000|Overall Study|Withdrawal by Subject|0|||
129995113|NCT02121834|467945037|FG001|Overall Study|Withdrawal by Subject|1|||
129995114|NCT02121834|467945038|FG002|Overall Study|Withdrawal by Subject|1|||
129995115|NCT02121834|467945039|FG003|Overall Study|Withdrawal by Subject|0|||
129995116|NCT02121834|467945040|FG004|Overall Study|Withdrawal by Subject|0|||
129995117|NCT02121834|467945041|FG005|Overall Study|Withdrawal by Subject|0|||
129995118|NCT02121834|467945042|FG006|Overall Study|Withdrawal by Subject|0|||
129995119|NCT02121834|467945036|FG000|Overall Study|Lost to Follow-up|0|||
129995120|NCT02121834|467945037|FG001|Overall Study|Lost to Follow-up|0|||
129995121|NCT02121834|467945038|FG002|Overall Study|Lost to Follow-up|1|||
129995122|NCT02121834|467945039|FG003|Overall Study|Lost to Follow-up|0|||
129995123|NCT02121834|467945040|FG004|Overall Study|Lost to Follow-up|0|||
129995124|NCT02121834|467945041|FG005|Overall Study|Lost to Follow-up|0|||
130334609|NCT01621802|469195506|FG003|Overall Study|Migrated/moved from study area|0|||
129995125|NCT02121834|467945042|FG006|Overall Study|Lost to Follow-up|0|||
129995126|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
129995127|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
130334610|NCT01621802|469195507|FG004|Overall Study|Migrated/moved from study area|1|||
130334611|NCT01621802|469195508|FG005|Overall Study|Migrated/moved from study area|0|||
129995128|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Death|0|||
130334612|NCT01621802|469195503|FG000|Overall Study|Others|3|||
130334613|NCT01621802|469195504|FG001|Overall Study|Others|3|||
130334614|NCT01621802|469195505|FG002|Overall Study|Others|3|||
129995129|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Death|2|||
129995130|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129995131|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
129995132|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
129995133|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
129995134|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
129995135|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
129995136|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
129995137|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
129995138|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
129995139|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
129995140|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
129995141|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
129995142|NCT00343252|467945043|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
129995143|NCT00343252|467945044|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
129995144|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
129995145|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
129995146|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Death|3|||
129995147|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Death|3|||
129995148|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129995149|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129995150|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
129995151|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
129995152|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
129995153|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
129995154|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
129995155|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
129995156|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
129995157|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
129995158|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
129995159|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
129995160|NCT00343252|467945043|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
129995161|NCT00343252|467945044|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
129995162|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
129995163|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
129995164|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Death|4|||
130334615|NCT01621802|469195506|FG003|Overall Study|Others|2|||
130334616|NCT01621802|469195507|FG004|Overall Study|Others|1|||
130334617|NCT01621802|469195508|FG005|Overall Study|Others|0|||
130334618|NCT01621802|469195503|FG000|Overall Study|Lost to Follow-up|36|||
130334619|NCT01621802|469195504|FG001|Overall Study|Lost to Follow-up|16|||
130334620|NCT01621802|469195505|FG002|Overall Study|Lost to Follow-up|24|||
130334621|NCT01621802|469195506|FG003|Overall Study|Lost to Follow-up|7|||
130334622|NCT01621802|469195507|FG004|Overall Study|Lost to Follow-up|31|||
130334623|NCT01621802|469195508|FG005|Overall Study|Lost to Follow-up|11|||
130334624|NCT03790696|469195509|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
130334625|NCT03790696|469195510|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
130334626|NCT01149148|469195511|FG000|Overall Study|Lost to Follow-up|1|||
130334627|NCT01149148|469195512|FG001|Overall Study|Lost to Follow-up|2|||
130334628|NCT01149148|469195511|FG000|Overall Study|Death|1|||
130334629|NCT01149148|469195512|FG001|Overall Study|Death|0|||
130334630|NCT03436082|469195513|FG000|Overall Study|Did not undergo procedure|1|||
130334631|NCT03436082|469195514|FG001|Overall Study|Did not undergo procedure|0|||
130334632|NCT00950859|469195517|FG000|Overall Study|Adverse Event|3|||
130334633|NCT00950859|469195518|FG001|Overall Study|Adverse Event|3|||
130334634|NCT00950859|469195517|FG000|Overall Study|Insufficient Viral Load Response|12|||
130334635|NCT00950859|469195518|FG001|Overall Study|Insufficient Viral Load Response|3|||
130334636|NCT00950859|469195517|FG000|Overall Study|Protocol Violation|1|||
130334637|NCT00950859|469195518|FG001|Overall Study|Protocol Violation|1|||
130334638|NCT00950859|469195517|FG000|Overall Study|Lost to Follow-up|0|||
130334639|NCT00950859|469195518|FG001|Overall Study|Lost to Follow-up|3|||
130334640|NCT04896086|469195519|FG000|Overall Study|Lost to Follow-up|0|||
130334641|NCT04896086|469195520|FG001|Overall Study|Lost to Follow-up|2|||
130334642|NCT04896086|469195521|FG002|Overall Study|Lost to Follow-up|1|||
130334643|NCT04896086|469195522|FG003|Overall Study|Lost to Follow-up|0|||
130334644|NCT04896086|469195523|FG004|Overall Study|Lost to Follow-up|0|||
130334645|NCT04896086|469195519|FG000|Overall Study|Physician Decision|0|||
130334646|NCT04896086|469195520|FG001|Overall Study|Physician Decision|1|||
130334647|NCT04896086|469195521|FG002|Overall Study|Physician Decision|0|||
130334648|NCT04896086|469195522|FG003|Overall Study|Physician Decision|0|||
129995165|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Death|5|||
129995166|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
129995167|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129995168|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
129995169|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
129995170|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
129995171|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
129995172|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
129995173|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
130334649|NCT04896086|469195523|FG004|Overall Study|Physician Decision|0|||
130334650|NCT04896086|469195519|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334651|NCT04896086|469195520|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334652|NCT04896086|469195521|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334653|NCT04896086|469195522|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
130334654|NCT04896086|469195523|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
130334655|NCT04896086|469195519|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334656|NCT04896086|469195520|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334657|NCT04896086|469195521|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334658|NCT04896086|469195522|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
130334659|NCT04896086|469195523|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
130334660|NCT02249832|469195526|FG000|Overall Study|Withdrawal by Subject|3|||
130334661|NCT02249832|469195526|FG000|Overall Study|Lost to Follow-up|10|||
130334662|NCT00243269|469195535|FG000|Overall Study|Protocol Violation|2|||
130334663|NCT00243269|469195536|FG001|Overall Study|Protocol Violation|1|||
130334664|NCT00243269|469195537|FG002|Overall Study|Protocol Violation|0|||
130334665|NCT00243269|469195538|FG003|Overall Study|Protocol Violation|1|||
130334666|NCT00243269|469195535|FG000|Overall Study|Lost to Follow-up|1|||
130334667|NCT00243269|469195536|FG001|Overall Study|Lost to Follow-up|0|||
130334668|NCT00243269|469195537|FG002|Overall Study|Lost to Follow-up|1|||
130334669|NCT00243269|469195538|FG003|Overall Study|Lost to Follow-up|3|||
130334670|NCT00970684|469195540|FG000|Overall Study|Lack of Efficacy|5|||
130334671|NCT00970684|469195540|FG000|Overall Study|Adverse Event|4|||
130334672|NCT00970684|469195540|FG000|Overall Study|Withdrawal by Subject|1|||
130334673|NCT00481091|469195541|FG000|Overall Study|Withdrawal by Subject|0|||
130334674|NCT00481091|469195542|FG001|Overall Study|Withdrawal by Subject|1|||
130334675|NCT00481091|469195543|FG002|Overall Study|Withdrawal by Subject|1|||
130334676|NCT00481091|469195544|FG003|Overall Study|Withdrawal by Subject|0|||
130334677|NCT00481091|469195545|FG004|Overall Study|Withdrawal by Subject|0|||
130334678|NCT00481091|469195546|FG005|Overall Study|Withdrawal by Subject|0|||
130334679|NCT00481091|469195547|FG006|Overall Study|Withdrawal by Subject|0|||
130334680|NCT00481091|469195548|FG007|Overall Study|Withdrawal by Subject|0|||
130334681|NCT00481091|469195549|FG008|Overall Study|Withdrawal by Subject|1|||
130334682|NCT00481091|469195550|FG009|Overall Study|Withdrawal by Subject|6|||
130334683|NCT00481091|469195541|FG000|Overall Study|Other, Not Specified|0|||
130334684|NCT00481091|469195542|FG001|Overall Study|Other, Not Specified|1|||
130334685|NCT00481091|469195543|FG002|Overall Study|Other, Not Specified|1|||
130334686|NCT00481091|469195544|FG003|Overall Study|Other, Not Specified|0|||
130334687|NCT00481091|469195545|FG004|Overall Study|Other, Not Specified|0|||
130334688|NCT00481091|469195546|FG005|Overall Study|Other, Not Specified|1|||
130334689|NCT00481091|469195547|FG006|Overall Study|Other, Not Specified|0|||
130334690|NCT00481091|469195548|FG007|Overall Study|Other, Not Specified|0|||
130334691|NCT00481091|469195549|FG008|Overall Study|Other, Not Specified|0|||
130334692|NCT00481091|469195550|FG009|Overall Study|Other, Not Specified|4|||
130334693|NCT00481091|469195541|FG000|Overall Study|Adverse Event|1|||
130334694|NCT00481091|469195542|FG001|Overall Study|Adverse Event|2|||
130334695|NCT00481091|469195543|FG002|Overall Study|Adverse Event|0|||
130334696|NCT00481091|469195544|FG003|Overall Study|Adverse Event|1|||
130334697|NCT00481091|469195545|FG004|Overall Study|Adverse Event|1|||
130334698|NCT00481091|469195546|FG005|Overall Study|Adverse Event|1|||
130334699|NCT00481091|469195547|FG006|Overall Study|Adverse Event|2|||
130334700|NCT00481091|469195548|FG007|Overall Study|Adverse Event|1|||
130334701|NCT00481091|469195549|FG008|Overall Study|Adverse Event|1|||
130334702|NCT00481091|469195550|FG009|Overall Study|Adverse Event|6|||
130334703|NCT00481091|469195541|FG000|Overall Study|Progressive disease clinical|0|||
130334704|NCT00481091|469195542|FG001|Overall Study|Progressive disease clinical|0|||
130334705|NCT00481091|469195543|FG002|Overall Study|Progressive disease clinical|0|||
130334706|NCT00481091|469195544|FG003|Overall Study|Progressive disease clinical|0|||
130334707|NCT00481091|469195545|FG004|Overall Study|Progressive disease clinical|0|||
130334708|NCT00481091|469195546|FG005|Overall Study|Progressive disease clinical|0|||
130334709|NCT00481091|469195547|FG006|Overall Study|Progressive disease clinical|0|||
130334710|NCT00481091|469195548|FG007|Overall Study|Progressive disease clinical|0|||
130334711|NCT00481091|469195549|FG008|Overall Study|Progressive disease clinical|1|||
130334712|NCT00481091|469195550|FG009|Overall Study|Progressive disease clinical|7|||
130334713|NCT00481091|469195541|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130334714|NCT00481091|469195542|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
130334715|NCT00481091|469195543|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334716|NCT00481091|469195544|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334717|NCT00481091|469195545|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334718|NCT00481091|469195546|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
129995174|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
129995175|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
129995176|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
129995177|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
129995178|NCT00343252|467945043|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
130334719|NCT00481091|469195547|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334720|NCT00481091|469195548|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334721|NCT00481091|469195549|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334722|NCT00481091|469195550|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
130334723|NCT00481091|469195541|FG000|Overall Study|Progressive disease other|1|||
130334724|NCT00481091|469195542|FG001|Overall Study|Progressive disease other|1|||
130334725|NCT00481091|469195543|FG002|Overall Study|Progressive disease other|0|||
130334726|NCT00481091|469195544|FG003|Overall Study|Progressive disease other|1|||
130334727|NCT00481091|469195545|FG004|Overall Study|Progressive disease other|1|||
130334728|NCT00481091|469195546|FG005|Overall Study|Progressive disease other|1|||
129995179|NCT00343252|467945044|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
129995180|NCT01740323|467945045|FG000|Overall Study|Adverse Event|1|||
129995181|NCT01740323|467945046|FG001|Overall Study|Adverse Event|0|||
130334729|NCT00481091|469195547|FG006|Overall Study|Progressive disease other|0|||
130334730|NCT00481091|469195548|FG007|Overall Study|Progressive disease other|2|||
130334731|NCT00481091|469195549|FG008|Overall Study|Progressive disease other|0|||
129995182|NCT01740323|467945045|FG000|Overall Study|Randomized but did not take study drug|1|||
129995183|NCT01740323|467945046|FG001|Overall Study|Randomized but did not take study drug|0|||
129995184|NCT03353350|467945057|FG000|30-week Core Treatment Period|Protocol Violation|1|||
129995185|NCT03353350|467945058|FG001|30-week Core Treatment Period|Protocol Violation|1|||
129995186|NCT03353350|467945059|FG002|30-week Core Treatment Period|Protocol Violation|1|||
129995187|NCT03353350|467945060|FG003|30-week Core Treatment Period|Protocol Violation|0|||
129995188|NCT03353350|467945057|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
129995189|NCT03353350|467945058|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
129995190|NCT03353350|467945059|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
129995191|NCT03353350|467945060|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
129995192|NCT03353350|467945057|FG000|30-week Core Treatment Period|Adverse Event|0|||
129995193|NCT03353350|467945058|FG001|30-week Core Treatment Period|Adverse Event|4|||
129995194|NCT03353350|467945059|FG002|30-week Core Treatment Period|Adverse Event|2|||
129995195|NCT03353350|467945060|FG003|30-week Core Treatment Period|Adverse Event|3|||
129995196|NCT03353350|467945057|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
129995197|NCT03353350|467945058|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
129995198|NCT03353350|467945059|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
129995199|NCT03353350|467945060|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
129995200|NCT03353350|467945057|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
129995201|NCT03353350|467945058|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
129995202|NCT03353350|467945059|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
129995203|NCT03353350|467945060|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
129995204|NCT03353350|467945057|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
129995205|NCT03353350|467945058|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
129995206|NCT03353350|467945059|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
129995207|NCT03353350|467945060|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
129995208|NCT03353350|467945057|FG000|26-week Treatment Extension Period|Adverse Event|1|||
129995209|NCT03353350|467945058|FG001|26-week Treatment Extension Period|Adverse Event|0|||
129995210|NCT03353350|467945059|FG002|26-week Treatment Extension Period|Adverse Event|0|||
129995211|NCT03353350|467945060|FG003|26-week Treatment Extension Period|Adverse Event|1|||
129995212|NCT03353350|467945057|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
129995213|NCT03353350|467945058|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
129995214|NCT03353350|467945059|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
129995215|NCT03353350|467945060|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
130334732|NCT00481091|469195550|FG009|Overall Study|Progressive disease other|0|||
130334733|NCT00481091|469195541|FG000|Overall Study|No reason given|0|||
130334734|NCT00481091|469195542|FG001|Overall Study|No reason given|0|||
130334735|NCT00481091|469195543|FG002|Overall Study|No reason given|1|||
129995216|NCT01423253|467945064|FG000|Overall Study|Adverse Event|2|||
129995217|NCT01423253|467945064|FG000|Overall Study|Lack of Efficacy|2|||
129995218|NCT01423253|467945064|FG000|Overall Study|Lost to Follow-up|1|||
129995219|NCT01423253|467945064|FG000|Overall Study|Protocol Violation|2|||
129995220|NCT01423253|467945064|FG000|Overall Study|Withdrawal by Subject|2|||
129995221|NCT00307125|467945067|FG000|Screening Phase|Adverse Event|1|||
129995222|NCT00307125|467945068|FG001|Screening Phase|Adverse Event|0|||
129995223|NCT00307125|467945069|FG002|Screening Phase|Adverse Event|0|||
129995224|NCT00307125|467945067|FG000|Screening Phase|Protocol Violation|27|||
129995225|NCT00307125|467945068|FG001|Screening Phase|Protocol Violation|0|||
129995226|NCT00307125|467945069|FG002|Screening Phase|Protocol Violation|0|||
129995227|NCT00307125|467945067|FG000|Screening Phase|Lost to Follow-up|87|||
129995228|NCT00307125|467945068|FG001|Screening Phase|Lost to Follow-up|0|||
129995229|NCT00307125|467945069|FG002|Screening Phase|Lost to Follow-up|0|||
129995230|NCT00307125|467945067|FG000|Screening Phase|Death|10|||
129995231|NCT00307125|467945068|FG001|Screening Phase|Death|0|||
129995232|NCT00307125|467945069|FG002|Screening Phase|Death|0|||
129995233|NCT00307125|467945067|FG000|Screening Phase|Withdrawal by Subject|77|||
129995234|NCT00307125|467945068|FG001|Screening Phase|Withdrawal by Subject|0|||
129995235|NCT00307125|467945069|FG002|Screening Phase|Withdrawal by Subject|0|||
129995236|NCT00307125|467945067|FG000|Screening Phase|Physician Decision|26|||
129995237|NCT00307125|467945068|FG001|Screening Phase|Physician Decision|0|||
129995238|NCT00307125|467945069|FG002|Screening Phase|Physician Decision|0|||
129995239|NCT00307125|467945067|FG000|Screening Phase|Sponsor Decision|4|||
129995240|NCT00307125|467945068|FG001|Screening Phase|Sponsor Decision|0|||
129995241|NCT00307125|467945069|FG002|Screening Phase|Sponsor Decision|0|||
129995242|NCT00307125|467945067|FG000|Screening Phase|Study Terminated|17|||
129995243|NCT00307125|467945068|FG001|Screening Phase|Study Terminated|0|||
129995244|NCT00307125|467945069|FG002|Screening Phase|Study Terminated|0|||
129995245|NCT00307125|467945067|FG000|Screening Phase|Graft Loss|3|||
129995246|NCT00307125|467945068|FG001|Screening Phase|Graft Loss|0|||
129995247|NCT00307125|467945069|FG002|Screening Phase|Graft Loss|0|||
129995248|NCT00307125|467945067|FG000|Screening Phase|Graft Failure|8|||
129995249|NCT00307125|467945068|FG001|Screening Phase|Graft Failure|0|||
129995250|NCT00307125|467945069|FG002|Screening Phase|Graft Failure|0|||
129995251|NCT00307125|467945067|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
129995252|NCT00307125|467945068|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
129995253|NCT00307125|467945069|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
129995254|NCT00307125|467945067|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
129995255|NCT00307125|467945068|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
129995256|NCT00307125|467945069|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
129995257|NCT00307125|467945067|FG000|Screening Phase|Moved or transferred facilities|34|||
129995258|NCT00307125|467945068|FG001|Screening Phase|Moved or transferred facilities|0|||
129995259|NCT00307125|467945069|FG002|Screening Phase|Moved or transferred facilities|0|||
129995260|NCT00307125|467945067|FG000|Screening Phase|Received Pancreas Transplant|8|||
129995261|NCT00307125|467945068|FG001|Screening Phase|Received Pancreas Transplant|0|||
129995262|NCT00307125|467945069|FG002|Screening Phase|Received Pancreas Transplant|0|||
129995263|NCT00307125|467945067|FG000|Screening Phase|Ineligible for pilot|4|||
129995264|NCT00307125|467945068|FG001|Screening Phase|Ineligible for pilot|0|||
129995265|NCT00307125|467945069|FG002|Screening Phase|Ineligible for pilot|0|||
129995266|NCT00307125|467945067|FG000|Screening Phase|Try to get pregnant|1|||
129995267|NCT00307125|467945068|FG001|Screening Phase|Try to get pregnant|0|||
129995268|NCT00307125|467945069|FG002|Screening Phase|Try to get pregnant|0|||
129995269|NCT00307125|467945067|FG000|Screening Phase|Developed acute leukemia|1|||
129995270|NCT00307125|467945068|FG001|Screening Phase|Developed acute leukemia|0|||
129995271|NCT00307125|467945069|FG002|Screening Phase|Developed acute leukemia|0|||
129995272|NCT00307125|467945067|FG000|Screening Phase|Metastatic colon cancer|1|||
129995273|NCT00307125|467945068|FG001|Screening Phase|Metastatic colon cancer|0|||
129995274|NCT00307125|467945069|FG002|Screening Phase|Metastatic colon cancer|0|||
129995275|NCT00307125|467945067|FG000|Screening Phase|Malignancy|1|||
129995276|NCT00307125|467945068|FG001|Screening Phase|Malignancy|0|||
129995277|NCT00307125|467945069|FG002|Screening Phase|Malignancy|0|||
129995278|NCT00307125|467945067|FG000|Screening Phase|PAK|1|||
129995279|NCT00307125|467945068|FG001|Screening Phase|PAK|0|||
129995280|NCT00307125|467945069|FG002|Screening Phase|PAK|0|||
129995281|NCT00307125|467945067|FG000|Screening Phase|Ineligible|1|||
129995282|NCT00307125|467945068|FG001|Screening Phase|Ineligible|0|||
129995283|NCT00307125|467945069|FG002|Screening Phase|Ineligible|0|||
129995284|NCT00307125|467945067|FG000|Screening Phase|Screen Error|1|||
129995285|NCT00307125|467945068|FG001|Screening Phase|Screen Error|0|||
129995286|NCT00307125|467945069|FG002|Screening Phase|Screen Error|0|||
129995287|NCT00307125|467945067|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
129995288|NCT00307125|467945068|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
129995289|NCT00307125|467945069|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
129995290|NCT00307125|467945067|FG000|Screening Phase|AMR and treated with rituximab|1|||
129995291|NCT00307125|467945068|FG001|Screening Phase|AMR and treated with rituximab|0|||
129995292|NCT00307125|467945069|FG002|Screening Phase|AMR and treated with rituximab|0|||
129995293|NCT00307125|467945067|FG000|Screening Phase|Coronary artery bypass|1|||
129995294|NCT00307125|467945068|FG001|Screening Phase|Coronary artery bypass|0|||
129995295|NCT00307125|467945069|FG002|Screening Phase|Coronary artery bypass|0|||
129995296|NCT00307125|467945067|FG000|Pilot Phase|Lost to Follow-up|0|||
129995297|NCT00307125|467945068|FG001|Pilot Phase|Lost to Follow-up|1|||
129995298|NCT00307125|467945069|FG002|Pilot Phase|Lost to Follow-up|0|||
129995299|NCT00307125|467945067|FG000|Pilot Phase|Withdrawal by Subject|0|||
129995300|NCT00307125|467945068|FG001|Pilot Phase|Withdrawal by Subject|1|||
129995301|NCT00307125|467945069|FG002|Pilot Phase|Withdrawal by Subject|1|||
129995302|NCT00051363|467945070|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
129995303|NCT00051363|467945071|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
129995304|NCT00051363|467945070|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
129995305|NCT00051363|467945071|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
129995306|NCT00051363|467945070|FG000|Overall Study|Death|2|||
129995307|NCT00051363|467945071|FG001|Overall Study|Death|2|||
129995308|NCT00051363|467945070|FG000|Overall Study|Excluded Pre-Randomization|2|||
129995309|NCT00051363|467945071|FG001|Overall Study|Excluded Pre-Randomization|5|||
130334736|NCT00481091|469195544|FG003|Overall Study|No reason given|1|||
130334737|NCT00481091|469195545|FG004|Overall Study|No reason given|1|||
130334738|NCT00481091|469195546|FG005|Overall Study|No reason given|0|||
130334739|NCT00481091|469195547|FG006|Overall Study|No reason given|1|||
130334740|NCT00481091|469195548|FG007|Overall Study|No reason given|1|||
130334741|NCT00481091|469195549|FG008|Overall Study|No reason given|1|||
130334742|NCT00481091|469195550|FG009|Overall Study|No reason given|4|||
129995310|NCT00147823|467945074|FG000|Overall Study|Lost to Follow-up|6|||
129995311|NCT00147823|467945075|FG001|Overall Study|Lost to Follow-up|12|||
129995312|NCT00147823|467945074|FG000|Overall Study|Physician Decision|1|||
129995313|NCT00147823|467945075|FG001|Overall Study|Physician Decision|0|||
129995314|NCT00147823|467945074|FG000|Overall Study|Withdrawal by Subject|0|||
129995315|NCT00147823|467945075|FG001|Overall Study|Withdrawal by Subject|1|||
129995316|NCT00147823|467945074|FG000|Overall Study|Did not receive vitoss due to infection|6|||
129995317|NCT00147823|467945075|FG001|Overall Study|Did not receive vitoss due to infection|2|||
129995318|NCT01032382|467945076|FG000|Overall Study|Disease dissemination|1|||
129995319|NCT01032382|467945077|FG001|Overall Study|Disease dissemination|1|||
129995320|NCT01032382|467945076|FG000|Overall Study|Treatment failure|3|||
129995321|NCT01032382|467945077|FG001|Overall Study|Treatment failure|1|||
129995322|NCT01032382|467945076|FG000|Overall Study|Index lesion relapse|1|||
129995323|NCT01032382|467945077|FG001|Overall Study|Index lesion relapse|3|||
129995324|NCT00412971|467945078|FG000|Overall Study|Lost to Follow-up|17|||
129995325|NCT00412971|467945079|FG001|Overall Study|Lost to Follow-up|9|||
129995326|NCT00412971|467945078|FG000|Overall Study|Protocol Violation|13|||
129995327|NCT00412971|467945079|FG001|Overall Study|Protocol Violation|1|||
129995328|NCT01012713|467945080|FG000|Overall Study|Lack of Efficacy|3|||
129995329|NCT02571049|467945081|FG000|Screening|Did not meet entry criteria|2|||
129995330|NCT02571049|467945082|FG001|Screening|Did not meet entry criteria|2|||
129995331|NCT02571049|467945081|FG000|Randomization|No migraine attack|0|||
129995332|NCT02571049|467945082|FG001|Randomization|No migraine attack|1|||
129995333|NCT02571049|467945081|FG000|Randomization|Adverse Event|0|||
129995334|NCT02571049|467945082|FG001|Randomization|Adverse Event|1|||
129995335|NCT00985153|467945083|FG000|Overall Study|Lost to Follow-up|16|||
129995336|NCT00985153|467945084|FG001|Overall Study|Lost to Follow-up|19|||
129995337|NCT00985153|467945085|FG002|Overall Study|Lost to Follow-up|17|||
129995338|NCT00985153|467945086|FG003|Overall Study|Lost to Follow-up|20|||
129995339|NCT00985153|467945083|FG000|Overall Study|Protocol Violation|3|||
129995340|NCT00985153|467945084|FG001|Overall Study|Protocol Violation|2|||
129995341|NCT00985153|467945085|FG002|Overall Study|Protocol Violation|4|||
129995342|NCT00985153|467945086|FG003|Overall Study|Protocol Violation|3|||
129995343|NCT00985153|467945083|FG000|Overall Study|Withdrawal by Subject|6|||
129995344|NCT00985153|467945084|FG001|Overall Study|Withdrawal by Subject|11|||
129995345|NCT00985153|467945085|FG002|Overall Study|Withdrawal by Subject|11|||
129995346|NCT00985153|467945086|FG003|Overall Study|Withdrawal by Subject|10|||
129995347|NCT00985153|467945083|FG000|Overall Study|Missed One or More Bleeds|7|||
129995348|NCT00985153|467945084|FG001|Overall Study|Missed One or More Bleeds|7|||
129995349|NCT00985153|467945085|FG002|Overall Study|Missed One or More Bleeds|8|||
129995350|NCT00985153|467945086|FG003|Overall Study|Missed One or More Bleeds|10|||
129995351|NCT00985153|467945083|FG000|Overall Study|Incomplete Safety Follow-up|3|||
129995352|NCT00985153|467945084|FG001|Overall Study|Incomplete Safety Follow-up|5|||
129995353|NCT00985153|467945085|FG002|Overall Study|Incomplete Safety Follow-up|4|||
129995354|NCT00985153|467945086|FG003|Overall Study|Incomplete Safety Follow-up|4|||
129995355|NCT01055262|467945087|FG000|Overall Study|Adverse Event|5|||
129995356|NCT01055262|467945087|FG000|Overall Study|Protocol Violation|3|||
129995357|NCT01055262|467945087|FG000|Overall Study|Uncooperativeness|1|||
129995358|NCT03370471|467945088|FG000|Overall Study|Withdrawal by Subject|6|||
129995359|NCT03370471|467945089|FG001|Overall Study|Withdrawal by Subject|1|||
129995360|NCT03370471|467945088|FG000|Overall Study|Unable to access veins for blood draw|0|||
130334743|NCT01296672|469195551|FG000|Overall Study|Lost to Follow-up|73|||
130334744|NCT01296672|469195552|FG001|Overall Study|Lost to Follow-up|18|||
130334745|NCT04661579|469195553|FG000|Overall Study|Lost to Follow-up|19|||
129995361|NCT03370471|467945089|FG001|Overall Study|Unable to access veins for blood draw|1|||
129995362|NCT03370471|467945088|FG000|Overall Study|Screen fail|1|||
129995363|NCT03370471|467945089|FG001|Overall Study|Screen fail|0|||
129995364|NCT00561951|467945091|FG000|Overall Study|Adverse Event|11|||
129995365|NCT00561951|467945092|FG001|Overall Study|Adverse Event|14|||
129995366|NCT00561951|467945093|FG002|Overall Study|Adverse Event|14|||
129995367|NCT00561951|467945091|FG000|Overall Study|Lack of Efficacy|5|||
129995368|NCT00561951|467945092|FG001|Overall Study|Lack of Efficacy|3|||
129995369|NCT00561951|467945093|FG002|Overall Study|Lack of Efficacy|2|||
129995370|NCT00561951|467945091|FG000|Overall Study|Lost to Follow-up|1|||
129995371|NCT00561951|467945092|FG001|Overall Study|Lost to Follow-up|1|||
129995372|NCT00561951|467945093|FG002|Overall Study|Lost to Follow-up|0|||
129995373|NCT00561951|467945091|FG000|Overall Study|Withdrawal by Subject|10|||
129995374|NCT00561951|467945092|FG001|Overall Study|Withdrawal by Subject|9|||
129995375|NCT00561951|467945093|FG002|Overall Study|Withdrawal by Subject|10|||
129995376|NCT00561951|467945091|FG000|Overall Study|Protocol Violation|4|||
129995377|NCT00561951|467945092|FG001|Overall Study|Protocol Violation|3|||
130334746|NCT04661579|469195554|FG001|Overall Study|Lost to Follow-up|10|||
130334747|NCT04661579|469195555|FG002|Overall Study|Lost to Follow-up|2|||
130334748|NCT04661579|469195556|FG003|Overall Study|Lost to Follow-up|7|||
130334749|NCT04661579|469195557|FG004|Overall Study|Lost to Follow-up|11|||
130334750|NCT04661579|469195553|FG000|Overall Study|Physician Decision|2|||
130334751|NCT04661579|469195554|FG001|Overall Study|Physician Decision|0|||
130334752|NCT04661579|469195555|FG002|Overall Study|Physician Decision|0|||
130334753|NCT04661579|469195556|FG003|Overall Study|Physician Decision|1|||
130334754|NCT04661579|469195557|FG004|Overall Study|Physician Decision|0|||
130334755|NCT04661579|469195553|FG000|Overall Study|Withdrawal by Subject|1|||
130334756|NCT04661579|469195554|FG001|Overall Study|Withdrawal by Subject|4|||
130334757|NCT04661579|469195555|FG002|Overall Study|Withdrawal by Subject|0|||
130334758|NCT04661579|469195556|FG003|Overall Study|Withdrawal by Subject|2|||
130334759|NCT04661579|469195557|FG004|Overall Study|Withdrawal by Subject|0|||
130334760|NCT04661579|469195553|FG000|Overall Study|Death|1|||
130334761|NCT04661579|469195554|FG001|Overall Study|Death|0|||
130334762|NCT04661579|469195555|FG002|Overall Study|Death|0|||
130334763|NCT04661579|469195556|FG003|Overall Study|Death|0|||
130334764|NCT04661579|469195557|FG004|Overall Study|Death|0|||
130334765|NCT04661579|469195553|FG000|Overall Study|Other|1|||
130334766|NCT04661579|469195554|FG001|Overall Study|Other|2|||
130334767|NCT04661579|469195555|FG002|Overall Study|Other|1|||
130334768|NCT04661579|469195556|FG003|Overall Study|Other|1|||
130334769|NCT04661579|469195557|FG004|Overall Study|Other|1|||
130334770|NCT04661579|469195553|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
130334771|NCT04661579|469195554|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
130334772|NCT04661579|469195555|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
130334773|NCT04661579|469195556|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
130334774|NCT04661579|469195557|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
130334775|NCT00796978|469195559|FG000|Overall Study|Cardiac adverse event|5|||
130334776|NCT00796978|469195559|FG000|Overall Study|Adverse Event|4|||
130334777|NCT00796978|469195559|FG000|Overall Study|Withdrawal by Subject|3|||
130334778|NCT00859456|469195560|FG000|Overall Study|Adverse Event|3|||
130334779|NCT00859456|469195560|FG000|Overall Study|Progressive disease|2|||
130334780|NCT00859456|469195560|FG000|Overall Study|Non-compliance|3|||
130334781|NCT00578292|469195561|FG000|Overall Study|Death|1|||
130334782|NCT00578292|469195561|FG000|Overall Study|Graft failure|2|||
130334783|NCT04849559|469195562|FG000|Overall Study|Withdrawal by Subject|2|||
130334784|NCT04849559|469195563|FG001|Overall Study|Withdrawal by Subject|1|||
130334785|NCT02910986|469195564|FG000|Overall Study|non-Latina|14|||
130334786|NCT02910986|469195565|FG001|Overall Study|non-Latina|13|||
130334787|NCT02910986|469195566|FG002|Overall Study|non-Latina|12|||
130334788|NCT02910986|469195564|FG000|Overall Study|Failure to return T! survey|72|||
130334789|NCT02910986|469195565|FG001|Overall Study|Failure to return T! survey|84|||
130334790|NCT02910986|469195566|FG002|Overall Study|Failure to return T! survey|72|||
130334791|NCT02910986|469195564|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
130334792|NCT02910986|469195565|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
129995378|NCT00561951|467945093|FG002|Overall Study|Protocol Violation|4|||
129995379|NCT00561951|467945091|FG000|Overall Study|Physician Decision|1|||
129995380|NCT00561951|467945092|FG001|Overall Study|Physician Decision|0|||
129995381|NCT00561951|467945093|FG002|Overall Study|Physician Decision|0|||
129995382|NCT00561951|467945091|FG000|Overall Study|Pregnancy|0|||
129995383|NCT00561951|467945092|FG001|Overall Study|Pregnancy|1|||
130334793|NCT02910986|469195566|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
130334794|NCT02910986|469195564|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
130334795|NCT02910986|469195565|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
130334796|NCT02910986|469195566|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
130334797|NCT03527732|469195569|FG000|Overall Study|Lost to Follow-up|21|||
130334798|NCT03527732|469195570|FG001|Overall Study|Lost to Follow-up|23|||
130334799|NCT03527732|469195571|FG002|Overall Study|Lost to Follow-up|80|||
130334800|NCT03527732|469195572|FG003|Overall Study|Lost to Follow-up|62|||
130334801|NCT03527732|469195573|FG004|Overall Study|Lost to Follow-up|12|||
130334802|NCT03527732|469195574|FG005|Overall Study|Lost to Follow-up|20|||
129884187|NCT01091428|467536278|FG001|Phase 1|Reason not specified|1|||
129884188|NCT01091428|467536279|FG002|Phase 1|Reason not specified|0|||
129884189|NCT01091428|467536280|FG003|Phase 1|Reason not specified|0|||
129884190|NCT01091428|467536277|FG000|Phase 1|Single-Patient IND|2|||
129884191|NCT01091428|467536278|FG001|Phase 1|Single-Patient IND|0|||
129884192|NCT01091428|467536279|FG002|Phase 1|Single-Patient IND|0|||
129884193|NCT01091428|467536280|FG003|Phase 1|Single-Patient IND|0|||
129884194|NCT01091428|467536277|FG000|Phase 2|Progressive Disease|0|||
129884195|NCT01091428|467536278|FG001|Phase 2|Progressive Disease|0|||
129884196|NCT01091428|467536279|FG002|Phase 2|Progressive Disease|44|||
129884197|NCT01091428|467536280|FG003|Phase 2|Progressive Disease|46|||
129884198|NCT01091428|467536277|FG000|Phase 2|Symptomatic Deterioration|0|||
129884199|NCT01091428|467536278|FG001|Phase 2|Symptomatic Deterioration|0|||
129884200|NCT01091428|467536279|FG002|Phase 2|Symptomatic Deterioration|1|||
129884201|NCT01091428|467536280|FG003|Phase 2|Symptomatic Deterioration|6|||
129884202|NCT01091428|467536277|FG000|Phase 2|Adverse Event|0|||
129884203|NCT01091428|467536278|FG001|Phase 2|Adverse Event|0|||
129884204|NCT01091428|467536279|FG002|Phase 2|Adverse Event|12|||
129884205|NCT01091428|467536280|FG003|Phase 2|Adverse Event|5|||
129884206|NCT01091428|467536277|FG000|Phase 2|Withdrawal by Subject|0|||
129884207|NCT01091428|467536278|FG001|Phase 2|Withdrawal by Subject|0|||
129884208|NCT01091428|467536279|FG002|Phase 2|Withdrawal by Subject|9|||
129884209|NCT01091428|467536280|FG003|Phase 2|Withdrawal by Subject|8|||
129884210|NCT01091428|467536277|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
129884211|NCT01091428|467536278|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
129884212|NCT01091428|467536279|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
129884213|NCT01091428|467536280|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
129884214|NCT01091428|467536277|FG000|Phase 2|Reason not specified|0|||
129884215|NCT01091428|467536278|FG001|Phase 2|Reason not specified|0|||
129884216|NCT01091428|467536279|FG002|Phase 2|Reason not specified|4|||
129884217|NCT01091428|467536280|FG003|Phase 2|Reason not specified|3|||
129884218|NCT01091428|467536277|FG000|Phase 2|Physician Decision|0|||
129884219|NCT01091428|467536278|FG001|Phase 2|Physician Decision|0|||
129884220|NCT01091428|467536279|FG002|Phase 2|Physician Decision|2|||
129884221|NCT01091428|467536280|FG003|Phase 2|Physician Decision|0|||
129884222|NCT03518658|467536283|FG000|Overall Study|Other|51|||
129884223|NCT03518658|467536284|FG001|Overall Study|Other|0|||
129884224|NCT02531295|467536285|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884225|NCT02531295|467536286|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884226|NCT02531295|467536287|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884227|NCT02531295|467536288|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884228|NCT02531295|467536289|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884229|NCT02531295|467536290|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
129884230|NCT04424290|467536292|FG000|Overall Study|Not treated|0|||
129884231|NCT04424290|467536293|FG001|Overall Study|Not treated|0|||
129884232|NCT04424290|467536294|FG002|Overall Study|Not treated|1|||
129884233|NCT04424290|467536295|FG003|Overall Study|Not treated|0|||
129884234|NCT04424290|467536296|FG004|Overall Study|Not treated|1|||
129884235|NCT04424290|467536292|FG000|Overall Study|Adverse Event|0|||
129884236|NCT04424290|467536293|FG001|Overall Study|Adverse Event|0|||
129884237|NCT04424290|467536294|FG002|Overall Study|Adverse Event|0|||
129884238|NCT04424290|467536295|FG003|Overall Study|Adverse Event|2|||
129884239|NCT04424290|467536296|FG004|Overall Study|Adverse Event|0|||
129884240|NCT04424290|467536292|FG000|Overall Study|Withdrawal by Subject|0|||
129884241|NCT04424290|467536293|FG001|Overall Study|Withdrawal by Subject|0|||
129884242|NCT04424290|467536294|FG002|Overall Study|Withdrawal by Subject|0|||
129884243|NCT04424290|467536295|FG003|Overall Study|Withdrawal by Subject|0|||
129884244|NCT04424290|467536296|FG004|Overall Study|Withdrawal by Subject|1|||
129884245|NCT04424290|467536292|FG000|Overall Study|Other than listed|0|||
129884246|NCT04424290|467536293|FG001|Overall Study|Other than listed|0|||
129884247|NCT04424290|467536294|FG002|Overall Study|Other than listed|0|||
129884248|NCT04424290|467536295|FG003|Overall Study|Other than listed|1|||
129884249|NCT04424290|467536296|FG004|Overall Study|Other than listed|0|||
129884250|NCT04249336|467536299|FG000|Overall Study|Lost to Follow-up|3|||
129884251|NCT04249336|467536300|FG001|Overall Study|Lost to Follow-up|3|||
129884252|NCT04249336|467536301|FG002|Overall Study|Lost to Follow-up|3|||
129884253|NCT04249336|467536302|FG003|Overall Study|Lost to Follow-up|3|||
129884254|NCT01242176|467536303|FG000|Washout Period of 7 Days|Adverse Event|0|||
129884255|NCT01242176|467536304|FG001|Washout Period of 7 Days|Adverse Event|2|||
129884256|NCT01242176|467536303|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
129884257|NCT01242176|467536304|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
129884258|NCT03390036|467536305|FG000|Overall Study|Lost to Follow-up|1|||
129884259|NCT03390036|467536306|FG001|Overall Study|Lost to Follow-up|0|||
129995384|NCT00561951|467945093|FG002|Overall Study|Pregnancy|0|||
129995385|NCT00561951|467945091|FG000|Overall Study|Meet Withdrawal Criterion|0|||
129995386|NCT00561951|467945092|FG001|Overall Study|Meet Withdrawal Criterion|1|||
129995387|NCT00561951|467945093|FG002|Overall Study|Meet Withdrawal Criterion|1|||
129995388|NCT00561951|467945091|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
129995389|NCT00561951|467945092|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
129995390|NCT00561951|467945093|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
129995391|NCT00392327|467945105|FG000|Overall Study|Death|1|||
129995392|NCT00392327|467945106|FG001|Overall Study|Death|0|||
129995393|NCT00392327|467945107|FG002|Overall Study|Death|1|||
129995394|NCT00392327|467945108|FG003|Overall Study|Death|0|||
129995395|NCT00392327|467945109|FG004|Overall Study|Death|0|||
129995396|NCT00392327|467945110|FG005|Overall Study|Death|0|||
129995397|NCT00392327|467945111|FG006|Overall Study|Death|0|||
129995398|NCT00392327|467945112|FG007|Overall Study|Death|0|||
129995399|NCT00392327|467945105|FG000|Overall Study|Lack of Efficacy|8|||
129995400|NCT00392327|467945106|FG001|Overall Study|Lack of Efficacy|8|||
129995401|NCT00392327|467945107|FG002|Overall Study|Lack of Efficacy|9|||
129995402|NCT00392327|467945108|FG003|Overall Study|Lack of Efficacy|6|||
129995403|NCT00392327|467945109|FG004|Overall Study|Lack of Efficacy|3|||
129995404|NCT00392327|467945110|FG005|Overall Study|Lack of Efficacy|3|||
129995405|NCT00392327|467945111|FG006|Overall Study|Lack of Efficacy|3|||
129995406|NCT00392327|467945112|FG007|Overall Study|Lack of Efficacy|3|||
129995407|NCT00392327|467945105|FG000|Overall Study|Physician Decision|3|||
129995408|NCT00392327|467945106|FG001|Overall Study|Physician Decision|5|||
129995409|NCT00392327|467945107|FG002|Overall Study|Physician Decision|2|||
129995410|NCT00392327|467945108|FG003|Overall Study|Physician Decision|2|||
129995411|NCT00392327|467945109|FG004|Overall Study|Physician Decision|0|||
129995412|NCT00392327|467945110|FG005|Overall Study|Physician Decision|1|||
129995413|NCT00392327|467945111|FG006|Overall Study|Physician Decision|5|||
129995414|NCT00392327|467945112|FG007|Overall Study|Physician Decision|3|||
129995415|NCT00392327|467945105|FG000|Overall Study|Protocol Violation|0|||
129995416|NCT00392327|467945106|FG001|Overall Study|Protocol Violation|0|||
129995417|NCT00392327|467945107|FG002|Overall Study|Protocol Violation|1|||
129995418|NCT00392327|467945108|FG003|Overall Study|Protocol Violation|0|||
129995419|NCT00392327|467945109|FG004|Overall Study|Protocol Violation|0|||
129995420|NCT00392327|467945110|FG005|Overall Study|Protocol Violation|0|||
129995421|NCT00392327|467945111|FG006|Overall Study|Protocol Violation|0|||
129995422|NCT00392327|467945112|FG007|Overall Study|Protocol Violation|0|||
129995423|NCT00392327|467945105|FG000|Overall Study|Withdrawal by Subject|3|||
129995424|NCT00392327|467945106|FG001|Overall Study|Withdrawal by Subject|2|||
129995425|NCT00392327|467945107|FG002|Overall Study|Withdrawal by Subject|4|||
129995426|NCT00392327|467945108|FG003|Overall Study|Withdrawal by Subject|6|||
129995427|NCT00392327|467945109|FG004|Overall Study|Withdrawal by Subject|0|||
129995428|NCT00392327|467945110|FG005|Overall Study|Withdrawal by Subject|1|||
129995429|NCT00392327|467945111|FG006|Overall Study|Withdrawal by Subject|1|||
129995430|NCT00392327|467945112|FG007|Overall Study|Withdrawal by Subject|5|||
129995431|NCT00392327|467945105|FG000|Overall Study|Ineligible|0|||
129995432|NCT00392327|467945106|FG001|Overall Study|Ineligible|4|||
129995433|NCT00392327|467945107|FG002|Overall Study|Ineligible|3|||
129995434|NCT00392327|467945108|FG003|Overall Study|Ineligible|2|||
129995435|NCT00392327|467945109|FG004|Overall Study|Ineligible|0|||
129995436|NCT00392327|467945110|FG005|Overall Study|Ineligible|0|||
129995437|NCT00392327|467945111|FG006|Overall Study|Ineligible|0|||
129995438|NCT00392327|467945112|FG007|Overall Study|Ineligible|0|||
129995439|NCT04508023|467945113|FG000|Overall Study|Withdrawal by Subject|1|||
129995440|NCT04508023|467945114|FG001|Overall Study|Withdrawal by Subject|2|||
129995441|NCT03261700|467945119|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
129995442|NCT03261700|467945120|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
129995443|NCT04223856|467945123|FG000|Overall Study|Progressive disease|153|||
129995444|NCT04223856|467945124|FG001|Overall Study|Progressive disease|73|||
129995445|NCT04223856|467945123|FG000|Overall Study|Adverse Event|97|||
129995446|NCT04223856|467945124|FG001|Overall Study|Adverse Event|62|||
129995447|NCT04223856|467945123|FG000|Overall Study|Physician Decision|9|||
129995448|NCT04223856|467945124|FG001|Overall Study|Physician Decision|28|||
129995449|NCT04223856|467945123|FG000|Overall Study|Withdrawal by Subject|22|||
129995450|NCT04223856|467945124|FG001|Overall Study|Withdrawal by Subject|24|||
129995451|NCT04223856|467945123|FG000|Overall Study|Other|7|||
129995452|NCT04223856|467945124|FG001|Overall Study|Other|2|||
129995453|NCT04223856|467945123|FG000|Overall Study|Randomized but not treated|2|||
129995454|NCT04223856|467945124|FG001|Overall Study|Randomized but not treated|11|||
129995455|NCT04223856|467945123|FG000|Overall Study|On-treatment|144|||
129995456|NCT04223856|467945124|FG001|Overall Study|On-treatment|0|||
129995457|NCT03226275|467945125|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129995458|NCT03226275|467945126|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129995459|NCT03226275|467945127|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
129995460|NCT03226275|467945128|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129995461|NCT03226275|467945125|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
129995462|NCT03226275|467945126|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
129995463|NCT03226275|467945127|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
129995464|NCT03226275|467945128|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
129995465|NCT01215422|467947954|FG000|Overall Study|Relocation|1|||
129995466|NCT01215422|467947955|FG001|Overall Study|Relocation|0|||
129995467|NCT01215422|467947956|FG002|Overall Study|Relocation|0|||
129995468|NCT01215422|467947957|FG003|Overall Study|Relocation|0|||
129995469|NCT01215422|467947954|FG000|Overall Study|Failed intubations|0|||
129995470|NCT01215422|467947955|FG001|Overall Study|Failed intubations|0|||
129995471|NCT01215422|467947956|FG002|Overall Study|Failed intubations|3|||
129995472|NCT01215422|467947957|FG003|Overall Study|Failed intubations|8|||
129995473|NCT01215422|467947954|FG000|Overall Study|Did not complete all intubations|7|||
129995474|NCT01215422|467947955|FG001|Overall Study|Did not complete all intubations|0|||
129995475|NCT01215422|467947956|FG002|Overall Study|Did not complete all intubations|0|||
129995476|NCT01215422|467947957|FG003|Overall Study|Did not complete all intubations|0|||
129995477|NCT00294554|467947964|FG000|Overall Study|Lack of Efficacy|0|||
129995478|NCT00294554|467947965|FG001|Overall Study|Lack of Efficacy|1|||
129995479|NCT00294554|467947964|FG000|Overall Study|Physician Decision|0|||
129995480|NCT00294554|467947965|FG001|Overall Study|Physician Decision|1|||
129995481|NCT00462865|467947966|FG000|Overall Study|Adverse Event|1|||
129995482|NCT02864381|467947967|FG000|Overall Study|Death|58|||
129995483|NCT02864381|467947968|FG001|Overall Study|Death|61|||
129995484|NCT02864381|467947967|FG000|Overall Study|Withdrew Consent|5|||
129995485|NCT02864381|467947968|FG001|Overall Study|Withdrew Consent|6|||
129995486|NCT02864381|467947967|FG000|Overall Study|Reason Unknown|7|||
129995487|NCT02864381|467947968|FG001|Overall Study|Reason Unknown|3|||
129995488|NCT02864381|467947967|FG000|Overall Study|Lost to Follow-up|1|||
129995489|NCT02864381|467947968|FG001|Overall Study|Lost to Follow-up|1|||
129995490|NCT02864381|467947967|FG000|Overall Study|Investigator's Discretion|1|||
129995491|NCT02864381|467947968|FG001|Overall Study|Investigator's Discretion|0|||
129995492|NCT02864381|467947967|FG000|Overall Study|Protocol Violation|0|||
129995493|NCT02864381|467947968|FG001|Overall Study|Protocol Violation|1|||
129995494|NCT04142450|467947969|FG000|Overall Study|Screen Failure|1|||
129995495|NCT04142450|467947969|FG000|Overall Study|Lost to Follow-up|1|||
129995496|NCT02544217|467947970|FG000|Overall Study|Withdrawal by Subject|1|||
129995497|NCT02544217|467947971|FG001|Overall Study|Withdrawal by Subject|1|||
129995498|NCT02544217|467947972|FG002|Overall Study|Withdrawal by Subject|0|||
129995499|NCT02544217|467947973|FG003|Overall Study|Withdrawal by Subject|0|||
129995500|NCT02544217|467947974|FG004|Overall Study|Withdrawal by Subject|0|||
129995501|NCT02544217|467947975|FG005|Overall Study|Withdrawal by Subject|0|||
129995502|NCT01146054|467947978|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
129995503|NCT01146054|467947978|FG000|Overall Study|Rapid tumor progression|2|||
129995504|NCT01146054|467947978|FG000|Overall Study|Other illness precluded treatment|2|||
130334803|NCT02280408|469195575|FG000|Overall Study|Lost to Follow-up|0|||
130334804|NCT02280408|469195576|FG001|Overall Study|Lost to Follow-up|2|||
130334805|NCT02280408|469195577|FG002|Overall Study|Lost to Follow-up|0|||
130334806|NCT02280408|469195578|FG003|Overall Study|Lost to Follow-up|0|||
130334807|NCT02474069|469195579|FG000|Selection Phase (SP)|Adverse Event|8|||
130334808|NCT02474069|469195580|FG001|Selection Phase (SP)|Adverse Event|0|||
130334809|NCT02474069|469195581|FG002|Selection Phase (SP)|Adverse Event|0|||
130334810|NCT02474069|469195579|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
130334811|NCT02474069|469195580|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
130334812|NCT02474069|469195581|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
130334813|NCT02474069|469195579|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
130334814|NCT02474069|469195580|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
130334815|NCT02474069|469195581|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
130334816|NCT02474069|469195579|FG000|Selection Phase (SP)|Physician Decision|1|||
130334817|NCT02474069|469195580|FG001|Selection Phase (SP)|Physician Decision|0|||
130334818|NCT02474069|469195581|FG002|Selection Phase (SP)|Physician Decision|0|||
130334819|NCT02474069|469195579|FG000|Selection Phase (SP)|Protocol Violation|1|||
130334820|NCT02474069|469195580|FG001|Selection Phase (SP)|Protocol Violation|0|||
130334821|NCT02474069|469195581|FG002|Selection Phase (SP)|Protocol Violation|0|||
130334822|NCT02474069|469195579|FG000|Selection Phase (SP)|No longer requires treatment|1|||
130334823|NCT02474069|469195580|FG001|Selection Phase (SP)|No longer requires treatment|0|||
130334824|NCT02474069|469195581|FG002|Selection Phase (SP)|No longer requires treatment|0|||
129995505|NCT01146054|467947978|FG000|Overall Study|Lost to Follow-up|1|||
129995506|NCT04335812|467947979|FG000|Overall Study|Withdrawal by Subject|1|||
129995507|NCT04335812|467947980|FG001|Overall Study|Withdrawal by Subject|3|||
129995508|NCT04335812|467947979|FG000|Overall Study|Lost to Follow-up|12|||
129995509|NCT04335812|467947980|FG001|Overall Study|Lost to Follow-up|12|||
129995510|NCT04335812|467947979|FG000|Overall Study|Did not engage in the intervention|22|||
129995511|NCT04335812|467947980|FG001|Overall Study|Did not engage in the intervention|18|||
130334825|NCT02474069|469195579|FG000|Selection Phase (SP)|Technical Problem|1|||
130334826|NCT02474069|469195580|FG001|Selection Phase (SP)|Technical Problem|0|||
130334827|NCT02474069|469195581|FG002|Selection Phase (SP)|Technical Problem|0|||
130334828|NCT02474069|469195579|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
129995512|NCT02901041|467947991|FG000|Overall Study|Withdrawal by PI|4|||
129995513|NCT02901041|467947992|FG001|Overall Study|Withdrawal by PI|8|||
129995514|NCT02901041|467947991|FG000|Overall Study|Withdrawal by Subject|7|||
129995515|NCT02901041|467947992|FG001|Overall Study|Withdrawal by Subject|3|||
129995516|NCT00975507|467947996|FG000|Overall Study|Adverse Event|1|||
129995517|NCT00975507|467947997|FG001|Overall Study|Adverse Event|0|||
129995518|NCT00975507|467947996|FG000|Overall Study|Lost to Follow-up|7|||
129995519|NCT00975507|467947997|FG001|Overall Study|Lost to Follow-up|1|||
129995520|NCT00975507|467947996|FG000|Overall Study|Protocol Violation|2|||
129995521|NCT00975507|467947997|FG001|Overall Study|Protocol Violation|0|||
129995522|NCT00975507|467947996|FG000|Overall Study|Withdrawal by Subject|10|||
129995523|NCT00975507|467947997|FG001|Overall Study|Withdrawal by Subject|3|||
129995524|NCT03249714|467947998|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
129995525|NCT03249714|467947999|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
129995526|NCT03249714|467947998|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
129995527|NCT03249714|467947999|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
129995528|NCT03249714|467947998|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
129995529|NCT03249714|467947999|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
129995530|NCT03249714|467947998|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
129995531|NCT03249714|467947999|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
129995532|NCT01112306|467948007|FG000|Overall Study|Death|175|||
129995533|NCT01112306|467948007|FG000|Overall Study|Lost to Follow-up|9|||
129995534|NCT01112306|467948007|FG000|Overall Study|Withdrawal by Subject|31|||
129995535|NCT01112306|467948007|FG000|Overall Study|Other|70|||
129995536|NCT01607554|467948011|FG000|Overall Study|Disease progression|2|||
129995537|NCT03952806|467948012|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
129995538|NCT03952806|467948013|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
129995539|NCT03952806|467948012|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
129995540|NCT03952806|467948013|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
129995541|NCT03952806|467948012|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
129995542|NCT03952806|467948013|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
129995543|NCT03952806|467948012|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
129995544|NCT03952806|467948013|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
129995545|NCT03952806|467948012|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
129995546|NCT03952806|467948013|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
129995547|NCT03952806|467948012|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
129995548|NCT03952806|467948013|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
129995549|NCT03952806|467948012|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
129995550|NCT03952806|467948013|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
129995551|NCT03952806|467948012|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
129995552|NCT03952806|467948013|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
129995553|NCT03952806|467948012|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
129995554|NCT03952806|467948013|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
129995555|NCT03952806|467948012|FG000|OLE Phase (48 Weeks)|Other|16|||
129995556|NCT03952806|467948013|FG001|OLE Phase (48 Weeks)|Other|13|||
129995557|NCT00655863|467948014|FG000|Overall Study|Lost to Follow-up|0|||
129995558|NCT00655863|467948015|FG001|Overall Study|Lost to Follow-up|0|||
129995559|NCT00655863|467948016|FG002|Overall Study|Lost to Follow-up|1|||
129995560|NCT01138007|467948017|FG000|Overall Study|Adverse Event|4|||
129995561|NCT01138007|467948018|FG001|Overall Study|Adverse Event|12|||
129995562|NCT01138007|467948019|FG002|Overall Study|Adverse Event|9|||
129995563|NCT01138007|467948017|FG000|Overall Study|Lack of Efficacy|2|||
129995564|NCT01138007|467948018|FG001|Overall Study|Lack of Efficacy|0|||
129995565|NCT01138007|467948019|FG002|Overall Study|Lack of Efficacy|6|||
129995566|NCT01138007|467948017|FG000|Overall Study|Protocol Violation|2|||
129995567|NCT01138007|467948018|FG001|Overall Study|Protocol Violation|3|||
129995568|NCT01138007|467948019|FG002|Overall Study|Protocol Violation|2|||
129995569|NCT01138007|467948017|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
129995570|NCT01138007|467948018|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
129995571|NCT01138007|467948019|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
130216126|NCT01826981|468753950|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216127|NCT01826981|468753951|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
129995572|NCT01138007|467948017|FG000|Overall Study|Lost to Follow-up|3|||
129995573|NCT01138007|467948018|FG001|Overall Study|Lost to Follow-up|3|||
129995574|NCT01138007|467948019|FG002|Overall Study|Lost to Follow-up|5|||
129995575|NCT01138007|467948017|FG000|Overall Study|Physician Decision|0|||
129995576|NCT01138007|467948018|FG001|Overall Study|Physician Decision|5|||
129995577|NCT01138007|467948019|FG002|Overall Study|Physician Decision|3|||
129995578|NCT01138007|467948017|FG000|Overall Study|Withdrawal by Subject|5|||
129995579|NCT01138007|467948018|FG001|Overall Study|Withdrawal by Subject|6|||
129995580|NCT01138007|467948019|FG002|Overall Study|Withdrawal by Subject|15|||
129995581|NCT03840486|467948020|FG000|Overall Study|Withdrawal by Subject|0|||
130216128|NCT01826981|468753952|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216129|NCT01826981|468753953|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
129995582|NCT03840486|467948021|FG001|Overall Study|Withdrawal by Subject|1|||
129995583|NCT03840486|467948022|FG002|Overall Study|Withdrawal by Subject|0|||
129995584|NCT03840486|467948023|FG003|Overall Study|Withdrawal by Subject|0|||
129995585|NCT03840486|467948024|FG004|Overall Study|Withdrawal by Subject|0|||
129995586|NCT03840486|467948025|FG005|Overall Study|Withdrawal by Subject|0|||
129995587|NCT03840486|467948026|FG006|Overall Study|Withdrawal by Subject|0|||
129995588|NCT03840486|467948027|FG007|Overall Study|Withdrawal by Subject|0|||
129995589|NCT03840486|467948028|FG008|Overall Study|Withdrawal by Subject|0|||
129995590|NCT03840486|467948029|FG009|Overall Study|Withdrawal by Subject|0|||
129995591|NCT03840486|467948030|FG010|Overall Study|Withdrawal by Subject|0|||
129995592|NCT03840486|467948031|FG011|Overall Study|Withdrawal by Subject|0|||
129995593|NCT04661878|467948032|FG000|Overall Study|Lost to Follow-up|6|||
129995594|NCT04661878|467948033|FG001|Overall Study|Lost to Follow-up|5|||
129995595|NCT04442737|467948040|FG000|Overall Study|Lost to Follow-up|1|||
129995596|NCT04442737|467948041|FG001|Overall Study|Lost to Follow-up|3|||
129995597|NCT04442737|467948040|FG000|Overall Study|Withdrawal by Subject|3|||
129995598|NCT04442737|467948041|FG001|Overall Study|Withdrawal by Subject|2|||
129995599|NCT04442737|467948040|FG000|Overall Study|Adverse Event|3|||
129995600|NCT04442737|467948041|FG001|Overall Study|Adverse Event|2|||
129995601|NCT04442737|467948040|FG000|Overall Study|Death|0|||
129995602|NCT04442737|467948041|FG001|Overall Study|Death|1|||
129995603|NCT04442737|467948040|FG000|Overall Study|Protocol Violation|0|||
129995604|NCT04442737|467948041|FG001|Overall Study|Protocol Violation|2|||
129995605|NCT04442737|467948040|FG000|Overall Study|Other|1|||
129995606|NCT04442737|467948041|FG001|Overall Study|Other|1|||
129995607|NCT00744523|467948042|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
129995608|NCT00744523|467948043|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
129995609|NCT01139021|467948046|FG000|Overall Study|Adverse Event|0|||
129995610|NCT01139021|467948047|FG001|Overall Study|Adverse Event|0|||
129995611|NCT01139021|467948048|FG002|Overall Study|Adverse Event|0|||
129995612|NCT01139021|467948049|FG003|Overall Study|Adverse Event|0|||
129995613|NCT01139021|467948050|FG004|Overall Study|Adverse Event|1|||
129995614|NCT01139021|467948051|FG005|Overall Study|Adverse Event|0|||
129995615|NCT01139021|467948046|FG000|Overall Study|Lost to Follow-up|0|||
129995616|NCT01139021|467948047|FG001|Overall Study|Lost to Follow-up|0|||
129995617|NCT01139021|467948048|FG002|Overall Study|Lost to Follow-up|0|||
129995618|NCT01139021|467948049|FG003|Overall Study|Lost to Follow-up|0|||
129995619|NCT01139021|467948050|FG004|Overall Study|Lost to Follow-up|2|||
129995620|NCT01139021|467948051|FG005|Overall Study|Lost to Follow-up|0|||
129995621|NCT01139021|467948046|FG000|Overall Study|Protocol Violation|1|||
129995622|NCT01139021|467948047|FG001|Overall Study|Protocol Violation|0|||
129995623|NCT01139021|467948048|FG002|Overall Study|Protocol Violation|0|||
129995624|NCT01139021|467948049|FG003|Overall Study|Protocol Violation|0|||
129995625|NCT01139021|467948050|FG004|Overall Study|Protocol Violation|2|||
129995626|NCT01139021|467948051|FG005|Overall Study|Protocol Violation|0|||
129995627|NCT01139021|467948046|FG000|Overall Study|Withdrawal by Subject|0|||
129995628|NCT01139021|467948047|FG001|Overall Study|Withdrawal by Subject|0|||
129995629|NCT01139021|467948048|FG002|Overall Study|Withdrawal by Subject|0|||
129995630|NCT01139021|467948049|FG003|Overall Study|Withdrawal by Subject|1|||
129995631|NCT01139021|467948050|FG004|Overall Study|Withdrawal by Subject|4|||
129995632|NCT01139021|467948051|FG005|Overall Study|Withdrawal by Subject|0|||
129995633|NCT05333224|467948052|FG000|Overall Study - Infants|Lost to Follow-up|1|||
129995634|NCT05333224|467948053|FG001|Overall Study - Infants|Lost to Follow-up|1|||
129995635|NCT00063154|467948054|FG000|Overall Study|Disease progression|27|||
129995636|NCT00063154|467948054|FG000|Overall Study|Adverse Event|2|||
129995637|NCT00063154|467948054|FG000|Overall Study|Physician Decision|10|||
129995638|NCT00063154|467948054|FG000|Overall Study|Death|3|||
129995639|NCT00063154|467948054|FG000|Overall Study|Reason unspecified|1|||
129995640|NCT00063154|467948054|FG000|Overall Study|Did not receive treatment|8|||
129995641|NCT01978262|467948055|FG000|Overall Study|Withdrawal by Subject|9|||
129995642|NCT01978262|467948055|FG000|Overall Study|Lost to Follow-up|2|||
129995643|NCT02168842|467948057|FG000|Overall Study|Withdrawal by Subject|5|||
129995644|NCT02168842|467948058|FG001|Overall Study|Withdrawal by Subject|3|||
129995645|NCT02168842|467948057|FG000|Overall Study|Lost to Follow-up|0|||
129995646|NCT02168842|467948058|FG001|Overall Study|Lost to Follow-up|2|||
129995647|NCT02168842|467948057|FG000|Overall Study|Death|2|||
129995648|NCT02168842|467948058|FG001|Overall Study|Death|1|||
129995649|NCT02168842|467948057|FG000|Overall Study|Physician Decision|1|||
129995650|NCT02168842|467948058|FG001|Overall Study|Physician Decision|2|||
129995651|NCT02019927|467948063|FG000|Overall Study|Lost to Follow-up|2|||
130334829|NCT02474069|469195580|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
129995652|NCT02019927|467948064|FG001|Overall Study|Lost to Follow-up|4|||
129995653|NCT02019927|467948065|FG002|Overall Study|Lost to Follow-up|1|||
129995654|NCT02019927|467948066|FG003|Overall Study|Lost to Follow-up|2|||
129995655|NCT02019927|467948067|FG004|Overall Study|Lost to Follow-up|3|||
129995656|NCT02019927|467948068|FG005|Overall Study|Lost to Follow-up|1|||
129995675|NCT01592864|467948079|FG000|Overall Study|Withdrawal by Subject|0|||
129995676|NCT01592864|467948080|FG001|Overall Study|Withdrawal by Subject|1|||
129995677|NCT01596621|467948083|FG000|Overall Study|Death|4|||
129995678|NCT01596621|467948083|FG000|Overall Study|Withdrawal by Subject|9|||
129995679|NCT01596621|467948083|FG000|Overall Study|Disease Progression|49|||
129995680|NCT01596621|467948083|FG000|Overall Study|Lost to Follow-up|3|||
129995681|NCT01596621|467948083|FG000|Overall Study|Other than specified|13|||
129995682|NCT00421707|467948088|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
129995683|NCT00421707|467948089|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
129995684|NCT00421707|467948088|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
129995685|NCT00421707|467948089|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
129995686|NCT00421707|467948088|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
129995687|NCT00421707|467948089|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
129995688|NCT00421707|467948088|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
129995689|NCT00421707|467948089|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
129995690|NCT00421707|467948088|FG000|Period 2: Washout|Adverse Event|1|||
129995691|NCT00421707|467948089|FG001|Period 2: Washout|Adverse Event|1|||
129995692|NCT00421707|467948088|FG000|Period 2: Washout|Withdrawal by Subject|0|||
129995693|NCT00421707|467948089|FG001|Period 2: Washout|Withdrawal by Subject|1|||
129995694|NCT00421707|467948088|FG000|Period 2: Washout|Lost to Follow-up|0|||
129995695|NCT00421707|467948089|FG001|Period 2: Washout|Lost to Follow-up|1|||
129995696|NCT00421707|467948088|FG000|Period 2: Washout|Other: Pregnancy|0|||
129995697|NCT00421707|467948089|FG001|Period 2: Washout|Other: Pregnancy|1|||
129995698|NCT00421707|467948088|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
129995699|NCT00421707|467948089|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
129995700|NCT00421707|467948088|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
129995701|NCT00421707|467948089|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
129995702|NCT00421707|467948088|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
129995703|NCT00421707|467948089|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
129995704|NCT01074216|467948090|FG000|Overall Study|Physician Decision|1|||
129995705|NCT01074216|467948090|FG000|Overall Study|Not Treated|12|||
129995706|NCT01723254|467948091|FG000|Overall Study|Conflict with work schedule|0|||
129995707|NCT01723254|467948092|FG001|Overall Study|Conflict with work schedule|0|||
129995708|NCT01723254|467948093|FG002|Overall Study|Conflict with work schedule|0|||
129995709|NCT01723254|467948094|FG003|Overall Study|Conflict with work schedule|0|||
129995710|NCT01723254|467948095|FG004|Overall Study|Conflict with work schedule|0|||
129995711|NCT01723254|467948096|FG005|Overall Study|Conflict with work schedule|0|||
129995712|NCT01723254|467948097|FG006|Overall Study|Conflict with work schedule|0|||
129995713|NCT01723254|467948098|FG007|Overall Study|Conflict with work schedule|1|||
129995714|NCT01723254|467948091|FG000|Overall Study|Personal issues|0|||
129995715|NCT01723254|467948092|FG001|Overall Study|Personal issues|0|||
129995716|NCT01723254|467948093|FG002|Overall Study|Personal issues|0|||
129995717|NCT01723254|467948094|FG003|Overall Study|Personal issues|0|||
129995718|NCT01723254|467948095|FG004|Overall Study|Personal issues|0|||
129995719|NCT01723254|467948096|FG005|Overall Study|Personal issues|1|||
129995720|NCT01723254|467948097|FG006|Overall Study|Personal issues|0|||
129995721|NCT01723254|467948098|FG007|Overall Study|Personal issues|0|||
129995722|NCT01723254|467948091|FG000|Overall Study|No longer have time to participate|0|||
129995723|NCT01723254|467948092|FG001|Overall Study|No longer have time to participate|0|||
129995724|NCT01723254|467948093|FG002|Overall Study|No longer have time to participate|0|||
129995725|NCT01723254|467948094|FG003|Overall Study|No longer have time to participate|1|||
129995726|NCT01723254|467948095|FG004|Overall Study|No longer have time to participate|0|||
129995727|NCT01723254|467948096|FG005|Overall Study|No longer have time to participate|0|||
129995728|NCT01723254|467948097|FG006|Overall Study|No longer have time to participate|0|||
129995729|NCT01723254|467948098|FG007|Overall Study|No longer have time to participate|0|||
129995730|NCT01723254|467948091|FG000|Overall Study|Move/Left to another country/city|0|||
129995731|NCT01723254|467948092|FG001|Overall Study|Move/Left to another country/city|0|||
129995732|NCT01723254|467948093|FG002|Overall Study|Move/Left to another country/city|2|||
129995733|NCT01723254|467948094|FG003|Overall Study|Move/Left to another country/city|1|||
129995734|NCT01723254|467948095|FG004|Overall Study|Move/Left to another country/city|1|||
129995735|NCT01723254|467948096|FG005|Overall Study|Move/Left to another country/city|0|||
129995736|NCT01723254|467948097|FG006|Overall Study|Move/Left to another country/city|0|||
129995737|NCT01723254|467948098|FG007|Overall Study|Move/Left to another country/city|0|||
129995738|NCT01723254|467948091|FG000|Overall Study|Protocol Violation|0|||
129995739|NCT01723254|467948092|FG001|Overall Study|Protocol Violation|1|||
129995740|NCT01723254|467948093|FG002|Overall Study|Protocol Violation|0|||
129995741|NCT01723254|467948094|FG003|Overall Study|Protocol Violation|0|||
129995742|NCT01723254|467948095|FG004|Overall Study|Protocol Violation|0|||
129995743|NCT01723254|467948096|FG005|Overall Study|Protocol Violation|0|||
129995744|NCT01723254|467948097|FG006|Overall Study|Protocol Violation|0|||
129995745|NCT01723254|467948098|FG007|Overall Study|Protocol Violation|0|||
129995746|NCT01723254|467948091|FG000|Overall Study|Withdrawal by Subject|1|||
129995747|NCT01723254|467948092|FG001|Overall Study|Withdrawal by Subject|2|||
129995748|NCT01723254|467948093|FG002|Overall Study|Withdrawal by Subject|1|||
129995749|NCT01723254|467948094|FG003|Overall Study|Withdrawal by Subject|0|||
129995750|NCT01723254|467948095|FG004|Overall Study|Withdrawal by Subject|1|||
129995751|NCT01723254|467948096|FG005|Overall Study|Withdrawal by Subject|1|||
129995752|NCT01723254|467948097|FG006|Overall Study|Withdrawal by Subject|1|||
129995753|NCT01723254|467948098|FG007|Overall Study|Withdrawal by Subject|2|||
129995754|NCT01323634|467948099|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
129995755|NCT01323634|467948100|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
129995756|NCT01323634|467948101|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
129995757|NCT01323634|467948099|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
129995758|NCT01323634|467948100|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
129995759|NCT01323634|467948101|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
129995760|NCT01323634|467948099|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
129995761|NCT01323634|467948100|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129995762|NCT01323634|467948101|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129995763|NCT01323634|467948099|FG000|2-week Run-in Period|Physician Decision|5|||
129995764|NCT01323634|467948100|FG001|2-week Run-in Period|Physician Decision|0|||
129995765|NCT01323634|467948101|FG002|2-week Run-in Period|Physician Decision|0|||
129995766|NCT01323634|467948099|FG000|2-week Run-in Period|Protocol Violation|1|||
129995767|NCT01323634|467948100|FG001|2-week Run-in Period|Protocol Violation|0|||
129995768|NCT01323634|467948101|FG002|2-week Run-in Period|Protocol Violation|0|||
129995769|NCT01323634|467948099|FG000|2-week Run-in Period|Adverse Event|1|||
129995770|NCT01323634|467948100|FG001|2-week Run-in Period|Adverse Event|0|||
129995771|NCT01323634|467948101|FG002|2-week Run-in Period|Adverse Event|0|||
129995772|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129995773|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
129995774|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
129995775|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129995776|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129995777|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
129995778|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129995779|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
129995780|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
129995781|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129995782|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129995783|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129995784|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
129995785|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
129995786|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
129995787|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129995788|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
129995789|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
129995790|NCT01323634|467948099|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
129995791|NCT01323634|467948100|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
129995792|NCT01323634|467948101|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
129995793|NCT05056987|467948102|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
129995794|NCT05056987|467948103|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
129995795|NCT05056987|467948102|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
129995796|NCT05056987|467948103|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
129995797|NCT02409368|467948104|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
129995798|NCT02409368|467948105|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
129995799|NCT02409368|467948106|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
130216130|NCT01826981|468753954|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
130216131|NCT02030119|468753955|FG000|Overall Study|Withdrawal by Subject|3|||
130216132|NCT02030119|468753956|FG001|Overall Study|Withdrawal by Subject|1|||
129995800|NCT02409368|467948107|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
129995801|NCT02409368|467948104|FG000|ECOG Reclassification|Death|1|||
129995802|NCT02409368|467948105|FG001|ECOG Reclassification|Death|5|||
129995803|NCT02409368|467948106|FG002|ECOG Reclassification|Death|0|||
129995804|NCT02409368|467948107|FG003|ECOG Reclassification|Death|0|||
129995805|NCT02409368|467948104|FG000|ECOG Reclassification|Disease Progression|113|||
129995806|NCT02409368|467948105|FG001|ECOG Reclassification|Disease Progression|382|||
129995807|NCT02409368|467948106|FG002|ECOG Reclassification|Disease Progression|70|||
129995808|NCT02409368|467948107|FG003|ECOG Reclassification|Disease Progression|1|||
129995809|NCT02409368|467948104|FG000|ECOG Reclassification|Lost to Follow-up|1|||
129995810|NCT02409368|467948105|FG001|ECOG Reclassification|Lost to Follow-up|5|||
129995811|NCT02409368|467948106|FG002|ECOG Reclassification|Lost to Follow-up|0|||
129995812|NCT02409368|467948107|FG003|ECOG Reclassification|Lost to Follow-up|0|||
129995813|NCT02409368|467948104|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
129995814|NCT02409368|467948105|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
129995815|NCT02409368|467948106|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
129995816|NCT02409368|467948107|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
129995817|NCT02409368|467948104|FG000|ECOG Reclassification|Poor/non-compliance|0|||
129995818|NCT02409368|467948105|FG001|ECOG Reclassification|Poor/non-compliance|3|||
129995819|NCT02409368|467948106|FG002|ECOG Reclassification|Poor/non-compliance|2|||
129995820|NCT02409368|467948107|FG003|ECOG Reclassification|Poor/non-compliance|0|||
129995821|NCT02409368|467948104|FG000|ECOG Reclassification|Study drug toxicity|17|||
129995822|NCT02409368|467948105|FG001|ECOG Reclassification|Study drug toxicity|42|||
129995823|NCT02409368|467948106|FG002|ECOG Reclassification|Study drug toxicity|7|||
129995824|NCT02409368|467948107|FG003|ECOG Reclassification|Study drug toxicity|0|||
129995825|NCT02409368|467948104|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
129995826|NCT02409368|467948105|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
129995827|NCT02409368|467948106|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
129995828|NCT02409368|467948107|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
129995829|NCT02409368|467948104|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
129995830|NCT02409368|467948105|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
129995831|NCT02409368|467948106|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
129995832|NCT02409368|467948107|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
129995833|NCT02409368|467948104|FG000|ECOG Reclassification|Participant withdrew consent|2|||
129995834|NCT02409368|467948105|FG001|ECOG Reclassification|Participant withdrew consent|3|||
129995835|NCT02409368|467948106|FG002|ECOG Reclassification|Participant withdrew consent|4|||
129995836|NCT02409368|467948107|FG003|ECOG Reclassification|Participant withdrew consent|0|||
129995837|NCT02409368|467948104|FG000|ECOG Reclassification|Other Reasons|5|||
129995838|NCT02409368|467948105|FG001|ECOG Reclassification|Other Reasons|26|||
129995839|NCT02409368|467948106|FG002|ECOG Reclassification|Other Reasons|2|||
129995840|NCT02409368|467948107|FG003|ECOG Reclassification|Other Reasons|0|||
129995841|NCT02409368|467948104|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
129995842|NCT02409368|467948105|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
129995843|NCT02409368|467948106|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
129995844|NCT02409368|467948107|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
129995845|NCT02041520|467948108|FG000|Overall Study|Adverse Event|2|||
129995846|NCT02041520|467948109|FG001|Overall Study|Adverse Event|1|||
129995847|NCT02041520|467948108|FG000|Overall Study|Withdrawal by Subject|3|||
129995848|NCT02041520|467948109|FG001|Overall Study|Withdrawal by Subject|4|||
129995849|NCT02041520|467948108|FG000|Overall Study|Protocol Violation|1|||
129995850|NCT02041520|467948109|FG001|Overall Study|Protocol Violation|0|||
129995851|NCT02041520|467948108|FG000|Overall Study|Lost to Follow-up|0|||
129995852|NCT02041520|467948109|FG001|Overall Study|Lost to Follow-up|1|||
129995853|NCT02041520|467948108|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
129995854|NCT02041520|467948109|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
129995855|NCT01759407|467948112|FG000|Overall Study|Protocol Violation|0|||
129995856|NCT01759407|467948113|FG001|Overall Study|Protocol Violation|2|||
129995857|NCT02678247|467948114|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
129995858|NCT02678247|467948115|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
129995859|NCT02678247|467948114|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
129995860|NCT02678247|467948115|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
129995861|NCT02678247|467948114|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
129995862|NCT02678247|467948115|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
129995863|NCT02678247|467948114|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
129995864|NCT02678247|467948115|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
129995865|NCT02678247|467948114|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
129995866|NCT02678247|467948115|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
129995867|NCT02678247|467948114|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
129995868|NCT02678247|467948115|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
129995869|NCT00026208|467948116|FG000|Overall Study|Complications of auto accident|1|||
129995870|NCT00026208|467948117|FG001|Overall Study|Complications of auto accident|0|||
129995871|NCT02225353|467948118|FG000|Overall Study|Lost to Follow-up|0|||
129995872|NCT02225353|467948119|FG001|Overall Study|Lost to Follow-up|1|||
129995873|NCT02225353|467948120|FG002|Overall Study|Lost to Follow-up|3|||
129995874|NCT02225353|467948118|FG000|Overall Study|Protocol Violation|4|||
129995875|NCT02225353|467948119|FG001|Overall Study|Protocol Violation|5|||
129995876|NCT02225353|467948120|FG002|Overall Study|Protocol Violation|12|||
129995877|NCT03604523|467948121|FG000|Overall Study|Physician Decision|1|||
129995878|NCT03604523|467948122|FG001|Overall Study|Physician Decision|0|||
129995879|NCT03442114|467948126|FG000|Overall Study|Lost to Follow-up|13|||
129995880|NCT03442114|467948127|FG001|Overall Study|Lost to Follow-up|13|||
129995881|NCT03442114|467948126|FG000|Overall Study|Physician Decision|2|||
129995882|NCT03442114|467948127|FG001|Overall Study|Physician Decision|2|||
129995883|NCT03442114|467948126|FG000|Overall Study|Protocol Violation|0|||
129995884|NCT03442114|467948127|FG001|Overall Study|Protocol Violation|2|||
129995885|NCT03442114|467948126|FG000|Overall Study|Withdrawal by Subject|1|||
129995886|NCT03442114|467948127|FG001|Overall Study|Withdrawal by Subject|3|||
129995887|NCT03442114|467948126|FG000|Overall Study|Guardianship Change|0|||
129995888|NCT03442114|467948127|FG001|Overall Study|Guardianship Change|1|||
129995889|NCT02903368|467948128|FG000|Part 1|Adverse Event|3|||
129995890|NCT02903368|467948129|FG001|Part 1|Adverse Event|0|||
129995891|NCT02903368|467948130|FG002|Part 1|Adverse Event|0|||
129995892|NCT02903368|467948131|FG003|Part 1|Adverse Event|0|||
129995893|NCT02903368|467948128|FG000|Part 1|Withdrawal by Subject|1|||
129995894|NCT02903368|467948129|FG001|Part 1|Withdrawal by Subject|0|||
129995895|NCT02903368|467948130|FG002|Part 1|Withdrawal by Subject|0|||
129995896|NCT02903368|467948131|FG003|Part 1|Withdrawal by Subject|0|||
129995897|NCT02903368|467948128|FG000|Part 2|Adverse Event|0|||
129995898|NCT02903368|467948129|FG001|Part 2|Adverse Event|0|||
129995899|NCT02903368|467948130|FG002|Part 2|Adverse Event|5|||
129995900|NCT02903368|467948131|FG003|Part 2|Adverse Event|0|||
129995901|NCT02903368|467948128|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
129995902|NCT02903368|467948129|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
129995903|NCT02903368|467948130|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
129995904|NCT02903368|467948131|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
129995905|NCT02903368|467948128|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
129995906|NCT02903368|467948129|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
129995907|NCT02903368|467948130|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
129995908|NCT02903368|467948131|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
129995909|NCT02903368|467948128|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
129995910|NCT02903368|467948129|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
129995911|NCT02903368|467948130|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
129995912|NCT02903368|467948131|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
129995913|NCT03588728|467949956|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
129995914|NCT03588728|467949957|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
129995915|NCT03588728|467949958|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
129995916|NCT03588728|467949959|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
129995917|NCT03588728|467949956|FG000|Overall Study|Lab shut down due to COVID-19|0|||
129995918|NCT03588728|467949957|FG001|Overall Study|Lab shut down due to COVID-19|0|||
129995919|NCT03588728|467949958|FG002|Overall Study|Lab shut down due to COVID-19|0|||
129995920|NCT03588728|467949959|FG003|Overall Study|Lab shut down due to COVID-19|1|||
129995921|NCT03588728|467949956|FG000|Overall Study|multiple technical issues|1|||
129995922|NCT03588728|467949957|FG001|Overall Study|multiple technical issues|0|||
129995923|NCT03588728|467949958|FG002|Overall Study|multiple technical issues|0|||
129995924|NCT03588728|467949959|FG003|Overall Study|multiple technical issues|0|||
129995925|NCT03588728|467949956|FG000|Overall Study|Hospitalized for COVID|1|||
129995926|NCT03588728|467949957|FG001|Overall Study|Hospitalized for COVID|0|||
129995927|NCT03588728|467949958|FG002|Overall Study|Hospitalized for COVID|0|||
129995928|NCT03588728|467949959|FG003|Overall Study|Hospitalized for COVID|0|||
129995929|NCT03588728|467949956|FG000|Overall Study|Schedule change unable to attend sessions|1|||
129995930|NCT03588728|467949957|FG001|Overall Study|Schedule change unable to attend sessions|0|||
129995931|NCT03588728|467949958|FG002|Overall Study|Schedule change unable to attend sessions|0|||
129995932|NCT03588728|467949959|FG003|Overall Study|Schedule change unable to attend sessions|0|||
129995933|NCT02027701|467949960|FG000|Overall Study|Adverse Event|3|||
129995934|NCT02027701|467949960|FG000|Overall Study|Lack of Efficacy|8|||
129995935|NCT02027701|467949960|FG000|Overall Study|Physician Decision|2|||
129995936|NCT02027701|467949960|FG000|Overall Study|Withdrawal by Subject|3|||
129995937|NCT02982187|467949961|FG000|Overall Study|Withdrawal by Subject|0|||
129995938|NCT02982187|467949962|FG001|Overall Study|Withdrawal by Subject|0|||
129995939|NCT02982187|467949963|FG002|Overall Study|Withdrawal by Subject|0|||
129995940|NCT02982187|467949964|FG003|Overall Study|Withdrawal by Subject|0|||
129995941|NCT02982187|467949965|FG004|Overall Study|Withdrawal by Subject|0|||
129995942|NCT02982187|467949966|FG005|Overall Study|Withdrawal by Subject|0|||
129995943|NCT02982187|467949967|FG006|Overall Study|Withdrawal by Subject|1|||
129995944|NCT02982187|467949968|FG007|Overall Study|Withdrawal by Subject|0|||
129995945|NCT00887679|467949969|FG000|Overall Study|Withdrawal by Subject|1|||
129995946|NCT00887679|467949969|FG000|Overall Study|Lost to Follow-up|4|||
129995947|NCT00887679|467949969|FG000|Overall Study|Physician Decision|5|||
129995948|NCT01026454|467949970|FG000|Second Intervention|Pregnancy|1|||
129995949|NCT01026454|467949971|FG001|Second Intervention|Pregnancy|1|||
129995950|NCT00394953|467949972|FG000|First Treatment Period|Adverse Event|1|||
129995951|NCT00394953|467949973|FG001|First Treatment Period|Adverse Event|2|||
129995952|NCT00394953|467949972|FG000|First Treatment Period|Death|6|||
129995953|NCT00394953|467949973|FG001|First Treatment Period|Death|7|||
129995954|NCT00394953|467949972|FG000|First Treatment Period|Lack of Efficacy|1|||
129995955|NCT00394953|467949973|FG001|First Treatment Period|Lack of Efficacy|1|||
129995956|NCT00394953|467949972|FG000|First Treatment Period|Withdrawal by Subject|6|||
129995957|NCT00394953|467949973|FG001|First Treatment Period|Withdrawal by Subject|3|||
129995958|NCT00394953|467949972|FG000|First Treatment Period|Lost to Follow-up|0|||
129995959|NCT00394953|467949973|FG001|First Treatment Period|Lost to Follow-up|1|||
129995960|NCT00394953|467949972|FG000|First Treatment Period|Renal transplant|11|||
129995961|NCT00394953|467949973|FG001|First Treatment Period|Renal transplant|7|||
129995962|NCT00394953|467949972|FG000|First Treatment Period|Not defined|4|||
129995963|NCT00394953|467949973|FG001|First Treatment Period|Not defined|1|||
129995964|NCT00394953|467949972|FG000|Second Treatment Period|Adverse Event|2|||
129995965|NCT00394953|467949973|FG001|Second Treatment Period|Adverse Event|5|||
129995966|NCT00394953|467949972|FG000|Second Treatment Period|Death|8|||
129995967|NCT00394953|467949973|FG001|Second Treatment Period|Death|4|||
129995968|NCT00394953|467949972|FG000|Second Treatment Period|Lack of Efficacy|9|||
129995969|NCT00394953|467949973|FG001|Second Treatment Period|Lack of Efficacy|47|||
129995970|NCT00394953|467949972|FG000|Second Treatment Period|Withdrawal by Subject|3|||
129995971|NCT00394953|467949973|FG001|Second Treatment Period|Withdrawal by Subject|3|||
129995972|NCT00394953|467949972|FG000|Second Treatment Period|Lost to Follow-up|0|||
129995973|NCT00394953|467949973|FG001|Second Treatment Period|Lost to Follow-up|1|||
129995974|NCT00394953|467949972|FG000|Second Treatment Period|Renal transplant|4|||
129995975|NCT00394953|467949973|FG001|Second Treatment Period|Renal transplant|6|||
129995976|NCT00394953|467949972|FG000|Second Treatment Period|Not defined|3|||
129995977|NCT00394953|467949973|FG001|Second Treatment Period|Not defined|8|||
129995978|NCT03181451|467949977|FG000|Overall Study|Adverse Event|0|||
129995979|NCT03181451|467949978|FG001|Overall Study|Adverse Event|1|||
129995980|NCT03181451|467949979|FG002|Overall Study|Adverse Event|0|||
129995981|NCT03181451|467949977|FG000|Overall Study|Withdrawal by Subject|0|||
129995982|NCT03181451|467949978|FG001|Overall Study|Withdrawal by Subject|1|||
129995983|NCT03181451|467949979|FG002|Overall Study|Withdrawal by Subject|0|||
129995984|NCT02196714|467949983|FG000|Overall Study|Protocol Violation|0|||
129995985|NCT02196714|467949984|FG001|Overall Study|Protocol Violation|0|||
129995986|NCT02196714|467949985|FG002|Overall Study|Protocol Violation|1|||
129995987|NCT02196714|467949986|FG003|Overall Study|Protocol Violation|0|||
129995988|NCT01326533|467949993|FG000|Overall Study|Lost to Follow-up|2|||
129995989|NCT01326533|467949994|FG001|Overall Study|Lost to Follow-up|0|||
129995990|NCT01326533|467949993|FG000|Overall Study|Withdrawal by Subject|1|||
129995991|NCT01326533|467949994|FG001|Overall Study|Withdrawal by Subject|0|||
129995992|NCT01326533|467949993|FG000|Overall Study|Adverse Event|1|||
129995993|NCT01326533|467949994|FG001|Overall Study|Adverse Event|0|||
129995994|NCT04079803|467949995|FG000|Overall Study|Withdrawal by Subject|0|||
129995995|NCT04079803|467949996|FG001|Overall Study|Withdrawal by Subject|0|||
129995996|NCT04079803|467949997|FG002|Overall Study|Withdrawal by Subject|1|||
129995997|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
129995998|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
129995999|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
129996000|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
129996001|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
129996002|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
129996003|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
129996004|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
129996005|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
130334830|NCT02474069|469195581|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
130334831|NCT02474069|469195579|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
130334832|NCT02474069|469195580|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
129996006|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
129996007|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
129996008|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
129996009|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
129996010|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
129996011|NCT01294683|467949998|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
129996012|NCT01294683|467949999|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
129996013|NCT01294683|467949998|FG000|Post Crossover (Period III)|Adverse Event|6|||
129996014|NCT01294683|467949999|FG001|Post Crossover (Period III)|Adverse Event|6|||
129996015|NCT01294683|467949998|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
129996016|NCT01294683|467949999|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
129996017|NCT01294683|467949998|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
129996018|NCT01294683|467949999|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
129996019|NCT01294683|467949998|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
129996020|NCT01294683|467949999|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
129996021|NCT01881750|467950000|FG000|Overall Study|Changes in concomitant therapies|2|||
129996022|NCT01881750|467950001|FG001|Overall Study|Changes in concomitant therapies|3|||
129996023|NCT01881750|467950000|FG000|Overall Study|Lost to Follow-up|0|||
129996024|NCT01881750|467950001|FG001|Overall Study|Lost to Follow-up|1|||
129996025|NCT00926211|467950003|FG000|Overall Study|Lost to Follow-up|1|||
129996026|NCT01585987|467950006|FG000|Randomized|Withdrawal by Subject|0|||
129996027|NCT01585987|467950007|FG001|Randomized|Withdrawal by Subject|4|||
129996028|NCT01585987|467950006|FG000|Randomized|No longer met criteria|0|||
129996029|NCT01585987|467950007|FG001|Randomized|No longer met criteria|2|||
129996030|NCT01585987|467950006|FG000|Treated|Disease Progression|39|||
129996031|NCT01585987|467950007|FG001|Treated|Disease Progression|36|||
129996032|NCT01585987|467950006|FG000|Treated|Study Drug Toxicity|9|||
129996033|NCT01585987|467950007|FG001|Treated|Study Drug Toxicity|5|||
129996034|NCT01585987|467950006|FG000|Treated|Adverse Event|3|||
129996035|NCT01585987|467950007|FG001|Treated|Adverse Event|0|||
129996036|NCT01585987|467950006|FG000|Treated|Withdrawal by Subject|1|||
129996037|NCT01585987|467950007|FG001|Treated|Withdrawal by Subject|2|||
129996038|NCT01585987|467950006|FG000|Treated|Death|1|||
129996039|NCT01585987|467950007|FG001|Treated|Death|0|||
129996040|NCT01585987|467950006|FG000|Treated|Lost to Follow-up|0|||
129996041|NCT01585987|467950007|FG001|Treated|Lost to Follow-up|1|||
129996042|NCT01585987|467950006|FG000|Treated|Maximum Clinical Benefit|0|||
129996043|NCT01585987|467950007|FG001|Treated|Maximum Clinical Benefit|1|||
129996044|NCT01585987|467950006|FG000|Treated|Non-Specified|1|||
129996045|NCT01585987|467950007|FG001|Treated|Non-Specified|2|||
129996046|NCT01585987|467950006|FG000|Treated|Subject Request|0|||
129996047|NCT01585987|467950007|FG001|Treated|Subject Request|1|||
129996048|NCT01585987|467950006|FG000|Treated|Poor/Non-Compliance|0|||
129996049|NCT01585987|467950007|FG001|Treated|Poor/Non-Compliance|1|||
129996050|NCT00413972|467950011|FG000|Overall Study|Adverse Event|2|||
129996051|NCT00413972|467950012|FG001|Overall Study|Adverse Event|1|||
129996052|NCT00413972|467950013|FG002|Overall Study|Adverse Event|0|||
129996053|NCT00413972|467950014|FG003|Overall Study|Adverse Event|0|||
129996054|NCT00413972|467950011|FG000|Overall Study|Lost to Follow-up|1|||
129996055|NCT00413972|467950012|FG001|Overall Study|Lost to Follow-up|2|||
129996056|NCT00413972|467950013|FG002|Overall Study|Lost to Follow-up|1|||
129996057|NCT00413972|467950014|FG003|Overall Study|Lost to Follow-up|0|||
129996058|NCT00413972|467950011|FG000|Overall Study|Withdrawal by Subject|4|||
129996059|NCT00413972|467950012|FG001|Overall Study|Withdrawal by Subject|5|||
129996060|NCT00413972|467950013|FG002|Overall Study|Withdrawal by Subject|7|||
129996061|NCT00413972|467950014|FG003|Overall Study|Withdrawal by Subject|2|||
129996062|NCT00413972|467950011|FG000|Overall Study|Protocol Violation|0|||
129996063|NCT00413972|467950012|FG001|Overall Study|Protocol Violation|0|||
129996064|NCT00413972|467950013|FG002|Overall Study|Protocol Violation|2|||
129996065|NCT00413972|467950014|FG003|Overall Study|Protocol Violation|0|||
129996066|NCT00413972|467950011|FG000|Overall Study|Other|0|||
129996067|NCT00413972|467950012|FG001|Overall Study|Other|0|||
129996068|NCT00413972|467950013|FG002|Overall Study|Other|0|||
129996069|NCT00413972|467950014|FG003|Overall Study|Other|1|||
129996070|NCT03737474|467950015|FG000|Overall Study|Adverse Event|18|||
129996071|NCT03737474|467950016|FG001|Overall Study|Adverse Event|48|||
129996072|NCT03737474|467950015|FG000|Overall Study|Lack of Efficacy|1|||
129996073|NCT03737474|467950016|FG001|Overall Study|Lack of Efficacy|3|||
129996074|NCT03737474|467950015|FG000|Overall Study|Protocol Violation|0|||
129996075|NCT03737474|467950016|FG001|Overall Study|Protocol Violation|8|||
129996076|NCT03737474|467950015|FG000|Overall Study|Withdrawal by Subject|5|||
129996077|NCT03737474|467950016|FG001|Overall Study|Withdrawal by Subject|20|||
129996078|NCT03737474|467950015|FG000|Overall Study|Non-compliance With Study Drug|0|||
129996079|NCT03737474|467950016|FG001|Overall Study|Non-compliance With Study Drug|1|||
129996080|NCT03737474|467950015|FG000|Overall Study|Physician Decision|1|||
129996081|NCT03737474|467950016|FG001|Overall Study|Physician Decision|4|||
129996082|NCT02513745|467950017|FG000|Overall Study|Criteria at time of surgery not met.|3|||
129996083|NCT02513745|467950018|FG001|Overall Study|Criteria at time of surgery not met.|3|||
129996084|NCT01209143|467950019|FG000|Overall Study|Adverse Event|2|||
129996085|NCT01209143|467950020|FG001|Overall Study|Adverse Event|1|||
129996086|NCT01209143|467950019|FG000|Overall Study|Death|0|||
129996087|NCT01209143|467950020|FG001|Overall Study|Death|1|||
129996088|NCT01209143|467950019|FG000|Overall Study|Physician Decision|3|||
129996089|NCT01209143|467950020|FG001|Overall Study|Physician Decision|1|||
129996090|NCT01209143|467950019|FG000|Overall Study|Lost to Follow-up|1|||
129996091|NCT01209143|467950020|FG001|Overall Study|Lost to Follow-up|0|||
129996092|NCT01209143|467950019|FG000|Overall Study|Withdrawal by Subject|2|||
129996093|NCT01209143|467950020|FG001|Overall Study|Withdrawal by Subject|1|||
129996094|NCT01209143|467950019|FG000|Overall Study|Disease progression|11|||
129996095|NCT01209143|467950020|FG001|Overall Study|Disease progression|16|||
129996096|NCT01145755|467950021|FG000|Overall Study|Adverse Event|2|||
129996097|NCT01145755|467950022|FG001|Overall Study|Adverse Event|4|||
129996098|NCT01145755|467950023|FG002|Overall Study|Adverse Event|2|||
129996099|NCT01145755|467950021|FG000|Overall Study|Withdrawal by Subject|2|||
129996100|NCT01145755|467950022|FG001|Overall Study|Withdrawal by Subject|2|||
129996101|NCT01145755|467950023|FG002|Overall Study|Withdrawal by Subject|2|||
129996102|NCT01145755|467950021|FG000|Overall Study|Lost to Follow-up|2|||
129996103|NCT01145755|467950022|FG001|Overall Study|Lost to Follow-up|3|||
129996104|NCT01145755|467950023|FG002|Overall Study|Lost to Follow-up|1|||
129996105|NCT01145755|467950021|FG000|Overall Study|Protocol Violation|0|||
129996106|NCT01145755|467950022|FG001|Overall Study|Protocol Violation|3|||
129996107|NCT01145755|467950023|FG002|Overall Study|Protocol Violation|1|||
129996108|NCT01145755|467950021|FG000|Overall Study|Study Closure|14|||
129996109|NCT01145755|467950022|FG001|Overall Study|Study Closure|14|||
129996110|NCT01145755|467950023|FG002|Overall Study|Study Closure|17|||
129996111|NCT01145755|467950021|FG000|Overall Study|Lack of Efficacy|0|||
129996112|NCT01145755|467950022|FG001|Overall Study|Lack of Efficacy|1|||
129996113|NCT01145755|467950023|FG002|Overall Study|Lack of Efficacy|0|||
129996114|NCT01145755|467950021|FG000|Overall Study|Patient could not swollow medication|0|||
129996115|NCT01145755|467950022|FG001|Overall Study|Patient could not swollow medication|0|||
129996116|NCT01145755|467950023|FG002|Overall Study|Patient could not swollow medication|1|||
129996117|NCT01145755|467950021|FG000|Overall Study|Withdrawal by Subject|0|||
129996118|NCT01145755|467950022|FG001|Overall Study|Withdrawal by Subject|0|||
129996119|NCT01145755|467950023|FG002|Overall Study|Withdrawal by Subject|1|||
129996120|NCT01145755|467950021|FG000|Overall Study|Positive urine ethanol|0|||
129996121|NCT01145755|467950022|FG001|Overall Study|Positive urine ethanol|1|||
129996122|NCT01145755|467950023|FG002|Overall Study|Positive urine ethanol|0|||
129996123|NCT01139658|467950031|FG000|Overall Study|Adverse Event|10|||
129996124|NCT01139658|467950032|FG001|Overall Study|Adverse Event|27|||
129996125|NCT01139658|467950031|FG000|Overall Study|Lack of Efficacy|15|||
129996126|NCT01139658|467950032|FG001|Overall Study|Lack of Efficacy|7|||
129996127|NCT01139658|467950031|FG000|Overall Study|Withdrawal by Subject|2|||
129996128|NCT01139658|467950032|FG001|Overall Study|Withdrawal by Subject|4|||
129996129|NCT01139658|467950031|FG000|Overall Study|No documentation of treatment|1|||
129996130|NCT01139658|467950032|FG001|Overall Study|No documentation of treatment|0|||
129996131|NCT01139658|467950031|FG000|Overall Study|Other|28|||
129996132|NCT01139658|467950032|FG001|Overall Study|Other|75|||
129996133|NCT00753272|467950038|FG000|Overall Study|Adverse Event|878|||
129996134|NCT00753272|467950039|FG001|Overall Study|Adverse Event|869|||
129996135|NCT00753272|467950038|FG000|Overall Study|Protocol Violation|28|||
129996136|NCT00753272|467950039|FG001|Overall Study|Protocol Violation|46|||
129996137|NCT00753272|467950038|FG000|Overall Study|Withdrawal by Subject|2481|||
129996138|NCT00753272|467950039|FG001|Overall Study|Withdrawal by Subject|2407|||
129996139|NCT00753272|467950038|FG000|Overall Study|Lost to Follow-up|491|||
129996140|NCT00753272|467950039|FG001|Overall Study|Lost to Follow-up|497|||
129996141|NCT00753272|467950038|FG000|Overall Study|Other|1104|||
129996142|NCT00753272|467950039|FG001|Overall Study|Other|1088|||
129996143|NCT00971243|467950040|FG000|Double Blind Period|Adverse Event|2|||
129996144|NCT00971243|467950041|FG001|Double Blind Period|Adverse Event|3|||
129996145|NCT00971243|467950042|FG002|Double Blind Period|Adverse Event|2|||
129996146|NCT00971243|467950043|FG003|Double Blind Period|Adverse Event|2|||
129996147|NCT00971243|467950044|FG004|Double Blind Period|Adverse Event|3|||
129996148|NCT00971243|467950040|FG000|Double Blind Period|Lost to Follow-up|0|||
129996149|NCT00971243|467950041|FG001|Double Blind Period|Lost to Follow-up|1|||
129996150|NCT00971243|467950042|FG002|Double Blind Period|Lost to Follow-up|1|||
129996151|NCT00971243|467950043|FG003|Double Blind Period|Lost to Follow-up|0|||
129996152|NCT00971243|467950044|FG004|Double Blind Period|Lost to Follow-up|1|||
129996153|NCT00971243|467950040|FG000|Double Blind Period|Physician Decision|10|||
129996154|NCT00971243|467950041|FG001|Double Blind Period|Physician Decision|6|||
129996155|NCT00971243|467950042|FG002|Double Blind Period|Physician Decision|7|||
129996156|NCT00971243|467950043|FG003|Double Blind Period|Physician Decision|6|||
129996157|NCT00971243|467950044|FG004|Double Blind Period|Physician Decision|7|||
129996158|NCT00971243|467950040|FG000|Double Blind Period|Protocol Violation|2|||
129996159|NCT00971243|467950041|FG001|Double Blind Period|Protocol Violation|0|||
129996160|NCT00971243|467950042|FG002|Double Blind Period|Protocol Violation|3|||
129996161|NCT00971243|467950043|FG003|Double Blind Period|Protocol Violation|2|||
129996162|NCT00971243|467950044|FG004|Double Blind Period|Protocol Violation|2|||
129996163|NCT00971243|467950040|FG000|Double Blind Period|Withdrawal by Subject|4|||
129996164|NCT00971243|467950041|FG001|Double Blind Period|Withdrawal by Subject|1|||
129996165|NCT00971243|467950042|FG002|Double Blind Period|Withdrawal by Subject|4|||
129996166|NCT00971243|467950043|FG003|Double Blind Period|Withdrawal by Subject|4|||
129996167|NCT00971243|467950044|FG004|Double Blind Period|Withdrawal by Subject|4|||
129996168|NCT00971243|467950040|FG000|Double Blind Period|Other reasons|1|||
129996169|NCT00971243|467950041|FG001|Double Blind Period|Other reasons|0|||
129996170|NCT00971243|467950042|FG002|Double Blind Period|Other reasons|2|||
129996171|NCT00971243|467950043|FG003|Double Blind Period|Other reasons|0|||
129996172|NCT00971243|467950044|FG004|Double Blind Period|Other reasons|1|||
129996173|NCT00971243|467950040|FG000|Open-label Period|Adverse Event|1|||
129996174|NCT00971243|467950041|FG001|Open-label Period|Adverse Event|0|||
129996175|NCT00971243|467950042|FG002|Open-label Period|Adverse Event|1|||
129996176|NCT00971243|467950043|FG003|Open-label Period|Adverse Event|1|||
129996177|NCT00971243|467950044|FG004|Open-label Period|Adverse Event|0|||
129996178|NCT00971243|467950040|FG000|Open-label Period|Physician Decision|5|||
129996179|NCT00971243|467950041|FG001|Open-label Period|Physician Decision|9|||
129996180|NCT00971243|467950042|FG002|Open-label Period|Physician Decision|3|||
129996181|NCT00971243|467950043|FG003|Open-label Period|Physician Decision|7|||
129996182|NCT00971243|467950044|FG004|Open-label Period|Physician Decision|2|||
129996183|NCT00971243|467950040|FG000|Open-label Period|Protocol Violation|1|||
129996184|NCT00971243|467950041|FG001|Open-label Period|Protocol Violation|1|||
129996185|NCT00971243|467950042|FG002|Open-label Period|Protocol Violation|1|||
129996186|NCT00971243|467950043|FG003|Open-label Period|Protocol Violation|0|||
129996187|NCT00971243|467950044|FG004|Open-label Period|Protocol Violation|1|||
129996188|NCT00971243|467950040|FG000|Open-label Period|Withdrawal by Subject|1|||
129996189|NCT00971243|467950041|FG001|Open-label Period|Withdrawal by Subject|0|||
129996190|NCT00971243|467950042|FG002|Open-label Period|Withdrawal by Subject|0|||
129996191|NCT00971243|467950043|FG003|Open-label Period|Withdrawal by Subject|2|||
129996192|NCT00971243|467950044|FG004|Open-label Period|Withdrawal by Subject|1|||
129996193|NCT00971243|467950040|FG000|Open-label Period|Other reason|0|||
129996194|NCT00971243|467950041|FG001|Open-label Period|Other reason|0|||
129996195|NCT00971243|467950042|FG002|Open-label Period|Other reason|0|||
129996196|NCT00971243|467950043|FG003|Open-label Period|Other reason|0|||
129996197|NCT00971243|467950044|FG004|Open-label Period|Other reason|2|||
129996198|NCT02092220|467950046|FG000|Period 1|Unrelated Illness|0|||
129996199|NCT02092220|467950047|FG001|Period 1|Unrelated Illness|2|||
129996200|NCT02092220|467950046|FG000|Period 2|Severe Hypoglycaemia|1|||
129996201|NCT02092220|467950047|FG001|Period 2|Severe Hypoglycaemia|0|||
129996202|NCT02092220|467950046|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
129996203|NCT02092220|467950047|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
129996204|NCT03170154|467950050|FG000|Overall Study|Lost to Follow-up|4|||
129996205|NCT03170154|467950050|FG000|Overall Study|Death|2|||
129996206|NCT03170154|467950050|FG000|Overall Study|Withdrawal by Subject|2|||
129996207|NCT05266586|467950051|FG000|Overall Study|Adverse Event|2|||
129996208|NCT05266586|467950052|FG001|Overall Study|Adverse Event|2|||
129996209|NCT05266586|467950053|FG002|Overall Study|Adverse Event|1|||
129996210|NCT05266586|467950051|FG000|Overall Study|Withdrawal by Subject|1|||
129996211|NCT05266586|467950052|FG001|Overall Study|Withdrawal by Subject|0|||
129996212|NCT05266586|467950053|FG002|Overall Study|Withdrawal by Subject|1|||
129996213|NCT05266586|467950051|FG000|Overall Study|Non-compliance with study drug|0|||
129996214|NCT05266586|467950052|FG001|Overall Study|Non-compliance with study drug|1|||
129996215|NCT05266586|467950053|FG002|Overall Study|Non-compliance with study drug|0|||
129996216|NCT05266586|467950051|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
129996217|NCT05266586|467950052|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
129996218|NCT05266586|467950053|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
129996219|NCT01117857|467950054|FG000|Overall Study|Lost to Follow-up|4|||
129996220|NCT01117857|467950054|FG000|Overall Study|Withdrawal by Subject|4|||
129996221|NCT01117857|467950054|FG000|Overall Study|Physician Decision|1|||
129996222|NCT00633061|467950055|FG000|Overall Study|Study closed|86|||
129996223|NCT00633061|467950056|FG001|Overall Study|Study closed|0|||
129996224|NCT05245097|467950057|FG000|Overall Study|Adverse Event|13|||
129996225|NCT05245097|467950058|FG001|Overall Study|Adverse Event|2|||
129996226|NCT05245097|467950057|FG000|Overall Study|Protocol Violation|8|||
129996227|NCT05245097|467950058|FG001|Overall Study|Protocol Violation|6|||
129996228|NCT05245097|467950057|FG000|Overall Study|Withdrawal by Subject|18|||
129996229|NCT05245097|467950058|FG001|Overall Study|Withdrawal by Subject|0|||
129996230|NCT05245097|467950057|FG000|Overall Study|Death|6|||
129996231|NCT05245097|467950058|FG001|Overall Study|Death|7|||
129996232|NCT05245097|467950057|FG000|Overall Study|Physician Decision|6|||
129996233|NCT05245097|467950058|FG001|Overall Study|Physician Decision|0|||
129996234|NCT05245097|467950057|FG000|Overall Study|Relocation|4|||
129996235|NCT05245097|467950058|FG001|Overall Study|Relocation|3|||
129996236|NCT00607022|467950066|FG000|Overall Study|Withdrawal by Subject|1|||
129996237|NCT00607022|467950067|FG001|Overall Study|Withdrawal by Subject|0|||
129996238|NCT00607022|467950068|FG002|Overall Study|Withdrawal by Subject|0|||
129996239|NCT02730598|467950071|FG000|Overall Study|Withdrawal by Subject|3|||
129996240|NCT02730598|467950072|FG001|Overall Study|Withdrawal by Subject|3|||
129996241|NCT02730598|467950071|FG000|Overall Study|Protocol Violation|0|||
129996242|NCT02730598|467950072|FG001|Overall Study|Protocol Violation|1|||
129996243|NCT02730598|467950071|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
129996244|NCT02730598|467950072|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
129996245|NCT03282240|467950073|FG000|Overall Study|Adverse Event|2|||
129996246|NCT03282240|467950074|FG001|Overall Study|Adverse Event|2|||
129996247|NCT03282240|467950075|FG002|Overall Study|Adverse Event|0|||
129996248|NCT03282240|467950073|FG000|Overall Study|Lost to Follow-up|3|||
129996249|NCT03282240|467950074|FG001|Overall Study|Lost to Follow-up|0|||
129996250|NCT03282240|467950075|FG002|Overall Study|Lost to Follow-up|0|||
129996251|NCT03282240|467950073|FG000|Overall Study|Protocol Deviation|4|||
129996252|NCT03282240|467950074|FG001|Overall Study|Protocol Deviation|1|||
129996253|NCT03282240|467950075|FG002|Overall Study|Protocol Deviation|2|||
129996254|NCT03282240|467950073|FG000|Overall Study|Withdrawal by Subject|1|||
129996255|NCT03282240|467950074|FG001|Overall Study|Withdrawal by Subject|0|||
129996256|NCT03282240|467950075|FG002|Overall Study|Withdrawal by Subject|1|||
129996257|NCT01675479|467950076|FG000|Overall Study|Lost to Follow-up|11|||
129996258|NCT03254485|467950077|FG000|Overall Study|Adverse Event|3|||
129996259|NCT03254485|467950078|FG001|Overall Study|Adverse Event|0|||
129996260|NCT03254485|467950079|FG002|Overall Study|Adverse Event|0|||
129996261|NCT03254485|467950080|FG003|Overall Study|Adverse Event|6|||
129996262|NCT03254485|467950077|FG000|Overall Study|Protocol Violation|6|||
129996263|NCT03254485|467950078|FG001|Overall Study|Protocol Violation|0|||
129996264|NCT03254485|467950079|FG002|Overall Study|Protocol Violation|0|||
129996265|NCT03254485|467950080|FG003|Overall Study|Protocol Violation|2|||
129996266|NCT03254485|467950077|FG000|Overall Study|Withdrawal by Subject|1|||
129996267|NCT03254485|467950078|FG001|Overall Study|Withdrawal by Subject|0|||
129996268|NCT03254485|467950079|FG002|Overall Study|Withdrawal by Subject|0|||
129996269|NCT03254485|467950080|FG003|Overall Study|Withdrawal by Subject|4|||
129996270|NCT03254485|467950077|FG000|Overall Study|Death|0|||
129996271|NCT03254485|467950078|FG001|Overall Study|Death|0|||
129996272|NCT03254485|467950079|FG002|Overall Study|Death|0|||
129996273|NCT03254485|467950080|FG003|Overall Study|Death|1|||
129996274|NCT03254485|467950077|FG000|Overall Study|Lost to Follow-up|1|||
129996275|NCT03254485|467950078|FG001|Overall Study|Lost to Follow-up|0|||
129996276|NCT03254485|467950079|FG002|Overall Study|Lost to Follow-up|0|||
129996277|NCT03254485|467950080|FG003|Overall Study|Lost to Follow-up|0|||
129996278|NCT03254485|467950077|FG000|Overall Study|Other|1|||
129996279|NCT03254485|467950078|FG001|Overall Study|Other|0|||
129996280|NCT03254485|467950079|FG002|Overall Study|Other|0|||
129996281|NCT03254485|467950080|FG003|Overall Study|Other|2|||
129996282|NCT02146326|467950081|FG000|Overall Study|Lost to Follow-up|3|||
129996283|NCT02146326|467950082|FG001|Overall Study|Lost to Follow-up|3|||
129996284|NCT02146326|467950083|FG002|Overall Study|Lost to Follow-up|11|||
129996285|NCT02146326|467950084|FG003|Overall Study|Lost to Follow-up|19|||
129996286|NCT02146326|467950081|FG000|Overall Study|Withdrawal by Subject|2|||
129996287|NCT02146326|467950082|FG001|Overall Study|Withdrawal by Subject|1|||
129996288|NCT02146326|467950083|FG002|Overall Study|Withdrawal by Subject|15|||
130334833|NCT02474069|469195581|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
130334834|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
130334835|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
130334836|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
130334837|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
130334838|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
130334839|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
130334840|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
130334841|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
130334842|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
130334843|NCT02474069|469195579|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
130334844|NCT02474069|469195580|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
130334845|NCT02474069|469195581|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
130334846|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
130334847|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
130334848|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
130334849|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
130334850|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
130334851|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
130334852|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
130334853|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
130334854|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
130334855|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
130334856|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
130334857|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
130334858|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
129996289|NCT02146326|467950084|FG003|Overall Study|Withdrawal by Subject|11|||
129996290|NCT02146326|467950081|FG000|Overall Study|Separated from mental health center|23|||
129996291|NCT02146326|467950082|FG001|Overall Study|Separated from mental health center|33|||
129996292|NCT02146326|467950083|FG002|Overall Study|Separated from mental health center|0|||
129996293|NCT02146326|467950084|FG003|Overall Study|Separated from mental health center|0|||
129996294|NCT02146326|467950081|FG000|Overall Study|Incarcerated|0|||
129996295|NCT02146326|467950082|FG001|Overall Study|Incarcerated|0|||
129996296|NCT02146326|467950083|FG002|Overall Study|Incarcerated|3|||
129996297|NCT02146326|467950084|FG003|Overall Study|Incarcerated|8|||
129996298|NCT02146326|467950081|FG000|Overall Study|Death|0|||
129996299|NCT02146326|467950082|FG001|Overall Study|Death|0|||
129996300|NCT02146326|467950083|FG002|Overall Study|Death|4|||
129996301|NCT02146326|467950084|FG003|Overall Study|Death|4|||
129996302|NCT02146326|467950081|FG000|Overall Study|Unable to complete interview|0|||
129996303|NCT02146326|467950082|FG001|Overall Study|Unable to complete interview|0|||
129996304|NCT02146326|467950083|FG002|Overall Study|Unable to complete interview|10|||
129996305|NCT02146326|467950084|FG003|Overall Study|Unable to complete interview|6|||
129996306|NCT02910739|467950085|FG000|Overall Study|Adverse Event|1|||
129996307|NCT02910739|467950086|FG001|Overall Study|Adverse Event|0|||
129996308|NCT02910739|467950087|FG002|Overall Study|Adverse Event|0|||
129996309|NCT02910739|467950088|FG003|Overall Study|Adverse Event|0|||
129996310|NCT01340651|467950090|FG000|Overall Study|Adverse Event|3|||
129996311|NCT01340651|467950090|FG000|Overall Study|Consent Withdrawn|2|||
129996312|NCT01340651|467950090|FG000|Overall Study|Commercial Supply per Sponsor|12|||
129996313|NCT01696942|467950095|FG000|Overall Study|Withdrawal by Subject|1|||
129996314|NCT01696942|467950096|FG001|Overall Study|Withdrawal by Subject|0|||
129996315|NCT01696942|467950095|FG000|Overall Study|Protocol Violation|1|||
129996316|NCT01696942|467950096|FG001|Overall Study|Protocol Violation|2|||
129996317|NCT01696942|467950095|FG000|Overall Study|screen failure|0|||
129996318|NCT01696942|467950096|FG001|Overall Study|screen failure|1|||
129996319|NCT01598311|467950101|FG000|Overall Study|Physician Decision|4|||
129996320|NCT01598311|467950102|FG001|Overall Study|Physician Decision|5|||
129996321|NCT01598311|467950101|FG000|Overall Study|Adverse Event|9|||
129996322|NCT01598311|467950102|FG001|Overall Study|Adverse Event|13|||
129996323|NCT01598311|467950101|FG000|Overall Study|Lost to Follow-up|7|||
129996324|NCT01598311|467950102|FG001|Overall Study|Lost to Follow-up|12|||
129996325|NCT01598311|467950101|FG000|Overall Study|Withdrawal by Subject|9|||
129996326|NCT01598311|467950102|FG001|Overall Study|Withdrawal by Subject|13|||
129996327|NCT01598311|467950101|FG000|Overall Study|No reason provided.|0|||
129996328|NCT01598311|467950102|FG001|Overall Study|No reason provided.|5|||
129996329|NCT01598311|467950101|FG000|Overall Study|Randomized but never treated|8|||
129996330|NCT01598311|467950102|FG001|Overall Study|Randomized but never treated|5|||
129996331|NCT01598311|467950101|FG000|Overall Study|Treated but no confirmed CDAD|9|||
129996332|NCT01598311|467950102|FG001|Overall Study|Treated but no confirmed CDAD|8|||
129996333|NCT01598311|467950101|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
129996334|NCT01598311|467950102|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
129996335|NCT00688103|467950103|FG000|Overall Study|Adverse Event|4|||
129996336|NCT00688103|467950104|FG001|Overall Study|Adverse Event|1|||
129996337|NCT00688103|467950103|FG000|Overall Study|Lack of Efficacy|11|||
129996338|NCT00688103|467950104|FG001|Overall Study|Lack of Efficacy|1|||
129996339|NCT00688103|467950103|FG000|Overall Study|Withdrawal by Subject|4|||
129996340|NCT00688103|467950104|FG001|Overall Study|Withdrawal by Subject|2|||
129996341|NCT00688103|467950103|FG000|Overall Study|complex reasons|11|||
129996342|NCT00688103|467950104|FG001|Overall Study|complex reasons|9|||
129996343|NCT01313117|467950105|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
129996344|NCT01313117|467950105|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
129996345|NCT03602261|467950108|FG000|Overall Study|Adverse Event|5|||
129996346|NCT03602261|467950109|FG001|Overall Study|Adverse Event|1|||
129996347|NCT03602261|467950108|FG000|Overall Study|Physician Decision|1|||
129996348|NCT03602261|467950109|FG001|Overall Study|Physician Decision|0|||
129996349|NCT03602261|467950108|FG000|Overall Study|Withdrawal by Subject|1|||
129996350|NCT03602261|467950109|FG001|Overall Study|Withdrawal by Subject|1|||
129996351|NCT03602261|467950108|FG000|Overall Study|Lack of Efficacy|0|||
129996352|NCT03602261|467950109|FG001|Overall Study|Lack of Efficacy|1|||
129996353|NCT03602261|467950108|FG000|Overall Study|Subject moving out of state|1|||
129996354|NCT03602261|467950109|FG001|Overall Study|Subject moving out of state|0|||
129996355|NCT05677893|467951833|FG000|Overall Study|Withdrawal by Subject|0|||
129996356|NCT05677893|467951834|FG001|Overall Study|Withdrawal by Subject|0|||
129996357|NCT05677893|467951835|FG002|Overall Study|Withdrawal by Subject|0|||
129996358|NCT05677893|467951836|FG003|Overall Study|Withdrawal by Subject|0|||
129996359|NCT05677893|467951837|FG004|Overall Study|Withdrawal by Subject|1|||
129996360|NCT05677893|467951838|FG005|Overall Study|Withdrawal by Subject|1|||
129996361|NCT05677893|467951839|FG006|Overall Study|Withdrawal by Subject|0|||
129996362|NCT05677893|467951833|FG000|Overall Study|Others|1|||
129996363|NCT05677893|467951834|FG001|Overall Study|Others|0|||
129996364|NCT05677893|467951835|FG002|Overall Study|Others|0|||
129996365|NCT05677893|467951836|FG003|Overall Study|Others|0|||
129996366|NCT05677893|467951837|FG004|Overall Study|Others|0|||
129996367|NCT05677893|467951838|FG005|Overall Study|Others|0|||
129996368|NCT05677893|467951839|FG006|Overall Study|Others|0|||
129996369|NCT01485354|467951842|FG000|Overall Study|Withdrawal by Subject|5|||
129996370|NCT02101034|467951843|FG000|Overall Study|Enrolled but did not start treatment|0|||
129996371|NCT02101034|467951844|FG001|Overall Study|Enrolled but did not start treatment|0|||
129996372|NCT02101034|467951845|FG002|Overall Study|Enrolled but did not start treatment|1|||
129996373|NCT02101034|467951846|FG003|Overall Study|Enrolled but did not start treatment|0|||
129996374|NCT02101034|467951847|FG004|Overall Study|Enrolled but did not start treatment|0|||
129996375|NCT01103245|467951852|FG000|Overall Study|Withdrawal by Subject|1|||
129996376|NCT01103245|467951853|FG001|Overall Study|Withdrawal by Subject|0|||
129996377|NCT01103245|467951854|FG002|Overall Study|Withdrawal by Subject|3|||
129996378|NCT01103245|467951855|FG003|Overall Study|Withdrawal by Subject|0|||
129996379|NCT01103245|467951852|FG000|Overall Study|Inadequate IV access|1|||
129996380|NCT01103245|467951853|FG001|Overall Study|Inadequate IV access|0|||
129996381|NCT01103245|467951854|FG002|Overall Study|Inadequate IV access|0|||
129996382|NCT01103245|467951855|FG003|Overall Study|Inadequate IV access|0|||
129996383|NCT01103245|467951852|FG000|Overall Study|Adverse Event|0|||
129996384|NCT01103245|467951853|FG001|Overall Study|Adverse Event|2|||
129996385|NCT01103245|467951854|FG002|Overall Study|Adverse Event|1|||
129996386|NCT01103245|467951855|FG003|Overall Study|Adverse Event|0|||
129996387|NCT01103245|467951852|FG000|Overall Study|Physician Decision|1|||
129996388|NCT01103245|467951853|FG001|Overall Study|Physician Decision|0|||
129996389|NCT01103245|467951854|FG002|Overall Study|Physician Decision|0|||
129996390|NCT01103245|467951855|FG003|Overall Study|Physician Decision|0|||
129996391|NCT01101477|467951857|FG000|Overall Study|Protocol Violation|5|||
129996392|NCT01101477|467951858|FG001|Overall Study|Protocol Violation|3|||
129996393|NCT01101477|467951859|FG002|Overall Study|Protocol Violation|1|||
129996394|NCT00720941|467951860|FG000|Overall Study|Protocol Violation|1|||
129996395|NCT00720941|467951861|FG001|Overall Study|Protocol Violation|2|||
129996396|NCT00720941|467951860|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
129996397|NCT00720941|467951861|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
129996398|NCT00720941|467951860|FG000|Overall Study|Lost to Follow-up|20|||
129996399|NCT00720941|467951861|FG001|Overall Study|Lost to Follow-up|15|||
129996400|NCT00720941|467951860|FG000|Overall Study|Physician Decision|14|||
129996401|NCT00720941|467951861|FG001|Overall Study|Physician Decision|12|||
129996402|NCT00720941|467951860|FG000|Overall Study|Withdrawal by Subject|29|||
129996403|NCT00720941|467951861|FG001|Overall Study|Withdrawal by Subject|36|||
129996404|NCT00604279|467951862|FG000|Overall Study|Lack of Efficacy|22|||
129996405|NCT00604279|467951863|FG001|Overall Study|Lack of Efficacy|9|||
129996406|NCT00604279|467951862|FG000|Overall Study|Lost to Follow-up|9|||
129996407|NCT00604279|467951863|FG001|Overall Study|Lost to Follow-up|14|||
129996408|NCT00604279|467951862|FG000|Overall Study|Pregnancy|2|||
129996409|NCT00604279|467951863|FG001|Overall Study|Pregnancy|0|||
129996410|NCT00604279|467951862|FG000|Overall Study|Protocol Violation|3|||
129996411|NCT00604279|467951863|FG001|Overall Study|Protocol Violation|1|||
129996412|NCT00604279|467951862|FG000|Overall Study|Withdrawal by Subject|16|||
129996413|NCT00604279|467951863|FG001|Overall Study|Withdrawal by Subject|5|||
129996414|NCT00604279|467951862|FG000|Overall Study|Adverse Event|4|||
129996415|NCT00604279|467951863|FG001|Overall Study|Adverse Event|5|||
129996416|NCT00604279|467951862|FG000|Overall Study|Other|8|||
129996417|NCT00604279|467951863|FG001|Overall Study|Other|4|||
129996418|NCT00355056|467951864|FG000|Randomization Period|Early Termination|4|||
129996419|NCT00355056|467951865|FG001|Randomization Period|Early Termination|6|||
129996420|NCT01072877|467951871|FG000|Overall Study|Lost to Follow-up|1|||
129996421|NCT01072877|467951872|FG001|Overall Study|Lost to Follow-up|1|||
129996422|NCT01072877|467951873|FG002|Overall Study|Lost to Follow-up|0|||
129996423|NCT01072877|467951874|FG003|Overall Study|Lost to Follow-up|2|||
129996424|NCT01072877|467951875|FG004|Overall Study|Lost to Follow-up|0|||
129996425|NCT00995020|467951876|FG000|Overall Study|margin analysis not performed|2|||
129996426|NCT00995020|467951877|FG001|Overall Study|margin analysis not performed|5|||
129996427|NCT00995020|467951876|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
129996428|NCT00995020|467951877|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
129996429|NCT02720536|467951878|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
129996430|NCT02720536|467951878|FG000|Overall Study|PR - pregnancy|2|||
129996431|NCT02720536|467951878|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
129996432|NCT02720536|467951878|FG000|Overall Study|PR - death|1|||
129996433|NCT02720536|467951878|FG000|Overall Study|PR - adverse event|1|||
129996434|NCT02720536|467951878|FG000|Overall Study|PR - abnormal lab value(s)|1|||
129996435|NCT02720536|467951878|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
129996436|NCT02382016|467951882|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
129996437|NCT02382016|467951883|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
129996438|NCT02382016|467951882|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
129996439|NCT02382016|467951883|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
129996440|NCT02382016|467951882|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
129996441|NCT02382016|467951883|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
129996442|NCT02382016|467951882|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
129996443|NCT02382016|467951883|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
129996444|NCT02382016|467951882|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
129996445|NCT02382016|467951883|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
129996446|NCT02382016|467951882|FG000|Open-label (OL) Treatment Period|Death|4|||
129996447|NCT02382016|467951883|FG001|Open-label (OL) Treatment Period|Death|0|||
129996448|NCT02382016|467951882|FG000|OL Extension Period|Physician Decision|3|||
129996449|NCT02382016|467951883|FG001|OL Extension Period|Physician Decision|0|||
129996450|NCT02382016|467951882|FG000|OL Extension Period|Death|2|||
129996451|NCT02382016|467951883|FG001|OL Extension Period|Death|0|||
129996452|NCT02382016|467951882|FG000|OL Extension Period|Withdrawal by Subject|1|||
129996453|NCT02382016|467951883|FG001|OL Extension Period|Withdrawal by Subject|0|||
129996454|NCT00084266|467951884|FG000|Overall Study|Death|42|||
129996455|NCT00084266|467951885|FG001|Overall Study|Death|39|||
129996456|NCT00084266|467951884|FG000|Overall Study|Adverse Event|8|||
129996457|NCT00084266|467951885|FG001|Overall Study|Adverse Event|5|||
129996458|NCT00084266|467951884|FG000|Overall Study|Lack of Efficacy|2|||
129996459|NCT00084266|467951885|FG001|Overall Study|Lack of Efficacy|4|||
129996460|NCT00084266|467951884|FG000|Overall Study|Lost to Follow-up|5|||
129996461|NCT00084266|467951885|FG001|Overall Study|Lost to Follow-up|3|||
129996462|NCT00084266|467951884|FG000|Overall Study|Participant not willing to participate|3|||
129996463|NCT00084266|467951885|FG001|Overall Study|Participant not willing to participate|8|||
129996464|NCT00084266|467951884|FG000|Overall Study|Other|360|||
129996465|NCT00084266|467951885|FG001|Overall Study|Other|344|||
129996466|NCT00084266|467951884|FG000|Overall Study|Randomized not treated|21|||
129996467|NCT00084266|467951885|FG001|Overall Study|Randomized not treated|20|||
129996468|NCT00730171|467951886|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
129996469|NCT00730171|467951886|FG000|Overall Study|Adverse Event|193|||
129996470|NCT00730171|467951886|FG000|Overall Study|Protocol Violation|48|||
129996471|NCT00730171|467951886|FG000|Overall Study|Withdrawal by Subject|202|||
129996472|NCT00730171|467951886|FG000|Overall Study|Lost to Follow-up|121|||
129996473|NCT00730171|467951886|FG000|Overall Study|Insufficient Therapeutic Response|141|||
129996474|NCT00730171|467951886|FG000|Overall Study|Other|61|||
129996475|NCT01729156|467951887|FG000|Overall Study|Withdrawal by Subject|1|||
129996476|NCT01729156|467951888|FG001|Overall Study|Withdrawal by Subject|0|||
129996477|NCT01729156|467951889|FG002|Overall Study|Withdrawal by Subject|0|||
129996478|NCT00719563|467951890|FG000|Overall Study|Adverse Event|16|||
129996479|NCT00719563|467951891|FG001|Overall Study|Adverse Event|13|||
129996480|NCT00719563|467951890|FG000|Overall Study|Medical condition changed|3|||
129996481|NCT00719563|467951891|FG001|Overall Study|Medical condition changed|5|||
129996482|NCT00719563|467951890|FG000|Overall Study|Lack of Efficacy|3|||
129996483|NCT00719563|467951891|FG001|Overall Study|Lack of Efficacy|7|||
129996484|NCT00719563|467951890|FG000|Overall Study|Personal reasons|6|||
129996485|NCT00719563|467951891|FG001|Overall Study|Personal reasons|7|||
129996486|NCT00719563|467951890|FG000|Overall Study|Unknown reasons|4|||
129996487|NCT00719563|467951891|FG001|Overall Study|Unknown reasons|6|||
129996488|NCT00719563|467951890|FG000|Overall Study|Noncompliant|1|||
129996489|NCT00719563|467951891|FG001|Overall Study|Noncompliant|1|||
129996490|NCT00719563|467951890|FG000|Overall Study|Lost to Follow-up|5|||
129996491|NCT00719563|467951891|FG001|Overall Study|Lost to Follow-up|3|||
129996492|NCT00792805|467951894|FG000|Overall Study|Adverse Event|12|||
129996493|NCT00792805|467951895|FG001|Overall Study|Adverse Event|10|||
129996494|NCT00792805|467951896|FG002|Overall Study|Adverse Event|10|||
129996495|NCT00792805|467951894|FG000|Overall Study|Subject withdrew consent|5|||
129996496|NCT00792805|467951895|FG001|Overall Study|Subject withdrew consent|6|||
129996497|NCT00792805|467951896|FG002|Overall Study|Subject withdrew consent|5|||
129996498|NCT00792805|467951894|FG000|Overall Study|Administrative problems|2|||
129996499|NCT00792805|467951895|FG001|Overall Study|Administrative problems|0|||
129996500|NCT00792805|467951896|FG002|Overall Study|Administrative problems|4|||
129996501|NCT00792805|467951894|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129996502|NCT00792805|467951895|FG001|Overall Study|Abnormal test procedure result(s)|2|||
129996503|NCT00792805|467951896|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129996504|NCT00792805|467951894|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129996505|NCT00792805|467951895|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129996506|NCT00792805|467951896|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
129996507|NCT00792805|467951894|FG000|Overall Study|Lost to Follow-up|1|||
129996508|NCT00792805|467951895|FG001|Overall Study|Lost to Follow-up|1|||
129996509|NCT00792805|467951896|FG002|Overall Study|Lost to Follow-up|6|||
129996510|NCT00792805|467951894|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129996511|NCT00792805|467951895|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129996512|NCT00792805|467951896|FG002|Overall Study|Abnormal laboratory value(s)|1|||
129996513|NCT00792805|467951894|FG000|Overall Study|Protocol deviation|0|||
129996514|NCT00792805|467951895|FG001|Overall Study|Protocol deviation|1|||
129996515|NCT00792805|467951896|FG002|Overall Study|Protocol deviation|1|||
129996516|NCT03224325|467951897|FG000|Overall Study|Adverse Event|1|||
129996517|NCT03224325|467951898|FG001|Overall Study|Adverse Event|0|||
129996518|NCT03224325|467951899|FG002|Overall Study|Adverse Event|0|||
129996519|NCT03224325|467951900|FG003|Overall Study|Adverse Event|0|||
129996520|NCT03224325|467951901|FG004|Overall Study|Adverse Event|0|||
129996521|NCT03224325|467951902|FG005|Overall Study|Adverse Event|0|||
129996522|NCT03224325|467951903|FG006|Overall Study|Adverse Event|1|||
129996523|NCT03224325|467951897|FG000|Overall Study|Withdrawal by Subject|0|||
129996524|NCT03224325|467951898|FG001|Overall Study|Withdrawal by Subject|0|||
129996525|NCT03224325|467951899|FG002|Overall Study|Withdrawal by Subject|0|||
129996526|NCT03224325|467951900|FG003|Overall Study|Withdrawal by Subject|1|||
129996527|NCT03224325|467951901|FG004|Overall Study|Withdrawal by Subject|0|||
129996528|NCT03224325|467951902|FG005|Overall Study|Withdrawal by Subject|0|||
129996529|NCT03224325|467951903|FG006|Overall Study|Withdrawal by Subject|0|||
129996530|NCT02120625|467951905|FG000|Overall Study|Physician Decision|2|||
129996531|NCT02952001|467951908|FG000|Overall Study|Adverse Event|3|||
129996532|NCT02952001|467951909|FG001|Overall Study|Adverse Event|0|||
129996533|NCT02952001|467951908|FG000|Overall Study|Prohibited therapy|10|||
129996534|NCT02952001|467951909|FG001|Overall Study|Prohibited therapy|3|||
129996535|NCT02952001|467951908|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
129996536|NCT02952001|467951909|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
129996537|NCT00937833|467951912|FG000|Overall Study|Protocol Violation|1|||
129996538|NCT00937833|467951913|FG001|Overall Study|Protocol Violation|2|||
129996539|NCT00937833|467951912|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
129996540|NCT00937833|467951913|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
129996541|NCT00937833|467951912|FG000|Overall Study|Lost to Follow-up|10|||
129996542|NCT00937833|467951913|FG001|Overall Study|Lost to Follow-up|8|||
129996543|NCT00937833|467951912|FG000|Overall Study|Withdrawal by Subject|4|||
129996544|NCT00937833|467951913|FG001|Overall Study|Withdrawal by Subject|6|||
129996545|NCT03278106|467951915|FG000|Overall Study|No protocol treatment|1|||
129996546|NCT00818389|467951916|FG000|Overall Study|Death|1|||
129996547|NCT00818389|467951917|FG001|Overall Study|Death|3|||
129996548|NCT00818389|467951916|FG000|Overall Study|ALS Disease Progression|1|||
129996549|NCT00818389|467951917|FG001|Overall Study|ALS Disease Progression|0|||
129996550|NCT00818389|467951916|FG000|Overall Study|Withdrawal by Subject|2|||
129996551|NCT00818389|467951917|FG001|Overall Study|Withdrawal by Subject|2|||
129996552|NCT00818389|467951916|FG000|Overall Study|Adverse Event|0|||
129996553|NCT00818389|467951917|FG001|Overall Study|Adverse Event|1|||
129996554|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
129996555|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
129996556|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
129996557|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
129996558|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
129996559|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
129996560|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
129996561|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
129996562|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
129996563|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
129996564|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
129996565|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
129996566|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
129996567|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
129996568|NCT03548987|467951918|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
129996569|NCT03548987|467951919|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
129996570|NCT03548987|467951918|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
129996571|NCT03548987|467951919|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
129996572|NCT03548987|467951918|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
129996573|NCT03548987|467951919|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
129996574|NCT03548987|467951918|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
129996575|NCT03548987|467951919|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
129996576|NCT03548987|467951918|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
129996577|NCT03548987|467951919|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
129996578|NCT03548987|467951918|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
129996579|NCT03548987|467951919|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
129996580|NCT03548987|467951918|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
129996581|NCT03548987|467951919|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
129996582|NCT00756470|467951921|FG000|Overall Study|Withdrawal by Subject|1|||
129996583|NCT00756470|467951921|FG000|Overall Study|Adverse Event|4|||
129996584|NCT00820027|467951922|FG000|Overall Study|Adverse Event|15|||
129996585|NCT00820027|467951923|FG001|Overall Study|Adverse Event|8|||
129996586|NCT00820027|467951924|FG002|Overall Study|Adverse Event|10|||
129996587|NCT00820027|467951925|FG003|Overall Study|Adverse Event|5|||
129996588|NCT00820027|467951922|FG000|Overall Study|Lack of Efficacy|2|||
129996589|NCT00820027|467951923|FG001|Overall Study|Lack of Efficacy|1|||
129996590|NCT00820027|467951924|FG002|Overall Study|Lack of Efficacy|2|||
129996591|NCT00820027|467951925|FG003|Overall Study|Lack of Efficacy|2|||
129996592|NCT00820027|467951922|FG000|Overall Study|Physician Decision|0|||
129996593|NCT00820027|467951923|FG001|Overall Study|Physician Decision|1|||
129996594|NCT00820027|467951924|FG002|Overall Study|Physician Decision|1|||
129996595|NCT00820027|467951925|FG003|Overall Study|Physician Decision|0|||
130334859|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
129996596|NCT00820027|467951922|FG000|Overall Study|Protocol Violation|3|||
129996597|NCT00820027|467951923|FG001|Overall Study|Protocol Violation|0|||
129996598|NCT00820027|467951924|FG002|Overall Study|Protocol Violation|4|||
130334860|NCT04173494|469195582|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
129996599|NCT00820027|467951925|FG003|Overall Study|Protocol Violation|0|||
129996600|NCT00820027|467951922|FG000|Overall Study|Withdrawal by Subject|6|||
129996601|NCT00820027|467951923|FG001|Overall Study|Withdrawal by Subject|4|||
129996602|NCT00820027|467951924|FG002|Overall Study|Withdrawal by Subject|4|||
129996603|NCT00820027|467951925|FG003|Overall Study|Withdrawal by Subject|6|||
129996604|NCT03285178|467951926|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
129996605|NCT03285178|467951927|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129996606|NCT03285178|467951928|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129996607|NCT03285178|467951929|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129996608|NCT03285178|467951930|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129996609|NCT03285178|467951931|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129996610|NCT03285178|467951932|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129996611|NCT03285178|467951926|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
129996612|NCT03285178|467951927|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129996613|NCT03285178|467951928|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129996614|NCT03285178|467951929|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129996615|NCT03285178|467951930|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129996616|NCT03285178|467951931|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129996617|NCT03285178|467951932|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129996618|NCT03285178|467951926|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
129996619|NCT03285178|467951927|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
129996620|NCT03285178|467951928|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
129996621|NCT03285178|467951929|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
129996622|NCT03285178|467951930|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
129996623|NCT03285178|467951931|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
129996624|NCT03285178|467951932|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
129996625|NCT03285178|467951926|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
129996626|NCT03285178|467951927|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129996627|NCT03285178|467951928|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129996628|NCT03285178|467951929|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129996629|NCT03285178|467951930|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129996630|NCT03285178|467951931|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129996631|NCT03285178|467951932|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129996632|NCT03285178|467951926|FG000|Single-Blind Run-In Period|Physician Decision|2|||
129996633|NCT03285178|467951927|FG001|Single-Blind Run-In Period|Physician Decision|0|||
129996634|NCT03285178|467951928|FG002|Single-Blind Run-In Period|Physician Decision|0|||
129996635|NCT03285178|467951929|FG003|Single-Blind Run-In Period|Physician Decision|0|||
129996636|NCT03285178|467951930|FG004|Single-Blind Run-In Period|Physician Decision|0|||
129996637|NCT03285178|467951931|FG005|Single-Blind Run-In Period|Physician Decision|0|||
129996638|NCT03285178|467951932|FG006|Single-Blind Run-In Period|Physician Decision|0|||
129996639|NCT03285178|467951926|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129996640|NCT03285178|467951927|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
129996641|NCT03285178|467951928|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
129996642|NCT03285178|467951929|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129996643|NCT03285178|467951930|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129996644|NCT03285178|467951931|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129996645|NCT03285178|467951932|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129996646|NCT03285178|467951926|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129996647|NCT03285178|467951927|FG001|Double-Blind Treatment Period|Adverse Event|0|||
129996648|NCT03285178|467951928|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129996649|NCT03285178|467951929|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129996650|NCT03285178|467951930|FG004|Double-Blind Treatment Period|Adverse Event|0|||
129996651|NCT03285178|467951931|FG005|Double-Blind Treatment Period|Adverse Event|0|||
129996652|NCT03285178|467951932|FG006|Double-Blind Treatment Period|Adverse Event|2|||
129996653|NCT03285178|467951926|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129996654|NCT03285178|467951927|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129996655|NCT03285178|467951928|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
129996656|NCT03285178|467951929|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
129996657|NCT03285178|467951930|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
129996658|NCT03285178|467951931|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
129996659|NCT03285178|467951932|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
129996660|NCT03285178|467951926|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129996661|NCT03285178|467951927|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129996662|NCT03285178|467951928|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129996663|NCT03285178|467951929|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129996664|NCT03285178|467951930|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129996665|NCT03285178|467951931|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129996666|NCT03285178|467951932|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129996667|NCT03285178|467951926|FG000|Double-Blind Treatment Period|COVID-19|0|||
129996668|NCT03285178|467951927|FG001|Double-Blind Treatment Period|COVID-19|0|||
129996669|NCT03285178|467951928|FG002|Double-Blind Treatment Period|COVID-19|1|||
129996670|NCT03285178|467951929|FG003|Double-Blind Treatment Period|COVID-19|0|||
129996671|NCT03285178|467951930|FG004|Double-Blind Treatment Period|COVID-19|0|||
129996672|NCT03285178|467951931|FG005|Double-Blind Treatment Period|COVID-19|0|||
129996673|NCT03285178|467951932|FG006|Double-Blind Treatment Period|COVID-19|0|||
129996674|NCT01388790|467951933|FG000|Overall Study|Ongoing at data cut-off date|8|||
129996675|NCT01128894|467951934|FG000|Overall Study|Adverse Event|31|||
129996676|NCT01128894|467951935|FG001|Overall Study|Adverse Event|41|||
129996677|NCT01128894|467951934|FG000|Overall Study|Protocol Violation|2|||
129996678|NCT01128894|467951935|FG001|Overall Study|Protocol Violation|1|||
129996679|NCT01128894|467951934|FG000|Overall Study|Noncompliance|4|||
129996680|NCT01128894|467951935|FG001|Overall Study|Noncompliance|5|||
129996681|NCT01128894|467951934|FG000|Overall Study|Lost to Follow-up|8|||
129996682|NCT01128894|467951935|FG001|Overall Study|Lost to Follow-up|8|||
129996683|NCT01128894|467951934|FG000|Overall Study|Withdrawal by Subject|10|||
129996684|NCT01128894|467951935|FG001|Overall Study|Withdrawal by Subject|12|||
129996685|NCT01128894|467951934|FG000|Overall Study|Physician Decision|2|||
129996686|NCT01128894|467951935|FG001|Overall Study|Physician Decision|1|||
129996687|NCT01128894|467951934|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
129996688|NCT01128894|467951935|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
129996689|NCT00195507|467951936|FG000|Overall Study|Adverse Event|24|||
129996690|NCT00195507|467951937|FG001|Overall Study|Adverse Event|13|||
129996691|NCT00195507|467951936|FG000|Overall Study|Death|0|||
129996692|NCT00195507|467951937|FG001|Overall Study|Death|1|||
129996693|NCT00195507|467951936|FG000|Overall Study|Failed to Return|4|||
129996694|NCT00195507|467951937|FG001|Overall Study|Failed to Return|3|||
129996695|NCT00195507|467951936|FG000|Overall Study|Physician Decision|1|||
129996696|NCT00195507|467951937|FG001|Overall Study|Physician Decision|2|||
129996697|NCT00195507|467951936|FG000|Overall Study|Lost to Follow-up|3|||
129996698|NCT00195507|467951937|FG001|Overall Study|Lost to Follow-up|2|||
129996699|NCT00195507|467951936|FG000|Overall Study|Protocol Violation|5|||
129996700|NCT00195507|467951937|FG001|Overall Study|Protocol Violation|4|||
129996701|NCT00195507|467951936|FG000|Overall Study|Lack of Efficacy|40|||
129996702|NCT00195507|467951937|FG001|Overall Study|Lack of Efficacy|67|||
129996703|NCT00195507|467951936|FG000|Overall Study|Withdrawal by Subject|16|||
129996704|NCT00195507|467951937|FG001|Overall Study|Withdrawal by Subject|23|||
129996705|NCT00195507|467951936|FG000|Overall Study|Protocol Deviation|6|||
129996706|NCT00195507|467951937|FG001|Overall Study|Protocol Deviation|3|||
129996707|NCT00973362|467951938|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
129996708|NCT00973362|467951939|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
129996709|NCT00973362|467951938|FG000|Baseline Evaluation|No colposcopy visit|62|||
129996710|NCT00973362|467951939|FG001|Baseline Evaluation|No colposcopy visit|0|||
129996711|NCT00973362|467951938|FG000|Baseline Evaluation|Inevaluable|686|||
129996712|NCT00973362|467951939|FG001|Baseline Evaluation|Inevaluable|223|||
129996713|NCT00973362|467951938|FG000|3-Year Follow-up|Lost to Follow-up|17|||
129996714|NCT00973362|467951939|FG001|3-Year Follow-up|Lost to Follow-up|0|||
129996715|NCT01630434|467951946|FG000|Overall Study|Donor lungs turned down|1|||
129996716|NCT01630434|467951947|FG001|Overall Study|Donor lungs turned down|0|||
129996717|NCT01630434|467951946|FG000|Overall Study|Protocol Violation|9|||
129996718|NCT01630434|467951947|FG001|Overall Study|Protocol Violation|4|||
129996719|NCT01630434|467951946|FG000|Overall Study|Death|20|||
129996720|NCT01630434|467951947|FG001|Overall Study|Death|26|||
129996721|NCT02578862|467951948|FG000|Overall Study|Withdrawal by Subject|0|||
129996722|NCT02578862|467951949|FG001|Overall Study|Withdrawal by Subject|1|||
129996723|NCT02578862|467951948|FG000|Overall Study|Unplanned unilateral procedure|0|||
129996724|NCT02578862|467951949|FG001|Overall Study|Unplanned unilateral procedure|1|||
129996725|NCT02893930|467951950|FG000|Overall Study|Adverse Event|3|||
129996726|NCT02893930|467951950|FG000|Overall Study|Death|1|||
129996727|NCT02893930|467951950|FG000|Overall Study|Disease progression|5|||
129996728|NCT02893930|467951950|FG000|Overall Study|Withdrawal by Subject|2|||
129996729|NCT02893930|467951950|FG000|Overall Study|Physician Decision|1|||
129996730|NCT02893930|467951950|FG000|Overall Study|Ineligible|1|||
129996731|NCT02804178|467951953|FG000|Overall Study|Adverse Event|1|||
129996732|NCT01106404|467951954|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
129996733|NCT01106404|467951955|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
129996734|NCT01106404|467951954|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
129996735|NCT01106404|467951955|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
129996736|NCT01106404|467951954|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
129996737|NCT01106404|467951955|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
129996738|NCT01106404|467951954|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
129996739|NCT01106404|467951955|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
129996740|NCT01290601|467951956|FG000|Overall Study|Adverse Event|0|||
129996741|NCT01290601|467951957|FG001|Overall Study|Adverse Event|2|||
129996742|NCT01290601|467951958|FG002|Overall Study|Adverse Event|0|||
129996743|NCT01290601|467951959|FG003|Overall Study|Adverse Event|0|||
129996744|NCT01290601|467951956|FG000|Overall Study|Lack of Efficacy|2|||
129996745|NCT01290601|467951957|FG001|Overall Study|Lack of Efficacy|1|||
129996746|NCT01290601|467951958|FG002|Overall Study|Lack of Efficacy|0|||
129996747|NCT01290601|467951959|FG003|Overall Study|Lack of Efficacy|0|||
129996748|NCT01290601|467951956|FG000|Overall Study|Lost to Follow-up|7|||
129996749|NCT01290601|467951957|FG001|Overall Study|Lost to Follow-up|2|||
129996750|NCT01290601|467951958|FG002|Overall Study|Lost to Follow-up|0|||
129996751|NCT01290601|467951959|FG003|Overall Study|Lost to Follow-up|0|||
129996752|NCT01290601|467951956|FG000|Overall Study|Other|1|||
129996753|NCT01290601|467951957|FG001|Overall Study|Other|0|||
129996754|NCT01290601|467951958|FG002|Overall Study|Other|0|||
129996755|NCT01290601|467951959|FG003|Overall Study|Other|0|||
129996756|NCT01290601|467951956|FG000|Overall Study|Protocol Violation|1|||
129996757|NCT01290601|467951957|FG001|Overall Study|Protocol Violation|0|||
129996758|NCT01290601|467951958|FG002|Overall Study|Protocol Violation|0|||
129996759|NCT01290601|467951959|FG003|Overall Study|Protocol Violation|0|||
129996760|NCT00775450|467951960|FG000|Overall Study|Serious Adverse Event|2|||
129996761|NCT00775450|467951961|FG001|Overall Study|Serious Adverse Event|0|||
129996762|NCT00775450|467951962|FG002|Overall Study|Serious Adverse Event|0|||
129996763|NCT00775450|467951963|FG003|Overall Study|Serious Adverse Event|0|||
129996764|NCT00775450|467951964|FG004|Overall Study|Serious Adverse Event|0|||
129996765|NCT00775450|467951960|FG000|Overall Study|Protocol Violation|0|||
129996766|NCT00775450|467951961|FG001|Overall Study|Protocol Violation|0|||
129996767|NCT00775450|467951962|FG002|Overall Study|Protocol Violation|0|||
129996768|NCT00775450|467951963|FG003|Overall Study|Protocol Violation|0|||
129996769|NCT00775450|467951964|FG004|Overall Study|Protocol Violation|1|||
129996770|NCT00775450|467951960|FG000|Overall Study|Withdrawal by Subject|1|||
129996771|NCT00775450|467951961|FG001|Overall Study|Withdrawal by Subject|0|||
129996772|NCT00775450|467951962|FG002|Overall Study|Withdrawal by Subject|0|||
129996773|NCT00775450|467951963|FG003|Overall Study|Withdrawal by Subject|0|||
129996774|NCT00775450|467951964|FG004|Overall Study|Withdrawal by Subject|1|||
129996775|NCT01749540|467951971|FG000|Overall Study|Protocol Violation|0|||
129996776|NCT01749540|467951972|FG001|Overall Study|Protocol Violation|0|||
129996777|NCT01749540|467951973|FG002|Overall Study|Protocol Violation|0|||
129996778|NCT01749540|467951974|FG003|Overall Study|Protocol Violation|0|||
129996779|NCT01749540|467951975|FG004|Overall Study|Protocol Violation|0|||
129996780|NCT01749540|467951976|FG005|Overall Study|Protocol Violation|1|||
129996781|NCT01749540|467951977|FG006|Overall Study|Protocol Violation|1|||
129996782|NCT01749540|467951971|FG000|Overall Study|Withdrawal by Subject|0|||
129996783|NCT01749540|467951972|FG001|Overall Study|Withdrawal by Subject|0|||
129996784|NCT01749540|467951973|FG002|Overall Study|Withdrawal by Subject|0|||
129996785|NCT01749540|467951974|FG003|Overall Study|Withdrawal by Subject|1|||
129996786|NCT01749540|467951975|FG004|Overall Study|Withdrawal by Subject|0|||
129996787|NCT01749540|467951976|FG005|Overall Study|Withdrawal by Subject|0|||
129996788|NCT01749540|467951977|FG006|Overall Study|Withdrawal by Subject|0|||
130334861|NCT04173494|469195583|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
130334862|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
130334863|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
130334864|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
130334865|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
130334866|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
130334867|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
130334868|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
130334869|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
130334870|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
130334871|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
129996789|NCT01749540|467951971|FG000|Overall Study|Initiated into extension study A536-06|0|||
129996790|NCT01749540|467951972|FG001|Overall Study|Initiated into extension study A536-06|0|||
129996791|NCT01749540|467951973|FG002|Overall Study|Initiated into extension study A536-06|0|||
129996792|NCT01749540|467951974|FG003|Overall Study|Initiated into extension study A536-06|0|||
129996793|NCT01749540|467951975|FG004|Overall Study|Initiated into extension study A536-06|0|||
129996794|NCT01749540|467951976|FG005|Overall Study|Initiated into extension study A536-06|2|||
129996795|NCT01749540|467951977|FG006|Overall Study|Initiated into extension study A536-06|24|||
129996796|NCT00576836|467951978|FG000|Overall Study|Death|0|||
129996797|NCT00576836|467951979|FG001|Overall Study|Death|1|||
129996798|NCT00576836|467951978|FG000|Overall Study|Physician Decision|0|||
129996799|NCT00576836|467951979|FG001|Overall Study|Physician Decision|1|||
129996800|NCT00564018|467951980|FG000|Overall Study|Withdrawal by Subject|2|||
129996801|NCT00564018|467951981|FG001|Overall Study|Withdrawal by Subject|3|||
129996802|NCT00564018|467951982|FG002|Overall Study|Withdrawal by Subject|1|||
129996803|NCT01296347|467951983|FG000|Allocation|Withdrawal by Subject|1|||
129996804|NCT01296347|467951984|FG001|Allocation|Withdrawal by Subject|2|||
129996805|NCT01296347|467951983|FG000|Allocation|Lack of Efficacy|1|||
129996806|NCT01296347|467951984|FG001|Allocation|Lack of Efficacy|2|||
129996807|NCT01296347|467951983|FG000|Allocation|not received infusion|1|||
129996808|NCT01296347|467951984|FG001|Allocation|not received infusion|0|||
129996809|NCT01296347|467951983|FG000|6 Week Follow up|Death|0|||
129996810|NCT01296347|467951984|FG001|6 Week Follow up|Death|1|||
129996811|NCT01296347|467951983|FG000|3 Month Follow up|Death|1|||
129996812|NCT01296347|467951984|FG001|3 Month Follow up|Death|0|||
129996813|NCT01296347|467951983|FG000|3 Month Follow up|Lost to Follow-up|0|||
129996814|NCT01296347|467951984|FG001|3 Month Follow up|Lost to Follow-up|1|||
129996815|NCT01296347|467951983|FG000|6 Month Follow up|Death|2|||
129996816|NCT01296347|467951984|FG001|6 Month Follow up|Death|1|||
129996817|NCT01296347|467951983|FG000|6 Month Follow up|Lost to Follow-up|0|||
129996818|NCT01296347|467951984|FG001|6 Month Follow up|Lost to Follow-up|1|||
129996819|NCT01296347|467951983|FG000|12 Month Follow up|Lost to Follow-up|3|||
129996820|NCT01296347|467951984|FG001|12 Month Follow up|Lost to Follow-up|1|||
129996821|NCT01296347|467951983|FG000|12 Month Follow up|Death|1|||
129996822|NCT01296347|467951984|FG001|12 Month Follow up|Death|1|||
129996823|NCT01296347|467951983|FG000|12 Month Follow up|Withdrawal by Subject|0|||
129996824|NCT01296347|467951984|FG001|12 Month Follow up|Withdrawal by Subject|1|||
129996825|NCT02240693|467951985|FG000|Overall Study|Adverse Event|0|||
129996826|NCT02240693|467951986|FG001|Overall Study|Adverse Event|0|||
129996827|NCT02240693|467951987|FG002|Overall Study|Adverse Event|0|||
129996828|NCT02240693|467951988|FG003|Overall Study|Adverse Event|0|||
129996829|NCT02240693|467951989|FG004|Overall Study|Adverse Event|1|||
129996830|NCT02240693|467951985|FG000|Overall Study|Withdrawal by Subject|0|||
129996831|NCT02240693|467951986|FG001|Overall Study|Withdrawal by Subject|0|||
129996832|NCT02240693|467951987|FG002|Overall Study|Withdrawal by Subject|2|||
129996833|NCT02240693|467951988|FG003|Overall Study|Withdrawal by Subject|1|||
129996834|NCT02240693|467951989|FG004|Overall Study|Withdrawal by Subject|0|||
129996835|NCT02240693|467951985|FG000|Overall Study|Other than specified|0|||
129996836|NCT02240693|467951986|FG001|Overall Study|Other than specified|0|||
129996837|NCT02240693|467951987|FG002|Overall Study|Other than specified|2|||
129996838|NCT02240693|467951988|FG003|Overall Study|Other than specified|0|||
129996839|NCT02240693|467951989|FG004|Overall Study|Other than specified|0|||
129996840|NCT01116882|467951990|FG000|30-day|Lost to Follow-up|50|||
129996841|NCT01116882|467951991|FG001|30-day|Lost to Follow-up|21|||
129996842|NCT01116882|467951990|FG000|30-day|Withdrawal by Subject|2|||
129996843|NCT01116882|467951991|FG001|30-day|Withdrawal by Subject|4|||
129996844|NCT01116882|467951990|FG000|30-day|Other Reasons|16|||
129996845|NCT01116882|467951991|FG001|30-day|Other Reasons|6|||
129996846|NCT01116882|467951990|FG000|12-month|Lost to Follow-up|111|||
129996847|NCT01116882|467951991|FG001|12-month|Lost to Follow-up|42|||
129996848|NCT01116882|467951990|FG000|12-month|Other Reasons|151|||
129996849|NCT01116882|467951991|FG001|12-month|Other Reasons|49|||
129996850|NCT01116882|467951990|FG000|12-month|Withdrawal by Subject|5|||
129996851|NCT01116882|467951991|FG001|12-month|Withdrawal by Subject|8|||
129996852|NCT02739360|467951994|FG000|Overall Study|Adverse Event|1|||
129996853|NCT02739360|467951994|FG000|Overall Study|Study terminated by Sponsor|2|||
129996854|NCT01193920|467951995|FG000|Overall Study|Withdrawal by Subject|1|||
129996855|NCT01193920|467951996|FG001|Overall Study|Withdrawal by Subject|0|||
129996856|NCT01193920|467951997|FG002|Overall Study|Withdrawal by Subject|5|||
129996857|NCT01193920|467951998|FG003|Overall Study|Withdrawal by Subject|1|||
129996858|NCT01193920|467951999|FG004|Overall Study|Withdrawal by Subject|3|||
129996859|NCT01193920|467952000|FG005|Overall Study|Withdrawal by Subject|1|||
129996860|NCT01193920|467952001|FG006|Overall Study|Withdrawal by Subject|3|||
129996861|NCT01193920|467952002|FG007|Overall Study|Withdrawal by Subject|0|||
129996862|NCT01193920|467952003|FG008|Overall Study|Withdrawal by Subject|1|||
129996863|NCT01193920|467952004|FG009|Overall Study|Withdrawal by Subject|0|||
129996864|NCT01193920|467951995|FG000|Overall Study|Lost to Follow-up|1|||
129996865|NCT01193920|467951996|FG001|Overall Study|Lost to Follow-up|0|||
129996866|NCT01193920|467951997|FG002|Overall Study|Lost to Follow-up|1|||
129996867|NCT01193920|467951998|FG003|Overall Study|Lost to Follow-up|1|||
129996868|NCT01193920|467951999|FG004|Overall Study|Lost to Follow-up|3|||
129996869|NCT01193920|467952000|FG005|Overall Study|Lost to Follow-up|3|||
129996870|NCT01193920|467952001|FG006|Overall Study|Lost to Follow-up|1|||
129996871|NCT01193920|467952002|FG007|Overall Study|Lost to Follow-up|0|||
129996872|NCT01193920|467952003|FG008|Overall Study|Lost to Follow-up|2|||
129996873|NCT01193920|467952004|FG009|Overall Study|Lost to Follow-up|3|||
129996874|NCT01193920|467951995|FG000|Overall Study|Protocol Violation|1|||
129996875|NCT01193920|467951996|FG001|Overall Study|Protocol Violation|0|||
129996876|NCT01193920|467951997|FG002|Overall Study|Protocol Violation|0|||
129996877|NCT01193920|467951998|FG003|Overall Study|Protocol Violation|0|||
129996878|NCT01193920|467951999|FG004|Overall Study|Protocol Violation|0|||
129996879|NCT01193920|467952000|FG005|Overall Study|Protocol Violation|0|||
129996880|NCT01193920|467952001|FG006|Overall Study|Protocol Violation|0|||
129996881|NCT01193920|467952002|FG007|Overall Study|Protocol Violation|0|||
129996882|NCT01193920|467952003|FG008|Overall Study|Protocol Violation|0|||
129996883|NCT01193920|467952004|FG009|Overall Study|Protocol Violation|0|||
129996884|NCT01193920|467951995|FG000|Overall Study|Death|0|||
129996885|NCT01193920|467951996|FG001|Overall Study|Death|0|||
129996886|NCT01193920|467951997|FG002|Overall Study|Death|0|||
129996887|NCT01193920|467951998|FG003|Overall Study|Death|1|||
129996888|NCT01193920|467951999|FG004|Overall Study|Death|0|||
129996889|NCT01193920|467952000|FG005|Overall Study|Death|0|||
129996890|NCT01193920|467952001|FG006|Overall Study|Death|2|||
129996891|NCT01193920|467952002|FG007|Overall Study|Death|3|||
129996892|NCT01193920|467952003|FG008|Overall Study|Death|2|||
129996893|NCT01193920|467952004|FG009|Overall Study|Death|4|||
129996894|NCT01193920|467951995|FG000|Overall Study|Unable to classify|0|||
129996895|NCT01193920|467951996|FG001|Overall Study|Unable to classify|0|||
129996896|NCT01193920|467951997|FG002|Overall Study|Unable to classify|0|||
129996897|NCT01193920|467951998|FG003|Overall Study|Unable to classify|1|||
129996898|NCT01193920|467951999|FG004|Overall Study|Unable to classify|0|||
129996899|NCT01193920|467952000|FG005|Overall Study|Unable to classify|0|||
129996900|NCT01193920|467952001|FG006|Overall Study|Unable to classify|0|||
129996901|NCT01193920|467952002|FG007|Overall Study|Unable to classify|1|||
129996902|NCT01193920|467952003|FG008|Overall Study|Unable to classify|0|||
130334872|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
130334873|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
130334874|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
130334875|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
130334876|NCT04173494|469195582|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
130334877|NCT04173494|469195583|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
130334878|NCT01623050|469195586|FG000|Overall Study|Lost to Follow-up|9|||
130334879|NCT01191762|469195587|FG000|Overall Study|Adverse Event|1|||
130334880|NCT01191762|469195588|FG001|Overall Study|Adverse Event|0|||
130334881|NCT00459186|469195589|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
130334882|NCT00459186|469195589|FG000|PET Imaging and Assessment|Adverse Event|3|||
130334883|NCT03710083|469195590|FG000|Overall Study|Withdrawal by Subject|2|||
129996903|NCT01193920|467952004|FG009|Overall Study|Unable to classify|0|||
129996904|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
129996905|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
129996906|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
129996907|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
129996908|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
130334884|NCT03710083|469195590|FG000|Overall Study|Unsuccessful Procedure|1|||
129996909|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
129996910|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
129996911|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
129996912|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
129996913|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
129996914|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
130334885|NCT00838513|469195591|FG000|Screening Period|Screen Failure|3|||
130334886|NCT00838513|469195591|FG000|Extension Treatment Period|Death|1|||
129884260|NCT03390036|467536307|FG002|Overall Study|Lost to Follow-up|0|||
129884261|NCT03390036|467536305|FG000|Overall Study|Lack of Efficacy|1|||
129884262|NCT03390036|467536306|FG001|Overall Study|Lack of Efficacy|0|||
129884263|NCT03390036|467536307|FG002|Overall Study|Lack of Efficacy|0|||
129884264|NCT00358215|467536308|FG000|Overall Study|Ineligibility determined|4|||
129884265|NCT00358215|467536309|FG001|Overall Study|Ineligibility determined|3|||
129884266|NCT00358215|467536308|FG000|Overall Study|Adverse Event|83|||
129884267|NCT00358215|467536309|FG001|Overall Study|Adverse Event|65|||
129884268|NCT00358215|467536308|FG000|Overall Study|Withdrawal by Subject|111|||
129884269|NCT00358215|467536309|FG001|Overall Study|Withdrawal by Subject|102|||
129884270|NCT00358215|467536308|FG000|Overall Study|Participant request|65|||
129884271|NCT00358215|467536309|FG001|Overall Study|Participant request|64|||
129884272|NCT00358215|467536308|FG000|Overall Study|Physician Decision|47|||
129884273|NCT00358215|467536309|FG001|Overall Study|Physician Decision|39|||
129884274|NCT00358215|467536308|FG000|Overall Study|Lost to Follow-up|16|||
129884275|NCT00358215|467536309|FG001|Overall Study|Lost to Follow-up|22|||
129884276|NCT00358215|467536308|FG000|Overall Study|Death|265|||
129884277|NCT00358215|467536309|FG001|Overall Study|Death|281|||
129884278|NCT00358215|467536308|FG000|Overall Study|Protocol Violation|64|||
129884279|NCT00358215|467536309|FG001|Overall Study|Protocol Violation|59|||
129884280|NCT00358215|467536308|FG000|Overall Study|Pregnancy|1|||
129884281|NCT00358215|467536309|FG001|Overall Study|Pregnancy|0|||
129884282|NCT00358215|467536308|FG000|Overall Study|Other|21|||
129884283|NCT00358215|467536309|FG001|Overall Study|Other|14|||
129996915|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
129996916|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
129996917|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
129996918|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
129996919|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
129996920|NCT01231516|467952005|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
129996921|NCT01231516|467952006|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
130334887|NCT00838513|469195591|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
129996922|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
129996923|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
129996924|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
129996925|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
129996926|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
129996927|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
129996928|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
129996929|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
129996930|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
129996931|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
129996932|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
129996933|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
129996934|NCT01231516|467952005|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
129996935|NCT01231516|467952006|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
129996936|NCT00810394|467952007|FG000|Overall Study|Withdrawal by Subject|3|||
129996937|NCT02805725|467953571|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
129996938|NCT02805725|467953572|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
129996939|NCT02805725|467953573|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
129996940|NCT02805725|467953574|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
129996941|NCT02805725|467953575|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
129996942|NCT02805725|467953571|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
129996943|NCT02805725|467953572|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
129996944|NCT02805725|467953573|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
129996945|NCT02805725|467953574|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
129996946|NCT02805725|467953575|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
129996947|NCT02805725|467953571|FG000|Phase II|Protocol Violation|0|||
129996948|NCT02805725|467953572|FG001|Phase II|Protocol Violation|0|||
129996949|NCT02805725|467953573|FG002|Phase II|Protocol Violation|0|||
129996950|NCT02805725|467953574|FG003|Phase II|Protocol Violation|0|||
129996951|NCT02805725|467953575|FG004|Phase II|Protocol Violation|6|||
129996952|NCT01195545|467953576|FG000|Overall Study|Protocol Violation|4|||
129996953|NCT02425644|467953577|FG000|Overall Study|Lost to Follow-up|2|||
129996954|NCT02425644|467953578|FG001|Overall Study|Lost to Follow-up|3|||
129996955|NCT02425644|467953577|FG000|Overall Study|Withdrawal by Subject|41|||
129996956|NCT02425644|467953578|FG001|Overall Study|Withdrawal by Subject|36|||
129996957|NCT02425644|467953577|FG000|Overall Study|Lack of Efficacy|3|||
129996958|NCT02425644|467953578|FG001|Overall Study|Lack of Efficacy|10|||
129996959|NCT02425644|467953577|FG000|Overall Study|Adverse Event|13|||
129996960|NCT02425644|467953578|FG001|Overall Study|Adverse Event|3|||
129996961|NCT02425644|467953577|FG000|Overall Study|Death|0|||
129996962|NCT02425644|467953578|FG001|Overall Study|Death|2|||
129996963|NCT02425644|467953577|FG000|Overall Study|Other|18|||
130334888|NCT01388335|469195596|FG000|Period 1|Progressive Disease|1|||
130334889|NCT01388335|469195596|FG000|Period 2|Progressive Disease|2|||
130334890|NCT01388335|469195596|FG000|Period 2|Sponsor Decision|1|||
130334891|NCT01388335|469195596|FG000|Safety Extension|Progressive Disease|7|||
130334892|NCT00889720|469195597|FG000|Overall Study|Withdrawal by Subject|4|||
130334893|NCT00889720|469195597|FG000|Overall Study|Other|4|||
130334894|NCT00670306|469195598|FG000|Overall Study|Adverse Event|8|||
130334895|NCT00670306|469195598|FG000|Overall Study|Lack of Efficacy|10|||
130334896|NCT00670306|469195598|FG000|Overall Study|Withdrawal by Subject|9|||
130334897|NCT00670306|469195598|FG000|Overall Study|Physician Decision|1|||
130334898|NCT00670306|469195598|FG000|Overall Study|Lost to Follow-up|8|||
129996964|NCT02425644|467953578|FG001|Overall Study|Other|17|||
129996965|NCT00567268|467953579|FG000|Overall Study|Protocol Violation|7|||
129996966|NCT00567268|467953579|FG000|Overall Study|Lost to Follow-up|36|||
129996967|NCT00567268|467953579|FG000|Overall Study|No Visit After First Day of Treatment|2|||
130334899|NCT00670306|469195598|FG000|Overall Study|incl/excl criterias did not meet|19|||
130334900|NCT00775593|469195599|FG000|Overall Study|Unmet eligibility criteria|6|||
129996968|NCT00567268|467953579|FG000|Overall Study|No Drug Administration|4|||
130334901|NCT00775593|469195599|FG000|Overall Study|Death|1|||
130334902|NCT03904693|469195600|FG000|Overall Study|Death|0|||
130334903|NCT03904693|469195601|FG001|Overall Study|Death|0|||
130334904|NCT03904693|469195602|FG002|Overall Study|Death|3|||
129996969|NCT00567268|467953579|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
129996970|NCT01717989|467953580|FG000|Overall Study|Ineligibility determined|6|||
129996971|NCT01717989|467953580|FG000|Overall Study|Protocol deviation|6|||
129996972|NCT01717989|467953580|FG000|Overall Study|Withdrawal by Subject|11|||
129996973|NCT01717989|467953580|FG000|Overall Study|Physician Decision|2|||
129996974|NCT01717989|467953580|FG000|Overall Study|Lost to Follow-up|11|||
129996975|NCT01717989|467953580|FG000|Overall Study|Death|439|||
129996976|NCT01717989|467953580|FG000|Overall Study|Protocol-specified criteria|551|||
129996977|NCT01717989|467953580|FG000|Overall Study|Other|40|||
129996978|NCT02824263|467953581|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
129996979|NCT02824263|467953582|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
129996980|NCT02824263|467953581|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
129996981|NCT02824263|467953582|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
129996982|NCT00667355|467953583|FG000|Overall Study|Adverse Event|5|||
129996983|NCT00667355|467953583|FG000|Overall Study|Lost to Follow-up|1|||
129996984|NCT00667355|467953583|FG000|Overall Study|Other reason was not specified|5|||
129996985|NCT00068588|467953588|FG000|Overall Study|Adverse Event|0|||
129996986|NCT00068588|467953589|FG001|Overall Study|Adverse Event|0|||
129996987|NCT00068588|467953590|FG002|Overall Study|Adverse Event|2|||
129996988|NCT00068588|467953588|FG000|Overall Study|Withdrawal by Subject|0|||
129996989|NCT00068588|467953589|FG001|Overall Study|Withdrawal by Subject|0|||
129996990|NCT00068588|467953590|FG002|Overall Study|Withdrawal by Subject|1|||
129996991|NCT00068588|467953588|FG000|Overall Study|Poor KPS|0|||
129996992|NCT00068588|467953589|FG001|Overall Study|Poor KPS|0|||
129996993|NCT00068588|467953590|FG002|Overall Study|Poor KPS|1|||
129996994|NCT05193500|467953591|FG000|Overall Study|Withdrawal by Subject|7|||
129996995|NCT05193500|467953592|FG001|Overall Study|Withdrawal by Subject|4|||
129996996|NCT05193500|467953593|FG002|Overall Study|Withdrawal by Subject|3|||
129996997|NCT05193500|467953594|FG003|Overall Study|Withdrawal by Subject|5|||
129996998|NCT02604433|467953597|FG000|Overall Study|Withdrawal by Subject|37|||
129996999|NCT02604433|467953598|FG001|Overall Study|Withdrawal by Subject|16|||
129997000|NCT02604433|467953597|FG000|Overall Study|Adverse Event|4|||
129997001|NCT02604433|467953598|FG001|Overall Study|Adverse Event|0|||
129997002|NCT02604433|467953597|FG000|Overall Study|Other reasons|3|||
129997003|NCT02604433|467953598|FG001|Overall Study|Other reasons|5|||
129997004|NCT02604433|467953597|FG000|Overall Study|Death|4|||
129997005|NCT02604433|467953598|FG001|Overall Study|Death|1|||
129997006|NCT02604433|467953597|FG000|Overall Study|Transition to Rollover Protocol|169|||
129997007|NCT02604433|467953598|FG001|Overall Study|Transition to Rollover Protocol|82|||
129997008|NCT02604433|467953597|FG000|Overall Study|Physician Decision|1|||
129997009|NCT02604433|467953598|FG001|Overall Study|Physician Decision|1|||
129997010|NCT02604433|467953597|FG000|Overall Study|Lack of Efficacy|0|||
129997011|NCT02604433|467953598|FG001|Overall Study|Lack of Efficacy|1|||
129997012|NCT03437278|467953599|FG000|Overall Study|Adverse Event|0|||
129997013|NCT03437278|467953600|FG001|Overall Study|Adverse Event|0|||
129997014|NCT03437278|467953601|FG002|Overall Study|Adverse Event|1|||
129997015|NCT03437278|467953599|FG000|Overall Study|Progressive disease|1|||
129997016|NCT03437278|467953600|FG001|Overall Study|Progressive disease|0|||
129997017|NCT03437278|467953601|FG002|Overall Study|Progressive disease|0|||
129997018|NCT03437278|467953599|FG000|Overall Study|Physician Decision|1|||
129997019|NCT03437278|467953600|FG001|Overall Study|Physician Decision|0|||
129997020|NCT03437278|467953601|FG002|Overall Study|Physician Decision|1|||
129997021|NCT02202551|467953602|FG000|Overall Study|Adverse Event|8|||
129997022|NCT02202551|467953603|FG001|Overall Study|Adverse Event|19|||
129997023|NCT02202551|467953604|FG002|Overall Study|Adverse Event|5|||
129997024|NCT02202551|467953605|FG003|Overall Study|Adverse Event|9|||
129997025|NCT02202551|467953602|FG000|Overall Study|Death|3|||
129997026|NCT02202551|467953603|FG001|Overall Study|Death|2|||
129997027|NCT02202551|467953604|FG002|Overall Study|Death|1|||
129997028|NCT02202551|467953605|FG003|Overall Study|Death|1|||
129997029|NCT02202551|467953602|FG000|Overall Study|Lost to Follow-up|0|||
129997030|NCT02202551|467953603|FG001|Overall Study|Lost to Follow-up|1|||
129997031|NCT02202551|467953604|FG002|Overall Study|Lost to Follow-up|0|||
129997032|NCT02202551|467953605|FG003|Overall Study|Lost to Follow-up|1|||
129997033|NCT02202551|467953602|FG000|Overall Study|Needed to take excluded medication|0|||
129997034|NCT02202551|467953603|FG001|Overall Study|Needed to take excluded medication|2|||
129997035|NCT02202551|467953604|FG002|Overall Study|Needed to take excluded medication|0|||
129997036|NCT02202551|467953605|FG003|Overall Study|Needed to take excluded medication|1|||
129997037|NCT02202551|467953602|FG000|Overall Study|Subject moved away|0|||
129997038|NCT02202551|467953603|FG001|Overall Study|Subject moved away|1|||
129997039|NCT02202551|467953604|FG002|Overall Study|Subject moved away|0|||
129997040|NCT02202551|467953605|FG003|Overall Study|Subject moved away|0|||
129997041|NCT02202551|467953602|FG000|Overall Study|DBS surgery|3|||
129997042|NCT02202551|467953603|FG001|Overall Study|DBS surgery|0|||
129997043|NCT02202551|467953604|FG002|Overall Study|DBS surgery|0|||
129997044|NCT02202551|467953605|FG003|Overall Study|DBS surgery|0|||
129997045|NCT02202551|467953602|FG000|Overall Study|Dyskinesia upon taper|1|||
129997046|NCT02202551|467953603|FG001|Overall Study|Dyskinesia upon taper|0|||
129997047|NCT02202551|467953604|FG002|Overall Study|Dyskinesia upon taper|0|||
129997048|NCT02202551|467953605|FG003|Overall Study|Dyskinesia upon taper|0|||
129997049|NCT02202551|467953602|FG000|Overall Study|Lack of Efficacy|0|||
129997050|NCT02202551|467953603|FG001|Overall Study|Lack of Efficacy|1|||
129997051|NCT02202551|467953604|FG002|Overall Study|Lack of Efficacy|0|||
129997052|NCT02202551|467953605|FG003|Overall Study|Lack of Efficacy|0|||
129997053|NCT02202551|467953602|FG000|Overall Study|Physician Decision|1|||
129997054|NCT02202551|467953603|FG001|Overall Study|Physician Decision|0|||
129997055|NCT02202551|467953604|FG002|Overall Study|Physician Decision|0|||
129997056|NCT02202551|467953605|FG003|Overall Study|Physician Decision|0|||
129997057|NCT02202551|467953602|FG000|Overall Study|Site closure|3|||
129997058|NCT02202551|467953603|FG001|Overall Study|Site closure|0|||
129997059|NCT02202551|467953604|FG002|Overall Study|Site closure|0|||
129997060|NCT02202551|467953605|FG003|Overall Study|Site closure|1|||
129997061|NCT02202551|467953602|FG000|Overall Study|Unable to complete visits per protocol|1|||
129997062|NCT02202551|467953603|FG001|Overall Study|Unable to complete visits per protocol|0|||
129997063|NCT02202551|467953604|FG002|Overall Study|Unable to complete visits per protocol|0|||
129997064|NCT02202551|467953605|FG003|Overall Study|Unable to complete visits per protocol|0|||
129997065|NCT02202551|467953602|FG000|Overall Study|Worsening Dyskinesia|0|||
129997066|NCT02202551|467953603|FG001|Overall Study|Worsening Dyskinesia|0|||
129997067|NCT02202551|467953604|FG002|Overall Study|Worsening Dyskinesia|0|||
129997068|NCT02202551|467953605|FG003|Overall Study|Worsening Dyskinesia|1|||
129997069|NCT02202551|467953602|FG000|Overall Study|Protocol Violation|0|||
129997070|NCT02202551|467953603|FG001|Overall Study|Protocol Violation|1|||
129997071|NCT02202551|467953604|FG002|Overall Study|Protocol Violation|0|||
129997072|NCT02202551|467953605|FG003|Overall Study|Protocol Violation|0|||
129997073|NCT02202551|467953602|FG000|Overall Study|Sponsor's decision|2|||
129997074|NCT02202551|467953603|FG001|Overall Study|Sponsor's decision|0|||
129997075|NCT02202551|467953604|FG002|Overall Study|Sponsor's decision|0|||
129997076|NCT02202551|467953605|FG003|Overall Study|Sponsor's decision|0|||
129997077|NCT02202551|467953602|FG000|Overall Study|Subject unwilling to proceed|1|||
129997078|NCT02202551|467953603|FG001|Overall Study|Subject unwilling to proceed|5|||
129997079|NCT02202551|467953604|FG002|Overall Study|Subject unwilling to proceed|3|||
129997080|NCT02202551|467953605|FG003|Overall Study|Subject unwilling to proceed|5|||
129997081|NCT02202551|467953602|FG000|Overall Study|Subject consent withdrawn|0|||
129997082|NCT02202551|467953603|FG001|Overall Study|Subject consent withdrawn|3|||
129997083|NCT02202551|467953604|FG002|Overall Study|Subject consent withdrawn|1|||
129997084|NCT02202551|467953605|FG003|Overall Study|Subject consent withdrawn|2|||
129997085|NCT02202551|467953602|FG000|Overall Study|eGFR<50mL/min/m2|2|||
129997086|NCT02202551|467953603|FG001|Overall Study|eGFR<50mL/min/m2|2|||
129997087|NCT02202551|467953604|FG002|Overall Study|eGFR<50mL/min/m2|0|||
129997088|NCT02202551|467953605|FG003|Overall Study|eGFR<50mL/min/m2|1|||
129997089|NCT02147353|467953606|FG000|Overall Study|Lost to Follow-up|2|||
129997090|NCT02147353|467953607|FG001|Overall Study|Lost to Follow-up|0|||
129997091|NCT02147353|467953606|FG000|Overall Study|unable to make visits|4|||
129997092|NCT02147353|467953607|FG001|Overall Study|unable to make visits|0|||
129997093|NCT02147353|467953606|FG000|Overall Study|medication noncompliance|3|||
129997094|NCT02147353|467953607|FG001|Overall Study|medication noncompliance|0|||
129997095|NCT01776424|467953612|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
129997096|NCT01776424|467953613|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
129997097|NCT01776424|467953614|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
129997098|NCT01776424|467953612|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
129997099|NCT01776424|467953613|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
129997100|NCT01776424|467953614|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
129997101|NCT01776424|467953612|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
129997102|NCT01776424|467953613|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
129997103|NCT01776424|467953614|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
129997104|NCT01776424|467953612|FG000|LTOLE Part (Open Label)|Refused|5|||
129997105|NCT01776424|467953613|FG001|LTOLE Part (Open Label)|Refused|2|||
129997106|NCT01776424|467953614|FG002|LTOLE Part (Open Label)|Refused|11|||
129997107|NCT01776424|467953612|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
129997108|NCT01776424|467953613|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
129997109|NCT01776424|467953614|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
129997110|NCT00146757|467953615|FG000|Overall Study|Death|1|||
129997111|NCT00146757|467953616|FG001|Overall Study|Death|0|||
129997112|NCT00146757|467953615|FG000|Overall Study|Adverse Event|1|||
129997113|NCT00146757|467953616|FG001|Overall Study|Adverse Event|0|||
129997114|NCT02349360|467953626|FG000|Overall Study|Withdrawal by Subject|0|||
129997115|NCT02349360|467953627|FG001|Overall Study|Withdrawal by Subject|1|||
129997116|NCT01176773|467953628|FG000|Overall Study|Screen Failure|2|||
129997117|NCT01176773|467953628|FG000|Overall Study|Withdrew consent|1|||
129997118|NCT01794923|467953645|FG000|Overall Study|Adverse Event|0|||
129997119|NCT01794923|467953646|FG001|Overall Study|Adverse Event|0|||
129997120|NCT01794923|467953647|FG002|Overall Study|Adverse Event|1|||
129997121|NCT00752622|467953657|FG000|Induction Phase|Adverse Event|3|||
129997122|NCT00752622|467953657|FG000|Induction Phase|Other|3|||
129997123|NCT00752622|467953657|FG000|Induction Phase|Non-responder|14|||
129997124|NCT00752622|467953657|FG000|Induction Phase|Withdrawal by Subject|1|||
129997125|NCT00752622|467953657|FG000|Induction Phase|Premature study termination|14|||
129997126|NCT00752622|467953657|FG000|Observational Phase|Premature Study Termination|36|||
129997127|NCT00752622|467953657|FG000|Observational Phase|Non-responder|2|||
129997128|NCT00752622|467953657|FG000|Observational Phase|Withdrawal by Subject|2|||
129997129|NCT00752622|467953657|FG000|Observational Phase|Adverse Event|1|||
129997130|NCT00752622|467953657|FG000|Observational Phase|Other|2|||
129997131|NCT00752622|467953657|FG000|Interventional Phase|Non-responder|2|||
129997132|NCT00752622|467953657|FG000|Interventional Phase|Physician Decision|1|||
129997133|NCT00752622|467953657|FG000|Interventional Phase|Premature Study Termination|5|||
129997134|NCT00894686|467953658|FG000|Overall Study|Withdrawal by Subject|50|||
129997135|NCT00894686|467953658|FG000|Overall Study|Physician Decision|1|||
129997136|NCT00894686|467953658|FG000|Overall Study|Other|5|||
129997137|NCT03267940|467953661|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
129997138|NCT03267940|467953662|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
129997139|NCT03267940|467953663|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129997140|NCT03267940|467953664|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129997141|NCT03267940|467953665|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129997142|NCT03267940|467953666|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129997143|NCT03267940|467953661|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129997144|NCT03267940|467953662|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
129997145|NCT03267940|467953663|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129997146|NCT03267940|467953664|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129997147|NCT03267940|467953665|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129997148|NCT03267940|467953666|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129997149|NCT03267940|467953661|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129997150|NCT03267940|467953662|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
129997151|NCT03267940|467953663|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129997152|NCT03267940|467953664|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129997153|NCT03267940|467953665|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129997154|NCT03267940|467953666|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129997155|NCT03267940|467953661|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
129997156|NCT03267940|467953662|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
129997157|NCT03267940|467953663|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129997158|NCT03267940|467953664|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129997159|NCT03267940|467953665|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129997160|NCT03267940|467953666|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129997161|NCT03267940|467953661|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129997162|NCT03267940|467953662|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129997163|NCT03267940|467953663|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129997164|NCT03267940|467953664|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
129997165|NCT03267940|467953665|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
129997166|NCT03267940|467953666|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129997167|NCT03267940|467953661|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
129997168|NCT03267940|467953662|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
129997169|NCT03267940|467953663|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
129997170|NCT03267940|467953664|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
129997171|NCT03267940|467953665|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
129997172|NCT03267940|467953666|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
129997173|NCT03267940|467953661|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
129997174|NCT03267940|467953662|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
129997175|NCT03267940|467953663|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
129997176|NCT03267940|467953664|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
129997177|NCT03267940|467953665|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
129997178|NCT03267940|467953666|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
129997179|NCT03267940|467953661|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
129997180|NCT03267940|467953662|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
129997181|NCT03267940|467953663|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
129997182|NCT03267940|467953664|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
129997183|NCT03267940|467953665|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
129997184|NCT03267940|467953666|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
129997185|NCT03267940|467953661|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
129997186|NCT03267940|467953662|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
130334905|NCT03904693|469195600|FG000|Overall Study|Physician Decision|0|||
130334906|NCT03904693|469195601|FG001|Overall Study|Physician Decision|0|||
129997187|NCT03267940|467953663|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
129997188|NCT03267940|467953664|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
129997189|NCT03267940|467953665|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
129997190|NCT03267940|467953666|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
129997191|NCT00388154|467953673|FG000|Overall Study|Withdrawal by Subject|1|||
129997192|NCT01948908|467953676|FG000|Overall Study|Protocol Violation|1|||
129997193|NCT01948908|467953677|FG001|Overall Study|Protocol Violation|0|||
129997194|NCT01948908|467953678|FG002|Overall Study|Protocol Violation|2|||
129997195|NCT03291587|467953679|FG000|Overall Study|Lost to Follow-up|62|||
129997196|NCT03291587|467953680|FG001|Overall Study|Lost to Follow-up|43|||
129997197|NCT03291587|467953679|FG000|Overall Study|Refused to Answer|5|||
129997198|NCT03291587|467953680|FG001|Overall Study|Refused to Answer|2|||
129997199|NCT03291587|467953679|FG000|Overall Study|Death|2|||
129997200|NCT03291587|467953680|FG001|Overall Study|Death|4|||
129997201|NCT03291587|467953679|FG000|Overall Study|Not interested in participating|8|||
129997202|NCT03291587|467953680|FG001|Overall Study|Not interested in participating|6|||
129997203|NCT03291587|467953679|FG000|Overall Study|Too busy to participate|4|||
129997204|NCT03291587|467953680|FG001|Overall Study|Too busy to participate|2|||
129997205|NCT00796120|467953682|FG000|Overall Study|Death|3|||
129997206|NCT00796120|467953683|FG001|Overall Study|Death|0|||
129997207|NCT00796120|467953682|FG000|Overall Study|Adverse Event|11|||
129997208|NCT00796120|467953683|FG001|Overall Study|Adverse Event|6|||
129997209|NCT00796120|467953682|FG000|Overall Study|Progressive disease|22|||
129997210|NCT00796120|467953683|FG001|Overall Study|Progressive disease|13|||
129997211|NCT00796120|467953682|FG000|Overall Study|Participant refusal|3|||
129997212|NCT00796120|467953683|FG001|Overall Study|Participant refusal|4|||
129997213|NCT00796120|467953682|FG000|Overall Study|Other|6|||
129997214|NCT00796120|467953683|FG001|Overall Study|Other|17|||
129997215|NCT00796120|467953682|FG000|Overall Study|Physician Decision|16|||
129997216|NCT00796120|467953683|FG001|Overall Study|Physician Decision|17|||
129997217|NCT00796120|467953682|FG000|Overall Study|Randomized but not treated|0|||
129997218|NCT00796120|467953683|FG001|Overall Study|Randomized but not treated|3|||
129997219|NCT02520284|467953684|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
129997220|NCT02520284|467953685|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
129997221|NCT02520284|467953686|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
129997222|NCT02520284|467953684|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
129997223|NCT02520284|467953685|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
129997224|NCT02520284|467953686|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
129997225|NCT02520284|467953684|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
129997226|NCT02520284|467953685|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
129997227|NCT02520284|467953686|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
129997228|NCT02520284|467953684|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
129997229|NCT02520284|467953685|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
129997230|NCT02520284|467953686|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
129997231|NCT02520284|467953684|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
129997232|NCT02520284|467953685|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
129997233|NCT02520284|467953686|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
129997234|NCT02520284|467953684|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
129997235|NCT02520284|467953685|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
129997236|NCT02520284|467953686|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
129997237|NCT02520284|467953684|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
129997238|NCT02520284|467953685|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
129997239|NCT02520284|467953686|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
129997240|NCT02520284|467953684|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
129997241|NCT02520284|467953685|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
129997242|NCT02520284|467953686|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
129997243|NCT02520284|467953684|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
129997244|NCT02520284|467953685|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
129997245|NCT02520284|467953686|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
129997246|NCT02520284|467953684|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
129997247|NCT02520284|467953685|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
129997248|NCT02520284|467953686|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
129997249|NCT02520284|467953684|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
129997250|NCT02520284|467953685|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
129997251|NCT02520284|467953686|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
129997252|NCT01898923|467953687|FG000|Overall Study|Lack of Efficacy|5|||
129997253|NCT01898923|467953688|FG001|Overall Study|Lack of Efficacy|6|||
129997254|NCT01898923|467953687|FG000|Overall Study|Adverse Event|3|||
129997255|NCT01898923|467953688|FG001|Overall Study|Adverse Event|1|||
129997256|NCT01898923|467953687|FG000|Overall Study|Lost to Follow-up|0|||
129997257|NCT01898923|467953688|FG001|Overall Study|Lost to Follow-up|1|||
129997258|NCT01898923|467953687|FG000|Overall Study|Withdrawal by Subject|4|||
129997259|NCT01898923|467953688|FG001|Overall Study|Withdrawal by Subject|7|||
129997260|NCT01898923|467953687|FG000|Overall Study|Physician Decision|3|||
129997261|NCT01898923|467953688|FG001|Overall Study|Physician Decision|4|||
129997262|NCT01898923|467953687|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
129997263|NCT01898923|467953688|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
129997264|NCT00381303|467953693|FG000|Overall Study|Lost to Follow-up|25|||
129997265|NCT00381303|467953694|FG001|Overall Study|Lost to Follow-up|9|||
129997266|NCT00381303|467953693|FG000|Overall Study|AE/HIV-related event|22|||
129997267|NCT00381303|467953694|FG001|Overall Study|AE/HIV-related event|6|||
129997268|NCT00381303|467953693|FG000|Overall Study|Non-Adherence|13|||
129997269|NCT00381303|467953694|FG001|Overall Study|Non-Adherence|6|||
129997270|NCT00381303|467953693|FG000|Overall Study|Withdrawal by Subject|13|||
129997271|NCT00381303|467953694|FG001|Overall Study|Withdrawal by Subject|6|||
129997272|NCT00381303|467953693|FG000|Overall Study|Virologic failure|6|||
129997273|NCT00381303|467953694|FG001|Overall Study|Virologic failure|4|||
129997274|NCT00381303|467953693|FG000|Overall Study|Ineligible to continue the trial|2|||
129997275|NCT00381303|467953694|FG001|Overall Study|Ineligible to continue the trial|1|||
129997276|NCT00381303|467953693|FG000|Overall Study|Pregnancy|2|||
129997277|NCT00381303|467953694|FG001|Overall Study|Pregnancy|0|||
129997278|NCT00381303|467953693|FG000|Overall Study|Physician Decision|1|||
129997279|NCT00381303|467953694|FG001|Overall Study|Physician Decision|0|||
129997280|NCT00381303|467953693|FG000|Overall Study|Physician's decision to close the site|3|||
129997281|NCT00381303|467953694|FG001|Overall Study|Physician's decision to close the site|1|||
129997282|NCT00381303|467953693|FG000|Overall Study|Subject moved out of state|2|||
129997283|NCT00381303|467953694|FG001|Overall Study|Subject moved out of state|0|||
129997284|NCT00381303|467953693|FG000|Overall Study|Subject taking too many different meds|1|||
129997285|NCT00381303|467953694|FG001|Overall Study|Subject taking too many different meds|0|||
129997286|NCT00381303|467953693|FG000|Overall Study|No virologic response by week 12|1|||
129997287|NCT00381303|467953694|FG001|Overall Study|No virologic response by week 12|0|||
129997288|NCT00381303|467953693|FG000|Overall Study|Subject was too busy for appointments|1|||
129997289|NCT00381303|467953694|FG001|Overall Study|Subject was too busy for appointments|0|||
129997290|NCT00381303|467953693|FG000|Overall Study|Subject did not continue visits|1|||
129997291|NCT00381303|467953694|FG001|Overall Study|Subject did not continue visits|0|||
129997292|NCT00381303|467953693|FG000|Overall Study|Subject primary physician's decision|1|||
129997293|NCT00381303|467953694|FG001|Overall Study|Subject primary physician's decision|0|||
129997294|NCT01211522|467953695|FG000|Overall Study|Withdrawal by Subject|3|||
129997295|NCT01211522|467953696|FG001|Overall Study|Withdrawal by Subject|7|||
129997296|NCT01211522|467953697|FG002|Overall Study|Withdrawal by Subject|5|||
129997297|NCT00547365|467953699|FG000|Overall Study|Physician Decision|1|||
129997298|NCT00547365|467953699|FG000|Overall Study|Lost to Follow-up|1|||
129997299|NCT00547365|467953699|FG000|Overall Study|Protocol Violation|2|||
129997300|NCT00547365|467953699|FG000|Overall Study|death (not related to study)|4|||
129997301|NCT00504881|467953700|FG000|Overall Study|Lack of Efficacy|1|||
129997302|NCT00504881|467953701|FG001|Overall Study|Lack of Efficacy|5|||
129997303|NCT00504881|467953700|FG000|Overall Study|Lost to Follow-up|0|||
129997304|NCT00504881|467953701|FG001|Overall Study|Lost to Follow-up|2|||
129997305|NCT00504881|467953700|FG000|Overall Study|Withdrawal by Subject|1|||
129997306|NCT00504881|467953701|FG001|Overall Study|Withdrawal by Subject|4|||
129997307|NCT00504881|467953700|FG000|Overall Study|Non-Compliance|1|||
129997308|NCT00504881|467953701|FG001|Overall Study|Non-Compliance|0|||
129997309|NCT00504881|467953700|FG000|Overall Study|No Birth Control|0|||
129997310|NCT00504881|467953701|FG001|Overall Study|No Birth Control|1|||
129997311|NCT00504881|467953700|FG000|Overall Study|Safety Visit not performed|0|||
129997312|NCT00504881|467953701|FG001|Overall Study|Safety Visit not performed|1|||
129997313|NCT00504881|467953700|FG000|Overall Study|AE, serious fatal|0|||
129997314|NCT00504881|467953701|FG001|Overall Study|AE, serious fatal|1|||
129997315|NCT00504881|467953700|FG000|Overall Study|SAE, non-fatal|2|||
129997316|NCT00504881|467953701|FG001|Overall Study|SAE, non-fatal|6|||
129997317|NCT00504881|467953700|FG000|Overall Study|AE, non-serious non-fatal|4|||
129997318|NCT00504881|467953701|FG001|Overall Study|AE, non-serious non-fatal|14|||
129997319|NCT00504881|467953700|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129997320|NCT00504881|467953701|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
129997321|NCT00504881|467953700|FG000|Overall Study|AE of unknown type|1|||
129997322|NCT00504881|467953701|FG001|Overall Study|AE of unknown type|0|||
129997323|NCT01777269|467953702|FG000|Overall Study|Adverse Event|24|||
129884284|NCT00358215|467536308|FG000|Overall Study|Did not receive investigational product|2|||
129997324|NCT01777269|467953703|FG001|Overall Study|Adverse Event|33|||
129997325|NCT01777269|467953702|FG000|Overall Study|Lack of Efficacy|8|||
129997326|NCT01777269|467953703|FG001|Overall Study|Lack of Efficacy|10|||
129997327|NCT01777269|467953702|FG000|Overall Study|Protocol Violation|4|||
129997328|NCT01777269|467953703|FG001|Overall Study|Protocol Violation|4|||
129997329|NCT01777269|467953702|FG000|Overall Study|Participants reached stopping criteria|1|||
129997330|NCT01777269|467953703|FG001|Overall Study|Participants reached stopping criteria|1|||
129997331|NCT01777269|467953702|FG000|Overall Study|Lost to Follow-up|4|||
129997332|NCT01777269|467953703|FG001|Overall Study|Lost to Follow-up|0|||
129997333|NCT01777269|467953702|FG000|Overall Study|Physician Decision|5|||
129997334|NCT01777269|467953703|FG001|Overall Study|Physician Decision|2|||
129997335|NCT01777269|467953702|FG000|Overall Study|Withdrawal by Subject|9|||
129997336|NCT01777269|467953703|FG001|Overall Study|Withdrawal by Subject|9|||
129997337|NCT01966471|467953705|FG000|Overall Study|Death|44|||
129997338|NCT01966471|467953706|FG001|Overall Study|Death|56|||
129997339|NCT01966471|467953705|FG000|Overall Study|Lost to Follow-up|46|||
129997340|NCT01966471|467953706|FG001|Overall Study|Lost to Follow-up|39|||
129997341|NCT01966471|467953705|FG000|Overall Study|Various reasons|4|||
129997342|NCT01966471|467953706|FG001|Overall Study|Various reasons|4|||
129997343|NCT01966471|467953705|FG000|Overall Study|Physician Decision|7|||
129997344|NCT01966471|467953706|FG001|Overall Study|Physician Decision|5|||
129997345|NCT01966471|467953705|FG000|Overall Study|Study Terminated By Sponsor|758|||
129997346|NCT01966471|467953706|FG001|Overall Study|Study Terminated By Sponsor|773|||
129997347|NCT01966471|467953705|FG000|Overall Study|Withdrawal by Subject|59|||
129997348|NCT01966471|467953706|FG001|Overall Study|Withdrawal by Subject|51|||
129997349|NCT01030198|467953707|FG000|Overall Study|Could not measure efficacy accurately|0|||
129997350|NCT01030198|467953708|FG001|Overall Study|Could not measure efficacy accurately|7|||
129997351|NCT02370043|467953709|FG000|Overall Study|Withdrawal by Subject|0|||
129997352|NCT02370043|467953710|FG001|Overall Study|Withdrawal by Subject|0|||
129997353|NCT02370043|467953711|FG002|Overall Study|Withdrawal by Subject|0|||
129997354|NCT02370043|467953712|FG003|Overall Study|Withdrawal by Subject|0|||
129997355|NCT02370043|467953713|FG004|Overall Study|Withdrawal by Subject|1|||
129997356|NCT02370043|467953714|FG005|Overall Study|Withdrawal by Subject|1|||
129997357|NCT00688181|467953715|FG000|Overall Study|Lost to Follow-up|17|||
129997358|NCT00688181|467953715|FG000|Overall Study|Unknown Reason|4|||
129997359|NCT00688181|467953715|FG000|Overall Study|Non-clinical Reason|2|||
129997360|NCT01050205|467953716|FG000|Overall Study|Lost to Follow-up|7|||
129997361|NCT01050205|467953717|FG001|Overall Study|Lost to Follow-up|1|||
129997362|NCT01050205|467953716|FG000|Overall Study|Withdrawal by Subject|1|||
129997363|NCT01050205|467953717|FG001|Overall Study|Withdrawal by Subject|1|||
129997364|NCT01050205|467953716|FG000|Overall Study|Relocated from area|1|||
129997365|NCT01050205|467953717|FG001|Overall Study|Relocated from area|2|||
129997366|NCT01050205|467953716|FG000|Overall Study|Discontinued Intervention|2|||
129997367|NCT01050205|467953717|FG001|Overall Study|Discontinued Intervention|0|||
129997368|NCT01119001|467953718|FG000|Overall Study|Withdrawal by Subject|2|||
129997369|NCT00954421|467953719|FG000|Screening|screen failures|3|||
129997370|NCT00954421|467953719|FG000|6 Months of DBS|Withdrawal by Subject|1|||
129997371|NCT00954421|467953719|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
129997372|NCT00777946|467953720|FG000|Overall Study|Adverse Event|11|||
129997373|NCT00777946|467953721|FG001|Overall Study|Adverse Event|1|||
129997374|NCT00777946|467953722|FG002|Overall Study|Adverse Event|3|||
129997375|NCT00777946|467953720|FG000|Overall Study|Lack of Efficacy|0|||
129997376|NCT00777946|467953721|FG001|Overall Study|Lack of Efficacy|0|||
129997377|NCT00777946|467953722|FG002|Overall Study|Lack of Efficacy|9|||
129997378|NCT00777946|467953720|FG000|Overall Study|Condition no longer required study drug|1|||
129997379|NCT00777946|467953721|FG001|Overall Study|Condition no longer required study drug|0|||
129997380|NCT00777946|467953722|FG002|Overall Study|Condition no longer required study drug|0|||
129997381|NCT00777946|467953720|FG000|Overall Study|Patient withdrew consent|3|||
129997382|NCT00777946|467953721|FG001|Overall Study|Patient withdrew consent|2|||
129997383|NCT00777946|467953722|FG002|Overall Study|Patient withdrew consent|3|||
129997384|NCT00777946|467953720|FG000|Overall Study|Lost to Follow-up|3|||
130334907|NCT03904693|469195602|FG002|Overall Study|Physician Decision|2|||
130334908|NCT03904693|469195600|FG000|Overall Study|Withdrawal by Subject|0|||
130334909|NCT03904693|469195601|FG001|Overall Study|Withdrawal by Subject|1|||
130334910|NCT03904693|469195602|FG002|Overall Study|Withdrawal by Subject|4|||
130334911|NCT02100696|469195603|FG000|Induction Phase|Adverse Event|0|||
130334912|NCT02100696|469195604|FG001|Induction Phase|Adverse Event|0|||
130334913|NCT02100696|469195605|FG002|Induction Phase|Adverse Event|1|||
130334914|NCT02100696|469195606|FG003|Induction Phase|Adverse Event|0|||
130334915|NCT02100696|469195607|FG004|Induction Phase|Adverse Event|0|||
130334916|NCT02100696|469195608|FG005|Induction Phase|Adverse Event|0|||
129997385|NCT00777946|467953721|FG001|Overall Study|Lost to Follow-up|1|||
129997386|NCT00777946|467953722|FG002|Overall Study|Lost to Follow-up|0|||
129997387|NCT00777946|467953720|FG000|Overall Study|Protocol deviation|2|||
129997388|NCT00777946|467953721|FG001|Overall Study|Protocol deviation|1|||
129997389|NCT00777946|467953722|FG002|Overall Study|Protocol deviation|1|||
129997390|NCT00777946|467953720|FG000|Overall Study|Randomized in error|1|||
129997391|NCT00777946|467953721|FG001|Overall Study|Randomized in error|1|||
129997392|NCT00777946|467953722|FG002|Overall Study|Randomized in error|0|||
129997393|NCT03217266|467955241|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
129997394|NCT03217266|467955242|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
129997395|NCT03217266|467955243|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
130334917|NCT02100696|469195603|FG000|Induction Phase|Lost to Follow-up|1|||
129997396|NCT03217266|467955244|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
129997397|NCT03217266|467955241|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
129997398|NCT03217266|467955242|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
129997399|NCT03217266|467955243|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
129997400|NCT03217266|467955244|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
129997401|NCT03217266|467955241|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
129997402|NCT03217266|467955242|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
129997403|NCT03217266|467955243|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
129997404|NCT03217266|467955244|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
129997405|NCT01390181|467955245|FG000|Overall Study|Lost to Follow-up|1|||
129997406|NCT01390181|467955245|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
129997407|NCT01256658|467955247|FG000|Period 1|Lost to Follow-up|837|||
129997408|NCT01256658|467955248|FG001|Period 1|Lost to Follow-up|661|||
129997409|NCT01256658|467955247|FG000|Period 1|Withdrawal by Subject|35|||
129997410|NCT01256658|467955248|FG001|Period 1|Withdrawal by Subject|43|||
129997411|NCT01256658|467955247|FG000|Period 1|Death|48|||
129997412|NCT01256658|467955248|FG001|Period 1|Death|44|||
129997413|NCT00909792|467955249|FG000|Period 1|Did not meet inclusion criteria|0|||
129997414|NCT00909792|467955250|FG001|Period 1|Did not meet inclusion criteria|1|||
129997415|NCT00909792|467955249|FG000|Period 2|Biomicroscopy|1|||
129997416|NCT00909792|467955250|FG001|Period 2|Biomicroscopy|0|||
129997417|NCT00909792|467955249|FG000|Period 2|Lost to Follow-up|0|||
129997418|NCT00909792|467955250|FG001|Period 2|Lost to Follow-up|1|||
129997419|NCT02525861|467955256|FG000|Overall Study|Adverse Event|1|||
129997420|NCT02525861|467955257|FG001|Overall Study|Adverse Event|0|||
129997421|NCT02525861|467955256|FG000|Overall Study|Withdrawal by Subject|0|||
129997422|NCT02525861|467955257|FG001|Overall Study|Withdrawal by Subject|1|||
129997423|NCT02525861|467955256|FG000|Overall Study|Physician Decision|0|||
129997424|NCT02525861|467955257|FG001|Overall Study|Physician Decision|1|||
129997425|NCT01794520|467955258|FG000|Overall Study|Adverse events- related to progression|0|||
129997426|NCT01794520|467955259|FG001|Overall Study|Adverse events- related to progression|0|||
129997427|NCT01794520|467955260|FG002|Overall Study|Adverse events- related to progression|1|||
129997428|NCT01794520|467955261|FG003|Overall Study|Adverse events- related to progression|2|||
129997429|NCT01794520|467955262|FG004|Overall Study|Adverse events- related to progression|0|||
129997430|NCT01794520|467955263|FG005|Overall Study|Adverse events- related to progression|1|||
129997431|NCT01794520|467955264|FG006|Overall Study|Adverse events- related to progression|0|||
129997432|NCT01794520|467955258|FG000|Overall Study|Adverse event- not related to progression|1|||
129997433|NCT01794520|467955259|FG001|Overall Study|Adverse event- not related to progression|1|||
129997434|NCT01794520|467955260|FG002|Overall Study|Adverse event- not related to progression|0|||
129997435|NCT01794520|467955261|FG003|Overall Study|Adverse event- not related to progression|0|||
129997436|NCT01794520|467955262|FG004|Overall Study|Adverse event- not related to progression|2|||
129997437|NCT01794520|467955263|FG005|Overall Study|Adverse event- not related to progression|0|||
129997438|NCT01794520|467955264|FG006|Overall Study|Adverse event- not related to progression|0|||
129997439|NCT01794520|467955258|FG000|Overall Study|Progressive disease|5|||
129997440|NCT01794520|467955259|FG001|Overall Study|Progressive disease|6|||
129997441|NCT01794520|467955260|FG002|Overall Study|Progressive disease|2|||
129997442|NCT01794520|467955261|FG003|Overall Study|Progressive disease|5|||
129997443|NCT01794520|467955262|FG004|Overall Study|Progressive disease|27|||
129997444|NCT01794520|467955263|FG005|Overall Study|Progressive disease|18|||
129997445|NCT01794520|467955264|FG006|Overall Study|Progressive disease|0|||
129997446|NCT01794520|467955258|FG000|Overall Study|Withdrew consent|0|||
129997447|NCT01794520|467955259|FG001|Overall Study|Withdrew consent|0|||
129997448|NCT01794520|467955260|FG002|Overall Study|Withdrew consent|1|||
129997449|NCT01794520|467955261|FG003|Overall Study|Withdrew consent|1|||
129997450|NCT01794520|467955262|FG004|Overall Study|Withdrew consent|0|||
129997451|NCT01794520|467955263|FG005|Overall Study|Withdrew consent|0|||
129997452|NCT01794520|467955264|FG006|Overall Study|Withdrew consent|0|||
129997453|NCT01794520|467955258|FG000|Overall Study|Lost to Follow-up|0|||
129997454|NCT01794520|467955259|FG001|Overall Study|Lost to Follow-up|0|||
129997455|NCT01794520|467955260|FG002|Overall Study|Lost to Follow-up|0|||
129997456|NCT01794520|467955261|FG003|Overall Study|Lost to Follow-up|0|||
129997457|NCT01794520|467955262|FG004|Overall Study|Lost to Follow-up|1|||
130334918|NCT02100696|469195604|FG001|Induction Phase|Lost to Follow-up|0|||
130334919|NCT02100696|469195605|FG002|Induction Phase|Lost to Follow-up|1|||
130334920|NCT02100696|469195606|FG003|Induction Phase|Lost to Follow-up|0|||
130334921|NCT02100696|469195607|FG004|Induction Phase|Lost to Follow-up|0|||
129997458|NCT01794520|467955263|FG005|Overall Study|Lost to Follow-up|0|||
129997459|NCT01794520|467955264|FG006|Overall Study|Lost to Follow-up|0|||
129997460|NCT01794520|467955258|FG000|Overall Study|Toxicity|0|||
129997461|NCT01794520|467955259|FG001|Overall Study|Toxicity|2|||
129997462|NCT01794520|467955260|FG002|Overall Study|Toxicity|0|||
129997463|NCT01794520|467955261|FG003|Overall Study|Toxicity|0|||
129997464|NCT01794520|467955262|FG004|Overall Study|Toxicity|0|||
129997465|NCT01794520|467955263|FG005|Overall Study|Toxicity|0|||
129997466|NCT01794520|467955264|FG006|Overall Study|Toxicity|0|||
130334922|NCT02100696|469195608|FG005|Induction Phase|Lost to Follow-up|0|||
129997467|NCT01794520|467955258|FG000|Overall Study|Study terminated by sponsor|0|||
129997468|NCT01794520|467955259|FG001|Overall Study|Study terminated by sponsor|0|||
129997469|NCT01794520|467955260|FG002|Overall Study|Study terminated by sponsor|1|||
129997470|NCT01794520|467955261|FG003|Overall Study|Study terminated by sponsor|0|||
129997471|NCT01794520|467955262|FG004|Overall Study|Study terminated by sponsor|1|||
129997472|NCT01794520|467955263|FG005|Overall Study|Study terminated by sponsor|0|||
129997473|NCT01794520|467955264|FG006|Overall Study|Study terminated by sponsor|7|||
129997474|NCT01794520|467955258|FG000|Overall Study|Death|0|||
129997475|NCT01794520|467955259|FG001|Overall Study|Death|0|||
129997476|NCT01794520|467955260|FG002|Overall Study|Death|0|||
129997477|NCT01794520|467955261|FG003|Overall Study|Death|0|||
129997478|NCT01794520|467955262|FG004|Overall Study|Death|1|||
129997479|NCT01794520|467955263|FG005|Overall Study|Death|0|||
129997480|NCT01794520|467955264|FG006|Overall Study|Death|22|||
129997481|NCT01794520|467955258|FG000|Overall Study|Other, not specified|0|||
129997482|NCT01794520|467955259|FG001|Overall Study|Other, not specified|0|||
129997483|NCT01794520|467955260|FG002|Overall Study|Other, not specified|1|||
129997484|NCT01794520|467955261|FG003|Overall Study|Other, not specified|1|||
129997485|NCT01794520|467955262|FG004|Overall Study|Other, not specified|4|||
129997486|NCT01794520|467955263|FG005|Overall Study|Other, not specified|1|||
129997487|NCT01794520|467955264|FG006|Overall Study|Other, not specified|2|||
129997488|NCT04796896|467955266|FG000|Overall Study|Adverse Event|1|||
129997489|NCT04796896|467955267|FG001|Overall Study|Adverse Event|0|||
129997490|NCT04796896|467955268|FG002|Overall Study|Adverse Event|0|||
129997491|NCT04796896|467955269|FG003|Overall Study|Adverse Event|0|||
129997492|NCT04796896|467955270|FG004|Overall Study|Adverse Event|0|||
129997493|NCT04796896|467955271|FG005|Overall Study|Adverse Event|1|||
129997494|NCT04796896|467955272|FG006|Overall Study|Adverse Event|1|||
129997495|NCT04796896|467955273|FG007|Overall Study|Adverse Event|0|||
129997496|NCT04796896|467955274|FG008|Overall Study|Adverse Event|1|||
129997497|NCT04796896|467955275|FG009|Overall Study|Adverse Event|1|||
129997498|NCT04796896|467955276|FG010|Overall Study|Adverse Event|1|||
129997499|NCT04796896|467955277|FG011|Overall Study|Adverse Event|0|||
129997500|NCT04796896|467955266|FG000|Overall Study|Lost to Follow-up|24|||
129997501|NCT04796896|467955267|FG001|Overall Study|Lost to Follow-up|15|||
129997502|NCT04796896|467955268|FG002|Overall Study|Lost to Follow-up|6|||
129997503|NCT04796896|467955269|FG003|Overall Study|Lost to Follow-up|4|||
129997504|NCT04796896|467955270|FG004|Overall Study|Lost to Follow-up|21|||
129997505|NCT04796896|467955271|FG005|Overall Study|Lost to Follow-up|55|||
129997506|NCT04796896|467955272|FG006|Overall Study|Lost to Follow-up|237|||
129997507|NCT04796896|467955273|FG007|Overall Study|Lost to Follow-up|52|||
129997508|NCT04796896|467955274|FG008|Overall Study|Lost to Follow-up|221|||
129997509|NCT04796896|467955275|FG009|Overall Study|Lost to Follow-up|43|||
129997510|NCT04796896|467955276|FG010|Overall Study|Lost to Follow-up|142|||
129997511|NCT04796896|467955277|FG011|Overall Study|Lost to Follow-up|18|||
129997512|NCT04796896|467955266|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
129997513|NCT04796896|467955267|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
129997514|NCT04796896|467955268|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
129997515|NCT04796896|467955269|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
129997516|NCT04796896|467955270|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
129997517|NCT04796896|467955271|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
129997518|NCT04796896|467955272|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
129997519|NCT04796896|467955273|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
129997520|NCT04796896|467955274|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
129997521|NCT04796896|467955275|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
129997522|NCT04796896|467955276|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
129997523|NCT04796896|467955277|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
129997524|NCT04796896|467955266|FG000|Overall Study|Physician Decision|1|||
129997525|NCT04796896|467955267|FG001|Overall Study|Physician Decision|0|||
129997526|NCT04796896|467955268|FG002|Overall Study|Physician Decision|0|||
129997527|NCT04796896|467955269|FG003|Overall Study|Physician Decision|0|||
129997528|NCT04796896|467955270|FG004|Overall Study|Physician Decision|0|||
129997529|NCT04796896|467955271|FG005|Overall Study|Physician Decision|3|||
129997530|NCT04796896|467955272|FG006|Overall Study|Physician Decision|18|||
129997531|NCT04796896|467955273|FG007|Overall Study|Physician Decision|1|||
129997532|NCT04796896|467955274|FG008|Overall Study|Physician Decision|7|||
129997533|NCT04796896|467955275|FG009|Overall Study|Physician Decision|0|||
129997534|NCT04796896|467955276|FG010|Overall Study|Physician Decision|5|||
129997535|NCT04796896|467955277|FG011|Overall Study|Physician Decision|0|||
129997536|NCT04796896|467955266|FG000|Overall Study|Withdrawal by Subject|36|||
129997537|NCT04796896|467955267|FG001|Overall Study|Withdrawal by Subject|31|||
129997538|NCT04796896|467955268|FG002|Overall Study|Withdrawal by Subject|11|||
129997539|NCT04796896|467955269|FG003|Overall Study|Withdrawal by Subject|8|||
129997540|NCT04796896|467955270|FG004|Overall Study|Withdrawal by Subject|16|||
129997541|NCT04796896|467955271|FG005|Overall Study|Withdrawal by Subject|162|||
129997542|NCT04796896|467955272|FG006|Overall Study|Withdrawal by Subject|299|||
130334923|NCT02100696|469195603|FG000|Induction Phase|Protocol Violation|0|||
129997543|NCT04796896|467955273|FG007|Overall Study|Withdrawal by Subject|149|||
129997544|NCT04796896|467955274|FG008|Overall Study|Withdrawal by Subject|303|||
129997545|NCT04796896|467955275|FG009|Overall Study|Withdrawal by Subject|94|||
129997546|NCT04796896|467955276|FG010|Overall Study|Withdrawal by Subject|192|||
129997547|NCT04796896|467955277|FG011|Overall Study|Withdrawal by Subject|16|||
129997548|NCT04796896|467955266|FG000|Overall Study|Other Than Specified|6|||
129997549|NCT04796896|467955267|FG001|Overall Study|Other Than Specified|5|||
129997550|NCT04796896|467955268|FG002|Overall Study|Other Than Specified|3|||
129997551|NCT04796896|467955269|FG003|Overall Study|Other Than Specified|2|||
129997552|NCT04796896|467955270|FG004|Overall Study|Other Than Specified|6|||
129997553|NCT04796896|467955271|FG005|Overall Study|Other Than Specified|31|||
129997554|NCT04796896|467955272|FG006|Overall Study|Other Than Specified|86|||
129997555|NCT04796896|467955273|FG007|Overall Study|Other Than Specified|66|||
129997556|NCT04796896|467955274|FG008|Overall Study|Other Than Specified|388|||
130334924|NCT02100696|469195604|FG001|Induction Phase|Protocol Violation|1|||
129997557|NCT04796896|467955275|FG009|Overall Study|Other Than Specified|48|||
129997558|NCT04796896|467955276|FG010|Overall Study|Other Than Specified|258|||
129997559|NCT04796896|467955277|FG011|Overall Study|Other Than Specified|4|||
129997560|NCT04796896|467955266|FG000|Overall Study|Protocol Deviation|0|||
129997561|NCT04796896|467955267|FG001|Overall Study|Protocol Deviation|0|||
129997562|NCT04796896|467955268|FG002|Overall Study|Protocol Deviation|0|||
130334925|NCT02100696|469195605|FG002|Induction Phase|Protocol Violation|1|||
130334926|NCT02100696|469195606|FG003|Induction Phase|Protocol Violation|0|||
130334927|NCT02100696|469195607|FG004|Induction Phase|Protocol Violation|0|||
130334928|NCT02100696|469195608|FG005|Induction Phase|Protocol Violation|0|||
130334929|NCT02100696|469195603|FG000|Induction Phase|Withdrawal by Subject|8|||
130334930|NCT02100696|469195604|FG001|Induction Phase|Withdrawal by Subject|2|||
130334931|NCT02100696|469195605|FG002|Induction Phase|Withdrawal by Subject|13|||
130334932|NCT02100696|469195606|FG003|Induction Phase|Withdrawal by Subject|0|||
130334933|NCT02100696|469195607|FG004|Induction Phase|Withdrawal by Subject|0|||
130334934|NCT02100696|469195608|FG005|Induction Phase|Withdrawal by Subject|0|||
130334935|NCT02100696|469195603|FG000|Induction Phase|Physician Decision|1|||
130334936|NCT02100696|469195604|FG001|Induction Phase|Physician Decision|0|||
130334937|NCT02100696|469195605|FG002|Induction Phase|Physician Decision|2|||
130334938|NCT02100696|469195606|FG003|Induction Phase|Physician Decision|0|||
130334939|NCT02100696|469195607|FG004|Induction Phase|Physician Decision|0|||
130334940|NCT02100696|469195608|FG005|Induction Phase|Physician Decision|0|||
130334941|NCT02100696|469195603|FG000|Induction Phase|Multiple Reasons|5|||
130334942|NCT02100696|469195604|FG001|Induction Phase|Multiple Reasons|2|||
130334943|NCT02100696|469195605|FG002|Induction Phase|Multiple Reasons|8|||
130334944|NCT02100696|469195606|FG003|Induction Phase|Multiple Reasons|0|||
130334945|NCT02100696|469195607|FG004|Induction Phase|Multiple Reasons|0|||
130334946|NCT02100696|469195608|FG005|Induction Phase|Multiple Reasons|0|||
130334947|NCT02100696|469195603|FG000|Maintenance Phase|Adverse Event|0|||
130334948|NCT02100696|469195604|FG001|Maintenance Phase|Adverse Event|0|||
130334949|NCT02100696|469195605|FG002|Maintenance Phase|Adverse Event|0|||
130334950|NCT02100696|469195606|FG003|Maintenance Phase|Adverse Event|0|||
130334951|NCT02100696|469195607|FG004|Maintenance Phase|Adverse Event|0|||
130334952|NCT02100696|469195608|FG005|Maintenance Phase|Adverse Event|2|||
130334953|NCT02100696|469195603|FG000|Maintenance Phase|Lost to Follow-up|0|||
130334954|NCT02100696|469195604|FG001|Maintenance Phase|Lost to Follow-up|0|||
130334955|NCT02100696|469195605|FG002|Maintenance Phase|Lost to Follow-up|0|||
130334956|NCT02100696|469195606|FG003|Maintenance Phase|Lost to Follow-up|0|||
130334957|NCT02100696|469195607|FG004|Maintenance Phase|Lost to Follow-up|1|||
130334958|NCT02100696|469195608|FG005|Maintenance Phase|Lost to Follow-up|0|||
130334959|NCT02100696|469195603|FG000|Maintenance Phase|Protocol Violation|0|||
130334960|NCT02100696|469195604|FG001|Maintenance Phase|Protocol Violation|0|||
130334961|NCT02100696|469195605|FG002|Maintenance Phase|Protocol Violation|0|||
130334962|NCT02100696|469195606|FG003|Maintenance Phase|Protocol Violation|0|||
130334963|NCT02100696|469195607|FG004|Maintenance Phase|Protocol Violation|1|||
130334964|NCT02100696|469195608|FG005|Maintenance Phase|Protocol Violation|0|||
130334965|NCT02100696|469195603|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130334966|NCT02100696|469195604|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130334967|NCT02100696|469195605|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130334968|NCT02100696|469195606|FG003|Maintenance Phase|Withdrawal by Subject|1|||
130334969|NCT02100696|469195607|FG004|Maintenance Phase|Withdrawal by Subject|4|||
130334970|NCT02100696|469195608|FG005|Maintenance Phase|Withdrawal by Subject|2|||
130334971|NCT02100696|469195603|FG000|Maintenance Phase|Physician Decision|0|||
130334972|NCT02100696|469195604|FG001|Maintenance Phase|Physician Decision|0|||
129997563|NCT04796896|467955269|FG003|Overall Study|Protocol Deviation|1|||
130334973|NCT02100696|469195605|FG002|Maintenance Phase|Physician Decision|0|||
130334974|NCT02100696|469195606|FG003|Maintenance Phase|Physician Decision|0|||
130334975|NCT02100696|469195607|FG004|Maintenance Phase|Physician Decision|1|||
130334976|NCT02100696|469195608|FG005|Maintenance Phase|Physician Decision|0|||
129997564|NCT04796896|467955270|FG004|Overall Study|Protocol Deviation|1|||
130334977|NCT02100696|469195603|FG000|Maintenance Phase|Multiple Reasons|0|||
130334978|NCT02100696|469195604|FG001|Maintenance Phase|Multiple Reasons|0|||
130334979|NCT02100696|469195605|FG002|Maintenance Phase|Multiple Reasons|0|||
130334980|NCT02100696|469195606|FG003|Maintenance Phase|Multiple Reasons|0|||
130334981|NCT02100696|469195607|FG004|Maintenance Phase|Multiple Reasons|2|||
130334982|NCT02100696|469195608|FG005|Maintenance Phase|Multiple Reasons|1|||
130334983|NCT03865381|469195611|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
130334984|NCT03865381|469195611|FG000|Overall Study|Withdrawal by Subject|2|||
130334985|NCT05626322|469195612|FG000|Overall Study|Death|2|||
130334986|NCT05626322|469195613|FG001|Overall Study|Death|0|||
130334987|NCT05626322|469195614|FG002|Overall Study|Death|0|||
130334988|NCT05626322|469195612|FG000|Overall Study|Physician Decision|1|||
130334989|NCT05626322|469195613|FG001|Overall Study|Physician Decision|0|||
129997565|NCT04796896|467955271|FG005|Overall Study|Protocol Deviation|2|||
129997566|NCT04796896|467955272|FG006|Overall Study|Protocol Deviation|2|||
129997567|NCT04796896|467955273|FG007|Overall Study|Protocol Deviation|2|||
129997568|NCT04796896|467955274|FG008|Overall Study|Protocol Deviation|2|||
129997569|NCT04796896|467955275|FG009|Overall Study|Protocol Deviation|1|||
129997570|NCT04796896|467955276|FG010|Overall Study|Protocol Deviation|0|||
129997571|NCT04796896|467955277|FG011|Overall Study|Protocol Deviation|0|||
129997572|NCT04796896|467955266|FG000|Overall Study|Missing|0|||
129997573|NCT04796896|467955267|FG001|Overall Study|Missing|0|||
129997574|NCT04796896|467955268|FG002|Overall Study|Missing|0|||
129997575|NCT04796896|467955269|FG003|Overall Study|Missing|0|||
129997576|NCT04796896|467955270|FG004|Overall Study|Missing|0|||
129997577|NCT04796896|467955271|FG005|Overall Study|Missing|0|||
129997578|NCT04796896|467955272|FG006|Overall Study|Missing|2|||
129997579|NCT04796896|467955273|FG007|Overall Study|Missing|1|||
129997580|NCT04796896|467955274|FG008|Overall Study|Missing|2|||
129997581|NCT04796896|467955275|FG009|Overall Study|Missing|1|||
129997582|NCT04796896|467955276|FG010|Overall Study|Missing|1|||
129997583|NCT04796896|467955277|FG011|Overall Study|Missing|0|||
129997584|NCT04796896|467955266|FG000|Overall Study|Death|0|||
129997585|NCT04796896|467955267|FG001|Overall Study|Death|0|||
129997586|NCT04796896|467955268|FG002|Overall Study|Death|0|||
129997587|NCT04796896|467955269|FG003|Overall Study|Death|0|||
129997588|NCT04796896|467955270|FG004|Overall Study|Death|0|||
129997589|NCT04796896|467955271|FG005|Overall Study|Death|0|||
129997590|NCT04796896|467955272|FG006|Overall Study|Death|0|||
129997591|NCT04796896|467955273|FG007|Overall Study|Death|0|||
129997592|NCT04796896|467955274|FG008|Overall Study|Death|1|||
129997593|NCT04796896|467955275|FG009|Overall Study|Death|0|||
129997594|NCT04796896|467955276|FG010|Overall Study|Death|0|||
129997595|NCT04796896|467955277|FG011|Overall Study|Death|0|||
129997596|NCT04356183|467955278|FG000|Overall Study|Lost to Follow-up|1|||
129997597|NCT04356183|467955279|FG001|Overall Study|Lost to Follow-up|0|||
129997598|NCT04356183|467955278|FG000|Overall Study|Withdrawal by Subject|1|||
129997599|NCT04356183|467955279|FG001|Overall Study|Withdrawal by Subject|1|||
129997600|NCT01177787|467955280|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
129997601|NCT01177787|467955280|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
129997602|NCT01177787|467955280|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
129997603|NCT00402363|467955283|FG000|Overall Study|Adverse Event|9|||
129997604|NCT00402363|467955284|FG001|Overall Study|Adverse Event|14|||
129997605|NCT00402363|467955285|FG002|Overall Study|Adverse Event|2|||
129997606|NCT00402363|467955286|FG003|Overall Study|Adverse Event|2|||
129997607|NCT00402363|467955283|FG000|Overall Study|Withdrew Consent|10|||
129997608|NCT00402363|467955284|FG001|Overall Study|Withdrew Consent|5|||
129997609|NCT00402363|467955285|FG002|Overall Study|Withdrew Consent|2|||
129997610|NCT00402363|467955286|FG003|Overall Study|Withdrew Consent|1|||
129997611|NCT00402363|467955283|FG000|Overall Study|Protocol Violation|3|||
130334990|NCT05626322|469195614|FG002|Overall Study|Physician Decision|0|||
130334991|NCT05626322|469195612|FG000|Overall Study|Progressive Disease|0|||
130334992|NCT05626322|469195613|FG001|Overall Study|Progressive Disease|1|||
130334993|NCT05626322|469195614|FG002|Overall Study|Progressive Disease|1|||
130334994|NCT05626322|469195612|FG000|Overall Study|Study terminated by sponsor|0|||
130334995|NCT05626322|469195613|FG001|Overall Study|Study terminated by sponsor|1|||
130334996|NCT05626322|469195614|FG002|Overall Study|Study terminated by sponsor|0|||
130334997|NCT01668589|469195619|FG000|Overall Study|Lost to Follow-up|29|||
130334998|NCT01668589|469195620|FG001|Overall Study|Lost to Follow-up|37|||
130334999|NCT01668589|469195621|FG002|Overall Study|Lost to Follow-up|15|||
129997612|NCT00402363|467955284|FG001|Overall Study|Protocol Violation|5|||
129997613|NCT00402363|467955285|FG002|Overall Study|Protocol Violation|0|||
129997614|NCT00402363|467955286|FG003|Overall Study|Protocol Violation|3|||
129997615|NCT00402363|467955283|FG000|Overall Study|Lost to Follow-up|5|||
129997616|NCT00402363|467955284|FG001|Overall Study|Lost to Follow-up|4|||
129997617|NCT00402363|467955285|FG002|Overall Study|Lost to Follow-up|0|||
129997618|NCT00402363|467955286|FG003|Overall Study|Lost to Follow-up|2|||
129997619|NCT00402363|467955283|FG000|Overall Study|"Captured as Other"|6|||
129997620|NCT00402363|467955284|FG001|Overall Study|"Captured as Other"|2|||
129997621|NCT00402363|467955285|FG002|Overall Study|"Captured as Other"|2|||
129997622|NCT00402363|467955286|FG003|Overall Study|"Captured as Other"|2|||
129997623|NCT00293722|467955287|FG000|Overall Study|Other|427|||
129997624|NCT03037619|467955288|FG000|Overall Study|Lost to Follow-up|0|||
129997625|NCT03037619|467955289|FG001|Overall Study|Lost to Follow-up|1|||
129997626|NCT01498289|467955290|FG000|Overall Study|Adverse Event|16|||
129997627|NCT01498289|467955291|FG001|Overall Study|Adverse Event|18|||
129997628|NCT01498289|467955290|FG000|Overall Study|Death|6|||
129997629|NCT01498289|467955291|FG001|Overall Study|Death|8|||
129997630|NCT01498289|467955290|FG000|Overall Study|Withdrawal unrelated to AE|16|||
129997631|NCT01498289|467955291|FG001|Overall Study|Withdrawal unrelated to AE|16|||
129997632|NCT01498289|467955290|FG000|Overall Study|Progression/relapse|53|||
129997633|NCT01498289|467955291|FG001|Overall Study|Progression/relapse|59|||
129997634|NCT01498289|467955290|FG000|Overall Study|Not protocol specified|7|||
129997635|NCT01498289|467955291|FG001|Overall Study|Not protocol specified|2|||
129997636|NCT01498289|467955290|FG000|Overall Study|Reason under review|0|||
129997637|NCT01498289|467955291|FG001|Overall Study|Reason under review|1|||
129997638|NCT02030405|467955299|FG000|Overall Study|Withdrawal by Subject|1|||
129997639|NCT02030405|467955299|FG000|Overall Study|Lost to Follow-up|1|||
129997640|NCT00803270|467955300|FG000|Overall Study|Lost to Follow-up|1|||
129997641|NCT00803270|467955301|FG001|Overall Study|Lost to Follow-up|2|||
129997642|NCT00593957|467955305|FG000|Overall Study|Physician Decision|0|||
129997643|NCT00593957|467955306|FG001|Overall Study|Physician Decision|1|||
129997644|NCT00593957|467955307|FG002|Overall Study|Physician Decision|2|||
129997645|NCT00494481|467955310|FG000|Overall Study|Condition under investigation worsened|11|||
129997646|NCT00494481|467955311|FG001|Overall Study|Condition under investigation worsened|13|||
129997647|NCT00494481|467955310|FG000|Overall Study|Adverse Event|15|||
129997648|NCT00494481|467955311|FG001|Overall Study|Adverse Event|11|||
129997649|NCT00494481|467955310|FG000|Overall Study|Other|1|||
129997650|NCT00494481|467955311|FG001|Overall Study|Other|0|||
129997651|NCT00494481|467955310|FG000|Overall Study|Never received IP|2|||
129997652|NCT00494481|467955311|FG001|Overall Study|Never received IP|0|||
129997653|NCT02973048|467955312|FG000|Overall Study|Epidural catheter insertion failure|1|||
129997654|NCT02973048|467955313|FG001|Overall Study|Epidural catheter insertion failure|0|||
129997655|NCT02973048|467955312|FG000|Overall Study|Withdrawal by Subject|0|||
129997656|NCT02973048|467955313|FG001|Overall Study|Withdrawal by Subject|3|||
129997657|NCT00332189|467955314|FG000|Overall Study|Adverse Event|3|||
129997658|NCT00332189|467955314|FG000|Overall Study|Uncooperative/Noncompliant|3|||
129997659|NCT00332189|467955314|FG000|Overall Study|Withdrawal by Subject|9|||
129997660|NCT00332189|467955314|FG000|Overall Study|Lack of Efficacy|4|||
129997661|NCT00332189|467955314|FG000|Overall Study|Moved out of country|2|||
129997662|NCT02279862|467955316|FG000|Overall Study|Study drug toxicity|3|||
129997663|NCT02279862|467955317|FG001|Overall Study|Study drug toxicity|6|||
129997664|NCT02279862|467955316|FG000|Overall Study|No longer meets criteria|0|||
129997665|NCT02279862|467955317|FG001|Overall Study|No longer meets criteria|1|||
129997666|NCT02279862|467955316|FG000|Overall Study|Administrative reason by sponsor|0|||
129997667|NCT02279862|467955317|FG001|Overall Study|Administrative reason by sponsor|1|||
129997668|NCT02279862|467955316|FG000|Overall Study|Disease progression|5|||
129997669|NCT02279862|467955317|FG001|Overall Study|Disease progression|2|||
129997670|NCT02279862|467955316|FG000|Overall Study|Study closed by sponsor|16|||
129997671|NCT02279862|467955317|FG001|Overall Study|Study closed by sponsor|13|||
129997672|NCT02279862|467955316|FG000|Overall Study|Other|1|||
129997673|NCT02279862|467955317|FG001|Overall Study|Other|2|||
129997674|NCT02279862|467955316|FG000|Overall Study|Withdrawal by Subject|1|||
129997675|NCT02279862|467955317|FG001|Overall Study|Withdrawal by Subject|0|||
129997676|NCT03707925|467955319|FG000|Overall Study|Inevaluable|1|||
129997677|NCT03431857|467955321|FG000|Overall Study|Death|6|||
129997678|NCT03431857|467955321|FG000|Overall Study|Lost to Follow-up|41|||
129997679|NCT03431857|467955321|FG000|Overall Study|Adverse Event|6|||
129997680|NCT03431857|467955321|FG000|Overall Study|Withdrawal by Subject|1|||
129997681|NCT01163721|467955324|FG000|Overall Study|Adverse Event|5|||
129997682|NCT01163721|467955325|FG001|Overall Study|Adverse Event|6|||
129997683|NCT01163721|467955324|FG000|Overall Study|Withdrawal by Subject|3|||
129997684|NCT01163721|467955325|FG001|Overall Study|Withdrawal by Subject|4|||
129997685|NCT01163721|467955324|FG000|Overall Study|Lost to Follow-up|0|||
129997686|NCT01163721|467955325|FG001|Overall Study|Lost to Follow-up|1|||
129997687|NCT01163721|467955324|FG000|Overall Study|Physician Decision|0|||
129997688|NCT01163721|467955325|FG001|Overall Study|Physician Decision|1|||
129997689|NCT01472380|467955328|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
129997690|NCT01472380|467955328|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
129997691|NCT02511678|467955329|FG000|Overall Study|Withdrawal by Subject|2|||
129997692|NCT02511678|467955329|FG000|Overall Study|Lost to Follow-up|4|||
129997693|NCT02511678|467955329|FG000|Overall Study|Death|19|||
129997694|NCT02511678|467955329|FG000|Overall Study|Adverse Event|1|||
129997695|NCT02511678|467955329|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
129997696|NCT02511678|467955329|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
129997697|NCT02511678|467955329|FG000|Overall Study|Required Radiofrequency Ablation|1|||
129997698|NCT02511678|467955329|FG000|Overall Study|Biopsy was Negative|1|||
129997699|NCT02511678|467955329|FG000|Overall Study|Protocol Violation|1|||
129997700|NCT02511678|467955329|FG000|Overall Study|Received Radiation Treatment|1|||
129997701|NCT01295281|467955330|FG000|First Intervention (7 Days)|Death|0|||
130335000|NCT01668589|469195622|FG003|Overall Study|Lost to Follow-up|5|||
130335001|NCT01668589|469195619|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
130335002|NCT01668589|469195620|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
130335003|NCT01668589|469195621|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
130335004|NCT01668589|469195622|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
130335005|NCT01668589|469195619|FG000|Overall Study|Death|12|||
129997702|NCT01295281|467955331|FG001|First Intervention (7 Days)|Death|1|||
129997703|NCT00292461|467955332|FG000|Overall Study|Adverse Event|4|||
129997704|NCT00292461|467955333|FG001|Overall Study|Adverse Event|2|||
129997705|NCT00292461|467955332|FG000|Overall Study|Lack of Efficacy|1|||
129997706|NCT00292461|467955333|FG001|Overall Study|Lack of Efficacy|0|||
129997707|NCT00292461|467955332|FG000|Overall Study|Withdrawal by Subject|0|||
129997708|NCT00292461|467955333|FG001|Overall Study|Withdrawal by Subject|1|||
129997709|NCT00292461|467955332|FG000|Overall Study|Protocol Violation|4|||
129997710|NCT00292461|467955333|FG001|Overall Study|Protocol Violation|3|||
129997711|NCT00292461|467955332|FG000|Overall Study|Lost to Follow-up|1|||
129997712|NCT00292461|467955333|FG001|Overall Study|Lost to Follow-up|0|||
129997713|NCT04484259|467955349|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129997714|NCT04484259|467955350|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
130335006|NCT01668589|469195620|FG001|Overall Study|Death|3|||
130335007|NCT01668589|469195621|FG002|Overall Study|Death|2|||
130335008|NCT01668589|469195622|FG003|Overall Study|Death|11|||
130335009|NCT01668589|469195619|FG000|Overall Study|Other|44|||
130335010|NCT01668589|469195620|FG001|Overall Study|Other|10|||
129997715|NCT04484259|467955351|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129997716|NCT04484259|467955352|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
129997717|NCT04484259|467955353|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129997718|NCT04484259|467955349|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129997719|NCT04484259|467955350|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129997720|NCT04484259|467955351|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129997721|NCT04484259|467955352|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
129997722|NCT04484259|467955353|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129997723|NCT04484259|467955349|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129997724|NCT04484259|467955350|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129997725|NCT04484259|467955351|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129997726|NCT04484259|467955352|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
129997727|NCT04484259|467955353|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129997728|NCT04484259|467955349|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129997729|NCT04484259|467955350|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129997730|NCT04484259|467955351|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129997731|NCT04484259|467955352|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
129997732|NCT04484259|467955353|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129997733|NCT04484259|467955349|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129997734|NCT04484259|467955350|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129997735|NCT04484259|467955351|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129997736|NCT04484259|467955352|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129997737|NCT04484259|467955353|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
129997738|NCT04484259|467955349|FG000|Randomized Treatment|Withdrawal by Subject|1|||
129997739|NCT04484259|467955350|FG001|Randomized Treatment|Withdrawal by Subject|0|||
129997740|NCT04484259|467955351|FG002|Randomized Treatment|Withdrawal by Subject|0|||
129997741|NCT04484259|467955352|FG003|Randomized Treatment|Withdrawal by Subject|0|||
129997742|NCT04484259|467955353|FG004|Randomized Treatment|Withdrawal by Subject|0|||
129997743|NCT04908189|467955354|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
129997744|NCT04908189|467955355|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
129997745|NCT04908189|467955356|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
129997746|NCT04908189|467955354|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
129997747|NCT04908189|467955355|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
129997748|NCT04908189|467955356|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
129997749|NCT04908189|467955354|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
129997750|NCT04908189|467955355|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
129997751|NCT04908189|467955356|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
129997752|NCT04908189|467955354|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
129997753|NCT04908189|467955355|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
129997754|NCT04908189|467955356|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
130335011|NCT01668589|469195621|FG002|Overall Study|Other|7|||
129997755|NCT04908189|467955354|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
129997756|NCT04908189|467955355|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
130335012|NCT01668589|469195622|FG003|Overall Study|Other|15|||
129997757|NCT04908189|467955356|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
129997758|NCT04908189|467955354|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
129997759|NCT04908189|467955355|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
129997760|NCT04908189|467955356|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
129997761|NCT04908189|467955354|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
129997762|NCT04908189|467955355|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
129997763|NCT04908189|467955356|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
129997764|NCT04908189|467955354|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
129997765|NCT04908189|467955355|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
129997766|NCT04908189|467955356|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
129997767|NCT04908189|467955354|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
129997768|NCT04908189|467955355|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
129997769|NCT04908189|467955356|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
129997770|NCT04908189|467955354|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
129997771|NCT04908189|467955355|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
129997772|NCT04908189|467955356|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
129997773|NCT04908189|467955354|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
129997774|NCT04908189|467955355|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
129997775|NCT04908189|467955356|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
129997776|NCT04908189|467955354|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
129997777|NCT04908189|467955355|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
129997778|NCT04908189|467955356|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
129997779|NCT01411839|467955358|FG000|Overall Study|Lost to Follow-up|4|||
129997780|NCT01411839|467955359|FG001|Overall Study|Lost to Follow-up|3|||
129997781|NCT05461794|467955362|FG000|Overall Study|Withdrawal by Subject|1|||
130335013|NCT01519167|469195623|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
130335014|NCT01519167|469195624|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
130335015|NCT01519167|469195623|FG000|Overall Study|Adverse Event|0|||
129997782|NCT05461794|467955363|FG001|Overall Study|Withdrawal by Subject|1|||
129997783|NCT05461794|467955364|FG002|Overall Study|Withdrawal by Subject|3|||
129997784|NCT05461794|467955362|FG000|Overall Study|Study Terminated By Sponsor|18|||
129997785|NCT05461794|467955363|FG001|Overall Study|Study Terminated By Sponsor|13|||
129997786|NCT05461794|467955364|FG002|Overall Study|Study Terminated By Sponsor|16|||
129997787|NCT05461794|467955362|FG000|Overall Study|Death|20|||
129997788|NCT05461794|467955363|FG001|Overall Study|Death|5|||
129997789|NCT05461794|467955364|FG002|Overall Study|Death|19|||
129997790|NCT00467285|467955365|FG000|Overall Study|Lost to Follow-up|4|||
129997791|NCT00467285|467955366|FG001|Overall Study|Lost to Follow-up|4|||
129997792|NCT01853982|467955367|FG000|Overall Study|Withdrawal by Subject|1|||
129997793|NCT01853982|467955368|FG001|Overall Study|Withdrawal by Subject|0|||
129997794|NCT01853982|467955367|FG000|Overall Study|Death|1|||
129997795|NCT01853982|467955368|FG001|Overall Study|Death|0|||
129997796|NCT01853982|467955367|FG000|Overall Study|Lost to Follow-up|0|||
129997797|NCT01853982|467955368|FG001|Overall Study|Lost to Follow-up|1|||
129997798|NCT05066724|467955374|FG000|Overall Study|Adverse Event|1|||
129997799|NCT05066724|467955374|FG000|Overall Study|Non-Compliance With Study Drug|5|||
129997800|NCT05066724|467955374|FG000|Overall Study|Withdrawal by Subject|6|||
129997801|NCT05066724|467955374|FG000|Overall Study|Physician Decision|2|||
129997802|NCT00475033|467955377|FG000|Infant Series|Failed to return|3|||
129997803|NCT00475033|467955378|FG001|Infant Series|Failed to return|4|||
129997804|NCT00475033|467955377|FG000|Infant Series|Parent or legal guardian request|1|||
129997805|NCT00475033|467955378|FG001|Infant Series|Parent or legal guardian request|5|||
129997806|NCT00475033|467955377|FG000|Infant Series|Protocol Violation|1|||
129997807|NCT00475033|467955378|FG001|Infant Series|Protocol Violation|2|||
129997808|NCT00475033|467955377|FG000|Infant Series|Lost to Follow-up|2|||
129997809|NCT00475033|467955378|FG001|Infant Series|Lost to Follow-up|0|||
129997810|NCT00475033|467955377|FG000|Infant Series|Adverse Event|0|||
129997811|NCT00475033|467955378|FG001|Infant Series|Adverse Event|2|||
129997812|NCT00475033|467955377|FG000|After the Infant Series|Adverse Event|0|||
129997813|NCT00475033|467955378|FG001|After the Infant Series|Adverse Event|4|||
129997814|NCT00475033|467955377|FG000|After the Infant Series|Parent or legal guardian request|2|||
129997815|NCT00475033|467955378|FG001|After the Infant Series|Parent or legal guardian request|2|||
130335016|NCT01519167|469195624|FG001|Overall Study|Adverse Event|1|||
130335017|NCT01519167|469195623|FG000|Overall Study|Lack of Efficacy|0|||
130335018|NCT01519167|469195624|FG001|Overall Study|Lack of Efficacy|1|||
130335019|NCT01519167|469195623|FG000|Overall Study|Medical condition changes&deep sedation|0|||
130335020|NCT01519167|469195624|FG001|Overall Study|Medical condition changes&deep sedation|2|||
129997816|NCT00475033|467955377|FG000|After the Infant Series|Failed to return|2|||
129997817|NCT00475033|467955378|FG001|After the Infant Series|Failed to return|1|||
129997818|NCT00475033|467955377|FG000|After the Infant Series|Protocol Violation|1|||
129884285|NCT00358215|467536309|FG001|Overall Study|Did not receive investigational product|3|||
129997819|NCT00475033|467955378|FG001|After the Infant Series|Protocol Violation|0|||
129997820|NCT00475033|467955377|FG000|After the Infant Series|Lost to Follow-up|1|||
129997821|NCT00475033|467955378|FG001|After the Infant Series|Lost to Follow-up|0|||
129997822|NCT00475033|467955377|FG000|After the Infant Series|Other|0|||
129997823|NCT00475033|467955378|FG001|After the Infant Series|Other|1|||
129997824|NCT00475033|467955377|FG000|Toddler Dose|Parent or legal guardian request|2|||
129997825|NCT00475033|467955378|FG001|Toddler Dose|Parent or legal guardian request|0|||
129997826|NCT00475033|467955377|FG000|Toddler Dose|Failed to return|1|||
129997827|NCT00475033|467955378|FG001|Toddler Dose|Failed to return|0|||
129997828|NCT00475033|467955377|FG000|Toddler Dose|Lost to Follow-up|1|||
129997829|NCT00475033|467955378|FG001|Toddler Dose|Lost to Follow-up|0|||
129997830|NCT03444324|467955381|FG000|Overall Study|Withdrawal by Subject|0|||
129997831|NCT03444324|467955382|FG001|Overall Study|Withdrawal by Subject|1|||
129997832|NCT03444324|467955381|FG000|Overall Study|Lost to Follow-up|4|||
129997833|NCT03444324|467955382|FG001|Overall Study|Lost to Follow-up|2|||
129997834|NCT03444324|467955381|FG000|Overall Study|Protocol Violation|0|||
129997835|NCT03444324|467955382|FG001|Overall Study|Protocol Violation|1|||
129997836|NCT03444324|467955381|FG000|Overall Study|Lack of Trial Compliance|1|||
129997837|NCT03444324|467955382|FG001|Overall Study|Lack of Trial Compliance|1|||
129997838|NCT03444324|467955381|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
129997839|NCT03444324|467955382|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
129997840|NCT00658684|467955383|FG000|Overall Study|Adverse Event|10|||
129997841|NCT00658684|467955384|FG001|Overall Study|Adverse Event|8|||
129997842|NCT00658684|467955385|FG002|Overall Study|Adverse Event|2|||
129997843|NCT00658684|467955386|FG003|Overall Study|Adverse Event|0|||
129997844|NCT00658684|467955383|FG000|Overall Study|Withdrawal by Subject|6|||
129997845|NCT00658684|467955384|FG001|Overall Study|Withdrawal by Subject|4|||
129997846|NCT00658684|467955385|FG002|Overall Study|Withdrawal by Subject|1|||
129997847|NCT00658684|467955386|FG003|Overall Study|Withdrawal by Subject|1|||
129997848|NCT00658684|467955383|FG000|Overall Study|Lack of Efficacy|1|||
129997849|NCT00658684|467955384|FG001|Overall Study|Lack of Efficacy|1|||
129997850|NCT00658684|467955385|FG002|Overall Study|Lack of Efficacy|0|||
129997851|NCT00658684|467955386|FG003|Overall Study|Lack of Efficacy|0|||
129997852|NCT00658684|467955383|FG000|Overall Study|Protocol Violation|1|||
129997853|NCT00658684|467955384|FG001|Overall Study|Protocol Violation|1|||
129997854|NCT00658684|467955385|FG002|Overall Study|Protocol Violation|0|||
129997855|NCT00658684|467955386|FG003|Overall Study|Protocol Violation|0|||
129997856|NCT00658684|467955383|FG000|Overall Study|Pregnancy|1|||
129997857|NCT00658684|467955384|FG001|Overall Study|Pregnancy|1|||
129997858|NCT00658684|467955385|FG002|Overall Study|Pregnancy|0|||
129997859|NCT00658684|467955386|FG003|Overall Study|Pregnancy|0|||
129997860|NCT06515483|467955389|FG000|Overall Study|Subject withdraw due to family issues|1|||
129997861|NCT06515483|467955390|FG001|Overall Study|Subject withdraw due to family issues|0|||
129997862|NCT02634346|467956606|FG000|Overall Study|Withdrawal by Subject|8|||
129997863|NCT02634346|467956607|FG001|Overall Study|Withdrawal by Subject|9|||
129997864|NCT02634346|467956608|FG002|Overall Study|Withdrawal by Subject|8|||
129997865|NCT02634346|467956606|FG000|Overall Study|Adverse Event|2|||
129997866|NCT02634346|467956607|FG001|Overall Study|Adverse Event|2|||
129997867|NCT02634346|467956608|FG002|Overall Study|Adverse Event|7|||
129997868|NCT02634346|467956606|FG000|Overall Study|Lack of Efficacy|1|||
129997869|NCT02634346|467956607|FG001|Overall Study|Lack of Efficacy|2|||
129997870|NCT02634346|467956608|FG002|Overall Study|Lack of Efficacy|8|||
129997871|NCT02634346|467956606|FG000|Overall Study|Lost to Follow-up|1|||
129997872|NCT02634346|467956607|FG001|Overall Study|Lost to Follow-up|0|||
129997873|NCT02634346|467956608|FG002|Overall Study|Lost to Follow-up|0|||
129997874|NCT02634346|467956606|FG000|Overall Study|Protocol Violation|0|||
129997875|NCT02634346|467956607|FG001|Overall Study|Protocol Violation|1|||
129997876|NCT02634346|467956608|FG002|Overall Study|Protocol Violation|0|||
129997877|NCT00568321|467956609|FG000|Overall Study|Adverse Event|1|||
129997878|NCT00568321|467956610|FG001|Overall Study|Adverse Event|0|||
129997879|NCT00568321|467956611|FG002|Overall Study|Adverse Event|0|||
129997880|NCT00568321|467956609|FG000|Overall Study|Lack of Efficacy|8|||
129997881|NCT00568321|467956610|FG001|Overall Study|Lack of Efficacy|5|||
129997882|NCT00568321|467956611|FG002|Overall Study|Lack of Efficacy|6|||
129997883|NCT00568321|467956609|FG000|Overall Study|Lost to Follow-up|0|||
129997884|NCT00568321|467956610|FG001|Overall Study|Lost to Follow-up|0|||
129997885|NCT00568321|467956611|FG002|Overall Study|Lost to Follow-up|1|||
129997886|NCT00568321|467956609|FG000|Overall Study|Withdrawal by Subject|2|||
129997887|NCT00568321|467956610|FG001|Overall Study|Withdrawal by Subject|0|||
129997888|NCT00568321|467956611|FG002|Overall Study|Withdrawal by Subject|0|||
129997889|NCT00568321|467956609|FG000|Overall Study|Protocol Violation|0|||
129997890|NCT00568321|467956610|FG001|Overall Study|Protocol Violation|0|||
130216133|NCT02030119|468753957|FG002|Overall Study|Withdrawal by Subject|5|||
129997891|NCT00568321|467956611|FG002|Overall Study|Protocol Violation|1|||
129997892|NCT00568321|467956609|FG000|Overall Study|Randomized, not treated|2|||
129997893|NCT00568321|467956610|FG001|Overall Study|Randomized, not treated|0|||
129997894|NCT00568321|467956611|FG002|Overall Study|Randomized, not treated|1|||
129997895|NCT01676909|467956612|FG000|Overall Study|Withdrawal by Subject|3|||
130335021|NCT01519167|469195623|FG000|Overall Study|Physician Decision|0|||
130335022|NCT01519167|469195624|FG001|Overall Study|Physician Decision|1|||
130335023|NCT04200352|469195632|FG000|Overall Study|Death|1|||
130335024|NCT04200352|469195632|FG000|Overall Study|Adverse Event|6|||
130335025|NCT04200352|469195632|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130335026|NCT04200352|469195632|FG000|Overall Study|Lack of Efficacy|1|||
130335027|NCT04200352|469195632|FG000|Overall Study|Other than specified|6|||
130335028|NCT00233064|469195633|FG000|Overall Study|Lost to Follow-up|7|||
130335029|NCT00233064|469195634|FG001|Overall Study|Lost to Follow-up|7|||
130335030|NCT00233064|469195633|FG000|Overall Study|Withdrawal by Subject|5|||
130335031|NCT00233064|469195634|FG001|Overall Study|Withdrawal by Subject|3|||
129997896|NCT01676909|467956613|FG001|Overall Study|Withdrawal by Subject|5|||
129997897|NCT01676909|467956612|FG000|Overall Study|Lost to Follow-up|15|||
129997898|NCT01676909|467956613|FG001|Overall Study|Lost to Follow-up|9|||
129997899|NCT02175004|467956614|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
129997900|NCT02175004|467956615|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
129997901|NCT02175004|467956614|FG000|Overall Study|Investigator Judgment|1|||
129997902|NCT02175004|467956615|FG001|Overall Study|Investigator Judgment|4|||
129997903|NCT02175004|467956614|FG000|Overall Study|Voluntary Withdrawal|6|||
129997904|NCT02175004|467956615|FG001|Overall Study|Voluntary Withdrawal|19|||
129997905|NCT02175004|467956614|FG000|Overall Study|Liver Transplant|1|||
129997906|NCT02175004|467956615|FG001|Overall Study|Liver Transplant|0|||
129997907|NCT02175004|467956614|FG000|Overall Study|Disease Progression|1|||
129997908|NCT02175004|467956615|FG001|Overall Study|Disease Progression|0|||
129997909|NCT02175004|467956614|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
129997910|NCT02175004|467956615|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
129997911|NCT00221195|467956616|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
129997912|NCT00221195|467956617|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
129997913|NCT00221195|467956616|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
129997914|NCT00221195|467956617|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
129997915|NCT00221195|467956616|FG000|Washout Period (Months 7-9)|Death|0|||
129997916|NCT00221195|467956617|FG001|Washout Period (Months 7-9)|Death|1|||
129997917|NCT00221195|467956616|FG000|Therapy 2 (Months 10-15)|Death|1|||
129997918|NCT00221195|467956617|FG001|Therapy 2 (Months 10-15)|Death|0|||
129997919|NCT00221195|467956616|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
129997920|NCT00221195|467956617|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
129997921|NCT00823901|467956618|FG000|Overall Study|Adverse Event|1|||
129997922|NCT00823901|467956619|FG001|Overall Study|Adverse Event|1|||
130335032|NCT00233064|469195633|FG000|Overall Study|Death|0|||
130335033|NCT00233064|469195634|FG001|Overall Study|Death|1|||
130335034|NCT00233064|469195633|FG000|Overall Study|Relocation|0|||
130335035|NCT00233064|469195634|FG001|Overall Study|Relocation|1|||
130335036|NCT00233064|469195633|FG000|Overall Study|Protocol Violation|1|||
130335037|NCT00233064|469195634|FG001|Overall Study|Protocol Violation|0|||
130335038|NCT00233064|469195633|FG000|Overall Study|Moved to Dom. Republic|1|||
130335039|NCT00233064|469195634|FG001|Overall Study|Moved to Dom. Republic|0|||
130335040|NCT01120964|469195641|FG000|Overall Study|Did not receive full treatment|1|||
130335041|NCT01120964|469195642|FG001|Overall Study|Did not receive full treatment|0|||
130335042|NCT04237116|469195646|FG000|Overall Study|Adverse Event|0|||
130335043|NCT04237116|469195647|FG001|Overall Study|Adverse Event|1|||
130335044|NCT04237116|469195646|FG000|Overall Study|Study terminated by Sponsor|4|||
130335045|NCT04237116|469195647|FG001|Overall Study|Study terminated by Sponsor|1|||
130335046|NCT00829504|469195648|FG000|First Intervention|Adverse Event|1|||
130335047|NCT00829504|469195649|FG001|First Intervention|Adverse Event|0|||
130335048|NCT00829504|469195648|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130335049|NCT00829504|469195649|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130335050|NCT00829504|469195648|FG000|Second Intervention|Physician Decision|1|||
130335051|NCT00829504|469195649|FG001|Second Intervention|Physician Decision|0|||
130335052|NCT03212144|469195650|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
130335053|NCT03212144|469195651|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
130335054|NCT03212144|469195650|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
130335055|NCT03212144|469195651|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
129997923|NCT00823901|467956618|FG000|Overall Study|Lack of Efficacy|1|||
129997924|NCT00823901|467956619|FG001|Overall Study|Lack of Efficacy|0|||
130335056|NCT00599339|469195652|FG000|Overall Study|Adverse Event|79|||
130335057|NCT00599339|469195652|FG000|Overall Study|Withdrawal by Subject|137|||
130335058|NCT00599339|469195652|FG000|Overall Study|Other Reason|179|||
130335059|NCT00599339|469195652|FG000|Overall Study|Lost to Follow-up|221|||
130335060|NCT00599339|469195652|FG000|Overall Study|No valid data consent|36|||
130335061|NCT00599339|469195652|FG000|Overall Study|Study Termination Status Unknown|12|||
130335062|NCT02102204|469197327|FG000|Overall Study|Withdrawal by Subject|137|||
130335063|NCT02102204|469197327|FG000|Overall Study|Death|92|||
130335064|NCT02102204|469197327|FG000|Overall Study|Lost to Follow-up|65|||
129997925|NCT00823901|467956618|FG000|Overall Study|Lost to Follow-up|2|||
130335065|NCT02102204|469197327|FG000|Overall Study|Sponsor Decision|5|||
130335066|NCT02102204|469197327|FG000|Overall Study|Ongoing|5|||
129997926|NCT00823901|467956619|FG001|Overall Study|Lost to Follow-up|1|||
129997927|NCT01369511|467956620|FG000|Overall Study|Adverse Event|1|||
129997928|NCT01369511|467956621|FG001|Overall Study|Adverse Event|1|||
129997929|NCT01369511|467956622|FG002|Overall Study|Adverse Event|5|||
129997930|NCT01369511|467956623|FG003|Overall Study|Adverse Event|0|||
129997931|NCT01369511|467956620|FG000|Overall Study|Entry criteria not met|2|||
129997932|NCT01369511|467956621|FG001|Overall Study|Entry criteria not met|0|||
129997933|NCT01369511|467956622|FG002|Overall Study|Entry criteria not met|0|||
129997934|NCT01369511|467956623|FG003|Overall Study|Entry criteria not met|1|||
129997935|NCT01369511|467956620|FG000|Overall Study|Lost to Follow-up|0|||
129997936|NCT01369511|467956621|FG001|Overall Study|Lost to Follow-up|1|||
129997937|NCT01369511|467956622|FG002|Overall Study|Lost to Follow-up|1|||
129997938|NCT01369511|467956623|FG003|Overall Study|Lost to Follow-up|2|||
129997939|NCT01369511|467956620|FG000|Overall Study|Protocol Violation|0|||
129997940|NCT01369511|467956621|FG001|Overall Study|Protocol Violation|1|||
129997941|NCT01369511|467956622|FG002|Overall Study|Protocol Violation|0|||
129997942|NCT01369511|467956623|FG003|Overall Study|Protocol Violation|2|||
129997943|NCT01369511|467956620|FG000|Overall Study|Physician Decision|3|||
129997944|NCT01369511|467956621|FG001|Overall Study|Physician Decision|4|||
129997945|NCT01369511|467956622|FG002|Overall Study|Physician Decision|0|||
129997946|NCT01369511|467956623|FG003|Overall Study|Physician Decision|0|||
129997947|NCT01369511|467956620|FG000|Overall Study|Sponsor decision|2|||
129997948|NCT01369511|467956621|FG001|Overall Study|Sponsor decision|0|||
129997949|NCT01369511|467956622|FG002|Overall Study|Sponsor decision|1|||
129997950|NCT01369511|467956623|FG003|Overall Study|Sponsor decision|0|||
129997951|NCT01369511|467956620|FG000|Overall Study|Withdrawal by Subject|5|||
129997952|NCT01369511|467956621|FG001|Overall Study|Withdrawal by Subject|6|||
129997953|NCT01369511|467956622|FG002|Overall Study|Withdrawal by Subject|4|||
129997954|NCT01369511|467956623|FG003|Overall Study|Withdrawal by Subject|6|||
129997955|NCT01376349|467956626|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
129997956|NCT01376349|467956627|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
129997957|NCT01376349|467956628|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
129997958|NCT01376349|467956626|FG000|Raondomized Treatment|Adverse Event|13|||
129997959|NCT01376349|467956627|FG001|Raondomized Treatment|Adverse Event|17|||
129997960|NCT01376349|467956628|FG002|Raondomized Treatment|Adverse Event|14|||
129997961|NCT01376349|467956626|FG000|Raondomized Treatment|Unkown|1|||
129997962|NCT01376349|467956627|FG001|Raondomized Treatment|Unkown|2|||
129997963|NCT01376349|467956628|FG002|Raondomized Treatment|Unkown|1|||
129997964|NCT01376349|467956626|FG000|Raondomized Treatment|Alternative Treatment|0|||
129997965|NCT01376349|467956627|FG001|Raondomized Treatment|Alternative Treatment|0|||
129997966|NCT01376349|467956628|FG002|Raondomized Treatment|Alternative Treatment|1|||
129997967|NCT01180998|467956629|FG000|Overall Study|Poor Vision|0|||
129997968|NCT01180998|467956630|FG001|Overall Study|Poor Vision|2|||
129997969|NCT01180998|467956631|FG002|Overall Study|Poor Vision|2|||
129997970|NCT01180998|467956629|FG000|Overall Study|Lost to Follow-up|0|||
129997971|NCT01180998|467956630|FG001|Overall Study|Lost to Follow-up|0|||
129997972|NCT01180998|467956631|FG002|Overall Study|Lost to Follow-up|1|||
129997973|NCT01180998|467956629|FG000|Overall Study|Protocol Violation|1|||
129997974|NCT01180998|467956630|FG001|Overall Study|Protocol Violation|2|||
129997975|NCT01180998|467956631|FG002|Overall Study|Protocol Violation|0|||
129997976|NCT01180998|467956629|FG000|Overall Study|Withdrawal by Subject|0|||
129997977|NCT01180998|467956630|FG001|Overall Study|Withdrawal by Subject|0|||
129997978|NCT01180998|467956631|FG002|Overall Study|Withdrawal by Subject|1|||
129997979|NCT01180998|467956629|FG000|Overall Study|Poor comfort|3|||
129997980|NCT01180998|467956630|FG001|Overall Study|Poor comfort|0|||
129997981|NCT01180998|467956631|FG002|Overall Study|Poor comfort|4|||
129997982|NCT01180998|467956629|FG000|Overall Study|Poor lens handling|0|||
129997983|NCT01180998|467956630|FG001|Overall Study|Poor lens handling|0|||
129997984|NCT01180998|467956631|FG002|Overall Study|Poor lens handling|2|||
129997985|NCT00162032|467956632|FG000|Overall Study|Lost to Follow-up|4|||
129997986|NCT00162032|467956633|FG001|Overall Study|Lost to Follow-up|2|||
129997987|NCT00162032|467956632|FG000|Overall Study|Reason not specified|1|||
129997988|NCT00162032|467956633|FG001|Overall Study|Reason not specified|0|||
129997989|NCT01176968|467956634|FG000|Overall Study|Adverse Event|10|||
129997990|NCT01176968|467956635|FG001|Overall Study|Adverse Event|11|||
129997991|NCT01176968|467956634|FG000|Overall Study|Death|2|||
129997992|NCT01176968|467956635|FG001|Overall Study|Death|3|||
129997993|NCT01176968|467956634|FG000|Overall Study|Lack of Efficacy|0|||
129997994|NCT01176968|467956635|FG001|Overall Study|Lack of Efficacy|1|||
129997995|NCT01176968|467956634|FG000|Overall Study|Lost to Follow-up|16|||
129997996|NCT01176968|467956635|FG001|Overall Study|Lost to Follow-up|14|||
129997997|NCT01176968|467956634|FG000|Overall Study|Withdrawal by Subject|48|||
129997998|NCT01176968|467956635|FG001|Overall Study|Withdrawal by Subject|48|||
129997999|NCT01176968|467956634|FG000|Overall Study|Protocol Violation|2|||
129998000|NCT01176968|467956635|FG001|Overall Study|Protocol Violation|1|||
129998001|NCT01176968|467956634|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129998002|NCT01176968|467956635|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
129998003|NCT01176968|467956634|FG000|Overall Study|Study terminated by sponsor|0|||
129998004|NCT01176968|467956635|FG001|Overall Study|Study terminated by sponsor|1|||
129998005|NCT01176968|467956634|FG000|Overall Study|Reason not defined|5|||
129998006|NCT01176968|467956635|FG001|Overall Study|Reason not defined|3|||
129998007|NCT00833911|467956636|FG000|Titration|Adverse Event|18|||
129998008|NCT00833911|467956636|FG000|Titration|Withdrawal by Subject|3|||
129998009|NCT00833911|467956636|FG000|Maintenance Phase I|Adverse Event|73|||
129998010|NCT00833911|467956636|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
129998011|NCT00833911|467956636|FG000|Maintenance Phase I|Physician Decision|10|||
129998012|NCT00833911|467956636|FG000|Maintenance Phase I|Lack of Efficacy|4|||
129998013|NCT00833911|467956636|FG000|Maintenance Phase II|Adverse Event|6|||
129998014|NCT00833911|467956636|FG000|Maintenance Phase II|Physician Decision|2|||
129998015|NCT00833911|467956636|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
129998016|NCT00833911|467956636|FG000|Maintenance Phase II|Lack of Efficacy|1|||
129998017|NCT00718640|467956637|FG000|Overall Study|Adverse Event|4|||
129998018|NCT00718640|467956637|FG000|Overall Study|Death|1|||
129998019|NCT00718640|467956637|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
129998020|NCT01137955|467956640|FG000|Overall Study|Withdrawal by Subject|5|||
129998021|NCT01137955|467956641|FG001|Overall Study|Withdrawal by Subject|4|||
129998022|NCT01207596|467956642|FG000|Overall Study|Physician Decision|4|||
129998023|NCT01207596|467956642|FG000|Overall Study|Lack of Efficacy|1|||
129998024|NCT01207596|467956642|FG000|Overall Study|Adverse Event|3|||
129998025|NCT01207596|467956642|FG000|Overall Study|Withdrawal by Subject|1|||
129998026|NCT00216203|467956645|FG000|Overall Study|Withdrawal by Subject|2|||
129998027|NCT04098068|467956646|FG000|Overall Study|Disease Progression|7|||
129998028|NCT04098068|467956646|FG000|Overall Study|Withdrawal by Subject|2|||
129998029|NCT04098068|467956646|FG000|Overall Study|New Cancer Diagnosis|1|||
129998030|NCT03871829|467956647|FG000|Overall Study|Lost to Follow-up|0|||
129998031|NCT03871829|467956648|FG001|Overall Study|Lost to Follow-up|1|||
129998032|NCT03871829|467956647|FG000|Overall Study|Withdrawal by Subject|1|||
129998033|NCT03871829|467956648|FG001|Overall Study|Withdrawal by Subject|1|||
129998034|NCT03871829|467956647|FG000|Overall Study|Death|12|||
129998035|NCT03871829|467956648|FG001|Overall Study|Death|8|||
129998036|NCT03871829|467956647|FG000|Overall Study|Study terminated by sponsor|31|||
129998037|NCT03871829|467956648|FG001|Overall Study|Study terminated by sponsor|34|||
129998038|NCT01106014|467956649|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
129998039|NCT01106014|467956650|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
129998040|NCT01106014|467956649|FG000|Overall Study|Adverse Event|78|||
129998041|NCT01106014|467956650|FG001|Overall Study|Adverse Event|42|||
129998042|NCT01106014|467956649|FG000|Overall Study|Withdrawal by Subject|43|||
129998043|NCT01106014|467956650|FG001|Overall Study|Withdrawal by Subject|37|||
129998044|NCT01106014|467956649|FG000|Overall Study|Administrative reason|7|||
129998045|NCT01106014|467956650|FG001|Overall Study|Administrative reason|6|||
129998046|NCT01106014|467956649|FG000|Overall Study|Lost to Follow-up|2|||
129998047|NCT01106014|467956650|FG001|Overall Study|Lost to Follow-up|3|||
129998048|NCT00784693|467956656|FG000|Overall Study|Lost to Follow-up|0|||
129998049|NCT00784693|467956657|FG001|Overall Study|Lost to Follow-up|1|||
129998050|NCT00784693|467956656|FG000|Overall Study|Lack of Efficacy|1|||
129998051|NCT00784693|467956657|FG001|Overall Study|Lack of Efficacy|1|||
129998052|NCT00784693|467956656|FG000|Overall Study|Withdrawal by Subject|0|||
129998053|NCT00784693|467956657|FG001|Overall Study|Withdrawal by Subject|4|||
129998054|NCT00784693|467956656|FG000|Overall Study|Randomized but not Treated|1|||
129998055|NCT00784693|467956657|FG001|Overall Study|Randomized but not Treated|0|||
129998056|NCT00784693|467956656|FG000|Overall Study|Other|1|||
129998057|NCT00784693|467956657|FG001|Overall Study|Other|0|||
129998058|NCT05458479|467956658|FG000|Overall Study|Lost to Follow-up|1|||
129998059|NCT00908232|467956659|FG000|Cycle 1 to 4|Death|5|||
129998060|NCT00908232|467956660|FG001|Cycle 1 to 4|Death|0|||
129998061|NCT00908232|467956661|FG002|Cycle 1 to 4|Death|0|||
129998062|NCT00908232|467956662|FG003|Cycle 1 to 4|Death|0|||
129998063|NCT00908232|467956659|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
129998064|NCT00908232|467956660|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
129998065|NCT00908232|467956661|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
129998066|NCT00908232|467956662|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
129998067|NCT00908232|467956659|FG000|Cycle 1 to 4|Progressive Disease|6|||
129998068|NCT00908232|467956660|FG001|Cycle 1 to 4|Progressive Disease|0|||
129998069|NCT00908232|467956661|FG002|Cycle 1 to 4|Progressive Disease|0|||
129998070|NCT00908232|467956662|FG003|Cycle 1 to 4|Progressive Disease|0|||
129998071|NCT00908232|467956659|FG000|Cycle 1 to 4|Adverse Event|12|||
129998072|NCT00908232|467956660|FG001|Cycle 1 to 4|Adverse Event|0|||
129998073|NCT00908232|467956661|FG002|Cycle 1 to 4|Adverse Event|0|||
129998074|NCT00908232|467956662|FG003|Cycle 1 to 4|Adverse Event|0|||
129998075|NCT00908232|467956659|FG000|Cycle 1 to 4|Other|1|||
129998076|NCT00908232|467956660|FG001|Cycle 1 to 4|Other|0|||
129998077|NCT00908232|467956661|FG002|Cycle 1 to 4|Other|0|||
129998078|NCT00908232|467956662|FG003|Cycle 1 to 4|Other|0|||
129998079|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
129998080|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
129998081|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
129998082|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
129998083|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
129998084|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
129998085|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
129998086|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
129998087|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
129998088|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
129998089|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
129998090|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
129998091|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
129998092|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
129998093|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
129998094|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
129998095|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
129998096|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
129998097|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
129998098|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
129998099|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
129998100|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
129998101|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
129998102|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
129998103|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
129998104|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
129998105|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
129998106|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
129998107|NCT00908232|467956659|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
129998108|NCT00908232|467956660|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129998109|NCT00908232|467956661|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129998110|NCT00908232|467956662|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129998111|NCT02260882|467956663|FG000|Overall Study|Protocol Violation|0|||
129998112|NCT02260882|467956664|FG001|Overall Study|Protocol Violation|1|||
129998113|NCT02119325|467956665|FG000|Washout Period 1|Adverse Event|0|||
129998114|NCT02119325|467956666|FG001|Washout Period 1|Adverse Event|1|||
129998115|NCT01386658|467956667|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
129998116|NCT01386658|467956668|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
129998117|NCT01386658|467956667|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
129998118|NCT01386658|467956668|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
129998119|NCT00954174|467956669|FG000|Overall Study|Adverse Event|28|||
129998120|NCT00954174|467956670|FG001|Overall Study|Adverse Event|23|||
129998121|NCT00954174|467956671|FG002|Overall Study|Adverse Event|4|||
129998122|NCT00954174|467956672|FG003|Overall Study|Adverse Event|9|||
129998123|NCT00954174|467956669|FG000|Overall Study|Death|4|||
129998124|NCT00954174|467956670|FG001|Overall Study|Death|2|||
129998125|NCT00954174|467956671|FG002|Overall Study|Death|0|||
129998126|NCT00954174|467956672|FG003|Overall Study|Death|0|||
129998127|NCT00954174|467956669|FG000|Overall Study|Lack of Efficacy|32|||
129998128|NCT00954174|467956670|FG001|Overall Study|Lack of Efficacy|22|||
129998129|NCT00954174|467956671|FG002|Overall Study|Lack of Efficacy|8|||
129998130|NCT00954174|467956672|FG003|Overall Study|Lack of Efficacy|6|||
129998131|NCT00954174|467956669|FG000|Overall Study|Withdrawal by Subject|14|||
129998132|NCT00954174|467956670|FG001|Overall Study|Withdrawal by Subject|10|||
129998133|NCT00954174|467956671|FG002|Overall Study|Withdrawal by Subject|4|||
129998134|NCT00954174|467956672|FG003|Overall Study|Withdrawal by Subject|3|||
129998135|NCT00954174|467956669|FG000|Overall Study|Medical Reason|4|||
129998136|NCT00954174|467956670|FG001|Overall Study|Medical Reason|2|||
129998137|NCT00954174|467956671|FG002|Overall Study|Medical Reason|1|||
129998138|NCT00954174|467956672|FG003|Overall Study|Medical Reason|0|||
129998139|NCT00954174|467956669|FG000|Overall Study|Ineligible|40|||
129998140|NCT00954174|467956670|FG001|Overall Study|Ineligible|47|||
129998141|NCT00954174|467956671|FG002|Overall Study|Ineligible|7|||
129998142|NCT00954174|467956672|FG003|Overall Study|Ineligible|4|||
129998143|NCT00954174|467956669|FG000|Overall Study|Never Treated|4|||
130335067|NCT02260180|469197328|FG000|Overall Study|Adverse Event|2|||
130335068|NCT02260180|469197329|FG001|Overall Study|Adverse Event|0|||
130335069|NCT02260180|469197330|FG002|Overall Study|Adverse Event|1|||
130335070|NCT03860818|469197333|FG000|Overall Study|Death|144|||
129998144|NCT00954174|467956670|FG001|Overall Study|Never Treated|17|||
129998145|NCT00954174|467956671|FG002|Overall Study|Never Treated|0|||
129998146|NCT00954174|467956672|FG003|Overall Study|Never Treated|3|||
129998147|NCT00986440|467956676|FG000|Overall Study|Progressive disease|27|||
129998148|NCT00986440|467956677|FG001|Overall Study|Progressive disease|37|||
129998149|NCT00986440|467956676|FG000|Overall Study|Serious adverse event or adverse event|9|||
129998150|NCT00986440|467956677|FG001|Overall Study|Serious adverse event or adverse event|2|||
129998151|NCT00986440|467956676|FG000|Overall Study|Withdrawal by Subject|1|||
130335071|NCT03860818|469197334|FG001|Overall Study|Death|195|||
129884286|NCT04329104|467536316|FG000|Efficacy Study|Withdrawal by Subject|0|||
129998152|NCT00986440|467956677|FG001|Overall Study|Withdrawal by Subject|2|||
129998153|NCT00986440|467956676|FG000|Overall Study|Screen failure (not dosed)|4|||
129998154|NCT00986440|467956677|FG001|Overall Study|Screen failure (not dosed)|2|||
129998155|NCT00651157|467956678|FG000|Overall Study|Death|1|||
129998156|NCT00651157|467956678|FG000|Overall Study|Protocol Violation|1|||
129998157|NCT05125679|467956679|FG000|Overall Study|Study Terminated by Sponsor|2|||
129998158|NCT05125679|467956680|FG001|Overall Study|Study Terminated by Sponsor|5|||
129998159|NCT04683731|467956685|FG000|Overall Study|Withdrawal by Subject|1|||
129998160|NCT04683731|467956686|FG001|Overall Study|Withdrawal by Subject|0|||
129998161|NCT04683731|467956687|FG002|Overall Study|Withdrawal by Subject|3|||
129998162|NCT04683731|467956688|FG003|Overall Study|Withdrawal by Subject|2|||
129998163|NCT04683731|467956685|FG000|Overall Study|Determined patient was not eligible|3|||
129998164|NCT04683731|467956686|FG001|Overall Study|Determined patient was not eligible|3|||
129998165|NCT04683731|467956687|FG002|Overall Study|Determined patient was not eligible|12|||
129998166|NCT04683731|467956688|FG003|Overall Study|Determined patient was not eligible|3|||
130335072|NCT03860818|469197333|FG000|Overall Study|Graft Loss|32|||
130335073|NCT03860818|469197334|FG001|Overall Study|Graft Loss|45|||
130335074|NCT03126344|469197335|FG000|Overall Study|Lost to Follow-up|0|||
130335075|NCT03126344|469197336|FG001|Overall Study|Lost to Follow-up|0|||
130335076|NCT03126344|469197337|FG002|Overall Study|Lost to Follow-up|5|||
130335077|NCT03052400|469197338|FG000|Overall Study|Lost to Follow-up|1|||
130335078|NCT03052400|469197339|FG001|Overall Study|Lost to Follow-up|0|||
130335079|NCT03052400|469197338|FG000|Overall Study|Withdrawal by Subject|0|||
130335080|NCT03052400|469197339|FG001|Overall Study|Withdrawal by Subject|1|||
130335081|NCT00555061|469197340|FG000|Overall Study|Adverse Event|3|||
130335082|NCT00555061|469197340|FG000|Overall Study|Protocol Violation|1|||
130335083|NCT00555061|469197340|FG000|Overall Study|Lost to Follow-up|2|||
130335084|NCT00555061|469197340|FG000|Overall Study|Withdrawal by Subject|2|||
130335085|NCT00555061|469197340|FG000|Overall Study|Participant enrolled, but never treated|1|||
130335086|NCT01396447|469197341|FG000|Overall Study|Did Not Receive Treatment|3|||
130335087|NCT01396447|469197342|FG001|Overall Study|Did Not Receive Treatment|2|||
130335088|NCT01396447|469197343|FG002|Overall Study|Did Not Receive Treatment|1|||
130335089|NCT01396447|469197344|FG003|Overall Study|Did Not Receive Treatment|0|||
130335090|NCT01396447|469197341|FG000|Overall Study|Adverse Event|15|||
130335091|NCT01396447|469197342|FG001|Overall Study|Adverse Event|12|||
130335092|NCT01396447|469197343|FG002|Overall Study|Adverse Event|12|||
130335093|NCT01396447|469197344|FG003|Overall Study|Adverse Event|17|||
130335094|NCT01396447|469197341|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130335095|NCT01396447|469197342|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130335096|NCT01396447|469197343|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130335097|NCT01396447|469197344|FG003|Overall Study|Insufficient Therapeutic Response|4|||
130335098|NCT01396447|469197341|FG000|Overall Study|Protocol Violation|5|||
130335099|NCT01396447|469197342|FG001|Overall Study|Protocol Violation|2|||
130335100|NCT01396447|469197343|FG002|Overall Study|Protocol Violation|3|||
130335101|NCT01396447|469197344|FG003|Overall Study|Protocol Violation|7|||
130335102|NCT01396447|469197341|FG000|Overall Study|Withdrawal of Consent|11|||
130335103|NCT01396447|469197342|FG001|Overall Study|Withdrawal of Consent|9|||
130335104|NCT01396447|469197343|FG002|Overall Study|Withdrawal of Consent|4|||
130335105|NCT01396447|469197344|FG003|Overall Study|Withdrawal of Consent|15|||
130335106|NCT01396447|469197341|FG000|Overall Study|Lost to Follow-up|4|||
130335107|NCT01396447|469197342|FG001|Overall Study|Lost to Follow-up|8|||
130335108|NCT01396447|469197343|FG002|Overall Study|Lost to Follow-up|7|||
130335109|NCT01396447|469197344|FG003|Overall Study|Lost to Follow-up|9|||
130335110|NCT01396447|469197341|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130335111|NCT01396447|469197342|FG001|Overall Study|Other Miscellaneous Reasons|2|||
130335112|NCT01396447|469197343|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130335113|NCT01396447|469197344|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130335114|NCT04881942|469197345|FG000|Overall Study|Adverse Event|0|||
130335115|NCT04881942|469197346|FG001|Overall Study|Adverse Event|0|||
130335116|NCT04881942|469197347|FG002|Overall Study|Adverse Event|0|||
130335117|NCT04881942|469197348|FG003|Overall Study|Adverse Event|0|||
130335118|NCT04881942|469197349|FG004|Overall Study|Adverse Event|1|||
130335119|NCT04881942|469197345|FG000|Overall Study|Alternates|0|||
129998167|NCT00458341|467956691|FG000|Cycle 1|Adverse Event|1|||
129998168|NCT00458341|467956692|FG001|Cycle 1|Adverse Event|0|||
129998169|NCT01210118|467956695|FG000|Overall Study|Lost to Follow-up|1|||
129998170|NCT01210118|467956696|FG001|Overall Study|Lost to Follow-up|1|||
130335120|NCT04881942|469197346|FG001|Overall Study|Alternates|0|||
130335121|NCT04881942|469197347|FG002|Overall Study|Alternates|0|||
130335122|NCT04881942|469197348|FG003|Overall Study|Alternates|0|||
130335123|NCT04881942|469197349|FG004|Overall Study|Alternates|2|||
130335124|NCT01349959|469197350|FG000|Overall Study|Adverse Event|7|||
130335125|NCT02675634|469197351|FG000|Test Period 1|Adverse Event|0|||
130335126|NCT02675634|469197352|FG001|Test Period 1|Adverse Event|1|||
130335127|NCT02675634|469197353|FG002|Test Period 1|Adverse Event|0|||
130335128|NCT02675634|469197354|FG003|Test Period 1|Adverse Event|1|||
130335129|NCT02675634|469197355|FG004|Test Period 1|Adverse Event|0|||
130335130|NCT02675634|469197356|FG005|Test Period 1|Adverse Event|0|||
129998171|NCT01210118|467956695|FG000|Overall Study|Protocol Violation|1|||
129998172|NCT01210118|467956696|FG001|Overall Study|Protocol Violation|1|||
129998173|NCT01210118|467956695|FG000|Overall Study|Spontaneous abortion|1|||
129998174|NCT01210118|467956696|FG001|Overall Study|Spontaneous abortion|3|||
129998175|NCT02958267|467956699|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
129998176|NCT02958267|467956700|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
129998177|NCT02958267|467956699|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
129998178|NCT02958267|467956700|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
129998179|NCT02958267|467956699|FG000|Follow-up Visits|Additional treatment pursued|2|||
129998180|NCT02958267|467956700|FG001|Follow-up Visits|Additional treatment pursued|1|||
129998181|NCT02684357|467956701|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
129998182|NCT02684357|467956702|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
129998183|NCT02684357|467956703|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
129998184|NCT02684357|467956704|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
129998185|NCT02684357|467956705|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
129998186|NCT02684357|467956706|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
129998187|NCT02684357|467956701|FG000|Part A|Lost to Follow-up|0|||
129998188|NCT02684357|467956702|FG001|Part A|Lost to Follow-up|2|||
129998189|NCT02684357|467956703|FG002|Part A|Lost to Follow-up|2|||
129998190|NCT02684357|467956704|FG003|Part A|Lost to Follow-up|0|||
129998191|NCT02684357|467956705|FG004|Part A|Lost to Follow-up|0|||
129998192|NCT02684357|467956706|FG005|Part A|Lost to Follow-up|0|||
129998193|NCT02684357|467956701|FG000|Part A|Withdrawal by Subject|3|||
129998194|NCT02684357|467956702|FG001|Part A|Withdrawal by Subject|0|||
129998195|NCT02684357|467956703|FG002|Part A|Withdrawal by Subject|0|||
129998196|NCT02684357|467956704|FG003|Part A|Withdrawal by Subject|0|||
129998197|NCT02684357|467956705|FG004|Part A|Withdrawal by Subject|0|||
129998198|NCT02684357|467956706|FG005|Part A|Withdrawal by Subject|0|||
129998199|NCT02684357|467956701|FG000|Part A|Other|0|||
129998200|NCT02684357|467956702|FG001|Part A|Other|1|||
129998201|NCT02684357|467956703|FG002|Part A|Other|0|||
129998202|NCT02684357|467956704|FG003|Part A|Other|0|||
129998203|NCT02684357|467956705|FG004|Part A|Other|0|||
129998204|NCT02684357|467956706|FG005|Part A|Other|0|||
129998205|NCT02684357|467956701|FG000|Part B|Adverse Event (Other)|0|||
129998206|NCT02684357|467956702|FG001|Part B|Adverse Event (Other)|0|||
129998207|NCT02684357|467956703|FG002|Part B|Adverse Event (Other)|0|||
129998208|NCT02684357|467956704|FG003|Part B|Adverse Event (Other)|1|||
129998209|NCT02684357|467956705|FG004|Part B|Adverse Event (Other)|1|||
129998210|NCT02684357|467956706|FG005|Part B|Adverse Event (Other)|1|||
129998211|NCT02684357|467956701|FG000|Part B|Lost to Follow-up|0|||
129998212|NCT02684357|467956702|FG001|Part B|Lost to Follow-up|0|||
129998213|NCT02684357|467956703|FG002|Part B|Lost to Follow-up|0|||
129998214|NCT02684357|467956704|FG003|Part B|Lost to Follow-up|1|||
129998215|NCT02684357|467956705|FG004|Part B|Lost to Follow-up|1|||
129998216|NCT02684357|467956706|FG005|Part B|Lost to Follow-up|7|||
129998217|NCT02684357|467956701|FG000|Part B|Withdrawal by Subject|0|||
129998218|NCT02684357|467956702|FG001|Part B|Withdrawal by Subject|0|||
129998219|NCT02684357|467956703|FG002|Part B|Withdrawal by Subject|0|||
129998220|NCT02684357|467956704|FG003|Part B|Withdrawal by Subject|0|||
129998221|NCT02684357|467956705|FG004|Part B|Withdrawal by Subject|2|||
129998222|NCT02684357|467956706|FG005|Part B|Withdrawal by Subject|4|||
129998223|NCT02684357|467956701|FG000|Part B|Other|0|||
129998224|NCT02684357|467956702|FG001|Part B|Other|0|||
129998225|NCT02684357|467956703|FG002|Part B|Other|0|||
129998226|NCT02684357|467956704|FG003|Part B|Other|1|||
129998227|NCT02684357|467956705|FG004|Part B|Other|0|||
129998228|NCT02684357|467956706|FG005|Part B|Other|1|||
129998229|NCT01079130|467956707|FG000|Overall Study|Adverse Event|1|||
129998230|NCT01079130|467956708|FG001|Overall Study|Adverse Event|1|||
129998231|NCT01079130|467956709|FG002|Overall Study|Adverse Event|0|||
129998232|NCT01079130|467956710|FG003|Overall Study|Adverse Event|1|||
129998233|NCT01079130|467956711|FG004|Overall Study|Adverse Event|5|||
129998234|NCT01079130|467956712|FG005|Overall Study|Adverse Event|1|||
129998235|NCT01079130|467956707|FG000|Overall Study|Administrative problems|1|||
129998236|NCT01079130|467956708|FG001|Overall Study|Administrative problems|3|||
129998237|NCT01079130|467956709|FG002|Overall Study|Administrative problems|0|||
129998238|NCT01079130|467956710|FG003|Overall Study|Administrative problems|0|||
129998239|NCT01079130|467956711|FG004|Overall Study|Administrative problems|0|||
129998240|NCT01079130|467956712|FG005|Overall Study|Administrative problems|1|||
129998241|NCT01079130|467956707|FG000|Overall Study|Withdrawal by Subject|0|||
129998242|NCT01079130|467956708|FG001|Overall Study|Withdrawal by Subject|1|||
129998243|NCT01079130|467956709|FG002|Overall Study|Withdrawal by Subject|0|||
129998244|NCT01079130|467956710|FG003|Overall Study|Withdrawal by Subject|0|||
129998245|NCT01079130|467956711|FG004|Overall Study|Withdrawal by Subject|1|||
129998246|NCT01079130|467956712|FG005|Overall Study|Withdrawal by Subject|3|||
129998247|NCT01079130|467956707|FG000|Overall Study|Protocol deviation|0|||
129998248|NCT01079130|467956708|FG001|Overall Study|Protocol deviation|2|||
129998249|NCT01079130|467956709|FG002|Overall Study|Protocol deviation|1|||
129998250|NCT01079130|467956710|FG003|Overall Study|Protocol deviation|2|||
129998251|NCT01079130|467956711|FG004|Overall Study|Protocol deviation|0|||
129998252|NCT01079130|467956712|FG005|Overall Study|Protocol deviation|0|||
129998253|NCT01079130|467956707|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129998254|NCT01079130|467956708|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129998255|NCT01079130|467956709|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129998256|NCT01079130|467956710|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129998257|NCT01079130|467956711|FG004|Overall Study|Abnormal test procedure result(s)|1|||
129998258|NCT01079130|467956712|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130335131|NCT02675634|469197351|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
130335132|NCT02675634|469197352|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
129998259|NCT01079130|467956707|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129998260|NCT01079130|467956708|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129998261|NCT01079130|467956709|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129998262|NCT01079130|467956710|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129998263|NCT01079130|467956711|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
129998264|NCT01079130|467956712|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
129998265|NCT01079130|467956707|FG000|Overall Study|Lost to Follow-up|0|||
129998266|NCT01079130|467956708|FG001|Overall Study|Lost to Follow-up|0|||
129998267|NCT01079130|467956709|FG002|Overall Study|Lost to Follow-up|0|||
129998268|NCT01079130|467956710|FG003|Overall Study|Lost to Follow-up|0|||
129998269|NCT01079130|467956711|FG004|Overall Study|Lost to Follow-up|1|||
129998270|NCT01079130|467956712|FG005|Overall Study|Lost to Follow-up|0|||
129998271|NCT01839487|467956713|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
129998272|NCT01839487|467956714|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129998273|NCT01839487|467956715|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129998274|NCT01839487|467956716|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129998275|NCT01839487|467956717|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129998276|NCT01839487|467956718|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129998277|NCT01839487|467956713|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
129998278|NCT01839487|467956714|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
129998279|NCT01839487|467956715|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129998280|NCT01839487|467956716|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129998281|NCT01839487|467956717|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129998282|NCT01839487|467956718|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129998283|NCT01839487|467956713|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129998284|NCT01839487|467956714|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
129998285|NCT01839487|467956715|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129998286|NCT01839487|467956716|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129998287|NCT01839487|467956717|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129998288|NCT01839487|467956718|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129998289|NCT01839487|467956713|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
129998290|NCT01839487|467956714|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129998291|NCT01839487|467956715|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129998292|NCT01839487|467956716|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129998293|NCT01839487|467956717|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129998294|NCT01839487|467956718|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129998295|NCT01839487|467956713|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
129998296|NCT01839487|467956714|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
129998297|NCT01839487|467956715|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
129998298|NCT01839487|467956716|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
129998299|NCT01839487|467956717|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
129998300|NCT01839487|467956718|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
129998301|NCT01839487|467956713|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
129998302|NCT01839487|467956714|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
130335133|NCT02675634|469197353|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
130335134|NCT02675634|469197354|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
130335135|NCT02675634|469197355|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
130335136|NCT02675634|469197356|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
130335137|NCT02675634|469197351|FG000|Test Period 2|Lack of Efficacy|1|||
130335138|NCT02675634|469197352|FG001|Test Period 2|Lack of Efficacy|0|||
130335139|NCT02675634|469197353|FG002|Test Period 2|Lack of Efficacy|0|||
130335140|NCT02675634|469197354|FG003|Test Period 2|Lack of Efficacy|0|||
130335141|NCT02675634|469197355|FG004|Test Period 2|Lack of Efficacy|0|||
130335142|NCT02675634|469197356|FG005|Test Period 2|Lack of Efficacy|0|||
130335143|NCT02675634|469197351|FG000|Test Period 2|Adverse Event|0|||
130335144|NCT02675634|469197352|FG001|Test Period 2|Adverse Event|0|||
130335145|NCT02675634|469197353|FG002|Test Period 2|Adverse Event|0|||
130335146|NCT02675634|469197354|FG003|Test Period 2|Adverse Event|0|||
130335147|NCT02675634|469197355|FG004|Test Period 2|Adverse Event|0|||
129998303|NCT01839487|467956715|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
129998304|NCT01839487|467956716|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
129998305|NCT01839487|467956717|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
129998306|NCT01839487|467956718|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
129998307|NCT01839487|467956713|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129998308|NCT01839487|467956714|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129998309|NCT01839487|467956715|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
129998310|NCT01839487|467956716|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129998311|NCT01839487|467956717|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
129998312|NCT01839487|467956718|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129998313|NCT01839487|467956713|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
129998314|NCT01839487|467956714|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
129998315|NCT01839487|467956715|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
129998316|NCT01839487|467956716|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
129998317|NCT01839487|467956717|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
129998318|NCT01839487|467956718|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
129998319|NCT01839487|467956713|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
129998320|NCT01839487|467956714|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
129998321|NCT01839487|467956715|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
129998322|NCT01839487|467956716|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
129998323|NCT01839487|467956717|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
129998324|NCT01839487|467956718|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
129998325|NCT01658826|467956729|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
129998326|NCT01658826|467956730|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
129998327|NCT01658826|467956729|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
129998328|NCT01658826|467956730|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
129998329|NCT01658826|467956729|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
129998330|NCT01658826|467956730|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
129998331|NCT01658826|467956729|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
129998332|NCT01658826|467956730|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
129998333|NCT01658826|467956729|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
129998334|NCT01658826|467956730|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
129998335|NCT01658826|467956729|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
129998336|NCT01658826|467956730|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
130335148|NCT02675634|469197356|FG005|Test Period 2|Adverse Event|1|||
130335149|NCT01652534|469197357|FG000|Overall Study|Lack of Efficacy|1|||
130335150|NCT01652534|469197358|FG001|Overall Study|Lack of Efficacy|0|||
130335151|NCT02105961|469197359|FG000|Overall Study|Adverse Event|18|||
130335152|NCT02105961|469197360|FG001|Overall Study|Adverse Event|7|||
130335153|NCT02105961|469197361|FG002|Overall Study|Adverse Event|13|||
130335154|NCT02105961|469197359|FG000|Overall Study|Lack of Efficacy|3|||
130335155|NCT02105961|469197360|FG001|Overall Study|Lack of Efficacy|0|||
130335156|NCT02105961|469197361|FG002|Overall Study|Lack of Efficacy|3|||
130335157|NCT02105961|469197359|FG000|Overall Study|Lost to Follow-up|2|||
130335158|NCT02105961|469197360|FG001|Overall Study|Lost to Follow-up|0|||
130335159|NCT02105961|469197361|FG002|Overall Study|Lost to Follow-up|1|||
130335160|NCT02105961|469197359|FG000|Overall Study|Physician Decision|3|||
130335161|NCT02105961|469197360|FG001|Overall Study|Physician Decision|3|||
130335162|NCT02105961|469197361|FG002|Overall Study|Physician Decision|2|||
130335163|NCT02105961|469197359|FG000|Overall Study|Withdrawal by Subject|15|||
130335164|NCT02105961|469197360|FG001|Overall Study|Withdrawal by Subject|7|||
130335165|NCT02105961|469197361|FG002|Overall Study|Withdrawal by Subject|11|||
130335166|NCT03860259|469197362|FG000|Overall Study|Lost to Follow-up|5|||
130335167|NCT03860259|469197363|FG001|Overall Study|Lost to Follow-up|5|||
130335168|NCT03860259|469197362|FG000|Overall Study|Protocol Violation|1|||
130335169|NCT03860259|469197363|FG001|Overall Study|Protocol Violation|0|||
130335170|NCT00811018|469197364|FG000|Overall Study|Additional Chronic Treatment|31|||
130335171|NCT00811018|469197364|FG000|Overall Study|Adverse Event|79|||
130335172|NCT00811018|469197364|FG000|Overall Study|Death|147|||
130335173|NCT00811018|469197364|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
130335174|NCT00811018|469197364|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
130335175|NCT00811018|469197364|FG000|Overall Study|Investigator Decision|57|||
130335176|NCT00811018|469197364|FG000|Overall Study|Lost to Follow-up|19|||
130335177|NCT00811018|469197364|FG000|Overall Study|Pregnancy|6|||
130335178|NCT00811018|469197364|FG000|Overall Study|Sponsor Decision|450|||
130335179|NCT00811018|469197364|FG000|Overall Study|Withdrawal by Subject|70|||
130335180|NCT00811018|469197364|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
130335181|NCT00811018|469197364|FG000|Overall Study|Other|26|||
130335182|NCT00934362|469197368|FG000|Overall Study|Adverse Event|1|||
130335183|NCT00934362|469197369|FG001|Overall Study|Adverse Event|0|||
130335184|NCT01092117|469197370|FG000|Index Procedure to 1 Month|Death|1|||
130335185|NCT01092117|469197370|FG000|1 Month|Death|1|||
130335186|NCT01092117|469197370|FG000|1 Month|Withdrawal by Subject|1|||
130335187|NCT01092117|469197370|FG000|1 Month|Lost to Follow-up|1|||
129998337|NCT01658826|467956729|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
129998338|NCT01658826|467956730|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
129998339|NCT01658826|467956729|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
129998340|NCT01658826|467956730|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
129998341|NCT01658826|467956729|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
129998342|NCT01658826|467956730|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
129998343|NCT01422850|467956733|FG000|Overall Study|Physician Decision|3|||
129998344|NCT04484831|467956734|FG000|Overall Study|Withdrawal by Subject|1|||
129998345|NCT04484831|467956735|FG001|Overall Study|Withdrawal by Subject|0|||
129998346|NCT02244996|467956736|FG000|Overall Study|Lack of Efficacy|2|||
129998347|NCT02244996|467956737|FG001|Overall Study|Lack of Efficacy|6|||
129998348|NCT01335009|467956738|FG000|Overall Study|Too ill to travel to study sites|1|||
129998349|NCT01335009|467956739|FG001|Overall Study|Too ill to travel to study sites|0|||
129998350|NCT01335009|467956738|FG000|Overall Study|Death|28|||
129998351|NCT01335009|467956739|FG001|Overall Study|Death|32|||
129998352|NCT01335009|467956738|FG000|Overall Study|Withdrawal by Subject|1|||
129998353|NCT01335009|467956739|FG001|Overall Study|Withdrawal by Subject|1|||
129998354|NCT01335009|467956738|FG000|Overall Study|Lost to Follow-up|1|||
129998355|NCT01335009|467956739|FG001|Overall Study|Lost to Follow-up|0|||
129998356|NCT04821869|467956740|FG000|Overall Study|Adverse Event|4|||
129998357|NCT04821869|467956740|FG000|Overall Study|Withdrawal by Subject|2|||
129998358|NCT04821869|467956740|FG000|Overall Study|Did not meet FEV1 criteria|1|||
129998359|NCT03511053|467958187|FG000|Overall Study|Withdrawal by Subject|1|||
129998360|NCT01128361|467958188|FG000|Overall Study|Lost to Follow-up|0|||
129998361|NCT01128361|467958189|FG001|Overall Study|Lost to Follow-up|1|||
129998362|NCT01128361|467958188|FG000|Overall Study|Withdrawal by Subject|5|||
129998363|NCT01128361|467958189|FG001|Overall Study|Withdrawal by Subject|2|||
129998364|NCT01929980|467958190|FG000|Overall Study|Physician Decision|1|||
129998365|NCT00985166|467958191|FG000|Overall Study|Lost to Follow-up|3|||
129998366|NCT00985166|467958192|FG001|Overall Study|Lost to Follow-up|2|||
129998367|NCT00985166|467958193|FG002|Overall Study|Lost to Follow-up|2|||
129998368|NCT00985166|467958191|FG000|Overall Study|Withdrawal by Subject|3|||
129998369|NCT00985166|467958192|FG001|Overall Study|Withdrawal by Subject|2|||
129998370|NCT00985166|467958193|FG002|Overall Study|Withdrawal by Subject|0|||
129998371|NCT00985166|467958191|FG000|Overall Study|Test not done|2|||
129998372|NCT00985166|467958192|FG001|Overall Study|Test not done|0|||
129998373|NCT00985166|467958193|FG002|Overall Study|Test not done|4|||
129998374|NCT00985166|467958191|FG000|Overall Study|Other|1|||
129998375|NCT00985166|467958192|FG001|Overall Study|Other|0|||
129998376|NCT00985166|467958193|FG002|Overall Study|Other|1|||
129998377|NCT01028222|467958194|FG000|Overall Study|Protocol deviation|1|||
129998378|NCT01028222|467958195|FG001|Overall Study|Protocol deviation|0|||
129998379|NCT01028222|467958194|FG000|Overall Study|Disease progression|33|||
129998380|NCT01028222|467958195|FG001|Overall Study|Disease progression|9|||
129998381|NCT01028222|467958194|FG000|Overall Study|Administrative problems|1|||
129998382|NCT01028222|467958195|FG001|Overall Study|Administrative problems|1|||
129998383|NCT01028222|467958194|FG000|Overall Study|Lost to Follow-up|0|||
129998384|NCT01028222|467958195|FG001|Overall Study|Lost to Follow-up|1|||
129998385|NCT01028222|467958194|FG000|Overall Study|Withdrawal by Subject|1|||
129998386|NCT01028222|467958195|FG001|Overall Study|Withdrawal by Subject|0|||
129998387|NCT01028222|467958194|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
129998388|NCT01028222|467958195|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
129998389|NCT01028222|467958194|FG000|Overall Study|Adverse Event|2|||
129998390|NCT01028222|467958195|FG001|Overall Study|Adverse Event|0|||
130335188|NCT01092117|469197370|FG000|6 Months|Death|2|||
130335189|NCT01092117|469197370|FG000|6 Months|Withdrawal by Subject|3|||
130335190|NCT01092117|469197370|FG000|12 Month|Death|11|||
130335191|NCT01092117|469197370|FG000|12 Month|Withdrawal by Subject|2|||
130335192|NCT01092117|469197370|FG000|12 Month|Lost to Follow-up|1|||
130335193|NCT01092117|469197370|FG000|Year 2|Death|5|||
130335194|NCT01092117|469197370|FG000|Year 2|Withdrawal by Subject|4|||
129884287|NCT04329104|467536317|FG001|Efficacy Study|Withdrawal by Subject|0|||
129998391|NCT00146328|467958198|FG000|Overall Study|Adverse Event|39|||
129998392|NCT00146328|467958199|FG001|Overall Study|Adverse Event|48|||
129998393|NCT00146328|467958200|FG002|Overall Study|Adverse Event|79|||
129998394|NCT00146328|467958198|FG000|Overall Study|Protocol Violation|11|||
129998395|NCT00146328|467958199|FG001|Overall Study|Protocol Violation|6|||
129998396|NCT00146328|467958200|FG002|Overall Study|Protocol Violation|12|||
129998397|NCT00146328|467958198|FG000|Overall Study|Lost to Follow-up|7|||
130335195|NCT01092117|469197370|FG000|Year 2|Lost to Follow-up|1|||
130335196|NCT01092117|469197370|FG000|Year 3|Death|7|||
130335197|NCT01092117|469197370|FG000|Year 3|Withdrawal by Subject|9|||
130335198|NCT01092117|469197370|FG000|Year 3|Lost to Follow-up|3|||
130335199|NCT01092117|469197370|FG000|Year 4|Death|8|||
129998398|NCT00146328|467958199|FG001|Overall Study|Lost to Follow-up|4|||
129998399|NCT00146328|467958200|FG002|Overall Study|Lost to Follow-up|7|||
129998400|NCT00146328|467958198|FG000|Overall Study|Withdrawal by Subject|16|||
129998401|NCT00146328|467958199|FG001|Overall Study|Withdrawal by Subject|16|||
129998402|NCT00146328|467958200|FG002|Overall Study|Withdrawal by Subject|22|||
129998403|NCT00146328|467958198|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
129998404|NCT00146328|467958199|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
129998405|NCT00146328|467958200|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
129998406|NCT00146328|467958198|FG000|Overall Study|Trial ended/site closed|8|||
129998407|NCT00146328|467958199|FG001|Overall Study|Trial ended/site closed|2|||
129998408|NCT00146328|467958200|FG002|Overall Study|Trial ended/site closed|19|||
129998409|NCT00146328|467958198|FG000|Overall Study|Patient decision to end|0|||
129998410|NCT00146328|467958199|FG001|Overall Study|Patient decision to end|1|||
129998411|NCT00146328|467958200|FG002|Overall Study|Patient decision to end|6|||
129998412|NCT00146328|467958198|FG000|Overall Study|Enroll into other trial|2|||
129998413|NCT00146328|467958199|FG001|Overall Study|Enroll into other trial|4|||
129998414|NCT00146328|467958200|FG002|Overall Study|Enroll into other trial|2|||
129998415|NCT00146328|467958198|FG000|Overall Study|Death|0|||
129998416|NCT00146328|467958199|FG001|Overall Study|Death|1|||
129998417|NCT00146328|467958200|FG002|Overall Study|Death|1|||
129998418|NCT00146328|467958198|FG000|Overall Study|Moved|2|||
129998419|NCT00146328|467958199|FG001|Overall Study|Moved|0|||
129998420|NCT00146328|467958200|FG002|Overall Study|Moved|0|||
129998421|NCT00146328|467958198|FG000|Overall Study|Interaction with other medication|2|||
129998422|NCT00146328|467958199|FG001|Overall Study|Interaction with other medication|0|||
129998423|NCT00146328|467958200|FG002|Overall Study|Interaction with other medication|1|||
129998424|NCT00300781|467958201|FG000|Overall Study|Disease Progression|55|||
129998425|NCT00300781|467958202|FG001|Overall Study|Disease Progression|52|||
129998426|NCT00300781|467958201|FG000|Overall Study|Adverse Event|5|||
129998427|NCT00300781|467958202|FG001|Overall Study|Adverse Event|6|||
129998428|NCT00300781|467958201|FG000|Overall Study|Withdrawal by Subject|1|||
129998429|NCT00300781|467958202|FG001|Overall Study|Withdrawal by Subject|2|||
129998430|NCT00300781|467958201|FG000|Overall Study|Physician Decision|1|||
129998431|NCT00300781|467958202|FG001|Overall Study|Physician Decision|0|||
129998432|NCT00300781|467958201|FG000|Overall Study|Not Recorded|0|||
129998433|NCT00300781|467958202|FG001|Overall Study|Not Recorded|1|||
129998434|NCT00300781|467958201|FG000|Overall Study|Symptomatic Deterioration|1|||
129998435|NCT00300781|467958202|FG001|Overall Study|Symptomatic Deterioration|0|||
129998436|NCT00300781|467958201|FG000|Overall Study|Lost to Follow-up|0|||
129998437|NCT00300781|467958202|FG001|Overall Study|Lost to Follow-up|1|||
129998438|NCT02072434|467958203|FG000|Overall Study|Protocol Violation|10|||
129998439|NCT02072434|467958204|FG001|Overall Study|Protocol Violation|9|||
129998440|NCT02072434|467958203|FG000|Overall Study|Physician Decision|5|||
130335200|NCT01092117|469197370|FG000|Year 4|Withdrawal by Subject|4|||
130335201|NCT01092117|469197370|FG000|Year 4|Lost to Follow-up|4|||
130335202|NCT04380519|469197371|FG000|Overall Study|Withdrawal by Subject|4|||
130335203|NCT04380519|469197372|FG001|Overall Study|Withdrawal by Subject|0|||
130335204|NCT04380519|469197373|FG002|Overall Study|Withdrawal by Subject|1|||
130335205|NCT04380519|469197371|FG000|Overall Study|Death|14|||
130335206|NCT04380519|469197372|FG001|Overall Study|Death|9|||
130335207|NCT04380519|469197373|FG002|Overall Study|Death|6|||
130335208|NCT04380519|469197371|FG000|Overall Study|Adverse Event|0|||
130335209|NCT04380519|469197372|FG001|Overall Study|Adverse Event|1|||
130335210|NCT04380519|469197373|FG002|Overall Study|Adverse Event|0|||
130335211|NCT04380519|469197371|FG000|Overall Study|relatives' decision|0|||
130335212|NCT04380519|469197372|FG001|Overall Study|relatives' decision|1|||
130335213|NCT04380519|469197373|FG002|Overall Study|relatives' decision|0|||
130335214|NCT02147561|469197376|FG000|Overall Study|Lost to Follow-up|3|||
130335215|NCT02147561|469197376|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
130335216|NCT00393861|469197379|FG000|Overall Study|Adverse Event|2|||
130335217|NCT00393861|469197379|FG000|Overall Study|Disease Progression|24|||
130335218|NCT05300763|469197380|FG000|Overall Study|Adverse Event|0|||
130335219|NCT05300763|469197381|FG001|Overall Study|Adverse Event|1|||
130335220|NCT05300763|469197380|FG000|Overall Study|Major Protocol Deviation|1|||
129998441|NCT02072434|467958204|FG001|Overall Study|Physician Decision|10|||
129998442|NCT02072434|467958203|FG000|Overall Study|Adverse event, serious fatal|1|||
129998443|NCT02072434|467958204|FG001|Overall Study|Adverse event, serious fatal|6|||
129998444|NCT02072434|467958203|FG000|Overall Study|Adverse Event|7|||
129998445|NCT02072434|467958204|FG001|Overall Study|Adverse Event|6|||
129998446|NCT02072434|467958203|FG000|Overall Study|Withdrawal by Subject|17|||
129998447|NCT02072434|467958204|FG001|Overall Study|Withdrawal by Subject|29|||
129998448|NCT02072434|467958203|FG000|Overall Study|Other|14|||
129998449|NCT02072434|467958204|FG001|Overall Study|Other|29|||
129998450|NCT02072434|467958203|FG000|Overall Study|Lost to Follow-up|0|||
130335221|NCT05300763|469197381|FG001|Overall Study|Major Protocol Deviation|0|||
130335222|NCT05300763|469197380|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
130335223|NCT05300763|469197381|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130335224|NCT01727024|469197382|FG000|Period 1|Lost to Follow-up|1|||
129998451|NCT02072434|467958204|FG001|Overall Study|Lost to Follow-up|1|||
129998452|NCT02960854|467958209|FG000|Overall Study|Not Disclosed|2|||
129998453|NCT02960854|467958210|FG001|Overall Study|Not Disclosed|2|||
129998454|NCT02960854|467958209|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
129998455|NCT02960854|467958210|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
129998456|NCT02960854|467958209|FG000|Overall Study|Subject Withdrew Consent|0|||
129998457|NCT02960854|467958210|FG001|Overall Study|Subject Withdrew Consent|1|||
129998458|NCT02960854|467958209|FG000|Overall Study|Death|4|||
129998459|NCT02960854|467958210|FG001|Overall Study|Death|6|||
129998460|NCT04263909|467958211|FG000|Overall Study|Physician Decision|1|||
129998461|NCT04263909|467958212|FG001|Overall Study|Physician Decision|0|||
129998462|NCT04263909|467958213|FG002|Overall Study|Physician Decision|0|||
129998463|NCT04263909|467958211|FG000|Overall Study|Adverse Event|3|||
129998464|NCT04263909|467958212|FG001|Overall Study|Adverse Event|0|||
129998465|NCT04263909|467958213|FG002|Overall Study|Adverse Event|0|||
129998466|NCT04263909|467958211|FG000|Overall Study|Protocol Violation|5|||
129998467|NCT04263909|467958212|FG001|Overall Study|Protocol Violation|0|||
130335225|NCT01727024|469197383|FG001|Period 1|Lost to Follow-up|1|||
130335226|NCT01727024|469197382|FG000|Period 1|Withdrawal by Subject|2|||
130335227|NCT01727024|469197383|FG001|Period 1|Withdrawal by Subject|3|||
130335228|NCT01485172|469197384|FG000|Overall Study|Adverse Event|2|||
130335229|NCT01485172|469197385|FG001|Overall Study|Adverse Event|1|||
130335230|NCT01485172|469197386|FG002|Overall Study|Adverse Event|2|||
130335231|NCT01485172|469197387|FG003|Overall Study|Adverse Event|2|||
130335232|NCT01485172|469197388|FG004|Overall Study|Adverse Event|1|||
130335233|NCT01485172|469197389|FG005|Overall Study|Adverse Event|2|||
130335234|NCT01485172|469197384|FG000|Overall Study|Lack of Efficacy|2|||
130335235|NCT01485172|469197385|FG001|Overall Study|Lack of Efficacy|0|||
129998468|NCT04263909|467958213|FG002|Overall Study|Protocol Violation|0|||
129998469|NCT04288778|467958214|FG000|Overall Study|Withdrawal by Subject|2|||
129998470|NCT04288778|467958214|FG000|Overall Study|Adverse Event|5|||
129998471|NCT04288778|467958214|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129998472|NCT04288778|467958214|FG000|Overall Study|Other|1|||
129998473|NCT04288778|467958214|FG000|Overall Study|Started but not treated|2|||
129998474|NCT01324323|467958215|FG000|Overall Study|Withdrawal by Subject|1|||
129998475|NCT03153137|467958216|FG000|Overall Study|Lost to Follow-up|1|||
129998476|NCT03153137|467958217|FG001|Overall Study|Lost to Follow-up|0|||
129998477|NCT03153137|467958216|FG000|Overall Study|Withdrawal by Subject|2|||
129998478|NCT03153137|467958217|FG001|Overall Study|Withdrawal by Subject|1|||
129998479|NCT03153137|467958216|FG000|Overall Study|Physician Decision|0|||
129998480|NCT03153137|467958217|FG001|Overall Study|Physician Decision|3|||
129998481|NCT00993915|467958224|FG000|Overall Study|Insufficient clinical response|3|||
129998482|NCT00993915|467958224|FG000|Overall Study|Withdrawal by Subject|2|||
129998483|NCT00993915|467958224|FG000|Overall Study|Other|1|||
129998484|NCT00993915|467958224|FG000|Overall Study|Ongoing|3|||
129998485|NCT04209621|467958232|FG000|Overall Study|Death|1|||
129998486|NCT04209621|467958232|FG000|Overall Study|Study Terminated Early|2|||
129998487|NCT02249767|467958233|FG000|Overall Study|Did not use medication|8|||
129998488|NCT02249767|467958234|FG001|Overall Study|Did not use medication|9|||
129998489|NCT02249767|467958235|FG002|Overall Study|Did not use medication|8|||
129998490|NCT01372410|467958236|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
129998491|NCT01372410|467958237|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
129998492|NCT01372410|467958238|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129998493|NCT01372410|467958239|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129998494|NCT01372410|467958240|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
129998495|NCT01372410|467958241|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129998496|NCT01372410|467958242|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129998497|NCT01372410|467958243|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129998498|NCT01372410|467958236|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
129998499|NCT01372410|467958237|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
129998500|NCT01372410|467958238|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
130335236|NCT01485172|469197386|FG002|Overall Study|Lack of Efficacy|0|||
130335237|NCT01485172|469197387|FG003|Overall Study|Lack of Efficacy|0|||
129998501|NCT01372410|467958239|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
129998502|NCT01372410|467958240|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
129998503|NCT01372410|467958241|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
129998504|NCT01372410|467958242|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
130335238|NCT01485172|469197388|FG004|Overall Study|Lack of Efficacy|0|||
129998505|NCT01372410|467958243|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
129998506|NCT01372410|467958236|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998507|NCT01372410|467958237|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998508|NCT01372410|467958238|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998509|NCT01372410|467958239|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998510|NCT01372410|467958240|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
130335239|NCT01485172|469197389|FG005|Overall Study|Lack of Efficacy|0|||
130335240|NCT01485172|469197384|FG000|Overall Study|Protocol Violation|0|||
130335241|NCT01485172|469197385|FG001|Overall Study|Protocol Violation|0|||
129998511|NCT01372410|467958241|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998512|NCT01372410|467958242|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998513|NCT01372410|467958243|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129998514|NCT01372410|467958236|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998515|NCT01372410|467958237|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998516|NCT01372410|467958238|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998517|NCT01372410|467958239|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998518|NCT01372410|467958240|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998519|NCT01372410|467958241|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998520|NCT01372410|467958242|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
129998521|NCT01372410|467958243|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129998522|NCT01372410|467958236|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
129998523|NCT01372410|467958237|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129998524|NCT01372410|467958238|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129998525|NCT01372410|467958239|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129998526|NCT01372410|467958240|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129998527|NCT01372410|467958241|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129998528|NCT01372410|467958242|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129998529|NCT01372410|467958243|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
129998530|NCT01372410|467958236|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998531|NCT01372410|467958237|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998532|NCT01372410|467958238|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998533|NCT01372410|467958239|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998534|NCT01372410|467958240|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
129998535|NCT01372410|467958241|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998536|NCT01372410|467958242|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998537|NCT01372410|467958243|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129998538|NCT01372410|467958236|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129998539|NCT01372410|467958237|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129998540|NCT01372410|467958238|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129998541|NCT01372410|467958239|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129998542|NCT01372410|467958240|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
129998543|NCT01372410|467958241|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129998544|NCT01372410|467958242|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
129998545|NCT01372410|467958243|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
129998546|NCT01372410|467958236|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998547|NCT01372410|467958237|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998548|NCT01372410|467958238|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998549|NCT01372410|467958239|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998550|NCT01372410|467958240|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998551|NCT01372410|467958241|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998552|NCT01372410|467958242|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129998553|NCT01372410|467958243|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
129998554|NCT01372410|467958236|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998555|NCT01372410|467958237|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998556|NCT01372410|467958238|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
129998557|NCT01372410|467958239|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998558|NCT01372410|467958240|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998559|NCT01372410|467958241|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998560|NCT01372410|467958242|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998561|NCT01372410|467958243|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
129998562|NCT01372410|467958236|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998563|NCT01372410|467958237|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998564|NCT01372410|467958238|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998565|NCT01372410|467958239|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998566|NCT01372410|467958240|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998567|NCT01372410|467958241|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
129998568|NCT01372410|467958242|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998569|NCT01372410|467958243|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129998570|NCT04585646|467958244|FG000|First Intervention|Physician Decision|1|||
129998571|NCT04585646|467958245|FG001|First Intervention|Physician Decision|0|||
129998572|NCT04585646|467958244|FG000|First Intervention|Lost to Follow-up|0|||
129998573|NCT04585646|467958245|FG001|First Intervention|Lost to Follow-up|3|||
129998574|NCT04585646|467958244|FG000|First Intervention|Withdrawal by Subject|0|||
129998575|NCT04585646|467958245|FG001|First Intervention|Withdrawal by Subject|1|||
129998576|NCT02465463|467958247|FG000|Overall Study|Lost to Follow-up|2|||
129998577|NCT02465463|467958248|FG001|Overall Study|Lost to Follow-up|1|||
129998578|NCT02465463|467958247|FG000|Overall Study|Death|1|||
129998579|NCT02465463|467958248|FG001|Overall Study|Death|0|||
129998580|NCT02465463|467958247|FG000|Overall Study|Protocol Violation|1|||
129998581|NCT02465463|467958248|FG001|Overall Study|Protocol Violation|0|||
129998582|NCT01067326|467958251|FG000|Overall Study|Adverse Event|0|||
129998583|NCT01067326|467958252|FG001|Overall Study|Adverse Event|2|||
129998584|NCT01067326|467958251|FG000|Overall Study|Withdrawal by Subject|1|||
129998585|NCT01067326|467958252|FG001|Overall Study|Withdrawal by Subject|0|||
129998586|NCT01067326|467958251|FG000|Overall Study|Early Study Termination|1|||
129998587|NCT01067326|467958252|FG001|Overall Study|Early Study Termination|1|||
129998588|NCT01230788|467958257|FG000|Overall Study|Prescribed exclusion drug|1|||
129998589|NCT01603082|467958258|FG000|Overall Study|Adverse Event|0|||
129998590|NCT01603082|467958259|FG001|Overall Study|Adverse Event|1|||
129998591|NCT01603082|467958258|FG000|Overall Study|Withdrawal by Subject|1|||
129998592|NCT01603082|467958259|FG001|Overall Study|Withdrawal by Subject|0|||
129998593|NCT01603082|467958258|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
129998594|NCT01603082|467958259|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
129998595|NCT01019317|467958261|FG000|Overall Study|Not Eligible|4|||
129998596|NCT03294109|467958263|FG000|Overall Study|Withdrawal by Subject|6|||
129998597|NCT03294109|467958264|FG001|Overall Study|Withdrawal by Subject|5|||
129998598|NCT04744285|467958265|FG000|Overall Study|Withdrawal by Subject|1|||
129998599|NCT04744285|467958266|FG001|Overall Study|Withdrawal by Subject|1|||
129998600|NCT04744285|467958267|FG002|Overall Study|Withdrawal by Subject|2|||
129998601|NCT04744285|467958268|FG003|Overall Study|Withdrawal by Subject|1|||
129998602|NCT01774084|467958269|FG000|Overall Study|Personal reasons|1|||
129998603|NCT01774084|467958270|FG001|Overall Study|Personal reasons|0|||
129998604|NCT00821431|467958271|FG000|Overall Study|Adverse Event|6|||
129998605|NCT00821431|467958272|FG001|Overall Study|Adverse Event|3|||
129998606|NCT00821431|467958271|FG000|Overall Study|Withdrawal by Subject|5|||
129998607|NCT00821431|467958272|FG001|Overall Study|Withdrawal by Subject|0|||
129998608|NCT00821431|467958271|FG000|Overall Study|Lost to Follow-up|1|||
129998609|NCT00821431|467958272|FG001|Overall Study|Lost to Follow-up|0|||
129998610|NCT00821431|467958271|FG000|Overall Study|Protocol Violation|3|||
129998611|NCT00821431|467958272|FG001|Overall Study|Protocol Violation|1|||
129998612|NCT00821431|467958271|FG000|Overall Study|Physician Decision|0|||
129998613|NCT00821431|467958272|FG001|Overall Study|Physician Decision|1|||
129998614|NCT04526197|467958277|FG000|Period 1|Adverse Event|0|||
129998615|NCT04526197|467958278|FG001|Period 1|Adverse Event|1|||
129998616|NCT04526197|467958277|FG000|Period 1|Withdrawal by Subject|1|||
129998617|NCT04526197|467958278|FG001|Period 1|Withdrawal by Subject|0|||
129998618|NCT04526197|467958277|FG000|Period 2|Adverse Event|0|||
129998619|NCT04526197|467958278|FG001|Period 2|Adverse Event|1|||
129998620|NCT04526197|467958277|FG000|Period 2|Withdrawal by Subject|0|||
129998621|NCT04526197|467958278|FG001|Period 2|Withdrawal by Subject|1|||
129998622|NCT00372385|467958279|FG000|Overall Study|Adverse Event|6|||
129998623|NCT00372385|467958280|FG001|Overall Study|Adverse Event|11|||
129998624|NCT00372385|467958281|FG002|Overall Study|Adverse Event|9|||
129998625|NCT00372385|467958282|FG003|Overall Study|Adverse Event|7|||
129998626|NCT00372385|467958279|FG000|Overall Study|Noncompliance|0|||
129998627|NCT00372385|467958280|FG001|Overall Study|Noncompliance|1|||
129998628|NCT00372385|467958281|FG002|Overall Study|Noncompliance|1|||
129998629|NCT00372385|467958282|FG003|Overall Study|Noncompliance|1|||
129998630|NCT00372385|467958279|FG000|Overall Study|Physician Decision|1|||
129998631|NCT00372385|467958280|FG001|Overall Study|Physician Decision|0|||
129998632|NCT00372385|467958281|FG002|Overall Study|Physician Decision|0|||
129998633|NCT00372385|467958282|FG003|Overall Study|Physician Decision|0|||
129998634|NCT00372385|467958279|FG000|Overall Study|Lost to Follow-up|2|||
129998635|NCT00372385|467958280|FG001|Overall Study|Lost to Follow-up|0|||
129998636|NCT00372385|467958281|FG002|Overall Study|Lost to Follow-up|0|||
129998637|NCT00372385|467958282|FG003|Overall Study|Lost to Follow-up|0|||
129998638|NCT00372385|467958279|FG000|Overall Study|Withdrawal by Subject|2|||
129998639|NCT00372385|467958280|FG001|Overall Study|Withdrawal by Subject|1|||
129998640|NCT00372385|467958281|FG002|Overall Study|Withdrawal by Subject|0|||
129998641|NCT00372385|467958282|FG003|Overall Study|Withdrawal by Subject|0|||
129998642|NCT00372385|467958279|FG000|Overall Study|Refusal of Treatment|3|||
129998643|NCT00372385|467958280|FG001|Overall Study|Refusal of Treatment|6|||
129998644|NCT00372385|467958281|FG002|Overall Study|Refusal of Treatment|0|||
129998645|NCT00372385|467958282|FG003|Overall Study|Refusal of Treatment|0|||
129998646|NCT00372385|467958279|FG000|Overall Study|No Response|1|||
129998647|NCT00372385|467958280|FG001|Overall Study|No Response|1|||
129998648|NCT00372385|467958281|FG002|Overall Study|No Response|0|||
129998649|NCT00372385|467958282|FG003|Overall Study|No Response|0|||
129998650|NCT00372385|467958279|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
129998651|NCT00372385|467958280|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129998652|NCT00372385|467958281|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129998653|NCT00372385|467958282|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129998654|NCT00372385|467958279|FG000|Overall Study|Virologic Stopping Rule|17|||
129998655|NCT00372385|467958280|FG001|Overall Study|Virologic Stopping Rule|0|||
129998656|NCT00372385|467958281|FG002|Overall Study|Virologic Stopping Rule|0|||
129998657|NCT00372385|467958282|FG003|Overall Study|Virologic Stopping Rule|0|||
130335242|NCT01485172|469197386|FG002|Overall Study|Protocol Violation|4|||
130335243|NCT01485172|469197387|FG003|Overall Study|Protocol Violation|5|||
130335244|NCT01485172|469197388|FG004|Overall Study|Protocol Violation|1|||
130335245|NCT01485172|469197389|FG005|Overall Study|Protocol Violation|0|||
130335246|NCT01485172|469197384|FG000|Overall Study|Protocol defined stopping criteria|1|||
130335247|NCT01485172|469197385|FG001|Overall Study|Protocol defined stopping criteria|0|||
130335248|NCT01485172|469197386|FG002|Overall Study|Protocol defined stopping criteria|0|||
129998658|NCT02411578|467958285|FG000|Crossover Trial Phase|Pregnancy|0|||
129998659|NCT02411578|467958286|FG001|Crossover Trial Phase|Pregnancy|1|||
129998660|NCT01906346|467958287|FG000|Overall Study|AEs|1|||
129998661|NCT01323621|467958290|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
130335249|NCT01485172|469197387|FG003|Overall Study|Protocol defined stopping criteria|0|||
130335250|NCT01485172|469197388|FG004|Overall Study|Protocol defined stopping criteria|1|||
130335251|NCT01485172|469197389|FG005|Overall Study|Protocol defined stopping criteria|0|||
130335252|NCT01485172|469197384|FG000|Overall Study|Lost to Follow-up|0|||
130335253|NCT01485172|469197385|FG001|Overall Study|Lost to Follow-up|0|||
130335254|NCT01485172|469197386|FG002|Overall Study|Lost to Follow-up|1|||
130335255|NCT01485172|469197387|FG003|Overall Study|Lost to Follow-up|0|||
130335256|NCT01485172|469197388|FG004|Overall Study|Lost to Follow-up|0|||
130335257|NCT01485172|469197389|FG005|Overall Study|Lost to Follow-up|1|||
130335258|NCT01485172|469197384|FG000|Overall Study|Physician Decision|0|||
130335259|NCT01485172|469197385|FG001|Overall Study|Physician Decision|0|||
130335260|NCT01485172|469197386|FG002|Overall Study|Physician Decision|0|||
130335261|NCT01485172|469197387|FG003|Overall Study|Physician Decision|0|||
130335262|NCT01485172|469197388|FG004|Overall Study|Physician Decision|1|||
130335263|NCT01485172|469197389|FG005|Overall Study|Physician Decision|0|||
130335264|NCT01485172|469197384|FG000|Overall Study|Withdrawal by Subject|2|||
130335265|NCT01485172|469197385|FG001|Overall Study|Withdrawal by Subject|0|||
130335266|NCT01485172|469197386|FG002|Overall Study|Withdrawal by Subject|0|||
130335267|NCT01485172|469197387|FG003|Overall Study|Withdrawal by Subject|1|||
130335268|NCT01485172|469197388|FG004|Overall Study|Withdrawal by Subject|1|||
130335269|NCT01485172|469197389|FG005|Overall Study|Withdrawal by Subject|1|||
130335270|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
130335271|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
130335272|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
130335273|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
130335274|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
130335275|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
130335276|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
130335277|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
130335278|NCT02283762|469197393|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
130335279|NCT02283762|469197394|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
129998662|NCT01323621|467958291|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
129998663|NCT01323621|467958292|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
129998664|NCT01323621|467958290|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
129998665|NCT01323621|467958291|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
129998666|NCT01323621|467958292|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
129998667|NCT01323621|467958290|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
129998668|NCT01323621|467958291|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
129998669|NCT01323621|467958292|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
129998670|NCT01323621|467958290|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
129998671|NCT01323621|467958291|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
129998672|NCT01323621|467958292|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
129998673|NCT01323621|467958290|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
129998674|NCT01323621|467958291|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
129998675|NCT01323621|467958292|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
129998676|NCT01323621|467958290|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
129998677|NCT01323621|467958291|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
129998678|NCT01323621|467958292|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
129998679|NCT01323621|467958290|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
130335280|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
130335281|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
129998680|NCT01323621|467958291|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
130335282|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
130335283|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
130335284|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
130335285|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
130335286|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
130335287|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
130335288|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
130335289|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
129998681|NCT01323621|467958292|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
129998682|NCT01323621|467958290|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
129998683|NCT01323621|467958291|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
129998684|NCT01323621|467958292|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
129998685|NCT01323621|467958290|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
129998686|NCT01323621|467958291|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
129998687|NCT01323621|467958292|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
129998688|NCT01323621|467958290|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129998689|NCT01323621|467958291|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129998690|NCT01323621|467958292|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129998691|NCT01323621|467958290|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
129998692|NCT01323621|467958291|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
129998693|NCT01323621|467958292|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
129998694|NCT01323621|467958290|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129998695|NCT01323621|467958291|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
129998696|NCT01323621|467958292|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
129998697|NCT04226833|467958293|FG000|Overall Study|Death|0|||
129998698|NCT04226833|467958294|FG001|Overall Study|Death|0|||
129998699|NCT04226833|467958295|FG002|Overall Study|Death|1|||
129998700|NCT04226833|467958296|FG003|Overall Study|Death|0|||
129998701|NCT00364156|467958299|FG000|Overall Study|Withdrawal by Subject|73|||
129998702|NCT00364156|467958300|FG001|Overall Study|Withdrawal by Subject|80|||
129998703|NCT00364156|467958299|FG000|Overall Study|Protocol Violation|6|||
129998704|NCT00364156|467958300|FG001|Overall Study|Protocol Violation|1|||
129998705|NCT01557348|467958303|FG000|Overall Study|Adverse Event|6|||
129998706|NCT01557348|467958304|FG001|Overall Study|Adverse Event|16|||
129998707|NCT01557348|467958303|FG000|Overall Study|Infusion reaction event|5|||
129998708|NCT01557348|467958304|FG001|Overall Study|Infusion reaction event|5|||
129998709|NCT01557348|467958303|FG000|Overall Study|Death|7|||
129998710|NCT01557348|467958304|FG001|Overall Study|Death|4|||
129998711|NCT01557348|467958303|FG000|Overall Study|Insufficient Therapeutic Response|13|||
129998712|NCT01557348|467958304|FG001|Overall Study|Insufficient Therapeutic Response|28|||
129998713|NCT01557348|467958303|FG000|Overall Study|Withdrawal by Subject|5|||
129998714|NCT01557348|467958304|FG001|Overall Study|Withdrawal by Subject|4|||
129998715|NCT01557348|467958303|FG000|Overall Study|Lost to Follow-up|26|||
129998716|NCT01557348|467958304|FG001|Overall Study|Lost to Follow-up|22|||
129998717|NCT01557348|467958303|FG000|Overall Study|Administrative|18|||
129998718|NCT01557348|467958304|FG001|Overall Study|Administrative|11|||
129998719|NCT02000427|467958309|FG000|Overall Study|Death|22|||
129998720|NCT02708095|467958312|FG000|Overall Study|Adverse Event|4|||
129998721|NCT02708095|467958313|FG001|Overall Study|Adverse Event|10|||
129998722|NCT02708095|467958314|FG002|Overall Study|Adverse Event|11|||
129998723|NCT02708095|467958312|FG000|Overall Study|Lack of Efficacy|9|||
129998724|NCT02708095|467958313|FG001|Overall Study|Lack of Efficacy|3|||
129998725|NCT02708095|467958314|FG002|Overall Study|Lack of Efficacy|0|||
129998726|NCT02708095|467958312|FG000|Overall Study|Lost to Follow-up|2|||
129998727|NCT02708095|467958313|FG001|Overall Study|Lost to Follow-up|0|||
129998728|NCT02708095|467958314|FG002|Overall Study|Lost to Follow-up|0|||
129998729|NCT02708095|467958312|FG000|Overall Study|Physician Decision|2|||
129998730|NCT02708095|467958313|FG001|Overall Study|Physician Decision|3|||
129998731|NCT02708095|467958314|FG002|Overall Study|Physician Decision|2|||
129998732|NCT02708095|467958312|FG000|Overall Study|Protocol Violation|0|||
129998733|NCT02708095|467958313|FG001|Overall Study|Protocol Violation|0|||
129998734|NCT02708095|467958314|FG002|Overall Study|Protocol Violation|1|||
129998735|NCT02708095|467958312|FG000|Overall Study|Withdrawal by Subject|5|||
129998736|NCT02708095|467958313|FG001|Overall Study|Withdrawal by Subject|3|||
129998737|NCT02708095|467958314|FG002|Overall Study|Withdrawal by Subject|4|||
129998738|NCT01313650|467958317|FG000|Overall Study|Adverse Event|9|||
129998739|NCT01313650|467958318|FG001|Overall Study|Adverse Event|34|||
129998740|NCT01313650|467958319|FG002|Overall Study|Adverse Event|24|||
129998741|NCT01313650|467958320|FG003|Overall Study|Adverse Event|23|||
129998742|NCT01313650|467958317|FG000|Overall Study|Lack of Efficacy|37|||
129998743|NCT01313650|467958318|FG001|Overall Study|Lack of Efficacy|20|||
130335290|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
129998744|NCT01313650|467958319|FG002|Overall Study|Lack of Efficacy|32|||
130335291|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
129998745|NCT01313650|467958320|FG003|Overall Study|Lack of Efficacy|20|||
129998746|NCT01313650|467958317|FG000|Overall Study|Lost to Follow-up|1|||
130335292|NCT02283762|469197393|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
129998747|NCT01313650|467958318|FG001|Overall Study|Lost to Follow-up|0|||
129998748|NCT01313650|467958319|FG002|Overall Study|Lost to Follow-up|3|||
129998749|NCT01313650|467958320|FG003|Overall Study|Lost to Follow-up|2|||
129998750|NCT01313650|467958317|FG000|Overall Study|Withdrawal by Subject|16|||
129998751|NCT01313650|467958318|FG001|Overall Study|Withdrawal by Subject|20|||
129998752|NCT01313650|467958319|FG002|Overall Study|Withdrawal by Subject|15|||
129998753|NCT01313650|467958320|FG003|Overall Study|Withdrawal by Subject|15|||
129998754|NCT01313650|467958317|FG000|Overall Study|Protocol Violation|4|||
129998755|NCT01313650|467958318|FG001|Overall Study|Protocol Violation|7|||
129998756|NCT01313650|467958319|FG002|Overall Study|Protocol Violation|5|||
129998757|NCT01313650|467958320|FG003|Overall Study|Protocol Violation|6|||
129998758|NCT01313650|467958317|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
129998759|NCT01313650|467958318|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
129998760|NCT01313650|467958319|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
129998761|NCT01313650|467958320|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
129998762|NCT04540133|467958321|FG000|Overall Study|Lost to Follow-up|1|||
129998763|NCT04540133|467958322|FG001|Overall Study|Lost to Follow-up|0|||
129998764|NCT03153111|467958323|FG000|Overall Study|Death|2|||
129998765|NCT03153111|467958324|FG001|Overall Study|Death|5|||
129998766|NCT03153111|467958323|FG000|Overall Study|Lost to Follow-up|1|||
129998767|NCT03153111|467958324|FG001|Overall Study|Lost to Follow-up|0|||
129998768|NCT03153111|467958323|FG000|Overall Study|Physician Decision|5|||
129998769|NCT03153111|467958324|FG001|Overall Study|Physician Decision|1|||
129998770|NCT03153111|467958323|FG000|Overall Study|Withdrawal by Subject|3|||
129998771|NCT03153111|467958324|FG001|Overall Study|Withdrawal by Subject|3|||
129998772|NCT03891524|467958325|FG000|Overall Study|Death|0|||
129998773|NCT03891524|467958326|FG001|Overall Study|Death|0|||
129998774|NCT03891524|467958327|FG002|Overall Study|Death|0|||
129998775|NCT03891524|467958328|FG003|Overall Study|Death|0|||
129998776|NCT03891524|467958329|FG004|Overall Study|Death|0|||
129998777|NCT03891524|467958330|FG005|Overall Study|Death|0|||
129998778|NCT03891524|467958331|FG006|Overall Study|Death|0|||
129998779|NCT03891524|467958332|FG007|Overall Study|Death|1|||
129998780|NCT03891524|467958325|FG000|Overall Study|Withdrawal by Subject|0|||
129998781|NCT03891524|467958326|FG001|Overall Study|Withdrawal by Subject|1|||
129998782|NCT03891524|467958327|FG002|Overall Study|Withdrawal by Subject|2|||
129998783|NCT03891524|467958328|FG003|Overall Study|Withdrawal by Subject|1|||
129998784|NCT03891524|467958329|FG004|Overall Study|Withdrawal by Subject|2|||
129998785|NCT03891524|467958330|FG005|Overall Study|Withdrawal by Subject|2|||
129998786|NCT03891524|467958331|FG006|Overall Study|Withdrawal by Subject|2|||
129998787|NCT03891524|467958332|FG007|Overall Study|Withdrawal by Subject|1|||
129998788|NCT03471871|467958334|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129998789|NCT03471871|467958335|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129998790|NCT03471871|467958336|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
129998791|NCT03471871|467958337|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129998792|NCT03471871|467958338|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129998793|NCT03471871|467958334|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
129998794|NCT03471871|467958335|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
129998795|NCT03471871|467958336|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
129998796|NCT03471871|467958337|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
129998797|NCT03471871|467958338|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
129998798|NCT03471871|467958334|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129998799|NCT03471871|467958335|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129998800|NCT03471871|467958336|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129998801|NCT03471871|467958337|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129998802|NCT03471871|467958338|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
129998803|NCT03471871|467958334|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129998804|NCT03471871|467958335|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129998805|NCT03471871|467958336|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129998806|NCT03471871|467958337|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129998807|NCT03471871|467958338|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
129998808|NCT03471871|467958334|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129998809|NCT03471871|467958335|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129998810|NCT03471871|467958336|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129998811|NCT03471871|467958337|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
129998812|NCT03471871|467958338|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129998813|NCT03040622|467958339|FG000|Overall Study|unable to implant device|3|||
129998814|NCT03971422|467959553|FG000|Overall Study|Lost to Follow-up|0|||
129998815|NCT03971422|467959554|FG001|Overall Study|Lost to Follow-up|1|||
129998816|NCT03971422|467959555|FG002|Overall Study|Lost to Follow-up|0|||
129998817|NCT03971422|467959553|FG000|Overall Study|Lack of Efficacy|5|||
129998818|NCT03971422|467959554|FG001|Overall Study|Lack of Efficacy|1|||
129998819|NCT03971422|467959555|FG002|Overall Study|Lack of Efficacy|1|||
129998820|NCT03971422|467959553|FG000|Overall Study|Adverse event, not fatal|2|||
129998821|NCT03971422|467959554|FG001|Overall Study|Adverse event, not fatal|2|||
129998822|NCT03971422|467959555|FG002|Overall Study|Adverse event, not fatal|5|||
129998823|NCT03971422|467959553|FG000|Overall Study|Worsening of MG Symptoms|1|||
129998824|NCT03971422|467959554|FG001|Overall Study|Worsening of MG Symptoms|4|||
129998825|NCT03971422|467959555|FG002|Overall Study|Worsening of MG Symptoms|2|||
129998826|NCT03971422|467959553|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
129998827|NCT03971422|467959554|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
129998828|NCT03971422|467959555|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
129998829|NCT03971422|467959553|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
129998830|NCT03971422|467959554|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
129998831|NCT03971422|467959555|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
129998832|NCT03971422|467959553|FG000|Overall Study|Due to COVID-19 pandemic|0|||
129998833|NCT03971422|467959554|FG001|Overall Study|Due to COVID-19 pandemic|1|||
129998834|NCT03971422|467959555|FG002|Overall Study|Due to COVID-19 pandemic|1|||
130335293|NCT02283762|469197394|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
130335294|NCT00202878|469197395|FG000|Overall Study|Death|964|||
130335295|NCT00202878|469197396|FG001|Overall Study|Death|968|||
130335296|NCT00202878|469197395|FG000|Overall Study|Only Vital Status Known|357|||
130335297|NCT00202878|469197396|FG001|Overall Study|Only Vital Status Known|356|||
130335298|NCT00202878|469197395|FG000|Overall Study|Lost to Follow-up|44|||
130335299|NCT00202878|469197396|FG001|Overall Study|Lost to Follow-up|49|||
130335300|NCT00202878|469197395|FG000|Overall Study|Site Closure|39|||
130335301|NCT00202878|469197396|FG001|Overall Study|Site Closure|36|||
130335302|NCT00202878|469197395|FG000|Overall Study|Withdrawal by Subject|795|||
130335303|NCT00202878|469197396|FG001|Overall Study|Withdrawal by Subject|808|||
130335304|NCT02920242|469197397|FG000|Overall Study|Withdrawal by Subject|1|||
130335305|NCT02920242|469197398|FG001|Overall Study|Withdrawal by Subject|0|||
130335306|NCT02920242|469197399|FG002|Overall Study|Withdrawal by Subject|1|||
130335307|NCT02920242|469197397|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
130335308|NCT02920242|469197398|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
130335309|NCT02920242|469197399|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
130335310|NCT01587014|469197400|FG000|Overall Study|Death|2|||
130335311|NCT03801031|469197405|FG000|Overall Study|Lost to Follow-up|1|||
130335312|NCT03801031|469197406|FG001|Overall Study|Lost to Follow-up|0|||
130335313|NCT03801031|469197405|FG000|Overall Study|Unable to comply|1|||
130335314|NCT03801031|469197406|FG001|Overall Study|Unable to comply|0|||
130335315|NCT03801031|469197405|FG000|Overall Study|Withdrawal by Subject|0|||
130335316|NCT03801031|469197406|FG001|Overall Study|Withdrawal by Subject|1|||
130335317|NCT02948088|469197407|FG000|Overall Study|Lost to Follow-up|8|||
130335318|NCT02948088|469197407|FG000|Overall Study|Death|1|||
130335319|NCT02948088|469197407|FG000|Overall Study|Withdrawal by Subject|4|||
130335320|NCT02948088|469197407|FG000|Overall Study|Other|2|||
130335321|NCT01942733|469197408|FG000|Overall Study|Lost to Follow-up|1|||
130335322|NCT01942733|469197408|FG000|Overall Study|Non-compliance with IMP|1|||
130335323|NCT01942733|469197408|FG000|Overall Study|Administrative|1|||
130335324|NCT01409811|469197409|FG000|Overall Study|Insurance denial|1|||
130335325|NCT00634101|469197410|FG000|Overall Study|Study Terminated|3|||
130335326|NCT00634101|469197411|FG001|Overall Study|Study Terminated|3|||
130335327|NCT00634101|469197410|FG000|Overall Study|Lost to Follow-up|2|||
130335328|NCT00634101|469197411|FG001|Overall Study|Lost to Follow-up|0|||
130335329|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
130335330|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
130335331|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
130335332|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
130335333|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
130335334|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
130335335|NCT00139477|469197416|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
130335336|NCT00139477|469197417|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
130335337|NCT00139477|469197416|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
130335338|NCT00139477|469197417|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
130335339|NCT00139477|469197416|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
130335340|NCT00139477|469197417|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
130335341|NCT00139477|469197416|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
130335342|NCT00139477|469197417|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
129998835|NCT04751656|467959558|FG000|Overall Study|Lost to Follow-up|1|||
129998836|NCT03566810|467959559|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
129998837|NCT03566810|467959560|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
130335343|NCT00573144|469197419|FG000|Overall Study|Withdrawal by Subject|2|||
130335344|NCT00573144|469197420|FG001|Overall Study|Withdrawal by Subject|3|||
130335345|NCT02625909|469197421|FG000|Overall Study|Death|2|||
130335346|NCT02625909|469197422|FG001|Overall Study|Death|0|||
130335347|NCT02625909|469197421|FG000|Overall Study|Lost to Follow-up|3|||
130335348|NCT02625909|469197422|FG001|Overall Study|Lost to Follow-up|5|||
130335349|NCT02625909|469197421|FG000|Overall Study|Lack of Efficacy|9|||
130335350|NCT02625909|469197422|FG001|Overall Study|Lack of Efficacy|2|||
130335351|NCT02625909|469197421|FG000|Overall Study|Reinfection|3|||
130335352|NCT02625909|469197422|FG001|Overall Study|Reinfection|2|||
130335353|NCT00953056|469197423|FG000|Overall Study|Withdrew Consent|0|||
130335354|NCT00953056|469197424|FG001|Overall Study|Withdrew Consent|0|||
129998838|NCT03566810|467959561|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
129998839|NCT03566810|467959562|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
129998840|NCT01955122|467959570|FG000|Overall Study|Physician Decision|5|||
129998841|NCT01955122|467959571|FG001|Overall Study|Physician Decision|5|||
129998842|NCT00826111|467959572|FG000|Overall Study|Lost to Follow-up|0|||
129998843|NCT00826111|467959573|FG001|Overall Study|Lost to Follow-up|1|||
129998844|NCT00826111|467959572|FG000|Overall Study|Protocol Violation|1|||
129998845|NCT00826111|467959573|FG001|Overall Study|Protocol Violation|0|||
129998846|NCT00826111|467959572|FG000|Overall Study|Withdrawal by Subject|5|||
129998847|NCT00826111|467959573|FG001|Overall Study|Withdrawal by Subject|0|||
129998848|NCT00826111|467959572|FG000|Overall Study|Physician Decision|1|||
129998849|NCT00826111|467959573|FG001|Overall Study|Physician Decision|1|||
129998850|NCT01672788|467959574|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
129998851|NCT01672788|467959575|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
129998852|NCT01672788|467959576|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
129998853|NCT01672788|467959577|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
129998854|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
129998855|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
129998856|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
129998857|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
129998858|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
129998859|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
129998860|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
129998861|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
129998862|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
129998863|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
129998864|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
129998865|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
129998866|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Death|3|||
129998867|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Death|1|||
129998868|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
129998869|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
129998870|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Adverse Event|7|||
129998871|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Adverse Event|8|||
129998872|NCT03236246|467959580|FG000|24-Week Dose Titration Period|Captured as Other|1|||
129998873|NCT03236246|467959581|FG001|24-Week Dose Titration Period|Captured as Other|2|||
129998874|NCT03236246|467959580|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
129998875|NCT03236246|467959581|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
129998876|NCT03236246|467959580|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
129998877|NCT03236246|467959581|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
129998878|NCT03236246|467959580|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
129998879|NCT03236246|467959581|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
129998880|NCT03236246|467959580|FG000|24-Week Dose Maintenance Period|Death|0|||
129998881|NCT03236246|467959581|FG001|24-Week Dose Maintenance Period|Death|1|||
129998882|NCT03236246|467959580|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
129998883|NCT03236246|467959581|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
129998884|NCT02598557|467959582|FG000|Overall Study|Withdrawal by Subject|1|||
129998885|NCT02598557|467959583|FG001|Overall Study|Withdrawal by Subject|0|||
129998886|NCT02598557|467959584|FG002|Overall Study|Withdrawal by Subject|1|||
129998887|NCT02598557|467959582|FG000|Overall Study|Participant did not start treatment|2|||
129998888|NCT02598557|467959583|FG001|Overall Study|Participant did not start treatment|1|||
129998889|NCT02598557|467959584|FG002|Overall Study|Participant did not start treatment|1|||
129998890|NCT02598557|467959582|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
129998891|NCT02598557|467959583|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
129998892|NCT02598557|467959584|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
129998893|NCT02598557|467959582|FG000|Overall Study|Adverse Event|1|||
129998894|NCT02598557|467959583|FG001|Overall Study|Adverse Event|1|||
129998895|NCT02598557|467959584|FG002|Overall Study|Adverse Event|0|||
129998896|NCT01117454|467959587|FG000|Overall Study|Pregnancy|0|||
129998897|NCT01117454|467959588|FG001|Overall Study|Pregnancy|1|||
129998898|NCT00888433|467959589|FG000|Overall Study|Withdrawal by Subject|1|||
129998899|NCT00888433|467959590|FG001|Overall Study|Withdrawal by Subject|2|||
129998900|NCT00888433|467959589|FG000|Overall Study|Missed Visit|2|||
130335355|NCT00953056|469197425|FG002|Overall Study|Withdrew Consent|0|||
129998901|NCT00888433|467959590|FG001|Overall Study|Missed Visit|1|||
129998902|NCT01681628|467959591|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
129998903|NCT01681628|467959592|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
129998904|NCT01681628|467959591|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
129998905|NCT01681628|467959592|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
129998906|NCT01681628|467959591|FG000|19 Months Follow-up|Death|1|||
129998907|NCT01681628|467959592|FG001|19 Months Follow-up|Death|0|||
130335356|NCT00953056|469197426|FG003|Overall Study|Withdrew Consent|0|||
129998908|NCT01681628|467959591|FG000|19 Months Follow-up|Lost to Follow-up|61|||
129998909|NCT01681628|467959592|FG001|19 Months Follow-up|Lost to Follow-up|43|||
129998910|NCT01637623|467959601|FG000|Overall Study|Lost to Follow-up|0|||
129998911|NCT01637623|467959602|FG001|Overall Study|Lost to Follow-up|0|||
129998912|NCT01637623|467959603|FG002|Overall Study|Lost to Follow-up|2|||
129998913|NCT01637623|467959601|FG000|Overall Study|Physician Decision|1|||
129998914|NCT01637623|467959602|FG001|Overall Study|Physician Decision|0|||
129998915|NCT01637623|467959603|FG002|Overall Study|Physician Decision|1|||
129998916|NCT02170389|467959606|FG000|Overall Study|Study terminated prior to start of treat|1|||
129998917|NCT01008696|467959608|FG000|Overall Study|Participant's evasion of hospital visit|5|||
129998918|NCT01008696|467959609|FG001|Overall Study|Participant's evasion of hospital visit|4|||
129998919|NCT01008696|467959608|FG000|Overall Study|Withdrawal by Subject|2|||
129998920|NCT01008696|467959609|FG001|Overall Study|Withdrawal by Subject|4|||
129998921|NCT01008696|467959608|FG000|Overall Study|Physician Decision|5|||
129998922|NCT01008696|467959609|FG001|Overall Study|Physician Decision|1|||
129998923|NCT01008696|467959608|FG000|Overall Study|Adverse Event|1|||
129998924|NCT01008696|467959609|FG001|Overall Study|Adverse Event|0|||
129998925|NCT01008696|467959608|FG000|Overall Study|Participants' non-cooperation|2|||
129998926|NCT01008696|467959609|FG001|Overall Study|Participants' non-cooperation|3|||
129998927|NCT01008696|467959608|FG000|Overall Study|Other|2|||
129998928|NCT01008696|467959609|FG001|Overall Study|Other|3|||
129998929|NCT01008696|467959608|FG000|Overall Study|Other|0|||
129998930|NCT01008696|467959609|FG001|Overall Study|Other|2|||
129998931|NCT01054144|467959610|FG000|Overall Study|Death|2|||
129998932|NCT03118674|467959612|FG000|Overall Study|Lost to Follow-up|2|||
129998933|NCT03118674|467959612|FG000|Overall Study|Screen Faliure|8|||
129998934|NCT03118674|467959612|FG000|Overall Study|Withdrawal by Subject|5|||
129998935|NCT00769860|467959619|FG000|Overall Study|Withdrawal by Subject|2|||
129998936|NCT00769860|467959620|FG001|Overall Study|Withdrawal by Subject|0|||
129998937|NCT01699789|467959623|FG000|Overall Study|Withdrawal by Subject|18|||
129998938|NCT01699789|467959624|FG001|Overall Study|Withdrawal by Subject|23|||
129998939|NCT01699789|467959623|FG000|Overall Study|Death|1|||
129998940|NCT01699789|467959624|FG001|Overall Study|Death|2|||
129998941|NCT01699789|467959623|FG000|Overall Study|Lost to Follow-up|83|||
129998942|NCT01699789|467959624|FG001|Overall Study|Lost to Follow-up|101|||
129998943|NCT02876835|467959625|FG000|Treatment Period (51.1 Month)|Other|1|||
129998944|NCT02876835|467959626|FG001|Treatment Period (51.1 Month)|Other|0|||
129998945|NCT02876835|467959625|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
129998946|NCT02876835|467959626|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
129998947|NCT02876835|467959625|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
129998948|NCT02876835|467959626|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
129998949|NCT02876835|467959625|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
129998950|NCT02876835|467959626|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
129998951|NCT02540538|467959628|FG000|Overall Study|Pregnancy|0|||
129998952|NCT02540538|467959629|FG001|Overall Study|Pregnancy|1|||
129998953|NCT02540538|467959630|FG002|Overall Study|Pregnancy|0|||
129998954|NCT01891721|467959634|FG000|Overall Study|Lost to Follow-up|10|||
129998955|NCT01891721|467959635|FG001|Overall Study|Lost to Follow-up|5|||
129998956|NCT01891721|467959636|FG002|Overall Study|Lost to Follow-up|1|||
129998957|NCT04343248|467959637|FG000|Overall Study|Withdrawal by Subject|5|||
129998958|NCT04343248|467959638|FG001|Overall Study|Withdrawal by Subject|6|||
129998959|NCT04343248|467959637|FG000|Overall Study|Death|1|||
129998960|NCT04343248|467959638|FG001|Overall Study|Death|2|||
129998961|NCT04343248|467959637|FG000|Overall Study|Lost to Follow-up|9|||
129998962|NCT04343248|467959638|FG001|Overall Study|Lost to Follow-up|6|||
129998963|NCT04343248|467959637|FG000|Overall Study|Physician Decision|0|||
129998964|NCT04343248|467959638|FG001|Overall Study|Physician Decision|1|||
129998965|NCT04343248|467959637|FG000|Overall Study|Adverse Event|1|||
129998966|NCT04343248|467959638|FG001|Overall Study|Adverse Event|0|||
129998967|NCT05393037|467959639|FG000|Part A|Death|1|||
129998968|NCT05393037|467959640|FG001|Part A|Death|0|||
129998969|NCT05393037|467959639|FG000|Part A|Lost to Follow-up|1|||
129998970|NCT05393037|467959640|FG001|Part A|Lost to Follow-up|1|||
129998971|NCT05393037|467959639|FG000|Part A|Withdrawal by Subject|2|||
129998972|NCT05393037|467959640|FG001|Part A|Withdrawal by Subject|4|||
129998973|NCT05393037|467959639|FG000|Part B|Lost to Follow-up|1|||
129998974|NCT05393037|467959640|FG001|Part B|Lost to Follow-up|0|||
129998975|NCT00174265|467959643|FG000|Overall Study|Adverse Event|7|||
129998976|NCT00174265|467959644|FG001|Overall Study|Adverse Event|4|||
129998977|NCT00174265|467959643|FG000|Overall Study|Lack of Efficacy|2|||
129998978|NCT00174265|467959644|FG001|Overall Study|Lack of Efficacy|2|||
129998979|NCT00174265|467959643|FG000|Overall Study|Withdrawal by Subject|3|||
129998980|NCT00174265|467959644|FG001|Overall Study|Withdrawal by Subject|5|||
129998981|NCT00174265|467959643|FG000|Overall Study|Lost to Follow-up|1|||
129998982|NCT00174265|467959644|FG001|Overall Study|Lost to Follow-up|0|||
129998983|NCT00174265|467959643|FG000|Overall Study|Other (Not specified)|16|||
129998984|NCT00174265|467959644|FG001|Overall Study|Other (Not specified)|10|||
129998985|NCT01572922|467959646|FG000|Overall Study|Adverse Event|1|||
129998986|NCT01572922|467959646|FG000|Overall Study|Protocol Violation|1|||
129998987|NCT01572922|467959646|FG000|Overall Study|Death|1|||
129998988|NCT00445068|467959647|FG000|Overall Study|Disease progression|26|||
129998989|NCT00445068|467959647|FG000|Overall Study|Adverse Event|5|||
129998990|NCT00445068|467959647|FG000|Overall Study|Abnormal laboratory value|2|||
129998991|NCT00445068|467959647|FG000|Overall Study|Withdrawal by Subject|2|||
129998992|NCT00445068|467959647|FG000|Overall Study|Death|1|||
129998993|NCT03144804|467959650|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
129998994|NCT04091451|467959653|FG000|Overall Study|Adverse Event|15|||
129998995|NCT04091451|467959654|FG001|Overall Study|Adverse Event|10|||
129998996|NCT04091451|467959653|FG000|Overall Study|Lost to Follow-up|8|||
129998997|NCT04091451|467959654|FG001|Overall Study|Lost to Follow-up|8|||
129998998|NCT04091451|467959653|FG000|Overall Study|Protocol Violation|5|||
129998999|NCT04091451|467959654|FG001|Overall Study|Protocol Violation|4|||
129999000|NCT04091451|467959653|FG000|Overall Study|Withdrawal by Subject|21|||
129999001|NCT04091451|467959654|FG001|Overall Study|Withdrawal by Subject|27|||
129999002|NCT04091451|467959653|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
129999003|NCT04091451|467959654|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
129999004|NCT04091451|467959653|FG000|Overall Study|Migrated/moved from the study area|3|||
129999005|NCT04091451|467959654|FG001|Overall Study|Migrated/moved from the study area|5|||
129999006|NCT04091451|467959653|FG000|Overall Study|Suspected HZ episode|1|||
129999007|NCT04091451|467959654|FG001|Overall Study|Suspected HZ episode|0|||
129999008|NCT03769181|467961591|FG000|Overall Study|Adverse Event|1|||
129999009|NCT03769181|467961592|FG001|Overall Study|Adverse Event|0|||
129999010|NCT03769181|467961593|FG002|Overall Study|Adverse Event|2|||
129999011|NCT03769181|467961594|FG003|Overall Study|Adverse Event|4|||
129999012|NCT03769181|467961591|FG000|Overall Study|Withdrawal by Subject|1|||
129999013|NCT03769181|467961592|FG001|Overall Study|Withdrawal by Subject|0|||
129999014|NCT03769181|467961593|FG002|Overall Study|Withdrawal by Subject|2|||
129999015|NCT03769181|467961594|FG003|Overall Study|Withdrawal by Subject|1|||
129999016|NCT03769181|467961591|FG000|Overall Study|Progressive disease|9|||
129999017|NCT03769181|467961592|FG001|Overall Study|Progressive disease|7|||
129999018|NCT03769181|467961593|FG002|Overall Study|Progressive disease|13|||
129999019|NCT03769181|467961594|FG003|Overall Study|Progressive disease|6|||
129999020|NCT03769181|467961591|FG000|Overall Study|Other - Unspecified|2|||
129999021|NCT03769181|467961592|FG001|Overall Study|Other - Unspecified|1|||
129999022|NCT03769181|467961593|FG002|Overall Study|Other - Unspecified|0|||
129999023|NCT03769181|467961594|FG003|Overall Study|Other - Unspecified|0|||
129999024|NCT03338192|467961596|FG000|Year One to Year Two|High Blood Pressure|7|||
129999025|NCT03338192|467961597|FG001|Year One to Year Two|High Blood Pressure|1|||
129999026|NCT03338192|467961596|FG000|Year One to Year Two|HIV +|1|||
129999027|NCT03338192|467961597|FG001|Year One to Year Two|HIV +|0|||
129999028|NCT03338192|467961596|FG000|Year Two to Year Four|High Blood Pressure|1|||
129999029|NCT03338192|467961597|FG001|Year Two to Year Four|High Blood Pressure|0|||
129999030|NCT03338192|467961596|FG000|Year Two to Year Four|HIV +|2|||
129999031|NCT03338192|467961597|FG001|Year Two to Year Four|HIV +|0|||
129999032|NCT03338192|467961596|FG000|Year Four to Year Six|High Blood Pressure|2|||
129999033|NCT03338192|467961597|FG001|Year Four to Year Six|High Blood Pressure|1|||
129999034|NCT02076113|467961600|FG000|Overall Study|Lost to Follow-up|4|||
129999035|NCT02076113|467961601|FG001|Overall Study|Lost to Follow-up|1|||
129999036|NCT02076113|467961600|FG000|Overall Study|Withdrawal by Subject|2|||
129999037|NCT02076113|467961601|FG001|Overall Study|Withdrawal by Subject|3|||
129999038|NCT02076113|467961600|FG000|Overall Study|Death|1|||
129999039|NCT02076113|467961601|FG001|Overall Study|Death|3|||
129999040|NCT01383161|467961604|FG000|Overall Study|Adverse Event|5|||
129999041|NCT01383161|467961605|FG001|Overall Study|Adverse Event|1|||
129999042|NCT01383161|467961604|FG000|Overall Study|Withdrawal by Subject|0|||
129999043|NCT01383161|467961605|FG001|Overall Study|Withdrawal by Subject|2|||
129999044|NCT01383161|467961604|FG000|Overall Study|Lack of Efficacy|0|||
129999045|NCT01383161|467961605|FG001|Overall Study|Lack of Efficacy|1|||
129999046|NCT03942406|467961612|FG000|Overall Study|Lost to Follow-up|4|||
129999047|NCT03942406|467961613|FG001|Overall Study|Lost to Follow-up|5|||
129999048|NCT03942406|467961614|FG002|Overall Study|Lost to Follow-up|3|||
129999049|NCT03942406|467961615|FG003|Overall Study|Lost to Follow-up|7|||
129999050|NCT03942406|467961616|FG004|Overall Study|Lost to Follow-up|1|||
129999051|NCT03942406|467961617|FG005|Overall Study|Lost to Follow-up|0|||
129999052|NCT03942406|467961618|FG006|Overall Study|Lost to Follow-up|0|||
129999053|NCT03942406|467961612|FG000|Overall Study|Withdrawal by Subject|3|||
129999054|NCT03942406|467961613|FG001|Overall Study|Withdrawal by Subject|1|||
129999055|NCT03942406|467961614|FG002|Overall Study|Withdrawal by Subject|1|||
129999056|NCT03942406|467961615|FG003|Overall Study|Withdrawal by Subject|3|||
129999057|NCT03942406|467961616|FG004|Overall Study|Withdrawal by Subject|0|||
129999058|NCT03942406|467961617|FG005|Overall Study|Withdrawal by Subject|0|||
129999059|NCT03942406|467961618|FG006|Overall Study|Withdrawal by Subject|0|||
129999060|NCT03942406|467961612|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
129999061|NCT03942406|467961613|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
129999062|NCT03942406|467961614|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
130335357|NCT00953056|469197427|FG004|Overall Study|Withdrew Consent|2|||
129999063|NCT03942406|467961615|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
129999064|NCT03942406|467961616|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
129999065|NCT03942406|467961617|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
129999066|NCT03942406|467961618|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
129999067|NCT05628285|467961621|FG000|Overall Study|Lost to Follow-up|1|||
129999068|NCT03801902|467961622|FG000|Overall Study|Did not receive protocol treatment.|1|||
129999069|NCT03801902|467961623|FG001|Overall Study|Did not receive protocol treatment.|0|||
129999070|NCT03801902|467961624|FG002|Overall Study|Did not receive protocol treatment.|0|||
129999071|NCT03801902|467961625|FG003|Overall Study|Did not receive protocol treatment.|0|||
129999072|NCT02993523|467961628|FG000|Overall Study|Withdrew Consent|0|||
129999073|NCT02993523|467961629|FG001|Overall Study|Withdrew Consent|0|||
129999074|NCT02993523|467961630|FG002|Overall Study|Withdrew Consent|2|||
129999075|NCT02993523|467961631|FG003|Overall Study|Withdrew Consent|9|||
129999076|NCT02993523|467961632|FG004|Overall Study|Withdrew Consent|0|||
129999077|NCT02993523|467961628|FG000|Overall Study|Lost to Follow-up|0|||
129999078|NCT02993523|467961629|FG001|Overall Study|Lost to Follow-up|0|||
129999079|NCT02993523|467961630|FG002|Overall Study|Lost to Follow-up|3|||
129999080|NCT02993523|467961631|FG003|Overall Study|Lost to Follow-up|6|||
129999081|NCT02993523|467961632|FG004|Overall Study|Lost to Follow-up|0|||
129999082|NCT02993523|467961628|FG000|Overall Study|Death|1|||
129999083|NCT02993523|467961629|FG001|Overall Study|Death|1|||
129999084|NCT02993523|467961630|FG002|Overall Study|Death|138|||
129999085|NCT02993523|467961631|FG003|Overall Study|Death|222|||
129999086|NCT02993523|467961632|FG004|Overall Study|Death|6|||
129999087|NCT02993523|467961628|FG000|Overall Study|Reason not Specified|0|||
129999088|NCT02993523|467961629|FG001|Overall Study|Reason not Specified|0|||
129999089|NCT02993523|467961630|FG002|Overall Study|Reason not Specified|1|||
129999090|NCT02993523|467961631|FG003|Overall Study|Reason not Specified|1|||
129999091|NCT02993523|467961632|FG004|Overall Study|Reason not Specified|0|||
129999092|NCT02310672|467961633|FG000|Overall Study|Death|1|||
129999093|NCT02310672|467961633|FG000|Overall Study|Lost to Follow-up|1|||
129999094|NCT02310672|467961633|FG000|Overall Study|Withdrawal by Subject|1|||
129999095|NCT02310672|467961633|FG000|Overall Study|Sponsor's decision|12|||
129999096|NCT00528866|467961634|FG000|Overall Study|Protocol Violation|6|||
129999097|NCT01601847|467961635|FG000|Overall Study|Death|1|||
129999098|NCT01601847|467961636|FG001|Overall Study|Death|0|||
129999099|NCT01601847|467961635|FG000|Overall Study|Withdrawal by Subject|11|||
129999100|NCT01601847|467961636|FG001|Overall Study|Withdrawal by Subject|7|||
129999101|NCT01601847|467961635|FG000|Overall Study|Lost to Follow-up|1|||
129999102|NCT01601847|467961636|FG001|Overall Study|Lost to Follow-up|3|||
129999103|NCT01284062|467961637|FG000|Overall Study|Adverse Event|4|||
129999104|NCT01284062|467961638|FG001|Overall Study|Adverse Event|5|||
129999105|NCT01284062|467961639|FG002|Overall Study|Adverse Event|0|||
129999106|NCT01284062|467961640|FG003|Overall Study|Adverse Event|5|||
130335358|NCT00953056|469197428|FG005|Overall Study|Withdrew Consent|3|||
130335359|NCT00953056|469197423|FG000|Overall Study|Serious Adverse Event|0|||
130335360|NCT00953056|469197424|FG001|Overall Study|Serious Adverse Event|0|||
130335361|NCT00953056|469197425|FG002|Overall Study|Serious Adverse Event|0|||
130335362|NCT00953056|469197426|FG003|Overall Study|Serious Adverse Event|0|||
130335363|NCT00953056|469197427|FG004|Overall Study|Serious Adverse Event|0|||
130335364|NCT00953056|469197428|FG005|Overall Study|Serious Adverse Event|1|||
130335365|NCT02367833|469197429|FG000|Overall Study|Withdrawal by Subject|1|||
130335366|NCT02367833|469197430|FG001|Overall Study|Withdrawal by Subject|1|||
130335367|NCT02367833|469197431|FG002|Overall Study|Withdrawal by Subject|0|||
130335368|NCT01077076|469197432|FG000|First Intervention|Withdrawal by Subject|1|||
130335369|NCT01077076|469197433|FG001|First Intervention|Withdrawal by Subject|0|||
130335370|NCT01077076|469197434|FG002|First Intervention|Withdrawal by Subject|0|||
130335371|NCT01077076|469197435|FG003|First Intervention|Withdrawal by Subject|0|||
130335372|NCT01077076|469197436|FG004|First Intervention|Withdrawal by Subject|0|||
129999107|NCT01284062|467961637|FG000|Overall Study|Lack of Efficacy|3|||
129999108|NCT01284062|467961638|FG001|Overall Study|Lack of Efficacy|2|||
129999109|NCT01284062|467961639|FG002|Overall Study|Lack of Efficacy|2|||
129999110|NCT01284062|467961640|FG003|Overall Study|Lack of Efficacy|1|||
129999111|NCT01284062|467961637|FG000|Overall Study|Medication error without adverse event|0|||
129999112|NCT01284062|467961638|FG001|Overall Study|Medication error without adverse event|0|||
129999113|NCT01284062|467961639|FG002|Overall Study|Medication error without adverse event|1|||
129999114|NCT01284062|467961640|FG003|Overall Study|Medication error without adverse event|0|||
129999115|NCT01284062|467961637|FG000|Overall Study|Protocol Violation|1|||
129999116|NCT01284062|467961638|FG001|Overall Study|Protocol Violation|0|||
129999117|NCT01284062|467961639|FG002|Overall Study|Protocol Violation|0|||
129999118|NCT01284062|467961640|FG003|Overall Study|Protocol Violation|2|||
129999119|NCT01284062|467961637|FG000|Overall Study|Withdrawal by Subject|3|||
129999120|NCT01284062|467961638|FG001|Overall Study|Withdrawal by Subject|1|||
130335373|NCT01077076|469197437|FG005|First Intervention|Withdrawal by Subject|0|||
130335374|NCT01077076|469197432|FG000|Third Intervention|Death in the participant's family|0|||
130335375|NCT01077076|469197433|FG001|Third Intervention|Death in the participant's family|0|||
129999121|NCT01284062|467961639|FG002|Overall Study|Withdrawal by Subject|2|||
129999122|NCT01284062|467961640|FG003|Overall Study|Withdrawal by Subject|5|||
129999123|NCT01284062|467961637|FG000|Overall Study|Other|0|||
129999124|NCT01284062|467961638|FG001|Overall Study|Other|0|||
129999125|NCT01284062|467961639|FG002|Overall Study|Other|0|||
129999126|NCT01284062|467961640|FG003|Overall Study|Other|1|||
129999127|NCT01284062|467961637|FG000|Overall Study|Site Closed|0|||
129999128|NCT01284062|467961638|FG001|Overall Study|Site Closed|0|||
129999129|NCT01284062|467961639|FG002|Overall Study|Site Closed|1|||
129999130|NCT01284062|467961640|FG003|Overall Study|Site Closed|0|||
129999131|NCT02234323|467961641|FG000|All Enrolled|Not Treated: Completed study in database|2|||
129999132|NCT02234323|467961641|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
129999133|NCT02234323|467961641|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
129999134|NCT02234323|467961641|FG000|All Treated|Death|1|||
129999135|NCT02234323|467961641|FG000|All Treated|Physician Decision|5|||
129999136|NCT02234323|467961641|FG000|All Treated|Lack of Efficacy|3|||
129999137|NCT02234323|467961641|FG000|All Treated|Exceeded lab value limit|2|||
129999138|NCT02234323|467961641|FG000|All Treated|Other|7|||
129999139|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
129999140|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
129999141|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
129999142|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
129999143|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
129999144|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
129999145|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
129999146|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
129999147|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Death|1|||
129999148|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Death|1|||
129999149|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
129999150|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
129999151|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
129999152|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
129999153|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
130335376|NCT01077076|469197434|FG002|Third Intervention|Death in the participant's family|0|||
130335377|NCT01077076|469197435|FG003|Third Intervention|Death in the participant's family|0|||
130335378|NCT01077076|469197436|FG004|Third Intervention|Death in the participant's family|0|||
130335379|NCT01077076|469197437|FG005|Third Intervention|Death in the participant's family|1|||
130335380|NCT00035932|469197438|FG000|Overall Study|Adverse Event|10|||
130335381|NCT00035932|469197439|FG001|Overall Study|Adverse Event|9|||
130335382|NCT00035932|469197440|FG002|Overall Study|Adverse Event|9|||
130335383|NCT00035932|469197438|FG000|Overall Study|Death|0|||
130335384|NCT00035932|469197439|FG001|Overall Study|Death|0|||
130335385|NCT00035932|469197440|FG002|Overall Study|Death|1|||
130335386|NCT00035932|469197438|FG000|Overall Study|Disease Progression / Relapse|1|||
130335387|NCT00035932|469197439|FG001|Overall Study|Disease Progression / Relapse|1|||
130335388|NCT00035932|469197440|FG002|Overall Study|Disease Progression / Relapse|0|||
130335389|NCT00035932|469197438|FG000|Overall Study|Lost to Follow-up|4|||
130335390|NCT00035932|469197439|FG001|Overall Study|Lost to Follow-up|4|||
130335391|NCT00035932|469197440|FG002|Overall Study|Lost to Follow-up|3|||
130335392|NCT00035932|469197438|FG000|Overall Study|Noncompliance|6|||
130335393|NCT00035932|469197439|FG001|Overall Study|Noncompliance|7|||
130335394|NCT00035932|469197440|FG002|Overall Study|Noncompliance|6|||
130335395|NCT00035932|469197438|FG000|Overall Study|Protocol Violation While on Study|0|||
130335396|NCT00035932|469197439|FG001|Overall Study|Protocol Violation While on Study|1|||
130335397|NCT00035932|469197440|FG002|Overall Study|Protocol Violation While on Study|2|||
130335398|NCT00035932|469197438|FG000|Overall Study|Withdrawal by Subject|1|||
130335399|NCT00035932|469197439|FG001|Overall Study|Withdrawal by Subject|5|||
130335400|NCT00035932|469197440|FG002|Overall Study|Withdrawal by Subject|0|||
130335401|NCT00035932|469197438|FG000|Overall Study|Study Termination by Sponsor|1|||
130335402|NCT00035932|469197439|FG001|Overall Study|Study Termination by Sponsor|0|||
129999154|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
129999155|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
130335403|NCT00035932|469197440|FG002|Overall Study|Study Termination by Sponsor|0|||
130335404|NCT00035932|469197438|FG000|Overall Study|Lack of Efficacy|33|||
130335405|NCT00035932|469197439|FG001|Overall Study|Lack of Efficacy|33|||
129999156|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
129999157|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
129999158|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
129999159|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
129999160|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
130335406|NCT00035932|469197440|FG002|Overall Study|Lack of Efficacy|28|||
130335407|NCT04413617|469197443|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130335408|NCT04413617|469197444|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
129999161|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
129999162|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
129999163|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
129999164|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
129999165|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
129999166|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
129999167|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
129999168|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
129999169|NCT00559585|467961642|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
129999170|NCT00559585|467961643|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
129999171|NCT00559585|467961642|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
129999172|NCT00559585|467961643|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
129999173|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
129999174|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
129999175|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
129999176|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
129999177|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
129999178|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
129999179|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
129999180|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
129999181|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
130335409|NCT04413617|469197445|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130335410|NCT04413617|469197446|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
130335411|NCT04413617|469197447|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
130335412|NCT04413617|469197443|FG000|Overall Study|Protocol Violation|0|||
130335413|NCT04413617|469197444|FG001|Overall Study|Protocol Violation|1|||
130335414|NCT04413617|469197445|FG002|Overall Study|Protocol Violation|0|||
130335415|NCT04413617|469197446|FG003|Overall Study|Protocol Violation|0|||
130335416|NCT04413617|469197447|FG004|Overall Study|Protocol Violation|1|||
130335417|NCT04413617|469197443|FG000|Overall Study|Lack of Efficacy|2|||
130335418|NCT04413617|469197444|FG001|Overall Study|Lack of Efficacy|0|||
130335419|NCT04413617|469197445|FG002|Overall Study|Lack of Efficacy|2|||
130335420|NCT04413617|469197446|FG003|Overall Study|Lack of Efficacy|1|||
130335421|NCT04413617|469197447|FG004|Overall Study|Lack of Efficacy|0|||
130335422|NCT04413617|469197443|FG000|Overall Study|Withdrawal by Subject|3|||
130335423|NCT04413617|469197444|FG001|Overall Study|Withdrawal by Subject|4|||
130335424|NCT04413617|469197445|FG002|Overall Study|Withdrawal by Subject|2|||
130335425|NCT04413617|469197446|FG003|Overall Study|Withdrawal by Subject|5|||
130335426|NCT04413617|469197447|FG004|Overall Study|Withdrawal by Subject|3|||
130335427|NCT04413617|469197443|FG000|Overall Study|Death|1|||
130335428|NCT04413617|469197444|FG001|Overall Study|Death|0|||
130335429|NCT04413617|469197445|FG002|Overall Study|Death|0|||
130335430|NCT04413617|469197446|FG003|Overall Study|Death|0|||
130335431|NCT04413617|469197447|FG004|Overall Study|Death|0|||
130335432|NCT04413617|469197443|FG000|Overall Study|Adverse Event|1|||
130335433|NCT04413617|469197444|FG001|Overall Study|Adverse Event|0|||
130335434|NCT04413617|469197445|FG002|Overall Study|Adverse Event|0|||
130335435|NCT04413617|469197446|FG003|Overall Study|Adverse Event|1|||
130335436|NCT04413617|469197447|FG004|Overall Study|Adverse Event|1|||
130335437|NCT04413617|469197443|FG000|Overall Study|COVID-19|0|||
130335438|NCT04413617|469197444|FG001|Overall Study|COVID-19|1|||
130335439|NCT04413617|469197445|FG002|Overall Study|COVID-19|0|||
130335440|NCT04413617|469197446|FG003|Overall Study|COVID-19|0|||
130335441|NCT04413617|469197447|FG004|Overall Study|COVID-19|0|||
130335442|NCT01327482|469197448|FG000|Overall Study|Adverse Event|1|||
130335443|NCT00476229|469197449|FG000|Overall Study|Progressive shortness of breath|1|||
130335444|NCT02164461|469197450|FG000|Overall Study|Adverse Event|0|||
130335445|NCT02164461|469197451|FG001|Overall Study|Adverse Event|0|||
130335446|NCT02164461|469197452|FG002|Overall Study|Adverse Event|1|||
130335447|NCT02164461|469197450|FG000|Overall Study|Disease Progression|1|||
130335448|NCT02164461|469197451|FG001|Overall Study|Disease Progression|3|||
130335449|NCT02164461|469197452|FG002|Overall Study|Disease Progression|4|||
130335450|NCT02164461|469197450|FG000|Overall Study|Withdrawal by Subject|0|||
130335451|NCT02164461|469197451|FG001|Overall Study|Withdrawal by Subject|3|||
130335452|NCT02164461|469197452|FG002|Overall Study|Withdrawal by Subject|0|||
130335453|NCT01192191|469197454|FG000|Overall Study|Adverse Event|7|||
130335454|NCT01192191|469197455|FG001|Overall Study|Adverse Event|12|||
130335455|NCT01192191|469197454|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
130335456|NCT01192191|469197455|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
130335457|NCT01192191|469197454|FG000|Overall Study|Lost to Follow-up|0|||
130335458|NCT01192191|469197455|FG001|Overall Study|Lost to Follow-up|1|||
130335459|NCT01192191|469197454|FG000|Overall Study|Withdrawal by Subject|1|||
130335460|NCT01192191|469197455|FG001|Overall Study|Withdrawal by Subject|6|||
130335461|NCT01583296|469197458|FG000|Overall Study|Withdrawal by Subject|11|||
130335462|NCT01583296|469197459|FG001|Overall Study|Withdrawal by Subject|10|||
130335463|NCT01047553|469197460|FG000|Overall Study|Adverse Event|10|||
130335464|NCT01047553|469197461|FG001|Overall Study|Adverse Event|5|||
129999182|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
129999183|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
129999184|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
129999185|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
129999186|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
129999187|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
129999188|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
129999189|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
129999190|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
129999191|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
129999192|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
129999193|NCT00559585|467961642|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
130335465|NCT01047553|469197460|FG000|Overall Study|Withdrawal by Subject|4|||
130335466|NCT01047553|469197461|FG001|Overall Study|Withdrawal by Subject|2|||
130335467|NCT01047553|469197460|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
130335468|NCT01047553|469197461|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
130335469|NCT01047553|469197460|FG000|Overall Study|Lost to Follow-up|1|||
130335470|NCT01047553|469197461|FG001|Overall Study|Lost to Follow-up|0|||
130335471|NCT01047553|469197460|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
130335472|NCT01047553|469197461|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
130335473|NCT01047553|469197460|FG000|Overall Study|PI's decision|0|||
130335474|NCT01047553|469197461|FG001|Overall Study|PI's decision|1|||
130335475|NCT01063283|469197462|FG000|Cycle 1|Adverse Event|2|||
130335476|NCT01063283|469197463|FG001|Cycle 1|Adverse Event|0|||
130335477|NCT01063283|469197464|FG002|Cycle 1|Adverse Event|0|||
130335478|NCT01063283|469197462|FG000|Cycle 1|Technical failure in data collection|1|||
130335479|NCT01063283|469197463|FG001|Cycle 1|Technical failure in data collection|0|||
130335480|NCT01063283|469197464|FG002|Cycle 1|Technical failure in data collection|0|||
130335481|NCT03179319|469197465|FG000|Overall Study|Lost to Follow-up|6|||
130335482|NCT03179319|469197466|FG001|Overall Study|Lost to Follow-up|0|||
130335483|NCT01120717|469197467|FG000|Overall Study|Withdrawal by Subject|11|||
130335484|NCT01120717|469197468|FG001|Overall Study|Withdrawal by Subject|6|||
130335485|NCT01120717|469197467|FG000|Overall Study|Adverse Event|10|||
130335486|NCT01120717|469197468|FG001|Overall Study|Adverse Event|6|||
130335487|NCT01120717|469197467|FG000|Overall Study|Protocol Deviation|2|||
130335488|NCT01120717|469197468|FG001|Overall Study|Protocol Deviation|5|||
130335489|NCT01120717|469197467|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130335490|NCT01120717|469197468|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130335491|NCT01120717|469197467|FG000|Overall Study|Lost to Follow-up|2|||
130335492|NCT01120717|469197468|FG001|Overall Study|Lost to Follow-up|3|||
130335493|NCT01120717|469197467|FG000|Overall Study|Death|3|||
130335494|NCT01120717|469197468|FG001|Overall Study|Death|1|||
130335495|NCT01120717|469197467|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130335496|NCT01120717|469197468|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130335497|NCT00948441|469197475|FG000|Overall Study|no longer meet inclusion criteria|1|||
130335498|NCT00948441|469197476|FG001|Overall Study|no longer meet inclusion criteria|4|||
130335499|NCT00472030|469197480|FG000|Overall Study|Physician Decision|1|||
130335500|NCT00472030|469197481|FG001|Overall Study|Physician Decision|0|||
130335501|NCT04198714|469197482|FG000|Overall Study|Physician Decision|0|||
130335502|NCT04198714|469197483|FG001|Overall Study|Physician Decision|1|||
130335503|NCT02923921|469199644|FG000|Overall Study|Sponsor Decision|39|||
130335504|NCT02923921|469199645|FG001|Overall Study|Sponsor Decision|38|||
130335505|NCT02923921|469199644|FG000|Overall Study|Lost to Follow-up|1|||
130335506|NCT02923921|469199645|FG001|Overall Study|Lost to Follow-up|0|||
130335507|NCT02923921|469199644|FG000|Overall Study|Withdrawal by Subject|6|||
130335508|NCT02923921|469199645|FG001|Overall Study|Withdrawal by Subject|13|||
130335509|NCT02923921|469199644|FG000|Overall Study|Unknown, Not Collected|7|||
130335510|NCT02923921|469199645|FG001|Overall Study|Unknown, Not Collected|6|||
130335511|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
129999194|NCT00559585|467961643|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
129999195|NCT04614662|467961644|FG000|Overall Study|Withdrawal by Subject|0|||
130335512|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
130335513|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
130335514|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
130335515|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
130335516|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
130335517|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
130335518|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
130335519|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
130335520|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
129999196|NCT04614662|467961645|FG001|Overall Study|Withdrawal by Subject|1|||
129999197|NCT01717768|467961649|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999198|NCT01717768|467961650|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
129999199|NCT01717768|467961651|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999200|NCT01717768|467961652|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999201|NCT01717768|467961653|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999202|NCT01717768|467961654|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999203|NCT01717768|467961655|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999204|NCT01717768|467961656|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999205|NCT01717768|467961657|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999206|NCT01717768|467961658|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999207|NCT01717768|467961659|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999208|NCT01717768|467961660|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129999209|NCT01717768|467961649|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999210|NCT01717768|467961650|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999211|NCT01717768|467961651|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999212|NCT01717768|467961652|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999213|NCT01717768|467961653|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999214|NCT01717768|467961654|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999215|NCT01717768|467961655|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999216|NCT01717768|467961656|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999217|NCT01717768|467961657|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999218|NCT01717768|467961658|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999219|NCT01717768|467961659|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129999220|NCT01717768|467961660|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
129999221|NCT01717768|467961649|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999222|NCT01717768|467961650|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999223|NCT01717768|467961651|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999224|NCT01717768|467961652|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999225|NCT01717768|467961653|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999226|NCT01717768|467961654|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999227|NCT01717768|467961655|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999228|NCT01717768|467961656|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
129999229|NCT01717768|467961657|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999230|NCT01717768|467961658|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999231|NCT01717768|467961659|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999232|NCT01717768|467961660|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129999233|NCT01717768|467961649|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999234|NCT01717768|467961650|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999235|NCT01717768|467961651|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999236|NCT01717768|467961652|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999237|NCT01717768|467961653|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999238|NCT01717768|467961654|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999239|NCT01717768|467961655|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999240|NCT01717768|467961656|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999241|NCT01717768|467961657|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999242|NCT01717768|467961658|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
129999243|NCT01717768|467961659|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999244|NCT01717768|467961660|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129999245|NCT00448435|467961661|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
129999246|NCT00448435|467961662|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129999247|NCT04195581|467961665|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
129999248|NCT04195581|467961665|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
129999249|NCT04195581|467961665|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
129999250|NCT04195581|467961665|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
129999251|NCT04195581|467961665|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
129884288|NCT04329104|467536318|FG002|Efficacy Study|Withdrawal by Subject|0|||
129884289|NCT04329104|467536319|FG003|Efficacy Study|Withdrawal by Subject|5|||
129884290|NCT04329104|467536320|FG004|Efficacy Study|Withdrawal by Subject|6|||
129884291|NCT04329104|467536321|FG005|Efficacy Study|Withdrawal by Subject|8|||
129884292|NCT01024959|467536325|FG000|Overall Study|ineligible|12|||
129884293|NCT01024959|467536325|FG000|Overall Study|results not evaluable|12|||
129884294|NCT01024959|467536325|FG000|Overall Study|missing results required for analysis|17|||
129884295|NCT00636792|467536326|FG000|Overall Study|Adverse Event|16|||
129884296|NCT00636792|467536326|FG000|Overall Study|Physician Decision|7|||
129999252|NCT04195581|467961665|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
129999253|NCT01387230|467961666|FG000|Overall Study|Adverse Event|0|||
129999254|NCT01387230|467961667|FG001|Overall Study|Adverse Event|1|||
129999255|NCT01387230|467961668|FG002|Overall Study|Adverse Event|3|||
129999256|NCT01387230|467961666|FG000|Overall Study|Lack of Efficacy|8|||
129999257|NCT01387230|467961667|FG001|Overall Study|Lack of Efficacy|5|||
129999258|NCT01387230|467961668|FG002|Overall Study|Lack of Efficacy|4|||
129999259|NCT01387230|467961666|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
129999260|NCT01387230|467961667|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
129999261|NCT01387230|467961668|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
129999262|NCT01387230|467961666|FG000|Overall Study|Lost to Follow-up|0|||
129999263|NCT01387230|467961667|FG001|Overall Study|Lost to Follow-up|0|||
129999264|NCT01387230|467961668|FG002|Overall Study|Lost to Follow-up|1|||
129999265|NCT01387230|467961666|FG000|Overall Study|Withdrawal by Subject|4|||
129999266|NCT01387230|467961667|FG001|Overall Study|Withdrawal by Subject|1|||
129999267|NCT01387230|467961668|FG002|Overall Study|Withdrawal by Subject|0|||
129999268|NCT01237340|467961671|FG000|Overall Study|Adverse Event|3|||
129999269|NCT01237340|467961671|FG000|Overall Study|Withdrawal by Subject|1|||
129999270|NCT01237340|467961671|FG000|Overall Study|Early termination of the trial|36|||
129999271|NCT01843218|467961672|FG000|Overall Study|Withdrawal by Subject|5|||
129999272|NCT01136811|467961673|FG000|Overall Study|Physician Decision|11|||
129999273|NCT00403754|467961676|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
129999274|NCT00403754|467961677|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
129999275|NCT00403754|467961678|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
129999276|NCT00403754|467961679|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
129999277|NCT00403754|467961676|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
129999278|NCT00403754|467961677|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
129999279|NCT00403754|467961678|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
129999280|NCT00403754|467961679|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
129999281|NCT03829319|467961682|FG000|Overall Study|Sponsor's Decision|4|||
129999282|NCT03829319|467961683|FG001|Overall Study|Sponsor's Decision|90|||
129999283|NCT03829319|467961684|FG002|Overall Study|Sponsor's Decision|102|||
129999284|NCT03829319|467961682|FG000|Overall Study|Withdrawal by Subject|1|||
129999285|NCT03829319|467961683|FG001|Overall Study|Withdrawal by Subject|5|||
129999286|NCT03829319|467961684|FG002|Overall Study|Withdrawal by Subject|4|||
129999287|NCT03829319|467961682|FG000|Overall Study|Physician Decision|0|||
129999288|NCT03829319|467961683|FG001|Overall Study|Physician Decision|3|||
129999289|NCT03829319|467961684|FG002|Overall Study|Physician Decision|0|||
129999290|NCT03829319|467961682|FG000|Overall Study|Lost to Follow-up|0|||
129999291|NCT03829319|467961683|FG001|Overall Study|Lost to Follow-up|0|||
129999292|NCT03829319|467961684|FG002|Overall Study|Lost to Follow-up|1|||
129999293|NCT03829319|467961682|FG000|Overall Study|Death|8|||
129999294|NCT03829319|467961683|FG001|Overall Study|Death|277|||
129999295|NCT03829319|467961684|FG002|Overall Study|Death|266|||
129999296|NCT04498832|467961685|FG000|Overall Study|Adverse Event|1|||
129999297|NCT04498832|467961686|FG001|Overall Study|Adverse Event|3|||
129999298|NCT04498832|467961685|FG000|Overall Study|Withdrawal by Subject|0|||
129999299|NCT04498832|467961686|FG001|Overall Study|Withdrawal by Subject|1|||
129999300|NCT01012739|467961687|FG000|Treatment Period 1|Adverse Event|0|||
129999301|NCT01012739|467961688|FG001|Treatment Period 1|Adverse Event|0|||
129999302|NCT01012739|467961689|FG002|Treatment Period 1|Adverse Event|0|||
129999303|NCT01012739|467961690|FG003|Treatment Period 1|Adverse Event|1|||
129999304|NCT01012739|467961687|FG000|Treatment Period 2|Abnormal test procedure results|0|||
129999305|NCT01012739|467961688|FG001|Treatment Period 2|Abnormal test procedure results|0|||
129999306|NCT01012739|467961689|FG002|Treatment Period 2|Abnormal test procedure results|0|||
129999307|NCT01012739|467961690|FG003|Treatment Period 2|Abnormal test procedure results|1|||
129999308|NCT03049735|467961695|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
129999309|NCT03049735|467961696|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
129999310|NCT03049735|467961697|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
129999311|NCT03049735|467961695|FG000|Overall Study|Other|5|||
129999312|NCT03049735|467961696|FG001|Overall Study|Other|3|||
129999313|NCT03049735|467961697|FG002|Overall Study|Other|1|||
129999314|NCT03049735|467961695|FG000|Overall Study|Lack of Efficacy|4|||
129999315|NCT03049735|467961696|FG001|Overall Study|Lack of Efficacy|0|||
129999316|NCT03049735|467961697|FG002|Overall Study|Lack of Efficacy|3|||
129999317|NCT03049735|467961695|FG000|Overall Study|Protocol deviation|1|||
129999318|NCT03049735|467961696|FG001|Overall Study|Protocol deviation|0|||
129999319|NCT03049735|467961697|FG002|Overall Study|Protocol deviation|0|||
129999320|NCT03049735|467961695|FG000|Overall Study|Pregnancy|0|||
129999321|NCT03049735|467961696|FG001|Overall Study|Pregnancy|0|||
129999322|NCT03049735|467961697|FG002|Overall Study|Pregnancy|1|||
129999323|NCT03049735|467961695|FG000|Overall Study|Adverse Event|7|||
129999324|NCT03049735|467961696|FG001|Overall Study|Adverse Event|18|||
129999325|NCT03049735|467961697|FG002|Overall Study|Adverse Event|5|||
129999326|NCT03049735|467961695|FG000|Overall Study|Withdrawal by Subject|10|||
129999327|NCT03049735|467961696|FG001|Overall Study|Withdrawal by Subject|3|||
129999328|NCT03049735|467961697|FG002|Overall Study|Withdrawal by Subject|7|||
129999329|NCT03049735|467961695|FG000|Overall Study|Lost to Follow-up|1|||
129999330|NCT03049735|467961696|FG001|Overall Study|Lost to Follow-up|5|||
129999331|NCT03049735|467961697|FG002|Overall Study|Lost to Follow-up|5|||
129999332|NCT00390910|467961698|FG000|Overall Study|Adverse Event|1|||
129999333|NCT00390910|467961699|FG001|Overall Study|Adverse Event|0|||
129999334|NCT00390910|467961700|FG002|Overall Study|Adverse Event|0|||
129999335|NCT00390910|467961698|FG000|Overall Study|Lost to Follow-up|0|||
129999336|NCT00390910|467961699|FG001|Overall Study|Lost to Follow-up|1|||
129999337|NCT00390910|467961700|FG002|Overall Study|Lost to Follow-up|5|||
129999338|NCT00390910|467961698|FG000|Overall Study|Withdrawal by Subject|1|||
129999339|NCT00390910|467961699|FG001|Overall Study|Withdrawal by Subject|3|||
129999340|NCT00390910|467961700|FG002|Overall Study|Withdrawal by Subject|2|||
129999341|NCT00390910|467961698|FG000|Overall Study|Migrated/moved from study area|0|||
129999342|NCT00390910|467961699|FG001|Overall Study|Migrated/moved from study area|0|||
129999343|NCT00390910|467961700|FG002|Overall Study|Migrated/moved from study area|3|||
129999344|NCT03231943|467961705|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999345|NCT03231943|467961706|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
129999346|NCT03231943|467961707|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
129999347|NCT03231943|467961708|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999348|NCT03231943|467961709|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999349|NCT03231943|467961710|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999350|NCT03231943|467961711|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999351|NCT03231943|467961712|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999352|NCT03231943|467961713|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999353|NCT03231943|467961714|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999354|NCT03231943|467961715|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999355|NCT03231943|467961716|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999356|NCT03231943|467961717|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129999357|NCT03231943|467961705|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999358|NCT03231943|467961706|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
129999359|NCT03231943|467961707|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999360|NCT03231943|467961708|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999361|NCT03231943|467961709|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999362|NCT03231943|467961710|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999363|NCT03231943|467961711|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999364|NCT03231943|467961712|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999365|NCT03231943|467961713|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999366|NCT03231943|467961714|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999367|NCT03231943|467961715|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999368|NCT03231943|467961716|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999369|NCT03231943|467961717|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129999370|NCT03231943|467961705|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
129999371|NCT03231943|467961706|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999372|NCT03231943|467961707|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999373|NCT03231943|467961708|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999374|NCT03231943|467961709|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999375|NCT03231943|467961710|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999376|NCT03231943|467961711|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999377|NCT03231943|467961712|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999378|NCT03231943|467961713|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999379|NCT03231943|467961714|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999380|NCT03231943|467961715|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999381|NCT03231943|467961716|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129999382|NCT03231943|467961717|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
130335521|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
130335522|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
130335523|NCT00479687|469199646|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
130335524|NCT00479687|469199647|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
130335525|NCT00479687|469199648|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
130335526|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
130335527|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
130335528|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
130335529|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
129999383|NCT03231943|467961705|FG000|Part 2|Adverse Event|0|||
129999384|NCT03231943|467961706|FG001|Part 2|Adverse Event|0|||
129999385|NCT03231943|467961707|FG002|Part 2|Adverse Event|0|||
129999386|NCT03231943|467961708|FG003|Part 2|Adverse Event|0|||
129999387|NCT03231943|467961709|FG004|Part 2|Adverse Event|0|||
129999388|NCT03231943|467961710|FG005|Part 2|Adverse Event|0|||
129999389|NCT03231943|467961711|FG006|Part 2|Adverse Event|0|||
129999390|NCT03231943|467961712|FG007|Part 2|Adverse Event|0|||
130335530|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
129999391|NCT03231943|467961713|FG008|Part 2|Adverse Event|0|||
129999392|NCT03231943|467961714|FG009|Part 2|Adverse Event|0|||
129999393|NCT03231943|467961715|FG010|Part 2|Adverse Event|1|||
129999394|NCT03231943|467961716|FG011|Part 2|Adverse Event|0|||
130335531|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
130335532|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
130335533|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
130335534|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
130335535|NCT00479687|469199646|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
129999395|NCT03231943|467961717|FG012|Part 2|Adverse Event|0|||
129999396|NCT03231943|467961705|FG000|Part 2|Withdrawal by Subject|0|||
129999397|NCT03231943|467961706|FG001|Part 2|Withdrawal by Subject|0|||
129999398|NCT03231943|467961707|FG002|Part 2|Withdrawal by Subject|0|||
130335536|NCT00479687|469199647|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
130335537|NCT00479687|469199648|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
130335538|NCT00295880|469199649|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
129999399|NCT03231943|467961708|FG003|Part 2|Withdrawal by Subject|0|||
129999400|NCT03231943|467961709|FG004|Part 2|Withdrawal by Subject|0|||
129999401|NCT03231943|467961710|FG005|Part 2|Withdrawal by Subject|0|||
129999402|NCT03231943|467961711|FG006|Part 2|Withdrawal by Subject|0|||
129999403|NCT03231943|467961712|FG007|Part 2|Withdrawal by Subject|0|||
129999404|NCT03231943|467961713|FG008|Part 2|Withdrawal by Subject|0|||
129999405|NCT03231943|467961714|FG009|Part 2|Withdrawal by Subject|0|||
129999406|NCT03231943|467961715|FG010|Part 2|Withdrawal by Subject|0|||
129999407|NCT03231943|467961716|FG011|Part 2|Withdrawal by Subject|1|||
129999408|NCT03231943|467961717|FG012|Part 2|Withdrawal by Subject|0|||
129999409|NCT02906787|467961719|FG000|Overall Study|Withdrawal by Subject|12|||
129999410|NCT02906787|467961720|FG001|Overall Study|Withdrawal by Subject|10|||
129999411|NCT02906787|467961719|FG000|Overall Study|Missed|24|||
129999412|NCT02906787|467961720|FG001|Overall Study|Missed|22|||
129999413|NCT02818920|467961721|FG000|Overall Study|Unresectable|4|||
129999414|NCT02818920|467961721|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
129999415|NCT02818920|467961721|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
129999416|NCT02818920|467961721|FG000|Overall Study|Adverse Event|3|||
129999417|NCT02818920|467961721|FG000|Overall Study|Developed Other Disease|1|||
129999418|NCT02818920|467961721|FG000|Overall Study|Refused Further Treatment|1|||
129999419|NCT04824521|467961724|FG000|Overall Study|Lost to Follow-up|1|||
129999420|NCT00447382|467961725|FG000|Overall Study|Adverse Event|1|||
129999421|NCT00447382|467961726|FG001|Overall Study|Adverse Event|1|||
129999422|NCT00447382|467961725|FG000|Overall Study|Lack of Efficacy|1|||
129999423|NCT00447382|467961726|FG001|Overall Study|Lack of Efficacy|0|||
129999424|NCT00447382|467961725|FG000|Overall Study|Protocol Violation|2|||
129999425|NCT00447382|467961726|FG001|Overall Study|Protocol Violation|0|||
129999426|NCT00447382|467961725|FG000|Overall Study|Unclassified|2|||
129999427|NCT00447382|467961726|FG001|Overall Study|Unclassified|5|||
129999428|NCT02673619|467961727|FG000|Overall Study|Lost to Follow-up|1|||
129999429|NCT02673619|467961728|FG001|Overall Study|Lost to Follow-up|0|||
129999430|NCT02673619|467961729|FG002|Overall Study|Lost to Follow-up|0|||
129999431|NCT02673619|467961730|FG003|Overall Study|Lost to Follow-up|0|||
129999432|NCT02673619|467961727|FG000|Overall Study|Withdrawal by Subject|1|||
129999433|NCT02673619|467961728|FG001|Overall Study|Withdrawal by Subject|1|||
129999434|NCT02673619|467961729|FG002|Overall Study|Withdrawal by Subject|1|||
129999435|NCT02673619|467961730|FG003|Overall Study|Withdrawal by Subject|0|||
129999436|NCT02673619|467961727|FG000|Overall Study|Adverse Event|0|||
129999437|NCT02673619|467961728|FG001|Overall Study|Adverse Event|0|||
129999438|NCT02673619|467961729|FG002|Overall Study|Adverse Event|1|||
129999439|NCT02673619|467961730|FG003|Overall Study|Adverse Event|0|||
129999440|NCT02673619|467961727|FG000|Overall Study|Lack of Efficacy|0|||
129999441|NCT02673619|467961728|FG001|Overall Study|Lack of Efficacy|0|||
129999442|NCT02673619|467961729|FG002|Overall Study|Lack of Efficacy|1|||
129999443|NCT02673619|467961730|FG003|Overall Study|Lack of Efficacy|0|||
129999444|NCT04600336|467961731|FG000|Initial Treatment|Withdrawal by Subject|1|||
129999445|NCT04600336|467961732|FG001|Initial Treatment|Withdrawal by Subject|2|||
129999446|NCT04600336|467961733|FG002|Initial Treatment|Withdrawal by Subject|0|||
129999447|NCT04600336|467961734|FG003|Initial Treatment|Withdrawal by Subject|0|||
129999448|NCT04600336|467961731|FG000|Initial Treatment|Adverse Event|0|||
129999449|NCT04600336|467961732|FG001|Initial Treatment|Adverse Event|2|||
129999450|NCT04600336|467961733|FG002|Initial Treatment|Adverse Event|0|||
129999451|NCT04600336|467961734|FG003|Initial Treatment|Adverse Event|0|||
129999452|NCT04600336|467961731|FG000|Initial Treatment|Other complicating disease|0|||
129999453|NCT04600336|467961732|FG001|Initial Treatment|Other complicating disease|0|||
129999454|NCT04600336|467961733|FG002|Initial Treatment|Other complicating disease|1|||
129999455|NCT04600336|467961734|FG003|Initial Treatment|Other complicating disease|0|||
129999456|NCT04600336|467961731|FG000|Crossover Treatment|Withdrawal by Subject|0|||
129999457|NCT04600336|467961732|FG001|Crossover Treatment|Withdrawal by Subject|0|||
129999458|NCT04600336|467961733|FG002|Crossover Treatment|Withdrawal by Subject|2|||
129999459|NCT04600336|467961734|FG003|Crossover Treatment|Withdrawal by Subject|1|||
129999460|NCT04600336|467961731|FG000|Crossover Treatment|Adverse Event|0|||
129999461|NCT04600336|467961732|FG001|Crossover Treatment|Adverse Event|0|||
129999462|NCT04600336|467961733|FG002|Crossover Treatment|Adverse Event|1|||
129999463|NCT04600336|467961734|FG003|Crossover Treatment|Adverse Event|1|||
129999464|NCT03078907|467963507|FG000|Overall Study|Adverse Event|2|||
129999465|NCT03078907|467963508|FG001|Overall Study|Adverse Event|0|||
129999466|NCT03078907|467963507|FG000|Overall Study|Other|1|||
129999467|NCT03078907|467963508|FG001|Overall Study|Other|0|||
129999468|NCT03078907|467963507|FG000|Overall Study|Protocol Violation|0|||
129999469|NCT03078907|467963508|FG001|Overall Study|Protocol Violation|1|||
129999470|NCT03808688|467963509|FG000|Overall Study|Adverse Event|13|||
129999471|NCT03808688|467963510|FG001|Overall Study|Adverse Event|17|||
129999472|NCT03808688|467963509|FG000|Overall Study|Lack of Efficacy|2|||
129999473|NCT03808688|467963510|FG001|Overall Study|Lack of Efficacy|0|||
129999474|NCT03808688|467963509|FG000|Overall Study|Lost to Follow-up|0|||
129999475|NCT03808688|467963510|FG001|Overall Study|Lost to Follow-up|2|||
129999476|NCT03808688|467963509|FG000|Overall Study|Withdrawal by Subject|1|||
129999477|NCT03808688|467963510|FG001|Overall Study|Withdrawal by Subject|0|||
129999478|NCT03808688|467963509|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
129999479|NCT03808688|467963510|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
129999480|NCT03808688|467963509|FG000|Overall Study|IOP Too High|1|||
129999481|NCT03808688|467963510|FG001|Overall Study|IOP Too High|1|||
129999482|NCT03808688|467963509|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
129999483|NCT03808688|467963510|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
129999484|NCT03808688|467963509|FG000|Overall Study|Visit Out of Window|0|||
129999485|NCT03808688|467963510|FG001|Overall Study|Visit Out of Window|1|||
129999486|NCT03808688|467963509|FG000|Overall Study|Medication Non-Compliance|0|||
129999487|NCT03808688|467963510|FG001|Overall Study|Medication Non-Compliance|1|||
129999488|NCT03329196|467963511|FG000|Overall Study|Adverse Event|10|||
129999489|NCT03329196|467963512|FG001|Overall Study|Adverse Event|5|||
129999490|NCT03329196|467963511|FG000|Overall Study|Physician Decision|2|||
129999491|NCT03329196|467963512|FG001|Overall Study|Physician Decision|2|||
129999492|NCT03329196|467963511|FG000|Overall Study|Withdrawal by Subject|11|||
129999493|NCT03329196|467963512|FG001|Overall Study|Withdrawal by Subject|3|||
129999494|NCT03329196|467963511|FG000|Overall Study|Hepatic function abnormalities|0|||
129999495|NCT03329196|467963512|FG001|Overall Study|Hepatic function abnormalities|1|||
129999496|NCT03329196|467963511|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
129999497|NCT03329196|467963512|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
129999498|NCT03329196|467963511|FG000|Overall Study|Difficult to control Hb|2|||
129999499|NCT03329196|467963512|FG001|Overall Study|Difficult to control Hb|3|||
129999500|NCT03329196|467963511|FG000|Overall Study|Dialysis or renal transplant|13|||
129999501|NCT03329196|467963512|FG001|Overall Study|Dialysis or renal transplant|15|||
129999502|NCT03434353|467963519|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
129999503|NCT03434353|467963520|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
129999504|NCT03434353|467963521|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
129999505|NCT03434353|467963522|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
129999506|NCT03434353|467963523|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
129999507|NCT03434353|467963519|FG000|Overall Study|Withdrew consent|1|||
129999508|NCT03434353|467963520|FG001|Overall Study|Withdrew consent|0|||
129999509|NCT03434353|467963521|FG002|Overall Study|Withdrew consent|3|||
129999510|NCT03434353|467963522|FG003|Overall Study|Withdrew consent|0|||
129999511|NCT03434353|467963523|FG004|Overall Study|Withdrew consent|0|||
129999512|NCT03434353|467963519|FG000|Overall Study|Adverse Event|1|||
129999513|NCT03434353|467963520|FG001|Overall Study|Adverse Event|0|||
129999514|NCT03434353|467963521|FG002|Overall Study|Adverse Event|0|||
129999515|NCT03434353|467963522|FG003|Overall Study|Adverse Event|0|||
129999516|NCT03434353|467963523|FG004|Overall Study|Adverse Event|1|||
130335539|NCT00295880|469199649|FG000|Overall Study|Unit randomization did not occur|1|||
130335540|NCT01474239|469199650|FG000|Overall Study|Disease Progression|37|||
130335541|NCT01474239|469199651|FG001|Overall Study|Disease Progression|25|||
130335542|NCT01474239|469199650|FG000|Overall Study|Adverse Event|12|||
130335543|NCT01474239|469199651|FG001|Overall Study|Adverse Event|3|||
130335544|NCT01474239|469199650|FG000|Overall Study|Withdrawal by Subject|1|||
129884297|NCT00636792|467536326|FG000|Overall Study|Progressive Disease|4|||
129884298|NCT00636792|467536326|FG000|Overall Study|Withdrawal by Subject|3|||
129884299|NCT00636792|467536326|FG000|Overall Study|Other|3|||
129884300|NCT01987596|467536329|FG000|Overall Study|Physician Decision|1|||
129884301|NCT01987596|467536330|FG001|Overall Study|Physician Decision|0|||
129884302|NCT01987596|467536329|FG000|Overall Study|Progressive Disease; missing all period|0|||
129884303|NCT01987596|467536330|FG001|Overall Study|Progressive Disease; missing all period|1|||
129884304|NCT00709592|467536331|FG000|Overall Study|Unable to proceed to transplant|0|||
129884305|NCT00709592|467536332|FG001|Overall Study|Unable to proceed to transplant|1|||
129884306|NCT01129336|467536333|FG000|Overall Study|Protocol Violation|1|||
129999517|NCT03434353|467963519|FG000|Overall Study|Lost to Follow-up|2|||
130335545|NCT01474239|469199651|FG001|Overall Study|Withdrawal by Subject|2|||
129884307|NCT01129336|467536334|FG001|Overall Study|Protocol Violation|0|||
129884308|NCT01129336|467536333|FG000|Overall Study|Disease Progression|1|||
129999518|NCT03434353|467963520|FG001|Overall Study|Lost to Follow-up|0|||
129999519|NCT03434353|467963521|FG002|Overall Study|Lost to Follow-up|0|||
129999520|NCT03434353|467963522|FG003|Overall Study|Lost to Follow-up|0|||
129999521|NCT03434353|467963523|FG004|Overall Study|Lost to Follow-up|0|||
129999522|NCT01990534|467963526|FG000|Overall Study|Death|22|||
129999523|NCT01990534|467963526|FG000|Overall Study|Progressive disease|3|||
129999524|NCT01990534|467963526|FG000|Overall Study|Protocol Violation|1|||
129999525|NCT01990534|467963526|FG000|Overall Study|Withdrawal of Informed Consent|2|||
129999526|NCT01990534|467963526|FG000|Overall Study|Symptomatic Deterioration|1|||
129999527|NCT01990534|467963526|FG000|Overall Study|Withdrawal by Subject|3|||
129999528|NCT01990534|467963526|FG000|Overall Study|Reason not Specified|2|||
129999529|NCT01990534|467963526|FG000|Overall Study|Lost to Follow-up|1|||
129999530|NCT00234494|467963527|FG000|Overall Study|Protocol Violation|2|||
129999531|NCT01831544|467963530|FG000|Overall Study|Death|1|||
129999532|NCT01831544|467963530|FG000|Overall Study|Still on original MVAD device|2|||
129999533|NCT04175808|467963533|FG000|Part A|Miscellaneous|2|||
129999534|NCT04175808|467963534|FG001|Part A|Miscellaneous|0|||
129999535|NCT04175808|467963535|FG002|Part A|Miscellaneous|0|||
129999536|NCT04175808|467963536|FG003|Part A|Miscellaneous|0|||
129999537|NCT04175808|467963537|FG004|Part A|Miscellaneous|0|||
129999538|NCT04175808|467963538|FG005|Part A|Miscellaneous|0|||
129999539|NCT04175808|467963539|FG006|Part A|Miscellaneous|0|||
129999540|NCT02021292|467963543|FG000|Overall Study|Physician Decision|0|||
129999541|NCT02021292|467963544|FG001|Overall Study|Physician Decision|1|||
129999542|NCT02021292|467963543|FG000|Overall Study|Lost to Follow-up|0|||
129999543|NCT02021292|467963544|FG001|Overall Study|Lost to Follow-up|1|||
129999544|NCT02021292|467963543|FG000|Overall Study|Death|0|||
129999545|NCT02021292|467963544|FG001|Overall Study|Death|1|||
129999546|NCT05972733|467963545|FG000|Overall Study|Lost to Follow-up|2|||
129999547|NCT05972733|467963545|FG000|Overall Study|Withdrawal by Subject|1|||
129999548|NCT04982588|467963548|FG000|Overall Study|Withdrawal by Subject|2|||
129999549|NCT02366728|467963549|FG000|Overall Study|Death|0|||
129999550|NCT02366728|467963550|FG001|Overall Study|Death|0|||
129999551|NCT02366728|467963551|FG002|Overall Study|Death|1|||
129999552|NCT02366728|467963549|FG000|Overall Study|Adverse Event|1|||
129999553|NCT02366728|467963550|FG001|Overall Study|Adverse Event|0|||
129999554|NCT02366728|467963551|FG002|Overall Study|Adverse Event|0|||
129999555|NCT02366728|467963549|FG000|Overall Study|Screen Failure|2|||
129999556|NCT02366728|467963550|FG001|Overall Study|Screen Failure|1|||
129999557|NCT02366728|467963551|FG002|Overall Study|Screen Failure|0|||
129999558|NCT02366728|467963549|FG000|Overall Study|Only yielded 2 vaccines|1|||
129999559|NCT02366728|467963550|FG001|Overall Study|Only yielded 2 vaccines|0|||
129999560|NCT02366728|467963551|FG002|Overall Study|Only yielded 2 vaccines|0|||
129999561|NCT00992511|467963553|FG000|Overall Study|Migrated/moved from study area|1|||
129999562|NCT00992511|467963554|FG001|Overall Study|Migrated/moved from study area|0|||
129999563|NCT00992511|467963555|FG002|Overall Study|Migrated/moved from study area|1|||
129999564|NCT00992511|467963556|FG003|Overall Study|Migrated/moved from study area|2|||
129999565|NCT00992511|467963553|FG000|Overall Study|Lost to Follow-up|1|||
129999566|NCT00992511|467963554|FG001|Overall Study|Lost to Follow-up|0|||
129999567|NCT00992511|467963555|FG002|Overall Study|Lost to Follow-up|0|||
129999568|NCT00992511|467963556|FG003|Overall Study|Lost to Follow-up|2|||
129999569|NCT00992511|467963553|FG000|Overall Study|Withdrawal by Subject|0|||
129999570|NCT00992511|467963554|FG001|Overall Study|Withdrawal by Subject|0|||
129999571|NCT00992511|467963555|FG002|Overall Study|Withdrawal by Subject|1|||
129999572|NCT00992511|467963556|FG003|Overall Study|Withdrawal by Subject|1|||
129999573|NCT04498169|467963557|FG000|Study Completion|Adverse Event|1|||
129999574|NCT04498169|467963558|FG001|Study Completion|Adverse Event|1|||
129999575|NCT04615247|467963559|FG000|Overall Study|Adverse Event|0|||
129999576|NCT04615247|467963560|FG001|Overall Study|Adverse Event|2|||
129999577|NCT04615247|467963559|FG000|Overall Study|Withdrawal by Subject|1|||
129999578|NCT04615247|467963560|FG001|Overall Study|Withdrawal by Subject|1|||
129999579|NCT03694418|467963563|FG000|Overall Study|Lost to Follow-up|115|||
129999580|NCT03694418|467963564|FG001|Overall Study|Lost to Follow-up|23|||
129999581|NCT03694418|467963565|FG002|Overall Study|Lost to Follow-up|12|||
129999582|NCT03694418|467963566|FG003|Overall Study|Lost to Follow-up|12|||
129999583|NCT03694418|467963567|FG004|Overall Study|Lost to Follow-up|13|||
129999584|NCT02644941|467963575|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
129999585|NCT02644941|467963576|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
129999586|NCT03027557|467963582|FG000|Overall Study|Adverse Event|1|||
129999587|NCT03027557|467963583|FG001|Overall Study|Adverse Event|0|||
129999588|NCT03027557|467963584|FG002|Overall Study|Adverse Event|0|||
129999589|NCT01610687|467963589|FG000|Overall Study|Lack of Efficacy|26|||
129999590|NCT01610687|467963589|FG000|Overall Study|Adverse Event|18|||
129999591|NCT01610687|467963589|FG000|Overall Study|Moved out of area|6|||
129999592|NCT01610687|467963589|FG000|Overall Study|Withdrawal by Subject|7|||
129999593|NCT01610687|467963589|FG000|Overall Study|Lost to Follow-up|4|||
129999594|NCT01610687|467963589|FG000|Overall Study|Symptom control without study medication|2|||
129999595|NCT01610687|467963589|FG000|Overall Study|Unable to make journey|1|||
129999596|NCT01610687|467963589|FG000|Overall Study|Death|1|||
130335546|NCT01474239|469199650|FG000|Overall Study|Death|1|||
130335547|NCT01474239|469199651|FG001|Overall Study|Death|1|||
130335548|NCT01474239|469199650|FG000|Overall Study|Clinical Disease Progression|7|||
130335549|NCT01474239|469199651|FG001|Overall Study|Clinical Disease Progression|1|||
129999597|NCT01610687|467963589|FG000|Overall Study|Cannabis affecting job|1|||
129999598|NCT01610687|467963589|FG000|Overall Study|Felt more alter without study medication|1|||
129999599|NCT03836807|467963590|FG000|Overall Study|Physician Decision|1|||
129999600|NCT03836807|467963591|FG001|Overall Study|Physician Decision|0|||
129999601|NCT02430051|467963592|FG000|Overall Study|Withdrawal by Subject|6|||
129999602|NCT02430051|467963593|FG001|Overall Study|Withdrawal by Subject|3|||
129999603|NCT02430051|467963592|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
129999604|NCT02430051|467963593|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
129999605|NCT02430051|467963592|FG000|Overall Study|Protocol Violation|1|||
129999606|NCT02430051|467963593|FG001|Overall Study|Protocol Violation|0|||
129999607|NCT02019420|467963594|FG000|Overall Study|Did not receive study drug|2|||
129999608|NCT02019420|467963595|FG001|Overall Study|Did not receive study drug|2|||
129999609|NCT02019420|467963594|FG000|Overall Study|Withdrawal by Subject|1|||
129999610|NCT02019420|467963595|FG001|Overall Study|Withdrawal by Subject|3|||
129999611|NCT02019420|467963594|FG000|Overall Study|At request of sponsor or investigator|0|||
129999612|NCT02019420|467963595|FG001|Overall Study|At request of sponsor or investigator|1|||
129999613|NCT02019420|467963594|FG000|Overall Study|Death|104|||
129999614|NCT02019420|467963595|FG001|Overall Study|Death|99|||
129999615|NCT02019420|467963594|FG000|Overall Study|Transferred to other care facility|1|||
129999616|NCT02019420|467963595|FG001|Overall Study|Transferred to other care facility|1|||
129999617|NCT01009554|467963596|FG000|Overall Study|Adverse Event|1|||
129999618|NCT01009554|467963597|FG001|Overall Study|Adverse Event|1|||
129999619|NCT01009554|467963596|FG000|Overall Study|Withdrawal by Subject|1|||
129999620|NCT01009554|467963597|FG001|Overall Study|Withdrawal by Subject|3|||
129999621|NCT01009554|467963596|FG000|Overall Study|Noncompliant with Study Product|0|||
129999622|NCT01009554|467963597|FG001|Overall Study|Noncompliant with Study Product|3|||
129999623|NCT01605253|467963598|FG000|Overall Study|Physician Decision|3|||
129999624|NCT01605253|467963599|FG001|Overall Study|Physician Decision|2|||
129999625|NCT01605253|467963598|FG000|Overall Study|Lost to Follow-up|3|||
129999626|NCT01605253|467963599|FG001|Overall Study|Lost to Follow-up|1|||
129999627|NCT04598477|467963606|FG000|Overall Study|Adverse Event|2|||
129999628|NCT04598477|467963607|FG001|Overall Study|Adverse Event|0|||
129999629|NCT04598477|467963606|FG000|Overall Study|Death|0|||
129999630|NCT04598477|467963607|FG001|Overall Study|Death|1|||
129999631|NCT04598477|467963606|FG000|Overall Study|Lost to Follow-up|1|||
129999632|NCT04598477|467963607|FG001|Overall Study|Lost to Follow-up|0|||
129999633|NCT04598477|467963606|FG000|Overall Study|Physician Decision|7|||
129999634|NCT04598477|467963607|FG001|Overall Study|Physician Decision|2|||
129999635|NCT04598477|467963606|FG000|Overall Study|Pregnancy|0|||
129999636|NCT04598477|467963607|FG001|Overall Study|Pregnancy|1|||
129999637|NCT04598477|467963606|FG000|Overall Study|Requires Prohibited Medication|0|||
129999638|NCT04598477|467963607|FG001|Overall Study|Requires Prohibited Medication|1|||
129999639|NCT04598477|467963606|FG000|Overall Study|Study Terminated by Sponsor|18|||
129999640|NCT04598477|467963607|FG001|Overall Study|Study Terminated by Sponsor|12|||
129999641|NCT04598477|467963606|FG000|Overall Study|Withdrawal by Subject|16|||
129999642|NCT04598477|467963607|FG001|Overall Study|Withdrawal by Subject|12|||
129999643|NCT04598477|467963606|FG000|Overall Study|Other|15|||
129999644|NCT04598477|467963607|FG001|Overall Study|Other|8|||
129999645|NCT02499770|467963612|FG000|Overall Study|Death|17|||
129999646|NCT02499770|467963613|FG001|Overall Study|Death|56|||
129999647|NCT02499770|467963612|FG000|Overall Study|Study completion|1|||
129999648|NCT02499770|467963613|FG001|Overall Study|Study completion|10|||
129999649|NCT02499770|467963612|FG000|Overall Study|Withdrawal by Subject|0|||
129999650|NCT02499770|467963613|FG001|Overall Study|Withdrawal by Subject|7|||
129999651|NCT02499770|467963612|FG000|Overall Study|Lost to Follow-up|0|||
130335550|NCT01474239|469199650|FG000|Overall Study|Withdrawal for Economic Reason|1|||
129999652|NCT02499770|467963613|FG001|Overall Study|Lost to Follow-up|2|||
129999653|NCT02499770|467963612|FG000|Overall Study|Subject declined further treatment|1|||
129999654|NCT02499770|467963613|FG001|Overall Study|Subject declined further treatment|0|||
130335551|NCT01474239|469199651|FG001|Overall Study|Withdrawal for Economic Reason|0|||
129999655|NCT02499770|467963612|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
129999656|NCT02499770|467963613|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
129999657|NCT02499770|467963612|FG000|Overall Study|Randomized but not enrolled|0|||
129999658|NCT02499770|467963613|FG001|Overall Study|Randomized but not enrolled|1|||
129999659|NCT02038920|467963614|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
130335552|NCT01139008|469199652|FG000|Overall Study|Withdrawal by Subject|5|||
129999660|NCT02038920|467963615|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
129999661|NCT02038920|467963616|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
130335553|NCT01139008|469199652|FG000|Overall Study|Non-compliant, lost product|1|||
130335554|NCT01715857|469199653|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
129999662|NCT02038920|467963617|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129999663|NCT02038920|467963618|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129999664|NCT02038920|467963619|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129999665|NCT02038920|467963614|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
129999666|NCT02038920|467963615|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129999667|NCT02038920|467963616|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129999668|NCT02038920|467963617|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129999669|NCT02038920|467963618|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129999670|NCT02038920|467963619|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129999671|NCT02038920|467963614|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
129999672|NCT02038920|467963615|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
129999673|NCT02038920|467963616|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129999674|NCT02038920|467963617|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129999675|NCT02038920|467963618|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129999676|NCT02038920|467963619|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129999677|NCT02038920|467963614|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
129999678|NCT02038920|467963615|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
129999679|NCT02038920|467963616|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
129999680|NCT02038920|467963617|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
129999681|NCT02038920|467963618|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
129999682|NCT02038920|467963619|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
129999683|NCT02038920|467963614|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129999684|NCT02038920|467963615|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129999685|NCT02038920|467963616|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
129999686|NCT02038920|467963617|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129999687|NCT02038920|467963618|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129999688|NCT02038920|467963619|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129999689|NCT02038920|467963614|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
129999690|NCT02038920|467963615|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
129999691|NCT02038920|467963616|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
129999692|NCT02038920|467963617|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
129999693|NCT02038920|467963618|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
129999694|NCT02038920|467963619|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
129999695|NCT02038920|467963614|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129999696|NCT02038920|467963615|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129999697|NCT02038920|467963616|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129999698|NCT02038920|467963617|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129999699|NCT02038920|467963618|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129999700|NCT02038920|467963619|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
129999701|NCT02038920|467963614|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129999702|NCT02038920|467963615|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129999703|NCT02038920|467963616|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129999704|NCT02038920|467963617|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129999705|NCT02038920|467963618|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129999706|NCT02038920|467963619|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
129999707|NCT02038920|467963614|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129999708|NCT02038920|467963615|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129999709|NCT02038920|467963616|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129999710|NCT02038920|467963617|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129999711|NCT02038920|467963618|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129999712|NCT02038920|467963619|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
129999713|NCT02038920|467963614|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129999714|NCT02038920|467963615|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129999715|NCT02038920|467963616|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129999716|NCT02038920|467963617|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129999717|NCT02038920|467963618|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129999718|NCT02038920|467963619|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
129999719|NCT02038920|467963614|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129999720|NCT02038920|467963615|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129999721|NCT02038920|467963616|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129999722|NCT02038920|467963617|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129999723|NCT02038920|467963618|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129999724|NCT02038920|467963619|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
129999725|NCT02038920|467963614|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129999726|NCT02038920|467963615|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
130335555|NCT00505778|469199654|FG000|Overall Study|Adverse Event|2|||
129999727|NCT02038920|467963616|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129999728|NCT02038920|467963617|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129999729|NCT02038920|467963618|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129999730|NCT02038920|467963619|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
129999731|NCT00047320|467963620|FG000|Overall Study|Lack of Efficacy|8|||
129999732|NCT00047320|467963620|FG000|Overall Study|Lost to Follow-up|1|||
129999733|NCT00047320|467963620|FG000|Overall Study|Physician Decision|8|||
129999734|NCT00047320|467963620|FG000|Overall Study|Withdrawal by Subject|9|||
129999735|NCT00047320|467963620|FG000|Overall Study|Ineligible|2|||
129999736|NCT00866697|467963621|FG000|Overall Study|Study closed/terminated|156|||
129999737|NCT00866697|467963622|FG001|Overall Study|Study closed/terminated|138|||
129999738|NCT00866697|467963621|FG000|Overall Study|Lost to Follow-up|22|||
129999739|NCT00866697|467963622|FG001|Overall Study|Lost to Follow-up|28|||
129999740|NCT00866697|467963621|FG000|Overall Study|Physician Decision|3|||
129999741|NCT00866697|467963622|FG001|Overall Study|Physician Decision|5|||
129999742|NCT00866697|467963621|FG000|Overall Study|Withdrawal by Subject|33|||
129999743|NCT00866697|467963622|FG001|Overall Study|Withdrawal by Subject|57|||
129999744|NCT04376060|467963623|FG000|Overall Study|Physician Decision|1|||
129999745|NCT04275297|467963624|FG000|Overall Study|Lost to Follow-up|1|||
129999746|NCT04275297|467963625|FG001|Overall Study|Lost to Follow-up|1|||
129999747|NCT01521897|467965026|FG000|Overall Study|Protocol Violation|18|||
129999748|NCT01521897|467965026|FG000|Overall Study|Lost to Follow-up|5|||
129999749|NCT02194062|467965033|FG000|Overall Study|Lost to Follow-up|2|||
129999750|NCT02194062|467965034|FG001|Overall Study|Lost to Follow-up|2|||
129999751|NCT02194062|467965035|FG002|Overall Study|Lost to Follow-up|5|||
129999752|NCT02276872|467965036|FG000|Overall Study|Adverse Event|1|||
129999753|NCT02276872|467965037|FG001|Overall Study|Adverse Event|0|||
129999754|NCT02276872|467965038|FG002|Overall Study|Adverse Event|0|||
129999755|NCT04147234|467965039|FG000|Overall Study|Clinical deterioration|0|||
129999756|NCT04147234|467965040|FG001|Overall Study|Clinical deterioration|0|||
129999757|NCT04147234|467965041|FG002|Overall Study|Clinical deterioration|1|||
129999758|NCT04147234|467965042|FG003|Overall Study|Clinical deterioration|0|||
129999759|NCT04147234|467965043|FG004|Overall Study|Clinical deterioration|0|||
129999760|NCT04147234|467965044|FG005|Overall Study|Clinical deterioration|0|||
129999761|NCT04147234|467965045|FG006|Overall Study|Clinical deterioration|0|||
129999762|NCT04147234|467965039|FG000|Overall Study|Withdrawal by Subject|0|||
129999763|NCT04147234|467965040|FG001|Overall Study|Withdrawal by Subject|1|||
129999764|NCT04147234|467965041|FG002|Overall Study|Withdrawal by Subject|1|||
129999765|NCT04147234|467965042|FG003|Overall Study|Withdrawal by Subject|0|||
129999766|NCT04147234|467965043|FG004|Overall Study|Withdrawal by Subject|0|||
129999767|NCT04147234|467965044|FG005|Overall Study|Withdrawal by Subject|0|||
129999768|NCT04147234|467965045|FG006|Overall Study|Withdrawal by Subject|0|||
129999769|NCT04147234|467965039|FG000|Overall Study|Clinical disease progression|1|||
129999770|NCT04147234|467965040|FG001|Overall Study|Clinical disease progression|3|||
129999771|NCT04147234|467965041|FG002|Overall Study|Clinical disease progression|1|||
129999772|NCT04147234|467965042|FG003|Overall Study|Clinical disease progression|1|||
129999773|NCT04147234|467965043|FG004|Overall Study|Clinical disease progression|0|||
129999774|NCT04147234|467965044|FG005|Overall Study|Clinical disease progression|1|||
129999775|NCT04147234|467965045|FG006|Overall Study|Clinical disease progression|0|||
129999776|NCT04147234|467965039|FG000|Overall Study|Objective disease progression|6|||
129999777|NCT04147234|467965040|FG001|Overall Study|Objective disease progression|4|||
129999778|NCT04147234|467965041|FG002|Overall Study|Objective disease progression|3|||
129999779|NCT04147234|467965042|FG003|Overall Study|Objective disease progression|3|||
129999780|NCT04147234|467965043|FG004|Overall Study|Objective disease progression|5|||
129999781|NCT04147234|467965044|FG005|Overall Study|Objective disease progression|2|||
129999782|NCT04147234|467965045|FG006|Overall Study|Objective disease progression|3|||
130335556|NCT00505778|469199655|FG001|Overall Study|Adverse Event|7|||
130335557|NCT00505778|469199654|FG000|Overall Study|Physician Decision|8|||
130335558|NCT00505778|469199655|FG001|Overall Study|Physician Decision|14|||
130335559|NCT00505778|469199654|FG000|Overall Study|Lost to Follow-up|17|||
130335560|NCT00505778|469199655|FG001|Overall Study|Lost to Follow-up|23|||
130335561|NCT00505778|469199654|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
129999783|NCT04147234|467965039|FG000|Overall Study|Adverse Event|0|||
129999784|NCT04147234|467965040|FG001|Overall Study|Adverse Event|0|||
129999785|NCT04147234|467965041|FG002|Overall Study|Adverse Event|0|||
129999786|NCT04147234|467965042|FG003|Overall Study|Adverse Event|0|||
129999787|NCT04147234|467965043|FG004|Overall Study|Adverse Event|1|||
129999788|NCT04147234|467965044|FG005|Overall Study|Adverse Event|0|||
129999789|NCT04147234|467965045|FG006|Overall Study|Adverse Event|0|||
129999790|NCT02596620|467965046|FG000|Overall Study|Lost to Follow-up|1|||
129999791|NCT02596620|467965047|FG001|Overall Study|Lost to Follow-up|1|||
129999792|NCT00867113|467965048|FG000|Treatment Period|Adverse Event|15|||
130335562|NCT00505778|469199655|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
129999793|NCT00867113|467965048|FG000|Treatment Period|Death|2|||
129999794|NCT00867113|467965048|FG000|Treatment Period|Withdrawal by Subject|19|||
129999795|NCT00867113|467965048|FG000|Treatment Period|Lost to Follow-up|3|||
129999796|NCT00867113|467965048|FG000|Treatment Period|Administrative problems|1|||
129999797|NCT00867113|467965048|FG000|Treatment Period|Disease progression/relapse|1|||
129999798|NCT00867113|467965048|FG000|Treatment Period|Protocol Violation|4|||
129999799|NCT00867113|467965048|FG000|Post Treatment After Survival Follow-up|Death|1|||
129999800|NCT00867113|467965048|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
129999801|NCT00867113|467965048|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
129999802|NCT00867113|467965048|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
129999803|NCT01886313|467965049|FG000|Overall Study|Adverse Event|1|||
129999804|NCT01886313|467965050|FG001|Overall Study|Adverse Event|1|||
129999805|NCT00634010|467965054|FG000|Overall Study|Adverse Event|2|||
129999806|NCT00634010|467965055|FG001|Overall Study|Adverse Event|5|||
129999807|NCT00634010|467965054|FG000|Overall Study|Withdrawal by Subject|5|||
129999808|NCT00634010|467965055|FG001|Overall Study|Withdrawal by Subject|6|||
129999809|NCT00634010|467965054|FG000|Overall Study|Physician Decision|1|||
129999810|NCT00634010|467965055|FG001|Overall Study|Physician Decision|1|||
129999811|NCT00634010|467965054|FG000|Overall Study|Disease Progression|1|||
129999812|NCT00634010|467965055|FG001|Overall Study|Disease Progression|1|||
129999813|NCT00634010|467965054|FG000|Overall Study|Non-Compliant|1|||
129999814|NCT00634010|467965055|FG001|Overall Study|Non-Compliant|1|||
129999815|NCT02066051|467965059|FG000|Overall Study|Subject developed active GVHD|1|||
129999816|NCT01272947|467965060|FG000|Overall Study|Abnormal Laboratory Value|2|||
129999817|NCT01272947|467965061|FG001|Overall Study|Abnormal Laboratory Value|2|||
129999818|NCT02510560|467965063|FG000|Overall Study|Discontinued from Treatment|27|||
129999819|NCT02510560|467965064|FG001|Overall Study|Discontinued from Treatment|18|||
129999820|NCT02510560|467965065|FG002|Overall Study|Discontinued from Treatment|19|||
129999821|NCT02510560|467965063|FG000|Overall Study|Other|4|||
129999822|NCT02510560|467965064|FG001|Overall Study|Other|4|||
129999823|NCT02510560|467965065|FG002|Overall Study|Other|3|||
129999824|NCT00132496|467965066|FG000|Overall Study|Withdrawal by Subject|1|||
129999825|NCT00132496|467965067|FG001|Overall Study|Withdrawal by Subject|2|||
129999826|NCT00132496|467965066|FG000|Overall Study|Physician Decision|1|||
129999827|NCT00132496|467965067|FG001|Overall Study|Physician Decision|0|||
129999828|NCT01093625|467965072|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
129999829|NCT01093625|467965073|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
129999830|NCT01093625|467965072|FG000|2-Week Visit|Withdrawal by Subject|1|||
129999831|NCT01093625|467965073|FG001|2-Week Visit|Withdrawal by Subject|0|||
129999832|NCT01093625|467965072|FG000|1-Month Visit|Lost to Follow-up|2|||
129999833|NCT01093625|467965073|FG001|1-Month Visit|Lost to Follow-up|0|||
129999834|NCT01093625|467965072|FG000|3-Month Visit|Lost to Follow-up|2|||
129999835|NCT01093625|467965073|FG001|3-Month Visit|Lost to Follow-up|0|||
129999836|NCT01093625|467965072|FG000|6-Month Visit|Withdrawal by Subject|6|||
129999837|NCT01093625|467965073|FG001|6-Month Visit|Withdrawal by Subject|7|||
129999838|NCT01093625|467965072|FG000|6-Month Visit|Lost to Follow-up|2|||
129999839|NCT01093625|467965073|FG001|6-Month Visit|Lost to Follow-up|2|||
129999840|NCT01093625|467965072|FG000|1-Year Visit|Lost to Follow-up|5|||
129999841|NCT01093625|467965073|FG001|1-Year Visit|Lost to Follow-up|3|||
129999842|NCT01431534|467965076|FG000|Treatment Phase|Adverse Event|0|||
129999843|NCT01431534|467965077|FG001|Treatment Phase|Adverse Event|0|||
129999844|NCT01431534|467965078|FG002|Treatment Phase|Adverse Event|1|||
129999845|NCT01431534|467965076|FG000|Treatment Phase|Progressive Disease|4|||
129999846|NCT01431534|467965077|FG001|Treatment Phase|Progressive Disease|3|||
129999847|NCT01431534|467965078|FG002|Treatment Phase|Progressive Disease|10|||
129999848|NCT02554903|467965081|FG000|Overall Study|Death|1|||
129999849|NCT02554903|467965082|FG001|Overall Study|Death|1|||
129999850|NCT02554903|467965081|FG000|Overall Study|Physician Decision|2|||
129999851|NCT02554903|467965082|FG001|Overall Study|Physician Decision|2|||
129999852|NCT02554903|467965081|FG000|Overall Study|Heart Transplant|1|||
129999853|NCT02554903|467965082|FG001|Overall Study|Heart Transplant|2|||
129999854|NCT02742766|467965083|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999855|NCT02742766|467965084|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999856|NCT02742766|467965085|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999857|NCT02742766|467965086|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999858|NCT02742766|467965087|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999859|NCT02742766|467965088|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999860|NCT02742766|467965089|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999861|NCT02742766|467965090|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999862|NCT02742766|467965091|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999863|NCT02742766|467965092|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999864|NCT02742766|467965093|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999865|NCT02742766|467965094|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999866|NCT02742766|467965095|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999867|NCT02742766|467965096|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
129999868|NCT02742766|467965097|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999869|NCT02742766|467965098|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999870|NCT02742766|467965099|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999871|NCT02742766|467965100|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129999872|NCT02742766|467965101|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
130335563|NCT00505778|469199654|FG000|Overall Study|Protocol Violation|7|||
130335564|NCT00505778|469199655|FG001|Overall Study|Protocol Violation|9|||
130335565|NCT00505778|469199654|FG000|Overall Study|Withdrawal by Subject|29|||
130335566|NCT00505778|469199655|FG001|Overall Study|Withdrawal by Subject|14|||
130335567|NCT00505778|469199654|FG000|Overall Study|Relapse|65|||
130335568|NCT00505778|469199655|FG001|Overall Study|Relapse|65|||
130335569|NCT00505778|469199654|FG000|Overall Study|Took No Study Drug|2|||
130335570|NCT00505778|469199655|FG001|Overall Study|Took No Study Drug|2|||
130335571|NCT05367492|469199657|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
130335572|NCT05367492|469199658|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
130335573|NCT05367492|469199659|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
130335574|NCT05367492|469199657|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
130335575|NCT05367492|469199658|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
130335576|NCT05367492|469199659|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
130335577|NCT05367492|469199657|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
130335578|NCT05367492|469199658|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
130335579|NCT05367492|469199659|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
130335580|NCT05367492|469199657|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
130335581|NCT05367492|469199658|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
130335582|NCT05367492|469199659|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
130335583|NCT00808080|469199661|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
130335584|NCT00423917|469199664|FG000|Overall Study|Cancel|2|||
130335585|NCT00423917|469199664|FG000|Overall Study|Ineligible|1|||
130335586|NCT03085797|469199665|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
130335587|NCT03085797|469199666|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
130335588|NCT03085797|469199665|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
130335589|NCT03085797|469199666|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
130335590|NCT03085797|469199665|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
130335591|NCT03085797|469199666|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
130335592|NCT01837823|469199667|FG000|Overall Study|Lost to Follow-up|6|||
130335593|NCT00436345|469199672|FG000|Overall Study|ICU resident beyond follow-up period|3|||
130335594|NCT00436345|469199673|FG001|Overall Study|ICU resident beyond follow-up period|0|||
130335595|NCT01175083|469199674|FG000|Primary Epoch|Withdrawal by Subject|0|||
130335596|NCT01175083|469199675|FG001|Primary Epoch|Withdrawal by Subject|0|||
130335597|NCT01175083|469199676|FG002|Primary Epoch|Withdrawal by Subject|0|||
130335598|NCT01175083|469199677|FG003|Primary Epoch|Withdrawal by Subject|0|||
130335599|NCT01175083|469199678|FG004|Primary Epoch|Withdrawal by Subject|0|||
130335600|NCT01175083|469199679|FG005|Primary Epoch|Withdrawal by Subject|2|||
130335601|NCT01175083|469199674|FG000|Primary Epoch|Lost to Follow-up|0|||
130335602|NCT01175083|469199675|FG001|Primary Epoch|Lost to Follow-up|0|||
130335603|NCT01175083|469199676|FG002|Primary Epoch|Lost to Follow-up|0|||
130335604|NCT01175083|469199677|FG003|Primary Epoch|Lost to Follow-up|0|||
130335605|NCT01175083|469199678|FG004|Primary Epoch|Lost to Follow-up|0|||
130335606|NCT01175083|469199679|FG005|Primary Epoch|Lost to Follow-up|1|||
130335607|NCT01175083|469199674|FG000|Booster Epoch|Death|0|||
130335608|NCT01175083|469199675|FG001|Booster Epoch|Death|0|||
130335609|NCT01175083|469199676|FG002|Booster Epoch|Death|1|||
130335610|NCT01175083|469199677|FG003|Booster Epoch|Death|0|||
130335611|NCT01175083|469199678|FG004|Booster Epoch|Death|0|||
130335612|NCT01175083|469199679|FG005|Booster Epoch|Death|0|||
130335613|NCT01175083|469199674|FG000|Booster Epoch|Withdrawal by Subject|0|||
130335614|NCT01175083|469199675|FG001|Booster Epoch|Withdrawal by Subject|0|||
130335615|NCT01175083|469199676|FG002|Booster Epoch|Withdrawal by Subject|0|||
130335616|NCT01175083|469199677|FG003|Booster Epoch|Withdrawal by Subject|1|||
130335617|NCT01175083|469199678|FG004|Booster Epoch|Withdrawal by Subject|0|||
130335618|NCT01175083|469199679|FG005|Booster Epoch|Withdrawal by Subject|0|||
130335619|NCT00475306|469199680|FG000|Overall Study|Protocol Violation|1|||
130335620|NCT00475306|469199681|FG001|Overall Study|Protocol Violation|1|||
130335621|NCT00475306|469199682|FG002|Overall Study|Protocol Violation|0|||
130335622|NCT00475306|469199683|FG003|Overall Study|Protocol Violation|1|||
130335623|NCT01716052|469199684|FG000|Overall Study|Withdrawal of funding|1|||
130335624|NCT01716052|469199685|FG001|Overall Study|Withdrawal of funding|1|||
130335625|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
130335626|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
130335627|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
130335628|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
130335629|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
130335630|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
130335631|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
129999873|NCT02742766|467965083|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
130335632|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
130335633|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
130335634|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
129999874|NCT02742766|467965084|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999875|NCT02742766|467965085|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999876|NCT02742766|467965086|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999877|NCT02742766|467965087|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999878|NCT02742766|467965088|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999879|NCT02742766|467965089|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999880|NCT02742766|467965090|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999881|NCT02742766|467965091|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999882|NCT02742766|467965092|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999883|NCT02742766|467965093|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999884|NCT02742766|467965094|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999885|NCT02742766|467965095|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
129999886|NCT02742766|467965096|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
129999887|NCT02742766|467965097|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
130335635|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
130335636|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
129999888|NCT02742766|467965098|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
129999889|NCT02742766|467965099|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999890|NCT02742766|467965100|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999891|NCT02742766|467965101|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
129999892|NCT04427501|467965102|FG000|Overall Study|Death|0|||
129999893|NCT04427501|467965103|FG001|Overall Study|Death|0|||
129999894|NCT04427501|467965104|FG002|Overall Study|Death|0|||
130335637|NCT02405442|469199686|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130335638|NCT02405442|469199687|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
129999895|NCT04427501|467965105|FG003|Overall Study|Death|0|||
129999896|NCT04427501|467965106|FG004|Overall Study|Death|0|||
129999897|NCT04427501|467965107|FG005|Overall Study|Death|15|||
130335639|NCT02405442|469199688|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130335640|NCT02405442|469199689|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
130335641|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
130335642|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
130335643|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
130335644|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
130335645|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
130335646|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
130335647|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
130335648|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
130335649|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
130335650|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
130335651|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
130335652|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
130335653|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
130335654|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
130335655|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
130335656|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
130335657|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130335658|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
130335659|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130335660|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
130335661|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130335662|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
130335663|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130335664|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
130335665|NCT02405442|469199686|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130335666|NCT02405442|469199687|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
130335667|NCT02405442|469199688|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130335668|NCT02405442|469199689|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
130335669|NCT02405442|469199686|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130335670|NCT02405442|469199687|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
129999898|NCT04427501|467965108|FG006|Overall Study|Death|0|||
129999899|NCT04427501|467965109|FG007|Overall Study|Death|0|||
129999900|NCT04427501|467965110|FG008|Overall Study|Death|0|||
129999901|NCT04427501|467965111|FG009|Overall Study|Death|0|||
129999902|NCT04427501|467965112|FG010|Overall Study|Death|0|||
129999903|NCT04427501|467965113|FG011|Overall Study|Death|0|||
130216134|NCT02030119|468753958|FG003|Overall Study|Withdrawal by Subject|3|||
129999904|NCT04427501|467965102|FG000|Overall Study|Lost to Follow-up|5|||
129999905|NCT04427501|467965103|FG001|Overall Study|Lost to Follow-up|1|||
129999906|NCT04427501|467965104|FG002|Overall Study|Lost to Follow-up|2|||
129999907|NCT04427501|467965105|FG003|Overall Study|Lost to Follow-up|0|||
129999908|NCT04427501|467965106|FG004|Overall Study|Lost to Follow-up|2|||
129999909|NCT04427501|467965107|FG005|Overall Study|Lost to Follow-up|11|||
129999910|NCT04427501|467965108|FG006|Overall Study|Lost to Follow-up|10|||
129999911|NCT04427501|467965109|FG007|Overall Study|Lost to Follow-up|10|||
129999912|NCT04427501|467965110|FG008|Overall Study|Lost to Follow-up|2|||
129999913|NCT04427501|467965111|FG009|Overall Study|Lost to Follow-up|5|||
129999914|NCT04427501|467965112|FG010|Overall Study|Lost to Follow-up|2|||
129999915|NCT04427501|467965113|FG011|Overall Study|Lost to Follow-up|0|||
129999916|NCT04427501|467965102|FG000|Overall Study|Physician Decision|0|||
129999917|NCT04427501|467965103|FG001|Overall Study|Physician Decision|3|||
129999918|NCT04427501|467965104|FG002|Overall Study|Physician Decision|0|||
129999919|NCT04427501|467965105|FG003|Overall Study|Physician Decision|0|||
129999920|NCT04427501|467965106|FG004|Overall Study|Physician Decision|0|||
129999921|NCT04427501|467965107|FG005|Overall Study|Physician Decision|0|||
129999922|NCT04427501|467965108|FG006|Overall Study|Physician Decision|2|||
129999923|NCT04427501|467965109|FG007|Overall Study|Physician Decision|0|||
129999924|NCT04427501|467965110|FG008|Overall Study|Physician Decision|0|||
129999925|NCT04427501|467965111|FG009|Overall Study|Physician Decision|0|||
129999926|NCT04427501|467965112|FG010|Overall Study|Physician Decision|0|||
129999927|NCT04427501|467965113|FG011|Overall Study|Physician Decision|0|||
129999928|NCT04427501|467965102|FG000|Overall Study|Withdrawal by Subject|9|||
129999929|NCT04427501|467965103|FG001|Overall Study|Withdrawal by Subject|2|||
129999930|NCT04427501|467965104|FG002|Overall Study|Withdrawal by Subject|2|||
129999931|NCT04427501|467965105|FG003|Overall Study|Withdrawal by Subject|3|||
129999932|NCT04427501|467965106|FG004|Overall Study|Withdrawal by Subject|7|||
129999933|NCT04427501|467965107|FG005|Overall Study|Withdrawal by Subject|25|||
129999934|NCT04427501|467965108|FG006|Overall Study|Withdrawal by Subject|15|||
129999935|NCT04427501|467965109|FG007|Overall Study|Withdrawal by Subject|7|||
129999936|NCT04427501|467965110|FG008|Overall Study|Withdrawal by Subject|4|||
129999937|NCT04427501|467965111|FG009|Overall Study|Withdrawal by Subject|1|||
129999938|NCT04427501|467965112|FG010|Overall Study|Withdrawal by Subject|4|||
129999939|NCT04427501|467965113|FG011|Overall Study|Withdrawal by Subject|0|||
129999940|NCT04427501|467965102|FG000|Overall Study|Other - as reported by the investigator|1|||
129999941|NCT04427501|467965103|FG001|Overall Study|Other - as reported by the investigator|0|||
129999942|NCT04427501|467965104|FG002|Overall Study|Other - as reported by the investigator|0|||
129999943|NCT04427501|467965105|FG003|Overall Study|Other - as reported by the investigator|0|||
129999944|NCT04427501|467965106|FG004|Overall Study|Other - as reported by the investigator|0|||
129999945|NCT04427501|467965107|FG005|Overall Study|Other - as reported by the investigator|6|||
129999946|NCT04427501|467965108|FG006|Overall Study|Other - as reported by the investigator|6|||
129999947|NCT04427501|467965109|FG007|Overall Study|Other - as reported by the investigator|0|||
129999948|NCT04427501|467965110|FG008|Overall Study|Other - as reported by the investigator|0|||
129999949|NCT04427501|467965111|FG009|Overall Study|Other - as reported by the investigator|0|||
129999950|NCT04427501|467965112|FG010|Overall Study|Other - as reported by the investigator|0|||
129999951|NCT04427501|467965113|FG011|Overall Study|Other - as reported by the investigator|0|||
129999952|NCT04427501|467965102|FG000|Overall Study|Other|0|||
129999953|NCT04427501|467965103|FG001|Overall Study|Other|0|||
129999954|NCT04427501|467965104|FG002|Overall Study|Other|0|||
129999955|NCT04427501|467965105|FG003|Overall Study|Other|0|||
129999956|NCT04427501|467965106|FG004|Overall Study|Other|0|||
129999957|NCT04427501|467965107|FG005|Overall Study|Other|0|||
129999958|NCT04427501|467965108|FG006|Overall Study|Other|0|||
129999959|NCT04427501|467965109|FG007|Overall Study|Other|0|||
129999960|NCT04427501|467965110|FG008|Overall Study|Other|0|||
129999961|NCT04427501|467965111|FG009|Overall Study|Other|0|||
129999962|NCT04427501|467965112|FG010|Overall Study|Other|0|||
129999963|NCT04427501|467965113|FG011|Overall Study|Other|1|||
129999964|NCT02846532|467965117|FG000|Overall Study|Lost to Follow-up|0|||
129999965|NCT02846532|467965118|FG001|Overall Study|Lost to Follow-up|1|||
129999966|NCT02846532|467965119|FG002|Overall Study|Lost to Follow-up|1|||
129999967|NCT02846532|467965117|FG000|Overall Study|Withdrawal by Subject|1|||
129999968|NCT02846532|467965118|FG001|Overall Study|Withdrawal by Subject|2|||
129999969|NCT02846532|467965119|FG002|Overall Study|Withdrawal by Subject|0|||
129999970|NCT03951220|467965120|FG000|Overall Study|Withdrawal by Subject|9|||
129999971|NCT03951220|467965121|FG001|Overall Study|Withdrawal by Subject|2|||
129999972|NCT03951220|467965122|FG002|Overall Study|Withdrawal by Subject|0|||
129999973|NCT06132425|467965123|FG000|Overall Study|Withdrawal by Subject|3|||
129999974|NCT06132425|467965124|FG001|Overall Study|Withdrawal by Subject|0|||
129999975|NCT06132425|467965123|FG000|Overall Study|Did not follow study instructions|0|||
129999976|NCT06132425|467965124|FG001|Overall Study|Did not follow study instructions|2|||
129999977|NCT06132425|467965123|FG000|Overall Study|Lost to Follow-up|3|||
129999978|NCT06132425|467965124|FG001|Overall Study|Lost to Follow-up|5|||
129999979|NCT05579990|467965130|FG000|Overall Study|Lost to Follow-up|3|||
129999980|NCT01019980|467965133|FG000|Overall Study|Drug not available.|2|||
129999981|NCT01019980|467965134|FG001|Overall Study|Drug not available.|0|||
129999982|NCT02383589|467965150|FG000|Treatment Period|Adverse Event|1|||
129999983|NCT02383589|467965151|FG001|Treatment Period|Adverse Event|3|||
129999984|NCT02383589|467965150|FG000|Treatment Period|Lost to Follow-up|0|||
129999985|NCT02383589|467965151|FG001|Treatment Period|Lost to Follow-up|1|||
129999986|NCT02383589|467965150|FG000|Treatment Period|Withdrawal by Subject|0|||
129999987|NCT02383589|467965151|FG001|Treatment Period|Withdrawal by Subject|5|||
129999988|NCT02383589|467965150|FG000|Treatment Period|Non-compliance with study drug|0|||
129999989|NCT02383589|467965151|FG001|Treatment Period|Non-compliance with study drug|1|||
129999990|NCT02383589|467965150|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
129999991|NCT02383589|467965151|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
129999992|NCT02383589|467965150|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
129999993|NCT02383589|467965151|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
129999994|NCT02383589|467965150|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
129999995|NCT02383589|467965151|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
129999996|NCT04225806|467965152|FG000|Overall Study|Trial termination|15|||
129999997|NCT02408861|467965153|FG000|Overall Study|Death|0|||
129999998|NCT02408861|467965154|FG001|Overall Study|Death|3|||
129999999|NCT02408861|467965155|FG002|Overall Study|Death|1|||
130000000|NCT02408861|467965156|FG003|Overall Study|Death|2|||
130000001|NCT02408861|467965157|FG004|Overall Study|Death|4|||
130000002|NCT02408861|467965158|FG005|Overall Study|Death|1|||
130000003|NCT02408861|467965159|FG006|Overall Study|Death|0|||
130000004|NCT02408861|467965153|FG000|Overall Study|Lost to Follow-up|0|||
130000005|NCT02408861|467965154|FG001|Overall Study|Lost to Follow-up|0|||
130000006|NCT02408861|467965155|FG002|Overall Study|Lost to Follow-up|1|||
130000007|NCT02408861|467965156|FG003|Overall Study|Lost to Follow-up|1|||
130000008|NCT02408861|467965157|FG004|Overall Study|Lost to Follow-up|4|||
130000009|NCT02408861|467965158|FG005|Overall Study|Lost to Follow-up|2|||
130000010|NCT02408861|467965159|FG006|Overall Study|Lost to Follow-up|1|||
130000011|NCT02408861|467965153|FG000|Overall Study|Disease Progression|0|||
130000012|NCT02408861|467965154|FG001|Overall Study|Disease Progression|0|||
130000013|NCT02408861|467965155|FG002|Overall Study|Disease Progression|1|||
130000014|NCT02408861|467965156|FG003|Overall Study|Disease Progression|0|||
130000015|NCT02408861|467965157|FG004|Overall Study|Disease Progression|3|||
130000016|NCT02408861|467965158|FG005|Overall Study|Disease Progression|1|||
130000017|NCT02408861|467965159|FG006|Overall Study|Disease Progression|1|||
130000018|NCT02408861|467965153|FG000|Overall Study|Adverse Event|1|||
130000019|NCT02408861|467965154|FG001|Overall Study|Adverse Event|0|||
130000020|NCT02408861|467965155|FG002|Overall Study|Adverse Event|1|||
130000021|NCT02408861|467965156|FG003|Overall Study|Adverse Event|0|||
130000022|NCT02408861|467965157|FG004|Overall Study|Adverse Event|2|||
130000023|NCT02408861|467965158|FG005|Overall Study|Adverse Event|0|||
130335671|NCT02405442|469199688|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130335672|NCT02405442|469199689|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
130335673|NCT02405442|469199686|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130335674|NCT02405442|469199687|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
130335675|NCT02405442|469199688|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130335676|NCT02405442|469199689|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
130335677|NCT02405442|469199686|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
130335678|NCT02405442|469199687|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130335679|NCT02405442|469199688|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130335680|NCT02405442|469199689|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
130335681|NCT02078960|469199690|FG000|Treatment Period|Other|0|||
130335682|NCT02078960|469199691|FG001|Treatment Period|Other|0|||
130335683|NCT02078960|469199692|FG002|Treatment Period|Other|1|||
130335684|NCT02078960|469199690|FG000|Treatment Period|Lack of Efficacy|0|||
130335685|NCT02078960|469199691|FG001|Treatment Period|Lack of Efficacy|1|||
130335686|NCT02078960|469199692|FG002|Treatment Period|Lack of Efficacy|0|||
130335687|NCT02078960|469199690|FG000|Treatment Period|Disease progression - accelerated phase|0|||
130335688|NCT02078960|469199691|FG001|Treatment Period|Disease progression - accelerated phase|1|||
130335689|NCT02078960|469199692|FG002|Treatment Period|Disease progression - accelerated phase|0|||
130335690|NCT02078960|469199690|FG000|Treatment Period|Disease progression - blast phase|1|||
130335691|NCT02078960|469199691|FG001|Treatment Period|Disease progression - blast phase|0|||
130335692|NCT02078960|469199692|FG002|Treatment Period|Disease progression - blast phase|0|||
130335693|NCT02078960|469199690|FG000|Treatment Period|Withdrawal by Subject|0|||
130335694|NCT02078960|469199691|FG001|Treatment Period|Withdrawal by Subject|1|||
130335695|NCT02078960|469199692|FG002|Treatment Period|Withdrawal by Subject|1|||
130335696|NCT02078960|469199690|FG000|Treatment Period|Adverse Event|1|||
130335697|NCT02078960|469199691|FG001|Treatment Period|Adverse Event|0|||
130335698|NCT02078960|469199692|FG002|Treatment Period|Adverse Event|0|||
130000024|NCT02408861|467965159|FG006|Overall Study|Adverse Event|0|||
130000025|NCT02408861|467965153|FG000|Overall Study|Physician Decision|1|||
130000026|NCT02408861|467965154|FG001|Overall Study|Physician Decision|1|||
130335699|NCT02078960|469199690|FG000|Treatment Period|Death|0|||
130335700|NCT02078960|469199691|FG001|Treatment Period|Death|0|||
130000027|NCT02408861|467965155|FG002|Overall Study|Physician Decision|1|||
130000028|NCT02408861|467965156|FG003|Overall Study|Physician Decision|0|||
130000029|NCT02408861|467965157|FG004|Overall Study|Physician Decision|0|||
130335701|NCT02078960|469199692|FG002|Treatment Period|Death|1|||
130335702|NCT02078960|469199690|FG000|Follow-up Period|Death|2|||
130335703|NCT02078960|469199691|FG001|Follow-up Period|Death|0|||
130335704|NCT02078960|469199692|FG002|Follow-up Period|Death|0|||
130335705|NCT02078960|469199690|FG000|Follow-up Period|Lost to Follow-up|0|||
130335706|NCT02078960|469199691|FG001|Follow-up Period|Lost to Follow-up|1|||
130335707|NCT02078960|469199692|FG002|Follow-up Period|Lost to Follow-up|0|||
130335708|NCT03275350|469199694|FG000|Overall Study|Lost to Follow-up|4|||
130335709|NCT03275350|469199695|FG001|Overall Study|Lost to Follow-up|6|||
130335710|NCT03275350|469199694|FG000|Overall Study|Death|2|||
130335711|NCT03275350|469199695|FG001|Overall Study|Death|1|||
130335712|NCT03275350|469199694|FG000|Overall Study|Physician Decision|1|||
130335713|NCT03275350|469199695|FG001|Overall Study|Physician Decision|0|||
130335714|NCT03275350|469199694|FG000|Overall Study|Incarcerated|1|||
130335715|NCT03275350|469199695|FG001|Overall Study|Incarcerated|1|||
130335716|NCT00975689|469199698|FG000|Overall Study|Adverse Event|0|||
129884309|NCT01129336|467536334|FG001|Overall Study|Disease Progression|4|||
129884310|NCT01129336|467536333|FG000|Overall Study|Lost to Follow-up|1|||
129884311|NCT01129336|467536334|FG001|Overall Study|Lost to Follow-up|0|||
129884312|NCT01129336|467536333|FG000|Overall Study|Withdrawal by Subject|7|||
129884313|NCT01129336|467536334|FG001|Overall Study|Withdrawal by Subject|4|||
129884314|NCT01129336|467536333|FG000|Overall Study|Adverse Event|0|||
129884315|NCT01129336|467536334|FG001|Overall Study|Adverse Event|1|||
129884316|NCT01129336|467536333|FG000|Overall Study|Missing Study Completion Status|2|||
129884317|NCT01129336|467536334|FG001|Overall Study|Missing Study Completion Status|3|||
129884318|NCT01129336|467536333|FG000|Overall Study|Death|0|||
129884319|NCT01129336|467536334|FG001|Overall Study|Death|4|||
129884320|NCT00358150|467536335|FG000|Overall Study|Adverse Event|3|||
129884321|NCT00358150|467536335|FG000|Overall Study|Withdrawal by Subject|1|||
129884322|NCT00358150|467536335|FG000|Overall Study|Undefined|3|||
129884323|NCT04668989|467536336|FG000|First Intervention|Covid-19 related self-isolation|0|||
129884324|NCT04668989|467536337|FG001|First Intervention|Covid-19 related self-isolation|1|||
129884325|NCT04668989|467536336|FG000|Second Intervention|Adverse Event|0|||
129884326|NCT04668989|467536337|FG001|Second Intervention|Adverse Event|1|||
129884327|NCT00179010|467536341|FG000|Overall Study|Muscle probe defective|1|||
129884328|NCT00179010|467536342|FG001|Overall Study|Muscle probe defective|1|||
129884329|NCT00179010|467536341|FG000|Overall Study|Failure to place arterial line|0|||
129884330|NCT00179010|467536342|FG001|Overall Study|Failure to place arterial line|1|||
129884331|NCT01622348|467536343|FG000|Overall Study|Withdrawal by Subject|1|||
129884332|NCT01622348|467536344|FG001|Overall Study|Withdrawal by Subject|0|||
129884333|NCT01622348|467536345|FG002|Overall Study|Withdrawal by Subject|1|||
129884334|NCT01592695|467536354|FG000|Overall Study|Lost to Follow-up|8|||
129884335|NCT01592695|467536355|FG001|Overall Study|Lost to Follow-up|4|||
129884336|NCT00919893|467536362|FG000|Overall Study|Protocol Violation|19|||
129884337|NCT00919893|467536363|FG001|Overall Study|Protocol Violation|9|||
129884338|NCT01375959|467536369|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
129884339|NCT01375959|467536370|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
129884340|NCT01375959|467536369|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
129884341|NCT01375959|467536370|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
129884342|NCT01375959|467536369|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129884343|NCT01375959|467536370|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
129884344|NCT00178256|467536371|FG000|Overall Study|Adverse Event|2|||
129884345|NCT00178256|467536372|FG001|Overall Study|Adverse Event|0|||
129884346|NCT00178256|467536373|FG002|Overall Study|Adverse Event|0|||
129884347|NCT00178256|467536374|FG003|Overall Study|Adverse Event|0|||
129884348|NCT00178256|467536371|FG000|Overall Study|Death|0|||
129884349|NCT00178256|467536372|FG001|Overall Study|Death|1|||
129884350|NCT00178256|467536373|FG002|Overall Study|Death|0|||
129884351|NCT00178256|467536374|FG003|Overall Study|Death|1|||
129884352|NCT00178256|467536371|FG000|Overall Study|Cancer progression|2|||
129884353|NCT00178256|467536372|FG001|Overall Study|Cancer progression|0|||
129884354|NCT00178256|467536373|FG002|Overall Study|Cancer progression|0|||
129884355|NCT00178256|467536374|FG003|Overall Study|Cancer progression|1|||
129884356|NCT01763788|467536375|FG000|Overall Study|Lost to Follow-up|0|||
129884357|NCT01763788|467536376|FG001|Overall Study|Lost to Follow-up|0|||
130000030|NCT02408861|467965158|FG005|Overall Study|Physician Decision|1|||
129884358|NCT01763788|467536377|FG002|Overall Study|Lost to Follow-up|1|||
129884359|NCT01763788|467536378|FG003|Overall Study|Lost to Follow-up|0|||
129884360|NCT03893825|467536379|FG000|Overall Study|Death|2|||
129884361|NCT03893825|467536380|FG001|Overall Study|Death|1|||
129884362|NCT03893825|467536379|FG000|Overall Study|Adverse Event|0|||
129884363|NCT03893825|467536380|FG001|Overall Study|Adverse Event|2|||
129884364|NCT03893825|467536379|FG000|Overall Study|Withdrawal by Subject|19|||
129884365|NCT03893825|467536380|FG001|Overall Study|Withdrawal by Subject|21|||
129884366|NCT03893825|467536379|FG000|Overall Study|Protocol deviation|1|||
129884367|NCT03893825|467536380|FG001|Overall Study|Protocol deviation|0|||
129884368|NCT03893825|467536379|FG000|Overall Study|Lost to Follow-up|10|||
130335717|NCT00975689|469199699|FG001|Overall Study|Adverse Event|3|||
129884369|NCT03893825|467536380|FG001|Overall Study|Lost to Follow-up|10|||
130000031|NCT02408861|467965159|FG006|Overall Study|Physician Decision|0|||
130000032|NCT02408861|467965153|FG000|Overall Study|Protocol Violation|1|||
130000033|NCT02408861|467965154|FG001|Overall Study|Protocol Violation|0|||
130000034|NCT02408861|467965155|FG002|Overall Study|Protocol Violation|0|||
130000035|NCT02408861|467965156|FG003|Overall Study|Protocol Violation|0|||
130000036|NCT02408861|467965157|FG004|Overall Study|Protocol Violation|0|||
130000037|NCT02408861|467965158|FG005|Overall Study|Protocol Violation|0|||
130000038|NCT02408861|467965159|FG006|Overall Study|Protocol Violation|0|||
130000039|NCT02408861|467965153|FG000|Overall Study|Withdrawal by Subject|0|||
130000040|NCT02408861|467965154|FG001|Overall Study|Withdrawal by Subject|0|||
130000041|NCT02408861|467965155|FG002|Overall Study|Withdrawal by Subject|0|||
130000042|NCT02408861|467965156|FG003|Overall Study|Withdrawal by Subject|0|||
130000043|NCT02408861|467965157|FG004|Overall Study|Withdrawal by Subject|1|||
130000044|NCT02408861|467965158|FG005|Overall Study|Withdrawal by Subject|1|||
130000045|NCT02408861|467965159|FG006|Overall Study|Withdrawal by Subject|0|||
130000046|NCT02408861|467965153|FG000|Overall Study|Other Treatment|0|||
130000047|NCT02408861|467965154|FG001|Overall Study|Other Treatment|0|||
130000048|NCT02408861|467965155|FG002|Overall Study|Other Treatment|0|||
130000049|NCT02408861|467965156|FG003|Overall Study|Other Treatment|0|||
130000050|NCT02408861|467965157|FG004|Overall Study|Other Treatment|0|||
130000051|NCT02408861|467965158|FG005|Overall Study|Other Treatment|1|||
130000052|NCT02408861|467965159|FG006|Overall Study|Other Treatment|1|||
130000053|NCT05460273|467965160|FG000|Overall Study|Death|43|||
130000054|NCT05460273|467965161|FG001|Overall Study|Death|9|||
130000055|NCT05460273|467965160|FG000|Overall Study|Lost to Follow-up|7|||
130000056|NCT05460273|467965161|FG001|Overall Study|Lost to Follow-up|0|||
130000057|NCT05460273|467965160|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
130000058|NCT05460273|467965161|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
130000059|NCT04124614|467965162|FG000|Placebo Run-in Period|Not Randomized|34|||
130335718|NCT00975689|469199698|FG000|Overall Study|Withdrawal by Subject|1|||
130335719|NCT00975689|469199699|FG001|Overall Study|Withdrawal by Subject|0|||
130335720|NCT00975689|469199698|FG000|Overall Study|Physician Decision|1|||
130335721|NCT00975689|469199699|FG001|Overall Study|Physician Decision|0|||
130335722|NCT02597478|469199704|FG000|Overall Study|Withdrawal by Subject|2|||
130000060|NCT04124614|467965163|FG001|Placebo Run-in Period|Not Randomized|0|||
130000061|NCT04124614|467965164|FG002|Placebo Run-in Period|Not Randomized|0|||
130335723|NCT02597478|469199705|FG001|Overall Study|Withdrawal by Subject|0|||
130335724|NCT02597478|469199704|FG000|Overall Study|Change of opioid dose|1|||
130335725|NCT02597478|469199705|FG001|Overall Study|Change of opioid dose|0|||
130335726|NCT02597478|469199704|FG000|Overall Study|Insufficient exertional dyspnea|0|||
130335727|NCT02597478|469199705|FG001|Overall Study|Insufficient exertional dyspnea|1|||
130335728|NCT01652469|469199706|FG000|Overall Study|Withdrawal by Subject|1|||
130335729|NCT01652469|469199707|FG001|Overall Study|Withdrawal by Subject|4|||
130335730|NCT01652469|469199706|FG000|Overall Study|Lost to Follow-up|0|||
130335731|NCT01652469|469199707|FG001|Overall Study|Lost to Follow-up|2|||
130335732|NCT01402102|469199708|FG000|Overall Study|Protocol Violation|1|||
130335733|NCT01402102|469199709|FG001|Overall Study|Protocol Violation|0|||
130335734|NCT01402102|469199708|FG000|Overall Study|Insufficiency of compliance|1|||
130335735|NCT01402102|469199709|FG001|Overall Study|Insufficiency of compliance|1|||
130335736|NCT01402102|469199708|FG000|Overall Study|Withdrawal by Subject|0|||
130335737|NCT01402102|469199709|FG001|Overall Study|Withdrawal by Subject|2|||
130335738|NCT01305577|469199711|FG000|Overall Study|Adverse Event|2|||
130335739|NCT01305577|469199712|FG001|Overall Study|Adverse Event|2|||
130335740|NCT01305577|469199713|FG002|Overall Study|Adverse Event|1|||
130335741|NCT01305577|469199711|FG000|Overall Study|Withdrawal by Subject|7|||
130335742|NCT01305577|469199712|FG001|Overall Study|Withdrawal by Subject|5|||
130335743|NCT01305577|469199713|FG002|Overall Study|Withdrawal by Subject|6|||
130335744|NCT01305577|469199711|FG000|Overall Study|Lost to Follow-up|4|||
130335745|NCT01305577|469199712|FG001|Overall Study|Lost to Follow-up|3|||
130335746|NCT01305577|469199713|FG002|Overall Study|Lost to Follow-up|2|||
130335747|NCT01305577|469199711|FG000|Overall Study|Protocol Deviation|0|||
130335748|NCT01305577|469199712|FG001|Overall Study|Protocol Deviation|1|||
130335749|NCT01305577|469199713|FG002|Overall Study|Protocol Deviation|1|||
130335750|NCT00905645|469199714|FG000|Overall Study|Death (not device related)|10|||
130335751|NCT00905645|469199715|FG001|Overall Study|Death (not device related)|4|||
130335752|NCT00905645|469199716|FG002|Overall Study|Death (not device related)|15|||
130000062|NCT04124614|467965162|FG000|Double Blind Treatment Period|Adverse Event|0|||
130000063|NCT04124614|467965163|FG001|Double Blind Treatment Period|Adverse Event|7|||
130000064|NCT04124614|467965164|FG002|Double Blind Treatment Period|Adverse Event|22|||
130000065|NCT04124614|467965162|FG000|Double Blind Treatment Period|Death|0|||
130000066|NCT04124614|467965163|FG001|Double Blind Treatment Period|Death|0|||
130335753|NCT00905645|469199717|FG003|Overall Study|Death (not device related)|8|||
130335754|NCT00905645|469199714|FG000|Overall Study|Explantation of study device(s)|78|||
130335755|NCT00905645|469199715|FG001|Overall Study|Explantation of study device(s)|47|||
130335756|NCT00905645|469199716|FG002|Overall Study|Explantation of study device(s)|28|||
130000067|NCT04124614|467965164|FG002|Double Blind Treatment Period|Death|1|||
130000068|NCT04124614|467965162|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130000069|NCT04124614|467965163|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
130000070|NCT04124614|467965164|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
130000071|NCT04124614|467965162|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
130000072|NCT04124614|467965163|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
130000073|NCT04124614|467965164|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
130000074|NCT04124614|467965162|FG000|Double Blind Treatment Period|Physician Decision|0|||
130000075|NCT04124614|467965163|FG001|Double Blind Treatment Period|Physician Decision|0|||
130000076|NCT04124614|467965164|FG002|Double Blind Treatment Period|Physician Decision|3|||
130000077|NCT04124614|467965162|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
130000078|NCT04124614|467965163|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
130000079|NCT04124614|467965164|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
130000080|NCT04124614|467965162|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130000081|NCT04124614|467965163|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
130000082|NCT04124614|467965164|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
130000083|NCT04124614|467965162|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
130000084|NCT04124614|467965163|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
130000085|NCT04124614|467965164|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
130000086|NCT00726622|467966175|FG000|Overall Study|Withdrawal by Subject|16|||
130000087|NCT00726622|467966176|FG001|Overall Study|Withdrawal by Subject|2|||
130000088|NCT00726622|467966175|FG000|Overall Study|Physician Decision|0|||
130000089|NCT00726622|467966176|FG001|Overall Study|Physician Decision|1|||
130000090|NCT00726622|467966175|FG000|Overall Study|Metastasis|2|||
130000091|NCT00726622|467966176|FG001|Overall Study|Metastasis|0|||
130000092|NCT01940354|467966177|FG000|Overall Study|Withdrawal by Subject|4|||
130000093|NCT01940354|467966178|FG001|Overall Study|Withdrawal by Subject|2|||
130000094|NCT03872453|467966179|FG000|Overall Study|Adverse Event|1|||
130000095|NCT03872453|467966180|FG001|Overall Study|Adverse Event|1|||
130000096|NCT03872453|467966181|FG002|Overall Study|Adverse Event|0|||
130000097|NCT03872453|467966182|FG003|Overall Study|Adverse Event|0|||
130000098|NCT03872453|467966179|FG000|Overall Study|Lost to Follow-up|8|||
130000099|NCT03872453|467966180|FG001|Overall Study|Lost to Follow-up|7|||
130000100|NCT03872453|467966181|FG002|Overall Study|Lost to Follow-up|4|||
130000101|NCT03872453|467966182|FG003|Overall Study|Lost to Follow-up|4|||
130000102|NCT03872453|467966179|FG000|Overall Study|Never Treated Migraine|19|||
130000103|NCT03872453|467966180|FG001|Overall Study|Never Treated Migraine|17|||
130000104|NCT03872453|467966181|FG002|Overall Study|Never Treated Migraine|13|||
130000105|NCT03872453|467966182|FG003|Overall Study|Never Treated Migraine|12|||
130000106|NCT03872453|467966179|FG000|Overall Study|Pregnancy|1|||
130000107|NCT03872453|467966180|FG001|Overall Study|Pregnancy|0|||
130000108|NCT03872453|467966181|FG002|Overall Study|Pregnancy|0|||
130000109|NCT03872453|467966182|FG003|Overall Study|Pregnancy|0|||
130000110|NCT03872453|467966179|FG000|Overall Study|Protocol Deviation|2|||
130000111|NCT03872453|467966180|FG001|Overall Study|Protocol Deviation|0|||
130000112|NCT03872453|467966181|FG002|Overall Study|Protocol Deviation|0|||
130000113|NCT03872453|467966182|FG003|Overall Study|Protocol Deviation|2|||
130000114|NCT03872453|467966179|FG000|Overall Study|Withdrawal by Subject|0|||
130000115|NCT03872453|467966180|FG001|Overall Study|Withdrawal by Subject|1|||
130000116|NCT03872453|467966181|FG002|Overall Study|Withdrawal by Subject|2|||
130000117|NCT03872453|467966182|FG003|Overall Study|Withdrawal by Subject|0|||
130000118|NCT03872453|467966179|FG000|Overall Study|Other Than Specified|1|||
130000119|NCT03872453|467966180|FG001|Overall Study|Other Than Specified|0|||
130000120|NCT03872453|467966181|FG002|Overall Study|Other Than Specified|0|||
130000121|NCT03872453|467966182|FG003|Overall Study|Other Than Specified|0|||
130000122|NCT00352885|467966183|FG000|Overall Study|Withdrawal by Subject|0|||
130000123|NCT00352885|467966184|FG001|Overall Study|Withdrawal by Subject|3|||
130000124|NCT00352885|467966183|FG000|Overall Study|Development of major depression|0|||
130000125|NCT00352885|467966184|FG001|Overall Study|Development of major depression|1|||
130000126|NCT00352885|467966183|FG000|Overall Study|Progression of metastatic melanoma|5|||
130000127|NCT00352885|467966184|FG001|Overall Study|Progression of metastatic melanoma|3|||
130000128|NCT00352885|467966183|FG000|Overall Study|Side effects of IL-2 administration|1|||
130000129|NCT00352885|467966184|FG001|Overall Study|Side effects of IL-2 administration|0|||
130000130|NCT03756350|467966186|FG000|Overall Study|Lost to Follow-up|1|||
130000131|NCT00440700|467966187|FG000|Overall Study|Withdrawal by Subject|8|||
130000132|NCT00440700|467966188|FG001|Overall Study|Withdrawal by Subject|8|||
130000133|NCT00440700|467966189|FG002|Overall Study|Withdrawal by Subject|4|||
130000134|NCT01131351|467966190|FG000|Overall Study|Adverse Event|0|||
130000135|NCT01131351|467966191|FG001|Overall Study|Adverse Event|2|||
130000136|NCT01131351|467966190|FG000|Overall Study|Protocol Deviation|0|||
130000137|NCT01131351|467966191|FG001|Overall Study|Protocol Deviation|1|||
130000138|NCT01423812|467966193|FG000|Overall Study|Lost to Follow-up|2|||
130000139|NCT01423812|467966194|FG001|Overall Study|Lost to Follow-up|2|||
130000140|NCT01423812|467966193|FG000|Overall Study|Withdrawal by Subject|1|||
130000141|NCT01423812|467966194|FG001|Overall Study|Withdrawal by Subject|2|||
130000142|NCT01179672|467966195|FG000|Overall Study|Adverse Event|17|||
130000143|NCT01179672|467966196|FG001|Overall Study|Adverse Event|8|||
130000144|NCT01179672|467966195|FG000|Overall Study|Withdrawal by Subject|10|||
130000145|NCT01179672|467966196|FG001|Overall Study|Withdrawal by Subject|12|||
130000146|NCT01179672|467966195|FG000|Overall Study|Entry Criteria Not Met|0|||
130000147|NCT01179672|467966196|FG001|Overall Study|Entry Criteria Not Met|2|||
130000148|NCT01179672|467966195|FG000|Overall Study|Lost to Follow-up|0|||
130000149|NCT01179672|467966196|FG001|Overall Study|Lost to Follow-up|1|||
130000150|NCT01179672|467966195|FG000|Overall Study|Protocol Violation|2|||
130000151|NCT01179672|467966196|FG001|Overall Study|Protocol Violation|2|||
130000152|NCT01179672|467966195|FG000|Overall Study|Physician Decision|1|||
130000153|NCT01179672|467966196|FG001|Overall Study|Physician Decision|1|||
130000154|NCT01187550|467966199|FG000|Overall Study|Protocol Violation|3|||
130000155|NCT01187550|467966200|FG001|Overall Study|Protocol Violation|1|||
130000156|NCT01187550|467966199|FG000|Overall Study|Other|3|||
130000157|NCT01187550|467966200|FG001|Overall Study|Other|0|||
130000158|NCT01187550|467966199|FG000|Overall Study|Randomized but not treated|8|||
130000159|NCT01187550|467966200|FG001|Overall Study|Randomized but not treated|0|||
130000160|NCT02748018|467966201|FG000|Study Period|Adverse Event|1|||
130000161|NCT02748018|467966202|FG001|Study Period|Adverse Event|3|||
130000162|NCT02748018|467966203|FG002|Study Period|Adverse Event|4|||
130000163|NCT02748018|467966204|FG003|Study Period|Adverse Event|0|||
130000164|NCT02748018|467966205|FG004|Study Period|Adverse Event|3|||
130000165|NCT02748018|467966206|FG005|Study Period|Adverse Event|3|||
130000166|NCT02748018|467966201|FG000|Study Period|Withdrawal by Subject|7|||
130000167|NCT02748018|467966202|FG001|Study Period|Withdrawal by Subject|4|||
130000168|NCT02748018|467966203|FG002|Study Period|Withdrawal by Subject|4|||
130000169|NCT02748018|467966204|FG003|Study Period|Withdrawal by Subject|11|||
130000170|NCT02748018|467966205|FG004|Study Period|Withdrawal by Subject|12|||
130000171|NCT02748018|467966206|FG005|Study Period|Withdrawal by Subject|10|||
130000172|NCT02748018|467966201|FG000|Study Period|Pregnancy|0|||
130000173|NCT02748018|467966202|FG001|Study Period|Pregnancy|1|||
130000174|NCT02748018|467966203|FG002|Study Period|Pregnancy|0|||
130000175|NCT02748018|467966204|FG003|Study Period|Pregnancy|0|||
130000176|NCT02748018|467966205|FG004|Study Period|Pregnancy|1|||
130000177|NCT02748018|467966206|FG005|Study Period|Pregnancy|0|||
130000178|NCT02748018|467966201|FG000|Study Period|Physician Decision|2|||
130000179|NCT02748018|467966202|FG001|Study Period|Physician Decision|2|||
130000180|NCT02748018|467966203|FG002|Study Period|Physician Decision|1|||
130000181|NCT02748018|467966204|FG003|Study Period|Physician Decision|0|||
130000182|NCT02748018|467966205|FG004|Study Period|Physician Decision|2|||
130000183|NCT02748018|467966206|FG005|Study Period|Physician Decision|0|||
130000184|NCT02748018|467966201|FG000|Study Period|Lost to Follow-up|0|||
130000185|NCT02748018|467966202|FG001|Study Period|Lost to Follow-up|0|||
130000186|NCT02748018|467966203|FG002|Study Period|Lost to Follow-up|0|||
130000187|NCT02748018|467966204|FG003|Study Period|Lost to Follow-up|2|||
130000188|NCT02748018|467966205|FG004|Study Period|Lost to Follow-up|0|||
130000189|NCT02748018|467966206|FG005|Study Period|Lost to Follow-up|1|||
130000190|NCT02748018|467966201|FG000|Continuation Period|Adverse Event|2|||
130000191|NCT02748018|467966202|FG001|Continuation Period|Adverse Event|0|||
130000192|NCT02748018|467966203|FG002|Continuation Period|Adverse Event|1|||
130000193|NCT02748018|467966204|FG003|Continuation Period|Adverse Event|1|||
130000194|NCT02748018|467966205|FG004|Continuation Period|Adverse Event|1|||
130000195|NCT02748018|467966206|FG005|Continuation Period|Adverse Event|4|||
130000196|NCT02748018|467966201|FG000|Continuation Period|Withdrawal by Subject|3|||
130000197|NCT02748018|467966202|FG001|Continuation Period|Withdrawal by Subject|5|||
130000198|NCT02748018|467966203|FG002|Continuation Period|Withdrawal by Subject|3|||
130000199|NCT02748018|467966204|FG003|Continuation Period|Withdrawal by Subject|9|||
130000200|NCT02748018|467966205|FG004|Continuation Period|Withdrawal by Subject|11|||
130000201|NCT02748018|467966206|FG005|Continuation Period|Withdrawal by Subject|1|||
130000202|NCT02748018|467966201|FG000|Continuation Period|Lost to Follow-up|0|||
130000203|NCT02748018|467966202|FG001|Continuation Period|Lost to Follow-up|2|||
130000204|NCT02748018|467966203|FG002|Continuation Period|Lost to Follow-up|1|||
130000205|NCT02748018|467966204|FG003|Continuation Period|Lost to Follow-up|0|||
130000206|NCT02748018|467966205|FG004|Continuation Period|Lost to Follow-up|1|||
130000207|NCT02748018|467966206|FG005|Continuation Period|Lost to Follow-up|0|||
130000208|NCT02748018|467966201|FG000|Continuation Period|Pregnancy|1|||
130000209|NCT02748018|467966202|FG001|Continuation Period|Pregnancy|2|||
130000210|NCT02748018|467966203|FG002|Continuation Period|Pregnancy|0|||
130000211|NCT02748018|467966204|FG003|Continuation Period|Pregnancy|0|||
130000212|NCT02748018|467966205|FG004|Continuation Period|Pregnancy|0|||
130000213|NCT02748018|467966206|FG005|Continuation Period|Pregnancy|0|||
130000214|NCT02748018|467966201|FG000|Continuation Period|Physician Decision|0|||
130000215|NCT02748018|467966202|FG001|Continuation Period|Physician Decision|1|||
130000216|NCT02748018|467966203|FG002|Continuation Period|Physician Decision|2|||
130000217|NCT02748018|467966204|FG003|Continuation Period|Physician Decision|0|||
130000218|NCT02748018|467966205|FG004|Continuation Period|Physician Decision|2|||
130000219|NCT02748018|467966206|FG005|Continuation Period|Physician Decision|1|||
130000220|NCT02748018|467966201|FG000|Continuation Period|Protocol Violation|0|||
130000221|NCT02748018|467966202|FG001|Continuation Period|Protocol Violation|1|||
130000222|NCT02748018|467966203|FG002|Continuation Period|Protocol Violation|0|||
130000223|NCT02748018|467966204|FG003|Continuation Period|Protocol Violation|0|||
130000224|NCT02748018|467966205|FG004|Continuation Period|Protocol Violation|0|||
130000225|NCT02748018|467966206|FG005|Continuation Period|Protocol Violation|0|||
130000226|NCT01233869|467966207|FG000|Initial Treatment Period (24 Months)|Death|1|||
130000227|NCT01233869|467966208|FG001|Initial Treatment Period (24 Months)|Death|0|||
130000228|NCT01233869|467966209|FG002|Initial Treatment Period (24 Months)|Death|0|||
130000229|NCT01233869|467966210|FG003|Initial Treatment Period (24 Months)|Death|0|||
130000230|NCT01233869|467966207|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
130000231|NCT01233869|467966208|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
130000232|NCT01233869|467966209|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
130000233|NCT01233869|467966210|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
130000234|NCT01233869|467966207|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
130000235|NCT01233869|467966208|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
130000236|NCT01233869|467966209|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
130000237|NCT01233869|467966210|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
130000238|NCT01233869|467966207|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
130000239|NCT01233869|467966208|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
130000240|NCT01233869|467966209|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
130000241|NCT01233869|467966210|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
130000242|NCT01233869|467966207|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
130000243|NCT01233869|467966208|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
130000244|NCT01233869|467966209|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
130000245|NCT01233869|467966210|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
130000246|NCT01233869|467966207|FG000|Extended Treatment Period (46 Months)|Other|3|||
130000247|NCT01233869|467966208|FG001|Extended Treatment Period (46 Months)|Other|0|||
130000248|NCT01233869|467966209|FG002|Extended Treatment Period (46 Months)|Other|0|||
130000249|NCT01233869|467966210|FG003|Extended Treatment Period (46 Months)|Other|3|||
130000250|NCT01233869|467966207|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
130000251|NCT01233869|467966208|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
130000252|NCT01233869|467966209|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
130000253|NCT01233869|467966210|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
130000254|NCT00537485|467966211|FG000|Overall Study|Adverse Event|10|||
130000255|NCT00537485|467966212|FG001|Overall Study|Adverse Event|5|||
130000256|NCT00537485|467966211|FG000|Overall Study|Withdrawal by Subject|3|||
130000257|NCT00537485|467966212|FG001|Overall Study|Withdrawal by Subject|2|||
130000258|NCT00537485|467966211|FG000|Overall Study|Withdrawal by Subject|1|||
130000259|NCT00537485|467966212|FG001|Overall Study|Withdrawal by Subject|3|||
130000260|NCT00537485|467966211|FG000|Overall Study|Physician Decision|1|||
130000261|NCT00537485|467966212|FG001|Overall Study|Physician Decision|0|||
130000262|NCT05696236|467966222|FG000|Overall Study|Lost to Follow-up|1|||
130000263|NCT05696236|467966223|FG001|Overall Study|Lost to Follow-up|0|||
130000264|NCT05696236|467966222|FG000|Overall Study|Later determined to not be eligible for participation|0|||
130000265|NCT05696236|467966223|FG001|Overall Study|Later determined to not be eligible for participation|1|||
130000266|NCT05696236|467966222|FG000|Overall Study|Withdrawal by Subject|2|||
130000267|NCT05696236|467966223|FG001|Overall Study|Withdrawal by Subject|2|||
130000268|NCT01145495|467966226|FG000|Overall Study|Adverse Event|6|||
130000269|NCT01145495|467966226|FG000|Overall Study|Withdrawal by Subject|6|||
130000270|NCT01145495|467966226|FG000|Overall Study|Disease progression after respone|2|||
130000271|NCT00312221|467966227|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
130000272|NCT00312221|467966228|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130000273|NCT00312221|467966229|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130335757|NCT00905645|469199717|FG003|Overall Study|Explantation of study device(s)|21|||
130335758|NCT00905645|469199714|FG000|Overall Study|Subject Request|41|||
130335759|NCT00905645|469199715|FG001|Overall Study|Subject Request|17|||
130335760|NCT00905645|469199716|FG002|Overall Study|Subject Request|13|||
130335761|NCT00905645|469199717|FG003|Overall Study|Subject Request|11|||
129884370|NCT03893825|467536379|FG000|Overall Study|Other than specified|7|||
130000274|NCT00312221|467966230|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
130000275|NCT00312221|467966227|FG000|Open-label Run-in Period|Adverse Event|74|||
130000276|NCT00312221|467966228|FG001|Open-label Run-in Period|Adverse Event|0|||
130000277|NCT00312221|467966229|FG002|Open-label Run-in Period|Adverse Event|0|||
130000278|NCT00312221|467966230|FG003|Open-label Run-in Period|Adverse Event|0|||
130000279|NCT00312221|467966227|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
130000280|NCT00312221|467966228|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130000281|NCT00312221|467966229|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130000282|NCT00312221|467966230|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
130000283|NCT00312221|467966227|FG000|Open-label Run-in Period|Administrative|42|||
130000284|NCT00312221|467966228|FG001|Open-label Run-in Period|Administrative|0|||
130335762|NCT00905645|469199714|FG000|Overall Study|Lost to Follow-up|299|||
130335763|NCT00905645|469199715|FG001|Overall Study|Lost to Follow-up|103|||
130335764|NCT00905645|469199716|FG002|Overall Study|Lost to Follow-up|51|||
130000285|NCT00312221|467966229|FG002|Open-label Run-in Period|Administrative|0|||
130000286|NCT00312221|467966230|FG003|Open-label Run-in Period|Administrative|0|||
130000287|NCT00312221|467966227|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
130000288|NCT00312221|467966228|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130000289|NCT00312221|467966229|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130000290|NCT00312221|467966230|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
130000291|NCT00312221|467966227|FG000|Open-label Run-in Period|Did not qualify|5|||
130000292|NCT00312221|467966228|FG001|Open-label Run-in Period|Did not qualify|0|||
130000293|NCT00312221|467966229|FG002|Open-label Run-in Period|Did not qualify|0|||
130000294|NCT00312221|467966230|FG003|Open-label Run-in Period|Did not qualify|0|||
130000295|NCT00312221|467966227|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130000296|NCT00312221|467966228|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130000297|NCT00312221|467966229|FG002|Double-blind Phase|Withdrawal by Subject|8|||
130000298|NCT00312221|467966230|FG003|Double-blind Phase|Withdrawal by Subject|7|||
130000299|NCT00312221|467966227|FG000|Double-blind Phase|Adverse Event|0|||
130000300|NCT00312221|467966228|FG001|Double-blind Phase|Adverse Event|10|||
130000301|NCT00312221|467966229|FG002|Double-blind Phase|Adverse Event|19|||
130000302|NCT00312221|467966230|FG003|Double-blind Phase|Adverse Event|18|||
130000303|NCT00312221|467966227|FG000|Double-blind Phase|Lost to Follow-up|0|||
130000304|NCT00312221|467966228|FG001|Double-blind Phase|Lost to Follow-up|0|||
130000305|NCT00312221|467966229|FG002|Double-blind Phase|Lost to Follow-up|2|||
130000306|NCT00312221|467966230|FG003|Double-blind Phase|Lost to Follow-up|2|||
130000307|NCT00312221|467966227|FG000|Double-blind Phase|Administrative|0|||
130000308|NCT00312221|467966228|FG001|Double-blind Phase|Administrative|26|||
130000309|NCT00312221|467966229|FG002|Double-blind Phase|Administrative|37|||
130000310|NCT00312221|467966230|FG003|Double-blind Phase|Administrative|33|||
130000311|NCT00312221|467966227|FG000|Double-blind Phase|Lack of Efficacy|0|||
130000312|NCT00312221|467966228|FG001|Double-blind Phase|Lack of Efficacy|17|||
130000313|NCT00312221|467966229|FG002|Double-blind Phase|Lack of Efficacy|6|||
130000314|NCT00312221|467966230|FG003|Double-blind Phase|Lack of Efficacy|10|||
130000315|NCT02060721|467966231|FG000|Overall Study|Lost to Follow-up|1|||
130000316|NCT02060721|467966231|FG000|Overall Study|Physician Decision|2|||
130000317|NCT02060721|467966231|FG000|Overall Study|Death|14|||
130000318|NCT02060721|467966231|FG000|Overall Study|Withdrawal by Subject|2|||
130000319|NCT02060721|467966231|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
130000320|NCT00117507|467966232|FG000|Overall Study|Adverse Event|4|||
130000321|NCT00117507|467966232|FG000|Overall Study|Abnormal laboratory values|3|||
130000322|NCT00117507|467966232|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130000323|NCT00117507|467966232|FG000|Overall Study|Patient withdrew consent|4|||
130000324|NCT00117507|467966232|FG000|Overall Study|Death|3|||
130000325|NCT05105789|467966233|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
130000326|NCT01003990|467966236|FG000|Overall Study|Adverse Event|8|||
130000327|NCT01003990|467966237|FG001|Overall Study|Adverse Event|5|||
130000328|NCT01003990|467966238|FG002|Overall Study|Adverse Event|11|||
130000329|NCT01003990|467966236|FG000|Overall Study|Death|0|||
130000330|NCT01003990|467966237|FG001|Overall Study|Death|8|||
130000331|NCT01003990|467966238|FG002|Overall Study|Death|1|||
130000332|NCT01003990|467966236|FG000|Overall Study|Lack of Efficacy|10|||
130000333|NCT01003990|467966237|FG001|Overall Study|Lack of Efficacy|2|||
130000334|NCT01003990|467966238|FG002|Overall Study|Lack of Efficacy|3|||
130000335|NCT01003990|467966236|FG000|Overall Study|Lost to Follow-up|30|||
130000336|NCT01003990|467966237|FG001|Overall Study|Lost to Follow-up|12|||
130000337|NCT01003990|467966238|FG002|Overall Study|Lost to Follow-up|7|||
130000338|NCT01003990|467966236|FG000|Overall Study|Reasons Not Identified|14|||
130000339|NCT01003990|467966237|FG001|Overall Study|Reasons Not Identified|13|||
130000340|NCT01003990|467966238|FG002|Overall Study|Reasons Not Identified|8|||
130000341|NCT01003990|467966236|FG000|Overall Study|Poor/Non-compliance|4|||
130000342|NCT01003990|467966237|FG001|Overall Study|Poor/Non-compliance|3|||
130000343|NCT01003990|467966238|FG002|Overall Study|Poor/Non-compliance|2|||
130000344|NCT01003990|467966236|FG000|Overall Study|Pregnancy|10|||
130000345|NCT01003990|467966237|FG001|Overall Study|Pregnancy|2|||
130000346|NCT01003990|467966238|FG002|Overall Study|Pregnancy|4|||
130000347|NCT01003990|467966236|FG000|Overall Study|No Longer Met Study Criteria|4|||
130000348|NCT01003990|467966237|FG001|Overall Study|No Longer Met Study Criteria|1|||
130000349|NCT01003990|467966238|FG002|Overall Study|No Longer Met Study Criteria|0|||
130000350|NCT01003990|467966236|FG000|Overall Study|Subject Withdrew Consent|12|||
130000351|NCT01003990|467966237|FG001|Overall Study|Subject Withdrew Consent|5|||
130000352|NCT01003990|467966238|FG002|Overall Study|Subject Withdrew Consent|7|||
130000353|NCT03690141|467966241|FG000|Overall Study|Adverse Event|5|||
130000354|NCT03690141|467966241|FG000|Overall Study|Withdrawal by Subject|3|||
130000355|NCT03690141|467966241|FG000|Overall Study|Physician Decision|4|||
130000356|NCT03690141|467966241|FG000|Overall Study|Disease progression|4|||
130000357|NCT01807923|467966242|FG000|Overall Study|Adverse Event|2|||
130000358|NCT01807923|467966243|FG001|Overall Study|Adverse Event|1|||
130000359|NCT01807923|467966244|FG002|Overall Study|Adverse Event|2|||
130000360|NCT01807923|467966242|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130000361|NCT01807923|467966243|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130335765|NCT00905645|469199717|FG003|Overall Study|Lost to Follow-up|12|||
130000362|NCT01807923|467966244|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130000363|NCT01807923|467966242|FG000|Overall Study|Physician Decision|0|||
130000364|NCT01807923|467966243|FG001|Overall Study|Physician Decision|0|||
130000365|NCT01807923|467966244|FG002|Overall Study|Physician Decision|1|||
130000366|NCT01807923|467966242|FG000|Overall Study|Not Eligible (Genotype)|0|||
130000367|NCT01807923|467966243|FG001|Overall Study|Not Eligible (Genotype)|0|||
130000368|NCT01807923|467966244|FG002|Overall Study|Not Eligible (Genotype)|1|||
130000369|NCT01807923|467966242|FG000|Overall Study|Randomized But Not Treated|3|||
130000370|NCT01807923|467966243|FG001|Overall Study|Randomized But Not Treated|2|||
130000371|NCT01807923|467966244|FG002|Overall Study|Randomized But Not Treated|5|||
130000372|NCT02014740|467966248|FG000|Overall Study|Lost to Follow-up|4|||
130000373|NCT02014740|467966249|FG001|Overall Study|Lost to Follow-up|4|||
130000374|NCT02014740|467966248|FG000|Overall Study|Withdrawal by Subject|2|||
130000375|NCT02014740|467966249|FG001|Overall Study|Withdrawal by Subject|1|||
130000376|NCT00999713|467966250|FG000|Overall Study|Physician Decision|2|||
130000377|NCT00999713|467966251|FG001|Overall Study|Physician Decision|0|||
130000378|NCT00639223|467966252|FG000|Overall Study|Lost to Follow-up|0|||
130000379|NCT00639223|467966253|FG001|Overall Study|Lost to Follow-up|2|||
130000380|NCT04936841|467966254|FG000|Overall Study|Death|1|||
130000381|NCT03739437|467966255|FG000|Overall Study|Lost to Follow-up|2|||
130000382|NCT03739437|467966256|FG001|Overall Study|Lost to Follow-up|5|||
130000383|NCT01395316|467966259|FG000|Overall Study|Lost to Follow-up|2|||
130000384|NCT01395316|467966259|FG000|Overall Study|poor MRI quality|1|||
130000385|NCT03359590|467966260|FG000|First Intervention|Withdrawal by Subject|1|||
130000386|NCT03359590|467966261|FG001|First Intervention|Withdrawal by Subject|1|||
130000387|NCT03359590|467966260|FG000|First Intervention|Protocol Violation|0|||
130000388|NCT03359590|467966261|FG001|First Intervention|Protocol Violation|1|||
130000389|NCT04890054|467967998|FG000|Overall Study|Lost to Follow-up|202|||
130000390|NCT04890054|467967999|FG001|Overall Study|Lost to Follow-up|219|||
130000391|NCT01310803|467968003|FG000|Overall Study|Subject terminated by Sponsor|1|||
130000392|NCT01310803|467968004|FG001|Overall Study|Subject terminated by Sponsor|0|||
130000393|NCT01306890|467968005|FG000|Overall Study|Adverse Event|2|||
130000394|NCT01306890|467968005|FG000|Overall Study|Death|1223|||
130000395|NCT01306890|467968005|FG000|Overall Study|Lost to Follow-up|58|||
130000396|NCT01306890|467968005|FG000|Overall Study|Withdrawal by Subject|88|||
130000397|NCT01306890|467968005|FG000|Overall Study|Unspecified reasons|104|||
130000398|NCT01306890|467968005|FG000|Overall Study|Study Termination|3|||
130000399|NCT01306890|467968005|FG000|Overall Study|No discontinuation documentation|41|||
130000400|NCT03047551|467968010|FG000|Overall Study|Did not receive TAS|1|||
130000401|NCT03047551|467968011|FG001|Overall Study|Did not receive TAS|0|||
130000402|NCT03047551|467968010|FG000|Overall Study|Physician Decision|1|||
130000403|NCT03047551|467968011|FG001|Overall Study|Physician Decision|0|||
130000404|NCT03047551|467968010|FG000|Overall Study|Withdrawal by Subject|0|||
130000405|NCT03047551|467968011|FG001|Overall Study|Withdrawal by Subject|1|||
130000406|NCT03047551|467968010|FG000|Overall Study|Probe malfunction|0|||
130000407|NCT03047551|467968011|FG001|Overall Study|Probe malfunction|1|||
130000408|NCT03047551|467968010|FG000|Overall Study|Ineligible|0|||
130000409|NCT03047551|467968011|FG001|Overall Study|Ineligible|1|||
130000410|NCT03873493|467968012|FG000|Overall Study|Withdrawal by Subject|1|||
130000411|NCT03873493|467968012|FG000|Overall Study|Death|9|||
130000412|NCT03873493|467968012|FG000|Overall Study|Lost to Follow-up|1|||
130000413|NCT03873493|467968012|FG000|Overall Study|Study Terminated by Sponsor|1|||
130000414|NCT03873493|467968012|FG000|Overall Study|Other|2|||
130000415|NCT01096342|467968015|FG000|Overall Study|Protocol Violation|1|||
130000416|NCT04906616|467968016|FG000|Overall Study|Divorce|3|||
130000417|NCT04906616|467968017|FG001|Overall Study|Divorce|2|||
130000418|NCT03739762|467968018|FG000|Overall Study|Lost to Follow-up|1|||
130000419|NCT03739762|467968019|FG001|Overall Study|Lost to Follow-up|1|||
130000420|NCT03739762|467968018|FG000|Overall Study|Withdrawal by Subject|2|||
130000421|NCT03739762|467968019|FG001|Overall Study|Withdrawal by Subject|6|||
130000422|NCT02464228|467968022|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
130000423|NCT02464228|467968023|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
130000424|NCT02464228|467968024|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
130000425|NCT02464228|467968025|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
130000426|NCT02464228|467968022|FG000|Overall Study|Physician Decision|2|||
130000427|NCT02464228|467968023|FG001|Overall Study|Physician Decision|0|||
130000428|NCT02464228|467968024|FG002|Overall Study|Physician Decision|1|||
130000429|NCT02464228|467968025|FG003|Overall Study|Physician Decision|0|||
130000430|NCT02464228|467968022|FG000|Overall Study|Miscellaneous|1|||
130000431|NCT02464228|467968023|FG001|Overall Study|Miscellaneous|0|||
130000432|NCT02464228|467968024|FG002|Overall Study|Miscellaneous|1|||
130000433|NCT02464228|467968025|FG003|Overall Study|Miscellaneous|0|||
130000434|NCT02464228|467968022|FG000|Overall Study|Adverse Event|9|||
130000435|NCT02464228|467968023|FG001|Overall Study|Adverse Event|0|||
130000436|NCT02464228|467968024|FG002|Overall Study|Adverse Event|3|||
130000437|NCT02464228|467968025|FG003|Overall Study|Adverse Event|0|||
130000438|NCT02464228|467968022|FG000|Overall Study|Withdrawal by Subject|1|||
130000439|NCT02464228|467968023|FG001|Overall Study|Withdrawal by Subject|1|||
130000440|NCT02464228|467968024|FG002|Overall Study|Withdrawal by Subject|1|||
130000441|NCT02464228|467968025|FG003|Overall Study|Withdrawal by Subject|0|||
130000442|NCT02464228|467968022|FG000|Overall Study|Disease Progression|22|||
130000443|NCT02464228|467968023|FG001|Overall Study|Disease Progression|12|||
130000444|NCT02464228|467968024|FG002|Overall Study|Disease Progression|5|||
130000445|NCT02464228|467968025|FG003|Overall Study|Disease Progression|2|||
130000446|NCT00385203|467968028|FG000|Overall Study|Adverse Event|5|||
130000447|NCT00385203|467968029|FG001|Overall Study|Adverse Event|4|||
130000448|NCT00385203|467968028|FG000|Overall Study|Death|1|||
130000449|NCT00385203|467968029|FG001|Overall Study|Death|0|||
130000450|NCT00385203|467968028|FG000|Overall Study|Condition under investigation worsened|18|||
130000451|NCT00385203|467968029|FG001|Overall Study|Condition under investigation worsened|3|||
130000452|NCT00385203|467968028|FG000|Overall Study|Incorrect enrollment|2|||
130000453|NCT00385203|467968029|FG001|Overall Study|Incorrect enrollment|0|||
130000454|NCT03308942|467968030|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
130000455|NCT03308942|467968031|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
130000456|NCT03308942|467968032|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
130000457|NCT03308942|467968033|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
130000458|NCT03308942|467968034|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
130000459|NCT03308942|467968030|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
130000460|NCT03308942|467968031|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
130000461|NCT03308942|467968032|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
130000462|NCT03308942|467968033|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
130000463|NCT03308942|467968034|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
130000464|NCT03308942|467968030|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130000465|NCT03308942|467968031|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
130000466|NCT03308942|467968032|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130000467|NCT03308942|467968033|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130000468|NCT03308942|467968034|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
130000469|NCT03308942|467968030|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
130000470|NCT03308942|467968031|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
130000471|NCT03308942|467968032|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
130000472|NCT03308942|467968033|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
130000473|NCT03308942|467968034|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
130000474|NCT03308942|467968030|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130000475|NCT03308942|467968031|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130000476|NCT03308942|467968032|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130000477|NCT03308942|467968033|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
130000478|NCT03308942|467968034|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
130000479|NCT03308942|467968030|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130000480|NCT03308942|467968031|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130000481|NCT03308942|467968032|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130000482|NCT03308942|467968033|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
130000483|NCT03308942|467968034|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
130000484|NCT03308942|467968030|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130000485|NCT03308942|467968031|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130000486|NCT03308942|467968032|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130000487|NCT03308942|467968033|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
130000488|NCT03308942|467968034|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
130000489|NCT02294682|467968035|FG000|Overall Study|Could not swallow pills|1|||
130000490|NCT02294682|467968036|FG001|Overall Study|Could not swallow pills|0|||
130000491|NCT03422172|467968039|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
130000492|NCT03422172|467968039|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
130000493|NCT03422172|467968039|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
130000494|NCT00404066|467968042|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
130000495|NCT00404066|467968042|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
130000496|NCT00129623|467968043|FG000|Overall Study|Adverse Event|3|||
130000497|NCT00129623|467968044|FG001|Overall Study|Adverse Event|7|||
130000498|NCT00129623|467968043|FG000|Overall Study|Refused Treatment|5|||
130000499|NCT00129623|467968044|FG001|Overall Study|Refused Treatment|3|||
130000500|NCT00129623|467968043|FG000|Overall Study|Failure to Return|1|||
130000501|NCT00129623|467968044|FG001|Overall Study|Failure to Return|1|||
130000502|NCT00129623|467968043|FG000|Overall Study|Relocated job out of state|1|||
130000503|NCT00129623|467968044|FG001|Overall Study|Relocated job out of state|0|||
130000504|NCT00129623|467968043|FG000|Overall Study|Uncertainty to return|0|||
130000505|NCT00129623|467968044|FG001|Overall Study|Uncertainty to return|1|||
130000506|NCT02616614|467968045|FG000|Overall Study|Withdrawal by Subject|10|||
130000507|NCT02616614|467968046|FG001|Overall Study|Withdrawal by Subject|5|||
130000508|NCT02616614|467968047|FG002|Overall Study|Withdrawal by Subject|6|||
130000509|NCT02616614|467968045|FG000|Overall Study|Physician Decision|2|||
130000510|NCT02616614|467968046|FG001|Overall Study|Physician Decision|1|||
130000511|NCT02616614|467968047|FG002|Overall Study|Physician Decision|0|||
130000512|NCT02616614|467968045|FG000|Overall Study|Adverse Event|1|||
130000513|NCT02616614|467968046|FG001|Overall Study|Adverse Event|4|||
130000514|NCT02616614|467968047|FG002|Overall Study|Adverse Event|1|||
130000515|NCT02616614|467968045|FG000|Overall Study|Protocol Violation|0|||
130000516|NCT02616614|467968046|FG001|Overall Study|Protocol Violation|3|||
130000517|NCT02616614|467968047|FG002|Overall Study|Protocol Violation|1|||
130000518|NCT02616614|467968045|FG000|Overall Study|Prohibited Medication|12|||
130000519|NCT02616614|467968046|FG001|Overall Study|Prohibited Medication|9|||
130000520|NCT02616614|467968047|FG002|Overall Study|Prohibited Medication|5|||
130000521|NCT02616614|467968045|FG000|Overall Study|More than 3 applications missed|6|||
130000522|NCT02616614|467968046|FG001|Overall Study|More than 3 applications missed|8|||
130000523|NCT02616614|467968047|FG002|Overall Study|More than 3 applications missed|1|||
130000524|NCT02616614|467968045|FG000|Overall Study|Lost to Follow-up|31|||
130000525|NCT02616614|467968046|FG001|Overall Study|Lost to Follow-up|28|||
130000526|NCT02616614|467968047|FG002|Overall Study|Lost to Follow-up|13|||
130000527|NCT02616614|467968045|FG000|Overall Study|Pregnancy|2|||
130000528|NCT02616614|467968046|FG001|Overall Study|Pregnancy|0|||
130000529|NCT02616614|467968047|FG002|Overall Study|Pregnancy|1|||
130000530|NCT02616614|467968045|FG000|Overall Study|Other|1|||
130000531|NCT02616614|467968046|FG001|Overall Study|Other|2|||
130000532|NCT02616614|467968047|FG002|Overall Study|Other|1|||
130000533|NCT02315898|467968048|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
130000534|NCT02315898|467968049|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
130000535|NCT02315898|467968050|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
130000536|NCT02315898|467968051|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
130000537|NCT02445755|467968052|FG000|Overall Study|Withdrawal by Subject|2|||
130000538|NCT02445755|467968052|FG000|Overall Study|Protocol Violation|6|||
130000539|NCT02445755|467968052|FG000|Overall Study|Screen Failure|5|||
130000540|NCT03239483|467968053|FG000|Overall Study|Lost to Follow-up|1|||
130000541|NCT03239483|467968054|FG001|Overall Study|Lost to Follow-up|0|||
130000542|NCT03239483|467968053|FG000|Overall Study|Withdrawal by Subject|1|||
130000543|NCT03239483|467968054|FG001|Overall Study|Withdrawal by Subject|0|||
130000544|NCT05352048|467968055|FG000|Overall Study|Lost to Follow-up|1|||
130000545|NCT05352048|467968055|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
130000546|NCT01296035|467968070|FG000|Overall Study|Withdrawal by Subject|1|||
130000547|NCT04464265|467968071|FG000|Overall Study|Physician Decision|2|||
130000548|NCT00056862|467968076|FG000|Overall Study|Protocol Violation|1|||
130000549|NCT00056862|467968077|FG001|Overall Study|Protocol Violation|0|||
130000550|NCT02378220|467968078|FG000|Overall Study|Death|6|||
130000551|NCT02378220|467968079|FG001|Overall Study|Death|1|||
130000552|NCT00578786|467968080|FG000|Overall Study|Adverse Event|27|||
130000553|NCT00578786|467968081|FG001|Overall Study|Adverse Event|37|||
130000554|NCT00578786|467968082|FG002|Overall Study|Adverse Event|17|||
130000555|NCT00578786|467968080|FG000|Overall Study|Lack of Efficacy|2|||
130000556|NCT00578786|467968081|FG001|Overall Study|Lack of Efficacy|5|||
130000557|NCT00578786|467968082|FG002|Overall Study|Lack of Efficacy|2|||
130000558|NCT00578786|467968080|FG000|Overall Study|Early Escape from Prior Study|2|||
130000559|NCT00578786|467968081|FG001|Overall Study|Early Escape from Prior Study|1|||
130000560|NCT00578786|467968082|FG002|Overall Study|Early Escape from Prior Study|2|||
130000561|NCT00578786|467968080|FG000|Overall Study|Withdrawal by Subject|7|||
130000562|NCT00578786|467968081|FG001|Overall Study|Withdrawal by Subject|8|||
130000563|NCT00578786|467968082|FG002|Overall Study|Withdrawal by Subject|5|||
130000564|NCT00578786|467968080|FG000|Overall Study|Protocol Violation|0|||
130000565|NCT00578786|467968081|FG001|Overall Study|Protocol Violation|3|||
130000566|NCT00578786|467968082|FG002|Overall Study|Protocol Violation|1|||
130000567|NCT00578786|467968080|FG000|Overall Study|Physician Decision|1|||
130000568|NCT00578786|467968081|FG001|Overall Study|Physician Decision|0|||
130000569|NCT00578786|467968082|FG002|Overall Study|Physician Decision|1|||
130000570|NCT00578786|467968080|FG000|Overall Study|Sponsor Decision|0|||
130000571|NCT00578786|467968081|FG001|Overall Study|Sponsor Decision|0|||
130000572|NCT00578786|467968082|FG002|Overall Study|Sponsor Decision|1|||
130000573|NCT00578786|467968080|FG000|Overall Study|Lost to Follow-up|0|||
130000574|NCT00578786|467968081|FG001|Overall Study|Lost to Follow-up|4|||
130000575|NCT00578786|467968082|FG002|Overall Study|Lost to Follow-up|0|||
130000576|NCT00578786|467968080|FG000|Overall Study|Pregnancy|0|||
130000577|NCT00578786|467968081|FG001|Overall Study|Pregnancy|1|||
130000578|NCT00578786|467968082|FG002|Overall Study|Pregnancy|0|||
130000579|NCT00578786|467968080|FG000|Overall Study|Not Otherwise Specified|0|||
130000580|NCT00578786|467968081|FG001|Overall Study|Not Otherwise Specified|4|||
130000581|NCT00578786|467968082|FG002|Overall Study|Not Otherwise Specified|1|||
130000582|NCT00578786|467968080|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
130000583|NCT00578786|467968081|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
130335766|NCT01386970|469199718|FG000|Overall Study|Withdrawal by Subject|0|||
130000584|NCT00578786|467968082|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
130000585|NCT00866723|467968083|FG000|Overall Study|Withdrawal by Subject|1|||
130000586|NCT00866723|467968083|FG000|Overall Study|Disease Progression|4|||
130000587|NCT00323297|467968084|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
130000588|NCT00323297|467968085|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
130000589|NCT00323297|467968084|FG000|Part A (Double Blind Randomized)|Death|0|||
130000590|NCT00323297|467968085|FG001|Part A (Double Blind Randomized)|Death|1|||
130000591|NCT00323297|467968084|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
130000592|NCT00323297|467968085|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
130000593|NCT00323297|467968084|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
130000594|NCT00323297|467968085|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
130000595|NCT00323297|467968084|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
130000596|NCT00323297|467968085|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
130000597|NCT00323297|467968084|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
130000598|NCT00323297|467968085|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
130000599|NCT00323297|467968084|FG000|Part B (Open-label)|Death|0|||
130000600|NCT00323297|467968085|FG001|Part B (Open-label)|Death|1|||
130000601|NCT00323297|467968084|FG000|Part B (Open-label)|Reason unspecified|0|||
130000602|NCT00323297|467968085|FG001|Part B (Open-label)|Reason unspecified|1|||
130000603|NCT00323297|467968084|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
130000604|NCT00323297|467968085|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
130000605|NCT00323297|467968084|FG000|Part B (Open-label)|Lack of Efficacy|3|||
130000606|NCT00323297|467968085|FG001|Part B (Open-label)|Lack of Efficacy|1|||
130000607|NCT00323297|467968084|FG000|Part B (Open-label)|Adverse Event|5|||
130000608|NCT00323297|467968085|FG001|Part B (Open-label)|Adverse Event|5|||
130000609|NCT00323297|467968084|FG000|Part B (Open-label)|Protocol Violation|0|||
130000610|NCT00323297|467968085|FG001|Part B (Open-label)|Protocol Violation|1|||
130000611|NCT01641809|467968086|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
130000612|NCT01641809|467968087|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
130000613|NCT01641809|467968088|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
130000614|NCT01641809|467968089|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
130000615|NCT01641809|467968086|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
130000616|NCT01641809|467968087|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
130000617|NCT01641809|467968088|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
130000618|NCT01641809|467968089|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
130000619|NCT01641809|467968086|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
130000620|NCT01641809|467968087|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
130000621|NCT01641809|467968088|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
130000622|NCT01641809|467968089|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
130000623|NCT01641809|467968086|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
130000624|NCT01641809|467968087|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
130335767|NCT01386970|469199719|FG001|Overall Study|Withdrawal by Subject|1|||
130335768|NCT01386970|469199718|FG000|Overall Study|Adverse Event|4|||
130335769|NCT01386970|469199719|FG001|Overall Study|Adverse Event|1|||
130335770|NCT04931888|469199720|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
130335771|NCT04931888|469199721|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
130335772|NCT04931888|469199722|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
130335773|NCT04931888|469199723|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
130335774|NCT01976741|469199735|FG000|Overall Study|Withdrawal by Subject|1|||
130000625|NCT01641809|467968088|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
130000626|NCT01641809|467968089|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
130000627|NCT01641809|467968086|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
130000628|NCT01641809|467968087|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
130000629|NCT01641809|467968088|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
130000630|NCT01641809|467968089|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
130000631|NCT01641809|467968086|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
130000632|NCT01641809|467968087|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
130000633|NCT01641809|467968088|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
130000634|NCT01641809|467968089|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
130000635|NCT01641809|467968086|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
130000636|NCT01641809|467968087|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
130000637|NCT01641809|467968088|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
130000638|NCT01641809|467968089|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
130335775|NCT01976741|469199736|FG001|Overall Study|Withdrawal by Subject|0|||
130000639|NCT01641809|467968086|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
130000640|NCT01641809|467968087|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
130000641|NCT01641809|467968088|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
130000642|NCT01641809|467968089|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
130000643|NCT01641809|467968086|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
130000644|NCT01641809|467968087|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
130000645|NCT01641809|467968088|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
130000646|NCT01641809|467968089|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
130000647|NCT01641809|467968086|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
130000648|NCT01641809|467968087|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
130000649|NCT01641809|467968088|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
130000650|NCT01641809|467968089|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
130000651|NCT01641809|467968086|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
130000652|NCT01641809|467968087|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
130000653|NCT01641809|467968088|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
130000654|NCT01641809|467968089|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
130000655|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
130000656|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
130000657|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
130000658|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
130000659|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
130000660|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
130000661|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
130000662|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
130000663|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
130000664|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
130000665|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
130000666|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
130000667|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
130000668|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
130000669|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
130000670|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
130000671|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
130000672|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
130000673|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
130000674|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
130000675|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
130000676|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
130000677|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
130000678|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
130000679|NCT01641809|467968086|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
130000680|NCT01641809|467968087|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
130000681|NCT01641809|467968088|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
130000682|NCT01641809|467968089|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
130000683|NCT01251120|467968091|FG000|Overall Study|Lack of Efficacy|0|||
130000684|NCT01251120|467968092|FG001|Overall Study|Lack of Efficacy|1|||
130000685|NCT01822522|467968093|FG000|Overall Study|Adverse Event|1|||
130000686|NCT01822522|467968094|FG001|Overall Study|Adverse Event|1|||
130000687|NCT01822522|467968095|FG002|Overall Study|Adverse Event|1|||
130000688|NCT01822522|467968096|FG003|Overall Study|Adverse Event|0|||
130000689|NCT01822522|467968097|FG004|Overall Study|Adverse Event|0|||
130000690|NCT01822522|467968098|FG005|Overall Study|Adverse Event|1|||
130000691|NCT01822522|467968093|FG000|Overall Study|Death|3|||
130000692|NCT01822522|467968094|FG001|Overall Study|Death|0|||
130000693|NCT01822522|467968095|FG002|Overall Study|Death|2|||
130000694|NCT01822522|467968096|FG003|Overall Study|Death|0|||
130000695|NCT01822522|467968097|FG004|Overall Study|Death|0|||
130000696|NCT01822522|467968098|FG005|Overall Study|Death|0|||
130000697|NCT01822522|467968093|FG000|Overall Study|Lost to Follow-up|0|||
130000698|NCT01822522|467968094|FG001|Overall Study|Lost to Follow-up|0|||
130000699|NCT01822522|467968095|FG002|Overall Study|Lost to Follow-up|1|||
130000700|NCT01822522|467968096|FG003|Overall Study|Lost to Follow-up|1|||
130000701|NCT01822522|467968097|FG004|Overall Study|Lost to Follow-up|0|||
130000702|NCT01822522|467968098|FG005|Overall Study|Lost to Follow-up|1|||
130000703|NCT01822522|467968093|FG000|Overall Study|Withdrawal by Subject|0|||
130000704|NCT01822522|467968094|FG001|Overall Study|Withdrawal by Subject|0|||
130000705|NCT01822522|467968095|FG002|Overall Study|Withdrawal by Subject|0|||
130000706|NCT01822522|467968096|FG003|Overall Study|Withdrawal by Subject|1|||
130000707|NCT01822522|467968097|FG004|Overall Study|Withdrawal by Subject|0|||
130000708|NCT01822522|467968098|FG005|Overall Study|Withdrawal by Subject|0|||
130000709|NCT01822522|467968093|FG000|Overall Study|Lack of Efficacy|0|||
130000710|NCT01822522|467968094|FG001|Overall Study|Lack of Efficacy|0|||
130000711|NCT01822522|467968095|FG002|Overall Study|Lack of Efficacy|0|||
130000712|NCT01822522|467968096|FG003|Overall Study|Lack of Efficacy|0|||
130000713|NCT01822522|467968097|FG004|Overall Study|Lack of Efficacy|0|||
130000714|NCT01822522|467968098|FG005|Overall Study|Lack of Efficacy|2|||
130216135|NCT02030119|468753955|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
130000715|NCT02558231|467968099|FG000|Overall Study|Death|4|||
130000716|NCT02558231|467968100|FG001|Overall Study|Death|12|||
130000717|NCT02558231|467968099|FG000|Overall Study|Lost to Follow-up|7|||
130000718|NCT02558231|467968100|FG001|Overall Study|Lost to Follow-up|4|||
130000719|NCT02558231|467968099|FG000|Overall Study|Withdrawal by Subject|7|||
130000720|NCT02558231|467968100|FG001|Overall Study|Withdrawal by Subject|4|||
130000721|NCT02558231|467968099|FG000|Overall Study|Physician Decision|7|||
130000722|NCT02558231|467968100|FG001|Overall Study|Physician Decision|5|||
130000723|NCT02558231|467968099|FG000|Overall Study|Sponsor Decision|0|||
130000724|NCT02558231|467968100|FG001|Overall Study|Sponsor Decision|1|||
130000725|NCT01006265|467968101|FG000|Overall Study|Lost to Follow-up|1|||
130000726|NCT01006265|467968102|FG001|Overall Study|Lost to Follow-up|0|||
130000727|NCT01006265|467968103|FG002|Overall Study|Lost to Follow-up|1|||
130000728|NCT01006265|467968104|FG003|Overall Study|Lost to Follow-up|0|||
130000729|NCT01006265|467968101|FG000|Overall Study|Withdrawal by Subject|4|||
130000730|NCT01006265|467968102|FG001|Overall Study|Withdrawal by Subject|7|||
130000731|NCT01006265|467968103|FG002|Overall Study|Withdrawal by Subject|5|||
130000732|NCT01006265|467968104|FG003|Overall Study|Withdrawal by Subject|5|||
130000733|NCT01006265|467968101|FG000|Overall Study|Administrative reason|1|||
130000734|NCT01006265|467968102|FG001|Overall Study|Administrative reason|2|||
130000735|NCT01006265|467968103|FG002|Overall Study|Administrative reason|3|||
130000736|NCT01006265|467968104|FG003|Overall Study|Administrative reason|0|||
130000737|NCT04233164|467968105|FG000|Overall Study|Unable to obtain specimen|0|||
130000738|NCT04233164|467968106|FG001|Overall Study|Unable to obtain specimen|1|||
130000739|NCT04014361|467968107|FG000|Period 2|Physician Decision|0|||
130000740|NCT04014361|467968108|FG001|Period 2|Physician Decision|0|||
130000741|NCT04014361|467968109|FG002|Period 2|Physician Decision|0|||
130000742|NCT04014361|467968110|FG003|Period 2|Physician Decision|1|||
130000743|NCT04014361|467968111|FG004|Period 2|Physician Decision|0|||
130000744|NCT04014361|467968112|FG005|Period 2|Physician Decision|0|||
130000745|NCT04014361|467968113|FG006|Period 2|Physician Decision|0|||
130000746|NCT04014361|467968114|FG007|Period 2|Physician Decision|0|||
130000747|NCT02593786|467968116|FG000|Overall Study|Disease progression|12|||
130000748|NCT02593786|467968117|FG001|Overall Study|Disease progression|16|||
130000749|NCT02593786|467968118|FG002|Overall Study|Disease progression|10|||
130000750|NCT02593786|467968119|FG003|Overall Study|Disease progression|7|||
130000751|NCT02593786|467968116|FG000|Overall Study|Study drug toxicity|1|||
130000752|NCT02593786|467968117|FG001|Overall Study|Study drug toxicity|0|||
130000753|NCT02593786|467968118|FG002|Overall Study|Study drug toxicity|0|||
130000754|NCT02593786|467968119|FG003|Overall Study|Study drug toxicity|0|||
130000755|NCT02593786|467968116|FG000|Overall Study|Adverse event unrelated to study drug|1|||
130000756|NCT02593786|467968117|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130000757|NCT02593786|467968118|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130000758|NCT02593786|467968119|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130000759|NCT02593786|467968116|FG000|Overall Study|Participant request to discontinue study therapy|0|||
130000760|NCT02593786|467968117|FG001|Overall Study|Participant request to discontinue study therapy|2|||
130000761|NCT02593786|467968118|FG002|Overall Study|Participant request to discontinue study therapy|0|||
130000762|NCT02593786|467968119|FG003|Overall Study|Participant request to discontinue study therapy|0|||
130000763|NCT02593786|467968116|FG000|Overall Study|Other reasons|1|||
130000764|NCT02593786|467968117|FG001|Overall Study|Other reasons|1|||
130000765|NCT02593786|467968118|FG002|Overall Study|Other reasons|0|||
130000766|NCT02593786|467968119|FG003|Overall Study|Other reasons|5|||
130000767|NCT01130051|467968120|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
130000768|NCT01130051|467968121|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
130000769|NCT01130051|467968120|FG000|Washout Period of 14 Days|Protocol Violation|1|||
130000770|NCT01130051|467968121|FG001|Washout Period of 14 Days|Protocol Violation|1|||
130000771|NCT04252287|467968125|FG000|Overall Study|Death|5|||
130000772|NCT04252287|467968126|FG001|Overall Study|Death|3|||
130000773|NCT04252287|467968125|FG000|Overall Study|Lost to Follow-up|4|||
130335776|NCT01976741|469199737|FG002|Overall Study|Withdrawal by Subject|1|||
130335777|NCT01976741|469199738|FG003|Overall Study|Withdrawal by Subject|1|||
130335778|NCT01976741|469199739|FG004|Overall Study|Withdrawal by Subject|0|||
130000774|NCT04252287|467968126|FG001|Overall Study|Lost to Follow-up|6|||
130000775|NCT04252287|467968125|FG000|Overall Study|Withdrawal by Subject|19|||
130000776|NCT04252287|467968126|FG001|Overall Study|Withdrawal by Subject|16|||
130000777|NCT04252287|467968125|FG000|Overall Study|Protocol Violation|3|||
130000778|NCT04252287|467968126|FG001|Overall Study|Protocol Violation|4|||
130000779|NCT00835120|467968132|FG000|Overall Study|Lack of Efficacy|1|||
130000780|NCT00835120|467968132|FG000|Overall Study|Lost to Follow-up|3|||
130000781|NCT00835120|467968132|FG000|Overall Study|Adverse Event|2|||
130000782|NCT00835120|467968132|FG000|Overall Study|Withdrawal by Subject|2|||
130000783|NCT01298518|467968134|FG000|Overall Study|Withdrawal by Subject|0|||
130000784|NCT01298518|467968135|FG001|Overall Study|Withdrawal by Subject|0|||
130000785|NCT01298518|467968136|FG002|Overall Study|Withdrawal by Subject|1|||
130000786|NCT02273726|467968137|FG000|Overall Study|Death|70|||
130000787|NCT02273726|467968138|FG001|Overall Study|Death|62|||
130000788|NCT02273726|467968137|FG000|Overall Study|Withdrawal by Subject|41|||
130000789|NCT02273726|467968138|FG001|Overall Study|Withdrawal by Subject|29|||
130335779|NCT01976741|469199740|FG005|Overall Study|Withdrawal by Subject|0|||
130335780|NCT01976741|469199741|FG006|Overall Study|Withdrawal by Subject|1|||
130335781|NCT01976741|469199742|FG007|Overall Study|Withdrawal by Subject|4|||
130335782|NCT01976741|469199743|FG008|Overall Study|Withdrawal by Subject|0|||
130335783|NCT01976741|469199744|FG009|Overall Study|Withdrawal by Subject|0|||
130335784|NCT01976741|469199735|FG000|Overall Study|Adverse Event|0|||
130335785|NCT01976741|469199736|FG001|Overall Study|Adverse Event|0|||
130335786|NCT01976741|469199737|FG002|Overall Study|Adverse Event|2|||
130335787|NCT01976741|469199738|FG003|Overall Study|Adverse Event|0|||
130335788|NCT01976741|469199739|FG004|Overall Study|Adverse Event|0|||
130335789|NCT01976741|469199740|FG005|Overall Study|Adverse Event|0|||
130335790|NCT01976741|469199741|FG006|Overall Study|Adverse Event|3|||
130335791|NCT01976741|469199742|FG007|Overall Study|Adverse Event|8|||
130335792|NCT01976741|469199743|FG008|Overall Study|Adverse Event|1|||
130335793|NCT01976741|469199744|FG009|Overall Study|Adverse Event|4|||
130335794|NCT02167139|469199745|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
129884371|NCT03893825|467536380|FG001|Overall Study|Other than specified|6|||
130000790|NCT02273726|467968137|FG000|Overall Study|Kidney transplant|31|||
130000791|NCT02273726|467968138|FG001|Overall Study|Kidney transplant|39|||
130000792|NCT02273726|467968137|FG000|Overall Study|Physician Decision|30|||
130000793|NCT02273726|467968138|FG001|Overall Study|Physician Decision|15|||
130000794|NCT02273726|467968137|FG000|Overall Study|Adverse Event|27|||
130000795|NCT02273726|467968138|FG001|Overall Study|Adverse Event|9|||
130000796|NCT02273726|467968137|FG000|Overall Study|Lost to Follow-up|6|||
130000797|NCT02273726|467968138|FG001|Overall Study|Lost to Follow-up|3|||
130000798|NCT02273726|467968137|FG000|Overall Study|Lack of Efficacy|6|||
130000799|NCT02273726|467968138|FG001|Overall Study|Lack of Efficacy|1|||
130000800|NCT02273726|467968137|FG000|Overall Study|Protocol Violation|4|||
130000801|NCT02273726|467968138|FG001|Overall Study|Protocol Violation|0|||
130000802|NCT02273726|467968137|FG000|Overall Study|Other than specified|28|||
130000803|NCT02273726|467968138|FG001|Overall Study|Other than specified|30|||
130000804|NCT03610165|467968139|FG000|Overall Study|Device didn't work|0|||
130000805|NCT03610165|467968140|FG001|Overall Study|Device didn't work|1|||
130000806|NCT02129205|467968141|FG000|Overall Study|Withdrawal by Subject|0|||
130000807|NCT02129205|467968142|FG001|Overall Study|Withdrawal by Subject|0|||
130000808|NCT02129205|467968143|FG002|Overall Study|Withdrawal by Subject|0|||
130000809|NCT02129205|467968144|FG003|Overall Study|Withdrawal by Subject|0|||
130000810|NCT02129205|467968145|FG004|Overall Study|Withdrawal by Subject|1|||
130000811|NCT02129205|467968146|FG005|Overall Study|Withdrawal by Subject|1|||
130000812|NCT02129205|467968147|FG006|Overall Study|Withdrawal by Subject|1|||
130000813|NCT02129205|467968148|FG007|Overall Study|Withdrawal by Subject|0|||
130000814|NCT02129205|467968149|FG008|Overall Study|Withdrawal by Subject|1|||
130000815|NCT02129205|467968150|FG009|Overall Study|Withdrawal by Subject|0|||
130000816|NCT02129205|467968141|FG000|Overall Study|Other|1|||
130000817|NCT02129205|467968142|FG001|Overall Study|Other|0|||
130000818|NCT02129205|467968143|FG002|Overall Study|Other|0|||
130000819|NCT02129205|467968144|FG003|Overall Study|Other|0|||
130000820|NCT02129205|467968145|FG004|Overall Study|Other|2|||
130000821|NCT02129205|467968146|FG005|Overall Study|Other|3|||
130000822|NCT02129205|467968147|FG006|Overall Study|Other|3|||
130000823|NCT02129205|467968148|FG007|Overall Study|Other|2|||
130000824|NCT02129205|467968149|FG008|Overall Study|Other|1|||
130000825|NCT02129205|467968150|FG009|Overall Study|Other|0|||
130000826|NCT01810016|467968151|FG000|Overall Study|Progressive disease|1|||
130000827|NCT01810016|467968152|FG001|Overall Study|Progressive disease|1|||
130000828|NCT01810016|467968153|FG002|Overall Study|Progressive disease|0|||
130000829|NCT01810016|467968151|FG000|Overall Study|Death|0|||
130000830|NCT01810016|467968152|FG001|Overall Study|Death|0|||
130000831|NCT01810016|467968153|FG002|Overall Study|Death|1|||
130098740|NCT03426995|468319305|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130000832|NCT00708175|467968154|FG000|Overall Study|Adverse Event|4|||
130000833|NCT00708175|467968155|FG001|Overall Study|Adverse Event|5|||
130000834|NCT00708175|467968154|FG000|Overall Study|Protocol Violation|2|||
130000835|NCT00708175|467968155|FG001|Overall Study|Protocol Violation|3|||
130000836|NCT00708175|467968154|FG000|Overall Study|Lost to Follow-up|5|||
130000837|NCT00708175|467968155|FG001|Overall Study|Lost to Follow-up|3|||
130000838|NCT00708175|467968154|FG000|Overall Study|Withdrawal by Subject|5|||
130000839|NCT00708175|467968155|FG001|Overall Study|Withdrawal by Subject|7|||
130000840|NCT00708175|467968154|FG000|Overall Study|BMD loss >7%|2|||
130000841|NCT00708175|467968155|FG001|Overall Study|BMD loss >7%|3|||
130000842|NCT04435782|467968161|FG000|Overall Study|Study terminated by sponsor|4|||
130000843|NCT03672461|467968162|FG000|Overall Study|COVID Related|4|||
130000844|NCT03672461|467968163|FG001|Overall Study|COVID Related|2|||
130000845|NCT03672461|467968162|FG000|Overall Study|Adverse Event|2|||
130000846|NCT03672461|467968163|FG001|Overall Study|Adverse Event|0|||
130335795|NCT02167139|469199746|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
130335796|NCT02167139|469199747|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
130000847|NCT03672461|467968162|FG000|Overall Study|Serious Adverse Event|0|||
130335797|NCT02167139|469199748|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
130000848|NCT03672461|467968163|FG001|Overall Study|Serious Adverse Event|1|||
130000849|NCT03672461|467968162|FG000|Overall Study|Too Busy|3|||
130000850|NCT03672461|467968163|FG001|Overall Study|Too Busy|1|||
130000851|NCT03672461|467968162|FG000|Overall Study|Lost to Follow-up|1|||
130000852|NCT03672461|467968163|FG001|Overall Study|Lost to Follow-up|2|||
130000853|NCT03672461|467968162|FG000|Overall Study|Family|2|||
130000854|NCT03672461|467968163|FG001|Overall Study|Family|2|||
130000855|NCT03672461|467968162|FG000|Overall Study|No remote technology access|0|||
130000856|NCT03672461|467968163|FG001|Overall Study|No remote technology access|1|||
130000857|NCT03672461|467968162|FG000|Overall Study|Withdrawal by Subject|1|||
130000858|NCT03672461|467968163|FG001|Overall Study|Withdrawal by Subject|0|||
130000859|NCT03672461|467968162|FG000|Overall Study|Cannot tolerate intervention|1|||
130000860|NCT03672461|467968163|FG001|Overall Study|Cannot tolerate intervention|0|||
130000861|NCT03672461|467968162|FG000|Overall Study|Incomplete outcome data|6|||
130000862|NCT03672461|467968163|FG001|Overall Study|Incomplete outcome data|1|||
130000863|NCT07052682|467968164|FG000|Overall Study|Withdrawal by Subject|4|||
130000864|NCT04667247|467968165|FG000|Overall Study|Withdrawal by Subject|0|||
130000865|NCT04667247|467968166|FG001|Overall Study|Withdrawal by Subject|1|||
130000866|NCT01444651|467969877|FG000|Overall Study|Adverse Event|3|||
130000867|NCT01444651|467969878|FG001|Overall Study|Adverse Event|2|||
130000868|NCT01444651|467969877|FG000|Overall Study|Lost to Follow-up|5|||
130000869|NCT01444651|467969878|FG001|Overall Study|Lost to Follow-up|5|||
130000870|NCT01444651|467969877|FG000|Overall Study|Non-fasting|2|||
130000871|NCT01444651|467969878|FG001|Overall Study|Non-fasting|1|||
130000872|NCT01444651|467969877|FG000|Overall Study|Missing data|1|||
130000873|NCT01444651|467969878|FG001|Overall Study|Missing data|1|||
130000874|NCT01436071|467969879|FG000|Overall Study|Adverse Event|1|||
130000875|NCT01436071|467969880|FG001|Overall Study|Adverse Event|0|||
130000876|NCT01436071|467969879|FG000|Overall Study|Lack of Efficacy|16|||
130000877|NCT01436071|467969880|FG001|Overall Study|Lack of Efficacy|7|||
130000878|NCT01436071|467969879|FG000|Overall Study|Protocol Violation|0|||
130000879|NCT01436071|467969880|FG001|Overall Study|Protocol Violation|1|||
130000880|NCT01436071|467969879|FG000|Overall Study|Lost to Follow-up|3|||
130000881|NCT01436071|467969880|FG001|Overall Study|Lost to Follow-up|1|||
130000882|NCT01436071|467969879|FG000|Overall Study|Physician Decision|1|||
130000883|NCT01436071|467969880|FG001|Overall Study|Physician Decision|0|||
130000884|NCT01436071|467969879|FG000|Overall Study|Withdrawal by Subject|2|||
130000885|NCT01436071|467969880|FG001|Overall Study|Withdrawal by Subject|2|||
130000886|NCT01436071|467969879|FG000|Overall Study|Did Not Receive Trial Medication|3|||
130000887|NCT01436071|467969880|FG001|Overall Study|Did Not Receive Trial Medication|3|||
130000888|NCT02462928|467969884|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130000889|NCT02462928|467969885|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130000890|NCT02462928|467969886|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
130000891|NCT02462928|467969884|FG000|Overall Study|Adverse Event|47|||
130000892|NCT02462928|467969885|FG001|Overall Study|Adverse Event|51|||
130000893|NCT02462928|467969886|FG002|Overall Study|Adverse Event|25|||
130000894|NCT02462928|467969884|FG000|Overall Study|Lack of Efficacy|3|||
130000895|NCT02462928|467969885|FG001|Overall Study|Lack of Efficacy|8|||
130000896|NCT02462928|467969886|FG002|Overall Study|Lack of Efficacy|3|||
130000897|NCT02462928|467969884|FG000|Overall Study|Lost to Follow-up|4|||
130000898|NCT02462928|467969885|FG001|Overall Study|Lost to Follow-up|4|||
130000899|NCT02462928|467969886|FG002|Overall Study|Lost to Follow-up|1|||
130000900|NCT02462928|467969884|FG000|Overall Study|Withdrawal by Patient|31|||
130000901|NCT02462928|467969885|FG001|Overall Study|Withdrawal by Patient|21|||
130000902|NCT02462928|467969886|FG002|Overall Study|Withdrawal by Patient|21|||
130000903|NCT02462928|467969884|FG000|Overall Study|Protocol Violation|0|||
130000904|NCT02462928|467969885|FG001|Overall Study|Protocol Violation|1|||
130000905|NCT02462928|467969886|FG002|Overall Study|Protocol Violation|0|||
130000906|NCT02462928|467969884|FG000|Overall Study|Reason not Specified|4|||
130000907|NCT02462928|467969885|FG001|Overall Study|Reason not Specified|6|||
129884372|NCT00708305|467536383|FG000|Period 1|Protocol Violation|1|||
130000908|NCT02462928|467969886|FG002|Overall Study|Reason not Specified|5|||
130000909|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
130000910|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
130000911|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
130000912|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
130000913|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
130000914|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
130000915|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
130000916|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
130000917|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
130000918|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
130000919|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
130000920|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
130000921|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
130000922|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
130000923|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
130000924|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
130000925|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
130000926|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
130000927|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Early termination|0|||
130000928|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Early termination|0|||
130000929|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Early termination|34|||
130000930|NCT01493557|467969887|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
130000931|NCT01493557|467969888|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
130000932|NCT01493557|467969889|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
130000933|NCT01493557|467969887|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
130000934|NCT01493557|467969888|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
130000935|NCT01493557|467969889|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
130000936|NCT01493557|467969887|FG000|Randomized to Management Strategies|Other adverse event|8|||
130000937|NCT01493557|467969888|FG001|Randomized to Management Strategies|Other adverse event|5|||
130000938|NCT01493557|467969889|FG002|Randomized to Management Strategies|Other adverse event|0|||
130000939|NCT01493557|467969887|FG000|Randomized to Management Strategies|Protocol Violation|3|||
130000940|NCT01493557|467969888|FG001|Randomized to Management Strategies|Protocol Violation|0|||
130000941|NCT01493557|467969889|FG002|Randomized to Management Strategies|Protocol Violation|0|||
130000942|NCT01493557|467969887|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
130335798|NCT02167139|469199745|FG000|Randomised, Double-blind|Adverse Event|2|||
130335799|NCT02167139|469199746|FG001|Randomised, Double-blind|Adverse Event|9|||
130335800|NCT02167139|469199747|FG002|Randomised, Double-blind|Adverse Event|0|||
130335801|NCT02167139|469199748|FG003|Randomised, Double-blind|Adverse Event|0|||
130335802|NCT02167139|469199745|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
130335803|NCT02167139|469199746|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
130335804|NCT02167139|469199747|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
130335805|NCT02167139|469199748|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
130335806|NCT02167139|469199745|FG000|Randomised, Double-blind|Other|3|||
130335807|NCT02167139|469199746|FG001|Randomised, Double-blind|Other|0|||
130335808|NCT02167139|469199747|FG002|Randomised, Double-blind|Other|0|||
130335809|NCT02167139|469199748|FG003|Randomised, Double-blind|Other|0|||
130335810|NCT02167139|469199745|FG000|Transition-extension|Adverse Event|2|||
130335811|NCT02167139|469199746|FG001|Transition-extension|Adverse Event|0|||
130335812|NCT02167139|469199747|FG002|Transition-extension|Adverse Event|2|||
130335813|NCT02167139|469199748|FG003|Transition-extension|Adverse Event|3|||
130335814|NCT02167139|469199745|FG000|Transition-extension|Withdrawal by Subject|2|||
130335815|NCT02167139|469199746|FG001|Transition-extension|Withdrawal by Subject|0|||
130335816|NCT02167139|469199747|FG002|Transition-extension|Withdrawal by Subject|4|||
130335817|NCT02167139|469199748|FG003|Transition-extension|Withdrawal by Subject|1|||
130335818|NCT02167139|469199745|FG000|Transition-extension|Lack of Efficacy|0|||
130335819|NCT02167139|469199746|FG001|Transition-extension|Lack of Efficacy|0|||
130335820|NCT02167139|469199747|FG002|Transition-extension|Lack of Efficacy|1|||
130335821|NCT02167139|469199748|FG003|Transition-extension|Lack of Efficacy|1|||
130335822|NCT02167139|469199745|FG000|Transition-extension|Other|1|||
130335823|NCT02167139|469199746|FG001|Transition-extension|Other|0|||
130335824|NCT02167139|469199747|FG002|Transition-extension|Other|1|||
130335825|NCT02167139|469199748|FG003|Transition-extension|Other|0|||
130335826|NCT02167139|469199745|FG000|Transition-extension|Lost to Follow-up|1|||
130335827|NCT02167139|469199746|FG001|Transition-extension|Lost to Follow-up|0|||
130335828|NCT02167139|469199747|FG002|Transition-extension|Lost to Follow-up|0|||
130335829|NCT02167139|469199748|FG003|Transition-extension|Lost to Follow-up|0|||
130335830|NCT03350672|469199751|FG000|Overall Study|Withdrawal by Subject|7|||
130335831|NCT03350672|469199752|FG001|Overall Study|Withdrawal by Subject|0|||
130335832|NCT03350672|469199753|FG002|Overall Study|Withdrawal by Subject|0|||
130335833|NCT02504216|469199754|FG000|Overall Study|Lost to Follow-up|3|||
130335834|NCT02504216|469199755|FG001|Overall Study|Lost to Follow-up|3|||
130335835|NCT02504216|469199754|FG000|Overall Study|Withdrawal by Subject|8|||
130335836|NCT02504216|469199755|FG001|Overall Study|Withdrawal by Subject|12|||
130335837|NCT00223080|469199756|FG000|Overall Study|Withdrawal by Subject|253|||
130000943|NCT01493557|467969888|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
130000944|NCT01493557|467969889|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
130335838|NCT00223080|469199757|FG001|Overall Study|Withdrawal by Subject|232|||
130335839|NCT00223080|469199756|FG000|Overall Study|Required contraindicated med|0|||
130335840|NCT00223080|469199757|FG001|Overall Study|Required contraindicated med|1|||
130335841|NCT00223080|469199756|FG000|Overall Study|Non-compliant|7|||
130335842|NCT00223080|469199757|FG001|Overall Study|Non-compliant|7|||
130335843|NCT00223080|469199756|FG000|Overall Study|Moved from study area|37|||
130335844|NCT00223080|469199757|FG001|Overall Study|Moved from study area|47|||
130335845|NCT00223080|469199756|FG000|Overall Study|Lost to Follow-up|259|||
130335846|NCT00223080|469199757|FG001|Overall Study|Lost to Follow-up|284|||
130335847|NCT00223080|469199756|FG000|Overall Study|Death|85|||
130335848|NCT00223080|469199757|FG001|Overall Study|Death|74|||
130335849|NCT00223080|469199756|FG000|Overall Study|Other|14|||
130335850|NCT00223080|469199757|FG001|Overall Study|Other|11|||
130335851|NCT00223080|469199756|FG000|Overall Study|Reason not provided|141|||
130335852|NCT00223080|469199757|FG001|Overall Study|Reason not provided|140|||
130000945|NCT01493557|467969887|FG000|Randomized to Management Strategies|Other than stated above|1|||
130000946|NCT01493557|467969888|FG001|Randomized to Management Strategies|Other than stated above|3|||
130335853|NCT00223080|469199756|FG000|Overall Study|Adverse Event|0|||
130335854|NCT00223080|469199757|FG001|Overall Study|Adverse Event|1|||
130335855|NCT02598583|469199758|FG000|Extension Period|Withdrawal by Subject|1|||
130335856|NCT02598583|469199759|FG001|Extension Period|Withdrawal by Subject|0|||
130335857|NCT03237286|469199760|FG000|Overall Study|Withdrawal by Subject|1|||
130335858|NCT03237286|469199761|FG001|Overall Study|Withdrawal by Subject|0|||
130335859|NCT03237286|469199762|FG002|Overall Study|Withdrawal by Subject|2|||
130000947|NCT01493557|467969889|FG002|Randomized to Management Strategies|Other than stated above|0|||
130000948|NCT01493557|467969887|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
130000949|NCT01493557|467969888|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
130000950|NCT01493557|467969889|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
130000951|NCT01493557|467969887|FG000|Adding the Second Strategy|Other adverse event|1|||
130000952|NCT01493557|467969888|FG001|Adding the Second Strategy|Other adverse event|2|||
130000953|NCT01493557|467969889|FG002|Adding the Second Strategy|Other adverse event|0|||
130000954|NCT01493557|467969887|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
130000955|NCT01493557|467969888|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
130000956|NCT01493557|467969889|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
130000957|NCT01890148|467969904|FG000|Overall Study|Adverse Event|1|||
130000958|NCT01215175|467969905|FG000|Overall Study|Lost to Follow-up|0|||
130000959|NCT01215175|467969906|FG001|Overall Study|Lost to Follow-up|1|||
130000960|NCT01215175|467969907|FG002|Overall Study|Lost to Follow-up|0|||
130000961|NCT01215175|467969908|FG003|Overall Study|Lost to Follow-up|1|||
130000962|NCT01215175|467969909|FG004|Overall Study|Lost to Follow-up|0|||
130000963|NCT01678209|467969910|FG000|Overall Study|could not scan twice|1|||
130000964|NCT01678209|467969911|FG001|Overall Study|could not scan twice|1|||
130000965|NCT01678209|467969912|FG002|Overall Study|could not scan twice|1|||
130000966|NCT01678209|467969910|FG000|Overall Study|scheduling conflicts|0|||
130000967|NCT01678209|467969911|FG001|Overall Study|scheduling conflicts|0|||
130000968|NCT01678209|467969912|FG002|Overall Study|scheduling conflicts|1|||
130000969|NCT01678209|467969910|FG000|Overall Study|screen fail|16|||
130000970|NCT01678209|467969911|FG001|Overall Study|screen fail|17|||
130000971|NCT01678209|467969912|FG002|Overall Study|screen fail|16|||
130000972|NCT00702845|467969913|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
130000973|NCT00702845|467969914|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
130000974|NCT00702845|467969913|FG000|Overall Study|Too high ovarian response|5|||
130000975|NCT00702845|467969914|FG001|Overall Study|Too high ovarian response|1|||
130000976|NCT00702845|467969913|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
130000977|NCT00702845|467969914|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
130000978|NCT00702845|467969913|FG000|Overall Study|Insufficient ovarian response|1|||
130000979|NCT00702845|467969914|FG001|Overall Study|Insufficient ovarian response|0|||
130000980|NCT00702845|467969913|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
130000981|NCT00702845|467969914|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
130000982|NCT00702845|467969913|FG000|Overall Study|No or abnormal fertilization|4|||
130000983|NCT00702845|467969914|FG001|Overall Study|No or abnormal fertilization|2|||
130000984|NCT00702845|467969913|FG000|Overall Study|Patient's decision|2|||
130000985|NCT00702845|467969914|FG001|Overall Study|Patient's decision|1|||
130000986|NCT00702845|467969913|FG000|Overall Study|Not randomized|0|||
130000987|NCT00702845|467969914|FG001|Overall Study|Not randomized|1|||
130000988|NCT00698451|467969921|FG000|Overall Study|Adverse Event|22|||
130000989|NCT00698451|467969921|FG000|Overall Study|Physician Decision|2|||
130000990|NCT00698451|467969921|FG000|Overall Study|Protocol Violation|6|||
130000991|NCT00698451|467969921|FG000|Overall Study|Withdrawal by Subject|6|||
130000992|NCT00698451|467969921|FG000|Overall Study|Disease progression|3|||
130000993|NCT02224599|467969922|FG000|Overall Study|Physician Decision|1|||
130335860|NCT03237286|469199760|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
130335861|NCT03237286|469199761|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
130000994|NCT02224599|467969922|FG000|Overall Study|Progression of Disease|1|||
130000995|NCT00733304|467969923|FG000|Overall Study|Adverse Event|3|||
130000996|NCT00733304|467969924|FG001|Overall Study|Adverse Event|0|||
130335862|NCT03237286|469199762|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
130000997|NCT00733304|467969925|FG002|Overall Study|Adverse Event|0|||
130000998|NCT00733304|467969923|FG000|Overall Study|Lack of Efficacy|0|||
130000999|NCT00733304|467969924|FG001|Overall Study|Lack of Efficacy|0|||
130335863|NCT00947882|469199772|FG000|Overall Study|Adverse Event|0|||
130001000|NCT00733304|467969925|FG002|Overall Study|Lack of Efficacy|2|||
130001001|NCT00733304|467969923|FG000|Overall Study|Lost to Follow-up|0|||
130001002|NCT00733304|467969924|FG001|Overall Study|Lost to Follow-up|1|||
130001003|NCT00733304|467969925|FG002|Overall Study|Lost to Follow-up|0|||
130001004|NCT00733304|467969923|FG000|Overall Study|Physician Decision|3|||
130001005|NCT00733304|467969924|FG001|Overall Study|Physician Decision|1|||
130001006|NCT00733304|467969925|FG002|Overall Study|Physician Decision|3|||
130001007|NCT00733304|467969923|FG000|Overall Study|Withdrawal by Subject|1|||
130001008|NCT00733304|467969924|FG001|Overall Study|Withdrawal by Subject|1|||
130001009|NCT00733304|467969925|FG002|Overall Study|Withdrawal by Subject|0|||
130001010|NCT03155373|467969926|FG000|Overall Study|No longer required surgery|1|||
130001011|NCT03155373|467969926|FG000|Overall Study|Protocol Violation|1|||
130001012|NCT03155373|467969926|FG000|Overall Study|Death|2|||
130001013|NCT03155373|467969926|FG000|Overall Study|Withdrawal by Subject|3|||
130001014|NCT00596934|467969927|FG000|Overall Study|Protocol Violation|1|||
130001015|NCT00596934|467969927|FG000|Overall Study|Withdrawal by Subject|1|||
130001016|NCT01214187|467969930|FG000|Overall Study|Adverse Event|6|||
130001017|NCT01214187|467969931|FG001|Overall Study|Adverse Event|2|||
130001018|NCT01214187|467969930|FG000|Overall Study|Death|1|||
130001019|NCT01214187|467969931|FG001|Overall Study|Death|1|||
130001020|NCT01214187|467969930|FG000|Overall Study|Withdrawal by Subject|0|||
130001021|NCT01214187|467969931|FG001|Overall Study|Withdrawal by Subject|3|||
130001022|NCT02308007|467969935|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
130001023|NCT02308007|467969936|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
130001024|NCT02308007|467969937|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
130001025|NCT02308007|467969935|FG000|Overall Study|Positive for STD at Baseline|7|||
130001026|NCT02308007|467969936|FG001|Overall Study|Positive for STD at Baseline|11|||
130001027|NCT02308007|467969937|FG002|Overall Study|Positive for STD at Baseline|7|||
130001028|NCT02308007|467969935|FG000|Overall Study|Lost to Follow-up|3|||
130001029|NCT02308007|467969936|FG001|Overall Study|Lost to Follow-up|0|||
130001030|NCT02308007|467969937|FG002|Overall Study|Lost to Follow-up|1|||
130001031|NCT03678103|467969938|FG000|Overall Study|Withdrawn prior to completion|4|||
130001032|NCT01241552|467969943|FG000|Overall Study|Lack of Efficacy|1|||
130001033|NCT01241552|467969944|FG001|Overall Study|Lack of Efficacy|0|||
130001034|NCT01241552|467969945|FG002|Overall Study|Lack of Efficacy|0|||
130001035|NCT01241552|467969946|FG003|Overall Study|Lack of Efficacy|0|||
130001036|NCT01241552|467969943|FG000|Overall Study|Death|26|||
130001037|NCT01241552|467969944|FG001|Overall Study|Death|30|||
130001038|NCT01241552|467969945|FG002|Overall Study|Death|20|||
130001039|NCT01241552|467969946|FG003|Overall Study|Death|25|||
130001040|NCT01241552|467969943|FG000|Overall Study|Adverse Event|1|||
130001041|NCT01241552|467969944|FG001|Overall Study|Adverse Event|1|||
130001042|NCT01241552|467969945|FG002|Overall Study|Adverse Event|0|||
130001043|NCT01241552|467969946|FG003|Overall Study|Adverse Event|0|||
130001044|NCT01241552|467969943|FG000|Overall Study|Technical Problems|2|||
130001045|NCT01241552|467969944|FG001|Overall Study|Technical Problems|0|||
130001046|NCT01241552|467969945|FG002|Overall Study|Technical Problems|2|||
130001047|NCT01241552|467969946|FG003|Overall Study|Technical Problems|2|||
130001048|NCT01241552|467969943|FG000|Overall Study|Progressive Disease|0|||
130001049|NCT01241552|467969944|FG001|Overall Study|Progressive Disease|0|||
130001050|NCT01241552|467969945|FG002|Overall Study|Progressive Disease|1|||
130001051|NCT01241552|467969946|FG003|Overall Study|Progressive Disease|2|||
130001052|NCT01241552|467969943|FG000|Overall Study|Protocol Violation|0|||
130001053|NCT01241552|467969944|FG001|Overall Study|Protocol Violation|2|||
130001054|NCT01241552|467969945|FG002|Overall Study|Protocol Violation|6|||
130001055|NCT01241552|467969946|FG003|Overall Study|Protocol Violation|1|||
130001056|NCT01241552|467969943|FG000|Overall Study|Withdrawal by Subject|7|||
130001057|NCT01241552|467969944|FG001|Overall Study|Withdrawal by Subject|15|||
130001058|NCT01241552|467969945|FG002|Overall Study|Withdrawal by Subject|14|||
130001059|NCT01241552|467969946|FG003|Overall Study|Withdrawal by Subject|15|||
130001060|NCT01241552|467969943|FG000|Overall Study|Physician Decision|2|||
130001061|NCT01241552|467969944|FG001|Overall Study|Physician Decision|4|||
130001062|NCT01241552|467969945|FG002|Overall Study|Physician Decision|2|||
130001063|NCT01241552|467969946|FG003|Overall Study|Physician Decision|3|||
130001064|NCT01241552|467969943|FG000|Overall Study|Lost to Follow-up|2|||
130001065|NCT01241552|467969944|FG001|Overall Study|Lost to Follow-up|11|||
130001066|NCT01241552|467969945|FG002|Overall Study|Lost to Follow-up|15|||
130001067|NCT01241552|467969946|FG003|Overall Study|Lost to Follow-up|16|||
130001068|NCT00528567|467969947|FG000|Overall Study|Death|4|||
130001069|NCT00528567|467969948|FG001|Overall Study|Death|5|||
130001070|NCT00528567|467969947|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
130001071|NCT00528567|467969948|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
130001072|NCT00528567|467969947|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
130001073|NCT00528567|467969948|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
130001074|NCT00528567|467969947|FG000|Overall Study|Violation Criteria at Entry|3|||
130001075|NCT00528567|467969948|FG001|Overall Study|Violation Criteria at Entry|17|||
130001076|NCT00528567|467969947|FG000|Overall Study|Withdrew Consent|59|||
130001077|NCT00528567|467969948|FG001|Overall Study|Withdrew Consent|55|||
130335864|NCT00947882|469199773|FG001|Overall Study|Adverse Event|1|||
130001078|NCT00528567|467969947|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
130001079|NCT00528567|467969948|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
130001080|NCT00528567|467969947|FG000|Overall Study|Failure to Return|1|||
130001081|NCT00528567|467969948|FG001|Overall Study|Failure to Return|4|||
130001082|NCT00528567|467969947|FG000|Overall Study|Other Protocol Violation|5|||
130001083|NCT00528567|467969948|FG001|Overall Study|Other Protocol Violation|21|||
130001084|NCT00528567|467969947|FG000|Overall Study|Administrative/Other|22|||
130001085|NCT00528567|467969948|FG001|Overall Study|Administrative/Other|75|||
130001086|NCT00631189|467969951|FG000|Initial Phase|Protocol Violation|347|||
130001087|NCT00631189|467969952|FG001|Initial Phase|Protocol Violation|0|||
130001088|NCT00631189|467969953|FG002|Initial Phase|Protocol Violation|0|||
130001089|NCT00631189|467969954|FG003|Initial Phase|Protocol Violation|0|||
130001090|NCT00631189|467969951|FG000|Initial Phase|Withdrawal by Subject|4|||
130001091|NCT00631189|467969952|FG001|Initial Phase|Withdrawal by Subject|0|||
130001092|NCT00631189|467969953|FG002|Initial Phase|Withdrawal by Subject|0|||
130001093|NCT00631189|467969954|FG003|Initial Phase|Withdrawal by Subject|0|||
130001094|NCT00631189|467969951|FG000|Treatment Phase|Withdrawal by Subject|0|||
130001095|NCT00631189|467969952|FG001|Treatment Phase|Withdrawal by Subject|2|||
130001096|NCT00631189|467969953|FG002|Treatment Phase|Withdrawal by Subject|1|||
130001097|NCT00631189|467969954|FG003|Treatment Phase|Withdrawal by Subject|1|||
130001098|NCT00631189|467969951|FG000|Treatment Phase|Protocol Violation|0|||
130001099|NCT00631189|467969952|FG001|Treatment Phase|Protocol Violation|1|||
130001100|NCT00631189|467969953|FG002|Treatment Phase|Protocol Violation|6|||
130001101|NCT00631189|467969954|FG003|Treatment Phase|Protocol Violation|2|||
130001102|NCT00631189|467969951|FG000|Treatment Phase|Adverse Event|0|||
130001103|NCT00631189|467969952|FG001|Treatment Phase|Adverse Event|3|||
130001104|NCT00631189|467969953|FG002|Treatment Phase|Adverse Event|2|||
130001105|NCT00631189|467969954|FG003|Treatment Phase|Adverse Event|4|||
130001106|NCT00631189|467969951|FG000|Treatment Phase|Lost to Follow-up|0|||
130001107|NCT00631189|467969952|FG001|Treatment Phase|Lost to Follow-up|1|||
130001108|NCT00631189|467969953|FG002|Treatment Phase|Lost to Follow-up|0|||
130001109|NCT00631189|467969954|FG003|Treatment Phase|Lost to Follow-up|0|||
130001110|NCT00631189|467969951|FG000|Treatment Phase|Pregnancy|0|||
130001111|NCT00631189|467969952|FG001|Treatment Phase|Pregnancy|0|||
130001112|NCT00631189|467969953|FG002|Treatment Phase|Pregnancy|1|||
130001113|NCT00631189|467969954|FG003|Treatment Phase|Pregnancy|0|||
130001114|NCT00631189|467969951|FG000|Treatment Phase|patient did not take pravastatin|0|||
130001115|NCT00631189|467969952|FG001|Treatment Phase|patient did not take pravastatin|0|||
130001116|NCT00631189|467969953|FG002|Treatment Phase|patient did not take pravastatin|1|||
130001117|NCT00631189|467969954|FG003|Treatment Phase|patient did not take pravastatin|0|||
130001118|NCT00974090|467969955|FG000|Period 1: Double Blind Period|Adverse Event|2|||
130001119|NCT00974090|467969956|FG001|Period 1: Double Blind Period|Adverse Event|1|||
130001120|NCT00974090|467969955|FG000|Period 1: Double Blind Period|Physician Decision|1|||
130001121|NCT00974090|467969956|FG001|Period 1: Double Blind Period|Physician Decision|0|||
130001122|NCT00974090|467969955|FG000|Period 2: Open-label Period|Adverse Event|4|||
130001123|NCT00974090|467969956|FG001|Period 2: Open-label Period|Adverse Event|6|||
130001124|NCT00974090|467969955|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
130001125|NCT00974090|467969956|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
130001126|NCT00974090|467969955|FG000|Period 2: Open-label Period|Physician Decision|0|||
130001127|NCT00974090|467969956|FG001|Period 2: Open-label Period|Physician Decision|3|||
130001128|NCT00974090|467969955|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
130001129|NCT00974090|467969956|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
130001130|NCT03189862|467969957|FG000|Overall Study|Withdrawal by Subject|1|||
130001131|NCT03189862|467969958|FG001|Overall Study|Withdrawal by Subject|0|||
130001132|NCT03189862|467969957|FG000|Overall Study|Lost to Follow-up|54|||
130001133|NCT03189862|467969958|FG001|Overall Study|Lost to Follow-up|62|||
130001134|NCT01829360|467969959|FG000|Overall Study|Protocol Violation|0|||
130001135|NCT01829360|467969960|FG001|Overall Study|Protocol Violation|0|||
130001136|NCT01829360|467969961|FG002|Overall Study|Protocol Violation|1|||
130001137|NCT01829360|467969962|FG003|Overall Study|Protocol Violation|0|||
130001138|NCT03838198|467969967|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
130001139|NCT03838198|467969968|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
130001140|NCT03838198|467969969|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
130001141|NCT03838198|467969970|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
130001142|NCT03838198|467969967|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
130001143|NCT03838198|467969968|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
130001144|NCT03838198|467969969|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
130001145|NCT03838198|467969970|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
130001146|NCT01271803|467969971|FG000|Overall Study|Progressive disease|0|||
130001147|NCT01271803|467969972|FG001|Overall Study|Progressive disease|0|||
130001148|NCT01271803|467969973|FG002|Overall Study|Progressive disease|2|||
130001149|NCT01271803|467969971|FG000|Overall Study|Death|53|||
130001150|NCT01271803|467969972|FG001|Overall Study|Death|34|||
130335865|NCT00947882|469199774|FG002|Overall Study|Adverse Event|4|||
130335866|NCT00947882|469199775|FG003|Overall Study|Adverse Event|4|||
130335867|NCT00947882|469199772|FG000|Overall Study|Withdrawal by Subject|2|||
130335868|NCT00947882|469199773|FG001|Overall Study|Withdrawal by Subject|0|||
130335869|NCT00947882|469199774|FG002|Overall Study|Withdrawal by Subject|8|||
130335870|NCT00947882|469199775|FG003|Overall Study|Withdrawal by Subject|2|||
130335871|NCT00947882|469199772|FG000|Overall Study|Protocol Violation|0|||
130335872|NCT00947882|469199773|FG001|Overall Study|Protocol Violation|0|||
130335873|NCT00947882|469199774|FG002|Overall Study|Protocol Violation|1|||
130335874|NCT00947882|469199775|FG003|Overall Study|Protocol Violation|0|||
130335875|NCT00947882|469199772|FG000|Overall Study|Lost to Follow-up|0|||
130335876|NCT00947882|469199773|FG001|Overall Study|Lost to Follow-up|2|||
130335877|NCT00947882|469199774|FG002|Overall Study|Lost to Follow-up|1|||
130335878|NCT00947882|469199775|FG003|Overall Study|Lost to Follow-up|0|||
130001151|NCT01271803|467969973|FG002|Overall Study|Death|0|||
130001152|NCT01271803|467969971|FG000|Overall Study|Withdrawal by Subject|1|||
130001153|NCT01271803|467969972|FG001|Overall Study|Withdrawal by Subject|5|||
130001154|NCT01271803|467969973|FG002|Overall Study|Withdrawal by Subject|0|||
130001155|NCT01271803|467969971|FG000|Overall Study|Lost to Follow-up|1|||
130001156|NCT01271803|467969972|FG001|Overall Study|Lost to Follow-up|0|||
130001157|NCT01271803|467969973|FG002|Overall Study|Lost to Follow-up|0|||
130001158|NCT02178553|467969979|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
130335879|NCT00947882|469199772|FG000|Overall Study|Other/Unknown|10|||
130335880|NCT00947882|469199773|FG001|Overall Study|Other/Unknown|13|||
130335881|NCT00947882|469199774|FG002|Overall Study|Other/Unknown|3|||
130335882|NCT00947882|469199775|FG003|Overall Study|Other/Unknown|6|||
130335883|NCT00947882|469199772|FG000|Overall Study|Trial Terminated by Sponsor|62|||
130335884|NCT00947882|469199773|FG001|Overall Study|Trial Terminated by Sponsor|61|||
130335885|NCT00947882|469199774|FG002|Overall Study|Trial Terminated by Sponsor|62|||
130335886|NCT00947882|469199775|FG003|Overall Study|Trial Terminated by Sponsor|70|||
130001159|NCT02178553|467969980|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
130001160|NCT02178553|467969979|FG000|Overall Study|Physician Decision|0|||
130001161|NCT02178553|467969980|FG001|Overall Study|Physician Decision|4|||
130001162|NCT02178553|467969979|FG000|Overall Study|Technical problem with injection|1|||
130001163|NCT02178553|467969980|FG001|Overall Study|Technical problem with injection|3|||
130001164|NCT02187809|467969981|FG000|Overall Study|The study was terminated|3|||
130001165|NCT05085665|467969982|FG000|Overall Study|Physician Decision|2|||
130001166|NCT00778622|467969983|FG000|Overall Study|Adverse Event|5|||
130001167|NCT00778622|467969984|FG001|Overall Study|Adverse Event|4|||
130001168|NCT00778622|467969985|FG002|Overall Study|Adverse Event|7|||
130001169|NCT00778622|467969983|FG000|Overall Study|Withdrawal by Subject|4|||
130001170|NCT00778622|467969984|FG001|Overall Study|Withdrawal by Subject|5|||
130001171|NCT00778622|467969985|FG002|Overall Study|Withdrawal by Subject|5|||
130001172|NCT00778622|467969983|FG000|Overall Study|Lost to Follow-up|3|||
130001173|NCT00778622|467969984|FG001|Overall Study|Lost to Follow-up|3|||
130001174|NCT00778622|467969985|FG002|Overall Study|Lost to Follow-up|2|||
130001175|NCT00778622|467969983|FG000|Overall Study|Protocol Violation|0|||
130001176|NCT00778622|467969984|FG001|Overall Study|Protocol Violation|3|||
130001177|NCT00778622|467969985|FG002|Overall Study|Protocol Violation|0|||
130001178|NCT00778622|467969983|FG000|Overall Study|Lack of Efficacy|2|||
130001179|NCT00778622|467969984|FG001|Overall Study|Lack of Efficacy|0|||
130001180|NCT00778622|467969985|FG002|Overall Study|Lack of Efficacy|0|||
130001181|NCT00778622|467969983|FG000|Overall Study|immigration|1|||
130001182|NCT00778622|467969984|FG001|Overall Study|immigration|0|||
130001183|NCT00778622|467969985|FG002|Overall Study|immigration|0|||
130001184|NCT00778622|467969983|FG000|Overall Study|Other|1|||
130001185|NCT00778622|467969984|FG001|Overall Study|Other|0|||
130001186|NCT00778622|467969985|FG002|Overall Study|Other|1|||
130001187|NCT00890929|467969986|FG000|Overall Study|Death before treatment|2|||
130001188|NCT00890929|467969986|FG000|Overall Study|Withdrawal by Subject|3|||
130001189|NCT00890929|467969986|FG000|Overall Study|Physician Decision|1|||
130001190|NCT01840605|467969989|FG000|Overall Study|Adverse Event|0|||
130001191|NCT01840605|467969990|FG001|Overall Study|Adverse Event|1|||
130335887|NCT01262820|469199776|FG000|Overall Study|Adverse Event|5|||
129884373|NCT00708305|467536384|FG001|Period 1|Protocol Violation|0|||
130001192|NCT01840605|467969989|FG000|Overall Study|Physician Decision|2|||
130001193|NCT01840605|467969990|FG001|Overall Study|Physician Decision|1|||
130001194|NCT03065023|467969991|FG000|Overall Study|Progressive Disease|0|||
130001195|NCT03065023|467969992|FG001|Overall Study|Progressive Disease|1|||
130001196|NCT03065023|467969993|FG002|Overall Study|Progressive Disease|0|||
130001197|NCT03065023|467969994|FG003|Overall Study|Progressive Disease|0|||
130001198|NCT03065023|467969995|FG004|Overall Study|Progressive Disease|0|||
130001199|NCT03065023|467969991|FG000|Overall Study|Death|2|||
130001200|NCT03065023|467969992|FG001|Overall Study|Death|0|||
130335888|NCT01262820|469199776|FG000|Overall Study|Lack of Efficacy|9|||
130335889|NCT01262820|469199776|FG000|Overall Study|Drug held for 21+ days|1|||
130335890|NCT00104520|469199777|FG000|Overall Study|Unrelated adverse event|34|||
130001201|NCT03065023|467969993|FG002|Overall Study|Death|1|||
130335891|NCT00104520|469199778|FG001|Overall Study|Unrelated adverse event|47|||
130335892|NCT00104520|469199777|FG000|Overall Study|Study drug intolerance|0|||
130001202|NCT03065023|467969994|FG003|Overall Study|Death|1|||
130001203|NCT03065023|467969995|FG004|Overall Study|Death|0|||
130001204|NCT03065023|467969991|FG000|Overall Study|Lost to Follow-up|0|||
130001205|NCT03065023|467969992|FG001|Overall Study|Lost to Follow-up|1|||
130001206|NCT03065023|467969993|FG002|Overall Study|Lost to Follow-up|0|||
130001207|NCT03065023|467969994|FG003|Overall Study|Lost to Follow-up|0|||
130001208|NCT03065023|467969995|FG004|Overall Study|Lost to Follow-up|0|||
130001209|NCT03065023|467969991|FG000|Overall Study|Participant Decision|0|||
130001210|NCT03065023|467969992|FG001|Overall Study|Participant Decision|0|||
130001211|NCT03065023|467969993|FG002|Overall Study|Participant Decision|0|||
130001212|NCT03065023|467969994|FG003|Overall Study|Participant Decision|1|||
130001213|NCT03065023|467969995|FG004|Overall Study|Participant Decision|0|||
130001214|NCT03065023|467969991|FG000|Overall Study|Withdrawal by Subject|0|||
130001215|NCT03065023|467969992|FG001|Overall Study|Withdrawal by Subject|0|||
130001216|NCT03065023|467969993|FG002|Overall Study|Withdrawal by Subject|0|||
130001217|NCT03065023|467969994|FG003|Overall Study|Withdrawal by Subject|1|||
130001218|NCT03065023|467969995|FG004|Overall Study|Withdrawal by Subject|0|||
130001219|NCT04029961|467969996|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
130001220|NCT04029961|467969997|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
130001221|NCT04029961|467969996|FG000|Overall Study|Change in Treatment Course|0|||
130001222|NCT04029961|467969997|FG001|Overall Study|Change in Treatment Course|1|||
130001223|NCT03427125|467969998|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
130001224|NCT03427125|467969999|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
130001225|NCT03427125|467970000|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
130001226|NCT05975840|467970001|FG000|Overall Study|Other|1|||
130001227|NCT05975840|467970002|FG001|Overall Study|Other|0|||
130001228|NCT05975840|467970003|FG002|Overall Study|Other|0|||
130001229|NCT05975840|467970004|FG003|Overall Study|Other|0|||
130001230|NCT05975840|467970005|FG004|Overall Study|Other|1|||
130001231|NCT05975840|467970006|FG005|Overall Study|Other|0|||
130001232|NCT05975840|467970007|FG006|Overall Study|Other|0|||
130001233|NCT05975840|467970008|FG007|Overall Study|Other|0|||
130001234|NCT05975840|467970001|FG000|Overall Study|Lost to Follow-up|3|||
130001235|NCT05975840|467970002|FG001|Overall Study|Lost to Follow-up|6|||
130001236|NCT05975840|467970003|FG002|Overall Study|Lost to Follow-up|3|||
130001237|NCT05975840|467970004|FG003|Overall Study|Lost to Follow-up|1|||
130001238|NCT05975840|467970005|FG004|Overall Study|Lost to Follow-up|4|||
130001239|NCT05975840|467970006|FG005|Overall Study|Lost to Follow-up|1|||
130001240|NCT05975840|467970007|FG006|Overall Study|Lost to Follow-up|2|||
130001241|NCT05975840|467970008|FG007|Overall Study|Lost to Follow-up|4|||
130001242|NCT05975840|467970001|FG000|Overall Study|Migrated/moved from the study area|1|||
130001243|NCT05975840|467970002|FG001|Overall Study|Migrated/moved from the study area|0|||
130001244|NCT05975840|467970003|FG002|Overall Study|Migrated/moved from the study area|0|||
130001245|NCT05975840|467970004|FG003|Overall Study|Migrated/moved from the study area|0|||
130001246|NCT05975840|467970005|FG004|Overall Study|Migrated/moved from the study area|0|||
130001247|NCT05975840|467970006|FG005|Overall Study|Migrated/moved from the study area|0|||
130001248|NCT05975840|467970007|FG006|Overall Study|Migrated/moved from the study area|0|||
130001249|NCT05975840|467970008|FG007|Overall Study|Migrated/moved from the study area|0|||
130001250|NCT05975840|467970001|FG000|Overall Study|Withdrawal by Subject|0|||
130001251|NCT05975840|467970002|FG001|Overall Study|Withdrawal by Subject|5|||
130001252|NCT05975840|467970003|FG002|Overall Study|Withdrawal by Subject|2|||
130001253|NCT05975840|467970004|FG003|Overall Study|Withdrawal by Subject|2|||
130001254|NCT05975840|467970005|FG004|Overall Study|Withdrawal by Subject|0|||
130001255|NCT05975840|467970006|FG005|Overall Study|Withdrawal by Subject|2|||
130001256|NCT05975840|467970007|FG006|Overall Study|Withdrawal by Subject|2|||
130001257|NCT05975840|467970008|FG007|Overall Study|Withdrawal by Subject|1|||
130001258|NCT05975840|467970001|FG000|Overall Study|Protocol Violation|0|||
130001259|NCT05975840|467970002|FG001|Overall Study|Protocol Violation|1|||
130001260|NCT05975840|467970003|FG002|Overall Study|Protocol Violation|0|||
130001261|NCT05975840|467970004|FG003|Overall Study|Protocol Violation|0|||
130001262|NCT05975840|467970005|FG004|Overall Study|Protocol Violation|0|||
130001263|NCT05975840|467970006|FG005|Overall Study|Protocol Violation|0|||
130001264|NCT05975840|467970007|FG006|Overall Study|Protocol Violation|0|||
130001265|NCT05975840|467970008|FG007|Overall Study|Protocol Violation|0|||
130001266|NCT05975840|467970001|FG000|Overall Study|Adverse Event|0|||
130001267|NCT05975840|467970002|FG001|Overall Study|Adverse Event|0|||
130001268|NCT05975840|467970003|FG002|Overall Study|Adverse Event|0|||
130001269|NCT05975840|467970004|FG003|Overall Study|Adverse Event|1|||
130001270|NCT05975840|467970005|FG004|Overall Study|Adverse Event|0|||
130001271|NCT05975840|467970006|FG005|Overall Study|Adverse Event|0|||
130001272|NCT05975840|467970007|FG006|Overall Study|Adverse Event|0|||
130001273|NCT05975840|467970008|FG007|Overall Study|Adverse Event|0|||
130001274|NCT05975840|467970001|FG000|Overall Study|Death|0|||
130001275|NCT05975840|467970002|FG001|Overall Study|Death|1|||
130001276|NCT05975840|467970003|FG002|Overall Study|Death|0|||
130001277|NCT05975840|467970004|FG003|Overall Study|Death|0|||
130001278|NCT05975840|467970005|FG004|Overall Study|Death|0|||
130001279|NCT05975840|467970006|FG005|Overall Study|Death|0|||
130001280|NCT05975840|467970007|FG006|Overall Study|Death|0|||
130001281|NCT05975840|467970008|FG007|Overall Study|Death|1|||
130001282|NCT00671554|467970011|FG000|Overall Study|Disease progression|3|||
130001283|NCT02877927|467970012|FG000|Overall Study|Adverse Event|1|||
130001284|NCT02877927|467970013|FG001|Overall Study|Adverse Event|0|||
130001285|NCT02877927|467970012|FG000|Overall Study|Lost to Follow-up|37|||
130001286|NCT02877927|467970013|FG001|Overall Study|Lost to Follow-up|38|||
130001287|NCT02877927|467970012|FG000|Overall Study|Withdrawal by Subject|11|||
130001288|NCT02877927|467970013|FG001|Overall Study|Withdrawal by Subject|12|||
130001289|NCT02877927|467970012|FG000|Overall Study|Physician Decision|0|||
130001290|NCT02877927|467970013|FG001|Overall Study|Physician Decision|1|||
130001291|NCT02877927|467970012|FG000|Overall Study|Missed EOT/PTE Visit|5|||
130001292|NCT02877927|467970013|FG001|Overall Study|Missed EOT/PTE Visit|6|||
130001293|NCT06950879|467970021|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
130001294|NCT00594516|467971433|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
130001295|NCT00594516|467971434|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
130001296|NCT00594516|467971435|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
130001297|NCT00594516|467971433|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
130001298|NCT00594516|467971434|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
130001299|NCT00594516|467971435|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
130001300|NCT00594516|467971433|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
130001301|NCT00594516|467971434|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
130001302|NCT00594516|467971435|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
130001303|NCT00594516|467971433|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
130001304|NCT00594516|467971434|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
130001305|NCT00594516|467971435|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
130001306|NCT00594516|467971433|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
130001307|NCT00594516|467971434|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
130001308|NCT00594516|467971435|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
130001309|NCT00594516|467971433|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
130001310|NCT00594516|467971434|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
130001311|NCT00594516|467971435|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
130001312|NCT00594516|467971433|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
130001313|NCT00594516|467971434|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
130001314|NCT00594516|467971435|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
130001315|NCT00594516|467971433|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
130001316|NCT00594516|467971434|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
130001317|NCT00594516|467971435|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
130001318|NCT00594516|467971433|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
130001319|NCT00594516|467971434|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
130001320|NCT00594516|467971435|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
130001321|NCT02973425|467971439|FG000|Overall Study|Lost to Follow-up|49|||
130001322|NCT02973425|467971440|FG001|Overall Study|Lost to Follow-up|53|||
130001323|NCT03876171|467971441|FG000|Overall Study|Withdrawal by Subject|3|||
130001324|NCT03876171|467971442|FG001|Overall Study|Withdrawal by Subject|3|||
130001325|NCT03876171|467971441|FG000|Overall Study|Re-arrest|0|||
130001326|NCT03876171|467971442|FG001|Overall Study|Re-arrest|4|||
130001327|NCT03503513|467971443|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
130001328|NCT03503513|467971443|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
130001329|NCT03503513|467971443|FG000|Overall Study|Physician Decision|3|||
130001330|NCT03503513|467971443|FG000|Overall Study|Withdrawal by Subject|2|||
130001331|NCT03503513|467971443|FG000|Overall Study|Lost to Follow-up|1|||
130001332|NCT00929656|467971448|FG000|Overall Study|Lost to Follow-up|0|||
130001333|NCT00929656|467971449|FG001|Overall Study|Lost to Follow-up|1|||
130001334|NCT00607880|467971450|FG000|Overall Study|Unable to place port due to occlusion|1|||
130001335|NCT00607880|467971451|FG001|Overall Study|Unable to place port due to occlusion|0|||
130001336|NCT01170039|467971452|FG000|Overall Study|Withdrawal by Subject|5|||
130001337|NCT01170039|467971453|FG001|Overall Study|Withdrawal by Subject|3|||
130001338|NCT01170039|467971452|FG000|Overall Study|Lack of funding, drug not available|3|||
130001339|NCT01170039|467971453|FG001|Overall Study|Lack of funding, drug not available|3|||
130001340|NCT00908583|467971454|FG000|Phase 1|Withdrawal by Subject|1|||
130001341|NCT00908583|467971454|FG000|Phase 1|Adverse Event|4|||
130001342|NCT00908583|467971454|FG000|Phase 2|Physician Decision|1|||
130001343|NCT00908583|467971454|FG000|Phase 2|Adverse Event|1|||
130001344|NCT00908583|467971454|FG000|Phase 3|Adverse Event|2|||
130001345|NCT00908583|467971454|FG000|Phase 4|Adverse Event|1|||
130001346|NCT00908583|467971454|FG000|Phase 4|Physician Decision|1|||
130001347|NCT00908583|467971454|FG000|Phase 5|Adverse Event|3|||
130001348|NCT00993954|467971455|FG000|Overall Study|Protocol Violation|21|||
130001349|NCT00993954|467971456|FG001|Overall Study|Protocol Violation|2|||
130001350|NCT00860951|467971457|FG000|Overall Study|Withdrawal by Subject|2|||
130335893|NCT00104520|469199778|FG001|Overall Study|Study drug intolerance|1|||
130335894|NCT00104520|469199777|FG000|Overall Study|Related adverse event|13|||
130335895|NCT00104520|469199778|FG001|Overall Study|Related adverse event|15|||
130335896|NCT00104520|469199777|FG000|Overall Study|Lost to Follow-up|1|||
130335897|NCT00104520|469199778|FG001|Overall Study|Lost to Follow-up|0|||
130335898|NCT00104520|469199777|FG000|Overall Study|Noncompliance|0|||
130335899|NCT00104520|469199778|FG001|Overall Study|Noncompliance|2|||
130335900|NCT00104520|469199777|FG000|Overall Study|Personal/administrative|1|||
130335901|NCT00104520|469199778|FG001|Overall Study|Personal/administrative|1|||
130335902|NCT00104520|469199777|FG000|Overall Study|Other|1|||
130335903|NCT00104520|469199778|FG001|Overall Study|Other|5|||
130335904|NCT01026324|469199780|FG000|Follow up/Survival|Withdrawal by Subject|1|||
130335905|NCT01026324|469199781|FG001|Follow up/Survival|Withdrawal by Subject|0|||
130335906|NCT01026324|469199782|FG002|Follow up/Survival|Withdrawal by Subject|0|||
130335907|NCT05188053|469199783|FG000|Overall Study|Lost to Follow-up|23|||
130335908|NCT05188053|469199784|FG001|Overall Study|Lost to Follow-up|30|||
130335909|NCT05188053|469199783|FG000|Overall Study|Protocol Violation|16|||
130335910|NCT05188053|469199784|FG001|Overall Study|Protocol Violation|16|||
130001351|NCT00860951|467971457|FG000|Overall Study|Lost to Follow-up|5|||
130335911|NCT05188053|469199783|FG000|Overall Study|Physician Decision|3|||
130335912|NCT05188053|469199784|FG001|Overall Study|Physician Decision|0|||
130335913|NCT05188053|469199783|FG000|Overall Study|Withdrawal by Subject|0|||
130335914|NCT05188053|469199784|FG001|Overall Study|Withdrawal by Subject|1|||
130335915|NCT05334212|469199785|FG000|Overall Study|Study terminated prematurely|7|||
130335916|NCT01561313|469199786|FG000|Overall Study|Withdrawal by Subject|1|||
130335917|NCT01561313|469199787|FG001|Overall Study|Withdrawal by Subject|0|||
130335918|NCT01561313|469199786|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
130335919|NCT01561313|469199787|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
130335920|NCT04393454|469199788|FG000|Overall Study|Death|1|||
130335921|NCT04393454|469199788|FG000|Overall Study|Lost to Follow-up|1|||
130335922|NCT03304249|469199790|FG000|Overall Study|Lost to Follow-up|8|||
130335923|NCT03304249|469199791|FG001|Overall Study|Lost to Follow-up|10|||
130335924|NCT03304249|469199790|FG000|Overall Study|Withdrawal by Subject|12|||
130335925|NCT03304249|469199791|FG001|Overall Study|Withdrawal by Subject|2|||
130335926|NCT03304249|469199790|FG000|Overall Study|Moved Out of District|4|||
130335927|NCT03304249|469199791|FG001|Overall Study|Moved Out of District|2|||
130335928|NCT04189224|469199792|FG000|Period 2|Adverse Event|0|||
130335929|NCT04189224|469199793|FG001|Period 2|Adverse Event|1|||
130335930|NCT02970942|469199794|FG000|Overall Study|Death|0|||
130335931|NCT02970942|469199795|FG001|Overall Study|Death|1|||
130335932|NCT02970942|469199796|FG002|Overall Study|Death|0|||
130335933|NCT02970942|469199797|FG003|Overall Study|Death|0|||
130335934|NCT02970942|469199794|FG000|Overall Study|Lost to Follow-up|1|||
130335935|NCT02970942|469199795|FG001|Overall Study|Lost to Follow-up|0|||
130335936|NCT02970942|469199796|FG002|Overall Study|Lost to Follow-up|2|||
130335937|NCT02970942|469199797|FG003|Overall Study|Lost to Follow-up|1|||
130001352|NCT00727649|467971458|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
130001353|NCT00727649|467971459|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
130001354|NCT00727649|467971458|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
130001355|NCT00727649|467971459|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
130001356|NCT00727649|467971458|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
130001357|NCT00727649|467971459|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
130001358|NCT00727649|467971458|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
130001359|NCT00727649|467971459|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
130001360|NCT00727649|467971458|FG000|Second Intervention (4-weeks)|Death|1|||
130001361|NCT00727649|467971459|FG001|Second Intervention (4-weeks)|Death|0|||
130001362|NCT00727649|467971458|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
130001363|NCT00727649|467971459|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
130001364|NCT00727649|467971458|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
130001365|NCT00727649|467971459|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
130001366|NCT03823404|467971461|FG000|Overall Study|Lost to Follow-up|1|||
130001367|NCT03823404|467971462|FG001|Overall Study|Lost to Follow-up|2|||
130001368|NCT03823404|467971463|FG002|Overall Study|Lost to Follow-up|3|||
130001369|NCT03823404|467971461|FG000|Overall Study|Protocol Violation|2|||
130001370|NCT03823404|467971462|FG001|Overall Study|Protocol Violation|0|||
130001371|NCT03823404|467971463|FG002|Overall Study|Protocol Violation|2|||
130335938|NCT02970942|469199794|FG000|Overall Study|Withdrawal by Subject|3|||
130335939|NCT02970942|469199795|FG001|Overall Study|Withdrawal by Subject|5|||
130335940|NCT02970942|469199796|FG002|Overall Study|Withdrawal by Subject|3|||
130335941|NCT02970942|469199797|FG003|Overall Study|Withdrawal by Subject|2|||
130001372|NCT03823404|467971461|FG000|Overall Study|Adverse Event|35|||
130335942|NCT02529553|469199798|FG000|Overall Study|Progressive Disease|1|||
130335943|NCT02529553|469199799|FG001|Overall Study|Progressive Disease|0|||
130335944|NCT02529553|469199800|FG002|Overall Study|Progressive Disease|1|||
130335945|NCT02529553|469199801|FG003|Overall Study|Progressive Disease|3|||
130335946|NCT02529553|469199802|FG004|Overall Study|Progressive Disease|2|||
130335947|NCT02529553|469199803|FG005|Overall Study|Progressive Disease|3|||
129884374|NCT00708305|467536385|FG002|Period 1|Protocol Violation|1|||
130001373|NCT03823404|467971462|FG001|Overall Study|Adverse Event|38|||
130001374|NCT03823404|467971463|FG002|Overall Study|Adverse Event|8|||
130001375|NCT03823404|467971461|FG000|Overall Study|Withdrawal by Subject|38|||
130001376|NCT03823404|467971462|FG001|Overall Study|Withdrawal by Subject|40|||
130001377|NCT03823404|467971463|FG002|Overall Study|Withdrawal by Subject|35|||
130001378|NCT03823404|467971461|FG000|Overall Study|Death|4|||
130001379|NCT03823404|467971462|FG001|Overall Study|Death|0|||
130335948|NCT02529553|469199804|FG006|Overall Study|Progressive Disease|3|||
130001380|NCT03823404|467971463|FG002|Overall Study|Death|0|||
130001381|NCT03823404|467971461|FG000|Overall Study|Other: Various reasons provided|5|||
130001382|NCT03823404|467971462|FG001|Overall Study|Other: Various reasons provided|5|||
130001383|NCT03823404|467971463|FG002|Overall Study|Other: Various reasons provided|6|||
130001384|NCT03383289|467971466|FG000|Overall Study|Death|83|||
130001385|NCT03383289|467971467|FG001|Overall Study|Death|78|||
130001386|NCT03383289|467971466|FG000|Overall Study|discharge from facility|84|||
130001387|NCT03383289|467971467|FG001|Overall Study|discharge from facility|84|||
130001388|NCT03383289|467971466|FG000|Overall Study|Withdrawal by Subject|4|||
130001389|NCT03383289|467971467|FG001|Overall Study|Withdrawal by Subject|1|||
130001390|NCT00832117|467971468|FG000|Overall Study|Death|1|||
130001391|NCT00832117|467971468|FG000|Overall Study|Disease Progression|11|||
130001392|NCT04439071|467971469|FG000|Overall Study|Lost to Follow-up|0|||
130001393|NCT04439071|467971470|FG001|Overall Study|Lost to Follow-up|3|||
130001394|NCT04439071|467971469|FG000|Overall Study|Withdrawal by Subject|3|||
130001395|NCT04439071|467971470|FG001|Overall Study|Withdrawal by Subject|8|||
130001396|NCT04439071|467971469|FG000|Overall Study|Death|6|||
130001397|NCT04439071|467971470|FG001|Overall Study|Death|4|||
130001398|NCT04439071|467971469|FG000|Overall Study|Other than specified|3|||
130001399|NCT04439071|467971470|FG001|Overall Study|Other than specified|3|||
130001400|NCT04439071|467971469|FG000|Overall Study|Randomized but not treated|2|||
130001401|NCT04439071|467971470|FG001|Overall Study|Randomized but not treated|0|||
130001402|NCT01524133|467971473|FG000|Treatment Phase|Withdrawal by Subject|13|||
130001403|NCT01524133|467971474|FG001|Treatment Phase|Withdrawal by Subject|28|||
130001404|NCT01524133|467971475|FG002|Treatment Phase|Withdrawal by Subject|31|||
130001405|NCT01524133|467971473|FG000|Treatment Phase|Physician Decision|6|||
130001406|NCT01524133|467971474|FG001|Treatment Phase|Physician Decision|3|||
130001407|NCT01524133|467971475|FG002|Treatment Phase|Physician Decision|3|||
130001408|NCT01524133|467971473|FG000|Treatment Phase|Lost to Follow-up|0|||
130335949|NCT02529553|469199805|FG007|Overall Study|Progressive Disease|5|||
130335950|NCT02529553|469199806|FG008|Overall Study|Progressive Disease|3|||
130335951|NCT02529553|469199798|FG000|Overall Study|Physician Decision|0|||
130335952|NCT02529553|469199799|FG001|Overall Study|Physician Decision|1|||
130335953|NCT02529553|469199800|FG002|Overall Study|Physician Decision|0|||
130335954|NCT02529553|469199801|FG003|Overall Study|Physician Decision|0|||
130335955|NCT02529553|469199802|FG004|Overall Study|Physician Decision|1|||
130335956|NCT02529553|469199803|FG005|Overall Study|Physician Decision|0|||
130335957|NCT02529553|469199804|FG006|Overall Study|Physician Decision|0|||
130335958|NCT02529553|469199805|FG007|Overall Study|Physician Decision|0|||
130335959|NCT02529553|469199806|FG008|Overall Study|Physician Decision|0|||
130335960|NCT02529553|469199798|FG000|Overall Study|Withdrawal by Subject|0|||
130335961|NCT02529553|469199799|FG001|Overall Study|Withdrawal by Subject|0|||
130335962|NCT02529553|469199800|FG002|Overall Study|Withdrawal by Subject|0|||
130335963|NCT02529553|469199801|FG003|Overall Study|Withdrawal by Subject|0|||
130335964|NCT02529553|469199802|FG004|Overall Study|Withdrawal by Subject|0|||
130335965|NCT02529553|469199803|FG005|Overall Study|Withdrawal by Subject|1|||
130335966|NCT02529553|469199804|FG006|Overall Study|Withdrawal by Subject|0|||
130335967|NCT02529553|469199805|FG007|Overall Study|Withdrawal by Subject|1|||
130335968|NCT02529553|469199806|FG008|Overall Study|Withdrawal by Subject|0|||
130335969|NCT00488683|469199807|FG000|Overall Study|Withdrawal by Subject|1|||
130335970|NCT00488683|469199808|FG001|Overall Study|Withdrawal by Subject|2|||
130335971|NCT00488683|469199809|FG002|Overall Study|Withdrawal by Subject|2|||
130335972|NCT00488683|469199807|FG000|Overall Study|Lost to Follow-up|5|||
130335973|NCT00488683|469199808|FG001|Overall Study|Lost to Follow-up|3|||
130335974|NCT00488683|469199809|FG002|Overall Study|Lost to Follow-up|0|||
130335975|NCT00488683|469199807|FG000|Overall Study|Protocol Violation|5|||
130335976|NCT00488683|469199808|FG001|Overall Study|Protocol Violation|1|||
130335977|NCT00488683|469199809|FG002|Overall Study|Protocol Violation|0|||
130335978|NCT00488683|469199807|FG000|Overall Study|Unable to Classify|1|||
130001409|NCT01524133|467971474|FG001|Treatment Phase|Lost to Follow-up|1|||
130001410|NCT01524133|467971475|FG002|Treatment Phase|Lost to Follow-up|2|||
130001411|NCT01524133|467971473|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
130001412|NCT01524133|467971474|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
130001413|NCT01524133|467971475|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
130001414|NCT01524133|467971473|FG000|Overall Study 52 Weeks|Physician Decision|1|||
130335979|NCT00488683|469199808|FG001|Overall Study|Unable to Classify|0|||
130335980|NCT00488683|469199809|FG002|Overall Study|Unable to Classify|0|||
130335981|NCT01865552|469201305|FG000|Period 1|Adverse Event|1|||
130335982|NCT01865552|469201306|FG001|Period 1|Adverse Event|0|||
130335983|NCT01865552|469201307|FG002|Period 1|Adverse Event|0|||
130335984|NCT01865552|469201308|FG003|Period 1|Adverse Event|1|||
130001415|NCT01524133|467971474|FG001|Overall Study 52 Weeks|Physician Decision|0|||
130001416|NCT01524133|467971475|FG002|Overall Study 52 Weeks|Physician Decision|2|||
130001417|NCT01524133|467971473|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
130001418|NCT01524133|467971474|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
130001419|NCT01524133|467971475|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
130001420|NCT00059839|467971476|FG000|Overall Study|Death|1|||
130001421|NCT00059839|467971477|FG001|Overall Study|Death|1|||
130001422|NCT00059839|467971476|FG000|Overall Study|Lack of Efficacy|6|||
130001423|NCT00059839|467971477|FG001|Overall Study|Lack of Efficacy|5|||
130001424|NCT00059839|467971476|FG000|Overall Study|Lost to Follow-up|2|||
130001425|NCT00059839|467971477|FG001|Overall Study|Lost to Follow-up|0|||
130001426|NCT00059839|467971476|FG000|Overall Study|Physician Decision|1|||
130001427|NCT00059839|467971477|FG001|Overall Study|Physician Decision|2|||
130001428|NCT00059839|467971476|FG000|Overall Study|Withdrawal by Subject|1|||
130001429|NCT00059839|467971477|FG001|Overall Study|Withdrawal by Subject|6|||
130001430|NCT00059839|467971476|FG000|Overall Study|Ineligible|1|||
130001431|NCT00059839|467971477|FG001|Overall Study|Ineligible|3|||
130001432|NCT03842163|467971478|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
130001433|NCT03842163|467971478|FG000|Overall Study|Scintigraphy was not performed|44|||
130001434|NCT03829241|467971479|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
130001435|NCT03829241|467971480|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
130001436|NCT03829241|467971479|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
130001437|NCT03829241|467971480|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
130001438|NCT03829241|467971479|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
130001439|NCT03829241|467971480|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
130001440|NCT03829241|467971479|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
130001441|NCT03829241|467971480|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
130001442|NCT03829241|467971479|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
130001443|NCT03829241|467971480|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
130001444|NCT03829241|467971479|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
130001445|NCT03829241|467971480|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
130001446|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
130001447|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
130001448|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
130001449|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
130001450|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
130001451|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
130001452|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
130001453|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
130001454|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
130001455|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
130001456|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
130001457|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
130001458|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
130001459|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
130001460|NCT03829241|467971479|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
130001461|NCT03829241|467971480|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
130001462|NCT01132612|467971492|FG000|Overall Study|Death|0|||
130001463|NCT01132612|467971493|FG001|Overall Study|Death|0|||
130001464|NCT01132612|467971494|FG002|Overall Study|Death|1|||
130001465|NCT01132612|467971492|FG000|Overall Study|Protocol deviation|0|||
130001466|NCT01132612|467971493|FG001|Overall Study|Protocol deviation|0|||
130001467|NCT01132612|467971494|FG002|Overall Study|Protocol deviation|3|||
130001468|NCT01132612|467971492|FG000|Overall Study|Lost to Follow-up|2|||
130001469|NCT01132612|467971493|FG001|Overall Study|Lost to Follow-up|2|||
130001470|NCT01132612|467971494|FG002|Overall Study|Lost to Follow-up|7|||
130001471|NCT01132612|467971492|FG000|Overall Study|Adverse Event|5|||
130001472|NCT01132612|467971493|FG001|Overall Study|Adverse Event|2|||
130001473|NCT01132612|467971494|FG002|Overall Study|Adverse Event|15|||
130001474|NCT01132612|467971492|FG000|Overall Study|Withdrawal by Subject|5|||
130001475|NCT01132612|467971493|FG001|Overall Study|Withdrawal by Subject|8|||
130001476|NCT01132612|467971494|FG002|Overall Study|Withdrawal by Subject|19|||
130001477|NCT01132612|467971492|FG000|Overall Study|Administrative problems|5|||
130001478|NCT01132612|467971493|FG001|Overall Study|Administrative problems|1|||
130001479|NCT01132612|467971494|FG002|Overall Study|Administrative problems|52|||
130001480|NCT01132612|467971492|FG000|Overall Study|Lack of Efficacy|23|||
130001481|NCT01132612|467971493|FG001|Overall Study|Lack of Efficacy|22|||
130001482|NCT01132612|467971494|FG002|Overall Study|Lack of Efficacy|73|||
130001483|NCT02252536|467971495|FG000|Overall Study|Lost to Follow-up|5|||
130001484|NCT02252536|467971496|FG001|Overall Study|Lost to Follow-up|3|||
130001485|NCT01438151|467971498|FG000|Overall Study|study terminated|8|||
130001486|NCT01026142|467971511|FG000|Overall Study|Death|136|||
130001487|NCT01026142|467971512|FG001|Overall Study|Death|134|||
130001488|NCT01026142|467971511|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
130001489|NCT01026142|467971512|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
130001490|NCT01862640|467971515|FG000|Overall Study|Adverse Event|4|||
130001491|NCT01862640|467971516|FG001|Overall Study|Adverse Event|10|||
130001492|NCT01862640|467971517|FG002|Overall Study|Adverse Event|6|||
130001493|NCT01862640|467971518|FG003|Overall Study|Adverse Event|8|||
130001494|NCT01862640|467971515|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130001495|NCT01862640|467971516|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130001496|NCT01862640|467971517|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
130001497|NCT01862640|467971518|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
130001498|NCT01862640|467971515|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
130001499|NCT01862640|467971516|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
130001500|NCT01862640|467971517|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
130001501|NCT01862640|467971518|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
130001502|NCT01862640|467971515|FG000|Overall Study|Withdrawal by Subject|2|||
130001503|NCT01862640|467971516|FG001|Overall Study|Withdrawal by Subject|4|||
130001504|NCT01862640|467971517|FG002|Overall Study|Withdrawal by Subject|8|||
130001505|NCT01862640|467971518|FG003|Overall Study|Withdrawal by Subject|5|||
130001506|NCT01862640|467971515|FG000|Overall Study|Protocol Deviation|0|||
130001507|NCT01862640|467971516|FG001|Overall Study|Protocol Deviation|0|||
130001508|NCT01862640|467971517|FG002|Overall Study|Protocol Deviation|1|||
130001509|NCT01862640|467971518|FG003|Overall Study|Protocol Deviation|0|||
130001510|NCT05211739|467971519|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
130001511|NCT05211739|467971520|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
130001512|NCT05211739|467971519|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
130001513|NCT05211739|467971520|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
130001514|NCT05211739|467971519|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
130001515|NCT05211739|467971520|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
130001516|NCT05211739|467971519|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
130001517|NCT05211739|467971520|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
130001518|NCT01975428|467971521|FG000|Overall Study|Lost to Follow-up|17|||
130001519|NCT01975428|467971522|FG001|Overall Study|Lost to Follow-up|4|||
130001520|NCT01975428|467971521|FG000|Overall Study|Withdrawal by Subject|3|||
130001521|NCT01975428|467971522|FG001|Overall Study|Withdrawal by Subject|10|||
130001522|NCT00728481|467971523|FG000|Overall Study|Withdrawal by Subject|0|||
130001523|NCT00728481|467971524|FG001|Overall Study|Withdrawal by Subject|1|||
130001524|NCT00728481|467971523|FG000|Overall Study|Adverse Event|0|||
130001525|NCT00728481|467971524|FG001|Overall Study|Adverse Event|1|||
130001526|NCT00728481|467971523|FG000|Overall Study|Study medication non-compliance|0|||
130001527|NCT00728481|467971524|FG001|Overall Study|Study medication non-compliance|2|||
130001528|NCT00728481|467971523|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
130001529|NCT00728481|467971524|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
130001530|NCT00041067|467971525|FG000|Overall Study|Adverse Event|20|||
130001531|NCT00041067|467971525|FG000|Overall Study|Progression|19|||
130001532|NCT00041067|467971525|FG000|Overall Study|Patient refusal|12|||
130001533|NCT00041067|467971525|FG000|Overall Study|Other reasons|23|||
130001534|NCT00041067|467971525|FG000|Overall Study|Ineligible|2|||
130001535|NCT01505010|467971526|FG000|Overall Study|Protocol Violation|0|||
130001536|NCT01505010|467971527|FG001|Overall Study|Protocol Violation|1|||
130001537|NCT01505010|467971526|FG000|Overall Study|Lost to Follow-up|0|||
130001538|NCT01505010|467971527|FG001|Overall Study|Lost to Follow-up|1|||
130001539|NCT00882310|467971536|FG000|Overall Study|Screen Failure|10|||
130001540|NCT00882310|467971536|FG000|Overall Study|Never received treatment|1|||
130001541|NCT00882310|467971536|FG000|Overall Study|Death|6|||
130001542|NCT00882310|467971536|FG000|Overall Study|Progression of disease|4|||
130001543|NCT00882310|467971536|FG000|Overall Study|Adverse Event|1|||
130001544|NCT01351623|467971543|FG000|Overall Study|Protocol Violation|2|||
130001545|NCT01351623|467971543|FG000|Overall Study|Adverse Event|4|||
130335985|NCT01865552|469201309|FG004|Period 1|Adverse Event|1|||
130335986|NCT01865552|469201310|FG005|Period 1|Adverse Event|1|||
130335987|NCT01865552|469201305|FG000|Period 1|Pathological lab|0|||
130335988|NCT01865552|469201306|FG001|Period 1|Pathological lab|0|||
130335989|NCT01865552|469201307|FG002|Period 1|Pathological lab|0|||
130335990|NCT01865552|469201308|FG003|Period 1|Pathological lab|0|||
130001546|NCT01351623|467971543|FG000|Overall Study|Withdrawal by Subject|1|||
130335991|NCT01865552|469201309|FG004|Period 1|Pathological lab|1|||
130335992|NCT01865552|469201310|FG005|Period 1|Pathological lab|0|||
130335993|NCT01865552|469201305|FG000|Period 1|Other|0|||
130335994|NCT01865552|469201306|FG001|Period 1|Other|0|||
129884375|NCT00708305|467536386|FG003|Period 1|Protocol Violation|0|||
130335995|NCT01865552|469201307|FG002|Period 1|Other|0|||
129884376|NCT00708305|467536383|FG000|Period 1|Other Reason|0|||
130001547|NCT01351623|467971543|FG000|Overall Study|Death|2|||
130001548|NCT04201821|467971544|FG000|Overall Study|Withdrawal by Subject|2|||
130001549|NCT01130974|467971545|FG000|Overall Study|Protocol Violation|10|||
130335996|NCT01865552|469201308|FG003|Period 1|Other|0|||
130335997|NCT01865552|469201309|FG004|Period 1|Other|1|||
130335998|NCT01865552|469201310|FG005|Period 1|Other|0|||
130335999|NCT02175199|469201313|FG000|Overall Study|Withdrawal by Subject|1|||
130001550|NCT01130974|467971546|FG001|Overall Study|Protocol Violation|10|||
130001551|NCT01130974|467971545|FG000|Overall Study|Withdrawal by Subject|0|||
130001552|NCT01130974|467971546|FG001|Overall Study|Withdrawal by Subject|1|||
130001553|NCT01130974|467971545|FG000|Overall Study|Ineligibility criteria|5|||
130001554|NCT01130974|467971546|FG001|Overall Study|Ineligibility criteria|2|||
130001555|NCT00387764|467971547|FG000|Overall Study|Adverse Event|12|||
130001556|NCT00387764|467971547|FG000|Overall Study|Withdrawal by Subject|8|||
130001557|NCT00387764|467971547|FG000|Overall Study|Sponsor Terminated Study|1|||
130001558|NCT00387764|467971547|FG000|Overall Study|Physician Decision|1|||
130001559|NCT00387764|467971547|FG000|Overall Study|Other|2|||
130001560|NCT00387764|467971547|FG000|Overall Study|Death|7|||
130001561|NCT01184053|467971548|FG000|Overall Study|progression while on treatment|3|||
130001562|NCT04399122|467971549|FG000|Overall Study|Lost to Follow-up|2|||
130001563|NCT04399122|467971550|FG001|Overall Study|Lost to Follow-up|0|||
130001564|NCT04399122|467971549|FG000|Overall Study|Withdrawal by Subject|1|||
130001565|NCT04399122|467971550|FG001|Overall Study|Withdrawal by Subject|0|||
130001566|NCT02536755|467971553|FG000|Overall Study|Adverse Event|4|||
130001567|NCT02301936|467971554|FG000|Overall Study|Lost to Follow-up|1|||
130001568|NCT02301936|467971555|FG001|Overall Study|Lost to Follow-up|0|||
130001569|NCT01174238|467971556|FG000|Overall Study|Lost to Follow-up|2|||
130001570|NCT01102803|467971558|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
130001571|NCT01102803|467971559|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
130001572|NCT01102803|467971558|FG000|Post to Follow-Up|Lost to Follow-up|1|||
130001573|NCT01102803|467971559|FG001|Post to Follow-Up|Lost to Follow-up|3|||
130336000|NCT02175199|469201314|FG001|Overall Study|Withdrawal by Subject|5|||
130336001|NCT02175199|469201313|FG000|Overall Study|Randomized in Error|1|||
130336002|NCT02175199|469201314|FG001|Overall Study|Randomized in Error|0|||
130336003|NCT02175199|469201313|FG000|Overall Study|Sponsor Decision|1|||
130336004|NCT02175199|469201314|FG001|Overall Study|Sponsor Decision|0|||
130336005|NCT03983317|469201321|FG000|Overall Study|Physician Decision|5|||
130336006|NCT01761162|469201322|FG000|Overall Study|Withdrawal by Subject|3|||
130336007|NCT02741518|469201323|FG000|Overall Study|Withdrawal by Subject|1|||
130336008|NCT02741518|469201324|FG001|Overall Study|Withdrawal by Subject|1|||
130336009|NCT01349049|469201325|FG000|Overall Study|Disease progression|3|||
130336010|NCT01349049|469201326|FG001|Overall Study|Disease progression|5|||
130336011|NCT01349049|469201327|FG002|Overall Study|Disease progression|3|||
130336012|NCT01349049|469201328|FG003|Overall Study|Disease progression|2|||
130336013|NCT01349049|469201329|FG004|Overall Study|Disease progression|2|||
130336014|NCT01349049|469201330|FG005|Overall Study|Disease progression|2|||
130336015|NCT01349049|469201331|FG006|Overall Study|Disease progression|3|||
130336016|NCT01349049|469201332|FG007|Overall Study|Disease progression|2|||
130336017|NCT01349049|469201333|FG008|Overall Study|Disease progression|33|||
130336018|NCT01349049|469201325|FG000|Overall Study|Adverse Event|0|||
130336019|NCT01349049|469201326|FG001|Overall Study|Adverse Event|1|||
130336020|NCT01349049|469201327|FG002|Overall Study|Adverse Event|0|||
130336021|NCT01349049|469201328|FG003|Overall Study|Adverse Event|0|||
130336022|NCT01349049|469201329|FG004|Overall Study|Adverse Event|0|||
130336023|NCT01349049|469201330|FG005|Overall Study|Adverse Event|3|||
130336024|NCT01349049|469201331|FG006|Overall Study|Adverse Event|1|||
130336025|NCT01349049|469201332|FG007|Overall Study|Adverse Event|0|||
130336026|NCT01349049|469201333|FG008|Overall Study|Adverse Event|4|||
130336027|NCT01349049|469201325|FG000|Overall Study|Physician Decision|0|||
130336028|NCT01349049|469201326|FG001|Overall Study|Physician Decision|1|||
130336029|NCT01349049|469201327|FG002|Overall Study|Physician Decision|0|||
130336030|NCT01349049|469201328|FG003|Overall Study|Physician Decision|0|||
130336031|NCT01349049|469201329|FG004|Overall Study|Physician Decision|0|||
130336032|NCT01349049|469201330|FG005|Overall Study|Physician Decision|0|||
130336033|NCT01349049|469201331|FG006|Overall Study|Physician Decision|0|||
130001574|NCT02684279|467971560|FG000|Overall Study|Adverse Event|87|||
130001575|NCT02684279|467971560|FG000|Overall Study|Lack of Efficacy|4|||
130336034|NCT01349049|469201332|FG007|Overall Study|Physician Decision|0|||
130336035|NCT01349049|469201333|FG008|Overall Study|Physician Decision|2|||
130336036|NCT01349049|469201325|FG000|Overall Study|Protocol Violation|0|||
130336037|NCT01349049|469201326|FG001|Overall Study|Protocol Violation|0|||
130336038|NCT01349049|469201327|FG002|Overall Study|Protocol Violation|0|||
130336039|NCT01349049|469201328|FG003|Overall Study|Protocol Violation|0|||
129884377|NCT00708305|467536384|FG001|Period 1|Other Reason|0|||
130001576|NCT02684279|467971560|FG000|Overall Study|Lost to Follow-up|61|||
130001577|NCT02684279|467971560|FG000|Overall Study|Protocol Violation|6|||
130001578|NCT02684279|467971560|FG000|Overall Study|Pregnancy|8|||
130001579|NCT02684279|467971560|FG000|Overall Study|Withdrawal by Subject|92|||
130001580|NCT02684279|467971560|FG000|Overall Study|non-compliance with study drug|9|||
130336040|NCT01349049|469201329|FG004|Overall Study|Protocol Violation|0|||
130336041|NCT01349049|469201330|FG005|Overall Study|Protocol Violation|0|||
130336042|NCT01349049|469201331|FG006|Overall Study|Protocol Violation|0|||
130336043|NCT01349049|469201332|FG007|Overall Study|Protocol Violation|0|||
130336044|NCT01349049|469201333|FG008|Overall Study|Protocol Violation|1|||
130336045|NCT01349049|469201325|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
130336046|NCT01349049|469201326|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
130336047|NCT01349049|469201327|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
130336048|NCT01349049|469201328|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
130336049|NCT01349049|469201329|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
130336050|NCT01349049|469201330|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
130001581|NCT02684279|467971560|FG000|Overall Study|non compliance with study visits|2|||
130001582|NCT02684279|467971560|FG000|Overall Study|subject to have surgery|1|||
130001583|NCT02684279|467971560|FG000|Overall Study|family emergency|1|||
130001584|NCT02684279|467971560|FG000|Overall Study|Site closures|7|||
130001585|NCT02684279|467971560|FG000|Overall Study|Physician Decision|1|||
130001586|NCT02733185|467971561|FG000|Overall Study|Withdrawal by Subject|12|||
130001587|NCT02733185|467971562|FG001|Overall Study|Withdrawal by Subject|10|||
130001588|NCT02733185|467971563|FG002|Overall Study|Withdrawal by Subject|17|||
130001589|NCT02733185|467971564|FG003|Overall Study|Withdrawal by Subject|21|||
130001590|NCT02733185|467971561|FG000|Overall Study|Death|46|||
130001591|NCT02733185|467971562|FG001|Overall Study|Death|34|||
130001592|NCT02733185|467971563|FG002|Overall Study|Death|35|||
130001593|NCT02733185|467971564|FG003|Overall Study|Death|43|||
130001594|NCT02733185|467971561|FG000|Overall Study|Lost to Follow-up|17|||
130001595|NCT02733185|467971562|FG001|Overall Study|Lost to Follow-up|18|||
130001596|NCT02733185|467971563|FG002|Overall Study|Lost to Follow-up|16|||
130001597|NCT02733185|467971564|FG003|Overall Study|Lost to Follow-up|11|||
130001598|NCT01624259|467971565|FG000|Overall Study|Adverse Event|18|||
130001599|NCT01624259|467971566|FG001|Overall Study|Adverse Event|18|||
130001600|NCT01624259|467971565|FG000|Overall Study|Protocol Violation|1|||
130001601|NCT01624259|467971566|FG001|Overall Study|Protocol Violation|2|||
130001602|NCT01624259|467971565|FG000|Overall Study|Withdrawal by Subject|5|||
130001603|NCT01624259|467971566|FG001|Overall Study|Withdrawal by Subject|7|||
130001604|NCT01624259|467971565|FG000|Overall Study|Physician Decision|1|||
130001605|NCT01624259|467971566|FG001|Overall Study|Physician Decision|1|||
130001606|NCT01624259|467971565|FG000|Overall Study|Lost to Follow-up|2|||
130001607|NCT01624259|467971566|FG001|Overall Study|Lost to Follow-up|3|||
130001608|NCT01624259|467971565|FG000|Overall Study|Abnormal laboratory measure|3|||
130001609|NCT01624259|467971566|FG001|Overall Study|Abnormal laboratory measure|0|||
130001610|NCT03828292|467971567|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130001611|NCT03828292|467971568|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
130001612|NCT03828292|467971569|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130001613|NCT03828292|467971570|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130001614|NCT03828292|467971571|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130001615|NCT03828292|467971572|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
130001616|NCT03828292|467971567|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130001617|NCT03828292|467971568|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130001618|NCT03828292|467971569|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
130001619|NCT03828292|467971570|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130001620|NCT03828292|467971571|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130001621|NCT03828292|467971572|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
130001622|NCT03828292|467971567|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130001623|NCT03828292|467971568|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130001624|NCT03828292|467971569|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130001625|NCT03828292|467971570|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
130001626|NCT03828292|467971571|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130001627|NCT03828292|467971572|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
130001628|NCT03828292|467971567|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130001629|NCT03828292|467971568|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130001630|NCT03828292|467971569|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130001631|NCT03828292|467971570|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
130001632|NCT03828292|467971571|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130001633|NCT03828292|467971572|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
130001634|NCT03828292|467971567|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130001635|NCT03828292|467971568|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130001636|NCT03828292|467971569|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
130001637|NCT03828292|467971570|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
130001638|NCT03828292|467971571|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130001639|NCT03828292|467971572|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
130001640|NCT04752475|467973388|FG000|Overall Study|Withdrawal by Subject|1|||
130001641|NCT04752475|467973389|FG001|Overall Study|Withdrawal by Subject|1|||
130001642|NCT02113579|467973392|FG000|Overall Study|Adverse Event|1|||
130001643|NCT02113579|467973393|FG001|Overall Study|Adverse Event|0|||
130001644|NCT02113579|467973392|FG000|Overall Study|Withdrawal by Subject|3|||
130001645|NCT02113579|467973393|FG001|Overall Study|Withdrawal by Subject|2|||
130001646|NCT02113579|467973392|FG000|Overall Study|Lost to Follow-up|6|||
130001647|NCT02113579|467973393|FG001|Overall Study|Lost to Follow-up|2|||
130336051|NCT01349049|469201331|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
130336052|NCT01349049|469201332|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
130336053|NCT01349049|469201333|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
130336054|NCT01349049|469201325|FG000|Overall Study|Other|0|||
130336055|NCT01349049|469201326|FG001|Overall Study|Other|0|||
130336056|NCT01349049|469201327|FG002|Overall Study|Other|0|||
130336057|NCT01349049|469201328|FG003|Overall Study|Other|0|||
130336058|NCT01349049|469201329|FG004|Overall Study|Other|0|||
130336059|NCT01349049|469201330|FG005|Overall Study|Other|1|||
130336060|NCT01349049|469201331|FG006|Overall Study|Other|0|||
130336061|NCT01349049|469201332|FG007|Overall Study|Other|0|||
130336062|NCT01349049|469201333|FG008|Overall Study|Other|4|||
130336063|NCT01349049|469201325|FG000|Overall Study|Death|0|||
130336064|NCT01349049|469201326|FG001|Overall Study|Death|0|||
130336065|NCT01349049|469201327|FG002|Overall Study|Death|0|||
130336066|NCT01349049|469201328|FG003|Overall Study|Death|0|||
130336067|NCT01349049|469201329|FG004|Overall Study|Death|0|||
130336068|NCT01349049|469201330|FG005|Overall Study|Death|0|||
130336069|NCT01349049|469201331|FG006|Overall Study|Death|0|||
130336070|NCT01349049|469201332|FG007|Overall Study|Death|1|||
130336071|NCT01349049|469201333|FG008|Overall Study|Death|5|||
130336072|NCT01349049|469201325|FG000|Overall Study|Non-compliance|0|||
130001648|NCT02217436|467973394|FG000|Overall Study|Protocol Violation|1|||
130001649|NCT02217436|467973395|FG001|Overall Study|Protocol Violation|1|||
130001650|NCT02217436|467973394|FG000|Overall Study|Incomplete data|0|||
130001651|NCT02217436|467973395|FG001|Overall Study|Incomplete data|1|||
130336073|NCT01349049|469201326|FG001|Overall Study|Non-compliance|0|||
130336074|NCT01349049|469201327|FG002|Overall Study|Non-compliance|0|||
130336075|NCT01349049|469201328|FG003|Overall Study|Non-compliance|1|||
130336076|NCT01349049|469201329|FG004|Overall Study|Non-compliance|0|||
130336077|NCT01349049|469201330|FG005|Overall Study|Non-compliance|0|||
130336078|NCT01349049|469201331|FG006|Overall Study|Non-compliance|0|||
130336079|NCT01349049|469201332|FG007|Overall Study|Non-compliance|0|||
130336080|NCT01349049|469201333|FG008|Overall Study|Non-compliance|0|||
130336081|NCT01349049|469201325|FG000|Overall Study|Withdrawal by Subject|0|||
130336082|NCT01349049|469201326|FG001|Overall Study|Withdrawal by Subject|0|||
130336083|NCT01349049|469201327|FG002|Overall Study|Withdrawal by Subject|0|||
130336084|NCT01349049|469201328|FG003|Overall Study|Withdrawal by Subject|0|||
130336085|NCT01349049|469201329|FG004|Overall Study|Withdrawal by Subject|0|||
130336086|NCT01349049|469201330|FG005|Overall Study|Withdrawal by Subject|0|||
130336087|NCT01349049|469201331|FG006|Overall Study|Withdrawal by Subject|0|||
130336088|NCT01349049|469201332|FG007|Overall Study|Withdrawal by Subject|0|||
130336089|NCT01349049|469201333|FG008|Overall Study|Withdrawal by Subject|6|||
130336090|NCT04681352|469201340|FG000|Overall Study|Lost to Follow-up|2|||
130336091|NCT04681352|469201340|FG000|Overall Study|Withdrawal by Subject|22|||
130336092|NCT01643772|469201341|FG000|Overall Study|Protocol Violation|0|||
130336093|NCT01643772|469201342|FG001|Overall Study|Protocol Violation|0|||
130336094|NCT01643772|469201343|FG002|Overall Study|Protocol Violation|0|||
130336095|NCT01643772|469201344|FG003|Overall Study|Protocol Violation|1|||
130336096|NCT01643772|469201341|FG000|Overall Study|Adverse Event|0|||
130336097|NCT01643772|469201342|FG001|Overall Study|Adverse Event|0|||
130336098|NCT01643772|469201343|FG002|Overall Study|Adverse Event|0|||
130336099|NCT01643772|469201344|FG003|Overall Study|Adverse Event|1|||
130336100|NCT02881567|469201351|FG000|Overall Study|Adverse Event|1|||
130336101|NCT02881567|469201351|FG000|Overall Study|Lost to Follow-up|3|||
130336102|NCT02881567|469201351|FG000|Overall Study|Consent withdrawn|1|||
130336103|NCT02881567|469201351|FG000|Overall Study|Investigator decision|1|||
130336104|NCT02881567|469201351|FG000|Overall Study|Study terminated by sponsor|9|||
130336105|NCT02881567|469201351|FG000|Overall Study|Reason not Specified|3|||
130336106|NCT00373113|469201352|FG000|Overall Study|Death|1|||
130336107|NCT00373113|469201353|FG001|Overall Study|Death|7|||
130336108|NCT00373113|469201352|FG000|Overall Study|Adverse Event|38|||
130001652|NCT01667081|467973398|FG000|Overall Study|Death|43|||
130336109|NCT00373113|469201353|FG001|Overall Study|Adverse Event|24|||
130336110|NCT00373113|469201352|FG000|Overall Study|Study terminated by sponsor|9|||
130336111|NCT00373113|469201353|FG001|Overall Study|Study terminated by sponsor|1|||
130336112|NCT00373113|469201352|FG000|Overall Study|Global deterioration of health status|10|||
130336113|NCT00373113|469201353|FG001|Overall Study|Global deterioration of health status|7|||
130336114|NCT00373113|469201352|FG000|Overall Study|Lost to Follow-up|1|||
130336115|NCT00373113|469201353|FG001|Overall Study|Lost to Follow-up|3|||
130336116|NCT00373113|469201352|FG000|Overall Study|Objective progression or relapse|150|||
130336117|NCT00373113|469201353|FG001|Overall Study|Objective progression or relapse|169|||
130336118|NCT00373113|469201352|FG000|Overall Study|Other|14|||
130336119|NCT00373113|469201353|FG001|Overall Study|Other|17|||
130336120|NCT00373113|469201352|FG000|Overall Study|Protocol Violation|5|||
130001653|NCT01667081|467973399|FG001|Overall Study|Death|3|||
130336121|NCT00373113|469201353|FG001|Overall Study|Protocol Violation|1|||
130336122|NCT00373113|469201352|FG000|Overall Study|Withdrawal by Subject|10|||
130336123|NCT00373113|469201353|FG001|Overall Study|Withdrawal by Subject|15|||
130336124|NCT04248491|469201354|FG000|Overall Study|Lost to Follow-up|1|||
130001654|NCT01667081|467973398|FG000|Overall Study|Lost to Follow-up|99|||
130001655|NCT01667081|467973399|FG001|Overall Study|Lost to Follow-up|48|||
130001656|NCT01667081|467973398|FG000|Overall Study|Physician Decision|16|||
130001657|NCT01667081|467973399|FG001|Overall Study|Physician Decision|2|||
130001658|NCT01667081|467973398|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
130001659|NCT01667081|467973399|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
130001660|NCT01667081|467973398|FG000|Overall Study|Withdrawal by Subject|90|||
130001661|NCT01667081|467973399|FG001|Overall Study|Withdrawal by Subject|35|||
130336125|NCT04248491|469201355|FG001|Overall Study|Lost to Follow-up|0|||
130336126|NCT02364336|469201359|FG000|Overall Study|Adverse Event|0|||
130336127|NCT02364336|469201360|FG001|Overall Study|Adverse Event|1|||
130001662|NCT03034460|467973400|FG000|Overall Study|Adverse Event|0|||
130001663|NCT03034460|467973401|FG001|Overall Study|Adverse Event|1|||
130001664|NCT03034460|467973400|FG000|Overall Study|Withdrawal by Subject|2|||
130001665|NCT03034460|467973401|FG001|Overall Study|Withdrawal by Subject|2|||
130001666|NCT03034460|467973400|FG000|Overall Study|Personal Reasons|1|||
130001667|NCT03034460|467973401|FG001|Overall Study|Personal Reasons|0|||
130001668|NCT01798992|467973402|FG000|Overall Study|Administrative withdrawal|0|||
130001669|NCT01798992|467973403|FG001|Overall Study|Administrative withdrawal|1|||
130001670|NCT01798992|467973404|FG002|Overall Study|Administrative withdrawal|0|||
130001671|NCT01798992|467973405|FG003|Overall Study|Administrative withdrawal|1|||
130001672|NCT01798992|467973402|FG000|Overall Study|Lost to Follow-up|0|||
130001673|NCT01798992|467973403|FG001|Overall Study|Lost to Follow-up|1|||
130001674|NCT01798992|467973404|FG002|Overall Study|Lost to Follow-up|1|||
130001675|NCT01798992|467973405|FG003|Overall Study|Lost to Follow-up|0|||
130001676|NCT01798992|467973402|FG000|Overall Study|Insufficient biopsy tissue|0|||
130001677|NCT01798992|467973403|FG001|Overall Study|Insufficient biopsy tissue|0|||
130001678|NCT01798992|467973404|FG002|Overall Study|Insufficient biopsy tissue|1|||
130336128|NCT01731938|469201361|FG000|Preliminary Part I|Withdrawal by Subject|2|||
130336129|NCT01731938|469201362|FG001|Preliminary Part I|Withdrawal by Subject|2|||
130336130|NCT01731938|469201361|FG000|Preliminary Part I|Physician Decision|1|||
130336131|NCT01731938|469201362|FG001|Preliminary Part I|Physician Decision|0|||
130336132|NCT01731938|469201361|FG000|Preliminary Part I|Lost to Follow-up|0|||
130336133|NCT01731938|469201362|FG001|Preliminary Part I|Lost to Follow-up|3|||
130336134|NCT01731938|469201361|FG000|Preliminary Part I|Missed Week 6 visit|0|||
130336135|NCT01731938|469201362|FG001|Preliminary Part I|Missed Week 6 visit|3|||
130336136|NCT01731938|469201361|FG000|Primary Part II|Withdrawal by Subject|5|||
130336137|NCT01731938|469201362|FG001|Primary Part II|Withdrawal by Subject|4|||
130336138|NCT01731938|469201361|FG000|Primary Part II|Lost to Follow-up|4|||
130336139|NCT01731938|469201362|FG001|Primary Part II|Lost to Follow-up|5|||
130336140|NCT01731938|469201361|FG000|Primary Part II|Death|2|||
130336141|NCT01731938|469201362|FG001|Primary Part II|Death|1|||
130336142|NCT01731938|469201361|FG000|Primary Part II|Missed Week 6 visit|2|||
130336143|NCT01731938|469201362|FG001|Primary Part II|Missed Week 6 visit|3|||
130336144|NCT00771953|469201363|FG000|Overall Study|Adverse Event|5|||
130336145|NCT00771953|469201364|FG001|Overall Study|Adverse Event|3|||
130336146|NCT00771953|469201363|FG000|Overall Study|Death|2|||
130336147|NCT00771953|469201364|FG001|Overall Study|Death|2|||
130336148|NCT00771953|469201363|FG000|Overall Study|Progression before active Tx|1|||
130336149|NCT00771953|469201364|FG001|Overall Study|Progression before active Tx|2|||
130336150|NCT00771953|469201363|FG000|Overall Study|Sponsor decision|1|||
130336151|NCT00771953|469201364|FG001|Overall Study|Sponsor decision|0|||
130336152|NCT00771953|469201363|FG000|Overall Study|Other complicating disease|1|||
130336153|NCT00771953|469201364|FG001|Overall Study|Other complicating disease|0|||
130336154|NCT00771953|469201363|FG000|Overall Study|Withdrawal by Subject|0|||
130336155|NCT00771953|469201364|FG001|Overall Study|Withdrawal by Subject|3|||
130336156|NCT00856518|469201368|FG000|Overall Study|Lost to Follow-up|4|||
130336157|NCT00856518|469201369|FG001|Overall Study|Lost to Follow-up|2|||
130336158|NCT00947193|469201370|FG000|Overall Study|Lost to Follow-up|1|||
130336159|NCT00947193|469201371|FG001|Overall Study|Lost to Follow-up|0|||
130336160|NCT00947193|469201370|FG000|Overall Study|Withdrawal by Subject|1|||
130336161|NCT00947193|469201371|FG001|Overall Study|Withdrawal by Subject|0|||
130336162|NCT00947193|469201370|FG000|Overall Study|Factor VIII >1%|1|||
130001679|NCT01798992|467973405|FG003|Overall Study|Insufficient biopsy tissue|0|||
130001680|NCT03085758|467973414|FG000|Overall Study|Death|26|||
130001681|NCT03085758|467973415|FG001|Overall Study|Death|24|||
130001682|NCT03085758|467973416|FG002|Overall Study|Death|53|||
130001683|NCT03085758|467973414|FG000|Overall Study|Lost to Follow-up|1|||
130336163|NCT00947193|469201371|FG001|Overall Study|Factor VIII >1%|0|||
130336164|NCT00926029|469201373|FG000|Overall Study|Lost to Follow-up|2|||
130336165|NCT00926029|469201374|FG001|Overall Study|Lost to Follow-up|1|||
130336166|NCT00926029|469201375|FG002|Overall Study|Lost to Follow-up|1|||
130336167|NCT05246514|469201376|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
130336168|NCT05246514|469201376|FG000|Overall Study|Withdrawal by Subject|1|||
130336169|NCT05246514|469201376|FG000|Overall Study|Death|13|||
130336170|NCT04154189|469201377|FG000|Overall Study|Withdrawal by Subject|4|||
130336171|NCT04154189|469201378|FG001|Overall Study|Withdrawal by Subject|6|||
130336172|NCT04154189|469201377|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
130336173|NCT04154189|469201378|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
130336174|NCT04154189|469201377|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
130336175|NCT04154189|469201378|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
130336176|NCT04154189|469201377|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
130336177|NCT04154189|469201378|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
130336178|NCT04154189|469201377|FG000|Overall Study|Death|25|||
130336179|NCT04154189|469201378|FG001|Overall Study|Death|25|||
130336180|NCT00486291|469201379|FG000|Overall Study|Adverse Event|3|||
130336181|NCT00486291|469201380|FG001|Overall Study|Adverse Event|4|||
130336182|NCT00486291|469201379|FG000|Overall Study|Lost to Follow-up|3|||
130336183|NCT00486291|469201380|FG001|Overall Study|Lost to Follow-up|7|||
130336184|NCT00486291|469201379|FG000|Overall Study|protocol non-compliance|10|||
130336185|NCT00486291|469201380|FG001|Overall Study|protocol non-compliance|15|||
130336186|NCT00486291|469201379|FG000|Overall Study|requirement for restricted medication|0|||
130336187|NCT00486291|469201380|FG001|Overall Study|requirement for restricted medication|3|||
130336188|NCT00126490|469201381|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
130336189|NCT00975780|469201382|FG000|Follow Up|Death|88|||
130336190|NCT00975780|469201383|FG001|Follow Up|Death|122|||
130336191|NCT00975780|469201382|FG000|Follow Up|Facility Withdrawal|7|||
130336192|NCT00975780|469201383|FG001|Follow Up|Facility Withdrawal|23|||
130336193|NCT00975780|469201382|FG000|Follow Up|Discharged from Facility|7|||
130336194|NCT00975780|469201383|FG001|Follow Up|Discharged from Facility|12|||
130336195|NCT03051178|469201386|FG000|Overall Study|Withdrawal by Subject|5|||
130336196|NCT01598506|469201387|FG000|Overall Study|Withdrawal by Subject|2|||
130336197|NCT04080167|469201390|FG000|Overall Study|Lost to Follow-up-Patients|7|||
130336198|NCT04080167|469201391|FG001|Overall Study|Lost to Follow-up-Patients|14|||
130336199|NCT04080167|469201392|FG002|Overall Study|Lost to Follow-up-Patients|0|||
130336200|NCT04080167|469201390|FG000|Overall Study|Lost to Follow-up-Providers|2|||
130336201|NCT04080167|469201391|FG001|Overall Study|Lost to Follow-up-Providers|2|||
130336202|NCT04080167|469201392|FG002|Overall Study|Lost to Follow-up-Providers|0|||
130336203|NCT04080167|469201390|FG000|Overall Study|Withdrawal by Subject|1|||
130336204|NCT04080167|469201391|FG001|Overall Study|Withdrawal by Subject|2|||
130336205|NCT04080167|469201392|FG002|Overall Study|Withdrawal by Subject|0|||
130336206|NCT04080167|469201390|FG000|Overall Study|Withdrawal by Provider|0|||
130336207|NCT04080167|469201391|FG001|Overall Study|Withdrawal by Provider|0|||
130336208|NCT04080167|469201392|FG002|Overall Study|Withdrawal by Provider|4|||
130336209|NCT04080167|469201390|FG000|Overall Study|Death-Patient|2|||
130336210|NCT04080167|469201391|FG001|Overall Study|Death-Patient|1|||
130336211|NCT04080167|469201392|FG002|Overall Study|Death-Patient|0|||
130336212|NCT04080167|469201390|FG000|Overall Study|Hydroxyurea New Starts|0|||
130336213|NCT04080167|469201391|FG001|Overall Study|Hydroxyurea New Starts|0|||
130336214|NCT04080167|469201392|FG002|Overall Study|Hydroxyurea New Starts|1|||
130336215|NCT04080167|469201390|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
130336216|NCT04080167|469201391|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
130336217|NCT04080167|469201392|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
130336218|NCT00312195|469201393|FG000|Overall Study|Adverse Event|4|||
130336219|NCT00312195|469201394|FG001|Overall Study|Adverse Event|6|||
130336220|NCT00312195|469201393|FG000|Overall Study|Lost to Follow-up|1|||
130336221|NCT00312195|469201394|FG001|Overall Study|Lost to Follow-up|0|||
130336222|NCT00312195|469201393|FG000|Overall Study|Protocol Violation|1|||
130336223|NCT00312195|469201394|FG001|Overall Study|Protocol Violation|0|||
130336224|NCT02511106|469201395|FG000|Overall Study|Lost to Follow-up|6|||
130336225|NCT02511106|469201396|FG001|Overall Study|Lost to Follow-up|4|||
130336226|NCT02511106|469201395|FG000|Overall Study|Withdrawal by Subject|24|||
130336227|NCT02511106|469201396|FG001|Overall Study|Withdrawal by Subject|21|||
130001684|NCT03085758|467973415|FG001|Overall Study|Lost to Follow-up|1|||
130001685|NCT03085758|467973416|FG002|Overall Study|Lost to Follow-up|1|||
130001686|NCT03085758|467973414|FG000|Overall Study|Withdrawal by Subject|2|||
130001687|NCT03085758|467973415|FG001|Overall Study|Withdrawal by Subject|2|||
130001688|NCT03085758|467973416|FG002|Overall Study|Withdrawal by Subject|1|||
130001689|NCT03085758|467973414|FG000|Overall Study|Refusal to recall it up to day 90|0|||
130336228|NCT02511106|469201395|FG000|Overall Study|Death|42|||
130336229|NCT02511106|469201396|FG001|Overall Study|Death|82|||
130336230|NCT02511106|469201395|FG000|Overall Study|Ongoing study at data cut-off|3|||
130001690|NCT03085758|467973415|FG001|Overall Study|Refusal to recall it up to day 90|0|||
130001691|NCT03085758|467973416|FG002|Overall Study|Refusal to recall it up to day 90|1|||
130336231|NCT02511106|469201396|FG001|Overall Study|Ongoing study at data cut-off|2|||
130336232|NCT02511106|469201395|FG000|Overall Study|Without specified reason|3|||
130336233|NCT02511106|469201396|FG001|Overall Study|Without specified reason|0|||
130336234|NCT02657408|469201397|FG000|Overall Study|Adverse Event|3|||
130336235|NCT02657408|469201398|FG001|Overall Study|Adverse Event|7|||
130336236|NCT00324961|469201401|FG000|Overall Study|Adverse Event|5|||
130336237|NCT00324961|469201401|FG000|Overall Study|Consent Withdrawn|11|||
130001692|NCT03085758|467973414|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
130001693|NCT03085758|467973415|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
130001694|NCT03085758|467973416|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
130001695|NCT04004429|467973419|FG000|Overall Study|Protocol Violation|1|||
130001696|NCT04004429|467973420|FG001|Overall Study|Protocol Violation|0|||
130001697|NCT04004429|467973421|FG002|Overall Study|Protocol Violation|0|||
130001698|NCT04004429|467973419|FG000|Overall Study|Physician Decision|0|||
130001699|NCT04004429|467973420|FG001|Overall Study|Physician Decision|1|||
130001700|NCT04004429|467973421|FG002|Overall Study|Physician Decision|1|||
130001701|NCT04004429|467973419|FG000|Overall Study|Withdrawal by Subject|1|||
130001702|NCT04004429|467973420|FG001|Overall Study|Withdrawal by Subject|1|||
130001703|NCT04004429|467973421|FG002|Overall Study|Withdrawal by Subject|1|||
130001704|NCT01122576|467973422|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
130001705|NCT01122576|467973423|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
130001706|NCT01122576|467973424|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
130001707|NCT01122576|467973422|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
130001708|NCT01122576|467973423|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
130001709|NCT01122576|467973424|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
130001710|NCT01122576|467973422|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
130001711|NCT01122576|467973423|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
130001712|NCT01122576|467973424|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
130001713|NCT00381563|467973429|FG000|Overall Study|Withdrawal by Subject|5|||
130001714|NCT00381563|467973430|FG001|Overall Study|Withdrawal by Subject|5|||
130001715|NCT00381563|467973429|FG000|Overall Study|Lost to Follow-up|2|||
130001716|NCT00381563|467973430|FG001|Overall Study|Lost to Follow-up|0|||
130001717|NCT00381563|467973429|FG000|Overall Study|Protocol Violation|0|||
130001718|NCT00381563|467973430|FG001|Overall Study|Protocol Violation|1|||
130001719|NCT00931944|467973432|FG000|Overall Study|Adverse Event|4|||
130001720|NCT00931944|467973432|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
130001721|NCT00931944|467973432|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
130001722|NCT00931944|467973432|FG000|Overall Study|Death|28|||
130001723|NCT00931944|467973432|FG000|Overall Study|Other|2|||
130001724|NCT01109173|467973433|FG000|Overall Study|Adverse Event|15|||
130001725|NCT01109173|467973434|FG001|Overall Study|Adverse Event|17|||
130001726|NCT01109173|467973435|FG002|Overall Study|Adverse Event|9|||
130001727|NCT01109173|467973436|FG003|Overall Study|Adverse Event|6|||
130001728|NCT01109173|467973433|FG000|Overall Study|Lost to Follow-up|0|||
130001729|NCT01109173|467973434|FG001|Overall Study|Lost to Follow-up|1|||
130001730|NCT01109173|467973435|FG002|Overall Study|Lost to Follow-up|0|||
130001731|NCT01109173|467973436|FG003|Overall Study|Lost to Follow-up|0|||
130001732|NCT01109173|467973433|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
130001733|NCT01109173|467973434|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
130001734|NCT01109173|467973435|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
130001735|NCT01109173|467973436|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
130001736|NCT01109173|467973433|FG000|Overall Study|Noncompliance|0|||
130001737|NCT01109173|467973434|FG001|Overall Study|Noncompliance|1|||
130001738|NCT01109173|467973435|FG002|Overall Study|Noncompliance|0|||
130001739|NCT01109173|467973436|FG003|Overall Study|Noncompliance|0|||
130001740|NCT01109173|467973433|FG000|Overall Study|Treatment Failure|25|||
130001741|NCT01109173|467973434|FG001|Overall Study|Treatment Failure|32|||
130001742|NCT01109173|467973435|FG002|Overall Study|Treatment Failure|69|||
130001743|NCT01109173|467973436|FG003|Overall Study|Treatment Failure|64|||
130001744|NCT01109173|467973433|FG000|Overall Study|Protocol Violation|4|||
130001745|NCT01109173|467973434|FG001|Overall Study|Protocol Violation|5|||
130001746|NCT01109173|467973435|FG002|Overall Study|Protocol Violation|1|||
130001747|NCT01109173|467973436|FG003|Overall Study|Protocol Violation|2|||
130001748|NCT01109173|467973433|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
130001749|NCT01109173|467973434|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
130001750|NCT01109173|467973435|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
130001751|NCT01109173|467973436|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
130001752|NCT01109173|467973433|FG000|Overall Study|Not Specifiied|5|||
130001753|NCT01109173|467973434|FG001|Overall Study|Not Specifiied|4|||
130001754|NCT01109173|467973435|FG002|Overall Study|Not Specifiied|9|||
130001755|NCT01109173|467973436|FG003|Overall Study|Not Specifiied|14|||
130001756|NCT00006392|467973443|FG000|Overall Study|Ineligible|11|||
130001757|NCT00006392|467973444|FG001|Overall Study|Ineligible|3|||
130001758|NCT00006392|467973445|FG002|Overall Study|Ineligible|5|||
130001759|NCT00006392|467973446|FG003|Overall Study|Ineligible|5|||
130001760|NCT00006392|467973443|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
130001761|NCT00006392|467973444|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
130001762|NCT00006392|467973445|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
130001763|NCT00006392|467973446|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
130001764|NCT02459769|467973447|FG000|Overall Study|Withdrawal by Subject|7|||
130001765|NCT02459769|467973448|FG001|Overall Study|Withdrawal by Subject|4|||
130001766|NCT02459769|467973449|FG002|Overall Study|Withdrawal by Subject|8|||
130001767|NCT02459769|467973450|FG003|Overall Study|Withdrawal by Subject|5|||
130001768|NCT02459769|467973447|FG000|Overall Study|Lost to Follow-up|1|||
130336238|NCT00324961|469201401|FG000|Overall Study|Lost to Follow-up|22|||
130336239|NCT00324961|469201401|FG000|Overall Study|Protocol Violation|3|||
130336240|NCT00324961|469201401|FG000|Overall Study|Other|2|||
130336241|NCT00344487|469201402|FG000|Overall Study|immunologic failure|1|||
130001769|NCT02459769|467973448|FG001|Overall Study|Lost to Follow-up|0|||
130001770|NCT02459769|467973449|FG002|Overall Study|Lost to Follow-up|1|||
130001771|NCT02459769|467973450|FG003|Overall Study|Lost to Follow-up|0|||
130001772|NCT01186796|467973451|FG000|Overall Study|Adverse Event|3|||
130001773|NCT01186796|467973452|FG001|Overall Study|Adverse Event|0|||
130001774|NCT01186796|467973451|FG000|Overall Study|Withdrawal by Subject|1|||
130001775|NCT01186796|467973452|FG001|Overall Study|Withdrawal by Subject|1|||
130001776|NCT01186796|467973451|FG000|Overall Study|Protocol Violation|0|||
130001777|NCT01186796|467973452|FG001|Overall Study|Protocol Violation|1|||
130001778|NCT01287364|467973454|FG000|Overall Study|Adverse Event|0|||
130001779|NCT01287364|467973455|FG001|Overall Study|Adverse Event|3|||
130001780|NCT01287364|467973454|FG000|Overall Study|Protocol Violation|5|||
130001781|NCT01287364|467973455|FG001|Overall Study|Protocol Violation|5|||
130001782|NCT01287364|467973454|FG000|Overall Study|Other Reason|4|||
130001783|NCT01287364|467973455|FG001|Overall Study|Other Reason|2|||
130001784|NCT05372653|467973463|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
130001785|NCT05372653|467973464|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
130001786|NCT05372653|467973463|FG000|Overall Study|Adverse Event|0|||
130001787|NCT05372653|467973464|FG001|Overall Study|Adverse Event|1|||
130001788|NCT00711529|467973465|FG000|Overall Study|Protocol Violation|2|||
130001789|NCT00711529|467973466|FG001|Overall Study|Protocol Violation|0|||
130001790|NCT00711529|467973465|FG000|Overall Study|Withdrawal by Subject|2|||
130001791|NCT00711529|467973466|FG001|Overall Study|Withdrawal by Subject|6|||
130001792|NCT03740997|467973470|FG000|Overall Study|Withdrawal by Subject|1|||
130001793|NCT03740997|467973471|FG001|Overall Study|Withdrawal by Subject|0|||
130001794|NCT03740997|467973470|FG000|Overall Study|Participant was unable to complete study procedures|1|||
130001795|NCT03740997|467973471|FG001|Overall Study|Participant was unable to complete study procedures|0|||
130001796|NCT01829425|467973472|FG000|Overall Study|Withdrawal by Subject|4|||
130001797|NCT01829425|467973473|FG001|Overall Study|Withdrawal by Subject|3|||
130001798|NCT01829425|467973472|FG000|Overall Study|Lost to Follow-up|2|||
130001799|NCT01829425|467973473|FG001|Overall Study|Lost to Follow-up|1|||
130001800|NCT04178967|467973474|FG000|Induction Period|Adverse Event|4|||
130001801|NCT04178967|467973475|FG001|Induction Period|Adverse Event|6|||
130001802|NCT04178967|467973476|FG002|Induction Period|Adverse Event|0|||
130001803|NCT04178967|467973477|FG003|Induction Period|Adverse Event|0|||
130001804|NCT04178967|467973478|FG004|Induction Period|Adverse Event|0|||
130001805|NCT04178967|467973479|FG005|Induction Period|Adverse Event|0|||
130001806|NCT04178967|467973480|FG006|Induction Period|Adverse Event|0|||
130001807|NCT04178967|467973481|FG007|Induction Period|Adverse Event|0|||
130001808|NCT04178967|467973482|FG008|Induction Period|Adverse Event|0|||
130001809|NCT04178967|467973483|FG009|Induction Period|Adverse Event|0|||
130001810|NCT04178967|467973484|FG010|Induction Period|Adverse Event|0|||
130001811|NCT04178967|467973474|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
130001812|NCT04178967|467973475|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
130001813|NCT04178967|467973476|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
130001814|NCT04178967|467973477|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
130001815|NCT04178967|467973478|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
130001816|NCT04178967|467973479|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
130001817|NCT04178967|467973480|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
130001818|NCT04178967|467973481|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
130001819|NCT04178967|467973482|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
130001820|NCT04178967|467973483|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
130001821|NCT04178967|467973484|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
130001822|NCT04178967|467973474|FG000|Induction Period|Lack of Efficacy|4|||
130001823|NCT04178967|467973475|FG001|Induction Period|Lack of Efficacy|1|||
130001824|NCT04178967|467973476|FG002|Induction Period|Lack of Efficacy|0|||
130001825|NCT04178967|467973477|FG003|Induction Period|Lack of Efficacy|0|||
130001826|NCT04178967|467973478|FG004|Induction Period|Lack of Efficacy|0|||
130001827|NCT04178967|467973479|FG005|Induction Period|Lack of Efficacy|0|||
130001828|NCT04178967|467973480|FG006|Induction Period|Lack of Efficacy|0|||
130001829|NCT04178967|467973481|FG007|Induction Period|Lack of Efficacy|0|||
130001830|NCT04178967|467973482|FG008|Induction Period|Lack of Efficacy|0|||
130001831|NCT04178967|467973483|FG009|Induction Period|Lack of Efficacy|0|||
130001832|NCT04178967|467973484|FG010|Induction Period|Lack of Efficacy|0|||
130001833|NCT04178967|467973474|FG000|Induction Period|Protocol Violation|0|||
130336242|NCT01459497|469201406|FG000|Overall Study|Inability to meet trial constraints.|1|||
129884378|NCT00708305|467536385|FG002|Period 1|Other Reason|0|||
130001834|NCT04178967|467973475|FG001|Induction Period|Protocol Violation|6|||
130001835|NCT04178967|467973476|FG002|Induction Period|Protocol Violation|0|||
130001836|NCT04178967|467973477|FG003|Induction Period|Protocol Violation|0|||
130001837|NCT04178967|467973478|FG004|Induction Period|Protocol Violation|0|||
130001838|NCT04178967|467973479|FG005|Induction Period|Protocol Violation|0|||
130001839|NCT04178967|467973480|FG006|Induction Period|Protocol Violation|0|||
130336243|NCT01459497|469201407|FG001|Overall Study|Inability to meet trial constraints.|0|||
130001840|NCT04178967|467973481|FG007|Induction Period|Protocol Violation|0|||
130001841|NCT04178967|467973482|FG008|Induction Period|Protocol Violation|0|||
130001842|NCT04178967|467973483|FG009|Induction Period|Protocol Violation|0|||
130001843|NCT04178967|467973484|FG010|Induction Period|Protocol Violation|0|||
130001844|NCT04178967|467973474|FG000|Induction Period|Withdrawal by Subject|6|||
130001845|NCT04178967|467973475|FG001|Induction Period|Withdrawal by Subject|4|||
130001846|NCT04178967|467973476|FG002|Induction Period|Withdrawal by Subject|0|||
130001847|NCT04178967|467973477|FG003|Induction Period|Withdrawal by Subject|0|||
130001848|NCT04178967|467973478|FG004|Induction Period|Withdrawal by Subject|0|||
130001849|NCT04178967|467973479|FG005|Induction Period|Withdrawal by Subject|0|||
130001850|NCT04178967|467973480|FG006|Induction Period|Withdrawal by Subject|0|||
130001851|NCT04178967|467973481|FG007|Induction Period|Withdrawal by Subject|0|||
130001852|NCT04178967|467973482|FG008|Induction Period|Withdrawal by Subject|0|||
130001853|NCT04178967|467973483|FG009|Induction Period|Withdrawal by Subject|0|||
130001854|NCT04178967|467973484|FG010|Induction Period|Withdrawal by Subject|0|||
130001855|NCT04178967|467973474|FG000|Induction Period|Lost to Follow-up|2|||
130001856|NCT04178967|467973475|FG001|Induction Period|Lost to Follow-up|0|||
130001857|NCT04178967|467973476|FG002|Induction Period|Lost to Follow-up|0|||
130001858|NCT04178967|467973477|FG003|Induction Period|Lost to Follow-up|0|||
130001859|NCT04178967|467973478|FG004|Induction Period|Lost to Follow-up|0|||
130001860|NCT04178967|467973479|FG005|Induction Period|Lost to Follow-up|0|||
130001861|NCT04178967|467973480|FG006|Induction Period|Lost to Follow-up|0|||
130001862|NCT04178967|467973481|FG007|Induction Period|Lost to Follow-up|0|||
130001863|NCT04178967|467973482|FG008|Induction Period|Lost to Follow-up|0|||
130001864|NCT04178967|467973483|FG009|Induction Period|Lost to Follow-up|0|||
130001865|NCT04178967|467973484|FG010|Induction Period|Lost to Follow-up|0|||
130001866|NCT04178967|467973474|FG000|Induction Period|Participant Missed Study Visits|0|||
130001867|NCT04178967|467973475|FG001|Induction Period|Participant Missed Study Visits|1|||
130001868|NCT04178967|467973476|FG002|Induction Period|Participant Missed Study Visits|0|||
130001869|NCT04178967|467973477|FG003|Induction Period|Participant Missed Study Visits|0|||
130001870|NCT04178967|467973478|FG004|Induction Period|Participant Missed Study Visits|0|||
130001871|NCT04178967|467973479|FG005|Induction Period|Participant Missed Study Visits|0|||
130001872|NCT04178967|467973480|FG006|Induction Period|Participant Missed Study Visits|0|||
130001873|NCT04178967|467973481|FG007|Induction Period|Participant Missed Study Visits|0|||
130001874|NCT04178967|467973482|FG008|Induction Period|Participant Missed Study Visits|0|||
130001875|NCT04178967|467973483|FG009|Induction Period|Participant Missed Study Visits|0|||
130001876|NCT04178967|467973484|FG010|Induction Period|Participant Missed Study Visits|0|||
130001877|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001878|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001879|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001880|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001881|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001882|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
130001883|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
130001884|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
130001885|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001886|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001887|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
130001888|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001889|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001890|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001891|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001892|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001893|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
130001894|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001895|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001896|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001897|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001898|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130001899|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130336244|NCT01459497|469201406|FG000|Overall Study|Physician Decision|1|||
130336245|NCT01459497|469201407|FG001|Overall Study|Physician Decision|1|||
130336246|NCT01459497|469201406|FG000|Overall Study|Hospitalization.|0|||
130336247|NCT01459497|469201407|FG001|Overall Study|Hospitalization.|3|||
130001900|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001901|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001902|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130001903|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001904|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130336248|NCT01459497|469201406|FG000|Overall Study|Disease progression.|0|||
130336249|NCT01459497|469201407|FG001|Overall Study|Disease progression.|1|||
130336250|NCT03530124|469201410|FG000|Overall Study|Withdrawal by Subject|0|||
130336251|NCT03530124|469201411|FG001|Overall Study|Withdrawal by Subject|1|||
130336252|NCT03530124|469201410|FG000|Overall Study|Protocol Violation|1|||
130336253|NCT03530124|469201411|FG001|Overall Study|Protocol Violation|0|||
130336254|NCT03530124|469201410|FG000|Overall Study|Discharged prior to study completion|1|||
130336255|NCT03530124|469201411|FG001|Overall Study|Discharged prior to study completion|0|||
130336256|NCT05343624|469201412|FG000|Overall Study|Chart review not completed|1|||
130336257|NCT00862082|469201413|FG000|Overall Study|Sponsor decision to terminate the study|5|||
130336258|NCT00862082|469201414|FG001|Overall Study|Sponsor decision to terminate the study|0|||
130336259|NCT00862082|469201413|FG000|Overall Study|Withdrawal by Subject|0|||
130336260|NCT00862082|469201414|FG001|Overall Study|Withdrawal by Subject|1|||
130336261|NCT02447302|469201426|FG000|Overall Study|Physician Decision|1|||
130336262|NCT02447302|469201427|FG001|Overall Study|Physician Decision|0|||
130336263|NCT02447302|469201428|FG002|Overall Study|Physician Decision|0|||
130336264|NCT02447302|469201426|FG000|Overall Study|Adverse Event|4|||
130336265|NCT02447302|469201427|FG001|Overall Study|Adverse Event|3|||
130336266|NCT02447302|469201428|FG002|Overall Study|Adverse Event|0|||
130336267|NCT02447302|469201426|FG000|Overall Study|Withdrawal by Subject|0|||
130336268|NCT02447302|469201427|FG001|Overall Study|Withdrawal by Subject|1|||
130336269|NCT02447302|469201428|FG002|Overall Study|Withdrawal by Subject|5|||
130336270|NCT02447302|469201426|FG000|Overall Study|Sponsor Decision|0|||
130336271|NCT02447302|469201427|FG001|Overall Study|Sponsor Decision|0|||
130336272|NCT02447302|469201428|FG002|Overall Study|Sponsor Decision|1|||
130336273|NCT01456897|469201431|FG000|Overall Study|Adverse Event|19|||
130336274|NCT01456897|469201432|FG001|Overall Study|Adverse Event|22|||
130336275|NCT01456897|469201431|FG000|Overall Study|Protocol Violation|3|||
130336276|NCT01456897|469201432|FG001|Overall Study|Protocol Violation|4|||
130336277|NCT01456897|469201431|FG000|Overall Study|Physician Decision|5|||
130336278|NCT01456897|469201432|FG001|Overall Study|Physician Decision|3|||
130336279|NCT01456897|469201431|FG000|Overall Study|Withdrawal by Subject|44|||
130336280|NCT01456897|469201432|FG001|Overall Study|Withdrawal by Subject|17|||
130336281|NCT01456897|469201431|FG000|Overall Study|Lack of Efficacy|4|||
130336282|NCT01456897|469201432|FG001|Overall Study|Lack of Efficacy|11|||
130336283|NCT01396070|469201438|FG000|Overall Study|Withdrawal by Subject|2|||
130336284|NCT01396070|469201438|FG000|Overall Study|Death|2|||
130336285|NCT01396070|469201438|FG000|Overall Study|Adverse Event|8|||
130336286|NCT01396070|469201438|FG000|Overall Study|Physician Decision|3|||
130336287|NCT01396070|469201438|FG000|Overall Study|Lack of Efficacy|4|||
130336288|NCT02152956|469201440|FG000|Overall Study|Adverse Event|0|||
130336289|NCT02152956|469201441|FG001|Overall Study|Adverse Event|0|||
130336290|NCT02152956|469201442|FG002|Overall Study|Adverse Event|0|||
130336291|NCT02152956|469201443|FG003|Overall Study|Adverse Event|0|||
130336292|NCT02152956|469201444|FG004|Overall Study|Adverse Event|0|||
130336293|NCT02152956|469201445|FG005|Overall Study|Adverse Event|0|||
130336294|NCT02152956|469201446|FG006|Overall Study|Adverse Event|0|||
130001905|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001906|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001907|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001908|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001909|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130001910|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001911|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001912|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001913|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001914|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001915|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001916|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
130001917|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001918|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001919|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
130001920|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
130336295|NCT02152956|469201447|FG007|Overall Study|Adverse Event|0|||
130336296|NCT02152956|469201448|FG008|Overall Study|Adverse Event|0|||
130336297|NCT02152956|469201449|FG009|Overall Study|Adverse Event|0|||
130336298|NCT02152956|469201450|FG010|Overall Study|Adverse Event|0|||
130336299|NCT02152956|469201451|FG011|Overall Study|Adverse Event|4|||
130336300|NCT02152956|469201452|FG012|Overall Study|Adverse Event|0|||
130336301|NCT02152956|469201440|FG000|Overall Study|Death|0|||
130336302|NCT02152956|469201441|FG001|Overall Study|Death|3|||
130001921|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130336303|NCT02152956|469201442|FG002|Overall Study|Death|3|||
130336304|NCT02152956|469201443|FG003|Overall Study|Death|4|||
130336305|NCT02152956|469201444|FG004|Overall Study|Death|1|||
130336306|NCT02152956|469201445|FG005|Overall Study|Death|2|||
130336307|NCT02152956|469201446|FG006|Overall Study|Death|6|||
130001922|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001923|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001924|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001925|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
130001926|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
130001927|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001928|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
130001929|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001930|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001931|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130001932|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130001933|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130001934|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130001935|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130001936|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130001937|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
130001938|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
130001939|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
130001940|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130001941|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130001942|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
130001943|NCT04178967|467973474|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001944|NCT04178967|467973475|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001945|NCT04178967|467973476|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001946|NCT04178967|467973477|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130001947|NCT04178967|467973478|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001948|NCT04178967|467973479|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
130001949|NCT04178967|467973480|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130001950|NCT04178967|467973481|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
130001951|NCT04178967|467973482|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001952|NCT04178967|467973483|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001953|NCT04178967|467973484|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130001954|NCT04178967|467973474|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001955|NCT04178967|467973475|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001956|NCT04178967|467973476|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130336308|NCT02152956|469201447|FG007|Overall Study|Death|6|||
130336309|NCT02152956|469201448|FG008|Overall Study|Death|4|||
130336310|NCT02152956|469201449|FG009|Overall Study|Death|5|||
130336311|NCT02152956|469201450|FG010|Overall Study|Death|3|||
130336312|NCT02152956|469201451|FG011|Overall Study|Death|143|||
130336313|NCT02152956|469201452|FG012|Overall Study|Death|12|||
130336314|NCT02152956|469201440|FG000|Overall Study|Lost to Follow-up|0|||
130336315|NCT02152956|469201441|FG001|Overall Study|Lost to Follow-up|1|||
130336316|NCT02152956|469201442|FG002|Overall Study|Lost to Follow-up|0|||
130336317|NCT02152956|469201443|FG003|Overall Study|Lost to Follow-up|0|||
130336318|NCT02152956|469201444|FG004|Overall Study|Lost to Follow-up|0|||
130336319|NCT02152956|469201445|FG005|Overall Study|Lost to Follow-up|0|||
130336320|NCT02152956|469201446|FG006|Overall Study|Lost to Follow-up|0|||
130336321|NCT02152956|469201447|FG007|Overall Study|Lost to Follow-up|0|||
130336322|NCT02152956|469201448|FG008|Overall Study|Lost to Follow-up|0|||
130336323|NCT02152956|469201449|FG009|Overall Study|Lost to Follow-up|0|||
130336324|NCT02152956|469201450|FG010|Overall Study|Lost to Follow-up|0|||
130336325|NCT02152956|469201451|FG011|Overall Study|Lost to Follow-up|3|||
130336326|NCT02152956|469201452|FG012|Overall Study|Lost to Follow-up|0|||
130336327|NCT02152956|469201440|FG000|Overall Study|Withdrawal by Subject|1|||
130336328|NCT02152956|469201441|FG001|Overall Study|Withdrawal by Subject|0|||
130336329|NCT02152956|469201442|FG002|Overall Study|Withdrawal by Subject|1|||
130336330|NCT02152956|469201443|FG003|Overall Study|Withdrawal by Subject|0|||
130336331|NCT02152956|469201444|FG004|Overall Study|Withdrawal by Subject|2|||
130336332|NCT02152956|469201445|FG005|Overall Study|Withdrawal by Subject|2|||
130336333|NCT02152956|469201446|FG006|Overall Study|Withdrawal by Subject|0|||
130336334|NCT02152956|469201447|FG007|Overall Study|Withdrawal by Subject|0|||
130336335|NCT02152956|469201448|FG008|Overall Study|Withdrawal by Subject|1|||
130336336|NCT02152956|469201449|FG009|Overall Study|Withdrawal by Subject|0|||
130336337|NCT02152956|469201450|FG010|Overall Study|Withdrawal by Subject|0|||
130336338|NCT02152956|469201451|FG011|Overall Study|Withdrawal by Subject|4|||
130336339|NCT02152956|469201452|FG012|Overall Study|Withdrawal by Subject|0|||
130336340|NCT02152956|469201440|FG000|Overall Study|Physician Decision|0|||
130336341|NCT02152956|469201441|FG001|Overall Study|Physician Decision|0|||
130336342|NCT02152956|469201442|FG002|Overall Study|Physician Decision|0|||
130336343|NCT02152956|469201443|FG003|Overall Study|Physician Decision|0|||
130336344|NCT02152956|469201444|FG004|Overall Study|Physician Decision|0|||
130336345|NCT02152956|469201445|FG005|Overall Study|Physician Decision|0|||
130001957|NCT04178967|467973477|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001958|NCT04178967|467973478|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001959|NCT04178967|467973479|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001960|NCT04178967|467973480|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130336346|NCT02152956|469201446|FG006|Overall Study|Physician Decision|0|||
130336347|NCT02152956|469201447|FG007|Overall Study|Physician Decision|0|||
130336348|NCT02152956|469201448|FG008|Overall Study|Physician Decision|0|||
130336349|NCT02152956|469201449|FG009|Overall Study|Physician Decision|0|||
130336350|NCT02152956|469201450|FG010|Overall Study|Physician Decision|0|||
130336351|NCT02152956|469201451|FG011|Overall Study|Physician Decision|1|||
130336352|NCT02152956|469201452|FG012|Overall Study|Physician Decision|0|||
130336353|NCT02152956|469201440|FG000|Overall Study|Study terminated by sponsor|0|||
130336354|NCT02152956|469201441|FG001|Overall Study|Study terminated by sponsor|0|||
130336355|NCT02152956|469201442|FG002|Overall Study|Study terminated by sponsor|0|||
130336356|NCT02152956|469201443|FG003|Overall Study|Study terminated by sponsor|0|||
130336357|NCT02152956|469201444|FG004|Overall Study|Study terminated by sponsor|0|||
130336358|NCT02152956|469201445|FG005|Overall Study|Study terminated by sponsor|0|||
130336359|NCT02152956|469201446|FG006|Overall Study|Study terminated by sponsor|0|||
130336360|NCT02152956|469201447|FG007|Overall Study|Study terminated by sponsor|0|||
130336361|NCT02152956|469201448|FG008|Overall Study|Study terminated by sponsor|0|||
130336362|NCT02152956|469201449|FG009|Overall Study|Study terminated by sponsor|0|||
130336363|NCT02152956|469201450|FG010|Overall Study|Study terminated by sponsor|0|||
130336364|NCT02152956|469201451|FG011|Overall Study|Study terminated by sponsor|29|||
130336365|NCT02152956|469201452|FG012|Overall Study|Study terminated by sponsor|0|||
130336366|NCT02152956|469201440|FG000|Overall Study|progressive disease|0|||
130336367|NCT02152956|469201441|FG001|Overall Study|progressive disease|0|||
130336368|NCT02152956|469201442|FG002|Overall Study|progressive disease|0|||
130336369|NCT02152956|469201443|FG003|Overall Study|progressive disease|0|||
130336370|NCT02152956|469201444|FG004|Overall Study|progressive disease|0|||
130336371|NCT02152956|469201445|FG005|Overall Study|progressive disease|0|||
130001961|NCT04178967|467973481|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001962|NCT04178967|467973482|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
130001963|NCT04178967|467973483|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
130001964|NCT04178967|467973484|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130001965|NCT04178967|467973474|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001966|NCT04178967|467973475|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001967|NCT04178967|467973476|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001968|NCT04178967|467973477|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001969|NCT04178967|467973478|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001970|NCT04178967|467973479|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001971|NCT04178967|467973480|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001972|NCT04178967|467973481|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130001973|NCT04178967|467973482|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
130001974|NCT04178967|467973483|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
130001975|NCT04178967|467973484|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
130001976|NCT04178967|467973474|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001977|NCT04178967|467973475|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001978|NCT04178967|467973476|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001979|NCT04178967|467973477|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001980|NCT04178967|467973478|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001981|NCT04178967|467973479|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001982|NCT04178967|467973480|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001983|NCT04178967|467973481|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001984|NCT04178967|467973482|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001985|NCT04178967|467973483|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
130001986|NCT04178967|467973484|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130001987|NCT04178967|467973474|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001988|NCT04178967|467973475|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001989|NCT04178967|467973476|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001990|NCT04178967|467973477|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001991|NCT04178967|467973478|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130336372|NCT02152956|469201446|FG006|Overall Study|progressive disease|0|||
130336373|NCT02152956|469201447|FG007|Overall Study|progressive disease|0|||
130336374|NCT02152956|469201448|FG008|Overall Study|progressive disease|1|||
130336375|NCT02152956|469201449|FG009|Overall Study|progressive disease|0|||
130336376|NCT02152956|469201450|FG010|Overall Study|progressive disease|0|||
130336377|NCT02152956|469201451|FG011|Overall Study|progressive disease|1|||
130336378|NCT02152956|469201452|FG012|Overall Study|progressive disease|0|||
130336379|NCT02445794|469201453|FG000|Overall Study|Adverse Event|0|||
130336380|NCT02445794|469201454|FG001|Overall Study|Adverse Event|0|||
130336381|NCT02445794|469201455|FG002|Overall Study|Adverse Event|2|||
130001992|NCT04178967|467973479|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001993|NCT04178967|467973480|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001994|NCT04178967|467973481|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130001995|NCT04178967|467973482|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
130001996|NCT04178967|467973483|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
130001997|NCT04178967|467973484|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130001998|NCT04178967|467973474|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130001999|NCT04178967|467973475|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002000|NCT04178967|467973476|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002001|NCT04178967|467973477|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002002|NCT04178967|467973478|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130336382|NCT02445794|469201456|FG003|Overall Study|Adverse Event|0|||
130336383|NCT01064947|469201458|FG000|Overall Study|negative culture|41|||
130336384|NCT04549545|469203413|FG000|Initial Period|Withdrawal by Subject|4|||
130336385|NCT04549545|469203414|FG001|Initial Period|Withdrawal by Subject|0|||
130336386|NCT04549545|469203413|FG000|Initial Period|Additional ENT Procedure|3|||
130336387|NCT04549545|469203414|FG001|Initial Period|Additional ENT Procedure|0|||
130336388|NCT04549545|469203413|FG000|Initial Period|Lost to Follow-up|3|||
130336389|NCT04549545|469203414|FG001|Initial Period|Lost to Follow-up|1|||
130336390|NCT04549545|469203413|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
130336391|NCT04549545|469203414|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
130336392|NCT04549545|469203413|FG000|Crossover Period|Additional ENT Procedure|0|||
130336393|NCT04549545|469203414|FG001|Crossover Period|Additional ENT Procedure|6|||
130336394|NCT04549545|469203413|FG000|Crossover Period|Lost to Follow-up|0|||
130336395|NCT04549545|469203414|FG001|Crossover Period|Lost to Follow-up|1|||
130336396|NCT04549545|469203413|FG000|Crossover Period|Withdrawal by Subject|0|||
130336397|NCT04549545|469203414|FG001|Crossover Period|Withdrawal by Subject|4|||
130336398|NCT01006291|469203415|FG000|Overall Study|Adverse Event|2|||
130336399|NCT01006291|469203416|FG001|Overall Study|Adverse Event|1|||
130336400|NCT01006291|469203417|FG002|Overall Study|Adverse Event|2|||
130002003|NCT04178967|467973479|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002004|NCT04178967|467973480|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002005|NCT04178967|467973481|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002006|NCT04178967|467973482|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002007|NCT04178967|467973483|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
130002008|NCT04178967|467973484|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
130002009|NCT04178967|467973474|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002010|NCT04178967|467973475|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002011|NCT04178967|467973476|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002012|NCT04178967|467973477|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002013|NCT04178967|467973478|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002014|NCT04178967|467973479|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002015|NCT04178967|467973480|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002016|NCT04178967|467973481|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002017|NCT04178967|467973482|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002018|NCT04178967|467973483|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
130002019|NCT04178967|467973484|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
130002020|NCT03681951|467973485|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
130002021|NCT03681951|467973486|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002022|NCT03681951|467973487|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002023|NCT03681951|467973488|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002024|NCT03681951|467973489|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002025|NCT03681951|467973490|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002026|NCT03681951|467973491|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002027|NCT03681951|467973492|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
130002028|NCT03681951|467973485|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
130002029|NCT03681951|467973486|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130002030|NCT03681951|467973487|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130002031|NCT03681951|467973488|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130336401|NCT01006291|469203415|FG000|Overall Study|Lack of Efficacy|2|||
130336402|NCT01006291|469203416|FG001|Overall Study|Lack of Efficacy|2|||
130336403|NCT01006291|469203417|FG002|Overall Study|Lack of Efficacy|1|||
130336404|NCT01006291|469203415|FG000|Overall Study|Protocol Violation|3|||
130336405|NCT01006291|469203416|FG001|Overall Study|Protocol Violation|3|||
130336406|NCT01006291|469203417|FG002|Overall Study|Protocol Violation|3|||
130336407|NCT01006291|469203415|FG000|Overall Study|Withdrawal criteria|5|||
130336408|NCT01006291|469203416|FG001|Overall Study|Withdrawal criteria|4|||
130336409|NCT01006291|469203417|FG002|Overall Study|Withdrawal criteria|4|||
130336410|NCT01006291|469203415|FG000|Overall Study|Other|14|||
130336411|NCT01006291|469203416|FG001|Overall Study|Other|14|||
130336412|NCT01006291|469203417|FG002|Overall Study|Other|17|||
130336413|NCT03079102|469203418|FG000|Overall Study|Physician Decision|0|||
130336414|NCT03079102|469203419|FG001|Overall Study|Physician Decision|1|||
130336415|NCT02810444|469203420|FG000|Overall Study|Screen Failures|14|||
130336416|NCT02810444|469203420|FG000|Overall Study|Withdrawal by Subject|4|||
130002032|NCT03681951|467973489|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130002033|NCT03681951|467973490|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130336417|NCT02810444|469203420|FG000|Overall Study|Adverse Event|3|||
130336418|NCT02785770|469203421|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
130336419|NCT02785770|469203422|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
130336420|NCT02785770|469203423|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
130336421|NCT02785770|469203424|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
130002034|NCT03681951|467973491|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130002035|NCT03681951|467973492|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
130002036|NCT03681951|467973485|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
130002037|NCT03681951|467973486|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002038|NCT03681951|467973487|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002039|NCT03681951|467973488|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002040|NCT03681951|467973489|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002041|NCT03681951|467973490|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002042|NCT03681951|467973491|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002043|NCT03681951|467973492|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
130002044|NCT00628251|467973493|FG000|Randomised Part|Withdrawal by Subject|0|||
130002045|NCT00628251|467973494|FG001|Randomised Part|Withdrawal by Subject|0|||
130002046|NCT00628251|467973495|FG002|Randomised Part|Withdrawal by Subject|1|||
130002047|NCT00628251|467973493|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
130002048|NCT00628251|467973494|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
130002049|NCT00628251|467973495|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
130002050|NCT00628251|467973493|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
130002051|NCT00628251|467973494|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
130002052|NCT00628251|467973495|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
130002053|NCT00628251|467973493|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
130002054|NCT00628251|467973494|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
130002055|NCT00628251|467973495|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
130002056|NCT00628251|467973493|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
130002057|NCT00628251|467973494|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
130002058|NCT00628251|467973495|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
130002059|NCT00628251|467973493|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
130002060|NCT00628251|467973494|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
130002061|NCT00628251|467973495|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
130002062|NCT01020448|467973496|FG000|Pre-assignment|Adverse Event|6|||
130002063|NCT01020448|467973496|FG000|Pre-assignment|Withdrawal by Subject|5|||
130002064|NCT01020448|467973496|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
130002065|NCT01020448|467973496|FG000|Treatment|Adverse Event|11|||
130002066|NCT01020448|467973496|FG000|Treatment|Consent Withdrawn|3|||
130002067|NCT01020448|467973496|FG000|Treatment|Disease Progression|2|||
130002068|NCT01020448|467973496|FG000|Treatment|Lack of Efficacy|8|||
130002069|NCT01020448|467973496|FG000|Treatment|Lost to Follow-up|2|||
130002070|NCT02545322|467973497|FG000|Overall Study|Withdrawal by Subject|3|||
130336422|NCT02785770|469203421|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
130336423|NCT02785770|469203422|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
130336424|NCT02785770|469203423|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
130336425|NCT02785770|469203424|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
130336426|NCT02785770|469203421|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
130336427|NCT02785770|469203422|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
130336428|NCT02785770|469203423|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
130336429|NCT02785770|469203424|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
130336430|NCT04518995|469203425|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
130336431|NCT04518995|469203426|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
130336432|NCT04518995|469203427|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
130336433|NCT04518995|469203425|FG000|Overall Study|Lack of Efficacy|2|||
130336434|NCT04518995|469203426|FG001|Overall Study|Lack of Efficacy|1|||
130002071|NCT01968070|467973498|FG000|Period 1|Withdrawal by Subject|0|||
130002072|NCT01968070|467973499|FG001|Period 1|Withdrawal by Subject|1|||
130002073|NCT01968070|467973500|FG002|Period 1|Withdrawal by Subject|0|||
130002074|NCT01968070|467973501|FG003|Period 1|Withdrawal by Subject|0|||
130002075|NCT01968070|467973502|FG004|Period 1|Withdrawal by Subject|0|||
130336435|NCT04518995|469203427|FG002|Overall Study|Lack of Efficacy|0|||
130336436|NCT04518995|469203425|FG000|Overall Study|Non-compliance With Study Drug|0|||
130002076|NCT01968070|467973503|FG005|Period 1|Withdrawal by Subject|0|||
130002077|NCT01968070|467973504|FG006|Period 1|Withdrawal by Subject|1|||
130002078|NCT01968070|467973505|FG007|Period 1|Withdrawal by Subject|0|||
130002079|NCT01968070|467973506|FG008|Period 1|Withdrawal by Subject|0|||
130002080|NCT01968070|467973507|FG009|Period 1|Withdrawal by Subject|0|||
130002081|NCT01968070|467973508|FG010|Period 1|Withdrawal by Subject|0|||
130002082|NCT01968070|467973509|FG011|Period 1|Withdrawal by Subject|0|||
130002083|NCT01968070|467973510|FG012|Period 1|Withdrawal by Subject|0|||
130002084|NCT01968070|467973511|FG013|Period 1|Withdrawal by Subject|0|||
130002085|NCT01968070|467973512|FG014|Period 1|Withdrawal by Subject|0|||
130002086|NCT01968070|467973513|FG015|Period 1|Withdrawal by Subject|1|||
130002087|NCT01968070|467973514|FG016|Period 1|Withdrawal by Subject|0|||
130002088|NCT01968070|467973515|FG017|Period 1|Withdrawal by Subject|0|||
130002089|NCT01968070|467973498|FG000|Period 1|Protocol Violation|0|||
130002090|NCT01968070|467973499|FG001|Period 1|Protocol Violation|0|||
130002091|NCT01968070|467973500|FG002|Period 1|Protocol Violation|0|||
130002092|NCT01968070|467973501|FG003|Period 1|Protocol Violation|1|||
130002093|NCT01968070|467973502|FG004|Period 1|Protocol Violation|1|||
130002094|NCT01968070|467973503|FG005|Period 1|Protocol Violation|0|||
130002095|NCT01968070|467973504|FG006|Period 1|Protocol Violation|0|||
130002096|NCT01968070|467973505|FG007|Period 1|Protocol Violation|0|||
130002097|NCT01968070|467973506|FG008|Period 1|Protocol Violation|0|||
130002098|NCT01968070|467973507|FG009|Period 1|Protocol Violation|0|||
130002099|NCT01968070|467973508|FG010|Period 1|Protocol Violation|0|||
130002100|NCT01968070|467973509|FG011|Period 1|Protocol Violation|0|||
130002101|NCT01968070|467973510|FG012|Period 1|Protocol Violation|0|||
130002102|NCT01968070|467973511|FG013|Period 1|Protocol Violation|0|||
130002103|NCT01968070|467973512|FG014|Period 1|Protocol Violation|0|||
130002104|NCT01968070|467973513|FG015|Period 1|Protocol Violation|0|||
130002105|NCT01968070|467973514|FG016|Period 1|Protocol Violation|0|||
130002106|NCT01968070|467973515|FG017|Period 1|Protocol Violation|0|||
130002107|NCT01968070|467973498|FG000|Period 1|Lost to Follow-up|0|||
130002108|NCT01968070|467973499|FG001|Period 1|Lost to Follow-up|0|||
130002109|NCT01968070|467973500|FG002|Period 1|Lost to Follow-up|0|||
130002110|NCT01968070|467973501|FG003|Period 1|Lost to Follow-up|1|||
130002111|NCT01968070|467973502|FG004|Period 1|Lost to Follow-up|0|||
130002112|NCT01968070|467973503|FG005|Period 1|Lost to Follow-up|0|||
130002113|NCT01968070|467973504|FG006|Period 1|Lost to Follow-up|0|||
130002114|NCT01968070|467973505|FG007|Period 1|Lost to Follow-up|0|||
130002115|NCT01968070|467973506|FG008|Period 1|Lost to Follow-up|0|||
130002116|NCT01968070|467973507|FG009|Period 1|Lost to Follow-up|0|||
130002117|NCT01968070|467973508|FG010|Period 1|Lost to Follow-up|0|||
130002118|NCT01968070|467973509|FG011|Period 1|Lost to Follow-up|0|||
130002119|NCT01968070|467973510|FG012|Period 1|Lost to Follow-up|0|||
130002120|NCT01968070|467973511|FG013|Period 1|Lost to Follow-up|0|||
130002121|NCT01968070|467973512|FG014|Period 1|Lost to Follow-up|0|||
130002122|NCT01968070|467973513|FG015|Period 1|Lost to Follow-up|0|||
130002123|NCT01968070|467973514|FG016|Period 1|Lost to Follow-up|0|||
130002124|NCT01968070|467973515|FG017|Period 1|Lost to Follow-up|0|||
130002125|NCT01968070|467973498|FG000|Period 1|Adverse Event|0|||
130002126|NCT01968070|467973499|FG001|Period 1|Adverse Event|0|||
130002127|NCT01968070|467973500|FG002|Period 1|Adverse Event|0|||
130002128|NCT01968070|467973501|FG003|Period 1|Adverse Event|0|||
130002129|NCT01968070|467973502|FG004|Period 1|Adverse Event|0|||
130002130|NCT01968070|467973503|FG005|Period 1|Adverse Event|0|||
130002131|NCT01968070|467973504|FG006|Period 1|Adverse Event|1|||
130002132|NCT01968070|467973505|FG007|Period 1|Adverse Event|0|||
130002133|NCT01968070|467973506|FG008|Period 1|Adverse Event|0|||
130002134|NCT01968070|467973507|FG009|Period 1|Adverse Event|0|||
130002135|NCT01968070|467973508|FG010|Period 1|Adverse Event|0|||
130002136|NCT01968070|467973509|FG011|Period 1|Adverse Event|0|||
130002137|NCT01968070|467973510|FG012|Period 1|Adverse Event|0|||
130002138|NCT01968070|467973511|FG013|Period 1|Adverse Event|0|||
130002139|NCT01968070|467973512|FG014|Period 1|Adverse Event|0|||
130002140|NCT01968070|467973513|FG015|Period 1|Adverse Event|0|||
130002141|NCT01968070|467973514|FG016|Period 1|Adverse Event|0|||
130002142|NCT01968070|467973515|FG017|Period 1|Adverse Event|0|||
130002143|NCT01968070|467973498|FG000|Period 1|Physician Decision|0|||
130002144|NCT01968070|467973499|FG001|Period 1|Physician Decision|0|||
130002145|NCT01968070|467973500|FG002|Period 1|Physician Decision|0|||
130002146|NCT01968070|467973501|FG003|Period 1|Physician Decision|0|||
130002147|NCT01968070|467973502|FG004|Period 1|Physician Decision|0|||
130002148|NCT01968070|467973503|FG005|Period 1|Physician Decision|0|||
130002149|NCT01968070|467973504|FG006|Period 1|Physician Decision|0|||
130002150|NCT01968070|467973505|FG007|Period 1|Physician Decision|0|||
130002151|NCT01968070|467973506|FG008|Period 1|Physician Decision|0|||
130002152|NCT01968070|467973507|FG009|Period 1|Physician Decision|0|||
130002153|NCT01968070|467973508|FG010|Period 1|Physician Decision|0|||
130002154|NCT01968070|467973509|FG011|Period 1|Physician Decision|1|||
130002155|NCT01968070|467973510|FG012|Period 1|Physician Decision|0|||
130002156|NCT01968070|467973511|FG013|Period 1|Physician Decision|0|||
130002157|NCT01968070|467973512|FG014|Period 1|Physician Decision|0|||
130002158|NCT01968070|467973513|FG015|Period 1|Physician Decision|0|||
130336437|NCT04518995|469203426|FG001|Overall Study|Non-compliance With Study Drug|3|||
130336438|NCT04518995|469203427|FG002|Overall Study|Non-compliance With Study Drug|2|||
130336439|NCT04518995|469203425|FG000|Overall Study|Pregnancy|0|||
130336440|NCT04518995|469203426|FG001|Overall Study|Pregnancy|0|||
130002159|NCT01968070|467973514|FG016|Period 1|Physician Decision|0|||
130002160|NCT01968070|467973515|FG017|Period 1|Physician Decision|0|||
130002161|NCT01968070|467973498|FG000|Period 2|Withdrawal by Subject|0|||
130002162|NCT01968070|467973499|FG001|Period 2|Withdrawal by Subject|0|||
130002163|NCT01968070|467973500|FG002|Period 2|Withdrawal by Subject|0|||
130002164|NCT01968070|467973501|FG003|Period 2|Withdrawal by Subject|0|||
130002165|NCT01968070|467973502|FG004|Period 2|Withdrawal by Subject|1|||
130002166|NCT01968070|467973503|FG005|Period 2|Withdrawal by Subject|0|||
130002167|NCT01968070|467973504|FG006|Period 2|Withdrawal by Subject|0|||
130002168|NCT01968070|467973505|FG007|Period 2|Withdrawal by Subject|0|||
130002169|NCT01968070|467973506|FG008|Period 2|Withdrawal by Subject|0|||
130002170|NCT01968070|467973507|FG009|Period 2|Withdrawal by Subject|0|||
130002171|NCT01968070|467973508|FG010|Period 2|Withdrawal by Subject|0|||
130002172|NCT01968070|467973509|FG011|Period 2|Withdrawal by Subject|0|||
130002173|NCT01968070|467973510|FG012|Period 2|Withdrawal by Subject|0|||
130002174|NCT01968070|467973511|FG013|Period 2|Withdrawal by Subject|0|||
130002175|NCT01968070|467973512|FG014|Period 2|Withdrawal by Subject|0|||
130002176|NCT01968070|467973513|FG015|Period 2|Withdrawal by Subject|0|||
130002177|NCT01968070|467973514|FG016|Period 2|Withdrawal by Subject|0|||
130002178|NCT01968070|467973515|FG017|Period 2|Withdrawal by Subject|0|||
130002179|NCT00108069|467973520|FG000|Overall Study|Never rec'd study drug|0|||
130002180|NCT00108069|467973521|FG001|Overall Study|Never rec'd study drug|1|||
130002181|NCT00108069|467973520|FG000|Overall Study|Adverse Event|1|||
130002182|NCT00108069|467973521|FG001|Overall Study|Adverse Event|1|||
130002183|NCT00108069|467973520|FG000|Overall Study|Withdrawal by Subject|1|||
130002184|NCT00108069|467973521|FG001|Overall Study|Withdrawal by Subject|0|||
130002185|NCT00108069|467973520|FG000|Overall Study|Death|1|||
130002186|NCT00108069|467973521|FG001|Overall Study|Death|0|||
130002187|NCT00108069|467973520|FG000|Overall Study|Progessive disease|27|||
130002188|NCT00108069|467973521|FG001|Overall Study|Progessive disease|11|||
130002189|NCT00995007|467973522|FG000|Overall Study|Withdrew consent|1|||
130002190|NCT00995007|467973523|FG001|Overall Study|Withdrew consent|0|||
130002191|NCT00995007|467973522|FG000|Overall Study|Refused further treatment|8|||
130002192|NCT00995007|467973523|FG001|Overall Study|Refused further treatment|2|||
130002193|NCT00995007|467973522|FG000|Overall Study|Toxicity|8|||
130002194|NCT00995007|467973523|FG001|Overall Study|Toxicity|0|||
130002195|NCT01910116|467973524|FG000|Overall Study|Adverse Event|0|||
130002196|NCT01910116|467973525|FG001|Overall Study|Adverse Event|3|||
130002197|NCT01910116|467973524|FG000|Overall Study|Lack of Efficacy|3|||
130002198|NCT01910116|467973525|FG001|Overall Study|Lack of Efficacy|4|||
130002199|NCT01910116|467973524|FG000|Overall Study|Lost to Follow-up|1|||
130002200|NCT01910116|467973525|FG001|Overall Study|Lost to Follow-up|0|||
130002201|NCT01910116|467973524|FG000|Overall Study|Protocol Violation|1|||
130002202|NCT01910116|467973525|FG001|Overall Study|Protocol Violation|2|||
130002203|NCT01910116|467973524|FG000|Overall Study|Withdrawal by Subject|8|||
130002204|NCT01910116|467973525|FG001|Overall Study|Withdrawal by Subject|3|||
130002205|NCT01910116|467973524|FG000|Overall Study|uncertain allocation|1|||
130002206|NCT01910116|467973525|FG001|Overall Study|uncertain allocation|3|||
130002207|NCT01910116|467973524|FG000|Overall Study|incomplete data|0|||
130002208|NCT01910116|467973525|FG001|Overall Study|incomplete data|1|||
130002209|NCT04029116|467973526|FG000|Overall Study|Adverse Event|0|||
130002210|NCT04029116|467973527|FG001|Overall Study|Adverse Event|2|||
130002211|NCT04029116|467973526|FG000|Overall Study|Lost to Follow-up|3|||
130002212|NCT04029116|467973527|FG001|Overall Study|Lost to Follow-up|5|||
130002213|NCT04029116|467973526|FG000|Overall Study|Physician Decision|2|||
130002214|NCT04029116|467973527|FG001|Overall Study|Physician Decision|0|||
130002215|NCT04029116|467973526|FG000|Overall Study|Pregnancy|1|||
130002216|NCT04029116|467973527|FG001|Overall Study|Pregnancy|2|||
130002217|NCT04029116|467973526|FG000|Overall Study|Withdrawal by Subject|4|||
130002218|NCT04029116|467973527|FG001|Overall Study|Withdrawal by Subject|6|||
130002219|NCT04029116|467973526|FG000|Overall Study|Other|2|||
130002220|NCT04029116|467973527|FG001|Overall Study|Other|1|||
130002221|NCT03606980|467973528|FG000|Overall Study|Lost to Follow-up|3|||
130002222|NCT03606980|467973529|FG001|Overall Study|Lost to Follow-up|2|||
130002223|NCT03606980|467973530|FG002|Overall Study|Lost to Follow-up|3|||
130002224|NCT03606980|467973528|FG000|Overall Study|Withdrawal by Subject|1|||
130002225|NCT03606980|467973529|FG001|Overall Study|Withdrawal by Subject|0|||
130002226|NCT03606980|467973530|FG002|Overall Study|Withdrawal by Subject|4|||
130002227|NCT02469896|467973533|FG000|Overall Study|Withdrawal by Subject|2|||
130002228|NCT02469896|467973534|FG001|Overall Study|Withdrawal by Subject|0|||
130002229|NCT01294150|467973535|FG000|Overall Study|Physician Decision|2|||
130336441|NCT04518995|469203427|FG002|Overall Study|Pregnancy|1|||
130336442|NCT04518995|469203425|FG000|Overall Study|Protocol Violation|2|||
130002230|NCT01294150|467973536|FG001|Overall Study|Physician Decision|2|||
130002231|NCT03675776|467973537|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
130002232|NCT03675776|467973538|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
130002233|NCT03675776|467973539|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
130002234|NCT03675776|467973537|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
130002235|NCT03675776|467973538|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130002236|NCT03675776|467973539|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130002237|NCT02401412|467973540|FG000|Overall Study|Lost to Follow-up|1|||
130002238|NCT02401412|467973541|FG001|Overall Study|Lost to Follow-up|0|||
130002239|NCT02401412|467973540|FG000|Overall Study|Discontinued Intervention|15|||
130002240|NCT02401412|467973541|FG001|Overall Study|Discontinued Intervention|21|||
130002241|NCT02401412|467973540|FG000|Overall Study|Withdrawal by Subject|4|||
130002242|NCT02401412|467973541|FG001|Overall Study|Withdrawal by Subject|4|||
130002243|NCT02401412|467973540|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
130002244|NCT02401412|467973541|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
130002245|NCT02401412|467973540|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
130002246|NCT02401412|467973541|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
130002247|NCT04246801|467973542|FG000|Overall Study|Adverse Event|1|||
130002248|NCT04246801|467973543|FG001|Overall Study|Adverse Event|1|||
130002249|NCT04246801|467973542|FG000|Overall Study|Protocol Violation|1|||
130002250|NCT04246801|467973543|FG001|Overall Study|Protocol Violation|1|||
130002251|NCT04246801|467973542|FG000|Overall Study|Lack of Efficacy|0|||
130002252|NCT04246801|467973543|FG001|Overall Study|Lack of Efficacy|2|||
130002253|NCT04246801|467973542|FG000|Overall Study|Lost to Follow-up|1|||
130002254|NCT04246801|467973543|FG001|Overall Study|Lost to Follow-up|1|||
130002255|NCT04246801|467973542|FG000|Overall Study|Withdrawal by Subject|2|||
130002256|NCT04246801|467973543|FG001|Overall Study|Withdrawal by Subject|1|||
130002257|NCT03684642|467973544|FG000|Overall Study|Adverse Event|6|||
130002258|NCT03684642|467973545|FG001|Overall Study|Adverse Event|15|||
130002259|NCT03684642|467973546|FG002|Overall Study|Adverse Event|11|||
130002260|NCT03684642|467973544|FG000|Overall Study|Withdrawal by Subject|35|||
130002261|NCT03684642|467973545|FG001|Overall Study|Withdrawal by Subject|53|||
130002262|NCT03684642|467973546|FG002|Overall Study|Withdrawal by Subject|23|||
130002263|NCT03684642|467973544|FG000|Overall Study|Lack of Efficacy|0|||
130002264|NCT03684642|467973545|FG001|Overall Study|Lack of Efficacy|0|||
130002265|NCT03684642|467973546|FG002|Overall Study|Lack of Efficacy|1|||
130002266|NCT03684642|467973544|FG000|Overall Study|Poor compliance to protocol|0|||
130002267|NCT03684642|467973545|FG001|Overall Study|Poor compliance to protocol|4|||
130002268|NCT03684642|467973546|FG002|Overall Study|Poor compliance to protocol|1|||
130002269|NCT03684642|467973544|FG000|Overall Study|Other than specified|62|||
130002270|NCT03684642|467973545|FG001|Overall Study|Other than specified|60|||
130002271|NCT03684642|467973546|FG002|Overall Study|Other than specified|67|||
130002272|NCT03684642|467973544|FG000|Overall Study|Randomized and not treated|0|||
130002273|NCT03684642|467973545|FG001|Overall Study|Randomized and not treated|0|||
130002274|NCT03684642|467973546|FG002|Overall Study|Randomized and not treated|1|||
130002275|NCT03684642|467973544|FG000|Overall Study|Missing completion status but alive at last contact|0|||
130002276|NCT03684642|467973545|FG001|Overall Study|Missing completion status but alive at last contact|1|||
130002277|NCT03684642|467973546|FG002|Overall Study|Missing completion status but alive at last contact|2|||
130002278|NCT00805025|467973556|FG000|Overall Study|Screened but not enrolled/treated|42|||
130002279|NCT00805025|467973556|FG000|Overall Study|Adverse Event|4|||
130002280|NCT00805025|467973556|FG000|Overall Study|Withdrawal by Subject|2|||
130002281|NCT00805025|467973556|FG000|Overall Study|Physician Decision|1|||
130002282|NCT00375219|467973557|FG000|Overall Study|Failure to achieve a response|16|||
130002283|NCT00375219|467973558|FG001|Overall Study|Failure to achieve a response|2|||
130002284|NCT00375219|467973559|FG002|Overall Study|Failure to achieve a response|0|||
130002285|NCT00375219|467973557|FG000|Overall Study|Adverse Event|8|||
130002286|NCT00375219|467973558|FG001|Overall Study|Adverse Event|2|||
130002287|NCT00375219|467973559|FG002|Overall Study|Adverse Event|1|||
130002288|NCT00375219|467973557|FG000|Overall Study|Protocol Violation|1|||
130002289|NCT00375219|467973558|FG001|Overall Study|Protocol Violation|0|||
130002290|NCT00375219|467973559|FG002|Overall Study|Protocol Violation|1|||
130002291|NCT00375219|467973557|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
130002292|NCT00375219|467973558|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
130002293|NCT00375219|467973559|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
130002294|NCT00375219|467973557|FG000|Overall Study|Lost to Follow-up|1|||
130002295|NCT00375219|467973558|FG001|Overall Study|Lost to Follow-up|1|||
130002296|NCT00375219|467973559|FG002|Overall Study|Lost to Follow-up|0|||
130002297|NCT00375219|467973557|FG000|Overall Study|Disease progression|18|||
130002298|NCT00375219|467973558|FG001|Overall Study|Disease progression|9|||
130002299|NCT00375219|467973559|FG002|Overall Study|Disease progression|12|||
130002300|NCT00375219|467973557|FG000|Overall Study|Death|4|||
130002301|NCT00375219|467973558|FG001|Overall Study|Death|3|||
130002302|NCT00375219|467973559|FG002|Overall Study|Death|7|||
130002303|NCT00375219|467973557|FG000|Overall Study|Hematologic resistance|1|||
130002304|NCT00375219|467973558|FG001|Overall Study|Hematologic resistance|0|||
130002305|NCT00375219|467973559|FG002|Overall Study|Hematologic resistance|0|||
130002306|NCT00375219|467973557|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
130002307|NCT00375219|467973558|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
130336443|NCT04518995|469203426|FG001|Overall Study|Protocol Violation|0|||
130336444|NCT04518995|469203427|FG002|Overall Study|Protocol Violation|1|||
130336445|NCT04518995|469203425|FG000|Overall Study|Reason not Specified|4|||
130336446|NCT04518995|469203426|FG001|Overall Study|Reason not Specified|11|||
130336447|NCT04518995|469203427|FG002|Overall Study|Reason not Specified|2|||
130336448|NCT04518995|469203425|FG000|Overall Study|Lost to Follow-up|1|||
130336449|NCT04518995|469203426|FG001|Overall Study|Lost to Follow-up|10|||
130336450|NCT04518995|469203427|FG002|Overall Study|Lost to Follow-up|6|||
130336451|NCT02891070|469203432|FG000|Overall Study|Adverse Event|1|||
130336452|NCT02891070|469203433|FG001|Overall Study|Adverse Event|0|||
130002308|NCT00375219|467973559|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
130002309|NCT00375219|467973557|FG000|Overall Study|Allograft|2|||
130002310|NCT00375219|467973558|FG001|Overall Study|Allograft|0|||
130002311|NCT00375219|467973559|FG002|Overall Study|Allograft|0|||
130002312|NCT00375219|467973557|FG000|Overall Study|Cord blood transplantation|1|||
130002313|NCT00375219|467973558|FG001|Overall Study|Cord blood transplantation|0|||
130002314|NCT00375219|467973559|FG002|Overall Study|Cord blood transplantation|0|||
130002315|NCT00375219|467973557|FG000|Overall Study|Withdrawal by Subject|1|||
130002316|NCT00375219|467973558|FG001|Overall Study|Withdrawal by Subject|0|||
130002317|NCT00375219|467973559|FG002|Overall Study|Withdrawal by Subject|0|||
130002318|NCT01479829|467973560|FG000|Overall Study|Withdrawal by Subject|8|||
130002319|NCT01479829|467973561|FG001|Overall Study|Withdrawal by Subject|10|||
130002320|NCT00601250|467973562|FG000|Overall Study|Adverse Event|3|||
130002321|NCT00601250|467973563|FG001|Overall Study|Adverse Event|9|||
130002322|NCT00601250|467973562|FG000|Overall Study|Protocol Violation|3|||
130002323|NCT00601250|467973563|FG001|Overall Study|Protocol Violation|2|||
130002324|NCT00601250|467973562|FG000|Overall Study|Lost to Follow-up|2|||
130002325|NCT00601250|467973563|FG001|Overall Study|Lost to Follow-up|6|||
130002326|NCT00601250|467973562|FG000|Overall Study|Withdrawal by Subject|4|||
130002327|NCT00601250|467973563|FG001|Overall Study|Withdrawal by Subject|13|||
130002328|NCT00601250|467973562|FG000|Overall Study|Other incl. lack of efficacy|2|||
130002329|NCT00601250|467973563|FG001|Overall Study|Other incl. lack of efficacy|9|||
130002330|NCT01791803|467973564|FG000|Overall Study|Withdrawal by Subject|0|||
130002331|NCT01791803|467973565|FG001|Overall Study|Withdrawal by Subject|0|||
130002332|NCT01791803|467973566|FG002|Overall Study|Withdrawal by Subject|0|||
130002333|NCT01791803|467973567|FG003|Overall Study|Withdrawal by Subject|2|||
130002334|NCT01791803|467973564|FG000|Overall Study|Physician Decision|0|||
130002335|NCT01791803|467973565|FG001|Overall Study|Physician Decision|2|||
130002336|NCT01791803|467973566|FG002|Overall Study|Physician Decision|0|||
130002337|NCT01791803|467973567|FG003|Overall Study|Physician Decision|1|||
130002338|NCT01791803|467973564|FG000|Overall Study|Death|0|||
130002339|NCT01791803|467973565|FG001|Overall Study|Death|0|||
130002340|NCT01791803|467973566|FG002|Overall Study|Death|2|||
130002341|NCT01791803|467973567|FG003|Overall Study|Death|2|||
130002342|NCT04572854|467973568|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
130002343|NCT04572854|467973569|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
130002344|NCT04572854|467973570|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
130002345|NCT04572854|467973571|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
130002346|NCT04572854|467973568|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
130002347|NCT04572854|467973569|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
130002348|NCT04572854|467973570|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
130002349|NCT04572854|467973571|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
130002350|NCT01444456|467973573|FG000|Overall Study|Withdrawal by Subject|21|||
130002351|NCT01444456|467973573|FG000|Overall Study|Physician Decision|9|||
130002352|NCT01444456|467973573|FG000|Overall Study|Lost to Follow-up|37|||
130002353|NCT01444456|467973573|FG000|Overall Study|Death|73|||
130002354|NCT01444456|467973573|FG000|Overall Study|Ineligibility determined|23|||
130002355|NCT01444456|467973573|FG000|Overall Study|Other|18|||
130002356|NCT01444456|467973573|FG000|Overall Study|Not treated|104|||
130002357|NCT04313153|467975018|FG000|Overall Study|Adverse Event (includes Death)|14|||
130002358|NCT04313153|467975019|FG001|Overall Study|Adverse Event (includes Death)|19|||
130002359|NCT04313153|467975020|FG002|Overall Study|Adverse Event (includes Death)|10|||
130002360|NCT04313153|467975018|FG000|Overall Study|Physician Decision|4|||
130002361|NCT04313153|467975019|FG001|Overall Study|Physician Decision|2|||
130002362|NCT04313153|467975020|FG002|Overall Study|Physician Decision|1|||
130002363|NCT04313153|467975018|FG000|Overall Study|Withdrawal by Subject|7|||
130002364|NCT04313153|467975019|FG001|Overall Study|Withdrawal by Subject|6|||
130002365|NCT04313153|467975020|FG002|Overall Study|Withdrawal by Subject|2|||
130002366|NCT04313153|467975018|FG000|Overall Study|Lack of Efficacy|3|||
130002367|NCT04313153|467975019|FG001|Overall Study|Lack of Efficacy|3|||
130002368|NCT04313153|467975020|FG002|Overall Study|Lack of Efficacy|0|||
130002369|NCT04313153|467975018|FG000|Overall Study|Lost to Follow-up|1|||
130002370|NCT04313153|467975019|FG001|Overall Study|Lost to Follow-up|0|||
130336453|NCT02891070|469203432|FG000|Overall Study|Physician Decision|0|||
130336454|NCT02891070|469203433|FG001|Overall Study|Physician Decision|1|||
130002371|NCT04313153|467975020|FG002|Overall Study|Lost to Follow-up|2|||
130336455|NCT02891070|469203432|FG000|Overall Study|Lost to Follow-up|4|||
130336456|NCT02891070|469203433|FG001|Overall Study|Lost to Follow-up|4|||
130336457|NCT02891070|469203432|FG000|Overall Study|Other|1|||
130336458|NCT02891070|469203433|FG001|Overall Study|Other|0|||
130336459|NCT02891070|469203432|FG000|Overall Study|Protocol Violation|0|||
130336460|NCT02891070|469203433|FG001|Overall Study|Protocol Violation|1|||
130336461|NCT02891070|469203432|FG000|Overall Study|Withdrawal by Subject|1|||
130336462|NCT02891070|469203433|FG001|Overall Study|Withdrawal by Subject|2|||
130336463|NCT02891070|469203432|FG000|Overall Study|Death|3|||
130336464|NCT02891070|469203433|FG001|Overall Study|Death|0|||
130336465|NCT04491604|469203436|FG000|Overall Study|Withdrawal by Subject|3|||
130336466|NCT00545272|469203437|FG000|Overall Study|Protocol deviation|0|||
130336467|NCT00545272|469203438|FG001|Overall Study|Protocol deviation|1|||
130336468|NCT00545272|469203439|FG002|Overall Study|Protocol deviation|0|||
130336469|NCT00545272|469203440|FG003|Overall Study|Protocol deviation|1|||
130336470|NCT00545272|469203441|FG004|Overall Study|Protocol deviation|0|||
130336471|NCT00545272|469203442|FG005|Overall Study|Protocol deviation|1|||
130336472|NCT00545272|469203437|FG000|Overall Study|Adverse Event|0|||
130336473|NCT00545272|469203438|FG001|Overall Study|Adverse Event|0|||
130336474|NCT00545272|469203439|FG002|Overall Study|Adverse Event|1|||
130336475|NCT00545272|469203440|FG003|Overall Study|Adverse Event|0|||
130336476|NCT00545272|469203441|FG004|Overall Study|Adverse Event|0|||
130336477|NCT00545272|469203442|FG005|Overall Study|Adverse Event|1|||
130336478|NCT00545272|469203437|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130336479|NCT00545272|469203438|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130336480|NCT00545272|469203439|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130336481|NCT00545272|469203440|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130336482|NCT00545272|469203441|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130336483|NCT00545272|469203442|FG005|Overall Study|Abnormal laboratory value(s)|1|||
130336484|NCT00545272|469203437|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130336485|NCT00545272|469203438|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130336486|NCT00545272|469203439|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130336487|NCT00545272|469203440|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130336488|NCT00545272|469203441|FG004|Overall Study|Abnormal test procedure result(s)|1|||
130336489|NCT00545272|469203442|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130336490|NCT00545272|469203437|FG000|Overall Study|Lost to Follow-up|0|||
130336491|NCT00545272|469203438|FG001|Overall Study|Lost to Follow-up|0|||
130336492|NCT00545272|469203439|FG002|Overall Study|Lost to Follow-up|0|||
130336493|NCT00545272|469203440|FG003|Overall Study|Lost to Follow-up|0|||
130336494|NCT00545272|469203441|FG004|Overall Study|Lost to Follow-up|1|||
130336495|NCT00545272|469203442|FG005|Overall Study|Lost to Follow-up|0|||
130336496|NCT02934503|469203443|FG000|Overall Study|progression of disease|3|||
130336497|NCT02934503|469203443|FG000|Overall Study|Withdrawal by Subject|1|||
130336498|NCT00724867|469203444|FG000|Overall Study|Adverse Event|25|||
130336499|NCT00724867|469203444|FG000|Overall Study|Lack of Efficacy|14|||
130336500|NCT00724867|469203444|FG000|Overall Study|Lost to Follow-up|12|||
130336501|NCT00724867|469203444|FG000|Overall Study|Non-compliance with study drug|6|||
130002372|NCT04313153|467975018|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
130002373|NCT04313153|467975019|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
130336502|NCT00724867|469203444|FG000|Overall Study|Physician Decision|17|||
130336503|NCT00724867|469203444|FG000|Overall Study|Protocol Violation|1|||
130336504|NCT00724867|469203444|FG000|Overall Study|Withdrawal by Subject|31|||
130336505|NCT00724867|469203444|FG000|Overall Study|Sponsor decision to end study|14|||
130336506|NCT00724867|469203444|FG000|Overall Study|Subject incarcerated|1|||
130002374|NCT04313153|467975020|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
130002375|NCT04313153|467975018|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
130002376|NCT04313153|467975019|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
130002377|NCT04313153|467975020|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
130002378|NCT04313153|467975018|FG000|Overall Study|Change in Dialysis Modality|0|||
130002379|NCT04313153|467975019|FG001|Overall Study|Change in Dialysis Modality|1|||
130002380|NCT04313153|467975020|FG002|Overall Study|Change in Dialysis Modality|2|||
130002381|NCT04313153|467975018|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
130002382|NCT04313153|467975019|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
130002383|NCT04313153|467975020|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
130002384|NCT04313153|467975018|FG000|Overall Study|Other|5|||
130002385|NCT04313153|467975019|FG001|Overall Study|Other|3|||
130336507|NCT00724867|469203444|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
130336508|NCT00724867|469203444|FG000|Overall Study|Subject moved out of state|1|||
130336509|NCT00724867|469203444|FG000|Overall Study|Elected to exit due to site closure|2|||
130336510|NCT04335136|469203446|FG000|Overall Study|Death|8|||
130336511|NCT04335136|469203447|FG001|Overall Study|Death|4|||
130336512|NCT04335136|469203446|FG000|Overall Study|Lost to Follow-up|2|||
130336513|NCT04335136|469203447|FG001|Overall Study|Lost to Follow-up|0|||
130336514|NCT04335136|469203446|FG000|Overall Study|Protocol Violation|1|||
130336515|NCT04335136|469203447|FG001|Overall Study|Protocol Violation|0|||
130002386|NCT04313153|467975020|FG002|Overall Study|Other|2|||
130002387|NCT00332839|467975021|FG000|Core (Months 0 - 12)|Administrative problems|1|||
130002388|NCT00332839|467975022|FG001|Core (Months 0 - 12)|Administrative problems|1|||
130002389|NCT00332839|467975021|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
130002390|NCT00332839|467975022|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
130002391|NCT00332839|467975021|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
130002392|NCT00332839|467975022|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
130002393|NCT00332839|467975021|FG000|Core (Months 0 - 12)|Adverse Event|5|||
130002394|NCT00332839|467975022|FG001|Core (Months 0 - 12)|Adverse Event|15|||
130002395|NCT00332839|467975021|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
130002396|NCT00332839|467975022|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
130002397|NCT00332839|467975021|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
130002398|NCT00332839|467975022|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
130002399|NCT00332839|467975021|FG000|Follow-up (Months 12 - 60)|Death|1|||
130002400|NCT00332839|467975022|FG001|Follow-up (Months 12 - 60)|Death|1|||
130002401|NCT04641299|467975024|FG000|Overall Study|Adverse Event|0|||
130002402|NCT04641299|467975025|FG001|Overall Study|Adverse Event|0|||
130002403|NCT04641299|467975026|FG002|Overall Study|Adverse Event|2|||
130002404|NCT04641299|467975027|FG003|Overall Study|Adverse Event|0|||
130002405|NCT04641299|467975024|FG000|Overall Study|Lost to Follow-up|0|||
130002406|NCT04641299|467975025|FG001|Overall Study|Lost to Follow-up|1|||
130002407|NCT04641299|467975026|FG002|Overall Study|Lost to Follow-up|0|||
130002408|NCT04641299|467975027|FG003|Overall Study|Lost to Follow-up|0|||
130002409|NCT04641299|467975024|FG000|Overall Study|Withdrawal by Subject|1|||
130002410|NCT04641299|467975025|FG001|Overall Study|Withdrawal by Subject|0|||
130002411|NCT04641299|467975026|FG002|Overall Study|Withdrawal by Subject|0|||
130002412|NCT04641299|467975027|FG003|Overall Study|Withdrawal by Subject|0|||
130002413|NCT04641299|467975024|FG000|Overall Study|Reason not given|1|||
130002414|NCT04641299|467975025|FG001|Overall Study|Reason not given|0|||
130002415|NCT04641299|467975026|FG002|Overall Study|Reason not given|0|||
130002416|NCT04641299|467975027|FG003|Overall Study|Reason not given|0|||
130002417|NCT01016964|467975030|FG000|Overall Study|Lost to Follow-up|3|||
130002418|NCT01016964|467975031|FG001|Overall Study|Lost to Follow-up|3|||
130002419|NCT01920594|467975032|FG000|Overall Study|Adverse Event|4|||
130002420|NCT01920594|467975033|FG001|Overall Study|Adverse Event|2|||
130002421|NCT01920594|467975032|FG000|Overall Study|Lost to Follow-up|1|||
130002422|NCT01920594|467975033|FG001|Overall Study|Lost to Follow-up|0|||
130002423|NCT01920594|467975032|FG000|Overall Study|Recovery|2|||
130002424|NCT01920594|467975033|FG001|Overall Study|Recovery|0|||
130002425|NCT01920594|467975032|FG000|Overall Study|Investigator discretion|0|||
130002426|NCT01920594|467975033|FG001|Overall Study|Investigator discretion|1|||
130002427|NCT00928564|467975034|FG000|Overall Study|Lost to Follow-up|6|||
130002428|NCT00928564|467975035|FG001|Overall Study|Lost to Follow-up|0|||
130002429|NCT02460497|467975039|FG000|Overall Study|Participant Requested Withdrawal|4|||
130002430|NCT02460497|467975039|FG000|Overall Study|Non-Compliance|1|||
130002431|NCT02460497|467975039|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
130002432|NCT02460497|467975039|FG000|Overall Study|Lost to Follow-up|2|||
130002433|NCT02460497|467975039|FG000|Overall Study|Investigator Decision|1|||
130002434|NCT02012296|467975044|FG000|Overall Study|Lack of Efficacy|0|||
130002435|NCT02012296|467975045|FG001|Overall Study|Lack of Efficacy|0|||
130002436|NCT02012296|467975046|FG002|Overall Study|Lack of Efficacy|15|||
130002437|NCT02012296|467975044|FG000|Overall Study|Adverse Event|0|||
130002438|NCT02012296|467975045|FG001|Overall Study|Adverse Event|0|||
130002439|NCT02012296|467975046|FG002|Overall Study|Adverse Event|2|||
130002440|NCT02012296|467975044|FG000|Overall Study|Early study closure|0|||
130002441|NCT02012296|467975045|FG001|Overall Study|Early study closure|0|||
130002442|NCT02012296|467975046|FG002|Overall Study|Early study closure|5|||
130002443|NCT02012296|467975044|FG000|Overall Study|Protocol Violation|0|||
130002444|NCT02012296|467975045|FG001|Overall Study|Protocol Violation|1|||
130002445|NCT02012296|467975046|FG002|Overall Study|Protocol Violation|0|||
130002446|NCT01448213|467975047|FG000|Overall Study|Lost to Follow-up|12|||
130002447|NCT01448213|467975048|FG001|Overall Study|Lost to Follow-up|10|||
130002448|NCT01448213|467975047|FG000|Overall Study|Adverse Event|4|||
130002449|NCT01448213|467975048|FG001|Overall Study|Adverse Event|10|||
130002450|NCT01448213|467975047|FG000|Overall Study|Protocol Violation|1|||
130002451|NCT01448213|467975048|FG001|Overall Study|Protocol Violation|2|||
130002452|NCT01330914|467975049|FG000|Overall Study|Withdrawal by Subject|4|||
130002453|NCT01330914|467975049|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
130002454|NCT02615470|467975050|FG000|Overall Study|Lost to Follow-up|21|||
130002455|NCT02615470|467975051|FG001|Overall Study|Lost to Follow-up|32|||
130002456|NCT01650285|467975054|FG000|Overall Study|Adverse Event|1|||
130002457|NCT00659529|467975055|FG000|Overall Study|Withdrawal by Subject|4|||
130002458|NCT00659529|467975055|FG000|Overall Study|Protocol Violation|3|||
130002459|NCT00659529|467975055|FG000|Overall Study|Screen failure|9|||
130002460|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
130002461|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130002462|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130002463|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130336516|NCT04335136|469203446|FG000|Overall Study|Withdrawal by Subject|1|||
130336517|NCT04335136|469203447|FG001|Overall Study|Withdrawal by Subject|1|||
130336518|NCT04335136|469203446|FG000|Overall Study|Health-threatening condition|0|||
130336519|NCT04335136|469203447|FG001|Overall Study|Health-threatening condition|1|||
130336520|NCT04335136|469203446|FG000|Overall Study|Adverse Event|0|||
130336521|NCT04335136|469203447|FG001|Overall Study|Adverse Event|1|||
130336522|NCT04335136|469203446|FG000|Overall Study|Erroneously randomized|2|||
130336523|NCT04335136|469203447|FG001|Overall Study|Erroneously randomized|0|||
130336524|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
130336525|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
130336526|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
130336527|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
130336528|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
130336529|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130336530|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130336531|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
130336532|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
130336533|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130336534|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130336535|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
130336536|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130336537|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
130336538|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130336539|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
130336540|NCT02834793|469203448|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130336541|NCT02834793|469203449|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
130336542|NCT02834793|469203450|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130336543|NCT02834793|469203451|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
130336544|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130336545|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130336546|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
130336547|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
130336548|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130336549|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130336550|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
130336551|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
130336552|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130336553|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130336554|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
130336555|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
130336556|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130336557|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130336558|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
130336559|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
130336560|NCT02834793|469203448|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
130336561|NCT02834793|469203449|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
130336562|NCT02834793|469203450|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
130336563|NCT02834793|469203451|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
130336564|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130336565|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130336566|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
130336567|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
130336568|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130336569|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130336570|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
130336571|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
130336572|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130336573|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130336574|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
130336575|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
130336576|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
130336577|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
130336578|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
130336579|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
130336580|NCT02834793|469203448|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130336581|NCT02834793|469203449|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130336582|NCT02834793|469203450|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
130336583|NCT02834793|469203451|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
130336584|NCT01049009|469203452|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130002464|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
130002465|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
130002466|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130002467|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130002468|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130002469|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
130002470|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
130002471|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130002472|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130002473|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130002474|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
130336585|NCT01049009|469203453|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
130336586|NCT01049009|469203452|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130336587|NCT01049009|469203453|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130336588|NCT01049009|469203452|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
130336589|NCT01049009|469203453|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
130336590|NCT01049009|469203452|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
130336591|NCT01049009|469203453|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
130336592|NCT02423902|469203454|FG000|Overall Study|Disease progression|1|||
130336593|NCT02423902|469203455|FG001|Overall Study|Disease progression|4|||
130336594|NCT02136069|469203456|FG000|Overall Study|UC flare-up|1|||
130336595|NCT02136069|469203457|FG001|Overall Study|UC flare-up|0|||
130336596|NCT02136069|469203456|FG000|Overall Study|Adverse Event|6|||
130336597|NCT02136069|469203457|FG001|Overall Study|Adverse Event|8|||
130336598|NCT02136069|469203456|FG000|Overall Study|Death|0|||
130336599|NCT02136069|469203457|FG001|Overall Study|Death|1|||
130336600|NCT02136069|469203456|FG000|Overall Study|Lack of Efficacy|10|||
130336601|NCT02136069|469203457|FG001|Overall Study|Lack of Efficacy|4|||
130336602|NCT02136069|469203456|FG000|Overall Study|Lost to Follow-up|1|||
130336603|NCT02136069|469203457|FG001|Overall Study|Lost to Follow-up|0|||
130336604|NCT02136069|469203456|FG000|Overall Study|Non-Compliance|1|||
130336605|NCT02136069|469203457|FG001|Overall Study|Non-Compliance|0|||
130336606|NCT02136069|469203456|FG000|Overall Study|Physician Decision|5|||
130336607|NCT02136069|469203457|FG001|Overall Study|Physician Decision|4|||
130336608|NCT02136069|469203456|FG000|Overall Study|Withdrawal by Subject|10|||
130336609|NCT02136069|469203457|FG001|Overall Study|Withdrawal by Subject|11|||
130336610|NCT04538144|469203458|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
130336611|NCT04538144|469203459|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
130336612|NCT04538144|469203460|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
130336613|NCT04538144|469203461|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
130336614|NCT01092546|469203462|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
130336615|NCT00622440|469203463|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
130336616|NCT00622440|469203464|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
130336617|NCT00622440|469203463|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
130336618|NCT00622440|469203464|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
130336619|NCT00622440|469203463|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
130336620|NCT00622440|469203464|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
130336621|NCT00622440|469203463|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
130336622|NCT00622440|469203464|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
130336623|NCT01667419|469203469|FG000|Overall Study|Reason Not Specified|1|||
130336624|NCT01667419|469203470|FG001|Overall Study|Reason Not Specified|0|||
130336625|NCT01667419|469203471|FG002|Overall Study|Reason Not Specified|0|||
130336626|NCT01667419|469203472|FG003|Overall Study|Reason Not Specified|0|||
130336627|NCT01667419|469203469|FG000|Overall Study|Withdrawal by Subject|16|||
130336628|NCT01667419|469203470|FG001|Overall Study|Withdrawal by Subject|8|||
130336629|NCT01667419|469203471|FG002|Overall Study|Withdrawal by Subject|9|||
130336630|NCT01667419|469203472|FG003|Overall Study|Withdrawal by Subject|8|||
130336631|NCT01667419|469203469|FG000|Overall Study|Non-compliance|0|||
130336632|NCT01667419|469203470|FG001|Overall Study|Non-compliance|0|||
130336633|NCT01667419|469203471|FG002|Overall Study|Non-compliance|0|||
130336634|NCT01667419|469203472|FG003|Overall Study|Non-compliance|1|||
130336635|NCT01667419|469203469|FG000|Overall Study|Protocol Violation|1|||
130336636|NCT01667419|469203470|FG001|Overall Study|Protocol Violation|0|||
130336637|NCT01667419|469203471|FG002|Overall Study|Protocol Violation|0|||
130336638|NCT01667419|469203472|FG003|Overall Study|Protocol Violation|0|||
130336639|NCT01667419|469203469|FG000|Overall Study|Lost to Follow-up|7|||
130336640|NCT01667419|469203470|FG001|Overall Study|Lost to Follow-up|6|||
130336641|NCT01667419|469203471|FG002|Overall Study|Lost to Follow-up|2|||
130336642|NCT01667419|469203472|FG003|Overall Study|Lost to Follow-up|4|||
130336643|NCT01667419|469203469|FG000|Overall Study|Death|18|||
130336644|NCT01667419|469203470|FG001|Overall Study|Death|33|||
130336645|NCT01667419|469203471|FG002|Overall Study|Death|25|||
130336646|NCT01667419|469203472|FG003|Overall Study|Death|26|||
130336647|NCT04364984|469203473|FG000|Overall Study|Death|2|||
130336648|NCT04364984|469203474|FG001|Overall Study|Death|2|||
130336649|NCT04364984|469203475|FG002|Overall Study|Death|0|||
130336650|NCT01941186|469203476|FG000|Follow-up|Lost to Follow-up|1|||
130336651|NCT01941186|469203477|FG001|Follow-up|Lost to Follow-up|0|||
130336652|NCT02722304|469203478|FG000|Overall Study|Study Terminated by Sponsor|1|||
130336653|NCT02722304|469203479|FG001|Overall Study|Study Terminated by Sponsor|0|||
130336654|NCT02722304|469203480|FG002|Overall Study|Study Terminated by Sponsor|2|||
130336655|NCT02722304|469203481|FG003|Overall Study|Study Terminated by Sponsor|1|||
130336656|NCT02722304|469203482|FG004|Overall Study|Study Terminated by Sponsor|1|||
130336657|NCT02722304|469203478|FG000|Overall Study|Other|0|||
130336658|NCT02722304|469203479|FG001|Overall Study|Other|0|||
130336659|NCT02722304|469203480|FG002|Overall Study|Other|0|||
130336660|NCT02722304|469203481|FG003|Overall Study|Other|1|||
130336661|NCT02722304|469203482|FG004|Overall Study|Other|1|||
130336662|NCT01068600|469203483|FG000|Overall Study|Withdrawal by Subject|5|||
130336663|NCT01068600|469203484|FG001|Overall Study|Withdrawal by Subject|6|||
130336664|NCT01068600|469203483|FG000|Overall Study|Adverse Event|3|||
130336665|NCT01068600|469203484|FG001|Overall Study|Adverse Event|3|||
130336666|NCT01068600|469203483|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130336667|NCT01068600|469203484|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130336668|NCT01068600|469203483|FG000|Overall Study|Lost to Follow-up|1|||
130336669|NCT01068600|469203484|FG001|Overall Study|Lost to Follow-up|2|||
130336670|NCT01068600|469203483|FG000|Overall Study|Protocol deviation|1|||
130336671|NCT01068600|469203484|FG001|Overall Study|Protocol deviation|1|||
130336672|NCT01068600|469203483|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130336673|NCT01068600|469203484|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130336674|NCT01068600|469203483|FG000|Overall Study|Administrative problems|0|||
130336675|NCT01068600|469203484|FG001|Overall Study|Administrative problems|1|||
130336676|NCT02644109|469203485|FG000|Overall Study|Adverse Event|0|||
130336677|NCT02644109|469203486|FG001|Overall Study|Adverse Event|4|||
130336678|NCT01519869|469203489|FG000|Overall Study|Lost to Follow-up|1|||
130336679|NCT03023813|469203490|FG000|Overall Study|Lost to Follow-up|1|||
130336680|NCT03023813|469203491|FG001|Overall Study|Lost to Follow-up|2|||
130336681|NCT03023813|469203492|FG002|Overall Study|Lost to Follow-up|0|||
130336682|NCT00329797|469203499|FG000|Overall Study|Protocol Violation|1|||
130336683|NCT00329797|469203500|FG001|Overall Study|Protocol Violation|0|||
130336684|NCT00329797|469203499|FG000|Overall Study|Withdrawal by Subject|6|||
130336685|NCT00329797|469203500|FG001|Overall Study|Withdrawal by Subject|6|||
130336686|NCT04254913|469203503|FG000|Overall Study|Adverse Event|1|||
130336687|NCT01396057|469203504|FG000|Overall Study|Adverse Event|2|||
130336688|NCT01396057|469203505|FG001|Overall Study|Adverse Event|6|||
130336689|NCT01396057|469203504|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130336690|NCT01396057|469203505|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130336691|NCT01396057|469203504|FG000|Overall Study|Protocol deviation|4|||
130336692|NCT01396057|469203505|FG001|Overall Study|Protocol deviation|4|||
130336693|NCT01396057|469203504|FG000|Overall Study|Consent withdrawn|3|||
130336694|NCT01396057|469203505|FG001|Overall Study|Consent withdrawn|2|||
130336695|NCT04535453|469203506|FG000|Overall Study|Death|0|||
130336696|NCT04535453|469203507|FG001|Overall Study|Death|1|||
130336697|NCT04535453|469203508|FG002|Overall Study|Death|0|||
130336698|NCT04535453|469203509|FG003|Overall Study|Death|0|||
130336699|NCT04535453|469203510|FG004|Overall Study|Death|0|||
130336700|NCT04535453|469203511|FG005|Overall Study|Death|0|||
130336701|NCT04535453|469203512|FG006|Overall Study|Death|0|||
130336702|NCT04535453|469203513|FG007|Overall Study|Death|0|||
130336703|NCT04535453|469203514|FG008|Overall Study|Death|0|||
130336704|NCT04535453|469203515|FG009|Overall Study|Death|0|||
130336705|NCT04535453|469203516|FG010|Overall Study|Death|0|||
130336706|NCT04535453|469203517|FG011|Overall Study|Death|0|||
130336707|NCT04535453|469203506|FG000|Overall Study|Lost to Follow-up|1|||
130336708|NCT04535453|469203507|FG001|Overall Study|Lost to Follow-up|1|||
130336709|NCT04535453|469203508|FG002|Overall Study|Lost to Follow-up|1|||
130336710|NCT04535453|469203509|FG003|Overall Study|Lost to Follow-up|0|||
130336711|NCT04535453|469203510|FG004|Overall Study|Lost to Follow-up|3|||
130336712|NCT04535453|469203511|FG005|Overall Study|Lost to Follow-up|1|||
130336713|NCT04535453|469203512|FG006|Overall Study|Lost to Follow-up|0|||
130336714|NCT04535453|469203513|FG007|Overall Study|Lost to Follow-up|0|||
130336715|NCT04535453|469203514|FG008|Overall Study|Lost to Follow-up|1|||
130336716|NCT04535453|469203515|FG009|Overall Study|Lost to Follow-up|1|||
130336717|NCT04535453|469203516|FG010|Overall Study|Lost to Follow-up|0|||
130336718|NCT04535453|469203517|FG011|Overall Study|Lost to Follow-up|0|||
130336719|NCT04535453|469203506|FG000|Overall Study|Physician Decision|0|||
130336720|NCT04535453|469203507|FG001|Overall Study|Physician Decision|0|||
130336721|NCT04535453|469203508|FG002|Overall Study|Physician Decision|0|||
130336722|NCT04535453|469203509|FG003|Overall Study|Physician Decision|1|||
130336723|NCT04535453|469203510|FG004|Overall Study|Physician Decision|0|||
130336724|NCT04535453|469203511|FG005|Overall Study|Physician Decision|0|||
130336725|NCT04535453|469203512|FG006|Overall Study|Physician Decision|0|||
130336726|NCT04535453|469203513|FG007|Overall Study|Physician Decision|0|||
130336727|NCT04535453|469203514|FG008|Overall Study|Physician Decision|0|||
130336728|NCT04535453|469203515|FG009|Overall Study|Physician Decision|0|||
130336729|NCT04535453|469203516|FG010|Overall Study|Physician Decision|0|||
130336730|NCT04535453|469203517|FG011|Overall Study|Physician Decision|0|||
130336731|NCT04535453|469203506|FG000|Overall Study|Withdrawal by Subject|3|||
130336732|NCT04535453|469203507|FG001|Overall Study|Withdrawal by Subject|6|||
130336733|NCT04535453|469203508|FG002|Overall Study|Withdrawal by Subject|3|||
130336734|NCT04535453|469203509|FG003|Overall Study|Withdrawal by Subject|3|||
130336735|NCT04535453|469203510|FG004|Overall Study|Withdrawal by Subject|2|||
130336736|NCT04535453|469203511|FG005|Overall Study|Withdrawal by Subject|1|||
130336737|NCT04535453|469203512|FG006|Overall Study|Withdrawal by Subject|1|||
130336738|NCT04535453|469203513|FG007|Overall Study|Withdrawal by Subject|1|||
130336739|NCT04535453|469203514|FG008|Overall Study|Withdrawal by Subject|1|||
130336740|NCT04535453|469203515|FG009|Overall Study|Withdrawal by Subject|1|||
130336741|NCT04535453|469203516|FG010|Overall Study|Withdrawal by Subject|0|||
130336742|NCT04535453|469203517|FG011|Overall Study|Withdrawal by Subject|1|||
130336743|NCT04535453|469203506|FG000|Overall Study|Other|0|||
130336744|NCT04535453|469203507|FG001|Overall Study|Other|0|||
130336745|NCT04535453|469203508|FG002|Overall Study|Other|1|||
130336746|NCT04535453|469203509|FG003|Overall Study|Other|0|||
130336747|NCT04535453|469203510|FG004|Overall Study|Other|1|||
130336748|NCT04535453|469203511|FG005|Overall Study|Other|0|||
130336749|NCT04535453|469203512|FG006|Overall Study|Other|1|||
130336750|NCT04535453|469203513|FG007|Overall Study|Other|1|||
130336751|NCT04535453|469203514|FG008|Overall Study|Other|1|||
130336752|NCT04535453|469203515|FG009|Overall Study|Other|0|||
130336753|NCT04535453|469203516|FG010|Overall Study|Other|0|||
130336754|NCT04535453|469203517|FG011|Overall Study|Other|0|||
130336755|NCT02695420|469203518|FG000|Overall Study|Death|0|||
130336756|NCT02695420|469203519|FG001|Overall Study|Death|1|||
130336757|NCT02695420|469203520|FG002|Overall Study|Death|0|||
130336758|NCT02695420|469203521|FG003|Overall Study|Death|0|||
130336759|NCT00916929|469203524|FG000|Overall Study|Lost to Follow-up|1|||
130336760|NCT00916929|469203525|FG001|Overall Study|Lost to Follow-up|3|||
130336761|NCT00916929|469203524|FG000|Overall Study|Death|5|||
130336762|NCT00916929|469203525|FG001|Overall Study|Death|10|||
130336763|NCT00916929|469203524|FG000|Overall Study|Withdrawal by Subject|1|||
130336764|NCT00916929|469203525|FG001|Overall Study|Withdrawal by Subject|5|||
130336765|NCT00916929|469203524|FG000|Overall Study|Left ventricular epicardial lead|1|||
130336766|NCT00916929|469203525|FG001|Overall Study|Left ventricular epicardial lead|2|||
130336767|NCT00916929|469203524|FG000|Overall Study|Transferred to hospice care|1|||
130336768|NCT00916929|469203525|FG001|Overall Study|Transferred to hospice care|1|||
130336769|NCT00916929|469203524|FG000|Overall Study|System explant|1|||
130336770|NCT00916929|469203525|FG001|Overall Study|System explant|0|||
130336771|NCT00916929|469203524|FG000|Overall Study|Moved to another state|0|||
130336772|NCT00916929|469203525|FG001|Overall Study|Moved to another state|1|||
130336773|NCT00916929|469203524|FG000|Overall Study|Device unable to process impedance data|0|||
130336774|NCT00916929|469203525|FG001|Overall Study|Device unable to process impedance data|7|||
130336775|NCT01742286|469203527|FG000|Escalation Phase|Administrative problems|1|||
130336776|NCT01742286|469203528|FG001|Escalation Phase|Administrative problems|1|||
130336777|NCT01742286|469203529|FG002|Escalation Phase|Administrative problems|0|||
130336778|NCT01742286|469203530|FG003|Escalation Phase|Administrative problems|0|||
130336779|NCT01742286|469203531|FG004|Escalation Phase|Administrative problems|0|||
130336780|NCT01742286|469203532|FG005|Escalation Phase|Administrative problems|0|||
130336781|NCT01742286|469203533|FG006|Escalation Phase|Administrative problems|2|||
130336782|NCT01742286|469203527|FG000|Escalation Phase|Adverse Event|0|||
130336783|NCT01742286|469203528|FG001|Escalation Phase|Adverse Event|1|||
130336784|NCT01742286|469203529|FG002|Escalation Phase|Adverse Event|2|||
130336785|NCT01742286|469203530|FG003|Escalation Phase|Adverse Event|0|||
130336786|NCT01742286|469203531|FG004|Escalation Phase|Adverse Event|0|||
130336787|NCT01742286|469203532|FG005|Escalation Phase|Adverse Event|1|||
130336788|NCT01742286|469203533|FG006|Escalation Phase|Adverse Event|0|||
130336789|NCT01742286|469203527|FG000|Escalation Phase|Disease progression|3|||
130336790|NCT01742286|469203528|FG001|Escalation Phase|Disease progression|7|||
130336791|NCT01742286|469203529|FG002|Escalation Phase|Disease progression|4|||
130336792|NCT01742286|469203530|FG003|Escalation Phase|Disease progression|1|||
130336793|NCT01742286|469203531|FG004|Escalation Phase|Disease progression|4|||
130336794|NCT01742286|469203532|FG005|Escalation Phase|Disease progression|3|||
130336795|NCT01742286|469203533|FG006|Escalation Phase|Disease progression|2|||
130336796|NCT01742286|469203527|FG000|Escalation Phase|Death|0|||
130336797|NCT01742286|469203528|FG001|Escalation Phase|Death|0|||
130336798|NCT01742286|469203529|FG002|Escalation Phase|Death|0|||
130336799|NCT01742286|469203530|FG003|Escalation Phase|Death|0|||
130336800|NCT01742286|469203531|FG004|Escalation Phase|Death|0|||
130336801|NCT01742286|469203532|FG005|Escalation Phase|Death|1|||
130336802|NCT01742286|469203533|FG006|Escalation Phase|Death|0|||
130336803|NCT01742286|469203527|FG000|Escalation Phase|Physician Decision|0|||
130336804|NCT01742286|469203528|FG001|Escalation Phase|Physician Decision|3|||
130336805|NCT01742286|469203529|FG002|Escalation Phase|Physician Decision|0|||
130336806|NCT01742286|469203530|FG003|Escalation Phase|Physician Decision|1|||
130336807|NCT01742286|469203531|FG004|Escalation Phase|Physician Decision|0|||
130336808|NCT01742286|469203532|FG005|Escalation Phase|Physician Decision|0|||
130336809|NCT01742286|469203533|FG006|Escalation Phase|Physician Decision|2|||
130336810|NCT01742286|469203527|FG000|Escalation Phase|Subject/guardian decision|1|||
130336811|NCT01742286|469203528|FG001|Escalation Phase|Subject/guardian decision|0|||
130336812|NCT01742286|469203529|FG002|Escalation Phase|Subject/guardian decision|0|||
130336813|NCT01742286|469203530|FG003|Escalation Phase|Subject/guardian decision|0|||
130336814|NCT01742286|469203531|FG004|Escalation Phase|Subject/guardian decision|0|||
130336815|NCT01742286|469203532|FG005|Escalation Phase|Subject/guardian decision|0|||
130336816|NCT01742286|469203533|FG006|Escalation Phase|Subject/guardian decision|0|||
130336817|NCT01742286|469203527|FG000|Expansion Phase|Administrative problems|0|||
130336818|NCT01742286|469203528|FG001|Expansion Phase|Administrative problems|0|||
130336819|NCT01742286|469203529|FG002|Expansion Phase|Administrative problems|0|||
130336820|NCT01742286|469203530|FG003|Expansion Phase|Administrative problems|0|||
130336821|NCT01742286|469203531|FG004|Expansion Phase|Administrative problems|0|||
130336822|NCT01742286|469203532|FG005|Expansion Phase|Administrative problems|0|||
130336823|NCT01742286|469203533|FG006|Expansion Phase|Administrative problems|5|||
130336824|NCT01742286|469203527|FG000|Expansion Phase|Physician Decision|0|||
130336825|NCT01742286|469203528|FG001|Expansion Phase|Physician Decision|0|||
130336826|NCT01742286|469203529|FG002|Expansion Phase|Physician Decision|4|||
130336827|NCT01742286|469203530|FG003|Expansion Phase|Physician Decision|0|||
130336828|NCT01742286|469203531|FG004|Expansion Phase|Physician Decision|0|||
130336829|NCT01742286|469203532|FG005|Expansion Phase|Physician Decision|0|||
130336830|NCT01742286|469203533|FG006|Expansion Phase|Physician Decision|9|||
130336831|NCT01742286|469203527|FG000|Expansion Phase|Adverse Event|0|||
130336832|NCT01742286|469203528|FG001|Expansion Phase|Adverse Event|0|||
130336833|NCT01742286|469203529|FG002|Expansion Phase|Adverse Event|0|||
130336834|NCT01742286|469203530|FG003|Expansion Phase|Adverse Event|0|||
130336835|NCT01742286|469203531|FG004|Expansion Phase|Adverse Event|0|||
130336836|NCT01742286|469203532|FG005|Expansion Phase|Adverse Event|0|||
130336837|NCT01742286|469203533|FG006|Expansion Phase|Adverse Event|6|||
130336838|NCT01742286|469203527|FG000|Expansion Phase|Disease progression|0|||
130336839|NCT01742286|469203528|FG001|Expansion Phase|Disease progression|0|||
130336840|NCT01742286|469203529|FG002|Expansion Phase|Disease progression|3|||
130336841|NCT01742286|469203530|FG003|Expansion Phase|Disease progression|0|||
130336842|NCT01742286|469203531|FG004|Expansion Phase|Disease progression|0|||
130336843|NCT01742286|469203532|FG005|Expansion Phase|Disease progression|0|||
130336844|NCT01742286|469203533|FG006|Expansion Phase|Disease progression|15|||
130336845|NCT01742286|469203527|FG000|Expansion Phase|Withdrawal by Subject|0|||
130336846|NCT01742286|469203528|FG001|Expansion Phase|Withdrawal by Subject|0|||
130336847|NCT01742286|469203529|FG002|Expansion Phase|Withdrawal by Subject|0|||
130336848|NCT01742286|469203530|FG003|Expansion Phase|Withdrawal by Subject|0|||
130336849|NCT01742286|469203531|FG004|Expansion Phase|Withdrawal by Subject|0|||
130336850|NCT01742286|469203532|FG005|Expansion Phase|Withdrawal by Subject|0|||
130336851|NCT01742286|469203533|FG006|Expansion Phase|Withdrawal by Subject|1|||
130336852|NCT04530136|469203534|FG000|Overall Study|Lost to Follow-up|2|||
130336853|NCT04530136|469203535|FG001|Overall Study|Lost to Follow-up|3|||
130336854|NCT04530136|469203534|FG000|Overall Study|Withdrawal by Subject|1|||
130336855|NCT04530136|469203535|FG001|Overall Study|Withdrawal by Subject|0|||
130336856|NCT04530136|469203534|FG000|Overall Study|Death|0|||
130336857|NCT04530136|469203535|FG001|Overall Study|Death|1|||
130336858|NCT02087423|469203536|FG000|Overall Study|Withdrawal by Subject|20|||
130336859|NCT02087423|469203537|FG001|Overall Study|Withdrawal by Subject|20|||
130336860|NCT02087423|469203538|FG002|Overall Study|Withdrawal by Subject|3|||
130336861|NCT02087423|469203536|FG000|Overall Study|Death|68|||
130336862|NCT02087423|469203537|FG001|Overall Study|Death|207|||
130336863|NCT02087423|469203538|FG002|Overall Study|Death|40|||
130336864|NCT02087423|469203536|FG000|Overall Study|Lost to Follow-up|0|||
130336865|NCT02087423|469203537|FG001|Overall Study|Lost to Follow-up|2|||
130336866|NCT02087423|469203538|FG002|Overall Study|Lost to Follow-up|0|||
130336867|NCT02087423|469203536|FG000|Overall Study|Terminated from study at final DCO|23|||
130336868|NCT02087423|469203537|FG001|Overall Study|Terminated from study at final DCO|36|||
130336869|NCT02087423|469203538|FG002|Overall Study|Terminated from study at final DCO|25|||
130336870|NCT01387542|469203539|FG000|Overall Study|Adverse Event|3|||
130336871|NCT01387542|469203539|FG000|Overall Study|Withdrawal by Subject|1|||
130336872|NCT01387542|469203539|FG000|Overall Study|Changed diagnosis|1|||
130336873|NCT01387542|469203539|FG000|Overall Study|Insufficient response|1|||
130336874|NCT01387542|469203539|FG000|Overall Study|Non-compliant|1|||
130336875|NCT01387542|469203539|FG000|Overall Study|Lost to Follow-up|1|||
130336876|NCT01010867|469203540|FG000|Overall Study|< 50% adherence to probiotic|1|||
130336877|NCT01233232|469203543|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
130336878|NCT01233232|469203544|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
130336879|NCT01233232|469203545|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
130336880|NCT02762370|469203546|FG000|Overall Study|Protocol Violation|1|||
130336881|NCT02762370|469203547|FG001|Overall Study|Protocol Violation|0|||
130336882|NCT03500224|469203548|FG000|Overall Study|Withdrawal by Subject|2|||
130336883|NCT01324401|469203551|FG000|Overall Study|Withdrawn before any treatment|0|||
130336884|NCT01324401|469203552|FG001|Overall Study|Withdrawn before any treatment|3|||
130002475|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
130002476|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130002477|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130336885|NCT01324401|469203551|FG000|Overall Study|Adverse Event|1|||
130336886|NCT01324401|469203552|FG001|Overall Study|Adverse Event|3|||
130336887|NCT01708902|469203554|FG000|Overall Study|Adverse Event|3|||
130336888|NCT01708902|469203555|FG001|Overall Study|Adverse Event|4|||
130336889|NCT01708902|469203556|FG002|Overall Study|Adverse Event|9|||
130336890|NCT01708902|469203557|FG003|Overall Study|Adverse Event|2|||
130336891|NCT01708902|469203558|FG004|Overall Study|Adverse Event|7|||
130336892|NCT01708902|469203559|FG005|Overall Study|Adverse Event|3|||
130336893|NCT01708902|469203560|FG006|Overall Study|Adverse Event|5|||
130336894|NCT01708902|469203554|FG000|Overall Study|Lack of Efficacy|3|||
130336895|NCT01708902|469203555|FG001|Overall Study|Lack of Efficacy|1|||
130336896|NCT01708902|469203556|FG002|Overall Study|Lack of Efficacy|0|||
130336897|NCT01708902|469203557|FG003|Overall Study|Lack of Efficacy|0|||
130336898|NCT01708902|469203558|FG004|Overall Study|Lack of Efficacy|0|||
130336899|NCT01708902|469203559|FG005|Overall Study|Lack of Efficacy|1|||
130336900|NCT01708902|469203560|FG006|Overall Study|Lack of Efficacy|0|||
130336901|NCT01708902|469203554|FG000|Overall Study|Non compliance with protocol|0|||
130336902|NCT01708902|469203555|FG001|Overall Study|Non compliance with protocol|2|||
130336903|NCT01708902|469203556|FG002|Overall Study|Non compliance with protocol|1|||
130336904|NCT01708902|469203557|FG003|Overall Study|Non compliance with protocol|3|||
130336905|NCT01708902|469203558|FG004|Overall Study|Non compliance with protocol|0|||
130336906|NCT01708902|469203559|FG005|Overall Study|Non compliance with protocol|0|||
130336907|NCT01708902|469203560|FG006|Overall Study|Non compliance with protocol|0|||
130336908|NCT01708902|469203554|FG000|Overall Study|Lost to Follow-up|2|||
130336909|NCT01708902|469203555|FG001|Overall Study|Lost to Follow-up|1|||
130336910|NCT01708902|469203556|FG002|Overall Study|Lost to Follow-up|2|||
130336911|NCT01708902|469203557|FG003|Overall Study|Lost to Follow-up|2|||
130336912|NCT01708902|469203558|FG004|Overall Study|Lost to Follow-up|0|||
130336913|NCT01708902|469203559|FG005|Overall Study|Lost to Follow-up|0|||
130336914|NCT01708902|469203560|FG006|Overall Study|Lost to Follow-up|1|||
130336915|NCT01708902|469203554|FG000|Overall Study|Refused to continue trial medication|8|||
130336916|NCT01708902|469203555|FG001|Overall Study|Refused to continue trial medication|0|||
130336917|NCT01708902|469203556|FG002|Overall Study|Refused to continue trial medication|4|||
130336918|NCT01708902|469203557|FG003|Overall Study|Refused to continue trial medication|2|||
130336919|NCT01708902|469203558|FG004|Overall Study|Refused to continue trial medication|8|||
130336920|NCT01708902|469203559|FG005|Overall Study|Refused to continue trial medication|1|||
130336921|NCT01708902|469203560|FG006|Overall Study|Refused to continue trial medication|1|||
130336922|NCT01708902|469203554|FG000|Overall Study|Other Reason|1|||
130336923|NCT01708902|469203555|FG001|Overall Study|Other Reason|0|||
130336924|NCT01708902|469203556|FG002|Overall Study|Other Reason|1|||
130336925|NCT01708902|469203557|FG003|Overall Study|Other Reason|1|||
130336926|NCT01708902|469203558|FG004|Overall Study|Other Reason|1|||
130336927|NCT01708902|469203559|FG005|Overall Study|Other Reason|2|||
130336928|NCT01708902|469203560|FG006|Overall Study|Other Reason|0|||
130336929|NCT02633020|469203562|FG000|Overall Study|Adverse Event|1|||
130336930|NCT02633020|469203563|FG001|Overall Study|Adverse Event|0|||
130336931|NCT00530816|469203564|FG000|Overall Study|Progressive Disease|16|||
130336932|NCT00530816|469203565|FG001|Overall Study|Progressive Disease|24|||
130336933|NCT00530816|469203566|FG002|Overall Study|Progressive Disease|24|||
130336934|NCT00530816|469203564|FG000|Overall Study|Adverse Event|6|||
130336935|NCT00530816|469203565|FG001|Overall Study|Adverse Event|13|||
130336936|NCT00530816|469203566|FG002|Overall Study|Adverse Event|7|||
130336937|NCT00530816|469203564|FG000|Overall Study|Other|3|||
130336938|NCT00530816|469203565|FG001|Overall Study|Other|3|||
130336939|NCT00530816|469203566|FG002|Overall Study|Other|4|||
130336940|NCT00530816|469203564|FG000|Overall Study|Withdrawal by Subject|1|||
130336941|NCT00530816|469203565|FG001|Overall Study|Withdrawal by Subject|2|||
130336942|NCT00530816|469203566|FG002|Overall Study|Withdrawal by Subject|6|||
130336943|NCT01136785|469203567|FG000|Overall Study|Protocol Violation|2|||
130336944|NCT01136785|469203568|FG001|Overall Study|Protocol Violation|1|||
130336945|NCT01388985|469203571|FG000|Overall Study|Death|0|||
130336946|NCT01388985|469203572|FG001|Overall Study|Death|1|||
130336947|NCT01388985|469203571|FG000|Overall Study|Lost to Follow-up|30|||
130336948|NCT01388985|469203572|FG001|Overall Study|Lost to Follow-up|30|||
130336949|NCT01388985|469203571|FG000|Overall Study|Withdrawal by Subject|13|||
130336950|NCT01388985|469203572|FG001|Overall Study|Withdrawal by Subject|4|||
130336951|NCT01388985|469203571|FG000|Overall Study|Subject unavailable|1|||
130336952|NCT01388985|469203572|FG001|Overall Study|Subject unavailable|1|||
130002478|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130336953|NCT01388985|469203571|FG000|Overall Study|Other (no reason)|0|||
130336954|NCT01388985|469203572|FG001|Overall Study|Other (no reason)|1|||
130002479|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
130336955|NCT01388985|469203571|FG000|Overall Study|Error of nurse|5|||
130336956|NCT01388985|469203572|FG001|Overall Study|Error of nurse|1|||
130336957|NCT01057589|469203573|FG000|Overall Study|Disease Progression|35|||
130336958|NCT01057589|469203573|FG000|Overall Study|Adverse Event|10|||
130336959|NCT01057589|469203573|FG000|Overall Study|Physician Decision|8|||
130336960|NCT01057589|469203573|FG000|Overall Study|Withdrawal by Subject|3|||
130336961|NCT01057589|469203573|FG000|Overall Study|Sponsor Decision|1|||
130336962|NCT01057589|469203573|FG000|Overall Study|Death|8|||
130336963|NCT01057589|469203573|FG000|Overall Study|Lost to Follow-up|1|||
130336964|NCT02954172|469203578|FG000|Overall Study|Protocol Violation|3|||
130336965|NCT02954172|469203579|FG001|Overall Study|Protocol Violation|0|||
130336966|NCT02954172|469203578|FG000|Overall Study|allergic reaction|2|||
130336967|NCT02954172|469203579|FG001|Overall Study|allergic reaction|1|||
130336968|NCT02954172|469203578|FG000|Overall Study|non-measurable lesions at baseline|1|||
130336969|NCT02954172|469203579|FG001|Overall Study|non-measurable lesions at baseline|2|||
130336970|NCT00853567|469203580|FG000|Overall Study|Study prematurely terminated|71|||
130336971|NCT01497366|469203584|FG000|Overall Study|Virologic failure|2|||
130336972|NCT01497366|469203585|FG001|Overall Study|Virologic failure|50|||
130336973|NCT01497366|469203584|FG000|Overall Study|Lost to Follow-up|11|||
130336974|NCT01497366|469203585|FG001|Overall Study|Lost to Follow-up|10|||
130336975|NCT01497366|469203584|FG000|Overall Study|Withdrawal by Subject|6|||
130336976|NCT01497366|469203585|FG001|Overall Study|Withdrawal by Subject|6|||
130336977|NCT01497366|469203584|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
130336978|NCT01497366|469203585|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
130336979|NCT01497366|469203584|FG000|Overall Study|Other|5|||
130336980|NCT01497366|469203585|FG001|Overall Study|Other|0|||
130336981|NCT01497366|469203584|FG000|Overall Study|Death|1|||
130336982|NCT01497366|469203585|FG001|Overall Study|Death|1|||
130336983|NCT01497366|469203584|FG000|Overall Study|Randomized but not treated|7|||
130336984|NCT01497366|469203585|FG001|Overall Study|Randomized but not treated|21|||
130336985|NCT02745080|469203599|FG000|Overall Study|Adverse Event|13|||
130002480|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
130336986|NCT02745080|469203600|FG001|Overall Study|Adverse Event|21|||
130002481|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130002482|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130002483|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130002484|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
130002485|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
130002486|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130002487|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130002488|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130336987|NCT02745080|469203599|FG000|Overall Study|Lack of Efficacy|11|||
130336988|NCT02745080|469203600|FG001|Overall Study|Lack of Efficacy|23|||
130336989|NCT02745080|469203599|FG000|Overall Study|Lost to Follow-up|3|||
130336990|NCT02745080|469203600|FG001|Overall Study|Lost to Follow-up|3|||
130336991|NCT02745080|469203599|FG000|Overall Study|Physician Decision|3|||
130336992|NCT02745080|469203600|FG001|Overall Study|Physician Decision|0|||
130336993|NCT02745080|469203599|FG000|Overall Study|Protocol Violation|3|||
130336994|NCT02745080|469203600|FG001|Overall Study|Protocol Violation|1|||
130336995|NCT02745080|469203599|FG000|Overall Study|Withdrawal by Subject|22|||
130336996|NCT02745080|469203600|FG001|Overall Study|Withdrawal by Subject|41|||
130336997|NCT00531427|469203603|FG000|Overall Study|Withdrawal by Subject|7|||
130336998|NCT00531427|469203604|FG001|Overall Study|Withdrawal by Subject|13|||
130336999|NCT00531427|469203603|FG000|Overall Study|Adverse Event|44|||
130337000|NCT00531427|469203604|FG001|Overall Study|Adverse Event|30|||
130337001|NCT00531427|469203603|FG000|Overall Study|Lost to Follow-up|4|||
130337002|NCT00531427|469203604|FG001|Overall Study|Lost to Follow-up|3|||
130337003|NCT00531427|469203603|FG000|Overall Study|Lack of Efficacy|14|||
130337004|NCT00531427|469203604|FG001|Overall Study|Lack of Efficacy|39|||
130337005|NCT00531427|469203603|FG000|Overall Study|Administrative|4|||
130337006|NCT00531427|469203604|FG001|Overall Study|Administrative|9|||
130337007|NCT00843284|469205417|FG000|Overall Study|Adverse Event|39|||
130337008|NCT00843284|469205417|FG000|Overall Study|Lack of Efficacy|5|||
130337009|NCT00843284|469205417|FG000|Overall Study|Lost to Follow-up|11|||
130337010|NCT00843284|469205417|FG000|Overall Study|Other|10|||
130337011|NCT00843284|469205417|FG000|Overall Study|Withdrawal by Subject|4|||
130337012|NCT00843284|469205417|FG000|Overall Study|Death|3|||
130337013|NCT00798759|469205421|FG000|Overall Study|Adverse Event|3|||
130337014|NCT00798759|469205422|FG001|Overall Study|Adverse Event|3|||
130337015|NCT00798759|469205421|FG000|Overall Study|Lost to Follow-up|1|||
130002489|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
130337016|NCT00798759|469205422|FG001|Overall Study|Lost to Follow-up|1|||
130337017|NCT00798759|469205421|FG000|Overall Study|Protocol Violation|4|||
130337018|NCT00798759|469205422|FG001|Overall Study|Protocol Violation|8|||
130337019|NCT00798759|469205421|FG000|Overall Study|Other|0|||
130337020|NCT00798759|469205422|FG001|Overall Study|Other|1|||
130337021|NCT00724711|469205423|FG000|Overall Study|Adverse Event|7|||
130337022|NCT00724711|469205424|FG001|Overall Study|Adverse Event|3|||
130337023|NCT00724711|469205423|FG000|Overall Study|Pregnancy|0|||
130337024|NCT00724711|469205424|FG001|Overall Study|Pregnancy|1|||
130337025|NCT00724711|469205423|FG000|Overall Study|Lack of Efficacy|0|||
130337026|NCT00724711|469205424|FG001|Overall Study|Lack of Efficacy|1|||
130337027|NCT00724711|469205423|FG000|Overall Study|Physician Decision|0|||
130337028|NCT00724711|469205424|FG001|Overall Study|Physician Decision|3|||
130337029|NCT00724711|469205423|FG000|Overall Study|Withdrawal by Subject|5|||
130337030|NCT00724711|469205424|FG001|Overall Study|Withdrawal by Subject|4|||
130337031|NCT00724711|469205423|FG000|Overall Study|Lost to Follow-up|4|||
130337032|NCT00724711|469205424|FG001|Overall Study|Lost to Follow-up|5|||
130337033|NCT00724711|469205423|FG000|Overall Study|Protocol Violation|1|||
130337034|NCT00724711|469205424|FG001|Overall Study|Protocol Violation|0|||
130337035|NCT01945710|469205425|FG000|Overall Study|Progressive Disease|5|||
130337036|NCT01945710|469205426|FG001|Overall Study|Progressive Disease|4|||
130337037|NCT01945710|469205427|FG002|Overall Study|Progressive Disease|3|||
130337038|NCT01945710|469205428|FG003|Overall Study|Progressive Disease|2|||
130337039|NCT01945710|469205429|FG004|Overall Study|Progressive Disease|7|||
130337040|NCT01945710|469205430|FG005|Overall Study|Progressive Disease|3|||
130337041|NCT01945710|469205431|FG006|Overall Study|Progressive Disease|19|||
130337042|NCT01945710|469205425|FG000|Overall Study|Adverse Event|0|||
130337043|NCT01945710|469205426|FG001|Overall Study|Adverse Event|1|||
130337044|NCT01945710|469205427|FG002|Overall Study|Adverse Event|0|||
130337045|NCT01945710|469205428|FG003|Overall Study|Adverse Event|0|||
130337046|NCT01945710|469205429|FG004|Overall Study|Adverse Event|0|||
130337047|NCT01945710|469205430|FG005|Overall Study|Adverse Event|0|||
130337048|NCT01945710|469205431|FG006|Overall Study|Adverse Event|0|||
130337049|NCT01945710|469205425|FG000|Overall Study|Other|2|||
130337050|NCT01945710|469205426|FG001|Overall Study|Other|0|||
130337051|NCT01945710|469205427|FG002|Overall Study|Other|3|||
130337052|NCT01945710|469205428|FG003|Overall Study|Other|1|||
130337053|NCT01945710|469205429|FG004|Overall Study|Other|1|||
130337054|NCT01945710|469205430|FG005|Overall Study|Other|0|||
130337055|NCT01945710|469205431|FG006|Overall Study|Other|4|||
130337056|NCT01945710|469205425|FG000|Overall Study|Withdrawal by Subject|0|||
130337057|NCT01945710|469205426|FG001|Overall Study|Withdrawal by Subject|1|||
130337058|NCT01945710|469205427|FG002|Overall Study|Withdrawal by Subject|1|||
130337059|NCT01945710|469205428|FG003|Overall Study|Withdrawal by Subject|0|||
130337060|NCT01945710|469205429|FG004|Overall Study|Withdrawal by Subject|1|||
130337061|NCT01945710|469205430|FG005|Overall Study|Withdrawal by Subject|0|||
130337062|NCT01945710|469205431|FG006|Overall Study|Withdrawal by Subject|0|||
130337063|NCT00375609|469205432|FG000|Overall Study|Did not receive treatment|1|||
130337064|NCT00375609|469205433|FG001|Overall Study|Did not receive treatment|0|||
130337065|NCT00375609|469205434|FG002|Overall Study|Did not receive treatment|0|||
130337066|NCT00375609|469205432|FG000|Overall Study|Adverse Event|0|||
130337067|NCT00375609|469205433|FG001|Overall Study|Adverse Event|3|||
130337068|NCT00375609|469205434|FG002|Overall Study|Adverse Event|0|||
130337069|NCT00375609|469205432|FG000|Overall Study|Lost to Follow-up|1|||
130337070|NCT00375609|469205433|FG001|Overall Study|Lost to Follow-up|0|||
130337071|NCT00375609|469205434|FG002|Overall Study|Lost to Follow-up|0|||
130002490|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
130002491|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130002492|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130002493|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130002494|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
130002495|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
130002496|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130002497|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130002498|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130002499|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
130002500|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
130002501|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130002502|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130002503|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130002504|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
130002505|NCT03627767|467975060|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
130002506|NCT03627767|467975061|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130337072|NCT00375609|469205432|FG000|Overall Study|Physician Decision|0|||
130337073|NCT00375609|469205433|FG001|Overall Study|Physician Decision|0|||
130337074|NCT00375609|469205434|FG002|Overall Study|Physician Decision|1|||
130337075|NCT00375609|469205432|FG000|Overall Study|Withdrawal by Subject|1|||
130337076|NCT00375609|469205433|FG001|Overall Study|Withdrawal by Subject|4|||
130337077|NCT00375609|469205434|FG002|Overall Study|Withdrawal by Subject|0|||
130337078|NCT00375609|469205432|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
130337079|NCT00375609|469205433|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
130002507|NCT03627767|467975062|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130002508|NCT03627767|467975063|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130002509|NCT03627767|467975064|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
130002510|NCT03627767|467975060|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
130002511|NCT03627767|467975061|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
130002512|NCT03627767|467975062|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
130002513|NCT03627767|467975063|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
130002514|NCT03627767|467975064|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
130002515|NCT03627767|467975060|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130002516|NCT03627767|467975061|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130002517|NCT03627767|467975062|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
130002518|NCT03627767|467975063|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
130002519|NCT03627767|467975064|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
130002520|NCT03627767|467975060|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
130002521|NCT03627767|467975061|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
130337080|NCT00375609|469205434|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
130337081|NCT02338882|469205439|FG000|Overall Study|Death|1|||
130337082|NCT02338882|469205440|FG001|Overall Study|Death|0|||
130337083|NCT02338882|469205439|FG000|Overall Study|Lost to Follow-up|6|||
130337084|NCT02338882|469205440|FG001|Overall Study|Lost to Follow-up|3|||
130337085|NCT04838977|469205443|FG000|Overall Study|Lost to Follow-up|2|||
130337086|NCT04838977|469205444|FG001|Overall Study|Lost to Follow-up|3|||
130337087|NCT04838977|469205443|FG000|Overall Study|Withdrawal by Subject|1|||
130337088|NCT04838977|469205444|FG001|Overall Study|Withdrawal by Subject|1|||
130337089|NCT00095940|469205446|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
130337090|NCT00095940|469205447|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
130337091|NCT00095940|469205448|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
130337092|NCT00095940|469205449|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
130337093|NCT00095940|469205450|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
130337094|NCT00095940|469205451|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
130337095|NCT00095940|469205452|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
130337096|NCT00095940|469205453|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
130337097|NCT00095940|469205454|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
130337098|NCT00095940|469205446|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337099|NCT00095940|469205447|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337100|NCT00095940|469205448|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337101|NCT00095940|469205449|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337102|NCT00095940|469205450|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337103|NCT00095940|469205451|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337104|NCT00095940|469205452|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337105|NCT00095940|469205453|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
130337106|NCT00095940|469205454|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
130337107|NCT00095940|469205446|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337108|NCT00095940|469205447|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337109|NCT00095940|469205448|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337110|NCT00095940|469205449|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337111|NCT00095940|469205450|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337112|NCT00095940|469205451|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337113|NCT00095940|469205452|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337114|NCT00095940|469205453|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
130337115|NCT00095940|469205454|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
130337116|NCT01536067|469205458|FG000|Overall Study|Disease Progression|1|||
130337117|NCT03120351|469205459|FG000|Overall Study|Physician Decision|1|||
130337118|NCT03120351|469205460|FG001|Overall Study|Physician Decision|1|||
130002522|NCT03627767|467975062|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
130002523|NCT03627767|467975063|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
130002524|NCT03627767|467975064|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
130002525|NCT03627767|467975060|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130002526|NCT03627767|467975061|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
130002527|NCT03627767|467975062|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
130337119|NCT01256190|469205461|FG000|Overall Study|Lost to Follow-up|2|||
130337120|NCT01256190|469205462|FG001|Overall Study|Lost to Follow-up|0|||
130337121|NCT02350478|469205463|FG000|Overall Study|Lost to Follow-up|5|||
130337122|NCT02350478|469205464|FG001|Overall Study|Lost to Follow-up|1|||
130337123|NCT03646123|469205477|FG000|Overall Study|Withdrawal by Subject|2|||
130337124|NCT03646123|469205478|FG001|Overall Study|Withdrawal by Subject|2|||
130337125|NCT03646123|469205479|FG002|Overall Study|Withdrawal by Subject|3|||
130337126|NCT03646123|469205477|FG000|Overall Study|Study termination by sponsor|0|||
130337127|NCT03646123|469205478|FG001|Overall Study|Study termination by sponsor|45|||
130337128|NCT03646123|469205479|FG002|Overall Study|Study termination by sponsor|139|||
130337129|NCT03646123|469205477|FG000|Overall Study|Lost to Follow-up|4|||
130337130|NCT03646123|469205478|FG001|Overall Study|Lost to Follow-up|10|||
130337131|NCT03646123|469205479|FG002|Overall Study|Lost to Follow-up|10|||
130337132|NCT03646123|469205477|FG000|Overall Study|Death|2|||
130337133|NCT03646123|469205478|FG001|Overall Study|Death|1|||
130337134|NCT03646123|469205479|FG002|Overall Study|Death|1|||
130337135|NCT03646123|469205477|FG000|Overall Study|Other|2|||
130337136|NCT03646123|469205478|FG001|Overall Study|Other|0|||
130337137|NCT03646123|469205479|FG002|Overall Study|Other|2|||
130337138|NCT04195893|469205486|FG000|Second Intervention|Withdrawal by Subject|1|||
130337139|NCT04195893|469205487|FG001|Second Intervention|Withdrawal by Subject|0|||
130337140|NCT03679754|469205490|FG000|Overall Study|Investigator request|1|||
130337141|NCT00964171|469205491|FG000|Overall Study|Death|5|||
130337142|NCT03037580|469205495|FG000|Overall Study|Withdrawal by Subject|3|||
130337143|NCT03037580|469205496|FG001|Overall Study|Withdrawal by Subject|0|||
130337144|NCT03037580|469205495|FG000|Overall Study|Adverse Event|1|||
130337145|NCT03037580|469205496|FG001|Overall Study|Adverse Event|0|||
130337146|NCT03037580|469205495|FG000|Overall Study|Study Terminated by Sponsor|12|||
130337147|NCT03037580|469205496|FG001|Overall Study|Study Terminated by Sponsor|15|||
130337148|NCT03037580|469205495|FG000|Overall Study|Death|0|||
130337149|NCT03037580|469205496|FG001|Overall Study|Death|1|||
130337150|NCT02442804|469205497|FG000|Overall Study|Withdrawal by Subject|0|||
130337151|NCT02442804|469205498|FG001|Overall Study|Withdrawal by Subject|1|||
130337152|NCT02442804|469205497|FG000|Overall Study|Adverse Event|1|||
130337153|NCT02442804|469205498|FG001|Overall Study|Adverse Event|0|||
130337154|NCT02036853|469205499|FG000|Overall Study|Adverse Event|0|||
130337155|NCT02036853|469205500|FG001|Overall Study|Adverse Event|2|||
130337156|NCT02036853|469205499|FG000|Overall Study|Lack of Efficacy|0|||
130337157|NCT02036853|469205500|FG001|Overall Study|Lack of Efficacy|2|||
130337158|NCT02036853|469205499|FG000|Overall Study|Physician Decision|0|||
130337159|NCT02036853|469205500|FG001|Overall Study|Physician Decision|1|||
130337160|NCT02036853|469205499|FG000|Overall Study|Withdrawal by Subject|0|||
130337161|NCT02036853|469205500|FG001|Overall Study|Withdrawal by Subject|1|||
130337162|NCT01309282|469205504|FG000|Overall Study|Lost to Follow-up|1|||
130337163|NCT00499590|469205507|FG000|Overall Study|Study Terminated|112|||
130337164|NCT00499590|469205508|FG001|Overall Study|Study Terminated|112|||
130337165|NCT00499590|469205509|FG002|Overall Study|Study Terminated|112|||
130337166|NCT00499590|469205507|FG000|Overall Study|Not treated|1|||
130337167|NCT00499590|469205508|FG001|Overall Study|Not treated|0|||
130337168|NCT00499590|469205509|FG002|Overall Study|Not treated|1|||
130337169|NCT05661851|469205511|FG000|Overall Study|Protocol Violation|1|||
130337170|NCT05661851|469205512|FG001|Overall Study|Protocol Violation|1|||
130337171|NCT05661851|469205511|FG000|Overall Study|Covid-19 Related|3|||
130337172|NCT05661851|469205512|FG001|Overall Study|Covid-19 Related|4|||
130337173|NCT05661851|469205511|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
130337174|NCT05661851|469205512|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
130337175|NCT05661851|469205511|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
130337176|NCT05661851|469205512|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
130337177|NCT00612807|469205513|FG000|Overall Study|Withdrawal by Subject|2|||
130337178|NCT00612807|469205514|FG001|Overall Study|Withdrawal by Subject|0|||
130337179|NCT02055118|469205521|FG000|Overall Study|Withdrawal by Subject|0|||
130337180|NCT02055118|469205522|FG001|Overall Study|Withdrawal by Subject|2|||
130337181|NCT02055118|469205523|FG002|Overall Study|Withdrawal by Subject|0|||
130337182|NCT02281383|469205524|FG000|Overall Study|Progressive Disease|1|||
130337183|NCT02281383|469205524|FG000|Overall Study|Withdrawal by Subject|6|||
130337184|NCT02281383|469205524|FG000|Overall Study|Protocol Violation|2|||
130337185|NCT02281383|469205524|FG000|Overall Study|Death|1|||
130337186|NCT02281383|469205524|FG000|Overall Study|Adverse Event|2|||
130337187|NCT02259088|469205525|FG000|Overall Study|Adverse Event|6|||
130002528|NCT03627767|467975063|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
130002529|NCT03627767|467975064|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
130002530|NCT03627767|467975060|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130337188|NCT02259088|469205526|FG001|Overall Study|Adverse Event|4|||
130052073|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
130337189|NCT02259088|469205525|FG000|Overall Study|Lost to Follow-up|2|||
130337190|NCT02259088|469205526|FG001|Overall Study|Lost to Follow-up|0|||
130337191|NCT02259088|469205525|FG000|Overall Study|Death|2|||
130337192|NCT02259088|469205526|FG001|Overall Study|Death|0|||
130337193|NCT02259088|469205525|FG000|Overall Study|Physician Decision|5|||
130337194|NCT02259088|469205526|FG001|Overall Study|Physician Decision|2|||
130337195|NCT02259088|469205525|FG000|Overall Study|Protocol deviation|5|||
130337196|NCT02259088|469205526|FG001|Overall Study|Protocol deviation|0|||
130337197|NCT02259088|469205525|FG000|Overall Study|Subject/guardian decision|8|||
130337198|NCT02259088|469205526|FG001|Overall Study|Subject/guardian decision|8|||
130337199|NCT01001325|469205529|FG000|Overall Study|Lost to Follow-up|16|||
130002531|NCT03627767|467975061|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130002532|NCT03627767|467975062|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
130002533|NCT03627767|467975063|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130002534|NCT03627767|467975064|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
130002535|NCT03627767|467975060|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
130002536|NCT03627767|467975061|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
130002537|NCT03627767|467975062|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
130002538|NCT03627767|467975063|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
130002539|NCT03627767|467975064|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
130002540|NCT03627767|467975060|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130002541|NCT03627767|467975061|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130002542|NCT03627767|467975062|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130002543|NCT03627767|467975063|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
130002544|NCT03627767|467975064|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
130002545|NCT03627767|467975060|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130002546|NCT03627767|467975061|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130002547|NCT03627767|467975062|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130002548|NCT03627767|467975063|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
130002549|NCT03627767|467975064|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
130002550|NCT03627767|467975060|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130002551|NCT03627767|467975061|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130002552|NCT03627767|467975062|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130002553|NCT03627767|467975063|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
130002554|NCT03627767|467975064|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
130002555|NCT03627767|467975060|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
130002556|NCT03627767|467975061|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
130002557|NCT03627767|467975062|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
130002558|NCT03627767|467975063|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
130002559|NCT03627767|467975064|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
130002560|NCT04163900|467975067|FG000|Overall Study|Radiological disease progression|112|||
130002561|NCT04163900|467975068|FG001|Overall Study|Radiological disease progression|127|||
130002562|NCT04163900|467975067|FG000|Overall Study|Study closure|98|||
130002563|NCT04163900|467975068|FG001|Overall Study|Study closure|133|||
130002564|NCT04163900|467975067|FG000|Overall Study|Adverse Event|78|||
130002565|NCT04163900|467975068|FG001|Overall Study|Adverse Event|32|||
130002566|NCT04163900|467975067|FG000|Overall Study|Withdrawal by Subject|37|||
130002567|NCT04163900|467975068|FG001|Overall Study|Withdrawal by Subject|34|||
130002568|NCT04163900|467975067|FG000|Overall Study|Death|29|||
130002569|NCT04163900|467975068|FG001|Overall Study|Death|16|||
130002570|NCT04163900|467975067|FG000|Overall Study|Physician Decision|17|||
130002571|NCT04163900|467975068|FG001|Overall Study|Physician Decision|25|||
130002572|NCT04163900|467975067|FG000|Overall Study|Clinical disease progression|14|||
130002573|NCT04163900|467975068|FG001|Overall Study|Clinical disease progression|13|||
130002574|NCT04163900|467975067|FG000|Overall Study|Protocol Violation|3|||
130002575|NCT04163900|467975068|FG001|Overall Study|Protocol Violation|4|||
130002576|NCT04163900|467975067|FG000|Overall Study|Lost to Follow-up|0|||
130002577|NCT04163900|467975068|FG001|Overall Study|Lost to Follow-up|1|||
130002578|NCT01873417|467975069|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
130002579|NCT01873417|467975069|FG000|Overall Study|Adverse Event|24|||
130002580|NCT01873417|467975069|FG000|Overall Study|Lost to Follow-up|2|||
130002581|NCT01873417|467975069|FG000|Overall Study|Withdrawal by Subject|2|||
130337200|NCT01001325|469205530|FG001|Overall Study|Lost to Follow-up|10|||
130337201|NCT01001325|469205529|FG000|Overall Study|Protocol Violation|2|||
130337202|NCT01001325|469205530|FG001|Overall Study|Protocol Violation|0|||
130337203|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
130337204|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337205|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337206|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337207|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
130337208|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
130337209|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
130002582|NCT01873417|467975069|FG000|Overall Study|Physician Decision|3|||
130002583|NCT00785044|467975070|FG000|Overall Study|Dosed at non-participating sites|152|||
130002584|NCT00785044|467975070|FG000|Overall Study|Death|77|||
130002585|NCT00785044|467975070|FG000|Overall Study|Lost to Follow-up|266|||
130002586|NCT00785044|467975070|FG000|Overall Study|Withdrawal by Subject|1|||
130002587|NCT01830855|467975071|FG000|Overall Study|Other|7|||
130002588|NCT01830855|467975072|FG001|Overall Study|Other|1|||
130002589|NCT01830855|467975073|FG002|Overall Study|Other|4|||
130002590|NCT01830855|467975074|FG003|Overall Study|Other|4|||
130002591|NCT01830855|467975071|FG000|Overall Study|Medication error without associated AE|1|||
130337210|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
130337211|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
130337212|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
130337213|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
130337214|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337215|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337216|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337217|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
130337218|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
130337219|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
130337220|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
130337221|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
130337222|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
130337223|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
130337224|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337225|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337226|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337227|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
130337228|NCT01584440|469205531|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337229|NCT01584440|469205532|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
130337230|NCT01584440|469205533|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337231|NCT01584440|469205534|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337232|NCT01584440|469205535|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
130337233|NCT01584440|469205531|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130337234|NCT01584440|469205532|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130337235|NCT01584440|469205533|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
130337236|NCT01584440|469205534|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
130337237|NCT01584440|469205535|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
130337238|NCT01584440|469205531|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
130337239|NCT01584440|469205532|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
130337240|NCT01584440|469205533|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
130337241|NCT01584440|469205534|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
130337242|NCT01584440|469205535|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
130337243|NCT01584440|469205531|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337244|NCT01584440|469205532|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337245|NCT01584440|469205533|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
130337246|NCT01584440|469205534|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337247|NCT01584440|469205535|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
130337248|NCT00899431|469205536|FG000|Overall Study|Physician Decision|1|||
130337249|NCT00899431|469205537|FG001|Overall Study|Physician Decision|0|||
130337250|NCT00899431|469205538|FG002|Overall Study|Physician Decision|0|||
130337251|NCT00661427|469205539|FG000|Overall Study|Adverse Event|5|||
130337252|NCT00661427|469205540|FG001|Overall Study|Adverse Event|5|||
130337253|NCT00661427|469205539|FG000|Overall Study|Patient not treated|0|||
130337254|NCT00661427|469205540|FG001|Overall Study|Patient not treated|2|||
130337255|NCT01821560|469205541|FG000|Overall Study|Lost to Follow-up|5|||
130337256|NCT01821560|469205542|FG001|Overall Study|Lost to Follow-up|5|||
130337257|NCT01821560|469205541|FG000|Overall Study|Withdrawal by Subject|1|||
130337258|NCT01821560|469205542|FG001|Overall Study|Withdrawal by Subject|1|||
130337259|NCT01821560|469205541|FG000|Overall Study|Protocol Violation|0|||
130337260|NCT01821560|469205542|FG001|Overall Study|Protocol Violation|1|||
130337261|NCT01338298|469205543|FG000|Overall Study|Withdrawal by Subject|1|||
130337262|NCT01338298|469205544|FG001|Overall Study|Withdrawal by Subject|1|||
130337263|NCT01338298|469205543|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
130337264|NCT01338298|469205544|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
130337265|NCT01338298|469205543|FG000|Overall Study|Administrative error|0|||
130337266|NCT01338298|469205544|FG001|Overall Study|Administrative error|1|||
130337267|NCT01338298|469205543|FG000|Overall Study|Positive symptom worsening|1|||
130337268|NCT01338298|469205544|FG001|Overall Study|Positive symptom worsening|0|||
130337269|NCT01338298|469205543|FG000|Overall Study|Depressive symptoms and nausea|1|||
130337270|NCT01338298|469205544|FG001|Overall Study|Depressive symptoms and nausea|0|||
130337271|NCT01338298|469205543|FG000|Overall Study|Non-adherence|1|||
130337272|NCT01338298|469205544|FG001|Overall Study|Non-adherence|0|||
130337273|NCT02872285|469205545|FG000|Overall Study|Withdrawal by Subject|2|||
130337274|NCT02872285|469205546|FG001|Overall Study|Withdrawal by Subject|0|||
130337275|NCT02872285|469205545|FG000|Overall Study|Lost to Follow-up|2|||
130337276|NCT02872285|469205546|FG001|Overall Study|Lost to Follow-up|2|||
130002592|NCT01830855|467975072|FG001|Overall Study|Medication error without associated AE|0|||
130337277|NCT02872285|469205545|FG000|Overall Study|Discontinued due to back surgery|1|||
130337278|NCT02872285|469205546|FG001|Overall Study|Discontinued due to back surgery|0|||
130337279|NCT01253577|469205549|FG000|Overall Study|Lost to Follow-up|3|||
130337280|NCT00334113|469205550|FG000|Overall Study|Lost to Follow-up|2|||
130337281|NCT00334113|469205551|FG001|Overall Study|Lost to Follow-up|2|||
130337282|NCT00334113|469205550|FG000|Overall Study|Withdrawal by Subject|0|||
130337283|NCT00334113|469205551|FG001|Overall Study|Withdrawal by Subject|1|||
130337284|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
130337285|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
130337286|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
130337287|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
130337288|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Other|2|||
130337289|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
130337290|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
130337291|NCT02509026|469205552|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
130337292|NCT02509026|469205552|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
130337293|NCT02509026|469205552|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
130337294|NCT02509026|469205552|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
130337295|NCT02509026|469205552|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
130337296|NCT02509026|469205552|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
130337297|NCT00721968|469205553|FG000|Overall Study|Lost to Follow-up|2|||
130337298|NCT00721968|469205554|FG001|Overall Study|Lost to Follow-up|0|||
130337299|NCT05601544|469205555|FG000|Phase 2 Period 1|Adverse Event|0|||
130337300|NCT05601544|469205556|FG001|Phase 2 Period 1|Adverse Event|1|||
130337301|NCT05601544|469205557|FG002|Phase 2 Period 1|Adverse Event|0|||
130337302|NCT05601544|469205558|FG003|Phase 2 Period 1|Adverse Event|0|||
130337303|NCT05601544|469205559|FG004|Phase 2 Period 1|Adverse Event|0|||
130337304|NCT05601544|469205560|FG005|Phase 2 Period 1|Adverse Event|0|||
130337305|NCT02626624|469205572|FG000|Overall Study|Adverse Event|1|||
130337306|NCT02626624|469205572|FG000|Overall Study|Lost to Follow-up|3|||
130337307|NCT02626624|469205572|FG000|Overall Study|Protocol Violation|4|||
130337308|NCT02626624|469205572|FG000|Overall Study|Death|2|||
130337309|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
130337310|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
130337311|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
130337312|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
130337313|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
130337314|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130337315|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130337316|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
130337317|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
130337318|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130337319|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130337320|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
130337321|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
130337322|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130337323|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130337324|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
130337325|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
130337326|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130337327|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130337328|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
130337329|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
130337330|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130337331|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130002593|NCT01830855|467975073|FG002|Overall Study|Medication error without associated AE|0|||
130002594|NCT01830855|467975074|FG003|Overall Study|Medication error without associated AE|1|||
130002595|NCT01830855|467975071|FG000|Overall Study|Pregnancy|3|||
130002596|NCT01830855|467975072|FG001|Overall Study|Pregnancy|1|||
130002597|NCT01830855|467975073|FG002|Overall Study|Pregnancy|2|||
130002598|NCT01830855|467975074|FG003|Overall Study|Pregnancy|1|||
130002599|NCT01830855|467975071|FG000|Overall Study|No longer meets eligibility criteria|11|||
130002600|NCT01830855|467975072|FG001|Overall Study|No longer meets eligibility criteria|2|||
130002601|NCT01830855|467975073|FG002|Overall Study|No longer meets eligibility criteria|3|||
130002602|NCT01830855|467975074|FG003|Overall Study|No longer meets eligibility criteria|5|||
130002603|NCT01830855|467975071|FG000|Overall Study|Adverse Event|11|||
130002604|NCT01830855|467975072|FG001|Overall Study|Adverse Event|5|||
130002605|NCT01830855|467975073|FG002|Overall Study|Adverse Event|6|||
130002606|NCT01830855|467975074|FG003|Overall Study|Adverse Event|3|||
130002607|NCT01830855|467975071|FG000|Overall Study|Protocol deviation|10|||
130002608|NCT01830855|467975072|FG001|Overall Study|Protocol deviation|5|||
130002609|NCT01830855|467975073|FG002|Overall Study|Protocol deviation|6|||
130002610|NCT01830855|467975074|FG003|Overall Study|Protocol deviation|6|||
130337332|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
130337333|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
130337334|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130002611|NCT01830855|467975071|FG000|Overall Study|Withdrawal by Subject|33|||
130002612|NCT01830855|467975072|FG001|Overall Study|Withdrawal by Subject|14|||
130002613|NCT01830855|467975073|FG002|Overall Study|Withdrawal by Subject|10|||
130337335|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130337336|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
130337337|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
130337338|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130337339|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130337340|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
130337341|NCT03818035|469205575|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
130337342|NCT03818035|469205576|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
130337343|NCT03818035|469205577|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
130337344|NCT03818035|469205578|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
130337345|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130337346|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130337347|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
130337348|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
130337349|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
130337350|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
130337351|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
130337352|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
130337353|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130337354|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130337355|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
130337356|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
130337357|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
130337358|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
130337359|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
130337360|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
130337361|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
130337362|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
130337363|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
130337364|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
130337365|NCT03818035|469205575|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
130337366|NCT03818035|469205576|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
130337367|NCT03818035|469205577|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
130337368|NCT03818035|469205578|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
130337369|NCT03374202|469205581|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
130337370|NCT03374202|469205582|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
130337371|NCT03374202|469205583|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
130337372|NCT03374202|469205581|FG000|Five Year Long Term Follow Up|Death|0|||
130337373|NCT03374202|469205582|FG001|Five Year Long Term Follow Up|Death|1|||
130337374|NCT03374202|469205583|FG002|Five Year Long Term Follow Up|Death|0|||
130002614|NCT01830855|467975074|FG003|Overall Study|Withdrawal by Subject|12|||
130002615|NCT01830855|467975071|FG000|Overall Study|No longer willing to participate|32|||
130002616|NCT01830855|467975072|FG001|Overall Study|No longer willing to participate|13|||
130002617|NCT01830855|467975073|FG002|Overall Study|No longer willing to participate|12|||
130002618|NCT01830855|467975074|FG003|Overall Study|No longer willing to participate|17|||
130002619|NCT01830855|467975071|FG000|Overall Study|Lost to Follow-up|47|||
130002620|NCT01830855|467975072|FG001|Overall Study|Lost to Follow-up|20|||
130002621|NCT01830855|467975073|FG002|Overall Study|Lost to Follow-up|23|||
130002622|NCT01830855|467975074|FG003|Overall Study|Lost to Follow-up|33|||
130002623|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Adverse Event|2|||
130002624|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Adverse Event|2|||
130002625|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Adverse Event|4|||
130002626|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Adverse Event|0|||
130002627|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Adverse Event|0|||
130002628|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Progressive disease|0|||
130002629|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Progressive disease|0|||
130002630|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Progressive disease|1|||
130002631|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Progressive disease|0|||
130002632|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Progressive disease|0|||
130002633|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
130002634|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
130002635|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
130002636|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
130002637|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
130002638|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
130002639|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130002640|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130337375|NCT01868542|469207292|FG000|Overall Study|Protocol Violation|0|||
130337376|NCT01868542|469207293|FG001|Overall Study|Protocol Violation|1|||
130337377|NCT01868542|469207292|FG000|Overall Study|Unclassified|0|||
130337378|NCT01868542|469207293|FG001|Overall Study|Unclassified|1|||
130337379|NCT00122980|469207300|FG000|Overall Study|Death|0|||
130002641|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130337380|NCT00122980|469207301|FG001|Overall Study|Death|1|||
130337381|NCT00122980|469207300|FG000|Overall Study|Physician Decision|2|||
130002642|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
130002643|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
130337382|NCT00122980|469207301|FG001|Overall Study|Physician Decision|0|||
130337383|NCT00122980|469207300|FG000|Overall Study|Protocol Violation|5|||
130337384|NCT00122980|469207301|FG001|Overall Study|Protocol Violation|1|||
130337385|NCT00122980|469207300|FG000|Overall Study|Withdrawal by Subject|2|||
130337386|NCT00122980|469207301|FG001|Overall Study|Withdrawal by Subject|3|||
130337387|NCT00122980|469207300|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
130337388|NCT00122980|469207301|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
130337389|NCT00122980|469207300|FG000|Overall Study|Study termination|27|||
130337390|NCT00122980|469207301|FG001|Overall Study|Study termination|35|||
130337391|NCT01124864|469207302|FG000|Overall Study|Follow up phase competed as per protocol|18|||
130337392|NCT01124864|469207303|FG001|Overall Study|Follow up phase competed as per protocol|22|||
130337393|NCT01124864|469207304|FG002|Overall Study|Follow up phase competed as per protocol|24|||
130337394|NCT01124864|469207305|FG003|Overall Study|Follow up phase competed as per protocol|18|||
130337395|NCT01124864|469207306|FG004|Overall Study|Follow up phase competed as per protocol|26|||
130337396|NCT01124864|469207307|FG005|Overall Study|Follow up phase competed as per protocol|2|||
130337397|NCT01124864|469207302|FG000|Overall Study|Death|6|||
130337398|NCT01124864|469207303|FG001|Overall Study|Death|9|||
130337399|NCT01124864|469207304|FG002|Overall Study|Death|6|||
130337400|NCT01124864|469207305|FG003|Overall Study|Death|2|||
130337401|NCT01124864|469207306|FG004|Overall Study|Death|1|||
130337402|NCT01124864|469207307|FG005|Overall Study|Death|0|||
130337403|NCT01124864|469207302|FG000|Overall Study|Withdrawal by Subject|2|||
130337404|NCT01124864|469207303|FG001|Overall Study|Withdrawal by Subject|3|||
130337405|NCT01124864|469207304|FG002|Overall Study|Withdrawal by Subject|4|||
130337406|NCT01124864|469207305|FG003|Overall Study|Withdrawal by Subject|0|||
130337407|NCT01124864|469207306|FG004|Overall Study|Withdrawal by Subject|2|||
130002644|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
130002645|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
130002646|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
130002647|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
130002648|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
130002649|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
130002650|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
130002651|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
130002652|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
130002653|NCT03523728|467975075|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
130002654|NCT03523728|467975076|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
130337408|NCT01124864|469207307|FG005|Overall Study|Withdrawal by Subject|1|||
130337409|NCT01124864|469207302|FG000|Overall Study|Lost to Follow-up|1|||
130337410|NCT01124864|469207303|FG001|Overall Study|Lost to Follow-up|1|||
130002655|NCT03523728|467975077|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
130337411|NCT01124864|469207304|FG002|Overall Study|Lost to Follow-up|0|||
130002656|NCT03523728|467975078|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
130002657|NCT03523728|467975079|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
130002658|NCT03523728|467975075|FG000|Stage 2 (24 Months)|Adverse Event|0|||
130002659|NCT03523728|467975076|FG001|Stage 2 (24 Months)|Adverse Event|0|||
130002660|NCT03523728|467975077|FG002|Stage 2 (24 Months)|Adverse Event|0|||
130002661|NCT03523728|467975078|FG003|Stage 2 (24 Months)|Adverse Event|1|||
130002662|NCT03523728|467975079|FG004|Stage 2 (24 Months)|Adverse Event|2|||
130002663|NCT03523728|467975075|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130002664|NCT03523728|467975076|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130002665|NCT03523728|467975077|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130002666|NCT03523728|467975078|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
130002667|NCT03523728|467975079|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
130002668|NCT03523728|467975075|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
130002669|NCT03523728|467975076|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
130002670|NCT03523728|467975077|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
130002671|NCT03523728|467975078|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
130002672|NCT03523728|467975079|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
130002673|NCT03523728|467975075|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
130337412|NCT01124864|469207305|FG003|Overall Study|Lost to Follow-up|1|||
130337413|NCT01124864|469207306|FG004|Overall Study|Lost to Follow-up|0|||
130337414|NCT01124864|469207307|FG005|Overall Study|Lost to Follow-up|0|||
130002674|NCT03523728|467975076|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
130002675|NCT03523728|467975077|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
130002676|NCT03523728|467975078|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
130002677|NCT03523728|467975079|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
130002678|NCT03523728|467975075|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
130337415|NCT01124864|469207302|FG000|Overall Study|Protocol Violation|1|||
130337416|NCT01124864|469207303|FG001|Overall Study|Protocol Violation|0|||
130337417|NCT01124864|469207304|FG002|Overall Study|Protocol Violation|0|||
130337418|NCT01124864|469207305|FG003|Overall Study|Protocol Violation|0|||
130002679|NCT03523728|467975076|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
130002680|NCT03523728|467975077|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
130337419|NCT01124864|469207306|FG004|Overall Study|Protocol Violation|1|||
130337420|NCT01124864|469207307|FG005|Overall Study|Protocol Violation|0|||
130002681|NCT03523728|467975078|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
130337421|NCT01243242|469207308|FG000|Overall Study|Adverse Event|1|||
130337422|NCT01243242|469207309|FG001|Overall Study|Adverse Event|1|||
130337423|NCT01243242|469207308|FG000|Overall Study|Withdrawal by Subject|1|||
130337424|NCT01243242|469207309|FG001|Overall Study|Withdrawal by Subject|1|||
130337425|NCT01243242|469207308|FG000|Overall Study|Physician Decision|0|||
130337426|NCT01243242|469207309|FG001|Overall Study|Physician Decision|1|||
130337427|NCT01243242|469207308|FG000|Overall Study|sponsor decision|0|||
130337428|NCT01243242|469207309|FG001|Overall Study|sponsor decision|1|||
130337429|NCT01243242|469207308|FG000|Overall Study|non compliance|1|||
130337430|NCT01243242|469207309|FG001|Overall Study|non compliance|0|||
130337431|NCT01256294|469207319|FG000|Overall Study|Adverse Event|1|||
130337432|NCT01256294|469207320|FG001|Overall Study|Adverse Event|0|||
130337433|NCT01256294|469207319|FG000|Overall Study|Withdrawal by Subject|1|||
130337434|NCT01256294|469207320|FG001|Overall Study|Withdrawal by Subject|1|||
130337435|NCT01256294|469207319|FG000|Overall Study|Protocol deviation|2|||
130337436|NCT01256294|469207320|FG001|Overall Study|Protocol deviation|1|||
130337437|NCT02160899|469207321|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130337438|NCT02160899|469207322|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130337439|NCT02160899|469207323|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
130337440|NCT02160899|469207324|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
130337441|NCT02160899|469207325|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
130337442|NCT02160899|469207326|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
130337443|NCT01368562|469207327|FG000|Overall Study|Adverse Event|1|||
130337444|NCT01368562|469207327|FG000|Overall Study|Disease progression|1|||
130337445|NCT01368562|469207327|FG000|Overall Study|Lost to Follow-up|1|||
130337446|NCT01368562|469207327|FG000|Overall Study|Death|6|||
130337447|NCT01368562|469207327|FG000|Overall Study|Unresponsive to treatment|5|||
130337448|NCT01368562|469207327|FG000|Overall Study|Other|3|||
130337449|NCT01368562|469207327|FG000|Overall Study|Other than specified|2|||
130337450|NCT01754727|469207328|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
130337451|NCT00669409|469207331|FG000|Part 2|Withdrawal by Subject|0|||
130337452|NCT00669409|469207332|FG001|Part 2|Withdrawal by Subject|0|||
130337453|NCT00669409|469207333|FG002|Part 2|Withdrawal by Subject|0|||
130337454|NCT00669409|469207334|FG003|Part 2|Withdrawal by Subject|0|||
130337455|NCT00669409|469207335|FG004|Part 2|Withdrawal by Subject|0|||
130337456|NCT00669409|469207336|FG005|Part 2|Withdrawal by Subject|0|||
130337457|NCT00669409|469207337|FG006|Part 2|Withdrawal by Subject|0|||
130337458|NCT00669409|469207338|FG007|Part 2|Withdrawal by Subject|0|||
130337459|NCT00669409|469207339|FG008|Part 2|Withdrawal by Subject|0|||
130337460|NCT00669409|469207340|FG009|Part 2|Withdrawal by Subject|1|||
130337461|NCT00669409|469207341|FG010|Part 2|Withdrawal by Subject|0|||
130337462|NCT02314637|469207342|FG000|Overall Study|Adverse Event|4|||
130337463|NCT02314637|469207343|FG001|Overall Study|Adverse Event|8|||
130337464|NCT02314637|469207342|FG000|Overall Study|Lack of Efficacy|1|||
130337465|NCT02314637|469207343|FG001|Overall Study|Lack of Efficacy|0|||
130337466|NCT02314637|469207342|FG000|Overall Study|Physician Decision|5|||
130002682|NCT03523728|467975079|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
130002683|NCT00621751|467975080|FG000|Overall Study|Adverse Event|0|||
130002684|NCT00621751|467975081|FG001|Overall Study|Adverse Event|1|||
130002685|NCT00295633|467975082|FG000|Overall Study|Lack of Efficacy|19|||
130002686|NCT00295633|467975083|FG001|Overall Study|Lack of Efficacy|7|||
130002687|NCT00295633|467975084|FG002|Overall Study|Lack of Efficacy|16|||
130002688|NCT00295633|467975082|FG000|Overall Study|Withdrawal of consent by subject|16|||
130002689|NCT00295633|467975083|FG001|Overall Study|Withdrawal of consent by subject|16|||
130002690|NCT00295633|467975084|FG002|Overall Study|Withdrawal of consent by subject|26|||
130002691|NCT00295633|467975082|FG000|Overall Study|Adverse Event|9|||
130002692|NCT00295633|467975083|FG001|Overall Study|Adverse Event|17|||
130002693|NCT00295633|467975084|FG002|Overall Study|Adverse Event|9|||
130337467|NCT02314637|469207343|FG001|Overall Study|Physician Decision|2|||
130337468|NCT02314637|469207342|FG000|Overall Study|Withdrawal by Subject|5|||
130337469|NCT02314637|469207343|FG001|Overall Study|Withdrawal by Subject|4|||
130337470|NCT02314637|469207342|FG000|Overall Study|Other Reason|1|||
130337471|NCT02314637|469207343|FG001|Overall Study|Other Reason|0|||
130337472|NCT03539549|469207344|FG000|Overall Study|Adverse Event|12|||
130337473|NCT03539549|469207344|FG000|Overall Study|Lost to Follow-up|1|||
130337474|NCT03539549|469207344|FG000|Overall Study|Death|2|||
130337475|NCT03539549|469207344|FG000|Overall Study|Progressive Disease|1|||
130337476|NCT03539549|469207344|FG000|Overall Study|Reason not Specified|1|||
130337477|NCT02864862|469207345|FG000|Overall Study|Lost to Follow-up|1|||
130337478|NCT02864862|469207346|FG001|Overall Study|Lost to Follow-up|0|||
130337479|NCT02864862|469207347|FG002|Overall Study|Lost to Follow-up|1|||
130002694|NCT00295633|467975082|FG000|Overall Study|Lost to Follow-up|6|||
130002695|NCT00295633|467975083|FG001|Overall Study|Lost to Follow-up|11|||
130002696|NCT00295633|467975084|FG002|Overall Study|Lost to Follow-up|7|||
130002697|NCT00295633|467975082|FG000|Overall Study|Physician Decision|9|||
130337480|NCT02864862|469207345|FG000|Overall Study|Protocol Violation|0|||
130337481|NCT02864862|469207346|FG001|Overall Study|Protocol Violation|0|||
130337482|NCT02864862|469207347|FG002|Overall Study|Protocol Violation|1|||
130337483|NCT04693234|469207351|FG000|Overall Study|Death|79|||
130337484|NCT04693234|469207352|FG001|Overall Study|Death|19|||
130337485|NCT04693234|469207351|FG000|Overall Study|Sponsor Ended Study|47|||
130337486|NCT04693234|469207352|FG001|Overall Study|Sponsor Ended Study|18|||
130337487|NCT04693234|469207351|FG000|Overall Study|Withdrawal by Subject|10|||
130337488|NCT04693234|469207352|FG001|Overall Study|Withdrawal by Subject|2|||
130337489|NCT04693234|469207351|FG000|Overall Study|Lost to Follow-up|2|||
130337490|NCT04693234|469207352|FG001|Overall Study|Lost to Follow-up|1|||
130337491|NCT04643158|469207353|FG000|Overall Study|Study terminated by sponsor|0|||
130337492|NCT04643158|469207354|FG001|Overall Study|Study terminated by sponsor|0|||
130337493|NCT04643158|469207355|FG002|Overall Study|Study terminated by sponsor|1|||
130337494|NCT04643158|469207356|FG003|Overall Study|Study terminated by sponsor|0|||
130337495|NCT04643158|469207357|FG004|Overall Study|Study terminated by sponsor|0|||
130337496|NCT04643158|469207358|FG005|Overall Study|Study terminated by sponsor|1|||
130337497|NCT04643158|469207359|FG006|Overall Study|Study terminated by sponsor|0|||
130337498|NCT04643158|469207353|FG000|Overall Study|Global/country situation|0|||
130337499|NCT04643158|469207354|FG001|Overall Study|Global/country situation|0|||
130337500|NCT04643158|469207355|FG002|Overall Study|Global/country situation|1|||
130337501|NCT04643158|469207356|FG003|Overall Study|Global/country situation|0|||
130337502|NCT04643158|469207357|FG004|Overall Study|Global/country situation|0|||
130337503|NCT04643158|469207358|FG005|Overall Study|Global/country situation|0|||
130337504|NCT04643158|469207359|FG006|Overall Study|Global/country situation|0|||
130337505|NCT04643158|469207353|FG000|Overall Study|Withdrawal by Subject|0|||
130337506|NCT04643158|469207354|FG001|Overall Study|Withdrawal by Subject|0|||
130337507|NCT04643158|469207355|FG002|Overall Study|Withdrawal by Subject|0|||
130337508|NCT04643158|469207356|FG003|Overall Study|Withdrawal by Subject|0|||
130337509|NCT04643158|469207357|FG004|Overall Study|Withdrawal by Subject|0|||
130337510|NCT04643158|469207358|FG005|Overall Study|Withdrawal by Subject|1|||
130337511|NCT04643158|469207359|FG006|Overall Study|Withdrawal by Subject|0|||
130337512|NCT04540198|469207360|FG000|Overall Study|Lost to Follow-up|25|||
130337513|NCT04540198|469207361|FG001|Overall Study|Lost to Follow-up|23|||
130337514|NCT04540198|469207360|FG000|Overall Study|Withdrawal by Subject|15|||
130337515|NCT04540198|469207361|FG001|Overall Study|Withdrawal by Subject|9|||
130337516|NCT04540198|469207360|FG000|Overall Study|Discontinued|1|||
130337517|NCT04540198|469207361|FG001|Overall Study|Discontinued|0|||
130337518|NCT02888119|469207362|FG000|Overall Study|Lost to Follow-up|5|||
130337519|NCT02888119|469207363|FG001|Overall Study|Lost to Follow-up|4|||
130337520|NCT02888119|469207364|FG002|Overall Study|Lost to Follow-up|0|||
130337521|NCT02123472|469207366|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
130337522|NCT02123472|469207367|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
130337523|NCT01474018|469207368|FG000|Overall Study|Lost to Follow-up|0|||
130337524|NCT01474018|469207369|FG001|Overall Study|Lost to Follow-up|1|||
130337525|NCT01474018|469207368|FG000|Overall Study|Withdrawal by Subject|0|||
130337526|NCT01474018|469207369|FG001|Overall Study|Withdrawal by Subject|2|||
130337527|NCT02433080|469207370|FG000|Overall Study|Lost to Follow-up|1|||
130337528|NCT02433080|469207371|FG001|Overall Study|Lost to Follow-up|2|||
130337529|NCT02433080|469207370|FG000|Overall Study|Withdrawal by Subject|0|||
130337530|NCT02433080|469207371|FG001|Overall Study|Withdrawal by Subject|2|||
130337531|NCT01015638|469207374|FG000|Overall Study|Withdrawal by Subject|1|||
130337532|NCT01015638|469207375|FG001|Overall Study|Withdrawal by Subject|0|||
130337533|NCT00910299|469207381|FG000|Overall Study|Withdrawal by Subject|16|||
130337534|NCT00910299|469207382|FG001|Overall Study|Withdrawal by Subject|13|||
130337535|NCT00910299|469207381|FG000|Overall Study|Sponsor Decision|58|||
130337536|NCT00910299|469207382|FG001|Overall Study|Sponsor Decision|60|||
130337537|NCT00910299|469207381|FG000|Overall Study|Didn't receive any study drug|2|||
130337538|NCT00910299|469207382|FG001|Overall Study|Didn't receive any study drug|1|||
130337539|NCT00711477|469207383|FG000|Overall Study|Adverse Event|3|||
130337540|NCT00711477|469207384|FG001|Overall Study|Adverse Event|1|||
130337541|NCT00711477|469207383|FG000|Overall Study|Lost to Follow-up|0|||
130337542|NCT00711477|469207384|FG001|Overall Study|Lost to Follow-up|1|||
130337543|NCT00711477|469207383|FG000|Overall Study|Noncompliance|0|||
130337544|NCT00711477|469207384|FG001|Overall Study|Noncompliance|1|||
130337545|NCT02929407|469207389|FG000|Overall Study|Adverse Event|1|||
130337546|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
130337547|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130337548|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130337549|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
130337550|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Death|3|||
130337551|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Death|0|||
130337552|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Death|0|||
130337553|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Death|0|||
130337554|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
130337555|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130337556|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130337557|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
130337558|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
130002698|NCT00295633|467975083|FG001|Overall Study|Physician Decision|10|||
130337559|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130337560|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130337561|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
130337562|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
130337563|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
130337564|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
130337565|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
130337566|NCT00884741|469207390|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
130337567|NCT00884741|469207391|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130337568|NCT00884741|469207392|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130337569|NCT00884741|469207393|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
130337570|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130337571|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
130337572|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130337573|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
130337574|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
130337575|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
130337576|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
130002699|NCT00295633|467975084|FG002|Overall Study|Physician Decision|8|||
130002700|NCT00295633|467975082|FG000|Overall Study|Poor/Noncompliance|2|||
130002701|NCT00295633|467975083|FG001|Overall Study|Poor/Noncompliance|2|||
130337577|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
130337578|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130337579|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
130337580|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130337581|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
130337582|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130337583|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
130337584|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130337585|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
130337586|NCT00884741|469207390|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130337587|NCT00884741|469207391|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
130337588|NCT00884741|469207392|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130337589|NCT00884741|469207393|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
130337590|NCT00884741|469207390|FG000|Randomization|Protocol Violation|0|||
130337591|NCT00884741|469207391|FG001|Randomization|Protocol Violation|0|||
130337592|NCT00884741|469207392|FG002|Randomization|Protocol Violation|8|||
130337593|NCT00884741|469207393|FG003|Randomization|Protocol Violation|8|||
130337594|NCT01014910|469207394|FG000|Overall Study|Withdrawal by Subject|0|||
130337595|NCT01014910|469207395|FG001|Overall Study|Withdrawal by Subject|2|||
130337596|NCT00145977|469207396|FG000|Overall Study|Lack of Efficacy|0|||
130337597|NCT00145977|469207397|FG001|Overall Study|Lack of Efficacy|4|||
130337598|NCT00145977|469207396|FG000|Overall Study|Lost to Follow-up|1|||
130337599|NCT00145977|469207397|FG001|Overall Study|Lost to Follow-up|0|||
130337600|NCT00145977|469207396|FG000|Overall Study|Withdrawal by Subject|1|||
130337601|NCT00145977|469207397|FG001|Overall Study|Withdrawal by Subject|0|||
130337602|NCT00782834|469207398|FG000|Treatment Phase|fibrous tumor not GIST|1|||
130337603|NCT01215097|469207400|FG000|Overall Study|Adverse Event|1|||
130337604|NCT01215097|469207401|FG001|Overall Study|Adverse Event|3|||
130337605|NCT01215097|469207400|FG000|Overall Study|Protocol Violation|0|||
130337606|NCT01215097|469207401|FG001|Overall Study|Protocol Violation|2|||
130337607|NCT01215097|469207400|FG000|Overall Study|Lost to Follow-up|2|||
130337608|NCT01215097|469207401|FG001|Overall Study|Lost to Follow-up|0|||
130337609|NCT01215097|469207400|FG000|Overall Study|Withdrawal by Subject|6|||
130337610|NCT01215097|469207401|FG001|Overall Study|Withdrawal by Subject|3|||
130337611|NCT01215097|469207400|FG000|Overall Study|Lack of Efficacy|0|||
130337612|NCT01215097|469207401|FG001|Overall Study|Lack of Efficacy|3|||
130337613|NCT01215097|469207400|FG000|Overall Study|patient's refusal to come|2|||
130337614|NCT01215097|469207401|FG001|Overall Study|patient's refusal to come|2|||
130337615|NCT01215097|469207400|FG000|Overall Study|patient's private reason|1|||
130337616|NCT01215097|469207401|FG001|Overall Study|patient's private reason|1|||
130337617|NCT02252939|469207403|FG000|Overall Study|Lost to Follow-up|3|||
130337618|NCT01033448|469207404|FG000|Overall Study|Withdrawal by Subject|4|||
130002702|NCT00295633|467975084|FG002|Overall Study|Poor/Noncompliance|6|||
130337619|NCT01033448|469207404|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
130337620|NCT01033448|469207404|FG000|Overall Study|Lost to Follow-up|3|||
130337621|NCT01033448|469207404|FG000|Overall Study|Withdrew due to other reasons|3|||
130337622|NCT01033448|469207404|FG000|Overall Study|Unknown disposition|1|||
130002703|NCT00295633|467975082|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130052074|NCT05137041|468147193|FG000|Overall Study|Lost to Follow-up|1|||
130002704|NCT00295633|467975083|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
130002705|NCT00295633|467975084|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
130002706|NCT00295633|467975082|FG000|Overall Study|Death|1|||
130002707|NCT00295633|467975083|FG001|Overall Study|Death|1|||
130002708|NCT00295633|467975084|FG002|Overall Study|Death|0|||
130002709|NCT00295633|467975082|FG000|Overall Study|Administrative reason by sponsor|0|||
130002710|NCT00295633|467975083|FG001|Overall Study|Administrative reason by sponsor|0|||
130002711|NCT00295633|467975084|FG002|Overall Study|Administrative reason by sponsor|1|||
130002712|NCT00419120|467975086|FG000|Long Term Follow up Period|study ongoing|10|||
130002713|NCT01950247|467975087|FG000|Overall Study|Withdrawal by Subject|28|||
130002714|NCT01950247|467975088|FG001|Overall Study|Withdrawal by Subject|13|||
130002715|NCT01950247|467975087|FG000|Overall Study|Lost to Follow-up|18|||
130002716|NCT01950247|467975088|FG001|Overall Study|Lost to Follow-up|16|||
130002717|NCT01950247|467975087|FG000|Overall Study|Physician Decision|3|||
130002718|NCT01950247|467975088|FG001|Overall Study|Physician Decision|4|||
130002719|NCT01950247|467975087|FG000|Overall Study|Adverse Event|3|||
130002720|NCT01950247|467975088|FG001|Overall Study|Adverse Event|2|||
130002721|NCT01950247|467975087|FG000|Overall Study|Death|1|||
130002722|NCT01950247|467975088|FG001|Overall Study|Death|1|||
130002723|NCT01950247|467975087|FG000|Overall Study|Not Defined|4|||
130002724|NCT01950247|467975088|FG001|Overall Study|Not Defined|10|||
130002725|NCT00763971|467975089|FG000|Overall Study|Adverse Event|5|||
130002726|NCT00763971|467975090|FG001|Overall Study|Adverse Event|2|||
130002727|NCT00763971|467975091|FG002|Overall Study|Adverse Event|4|||
130002728|NCT00763971|467975089|FG000|Overall Study|Protocol Violation|3|||
130002729|NCT00763971|467975090|FG001|Overall Study|Protocol Violation|3|||
130002730|NCT00763971|467975091|FG002|Overall Study|Protocol Violation|2|||
130002731|NCT00763971|467975089|FG000|Overall Study|Withdrawal by Subject|4|||
130002732|NCT00763971|467975090|FG001|Overall Study|Withdrawal by Subject|5|||
130002733|NCT00763971|467975091|FG002|Overall Study|Withdrawal by Subject|5|||
130337623|NCT01818752|469207405|FG000|Overall Study|Adverse Event|64|||
130337624|NCT01818752|469207406|FG001|Overall Study|Adverse Event|74|||
130337625|NCT01818752|469207405|FG000|Overall Study|Death|14|||
130337626|NCT01818752|469207406|FG001|Overall Study|Death|18|||
130337627|NCT01818752|469207405|FG000|Overall Study|Non-compliance|16|||
130337628|NCT01818752|469207406|FG001|Overall Study|Non-compliance|20|||
130337629|NCT01818752|469207405|FG000|Overall Study|Withdrawal by Subject|15|||
130337630|NCT01818752|469207406|FG001|Overall Study|Withdrawal by Subject|14|||
130337631|NCT01818752|469207405|FG000|Overall Study|Physician Decision|9|||
130337632|NCT01818752|469207406|FG001|Overall Study|Physician Decision|8|||
130337633|NCT01818752|469207405|FG000|Overall Study|Disease Progression|54|||
130337634|NCT01818752|469207406|FG001|Overall Study|Disease Progression|48|||
130337635|NCT01818752|469207405|FG000|Overall Study|Other|7|||
130337636|NCT01818752|469207406|FG001|Overall Study|Other|8|||
130337637|NCT01818752|469207405|FG000|Overall Study|Continuing Treatment|1|||
130337638|NCT01818752|469207406|FG001|Overall Study|Continuing Treatment|4|||
130337639|NCT01818752|469207405|FG000|Overall Study|Randomized but not Dosed|7|||
130337640|NCT01818752|469207406|FG001|Overall Study|Randomized but not Dosed|4|||
130337641|NCT04270370|469207407|FG000|Overall Study|Lost to Follow-up|1|||
130337642|NCT04270370|469207408|FG001|Overall Study|Lost to Follow-up|0|||
130337643|NCT04270370|469207409|FG002|Overall Study|Lost to Follow-up|0|||
130337644|NCT04270370|469207410|FG003|Overall Study|Lost to Follow-up|0|||
130337645|NCT04270370|469207411|FG004|Overall Study|Lost to Follow-up|0|||
130337646|NCT04270370|469207412|FG005|Overall Study|Lost to Follow-up|0|||
130337647|NCT04270370|469207413|FG006|Overall Study|Lost to Follow-up|0|||
130337648|NCT04270370|469207414|FG007|Overall Study|Lost to Follow-up|0|||
130337649|NCT04270370|469207415|FG008|Overall Study|Lost to Follow-up|1|||
130337650|NCT04270370|469207416|FG009|Overall Study|Lost to Follow-up|0|||
130337651|NCT04270370|469207417|FG010|Overall Study|Lost to Follow-up|0|||
130337652|NCT04270370|469207418|FG011|Overall Study|Lost to Follow-up|0|||
130337653|NCT01324141|469207419|FG000|Overall Study|Declined to participate before treatment started|1|||
130337654|NCT01324141|469207419|FG000|Overall Study|Disease progression on study|1|||
130337655|NCT00870584|469207422|FG000|Overall Study|Adverse Event|3|||
130002734|NCT00763971|467975089|FG000|Overall Study|Lost to Follow-up|0|||
130337656|NCT00870584|469207423|FG001|Overall Study|Adverse Event|3|||
130337657|NCT00870584|469207422|FG000|Overall Study|Withdrawal by Subject|6|||
130337658|NCT00870584|469207423|FG001|Overall Study|Withdrawal by Subject|7|||
130337659|NCT00870584|469207422|FG000|Overall Study|Lost to Follow-up|5|||
130337660|NCT00870584|469207423|FG001|Overall Study|Lost to Follow-up|1|||
130002735|NCT00763971|467975090|FG001|Overall Study|Lost to Follow-up|1|||
130002736|NCT00763971|467975091|FG002|Overall Study|Lost to Follow-up|0|||
130002737|NCT00763971|467975089|FG000|Overall Study|Lack of Efficacy|11|||
130002738|NCT00763971|467975090|FG001|Overall Study|Lack of Efficacy|22|||
130002739|NCT00763971|467975091|FG002|Overall Study|Lack of Efficacy|54|||
130002740|NCT00763971|467975089|FG000|Overall Study|Unable to swallow capsule|2|||
130337661|NCT00870584|469207422|FG000|Overall Study|Protocol Deviation|2|||
130337662|NCT00870584|469207423|FG001|Overall Study|Protocol Deviation|2|||
130002741|NCT00763971|467975090|FG001|Overall Study|Unable to swallow capsule|1|||
130002742|NCT00763971|467975091|FG002|Overall Study|Unable to swallow capsule|1|||
130002743|NCT00763971|467975089|FG000|Overall Study|Personal reason|3|||
130002744|NCT00763971|467975090|FG001|Overall Study|Personal reason|0|||
130002745|NCT00763971|467975091|FG002|Overall Study|Personal reason|0|||
130002746|NCT00763971|467975089|FG000|Overall Study|Exclusion criteria met|1|||
130002747|NCT00763971|467975090|FG001|Overall Study|Exclusion criteria met|0|||
130002748|NCT00763971|467975091|FG002|Overall Study|Exclusion criteria met|0|||
130002749|NCT00763971|467975089|FG000|Overall Study|Sponsor decision|1|||
130002750|NCT00763971|467975090|FG001|Overall Study|Sponsor decision|0|||
130002751|NCT00763971|467975091|FG002|Overall Study|Sponsor decision|0|||
130002752|NCT00763971|467975089|FG000|Overall Study|Due to holiday season|2|||
130337663|NCT02560025|469207424|FG000|Overall Study|Ineligible after consent/ registration|3|||
130337664|NCT02703337|469207425|FG000|Period One (Part A)|Withdrawal by Subject|0|||
130337665|NCT02703337|469207426|FG001|Period One (Part A)|Withdrawal by Subject|0|||
130337666|NCT02703337|469207427|FG002|Period One (Part A)|Withdrawal by Subject|0|||
130337667|NCT02703337|469207428|FG003|Period One (Part A)|Withdrawal by Subject|0|||
130337668|NCT02703337|469207429|FG004|Period One (Part A)|Withdrawal by Subject|1|||
130002753|NCT00763971|467975090|FG001|Overall Study|Due to holiday season|0|||
130002754|NCT00763971|467975091|FG002|Overall Study|Due to holiday season|1|||
130002755|NCT00763971|467975089|FG000|Overall Study|Randomization error|0|||
130002756|NCT00763971|467975090|FG001|Overall Study|Randomization error|0|||
130002757|NCT00763971|467975091|FG002|Overall Study|Randomization error|1|||
130002758|NCT00763971|467975089|FG000|Overall Study|Medical monitor decision|0|||
130002759|NCT00763971|467975090|FG001|Overall Study|Medical monitor decision|0|||
130002760|NCT00763971|467975091|FG002|Overall Study|Medical monitor decision|1|||
130002761|NCT00763971|467975089|FG000|Overall Study|Moved to another country|0|||
130002762|NCT00763971|467975090|FG001|Overall Study|Moved to another country|1|||
130002763|NCT00763971|467975091|FG002|Overall Study|Moved to another country|0|||
130002764|NCT00763971|467975089|FG000|Overall Study|Subject wanted dose reduction|0|||
130002765|NCT00763971|467975090|FG001|Overall Study|Subject wanted dose reduction|1|||
130002766|NCT00763971|467975091|FG002|Overall Study|Subject wanted dose reduction|0|||
130002767|NCT00763971|467975089|FG000|Overall Study|Lack of availability|0|||
130002768|NCT00763971|467975090|FG001|Overall Study|Lack of availability|1|||
130002769|NCT00763971|467975091|FG002|Overall Study|Lack of availability|0|||
130002770|NCT00763971|467975089|FG000|Overall Study|Performed final visit on phone|0|||
130002771|NCT00763971|467975090|FG001|Overall Study|Performed final visit on phone|1|||
130002772|NCT00763971|467975091|FG002|Overall Study|Performed final visit on phone|0|||
130002773|NCT00763971|467975089|FG000|Overall Study|Participation in 489-326 required|1|||
130002774|NCT00763971|467975090|FG001|Overall Study|Participation in 489-326 required|0|||
130002775|NCT00763971|467975091|FG002|Overall Study|Participation in 489-326 required|0|||
130002776|NCT00710879|467975093|FG000|Overall Study|Lost to Follow-up|2|||
130002777|NCT00710879|467975094|FG001|Overall Study|Lost to Follow-up|1|||
130002778|NCT00710879|467975093|FG000|Overall Study|Protocol Violation|0|||
130002779|NCT00710879|467975094|FG001|Overall Study|Protocol Violation|3|||
130002780|NCT01809132|467975095|FG000|Overall Study|Withdrawal by Subject|0|||
130002781|NCT01809132|467975096|FG001|Overall Study|Withdrawal by Subject|0|||
130002782|NCT01809132|467975097|FG002|Overall Study|Withdrawal by Subject|1|||
130002783|NCT03349775|467975098|FG000|Overall Study|Side Effects|1|||
130002784|NCT03349775|467975099|FG001|Overall Study|Side Effects|2|||
130002785|NCT03349775|467975098|FG000|Overall Study|Withdrawal by Subject|1|||
130002786|NCT03349775|467975099|FG001|Overall Study|Withdrawal by Subject|1|||
130002787|NCT03349775|467975098|FG000|Overall Study|No primary outcome measurements|0|||
130002788|NCT03349775|467975099|FG001|Overall Study|No primary outcome measurements|1|||
130002789|NCT01516970|467975100|FG000|Overall Study|Lost to Follow-up|7|||
130002790|NCT01516970|467975101|FG001|Overall Study|Lost to Follow-up|8|||
130002791|NCT01516970|467975100|FG000|Overall Study|Adverse Event|1|||
130002792|NCT01516970|467975101|FG001|Overall Study|Adverse Event|5|||
130002793|NCT01516970|467975100|FG000|Overall Study|Withdrawal by Subject|1|||
130002794|NCT01516970|467975101|FG001|Overall Study|Withdrawal by Subject|1|||
130002795|NCT01516970|467975100|FG000|Overall Study|Other|9|||
130002796|NCT01516970|467975101|FG001|Overall Study|Other|7|||
130002797|NCT00434421|467975102|FG000|Overall Study|Withdrawal by Subject|1|||
130002798|NCT00434421|467975102|FG000|Overall Study|Non-compliance with study treatment|1|||
130002799|NCT01756040|467975103|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
130002800|NCT01756040|467975103|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
130002801|NCT01756040|467975103|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
130002802|NCT01205438|467975104|FG000|Overall Study|Adverse Event|19|||
130002803|NCT01205438|467975105|FG001|Overall Study|Adverse Event|17|||
130337669|NCT02703337|469207430|FG005|Period One (Part A)|Withdrawal by Subject|0|||
130337670|NCT02703337|469207431|FG006|Period One (Part A)|Withdrawal by Subject|0|||
130002804|NCT01205438|467975106|FG002|Overall Study|Adverse Event|24|||
130002805|NCT01205438|467975104|FG000|Overall Study|Death|1|||
130002806|NCT01205438|467975105|FG001|Overall Study|Death|1|||
130002807|NCT01205438|467975106|FG002|Overall Study|Death|3|||
130002808|NCT01205438|467975104|FG000|Overall Study|Entry Criteria Not Met|16|||
130002809|NCT01205438|467975105|FG001|Overall Study|Entry Criteria Not Met|15|||
130002810|NCT01205438|467975106|FG002|Overall Study|Entry Criteria Not Met|13|||
130337671|NCT02703337|469207432|FG007|Period One (Part A)|Withdrawal by Subject|0|||
130337672|NCT00282308|469207433|FG000|Treatment Period|Lost to Follow-up|1|||
130337673|NCT00282308|469207434|FG001|Treatment Period|Lost to Follow-up|0|||
130337674|NCT00282308|469207435|FG002|Treatment Period|Lost to Follow-up|0|||
130337675|NCT00282308|469207433|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
130337676|NCT00282308|469207434|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
130337677|NCT00282308|469207435|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
130337678|NCT00282308|469207433|FG000|Treatment Period|Adverse Event|0|||
130337679|NCT00282308|469207434|FG001|Treatment Period|Adverse Event|2|||
130337680|NCT00282308|469207435|FG002|Treatment Period|Adverse Event|0|||
130337681|NCT00282308|469207433|FG000|Treatment Period|Not Treated with Study Drug|1|||
130337682|NCT00282308|469207434|FG001|Treatment Period|Not Treated with Study Drug|0|||
130337683|NCT00282308|469207435|FG002|Treatment Period|Not Treated with Study Drug|0|||
130337684|NCT00282308|469207433|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
130337685|NCT00282308|469207434|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
130337686|NCT00282308|469207435|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
130337687|NCT00282308|469207433|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
130337688|NCT00282308|469207434|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
130002811|NCT01205438|467975104|FG000|Overall Study|Lack of Efficacy|14|||
130002812|NCT01205438|467975105|FG001|Overall Study|Lack of Efficacy|11|||
130002813|NCT01205438|467975106|FG002|Overall Study|Lack of Efficacy|14|||
130337689|NCT00282308|469207435|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
130337690|NCT00282308|469207433|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
130337691|NCT00282308|469207434|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
130337692|NCT00282308|469207435|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
130337693|NCT00282308|469207433|FG000|Safety Follow-up Period|Adverse Event|0|||
130337694|NCT00282308|469207434|FG001|Safety Follow-up Period|Adverse Event|0|||
130337695|NCT00282308|469207435|FG002|Safety Follow-up Period|Adverse Event|1|||
130337696|NCT00282308|469207433|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
130337697|NCT00282308|469207434|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130337698|NCT00282308|469207435|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
130337699|NCT00282308|469207433|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
130337700|NCT00282308|469207434|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
130337701|NCT00282308|469207435|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
130337702|NCT00282308|469207433|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
130337703|NCT00282308|469207434|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
130337704|NCT00282308|469207435|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
130337705|NCT04303195|469207436|FG000|Overall Study|Adverse Event|1|||
130337706|NCT04303195|469207437|FG001|Overall Study|Adverse Event|3|||
130337707|NCT04303195|469207438|FG002|Overall Study|Adverse Event|7|||
130337708|NCT04303195|469207439|FG003|Overall Study|Adverse Event|0|||
130337709|NCT04303195|469207436|FG000|Overall Study|Lost to Follow-up|1|||
130337710|NCT04303195|469207437|FG001|Overall Study|Lost to Follow-up|0|||
130337711|NCT04303195|469207438|FG002|Overall Study|Lost to Follow-up|1|||
130337712|NCT04303195|469207439|FG003|Overall Study|Lost to Follow-up|4|||
130337713|NCT04303195|469207436|FG000|Overall Study|Withdrawal by Subject|3|||
130337714|NCT04303195|469207437|FG001|Overall Study|Withdrawal by Subject|1|||
130337715|NCT04303195|469207438|FG002|Overall Study|Withdrawal by Subject|1|||
130337716|NCT04303195|469207439|FG003|Overall Study|Withdrawal by Subject|1|||
130337717|NCT04303195|469207436|FG000|Overall Study|No study drug administered or protocol deviation|0|||
130337718|NCT04303195|469207437|FG001|Overall Study|No study drug administered or protocol deviation|2|||
130337719|NCT04303195|469207438|FG002|Overall Study|No study drug administered or protocol deviation|0|||
130337720|NCT04303195|469207439|FG003|Overall Study|No study drug administered or protocol deviation|2|||
130337721|NCT06457204|469207440|FG000|Washout|Adverse Event|0|||
130337722|NCT06457204|469207441|FG001|Washout|Adverse Event|2|||
130337723|NCT01065454|469207442|FG000|Treatment|Adverse Event|7|||
130337724|NCT01065454|469207443|FG001|Treatment|Adverse Event|4|||
130337725|NCT01065454|469207444|FG002|Treatment|Adverse Event|3|||
130337726|NCT01065454|469207445|FG003|Treatment|Adverse Event|6|||
130337727|NCT01065454|469207442|FG000|Treatment|Death|1|||
130337728|NCT01065454|469207443|FG001|Treatment|Death|0|||
130337729|NCT01065454|469207444|FG002|Treatment|Death|0|||
130337730|NCT01065454|469207445|FG003|Treatment|Death|0|||
130337731|NCT01065454|469207442|FG000|Treatment|Non-compliance|1|||
130337732|NCT01065454|469207443|FG001|Treatment|Non-compliance|0|||
130002814|NCT01205438|467975104|FG000|Overall Study|Lost to Follow-up|6|||
130337733|NCT01065454|469207444|FG002|Treatment|Non-compliance|0|||
130337734|NCT01065454|469207445|FG003|Treatment|Non-compliance|1|||
130337735|NCT01065454|469207442|FG000|Treatment|Protocol Decision|0|||
130337736|NCT01065454|469207443|FG001|Treatment|Protocol Decision|0|||
130337737|NCT01065454|469207444|FG002|Treatment|Protocol Decision|3|||
130337738|NCT01065454|469207445|FG003|Treatment|Protocol Decision|2|||
130337739|NCT01065454|469207442|FG000|Treatment|Protocol Violation|1|||
130002815|NCT01205438|467975105|FG001|Overall Study|Lost to Follow-up|7|||
130002816|NCT01205438|467975106|FG002|Overall Study|Lost to Follow-up|8|||
130002817|NCT01205438|467975104|FG000|Overall Study|Withdrawal by Subject|19|||
130002818|NCT01205438|467975105|FG001|Overall Study|Withdrawal by Subject|25|||
130002819|NCT01205438|467975106|FG002|Overall Study|Withdrawal by Subject|19|||
130002820|NCT01205438|467975104|FG000|Overall Study|Physician Decision|0|||
130002821|NCT01205438|467975105|FG001|Overall Study|Physician Decision|3|||
130002822|NCT01205438|467975106|FG002|Overall Study|Physician Decision|2|||
130002823|NCT01205438|467975104|FG000|Overall Study|Protocol Violation|2|||
130216136|NCT02030119|468753956|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
130216137|NCT02030119|468753957|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
130216138|NCT02030119|468753958|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
130216139|NCT00759655|468753959|FG000|Overall Study|Termination of the study by sponsor|1|||
130216140|NCT02213380|468753962|FG000|Underwent Randomization|Withdrawal by Subject|2|||
130216141|NCT02213380|468753963|FG001|Underwent Randomization|Withdrawal by Subject|0|||
130216142|NCT02213380|468753962|FG000|Underwent Randomization|Not treated|3|||
130216143|NCT02213380|468753963|FG001|Underwent Randomization|Not treated|3|||
130216144|NCT02213380|468753962|FG000|Per-protocol Analysis|Protocol Violation|32|||
130216145|NCT02213380|468753963|FG001|Per-protocol Analysis|Protocol Violation|36|||
130216146|NCT01310127|468753964|FG000|Overall Study|Protocol Violation|1|||
130216147|NCT01310127|468753965|FG001|Overall Study|Protocol Violation|1|||
130216148|NCT01310127|468753964|FG000|Overall Study|advanced psc cataract outlier|1|||
130216149|NCT01310127|468753965|FG001|Overall Study|advanced psc cataract outlier|0|||
130216150|NCT03498313|468753966|FG000|Experimental Period 1|Adverse Event|1|||
130216151|NCT03498313|468753967|FG001|Experimental Period 1|Adverse Event|0|||
130216152|NCT03498313|468753968|FG002|Experimental Period 1|Adverse Event|0|||
130216153|NCT03498313|468753969|FG003|Experimental Period 1|Adverse Event|1|||
130216154|NCT03498313|468753970|FG004|Experimental Period 1|Adverse Event|0|||
130216155|NCT03498313|468753971|FG005|Experimental Period 1|Adverse Event|0|||
130216156|NCT03498313|468753966|FG000|Experimental Period 1|Withdrawal by Subject|0|||
130216157|NCT03498313|468753967|FG001|Experimental Period 1|Withdrawal by Subject|1|||
130216158|NCT03498313|468753968|FG002|Experimental Period 1|Withdrawal by Subject|0|||
130216159|NCT03498313|468753969|FG003|Experimental Period 1|Withdrawal by Subject|0|||
130216160|NCT03498313|468753970|FG004|Experimental Period 1|Withdrawal by Subject|0|||
130216161|NCT03498313|468753971|FG005|Experimental Period 1|Withdrawal by Subject|0|||
130216162|NCT03498313|468753966|FG000|Washout Period 1|Anovulation|1|||
130216163|NCT03498313|468753967|FG001|Washout Period 1|Anovulation|0|||
130216164|NCT03498313|468753968|FG002|Washout Period 1|Anovulation|0|||
130216165|NCT03498313|468753969|FG003|Washout Period 1|Anovulation|0|||
130216166|NCT03498313|468753970|FG004|Washout Period 1|Anovulation|0|||
130216167|NCT03498313|468753971|FG005|Washout Period 1|Anovulation|0|||
130216168|NCT03498313|468753966|FG000|Washout Period 1|Withdrawal by Subject|0|||
130216169|NCT03498313|468753967|FG001|Washout Period 1|Withdrawal by Subject|3|||
130216170|NCT03498313|468753968|FG002|Washout Period 1|Withdrawal by Subject|0|||
130216171|NCT03498313|468753969|FG003|Washout Period 1|Withdrawal by Subject|1|||
130216172|NCT03498313|468753970|FG004|Washout Period 1|Withdrawal by Subject|0|||
130216173|NCT03498313|468753971|FG005|Washout Period 1|Withdrawal by Subject|1|||
130216174|NCT03498313|468753966|FG000|Experimental Period 2|Adverse Event|0|||
130216175|NCT03498313|468753967|FG001|Experimental Period 2|Adverse Event|0|||
130216176|NCT03498313|468753968|FG002|Experimental Period 2|Adverse Event|0|||
130216177|NCT03498313|468753969|FG003|Experimental Period 2|Adverse Event|0|||
130216178|NCT03498313|468753970|FG004|Experimental Period 2|Adverse Event|1|||
130216179|NCT03498313|468753971|FG005|Experimental Period 2|Adverse Event|2|||
130216180|NCT03498313|468753966|FG000|Washout Period 2|Physician Decision|1|||
130216181|NCT03498313|468753967|FG001|Washout Period 2|Physician Decision|0|||
130216182|NCT03498313|468753968|FG002|Washout Period 2|Physician Decision|0|||
130216183|NCT03498313|468753969|FG003|Washout Period 2|Physician Decision|1|||
130216184|NCT03498313|468753970|FG004|Washout Period 2|Physician Decision|0|||
130216185|NCT03498313|468753971|FG005|Washout Period 2|Physician Decision|1|||
130216186|NCT03498313|468753966|FG000|Washout Period 2|Withdrawal by Subject|3|||
130216187|NCT03498313|468753967|FG001|Washout Period 2|Withdrawal by Subject|2|||
130216188|NCT03498313|468753968|FG002|Washout Period 2|Withdrawal by Subject|0|||
130216189|NCT03498313|468753969|FG003|Washout Period 2|Withdrawal by Subject|0|||
130216190|NCT03498313|468753970|FG004|Washout Period 2|Withdrawal by Subject|2|||
130216191|NCT03498313|468753971|FG005|Washout Period 2|Withdrawal by Subject|0|||
130216192|NCT03498313|468753966|FG000|Washout Period 2|Anovulation|0|||
130216193|NCT03498313|468753967|FG001|Washout Period 2|Anovulation|0|||
130216194|NCT03498313|468753968|FG002|Washout Period 2|Anovulation|0|||
130337740|NCT01065454|469207443|FG001|Treatment|Protocol Violation|0|||
130002824|NCT01205438|467975105|FG001|Overall Study|Protocol Violation|7|||
130002825|NCT01205438|467975106|FG002|Overall Study|Protocol Violation|4|||
130216195|NCT03498313|468753969|FG003|Washout Period 2|Anovulation|0|||
130216196|NCT03498313|468753970|FG004|Washout Period 2|Anovulation|0|||
130216197|NCT03498313|468753971|FG005|Washout Period 2|Anovulation|1|||
130216198|NCT00184002|468753972|FG000|Overall Study|Adverse Event|9|||
130216199|NCT00184002|468753972|FG000|Overall Study|Death|3|||
130216200|NCT00184002|468753972|FG000|Overall Study|Physician Decision|1|||
130002826|NCT01205438|467975104|FG000|Overall Study|Sponsor Decision|0|||
130002827|NCT01205438|467975105|FG001|Overall Study|Sponsor Decision|1|||
130002828|NCT01205438|467975106|FG002|Overall Study|Sponsor Decision|1|||
130002829|NCT03631667|467975111|FG000|Overall Study|Withdrawal by Subject|3|||
130002830|NCT00884325|467975112|FG000|Overall Study|Lost to Follow-up|1|||
130002831|NCT00884325|467975113|FG001|Overall Study|Lost to Follow-up|2|||
130002832|NCT00884325|467975112|FG000|Overall Study|Lack of Efficacy|0|||
130002833|NCT00884325|467975113|FG001|Overall Study|Lack of Efficacy|1|||
130002834|NCT00884325|467975112|FG000|Overall Study|Withdrawal by Subject|1|||
130002835|NCT00884325|467975113|FG001|Overall Study|Withdrawal by Subject|1|||
130002836|NCT00884325|467975112|FG000|Overall Study|Not provided|1|||
130002837|NCT00884325|467975113|FG001|Overall Study|Not provided|0|||
130002838|NCT00892177|467975114|FG000|Phase II|Ineligible|0|||
130002839|NCT00892177|467975115|FG001|Phase II|Ineligible|0|||
130002840|NCT00892177|467975116|FG002|Phase II|Ineligible|0|||
130002841|NCT00892177|467975117|FG003|Phase II|Ineligible|0|||
130002842|NCT00892177|467975118|FG004|Phase II|Ineligible|1|||
130002843|NCT00892177|467975119|FG005|Phase II|Ineligible|1|||
130002844|NCT00892177|467975114|FG000|Phase II|Withdrawal by Subject|0|||
130002845|NCT00892177|467975115|FG001|Phase II|Withdrawal by Subject|0|||
130002846|NCT00892177|467975116|FG002|Phase II|Withdrawal by Subject|0|||
130002847|NCT00892177|467975117|FG003|Phase II|Withdrawal by Subject|0|||
130002848|NCT00892177|467975118|FG004|Phase II|Withdrawal by Subject|4|||
130002849|NCT00892177|467975119|FG005|Phase II|Withdrawal by Subject|1|||
130002850|NCT01446016|467975122|FG000|Overall Study|Lost to Follow-up|3|||
130002851|NCT01446016|467975122|FG000|Overall Study|Withdrawal by Subject|1|||
130337741|NCT01065454|469207444|FG002|Treatment|Protocol Violation|1|||
130337742|NCT01065454|469207445|FG003|Treatment|Protocol Violation|0|||
130337743|NCT01065454|469207442|FG000|Treatment|Withdrawal by Subject|3|||
130337744|NCT01065454|469207443|FG001|Treatment|Withdrawal by Subject|1|||
130337745|NCT01065454|469207444|FG002|Treatment|Withdrawal by Subject|2|||
130337746|NCT01065454|469207445|FG003|Treatment|Withdrawal by Subject|3|||
130337747|NCT01065454|469207442|FG000|Follow up|Adverse Event|1|||
130337748|NCT01065454|469207443|FG001|Follow up|Adverse Event|0|||
130337749|NCT01065454|469207444|FG002|Follow up|Adverse Event|0|||
130337750|NCT01065454|469207445|FG003|Follow up|Adverse Event|1|||
130337751|NCT01065454|469207442|FG000|Follow up|Death|0|||
130337752|NCT01065454|469207443|FG001|Follow up|Death|1|||
130337753|NCT01065454|469207444|FG002|Follow up|Death|1|||
130337754|NCT01065454|469207445|FG003|Follow up|Death|0|||
130337755|NCT01065454|469207442|FG000|Follow up|Lost to Follow-up|0|||
130337756|NCT01065454|469207443|FG001|Follow up|Lost to Follow-up|0|||
130337757|NCT01065454|469207444|FG002|Follow up|Lost to Follow-up|0|||
130337758|NCT01065454|469207445|FG003|Follow up|Lost to Follow-up|1|||
130337759|NCT01065454|469207442|FG000|Follow up|Progressive disease|0|||
130337760|NCT01065454|469207443|FG001|Follow up|Progressive disease|0|||
130337761|NCT01065454|469207444|FG002|Follow up|Progressive disease|0|||
130337762|NCT01065454|469207445|FG003|Follow up|Progressive disease|1|||
130337763|NCT01065454|469207442|FG000|Follow up|Withdrawal by Subject|1|||
130337764|NCT01065454|469207443|FG001|Follow up|Withdrawal by Subject|1|||
130337765|NCT01065454|469207444|FG002|Follow up|Withdrawal by Subject|1|||
130337766|NCT01065454|469207445|FG003|Follow up|Withdrawal by Subject|0|||
130337767|NCT01065454|469207442|FG000|Follow up|study ongoing|37|||
130337768|NCT01065454|469207443|FG001|Follow up|study ongoing|22|||
130337769|NCT01065454|469207444|FG002|Follow up|study ongoing|15|||
130337770|NCT01065454|469207445|FG003|Follow up|study ongoing|41|||
130337771|NCT01601652|469207446|FG000|Overall Study|Death|1|||
130337772|NCT01097005|469207456|FG000|Overall Study|Case Report Form not collected|18|||
130337773|NCT01097005|469207456|FG000|Overall Study|Subjects cannot visit the hospital|1|||
130337774|NCT01097005|469207456|FG000|Overall Study|Poor medication compliance|1|||
130337775|NCT01097005|469207456|FG000|Overall Study|No examination data available|244|||
130337776|NCT01097005|469207456|FG000|Overall Study|Deviation from exclusion criteria|37|||
130337777|NCT01097005|469207456|FG000|Overall Study|Adverse Event|14|||
130337778|NCT01097005|469207456|FG000|Overall Study|Discontinuance by complication|50|||
130337779|NCT01395524|469208723|FG000|Overall Study|Non-compliance with study schedule|1|||
130337780|NCT01395524|469208724|FG001|Overall Study|Non-compliance with study schedule|0|||
130337781|NCT01395524|469208725|FG002|Overall Study|Non-compliance with study schedule|1|||
130002852|NCT01446016|467975122|FG000|Overall Study|Toxicity|3|||
130002853|NCT03334409|467975132|FG000|Overall Study|Did not meet inclusion criteria|1|||
130002854|NCT03334409|467975133|FG001|Overall Study|Did not meet inclusion criteria|0|||
130337782|NCT01395524|469208723|FG000|Overall Study|Lost to Follow-up|3|||
130337783|NCT01395524|469208724|FG001|Overall Study|Lost to Follow-up|1|||
130337784|NCT01395524|469208725|FG002|Overall Study|Lost to Follow-up|1|||
130002855|NCT01230554|467975136|FG000|Overall Study|Lost to Follow-up|2|||
130002856|NCT01230554|467975136|FG000|Overall Study|Inability to maintain visit schedule|1|||
130002857|NCT03933397|467975137|FG000|Overall Study|No emergency department visit|65|||
130002858|NCT03933397|467975138|FG001|Overall Study|No emergency department visit|71|||
130002859|NCT03933397|467975137|FG000|Overall Study|Missed emergency department visit|25|||
130337785|NCT01395524|469208723|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
130337786|NCT01395524|469208724|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
130337787|NCT01395524|469208725|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
130337788|NCT01395524|469208723|FG000|Overall Study|Severe noncompliance with protocol|1|||
130337789|NCT01395524|469208724|FG001|Overall Study|Severe noncompliance with protocol|0|||
130337790|NCT01395524|469208725|FG002|Overall Study|Severe noncompliance with protocol|0|||
130337791|NCT01395524|469208723|FG000|Overall Study|Adverse Event|4|||
130337792|NCT01395524|469208724|FG001|Overall Study|Adverse Event|4|||
130337793|NCT01395524|469208725|FG002|Overall Study|Adverse Event|3|||
130337794|NCT01395524|469208723|FG000|Overall Study|Death|1|||
130337795|NCT01395524|469208724|FG001|Overall Study|Death|0|||
130337796|NCT01395524|469208725|FG002|Overall Study|Death|0|||
130337797|NCT01395524|469208723|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
130337798|NCT01395524|469208724|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130337799|NCT01395524|469208725|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130337800|NCT01395524|469208723|FG000|Overall Study|Withdrawal by Subject|4|||
130337801|NCT01395524|469208724|FG001|Overall Study|Withdrawal by Subject|8|||
130337802|NCT01395524|469208725|FG002|Overall Study|Withdrawal by Subject|8|||
130337803|NCT01395524|469208723|FG000|Overall Study|Did not receive treatment|1|||
130337804|NCT01395524|469208724|FG001|Overall Study|Did not receive treatment|1|||
130337805|NCT01395524|469208725|FG002|Overall Study|Did not receive treatment|3|||
130337806|NCT01395524|469208723|FG000|Overall Study|Subject had spinal surgery|0|||
130337807|NCT01395524|469208724|FG001|Overall Study|Subject had spinal surgery|0|||
130337808|NCT01395524|469208725|FG002|Overall Study|Subject had spinal surgery|1|||
130337809|NCT01657461|469208726|FG000|Overall Study|Death|9|||
130337810|NCT01657461|469208727|FG001|Overall Study|Death|12|||
130337811|NCT01657461|469208726|FG000|Overall Study|Lost to Follow-up|0|||
130337812|NCT01657461|469208727|FG001|Overall Study|Lost to Follow-up|3|||
130337813|NCT01657461|469208726|FG000|Overall Study|Physician Decision|0|||
130337814|NCT01657461|469208727|FG001|Overall Study|Physician Decision|2|||
130337815|NCT01657461|469208726|FG000|Overall Study|Withdrawal by Subject|1|||
130337816|NCT01657461|469208727|FG001|Overall Study|Withdrawal by Subject|3|||
130337817|NCT00942994|469208731|FG000|Overall Study|Adverse Event|7|||
130337818|NCT00942994|469208732|FG001|Overall Study|Adverse Event|4|||
130337819|NCT00942994|469208731|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130337820|NCT00942994|469208732|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130337821|NCT00942994|469208731|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130337822|NCT00942994|469208732|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130337823|NCT00942994|469208731|FG000|Overall Study|Patient withdrew consent|5|||
130337824|NCT00942994|469208732|FG001|Overall Study|Patient withdrew consent|8|||
130337825|NCT00942994|469208731|FG000|Overall Study|Lost to Follow-up|1|||
130337826|NCT00942994|469208732|FG001|Overall Study|Lost to Follow-up|4|||
130337827|NCT00942994|469208731|FG000|Overall Study|Protocol deviation|1|||
130337828|NCT00942994|469208732|FG001|Overall Study|Protocol deviation|2|||
130337829|NCT03583385|469208733|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130337830|NCT03583385|469208734|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130337831|NCT03583385|469208733|FG000|Treatment Period 2|Adverse Event|1|||
130337832|NCT03583385|469208734|FG001|Treatment Period 2|Adverse Event|0|||
130337833|NCT01311024|469208746|FG000|Overall Study|Protocol Violation|35|||
130337834|NCT01311024|469208747|FG001|Overall Study|Protocol Violation|22|||
130337835|NCT01523275|469208748|FG000|Overall Study|Lost to Follow-up|1|||
130002860|NCT03933397|467975138|FG001|Overall Study|Missed emergency department visit|30|||
130002861|NCT03933397|467975137|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
130002862|NCT03933397|467975138|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
130002863|NCT03933397|467975137|FG000|Overall Study|Withdrawal by Subject|1|||
130002864|NCT03933397|467975138|FG001|Overall Study|Withdrawal by Subject|0|||
130337836|NCT01523275|469208749|FG001|Overall Study|Lost to Follow-up|2|||
130337837|NCT01523275|469208748|FG000|Overall Study|Withdrawal by Subject|1|||
130337838|NCT01523275|469208749|FG001|Overall Study|Withdrawal by Subject|0|||
130337839|NCT05573386|469208750|FG000|Overall Study|Withdrawal by Subject|3|||
130337840|NCT05573386|469208751|FG001|Overall Study|Withdrawal by Subject|2|||
130337841|NCT01802073|469208752|FG000|Overall Study|Lost to Follow-up|0|||
130337842|NCT01802073|469208753|FG001|Overall Study|Lost to Follow-up|1|||
130337843|NCT01802073|469208752|FG000|Overall Study|Non-compliant|4|||
130337844|NCT01802073|469208753|FG001|Overall Study|Non-compliant|2|||
130337845|NCT01802073|469208752|FG000|Overall Study|Withdrawal by Subject|1|||
130337846|NCT01802073|469208753|FG001|Overall Study|Withdrawal by Subject|1|||
130337847|NCT01802073|469208752|FG000|Overall Study|Physician Decision|0|||
130337848|NCT01802073|469208753|FG001|Overall Study|Physician Decision|7|||
130337849|NCT00918736|469208756|FG000|Overall Study|Withdrawal by Subject|4|||
130337850|NCT01137604|469208757|FG000|Overall Study|Adverse Event|3|||
130002865|NCT03933397|467975137|FG000|Overall Study|Physician Decision|1|||
130337851|NCT01137604|469208758|FG001|Overall Study|Adverse Event|6|||
130337852|NCT01137604|469208759|FG002|Overall Study|Adverse Event|9|||
130002866|NCT03933397|467975138|FG001|Overall Study|Physician Decision|1|||
130337853|NCT01137604|469208760|FG003|Overall Study|Adverse Event|9|||
130337854|NCT01137604|469208757|FG000|Overall Study|Participant Choice|0|||
130337855|NCT01137604|469208758|FG001|Overall Study|Participant Choice|2|||
130337856|NCT01137604|469208759|FG002|Overall Study|Participant Choice|2|||
130337857|NCT01137604|469208760|FG003|Overall Study|Participant Choice|0|||
130337858|NCT01137604|469208757|FG000|Overall Study|Withdrawal of consent|0|||
130337859|NCT01137604|469208758|FG001|Overall Study|Withdrawal of consent|0|||
130337860|NCT01137604|469208759|FG002|Overall Study|Withdrawal of consent|0|||
130337861|NCT01137604|469208760|FG003|Overall Study|Withdrawal of consent|2|||
130337862|NCT01137604|469208757|FG000|Overall Study|Clinical progression/deterioration|1|||
130337863|NCT01137604|469208758|FG001|Overall Study|Clinical progression/deterioration|2|||
130337864|NCT01137604|469208759|FG002|Overall Study|Clinical progression/deterioration|2|||
130337865|NCT01137604|469208760|FG003|Overall Study|Clinical progression/deterioration|0|||
130337866|NCT03462511|469208764|FG000|Overall Study|Withdrawal by Subject|2|||
130337867|NCT03462511|469208765|FG001|Overall Study|Withdrawal by Subject|3|||
130337868|NCT02925416|469208766|FG000|Overall Study|Adverse Event|2|||
130337869|NCT02925416|469208767|FG001|Overall Study|Adverse Event|0|||
130337870|NCT00200356|469208768|FG000|Overall Study|Lack of Efficacy|3|||
130337871|NCT00200356|469208769|FG001|Overall Study|Lack of Efficacy|3|||
130337872|NCT00200356|469208768|FG000|Overall Study|Protocol Violation|4|||
130337873|NCT00200356|469208769|FG001|Overall Study|Protocol Violation|4|||
130337874|NCT00200356|469208768|FG000|Overall Study|Nontreatment|1|||
130337875|NCT00200356|469208769|FG001|Overall Study|Nontreatment|0|||
130337876|NCT01297491|469208770|FG000|Overall Study|Adverse Event|11|||
130337877|NCT01297491|469208771|FG001|Overall Study|Adverse Event|6|||
130337878|NCT01297491|469208770|FG000|Overall Study|Physician Decision|3|||
130337879|NCT01297491|469208771|FG001|Overall Study|Physician Decision|2|||
130337880|NCT01297491|469208770|FG000|Overall Study|Progressive disease|11|||
130337881|NCT01297491|469208771|FG001|Overall Study|Progressive disease|20|||
130337882|NCT01297491|469208770|FG000|Overall Study|Patient/Guardian decision|3|||
130337883|NCT01297491|469208771|FG001|Overall Study|Patient/Guardian decision|4|||
130337884|NCT01297491|469208770|FG000|Overall Study|Death|2|||
130337885|NCT01297491|469208771|FG001|Overall Study|Death|1|||
130337886|NCT02424578|469208775|FG000|Overall Study|Withdrawal by Subject|0|||
130337887|NCT02424578|469208776|FG001|Overall Study|Withdrawal by Subject|1|||
130337888|NCT01703754|469208781|FG000|Overall Study|Clinically significant disease progression|2|||
130337889|NCT01703754|469208782|FG001|Overall Study|Clinically significant disease progression|2|||
130337890|NCT01703754|469208783|FG002|Overall Study|Clinically significant disease progression|1|||
130337891|NCT01703754|469208781|FG000|Overall Study|Adverse Event|1|||
130337892|NCT01703754|469208782|FG001|Overall Study|Adverse Event|1|||
130337893|NCT01703754|469208783|FG002|Overall Study|Adverse Event|0|||
130337894|NCT01703754|469208781|FG000|Overall Study|Withdrawal by Subject|2|||
130337895|NCT01703754|469208782|FG001|Overall Study|Withdrawal by Subject|0|||
130337896|NCT01703754|469208783|FG002|Overall Study|Withdrawal by Subject|0|||
130337897|NCT01989208|469208784|FG000|200 mg (7 Days)|Protocol Violation|0|||
130337898|NCT01989208|469208785|FG001|200 mg (7 Days)|Protocol Violation|1|||
130337899|NCT04973436|469208786|FG000|Overall Study|Lost to Follow-up|3|||
130337900|NCT04973436|469208786|FG000|Overall Study|Withdrawal by Subject|1|||
130337901|NCT04973436|469208786|FG000|Overall Study|Death|2|||
130337902|NCT00566696|469208787|FG000|Overall Study|Met Exclusion Criteria|2|||
130337903|NCT00566696|469208787|FG000|Overall Study|Muromonab not available|1|||
130337904|NCT00566696|469208787|FG000|Overall Study|Health Status Change|1|||
130337905|NCT00566696|469208787|FG000|Overall Study|Physician Decision|1|||
130337906|NCT00566696|469208787|FG000|Overall Study|Non-Patient Donors|37|||
130337907|NCT02872935|469208788|FG000|Overall Study|Other|0|||
130337908|NCT02872935|469208789|FG001|Overall Study|Other|1|||
130337909|NCT01276054|469208793|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
130337910|NCT01276054|469208794|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
130337911|NCT02640508|469208795|FG000|Overall Study|Death|19|||
130337912|NCT02640508|469208795|FG000|Overall Study|Withdrawal by Subject|8|||
130002867|NCT03933397|467975137|FG000|Overall Study|missing pain score|1|||
130002868|NCT03933397|467975138|FG001|Overall Study|missing pain score|1|||
130002869|NCT03933397|467975137|FG000|Overall Study|Confirmed COVID-19|1|||
130002870|NCT03933397|467975138|FG001|Overall Study|Confirmed COVID-19|2|||
130002871|NCT02966223|467975139|FG000|Overall Study|Physician Decision|3|||
130002872|NCT02966223|467975139|FG000|Overall Study|Withdrawal by Subject|11|||
130002873|NCT02966223|467975139|FG000|Overall Study|Lost to Follow-up|1|||
130002874|NCT01326728|467975140|FG000|Overall Study|Death|13|||
130337913|NCT02640508|469208795|FG000|Overall Study|Physician Decision|1|||
130337914|NCT02640508|469208795|FG000|Overall Study|Lost to Follow-up|1|||
130337915|NCT02792829|469208796|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337916|NCT02792829|469208797|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
130002875|NCT01326728|467975141|FG001|Overall Study|Death|0|||
130002876|NCT01326728|467975140|FG000|Overall Study|Early closure of study|34|||
130337917|NCT02792829|469208798|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130002877|NCT01326728|467975141|FG001|Overall Study|Early closure of study|9|||
130002878|NCT03785678|467975144|FG000|Overall Study|Death|44|||
130337918|NCT02792829|469208799|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337919|NCT02792829|469208800|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337920|NCT02792829|469208801|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337921|NCT02792829|469208802|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337922|NCT02792829|469208803|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
130337923|NCT02792829|469208796|FG000|Treatment Period 2|Adverse Event|0|||
130337924|NCT02792829|469208797|FG001|Treatment Period 2|Adverse Event|0|||
130337925|NCT02792829|469208798|FG002|Treatment Period 2|Adverse Event|0|||
130337926|NCT02792829|469208799|FG003|Treatment Period 2|Adverse Event|0|||
130337927|NCT02792829|469208800|FG004|Treatment Period 2|Adverse Event|1|||
130337928|NCT02792829|469208801|FG005|Treatment Period 2|Adverse Event|0|||
130337929|NCT02792829|469208802|FG006|Treatment Period 2|Adverse Event|1|||
130337930|NCT02792829|469208803|FG007|Treatment Period 2|Adverse Event|1|||
130337931|NCT02792829|469208796|FG000|Treatment Period 2|Use of proscribed medications|0|||
130337932|NCT02792829|469208797|FG001|Treatment Period 2|Use of proscribed medications|0|||
130337933|NCT02792829|469208798|FG002|Treatment Period 2|Use of proscribed medications|0|||
130337934|NCT02792829|469208799|FG003|Treatment Period 2|Use of proscribed medications|0|||
130002879|NCT03785678|467975145|FG001|Overall Study|Death|42|||
130002880|NCT03785678|467975144|FG000|Overall Study|Lost to Follow-up|4|||
130002881|NCT03785678|467975145|FG001|Overall Study|Lost to Follow-up|2|||
130337935|NCT02792829|469208800|FG004|Treatment Period 2|Use of proscribed medications|0|||
130337936|NCT02792829|469208801|FG005|Treatment Period 2|Use of proscribed medications|0|||
130337937|NCT02792829|469208802|FG006|Treatment Period 2|Use of proscribed medications|0|||
130337938|NCT02792829|469208803|FG007|Treatment Period 2|Use of proscribed medications|1|||
130337939|NCT05405257|469208804|FG000|Overall Study|Withdrawal by Subject|1|||
130337940|NCT00452361|469208805|FG000|Overall Study|Adverse Event|8|||
130337941|NCT00452361|469208806|FG001|Overall Study|Adverse Event|0|||
130337942|NCT00452361|469208805|FG000|Overall Study|Withdrawal by Subject|0|||
130337943|NCT00452361|469208806|FG001|Overall Study|Withdrawal by Subject|1|||
130337944|NCT00452361|469208805|FG000|Overall Study|Premature termination|13|||
130337945|NCT00452361|469208806|FG001|Overall Study|Premature termination|9|||
130337946|NCT00776919|469208807|FG000|Overall Study|Withdrawal by Subject|16|||
130002882|NCT03785678|467975144|FG000|Overall Study|Physician Decision|0|||
130002883|NCT03785678|467975145|FG001|Overall Study|Physician Decision|2|||
130002884|NCT03785678|467975144|FG000|Overall Study|Withdrawal by Subject|5|||
130002885|NCT03785678|467975145|FG001|Overall Study|Withdrawal by Subject|3|||
130002886|NCT02374021|467975147|FG000|Overall Study|Adverse Event|1|||
130002887|NCT02374021|467975148|FG001|Overall Study|Adverse Event|0|||
130002888|NCT02374021|467975147|FG000|Overall Study|Lost to Follow-up|3|||
130002889|NCT02374021|467975148|FG001|Overall Study|Lost to Follow-up|2|||
130002890|NCT02374021|467975147|FG000|Overall Study|Physician Decision|0|||
130002891|NCT02374021|467975148|FG001|Overall Study|Physician Decision|3|||
130002892|NCT02374021|467975147|FG000|Overall Study|Withdrawal by Subject|6|||
130002893|NCT02374021|467975148|FG001|Overall Study|Withdrawal by Subject|5|||
130002894|NCT02374021|467975147|FG000|Overall Study|Poor Adherence|0|||
130002895|NCT02374021|467975148|FG001|Overall Study|Poor Adherence|1|||
130002896|NCT02374021|467975147|FG000|Overall Study|Scan protocol not followed|0|||
130002897|NCT02374021|467975148|FG001|Overall Study|Scan protocol not followed|1|||
130002898|NCT02374021|467975147|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
130002899|NCT02374021|467975148|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
130002900|NCT01667107|467975149|FG000|Overall Study|Adverse Event|4|||
130002901|NCT01667107|467975150|FG001|Overall Study|Adverse Event|3|||
130002902|NCT01667107|467975149|FG000|Overall Study|Tolerability issues|0|||
130002903|NCT01667107|467975150|FG001|Overall Study|Tolerability issues|2|||
130002904|NCT01667107|467975149|FG000|Overall Study|Protocol Violation|0|||
130002905|NCT01667107|467975150|FG001|Overall Study|Protocol Violation|1|||
130002906|NCT01667107|467975149|FG000|Overall Study|Lack of Efficacy|0|||
130002907|NCT01667107|467975150|FG001|Overall Study|Lack of Efficacy|1|||
130337947|NCT00776919|469208808|FG001|Overall Study|Withdrawal by Subject|14|||
130337948|NCT00776919|469208809|FG002|Overall Study|Withdrawal by Subject|15|||
130337949|NCT00776919|469208810|FG003|Overall Study|Withdrawal by Subject|26|||
130337950|NCT00776919|469208807|FG000|Overall Study|Lost to Follow-up|8|||
130337951|NCT00776919|469208808|FG001|Overall Study|Lost to Follow-up|12|||
130337952|NCT00776919|469208809|FG002|Overall Study|Lost to Follow-up|11|||
130337953|NCT00776919|469208810|FG003|Overall Study|Lost to Follow-up|8|||
130337954|NCT00776919|469208807|FG000|Overall Study|Adverse Event|1|||
130002908|NCT01162239|467975153|FG000|Treatment Phase|Withdrawal by Subject|1|||
130002909|NCT01162239|467975154|FG001|Treatment Phase|Withdrawal by Subject|3|||
130002910|NCT01162239|467975155|FG002|Treatment Phase|Withdrawal by Subject|2|||
130002911|NCT01162239|467975156|FG003|Treatment Phase|Withdrawal by Subject|3|||
130002912|NCT01162239|467975153|FG000|Treatment Phase|Death|0|||
130002913|NCT01162239|467975154|FG001|Treatment Phase|Death|0|||
130002914|NCT01162239|467975155|FG002|Treatment Phase|Death|0|||
130002915|NCT01162239|467975156|FG003|Treatment Phase|Death|1|||
130002916|NCT01162239|467975153|FG000|Treatment Phase|Lost to Follow-up|5|||
130216201|NCT00184002|468753972|FG000|Overall Study|Withdrawal by Subject|4|||
130337955|NCT00776919|469208808|FG001|Overall Study|Adverse Event|0|||
130337956|NCT00776919|469208809|FG002|Overall Study|Adverse Event|2|||
130337957|NCT00776919|469208810|FG003|Overall Study|Adverse Event|2|||
130002917|NCT01162239|467975154|FG001|Treatment Phase|Lost to Follow-up|4|||
130002918|NCT01162239|467975155|FG002|Treatment Phase|Lost to Follow-up|2|||
130002919|NCT01162239|467975156|FG003|Treatment Phase|Lost to Follow-up|1|||
130002920|NCT01162239|467975153|FG000|Extended Follow-up|Lost to Follow-up|8|||
130002921|NCT01162239|467975154|FG001|Extended Follow-up|Lost to Follow-up|13|||
130002922|NCT01162239|467975155|FG002|Extended Follow-up|Lost to Follow-up|8|||
130002923|NCT01162239|467975156|FG003|Extended Follow-up|Lost to Follow-up|6|||
130002924|NCT00228566|467975157|FG000|Overall Study|Adverse Event|31|||
130002925|NCT00228566|467975157|FG000|Overall Study|Lack of Efficacy|14|||
130002926|NCT00228566|467975157|FG000|Overall Study|Lost to Follow-up|16|||
130002927|NCT00228566|467975157|FG000|Overall Study|Physician Decision|5|||
130002928|NCT00228566|467975157|FG000|Overall Study|Withdrawal by Subject|4|||
130002929|NCT00228566|467975157|FG000|Overall Study|Miscellaneous|1|||
130002930|NCT04448756|467975160|FG000|Overall Study|Adverse Event|0|||
130002931|NCT04448756|467975161|FG001|Overall Study|Adverse Event|1|||
130002932|NCT04448756|467975162|FG002|Overall Study|Adverse Event|0|||
130002933|NCT04448756|467975160|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
130002934|NCT04448756|467975161|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
130002935|NCT04448756|467975162|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
130002936|NCT04448756|467975160|FG000|Overall Study|Withdrawal by Subject|0|||
130002937|NCT04448756|467975161|FG001|Overall Study|Withdrawal by Subject|3|||
130337958|NCT00776919|469208807|FG000|Overall Study|Protocol Violation|1|||
130337959|NCT00776919|469208808|FG001|Overall Study|Protocol Violation|2|||
130337960|NCT00776919|469208809|FG002|Overall Study|Protocol Violation|0|||
130337961|NCT00776919|469208810|FG003|Overall Study|Protocol Violation|1|||
130337962|NCT00776919|469208807|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
130337963|NCT00776919|469208808|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
130337964|NCT00776919|469208809|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
130337965|NCT00776919|469208810|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
130337966|NCT03116152|469208813|FG000|Overall Study|Disease Progression|49|||
130337967|NCT03116152|469208814|FG001|Overall Study|Disease Progression|47|||
130337968|NCT03116152|469208813|FG000|Overall Study|Death|5|||
130337969|NCT03116152|469208814|FG001|Overall Study|Death|2|||
130337970|NCT03116152|469208813|FG000|Overall Study|Adverse Event|21|||
130337971|NCT03116152|469208814|FG001|Overall Study|Adverse Event|7|||
130337972|NCT03116152|469208813|FG000|Overall Study|Protocol Violation|2|||
130337973|NCT03116152|469208814|FG001|Overall Study|Protocol Violation|2|||
130337974|NCT03116152|469208813|FG000|Overall Study|Withdrawal by Subject|0|||
130337975|NCT03116152|469208814|FG001|Overall Study|Withdrawal by Subject|1|||
130337976|NCT03116152|469208813|FG000|Overall Study|Physician Decision|3|||
130337977|NCT03116152|469208814|FG001|Overall Study|Physician Decision|2|||
130337978|NCT03116152|469208813|FG000|Overall Study|other|11|||
130337979|NCT03116152|469208814|FG001|Overall Study|other|34|||
130337980|NCT02379637|469208818|FG000|Overall Study|Protocol Violation|0|||
130337981|NCT02379637|469208819|FG001|Overall Study|Protocol Violation|1|||
130337982|NCT02379637|469208818|FG000|Overall Study|Adverse Event|1|||
130337983|NCT02379637|469208819|FG001|Overall Study|Adverse Event|0|||
130337984|NCT02379637|469208818|FG000|Overall Study|Withdrawal by Subject|1|||
130337985|NCT02379637|469208819|FG001|Overall Study|Withdrawal by Subject|0|||
130337986|NCT02791763|469208820|FG000|Overall Study|Protocol Violation|0|||
130337987|NCT02791763|469208821|FG001|Overall Study|Protocol Violation|0|||
130337988|NCT02791763|469208822|FG002|Overall Study|Protocol Violation|1|||
130337989|NCT02791763|469208820|FG000|Overall Study|Withdrawal by Subject|5|||
130337990|NCT02791763|469208821|FG001|Overall Study|Withdrawal by Subject|1|||
130337991|NCT02791763|469208822|FG002|Overall Study|Withdrawal by Subject|0|||
130337992|NCT02791763|469208820|FG000|Overall Study|Physician Decision|0|||
130337993|NCT02791763|469208821|FG001|Overall Study|Physician Decision|1|||
130337994|NCT02791763|469208822|FG002|Overall Study|Physician Decision|0|||
130337995|NCT02791763|469208820|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
130337996|NCT02791763|469208821|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
130337997|NCT02791763|469208822|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
130337998|NCT02791763|469208820|FG000|Overall Study|Cancer event|1|||
130337999|NCT02791763|469208821|FG001|Overall Study|Cancer event|3|||
130338000|NCT02791763|469208822|FG002|Overall Study|Cancer event|0|||
130338001|NCT02791763|469208820|FG000|Overall Study|Participant had renal transplant|3|||
130338002|NCT02791763|469208821|FG001|Overall Study|Participant had renal transplant|0|||
130338003|NCT02791763|469208822|FG002|Overall Study|Participant had renal transplant|0|||
130338004|NCT02791763|469208820|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
130338005|NCT02791763|469208821|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
130338006|NCT02791763|469208822|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
130338007|NCT02791763|469208820|FG000|Overall Study|Adverse Event|12|||
130002938|NCT04448756|467975162|FG002|Overall Study|Withdrawal by Subject|1|||
130002939|NCT04448756|467975160|FG000|Overall Study|Death|2|||
130002940|NCT04448756|467975161|FG001|Overall Study|Death|1|||
130002941|NCT04448756|467975162|FG002|Overall Study|Death|0|||
130338008|NCT02791763|469208821|FG001|Overall Study|Adverse Event|13|||
130338009|NCT02791763|469208822|FG002|Overall Study|Adverse Event|7|||
130338010|NCT03179605|469208823|FG000|Overall Study|Withdrawal by Subject|1|||
130002942|NCT00232141|467975163|FG000|Overall Study|Adverse Event|9|||
130002943|NCT00232141|467975164|FG001|Overall Study|Adverse Event|4|||
130002944|NCT00232141|467975163|FG000|Overall Study|Lack of Efficacy|0|||
130216202|NCT02171429|468753973|FG000|Overall Study|Other|0|||
130216203|NCT02171429|468753974|FG001|Overall Study|Other|1|||
130216204|NCT02171429|468753975|FG002|Overall Study|Other|1|||
130216205|NCT02171429|468753973|FG000|Overall Study|Non-Compliance|0|||
130216206|NCT02171429|468753974|FG001|Overall Study|Non-Compliance|0|||
130216207|NCT02171429|468753975|FG002|Overall Study|Non-Compliance|1|||
130216208|NCT02171429|468753973|FG000|Overall Study|Physician Decision|0|||
130216209|NCT02171429|468753974|FG001|Overall Study|Physician Decision|0|||
130216210|NCT02171429|468753975|FG002|Overall Study|Physician Decision|1|||
130216211|NCT02171429|468753973|FG000|Overall Study|Withdrawal by Subject|1|||
130216212|NCT02171429|468753974|FG001|Overall Study|Withdrawal by Subject|1|||
130216213|NCT02171429|468753975|FG002|Overall Study|Withdrawal by Subject|1|||
130216214|NCT02171429|468753973|FG000|Overall Study|Lost to Follow-up|0|||
130216215|NCT02171429|468753974|FG001|Overall Study|Lost to Follow-up|1|||
130216216|NCT02171429|468753975|FG002|Overall Study|Lost to Follow-up|0|||
130216217|NCT02171429|468753973|FG000|Overall Study|Death|0|||
130216218|NCT02171429|468753974|FG001|Overall Study|Death|0|||
130216219|NCT02171429|468753975|FG002|Overall Study|Death|1|||
130216220|NCT02020889|468753977|FG000|Overall Study|Adverse Event|0|||
130216221|NCT02020889|468753978|FG001|Overall Study|Adverse Event|1|||
130216222|NCT02020889|468753977|FG000|Overall Study|Lack of Efficacy|1|||
130216223|NCT02020889|468753978|FG001|Overall Study|Lack of Efficacy|0|||
130216224|NCT02020889|468753977|FG000|Overall Study|Lost to Follow-up|1|||
130216225|NCT02020889|468753978|FG001|Overall Study|Lost to Follow-up|0|||
130216226|NCT02020889|468753977|FG000|Overall Study|Physician Decision|2|||
130216227|NCT02020889|468753978|FG001|Overall Study|Physician Decision|0|||
130216228|NCT02020889|468753977|FG000|Overall Study|Withdrawal by Subject|3|||
130216229|NCT02020889|468753978|FG001|Overall Study|Withdrawal by Subject|2|||
130216230|NCT02768792|468753979|FG000|Overall Study|Adverse Event|1|||
130216231|NCT05980013|468753980|FG000|Overall Study|Withdrawal by Subject|0|||
130216232|NCT05980013|468753981|FG001|Overall Study|Withdrawal by Subject|1|||
130216233|NCT05980013|468753980|FG000|Overall Study|Device Error|0|||
130216234|NCT05980013|468753981|FG001|Overall Study|Device Error|1|||
130216235|NCT01768559|468753982|FG000|Overall Study|Randomized but not treated|0|||
130216236|NCT01768559|468753983|FG001|Overall Study|Randomized but not treated|0|||
130216237|NCT01768559|468753984|FG002|Overall Study|Randomized but not treated|1|||
130216238|NCT01768559|468753982|FG000|Overall Study|Adverse Event|15|||
130216239|NCT01768559|468753983|FG001|Overall Study|Adverse Event|2|||
130216240|NCT01768559|468753984|FG002|Overall Study|Adverse Event|5|||
130216241|NCT01768559|468753982|FG000|Overall Study|Lack of Efficacy|6|||
130216242|NCT01768559|468753983|FG001|Overall Study|Lack of Efficacy|4|||
130216243|NCT01768559|468753984|FG002|Overall Study|Lack of Efficacy|0|||
130216244|NCT01768559|468753982|FG000|Overall Study|Poor compliance to protocol|0|||
130216245|NCT01768559|468753983|FG001|Overall Study|Poor compliance to protocol|3|||
130216246|NCT01768559|468753984|FG002|Overall Study|Poor compliance to protocol|2|||
130216247|NCT01768559|468753982|FG000|Overall Study|Other than specified|9|||
130216248|NCT01768559|468753983|FG001|Overall Study|Other than specified|8|||
130216249|NCT01768559|468753984|FG002|Overall Study|Other than specified|5|||
130216250|NCT00398047|468753989|FG000|Overall Study|all patient progressed before completion|3|||
130216251|NCT00902746|468753990|FG000|Overall Study|Protocol Violation|7|||
130216252|NCT00902746|468753990|FG000|Overall Study|Withdrawal by Subject|16|||
130216253|NCT00902746|468753990|FG000|Overall Study|Adverse Event|8|||
130216254|NCT00902746|468753990|FG000|Overall Study|Lost to Follow-up|3|||
130216255|NCT00902746|468753990|FG000|Overall Study|Physician Decision|2|||
130216256|NCT02347072|468753992|FG000|Overall Study|Adverse Event|2|||
130216257|NCT02347072|468753992|FG000|Overall Study|Withdrawal by Subject|6|||
130216258|NCT02347072|468753992|FG000|Overall Study|Physician Decision|1|||
130216259|NCT02347072|468753992|FG000|Overall Study|Lost to Follow-up|2|||
130216260|NCT02347072|468753992|FG000|Overall Study|Protocol Violation|1|||
130216261|NCT02347072|468753992|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
130216262|NCT02793947|468755479|FG000|Overall Study|Death|1|||
130216263|NCT02793947|468755480|FG001|Overall Study|Death|0|||
130216264|NCT02793947|468755479|FG000|Overall Study|Physician Decision|1|||
130216265|NCT02793947|468755480|FG001|Overall Study|Physician Decision|5|||
130216266|NCT03746405|468755488|FG000|Overall Study|Withdrawal by Subject|3|||
130216267|NCT03746405|468755489|FG001|Overall Study|Withdrawal by Subject|0|||
130216268|NCT03746405|468755488|FG000|Overall Study|technical difficulties|0|||
130216269|NCT03746405|468755489|FG001|Overall Study|technical difficulties|2|||
130216270|NCT03479008|468755490|FG000|Overall Study|Withdrawal by Subject|3|||
130216271|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
130216272|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
130002945|NCT00232141|467975164|FG001|Overall Study|Lack of Efficacy|3|||
130216273|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
130216274|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
130216275|NCT00412932|468755491|FG000|Olmesartan (Olm) 20 mg|Other|1|||
130216276|NCT00412932|468755491|FG000|Olmesartan 40 mg|Adverse Event|4|||
130338011|NCT00635999|469208824|FG000|Overall Study|Withdrawal by Subject|4|||
130338012|NCT00635999|469208825|FG001|Overall Study|Withdrawal by Subject|2|||
130216277|NCT00412932|468755491|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
130338013|NCT00635999|469208826|FG002|Overall Study|Withdrawal by Subject|1|||
130338014|NCT02410343|469208827|FG000|Core Period (24 Weeks)|Adverse Event|1|||
130338015|NCT02410343|469208828|FG001|Core Period (24 Weeks)|Adverse Event|0|||
130338016|NCT02410343|469208827|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
130338017|NCT02410343|469208828|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
130338018|NCT02410343|469208827|FG000|Extension Period (12 Months)|Adverse Event|1|||
130338019|NCT02410343|469208828|FG001|Extension Period (12 Months)|Adverse Event|0|||
130338020|NCT02410343|469208827|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
130338021|NCT02410343|469208828|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
130338022|NCT00228553|469208829|FG000|Overall Study|Adverse Event|112|||
130338023|NCT00228553|469208829|FG000|Overall Study|Lack of Efficacy|34|||
130338024|NCT00228553|469208829|FG000|Overall Study|Lost to Follow-up|67|||
130338025|NCT00228553|469208829|FG000|Overall Study|Physician Decision|48|||
130338026|NCT00228553|469208829|FG000|Overall Study|Protocol Violation|6|||
130338027|NCT00228553|469208829|FG000|Overall Study|Withdrawal by Subject|115|||
130338028|NCT00228553|469208829|FG000|Overall Study|Pregnancy|2|||
130338029|NCT00228553|469208829|FG000|Overall Study|Miscellaneous|46|||
130338030|NCT02878798|469208830|FG000|Overall Study|Withdrawal by Subject|5|||
130338031|NCT02878798|469208831|FG001|Overall Study|Withdrawal by Subject|4|||
130338032|NCT02878798|469208830|FG000|Overall Study|Lost to Follow-up|2|||
130338033|NCT02878798|469208831|FG001|Overall Study|Lost to Follow-up|2|||
130338034|NCT02878798|469208830|FG000|Overall Study|Protocol Violation|0|||
130338035|NCT02878798|469208831|FG001|Overall Study|Protocol Violation|1|||
130338036|NCT02720042|469208832|FG000|Overall Study|Death|3|||
130338037|NCT02720042|469208832|FG000|Overall Study|Lost to Follow-up|4|||
130338038|NCT02720042|469208832|FG000|Overall Study|Withdrawal by Subject|1|||
130338039|NCT02720042|469208832|FG000|Overall Study|Physician Decision|3|||
130338040|NCT02720042|469208832|FG000|Overall Study|Phasix Mesh explanted|1|||
130338041|NCT02720042|469208832|FG000|Overall Study|unable due to non-study-related illness|3|||
130338042|NCT00101452|469208835|FG000|Overall Study|Adverse Event|2|||
130338043|NCT00101452|469208836|FG001|Overall Study|Adverse Event|0|||
130338044|NCT00101452|469208837|FG002|Overall Study|Adverse Event|1|||
130338045|NCT00101452|469208835|FG000|Overall Study|Lost to Follow-up|13|||
130338046|NCT00101452|469208836|FG001|Overall Study|Lost to Follow-up|8|||
130338047|NCT00101452|469208837|FG002|Overall Study|Lost to Follow-up|14|||
130338048|NCT00101452|469208835|FG000|Overall Study|Withdrawal by Subject|10|||
130338049|NCT00101452|469208836|FG001|Overall Study|Withdrawal by Subject|14|||
130338050|NCT00101452|469208837|FG002|Overall Study|Withdrawal by Subject|9|||
130338051|NCT00101452|469208835|FG000|Overall Study|Baseline Fail|2|||
130338052|NCT00101452|469208836|FG001|Overall Study|Baseline Fail|1|||
130338053|NCT00101452|469208837|FG002|Overall Study|Baseline Fail|2|||
130338054|NCT00101452|469208835|FG000|Overall Study|Physician Decision|0|||
130338055|NCT00101452|469208836|FG001|Overall Study|Physician Decision|3|||
130338056|NCT00101452|469208837|FG002|Overall Study|Physician Decision|2|||
130338057|NCT00101452|469208835|FG000|Overall Study|Protocol Violation|2|||
130338058|NCT00101452|469208836|FG001|Overall Study|Protocol Violation|1|||
130338059|NCT00101452|469208837|FG002|Overall Study|Protocol Violation|3|||
130338060|NCT00101452|469208835|FG000|Overall Study|Other|15|||
130338061|NCT00101452|469208836|FG001|Overall Study|Other|16|||
130338062|NCT00101452|469208837|FG002|Overall Study|Other|12|||
130338063|NCT01516034|469208840|FG000|Overall Study|Physician Decision|1|||
130338064|NCT01516034|469208840|FG000|Overall Study|Lack of Efficacy|7|||
130338065|NCT05477108|469208845|FG000|Overall Study|Participants randomized, not treated|1|||
130338066|NCT05477108|469208846|FG001|Overall Study|Participants randomized, not treated|1|||
130338067|NCT05477108|469208847|FG002|Overall Study|Participants randomized, not treated|1|||
130338068|NCT05477108|469208845|FG000|Overall Study|Physician Decision|0|||
130338069|NCT05477108|469208846|FG001|Overall Study|Physician Decision|0|||
130338070|NCT05477108|469208847|FG002|Overall Study|Physician Decision|1|||
130338071|NCT05477108|469208845|FG000|Overall Study|withdrawn from study|0|||
130338072|NCT05477108|469208846|FG001|Overall Study|withdrawn from study|0|||
130338073|NCT05477108|469208847|FG002|Overall Study|withdrawn from study|1|||
130338074|NCT02660983|469208848|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
130338075|NCT02660983|469208849|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
130338076|NCT02660983|469208848|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
130338077|NCT02660983|469208849|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
130338078|NCT02660983|469208848|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
130338079|NCT02660983|469208849|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
130338080|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
130338081|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
130338082|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
130338083|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
130338084|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
130338085|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
130338086|NCT02660983|469208848|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
130338087|NCT02660983|469208849|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
130338088|NCT01165216|469208857|FG000|Overall Study|Adverse Event|6|||
130338089|NCT01165216|469208858|FG001|Overall Study|Adverse Event|3|||
130338090|NCT01165216|469208857|FG000|Overall Study|Withdrawal by Subject|1|||
130338091|NCT01165216|469208858|FG001|Overall Study|Withdrawal by Subject|1|||
130338092|NCT01165216|469208857|FG000|Overall Study|Disease progression|1|||
130338093|NCT01165216|469208858|FG001|Overall Study|Disease progression|3|||
130338094|NCT05688670|469208860|FG000|Overall Study|Change in surgery plan|1|||
130338095|NCT05688670|469208861|FG001|Overall Study|Change in surgery plan|4|||
130338096|NCT05688670|469208860|FG000|Overall Study|Inability to extubate|1|||
130338097|NCT05688670|469208861|FG001|Overall Study|Inability to extubate|2|||
130338098|NCT05688670|469208860|FG000|Overall Study|Day of surgery cancellation|0|||
130338099|NCT05688670|469208861|FG001|Overall Study|Day of surgery cancellation|1|||
130338100|NCT05688670|469208860|FG000|Overall Study|Reintubated on PCICU arrival|0|||
130338101|NCT05688670|469208861|FG001|Overall Study|Reintubated on PCICU arrival|1|||
130338102|NCT03425253|469208862|FG000|Overall Study|Adverse Event|2|||
130338103|NCT03425253|469208862|FG000|Overall Study|Lost to Follow-up|3|||
130338104|NCT03425253|469208862|FG000|Overall Study|Withdrew Consent|6|||
130338105|NCT03425253|469208862|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
130338106|NCT01217307|469210758|FG000|Overall Study|Withdrawal by Subject|0|||
130338107|NCT01217307|469210759|FG001|Overall Study|Withdrawal by Subject|1|||
130338108|NCT04129151|469210762|FG000|Overall Study|Adverse Event|1|||
130338109|NCT04129151|469210762|FG000|Overall Study|Disease Progression|7|||
130338110|NCT04129151|469210762|FG000|Overall Study|Study closure|1|||
130338111|NCT02730195|469210763|FG000|Overall Study|Withdrawal by Subject|1|||
130338112|NCT01463007|469210764|FG000|Overall Study|Physician Decision|1|||
130338113|NCT00689117|469210765|FG000|Overall Study|Adverse Event|6|||
130338114|NCT00689117|469210766|FG001|Overall Study|Adverse Event|0|||
130338115|NCT00689117|469210767|FG002|Overall Study|Adverse Event|5|||
130338116|NCT00689117|469210768|FG003|Overall Study|Adverse Event|0|||
130338117|NCT00689117|469210765|FG000|Overall Study|Lost to Follow-up|26|||
130338118|NCT00689117|469210766|FG001|Overall Study|Lost to Follow-up|19|||
130338119|NCT00689117|469210767|FG002|Overall Study|Lost to Follow-up|17|||
130338120|NCT00689117|469210768|FG003|Overall Study|Lost to Follow-up|11|||
130338121|NCT00689117|469210765|FG000|Overall Study|Lack of Efficacy|1|||
130338122|NCT00689117|469210766|FG001|Overall Study|Lack of Efficacy|2|||
130338123|NCT00689117|469210767|FG002|Overall Study|Lack of Efficacy|2|||
130338124|NCT00689117|469210768|FG003|Overall Study|Lack of Efficacy|2|||
130338125|NCT00689117|469210765|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
130338126|NCT00689117|469210766|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
130338127|NCT00689117|469210767|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
130338128|NCT00689117|469210768|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
130338129|NCT00689117|469210765|FG000|Overall Study|Withdrawal by Subject|19|||
130338130|NCT00689117|469210766|FG001|Overall Study|Withdrawal by Subject|18|||
130338131|NCT00689117|469210767|FG002|Overall Study|Withdrawal by Subject|26|||
130338132|NCT00689117|469210768|FG003|Overall Study|Withdrawal by Subject|13|||
130338133|NCT00689117|469210765|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
130338134|NCT00689117|469210766|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
130338135|NCT00689117|469210767|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
130338136|NCT00689117|469210768|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
130338137|NCT00689117|469210765|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130338138|NCT00689117|469210766|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
130338139|NCT00689117|469210767|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130338140|NCT00689117|469210768|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130338141|NCT00689117|469210765|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
130338142|NCT00689117|469210766|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
130338143|NCT00689117|469210767|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
130002946|NCT00232141|467975163|FG000|Overall Study|Lost to Follow-up|9|||
130002947|NCT00232141|467975164|FG001|Overall Study|Lost to Follow-up|6|||
130002948|NCT00232141|467975163|FG000|Overall Study|Other|8|||
130338144|NCT00689117|469210768|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
130338145|NCT00689117|469210765|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
130338146|NCT00689117|469210766|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
130338147|NCT00689117|469210767|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
130002949|NCT00232141|467975164|FG001|Overall Study|Other|10|||
130002950|NCT00232141|467975163|FG000|Overall Study|Withdrawal by Subject|5|||
130338148|NCT00689117|469210768|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
130338149|NCT00689117|469210765|FG000|Overall Study|Use of Prohibitive Medication|2|||
130338150|NCT00689117|469210766|FG001|Overall Study|Use of Prohibitive Medication|1|||
130338151|NCT00689117|469210767|FG002|Overall Study|Use of Prohibitive Medication|3|||
130338152|NCT00689117|469210768|FG003|Overall Study|Use of Prohibitive Medication|0|||
130338153|NCT00689117|469210765|FG000|Overall Study|Pregnancy|0|||
130002951|NCT00232141|467975164|FG001|Overall Study|Withdrawal by Subject|3|||
130002952|NCT00972777|467975172|FG000|Overall Study|Adverse Event|3|||
130002953|NCT00972777|467975173|FG001|Overall Study|Adverse Event|2|||
130002954|NCT00972777|467975172|FG000|Overall Study|Lost to Follow-up|0|||
130002955|NCT00972777|467975173|FG001|Overall Study|Lost to Follow-up|4|||
130002956|NCT00972777|467975172|FG000|Overall Study|Withdrawal by Subject|4|||
130002957|NCT00972777|467975173|FG001|Overall Study|Withdrawal by Subject|5|||
130002958|NCT00972777|467975172|FG000|Overall Study|Physician Decision|4|||
130002959|NCT00972777|467975173|FG001|Overall Study|Physician Decision|0|||
130002960|NCT00972777|467975172|FG000|Overall Study|Protocol Violation|0|||
130338154|NCT00689117|469210766|FG001|Overall Study|Pregnancy|2|||
130338155|NCT00689117|469210767|FG002|Overall Study|Pregnancy|0|||
130338156|NCT00689117|469210768|FG003|Overall Study|Pregnancy|2|||
130338157|NCT00689117|469210765|FG000|Overall Study|Incarceration|2|||
130338158|NCT00689117|469210766|FG001|Overall Study|Incarceration|0|||
130338159|NCT00689117|469210767|FG002|Overall Study|Incarceration|0|||
130338160|NCT00689117|469210768|FG003|Overall Study|Incarceration|0|||
130338161|NCT00689117|469210765|FG000|Overall Study|Fear of Birth Defects|0|||
130338162|NCT00689117|469210766|FG001|Overall Study|Fear of Birth Defects|0|||
130338163|NCT00689117|469210767|FG002|Overall Study|Fear of Birth Defects|1|||
130338164|NCT00689117|469210768|FG003|Overall Study|Fear of Birth Defects|0|||
130338165|NCT00689117|469210765|FG000|Overall Study|Transportation|1|||
130338166|NCT00689117|469210766|FG001|Overall Study|Transportation|0|||
130338167|NCT00689117|469210767|FG002|Overall Study|Transportation|0|||
130338168|NCT00689117|469210768|FG003|Overall Study|Transportation|0|||
130338169|NCT00689117|469210765|FG000|Overall Study|Patient Withdrew from Study|0|||
130338170|NCT00689117|469210766|FG001|Overall Study|Patient Withdrew from Study|0|||
130338171|NCT00689117|469210767|FG002|Overall Study|Patient Withdrew from Study|0|||
130338172|NCT00689117|469210768|FG003|Overall Study|Patient Withdrew from Study|1|||
130338173|NCT00689117|469210765|FG000|Overall Study|Personal Reason|0|||
130338174|NCT00689117|469210766|FG001|Overall Study|Personal Reason|1|||
130338175|NCT00689117|469210767|FG002|Overall Study|Personal Reason|0|||
130338176|NCT00689117|469210768|FG003|Overall Study|Personal Reason|0|||
130338177|NCT00689117|469210765|FG000|Overall Study|Dispensing Error|0|||
130338178|NCT00689117|469210766|FG001|Overall Study|Dispensing Error|1|||
130338179|NCT00689117|469210767|FG002|Overall Study|Dispensing Error|0|||
130338180|NCT00689117|469210768|FG003|Overall Study|Dispensing Error|0|||
130338181|NCT01206322|469210769|FG000|Overall Study|Adverse Event|0|||
130338182|NCT01206322|469210770|FG001|Overall Study|Adverse Event|0|||
130338183|NCT01206322|469210771|FG002|Overall Study|Adverse Event|0|||
130338184|NCT01206322|469210772|FG003|Overall Study|Adverse Event|1|||
130338185|NCT00859638|469210775|FG000|Overall Study|Lost to Follow-up|6|||
130338186|NCT00859638|469210776|FG001|Overall Study|Lost to Follow-up|1|||
130338187|NCT00859638|469210775|FG000|Overall Study|Withdrawal by Subject|3|||
130338188|NCT00859638|469210776|FG001|Overall Study|Withdrawal by Subject|2|||
130338189|NCT00859638|469210775|FG000|Overall Study|Ill health|1|||
130338190|NCT00859638|469210776|FG001|Overall Study|Ill health|1|||
130338191|NCT02969408|469210777|FG000|Overall Study|Adverse Event|2|||
130338192|NCT02969408|469210777|FG000|Overall Study|Withdrawal by Subject|8|||
130338193|NCT02969408|469210777|FG000|Overall Study|Lost to Follow-up|4|||
130338194|NCT02969408|469210777|FG000|Overall Study|Protocol Violation|1|||
130338195|NCT02969408|469210777|FG000|Overall Study|Other than specified|1|||
130338196|NCT02779556|469210778|FG000|Baseline|Partial baseline interview completed|1|||
130338197|NCT02779556|469210779|FG001|Baseline|Partial baseline interview completed|0|||
130338198|NCT02779556|469210778|FG000|3 Months|Lost to Follow-up|40|||
130338199|NCT02779556|469210779|FG001|3 Months|Lost to Follow-up|29|||
130338200|NCT02779556|469210778|FG000|3 Months|Missed 3 month clinic visit|27|||
130338201|NCT02779556|469210779|FG001|3 Months|Missed 3 month clinic visit|19|||
130338202|NCT02779556|469210778|FG000|6 Month|Lost to Follow-up|33|||
130338203|NCT02779556|469210779|FG001|6 Month|Lost to Follow-up|39|||
130338204|NCT02779556|469210778|FG000|6 Month HbA1c|No value collected during window|69|||
130338205|NCT02779556|469210779|FG001|6 Month HbA1c|No value collected during window|50|||
130338206|NCT02779556|469210778|FG000|12 Month HbA1c|No value collected during window|138|||
130338207|NCT02779556|469210779|FG001|12 Month HbA1c|No value collected during window|102|||
130338208|NCT03110770|469210783|FG000|Overall Study|Death|1|||
130338209|NCT03110770|469210784|FG001|Overall Study|Death|0|||
130338210|NCT03110770|469210785|FG002|Overall Study|Death|0|||
130338211|NCT03110770|469210786|FG003|Overall Study|Death|1|||
130002961|NCT00972777|467975173|FG001|Overall Study|Protocol Violation|2|||
130002962|NCT00972777|467975172|FG000|Overall Study|Screening Failure|2|||
130338212|NCT03110770|469210787|FG004|Overall Study|Death|0|||
130338213|NCT03110770|469210783|FG000|Overall Study|Enrolled but did not receive product|0|||
130338214|NCT03110770|469210784|FG001|Overall Study|Enrolled but did not receive product|0|||
130338215|NCT03110770|469210785|FG002|Overall Study|Enrolled but did not receive product|0|||
130338216|NCT03110770|469210786|FG003|Overall Study|Enrolled but did not receive product|8|||
130338217|NCT03110770|469210787|FG004|Overall Study|Enrolled but did not receive product|7|||
130338218|NCT03110770|469210783|FG000|Overall Study|Lost to Follow-up|0|||
130338219|NCT03110770|469210784|FG001|Overall Study|Lost to Follow-up|0|||
130338220|NCT03110770|469210785|FG002|Overall Study|Lost to Follow-up|0|||
130338221|NCT03110770|469210786|FG003|Overall Study|Lost to Follow-up|53|||
130338222|NCT03110770|469210787|FG004|Overall Study|Lost to Follow-up|45|||
130338223|NCT03110770|469210783|FG000|Overall Study|Investigator Decision|0|||
130338224|NCT03110770|469210784|FG001|Overall Study|Investigator Decision|0|||
130338225|NCT03110770|469210785|FG002|Overall Study|Investigator Decision|0|||
130338226|NCT03110770|469210786|FG003|Overall Study|Investigator Decision|5|||
130338227|NCT03110770|469210787|FG004|Overall Study|Investigator Decision|3|||
130002963|NCT00972777|467975173|FG001|Overall Study|Screening Failure|1|||
130002964|NCT00972777|467975172|FG000|Overall Study|Missed visit|1|||
130002965|NCT00972777|467975173|FG001|Overall Study|Missed visit|0|||
130002966|NCT01093326|467975174|FG000|Overall Study|Death|0|||
130002967|NCT01093326|467975175|FG001|Overall Study|Death|1|||
130002968|NCT01093326|467975176|FG002|Overall Study|Death|0|||
130002969|NCT01093326|467975174|FG000|Overall Study|Lack of Efficacy|7|||
130002970|NCT01093326|467975175|FG001|Overall Study|Lack of Efficacy|6|||
130002971|NCT01093326|467975176|FG002|Overall Study|Lack of Efficacy|3|||
130002972|NCT01093326|467975174|FG000|Overall Study|Lost to Follow-up|2|||
130002973|NCT01093326|467975175|FG001|Overall Study|Lost to Follow-up|5|||
130002974|NCT01093326|467975176|FG002|Overall Study|Lost to Follow-up|4|||
130002975|NCT01093326|467975174|FG000|Overall Study|Physician Decision|3|||
130002976|NCT01093326|467975175|FG001|Overall Study|Physician Decision|1|||
130002977|NCT01093326|467975176|FG002|Overall Study|Physician Decision|3|||
130002978|NCT01093326|467975174|FG000|Overall Study|Withdrawal by Subject|30|||
130002979|NCT01093326|467975175|FG001|Overall Study|Withdrawal by Subject|27|||
130002980|NCT01093326|467975176|FG002|Overall Study|Withdrawal by Subject|26|||
130002981|NCT01093326|467975174|FG000|Overall Study|Adverse Event|2|||
130002982|NCT01093326|467975175|FG001|Overall Study|Adverse Event|1|||
130002983|NCT01093326|467975176|FG002|Overall Study|Adverse Event|4|||
130002984|NCT01093326|467975174|FG000|Overall Study|Other|0|||
130002985|NCT01093326|467975175|FG001|Overall Study|Other|0|||
130002986|NCT01093326|467975176|FG002|Overall Study|Other|1|||
130002987|NCT04263896|467975177|FG000|Overall Study|Withdrawal by Subject|2|||
130002988|NCT04263896|467975178|FG001|Overall Study|Withdrawal by Subject|4|||
130002989|NCT04263896|467975177|FG000|Overall Study|converted to open procedure|0|||
130002990|NCT04263896|467975178|FG001|Overall Study|converted to open procedure|1|||
130002991|NCT04263896|467975177|FG000|Overall Study|Lost to Follow-up|9|||
130002992|NCT04263896|467975178|FG001|Overall Study|Lost to Follow-up|11|||
130002993|NCT04263896|467975177|FG000|Overall Study|surveys lost in mail|5|||
130002994|NCT04263896|467975178|FG001|Overall Study|surveys lost in mail|3|||
130002995|NCT04263896|467975177|FG000|Overall Study|excluded from analysis|1|||
130002996|NCT04263896|467975178|FG001|Overall Study|excluded from analysis|0|||
130002997|NCT05586269|467976404|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
130002998|NCT05586269|467976405|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
130002999|NCT05586269|467976406|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
130003000|NCT05586269|467976407|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
130003001|NCT05586269|467976404|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
130003002|NCT05586269|467976405|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
130003003|NCT05586269|467976406|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
130003004|NCT05586269|467976407|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
130003005|NCT00523718|467976409|FG000|Overall Study|Withdrawal by Subject|1|||
130003006|NCT00523718|467976410|FG001|Overall Study|Withdrawal by Subject|0|||
130003007|NCT00523718|467976409|FG000|Overall Study|Protocol Violation|2|||
130003008|NCT00523718|467976410|FG001|Overall Study|Protocol Violation|0|||
130003009|NCT03441334|467976411|FG000|Overall Study|Withdrawal by Subject|1|||
130003010|NCT03441334|467976412|FG001|Overall Study|Withdrawal by Subject|0|||
130003011|NCT01628107|467976416|FG000|Overall Study|Withdrawal by Subject|17|||
130003012|NCT01628107|467976416|FG000|Overall Study|Lost to Follow-up|4|||
130003013|NCT01628107|467976416|FG000|Overall Study|Adverse Event|33|||
130003014|NCT01628107|467976416|FG000|Overall Study|Physician Decision|2|||
130003015|NCT01628107|467976416|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
130003016|NCT01628107|467976416|FG000|Overall Study|Non-compliant with Study Procedures|10|||
130003017|NCT01628107|467976416|FG000|Overall Study|Not Treated|8|||
130003018|NCT01628107|467976416|FG000|Overall Study|Sponsor Decision|11|||
130003019|NCT01628107|467976416|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
130003020|NCT01628107|467976416|FG000|Overall Study|Relocated|8|||
130003021|NCT01628107|467976416|FG000|Overall Study|Kidney Transplant|9|||
130003022|NCT01628107|467976416|FG000|Overall Study|Use of Standard of Care|9|||
130003023|NCT02953639|467976417|FG000|Overall Study|Adverse Event|2|||
130003024|NCT02953639|467976418|FG001|Overall Study|Adverse Event|0|||
130003025|NCT02953639|467976419|FG002|Overall Study|Adverse Event|1|||
130003026|NCT02953639|467976417|FG000|Overall Study|Lost to Follow-up|8|||
130003027|NCT02953639|467976418|FG001|Overall Study|Lost to Follow-up|4|||
130003028|NCT02953639|467976419|FG002|Overall Study|Lost to Follow-up|3|||
130003029|NCT02953639|467976417|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130003030|NCT02953639|467976418|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130003031|NCT02953639|467976419|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130003032|NCT02953639|467976417|FG000|Overall Study|Multiple Reasons|1|||
130338228|NCT03110770|469210783|FG000|Overall Study|Withdrawal by Subject|0|||
130003033|NCT02953639|467976418|FG001|Overall Study|Multiple Reasons|0|||
130003034|NCT02953639|467976419|FG002|Overall Study|Multiple Reasons|1|||
130003035|NCT02953639|467976417|FG000|Overall Study|Physician Decision|1|||
130003036|NCT02953639|467976418|FG001|Overall Study|Physician Decision|0|||
130003037|NCT02953639|467976419|FG002|Overall Study|Physician Decision|0|||
130003038|NCT02953639|467976417|FG000|Overall Study|Withdrawal by Subject|7|||
130003039|NCT02953639|467976418|FG001|Overall Study|Withdrawal by Subject|8|||
130003040|NCT02953639|467976419|FG002|Overall Study|Withdrawal by Subject|10|||
130003041|NCT02953639|467976417|FG000|Overall Study|Completed or Discontinued information is missing|1|||
130003042|NCT02953639|467976418|FG001|Overall Study|Completed or Discontinued information is missing|0|||
130003043|NCT02953639|467976419|FG002|Overall Study|Completed or Discontinued information is missing|0|||
130003044|NCT01087957|467976420|FG000|Overall Study|Death|2|||
130003045|NCT01087957|467976421|FG001|Overall Study|Death|2|||
130003046|NCT01087957|467976420|FG000|Overall Study|Lost to Follow-up|3|||
130003047|NCT01087957|467976421|FG001|Overall Study|Lost to Follow-up|4|||
130003048|NCT01087957|467976420|FG000|Overall Study|Protocol Violation|13|||
130003049|NCT01087957|467976421|FG001|Overall Study|Protocol Violation|25|||
130003050|NCT01087957|467976420|FG000|Overall Study|Withdrawal by Subject|18|||
130003051|NCT01087957|467976421|FG001|Overall Study|Withdrawal by Subject|15|||
130003052|NCT01087957|467976420|FG000|Overall Study|Physician Decision|5|||
130003053|NCT01087957|467976421|FG001|Overall Study|Physician Decision|9|||
130003054|NCT01186939|467976422|FG000|Overall Study|Death|7|||
130003055|NCT01186939|467976422|FG000|Overall Study|Withdrawal by Subject|2|||
130003056|NCT01186939|467976422|FG000|Overall Study|No longer receiving clinical benefit|17|||
130003057|NCT01186939|467976422|FG000|Overall Study|Program closed|5|||
130003058|NCT01186939|467976422|FG000|Overall Study|Sponsor decision|4|||
130003059|NCT01186939|467976422|FG000|Overall Study|Started additional treatment|1|||
130338229|NCT03110770|469210784|FG001|Overall Study|Withdrawal by Subject|0|||
130003060|NCT01186939|467976422|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
130003061|NCT01186939|467976422|FG000|Overall Study|Myocardial infarction|1|||
130003062|NCT01186939|467976422|FG000|Overall Study|Bone marrow transplant|1|||
130003063|NCT01186939|467976422|FG000|Overall Study|Transformation to AML|1|||
130003064|NCT00616434|467976427|FG000|Overall Study|Adverse Event|5|||
130003065|NCT00616434|467976428|FG001|Overall Study|Adverse Event|2|||
130003066|NCT00616434|467976427|FG000|Overall Study|Physician Decision|0|||
130003067|NCT00616434|467976428|FG001|Overall Study|Physician Decision|4|||
130003068|NCT00616434|467976427|FG000|Overall Study|Withdrawal by Subject|1|||
130003069|NCT00616434|467976428|FG001|Overall Study|Withdrawal by Subject|1|||
130003070|NCT00616434|467976427|FG000|Overall Study|Protocol deviation|0|||
130003071|NCT00616434|467976428|FG001|Overall Study|Protocol deviation|1|||
130003072|NCT01754857|467976429|FG000|Overall Study|Adverse Event|7|||
130003073|NCT01754857|467976429|FG000|Overall Study|Disease progression|3|||
130338230|NCT03110770|469210785|FG002|Overall Study|Withdrawal by Subject|0|||
130338231|NCT03110770|469210786|FG003|Overall Study|Withdrawal by Subject|24|||
130338232|NCT03110770|469210787|FG004|Overall Study|Withdrawal by Subject|24|||
130338233|NCT03110770|469210783|FG000|Overall Study|Moved from area|5|||
130338234|NCT03110770|469210784|FG001|Overall Study|Moved from area|0|||
130338235|NCT03110770|469210785|FG002|Overall Study|Moved from area|2|||
130338236|NCT03110770|469210786|FG003|Overall Study|Moved from area|42|||
130338237|NCT03110770|469210787|FG004|Overall Study|Moved from area|43|||
130338238|NCT03110770|469210783|FG000|Overall Study|Illness/Injury unrelated to product|0|||
130338239|NCT03110770|469210784|FG001|Overall Study|Illness/Injury unrelated to product|0|||
130338240|NCT03110770|469210785|FG002|Overall Study|Illness/Injury unrelated to product|0|||
130338241|NCT03110770|469210786|FG003|Overall Study|Illness/Injury unrelated to product|0|||
130338242|NCT03110770|469210787|FG004|Overall Study|Illness/Injury unrelated to product|1|||
130338243|NCT01086358|469210790|FG000|First Intervention|Lost to Follow-up|9|||
130338244|NCT01086358|469210791|FG001|First Intervention|Lost to Follow-up|4|||
130338245|NCT01086358|469210790|FG000|First Intervention|Withdrawal by Subject|0|||
130338246|NCT01086358|469210791|FG001|First Intervention|Withdrawal by Subject|1|||
130338247|NCT01086358|469210790|FG000|Second Intervention|Lost to Follow-up|4|||
130338248|NCT01086358|469210791|FG001|Second Intervention|Lost to Follow-up|4|||
130338249|NCT01767142|469210792|FG000|Overall Study|Lost to Follow-up|3|||
130338250|NCT03206788|469210795|FG000|Overall Study|Withdrawal by Subject|0|||
130338251|NCT03206788|469210796|FG001|Overall Study|Withdrawal by Subject|1|||
130338252|NCT03206788|469210795|FG000|Overall Study|Adverse Event|0|||
130003074|NCT01754857|467976429|FG000|Overall Study|Physician Decision|2|||
130003075|NCT01754857|467976429|FG000|Overall Study|Withdrawal by Subject|3|||
130003076|NCT01754857|467976429|FG000|Overall Study|other complicating disease|1|||
130003077|NCT01754857|467976429|FG000|Overall Study|ineligible to continue onto maintenance|1|||
130003078|NCT01754857|467976429|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
130003079|NCT01754857|467976429|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
130003080|NCT01509079|467976430|FG000|Overall Study|Lack of Efficacy|0|||
130003081|NCT01509079|467976431|FG001|Overall Study|Lack of Efficacy|2|||
130003082|NCT01509079|467976430|FG000|Overall Study|started an excluded medication|0|||
130003083|NCT01509079|467976431|FG001|Overall Study|started an excluded medication|1|||
130338253|NCT03206788|469210796|FG001|Overall Study|Adverse Event|1|||
130003084|NCT01399190|467976434|FG000|Overall Study|Not Eligible for Final Analysis|5|||
130003085|NCT01399190|467976434|FG000|Overall Study|Adverse Event|8|||
130216278|NCT00412932|468755491|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
130216279|NCT00412932|468755491|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
130216280|NCT00412932|468755491|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
130216281|NCT00412932|468755491|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
130216282|NCT00412932|468755491|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
130216283|NCT01490840|468755492|FG000|Phase 1|Lost to Follow-up|1|||
130216284|NCT01490840|468755493|FG001|Phase 1|Lost to Follow-up|0|||
130216285|NCT01490840|468755492|FG000|Phase 1|Adverse Event|2|||
130216286|NCT01490840|468755493|FG001|Phase 1|Adverse Event|1|||
130216287|NCT01490840|468755492|FG000|Phase 1|Withdrawal by Subject|6|||
130216288|NCT01490840|468755493|FG001|Phase 1|Withdrawal by Subject|5|||
130216289|NCT01490840|468755492|FG000|Phase 1|Visit 6a omitted|1|||
130216290|NCT01490840|468755493|FG001|Phase 1|Visit 6a omitted|0|||
130216291|NCT01490840|468755492|FG000|Phase 2|Withdrawal by Subject|4|||
130216292|NCT01490840|468755493|FG001|Phase 2|Withdrawal by Subject|3|||
130216293|NCT01490840|468755492|FG000|Phase 2|Permanent interruption of fingolimod|0|||
130216294|NCT01490840|468755493|FG001|Phase 2|Permanent interruption of fingolimod|1|||
130216295|NCT01490840|468755492|FG000|Phase 2|Lost to Follow-up|1|||
130216296|NCT01490840|468755493|FG001|Phase 2|Lost to Follow-up|1|||
130216297|NCT01490840|468755492|FG000|Phase 2|Adverse Event|1|||
130216298|NCT01490840|468755493|FG001|Phase 2|Adverse Event|1|||
130216299|NCT01704755|468755497|FG000|Overall Study|Adverse Event|4|||
130216300|NCT01704755|468755498|FG001|Overall Study|Adverse Event|1|||
130216301|NCT01704755|468755497|FG000|Overall Study|Lost to Follow-up|3|||
130216302|NCT01704755|468755498|FG001|Overall Study|Lost to Follow-up|4|||
130216303|NCT01704755|468755497|FG000|Overall Study|Withdrew consent|1|||
130216304|NCT01704755|468755498|FG001|Overall Study|Withdrew consent|1|||
130216305|NCT01704755|468755497|FG000|Overall Study|Other (not specified)|3|||
130216306|NCT01704755|468755498|FG001|Overall Study|Other (not specified)|1|||
130216307|NCT01704755|468755497|FG000|Overall Study|Withdrew consent and personal issues|1|||
130216308|NCT01704755|468755498|FG001|Overall Study|Withdrew consent and personal issues|0|||
130216309|NCT04105842|468755499|FG000|Overall Study|Withdrawal by Subject|2|||
130216310|NCT01639703|468755500|FG000|Overall Study|Withdrawal by Subject|5|||
130216311|NCT01639703|468755500|FG000|Overall Study|Other reason|7|||
130216312|NCT02087670|468755501|FG000|Overall Study|Withdrawal by Subject|3|||
130216313|NCT02087670|468755502|FG001|Overall Study|Withdrawal by Subject|2|||
130216314|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
130216315|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
130216316|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
130216317|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
130216318|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
130216319|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130216320|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130216321|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
130216322|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
130216323|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
130216324|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
130216325|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
130216326|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130216327|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130216328|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
130216329|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
130216330|NCT01042392|468755503|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
130216331|NCT01042392|468755504|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130216332|NCT01042392|468755505|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130216333|NCT01042392|468755506|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
130216334|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130216335|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130216336|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
130216337|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
130216338|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
130216339|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130216340|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130216341|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
130216342|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130216343|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130338254|NCT03206788|469210795|FG000|Overall Study|Physician Decision|0|||
130052075|NCT05137041|468147194|FG001|Overall Study|Lost to Follow-up|1|||
130338255|NCT03206788|469210796|FG001|Overall Study|Physician Decision|1|||
130338256|NCT02471612|469210797|FG000|Overall Study|Lost to Follow-up|2|||
130338257|NCT02082340|469210798|FG000|Overall Study|Lost to Follow-up|1|||
130338258|NCT02082340|469210799|FG001|Overall Study|Lost to Follow-up|1|||
130338259|NCT05194579|469210806|FG000|Overall Study|Lost to Follow-up|2|||
130338260|NCT05194579|469210807|FG001|Overall Study|Lost to Follow-up|3|||
130338261|NCT05194579|469210806|FG000|Overall Study|Withdrawal by Subject|3|||
130338262|NCT05194579|469210807|FG001|Overall Study|Withdrawal by Subject|4|||
130338263|NCT05194579|469210806|FG000|Overall Study|Refused further study procedures|0|||
130338264|NCT05194579|469210807|FG001|Overall Study|Refused further study procedures|1|||
130338265|NCT05194579|469210806|FG000|Overall Study|Protocol deviation|1|||
130338266|NCT05194579|469210807|FG001|Overall Study|Protocol deviation|0|||
130338267|NCT03595228|469210808|FG000|Overall Study|Death|2|||
130338268|NCT03595228|469210808|FG000|Overall Study|Lack of Efficacy|13|||
130338269|NCT03595228|469210808|FG000|Overall Study|Withdrawal by Subject|3|||
130338270|NCT03595228|469210808|FG000|Overall Study|Withdrawal by Sponsor|1|||
130338271|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
130338272|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
130338273|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
130338274|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
130338275|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
130338276|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
130338277|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
130338278|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
130338279|NCT00435045|469210813|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
130338280|NCT00435045|469210814|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
130338281|NCT00435045|469210813|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
130338282|NCT00435045|469210814|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
130338283|NCT00435045|469210813|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
130338284|NCT00435045|469210814|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
130338285|NCT00435045|469210813|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
130338286|NCT00435045|469210814|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
130338287|NCT00435045|469210813|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
130338288|NCT00435045|469210814|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
130338289|NCT00435045|469210813|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
130338290|NCT00435045|469210814|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
130338291|NCT00435045|469210813|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
130338292|NCT00435045|469210814|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
130338293|NCT00567255|469210815|FG000|Overall Study|Adverse Event|241|||
130338294|NCT00567255|469210816|FG001|Overall Study|Adverse Event|68|||
130338295|NCT00567255|469210815|FG000|Overall Study|Lost to Follow-up|77|||
130338296|NCT00567255|469210816|FG001|Overall Study|Lost to Follow-up|48|||
130338297|NCT00567255|469210815|FG000|Overall Study|Withdrawal by Subject|75|||
130338298|NCT00567255|469210816|FG001|Overall Study|Withdrawal by Subject|56|||
130338299|NCT00567255|469210815|FG000|Overall Study|Lack of Efficacy|19|||
130338300|NCT00567255|469210816|FG001|Overall Study|Lack of Efficacy|33|||
130338301|NCT00567255|469210815|FG000|Overall Study|Protocol Violation|20|||
130338302|NCT00567255|469210816|FG001|Overall Study|Protocol Violation|8|||
130338303|NCT00567255|469210815|FG000|Overall Study|Pregnancy|6|||
130338304|NCT00567255|469210816|FG001|Overall Study|Pregnancy|0|||
130338305|NCT00567255|469210815|FG000|Overall Study|Drug noncompliance,moved,other|25|||
130338306|NCT00567255|469210816|FG001|Overall Study|Drug noncompliance,moved,other|15|||
130338307|NCT03083990|469210819|FG000|Overall Study|Adverse Event|1|||
130338308|NCT03083990|469210820|FG001|Overall Study|Adverse Event|0|||
130338309|NCT00984620|469210821|FG000|Overall Study|Adverse Event|5|||
130338310|NCT00984620|469210822|FG001|Overall Study|Adverse Event|5|||
130338311|NCT00984620|469210821|FG000|Overall Study|Lost to Follow-up|1|||
130003086|NCT01399190|467976434|FG000|Overall Study|Participant's Request|5|||
130003087|NCT01399190|467976434|FG000|Overall Study|Physician Decision|2|||
130003088|NCT00436618|467976438|FG000|Overall Study|Withdrawal by Subject|5|||
130338312|NCT00984620|469210822|FG001|Overall Study|Lost to Follow-up|1|||
130338313|NCT00984620|469210821|FG000|Overall Study|Withdrawal by Subject|0|||
130338314|NCT00984620|469210822|FG001|Overall Study|Withdrawal by Subject|2|||
130338315|NCT00984620|469210821|FG000|Overall Study|reason other than listed above|0|||
130338316|NCT00984620|469210822|FG001|Overall Study|reason other than listed above|4|||
130338317|NCT01018810|469210823|FG000|Overall Study|Withdrawal by Subject|0|||
130338318|NCT01018810|469210824|FG001|Overall Study|Withdrawal by Subject|1|||
130338319|NCT01018810|469210825|FG002|Overall Study|Withdrawal by Subject|0|||
130338320|NCT01018810|469210826|FG003|Overall Study|Withdrawal by Subject|0|||
130338321|NCT01018810|469210827|FG004|Overall Study|Withdrawal by Subject|0|||
130338322|NCT01018810|469210823|FG000|Overall Study|Sponsor Decision|2|||
130338323|NCT01018810|469210824|FG001|Overall Study|Sponsor Decision|0|||
130338324|NCT01018810|469210825|FG002|Overall Study|Sponsor Decision|1|||
130338325|NCT01018810|469210826|FG003|Overall Study|Sponsor Decision|1|||
130338326|NCT01018810|469210827|FG004|Overall Study|Sponsor Decision|1|||
130338327|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
130338328|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
130338329|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Adverse Event|7|||
130338330|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Adverse Event|6|||
130338331|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
130338332|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
130338333|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Physician Decision|4|||
130338334|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Physician Decision|4|||
130338335|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
130338336|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
130338337|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
130338338|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
130338339|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
130338340|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
130338341|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Non-compliance|1|||
130338342|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Non-compliance|0|||
130338343|NCT00470834|469210828|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
130338344|NCT00470834|469210829|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
130338345|NCT00470834|469210828|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
130338346|NCT00470834|469210829|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
130338347|NCT00470834|469210828|FG000|Extension Period (24 Months)|Adverse Event|3|||
130338348|NCT00470834|469210829|FG001|Extension Period (24 Months)|Adverse Event|4|||
130338349|NCT00470834|469210828|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
130338350|NCT00470834|469210829|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
130338351|NCT00470834|469210828|FG000|Extension Period (24 Months)|Physician Decision|4|||
130338352|NCT00470834|469210829|FG001|Extension Period (24 Months)|Physician Decision|3|||
130338353|NCT00470834|469210828|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
130338354|NCT00470834|469210829|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
130338355|NCT00470834|469210828|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
130338356|NCT00470834|469210829|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
130338357|NCT00470834|469210828|FG000|Extension Period (24 Months)|Non-compliance|0|||
130338358|NCT00470834|469210829|FG001|Extension Period (24 Months)|Non-compliance|1|||
130338359|NCT00470834|469210828|FG000|Extension Period (24 Months)|Disease Progression|0|||
130338360|NCT00470834|469210829|FG001|Extension Period (24 Months)|Disease Progression|1|||
130338361|NCT00862641|469210832|FG000|Overall Study|Randomized, but drug not received|1|||
130338362|NCT00862641|469210833|FG001|Overall Study|Randomized, but drug not received|4|||
130338363|NCT00862641|469210834|FG002|Overall Study|Randomized, but drug not received|1|||
130338364|NCT00862641|469210835|FG003|Overall Study|Randomized, but drug not received|4|||
130338365|NCT02365480|469210836|FG000|Overall Study|Withdrawal by Subject|2|||
130338366|NCT02365480|469210837|FG001|Overall Study|Withdrawal by Subject|0|||
130338367|NCT04534686|469210838|FG000|Baseline Measurement|Lost to Follow-up|4|||
130338368|NCT04534686|469210839|FG001|Baseline Measurement|Lost to Follow-up|6|||
130338369|NCT04534686|469210838|FG000|Baseline Measurement|Withdrawal by Subject|3|||
130338370|NCT04534686|469210839|FG001|Baseline Measurement|Withdrawal by Subject|1|||
130338371|NCT04534686|469210838|FG000|Intervention|Withdrawal by Subject|2|||
130338372|NCT04534686|469210839|FG001|Intervention|Withdrawal by Subject|2|||
130338373|NCT01781299|469210843|FG000|Overall Study|Withdrawal by Subject|0|||
130338374|NCT01781299|469210844|FG001|Overall Study|Withdrawal by Subject|1|||
130338375|NCT01798849|469210848|FG000|Overall Study|Physician Decision|0|||
130338376|NCT01798849|469210849|FG001|Overall Study|Physician Decision|0|||
130338377|NCT01798849|469210850|FG002|Overall Study|Physician Decision|1|||
130338378|NCT02636361|469210851|FG000|Period 4|Physician Decision|0|||
130338379|NCT02636361|469210852|FG001|Period 4|Physician Decision|0|||
130003089|NCT00436618|467976439|FG001|Overall Study|Withdrawal by Subject|8|||
130003090|NCT00436618|467976440|FG002|Overall Study|Withdrawal by Subject|11|||
130003091|NCT00436618|467976438|FG000|Overall Study|Adverse Event|8|||
130003092|NCT00436618|467976439|FG001|Overall Study|Adverse Event|8|||
130003093|NCT00436618|467976440|FG002|Overall Study|Adverse Event|9|||
130003094|NCT00436618|467976438|FG000|Overall Study|Alternate Treatment|3|||
130338380|NCT02636361|469210853|FG002|Period 4|Physician Decision|0|||
130338381|NCT02636361|469210854|FG003|Period 4|Physician Decision|1|||
130338382|NCT02636361|469210855|FG004|Period 4|Physician Decision|0|||
130338383|NCT02032238|469210856|FG000|Overall Study|Lost to Follow-up|2|||
130338384|NCT02032238|469210857|FG001|Overall Study|Lost to Follow-up|0|||
130003095|NCT00436618|467976439|FG001|Overall Study|Alternate Treatment|4|||
130338385|NCT00246740|469210866|FG000|Initial Enrollment|Death|1|||
130338386|NCT00246740|469210867|FG001|Initial Enrollment|Death|0|||
130338387|NCT00246740|469210866|FG000|Initial Enrollment|Additional surgery scheduled|0|||
130338388|NCT00246740|469210867|FG001|Initial Enrollment|Additional surgery scheduled|2|||
130338389|NCT00246740|469210866|FG000|Initial Enrollment|Surgery schedule change|4|||
130338390|NCT00246740|469210867|FG001|Initial Enrollment|Surgery schedule change|4|||
130003096|NCT00436618|467976440|FG002|Overall Study|Alternate Treatment|12|||
130003097|NCT00436618|467976438|FG000|Overall Study|Other Medical Problems|3|||
130003098|NCT00436618|467976439|FG001|Overall Study|Other Medical Problems|1|||
130003099|NCT00436618|467976440|FG002|Overall Study|Other Medical Problems|7|||
130003100|NCT00436618|467976438|FG000|Overall Study|Death|4|||
130003101|NCT00436618|467976439|FG001|Overall Study|Death|2|||
130003102|NCT00436618|467976440|FG002|Overall Study|Death|3|||
130003103|NCT00436618|467976438|FG000|Overall Study|New Primary or Other Reasons|6|||
130003104|NCT00436618|467976439|FG001|Overall Study|New Primary or Other Reasons|2|||
130003105|NCT00436618|467976440|FG002|Overall Study|New Primary or Other Reasons|12|||
130003106|NCT00436618|467976438|FG000|Overall Study|Still on treatment|1|||
130003107|NCT00436618|467976439|FG001|Overall Study|Still on treatment|2|||
130338391|NCT00246740|469210866|FG000|Initial Enrollment|Other|1|||
130338392|NCT00246740|469210867|FG001|Initial Enrollment|Other|2|||
130003108|NCT00436618|467976440|FG002|Overall Study|Still on treatment|7|||
130003109|NCT00698204|467976441|FG000|Overall Study|Withdrawal by Subject|1|||
130003110|NCT00698204|467976442|FG001|Overall Study|Withdrawal by Subject|0|||
130003111|NCT03083847|467976443|FG000|Main|Physician Decision|0|||
130003112|NCT03083847|467976444|FG001|Main|Physician Decision|0|||
130003113|NCT03083847|467976445|FG002|Main|Physician Decision|0|||
130003114|NCT03083847|467976446|FG003|Main|Physician Decision|0|||
130003115|NCT03083847|467976447|FG004|Main|Physician Decision|0|||
130003116|NCT03083847|467976448|FG005|Main|Physician Decision|1|||
130003117|NCT03083847|467976449|FG006|Main|Physician Decision|0|||
130003118|NCT03083847|467976450|FG007|Main|Physician Decision|0|||
130003119|NCT03083847|467976451|FG008|Main|Physician Decision|0|||
130003120|NCT03083847|467976452|FG009|Main|Physician Decision|0|||
130003121|NCT03083847|467976443|FG000|Main|Pregnancy|0|||
130003122|NCT03083847|467976444|FG001|Main|Pregnancy|0|||
130003123|NCT03083847|467976445|FG002|Main|Pregnancy|0|||
130003124|NCT03083847|467976446|FG003|Main|Pregnancy|0|||
130003125|NCT03083847|467976447|FG004|Main|Pregnancy|0|||
130003126|NCT03083847|467976448|FG005|Main|Pregnancy|0|||
130003127|NCT03083847|467976449|FG006|Main|Pregnancy|0|||
130003128|NCT03083847|467976450|FG007|Main|Pregnancy|1|||
130003129|NCT03083847|467976451|FG008|Main|Pregnancy|0|||
130003130|NCT03083847|467976452|FG009|Main|Pregnancy|0|||
130003131|NCT03083847|467976443|FG000|Main|Adverse Event|0|||
130003132|NCT03083847|467976444|FG001|Main|Adverse Event|0|||
130003133|NCT03083847|467976445|FG002|Main|Adverse Event|0|||
130003134|NCT03083847|467976446|FG003|Main|Adverse Event|0|||
130003135|NCT03083847|467976447|FG004|Main|Adverse Event|0|||
130003136|NCT03083847|467976448|FG005|Main|Adverse Event|0|||
130003137|NCT03083847|467976449|FG006|Main|Adverse Event|0|||
130003138|NCT03083847|467976450|FG007|Main|Adverse Event|2|||
130003139|NCT03083847|467976451|FG008|Main|Adverse Event|0|||
130003140|NCT03083847|467976452|FG009|Main|Adverse Event|0|||
130003141|NCT03083847|467976443|FG000|Main|Withdrawal by Subject|0|||
130003142|NCT03083847|467976444|FG001|Main|Withdrawal by Subject|0|||
130003143|NCT03083847|467976445|FG002|Main|Withdrawal by Subject|0|||
130338393|NCT02969655|469210869|FG000|Overall Study|Withdrawal by Subject|3|||
130338394|NCT02969655|469210870|FG001|Overall Study|Withdrawal by Subject|2|||
130338395|NCT02969655|469210869|FG000|Overall Study|Physician Decision|4|||
130338396|NCT02969655|469210870|FG001|Overall Study|Physician Decision|3|||
130338397|NCT02969655|469210869|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
130338398|NCT02969655|469210870|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
130003144|NCT03083847|467976446|FG003|Main|Withdrawal by Subject|0|||
130003145|NCT03083847|467976447|FG004|Main|Withdrawal by Subject|0|||
130003146|NCT03083847|467976448|FG005|Main|Withdrawal by Subject|0|||
130003147|NCT03083847|467976449|FG006|Main|Withdrawal by Subject|1|||
130003148|NCT03083847|467976450|FG007|Main|Withdrawal by Subject|1|||
130003149|NCT03083847|467976451|FG008|Main|Withdrawal by Subject|0|||
130338399|NCT02969655|469210869|FG000|Overall Study|Adverse Event|10|||
130003150|NCT03083847|467976452|FG009|Main|Withdrawal by Subject|0|||
130003151|NCT01949155|467976454|FG000|Overall Study|Lost to Follow-up|1|||
130003152|NCT01949155|467976455|FG001|Overall Study|Lost to Follow-up|0|||
130003153|NCT01949155|467976454|FG000|Overall Study|Protocol Violation|1|||
130003154|NCT01949155|467976455|FG001|Overall Study|Protocol Violation|0|||
130003155|NCT00314249|467976456|FG000|Overall Study|Adverse Event|73|||
130003156|NCT00314249|467976457|FG001|Overall Study|Adverse Event|94|||
130003157|NCT00314249|467976456|FG000|Overall Study|Lack of Efficacy|33|||
130003158|NCT00314249|467976457|FG001|Overall Study|Lack of Efficacy|24|||
130003159|NCT00314249|467976456|FG000|Overall Study|Withdrawal by Subject|21|||
130003160|NCT00314249|467976457|FG001|Overall Study|Withdrawal by Subject|28|||
130003161|NCT00314249|467976456|FG000|Overall Study|Lost to Follow-up|15|||
129884379|NCT00708305|467536386|FG003|Period 1|Other Reason|2|||
130003162|NCT00314249|467976457|FG001|Overall Study|Lost to Follow-up|9|||
130003163|NCT00314249|467976456|FG000|Overall Study|Physician Decision|1|||
130003164|NCT00314249|467976457|FG001|Overall Study|Physician Decision|1|||
130003165|NCT00314249|467976456|FG000|Overall Study|Withdrawn for other reasons|4|||
130003166|NCT00314249|467976457|FG001|Overall Study|Withdrawn for other reasons|1|||
130003167|NCT00314249|467976456|FG000|Overall Study|Non-Compliant|5|||
130003168|NCT00314249|467976457|FG001|Overall Study|Non-Compliant|6|||
130338400|NCT02969655|469210870|FG001|Overall Study|Adverse Event|8|||
130338401|NCT01510769|469210871|FG000|Overall Study|Adverse Event|7|||
130338402|NCT01510769|469210872|FG001|Overall Study|Adverse Event|6|||
130338403|NCT01510769|469210873|FG002|Overall Study|Adverse Event|4|||
130338404|NCT01510769|469210871|FG000|Overall Study|Gout Flare|0|||
130338405|NCT01510769|469210872|FG001|Overall Study|Gout Flare|3|||
130338406|NCT01510769|469210873|FG002|Overall Study|Gout Flare|1|||
130338407|NCT01510769|469210871|FG000|Overall Study|Protocol Violation|11|||
130338408|NCT01510769|469210872|FG001|Overall Study|Protocol Violation|10|||
130338409|NCT01510769|469210873|FG002|Overall Study|Protocol Violation|9|||
130338410|NCT01510769|469210871|FG000|Overall Study|Lost to Follow-up|5|||
130338411|NCT01510769|469210872|FG001|Overall Study|Lost to Follow-up|1|||
130338412|NCT01510769|469210873|FG002|Overall Study|Lost to Follow-up|5|||
130338413|NCT01510769|469210871|FG000|Overall Study|Withdrawal by Subject|3|||
130338414|NCT01510769|469210872|FG001|Overall Study|Withdrawal by Subject|4|||
130338415|NCT01510769|469210873|FG002|Overall Study|Withdrawal by Subject|3|||
130338416|NCT01510769|469210871|FG000|Overall Study|Death|1|||
130338417|NCT01510769|469210872|FG001|Overall Study|Death|1|||
130338418|NCT01510769|469210873|FG002|Overall Study|Death|0|||
130338419|NCT00335764|469210876|FG000|Overall Study|wrong histology|1|||
130338420|NCT00335764|469210877|FG001|Overall Study|wrong histology|0|||
130338421|NCT00335764|469210878|FG002|Overall Study|wrong histology|0|||
130338422|NCT00335764|469210879|FG003|Overall Study|wrong histology|0|||
130338423|NCT00335764|469210880|FG004|Overall Study|wrong histology|1|||
130338424|NCT02466659|469210881|FG000|Overall Study|Lost to Follow-up|5|||
130338425|NCT02466659|469210882|FG001|Overall Study|Lost to Follow-up|2|||
130338426|NCT01536392|469210885|FG000|Overall Study|Adverse Event|2|||
130338427|NCT01536392|469210886|FG001|Overall Study|Adverse Event|2|||
130338428|NCT01536392|469210885|FG000|Overall Study|Physician Decision|2|||
130338429|NCT01536392|469210886|FG001|Overall Study|Physician Decision|3|||
130338430|NCT01536392|469210885|FG000|Overall Study|Withdrawal by Subject|3|||
130338431|NCT01536392|469210886|FG001|Overall Study|Withdrawal by Subject|6|||
130338432|NCT01536392|469210885|FG000|Overall Study|Non Compliance|3|||
130338433|NCT01536392|469210886|FG001|Overall Study|Non Compliance|4|||
130338434|NCT01536392|469210885|FG000|Overall Study|Completed therapy early|3|||
130338435|NCT01536392|469210886|FG001|Overall Study|Completed therapy early|0|||
130338436|NCT00934440|469210887|FG000|Overall Study|Lost to Follow-up|1|||
130338437|NCT03060551|469210888|FG000|Overall Study|Withdrawal by Subject|1|||
130338438|NCT03060551|469210888|FG000|Overall Study|Adverse Event|1|||
130338439|NCT04614324|469210893|FG000|Overall Study|Lost to Follow-up|3|||
130338440|NCT04614324|469210893|FG000|Overall Study|Physician Decision|1|||
130338441|NCT04614324|469210893|FG000|Overall Study|Withdrawal by Subject|2|||
130338442|NCT04614324|469210893|FG000|Overall Study|Remaining in Follow up|123|||
130338443|NCT05289037|469210894|FG000|Overall Study|Withdrawal by Subject|7|||
130338444|NCT05289037|469210895|FG001|Overall Study|Withdrawal by Subject|0|||
130338445|NCT05289037|469210896|FG002|Overall Study|Withdrawal by Subject|3|||
130338446|NCT05289037|469210897|FG003|Overall Study|Withdrawal by Subject|3|||
130338447|NCT05289037|469210898|FG004|Overall Study|Withdrawal by Subject|1|||
130338448|NCT05289037|469210899|FG005|Overall Study|Withdrawal by Subject|5|||
130338449|NCT05289037|469210900|FG006|Overall Study|Withdrawal by Subject|2|||
130338450|NCT05289037|469210901|FG007|Overall Study|Withdrawal by Subject|1|||
130338451|NCT05289037|469210902|FG008|Overall Study|Withdrawal by Subject|2|||
130338452|NCT05289037|469210903|FG009|Overall Study|Withdrawal by Subject|2|||
130338453|NCT05289037|469210904|FG010|Overall Study|Withdrawal by Subject|1|||
130338454|NCT05289037|469210905|FG011|Overall Study|Withdrawal by Subject|0|||
130338455|NCT05289037|469210906|FG012|Overall Study|Withdrawal by Subject|1|||
130338456|NCT05289037|469210907|FG013|Overall Study|Withdrawal by Subject|2|||
130338457|NCT05289037|469210908|FG014|Overall Study|Withdrawal by Subject|0|||
130338458|NCT05289037|469210909|FG015|Overall Study|Withdrawal by Subject|3|||
130338459|NCT05289037|469210910|FG016|Overall Study|Withdrawal by Subject|3|||
130338460|NCT05289037|469210894|FG000|Overall Study|Lost to Follow-up|1|||
130338461|NCT05289037|469210895|FG001|Overall Study|Lost to Follow-up|4|||
130338462|NCT05289037|469210896|FG002|Overall Study|Lost to Follow-up|3|||
130338463|NCT05289037|469210897|FG003|Overall Study|Lost to Follow-up|3|||
130338464|NCT05289037|469210898|FG004|Overall Study|Lost to Follow-up|3|||
130338465|NCT05289037|469210899|FG005|Overall Study|Lost to Follow-up|2|||
130338466|NCT05289037|469210900|FG006|Overall Study|Lost to Follow-up|3|||
130338467|NCT05289037|469210901|FG007|Overall Study|Lost to Follow-up|2|||
130338468|NCT05289037|469210902|FG008|Overall Study|Lost to Follow-up|2|||
130338469|NCT05289037|469210903|FG009|Overall Study|Lost to Follow-up|1|||
130338470|NCT05289037|469210904|FG010|Overall Study|Lost to Follow-up|3|||
130338471|NCT05289037|469210905|FG011|Overall Study|Lost to Follow-up|4|||
130338472|NCT05289037|469210906|FG012|Overall Study|Lost to Follow-up|2|||
130338473|NCT05289037|469210907|FG013|Overall Study|Lost to Follow-up|7|||
130338474|NCT05289037|469210908|FG014|Overall Study|Lost to Follow-up|4|||
130338475|NCT05289037|469210909|FG015|Overall Study|Lost to Follow-up|6|||
130338476|NCT05289037|469210910|FG016|Overall Study|Lost to Follow-up|4|||
130338477|NCT05289037|469210894|FG000|Overall Study|Death|0|||
130338478|NCT05289037|469210895|FG001|Overall Study|Death|0|||
130338479|NCT05289037|469210896|FG002|Overall Study|Death|0|||
130338480|NCT05289037|469210897|FG003|Overall Study|Death|0|||
130338481|NCT05289037|469210898|FG004|Overall Study|Death|0|||
130338482|NCT05289037|469210899|FG005|Overall Study|Death|1|||
130338483|NCT05289037|469210900|FG006|Overall Study|Death|0|||
130338484|NCT05289037|469210901|FG007|Overall Study|Death|0|||
130338485|NCT05289037|469210902|FG008|Overall Study|Death|0|||
130003169|NCT00210184|467976458|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
130003170|NCT01118325|467976461|FG000|Overall Study|Adverse Event|1|||
130003171|NCT01118325|467976462|FG001|Overall Study|Adverse Event|0|||
130003172|NCT01118325|467976463|FG002|Overall Study|Adverse Event|1|||
130003173|NCT00975715|467976464|FG000|Titration Period|Adverse Event|6|||
130003174|NCT00975715|467976465|FG001|Titration Period|Adverse Event|0|||
130003175|NCT00975715|467976464|FG000|Titration Period|Protocol Violation|1|||
130003176|NCT00975715|467976465|FG001|Titration Period|Protocol Violation|0|||
130003177|NCT00975715|467976464|FG000|Maintenance Period|Adverse Event|2|||
130003178|NCT00975715|467976465|FG001|Maintenance Period|Adverse Event|1|||
130003179|NCT01674712|467976472|FG000|Overall Study|Adverse Event|5|||
130003180|NCT01674712|467976473|FG001|Overall Study|Adverse Event|6|||
130003181|NCT01674712|467976474|FG002|Overall Study|Adverse Event|3|||
130003182|NCT01674712|467976475|FG003|Overall Study|Adverse Event|4|||
130003183|NCT01674712|467976476|FG004|Overall Study|Adverse Event|6|||
130003184|NCT01674712|467976472|FG000|Overall Study|Lost to Follow-up|1|||
130003185|NCT01674712|467976473|FG001|Overall Study|Lost to Follow-up|0|||
130003186|NCT01674712|467976474|FG002|Overall Study|Lost to Follow-up|0|||
130003187|NCT01674712|467976475|FG003|Overall Study|Lost to Follow-up|0|||
130003188|NCT01674712|467976476|FG004|Overall Study|Lost to Follow-up|0|||
130003189|NCT01674712|467976472|FG000|Overall Study|Protocol Violation|2|||
130003190|NCT01674712|467976473|FG001|Overall Study|Protocol Violation|0|||
130003191|NCT01674712|467976474|FG002|Overall Study|Protocol Violation|0|||
130003192|NCT01674712|467976475|FG003|Overall Study|Protocol Violation|0|||
130003193|NCT01674712|467976476|FG004|Overall Study|Protocol Violation|0|||
130003194|NCT01674712|467976472|FG000|Overall Study|Withdrawal by Subject|2|||
130003195|NCT01674712|467976473|FG001|Overall Study|Withdrawal by Subject|2|||
130003196|NCT01674712|467976474|FG002|Overall Study|Withdrawal by Subject|5|||
130003197|NCT01674712|467976475|FG003|Overall Study|Withdrawal by Subject|4|||
130003198|NCT01674712|467976476|FG004|Overall Study|Withdrawal by Subject|3|||
130003199|NCT01674712|467976472|FG000|Overall Study|Administrative|0|||
130003200|NCT01674712|467976473|FG001|Overall Study|Administrative|1|||
130003201|NCT01674712|467976474|FG002|Overall Study|Administrative|0|||
130003202|NCT01674712|467976475|FG003|Overall Study|Administrative|0|||
130003203|NCT01674712|467976476|FG004|Overall Study|Administrative|1|||
130003204|NCT01674712|467976472|FG000|Overall Study|Lack of Efficacy|0|||
130338486|NCT05289037|469210903|FG009|Overall Study|Death|0|||
130003205|NCT01674712|467976473|FG001|Overall Study|Lack of Efficacy|0|||
130003206|NCT01674712|467976474|FG002|Overall Study|Lack of Efficacy|1|||
130003207|NCT01674712|467976475|FG003|Overall Study|Lack of Efficacy|0|||
130003208|NCT01674712|467976476|FG004|Overall Study|Lack of Efficacy|1|||
130003209|NCT00874770|467976477|FG000|Overall Study|Lack of Efficacy|2|||
130003210|NCT00874770|467976478|FG001|Overall Study|Lack of Efficacy|0|||
130003211|NCT00874770|467976479|FG002|Overall Study|Lack of Efficacy|0|||
130003212|NCT00874770|467976480|FG003|Overall Study|Lack of Efficacy|2|||
130003213|NCT00874770|467976477|FG000|Overall Study|Adverse Event|1|||
130003214|NCT00874770|467976478|FG001|Overall Study|Adverse Event|1|||
130003215|NCT00874770|467976479|FG002|Overall Study|Adverse Event|4|||
130003216|NCT00874770|467976480|FG003|Overall Study|Adverse Event|2|||
130003217|NCT00874770|467976477|FG000|Overall Study|Lost to Follow-up|1|||
130003218|NCT00874770|467976478|FG001|Overall Study|Lost to Follow-up|0|||
130003219|NCT00874770|467976479|FG002|Overall Study|Lost to Follow-up|0|||
130003220|NCT00874770|467976480|FG003|Overall Study|Lost to Follow-up|1|||
130338487|NCT05289037|469210904|FG010|Overall Study|Death|0|||
130003221|NCT00874770|467976477|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
130003222|NCT00874770|467976478|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
130003223|NCT00874770|467976479|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
130003224|NCT00874770|467976480|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
130003225|NCT05395104|467976481|FG000|Overall Study|Met Liver Stopping Criteria|1|||
130003226|NCT05395104|467976481|FG000|Overall Study|Withdrawal by Subject|1|||
130003227|NCT03974334|467976482|FG000|Overall Study|Lost to Follow-up|1|||
130003228|NCT00024167|467976483|FG000|Overall Study|Death|53|||
130003229|NCT00024167|467976484|FG001|Overall Study|Death|47|||
130003230|NCT01379573|467976501|FG000|Overall Study|Lost to Follow-up|1|||
130003231|NCT01379573|467976501|FG000|Overall Study|Screen Failure|10|||
130003232|NCT00962390|467976502|FG000|Overall Study|Adverse Event|0|||
130003233|NCT00962390|467976503|FG001|Overall Study|Adverse Event|0|||
130338488|NCT05289037|469210905|FG011|Overall Study|Death|0|||
130003234|NCT00962390|467976504|FG002|Overall Study|Adverse Event|3|||
130003235|NCT00962390|467976505|FG003|Overall Study|Adverse Event|1|||
130003236|NCT00962390|467976502|FG000|Overall Study|Lost to Follow-up|2|||
130003237|NCT00962390|467976503|FG001|Overall Study|Lost to Follow-up|2|||
130338489|NCT05289037|469210906|FG012|Overall Study|Death|0|||
130338490|NCT05289037|469210907|FG013|Overall Study|Death|0|||
130003238|NCT00962390|467976504|FG002|Overall Study|Lost to Follow-up|0|||
130003239|NCT00962390|467976505|FG003|Overall Study|Lost to Follow-up|0|||
130003240|NCT00962390|467976502|FG000|Overall Study|Protocol Violation|1|||
130003241|NCT00962390|467976503|FG001|Overall Study|Protocol Violation|0|||
130003242|NCT00962390|467976504|FG002|Overall Study|Protocol Violation|0|||
130003243|NCT00962390|467976505|FG003|Overall Study|Protocol Violation|0|||
130003244|NCT00962390|467976502|FG000|Overall Study|Withdrawal by Subject|1|||
130338491|NCT05289037|469210908|FG014|Overall Study|Death|1|||
130338492|NCT05289037|469210909|FG015|Overall Study|Death|0|||
130338493|NCT05289037|469210910|FG016|Overall Study|Death|0|||
130338494|NCT05289037|469210894|FG000|Overall Study|Did not receive vaccine|0|||
130338495|NCT05289037|469210895|FG001|Overall Study|Did not receive vaccine|3|||
130338496|NCT05289037|469210896|FG002|Overall Study|Did not receive vaccine|0|||
130338497|NCT05289037|469210897|FG003|Overall Study|Did not receive vaccine|0|||
130338498|NCT05289037|469210898|FG004|Overall Study|Did not receive vaccine|1|||
130338499|NCT05289037|469210899|FG005|Overall Study|Did not receive vaccine|1|||
130338500|NCT05289037|469210900|FG006|Overall Study|Did not receive vaccine|1|||
130338501|NCT05289037|469210901|FG007|Overall Study|Did not receive vaccine|0|||
130338502|NCT05289037|469210902|FG008|Overall Study|Did not receive vaccine|0|||
130338503|NCT05289037|469210903|FG009|Overall Study|Did not receive vaccine|0|||
130338504|NCT05289037|469210904|FG010|Overall Study|Did not receive vaccine|0|||
130338505|NCT05289037|469210905|FG011|Overall Study|Did not receive vaccine|0|||
130338506|NCT05289037|469210906|FG012|Overall Study|Did not receive vaccine|0|||
130338507|NCT05289037|469210907|FG013|Overall Study|Did not receive vaccine|0|||
130338508|NCT05289037|469210908|FG014|Overall Study|Did not receive vaccine|1|||
130338509|NCT05289037|469210909|FG015|Overall Study|Did not receive vaccine|0|||
130338510|NCT05289037|469210910|FG016|Overall Study|Did not receive vaccine|0|||
130338511|NCT05289037|469210894|FG000|Overall Study|Unable to make last visit|0|||
130338512|NCT05289037|469210895|FG001|Overall Study|Unable to make last visit|0|||
130338513|NCT05289037|469210896|FG002|Overall Study|Unable to make last visit|1|||
130338514|NCT05289037|469210897|FG003|Overall Study|Unable to make last visit|0|||
130338515|NCT05289037|469210898|FG004|Overall Study|Unable to make last visit|0|||
130338516|NCT05289037|469210899|FG005|Overall Study|Unable to make last visit|0|||
130338517|NCT05289037|469210900|FG006|Overall Study|Unable to make last visit|0|||
130338518|NCT05289037|469210901|FG007|Overall Study|Unable to make last visit|0|||
130338519|NCT05289037|469210902|FG008|Overall Study|Unable to make last visit|0|||
130338520|NCT05289037|469210903|FG009|Overall Study|Unable to make last visit|0|||
130338521|NCT05289037|469210904|FG010|Overall Study|Unable to make last visit|0|||
130338522|NCT05289037|469210905|FG011|Overall Study|Unable to make last visit|0|||
130338523|NCT05289037|469210906|FG012|Overall Study|Unable to make last visit|0|||
130338524|NCT05289037|469210907|FG013|Overall Study|Unable to make last visit|0|||
130338525|NCT05289037|469210908|FG014|Overall Study|Unable to make last visit|0|||
130338526|NCT05289037|469210909|FG015|Overall Study|Unable to make last visit|0|||
130338527|NCT05289037|469210910|FG016|Overall Study|Unable to make last visit|0|||
130338528|NCT05289037|469210894|FG000|Overall Study|Protocol deviation|0|||
130338529|NCT05289037|469210895|FG001|Overall Study|Protocol deviation|0|||
130338530|NCT05289037|469210896|FG002|Overall Study|Protocol deviation|0|||
130338531|NCT05289037|469210897|FG003|Overall Study|Protocol deviation|0|||
130338532|NCT05289037|469210898|FG004|Overall Study|Protocol deviation|0|||
130338533|NCT05289037|469210899|FG005|Overall Study|Protocol deviation|0|||
130338534|NCT05289037|469210900|FG006|Overall Study|Protocol deviation|0|||
130338535|NCT05289037|469210901|FG007|Overall Study|Protocol deviation|0|||
130338536|NCT05289037|469210902|FG008|Overall Study|Protocol deviation|0|||
130338537|NCT05289037|469210903|FG009|Overall Study|Protocol deviation|0|||
130338538|NCT05289037|469210904|FG010|Overall Study|Protocol deviation|0|||
130338539|NCT05289037|469210905|FG011|Overall Study|Protocol deviation|0|||
130338540|NCT05289037|469210906|FG012|Overall Study|Protocol deviation|0|||
130003245|NCT00962390|467976503|FG001|Overall Study|Withdrawal by Subject|1|||
130098741|NCT03426995|468319306|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130338541|NCT05289037|469210907|FG013|Overall Study|Protocol deviation|0|||
130338542|NCT05289037|469210908|FG014|Overall Study|Protocol deviation|0|||
130338543|NCT05289037|469210909|FG015|Overall Study|Protocol deviation|1|||
130338544|NCT05289037|469210910|FG016|Overall Study|Protocol deviation|0|||
130338545|NCT05141448|469210911|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338546|NCT05141448|469210912|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
130338547|NCT05141448|469210913|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338548|NCT05141448|469210914|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338549|NCT05141448|469210915|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338550|NCT05141448|469210916|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130338551|NCT05141448|469210911|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338552|NCT05141448|469210912|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338553|NCT05141448|469210913|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338554|NCT05141448|469210914|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130003246|NCT00962390|467976504|FG002|Overall Study|Withdrawal by Subject|1|||
129884380|NCT00708305|467536383|FG000|Period 2|Lost to Follow-up|0|||
130338555|NCT05141448|469210915|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130338556|NCT05141448|469210916|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130338557|NCT05141448|469210911|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338558|NCT05141448|469210912|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130338559|NCT05141448|469210913|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338560|NCT05141448|469210914|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338561|NCT05141448|469210915|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338562|NCT05141448|469210916|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130338563|NCT05141448|469210911|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338564|NCT05141448|469210912|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338565|NCT05141448|469210913|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338566|NCT05141448|469210914|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338567|NCT05141448|469210915|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
130338568|NCT05141448|469210916|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
130338569|NCT05141448|469210911|FG000|Period 2|COVID-19 Related|0|||
130338570|NCT05141448|469210912|FG001|Period 2|COVID-19 Related|0|||
130338571|NCT05141448|469210913|FG002|Period 2|COVID-19 Related|0|||
130338572|NCT05141448|469210914|FG003|Period 2|COVID-19 Related|1|||
130338573|NCT05141448|469210915|FG004|Period 2|COVID-19 Related|0|||
130338574|NCT05141448|469210916|FG005|Period 2|COVID-19 Related|1|||
130338575|NCT05141448|469210911|FG000|3|Covid-19 related|2|||
130338576|NCT05141448|469210912|FG001|3|Covid-19 related|0|||
130338577|NCT05141448|469210913|FG002|3|Covid-19 related|0|||
130338578|NCT05141448|469210914|FG003|3|Covid-19 related|0|||
130338579|NCT05141448|469210915|FG004|3|Covid-19 related|0|||
130338580|NCT05141448|469210916|FG005|3|Covid-19 related|1|||
130338581|NCT05141448|469210911|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
130338582|NCT05141448|469210912|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
130338583|NCT05141448|469210913|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
130338584|NCT05141448|469210914|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
130338585|NCT05141448|469210915|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
130338586|NCT05141448|469210916|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
130338587|NCT04627285|469210917|FG000|Overall Study|Adverse Event|0|||
130338588|NCT04627285|469210918|FG001|Overall Study|Adverse Event|2|||
130338589|NCT04627285|469210917|FG000|Overall Study|Lost to Follow-up|1|||
130338590|NCT04627285|469210918|FG001|Overall Study|Lost to Follow-up|0|||
130338591|NCT04627285|469210917|FG000|Overall Study|Withdrawal by Subject|1|||
130338592|NCT04627285|469210918|FG001|Overall Study|Withdrawal by Subject|1|||
130338593|NCT04627285|469210917|FG000|Overall Study|Sponsor decision|5|||
130338594|NCT04627285|469210918|FG001|Overall Study|Sponsor decision|0|||
130338595|NCT04627285|469210917|FG000|Overall Study|Participant left country; aunt informed the site|0|||
130338596|NCT04627285|469210918|FG001|Overall Study|Participant left country; aunt informed the site|1|||
130338597|NCT02051933|469213097|FG000|Overall Study|Physician Decision|0|||
130338598|NCT02051933|469213098|FG001|Overall Study|Physician Decision|1|||
130338599|NCT01221285|469213099|FG000|Overall Study|Withdrawal by Subject|1|||
130338600|NCT02123251|469213100|FG000|Overall Study|Death|1|||
130338601|NCT02123251|469213101|FG001|Overall Study|Death|1|||
130338602|NCT02123251|469213100|FG000|Overall Study|Withdrawal by Subject|0|||
130338603|NCT02123251|469213101|FG001|Overall Study|Withdrawal by Subject|3|||
130338604|NCT02123251|469213100|FG000|Overall Study|Lost Medicaid eligibility|29|||
130338605|NCT02123251|469213101|FG001|Overall Study|Lost Medicaid eligibility|22|||
130338606|NCT02123251|469213100|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
130338607|NCT02123251|469213101|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
130338608|NCT01904773|469213102|FG000|Screen|Screen failure|3|||
130338609|NCT01904773|469213103|FG001|Screen|Screen failure|0|||
130338610|NCT01904773|469213104|FG002|Screen|Screen failure|0|||
130338611|NCT01904773|469213105|FG003|Screen|Screen failure|0|||
130338612|NCT01904773|469213106|FG004|Screen|Screen failure|0|||
130338613|NCT01904773|469213107|FG005|Screen|Screen failure|0|||
130338614|NCT01904773|469213108|FG006|Screen|Screen failure|0|||
130338615|NCT01904773|469213109|FG007|Screen|Screen failure|0|||
130338616|NCT01904773|469213110|FG008|Screen|Screen failure|0|||
130338617|NCT01904773|469213102|FG000|Screen|Withdrawal by Subject|1|||
130338618|NCT01904773|469213103|FG001|Screen|Withdrawal by Subject|0|||
130338619|NCT01904773|469213104|FG002|Screen|Withdrawal by Subject|0|||
130338620|NCT01904773|469213105|FG003|Screen|Withdrawal by Subject|0|||
130338621|NCT01904773|469213106|FG004|Screen|Withdrawal by Subject|0|||
130338622|NCT01904773|469213107|FG005|Screen|Withdrawal by Subject|0|||
130338623|NCT01904773|469213108|FG006|Screen|Withdrawal by Subject|0|||
130338624|NCT01904773|469213109|FG007|Screen|Withdrawal by Subject|0|||
130338625|NCT01904773|469213110|FG008|Screen|Withdrawal by Subject|0|||
130338626|NCT01904773|469213102|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
130338627|NCT01904773|469213103|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338628|NCT01904773|469213104|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130003247|NCT00962390|467976505|FG003|Overall Study|Withdrawal by Subject|0|||
130003248|NCT02613884|467976506|FG000|Overall Study|Death|1|||
130003249|NCT02613884|467976506|FG000|Overall Study|Lost to Follow-up|1|||
130003250|NCT00770770|467976507|FG000|Overall Study|Lost to Follow-up|1|||
130003251|NCT00770770|467976508|FG001|Overall Study|Lost to Follow-up|0|||
130003252|NCT00770770|467976507|FG000|Overall Study|Withdrawal by Subject|1|||
130003253|NCT00770770|467976508|FG001|Overall Study|Withdrawal by Subject|0|||
130003254|NCT00770770|467976507|FG000|Overall Study|Death|0|||
130003255|NCT00770770|467976508|FG001|Overall Study|Death|1|||
130003256|NCT00770770|467976507|FG000|Overall Study|Study Terminated|8|||
130003257|NCT00770770|467976508|FG001|Overall Study|Study Terminated|0|||
130003258|NCT00685685|467976519|FG000|Washout Period of 7 Days|Adverse Event|2|||
130003259|NCT00685685|467976520|FG001|Washout Period of 7 Days|Adverse Event|0|||
130003260|NCT00685685|467976519|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130003261|NCT00685685|467976520|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130003262|NCT04513665|467976521|FG000|Overall Study|Adverse Event|2|||
130003263|NCT04513665|467976522|FG001|Overall Study|Adverse Event|0|||
130003264|NCT04513665|467976521|FG000|Overall Study|Lack of Efficacy|14|||
130003265|NCT04513665|467976522|FG001|Overall Study|Lack of Efficacy|0|||
130003266|NCT02608879|467976524|FG000|Overall Study|Lost to Follow-up|1|||
130003267|NCT02608879|467976525|FG001|Overall Study|Lost to Follow-up|0|||
130003268|NCT02608879|467976526|FG002|Overall Study|Lost to Follow-up|0|||
130003269|NCT02608879|467976524|FG000|Overall Study|Did not meet continuation criteria|0|||
130003270|NCT02608879|467976525|FG001|Overall Study|Did not meet continuation criteria|0|||
130003271|NCT02608879|467976526|FG002|Overall Study|Did not meet continuation criteria|3|||
130003272|NCT03007979|467976527|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
130003273|NCT04223791|467976528|FG000|Overall Study|Lost to Follow-up|0|||
130003274|NCT04223791|467976529|FG001|Overall Study|Lost to Follow-up|4|||
130003275|NCT04223791|467976528|FG000|Overall Study|Physician Decision|5|||
130003276|NCT04223791|467976529|FG001|Overall Study|Physician Decision|1|||
130003277|NCT04223791|467976528|FG000|Overall Study|Protocol Violation|1|||
130003278|NCT04223791|467976529|FG001|Overall Study|Protocol Violation|1|||
130003279|NCT04223791|467976528|FG000|Overall Study|Withdrawal by Subject|10|||
130003280|NCT04223791|467976529|FG001|Overall Study|Withdrawal by Subject|12|||
130003281|NCT04223791|467976528|FG000|Overall Study|Pregnancy|1|||
130003282|NCT04223791|467976529|FG001|Overall Study|Pregnancy|1|||
130003283|NCT04223791|467976528|FG000|Overall Study|Ongoing in Study|305|||
130003284|NCT04223791|467976529|FG001|Overall Study|Ongoing in Study|302|||
130003285|NCT00088907|467977887|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
130003286|NCT00088907|467977888|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
130003287|NCT00088907|467977887|FG000|Randomized Study (Step 1)|Adverse Event|14|||
130003288|NCT00088907|467977888|FG001|Randomized Study (Step 1)|Adverse Event|19|||
130003289|NCT00088907|467977887|FG000|Randomized Study (Step 1)|Death|11|||
130003290|NCT00088907|467977888|FG001|Randomized Study (Step 1)|Death|12|||
130003291|NCT00088907|467977887|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
130003292|NCT00088907|467977888|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
130003293|NCT00088907|467977887|FG000|Randomized Study (Step 1)|complicating disease|3|||
130003294|NCT00088907|467977888|FG001|Randomized Study (Step 1)|complicating disease|1|||
130003295|NCT00088907|467977887|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
130003296|NCT00088907|467977888|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
130003297|NCT00088907|467977887|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
130003298|NCT00088907|467977888|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
130003299|NCT00088907|467977887|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
130003300|NCT00088907|467977888|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
130003301|NCT00088907|467977887|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
130003302|NCT00088907|467977888|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
130003303|NCT00088907|467977887|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
130003304|NCT00088907|467977888|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
130003305|NCT00088907|467977887|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
130003306|NCT00088907|467977888|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
130003307|NCT03426787|467977893|FG000|Overall Study|Withdrawal by Subject|6|||
130003308|NCT03426787|467977893|FG000|Overall Study|Lost to Follow-up|7|||
130003309|NCT03426787|467977893|FG000|Overall Study|Unrelated to intervention death|1|||
130003310|NCT00395863|467977894|FG000|Overall Study|Patients did not complete both exams|2|||
130003311|NCT00395863|467977895|FG001|Overall Study|Patients did not complete both exams|3|||
130003312|NCT02592551|467977898|FG000|Overall Study|Not evaluable|1|||
130003313|NCT02592551|467977899|FG001|Overall Study|Not evaluable|3|||
130003314|NCT02592551|467977900|FG002|Overall Study|Not evaluable|0|||
130003315|NCT01876251|467977901|FG000|Overall Study|Clinical progression|1|||
130003316|NCT01876251|467977902|FG001|Overall Study|Clinical progression|0|||
129884381|NCT00708305|467536384|FG001|Period 2|Lost to Follow-up|1|||
130003317|NCT01876251|467977903|FG002|Overall Study|Clinical progression|0|||
130003318|NCT01876251|467977901|FG000|Overall Study|Death|2|||
130003319|NCT01876251|467977902|FG001|Overall Study|Death|0|||
130003320|NCT01876251|467977903|FG002|Overall Study|Death|1|||
130338629|NCT01904773|469213105|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338630|NCT01904773|469213106|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338631|NCT01904773|469213107|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338632|NCT01904773|469213108|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338633|NCT01904773|469213109|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338634|NCT01904773|469213110|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
130338635|NCT01904773|469213102|FG000|First Intervention|Adverse Event|0|||
130338636|NCT01904773|469213103|FG001|First Intervention|Adverse Event|0|||
130338637|NCT01904773|469213104|FG002|First Intervention|Adverse Event|0|||
130338638|NCT01904773|469213105|FG003|First Intervention|Adverse Event|0|||
130338639|NCT01904773|469213106|FG004|First Intervention|Adverse Event|0|||
130338640|NCT01904773|469213107|FG005|First Intervention|Adverse Event|0|||
130338641|NCT01904773|469213108|FG006|First Intervention|Adverse Event|1|||
130338642|NCT01904773|469213109|FG007|First Intervention|Adverse Event|0|||
130338643|NCT01904773|469213110|FG008|First Intervention|Adverse Event|0|||
130338644|NCT01904773|469213102|FG000|Placebo Washout First Intervention|Condition worsened|0|||
130338645|NCT01904773|469213103|FG001|Placebo Washout First Intervention|Condition worsened|1|||
130338646|NCT01904773|469213104|FG002|Placebo Washout First Intervention|Condition worsened|0|||
130338647|NCT01904773|469213105|FG003|Placebo Washout First Intervention|Condition worsened|0|||
130338648|NCT01904773|469213106|FG004|Placebo Washout First Intervention|Condition worsened|0|||
130338649|NCT01904773|469213107|FG005|Placebo Washout First Intervention|Condition worsened|0|||
130338650|NCT01904773|469213108|FG006|Placebo Washout First Intervention|Condition worsened|0|||
130338651|NCT01904773|469213109|FG007|Placebo Washout First Intervention|Condition worsened|0|||
130338652|NCT01904773|469213110|FG008|Placebo Washout First Intervention|Condition worsened|0|||
130338653|NCT01904773|469213102|FG000|Fifth Intervention|Adverse Event|0|||
130338654|NCT01904773|469213103|FG001|Fifth Intervention|Adverse Event|0|||
130338655|NCT01904773|469213104|FG002|Fifth Intervention|Adverse Event|0|||
130338656|NCT01904773|469213105|FG003|Fifth Intervention|Adverse Event|0|||
130338657|NCT01904773|469213106|FG004|Fifth Intervention|Adverse Event|0|||
130338658|NCT01904773|469213107|FG005|Fifth Intervention|Adverse Event|0|||
130338659|NCT01904773|469213108|FG006|Fifth Intervention|Adverse Event|0|||
130338660|NCT01904773|469213109|FG007|Fifth Intervention|Adverse Event|1|||
130338661|NCT01904773|469213110|FG008|Fifth Intervention|Adverse Event|0|||
130338662|NCT01904773|469213102|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338663|NCT01904773|469213103|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
130338664|NCT01904773|469213104|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338665|NCT01904773|469213105|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338666|NCT01904773|469213106|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338667|NCT01904773|469213107|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338668|NCT01904773|469213108|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338669|NCT01904773|469213109|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338670|NCT01904773|469213110|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
130338671|NCT00220779|469213114|FG000|Overall Study|Adverse Event|1|||
130338672|NCT00220779|469213115|FG001|Overall Study|Adverse Event|0|||
130338673|NCT00220779|469213116|FG002|Overall Study|Adverse Event|0|||
130338674|NCT00220779|469213114|FG000|Overall Study|Withdrawal by Subject|1|||
130338675|NCT00220779|469213115|FG001|Overall Study|Withdrawal by Subject|4|||
130338676|NCT00220779|469213116|FG002|Overall Study|Withdrawal by Subject|1|||
130338677|NCT00220779|469213114|FG000|Overall Study|Non-compliance|1|||
130338678|NCT00220779|469213115|FG001|Overall Study|Non-compliance|0|||
130338679|NCT00220779|469213116|FG002|Overall Study|Non-compliance|0|||
130338680|NCT00220779|469213114|FG000|Overall Study|Too time consuming|1|||
130338681|NCT00220779|469213115|FG001|Overall Study|Too time consuming|0|||
130338682|NCT00220779|469213116|FG002|Overall Study|Too time consuming|0|||
130338683|NCT00220779|469213114|FG000|Overall Study|Pregnancy|0|||
130338684|NCT00220779|469213115|FG001|Overall Study|Pregnancy|0|||
130338685|NCT00220779|469213116|FG002|Overall Study|Pregnancy|2|||
130338686|NCT00220779|469213114|FG000|Overall Study|Lack of Efficacy|3|||
130003321|NCT01876251|467977901|FG000|Overall Study|Participant started new treatment|1|||
130003322|NCT01876251|467977902|FG001|Overall Study|Participant started new treatment|0|||
130216344|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
130338687|NCT00220779|469213115|FG001|Overall Study|Lack of Efficacy|0|||
130338688|NCT00220779|469213116|FG002|Overall Study|Lack of Efficacy|1|||
130338689|NCT02248675|469213117|FG000|Overall Study|Lost to Follow-up|3|||
130338690|NCT02248675|469213118|FG001|Overall Study|Lost to Follow-up|1|||
130338691|NCT03390101|469213121|FG000|Weeks 0-12|Withdrawal by Subject|0|||
130338692|NCT03390101|469213122|FG001|Weeks 0-12|Withdrawal by Subject|1|||
130338693|NCT03390101|469213123|FG002|Weeks 0-12|Withdrawal by Subject|1|||
130338694|NCT03390101|469213121|FG000|Weeks 0-12|Lost to Follow-up|0|||
130338695|NCT03390101|469213122|FG001|Weeks 0-12|Lost to Follow-up|1|||
130338696|NCT03390101|469213123|FG002|Weeks 0-12|Lost to Follow-up|0|||
130338697|NCT03390101|469213121|FG000|Weeks 12-54|Withdrawal by Subject|0|||
130338698|NCT03390101|469213122|FG001|Weeks 12-54|Withdrawal by Subject|3|||
130003323|NCT01876251|467977903|FG002|Overall Study|Participant started new treatment|1|||
130003324|NCT01876251|467977901|FG000|Overall Study|Participant refused further follow-up|0|||
130003325|NCT01876251|467977902|FG001|Overall Study|Participant refused further follow-up|0|||
130003326|NCT01876251|467977903|FG002|Overall Study|Participant refused further follow-up|1|||
130003327|NCT01876251|467977901|FG000|Overall Study|Study terminated|1|||
130003328|NCT01876251|467977902|FG001|Overall Study|Study terminated|0|||
130003329|NCT01876251|467977903|FG002|Overall Study|Study terminated|0|||
130003330|NCT01876251|467977901|FG000|Overall Study|Objective progression or relapse|10|||
130003331|NCT01876251|467977902|FG001|Overall Study|Objective progression or relapse|3|||
130003332|NCT01876251|467977903|FG002|Overall Study|Objective progression or relapse|8|||
130003333|NCT00268437|467977904|FG000|Overall Study|Ineligible|1|||
130003334|NCT02020863|467977907|FG000|Overall Study|Discovery of Metastatic disease|4|||
130003335|NCT02020863|467977907|FG000|Overall Study|Team chose not to place an a line|1|||
130003336|NCT00907257|467977909|FG000|Overall Study|Adverse Event|0|||
130003337|NCT00907257|467977910|FG001|Overall Study|Adverse Event|4|||
130003338|NCT00907257|467977909|FG000|Overall Study|Protocol Violation|1|||
130003339|NCT00907257|467977910|FG001|Overall Study|Protocol Violation|2|||
130003340|NCT00907257|467977909|FG000|Overall Study|Lost to Follow-up|3|||
130003341|NCT00907257|467977910|FG001|Overall Study|Lost to Follow-up|3|||
130003342|NCT00907257|467977909|FG000|Overall Study|Withdrawal by Subject|1|||
130003343|NCT00907257|467977910|FG001|Overall Study|Withdrawal by Subject|2|||
130003344|NCT00907257|467977909|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
130003345|NCT00907257|467977910|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
130003346|NCT00907257|467977909|FG000|Overall Study|Moved|1|||
130003347|NCT00907257|467977910|FG001|Overall Study|Moved|0|||
130003348|NCT00907257|467977909|FG000|Overall Study|Personal Reasons|6|||
130003349|NCT00907257|467977910|FG001|Overall Study|Personal Reasons|1|||
130003350|NCT00283049|467977911|FG000|Overall Study|Adverse Event|6|||
130003351|NCT00283049|467977912|FG001|Overall Study|Adverse Event|1|||
130003352|NCT00283049|467977913|FG002|Overall Study|Adverse Event|4|||
130003353|NCT00283049|467977911|FG000|Overall Study|Protocol Violation|3|||
130003354|NCT00283049|467977912|FG001|Overall Study|Protocol Violation|0|||
130003355|NCT00283049|467977913|FG002|Overall Study|Protocol Violation|3|||
130003356|NCT00283049|467977911|FG000|Overall Study|Death|1|||
130003357|NCT00283049|467977912|FG001|Overall Study|Death|1|||
130003358|NCT00283049|467977913|FG002|Overall Study|Death|1|||
130003359|NCT00283049|467977911|FG000|Overall Study|Lack of Efficacy|0|||
130003360|NCT00283049|467977912|FG001|Overall Study|Lack of Efficacy|1|||
130003361|NCT00283049|467977913|FG002|Overall Study|Lack of Efficacy|1|||
130003362|NCT00283049|467977911|FG000|Overall Study|Lost to Follow-up|4|||
130003363|NCT00283049|467977912|FG001|Overall Study|Lost to Follow-up|2|||
130003364|NCT00283049|467977913|FG002|Overall Study|Lost to Follow-up|5|||
130003365|NCT00283049|467977911|FG000|Overall Study|Withdrawal by Subject|26|||
130003366|NCT00283049|467977912|FG001|Overall Study|Withdrawal by Subject|24|||
130003367|NCT00283049|467977913|FG002|Overall Study|Withdrawal by Subject|19|||
130003368|NCT00283049|467977911|FG000|Overall Study|Discontinuation of Study|18|||
130003369|NCT00283049|467977912|FG001|Overall Study|Discontinuation of Study|16|||
130003370|NCT00283049|467977913|FG002|Overall Study|Discontinuation of Study|20|||
130003371|NCT00283049|467977911|FG000|Overall Study|No longer requires study treatment|0|||
130003372|NCT00283049|467977912|FG001|Overall Study|No longer requires study treatment|0|||
130003373|NCT00283049|467977913|FG002|Overall Study|No longer requires study treatment|1|||
130003374|NCT01086410|467977914|FG000|Overall Study|Adverse Event|1|||
130003375|NCT01086410|467977915|FG001|Overall Study|Adverse Event|0|||
130003376|NCT01086410|467977916|FG002|Overall Study|Adverse Event|0|||
130003377|NCT01086410|467977917|FG003|Overall Study|Adverse Event|2|||
130003378|NCT01086410|467977914|FG000|Overall Study|Lack of Efficacy|1|||
130003379|NCT01086410|467977915|FG001|Overall Study|Lack of Efficacy|1|||
130003380|NCT01086410|467977916|FG002|Overall Study|Lack of Efficacy|0|||
130003381|NCT01086410|467977917|FG003|Overall Study|Lack of Efficacy|0|||
130003382|NCT01086410|467977914|FG000|Overall Study|Protocol Violation|1|||
130003383|NCT01086410|467977915|FG001|Overall Study|Protocol Violation|1|||
130003384|NCT01086410|467977916|FG002|Overall Study|Protocol Violation|0|||
130003385|NCT01086410|467977917|FG003|Overall Study|Protocol Violation|0|||
130003386|NCT01086410|467977914|FG000|Overall Study|Lost to Follow-up|0|||
130003387|NCT01086410|467977915|FG001|Overall Study|Lost to Follow-up|0|||
130003388|NCT01086410|467977916|FG002|Overall Study|Lost to Follow-up|1|||
130003389|NCT01086410|467977917|FG003|Overall Study|Lost to Follow-up|0|||
130003390|NCT04196803|467977918|FG000|Overall Study|Withdrawal by Subject|1|||
130003391|NCT04196803|467977919|FG001|Overall Study|Withdrawal by Subject|3|||
130003392|NCT04196803|467977918|FG000|Overall Study|Adverse Event|4|||
130003393|NCT04196803|467977919|FG001|Overall Study|Adverse Event|2|||
130338699|NCT03390101|469213123|FG002|Weeks 12-54|Withdrawal by Subject|1|||
130003394|NCT04196803|467977918|FG000|Overall Study|Lost to Follow-up|0|||
130003395|NCT04196803|467977919|FG001|Overall Study|Lost to Follow-up|1|||
130003396|NCT01022996|467977920|FG000|Overall Study|Adverse Event|14|||
130003397|NCT01022996|467977920|FG000|Overall Study|Withdrawal by Subject|3|||
130003398|NCT01022996|467977920|FG000|Overall Study|Lost to Follow-up|1|||
130003399|NCT01022996|467977920|FG000|Overall Study|Administrative problems|6|||
130003400|NCT01022996|467977920|FG000|Overall Study|Disease Progression|32|||
130003401|NCT01022996|467977920|FG000|Overall Study|Protocol Violation|1|||
130003402|NCT00930722|467977921|FG000|Overall Study|Lost to Follow-up|16|||
130003403|NCT00930722|467977921|FG000|Overall Study|No longer willing to participate|9|||
130003404|NCT00930722|467977921|FG000|Overall Study|Study terminated by sponsor|2|||
130003405|NCT01069120|467977922|FG000|Overall Study|Study prematurely terminated|27|||
130003406|NCT05097716|467977923|FG000|Period 1|Adverse Event|1|||
130003407|NCT05097716|467977923|FG000|Period 1|Close contact with highly-transmissible infection|1|||
130003408|NCT03945591|467977926|FG000|Overall Study|Participant not transplanted|1|||
130003409|NCT03945591|467977926|FG000|Overall Study|Change in treatment plan|3|||
130003410|NCT03945591|467977926|FG000|Overall Study|Adverse Event|1|||
130003411|NCT01970488|467977928|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
130098742|NCT03426995|468319307|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130216345|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
130216346|NCT01042392|468755503|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
130216347|NCT01042392|468755504|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130216348|NCT01042392|468755505|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130216349|NCT01042392|468755506|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
130216350|NCT00587795|468755507|FG000|Overall Study|Withdrawal by Subject|1|||
130216351|NCT00587795|468755508|FG001|Overall Study|Withdrawal by Subject|0|||
130216352|NCT02869893|468755513|FG000|Overall Study|participant aversion to IV|5|||
130216353|NCT02869893|468755513|FG000|Overall Study|participant fear of MRI scanner|2|||
130216354|NCT03146741|468755514|FG000|Overall Study|Txp with non-HCV+ heart|4|||
130216355|NCT03146741|468755514|FG000|Overall Study|Listeted for MOT|2|||
130216356|NCT03146741|468755514|FG000|Overall Study|Physician Decision|2|||
130216357|NCT03146741|468755514|FG000|Overall Study|Awaiting txp|2|||
130216358|NCT00837967|468755515|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
130216359|NCT00837967|468755516|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
130216360|NCT00551525|468755517|FG000|Overall Study|Protocol Violation|5|||
130216361|NCT04676724|468755518|FG000|Overall Study|Adverse Event|2|||
130216362|NCT04676724|468755519|FG001|Overall Study|Adverse Event|0|||
130216363|NCT04676724|468755518|FG000|Overall Study|Lost to Follow-up|1|||
130216364|NCT04676724|468755519|FG001|Overall Study|Lost to Follow-up|0|||
130216365|NCT04676724|468755518|FG000|Overall Study|Physician Decision|0|||
130216366|NCT04676724|468755519|FG001|Overall Study|Physician Decision|1|||
130216367|NCT04676724|468755518|FG000|Overall Study|Withdrawal by Subject|3|||
130216368|NCT04676724|468755519|FG001|Overall Study|Withdrawal by Subject|2|||
130216369|NCT02081001|468755525|FG000|Overall Study|Adverse Event|0|||
130216370|NCT02081001|468755526|FG001|Overall Study|Adverse Event|0|||
130216371|NCT02081001|468755527|FG002|Overall Study|Adverse Event|0|||
130216372|NCT02081001|468755528|FG003|Overall Study|Adverse Event|0|||
130216373|NCT02081001|468755529|FG004|Overall Study|Adverse Event|1|||
130216374|NCT02081001|468755530|FG005|Overall Study|Adverse Event|0|||
130216375|NCT02081001|468755531|FG006|Overall Study|Adverse Event|0|||
130216376|NCT02081001|468755532|FG007|Overall Study|Adverse Event|0|||
130216377|NCT02081001|468755533|FG008|Overall Study|Adverse Event|0|||
130216378|NCT02081001|468755534|FG009|Overall Study|Adverse Event|0|||
130216379|NCT02081001|468755535|FG010|Overall Study|Adverse Event|0|||
130216380|NCT02081001|468755536|FG011|Overall Study|Adverse Event|0|||
130216381|NCT02588092|468755557|FG000|Overall Study|Death|4|||
130216382|NCT02588092|468755558|FG001|Overall Study|Death|3|||
130216383|NCT02588092|468755559|FG002|Overall Study|Death|3|||
130216384|NCT02588092|468755560|FG003|Overall Study|Death|3|||
130216385|NCT02588092|468755561|FG004|Overall Study|Death|2|||
130216386|NCT02588092|468755562|FG005|Overall Study|Death|2|||
130216387|NCT02588092|468755563|FG006|Overall Study|Death|2|||
130216388|NCT02588092|468755564|FG007|Overall Study|Death|1|||
130216389|NCT02588092|468755565|FG008|Overall Study|Death|5|||
130216390|NCT02588092|468755566|FG009|Overall Study|Death|2|||
130216391|NCT02588092|468755557|FG000|Overall Study|Withdrawal by Subject|0|||
130216392|NCT02588092|468755558|FG001|Overall Study|Withdrawal by Subject|0|||
130216393|NCT02588092|468755559|FG002|Overall Study|Withdrawal by Subject|0|||
130216394|NCT02588092|468755560|FG003|Overall Study|Withdrawal by Subject|0|||
130216395|NCT02588092|468755561|FG004|Overall Study|Withdrawal by Subject|0|||
130216396|NCT02588092|468755562|FG005|Overall Study|Withdrawal by Subject|1|||
130216397|NCT02588092|468755563|FG006|Overall Study|Withdrawal by Subject|1|||
130216398|NCT02588092|468755564|FG007|Overall Study|Withdrawal by Subject|2|||
130216399|NCT02588092|468755565|FG008|Overall Study|Withdrawal by Subject|0|||
130216400|NCT02588092|468755566|FG009|Overall Study|Withdrawal by Subject|0|||
130216401|NCT02588092|468755557|FG000|Overall Study|Started Another Treatment|0|||
130216402|NCT02588092|468755558|FG001|Overall Study|Started Another Treatment|0|||
130216403|NCT02588092|468755559|FG002|Overall Study|Started Another Treatment|0|||
130216404|NCT02588092|468755560|FG003|Overall Study|Started Another Treatment|0|||
130216405|NCT02588092|468755561|FG004|Overall Study|Started Another Treatment|1|||
130216406|NCT02588092|468755562|FG005|Overall Study|Started Another Treatment|0|||
130216407|NCT02588092|468755563|FG006|Overall Study|Started Another Treatment|0|||
130216408|NCT02588092|468755564|FG007|Overall Study|Started Another Treatment|1|||
130003412|NCT01970488|467977929|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
130003413|NCT01970488|467977930|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
130003414|NCT01970488|467977931|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
130003415|NCT01970488|467977932|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
130003416|NCT01970488|467977928|FG000|Part 1: Through Week 16|Protocol Violation|1|||
130003417|NCT01970488|467977929|FG001|Part 1: Through Week 16|Protocol Violation|2|||
130003418|NCT01970488|467977930|FG002|Part 1: Through Week 16|Protocol Violation|0|||
130003419|NCT01970488|467977931|FG003|Part 1: Through Week 16|Protocol Violation|0|||
130003420|NCT01970488|467977932|FG004|Part 1: Through Week 16|Protocol Violation|0|||
130003421|NCT01970488|467977928|FG000|Part 1: Through Week 16|Adverse Event|6|||
130003422|NCT01970488|467977929|FG001|Part 1: Through Week 16|Adverse Event|5|||
130003423|NCT01970488|467977930|FG002|Part 1: Through Week 16|Adverse Event|0|||
130003424|NCT01970488|467977931|FG003|Part 1: Through Week 16|Adverse Event|0|||
130003425|NCT01970488|467977932|FG004|Part 1: Through Week 16|Adverse Event|0|||
130003426|NCT01970488|467977928|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
130338700|NCT03390101|469213121|FG000|Weeks 12-54|Pregnancy|1|||
130338701|NCT03390101|469213122|FG001|Weeks 12-54|Pregnancy|0|||
130338702|NCT03390101|469213123|FG002|Weeks 12-54|Pregnancy|0|||
130338703|NCT03390101|469213121|FG000|Weeks 12-54|Adverse Event|2|||
130338704|NCT03390101|469213122|FG001|Weeks 12-54|Adverse Event|1|||
130338705|NCT03390101|469213123|FG002|Weeks 12-54|Adverse Event|1|||
130338706|NCT00281658|469213128|FG000|Randomized Phase|Adverse Event|0|||
130338707|NCT00281658|469213129|FG001|Randomized Phase|Adverse Event|2|||
130338708|NCT00281658|469213130|FG002|Randomized Phase|Adverse Event|0|||
130338709|NCT00281658|469213131|FG003|Randomized Phase|Adverse Event|0|||
130003427|NCT01970488|467977929|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
130003428|NCT01970488|467977930|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
130003429|NCT01970488|467977931|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
130003430|NCT01970488|467977932|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
130003431|NCT01970488|467977928|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
130003432|NCT01970488|467977929|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
130003433|NCT01970488|467977930|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
130003434|NCT01970488|467977931|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
130003435|NCT01970488|467977932|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
130003436|NCT01970488|467977928|FG000|Part 2: Post Week 16|Physician Decision|0|||
130003437|NCT01970488|467977929|FG001|Part 2: Post Week 16|Physician Decision|0|||
130003438|NCT01970488|467977930|FG002|Part 2: Post Week 16|Physician Decision|0|||
130003439|NCT01970488|467977931|FG003|Part 2: Post Week 16|Physician Decision|0|||
130003440|NCT01970488|467977932|FG004|Part 2: Post Week 16|Physician Decision|1|||
130003441|NCT01970488|467977928|FG000|Part 2: Post Week 16|Non-compliance|0|||
130003442|NCT01970488|467977929|FG001|Part 2: Post Week 16|Non-compliance|0|||
130003443|NCT01970488|467977930|FG002|Part 2: Post Week 16|Non-compliance|1|||
130003444|NCT01970488|467977931|FG003|Part 2: Post Week 16|Non-compliance|0|||
130003445|NCT01970488|467977932|FG004|Part 2: Post Week 16|Non-compliance|0|||
130003446|NCT01970488|467977928|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
130003447|NCT01970488|467977929|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
130003448|NCT01970488|467977930|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
130003449|NCT01970488|467977931|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
130003450|NCT01970488|467977932|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
130003451|NCT01970488|467977928|FG000|Part 2: Post Week 16|Adverse Event|0|||
130003452|NCT01970488|467977929|FG001|Part 2: Post Week 16|Adverse Event|0|||
130003453|NCT01970488|467977930|FG002|Part 2: Post Week 16|Adverse Event|5|||
130003454|NCT01970488|467977931|FG003|Part 2: Post Week 16|Adverse Event|1|||
130003455|NCT01970488|467977932|FG004|Part 2: Post Week 16|Adverse Event|1|||
130003456|NCT01970488|467977928|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
130003457|NCT01970488|467977929|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
130003458|NCT01970488|467977930|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
130003459|NCT01970488|467977931|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
130003460|NCT01970488|467977932|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
130003461|NCT01970488|467977928|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
130003462|NCT01970488|467977929|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
130003463|NCT01970488|467977930|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
130003464|NCT01970488|467977931|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
130003465|NCT01970488|467977932|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
130003466|NCT00851682|467977933|FG000|Overall Study|screen failure|5|||
130003467|NCT00851682|467977934|FG001|Overall Study|screen failure|0|||
130003468|NCT04060563|467977935|FG000|Overall Study|Lost to Follow-up|1|||
130003469|NCT04060563|467977936|FG001|Overall Study|Lost to Follow-up|1|||
130003470|NCT04060563|467977935|FG000|Overall Study|Physician Decision|0|||
130003471|NCT04060563|467977936|FG001|Overall Study|Physician Decision|1|||
130003472|NCT01514136|467977937|FG000|Test Period 1; Test A|Protocol Violation|1|||
130003473|NCT01514136|467977938|FG001|Test Period 1; Test A|Protocol Violation|0|||
130338710|NCT00281658|469213128|FG000|Randomized Phase|Lost to Follow-up|34|||
130338711|NCT00281658|469213129|FG001|Randomized Phase|Lost to Follow-up|27|||
130338712|NCT00281658|469213130|FG002|Randomized Phase|Lost to Follow-up|0|||
130338713|NCT00281658|469213131|FG003|Randomized Phase|Lost to Follow-up|0|||
130338714|NCT00281658|469213128|FG000|Randomized Phase|Withdrawal by Subject|8|||
130338715|NCT00281658|469213129|FG001|Randomized Phase|Withdrawal by Subject|7|||
130338716|NCT00281658|469213130|FG002|Randomized Phase|Withdrawal by Subject|0|||
130003474|NCT01514136|467977939|FG002|Test Period 1; Test A|Protocol Violation|0|||
130338717|NCT00281658|469213131|FG003|Randomized Phase|Withdrawal by Subject|0|||
130338718|NCT00281658|469213128|FG000|Randomized Phase|Study closed/terminated|1|||
130338719|NCT00281658|469213129|FG001|Randomized Phase|Study closed/terminated|1|||
130338720|NCT00281658|469213130|FG002|Randomized Phase|Study closed/terminated|0|||
130338721|NCT00281658|469213131|FG003|Randomized Phase|Study closed/terminated|0|||
130338722|NCT00281658|469213128|FG000|Randomized Phase|Disease progression|36|||
130338723|NCT00281658|469213129|FG001|Randomized Phase|Disease progression|27|||
130338724|NCT00281658|469213130|FG002|Randomized Phase|Disease progression|0|||
130338725|NCT00281658|469213131|FG003|Randomized Phase|Disease progression|0|||
130338726|NCT00281658|469213128|FG000|Randomized Phase|Physician Decision|1|||
130338727|NCT00281658|469213129|FG001|Randomized Phase|Physician Decision|1|||
130338728|NCT00281658|469213130|FG002|Randomized Phase|Physician Decision|0|||
130338729|NCT00281658|469213131|FG003|Randomized Phase|Physician Decision|0|||
130338730|NCT00281658|469213128|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
130338731|NCT00281658|469213129|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
130338732|NCT00281658|469213130|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
130338733|NCT00281658|469213131|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
130338734|NCT00281658|469213128|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
130338735|NCT00281658|469213129|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
130338736|NCT00281658|469213130|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
130338737|NCT00281658|469213131|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
130338738|NCT00281658|469213128|FG000|Randomized Phase|Treatment ongoing|1|||
130338739|NCT00281658|469213129|FG001|Randomized Phase|Treatment ongoing|0|||
130338740|NCT00281658|469213130|FG002|Randomized Phase|Treatment ongoing|0|||
130338741|NCT00281658|469213131|FG003|Randomized Phase|Treatment ongoing|0|||
130338742|NCT00281658|469213128|FG000|Open Label Phase|Adverse Event|0|||
130338743|NCT00281658|469213129|FG001|Open Label Phase|Adverse Event|0|||
130338744|NCT00281658|469213130|FG002|Open Label Phase|Adverse Event|1|||
130338745|NCT00281658|469213131|FG003|Open Label Phase|Adverse Event|0|||
130338746|NCT00281658|469213128|FG000|Open Label Phase|Lost to Follow-up|0|||
130338747|NCT00281658|469213129|FG001|Open Label Phase|Lost to Follow-up|0|||
130338748|NCT00281658|469213130|FG002|Open Label Phase|Lost to Follow-up|16|||
130338749|NCT00281658|469213131|FG003|Open Label Phase|Lost to Follow-up|2|||
130338750|NCT00281658|469213128|FG000|Open Label Phase|Withdrawal by Subject|0|||
130338751|NCT00281658|469213129|FG001|Open Label Phase|Withdrawal by Subject|0|||
130338752|NCT00281658|469213130|FG002|Open Label Phase|Withdrawal by Subject|3|||
130338753|NCT00281658|469213131|FG003|Open Label Phase|Withdrawal by Subject|2|||
130338754|NCT00281658|469213128|FG000|Open Label Phase|Disease progression|0|||
130338755|NCT00281658|469213129|FG001|Open Label Phase|Disease progression|0|||
130338756|NCT00281658|469213130|FG002|Open Label Phase|Disease progression|18|||
130338757|NCT00281658|469213131|FG003|Open Label Phase|Disease progression|0|||
130338758|NCT00281658|469213128|FG000|Open Label Phase|Physician Decision|0|||
130338759|NCT00281658|469213129|FG001|Open Label Phase|Physician Decision|0|||
130338760|NCT00281658|469213130|FG002|Open Label Phase|Physician Decision|1|||
130338761|NCT00281658|469213131|FG003|Open Label Phase|Physician Decision|0|||
130338762|NCT00281658|469213128|FG000|Open Label Phase|Relocation of patient|0|||
130338763|NCT00281658|469213129|FG001|Open Label Phase|Relocation of patient|0|||
130338764|NCT00281658|469213130|FG002|Open Label Phase|Relocation of patient|1|||
130338765|NCT00281658|469213131|FG003|Open Label Phase|Relocation of patient|0|||
130338766|NCT00281658|469213128|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
130338767|NCT00281658|469213129|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
130338768|NCT00281658|469213130|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
130338769|NCT00281658|469213131|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
130338770|NCT00813943|469213135|FG000|Overall Study|Ongoing at cut-off date|5|||
130338771|NCT00813943|469213136|FG001|Overall Study|Ongoing at cut-off date|5|||
130003475|NCT01514136|467977940|FG003|Test Period 1; Test A|Protocol Violation|0|||
130003476|NCT01514136|467977941|FG004|Test Period 1; Test A|Protocol Violation|0|||
130003477|NCT01514136|467977942|FG005|Test Period 1; Test A|Protocol Violation|0|||
130338772|NCT00813943|469213137|FG002|Overall Study|Ongoing at cut-off date|3|||
130338773|NCT01343693|469213138|FG000|Overall Study|Lost to Follow-up|9|||
130338774|NCT01235598|469213139|FG000|Overall Study|Adverse Event|0|||
130338775|NCT01235598|469213140|FG001|Overall Study|Adverse Event|3|||
130338776|NCT01235598|469213139|FG000|Overall Study|Lack of Efficacy|0|||
130338777|NCT01235598|469213140|FG001|Overall Study|Lack of Efficacy|1|||
130338778|NCT01235598|469213139|FG000|Overall Study|Withdrawal by Subject|1|||
130338779|NCT01235598|469213140|FG001|Overall Study|Withdrawal by Subject|0|||
130338780|NCT02551991|469213141|FG000|Overall Study|Death|5|||
130338781|NCT02551991|469213142|FG001|Overall Study|Death|7|||
130003478|NCT01514136|467977943|FG006|Test Period 1; Test A|Protocol Violation|0|||
130003479|NCT01514136|467977944|FG007|Test Period 1; Test A|Protocol Violation|0|||
130003480|NCT01514136|467977937|FG000|Test Period 1; Test A|Break from study holiday|2|||
130003481|NCT01514136|467977938|FG001|Test Period 1; Test A|Break from study holiday|0|||
130003482|NCT01514136|467977939|FG002|Test Period 1; Test A|Break from study holiday|0|||
130003483|NCT01514136|467977940|FG003|Test Period 1; Test A|Break from study holiday|0|||
130003484|NCT01514136|467977941|FG004|Test Period 1; Test A|Break from study holiday|0|||
130003485|NCT01514136|467977942|FG005|Test Period 1; Test A|Break from study holiday|0|||
130003486|NCT01514136|467977943|FG006|Test Period 1; Test A|Break from study holiday|0|||
130003487|NCT01514136|467977944|FG007|Test Period 1; Test A|Break from study holiday|0|||
130003488|NCT01514136|467977937|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
130003489|NCT01514136|467977938|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
130003490|NCT01514136|467977939|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
130003491|NCT01514136|467977940|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
130003492|NCT01514136|467977941|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
130003493|NCT01514136|467977942|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
130003494|NCT01514136|467977943|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
130003495|NCT01514136|467977944|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
130003496|NCT01514136|467977937|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
130338782|NCT02551991|469213143|FG002|Overall Study|Death|8|||
130003497|NCT01514136|467977938|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
130003498|NCT01514136|467977939|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
130003499|NCT01514136|467977940|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
130003500|NCT01514136|467977941|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
130003501|NCT01514136|467977942|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
130003502|NCT01514136|467977943|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
130003503|NCT01514136|467977944|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
130003504|NCT01514136|467977937|FG000|Test Period 2; Test A*|Adverse Event|0|||
130003505|NCT01514136|467977938|FG001|Test Period 2; Test A*|Adverse Event|0|||
130003506|NCT01514136|467977939|FG002|Test Period 2; Test A*|Adverse Event|0|||
130003507|NCT01514136|467977940|FG003|Test Period 2; Test A*|Adverse Event|0|||
130003508|NCT01514136|467977941|FG004|Test Period 2; Test A*|Adverse Event|1|||
130003509|NCT01514136|467977942|FG005|Test Period 2; Test A*|Adverse Event|0|||
130338783|NCT02551991|469213144|FG003|Overall Study|Death|7|||
130338784|NCT02551991|469213145|FG004|Overall Study|Death|17|||
130338785|NCT02551991|469213141|FG000|Overall Study|Withdrawal by Subject|1|||
130003510|NCT01514136|467977943|FG006|Test Period 2; Test A*|Adverse Event|0|||
130003511|NCT01514136|467977944|FG007|Test Period 2; Test A*|Adverse Event|0|||
130338786|NCT02551991|469213142|FG001|Overall Study|Withdrawal by Subject|0|||
130338787|NCT02551991|469213143|FG002|Overall Study|Withdrawal by Subject|0|||
130338788|NCT02551991|469213144|FG003|Overall Study|Withdrawal by Subject|0|||
130338789|NCT02551991|469213145|FG004|Overall Study|Withdrawal by Subject|2|||
130338790|NCT02551991|469213141|FG000|Overall Study|Lost to Follow-up|0|||
130338791|NCT02551991|469213142|FG001|Overall Study|Lost to Follow-up|0|||
130338792|NCT02551991|469213143|FG002|Overall Study|Lost to Follow-up|1|||
130338793|NCT02551991|469213144|FG003|Overall Study|Lost to Follow-up|0|||
130338794|NCT02551991|469213145|FG004|Overall Study|Lost to Follow-up|0|||
130338795|NCT02551991|469213141|FG000|Overall Study|Sponsor Decision|1|||
130338796|NCT02551991|469213142|FG001|Overall Study|Sponsor Decision|0|||
130338797|NCT02551991|469213143|FG002|Overall Study|Sponsor Decision|1|||
130338798|NCT02551991|469213144|FG003|Overall Study|Sponsor Decision|0|||
130338799|NCT02551991|469213145|FG004|Overall Study|Sponsor Decision|5|||
130338800|NCT02551991|469213141|FG000|Overall Study|Other|0|||
130338801|NCT02551991|469213142|FG001|Overall Study|Other|0|||
130338802|NCT02551991|469213143|FG002|Overall Study|Other|0|||
130338803|NCT02551991|469213144|FG003|Overall Study|Other|0|||
130338804|NCT02551991|469213145|FG004|Overall Study|Other|1|||
130338805|NCT00265148|469213146|FG000|Overall Study|Adverse Event|2|||
130338806|NCT00265148|469213147|FG001|Overall Study|Adverse Event|2|||
130338807|NCT00265148|469213146|FG000|Overall Study|Lack of Efficacy|0|||
130338808|NCT00265148|469213147|FG001|Overall Study|Lack of Efficacy|2|||
130003512|NCT01514136|467977937|FG000|Test Period 2; Test A*|Holiday|0|||
130003513|NCT01514136|467977938|FG001|Test Period 2; Test A*|Holiday|0|||
130003514|NCT01514136|467977939|FG002|Test Period 2; Test A*|Holiday|0|||
130003515|NCT01514136|467977940|FG003|Test Period 2; Test A*|Holiday|0|||
130003516|NCT01514136|467977941|FG004|Test Period 2; Test A*|Holiday|1|||
130003517|NCT01514136|467977942|FG005|Test Period 2; Test A*|Holiday|0|||
130003518|NCT01514136|467977943|FG006|Test Period 2; Test A*|Holiday|0|||
130003519|NCT01514136|467977944|FG007|Test Period 2; Test A*|Holiday|0|||
130003520|NCT01514136|467977937|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
130338809|NCT00265148|469213146|FG000|Overall Study|Protocol Violation|3|||
130338810|NCT00265148|469213147|FG001|Overall Study|Protocol Violation|2|||
130338811|NCT00265148|469213146|FG000|Overall Study|Lost to Follow-up|0|||
130338812|NCT00265148|469213147|FG001|Overall Study|Lost to Follow-up|1|||
130338813|NCT00265148|469213146|FG000|Overall Study|Withdrawal by Subject|2|||
130338814|NCT00265148|469213147|FG001|Overall Study|Withdrawal by Subject|1|||
130338815|NCT00265148|469213146|FG000|Overall Study|Physician Decision|1|||
130216409|NCT02588092|468755565|FG008|Overall Study|Started Another Treatment|0|||
130216410|NCT02588092|468755566|FG009|Overall Study|Started Another Treatment|0|||
130216411|NCT02588092|468755557|FG000|Overall Study|Sponsor Decision|0|||
130216412|NCT02588092|468755558|FG001|Overall Study|Sponsor Decision|0|||
130216413|NCT02588092|468755559|FG002|Overall Study|Sponsor Decision|0|||
130216414|NCT02588092|468755560|FG003|Overall Study|Sponsor Decision|0|||
130216415|NCT02588092|468755561|FG004|Overall Study|Sponsor Decision|0|||
130216416|NCT02588092|468755562|FG005|Overall Study|Sponsor Decision|0|||
130216417|NCT02588092|468755563|FG006|Overall Study|Sponsor Decision|0|||
130216418|NCT02588092|468755564|FG007|Overall Study|Sponsor Decision|0|||
130216419|NCT02588092|468755565|FG008|Overall Study|Sponsor Decision|1|||
130216420|NCT02588092|468755566|FG009|Overall Study|Sponsor Decision|1|||
130216421|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
130216422|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
130216423|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
130216424|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
130216425|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
130216426|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
130216427|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|Death|0|||
130216428|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|Death|1|||
130216429|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|Death|0|||
130216430|NCT01030718|468755567|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
130216431|NCT01030718|468755568|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
130216432|NCT01030718|468755569|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
130216433|NCT01030718|468755567|FG000|Study CA180-036 Only|insufficient effect|1|||
130216434|NCT01030718|468755568|FG001|Study CA180-036 Only|insufficient effect|1|||
130216435|NCT01030718|468755569|FG002|Study CA180-036 Only|insufficient effect|5|||
130216436|NCT01030718|468755567|FG000|Study CA180-036 Only|Adverse Event|2|||
130216437|NCT01030718|468755568|FG001|Study CA180-036 Only|Adverse Event|3|||
130216438|NCT01030718|468755569|FG002|Study CA180-036 Only|Adverse Event|0|||
130216439|NCT01030718|468755567|FG000|Study CA180-036 Only|Death|0|||
130216440|NCT01030718|468755568|FG001|Study CA180-036 Only|Death|1|||
130216441|NCT01030718|468755569|FG002|Study CA180-036 Only|Death|0|||
130216442|NCT01030718|468755567|FG000|Study CA180-036 Only|Other Reasons|0|||
130216443|NCT01030718|468755568|FG001|Study CA180-036 Only|Other Reasons|2|||
130216444|NCT01030718|468755569|FG002|Study CA180-036 Only|Other Reasons|0|||
130216445|NCT00099632|468755572|FG000|Overall Study|Lost to Follow-up|1|||
130216446|NCT00099632|468755573|FG001|Overall Study|Lost to Follow-up|0|||
130216447|NCT00099632|468755574|FG002|Overall Study|Lost to Follow-up|3|||
130216448|NCT00099632|468755575|FG003|Overall Study|Lost to Follow-up|1|||
130216449|NCT00099632|468755576|FG004|Overall Study|Lost to Follow-up|1|||
130216450|NCT00099632|468755577|FG005|Overall Study|Lost to Follow-up|0|||
130216451|NCT00099632|468755572|FG000|Overall Study|Withdrawal by Subject|0|||
130216452|NCT00099632|468755573|FG001|Overall Study|Withdrawal by Subject|1|||
130216453|NCT00099632|468755574|FG002|Overall Study|Withdrawal by Subject|0|||
130216454|NCT00099632|468755575|FG003|Overall Study|Withdrawal by Subject|0|||
130216455|NCT00099632|468755576|FG004|Overall Study|Withdrawal by Subject|0|||
130216456|NCT00099632|468755577|FG005|Overall Study|Withdrawal by Subject|1|||
130216457|NCT00099632|468755572|FG000|Overall Study|Protocol Violation|0|||
130216458|NCT00099632|468755573|FG001|Overall Study|Protocol Violation|0|||
130216459|NCT00099632|468755574|FG002|Overall Study|Protocol Violation|0|||
130216460|NCT00099632|468755575|FG003|Overall Study|Protocol Violation|0|||
130216461|NCT00099632|468755576|FG004|Overall Study|Protocol Violation|0|||
130216462|NCT00099632|468755577|FG005|Overall Study|Protocol Violation|1|||
130216463|NCT00423813|468755578|FG000|Overall Study|Adverse Event|11|||
130216464|NCT00423813|468755579|FG001|Overall Study|Adverse Event|30|||
130216465|NCT00423813|468755580|FG002|Overall Study|Adverse Event|40|||
130216466|NCT00423813|468755578|FG000|Overall Study|Withdrawal by Subject|6|||
130216467|NCT00423813|468755579|FG001|Overall Study|Withdrawal by Subject|8|||
130216468|NCT00423813|468755580|FG002|Overall Study|Withdrawal by Subject|5|||
130216469|NCT00423813|468755578|FG000|Overall Study|Lost to Follow-up|5|||
130216470|NCT00423813|468755579|FG001|Overall Study|Lost to Follow-up|4|||
130216471|NCT00423813|468755580|FG002|Overall Study|Lost to Follow-up|4|||
130216472|NCT00423813|468755578|FG000|Overall Study|Lack of Efficacy|23|||
130216473|NCT00423813|468755579|FG001|Overall Study|Lack of Efficacy|18|||
130216474|NCT00423813|468755580|FG002|Overall Study|Lack of Efficacy|19|||
130216475|NCT00423813|468755578|FG000|Overall Study|Physician Decision|2|||
130216476|NCT00423813|468755579|FG001|Overall Study|Physician Decision|0|||
130216477|NCT00423813|468755580|FG002|Overall Study|Physician Decision|0|||
130216478|NCT00423813|468755578|FG000|Overall Study|Sponsor Decision|0|||
130216479|NCT00423813|468755579|FG001|Overall Study|Sponsor Decision|1|||
130216480|NCT00423813|468755580|FG002|Overall Study|Sponsor Decision|0|||
130216481|NCT00423813|468755578|FG000|Overall Study|Protocol Violation|9|||
130216482|NCT00423813|468755579|FG001|Overall Study|Protocol Violation|4|||
130216483|NCT00423813|468755580|FG002|Overall Study|Protocol Violation|4|||
130216484|NCT00423813|468755578|FG000|Overall Study|Pregnancy|0|||
130216485|NCT00423813|468755579|FG001|Overall Study|Pregnancy|0|||
130216486|NCT00423813|468755580|FG002|Overall Study|Pregnancy|1|||
130338816|NCT00265148|469213147|FG001|Overall Study|Physician Decision|0|||
130003521|NCT01514136|467977938|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
130338817|NCT00265148|469213146|FG000|Overall Study|Increasing frailty|0|||
130003522|NCT01514136|467977939|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
130003523|NCT01514136|467977940|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
130003524|NCT01514136|467977941|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
130003525|NCT01514136|467977942|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
130003526|NCT01514136|467977943|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
130338818|NCT00265148|469213147|FG001|Overall Study|Increasing frailty|1|||
130338819|NCT00265148|469213146|FG000|Overall Study|Subject chose to change of the dose|1|||
130338820|NCT00265148|469213147|FG001|Overall Study|Subject chose to change of the dose|0|||
130003527|NCT01514136|467977944|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
130003528|NCT01514136|467977937|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
130003529|NCT01514136|467977938|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
130003530|NCT01514136|467977939|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
130338821|NCT00387790|469213152|FG000|Overall Study|Adverse Event|5|||
130338822|NCT00387790|469213152|FG000|Overall Study|Lack of Efficacy|2|||
130338823|NCT00387790|469213152|FG000|Overall Study|Physician Decision|2|||
130338824|NCT00387790|469213152|FG000|Overall Study|Withdrawal by Subject|3|||
130338825|NCT00387790|469213152|FG000|Overall Study|Ineligible for study|2|||
130338826|NCT01874340|469213155|FG000|Overall Study|Study terminated by Sponsor|6|||
130338827|NCT01874340|469213156|FG001|Overall Study|Study terminated by Sponsor|8|||
130338828|NCT01874340|469213157|FG002|Overall Study|Study terminated by Sponsor|8|||
130338829|NCT01874340|469213158|FG003|Overall Study|Study terminated by Sponsor|4|||
130338830|NCT01874340|469213155|FG000|Overall Study|Withdrawal by Subject|0|||
130338831|NCT01874340|469213156|FG001|Overall Study|Withdrawal by Subject|0|||
130338832|NCT01874340|469213157|FG002|Overall Study|Withdrawal by Subject|0|||
130338833|NCT01874340|469213158|FG003|Overall Study|Withdrawal by Subject|1|||
130338834|NCT00444678|469213167|FG000|Overall Study|Toxicity|11|||
130338835|NCT00444678|469213167|FG000|Overall Study|Disease Progression|12|||
130338836|NCT00444678|469213167|FG000|Overall Study|Death|3|||
130338837|NCT00444678|469213167|FG000|Overall Study|Physician Decision|3|||
130338838|NCT00444678|469213167|FG000|Overall Study|Withdrawal by Subject|2|||
130338839|NCT00606905|469213170|FG000|Overall Study|No Pregnancy|9|||
130338840|NCT00606905|469213171|FG001|Overall Study|No Pregnancy|6|||
130338841|NCT00606905|469213170|FG000|Overall Study|Non-Index Pregnancy|1|||
130338842|NCT00606905|469213171|FG001|Overall Study|Non-Index Pregnancy|4|||
130338843|NCT00606905|469213170|FG000|Overall Study|Withdrew|5|||
130338844|NCT00606905|469213171|FG001|Overall Study|Withdrew|5|||
130338845|NCT03179202|469213172|FG000|Overall Study|Screen Failure|67|||
130338846|NCT03179202|469213172|FG000|Overall Study|Subject Lost to Follow Up|12|||
130338847|NCT03179202|469213172|FG000|Overall Study|Withdrawal by Subject|7|||
130338848|NCT03179202|469213172|FG000|Overall Study|Adverse Event|3|||
130338849|NCT03179202|469213172|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
130338850|NCT03179202|469213172|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
130338851|NCT03255629|469213173|FG000|Overall Study|Adverse Event|1|||
130338852|NCT03255629|469213174|FG001|Overall Study|Adverse Event|0|||
130338853|NCT03255629|469213173|FG000|Overall Study|did not experience hypoglycemia|2|||
130338854|NCT03255629|469213174|FG001|Overall Study|did not experience hypoglycemia|1|||
130338855|NCT01625260|469213182|FG000|Overall Study|Adverse Event|3|||
130338856|NCT01625260|469213183|FG001|Overall Study|Adverse Event|0|||
130338857|NCT01625260|469213182|FG000|Overall Study|Study Terminated by Investigator|2|||
130338858|NCT01625260|469213183|FG001|Overall Study|Study Terminated by Investigator|0|||
130338859|NCT01625260|469213182|FG000|Overall Study|Disease Progression|2|||
130338860|NCT01625260|469213183|FG001|Overall Study|Disease Progression|0|||
130338861|NCT01625260|469213182|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
130338862|NCT01625260|469213183|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
130338863|NCT03899805|469213184|FG000|Overall Study|Physician Decision|3|||
130338864|NCT03899805|469213185|FG001|Overall Study|Physician Decision|0|||
130338865|NCT03899805|469213186|FG002|Overall Study|Physician Decision|2|||
130338866|NCT03899805|469213184|FG000|Overall Study|Withdrawal by Subject|1|||
130338867|NCT03899805|469213185|FG001|Overall Study|Withdrawal by Subject|0|||
130338868|NCT03899805|469213186|FG002|Overall Study|Withdrawal by Subject|2|||
130338869|NCT03899805|469213184|FG000|Overall Study|Progressive Disease|10|||
130338870|NCT03899805|469213185|FG001|Overall Study|Progressive Disease|18|||
130338871|NCT03899805|469213186|FG002|Overall Study|Progressive Disease|12|||
130003531|NCT01514136|467977940|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
130003532|NCT01514136|467977941|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
130003533|NCT01514136|467977942|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
130003534|NCT01514136|467977943|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
130338872|NCT03899805|469213184|FG000|Overall Study|Adverse Event|3|||
130338873|NCT03899805|469213185|FG001|Overall Study|Adverse Event|1|||
130338874|NCT03899805|469213186|FG002|Overall Study|Adverse Event|0|||
130338875|NCT03899805|469213184|FG000|Overall Study|Death|2|||
130338876|NCT03899805|469213185|FG001|Overall Study|Death|0|||
130338877|NCT03899805|469213186|FG002|Overall Study|Death|0|||
130338878|NCT03899805|469213184|FG000|Overall Study|Came off for surgery|0|||
130338879|NCT03899805|469213185|FG001|Overall Study|Came off for surgery|0|||
130338880|NCT03899805|469213186|FG002|Overall Study|Came off for surgery|1|||
130338881|NCT03317405|469213187|FG000|Overall Study|Withdrawal by Subject|1|||
130338882|NCT03317405|469213188|FG001|Overall Study|Withdrawal by Subject|0|||
130338883|NCT03317405|469213189|FG002|Overall Study|Withdrawal by Subject|0|||
130338884|NCT03317405|469213187|FG000|Overall Study|Physician Decision|0|||
130338885|NCT03317405|469213188|FG001|Overall Study|Physician Decision|0|||
130338886|NCT03317405|469213189|FG002|Overall Study|Physician Decision|1|||
130338887|NCT03317405|469213187|FG000|Overall Study|Surgery Rescheduled|0|||
130338888|NCT03317405|469213188|FG001|Overall Study|Surgery Rescheduled|1|||
130338889|NCT03317405|469213189|FG002|Overall Study|Surgery Rescheduled|0|||
130338890|NCT01024309|469213190|FG000|Overall Study|Physician Decision|4|||
130338891|NCT01024309|469213191|FG001|Overall Study|Physician Decision|0|||
130338892|NCT01024309|469213190|FG000|Overall Study|Withdrawal by Subject|4|||
130338893|NCT01024309|469213191|FG001|Overall Study|Withdrawal by Subject|4|||
130338894|NCT01639729|469213194|FG000|Overall Study|Withdrawal by Subject|1|||
130338895|NCT01639729|469213195|FG001|Overall Study|Withdrawal by Subject|0|||
130338896|NCT01639729|469213196|FG002|Overall Study|Withdrawal by Subject|1|||
130338897|NCT01639729|469213197|FG003|Overall Study|Withdrawal by Subject|1|||
130338898|NCT01639729|469213198|FG004|Overall Study|Withdrawal by Subject|0|||
130338899|NCT01639729|469213199|FG005|Overall Study|Withdrawal by Subject|0|||
130338900|NCT01640314|469213202|FG000|Overall Study|Protocol Violation|0|||
130338901|NCT01640314|469213203|FG001|Overall Study|Protocol Violation|1|||
130338902|NCT03672097|469213204|FG000|Period 1|Withdrawal by Subject|2|||
130338903|NCT03672097|469213204|FG000|Period 1|Adverse Event|1|||
130338904|NCT03672097|469213204|FG000|Period 1|Did not receive treatment|1|||
130338905|NCT03672097|469213204|FG000|Period 2|Withdrawal by Subject|3|||
130338906|NCT03672097|469213204|FG000|Period 2|Other|1|||
130338907|NCT01290796|469213205|FG000|Overall Study|Lost to Follow-up|21|||
130338908|NCT01290796|469213205|FG000|Overall Study|Withdrawal by Subject|4|||
130338909|NCT01290796|469213205|FG000|Overall Study|Physician Decision|2|||
130338910|NCT01290796|469213205|FG000|Overall Study|Secondary Surgical Intervention|2|||
130338911|NCT01290796|469213205|FG000|Overall Study|Withdrawal by Sponsor|1|||
130338912|NCT03087617|469213206|FG000|Overall Study|Lost to Follow-up|32|||
130338913|NCT03087617|469213207|FG001|Overall Study|Lost to Follow-up|30|||
130338914|NCT03087617|469213208|FG002|Overall Study|Lost to Follow-up|30|||
130338915|NCT03087617|469213209|FG003|Overall Study|Lost to Follow-up|39|||
130338916|NCT04450381|469213211|FG000|Overall Study|Protocol Violation|4|||
130338917|NCT04450381|469213211|FG000|Overall Study|Wrong device setting|2|||
130338918|NCT04556383|469213219|FG000|PCP|Lack of Efficacy|28|||
130338919|NCT04556383|469213220|FG001|PCP|Lack of Efficacy|23|||
130338920|NCT04556383|469213221|FG002|PCP|Lack of Efficacy|23|||
130338921|NCT04556383|469213222|FG003|PCP|Lack of Efficacy|0|||
130338922|NCT04556383|469213219|FG000|PCP|Study terminated by sponsor|15|||
130338923|NCT04556383|469213220|FG001|PCP|Study terminated by sponsor|13|||
130338924|NCT04556383|469213221|FG002|PCP|Study terminated by sponsor|16|||
130338925|NCT04556383|469213222|FG003|PCP|Study terminated by sponsor|0|||
130338926|NCT04556383|469213219|FG000|PCP|Withdrawal by Subject|8|||
130338927|NCT04556383|469213220|FG001|PCP|Withdrawal by Subject|6|||
130338928|NCT04556383|469213221|FG002|PCP|Withdrawal by Subject|6|||
130338929|NCT04556383|469213222|FG003|PCP|Withdrawal by Subject|0|||
130338930|NCT04556383|469213219|FG000|PCP|Adverse Event|1|||
130338931|NCT04556383|469213220|FG001|PCP|Adverse Event|7|||
130338932|NCT04556383|469213221|FG002|PCP|Adverse Event|7|||
130338933|NCT04556383|469213222|FG003|PCP|Adverse Event|0|||
130338934|NCT04556383|469213219|FG000|PCP|Other, Not Specified|1|||
130338935|NCT04556383|469213220|FG001|PCP|Other, Not Specified|2|||
130338936|NCT04556383|469213221|FG002|PCP|Other, Not Specified|1|||
130338937|NCT04556383|469213222|FG003|PCP|Other, Not Specified|0|||
130338938|NCT04556383|469213219|FG000|PCP|Protocol Violation|1|||
130338939|NCT04556383|469213220|FG001|PCP|Protocol Violation|0|||
130338940|NCT04556383|469213221|FG002|PCP|Protocol Violation|1|||
130338941|NCT04556383|469213222|FG003|PCP|Protocol Violation|0|||
130338942|NCT04556383|469213219|FG000|PCP|Lost to Follow-up|1|||
130338943|NCT04556383|469213220|FG001|PCP|Lost to Follow-up|0|||
130338944|NCT04556383|469213221|FG002|PCP|Lost to Follow-up|0|||
130338945|NCT04556383|469213222|FG003|PCP|Lost to Follow-up|0|||
130338946|NCT04556383|469213219|FG000|PCP|Physician Decision|0|||
130338947|NCT04556383|469213220|FG001|PCP|Physician Decision|1|||
130338948|NCT04556383|469213221|FG002|PCP|Physician Decision|0|||
130338949|NCT04556383|469213222|FG003|PCP|Physician Decision|0|||
130338950|NCT04556383|469213219|FG000|PCP|Site terminated by sponsor|0|||
130338951|NCT04556383|469213220|FG001|PCP|Site terminated by sponsor|1|||
130338952|NCT04556383|469213221|FG002|PCP|Site terminated by sponsor|0|||
130338953|NCT04556383|469213222|FG003|PCP|Site terminated by sponsor|0|||
130338954|NCT04556383|469213219|FG000|OLE|Study terminated by sponsor|0|||
130338955|NCT04556383|469213220|FG001|OLE|Study terminated by sponsor|0|||
130338956|NCT04556383|469213221|FG002|OLE|Study terminated by sponsor|0|||
130338957|NCT04556383|469213222|FG003|OLE|Study terminated by sponsor|68|||
130338958|NCT04556383|469213219|FG000|OLE|Withdrawal by Subject|0|||
130338959|NCT04556383|469213220|FG001|OLE|Withdrawal by Subject|0|||
130338960|NCT04556383|469213221|FG002|OLE|Withdrawal by Subject|0|||
130338961|NCT04556383|469213222|FG003|OLE|Withdrawal by Subject|10|||
130338962|NCT04556383|469213219|FG000|OLE|Lack of Efficacy|0|||
130338963|NCT04556383|469213220|FG001|OLE|Lack of Efficacy|0|||
130338964|NCT04556383|469213221|FG002|OLE|Lack of Efficacy|0|||
130338965|NCT04556383|469213222|FG003|OLE|Lack of Efficacy|7|||
130338966|NCT04556383|469213219|FG000|OLE|Adverse Event|0|||
130003535|NCT01514136|467977944|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
130003536|NCT01514136|467977937|FG000|Test Period 2; Test C*|holiday|0|||
130003537|NCT01514136|467977938|FG001|Test Period 2; Test C*|holiday|0|||
130003538|NCT01514136|467977939|FG002|Test Period 2; Test C*|holiday|0|||
130003539|NCT01514136|467977940|FG003|Test Period 2; Test C*|holiday|0|||
130003540|NCT01514136|467977941|FG004|Test Period 2; Test C*|holiday|0|||
130003541|NCT01514136|467977942|FG005|Test Period 2; Test C*|holiday|0|||
130003542|NCT01514136|467977943|FG006|Test Period 2; Test C*|holiday|1|||
130003543|NCT01514136|467977944|FG007|Test Period 2; Test C*|holiday|0|||
130003544|NCT01514136|467977937|FG000|Test Period 2; Test C*|Protocol Violation|0|||
130003545|NCT01514136|467977938|FG001|Test Period 2; Test C*|Protocol Violation|0|||
130003546|NCT01514136|467977939|FG002|Test Period 2; Test C*|Protocol Violation|0|||
130003547|NCT01514136|467977940|FG003|Test Period 2; Test C*|Protocol Violation|0|||
130003548|NCT01514136|467977941|FG004|Test Period 2; Test C*|Protocol Violation|0|||
130003549|NCT01514136|467977942|FG005|Test Period 2; Test C*|Protocol Violation|0|||
130003550|NCT01514136|467977943|FG006|Test Period 2; Test C*|Protocol Violation|1|||
130003551|NCT01514136|467977944|FG007|Test Period 2; Test C*|Protocol Violation|0|||
130003552|NCT02941926|467977945|FG000|Core Phase|Progressive disease|1109|||
130003553|NCT02941926|467977945|FG000|Core Phase|Adverse Event|504|||
130003554|NCT02941926|467977945|FG000|Core Phase|Subject/guardian decision|127|||
130003555|NCT02941926|467977945|FG000|Core Phase|Physician Decision|112|||
130003556|NCT02941926|467977945|FG000|Core Phase|Death|46|||
130003557|NCT02941926|467977945|FG000|Core Phase|Protocol deviation|34|||
130003558|NCT02941926|467977945|FG000|Core Phase|Lost to Follow-up|8|||
130003559|NCT02941926|467977945|FG000|Core Phase|Technical problems|5|||
130003560|NCT02941926|467977945|FG000|Extension Phase|Physician Decision|155|||
130003561|NCT02941926|467977945|FG000|Extension Phase|Progressive disease|115|||
130003562|NCT02941926|467977945|FG000|Extension Phase|Adverse Event|13|||
130003563|NCT02941926|467977945|FG000|Extension Phase|Subject/Guardian decision|12|||
130003564|NCT02941926|467977945|FG000|Extension Phase|Death|6|||
130003565|NCT02729740|467977946|FG000|Overall Study|Early Termination|130|||
130003566|NCT02729740|467977946|FG000|Overall Study|Other|1|||
130003567|NCT00601705|467977950|FG000|Overall Study|Withdrawal by Subject|1|||
130003568|NCT03044249|467977953|FG000|Overall Study|Adverse Event|4|||
130003569|NCT03044249|467977954|FG001|Overall Study|Adverse Event|9|||
130003570|NCT03044249|467977953|FG000|Overall Study|Lost to Follow-up|1|||
130003571|NCT03044249|467977954|FG001|Overall Study|Lost to Follow-up|0|||
130003572|NCT03044249|467977953|FG000|Overall Study|Non-compliance with Study Drug|1|||
130003573|NCT03044249|467977954|FG001|Overall Study|Non-compliance with Study Drug|0|||
130003574|NCT03044249|467977953|FG000|Overall Study|Study Terminated by Sponsor|2|||
130003575|NCT03044249|467977954|FG001|Overall Study|Study Terminated by Sponsor|0|||
130003576|NCT03044249|467977953|FG000|Overall Study|Withdrawal by Subject|2|||
130003577|NCT03044249|467977954|FG001|Overall Study|Withdrawal by Subject|5|||
130003578|NCT02101021|467977955|FG000|Overall Study|Death|4|||
130003579|NCT02101021|467977956|FG001|Overall Study|Death|3|||
130003580|NCT02101021|467977957|FG002|Overall Study|Death|6|||
130003581|NCT02101021|467977958|FG003|Overall Study|Death|0|||
130003582|NCT02101021|467977959|FG004|Overall Study|Death|3|||
130003583|NCT02101021|467977955|FG000|Overall Study|Withdrew Consent from study|1|||
130003584|NCT02101021|467977956|FG001|Overall Study|Withdrew Consent from study|1|||
130003585|NCT02101021|467977957|FG002|Overall Study|Withdrew Consent from study|0|||
130003586|NCT02101021|467977958|FG003|Overall Study|Withdrew Consent from study|2|||
130003587|NCT02101021|467977959|FG004|Overall Study|Withdrew Consent from study|0|||
130003588|NCT02101021|467977955|FG000|Overall Study|Lost to Follow-up|1|||
130003589|NCT02101021|467977956|FG001|Overall Study|Lost to Follow-up|0|||
130003590|NCT02101021|467977957|FG002|Overall Study|Lost to Follow-up|0|||
130003591|NCT02101021|467977958|FG003|Overall Study|Lost to Follow-up|0|||
130003592|NCT02101021|467977959|FG004|Overall Study|Lost to Follow-up|0|||
130003593|NCT02101021|467977955|FG000|Overall Study|Study Terminated by Sponsor|1|||
130338967|NCT04556383|469213220|FG001|OLE|Adverse Event|0|||
130003594|NCT02101021|467977956|FG001|Overall Study|Study Terminated by Sponsor|0|||
130003595|NCT02101021|467977957|FG002|Overall Study|Study Terminated by Sponsor|1|||
130216487|NCT00423813|468755578|FG000|Overall Study|Subject started night shift work|1|||
130003596|NCT02101021|467977958|FG003|Overall Study|Study Terminated by Sponsor|1|||
130003597|NCT02101021|467977959|FG004|Overall Study|Study Terminated by Sponsor|1|||
130003598|NCT01621542|467977960|FG000|Overall Study|Adverse Event|0|||
130003599|NCT01621542|467977961|FG001|Overall Study|Adverse Event|0|||
130003600|NCT01621542|467977962|FG002|Overall Study|Adverse Event|1|||
130003601|NCT01621542|467977963|FG003|Overall Study|Adverse Event|3|||
130003602|NCT01621542|467977964|FG004|Overall Study|Adverse Event|0|||
130003603|NCT01621542|467977965|FG005|Overall Study|Adverse Event|0|||
130003604|NCT01621542|467977960|FG000|Overall Study|Death|0|||
130216488|NCT00423813|468755579|FG001|Overall Study|Subject started night shift work|0|||
130338968|NCT04556383|469213221|FG002|OLE|Adverse Event|0|||
130003605|NCT01621542|467977961|FG001|Overall Study|Death|1|||
130003606|NCT01621542|467977962|FG002|Overall Study|Death|0|||
130338969|NCT04556383|469213222|FG003|OLE|Adverse Event|2|||
130338970|NCT04556383|469213219|FG000|OLE|Other, Not Specified|0|||
130338971|NCT04556383|469213220|FG001|OLE|Other, Not Specified|0|||
130338972|NCT04556383|469213221|FG002|OLE|Other, Not Specified|0|||
130338973|NCT04556383|469213222|FG003|OLE|Other, Not Specified|2|||
130338974|NCT04556383|469213219|FG000|OLE|Death|0|||
130338975|NCT04556383|469213220|FG001|OLE|Death|0|||
130338976|NCT04556383|469213221|FG002|OLE|Death|0|||
130338977|NCT04556383|469213222|FG003|OLE|Death|1|||
130338978|NCT04556383|469213219|FG000|OLE|Lost to Follow-up|0|||
130338979|NCT04556383|469213220|FG001|OLE|Lost to Follow-up|0|||
130338980|NCT04556383|469213221|FG002|OLE|Lost to Follow-up|0|||
130338981|NCT04556383|469213222|FG003|OLE|Lost to Follow-up|1|||
130338982|NCT01994889|469213228|FG000|Overall Study|Adverse Event|5|||
130338983|NCT01994889|469213229|FG001|Overall Study|Adverse Event|12|||
130338984|NCT01994889|469213230|FG002|Overall Study|Adverse Event|11|||
130338985|NCT01994889|469213228|FG000|Overall Study|Cardiac Device Implantation|0|||
130338986|NCT01994889|469213229|FG001|Overall Study|Cardiac Device Implantation|2|||
130338987|NCT01994889|469213230|FG002|Overall Study|Cardiac Device Implantation|0|||
130338988|NCT01994889|469213228|FG000|Overall Study|Organ Transplantation|1|||
130338989|NCT01994889|469213229|FG001|Overall Study|Organ Transplantation|5|||
130338990|NCT01994889|469213230|FG002|Overall Study|Organ Transplantation|5|||
130338991|NCT01994889|469213228|FG000|Overall Study|No longer willing to participate|8|||
130338992|NCT01994889|469213229|FG001|Overall Study|No longer willing to participate|17|||
130338993|NCT01994889|469213230|FG002|Overall Study|No longer willing to participate|37|||
130338994|NCT01994889|469213228|FG000|Overall Study|Lost to Follow-up|0|||
130338995|NCT01994889|469213229|FG001|Overall Study|Lost to Follow-up|1|||
130338996|NCT01994889|469213230|FG002|Overall Study|Lost to Follow-up|0|||
130338997|NCT01994889|469213228|FG000|Overall Study|Protocol Violation|0|||
130338998|NCT01994889|469213229|FG001|Overall Study|Protocol Violation|1|||
130338999|NCT01994889|469213230|FG002|Overall Study|Protocol Violation|1|||
130339000|NCT01994889|469213228|FG000|Overall Study|Death|14|||
130339001|NCT01994889|469213229|FG001|Overall Study|Death|25|||
130339002|NCT01994889|469213230|FG002|Overall Study|Death|38|||
130339003|NCT00929643|469213231|FG000|Overall Study|Protocol Violation|2|||
130339004|NCT02873429|469213234|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
130339005|NCT02873429|469213235|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
130339006|NCT02873429|469213234|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
130339007|NCT02873429|469213235|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
130339008|NCT02873429|469213234|FG000|16 Weeks|Lost to Follow-up|3|||
130339009|NCT02873429|469213235|FG001|16 Weeks|Lost to Follow-up|0|||
130339010|NCT00744042|469213236|FG000|Overall Study|Withdrawal by Subject|1|||
130339011|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
130339012|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
130339013|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
130339014|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130339015|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
130339016|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
130339017|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130339018|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130339019|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
130339020|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130339021|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
130339022|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130339023|NCT03158285|469213240|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
130339024|NCT03158285|469213241|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
130339025|NCT03158285|469213242|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
130339026|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
130339027|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
130339028|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
130003607|NCT01621542|467977963|FG003|Overall Study|Death|0|||
130339029|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
130339030|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
130339031|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
130339032|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
130339033|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
130339034|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
130003608|NCT01621542|467977964|FG004|Overall Study|Death|0|||
130003609|NCT01621542|467977965|FG005|Overall Study|Death|0|||
130003610|NCT01621542|467977960|FG000|Overall Study|Physician Decision|1|||
130339035|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
130339036|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
130339037|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
130003611|NCT01621542|467977961|FG001|Overall Study|Physician Decision|0|||
130003612|NCT01621542|467977962|FG002|Overall Study|Physician Decision|1|||
130003613|NCT01621542|467977963|FG003|Overall Study|Physician Decision|13|||
130003614|NCT01621542|467977964|FG004|Overall Study|Physician Decision|3|||
130339038|NCT03158285|469213240|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
130339039|NCT03158285|469213241|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
130339040|NCT03158285|469213242|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
130339041|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
130339042|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
130339043|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
130339044|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
130339045|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
130339046|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
130339047|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
130339048|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
130339049|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
130339050|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
130339051|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
130339052|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
130339053|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Death|1|||
130339054|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Death|0|||
130339055|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Death|0|||
130339056|NCT03158285|469213240|FG000|Active Treatment Period: Week 52-100|Other|4|||
130339057|NCT03158285|469213241|FG001|Active Treatment Period: Week 52-100|Other|1|||
130339058|NCT03158285|469213242|FG002|Active Treatment Period: Week 52-100|Other|0|||
130339059|NCT02228980|469213243|FG000|Overall Study|Adverse Event|14|||
130339060|NCT02228980|469213244|FG001|Overall Study|Adverse Event|0|||
130339061|NCT02228980|469213245|FG002|Overall Study|Adverse Event|0|||
130339062|NCT02228980|469213246|FG003|Overall Study|Adverse Event|0|||
130339063|NCT02228980|469213243|FG000|Overall Study|Protocol Violation|7|||
130339064|NCT02228980|469213244|FG001|Overall Study|Protocol Violation|0|||
130339065|NCT02228980|469213245|FG002|Overall Study|Protocol Violation|0|||
130339066|NCT02228980|469213246|FG003|Overall Study|Protocol Violation|0|||
130339067|NCT02228980|469213243|FG000|Overall Study|Withdrawal by Subject|3|||
130339068|NCT02228980|469213244|FG001|Overall Study|Withdrawal by Subject|3|||
130339069|NCT02228980|469213245|FG002|Overall Study|Withdrawal by Subject|2|||
130339070|NCT02228980|469213246|FG003|Overall Study|Withdrawal by Subject|3|||
130339071|NCT04629066|469213247|FG000|Overall Study|Lost to Follow-up|3|||
130339072|NCT04629066|469213248|FG001|Overall Study|Lost to Follow-up|2|||
130339073|NCT00530504|469213251|FG000|Overall Study|Death|54|||
130339074|NCT00530504|469213251|FG000|Overall Study|Lost to Follow-up|26|||
130339075|NCT00530504|469213251|FG000|Overall Study|Withdrawal by Subject|39|||
130339076|NCT00530504|469213251|FG000|Overall Study|Exited study due to other reasons|33|||
130339077|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339078|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
130339079|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339080|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
130339081|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339082|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
130339083|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
130339084|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
130339085|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
130339086|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
130339087|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339088|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
130339089|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339090|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339091|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339092|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130003615|NCT01621542|467977965|FG005|Overall Study|Physician Decision|1|||
130003616|NCT01621542|467977960|FG000|Overall Study|Withdrawal by Subject|2|||
130003617|NCT01621542|467977961|FG001|Overall Study|Withdrawal by Subject|0|||
130339093|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339094|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
130339095|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339096|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
130003618|NCT01621542|467977962|FG002|Overall Study|Withdrawal by Subject|1|||
130003619|NCT01621542|467977963|FG003|Overall Study|Withdrawal by Subject|3|||
130339097|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
130003620|NCT01621542|467977964|FG004|Overall Study|Withdrawal by Subject|3|||
130339098|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339099|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339100|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
130339101|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
130339102|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
130339103|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
130339104|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Other|0|||
130339105|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Other|0|||
130339106|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Other|1|||
130339107|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Other|1|||
130339108|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Other|0|||
130339109|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Other|0|||
130339110|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Other|0|||
130339111|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Other|1|||
130339112|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Other|0|||
130339113|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|Death|0|||
130339114|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|Death|0|||
130339115|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|Death|0|||
130339116|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|Death|0|||
130003621|NCT01621542|467977965|FG005|Overall Study|Withdrawal by Subject|3|||
130339117|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|Death|0|||
130339118|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|Death|1|||
130339119|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|Death|0|||
130339120|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|Death|0|||
130339121|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|Death|0|||
130339122|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339123|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339124|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339125|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339126|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339127|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
130339128|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
130339129|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339130|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
130339131|NCT00557856|469213260|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
130339132|NCT00557856|469213261|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339133|NCT00557856|469213262|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339134|NCT00557856|469213263|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339135|NCT00557856|469213264|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339136|NCT00557856|469213265|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339137|NCT00557856|469213266|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339138|NCT00557856|469213267|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339139|NCT00557856|469213268|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
130339140|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339141|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339142|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339143|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339144|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339145|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339146|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339147|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
130339148|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
130339149|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339150|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339151|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339152|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339153|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130003622|NCT01621542|467977960|FG000|Overall Study|progression/treatment failure|2|||
130003623|NCT01621542|467977961|FG001|Overall Study|progression/treatment failure|4|||
130003624|NCT01621542|467977962|FG002|Overall Study|progression/treatment failure|3|||
130003625|NCT01621542|467977963|FG003|Overall Study|progression/treatment failure|7|||
130003626|NCT01621542|467977964|FG004|Overall Study|progression/treatment failure|3|||
130003627|NCT01621542|467977965|FG005|Overall Study|progression/treatment failure|5|||
130339154|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339155|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130339156|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
130003628|NCT01621542|467977960|FG000|Overall Study|Protocol Violation|0|||
130216489|NCT00423813|468755580|FG002|Overall Study|Subject started night shift work|0|||
130003629|NCT01621542|467977961|FG001|Overall Study|Protocol Violation|0|||
130003630|NCT01621542|467977962|FG002|Overall Study|Protocol Violation|0|||
130003631|NCT01621542|467977963|FG003|Overall Study|Protocol Violation|1|||
130003632|NCT01621542|467977964|FG004|Overall Study|Protocol Violation|0|||
130003633|NCT01621542|467977965|FG005|Overall Study|Protocol Violation|0|||
130003634|NCT01621542|467977960|FG000|Overall Study|study stopped by sponsor|0|||
130003635|NCT01621542|467977961|FG001|Overall Study|study stopped by sponsor|0|||
130003636|NCT01621542|467977962|FG002|Overall Study|study stopped by sponsor|0|||
130339157|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
130339158|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
130339159|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
130339160|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
130339161|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
130339162|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
130339163|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
130339164|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
130339165|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
130339166|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
130339167|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Other|0|||
130339168|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Other|0|||
130339169|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Other|0|||
130339170|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Other|0|||
130339171|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Other|0|||
130339172|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Other|0|||
130339173|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Other|0|||
130339174|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Other|0|||
130339175|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Other|1|||
130339176|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|Death|0|||
130339177|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|Death|0|||
130339178|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|Death|0|||
130339179|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|Death|0|||
130339180|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|Death|0|||
130339181|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|Death|0|||
130339182|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|Death|0|||
130339183|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|Death|0|||
130339184|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|Death|2|||
130339185|NCT00557856|469213260|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339186|NCT00557856|469213261|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339187|NCT00557856|469213262|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339188|NCT00557856|469213263|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339189|NCT00557856|469213264|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339190|NCT00557856|469213265|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339191|NCT00557856|469213266|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339192|NCT00557856|469213267|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
130339193|NCT00557856|469213268|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
130339194|NCT02537015|469213269|FG000|Overall Study|Adverse Event|3|||
130339195|NCT02537015|469213269|FG000|Overall Study|Withdrawal by Subject|2|||
130339196|NCT02537015|469213269|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130339197|NCT01808092|469213270|FG000|Overall Study|Death|39|||
130339198|NCT01808092|469213271|FG001|Overall Study|Death|29|||
130339199|NCT01808092|469213270|FG000|Overall Study|Lost to Follow-up|3|||
130339200|NCT01808092|469213271|FG001|Overall Study|Lost to Follow-up|7|||
130339201|NCT01808092|469213270|FG000|Overall Study|Withdrawal by Subject|9|||
130339202|NCT01808092|469213271|FG001|Overall Study|Withdrawal by Subject|4|||
130339203|NCT01808092|469213270|FG000|Overall Study|Other Eligibility criteria|3|||
130339204|NCT01808092|469213271|FG001|Overall Study|Other Eligibility criteria|5|||
130339205|NCT03952039|469213272|FG000|Overall Study|Adverse Event|22|||
130339206|NCT03952039|469213273|FG001|Overall Study|Adverse Event|8|||
130339207|NCT03952039|469213272|FG000|Overall Study|Withdrawal by Participant|17|||
130339208|NCT03952039|469213273|FG001|Overall Study|Withdrawal by Participant|12|||
130339209|NCT03952039|469213272|FG000|Overall Study|Death|13|||
130339210|NCT03952039|469213273|FG001|Overall Study|Death|6|||
130339211|NCT03952039|469213272|FG000|Overall Study|Lack of Efficacy|12|||
130339212|NCT03952039|469213273|FG001|Overall Study|Lack of Efficacy|2|||
130339213|NCT03952039|469213272|FG000|Overall Study|Physician Decision|9|||
130339214|NCT03952039|469213273|FG001|Overall Study|Physician Decision|3|||
130339215|NCT03952039|469213272|FG000|Overall Study|Progressive Disease|6|||
130339216|NCT03952039|469213273|FG001|Overall Study|Progressive Disease|4|||
130339217|NCT03952039|469213272|FG000|Overall Study|Other Reasons|12|||
130339218|NCT03952039|469213273|FG001|Overall Study|Other Reasons|4|||
130339219|NCT05009979|469213274|FG000|Overall Study|Withdrawal by Subject|1|||
130339220|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
130003637|NCT01621542|467977963|FG003|Overall Study|study stopped by sponsor|1|||
130003638|NCT01621542|467977964|FG004|Overall Study|study stopped by sponsor|0|||
130339221|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
130339222|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Physician Decision|1|||
130339223|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Physician Decision|1|||
130339224|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
130339225|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
130339226|NCT01888432|469214900|FG000|12-month Analysis (FAS)|Death|4|||
130339227|NCT01888432|469214901|FG001|12-month Analysis (FAS)|Death|3|||
130339228|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Graft loss|0|||
130339229|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Graft loss|1|||
130339230|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
130339231|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
130339232|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Physician Decision|2|||
130339233|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Physician Decision|4|||
130339234|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
130339235|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
130339236|NCT01888432|469214900|FG000|24-month Analysis (FAS)|Death|8|||
130339237|NCT01888432|469214901|FG001|24-month Analysis (FAS)|Death|4|||
130339238|NCT01888432|469214900|FG000|36-month Analysis (Extension)|Death|1|||
130339239|NCT01888432|469214901|FG001|36-month Analysis (Extension)|Death|0|||
130339240|NCT00130247|469214904|FG000|Overall Study|Pregnancy|1|||
130339241|NCT00130247|469214905|FG001|Overall Study|Pregnancy|0|||
130339242|NCT00130247|469214904|FG000|Overall Study|Post-randomization exclusion|1|||
130339243|NCT00130247|469214905|FG001|Overall Study|Post-randomization exclusion|2|||
130339244|NCT00130247|469214904|FG000|Overall Study|Not compliant with DOT|0|||
130339245|NCT00130247|469214905|FG001|Overall Study|Not compliant with DOT|2|||
130339246|NCT03844945|469214906|FG000|Overall Study|Adverse Event|1|||
130339247|NCT03844945|469214907|FG001|Overall Study|Adverse Event|1|||
130339248|NCT03844945|469214908|FG002|Overall Study|Adverse Event|4|||
130339249|NCT03844945|469214909|FG003|Overall Study|Adverse Event|0|||
130339250|NCT03844945|469214906|FG000|Overall Study|Withdrawal by Subject|0|||
130339251|NCT03844945|469214907|FG001|Overall Study|Withdrawal by Subject|0|||
130339252|NCT03844945|469214908|FG002|Overall Study|Withdrawal by Subject|1|||
130339253|NCT03844945|469214909|FG003|Overall Study|Withdrawal by Subject|0|||
130003639|NCT01621542|467977965|FG005|Overall Study|study stopped by sponsor|0|||
130003640|NCT01368042|467977966|FG000|Overall Study|Death|14|||
130003641|NCT01368042|467977966|FG000|Overall Study|Protocol Violation|11|||
130003642|NCT01368042|467977966|FG000|Overall Study|Lost to Follow-up|4|||
130003643|NCT01368042|467977966|FG000|Overall Study|Transplanted|1|||
130003644|NCT00955279|467977967|FG000|Overall Study|Other|0|||
130003645|NCT00955279|467977968|FG001|Overall Study|Other|0|||
130003646|NCT00955279|467977969|FG002|Overall Study|Other|3|||
130003647|NCT00955279|467977967|FG000|Overall Study|Death|1|||
130003648|NCT00955279|467977968|FG001|Overall Study|Death|1|||
130003649|NCT00955279|467977969|FG002|Overall Study|Death|1|||
130003650|NCT00955279|467977967|FG000|Overall Study|Lost to Follow-up|0|||
130003651|NCT00955279|467977968|FG001|Overall Study|Lost to Follow-up|3|||
130003652|NCT00955279|467977969|FG002|Overall Study|Lost to Follow-up|1|||
130003653|NCT00955279|467977967|FG000|Overall Study|Withdrawal by Subject|2|||
130003654|NCT00955279|467977968|FG001|Overall Study|Withdrawal by Subject|0|||
130003655|NCT00955279|467977969|FG002|Overall Study|Withdrawal by Subject|3|||
130003656|NCT00760669|467977970|FG000|Overall Study|Not assessed for overall improvement|18|||
130003657|NCT00760669|467977970|FG000|Overall Study|Participants missing efficacy assessment|6|||
130003658|NCT00760669|467977970|FG000|Overall Study|Participants with overlapping cases|1|||
130003659|NCT00760669|467977970|FG000|Overall Study|Took drug before entering in contract|5|||
130003660|NCT02663271|467977973|FG000|Overall Study|Withdrawal by Subject|5|||
130003661|NCT02663271|467977973|FG000|Overall Study|Lack of Efficacy|1|||
130003662|NCT01572675|467977974|FG000|Overall Study|End of prescribed treatment|140|||
130003663|NCT01572675|467977975|FG001|Overall Study|End of prescribed treatment|118|||
130003664|NCT01572675|467977974|FG000|Overall Study|Recovery|16|||
130003665|NCT01572675|467977975|FG001|Overall Study|Recovery|23|||
130003666|NCT01572675|467977974|FG000|Overall Study|Lack of Efficacy|31|||
130003667|NCT01572675|467977975|FG001|Overall Study|Lack of Efficacy|31|||
130003668|NCT01572675|467977974|FG000|Overall Study|Intolerance|6|||
130003669|NCT01572675|467977975|FG001|Overall Study|Intolerance|5|||
130003670|NCT01572675|467977974|FG000|Overall Study|Improved symptoms|8|||
130003671|NCT01572675|467977975|FG001|Overall Study|Improved symptoms|2|||
130003672|NCT01572675|467977974|FG000|Overall Study|Surgical intervention|3|||
130003673|NCT01572675|467977975|FG001|Overall Study|Surgical intervention|6|||
130003674|NCT01572675|467977974|FG000|Overall Study|Withdrawal by Subject|5|||
130003675|NCT01572675|467977975|FG001|Overall Study|Withdrawal by Subject|1|||
130003676|NCT01572675|467977974|FG000|Overall Study|Physician Decision|2|||
130003677|NCT01572675|467977975|FG001|Overall Study|Physician Decision|2|||
130003678|NCT01572675|467977974|FG000|Overall Study|Death unrelated to coxibs|1|||
130003679|NCT01572675|467977975|FG001|Overall Study|Death unrelated to coxibs|1|||
130003680|NCT01572675|467977974|FG000|Overall Study|Other disease detected|1|||
130003681|NCT01572675|467977975|FG001|Overall Study|Other disease detected|1|||
130003682|NCT01572675|467977974|FG000|Overall Study|Unknown reason|1|||
130339254|NCT03844945|469214906|FG000|Overall Study|Lack of Efficacy|0|||
130339255|NCT03844945|469214907|FG001|Overall Study|Lack of Efficacy|0|||
130339256|NCT03844945|469214908|FG002|Overall Study|Lack of Efficacy|0|||
130003683|NCT01572675|467977975|FG001|Overall Study|Unknown reason|1|||
130339257|NCT03844945|469214909|FG003|Overall Study|Lack of Efficacy|1|||
130339258|NCT04473235|469214910|FG000|Overall Study|Lost to Follow-up|6|||
130339259|NCT04473235|469214911|FG001|Overall Study|Lost to Follow-up|5|||
130339260|NCT04473235|469214910|FG000|Overall Study|Declined continuation|2|||
130339261|NCT04473235|469214911|FG001|Overall Study|Declined continuation|0|||
130339262|NCT04473235|469214910|FG000|Overall Study|Physician Decision|1|||
130339263|NCT04473235|469214911|FG001|Overall Study|Physician Decision|1|||
130339264|NCT04473235|469214910|FG000|Overall Study|Protocol Violation|10|||
130339265|NCT04473235|469214911|FG001|Overall Study|Protocol Violation|6|||
130339266|NCT01754402|469214912|FG000|Overall Study|Death|0|||
130339267|NCT01754402|469214913|FG001|Overall Study|Death|0|||
130339268|NCT01754402|469214914|FG002|Overall Study|Death|1|||
130339269|NCT01754402|469214912|FG000|Overall Study|Adverse Event|2|||
130339270|NCT01754402|469214913|FG001|Overall Study|Adverse Event|2|||
130339271|NCT01754402|469214914|FG002|Overall Study|Adverse Event|1|||
130339272|NCT01754402|469214912|FG000|Overall Study|Withdrawal by Subject|0|||
130339273|NCT01754402|469214913|FG001|Overall Study|Withdrawal by Subject|0|||
130339274|NCT01754402|469214914|FG002|Overall Study|Withdrawal by Subject|1|||
130339275|NCT01754402|469214912|FG000|Overall Study|Lack of Efficacy|0|||
130339276|NCT01754402|469214913|FG001|Overall Study|Lack of Efficacy|0|||
130339277|NCT01754402|469214914|FG002|Overall Study|Lack of Efficacy|1|||
130339278|NCT01282463|469214915|FG000|Overall Study|Lost to Follow-up|1|||
130339279|NCT01282463|469214916|FG001|Overall Study|Lost to Follow-up|0|||
130003684|NCT01572675|467977974|FG000|Overall Study|Rheumatologist new evaluation|0|||
130003685|NCT01572675|467977975|FG001|Overall Study|Rheumatologist new evaluation|1|||
130003686|NCT01572675|467977974|FG000|Overall Study|Missing data|1|||
130003687|NCT01572675|467977975|FG001|Overall Study|Missing data|4|||
130003688|NCT01572675|467977974|FG000|Overall Study|Lost to Follow-up|22|||
130003689|NCT01572675|467977975|FG001|Overall Study|Lost to Follow-up|27|||
130003690|NCT03346057|467977980|FG000|Overall Study|Death|1|||
130003691|NCT03346057|467977981|FG001|Overall Study|Death|2|||
130003692|NCT03346057|467977982|FG002|Overall Study|Death|0|||
130003693|NCT03346057|467977983|FG003|Overall Study|Death|0|||
130003694|NCT03346057|467977980|FG000|Overall Study|Lost to Follow-up|0|||
130003695|NCT03346057|467977981|FG001|Overall Study|Lost to Follow-up|2|||
130003696|NCT03346057|467977982|FG002|Overall Study|Lost to Follow-up|1|||
130003697|NCT03346057|467977983|FG003|Overall Study|Lost to Follow-up|0|||
130003698|NCT03346057|467977980|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
130003699|NCT03346057|467977981|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
130003700|NCT03346057|467977982|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
130003701|NCT03346057|467977983|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
130003702|NCT03346057|467977980|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
130003703|NCT03346057|467977981|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
130003704|NCT03346057|467977982|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
130003705|NCT03346057|467977983|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
130003706|NCT03346057|467977980|FG000|Overall Study|Physician Decision|3|||
130003707|NCT03346057|467977981|FG001|Overall Study|Physician Decision|2|||
130003708|NCT03346057|467977982|FG002|Overall Study|Physician Decision|0|||
130003709|NCT03346057|467977983|FG003|Overall Study|Physician Decision|2|||
130003710|NCT03346057|467977980|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
130003711|NCT03346057|467977981|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
130003712|NCT03346057|467977982|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
130003713|NCT03346057|467977983|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
130003714|NCT03346057|467977980|FG000|Overall Study|Withdrawal by Subject|1|||
130003715|NCT03346057|467977981|FG001|Overall Study|Withdrawal by Subject|0|||
130003716|NCT03346057|467977982|FG002|Overall Study|Withdrawal by Subject|0|||
130003717|NCT03346057|467977983|FG003|Overall Study|Withdrawal by Subject|0|||
130003718|NCT02921269|467977984|FG000|Overall Study|Did not complete DLT period|1|||
130003719|NCT02003014|467977994|FG000|Overall Study|Case report forms uncollected|9|||
130003720|NCT02003014|467977994|FG000|Overall Study|Treatment started after contract period|1|||
130003721|NCT02003014|467977994|FG000|Overall Study|Patient did not visit the study site|5|||
130003722|NCT02003014|467977994|FG000|Overall Study|Investigator's transfer|4|||
130003723|NCT01660451|467977995|FG000|Overall Study|Protocol Violation|0|||
130003724|NCT01660451|467977996|FG001|Overall Study|Protocol Violation|1|||
130003725|NCT01660451|467977997|FG002|Overall Study|Protocol Violation|1|||
130003726|NCT01660451|467977995|FG000|Overall Study|AE not associated with clinical disease progression|13|||
130003727|NCT01660451|467977996|FG001|Overall Study|AE not associated with clinical disease progression|10|||
130003728|NCT01660451|467977997|FG002|Overall Study|AE not associated with clinical disease progression|40|||
130339280|NCT01282463|469214917|FG002|Overall Study|Lost to Follow-up|0|||
130339281|NCT01282463|469214915|FG000|Overall Study|Withdrawal by Subject|6|||
130339282|NCT01282463|469214916|FG001|Overall Study|Withdrawal by Subject|2|||
130339283|NCT01282463|469214917|FG002|Overall Study|Withdrawal by Subject|3|||
130339284|NCT01282463|469214915|FG000|Overall Study|"Never Treated Death"|0|||
130339285|NCT01282463|469214916|FG001|Overall Study|"Never Treated Death"|1|||
130339286|NCT01282463|469214917|FG002|Overall Study|"Never Treated Death"|0|||
130339287|NCT01282463|469214915|FG000|Overall Study|"Never Treated PD"|0|||
130339288|NCT01282463|469214916|FG001|Overall Study|"Never Treated PD"|1|||
130339289|NCT01282463|469214917|FG002|Overall Study|"Never Treated PD"|0|||
130339290|NCT01282463|469214915|FG000|Overall Study|Protocol Violation|0|||
130339291|NCT01282463|469214916|FG001|Overall Study|Protocol Violation|0|||
130339292|NCT01282463|469214917|FG002|Overall Study|Protocol Violation|1|||
130339293|NCT01282463|469214915|FG000|Overall Study|Physician Decision|1|||
130339294|NCT01282463|469214916|FG001|Overall Study|Physician Decision|0|||
130339295|NCT01282463|469214917|FG002|Overall Study|Physician Decision|0|||
130339296|NCT00588861|469214923|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
130339297|NCT00588861|469214924|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
130339298|NCT00588861|469214923|FG000|6 Months|Patients did not return for follow-up|98|||
130339299|NCT00588861|469214924|FG001|6 Months|Patients did not return for follow-up|73|||
130339300|NCT00588861|469214923|FG000|1 Year|Patients did not return for follow-up|89|||
130339301|NCT00588861|469214924|FG001|1 Year|Patients did not return for follow-up|82|||
130339302|NCT00588861|469214923|FG000|2 Years|Patients did not return for follow-up|92|||
130339303|NCT00588861|469214924|FG001|2 Years|Patients did not return for follow-up|87|||
130339304|NCT00588861|469214923|FG000|4 Years|Patients did not return for follow-up|91|||
130339305|NCT00588861|469214924|FG001|4 Years|Patients did not return for follow-up|103|||
130339306|NCT00588861|469214923|FG000|6 Years|Patients did not return for follow-up|104|||
130339307|NCT00588861|469214924|FG001|6 Years|Patients did not return for follow-up|109|||
130339308|NCT00588861|469214923|FG000|8 Years|Patients did not return for follow-up|105|||
130339309|NCT00588861|469214924|FG001|8 Years|Patients did not return for follow-up|114|||
130339310|NCT00588861|469214923|FG000|10 Years|Incomplete due to study termination|107|||
130339311|NCT00588861|469214924|FG001|10 Years|Incomplete due to study termination|114|||
130339312|NCT01239992|469214925|FG000|Overall Study|Withdrawal by Subject|2|||
130339313|NCT02848729|469214928|FG000|Overall Study|Withdrawal by Subject|1|||
130339314|NCT02848729|469214929|FG001|Overall Study|Withdrawal by Subject|0|||
130339315|NCT02848729|469214928|FG000|Overall Study|Emesis|15|||
130339316|NCT02848729|469214929|FG001|Overall Study|Emesis|11|||
130339317|NCT00791076|469214930|FG000|Overall Study|Study was terminated,PI left institution|8|||
130339318|NCT02052414|469214933|FG000|Overall Study|Adverse Event|12|||
130339319|NCT02052414|469214933|FG000|Overall Study|Lack of Efficacy|2|||
130339320|NCT02052414|469214933|FG000|Overall Study|Withdrawal by Subject|3|||
130339321|NCT02704143|469214936|FG000|Overall Study|disease progression|10|||
130339322|NCT02151773|469214937|FG000|Overall Study|Protocol Deviation|64|||
130339323|NCT00395343|469214938|FG000|Overall Study|Adverse Event|13|||
130339324|NCT00395343|469214939|FG001|Overall Study|Adverse Event|5|||
130339325|NCT00395343|469214938|FG000|Overall Study|Lack of Efficacy|0|||
130339326|NCT00395343|469214939|FG001|Overall Study|Lack of Efficacy|1|||
130339327|NCT00395343|469214938|FG000|Overall Study|Lost to Follow-up|4|||
130339328|NCT00395343|469214939|FG001|Overall Study|Lost to Follow-up|4|||
130339329|NCT00395343|469214938|FG000|Overall Study|Physician Decision|2|||
130339330|NCT00395343|469214939|FG001|Overall Study|Physician Decision|4|||
130339331|NCT00395343|469214938|FG000|Overall Study|Protocol Violation|6|||
130339332|NCT00395343|469214939|FG001|Overall Study|Protocol Violation|8|||
130339333|NCT00395343|469214938|FG000|Overall Study|Withdrawal by Subject|11|||
130339334|NCT00395343|469214939|FG001|Overall Study|Withdrawal by Subject|12|||
130339335|NCT00395343|469214938|FG000|Overall Study|Other|5|||
130339336|NCT00395343|469214939|FG001|Overall Study|Other|2|||
130339337|NCT04605991|469214942|FG000|Overall Study|Adverse Event|5|||
130339338|NCT04605991|469214942|FG000|Overall Study|Lack of Efficacy|1|||
130339339|NCT04605991|469214942|FG000|Overall Study|Lost to Follow-up|8|||
130339340|NCT04605991|469214942|FG000|Overall Study|Physician Decision|4|||
130339341|NCT04605991|469214942|FG000|Overall Study|Withdrawal by Subject|14|||
130339342|NCT04605991|469214942|FG000|Overall Study|Non-compliance with study|1|||
130339343|NCT03263702|469214943|FG000|Overall Study|Lost to Follow-up|2|||
130339344|NCT03263702|469214944|FG001|Overall Study|Lost to Follow-up|2|||
130339345|NCT03263702|469214943|FG000|Overall Study|Withdrawal by Subject|1|||
130339346|NCT03263702|469214944|FG001|Overall Study|Withdrawal by Subject|2|||
130339347|NCT00966875|469214946|FG000|Part A|Adverse Event|2|||
130339348|NCT00966875|469214947|FG001|Part A|Adverse Event|1|||
130339349|NCT00966875|469214948|FG002|Part A|Adverse Event|0|||
130339350|NCT00966875|469214949|FG003|Part A|Adverse Event|1|||
130003729|NCT01660451|467977995|FG000|Overall Study|AE associated with clinical disease progression|1|||
130003730|NCT01660451|467977996|FG001|Overall Study|AE associated with clinical disease progression|3|||
130339351|NCT00966875|469214950|FG004|Part A|Adverse Event|0|||
130339352|NCT00966875|469214951|FG005|Part A|Adverse Event|1|||
130339353|NCT00966875|469214952|FG006|Part A|Adverse Event|0|||
130339354|NCT00966875|469214953|FG007|Part A|Adverse Event|3|||
130339355|NCT00966875|469214954|FG008|Part A|Adverse Event|3|||
130339356|NCT00966875|469214946|FG000|Part A|Entry Criteria|0|||
130339357|NCT00966875|469214947|FG001|Part A|Entry Criteria|0|||
130339358|NCT00966875|469214948|FG002|Part A|Entry Criteria|0|||
130339359|NCT00966875|469214949|FG003|Part A|Entry Criteria|0|||
130339360|NCT00966875|469214950|FG004|Part A|Entry Criteria|0|||
130339361|NCT00966875|469214951|FG005|Part A|Entry Criteria|2|||
130339362|NCT00966875|469214952|FG006|Part A|Entry Criteria|0|||
129884382|NCT00708305|467536385|FG002|Period 2|Lost to Follow-up|0|||
130339363|NCT00966875|469214953|FG007|Part A|Entry Criteria|0|||
130339364|NCT00966875|469214954|FG008|Part A|Entry Criteria|0|||
130339365|NCT00966875|469214946|FG000|Part A|Lack of Efficacy|0|||
130339366|NCT00966875|469214947|FG001|Part A|Lack of Efficacy|1|||
130339367|NCT00966875|469214948|FG002|Part A|Lack of Efficacy|0|||
130339368|NCT00966875|469214949|FG003|Part A|Lack of Efficacy|0|||
130339369|NCT00966875|469214950|FG004|Part A|Lack of Efficacy|0|||
130339370|NCT00966875|469214951|FG005|Part A|Lack of Efficacy|0|||
130339371|NCT00966875|469214952|FG006|Part A|Lack of Efficacy|4|||
130339372|NCT00966875|469214953|FG007|Part A|Lack of Efficacy|0|||
130339373|NCT00966875|469214954|FG008|Part A|Lack of Efficacy|0|||
130339374|NCT00966875|469214946|FG000|Part A|Lost to Follow-up|2|||
130339375|NCT00966875|469214947|FG001|Part A|Lost to Follow-up|0|||
130339376|NCT00966875|469214948|FG002|Part A|Lost to Follow-up|0|||
130339377|NCT00966875|469214949|FG003|Part A|Lost to Follow-up|0|||
130339378|NCT00966875|469214950|FG004|Part A|Lost to Follow-up|0|||
130339379|NCT00966875|469214951|FG005|Part A|Lost to Follow-up|1|||
130339380|NCT00966875|469214952|FG006|Part A|Lost to Follow-up|0|||
130339381|NCT00966875|469214953|FG007|Part A|Lost to Follow-up|0|||
130339382|NCT00966875|469214954|FG008|Part A|Lost to Follow-up|0|||
130339383|NCT00966875|469214946|FG000|Part A|Parent/Caregiver Decision|0|||
130339384|NCT00966875|469214947|FG001|Part A|Parent/Caregiver Decision|0|||
130339385|NCT00966875|469214948|FG002|Part A|Parent/Caregiver Decision|0|||
130339386|NCT00966875|469214949|FG003|Part A|Parent/Caregiver Decision|1|||
130339387|NCT00966875|469214950|FG004|Part A|Parent/Caregiver Decision|0|||
130339388|NCT00966875|469214951|FG005|Part A|Parent/Caregiver Decision|0|||
130339389|NCT00966875|469214952|FG006|Part A|Parent/Caregiver Decision|0|||
130339390|NCT00966875|469214953|FG007|Part A|Parent/Caregiver Decision|0|||
130339391|NCT00966875|469214954|FG008|Part A|Parent/Caregiver Decision|0|||
130339392|NCT00966875|469214946|FG000|Part A|Physician Decision|0|||
130339393|NCT00966875|469214947|FG001|Part A|Physician Decision|0|||
130339394|NCT00966875|469214948|FG002|Part A|Physician Decision|0|||
130339395|NCT00966875|469214949|FG003|Part A|Physician Decision|0|||
130339396|NCT00966875|469214950|FG004|Part A|Physician Decision|1|||
130339397|NCT00966875|469214951|FG005|Part A|Physician Decision|0|||
130339398|NCT00966875|469214952|FG006|Part A|Physician Decision|1|||
130339399|NCT00966875|469214953|FG007|Part A|Physician Decision|0|||
130339400|NCT00966875|469214954|FG008|Part A|Physician Decision|2|||
130339401|NCT00966875|469214946|FG000|Part A|Sponsor Decision|0|||
130339402|NCT00966875|469214947|FG001|Part A|Sponsor Decision|0|||
130339403|NCT00966875|469214948|FG002|Part A|Sponsor Decision|1|||
130339404|NCT00966875|469214949|FG003|Part A|Sponsor Decision|0|||
130339405|NCT00966875|469214950|FG004|Part A|Sponsor Decision|1|||
130339406|NCT00966875|469214951|FG005|Part A|Sponsor Decision|0|||
130339407|NCT00966875|469214952|FG006|Part A|Sponsor Decision|0|||
130339408|NCT00966875|469214953|FG007|Part A|Sponsor Decision|2|||
130339409|NCT00966875|469214954|FG008|Part A|Sponsor Decision|1|||
130339410|NCT00966875|469214946|FG000|Part A|Withdrawal by Subject|2|||
130339411|NCT00966875|469214947|FG001|Part A|Withdrawal by Subject|2|||
130339412|NCT00966875|469214948|FG002|Part A|Withdrawal by Subject|1|||
130339413|NCT00966875|469214949|FG003|Part A|Withdrawal by Subject|1|||
130339414|NCT00966875|469214950|FG004|Part A|Withdrawal by Subject|3|||
130339415|NCT00966875|469214951|FG005|Part A|Withdrawal by Subject|0|||
130339416|NCT00966875|469214952|FG006|Part A|Withdrawal by Subject|5|||
130339417|NCT00966875|469214953|FG007|Part A|Withdrawal by Subject|1|||
130339418|NCT00966875|469214954|FG008|Part A|Withdrawal by Subject|1|||
130003731|NCT01660451|467977997|FG002|Overall Study|AE associated with clinical disease progression|11|||
130003732|NCT01660451|467977995|FG000|Overall Study|Sponsor Decision|0|||
130003733|NCT01660451|467977996|FG001|Overall Study|Sponsor Decision|0|||
130339419|NCT00966875|469214946|FG000|Part A|Protocol Violation|0|||
130339420|NCT00966875|469214947|FG001|Part A|Protocol Violation|0|||
130339421|NCT00966875|469214948|FG002|Part A|Protocol Violation|0|||
130339422|NCT00966875|469214949|FG003|Part A|Protocol Violation|0|||
130339423|NCT00966875|469214950|FG004|Part A|Protocol Violation|0|||
130339424|NCT00966875|469214951|FG005|Part A|Protocol Violation|0|||
130339425|NCT00966875|469214952|FG006|Part A|Protocol Violation|2|||
130339426|NCT00966875|469214953|FG007|Part A|Protocol Violation|1|||
130339427|NCT00966875|469214954|FG008|Part A|Protocol Violation|1|||
130339428|NCT00966875|469214946|FG000|Part B|Adverse Event|0|||
130003734|NCT01660451|467977997|FG002|Overall Study|Sponsor Decision|1|||
130339429|NCT00966875|469214947|FG001|Part B|Adverse Event|1|||
130339430|NCT00966875|469214948|FG002|Part B|Adverse Event|1|||
130339431|NCT00966875|469214949|FG003|Part B|Adverse Event|0|||
130339432|NCT00966875|469214950|FG004|Part B|Adverse Event|1|||
130339433|NCT00966875|469214951|FG005|Part B|Adverse Event|0|||
130339434|NCT00966875|469214952|FG006|Part B|Adverse Event|5|||
130339435|NCT00966875|469214953|FG007|Part B|Adverse Event|2|||
130339436|NCT00966875|469214954|FG008|Part B|Adverse Event|2|||
130339437|NCT00966875|469214946|FG000|Part B|Death|0|||
130339438|NCT00966875|469214947|FG001|Part B|Death|0|||
130339439|NCT00966875|469214948|FG002|Part B|Death|1|||
130339440|NCT00966875|469214949|FG003|Part B|Death|0|||
130339441|NCT00966875|469214950|FG004|Part B|Death|0|||
130339442|NCT00966875|469214951|FG005|Part B|Death|0|||
130339443|NCT00966875|469214952|FG006|Part B|Death|0|||
130339444|NCT00966875|469214953|FG007|Part B|Death|1|||
130339445|NCT00966875|469214954|FG008|Part B|Death|0|||
130339446|NCT00966875|469214946|FG000|Part B|Lack of Efficacy|2|||
130339447|NCT00966875|469214947|FG001|Part B|Lack of Efficacy|1|||
130339448|NCT00966875|469214948|FG002|Part B|Lack of Efficacy|1|||
130339449|NCT00966875|469214949|FG003|Part B|Lack of Efficacy|1|||
130339450|NCT00966875|469214950|FG004|Part B|Lack of Efficacy|2|||
130339451|NCT00966875|469214951|FG005|Part B|Lack of Efficacy|3|||
130339452|NCT00966875|469214952|FG006|Part B|Lack of Efficacy|12|||
130339453|NCT00966875|469214953|FG007|Part B|Lack of Efficacy|9|||
130339454|NCT00966875|469214954|FG008|Part B|Lack of Efficacy|6|||
130339455|NCT00966875|469214946|FG000|Part B|Lost to Follow-up|0|||
130339456|NCT00966875|469214947|FG001|Part B|Lost to Follow-up|0|||
130339457|NCT00966875|469214948|FG002|Part B|Lost to Follow-up|0|||
130339458|NCT00966875|469214949|FG003|Part B|Lost to Follow-up|1|||
130339459|NCT00966875|469214950|FG004|Part B|Lost to Follow-up|0|||
130339460|NCT00966875|469214951|FG005|Part B|Lost to Follow-up|0|||
130003735|NCT01660451|467977995|FG000|Overall Study|Protocol Deviation|0|||
130003736|NCT01660451|467977996|FG001|Overall Study|Protocol Deviation|0|||
130003737|NCT01660451|467977997|FG002|Overall Study|Protocol Deviation|1|||
130003738|NCT01660451|467977995|FG000|Overall Study|Physician Decision|1|||
130003739|NCT01660451|467977996|FG001|Overall Study|Physician Decision|2|||
130003740|NCT01660451|467977997|FG002|Overall Study|Physician Decision|5|||
130003741|NCT01660451|467977995|FG000|Overall Study|Withdrawal by Subject|1|||
130003742|NCT01660451|467977996|FG001|Overall Study|Withdrawal by Subject|1|||
130003743|NCT01660451|467977997|FG002|Overall Study|Withdrawal by Subject|20|||
130003744|NCT01660451|467977995|FG000|Overall Study|Trial closure.|0|||
130003745|NCT01660451|467977996|FG001|Overall Study|Trial closure.|0|||
130003746|NCT01660451|467977997|FG002|Overall Study|Trial closure.|1|||
130003747|NCT01660451|467977995|FG000|Overall Study|Switching to other therapy|0|||
130003748|NCT01660451|467977996|FG001|Overall Study|Switching to other therapy|1|||
130003749|NCT01660451|467977997|FG002|Overall Study|Switching to other therapy|1|||
130003750|NCT01660451|467977995|FG000|Overall Study|Progressive disease - clinical progression|4|||
130003751|NCT01660451|467977996|FG001|Overall Study|Progressive disease - clinical progression|10|||
130339461|NCT00966875|469214952|FG006|Part B|Lost to Follow-up|0|||
130003752|NCT01660451|467977997|FG002|Overall Study|Progressive disease - clinical progression|9|||
130003753|NCT01660451|467977995|FG000|Overall Study|Progressive disease - radiological progression|12|||
130003754|NCT01660451|467977996|FG001|Overall Study|Progressive disease - radiological progression|23|||
130003755|NCT01660451|467977997|FG002|Overall Study|Progressive disease - radiological progression|50|||
130003756|NCT01660451|467977995|FG000|Overall Study|Death|1|||
130003757|NCT01660451|467977996|FG001|Overall Study|Death|0|||
130003758|NCT01660451|467977997|FG002|Overall Study|Death|1|||
130003759|NCT01660451|467977995|FG000|Overall Study|Other|0|||
130003760|NCT01660451|467977996|FG001|Overall Study|Other|0|||
130003761|NCT01660451|467977997|FG002|Overall Study|Other|1|||
130003762|NCT02456662|467977999|FG000|Overall Study|Lost to Follow-up|2|||
130003763|NCT02456662|467978000|FG001|Overall Study|Lost to Follow-up|1|||
130003764|NCT00504153|467978001|FG000|Overall Study|Withdrawal by Subject|1|||
130339462|NCT00966875|469214953|FG007|Part B|Lost to Follow-up|0|||
130339463|NCT00966875|469214954|FG008|Part B|Lost to Follow-up|1|||
130339464|NCT00966875|469214946|FG000|Part B|Physician Decision|0|||
130339465|NCT00966875|469214947|FG001|Part B|Physician Decision|0|||
130339466|NCT00966875|469214948|FG002|Part B|Physician Decision|1|||
130339467|NCT00966875|469214949|FG003|Part B|Physician Decision|0|||
130339468|NCT00966875|469214950|FG004|Part B|Physician Decision|2|||
130339469|NCT00966875|469214951|FG005|Part B|Physician Decision|1|||
130339470|NCT00966875|469214952|FG006|Part B|Physician Decision|0|||
130339471|NCT00966875|469214953|FG007|Part B|Physician Decision|0|||
130339472|NCT00966875|469214954|FG008|Part B|Physician Decision|2|||
130339473|NCT00966875|469214946|FG000|Part B|Sponsor Decision|1|||
130339474|NCT00966875|469214947|FG001|Part B|Sponsor Decision|0|||
130339475|NCT00966875|469214948|FG002|Part B|Sponsor Decision|0|||
130339476|NCT00966875|469214949|FG003|Part B|Sponsor Decision|0|||
130003765|NCT00504153|467978001|FG000|Overall Study|Adverse Event|4|||
130003766|NCT00504153|467978001|FG000|Overall Study|Death|1|||
130339477|NCT00966875|469214950|FG004|Part B|Sponsor Decision|0|||
130339478|NCT00966875|469214951|FG005|Part B|Sponsor Decision|1|||
130003767|NCT02322229|467978002|FG000|Overall Study|Physician Decision|2|||
130339479|NCT00966875|469214952|FG006|Part B|Sponsor Decision|0|||
130339480|NCT00966875|469214953|FG007|Part B|Sponsor Decision|2|||
130339481|NCT00966875|469214954|FG008|Part B|Sponsor Decision|1|||
130339482|NCT00966875|469214946|FG000|Part B|Withdrawal by Subject|2|||
130339483|NCT00966875|469214947|FG001|Part B|Withdrawal by Subject|1|||
130339484|NCT00966875|469214948|FG002|Part B|Withdrawal by Subject|2|||
130003768|NCT00705432|467978003|FG000|Treatment Period|Adverse Event|45|||
130003769|NCT00705432|467978004|FG001|Treatment Period|Adverse Event|37|||
130003770|NCT00705432|467978005|FG002|Treatment Period|Adverse Event|51|||
130003771|NCT00705432|467978006|FG003|Treatment Period|Adverse Event|12|||
130339485|NCT00966875|469214949|FG003|Part B|Withdrawal by Subject|1|||
130003772|NCT00705432|467978007|FG004|Treatment Period|Adverse Event|8|||
130339486|NCT00966875|469214950|FG004|Part B|Withdrawal by Subject|2|||
130339487|NCT00966875|469214951|FG005|Part B|Withdrawal by Subject|1|||
130339488|NCT00966875|469214952|FG006|Part B|Withdrawal by Subject|4|||
130339489|NCT00966875|469214953|FG007|Part B|Withdrawal by Subject|5|||
130003773|NCT00705432|467978008|FG005|Treatment Period|Adverse Event|9|||
130003774|NCT00705432|467978003|FG000|Treatment Period|Treatment failure|92|||
130003775|NCT00705432|467978004|FG001|Treatment Period|Treatment failure|42|||
130003776|NCT00705432|467978005|FG002|Treatment Period|Treatment failure|33|||
130003777|NCT00705432|467978006|FG003|Treatment Period|Treatment failure|25|||
130003778|NCT00705432|467978007|FG004|Treatment Period|Treatment failure|13|||
130003779|NCT00705432|467978008|FG005|Treatment Period|Treatment failure|14|||
130003780|NCT00705432|467978003|FG000|Treatment Period|Non medical reason|26|||
130003781|NCT00705432|467978004|FG001|Treatment Period|Non medical reason|32|||
130003782|NCT00705432|467978005|FG002|Treatment Period|Non medical reason|37|||
130003783|NCT00705432|467978006|FG003|Treatment Period|Non medical reason|4|||
130003784|NCT00705432|467978007|FG004|Treatment Period|Non medical reason|7|||
130003785|NCT00705432|467978008|FG005|Treatment Period|Non medical reason|7|||
130003786|NCT00705432|467978003|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
130003787|NCT00705432|467978004|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
130003788|NCT00705432|467978005|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
130003789|NCT00705432|467978006|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
130003790|NCT00705432|467978007|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
130003791|NCT00705432|467978008|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
130003792|NCT00705432|467978003|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
130003793|NCT00705432|467978004|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
130003794|NCT00705432|467978005|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
130003795|NCT00705432|467978006|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
130003796|NCT00705432|467978007|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
130003797|NCT00705432|467978008|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
130003798|NCT00521053|467978009|FG000|Observation Phase|Disease Progression|55|||
130003799|NCT00521053|467978009|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
130003800|NCT00521053|467978009|FG000|Observation Phase|Death|2|||
130003801|NCT00521053|467978009|FG000|Observation Phase|Adverse Event|1|||
130003802|NCT00521053|467978009|FG000|Observation Phase|Other non-study melanoma treatment|1|||
130003803|NCT00521053|467978009|FG000|Observation Phase|Physician Decision|1|||
130003804|NCT02281357|467978013|FG000|Overall Study|Adverse Event|2|||
130003805|NCT02281357|467978014|FG001|Overall Study|Adverse Event|1|||
130003806|NCT02281357|467978013|FG000|Overall Study|Lost to Follow-up|1|||
130003807|NCT02281357|467978014|FG001|Overall Study|Lost to Follow-up|0|||
130003808|NCT02281357|467978013|FG000|Overall Study|Withdrawal by Subject|4|||
130003809|NCT02281357|467978014|FG001|Overall Study|Withdrawal by Subject|3|||
130003810|NCT00482703|467978017|FG000|Overall Study|Poor compliance|1|||
130003811|NCT00482703|467978018|FG001|Overall Study|Poor compliance|0|||
130003812|NCT00729378|467979590|FG000|Baseline|Did not complete study measurements|72|||
130003813|NCT00729378|467979591|FG001|Baseline|Did not complete study measurements|33|||
130003814|NCT00729378|467979590|FG000|Baseline|Withdrawal by Subject|66|||
130003815|NCT00729378|467979591|FG001|Baseline|Withdrawal by Subject|59|||
130003816|NCT00729378|467979590|FG000|12-months|Lost to Follow-up|100|||
130003817|NCT00729378|467979591|FG001|12-months|Lost to Follow-up|65|||
130003818|NCT00729378|467979590|FG000|24-months|Lost to Follow-up|72|||
130003819|NCT00729378|467979591|FG001|24-months|Lost to Follow-up|51|||
130003820|NCT00729378|467979590|FG000|36-months|Lost to Follow-up|15|||
130003821|NCT00729378|467979591|FG001|36-months|Lost to Follow-up|6|||
130003822|NCT02246582|467979594|FG000|Overall Study|Withdrawal by Subject|3|||
130003823|NCT02246582|467979595|FG001|Overall Study|Withdrawal by Subject|4|||
130003824|NCT02060383|467979596|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
130003825|NCT02060383|467979597|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
130003826|NCT02060383|467979598|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
130003827|NCT02060383|467979599|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
130339490|NCT00966875|469214954|FG008|Part B|Withdrawal by Subject|5|||
130339491|NCT00966875|469214946|FG000|Part B|Entry Criteria|0|||
130339492|NCT00966875|469214947|FG001|Part B|Entry Criteria|0|||
130339493|NCT00966875|469214948|FG002|Part B|Entry Criteria|0|||
130339494|NCT00966875|469214949|FG003|Part B|Entry Criteria|0|||
130339495|NCT00966875|469214950|FG004|Part B|Entry Criteria|0|||
130339496|NCT00966875|469214951|FG005|Part B|Entry Criteria|0|||
130339497|NCT00966875|469214952|FG006|Part B|Entry Criteria|1|||
130339498|NCT00966875|469214953|FG007|Part B|Entry Criteria|0|||
130339499|NCT00966875|469214954|FG008|Part B|Entry Criteria|1|||
130003828|NCT02060383|467979600|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
130339500|NCT01589653|469214955|FG000|Overall Study|Protocol Violation|3|||
130003829|NCT02060383|467979596|FG000|Core Phase|Adverse Event|2|||
130003830|NCT02060383|467979597|FG001|Core Phase|Adverse Event|0|||
130003831|NCT02060383|467979598|FG002|Core Phase|Adverse Event|0|||
130339501|NCT01589653|469214956|FG001|Overall Study|Protocol Violation|1|||
130339502|NCT01589653|469214955|FG000|Overall Study|Withdrawal criteria|4|||
130003832|NCT02060383|467979599|FG003|Core Phase|Adverse Event|2|||
130003833|NCT02060383|467979600|FG004|Core Phase|Adverse Event|6|||
130003834|NCT02060383|467979596|FG000|Core Phase|Administrative problems|0|||
130003835|NCT02060383|467979597|FG001|Core Phase|Administrative problems|1|||
130339503|NCT01589653|469214956|FG001|Overall Study|Withdrawal criteria|7|||
130003836|NCT02060383|467979598|FG002|Core Phase|Administrative problems|0|||
130003837|NCT02060383|467979599|FG003|Core Phase|Administrative problems|0|||
130003838|NCT02060383|467979600|FG004|Core Phase|Administrative problems|0|||
130003839|NCT02060383|467979596|FG000|Core Phase|Protocol Violation|0|||
130003840|NCT02060383|467979597|FG001|Core Phase|Protocol Violation|0|||
130003841|NCT02060383|467979598|FG002|Core Phase|Protocol Violation|0|||
130003842|NCT02060383|467979599|FG003|Core Phase|Protocol Violation|1|||
130003843|NCT02060383|467979600|FG004|Core Phase|Protocol Violation|0|||
130003844|NCT02060383|467979596|FG000|Core Phase|Withdrawal by Subject|0|||
130003845|NCT02060383|467979597|FG001|Core Phase|Withdrawal by Subject|0|||
130003846|NCT02060383|467979598|FG002|Core Phase|Withdrawal by Subject|0|||
130003847|NCT02060383|467979599|FG003|Core Phase|Withdrawal by Subject|4|||
130003848|NCT02060383|467979600|FG004|Core Phase|Withdrawal by Subject|2|||
130003849|NCT02060383|467979596|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
130003850|NCT02060383|467979597|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
130003851|NCT02060383|467979598|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130003852|NCT02060383|467979599|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
130003853|NCT02060383|467979600|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
130003854|NCT02060383|467979596|FG000|Extension Phase|Adverse Event|1|||
130003855|NCT02060383|467979597|FG001|Extension Phase|Adverse Event|1|||
130339504|NCT01589653|469214955|FG000|Overall Study|Unclassified|0|||
130339505|NCT01589653|469214956|FG001|Overall Study|Unclassified|3|||
130339506|NCT04657666|469214957|FG000|Period 1|Withdrawal of participant consent|2|||
130339507|NCT04657666|469214958|FG001|Period 1|Withdrawal of participant consent|1|||
130339508|NCT04657666|469214957|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
130339509|NCT04657666|469214958|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
130339510|NCT04657666|469214957|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
130339511|NCT04657666|469214958|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
130339512|NCT04657666|469214957|FG000|Period 2|Other|2|||
130339513|NCT04657666|469214958|FG001|Period 2|Other|0|||
130339514|NCT04657666|469214957|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
130339515|NCT04657666|469214958|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
130339516|NCT02386189|469214959|FG000|Overall Study|Lost to Follow-up|2|||
130339517|NCT02386189|469214960|FG001|Overall Study|Lost to Follow-up|3|||
130339518|NCT02386189|469214959|FG000|Overall Study|Withdrawal by Subject|1|||
130339519|NCT02386189|469214960|FG001|Overall Study|Withdrawal by Subject|0|||
130339520|NCT02386189|469214959|FG000|Overall Study|Death|1|||
130339521|NCT02386189|469214960|FG001|Overall Study|Death|0|||
130339522|NCT03700684|469214969|FG000|Overall Study|COVID-19|0|||
130339523|NCT03700684|469214970|FG001|Overall Study|COVID-19|0|||
130339524|NCT03700684|469214971|FG002|Overall Study|COVID-19|2|||
130339525|NCT03319745|469214973|FG000|Overall Study|Death|1|||
130339526|NCT03319745|469214973|FG000|Overall Study|Toxicity Precluding Surgery|1|||
130339527|NCT01317550|469214974|FG000|Overall Study|Withdrawal by Subject|1|||
130339528|NCT01317550|469214975|FG001|Overall Study|Withdrawal by Subject|0|||
130339529|NCT01317550|469214976|FG002|Overall Study|Withdrawal by Subject|0|||
130339530|NCT01317550|469214977|FG003|Overall Study|Withdrawal by Subject|0|||
130339531|NCT01317550|469214974|FG000|Overall Study|Lack of compliance study med|1|||
130339532|NCT01317550|469214975|FG001|Overall Study|Lack of compliance study med|0|||
130339533|NCT01317550|469214976|FG002|Overall Study|Lack of compliance study med|0|||
130339534|NCT01317550|469214977|FG003|Overall Study|Lack of compliance study med|0|||
130339535|NCT00870103|469214978|FG000|Overall Study|Physician Decision|2|||
130339536|NCT00870103|469214978|FG000|Overall Study|Lost to Follow-up|2|||
130339537|NCT01120782|469214979|FG000|Overall Study|Test article shipping error|11|||
130339538|NCT04975438|469214980|FG000|Overall Study|Lost to Follow-up|1|||
130339539|NCT04975438|469214981|FG001|Overall Study|Lost to Follow-up|0|||
130339540|NCT04975438|469214982|FG002|Overall Study|Lost to Follow-up|1|||
130339541|NCT04975438|469214983|FG003|Overall Study|Lost to Follow-up|0|||
130339542|NCT04975438|469214980|FG000|Overall Study|Withdrawal by Subject|1|||
130339543|NCT04975438|469214981|FG001|Overall Study|Withdrawal by Subject|0|||
130339544|NCT04975438|469214982|FG002|Overall Study|Withdrawal by Subject|0|||
130339545|NCT04975438|469214983|FG003|Overall Study|Withdrawal by Subject|0|||
130339546|NCT00787267|469214985|FG000|Overall Study|Screen failure/Ineligible|10|||
130339547|NCT00787267|469214985|FG000|Overall Study|No Reason Provided|1|||
130339548|NCT00787267|469214985|FG000|Overall Study|Withdrawal by Subject|1|||
130339549|NCT00865280|469214986|FG000|Overall Study|Withdrawal by Subject|4|||
130003856|NCT02060383|467979598|FG002|Extension Phase|Adverse Event|2|||
130003857|NCT02060383|467979599|FG003|Extension Phase|Adverse Event|0|||
130003858|NCT02060383|467979600|FG004|Extension Phase|Adverse Event|1|||
130003859|NCT02060383|467979596|FG000|Extension Phase|Withdrawal by Subject|0|||
130339550|NCT00865280|469214987|FG001|Overall Study|Withdrawal by Subject|1|||
130339551|NCT00865280|469214986|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
130339552|NCT00865280|469214987|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
130339553|NCT00865280|469214986|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
130339554|NCT00865280|469214987|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
130339555|NCT00865280|469214986|FG000|Overall Study|Exclusion Condition|1|||
130339556|NCT00865280|469214987|FG001|Overall Study|Exclusion Condition|0|||
130339557|NCT00865280|469214986|FG000|Overall Study|Adverse Event|0|||
130003860|NCT02060383|467979597|FG001|Extension Phase|Withdrawal by Subject|1|||
130003861|NCT02060383|467979598|FG002|Extension Phase|Withdrawal by Subject|0|||
130003862|NCT02060383|467979599|FG003|Extension Phase|Withdrawal by Subject|0|||
130003863|NCT02060383|467979600|FG004|Extension Phase|Withdrawal by Subject|2|||
130003864|NCT02060383|467979596|FG000|Extension Phase|Administrative problems|1|||
130003865|NCT02060383|467979597|FG001|Extension Phase|Administrative problems|0|||
130003866|NCT02060383|467979598|FG002|Extension Phase|Administrative problems|0|||
130003867|NCT02060383|467979599|FG003|Extension Phase|Administrative problems|0|||
130339558|NCT00865280|469214987|FG001|Overall Study|Adverse Event|1|||
130339559|NCT01950013|469214994|FG000|Overall Study|Withdrawal by Subject|0|||
130339560|NCT01950013|469214995|FG001|Overall Study|Withdrawal by Subject|2|||
130339561|NCT01950013|469214996|FG002|Overall Study|Withdrawal by Subject|0|||
130339562|NCT03091348|469214999|FG000|Overall Study|Lost to Follow-up|2|||
130339563|NCT03091348|469215000|FG001|Overall Study|Lost to Follow-up|1|||
130339564|NCT00706342|469215001|FG000|Overall Study|Adverse Event|3|||
130339565|NCT00706342|469215001|FG000|Overall Study|Not responding to treatment|2|||
130339566|NCT00706342|469215001|FG000|Overall Study|Withdrawn due to failure to respond|1|||
130339567|NCT00706342|469215001|FG000|Overall Study|Death|1|||
130339568|NCT00706342|469215001|FG000|Overall Study|Withdrew from the study on his own.|1|||
130339569|NCT00706342|469215001|FG000|Overall Study|Investigator discretion|2|||
130339570|NCT00706342|469215001|FG000|Overall Study|Non-responder Week 12|1|||
130339571|NCT00706342|469215001|FG000|Overall Study|Ongoing|6|||
130339572|NCT00706342|469215001|FG000|Overall Study|WIthdrawal of consent|1|||
130339573|NCT01419197|469215003|FG000|Overall Study|Death|247|||
130339574|NCT01419197|469215004|FG001|Overall Study|Death|122|||
130339575|NCT01419197|469215003|FG000|Overall Study|Physician Decision|4|||
130339576|NCT01419197|469215004|FG001|Overall Study|Physician Decision|4|||
130339577|NCT01419197|469215003|FG000|Overall Study|Non-compliance|3|||
130339578|NCT01419197|469215004|FG001|Overall Study|Non-compliance|1|||
130339579|NCT01419197|469215003|FG000|Overall Study|Withdrawal by Subject|33|||
130339580|NCT01419197|469215004|FG001|Overall Study|Withdrawal by Subject|32|||
130339581|NCT01419197|469215003|FG000|Overall Study|Study Completed by Sponsor|103|||
130339582|NCT01419197|469215004|FG001|Overall Study|Study Completed by Sponsor|34|||
130339583|NCT01419197|469215003|FG000|Overall Study|Reason Not Specified|0|||
130339584|NCT01419197|469215004|FG001|Overall Study|Reason Not Specified|1|||
130339585|NCT01419197|469215003|FG000|Overall Study|Lost to Follow-up|14|||
130339586|NCT01419197|469215004|FG001|Overall Study|Lost to Follow-up|4|||
130339587|NCT00146848|469215005|FG000|Pre-randomization|Death|19|||
130339588|NCT00146848|469215006|FG001|Pre-randomization|Death|0|||
130339589|NCT00146848|469215007|FG002|Pre-randomization|Death|0|||
130339590|NCT00146848|469215005|FG000|Pre-randomization|Lost to Follow-up|70|||
130339591|NCT00146848|469215006|FG001|Pre-randomization|Lost to Follow-up|0|||
130339592|NCT00146848|469215007|FG002|Pre-randomization|Lost to Follow-up|0|||
130339593|NCT00146848|469215005|FG000|Pre-randomization|Physician Decision|8|||
130339594|NCT00146848|469215006|FG001|Pre-randomization|Physician Decision|0|||
130339595|NCT00146848|469215007|FG002|Pre-randomization|Physician Decision|0|||
130339596|NCT00146848|469215005|FG000|Pre-randomization|Protocol Violation|172|||
130339597|NCT00146848|469215006|FG001|Pre-randomization|Protocol Violation|0|||
130339598|NCT00146848|469215007|FG002|Pre-randomization|Protocol Violation|0|||
130339599|NCT00146848|469215005|FG000|Pre-randomization|Withdrawal by Subject|40|||
130339600|NCT00146848|469215006|FG001|Pre-randomization|Withdrawal by Subject|0|||
130339601|NCT00146848|469215007|FG002|Pre-randomization|Withdrawal by Subject|0|||
130339602|NCT00146848|469215005|FG000|Post-randomization|Lost to Follow-up|12|||
130339603|NCT00146848|469215006|FG001|Post-randomization|Lost to Follow-up|15|||
130339604|NCT00146848|469215007|FG002|Post-randomization|Lost to Follow-up|12|||
130339605|NCT00146848|469215005|FG000|Post-randomization|Withdrawn|26|||
130339606|NCT00146848|469215006|FG001|Post-randomization|Withdrawn|32|||
130339607|NCT00146848|469215007|FG002|Post-randomization|Withdrawn|27|||
130003868|NCT02060383|467979600|FG004|Extension Phase|Administrative problems|0|||
130003869|NCT02060383|467979596|FG000|Extension Phase|Death|0|||
130003870|NCT02060383|467979597|FG001|Extension Phase|Death|0|||
130098743|NCT03426995|468319308|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130339608|NCT00119678|469215008|FG000|Double-blind Treatment Period|Death|1|||
130339609|NCT00119678|469215009|FG001|Double-blind Treatment Period|Death|0|||
130339610|NCT00119678|469215008|FG000|Double-blind Treatment Period|Adverse Event|7|||
130339611|NCT00119678|469215009|FG001|Double-blind Treatment Period|Adverse Event|1|||
130339612|NCT00119678|469215008|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
130339613|NCT00119678|469215009|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
130339614|NCT00119678|469215008|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130339615|NCT00119678|469215009|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
130339616|NCT00119678|469215008|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
130339617|NCT00119678|469215009|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
130339618|NCT00119678|469215008|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
130339619|NCT00119678|469215009|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
130339620|NCT00119678|469215008|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
130339621|NCT00119678|469215009|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
130339622|NCT00119678|469215008|FG000|Double-blind Treatment Period|Pregnancy|0|||
130339623|NCT00119678|469215009|FG001|Double-blind Treatment Period|Pregnancy|2|||
130339624|NCT00119678|469215008|FG000|Double-blind Treatment Period|Not treated|1|||
130339625|NCT00119678|469215009|FG001|Double-blind Treatment Period|Not treated|2|||
130339626|NCT00119678|469215008|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
130339627|NCT00119678|469215009|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
130339628|NCT00119678|469215008|FG000|Open-label Treatment Period|Death|1|||
130003871|NCT02060383|467979598|FG002|Extension Phase|Death|1|||
130003872|NCT02060383|467979599|FG003|Extension Phase|Death|0|||
130003873|NCT02060383|467979600|FG004|Extension Phase|Death|1|||
130003874|NCT02060383|467979596|FG000|Extension Phase|Protocol Violation|0|||
130003875|NCT02060383|467979597|FG001|Extension Phase|Protocol Violation|0|||
130003876|NCT02060383|467979598|FG002|Extension Phase|Protocol Violation|0|||
130003877|NCT02060383|467979599|FG003|Extension Phase|Protocol Violation|0|||
130003878|NCT02060383|467979600|FG004|Extension Phase|Protocol Violation|1|||
130003879|NCT00761306|467979603|FG000|Overall Study|Adverse Event|5|||
130003880|NCT00761306|467979603|FG000|Overall Study|Lack of Efficacy|4|||
130003881|NCT00761306|467979603|FG000|Overall Study|Protocol Violation|2|||
130003882|NCT00761306|467979603|FG000|Overall Study|Withdrawal of Consent|3|||
130003883|NCT00761306|467979603|FG000|Overall Study|Lost to Follow-up|1|||
130003884|NCT00761306|467979603|FG000|Overall Study|Administrative or Other Reasons|5|||
130003885|NCT05162027|467979604|FG000|Overall Study|Adverse Event|1|||
130003886|NCT05162027|467979605|FG001|Overall Study|Adverse Event|0|||
130003887|NCT03335163|467979606|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
130003888|NCT03335163|467979606|FG000|Overall Study|Withdrawal by Subject|18|||
130003889|NCT03713034|467979607|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
130003890|NCT03713034|467979608|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
130003891|NCT02982239|467979611|FG000|Overall Study|Lost to Follow-up|3|||
130003892|NCT02982239|467979612|FG001|Overall Study|Lost to Follow-up|2|||
130003893|NCT02767323|467979617|FG000|Overall Study|Withdrawal by Subject|17|||
130003894|NCT02767323|467979618|FG001|Overall Study|Withdrawal by Subject|5|||
130003895|NCT02767323|467979619|FG002|Overall Study|Withdrawal by Subject|13|||
130003896|NCT02767323|467979620|FG003|Overall Study|Withdrawal by Subject|0|||
130003897|NCT02767323|467979617|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
130003898|NCT02767323|467979618|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
130003899|NCT02767323|467979619|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
130003900|NCT02767323|467979620|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
130003901|NCT04479436|467979624|FG000|Overall Study|Progressive disease|26|||
130003902|NCT04479436|467979625|FG001|Overall Study|Progressive disease|1|||
130003903|NCT04479436|467979624|FG000|Overall Study|Adverse Event|6|||
130003904|NCT04479436|467979625|FG001|Overall Study|Adverse Event|0|||
130003905|NCT04479436|467979624|FG000|Overall Study|Withdrawal by Subject|5|||
130003906|NCT04479436|467979625|FG001|Overall Study|Withdrawal by Subject|0|||
130003907|NCT04479436|467979624|FG000|Overall Study|Clinical progression|1|||
130003908|NCT04479436|467979625|FG001|Overall Study|Clinical progression|0|||
130003909|NCT04479436|467979624|FG000|Overall Study|Physician Decision|1|||
130003910|NCT04479436|467979625|FG001|Overall Study|Physician Decision|0|||
130003911|NCT00791258|467979632|FG000|Overall Study|Adverse Event|87|||
130003912|NCT00791258|467979632|FG000|Overall Study|Lost to Follow-up|18|||
130003913|NCT00791258|467979632|FG000|Overall Study|Protocol Violation|109|||
130003914|NCT00791258|467979632|FG000|Overall Study|Withdrawal by Subject|40|||
130003915|NCT00791258|467979632|FG000|Overall Study|Did not take medication for >3 days|1|||
130003916|NCT00791258|467979632|FG000|Overall Study|subject left area|2|||
130003917|NCT00791258|467979632|FG000|Overall Study|non-compliance|3|||
130339629|NCT00119678|469215009|FG001|Open-label Treatment Period|Death|0|||
130339630|NCT00119678|469215008|FG000|Open-label Treatment Period|Adverse Event|3|||
130339631|NCT00119678|469215009|FG001|Open-label Treatment Period|Adverse Event|0|||
130339632|NCT00119678|469215008|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
130339633|NCT00119678|469215009|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
130339634|NCT00119678|469215008|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
130339635|NCT00119678|469215009|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130339636|NCT00119678|469215008|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
130339637|NCT00119678|469215009|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
130339638|NCT00119678|469215008|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
130339639|NCT00119678|469215009|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
130339640|NCT00119678|469215008|FG000|Open-label Treatment Period|Pregnancy|1|||
130003918|NCT00791258|467979632|FG000|Overall Study|Subject incarcerated|1|||
130003919|NCT00791258|467979632|FG000|Overall Study|Subject required restricted medication|1|||
130003920|NCT00791258|467979632|FG000|Overall Study|Lack of Efficacy|1|||
130003921|NCT00058552|467979633|FG000|Overall Study|Died prior to receiving treatment|4|||
130339641|NCT00119678|469215009|FG001|Open-label Treatment Period|Pregnancy|0|||
129884383|NCT00708305|467536386|FG003|Period 2|Lost to Follow-up|0|||
130003922|NCT00058552|467979634|FG001|Overall Study|Died prior to receiving treatment|2|||
130003923|NCT00058552|467979633|FG000|Overall Study|Disease progression|52|||
130003924|NCT00058552|467979634|FG001|Overall Study|Disease progression|44|||
130003925|NCT00058552|467979633|FG000|Overall Study|Adverse Event|4|||
130003926|NCT00058552|467979634|FG001|Overall Study|Adverse Event|2|||
130003927|NCT00058552|467979633|FG000|Overall Study|Withdrawal by Subject|3|||
130003928|NCT00058552|467979634|FG001|Overall Study|Withdrawal by Subject|5|||
130003929|NCT00058552|467979633|FG000|Overall Study|Physician Decision|2|||
130003930|NCT00058552|467979634|FG001|Overall Study|Physician Decision|5|||
130003931|NCT00058552|467979633|FG000|Overall Study|Clinical disease progression|0|||
130003932|NCT00058552|467979634|FG001|Overall Study|Clinical disease progression|4|||
130003933|NCT02319668|467979635|FG000|Overall Study|Other (Not specified)|0|||
130003934|NCT02319668|467979636|FG001|Overall Study|Other (Not specified)|2|||
130003935|NCT01372150|467979637|FG000|Overall Study|Lack of Efficacy|3|||
130003936|NCT01372150|467979638|FG001|Overall Study|Lack of Efficacy|0|||
130003937|NCT01372150|467979639|FG002|Overall Study|Lack of Efficacy|1|||
130003938|NCT01372150|467979637|FG000|Overall Study|Lost to Follow-up|4|||
130003939|NCT01372150|467979638|FG001|Overall Study|Lost to Follow-up|5|||
130003940|NCT01372150|467979639|FG002|Overall Study|Lost to Follow-up|6|||
130003941|NCT01372150|467979637|FG000|Overall Study|Protocol Violation|1|||
130003942|NCT01372150|467979638|FG001|Overall Study|Protocol Violation|0|||
130003943|NCT01372150|467979639|FG002|Overall Study|Protocol Violation|3|||
130003944|NCT01372150|467979637|FG000|Overall Study|Withdrawal by Subject|2|||
130003945|NCT01372150|467979638|FG001|Overall Study|Withdrawal by Subject|7|||
130003946|NCT01372150|467979639|FG002|Overall Study|Withdrawal by Subject|2|||
130003947|NCT01372150|467979637|FG000|Overall Study|Other|1|||
130003948|NCT01372150|467979638|FG001|Overall Study|Other|0|||
130003949|NCT01372150|467979639|FG002|Overall Study|Other|2|||
130003950|NCT01372150|467979637|FG000|Overall Study|Adverse Event|2|||
130003951|NCT01372150|467979638|FG001|Overall Study|Adverse Event|1|||
130003952|NCT01372150|467979639|FG002|Overall Study|Adverse Event|2|||
130003953|NCT01372150|467979637|FG000|Overall Study|Randomized but not treated|0|||
130003954|NCT01372150|467979638|FG001|Overall Study|Randomized but not treated|1|||
130003955|NCT01372150|467979639|FG002|Overall Study|Randomized but not treated|0|||
130003956|NCT02316340|467979642|FG000|First Progression|Clinical progression|2|||
130003957|NCT02316340|467979643|FG001|First Progression|Clinical progression|1|||
130003958|NCT02316340|467979642|FG000|First Progression|Withdrawal by Subject|1|||
130003959|NCT02316340|467979643|FG001|First Progression|Withdrawal by Subject|0|||
130003960|NCT01986920|467979644|FG000|A- 101 25%|Withdrawal by Subject|1|||
130003961|NCT01986920|467979645|FG001|A- 101 25%|Withdrawal by Subject|0|||
130003962|NCT01986920|467979646|FG002|A- 101 25%|Withdrawal by Subject|0|||
130003963|NCT01986920|467979647|FG003|A- 101 25%|Withdrawal by Subject|0|||
130003964|NCT01986920|467979644|FG000|A-101 32.5%|Withdrawal by Subject|0|||
130003965|NCT01986920|467979645|FG001|A-101 32.5%|Withdrawal by Subject|1|||
130003966|NCT01986920|467979646|FG002|A-101 32.5%|Withdrawal by Subject|0|||
130003967|NCT01986920|467979647|FG003|A-101 32.5%|Withdrawal by Subject|0|||
130003968|NCT01986920|467979644|FG000|A-101 40%|Withdrawal by Subject|0|||
130003969|NCT01986920|467979645|FG001|A-101 40%|Withdrawal by Subject|0|||
130003970|NCT01986920|467979646|FG002|A-101 40%|Withdrawal by Subject|1|||
130003971|NCT01986920|467979647|FG003|A-101 40%|Withdrawal by Subject|0|||
130003972|NCT01986920|467979644|FG000|Placebo|Withdrawal by Subject|0|||
130003973|NCT01986920|467979645|FG001|Placebo|Withdrawal by Subject|0|||
130003974|NCT01986920|467979646|FG002|Placebo|Withdrawal by Subject|0|||
130003975|NCT01986920|467979647|FG003|Placebo|Withdrawal by Subject|1|||
130003976|NCT03781323|467979648|FG000|Overall Study|Withdrawal by Subject|1|||
130003977|NCT01338415|467979649|FG000|Core + Extension|Adverse Event|8|||
130003978|NCT01338415|467979650|FG001|Core + Extension|Adverse Event|6|||
130003979|NCT01338415|467979651|FG002|Core + Extension|Adverse Event|0|||
130003980|NCT01338415|467979649|FG000|Core + Extension|Withdrawal by Subject|1|||
130003981|NCT01338415|467979650|FG001|Core + Extension|Withdrawal by Subject|1|||
130003982|NCT01338415|467979651|FG002|Core + Extension|Withdrawal by Subject|0|||
130003983|NCT01338415|467979649|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
130003984|NCT01338415|467979650|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
130003985|NCT01338415|467979651|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
130003986|NCT01338415|467979649|FG000|Core + Extension|Other (administrative reason)|1|||
130003987|NCT01338415|467979650|FG001|Core + Extension|Other (administrative reason)|0|||
130003988|NCT01338415|467979651|FG002|Core + Extension|Other (administrative reason)|0|||
130003989|NCT01338415|467979649|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
130003990|NCT01338415|467979650|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
130003991|NCT01338415|467979651|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
130003992|NCT01338415|467979649|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
130003993|NCT01338415|467979650|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
130003994|NCT01338415|467979651|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
129884384|NCT00708305|467536383|FG000|Period 2|Protocol Violation|0|||
130003995|NCT01338415|467979649|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
130003996|NCT01338415|467979650|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
130339642|NCT00119678|469215008|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
130339643|NCT00119678|469215009|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
130339644|NCT01761240|469215010|FG000|Overall Study|Progressive disease:radiology assessment|3|||
130339645|NCT01761240|469215011|FG001|Overall Study|Progressive disease:radiology assessment|3|||
130339646|NCT01761240|469215012|FG002|Overall Study|Progressive disease:radiology assessment|0|||
130339647|NCT01761240|469215013|FG003|Overall Study|Progressive disease:radiology assessment|0|||
130339648|NCT01761240|469215014|FG004|Overall Study|Progressive disease:radiology assessment|0|||
130339649|NCT01761240|469215010|FG000|Overall Study|Progressive disease:clinical assessment|0|||
130339650|NCT01761240|469215011|FG001|Overall Study|Progressive disease:clinical assessment|0|||
130339651|NCT01761240|469215012|FG002|Overall Study|Progressive disease:clinical assessment|3|||
130339652|NCT01761240|469215013|FG003|Overall Study|Progressive disease:clinical assessment|1|||
130339653|NCT01761240|469215014|FG004|Overall Study|Progressive disease:clinical assessment|0|||
130339654|NCT01761240|469215010|FG000|Overall Study|Withdrawal by Subject|0|||
130339655|NCT01761240|469215011|FG001|Overall Study|Withdrawal by Subject|0|||
130339656|NCT01761240|469215012|FG002|Overall Study|Withdrawal by Subject|0|||
130339657|NCT01761240|469215013|FG003|Overall Study|Withdrawal by Subject|3|||
130339658|NCT01761240|469215014|FG004|Overall Study|Withdrawal by Subject|1|||
130339659|NCT01761240|469215010|FG000|Overall Study|Adverse Event|0|||
130339660|NCT01761240|469215011|FG001|Overall Study|Adverse Event|0|||
130339661|NCT01761240|469215012|FG002|Overall Study|Adverse Event|0|||
130339662|NCT01761240|469215013|FG003|Overall Study|Adverse Event|1|||
130339663|NCT01761240|469215014|FG004|Overall Study|Adverse Event|6|||
130339664|NCT01761240|469215010|FG000|Overall Study|Death|0|||
130339665|NCT01761240|469215011|FG001|Overall Study|Death|1|||
130339666|NCT01761240|469215012|FG002|Overall Study|Death|1|||
130339667|NCT01761240|469215013|FG003|Overall Study|Death|2|||
130339668|NCT01761240|469215014|FG004|Overall Study|Death|1|||
130339669|NCT01761240|469215010|FG000|Overall Study|Non-compliance|0|||
130339670|NCT01761240|469215011|FG001|Overall Study|Non-compliance|0|||
130339671|NCT01761240|469215012|FG002|Overall Study|Non-compliance|1|||
130339672|NCT01761240|469215013|FG003|Overall Study|Non-compliance|0|||
130339673|NCT01761240|469215014|FG004|Overall Study|Non-compliance|0|||
130339674|NCT00509145|469215015|FG000|Overall Study|Death|0|||
130339675|NCT00509145|469215016|FG001|Overall Study|Death|2|||
130339676|NCT00509145|469215015|FG000|Overall Study|Adverse Event|42|||
130339677|NCT00509145|469215016|FG001|Overall Study|Adverse Event|28|||
130339678|NCT00509145|469215015|FG000|Overall Study|Withdrawal by Subject|32|||
130339679|NCT00509145|469215016|FG001|Overall Study|Withdrawal by Subject|38|||
130339680|NCT00509145|469215015|FG000|Overall Study|Physician Decision|11|||
130339681|NCT00509145|469215016|FG001|Overall Study|Physician Decision|14|||
130339682|NCT00509145|469215015|FG000|Overall Study|Protocol Violation|1|||
130339683|NCT00509145|469215016|FG001|Overall Study|Protocol Violation|6|||
130339684|NCT00509145|469215015|FG000|Overall Study|Pregnancy|3|||
130339685|NCT00509145|469215016|FG001|Overall Study|Pregnancy|8|||
130339686|NCT00509145|469215015|FG000|Overall Study|Lost to Follow-up|6|||
130339687|NCT00509145|469215016|FG001|Overall Study|Lost to Follow-up|5|||
130339688|NCT00509145|469215015|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
130339689|NCT00509145|469215016|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
130339690|NCT00509145|469215015|FG000|Overall Study|Other|6|||
130339691|NCT00509145|469215016|FG001|Overall Study|Other|6|||
130339692|NCT00750152|469215017|FG000|Overall Study|Adverse Event|2|||
130339693|NCT00750152|469215018|FG001|Overall Study|Adverse Event|1|||
130339694|NCT00750152|469215017|FG000|Overall Study|Lost to Follow-up|8|||
130339695|NCT00750152|469215018|FG001|Overall Study|Lost to Follow-up|13|||
130339696|NCT00750152|469215017|FG000|Overall Study|Withdrawal by Subject|3|||
130339697|NCT00750152|469215018|FG001|Overall Study|Withdrawal by Subject|3|||
130339698|NCT00750152|469215017|FG000|Overall Study|Physician Decision|1|||
130339699|NCT00750152|469215018|FG001|Overall Study|Physician Decision|1|||
130339700|NCT00750152|469215017|FG000|Overall Study|Non-compliance|0|||
130339701|NCT00750152|469215018|FG001|Overall Study|Non-compliance|1|||
130339702|NCT00750152|469215017|FG000|Overall Study|Termination by sponsor|1|||
130098744|NCT03426995|468319309|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130339703|NCT00750152|469215018|FG001|Overall Study|Termination by sponsor|0|||
130339704|NCT00750152|469215017|FG000|Overall Study|Other|7|||
130339705|NCT00750152|469215018|FG001|Overall Study|Other|8|||
130339706|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
130339707|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339708|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339709|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
130339710|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
130339711|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
130339712|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
130339713|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
130339714|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
129884385|NCT00708305|467536384|FG001|Period 2|Protocol Violation|1|||
130339715|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
130339716|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
130339717|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
130339718|NCT01642615|469215019|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
130339719|NCT01642615|469215020|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
130339720|NCT01642615|469215021|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
130339721|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
130339722|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
130339723|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
130339724|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
130339725|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
130339726|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
130339727|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339728|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
130339729|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130339730|NCT01642615|469215019|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
130339731|NCT01642615|469215020|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
130339732|NCT01642615|469215021|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
130339733|NCT01028300|469215024|FG000|Overall Study|Study Terminated|4|||
130339734|NCT01214395|469215027|FG000|Overall Study|All patients had infection|5|||
130339735|NCT00715910|469215031|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
130339736|NCT00715910|469215032|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
130339737|NCT00715910|469215033|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
130339738|NCT00715910|469215034|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
130339739|NCT00715910|469215035|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
130339740|NCT00715910|469215036|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
130339741|NCT00715910|469215031|FG000|Booster and ESFU Phase|Other|0|||
130339742|NCT00715910|469215032|FG001|Booster and ESFU Phase|Other|0|||
130339743|NCT00715910|469215033|FG002|Booster and ESFU Phase|Other|0|||
130339744|NCT00715910|469215034|FG003|Booster and ESFU Phase|Other|5|||
130339745|NCT00715910|469215035|FG004|Booster and ESFU Phase|Other|1|||
130339746|NCT00715910|469215036|FG005|Booster and ESFU Phase|Other|0|||
130339747|NCT02034409|469215037|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
130339748|NCT02034409|469215038|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
130339749|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
130339750|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
130339751|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
130339752|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
130339753|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
130339754|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
130339755|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
130339756|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
130339757|NCT02034409|469215037|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
130339758|NCT02034409|469215038|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
130339759|NCT01030666|469215039|FG000|Overall Study|Lost to Follow-up|3|||
130339760|NCT01030666|469215040|FG001|Overall Study|Lost to Follow-up|2|||
130339761|NCT01699867|469215041|FG000|Overall Study|Screening Failure|3|||
130339762|NCT00006289|469215042|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
130339763|NCT00006289|469215043|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
130339764|NCT00006289|469215042|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
130339765|NCT00006289|469215043|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
130339766|NCT03703297|469215050|FG000|Overall Study|Death|115|||
130339767|NCT03703297|469215051|FG001|Overall Study|Death|0|||
130339768|NCT03703297|469215052|FG002|Overall Study|Death|144|||
130339769|NCT03703297|469215050|FG000|Overall Study|Withdrawal by Subject|9|||
130339770|NCT03703297|469215051|FG001|Overall Study|Withdrawal by Subject|0|||
130339771|NCT03703297|469215052|FG002|Overall Study|Withdrawal by Subject|11|||
130339772|NCT03703297|469215050|FG000|Overall Study|Ongoing at the time of DCO|140|||
130339773|NCT03703297|469215051|FG001|Overall Study|Ongoing at the time of DCO|200|||
130339774|NCT03703297|469215052|FG002|Overall Study|Ongoing at the time of DCO|111|||
130339775|NCT02156271|469217967|FG000|Overall Study|Physician Decision|4|||
130339776|NCT02156271|469217968|FG001|Overall Study|Physician Decision|3|||
130339777|NCT03320824|469217969|FG000|Overall Study|Withdrawal by Subject|8|||
130339778|NCT03320824|469217970|FG001|Overall Study|Withdrawal by Subject|1|||
130339779|NCT03320824|469217969|FG000|Overall Study|Lost to Follow-up|10|||
130339780|NCT03320824|469217970|FG001|Overall Study|Lost to Follow-up|1|||
130339781|NCT03320824|469217969|FG000|Overall Study|moved out of state|0|||
130339782|NCT03320824|469217970|FG001|Overall Study|moved out of state|1|||
130339783|NCT03320824|469217969|FG000|Overall Study|could not complete final visit|0|||
130339784|NCT03320824|469217970|FG001|Overall Study|could not complete final visit|1|||
130339785|NCT03387111|469217971|FG000|Overall Study|Progressive Disease|3|||
130003997|NCT01338415|467979651|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
130003998|NCT01338415|467979649|FG000|Exceptional Use Treatment Period|Death|0|||
130003999|NCT01338415|467979650|FG001|Exceptional Use Treatment Period|Death|0|||
130004000|NCT01338415|467979651|FG002|Exceptional Use Treatment Period|Death|1|||
130004001|NCT01526551|467979654|FG000|Overall Study|Lack of returned parental consent form|424|||
130004002|NCT05215262|467979655|FG000|Overall Study|Lost to Follow-up|12|||
130004003|NCT05215262|467979656|FG001|Overall Study|Lost to Follow-up|0|||
130004004|NCT04880447|467979657|FG000|Overall Study|No vaccination information|1|||
130004005|NCT04880447|467979657|FG000|Overall Study|No adverse event information (missing information)|1|||
130004006|NCT04880447|467979657|FG000|Overall Study|Disease not covered in this study|35|||
130004007|NCT00718549|467979662|FG000|Induction Phase|Disease Progression|1|||
130004008|NCT00718549|467979663|FG001|Induction Phase|Disease Progression|0|||
130004009|NCT00718549|467979664|FG002|Induction Phase|Disease Progression|0|||
130004010|NCT00718549|467979662|FG000|Induction Phase|Eligibility Criteria Violation|2|||
130004011|NCT00718549|467979663|FG001|Induction Phase|Eligibility Criteria Violation|0|||
130004012|NCT00718549|467979664|FG002|Induction Phase|Eligibility Criteria Violation|0|||
130339786|NCT03387111|469217971|FG000|Overall Study|Other|1|||
130339787|NCT02617485|469217978|FG000|Treatment and Observation Period|Adverse Event|9|||
130339788|NCT02617485|469217979|FG001|Treatment and Observation Period|Adverse Event|1|||
130339789|NCT02617485|469217978|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
130339790|NCT02617485|469217979|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
130339791|NCT02617485|469217978|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
130339792|NCT02617485|469217979|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
130004013|NCT00718549|467979662|FG000|Induction Phase|Early Termination - No Additional Info|59|||
130004014|NCT00718549|467979663|FG001|Induction Phase|Early Termination - No Additional Info|0|||
130004015|NCT00718549|467979664|FG002|Induction Phase|Early Termination - No Additional Info|0|||
130339793|NCT02617485|469217978|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
130339794|NCT02617485|469217979|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
130339795|NCT02617485|469217978|FG000|Treatment and Observation Period|Physician Decision|0|||
130339796|NCT02617485|469217979|FG001|Treatment and Observation Period|Physician Decision|1|||
130339797|NCT02617485|469217978|FG000|Follow-up Period|Adverse Event|1|||
130339798|NCT02617485|469217979|FG001|Follow-up Period|Adverse Event|0|||
130339799|NCT02617485|469217978|FG000|Follow-up Period|Withdrawal by Subject|1|||
130339800|NCT02617485|469217979|FG001|Follow-up Period|Withdrawal by Subject|0|||
130339801|NCT02617485|469217978|FG000|Follow-up Period|Disease progression|2|||
130339802|NCT02617485|469217979|FG001|Follow-up Period|Disease progression|1|||
130339803|NCT02617485|469217978|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
130339804|NCT02617485|469217979|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
130339805|NCT02617485|469217978|FG000|Follow-up Period|Patient needed radiotherapy|9|||
130339806|NCT02617485|469217979|FG001|Follow-up Period|Patient needed radiotherapy|5|||
130339807|NCT02617485|469217978|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
130339808|NCT02617485|469217979|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
130339809|NCT04590248|469217981|FG000|Overall Study|Lost to Follow-up|1|||
130339810|NCT04590248|469217981|FG000|Overall Study|Withdrawal by Subject|16|||
130339811|NCT04590248|469217981|FG000|Overall Study|Other|2|||
130339812|NCT00615901|469217982|FG000|Overall Study|Withdrawal by Subject|2|||
130339813|NCT00615901|469217982|FG000|Overall Study|Adverse Event|7|||
130339814|NCT03598114|469217983|FG000|Overall Study|Staff turnover/left the program|3|||
130339815|NCT03598114|469217984|FG001|Overall Study|Staff turnover/left the program|39|||
130339816|NCT02527200|469217985|FG000|Overall Study|Withdrawal by Subject|3|||
130339817|NCT02527200|469217986|FG001|Overall Study|Withdrawal by Subject|2|||
130339818|NCT02527200|469217987|FG002|Overall Study|Withdrawal by Subject|1|||
130339819|NCT02527200|469217988|FG003|Overall Study|Withdrawal by Subject|0|||
130339820|NCT02527200|469217985|FG000|Overall Study|Unclassified|0|||
130339821|NCT02527200|469217986|FG001|Overall Study|Unclassified|1|||
130339822|NCT02527200|469217987|FG002|Overall Study|Unclassified|0|||
130339823|NCT02527200|469217988|FG003|Overall Study|Unclassified|0|||
130339824|NCT02527200|469217985|FG000|Overall Study|Lost to Follow-up|0|||
130339825|NCT02527200|469217986|FG001|Overall Study|Lost to Follow-up|0|||
130339826|NCT02527200|469217987|FG002|Overall Study|Lost to Follow-up|1|||
130339827|NCT02527200|469217988|FG003|Overall Study|Lost to Follow-up|0|||
130339828|NCT04250077|469217992|FG000|Overall Study|Withdrawal by Subject|0|||
130339829|NCT04250077|469217993|FG001|Overall Study|Withdrawal by Subject|1|||
130339830|NCT04250077|469217994|FG002|Overall Study|Withdrawal by Subject|0|||
130339831|NCT04250077|469217992|FG000|Overall Study|Lost to Follow-up|2|||
130339832|NCT04250077|469217993|FG001|Overall Study|Lost to Follow-up|3|||
130004016|NCT00718549|467979662|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
130339833|NCT04250077|469217994|FG002|Overall Study|Lost to Follow-up|0|||
130339834|NCT01022398|469217995|FG000|Overall Study|Study terminated|2|||
130004017|NCT00718549|467979663|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
130339835|NCT01022398|469217996|FG001|Overall Study|Study terminated|2|||
130339836|NCT00640224|469217997|FG000|Overall Study|Lost to Follow-up|5|||
130339837|NCT00640224|469217998|FG001|Overall Study|Lost to Follow-up|2|||
130339838|NCT00640224|469217999|FG002|Overall Study|Lost to Follow-up|0|||
130339839|NCT00640224|469218000|FG003|Overall Study|Lost to Follow-up|0|||
130339840|NCT00640224|469217997|FG000|Overall Study|Withdrawal by Subject|1|||
130339841|NCT00640224|469217998|FG001|Overall Study|Withdrawal by Subject|0|||
130339842|NCT00640224|469217999|FG002|Overall Study|Withdrawal by Subject|0|||
130339843|NCT00640224|469218000|FG003|Overall Study|Withdrawal by Subject|0|||
130339844|NCT00640224|469217997|FG000|Overall Study|Headaches|0|||
130339845|NCT00640224|469217998|FG001|Overall Study|Headaches|1|||
130339846|NCT00640224|469217999|FG002|Overall Study|Headaches|0|||
130339847|NCT00640224|469218000|FG003|Overall Study|Headaches|0|||
130339848|NCT02937584|469218005|FG000|Period 1|Adverse Event|1|||
130339849|NCT02937584|469218006|FG001|Period 1|Adverse Event|2|||
130339850|NCT02937584|469218005|FG000|Washout|Adverse Event|0|||
130339851|NCT02937584|469218006|FG001|Washout|Adverse Event|1|||
130339852|NCT04075734|469218015|FG000|Overall Study|Lost to Follow-up|1|||
130339853|NCT04075734|469218016|FG001|Overall Study|Lost to Follow-up|1|||
130339854|NCT04075734|469218017|FG002|Overall Study|Lost to Follow-up|0|||
130339855|NCT04075734|469218015|FG000|Overall Study|Withdrawal by Subject|3|||
130339856|NCT04075734|469218016|FG001|Overall Study|Withdrawal by Subject|0|||
130339857|NCT04075734|469218017|FG002|Overall Study|Withdrawal by Subject|0|||
130004018|NCT00718549|467979664|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
130004019|NCT00718549|467979662|FG000|Maintenance/ Observation Phase|Death|0|||
130004020|NCT00718549|467979663|FG001|Maintenance/ Observation Phase|Death|1|||
130004021|NCT00718549|467979664|FG002|Maintenance/ Observation Phase|Death|2|||
130004022|NCT00718549|467979662|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
130004023|NCT00718549|467979663|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
130004024|NCT00718549|467979664|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
130004025|NCT00718549|467979662|FG000|Maintenance/ Observation Phase|Progression|0|||
130004026|NCT00718549|467979663|FG001|Maintenance/ Observation Phase|Progression|5|||
130004027|NCT00718549|467979664|FG002|Maintenance/ Observation Phase|Progression|14|||
130004028|NCT00718549|467979662|FG000|Maintenance/ Observation Phase|Relapse|0|||
130004029|NCT00718549|467979663|FG001|Maintenance/ Observation Phase|Relapse|3|||
130004030|NCT00718549|467979664|FG002|Maintenance/ Observation Phase|Relapse|2|||
130004031|NCT01353508|467979665|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130004032|NCT01353508|467979666|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130004033|NCT01353508|467979667|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
130004034|NCT01353508|467979668|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
130004035|NCT01353508|467979665|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
130004036|NCT01353508|467979666|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130004037|NCT01353508|467979667|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130004038|NCT01353508|467979668|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
130004039|NCT02606461|467979669|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130004040|NCT02606461|467979670|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130004041|NCT02606461|467979671|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
130004042|NCT02606461|467979672|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130004043|NCT02606461|467979673|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130004044|NCT02606461|467979674|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
130004045|NCT02092350|467979679|FG000|Overall Study|Adverse Event|0|||
130004046|NCT02092350|467979680|FG001|Overall Study|Adverse Event|3|||
130004047|NCT02092350|467979679|FG000|Overall Study|Death|2|||
130004048|NCT02092350|467979680|FG001|Overall Study|Death|5|||
130004049|NCT02092350|467979679|FG000|Overall Study|Lost to Follow-up|3|||
130004050|NCT02092350|467979680|FG001|Overall Study|Lost to Follow-up|1|||
130004051|NCT02092350|467979679|FG000|Overall Study|Protocol Violation|1|||
130004052|NCT02092350|467979680|FG001|Overall Study|Protocol Violation|0|||
130004053|NCT02092350|467979679|FG000|Overall Study|Physician Decision|1|||
130004054|NCT02092350|467979680|FG001|Overall Study|Physician Decision|1|||
130004055|NCT02092350|467979679|FG000|Overall Study|Screen Failure|1|||
130004056|NCT02092350|467979680|FG001|Overall Study|Screen Failure|0|||
130004057|NCT02092350|467979679|FG000|Overall Study|Withdrawal by Subject|2|||
130004058|NCT02092350|467979680|FG001|Overall Study|Withdrawal by Subject|2|||
130339858|NCT03615040|469218018|FG000|Overall Study|Withdrawal by Subject|2|||
130339859|NCT03615040|469218019|FG001|Overall Study|Withdrawal by Subject|1|||
130339860|NCT03615040|469218018|FG000|Overall Study|Physician Decision|2|||
130004059|NCT00239226|467979681|FG000|Overall Study|permAF during stabilization period|0|||
130004060|NCT00239226|467979682|FG001|Overall Study|permAF during stabilization period|0|||
130004061|NCT00239226|467979683|FG002|Overall Study|permAF during stabilization period|0|||
130339861|NCT03615040|469218019|FG001|Overall Study|Physician Decision|2|||
130339862|NCT03615040|469218018|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
130339863|NCT03615040|469218019|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
130339864|NCT03615040|469218018|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
130339865|NCT03615040|469218019|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
130339866|NCT03615040|469218018|FG000|Overall Study|Death|0|||
130339867|NCT03615040|469218019|FG001|Overall Study|Death|2|||
130339868|NCT01776307|469218020|FG000|Overall Study|Not dosed|0|||
130339869|NCT01776307|469218021|FG001|Overall Study|Not dosed|0|||
130339870|NCT01776307|469218022|FG002|Overall Study|Not dosed|1|||
130339871|NCT04074161|469218030|FG000|Overall Study|Withdrawal by Subject|2|||
130339872|NCT04074161|469218031|FG001|Overall Study|Withdrawal by Subject|4|||
130339873|NCT04074161|469218032|FG002|Overall Study|Withdrawal by Subject|1|||
130339874|NCT04074161|469218030|FG000|Overall Study|Lost to Follow-up|4|||
130339875|NCT04074161|469218031|FG001|Overall Study|Lost to Follow-up|5|||
130339876|NCT04074161|469218032|FG002|Overall Study|Lost to Follow-up|3|||
130339877|NCT03890666|469218039|FG000|Overall Study|Withdrawal by Subject|0|||
130339878|NCT03890666|469218040|FG001|Overall Study|Withdrawal by Subject|1|||
130339879|NCT03890666|469218039|FG000|Overall Study|Protocol deviation|1|||
130339880|NCT03890666|469218040|FG001|Overall Study|Protocol deviation|4|||
130339881|NCT03890666|469218039|FG000|Overall Study|Lost to Follow-up|2|||
130339882|NCT03890666|469218040|FG001|Overall Study|Lost to Follow-up|5|||
130339883|NCT03890666|469218039|FG000|Overall Study|Other than specified|1|||
130339884|NCT03890666|469218040|FG001|Overall Study|Other than specified|8|||
130339885|NCT03232333|469218041|FG000|Overall Study|Infection or Osteomyelitis|9|||
130339886|NCT03232333|469218041|FG000|Overall Study|Lost to Follow-up|4|||
130339887|NCT03232333|469218041|FG000|Overall Study|Withdrawal by Subject|2|||
130339888|NCT03052426|469218042|FG000|Overall Study|Withdrawal by Subject|0|||
130339889|NCT03052426|469218043|FG001|Overall Study|Withdrawal by Subject|1|||
130339890|NCT03052426|469218044|FG002|Overall Study|Withdrawal by Subject|0|||
130339891|NCT03052426|469218042|FG000|Overall Study|Lost to Follow-up|2|||
130339892|NCT03052426|469218043|FG001|Overall Study|Lost to Follow-up|0|||
130339893|NCT03052426|469218044|FG002|Overall Study|Lost to Follow-up|1|||
130339894|NCT01853839|469218046|FG000|Overall Study|Violated inclusion criteria|2|||
130339895|NCT01853839|469218046|FG000|Overall Study|Not meet ITT population definition|58|||
130339896|NCT01853839|469218046|FG000|Overall Study|End of treatment visit too early|33|||
130339897|NCT01853839|469218046|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
130339898|NCT04145219|469218047|FG000|Overall Study|Adverse Event|18|||
130339899|NCT04145219|469218048|FG001|Overall Study|Adverse Event|6|||
130339900|NCT04145219|469218047|FG000|Overall Study|Lost to Follow-up|2|||
130339901|NCT04145219|469218048|FG001|Overall Study|Lost to Follow-up|3|||
130339902|NCT04145219|469218047|FG000|Overall Study|Physician Decision|0|||
130339903|NCT04145219|469218048|FG001|Overall Study|Physician Decision|2|||
130339904|NCT04145219|469218047|FG000|Overall Study|Withdrawal by Subject|12|||
130339905|NCT04145219|469218048|FG001|Overall Study|Withdrawal by Subject|8|||
130339906|NCT04145219|469218047|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
130339907|NCT04145219|469218048|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
130339908|NCT02709538|469218049|FG000|Overall Study|Adverse Event|13|||
130339909|NCT02709538|469218050|FG001|Overall Study|Adverse Event|2|||
130339910|NCT02709538|469218051|FG002|Overall Study|Adverse Event|3|||
130339911|NCT02709538|469218049|FG000|Overall Study|Lack of Efficacy|1|||
130339912|NCT02709538|469218050|FG001|Overall Study|Lack of Efficacy|0|||
130339913|NCT02709538|469218051|FG002|Overall Study|Lack of Efficacy|0|||
130339914|NCT02709538|469218049|FG000|Overall Study|Lost to Follow-up|24|||
130004062|NCT00239226|467979684|FG003|Overall Study|permAF during stabilization period|3|||
130004063|NCT00239226|467979681|FG000|Overall Study|Lost to Follow-up|1|||
130004064|NCT00239226|467979682|FG001|Overall Study|Lost to Follow-up|0|||
130004065|NCT00239226|467979683|FG002|Overall Study|Lost to Follow-up|1|||
130004066|NCT00239226|467979684|FG003|Overall Study|Lost to Follow-up|0|||
130004067|NCT00646906|467979686|FG000|Crossover Period 1|Withdrawal by Subject|1|||
130004068|NCT00646906|467979687|FG001|Crossover Period 1|Withdrawal by Subject|0|||
130004069|NCT00646906|467979688|FG002|Crossover Period 1|Withdrawal by Subject|0|||
130004070|NCT00646906|467979689|FG003|Crossover Period 1|Withdrawal by Subject|0|||
130004071|NCT00646906|467979690|FG004|Crossover Period 1|Withdrawal by Subject|0|||
130004072|NCT00646906|467979691|FG005|Crossover Period 1|Withdrawal by Subject|1|||
130004073|NCT00646906|467979692|FG006|Crossover Period 1|Withdrawal by Subject|0|||
130004074|NCT00646906|467979686|FG000|Crossover Period 2|Withdrawal by Subject|0|||
130004075|NCT00646906|467979687|FG001|Crossover Period 2|Withdrawal by Subject|1|||
130004076|NCT00646906|467979688|FG002|Crossover Period 2|Withdrawal by Subject|2|||
130004077|NCT00646906|467979689|FG003|Crossover Period 2|Withdrawal by Subject|1|||
130004078|NCT00646906|467979690|FG004|Crossover Period 2|Withdrawal by Subject|0|||
130004079|NCT00646906|467979691|FG005|Crossover Period 2|Withdrawal by Subject|0|||
130339915|NCT02709538|469218050|FG001|Overall Study|Lost to Follow-up|8|||
130339916|NCT02709538|469218051|FG002|Overall Study|Lost to Follow-up|4|||
130339917|NCT02709538|469218049|FG000|Overall Study|Physician Decision|1|||
130339918|NCT02709538|469218050|FG001|Overall Study|Physician Decision|0|||
130004080|NCT00646906|467979692|FG006|Crossover Period 2|Withdrawal by Subject|0|||
130339919|NCT02709538|469218051|FG002|Overall Study|Physician Decision|0|||
130004081|NCT00646906|467979686|FG000|Crossover Period 2|Physician Decision|0|||
130339920|NCT02709538|469218049|FG000|Overall Study|Withdrawal by Subject|40|||
130339921|NCT02709538|469218050|FG001|Overall Study|Withdrawal by Subject|7|||
130339922|NCT02709538|469218051|FG002|Overall Study|Withdrawal by Subject|4|||
130339923|NCT02709538|469218049|FG000|Overall Study|Non-compliance with study procedures|5|||
130339924|NCT02709538|469218050|FG001|Overall Study|Non-compliance with study procedures|0|||
130339925|NCT02709538|469218051|FG002|Overall Study|Non-compliance with study procedures|0|||
130339926|NCT02709538|469218049|FG000|Overall Study|Non-compliance with study drug|2|||
130339927|NCT02709538|469218050|FG001|Overall Study|Non-compliance with study drug|0|||
130339928|NCT02709538|469218051|FG002|Overall Study|Non-compliance with study drug|0|||
130339929|NCT02709538|469218049|FG000|Overall Study|Protocol deviation|10|||
130339930|NCT02709538|469218050|FG001|Overall Study|Protocol deviation|4|||
130339931|NCT02709538|469218051|FG002|Overall Study|Protocol deviation|4|||
130339932|NCT02709538|469218049|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
130339933|NCT02709538|469218050|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
130339934|NCT02709538|469218051|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
130339935|NCT02709538|469218049|FG000|Overall Study|Other|16|||
130339936|NCT02709538|469218050|FG001|Overall Study|Other|7|||
130339937|NCT02709538|469218051|FG002|Overall Study|Other|5|||
130339938|NCT02059291|469218052|FG000|Epoch 2|Lack of Efficacy|0|||
130339939|NCT02059291|469218053|FG001|Epoch 2|Lack of Efficacy|0|||
130339940|NCT02059291|469218054|FG002|Epoch 2|Lack of Efficacy|0|||
130339941|NCT02059291|469218055|FG003|Epoch 2|Lack of Efficacy|1|||
130339942|NCT02059291|469218056|FG004|Epoch 2|Lack of Efficacy|0|||
130339943|NCT02059291|469218057|FG005|Epoch 2|Lack of Efficacy|1|||
130339944|NCT02059291|469218058|FG006|Epoch 2|Lack of Efficacy|0|||
130004082|NCT00646906|467979687|FG001|Crossover Period 2|Physician Decision|0|||
130004083|NCT00646906|467979688|FG002|Crossover Period 2|Physician Decision|0|||
130004084|NCT00646906|467979689|FG003|Crossover Period 2|Physician Decision|0|||
130004085|NCT00646906|467979690|FG004|Crossover Period 2|Physician Decision|0|||
130004086|NCT00646906|467979691|FG005|Crossover Period 2|Physician Decision|0|||
130004087|NCT00646906|467979692|FG006|Crossover Period 2|Physician Decision|1|||
130004088|NCT02448225|467979693|FG000|Overall Study|Withdrawal by Subject|1|||
130004089|NCT02448225|467979693|FG000|Overall Study|Did not get FSPG scan|18|||
130004090|NCT02448225|467979693|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
130004091|NCT02486653|467979696|FG000|Overall Study|Withdrawal by Subject|1|||
130004092|NCT02486653|467979697|FG001|Overall Study|Withdrawal by Subject|3|||
130004093|NCT02486653|467979696|FG000|Overall Study|Protocol Violation|1|||
130004094|NCT02486653|467979697|FG001|Overall Study|Protocol Violation|0|||
130004095|NCT02486653|467979696|FG000|Overall Study|surgery cancelled|4|||
130004096|NCT02486653|467979697|FG001|Overall Study|surgery cancelled|1|||
130004097|NCT01177384|467979699|FG000|Overall Study|Adverse Event|6|||
130004098|NCT01177384|467979700|FG001|Overall Study|Adverse Event|4|||
130339945|NCT02059291|469218059|FG007|Epoch 2|Lack of Efficacy|0|||
130339946|NCT02059291|469218060|FG008|Epoch 2|Lack of Efficacy|0|||
130339947|NCT02059291|469218061|FG009|Epoch 2|Lack of Efficacy|0|||
130339948|NCT02059291|469218062|FG010|Epoch 2|Lack of Efficacy|0|||
130339949|NCT02059291|469218063|FG011|Epoch 2|Lack of Efficacy|0|||
130339950|NCT02059291|469218064|FG012|Epoch 2|Lack of Efficacy|0|||
130339951|NCT02059291|469218065|FG013|Epoch 2|Lack of Efficacy|0|||
130339952|NCT02059291|469218066|FG014|Epoch 2|Lack of Efficacy|0|||
130339953|NCT02059291|469218067|FG015|Epoch 2|Lack of Efficacy|0|||
130339954|NCT02059291|469218068|FG016|Epoch 2|Lack of Efficacy|0|||
130339955|NCT02059291|469218069|FG017|Epoch 2|Lack of Efficacy|0|||
130339956|NCT02059291|469218070|FG018|Epoch 2|Lack of Efficacy|0|||
130339957|NCT02059291|469218071|FG019|Epoch 2|Lack of Efficacy|0|||
130339958|NCT02059291|469218072|FG020|Epoch 2|Lack of Efficacy|0|||
130339959|NCT02059291|469218073|FG021|Epoch 2|Lack of Efficacy|0|||
130339960|NCT02059291|469218074|FG022|Epoch 2|Lack of Efficacy|0|||
130339961|NCT02059291|469218075|FG023|Epoch 2|Lack of Efficacy|0|||
130339962|NCT02059291|469218076|FG024|Epoch 2|Lack of Efficacy|0|||
130339963|NCT02059291|469218052|FG000|Epoch 2|Adverse Event|0|||
130339964|NCT02059291|469218053|FG001|Epoch 2|Adverse Event|0|||
130339965|NCT02059291|469218054|FG002|Epoch 2|Adverse Event|1|||
130339966|NCT02059291|469218055|FG003|Epoch 2|Adverse Event|1|||
130339967|NCT02059291|469218056|FG004|Epoch 2|Adverse Event|0|||
130339968|NCT02059291|469218057|FG005|Epoch 2|Adverse Event|0|||
130339969|NCT02059291|469218058|FG006|Epoch 2|Adverse Event|0|||
130339970|NCT02059291|469218059|FG007|Epoch 2|Adverse Event|1|||
130339971|NCT02059291|469218060|FG008|Epoch 2|Adverse Event|1|||
130004099|NCT01177384|467979699|FG000|Overall Study|Lack of Efficacy|0|||
130339972|NCT02059291|469218061|FG009|Epoch 2|Adverse Event|0|||
130339973|NCT02059291|469218062|FG010|Epoch 2|Adverse Event|0|||
130339974|NCT02059291|469218063|FG011|Epoch 2|Adverse Event|0|||
130339975|NCT02059291|469218064|FG012|Epoch 2|Adverse Event|0|||
130339976|NCT02059291|469218065|FG013|Epoch 2|Adverse Event|0|||
130339977|NCT02059291|469218066|FG014|Epoch 2|Adverse Event|0|||
130339978|NCT02059291|469218067|FG015|Epoch 2|Adverse Event|0|||
130339979|NCT02059291|469218068|FG016|Epoch 2|Adverse Event|0|||
130339980|NCT02059291|469218069|FG017|Epoch 2|Adverse Event|0|||
130339981|NCT02059291|469218070|FG018|Epoch 2|Adverse Event|0|||
130339982|NCT02059291|469218071|FG019|Epoch 2|Adverse Event|0|||
130339983|NCT02059291|469218072|FG020|Epoch 2|Adverse Event|0|||
130339984|NCT02059291|469218073|FG021|Epoch 2|Adverse Event|0|||
130339985|NCT02059291|469218074|FG022|Epoch 2|Adverse Event|0|||
130339986|NCT02059291|469218075|FG023|Epoch 2|Adverse Event|0|||
130339987|NCT02059291|469218076|FG024|Epoch 2|Adverse Event|0|||
130339988|NCT02059291|469218052|FG000|Epoch 2|Withdrawal by Subject|0|||
130339989|NCT02059291|469218053|FG001|Epoch 2|Withdrawal by Subject|1|||
130339990|NCT02059291|469218054|FG002|Epoch 2|Withdrawal by Subject|0|||
130339991|NCT02059291|469218055|FG003|Epoch 2|Withdrawal by Subject|0|||
130339992|NCT02059291|469218056|FG004|Epoch 2|Withdrawal by Subject|0|||
130339993|NCT02059291|469218057|FG005|Epoch 2|Withdrawal by Subject|1|||
130339994|NCT02059291|469218058|FG006|Epoch 2|Withdrawal by Subject|0|||
130339995|NCT02059291|469218059|FG007|Epoch 2|Withdrawal by Subject|0|||
130339996|NCT02059291|469218060|FG008|Epoch 2|Withdrawal by Subject|1|||
130339997|NCT02059291|469218061|FG009|Epoch 2|Withdrawal by Subject|0|||
130339998|NCT02059291|469218062|FG010|Epoch 2|Withdrawal by Subject|0|||
130339999|NCT02059291|469218063|FG011|Epoch 2|Withdrawal by Subject|0|||
130340000|NCT02059291|469218064|FG012|Epoch 2|Withdrawal by Subject|0|||
130340001|NCT02059291|469218065|FG013|Epoch 2|Withdrawal by Subject|0|||
130340002|NCT02059291|469218066|FG014|Epoch 2|Withdrawal by Subject|0|||
130340003|NCT02059291|469218067|FG015|Epoch 2|Withdrawal by Subject|0|||
130340004|NCT02059291|469218068|FG016|Epoch 2|Withdrawal by Subject|0|||
130340005|NCT02059291|469218069|FG017|Epoch 2|Withdrawal by Subject|0|||
130340006|NCT02059291|469218070|FG018|Epoch 2|Withdrawal by Subject|0|||
130340007|NCT02059291|469218071|FG019|Epoch 2|Withdrawal by Subject|0|||
130340008|NCT02059291|469218072|FG020|Epoch 2|Withdrawal by Subject|0|||
130340009|NCT02059291|469218073|FG021|Epoch 2|Withdrawal by Subject|0|||
130340010|NCT02059291|469218074|FG022|Epoch 2|Withdrawal by Subject|0|||
130340011|NCT02059291|469218075|FG023|Epoch 2|Withdrawal by Subject|0|||
130340012|NCT02059291|469218076|FG024|Epoch 2|Withdrawal by Subject|0|||
130340013|NCT02059291|469218052|FG000|Epoch 3|Physician Decision|0|||
130340014|NCT02059291|469218053|FG001|Epoch 3|Physician Decision|0|||
130340015|NCT02059291|469218054|FG002|Epoch 3|Physician Decision|0|||
130340016|NCT02059291|469218055|FG003|Epoch 3|Physician Decision|0|||
130340017|NCT02059291|469218056|FG004|Epoch 3|Physician Decision|0|||
130340018|NCT02059291|469218057|FG005|Epoch 3|Physician Decision|0|||
130340019|NCT02059291|469218058|FG006|Epoch 3|Physician Decision|0|||
130340020|NCT02059291|469218059|FG007|Epoch 3|Physician Decision|0|||
130340021|NCT02059291|469218060|FG008|Epoch 3|Physician Decision|0|||
130340022|NCT02059291|469218061|FG009|Epoch 3|Physician Decision|0|||
130340023|NCT02059291|469218062|FG010|Epoch 3|Physician Decision|0|||
130340024|NCT02059291|469218063|FG011|Epoch 3|Physician Decision|0|||
130340025|NCT02059291|469218064|FG012|Epoch 3|Physician Decision|0|||
130340026|NCT02059291|469218065|FG013|Epoch 3|Physician Decision|1|||
130340027|NCT02059291|469218066|FG014|Epoch 3|Physician Decision|0|||
130340028|NCT02059291|469218067|FG015|Epoch 3|Physician Decision|1|||
130340029|NCT02059291|469218068|FG016|Epoch 3|Physician Decision|0|||
130340030|NCT02059291|469218069|FG017|Epoch 3|Physician Decision|0|||
130340031|NCT02059291|469218070|FG018|Epoch 3|Physician Decision|0|||
130004100|NCT01177384|467979700|FG001|Overall Study|Lack of Efficacy|1|||
130004101|NCT01177384|467979699|FG000|Overall Study|Lost to Follow-up|3|||
130004102|NCT01177384|467979700|FG001|Overall Study|Lost to Follow-up|4|||
130004103|NCT01177384|467979699|FG000|Overall Study|Physician Decision|0|||
130004104|NCT01177384|467979700|FG001|Overall Study|Physician Decision|3|||
130004105|NCT01177384|467979699|FG000|Overall Study|Protocol Violation|0|||
130004106|NCT01177384|467979700|FG001|Overall Study|Protocol Violation|2|||
130004107|NCT01177384|467979699|FG000|Overall Study|Withdrawal by Subject|5|||
130004108|NCT01177384|467979700|FG001|Overall Study|Withdrawal by Subject|12|||
130004109|NCT01849497|467979701|FG000|Overall Study|Withdrawal by Subject|1|||
130004110|NCT01849497|467979702|FG001|Overall Study|Withdrawal by Subject|2|||
130004111|NCT01849497|467979701|FG000|Overall Study|Sponsor Decision|0|||
130004112|NCT01849497|467979702|FG001|Overall Study|Sponsor Decision|1|||
130004113|NCT01849497|467979701|FG000|Overall Study|Lost to Follow-up|0|||
130004114|NCT01849497|467979702|FG001|Overall Study|Lost to Follow-up|1|||
130004115|NCT00307333|467979703|FG000|Overall Study|Lost to Follow-up|11|||
130004116|NCT00307333|467979704|FG001|Overall Study|Lost to Follow-up|3|||
130004117|NCT00698932|467979705|FG000|Overall Study|Adverse Event|0|||
130004118|NCT00698932|467979706|FG001|Overall Study|Adverse Event|2|||
130004119|NCT00698932|467979705|FG000|Overall Study|Incorrect enrollment|0|||
130004120|NCT00698932|467979706|FG001|Overall Study|Incorrect enrollment|2|||
130004121|NCT00698932|467979705|FG000|Overall Study|Study specific discontinuation criteria|3|||
130340032|NCT02059291|469218071|FG019|Epoch 3|Physician Decision|0|||
130340033|NCT02059291|469218072|FG020|Epoch 3|Physician Decision|0|||
130340034|NCT02059291|469218073|FG021|Epoch 3|Physician Decision|0|||
130340035|NCT02059291|469218074|FG022|Epoch 3|Physician Decision|0|||
130340036|NCT02059291|469218075|FG023|Epoch 3|Physician Decision|0|||
130340037|NCT02059291|469218076|FG024|Epoch 3|Physician Decision|0|||
130340038|NCT02059291|469218052|FG000|Epoch 3|Adverse Event|0|||
130340039|NCT02059291|469218053|FG001|Epoch 3|Adverse Event|0|||
130340040|NCT02059291|469218054|FG002|Epoch 3|Adverse Event|0|||
130004122|NCT00698932|467979706|FG001|Overall Study|Study specific discontinuation criteria|4|||
130340041|NCT02059291|469218055|FG003|Epoch 3|Adverse Event|0|||
130340042|NCT02059291|469218056|FG004|Epoch 3|Adverse Event|0|||
130340043|NCT02059291|469218057|FG005|Epoch 3|Adverse Event|0|||
130340044|NCT02059291|469218058|FG006|Epoch 3|Adverse Event|0|||
130340045|NCT02059291|469218059|FG007|Epoch 3|Adverse Event|0|||
130340046|NCT02059291|469218060|FG008|Epoch 3|Adverse Event|0|||
130340047|NCT02059291|469218061|FG009|Epoch 3|Adverse Event|0|||
130004123|NCT00698932|467979705|FG000|Overall Study|Withdrawal by Subject|11|||
130004124|NCT00698932|467979706|FG001|Overall Study|Withdrawal by Subject|23|||
130004125|NCT00698932|467979705|FG000|Overall Study|Lost to Follow-up|6|||
130340048|NCT02059291|469218062|FG010|Epoch 3|Adverse Event|0|||
130340049|NCT02059291|469218063|FG011|Epoch 3|Adverse Event|0|||
130340050|NCT02059291|469218064|FG012|Epoch 3|Adverse Event|0|||
130340051|NCT02059291|469218065|FG013|Epoch 3|Adverse Event|0|||
130004126|NCT00698932|467979706|FG001|Overall Study|Lost to Follow-up|1|||
130004127|NCT00698932|467979705|FG000|Overall Study|Severe non-compliance to protocol|1|||
130004128|NCT00698932|467979706|FG001|Overall Study|Severe non-compliance to protocol|2|||
130004129|NCT00698932|467979705|FG000|Overall Study|Safety reasons|0|||
130004130|NCT00698932|467979706|FG001|Overall Study|Safety reasons|2|||
130004131|NCT00698932|467979705|FG000|Overall Study|Death|1|||
130004132|NCT00698932|467979706|FG001|Overall Study|Death|0|||
130004133|NCT02632721|467979712|FG000|Overall Study|Adverse Event|0|||
130004134|NCT02632721|467979713|FG001|Overall Study|Adverse Event|0|||
130004135|NCT02632721|467979714|FG002|Overall Study|Adverse Event|2|||
130004136|NCT02632721|467979715|FG003|Overall Study|Adverse Event|5|||
130004137|NCT02632721|467979716|FG004|Overall Study|Adverse Event|3|||
130004138|NCT02632721|467979712|FG000|Overall Study|Dose limiting toxicity|0|||
130004139|NCT02632721|467979713|FG001|Overall Study|Dose limiting toxicity|0|||
130004140|NCT02632721|467979714|FG002|Overall Study|Dose limiting toxicity|0|||
130004141|NCT02632721|467979715|FG003|Overall Study|Dose limiting toxicity|1|||
130004142|NCT02632721|467979716|FG004|Overall Study|Dose limiting toxicity|0|||
130004143|NCT02632721|467979712|FG000|Overall Study|Progressive disease|3|||
130004144|NCT02632721|467979713|FG001|Overall Study|Progressive disease|0|||
130004145|NCT02632721|467979714|FG002|Overall Study|Progressive disease|4|||
130004146|NCT02632721|467979715|FG003|Overall Study|Progressive disease|6|||
130004147|NCT02632721|467979716|FG004|Overall Study|Progressive disease|5|||
130004148|NCT02632721|467979712|FG000|Overall Study|Refused to continue taking trial medication|0|||
130004149|NCT02632721|467979713|FG001|Overall Study|Refused to continue taking trial medication|1|||
130004150|NCT02632721|467979714|FG002|Overall Study|Refused to continue taking trial medication|1|||
130004151|NCT02632721|467979715|FG003|Overall Study|Refused to continue taking trial medication|1|||
130004152|NCT02632721|467979716|FG004|Overall Study|Refused to continue taking trial medication|2|||
130004153|NCT02632721|467979712|FG000|Overall Study|Inadequate clinical condition|0|||
130004154|NCT02632721|467979713|FG001|Overall Study|Inadequate clinical condition|0|||
130004155|NCT02632721|467979714|FG002|Overall Study|Inadequate clinical condition|0|||
130004156|NCT02632721|467979715|FG003|Overall Study|Inadequate clinical condition|0|||
130004157|NCT02632721|467979716|FG004|Overall Study|Inadequate clinical condition|1|||
130004158|NCT02632721|467979712|FG000|Overall Study|No meet eligibility|0|||
130004159|NCT02632721|467979713|FG001|Overall Study|No meet eligibility|0|||
130004160|NCT02632721|467979714|FG002|Overall Study|No meet eligibility|0|||
130004161|NCT02632721|467979715|FG003|Overall Study|No meet eligibility|0|||
130004162|NCT02632721|467979716|FG004|Overall Study|No meet eligibility|1|||
130004163|NCT02632721|467979712|FG000|Overall Study|Allergic reaction|0|||
130004164|NCT02632721|467979713|FG001|Overall Study|Allergic reaction|0|||
130004165|NCT02632721|467979714|FG002|Overall Study|Allergic reaction|0|||
130004166|NCT02632721|467979715|FG003|Overall Study|Allergic reaction|1|||
130004167|NCT02632721|467979716|FG004|Overall Study|Allergic reaction|0|||
130004168|NCT02632721|467979712|FG000|Overall Study|Receiving Decitabine locally|0|||
130004169|NCT02632721|467979713|FG001|Overall Study|Receiving Decitabine locally|0|||
130004170|NCT02632721|467979714|FG002|Overall Study|Receiving Decitabine locally|1|||
130216490|NCT00423813|468755578|FG000|Overall Study|Will start exclusionary medications|0|||
130216491|NCT00423813|468755579|FG001|Overall Study|Will start exclusionary medications|1|||
130216492|NCT00423813|468755580|FG002|Overall Study|Will start exclusionary medications|0|||
130216493|NCT00423813|468755578|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
130216494|NCT00423813|468755579|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
130216495|NCT00423813|468755580|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
130216496|NCT01386944|468755582|FG000|Overall Study|Adverse Event|26|||
130216497|NCT01386944|468755582|FG000|Overall Study|Lack of Efficacy|14|||
130216498|NCT01386944|468755582|FG000|Overall Study|Lost to Follow-up|8|||
130216499|NCT01386944|468755582|FG000|Overall Study|Unspecified reason|8|||
130216500|NCT03853291|468755583|FG000|Overall Study|Lost to Follow-up|1|||
130216501|NCT03853291|468755584|FG001|Overall Study|Lost to Follow-up|2|||
130216502|NCT03853291|468755585|FG002|Overall Study|Lost to Follow-up|0|||
130216503|NCT03853291|468755586|FG003|Overall Study|Lost to Follow-up|0|||
130216504|NCT03853291|468755587|FG004|Overall Study|Lost to Follow-up|0|||
130216505|NCT03853291|468755588|FG005|Overall Study|Lost to Follow-up|0|||
130216506|NCT03853291|468755583|FG000|Overall Study|Determined to be ineligible|1|||
130216507|NCT03853291|468755584|FG001|Overall Study|Determined to be ineligible|1|||
130216508|NCT03853291|468755585|FG002|Overall Study|Determined to be ineligible|0|||
130216509|NCT03853291|468755586|FG003|Overall Study|Determined to be ineligible|0|||
130216510|NCT03853291|468755587|FG004|Overall Study|Determined to be ineligible|0|||
130216511|NCT03853291|468755588|FG005|Overall Study|Determined to be ineligible|0|||
130216512|NCT03883477|468755589|FG000|Overall Study|Death|1|||
130216513|NCT03883477|468755590|FG001|Overall Study|Death|0|||
130340052|NCT02059291|469218066|FG014|Epoch 3|Adverse Event|0|||
130004171|NCT02632721|467979715|FG003|Overall Study|Receiving Decitabine locally|0|||
130004172|NCT02632721|467979716|FG004|Overall Study|Receiving Decitabine locally|0|||
130004173|NCT02632721|467979712|FG000|Overall Study|No benefit from study treatment|1|||
130004174|NCT02632721|467979713|FG001|Overall Study|No benefit from study treatment|1|||
130004175|NCT02632721|467979714|FG002|Overall Study|No benefit from study treatment|0|||
130004176|NCT02632721|467979715|FG003|Overall Study|No benefit from study treatment|0|||
130004177|NCT02632721|467979716|FG004|Overall Study|No benefit from study treatment|1|||
130004178|NCT02632721|467979712|FG000|Overall Study|Patient wish for other treatment|0|||
130004179|NCT02632721|467979713|FG001|Overall Study|Patient wish for other treatment|1|||
130004180|NCT02632721|467979714|FG002|Overall Study|Patient wish for other treatment|0|||
130004181|NCT02632721|467979715|FG003|Overall Study|Patient wish for other treatment|0|||
130004182|NCT02632721|467979716|FG004|Overall Study|Patient wish for other treatment|0|||
130004183|NCT02632721|467979712|FG000|Overall Study|Relapsed Pneumonia|0|||
130004184|NCT02632721|467979713|FG001|Overall Study|Relapsed Pneumonia|0|||
130004185|NCT02632721|467979714|FG002|Overall Study|Relapsed Pneumonia|0|||
130004186|NCT02632721|467979715|FG003|Overall Study|Relapsed Pneumonia|0|||
130004187|NCT02632721|467979716|FG004|Overall Study|Relapsed Pneumonia|1|||
130004188|NCT02632721|467979712|FG000|Overall Study|Therapy refractory AML|0|||
130004189|NCT02632721|467979713|FG001|Overall Study|Therapy refractory AML|0|||
130340053|NCT02059291|469218067|FG015|Epoch 3|Adverse Event|1|||
130340054|NCT02059291|469218068|FG016|Epoch 3|Adverse Event|0|||
130340055|NCT02059291|469218069|FG017|Epoch 3|Adverse Event|0|||
130340056|NCT02059291|469218070|FG018|Epoch 3|Adverse Event|0|||
130340057|NCT02059291|469218071|FG019|Epoch 3|Adverse Event|0|||
130340058|NCT02059291|469218072|FG020|Epoch 3|Adverse Event|0|||
130340059|NCT02059291|469218073|FG021|Epoch 3|Adverse Event|0|||
130340060|NCT02059291|469218074|FG022|Epoch 3|Adverse Event|0|||
130340061|NCT02059291|469218075|FG023|Epoch 3|Adverse Event|0|||
130340062|NCT02059291|469218076|FG024|Epoch 3|Adverse Event|0|||
130340063|NCT02059291|469218052|FG000|Epoch 3|Lack of Efficacy|0|||
130340064|NCT02059291|469218053|FG001|Epoch 3|Lack of Efficacy|0|||
130340065|NCT02059291|469218054|FG002|Epoch 3|Lack of Efficacy|0|||
130340066|NCT02059291|469218055|FG003|Epoch 3|Lack of Efficacy|0|||
130340067|NCT02059291|469218056|FG004|Epoch 3|Lack of Efficacy|0|||
130340068|NCT02059291|469218057|FG005|Epoch 3|Lack of Efficacy|0|||
130340069|NCT02059291|469218058|FG006|Epoch 3|Lack of Efficacy|0|||
130340070|NCT02059291|469218059|FG007|Epoch 3|Lack of Efficacy|0|||
130340071|NCT02059291|469218060|FG008|Epoch 3|Lack of Efficacy|0|||
130340072|NCT02059291|469218061|FG009|Epoch 3|Lack of Efficacy|0|||
130340073|NCT02059291|469218062|FG010|Epoch 3|Lack of Efficacy|0|||
130340074|NCT02059291|469218063|FG011|Epoch 3|Lack of Efficacy|0|||
130340075|NCT02059291|469218064|FG012|Epoch 3|Lack of Efficacy|0|||
130340076|NCT02059291|469218065|FG013|Epoch 3|Lack of Efficacy|0|||
130340077|NCT02059291|469218066|FG014|Epoch 3|Lack of Efficacy|0|||
130340078|NCT02059291|469218067|FG015|Epoch 3|Lack of Efficacy|3|||
130340079|NCT02059291|469218068|FG016|Epoch 3|Lack of Efficacy|0|||
130340080|NCT02059291|469218069|FG017|Epoch 3|Lack of Efficacy|0|||
130340081|NCT02059291|469218070|FG018|Epoch 3|Lack of Efficacy|0|||
130340082|NCT02059291|469218071|FG019|Epoch 3|Lack of Efficacy|0|||
130340083|NCT02059291|469218072|FG020|Epoch 3|Lack of Efficacy|0|||
130340084|NCT02059291|469218073|FG021|Epoch 3|Lack of Efficacy|0|||
130340085|NCT02059291|469218074|FG022|Epoch 3|Lack of Efficacy|0|||
130340086|NCT02059291|469218075|FG023|Epoch 3|Lack of Efficacy|0|||
130340087|NCT02059291|469218076|FG024|Epoch 3|Lack of Efficacy|0|||
130340088|NCT02059291|469218052|FG000|Epoch 3|Withdrawal by Subject|0|||
130340089|NCT02059291|469218053|FG001|Epoch 3|Withdrawal by Subject|0|||
130340090|NCT02059291|469218054|FG002|Epoch 3|Withdrawal by Subject|0|||
130340091|NCT02059291|469218055|FG003|Epoch 3|Withdrawal by Subject|0|||
130340092|NCT02059291|469218056|FG004|Epoch 3|Withdrawal by Subject|0|||
130340093|NCT02059291|469218057|FG005|Epoch 3|Withdrawal by Subject|0|||
130340094|NCT02059291|469218058|FG006|Epoch 3|Withdrawal by Subject|0|||
130340095|NCT02059291|469218059|FG007|Epoch 3|Withdrawal by Subject|0|||
130340096|NCT02059291|469218060|FG008|Epoch 3|Withdrawal by Subject|0|||
130340097|NCT02059291|469218061|FG009|Epoch 3|Withdrawal by Subject|0|||
130340098|NCT02059291|469218062|FG010|Epoch 3|Withdrawal by Subject|0|||
130340099|NCT02059291|469218063|FG011|Epoch 3|Withdrawal by Subject|0|||
130340100|NCT02059291|469218064|FG012|Epoch 3|Withdrawal by Subject|0|||
130340101|NCT02059291|469218065|FG013|Epoch 3|Withdrawal by Subject|0|||
130340102|NCT02059291|469218066|FG014|Epoch 3|Withdrawal by Subject|0|||
130004190|NCT02632721|467979714|FG002|Overall Study|Therapy refractory AML|0|||
130340103|NCT02059291|469218067|FG015|Epoch 3|Withdrawal by Subject|1|||
130340104|NCT02059291|469218068|FG016|Epoch 3|Withdrawal by Subject|0|||
130340105|NCT02059291|469218069|FG017|Epoch 3|Withdrawal by Subject|0|||
130340106|NCT02059291|469218070|FG018|Epoch 3|Withdrawal by Subject|0|||
130340107|NCT02059291|469218071|FG019|Epoch 3|Withdrawal by Subject|0|||
130340108|NCT02059291|469218072|FG020|Epoch 3|Withdrawal by Subject|0|||
130340109|NCT02059291|469218073|FG021|Epoch 3|Withdrawal by Subject|0|||
130340110|NCT02059291|469218074|FG022|Epoch 3|Withdrawal by Subject|0|||
130340111|NCT02059291|469218075|FG023|Epoch 3|Withdrawal by Subject|0|||
130340112|NCT02059291|469218076|FG024|Epoch 3|Withdrawal by Subject|0|||
130340113|NCT02059291|469218052|FG000|Epoch 4|Adverse Event|0|||
130340114|NCT02059291|469218053|FG001|Epoch 4|Adverse Event|0|||
130340115|NCT02059291|469218054|FG002|Epoch 4|Adverse Event|0|||
130340116|NCT02059291|469218055|FG003|Epoch 4|Adverse Event|0|||
130340117|NCT02059291|469218056|FG004|Epoch 4|Adverse Event|0|||
130340118|NCT02059291|469218057|FG005|Epoch 4|Adverse Event|0|||
130340119|NCT02059291|469218058|FG006|Epoch 4|Adverse Event|0|||
130340120|NCT02059291|469218059|FG007|Epoch 4|Adverse Event|0|||
130340121|NCT02059291|469218060|FG008|Epoch 4|Adverse Event|0|||
130340122|NCT02059291|469218061|FG009|Epoch 4|Adverse Event|0|||
130340123|NCT02059291|469218062|FG010|Epoch 4|Adverse Event|0|||
130340124|NCT02059291|469218063|FG011|Epoch 4|Adverse Event|0|||
130340125|NCT02059291|469218064|FG012|Epoch 4|Adverse Event|0|||
130340126|NCT02059291|469218065|FG013|Epoch 4|Adverse Event|0|||
130340127|NCT02059291|469218066|FG014|Epoch 4|Adverse Event|0|||
130340128|NCT02059291|469218067|FG015|Epoch 4|Adverse Event|0|||
130340129|NCT02059291|469218068|FG016|Epoch 4|Adverse Event|1|||
130340130|NCT02059291|469218069|FG017|Epoch 4|Adverse Event|0|||
130340131|NCT02059291|469218070|FG018|Epoch 4|Adverse Event|0|||
130340132|NCT02059291|469218071|FG019|Epoch 4|Adverse Event|0|||
130340133|NCT02059291|469218072|FG020|Epoch 4|Adverse Event|0|||
130340134|NCT02059291|469218073|FG021|Epoch 4|Adverse Event|0|||
130340135|NCT02059291|469218074|FG022|Epoch 4|Adverse Event|1|||
130340136|NCT02059291|469218075|FG023|Epoch 4|Adverse Event|0|||
130340137|NCT02059291|469218076|FG024|Epoch 4|Adverse Event|0|||
130340138|NCT02059291|469218052|FG000|Epoch 4|Pregnancy|0|||
130340139|NCT02059291|469218053|FG001|Epoch 4|Pregnancy|0|||
130340140|NCT02059291|469218054|FG002|Epoch 4|Pregnancy|0|||
130004191|NCT02632721|467979715|FG003|Overall Study|Therapy refractory AML|0|||
130004192|NCT02632721|467979716|FG004|Overall Study|Therapy refractory AML|1|||
130004193|NCT02632721|467979712|FG000|Overall Study|Increase of white blood cell count|0|||
130004194|NCT02632721|467979713|FG001|Overall Study|Increase of white blood cell count|0|||
130004195|NCT02632721|467979714|FG002|Overall Study|Increase of white blood cell count|0|||
130004196|NCT02632721|467979715|FG003|Overall Study|Increase of white blood cell count|0|||
130004197|NCT02632721|467979716|FG004|Overall Study|Increase of white blood cell count|1|||
130004198|NCT02632721|467979712|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130004199|NCT02632721|467979713|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130004200|NCT02632721|467979714|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
130004201|NCT02632721|467979715|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130004202|NCT02632721|467979716|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
130004203|NCT00544648|467979717|FG000|Overall Study|Withdrawal by Subject|1|||
130004204|NCT00544648|467979718|FG001|Overall Study|Withdrawal by Subject|0|||
130004205|NCT00544648|467979717|FG000|Overall Study|Adverse Event|1|||
130004206|NCT00544648|467979718|FG001|Overall Study|Adverse Event|1|||
130004207|NCT00544648|467979717|FG000|Overall Study|progression of disease|1|||
130004208|NCT00544648|467979718|FG001|Overall Study|progression of disease|0|||
130004209|NCT04166383|467979721|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
130004210|NCT04166383|467979721|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
130004211|NCT04166383|467979721|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
130004212|NCT03044886|467979723|FG000|Overall Study|Lost to Follow-up|15|||
130004213|NCT03044886|467979724|FG001|Overall Study|Lost to Follow-up|10|||
130004214|NCT03044886|467979725|FG002|Overall Study|Lost to Follow-up|12|||
130004215|NCT00074581|467979727|FG000|Overall Study|Death|15|||
130004216|NCT00074581|467979728|FG001|Overall Study|Death|16|||
130004217|NCT00074581|467979727|FG000|Overall Study|Withdrawal by Subject|50|||
130004218|NCT00074581|467979728|FG001|Overall Study|Withdrawal by Subject|49|||
130004219|NCT00074581|467979727|FG000|Overall Study|Unable to adhere to visit schedule|13|||
130004220|NCT00074581|467979728|FG001|Overall Study|Unable to adhere to visit schedule|14|||
130004221|NCT00074581|467979727|FG000|Overall Study|Relocated|14|||
130004222|NCT00074581|467979728|FG001|Overall Study|Relocated|9|||
130004223|NCT00074581|467979727|FG000|Overall Study|Were withdrawn by investigator|5|||
130004224|NCT00074581|467979728|FG001|Overall Study|Were withdrawn by investigator|2|||
130004225|NCT00074581|467979727|FG000|Overall Study|Lost to Follow-up|16|||
130004226|NCT00074581|467979728|FG001|Overall Study|Lost to Follow-up|11|||
130004227|NCT00074581|467979727|FG000|Overall Study|Ended relationship w. index participant|117|||
130004228|NCT00074581|467979728|FG001|Overall Study|Ended relationship w. index participant|106|||
130004229|NCT00074581|467979727|FG000|Overall Study|Other|14|||
130340141|NCT02059291|469218055|FG003|Epoch 4|Pregnancy|0|||
130004230|NCT00074581|467979728|FG001|Overall Study|Other|19|||
130004231|NCT04411628|467979733|FG000|Overall Study|Withdrawal by Subject|1|||
130340142|NCT02059291|469218056|FG004|Epoch 4|Pregnancy|0|||
130340143|NCT02059291|469218057|FG005|Epoch 4|Pregnancy|0|||
130340144|NCT02059291|469218058|FG006|Epoch 4|Pregnancy|0|||
130004232|NCT04411628|467979734|FG001|Overall Study|Withdrawal by Subject|1|||
130004233|NCT04411628|467979735|FG002|Overall Study|Withdrawal by Subject|2|||
130340145|NCT02059291|469218059|FG007|Epoch 4|Pregnancy|0|||
130340146|NCT02059291|469218060|FG008|Epoch 4|Pregnancy|0|||
130340147|NCT02059291|469218061|FG009|Epoch 4|Pregnancy|0|||
130340148|NCT02059291|469218062|FG010|Epoch 4|Pregnancy|0|||
130340149|NCT02059291|469218063|FG011|Epoch 4|Pregnancy|0|||
130340150|NCT02059291|469218064|FG012|Epoch 4|Pregnancy|0|||
130340151|NCT02059291|469218065|FG013|Epoch 4|Pregnancy|0|||
130340152|NCT02059291|469218066|FG014|Epoch 4|Pregnancy|0|||
130340153|NCT02059291|469218067|FG015|Epoch 4|Pregnancy|0|||
130340154|NCT02059291|469218068|FG016|Epoch 4|Pregnancy|1|||
130340155|NCT02059291|469218069|FG017|Epoch 4|Pregnancy|0|||
130340156|NCT02059291|469218070|FG018|Epoch 4|Pregnancy|0|||
130340157|NCT02059291|469218071|FG019|Epoch 4|Pregnancy|0|||
130340158|NCT02059291|469218072|FG020|Epoch 4|Pregnancy|0|||
130340159|NCT02059291|469218073|FG021|Epoch 4|Pregnancy|0|||
130340160|NCT02059291|469218074|FG022|Epoch 4|Pregnancy|0|||
130340161|NCT02059291|469218075|FG023|Epoch 4|Pregnancy|0|||
130340162|NCT02059291|469218076|FG024|Epoch 4|Pregnancy|0|||
130340163|NCT02059291|469218052|FG000|Epoch 4|Withdrawal by Subject|0|||
130340164|NCT02059291|469218053|FG001|Epoch 4|Withdrawal by Subject|0|||
130340165|NCT02059291|469218054|FG002|Epoch 4|Withdrawal by Subject|0|||
130340166|NCT02059291|469218055|FG003|Epoch 4|Withdrawal by Subject|0|||
130340167|NCT02059291|469218056|FG004|Epoch 4|Withdrawal by Subject|0|||
130340168|NCT02059291|469218057|FG005|Epoch 4|Withdrawal by Subject|0|||
130340169|NCT02059291|469218058|FG006|Epoch 4|Withdrawal by Subject|0|||
130340170|NCT02059291|469218059|FG007|Epoch 4|Withdrawal by Subject|0|||
130340171|NCT02059291|469218060|FG008|Epoch 4|Withdrawal by Subject|0|||
130340172|NCT02059291|469218061|FG009|Epoch 4|Withdrawal by Subject|0|||
130340173|NCT02059291|469218062|FG010|Epoch 4|Withdrawal by Subject|0|||
130340174|NCT02059291|469218063|FG011|Epoch 4|Withdrawal by Subject|0|||
130340175|NCT02059291|469218064|FG012|Epoch 4|Withdrawal by Subject|0|||
130340176|NCT02059291|469218065|FG013|Epoch 4|Withdrawal by Subject|0|||
130340177|NCT02059291|469218066|FG014|Epoch 4|Withdrawal by Subject|0|||
130340178|NCT02059291|469218067|FG015|Epoch 4|Withdrawal by Subject|0|||
130340179|NCT02059291|469218068|FG016|Epoch 4|Withdrawal by Subject|0|||
130340180|NCT02059291|469218069|FG017|Epoch 4|Withdrawal by Subject|0|||
130340181|NCT02059291|469218070|FG018|Epoch 4|Withdrawal by Subject|0|||
130340182|NCT02059291|469218071|FG019|Epoch 4|Withdrawal by Subject|0|||
130340183|NCT02059291|469218072|FG020|Epoch 4|Withdrawal by Subject|1|||
130340184|NCT02059291|469218073|FG021|Epoch 4|Withdrawal by Subject|0|||
130340185|NCT02059291|469218074|FG022|Epoch 4|Withdrawal by Subject|0|||
130340186|NCT02059291|469218075|FG023|Epoch 4|Withdrawal by Subject|0|||
130340187|NCT02059291|469218076|FG024|Epoch 4|Withdrawal by Subject|0|||
130340188|NCT02059291|469218052|FG000|Epoch 4|Lack of Efficacy|0|||
130340189|NCT02059291|469218053|FG001|Epoch 4|Lack of Efficacy|0|||
130340190|NCT02059291|469218054|FG002|Epoch 4|Lack of Efficacy|0|||
130340191|NCT02059291|469218055|FG003|Epoch 4|Lack of Efficacy|0|||
130340192|NCT02059291|469218056|FG004|Epoch 4|Lack of Efficacy|0|||
130340193|NCT02059291|469218057|FG005|Epoch 4|Lack of Efficacy|0|||
130340194|NCT02059291|469218058|FG006|Epoch 4|Lack of Efficacy|0|||
130340195|NCT02059291|469218059|FG007|Epoch 4|Lack of Efficacy|0|||
130340196|NCT02059291|469218060|FG008|Epoch 4|Lack of Efficacy|0|||
130340197|NCT02059291|469218061|FG009|Epoch 4|Lack of Efficacy|0|||
130340198|NCT02059291|469218062|FG010|Epoch 4|Lack of Efficacy|0|||
130340199|NCT02059291|469218063|FG011|Epoch 4|Lack of Efficacy|0|||
130340200|NCT02059291|469218064|FG012|Epoch 4|Lack of Efficacy|0|||
130340201|NCT02059291|469218065|FG013|Epoch 4|Lack of Efficacy|0|||
130340202|NCT02059291|469218066|FG014|Epoch 4|Lack of Efficacy|0|||
130340203|NCT02059291|469218067|FG015|Epoch 4|Lack of Efficacy|0|||
130340204|NCT02059291|469218068|FG016|Epoch 4|Lack of Efficacy|0|||
130340205|NCT02059291|469218069|FG017|Epoch 4|Lack of Efficacy|0|||
130340206|NCT02059291|469218070|FG018|Epoch 4|Lack of Efficacy|0|||
130340207|NCT02059291|469218071|FG019|Epoch 4|Lack of Efficacy|0|||
130340208|NCT02059291|469218072|FG020|Epoch 4|Lack of Efficacy|0|||
130340209|NCT02059291|469218073|FG021|Epoch 4|Lack of Efficacy|0|||
130340210|NCT02059291|469218074|FG022|Epoch 4|Lack of Efficacy|0|||
130340211|NCT02059291|469218075|FG023|Epoch 4|Lack of Efficacy|1|||
130340212|NCT02059291|469218076|FG024|Epoch 4|Lack of Efficacy|0|||
130340213|NCT01433289|469218077|FG000|Overall Study|Pregnancy|0|||
130340214|NCT01433289|469218078|FG001|Overall Study|Pregnancy|1|||
130340215|NCT01433289|469218079|FG002|Overall Study|Pregnancy|0|||
130340216|NCT01433289|469218080|FG003|Overall Study|Pregnancy|0|||
130340217|NCT04343235|469218081|FG000|Overall Study|Lost to Follow-up|3|||
130340218|NCT04343235|469218082|FG001|Overall Study|Lost to Follow-up|2|||
130340219|NCT01763996|469218083|FG000|Treatment Period 2|Adverse Event|0|||
130340220|NCT01763996|469218084|FG001|Treatment Period 2|Adverse Event|1|||
130340221|NCT01788215|469218087|FG000|Overall Study|Withdrawal by Subject|0|||
130340222|NCT01788215|469218088|FG001|Overall Study|Withdrawal by Subject|1|||
130340223|NCT01788215|469218087|FG000|Overall Study|Lost to Follow-up|2|||
130340224|NCT01788215|469218088|FG001|Overall Study|Lost to Follow-up|0|||
130340225|NCT00275340|469218089|FG000|Overall Study|Lost to Follow-up|2|||
130340226|NCT00275340|469218090|FG001|Overall Study|Lost to Follow-up|4|||
130340227|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
130340228|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
130340229|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
130340230|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
130340231|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
130340232|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
130340233|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
130340234|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
130340235|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
130340236|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
130340237|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
130340238|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
130340239|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
130340240|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
130340241|NCT00612105|469218094|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
130340242|NCT00612105|469218095|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
130340243|NCT00612105|469218094|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
130340244|NCT00612105|469218095|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
130340245|NCT00612105|469218094|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
130340246|NCT00612105|469218095|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
130340247|NCT00612105|469218094|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
130004234|NCT04411628|467979736|FG003|Overall Study|Withdrawal by Subject|0|||
130004235|NCT04411628|467979733|FG000|Overall Study|Lost to Follow-up|0|||
130340248|NCT00612105|469218095|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
130340249|NCT00612105|469218094|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
130340250|NCT00612105|469218095|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
130340251|NCT01105767|469218096|FG000|Overall Study|Lost to Follow-up|1160|||
130340252|NCT01105767|469218097|FG001|Overall Study|Lost to Follow-up|1614|||
130340253|NCT01105767|469218098|FG002|Overall Study|Lost to Follow-up|1184|||
130340254|NCT00743106|469218099|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
130340255|NCT00743106|469218100|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
130340256|NCT02674204|469218102|FG000|Overall Study|Adverse Event|1|||
130340257|NCT02674204|469218103|FG001|Overall Study|Adverse Event|0|||
130340258|NCT02874144|469218106|FG000|Overall Study|Lost to Follow-up|3|||
130340259|NCT02874144|469218107|FG001|Overall Study|Lost to Follow-up|5|||
130340260|NCT00486811|469218108|FG000|Overall Study|Adverse Event|28|||
130340261|NCT00486811|469218109|FG001|Overall Study|Adverse Event|60|||
130340262|NCT00486811|469218110|FG002|Overall Study|Adverse Event|135|||
130340263|NCT00486811|469218108|FG000|Overall Study|Lack of Efficacy|34|||
130340264|NCT00486811|469218109|FG001|Overall Study|Lack of Efficacy|14|||
130340265|NCT00486811|469218110|FG002|Overall Study|Lack of Efficacy|7|||
130340266|NCT00486811|469218108|FG000|Overall Study|Lost to Follow-up|4|||
130340267|NCT00486811|469218109|FG001|Overall Study|Lost to Follow-up|6|||
130340268|NCT00486811|469218110|FG002|Overall Study|Lost to Follow-up|4|||
130340269|NCT00486811|469218108|FG000|Overall Study|Withdrawal by Subject|33|||
130340270|NCT00486811|469218109|FG001|Overall Study|Withdrawal by Subject|44|||
130340271|NCT00486811|469218110|FG002|Overall Study|Withdrawal by Subject|58|||
130004236|NCT04411628|467979734|FG001|Overall Study|Lost to Follow-up|1|||
130004237|NCT04411628|467979735|FG002|Overall Study|Lost to Follow-up|0|||
130004238|NCT04411628|467979736|FG003|Overall Study|Lost to Follow-up|0|||
130004239|NCT00732251|467979737|FG000|Overall Study|Lost to Follow-up|3|||
130004240|NCT00732251|467979737|FG000|Overall Study|Withdrawal by Subject|3|||
130004241|NCT00732251|467979737|FG000|Overall Study|Early Term due to Site Closure|1|||
130004242|NCT01034540|467979738|FG000|Overall Study|Adverse Event|0|||
130004243|NCT01034540|467979739|FG001|Overall Study|Adverse Event|1|||
130004244|NCT03519867|467979742|FG000|Overall Study|Adverse Event|1|||
130004245|NCT03519867|467979743|FG001|Overall Study|Adverse Event|1|||
130004246|NCT03519867|467979744|FG002|Overall Study|Adverse Event|0|||
130004247|NCT03519867|467979745|FG003|Overall Study|Adverse Event|0|||
130004248|NCT03519867|467979746|FG004|Overall Study|Adverse Event|0|||
130004249|NCT03519867|467979747|FG005|Overall Study|Adverse Event|0|||
130004250|NCT03519867|467979748|FG006|Overall Study|Adverse Event|0|||
130004251|NCT03519867|467979749|FG007|Overall Study|Adverse Event|0|||
130004252|NCT03519867|467979750|FG008|Overall Study|Adverse Event|0|||
130004253|NCT03519867|467979751|FG009|Overall Study|Adverse Event|0|||
130004254|NCT03519867|467979742|FG000|Overall Study|Protocol Violation|0|||
130004255|NCT03519867|467979743|FG001|Overall Study|Protocol Violation|0|||
130004256|NCT03519867|467979744|FG002|Overall Study|Protocol Violation|0|||
130004257|NCT03519867|467979745|FG003|Overall Study|Protocol Violation|0|||
130004258|NCT03519867|467979746|FG004|Overall Study|Protocol Violation|0|||
130340272|NCT00486811|469218108|FG000|Overall Study|Study drug non-compliant|5|||
130340273|NCT00486811|469218109|FG001|Overall Study|Study drug non-compliant|6|||
130340274|NCT00486811|469218110|FG002|Overall Study|Study drug non-compliant|3|||
130340275|NCT00486811|469218108|FG000|Overall Study|All other|18|||
130340276|NCT00486811|469218109|FG001|Overall Study|All other|11|||
130004259|NCT03519867|467979747|FG005|Overall Study|Protocol Violation|1|||
130004260|NCT03519867|467979748|FG006|Overall Study|Protocol Violation|0|||
130004261|NCT03519867|467979749|FG007|Overall Study|Protocol Violation|0|||
130004262|NCT03519867|467979750|FG008|Overall Study|Protocol Violation|0|||
129884386|NCT00708305|467536385|FG002|Period 2|Protocol Violation|0|||
130004263|NCT03519867|467979751|FG009|Overall Study|Protocol Violation|0|||
130216514|NCT03883477|468755589|FG000|Overall Study|Protocol Violation|0|||
130340277|NCT00486811|469218110|FG002|Overall Study|All other|7|||
130340278|NCT03753789|469218111|FG000|Overall Study|Withdrawal by Subject|2|||
130340279|NCT01578850|469218116|FG000|Period 1|Insufficient Clinical Response|1|||
130340280|NCT01578850|469218117|FG001|Period 1|Insufficient Clinical Response|0|||
130340281|NCT01578850|469218118|FG002|Period 1|Insufficient Clinical Response|0|||
130340282|NCT01578850|469218116|FG000|Period 1|Adverse Event|11|||
130340283|NCT01578850|469218117|FG001|Period 1|Adverse Event|0|||
130340284|NCT01578850|469218118|FG002|Period 1|Adverse Event|0|||
130340285|NCT01578850|469218116|FG000|Period 1|Death|1|||
130340286|NCT01578850|469218117|FG001|Period 1|Death|0|||
130340287|NCT01578850|469218118|FG002|Period 1|Death|0|||
130340288|NCT01578850|469218116|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
130340289|NCT01578850|469218117|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
130340290|NCT01578850|469218118|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
130340291|NCT01578850|469218116|FG000|Period 1|Withdrawal by Subject|9|||
130340292|NCT01578850|469218117|FG001|Period 1|Withdrawal by Subject|0|||
130340293|NCT01578850|469218118|FG002|Period 1|Withdrawal by Subject|0|||
130340294|NCT01578850|469218116|FG000|Period 1|Study Terminated by Sponsor|3|||
130340295|NCT01578850|469218117|FG001|Period 1|Study Terminated by Sponsor|0|||
130340296|NCT01578850|469218118|FG002|Period 1|Study Terminated by Sponsor|0|||
130340297|NCT01578850|469218116|FG000|Period 2|Insufficient Clinical Response|0|||
130340298|NCT01578850|469218117|FG001|Period 2|Insufficient Clinical Response|1|||
130340299|NCT01578850|469218118|FG002|Period 2|Insufficient Clinical Response|0|||
130340300|NCT01578850|469218116|FG000|Period 2|Adverse Event|0|||
130340301|NCT01578850|469218117|FG001|Period 2|Adverse Event|3|||
130340302|NCT01578850|469218118|FG002|Period 2|Adverse Event|6|||
130340303|NCT01578850|469218116|FG000|Period 2|Lost to Follow-up|0|||
130340304|NCT01578850|469218117|FG001|Period 2|Lost to Follow-up|1|||
130340305|NCT01578850|469218118|FG002|Period 2|Lost to Follow-up|2|||
130340306|NCT01578850|469218116|FG000|Period 2|Withdrawal by Subject|0|||
130340307|NCT01578850|469218117|FG001|Period 2|Withdrawal by Subject|2|||
130340308|NCT01578850|469218118|FG002|Period 2|Withdrawal by Subject|2|||
130340309|NCT01578850|469218116|FG000|Period 2|Study Terminated by Sponsor|0|||
130340310|NCT01578850|469218117|FG001|Period 2|Study Terminated by Sponsor|5|||
130340311|NCT01578850|469218118|FG002|Period 2|Study Terminated by Sponsor|4|||
130340312|NCT01578850|469218116|FG000|Period 2|Unspecified Reasons|0|||
130340313|NCT01578850|469218117|FG001|Period 2|Unspecified Reasons|1|||
130340314|NCT01578850|469218118|FG002|Period 2|Unspecified Reasons|0|||
130340315|NCT01711216|469218121|FG000|Overall Study|Adverse Event|4|||
130340316|NCT01711216|469218121|FG000|Overall Study|Pregnancy|56|||
130340317|NCT01711216|469218121|FG000|Overall Study|Withdrawal by Subject|6|||
130340318|NCT01711216|469218121|FG000|Overall Study|Lost to Follow-up|46|||
130340319|NCT01711216|469218121|FG000|Overall Study|variety of other minor reasons|83|||
130340320|NCT01711216|469218121|FG000|Overall Study|no reason specified|22|||
130340321|NCT02929498|469218122|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
130340322|NCT02929498|469218123|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
130340323|NCT02929498|469218124|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
130340324|NCT02929498|469218122|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
130340325|NCT02929498|469218123|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
130340326|NCT02929498|469218124|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
130340327|NCT02744040|469218125|FG000|Overall Study|Withdrawal by Subject|3|||
130340328|NCT02744040|469218126|FG001|Overall Study|Withdrawal by Subject|2|||
130340329|NCT02744040|469218127|FG002|Overall Study|Withdrawal by Subject|2|||
130340330|NCT02744040|469218125|FG000|Overall Study|Physician Decision|0|||
130340331|NCT02744040|469218126|FG001|Overall Study|Physician Decision|8|||
130340332|NCT02744040|469218127|FG002|Overall Study|Physician Decision|13|||
130340333|NCT02744040|469218125|FG000|Overall Study|Lost to Follow-up|3|||
130340334|NCT02744040|469218126|FG001|Overall Study|Lost to Follow-up|1|||
130340335|NCT02744040|469218127|FG002|Overall Study|Lost to Follow-up|7|||
130340336|NCT00096356|469218128|FG000|Overall Study|Adverse Event|11|||
130340337|NCT00096356|469218129|FG001|Overall Study|Adverse Event|9|||
130340338|NCT00096356|469218128|FG000|Overall Study|Physician Decision|5|||
130340339|NCT00096356|469218129|FG001|Overall Study|Physician Decision|3|||
130340340|NCT00096356|469218128|FG000|Overall Study|Withdrawal by Subject|17|||
130340341|NCT00096356|469218129|FG001|Overall Study|Withdrawal by Subject|23|||
130340342|NCT00096356|469218128|FG000|Overall Study|Lack of Efficacy|1|||
130340343|NCT00096356|469218129|FG001|Overall Study|Lack of Efficacy|0|||
130340344|NCT00096356|469218128|FG000|Overall Study|multiple reasons|10|||
130340345|NCT00096356|469218129|FG001|Overall Study|multiple reasons|18|||
130340346|NCT04002908|469218133|FG000|Overall Study|Death|41|||
130340347|NCT04002908|469218134|FG001|Overall Study|Death|0|||
130216515|NCT03883477|468755590|FG001|Overall Study|Protocol Violation|1|||
130340348|NCT04002908|469218135|FG002|Overall Study|Death|0|||
130340349|NCT04002908|469218136|FG003|Overall Study|Death|0|||
130340350|NCT04002908|469218133|FG000|Overall Study|Withdrawal by Subject|112|||
130340351|NCT04002908|469218134|FG001|Overall Study|Withdrawal by Subject|0|||
130340352|NCT04002908|469218135|FG002|Overall Study|Withdrawal by Subject|0|||
130340353|NCT04002908|469218136|FG003|Overall Study|Withdrawal by Subject|0|||
130340354|NCT04002908|469218133|FG000|Overall Study|Lost to Follow-up|72|||
130340355|NCT04002908|469218134|FG001|Overall Study|Lost to Follow-up|0|||
130340356|NCT04002908|469218135|FG002|Overall Study|Lost to Follow-up|0|||
130340357|NCT04002908|469218136|FG003|Overall Study|Lost to Follow-up|0|||
130340358|NCT04002908|469218133|FG000|Overall Study|Infant died, so mother withdrawn|34|||
130340359|NCT04002908|469218134|FG001|Overall Study|Infant died, so mother withdrawn|0|||
130340360|NCT04002908|469218135|FG002|Overall Study|Infant died, so mother withdrawn|0|||
130340361|NCT04002908|469218136|FG003|Overall Study|Infant died, so mother withdrawn|0|||
130340362|NCT04359901|469218141|FG000|Overall Study|Withdrawal by Subject|0|||
130340363|NCT04359901|469218142|FG001|Overall Study|Withdrawal by Subject|1|||
130340364|NCT04359901|469218141|FG000|Overall Study|Death|6|||
130340365|NCT04359901|469218142|FG001|Overall Study|Death|2|||
130340366|NCT05092360|469218143|FG000|Overall Study|Withdrawal by Subject|21|||
130340367|NCT05092360|469218144|FG001|Overall Study|Withdrawal by Subject|4|||
130340368|NCT05092360|469218145|FG002|Overall Study|Withdrawal by Subject|9|||
130340369|NCT05092360|469218146|FG003|Overall Study|Withdrawal by Subject|26|||
130340370|NCT05092360|469218143|FG000|Overall Study|Death|97|||
130340371|NCT05092360|469218144|FG001|Overall Study|Death|14|||
130340372|NCT05092360|469218145|FG002|Overall Study|Death|31|||
130340373|NCT05092360|469218146|FG003|Overall Study|Death|101|||
130340374|NCT05092360|469218143|FG000|Overall Study|Lost to Follow-up|1|||
130004264|NCT03519867|467979742|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004265|NCT03519867|467979743|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130340375|NCT05092360|469218144|FG001|Overall Study|Lost to Follow-up|2|||
130340376|NCT05092360|469218145|FG002|Overall Study|Lost to Follow-up|2|||
130340377|NCT05092360|469218146|FG003|Overall Study|Lost to Follow-up|2|||
130340378|NCT05092360|469218143|FG000|Overall Study|Study terminated by sponsor|65|||
130340379|NCT05092360|469218144|FG001|Overall Study|Study terminated by sponsor|7|||
130340380|NCT05092360|469218145|FG002|Overall Study|Study terminated by sponsor|13|||
130340381|NCT05092360|469218146|FG003|Overall Study|Study terminated by sponsor|61|||
130340382|NCT01525225|469218149|FG000|Enrollment|No longer met study criteria|1|||
130340383|NCT01525225|469218149|FG000|Enrollment|Other|1|||
130340384|NCT00243841|469218150|FG000|Overall Study|Physician Decision|0|||
130340385|NCT00243841|469218151|FG001|Overall Study|Physician Decision|0|||
130340386|NCT00243841|469218152|FG002|Overall Study|Physician Decision|1|||
130340387|NCT00243841|469218153|FG003|Overall Study|Physician Decision|0|||
130340388|NCT00243841|469218154|FG004|Overall Study|Physician Decision|0|||
130340389|NCT00243841|469218155|FG005|Overall Study|Physician Decision|2|||
130340390|NCT00363545|469218156|FG000|Overall Study|Serious Adverse Event|0|||
130340391|NCT00363545|469218157|FG001|Overall Study|Serious Adverse Event|1|||
130004266|NCT03519867|467979744|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004267|NCT03519867|467979745|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004268|NCT03519867|467979746|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004269|NCT03519867|467979747|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004270|NCT03519867|467979748|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
130004271|NCT03519867|467979749|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004272|NCT03519867|467979750|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004273|NCT03519867|467979751|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
130004274|NCT03519867|467979742|FG000|Overall Study|Admin. of other reversal agent|1|||
130004275|NCT03519867|467979743|FG001|Overall Study|Admin. of other reversal agent|1|||
130004276|NCT03519867|467979744|FG002|Overall Study|Admin. of other reversal agent|0|||
130004277|NCT03519867|467979745|FG003|Overall Study|Admin. of other reversal agent|0|||
130004278|NCT03519867|467979746|FG004|Overall Study|Admin. of other reversal agent|0|||
130004279|NCT03519867|467979747|FG005|Overall Study|Admin. of other reversal agent|1|||
130004280|NCT03519867|467979748|FG006|Overall Study|Admin. of other reversal agent|0|||
130004281|NCT03519867|467979749|FG007|Overall Study|Admin. of other reversal agent|0|||
130340392|NCT00363545|469218156|FG000|Overall Study|Withdrawal by Subject|12|||
130340393|NCT00363545|469218157|FG001|Overall Study|Withdrawal by Subject|15|||
130340394|NCT00363545|469218156|FG000|Overall Study|Migrated/moved from study area|3|||
130340395|NCT00363545|469218157|FG001|Overall Study|Migrated/moved from study area|6|||
130340396|NCT00363545|469218156|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
130340397|NCT00363545|469218157|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
130340398|NCT00363545|469218156|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
130340399|NCT00363545|469218157|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
130340400|NCT00363545|469218156|FG000|Overall Study|Others|1|||
130340401|NCT00363545|469218157|FG001|Overall Study|Others|0|||
130340402|NCT01379508|469218158|FG000|Treatment to Week 104|Adverse Event|2|||
130340403|NCT01379508|469218159|FG001|Treatment to Week 104|Adverse Event|0|||
130340404|NCT01379508|469218160|FG002|Treatment to Week 104|Adverse Event|5|||
130340405|NCT01379508|469218161|FG003|Treatment to Week 104|Adverse Event|0|||
130004282|NCT03519867|467979750|FG008|Overall Study|Admin. of other reversal agent|0|||
130004283|NCT03519867|467979751|FG009|Overall Study|Admin. of other reversal agent|0|||
130004284|NCT03519867|467979742|FG000|Overall Study|Reason not provided|1|||
130340406|NCT01379508|469218158|FG000|Treatment to Week 104|Abnormal lab value|1|||
130340407|NCT01379508|469218159|FG001|Treatment to Week 104|Abnormal lab value|0|||
130004285|NCT03519867|467979743|FG001|Overall Study|Reason not provided|1|||
130004286|NCT03519867|467979744|FG002|Overall Study|Reason not provided|1|||
130004287|NCT03519867|467979745|FG003|Overall Study|Reason not provided|1|||
130004288|NCT03519867|467979746|FG004|Overall Study|Reason not provided|0|||
130004289|NCT03519867|467979747|FG005|Overall Study|Reason not provided|1|||
130004290|NCT03519867|467979748|FG006|Overall Study|Reason not provided|0|||
130004291|NCT03519867|467979749|FG007|Overall Study|Reason not provided|1|||
130004292|NCT03519867|467979750|FG008|Overall Study|Reason not provided|1|||
130004293|NCT03519867|467979751|FG009|Overall Study|Reason not provided|0|||
130004294|NCT01252810|467979752|FG000|Overall Study|Withdrawal by Subject|4|||
130004295|NCT01252810|467979753|FG001|Overall Study|Withdrawal by Subject|1|||
130004296|NCT01252810|467979752|FG000|Overall Study|Lost to Follow-up|0|||
130004297|NCT01252810|467979753|FG001|Overall Study|Lost to Follow-up|1|||
130004298|NCT01252810|467979752|FG000|Overall Study|Physician Decision|2|||
130004299|NCT01252810|467979753|FG001|Overall Study|Physician Decision|1|||
130004300|NCT01252810|467979752|FG000|Overall Study|Various reasons|8|||
130004301|NCT01252810|467979753|FG001|Overall Study|Various reasons|0|||
130004302|NCT01428661|467979754|FG000|Double-Masked Phase|Protocol Violation|9|||
130004303|NCT01428661|467979755|FG001|Double-Masked Phase|Protocol Violation|4|||
130004304|NCT01428661|467979756|FG002|Double-Masked Phase|Protocol Violation|0|||
130004305|NCT01428661|467979754|FG000|Double-Masked Phase|Adverse Event|13|||
130004306|NCT01428661|467979755|FG001|Double-Masked Phase|Adverse Event|4|||
130004307|NCT01428661|467979756|FG002|Double-Masked Phase|Adverse Event|0|||
130004308|NCT01428661|467979754|FG000|Double-Masked Phase|Lost to Follow-up|14|||
130004309|NCT01428661|467979755|FG001|Double-Masked Phase|Lost to Follow-up|14|||
130004310|NCT01428661|467979756|FG002|Double-Masked Phase|Lost to Follow-up|0|||
130004311|NCT01428661|467979754|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
130004312|NCT01428661|467979755|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
130004313|NCT01428661|467979756|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
130004314|NCT01428661|467979754|FG000|Double-Masked Phase|Lack of Efficacy|2|||
130004315|NCT01428661|467979755|FG001|Double-Masked Phase|Lack of Efficacy|1|||
130004316|NCT01428661|467979756|FG002|Double-Masked Phase|Lack of Efficacy|0|||
130004317|NCT01428661|467979754|FG000|Double-Masked Phase|*Various|1|||
130004318|NCT01428661|467979755|FG001|Double-Masked Phase|*Various|6|||
130004319|NCT01428661|467979756|FG002|Double-Masked Phase|*Various|0|||
130004320|NCT01428661|467979754|FG000|Open Label Extension|Protocol Violation|0|||
130004321|NCT01428661|467979755|FG001|Open Label Extension|Protocol Violation|0|||
130340408|NCT01379508|469218160|FG002|Treatment to Week 104|Abnormal lab value|0|||
130340409|NCT01379508|469218161|FG003|Treatment to Week 104|Abnormal lab value|0|||
130340410|NCT01379508|469218158|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
130340411|NCT01379508|469218159|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130340412|NCT01379508|469218160|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130340413|NCT01379508|469218161|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
130340414|NCT01379508|469218158|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
130340415|NCT01379508|469218159|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
130340416|NCT01379508|469218160|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
130340417|NCT01379508|469218161|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
130340418|NCT01379508|469218158|FG000|Treatment to Week 104|Lost to Follow-up|5|||
130340419|NCT01379508|469218159|FG001|Treatment to Week 104|Lost to Follow-up|0|||
130340420|NCT01379508|469218160|FG002|Treatment to Week 104|Lost to Follow-up|3|||
130340421|NCT01379508|469218161|FG003|Treatment to Week 104|Lost to Follow-up|0|||
130340422|NCT01379508|469218158|FG000|Treatment to Week 104|Administrative problems|3|||
130340423|NCT01379508|469218159|FG001|Treatment to Week 104|Administrative problems|1|||
130340424|NCT01379508|469218160|FG002|Treatment to Week 104|Administrative problems|0|||
130340425|NCT01379508|469218161|FG003|Treatment to Week 104|Administrative problems|0|||
130340426|NCT01379508|469218158|FG000|Treatment to Week 104|Protocol Violation|1|||
130340427|NCT01379508|469218159|FG001|Treatment to Week 104|Protocol Violation|1|||
130340428|NCT01379508|469218160|FG002|Treatment to Week 104|Protocol Violation|1|||
130340429|NCT01379508|469218161|FG003|Treatment to Week 104|Protocol Violation|0|||
130340430|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
130340431|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
130340432|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
130340433|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
130340434|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
130340435|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
130340436|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
130004322|NCT01428661|467979756|FG002|Open Label Extension|Protocol Violation|9|||
130004323|NCT01428661|467979754|FG000|Open Label Extension|Adverse Event|0|||
130004324|NCT01428661|467979755|FG001|Open Label Extension|Adverse Event|0|||
130004325|NCT01428661|467979756|FG002|Open Label Extension|Adverse Event|15|||
130004326|NCT01428661|467979754|FG000|Open Label Extension|Lost to Follow-up|0|||
130004327|NCT01428661|467979755|FG001|Open Label Extension|Lost to Follow-up|0|||
130004328|NCT01428661|467979756|FG002|Open Label Extension|Lost to Follow-up|38|||
130004329|NCT01428661|467979754|FG000|Open Label Extension|Withdrawal by Subject|0|||
130340437|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
130340438|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
130340439|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
130340440|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
130340441|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
130340442|NCT01379508|469218158|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
130340443|NCT01379508|469218159|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
130340444|NCT01379508|469218160|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
130340445|NCT01379508|469218161|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
130340446|NCT04236141|469219434|FG000|Overall Study|Death|18|||
130340447|NCT04236141|469219435|FG001|Overall Study|Death|10|||
130004330|NCT01428661|467979755|FG001|Open Label Extension|Withdrawal by Subject|0|||
130004331|NCT01428661|467979756|FG002|Open Label Extension|Withdrawal by Subject|49|||
130004332|NCT01428661|467979754|FG000|Open Label Extension|Lack of Efficacy|0|||
130004333|NCT01428661|467979755|FG001|Open Label Extension|Lack of Efficacy|0|||
130004334|NCT01428661|467979756|FG002|Open Label Extension|Lack of Efficacy|24|||
130340448|NCT04236141|469219434|FG000|Overall Study|Withdrawal by Participant|1|||
130340449|NCT04236141|469219435|FG001|Overall Study|Withdrawal by Participant|0|||
130340450|NCT04236141|469219434|FG000|Overall Study|Reason not Specified|1|||
130340451|NCT04236141|469219435|FG001|Overall Study|Reason not Specified|0|||
130340452|NCT04236141|469219434|FG000|Overall Study|Study terminated by Sponsor|8|||
130340453|NCT04236141|469219435|FG001|Overall Study|Study terminated by Sponsor|4|||
130340454|NCT01925131|469219436|FG000|Overall Study|Death|0|||
130340455|NCT01925131|469219437|FG001|Overall Study|Death|0|||
130340456|NCT01925131|469219438|FG002|Overall Study|Death|1|||
130340457|NCT01925131|469219439|FG003|Overall Study|Death|0|||
130340458|NCT01925131|469219440|FG004|Overall Study|Death|0|||
130340459|NCT01925131|469219441|FG005|Overall Study|Death|0|||
130340460|NCT01925131|469219436|FG000|Overall Study|Progression/Relapse|1|||
130340461|NCT01925131|469219437|FG001|Overall Study|Progression/Relapse|1|||
130340462|NCT01925131|469219438|FG002|Overall Study|Progression/Relapse|4|||
130340463|NCT01925131|469219439|FG003|Overall Study|Progression/Relapse|0|||
130340464|NCT01925131|469219440|FG004|Overall Study|Progression/Relapse|0|||
130340465|NCT01925131|469219441|FG005|Overall Study|Progression/Relapse|1|||
130004335|NCT01428661|467979754|FG000|Open Label Extension|**Various|0|||
130004336|NCT01428661|467979755|FG001|Open Label Extension|**Various|0|||
130004337|NCT01428661|467979756|FG002|Open Label Extension|**Various|185|||
130004338|NCT04376827|467979757|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
130004339|NCT04376827|467979758|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
130004340|NCT04376827|467979757|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
130004341|NCT04376827|467979758|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
130004342|NCT04376827|467979757|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
130004343|NCT04376827|467979758|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
130004344|NCT04376827|467979757|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
130004345|NCT04376827|467979758|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
130004346|NCT04376827|467979757|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
130004347|NCT04376827|467979758|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
130004348|NCT02229539|467981727|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
130004349|NCT02229539|467981728|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
130004350|NCT02229539|467981729|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
130004351|NCT02229539|467981727|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
130004352|NCT02229539|467981728|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
130004353|NCT02229539|467981729|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
130004354|NCT02229539|467981727|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
130004355|NCT02229539|467981728|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
130340466|NCT01925131|469219436|FG000|Overall Study|Patient Refusal|1|||
130340467|NCT01925131|469219437|FG001|Overall Study|Patient Refusal|0|||
130340468|NCT01925131|469219438|FG002|Overall Study|Patient Refusal|0|||
130340469|NCT01925131|469219439|FG003|Overall Study|Patient Refusal|0|||
130340470|NCT01925131|469219440|FG004|Overall Study|Patient Refusal|0|||
130340471|NCT01925131|469219441|FG005|Overall Study|Patient Refusal|0|||
130340472|NCT01925131|469219436|FG000|Overall Study|Adverse Event|0|||
130340473|NCT01925131|469219437|FG001|Overall Study|Adverse Event|0|||
130340474|NCT01925131|469219438|FG002|Overall Study|Adverse Event|2|||
130340475|NCT01925131|469219439|FG003|Overall Study|Adverse Event|0|||
130340476|NCT01925131|469219440|FG004|Overall Study|Adverse Event|1|||
130340477|NCT01925131|469219441|FG005|Overall Study|Adverse Event|3|||
130340478|NCT01925131|469219436|FG000|Overall Study|Other - Not Protocol Specified|3|||
130340479|NCT01925131|469219437|FG001|Overall Study|Other - Not Protocol Specified|1|||
130340480|NCT01925131|469219438|FG002|Overall Study|Other - Not Protocol Specified|2|||
130340481|NCT01925131|469219439|FG003|Overall Study|Other - Not Protocol Specified|5|||
130340482|NCT01925131|469219440|FG004|Overall Study|Other - Not Protocol Specified|10|||
130340483|NCT01925131|469219441|FG005|Overall Study|Other - Not Protocol Specified|6|||
130340484|NCT01696929|469219442|FG000|Overall Study|Physician Decision|1|||
130340485|NCT01794338|469219443|FG000|Overall Study|Death|2|||
130340486|NCT01794338|469219444|FG001|Overall Study|Death|0|||
130340487|NCT01794338|469219443|FG000|Overall Study|Lost to Follow-up|6|||
130340488|NCT01794338|469219444|FG001|Overall Study|Lost to Follow-up|9|||
130340489|NCT01954927|469219445|FG000|Overall Study|Withdrawal by Subject|3|||
130340490|NCT01954927|469219446|FG001|Overall Study|Withdrawal by Subject|1|||
130340491|NCT00955305|469219447|FG000|Overall Study|Disease progression|39|||
130340492|NCT00955305|469219448|FG001|Overall Study|Disease progression|41|||
130340493|NCT00955305|469219447|FG000|Overall Study|Adverse Event|22|||
130340494|NCT00955305|469219448|FG001|Overall Study|Adverse Event|22|||
130340495|NCT00955305|469219447|FG000|Overall Study|Death|2|||
130340496|NCT00955305|469219448|FG001|Overall Study|Death|1|||
130340497|NCT00955305|469219447|FG000|Overall Study|Withdrawal by Subject|5|||
130340498|NCT00955305|469219448|FG001|Overall Study|Withdrawal by Subject|4|||
130340499|NCT00955305|469219447|FG000|Overall Study|Alternative therapy|4|||
130340500|NCT00955305|469219448|FG001|Overall Study|Alternative therapy|0|||
130340501|NCT00955305|469219447|FG000|Overall Study|Other complicating disease|2|||
130340502|NCT00955305|469219448|FG001|Overall Study|Other complicating disease|4|||
130340503|NCT00955305|469219447|FG000|Overall Study|Physician Decision|1|||
130340504|NCT00955305|469219448|FG001|Overall Study|Physician Decision|0|||
130340505|NCT00955305|469219447|FG000|Overall Study|Continued presence of residual disease|0|||
130340506|NCT00955305|469219448|FG001|Overall Study|Continued presence of residual disease|1|||
130340507|NCT00955305|469219447|FG000|Overall Study|Functional decline|2|||
130340508|NCT00955305|469219448|FG001|Overall Study|Functional decline|0|||
130340509|NCT00955305|469219447|FG000|Overall Study|Maximum response achieved|0|||
130340510|NCT00955305|469219448|FG001|Overall Study|Maximum response achieved|1|||
130340511|NCT00955305|469219447|FG000|Overall Study|Lost to Follow-up|0|||
130340512|NCT00955305|469219448|FG001|Overall Study|Lost to Follow-up|1|||
130340513|NCT00955305|469219447|FG000|Overall Study|No off-treatment reason submitted|1|||
130340514|NCT00955305|469219448|FG001|Overall Study|No off-treatment reason submitted|0|||
130340515|NCT00955305|469219447|FG000|Overall Study|Never started protocol treatment|5|||
130340516|NCT00955305|469219448|FG001|Overall Study|Never started protocol treatment|5|||
130340517|NCT00955305|469219447|FG000|Overall Study|Ineligible|5|||
130340518|NCT00955305|469219448|FG001|Overall Study|Ineligible|7|||
130340519|NCT00109590|469219449|FG000|Overall Study|Lost to Follow-up|1|||
130340520|NCT00109590|469219450|FG001|Overall Study|Lost to Follow-up|0|||
130340521|NCT00109590|469219451|FG002|Overall Study|Lost to Follow-up|1|||
130340522|NCT00109590|469219449|FG000|Overall Study|Never Started Treatment|1|||
130340523|NCT00109590|469219450|FG001|Overall Study|Never Started Treatment|2|||
130340524|NCT00109590|469219451|FG002|Overall Study|Never Started Treatment|3|||
130340525|NCT03254108|469219455|FG000|Overall Study|Adverse Event|0|||
130340526|NCT03254108|469219456|FG001|Overall Study|Adverse Event|2|||
130340527|NCT03254108|469219457|FG002|Overall Study|Adverse Event|0|||
130340528|NCT03254108|469219458|FG003|Overall Study|Adverse Event|1|||
130340529|NCT03254108|469219459|FG004|Overall Study|Adverse Event|1|||
130340530|NCT03254108|469219455|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340531|NCT03254108|469219456|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340532|NCT03254108|469219457|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340533|NCT03254108|469219458|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
130340534|NCT03254108|469219459|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
130340535|NCT00745849|469219460|FG000|First Intervention|Withdrawal by Subject|0|||
130340536|NCT00745849|469219461|FG001|First Intervention|Withdrawal by Subject|1|||
130340537|NCT00745849|469219460|FG000|First Intervention|Lost to Follow-up|1|||
130340538|NCT00745849|469219461|FG001|First Intervention|Lost to Follow-up|1|||
130004356|NCT02229539|467981729|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
130004357|NCT02229539|467981727|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
130004358|NCT02229539|467981728|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
130004359|NCT02229539|467981729|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
130004360|NCT02229539|467981727|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
130004361|NCT02229539|467981728|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
130004362|NCT02229539|467981729|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
130004363|NCT02229539|467981727|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
130004364|NCT02229539|467981728|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
130004365|NCT02229539|467981729|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
130004366|NCT00880555|467981736|FG000|Overall Study|Physician Decision|0|||
130004367|NCT00880555|467981737|FG001|Overall Study|Physician Decision|8|||
130004368|NCT00880555|467981738|FG002|Overall Study|Physician Decision|0|||
130340539|NCT00745849|469219460|FG000|Second Intervention|Lost to Follow-up|2|||
130340540|NCT00745849|469219461|FG001|Second Intervention|Lost to Follow-up|1|||
130340541|NCT00409331|469219468|FG000|Overall Study|Physician Decision|1|||
130340542|NCT01511055|469219473|FG000|Overall Study|Withdrawal by Subject|6|||
130340543|NCT00830869|469219474|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
130004369|NCT00880555|467981739|FG003|Overall Study|Physician Decision|2|||
130004370|NCT00880555|467981740|FG004|Overall Study|Physician Decision|1|||
130004371|NCT00880555|467981741|FG005|Overall Study|Physician Decision|0|||
130004372|NCT00880555|467981736|FG000|Overall Study|Withdrawal by Subject|1|||
130004373|NCT00880555|467981737|FG001|Overall Study|Withdrawal by Subject|1|||
130004374|NCT00880555|467981738|FG002|Overall Study|Withdrawal by Subject|0|||
130004375|NCT00880555|467981739|FG003|Overall Study|Withdrawal by Subject|0|||
130004376|NCT00880555|467981740|FG004|Overall Study|Withdrawal by Subject|0|||
130004377|NCT00880555|467981741|FG005|Overall Study|Withdrawal by Subject|0|||
130004378|NCT00880555|467981736|FG000|Overall Study|Lack of resources (hired rater)|9|||
130004379|NCT00880555|467981737|FG001|Overall Study|Lack of resources (hired rater)|7|||
130004380|NCT00880555|467981738|FG002|Overall Study|Lack of resources (hired rater)|5|||
130004381|NCT00880555|467981739|FG003|Overall Study|Lack of resources (hired rater)|0|||
130004382|NCT00880555|467981740|FG004|Overall Study|Lack of resources (hired rater)|0|||
130004383|NCT00880555|467981741|FG005|Overall Study|Lack of resources (hired rater)|0|||
130004384|NCT00880555|467981736|FG000|Overall Study|Death|0|||
130004385|NCT00880555|467981737|FG001|Overall Study|Death|0|||
130004386|NCT00880555|467981738|FG002|Overall Study|Death|0|||
130004387|NCT00880555|467981739|FG003|Overall Study|Death|0|||
130004388|NCT00880555|467981740|FG004|Overall Study|Death|0|||
130004389|NCT00880555|467981741|FG005|Overall Study|Death|1|||
130340544|NCT00830869|469219475|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
130340545|NCT00830869|469219476|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
130340546|NCT00830869|469219477|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
130340547|NCT00830869|469219478|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
130340548|NCT00830869|469219479|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
130340549|NCT00830869|469219480|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
130340550|NCT00830869|469219481|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
130340551|NCT00830869|469219482|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
130340552|NCT00830869|469219483|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
130340553|NCT00830869|469219484|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
130340554|NCT00830869|469219485|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
130340555|NCT00830869|469219474|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
130340556|NCT00830869|469219475|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
130340557|NCT00830869|469219476|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
130340558|NCT00830869|469219477|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
130340559|NCT00830869|469219478|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
130340560|NCT00830869|469219479|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
130340561|NCT00830869|469219480|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
130340562|NCT00830869|469219481|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
130340563|NCT00830869|469219482|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
130340564|NCT00830869|469219483|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
130340565|NCT00830869|469219484|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
130340566|NCT00830869|469219485|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
130340567|NCT00830869|469219474|FG000|Period 1: Part 1|Adverse Event|0|||
130340568|NCT00830869|469219475|FG001|Period 1: Part 1|Adverse Event|0|||
130340569|NCT00830869|469219476|FG002|Period 1: Part 1|Adverse Event|0|||
130340570|NCT00830869|469219477|FG003|Period 1: Part 1|Adverse Event|0|||
130340571|NCT00830869|469219478|FG004|Period 1: Part 1|Adverse Event|0|||
130340572|NCT00830869|469219479|FG005|Period 1: Part 1|Adverse Event|1|||
130340573|NCT00830869|469219480|FG006|Period 1: Part 1|Adverse Event|1|||
130340574|NCT00830869|469219481|FG007|Period 1: Part 1|Adverse Event|0|||
130340575|NCT00830869|469219482|FG008|Period 1: Part 1|Adverse Event|0|||
130340576|NCT00830869|469219483|FG009|Period 1: Part 1|Adverse Event|0|||
130340577|NCT00830869|469219484|FG010|Period 1: Part 1|Adverse Event|0|||
130340578|NCT00830869|469219485|FG011|Period 1: Part 1|Adverse Event|0|||
130340579|NCT00830869|469219474|FG000|Period 1: Part 1|Progressive disease|1|||
130340580|NCT00830869|469219475|FG001|Period 1: Part 1|Progressive disease|0|||
130340581|NCT00830869|469219476|FG002|Period 1: Part 1|Progressive disease|1|||
130340582|NCT00830869|469219477|FG003|Period 1: Part 1|Progressive disease|6|||
130340583|NCT00830869|469219478|FG004|Period 1: Part 1|Progressive disease|4|||
130340584|NCT00830869|469219479|FG005|Period 1: Part 1|Progressive disease|4|||
130340585|NCT00830869|469219480|FG006|Period 1: Part 1|Progressive disease|1|||
130004390|NCT00880555|467981736|FG000|Overall Study|Lost to Follow-up|0|||
130004391|NCT00880555|467981737|FG001|Overall Study|Lost to Follow-up|1|||
130340586|NCT00830869|469219481|FG007|Period 1: Part 1|Progressive disease|0|||
130340587|NCT00830869|469219482|FG008|Period 1: Part 1|Progressive disease|0|||
130340588|NCT00830869|469219483|FG009|Period 1: Part 1|Progressive disease|0|||
130340589|NCT00830869|469219484|FG010|Period 1: Part 1|Progressive disease|0|||
130340590|NCT00830869|469219485|FG011|Period 1: Part 1|Progressive disease|0|||
130004392|NCT00880555|467981738|FG002|Overall Study|Lost to Follow-up|0|||
130004393|NCT00880555|467981739|FG003|Overall Study|Lost to Follow-up|0|||
130004394|NCT00880555|467981740|FG004|Overall Study|Lost to Follow-up|0|||
130004395|NCT00880555|467981741|FG005|Overall Study|Lost to Follow-up|0|||
130004396|NCT02982590|467981743|FG000|Overall Study|Lost to Follow-up|0|||
130004397|NCT02982590|467981744|FG001|Overall Study|Lost to Follow-up|1|||
130340591|NCT00830869|469219474|FG000|Period 2: Part 2|Protocol Violation|0|||
130340592|NCT00830869|469219475|FG001|Period 2: Part 2|Protocol Violation|0|||
130340593|NCT00830869|469219476|FG002|Period 2: Part 2|Protocol Violation|0|||
130340594|NCT00830869|469219477|FG003|Period 2: Part 2|Protocol Violation|0|||
130340595|NCT00830869|469219478|FG004|Period 2: Part 2|Protocol Violation|0|||
130340596|NCT00830869|469219479|FG005|Period 2: Part 2|Protocol Violation|0|||
130340597|NCT00830869|469219480|FG006|Period 2: Part 2|Protocol Violation|0|||
130340598|NCT00830869|469219481|FG007|Period 2: Part 2|Protocol Violation|1|||
130340599|NCT00830869|469219482|FG008|Period 2: Part 2|Protocol Violation|0|||
130340600|NCT00830869|469219483|FG009|Period 2: Part 2|Protocol Violation|1|||
130340601|NCT00830869|469219484|FG010|Period 2: Part 2|Protocol Violation|0|||
130340602|NCT00830869|469219485|FG011|Period 2: Part 2|Protocol Violation|0|||
130340603|NCT00830869|469219474|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
130340604|NCT00830869|469219475|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
130340605|NCT00830869|469219476|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
130340606|NCT00830869|469219477|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
130340607|NCT00830869|469219478|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
130340608|NCT00830869|469219479|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
130340609|NCT00830869|469219480|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
130340610|NCT00830869|469219481|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
130340611|NCT00830869|469219482|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
130340612|NCT00830869|469219483|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
130340613|NCT00830869|469219484|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
130340614|NCT00830869|469219485|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
130340615|NCT00830869|469219474|FG000|Period 2: Part 2|Adverse Event|0|||
130340616|NCT00830869|469219475|FG001|Period 2: Part 2|Adverse Event|0|||
130340617|NCT00830869|469219476|FG002|Period 2: Part 2|Adverse Event|0|||
130340618|NCT00830869|469219477|FG003|Period 2: Part 2|Adverse Event|0|||
130340619|NCT00830869|469219478|FG004|Period 2: Part 2|Adverse Event|0|||
130340620|NCT00830869|469219479|FG005|Period 2: Part 2|Adverse Event|0|||
130340621|NCT00830869|469219480|FG006|Period 2: Part 2|Adverse Event|0|||
130340622|NCT00830869|469219481|FG007|Period 2: Part 2|Adverse Event|4|||
130340623|NCT00830869|469219482|FG008|Period 2: Part 2|Adverse Event|3|||
130340624|NCT00830869|469219483|FG009|Period 2: Part 2|Adverse Event|2|||
130340625|NCT00830869|469219484|FG010|Period 2: Part 2|Adverse Event|2|||
130340626|NCT00830869|469219485|FG011|Period 2: Part 2|Adverse Event|0|||
130340627|NCT00830869|469219474|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
130340628|NCT00830869|469219475|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
130340629|NCT00830869|469219476|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
130340630|NCT00830869|469219477|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
130340631|NCT00830869|469219478|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
130340632|NCT00830869|469219479|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
130340633|NCT00830869|469219480|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
130340634|NCT00830869|469219481|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
130340635|NCT00830869|469219482|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
130340636|NCT00830869|469219483|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
130340637|NCT00830869|469219484|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
130340638|NCT00830869|469219485|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
130340639|NCT00830869|469219474|FG000|Period 2: Part 2|Progressive disease|0|||
130340640|NCT00830869|469219475|FG001|Period 2: Part 2|Progressive disease|0|||
130340641|NCT00830869|469219476|FG002|Period 2: Part 2|Progressive disease|0|||
130340642|NCT00830869|469219477|FG003|Period 2: Part 2|Progressive disease|0|||
130340643|NCT00830869|469219478|FG004|Period 2: Part 2|Progressive disease|0|||
130340644|NCT00830869|469219479|FG005|Period 2: Part 2|Progressive disease|0|||
130340645|NCT00830869|469219480|FG006|Period 2: Part 2|Progressive disease|0|||
130340646|NCT00830869|469219481|FG007|Period 2: Part 2|Progressive disease|14|||
130340647|NCT00830869|469219482|FG008|Period 2: Part 2|Progressive disease|11|||
130340648|NCT00830869|469219483|FG009|Period 2: Part 2|Progressive disease|12|||
130340649|NCT00830869|469219484|FG010|Period 2: Part 2|Progressive disease|8|||
130340650|NCT00830869|469219485|FG011|Period 2: Part 2|Progressive disease|15|||
130340651|NCT00830869|469219474|FG000|Period 2: Part 2|Other|0|||
130340652|NCT00830869|469219475|FG001|Period 2: Part 2|Other|0|||
130340653|NCT00830869|469219476|FG002|Period 2: Part 2|Other|0|||
130340654|NCT00830869|469219477|FG003|Period 2: Part 2|Other|0|||
130340655|NCT00830869|469219478|FG004|Period 2: Part 2|Other|0|||
130340656|NCT00830869|469219479|FG005|Period 2: Part 2|Other|0|||
130340657|NCT00830869|469219480|FG006|Period 2: Part 2|Other|0|||
130340658|NCT00830869|469219481|FG007|Period 2: Part 2|Other|0|||
130340659|NCT00830869|469219482|FG008|Period 2: Part 2|Other|0|||
130340660|NCT00830869|469219483|FG009|Period 2: Part 2|Other|1|||
130340661|NCT00830869|469219484|FG010|Period 2: Part 2|Other|0|||
130340662|NCT00830869|469219485|FG011|Period 2: Part 2|Other|0|||
130340663|NCT00617669|469219486|FG000|Overall Study|Withdrawal by Subject|71|||
130340664|NCT00617669|469219487|FG001|Overall Study|Withdrawal by Subject|77|||
130340665|NCT00617669|469219486|FG000|Overall Study|Lost to Follow-up|3|||
130340666|NCT00617669|469219487|FG001|Overall Study|Lost to Follow-up|2|||
129884387|NCT00708305|467536386|FG003|Period 2|Protocol Violation|0|||
130004398|NCT02982590|467981743|FG000|Overall Study|Death|4|||
130004399|NCT02982590|467981744|FG001|Overall Study|Death|0|||
130004400|NCT04422990|467981754|FG000|Overall Study|Withdrawal by Subject|0|||
130004401|NCT04422990|467981755|FG001|Overall Study|Withdrawal by Subject|1|||
130004402|NCT04422990|467981754|FG000|Overall Study|Travel|3|||
130004403|NCT04422990|467981755|FG001|Overall Study|Travel|0|||
130340667|NCT00617669|469219486|FG000|Overall Study|Adverse Event|87|||
130340668|NCT00617669|469219487|FG001|Overall Study|Adverse Event|76|||
130340669|NCT00617669|469219486|FG000|Overall Study|Protocol Violation|2|||
130340670|NCT00617669|469219487|FG001|Overall Study|Protocol Violation|3|||
130340671|NCT00617669|469219486|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
130340672|NCT00617669|469219487|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
130340673|NCT00617669|469219486|FG000|Overall Study|Patients randomized but not treated|2|||
130340674|NCT00617669|469219487|FG001|Overall Study|Patients randomized but not treated|3|||
130340675|NCT03745820|469219488|FG000|Overall Study|Adverse Event|0|||
130340676|NCT03745820|469219489|FG001|Overall Study|Adverse Event|3|||
130340677|NCT03745820|469219490|FG002|Overall Study|Adverse Event|2|||
130340678|NCT03745820|469219488|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130340679|NCT03745820|469219489|FG001|Overall Study|Non-Compliance with Study Drug|3|||
130340680|NCT03745820|469219490|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130340681|NCT03745820|469219488|FG000|Overall Study|Withdrawal by Subject|4|||
130340682|NCT03745820|469219489|FG001|Overall Study|Withdrawal by Subject|4|||
130340683|NCT03745820|469219490|FG002|Overall Study|Withdrawal by Subject|4|||
130340684|NCT03745820|469219488|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
130340685|NCT03745820|469219489|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
130340686|NCT03745820|469219490|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
130340687|NCT03745820|469219488|FG000|Overall Study|Lost to Follow-up|2|||
130340688|NCT03745820|469219489|FG001|Overall Study|Lost to Follow-up|0|||
130340689|NCT03745820|469219490|FG002|Overall Study|Lost to Follow-up|3|||
130340690|NCT03745820|469219488|FG000|Overall Study|Reason not Specified|2|||
130340691|NCT03745820|469219489|FG001|Overall Study|Reason not Specified|4|||
130340692|NCT03745820|469219490|FG002|Overall Study|Reason not Specified|1|||
130340693|NCT00507728|469219491|FG000|Randomization to Month 3|Lost to Follow-up|15|||
130340694|NCT00507728|469219492|FG001|Randomization to Month 3|Lost to Follow-up|14|||
130340695|NCT00507728|469219493|FG002|Randomization to Month 3|Lost to Follow-up|20|||
130340696|NCT00507728|469219491|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
130340697|NCT00507728|469219492|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
130340698|NCT00507728|469219493|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
130340699|NCT03680742|469219494|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
130340700|NCT01410357|469219495|FG000|Overall Study|Death|2|||
130340701|NCT01410357|469219496|FG001|Overall Study|Death|1|||
130340702|NCT01410357|469219495|FG000|Overall Study|Withdrawal by Subject|1|||
130340703|NCT01410357|469219496|FG001|Overall Study|Withdrawal by Subject|2|||
130340704|NCT01410357|469219495|FG000|Overall Study|Lost to Follow-up|23|||
130340705|NCT01410357|469219496|FG001|Overall Study|Lost to Follow-up|21|||
130340706|NCT00668733|469219497|FG000|Overall Study|Lost to Follow-up|2|||
130340707|NCT00668733|469219498|FG001|Overall Study|Lost to Follow-up|3|||
130340708|NCT00668733|469219497|FG000|Overall Study|Withdrawal by Subject|0|||
130340709|NCT00668733|469219498|FG001|Overall Study|Withdrawal by Subject|4|||
130340710|NCT01909791|469219499|FG000|Overall Study|Death|9|||
130340711|NCT01909791|469219500|FG001|Overall Study|Death|8|||
130340712|NCT01909791|469219501|FG002|Overall Study|Death|4|||
130340713|NCT01909791|469219499|FG000|Overall Study|Withdrawal by Subject|5|||
130340714|NCT01909791|469219500|FG001|Overall Study|Withdrawal by Subject|9|||
130340715|NCT01909791|469219501|FG002|Overall Study|Withdrawal by Subject|13|||
130340716|NCT01909791|469219499|FG000|Overall Study|Lost to Follow-up|5|||
130340717|NCT01909791|469219500|FG001|Overall Study|Lost to Follow-up|11|||
130340718|NCT01909791|469219501|FG002|Overall Study|Lost to Follow-up|10|||
130340719|NCT01909791|469219499|FG000|Overall Study|Missed Visit|2|||
130340720|NCT01909791|469219500|FG001|Overall Study|Missed Visit|0|||
130340721|NCT01909791|469219501|FG002|Overall Study|Missed Visit|1|||
130340722|NCT01659554|469219502|FG000|Overall Study|Study Termination|4|||
130340723|NCT00945906|469219505|FG000|Overall Study|Withdrawal by Subject|1|||
130340724|NCT00945906|469219505|FG000|Overall Study|Did not want to return for last visit|2|||
130340725|NCT00945906|469219505|FG000|Overall Study|Unable to return for last visit|2|||
130340726|NCT00945906|469219505|FG000|Overall Study|Moved to another country|2|||
130340727|NCT03330002|469219508|FG000|Overall Study|Lost to Follow-up|15|||
130340728|NCT03330002|469219508|FG000|Overall Study|Death|7|||
130340729|NCT00635219|469219509|FG000|Overall Study|Adverse Event|12|||
130340730|NCT00635219|469219510|FG001|Overall Study|Adverse Event|10|||
130340731|NCT00635219|469219511|FG002|Overall Study|Adverse Event|18|||
130340732|NCT00635219|469219512|FG003|Overall Study|Adverse Event|15|||
130004404|NCT00433914|467981758|FG000|Overall Study|Withdrawal by Subject|0|||
130340733|NCT00635219|469219513|FG004|Overall Study|Adverse Event|19|||
130340734|NCT00635219|469219509|FG000|Overall Study|Lack of Efficacy|5|||
130340735|NCT00635219|469219510|FG001|Overall Study|Lack of Efficacy|6|||
130004405|NCT00433914|467981759|FG001|Overall Study|Withdrawal by Subject|2|||
130340736|NCT00635219|469219511|FG002|Overall Study|Lack of Efficacy|3|||
130340737|NCT00635219|469219512|FG003|Overall Study|Lack of Efficacy|4|||
130340738|NCT00635219|469219513|FG004|Overall Study|Lack of Efficacy|6|||
130340739|NCT00635219|469219509|FG000|Overall Study|Non-compliance With Study Product|0|||
130340740|NCT00635219|469219510|FG001|Overall Study|Non-compliance With Study Product|0|||
130340741|NCT00635219|469219511|FG002|Overall Study|Non-compliance With Study Product|0|||
130340742|NCT00635219|469219512|FG003|Overall Study|Non-compliance With Study Product|2|||
130340743|NCT00635219|469219513|FG004|Overall Study|Non-compliance With Study Product|1|||
130340744|NCT00635219|469219509|FG000|Overall Study|Protocol Violation|0|||
130340745|NCT00635219|469219510|FG001|Overall Study|Protocol Violation|2|||
130340746|NCT00635219|469219511|FG002|Overall Study|Protocol Violation|3|||
130340747|NCT00635219|469219512|FG003|Overall Study|Protocol Violation|2|||
130340748|NCT00635219|469219513|FG004|Overall Study|Protocol Violation|4|||
130340749|NCT00635219|469219509|FG000|Overall Study|Withdrawal of Consent|8|||
130340750|NCT00635219|469219510|FG001|Overall Study|Withdrawal of Consent|6|||
130340751|NCT00635219|469219511|FG002|Overall Study|Withdrawal of Consent|8|||
130340752|NCT00635219|469219512|FG003|Overall Study|Withdrawal of Consent|11|||
130340753|NCT00635219|469219513|FG004|Overall Study|Withdrawal of Consent|8|||
130340754|NCT00635219|469219509|FG000|Overall Study|Lost to Follow-up|0|||
130340755|NCT00635219|469219510|FG001|Overall Study|Lost to Follow-up|0|||
130340756|NCT00635219|469219511|FG002|Overall Study|Lost to Follow-up|2|||
130340757|NCT00635219|469219512|FG003|Overall Study|Lost to Follow-up|0|||
130340758|NCT00635219|469219513|FG004|Overall Study|Lost to Follow-up|3|||
130340759|NCT00635219|469219509|FG000|Overall Study|Administrative or Other Reasons|0|||
130340760|NCT00635219|469219510|FG001|Overall Study|Administrative or Other Reasons|1|||
130340761|NCT00635219|469219511|FG002|Overall Study|Administrative or Other Reasons|1|||
130340762|NCT00635219|469219512|FG003|Overall Study|Administrative or Other Reasons|0|||
130340763|NCT00635219|469219513|FG004|Overall Study|Administrative or Other Reasons|1|||
130340764|NCT01598129|469219514|FG000|Overall Study|Disease progression|6|||
130340765|NCT01598129|469219514|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
130340766|NCT01598129|469219514|FG000|Overall Study|Withdrawal by Subject|1|||
130340767|NCT00505076|469219515|FG000|Overall Study|Adverse Event|1|||
130340768|NCT00505076|469219516|FG001|Overall Study|Adverse Event|0|||
130340769|NCT00505076|469219517|FG002|Overall Study|Adverse Event|1|||
130340770|NCT00505076|469219515|FG000|Overall Study|Protocol Violation|2|||
130340771|NCT00505076|469219516|FG001|Overall Study|Protocol Violation|1|||
130340772|NCT00505076|469219517|FG002|Overall Study|Protocol Violation|2|||
130340773|NCT00505076|469219515|FG000|Overall Study|Withdrawal by Subject|0|||
130340774|NCT00505076|469219516|FG001|Overall Study|Withdrawal by Subject|1|||
130340775|NCT00505076|469219517|FG002|Overall Study|Withdrawal by Subject|2|||
130340776|NCT00591318|469219520|FG000|Overall Study|Lack of Efficacy|2|||
130340777|NCT00591318|469219521|FG001|Overall Study|Lack of Efficacy|0|||
130340778|NCT00591318|469219520|FG000|Overall Study|Adverse Event|2|||
130340779|NCT00591318|469219521|FG001|Overall Study|Adverse Event|0|||
130340780|NCT00233454|469219524|FG000|Overall Study|Death|6|||
130340781|NCT04224688|469219528|FG000|Overall Study|Withdrawal by Subject|1|||
130340782|NCT04224688|469219529|FG001|Overall Study|Withdrawal by Subject|3|||
130340783|NCT04224688|469219528|FG000|Overall Study|Lack of Efficacy|1|||
130340784|NCT04224688|469219529|FG001|Overall Study|Lack of Efficacy|1|||
130340785|NCT04224688|469219528|FG000|Overall Study|Adverse event, not fatal|0|||
130340786|NCT04224688|469219529|FG001|Overall Study|Adverse event, not fatal|2|||
130004406|NCT00433914|467981758|FG000|Overall Study|Lost to Follow-up|0|||
130004407|NCT00433914|467981759|FG001|Overall Study|Lost to Follow-up|1|||
130340787|NCT04224688|469219528|FG000|Overall Study|COVID-19|0|||
130340788|NCT04224688|469219529|FG001|Overall Study|COVID-19|1|||
130340789|NCT02745145|469219532|FG000|Overall Study|Adverse Event|1|||
130004408|NCT02844920|467981760|FG000|Overall Study|Lost to Follow-up|2|||
130004409|NCT00800436|467981771|FG000|Overall Study|Withdrawal by Subject|0|||
130004410|NCT00800436|467981772|FG001|Overall Study|Withdrawal by Subject|0|||
130004411|NCT00800436|467981773|FG002|Overall Study|Withdrawal by Subject|1|||
130004412|NCT00800436|467981774|FG003|Overall Study|Withdrawal by Subject|1|||
130340790|NCT02745145|469219533|FG001|Overall Study|Adverse Event|0|||
130340791|NCT02745145|469219534|FG002|Overall Study|Adverse Event|0|||
130340792|NCT02745145|469219532|FG000|Overall Study|Death|0|||
130340793|NCT02745145|469219533|FG001|Overall Study|Death|1|||
130340794|NCT02745145|469219534|FG002|Overall Study|Death|0|||
130340795|NCT02745145|469219532|FG000|Overall Study|Progressive disease|0|||
130340796|NCT02745145|469219533|FG001|Overall Study|Progressive disease|0|||
130340797|NCT02745145|469219534|FG002|Overall Study|Progressive disease|1|||
130340798|NCT02745145|469219532|FG000|Overall Study|Withdrew consent|1|||
130340799|NCT02745145|469219533|FG001|Overall Study|Withdrew consent|1|||
130340800|NCT02745145|469219534|FG002|Overall Study|Withdrew consent|1|||
130340801|NCT02745145|469219532|FG000|Overall Study|Study Termination|8|||
130340802|NCT02745145|469219533|FG001|Overall Study|Study Termination|3|||
130340803|NCT02745145|469219534|FG002|Overall Study|Study Termination|7|||
130340804|NCT00388583|469219535|FG000|Overall Study|Protocol Violation|1|||
130340805|NCT00388583|469219536|FG001|Overall Study|Protocol Violation|0|||
130340806|NCT00388583|469219535|FG000|Overall Study|Withdrawal by Subject|3|||
130340807|NCT00388583|469219536|FG001|Overall Study|Withdrawal by Subject|3|||
130340808|NCT00388583|469219535|FG000|Overall Study|Serious Adverse Event|2|||
130340809|NCT00388583|469219536|FG001|Overall Study|Serious Adverse Event|0|||
130340810|NCT00388583|469219535|FG000|Overall Study|Did not receive vaccine|0|||
130340811|NCT00388583|469219536|FG001|Overall Study|Did not receive vaccine|1|||
130340812|NCT01155011|469219538|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
130340813|NCT01155011|469219539|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
130340814|NCT01155011|469219538|FG000|Baseline to 6 Months|investigator decision, moved|4|||
130340815|NCT01155011|469219539|FG001|Baseline to 6 Months|investigator decision, moved|5|||
130340816|NCT01155011|469219538|FG000|Baseline to 6 Months|Death|0|||
130340817|NCT01155011|469219539|FG001|Baseline to 6 Months|Death|1|||
130340818|NCT01155011|469219538|FG000|6 to 12 Months|Withdrawal by Subject|8|||
130340819|NCT01155011|469219539|FG001|6 to 12 Months|Withdrawal by Subject|5|||
130340820|NCT01155011|469219538|FG000|6 to 12 Months|Death|1|||
130340821|NCT01155011|469219539|FG001|6 to 12 Months|Death|5|||
130340822|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
130340823|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
130340824|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
130340825|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
130340826|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
130340827|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
130340828|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
130340829|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
130340830|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
130340831|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
130340832|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
130340833|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
130340834|NCT00322621|469219540|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
130340835|NCT00322621|469219541|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
130340836|NCT00322621|469219542|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
130340837|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
130340838|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
130340839|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
130340840|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
130340841|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
130340842|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
130340843|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
130340844|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
130340845|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
130340846|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
130340847|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
130340848|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
130340849|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
130340850|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
130340851|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
130340852|NCT00322621|469219540|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
130340853|NCT00322621|469219541|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
130340854|NCT00322621|469219542|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
130340855|NCT01743001|469219543|FG000|Overall Study|Physician Decision|1|||
130340856|NCT01743001|469219544|FG001|Overall Study|Physician Decision|0|||
130340857|NCT01743001|469219543|FG000|Overall Study|Pregnancy|1|||
130340858|NCT01743001|469219544|FG001|Overall Study|Pregnancy|0|||
130340859|NCT01743001|469219543|FG000|Overall Study|Death|1|||
130340860|NCT01743001|469219544|FG001|Overall Study|Death|0|||
130340861|NCT01565343|469219547|FG000|Overall Study|Administrative decision/technical issues|1|||
130340862|NCT01565343|469219548|FG001|Overall Study|Administrative decision/technical issues|0|||
130340863|NCT01565343|469219549|FG002|Overall Study|Administrative decision/technical issues|0|||
130340864|NCT00271505|469219562|FG000|Overall Study|Screen Failure|3|||
130340865|NCT00271505|469219562|FG000|Overall Study|Adverse Event|1|||
130340866|NCT00271505|469219562|FG000|Overall Study|Death|1|||
130340867|NCT03288142|469219568|FG000|Overall Study|Lost to Follow-up|22|||
130340868|NCT03288142|469219569|FG001|Overall Study|Lost to Follow-up|15|||
130340869|NCT00946153|469219570|FG000|Phase 2|Adverse Event|0|||
130340870|NCT00946153|469219571|FG001|Phase 2|Adverse Event|0|||
130340871|NCT00946153|469219572|FG002|Phase 2|Adverse Event|0|||
130340872|NCT00946153|469219573|FG003|Phase 2|Adverse Event|0|||
130340873|NCT00946153|469219574|FG004|Phase 2|Adverse Event|6|||
130340874|NCT00946153|469219570|FG000|Phase 2|Need more reduction of dose|0|||
130340875|NCT00946153|469219571|FG001|Phase 2|Need more reduction of dose|0|||
130340876|NCT00946153|469219572|FG002|Phase 2|Need more reduction of dose|0|||
130340877|NCT00946153|469219573|FG003|Phase 2|Need more reduction of dose|0|||
130340878|NCT00946153|469219574|FG004|Phase 2|Need more reduction of dose|2|||
130004413|NCT00800436|467981775|FG004|Overall Study|Withdrawal by Subject|0|||
130004414|NCT00800436|467981776|FG005|Overall Study|Withdrawal by Subject|0|||
130004415|NCT00800436|467981777|FG006|Overall Study|Withdrawal by Subject|0|||
130004416|NCT00766090|467981778|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004417|NCT00766090|467981779|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004418|NCT00766090|467981780|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004419|NCT00766090|467981781|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004420|NCT00766090|467981782|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004421|NCT00766090|467981783|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004422|NCT00766090|467981784|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004423|NCT00766090|467981785|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004424|NCT00766090|467981786|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
130004425|NCT00766090|467981787|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004426|NCT00766090|467981788|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004427|NCT00766090|467981789|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
130004428|NCT00766090|467981778|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
130004429|NCT00766090|467981779|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004430|NCT00766090|467981780|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130340879|NCT00946153|469219570|FG000|Phase 2|Physician Decision|0|||
130340880|NCT00946153|469219571|FG001|Phase 2|Physician Decision|0|||
130340881|NCT00946153|469219572|FG002|Phase 2|Physician Decision|0|||
130340882|NCT00946153|469219573|FG003|Phase 2|Physician Decision|0|||
130340883|NCT00946153|469219574|FG004|Phase 2|Physician Decision|1|||
130340884|NCT00946153|469219570|FG000|Phase 2|14 days washout for recovery due to AE|0|||
130340885|NCT00946153|469219571|FG001|Phase 2|14 days washout for recovery due to AE|0|||
130340886|NCT00946153|469219572|FG002|Phase 2|14 days washout for recovery due to AE|0|||
130340887|NCT00946153|469219573|FG003|Phase 2|14 days washout for recovery due to AE|0|||
130340888|NCT00946153|469219574|FG004|Phase 2|14 days washout for recovery due to AE|4|||
130340889|NCT01948193|469220964|FG000|Overall Study|Serious event|2|||
130340890|NCT01948193|469220964|FG000|Overall Study|Lost to Follow-up|7|||
130340891|NCT02522624|469220965|FG000|Overall Study|Technical failure|1|||
130340892|NCT02522624|469220966|FG001|Overall Study|Technical failure|0|||
130340893|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
130340894|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
130340895|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
130340896|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
130340897|NCT00490529|469220968|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
130340898|NCT00490529|469220968|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
130340899|NCT03254459|469220969|FG000|Overall Study|Adverse Event|7|||
130340900|NCT03254459|469220970|FG001|Overall Study|Adverse Event|20|||
130340901|NCT03254459|469220969|FG000|Overall Study|Withdrawal by Subject Consent|3|||
130340902|NCT03254459|469220970|FG001|Overall Study|Withdrawal by Subject Consent|1|||
130340903|NCT03254459|469220969|FG000|Overall Study|Lost to Follow-up|0|||
130340904|NCT03254459|469220970|FG001|Overall Study|Lost to Follow-up|1|||
130340905|NCT03254459|469220969|FG000|Overall Study|Miscellaneous|0|||
130340906|NCT03254459|469220970|FG001|Overall Study|Miscellaneous|1|||
130340907|NCT00727441|469220971|FG000|Overall Study|Disease Progression|11|||
130340908|NCT00727441|469220972|FG001|Overall Study|Disease Progression|14|||
130340909|NCT00727441|469220973|FG002|Overall Study|Disease Progression|17|||
130340910|NCT00727441|469220971|FG000|Overall Study|Eligibility|7|||
130340911|NCT00727441|469220972|FG001|Overall Study|Eligibility|5|||
130340912|NCT00727441|469220973|FG002|Overall Study|Eligibility|7|||
130340913|NCT00727441|469220971|FG000|Overall Study|Death|0|||
130340914|NCT00727441|469220972|FG001|Overall Study|Death|1|||
130340915|NCT00727441|469220973|FG002|Overall Study|Death|1|||
130340916|NCT00727441|469220971|FG000|Overall Study|Physician Decision|0|||
130340917|NCT00727441|469220972|FG001|Overall Study|Physician Decision|1|||
130340918|NCT00727441|469220973|FG002|Overall Study|Physician Decision|0|||
130340919|NCT00727441|469220971|FG000|Overall Study|Withdrawal by Subject|0|||
130340920|NCT00727441|469220972|FG001|Overall Study|Withdrawal by Subject|1|||
130340921|NCT00727441|469220973|FG002|Overall Study|Withdrawal by Subject|0|||
130340922|NCT00535288|469220974|FG000|Overall Study|Adverse Event|20|||
130340923|NCT00535288|469220975|FG001|Overall Study|Adverse Event|19|||
130340924|NCT00535288|469220976|FG002|Overall Study|Adverse Event|25|||
130340925|NCT00535288|469220977|FG003|Overall Study|Adverse Event|20|||
130340926|NCT00535288|469220978|FG004|Overall Study|Adverse Event|30|||
130340927|NCT00535288|469220974|FG000|Overall Study|Lost to Follow-up|0|||
130340928|NCT00535288|469220975|FG001|Overall Study|Lost to Follow-up|3|||
130340929|NCT00535288|469220976|FG002|Overall Study|Lost to Follow-up|0|||
130340930|NCT00535288|469220977|FG003|Overall Study|Lost to Follow-up|0|||
130340931|NCT00535288|469220978|FG004|Overall Study|Lost to Follow-up|0|||
130340932|NCT00535288|469220974|FG000|Overall Study|Lack of Efficacy|26|||
130004431|NCT00766090|467981781|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130340933|NCT00535288|469220975|FG001|Overall Study|Lack of Efficacy|3|||
130340934|NCT00535288|469220976|FG002|Overall Study|Lack of Efficacy|4|||
130340935|NCT00535288|469220977|FG003|Overall Study|Lack of Efficacy|4|||
130340936|NCT00535288|469220978|FG004|Overall Study|Lack of Efficacy|7|||
130340937|NCT00535288|469220974|FG000|Overall Study|Unwilling to cooperate|6|||
130340938|NCT00535288|469220975|FG001|Overall Study|Unwilling to cooperate|6|||
130340939|NCT00535288|469220976|FG002|Overall Study|Unwilling to cooperate|3|||
130340940|NCT00535288|469220977|FG003|Overall Study|Unwilling to cooperate|3|||
130340941|NCT00535288|469220978|FG004|Overall Study|Unwilling to cooperate|4|||
130340942|NCT00535288|469220974|FG000|Overall Study|Other|2|||
130340943|NCT00535288|469220975|FG001|Overall Study|Other|1|||
130340944|NCT00535288|469220976|FG002|Overall Study|Other|1|||
130340945|NCT00535288|469220977|FG003|Overall Study|Other|2|||
130340946|NCT00535288|469220978|FG004|Overall Study|Other|1|||
130340947|NCT01129583|469220984|FG000|Overall Study|Death|1|||
130340948|NCT01129583|469220985|FG001|Overall Study|Death|0|||
130340949|NCT01129583|469220984|FG000|Overall Study|Lost to Follow-up|1|||
130340950|NCT01129583|469220985|FG001|Overall Study|Lost to Follow-up|1|||
130340951|NCT01129583|469220984|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
130340952|NCT01129583|469220985|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
130340953|NCT02600871|469220986|FG000|Overall Study|Lost to Follow-up|13|||
130340954|NCT02600871|469220987|FG001|Overall Study|Lost to Follow-up|10|||
130340955|NCT03135119|469221003|FG000|Overall Study|Lost to Follow-up|2|||
130340956|NCT03135119|469221004|FG001|Overall Study|Lost to Follow-up|0|||
130340957|NCT03135119|469221003|FG000|Overall Study|Physician Decision|1|||
130340958|NCT03135119|469221004|FG001|Overall Study|Physician Decision|1|||
130340959|NCT03135119|469221003|FG000|Overall Study|COVID-19 Shutdown|2|||
130340960|NCT03135119|469221004|FG001|Overall Study|COVID-19 Shutdown|2|||
130340961|NCT00361634|469221009|FG000|Overall Study|Lost to Follow-up|1|||
130340962|NCT00361634|469221009|FG000|Overall Study|Withdrawal by Subject|1|||
130340963|NCT00833417|469221010|FG000|Overall Study|Adverse Event|5|||
130340964|NCT00833417|469221011|FG001|Overall Study|Adverse Event|16|||
130340965|NCT00833417|469221010|FG000|Overall Study|Death|1|||
130340966|NCT00833417|469221011|FG001|Overall Study|Death|3|||
130340967|NCT00833417|469221010|FG000|Overall Study|Lost to Follow-up|1|||
130340968|NCT00833417|469221011|FG001|Overall Study|Lost to Follow-up|2|||
130340969|NCT00833417|469221010|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
130340970|NCT00833417|469221011|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
130340971|NCT00833417|469221010|FG000|Overall Study|Patient Decision to Withdraw|4|||
130340972|NCT00833417|469221011|FG001|Overall Study|Patient Decision to Withdraw|23|||
130340973|NCT00833417|469221010|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
130340974|NCT00833417|469221011|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
130340975|NCT00833417|469221010|FG000|Overall Study|Disease Progression|18|||
130004432|NCT00766090|467981782|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004433|NCT00766090|467981783|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004434|NCT00766090|467981784|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004435|NCT00766090|467981785|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004436|NCT00766090|467981786|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004437|NCT00766090|467981787|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004438|NCT00766090|467981788|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004439|NCT00766090|467981789|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
130004440|NCT00766090|467981778|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130004441|NCT00766090|467981779|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004442|NCT00766090|467981780|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004443|NCT00766090|467981781|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130004444|NCT00766090|467981782|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004445|NCT00766090|467981783|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004446|NCT00766090|467981784|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004447|NCT00766090|467981785|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004448|NCT00766090|467981786|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004449|NCT00766090|467981787|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004450|NCT00766090|467981788|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004451|NCT00766090|467981789|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130004452|NCT00766090|467981778|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
130340976|NCT00833417|469221011|FG001|Overall Study|Disease Progression|17|||
130340977|NCT00833417|469221010|FG000|Overall Study|Reason Not Specified|0|||
130340978|NCT00833417|469221011|FG001|Overall Study|Reason Not Specified|1|||
130340979|NCT05315908|469221012|FG000|Overall Study|Lost to Follow-up|4477|||
130340980|NCT05315908|469221013|FG001|Overall Study|Lost to Follow-up|4606|||
130340981|NCT01561898|469221014|FG000|Overall Study|Withdrawal by Subject|0|||
130340982|NCT01561898|469221015|FG001|Overall Study|Withdrawal by Subject|8|||
130340983|NCT01561898|469221016|FG002|Overall Study|Withdrawal by Subject|12|||
130340984|NCT01561898|469221017|FG003|Overall Study|Withdrawal by Subject|5|||
130340985|NCT01561898|469221014|FG000|Overall Study|Lack of Efficacy|0|||
130340986|NCT01561898|469221015|FG001|Overall Study|Lack of Efficacy|8|||
130340987|NCT01561898|469221016|FG002|Overall Study|Lack of Efficacy|10|||
130340988|NCT01561898|469221017|FG003|Overall Study|Lack of Efficacy|5|||
130340989|NCT01561898|469221014|FG000|Overall Study|Worsening of complications|0|||
130340990|NCT01561898|469221015|FG001|Overall Study|Worsening of complications|1|||
130340991|NCT01561898|469221016|FG002|Overall Study|Worsening of complications|0|||
130340992|NCT01561898|469221017|FG003|Overall Study|Worsening of complications|0|||
130340993|NCT01561898|469221014|FG000|Overall Study|Lost to Follow-up|0|||
130340994|NCT01561898|469221015|FG001|Overall Study|Lost to Follow-up|0|||
130340995|NCT01561898|469221016|FG002|Overall Study|Lost to Follow-up|1|||
130340996|NCT01561898|469221017|FG003|Overall Study|Lost to Follow-up|0|||
130340997|NCT01561898|469221014|FG000|Overall Study|Adverse Event|1|||
130340998|NCT01561898|469221015|FG001|Overall Study|Adverse Event|19|||
130340999|NCT01561898|469221016|FG002|Overall Study|Adverse Event|14|||
130341000|NCT01561898|469221017|FG003|Overall Study|Adverse Event|9|||
130341001|NCT01561898|469221014|FG000|Overall Study|Physician Decision|1|||
130341002|NCT01561898|469221015|FG001|Overall Study|Physician Decision|5|||
130341003|NCT01561898|469221016|FG002|Overall Study|Physician Decision|7|||
130341004|NCT01561898|469221017|FG003|Overall Study|Physician Decision|1|||
130341005|NCT00294762|469221018|FG000|Overall Study|Did not receive study treatment|3|||
130341006|NCT00294762|469221019|FG001|Overall Study|Did not receive study treatment|3|||
130341007|NCT02238080|469221020|FG000|Overall Study|Death|13|||
130341008|NCT02238080|469221020|FG000|Overall Study|Treatment interrupted|6|||
130341009|NCT02238080|469221020|FG000|Overall Study|Withdrawal by Subject|2|||
130341010|NCT02238080|469221020|FG000|Overall Study|Other|4|||
130341011|NCT01738646|469221021|FG000|Overall Study|Still Receiving Treatment|2|||
130341012|NCT04093024|469221022|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
130341013|NCT04093024|469221023|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
130341014|NCT04093024|469221022|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
130341015|NCT04093024|469221023|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
130341016|NCT04093024|469221022|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
130341017|NCT04093024|469221023|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
130341018|NCT04093024|469221022|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
130341019|NCT04093024|469221023|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
130341020|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
130341021|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
130341022|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
130341023|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
130341024|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
130341025|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
130341026|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
130341027|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
130341028|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
130341029|NCT00647270|469221030|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
130341030|NCT00647270|469221031|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
130341031|NCT00647270|469221032|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
130341032|NCT00647270|469221030|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
130341033|NCT00647270|469221031|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
130341034|NCT00647270|469221032|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
130341035|NCT00647270|469221030|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
130341036|NCT00647270|469221031|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
130341037|NCT00647270|469221032|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
130341038|NCT00647270|469221030|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
130341039|NCT00647270|469221031|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
130341040|NCT00647270|469221032|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
130341041|NCT04493892|469221033|FG000|Overall Study|Withdrawal by Subject|15|||
130341042|NCT02366091|469221038|FG000|Overall Study|Withdrawal by Subject|3|||
130341043|NCT02366091|469221039|FG001|Overall Study|Withdrawal by Subject|7|||
130341044|NCT02366091|469221040|FG002|Overall Study|Withdrawal by Subject|3|||
130341045|NCT02366091|469221041|FG003|Overall Study|Withdrawal by Subject|1|||
130341046|NCT02160041|469221042|FG000|Overall Study|Adverse Event|11|||
130341047|NCT02160041|469221042|FG000|Overall Study|Death|2|||
130341048|NCT02160041|469221042|FG000|Overall Study|disease progression|57|||
130341049|NCT02160041|469221042|FG000|Overall Study|Protocol Violation|1|||
130341050|NCT02160041|469221042|FG000|Overall Study|non-compliance with study|1|||
130341051|NCT02160041|469221042|FG000|Overall Study|Physician Decision|3|||
130341052|NCT02160041|469221042|FG000|Overall Study|Withdrawal by Subject|8|||
130341053|NCT02160041|469221042|FG000|Overall Study|study terminated by by sponsor|1|||
130341054|NCT01403948|469221043|FG000|Overall Study|Progressive disease|0|||
130341055|NCT01403948|469221044|FG001|Overall Study|Progressive disease|2|||
130341056|NCT01403948|469221045|FG002|Overall Study|Progressive disease|2|||
130341057|NCT01403948|469221046|FG003|Overall Study|Progressive disease|4|||
130341058|NCT01403948|469221047|FG004|Overall Study|Progressive disease|2|||
130341059|NCT01403948|469221048|FG005|Overall Study|Progressive disease|6|||
130004453|NCT00766090|467981779|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004454|NCT00766090|467981780|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
130004455|NCT00766090|467981781|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004456|NCT00766090|467981782|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004457|NCT00766090|467981783|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004458|NCT00766090|467981784|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004459|NCT00766090|467981785|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004460|NCT00766090|467981786|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004461|NCT00766090|467981787|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004462|NCT00766090|467981788|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004463|NCT00766090|467981789|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
130004464|NCT00766090|467981778|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004465|NCT00766090|467981779|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004466|NCT00766090|467981780|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004467|NCT00766090|467981781|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004468|NCT00766090|467981782|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
130004469|NCT00766090|467981783|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004470|NCT00766090|467981784|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004471|NCT00766090|467981785|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004472|NCT00766090|467981786|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004473|NCT00766090|467981787|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004474|NCT00766090|467981788|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130004475|NCT00766090|467981789|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
130341060|NCT01403948|469221049|FG006|Overall Study|Progressive disease|2|||
130341061|NCT01403948|469221050|FG007|Overall Study|Progressive disease|4|||
130341062|NCT01403948|469221051|FG008|Overall Study|Progressive disease|5|||
130341063|NCT01403948|469221052|FG009|Overall Study|Progressive disease|5|||
130341064|NCT01403948|469221043|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341065|NCT01403948|469221044|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341066|NCT01403948|469221045|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341067|NCT01403948|469221046|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341068|NCT01403948|469221047|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
130341069|NCT01403948|469221048|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341070|NCT01403948|469221049|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
130341071|NCT01403948|469221050|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341072|NCT01403948|469221051|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
130341073|NCT01403948|469221052|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
130341074|NCT01403948|469221043|FG000|Overall Study|Lost to Follow-up|0|||
130341075|NCT01403948|469221044|FG001|Overall Study|Lost to Follow-up|0|||
130004476|NCT00766090|467981778|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004477|NCT00766090|467981779|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004478|NCT00766090|467981780|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
130004479|NCT00766090|467981781|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004480|NCT00766090|467981782|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004481|NCT00766090|467981783|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004482|NCT00766090|467981784|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004483|NCT00766090|467981785|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004484|NCT00766090|467981786|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004485|NCT00766090|467981787|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004486|NCT00766090|467981788|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004487|NCT00766090|467981789|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
130004488|NCT00766090|467981778|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
130004489|NCT00766090|467981779|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
130004490|NCT00766090|467981780|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
130004491|NCT00766090|467981781|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
130004492|NCT00766090|467981782|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
130004493|NCT00766090|467981783|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
130004494|NCT00766090|467981784|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
130004495|NCT00766090|467981785|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
130004496|NCT00766090|467981786|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
130341076|NCT01403948|469221045|FG002|Overall Study|Lost to Follow-up|0|||
130341077|NCT01403948|469221046|FG003|Overall Study|Lost to Follow-up|0|||
130004497|NCT00766090|467981787|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
130004498|NCT00766090|467981788|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
130004499|NCT00766090|467981789|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
130004500|NCT00766090|467981778|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004501|NCT00766090|467981779|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004502|NCT00766090|467981780|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130341078|NCT01403948|469221047|FG004|Overall Study|Lost to Follow-up|0|||
130341079|NCT01403948|469221048|FG005|Overall Study|Lost to Follow-up|0|||
130341080|NCT01403948|469221049|FG006|Overall Study|Lost to Follow-up|0|||
130004503|NCT00766090|467981781|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004504|NCT00766090|467981782|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004505|NCT00766090|467981783|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
130004506|NCT00766090|467981784|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004507|NCT00766090|467981785|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004508|NCT00766090|467981786|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004509|NCT00766090|467981787|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004510|NCT00766090|467981788|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004511|NCT00766090|467981789|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
130004512|NCT00766090|467981778|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004513|NCT00766090|467981779|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
130004514|NCT00766090|467981780|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004515|NCT00766090|467981781|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
130004516|NCT00766090|467981782|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004517|NCT00766090|467981783|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004518|NCT00766090|467981784|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004519|NCT00766090|467981785|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004520|NCT00766090|467981786|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004521|NCT00766090|467981787|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004522|NCT00766090|467981788|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
130004523|NCT00766090|467981789|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
130004524|NCT00766090|467981778|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004525|NCT00766090|467981779|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004526|NCT00766090|467981780|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004527|NCT00766090|467981781|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004528|NCT00766090|467981782|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
130004529|NCT00766090|467981783|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004530|NCT00766090|467981784|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004531|NCT00766090|467981785|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004532|NCT00766090|467981786|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004533|NCT00766090|467981787|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004534|NCT00766090|467981788|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004535|NCT00766090|467981789|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
130004536|NCT01106027|467981796|FG000|Overall Study|Lost graft early, discontinued|1|||
130004537|NCT02871778|467981797|FG000|Part A: Treatment Period 1|Adverse Event|1|||
130004538|NCT02871778|467981798|FG001|Part A: Treatment Period 1|Adverse Event|1|||
130004539|NCT02871778|467981799|FG002|Part A: Treatment Period 1|Adverse Event|1|||
130004540|NCT02871778|467981800|FG003|Part A: Treatment Period 1|Adverse Event|0|||
130004541|NCT02871778|467981801|FG004|Part A: Treatment Period 1|Adverse Event|0|||
130004542|NCT02871778|467981802|FG005|Part A: Treatment Period 1|Adverse Event|0|||
130004543|NCT02871778|467981803|FG006|Part A: Treatment Period 1|Adverse Event|0|||
130004544|NCT02871778|467981804|FG007|Part A: Treatment Period 1|Adverse Event|0|||
130004545|NCT02871778|467981797|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
130004546|NCT02871778|467981798|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
130004547|NCT02871778|467981799|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130004548|NCT02871778|467981800|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
130004549|NCT02871778|467981801|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130004550|NCT02871778|467981802|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130004551|NCT02871778|467981803|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130004552|NCT02871778|467981804|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
130004553|NCT02871778|467981797|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004554|NCT02871778|467981798|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004555|NCT02871778|467981799|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
130004556|NCT02871778|467981800|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004557|NCT02871778|467981801|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004558|NCT02871778|467981802|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004559|NCT02871778|467981803|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004560|NCT02871778|467981804|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
130004561|NCT02871778|467981797|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130004562|NCT02871778|467981798|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130004563|NCT02871778|467981799|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
130004564|NCT02871778|467981800|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130004565|NCT02871778|467981801|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130004566|NCT02871778|467981802|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130004567|NCT02871778|467981803|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130004568|NCT02871778|467981804|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
130341081|NCT01403948|469221050|FG007|Overall Study|Lost to Follow-up|0|||
130004569|NCT02871778|467981797|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004570|NCT02871778|467981798|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
130004571|NCT02871778|467981799|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004572|NCT02871778|467981800|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004573|NCT02871778|467981801|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004574|NCT02871778|467981802|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004575|NCT02871778|467981803|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004576|NCT02871778|467981804|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
130004577|NCT02871778|467981797|FG000|Part A: Treatment Period 2|Adverse Event|2|||
130004578|NCT02871778|467981798|FG001|Part A: Treatment Period 2|Adverse Event|2|||
130004579|NCT02871778|467981799|FG002|Part A: Treatment Period 2|Adverse Event|0|||
130004580|NCT02871778|467981800|FG003|Part A: Treatment Period 2|Adverse Event|0|||
130004581|NCT02871778|467981801|FG004|Part A: Treatment Period 2|Adverse Event|0|||
130004582|NCT02871778|467981802|FG005|Part A: Treatment Period 2|Adverse Event|0|||
130004583|NCT02871778|467981803|FG006|Part A: Treatment Period 2|Adverse Event|0|||
130004584|NCT02871778|467981804|FG007|Part A: Treatment Period 2|Adverse Event|0|||
130004585|NCT02871778|467981797|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004586|NCT02871778|467981798|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004587|NCT02871778|467981799|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004588|NCT02871778|467981800|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
130004589|NCT02871778|467981801|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004590|NCT02871778|467981802|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004591|NCT02871778|467981803|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004592|NCT02871778|467981804|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
130004593|NCT02871778|467981797|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
130004594|NCT02871778|467981798|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130004595|NCT02871778|467981799|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
130004596|NCT02871778|467981800|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130004597|NCT02871778|467981801|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130004598|NCT02871778|467981802|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130004599|NCT02871778|467981803|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130004600|NCT02871778|467981804|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
130004601|NCT02871778|467981797|FG000|Part B: Treatment Period 3|Adverse Event|0|||
130004602|NCT02871778|467981798|FG001|Part B: Treatment Period 3|Adverse Event|0|||
130004603|NCT02871778|467981799|FG002|Part B: Treatment Period 3|Adverse Event|0|||
130004604|NCT02871778|467981800|FG003|Part B: Treatment Period 3|Adverse Event|0|||
130004605|NCT02871778|467981801|FG004|Part B: Treatment Period 3|Adverse Event|1|||
130004606|NCT02871778|467981802|FG005|Part B: Treatment Period 3|Adverse Event|1|||
130004607|NCT02871778|467981803|FG006|Part B: Treatment Period 3|Adverse Event|1|||
130004608|NCT02871778|467981804|FG007|Part B: Treatment Period 3|Adverse Event|0|||
130004609|NCT02653300|467981806|FG000|Overall Study|Withdrawal by Subject|2|||
130004610|NCT02170779|467981826|FG000|Overall Study|Withdrawal by Subject|1|||
130004611|NCT02170779|467981827|FG001|Overall Study|Withdrawal by Subject|0|||
130004612|NCT02170779|467981826|FG000|Overall Study|Lost to Follow-up|0|||
130004613|NCT02170779|467981827|FG001|Overall Study|Lost to Follow-up|1|||
130004614|NCT00369785|467981828|FG000|Overall Study|Physician Decision|3|||
130004615|NCT00369785|467981829|FG001|Overall Study|Physician Decision|2|||
130004616|NCT00369785|467981828|FG000|Overall Study|Death|1|||
130004617|NCT00369785|467981829|FG001|Overall Study|Death|2|||
130004618|NCT00369785|467981828|FG000|Overall Study|Withdrawal by Subject|7|||
130004619|NCT00369785|467981829|FG001|Overall Study|Withdrawal by Subject|6|||
130004620|NCT00369785|467981828|FG000|Overall Study|Toxicity|6|||
130004621|NCT00369785|467981829|FG001|Overall Study|Toxicity|4|||
130004622|NCT00369785|467981828|FG000|Overall Study|Never started|0|||
130004623|NCT00369785|467981829|FG001|Overall Study|Never started|2|||
130004624|NCT00369785|467981828|FG000|Overall Study|Progression|4|||
130004625|NCT00369785|467981829|FG001|Overall Study|Progression|4|||
130004626|NCT00369785|467981828|FG000|Overall Study|Multiple reasons|6|||
130341082|NCT01403948|469221051|FG008|Overall Study|Lost to Follow-up|0|||
130341083|NCT01403948|469221052|FG009|Overall Study|Lost to Follow-up|1|||
130341084|NCT01403948|469221043|FG000|Overall Study|Refused cont. medication|0|||
130004627|NCT00369785|467981829|FG001|Overall Study|Multiple reasons|5|||
130004628|NCT00800683|467981830|FG000|Overall Study|Adverse Event|11|||
130004629|NCT00800683|467981831|FG001|Overall Study|Adverse Event|8|||
130004630|NCT00800683|467981830|FG000|Overall Study|Lost to Follow-up|3|||
130004631|NCT00800683|467981831|FG001|Overall Study|Lost to Follow-up|1|||
130004632|NCT00800683|467981830|FG000|Overall Study|Withdrawal by Subject|1|||
130004633|NCT00800683|467981831|FG001|Overall Study|Withdrawal by Subject|7|||
130004634|NCT00800683|467981830|FG000|Overall Study|Lack of Efficacy|1|||
130004635|NCT00800683|467981831|FG001|Overall Study|Lack of Efficacy|1|||
130004636|NCT00800683|467981830|FG000|Overall Study|Other|1|||
130004637|NCT00800683|467981831|FG001|Overall Study|Other|2|||
130004638|NCT04556136|467981839|FG000|Overall Study|Lost to Follow-up|6|||
130004639|NCT04556136|467981840|FG001|Overall Study|Lost to Follow-up|6|||
130004640|NCT04556136|467981839|FG000|Overall Study|Physician Decision|2|||
130004641|NCT04556136|467981840|FG001|Overall Study|Physician Decision|1|||
130004642|NCT04556136|467981839|FG000|Overall Study|Withdrawal by Subject|2|||
130004643|NCT04556136|467981840|FG001|Overall Study|Withdrawal by Subject|1|||
130004644|NCT02678416|467981841|FG000|Part 1|Withdrawal by Subject|1|||
130004645|NCT02678416|467981841|FG000|Part 2|Adverse Event|2|||
130004646|NCT02678416|467981841|FG000|Part 2|Withdrawal by Subject|1|||
130004647|NCT01848353|467981842|FG000|Phase 1|Withdrawal by Subject|3|||
130341085|NCT01403948|469221044|FG001|Overall Study|Refused cont. medication|0|||
130341086|NCT01403948|469221045|FG002|Overall Study|Refused cont. medication|0|||
130341087|NCT01403948|469221046|FG003|Overall Study|Refused cont. medication|0|||
130341088|NCT01403948|469221047|FG004|Overall Study|Refused cont. medication|1|||
130341089|NCT01403948|469221048|FG005|Overall Study|Refused cont. medication|0|||
130341090|NCT01403948|469221049|FG006|Overall Study|Refused cont. medication|0|||
130341091|NCT01403948|469221050|FG007|Overall Study|Refused cont. medication|0|||
130004648|NCT01848353|467981843|FG001|Phase 1|Withdrawal by Subject|1|||
130004649|NCT01848353|467981844|FG002|Phase 1|Withdrawal by Subject|0|||
130004650|NCT01848353|467981845|FG003|Phase 1|Withdrawal by Subject|0|||
130004651|NCT01848353|467981842|FG000|Phase 2|Withdrawal by Subject|3|||
130004652|NCT01848353|467981843|FG001|Phase 2|Withdrawal by Subject|2|||
130004653|NCT01848353|467981844|FG002|Phase 2|Withdrawal by Subject|0|||
130004654|NCT01848353|467981845|FG003|Phase 2|Withdrawal by Subject|0|||
130004655|NCT01848353|467981842|FG000|Phase 3|Withdrawal by Subject|1|||
130004656|NCT01848353|467981843|FG001|Phase 3|Withdrawal by Subject|1|||
130004657|NCT01848353|467981844|FG002|Phase 3|Withdrawal by Subject|0|||
130004658|NCT01848353|467981845|FG003|Phase 3|Withdrawal by Subject|0|||
130004659|NCT00935272|467981846|FG000|Overall Study|Lost to Follow-up|10|||
130004660|NCT00935272|467981847|FG001|Overall Study|Lost to Follow-up|3|||
130004661|NCT00935272|467981846|FG000|Overall Study|Withdrawal by Subject|8|||
130004662|NCT00935272|467981847|FG001|Overall Study|Withdrawal by Subject|2|||
130004663|NCT00935272|467981846|FG000|Overall Study|Physician Decision|1|||
130004664|NCT00935272|467981847|FG001|Overall Study|Physician Decision|0|||
130004665|NCT00935272|467981846|FG000|Overall Study|Protocol Violation|0|||
130004666|NCT00935272|467981847|FG001|Overall Study|Protocol Violation|1|||
130004667|NCT03492554|467981857|FG000|Overall Study|Protocol Violation|0|||
130004668|NCT03492554|467981858|FG001|Overall Study|Protocol Violation|14|||
130004669|NCT01478360|467981861|FG000|Overall Study|Lost to Follow-up|1|||
130004670|NCT01478360|467981862|FG001|Overall Study|Lost to Follow-up|0|||
130004671|NCT01478360|467981861|FG000|Overall Study|Adverse Event|0|||
130004672|NCT01478360|467981862|FG001|Overall Study|Adverse Event|1|||
130004673|NCT01478360|467981861|FG000|Overall Study|Administrative problems|1|||
130004674|NCT01478360|467981862|FG001|Overall Study|Administrative problems|2|||
130004675|NCT02289352|467981863|FG000|Overall Study|Withdrawal by Subject|1|||
130004676|NCT02289352|467981864|FG001|Overall Study|Withdrawal by Subject|1|||
130004677|NCT02289352|467981865|FG002|Overall Study|Withdrawal by Subject|0|||
130004678|NCT04340557|467981866|FG000|Overall Study|Transferred to ICU and/or death|1|||
130004679|NCT04340557|467981867|FG001|Overall Study|Transferred to ICU and/or death|2|||
130004680|NCT01221727|467981868|FG000|Overall Study|Physician Decision|2|||
130004681|NCT01221727|467981869|FG001|Overall Study|Physician Decision|0|||
130341092|NCT01403948|469221051|FG008|Overall Study|Refused cont. medication|0|||
130341093|NCT01403948|469221052|FG009|Overall Study|Refused cont. medication|1|||
130341094|NCT01403948|469221043|FG000|Overall Study|other than above|1|||
130341095|NCT01403948|469221044|FG001|Overall Study|other than above|2|||
130341096|NCT01403948|469221045|FG002|Overall Study|other than above|1|||
130341097|NCT01403948|469221046|FG003|Overall Study|other than above|0|||
130341098|NCT01403948|469221047|FG004|Overall Study|other than above|1|||
130341099|NCT01403948|469221048|FG005|Overall Study|other than above|1|||
130341100|NCT01403948|469221049|FG006|Overall Study|other than above|2|||
130341101|NCT01403948|469221050|FG007|Overall Study|other than above|0|||
130004682|NCT01221727|467981868|FG000|Overall Study|Withdrawal by Subject|1|||
130004683|NCT01221727|467981869|FG001|Overall Study|Withdrawal by Subject|1|||
130004684|NCT00529451|467981897|FG000|Overall Study|Subject withdrew consent|16|||
130004685|NCT00529451|467981898|FG001|Overall Study|Subject withdrew consent|21|||
130004686|NCT00529451|467981899|FG002|Overall Study|Subject withdrew consent|13|||
130004687|NCT00529451|467981900|FG003|Overall Study|Subject withdrew consent|12|||
130004688|NCT00529451|467981897|FG000|Overall Study|Adverse Event|9|||
130004689|NCT00529451|467981898|FG001|Overall Study|Adverse Event|16|||
130004690|NCT00529451|467981899|FG002|Overall Study|Adverse Event|14|||
130004691|NCT00529451|467981900|FG003|Overall Study|Adverse Event|8|||
130004692|NCT00529451|467981897|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
130341102|NCT01403948|469221051|FG008|Overall Study|other than above|0|||
130341103|NCT01403948|469221052|FG009|Overall Study|other than above|0|||
130004693|NCT00529451|467981898|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
130004694|NCT00529451|467981899|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
130341104|NCT00763698|469221053|FG000|Overall Study|Unsuccessful Implant|5|||
130341105|NCT00763698|469221053|FG000|Overall Study|Death|4|||
130341106|NCT00763698|469221053|FG000|Overall Study|Withdrawal by Subject|1|||
130341107|NCT01960907|469221056|FG000|Overall Study|Death|4|||
130341108|NCT01960907|469221057|FG001|Overall Study|Death|3|||
130341109|NCT01960907|469221056|FG000|Overall Study|Withdrawal by Subject|32|||
130004695|NCT00529451|467981900|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
130004696|NCT00529451|467981897|FG000|Overall Study|Lost to Follow-up|4|||
130004697|NCT00529451|467981898|FG001|Overall Study|Lost to Follow-up|7|||
130004698|NCT00529451|467981899|FG002|Overall Study|Lost to Follow-up|4|||
130341110|NCT01960907|469221057|FG001|Overall Study|Withdrawal by Subject|42|||
130341111|NCT00080899|469221058|FG000|Overall Study|Adverse Event|1|||
130004699|NCT00529451|467981900|FG003|Overall Study|Lost to Follow-up|4|||
130004700|NCT00529451|467981897|FG000|Overall Study|Protocol deviation|1|||
130004701|NCT00529451|467981898|FG001|Overall Study|Protocol deviation|1|||
130004702|NCT00529451|467981899|FG002|Overall Study|Protocol deviation|4|||
130341112|NCT00717236|469221059|FG000|Double-Blind Period|Adverse Event|33|||
130341113|NCT00717236|469221060|FG001|Double-Blind Period|Adverse Event|6|||
130341114|NCT00717236|469221059|FG000|Double-Blind Period|Lack of Efficacy|6|||
130004703|NCT00529451|467981900|FG003|Overall Study|Protocol deviation|1|||
130004704|NCT00529451|467981897|FG000|Overall Study|Administrative problems|1|||
130004705|NCT00529451|467981898|FG001|Overall Study|Administrative problems|1|||
130004706|NCT00529451|467981899|FG002|Overall Study|Administrative problems|0|||
130004707|NCT00529451|467981900|FG003|Overall Study|Administrative problems|2|||
130004708|NCT00911625|467981901|FG000|Overall Study|Lost to Follow-up|7|||
130004709|NCT00911625|467981902|FG001|Overall Study|Lost to Follow-up|0|||
130004710|NCT01289821|467981905|FG000|Treatment Period|Withdrawal by Subject|1|||
130004711|NCT01289821|467981905|FG000|Treatment Period|Physician Decision|3|||
130004712|NCT01289821|467981905|FG000|Treatment Period|Adverse Event|4|||
130004713|NCT01289821|467981905|FG000|Treatment Period|Radiological Progression|43|||
130004714|NCT01289821|467981905|FG000|Treatment Period|Clinical Progression|2|||
130004715|NCT01289821|467981905|FG000|Treatment Period|Therapeutic procedure required|1|||
130004716|NCT01289821|467981905|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
130004717|NCT01289821|467981905|FG000|Safety Follow-up Period|Protocol Violation|3|||
130004718|NCT01289821|467981905|FG000|Safety Follow-up Period|Unspecified reason|1|||
130004719|NCT01289821|467981905|FG000|Survival Follow-up Period|Protocol Violation|1|||
130004720|NCT01289821|467981905|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
130004721|NCT01289821|467981905|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
130004722|NCT00590044|467981909|FG000|Overall Study|Withdrawal by Subject|2|||
130004723|NCT00590044|467981910|FG001|Overall Study|Withdrawal by Subject|2|||
130004724|NCT00590044|467981909|FG000|Overall Study|wrong insulin arm assigned|1|||
130004725|NCT00590044|467981910|FG001|Overall Study|wrong insulin arm assigned|0|||
130004726|NCT00590044|467981909|FG000|Overall Study|Protocol Violation|1|||
130004727|NCT00590044|467981910|FG001|Overall Study|Protocol Violation|0|||
130004728|NCT01010633|467981916|FG000|Overall Study|Adverse Event|1|||
130004729|NCT01010633|467981917|FG001|Overall Study|Adverse Event|1|||
130004730|NCT01010633|467981916|FG000|Overall Study|Protocol Violation|1|||
130004731|NCT01010633|467981917|FG001|Overall Study|Protocol Violation|2|||
130004732|NCT01010633|467981916|FG000|Overall Study|Withdrawal by Subject|2|||
130004733|NCT01010633|467981917|FG001|Overall Study|Withdrawal by Subject|1|||
130004734|NCT01010633|467981916|FG000|Overall Study|Investigator decision|0|||
130004735|NCT01010633|467981917|FG001|Overall Study|Investigator decision|1|||
130004736|NCT02463071|467981918|FG000|Overall Study|Adverse Event|3|||
130004737|NCT02463071|467981919|FG001|Overall Study|Adverse Event|5|||
130004738|NCT02463071|467981920|FG002|Overall Study|Adverse Event|1|||
130004739|NCT02463071|467981918|FG000|Overall Study|Death|1|||
130004740|NCT02463071|467981919|FG001|Overall Study|Death|0|||
130004741|NCT02463071|467981920|FG002|Overall Study|Death|0|||
130004742|NCT02463071|467981918|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130004743|NCT02463071|467981919|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130004744|NCT02463071|467981920|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130004745|NCT02463071|467981918|FG000|Overall Study|Reason not specified|7|||
130004746|NCT02463071|467981919|FG001|Overall Study|Reason not specified|9|||
130004747|NCT02463071|467981920|FG002|Overall Study|Reason not specified|4|||
130004748|NCT02463071|467981918|FG000|Overall Study|Protocol Violation|0|||
130004749|NCT02463071|467981919|FG001|Overall Study|Protocol Violation|2|||
130004750|NCT02463071|467981920|FG002|Overall Study|Protocol Violation|0|||
130004751|NCT02463071|467981918|FG000|Overall Study|Lost to Follow-up|0|||
130004752|NCT02463071|467981919|FG001|Overall Study|Lost to Follow-up|0|||
130341115|NCT00717236|469221060|FG001|Double-Blind Period|Lack of Efficacy|6|||
130004753|NCT02463071|467981920|FG002|Overall Study|Lost to Follow-up|1|||
130004754|NCT01245387|467981921|FG000|Overall Study|Lost to Follow-up|106|||
130004755|NCT01245387|467981921|FG000|Overall Study|Lack of Efficacy|195|||
130004756|NCT01245387|467981921|FG000|Overall Study|Adverse Event|9|||
130004757|NCT01245387|467981921|FG000|Overall Study|Death|3|||
130004758|NCT01245387|467981921|FG000|Overall Study|Other|131|||
130004759|NCT01245387|467981921|FG000|Overall Study|Missing discontinuation status|369|||
130004760|NCT00757003|467981922|FG000|Overall Study|Death|33|||
130004761|NCT00757003|467981922|FG000|Overall Study|Lost to Follow-up|9|||
130004762|NCT00757003|467981922|FG000|Overall Study|Withdrawal by Subject|4|||
130004763|NCT00757003|467981922|FG000|Overall Study|Surgically explanted|2|||
130004764|NCT00757003|467981922|FG000|Overall Study|Not implanted|1|||
130341116|NCT00717236|469221059|FG000|Double-Blind Period|Lost to Follow-up|3|||
130341117|NCT00717236|469221060|FG001|Double-Blind Period|Lost to Follow-up|5|||
130004765|NCT02146599|467981938|FG000|Overall Study|Failed to meet inclusion criteria|5|||
130004766|NCT03061175|467981942|FG000|Baseline|Participant was deemed ineligible|1|||
130004767|NCT03061175|467981943|FG001|Baseline|Participant was deemed ineligible|0|||
130004768|NCT03061175|467981942|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
130004769|NCT03061175|467981943|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
130004770|NCT03061175|467981942|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
130004771|NCT03061175|467981943|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
130004772|NCT03061175|467981942|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
130004773|NCT03061175|467981943|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
130004774|NCT02243865|467981944|FG000|Overall Study|Protocol Violation|1|||
130004775|NCT02243865|467981945|FG001|Overall Study|Protocol Violation|3|||
130004776|NCT02243865|467981944|FG000|Overall Study|Lost to Follow-up|1|||
130004777|NCT02243865|467981945|FG001|Overall Study|Lost to Follow-up|1|||
130004778|NCT02243865|467981944|FG000|Overall Study|Withdrawal by Subject|1|||
130004779|NCT02243865|467981945|FG001|Overall Study|Withdrawal by Subject|0|||
130004780|NCT02243865|467981944|FG000|Overall Study|Adverse Event|1|||
130004781|NCT02243865|467981945|FG001|Overall Study|Adverse Event|1|||
130004782|NCT01235793|467981949|FG000|Overall Study|Death|6|||
130004783|NCT01159912|467981950|FG000|Overall Study|Adverse Event|2|||
130004784|NCT01159912|467981951|FG001|Overall Study|Adverse Event|2|||
130004785|NCT01159912|467981952|FG002|Overall Study|Adverse Event|3|||
130004786|NCT01159912|467981950|FG000|Overall Study|Lack of Efficacy|23|||
130004787|NCT01159912|467981951|FG001|Overall Study|Lack of Efficacy|15|||
130004788|NCT01159912|467981952|FG002|Overall Study|Lack of Efficacy|14|||
130004789|NCT01159912|467981950|FG000|Overall Study|Protocol Violation|1|||
130004790|NCT01159912|467981951|FG001|Overall Study|Protocol Violation|2|||
130004791|NCT01159912|467981952|FG002|Overall Study|Protocol Violation|3|||
130004792|NCT01159912|467981950|FG000|Overall Study|Lost to Follow-up|4|||
130004793|NCT01159912|467981951|FG001|Overall Study|Lost to Follow-up|0|||
130004794|NCT01159912|467981952|FG002|Overall Study|Lost to Follow-up|0|||
130004795|NCT01159912|467981950|FG000|Overall Study|Physician Decision|0|||
130004796|NCT01159912|467981951|FG001|Overall Study|Physician Decision|0|||
130004797|NCT01159912|467981952|FG002|Overall Study|Physician Decision|3|||
130004798|NCT01159912|467981950|FG000|Overall Study|Withdrawal by Subject|10|||
130004799|NCT01159912|467981951|FG001|Overall Study|Withdrawal by Subject|3|||
130004800|NCT01159912|467981952|FG002|Overall Study|Withdrawal by Subject|3|||
130004801|NCT04050670|467984560|FG000|Period 3|Physician Decision|0|||
130004802|NCT04050670|467984561|FG001|Period 3|Physician Decision|1|||
130004803|NCT04050670|467984562|FG002|Period 3|Physician Decision|0|||
130004804|NCT01168973|467984569|FG000|Overall Study|Progressive Disease|341|||
130004805|NCT01168973|467984570|FG001|Overall Study|Progressive Disease|429|||
130004806|NCT01168973|467984569|FG000|Overall Study|Adverse Event|94|||
130004807|NCT01168973|467984570|FG001|Overall Study|Adverse Event|55|||
130004808|NCT01168973|467984569|FG000|Overall Study|Withdrawal by Subject|90|||
130004809|NCT01168973|467984570|FG001|Overall Study|Withdrawal by Subject|53|||
130004810|NCT01168973|467984569|FG000|Overall Study|Death|42|||
130004811|NCT01168973|467984570|FG001|Overall Study|Death|45|||
130004812|NCT01168973|467984569|FG000|Overall Study|Physician Decision|37|||
130004813|NCT01168973|467984570|FG001|Overall Study|Physician Decision|19|||
130004814|NCT01168973|467984569|FG000|Overall Study|Sponsor Decision|2|||
130004815|NCT01168973|467984570|FG001|Overall Study|Sponsor Decision|1|||
130004816|NCT01168973|467984569|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
130004817|NCT01168973|467984570|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
130004818|NCT02230254|467984571|FG000|Overall Study|Lost to Follow-up|3|||
130004819|NCT02023242|467984572|FG000|Overall Study|Lost to Follow-up|3|||
130004820|NCT02023242|467984573|FG001|Overall Study|Lost to Follow-up|1|||
130004821|NCT02023242|467984572|FG000|Overall Study|Death|0|||
130004822|NCT02023242|467984573|FG001|Overall Study|Death|1|||
130004823|NCT00388505|467984577|FG000|Overall Study|Adverse Event or Death|43|||
130004824|NCT00388505|467984578|FG001|Overall Study|Adverse Event or Death|17|||
130004825|NCT00388505|467984577|FG000|Overall Study|Withdrawal by Subject|24|||
130004826|NCT00388505|467984578|FG001|Overall Study|Withdrawal by Subject|9|||
130004827|NCT00388505|467984577|FG000|Overall Study|Lost to Follow-up|5|||
130004828|NCT00388505|467984578|FG001|Overall Study|Lost to Follow-up|3|||
130004829|NCT00388505|467984577|FG000|Overall Study|Inappropriate Enrollment|0|||
130341118|NCT00717236|469221059|FG000|Double-Blind Period|Withdrawal by Subject|10|||
130004830|NCT00388505|467984578|FG001|Overall Study|Inappropriate Enrollment|1|||
130004831|NCT00388505|467984577|FG000|Overall Study|Administrative Reason|1|||
130004832|NCT00388505|467984578|FG001|Overall Study|Administrative Reason|0|||
130004833|NCT00388505|467984577|FG000|Overall Study|Protocol Violation|6|||
130004834|NCT00388505|467984578|FG001|Overall Study|Protocol Violation|5|||
130004835|NCT00388505|467984577|FG000|Overall Study|Unable to classify|4|||
130004836|NCT00388505|467984578|FG001|Overall Study|Unable to classify|3|||
130004837|NCT04854434|467984581|FG000|Overall Study|Death|1|||
130004838|NCT04854434|467984582|FG001|Overall Study|Death|3|||
130004839|NCT04854434|467984583|FG002|Overall Study|Death|4|||
130004840|NCT04854434|467984581|FG000|Overall Study|Study Terminated by Sponsor|2|||
130004841|NCT04854434|467984582|FG001|Overall Study|Study Terminated by Sponsor|0|||
130004842|NCT04854434|467984583|FG002|Overall Study|Study Terminated by Sponsor|0|||
130004843|NCT04854434|467984581|FG000|Overall Study|Other|1|||
130004844|NCT04854434|467984582|FG001|Overall Study|Other|1|||
130004845|NCT04854434|467984583|FG002|Overall Study|Other|0|||
130004846|NCT01274715|467984584|FG000|Overall Study|Lost to Follow-up|1|||
130004847|NCT01274715|467984584|FG000|Overall Study|After consent, met exclusion criteria.|1|||
130004848|NCT01274715|467984584|FG000|Overall Study|After consent, met exclusion criteria.|1|||
130004849|NCT01274715|467984584|FG000|Overall Study|After consent, met exclusion criteria.|1|||
130004850|NCT02285920|467984586|FG000|Overall Study|Kidney transplantation|2|||
130004851|NCT02285920|467984587|FG001|Overall Study|Kidney transplantation|2|||
130004852|NCT02285920|467984588|FG002|Overall Study|Kidney transplantation|2|||
130004853|NCT02285920|467984589|FG003|Overall Study|Kidney transplantation|0|||
130004854|NCT02285920|467984586|FG000|Overall Study|Change to peritoneal dialysis|0|||
130004855|NCT02285920|467984587|FG001|Overall Study|Change to peritoneal dialysis|0|||
130004856|NCT02285920|467984588|FG002|Overall Study|Change to peritoneal dialysis|1|||
130004857|NCT02285920|467984589|FG003|Overall Study|Change to peritoneal dialysis|0|||
130004858|NCT02285920|467984586|FG000|Overall Study|Transfer to non-participating unit|0|||
130004859|NCT02285920|467984587|FG001|Overall Study|Transfer to non-participating unit|1|||
130004860|NCT02285920|467984588|FG002|Overall Study|Transfer to non-participating unit|0|||
130004861|NCT02285920|467984589|FG003|Overall Study|Transfer to non-participating unit|0|||
130004862|NCT02285920|467984586|FG000|Overall Study|Dialysis discontinuation|0|||
130004863|NCT02285920|467984587|FG001|Overall Study|Dialysis discontinuation|1|||
130004864|NCT02285920|467984588|FG002|Overall Study|Dialysis discontinuation|0|||
130004865|NCT02285920|467984589|FG003|Overall Study|Dialysis discontinuation|0|||
130004866|NCT02285920|467984586|FG000|Overall Study|Death|2|||
130004867|NCT02285920|467984587|FG001|Overall Study|Death|0|||
130004868|NCT02285920|467984588|FG002|Overall Study|Death|2|||
130004869|NCT02285920|467984589|FG003|Overall Study|Death|1|||
130004870|NCT01480284|467984590|FG000|Overall Study|Withdrawal by Subject|2|||
130004871|NCT01480284|467984591|FG001|Overall Study|Withdrawal by Subject|0|||
130004872|NCT01480284|467984590|FG000|Overall Study|Adverse Event|1|||
130004873|NCT01480284|467984591|FG001|Overall Study|Adverse Event|0|||
130004874|NCT01480284|467984590|FG000|Overall Study|Study closed/terminated|3|||
130004875|NCT01480284|467984591|FG001|Overall Study|Study closed/terminated|0|||
130004876|NCT01480284|467984590|FG000|Overall Study|Lost to Follow-up|1|||
130004877|NCT01480284|467984591|FG001|Overall Study|Lost to Follow-up|0|||
130004878|NCT01480284|467984590|FG000|Overall Study|Physician Decision|1|||
130004879|NCT01480284|467984591|FG001|Overall Study|Physician Decision|0|||
130004880|NCT01641237|467984593|FG000|Period II|Withdrawal by Subject|1|||
130004881|NCT01641237|467984594|FG001|Period II|Withdrawal by Subject|0|||
130341119|NCT00717236|469221060|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130341120|NCT00717236|469221059|FG000|Double-Blind Period|Loss of efficacy|3|||
130341121|NCT00717236|469221060|FG001|Double-Blind Period|Loss of efficacy|0|||
130341122|NCT00717236|469221059|FG000|Double-Blind Period|Other: Death|1|||
130341123|NCT00717236|469221060|FG001|Double-Blind Period|Other: Death|0|||
130341124|NCT00717236|469221059|FG000|Double-Blind Period|Other: Pregnancy|1|||
130341125|NCT00717236|469221060|FG001|Double-Blind Period|Other: Pregnancy|0|||
130341126|NCT00717236|469221059|FG000|Double-Blind Period|Other: Protocol Violation|2|||
130341127|NCT00717236|469221060|FG001|Double-Blind Period|Other: Protocol Violation|0|||
130341128|NCT00717236|469221059|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
130341129|NCT00717236|469221060|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
130341130|NCT00717236|469221059|FG000|Double-Blind Period|Other: Site withdrew|2|||
130341131|NCT00717236|469221060|FG001|Double-Blind Period|Other: Site withdrew|0|||
130341132|NCT00717236|469221059|FG000|Double-Blind Period|Other: Screening failure|1|||
130341133|NCT00717236|469221060|FG001|Double-Blind Period|Other: Screening failure|0|||
130341134|NCT00717236|469221059|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
130341135|NCT00717236|469221060|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
130341136|NCT00717236|469221059|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
130341137|NCT00717236|469221060|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
130341138|NCT00717236|469221059|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
130004882|NCT01641237|467984595|FG002|Period II|Withdrawal by Subject|0|||
130004883|NCT01641237|467984596|FG003|Period II|Withdrawal by Subject|0|||
130004884|NCT01641237|467984593|FG000|Period III|Lost to Follow-up|1|||
130004885|NCT01641237|467984594|FG001|Period III|Lost to Follow-up|0|||
130004886|NCT01641237|467984595|FG002|Period III|Lost to Follow-up|0|||
130004887|NCT01641237|467984596|FG003|Period III|Lost to Follow-up|0|||
130004888|NCT02716675|467984608|FG000|Overall Study|Death|2|||
130004889|NCT02716675|467984609|FG001|Overall Study|Death|3|||
130004890|NCT02716675|467984610|FG002|Overall Study|Death|0|||
130004891|NCT02716675|467984608|FG000|Overall Study|Physician Decision|2|||
130004892|NCT02716675|467984609|FG001|Overall Study|Physician Decision|1|||
130004893|NCT02716675|467984610|FG002|Overall Study|Physician Decision|1|||
130004894|NCT02716675|467984608|FG000|Overall Study|Lost to Follow-up|100|||
130004895|NCT02716675|467984609|FG001|Overall Study|Lost to Follow-up|87|||
130341139|NCT00717236|469221060|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
130341140|NCT00717236|469221059|FG000|Double-Blind Period|Other: History of cancer|1|||
130004896|NCT02716675|467984610|FG002|Overall Study|Lost to Follow-up|99|||
130004897|NCT02716675|467984608|FG000|Overall Study|Withdrawal by Subject|22|||
130004898|NCT02716675|467984609|FG001|Overall Study|Withdrawal by Subject|25|||
130004899|NCT02716675|467984610|FG002|Overall Study|Withdrawal by Subject|20|||
130004900|NCT02716675|467984608|FG000|Overall Study|Protocol Violation|0|||
130004901|NCT02716675|467984609|FG001|Overall Study|Protocol Violation|3|||
130004902|NCT02716675|467984610|FG002|Overall Study|Protocol Violation|1|||
130004903|NCT02716675|467984608|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
130004904|NCT02716675|467984609|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
130341141|NCT00717236|469221060|FG001|Double-Blind Period|Other: History of cancer|0|||
130341142|NCT00717236|469221059|FG000|Double-Blind Period|Other: Sponsor request|1|||
130004905|NCT02716675|467984610|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
130004906|NCT02716675|467984608|FG000|Overall Study|Other|38|||
130004907|NCT02716675|467984609|FG001|Overall Study|Other|47|||
130004908|NCT02716675|467984610|FG002|Overall Study|Other|48|||
130004909|NCT00709111|467984611|FG000|Overall Study|Withdrawal by Subject|1|||
130004910|NCT00709111|467984611|FG000|Overall Study|Unable to attend clinic visits|1|||
130004911|NCT01301456|467984612|FG000|Stage 1|Withdrawal by Subject|0|||
130004912|NCT01301456|467984613|FG001|Stage 1|Withdrawal by Subject|0|||
130004913|NCT01301456|467984614|FG002|Stage 1|Withdrawal by Subject|1|||
130004914|NCT01301456|467984615|FG003|Stage 1|Withdrawal by Subject|0|||
130004915|NCT01301456|467984616|FG004|Stage 1|Withdrawal by Subject|1|||
130004916|NCT01301456|467984617|FG005|Stage 1|Withdrawal by Subject|0|||
130004917|NCT01301456|467984618|FG006|Stage 1|Withdrawal by Subject|0|||
130004918|NCT01301456|467984619|FG007|Stage 1|Withdrawal by Subject|0|||
130004919|NCT01301456|467984620|FG008|Stage 1|Withdrawal by Subject|0|||
130004920|NCT01301456|467984621|FG009|Stage 1|Withdrawal by Subject|0|||
130004921|NCT01301456|467984622|FG010|Stage 1|Withdrawal by Subject|0|||
130004922|NCT01301456|467984623|FG011|Stage 1|Withdrawal by Subject|0|||
130004923|NCT01301456|467984612|FG000|Stage 1|Randomized but not treated|0|||
130004924|NCT01301456|467984613|FG001|Stage 1|Randomized but not treated|0|||
130341143|NCT00717236|469221060|FG001|Double-Blind Period|Other: Sponsor request|0|||
130341144|NCT00717236|469221059|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
130341145|NCT00717236|469221060|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
130341146|NCT00717236|469221059|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
130341147|NCT00717236|469221060|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
130341148|NCT00717236|469221059|FG000|Double-Blind Period|Other: Subject moved|1|||
130341149|NCT00717236|469221060|FG001|Double-Blind Period|Other: Subject moved|1|||
130341150|NCT00717236|469221059|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
130341151|NCT00717236|469221060|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
130341152|NCT00717236|469221059|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
130341153|NCT00717236|469221060|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
130341154|NCT00717236|469221059|FG000|Double-Blind Period|Other: Transportation problems|0|||
130341155|NCT00717236|469221060|FG001|Double-Blind Period|Other: Transportation problems|1|||
130341156|NCT00717236|469221059|FG000|Double-Blind Period|Other: Investigator Decision|0|||
130341157|NCT00717236|469221060|FG001|Double-Blind Period|Other: Investigator Decision|1|||
130341158|NCT00717236|469221059|FG000|Open-Label Period|Adverse Event|29|||
130341159|NCT00717236|469221060|FG001|Open-Label Period|Adverse Event|4|||
130341160|NCT00717236|469221059|FG000|Open-Label Period|Lack of Efficacy|30|||
130341161|NCT00717236|469221060|FG001|Open-Label Period|Lack of Efficacy|8|||
130341162|NCT00717236|469221059|FG000|Open-Label Period|Lost to Follow-up|28|||
130341163|NCT00717236|469221060|FG001|Open-Label Period|Lost to Follow-up|4|||
130341164|NCT00717236|469221059|FG000|Open-Label Period|Withdrawal by Subject|20|||
130341165|NCT00717236|469221060|FG001|Open-Label Period|Withdrawal by Subject|2|||
130341166|NCT00717236|469221059|FG000|Open-Label Period|Loss of Efficacy|6|||
130341167|NCT00717236|469221060|FG001|Open-Label Period|Loss of Efficacy|1|||
130341168|NCT00717236|469221059|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
130341169|NCT00717236|469221060|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
130341170|NCT00717236|469221059|FG000|Open-Label Period|Other: Lack of Compliance|1|||
130341171|NCT00717236|469221060|FG001|Open-Label Period|Other: Lack of Compliance|1|||
130341172|NCT00717236|469221059|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
130341173|NCT00717236|469221060|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
130341174|NCT00717236|469221059|FG000|Open-Label Period|Other: Moved|1|||
130004925|NCT01301456|467984614|FG002|Stage 1|Randomized but not treated|0|||
130004926|NCT01301456|467984615|FG003|Stage 1|Randomized but not treated|0|||
130004927|NCT01301456|467984616|FG004|Stage 1|Randomized but not treated|0|||
130004928|NCT01301456|467984617|FG005|Stage 1|Randomized but not treated|0|||
130004929|NCT01301456|467984618|FG006|Stage 1|Randomized but not treated|1|||
130004930|NCT01301456|467984619|FG007|Stage 1|Randomized but not treated|0|||
130004931|NCT01301456|467984620|FG008|Stage 1|Randomized but not treated|0|||
130341175|NCT00717236|469221060|FG001|Open-Label Period|Other: Moved|0|||
130341176|NCT00717236|469221059|FG000|Open-Label Period|Other: Investigator Decision|1|||
130341177|NCT00717236|469221060|FG001|Open-Label Period|Other: Investigator Decision|0|||
130341178|NCT00717236|469221059|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
130341179|NCT00717236|469221060|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
130341180|NCT00717236|469221059|FG000|Open-Label Period|Other: Sponsor Request|3|||
130341181|NCT00717236|469221060|FG001|Open-Label Period|Other: Sponsor Request|0|||
130341182|NCT00717236|469221059|FG000|Open-Label Period|Other: Cataract Surgery|1|||
130341183|NCT00717236|469221060|FG001|Open-Label Period|Other: Cataract Surgery|0|||
130341184|NCT00717236|469221059|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
130341185|NCT00717236|469221060|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
130341186|NCT00717236|469221059|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
130341187|NCT00717236|469221060|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
130341188|NCT00717236|469221059|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
130341189|NCT00717236|469221060|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
130341190|NCT00475982|469221061|FG000|Overall Study|surgery rescheduled|7|||
130341191|NCT00475982|469221062|FG001|Overall Study|surgery rescheduled|3|||
130341192|NCT00783198|469221067|FG000|Overall Study|Adverse Event|15|||
130341193|NCT00783198|469221068|FG001|Overall Study|Adverse Event|19|||
130341194|NCT00783198|469221069|FG002|Overall Study|Adverse Event|3|||
130341195|NCT00783198|469221067|FG000|Overall Study|Lost to Follow-up|11|||
130341196|NCT00783198|469221068|FG001|Overall Study|Lost to Follow-up|1|||
130341197|NCT00783198|469221069|FG002|Overall Study|Lost to Follow-up|7|||
130004932|NCT01301456|467984621|FG009|Stage 1|Randomized but not treated|0|||
130341198|NCT00783198|469221067|FG000|Overall Study|Withdrawal by Subject|22|||
130341199|NCT00783198|469221068|FG001|Overall Study|Withdrawal by Subject|14|||
130341200|NCT00783198|469221069|FG002|Overall Study|Withdrawal by Subject|20|||
130341201|NCT00783198|469221067|FG000|Overall Study|Noncompliance with protocol|7|||
130341202|NCT00783198|469221068|FG001|Overall Study|Noncompliance with protocol|7|||
130341203|NCT00783198|469221069|FG002|Overall Study|Noncompliance with protocol|10|||
130341204|NCT00783198|469221067|FG000|Overall Study|Did not meet protocol eligibility|0|||
130341205|NCT00783198|469221068|FG001|Overall Study|Did not meet protocol eligibility|1|||
130341206|NCT00783198|469221069|FG002|Overall Study|Did not meet protocol eligibility|0|||
130341207|NCT00783198|469221067|FG000|Overall Study|Administrative|2|||
130341208|NCT00783198|469221068|FG001|Overall Study|Administrative|1|||
130341209|NCT00783198|469221069|FG002|Overall Study|Administrative|2|||
130341210|NCT03704636|469221070|FG000|Overall Study|Inadequate Venous Flow|3|||
130341211|NCT00539188|469221073|FG000|Overall Study|Withdrawal by Subject|1|||
130341212|NCT00539188|469221074|FG001|Overall Study|Withdrawal by Subject|0|||
130341213|NCT00539188|469221073|FG000|Overall Study|Lost to Follow-up|2|||
130341214|NCT00539188|469221074|FG001|Overall Study|Lost to Follow-up|1|||
130341215|NCT04784442|469221075|FG000|Overall Study|Adverse Event|1|||
130341216|NCT04784442|469221076|FG001|Overall Study|Adverse Event|0|||
130341217|NCT04784442|469221077|FG002|Overall Study|Adverse Event|2|||
130341218|NCT04784442|469221078|FG003|Overall Study|Adverse Event|1|||
130341219|NCT04784442|469221075|FG000|Overall Study|Protocol Violation|1|||
130341220|NCT04784442|469221076|FG001|Overall Study|Protocol Violation|0|||
130341221|NCT04784442|469221077|FG002|Overall Study|Protocol Violation|0|||
130341222|NCT04784442|469221078|FG003|Overall Study|Protocol Violation|0|||
130341223|NCT04784442|469221075|FG000|Overall Study|Non-compliance with study drug|1|||
130341224|NCT04784442|469221076|FG001|Overall Study|Non-compliance with study drug|0|||
130341225|NCT04784442|469221077|FG002|Overall Study|Non-compliance with study drug|0|||
130341226|NCT04784442|469221078|FG003|Overall Study|Non-compliance with study drug|0|||
130341227|NCT00852371|469221081|FG000|Overall Study|Lost to Follow-up|2|||
130341228|NCT00852371|469221082|FG001|Overall Study|Lost to Follow-up|3|||
130341229|NCT00852371|469221083|FG002|Overall Study|Lost to Follow-up|4|||
130341230|NCT00852371|469221084|FG003|Overall Study|Lost to Follow-up|2|||
130004933|NCT01301456|467984622|FG010|Stage 1|Randomized but not treated|0|||
130004934|NCT01301456|467984623|FG011|Stage 1|Randomized but not treated|0|||
130004935|NCT01301456|467984612|FG000|Stage 2|Adverse Event|0|||
130004936|NCT01301456|467984613|FG001|Stage 2|Adverse Event|0|||
130004937|NCT01301456|467984614|FG002|Stage 2|Adverse Event|0|||
130004938|NCT01301456|467984615|FG003|Stage 2|Adverse Event|0|||
130004939|NCT01301456|467984616|FG004|Stage 2|Adverse Event|0|||
130004940|NCT01301456|467984617|FG005|Stage 2|Adverse Event|0|||
130004941|NCT01301456|467984618|FG006|Stage 2|Adverse Event|0|||
130004942|NCT01301456|467984619|FG007|Stage 2|Adverse Event|0|||
130341231|NCT01590758|469221085|FG000|Overall Study|Withdrawal by Subject|0|||
130341232|NCT01590758|469221086|FG001|Overall Study|Withdrawal by Subject|3|||
130341233|NCT01590758|469221085|FG000|Overall Study|Physician Decision|1|||
130341234|NCT01590758|469221086|FG001|Overall Study|Physician Decision|2|||
130004943|NCT01301456|467984620|FG008|Stage 2|Adverse Event|0|||
130004944|NCT01301456|467984621|FG009|Stage 2|Adverse Event|0|||
130004945|NCT01301456|467984622|FG010|Stage 2|Adverse Event|1|||
130341235|NCT01590758|469221085|FG000|Overall Study|Lost to Follow-up|4|||
130341236|NCT01590758|469221086|FG001|Overall Study|Lost to Follow-up|2|||
130341237|NCT04525885|469221087|FG000|Overall Study|Screen Failure|1|||
130341238|NCT04525885|469221088|FG001|Overall Study|Screen Failure|0|||
130341239|NCT04525885|469221089|FG002|Overall Study|Screen Failure|0|||
130341240|NCT04525885|469221087|FG000|Overall Study|Withdrawal by Subject|14|||
130341241|NCT04525885|469221088|FG001|Overall Study|Withdrawal by Subject|6|||
130341242|NCT04525885|469221089|FG002|Overall Study|Withdrawal by Subject|20|||
130004946|NCT01301456|467984623|FG011|Stage 2|Adverse Event|0|||
130004947|NCT00915772|467984628|FG000|Overall Study|Adverse Event|12|||
130004948|NCT00915772|467984629|FG001|Overall Study|Adverse Event|13|||
130004949|NCT00915772|467984630|FG002|Overall Study|Adverse Event|11|||
130004950|NCT00915772|467984628|FG000|Overall Study|Protocol Violation|4|||
130004951|NCT00915772|467984629|FG001|Overall Study|Protocol Violation|1|||
130341243|NCT04525885|469221087|FG000|Overall Study|Physician Decision|1|||
130341244|NCT04525885|469221088|FG001|Overall Study|Physician Decision|0|||
130341245|NCT04525885|469221089|FG002|Overall Study|Physician Decision|1|||
130341246|NCT02756806|469221090|FG000|Overall Study|Study terminated early|5|||
130341247|NCT02717832|469221091|FG000|Overall Study|Inability to place IV|3|||
130341248|NCT01008423|469221092|FG000|Overall Study|Adverse Event|13|||
130341249|NCT01008423|469221093|FG001|Overall Study|Adverse Event|6|||
130341250|NCT01008423|469221092|FG000|Overall Study|Withdrawal by Subject|4|||
130341251|NCT01008423|469221093|FG001|Overall Study|Withdrawal by Subject|7|||
130341252|NCT01008423|469221092|FG000|Overall Study|Lost to Follow-up|0|||
130341253|NCT01008423|469221093|FG001|Overall Study|Lost to Follow-up|2|||
130341254|NCT01008423|469221092|FG000|Overall Study|Low Cortisol|0|||
130341255|NCT01008423|469221093|FG001|Overall Study|Low Cortisol|1|||
130341256|NCT01008423|469221092|FG000|Overall Study|Lack of Efficacy|0|||
130341257|NCT01008423|469221093|FG001|Overall Study|Lack of Efficacy|5|||
130341258|NCT01008423|469221092|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
130341259|NCT01008423|469221093|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
130341260|NCT01008423|469221092|FG000|Overall Study|Personal Conflict|1|||
130341261|NCT01008423|469221093|FG001|Overall Study|Personal Conflict|0|||
130341262|NCT01008423|469221092|FG000|Overall Study|Other|0|||
130341263|NCT01008423|469221093|FG001|Overall Study|Other|1|||
130341264|NCT00934843|469221095|FG000|Overall Study|Protocol Violation|0|||
130341265|NCT00934843|469221096|FG001|Overall Study|Protocol Violation|1|||
130341266|NCT01144299|469221097|FG000|Overall Study|Lost to Follow-up|1|||
130341267|NCT01144299|469221098|FG001|Overall Study|Lost to Follow-up|0|||
130341268|NCT01144299|469221097|FG000|Overall Study|Withdrawal by Subject|1|||
130341269|NCT01144299|469221098|FG001|Overall Study|Withdrawal by Subject|0|||
130341270|NCT03698591|469221101|FG000|Overall Study|Withdrawal by Subject|2|||
130341271|NCT03698591|469221102|FG001|Overall Study|Withdrawal by Subject|2|||
130341272|NCT03698591|469221101|FG000|Overall Study|Failed drug screen|1|||
130341273|NCT03698591|469221102|FG001|Overall Study|Failed drug screen|1|||
130341274|NCT03698591|469221101|FG000|Overall Study|Failed health screen|0|||
130341275|NCT03698591|469221102|FG001|Overall Study|Failed health screen|1|||
130341276|NCT03698591|469221101|FG000|Overall Study|Ineligible for financial compensation|1|||
130341277|NCT03698591|469221102|FG001|Overall Study|Ineligible for financial compensation|0|||
130341278|NCT03698591|469221101|FG000|Overall Study|Equipment Error|1|||
130341279|NCT03698591|469221102|FG001|Overall Study|Equipment Error|0|||
130341280|NCT03698591|469221101|FG000|Overall Study|Could not establish TMS dosage|0|||
130341281|NCT03698591|469221102|FG001|Overall Study|Could not establish TMS dosage|1|||
130341282|NCT01675167|469221104|FG000|Open-label Titration Phase|Adverse Event|81|||
130341283|NCT01675167|469221105|FG001|Open-label Titration Phase|Adverse Event|0|||
130341284|NCT01675167|469221106|FG002|Open-label Titration Phase|Adverse Event|0|||
130341285|NCT01675167|469221104|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
130341286|NCT01675167|469221105|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
130341287|NCT01675167|469221106|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
130341288|NCT01675167|469221104|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
130341289|NCT01675167|469221105|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
130341290|NCT01675167|469221106|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
130341291|NCT01675167|469221104|FG000|Open-label Titration Phase|Protocol Violation|43|||
130341292|NCT01675167|469221105|FG001|Open-label Titration Phase|Protocol Violation|0|||
130341293|NCT01675167|469221106|FG002|Open-label Titration Phase|Protocol Violation|0|||
130341294|NCT01675167|469221104|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
130341295|NCT01675167|469221105|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
130341296|NCT01675167|469221106|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
130004952|NCT00915772|467984630|FG002|Overall Study|Protocol Violation|2|||
130004953|NCT00915772|467984628|FG000|Overall Study|Lost to Follow-up|1|||
130341297|NCT01675167|469221104|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
130341298|NCT01675167|469221105|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
130341299|NCT01675167|469221106|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
130341300|NCT01675167|469221104|FG000|Open-label Titration Phase|Other|55|||
130341301|NCT01675167|469221105|FG001|Open-label Titration Phase|Other|0|||
130341302|NCT01675167|469221106|FG002|Open-label Titration Phase|Other|0|||
130341303|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
130341304|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
130341305|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
130341306|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130004954|NCT00915772|467984629|FG001|Overall Study|Lost to Follow-up|2|||
130004955|NCT00915772|467984630|FG002|Overall Study|Lost to Follow-up|2|||
130004956|NCT00915772|467984628|FG000|Overall Study|Lack of Efficacy|9|||
130004957|NCT00915772|467984629|FG001|Overall Study|Lack of Efficacy|15|||
130004958|NCT00915772|467984630|FG002|Overall Study|Lack of Efficacy|3|||
130004959|NCT00915772|467984628|FG000|Overall Study|Refused to continue trial medication|6|||
130004960|NCT00915772|467984629|FG001|Overall Study|Refused to continue trial medication|8|||
130004961|NCT00915772|467984630|FG002|Overall Study|Refused to continue trial medication|4|||
130004962|NCT00915772|467984628|FG000|Overall Study|Any other reason|4|||
130004963|NCT00915772|467984629|FG001|Overall Study|Any other reason|7|||
130004964|NCT00915772|467984630|FG002|Overall Study|Any other reason|7|||
130004965|NCT01383096|467984633|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
130004966|NCT01383096|467984634|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
130004967|NCT01383096|467984635|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
130004968|NCT01383096|467984633|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
130004969|NCT01383096|467984634|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
130004970|NCT01383096|467984635|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
130004971|NCT01383096|467984633|FG000|Third Intervention (8 Days)|Elevated AST|0|||
130004972|NCT01383096|467984634|FG001|Third Intervention (8 Days)|Elevated AST|1|||
130004973|NCT01383096|467984635|FG002|Third Intervention (8 Days)|Elevated AST|0|||
130004974|NCT01383096|467984633|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
130004975|NCT01383096|467984634|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
130004976|NCT01383096|467984635|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
130004977|NCT01383096|467984633|FG000|Third Intervention (8 Days)|Adverse Event|1|||
130004978|NCT01383096|467984634|FG001|Third Intervention (8 Days)|Adverse Event|0|||
130004979|NCT01383096|467984635|FG002|Third Intervention (8 Days)|Adverse Event|0|||
130004980|NCT01383096|467984633|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
130004981|NCT01383096|467984634|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
130004982|NCT01383096|467984635|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
130004983|NCT01383096|467984633|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
130004984|NCT01383096|467984634|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130004985|NCT01383096|467984635|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130341307|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130341308|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130341309|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130341310|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Adverse Event|5|||
130341311|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Adverse Event|13|||
130341312|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
130341313|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
130341314|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
130341315|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130341316|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130341317|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
130341318|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
130341319|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
130341320|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
130341321|NCT01675167|469221104|FG000|Double-blind Treatment Phase|Other|0|||
130341322|NCT01675167|469221105|FG001|Double-blind Treatment Phase|Other|7|||
130341323|NCT01675167|469221106|FG002|Double-blind Treatment Phase|Other|5|||
130341324|NCT00881868|469221107|FG000|Overall Study|Adverse Event|0|||
130341325|NCT00881868|469221108|FG001|Overall Study|Adverse Event|1|||
130341326|NCT00881868|469221107|FG000|Overall Study|Lost to Follow-up|2|||
130341327|NCT00881868|469221108|FG001|Overall Study|Lost to Follow-up|1|||
130341328|NCT00881868|469221107|FG000|Overall Study|Physician Decision|4|||
130341329|NCT00881868|469221108|FG001|Overall Study|Physician Decision|0|||
130341330|NCT00881868|469221107|FG000|Overall Study|Protocol Violation|2|||
130341331|NCT00881868|469221108|FG001|Overall Study|Protocol Violation|0|||
130341332|NCT03255083|469221109|FG000|Overall Study|Clinical progression|1|||
130341333|NCT03255083|469221110|FG001|Overall Study|Clinical progression|0|||
130341334|NCT03255083|469221111|FG002|Overall Study|Clinical progression|0|||
130341335|NCT03255083|469221112|FG003|Overall Study|Clinical progression|0|||
130341336|NCT03255083|469221109|FG000|Overall Study|Adverse Event|0|||
130341337|NCT03255083|469221110|FG001|Overall Study|Adverse Event|1|||
130341338|NCT03255083|469221111|FG002|Overall Study|Adverse Event|0|||
130341339|NCT03255083|469221112|FG003|Overall Study|Adverse Event|0|||
130341340|NCT03255083|469221109|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
130004986|NCT01383096|467984633|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
130004987|NCT01383096|467984634|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
130098745|NCT03426995|468319310|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
130098746|NCT03426995|468319292|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130341341|NCT03255083|469221110|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
130341342|NCT03255083|469221111|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
130341343|NCT03255083|469221112|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
130341344|NCT03255083|469221109|FG000|Overall Study|Withdrawal by Subject|1|||
130341345|NCT03255083|469221110|FG001|Overall Study|Withdrawal by Subject|1|||
130341346|NCT03255083|469221111|FG002|Overall Study|Withdrawal by Subject|1|||
130341347|NCT03255083|469221112|FG003|Overall Study|Withdrawal by Subject|0|||
130341348|NCT01182844|469221113|FG000|Overall Study|Withdrawal by Subject|0|||
130341349|NCT01182844|469221114|FG001|Overall Study|Withdrawal by Subject|2|||
130341350|NCT01457352|469221115|FG000|Period 1|Adverse Event|2|||
130341351|NCT01457352|469221116|FG001|Period 1|Adverse Event|0|||
130341352|NCT01457352|469221115|FG000|Period 1|Withdrawal by Subject|2|||
130341353|NCT01457352|469221116|FG001|Period 1|Withdrawal by Subject|0|||
130004988|NCT01383096|467984635|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
130004989|NCT01383096|467984633|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
130004990|NCT01383096|467984634|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130004991|NCT01383096|467984635|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
130004992|NCT01383096|467984633|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
130004993|NCT01383096|467984634|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
130004994|NCT01383096|467984635|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
130004995|NCT01383096|467984633|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
130004996|NCT01383096|467984634|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
130004997|NCT01383096|467984635|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
130004998|NCT01211535|467984636|FG000|Overall Study|Adverse Event|0|||
130004999|NCT01211535|467984637|FG001|Overall Study|Adverse Event|1|||
130005000|NCT03593850|467984640|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
130005001|NCT03593850|467984641|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
130005002|NCT01735279|467984642|FG000|Overall Study|Lost to Follow-up|11|||
130005003|NCT01735279|467984643|FG001|Overall Study|Lost to Follow-up|8|||
130005004|NCT00467779|467984648|FG000|Stage 1|Adverse Event|1|||
130005005|NCT00467779|467984649|FG001|Stage 1|Adverse Event|0|||
130216516|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
130216517|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
130216518|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
130216519|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
130216520|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
130216521|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
130216522|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
130216523|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130216524|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130216525|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
130216526|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
130216527|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
130216528|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
130216529|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
130216530|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
130216531|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
130216532|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
130005006|NCT00467779|467984650|FG002|Stage 1|Adverse Event|0|||
130005007|NCT00467779|467984651|FG003|Stage 1|Adverse Event|0|||
130005008|NCT00467779|467984652|FG004|Stage 1|Adverse Event|0|||
130005009|NCT00467779|467984653|FG005|Stage 1|Adverse Event|1|||
130005010|NCT00467779|467984654|FG006|Stage 1|Adverse Event|2|||
130005011|NCT00467779|467984655|FG007|Stage 1|Adverse Event|1|||
130005012|NCT00467779|467984656|FG008|Stage 1|Adverse Event|0|||
130005013|NCT00467779|467984657|FG009|Stage 1|Adverse Event|0|||
130005014|NCT00467779|467984658|FG010|Stage 1|Adverse Event|0|||
130005015|NCT00467779|467984659|FG011|Stage 1|Adverse Event|0|||
130005016|NCT00467779|467984660|FG012|Stage 1|Adverse Event|0|||
130005017|NCT00467779|467984661|FG013|Stage 1|Adverse Event|0|||
130005018|NCT00467779|467984662|FG014|Stage 1|Adverse Event|0|||
130005019|NCT00467779|467984648|FG000|Stage 1|Disease Progression|2|||
130005020|NCT00467779|467984649|FG001|Stage 1|Disease Progression|2|||
130005021|NCT00467779|467984650|FG002|Stage 1|Disease Progression|2|||
130005022|NCT00467779|467984651|FG003|Stage 1|Disease Progression|3|||
130005023|NCT00467779|467984652|FG004|Stage 1|Disease Progression|2|||
130005024|NCT00467779|467984653|FG005|Stage 1|Disease Progression|2|||
130005025|NCT00467779|467984654|FG006|Stage 1|Disease Progression|4|||
130005026|NCT00467779|467984655|FG007|Stage 1|Disease Progression|5|||
130005027|NCT00467779|467984656|FG008|Stage 1|Disease Progression|0|||
130005028|NCT00467779|467984657|FG009|Stage 1|Disease Progression|0|||
130005029|NCT00467779|467984658|FG010|Stage 1|Disease Progression|0|||
130216533|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130216534|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130341354|NCT01457352|469221115|FG000|Period 1|Physician Decision|2|||
130341355|NCT01457352|469221116|FG001|Period 1|Physician Decision|0|||
130005030|NCT00467779|467984659|FG011|Stage 1|Disease Progression|0|||
130005031|NCT00467779|467984660|FG012|Stage 1|Disease Progression|0|||
130341356|NCT01457352|469221115|FG000|Period 1|MS related disease progression|1|||
130341357|NCT01457352|469221116|FG001|Period 1|MS related disease progression|0|||
130341358|NCT01457352|469221115|FG000|Period 1|Withdrawn|1|||
130341359|NCT01457352|469221116|FG001|Period 1|Withdrawn|0|||
130341360|NCT01457352|469221115|FG000|Period 1|withdrew per sponsor|1|||
130341361|NCT01457352|469221116|FG001|Period 1|withdrew per sponsor|0|||
130341362|NCT01457352|469221115|FG000|Period 1|Protocol Violation|4|||
130341363|NCT01457352|469221116|FG001|Period 1|Protocol Violation|0|||
130341364|NCT01457352|469221115|FG000|Period 1|Did not meet eligibility criteria|3|||
130341365|NCT01457352|469221116|FG001|Period 1|Did not meet eligibility criteria|0|||
130341366|NCT01457352|469221115|FG000|Period 2|Withdrawal by Subject|23|||
130341367|NCT01457352|469221116|FG001|Period 2|Withdrawal by Subject|0|||
130341368|NCT01457352|469221115|FG000|Period 2|Adverse Event|22|||
130341369|NCT01457352|469221116|FG001|Period 2|Adverse Event|0|||
130341370|NCT01457352|469221115|FG000|Period 2|no analysis|10|||
130341371|NCT01457352|469221116|FG001|Period 2|no analysis|0|||
130341372|NCT01457352|469221115|FG000|Period 2|Lack of Efficacy|8|||
130341373|NCT01457352|469221116|FG001|Period 2|Lack of Efficacy|0|||
130341374|NCT01457352|469221115|FG000|Period 2|Protocol Violation|4|||
130341375|NCT01457352|469221116|FG001|Period 2|Protocol Violation|0|||
130341376|NCT01457352|469221115|FG000|Period 2|Sponsor's withdrawal|7|||
130341377|NCT01457352|469221116|FG001|Period 2|Sponsor's withdrawal|0|||
130341378|NCT01457352|469221115|FG000|Period 2|Lost to Follow-up|1|||
130341379|NCT01457352|469221116|FG001|Period 2|Lost to Follow-up|0|||
130341380|NCT01457352|469221115|FG000|Period 2|dose change|1|||
130341381|NCT01457352|469221116|FG001|Period 2|dose change|0|||
130341382|NCT01457352|469221115|FG000|Period 2|Physician Decision|1|||
130341383|NCT01457352|469221116|FG001|Period 2|Physician Decision|0|||
130341384|NCT01457352|469221115|FG000|Period 2|Did not meet eligibility criteria|3|||
130341385|NCT01457352|469221116|FG001|Period 2|Did not meet eligibility criteria|0|||
130341386|NCT01457352|469221115|FG000|Period 3|Adverse Event|1|||
130341387|NCT01457352|469221116|FG001|Period 3|Adverse Event|1|||
130005032|NCT00467779|467984661|FG013|Stage 1|Disease Progression|0|||
130005033|NCT00467779|467984662|FG014|Stage 1|Disease Progression|0|||
130005034|NCT00467779|467984648|FG000|Stage 1|Unspecified Reason|1|||
130341388|NCT01457352|469221115|FG000|Period 3|Withdrawal by Subject|0|||
130341389|NCT01457352|469221116|FG001|Period 3|Withdrawal by Subject|2|||
130005035|NCT00467779|467984649|FG001|Stage 1|Unspecified Reason|0|||
130005036|NCT00467779|467984650|FG002|Stage 1|Unspecified Reason|1|||
130005037|NCT00467779|467984651|FG003|Stage 1|Unspecified Reason|0|||
130005038|NCT00467779|467984652|FG004|Stage 1|Unspecified Reason|1|||
130005039|NCT00467779|467984653|FG005|Stage 1|Unspecified Reason|2|||
130005040|NCT00467779|467984654|FG006|Stage 1|Unspecified Reason|0|||
130005041|NCT00467779|467984655|FG007|Stage 1|Unspecified Reason|0|||
130005042|NCT00467779|467984656|FG008|Stage 1|Unspecified Reason|0|||
130005043|NCT00467779|467984657|FG009|Stage 1|Unspecified Reason|0|||
130005044|NCT00467779|467984658|FG010|Stage 1|Unspecified Reason|0|||
130005045|NCT00467779|467984659|FG011|Stage 1|Unspecified Reason|0|||
130005046|NCT00467779|467984660|FG012|Stage 1|Unspecified Reason|0|||
130005047|NCT00467779|467984661|FG013|Stage 1|Unspecified Reason|0|||
130005048|NCT00467779|467984662|FG014|Stage 1|Unspecified Reason|0|||
130005049|NCT00467779|467984648|FG000|Stage 1|Physician Decision|0|||
130005050|NCT00467779|467984649|FG001|Stage 1|Physician Decision|1|||
130005051|NCT00467779|467984650|FG002|Stage 1|Physician Decision|0|||
130005052|NCT00467779|467984651|FG003|Stage 1|Physician Decision|0|||
130005053|NCT00467779|467984652|FG004|Stage 1|Physician Decision|0|||
130005054|NCT00467779|467984653|FG005|Stage 1|Physician Decision|0|||
130005055|NCT00467779|467984654|FG006|Stage 1|Physician Decision|0|||
130005056|NCT00467779|467984655|FG007|Stage 1|Physician Decision|0|||
130005057|NCT00467779|467984656|FG008|Stage 1|Physician Decision|0|||
130005058|NCT00467779|467984657|FG009|Stage 1|Physician Decision|0|||
130005059|NCT00467779|467984658|FG010|Stage 1|Physician Decision|0|||
130005060|NCT00467779|467984659|FG011|Stage 1|Physician Decision|0|||
130005061|NCT00467779|467984660|FG012|Stage 1|Physician Decision|0|||
130005062|NCT00467779|467984661|FG013|Stage 1|Physician Decision|0|||
130005063|NCT00467779|467984662|FG014|Stage 1|Physician Decision|0|||
130216535|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
130341390|NCT01457352|469221115|FG000|Period 3|incorrect treatment|0|||
130341391|NCT01457352|469221116|FG001|Period 3|incorrect treatment|1|||
130341392|NCT01457352|469221115|FG000|Period 3|Sponsor's withdrawal|0|||
130341393|NCT01457352|469221116|FG001|Period 3|Sponsor's withdrawal|1|||
130341394|NCT04174365|469221117|FG000|Overall Study|Lost to Follow-up|1|||
130341395|NCT04174365|469221118|FG001|Overall Study|Lost to Follow-up|2|||
130341396|NCT04174365|469221117|FG000|Overall Study|Adverse Event|2|||
130005064|NCT00467779|467984648|FG000|Stage 1|Withdrawal by Subject|0|||
130005065|NCT00467779|467984649|FG001|Stage 1|Withdrawal by Subject|0|||
130005066|NCT00467779|467984650|FG002|Stage 1|Withdrawal by Subject|0|||
130341397|NCT04174365|469221118|FG001|Overall Study|Adverse Event|1|||
130341398|NCT04174365|469221117|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
130341399|NCT04174365|469221118|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
130005067|NCT00467779|467984651|FG003|Stage 1|Withdrawal by Subject|0|||
130005068|NCT00467779|467984652|FG004|Stage 1|Withdrawal by Subject|0|||
130005069|NCT00467779|467984653|FG005|Stage 1|Withdrawal by Subject|0|||
130005070|NCT00467779|467984654|FG006|Stage 1|Withdrawal by Subject|1|||
130005071|NCT00467779|467984655|FG007|Stage 1|Withdrawal by Subject|1|||
130005072|NCT00467779|467984656|FG008|Stage 1|Withdrawal by Subject|0|||
130341400|NCT04174365|469221117|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
130341401|NCT04174365|469221118|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
130341402|NCT04174365|469221117|FG000|Overall Study|Protocol Deviation|1|||
130341403|NCT04174365|469221118|FG001|Overall Study|Protocol Deviation|0|||
130341404|NCT04174365|469221117|FG000|Overall Study|Lack of Efficacy|0|||
130341405|NCT04174365|469221118|FG001|Overall Study|Lack of Efficacy|2|||
130341406|NCT04174365|469221117|FG000|Overall Study|Disease Relapse|1|||
130341407|NCT04174365|469221118|FG001|Overall Study|Disease Relapse|0|||
130341408|NCT04174365|469221117|FG000|Overall Study|Reason Not Specified|0|||
130341409|NCT04174365|469221118|FG001|Overall Study|Reason Not Specified|1|||
130341410|NCT01031836|469223034|FG000|Stage I|Adverse Event|1|||
130341411|NCT01031836|469223035|FG001|Stage I|Adverse Event|1|||
130341412|NCT01031836|469223036|FG002|Stage I|Adverse Event|0|||
130341413|NCT01031836|469223037|FG003|Stage I|Adverse Event|0|||
130341414|NCT01031836|469223038|FG004|Stage I|Adverse Event|0|||
130341415|NCT01031836|469223039|FG005|Stage I|Adverse Event|0|||
130341416|NCT01031836|469223034|FG000|Stage I|Other|0|||
130341417|NCT01031836|469223035|FG001|Stage I|Other|1|||
130341418|NCT01031836|469223036|FG002|Stage I|Other|0|||
130341419|NCT01031836|469223037|FG003|Stage I|Other|0|||
130341420|NCT01031836|469223038|FG004|Stage I|Other|0|||
130341421|NCT01031836|469223039|FG005|Stage I|Other|1|||
130341422|NCT01031836|469223034|FG000|Stage II|Adverse Event|0|||
130341423|NCT01031836|469223035|FG001|Stage II|Adverse Event|0|||
130341424|NCT01031836|469223036|FG002|Stage II|Adverse Event|2|||
130341425|NCT01031836|469223037|FG003|Stage II|Adverse Event|2|||
130341426|NCT01031836|469223038|FG004|Stage II|Adverse Event|1|||
130341427|NCT01031836|469223039|FG005|Stage II|Adverse Event|1|||
130341428|NCT01031836|469223034|FG000|Stage II|Other|2|||
130341429|NCT01031836|469223035|FG001|Stage II|Other|0|||
130341430|NCT01031836|469223036|FG002|Stage II|Other|0|||
130341431|NCT01031836|469223037|FG003|Stage II|Other|1|||
130341432|NCT01031836|469223038|FG004|Stage II|Other|1|||
130341433|NCT01031836|469223039|FG005|Stage II|Other|0|||
130341434|NCT03859973|469223047|FG000|Overall Study|Other reason than listed|3|||
130341435|NCT03859973|469223048|FG001|Overall Study|Other reason than listed|2|||
130341436|NCT03859973|469223047|FG000|Overall Study|COVID-19 related, not due to AE|3|||
130341437|NCT03859973|469223048|FG001|Overall Study|COVID-19 related, not due to AE|4|||
130341438|NCT03859973|469223047|FG000|Overall Study|Withdrawal by Subject|8|||
130341439|NCT03859973|469223048|FG001|Overall Study|Withdrawal by Subject|9|||
130341440|NCT03859973|469223047|FG000|Overall Study|Lost to Follow-up|2|||
130341441|NCT03859973|469223048|FG001|Overall Study|Lost to Follow-up|3|||
130341442|NCT03859973|469223047|FG000|Overall Study|Protocol Violation|1|||
130341443|NCT03859973|469223048|FG001|Overall Study|Protocol Violation|3|||
130341444|NCT03859973|469223047|FG000|Overall Study|Adverse Event|3|||
130341445|NCT03859973|469223048|FG001|Overall Study|Adverse Event|5|||
130341446|NCT02855541|469223049|FG000|Overall Study|Change in health status|2|||
130341447|NCT02855541|469223049|FG000|Overall Study|Withdrawal by Subject|2|||
130341448|NCT00422513|469223050|FG000|Overall Study|Lack of Efficacy|4|||
130341449|NCT00422513|469223051|FG001|Overall Study|Lack of Efficacy|5|||
130341450|NCT00422513|469223050|FG000|Overall Study|Protocol Violation|23|||
130341451|NCT00422513|469223051|FG001|Overall Study|Protocol Violation|7|||
130341452|NCT00422513|469223050|FG000|Overall Study|Refused Treatment|4|||
130341453|NCT00422513|469223051|FG001|Overall Study|Refused Treatment|2|||
130341454|NCT00422513|469223050|FG000|Overall Study|Withdrawal by Subject|2|||
130341455|NCT00422513|469223051|FG001|Overall Study|Withdrawal by Subject|1|||
130341456|NCT00422513|469223050|FG000|Overall Study|early termination of the study|67|||
130341457|NCT00422513|469223051|FG001|Overall Study|early termination of the study|80|||
130341458|NCT00422513|469223050|FG000|Overall Study|Adverse Event|4|||
130005073|NCT00467779|467984657|FG009|Stage 1|Withdrawal by Subject|0|||
130005074|NCT00467779|467984658|FG010|Stage 1|Withdrawal by Subject|0|||
130341459|NCT00422513|469223051|FG001|Overall Study|Adverse Event|4|||
130341460|NCT00422513|469223050|FG000|Overall Study|Death|3|||
130005075|NCT00467779|467984659|FG011|Stage 1|Withdrawal by Subject|0|||
130341461|NCT00422513|469223051|FG001|Overall Study|Death|7|||
130341462|NCT03032380|469223052|FG000|Overall Study|Adverse Event|0|||
130341463|NCT03032380|469223053|FG001|Overall Study|Adverse Event|1|||
130341464|NCT03032380|469223052|FG000|Overall Study|Lack of Efficacy|1|||
130341465|NCT03032380|469223053|FG001|Overall Study|Lack of Efficacy|0|||
130341466|NCT03032380|469223052|FG000|Overall Study|Withdrawal by Subject|2|||
130341467|NCT03032380|469223053|FG001|Overall Study|Withdrawal by Subject|3|||
130341468|NCT03032380|469223052|FG000|Overall Study|Recovery|0|||
130341469|NCT03032380|469223053|FG001|Overall Study|Recovery|1|||
130341470|NCT03032380|469223052|FG000|Overall Study|Death|39|||
130341471|NCT03032380|469223053|FG001|Overall Study|Death|34|||
130341472|NCT03032380|469223052|FG000|Overall Study|Other - Miscellaneous|0|||
130005076|NCT00467779|467984660|FG012|Stage 1|Withdrawal by Subject|0|||
130005077|NCT00467779|467984661|FG013|Stage 1|Withdrawal by Subject|0|||
130341473|NCT03032380|469223053|FG001|Overall Study|Other - Miscellaneous|1|||
130005078|NCT00467779|467984662|FG014|Stage 1|Withdrawal by Subject|0|||
130005079|NCT00467779|467984648|FG000|Stage 1A|Adverse Event|0|||
130005080|NCT00467779|467984649|FG001|Stage 1A|Adverse Event|0|||
130005081|NCT00467779|467984650|FG002|Stage 1A|Adverse Event|0|||
130005082|NCT00467779|467984651|FG003|Stage 1A|Adverse Event|0|||
130005083|NCT00467779|467984652|FG004|Stage 1A|Adverse Event|0|||
130005084|NCT00467779|467984653|FG005|Stage 1A|Adverse Event|0|||
130005085|NCT00467779|467984654|FG006|Stage 1A|Adverse Event|0|||
130005086|NCT00467779|467984655|FG007|Stage 1A|Adverse Event|0|||
130005087|NCT00467779|467984656|FG008|Stage 1A|Adverse Event|0|||
130005088|NCT00467779|467984657|FG009|Stage 1A|Adverse Event|0|||
130005089|NCT00467779|467984658|FG010|Stage 1A|Adverse Event|0|||
130005090|NCT00467779|467984659|FG011|Stage 1A|Adverse Event|0|||
130005091|NCT00467779|467984660|FG012|Stage 1A|Adverse Event|1|||
130005092|NCT00467779|467984661|FG013|Stage 1A|Adverse Event|0|||
130005093|NCT00467779|467984662|FG014|Stage 1A|Adverse Event|0|||
130005094|NCT00467779|467984648|FG000|Stage 1A|Death|0|||
130005095|NCT00467779|467984649|FG001|Stage 1A|Death|0|||
130005096|NCT00467779|467984650|FG002|Stage 1A|Death|0|||
130005097|NCT00467779|467984651|FG003|Stage 1A|Death|0|||
130005098|NCT00467779|467984652|FG004|Stage 1A|Death|0|||
130005099|NCT00467779|467984653|FG005|Stage 1A|Death|0|||
130005100|NCT00467779|467984654|FG006|Stage 1A|Death|0|||
130005101|NCT00467779|467984655|FG007|Stage 1A|Death|0|||
130005102|NCT00467779|467984656|FG008|Stage 1A|Death|0|||
130005103|NCT00467779|467984657|FG009|Stage 1A|Death|0|||
130005104|NCT00467779|467984658|FG010|Stage 1A|Death|0|||
130005105|NCT00467779|467984659|FG011|Stage 1A|Death|1|||
130005106|NCT00467779|467984660|FG012|Stage 1A|Death|1|||
130005107|NCT00467779|467984661|FG013|Stage 1A|Death|0|||
130005108|NCT00467779|467984662|FG014|Stage 1A|Death|0|||
130005109|NCT00467779|467984648|FG000|Stage 1A|Disease Progression|0|||
130005110|NCT00467779|467984649|FG001|Stage 1A|Disease Progression|0|||
130005111|NCT00467779|467984650|FG002|Stage 1A|Disease Progression|0|||
130005112|NCT00467779|467984651|FG003|Stage 1A|Disease Progression|0|||
130005113|NCT00467779|467984652|FG004|Stage 1A|Disease Progression|0|||
130005114|NCT00467779|467984653|FG005|Stage 1A|Disease Progression|0|||
130005115|NCT00467779|467984654|FG006|Stage 1A|Disease Progression|0|||
130005116|NCT00467779|467984655|FG007|Stage 1A|Disease Progression|0|||
130005117|NCT00467779|467984656|FG008|Stage 1A|Disease Progression|0|||
130005118|NCT00467779|467984657|FG009|Stage 1A|Disease Progression|2|||
130005119|NCT00467779|467984658|FG010|Stage 1A|Disease Progression|2|||
130005120|NCT00467779|467984659|FG011|Stage 1A|Disease Progression|5|||
130005121|NCT00467779|467984660|FG012|Stage 1A|Disease Progression|2|||
130005122|NCT00467779|467984661|FG013|Stage 1A|Disease Progression|0|||
130005123|NCT00467779|467984662|FG014|Stage 1A|Disease Progression|0|||
130005124|NCT00467779|467984648|FG000|Stage 1A|Physician Decision|0|||
130005125|NCT00467779|467984649|FG001|Stage 1A|Physician Decision|0|||
130005126|NCT00467779|467984650|FG002|Stage 1A|Physician Decision|0|||
130005127|NCT00467779|467984651|FG003|Stage 1A|Physician Decision|0|||
130005128|NCT00467779|467984652|FG004|Stage 1A|Physician Decision|0|||
130341474|NCT01128621|469223058|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
130341475|NCT01128621|469223059|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
130341476|NCT02267317|469223060|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
130341477|NCT02267317|469223061|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130341478|NCT02267317|469223062|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130341479|NCT02267317|469223063|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130005129|NCT00467779|467984653|FG005|Stage 1A|Physician Decision|0|||
130005130|NCT00467779|467984654|FG006|Stage 1A|Physician Decision|0|||
130005131|NCT00467779|467984655|FG007|Stage 1A|Physician Decision|0|||
130005132|NCT00467779|467984656|FG008|Stage 1A|Physician Decision|0|||
130005133|NCT00467779|467984657|FG009|Stage 1A|Physician Decision|1|||
130005134|NCT00467779|467984658|FG010|Stage 1A|Physician Decision|0|||
130005135|NCT00467779|467984659|FG011|Stage 1A|Physician Decision|0|||
130005136|NCT00467779|467984660|FG012|Stage 1A|Physician Decision|0|||
130005137|NCT00467779|467984661|FG013|Stage 1A|Physician Decision|0|||
130005138|NCT00467779|467984662|FG014|Stage 1A|Physician Decision|0|||
130005139|NCT00467779|467984648|FG000|Stage 1A|Withdrawal by Subject|0|||
130005140|NCT00467779|467984649|FG001|Stage 1A|Withdrawal by Subject|0|||
130005141|NCT00467779|467984650|FG002|Stage 1A|Withdrawal by Subject|0|||
130005142|NCT00467779|467984651|FG003|Stage 1A|Withdrawal by Subject|0|||
130005143|NCT00467779|467984652|FG004|Stage 1A|Withdrawal by Subject|0|||
130005144|NCT00467779|467984653|FG005|Stage 1A|Withdrawal by Subject|0|||
130005145|NCT00467779|467984654|FG006|Stage 1A|Withdrawal by Subject|0|||
130005146|NCT00467779|467984655|FG007|Stage 1A|Withdrawal by Subject|0|||
130005147|NCT00467779|467984656|FG008|Stage 1A|Withdrawal by Subject|0|||
130005148|NCT00467779|467984657|FG009|Stage 1A|Withdrawal by Subject|0|||
130005149|NCT00467779|467984658|FG010|Stage 1A|Withdrawal by Subject|1|||
130005150|NCT00467779|467984659|FG011|Stage 1A|Withdrawal by Subject|1|||
130005151|NCT00467779|467984660|FG012|Stage 1A|Withdrawal by Subject|1|||
130005152|NCT00467779|467984661|FG013|Stage 1A|Withdrawal by Subject|0|||
130005153|NCT00467779|467984662|FG014|Stage 1A|Withdrawal by Subject|0|||
130005154|NCT00467779|467984648|FG000|Stage 1A|Unspecified Reason|0|||
130005155|NCT00467779|467984649|FG001|Stage 1A|Unspecified Reason|0|||
130005156|NCT00467779|467984650|FG002|Stage 1A|Unspecified Reason|0|||
130005157|NCT00467779|467984651|FG003|Stage 1A|Unspecified Reason|0|||
130005158|NCT00467779|467984652|FG004|Stage 1A|Unspecified Reason|0|||
130005159|NCT00467779|467984653|FG005|Stage 1A|Unspecified Reason|0|||
130005160|NCT00467779|467984654|FG006|Stage 1A|Unspecified Reason|0|||
130005161|NCT00467779|467984655|FG007|Stage 1A|Unspecified Reason|0|||
130005162|NCT00467779|467984656|FG008|Stage 1A|Unspecified Reason|0|||
130005163|NCT00467779|467984657|FG009|Stage 1A|Unspecified Reason|0|||
130005164|NCT00467779|467984658|FG010|Stage 1A|Unspecified Reason|0|||
130005165|NCT00467779|467984659|FG011|Stage 1A|Unspecified Reason|1|||
130005166|NCT00467779|467984660|FG012|Stage 1A|Unspecified Reason|1|||
130005167|NCT00467779|467984661|FG013|Stage 1A|Unspecified Reason|0|||
130005168|NCT00467779|467984662|FG014|Stage 1A|Unspecified Reason|0|||
130005169|NCT00467779|467984648|FG000|Stage 2|Adverse Event|0|||
130005170|NCT00467779|467984649|FG001|Stage 2|Adverse Event|0|||
130005171|NCT00467779|467984650|FG002|Stage 2|Adverse Event|0|||
130005172|NCT00467779|467984651|FG003|Stage 2|Adverse Event|0|||
130005173|NCT00467779|467984652|FG004|Stage 2|Adverse Event|0|||
130005174|NCT00467779|467984653|FG005|Stage 2|Adverse Event|0|||
130005175|NCT00467779|467984654|FG006|Stage 2|Adverse Event|0|||
130005176|NCT00467779|467984655|FG007|Stage 2|Adverse Event|0|||
130005177|NCT00467779|467984656|FG008|Stage 2|Adverse Event|1|||
130005178|NCT00467779|467984657|FG009|Stage 2|Adverse Event|0|||
130341480|NCT02267317|469223064|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130341481|NCT02267317|469223065|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
130005179|NCT00467779|467984658|FG010|Stage 2|Adverse Event|0|||
130005180|NCT00467779|467984659|FG011|Stage 2|Adverse Event|0|||
130005181|NCT00467779|467984660|FG012|Stage 2|Adverse Event|0|||
130005182|NCT00467779|467984661|FG013|Stage 2|Adverse Event|0|||
130005183|NCT00467779|467984662|FG014|Stage 2|Adverse Event|0|||
130005184|NCT00467779|467984648|FG000|Stage 2|Death|0|||
130005185|NCT00467779|467984649|FG001|Stage 2|Death|0|||
130005186|NCT00467779|467984650|FG002|Stage 2|Death|0|||
130005187|NCT00467779|467984651|FG003|Stage 2|Death|0|||
130005188|NCT00467779|467984652|FG004|Stage 2|Death|0|||
130005189|NCT00467779|467984653|FG005|Stage 2|Death|0|||
130005190|NCT00467779|467984654|FG006|Stage 2|Death|0|||
130005191|NCT00467779|467984655|FG007|Stage 2|Death|0|||
130005192|NCT00467779|467984656|FG008|Stage 2|Death|1|||
130005193|NCT00467779|467984657|FG009|Stage 2|Death|0|||
130005194|NCT00467779|467984658|FG010|Stage 2|Death|0|||
130005195|NCT00467779|467984659|FG011|Stage 2|Death|0|||
130005196|NCT00467779|467984660|FG012|Stage 2|Death|0|||
130005197|NCT00467779|467984661|FG013|Stage 2|Death|0|||
130005198|NCT00467779|467984662|FG014|Stage 2|Death|0|||
130005199|NCT00467779|467984648|FG000|Stage 2|Disease Progression|0|||
130005200|NCT00467779|467984649|FG001|Stage 2|Disease Progression|0|||
130005201|NCT00467779|467984650|FG002|Stage 2|Disease Progression|0|||
130005202|NCT00467779|467984651|FG003|Stage 2|Disease Progression|0|||
130005203|NCT00467779|467984652|FG004|Stage 2|Disease Progression|0|||
130005204|NCT00467779|467984653|FG005|Stage 2|Disease Progression|0|||
130005205|NCT00467779|467984654|FG006|Stage 2|Disease Progression|0|||
130005206|NCT00467779|467984655|FG007|Stage 2|Disease Progression|0|||
130005207|NCT00467779|467984656|FG008|Stage 2|Disease Progression|16|||
130005208|NCT00467779|467984657|FG009|Stage 2|Disease Progression|0|||
130005209|NCT00467779|467984658|FG010|Stage 2|Disease Progression|0|||
130341482|NCT02267317|469223060|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
130341483|NCT02267317|469223061|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130341484|NCT02267317|469223062|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130005210|NCT00467779|467984659|FG011|Stage 2|Disease Progression|0|||
130005211|NCT00467779|467984660|FG012|Stage 2|Disease Progression|0|||
130005212|NCT00467779|467984661|FG013|Stage 2|Disease Progression|0|||
130005213|NCT00467779|467984662|FG014|Stage 2|Disease Progression|0|||
130005214|NCT00467779|467984648|FG000|Stage 2|Unspecified Reason|0|||
130005215|NCT00467779|467984649|FG001|Stage 2|Unspecified Reason|0|||
130341485|NCT02267317|469223063|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130005216|NCT00467779|467984650|FG002|Stage 2|Unspecified Reason|0|||
130005217|NCT00467779|467984651|FG003|Stage 2|Unspecified Reason|0|||
130005218|NCT00467779|467984652|FG004|Stage 2|Unspecified Reason|0|||
130341486|NCT02267317|469223064|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130005219|NCT00467779|467984653|FG005|Stage 2|Unspecified Reason|0|||
130005220|NCT00467779|467984654|FG006|Stage 2|Unspecified Reason|0|||
130005221|NCT00467779|467984655|FG007|Stage 2|Unspecified Reason|0|||
130005222|NCT00467779|467984656|FG008|Stage 2|Unspecified Reason|3|||
130005223|NCT00467779|467984657|FG009|Stage 2|Unspecified Reason|0|||
130005224|NCT00467779|467984658|FG010|Stage 2|Unspecified Reason|0|||
130005225|NCT00467779|467984659|FG011|Stage 2|Unspecified Reason|0|||
130005226|NCT00467779|467984660|FG012|Stage 2|Unspecified Reason|0|||
130005227|NCT00467779|467984661|FG013|Stage 2|Unspecified Reason|0|||
130005228|NCT00467779|467984662|FG014|Stage 2|Unspecified Reason|0|||
130005229|NCT00467779|467984648|FG000|Stage 2A|Adverse Event|0|||
130005230|NCT00467779|467984649|FG001|Stage 2A|Adverse Event|0|||
130005231|NCT00467779|467984650|FG002|Stage 2A|Adverse Event|0|||
130005232|NCT00467779|467984651|FG003|Stage 2A|Adverse Event|0|||
130005233|NCT00467779|467984652|FG004|Stage 2A|Adverse Event|0|||
130005234|NCT00467779|467984653|FG005|Stage 2A|Adverse Event|0|||
130005235|NCT00467779|467984654|FG006|Stage 2A|Adverse Event|0|||
130005236|NCT00467779|467984655|FG007|Stage 2A|Adverse Event|0|||
130005237|NCT00467779|467984656|FG008|Stage 2A|Adverse Event|0|||
130005238|NCT00467779|467984657|FG009|Stage 2A|Adverse Event|0|||
130005239|NCT00467779|467984658|FG010|Stage 2A|Adverse Event|0|||
130005240|NCT00467779|467984659|FG011|Stage 2A|Adverse Event|0|||
130005241|NCT00467779|467984660|FG012|Stage 2A|Adverse Event|0|||
130005242|NCT00467779|467984661|FG013|Stage 2A|Adverse Event|2|||
130005243|NCT00467779|467984662|FG014|Stage 2A|Adverse Event|0|||
130005244|NCT00467779|467984648|FG000|Stage 2A|Death|0|||
130005245|NCT00467779|467984649|FG001|Stage 2A|Death|0|||
130005246|NCT00467779|467984650|FG002|Stage 2A|Death|0|||
130005247|NCT00467779|467984651|FG003|Stage 2A|Death|0|||
130005248|NCT00467779|467984652|FG004|Stage 2A|Death|0|||
130005249|NCT00467779|467984653|FG005|Stage 2A|Death|0|||
130005250|NCT00467779|467984654|FG006|Stage 2A|Death|0|||
130005251|NCT00467779|467984655|FG007|Stage 2A|Death|0|||
130005252|NCT00467779|467984656|FG008|Stage 2A|Death|0|||
130005253|NCT00467779|467984657|FG009|Stage 2A|Death|0|||
130005254|NCT00467779|467984658|FG010|Stage 2A|Death|0|||
130005255|NCT00467779|467984659|FG011|Stage 2A|Death|0|||
130216536|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
130216537|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216538|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216539|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216540|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
130216541|NCT02137226|468755596|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
130216542|NCT02137226|468755597|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
130216543|NCT02137226|468755598|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
130216544|NCT02137226|468755599|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
130216545|NCT02137226|468755600|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
130216546|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
130216547|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
130216548|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
130216549|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
130216550|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
130216551|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
130216552|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
130216553|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
130216554|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
130216555|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
130216556|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
130216557|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
130216558|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
130216559|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
130216560|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
130216561|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216562|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216563|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
130216564|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216565|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
130216566|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216567|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216568|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
130216569|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216570|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
130216571|NCT02137226|468755596|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
130216572|NCT02137226|468755597|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
130216573|NCT02137226|468755598|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
130216574|NCT02137226|468755599|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
130216575|NCT02137226|468755600|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
130216576|NCT03762681|468755603|FG000|Part 1|Withdrawal by Subject|0|||
130216577|NCT03762681|468755604|FG001|Part 1|Withdrawal by Subject|0|||
130216578|NCT03762681|468755605|FG002|Part 1|Withdrawal by Subject|0|||
130216579|NCT03762681|468755606|FG003|Part 1|Withdrawal by Subject|1|||
130216580|NCT03762681|468755607|FG004|Part 1|Withdrawal by Subject|0|||
130216581|NCT03762681|468755608|FG005|Part 1|Withdrawal by Subject|0|||
130216582|NCT03762681|468755609|FG006|Part 1|Withdrawal by Subject|0|||
130216583|NCT03762681|468755610|FG007|Part 1|Withdrawal by Subject|0|||
130005256|NCT00467779|467984660|FG012|Stage 2A|Death|0|||
130005257|NCT00467779|467984661|FG013|Stage 2A|Death|1|||
130005258|NCT00467779|467984662|FG014|Stage 2A|Death|0|||
130005259|NCT00467779|467984648|FG000|Stage 2A|Disease Progression|0|||
130005260|NCT00467779|467984649|FG001|Stage 2A|Disease Progression|0|||
130005261|NCT00467779|467984650|FG002|Stage 2A|Disease Progression|0|||
130005262|NCT00467779|467984651|FG003|Stage 2A|Disease Progression|0|||
130005263|NCT00467779|467984652|FG004|Stage 2A|Disease Progression|0|||
130005264|NCT00467779|467984653|FG005|Stage 2A|Disease Progression|0|||
130005265|NCT00467779|467984654|FG006|Stage 2A|Disease Progression|0|||
130005266|NCT00467779|467984655|FG007|Stage 2A|Disease Progression|0|||
130005267|NCT00467779|467984656|FG008|Stage 2A|Disease Progression|0|||
130005268|NCT00467779|467984657|FG009|Stage 2A|Disease Progression|0|||
130005269|NCT00467779|467984658|FG010|Stage 2A|Disease Progression|0|||
130005270|NCT00467779|467984659|FG011|Stage 2A|Disease Progression|0|||
130005271|NCT00467779|467984660|FG012|Stage 2A|Disease Progression|0|||
130005272|NCT00467779|467984661|FG013|Stage 2A|Disease Progression|10|||
130005273|NCT00467779|467984662|FG014|Stage 2A|Disease Progression|0|||
130005274|NCT00467779|467984648|FG000|Stage 2A|Unspecified Reason|0|||
130005275|NCT00467779|467984649|FG001|Stage 2A|Unspecified Reason|0|||
130005276|NCT00467779|467984650|FG002|Stage 2A|Unspecified Reason|0|||
130005277|NCT00467779|467984651|FG003|Stage 2A|Unspecified Reason|0|||
130005278|NCT00467779|467984652|FG004|Stage 2A|Unspecified Reason|0|||
130341487|NCT02267317|469223065|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
130341488|NCT00796445|469223068|FG000|Overall Study|Protocol Violation|5|||
130341489|NCT00796445|469223069|FG001|Overall Study|Protocol Violation|3|||
130341490|NCT00796445|469223068|FG000|Overall Study|Adverse event, serious fatal|10|||
130341491|NCT00796445|469223069|FG001|Overall Study|Adverse event, serious fatal|5|||
130341492|NCT00796445|469223068|FG000|Overall Study|Adverse event, non-fatal|4|||
130341493|NCT00796445|469223069|FG001|Overall Study|Adverse event, non-fatal|0|||
130341494|NCT00796445|469223068|FG000|Overall Study|Disease progression/recurrence|537|||
130341495|NCT00796445|469223069|FG001|Overall Study|Disease progression/recurrence|268|||
130341496|NCT00796445|469223068|FG000|Overall Study|Other|10|||
130341497|NCT00796445|469223069|FG001|Overall Study|Other|7|||
130341498|NCT00796445|469223068|FG000|Overall Study|Withdrawal by Subject|18|||
130341499|NCT00796445|469223069|FG001|Overall Study|Withdrawal by Subject|9|||
130341500|NCT00796445|469223068|FG000|Overall Study|Invalid Informed Consent Form|1|||
130341501|NCT00796445|469223069|FG001|Overall Study|Invalid Informed Consent Form|0|||
130341502|NCT02208063|469223070|FG000|Overall Study|Death|3|||
130341503|NCT02208063|469223071|FG001|Overall Study|Death|5|||
130341504|NCT02208063|469223070|FG000|Overall Study|Not Specified in report|3|||
130341505|NCT02208063|469223071|FG001|Overall Study|Not Specified in report|4|||
130341506|NCT02208063|469223070|FG000|Overall Study|Withdrawal by Subject|5|||
130341507|NCT02208063|469223071|FG001|Overall Study|Withdrawal by Subject|2|||
130341508|NCT02208063|469223070|FG000|Overall Study|Lost to Follow-up|1|||
130341509|NCT02208063|469223071|FG001|Overall Study|Lost to Follow-up|0|||
130341510|NCT00917644|469223072|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
130341511|NCT00917644|469223073|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
130341512|NCT00917644|469223072|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
130341513|NCT00917644|469223073|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
130341514|NCT00917644|469223072|FG000|Period 2: Second Intervention|family emergency|1|||
130341515|NCT00917644|469223073|FG001|Period 2: Second Intervention|family emergency|0|||
130341516|NCT00422084|469223078|FG000|Overall Study|Adverse Event|21|||
130341517|NCT00422084|469223079|FG001|Overall Study|Adverse Event|7|||
130341518|NCT00422084|469223078|FG000|Overall Study|Withdrawal by Subject|12|||
130341519|NCT00422084|469223079|FG001|Overall Study|Withdrawal by Subject|9|||
130341520|NCT00422084|469223078|FG000|Overall Study|Lost to Follow-up|14|||
130341521|NCT00422084|469223079|FG001|Overall Study|Lost to Follow-up|9|||
130341522|NCT00422084|469223078|FG000|Overall Study|Protocol Violation|4|||
130005279|NCT00467779|467984653|FG005|Stage 2A|Unspecified Reason|0|||
130005280|NCT00467779|467984654|FG006|Stage 2A|Unspecified Reason|0|||
130005281|NCT00467779|467984655|FG007|Stage 2A|Unspecified Reason|0|||
130005282|NCT00467779|467984656|FG008|Stage 2A|Unspecified Reason|0|||
130341523|NCT00422084|469223079|FG001|Overall Study|Protocol Violation|1|||
130341524|NCT00422084|469223078|FG000|Overall Study|Lack of Efficacy|40|||
130341525|NCT00422084|469223079|FG001|Overall Study|Lack of Efficacy|42|||
130341526|NCT00422084|469223078|FG000|Overall Study|P. vivax infection|3|||
130341527|NCT00422084|469223079|FG001|Overall Study|P. vivax infection|6|||
130341528|NCT00422084|469223078|FG000|Overall Study|Cyesis|1|||
130341529|NCT00422084|469223079|FG001|Overall Study|Cyesis|0|||
130341530|NCT00422084|469223078|FG000|Overall Study|Withdrawn from study accidentally|1|||
130341531|NCT00422084|469223079|FG001|Overall Study|Withdrawn from study accidentally|0|||
130341532|NCT00422084|469223078|FG000|Overall Study|Non-compliance|1|||
130005283|NCT00467779|467984657|FG009|Stage 2A|Unspecified Reason|0|||
130005284|NCT00467779|467984658|FG010|Stage 2A|Unspecified Reason|0|||
130005285|NCT00467779|467984659|FG011|Stage 2A|Unspecified Reason|0|||
130005286|NCT00467779|467984660|FG012|Stage 2A|Unspecified Reason|0|||
130005287|NCT00467779|467984661|FG013|Stage 2A|Unspecified Reason|7|||
130005288|NCT00467779|467984662|FG014|Stage 2A|Unspecified Reason|0|||
130005289|NCT00467779|467984648|FG000|Stage 2A|Withdrawal by Subject|0|||
130005290|NCT00467779|467984649|FG001|Stage 2A|Withdrawal by Subject|0|||
130005291|NCT00467779|467984650|FG002|Stage 2A|Withdrawal by Subject|0|||
130005292|NCT00467779|467984651|FG003|Stage 2A|Withdrawal by Subject|0|||
130005293|NCT00467779|467984652|FG004|Stage 2A|Withdrawal by Subject|0|||
130005294|NCT00467779|467984653|FG005|Stage 2A|Withdrawal by Subject|0|||
130005295|NCT00467779|467984654|FG006|Stage 2A|Withdrawal by Subject|0|||
130005296|NCT00467779|467984655|FG007|Stage 2A|Withdrawal by Subject|0|||
130005297|NCT00467779|467984656|FG008|Stage 2A|Withdrawal by Subject|0|||
130005298|NCT00467779|467984657|FG009|Stage 2A|Withdrawal by Subject|0|||
130005299|NCT00467779|467984658|FG010|Stage 2A|Withdrawal by Subject|0|||
130005300|NCT00467779|467984659|FG011|Stage 2A|Withdrawal by Subject|0|||
130005301|NCT00467779|467984660|FG012|Stage 2A|Withdrawal by Subject|0|||
130005302|NCT00467779|467984661|FG013|Stage 2A|Withdrawal by Subject|1|||
130005303|NCT00467779|467984662|FG014|Stage 2A|Withdrawal by Subject|0|||
130005304|NCT00467779|467984648|FG000|Stage 3|Adverse Event|0|||
130005305|NCT00467779|467984649|FG001|Stage 3|Adverse Event|0|||
130005306|NCT00467779|467984650|FG002|Stage 3|Adverse Event|0|||
130005307|NCT00467779|467984651|FG003|Stage 3|Adverse Event|0|||
130005308|NCT00467779|467984652|FG004|Stage 3|Adverse Event|0|||
130005309|NCT00467779|467984653|FG005|Stage 3|Adverse Event|0|||
130005310|NCT00467779|467984654|FG006|Stage 3|Adverse Event|0|||
130005311|NCT00467779|467984655|FG007|Stage 3|Adverse Event|0|||
130005312|NCT00467779|467984656|FG008|Stage 3|Adverse Event|0|||
130005313|NCT00467779|467984657|FG009|Stage 3|Adverse Event|0|||
130005314|NCT00467779|467984658|FG010|Stage 3|Adverse Event|0|||
130005315|NCT00467779|467984659|FG011|Stage 3|Adverse Event|0|||
130005316|NCT00467779|467984660|FG012|Stage 3|Adverse Event|0|||
130005317|NCT00467779|467984661|FG013|Stage 3|Adverse Event|0|||
130005318|NCT00467779|467984662|FG014|Stage 3|Adverse Event|2|||
130005319|NCT00467779|467984648|FG000|Stage 3|Death|0|||
130005320|NCT00467779|467984649|FG001|Stage 3|Death|0|||
130005321|NCT00467779|467984650|FG002|Stage 3|Death|0|||
130005322|NCT00467779|467984651|FG003|Stage 3|Death|0|||
130005323|NCT00467779|467984652|FG004|Stage 3|Death|0|||
130005324|NCT00467779|467984653|FG005|Stage 3|Death|0|||
130005325|NCT00467779|467984654|FG006|Stage 3|Death|0|||
130005326|NCT00467779|467984655|FG007|Stage 3|Death|0|||
130005327|NCT00467779|467984656|FG008|Stage 3|Death|0|||
130005328|NCT00467779|467984657|FG009|Stage 3|Death|0|||
130005329|NCT00467779|467984658|FG010|Stage 3|Death|0|||
130005330|NCT00467779|467984659|FG011|Stage 3|Death|0|||
130005331|NCT00467779|467984660|FG012|Stage 3|Death|0|||
130005332|NCT00467779|467984661|FG013|Stage 3|Death|0|||
130005333|NCT00467779|467984662|FG014|Stage 3|Death|1|||
130005334|NCT00467779|467984648|FG000|Stage 3|Disease Progression|0|||
130005335|NCT00467779|467984649|FG001|Stage 3|Disease Progression|0|||
130005336|NCT00467779|467984650|FG002|Stage 3|Disease Progression|0|||
130005337|NCT00467779|467984651|FG003|Stage 3|Disease Progression|0|||
130005338|NCT00467779|467984652|FG004|Stage 3|Disease Progression|0|||
130005339|NCT00467779|467984653|FG005|Stage 3|Disease Progression|0|||
130005340|NCT00467779|467984654|FG006|Stage 3|Disease Progression|0|||
130005341|NCT00467779|467984655|FG007|Stage 3|Disease Progression|0|||
130005342|NCT00467779|467984656|FG008|Stage 3|Disease Progression|0|||
130005343|NCT00467779|467984657|FG009|Stage 3|Disease Progression|0|||
130005344|NCT00467779|467984658|FG010|Stage 3|Disease Progression|0|||
130005345|NCT00467779|467984659|FG011|Stage 3|Disease Progression|0|||
130005346|NCT00467779|467984660|FG012|Stage 3|Disease Progression|0|||
130005347|NCT00467779|467984661|FG013|Stage 3|Disease Progression|0|||
130005348|NCT00467779|467984662|FG014|Stage 3|Disease Progression|9|||
130005349|NCT00467779|467984648|FG000|Stage 3|Unspecified Reason|0|||
130005350|NCT00467779|467984649|FG001|Stage 3|Unspecified Reason|0|||
130005351|NCT00467779|467984650|FG002|Stage 3|Unspecified Reason|0|||
130005352|NCT00467779|467984651|FG003|Stage 3|Unspecified Reason|0|||
130005353|NCT00467779|467984652|FG004|Stage 3|Unspecified Reason|0|||
130005354|NCT00467779|467984653|FG005|Stage 3|Unspecified Reason|0|||
130005355|NCT00467779|467984654|FG006|Stage 3|Unspecified Reason|0|||
130005356|NCT00467779|467984655|FG007|Stage 3|Unspecified Reason|0|||
130005357|NCT00467779|467984656|FG008|Stage 3|Unspecified Reason|0|||
130005358|NCT00467779|467984657|FG009|Stage 3|Unspecified Reason|0|||
130005359|NCT00467779|467984658|FG010|Stage 3|Unspecified Reason|0|||
130005360|NCT00467779|467984659|FG011|Stage 3|Unspecified Reason|0|||
130005361|NCT00467779|467984660|FG012|Stage 3|Unspecified Reason|0|||
130005362|NCT00467779|467984661|FG013|Stage 3|Unspecified Reason|0|||
130005363|NCT00467779|467984662|FG014|Stage 3|Unspecified Reason|5|||
130005364|NCT01195090|467984665|FG000|Overall Study|Adverse Event|1|||
130005365|NCT01195090|467984666|FG001|Overall Study|Adverse Event|2|||
130005366|NCT01195090|467984665|FG000|Overall Study|Lost to Follow-up|2|||
130005367|NCT01195090|467984666|FG001|Overall Study|Lost to Follow-up|2|||
130005368|NCT01195090|467984665|FG000|Overall Study|Protocol Violation|3|||
130005369|NCT01195090|467984666|FG001|Overall Study|Protocol Violation|4|||
130005370|NCT05111041|467984667|FG000|Overall Study|Lost to Follow-up|6|||
130005371|NCT05111041|467984668|FG001|Overall Study|Lost to Follow-up|7|||
130005372|NCT05111041|467984667|FG000|Overall Study|Withdrawal by Subject|1|||
130005373|NCT05111041|467984668|FG001|Overall Study|Withdrawal by Subject|0|||
130005374|NCT01205230|467984669|FG000|Overall Study|Adverse Event|4|||
130005375|NCT01205230|467984670|FG001|Overall Study|Adverse Event|0|||
130005376|NCT01205230|467984669|FG000|Overall Study|Physician Decision|1|||
130005377|NCT01205230|467984670|FG001|Overall Study|Physician Decision|0|||
130005378|NCT00922480|467984671|FG000|Main Study|Protocol Violation|3|||
130005379|NCT00922480|467984672|FG001|Main Study|Protocol Violation|6|||
130005380|NCT00922480|467984671|FG000|Main Study|Adverse Event|6|||
130005381|NCT00922480|467984672|FG001|Main Study|Adverse Event|7|||
130005382|NCT00922480|467984671|FG000|Main Study|Lack of Efficacy|3|||
130005383|NCT00922480|467984672|FG001|Main Study|Lack of Efficacy|0|||
130005384|NCT00922480|467984671|FG000|Main Study|Withdrawal by Subject|20|||
130005385|NCT00922480|467984672|FG001|Main Study|Withdrawal by Subject|15|||
130005386|NCT00922480|467984671|FG000|Main Study|Lost to Follow-up|5|||
130005387|NCT00922480|467984672|FG001|Main Study|Lost to Follow-up|0|||
130005388|NCT00922480|467984671|FG000|Main Study|Physician Decision|0|||
130005389|NCT00922480|467984672|FG001|Main Study|Physician Decision|1|||
130005390|NCT00922480|467984671|FG000|Extension Study|Protocol Violation|3|||
130005391|NCT00922480|467984672|FG001|Extension Study|Protocol Violation|0|||
130005392|NCT00922480|467984671|FG000|Extension Study|Adverse Event|1|||
130005393|NCT00922480|467984672|FG001|Extension Study|Adverse Event|1|||
130005394|NCT00922480|467984671|FG000|Extension Study|Withdrawal by Subject|1|||
130005395|NCT00922480|467984672|FG001|Extension Study|Withdrawal by Subject|1|||
130005396|NCT00922480|467984671|FG000|Extension Study|Others|0|||
130005397|NCT00922480|467984672|FG001|Extension Study|Others|1|||
130005398|NCT04784897|467984673|FG000|Overall Study|Death|4|||
130005399|NCT04784897|467984674|FG001|Overall Study|Death|2|||
130005400|NCT04784897|467984675|FG002|Overall Study|Death|1|||
130005401|NCT04784897|467984673|FG000|Overall Study|Withdrawal by Subject|0|||
130005402|NCT04784897|467984674|FG001|Overall Study|Withdrawal by Subject|0|||
130005403|NCT04784897|467984675|FG002|Overall Study|Withdrawal by Subject|1|||
130005404|NCT04667377|467984676|FG000|Dose Escalation Period|Other not specified below|3|||
130005405|NCT04667377|467984677|FG001|Dose Escalation Period|Other not specified below|3|||
130005406|NCT04667377|467984678|FG002|Dose Escalation Period|Other not specified below|2|||
130005407|NCT04667377|467984679|FG003|Dose Escalation Period|Other not specified below|1|||
130005408|NCT04667377|467984680|FG004|Dose Escalation Period|Other not specified below|3|||
130005409|NCT04667377|467984676|FG000|Dose Escalation Period|Protocol Violation|2|||
130005410|NCT04667377|467984677|FG001|Dose Escalation Period|Protocol Violation|2|||
130005411|NCT04667377|467984678|FG002|Dose Escalation Period|Protocol Violation|0|||
130005412|NCT04667377|467984679|FG003|Dose Escalation Period|Protocol Violation|2|||
130005413|NCT04667377|467984680|FG004|Dose Escalation Period|Protocol Violation|1|||
130005414|NCT04667377|467984676|FG000|Dose Escalation Period|Burden of study procedures|2|||
130005415|NCT04667377|467984677|FG001|Dose Escalation Period|Burden of study procedures|1|||
130005416|NCT04667377|467984678|FG002|Dose Escalation Period|Burden of study procedures|1|||
130005417|NCT04667377|467984679|FG003|Dose Escalation Period|Burden of study procedures|1|||
130005418|NCT04667377|467984680|FG004|Dose Escalation Period|Burden of study procedures|5|||
130005419|NCT04667377|467984676|FG000|Dose Escalation Period|Change of residence|0|||
130005420|NCT04667377|467984677|FG001|Dose Escalation Period|Change of residence|0|||
130005421|NCT04667377|467984678|FG002|Dose Escalation Period|Change of residence|1|||
130005422|NCT04667377|467984679|FG003|Dose Escalation Period|Change of residence|0|||
130005423|NCT04667377|467984680|FG004|Dose Escalation Period|Change of residence|0|||
130005424|NCT04667377|467984676|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
130005425|NCT04667377|467984677|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
130005426|NCT04667377|467984678|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
130005427|NCT04667377|467984679|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
130005428|NCT04667377|467984680|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
130005429|NCT04667377|467984676|FG000|Dose Escalation Period|Adverse Event|9|||
130005430|NCT04667377|467984677|FG001|Dose Escalation Period|Adverse Event|10|||
130005431|NCT04667377|467984678|FG002|Dose Escalation Period|Adverse Event|12|||
130005432|NCT04667377|467984679|FG003|Dose Escalation Period|Adverse Event|17|||
130005433|NCT04667377|467984680|FG004|Dose Escalation Period|Adverse Event|3|||
130005434|NCT04667377|467984676|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
130005435|NCT04667377|467984677|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
130005436|NCT04667377|467984678|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
130005437|NCT04667377|467984679|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
130005438|NCT04667377|467984680|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
130005439|NCT04667377|467984676|FG000|Dose Escalation Period|Not treated|1|||
130005440|NCT04667377|467984677|FG001|Dose Escalation Period|Not treated|0|||
130005441|NCT04667377|467984678|FG002|Dose Escalation Period|Not treated|0|||
130005442|NCT04667377|467984679|FG003|Dose Escalation Period|Not treated|0|||
130005443|NCT04667377|467984680|FG004|Dose Escalation Period|Not treated|0|||
130005444|NCT04667377|467984676|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
130005445|NCT04667377|467984677|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
130216584|NCT03762681|468755603|FG000|Part 2a|Pandemic Travel Restrictions|0|||
130216585|NCT03762681|468755604|FG001|Part 2a|Pandemic Travel Restrictions|0|||
130005446|NCT04667377|467984678|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
130005447|NCT04667377|467984679|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
130005448|NCT04667377|467984680|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
130005449|NCT04667377|467984676|FG000|Dose Escalation Period|Lost to Follow-up|0|||
130005450|NCT04667377|467984677|FG001|Dose Escalation Period|Lost to Follow-up|1|||
130005451|NCT04667377|467984678|FG002|Dose Escalation Period|Lost to Follow-up|0|||
130005452|NCT04667377|467984679|FG003|Dose Escalation Period|Lost to Follow-up|0|||
130005453|NCT04667377|467984680|FG004|Dose Escalation Period|Lost to Follow-up|0|||
130005454|NCT04667377|467984676|FG000|Maintenance Period|Perceived lack of efficacy|0|||
130005455|NCT04667377|467984677|FG001|Maintenance Period|Perceived lack of efficacy|2|||
130005456|NCT04667377|467984678|FG002|Maintenance Period|Perceived lack of efficacy|1|||
130005457|NCT04667377|467984679|FG003|Maintenance Period|Perceived lack of efficacy|0|||
130005458|NCT04667377|467984680|FG004|Maintenance Period|Perceived lack of efficacy|1|||
130005459|NCT04667377|467984676|FG000|Maintenance Period|Adverse Event|2|||
130005460|NCT04667377|467984677|FG001|Maintenance Period|Adverse Event|8|||
130005461|NCT04667377|467984678|FG002|Maintenance Period|Adverse Event|5|||
130005462|NCT04667377|467984679|FG003|Maintenance Period|Adverse Event|4|||
130005463|NCT04667377|467984680|FG004|Maintenance Period|Adverse Event|1|||
130005464|NCT04667377|467984676|FG000|Maintenance Period|Adverse event: COVID infection|0|||
130005465|NCT04667377|467984677|FG001|Maintenance Period|Adverse event: COVID infection|1|||
130005466|NCT04667377|467984678|FG002|Maintenance Period|Adverse event: COVID infection|0|||
130005467|NCT04667377|467984679|FG003|Maintenance Period|Adverse event: COVID infection|0|||
130005468|NCT04667377|467984680|FG004|Maintenance Period|Adverse event: COVID infection|0|||
130005469|NCT04667377|467984676|FG000|Maintenance Period|COVID-related|0|||
130005470|NCT04667377|467984677|FG001|Maintenance Period|COVID-related|0|||
130005471|NCT04667377|467984678|FG002|Maintenance Period|COVID-related|1|||
130005472|NCT04667377|467984679|FG003|Maintenance Period|COVID-related|1|||
130005473|NCT04667377|467984680|FG004|Maintenance Period|COVID-related|0|||
130005474|NCT04667377|467984676|FG000|Maintenance Period|Protocol Violation|1|||
130005475|NCT04667377|467984677|FG001|Maintenance Period|Protocol Violation|0|||
130005476|NCT04667377|467984678|FG002|Maintenance Period|Protocol Violation|0|||
130005477|NCT04667377|467984679|FG003|Maintenance Period|Protocol Violation|0|||
130005478|NCT04667377|467984680|FG004|Maintenance Period|Protocol Violation|1|||
130005479|NCT04667377|467984676|FG000|Maintenance Period|Burden of study procedures|1|||
130005480|NCT04667377|467984677|FG001|Maintenance Period|Burden of study procedures|2|||
130005481|NCT04667377|467984678|FG002|Maintenance Period|Burden of study procedures|0|||
130005482|NCT04667377|467984679|FG003|Maintenance Period|Burden of study procedures|1|||
130005483|NCT04667377|467984680|FG004|Maintenance Period|Burden of study procedures|0|||
130005484|NCT04667377|467984676|FG000|Maintenance Period|Change of residence|0|||
130005485|NCT04667377|467984677|FG001|Maintenance Period|Change of residence|1|||
130005486|NCT04667377|467984678|FG002|Maintenance Period|Change of residence|0|||
130005487|NCT04667377|467984679|FG003|Maintenance Period|Change of residence|0|||
130005488|NCT04667377|467984680|FG004|Maintenance Period|Change of residence|1|||
130341533|NCT00422084|469223079|FG001|Overall Study|Non-compliance|0|||
130341534|NCT00422084|469223078|FG000|Overall Study|Re-location|0|||
130341535|NCT00422084|469223079|FG001|Overall Study|Re-location|1|||
130341536|NCT00422084|469223078|FG000|Overall Study|Not defined|1|||
130341537|NCT00422084|469223079|FG001|Overall Study|Not defined|1|||
130341538|NCT03774823|469223082|FG000|Overall Study|Withdrawal by Subject|1|||
130341539|NCT03774823|469223083|FG001|Overall Study|Withdrawal by Subject|1|||
130341540|NCT01253811|469223084|FG000|Overall Study|Withdrawal criteria|1|||
130341541|NCT01087736|469223085|FG000|Overall Study|Lost to Follow-up|1|||
130341542|NCT01087736|469223086|FG001|Overall Study|Lost to Follow-up|0|||
130341543|NCT01087736|469223085|FG000|Overall Study|Death|0|||
130341544|NCT01087736|469223086|FG001|Overall Study|Death|1|||
130341545|NCT01087736|469223085|FG000|Overall Study|Withdrawal by Subject|0|||
130341546|NCT01087736|469223086|FG001|Overall Study|Withdrawal by Subject|1|||
130341547|NCT00958438|469223090|FG000|Overall Study|Protocol Violation|3|||
130341548|NCT00958438|469223091|FG001|Overall Study|Protocol Violation|2|||
130341549|NCT00958438|469223092|FG002|Overall Study|Protocol Violation|2|||
130341550|NCT00958438|469223090|FG000|Overall Study|Withdrawal by Subject|4|||
130341551|NCT00958438|469223091|FG001|Overall Study|Withdrawal by Subject|2|||
130341552|NCT00958438|469223092|FG002|Overall Study|Withdrawal by Subject|1|||
130341553|NCT00958438|469223090|FG000|Overall Study|Adverse Event|0|||
130005489|NCT04667377|467984676|FG000|Maintenance Period|Missing|1|||
130005490|NCT04667377|467984677|FG001|Maintenance Period|Missing|0|||
130005491|NCT04667377|467984678|FG002|Maintenance Period|Missing|0|||
130341554|NCT00958438|469223091|FG001|Overall Study|Adverse Event|3|||
130341555|NCT00958438|469223092|FG002|Overall Study|Adverse Event|0|||
130341556|NCT00958438|469223090|FG000|Overall Study|Physician Decision|1|||
130341557|NCT00958438|469223091|FG001|Overall Study|Physician Decision|0|||
130341558|NCT00958438|469223092|FG002|Overall Study|Physician Decision|1|||
130341559|NCT00958438|469223090|FG000|Overall Study|Other than specified above|2|||
129884388|NCT00708305|467536383|FG000|Period 2|Other Reason|1|||
130341560|NCT00958438|469223091|FG001|Overall Study|Other than specified above|3|||
130341561|NCT00958438|469223092|FG002|Overall Study|Other than specified above|2|||
130341562|NCT00759564|469223093|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
130005492|NCT04667377|467984679|FG003|Maintenance Period|Missing|0|||
130005493|NCT04667377|467984680|FG004|Maintenance Period|Missing|0|||
130005494|NCT04667377|467984676|FG000|Maintenance Period|Other than listed above|2|||
130005495|NCT04667377|467984677|FG001|Maintenance Period|Other than listed above|0|||
130005496|NCT04667377|467984678|FG002|Maintenance Period|Other than listed above|3|||
130005497|NCT04667377|467984679|FG003|Maintenance Period|Other than listed above|2|||
130005498|NCT04667377|467984680|FG004|Maintenance Period|Other than listed above|6|||
130005499|NCT04667377|467984676|FG000|Maintenance Period|Withdrawal by Subject|0|||
130005500|NCT04667377|467984677|FG001|Maintenance Period|Withdrawal by Subject|1|||
130005501|NCT04667377|467984678|FG002|Maintenance Period|Withdrawal by Subject|0|||
130005502|NCT04667377|467984679|FG003|Maintenance Period|Withdrawal by Subject|0|||
130005503|NCT04667377|467984680|FG004|Maintenance Period|Withdrawal by Subject|0|||
130005504|NCT04667377|467984676|FG000|Maintenance Period|Lost to Follow-up|1|||
130005505|NCT04667377|467984677|FG001|Maintenance Period|Lost to Follow-up|0|||
130005506|NCT04667377|467984678|FG002|Maintenance Period|Lost to Follow-up|1|||
130005507|NCT04667377|467984679|FG003|Maintenance Period|Lost to Follow-up|0|||
130005508|NCT04667377|467984680|FG004|Maintenance Period|Lost to Follow-up|1|||
130005509|NCT01011439|467984681|FG000|Overall Study|Death|37|||
130005510|NCT01011439|467984681|FG000|Overall Study|Lost to Follow-up|4|||
130005511|NCT01011439|467984681|FG000|Overall Study|Withdrawal by Subject|1|||
130005512|NCT01011439|467984681|FG000|Overall Study|Sponsor's decision|15|||
130005513|NCT02428855|467984682|FG000|Overall Study|Withdrawal by Subject|2|||
130005514|NCT02066311|467984683|FG000|Overall Study|Adverse Event|4|||
130005515|NCT02066311|467984683|FG000|Overall Study|Withdrawal by Subject|1|||
130005516|NCT03198520|467984688|FG000|Overall Study|Physician Decision|2|||
130005517|NCT03198520|467984688|FG000|Overall Study|Protocol Violation|2|||
130005518|NCT03198520|467984688|FG000|Overall Study|Withdrawal by Subject|1|||
130005519|NCT03198520|467984688|FG000|Overall Study|Study Ended|1|||
130005520|NCT01670539|467984689|FG000|Overall Study|Death|3|||
130005521|NCT01670539|467984690|FG001|Overall Study|Death|5|||
130005522|NCT01670539|467984689|FG000|Overall Study|Withdrawal by Subject|3|||
130005523|NCT01670539|467984690|FG001|Overall Study|Withdrawal by Subject|0|||
130005524|NCT00536809|467984691|FG000|Phase II|Adverse Event|1|||
130005525|NCT00536809|467984691|FG000|Phase II|Referred for surgical resection|1|||
130005526|NCT01303965|467984692|FG000|Overall Study|Adverse Event|1|||
130005527|NCT01303965|467984693|FG001|Overall Study|Adverse Event|1|||
130005528|NCT01303965|467984692|FG000|Overall Study|Death|0|||
130005529|NCT01303965|467984693|FG001|Overall Study|Death|3|||
130005530|NCT01303965|467984692|FG000|Overall Study|Withdrawal by Subject|1|||
130005531|NCT01303965|467984693|FG001|Overall Study|Withdrawal by Subject|0|||
130005532|NCT01303965|467984692|FG000|Overall Study|Disease Progression|1|||
130005533|NCT01303965|467984693|FG001|Overall Study|Disease Progression|6|||
130005534|NCT01490814|467984699|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
130005535|NCT01490814|467984700|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
130005536|NCT01490814|467984699|FG000|Overall Study|Physician Decision|1|||
130005537|NCT01490814|467984700|FG001|Overall Study|Physician Decision|0|||
130005538|NCT01490814|467984699|FG000|Overall Study|Withdrawal by Subject|0|||
130005539|NCT01490814|467984700|FG001|Overall Study|Withdrawal by Subject|5|||
130005540|NCT03024970|467984704|FG000|First Intervention|Adverse Event|1|||
130341563|NCT00759564|469223094|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
130341564|NCT00759564|469223095|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
130341565|NCT00759564|469223096|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
130341566|NCT00759564|469223097|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
130341567|NCT02788279|469223098|FG000|Overall Study|Death|62|||
130341568|NCT02788279|469223099|FG001|Overall Study|Death|136|||
130341569|NCT02788279|469223100|FG002|Overall Study|Death|72|||
130341570|NCT02788279|469223098|FG000|Overall Study|Withdrawal by Subject|10|||
130341571|NCT02788279|469223099|FG001|Overall Study|Withdrawal by Subject|15|||
130341572|NCT02788279|469223100|FG002|Overall Study|Withdrawal by Subject|5|||
130341573|NCT02788279|469223098|FG000|Overall Study|Lost to Follow-up|0|||
130341574|NCT02788279|469223099|FG001|Overall Study|Lost to Follow-up|3|||
130341575|NCT02788279|469223100|FG002|Overall Study|Lost to Follow-up|2|||
130341576|NCT02788279|469223098|FG000|Overall Study|Sponsor decision|18|||
130341577|NCT02788279|469223099|FG001|Overall Study|Sponsor decision|29|||
130341578|NCT02788279|469223100|FG002|Overall Study|Sponsor decision|11|||
130341579|NCT00329849|469223101|FG000|Overall Study|Withdrawal by Subject|6|||
130005541|NCT03024970|467984705|FG001|First Intervention|Adverse Event|0|||
130341580|NCT00329849|469223102|FG001|Overall Study|Withdrawal by Subject|4|||
130341581|NCT00653432|469223103|FG000|Overall Study|Adverse Event|4|||
130341582|NCT00653432|469223104|FG001|Overall Study|Adverse Event|1|||
130005542|NCT03024970|467984704|FG000|Second Intervention|Lost to Follow-up|1|||
130341583|NCT00653432|469223103|FG000|Overall Study|Withdrawal by Subject|4|||
130005543|NCT03024970|467984705|FG001|Second Intervention|Lost to Follow-up|0|||
130005544|NCT00773136|467984708|FG000|Overall Study|Physician Decision|2|||
130005545|NCT00888381|467984713|FG000|Overall Study|Lost to Follow-up|0|||
130341584|NCT00653432|469223104|FG001|Overall Study|Withdrawal by Subject|5|||
130341585|NCT00653432|469223103|FG000|Overall Study|Lost to Follow-up|7|||
130341586|NCT00653432|469223104|FG001|Overall Study|Lost to Follow-up|6|||
130341587|NCT00653432|469223103|FG000|Overall Study|Use/Need of Con Therapy|2|||
130341588|NCT00653432|469223104|FG001|Overall Study|Use/Need of Con Therapy|1|||
130341589|NCT00653432|469223103|FG000|Overall Study|Other - Reason Not Provided|5|||
130341590|NCT00653432|469223104|FG001|Overall Study|Other - Reason Not Provided|3|||
130341591|NCT01782469|469223105|FG000|Overall Study|Lost to Follow-up|1|||
130341592|NCT00835211|469223109|FG000|First Intervention|Withdrawal by Subject|0|||
130341593|NCT00835211|469223110|FG001|First Intervention|Withdrawal by Subject|1|||
130341594|NCT00835211|469223109|FG000|Washout: 7 Days|Adverse Event|2|||
130341595|NCT00835211|469223110|FG001|Washout: 7 Days|Adverse Event|1|||
130341596|NCT00835211|469223109|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130341597|NCT00835211|469223110|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130341598|NCT02343549|469223111|FG000|Overall Study|Death|11|||
130341599|NCT02343549|469223111|FG000|Overall Study|Withdrawal by Subject|2|||
130341600|NCT01090323|469223112|FG000|Overall Study|Adverse Event|12|||
130341601|NCT01090323|469223113|FG001|Overall Study|Adverse Event|2|||
130341602|NCT01090323|469223112|FG000|Overall Study|Abnormal Lab Values|3|||
130341603|NCT01090323|469223113|FG001|Overall Study|Abnormal Lab Values|1|||
130341604|NCT01090323|469223112|FG000|Overall Study|Abnormal Test Procedure Results|2|||
130341605|NCT01090323|469223113|FG001|Overall Study|Abnormal Test Procedure Results|0|||
130341606|NCT01090323|469223112|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130341607|NCT01090323|469223113|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130341608|NCT01090323|469223112|FG000|Overall Study|Condition no longer requires drug|5|||
130341609|NCT01090323|469223113|FG001|Overall Study|Condition no longer requires drug|4|||
130341610|NCT01090323|469223112|FG000|Overall Study|Protocol Violation|2|||
130341611|NCT01090323|469223113|FG001|Overall Study|Protocol Violation|1|||
130341612|NCT01090323|469223112|FG000|Overall Study|Withdrew consent|33|||
130341613|NCT01090323|469223113|FG001|Overall Study|Withdrew consent|11|||
130341614|NCT01090323|469223112|FG000|Overall Study|Lost to Follow-up|11|||
130341615|NCT01090323|469223113|FG001|Overall Study|Lost to Follow-up|6|||
130341616|NCT01090323|469223112|FG000|Overall Study|Administrative problems|6|||
130005546|NCT00888381|467984714|FG001|Overall Study|Lost to Follow-up|1|||
130005547|NCT00097773|467984715|FG000|Overall Study|Lost to Follow-up|2|||
130005548|NCT00097773|467984716|FG001|Overall Study|Lost to Follow-up|2|||
130005549|NCT00097773|467984717|FG002|Overall Study|Lost to Follow-up|0|||
130005550|NCT00097773|467984718|FG003|Overall Study|Lost to Follow-up|1|||
130005551|NCT00097773|467984715|FG000|Overall Study|Physician Decision|2|||
130005552|NCT00097773|467984716|FG001|Overall Study|Physician Decision|2|||
130005553|NCT00097773|467984717|FG002|Overall Study|Physician Decision|3|||
130005554|NCT00097773|467984718|FG003|Overall Study|Physician Decision|1|||
130005555|NCT00097773|467984715|FG000|Overall Study|Withdrawal by Subject|3|||
130005556|NCT00097773|467984716|FG001|Overall Study|Withdrawal by Subject|3|||
130005557|NCT00097773|467984717|FG002|Overall Study|Withdrawal by Subject|3|||
130005558|NCT00097773|467984718|FG003|Overall Study|Withdrawal by Subject|1|||
130005559|NCT00097773|467984715|FG000|Overall Study|Adverse Event|0|||
130005560|NCT00097773|467984716|FG001|Overall Study|Adverse Event|1|||
130005561|NCT00097773|467984717|FG002|Overall Study|Adverse Event|0|||
130341617|NCT01090323|469223113|FG001|Overall Study|Administrative problems|4|||
130341618|NCT01090323|469223112|FG000|Overall Study|Death|1|||
130341619|NCT01090323|469223113|FG001|Overall Study|Death|2|||
130341620|NCT01090323|469223112|FG000|Overall Study|Stopped end of core|7|||
130341621|NCT01090323|469223113|FG001|Overall Study|Stopped end of core|0|||
130341622|NCT01090323|469223112|FG000|Overall Study|Stopped end of extension 1#|3|||
130341623|NCT01090323|469223113|FG001|Overall Study|Stopped end of extension 1#|1|||
130341624|NCT05498701|469223114|FG000|Period 3|Adverse Event|1|||
130341625|NCT05498701|469223115|FG001|Period 3|Adverse Event|0|||
130341626|NCT01864005|469223116|FG000|Overall Study|Protocol Violation|0|||
130341627|NCT01864005|469223117|FG001|Overall Study|Protocol Violation|1|||
130341628|NCT01864005|469223116|FG000|Overall Study|Withdrawal by Subject|0|||
130341629|NCT01864005|469223117|FG001|Overall Study|Withdrawal by Subject|1|||
130341630|NCT01864005|469223116|FG000|Overall Study|Incorrect enrolment|1|||
130341631|NCT01864005|469223117|FG001|Overall Study|Incorrect enrolment|0|||
130341632|NCT01864005|469223116|FG000|Overall Study|Disease need|1|||
130005562|NCT00097773|467984718|FG003|Overall Study|Adverse Event|0|||
130216586|NCT03762681|468755605|FG002|Part 2a|Pandemic Travel Restrictions|0|||
130341633|NCT01864005|469223117|FG001|Overall Study|Disease need|1|||
130341634|NCT01864005|469223116|FG000|Overall Study|Need GP IIb/IIIa|1|||
130341635|NCT01864005|469223117|FG001|Overall Study|Need GP IIb/IIIa|3|||
130216587|NCT03762681|468755606|FG003|Part 2a|Pandemic Travel Restrictions|0|||
130341636|NCT02184572|469223121|FG000|Overall Study|Lost to Follow-up|29|||
130341637|NCT02184572|469223122|FG001|Overall Study|Lost to Follow-up|21|||
130341638|NCT02184572|469223121|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
130341639|NCT02184572|469223122|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
130341640|NCT02184572|469223121|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
130341641|NCT02184572|469223122|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
129884389|NCT00708305|467536384|FG001|Period 2|Other Reason|0|||
130005563|NCT00097773|467984715|FG000|Overall Study|Other|1|||
130005564|NCT00097773|467984716|FG001|Overall Study|Other|0|||
130341642|NCT02184572|469223121|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
130005565|NCT00097773|467984717|FG002|Overall Study|Other|2|||
130005566|NCT00097773|467984718|FG003|Overall Study|Other|0|||
130005567|NCT00003702|467984719|FG000|Overall Study|Ineligible cell types|2|||
130005568|NCT00003702|467984720|FG001|Overall Study|Ineligible cell types|2|||
130005569|NCT00003702|467984719|FG000|Overall Study|Did not meet criteria for persistence|8|||
130005570|NCT00003702|467984720|FG001|Overall Study|Did not meet criteria for persistence|5|||
130005571|NCT00003702|467984719|FG000|Overall Study|WHO score > 6|2|||
130005572|NCT00003702|467984720|FG001|Overall Study|WHO score > 6|1|||
130005573|NCT00003702|467984719|FG000|Overall Study|Inadequate documentation of disease|1|||
130005574|NCT00003702|467984720|FG001|Overall Study|Inadequate documentation of disease|3|||
130005575|NCT01009034|467984721|FG000|Overall Study|Lost to Follow-up|2|||
130005576|NCT01009034|467984721|FG000|Overall Study|Withdrawal by Subject|2|||
130005577|NCT01494350|467984722|FG000|Overall Study|Worsening of lesion|1|||
130005578|NCT02054325|467984724|FG000|Overall Study|Lost to Follow-up|8|||
130005579|NCT02054325|467984725|FG001|Overall Study|Lost to Follow-up|5|||
130005580|NCT00617604|467984726|FG000|Overall Study|Death|2|||
130341643|NCT02184572|469223122|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
130341644|NCT02184572|469223121|FG000|Overall Study|Traveling Outside The Country|1|||
130341645|NCT02184572|469223122|FG001|Overall Study|Traveling Outside The Country|0|||
130341646|NCT02184572|469223121|FG000|Overall Study|Withdrawal by Subject|14|||
130341647|NCT02184572|469223122|FG001|Overall Study|Withdrawal by Subject|9|||
130341648|NCT00638183|469223126|FG000|Overall Study|Adverse Event|23|||
130341649|NCT00638183|469223126|FG000|Overall Study|Lack of Efficacy|14|||
130341650|NCT00638183|469223126|FG000|Overall Study|Physician Decision|9|||
130341651|NCT00638183|469223126|FG000|Overall Study|Lost to Follow-up|46|||
130341652|NCT00638183|469223126|FG000|Overall Study|Other reason not defined above|27|||
130341653|NCT00006409|469223127|FG000|Baseline|Protocol Violation|48|||
130341654|NCT00006409|469223128|FG001|Baseline|Protocol Violation|70|||
130341655|NCT00006409|469223129|FG002|Baseline|Protocol Violation|0|||
130341656|NCT00006409|469223130|FG003|Baseline|Protocol Violation|0|||
130341657|NCT00006409|469223131|FG004|Baseline|Protocol Violation|0|||
130341658|NCT00006409|469223132|FG005|Baseline|Protocol Violation|0|||
130341659|NCT00006409|469223127|FG000|Post-2 Year Intervention|Protocol Violation|0|||
130341660|NCT00006409|469223128|FG001|Post-2 Year Intervention|Protocol Violation|0|||
130341661|NCT00006409|469223129|FG002|Post-2 Year Intervention|Protocol Violation|251|||
130341662|NCT00006409|469223130|FG003|Post-2 Year Intervention|Protocol Violation|168|||
130341663|NCT00006409|469223131|FG004|Post-2 Year Intervention|Protocol Violation|0|||
130341664|NCT00006409|469223132|FG005|Post-2 Year Intervention|Protocol Violation|0|||
130341665|NCT00006409|469223127|FG000|Post-3 Year Intervention|Protocol Violation|0|||
130341666|NCT00006409|469223128|FG001|Post-3 Year Intervention|Protocol Violation|0|||
130341667|NCT00006409|469223129|FG002|Post-3 Year Intervention|Protocol Violation|0|||
130341668|NCT00006409|469223130|FG003|Post-3 Year Intervention|Protocol Violation|0|||
130341669|NCT00006409|469223131|FG004|Post-3 Year Intervention|Protocol Violation|62|||
130341670|NCT00006409|469223132|FG005|Post-3 Year Intervention|Protocol Violation|62|||
130341671|NCT02350764|469223133|FG000|Overall Study|Adverse Event|4|||
130341672|NCT02350764|469223133|FG000|Overall Study|Death|3|||
130341673|NCT02350764|469223133|FG000|Overall Study|Physician Decision|2|||
130341674|NCT02350764|469223133|FG000|Overall Study|Withdrawal by Subject|2|||
130341675|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130341676|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130341677|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130341678|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
130341679|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
130341680|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130341681|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130341682|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130341683|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130341684|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
130341685|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
130341686|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
130341687|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341688|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341689|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341690|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130341691|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
130341692|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
130341693|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130341694|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
130341695|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130005581|NCT00617604|467984727|FG001|Overall Study|Death|1|||
130005582|NCT00617604|467984726|FG000|Overall Study|Lost to Follow-up|1|||
130005583|NCT00617604|467984727|FG001|Overall Study|Lost to Follow-up|0|||
130005584|NCT00617604|467984726|FG000|Overall Study|Miscellaneous Reasons|8|||
130005585|NCT00617604|467984727|FG001|Overall Study|Miscellaneous Reasons|10|||
130005586|NCT00617604|467984726|FG000|Overall Study|Withdrawal by Subject|4|||
130005587|NCT00617604|467984727|FG001|Overall Study|Withdrawal by Subject|6|||
130005588|NCT00617604|467984726|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
130005589|NCT00617604|467984727|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
130005590|NCT03250832|467984728|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
130005591|NCT03250832|467984729|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
130341696|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130341697|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
130341698|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
130005592|NCT03250832|467984730|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
130005593|NCT03250832|467984731|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
130005594|NCT03250832|467984732|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
130005595|NCT03250832|467984733|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
130005596|NCT03250832|467984734|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
130005597|NCT03250832|467984735|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
130005598|NCT03250832|467984736|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
130005599|NCT03250832|467984737|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
130005600|NCT03250832|467984738|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
130005601|NCT03250832|467984739|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
130005602|NCT03250832|467984728|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
130005603|NCT03250832|467984729|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
130005604|NCT03250832|467984730|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
130005605|NCT03250832|467984731|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
130005606|NCT03250832|467984732|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
130005607|NCT03250832|467984733|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
130005608|NCT03250832|467984734|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
130005609|NCT03250832|467984735|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130005610|NCT03250832|467984736|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130005611|NCT03250832|467984737|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130005612|NCT03250832|467984738|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130005613|NCT03250832|467984739|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
130005614|NCT03250832|467984728|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005615|NCT03250832|467984729|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005616|NCT03250832|467984730|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
130005617|NCT03250832|467984731|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005618|NCT03250832|467984732|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005619|NCT03250832|467984733|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005620|NCT03250832|467984734|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005621|NCT03250832|467984735|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005622|NCT03250832|467984736|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005623|NCT03250832|467984737|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005624|NCT03250832|467984738|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005625|NCT03250832|467984739|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
130005626|NCT03250832|467984728|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005627|NCT03250832|467984729|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005628|NCT03250832|467984730|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005629|NCT03250832|467984731|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005630|NCT03250832|467984732|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005631|NCT03250832|467984733|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005632|NCT03250832|467984734|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005633|NCT03250832|467984735|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
130005634|NCT03250832|467984736|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005635|NCT03250832|467984737|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005636|NCT03250832|467984738|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005637|NCT03250832|467984739|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
130005638|NCT03250832|467984728|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005639|NCT03250832|467984729|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005640|NCT03250832|467984730|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130341699|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
130341700|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130341701|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130341702|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130005641|NCT03250832|467984731|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005642|NCT03250832|467984732|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130341703|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130341704|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130005643|NCT03250832|467984733|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005644|NCT03250832|467984734|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005645|NCT03250832|467984735|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
130005646|NCT03250832|467984736|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005647|NCT03250832|467984737|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005648|NCT03250832|467984738|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005649|NCT03250832|467984739|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
130005650|NCT03250832|467984728|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005651|NCT03250832|467984729|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005652|NCT03250832|467984730|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005653|NCT03250832|467984731|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005654|NCT03250832|467984732|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005655|NCT03250832|467984733|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005656|NCT03250832|467984734|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005657|NCT03250832|467984735|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
130005658|NCT03250832|467984736|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005659|NCT03250832|467984737|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005660|NCT03250832|467984738|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005661|NCT03250832|467984739|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
130005662|NCT03250832|467984728|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005663|NCT03250832|467984729|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005664|NCT03250832|467984730|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005665|NCT03250832|467984731|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005666|NCT03250832|467984732|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005667|NCT03250832|467984733|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005668|NCT03250832|467984734|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005669|NCT03250832|467984735|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
130005670|NCT03250832|467984736|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005671|NCT03250832|467984737|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005672|NCT03250832|467984738|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005673|NCT03250832|467984739|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
130005674|NCT03250832|467984728|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005675|NCT03250832|467984729|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005676|NCT03250832|467984730|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005677|NCT03250832|467984731|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005678|NCT03250832|467984732|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005679|NCT03250832|467984733|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005680|NCT03250832|467984734|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005681|NCT03250832|467984735|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
130005682|NCT03250832|467984736|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005683|NCT03250832|467984737|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005684|NCT03250832|467984738|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005685|NCT03250832|467984739|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
130005686|NCT03250832|467984728|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005687|NCT03250832|467984729|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005688|NCT03250832|467984730|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005689|NCT03250832|467984731|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005690|NCT03250832|467984732|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005691|NCT03250832|467984733|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005692|NCT03250832|467984734|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005693|NCT03250832|467984735|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005694|NCT03250832|467984736|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
130005695|NCT03250832|467984737|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
130005696|NCT03250832|467984738|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005697|NCT03250832|467984739|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
130005698|NCT03250832|467984728|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005699|NCT03250832|467984729|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005700|NCT03250832|467984730|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005701|NCT03250832|467984731|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130341705|NCT01328444|469223134|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130341706|NCT01328444|469223135|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
130341707|NCT01328444|469223136|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130341708|NCT01328444|469223137|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
130341709|NCT01328444|469223138|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
130341710|NCT01328444|469223139|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130341711|NCT01328444|469223134|FG000|Washout Period (14 Days)|Adverse Event|1|||
130005702|NCT03250832|467984732|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005703|NCT03250832|467984733|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005704|NCT03250832|467984734|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005705|NCT03250832|467984735|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005706|NCT03250832|467984736|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
130005707|NCT03250832|467984737|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
130005708|NCT03250832|467984738|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005709|NCT03250832|467984739|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
130005710|NCT03250832|467984728|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005711|NCT03250832|467984729|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005712|NCT03250832|467984730|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005713|NCT03250832|467984731|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005714|NCT03250832|467984732|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005715|NCT03250832|467984733|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130341712|NCT01328444|469223135|FG001|Washout Period (14 Days)|Adverse Event|1|||
130005716|NCT03250832|467984734|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005717|NCT03250832|467984735|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005718|NCT03250832|467984736|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
130005719|NCT03250832|467984737|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
130005720|NCT03250832|467984738|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005721|NCT03250832|467984739|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
130005722|NCT03250832|467984728|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005723|NCT03250832|467984729|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005724|NCT03250832|467984730|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005725|NCT03250832|467984731|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005726|NCT03250832|467984732|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005727|NCT03250832|467984733|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005728|NCT03250832|467984734|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005729|NCT03250832|467984735|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005730|NCT03250832|467984736|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005731|NCT03250832|467984737|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005732|NCT03250832|467984738|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
130005733|NCT03250832|467984739|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
130005734|NCT02303704|467984740|FG000|Overall Study|Protocol Violation|5|||
130005735|NCT02303704|467984741|FG001|Overall Study|Protocol Violation|9|||
130005736|NCT00397033|467984746|FG000|Overall Study|Adverse Event|7|||
130005737|NCT00397033|467984747|FG001|Overall Study|Adverse Event|10|||
130005738|NCT00397033|467984748|FG002|Overall Study|Adverse Event|4|||
130005739|NCT00397033|467984746|FG000|Overall Study|Lack of Efficacy|22|||
130005740|NCT00397033|467984747|FG001|Overall Study|Lack of Efficacy|12|||
130005741|NCT00397033|467984748|FG002|Overall Study|Lack of Efficacy|9|||
130005742|NCT00397033|467984746|FG000|Overall Study|Lost to Follow-up|3|||
130005743|NCT00397033|467984747|FG001|Overall Study|Lost to Follow-up|3|||
130005744|NCT00397033|467984748|FG002|Overall Study|Lost to Follow-up|3|||
130005745|NCT00397033|467984746|FG000|Overall Study|Withdrawal by Subject|12|||
130005746|NCT00397033|467984747|FG001|Overall Study|Withdrawal by Subject|7|||
130005747|NCT00397033|467984748|FG002|Overall Study|Withdrawal by Subject|5|||
130005748|NCT00397033|467984746|FG000|Overall Study|Other|0|||
130005749|NCT00397033|467984747|FG001|Overall Study|Other|5|||
130005750|NCT00397033|467984748|FG002|Overall Study|Other|2|||
130005751|NCT01984164|467984749|FG000|Overall Study|Withdrawal by Subject|4|||
130341713|NCT01328444|469223136|FG002|Washout Period (14 Days)|Adverse Event|0|||
130005752|NCT01984164|467984750|FG001|Overall Study|Withdrawal by Subject|3|||
130005753|NCT01984164|467984749|FG000|Overall Study|Adverse Event|5|||
130005754|NCT01984164|467984750|FG001|Overall Study|Adverse Event|19|||
130005755|NCT01984164|467984749|FG000|Overall Study|Lost to Follow-up|1|||
130005756|NCT01984164|467984750|FG001|Overall Study|Lost to Follow-up|3|||
130005757|NCT05293743|467984751|FG000|Overall Study|Withdrawal by Subject|1|||
130005758|NCT05293743|467984752|FG001|Overall Study|Withdrawal by Subject|0|||
130005759|NCT00667823|467984753|FG000|Overall Study|Lost to Follow-up|5|||
130005760|NCT00667823|467984753|FG000|Overall Study|Adverse Event|7|||
130005761|NCT00667823|467984753|FG000|Overall Study|Death|182|||
130341714|NCT01328444|469223137|FG003|Washout Period (14 Days)|Adverse Event|1|||
130341715|NCT01328444|469223138|FG004|Washout Period (14 Days)|Adverse Event|1|||
130005762|NCT00667823|467984753|FG000|Overall Study|Withdrawal by Subject|12|||
130005763|NCT00667823|467984753|FG000|Overall Study|Other|8|||
130005764|NCT00667823|467984753|FG000|Overall Study|Missing (completion page missing)|2|||
130005765|NCT00583024|467984754|FG000|Overall Study|Lost to Follow-up|4|||
130005766|NCT00682448|467986265|FG000|Overall Study|Adverse Event|1|||
130341716|NCT01328444|469223139|FG005|Washout Period (14 Days)|Adverse Event|2|||
130341717|NCT01328444|469223134|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
130005767|NCT00682448|467986266|FG001|Overall Study|Adverse Event|2|||
130005768|NCT00682448|467986265|FG000|Overall Study|Lack of Efficacy|1|||
130005769|NCT00682448|467986266|FG001|Overall Study|Lack of Efficacy|0|||
130005770|NCT00682448|467986265|FG000|Overall Study|Lost to Follow-up|1|||
130005771|NCT00682448|467986266|FG001|Overall Study|Lost to Follow-up|3|||
130005772|NCT00682448|467986265|FG000|Overall Study|Pregnancy|0|||
130005773|NCT00682448|467986266|FG001|Overall Study|Pregnancy|1|||
130005774|NCT00682448|467986265|FG000|Overall Study|Withdrawal by Subject|2|||
130005775|NCT00682448|467986266|FG001|Overall Study|Withdrawal by Subject|0|||
130005776|NCT00257166|467986270|FG000|Overall Study|Adverse Event|18|||
130005777|NCT00257166|467986271|FG001|Overall Study|Adverse Event|13|||
130005778|NCT00257166|467986270|FG000|Overall Study|Laboratory abnormality|1|||
130005779|NCT00257166|467986271|FG001|Overall Study|Laboratory abnormality|0|||
130005780|NCT00257166|467986270|FG000|Overall Study|Lost to Follow-up|8|||
130005781|NCT00257166|467986271|FG001|Overall Study|Lost to Follow-up|1|||
130005782|NCT00257166|467986270|FG000|Overall Study|Withdrawal by Subject|9|||
130005783|NCT00257166|467986271|FG001|Overall Study|Withdrawal by Subject|2|||
130005784|NCT00257166|467986270|FG000|Overall Study|Other|16|||
130005785|NCT00257166|467986271|FG001|Overall Study|Other|21|||
130005786|NCT00257166|467986270|FG000|Overall Study|Randomized, but not treated|1|||
130005787|NCT00257166|467986271|FG001|Overall Study|Randomized, but not treated|0|||
130005788|NCT02737852|467986274|FG000|Overall Study|Withdrawal by Subject|2|||
130005789|NCT00525044|467986277|FG000|Overall Study|Lost to Follow-up|0|||
130005790|NCT00525044|467986278|FG001|Overall Study|Lost to Follow-up|1|||
130005791|NCT02553265|467986280|FG000|Enrollment|Death|0|||
130005792|NCT02553265|467986281|FG001|Enrollment|Death|0|||
130005793|NCT02553265|467986282|FG002|Enrollment|Death|1|||
130005794|NCT02553265|467986280|FG000|First Intervention (28 Days)|Adverse Event|1|||
130005795|NCT02553265|467986281|FG001|First Intervention (28 Days)|Adverse Event|0|||
130005796|NCT02553265|467986282|FG002|First Intervention (28 Days)|Adverse Event|0|||
130005797|NCT02553265|467986280|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
130005798|NCT02553265|467986281|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
130005799|NCT02553265|467986282|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
130005800|NCT02553265|467986280|FG000|Second Intervention (28 Days)|Adverse Event|1|||
130005801|NCT02553265|467986281|FG001|Second Intervention (28 Days)|Adverse Event|0|||
130005802|NCT02553265|467986282|FG002|Second Intervention (28 Days)|Adverse Event|0|||
130005803|NCT02553265|467986280|FG000|Third Intervention (28 Days)|Adverse Event|1|||
130005804|NCT02553265|467986281|FG001|Third Intervention (28 Days)|Adverse Event|0|||
130005805|NCT02553265|467986282|FG002|Third Intervention (28 Days)|Adverse Event|0|||
130005806|NCT02553265|467986280|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
130005807|NCT02553265|467986281|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
130005808|NCT02553265|467986282|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
130005809|NCT04042740|467986283|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
130005810|NCT04042740|467986283|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
130005811|NCT02667275|467986286|FG000|Overall Study|Protocol Violation|11|||
130005812|NCT02667275|467986287|FG001|Overall Study|Protocol Violation|7|||
130005813|NCT02667275|467986286|FG000|Overall Study|Lost to Follow-up|0|||
130005814|NCT02667275|467986287|FG001|Overall Study|Lost to Follow-up|2|||
130005815|NCT02667275|467986286|FG000|Overall Study|Withdrawal by Subject|0|||
130005816|NCT02667275|467986287|FG001|Overall Study|Withdrawal by Subject|5|||
130005817|NCT02667275|467986286|FG000|Overall Study|Discontinued early without completing|0|||
130005818|NCT02667275|467986287|FG001|Overall Study|Discontinued early without completing|1|||
130005819|NCT02357134|467986288|FG000|Overall Study|Lost to Follow-up|1|||
130005820|NCT02357134|467986289|FG001|Overall Study|Lost to Follow-up|0|||
130005821|NCT02357134|467986290|FG002|Overall Study|Lost to Follow-up|0|||
130005822|NCT02357134|467986291|FG003|Overall Study|Lost to Follow-up|0|||
130005823|NCT03583450|467986292|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
130005824|NCT03583450|467986293|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
130005825|NCT03374995|467986294|FG000|Overall Study|Withdrawal by Subject|0|||
130005826|NCT03374995|467986295|FG001|Overall Study|Withdrawal by Subject|1|||
130005827|NCT01380730|467986298|FG000|Overall Study|Death|0|||
130341718|NCT01328444|469223135|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
130005828|NCT01380730|467986299|FG001|Overall Study|Death|0|||
130005829|NCT01380730|467986300|FG002|Overall Study|Death|0|||
130005830|NCT01380730|467986301|FG003|Overall Study|Death|0|||
130005831|NCT01380730|467986302|FG004|Overall Study|Death|1|||
130005832|NCT01380730|467986303|FG005|Overall Study|Death|0|||
130005833|NCT01380730|467986304|FG006|Overall Study|Death|0|||
130005834|NCT01380730|467986305|FG007|Overall Study|Death|0|||
130005835|NCT00041080|467986306|FG000|Overall Study|Adverse Event|21|||
130005836|NCT00041080|467986307|FG001|Overall Study|Adverse Event|1|||
130005837|NCT00041080|467986306|FG000|Overall Study|Withdrawal by Subject|6|||
130005838|NCT00041080|467986307|FG001|Overall Study|Withdrawal by Subject|6|||
130005839|NCT00041080|467986306|FG000|Overall Study|Concommitant Illness/Other|1|||
130005840|NCT00041080|467986307|FG001|Overall Study|Concommitant Illness/Other|2|||
130005841|NCT00041080|467986306|FG000|Overall Study|Did not start therapy|1|||
130005842|NCT00041080|467986307|FG001|Overall Study|Did not start therapy|1|||
130005843|NCT00041080|467986306|FG000|Overall Study|Ineligible|1|||
130341719|NCT01328444|469223136|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
130341720|NCT01328444|469223137|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
130341721|NCT01328444|469223138|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
130341722|NCT01328444|469223139|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
130341723|NCT01328444|469223134|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341724|NCT01328444|469223135|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341725|NCT01328444|469223136|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341726|NCT01328444|469223137|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341727|NCT01328444|469223138|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
130341728|NCT01328444|469223139|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
130341729|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
130005844|NCT00041080|467986307|FG001|Overall Study|Ineligible|0|||
130005845|NCT01994382|467986308|FG000|Overall Study|Informed consent withdrawn|0|||
130005846|NCT01994382|467986309|FG001|Overall Study|Informed consent withdrawn|0|||
130005847|NCT01994382|467986310|FG002|Overall Study|Informed consent withdrawn|0|||
130005848|NCT01994382|467986311|FG003|Overall Study|Informed consent withdrawn|0|||
130005849|NCT01994382|467986312|FG004|Overall Study|Informed consent withdrawn|0|||
130005850|NCT01994382|467986313|FG005|Overall Study|Informed consent withdrawn|0|||
130005851|NCT01994382|467986314|FG006|Overall Study|Informed consent withdrawn|1|||
130005852|NCT01994382|467986315|FG007|Overall Study|Informed consent withdrawn|0|||
130005853|NCT01994382|467986316|FG008|Overall Study|Informed consent withdrawn|0|||
130005854|NCT01994382|467986317|FG009|Overall Study|Informed consent withdrawn|0|||
130005855|NCT01994382|467986318|FG010|Overall Study|Informed consent withdrawn|0|||
130005856|NCT01994382|467986319|FG011|Overall Study|Informed consent withdrawn|0|||
130005857|NCT01994382|467986320|FG012|Overall Study|Informed consent withdrawn|0|||
130005858|NCT01994382|467986321|FG013|Overall Study|Informed consent withdrawn|0|||
130005859|NCT01994382|467986322|FG014|Overall Study|Informed consent withdrawn|0|||
130005860|NCT01994382|467986323|FG015|Overall Study|Informed consent withdrawn|0|||
130005861|NCT01994382|467986324|FG016|Overall Study|Informed consent withdrawn|0|||
130005862|NCT01994382|467986308|FG000|Overall Study|Progressive disease|3|||
130005863|NCT01994382|467986309|FG001|Overall Study|Progressive disease|4|||
130005864|NCT01994382|467986310|FG002|Overall Study|Progressive disease|4|||
130005865|NCT01994382|467986311|FG003|Overall Study|Progressive disease|3|||
130005866|NCT01994382|467986312|FG004|Overall Study|Progressive disease|2|||
130005867|NCT01994382|467986313|FG005|Overall Study|Progressive disease|3|||
130005868|NCT01994382|467986314|FG006|Overall Study|Progressive disease|3|||
130005869|NCT01994382|467986315|FG007|Overall Study|Progressive disease|6|||
130005870|NCT01994382|467986316|FG008|Overall Study|Progressive disease|2|||
130005871|NCT01994382|467986317|FG009|Overall Study|Progressive disease|2|||
130341730|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130341731|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130341732|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130005872|NCT01994382|467986318|FG010|Overall Study|Progressive disease|13|||
130005873|NCT01994382|467986319|FG011|Overall Study|Progressive disease|8|||
130005874|NCT01994382|467986320|FG012|Overall Study|Progressive disease|7|||
130005875|NCT01994382|467986321|FG013|Overall Study|Progressive disease|3|||
130005876|NCT01994382|467986322|FG014|Overall Study|Progressive disease|6|||
130005877|NCT01994382|467986323|FG015|Overall Study|Progressive disease|44|||
130005878|NCT01994382|467986324|FG016|Overall Study|Progressive disease|28|||
130005879|NCT01994382|467986308|FG000|Overall Study|Physician Decision|0|||
130005880|NCT01994382|467986309|FG001|Overall Study|Physician Decision|1|||
130005881|NCT01994382|467986310|FG002|Overall Study|Physician Decision|0|||
130005882|NCT01994382|467986311|FG003|Overall Study|Physician Decision|0|||
130005883|NCT01994382|467986312|FG004|Overall Study|Physician Decision|0|||
130341733|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
130341734|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130341735|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
130005884|NCT01994382|467986313|FG005|Overall Study|Physician Decision|0|||
130005885|NCT01994382|467986314|FG006|Overall Study|Physician Decision|0|||
130005886|NCT01994382|467986315|FG007|Overall Study|Physician Decision|0|||
130005887|NCT01994382|467986316|FG008|Overall Study|Physician Decision|0|||
130005888|NCT01994382|467986317|FG009|Overall Study|Physician Decision|0|||
130341736|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130005889|NCT01994382|467986318|FG010|Overall Study|Physician Decision|3|||
130005890|NCT01994382|467986319|FG011|Overall Study|Physician Decision|1|||
130005891|NCT01994382|467986320|FG012|Overall Study|Physician Decision|1|||
130341737|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130005892|NCT01994382|467986321|FG013|Overall Study|Physician Decision|0|||
130005893|NCT01994382|467986322|FG014|Overall Study|Physician Decision|1|||
130341738|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
130341739|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
130341740|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
130005894|NCT01994382|467986323|FG015|Overall Study|Physician Decision|4|||
130005895|NCT01994382|467986324|FG016|Overall Study|Physician Decision|2|||
130005896|NCT01994382|467986308|FG000|Overall Study|Death|0|||
130005897|NCT01994382|467986309|FG001|Overall Study|Death|0|||
130005898|NCT01994382|467986310|FG002|Overall Study|Death|0|||
130005899|NCT01994382|467986311|FG003|Overall Study|Death|0|||
130005900|NCT01994382|467986312|FG004|Overall Study|Death|1|||
130005901|NCT01994382|467986313|FG005|Overall Study|Death|0|||
130005902|NCT01994382|467986314|FG006|Overall Study|Death|0|||
130005903|NCT01994382|467986315|FG007|Overall Study|Death|0|||
130005904|NCT01994382|467986316|FG008|Overall Study|Death|1|||
130005905|NCT01994382|467986317|FG009|Overall Study|Death|1|||
130005906|NCT01994382|467986318|FG010|Overall Study|Death|0|||
130005907|NCT01994382|467986319|FG011|Overall Study|Death|0|||
130005908|NCT01994382|467986320|FG012|Overall Study|Death|0|||
130005909|NCT01994382|467986321|FG013|Overall Study|Death|0|||
130005910|NCT01994382|467986322|FG014|Overall Study|Death|0|||
130005911|NCT01994382|467986323|FG015|Overall Study|Death|1|||
130005912|NCT01994382|467986324|FG016|Overall Study|Death|0|||
130005913|NCT01994382|467986308|FG000|Overall Study|Adverse Event|0|||
130005914|NCT01994382|467986309|FG001|Overall Study|Adverse Event|1|||
130005915|NCT01994382|467986310|FG002|Overall Study|Adverse Event|2|||
130005916|NCT01994382|467986311|FG003|Overall Study|Adverse Event|0|||
130005917|NCT01994382|467986312|FG004|Overall Study|Adverse Event|0|||
130005918|NCT01994382|467986313|FG005|Overall Study|Adverse Event|0|||
130005919|NCT01994382|467986314|FG006|Overall Study|Adverse Event|0|||
130005920|NCT01994382|467986315|FG007|Overall Study|Adverse Event|0|||
130005921|NCT01994382|467986316|FG008|Overall Study|Adverse Event|0|||
130005922|NCT01994382|467986317|FG009|Overall Study|Adverse Event|0|||
130005923|NCT01994382|467986318|FG010|Overall Study|Adverse Event|15|||
130005924|NCT01994382|467986319|FG011|Overall Study|Adverse Event|2|||
130005925|NCT01994382|467986320|FG012|Overall Study|Adverse Event|7|||
130005926|NCT01994382|467986321|FG013|Overall Study|Adverse Event|3|||
130005927|NCT01994382|467986322|FG014|Overall Study|Adverse Event|17|||
130005928|NCT01994382|467986323|FG015|Overall Study|Adverse Event|6|||
130005929|NCT01994382|467986324|FG016|Overall Study|Adverse Event|3|||
130005930|NCT01994382|467986308|FG000|Overall Study|Other than specified|0|||
130005931|NCT01994382|467986309|FG001|Overall Study|Other than specified|0|||
130005932|NCT01994382|467986310|FG002|Overall Study|Other than specified|0|||
130005933|NCT01994382|467986311|FG003|Overall Study|Other than specified|0|||
130005934|NCT01994382|467986312|FG004|Overall Study|Other than specified|0|||
130005935|NCT01994382|467986313|FG005|Overall Study|Other than specified|0|||
130005936|NCT01994382|467986314|FG006|Overall Study|Other than specified|0|||
130005937|NCT01994382|467986315|FG007|Overall Study|Other than specified|0|||
130005938|NCT01994382|467986316|FG008|Overall Study|Other than specified|0|||
130005939|NCT01994382|467986317|FG009|Overall Study|Other than specified|0|||
130005940|NCT01994382|467986318|FG010|Overall Study|Other than specified|2|||
130005941|NCT01994382|467986319|FG011|Overall Study|Other than specified|0|||
130005942|NCT01994382|467986320|FG012|Overall Study|Other than specified|2|||
130005943|NCT01994382|467986321|FG013|Overall Study|Other than specified|0|||
130005944|NCT01994382|467986322|FG014|Overall Study|Other than specified|0|||
130005945|NCT01994382|467986323|FG015|Overall Study|Other than specified|4|||
130005946|NCT01994382|467986324|FG016|Overall Study|Other than specified|4|||
130005947|NCT01994382|467986308|FG000|Overall Study|Withdrawal by Subject|0|||
130005948|NCT01994382|467986309|FG001|Overall Study|Withdrawal by Subject|0|||
130005949|NCT01994382|467986310|FG002|Overall Study|Withdrawal by Subject|0|||
130005950|NCT01994382|467986311|FG003|Overall Study|Withdrawal by Subject|0|||
130005951|NCT01994382|467986312|FG004|Overall Study|Withdrawal by Subject|0|||
130005952|NCT01994382|467986313|FG005|Overall Study|Withdrawal by Subject|0|||
130005953|NCT01994382|467986314|FG006|Overall Study|Withdrawal by Subject|0|||
130005954|NCT01994382|467986315|FG007|Overall Study|Withdrawal by Subject|0|||
130005955|NCT01994382|467986316|FG008|Overall Study|Withdrawal by Subject|0|||
130005956|NCT01994382|467986317|FG009|Overall Study|Withdrawal by Subject|0|||
130005957|NCT01994382|467986318|FG010|Overall Study|Withdrawal by Subject|6|||
130005958|NCT01994382|467986319|FG011|Overall Study|Withdrawal by Subject|0|||
130005959|NCT01994382|467986320|FG012|Overall Study|Withdrawal by Subject|2|||
130005960|NCT01994382|467986321|FG013|Overall Study|Withdrawal by Subject|0|||
130005961|NCT01994382|467986322|FG014|Overall Study|Withdrawal by Subject|4|||
130005962|NCT01994382|467986323|FG015|Overall Study|Withdrawal by Subject|3|||
130005963|NCT01994382|467986324|FG016|Overall Study|Withdrawal by Subject|0|||
130005964|NCT01994382|467986308|FG000|Overall Study|Lost to Follow-up|0|||
130005965|NCT01994382|467986309|FG001|Overall Study|Lost to Follow-up|0|||
130005966|NCT01994382|467986310|FG002|Overall Study|Lost to Follow-up|0|||
130005967|NCT01994382|467986311|FG003|Overall Study|Lost to Follow-up|0|||
130005968|NCT01994382|467986312|FG004|Overall Study|Lost to Follow-up|0|||
130005969|NCT01994382|467986313|FG005|Overall Study|Lost to Follow-up|0|||
130005970|NCT01994382|467986314|FG006|Overall Study|Lost to Follow-up|0|||
130005971|NCT01994382|467986315|FG007|Overall Study|Lost to Follow-up|0|||
130005972|NCT01994382|467986316|FG008|Overall Study|Lost to Follow-up|0|||
130005973|NCT01994382|467986317|FG009|Overall Study|Lost to Follow-up|0|||
130005974|NCT01994382|467986318|FG010|Overall Study|Lost to Follow-up|1|||
130005975|NCT01994382|467986319|FG011|Overall Study|Lost to Follow-up|0|||
130005976|NCT01994382|467986320|FG012|Overall Study|Lost to Follow-up|0|||
130005977|NCT01994382|467986321|FG013|Overall Study|Lost to Follow-up|0|||
130005978|NCT01994382|467986322|FG014|Overall Study|Lost to Follow-up|0|||
130005979|NCT01994382|467986323|FG015|Overall Study|Lost to Follow-up|0|||
130005980|NCT01994382|467986324|FG016|Overall Study|Lost to Follow-up|0|||
130005981|NCT01994382|467986308|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005982|NCT01994382|467986309|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005983|NCT01994382|467986310|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005984|NCT01994382|467986311|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005985|NCT01994382|467986312|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005986|NCT01994382|467986313|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005987|NCT01994382|467986314|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005988|NCT01994382|467986315|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005989|NCT01994382|467986316|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005990|NCT01994382|467986317|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005991|NCT01994382|467986318|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
130005992|NCT01994382|467986319|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005993|NCT01994382|467986320|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
130005994|NCT01994382|467986321|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005995|NCT01994382|467986322|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
130005996|NCT01994382|467986323|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
130005997|NCT01994382|467986324|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
130005998|NCT01994382|467986308|FG000|Overall Study|Protocol violation/noncompliance|0|||
130005999|NCT01994382|467986309|FG001|Overall Study|Protocol violation/noncompliance|0|||
130006000|NCT01994382|467986310|FG002|Overall Study|Protocol violation/noncompliance|0|||
130006001|NCT01994382|467986311|FG003|Overall Study|Protocol violation/noncompliance|0|||
130006002|NCT01994382|467986312|FG004|Overall Study|Protocol violation/noncompliance|0|||
130006003|NCT01994382|467986313|FG005|Overall Study|Protocol violation/noncompliance|0|||
130006004|NCT01994382|467986314|FG006|Overall Study|Protocol violation/noncompliance|0|||
130006005|NCT01994382|467986315|FG007|Overall Study|Protocol violation/noncompliance|0|||
130006006|NCT01994382|467986316|FG008|Overall Study|Protocol violation/noncompliance|0|||
130006007|NCT01994382|467986317|FG009|Overall Study|Protocol violation/noncompliance|0|||
130006008|NCT01994382|467986318|FG010|Overall Study|Protocol violation/noncompliance|0|||
130006009|NCT01994382|467986319|FG011|Overall Study|Protocol violation/noncompliance|1|||
130006010|NCT01994382|467986320|FG012|Overall Study|Protocol violation/noncompliance|0|||
130006011|NCT01994382|467986321|FG013|Overall Study|Protocol violation/noncompliance|0|||
130006012|NCT01994382|467986322|FG014|Overall Study|Protocol violation/noncompliance|0|||
130006013|NCT01994382|467986323|FG015|Overall Study|Protocol violation/noncompliance|0|||
130006014|NCT01994382|467986324|FG016|Overall Study|Protocol violation/noncompliance|2|||
130341741|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
130341742|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341743|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341744|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341745|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
130341746|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
130341747|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341748|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341749|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341750|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130341751|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
130341752|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
130341753|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130341754|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
130341755|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130341756|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130341757|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
130341758|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
130341759|NCT01328444|469223134|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130341760|NCT01328444|469223135|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130341761|NCT01328444|469223136|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129884390|NCT00708305|467536385|FG002|Period 2|Other Reason|0|||
130006015|NCT01994382|467986308|FG000|Overall Study|Rolled over to Phase 2a|0|||
130006016|NCT01994382|467986309|FG001|Overall Study|Rolled over to Phase 2a|0|||
130006017|NCT01994382|467986310|FG002|Overall Study|Rolled over to Phase 2a|1|||
130006018|NCT01994382|467986311|FG003|Overall Study|Rolled over to Phase 2a|0|||
130006019|NCT01994382|467986312|FG004|Overall Study|Rolled over to Phase 2a|0|||
130341762|NCT01328444|469223137|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130341763|NCT01328444|469223138|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130341764|NCT01328444|469223139|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130341765|NCT03531632|469223140|FG000|Overall Study|Adverse Event|0|||
130341766|NCT03531632|469223141|FG001|Overall Study|Adverse Event|0|||
130341767|NCT03531632|469223142|FG002|Overall Study|Adverse Event|1|||
130341768|NCT03531632|469223140|FG000|Overall Study|Death|4|||
130341769|NCT03531632|469223141|FG001|Overall Study|Death|0|||
130341770|NCT03531632|469223142|FG002|Overall Study|Death|14|||
130341771|NCT03531632|469223140|FG000|Overall Study|Study Terminated|1|||
130341772|NCT03531632|469223141|FG001|Overall Study|Study Terminated|3|||
130341773|NCT03531632|469223142|FG002|Overall Study|Study Terminated|11|||
130341774|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
130341775|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
130341776|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
130341777|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
130341778|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
130341779|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
130341780|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130006020|NCT01994382|467986313|FG005|Overall Study|Rolled over to Phase 2a|0|||
130006021|NCT01994382|467986314|FG006|Overall Study|Rolled over to Phase 2a|0|||
130006022|NCT01994382|467986315|FG007|Overall Study|Rolled over to Phase 2a|0|||
130006023|NCT01994382|467986316|FG008|Overall Study|Rolled over to Phase 2a|0|||
130006024|NCT01994382|467986317|FG009|Overall Study|Rolled over to Phase 2a|2|||
130006025|NCT01994382|467986318|FG010|Overall Study|Rolled over to Phase 2a|0|||
130006026|NCT01994382|467986319|FG011|Overall Study|Rolled over to Phase 2a|0|||
130006027|NCT01994382|467986320|FG012|Overall Study|Rolled over to Phase 2a|0|||
130006028|NCT01994382|467986321|FG013|Overall Study|Rolled over to Phase 2a|0|||
130006029|NCT01994382|467986322|FG014|Overall Study|Rolled over to Phase 2a|0|||
130006030|NCT01994382|467986323|FG015|Overall Study|Rolled over to Phase 2a|0|||
130006031|NCT01994382|467986324|FG016|Overall Study|Rolled over to Phase 2a|0|||
130006032|NCT04353596|467986327|FG000|Overall Study|Protocol Violation|4|||
130006033|NCT04353596|467986328|FG001|Overall Study|Protocol Violation|4|||
130006034|NCT04353596|467986327|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
130006035|NCT04353596|467986328|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
130006036|NCT05418673|467986329|FG000|Overall Study|Study Terminated by Sponsor|2|||
130006037|NCT05418673|467986330|FG001|Overall Study|Study Terminated by Sponsor|4|||
130006038|NCT05418673|467986329|FG000|Overall Study|Lost to Follow-up|1|||
130006039|NCT05418673|467986330|FG001|Overall Study|Lost to Follow-up|0|||
130006040|NCT02665052|467986333|FG000|Overall Study|Lost to Follow-up|1|||
130006041|NCT02665052|467986334|FG001|Overall Study|Lost to Follow-up|0|||
130006042|NCT02665052|467986335|FG002|Overall Study|Lost to Follow-up|0|||
130006043|NCT02665052|467986336|FG003|Overall Study|Lost to Follow-up|0|||
130006044|NCT02665052|467986333|FG000|Overall Study|Withdrawal by Subject|1|||
130006045|NCT02665052|467986334|FG001|Overall Study|Withdrawal by Subject|1|||
130006046|NCT02665052|467986335|FG002|Overall Study|Withdrawal by Subject|0|||
130006047|NCT02665052|467986336|FG003|Overall Study|Withdrawal by Subject|5|||
130006048|NCT02665052|467986333|FG000|Overall Study|Adverse Event|1|||
130006049|NCT02665052|467986334|FG001|Overall Study|Adverse Event|1|||
130006050|NCT02665052|467986335|FG002|Overall Study|Adverse Event|0|||
130006051|NCT02665052|467986336|FG003|Overall Study|Adverse Event|0|||
130006052|NCT00823823|467986337|FG000|Overall Study|Lost to Follow-up|3|||
130006053|NCT00823823|467986338|FG001|Overall Study|Lost to Follow-up|1|||
130006054|NCT00823823|467986337|FG000|Overall Study|Protocol Violation|5|||
130006055|NCT00823823|467986338|FG001|Overall Study|Protocol Violation|5|||
130006056|NCT02234284|467986339|FG000|Overall Study|Death|4|||
130006057|NCT02234284|467986340|FG001|Overall Study|Death|2|||
130006058|NCT02234284|467986339|FG000|Overall Study|Withdrawal by Subject|1|||
130341781|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
130341782|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
130341783|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130006059|NCT02234284|467986340|FG001|Overall Study|Withdrawal by Subject|0|||
130006060|NCT02234284|467986339|FG000|Overall Study|Lost to Follow-up|20|||
130006061|NCT02234284|467986340|FG001|Overall Study|Lost to Follow-up|7|||
130006062|NCT01835015|467986341|FG000|Overall Study|Adverse Event|0|||
130006063|NCT01835015|467986342|FG001|Overall Study|Adverse Event|0|||
130006064|NCT01835015|467986343|FG002|Overall Study|Adverse Event|1|||
130006065|NCT01835015|467986344|FG003|Overall Study|Adverse Event|0|||
130006066|NCT01835015|467986345|FG004|Overall Study|Adverse Event|0|||
130006067|NCT00233363|467986352|FG000|Overall Study|Adverse Event|1|||
130006068|NCT00233363|467986353|FG001|Overall Study|Adverse Event|2|||
130006069|NCT00233363|467986352|FG000|Overall Study|Lack of Efficacy|0|||
130006070|NCT00233363|467986353|FG001|Overall Study|Lack of Efficacy|2|||
130006071|NCT00233363|467986352|FG000|Overall Study|Withdrawal by Subject|1|||
130006072|NCT00233363|467986353|FG001|Overall Study|Withdrawal by Subject|1|||
130006073|NCT00233363|467986352|FG000|Overall Study|Aggravation of complication|1|||
130006074|NCT00233363|467986353|FG001|Overall Study|Aggravation of complication|0|||
130006075|NCT01576172|467986354|FG000|Overall Study|Ineligible|2|||
130006076|NCT01576172|467986355|FG001|Overall Study|Ineligible|1|||
130006077|NCT01576172|467986354|FG000|Overall Study|Withdrawal by Subject|2|||
130006078|NCT01576172|467986355|FG001|Overall Study|Withdrawal by Subject|0|||
130006079|NCT01576172|467986354|FG000|Overall Study|Insurance issue|1|||
130006080|NCT01576172|467986355|FG001|Overall Study|Insurance issue|0|||
130006081|NCT02790138|467986356|FG000|Overall Study|Adverse Event|5|||
130006082|NCT02790138|467986357|FG001|Overall Study|Adverse Event|2|||
130006083|NCT02790138|467986356|FG000|Overall Study|Significant Protocol Deviation|0|||
130006084|NCT02790138|467986357|FG001|Overall Study|Significant Protocol Deviation|1|||
130006085|NCT02790138|467986356|FG000|Overall Study|Lost to Follow-up|1|||
130006086|NCT02790138|467986357|FG001|Overall Study|Lost to Follow-up|0|||
130006087|NCT02790138|467986356|FG000|Overall Study|Voluntary Withdrawal|8|||
130006088|NCT02790138|467986357|FG001|Overall Study|Voluntary Withdrawal|9|||
130006089|NCT02790138|467986356|FG000|Overall Study|Lack of Efficacy|6|||
130006090|NCT02790138|467986357|FG001|Overall Study|Lack of Efficacy|7|||
130006091|NCT02790138|467986356|FG000|Overall Study|Reason not Specified|1|||
130006092|NCT02790138|467986357|FG001|Overall Study|Reason not Specified|0|||
130006093|NCT01786603|467986358|FG000|Overall Study|Death|5|||
130006094|NCT01786603|467986359|FG001|Overall Study|Death|1|||
130006095|NCT01786603|467986358|FG000|Overall Study|Adverse Event|6|||
130006096|NCT01786603|467986359|FG001|Overall Study|Adverse Event|2|||
130006097|NCT01786603|467986358|FG000|Overall Study|Physician decision to withdraw|6|||
130006098|NCT01786603|467986359|FG001|Overall Study|Physician decision to withdraw|7|||
130006099|NCT01786603|467986358|FG000|Overall Study|Lost to Follow-up|1|||
130006100|NCT01786603|467986359|FG001|Overall Study|Lost to Follow-up|2|||
130006101|NCT01226459|467986360|FG000|Overall Study|Adverse Event|2|||
130006102|NCT01226459|467986361|FG001|Overall Study|Adverse Event|8|||
130006103|NCT01226459|467986360|FG000|Overall Study|Protocol Violation|4|||
130006104|NCT01226459|467986361|FG001|Overall Study|Protocol Violation|3|||
130006105|NCT01226459|467986360|FG000|Overall Study|Withdrawal by Subject|10|||
130006106|NCT01226459|467986361|FG001|Overall Study|Withdrawal by Subject|13|||
130006107|NCT01226459|467986360|FG000|Overall Study|Lost to Follow-up|4|||
130006108|NCT01226459|467986361|FG001|Overall Study|Lost to Follow-up|8|||
130006109|NCT01226459|467986360|FG000|Overall Study|Pregnancy|1|||
130006110|NCT01226459|467986361|FG001|Overall Study|Pregnancy|0|||
130006111|NCT00474708|467986362|FG000|Overall Study|Lack of Efficacy|11|||
130006112|NCT00474708|467986363|FG001|Overall Study|Lack of Efficacy|5|||
130006113|NCT00474708|467986362|FG000|Overall Study|Suicide ideation/behavior|0|||
130006114|NCT00474708|467986363|FG001|Overall Study|Suicide ideation/behavior|1|||
130006115|NCT00474708|467986362|FG000|Overall Study|Withdrawal by Subject|7|||
130006116|NCT00474708|467986363|FG001|Overall Study|Withdrawal by Subject|0|||
130006117|NCT00474708|467986362|FG000|Overall Study|Lack of compliance|12|||
130006118|NCT00474708|467986363|FG001|Overall Study|Lack of compliance|4|||
130006119|NCT00474708|467986362|FG000|Overall Study|Lost to Follow-up|18|||
130006120|NCT00474708|467986363|FG001|Overall Study|Lost to Follow-up|9|||
130006121|NCT00474708|467986362|FG000|Overall Study|Physician Decision|9|||
130006122|NCT00474708|467986363|FG001|Overall Study|Physician Decision|6|||
130006123|NCT03700320|467986367|FG000|Overall Study|Adverse Event|5|||
130006124|NCT03700320|467986368|FG001|Overall Study|Adverse Event|31|||
130006125|NCT03700320|467986367|FG000|Overall Study|Lack of Efficacy|2|||
130006126|NCT03700320|467986368|FG001|Overall Study|Lack of Efficacy|5|||
130006127|NCT03700320|467986367|FG000|Overall Study|Withdrawal by Subject|29|||
130006128|NCT03700320|467986368|FG001|Overall Study|Withdrawal by Subject|75|||
130006129|NCT03700320|467986367|FG000|Overall Study|Lost to Follow-up|16|||
130006130|NCT03700320|467986368|FG001|Overall Study|Lost to Follow-up|23|||
130006131|NCT03700320|467986367|FG000|Overall Study|Pregnancy|2|||
130006132|NCT03700320|467986368|FG001|Overall Study|Pregnancy|4|||
130341784|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130341785|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130341786|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130341787|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130341788|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
130341789|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130006133|NCT03700320|467986367|FG000|Overall Study|Protocol Deviation|7|||
130006134|NCT03700320|467986368|FG001|Overall Study|Protocol Deviation|31|||
130006135|NCT03700320|467986367|FG000|Overall Study|Non-compliance with Study Drug|1|||
130006136|NCT03700320|467986368|FG001|Overall Study|Non-compliance with Study Drug|3|||
130006137|NCT03700320|467986367|FG000|Overall Study|Reason not Specified|0|||
130006138|NCT03700320|467986368|FG001|Overall Study|Reason not Specified|1|||
130006139|NCT00175877|467986369|FG000|Overall Study|Adverse Event|136|||
130006140|NCT00175877|467986369|FG000|Overall Study|Withdrawal by Subject|141|||
130006141|NCT00175877|467986369|FG000|Overall Study|Lost to Follow-up|9|||
130006142|NCT00175877|467986369|FG000|Overall Study|Lack of Efficacy|26|||
130006143|NCT00175877|467986369|FG000|Overall Study|Protocol Violation|15|||
130006144|NCT00175877|467986369|FG000|Overall Study|Other Reason|20|||
130006145|NCT00175877|467986369|FG000|Overall Study|AE & Other|1|||
130006146|NCT00175877|467986369|FG000|Overall Study|Withdrawal by subject & Other|1|||
130006147|NCT01092143|467986372|FG000|Overall Study|Adverse Event|10|||
130006148|NCT01092143|467986373|FG001|Overall Study|Adverse Event|5|||
130006149|NCT01092143|467986374|FG002|Overall Study|Adverse Event|1|||
130006150|NCT01092143|467986375|FG003|Overall Study|Adverse Event|4|||
130006151|NCT01092143|467986376|FG004|Overall Study|Adverse Event|3|||
130006152|NCT01092143|467986372|FG000|Overall Study|Lost to Follow-up|1|||
130006153|NCT01092143|467986373|FG001|Overall Study|Lost to Follow-up|0|||
130006154|NCT01092143|467986374|FG002|Overall Study|Lost to Follow-up|1|||
130006155|NCT01092143|467986375|FG003|Overall Study|Lost to Follow-up|0|||
130006156|NCT01092143|467986376|FG004|Overall Study|Lost to Follow-up|0|||
130006157|NCT01092143|467986372|FG000|Overall Study|Consent withdrawn|2|||
130006158|NCT01092143|467986373|FG001|Overall Study|Consent withdrawn|1|||
130006159|NCT01092143|467986374|FG002|Overall Study|Consent withdrawn|0|||
130006160|NCT01092143|467986375|FG003|Overall Study|Consent withdrawn|1|||
130006161|NCT01092143|467986376|FG004|Overall Study|Consent withdrawn|3|||
130006162|NCT01092143|467986372|FG000|Overall Study|Not treated|0|||
130006163|NCT01092143|467986373|FG001|Overall Study|Not treated|0|||
130006164|NCT01092143|467986374|FG002|Overall Study|Not treated|1|||
130006165|NCT01092143|467986375|FG003|Overall Study|Not treated|0|||
130006166|NCT01092143|467986376|FG004|Overall Study|Not treated|0|||
130006167|NCT01092143|467986372|FG000|Overall Study|did not reversibility criteria|0|||
130006168|NCT01092143|467986373|FG001|Overall Study|did not reversibility criteria|0|||
130006169|NCT01092143|467986374|FG002|Overall Study|did not reversibility criteria|1|||
130006170|NCT01092143|467986375|FG003|Overall Study|did not reversibility criteria|0|||
130006171|NCT01092143|467986376|FG004|Overall Study|did not reversibility criteria|0|||
130006172|NCT01092143|467986372|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
130006173|NCT01092143|467986373|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
130006174|NCT01092143|467986374|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
130006175|NCT01092143|467986375|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
130006176|NCT01092143|467986376|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
130006177|NCT01092143|467986372|FG000|Overall Study|Ineligible patient|1|||
130006178|NCT01092143|467986373|FG001|Overall Study|Ineligible patient|0|||
130006179|NCT01092143|467986374|FG002|Overall Study|Ineligible patient|0|||
130006180|NCT01092143|467986375|FG003|Overall Study|Ineligible patient|0|||
130006181|NCT01092143|467986376|FG004|Overall Study|Ineligible patient|0|||
130006182|NCT01092143|467986372|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
130006183|NCT01092143|467986373|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
130006184|NCT01092143|467986374|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
130006185|NCT01092143|467986375|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
130006186|NCT01092143|467986376|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
130006187|NCT01092143|467986372|FG000|Overall Study|Patient travel|0|||
130006188|NCT01092143|467986373|FG001|Overall Study|Patient travel|0|||
130006189|NCT01092143|467986374|FG002|Overall Study|Patient travel|0|||
130006190|NCT01092143|467986375|FG003|Overall Study|Patient travel|0|||
130006191|NCT01092143|467986376|FG004|Overall Study|Patient travel|1|||
130006192|NCT01092143|467986372|FG000|Overall Study|Non compliance with study medication|0|||
130006193|NCT01092143|467986373|FG001|Overall Study|Non compliance with study medication|0|||
130006194|NCT01092143|467986374|FG002|Overall Study|Non compliance with study medication|0|||
130006195|NCT01092143|467986375|FG003|Overall Study|Non compliance with study medication|0|||
130006196|NCT01092143|467986376|FG004|Overall Study|Non compliance with study medication|1|||
130006197|NCT01092143|467986372|FG000|Overall Study|Randomized by mistake|0|||
130006198|NCT01092143|467986373|FG001|Overall Study|Randomized by mistake|0|||
130006199|NCT01092143|467986374|FG002|Overall Study|Randomized by mistake|0|||
130006200|NCT01092143|467986375|FG003|Overall Study|Randomized by mistake|1|||
130006201|NCT01092143|467986376|FG004|Overall Study|Randomized by mistake|0|||
130006202|NCT01092143|467986372|FG000|Overall Study|Pregnancy|0|||
130006203|NCT01092143|467986373|FG001|Overall Study|Pregnancy|0|||
130006204|NCT01092143|467986374|FG002|Overall Study|Pregnancy|0|||
130006205|NCT01092143|467986375|FG003|Overall Study|Pregnancy|1|||
130006206|NCT01092143|467986376|FG004|Overall Study|Pregnancy|0|||
130006207|NCT03986866|467986377|FG000|Overall Study|Withdrawal by Subject|0|||
130006208|NCT03986866|467986378|FG001|Overall Study|Withdrawal by Subject|3|||
130006209|NCT03986866|467986377|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
130006210|NCT03986866|467986378|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
130006211|NCT05093322|467986381|FG000|Overall Study|Death|6|||
130006212|NCT05093322|467986382|FG001|Overall Study|Death|2|||
130006213|NCT05093322|467986381|FG000|Overall Study|Other|4|||
130006214|NCT05093322|467986382|FG001|Overall Study|Other|1|||
130006215|NCT00545402|467986385|FG000|Overall Study|Discontinuation of treatment|17|||
130006216|NCT00545402|467986386|FG001|Overall Study|Discontinuation of treatment|9|||
130006217|NCT00545402|467986385|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
130006218|NCT00545402|467986386|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
130006219|NCT00545402|467986385|FG000|Overall Study|Death|5|||
130006220|NCT00545402|467986386|FG001|Overall Study|Death|7|||
130006221|NCT00545402|467986385|FG000|Overall Study|Graft loss|2|||
130006222|NCT00545402|467986386|FG001|Overall Study|Graft loss|4|||
130006223|NCT00545402|467986385|FG000|Overall Study|Withdrawal by Subject|0|||
130006224|NCT00545402|467986386|FG001|Overall Study|Withdrawal by Subject|1|||
130006225|NCT00545402|467986385|FG000|Overall Study|Protocol Violation|1|||
130006226|NCT00545402|467986386|FG001|Overall Study|Protocol Violation|0|||
130006227|NCT00545402|467986385|FG000|Overall Study|Reason not specified|1|||
130006228|NCT00545402|467986386|FG001|Overall Study|Reason not specified|1|||
130006229|NCT00555477|467986387|FG000|Overall Study|Adverse Event|0|||
130006230|NCT00555477|467986388|FG001|Overall Study|Adverse Event|9|||
130006231|NCT00555477|467986387|FG000|Overall Study|Withdrawal by Subject|1|||
130341790|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
130341791|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
130341792|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
130341793|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341794|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341795|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130006232|NCT00555477|467986388|FG001|Overall Study|Withdrawal by Subject|2|||
130006233|NCT00555477|467986387|FG000|Overall Study|Physician Decision|1|||
130006234|NCT00555477|467986388|FG001|Overall Study|Physician Decision|2|||
130006235|NCT01721876|467986389|FG000|Overall Study|Not treated|1|||
130006236|NCT01721876|467986390|FG001|Overall Study|Not treated|4|||
130006237|NCT01721876|467986389|FG000|Overall Study|Disease progression / relapse|123|||
130006238|NCT01721876|467986390|FG001|Overall Study|Disease progression / relapse|156|||
130006239|NCT01721876|467986389|FG000|Overall Study|Death|6|||
130006240|NCT01721876|467986390|FG001|Overall Study|Death|13|||
130006241|NCT01721876|467986389|FG000|Overall Study|Adverse Event|41|||
130006242|NCT01721876|467986390|FG001|Overall Study|Adverse Event|165|||
130006243|NCT01721876|467986389|FG000|Overall Study|Protocol Violation|2|||
130006244|NCT01721876|467986390|FG001|Overall Study|Protocol Violation|1|||
130006245|NCT01721876|467986389|FG000|Overall Study|Withdrawal by Subject|15|||
130006246|NCT01721876|467986390|FG001|Overall Study|Withdrawal by Subject|38|||
130006247|NCT01721876|467986389|FG000|Overall Study|Reason not listed|34|||
130006248|NCT01721876|467986390|FG001|Overall Study|Reason not listed|63|||
130006249|NCT01721876|467986389|FG000|Overall Study|Sponsor terminated trial|0|||
130006250|NCT01721876|467986390|FG001|Overall Study|Sponsor terminated trial|4|||
130006251|NCT01721057|467986393|FG000|Treatment Period|Withdrawal by Subject|11|||
130006252|NCT01721057|467986394|FG001|Treatment Period|Withdrawal by Subject|5|||
130006253|NCT01721057|467986395|FG002|Treatment Period|Withdrawal by Subject|8|||
130006254|NCT01721057|467986396|FG003|Treatment Period|Withdrawal by Subject|0|||
130006255|NCT01721057|467986397|FG004|Treatment Period|Withdrawal by Subject|0|||
130341796|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341797|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
130341798|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
130341799|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
130341800|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
130341801|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
130341802|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
130341803|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
130341804|NCT00600119|469223143|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
130341805|NCT00600119|469223144|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
130341806|NCT00600119|469223145|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341807|NCT00600119|469223146|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341808|NCT00600119|469223147|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341809|NCT00600119|469223148|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
130341810|NCT00600119|469223143|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
130341811|NCT00600119|469223144|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130341812|NCT00600119|469223145|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130341813|NCT00600119|469223146|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
130341814|NCT00600119|469223147|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
130341815|NCT00600119|469223148|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
130341816|NCT00600119|469223143|FG000|Double-blind Treatment Period|Other|0|||
130341817|NCT00600119|469223144|FG001|Double-blind Treatment Period|Other|0|||
130341818|NCT00600119|469223145|FG002|Double-blind Treatment Period|Other|0|||
130341819|NCT00600119|469223146|FG003|Double-blind Treatment Period|Other|0|||
130341820|NCT00600119|469223147|FG004|Double-blind Treatment Period|Other|2|||
130341821|NCT00600119|469223148|FG005|Double-blind Treatment Period|Other|1|||
130006256|NCT01721057|467986398|FG005|Treatment Period|Withdrawal by Subject|0|||
130006257|NCT01721057|467986399|FG006|Treatment Period|Withdrawal by Subject|0|||
130006258|NCT01721057|467986393|FG000|Treatment Period|Adverse Event|7|||
130006259|NCT01721057|467986394|FG001|Treatment Period|Adverse Event|10|||
130006260|NCT01721057|467986395|FG002|Treatment Period|Adverse Event|12|||
130006261|NCT01721057|467986396|FG003|Treatment Period|Adverse Event|0|||
130006262|NCT01721057|467986397|FG004|Treatment Period|Adverse Event|0|||
130006263|NCT01721057|467986398|FG005|Treatment Period|Adverse Event|0|||
130006264|NCT01721057|467986399|FG006|Treatment Period|Adverse Event|0|||
130006265|NCT01721057|467986393|FG000|Treatment Period|Lack of Efficacy|7|||
130006266|NCT01721057|467986394|FG001|Treatment Period|Lack of Efficacy|3|||
130006267|NCT01721057|467986395|FG002|Treatment Period|Lack of Efficacy|0|||
130006268|NCT01721057|467986396|FG003|Treatment Period|Lack of Efficacy|0|||
130006269|NCT01721057|467986397|FG004|Treatment Period|Lack of Efficacy|0|||
130006270|NCT01721057|467986398|FG005|Treatment Period|Lack of Efficacy|0|||
130006271|NCT01721057|467986399|FG006|Treatment Period|Lack of Efficacy|0|||
130006272|NCT01721057|467986393|FG000|Treatment Period|Lost to Follow-up|1|||
130006273|NCT01721057|467986394|FG001|Treatment Period|Lost to Follow-up|0|||
130006274|NCT01721057|467986395|FG002|Treatment Period|Lost to Follow-up|0|||
130006275|NCT01721057|467986396|FG003|Treatment Period|Lost to Follow-up|0|||
130006276|NCT01721057|467986397|FG004|Treatment Period|Lost to Follow-up|0|||
130006277|NCT01721057|467986398|FG005|Treatment Period|Lost to Follow-up|0|||
130006278|NCT01721057|467986399|FG006|Treatment Period|Lost to Follow-up|0|||
130006279|NCT01721057|467986393|FG000|Treatment Period|Physician Decision|0|||
130006280|NCT01721057|467986394|FG001|Treatment Period|Physician Decision|1|||
130006281|NCT01721057|467986395|FG002|Treatment Period|Physician Decision|3|||
130006282|NCT01721057|467986396|FG003|Treatment Period|Physician Decision|0|||
130006283|NCT01721057|467986397|FG004|Treatment Period|Physician Decision|0|||
130006284|NCT01721057|467986398|FG005|Treatment Period|Physician Decision|0|||
130006285|NCT01721057|467986399|FG006|Treatment Period|Physician Decision|0|||
130006286|NCT01721057|467986393|FG000|Treatment Period|Death|2|||
130006287|NCT01721057|467986394|FG001|Treatment Period|Death|0|||
130006288|NCT01721057|467986395|FG002|Treatment Period|Death|0|||
130006289|NCT01721057|467986396|FG003|Treatment Period|Death|0|||
130006290|NCT01721057|467986397|FG004|Treatment Period|Death|0|||
130006291|NCT01721057|467986398|FG005|Treatment Period|Death|0|||
130006292|NCT01721057|467986399|FG006|Treatment Period|Death|0|||
130006293|NCT01721057|467986393|FG000|Rescue Period|Adverse Event|0|||
130006294|NCT01721057|467986394|FG001|Rescue Period|Adverse Event|0|||
130006295|NCT01721057|467986395|FG002|Rescue Period|Adverse Event|0|||
130006296|NCT01721057|467986396|FG003|Rescue Period|Adverse Event|1|||
130006297|NCT01721057|467986397|FG004|Rescue Period|Adverse Event|0|||
130006298|NCT01721057|467986398|FG005|Rescue Period|Adverse Event|0|||
130006299|NCT01721057|467986399|FG006|Rescue Period|Adverse Event|0|||
130006300|NCT01721057|467986393|FG000|Rescue Period|Lack of Efficacy|0|||
130006301|NCT01721057|467986394|FG001|Rescue Period|Lack of Efficacy|0|||
130006302|NCT01721057|467986395|FG002|Rescue Period|Lack of Efficacy|0|||
130006303|NCT01721057|467986396|FG003|Rescue Period|Lack of Efficacy|2|||
130006304|NCT01721057|467986397|FG004|Rescue Period|Lack of Efficacy|0|||
130006305|NCT01721057|467986398|FG005|Rescue Period|Lack of Efficacy|0|||
130006306|NCT01721057|467986399|FG006|Rescue Period|Lack of Efficacy|0|||
130006307|NCT01202279|467986400|FG000|Overall Study|Adverse Event|8|||
130006308|NCT01202279|467986401|FG001|Overall Study|Adverse Event|6|||
130006309|NCT01202279|467986400|FG000|Overall Study|Withdrawal by Subject|13|||
130006310|NCT01202279|467986401|FG001|Overall Study|Withdrawal by Subject|10|||
130006311|NCT01202279|467986400|FG000|Overall Study|Physician Decision|0|||
130006312|NCT01202279|467986401|FG001|Overall Study|Physician Decision|1|||
130341822|NCT00600119|469223143|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341823|NCT00600119|469223144|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
130341824|NCT00600119|469223145|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341825|NCT00600119|469223146|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341826|NCT00600119|469223147|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
130341827|NCT00600119|469223148|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
130341828|NCT00600119|469223143|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341829|NCT00600119|469223144|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
130341830|NCT00600119|469223145|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341831|NCT00600119|469223146|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
129884391|NCT00708305|467536386|FG003|Period 2|Other Reason|1|||
129884392|NCT00708305|467536383|FG000|Period 3|Protocol Violation|0|||
130006313|NCT01202279|467986400|FG000|Overall Study|Lost to Follow-up|10|||
130006314|NCT01202279|467986401|FG001|Overall Study|Lost to Follow-up|7|||
130006315|NCT01202279|467986400|FG000|Overall Study|Protocol Violation|1|||
130006316|NCT01202279|467986401|FG001|Overall Study|Protocol Violation|1|||
130006317|NCT01202279|467986400|FG000|Overall Study|study compliance|5|||
130006318|NCT01202279|467986401|FG001|Overall Study|study compliance|2|||
130006319|NCT01177683|467986402|FG000|Study Treatment|Disease Progressions during treatment|2|||
130006320|NCT01177683|467986403|FG001|Study Treatment|Disease Progressions during treatment|0|||
130006321|NCT01177683|467986404|FG002|Study Treatment|Disease Progressions during treatment|3|||
130006322|NCT01177683|467986402|FG000|Study Treatment|Adverse Event|0|||
130006323|NCT01177683|467986403|FG001|Study Treatment|Adverse Event|1|||
130006324|NCT01177683|467986404|FG002|Study Treatment|Adverse Event|12|||
130006325|NCT01177683|467986402|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130006326|NCT01177683|467986403|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
130006327|NCT01177683|467986404|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
130006328|NCT01177683|467986402|FG000|Study Treatment|Alternative therapy|0|||
130006329|NCT01177683|467986403|FG001|Study Treatment|Alternative therapy|0|||
130006330|NCT01177683|467986404|FG002|Study Treatment|Alternative therapy|4|||
130006331|NCT01177683|467986402|FG000|Study Treatment|Physician Decision|1|||
130006332|NCT01177683|467986403|FG001|Study Treatment|Physician Decision|0|||
130006333|NCT01177683|467986404|FG002|Study Treatment|Physician Decision|1|||
130006334|NCT01177683|467986402|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
130006335|NCT01177683|467986403|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
130006336|NCT01177683|467986404|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
130006337|NCT01177683|467986402|FG000|Study Treatment|Symptomatic Deterioration|0|||
130341832|NCT00600119|469223147|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341833|NCT00600119|469223148|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
130341834|NCT00600119|469223143|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
130341835|NCT00600119|469223144|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
130341836|NCT00600119|469223145|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
130341837|NCT00600119|469223146|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
130341838|NCT00600119|469223147|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
130341839|NCT00600119|469223148|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
130341840|NCT00600119|469223143|FG000|Double-blind Treatment Period|Physician Decision|2|||
130341841|NCT00600119|469223144|FG001|Double-blind Treatment Period|Physician Decision|0|||
130341842|NCT00600119|469223145|FG002|Double-blind Treatment Period|Physician Decision|0|||
130341843|NCT00600119|469223146|FG003|Double-blind Treatment Period|Physician Decision|0|||
130341844|NCT00600119|469223147|FG004|Double-blind Treatment Period|Physician Decision|0|||
130006338|NCT01177683|467986403|FG001|Study Treatment|Symptomatic Deterioration|0|||
130006339|NCT01177683|467986404|FG002|Study Treatment|Symptomatic Deterioration|1|||
130006340|NCT01177683|467986402|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
130006341|NCT01177683|467986403|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
130006342|NCT01177683|467986404|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
130006343|NCT01177683|467986402|FG000|Follow up|Patient lost to follow up|0|||
130006344|NCT01177683|467986403|FG001|Follow up|Patient lost to follow up|0|||
130006345|NCT01177683|467986404|FG002|Follow up|Patient lost to follow up|2|||
130006346|NCT01177683|467986402|FG000|Follow up|Death|2|||
130006347|NCT01177683|467986403|FG001|Follow up|Death|1|||
130006348|NCT01177683|467986404|FG002|Follow up|Death|7|||
130006349|NCT01177683|467986402|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
130006350|NCT01177683|467986403|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
130006351|NCT01177683|467986404|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
130006352|NCT02546765|467986408|FG000|Overall Study|Withdrawal by Subject|0|||
130006353|NCT02546765|467986409|FG001|Overall Study|Withdrawal by Subject|1|||
130006354|NCT02546765|467986410|FG002|Overall Study|Withdrawal by Subject|0|||
130006355|NCT02546765|467986411|FG003|Overall Study|Withdrawal by Subject|0|||
130006356|NCT00475722|467986412|FG000|Overall Study|Withdrawal by Subject|12|||
130006357|NCT00475722|467986413|FG001|Overall Study|Withdrawal by Subject|12|||
130006358|NCT00475722|467986412|FG000|Overall Study|Protocol Violation|3|||
130006359|NCT00475722|467986413|FG001|Overall Study|Protocol Violation|0|||
130006360|NCT00916279|467986414|FG000|Overall Study|Death|2|||
130006361|NCT00916279|467986414|FG000|Overall Study|Lost to Follow-up|2|||
130006362|NCT02064920|467986415|FG000|Overall Study|Adverse Event|0|||
130006363|NCT02064920|467986416|FG001|Overall Study|Adverse Event|4|||
130006364|NCT02064920|467986415|FG000|Overall Study|Physician Decision|0|||
130006365|NCT02064920|467986416|FG001|Overall Study|Physician Decision|1|||
130006366|NCT02064920|467986415|FG000|Overall Study|Technical Problems|0|||
130006367|NCT02064920|467986416|FG001|Overall Study|Technical Problems|1|||
130006368|NCT02064920|467986415|FG000|Overall Study|Withdrawal by Subject|1|||
130006369|NCT02064920|467986416|FG001|Overall Study|Withdrawal by Subject|3|||
130006370|NCT02109562|467986417|FG000|Overall Study|Insufficient clinical response|2|||
130006371|NCT02109562|467986418|FG001|Overall Study|Insufficient clinical response|0|||
130006372|NCT02109562|467986419|FG002|Overall Study|Insufficient clinical response|4|||
130341845|NCT00600119|469223148|FG005|Double-blind Treatment Period|Physician Decision|0|||
130341846|NCT00600119|469223143|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130006373|NCT02109562|467986417|FG000|Overall Study|Adverse Event|0|||
130006374|NCT02109562|467986418|FG001|Overall Study|Adverse Event|2|||
130006375|NCT02109562|467986419|FG002|Overall Study|Adverse Event|3|||
130006376|NCT02109562|467986417|FG000|Overall Study|Lost to Follow-up|1|||
130006377|NCT02109562|467986418|FG001|Overall Study|Lost to Follow-up|0|||
130006378|NCT02109562|467986419|FG002|Overall Study|Lost to Follow-up|1|||
130006379|NCT02109562|467986417|FG000|Overall Study|Protocol Violation|0|||
130006380|NCT02109562|467986418|FG001|Overall Study|Protocol Violation|3|||
130006381|NCT02109562|467986419|FG002|Overall Study|Protocol Violation|1|||
130006382|NCT02109562|467986417|FG000|Overall Study|Withdrawal by Subject|20|||
130341847|NCT00600119|469223144|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130341848|NCT00600119|469223145|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130341849|NCT00600119|469223146|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130341850|NCT00600119|469223147|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
130006383|NCT02109562|467986418|FG001|Overall Study|Withdrawal by Subject|25|||
130006384|NCT02109562|467986419|FG002|Overall Study|Withdrawal by Subject|21|||
130006385|NCT02109562|467986417|FG000|Overall Study|Physician Decision|3|||
130006386|NCT02109562|467986418|FG001|Overall Study|Physician Decision|4|||
130006387|NCT02109562|467986419|FG002|Overall Study|Physician Decision|5|||
130006388|NCT00310804|467986420|FG000|Overall Study|Lost to Follow-up|2|||
130006389|NCT00310804|467986421|FG001|Overall Study|Lost to Follow-up|0|||
130006390|NCT00310804|467986420|FG000|Overall Study|Withdrawal by Subject|3|||
130006391|NCT00310804|467986421|FG001|Overall Study|Withdrawal by Subject|0|||
130006392|NCT00688155|467986426|FG000|Overall Study|Withdrawal by Subject|2|||
130006393|NCT00688155|467986427|FG001|Overall Study|Withdrawal by Subject|2|||
130006394|NCT00688155|467986428|FG002|Overall Study|Withdrawal by Subject|1|||
130006395|NCT00688155|467986429|FG003|Overall Study|Withdrawal by Subject|1|||
130006396|NCT03318978|467986432|FG000|Overall Study|Withdrawal by Subject|1|||
130006397|NCT03734016|467986436|FG000|Overall Study|Sponsor Ended Study|225|||
130006398|NCT03734016|467986437|FG001|Overall Study|Sponsor Ended Study|200|||
130006399|NCT03734016|467986436|FG000|Overall Study|Death|69|||
130006400|NCT03734016|467986437|FG001|Overall Study|Death|83|||
130006401|NCT03734016|467986436|FG000|Overall Study|Withdrawal by Subject|21|||
130006402|NCT03734016|467986437|FG001|Overall Study|Withdrawal by Subject|27|||
130006403|NCT03734016|467986436|FG000|Overall Study|Physician Decision|1|||
130006404|NCT03734016|467986437|FG001|Overall Study|Physician Decision|12|||
130006405|NCT03734016|467986436|FG000|Overall Study|Lost to Follow-up|6|||
130006406|NCT03734016|467986437|FG001|Overall Study|Lost to Follow-up|2|||
130006407|NCT03734016|467986436|FG000|Overall Study|Miscellaneous|5|||
130006408|NCT03734016|467986437|FG001|Overall Study|Miscellaneous|1|||
130006409|NCT02713542|467987771|FG000|Overall Study|Use of prohibited medication|14|||
130006410|NCT02713542|467987772|FG001|Overall Study|Use of prohibited medication|5|||
130006411|NCT02713542|467987771|FG000|Overall Study|Withdrawal by Subject|4|||
130006412|NCT02713542|467987772|FG001|Overall Study|Withdrawal by Subject|1|||
130006413|NCT00066742|467987773|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
130006414|NCT00066742|467987773|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
130006415|NCT00066742|467987773|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
130006416|NCT00066742|467987773|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
130006417|NCT00066742|467987773|FG000|Induction Chemoradiotherapy|Ineligible|3|||
130006418|NCT00066742|467987773|FG000|Consolidation Chemotherapy|not protocol specified|1|||
130006419|NCT00066742|467987773|FG000|Consolidation Chemotherapy|Ineligible|2|||
130006420|NCT01134614|467987777|FG000|Overall Study|Still on treatment as of March 2013|21|||
130006421|NCT01134614|467987778|FG001|Overall Study|Still on treatment as of March 2013|13|||
130006422|NCT01134614|467987777|FG000|Overall Study|Progressive disease|60|||
130006423|NCT01134614|467987778|FG001|Overall Study|Progressive disease|54|||
130006424|NCT01134614|467987777|FG000|Overall Study|Adverse Event|26|||
130006425|NCT01134614|467987778|FG001|Overall Study|Adverse Event|39|||
130006426|NCT01134614|467987777|FG000|Overall Study|Death|5|||
130006427|NCT01134614|467987778|FG001|Overall Study|Death|8|||
130006428|NCT01134614|467987777|FG000|Overall Study|Withdrawal by Subject|3|||
130006429|NCT01134614|467987778|FG001|Overall Study|Withdrawal by Subject|2|||
130006430|NCT01134614|467987777|FG000|Overall Study|Alternative therapy|2|||
130006431|NCT01134614|467987778|FG001|Overall Study|Alternative therapy|0|||
130006432|NCT01134614|467987777|FG000|Overall Study|Complicating disease|2|||
130006433|NCT01134614|467987778|FG001|Overall Study|Complicating disease|1|||
130006434|NCT01134614|467987777|FG000|Overall Study|Physician's decision|0|||
130006435|NCT01134614|467987778|FG001|Overall Study|Physician's decision|1|||
130006436|NCT01134614|467987777|FG000|Overall Study|Never started treatment|4|||
130006437|NCT01134614|467987778|FG001|Overall Study|Never started treatment|1|||
130006438|NCT01134614|467987777|FG000|Overall Study|Pt received tx not allowed on study|0|||
130006439|NCT01134614|467987778|FG001|Overall Study|Pt received tx not allowed on study|1|||
130006440|NCT01134614|467987777|FG000|Overall Study|Symptomatic deterioration|0|||
130006441|NCT01134614|467987778|FG001|Overall Study|Symptomatic deterioration|1|||
130006442|NCT01134614|467987777|FG000|Overall Study|Patient in hospice care|0|||
130006443|NCT01134614|467987778|FG001|Overall Study|Patient in hospice care|1|||
130006444|NCT01519934|467987779|FG000|Overall Study|Lost to Follow-up|3|||
130006445|NCT03861936|467987780|FG000|Overall Study|Withdrawal by Subject|4|||
130006446|NCT03861936|467987781|FG001|Overall Study|Withdrawal by Subject|1|||
130006447|NCT03861936|467987782|FG002|Overall Study|Withdrawal by Subject|3|||
130341851|NCT00600119|469223148|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
130341852|NCT00600119|469223143|FG000|Double-blind Treatment Period|Adverse Event|1|||
130006448|NCT03861936|467987780|FG000|Overall Study|Lost to Follow-up|5|||
130006449|NCT03861936|467987781|FG001|Overall Study|Lost to Follow-up|3|||
130006450|NCT03861936|467987782|FG002|Overall Study|Lost to Follow-up|3|||
130006451|NCT03861936|467987780|FG000|Overall Study|Physician Decision|0|||
130006452|NCT03861936|467987781|FG001|Overall Study|Physician Decision|1|||
130006453|NCT03861936|467987782|FG002|Overall Study|Physician Decision|0|||
130006454|NCT03861936|467987780|FG000|Overall Study|Protocol Deviation|0|||
130006455|NCT03861936|467987781|FG001|Overall Study|Protocol Deviation|0|||
130006456|NCT03861936|467987782|FG002|Overall Study|Protocol Deviation|1|||
130006457|NCT03861936|467987780|FG000|Overall Study|Reason not Specified|5|||
130006458|NCT03861936|467987781|FG001|Overall Study|Reason not Specified|5|||
130006459|NCT03861936|467987782|FG002|Overall Study|Reason not Specified|3|||
130006460|NCT00359021|467987783|FG000|Overall Study|Adverse Event|26|||
130006461|NCT00359021|467987784|FG001|Overall Study|Adverse Event|8|||
130006462|NCT00359021|467987783|FG000|Overall Study|Subject Non-Compliant|1|||
130006463|NCT00359021|467987784|FG001|Overall Study|Subject Non-Compliant|2|||
130006464|NCT00359021|467987783|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
130006465|NCT00359021|467987784|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
130006466|NCT00359021|467987783|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
130006467|NCT00359021|467987784|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
130006468|NCT00359021|467987783|FG000|Overall Study|Withdrawal by Subject|2|||
130006469|NCT00359021|467987784|FG001|Overall Study|Withdrawal by Subject|9|||
130006470|NCT00359021|467987783|FG000|Overall Study|Lost to Follow-up|1|||
130006471|NCT00359021|467987784|FG001|Overall Study|Lost to Follow-up|0|||
130006472|NCT00359021|467987783|FG000|Overall Study|Other|4|||
130006473|NCT00359021|467987784|FG001|Overall Study|Other|1|||
130006474|NCT00359021|467987783|FG000|Overall Study|Pregnancy|1|||
130006475|NCT00359021|467987784|FG001|Overall Study|Pregnancy|0|||
130006476|NCT01236573|467987785|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006477|NCT01236573|467987786|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006478|NCT01236573|467987787|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006479|NCT01236573|467987788|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006480|NCT01236573|467987789|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006481|NCT01236573|467987790|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006482|NCT01236573|467987791|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
130006483|NCT01236573|467987792|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006484|NCT01236573|467987793|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
130006485|NCT01236573|467987794|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
130006486|NCT01236573|467987795|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
130006487|NCT01236573|467987785|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006488|NCT01236573|467987786|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006489|NCT01236573|467987787|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006490|NCT01236573|467987788|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006491|NCT01236573|467987789|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006492|NCT01236573|467987790|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006493|NCT01236573|467987791|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006494|NCT01236573|467987792|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006495|NCT01236573|467987793|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
130006496|NCT01236573|467987794|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006497|NCT01236573|467987795|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
130006498|NCT01236573|467987785|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006499|NCT01236573|467987786|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006500|NCT01236573|467987787|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006501|NCT01236573|467987788|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006502|NCT01236573|467987789|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006503|NCT01236573|467987790|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006504|NCT01236573|467987791|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006505|NCT01236573|467987792|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006506|NCT01236573|467987793|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006507|NCT01236573|467987794|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
130006508|NCT01236573|467987795|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
130006509|NCT02161575|467987802|FG000|Overall Study|Protocol Violation|8|||
130006510|NCT02161575|467987802|FG000|Overall Study|Lack of Efficacy|1|||
130006511|NCT02161575|467987802|FG000|Overall Study|Adverse Event|2|||
130006512|NCT04109222|467987807|FG000|Overall Study|Adverse Event|1|||
130006513|NCT04109222|467987808|FG001|Overall Study|Adverse Event|0|||
130006514|NCT04109222|467987809|FG002|Overall Study|Adverse Event|0|||
130006515|NCT04569032|467987812|FG000|Overall Study|Death|10|||
130006516|NCT04569032|467987813|FG001|Overall Study|Death|13|||
130006517|NCT04569032|467987812|FG000|Overall Study|Withdrawal by Subject|2|||
130341853|NCT00600119|469223144|FG001|Double-blind Treatment Period|Adverse Event|1|||
130341854|NCT00600119|469223145|FG002|Double-blind Treatment Period|Adverse Event|0|||
130341855|NCT00600119|469223146|FG003|Double-blind Treatment Period|Adverse Event|1|||
130006518|NCT04569032|467987813|FG001|Overall Study|Withdrawal by Subject|0|||
130341856|NCT00600119|469223147|FG004|Double-blind Treatment Period|Adverse Event|2|||
130216588|NCT03762681|468755607|FG004|Part 2a|Pandemic Travel Restrictions|0|||
130006519|NCT04569032|467987812|FG000|Overall Study|Lost to Follow-up|0|||
130006520|NCT04569032|467987813|FG001|Overall Study|Lost to Follow-up|1|||
130006521|NCT04569032|467987812|FG000|Overall Study|In long term follow up|22|||
130006522|NCT04569032|467987813|FG001|Overall Study|In long term follow up|34|||
130006523|NCT00701090|467987815|FG000|Overall Study|Adverse Event|11|||
130006524|NCT00701090|467987816|FG001|Overall Study|Adverse Event|2|||
130006525|NCT00701090|467987815|FG000|Overall Study|Death|0|||
130006526|NCT00701090|467987816|FG001|Overall Study|Death|1|||
130006527|NCT00701090|467987815|FG000|Overall Study|Lack of Efficacy|5|||
130006528|NCT00701090|467987816|FG001|Overall Study|Lack of Efficacy|4|||
130006529|NCT00701090|467987815|FG000|Overall Study|Lost to Follow-up|9|||
130006530|NCT00701090|467987816|FG001|Overall Study|Lost to Follow-up|9|||
130006531|NCT00701090|467987815|FG000|Overall Study|Physician Decision|3|||
130006532|NCT00701090|467987816|FG001|Overall Study|Physician Decision|4|||
130006533|NCT00701090|467987815|FG000|Overall Study|Protocol Violation|2|||
130006534|NCT00701090|467987816|FG001|Overall Study|Protocol Violation|3|||
130006535|NCT00701090|467987815|FG000|Overall Study|Withdrawal by Subject|11|||
130006536|NCT00701090|467987816|FG001|Overall Study|Withdrawal by Subject|16|||
130006537|NCT00701090|467987815|FG000|Overall Study|Other|7|||
130006538|NCT00701090|467987816|FG001|Overall Study|Other|12|||
130006539|NCT00873366|467987817|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
130006540|NCT00873366|467987817|FG000|Overall Study|Off tamoxifen due to side effects|2|||
130006541|NCT00873366|467987817|FG000|Overall Study|Refused to continue DM-BT testing|3|||
130006542|NCT01537198|467987830|FG000|Overall Study|RSV infection|2|||
130006543|NCT01537198|467987830|FG000|Overall Study|Adverse Event|4|||
130006544|NCT01537198|467987830|FG000|Overall Study|No Further Visits to the Clinic|37|||
130006545|NCT01537198|467987830|FG000|Overall Study|Other|111|||
130006546|NCT04534491|467987831|FG000|Overall Study|Not completed end-of-study interview|24|||
130006547|NCT04534491|467987831|FG000|Overall Study|Non-users|70|||
130006548|NCT04534491|467987831|FG000|Overall Study|Non-verifiable users|58|||
130006549|NCT01231659|467987832|FG000|Overall Study|Adverse Event|9|||
130006550|NCT01231659|467987832|FG000|Overall Study|Disease Progression|48|||
130006551|NCT01231659|467987832|FG000|Overall Study|Death|2|||
130006552|NCT01231659|467987832|FG000|Overall Study|Patient refused to complete study visit|1|||
130006553|NCT01231659|467987832|FG000|Overall Study|Other protocol defined criteria|12|||
130006554|NCT00131469|467987833|FG000|Overall Study|Withdrawal by Subject|3|||
130006555|NCT00131469|467987834|FG001|Overall Study|Withdrawal by Subject|4|||
130006556|NCT00131469|467987833|FG000|Overall Study|Protocol Violation|3|||
130006557|NCT00131469|467987834|FG001|Overall Study|Protocol Violation|1|||
130006558|NCT00131469|467987833|FG000|Overall Study|Death|0|||
130006559|NCT00131469|467987834|FG001|Overall Study|Death|1|||
130006560|NCT00131469|467987833|FG000|Overall Study|Lost to Follow-up|0|||
130006561|NCT00131469|467987834|FG001|Overall Study|Lost to Follow-up|1|||
130006562|NCT00131469|467987833|FG000|Overall Study|scan not analyzable|3|||
130006563|NCT00131469|467987834|FG001|Overall Study|scan not analyzable|6|||
130006564|NCT00356889|467987835|FG000|Overall Study|Protocol Violation|2|||
130006565|NCT00356889|467987835|FG000|Overall Study|Adverse Event|1|||
130006566|NCT02247960|467987836|FG000|Patient Consent and Randomization|Physician Decision|2|||
130006567|NCT02247960|467987837|FG001|Patient Consent and Randomization|Physician Decision|2|||
130006568|NCT02247960|467987836|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
130006569|NCT02247960|467987837|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
130006570|NCT02247960|467987836|FG000|Catheter Removed|Lost to Follow-up|7|||
130006571|NCT02247960|467987837|FG001|Catheter Removed|Lost to Follow-up|10|||
130006572|NCT00702325|467987838|FG000|Overall Study|Adverse Event|1|||
130006573|NCT00702325|467987839|FG001|Overall Study|Adverse Event|0|||
130006574|NCT00702325|467987838|FG000|Overall Study|Withdrawal by Subject|7|||
130006575|NCT00702325|467987839|FG001|Overall Study|Withdrawal by Subject|7|||
130006576|NCT00702325|467987838|FG000|Overall Study|Lost to Follow-up|3|||
130006577|NCT00702325|467987839|FG001|Overall Study|Lost to Follow-up|4|||
130006578|NCT00702325|467987838|FG000|Overall Study|Incorrect enrollment|5|||
129884393|NCT00708305|467536384|FG001|Period 3|Protocol Violation|2|||
130006579|NCT00702325|467987839|FG001|Overall Study|Incorrect enrollment|7|||
130006580|NCT00702325|467987838|FG000|Overall Study|Developed study discontinuation criteria|18|||
130006581|NCT00702325|467987839|FG001|Overall Study|Developed study discontinuation criteria|28|||
130006582|NCT00702325|467987838|FG000|Overall Study|Severe noncompliance to protocol|3|||
130006583|NCT00702325|467987839|FG001|Overall Study|Severe noncompliance to protocol|3|||
130006584|NCT00702325|467987838|FG000|Overall Study|Termination due to lab results|1|||
130006585|NCT00702325|467987839|FG001|Overall Study|Termination due to lab results|0|||
130006586|NCT00702325|467987838|FG000|Overall Study|Didn't follow study medication dosage|0|||
130006587|NCT00702325|467987839|FG001|Overall Study|Didn't follow study medication dosage|2|||
130006588|NCT00702325|467987838|FG000|Overall Study|Withdrew consent|0|||
130006589|NCT00702325|467987839|FG001|Overall Study|Withdrew consent|1|||
130006590|NCT00702325|467987838|FG000|Overall Study|Incorrectly Discontinued|0|||
130006591|NCT00702325|467987839|FG001|Overall Study|Incorrectly Discontinued|1|||
130006592|NCT01022502|467987843|FG000|Overall Study|Adverse Event|1|||
130006593|NCT01022502|467987843|FG000|Overall Study|employment related reasons|1|||
130006594|NCT01022502|467987843|FG000|Overall Study|Withdrawal by Subject|1|||
130006595|NCT03716050|467987844|FG000|Overall Study|Lost to Follow-up|0|||
130006596|NCT03716050|467987845|FG001|Overall Study|Lost to Follow-up|0|||
130006597|NCT03716050|467987846|FG002|Overall Study|Lost to Follow-up|1|||
130006598|NCT03716050|467987847|FG003|Overall Study|Lost to Follow-up|0|||
130006599|NCT03716050|467987848|FG004|Overall Study|Lost to Follow-up|0|||
130006600|NCT03716050|467987849|FG005|Overall Study|Lost to Follow-up|0|||
130006601|NCT03716050|467987850|FG006|Overall Study|Lost to Follow-up|0|||
130006602|NCT03716050|467987851|FG007|Overall Study|Lost to Follow-up|0|||
130006603|NCT03716050|467987844|FG000|Overall Study|Physician Decision|0|||
130006604|NCT03716050|467987845|FG001|Overall Study|Physician Decision|0|||
130006605|NCT03716050|467987846|FG002|Overall Study|Physician Decision|0|||
130006606|NCT03716050|467987847|FG003|Overall Study|Physician Decision|1|||
130006607|NCT03716050|467987848|FG004|Overall Study|Physician Decision|0|||
130006608|NCT03716050|467987849|FG005|Overall Study|Physician Decision|0|||
130006609|NCT03716050|467987850|FG006|Overall Study|Physician Decision|0|||
130006610|NCT03716050|467987851|FG007|Overall Study|Physician Decision|0|||
130006611|NCT03716050|467987844|FG000|Overall Study|Protocol Violation|0|||
130006612|NCT03716050|467987845|FG001|Overall Study|Protocol Violation|0|||
130006613|NCT03716050|467987846|FG002|Overall Study|Protocol Violation|0|||
130006614|NCT03716050|467987847|FG003|Overall Study|Protocol Violation|1|||
130006615|NCT03716050|467987848|FG004|Overall Study|Protocol Violation|0|||
130006616|NCT03716050|467987849|FG005|Overall Study|Protocol Violation|0|||
130006617|NCT03716050|467987850|FG006|Overall Study|Protocol Violation|0|||
130006618|NCT03716050|467987851|FG007|Overall Study|Protocol Violation|2|||
130006619|NCT03123250|467987852|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
130006620|NCT01390272|467987853|FG000|Overall Study|Death|3|||
130006621|NCT01390272|467987854|FG001|Overall Study|Death|2|||
130006622|NCT01390272|467987853|FG000|Overall Study|Withdrawal by Subject|9|||
130006623|NCT01390272|467987854|FG001|Overall Study|Withdrawal by Subject|5|||
130006624|NCT01390272|467987853|FG000|Overall Study|Patient moved, no longer eligible|5|||
130006625|NCT01390272|467987854|FG001|Overall Study|Patient moved, no longer eligible|8|||
130006626|NCT03199040|467987855|FG000|Overall Study|Lack of Efficacy|2|||
130006627|NCT03199040|467987856|FG001|Overall Study|Lack of Efficacy|0|||
130006628|NCT03199040|467987855|FG000|Overall Study|Withdrawal by Subject|2|||
130006629|NCT03199040|467987856|FG001|Overall Study|Withdrawal by Subject|0|||
130006630|NCT03199040|467987855|FG000|Overall Study|Adverse Event|0|||
130006631|NCT03199040|467987856|FG001|Overall Study|Adverse Event|1|||
130006632|NCT03199040|467987855|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
130006633|NCT03199040|467987856|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
130006634|NCT00199836|467987857|FG000|Overall Study|Progressive Disease|5|||
130006635|NCT00199836|467987857|FG000|Overall Study|Death|1|||
130006636|NCT01854645|467987863|FG000|Overall Study|Protocol-Specified Criteria|13|||
130006637|NCT01854645|467987864|FG001|Overall Study|Protocol-Specified Criteria|10|||
130006638|NCT01854645|467987865|FG002|Overall Study|Protocol-Specified Criteria|8|||
130006639|NCT01854645|467987866|FG003|Overall Study|Protocol-Specified Criteria|5|||
130006640|NCT01854645|467987867|FG004|Overall Study|Protocol-Specified Criteria|7|||
130006641|NCT01854645|467987863|FG000|Overall Study|Administrative Reasons / Missing|0|||
130006642|NCT01854645|467987864|FG001|Overall Study|Administrative Reasons / Missing|0|||
130006643|NCT01854645|467987865|FG002|Overall Study|Administrative Reasons / Missing|0|||
130006644|NCT01854645|467987866|FG003|Overall Study|Administrative Reasons / Missing|1|||
130006645|NCT01854645|467987867|FG004|Overall Study|Administrative Reasons / Missing|1|||
130006646|NCT01854645|467987863|FG000|Overall Study|Protocol Violation|3|||
130006647|NCT01854645|467987864|FG001|Overall Study|Protocol Violation|0|||
130006648|NCT01854645|467987865|FG002|Overall Study|Protocol Violation|5|||
130006649|NCT01854645|467987866|FG003|Overall Study|Protocol Violation|4|||
130006650|NCT01854645|467987867|FG004|Overall Study|Protocol Violation|1|||
130006651|NCT01854645|467987863|FG000|Overall Study|Lost to Follow-up|10|||
130006652|NCT01854645|467987864|FG001|Overall Study|Lost to Follow-up|7|||
130006653|NCT01854645|467987865|FG002|Overall Study|Lost to Follow-up|8|||
130006654|NCT01854645|467987866|FG003|Overall Study|Lost to Follow-up|5|||
130006655|NCT01854645|467987867|FG004|Overall Study|Lost to Follow-up|0|||
130006656|NCT01854645|467987863|FG000|Overall Study|Physician Decision|1|||
130006657|NCT01854645|467987864|FG001|Overall Study|Physician Decision|5|||
130006658|NCT01854645|467987865|FG002|Overall Study|Physician Decision|3|||
130006659|NCT01854645|467987866|FG003|Overall Study|Physician Decision|3|||
130006660|NCT01854645|467987867|FG004|Overall Study|Physician Decision|7|||
130341857|NCT00600119|469223148|FG005|Double-blind Treatment Period|Adverse Event|10|||
130341858|NCT00600119|469223143|FG000|Follow-up Period|Adverse Event|0|||
130341859|NCT00600119|469223144|FG001|Follow-up Period|Adverse Event|0|||
130006661|NCT01854645|467987863|FG000|Overall Study|Withdrawal by Subject|31|||
130006662|NCT01854645|467987864|FG001|Overall Study|Withdrawal by Subject|41|||
130006663|NCT01854645|467987865|FG002|Overall Study|Withdrawal by Subject|30|||
130006664|NCT01854645|467987866|FG003|Overall Study|Withdrawal by Subject|21|||
130006665|NCT01854645|467987867|FG004|Overall Study|Withdrawal by Subject|24|||
130006666|NCT01854645|467987863|FG000|Overall Study|Lack of Efficacy|7|||
129884394|NCT00708305|467536385|FG002|Period 3|Protocol Violation|0|||
130006667|NCT01854645|467987864|FG001|Overall Study|Lack of Efficacy|12|||
130006668|NCT01854645|467987865|FG002|Overall Study|Lack of Efficacy|9|||
130341860|NCT00600119|469223145|FG002|Follow-up Period|Adverse Event|0|||
130006669|NCT01854645|467987866|FG003|Overall Study|Lack of Efficacy|3|||
130006670|NCT01854645|467987867|FG004|Overall Study|Lack of Efficacy|9|||
130006671|NCT01854645|467987863|FG000|Overall Study|Adverse Event|33|||
130006672|NCT01854645|467987864|FG001|Overall Study|Adverse Event|31|||
130006673|NCT01854645|467987865|FG002|Overall Study|Adverse Event|19|||
130006674|NCT01854645|467987866|FG003|Overall Study|Adverse Event|20|||
130006675|NCT01854645|467987867|FG004|Overall Study|Adverse Event|11|||
130006676|NCT00430482|467987868|FG000|Completed Treatment|Insufficient Treatment|7|||
130006677|NCT00430482|467987869|FG001|Completed Treatment|Insufficient Treatment|11|||
130006678|NCT01889238|467987871|FG000|Overall Study|Death|1|||
130006679|NCT01889238|467987871|FG000|Overall Study|Withdrawal by Subject|1|||
130006680|NCT01889238|467987871|FG000|Overall Study|Adverse Event|6|||
130006681|NCT01889238|467987871|FG000|Overall Study|Disease Progression|104|||
130006682|NCT01889238|467987871|FG000|Overall Study|Other|6|||
130006683|NCT04136184|467987872|FG000|Overall Study|Lost to Follow-up|0|||
130341861|NCT00600119|469223146|FG003|Follow-up Period|Adverse Event|0|||
130341862|NCT00600119|469223147|FG004|Follow-up Period|Adverse Event|0|||
130341863|NCT00600119|469223148|FG005|Follow-up Period|Adverse Event|1|||
130341864|NCT00600119|469223143|FG000|Follow-up Period|Other|1|||
130006684|NCT04136184|467987873|FG001|Overall Study|Lost to Follow-up|3|||
130006685|NCT04136184|467987872|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
130006686|NCT04136184|467987873|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
130006687|NCT02844816|467987877|FG000|Overall Study|No protocol treatment received|5|||
130006688|NCT02844816|467987878|FG001|Overall Study|No protocol treatment received|1|||
130006689|NCT02844816|467987877|FG000|Overall Study|Ineligible|22|||
130006690|NCT02844816|467987878|FG001|Overall Study|Ineligible|15|||
130006691|NCT02844816|467987877|FG000|Overall Study|Participant refusal|5|||
130006692|NCT02844816|467987878|FG001|Overall Study|Participant refusal|5|||
130006693|NCT02844816|467987877|FG000|Overall Study|Adverse Event|5|||
130006694|NCT02844816|467987878|FG001|Overall Study|Adverse Event|4|||
130006695|NCT02844816|467987877|FG000|Overall Study|Death|0|||
130006696|NCT02844816|467987878|FG001|Overall Study|Death|1|||
130006697|NCT02844816|467987877|FG000|Overall Study|Disease progression/recurrence|50|||
130006698|NCT02844816|467987878|FG001|Overall Study|Disease progression/recurrence|24|||
130006699|NCT02844816|467987877|FG000|Overall Study|Physician Decision|1|||
130006700|NCT02844816|467987878|FG001|Overall Study|Physician Decision|1|||
130006701|NCT02717754|467987880|FG000|Overall Study|Incorrect Infusion Duration|0|||
130006702|NCT02717754|467987881|FG001|Overall Study|Incorrect Infusion Duration|0|||
130006703|NCT02717754|467987882|FG002|Overall Study|Incorrect Infusion Duration|0|||
130006704|NCT02717754|467987883|FG003|Overall Study|Incorrect Infusion Duration|10|||
130006705|NCT02717754|467987884|FG004|Overall Study|Incorrect Infusion Duration|20|||
130006706|NCT02717754|467987885|FG005|Overall Study|Incorrect Infusion Duration|20|||
130006707|NCT01200238|467987886|FG000|Overall Study|Adverse Event|2|||
130006708|NCT01200238|467987887|FG001|Overall Study|Adverse Event|1|||
130006709|NCT01200238|467987886|FG000|Overall Study|Progressive Disease|5|||
130006710|NCT01200238|467987887|FG001|Overall Study|Progressive Disease|8|||
130006711|NCT01200238|467987886|FG000|Overall Study|Withdrawal by Subject|0|||
130006712|NCT01200238|467987887|FG001|Overall Study|Withdrawal by Subject|1|||
130006713|NCT01979835|467987888|FG000|Primary Outcome SA Measurment|failed insertion|18|||
130006714|NCT01979835|467987888|FG000|Follow-up|Lost to Follow-up|32|||
130006715|NCT02592018|467987889|FG000|Overall Study|Adverse Event|1|||
130006716|NCT02592018|467987889|FG000|Overall Study|Lost to Follow-up|1|||
130006717|NCT02710136|467987892|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
130006718|NCT02710136|467987893|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
130006719|NCT00418665|467987894|FG000|Treatment Period|Ineligibility determined|1|||
130006720|NCT00418665|467987895|FG001|Treatment Period|Ineligibility determined|1|||
130006721|NCT00418665|467987896|FG002|Treatment Period|Ineligibility determined|0|||
130341865|NCT00600119|469223144|FG001|Follow-up Period|Other|0|||
130341866|NCT00600119|469223145|FG002|Follow-up Period|Other|0|||
130341867|NCT00600119|469223146|FG003|Follow-up Period|Other|0|||
130341868|NCT00600119|469223147|FG004|Follow-up Period|Other|0|||
130341869|NCT00600119|469223148|FG005|Follow-up Period|Other|0|||
130341870|NCT03241368|469223149|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
130341871|NCT03241368|469223149|FG000|Overall Study|Lost to Follow-up|1|||
130006722|NCT00418665|467987894|FG000|Treatment Period|Adverse Event|2|||
130006723|NCT00418665|467987895|FG001|Treatment Period|Adverse Event|2|||
130006724|NCT00418665|467987896|FG002|Treatment Period|Adverse Event|0|||
130006725|NCT00418665|467987894|FG000|Treatment Period|Withdrawal by Subject|0|||
130006726|NCT00418665|467987895|FG001|Treatment Period|Withdrawal by Subject|3|||
130006727|NCT00418665|467987896|FG002|Treatment Period|Withdrawal by Subject|1|||
130006728|NCT00418665|467987894|FG000|Treatment Period|Requirement for alternative therapy|1|||
130006729|NCT00418665|467987895|FG001|Treatment Period|Requirement for alternative therapy|0|||
130006730|NCT00418665|467987896|FG002|Treatment Period|Requirement for alternative therapy|0|||
130341872|NCT03241368|469223149|FG000|Overall Study|Physician Decision|6|||
130341873|NCT03241368|469223149|FG000|Overall Study|Withdrawal by Subject|6|||
130341874|NCT03241368|469223149|FG000|Overall Study|Protocol Violation|1|||
130341875|NCT00729469|469223150|FG000|Overall Study|Adverse Event|14|||
130341876|NCT00729469|469223151|FG001|Overall Study|Adverse Event|25|||
130006731|NCT00418665|467987894|FG000|Treatment Period|Physician Decision|1|||
130006732|NCT00418665|467987895|FG001|Treatment Period|Physician Decision|0|||
130006733|NCT00418665|467987896|FG002|Treatment Period|Physician Decision|3|||
130006734|NCT00418665|467987894|FG000|Treatment Extension|Adverse Event|1|||
130006735|NCT00418665|467987895|FG001|Treatment Extension|Adverse Event|0|||
130006736|NCT00418665|467987896|FG002|Treatment Extension|Adverse Event|0|||
130006737|NCT00418665|467987894|FG000|Treatment Extension|Withdrawal by Subject|1|||
130006738|NCT00418665|467987895|FG001|Treatment Extension|Withdrawal by Subject|0|||
130006739|NCT00418665|467987896|FG002|Treatment Extension|Withdrawal by Subject|0|||
130006740|NCT00418665|467987894|FG000|Treatment Extension|Requirement for alternative therapy|2|||
130006741|NCT00418665|467987895|FG001|Treatment Extension|Requirement for alternative therapy|2|||
130006742|NCT00418665|467987896|FG002|Treatment Extension|Requirement for alternative therapy|0|||
130006743|NCT00418665|467987894|FG000|Treatment Extension|Physician Decision|2|||
130006744|NCT00418665|467987895|FG001|Treatment Extension|Physician Decision|2|||
130006745|NCT00418665|467987896|FG002|Treatment Extension|Physician Decision|1|||
130006746|NCT00418665|467987894|FG000|Treatment Extension|Death|0|||
130006747|NCT00418665|467987895|FG001|Treatment Extension|Death|0|||
130006748|NCT00418665|467987896|FG002|Treatment Extension|Death|1|||
130006749|NCT01133379|467987899|FG000|Overall Study|Withdrawal by Subject|0|||
130006750|NCT01133379|467987900|FG001|Overall Study|Withdrawal by Subject|1|||
130006751|NCT01133379|467987901|FG002|Overall Study|Withdrawal by Subject|1|||
130006752|NCT01133379|467987899|FG000|Overall Study|Lost to Follow-up|1|||
130006753|NCT01133379|467987900|FG001|Overall Study|Lost to Follow-up|1|||
130006754|NCT01133379|467987901|FG002|Overall Study|Lost to Follow-up|1|||
130006755|NCT00591214|467987902|FG000|Overall Study|Physician Decision|7|||
130006756|NCT00591214|467987902|FG000|Overall Study|Withdrawal by Subject|1|||
130006757|NCT01129921|467987905|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
130006758|NCT01129921|467987906|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
130006759|NCT01129921|467987905|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
130006760|NCT01129921|467987906|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
130006761|NCT01129921|467987905|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
130006762|NCT01129921|467987906|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
130006763|NCT01129921|467987905|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
130006764|NCT01129921|467987906|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
130006765|NCT05050318|467989060|FG000|Overall Study|Protocol Deviation|1|||
130006766|NCT05050318|467989061|FG001|Overall Study|Protocol Deviation|0|||
130006767|NCT05050318|467989062|FG002|Overall Study|Protocol Deviation|0|||
130006768|NCT00574145|467989070|FG000|Overall Study|Withdrawal by Subject|2|||
130006769|NCT00574145|467989071|FG001|Overall Study|Withdrawal by Subject|1|||
130006770|NCT03227471|467989075|FG000|Overall Study|Withdrawal by Subject|0|||
130006771|NCT03227471|467989076|FG001|Overall Study|Withdrawal by Subject|0|||
130006772|NCT03227471|467989077|FG002|Overall Study|Withdrawal by Subject|0|||
130006773|NCT03227471|467989078|FG003|Overall Study|Withdrawal by Subject|0|||
130006774|NCT03227471|467989079|FG004|Overall Study|Withdrawal by Subject|1|||
130006775|NCT03227471|467989080|FG005|Overall Study|Withdrawal by Subject|0|||
130006776|NCT03227471|467989081|FG006|Overall Study|Withdrawal by Subject|0|||
130006777|NCT03227471|467989082|FG007|Overall Study|Withdrawal by Subject|0|||
130006778|NCT03227471|467989083|FG008|Overall Study|Withdrawal by Subject|0|||
130006779|NCT03227471|467989084|FG009|Overall Study|Withdrawal by Subject|0|||
130006780|NCT03227471|467989085|FG010|Overall Study|Withdrawal by Subject|0|||
130006781|NCT03227471|467989086|FG011|Overall Study|Withdrawal by Subject|0|||
130006782|NCT03227471|467989087|FG012|Overall Study|Withdrawal by Subject|1|||
130006783|NCT03227471|467989088|FG013|Overall Study|Withdrawal by Subject|0|||
130006784|NCT03227471|467989089|FG014|Overall Study|Withdrawal by Subject|0|||
130006785|NCT03227471|467989075|FG000|Overall Study|Randomized, Never Dosed|0|||
130006786|NCT03227471|467989076|FG001|Overall Study|Randomized, Never Dosed|0|||
130006787|NCT03227471|467989077|FG002|Overall Study|Randomized, Never Dosed|0|||
130006788|NCT03227471|467989078|FG003|Overall Study|Randomized, Never Dosed|0|||
130006789|NCT03227471|467989079|FG004|Overall Study|Randomized, Never Dosed|0|||
130006790|NCT03227471|467989080|FG005|Overall Study|Randomized, Never Dosed|0|||
130006791|NCT03227471|467989081|FG006|Overall Study|Randomized, Never Dosed|0|||
130006792|NCT03227471|467989082|FG007|Overall Study|Randomized, Never Dosed|0|||
130006793|NCT03227471|467989083|FG008|Overall Study|Randomized, Never Dosed|0|||
130341877|NCT00729469|469223150|FG000|Overall Study|Lost to Follow-up|9|||
130341878|NCT00729469|469223151|FG001|Overall Study|Lost to Follow-up|9|||
130341879|NCT00729469|469223150|FG000|Overall Study|Protocol Violation|2|||
130006794|NCT03227471|467989084|FG009|Overall Study|Randomized, Never Dosed|0|||
130006795|NCT03227471|467989085|FG010|Overall Study|Randomized, Never Dosed|0|||
130006796|NCT03227471|467989086|FG011|Overall Study|Randomized, Never Dosed|0|||
130006797|NCT03227471|467989087|FG012|Overall Study|Randomized, Never Dosed|0|||
130006798|NCT03227471|467989088|FG013|Overall Study|Randomized, Never Dosed|0|||
130341880|NCT00729469|469223151|FG001|Overall Study|Protocol Violation|1|||
130341881|NCT00729469|469223150|FG000|Overall Study|Withdrawal by Subject|19|||
130006799|NCT03227471|467989089|FG014|Overall Study|Randomized, Never Dosed|1|||
130341882|NCT00729469|469223151|FG001|Overall Study|Withdrawal by Subject|8|||
130006800|NCT00382720|467989090|FG000|Overall Study|Adverse Event|21|||
130006801|NCT00382720|467989091|FG001|Overall Study|Adverse Event|23|||
130006802|NCT00382720|467989092|FG002|Overall Study|Adverse Event|15|||
130006803|NCT00382720|467989090|FG000|Overall Study|Protocol Violation|2|||
130006804|NCT00382720|467989091|FG001|Overall Study|Protocol Violation|5|||
130006805|NCT00382720|467989092|FG002|Overall Study|Protocol Violation|1|||
130006806|NCT00382720|467989090|FG000|Overall Study|Death|0|||
130006807|NCT00382720|467989091|FG001|Overall Study|Death|1|||
130006808|NCT00382720|467989092|FG002|Overall Study|Death|2|||
130006809|NCT00382720|467989090|FG000|Overall Study|Progressive disease|37|||
130006810|NCT00382720|467989091|FG001|Overall Study|Progressive disease|28|||
130006811|NCT00382720|467989092|FG002|Overall Study|Progressive disease|38|||
130006812|NCT00382720|467989090|FG000|Overall Study|Withdrew consent|1|||
130006813|NCT00382720|467989091|FG001|Overall Study|Withdrew consent|1|||
130006814|NCT00382720|467989092|FG002|Overall Study|Withdrew consent|2|||
130006815|NCT00382720|467989090|FG000|Overall Study|Withdrawal by Subject|11|||
130006816|NCT00382720|467989091|FG001|Overall Study|Withdrawal by Subject|20|||
130006817|NCT00382720|467989092|FG002|Overall Study|Withdrawal by Subject|12|||
130006818|NCT00382720|467989090|FG000|Overall Study|Surgery|1|||
130006819|NCT00382720|467989091|FG001|Overall Study|Surgery|1|||
130006820|NCT00382720|467989092|FG002|Overall Study|Surgery|4|||
130006821|NCT00382720|467989090|FG000|Overall Study|Patient did not receive study medication|1|||
130006822|NCT00382720|467989091|FG001|Overall Study|Patient did not receive study medication|1|||
130006823|NCT00382720|467989092|FG002|Overall Study|Patient did not receive study medication|4|||
130006824|NCT00382720|467989090|FG000|Overall Study|Clinically progressive disease|0|||
130006825|NCT00382720|467989091|FG001|Overall Study|Clinically progressive disease|1|||
130006826|NCT00382720|467989092|FG002|Overall Study|Clinically progressive disease|0|||
130006827|NCT00382720|467989090|FG000|Overall Study|Good prognosis|0|||
130006828|NCT00382720|467989091|FG001|Overall Study|Good prognosis|1|||
130006829|NCT00382720|467989092|FG002|Overall Study|Good prognosis|0|||
130006830|NCT00382720|467989090|FG000|Overall Study|Investigator/Clinical decision|5|||
130006831|NCT00382720|467989091|FG001|Overall Study|Investigator/Clinical decision|6|||
130006832|NCT00382720|467989092|FG002|Overall Study|Investigator/Clinical decision|6|||
130006833|NCT00382720|467989090|FG000|Overall Study|Discontinued at end of study|0|||
130006834|NCT00382720|467989091|FG001|Overall Study|Discontinued at end of study|1|||
130006835|NCT00382720|467989092|FG002|Overall Study|Discontinued at end of study|2|||
130006836|NCT02142738|467989095|FG000|Overall Study|Adverse Event|13|||
130006837|NCT02142738|467989096|FG001|Overall Study|Adverse Event|9|||
130006838|NCT02142738|467989095|FG000|Overall Study|Death|92|||
130006839|NCT02142738|467989096|FG001|Overall Study|Death|112|||
130006840|NCT02142738|467989095|FG000|Overall Study|Lost to Follow-up|0|||
130006841|NCT02142738|467989096|FG001|Overall Study|Lost to Follow-up|3|||
130006842|NCT02142738|467989095|FG000|Overall Study|Withdrawal by Subject|6|||
130006843|NCT02142738|467989096|FG001|Overall Study|Withdrawal by Subject|7|||
130006844|NCT02142738|467989095|FG000|Overall Study|Follow up ended by sponsor|43|||
130006845|NCT02142738|467989096|FG001|Overall Study|Follow up ended by sponsor|20|||
130006846|NCT03688880|467989097|FG000|Overall Study|Withdrawal by Subject|0|||
130006847|NCT03688880|467989098|FG001|Overall Study|Withdrawal by Subject|2|||
130006848|NCT03688880|467989097|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
130006849|NCT03688880|467989098|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
130006850|NCT03688880|467989097|FG000|Overall Study|Lost to Follow-up|4|||
130006851|NCT03688880|467989098|FG001|Overall Study|Lost to Follow-up|7|||
130006852|NCT03688880|467989097|FG000|Overall Study|Adverse Event|0|||
130006853|NCT03688880|467989098|FG001|Overall Study|Adverse Event|2|||
130006854|NCT03688880|467989097|FG000|Overall Study|Device deficiencies|0|||
130006855|NCT03688880|467989098|FG001|Overall Study|Device deficiencies|2|||
130006856|NCT03688880|467989097|FG000|Overall Study|Other|10|||
130006857|NCT03688880|467989098|FG001|Overall Study|Other|16|||
130006858|NCT01942148|467989100|FG000|Overall Study|Adverse Event|4|||
130006859|NCT01942148|467989100|FG000|Overall Study|Lack of Efficacy|2|||
130006860|NCT01942148|467989100|FG000|Overall Study|Physician Decision|11|||
130006861|NCT01942148|467989100|FG000|Overall Study|Protocol Violation|1|||
130006862|NCT01942148|467989100|FG000|Overall Study|Withdrawal by Subject|8|||
130006863|NCT01942148|467989100|FG000|Overall Study|Use of the prohibition medicine|1|||
130341883|NCT00729469|469223150|FG000|Overall Study|Other-Not mentioned|9|||
130341884|NCT00729469|469223151|FG001|Overall Study|Other-Not mentioned|4|||
130341885|NCT01270802|469223154|FG000|Overall Study|Withdrawal by Subject|1|||
130341886|NCT01270802|469223155|FG001|Overall Study|Withdrawal by Subject|0|||
130341887|NCT01270802|469223154|FG000|Overall Study|Adverse Event|1|||
130006864|NCT01858532|467989102|FG000|Overall Study|Adverse Event|58|||
130006865|NCT01858532|467989103|FG001|Overall Study|Adverse Event|50|||
130006866|NCT01858532|467989104|FG002|Overall Study|Adverse Event|23|||
130006867|NCT01858532|467989105|FG003|Overall Study|Adverse Event|28|||
130006868|NCT01858532|467989102|FG000|Overall Study|Withdrew consent|71|||
130006869|NCT01858532|467989103|FG001|Overall Study|Withdrew consent|93|||
130006870|NCT01858532|467989104|FG002|Overall Study|Withdrew consent|46|||
130006871|NCT01858532|467989105|FG003|Overall Study|Withdrew consent|27|||
130341888|NCT01270802|469223155|FG001|Overall Study|Adverse Event|0|||
130006872|NCT01858532|467989102|FG000|Overall Study|Lost to Follow-up|17|||
130006873|NCT01858532|467989103|FG001|Overall Study|Lost to Follow-up|26|||
130006874|NCT01858532|467989104|FG002|Overall Study|Lost to Follow-up|11|||
130006875|NCT01858532|467989105|FG003|Overall Study|Lost to Follow-up|14|||
130006876|NCT01858532|467989102|FG000|Overall Study|Deterioration of medical status|3|||
130006877|NCT01858532|467989103|FG001|Overall Study|Deterioration of medical status|4|||
130006878|NCT01858532|467989104|FG002|Overall Study|Deterioration of medical status|3|||
130006879|NCT01858532|467989105|FG003|Overall Study|Deterioration of medical status|7|||
130006880|NCT01858532|467989102|FG000|Overall Study|Investigator request|3|||
130006881|NCT01858532|467989103|FG001|Overall Study|Investigator request|4|||
130006882|NCT01858532|467989104|FG002|Overall Study|Investigator request|2|||
130006883|NCT01858532|467989105|FG003|Overall Study|Investigator request|6|||
130006884|NCT01858532|467989102|FG000|Overall Study|Other, not specified|29|||
130006885|NCT01858532|467989103|FG001|Overall Study|Other, not specified|15|||
130006886|NCT01858532|467989104|FG002|Overall Study|Other, not specified|13|||
130006887|NCT01858532|467989105|FG003|Overall Study|Other, not specified|11|||
130006888|NCT00514514|467989106|FG000|Pre-phase|Death|10|||
130006889|NCT00514514|467989107|FG001|Pre-phase|Death|0|||
130006890|NCT00514514|467989108|FG002|Pre-phase|Death|0|||
130006891|NCT00514514|467989106|FG000|Pre-phase|administrative problems|2|||
130006892|NCT00514514|467989107|FG001|Pre-phase|administrative problems|0|||
130006893|NCT00514514|467989108|FG002|Pre-phase|administrative problems|0|||
130006894|NCT00514514|467989106|FG000|Pre-phase|Protocol Violation|6|||
130006895|NCT00514514|467989107|FG001|Pre-phase|Protocol Violation|0|||
130006896|NCT00514514|467989108|FG002|Pre-phase|Protocol Violation|0|||
130006897|NCT00514514|467989106|FG000|Pre-phase|condition no longer requires study drug|7|||
130006898|NCT00514514|467989107|FG001|Pre-phase|condition no longer requires study drug|0|||
130006899|NCT00514514|467989108|FG002|Pre-phase|condition no longer requires study drug|0|||
130006900|NCT00514514|467989106|FG000|Pre-phase|abnormal test procedure results|15|||
130006901|NCT00514514|467989107|FG001|Pre-phase|abnormal test procedure results|0|||
130006902|NCT00514514|467989108|FG002|Pre-phase|abnormal test procedure results|0|||
130006903|NCT00514514|467989106|FG000|Pre-phase|Lost to Follow-up|2|||
130006904|NCT00514514|467989107|FG001|Pre-phase|Lost to Follow-up|0|||
130006905|NCT00514514|467989108|FG002|Pre-phase|Lost to Follow-up|0|||
130341889|NCT01270802|469223154|FG000|Overall Study|Lost to Follow-up|0|||
130006906|NCT00514514|467989106|FG000|Pre-phase|abnormal lab values|23|||
130006907|NCT00514514|467989107|FG001|Pre-phase|abnormal lab values|0|||
130006908|NCT00514514|467989108|FG002|Pre-phase|abnormal lab values|0|||
130006909|NCT00514514|467989106|FG000|Pre-phase|Lack of Efficacy|35|||
130006910|NCT00514514|467989107|FG001|Pre-phase|Lack of Efficacy|0|||
130006911|NCT00514514|467989108|FG002|Pre-phase|Lack of Efficacy|0|||
130006912|NCT00514514|467989106|FG000|Pre-phase|Adverse Event|137|||
130006913|NCT00514514|467989107|FG001|Pre-phase|Adverse Event|0|||
130006914|NCT00514514|467989108|FG002|Pre-phase|Adverse Event|0|||
130006915|NCT00514514|467989106|FG000|Pre-phase|Withdrawal by Subject|66|||
130006916|NCT00514514|467989107|FG001|Pre-phase|Withdrawal by Subject|0|||
130006917|NCT00514514|467989108|FG002|Pre-phase|Withdrawal by Subject|0|||
130006918|NCT00514514|467989106|FG000|Randomized - 9 Month|Death|3|||
130341890|NCT01270802|469223155|FG001|Overall Study|Lost to Follow-up|1|||
130341891|NCT01566214|469223156|FG000|Overall Study|Lost to Follow-up|3|||
130341892|NCT01566214|469223157|FG001|Overall Study|Lost to Follow-up|0|||
130341893|NCT00561977|469223158|FG000|Overall Study|Withdrawal by Subject|0|||
130341894|NCT00561977|469223159|FG001|Overall Study|Withdrawal by Subject|2|||
130341895|NCT00561977|469223160|FG002|Overall Study|Withdrawal by Subject|1|||
130341896|NCT00561977|469223158|FG000|Overall Study|Pregnancy|0|||
130341897|NCT00561977|469223159|FG001|Overall Study|Pregnancy|1|||
130341898|NCT00561977|469223160|FG002|Overall Study|Pregnancy|1|||
130341899|NCT04620798|469223163|FG000|Overall Study|Lost to Follow-up|126|||
130341900|NCT04620798|469223164|FG001|Overall Study|Lost to Follow-up|138|||
130341901|NCT01616693|469223168|FG000|Evaluated for Safety|Physician Decision|1|||
130341902|NCT01616693|469223169|FG001|Evaluated for Safety|Physician Decision|0|||
130341903|NCT01616693|469223170|FG002|Evaluated for Safety|Physician Decision|1|||
130341904|NCT01616693|469223171|FG003|Evaluated for Safety|Physician Decision|0|||
130341905|NCT01616693|469223168|FG000|Received Both Vaccines|Adverse Event|2|||
129884395|NCT00708305|467536386|FG003|Period 3|Protocol Violation|0|||
130006919|NCT00514514|467989107|FG001|Randomized - 9 Month|Death|2|||
130006920|NCT00514514|467989108|FG002|Randomized - 9 Month|Death|2|||
130006921|NCT00514514|467989106|FG000|Randomized - 9 Month|Administrative problems|1|||
130006922|NCT00514514|467989107|FG001|Randomized - 9 Month|Administrative problems|1|||
130006923|NCT00514514|467989108|FG002|Randomized - 9 Month|Administrative problems|2|||
130006924|NCT00514514|467989106|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
130006925|NCT00514514|467989107|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
130006926|NCT00514514|467989108|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
130006927|NCT00514514|467989106|FG000|Randomized - 9 Month|Protocol Violation|1|||
130341906|NCT01616693|469223169|FG001|Received Both Vaccines|Adverse Event|0|||
130341907|NCT01616693|469223170|FG002|Received Both Vaccines|Adverse Event|0|||
130341908|NCT01616693|469223171|FG003|Received Both Vaccines|Adverse Event|0|||
130341909|NCT01616693|469223168|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
130006928|NCT00514514|467989107|FG001|Randomized - 9 Month|Protocol Violation|1|||
130006929|NCT00514514|467989108|FG002|Randomized - 9 Month|Protocol Violation|0|||
130006930|NCT00514514|467989106|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
130006931|NCT00514514|467989107|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
130006932|NCT00514514|467989108|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
130006933|NCT00514514|467989106|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
130006934|NCT00514514|467989107|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
130006935|NCT00514514|467989108|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
130006936|NCT00514514|467989106|FG000|Randomized - 9 Month|Adverse Event|25|||
130006937|NCT00514514|467989107|FG001|Randomized - 9 Month|Adverse Event|44|||
130006938|NCT00514514|467989108|FG002|Randomized - 9 Month|Adverse Event|27|||
130006939|NCT00514514|467989106|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
130006940|NCT00514514|467989107|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
130341910|NCT01616693|469223169|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
130341911|NCT01616693|469223170|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
130341912|NCT01616693|469223171|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
130341913|NCT01616693|469223168|FG000|Received Both Vaccines|Lost to Follow-up|4|||
130341914|NCT01616693|469223169|FG001|Received Both Vaccines|Lost to Follow-up|3|||
130341915|NCT01616693|469223170|FG002|Received Both Vaccines|Lost to Follow-up|4|||
130341916|NCT01616693|469223171|FG003|Received Both Vaccines|Lost to Follow-up|4|||
130341917|NCT01616693|469223168|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
130341918|NCT01616693|469223169|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
130341919|NCT01616693|469223170|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
130341920|NCT01616693|469223171|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
130341921|NCT00832624|469223175|FG000|Overall Study|Study Terminated|10|||
130341922|NCT02395172|469223176|FG000|Overall Study|Participants randomized but not treated|3|||
130341923|NCT02395172|469223177|FG001|Overall Study|Participants randomized but not treated|31|||
130341924|NCT00653939|469223178|FG000|Overall Study|Adverse Event|1|||
130341925|NCT00653939|469223179|FG001|Overall Study|Adverse Event|3|||
130341926|NCT00653939|469223178|FG000|Overall Study|Withdrawal by Subject|3|||
130341927|NCT00653939|469223179|FG001|Overall Study|Withdrawal by Subject|3|||
130341928|NCT00653939|469223178|FG000|Overall Study|Physician Decision|4|||
130341929|NCT00653939|469223179|FG001|Overall Study|Physician Decision|0|||
130341930|NCT00653939|469223178|FG000|Overall Study|Disease Progression|2|||
130341931|NCT00653939|469223179|FG001|Overall Study|Disease Progression|3|||
130341932|NCT00653939|469223178|FG000|Overall Study|Other|2|||
130341933|NCT00653939|469223179|FG001|Overall Study|Other|6|||
130341934|NCT01546623|469223180|FG000|Overall Study|Adverse Event|2|||
130341935|NCT01546623|469223181|FG001|Overall Study|Adverse Event|3|||
130341936|NCT01546623|469223180|FG000|Overall Study|Major Protocol Deviation|1|||
130341937|NCT01546623|469223181|FG001|Overall Study|Major Protocol Deviation|1|||
130341938|NCT01546623|469223180|FG000|Overall Study|High Prostate specific antigen|2|||
130341939|NCT01546623|469223181|FG001|Overall Study|High Prostate specific antigen|1|||
130341940|NCT01546623|469223180|FG000|Overall Study|Did Not Receive Study Drug|1|||
130341941|NCT01546623|469223181|FG001|Overall Study|Did Not Receive Study Drug|1|||
130341942|NCT01134705|469223182|FG000|Overall Study|Adverse Event|1|||
130341943|NCT01134705|469223183|FG001|Overall Study|Adverse Event|7|||
130341944|NCT01134705|469223182|FG000|Overall Study|Withdrawal by Subject|6|||
130341945|NCT01134705|469223183|FG001|Overall Study|Withdrawal by Subject|6|||
130341946|NCT01134705|469223182|FG000|Overall Study|Pregnancy|1|||
130341947|NCT01134705|469223183|FG001|Overall Study|Pregnancy|0|||
130341948|NCT01134705|469223182|FG000|Overall Study|Lost to Follow-up|5|||
130341949|NCT01134705|469223183|FG001|Overall Study|Lost to Follow-up|2|||
130341950|NCT01134705|469223182|FG000|Overall Study|Protocol Violation|1|||
130341951|NCT01134705|469223183|FG001|Overall Study|Protocol Violation|1|||
130341952|NCT01134705|469223182|FG000|Overall Study|Other|1|||
130341953|NCT01134705|469223183|FG001|Overall Study|Other|6|||
130341954|NCT01375075|469223193|FG000|Overall Study|Adverse Event|0|||
130341955|NCT01375075|469223194|FG001|Overall Study|Adverse Event|0|||
130341956|NCT01375075|469223195|FG002|Overall Study|Adverse Event|3|||
130341957|NCT01375075|469223196|FG003|Overall Study|Adverse Event|1|||
130341958|NCT01375075|469223197|FG004|Overall Study|Adverse Event|0|||
130341959|NCT01375075|469223198|FG005|Overall Study|Adverse Event|1|||
130341960|NCT01375075|469223193|FG000|Overall Study|Entry Criterion Not Met|1|||
130341961|NCT01375075|469223194|FG001|Overall Study|Entry Criterion Not Met|0|||
130341962|NCT01375075|469223195|FG002|Overall Study|Entry Criterion Not Met|0|||
130341963|NCT01375075|469223196|FG003|Overall Study|Entry Criterion Not Met|0|||
130341964|NCT01375075|469223197|FG004|Overall Study|Entry Criterion Not Met|0|||
130341965|NCT01375075|469223198|FG005|Overall Study|Entry Criterion Not Met|1|||
130006941|NCT00514514|467989108|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
130006942|NCT00514514|467989106|FG000|Extension - 4 Years|Lost to Follow-up|12|||
130341966|NCT01375075|469223193|FG000|Overall Study|Withdrawal by Subject|0|||
130341967|NCT01375075|469223194|FG001|Overall Study|Withdrawal by Subject|1|||
130341968|NCT01375075|469223195|FG002|Overall Study|Withdrawal by Subject|0|||
130341969|NCT01375075|469223196|FG003|Overall Study|Withdrawal by Subject|0|||
130341970|NCT01375075|469223197|FG004|Overall Study|Withdrawal by Subject|0|||
130006943|NCT00514514|467989107|FG001|Extension - 4 Years|Lost to Follow-up|10|||
130006944|NCT00514514|467989108|FG002|Extension - 4 Years|Lost to Follow-up|9|||
130006945|NCT00514514|467989106|FG000|Extension - 4 Years|Administrative problems|3|||
130006946|NCT00514514|467989107|FG001|Extension - 4 Years|Administrative problems|1|||
130006947|NCT00514514|467989108|FG002|Extension - 4 Years|Administrative problems|1|||
130006948|NCT00514514|467989106|FG000|Extension - 4 Years|Death|8|||
130006949|NCT00514514|467989107|FG001|Extension - 4 Years|Death|3|||
130006950|NCT00514514|467989108|FG002|Extension - 4 Years|Death|6|||
130006951|NCT00514514|467989106|FG000|Extension - 4 Years|Adverse Event|9|||
130006952|NCT00514514|467989107|FG001|Extension - 4 Years|Adverse Event|6|||
130006953|NCT00514514|467989108|FG002|Extension - 4 Years|Adverse Event|3|||
130006954|NCT03785925|467989110|FG000|Overall Study|Withdrawal by Subject|15|||
130006955|NCT03785925|467989110|FG000|Overall Study|Lost to Follow-up|1|||
130006956|NCT01848288|467989111|FG000|Overall Study|Death|1|||
130006957|NCT01848288|467989111|FG000|Overall Study|Protocol Violation|1|||
130006958|NCT01848288|467989111|FG000|Overall Study|Withdrawal by Subject|1|||
130006959|NCT03794583|467989116|FG000|Overall Study|Death|8|||
130006960|NCT03794583|467989116|FG000|Overall Study|Study Terminated by Sponsor|24|||
130006961|NCT03794583|467989116|FG000|Overall Study|Withdrawal by Subject|9|||
130006962|NCT00003895|467989117|FG000|Overall Study|Adverse Event|4|||
130341971|NCT01375075|469223198|FG005|Overall Study|Withdrawal by Subject|1|||
130341972|NCT01011309|469223200|FG000|Overall Study|Adverse Event|2|||
130341973|NCT01011309|469223201|FG001|Overall Study|Adverse Event|1|||
130341974|NCT01011309|469223202|FG002|Overall Study|Adverse Event|2|||
130341975|NCT01011309|469223200|FG000|Overall Study|Lack of Efficacy|0|||
130006963|NCT00003895|467989118|FG001|Overall Study|Adverse Event|0|||
130006964|NCT00003895|467989117|FG000|Overall Study|Lack of Efficacy|1|||
130006965|NCT00003895|467989118|FG001|Overall Study|Lack of Efficacy|1|||
130006966|NCT00003895|467989117|FG000|Overall Study|Patient Vacation|2|||
130006967|NCT00003895|467989118|FG001|Overall Study|Patient Vacation|0|||
130006968|NCT00003895|467989117|FG000|Overall Study|Withdrawal by Subject|0|||
130006969|NCT00003895|467989118|FG001|Overall Study|Withdrawal by Subject|3|||
130006970|NCT00806195|467989119|FG000|Overall Study|Death|6|||
130006971|NCT00806195|467989120|FG001|Overall Study|Death|0|||
130006972|NCT00806195|467989121|FG002|Overall Study|Death|1|||
130006973|NCT00806195|467989122|FG003|Overall Study|Death|0|||
130006974|NCT00806195|467989119|FG000|Overall Study|Adverse Event|25|||
130006975|NCT00806195|467989120|FG001|Overall Study|Adverse Event|5|||
130006976|NCT00806195|467989121|FG002|Overall Study|Adverse Event|11|||
130006977|NCT00806195|467989122|FG003|Overall Study|Adverse Event|2|||
130006978|NCT00806195|467989119|FG000|Overall Study|Withdrawal by Subject|119|||
130006979|NCT00806195|467989120|FG001|Overall Study|Withdrawal by Subject|31|||
130006980|NCT00806195|467989121|FG002|Overall Study|Withdrawal by Subject|76|||
130006981|NCT00806195|467989122|FG003|Overall Study|Withdrawal by Subject|35|||
130006982|NCT00806195|467989119|FG000|Overall Study|Lost to Follow-up|217|||
130341976|NCT01011309|469223201|FG001|Overall Study|Lack of Efficacy|1|||
130341977|NCT01011309|469223202|FG002|Overall Study|Lack of Efficacy|0|||
130341978|NCT01011309|469223200|FG000|Overall Study|Protocol Violation|0|||
130006983|NCT00806195|467989120|FG001|Overall Study|Lost to Follow-up|66|||
130006984|NCT00806195|467989121|FG002|Overall Study|Lost to Follow-up|90|||
130341979|NCT01011309|469223201|FG001|Overall Study|Protocol Violation|1|||
130341980|NCT01011309|469223202|FG002|Overall Study|Protocol Violation|3|||
130341981|NCT00831493|469223203|FG000|Overall Study|Intractable nausea and vomiting|1|||
130341982|NCT03976648|469223212|FG000|Overall Study|Adverse Event|0|||
130341983|NCT03976648|469223213|FG001|Overall Study|Adverse Event|2|||
130341984|NCT03976648|469223212|FG000|Overall Study|Study terminated by sponsor|21|||
130341985|NCT03976648|469223213|FG001|Overall Study|Study terminated by sponsor|8|||
130341986|NCT01981551|469223214|FG000|Overall Study|Refused further treatment|8|||
130341987|NCT01981551|469223214|FG000|Overall Study|Adverse Event|1|||
130341988|NCT00960570|469223215|FG000|21 Day Washout Period|Adverse Event|1|||
130341989|NCT00960570|469223215|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
130341990|NCT00960570|469223215|FG000|1 Day Period Between Dosing|Adverse Event|2|||
130341991|NCT00960570|469223215|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
130341992|NCT01451437|469223216|FG000|Overall Study|Adverse Event|0|||
130341993|NCT01451437|469223217|FG001|Overall Study|Adverse Event|0|||
130341994|NCT01451437|469223218|FG002|Overall Study|Adverse Event|0|||
130006985|NCT00806195|467989122|FG003|Overall Study|Lost to Follow-up|34|||
130006986|NCT00806195|467989119|FG000|Overall Study|Inappropriate Enrollment|0|||
130006987|NCT00806195|467989120|FG001|Overall Study|Inappropriate Enrollment|1|||
130006988|NCT00806195|467989121|FG002|Overall Study|Inappropriate Enrollment|0|||
130006989|NCT00806195|467989122|FG003|Overall Study|Inappropriate Enrollment|0|||
130216589|NCT03762681|468755608|FG005|Part 2a|Pandemic Travel Restrictions|0|||
130341995|NCT01451437|469223219|FG003|Overall Study|Adverse Event|0|||
130341996|NCT01451437|469223220|FG004|Overall Study|Adverse Event|0|||
130341997|NCT01451437|469223221|FG005|Overall Study|Adverse Event|1|||
130006990|NCT00806195|467989119|FG000|Overall Study|Administrative Reason|113|||
130006991|NCT00806195|467989120|FG001|Overall Study|Administrative Reason|35|||
130006992|NCT00806195|467989121|FG002|Overall Study|Administrative Reason|66|||
130006993|NCT00806195|467989122|FG003|Overall Study|Administrative Reason|26|||
130006994|NCT00806195|467989119|FG000|Overall Study|Protocol Violation|34|||
130006995|NCT00806195|467989120|FG001|Overall Study|Protocol Violation|24|||
130006996|NCT00806195|467989121|FG002|Overall Study|Protocol Violation|26|||
130006997|NCT00806195|467989122|FG003|Overall Study|Protocol Violation|9|||
130006998|NCT02752035|467989125|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
130006999|NCT02752035|467989126|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
130007000|NCT02752035|467989127|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
130007001|NCT02752035|467989128|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
130007002|NCT02752035|467989125|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
130007003|NCT02752035|467989126|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
130007004|NCT02752035|467989127|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
130007005|NCT02752035|467989128|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
130007006|NCT02752035|467989125|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
130007007|NCT02752035|467989126|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
130007008|NCT02752035|467989127|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
130007009|NCT02752035|467989128|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
130007010|NCT02752035|467989125|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
130007011|NCT02752035|467989126|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
130007012|NCT02752035|467989127|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
130007013|NCT02752035|467989128|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
130007014|NCT02752035|467989125|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
130007015|NCT02752035|467989126|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
130007016|NCT02752035|467989127|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
130007017|NCT02752035|467989128|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
130007018|NCT02752035|467989125|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
130007019|NCT02752035|467989126|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
130007020|NCT02752035|467989127|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
130007021|NCT02752035|467989128|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
130007022|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
130007023|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
130007024|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
130007025|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
130007026|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
130007027|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
130007028|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
130007029|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
130007030|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
130007031|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
130007032|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
130007033|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
130007034|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
130007035|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
130007036|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
130007037|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
130007038|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
130007039|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
130007040|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
130007041|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
130007042|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Death|0|||
130007043|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Death|25|||
130007044|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Death|13|||
130007045|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Death|4|||
130007046|NCT02752035|467989125|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
130007047|NCT02752035|467989126|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
130007048|NCT02752035|467989127|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
130007049|NCT02752035|467989128|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
130007050|NCT02752035|467989125|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
130007051|NCT02752035|467989126|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
130007052|NCT02752035|467989127|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
130007053|NCT02752035|467989128|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
130007054|NCT02752035|467989125|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
130007055|NCT02752035|467989126|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
130007056|NCT02752035|467989127|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
130007057|NCT02752035|467989128|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
130007058|NCT02752035|467989125|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
130007059|NCT02752035|467989126|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
130007060|NCT02752035|467989127|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
130007061|NCT02752035|467989128|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
130007062|NCT02752035|467989125|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
130007063|NCT02752035|467989126|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
130007064|NCT02752035|467989127|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
130007065|NCT02752035|467989128|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
130007066|NCT00736034|467989131|FG000|Overall Study|Adverse Event|2|||
130007067|NCT02566577|467989132|FG000|Overall Study|Withdrawal by Subject|1|||
130007068|NCT02566577|467989133|FG001|Overall Study|Withdrawal by Subject|1|||
130007069|NCT02566577|467989132|FG000|Overall Study|Equipment failure|1|||
130007070|NCT02566577|467989133|FG001|Overall Study|Equipment failure|1|||
130007071|NCT02566577|467989132|FG000|Overall Study|Physical limitation|1|||
130007072|NCT02566577|467989133|FG001|Overall Study|Physical limitation|0|||
130007073|NCT00073528|467989142|FG000|Overall Study|Death|488|||
130007074|NCT00073528|467989143|FG001|Overall Study|Death|473|||
130007075|NCT00073528|467989142|FG000|Overall Study|Lost to Follow-up|52|||
130007076|NCT00073528|467989143|FG001|Overall Study|Lost to Follow-up|45|||
130007077|NCT00073528|467989142|FG000|Overall Study|Withdrawal by Subject|50|||
130007078|NCT00073528|467989143|FG001|Overall Study|Withdrawal by Subject|45|||
130341998|NCT01451437|469223222|FG006|Overall Study|Adverse Event|1|||
130341999|NCT01451437|469223223|FG007|Overall Study|Adverse Event|2|||
130342000|NCT01451437|469223224|FG008|Overall Study|Adverse Event|1|||
130007079|NCT00073528|467989142|FG000|Overall Study|Study terminated by Sponsor|10|||
130007080|NCT00073528|467989143|FG001|Overall Study|Study terminated by Sponsor|29|||
130007081|NCT00073528|467989142|FG000|Overall Study|Other|18|||
130007082|NCT00073528|467989143|FG001|Overall Study|Other|19|||
130007083|NCT00073528|467989142|FG000|Overall Study|Other|9|||
130007084|NCT00073528|467989143|FG001|Overall Study|Other|12|||
130007085|NCT00073528|467989142|FG000|Overall Study|Protocol Violation|3|||
130007086|NCT00073528|467989143|FG001|Overall Study|Protocol Violation|5|||
130007087|NCT03086057|467989144|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
130007088|NCT03086057|467989145|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
130007089|NCT03086057|467989146|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
130007090|NCT03086057|467989147|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
130007091|NCT03086057|467989144|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
130007092|NCT03086057|467989145|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
130007093|NCT03086057|467989146|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
130007094|NCT03086057|467989147|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
130007095|NCT03086057|467989144|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
130007096|NCT03086057|467989145|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
130007097|NCT03086057|467989146|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
130007098|NCT03086057|467989147|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
130007099|NCT03086057|467989144|FG000|Stage 1: PrEP Uptake|Death|1|||
130007100|NCT03086057|467989145|FG001|Stage 1: PrEP Uptake|Death|0|||
130007101|NCT03086057|467989146|FG002|Stage 1: PrEP Uptake|Death|0|||
130007102|NCT03086057|467989147|FG003|Stage 1: PrEP Uptake|Death|0|||
130007103|NCT03086057|467989144|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
130007104|NCT03086057|467989145|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
130007105|NCT03086057|467989146|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
130007106|NCT03086057|467989147|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
130007107|NCT03086057|467989144|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
130007108|NCT03086057|467989145|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
130007109|NCT03086057|467989146|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
130007110|NCT03086057|467989147|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
130007111|NCT03086057|467989144|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
130007112|NCT03086057|467989145|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
130007113|NCT03086057|467989146|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
130007114|NCT03086057|467989147|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
130007115|NCT04305275|467989150|FG000|Overall Study|Adverse Event|4|||
130007116|NCT04305275|467989151|FG001|Overall Study|Adverse Event|0|||
130007117|NCT04305275|467989150|FG000|Overall Study|Lost to Follow-up|1|||
130342001|NCT01451437|469223216|FG000|Overall Study|Physician Decision|1|||
130342002|NCT01451437|469223217|FG001|Overall Study|Physician Decision|1|||
130342003|NCT01451437|469223218|FG002|Overall Study|Physician Decision|2|||
130007118|NCT04305275|467989151|FG001|Overall Study|Lost to Follow-up|1|||
130007119|NCT04305275|467989150|FG000|Overall Study|Withdrawal by Participant|8|||
130007120|NCT04305275|467989151|FG001|Overall Study|Withdrawal by Participant|1|||
130007121|NCT01708291|467989162|FG000|Overall Study|fighting|2|||
130007122|NCT01708291|467989163|FG001|Overall Study|fighting|1|||
130007123|NCT01536951|467989164|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007124|NCT01536951|467989165|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007125|NCT01536951|467989166|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
130007126|NCT01536951|467989167|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007127|NCT01536951|467989168|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130216590|NCT03762681|468755609|FG006|Part 2a|Pandemic Travel Restrictions|0|||
130342004|NCT01451437|469223219|FG003|Overall Study|Physician Decision|0|||
130342005|NCT01451437|469223220|FG004|Overall Study|Physician Decision|0|||
130342006|NCT01451437|469223221|FG005|Overall Study|Physician Decision|0|||
130342007|NCT01451437|469223222|FG006|Overall Study|Physician Decision|0|||
130342008|NCT01451437|469223223|FG007|Overall Study|Physician Decision|0|||
130342009|NCT01451437|469223224|FG008|Overall Study|Physician Decision|0|||
130342010|NCT01451437|469223216|FG000|Overall Study|Disease Progression|0|||
130342011|NCT01451437|469223217|FG001|Overall Study|Disease Progression|0|||
130342012|NCT01451437|469223218|FG002|Overall Study|Disease Progression|1|||
130342013|NCT01451437|469223219|FG003|Overall Study|Disease Progression|1|||
130342014|NCT01451437|469223220|FG004|Overall Study|Disease Progression|3|||
130342015|NCT01451437|469223221|FG005|Overall Study|Disease Progression|2|||
130342016|NCT01451437|469223222|FG006|Overall Study|Disease Progression|3|||
130342017|NCT01451437|469223223|FG007|Overall Study|Disease Progression|1|||
130342018|NCT01451437|469223224|FG008|Overall Study|Disease Progression|3|||
130342019|NCT01451437|469223216|FG000|Overall Study|Protocol Violation|0|||
130342020|NCT01451437|469223217|FG001|Overall Study|Protocol Violation|0|||
130342021|NCT01451437|469223218|FG002|Overall Study|Protocol Violation|0|||
129884396|NCT00708305|467536383|FG000|Period 3|Other Reason|1|||
130007128|NCT01536951|467989169|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007129|NCT01536951|467989170|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007130|NCT01536951|467989171|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007131|NCT01536951|467989172|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
130007132|NCT01536951|467989164|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
130007133|NCT01536951|467989165|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
130007134|NCT01536951|467989166|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
130007135|NCT01536951|467989167|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
130007136|NCT01536951|467989168|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
130007137|NCT01536951|467989169|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
130007138|NCT01536951|467989170|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
130007139|NCT01536951|467989171|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
130007140|NCT01536951|467989172|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
130007141|NCT01843972|467989173|FG000|Overall Study|Withdrawal by Subject|0|||
130007142|NCT01843972|467989174|FG001|Overall Study|Withdrawal by Subject|0|||
130007143|NCT01843972|467989175|FG002|Overall Study|Withdrawal by Subject|0|||
130007144|NCT01843972|467989176|FG003|Overall Study|Withdrawal by Subject|0|||
130007145|NCT01843972|467989177|FG004|Overall Study|Withdrawal by Subject|1|||
130007146|NCT01843972|467989178|FG005|Overall Study|Withdrawal by Subject|0|||
130007147|NCT01843972|467989179|FG006|Overall Study|Withdrawal by Subject|0|||
130007148|NCT01843972|467989180|FG007|Overall Study|Withdrawal by Subject|0|||
130007149|NCT01843972|467989181|FG008|Overall Study|Withdrawal by Subject|0|||
130007150|NCT01843972|467989182|FG009|Overall Study|Withdrawal by Subject|0|||
130007151|NCT00932425|467989183|FG000|Overall Study|Lost to Follow-up|0|||
130007152|NCT00932425|467989184|FG001|Overall Study|Lost to Follow-up|1|||
130007153|NCT00932425|467989183|FG000|Overall Study|Withdrawal by Subject|0|||
130007154|NCT00932425|467989184|FG001|Overall Study|Withdrawal by Subject|1|||
130007155|NCT00382018|467989185|FG000|Overall Study|Progression|0|||
130007156|NCT00382018|467989186|FG001|Overall Study|Progression|136|||
130007157|NCT00382018|467989187|FG002|Overall Study|Progression|51|||
130007158|NCT00382018|467989188|FG003|Overall Study|Progression|43|||
130007159|NCT00382018|467989185|FG000|Overall Study|Death|0|||
130007160|NCT00382018|467989186|FG001|Overall Study|Death|9|||
130007161|NCT00382018|467989187|FG002|Overall Study|Death|7|||
130007162|NCT00382018|467989188|FG003|Overall Study|Death|11|||
130007163|NCT00382018|467989185|FG000|Overall Study|Withdrawal by Subject|0|||
130007164|NCT00382018|467989186|FG001|Overall Study|Withdrawal by Subject|4|||
130007165|NCT00382018|467989187|FG002|Overall Study|Withdrawal by Subject|3|||
130007166|NCT00382018|467989188|FG003|Overall Study|Withdrawal by Subject|4|||
130007167|NCT00382018|467989185|FG000|Overall Study|Other, not protocol specified|0|||
130007168|NCT00382018|467989186|FG001|Overall Study|Other, not protocol specified|16|||
130007169|NCT00382018|467989187|FG002|Overall Study|Other, not protocol specified|3|||
130007170|NCT00382018|467989188|FG003|Overall Study|Other, not protocol specified|1|||
130007171|NCT03805750|467989189|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
130007172|NCT03805750|467989190|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
130007173|NCT00789880|467989191|FG000|Overall Study|Adverse Event|0|||
130007174|NCT00789880|467989192|FG001|Overall Study|Adverse Event|0|||
130007175|NCT00789880|467989193|FG002|Overall Study|Adverse Event|0|||
130007176|NCT00789880|467989194|FG003|Overall Study|Adverse Event|0|||
130007177|NCT00789880|467989195|FG004|Overall Study|Adverse Event|1|||
130007178|NCT00789880|467989196|FG005|Overall Study|Adverse Event|0|||
130342022|NCT01451437|469223219|FG003|Overall Study|Protocol Violation|0|||
130342023|NCT01451437|469223220|FG004|Overall Study|Protocol Violation|0|||
130342024|NCT01451437|469223221|FG005|Overall Study|Protocol Violation|0|||
130342025|NCT01451437|469223222|FG006|Overall Study|Protocol Violation|1|||
130342026|NCT01451437|469223223|FG007|Overall Study|Protocol Violation|0|||
130342027|NCT01451437|469223224|FG008|Overall Study|Protocol Violation|0|||
130342028|NCT01451437|469223216|FG000|Overall Study|Withdrawal by Subject|0|||
130342029|NCT01451437|469223217|FG001|Overall Study|Withdrawal by Subject|0|||
130342030|NCT01451437|469223218|FG002|Overall Study|Withdrawal by Subject|0|||
130007179|NCT00789880|467989191|FG000|Overall Study|Protocol Violation|0|||
130007180|NCT00789880|467989192|FG001|Overall Study|Protocol Violation|1|||
130007181|NCT00789880|467989193|FG002|Overall Study|Protocol Violation|0|||
130007182|NCT00789880|467989194|FG003|Overall Study|Protocol Violation|1|||
130007183|NCT00789880|467989195|FG004|Overall Study|Protocol Violation|0|||
130007184|NCT00789880|467989196|FG005|Overall Study|Protocol Violation|0|||
130007185|NCT00789880|467989191|FG000|Overall Study|Withdrawal by Subject|1|||
130007186|NCT00789880|467989192|FG001|Overall Study|Withdrawal by Subject|0|||
130007187|NCT00789880|467989193|FG002|Overall Study|Withdrawal by Subject|0|||
130007188|NCT00789880|467989194|FG003|Overall Study|Withdrawal by Subject|0|||
130007189|NCT00789880|467989195|FG004|Overall Study|Withdrawal by Subject|2|||
130007190|NCT00789880|467989196|FG005|Overall Study|Withdrawal by Subject|0|||
130007191|NCT01977820|467989201|FG000|Overall Study|Sponsor terminated the study|1|||
130007192|NCT01977820|467989202|FG001|Overall Study|Sponsor terminated the study|1|||
130007193|NCT00493220|467989203|FG000|Third Intervention|Withdrawal by Subject|1|||
130007194|NCT00493220|467989204|FG001|Third Intervention|Withdrawal by Subject|0|||
130007195|NCT00493220|467989205|FG002|Third Intervention|Withdrawal by Subject|0|||
130007196|NCT00493220|467989206|FG003|Third Intervention|Withdrawal by Subject|0|||
130007197|NCT00493220|467989207|FG004|Third Intervention|Withdrawal by Subject|0|||
130007198|NCT00493220|467989208|FG005|Third Intervention|Withdrawal by Subject|0|||
130007199|NCT02568475|467989209|FG000|Overall Study|Lost to Follow-up|40|||
130007200|NCT02568475|467989210|FG001|Overall Study|Lost to Follow-up|39|||
130007201|NCT02568475|467989209|FG000|Overall Study|Withdrawal by Subject|2|||
130007202|NCT02568475|467989210|FG001|Overall Study|Withdrawal by Subject|0|||
130007203|NCT02568475|467989209|FG000|Overall Study|Discharged home|4|||
130007204|NCT02568475|467989210|FG001|Overall Study|Discharged home|4|||
130007205|NCT02568475|467989209|FG000|Overall Study|Short-term: Discharge location unknown|4|||
130007206|NCT02568475|467989210|FG001|Overall Study|Short-term: Discharge location unknown|0|||
130007207|NCT02568475|467989209|FG000|Overall Study|Transferred to another facility|1|||
130007208|NCT02568475|467989210|FG001|Overall Study|Transferred to another facility|0|||
130007209|NCT02625233|467989211|FG000|Overall Study|Adverse Event|2|||
130007210|NCT02625233|467989212|FG001|Overall Study|Adverse Event|0|||
130007211|NCT00445224|467989220|FG000|Specific Exercises|Withdrawal by Subject|3|||
130007212|NCT00445224|467989221|FG001|Specific Exercises|Withdrawal by Subject|3|||
130007213|NCT00445224|467989220|FG000|Specific Exercises|Withdrawal by Subject|1|||
130007214|NCT00445224|467989221|FG001|Specific Exercises|Withdrawal by Subject|0|||
130007215|NCT01704287|467990655|FG000|Initial Treatment Period|Death|139|||
130007216|NCT01704287|467990656|FG001|Initial Treatment Period|Death|129|||
130007217|NCT01704287|467990657|FG002|Initial Treatment Period|Death|71|||
130007218|NCT01704287|467990658|FG003|Initial Treatment Period|Death|0|||
130007219|NCT01704287|467990659|FG004|Initial Treatment Period|Death|0|||
130007220|NCT01704287|467990655|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
130007221|NCT01704287|467990656|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
130007222|NCT01704287|467990657|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
130007223|NCT01704287|467990658|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
130007224|NCT01704287|467990659|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
130007225|NCT01704287|467990655|FG000|Initial Treatment Period|Lost to Follow-up|5|||
130007226|NCT01704287|467990656|FG001|Initial Treatment Period|Lost to Follow-up|3|||
130007227|NCT01704287|467990657|FG002|Initial Treatment Period|Lost to Follow-up|0|||
130007228|NCT01704287|467990658|FG003|Initial Treatment Period|Lost to Follow-up|0|||
130007229|NCT01704287|467990659|FG004|Initial Treatment Period|Lost to Follow-up|0|||
130007230|NCT01704287|467990655|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
130007231|NCT01704287|467990656|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
130007232|NCT01704287|467990657|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
130007233|NCT01704287|467990658|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
130007234|NCT01704287|467990659|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
130007235|NCT01704287|467990655|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
130007236|NCT01704287|467990656|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
130007237|NCT01704287|467990657|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
130007238|NCT01704287|467990658|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
130007239|NCT01704287|467990659|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
130007240|NCT01704287|467990655|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
130007241|NCT01704287|467990656|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
130007242|NCT01704287|467990657|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
130007243|NCT01704287|467990658|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
130007244|NCT01704287|467990659|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
130007245|NCT01704287|467990655|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130007246|NCT01704287|467990656|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130007247|NCT01704287|467990657|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
130007248|NCT01704287|467990658|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
130007249|NCT01704287|467990659|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
129884397|NCT00708305|467536384|FG001|Period 3|Other Reason|0|||
130007250|NCT04024228|467990660|FG000|Overall Study|Adverse Event|1|||
130007251|NCT04024228|467990661|FG001|Overall Study|Adverse Event|0|||
130007252|NCT04024228|467990660|FG000|Overall Study|Protocol Deviation|0|||
130007253|NCT04024228|467990661|FG001|Overall Study|Protocol Deviation|2|||
130007254|NCT04024228|467990660|FG000|Overall Study|Withdrawal by Subject|3|||
130007255|NCT04024228|467990661|FG001|Overall Study|Withdrawal by Subject|4|||
130007256|NCT04490395|467990662|FG000|Overall Study|Lost to Follow-up|0|||
130007257|NCT04490395|467990663|FG001|Overall Study|Lost to Follow-up|1|||
130007258|NCT00938717|467990664|FG000|Overall Study|Adverse Event|10|||
130007259|NCT00938717|467990665|FG001|Overall Study|Adverse Event|41|||
130007260|NCT00938717|467990664|FG000|Overall Study|Protocol Violation|11|||
130007261|NCT00938717|467990665|FG001|Overall Study|Protocol Violation|8|||
130007262|NCT00938717|467990664|FG000|Overall Study|Withdrawal by Subject|26|||
130007263|NCT00938717|467990665|FG001|Overall Study|Withdrawal by Subject|24|||
130007264|NCT00938717|467990664|FG000|Overall Study|Lost to Follow-up|13|||
130007265|NCT00938717|467990665|FG001|Overall Study|Lost to Follow-up|18|||
130007266|NCT00938717|467990664|FG000|Overall Study|Lack of Efficacy|33|||
130007267|NCT00938717|467990665|FG001|Overall Study|Lack of Efficacy|15|||
130007268|NCT00938717|467990664|FG000|Overall Study|Other reason|5|||
130007269|NCT00938717|467990665|FG001|Overall Study|Other reason|2|||
130007270|NCT01462435|467990668|FG000|Overall Study|Lack of Efficacy|1|||
130007271|NCT01462435|467990669|FG001|Overall Study|Lack of Efficacy|0|||
130007272|NCT01462435|467990670|FG002|Overall Study|Lack of Efficacy|0|||
130007273|NCT01462435|467990671|FG003|Overall Study|Lack of Efficacy|3|||
130007274|NCT01462435|467990668|FG000|Overall Study|Physician Decision|0|||
130007275|NCT01462435|467990669|FG001|Overall Study|Physician Decision|0|||
130007276|NCT01462435|467990670|FG002|Overall Study|Physician Decision|1|||
130007277|NCT01462435|467990671|FG003|Overall Study|Physician Decision|0|||
130007278|NCT01462435|467990668|FG000|Overall Study|Withdrawal by Subject|0|||
130007279|NCT01462435|467990669|FG001|Overall Study|Withdrawal by Subject|0|||
130007280|NCT01462435|467990670|FG002|Overall Study|Withdrawal by Subject|0|||
130007281|NCT01462435|467990671|FG003|Overall Study|Withdrawal by Subject|1|||
130007282|NCT01462435|467990668|FG000|Overall Study|Lost to Follow-up|0|||
130007283|NCT01462435|467990669|FG001|Overall Study|Lost to Follow-up|0|||
130007284|NCT01462435|467990670|FG002|Overall Study|Lost to Follow-up|0|||
130007285|NCT01462435|467990671|FG003|Overall Study|Lost to Follow-up|1|||
130007286|NCT05092919|467990672|FG000|Overall Study|Lost to Follow-up|7|||
130007287|NCT05092919|467990672|FG000|Overall Study|Withdrawal by Subject|2|||
130007288|NCT02163187|467990674|FG000|Overall Study|Device removed|1|||
130007289|NCT02163187|467990675|FG001|Overall Study|Device removed|0|||
130007290|NCT02163187|467990674|FG000|Overall Study|Progressive disease|1|||
130007291|NCT02163187|467990675|FG001|Overall Study|Progressive disease|0|||
130007292|NCT00257725|467990676|FG000|Overall Study|Adverse Event|3|||
130007293|NCT02490475|467990681|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
130007294|NCT02490475|467990682|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
130007295|NCT02490475|467990683|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
130007296|NCT02490475|467990684|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
130007297|NCT02490475|467990681|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130007298|NCT02490475|467990682|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
130007299|NCT02490475|467990683|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130007300|NCT02490475|467990684|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
130007301|NCT02490475|467990681|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
130007302|NCT02490475|467990682|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
130007303|NCT02490475|467990683|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
130007304|NCT02490475|467990684|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
130007305|NCT02490475|467990681|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
130007306|NCT02490475|467990682|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
130007307|NCT02490475|467990683|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
130007308|NCT02490475|467990684|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
130007309|NCT02490475|467990681|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
130007310|NCT02490475|467990682|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
130007311|NCT02490475|467990683|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
130007312|NCT02490475|467990684|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
130007313|NCT02490475|467990681|FG000|Period 2: Extension Phase|Refused Treatment|0|||
130007314|NCT02490475|467990682|FG001|Period 2: Extension Phase|Refused Treatment|0|||
130007315|NCT02490475|467990683|FG002|Period 2: Extension Phase|Refused Treatment|0|||
130007316|NCT02490475|467990684|FG003|Period 2: Extension Phase|Refused Treatment|1|||
130007317|NCT02490475|467990681|FG000|Period 2: Extension Phase|Adverse Event|0|||
130007318|NCT02490475|467990682|FG001|Period 2: Extension Phase|Adverse Event|0|||
130007319|NCT02490475|467990683|FG002|Period 2: Extension Phase|Adverse Event|1|||
130007320|NCT02490475|467990684|FG003|Period 2: Extension Phase|Adverse Event|0|||
130007321|NCT00139776|467990685|FG000|Period I|Did not enter Period II|575|||
130007322|NCT00139776|467990686|FG001|Period I|Did not enter Period II|0|||
130007323|NCT00139776|467990687|FG002|Period I|Did not enter Period II|0|||
130007324|NCT00139776|467990688|FG003|Period I|Did not enter Period II|0|||
130007325|NCT00139776|467990685|FG000|Period II|Not Randomized into Period III|0|||
130007326|NCT00139776|467990686|FG001|Period II|Not Randomized into Period III|322|||
130007327|NCT00139776|467990687|FG002|Period II|Not Randomized into Period III|0|||
130007328|NCT00139776|467990688|FG003|Period II|Not Randomized into Period III|0|||
130007329|NCT00139776|467990685|FG000|Period III|Adverse Event|0|||
130007330|NCT00139776|467990686|FG001|Period III|Adverse Event|0|||
130007331|NCT00139776|467990687|FG002|Period III|Adverse Event|22|||
130007332|NCT00139776|467990688|FG003|Period III|Adverse Event|23|||
130007333|NCT00139776|467990685|FG000|Period III|Other|0|||
130007334|NCT00139776|467990686|FG001|Period III|Other|0|||
130007335|NCT00139776|467990687|FG002|Period III|Other|23|||
130007336|NCT00139776|467990688|FG003|Period III|Other|34|||
130007337|NCT00139776|467990685|FG000|Period III|Lack of Efficacy|0|||
130007338|NCT00139776|467990686|FG001|Period III|Lack of Efficacy|0|||
130007339|NCT00139776|467990687|FG002|Period III|Lack of Efficacy|10|||
130007340|NCT00139776|467990688|FG003|Period III|Lack of Efficacy|24|||
130007341|NCT00139776|467990685|FG000|Period III|Lost to Follow-up|0|||
130007342|NCT00139776|467990686|FG001|Period III|Lost to Follow-up|0|||
130007343|NCT00139776|467990687|FG002|Period III|Lost to Follow-up|5|||
130007344|NCT00139776|467990688|FG003|Period III|Lost to Follow-up|4|||
130007345|NCT00139776|467990685|FG000|Period III|Withdrawal by Subject|0|||
130007346|NCT00139776|467990686|FG001|Period III|Withdrawal by Subject|0|||
130007347|NCT00139776|467990687|FG002|Period III|Withdrawal by Subject|16|||
130007348|NCT00139776|467990688|FG003|Period III|Withdrawal by Subject|21|||
130007349|NCT04912245|467990689|FG000|Overall Study|Withdrawal by Subject|21|||
130007350|NCT04912245|467990690|FG001|Overall Study|Withdrawal by Subject|4|||
130007351|NCT04912245|467990689|FG000|Overall Study|Lost to Follow-up|5|||
130007352|NCT04912245|467990690|FG001|Overall Study|Lost to Follow-up|11|||
130007353|NCT01368536|467990697|FG000|Overall Study|Adverse Event|5|||
130007354|NCT01368536|467990698|FG001|Overall Study|Adverse Event|6|||
130007355|NCT01368536|467990699|FG002|Overall Study|Adverse Event|8|||
130007356|NCT01368536|467990697|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130007357|NCT01368536|467990698|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130007358|NCT01368536|467990699|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130007359|NCT01368536|467990697|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130007360|NCT01368536|467990698|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130007361|NCT01368536|467990699|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130007362|NCT01368536|467990697|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
130007363|NCT01368536|467990698|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130007364|NCT01368536|467990699|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130007365|NCT01368536|467990697|FG000|Overall Study|No longer required study medication|0|||
130007366|NCT01368536|467990698|FG001|Overall Study|No longer required study medication|0|||
130007367|NCT01368536|467990699|FG002|Overall Study|No longer required study medication|1|||
130007368|NCT01368536|467990697|FG000|Overall Study|Withdrawal by Subject|2|||
130007369|NCT01368536|467990698|FG001|Overall Study|Withdrawal by Subject|5|||
130007370|NCT01368536|467990699|FG002|Overall Study|Withdrawal by Subject|4|||
130007371|NCT01368536|467990697|FG000|Overall Study|Lost to Follow-up|3|||
130007372|NCT01368536|467990698|FG001|Overall Study|Lost to Follow-up|3|||
130007373|NCT01368536|467990699|FG002|Overall Study|Lost to Follow-up|5|||
130007374|NCT01368536|467990697|FG000|Overall Study|Administrative problems|34|||
130007375|NCT01368536|467990698|FG001|Overall Study|Administrative problems|39|||
130007376|NCT01368536|467990699|FG002|Overall Study|Administrative problems|35|||
130007377|NCT01368536|467990697|FG000|Overall Study|Protocol deviation|0|||
130007378|NCT01368536|467990698|FG001|Overall Study|Protocol deviation|3|||
130007379|NCT01368536|467990699|FG002|Overall Study|Protocol deviation|1|||
130007380|NCT01161043|467990700|FG000|Overall Study|Withdrawal by Subject|3|||
130007381|NCT02164929|467990701|FG000|Overall Study|Converted to open procedure|1|||
130007382|NCT02164929|467990702|FG001|Overall Study|Converted to open procedure|0|||
130007383|NCT02164929|467990703|FG002|Overall Study|Converted to open procedure|0|||
130007384|NCT02164929|467990704|FG003|Overall Study|Converted to open procedure|2|||
130007385|NCT02164929|467990701|FG000|Overall Study|Failed regional block|0|||
130007386|NCT02164929|467990702|FG001|Overall Study|Failed regional block|0|||
130007387|NCT02164929|467990703|FG002|Overall Study|Failed regional block|1|||
130007388|NCT02164929|467990704|FG003|Overall Study|Failed regional block|0|||
130007389|NCT00971178|467990705|FG000|Overall Study|Lost to Follow-up|2|||
130007390|NCT00971178|467990706|FG001|Overall Study|Lost to Follow-up|2|||
130007391|NCT00971178|467990707|FG002|Overall Study|Lost to Follow-up|2|||
130007392|NCT03023059|467990709|FG000|Overall Study|Withdrawal by Subject|5|||
130007393|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
130007394|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
130007395|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007396|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007397|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007398|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
130007399|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
130007400|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007401|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007402|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007403|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007404|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007405|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007406|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
130007407|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007408|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007409|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007410|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007411|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007412|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
130007413|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
130007414|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007415|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007416|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007417|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007418|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007419|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007420|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
130007421|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
130007422|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007423|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007424|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007425|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007426|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007427|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
130007428|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007429|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007430|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007431|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007432|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007433|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007434|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
130007435|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007436|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007437|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007438|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007439|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007440|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
130007441|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
130007442|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007443|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007444|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007445|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007446|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007447|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007448|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
130007449|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007450|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007451|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007452|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007453|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007454|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007455|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
130007456|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007457|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007458|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007459|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007460|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007461|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007462|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
130007463|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
130007464|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
130007465|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
130007466|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007467|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007468|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
130007469|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
130007470|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007471|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007472|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007473|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007474|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007475|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007476|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
130007477|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007478|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
130007479|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007480|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007481|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007482|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
130007483|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007484|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007485|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007486|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007487|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007488|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007489|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007490|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
130007491|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
130007492|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007493|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007494|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007495|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007496|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
130007497|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007498|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007499|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007500|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007501|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007502|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007503|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007504|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
130007505|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007506|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007507|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007508|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
130007509|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
130007510|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007511|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007512|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
130007513|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
130007514|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007515|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007516|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007517|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007518|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
130007519|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007520|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007521|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007522|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007523|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007524|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007525|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007526|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
130007527|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
130007528|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007529|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007530|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007531|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007532|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
130007533|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007534|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007535|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007536|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007537|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007538|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007539|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007540|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007541|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
130007542|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007543|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007544|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007545|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007546|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
130007547|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007548|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007549|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007550|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
130007551|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007552|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007553|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007554|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007555|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007556|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007557|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007558|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007559|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007560|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
130007561|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007562|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007563|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007564|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007565|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007566|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007567|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007568|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
130007569|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
130007570|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007571|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007572|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007573|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007574|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
130007575|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007576|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007577|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007578|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007579|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007580|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007581|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007582|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
130007583|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007584|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007585|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007586|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007587|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007588|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
130007589|NCT04033445|467990710|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007590|NCT04033445|467990711|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007591|NCT04033445|467990712|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007592|NCT04033445|467990713|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130052076|NCT05137041|468147193|FG000|Overall Study|Withdrawal by Subject|0|||
130342031|NCT01451437|469223219|FG003|Overall Study|Withdrawal by Subject|0|||
130342032|NCT01451437|469223220|FG004|Overall Study|Withdrawal by Subject|1|||
130342033|NCT01451437|469223221|FG005|Overall Study|Withdrawal by Subject|0|||
129884398|NCT00708305|467536385|FG002|Period 3|Other Reason|0|||
130007593|NCT04033445|467990714|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007594|NCT04033445|467990715|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007595|NCT04033445|467990716|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007596|NCT04033445|467990717|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
130007597|NCT04033445|467990718|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007598|NCT04033445|467990719|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007599|NCT04033445|467990720|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007600|NCT04033445|467990721|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007601|NCT04033445|467990722|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007602|NCT04033445|467990723|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
130007603|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007604|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007605|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007606|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007607|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007608|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007609|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007610|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007611|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
130007612|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
130007613|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
130007614|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
130007615|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
130007616|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
130007617|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007618|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007619|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007620|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007621|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007622|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007623|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007624|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007625|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
130007626|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
130007627|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
130007628|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
130007629|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
130007630|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
130007631|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007632|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007633|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007634|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007635|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007636|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130342034|NCT01451437|469223222|FG006|Overall Study|Withdrawal by Subject|1|||
130342035|NCT01451437|469223223|FG007|Overall Study|Withdrawal by Subject|0|||
130342036|NCT01451437|469223224|FG008|Overall Study|Withdrawal by Subject|0|||
130342037|NCT03472547|469223230|FG000|Overall Study|Withdrawal by Subject|30|||
130342038|NCT02043899|469224541|FG000|Overall Study|Adverse Event|3|||
130342039|NCT02043899|469224541|FG000|Overall Study|Physician Decision|1|||
130342040|NCT02043899|469224541|FG000|Overall Study|Withdrawal by Subject|2|||
130342041|NCT02043899|469224541|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
130342042|NCT02043899|469224541|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
130342043|NCT02043899|469224541|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
130342044|NCT02043899|469224541|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
130342045|NCT02043899|469224541|FG000|Overall Study|Treatment delayed|1|||
130342046|NCT01325337|469224542|FG000|Overall Study|Adverse Event|0|||
130007637|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007638|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007639|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130342047|NCT01325337|469224543|FG001|Overall Study|Adverse Event|2|||
130342048|NCT01325337|469224544|FG002|Overall Study|Adverse Event|2|||
130342049|NCT01325337|469224545|FG003|Overall Study|Adverse Event|1|||
130342050|NCT01325337|469224546|FG004|Overall Study|Adverse Event|2|||
130342051|NCT01325337|469224542|FG000|Overall Study|Lost to Follow-up|2|||
130342052|NCT01325337|469224543|FG001|Overall Study|Lost to Follow-up|2|||
130007640|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007641|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
130007642|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
130007643|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
130007644|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
130007645|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007646|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007647|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007648|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007649|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007650|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007651|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007652|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007653|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007654|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
130007655|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
130007656|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
130007657|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
130007658|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
130007659|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007660|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007661|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007662|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007663|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007664|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007665|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007666|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007667|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
130007668|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
130007669|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
130007670|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
130007671|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
130007672|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
130007673|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007674|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007675|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007676|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007677|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007678|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007679|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007680|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007681|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007682|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007683|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007684|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007685|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
130007686|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
130007687|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007688|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007689|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007690|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007691|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007692|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007693|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007694|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007695|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
130007696|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
130007697|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
130007698|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
130007699|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
130007700|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
130007701|NCT04033445|467990710|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007702|NCT04033445|467990711|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130342053|NCT01325337|469224544|FG002|Overall Study|Lost to Follow-up|2|||
130007703|NCT04033445|467990712|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007704|NCT04033445|467990713|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007705|NCT04033445|467990714|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007706|NCT04033445|467990715|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007707|NCT04033445|467990716|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007708|NCT04033445|467990717|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007709|NCT04033445|467990718|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007710|NCT04033445|467990719|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
130007711|NCT04033445|467990720|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007712|NCT04033445|467990721|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
130007713|NCT04033445|467990722|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
130007714|NCT04033445|467990723|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
130007715|NCT04754802|467990729|FG000|Overall Study|Lost to Follow-up|0|||
130007716|NCT04754802|467990730|FG001|Overall Study|Lost to Follow-up|2|||
130007717|NCT04754802|467990729|FG000|Overall Study|Withdrawal by Subject|2|||
130007718|NCT04754802|467990730|FG001|Overall Study|Withdrawal by Subject|0|||
130007719|NCT04451161|467990731|FG000|Overall Study|Lost to Follow-up|28|||
130007720|NCT04451161|467990732|FG001|Overall Study|Lost to Follow-up|37|||
130007721|NCT04451161|467990733|FG002|Overall Study|Lost to Follow-up|22|||
130007722|NCT04451161|467990734|FG003|Overall Study|Lost to Follow-up|13|||
130007723|NCT04451161|467990735|FG004|Overall Study|Lost to Follow-up|11|||
130007724|NCT04451161|467990736|FG005|Overall Study|Lost to Follow-up|14|||
130007725|NCT04451161|467990731|FG000|Overall Study|Withdrawal by Subject|3|||
130007726|NCT04451161|467990732|FG001|Overall Study|Withdrawal by Subject|0|||
130007727|NCT04451161|467990733|FG002|Overall Study|Withdrawal by Subject|0|||
130007728|NCT04451161|467990734|FG003|Overall Study|Withdrawal by Subject|0|||
130007729|NCT04451161|467990735|FG004|Overall Study|Withdrawal by Subject|2|||
130007730|NCT04451161|467990736|FG005|Overall Study|Withdrawal by Subject|4|||
130007731|NCT05525689|467990738|FG000|Overall Study|Lost to Follow-up|1|||
130007732|NCT05525689|467990739|FG001|Overall Study|Lost to Follow-up|0|||
130007733|NCT01671111|467990743|FG000|Overall Study|Adverse Event|2|||
130007734|NCT01671111|467990743|FG000|Overall Study|Lack of Efficacy|1|||
130007735|NCT01671111|467990743|FG000|Overall Study|Withdrawal by Subject|2|||
130007736|NCT01671111|467990743|FG000|Overall Study|Physician Decision|1|||
130007737|NCT01671111|467990743|FG000|Overall Study|Other|24|||
130342054|NCT01325337|469224545|FG003|Overall Study|Lost to Follow-up|1|||
130342055|NCT01325337|469224546|FG004|Overall Study|Lost to Follow-up|2|||
130342056|NCT01325337|469224542|FG000|Overall Study|Personal Reasons|2|||
130342057|NCT01325337|469224543|FG001|Overall Study|Personal Reasons|5|||
130342058|NCT01325337|469224544|FG002|Overall Study|Personal Reasons|4|||
130342059|NCT01325337|469224545|FG003|Overall Study|Personal Reasons|8|||
130342060|NCT01325337|469224546|FG004|Overall Study|Personal Reasons|3|||
130342061|NCT01325337|469224542|FG000|Overall Study|Withdrawal by Subject|1|||
130007738|NCT00596947|467990744|FG000|Overall Study|study halted due to low enrollment|5|||
130007739|NCT00596947|467990745|FG001|Overall Study|study halted due to low enrollment|3|||
130007740|NCT00596947|467990744|FG000|Overall Study|Lost to Follow-up|1|||
130007741|NCT00596947|467990745|FG001|Overall Study|Lost to Follow-up|0|||
130007742|NCT00496730|467990746|FG000|Overall Study|Lost to Follow-up|4|||
130007743|NCT00496730|467990747|FG001|Overall Study|Lost to Follow-up|3|||
130007744|NCT00496730|467990746|FG000|Overall Study|Withdrawal by Subject|2|||
130007745|NCT00496730|467990747|FG001|Overall Study|Withdrawal by Subject|2|||
130007746|NCT00113074|467990748|FG000|Overall Study|Lost to Follow-up|10|||
130007747|NCT00113074|467990749|FG001|Overall Study|Lost to Follow-up|10|||
130007748|NCT00113074|467990750|FG002|Overall Study|Lost to Follow-up|14|||
130007749|NCT03680911|467990751|FG000|At Home Treatment|Study Termination|3|||
130007750|NCT03680911|467990752|FG001|At Home Treatment|Study Termination|0|||
130007751|NCT03680911|467990751|FG000|At Home Treatment|Lost to Follow-up|0|||
130007752|NCT03680911|467990752|FG001|At Home Treatment|Lost to Follow-up|1|||
130007753|NCT03680911|467990751|FG000|At Home Treatment|Withdrawal by Subject|0|||
130007754|NCT03680911|467990752|FG001|At Home Treatment|Withdrawal by Subject|2|||
130007755|NCT03680911|467990751|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
130007756|NCT03680911|467990752|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
130007757|NCT02114268|467990753|FG000|Overall Study|Lost to Follow-up|4|||
130007758|NCT02114268|467990754|FG001|Overall Study|Lost to Follow-up|1|||
130007759|NCT02114268|467990755|FG002|Overall Study|Lost to Follow-up|1|||
130342062|NCT01325337|469224543|FG001|Overall Study|Withdrawal by Subject|0|||
130342063|NCT01325337|469224544|FG002|Overall Study|Withdrawal by Subject|1|||
130342064|NCT01325337|469224545|FG003|Overall Study|Withdrawal by Subject|0|||
130007760|NCT02114268|467990756|FG003|Overall Study|Lost to Follow-up|0|||
130007761|NCT02114268|467990757|FG004|Overall Study|Lost to Follow-up|0|||
130007762|NCT02114268|467990758|FG005|Overall Study|Lost to Follow-up|2|||
130007763|NCT02114268|467990753|FG000|Overall Study|Withdrawal by Subject|1|||
130007764|NCT02114268|467990754|FG001|Overall Study|Withdrawal by Subject|0|||
130007765|NCT02114268|467990755|FG002|Overall Study|Withdrawal by Subject|0|||
130007766|NCT02114268|467990756|FG003|Overall Study|Withdrawal by Subject|0|||
130007767|NCT02114268|467990757|FG004|Overall Study|Withdrawal by Subject|0|||
130007768|NCT02114268|467990758|FG005|Overall Study|Withdrawal by Subject|1|||
130007769|NCT02114268|467990753|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
130007770|NCT02114268|467990754|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
130007771|NCT02114268|467990755|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
130007772|NCT02114268|467990756|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
130007773|NCT02114268|467990757|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
130007774|NCT02114268|467990758|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
130007775|NCT03962738|467990759|FG000|Overall Study|Protocol Deviation|3|||
130007776|NCT03962738|467990760|FG001|Overall Study|Protocol Deviation|0|||
130007777|NCT03962738|467990761|FG002|Overall Study|Protocol Deviation|1|||
130007778|NCT03962738|467990762|FG003|Overall Study|Protocol Deviation|1|||
130007779|NCT03962738|467990759|FG000|Overall Study|Withdrawal by Subject|4|||
130007780|NCT03962738|467990760|FG001|Overall Study|Withdrawal by Subject|0|||
130007781|NCT03962738|467990761|FG002|Overall Study|Withdrawal by Subject|0|||
130007782|NCT03962738|467990762|FG003|Overall Study|Withdrawal by Subject|0|||
130007783|NCT03962738|467990759|FG000|Overall Study|Lost to Follow-up|0|||
130007784|NCT03962738|467990760|FG001|Overall Study|Lost to Follow-up|0|||
130007785|NCT03962738|467990761|FG002|Overall Study|Lost to Follow-up|1|||
130007786|NCT03962738|467990762|FG003|Overall Study|Lost to Follow-up|0|||
130007787|NCT00509067|467990763|FG000|Overall Study|Lost to Follow-up|1|||
130007788|NCT00509067|467990764|FG001|Overall Study|Lost to Follow-up|1|||
130007789|NCT00509067|467990763|FG000|Overall Study|Adverse Event|3|||
130007790|NCT00509067|467990764|FG001|Overall Study|Adverse Event|1|||
130007791|NCT00509067|467990763|FG000|Overall Study|Protocol Violation|0|||
130007792|NCT00509067|467990764|FG001|Overall Study|Protocol Violation|3|||
130007793|NCT00574288|467990765|FG000|Overall Study|Adverse Event|2|||
130007794|NCT00574288|467990766|FG001|Overall Study|Adverse Event|0|||
130007795|NCT00574288|467990767|FG002|Overall Study|Adverse Event|0|||
130007796|NCT00574288|467990768|FG003|Overall Study|Adverse Event|0|||
130007797|NCT00574288|467990769|FG004|Overall Study|Adverse Event|1|||
130007798|NCT00574288|467990770|FG005|Overall Study|Adverse Event|0|||
130007799|NCT00574288|467990771|FG006|Overall Study|Adverse Event|0|||
130007800|NCT00574288|467990765|FG000|Overall Study|Death|0|||
130007801|NCT00574288|467990766|FG001|Overall Study|Death|0|||
130007802|NCT00574288|467990767|FG002|Overall Study|Death|0|||
130007803|NCT00574288|467990768|FG003|Overall Study|Death|0|||
130007804|NCT00574288|467990769|FG004|Overall Study|Death|0|||
130007805|NCT00574288|467990770|FG005|Overall Study|Death|25|||
130007806|NCT00574288|467990771|FG006|Overall Study|Death|21|||
130007807|NCT00574288|467990765|FG000|Overall Study|Lost to Follow-up|0|||
130007808|NCT00574288|467990766|FG001|Overall Study|Lost to Follow-up|0|||
130007809|NCT00574288|467990767|FG002|Overall Study|Lost to Follow-up|0|||
130007810|NCT00574288|467990768|FG003|Overall Study|Lost to Follow-up|0|||
130007811|NCT00574288|467990769|FG004|Overall Study|Lost to Follow-up|0|||
130007812|NCT00574288|467990770|FG005|Overall Study|Lost to Follow-up|1|||
130007813|NCT00574288|467990771|FG006|Overall Study|Lost to Follow-up|2|||
130007814|NCT00574288|467990765|FG000|Overall Study|Study Terminated By Sponsor|0|||
130007815|NCT00574288|467990766|FG001|Overall Study|Study Terminated By Sponsor|0|||
130007816|NCT00574288|467990767|FG002|Overall Study|Study Terminated By Sponsor|0|||
130007817|NCT00574288|467990768|FG003|Overall Study|Study Terminated By Sponsor|0|||
130007818|NCT00574288|467990769|FG004|Overall Study|Study Terminated By Sponsor|0|||
130007819|NCT00574288|467990770|FG005|Overall Study|Study Terminated By Sponsor|0|||
130007820|NCT00574288|467990771|FG006|Overall Study|Study Terminated By Sponsor|5|||
130007821|NCT00574288|467990765|FG000|Overall Study|Progressive Disease|17|||
130007822|NCT00574288|467990766|FG001|Overall Study|Progressive Disease|2|||
130007823|NCT00574288|467990767|FG002|Overall Study|Progressive Disease|3|||
130007824|NCT00574288|467990768|FG003|Overall Study|Progressive Disease|2|||
130007825|NCT00574288|467990769|FG004|Overall Study|Progressive Disease|1|||
130007826|NCT00574288|467990770|FG005|Overall Study|Progressive Disease|0|||
130007827|NCT00574288|467990771|FG006|Overall Study|Progressive Disease|0|||
130007828|NCT00574288|467990765|FG000|Overall Study|Other|1|||
130007829|NCT00574288|467990766|FG001|Overall Study|Other|1|||
130007830|NCT00574288|467990767|FG002|Overall Study|Other|0|||
130007831|NCT00574288|467990768|FG003|Overall Study|Other|0|||
130007832|NCT00574288|467990769|FG004|Overall Study|Other|0|||
130007833|NCT00574288|467990770|FG005|Overall Study|Other|0|||
130007834|NCT00574288|467990771|FG006|Overall Study|Other|0|||
130007835|NCT02361944|467990774|FG000|Overall Study|surgery cancellation|0|||
130007836|NCT02361944|467990775|FG001|Overall Study|surgery cancellation|1|||
130007837|NCT03654976|467990776|FG000|Overall Study|Withdrawal by Subject|12|||
130007838|NCT03654976|467990777|FG001|Overall Study|Withdrawal by Subject|11|||
130007839|NCT03654976|467990776|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
130007840|NCT03654976|467990777|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
130007841|NCT03654976|467990776|FG000|Overall Study|Adverse Event|5|||
130007842|NCT03654976|467990777|FG001|Overall Study|Adverse Event|0|||
130007843|NCT03654976|467990776|FG000|Overall Study|Lost to Follow-up|2|||
130007844|NCT03654976|467990777|FG001|Overall Study|Lost to Follow-up|0|||
130007845|NCT03654976|467990776|FG000|Overall Study|Lack of Efficacy|0|||
130007846|NCT03654976|467990777|FG001|Overall Study|Lack of Efficacy|1|||
130007847|NCT00117598|467990778|FG000|Prior to Treatment Cross Over|Death|40|||
130342065|NCT01325337|469224546|FG004|Overall Study|Withdrawal by Subject|1|||
130342066|NCT02184455|469224554|FG000|Overall Study|Lost to Follow-up|1|||
130007848|NCT00117598|467990779|FG001|Prior to Treatment Cross Over|Death|41|||
130007849|NCT00117598|467990780|FG002|Prior to Treatment Cross Over|Death|37|||
130007850|NCT00117598|467990781|FG003|Prior to Treatment Cross Over|Death|0|||
130007851|NCT00117598|467990782|FG004|Prior to Treatment Cross Over|Death|0|||
130007852|NCT00117598|467990778|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
130007853|NCT00117598|467990779|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
130007854|NCT00117598|467990780|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
130007855|NCT00117598|467990781|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
130007856|NCT00117598|467990782|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
130007857|NCT00117598|467990778|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
130007858|NCT00117598|467990779|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
130007859|NCT00117598|467990780|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
130007860|NCT00117598|467990781|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
130007861|NCT00117598|467990782|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
130007862|NCT00117598|467990778|FG000|Prior to Treatment Cross Over|Other|15|||
130007863|NCT00117598|467990779|FG001|Prior to Treatment Cross Over|Other|9|||
130007864|NCT00117598|467990780|FG002|Prior to Treatment Cross Over|Other|9|||
130007865|NCT00117598|467990781|FG003|Prior to Treatment Cross Over|Other|0|||
130007866|NCT00117598|467990782|FG004|Prior to Treatment Cross Over|Other|0|||
130007867|NCT00117598|467990778|FG000|After Treament Cross Over|Death|0|||
130007868|NCT00117598|467990779|FG001|After Treament Cross Over|Death|0|||
130007869|NCT00117598|467990780|FG002|After Treament Cross Over|Death|0|||
130007870|NCT00117598|467990781|FG003|After Treament Cross Over|Death|1|||
130007871|NCT00117598|467990782|FG004|After Treament Cross Over|Death|2|||
130007872|NCT00117598|467990778|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
130007873|NCT00117598|467990779|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
130007874|NCT00117598|467990780|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
130007875|NCT00117598|467990781|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
130007876|NCT00117598|467990782|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
130007877|NCT00117598|467990778|FG000|After Treament Cross Over|Other|0|||
130007878|NCT00117598|467990779|FG001|After Treament Cross Over|Other|0|||
130007879|NCT00117598|467990780|FG002|After Treament Cross Over|Other|0|||
130007880|NCT00117598|467990781|FG003|After Treament Cross Over|Other|1|||
130007881|NCT00117598|467990782|FG004|After Treament Cross Over|Other|2|||
130007882|NCT03098836|467990783|FG000|Overall Study|Adverse Event|1|||
130007883|NCT03098836|467990784|FG001|Overall Study|Adverse Event|3|||
130007884|NCT03098836|467990783|FG000|Overall Study|Lack of Efficacy|30|||
130007885|NCT03098836|467990784|FG001|Overall Study|Lack of Efficacy|15|||
130007886|NCT03098836|467990783|FG000|Overall Study|Physician Decision|2|||
130007887|NCT03098836|467990784|FG001|Overall Study|Physician Decision|1|||
130007888|NCT03098836|467990783|FG000|Overall Study|Withdrawal by Subject|3|||
130007889|NCT03098836|467990784|FG001|Overall Study|Withdrawal by Subject|2|||
130007890|NCT04688775|467990787|FG000|Placebo-controlled Period|Randomized, not treated|1|||
130007891|NCT04688775|467990788|FG001|Placebo-controlled Period|Randomized, not treated|1|||
130007892|NCT04688775|467990789|FG002|Placebo-controlled Period|Randomized, not treated|0|||
130007893|NCT04688775|467990790|FG003|Placebo-controlled Period|Randomized, not treated|0|||
130007894|NCT04688775|467990787|FG000|Placebo-controlled Period|Adverse Event|2|||
130007895|NCT04688775|467990788|FG001|Placebo-controlled Period|Adverse Event|0|||
130007896|NCT04688775|467990789|FG002|Placebo-controlled Period|Adverse Event|0|||
130007897|NCT04688775|467990790|FG003|Placebo-controlled Period|Adverse Event|0|||
130007898|NCT04688775|467990787|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
130007899|NCT04688775|467990788|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
130007900|NCT04688775|467990789|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
130007901|NCT04688775|467990790|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
130007902|NCT04688775|467990787|FG000|Placebo-controlled Period|Protocol Violation|0|||
130007903|NCT04688775|467990788|FG001|Placebo-controlled Period|Protocol Violation|1|||
130007904|NCT04688775|467990789|FG002|Placebo-controlled Period|Protocol Violation|0|||
130342067|NCT01347580|469224555|FG000|Overall Study|Withdrawal by Subject|13|||
130007905|NCT04688775|467990790|FG003|Placebo-controlled Period|Protocol Violation|0|||
130342068|NCT01347580|469224556|FG001|Overall Study|Withdrawal by Subject|23|||
130007906|NCT04688775|467990787|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
130007907|NCT04688775|467990788|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
130007908|NCT04688775|467990789|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
130007909|NCT04688775|467990790|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
130007910|NCT04688775|467990787|FG000|Placebo-controlled Period|Other reasons|0|||
130007911|NCT04688775|467990788|FG001|Placebo-controlled Period|Other reasons|1|||
130007912|NCT04688775|467990789|FG002|Placebo-controlled Period|Other reasons|0|||
130007913|NCT04688775|467990790|FG003|Placebo-controlled Period|Other reasons|0|||
130007914|NCT04688775|467990787|FG000|Delayed Start Period|Adverse Event|0|||
130342069|NCT01347580|469224555|FG000|Overall Study|Death|30|||
130007915|NCT04688775|467990788|FG001|Delayed Start Period|Adverse Event|0|||
130342070|NCT01347580|469224556|FG001|Overall Study|Death|19|||
130342071|NCT01347580|469224555|FG000|Overall Study|Protocol Violation|10|||
130007916|NCT04688775|467990789|FG002|Delayed Start Period|Adverse Event|1|||
130007917|NCT04688775|467990790|FG003|Delayed Start Period|Adverse Event|0|||
130342072|NCT01347580|469224556|FG001|Overall Study|Protocol Violation|7|||
130342073|NCT01347580|469224555|FG000|Overall Study|Lost to Follow-up|3|||
130342074|NCT01347580|469224556|FG001|Overall Study|Lost to Follow-up|1|||
130342075|NCT01347580|469224555|FG000|Overall Study|Had other reason|9|||
130342076|NCT01347580|469224556|FG001|Overall Study|Had other reason|6|||
130342077|NCT01964755|469224559|FG000|Overall Study|Death|2|||
130342078|NCT02894502|469224560|FG000|Baseline|Withdrawal by Subject|24|||
130342079|NCT02894502|469224561|FG001|Baseline|Withdrawal by Subject|31|||
130342080|NCT02894502|469224562|FG002|Baseline|Withdrawal by Subject|36|||
130342081|NCT02894502|469224560|FG000|Baseline|Death|3|||
130342082|NCT02894502|469224561|FG001|Baseline|Death|1|||
130342083|NCT02894502|469224562|FG002|Baseline|Death|9|||
130342084|NCT02894502|469224560|FG000|First Follow up|Withdrawal by Subject|32|||
130342085|NCT02894502|469224561|FG001|First Follow up|Withdrawal by Subject|29|||
130342086|NCT02894502|469224562|FG002|First Follow up|Withdrawal by Subject|37|||
130342087|NCT02894502|469224560|FG000|First Follow up|Death|2|||
130342088|NCT02894502|469224561|FG001|First Follow up|Death|2|||
130007918|NCT04688775|467990787|FG000|Delayed Start Period|Lack of Efficacy|0|||
130007919|NCT04688775|467990788|FG001|Delayed Start Period|Lack of Efficacy|0|||
130007920|NCT04688775|467990789|FG002|Delayed Start Period|Lack of Efficacy|0|||
130007921|NCT04688775|467990790|FG003|Delayed Start Period|Lack of Efficacy|3|||
130007922|NCT04688775|467990787|FG000|Delayed Start Period|Withdrawal by Subject|0|||
130007923|NCT04688775|467990788|FG001|Delayed Start Period|Withdrawal by Subject|0|||
130007924|NCT04688775|467990789|FG002|Delayed Start Period|Withdrawal by Subject|2|||
130007925|NCT04688775|467990790|FG003|Delayed Start Period|Withdrawal by Subject|4|||
130007926|NCT04688775|467990787|FG000|Delayed Start Period|Lost to Follow-up|0|||
130007927|NCT04688775|467990788|FG001|Delayed Start Period|Lost to Follow-up|0|||
130007928|NCT04688775|467990789|FG002|Delayed Start Period|Lost to Follow-up|2|||
130007929|NCT04688775|467990790|FG003|Delayed Start Period|Lost to Follow-up|1|||
130007930|NCT04688775|467990787|FG000|Delayed Start Period|other reasons|0|||
130007931|NCT04688775|467990788|FG001|Delayed Start Period|other reasons|0|||
130007932|NCT04688775|467990789|FG002|Delayed Start Period|other reasons|1|||
130007933|NCT04688775|467990790|FG003|Delayed Start Period|other reasons|0|||
130007934|NCT00898443|467990791|FG000|Overall Study|Withdrawal by Subject|1|||
130007935|NCT00898443|467990792|FG001|Overall Study|Withdrawal by Subject|0|||
130007936|NCT01770912|467990793|FG000|Overall Study|Lost to Follow-up|2|||
130007937|NCT01770912|467990794|FG001|Overall Study|Lost to Follow-up|0|||
130007938|NCT04695392|467990795|FG000|Overall Study|Withdrawn by parent/guardian|0|||
130007939|NCT04695392|467990796|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130007940|NCT04695392|467990795|FG000|Overall Study|Withdrawn by physician|0|||
130007941|NCT04695392|467990796|FG001|Overall Study|Withdrawn by physician|1|||
130007942|NCT01817751|467990801|FG000|Overall Study|Physician Decision|1|||
130007943|NCT02811549|467990802|FG000|Overall Study|Lost to Follow-up|1|||
130007944|NCT02811549|467990802|FG000|Overall Study|Withdrawal by Subject|3|||
130007945|NCT02811549|467990802|FG000|Overall Study|Subject screen failed|4|||
130007946|NCT02811549|467990802|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
130007947|NCT03472924|467990804|FG000|Overall Study|Adverse Event|1|||
130007948|NCT03472924|467990805|FG001|Overall Study|Adverse Event|0|||
130007949|NCT00427349|467990806|FG000|Overall Study|Lack of Efficacy|23|||
130007950|NCT00427349|467990806|FG000|Overall Study|Adverse Event|14|||
130007951|NCT00427349|467990806|FG000|Overall Study|Death|1|||
130007952|NCT00427349|467990806|FG000|Overall Study|Withdrawal by Subject|3|||
130007953|NCT00427349|467990806|FG000|Overall Study|Alternative therapy|1|||
130007954|NCT00427349|467990806|FG000|Overall Study|Other|2|||
130007955|NCT00427349|467990806|FG000|Overall Study|Ineligible|1|||
130007956|NCT00427349|467990806|FG000|Overall Study|Never started therapy|1|||
130007957|NCT05082376|467990810|FG000|Overall Study|Lost to Follow-up|2|||
130007958|NCT04425720|467990813|FG000|Overall Study|Withdrawal by Subject|0|||
130342089|NCT02894502|469224562|FG002|First Follow up|Death|3|||
130342090|NCT02894502|469224560|FG000|Second Follow up|Withdrawal by Subject|13|||
130007959|NCT04425720|467990814|FG001|Overall Study|Withdrawal by Subject|20|||
130007960|NCT00290186|467990815|FG000|Overall Study|Adverse Event|1|||
130342091|NCT02894502|469224561|FG001|Second Follow up|Withdrawal by Subject|15|||
130342092|NCT02894502|469224562|FG002|Second Follow up|Withdrawal by Subject|13|||
130342093|NCT02894502|469224560|FG000|Second Follow up|Death|2|||
130007961|NCT00290186|467990816|FG001|Overall Study|Adverse Event|1|||
130007962|NCT00290186|467990815|FG000|Overall Study|Lost to Follow-up|3|||
130007963|NCT00290186|467990816|FG001|Overall Study|Lost to Follow-up|2|||
130007964|NCT00290186|467990815|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
130342094|NCT02894502|469224561|FG001|Second Follow up|Death|3|||
130007965|NCT00290186|467990816|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
130007966|NCT00290186|467990815|FG000|Overall Study|Withdrawal by Subject|0|||
130342095|NCT02894502|469224562|FG002|Second Follow up|Death|1|||
130342096|NCT02894502|469224560|FG000|Third Follow up|Withdrawal by Subject|5|||
130342097|NCT02894502|469224561|FG001|Third Follow up|Withdrawal by Subject|6|||
130342098|NCT02894502|469224562|FG002|Third Follow up|Withdrawal by Subject|3|||
130342099|NCT02894502|469224560|FG000|Third Follow up|Death|1|||
130342100|NCT02894502|469224561|FG001|Third Follow up|Death|1|||
130342101|NCT02894502|469224562|FG002|Third Follow up|Death|0|||
130342102|NCT01332799|469224566|FG000|Overall Study|Insufficient funding|10|||
130342103|NCT01332799|469224567|FG001|Overall Study|Insufficient funding|10|||
130342104|NCT02168387|469224570|FG000|Overall Study|Planned exubation|6|||
130342105|NCT02168387|469224571|FG001|Overall Study|Planned exubation|3|||
130342106|NCT02168387|469224570|FG000|Overall Study|Death|1|||
130342107|NCT02168387|469224571|FG001|Overall Study|Death|0|||
130342108|NCT03467152|469224572|FG000|Overall Study|Adverse Event|4|||
130342109|NCT03467152|469224573|FG001|Overall Study|Adverse Event|5|||
130342110|NCT03467152|469224574|FG002|Overall Study|Adverse Event|0|||
130342111|NCT03467152|469224572|FG000|Overall Study|Subject Choice|1|||
130342112|NCT03467152|469224573|FG001|Overall Study|Subject Choice|3|||
130342113|NCT03467152|469224574|FG002|Overall Study|Subject Choice|0|||
130342114|NCT03467152|469224572|FG000|Overall Study|Lost to Follow-up|1|||
130342115|NCT03467152|469224573|FG001|Overall Study|Lost to Follow-up|0|||
130342116|NCT03467152|469224574|FG002|Overall Study|Lost to Follow-up|0|||
130342117|NCT03467152|469224572|FG000|Overall Study|Withdrawal by Subject|4|||
130342118|NCT03467152|469224573|FG001|Overall Study|Withdrawal by Subject|2|||
130342119|NCT03467152|469224574|FG002|Overall Study|Withdrawal by Subject|0|||
130342120|NCT03467152|469224572|FG000|Overall Study|Others|3|||
130342121|NCT03467152|469224573|FG001|Overall Study|Others|0|||
130342122|NCT03467152|469224574|FG002|Overall Study|Others|0|||
130342123|NCT03467152|469224572|FG000|Overall Study|Not treated|3|||
130342124|NCT03467152|469224573|FG001|Overall Study|Not treated|1|||
130342125|NCT03467152|469224574|FG002|Overall Study|Not treated|6|||
130007967|NCT00290186|467990816|FG001|Overall Study|Withdrawal by Subject|1|||
130007968|NCT04085523|467990818|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130007969|NCT04085523|467990819|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130007970|NCT04085523|467990820|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130007971|NCT04085523|467990821|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130007972|NCT04085523|467990822|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
130007973|NCT04085523|467990823|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
130007974|NCT03697720|467992350|FG000|Overall Study|Lost to Follow-up|7|||
130007975|NCT03496012|467992355|FG000|Overall Study|Withdrawal by Subject|2|||
130007976|NCT03496012|467992356|FG001|Overall Study|Withdrawal by Subject|0|||
130007977|NCT03496012|467992357|FG002|Overall Study|Withdrawal by Subject|2|||
130007978|NCT03496012|467992355|FG000|Overall Study|Adverse Event|0|||
130007979|NCT03496012|467992356|FG001|Overall Study|Adverse Event|0|||
130007980|NCT03496012|467992357|FG002|Overall Study|Adverse Event|1|||
130007981|NCT03496012|467992355|FG000|Overall Study|Reason Not Specified|2|||
130007982|NCT03496012|467992356|FG001|Overall Study|Reason Not Specified|0|||
130007983|NCT03496012|467992357|FG002|Overall Study|Reason Not Specified|1|||
130007984|NCT00449670|467992358|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
130007985|NCT00449670|467992359|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
130007986|NCT00449670|467992358|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
130007987|NCT00449670|467992359|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
130007988|NCT00449670|467992358|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
130007989|NCT00449670|467992359|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
130007990|NCT00449670|467992358|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
130007991|NCT00449670|467992359|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
130007992|NCT00449670|467992358|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
130007993|NCT00449670|467992359|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
130007994|NCT00449670|467992358|FG000|Booster Phase (Study no.109873)|Other|0|||
130007995|NCT00449670|467992359|FG001|Booster Phase (Study no.109873)|Other|2|||
130007996|NCT04183790|467992360|FG000|Overall Study|Participants did not rollover to Part B|12|||
130007997|NCT04183790|467992361|FG001|Overall Study|Participants did not rollover to Part B|0|||
130007998|NCT04183790|467992360|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
130007999|NCT04183790|467992361|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130008000|NCT04183790|467992360|FG000|Overall Study|Commercial drug is available for participant|6|||
130008001|NCT04183790|467992361|FG001|Overall Study|Commercial drug is available for participant|0|||
130008002|NCT04183790|467992360|FG000|Overall Study|Adverse Event|1|||
130342126|NCT01236547|469224575|FG000|Overall Study|Protocol Violation|0|||
130342127|NCT01236547|469224576|FG001|Overall Study|Protocol Violation|1|||
130342128|NCT01236547|469224577|FG002|Overall Study|Protocol Violation|1|||
130342129|NCT01236547|469224578|FG003|Overall Study|Protocol Violation|6|||
130342130|NCT01236547|469224579|FG004|Overall Study|Protocol Violation|12|||
130342131|NCT00910624|469224581|FG000|Treatment Phase|Adverse Event|2|||
130342132|NCT00910624|469224582|FG001|Treatment Phase|Adverse Event|6|||
130342133|NCT00910624|469224583|FG002|Treatment Phase|Adverse Event|6|||
130342134|NCT00910624|469224584|FG003|Treatment Phase|Adverse Event|0|||
130342135|NCT00910624|469224581|FG000|Treatment Phase|Treatment Failure|23|||
130342136|NCT00910624|469224582|FG001|Treatment Phase|Treatment Failure|10|||
130342137|NCT00910624|469224583|FG002|Treatment Phase|Treatment Failure|0|||
130342138|NCT00910624|469224584|FG003|Treatment Phase|Treatment Failure|0|||
130342139|NCT00910624|469224581|FG000|Treatment Phase|Lost to Follow-up|0|||
130342140|NCT00910624|469224582|FG001|Treatment Phase|Lost to Follow-up|0|||
130342141|NCT00910624|469224583|FG002|Treatment Phase|Lost to Follow-up|1|||
130342142|NCT00910624|469224584|FG003|Treatment Phase|Lost to Follow-up|0|||
130342143|NCT00910624|469224581|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
130342144|NCT00910624|469224582|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
130342145|NCT00910624|469224583|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
130342146|NCT00910624|469224584|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
130342147|NCT00910624|469224581|FG000|Treatment Phase|Withdrawal by Subject|2|||
130342148|NCT00910624|469224582|FG001|Treatment Phase|Withdrawal by Subject|1|||
130342149|NCT00910624|469224583|FG002|Treatment Phase|Withdrawal by Subject|0|||
130342150|NCT00910624|469224584|FG003|Treatment Phase|Withdrawal by Subject|0|||
130342151|NCT00910624|469224581|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
130342152|NCT00910624|469224582|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
130342153|NCT00910624|469224583|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
130342154|NCT00910624|469224584|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
130342155|NCT00910624|469224581|FG000|Follow-Up Phase|Adverse Event|0|||
130342156|NCT00910624|469224582|FG001|Follow-Up Phase|Adverse Event|0|||
130342157|NCT00910624|469224583|FG002|Follow-Up Phase|Adverse Event|1|||
130342158|NCT00910624|469224584|FG003|Follow-Up Phase|Adverse Event|0|||
130342159|NCT00910624|469224581|FG000|Follow-Up Phase|Lost to Follow-up|3|||
130342160|NCT00910624|469224582|FG001|Follow-Up Phase|Lost to Follow-up|1|||
130342161|NCT00910624|469224583|FG002|Follow-Up Phase|Lost to Follow-up|2|||
130342162|NCT00910624|469224584|FG003|Follow-Up Phase|Lost to Follow-up|0|||
130342163|NCT00910624|469224581|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
130342164|NCT00910624|469224582|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
130342165|NCT00910624|469224583|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
130342166|NCT00910624|469224584|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
130342167|NCT00910624|469224581|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
130342168|NCT00910624|469224582|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130342169|NCT00910624|469224583|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
130342170|NCT00910624|469224584|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
130342171|NCT00910624|469224581|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
130342172|NCT00910624|469224582|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130342173|NCT00910624|469224583|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130342174|NCT00910624|469224584|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
130342175|NCT00910624|469224581|FG000|Follow-Up Phase|Administrative|0|||
130342176|NCT00910624|469224582|FG001|Follow-Up Phase|Administrative|1|||
130342177|NCT00910624|469224583|FG002|Follow-Up Phase|Administrative|1|||
130342178|NCT00910624|469224584|FG003|Follow-Up Phase|Administrative|0|||
130342179|NCT03005873|469224585|FG000|Overall Study|Prohibited medication use post radnomization|1|||
130342180|NCT03005873|469224586|FG001|Overall Study|Prohibited medication use post radnomization|1|||
130008003|NCT04183790|467992361|FG001|Overall Study|Adverse Event|0|||
130008004|NCT04183790|467992360|FG000|Overall Study|Not enrolled in 107 study|0|||
130008005|NCT04183790|467992361|FG001|Overall Study|Not enrolled in 107 study|2|||
130008006|NCT00937937|467992362|FG000|Overall Study|Adverse Event|6|||
130008007|NCT00937937|467992362|FG000|Overall Study|Withdrawal by Subject|2|||
130008008|NCT00937937|467992362|FG000|Overall Study|Progression/relapse|61|||
130008009|NCT00937937|467992362|FG000|Overall Study|Death|1|||
130008010|NCT00937937|467992362|FG000|Overall Study|Other|2|||
130008011|NCT03197493|467992363|FG000|Overall Study|Withdrawal by Subject|5|||
130008012|NCT02248259|467992364|FG000|Treatment Period 1|Adverse Event|0|||
130008013|NCT02248259|467992365|FG001|Treatment Period 1|Adverse Event|0|||
130008014|NCT02248259|467992366|FG002|Treatment Period 1|Adverse Event|1|||
130008015|NCT02248259|467992367|FG003|Treatment Period 1|Adverse Event|0|||
130008016|NCT02807480|467992368|FG000|Overall Study|Withdrawal by Subject|14|||
130008017|NCT02807480|467992369|FG001|Overall Study|Withdrawal by Subject|10|||
130008018|NCT02369848|467992370|FG000|Overall Study|Death|1|||
130008019|NCT02369848|467992370|FG000|Overall Study|Withdrawal by Subject|2|||
130008020|NCT02369848|467992370|FG000|Overall Study|Lost to Follow-up|1|||
130008021|NCT03281668|467992372|FG000|Overall Study|Physician Decision|1|||
130008022|NCT03281668|467992372|FG000|Overall Study|scheduling conflict, family circumstance|2|||
130008023|NCT03281668|467992372|FG000|Overall Study|Withdrawal by Subject|4|||
130008024|NCT03281668|467992372|FG000|Overall Study|Lost to Follow-up|1|||
130008025|NCT01543152|467992373|FG000|Overall Study|Withdrawal by Subject|0|||
130008026|NCT01543152|467992374|FG001|Overall Study|Withdrawal by Subject|2|||
130342181|NCT03005873|469224587|FG002|Overall Study|Prohibited medication use post radnomization|1|||
130342182|NCT03005873|469224585|FG000|Overall Study|Withdrew consent|0|||
130342183|NCT03005873|469224586|FG001|Overall Study|Withdrew consent|1|||
130342184|NCT03005873|469224587|FG002|Overall Study|Withdrew consent|2|||
130342185|NCT03005873|469224585|FG000|Overall Study|Lost to Follow-up|0|||
130008027|NCT01543152|467992375|FG002|Overall Study|Withdrawal by Subject|0|||
130008028|NCT01543152|467992376|FG003|Overall Study|Withdrawal by Subject|0|||
130008029|NCT01543152|467992377|FG004|Overall Study|Withdrawal by Subject|0|||
130342186|NCT03005873|469224586|FG001|Overall Study|Lost to Follow-up|1|||
130342187|NCT03005873|469224587|FG002|Overall Study|Lost to Follow-up|0|||
130342188|NCT03005873|469224585|FG000|Overall Study|Ineligible post randomization|0|||
130342189|NCT03005873|469224586|FG001|Overall Study|Ineligible post randomization|0|||
130342190|NCT03005873|469224587|FG002|Overall Study|Ineligible post randomization|1|||
130342191|NCT04140227|469224588|FG000|Overall Study|Withdrawal by Subject|26|||
130342192|NCT04140227|469224588|FG000|Overall Study|Lost to Follow-up|8|||
130342193|NCT04140227|469224588|FG000|Overall Study|Adverse Event|8|||
130342194|NCT04140227|469224588|FG000|Overall Study|Death|1|||
130342195|NCT04140227|469224588|FG000|Overall Study|Other|3|||
130342196|NCT04140227|469224588|FG000|Overall Study|Protocol Violation|2|||
130342197|NCT01713933|469224589|FG000|Overall Study|Lost to Follow-up|2|||
130342198|NCT01713933|469224589|FG000|Overall Study|Withdrawal by Subject|3|||
130342199|NCT01713933|469224589|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
130342200|NCT00412373|469224592|FG000|Overall Study|Adverse Event|8|||
130342201|NCT00412373|469224593|FG001|Overall Study|Adverse Event|13|||
130342202|NCT00412373|469224592|FG000|Overall Study|Lack of Efficacy|16|||
130008030|NCT02932410|467992378|FG000|Overall Study|Death|7|||
130008031|NCT02932410|467992379|FG001|Overall Study|Death|6|||
130008032|NCT02932410|467992380|FG002|Overall Study|Death|0|||
130008033|NCT02932410|467992381|FG003|Overall Study|Death|0|||
130008034|NCT02932410|467992378|FG000|Overall Study|Lost to Follow-up|1|||
130008035|NCT02932410|467992379|FG001|Overall Study|Lost to Follow-up|2|||
130008036|NCT02932410|467992380|FG002|Overall Study|Lost to Follow-up|0|||
130008037|NCT02932410|467992381|FG003|Overall Study|Lost to Follow-up|0|||
130008038|NCT02932410|467992378|FG000|Overall Study|Parent/Subjects decision|6|||
130008039|NCT02932410|467992379|FG001|Overall Study|Parent/Subjects decision|6|||
130008040|NCT02932410|467992380|FG002|Overall Study|Parent/Subjects decision|1|||
130342203|NCT00412373|469224593|FG001|Overall Study|Lack of Efficacy|22|||
130342204|NCT00412373|469224592|FG000|Overall Study|Lost to Follow-up|7|||
130342205|NCT00412373|469224593|FG001|Overall Study|Lost to Follow-up|13|||
130342206|NCT00412373|469224592|FG000|Overall Study|Withdrawal by Subject|8|||
130342207|NCT00412373|469224593|FG001|Overall Study|Withdrawal by Subject|27|||
130342208|NCT00412373|469224592|FG000|Overall Study|Other|2|||
130342209|NCT00412373|469224593|FG001|Overall Study|Other|2|||
130342210|NCT01009840|469224596|FG000|Overall Study|Lost to Follow-up|1|||
130342211|NCT01009840|469224596|FG000|Overall Study|Adverse Event|4|||
130342212|NCT01009840|469224596|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
130342213|NCT01009840|469224596|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
130342214|NCT01009840|469224596|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
130342215|NCT04022733|469224597|FG000|Overall Study|conversion to open surgery|3|||
130342216|NCT04022733|469224598|FG001|Overall Study|conversion to open surgery|2|||
130342217|NCT04022733|469224597|FG000|Overall Study|bradycardia|0|||
130342218|NCT04022733|469224598|FG001|Overall Study|bradycardia|1|||
130342219|NCT01104376|469224601|FG000|Overall Study|Withdrawal by Subject|15|||
130342220|NCT01104376|469224601|FG000|Overall Study|Consented but excluded after labs|13|||
130342221|NCT00797966|469224602|FG000|Phase A|Lost to Follow-up|0|||
130342222|NCT00797966|469224603|FG001|Phase A|Lost to Follow-up|0|||
130342223|NCT00797966|469224604|FG002|Phase A|Lost to Follow-up|0|||
130342224|NCT00797966|469224605|FG003|Phase A|Lost to Follow-up|0|||
130342225|NCT00797966|469224606|FG004|Phase A|Lost to Follow-up|33|||
130342226|NCT00797966|469224607|FG005|Phase A|Lost to Follow-up|0|||
130342227|NCT00797966|469224602|FG000|Phase A|Adverse Event|0|||
130342228|NCT00797966|469224603|FG001|Phase A|Adverse Event|0|||
130342229|NCT00797966|469224604|FG002|Phase A|Adverse Event|0|||
130342230|NCT00797966|469224605|FG003|Phase A|Adverse Event|0|||
130342231|NCT00797966|469224606|FG004|Phase A|Adverse Event|46|||
130342232|NCT00797966|469224607|FG005|Phase A|Adverse Event|0|||
130342233|NCT00797966|469224602|FG000|Phase A|Met withdrawal criteria|0|||
130342234|NCT00797966|469224603|FG001|Phase A|Met withdrawal criteria|0|||
130342235|NCT00797966|469224604|FG002|Phase A|Met withdrawal criteria|0|||
130342236|NCT00797966|469224605|FG003|Phase A|Met withdrawal criteria|0|||
130008041|NCT02932410|467992381|FG003|Overall Study|Parent/Subjects decision|0|||
130008042|NCT02932410|467992378|FG000|Overall Study|Physician Decision|0|||
130342237|NCT00797966|469224606|FG004|Phase A|Met withdrawal criteria|4|||
130342238|NCT00797966|469224607|FG005|Phase A|Met withdrawal criteria|0|||
130342239|NCT00797966|469224602|FG000|Phase A|Physician Decision|0|||
130342240|NCT00797966|469224603|FG001|Phase A|Physician Decision|0|||
130342241|NCT00797966|469224604|FG002|Phase A|Physician Decision|0|||
130342242|NCT00797966|469224605|FG003|Phase A|Physician Decision|0|||
130342243|NCT00797966|469224606|FG004|Phase A|Physician Decision|13|||
130342244|NCT00797966|469224607|FG005|Phase A|Physician Decision|0|||
130342245|NCT00797966|469224602|FG000|Phase A|Withdrawal by Subject|0|||
130008043|NCT02932410|467992379|FG001|Overall Study|Physician Decision|1|||
130342246|NCT00797966|469224603|FG001|Phase A|Withdrawal by Subject|0|||
130342247|NCT00797966|469224604|FG002|Phase A|Withdrawal by Subject|0|||
130342248|NCT00797966|469224605|FG003|Phase A|Withdrawal by Subject|0|||
130008044|NCT02932410|467992380|FG002|Overall Study|Physician Decision|0|||
130008045|NCT02932410|467992381|FG003|Overall Study|Physician Decision|0|||
130008046|NCT02573870|467992382|FG000|Overall Study|Adverse Event|0|||
130008047|NCT02573870|467992383|FG001|Overall Study|Adverse Event|2|||
130008048|NCT02573870|467992382|FG000|Overall Study|Lack of Efficacy|0|||
130008049|NCT02573870|467992383|FG001|Overall Study|Lack of Efficacy|1|||
130008050|NCT02573870|467992382|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
130008051|NCT02573870|467992383|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
130008052|NCT02573870|467992382|FG000|Overall Study|Lost to Follow-up|0|||
130008053|NCT02573870|467992383|FG001|Overall Study|Lost to Follow-up|1|||
130008054|NCT02573870|467992382|FG000|Overall Study|Other: Fail to Meet Visit|0|||
130008055|NCT02573870|467992383|FG001|Overall Study|Other: Fail to Meet Visit|2|||
130008056|NCT00762892|467992392|FG000|Overall Study|Lost to Follow-up|2|||
130008057|NCT00762892|467992393|FG001|Overall Study|Lost to Follow-up|5|||
130008058|NCT00762892|467992392|FG000|Overall Study|Withdrawal by Subject|0|||
130008059|NCT00762892|467992393|FG001|Overall Study|Withdrawal by Subject|1|||
130008060|NCT00762892|467992392|FG000|Overall Study|Death|1|||
130008061|NCT00762892|467992393|FG001|Overall Study|Death|0|||
130008062|NCT00762892|467992392|FG000|Overall Study|Pregnancy|1|||
130008063|NCT00762892|467992393|FG001|Overall Study|Pregnancy|0|||
130008064|NCT00762892|467992392|FG000|Overall Study|Incarceration|1|||
130008065|NCT00762892|467992393|FG001|Overall Study|Incarceration|0|||
130008066|NCT01007032|467992396|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
130008067|NCT01007032|467992397|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
130008068|NCT01007032|467992398|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
130008069|NCT01007032|467992399|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
130008070|NCT01007032|467992396|FG000|Overall Study|Withdrawal by Subject|0|||
130008071|NCT01007032|467992397|FG001|Overall Study|Withdrawal by Subject|0|||
130008072|NCT01007032|467992398|FG002|Overall Study|Withdrawal by Subject|0|||
130008073|NCT01007032|467992399|FG003|Overall Study|Withdrawal by Subject|1|||
130008074|NCT01841749|467992400|FG000|Overall Study|Protocol Violation|1|||
130008075|NCT00677820|467992401|FG000|Overall Study|Lost to Follow-up|1|||
130008076|NCT00677820|467992402|FG001|Overall Study|Lost to Follow-up|0|||
130008077|NCT01101438|467992406|FG000|Overall Study|Withdrawal by Subject|8|||
130008078|NCT01101438|467992407|FG001|Overall Study|Withdrawal by Subject|9|||
130008079|NCT00290290|467992430|FG000|Overall Study|Death|3|||
130008080|NCT00290290|467992431|FG001|Overall Study|Death|4|||
130008081|NCT00290290|467992430|FG000|Overall Study|Withdrawal by Subject|2|||
130008082|NCT00290290|467992431|FG001|Overall Study|Withdrawal by Subject|2|||
130008083|NCT00290290|467992430|FG000|Overall Study|Underwent clean surgical procedure|13|||
130008084|NCT00290290|467992431|FG001|Overall Study|Underwent clean surgical procedure|12|||
130008085|NCT00549939|467992439|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
130008086|NCT00549939|467992440|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
130008087|NCT00549939|467992441|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
130008088|NCT00549939|467992439|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
130008089|NCT00549939|467992440|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
130008090|NCT00549939|467992441|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
130008091|NCT00549939|467992439|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
130008092|NCT00549939|467992440|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
130008093|NCT00549939|467992441|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
130008094|NCT00549939|467992439|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
130008095|NCT00549939|467992440|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
130008096|NCT00549939|467992441|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
130008097|NCT00549939|467992439|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
130342249|NCT00797966|469224606|FG004|Phase A|Withdrawal by Subject|33|||
130342250|NCT00797966|469224607|FG005|Phase A|Withdrawal by Subject|0|||
130342251|NCT00797966|469224602|FG000|Phase A|Protocol deviation|0|||
130342252|NCT00797966|469224603|FG001|Phase A|Protocol deviation|0|||
130342253|NCT00797966|469224604|FG002|Phase A|Protocol deviation|0|||
130342254|NCT00797966|469224605|FG003|Phase A|Protocol deviation|0|||
130342255|NCT00797966|469224606|FG004|Phase A|Protocol deviation|56|||
130342256|NCT00797966|469224607|FG005|Phase A|Protocol deviation|0|||
130342257|NCT00797966|469224602|FG000|Phase B|Lost to Follow-up|0|||
130342258|NCT00797966|469224603|FG001|Phase B|Lost to Follow-up|1|||
130008098|NCT00549939|467992440|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
130008099|NCT00549939|467992441|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
130008100|NCT00549939|467992439|FG000|40-week Open Label Treatment Period|Other|0|||
130008101|NCT00549939|467992440|FG001|40-week Open Label Treatment Period|Other|1|||
130008102|NCT00549939|467992441|FG002|40-week Open Label Treatment Period|Other|4|||
130008103|NCT03677596|467992442|FG000|Overall Study|Adverse Event|0|||
130008104|NCT03677596|467992443|FG001|Overall Study|Adverse Event|1|||
130008105|NCT03677596|467992442|FG000|Overall Study|Death|10|||
130008106|NCT03677596|467992443|FG001|Overall Study|Death|6|||
130342259|NCT00797966|469224604|FG002|Phase B|Lost to Follow-up|3|||
130342260|NCT00797966|469224605|FG003|Phase B|Lost to Follow-up|0|||
130342261|NCT00797966|469224606|FG004|Phase B|Lost to Follow-up|0|||
130008107|NCT03677596|467992442|FG000|Overall Study|Lost to Follow-up|0|||
130008108|NCT03677596|467992443|FG001|Overall Study|Lost to Follow-up|1|||
130008109|NCT03677596|467992442|FG000|Overall Study|Progressive Disease|8|||
130008110|NCT03677596|467992443|FG001|Overall Study|Progressive Disease|8|||
130008111|NCT03677596|467992442|FG000|Overall Study|Withdrawal by Subject|3|||
130008112|NCT03677596|467992443|FG001|Overall Study|Withdrawal by Subject|0|||
130008113|NCT03677596|467992442|FG000|Overall Study|Disease Relapse|2|||
130008114|NCT03677596|467992443|FG001|Overall Study|Disease Relapse|2|||
130008115|NCT03677596|467992442|FG000|Overall Study|Other|0|||
130008116|NCT03677596|467992443|FG001|Overall Study|Other|1|||
130008117|NCT05197049|467992446|FG000|Overall Study|Death|0|||
130008118|NCT05197049|467992447|FG001|Overall Study|Death|1|||
130008119|NCT05197049|467992448|FG002|Overall Study|Death|0|||
130008120|NCT05197049|467992446|FG000|Overall Study|Lost to Follow-up|3|||
130008121|NCT05197049|467992447|FG001|Overall Study|Lost to Follow-up|1|||
130008122|NCT05197049|467992448|FG002|Overall Study|Lost to Follow-up|0|||
130008123|NCT05197049|467992446|FG000|Overall Study|Withdrawal by Subject|15|||
130008124|NCT05197049|467992447|FG001|Overall Study|Withdrawal by Subject|3|||
130008125|NCT05197049|467992448|FG002|Overall Study|Withdrawal by Subject|1|||
130008126|NCT05197049|467992446|FG000|Overall Study|GCP non-compliance|1|||
130008127|NCT05197049|467992447|FG001|Overall Study|GCP non-compliance|2|||
130008128|NCT05197049|467992448|FG002|Overall Study|GCP non-compliance|0|||
130008129|NCT00424749|467992457|FG000|Overall Study|Withdrawal by Subject|1|||
130008130|NCT02577406|467992458|FG000|Randomized Period|Death|1|||
130008131|NCT02577406|467992459|FG001|Randomized Period|Death|0|||
130008132|NCT02577406|467992458|FG000|Randomized Period|Other reasons|0|||
130008133|NCT02577406|467992459|FG001|Randomized Period|Other reasons|20|||
130008134|NCT02577406|467992458|FG000|Treatment Period|Death|38|||
130008135|NCT02577406|467992459|FG001|Treatment Period|Death|23|||
130008136|NCT02577406|467992458|FG000|Treatment Period|Adverse Event|17|||
130008137|NCT02577406|467992459|FG001|Treatment Period|Adverse Event|12|||
130008138|NCT02577406|467992458|FG000|Treatment Period|Progressive Disease|53|||
130008139|NCT02577406|467992459|FG001|Treatment Period|Progressive Disease|37|||
130008140|NCT02577406|467992458|FG000|Treatment Period|Withdrawal by Subject|10|||
130008141|NCT02577406|467992459|FG001|Treatment Period|Withdrawal by Subject|24|||
130008142|NCT02577406|467992458|FG000|Treatment Period|Lost to Follow-up|0|||
130008143|NCT02577406|467992459|FG001|Treatment Period|Lost to Follow-up|1|||
130008144|NCT02577406|467992458|FG000|Treatment Period|Transition to commercially available treatment|1|||
130008145|NCT02577406|467992459|FG001|Treatment Period|Transition to commercially available treatment|1|||
130008146|NCT02577406|467992458|FG000|Treatment Period|Physician Decision|1|||
130008147|NCT02577406|467992459|FG001|Treatment Period|Physician Decision|0|||
130008148|NCT02577406|467992458|FG000|Treatment Period|Disease Relapse|28|||
130008149|NCT02577406|467992459|FG001|Treatment Period|Disease Relapse|1|||
130008150|NCT02577406|467992458|FG000|Treatment Period|Protocol Violation|0|||
130008151|NCT02577406|467992459|FG001|Treatment Period|Protocol Violation|1|||
130008152|NCT02577406|467992458|FG000|Treatment Period|Other Reasons|3|||
130008153|NCT02577406|467992459|FG001|Treatment Period|Other Reasons|39|||
130008154|NCT02577406|467992458|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
130008155|NCT02577406|467992459|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
130008156|NCT02138617|467992460|FG000|Overall Study|Death|1|||
130008157|NCT02138617|467992461|FG001|Overall Study|Death|2|||
130008158|NCT02138617|467992462|FG002|Overall Study|Death|2|||
130008159|NCT02138617|467992460|FG000|Overall Study|Adverse Event|8|||
130008160|NCT02138617|467992461|FG001|Overall Study|Adverse Event|5|||
130342262|NCT00797966|469224607|FG005|Phase B|Lost to Follow-up|0|||
130008161|NCT02138617|467992462|FG002|Overall Study|Adverse Event|2|||
130008162|NCT02138617|467992460|FG000|Overall Study|Disease Progression|20|||
130008163|NCT02138617|467992461|FG001|Overall Study|Disease Progression|13|||
130008164|NCT02138617|467992462|FG002|Overall Study|Disease Progression|4|||
130342263|NCT00797966|469224602|FG000|Phase B|Adverse Event|2|||
130342264|NCT00797966|469224603|FG001|Phase B|Adverse Event|1|||
130342265|NCT00797966|469224604|FG002|Phase B|Adverse Event|3|||
130008165|NCT02138617|467992460|FG000|Overall Study|Withdrawal by Subject|7|||
130008166|NCT02138617|467992461|FG001|Overall Study|Withdrawal by Subject|10|||
130008167|NCT02138617|467992462|FG002|Overall Study|Withdrawal by Subject|2|||
130008168|NCT02138617|467992460|FG000|Overall Study|other complicating disease|0|||
130008169|NCT02138617|467992461|FG001|Overall Study|other complicating disease|2|||
130008170|NCT02138617|467992462|FG002|Overall Study|other complicating disease|0|||
130008171|NCT02138617|467992460|FG000|Overall Study|Protocol Violation|1|||
130008172|NCT02138617|467992461|FG001|Overall Study|Protocol Violation|0|||
130008173|NCT02138617|467992462|FG002|Overall Study|Protocol Violation|0|||
130008174|NCT02138617|467992460|FG000|Overall Study|Physician Decision|7|||
130008175|NCT02138617|467992461|FG001|Overall Study|Physician Decision|6|||
130008176|NCT02138617|467992462|FG002|Overall Study|Physician Decision|0|||
130008177|NCT02138617|467992460|FG000|Overall Study|financial reason|0|||
130008178|NCT02138617|467992461|FG001|Overall Study|financial reason|1|||
130008179|NCT02138617|467992462|FG002|Overall Study|financial reason|0|||
130008180|NCT02138617|467992460|FG000|Overall Study|other therapy|3|||
130008181|NCT02138617|467992461|FG001|Overall Study|other therapy|4|||
130342266|NCT00797966|469224605|FG003|Phase B|Adverse Event|1|||
130342267|NCT00797966|469224606|FG004|Phase B|Adverse Event|0|||
130342268|NCT00797966|469224607|FG005|Phase B|Adverse Event|0|||
130342269|NCT00797966|469224602|FG000|Phase B|Met Withdrawal Criteria|3|||
130342270|NCT00797966|469224603|FG001|Phase B|Met Withdrawal Criteria|3|||
130342271|NCT00797966|469224604|FG002|Phase B|Met Withdrawal Criteria|6|||
130342272|NCT00797966|469224605|FG003|Phase B|Met Withdrawal Criteria|1|||
130342273|NCT00797966|469224606|FG004|Phase B|Met Withdrawal Criteria|0|||
130342274|NCT00797966|469224607|FG005|Phase B|Met Withdrawal Criteria|0|||
130342275|NCT00797966|469224602|FG000|Phase B|Physician Decision|1|||
130342276|NCT00797966|469224603|FG001|Phase B|Physician Decision|0|||
130342277|NCT00797966|469224604|FG002|Phase B|Physician Decision|3|||
130342278|NCT00797966|469224605|FG003|Phase B|Physician Decision|1|||
130008182|NCT02138617|467992462|FG002|Overall Study|other therapy|0|||
130008183|NCT05807464|467992463|FG000|Overall Study|Adverse Event|1|||
130008184|NCT01846624|467992470|FG000|Overall Study|Died during induction, no midostaurin|1|||
130008185|NCT04702737|467992473|FG000|Overall Study|Decision by Sponsor|1|||
130008186|NCT04702737|467992473|FG000|Overall Study|Withdrawal of Consent from Study|3|||
130008187|NCT04702737|467992473|FG000|Overall Study|Lost to Follow-up|1|||
130008188|NCT04702737|467992473|FG000|Overall Study|Death|35|||
130008189|NCT00698997|467992474|FG000|Overall Study|Lost to Follow-up|3|||
130008190|NCT00698997|467992475|FG001|Overall Study|Lost to Follow-up|0|||
130008191|NCT00698997|467992474|FG000|Overall Study|Withdrawal by Subject|7|||
130008192|NCT00698997|467992475|FG001|Overall Study|Withdrawal by Subject|27|||
130008193|NCT01877915|467992478|FG000|Overall Study|Lost to Follow-up|10|||
130008194|NCT01877915|467992479|FG001|Overall Study|Lost to Follow-up|9|||
130008195|NCT01877915|467992478|FG000|Overall Study|Withdrawal by Subject|42|||
130008196|NCT01877915|467992479|FG001|Overall Study|Withdrawal by Subject|55|||
130008197|NCT01877915|467992478|FG000|Overall Study|Other|2|||
130008198|NCT01877915|467992479|FG001|Overall Study|Other|4|||
130008199|NCT03520959|467992480|FG000|Overall Study|Study terminated by Sponsor|0|||
130008200|NCT03520959|467992481|FG001|Overall Study|Study terminated by Sponsor|1|||
130008201|NCT01449461|467992482|FG000|Overall Study|Adverse Event|0|||
130008202|NCT01449461|467992483|FG001|Overall Study|Adverse Event|3|||
130008203|NCT01449461|467992484|FG002|Overall Study|Adverse Event|2|||
130008204|NCT01449461|467992485|FG003|Overall Study|Adverse Event|3|||
130008205|NCT01449461|467992486|FG004|Overall Study|Adverse Event|4|||
130008206|NCT01449461|467992487|FG005|Overall Study|Adverse Event|4|||
130008207|NCT01449461|467992482|FG000|Overall Study|Death|0|||
130008208|NCT01449461|467992483|FG001|Overall Study|Death|2|||
130008209|NCT01449461|467992484|FG002|Overall Study|Death|0|||
130008210|NCT01449461|467992485|FG003|Overall Study|Death|0|||
130008211|NCT01449461|467992486|FG004|Overall Study|Death|7|||
130008212|NCT01449461|467992487|FG005|Overall Study|Death|1|||
130008213|NCT01449461|467992482|FG000|Overall Study|Physician Decision|0|||
130008214|NCT01449461|467992483|FG001|Overall Study|Physician Decision|1|||
130008215|NCT01449461|467992484|FG002|Overall Study|Physician Decision|0|||
130008216|NCT01449461|467992485|FG003|Overall Study|Physician Decision|4|||
130008217|NCT01449461|467992486|FG004|Overall Study|Physician Decision|1|||
130008218|NCT01449461|467992487|FG005|Overall Study|Physician Decision|0|||
130008219|NCT01449461|467992482|FG000|Overall Study|Documented Progressive Disease|4|||
130008220|NCT01449461|467992483|FG001|Overall Study|Documented Progressive Disease|7|||
130008221|NCT01449461|467992484|FG002|Overall Study|Documented Progressive Disease|14|||
130008222|NCT01449461|467992485|FG003|Overall Study|Documented Progressive Disease|15|||
130008223|NCT01449461|467992486|FG004|Overall Study|Documented Progressive Disease|24|||
130008224|NCT01449461|467992487|FG005|Overall Study|Documented Progressive Disease|5|||
130008225|NCT01449461|467992482|FG000|Overall Study|Clinical Progressive Disease|2|||
130008226|NCT01449461|467992483|FG001|Overall Study|Clinical Progressive Disease|2|||
130008227|NCT01449461|467992484|FG002|Overall Study|Clinical Progressive Disease|0|||
130008228|NCT01449461|467992485|FG003|Overall Study|Clinical Progressive Disease|3|||
130008229|NCT01449461|467992486|FG004|Overall Study|Clinical Progressive Disease|4|||
130342279|NCT00797966|469224606|FG004|Phase B|Physician Decision|0|||
130008230|NCT01449461|467992487|FG005|Overall Study|Clinical Progressive Disease|2|||
130008231|NCT01449461|467992482|FG000|Overall Study|Protocol Violation|0|||
130008232|NCT01449461|467992483|FG001|Overall Study|Protocol Violation|0|||
130008233|NCT01449461|467992484|FG002|Overall Study|Protocol Violation|0|||
130008234|NCT01449461|467992485|FG003|Overall Study|Protocol Violation|1|||
130008235|NCT01449461|467992486|FG004|Overall Study|Protocol Violation|0|||
130008236|NCT01449461|467992487|FG005|Overall Study|Protocol Violation|0|||
130008237|NCT01449461|467992482|FG000|Overall Study|Site Terminated by Sponsor|0|||
130008238|NCT01449461|467992483|FG001|Overall Study|Site Terminated by Sponsor|1|||
130008239|NCT01449461|467992484|FG002|Overall Study|Site Terminated by Sponsor|2|||
130008240|NCT01449461|467992485|FG003|Overall Study|Site Terminated by Sponsor|3|||
130008241|NCT01449461|467992486|FG004|Overall Study|Site Terminated by Sponsor|4|||
130008242|NCT01449461|467992487|FG005|Overall Study|Site Terminated by Sponsor|1|||
130342280|NCT00797966|469224607|FG005|Phase B|Physician Decision|0|||
130342281|NCT00797966|469224602|FG000|Phase B|Withdrawal by Subject|1|||
130342282|NCT00797966|469224603|FG001|Phase B|Withdrawal by Subject|4|||
130008243|NCT01449461|467992482|FG000|Overall Study|Withdrawal by Subject|0|||
130342283|NCT00797966|469224604|FG002|Phase B|Withdrawal by Subject|3|||
130008244|NCT01449461|467992483|FG001|Overall Study|Withdrawal by Subject|1|||
130008245|NCT01449461|467992484|FG002|Overall Study|Withdrawal by Subject|0|||
130008246|NCT01449461|467992485|FG003|Overall Study|Withdrawal by Subject|0|||
130008247|NCT01449461|467992486|FG004|Overall Study|Withdrawal by Subject|2|||
130008248|NCT01449461|467992487|FG005|Overall Study|Withdrawal by Subject|1|||
130008249|NCT01449461|467992482|FG000|Overall Study|Reason not Specified|0|||
130008250|NCT01449461|467992483|FG001|Overall Study|Reason not Specified|1|||
130008251|NCT01449461|467992484|FG002|Overall Study|Reason not Specified|0|||
130008252|NCT01449461|467992485|FG003|Overall Study|Reason not Specified|3|||
130008253|NCT01449461|467992486|FG004|Overall Study|Reason not Specified|2|||
130008254|NCT01449461|467992487|FG005|Overall Study|Reason not Specified|1|||
130008255|NCT01357577|467992488|FG000|Overall Study|Lost to Follow-up|20|||
130008256|NCT01357577|467992489|FG001|Overall Study|Lost to Follow-up|16|||
130008257|NCT01357577|467992488|FG000|Overall Study|Withdrawal by Subject|16|||
130008258|NCT01357577|467992489|FG001|Overall Study|Withdrawal by Subject|8|||
130008259|NCT01357577|467992488|FG000|Overall Study|look at data in database?|1|||
130008260|NCT01357577|467992489|FG001|Overall Study|look at data in database?|2|||
130008261|NCT03977974|467992490|FG000|Period 2|Adverse Event|0|||
130008262|NCT03977974|467992491|FG001|Period 2|Adverse Event|0|||
130008263|NCT03977974|467992492|FG002|Period 2|Adverse Event|0|||
130008264|NCT03977974|467992493|FG003|Period 2|Adverse Event|0|||
130008265|NCT03977974|467992494|FG004|Period 2|Adverse Event|1|||
130008266|NCT03977974|467992495|FG005|Period 2|Adverse Event|0|||
130008267|NCT03977974|467992496|FG006|Period 2|Adverse Event|0|||
130008268|NCT03977974|467992497|FG007|Period 2|Adverse Event|0|||
130342284|NCT00797966|469224605|FG003|Phase B|Withdrawal by Subject|3|||
130342285|NCT00797966|469224606|FG004|Phase B|Withdrawal by Subject|0|||
130342286|NCT00797966|469224607|FG005|Phase B|Withdrawal by Subject|0|||
130342287|NCT00797966|469224602|FG000|Phase B|Protocol Deviation|4|||
130342288|NCT00797966|469224603|FG001|Phase B|Protocol Deviation|8|||
130342289|NCT00797966|469224604|FG002|Phase B|Protocol Deviation|2|||
130342290|NCT00797966|469224605|FG003|Phase B|Protocol Deviation|6|||
130342291|NCT00797966|469224606|FG004|Phase B|Protocol Deviation|0|||
130342292|NCT00797966|469224607|FG005|Phase B|Protocol Deviation|0|||
130342293|NCT00797966|469224602|FG000|Phase B|Lack of Efficacy|0|||
130342294|NCT00797966|469224603|FG001|Phase B|Lack of Efficacy|1|||
130342295|NCT00797966|469224604|FG002|Phase B|Lack of Efficacy|1|||
130342296|NCT00797966|469224605|FG003|Phase B|Lack of Efficacy|4|||
130342297|NCT00797966|469224606|FG004|Phase B|Lack of Efficacy|0|||
130342298|NCT00797966|469224607|FG005|Phase B|Lack of Efficacy|0|||
130342299|NCT00797966|469224602|FG000|Phase A+|Lost to Follow-up|0|||
130342300|NCT00797966|469224603|FG001|Phase A+|Lost to Follow-up|0|||
130342301|NCT00797966|469224604|FG002|Phase A+|Lost to Follow-up|0|||
130342302|NCT00797966|469224605|FG003|Phase A+|Lost to Follow-up|0|||
130342303|NCT00797966|469224606|FG004|Phase A+|Lost to Follow-up|0|||
130342304|NCT00797966|469224607|FG005|Phase A+|Lost to Follow-up|9|||
130342305|NCT00797966|469224602|FG000|Phase A+|Met withdrawal criteria|0|||
130342306|NCT00797966|469224603|FG001|Phase A+|Met withdrawal criteria|0|||
130342307|NCT00797966|469224604|FG002|Phase A+|Met withdrawal criteria|0|||
130342308|NCT00797966|469224605|FG003|Phase A+|Met withdrawal criteria|0|||
130342309|NCT00797966|469224606|FG004|Phase A+|Met withdrawal criteria|0|||
130342310|NCT00797966|469224607|FG005|Phase A+|Met withdrawal criteria|5|||
130342311|NCT00797966|469224602|FG000|Phase A+|Withdrawal by Subject|0|||
130342312|NCT00797966|469224603|FG001|Phase A+|Withdrawal by Subject|0|||
130342313|NCT00797966|469224604|FG002|Phase A+|Withdrawal by Subject|0|||
130342314|NCT00797966|469224605|FG003|Phase A+|Withdrawal by Subject|0|||
130342315|NCT00797966|469224606|FG004|Phase A+|Withdrawal by Subject|0|||
130342316|NCT00797966|469224607|FG005|Phase A+|Withdrawal by Subject|6|||
130342317|NCT00797966|469224602|FG000|Phase A+|Adverse Event|0|||
130342318|NCT00797966|469224603|FG001|Phase A+|Adverse Event|0|||
130342319|NCT00797966|469224604|FG002|Phase A+|Adverse Event|0|||
130342320|NCT00797966|469224605|FG003|Phase A+|Adverse Event|0|||
130008269|NCT03977974|467992498|FG008|Period 2|Adverse Event|0|||
130008270|NCT03977974|467992499|FG009|Period 2|Adverse Event|0|||
130342321|NCT00797966|469224606|FG004|Phase A+|Adverse Event|0|||
130008271|NCT03977974|467992500|FG010|Period 2|Adverse Event|0|||
130216591|NCT03762681|468755610|FG007|Part 2a|Pandemic Travel Restrictions|1|||
130342322|NCT00797966|469224607|FG005|Phase A+|Adverse Event|4|||
130342323|NCT00797966|469224602|FG000|Phase A+|Protocol deviation|0|||
130342324|NCT00797966|469224603|FG001|Phase A+|Protocol deviation|0|||
130342325|NCT00797966|469224604|FG002|Phase A+|Protocol deviation|0|||
130342326|NCT00797966|469224605|FG003|Phase A+|Protocol deviation|0|||
130342327|NCT00797966|469224606|FG004|Phase A+|Protocol deviation|0|||
130342328|NCT00797966|469224607|FG005|Phase A+|Protocol deviation|4|||
130342329|NCT01883453|469224613|FG000|Overall Study|No episode of common cold|25|||
130008272|NCT03977974|467992501|FG011|Period 2|Adverse Event|0|||
130008273|NCT03977974|467992502|FG012|Period 2|Adverse Event|0|||
130008274|NCT02322125|467993613|FG000|Overall Study|Withdrawal by Subject|2|||
130008275|NCT01524198|467993615|FG000|Overall Study|Protocol Violation|8|||
130008276|NCT01524198|467993616|FG001|Overall Study|Protocol Violation|6|||
130342330|NCT01883453|469224614|FG001|Overall Study|No episode of common cold|23|||
130342331|NCT00913458|469224617|FG000|Phase 1|Non-Responder|54|||
130008277|NCT01524198|467993615|FG000|Overall Study|Withdrawal by Subject|15|||
130008278|NCT01524198|467993616|FG001|Overall Study|Withdrawal by Subject|10|||
130008279|NCT01439282|467993617|FG000|Overall Study|Adverse Event|5|||
130008280|NCT01439282|467993618|FG001|Overall Study|Adverse Event|0|||
130008281|NCT01439282|467993617|FG000|Overall Study|Withdrawal by Subject|2|||
130008282|NCT01439282|467993618|FG001|Overall Study|Withdrawal by Subject|0|||
130008283|NCT01439282|467993617|FG000|Overall Study|Other|1|||
130008284|NCT01439282|467993618|FG001|Overall Study|Other|1|||
130008285|NCT04419610|467993619|FG000|Overall Study|Withdrawal by Subject|3|||
130008286|NCT04419610|467993620|FG001|Overall Study|Withdrawal by Subject|1|||
130008287|NCT04419610|467993619|FG000|Overall Study|Adverse Event|1|||
130008288|NCT04419610|467993620|FG001|Overall Study|Adverse Event|0|||
130008289|NCT04419610|467993619|FG000|Overall Study|discharged early|1|||
130008290|NCT04419610|467993620|FG001|Overall Study|discharged early|1|||
130008291|NCT02232802|467993621|FG000|Period 1|Sponsor request|1|||
130008292|NCT02232802|467993622|FG001|Period 1|Sponsor request|0|||
130008293|NCT02232802|467993621|FG000|Period 1|Adverse Event|1|||
130008294|NCT02232802|467993622|FG001|Period 1|Adverse Event|1|||
130008295|NCT00885703|467993630|FG000|Overall Study|Death|9|||
130008296|NCT00885703|467993631|FG001|Overall Study|Death|7|||
130008297|NCT00885703|467993632|FG002|Overall Study|Death|8|||
130008298|NCT00885703|467993633|FG003|Overall Study|Death|7|||
130008299|NCT00885703|467993634|FG004|Overall Study|Death|7|||
130008300|NCT00885703|467993635|FG005|Overall Study|Death|8|||
130008301|NCT00885703|467993636|FG006|Overall Study|Death|4|||
130008302|NCT00885703|467993630|FG000|Overall Study|Lost to Follow-up|0|||
130008303|NCT00885703|467993631|FG001|Overall Study|Lost to Follow-up|0|||
130008304|NCT00885703|467993632|FG002|Overall Study|Lost to Follow-up|1|||
130008305|NCT00885703|467993633|FG003|Overall Study|Lost to Follow-up|0|||
130008306|NCT00885703|467993634|FG004|Overall Study|Lost to Follow-up|0|||
130008307|NCT00885703|467993635|FG005|Overall Study|Lost to Follow-up|1|||
130008308|NCT00885703|467993636|FG006|Overall Study|Lost to Follow-up|0|||
130008309|NCT00885703|467993630|FG000|Overall Study|Withdrawal by Subject|0|||
130008310|NCT00885703|467993631|FG001|Overall Study|Withdrawal by Subject|0|||
130008311|NCT00885703|467993632|FG002|Overall Study|Withdrawal by Subject|0|||
130008312|NCT00885703|467993633|FG003|Overall Study|Withdrawal by Subject|1|||
130008313|NCT00885703|467993634|FG004|Overall Study|Withdrawal by Subject|3|||
130008314|NCT00885703|467993635|FG005|Overall Study|Withdrawal by Subject|1|||
130342332|NCT00913458|469224618|FG001|Phase 1|Non-Responder|0|||
130342333|NCT00913458|469224619|FG002|Phase 1|Non-Responder|0|||
130342334|NCT00913458|469224620|FG003|Phase 1|Non-Responder|0|||
130342335|NCT00913458|469224621|FG004|Phase 1|Non-Responder|0|||
130342336|NCT00913458|469224622|FG005|Phase 1|Non-Responder|0|||
130342337|NCT00913458|469224623|FG006|Phase 1|Non-Responder|0|||
130008315|NCT00885703|467993636|FG006|Overall Study|Withdrawal by Subject|1|||
130008316|NCT00885703|467993630|FG000|Overall Study|Ineligible (no CM)|1|||
130008317|NCT00885703|467993631|FG001|Overall Study|Ineligible (no CM)|3|||
130008318|NCT00885703|467993632|FG002|Overall Study|Ineligible (no CM)|2|||
130008319|NCT00885703|467993633|FG003|Overall Study|Ineligible (no CM)|1|||
130008320|NCT00885703|467993634|FG004|Overall Study|Ineligible (no CM)|2|||
130008321|NCT00885703|467993635|FG005|Overall Study|Ineligible (no CM)|3|||
130008322|NCT00885703|467993636|FG006|Overall Study|Ineligible (no CM)|1|||
130008323|NCT01183143|467993637|FG000|Overall Study|Protocol Violation|115|||
130008324|NCT01183143|467993637|FG000|Overall Study|Withdrawal by Subject|19|||
130008325|NCT01183143|467993637|FG000|Overall Study|Subject Questionnaires not returned|5|||
130008326|NCT01183143|467993637|FG000|Overall Study|Subjects enrolled, but not treated|11|||
130008327|NCT01502709|467993639|FG000|Overall Study|Lost to Follow-up|4|||
130008328|NCT01502709|467993640|FG001|Overall Study|Lost to Follow-up|0|||
130008329|NCT04096274|467993641|FG000|Phase I|Lost to Follow-up|5|||
130008330|NCT04096274|467993642|FG001|Phase I|Lost to Follow-up|5|||
130008331|NCT04096274|467993641|FG000|Phase II|Lost to Follow-up|11|||
130008332|NCT04096274|467993642|FG001|Phase II|Lost to Follow-up|11|||
130008333|NCT01490450|467993644|FG000|Period 1|Lack of Efficacy|2|||
130008334|NCT01490450|467993645|FG001|Period 1|Lack of Efficacy|0|||
130008335|NCT01490450|467993646|FG002|Period 1|Lack of Efficacy|3|||
130008336|NCT01490450|467993647|FG003|Period 1|Lack of Efficacy|0|||
130008337|NCT01490450|467993644|FG000|Period 1|Adverse Event|0|||
130008338|NCT01490450|467993645|FG001|Period 1|Adverse Event|0|||
130008339|NCT01490450|467993646|FG002|Period 1|Adverse Event|0|||
130008340|NCT01490450|467993647|FG003|Period 1|Adverse Event|5|||
130008341|NCT01490450|467993644|FG000|Period 1|Request to discontinue treatment|1|||
130008342|NCT01490450|467993645|FG001|Period 1|Request to discontinue treatment|0|||
130342338|NCT00913458|469224617|FG000|Phase 1|Subject Request|17|||
130342339|NCT00913458|469224618|FG001|Phase 1|Subject Request|0|||
130008343|NCT01490450|467993646|FG002|Period 1|Request to discontinue treatment|0|||
130008344|NCT01490450|467993647|FG003|Period 1|Request to discontinue treatment|0|||
130008345|NCT01490450|467993644|FG000|Period 1|Withdrawal by Subject|0|||
130008346|NCT01490450|467993645|FG001|Period 1|Withdrawal by Subject|0|||
130008347|NCT01490450|467993646|FG002|Period 1|Withdrawal by Subject|0|||
130008348|NCT01490450|467993647|FG003|Period 1|Withdrawal by Subject|3|||
130008349|NCT01490450|467993644|FG000|Period 1|No longer met study criteria|0|||
130342340|NCT00913458|469224619|FG002|Phase 1|Subject Request|0|||
130342341|NCT00913458|469224620|FG003|Phase 1|Subject Request|0|||
130342342|NCT00913458|469224621|FG004|Phase 1|Subject Request|0|||
130008350|NCT01490450|467993645|FG001|Period 1|No longer met study criteria|1|||
130008351|NCT01490450|467993646|FG002|Period 1|No longer met study criteria|1|||
130008352|NCT01490450|467993647|FG003|Period 1|No longer met study criteria|0|||
130008353|NCT01490450|467993644|FG000|Period 2|Lack of Efficacy|0|||
130008354|NCT01490450|467993645|FG001|Period 2|Lack of Efficacy|0|||
130008355|NCT01490450|467993646|FG002|Period 2|Lack of Efficacy|0|||
130008356|NCT01490450|467993647|FG003|Period 2|Lack of Efficacy|1|||
130008357|NCT01490450|467993644|FG000|Period 2|Adverse Event|1|||
130008358|NCT01490450|467993645|FG001|Period 2|Adverse Event|1|||
130008359|NCT01490450|467993646|FG002|Period 2|Adverse Event|0|||
130008360|NCT01490450|467993647|FG003|Period 2|Adverse Event|1|||
130008361|NCT01490450|467993644|FG000|Period 2|Withdrawal by Subject|1|||
130008362|NCT01490450|467993645|FG001|Period 2|Withdrawal by Subject|0|||
130008363|NCT01490450|467993646|FG002|Period 2|Withdrawal by Subject|0|||
130008364|NCT01490450|467993647|FG003|Period 2|Withdrawal by Subject|0|||
130008365|NCT01490450|467993644|FG000|Period 2|Lost to Follow-up|0|||
130008366|NCT01490450|467993645|FG001|Period 2|Lost to Follow-up|0|||
130008367|NCT01490450|467993646|FG002|Period 2|Lost to Follow-up|0|||
130008368|NCT01490450|467993647|FG003|Period 2|Lost to Follow-up|2|||
130008369|NCT01075412|467993648|FG000|Overall Study|Withdrawal by Subject|0|||
130008370|NCT01075412|467993649|FG001|Overall Study|Withdrawal by Subject|1|||
130008371|NCT01436084|467993656|FG000|Overall Study|Disease Progression|2|||
130008372|NCT01436084|467993656|FG000|Overall Study|Withdrawal by Subject|1|||
130008373|NCT01436084|467993656|FG000|Overall Study|Early Closure of Study|1|||
130008374|NCT03184077|467993658|FG000|Overall Study|Lost to Follow-up|21|||
130008375|NCT03184077|467993659|FG001|Overall Study|Lost to Follow-up|21|||
130008376|NCT03159091|467993662|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
130008377|NCT03159091|467993663|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
130008378|NCT03159091|467993662|FG000|Overall Study|Patient has taken no dose of study drug|0|||
130008379|NCT03159091|467993663|FG001|Overall Study|Patient has taken no dose of study drug|1|||
130008380|NCT00262522|467993664|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
130008381|NCT00262522|467993665|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
130008382|NCT00262522|467993666|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
130008383|NCT00262522|467993667|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
130008384|NCT00262522|467993664|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
130008385|NCT00262522|467993665|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
130008386|NCT00262522|467993666|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
130008387|NCT00262522|467993667|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
130008388|NCT00262522|467993664|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
130008389|NCT00262522|467993665|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
130008390|NCT00262522|467993666|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
130008391|NCT00262522|467993667|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
130008392|NCT00262522|467993664|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
130008393|NCT00262522|467993665|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
130008394|NCT00262522|467993666|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
130008395|NCT00262522|467993667|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
130008396|NCT00262522|467993664|FG000|Study Start Through 8 Weeks|Death|1|||
130008397|NCT00262522|467993665|FG001|Study Start Through 8 Weeks|Death|0|||
130008398|NCT00262522|467993666|FG002|Study Start Through 8 Weeks|Death|0|||
130008399|NCT00262522|467993667|FG003|Study Start Through 8 Weeks|Death|0|||
130008400|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
130008401|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
130008402|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
130008403|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
130008404|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
130008405|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
130008406|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
130008407|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
130008408|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
130008409|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
130008410|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
130008411|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
130008412|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
130008413|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
130008414|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
130008415|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
130008416|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Death|2|||
130008417|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Death|0|||
130008418|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Death|1|||
130342343|NCT00913458|469224622|FG005|Phase 1|Subject Request|0|||
130008419|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Death|0|||
130008420|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
130008421|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
130008422|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
130008423|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
130008424|NCT00262522|467993664|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
130008425|NCT00262522|467993665|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
130008426|NCT00262522|467993666|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
130008427|NCT00262522|467993667|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
130008428|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
130008429|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
130008430|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
130008431|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
130008432|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
130008433|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
130008434|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
130008435|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
130008436|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
130008437|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
130008438|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
130008439|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
130008440|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
130008441|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
130008442|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
130008443|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
130008444|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Death|2|||
130008445|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Death|0|||
130008446|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Death|2|||
130008447|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Death|0|||
130008448|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
130008449|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
130008450|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
130008451|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
130008452|NCT00262522|467993664|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
130008453|NCT00262522|467993665|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
130008454|NCT00262522|467993666|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
130008455|NCT00262522|467993667|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
130008456|NCT04814823|467993668|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
130008457|NCT03462719|467993669|FG000|Overall Study|Withdrawal by Subject|4|||
130008458|NCT03462719|467993670|FG001|Overall Study|Withdrawal by Subject|3|||
130008459|NCT03462719|467993669|FG000|Overall Study|Ongoing|87|||
130008460|NCT03462719|467993670|FG001|Overall Study|Ongoing|72|||
130008461|NCT03740165|467993671|FG000|Overall Study|Death|232|||
130008462|NCT03740165|467993672|FG001|Overall Study|Death|242|||
130008463|NCT03740165|467993673|FG002|Overall Study|Death|229|||
130008464|NCT03740165|467993671|FG000|Overall Study|Lost to Follow-up|0|||
130008465|NCT03740165|467993672|FG001|Overall Study|Lost to Follow-up|0|||
130008466|NCT03740165|467993673|FG002|Overall Study|Lost to Follow-up|1|||
130008467|NCT03740165|467993671|FG000|Overall Study|Withdrawal by Subject|7|||
130008468|NCT03740165|467993672|FG001|Overall Study|Withdrawal by Subject|4|||
130008469|NCT03740165|467993673|FG002|Overall Study|Withdrawal by Subject|3|||
130008470|NCT03740165|467993671|FG000|Overall Study|Ongoing in Study|216|||
130008471|NCT03740165|467993672|FG001|Overall Study|Ongoing in Study|212|||
130008472|NCT03740165|467993673|FG002|Overall Study|Ongoing in Study|221|||
130008473|NCT05318937|467993676|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130008474|NCT05318937|467993677|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130008475|NCT05318937|467993676|FG000|Overall Study|Lost to Follow-up|0|||
130008476|NCT05318937|467993677|FG001|Overall Study|Lost to Follow-up|1|||
130008477|NCT05318937|467993676|FG000|Overall Study|Withdrawal by Subject|0|||
130008478|NCT05318937|467993677|FG001|Overall Study|Withdrawal by Subject|2|||
130008479|NCT05318937|467993676|FG000|Overall Study|Protocol Violation|0|||
130008480|NCT05318937|467993677|FG001|Overall Study|Protocol Violation|1|||
130008481|NCT05678257|467993685|FG000|Overall Study|Withdrawal by Subject|2|||
130008482|NCT05678257|467993686|FG001|Overall Study|Withdrawal by Subject|0|||
130008483|NCT05678257|467993687|FG002|Overall Study|Withdrawal by Subject|5|||
130008484|NCT05678257|467993685|FG000|Overall Study|Physician Decision|1|||
130008485|NCT05678257|467993686|FG001|Overall Study|Physician Decision|0|||
130008486|NCT05678257|467993687|FG002|Overall Study|Physician Decision|1|||
130008487|NCT05678257|467993685|FG000|Overall Study|Adverse Event|1|||
130008488|NCT05678257|467993686|FG001|Overall Study|Adverse Event|3|||
130008489|NCT05678257|467993687|FG002|Overall Study|Adverse Event|1|||
130008490|NCT05678257|467993685|FG000|Overall Study|Progressive disease|11|||
130008491|NCT05678257|467993686|FG001|Overall Study|Progressive disease|18|||
130008492|NCT05678257|467993687|FG002|Overall Study|Progressive disease|7|||
130008493|NCT05678257|467993685|FG000|Overall Study|No longer clinically benefitting|2|||
130216592|NCT03148067|468755611|FG000|Overall Study|Lost to Follow-up|3|||
130008494|NCT05678257|467993686|FG001|Overall Study|No longer clinically benefitting|1|||
130008495|NCT05678257|467993687|FG002|Overall Study|No longer clinically benefitting|0|||
130008496|NCT05678257|467993685|FG000|Overall Study|Sponsor decision|5|||
130008497|NCT05678257|467993686|FG001|Overall Study|Sponsor decision|9|||
130008498|NCT05678257|467993687|FG002|Overall Study|Sponsor decision|8|||
130008499|NCT05678257|467993685|FG000|Overall Study|Protocol Violation|0|||
130008500|NCT05678257|467993686|FG001|Overall Study|Protocol Violation|0|||
130008501|NCT05678257|467993687|FG002|Overall Study|Protocol Violation|1|||
130008502|NCT05678257|467993685|FG000|Overall Study|Patient non-compliance|0|||
130008503|NCT05678257|467993686|FG001|Overall Study|Patient non-compliance|0|||
130008504|NCT05678257|467993687|FG002|Overall Study|Patient non-compliance|3|||
130008505|NCT02046096|467993688|FG000|Overall Study|Death|28|||
130008506|NCT02046096|467993689|FG001|Overall Study|Death|45|||
130008507|NCT02046096|467993688|FG000|Overall Study|Lost to Follow-up|9|||
130008508|NCT02046096|467993689|FG001|Overall Study|Lost to Follow-up|20|||
130008509|NCT02046096|467993688|FG000|Overall Study|Withdrawal by Subject|5|||
130008510|NCT02046096|467993689|FG001|Overall Study|Withdrawal by Subject|17|||
130008511|NCT02046096|467993688|FG000|Overall Study|Other endpoint|2|||
130008512|NCT02046096|467993689|FG001|Overall Study|Other endpoint|19|||
130008513|NCT05314517|467993690|FG000|Double-blind Period|Adverse Event|4|||
130008514|NCT05314517|467993691|FG001|Double-blind Period|Adverse Event|0|||
130008515|NCT05314517|467993692|FG002|Double-blind Period|Adverse Event|0|||
130008516|NCT05314517|467993693|FG003|Double-blind Period|Adverse Event|0|||
130008517|NCT05314517|467993690|FG000|Double-blind Period|Noncompliance|0|||
130008518|NCT05314517|467993691|FG001|Double-blind Period|Noncompliance|1|||
130008519|NCT05314517|467993692|FG002|Double-blind Period|Noncompliance|0|||
130008520|NCT05314517|467993693|FG003|Double-blind Period|Noncompliance|0|||
130008521|NCT05314517|467993690|FG000|Double-blind Period|Randomized, not treated|1|||
130008522|NCT05314517|467993691|FG001|Double-blind Period|Randomized, not treated|0|||
130008523|NCT05314517|467993692|FG002|Double-blind Period|Randomized, not treated|0|||
130008524|NCT05314517|467993693|FG003|Double-blind Period|Randomized, not treated|0|||
130008525|NCT05314517|467993690|FG000|Open-label Extension|Adverse Event|0|||
130008526|NCT05314517|467993691|FG001|Open-label Extension|Adverse Event|0|||
130008527|NCT05314517|467993692|FG002|Open-label Extension|Adverse Event|1|||
130008528|NCT05314517|467993693|FG003|Open-label Extension|Adverse Event|2|||
130008529|NCT05314517|467993690|FG000|Open-label Extension|Investigator decision|0|||
130008530|NCT05314517|467993691|FG001|Open-label Extension|Investigator decision|0|||
130008531|NCT05314517|467993692|FG002|Open-label Extension|Investigator decision|1|||
130008532|NCT05314517|467993693|FG003|Open-label Extension|Investigator decision|0|||
130008533|NCT05314517|467993690|FG000|Open-label Extension|Lost to Follow-up|0|||
130008534|NCT05314517|467993691|FG001|Open-label Extension|Lost to Follow-up|0|||
130008535|NCT05314517|467993692|FG002|Open-label Extension|Lost to Follow-up|0|||
130008536|NCT05314517|467993693|FG003|Open-label Extension|Lost to Follow-up|1|||
130008537|NCT05314517|467993690|FG000|Open-label Extension|Withdrawal by Subject|0|||
130008538|NCT05314517|467993691|FG001|Open-label Extension|Withdrawal by Subject|0|||
130008539|NCT05314517|467993692|FG002|Open-label Extension|Withdrawal by Subject|1|||
130008540|NCT05314517|467993693|FG003|Open-label Extension|Withdrawal by Subject|2|||
130008541|NCT05314517|467993690|FG000|Open-label Extension|Use of prohibited medication|0|||
130008542|NCT05314517|467993691|FG001|Open-label Extension|Use of prohibited medication|0|||
130008543|NCT05314517|467993692|FG002|Open-label Extension|Use of prohibited medication|1|||
130008544|NCT05314517|467993693|FG003|Open-label Extension|Use of prohibited medication|0|||
130008545|NCT05314517|467993690|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
130342344|NCT00913458|469224623|FG006|Phase 1|Subject Request|0|||
130008546|NCT05314517|467993691|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
130008547|NCT05314517|467993692|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
130008548|NCT05314517|467993693|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
130008549|NCT04969276|467993694|FG000|Overall Study|Protocol Deviation|0|||
130008550|NCT04969276|467993695|FG001|Overall Study|Protocol Deviation|1|||
130008551|NCT04969276|467993696|FG002|Overall Study|Protocol Deviation|0|||
130008552|NCT04969276|467993694|FG000|Overall Study|Withdrawal by Subject|1|||
130008553|NCT04969276|467993695|FG001|Overall Study|Withdrawal by Subject|10|||
130008554|NCT04969276|467993696|FG002|Overall Study|Withdrawal by Subject|0|||
130008555|NCT04969276|467993694|FG000|Overall Study|Lost to Follow-up|0|||
130342345|NCT00913458|469224617|FG000|Phase 1|Adverse Event|20|||
130342346|NCT00913458|469224618|FG001|Phase 1|Adverse Event|0|||
130008556|NCT04969276|467993695|FG001|Overall Study|Lost to Follow-up|1|||
130008557|NCT04969276|467993696|FG002|Overall Study|Lost to Follow-up|0|||
130008558|NCT04655144|467993700|FG000|Overall Study|Consumed THC|1|||
130008559|NCT04655144|467993701|FG001|Overall Study|Consumed THC|0|||
130008560|NCT04655144|467993700|FG000|Overall Study|Unilateral embolization|0|||
130342347|NCT00913458|469224619|FG002|Phase 1|Adverse Event|0|||
130342348|NCT00913458|469224620|FG003|Phase 1|Adverse Event|0|||
130008561|NCT04655144|467993701|FG001|Overall Study|Unilateral embolization|1|||
130008562|NCT04490018|467993705|FG000|Overall Study|Protocol Violation|0|||
130008563|NCT04490018|467993706|FG001|Overall Study|Protocol Violation|2|||
130008564|NCT04490018|467993707|FG002|Overall Study|Protocol Violation|1|||
130342349|NCT00913458|469224621|FG004|Phase 1|Adverse Event|0|||
130008565|NCT04490018|467993705|FG000|Overall Study|Lost to Follow-up|2|||
130008566|NCT04490018|467993706|FG001|Overall Study|Lost to Follow-up|2|||
130008567|NCT04490018|467993707|FG002|Overall Study|Lost to Follow-up|0|||
130008568|NCT04490018|467993705|FG000|Overall Study|Withdrawal by Subject|2|||
130008569|NCT04490018|467993706|FG001|Overall Study|Withdrawal by Subject|1|||
130008570|NCT04490018|467993707|FG002|Overall Study|Withdrawal by Subject|0|||
130008571|NCT04490018|467993705|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130008572|NCT04490018|467993706|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130008573|NCT04490018|467993707|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130008574|NCT00943579|467993709|FG000|Overall Study|Adverse Event|4|||
130008575|NCT00943579|467993710|FG001|Overall Study|Adverse Event|3|||
130008576|NCT00943579|467993709|FG000|Overall Study|Lack of Efficacy|2|||
130008577|NCT00943579|467993710|FG001|Overall Study|Lack of Efficacy|2|||
130008578|NCT00282295|467993711|FG000|Overall Study|Adverse Event|0|||
130008579|NCT00282295|467993712|FG001|Overall Study|Adverse Event|1|||
130008580|NCT00282295|467993713|FG002|Overall Study|Adverse Event|0|||
130008581|NCT00282295|467993711|FG000|Overall Study|Serious Adverse Events|0|||
130008582|NCT00282295|467993712|FG001|Overall Study|Serious Adverse Events|0|||
130008583|NCT00282295|467993713|FG002|Overall Study|Serious Adverse Events|1|||
130008584|NCT00282295|467993711|FG000|Overall Study|Protocol Violation|0|||
130008585|NCT00282295|467993712|FG001|Overall Study|Protocol Violation|2|||
130008586|NCT00282295|467993713|FG002|Overall Study|Protocol Violation|1|||
130008587|NCT00282295|467993711|FG000|Overall Study|Withdrawal by Subject|2|||
130008588|NCT00282295|467993712|FG001|Overall Study|Withdrawal by Subject|6|||
130008589|NCT00282295|467993713|FG002|Overall Study|Withdrawal by Subject|4|||
130008590|NCT00282295|467993711|FG000|Overall Study|Lost to Follow-up|1|||
130008591|NCT00282295|467993712|FG001|Overall Study|Lost to Follow-up|7|||
130008592|NCT00282295|467993713|FG002|Overall Study|Lost to Follow-up|2|||
130008593|NCT00282295|467993711|FG000|Overall Study|Other|0|||
130008594|NCT00282295|467993712|FG001|Overall Study|Other|1|||
130008595|NCT00282295|467993713|FG002|Overall Study|Other|0|||
130008596|NCT01401842|467993714|FG000|Overall Study|Withdrawal by Subject|3|||
130008597|NCT01401842|467993715|FG001|Overall Study|Withdrawal by Subject|2|||
130008598|NCT01401842|467993714|FG000|Overall Study|academic reason|4|||
130008599|NCT01401842|467993715|FG001|Overall Study|academic reason|1|||
130008600|NCT01401842|467993714|FG000|Overall Study|changed companies|20|||
130008601|NCT01401842|467993715|FG001|Overall Study|changed companies|34|||
130008602|NCT01401842|467993714|FG000|Overall Study|discharged from US Army|3|||
130008603|NCT01401842|467993715|FG001|Overall Study|discharged from US Army|4|||
130008604|NCT01401842|467993714|FG000|Overall Study|invalid follow-up strength data|1|||
130008605|NCT01401842|467993715|FG001|Overall Study|invalid follow-up strength data|4|||
130008606|NCT01401842|467993714|FG000|Overall Study|on profile|9|||
130008607|NCT01401842|467993715|FG001|Overall Study|on profile|5|||
130008608|NCT01401842|467993714|FG000|Overall Study|other/unknown|28|||
130008609|NCT01401842|467993715|FG001|Overall Study|other/unknown|17|||
130008610|NCT03337542|467993716|FG000|Overall Study|Withdrew Consent|17|||
130008611|NCT03337542|467993716|FG000|Overall Study|Allergic Adverse Event|1|||
130008612|NCT03337542|467993716|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
130008613|NCT03337542|467993716|FG000|Overall Study|Lost to Follow-up|1|||
130008614|NCT03337542|467993716|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
130008615|NCT00121108|467993717|FG000|Overall Study|Lost to Follow-up|10|||
130008616|NCT00121108|467993718|FG001|Overall Study|Lost to Follow-up|22|||
130342350|NCT00913458|469224622|FG005|Phase 1|Adverse Event|0|||
130342351|NCT00913458|469224623|FG006|Phase 1|Adverse Event|0|||
130342352|NCT00913458|469224617|FG000|Phase 1|Lost to Follow-up|2|||
130008617|NCT00121108|467993717|FG000|Overall Study|Withdrawal by Subject|106|||
130008618|NCT00121108|467993718|FG001|Overall Study|Withdrawal by Subject|195|||
130342353|NCT00913458|469224618|FG001|Phase 1|Lost to Follow-up|0|||
130342354|NCT00913458|469224619|FG002|Phase 1|Lost to Follow-up|0|||
130008619|NCT00121108|467993717|FG000|Overall Study|Death|5|||
130008620|NCT00121108|467993718|FG001|Overall Study|Death|8|||
130008621|NCT01380379|467993719|FG000|Overall Study|Pregnancy|1|||
130008622|NCT06156215|467993724|FG000|Overall Study|Withdrawal by Subject|2|||
130008623|NCT06156215|467993725|FG001|Overall Study|Withdrawal by Subject|4|||
130342355|NCT00913458|469224620|FG003|Phase 1|Lost to Follow-up|0|||
130342356|NCT00913458|469224621|FG004|Phase 1|Lost to Follow-up|0|||
130342357|NCT00913458|469224622|FG005|Phase 1|Lost to Follow-up|0|||
130008624|NCT06156215|467993726|FG002|Overall Study|Withdrawal by Subject|4|||
130008625|NCT06156215|467993727|FG003|Overall Study|Withdrawal by Subject|0|||
130342358|NCT00913458|469224623|FG006|Phase 1|Lost to Follow-up|0|||
130008626|NCT06156215|467993728|FG004|Overall Study|Withdrawal by Subject|2|||
130008627|NCT06156215|467993729|FG005|Overall Study|Withdrawal by Subject|2|||
130008628|NCT06156215|467993724|FG000|Overall Study|Left ED without completing study|9|||
130008629|NCT06156215|467993725|FG001|Overall Study|Left ED without completing study|3|||
130008630|NCT06156215|467993726|FG002|Overall Study|Left ED without completing study|9|||
130008631|NCT06156215|467993727|FG003|Overall Study|Left ED without completing study|0|||
130008632|NCT06156215|467993728|FG004|Overall Study|Left ED without completing study|8|||
130342359|NCT00913458|469224617|FG000|Phase 1|Protocol Violation|10|||
130342360|NCT00913458|469224618|FG001|Phase 1|Protocol Violation|0|||
130008633|NCT06156215|467993729|FG005|Overall Study|Left ED without completing study|16|||
130008634|NCT06156215|467993724|FG000|Overall Study|Physician Decision|1|||
130008635|NCT06156215|467993725|FG001|Overall Study|Physician Decision|0|||
130008636|NCT06156215|467993726|FG002|Overall Study|Physician Decision|0|||
130008637|NCT06156215|467993727|FG003|Overall Study|Physician Decision|0|||
130008638|NCT06156215|467993728|FG004|Overall Study|Physician Decision|0|||
130008639|NCT06156215|467993729|FG005|Overall Study|Physician Decision|0|||
130008640|NCT06156215|467993724|FG000|Overall Study|Became or found ineligible|2|||
130008641|NCT06156215|467993725|FG001|Overall Study|Became or found ineligible|0|||
130008642|NCT06156215|467993726|FG002|Overall Study|Became or found ineligible|2|||
130008643|NCT06156215|467993727|FG003|Overall Study|Became or found ineligible|0|||
130008644|NCT06156215|467993728|FG004|Overall Study|Became or found ineligible|1|||
130008645|NCT06156215|467993729|FG005|Overall Study|Became or found ineligible|2|||
130008646|NCT01251653|467995184|FG000|Overall Study|Progressive Disease|1|||
130008647|NCT01251653|467995185|FG001|Overall Study|Progressive Disease|7|||
130008648|NCT01251653|467995186|FG002|Overall Study|Progressive Disease|16|||
130008649|NCT01251653|467995187|FG003|Overall Study|Progressive Disease|4|||
130008650|NCT01251653|467995188|FG004|Overall Study|Progressive Disease|0|||
130008651|NCT01251653|467995189|FG005|Overall Study|Progressive Disease|17|||
130008652|NCT01251653|467995190|FG006|Overall Study|Progressive Disease|14|||
130008653|NCT01251653|467995191|FG007|Overall Study|Progressive Disease|7|||
130008654|NCT01251653|467995192|FG008|Overall Study|Progressive Disease|5|||
130008655|NCT01251653|467995184|FG000|Overall Study|Dose-limiting toxicity|0|||
130008656|NCT01251653|467995185|FG001|Overall Study|Dose-limiting toxicity|1|||
130008657|NCT01251653|467995186|FG002|Overall Study|Dose-limiting toxicity|1|||
130008658|NCT01251653|467995187|FG003|Overall Study|Dose-limiting toxicity|1|||
130008659|NCT01251653|467995188|FG004|Overall Study|Dose-limiting toxicity|0|||
130008660|NCT01251653|467995189|FG005|Overall Study|Dose-limiting toxicity|0|||
130008661|NCT01251653|467995190|FG006|Overall Study|Dose-limiting toxicity|2|||
130008662|NCT01251653|467995191|FG007|Overall Study|Dose-limiting toxicity|0|||
130008663|NCT01251653|467995192|FG008|Overall Study|Dose-limiting toxicity|0|||
130008664|NCT01251653|467995184|FG000|Overall Study|Adverse Event|1|||
130008665|NCT01251653|467995185|FG001|Overall Study|Adverse Event|0|||
130008666|NCT01251653|467995186|FG002|Overall Study|Adverse Event|2|||
130008667|NCT01251653|467995187|FG003|Overall Study|Adverse Event|1|||
130008668|NCT01251653|467995188|FG004|Overall Study|Adverse Event|1|||
130008669|NCT01251653|467995189|FG005|Overall Study|Adverse Event|0|||
130008670|NCT01251653|467995190|FG006|Overall Study|Adverse Event|2|||
130008671|NCT01251653|467995191|FG007|Overall Study|Adverse Event|2|||
130008672|NCT01251653|467995192|FG008|Overall Study|Adverse Event|1|||
130008673|NCT01251653|467995184|FG000|Overall Study|Withdrawal by Subject|1|||
130008674|NCT01251653|467995185|FG001|Overall Study|Withdrawal by Subject|0|||
130008675|NCT01251653|467995186|FG002|Overall Study|Withdrawal by Subject|1|||
130008676|NCT01251653|467995187|FG003|Overall Study|Withdrawal by Subject|0|||
130008677|NCT01251653|467995188|FG004|Overall Study|Withdrawal by Subject|1|||
130008678|NCT01251653|467995189|FG005|Overall Study|Withdrawal by Subject|1|||
130008679|NCT01251653|467995190|FG006|Overall Study|Withdrawal by Subject|0|||
130008680|NCT01251653|467995191|FG007|Overall Study|Withdrawal by Subject|1|||
130008681|NCT01251653|467995192|FG008|Overall Study|Withdrawal by Subject|0|||
130008682|NCT01251653|467995184|FG000|Overall Study|Other reason not mentioned above|0|||
130008683|NCT01251653|467995185|FG001|Overall Study|Other reason not mentioned above|0|||
130008684|NCT01251653|467995186|FG002|Overall Study|Other reason not mentioned above|0|||
130008685|NCT01251653|467995187|FG003|Overall Study|Other reason not mentioned above|0|||
130008686|NCT01251653|467995188|FG004|Overall Study|Other reason not mentioned above|0|||
130008687|NCT01251653|467995189|FG005|Overall Study|Other reason not mentioned above|0|||
130008688|NCT01251653|467995190|FG006|Overall Study|Other reason not mentioned above|0|||
130342361|NCT00913458|469224619|FG002|Phase 1|Protocol Violation|0|||
130342362|NCT00913458|469224620|FG003|Phase 1|Protocol Violation|0|||
130008689|NCT01251653|467995191|FG007|Overall Study|Other reason not mentioned above|2|||
130008690|NCT01251653|467995192|FG008|Overall Study|Other reason not mentioned above|0|||
130008691|NCT02833974|467995194|FG000|Overall Study|Lost to Follow-up|1|||
130342363|NCT00913458|469224621|FG004|Phase 1|Protocol Violation|0|||
130342364|NCT00913458|469224622|FG005|Phase 1|Protocol Violation|0|||
130342365|NCT00913458|469224623|FG006|Phase 1|Protocol Violation|0|||
130008692|NCT02833974|467995195|FG001|Overall Study|Lost to Follow-up|0|||
130008693|NCT02833974|467995194|FG000|Overall Study|Adverse Event|0|||
130008694|NCT02833974|467995195|FG001|Overall Study|Adverse Event|3|||
130008695|NCT00516048|467995197|FG000|Overall Study|Death|0|||
130008696|NCT00516048|467995198|FG001|Overall Study|Death|0|||
130008697|NCT00516048|467995199|FG002|Overall Study|Death|1|||
130342366|NCT00913458|469224617|FG000|Phase 1|Sponsor|2|||
130008698|NCT00516048|467995197|FG000|Overall Study|Subject Decision|0|||
130008699|NCT00516048|467995198|FG001|Overall Study|Subject Decision|2|||
130008700|NCT00516048|467995199|FG002|Overall Study|Subject Decision|0|||
130008701|NCT02053168|467995200|FG000|Overall Study|Withdrawal by Subject|1|||
130008702|NCT02053168|467995200|FG000|Overall Study|Physician Decision|1|||
130008703|NCT02053168|467995200|FG000|Overall Study|Lost to Follow-up|1|||
130008704|NCT00636675|467995201|FG000|Overall Study|Lost to Follow-up|121|||
130008705|NCT00636675|467995202|FG001|Overall Study|Lost to Follow-up|31|||
130008706|NCT00636675|467995201|FG000|Overall Study|Withdrawal by Subject|19|||
130008707|NCT00636675|467995202|FG001|Overall Study|Withdrawal by Subject|10|||
130008708|NCT02234479|467995207|FG000|Overall Study|Withdrawal by Subject|1|||
130008709|NCT02234479|467995208|FG001|Overall Study|Withdrawal by Subject|3|||
130008710|NCT02318667|467995209|FG000|Overall Study|Adverse Event|1|||
130008711|NCT02318667|467995209|FG000|Overall Study|Lack of Efficacy|6|||
130008712|NCT02318667|467995209|FG000|Overall Study|Protocol Violation|2|||
130008713|NCT00003535|467995210|FG000|Overall Study|Not evaluable|5|||
130008714|NCT02865018|467995212|FG000|Overall Study|Withdrawal by Subject|1|||
130008715|NCT00383084|467995220|FG000|Overall Study|Withdrawal by Subject|12|||
130008716|NCT00383084|467995221|FG001|Overall Study|Withdrawal by Subject|10|||
130008717|NCT02113436|467995222|FG000|Period 1: 8 Weeks|Adverse Event|1|||
130008718|NCT02113436|467995223|FG001|Period 1: 8 Weeks|Adverse Event|0|||
130008719|NCT02113436|467995224|FG002|Period 1: 8 Weeks|Adverse Event|0|||
130008720|NCT02113436|467995225|FG003|Period 1: 8 Weeks|Adverse Event|0|||
130008721|NCT02113436|467995222|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
130008722|NCT02113436|467995223|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
130008723|NCT02113436|467995224|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
130008724|NCT02113436|467995225|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
130008725|NCT02113436|467995222|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
130008726|NCT02113436|467995223|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
130008727|NCT02113436|467995224|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
130008728|NCT02113436|467995225|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
130008729|NCT02113436|467995222|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
130008730|NCT02113436|467995223|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
130008731|NCT02113436|467995224|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
130008732|NCT02113436|467995225|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
130008733|NCT02113436|467995222|FG000|Period 2: 16 Weeks|Adverse Event|0|||
130008734|NCT02113436|467995223|FG001|Period 2: 16 Weeks|Adverse Event|0|||
130008735|NCT02113436|467995224|FG002|Period 2: 16 Weeks|Adverse Event|4|||
130008736|NCT02113436|467995225|FG003|Period 2: 16 Weeks|Adverse Event|5|||
130008737|NCT02113436|467995222|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
130008738|NCT02113436|467995223|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
130008739|NCT02113436|467995224|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
130008740|NCT02113436|467995225|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
130008741|NCT02113436|467995222|FG000|Period 2: 16 Weeks|Physician Decision|0|||
130008742|NCT02113436|467995223|FG001|Period 2: 16 Weeks|Physician Decision|0|||
130008743|NCT02113436|467995224|FG002|Period 2: 16 Weeks|Physician Decision|2|||
130008744|NCT02113436|467995225|FG003|Period 2: 16 Weeks|Physician Decision|0|||
130008745|NCT02113436|467995222|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
130008746|NCT02113436|467995223|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
130008747|NCT02113436|467995224|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
130008748|NCT02113436|467995225|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
130008749|NCT02159729|467995226|FG000|Overall Study|Adverse Event|0|||
130008750|NCT02159729|467995227|FG001|Overall Study|Adverse Event|1|||
130008751|NCT02159729|467995226|FG000|Overall Study|Subject's Request|13|||
130008752|NCT02159729|467995227|FG001|Overall Study|Subject's Request|10|||
130008753|NCT02159729|467995226|FG000|Overall Study|Lost to Follow-up|24|||
130008754|NCT02159729|467995227|FG001|Overall Study|Lost to Follow-up|9|||
130008755|NCT02159729|467995226|FG000|Overall Study|Non compliance|2|||
130008756|NCT02159729|467995227|FG001|Overall Study|Non compliance|0|||
130008757|NCT02159729|467995226|FG000|Overall Study|Other Unspecified|3|||
130008758|NCT02159729|467995227|FG001|Overall Study|Other Unspecified|1|||
130008759|NCT02636582|467995228|FG000|Overall Study|Surgical Pathology|1|||
130008760|NCT02636582|467995229|FG001|Overall Study|Surgical Pathology|0|||
130008761|NCT01263483|467995230|FG000|Overall Study|Adverse Event|4|||
130008762|NCT01263483|467995231|FG001|Overall Study|Adverse Event|0|||
130008763|NCT01263483|467995232|FG002|Overall Study|Adverse Event|3|||
130008764|NCT01263483|467995230|FG000|Overall Study|Withdrawal by Subject|1|||
130008765|NCT01263483|467995231|FG001|Overall Study|Withdrawal by Subject|0|||
130008766|NCT01263483|467995232|FG002|Overall Study|Withdrawal by Subject|0|||
130008767|NCT01263483|467995230|FG000|Overall Study|Lack of Efficacy|2|||
130008768|NCT01263483|467995231|FG001|Overall Study|Lack of Efficacy|0|||
130008769|NCT01263483|467995232|FG002|Overall Study|Lack of Efficacy|0|||
130008770|NCT01263483|467995230|FG000|Overall Study|Protocol Violation|0|||
130008771|NCT01263483|467995231|FG001|Overall Study|Protocol Violation|1|||
130008772|NCT01263483|467995232|FG002|Overall Study|Protocol Violation|1|||
130008773|NCT01263483|467995230|FG000|Overall Study|Participant Unavailability|0|||
130008774|NCT01263483|467995231|FG001|Overall Study|Participant Unavailability|1|||
130008775|NCT01263483|467995232|FG002|Overall Study|Participant Unavailability|1|||
130008776|NCT00326209|467995233|FG000|Overall Study|Adverse Event|28|||
130008777|NCT00326209|467995233|FG000|Overall Study|Withdrawal by Subject|22|||
130008778|NCT00326209|467995233|FG000|Overall Study|Lack of Efficacy|31|||
130008779|NCT00326209|467995233|FG000|Overall Study|Lost to Follow-up|18|||
130008780|NCT00326209|467995233|FG000|Overall Study|Participant non-compliant|6|||
130008781|NCT00326209|467995233|FG000|Overall Study|Sponsor closed study|173|||
130008782|NCT00326209|467995233|FG000|Overall Study|Prohibited medication use|1|||
130008783|NCT00326209|467995233|FG000|Overall Study|Violation of entry criteria|1|||
130008784|NCT00326209|467995233|FG000|Overall Study|Withdrawn in error|1|||
130008785|NCT00326209|467995233|FG000|Overall Study|Pregnancy|1|||
130008786|NCT00714285|467995234|FG000|Overall Study|Lost to Follow-up|0|||
130008787|NCT00714285|467995235|FG001|Overall Study|Lost to Follow-up|2|||
130008788|NCT00714285|467995236|FG002|Overall Study|Lost to Follow-up|0|||
130008789|NCT00714285|467995237|FG003|Overall Study|Lost to Follow-up|1|||
130008790|NCT00714285|467995234|FG000|Overall Study|Migrated/moved from study area|0|||
130008791|NCT00714285|467995235|FG001|Overall Study|Migrated/moved from study area|1|||
130008792|NCT00714285|467995236|FG002|Overall Study|Migrated/moved from study area|0|||
130008793|NCT00714285|467995237|FG003|Overall Study|Migrated/moved from study area|0|||
130008794|NCT01372384|467995238|FG000|Overall Study|Progression of disease|3|||
130008795|NCT05500274|467995243|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
130008796|NCT05500274|467995244|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
130008797|NCT05500274|467995243|FG000|Overall Study|Lost to Follow-up|76|||
130008798|NCT05500274|467995244|FG001|Overall Study|Lost to Follow-up|51|||
130008799|NCT01555151|467995245|FG000|Overall Study|Withdrawal by Subject|6|||
130008800|NCT01555151|467995246|FG001|Overall Study|Withdrawal by Subject|2|||
130008801|NCT01555151|467995247|FG002|Overall Study|Withdrawal by Subject|0|||
130008802|NCT01555151|467995248|FG003|Overall Study|Withdrawal by Subject|2|||
130008803|NCT01555151|467995245|FG000|Overall Study|Administrative|3|||
130008804|NCT01555151|467995246|FG001|Overall Study|Administrative|1|||
130008805|NCT01555151|467995247|FG002|Overall Study|Administrative|2|||
130008806|NCT01555151|467995248|FG003|Overall Study|Administrative|0|||
130008807|NCT01555151|467995245|FG000|Overall Study|Protocol Violation|3|||
130008808|NCT01555151|467995246|FG001|Overall Study|Protocol Violation|3|||
130008809|NCT01555151|467995247|FG002|Overall Study|Protocol Violation|3|||
130008810|NCT01555151|467995248|FG003|Overall Study|Protocol Violation|5|||
130008811|NCT01555151|467995245|FG000|Overall Study|Adverse Event|1|||
130008812|NCT01555151|467995246|FG001|Overall Study|Adverse Event|2|||
130008813|NCT01555151|467995247|FG002|Overall Study|Adverse Event|1|||
130008814|NCT01555151|467995248|FG003|Overall Study|Adverse Event|2|||
130008815|NCT01555151|467995245|FG000|Overall Study|Lost to Follow-up|0|||
130008816|NCT01555151|467995246|FG001|Overall Study|Lost to Follow-up|0|||
130008817|NCT01555151|467995247|FG002|Overall Study|Lost to Follow-up|0|||
130008818|NCT01555151|467995248|FG003|Overall Study|Lost to Follow-up|1|||
130008819|NCT03596866|467995249|FG000|Overall Study|Site terminated by Sponsor|64|||
130008820|NCT03596866|467995250|FG001|Overall Study|Site terminated by Sponsor|65|||
130008821|NCT03596866|467995249|FG000|Overall Study|Death|37|||
130008822|NCT03596866|467995250|FG001|Overall Study|Death|24|||
130008823|NCT03596866|467995249|FG000|Overall Study|Withdrawal by Subject|4|||
130008824|NCT03596866|467995250|FG001|Overall Study|Withdrawal by Subject|6|||
130008825|NCT03596866|467995249|FG000|Overall Study|Missing|0|||
130008826|NCT03596866|467995250|FG001|Overall Study|Missing|6|||
130008827|NCT03596866|467995249|FG000|Overall Study|Lost to Follow-up|2|||
130008828|NCT03596866|467995250|FG001|Overall Study|Lost to Follow-up|3|||
130008829|NCT03596866|467995249|FG000|Overall Study|Protocol Violation|1|||
130008830|NCT03596866|467995250|FG001|Overall Study|Protocol Violation|0|||
130008831|NCT03596866|467995249|FG000|Overall Study|Reason Not Specified|14|||
130008832|NCT03596866|467995250|FG001|Overall Study|Reason Not Specified|13|||
130008833|NCT01961349|467995251|FG000|Overall Study|Withdrawal by Subject|1|||
130008834|NCT01961349|467995252|FG001|Overall Study|Withdrawal by Subject|4|||
130008835|NCT01961349|467995253|FG002|Overall Study|Withdrawal by Subject|0|||
130008836|NCT01961349|467995251|FG000|Overall Study|Adverse Event|0|||
130008837|NCT01961349|467995252|FG001|Overall Study|Adverse Event|0|||
130008838|NCT01961349|467995253|FG002|Overall Study|Adverse Event|1|||
130008839|NCT01961349|467995251|FG000|Overall Study|registration error, personal reason etc|2|||
130008840|NCT01961349|467995252|FG001|Overall Study|registration error, personal reason etc|2|||
130008841|NCT01961349|467995253|FG002|Overall Study|registration error, personal reason etc|1|||
130008842|NCT02576444|467995254|FG000|Overall Study|Death|1|||
130008843|NCT02576444|467995255|FG001|Overall Study|Death|1|||
130008844|NCT02576444|467995256|FG002|Overall Study|Death|0|||
130008845|NCT02576444|467995257|FG003|Overall Study|Death|0|||
130008846|NCT02576444|467995254|FG000|Overall Study|Withdrawal by Subject|0|||
130008847|NCT02576444|467995255|FG001|Overall Study|Withdrawal by Subject|0|||
130008848|NCT02576444|467995256|FG002|Overall Study|Withdrawal by Subject|2|||
130008849|NCT02576444|467995257|FG003|Overall Study|Withdrawal by Subject|0|||
130008850|NCT02576444|467995254|FG000|Overall Study|Adverse Event|0|||
130008851|NCT02576444|467995255|FG001|Overall Study|Adverse Event|0|||
130008852|NCT02576444|467995256|FG002|Overall Study|Adverse Event|1|||
130008853|NCT02576444|467995257|FG003|Overall Study|Adverse Event|0|||
130008854|NCT02576444|467995254|FG000|Overall Study|Physician Decision|0|||
129884399|NCT00708305|467536386|FG003|Period 3|Other Reason|0|||
130008855|NCT02576444|467995255|FG001|Overall Study|Physician Decision|0|||
130008856|NCT02576444|467995256|FG002|Overall Study|Physician Decision|1|||
130008857|NCT02576444|467995257|FG003|Overall Study|Physician Decision|0|||
130008858|NCT00829179|467995261|FG000|Overall Study|Withdrawal by Subject|1|||
130008859|NCT03000179|467995262|FG000|Overall Study|Lost to Follow-up|2|||
130008860|NCT01299376|467995263|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
130008861|NCT01299376|467995264|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
130008862|NCT01299376|467995263|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
130008863|NCT01299376|467995264|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
130008864|NCT01299376|467995263|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
130342367|NCT00913458|469224618|FG001|Phase 1|Sponsor|0|||
130342368|NCT00913458|469224619|FG002|Phase 1|Sponsor|0|||
130342369|NCT00913458|469224620|FG003|Phase 1|Sponsor|0|||
130342370|NCT00913458|469224621|FG004|Phase 1|Sponsor|0|||
130342371|NCT00913458|469224622|FG005|Phase 1|Sponsor|0|||
130342372|NCT00913458|469224623|FG006|Phase 1|Sponsor|0|||
130008865|NCT01299376|467995264|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
130008866|NCT01299376|467995263|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
130008867|NCT01299376|467995264|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
130008868|NCT01299376|467995263|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
130008869|NCT01299376|467995264|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
130008870|NCT01299376|467995263|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
130008871|NCT01299376|467995264|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
130008872|NCT01299376|467995263|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
130008873|NCT01299376|467995264|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
130008874|NCT01299376|467995263|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
130008875|NCT01299376|467995264|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
130008876|NCT01299376|467995263|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
130008877|NCT01299376|467995264|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
130008878|NCT01299376|467995263|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
130008879|NCT01299376|467995264|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
130008880|NCT01299376|467995263|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
130008881|NCT01299376|467995264|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
130008882|NCT02343159|467995265|FG000|Overall Study|Early Study Termination|16|||
130008883|NCT02343159|467995266|FG001|Overall Study|Early Study Termination|19|||
130008884|NCT02343159|467995267|FG002|Overall Study|Early Study Termination|23|||
130008885|NCT02343159|467995265|FG000|Overall Study|Physician Decision|2|||
130008886|NCT02343159|467995266|FG001|Overall Study|Physician Decision|0|||
130008887|NCT02343159|467995267|FG002|Overall Study|Physician Decision|1|||
130008888|NCT02343159|467995265|FG000|Overall Study|Withdrawal by Subject|3|||
130008889|NCT02343159|467995266|FG001|Overall Study|Withdrawal by Subject|0|||
130008890|NCT02343159|467995267|FG002|Overall Study|Withdrawal by Subject|2|||
130008891|NCT02343159|467995265|FG000|Overall Study|Lost to Follow-up|0|||
130008892|NCT02343159|467995266|FG001|Overall Study|Lost to Follow-up|2|||
130008893|NCT02343159|467995267|FG002|Overall Study|Lost to Follow-up|2|||
130008894|NCT02343159|467995265|FG000|Overall Study|Adverse Event|4|||
130008895|NCT02343159|467995266|FG001|Overall Study|Adverse Event|4|||
130008896|NCT02343159|467995267|FG002|Overall Study|Adverse Event|2|||
130008897|NCT02343159|467995265|FG000|Overall Study|Sponsor Decision|0|||
130008898|NCT02343159|467995266|FG001|Overall Study|Sponsor Decision|1|||
130008899|NCT02343159|467995267|FG002|Overall Study|Sponsor Decision|0|||
130008900|NCT02343159|467995265|FG000|Overall Study|Enrollment Error|1|||
130008901|NCT02343159|467995266|FG001|Overall Study|Enrollment Error|0|||
130008902|NCT02343159|467995267|FG002|Overall Study|Enrollment Error|0|||
130008903|NCT00865904|467995275|FG000|Overall Study|Randomized but not Treated|2|||
130008904|NCT00865904|467995276|FG001|Overall Study|Randomized but not Treated|0|||
130008905|NCT00865904|467995277|FG002|Overall Study|Randomized but not Treated|0|||
130008906|NCT00865904|467995278|FG003|Overall Study|Randomized but not Treated|1|||
130008907|NCT00865904|467995279|FG004|Overall Study|Randomized but not Treated|1|||
130008908|NCT03625687|467995280|FG000|Overall Study|Death|1|||
130008909|NCT04315181|467995285|FG000|Overall Study|Non-responsive to drug conditions.|1|||
130008910|NCT00711425|467995286|FG000|Overall Study|Protocol Violation|1|||
130008911|NCT00711425|467995286|FG000|Overall Study|Death|2|||
130008912|NCT00711425|467995286|FG000|Overall Study|Lost to Follow-up|1|||
130008913|NCT05879107|467995289|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
130008914|NCT05879107|467995290|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
130008915|NCT05879107|467995289|FG000|Overall Study|Migrated / moved from the study area|1|||
130008916|NCT05879107|467995290|FG001|Overall Study|Migrated / moved from the study area|1|||
130008917|NCT05879107|467995289|FG000|Overall Study|Lost to Follow-up|8|||
130008918|NCT05879107|467995290|FG001|Overall Study|Lost to Follow-up|13|||
130008919|NCT05879107|467995289|FG000|Overall Study|Death|0|||
130008920|NCT05879107|467995290|FG001|Overall Study|Death|2|||
130008921|NCT05879107|467995289|FG000|Overall Study|Other|0|||
130008922|NCT05879107|467995290|FG001|Overall Study|Other|3|||
130216593|NCT03148067|468755611|FG000|Overall Study|Death|1|||
130342373|NCT00913458|469224617|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
129884400|NCT02771210|467536387|FG000|Period 1|Adverse Event|5|||
130342374|NCT00913458|469224618|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
129884401|NCT02771210|467536388|FG001|Period 1|Adverse Event|3|||
130008923|NCT04607148|467995293|FG000|Overall Study|Withdrawal by Subject|0|||
130008924|NCT04607148|467995294|FG001|Overall Study|Withdrawal by Subject|4|||
130008925|NCT04607148|467995295|FG002|Overall Study|Withdrawal by Subject|2|||
130008926|NCT04607148|467995296|FG003|Overall Study|Withdrawal by Subject|8|||
130008927|NCT04607148|467995293|FG000|Overall Study|Study Terminated by Sponsor|14|||
130008928|NCT04607148|467995294|FG001|Overall Study|Study Terminated by Sponsor|59|||
130008929|NCT04607148|467995295|FG002|Overall Study|Study Terminated by Sponsor|9|||
130008930|NCT04607148|467995296|FG003|Overall Study|Study Terminated by Sponsor|39|||
130008931|NCT04607148|467995293|FG000|Overall Study|Sponsor Decision|0|||
130008932|NCT04607148|467995294|FG001|Overall Study|Sponsor Decision|0|||
130008933|NCT04607148|467995295|FG002|Overall Study|Sponsor Decision|1|||
130008934|NCT04607148|467995296|FG003|Overall Study|Sponsor Decision|0|||
130008935|NCT04607148|467995293|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130008936|NCT04607148|467995294|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130008937|NCT04607148|467995295|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130008938|NCT04607148|467995296|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130008939|NCT04607148|467995293|FG000|Overall Study|Lost to Follow-up|0|||
130008940|NCT04607148|467995294|FG001|Overall Study|Lost to Follow-up|2|||
130008941|NCT04607148|467995295|FG002|Overall Study|Lost to Follow-up|0|||
130008942|NCT04607148|467995296|FG003|Overall Study|Lost to Follow-up|0|||
130008943|NCT04607148|467995293|FG000|Overall Study|Death|0|||
130008944|NCT04607148|467995294|FG001|Overall Study|Death|3|||
130008945|NCT04607148|467995295|FG002|Overall Study|Death|0|||
130008946|NCT04607148|467995296|FG003|Overall Study|Death|1|||
130008947|NCT04607148|467995293|FG000|Overall Study|Adverse Event|0|||
130008948|NCT04607148|467995294|FG001|Overall Study|Adverse Event|1|||
130008949|NCT04607148|467995295|FG002|Overall Study|Adverse Event|0|||
130008950|NCT04607148|467995296|FG003|Overall Study|Adverse Event|0|||
130008951|NCT00916149|467995299|FG000|Overall Study|Lost to Follow-up|3|||
130008952|NCT00916149|467995300|FG001|Overall Study|Lost to Follow-up|2|||
130008953|NCT00916149|467995301|FG002|Overall Study|Lost to Follow-up|0|||
130008954|NCT00916149|467995299|FG000|Overall Study|Unable to place scalp EEG leads|1|||
130008955|NCT00916149|467995300|FG001|Overall Study|Unable to place scalp EEG leads|0|||
130008956|NCT00916149|467995301|FG002|Overall Study|Unable to place scalp EEG leads|0|||
130008957|NCT00589420|467995302|FG000|Overall Study|screen failure|1|||
130008958|NCT00912028|467995303|FG000|Overall Study|Lost to Follow-up|2|||
130008959|NCT00912028|467995304|FG001|Overall Study|Lost to Follow-up|3|||
130008960|NCT00912028|467995305|FG002|Overall Study|Lost to Follow-up|0|||
130216594|NCT05305989|468755616|FG000|Overall Study|Other|3|||
130342375|NCT00913458|469224619|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
130342376|NCT00913458|469224620|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
130342377|NCT00913458|469224621|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
130342378|NCT00913458|469224622|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
130342379|NCT00913458|469224623|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
130342380|NCT00913458|469224617|FG000|Phase 2|Non-Responder|0|||
130342381|NCT00913458|469224618|FG001|Phase 2|Non-Responder|5|||
130342382|NCT00913458|469224619|FG002|Phase 2|Non-Responder|7|||
130342383|NCT00913458|469224620|FG003|Phase 2|Non-Responder|12|||
130342384|NCT00913458|469224621|FG004|Phase 2|Non-Responder|0|||
130342385|NCT00913458|469224622|FG005|Phase 2|Non-Responder|0|||
130342386|NCT00913458|469224623|FG006|Phase 2|Non-Responder|0|||
130342387|NCT00913458|469224617|FG000|Phase 2|Subject Request|0|||
130342388|NCT00913458|469224618|FG001|Phase 2|Subject Request|0|||
130342389|NCT00913458|469224619|FG002|Phase 2|Subject Request|1|||
130342390|NCT00913458|469224620|FG003|Phase 2|Subject Request|2|||
130342391|NCT00913458|469224621|FG004|Phase 2|Subject Request|0|||
130342392|NCT00913458|469224622|FG005|Phase 2|Subject Request|0|||
130342393|NCT00913458|469224623|FG006|Phase 2|Subject Request|0|||
130342394|NCT00913458|469224617|FG000|Phase 2|Adverse Event|0|||
130342395|NCT00913458|469224618|FG001|Phase 2|Adverse Event|3|||
130342396|NCT00913458|469224619|FG002|Phase 2|Adverse Event|0|||
130342397|NCT00913458|469224620|FG003|Phase 2|Adverse Event|1|||
130342398|NCT00913458|469224621|FG004|Phase 2|Adverse Event|0|||
130342399|NCT00913458|469224622|FG005|Phase 2|Adverse Event|0|||
130342400|NCT00913458|469224623|FG006|Phase 2|Adverse Event|0|||
130342401|NCT00913458|469224617|FG000|Phase 2|Lost to Follow-up|0|||
130342402|NCT00913458|469224618|FG001|Phase 2|Lost to Follow-up|0|||
130342403|NCT00913458|469224619|FG002|Phase 2|Lost to Follow-up|0|||
130342404|NCT00913458|469224620|FG003|Phase 2|Lost to Follow-up|1|||
130008961|NCT00912028|467995306|FG003|Overall Study|Lost to Follow-up|1|||
130008962|NCT00912028|467995307|FG004|Overall Study|Lost to Follow-up|3|||
130008963|NCT00912028|467995303|FG000|Overall Study|Withdrawal by Subject|3|||
130008964|NCT00912028|467995304|FG001|Overall Study|Withdrawal by Subject|0|||
130342405|NCT00913458|469224621|FG004|Phase 2|Lost to Follow-up|0|||
130342406|NCT00913458|469224622|FG005|Phase 2|Lost to Follow-up|0|||
130342407|NCT00913458|469224623|FG006|Phase 2|Lost to Follow-up|0|||
130342408|NCT00913458|469224617|FG000|Phase 2|Protocol Violation|0|||
130342409|NCT00913458|469224618|FG001|Phase 2|Protocol Violation|2|||
130342410|NCT00913458|469224619|FG002|Phase 2|Protocol Violation|0|||
130342411|NCT00913458|469224620|FG003|Phase 2|Protocol Violation|0|||
130342412|NCT00913458|469224621|FG004|Phase 2|Protocol Violation|0|||
130342413|NCT00913458|469224622|FG005|Phase 2|Protocol Violation|0|||
130342414|NCT00913458|469224623|FG006|Phase 2|Protocol Violation|0|||
130342415|NCT00913458|469224617|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
130342416|NCT00913458|469224618|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
130342417|NCT00913458|469224619|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
130342418|NCT00913458|469224620|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
130342419|NCT00913458|469224621|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
130342420|NCT00913458|469224622|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
130342421|NCT00913458|469224623|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
130342422|NCT00913458|469224617|FG000|Phase 3|Adverse Event|0|||
130342423|NCT00913458|469224618|FG001|Phase 3|Adverse Event|0|||
130342424|NCT00913458|469224619|FG002|Phase 3|Adverse Event|0|||
130342425|NCT00913458|469224620|FG003|Phase 3|Adverse Event|0|||
130342426|NCT00913458|469224621|FG004|Phase 3|Adverse Event|5|||
130342427|NCT00913458|469224622|FG005|Phase 3|Adverse Event|4|||
130342428|NCT00913458|469224623|FG006|Phase 3|Adverse Event|1|||
130342429|NCT00913458|469224617|FG000|Phase 3|Lost to Follow-up|0|||
130342430|NCT00913458|469224618|FG001|Phase 3|Lost to Follow-up|0|||
130342431|NCT00913458|469224619|FG002|Phase 3|Lost to Follow-up|0|||
130342432|NCT00913458|469224620|FG003|Phase 3|Lost to Follow-up|0|||
130342433|NCT00913458|469224621|FG004|Phase 3|Lost to Follow-up|2|||
130342434|NCT00913458|469224622|FG005|Phase 3|Lost to Follow-up|0|||
130342435|NCT00913458|469224623|FG006|Phase 3|Lost to Follow-up|0|||
130342436|NCT00913458|469224617|FG000|Phase 3|Non-Responder|0|||
130342437|NCT00913458|469224618|FG001|Phase 3|Non-Responder|0|||
130342438|NCT00913458|469224619|FG002|Phase 3|Non-Responder|0|||
130342439|NCT00913458|469224620|FG003|Phase 3|Non-Responder|0|||
130342440|NCT00913458|469224621|FG004|Phase 3|Non-Responder|0|||
130342441|NCT00913458|469224622|FG005|Phase 3|Non-Responder|1|||
130342442|NCT00913458|469224623|FG006|Phase 3|Non-Responder|3|||
130342443|NCT00913458|469224617|FG000|Phase 3|Withdrawal by Subject|0|||
130342444|NCT00913458|469224618|FG001|Phase 3|Withdrawal by Subject|0|||
130342445|NCT00913458|469224619|FG002|Phase 3|Withdrawal by Subject|0|||
130342446|NCT00913458|469224620|FG003|Phase 3|Withdrawal by Subject|0|||
130342447|NCT00913458|469224621|FG004|Phase 3|Withdrawal by Subject|1|||
130342448|NCT00913458|469224622|FG005|Phase 3|Withdrawal by Subject|2|||
130342449|NCT00913458|469224623|FG006|Phase 3|Withdrawal by Subject|0|||
130342450|NCT00913458|469224617|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
130342451|NCT00913458|469224618|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
130342452|NCT00913458|469224619|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
130342453|NCT00913458|469224620|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
130342454|NCT00913458|469224621|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
130342455|NCT00913458|469224622|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
130342456|NCT00913458|469224623|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
130342457|NCT00357760|469224627|FG000|Overall Study|Disease progression|44|||
130342458|NCT00357760|469224628|FG001|Overall Study|Disease progression|17|||
130342459|NCT00357760|469224627|FG000|Overall Study|Adverse Event|10|||
130342460|NCT00357760|469224628|FG001|Overall Study|Adverse Event|7|||
130342461|NCT00357760|469224627|FG000|Overall Study|Death|0|||
130342462|NCT00357760|469224628|FG001|Overall Study|Death|3|||
130342463|NCT00357760|469224627|FG000|Overall Study|Alternative therapy|1|||
130342464|NCT00357760|469224628|FG001|Overall Study|Alternative therapy|0|||
130342465|NCT00357760|469224627|FG000|Overall Study|Withdrawal by Subject|0|||
130342466|NCT00357760|469224628|FG001|Overall Study|Withdrawal by Subject|2|||
130342467|NCT00357760|469224627|FG000|Overall Study|Never started treatment|2|||
130342468|NCT00357760|469224628|FG001|Overall Study|Never started treatment|1|||
130342469|NCT00357760|469224627|FG000|Overall Study|Ineligible|0|||
130342470|NCT00357760|469224628|FG001|Overall Study|Ineligible|2|||
130342471|NCT00357760|469224627|FG000|Overall Study|Physician Decision|2|||
130342472|NCT00357760|469224628|FG001|Overall Study|Physician Decision|1|||
130342473|NCT00357760|469224627|FG000|Overall Study|Protocol Violation|0|||
130342474|NCT00357760|469224628|FG001|Overall Study|Protocol Violation|1|||
130342475|NCT00357760|469224627|FG000|Overall Study|To receive hospice care|0|||
130342476|NCT00357760|469224628|FG001|Overall Study|To receive hospice care|1|||
130342477|NCT04136444|469224629|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
130342478|NCT04136444|469224630|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
130342479|NCT02238067|469224631|FG000|Overall Study|Not completed survey at Month 6|45|||
130342480|NCT00869778|469224632|FG000|Overall Study|Adverse Event|2|||
130342481|NCT00869778|469224633|FG001|Overall Study|Adverse Event|0|||
130342482|NCT00869778|469224634|FG002|Overall Study|Adverse Event|0|||
130342483|NCT00869778|469224632|FG000|Overall Study|Withdrawal by Subject|3|||
130342484|NCT00869778|469224633|FG001|Overall Study|Withdrawal by Subject|4|||
130342485|NCT00869778|469224634|FG002|Overall Study|Withdrawal by Subject|5|||
130342486|NCT00869778|469224632|FG000|Overall Study|Pregnancy|1|||
130342487|NCT00869778|469224633|FG001|Overall Study|Pregnancy|0|||
130342488|NCT00869778|469224634|FG002|Overall Study|Pregnancy|0|||
130342489|NCT00869778|469224632|FG000|Overall Study|Protocol Violation|5|||
130342490|NCT00869778|469224633|FG001|Overall Study|Protocol Violation|3|||
130342491|NCT00869778|469224634|FG002|Overall Study|Protocol Violation|5|||
130342492|NCT00869778|469224632|FG000|Overall Study|Unblinding|1|||
130342493|NCT00869778|469224633|FG001|Overall Study|Unblinding|0|||
130342494|NCT00869778|469224634|FG002|Overall Study|Unblinding|0|||
130342495|NCT03726996|469224637|FG000|Overall Study|Parent's decision|2|||
130342496|NCT03726996|469224637|FG000|Overall Study|Study early termination|2|||
130342497|NCT03180619|469224638|FG000|Overall Study|Withdrew Consent|5|||
130342498|NCT03180619|469224639|FG001|Overall Study|Withdrew Consent|0|||
130342499|NCT03180619|469224640|FG002|Overall Study|Withdrew Consent|2|||
130342500|NCT03180619|469224638|FG000|Overall Study|Death|2|||
130342501|NCT03180619|469224639|FG001|Overall Study|Death|1|||
130342502|NCT03180619|469224640|FG002|Overall Study|Death|2|||
130342503|NCT03180619|469224638|FG000|Overall Study|Adverse Event|2|||
130342504|NCT03180619|469224639|FG001|Overall Study|Adverse Event|0|||
130342505|NCT03180619|469224640|FG002|Overall Study|Adverse Event|1|||
130342506|NCT03180619|469224638|FG000|Overall Study|Investigator's discretion|2|||
130342507|NCT03180619|469224639|FG001|Overall Study|Investigator's discretion|0|||
130342508|NCT03180619|469224640|FG002|Overall Study|Investigator's discretion|1|||
130342509|NCT02743611|469224641|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
130342510|NCT02743611|469224642|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
130342511|NCT02743611|469224643|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
130342512|NCT02743611|469224644|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
130342513|NCT00402740|469224653|FG000|Overall Study|Withdrawal by Subject|18|||
130342514|NCT00402740|469224653|FG000|Overall Study|Death|50|||
130342515|NCT00402740|469224653|FG000|Overall Study|Lost to Follow-up|6|||
130342516|NCT00402740|469224653|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
130342517|NCT00402740|469224653|FG000|Overall Study|Subject disposition unknown.|1|||
130342518|NCT02342418|469224656|FG000|Overall Study|Adverse Event|0|||
130342519|NCT02342418|469224657|FG001|Overall Study|Adverse Event|1|||
130342520|NCT04255394|469224658|FG000|Overall Study|Death|35|||
130342521|NCT04255394|469224659|FG001|Overall Study|Death|25|||
130342522|NCT04255394|469224658|FG000|Overall Study|Device removed|2|||
130342523|NCT04255394|469224659|FG001|Overall Study|Device removed|10|||
130342524|NCT04255394|469224658|FG000|Overall Study|Withdrawal by Subject|9|||
130342525|NCT04255394|469224659|FG001|Overall Study|Withdrawal by Subject|8|||
130342526|NCT04255394|469224658|FG000|Overall Study|Screen Failure/Not treated|12|||
130342527|NCT04255394|469224659|FG001|Overall Study|Screen Failure/Not treated|8|||
130342528|NCT04255394|469224658|FG000|Overall Study|Lost to Follow-up|123|||
130342529|NCT04255394|469224659|FG001|Overall Study|Lost to Follow-up|265|||
130342530|NCT04255394|469224658|FG000|Overall Study|Adverse Event|1|||
130342531|NCT04255394|469224659|FG001|Overall Study|Adverse Event|3|||
130342532|NCT01159431|469224663|FG000|Overall Study|Adverse Event|1|||
130342533|NCT01159431|469224664|FG001|Overall Study|Adverse Event|2|||
130342534|NCT01159431|469224663|FG000|Overall Study|non-compliance|1|||
130342535|NCT01159431|469224664|FG001|Overall Study|non-compliance|1|||
130342536|NCT01159431|469224663|FG000|Overall Study|Lack of Efficacy|0|||
130342537|NCT01159431|469224664|FG001|Overall Study|Lack of Efficacy|3|||
130342538|NCT00534599|469224670|FG000|Overall Study|Adverse Event|25|||
130342539|NCT00534599|469224671|FG001|Overall Study|Adverse Event|4|||
130342540|NCT00534599|469224670|FG000|Overall Study|Incorrect enrollment|2|||
130342541|NCT00534599|469224671|FG001|Overall Study|Incorrect enrollment|1|||
130342542|NCT00534599|469224670|FG000|Overall Study|Mis-randomization|2|||
130342543|NCT00534599|469224671|FG001|Overall Study|Mis-randomization|2|||
130342544|NCT00534599|469224670|FG000|Overall Study|Developed study-specific d/c criteria|5|||
130342545|NCT00534599|469224671|FG001|Overall Study|Developed study-specific d/c criteria|0|||
130342546|NCT00534599|469224670|FG000|Overall Study|Lack of Efficacy|0|||
130342547|NCT00534599|469224671|FG001|Overall Study|Lack of Efficacy|1|||
130342548|NCT00534599|469224670|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
130342549|NCT00534599|469224671|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
130342550|NCT00534599|469224670|FG000|Overall Study|Protocol Violation|1|||
130342551|NCT00534599|469224671|FG001|Overall Study|Protocol Violation|3|||
130342552|NCT00534599|469224670|FG000|Overall Study|Lost to Follow-up|11|||
130342553|NCT00534599|469224671|FG001|Overall Study|Lost to Follow-up|14|||
130342554|NCT00534599|469224670|FG000|Overall Study|Withdrawal by Subject|4|||
130342555|NCT00534599|469224671|FG001|Overall Study|Withdrawal by Subject|6|||
130342556|NCT00534599|469224670|FG000|Overall Study|Other|7|||
130342557|NCT00534599|469224671|FG001|Overall Study|Other|0|||
130342558|NCT03645434|469224673|FG000|Period 1|Adverse Event|0|||
130342559|NCT03645434|469224674|FG001|Period 1|Adverse Event|0|||
130342560|NCT03645434|469224675|FG002|Period 1|Adverse Event|0|||
130342561|NCT03645434|469224676|FG003|Period 1|Adverse Event|1|||
130342562|NCT03645434|469224677|FG004|Period 1|Adverse Event|0|||
130342563|NCT03645434|469224678|FG005|Period 1|Adverse Event|0|||
130342564|NCT03645434|469224673|FG000|Period 1|COPD exacerbation|0|||
130342565|NCT03645434|469224674|FG001|Period 1|COPD exacerbation|0|||
130216595|NCT05305989|468755617|FG001|Overall Study|Other|2|||
130342566|NCT03645434|469224675|FG002|Period 1|COPD exacerbation|0|||
130342567|NCT03645434|469224676|FG003|Period 1|COPD exacerbation|0|||
130342568|NCT03645434|469224677|FG004|Period 1|COPD exacerbation|1|||
130342569|NCT03645434|469224678|FG005|Period 1|COPD exacerbation|0|||
130342570|NCT03865316|469227125|FG000|Overall Study|Procedure Cancelled|4|||
130342571|NCT03865316|469227125|FG000|Overall Study|Equipment failure|4|||
130342572|NCT03137069|469227130|FG000|Overall Study|Withdrawal by Subject|1|||
130342573|NCT03137069|469227131|FG001|Overall Study|Withdrawal by Subject|2|||
130342574|NCT03137069|469227132|FG002|Overall Study|Withdrawal by Subject|2|||
130342575|NCT03137069|469227133|FG003|Overall Study|Withdrawal by Subject|2|||
130342576|NCT03137069|469227134|FG004|Overall Study|Withdrawal by Subject|0|||
130342577|NCT03137069|469227135|FG005|Overall Study|Withdrawal by Subject|0|||
130342578|NCT03137069|469227130|FG000|Overall Study|Adverse Event|0|||
130342579|NCT03137069|469227131|FG001|Overall Study|Adverse Event|3|||
130342580|NCT03137069|469227132|FG002|Overall Study|Adverse Event|1|||
130342581|NCT03137069|469227133|FG003|Overall Study|Adverse Event|1|||
130342582|NCT03137069|469227134|FG004|Overall Study|Adverse Event|0|||
130342583|NCT03137069|469227135|FG005|Overall Study|Adverse Event|1|||
130342584|NCT03137069|469227130|FG000|Overall Study|Protocol Violation|0|||
130342585|NCT03137069|469227131|FG001|Overall Study|Protocol Violation|1|||
130342586|NCT03137069|469227132|FG002|Overall Study|Protocol Violation|0|||
130342587|NCT03137069|469227133|FG003|Overall Study|Protocol Violation|1|||
130342588|NCT03137069|469227134|FG004|Overall Study|Protocol Violation|1|||
130342589|NCT03137069|469227135|FG005|Overall Study|Protocol Violation|1|||
130342590|NCT03137069|469227130|FG000|Overall Study|Physician Decision|0|||
130342591|NCT03137069|469227131|FG001|Overall Study|Physician Decision|0|||
130342592|NCT03137069|469227132|FG002|Overall Study|Physician Decision|0|||
130342593|NCT03137069|469227133|FG003|Overall Study|Physician Decision|1|||
130342594|NCT03137069|469227134|FG004|Overall Study|Physician Decision|0|||
130342595|NCT03137069|469227135|FG005|Overall Study|Physician Decision|0|||
130342596|NCT03137069|469227130|FG000|Overall Study|Study Terminated by Sponsor|0|||
130342597|NCT03137069|469227131|FG001|Overall Study|Study Terminated by Sponsor|0|||
130342598|NCT03137069|469227132|FG002|Overall Study|Study Terminated by Sponsor|0|||
130342599|NCT03137069|469227133|FG003|Overall Study|Study Terminated by Sponsor|0|||
130342600|NCT03137069|469227134|FG004|Overall Study|Study Terminated by Sponsor|1|||
130342601|NCT03137069|469227135|FG005|Overall Study|Study Terminated by Sponsor|0|||
130342602|NCT03137069|469227130|FG000|Overall Study|Data Entry Error|0|||
130342603|NCT03137069|469227131|FG001|Overall Study|Data Entry Error|0|||
130342604|NCT03137069|469227132|FG002|Overall Study|Data Entry Error|0|||
130342605|NCT03137069|469227133|FG003|Overall Study|Data Entry Error|1|||
130342606|NCT03137069|469227134|FG004|Overall Study|Data Entry Error|0|||
130342607|NCT03137069|469227135|FG005|Overall Study|Data Entry Error|0|||
130342608|NCT00336856|469227136|FG000|Overall Study|Withdrawal by Subject|3|||
130342609|NCT00336856|469227136|FG000|Overall Study|Found ineligible at time of analysis|1|||
130342610|NCT00362180|469227138|FG000|Treated Period|Withdrawal by Subject|1|||
130342611|NCT00362180|469227139|FG001|Treated Period|Withdrawal by Subject|0|||
130342612|NCT00362180|469227140|FG002|Treated Period|Withdrawal by Subject|0|||
130342613|NCT00362180|469227141|FG003|Treated Period|Withdrawal by Subject|0|||
130342614|NCT00362180|469227142|FG004|Treated Period|Withdrawal by Subject|0|||
130342615|NCT00362180|469227143|FG005|Treated Period|Withdrawal by Subject|0|||
130342616|NCT00362180|469227144|FG006|Treated Period|Withdrawal by Subject|0|||
130342617|NCT00362180|469227145|FG007|Treated Period|Withdrawal by Subject|0|||
130342618|NCT00362180|469227146|FG008|Treated Period|Withdrawal by Subject|0|||
130342619|NCT00362180|469227138|FG000|Treated Period|Adverse Event|0|||
130342620|NCT00362180|469227139|FG001|Treated Period|Adverse Event|0|||
130342621|NCT00362180|469227140|FG002|Treated Period|Adverse Event|0|||
130342622|NCT00362180|469227141|FG003|Treated Period|Adverse Event|0|||
130342623|NCT00362180|469227142|FG004|Treated Period|Adverse Event|0|||
130342624|NCT00362180|469227143|FG005|Treated Period|Adverse Event|1|||
130342625|NCT00362180|469227144|FG006|Treated Period|Adverse Event|0|||
130342626|NCT00362180|469227145|FG007|Treated Period|Adverse Event|1|||
130342627|NCT00362180|469227146|FG008|Treated Period|Adverse Event|0|||
130342628|NCT02434471|469227149|FG000|Overall Study|Physician Decision|9|||
130342629|NCT00843778|469227150|FG000|Overall Study|Adverse Event|15|||
130342630|NCT00843778|469227150|FG000|Overall Study|Lack of Efficacy|14|||
130342631|NCT00843778|469227150|FG000|Overall Study|Loss of efficacy|2|||
130342632|NCT00843778|469227150|FG000|Overall Study|Withdrawal by Subject|4|||
130342633|NCT00369629|469227151|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
130342634|NCT00369629|469227152|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
130342635|NCT00369629|469227153|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
130342636|NCT00369629|469227154|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
130342637|NCT00369629|469227151|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130342638|NCT00369629|469227152|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130342639|NCT00369629|469227153|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
130342640|NCT00369629|469227154|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
130342641|NCT00369629|469227151|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
130342642|NCT00369629|469227152|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130342643|NCT00369629|469227153|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130342644|NCT00369629|469227154|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
130342645|NCT00369629|469227151|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
130342646|NCT00369629|469227152|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
130342647|NCT00369629|469227153|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
130342648|NCT00369629|469227154|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
130342649|NCT00369629|469227151|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
130342650|NCT00369629|469227152|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
130342651|NCT00369629|469227153|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
130342652|NCT00369629|469227154|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
130342653|NCT00369629|469227151|FG000|Completed 4 More Cycles|Progressive disease|2|||
130342654|NCT00369629|469227152|FG001|Completed 4 More Cycles|Progressive disease|1|||
130342655|NCT00369629|469227153|FG002|Completed 4 More Cycles|Progressive disease|2|||
130342656|NCT00369629|469227154|FG003|Completed 4 More Cycles|Progressive disease|0|||
130342657|NCT00369629|469227151|FG000|Follow up for 1 Year|Death|2|||
130342658|NCT00369629|469227152|FG001|Follow up for 1 Year|Death|1|||
130342659|NCT00369629|469227153|FG002|Follow up for 1 Year|Death|1|||
130342660|NCT00369629|469227154|FG003|Follow up for 1 Year|Death|0|||
130342661|NCT00369629|469227151|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
130342662|NCT00369629|469227152|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
130342663|NCT00369629|469227153|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
130342664|NCT00369629|469227154|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
130342665|NCT00369629|469227151|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
130342666|NCT00369629|469227152|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
130342667|NCT00369629|469227153|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
130342668|NCT00369629|469227154|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
130342669|NCT00538785|469227156|FG000|Overall Study|Death|9|||
130342670|NCT00538785|469227157|FG001|Overall Study|Death|10|||
130342671|NCT00538785|469227156|FG000|Overall Study|Withdrawal of consent|9|||
130342672|NCT00538785|469227157|FG001|Overall Study|Withdrawal of consent|7|||
130342673|NCT00538785|469227156|FG000|Overall Study|Lost to Follow-up|1|||
130342674|NCT00538785|469227157|FG001|Overall Study|Lost to Follow-up|0|||
130342675|NCT01478048|469227160|FG000|Overall Study|Disease Progression|52|||
130342676|NCT01478048|469227161|FG001|Overall Study|Disease Progression|35|||
130342677|NCT01478048|469227160|FG000|Overall Study|study drug toxicity|11|||
130342678|NCT01478048|469227161|FG001|Overall Study|study drug toxicity|14|||
130342679|NCT01478048|469227160|FG000|Overall Study|Adverse Event|2|||
130342680|NCT01478048|469227161|FG001|Overall Study|Adverse Event|11|||
130342681|NCT01478048|469227160|FG000|Overall Study|subject request to discontinue treatment|3|||
130342682|NCT01478048|469227161|FG001|Overall Study|subject request to discontinue treatment|5|||
130342683|NCT01478048|469227160|FG000|Overall Study|Withdrawal by Subject|2|||
130342684|NCT01478048|469227161|FG001|Overall Study|Withdrawal by Subject|5|||
130342685|NCT01478048|469227160|FG000|Overall Study|non-specified|6|||
130342686|NCT01478048|469227161|FG001|Overall Study|non-specified|4|||
130342687|NCT01478048|469227160|FG000|Overall Study|poor/non-compliance|0|||
130342688|NCT01478048|469227161|FG001|Overall Study|poor/non-compliance|1|||
130342689|NCT01478048|469227160|FG000|Overall Study|no longer meets study criteria|1|||
130342690|NCT01478048|469227161|FG001|Overall Study|no longer meets study criteria|0|||
130342691|NCT03642132|469227167|FG000|Chemotherapy Period|Adverse Event|1|||
130342692|NCT03642132|469227168|FG001|Chemotherapy Period|Adverse Event|1|||
130342693|NCT03642132|469227169|FG002|Chemotherapy Period|Adverse Event|0|||
130342694|NCT03642132|469227167|FG000|Chemotherapy Period|Physician's decision|4|||
130342695|NCT03642132|469227168|FG001|Chemotherapy Period|Physician's decision|1|||
130342696|NCT03642132|469227169|FG002|Chemotherapy Period|Physician's decision|0|||
130342697|NCT03642132|469227167|FG000|Chemotherapy Period|Progressive disease|0|||
130342698|NCT03642132|469227168|FG001|Chemotherapy Period|Progressive disease|0|||
130342699|NCT03642132|469227169|FG002|Chemotherapy Period|Progressive disease|1|||
130342700|NCT03642132|469227167|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
130342701|NCT03642132|469227168|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
130342702|NCT03642132|469227169|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
130342703|NCT03642132|469227167|FG000|Chemotherapy Period|Other|1|||
130342704|NCT03642132|469227168|FG001|Chemotherapy Period|Other|0|||
130342705|NCT03642132|469227169|FG002|Chemotherapy Period|Other|2|||
130342706|NCT03642132|469227167|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
130342707|NCT03642132|469227168|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
130342708|NCT03642132|469227169|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
130342709|NCT03642132|469227167|FG000|Maintenance Period|Adverse Event|1|||
130342710|NCT03642132|469227168|FG001|Maintenance Period|Adverse Event|2|||
130342711|NCT03642132|469227169|FG002|Maintenance Period|Adverse Event|0|||
130342712|NCT03642132|469227167|FG000|Maintenance Period|Non-compliance with study drug|0|||
130342713|NCT03642132|469227168|FG001|Maintenance Period|Non-compliance with study drug|0|||
130342714|NCT03642132|469227169|FG002|Maintenance Period|Non-compliance with study drug|1|||
130342715|NCT03642132|469227167|FG000|Maintenance Period|Physician's decision|2|||
130342716|NCT03642132|469227168|FG001|Maintenance Period|Physician's decision|2|||
130342717|NCT03642132|469227169|FG002|Maintenance Period|Physician's decision|2|||
130216596|NCT05305989|468755618|FG002|Overall Study|Other|0|||
130342718|NCT03642132|469227167|FG000|Maintenance Period|Progressive disease|9|||
130342719|NCT03642132|469227168|FG001|Maintenance Period|Progressive disease|3|||
130342720|NCT03642132|469227169|FG002|Maintenance Period|Progressive disease|6|||
130342721|NCT03642132|469227167|FG000|Maintenance Period|Other|0|||
130342722|NCT03642132|469227168|FG001|Maintenance Period|Other|0|||
130342723|NCT03642132|469227169|FG002|Maintenance Period|Other|3|||
130342724|NCT03642132|469227167|FG000|Maintenance Period|Withdrawal by Subject|1|||
130342725|NCT03642132|469227168|FG001|Maintenance Period|Withdrawal by Subject|1|||
130342726|NCT03642132|469227169|FG002|Maintenance Period|Withdrawal by Subject|2|||
130342727|NCT03642132|469227167|FG000|Follow-up Period|Other|0|||
130342728|NCT03642132|469227168|FG001|Follow-up Period|Other|0|||
130342729|NCT03642132|469227169|FG002|Follow-up Period|Other|1|||
130342730|NCT03642132|469227167|FG000|Follow-up Period|Withdrawal by Subject|1|||
130342731|NCT03642132|469227168|FG001|Follow-up Period|Withdrawal by Subject|2|||
130342732|NCT03642132|469227169|FG002|Follow-up Period|Withdrawal by Subject|0|||
130342733|NCT03642132|469227167|FG000|Follow-up Period|Study terminated by sponsor|1|||
130342734|NCT03642132|469227168|FG001|Follow-up Period|Study terminated by sponsor|0|||
130342735|NCT03642132|469227169|FG002|Follow-up Period|Study terminated by sponsor|1|||
130342736|NCT03642132|469227167|FG000|Follow-up Period|Lack of Efficacy|1|||
130342737|NCT03642132|469227168|FG001|Follow-up Period|Lack of Efficacy|0|||
130342738|NCT03642132|469227169|FG002|Follow-up Period|Lack of Efficacy|0|||
130342739|NCT03642132|469227167|FG000|Follow-up Period|Death|1|||
130342740|NCT03642132|469227168|FG001|Follow-up Period|Death|0|||
130342741|NCT03642132|469227169|FG002|Follow-up Period|Death|2|||
130342742|NCT03642132|469227167|FG000|Follow-up Period|Adverse Event|1|||
130342743|NCT03642132|469227168|FG001|Follow-up Period|Adverse Event|0|||
130342744|NCT03642132|469227169|FG002|Follow-up Period|Adverse Event|0|||
130342745|NCT03337490|469227170|FG000|Overall Study|Withdrawal by Subject|1|||
130342746|NCT03337490|469227171|FG001|Overall Study|Withdrawal by Subject|0|||
130342747|NCT03337490|469227172|FG002|Overall Study|Withdrawal by Subject|0|||
130342748|NCT03337490|469227170|FG000|Overall Study|Lack of Efficacy|10|||
130342749|NCT03337490|469227171|FG001|Overall Study|Lack of Efficacy|12|||
130342750|NCT03337490|469227172|FG002|Overall Study|Lack of Efficacy|35|||
130342751|NCT03337490|469227170|FG000|Overall Study|Physician Decision|0|||
130342752|NCT03337490|469227171|FG001|Overall Study|Physician Decision|1|||
130342753|NCT03337490|469227172|FG002|Overall Study|Physician Decision|0|||
130342754|NCT03337490|469227170|FG000|Overall Study|Lost to Follow-up|0|||
130342755|NCT03337490|469227171|FG001|Overall Study|Lost to Follow-up|1|||
130342756|NCT03337490|469227172|FG002|Overall Study|Lost to Follow-up|0|||
130342757|NCT01541397|469227173|FG000|Overall Study|Study ended prior to data collection|4|||
130342758|NCT01541397|469227174|FG001|Overall Study|Study ended prior to data collection|2|||
130342759|NCT02577887|469227175|FG000|Overall Study|Death|93|||
130342760|NCT02577887|469227175|FG000|Overall Study|Protocol Violation|125|||
130342761|NCT02577887|469227175|FG000|Overall Study|Withdrawal by Subject|80|||
130342762|NCT03560518|469227176|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
130342763|NCT03560518|469227177|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
130342764|NCT03560518|469227178|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
130342765|NCT03560518|469227176|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
130342766|NCT03560518|469227177|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
130342767|NCT03560518|469227178|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
130342768|NCT03560518|469227176|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130342769|NCT03560518|469227177|FG001|Double Blind Treatment Period|Protocol Violation|2|||
130342770|NCT03560518|469227178|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130342771|NCT03560518|469227176|FG000|Double Blind Treatment Period|Pregnancy|0|||
130342772|NCT03560518|469227177|FG001|Double Blind Treatment Period|Pregnancy|2|||
130342773|NCT03560518|469227178|FG002|Double Blind Treatment Period|Pregnancy|0|||
130342774|NCT03560518|469227176|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
130342775|NCT03560518|469227177|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
130342776|NCT03560518|469227178|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
130342777|NCT03560518|469227176|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
130342778|NCT03560518|469227177|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
130342779|NCT03560518|469227178|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
130342780|NCT03560518|469227176|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
130342781|NCT03560518|469227177|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
130342782|NCT03560518|469227178|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
130342783|NCT03560518|469227176|FG000|Double Blind Treatment Period|Adverse Event|0|||
130342784|NCT03560518|469227177|FG001|Double Blind Treatment Period|Adverse Event|3|||
130342785|NCT03560518|469227178|FG002|Double Blind Treatment Period|Adverse Event|1|||
130342786|NCT01689532|469227179|FG000|Overall Study|Adverse Event|9|||
130342787|NCT01689532|469227180|FG001|Overall Study|Adverse Event|5|||
130342788|NCT01689532|469227179|FG000|Overall Study|Lack of Efficacy|2|||
130342789|NCT01689532|469227180|FG001|Overall Study|Lack of Efficacy|2|||
130342790|NCT01689532|469227179|FG000|Overall Study|Withdrawal by Subject|1|||
130342791|NCT01689532|469227180|FG001|Overall Study|Withdrawal by Subject|2|||
130342792|NCT01689532|469227179|FG000|Overall Study|Physician Decision|2|||
130342793|NCT01689532|469227180|FG001|Overall Study|Physician Decision|0|||
130342794|NCT01363349|469227181|FG000|Overall Study|Adverse Event|6|||
130342795|NCT01363349|469227182|FG001|Overall Study|Adverse Event|7|||
130342796|NCT01363349|469227181|FG000|Overall Study|Lack of Efficacy|3|||
130342797|NCT01363349|469227182|FG001|Overall Study|Lack of Efficacy|10|||
130342798|NCT01363349|469227181|FG000|Overall Study|Non compliance/Protocol deviations|2|||
130342799|NCT01363349|469227182|FG001|Overall Study|Non compliance/Protocol deviations|2|||
130342800|NCT01363349|469227181|FG000|Overall Study|Withdrawal by Subject|14|||
130342801|NCT01363349|469227182|FG001|Overall Study|Withdrawal by Subject|6|||
130342802|NCT01363349|469227181|FG000|Overall Study|Lost to Follow-up|5|||
130342803|NCT01363349|469227182|FG001|Overall Study|Lost to Follow-up|6|||
130342804|NCT01363349|469227181|FG000|Overall Study|Not reported|36|||
130342805|NCT01363349|469227182|FG001|Overall Study|Not reported|37|||
130342806|NCT01363349|469227181|FG000|Overall Study|missing|1|||
130342807|NCT01363349|469227182|FG001|Overall Study|missing|2|||
130342808|NCT01958489|469227183|FG000|Period 2|Adverse Event|0|||
130342809|NCT01958489|469227184|FG001|Period 2|Adverse Event|1|||
130342810|NCT03595618|469227185|FG000|Overall Study|Adverse Event|16|||
130342811|NCT03595618|469227186|FG001|Overall Study|Adverse Event|17|||
130342812|NCT03595618|469227187|FG002|Overall Study|Adverse Event|20|||
130342813|NCT03595618|469227188|FG003|Overall Study|Adverse Event|8|||
130342814|NCT03595618|469227185|FG000|Overall Study|Withdrawal by Subject|12|||
130342815|NCT03595618|469227186|FG001|Overall Study|Withdrawal by Subject|14|||
130342816|NCT03595618|469227187|FG002|Overall Study|Withdrawal by Subject|14|||
130342817|NCT03595618|469227188|FG003|Overall Study|Withdrawal by Subject|10|||
130342818|NCT03595618|469227185|FG000|Overall Study|Lost to Follow-up|6|||
130342819|NCT03595618|469227186|FG001|Overall Study|Lost to Follow-up|4|||
130342820|NCT03595618|469227187|FG002|Overall Study|Lost to Follow-up|5|||
130342821|NCT03595618|469227188|FG003|Overall Study|Lost to Follow-up|6|||
130342822|NCT03595618|469227185|FG000|Overall Study|Protocol Violation|2|||
130342823|NCT03595618|469227186|FG001|Overall Study|Protocol Violation|0|||
130342824|NCT03595618|469227187|FG002|Overall Study|Protocol Violation|6|||
130342825|NCT03595618|469227188|FG003|Overall Study|Protocol Violation|2|||
130342826|NCT03595618|469227185|FG000|Overall Study|Physician Decision|0|||
130342827|NCT03595618|469227186|FG001|Overall Study|Physician Decision|0|||
130342828|NCT03595618|469227187|FG002|Overall Study|Physician Decision|1|||
130342829|NCT03595618|469227188|FG003|Overall Study|Physician Decision|2|||
130342830|NCT03595618|469227185|FG000|Overall Study|Miscellaneous|7|||
130342831|NCT03595618|469227186|FG001|Overall Study|Miscellaneous|5|||
130342832|NCT03595618|469227187|FG002|Overall Study|Miscellaneous|10|||
130342833|NCT03595618|469227188|FG003|Overall Study|Miscellaneous|6|||
130342834|NCT02338232|469227189|FG000|Overall Study|Screen Failure|3|||
130342835|NCT02338232|469227189|FG000|Overall Study|Withdrawal by Subject|6|||
130342836|NCT02338232|469227189|FG000|Overall Study|Adverse Event|2|||
130342837|NCT02279407|469227190|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
130342838|NCT02279407|469227191|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
130342839|NCT02279407|469227192|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
130342840|NCT02279407|469227193|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
130342841|NCT02279407|469227190|FG000|Overall Study|Withdrawal by Subject|1|||
130342842|NCT02279407|469227191|FG001|Overall Study|Withdrawal by Subject|0|||
130342843|NCT02279407|469227192|FG002|Overall Study|Withdrawal by Subject|1|||
130342844|NCT02279407|469227193|FG003|Overall Study|Withdrawal by Subject|1|||
130342845|NCT02279407|469227190|FG000|Overall Study|Adverse Event|1|||
130342846|NCT02279407|469227191|FG001|Overall Study|Adverse Event|1|||
130342847|NCT02279407|469227192|FG002|Overall Study|Adverse Event|2|||
130342848|NCT02279407|469227193|FG003|Overall Study|Adverse Event|0|||
130342849|NCT02500056|469227194|FG000|Overall Study|Lost to Follow-up|3|||
130342850|NCT02500056|469227195|FG001|Overall Study|Lost to Follow-up|7|||
130342851|NCT02500056|469227194|FG000|Overall Study|Recurrence|1|||
130342852|NCT02500056|469227195|FG001|Overall Study|Recurrence|0|||
130342853|NCT02500056|469227194|FG000|Overall Study|Death|3|||
130342854|NCT02500056|469227195|FG001|Overall Study|Death|1|||
130342855|NCT00864916|469227196|FG000|Overall Study|Lost to Follow-up|4|||
130342856|NCT00864916|469227197|FG001|Overall Study|Lost to Follow-up|4|||
130342857|NCT00864916|469227196|FG000|Overall Study|Protocol Violation|1|||
130342858|NCT00864916|469227197|FG001|Overall Study|Protocol Violation|0|||
130342859|NCT00864916|469227196|FG000|Overall Study|Withdrawal by Subject|1|||
130342860|NCT00864916|469227197|FG001|Overall Study|Withdrawal by Subject|0|||
130342861|NCT03996369|469227198|FG000|Overall Study|Protocol deviation|1|||
130342862|NCT03996369|469227199|FG001|Overall Study|Protocol deviation|1|||
130342863|NCT03996369|469227198|FG000|Overall Study|Physician Decision|4|||
130342864|NCT03996369|469227199|FG001|Overall Study|Physician Decision|2|||
130342865|NCT03996369|469227198|FG000|Overall Study|Participant decision|0|||
130342866|NCT03996369|469227199|FG001|Overall Study|Participant decision|1|||
130342867|NCT03996369|469227198|FG000|Overall Study|Lack of Efficacy|4|||
130342868|NCT03996369|469227199|FG001|Overall Study|Lack of Efficacy|0|||
130342869|NCT03996369|469227198|FG000|Overall Study|Adverse Event|9|||
130342870|NCT03996369|469227199|FG001|Overall Study|Adverse Event|0|||
130342871|NCT03996369|469227198|FG000|Overall Study|Withdrawal by Subject|6|||
130342872|NCT03996369|469227199|FG001|Overall Study|Withdrawal by Subject|8|||
130342873|NCT03996369|469227198|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
130342874|NCT03996369|469227199|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
130342875|NCT03996369|469227198|FG000|Overall Study|Lost to Follow-up|0|||
130342876|NCT03996369|469227199|FG001|Overall Study|Lost to Follow-up|1|||
130342877|NCT01185301|469227203|FG000|Overall Study|Adverse Event|3|||
130342878|NCT01185301|469227204|FG001|Overall Study|Adverse Event|0|||
130342879|NCT01185301|469227205|FG002|Overall Study|Adverse Event|2|||
130342880|NCT01185301|469227206|FG003|Overall Study|Adverse Event|3|||
130342881|NCT01185301|469227203|FG000|Overall Study|Withdrawal by Subject|7|||
130342882|NCT01185301|469227204|FG001|Overall Study|Withdrawal by Subject|5|||
130342883|NCT01185301|469227205|FG002|Overall Study|Withdrawal by Subject|2|||
130342884|NCT01185301|469227206|FG003|Overall Study|Withdrawal by Subject|3|||
130342885|NCT01185301|469227203|FG000|Overall Study|Lost to Follow-up|2|||
130342886|NCT01185301|469227204|FG001|Overall Study|Lost to Follow-up|0|||
130342887|NCT01185301|469227205|FG002|Overall Study|Lost to Follow-up|0|||
130342888|NCT01185301|469227206|FG003|Overall Study|Lost to Follow-up|1|||
130342889|NCT01185301|469227203|FG000|Overall Study|Other Reason|3|||
130342890|NCT01185301|469227204|FG001|Overall Study|Other Reason|2|||
130342891|NCT01185301|469227205|FG002|Overall Study|Other Reason|2|||
130342892|NCT01185301|469227206|FG003|Overall Study|Other Reason|2|||
130342893|NCT02683746|469227207|FG000|Overall Study|Adverse Event|3|||
130342894|NCT02683746|469227208|FG001|Overall Study|Adverse Event|2|||
130342895|NCT02683746|469227207|FG000|Overall Study|Lost to Follow-up|5|||
130342896|NCT02683746|469227208|FG001|Overall Study|Lost to Follow-up|6|||
130342897|NCT02683746|469227207|FG000|Overall Study|Withdrawal by Subject|6|||
130342898|NCT02683746|469227208|FG001|Overall Study|Withdrawal by Subject|5|||
130342899|NCT02683746|469227207|FG000|Overall Study|Physician Decision|2|||
130342900|NCT02683746|469227208|FG001|Overall Study|Physician Decision|1|||
130342901|NCT04987944|469227209|FG000|Overall Study|Adverse Event|0|||
130342902|NCT04987944|469227210|FG001|Overall Study|Adverse Event|1|||
130342903|NCT04987944|469227209|FG000|Overall Study|Withdrawal by Subject|0|||
130342904|NCT04987944|469227210|FG001|Overall Study|Withdrawal by Subject|1|||
130342905|NCT03077087|469227217|FG000|Overall Study|Physician Decision|2|||
130342906|NCT01989468|469227218|FG000|Overall Study|Adverse Event|10|||
130342907|NCT01989468|469227219|FG001|Overall Study|Adverse Event|15|||
130342908|NCT01989468|469227220|FG002|Overall Study|Adverse Event|4|||
130342909|NCT01989468|469227221|FG003|Overall Study|Adverse Event|5|||
130342910|NCT01989468|469227222|FG004|Overall Study|Adverse Event|4|||
130342911|NCT01989468|469227218|FG000|Overall Study|Lack of Efficacy|11|||
130342912|NCT01989468|469227219|FG001|Overall Study|Lack of Efficacy|11|||
130342913|NCT01989468|469227220|FG002|Overall Study|Lack of Efficacy|7|||
130342914|NCT01989468|469227221|FG003|Overall Study|Lack of Efficacy|4|||
130342915|NCT01989468|469227222|FG004|Overall Study|Lack of Efficacy|2|||
130342916|NCT01989468|469227218|FG000|Overall Study|Lost to Follow-up|5|||
130342917|NCT01989468|469227219|FG001|Overall Study|Lost to Follow-up|2|||
130342918|NCT01989468|469227220|FG002|Overall Study|Lost to Follow-up|0|||
130342919|NCT01989468|469227221|FG003|Overall Study|Lost to Follow-up|1|||
130342920|NCT01989468|469227222|FG004|Overall Study|Lost to Follow-up|1|||
130342921|NCT01989468|469227218|FG000|Overall Study|Physician Decision|4|||
130342922|NCT01989468|469227219|FG001|Overall Study|Physician Decision|1|||
130342923|NCT01989468|469227220|FG002|Overall Study|Physician Decision|0|||
130342924|NCT01989468|469227221|FG003|Overall Study|Physician Decision|1|||
130342925|NCT01989468|469227222|FG004|Overall Study|Physician Decision|0|||
130342926|NCT01989468|469227218|FG000|Overall Study|Pregnancy|0|||
130342927|NCT01989468|469227219|FG001|Overall Study|Pregnancy|1|||
130342928|NCT01989468|469227220|FG002|Overall Study|Pregnancy|0|||
130342929|NCT01989468|469227221|FG003|Overall Study|Pregnancy|0|||
130342930|NCT01989468|469227222|FG004|Overall Study|Pregnancy|0|||
130342931|NCT01989468|469227218|FG000|Overall Study|Technical Problems|3|||
130342932|NCT01989468|469227219|FG001|Overall Study|Technical Problems|1|||
130342933|NCT01989468|469227220|FG002|Overall Study|Technical Problems|3|||
130342934|NCT01989468|469227221|FG003|Overall Study|Technical Problems|1|||
130342935|NCT01989468|469227222|FG004|Overall Study|Technical Problems|0|||
130342936|NCT01989468|469227218|FG000|Overall Study|Subject Guardian Decision|11|||
130342937|NCT01989468|469227219|FG001|Overall Study|Subject Guardian Decision|6|||
130342938|NCT01989468|469227220|FG002|Overall Study|Subject Guardian Decision|4|||
130342939|NCT01989468|469227221|FG003|Overall Study|Subject Guardian Decision|4|||
130342940|NCT01989468|469227222|FG004|Overall Study|Subject Guardian Decision|1|||
130342941|NCT01989468|469227218|FG000|Overall Study|Death|3|||
130342942|NCT01989468|469227219|FG001|Overall Study|Death|0|||
130342943|NCT01989468|469227220|FG002|Overall Study|Death|1|||
130342944|NCT01989468|469227221|FG003|Overall Study|Death|0|||
130342945|NCT01989468|469227222|FG004|Overall Study|Death|0|||
130342946|NCT02112045|469227230|FG000|Overall Study|Withdrawal by Subject|1|||
130342947|NCT02112045|469227231|FG001|Overall Study|Withdrawal by Subject|0|||
130342948|NCT00977080|469227232|FG000|Overall Study|Adverse Event|2|||
130342949|NCT00977080|469227233|FG001|Overall Study|Adverse Event|7|||
130342950|NCT00977080|469227234|FG002|Overall Study|Adverse Event|7|||
130342951|NCT00977080|469227235|FG003|Overall Study|Adverse Event|7|||
130342952|NCT00977080|469227232|FG000|Overall Study|Withdrawal by Subject|1|||
130342953|NCT00977080|469227233|FG001|Overall Study|Withdrawal by Subject|5|||
130342954|NCT00977080|469227234|FG002|Overall Study|Withdrawal by Subject|1|||
130342955|NCT00977080|469227235|FG003|Overall Study|Withdrawal by Subject|5|||
130342956|NCT00977080|469227232|FG000|Overall Study|Protocol Violation|7|||
130342957|NCT00977080|469227233|FG001|Overall Study|Protocol Violation|3|||
130342958|NCT00977080|469227234|FG002|Overall Study|Protocol Violation|4|||
130342959|NCT00977080|469227235|FG003|Overall Study|Protocol Violation|3|||
130342960|NCT00977080|469227232|FG000|Overall Study|Noncompliance|0|||
130342961|NCT00977080|469227233|FG001|Overall Study|Noncompliance|2|||
130342962|NCT00977080|469227234|FG002|Overall Study|Noncompliance|1|||
130342963|NCT00977080|469227235|FG003|Overall Study|Noncompliance|0|||
130342964|NCT00977080|469227232|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130342965|NCT00977080|469227233|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130342966|NCT00977080|469227234|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
130342967|NCT00977080|469227235|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
130342968|NCT00977080|469227232|FG000|Overall Study|Required kidney transplantation|1|||
130342969|NCT00977080|469227233|FG001|Overall Study|Required kidney transplantation|3|||
130342970|NCT00977080|469227234|FG002|Overall Study|Required kidney transplantation|3|||
130342971|NCT00977080|469227235|FG003|Overall Study|Required kidney transplantation|1|||
130342972|NCT00977080|469227232|FG000|Overall Study|Travel for family reasons|1|||
130342973|NCT00977080|469227233|FG001|Overall Study|Travel for family reasons|0|||
130342974|NCT00977080|469227234|FG002|Overall Study|Travel for family reasons|0|||
130342975|NCT00977080|469227235|FG003|Overall Study|Travel for family reasons|0|||
130342976|NCT00441116|469227238|FG000|Overall Study|Adverse Event|1|||
130342977|NCT00441116|469227239|FG001|Overall Study|Adverse Event|1|||
130342978|NCT00441116|469227238|FG000|Overall Study|Withdrawal by Subject|1|||
130342979|NCT00441116|469227239|FG001|Overall Study|Withdrawal by Subject|0|||
130342980|NCT00441116|469227238|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
130342981|NCT00441116|469227239|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
130342982|NCT02509117|469227243|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342983|NCT02509117|469227244|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
130342984|NCT02509117|469227245|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342985|NCT02509117|469227246|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342986|NCT02509117|469227247|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342987|NCT02509117|469227248|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342988|NCT02509117|469227249|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342989|NCT02509117|469227250|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342990|NCT02509117|469227251|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342991|NCT02509117|469227252|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
130342992|NCT02509117|469227243|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342993|NCT02509117|469227244|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342994|NCT02509117|469227245|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342995|NCT02509117|469227246|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342996|NCT02509117|469227247|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342997|NCT02509117|469227248|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342998|NCT02509117|469227249|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130342999|NCT02509117|469227250|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130343000|NCT02509117|469227251|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
130343001|NCT02509117|469227252|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
130343002|NCT02509117|469227243|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343003|NCT02509117|469227244|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343004|NCT02509117|469227245|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343005|NCT02509117|469227246|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343006|NCT02509117|469227247|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343007|NCT02509117|469227248|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343008|NCT02509117|469227249|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343009|NCT02509117|469227250|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343010|NCT02509117|469227251|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
130343011|NCT02509117|469227252|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
130343012|NCT00548184|469227255|FG000|Overall Study|Adverse Event|3|||
130343013|NCT00548184|469227255|FG000|Overall Study|took other drug|1|||
130343014|NCT00548184|469227255|FG000|Overall Study|Found Her2 negative|1|||
130343015|NCT01765218|469227264|FG000|Overall Study|Protocol Violation|1|||
130343016|NCT01765218|469227265|FG001|Overall Study|Protocol Violation|2|||
130343017|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
130343018|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
130343019|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
130343020|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
130343021|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
130343022|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
130343023|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
130343024|NCT00946985|469227266|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
130343025|NCT00946985|469227266|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
130343026|NCT03148691|469227267|FG000|Overall Study|Protocol Violation|1|||
130343027|NCT03148691|469227268|FG001|Overall Study|Protocol Violation|2|||
130343028|NCT03148691|469227269|FG002|Overall Study|Protocol Violation|7|||
130343029|NCT03148691|469227267|FG000|Overall Study|Lost to Follow-up|0|||
130343030|NCT03148691|469227268|FG001|Overall Study|Lost to Follow-up|0|||
130343031|NCT03148691|469227269|FG002|Overall Study|Lost to Follow-up|1|||
130343032|NCT03148691|469227267|FG000|Overall Study|Other|1|||
130343033|NCT03148691|469227268|FG001|Overall Study|Other|0|||
130343034|NCT03148691|469227269|FG002|Overall Study|Other|0|||
130343035|NCT03148691|469227267|FG000|Overall Study|Withdrawal by Subject|1|||
130343036|NCT03148691|469227268|FG001|Overall Study|Withdrawal by Subject|0|||
130343037|NCT03148691|469227269|FG002|Overall Study|Withdrawal by Subject|0|||
130343038|NCT00171834|469227270|FG000|Overall Study|Adverse Event|2|||
130343039|NCT00171834|469227271|FG001|Overall Study|Adverse Event|1|||
130343040|NCT00171834|469227272|FG002|Overall Study|Adverse Event|3|||
130343041|NCT00171834|469227273|FG003|Overall Study|Adverse Event|2|||
130343042|NCT00171834|469227274|FG004|Overall Study|Adverse Event|2|||
130343043|NCT00171834|469227275|FG005|Overall Study|Adverse Event|15|||
130343044|NCT00171834|469227276|FG006|Overall Study|Adverse Event|1|||
130343045|NCT00171834|469227270|FG000|Overall Study|Withdrawal by Subject|0|||
130343046|NCT00171834|469227271|FG001|Overall Study|Withdrawal by Subject|2|||
130343047|NCT00171834|469227272|FG002|Overall Study|Withdrawal by Subject|0|||
130343048|NCT00171834|469227273|FG003|Overall Study|Withdrawal by Subject|1|||
130343049|NCT00171834|469227274|FG004|Overall Study|Withdrawal by Subject|1|||
130343050|NCT00171834|469227275|FG005|Overall Study|Withdrawal by Subject|1|||
130343051|NCT00171834|469227276|FG006|Overall Study|Withdrawal by Subject|0|||
130343052|NCT00171834|469227270|FG000|Overall Study|Death from study indication|0|||
130343053|NCT00171834|469227271|FG001|Overall Study|Death from study indication|1|||
130343054|NCT00171834|469227272|FG002|Overall Study|Death from study indication|0|||
130343055|NCT00171834|469227273|FG003|Overall Study|Death from study indication|0|||
130343056|NCT00171834|469227274|FG004|Overall Study|Death from study indication|1|||
130343057|NCT00171834|469227275|FG005|Overall Study|Death from study indication|0|||
130343058|NCT00171834|469227276|FG006|Overall Study|Death from study indication|0|||
130343059|NCT00171834|469227270|FG000|Overall Study|Disease Progression|4|||
130343060|NCT00171834|469227271|FG001|Overall Study|Disease Progression|8|||
130343061|NCT00171834|469227272|FG002|Overall Study|Disease Progression|8|||
130343062|NCT00171834|469227273|FG003|Overall Study|Disease Progression|9|||
130343063|NCT00171834|469227274|FG004|Overall Study|Disease Progression|2|||
130343064|NCT00171834|469227275|FG005|Overall Study|Disease Progression|18|||
130343065|NCT00171834|469227276|FG006|Overall Study|Disease Progression|3|||
130343066|NCT00171834|469227270|FG000|Overall Study|Treatment Duration Completed|0|||
130343067|NCT00171834|469227271|FG001|Overall Study|Treatment Duration Completed|0|||
130343068|NCT00171834|469227272|FG002|Overall Study|Treatment Duration Completed|1|||
130343069|NCT00171834|469227273|FG003|Overall Study|Treatment Duration Completed|0|||
130343070|NCT00171834|469227274|FG004|Overall Study|Treatment Duration Completed|2|||
130343071|NCT00171834|469227275|FG005|Overall Study|Treatment Duration Completed|1|||
130343072|NCT00171834|469227276|FG006|Overall Study|Treatment Duration Completed|0|||
130343073|NCT04345367|469227277|FG000|Overall Study|Other|3|||
130343074|NCT04345367|469227278|FG001|Overall Study|Other|4|||
130343075|NCT04345367|469227277|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
130343076|NCT04345367|469227278|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
130343077|NCT04345367|469227277|FG000|Overall Study|Withdrawal by Subject|11|||
130343078|NCT04345367|469227278|FG001|Overall Study|Withdrawal by Subject|11|||
130343079|NCT04345367|469227277|FG000|Overall Study|Protocol Violation|4|||
130343080|NCT04345367|469227278|FG001|Overall Study|Protocol Violation|3|||
130343081|NCT04345367|469227277|FG000|Overall Study|Lost to Follow-up|2|||
130343082|NCT04345367|469227278|FG001|Overall Study|Lost to Follow-up|4|||
130343083|NCT04345367|469227277|FG000|Overall Study|Lack of Efficacy|2|||
130343084|NCT04345367|469227278|FG001|Overall Study|Lack of Efficacy|0|||
130343085|NCT04345367|469227277|FG000|Overall Study|Death|2|||
130343086|NCT04345367|469227278|FG001|Overall Study|Death|0|||
130343087|NCT04345367|469227277|FG000|Overall Study|Adverse Event|10|||
130343088|NCT04345367|469227278|FG001|Overall Study|Adverse Event|9|||
130343089|NCT00796523|469227279|FG000|Overall Study|Lost to Follow-up|9|||
130343090|NCT00796523|469227280|FG001|Overall Study|Lost to Follow-up|7|||
130343091|NCT02431260|469227282|FG000|Overall Study|Subject Decision|0|||
130343092|NCT02431260|469227283|FG001|Overall Study|Subject Decision|1|||
130343093|NCT02431260|469227284|FG002|Overall Study|Subject Decision|1|||
130343094|NCT02431260|469227285|FG003|Overall Study|Subject Decision|0|||
130343095|NCT02431260|469227286|FG004|Overall Study|Subject Decision|0|||
130343096|NCT02431260|469227287|FG005|Overall Study|Subject Decision|0|||
130343097|NCT02431260|469227288|FG006|Overall Study|Subject Decision|0|||
130343098|NCT02431260|469227289|FG007|Overall Study|Subject Decision|0|||
130343099|NCT02431260|469227290|FG008|Overall Study|Subject Decision|1|||
130343100|NCT02431260|469227291|FG009|Overall Study|Subject Decision|1|||
130343101|NCT02431260|469227292|FG010|Overall Study|Subject Decision|0|||
130343102|NCT02431260|469227293|FG011|Overall Study|Subject Decision|1|||
130343103|NCT02431260|469227294|FG012|Overall Study|Subject Decision|0|||
130343104|NCT02431260|469227295|FG013|Overall Study|Subject Decision|0|||
130343105|NCT02431260|469227282|FG000|Overall Study|Death|4|||
130343106|NCT02431260|469227283|FG001|Overall Study|Death|4|||
130343107|NCT02431260|469227284|FG002|Overall Study|Death|3|||
130343108|NCT02431260|469227285|FG003|Overall Study|Death|4|||
130343109|NCT02431260|469227286|FG004|Overall Study|Death|2|||
130343110|NCT02431260|469227287|FG005|Overall Study|Death|2|||
130343111|NCT02431260|469227288|FG006|Overall Study|Death|3|||
130343112|NCT02431260|469227289|FG007|Overall Study|Death|1|||
130343113|NCT02431260|469227290|FG008|Overall Study|Death|6|||
130343114|NCT02431260|469227291|FG009|Overall Study|Death|6|||
130343115|NCT02431260|469227292|FG010|Overall Study|Death|3|||
130343116|NCT02431260|469227293|FG011|Overall Study|Death|2|||
130343117|NCT02431260|469227294|FG012|Overall Study|Death|5|||
130343118|NCT02431260|469227295|FG013|Overall Study|Death|1|||
130343119|NCT02431260|469227282|FG000|Overall Study|Lost to Follow-up|0|||
130343120|NCT02431260|469227283|FG001|Overall Study|Lost to Follow-up|0|||
130343121|NCT02431260|469227284|FG002|Overall Study|Lost to Follow-up|0|||
130343122|NCT02431260|469227285|FG003|Overall Study|Lost to Follow-up|0|||
130343123|NCT02431260|469227286|FG004|Overall Study|Lost to Follow-up|0|||
130343124|NCT02431260|469227287|FG005|Overall Study|Lost to Follow-up|1|||
130343125|NCT02431260|469227288|FG006|Overall Study|Lost to Follow-up|0|||
130343126|NCT02431260|469227289|FG007|Overall Study|Lost to Follow-up|0|||
130343127|NCT02431260|469227290|FG008|Overall Study|Lost to Follow-up|0|||
130343128|NCT02431260|469227291|FG009|Overall Study|Lost to Follow-up|0|||
130343129|NCT02431260|469227292|FG010|Overall Study|Lost to Follow-up|0|||
130343130|NCT02431260|469227293|FG011|Overall Study|Lost to Follow-up|0|||
130343131|NCT02431260|469227294|FG012|Overall Study|Lost to Follow-up|0|||
130343132|NCT02431260|469227295|FG013|Overall Study|Lost to Follow-up|0|||
130343133|NCT02431260|469227282|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130343134|NCT02431260|469227283|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130343135|NCT02431260|469227284|FG002|Overall Study|Study Terminated by the Sponsor|2|||
130343136|NCT02431260|469227285|FG003|Overall Study|Study Terminated by the Sponsor|1|||
130343137|NCT02431260|469227286|FG004|Overall Study|Study Terminated by the Sponsor|1|||
130343138|NCT02431260|469227287|FG005|Overall Study|Study Terminated by the Sponsor|0|||
130343139|NCT02431260|469227288|FG006|Overall Study|Study Terminated by the Sponsor|1|||
130343140|NCT02431260|469227289|FG007|Overall Study|Study Terminated by the Sponsor|2|||
130343141|NCT02431260|469227290|FG008|Overall Study|Study Terminated by the Sponsor|1|||
130343142|NCT02431260|469227291|FG009|Overall Study|Study Terminated by the Sponsor|1|||
130343143|NCT02431260|469227292|FG010|Overall Study|Study Terminated by the Sponsor|1|||
130343144|NCT02431260|469227293|FG011|Overall Study|Study Terminated by the Sponsor|0|||
130343145|NCT02431260|469227294|FG012|Overall Study|Study Terminated by the Sponsor|4|||
130343146|NCT02431260|469227295|FG013|Overall Study|Study Terminated by the Sponsor|0|||
130343147|NCT02431260|469227282|FG000|Overall Study|Physician Decision|0|||
130343148|NCT02431260|469227283|FG001|Overall Study|Physician Decision|0|||
130343149|NCT02431260|469227284|FG002|Overall Study|Physician Decision|0|||
130343150|NCT02431260|469227285|FG003|Overall Study|Physician Decision|0|||
130343151|NCT02431260|469227286|FG004|Overall Study|Physician Decision|0|||
130343152|NCT02431260|469227287|FG005|Overall Study|Physician Decision|1|||
130343153|NCT02431260|469227288|FG006|Overall Study|Physician Decision|0|||
130343154|NCT02431260|469227289|FG007|Overall Study|Physician Decision|0|||
130343155|NCT02431260|469227290|FG008|Overall Study|Physician Decision|0|||
130343156|NCT02431260|469227291|FG009|Overall Study|Physician Decision|0|||
130343157|NCT02431260|469227292|FG010|Overall Study|Physician Decision|0|||
130343158|NCT02431260|469227293|FG011|Overall Study|Physician Decision|0|||
130343159|NCT02431260|469227294|FG012|Overall Study|Physician Decision|0|||
130343160|NCT02431260|469227295|FG013|Overall Study|Physician Decision|0|||
130343161|NCT02431260|469227282|FG000|Overall Study|Other Unspecified|0|||
130343162|NCT02431260|469227283|FG001|Overall Study|Other Unspecified|0|||
130343163|NCT02431260|469227284|FG002|Overall Study|Other Unspecified|0|||
130343164|NCT02431260|469227285|FG003|Overall Study|Other Unspecified|0|||
130343165|NCT02431260|469227286|FG004|Overall Study|Other Unspecified|0|||
130343166|NCT02431260|469227287|FG005|Overall Study|Other Unspecified|0|||
130343167|NCT02431260|469227288|FG006|Overall Study|Other Unspecified|0|||
130343168|NCT02431260|469227289|FG007|Overall Study|Other Unspecified|0|||
130343169|NCT02431260|469227290|FG008|Overall Study|Other Unspecified|0|||
130343170|NCT02431260|469227291|FG009|Overall Study|Other Unspecified|0|||
130343171|NCT02431260|469227292|FG010|Overall Study|Other Unspecified|0|||
130343172|NCT02431260|469227293|FG011|Overall Study|Other Unspecified|1|||
130343173|NCT02431260|469227294|FG012|Overall Study|Other Unspecified|1|||
130343174|NCT02431260|469227295|FG013|Overall Study|Other Unspecified|0|||
130343175|NCT00439738|469227299|FG000|Overall Study|Withdrawal by Subject|16|||
130343176|NCT00439738|469227300|FG001|Overall Study|Withdrawal by Subject|13|||
130343177|NCT00439738|469227299|FG000|Overall Study|Adverse Event|6|||
130343178|NCT00439738|469227300|FG001|Overall Study|Adverse Event|4|||
130343179|NCT00439738|469227299|FG000|Overall Study|Lost to Follow-up|5|||
130343180|NCT00439738|469227300|FG001|Overall Study|Lost to Follow-up|6|||
130343181|NCT00439738|469227299|FG000|Overall Study|Protocol Violation|6|||
130343182|NCT00439738|469227300|FG001|Overall Study|Protocol Violation|3|||
130343183|NCT00439738|469227299|FG000|Overall Study|Lack of Efficacy|2|||
130343184|NCT00439738|469227300|FG001|Overall Study|Lack of Efficacy|2|||
130343185|NCT00439738|469227299|FG000|Overall Study|Abnormal Lab Values|1|||
130343186|NCT00439738|469227300|FG001|Overall Study|Abnormal Lab Values|0|||
130343187|NCT00978757|469227301|FG000|Overall Study|Physician Decision|1|||
130343188|NCT00978757|469227302|FG001|Overall Study|Physician Decision|3|||
130343189|NCT01700387|469227303|FG000|Overall Study|Withdrawal by Subject|1|||
130343190|NCT01700387|469227304|FG001|Overall Study|Withdrawal by Subject|2|||
130343191|NCT01700387|469227303|FG000|Overall Study|Adverse Event|1|||
130343192|NCT01700387|469227304|FG001|Overall Study|Adverse Event|1|||
130343193|NCT01700387|469227303|FG000|Overall Study|Lost to Follow-up|2|||
130343194|NCT01700387|469227304|FG001|Overall Study|Lost to Follow-up|1|||
130343195|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343196|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343197|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343198|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
130343199|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
130343200|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343201|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343202|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343203|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343204|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
130343205|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343206|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343207|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343208|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343209|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
130343210|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343211|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343212|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343213|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343214|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
130343215|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
130343216|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343217|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343218|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343219|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
130343220|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343221|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343222|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343223|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343224|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
130343225|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343226|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343227|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
130343228|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343229|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
130343230|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343231|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343232|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343233|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343234|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
130343235|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343236|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343237|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343238|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343239|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
130343240|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343241|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343242|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343243|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343244|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
130343245|NCT01185353|469227306|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
130343246|NCT01185353|469227307|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343247|NCT01185353|469227308|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343248|NCT01185353|469227309|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343249|NCT01185353|469227310|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
130343250|NCT01185353|469227311|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343251|NCT01185353|469227312|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343252|NCT01185353|469227313|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343253|NCT01185353|469227314|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343254|NCT01185353|469227315|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
130343255|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343256|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343257|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
130343258|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343259|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343260|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
130343261|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343262|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343263|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343264|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
130343265|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343266|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
130343267|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343268|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
130343269|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343270|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343271|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343272|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343273|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343274|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
130343275|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343276|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343277|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343278|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
130343279|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343280|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343281|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
130343282|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343283|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343284|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
130343285|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343286|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343287|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
130343288|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
130343289|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343290|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
130343291|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
130343292|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343293|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343294|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
130343295|NCT01185353|469227306|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343296|NCT01185353|469227307|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343297|NCT01185353|469227308|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343298|NCT01185353|469227309|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343299|NCT01185353|469227310|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343300|NCT01185353|469227311|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343301|NCT01185353|469227312|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
130343302|NCT01185353|469227313|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343303|NCT01185353|469227314|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343304|NCT01185353|469227315|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
130343305|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343306|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343307|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343308|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343309|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343310|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343311|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
130343312|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
130343313|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
130343314|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
130343315|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343316|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343317|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343318|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343319|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343320|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343321|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
130343322|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
130343323|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
130343324|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
130343325|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343326|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343327|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343328|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343329|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343330|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343331|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
130343332|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
130343333|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
130343334|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
130343335|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343336|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343337|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343338|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343339|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343340|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343341|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343342|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343343|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
130343344|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
130343345|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Death|0|||
130343346|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Death|0|||
130343347|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Death|0|||
130343348|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Death|0|||
130343349|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Death|0|||
130343350|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Death|0|||
130343351|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Death|0|||
130343352|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Death|0|||
130343353|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Death|0|||
130343354|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Death|1|||
130343355|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343356|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343357|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343358|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343359|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343360|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343361|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343362|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343363|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
130343364|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
130343365|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343366|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343367|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343368|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343369|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343370|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343371|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343372|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343373|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
130343374|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
130343375|NCT01185353|469227306|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343376|NCT01185353|469227307|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343377|NCT01185353|469227308|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343378|NCT01185353|469227309|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343379|NCT01185353|469227310|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343380|NCT01185353|469227311|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343381|NCT01185353|469227312|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343382|NCT01185353|469227313|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343383|NCT01185353|469227314|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
130343384|NCT01185353|469227315|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
130343385|NCT01185353|469227306|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343386|NCT01185353|469227307|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343387|NCT01185353|469227308|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343388|NCT01185353|469227309|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343389|NCT01185353|469227310|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343390|NCT01185353|469227311|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343391|NCT01185353|469227312|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343392|NCT01185353|469227313|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
130343393|NCT01185353|469227314|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
130343394|NCT01185353|469227315|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
130343395|NCT01185353|469227306|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343396|NCT01185353|469227307|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343397|NCT01185353|469227308|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343398|NCT01185353|469227309|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343399|NCT01185353|469227310|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343400|NCT01185353|469227311|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343401|NCT01185353|469227312|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
130343402|NCT01185353|469227313|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
130343403|NCT01185353|469227314|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
130343404|NCT01185353|469227315|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
130343405|NCT01185353|469227306|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343406|NCT01185353|469227307|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130216597|NCT05305989|468755616|FG000|Overall Study|Sponsor decision|2|||
130343407|NCT01185353|469227308|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343408|NCT01185353|469227309|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343409|NCT01185353|469227310|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343410|NCT01185353|469227311|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343411|NCT01185353|469227312|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343412|NCT01185353|469227313|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
130343413|NCT01185353|469227314|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
130343414|NCT01185353|469227315|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
130343415|NCT02270944|469227316|FG000|Overall Study|Lost to Follow-up|9|||
130343416|NCT02270944|469227317|FG001|Overall Study|Lost to Follow-up|4|||
130343417|NCT02270944|469227316|FG000|Overall Study|Withdrawal by Subject|2|||
130343418|NCT02270944|469227317|FG001|Overall Study|Withdrawal by Subject|1|||
130343419|NCT01978938|469227318|FG000|Overall Study|Lost to Follow-up|12|||
130343420|NCT01978938|469227319|FG001|Overall Study|Lost to Follow-up|6|||
130343421|NCT01978938|469227318|FG000|Overall Study|Withdrawal by Subject|8|||
130343422|NCT01978938|469227319|FG001|Overall Study|Withdrawal by Subject|4|||
130343423|NCT01978938|469227318|FG000|Overall Study|Adverse Event, non-fatal|2|||
130343424|NCT01978938|469227319|FG001|Overall Study|Adverse Event, non-fatal|1|||
130343425|NCT01978938|469227318|FG000|Overall Study|Participant noncompliance|1|||
130343426|NCT01978938|469227319|FG001|Overall Study|Participant noncompliance|1|||
130343427|NCT01978938|469227318|FG000|Overall Study|Did not meet inclusion criteria|0|||
130343428|NCT01978938|469227319|FG001|Overall Study|Did not meet inclusion criteria|1|||
130343429|NCT01978938|469227318|FG000|Overall Study|Previously scheduled procedure|0|||
130343430|NCT01978938|469227319|FG001|Overall Study|Previously scheduled procedure|1|||
130343431|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
130343432|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
130343433|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
130343434|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
130343435|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
130343436|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
130343437|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
130343438|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
130343439|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
130343440|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
130343441|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
130343442|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
130343443|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
130343444|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
130343445|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
130343446|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
130343447|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
130343448|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130343449|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130343450|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
130343451|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
130343452|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130343453|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
130343454|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130343455|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
130343456|NCT00095147|469227320|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
130343457|NCT00095147|469227321|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
130343458|NCT00095147|469227322|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130343459|NCT00095147|469227323|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130343460|NCT00095147|469227324|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
130343461|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
130343462|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
130343463|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
130343464|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
130343465|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
130343466|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
130343467|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
130343468|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130343469|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130343470|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
130343471|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
130343472|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
130343473|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
130343474|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
130343475|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
130343476|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
130343477|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
130343478|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130343479|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130343480|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
130343481|NCT00095147|469227320|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
130343482|NCT00095147|469227321|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130343483|NCT00095147|469227322|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130343484|NCT00095147|469227323|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
130343485|NCT00095147|469227324|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
130343486|NCT00095147|469227320|FG000|Long-term Extension Period|Death|0|||
130343487|NCT00095147|469227321|FG001|Long-term Extension Period|Death|0|||
130343488|NCT00095147|469227322|FG002|Long-term Extension Period|Death|0|||
130343489|NCT00095147|469227323|FG003|Long-term Extension Period|Death|0|||
130343490|NCT00095147|469227324|FG004|Long-term Extension Period|Death|3|||
130343491|NCT00095147|469227320|FG000|Long-term Extension Period|Adverse Event|0|||
130343492|NCT00095147|469227321|FG001|Long-term Extension Period|Adverse Event|0|||
130343493|NCT00095147|469227322|FG002|Long-term Extension Period|Adverse Event|0|||
130343494|NCT00095147|469227323|FG003|Long-term Extension Period|Adverse Event|0|||
130343495|NCT00095147|469227324|FG004|Long-term Extension Period|Adverse Event|11|||
130343496|NCT00095147|469227320|FG000|Long-term Extension Period|Lack of Efficacy|0|||
130343497|NCT00095147|469227321|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130343498|NCT00095147|469227322|FG002|Long-term Extension Period|Lack of Efficacy|0|||
130343499|NCT00095147|469227323|FG003|Long-term Extension Period|Lack of Efficacy|0|||
130343500|NCT00095147|469227324|FG004|Long-term Extension Period|Lack of Efficacy|9|||
129884402|NCT02771210|467536387|FG000|Period 1|Lack of Efficacy|3|||
130343501|NCT00095147|469227320|FG000|Long-term Extension Period|Lost to Follow-up|0|||
130343502|NCT00095147|469227321|FG001|Long-term Extension Period|Lost to Follow-up|0|||
130343503|NCT00095147|469227322|FG002|Long-term Extension Period|Lost to Follow-up|0|||
130343504|NCT00095147|469227323|FG003|Long-term Extension Period|Lost to Follow-up|0|||
130343505|NCT00095147|469227324|FG004|Long-term Extension Period|Lost to Follow-up|6|||
130343506|NCT00095147|469227320|FG000|Long-term Extension Period|Withdrawal of consent|0|||
130343507|NCT00095147|469227321|FG001|Long-term Extension Period|Withdrawal of consent|0|||
130343508|NCT00095147|469227322|FG002|Long-term Extension Period|Withdrawal of consent|0|||
130343509|NCT00095147|469227323|FG003|Long-term Extension Period|Withdrawal of consent|0|||
130343510|NCT00095147|469227324|FG004|Long-term Extension Period|Withdrawal of consent|12|||
130343511|NCT00095147|469227320|FG000|Long-term Extension Period|Pregnancy|0|||
130343512|NCT00095147|469227321|FG001|Long-term Extension Period|Pregnancy|0|||
130343513|NCT00095147|469227322|FG002|Long-term Extension Period|Pregnancy|0|||
130343514|NCT00095147|469227323|FG003|Long-term Extension Period|Pregnancy|0|||
130343515|NCT00095147|469227324|FG004|Long-term Extension Period|Pregnancy|1|||
130343516|NCT00095147|469227320|FG000|Long-term Extension Period|No longer meets study criteria|0|||
130343517|NCT00095147|469227321|FG001|Long-term Extension Period|No longer meets study criteria|0|||
130343518|NCT00095147|469227322|FG002|Long-term Extension Period|No longer meets study criteria|0|||
130343519|NCT00095147|469227323|FG003|Long-term Extension Period|No longer meets study criteria|0|||
130343520|NCT00095147|469227324|FG004|Long-term Extension Period|No longer meets study criteria|1|||
130343521|NCT00095147|469227320|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
130343522|NCT00095147|469227321|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
130343523|NCT00095147|469227322|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
130343524|NCT00095147|469227323|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
130343525|NCT00095147|469227324|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
130343526|NCT00095147|469227320|FG000|Long-term Extension Period|Leaving country|0|||
130343527|NCT00095147|469227321|FG001|Long-term Extension Period|Leaving country|0|||
130343528|NCT00095147|469227322|FG002|Long-term Extension Period|Leaving country|0|||
130343529|NCT00095147|469227323|FG003|Long-term Extension Period|Leaving country|0|||
130343530|NCT00095147|469227324|FG004|Long-term Extension Period|Leaving country|1|||
130343531|NCT03678870|469227328|FG000|Overall Study|prescribed non- protocol medications|10|||
130343532|NCT03678870|469227329|FG001|Overall Study|prescribed non- protocol medications|6|||
130343533|NCT03678870|469227328|FG000|Overall Study|Lost to Follow-up|3|||
130343534|NCT03678870|469227329|FG001|Overall Study|Lost to Follow-up|2|||
130343535|NCT03104816|469227331|FG000|Overall Study|Lack of Efficacy|0|||
130008965|NCT00912028|467995305|FG002|Overall Study|Withdrawal by Subject|0|||
130008966|NCT00912028|467995306|FG003|Overall Study|Withdrawal by Subject|0|||
130008967|NCT00912028|467995307|FG004|Overall Study|Withdrawal by Subject|0|||
130008968|NCT00942175|467995308|FG000|Overall Study|Adverse Event|2|||
130008969|NCT00942175|467995309|FG001|Overall Study|Adverse Event|1|||
130008970|NCT00942175|467995310|FG002|Overall Study|Adverse Event|0|||
130008971|NCT00942175|467995311|FG003|Overall Study|Adverse Event|0|||
130008972|NCT00942175|467995308|FG000|Overall Study|Protocol Violation|0|||
130008973|NCT00942175|467995309|FG001|Overall Study|Protocol Violation|1|||
130008974|NCT00942175|467995310|FG002|Overall Study|Protocol Violation|2|||
130008975|NCT00942175|467995311|FG003|Overall Study|Protocol Violation|0|||
130008976|NCT00942175|467995308|FG000|Overall Study|Pregnancy|0|||
130008977|NCT00942175|467995309|FG001|Overall Study|Pregnancy|0|||
130008978|NCT00942175|467995310|FG002|Overall Study|Pregnancy|0|||
130008979|NCT00942175|467995311|FG003|Overall Study|Pregnancy|1|||
130008980|NCT00942175|467995308|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
130008981|NCT00942175|467995309|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
130008982|NCT00942175|467995310|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
130008983|NCT00942175|467995311|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
130008984|NCT00942175|467995308|FG000|Overall Study|Low Platelet Count|0|||
130008985|NCT00942175|467995309|FG001|Overall Study|Low Platelet Count|2|||
130008986|NCT00942175|467995310|FG002|Overall Study|Low Platelet Count|0|||
130008987|NCT00942175|467995311|FG003|Overall Study|Low Platelet Count|0|||
130008988|NCT02664272|467995312|FG000|Overall Study|Fluoroscopic images not made available|2|||
130008989|NCT03073980|467995313|FG000|Overall Study|Lost to Follow-up|10|||
130008990|NCT03073980|467995314|FG001|Overall Study|Lost to Follow-up|2|||
130008991|NCT03073980|467995315|FG002|Overall Study|Lost to Follow-up|9|||
130008992|NCT03073980|467995313|FG000|Overall Study|No post-procedure data|0|||
130008993|NCT03073980|467995314|FG001|Overall Study|No post-procedure data|0|||
130008994|NCT03073980|467995315|FG002|Overall Study|No post-procedure data|2|||
130008995|NCT00545064|467995316|FG000|Overall Study|Lost to Follow-up|3|||
130008996|NCT00545064|467995316|FG000|Overall Study|Withdrawal by Subject|2|||
130008997|NCT00545064|467995316|FG000|Overall Study|did not complete course of treatment|1|||
130008998|NCT00545064|467995316|FG000|Overall Study|cancel all appointments, no rebooking|1|||
130008999|NCT00545064|467995316|FG000|Overall Study|inclement weather|1|||
130009000|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
130216598|NCT05305989|468755617|FG001|Overall Study|Sponsor decision|1|||
130343536|NCT03104816|469227332|FG001|Overall Study|Lack of Efficacy|2|||
130009001|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
130009002|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
130009003|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
130009004|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
130009005|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
130009006|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130009007|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130009008|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
130009009|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
130009010|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130009011|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130009012|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
130009013|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
130009014|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
130009015|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
130009016|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
130009017|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
130009018|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
130009019|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
130009020|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
130009021|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
130009022|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130009023|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
130009024|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Death|2|||
130009025|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Death|1|||
130009026|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Death|0|||
130009027|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Death|0|||
130009028|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130009029|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130009030|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130009031|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130009032|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
130009033|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
130009034|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
130009035|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
130009036|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130009037|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130009038|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130009039|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130009040|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
130009041|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
130009042|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
130009043|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
130009044|NCT01940471|467995319|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
130009045|NCT01940471|467995320|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
130009046|NCT01940471|467995321|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
130009047|NCT01940471|467995322|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
130009048|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130009049|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130009050|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
130009051|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
130009052|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130009053|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130009054|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
130009055|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
130009056|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130009057|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130009058|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
130009059|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
130009060|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
130009061|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
130009062|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
130009063|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
130009064|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130009065|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130009066|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
130009067|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
130009068|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130009069|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130009070|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
130216599|NCT05305989|468755618|FG002|Overall Study|Sponsor decision|0|||
130009071|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
130009072|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130009073|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130009074|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
130009075|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130009076|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
130009077|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
130009078|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
130009079|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
130009080|NCT01940471|467995319|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130009081|NCT01940471|467995320|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130009082|NCT01940471|467995321|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
130009083|NCT01940471|467995322|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130009084|NCT00258674|467995323|FG000|Overall Study|Death|32|||
130009085|NCT00258674|467995324|FG001|Overall Study|Death|53|||
130009086|NCT00258674|467995325|FG002|Overall Study|Death|34|||
130009087|NCT03715153|467995326|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
130009088|NCT03715153|467995327|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
130009089|NCT03715153|467995326|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
130009090|NCT03715153|467995327|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
130009091|NCT03715153|467995326|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
130009092|NCT03715153|467995327|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
130009093|NCT03715153|467995326|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
130009094|NCT03715153|467995327|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
130009095|NCT03715153|467995326|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
130009096|NCT03715153|467995327|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
130009097|NCT03715153|467995326|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
130009098|NCT03715153|467995327|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
130009099|NCT01358760|467995332|FG000|Overall Study|Adverse Event|3|||
130009100|NCT01358760|467995333|FG001|Overall Study|Adverse Event|4|||
130009101|NCT01358760|467995334|FG002|Overall Study|Adverse Event|3|||
130009102|NCT01358760|467995332|FG000|Overall Study|Lost to Follow-up|1|||
130009103|NCT01358760|467995333|FG001|Overall Study|Lost to Follow-up|1|||
130009104|NCT01358760|467995334|FG002|Overall Study|Lost to Follow-up|3|||
130009105|NCT01358760|467995332|FG000|Overall Study|Withdrawal by Subject|5|||
130009106|NCT01358760|467995333|FG001|Overall Study|Withdrawal by Subject|3|||
130009107|NCT01358760|467995334|FG002|Overall Study|Withdrawal by Subject|2|||
130009108|NCT01358760|467995332|FG000|Overall Study|Physician Decision|1|||
130009109|NCT01358760|467995333|FG001|Overall Study|Physician Decision|0|||
130009110|NCT01358760|467995334|FG002|Overall Study|Physician Decision|1|||
130009111|NCT01358760|467995332|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
130009112|NCT01358760|467995333|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
130009113|NCT01358760|467995334|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
130009114|NCT01506960|467995337|FG000|Overall Study|Did not meet angiographic criteria|47|||
130009115|NCT00450723|467995339|FG000|Overall Study|Physician Decision|5|||
130009116|NCT03574753|467995340|FG000|Overall Study|Adverse Event|3|||
130009117|NCT03574753|467995340|FG000|Overall Study|Progression/relapse|19|||
130009118|NCT03574753|467995340|FG000|Overall Study|Death|1|||
130343537|NCT03104816|469227333|FG002|Overall Study|Lack of Efficacy|0|||
130343538|NCT03104816|469227331|FG000|Overall Study|Protocol Violation|2|||
130343539|NCT03104816|469227332|FG001|Overall Study|Protocol Violation|0|||
130343540|NCT03104816|469227333|FG002|Overall Study|Protocol Violation|2|||
130343541|NCT01227629|469227335|FG000|Overall Study|Adverse Event|2|||
130343542|NCT01227629|469227336|FG001|Overall Study|Adverse Event|2|||
130343543|NCT01227629|469227337|FG002|Overall Study|Adverse Event|1|||
130343544|NCT01227629|469227338|FG003|Overall Study|Adverse Event|6|||
130343545|NCT01227629|469227339|FG004|Overall Study|Adverse Event|1|||
130343546|NCT01227629|469227340|FG005|Overall Study|Adverse Event|1|||
129884403|NCT02771210|467536388|FG001|Period 1|Lack of Efficacy|6|||
130009119|NCT01744665|467995341|FG000|Monitoring Phase|Adverse Event|4|||
130009120|NCT01744665|467995341|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
130009121|NCT01744665|467995341|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
130009122|NCT01744665|467995341|FG000|Monitoring Phase|Withdrawal by Subject|5|||
130009123|NCT01744665|467995341|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
130009124|NCT01744665|467995341|FG000|Consolidation Phase|Adverse Event|2|||
130009125|NCT01744665|467995341|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
130009126|NCT01744665|467995341|FG000|Consolidation Phase|Withdrawal by Subject|4|||
130009127|NCT01744665|467995341|FG000|Consolidation Phase|Administrative problems|9|||
130009128|NCT01744665|467995341|FG000|Re-initiation Phase|Administrative problems|10|||
130009129|NCT01744665|467995341|FG000|Re-initiation Phase|Adverse Event|1|||
130343547|NCT01227629|469227341|FG006|Overall Study|Adverse Event|6|||
130343548|NCT01227629|469227342|FG007|Overall Study|Adverse Event|6|||
130343549|NCT01227629|469227343|FG008|Overall Study|Adverse Event|4|||
130009130|NCT01744665|467995341|FG000|Re-initiation Phase|No longer required treatment|1|||
130009131|NCT01744665|467995341|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
130009132|NCT02044133|467995344|FG000|Overall Study|Lost to Follow-up|1|||
130009133|NCT02044133|467995345|FG001|Overall Study|Lost to Follow-up|1|||
130009134|NCT02044133|467995344|FG000|Overall Study|Death|1|||
130009135|NCT02044133|467995345|FG001|Overall Study|Death|0|||
130009136|NCT02044133|467995344|FG000|Overall Study|Release|3|||
130009137|NCT02044133|467995345|FG001|Overall Study|Release|4|||
130009138|NCT02044133|467995344|FG000|Overall Study|Transfer|1|||
130009139|NCT02044133|467995345|FG001|Overall Study|Transfer|0|||
130009140|NCT02044133|467995344|FG000|Overall Study|refusal of blood sampling|0|||
130009141|NCT02044133|467995345|FG001|Overall Study|refusal of blood sampling|1|||
130009142|NCT00766038|467997272|FG000|Overall Study|Lost to Follow-up|15|||
130009143|NCT00766038|467997273|FG001|Overall Study|Lost to Follow-up|14|||
130009144|NCT00847145|467997278|FG000|Overall Study|AE or Death|0|||
130009145|NCT00847145|467997279|FG001|Overall Study|AE or Death|1|||
130009146|NCT00847145|467997280|FG002|Overall Study|AE or Death|1|||
130009147|NCT00847145|467997281|FG003|Overall Study|AE or Death|0|||
130009148|NCT00847145|467997282|FG004|Overall Study|AE or Death|0|||
130343550|NCT01227629|469227344|FG009|Overall Study|Adverse Event|0|||
130343551|NCT01227629|469227335|FG000|Overall Study|Protocol Violation|0|||
130009149|NCT00847145|467997283|FG005|Overall Study|AE or Death|0|||
130009150|NCT00847145|467997284|FG006|Overall Study|AE or Death|0|||
130009151|NCT00847145|467997285|FG007|Overall Study|AE or Death|0|||
130009152|NCT00847145|467997278|FG000|Overall Study|Withdrawal by Subject|3|||
130009153|NCT00847145|467997279|FG001|Overall Study|Withdrawal by Subject|4|||
130009154|NCT00847145|467997280|FG002|Overall Study|Withdrawal by Subject|6|||
130009155|NCT00847145|467997281|FG003|Overall Study|Withdrawal by Subject|1|||
130009156|NCT00847145|467997282|FG004|Overall Study|Withdrawal by Subject|0|||
130009157|NCT00847145|467997283|FG005|Overall Study|Withdrawal by Subject|0|||
130009158|NCT00847145|467997284|FG006|Overall Study|Withdrawal by Subject|1|||
130009159|NCT00847145|467997285|FG007|Overall Study|Withdrawal by Subject|1|||
130009160|NCT00847145|467997278|FG000|Overall Study|Lost to Follow-up|3|||
130009161|NCT00847145|467997279|FG001|Overall Study|Lost to Follow-up|1|||
130009162|NCT00847145|467997280|FG002|Overall Study|Lost to Follow-up|1|||
130009163|NCT00847145|467997281|FG003|Overall Study|Lost to Follow-up|0|||
130009164|NCT00847145|467997282|FG004|Overall Study|Lost to Follow-up|4|||
130009165|NCT00847145|467997283|FG005|Overall Study|Lost to Follow-up|4|||
130009166|NCT00847145|467997284|FG006|Overall Study|Lost to Follow-up|8|||
130009167|NCT00847145|467997285|FG007|Overall Study|Lost to Follow-up|2|||
130009168|NCT00847145|467997278|FG000|Overall Study|Inappropriate enrollment|0|||
130009169|NCT00847145|467997279|FG001|Overall Study|Inappropriate enrollment|0|||
130009170|NCT00847145|467997280|FG002|Overall Study|Inappropriate enrollment|0|||
130009171|NCT00847145|467997281|FG003|Overall Study|Inappropriate enrollment|0|||
130009172|NCT00847145|467997282|FG004|Overall Study|Inappropriate enrollment|1|||
130009173|NCT00847145|467997283|FG005|Overall Study|Inappropriate enrollment|0|||
130009174|NCT00847145|467997284|FG006|Overall Study|Inappropriate enrollment|0|||
130009175|NCT00847145|467997285|FG007|Overall Study|Inappropriate enrollment|0|||
130009176|NCT00847145|467997278|FG000|Overall Study|Protocol Violation|0|||
130009177|NCT00847145|467997279|FG001|Overall Study|Protocol Violation|0|||
130009178|NCT00847145|467997280|FG002|Overall Study|Protocol Violation|3|||
130009179|NCT00847145|467997281|FG003|Overall Study|Protocol Violation|0|||
130009180|NCT00847145|467997282|FG004|Overall Study|Protocol Violation|1|||
130343552|NCT01227629|469227336|FG001|Overall Study|Protocol Violation|0|||
130343553|NCT01227629|469227337|FG002|Overall Study|Protocol Violation|0|||
130343554|NCT01227629|469227338|FG003|Overall Study|Protocol Violation|1|||
130343555|NCT01227629|469227339|FG004|Overall Study|Protocol Violation|0|||
130343556|NCT01227629|469227340|FG005|Overall Study|Protocol Violation|0|||
130343557|NCT01227629|469227341|FG006|Overall Study|Protocol Violation|0|||
130343558|NCT01227629|469227342|FG007|Overall Study|Protocol Violation|0|||
130343559|NCT01227629|469227343|FG008|Overall Study|Protocol Violation|0|||
130343560|NCT01227629|469227344|FG009|Overall Study|Protocol Violation|0|||
130343561|NCT01227629|469227335|FG000|Overall Study|Lost to Follow-up|0|||
130343562|NCT01227629|469227336|FG001|Overall Study|Lost to Follow-up|0|||
130009181|NCT00847145|467997283|FG005|Overall Study|Protocol Violation|0|||
130009182|NCT00847145|467997284|FG006|Overall Study|Protocol Violation|0|||
130009183|NCT00847145|467997285|FG007|Overall Study|Protocol Violation|1|||
130009184|NCT00307151|467997287|FG000|Overall Study|Death|4|||
130009185|NCT00307151|467997288|FG001|Overall Study|Death|3|||
130009186|NCT00307151|467997289|FG002|Overall Study|Death|10|||
130009187|NCT00307151|467997290|FG003|Overall Study|Death|3|||
130009188|NCT00307151|467997287|FG000|Overall Study|Severe debilitation, unable to continue|1|||
130009189|NCT00307151|467997288|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130009190|NCT00307151|467997289|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130009191|NCT00307151|467997290|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130009192|NCT00307151|467997287|FG000|Overall Study|Subject unable to get to clinic|1|||
130343563|NCT01227629|469227337|FG002|Overall Study|Lost to Follow-up|0|||
130343564|NCT01227629|469227338|FG003|Overall Study|Lost to Follow-up|0|||
130343565|NCT01227629|469227339|FG004|Overall Study|Lost to Follow-up|1|||
130343566|NCT01227629|469227340|FG005|Overall Study|Lost to Follow-up|0|||
130009193|NCT00307151|467997288|FG001|Overall Study|Subject unable to get to clinic|0|||
130009194|NCT00307151|467997289|FG002|Overall Study|Subject unable to get to clinic|6|||
130009195|NCT00307151|467997290|FG003|Overall Study|Subject unable to get to clinic|2|||
130009196|NCT00307151|467997287|FG000|Overall Study|Withdrew consent|0|||
130009197|NCT00307151|467997288|FG001|Overall Study|Withdrew consent|1|||
130009198|NCT00307151|467997289|FG002|Overall Study|Withdrew consent|1|||
130009199|NCT00307151|467997290|FG003|Overall Study|Withdrew consent|3|||
130009200|NCT00307151|467997287|FG000|Overall Study|Not willing to adhere to study reqs|2|||
130009201|NCT00307151|467997288|FG001|Overall Study|Not willing to adhere to study reqs|0|||
130009202|NCT00307151|467997289|FG002|Overall Study|Not willing to adhere to study reqs|2|||
130009203|NCT00307151|467997290|FG003|Overall Study|Not willing to adhere to study reqs|2|||
130009204|NCT00307151|467997287|FG000|Overall Study|Clinic unable to contact subject|3|||
130009205|NCT00307151|467997288|FG001|Overall Study|Clinic unable to contact subject|3|||
130009206|NCT00307151|467997289|FG002|Overall Study|Clinic unable to contact subject|1|||
130009207|NCT00307151|467997290|FG003|Overall Study|Clinic unable to contact subject|1|||
130009208|NCT02966509|467997293|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
130009209|NCT02966509|467997294|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
130009210|NCT02966509|467997293|FG000|Baseline Satisfaction Survey|Death|0|||
130009211|NCT02966509|467997294|FG001|Baseline Satisfaction Survey|Death|1|||
130009212|NCT02966509|467997293|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
130009213|NCT02966509|467997294|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
130009214|NCT02966509|467997293|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
130009215|NCT02966509|467997294|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
130009216|NCT02966509|467997293|FG000|6 Month Satisfaction Decision Survey|Death|22|||
130009217|NCT02966509|467997294|FG001|6 Month Satisfaction Decision Survey|Death|25|||
130009218|NCT02966509|467997293|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
130009219|NCT02966509|467997294|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
130009220|NCT02966509|467997293|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
130009221|NCT02966509|467997294|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
130009222|NCT02966509|467997293|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
130009223|NCT02966509|467997294|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
130009224|NCT02966509|467997293|FG000|6 Month Satisfaction Survey|Death|36|||
130009225|NCT02966509|467997294|FG001|6 Month Satisfaction Survey|Death|33|||
130009226|NCT02966509|467997293|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
130009227|NCT02966509|467997294|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
130009228|NCT02966509|467997293|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
130009229|NCT02966509|467997294|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
130009230|NCT02966509|467997293|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
130009231|NCT02966509|467997294|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
130009232|NCT02966509|467997293|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
130009233|NCT02966509|467997294|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
130009234|NCT02966509|467997293|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
130009235|NCT02966509|467997294|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
130009236|NCT01717287|467997297|FG000|Overall Study|Lost to Follow-up|0|||
130009237|NCT01717287|467997298|FG001|Overall Study|Lost to Follow-up|2|||
130009238|NCT01717287|467997297|FG000|Overall Study|Protocol Violation|0|||
130009239|NCT01717287|467997298|FG001|Overall Study|Protocol Violation|1|||
130009240|NCT00054704|467997305|FG000|Overall Study|Lack of Efficacy|2|||
130009241|NCT00054704|467997306|FG001|Overall Study|Lack of Efficacy|3|||
130009242|NCT00054704|467997305|FG000|Overall Study|Adverse Event|3|||
129884404|NCT02771210|467536387|FG000|Period 1|Lost to Follow-up|2|||
130009243|NCT00054704|467997306|FG001|Overall Study|Adverse Event|1|||
130009244|NCT00054704|467997305|FG000|Overall Study|Lost to Follow-up|0|||
129884405|NCT02771210|467536388|FG001|Period 1|Lost to Follow-up|0|||
130009245|NCT00054704|467997306|FG001|Overall Study|Lost to Follow-up|1|||
130009246|NCT00362414|467997307|FG000|Overall Study|Death|2|||
130009247|NCT00362414|467997307|FG000|Overall Study|Adverse Event|1|||
130009248|NCT01469182|467997310|FG000|Overall Study|Adverse Event|21|||
130009249|NCT01469182|467997311|FG001|Overall Study|Adverse Event|3|||
130009250|NCT01469182|467997310|FG000|Overall Study|Lost to Follow-up|3|||
130009251|NCT01469182|467997311|FG001|Overall Study|Lost to Follow-up|0|||
130009252|NCT01469182|467997310|FG000|Overall Study|Withdrawal by Subject|4|||
130343567|NCT01227629|469227341|FG006|Overall Study|Lost to Follow-up|0|||
130343568|NCT01227629|469227342|FG007|Overall Study|Lost to Follow-up|0|||
130343569|NCT01227629|469227343|FG008|Overall Study|Lost to Follow-up|0|||
130343570|NCT01227629|469227344|FG009|Overall Study|Lost to Follow-up|0|||
130343571|NCT01227629|469227335|FG000|Overall Study|Withdrawal by Subject|0|||
130343572|NCT01227629|469227336|FG001|Overall Study|Withdrawal by Subject|0|||
130343573|NCT01227629|469227337|FG002|Overall Study|Withdrawal by Subject|0|||
130343574|NCT01227629|469227338|FG003|Overall Study|Withdrawal by Subject|0|||
130343575|NCT01227629|469227339|FG004|Overall Study|Withdrawal by Subject|0|||
130343576|NCT01227629|469227340|FG005|Overall Study|Withdrawal by Subject|0|||
130343577|NCT01227629|469227341|FG006|Overall Study|Withdrawal by Subject|2|||
130343578|NCT01227629|469227342|FG007|Overall Study|Withdrawal by Subject|0|||
130343579|NCT01227629|469227343|FG008|Overall Study|Withdrawal by Subject|0|||
130343580|NCT01227629|469227344|FG009|Overall Study|Withdrawal by Subject|1|||
130343581|NCT01227629|469227335|FG000|Overall Study|Other|0|||
130343582|NCT01227629|469227336|FG001|Overall Study|Other|0|||
130343583|NCT01227629|469227337|FG002|Overall Study|Other|0|||
130343584|NCT01227629|469227338|FG003|Overall Study|Other|1|||
130343585|NCT01227629|469227339|FG004|Overall Study|Other|0|||
130343586|NCT01227629|469227340|FG005|Overall Study|Other|0|||
130343587|NCT01227629|469227341|FG006|Overall Study|Other|0|||
130343588|NCT01227629|469227342|FG007|Overall Study|Other|0|||
130343589|NCT01227629|469227343|FG008|Overall Study|Other|2|||
130343590|NCT01227629|469227344|FG009|Overall Study|Other|1|||
130343591|NCT03338959|469229033|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
130343592|NCT03338959|469229033|FG000|Overall Study|Physician Decision|1|||
130343593|NCT01604278|469229034|FG000|Overall Study|Lack of Efficacy|0|||
130343594|NCT01604278|469229035|FG001|Overall Study|Lack of Efficacy|1|||
130343595|NCT01604278|469229034|FG000|Overall Study|Lost to Follow-up|1|||
130343596|NCT01604278|469229035|FG001|Overall Study|Lost to Follow-up|0|||
130343597|NCT01604278|469229034|FG000|Overall Study|Administrative problems|2|||
130343598|NCT01604278|469229035|FG001|Overall Study|Administrative problems|1|||
130343599|NCT01604278|469229034|FG000|Overall Study|Withdrawal by Subject|3|||
130343600|NCT01604278|469229035|FG001|Overall Study|Withdrawal by Subject|3|||
130343601|NCT01604278|469229034|FG000|Overall Study|Adverse Event|3|||
130343602|NCT01604278|469229035|FG001|Overall Study|Adverse Event|5|||
130343603|NCT01604278|469229034|FG000|Overall Study|Protocol Deviation|5|||
130343604|NCT01604278|469229035|FG001|Overall Study|Protocol Deviation|3|||
130343605|NCT03328182|469229038|FG000|Overall Study|Withdrawal by Subject|1|||
130343606|NCT03328182|469229038|FG000|Overall Study|Protocol Violation|2|||
130343607|NCT03328182|469229038|FG000|Overall Study|No Product Evaluated|1|||
130343608|NCT00874939|469229042|FG000|Overall Study|Study terminated|4|||
130343609|NCT02870933|469229043|FG000|Overall Study|Death|2|||
130343610|NCT02870933|469229044|FG001|Overall Study|Death|1|||
130343611|NCT02870933|469229043|FG000|Overall Study|Withdrawal by Subject|0|||
130343612|NCT02870933|469229044|FG001|Overall Study|Withdrawal by Subject|1|||
130343613|NCT01250496|469229045|FG000|Overall Study|Study terminated|124|||
130343614|NCT01250496|469229046|FG001|Overall Study|Study terminated|124|||
130343615|NCT01425463|469229052|FG000|Overall Study|Adverse Event|5|||
130343616|NCT01425463|469229053|FG001|Overall Study|Adverse Event|7|||
130343617|NCT01425463|469229052|FG000|Overall Study|Lack of Efficacy|1|||
130343618|NCT01425463|469229053|FG001|Overall Study|Lack of Efficacy|1|||
130343619|NCT01425463|469229052|FG000|Overall Study|Protocol Violation|2|||
130343620|NCT01425463|469229053|FG001|Overall Study|Protocol Violation|2|||
130343621|NCT01425463|469229052|FG000|Overall Study|Lost to Follow-up|5|||
130343622|NCT01425463|469229053|FG001|Overall Study|Lost to Follow-up|2|||
130009253|NCT01469182|467997311|FG001|Overall Study|Withdrawal by Subject|1|||
130343623|NCT01425463|469229052|FG000|Overall Study|Withdrawal by Subject|7|||
130343624|NCT01425463|469229053|FG001|Overall Study|Withdrawal by Subject|5|||
130343625|NCT01425463|469229052|FG000|Overall Study|Unknown Reason|4|||
130343626|NCT01425463|469229053|FG001|Overall Study|Unknown Reason|7|||
130343627|NCT01328366|469229058|FG000|Overall Study|Death|1|||
130343628|NCT01328366|469229058|FG000|Overall Study|Withdrawal by Subject|2|||
130343629|NCT01328366|469229058|FG000|Overall Study|Lost to Follow-up|7|||
130343630|NCT01122264|469229059|FG000|Overall Study|Adverse Event|6|||
130343631|NCT01122264|469229060|FG001|Overall Study|Adverse Event|5|||
130343632|NCT01122264|469229061|FG002|Overall Study|Adverse Event|7|||
130343633|NCT01122264|469229059|FG000|Overall Study|Death|1|||
130343634|NCT01122264|469229060|FG001|Overall Study|Death|0|||
130343635|NCT01122264|469229061|FG002|Overall Study|Death|0|||
130343636|NCT01122264|469229059|FG000|Overall Study|Lost to Follow-up|5|||
129884406|NCT02771210|467536387|FG000|Period 1|Physician Decision|0|||
130009254|NCT01469182|467997310|FG000|Overall Study|Protocol Violation|4|||
130009255|NCT01469182|467997311|FG001|Overall Study|Protocol Violation|2|||
130009256|NCT01469182|467997310|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
130009257|NCT01469182|467997311|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
130009258|NCT02687542|467997312|FG000|Overall Study|Medication error without associated AEs|0|||
130009259|NCT02687542|467997313|FG001|Overall Study|Medication error without associated AEs|0|||
130009260|NCT02687542|467997314|FG002|Overall Study|Medication error without associated AEs|0|||
130009261|NCT02687542|467997315|FG003|Overall Study|Medication error without associated AEs|0|||
130009262|NCT02687542|467997316|FG004|Overall Study|Medication error without associated AEs|1|||
130009263|NCT02687542|467997312|FG000|Overall Study|Lost to Follow-up|0|||
130009264|NCT02687542|467997313|FG001|Overall Study|Lost to Follow-up|0|||
130009265|NCT02687542|467997314|FG002|Overall Study|Lost to Follow-up|0|||
130009266|NCT02687542|467997315|FG003|Overall Study|Lost to Follow-up|0|||
130009267|NCT02687542|467997316|FG004|Overall Study|Lost to Follow-up|1|||
130009268|NCT02687542|467997312|FG000|Overall Study|Protocol Violation|0|||
130009269|NCT02687542|467997313|FG001|Overall Study|Protocol Violation|1|||
130009270|NCT02687542|467997314|FG002|Overall Study|Protocol Violation|0|||
130009271|NCT02687542|467997315|FG003|Overall Study|Protocol Violation|0|||
130009272|NCT02687542|467997316|FG004|Overall Study|Protocol Violation|0|||
130009273|NCT02687542|467997312|FG000|Overall Study|Other|5|||
130009274|NCT02687542|467997313|FG001|Overall Study|Other|9|||
130009275|NCT02687542|467997314|FG002|Overall Study|Other|10|||
130009276|NCT02687542|467997315|FG003|Overall Study|Other|6|||
130009277|NCT02687542|467997316|FG004|Overall Study|Other|5|||
130009278|NCT02687542|467997312|FG000|Overall Study|Adverse Event|3|||
130009279|NCT02687542|467997313|FG001|Overall Study|Adverse Event|1|||
130009280|NCT02687542|467997314|FG002|Overall Study|Adverse Event|3|||
130009281|NCT02687542|467997315|FG003|Overall Study|Adverse Event|2|||
130009282|NCT02687542|467997316|FG004|Overall Study|Adverse Event|9|||
130009283|NCT02687542|467997312|FG000|Overall Study|Withdrawal by Subject|0|||
130009284|NCT02687542|467997313|FG001|Overall Study|Withdrawal by Subject|1|||
130009285|NCT02687542|467997314|FG002|Overall Study|Withdrawal by Subject|1|||
130009286|NCT02687542|467997315|FG003|Overall Study|Withdrawal by Subject|2|||
130009287|NCT02687542|467997316|FG004|Overall Study|Withdrawal by Subject|4|||
130009288|NCT00096785|467997319|FG000|Overall Study|Lost to Follow-up|1|||
130009289|NCT00096785|467997320|FG001|Overall Study|Lost to Follow-up|0|||
130009290|NCT00096785|467997319|FG000|Overall Study|Withdrawal by Subject|0|||
130009291|NCT00096785|467997320|FG001|Overall Study|Withdrawal by Subject|1|||
130009292|NCT00096785|467997319|FG000|Overall Study|Relocated|1|||
130009293|NCT00096785|467997320|FG001|Overall Study|Relocated|0|||
130009294|NCT04053868|467997321|FG000|Overall Study|Withdrawal by Subject|1|||
130009295|NCT04053868|467997322|FG001|Overall Study|Withdrawal by Subject|0|||
130009296|NCT01838616|467997323|FG000|Titration Period|Adverse Event|18|||
130009297|NCT01838616|467997324|FG001|Titration Period|Adverse Event|48|||
130009298|NCT01838616|467997323|FG000|Titration Period|Lack of Efficacy|5|||
130009299|NCT01838616|467997324|FG001|Titration Period|Lack of Efficacy|12|||
130009300|NCT01838616|467997323|FG000|Titration Period|Withdrawal by Subject|5|||
130009301|NCT01838616|467997324|FG001|Titration Period|Withdrawal by Subject|5|||
130009302|NCT01838616|467997323|FG000|Titration Period|Technical problems|1|||
130009303|NCT01838616|467997324|FG001|Titration Period|Technical problems|0|||
130009304|NCT01838616|467997323|FG000|Titration Period|Other|1|||
130009305|NCT01838616|467997324|FG001|Titration Period|Other|0|||
130009306|NCT01838616|467997323|FG000|Titration Period|Protocol Violation|0|||
130009307|NCT01838616|467997324|FG001|Titration Period|Protocol Violation|1|||
130009308|NCT01838616|467997323|FG000|Continuation Period|Lack of Efficacy|3|||
130009309|NCT01838616|467997324|FG001|Continuation Period|Lack of Efficacy|5|||
130009310|NCT01838616|467997323|FG000|Continuation Period|Adverse Event|8|||
130009311|NCT01838616|467997324|FG001|Continuation Period|Adverse Event|4|||
130009312|NCT01838616|467997323|FG000|Continuation Period|Protocol Violation|2|||
130009313|NCT01838616|467997324|FG001|Continuation Period|Protocol Violation|0|||
130009314|NCT01838616|467997323|FG000|Continuation Period|Lost to Follow-up|1|||
130216600|NCT05305989|468755616|FG000|Overall Study|Protocol Violation|0|||
130009315|NCT01838616|467997324|FG001|Continuation Period|Lost to Follow-up|0|||
130009316|NCT01838616|467997323|FG000|Continuation Period|Withdrawal by Subject|0|||
130009317|NCT01838616|467997324|FG001|Continuation Period|Withdrawal by Subject|4|||
130009318|NCT01838616|467997323|FG000|Continuation Period|Technical problems|0|||
130009319|NCT01838616|467997324|FG001|Continuation Period|Technical problems|1|||
130009320|NCT01838616|467997323|FG000|Pick-up Arm|Lack of Efficacy|4|||
130009321|NCT01838616|467997324|FG001|Pick-up Arm|Lack of Efficacy|0|||
130009322|NCT01838616|467997323|FG000|Pick-up Arm|Adverse Event|9|||
130009323|NCT01838616|467997324|FG001|Pick-up Arm|Adverse Event|0|||
130009324|NCT01838616|467997323|FG000|Pick-up Arm|Withdrawal by Subject|1|||
130009325|NCT01838616|467997324|FG001|Pick-up Arm|Withdrawal by Subject|0|||
130009326|NCT01838616|467997323|FG000|Pick-up Arm|Technical problems|1|||
130009327|NCT01838616|467997324|FG001|Pick-up Arm|Technical problems|0|||
130009328|NCT01566773|467997327|FG000|Overall Study|Protocol specified criteria|4|||
130009329|NCT01566773|467997327|FG000|Overall Study|Protocol Violation|4|||
130009330|NCT01566773|467997327|FG000|Overall Study|Withdrawal by Subject|9|||
130009331|NCT01566773|467997327|FG000|Overall Study|Administrative reason|1|||
130009332|NCT01566773|467997327|FG000|Overall Study|Adverse Event|10|||
130009333|NCT01566773|467997327|FG000|Overall Study|Physician Decision|2|||
130009334|NCT00833053|467997328|FG000|Overall Study|Adverse Event|4|||
130009335|NCT00833053|467997329|FG001|Overall Study|Adverse Event|0|||
130009336|NCT00833053|467997328|FG000|Overall Study|Treatment Failure|3|||
130009337|NCT00833053|467997329|FG001|Overall Study|Treatment Failure|1|||
130009338|NCT00833053|467997328|FG000|Overall Study|Withdrawal by Subject|0|||
130009339|NCT00833053|467997329|FG001|Overall Study|Withdrawal by Subject|1|||
130009340|NCT00833053|467997328|FG000|Overall Study|Protocol Violation|2|||
130009341|NCT00833053|467997329|FG001|Overall Study|Protocol Violation|1|||
130009342|NCT02187471|467997332|FG000|Overall Study|Protocol Violation|4|||
130009343|NCT02187471|467997333|FG001|Overall Study|Protocol Violation|5|||
130009344|NCT02187471|467997334|FG002|Overall Study|Protocol Violation|4|||
130009345|NCT02187471|467997335|FG003|Overall Study|Protocol Violation|4|||
130009346|NCT02187471|467997332|FG000|Overall Study|Missing|0|||
130009347|NCT02187471|467997333|FG001|Overall Study|Missing|0|||
130009348|NCT02187471|467997334|FG002|Overall Study|Missing|0|||
130009349|NCT02187471|467997335|FG003|Overall Study|Missing|1|||
130009350|NCT02187471|467997332|FG000|Overall Study|Lack of Efficacy|18|||
130009351|NCT02187471|467997333|FG001|Overall Study|Lack of Efficacy|9|||
130009352|NCT02187471|467997334|FG002|Overall Study|Lack of Efficacy|13|||
130009353|NCT02187471|467997335|FG003|Overall Study|Lack of Efficacy|11|||
130009354|NCT02187471|467997332|FG000|Overall Study|Adverse Event|24|||
130009355|NCT02187471|467997333|FG001|Overall Study|Adverse Event|34|||
130009356|NCT02187471|467997334|FG002|Overall Study|Adverse Event|44|||
130009357|NCT02187471|467997335|FG003|Overall Study|Adverse Event|36|||
130009358|NCT02187471|467997332|FG000|Overall Study|Withdrawal by Subject|23|||
130009359|NCT02187471|467997333|FG001|Overall Study|Withdrawal by Subject|29|||
130009360|NCT02187471|467997334|FG002|Overall Study|Withdrawal by Subject|22|||
130009361|NCT02187471|467997335|FG003|Overall Study|Withdrawal by Subject|24|||
130009362|NCT02187471|467997332|FG000|Overall Study|Other|7|||
130009363|NCT02187471|467997333|FG001|Overall Study|Other|5|||
130009364|NCT02187471|467997334|FG002|Overall Study|Other|3|||
130009365|NCT02187471|467997335|FG003|Overall Study|Other|4|||
130009366|NCT02236520|467997336|FG000|Overall Study|Physician Decision|0|||
130009367|NCT02236520|467997337|FG001|Overall Study|Physician Decision|5|||
130009368|NCT02236520|467997338|FG002|Overall Study|Physician Decision|0|||
130009369|NCT02236520|467997339|FG003|Overall Study|Physician Decision|0|||
130009370|NCT02236520|467997336|FG000|Overall Study|Withdrawal by Subject|1|||
130009371|NCT02236520|467997337|FG001|Overall Study|Withdrawal by Subject|0|||
130009372|NCT02236520|467997338|FG002|Overall Study|Withdrawal by Subject|0|||
130009373|NCT02236520|467997339|FG003|Overall Study|Withdrawal by Subject|1|||
130009374|NCT02236520|467997336|FG000|Overall Study|Pregnancy|1|||
130009375|NCT02236520|467997337|FG001|Overall Study|Pregnancy|0|||
130009376|NCT02236520|467997338|FG002|Overall Study|Pregnancy|0|||
130009377|NCT02236520|467997339|FG003|Overall Study|Pregnancy|0|||
130009378|NCT01785160|467997340|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
130009379|NCT01785160|467997340|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
130009380|NCT00957528|467997341|FG000|Overall Study|Protocol Violation|0|||
130009381|NCT00957528|467997342|FG001|Overall Study|Protocol Violation|1|||
130009382|NCT00957528|467997343|FG002|Overall Study|Protocol Violation|0|||
130009383|NCT00957528|467997341|FG000|Overall Study|Withdrawal by Subject|0|||
130009384|NCT00957528|467997342|FG001|Overall Study|Withdrawal by Subject|0|||
130343637|NCT01122264|469229060|FG001|Overall Study|Lost to Follow-up|9|||
130343638|NCT01122264|469229061|FG002|Overall Study|Lost to Follow-up|13|||
130343639|NCT01122264|469229059|FG000|Overall Study|Entry Criteria Not Met|1|||
130343640|NCT01122264|469229060|FG001|Overall Study|Entry Criteria Not Met|0|||
130343641|NCT01122264|469229061|FG002|Overall Study|Entry Criteria Not Met|0|||
130009385|NCT00957528|467997343|FG002|Overall Study|Withdrawal by Subject|1|||
130343642|NCT01122264|469229059|FG000|Overall Study|Protocol Violation|7|||
130009386|NCT02081534|467997344|FG000|Overall Study|Adverse Event|5|||
130009387|NCT02081534|467997345|FG001|Overall Study|Adverse Event|4|||
130009388|NCT02081534|467997346|FG002|Overall Study|Adverse Event|3|||
130009389|NCT02081534|467997347|FG003|Overall Study|Adverse Event|10|||
130009390|NCT02081534|467997348|FG004|Overall Study|Adverse Event|2|||
130009391|NCT02081534|467997349|FG005|Overall Study|Adverse Event|8|||
130009392|NCT02081534|467997350|FG006|Overall Study|Adverse Event|2|||
130009393|NCT02081534|467997344|FG000|Overall Study|Withdrawal by Subject|0|||
130009394|NCT02081534|467997345|FG001|Overall Study|Withdrawal by Subject|1|||
130343643|NCT01122264|469229060|FG001|Overall Study|Protocol Violation|7|||
130009395|NCT02081534|467997346|FG002|Overall Study|Withdrawal by Subject|1|||
130009396|NCT02081534|467997347|FG003|Overall Study|Withdrawal by Subject|1|||
130009397|NCT02081534|467997348|FG004|Overall Study|Withdrawal by Subject|1|||
130009398|NCT02081534|467997349|FG005|Overall Study|Withdrawal by Subject|0|||
130009399|NCT02081534|467997350|FG006|Overall Study|Withdrawal by Subject|1|||
130009400|NCT02081534|467997344|FG000|Overall Study|Protocol Violation|0|||
130009401|NCT02081534|467997345|FG001|Overall Study|Protocol Violation|3|||
130009402|NCT02081534|467997346|FG002|Overall Study|Protocol Violation|0|||
130009403|NCT02081534|467997347|FG003|Overall Study|Protocol Violation|0|||
130009404|NCT02081534|467997348|FG004|Overall Study|Protocol Violation|0|||
130009405|NCT02081534|467997349|FG005|Overall Study|Protocol Violation|0|||
130009406|NCT02081534|467997350|FG006|Overall Study|Protocol Violation|1|||
130009407|NCT02081534|467997344|FG000|Overall Study|Lost to Follow-up|0|||
130009408|NCT02081534|467997345|FG001|Overall Study|Lost to Follow-up|0|||
130009409|NCT02081534|467997346|FG002|Overall Study|Lost to Follow-up|0|||
130009410|NCT02081534|467997347|FG003|Overall Study|Lost to Follow-up|2|||
130009411|NCT02081534|467997348|FG004|Overall Study|Lost to Follow-up|1|||
130009412|NCT02081534|467997349|FG005|Overall Study|Lost to Follow-up|1|||
130009413|NCT02081534|467997350|FG006|Overall Study|Lost to Follow-up|0|||
130009414|NCT01033734|467997351|FG000|Overall Study|Withdrawal by Subject|1|||
130009415|NCT02289742|467997352|FG000|First Wear Period|Adverse event prior to treatment|0|||
130009416|NCT02289742|467997353|FG001|First Wear Period|Adverse event prior to treatment|1|||
130009417|NCT02289742|467997354|FG002|First Wear Period|Adverse event prior to treatment|0|||
130009418|NCT02289742|467997355|FG003|First Wear Period|Adverse event prior to treatment|0|||
130009419|NCT02289742|467997352|FG000|First Wear Period|Adverse Event|0|||
130009420|NCT02289742|467997353|FG001|First Wear Period|Adverse Event|0|||
130343644|NCT01122264|469229061|FG002|Overall Study|Protocol Violation|9|||
130343645|NCT01122264|469229059|FG000|Overall Study|Withdrawal by Subject|6|||
130343646|NCT01122264|469229060|FG001|Overall Study|Withdrawal by Subject|6|||
130343647|NCT01122264|469229061|FG002|Overall Study|Withdrawal by Subject|16|||
130343648|NCT01122264|469229059|FG000|Overall Study|Physician Decision|3|||
130343649|NCT01122264|469229060|FG001|Overall Study|Physician Decision|1|||
130343650|NCT01122264|469229061|FG002|Overall Study|Physician Decision|1|||
130343651|NCT01122264|469229059|FG000|Overall Study|Lack of Efficacy|3|||
130343652|NCT01122264|469229060|FG001|Overall Study|Lack of Efficacy|1|||
130343653|NCT01122264|469229061|FG002|Overall Study|Lack of Efficacy|1|||
130343654|NCT04585009|469229070|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
130343655|NCT04585009|469229071|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343656|NCT04585009|469229072|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343657|NCT04585009|469229073|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343658|NCT04585009|469229074|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343659|NCT04585009|469229075|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343660|NCT04585009|469229076|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343661|NCT04585009|469229077|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343662|NCT04585009|469229078|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343663|NCT04585009|469229079|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343664|NCT04585009|469229080|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343665|NCT04585009|469229081|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
130343666|NCT04585009|469229070|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
130343667|NCT04585009|469229071|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343668|NCT04585009|469229072|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343669|NCT04585009|469229073|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343670|NCT04585009|469229074|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343671|NCT04585009|469229075|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343672|NCT04585009|469229076|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343673|NCT04585009|469229077|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343674|NCT04585009|469229078|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343675|NCT04585009|469229079|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343676|NCT04585009|469229080|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343677|NCT04585009|469229081|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
130343678|NCT04585009|469229070|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343679|NCT04585009|469229071|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343680|NCT04585009|469229072|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343681|NCT04585009|469229073|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343682|NCT04585009|469229074|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130009421|NCT02289742|467997354|FG002|First Wear Period|Adverse Event|1|||
130009422|NCT02289742|467997355|FG003|First Wear Period|Adverse Event|0|||
130009423|NCT02289742|467997352|FG000|First Wear Period|Other prior to treatment|0|||
130009424|NCT02289742|467997353|FG001|First Wear Period|Other prior to treatment|0|||
129884407|NCT02771210|467536388|FG001|Period 1|Physician Decision|1|||
130009425|NCT02289742|467997354|FG002|First Wear Period|Other prior to treatment|0|||
130009426|NCT02289742|467997355|FG003|First Wear Period|Other prior to treatment|1|||
130009427|NCT02289742|467997352|FG000|Third Wear Period|Adverse Event|0|||
130009428|NCT02289742|467997353|FG001|Third Wear Period|Adverse Event|1|||
130009429|NCT02289742|467997354|FG002|Third Wear Period|Adverse Event|0|||
130009430|NCT02289742|467997355|FG003|Third Wear Period|Adverse Event|0|||
130009431|NCT02289742|467997352|FG000|Third Wear Period|Reason not given|0|||
130009432|NCT02289742|467997353|FG001|Third Wear Period|Reason not given|0|||
130009433|NCT02289742|467997354|FG002|Third Wear Period|Reason not given|0|||
130009434|NCT02289742|467997355|FG003|Third Wear Period|Reason not given|1|||
130009435|NCT02181816|467997356|FG000|Overall Study|Case Report Forms Uncollected|38|||
130009436|NCT02181816|467997356|FG000|Overall Study|Protocol Deviation|21|||
130009437|NCT01365039|467997357|FG000|Overall Study|Study related symptoms and complaints|1|||
130009438|NCT01365039|467997358|FG001|Overall Study|Study related symptoms and complaints|0|||
130009439|NCT03807349|467997361|FG000|Overall Study|Early Study Termination|9|||
130009440|NCT00294060|467997362|FG000|Overall Study|Death|225|||
130009441|NCT00294060|467997362|FG000|Overall Study|Other|59|||
130009442|NCT00294060|467997362|FG000|Overall Study|Lost to Follow-up|55|||
130009443|NCT00294060|467997362|FG000|Overall Study|Withdrawal by Subject|11|||
130009444|NCT00294060|467997362|FG000|Overall Study|Physician Decision|797|||
130009445|NCT00294060|467997362|FG000|Overall Study|Medical condition|3|||
130009446|NCT00294060|467997362|FG000|Overall Study|Device explanted/not replaced|23|||
130009447|NCT01360554|467997363|FG000|Overall Study|Death|359|||
130009448|NCT01360554|467997364|FG001|Overall Study|Death|371|||
130009449|NCT01360554|467997363|FG000|Overall Study|Lost to Follow-up|4|||
130009450|NCT01360554|467997364|FG001|Overall Study|Lost to Follow-up|4|||
130009451|NCT01360554|467997363|FG000|Overall Study|Withdrawal by Subject|23|||
130009452|NCT01360554|467997364|FG001|Overall Study|Withdrawal by Subject|24|||
130009453|NCT01360554|467997363|FG000|Overall Study|Study terminated by sponsor|49|||
130009454|NCT01360554|467997364|FG001|Overall Study|Study terminated by sponsor|37|||
130009455|NCT01360554|467997363|FG000|Overall Study|Other, not specified|1|||
130009456|NCT01360554|467997364|FG001|Overall Study|Other, not specified|0|||
130009457|NCT01360554|467997363|FG000|Overall Study|Randomized but not treated.|3|||
130009458|NCT01360554|467997364|FG001|Overall Study|Randomized but not treated.|3|||
130009459|NCT00187096|467997366|FG000|Overall Study|unacceptable toxicity|0|||
130009460|NCT00187096|467997367|FG001|Overall Study|unacceptable toxicity|0|||
130009461|NCT00187096|467997368|FG002|Overall Study|unacceptable toxicity|1|||
130009462|NCT00253643|467997369|FG000|Overall Study|Withdrawal by Subject|0|||
130009463|NCT00253643|467997370|FG001|Overall Study|Withdrawal by Subject|0|||
130009464|NCT00253643|467997371|FG002|Overall Study|Withdrawal by Subject|1|||
130009465|NCT00253643|467997372|FG003|Overall Study|Withdrawal by Subject|1|||
130009466|NCT00253643|467997369|FG000|Overall Study|Non-Compliance|0|||
130009467|NCT00253643|467997370|FG001|Overall Study|Non-Compliance|0|||
130009468|NCT00253643|467997371|FG002|Overall Study|Non-Compliance|0|||
130009469|NCT00253643|467997372|FG003|Overall Study|Non-Compliance|2|||
130009470|NCT01131676|467997373|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
130009471|NCT01131676|467997374|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
130009472|NCT01131676|467997375|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
130009473|NCT01131676|467997373|FG000|Discontinuation From Treatment|Not treated|4|||
130009474|NCT01131676|467997374|FG001|Discontinuation From Treatment|Not treated|2|||
130009475|NCT01131676|467997375|FG002|Discontinuation From Treatment|Not treated|2|||
130009476|NCT01131676|467997373|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
130009477|NCT01131676|467997374|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
130009478|NCT01131676|467997375|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
130009479|NCT01131676|467997373|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
130009480|NCT01131676|467997374|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
130343683|NCT04585009|469229075|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130009481|NCT01131676|467997375|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
130009482|NCT01131676|467997373|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
130009483|NCT01131676|467997374|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
130343684|NCT04585009|469229076|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343685|NCT04585009|469229077|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
130343686|NCT04585009|469229078|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343687|NCT04585009|469229079|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343688|NCT04585009|469229080|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130343689|NCT04585009|469229081|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
130009484|NCT01131676|467997375|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
130009485|NCT01131676|467997373|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
130343690|NCT04585009|469229070|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130009486|NCT01131676|467997374|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
130009487|NCT01131676|467997375|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
130009488|NCT01131676|467997373|FG000|Discontinuation From Treatment|Other than those specified|162|||
130009489|NCT01131676|467997374|FG001|Discontinuation From Treatment|Other than those specified|142|||
130009490|NCT01131676|467997375|FG002|Discontinuation From Treatment|Other than those specified|125|||
130009491|NCT01131676|467997373|FG000|Discontinuation From Treatment|Adverse Event|303|||
130009492|NCT01131676|467997374|FG001|Discontinuation From Treatment|Adverse Event|267|||
130009493|NCT01131676|467997375|FG002|Discontinuation From Treatment|Adverse Event|273|||
130009494|NCT01131676|467997373|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
130009495|NCT01131676|467997374|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
130009496|NCT01131676|467997375|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
130009497|NCT01131676|467997373|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
130009498|NCT01131676|467997374|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
130009499|NCT01131676|467997375|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
130009500|NCT01131676|467997373|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
130009501|NCT01131676|467997374|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
130009502|NCT01131676|467997375|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
130009503|NCT01131676|467997373|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
130009504|NCT01131676|467997374|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
130009505|NCT01131676|467997375|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
130009506|NCT01131676|467997373|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
130009507|NCT01131676|467997374|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
130009508|NCT01131676|467997375|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
130009509|NCT01131676|467997373|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
130009510|NCT01131676|467997374|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
130009511|NCT01131676|467997375|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
130009512|NCT01816061|467997378|FG000|Overall Study|Lost to Follow-up|13|||
130009513|NCT01816061|467997379|FG001|Overall Study|Lost to Follow-up|24|||
130009514|NCT01376778|467997380|FG000|Overall Study|Lost to Follow-up|3|||
130009515|NCT01376778|467997381|FG001|Overall Study|Lost to Follow-up|2|||
130009516|NCT00928889|467997382|FG000|Overall Study|Lost to Follow-up|3|||
130009517|NCT00928889|467997383|FG001|Overall Study|Lost to Follow-up|1|||
130009518|NCT00928889|467997382|FG000|Overall Study|Protocol Violation|0|||
130009519|NCT00928889|467997383|FG001|Overall Study|Protocol Violation|1|||
130009520|NCT00928889|467997382|FG000|Overall Study|Adverse Event|1|||
130009521|NCT00928889|467997383|FG001|Overall Study|Adverse Event|0|||
130009522|NCT00928889|467997382|FG000|Overall Study|Other|1|||
130009523|NCT00928889|467997383|FG001|Overall Study|Other|0|||
130009524|NCT04712110|467997384|FG000|Overall Study|Lost to Follow-up|0|||
130009525|NCT04712110|467997385|FG001|Overall Study|Lost to Follow-up|1|||
130009526|NCT04712110|467997384|FG000|Overall Study|Withdrawal by Subject|0|||
130009527|NCT04712110|467997385|FG001|Overall Study|Withdrawal by Subject|4|||
130009528|NCT04712110|467997384|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
130009529|NCT04712110|467997385|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
130009530|NCT01517893|467997386|FG000|Overall Study|Withdrawal by Subject|3|||
130009531|NCT01517893|467997387|FG001|Overall Study|Withdrawal by Subject|0|||
130009532|NCT01431274|467997389|FG000|Overall Study|Adverse Event|51|||
130009533|NCT01431274|467997390|FG001|Overall Study|Adverse Event|37|||
130009534|NCT01431274|467997391|FG002|Overall Study|Adverse Event|43|||
130009535|NCT01431274|467997392|FG003|Overall Study|Adverse Event|30|||
130009536|NCT01431274|467997393|FG004|Overall Study|Adverse Event|37|||
130009537|NCT01431274|467997389|FG000|Overall Study|Consent withdrawn not due to AE|29|||
130009538|NCT01431274|467997390|FG001|Overall Study|Consent withdrawn not due to AE|20|||
130009539|NCT01431274|467997391|FG002|Overall Study|Consent withdrawn not due to AE|17|||
130009540|NCT01431274|467997392|FG003|Overall Study|Consent withdrawn not due to AE|20|||
130009541|NCT01431274|467997393|FG004|Overall Study|Consent withdrawn not due to AE|11|||
130009542|NCT01431274|467997389|FG000|Overall Study|Non compliant with protocol|5|||
130009543|NCT01431274|467997390|FG001|Overall Study|Non compliant with protocol|8|||
130009544|NCT01431274|467997391|FG002|Overall Study|Non compliant with protocol|4|||
130009545|NCT01431274|467997392|FG003|Overall Study|Non compliant with protocol|4|||
130009546|NCT01431274|467997393|FG004|Overall Study|Non compliant with protocol|4|||
130009547|NCT01431274|467997389|FG000|Overall Study|Lost to Follow-up|6|||
130009548|NCT01431274|467997390|FG001|Overall Study|Lost to Follow-up|7|||
130009549|NCT01431274|467997391|FG002|Overall Study|Lost to Follow-up|1|||
130009550|NCT01431274|467997392|FG003|Overall Study|Lost to Follow-up|4|||
130009551|NCT01431274|467997393|FG004|Overall Study|Lost to Follow-up|0|||
130009552|NCT01431274|467997389|FG000|Overall Study|Other reason not stated above|6|||
130009553|NCT01431274|467997390|FG001|Overall Study|Other reason not stated above|5|||
130009554|NCT01431274|467997391|FG002|Overall Study|Other reason not stated above|7|||
130009555|NCT01431274|467997392|FG003|Overall Study|Other reason not stated above|2|||
130009556|NCT01431274|467997393|FG004|Overall Study|Other reason not stated above|4|||
130009557|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
130009558|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
130009559|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Death|0|||
130009560|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Death|1|||
130009561|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
130009562|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
130009563|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
130009564|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
130009565|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
130009566|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
130009567|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
130009568|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
130009569|NCT00843518|467997394|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
130009570|NCT00843518|467997395|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
130009571|NCT00827606|467997396|FG000|Overall Study|Protocol Violation|4|||
130009572|NCT00827606|467997397|FG001|Overall Study|Protocol Violation|3|||
130009573|NCT00827606|467997396|FG000|Overall Study|Lost to Follow-up|3|||
130009574|NCT00827606|467997397|FG001|Overall Study|Lost to Follow-up|1|||
130009575|NCT00827606|467997396|FG000|Overall Study|Withdrawal by Subject|7|||
130009576|NCT00827606|467997397|FG001|Overall Study|Withdrawal by Subject|6|||
130009577|NCT00827606|467997396|FG000|Overall Study|Pregnancy|0|||
130009578|NCT00827606|467997397|FG001|Overall Study|Pregnancy|1|||
130009579|NCT00827606|467997396|FG000|Overall Study|Other|5|||
130009580|NCT00827606|467997397|FG001|Overall Study|Other|13|||
130009581|NCT00827606|467997396|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
130009582|NCT00827606|467997397|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
130009583|NCT00827606|467997396|FG000|Overall Study|Adverse Event|4|||
130009584|NCT00827606|467997397|FG001|Overall Study|Adverse Event|2|||
130009585|NCT04037748|467997400|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130009586|NCT04037748|467997401|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130009587|NCT04037748|467997400|FG000|Treatment Period 1|Adverse Event|1|||
130009588|NCT04037748|467997401|FG001|Treatment Period 1|Adverse Event|1|||
130009589|NCT04037748|467997400|FG000|Treatment Period 1|Protocol Violation|4|||
130009590|NCT04037748|467997401|FG001|Treatment Period 1|Protocol Violation|5|||
130009591|NCT04037748|467997400|FG000|Treatment Period 2|Adverse Event|0|||
130009592|NCT04037748|467997401|FG001|Treatment Period 2|Adverse Event|1|||
130009593|NCT04037748|467997400|FG000|Treatment Period 2|Protocol Violation|2|||
130009594|NCT04037748|467997401|FG001|Treatment Period 2|Protocol Violation|0|||
130009595|NCT04544475|467997406|FG000|Overall Study|Withdrawal by Subject|1|||
130009596|NCT04544475|467997407|FG001|Overall Study|Withdrawal by Subject|3|||
130009597|NCT01378858|467997408|FG000|Overall Study|Withdrawal by Subject|4|||
130009598|NCT01378858|467997409|FG001|Overall Study|Withdrawal by Subject|4|||
130009599|NCT00501007|467997410|FG000|Overall Study|Inclusion criteria not met.|29|||
130009600|NCT00501007|467997411|FG001|Overall Study|Inclusion criteria not met.|25|||
130009601|NCT02973087|467997414|FG000|Overall Study|Withdrawal by Subject|2|||
130009602|NCT02973087|467997415|FG001|Overall Study|Withdrawal by Subject|1|||
130009603|NCT02973087|467997414|FG000|Overall Study|Adverse Event|1|||
130009604|NCT02973087|467997415|FG001|Overall Study|Adverse Event|0|||
130009605|NCT02973087|467997414|FG000|Overall Study|other|1|||
130009606|NCT02973087|467997415|FG001|Overall Study|other|1|||
130009607|NCT04143009|467997416|FG000|Pilot Trial|Lost to Follow-up|0|||
130009608|NCT04143009|467997417|FG001|Pilot Trial|Lost to Follow-up|1|||
130009609|NCT04143009|467997418|FG002|Pilot Trial|Lost to Follow-up|1|||
130009610|NCT04857996|467997419|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
130009611|NCT04857996|467997420|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
130009612|NCT04857996|467997419|FG000|Overall Study|Lost to Follow-up|1|||
130009613|NCT04857996|467997420|FG001|Overall Study|Lost to Follow-up|3|||
130009614|NCT04857996|467997419|FG000|Overall Study|Site Closure|1|||
130009615|NCT04857996|467997420|FG001|Overall Study|Site Closure|0|||
130009616|NCT04857996|467997419|FG000|Overall Study|Withdrawal by Subject|1|||
130009617|NCT04857996|467997420|FG001|Overall Study|Withdrawal by Subject|0|||
130009618|NCT01538628|467997421|FG000|Overall Study|Withdrawal by Subject|1|||
130009619|NCT01538628|467997422|FG001|Overall Study|Withdrawal by Subject|1|||
130009620|NCT01538628|467997421|FG000|Overall Study|Lost to Follow-up|0|||
130009621|NCT01538628|467997422|FG001|Overall Study|Lost to Follow-up|1|||
130009622|NCT00736255|467998507|FG000|Overall Study|Adverse Event|1|||
130009623|NCT00736255|467998508|FG001|Overall Study|Adverse Event|0|||
130009624|NCT00736255|467998507|FG000|Overall Study|Physician Decision|1|||
130009625|NCT00736255|467998508|FG001|Overall Study|Physician Decision|0|||
130009626|NCT00736255|467998507|FG000|Overall Study|Non-compliance|1|||
130009627|NCT00736255|467998508|FG001|Overall Study|Non-compliance|1|||
130009628|NCT00404820|467998509|FG000|Overall Study|Adverse Event|4|||
130009629|NCT00404820|467998510|FG001|Overall Study|Adverse Event|16|||
130009630|NCT00404820|467998509|FG000|Overall Study|Withdrawal by Subject|5|||
130009631|NCT00404820|467998510|FG001|Overall Study|Withdrawal by Subject|3|||
130009632|NCT00404820|467998509|FG000|Overall Study|Lost to Follow-up|7|||
130009633|NCT00404820|467998510|FG001|Overall Study|Lost to Follow-up|3|||
130009634|NCT00404820|467998509|FG000|Overall Study|Administrative problems|2|||
130009635|NCT00404820|467998510|FG001|Overall Study|Administrative problems|0|||
130009636|NCT00404820|467998509|FG000|Overall Study|Death|1|||
130009637|NCT00404820|467998510|FG001|Overall Study|Death|0|||
130009638|NCT00404820|467998509|FG000|Overall Study|Other|0|||
130009639|NCT00404820|467998510|FG001|Overall Study|Other|2|||
130009640|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
130009641|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
130009642|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130009643|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130009644|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
130343691|NCT04585009|469229071|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130009645|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
130009646|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
130009647|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
130009648|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
130009649|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
130009650|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
130009651|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
130009652|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
130009653|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
130009654|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
130009655|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
130009656|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
130009657|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
130009658|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
130009659|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
130009660|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
130009661|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
130009662|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
130009663|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
130009664|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
130009665|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130009666|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130009667|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
130009668|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130009669|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
130009670|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009671|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130009672|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130009673|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130343692|NCT04585009|469229072|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343693|NCT04585009|469229073|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343694|NCT04585009|469229074|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
130009674|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009675|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130009676|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
130009677|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
130009678|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
130009679|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
130009680|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
130009681|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
130009682|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
130009683|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
130009684|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130009685|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130009686|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130009687|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
130009688|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
130009689|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130009690|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130009691|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130009692|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130009693|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
130009694|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130009695|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
130009696|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130009697|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130009698|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130009699|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
130009700|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130009701|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
130009702|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130009703|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130009704|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130009705|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
130009706|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130009707|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
130009708|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130009709|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130009710|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130009711|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
130009712|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130009713|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
130009714|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130009715|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130009716|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130009717|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
130009718|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130009719|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130009720|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130009721|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
130009722|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130009723|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
130009724|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130009725|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130009726|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130009727|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
130009728|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130009729|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
130009730|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130009731|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130009732|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130009733|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130009734|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
130009735|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
130009736|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130009737|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130343695|NCT04585009|469229075|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130009738|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130009739|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130009740|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
130009741|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
130009742|NCT00111800|467998511|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130009743|NCT00111800|467998512|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130009744|NCT00111800|467998513|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130009745|NCT00111800|467998514|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130009746|NCT00111800|467998515|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
130009747|NCT00111800|467998516|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
130009748|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
130009749|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
130009750|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
130009751|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
130009752|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
130009753|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
130009754|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130009755|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
130009756|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
130009757|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130009758|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130009759|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
130009760|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
130009761|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
130009762|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
130009763|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
130009764|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
130009765|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
130009766|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130009767|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
130009768|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130009769|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130009770|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
130009771|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
130009772|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009773|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009774|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
130009775|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009776|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009777|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
130009778|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130009779|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
130009780|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130009781|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130009782|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130009783|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
130009784|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130009785|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130009786|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
130009787|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130009788|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130009789|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
130009790|NCT00111800|467998511|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130009791|NCT00111800|467998512|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130009792|NCT00111800|467998513|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
130009793|NCT00111800|467998514|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130009794|NCT00111800|467998515|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130009795|NCT00111800|467998516|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
130009796|NCT01549275|467998518|FG000|Overall Study|Lost to Follow-up|1|||
130009797|NCT01549275|467998519|FG001|Overall Study|Lost to Follow-up|0|||
130009798|NCT02969187|467998522|FG000|Overall Study|Physician Decision|12|||
130009799|NCT02969187|467998523|FG001|Overall Study|Physician Decision|13|||
130009800|NCT01486927|467998524|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
130343696|NCT04585009|469229076|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343697|NCT04585009|469229077|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343698|NCT04585009|469229078|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343699|NCT04585009|469229079|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343700|NCT04585009|469229080|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343701|NCT04585009|469229081|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
130343702|NCT04585009|469229070|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343703|NCT04585009|469229071|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343704|NCT04585009|469229072|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343705|NCT04585009|469229073|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343706|NCT04585009|469229074|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343707|NCT04585009|469229075|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343708|NCT04585009|469229076|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343709|NCT04585009|469229077|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343710|NCT04585009|469229078|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343711|NCT04585009|469229079|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
130343712|NCT04585009|469229080|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343713|NCT04585009|469229081|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
130343714|NCT04585009|469229070|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343715|NCT04585009|469229071|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343716|NCT04585009|469229072|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343717|NCT04585009|469229073|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343718|NCT04585009|469229074|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343719|NCT04585009|469229075|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343720|NCT04585009|469229076|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343721|NCT04585009|469229077|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343722|NCT04585009|469229078|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343723|NCT04585009|469229079|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343724|NCT04585009|469229080|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
130343725|NCT04585009|469229081|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
130343726|NCT00097981|469229082|FG000|Overall Study|Adverse Event|31|||
130343727|NCT00097981|469229083|FG001|Overall Study|Adverse Event|44|||
130343728|NCT00097981|469229082|FG000|Overall Study|Withdrawal by Subject|10|||
130343729|NCT00097981|469229083|FG001|Overall Study|Withdrawal by Subject|8|||
130343730|NCT00097981|469229082|FG000|Overall Study|Protocol Violation|1|||
130343731|NCT00097981|469229083|FG001|Overall Study|Protocol Violation|1|||
130343732|NCT00097981|469229082|FG000|Overall Study|Death|2|||
130343733|NCT00097981|469229083|FG001|Overall Study|Death|4|||
130343734|NCT00097981|469229082|FG000|Overall Study|Physician Decision|7|||
130343735|NCT00097981|469229083|FG001|Overall Study|Physician Decision|1|||
130343736|NCT00097981|469229082|FG000|Overall Study|Disease Progression|8|||
130343737|NCT00097981|469229083|FG001|Overall Study|Disease Progression|2|||
130343738|NCT00097981|469229082|FG000|Overall Study|Transplant planned|28|||
130343739|NCT00097981|469229083|FG001|Overall Study|Transplant planned|27|||
130343740|NCT00097981|469229082|FG000|Overall Study|Other|19|||
130343741|NCT00097981|469229083|FG001|Overall Study|Other|13|||
130343742|NCT01002820|469229086|FG000|Overall Study|Adverse Event|1|||
130343743|NCT01002820|469229086|FG000|Overall Study|Withdrawal by Subject|2|||
130343744|NCT01002820|469229086|FG000|Overall Study|Lack of Efficacy|1|||
130009801|NCT01486927|467998524|FG000|Overall Study|Physician Decision|1|||
130009802|NCT01486927|467998524|FG000|Overall Study|50 Exposure days not reached|2|||
130343745|NCT01673347|469229088|FG000|Overall Study|failure of allograft|7|||
130343746|NCT00895011|469229092|FG000|Overall Study|Withdrawal by Subject|14|||
130343747|NCT00895011|469229093|FG001|Overall Study|Withdrawal by Subject|7|||
130343748|NCT00895011|469229094|FG002|Overall Study|Withdrawal by Subject|2|||
130343749|NCT00895011|469229092|FG000|Overall Study|Lost to Follow-up|5|||
130343750|NCT00895011|469229093|FG001|Overall Study|Lost to Follow-up|4|||
130343751|NCT00895011|469229094|FG002|Overall Study|Lost to Follow-up|1|||
130343752|NCT00895011|469229092|FG000|Overall Study|Protocol Violation|3|||
130343753|NCT00895011|469229093|FG001|Overall Study|Protocol Violation|1|||
130009803|NCT01486927|467998524|FG000|Overall Study|Withdrawal by Subject|8|||
130009804|NCT01486927|467998524|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
130009805|NCT00365456|467998525|FG000|Trial Period I (12 Months)|Adverse Event|84|||
130216601|NCT05305989|468755617|FG001|Overall Study|Protocol Violation|1|||
130343754|NCT00895011|469229094|FG002|Overall Study|Protocol Violation|3|||
130343755|NCT00895011|469229092|FG000|Overall Study|Adverse Event|1|||
130343756|NCT00895011|469229093|FG001|Overall Study|Adverse Event|2|||
130343757|NCT00895011|469229094|FG002|Overall Study|Adverse Event|2|||
130343758|NCT00895011|469229092|FG000|Overall Study|schedule conflict|1|||
130343759|NCT00895011|469229093|FG001|Overall Study|schedule conflict|0|||
130343760|NCT00895011|469229094|FG002|Overall Study|schedule conflict|0|||
130343761|NCT02661178|469229095|FG000|Part 1|Protocol Violation|1|||
130343762|NCT02661178|469229096|FG001|Part 1|Protocol Violation|0|||
130343763|NCT02661178|469229097|FG002|Part 1|Protocol Violation|0|||
130343764|NCT02661178|469229098|FG003|Part 1|Protocol Violation|0|||
130343765|NCT02661178|469229099|FG004|Part 1|Protocol Violation|0|||
130343766|NCT02661178|469229100|FG005|Part 1|Protocol Violation|0|||
130343767|NCT02661178|469229101|FG006|Part 1|Protocol Violation|0|||
130343768|NCT02661178|469229102|FG007|Part 1|Protocol Violation|0|||
130343769|NCT02661178|469229103|FG008|Part 1|Protocol Violation|0|||
130343770|NCT02661178|469229104|FG009|Part 1|Protocol Violation|0|||
130343771|NCT02661178|469229105|FG010|Part 1|Protocol Violation|0|||
130343772|NCT02661178|469229106|FG011|Part 1|Protocol Violation|0|||
130343773|NCT02661178|469229107|FG012|Part 1|Protocol Violation|0|||
130343774|NCT02661178|469229108|FG013|Part 1|Protocol Violation|0|||
130343775|NCT02661178|469229109|FG014|Part 1|Protocol Violation|0|||
130343776|NCT01369329|469229111|FG000|Overall Study|Withdrawal by Subject|8|||
130343777|NCT01369329|469229112|FG001|Overall Study|Withdrawal by Subject|6|||
130343778|NCT01369329|469229113|FG002|Overall Study|Withdrawal by Subject|10|||
130343779|NCT01369329|469229111|FG000|Overall Study|Lost to Follow-up|2|||
130343780|NCT01369329|469229112|FG001|Overall Study|Lost to Follow-up|2|||
130343781|NCT01369329|469229113|FG002|Overall Study|Lost to Follow-up|2|||
130343782|NCT01369329|469229111|FG000|Overall Study|Other|2|||
130343783|NCT01369329|469229112|FG001|Overall Study|Other|3|||
130343784|NCT01369329|469229113|FG002|Overall Study|Other|2|||
130343785|NCT01101308|469229114|FG000|Period 1|Adverse Event|2|||
130343786|NCT01101308|469229115|FG001|Period 1|Adverse Event|1|||
130343787|NCT01101308|469229114|FG000|Period 1|Positive for cotinine|1|||
130343788|NCT01101308|469229115|FG001|Period 1|Positive for cotinine|0|||
130343789|NCT01579812|469229116|FG000|Overall Study|Ineligible after treatment start|40|||
130343790|NCT01579812|469229116|FG000|Overall Study|Patient choice|3|||
130343791|NCT01579812|469229116|FG000|Overall Study|Noncompliance|3|||
130343792|NCT01579812|469229116|FG000|Overall Study|Withdrawal by Subject|6|||
130343793|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
130343794|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343795|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343796|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343797|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343798|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
130343799|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
130343800|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343801|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343802|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343803|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343804|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
130343805|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
130343806|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343807|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343808|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343809|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343810|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
130343811|NCT01133990|469229119|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
130343812|NCT01133990|469229120|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343813|NCT01133990|469229121|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343814|NCT01133990|469229122|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343815|NCT01133990|469229123|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343816|NCT01133990|469229124|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
130343817|NCT05277337|469229125|FG000|Overall Study|Lost to Follow-up|2|||
130343818|NCT05277337|469229126|FG001|Overall Study|Lost to Follow-up|0|||
130343819|NCT05277337|469229125|FG000|Overall Study|Withdrawal by Subject|1|||
130343820|NCT05277337|469229126|FG001|Overall Study|Withdrawal by Subject|0|||
130343821|NCT02282345|469229128|FG000|Overall Study|Progression|0|||
130343822|NCT02282345|469229129|FG001|Overall Study|Progression|1|||
130343823|NCT01038869|469229130|FG000|Overall Study|Withdrawal by Subject|1|||
130343824|NCT01038869|469229130|FG000|Overall Study|Lost to Follow-up|6|||
130343825|NCT04905498|469229133|FG000|Overall Study|Lost to Follow-up|0|||
130009806|NCT00365456|467998526|FG001|Trial Period I (12 Months)|Adverse Event|0|||
130009807|NCT00365456|467998525|FG000|Trial Period I (12 Months)|Non-compliance|3|||
130009808|NCT00365456|467998526|FG001|Trial Period I (12 Months)|Non-compliance|0|||
130009809|NCT00365456|467998525|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
130009810|NCT00365456|467998526|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
130009811|NCT00365456|467998525|FG000|Trial Period I (12 Months)|Other|11|||
130009812|NCT00365456|467998526|FG001|Trial Period I (12 Months)|Other|0|||
130009813|NCT00365456|467998525|FG000|Trial Period II (12 Months)|Adverse Event|0|||
130009814|NCT00365456|467998526|FG001|Trial Period II (12 Months)|Adverse Event|6|||
130009815|NCT00365456|467998525|FG000|Trial Period II (12 Months)|Non-compliance|0|||
130009816|NCT00365456|467998526|FG001|Trial Period II (12 Months)|Non-compliance|2|||
130009817|NCT00365456|467998525|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
130009818|NCT00365456|467998526|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
130009819|NCT00365456|467998525|FG000|Trial Period II (12 Months)|Other|0|||
130009820|NCT00365456|467998526|FG001|Trial Period II (12 Months)|Other|1|||
130009821|NCT00365456|467998525|FG000|Trial Period III (12 Months)|Adverse Event|13|||
130009822|NCT00365456|467998526|FG001|Trial Period III (12 Months)|Adverse Event|3|||
130009823|NCT00365456|467998525|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
130009824|NCT00365456|467998526|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
130009825|NCT00365456|467998525|FG000|Trial Period III (12 Months)|Other|1|||
130009826|NCT00365456|467998526|FG001|Trial Period III (12 Months)|Other|1|||
130009827|NCT03668600|467998527|FG000|Overall Study|Study Terminated by the Sponsor|157|||
130009828|NCT03668600|467998527|FG000|Overall Study|Protocol Violation|1|||
130009829|NCT03668600|467998527|FG000|Overall Study|Pregnancy|1|||
130343826|NCT04905498|469229134|FG001|Overall Study|Lost to Follow-up|2|||
130343827|NCT04905498|469229133|FG000|Overall Study|COVID lockdown|1|||
130343828|NCT04905498|469229134|FG001|Overall Study|COVID lockdown|0|||
130343829|NCT03222492|469229137|FG000|Overall Study|Withdrawal by Subject|0|||
130343830|NCT03222492|469229138|FG001|Overall Study|Withdrawal by Subject|0|||
130343831|NCT03222492|469229139|FG002|Overall Study|Withdrawal by Subject|1|||
130343832|NCT03222492|469229140|FG003|Overall Study|Withdrawal by Subject|0|||
130343833|NCT03222492|469229137|FG000|Overall Study|COVID-19 related|0|||
130343834|NCT03222492|469229138|FG001|Overall Study|COVID-19 related|0|||
130343835|NCT03222492|469229139|FG002|Overall Study|COVID-19 related|1|||
130343836|NCT03222492|469229140|FG003|Overall Study|COVID-19 related|0|||
130343837|NCT01224782|469229143|FG000|Overall Study|Lost to Follow-up|177|||
130343838|NCT01224782|469229143|FG000|Overall Study|Withdrawal by Subject|16|||
130343839|NCT01224782|469229143|FG000|Overall Study|Death|14|||
130343840|NCT01224782|469229143|FG000|Overall Study|Improvement|13|||
130343841|NCT01224782|469229143|FG000|Overall Study|Adverse Event|12|||
130343842|NCT01224782|469229143|FG000|Overall Study|Adverse Reaction|11|||
130343843|NCT01224782|469229143|FG000|Overall Study|Noncompliance|10|||
130343844|NCT01224782|469229143|FG000|Overall Study|Other|4|||
130343845|NCT01224782|469229143|FG000|Overall Study|Start of Dialysis|3|||
130343846|NCT01224782|469229143|FG000|Overall Study|Change of Treatment|1|||
130343847|NCT01224782|469229143|FG000|Overall Study|Financial Reasons|1|||
130343848|NCT01224782|469229143|FG000|Overall Study|Deterioration|1|||
130343849|NCT01224782|469229143|FG000|Overall Study|Transplantation|1|||
130343850|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343851|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343852|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343853|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343854|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343855|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
130343856|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
130343857|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343858|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343859|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
130343860|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343861|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343862|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343863|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
130343864|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
130343865|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343866|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343867|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343868|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343869|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343870|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
130343871|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
130343872|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
130343873|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
130343874|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
130343875|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
130343876|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
130343877|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
130343878|NCT00065429|469229146|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343879|NCT00065429|469229147|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343880|NCT00065429|469229148|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343881|NCT00065429|469229149|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
130343882|NCT00065429|469229150|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
130343883|NCT00065429|469229151|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
130343884|NCT00065429|469229152|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
130343885|NCT00065429|469229146|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343886|NCT00065429|469229147|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343887|NCT00065429|469229148|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130009830|NCT03668600|467998527|FG000|Overall Study|Lost to Follow-up|7|||
130343888|NCT00065429|469229149|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343889|NCT00065429|469229150|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
130343890|NCT00065429|469229151|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343891|NCT00065429|469229152|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
130343892|NCT00065429|469229146|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343893|NCT00065429|469229147|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130009831|NCT03668600|467998527|FG000|Overall Study|Withdrawal by Subject|56|||
130009832|NCT03668600|467998527|FG000|Overall Study|Lack of Efficacy|7|||
130009833|NCT03668600|467998527|FG000|Overall Study|Adverse Event|1|||
130009834|NCT01476475|467998529|FG000|Overall Study|Adverse Event|6|||
130009835|NCT01476475|467998530|FG001|Overall Study|Adverse Event|0|||
130009836|NCT01476475|467998529|FG000|Overall Study|Poor compliance to protocol|1|||
130009837|NCT01476475|467998530|FG001|Overall Study|Poor compliance to protocol|1|||
130009838|NCT01476475|467998529|FG000|Overall Study|Other reasons|4|||
130009839|NCT01476475|467998530|FG001|Overall Study|Other reasons|2|||
130009840|NCT01278745|467998531|FG000|Overall Study|Death|2|||
130009841|NCT01278745|467998532|FG001|Overall Study|Death|5|||
130009842|NCT01278745|467998533|FG002|Overall Study|Death|7|||
130009843|NCT01278745|467998534|FG003|Overall Study|Death|0|||
130009844|NCT01278745|467998531|FG000|Overall Study|Physician Decision|1|||
130009845|NCT01278745|467998532|FG001|Overall Study|Physician Decision|0|||
130009846|NCT01278745|467998533|FG002|Overall Study|Physician Decision|0|||
130009847|NCT01278745|467998534|FG003|Overall Study|Physician Decision|9|||
130009848|NCT01278745|467998531|FG000|Overall Study|Withdrawal by Subject|1|||
130009849|NCT01278745|467998532|FG001|Overall Study|Withdrawal by Subject|1|||
130009850|NCT01278745|467998533|FG002|Overall Study|Withdrawal by Subject|5|||
130009851|NCT01278745|467998534|FG003|Overall Study|Withdrawal by Subject|1|||
130009852|NCT01278745|467998531|FG000|Overall Study|Sponsor Decision|1|||
130009853|NCT01278745|467998532|FG001|Overall Study|Sponsor Decision|0|||
130343894|NCT00065429|469229148|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343895|NCT00065429|469229149|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343896|NCT00065429|469229150|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
130343897|NCT00065429|469229151|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343898|NCT00065429|469229152|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
130343899|NCT00781885|469229154|FG000|Overall Study|Physician Decision|1|||
130343900|NCT01755026|469229155|FG000|Overall Study|Adverse Event|1|||
130343901|NCT01755026|469229156|FG001|Overall Study|Adverse Event|0|||
130343902|NCT01755026|469229155|FG000|Overall Study|Withdrawal by Subject|1|||
130343903|NCT01755026|469229156|FG001|Overall Study|Withdrawal by Subject|1|||
130343904|NCT01806662|469229163|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
130343905|NCT01806662|469229164|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
130343906|NCT01806662|469229163|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
130343907|NCT01806662|469229164|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
130343908|NCT01806662|469229163|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
130343909|NCT01806662|469229164|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
130343910|NCT01806662|469229163|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
130343911|NCT01806662|469229164|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
130343912|NCT01917656|469229172|FG000|Overall Study|Adverse Event|11|||
130343913|NCT01917656|469229173|FG001|Overall Study|Adverse Event|0|||
130343914|NCT01917656|469229172|FG000|Overall Study|Withdrawal criteria|8|||
130343915|NCT01917656|469229173|FG001|Overall Study|Withdrawal criteria|14|||
130343916|NCT01917656|469229172|FG000|Overall Study|Unclassified|0|||
130343917|NCT01917656|469229173|FG001|Overall Study|Unclassified|3|||
130343918|NCT01917656|469229172|FG000|Overall Study|Withdrawal by Subject|4|||
130343919|NCT01917656|469229173|FG001|Overall Study|Withdrawal by Subject|3|||
130343920|NCT01917656|469229172|FG000|Overall Study|Lost to Follow-up|3|||
130343921|NCT01917656|469229173|FG001|Overall Study|Lost to Follow-up|4|||
130343922|NCT02081859|469229174|FG000|Overall Study|No fertilization|2|||
130343923|NCT02081859|469229175|FG001|Overall Study|No fertilization|2|||
130343924|NCT02081859|469229174|FG000|Overall Study|No sperm|1|||
130343925|NCT02081859|469229175|FG001|Overall Study|No sperm|0|||
130343926|NCT02081859|469229174|FG000|Overall Study|Unanticipated freeze all cycle|2|||
130343927|NCT02081859|469229175|FG001|Overall Study|Unanticipated freeze all cycle|6|||
130343928|NCT02081859|469229174|FG000|Overall Study|< 4 embryos|27|||
130343929|NCT02081859|469229175|FG001|Overall Study|< 4 embryos|23|||
130343930|NCT02081859|469229174|FG000|Overall Study|Other reasons|2|||
130343931|NCT02081859|469229175|FG001|Overall Study|Other reasons|0|||
130343932|NCT02285062|469229176|FG000|Pre-Treatment Period|Protocol Violation|0|||
130343933|NCT02285062|469229177|FG001|Pre-Treatment Period|Protocol Violation|2|||
130343934|NCT02285062|469229176|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
130343935|NCT02285062|469229177|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130343936|NCT02015221|469229178|FG000|Overall Study|Withdrawal by Subject|8|||
130343937|NCT02015221|469229179|FG001|Overall Study|Withdrawal by Subject|6|||
130343938|NCT02015221|469229178|FG000|Overall Study|Lost to Follow-up|1|||
130343939|NCT02015221|469229179|FG001|Overall Study|Lost to Follow-up|0|||
130009854|NCT01278745|467998533|FG002|Overall Study|Sponsor Decision|62|||
130009855|NCT01278745|467998534|FG003|Overall Study|Sponsor Decision|6|||
130009856|NCT01278745|467998531|FG000|Overall Study|Ineligible|0|||
130343940|NCT01870076|469229186|FG000|Overall Study|Withdrawal by Subject|1|||
130343941|NCT01870076|469229187|FG001|Overall Study|Withdrawal by Subject|0|||
130343942|NCT01870076|469229188|FG002|Overall Study|Withdrawal by Subject|1|||
130009857|NCT01278745|467998532|FG001|Overall Study|Ineligible|0|||
130009858|NCT01278745|467998533|FG002|Overall Study|Ineligible|42|||
130009859|NCT01278745|467998534|FG003|Overall Study|Ineligible|61|||
130009860|NCT01278745|467998531|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
130009861|NCT01278745|467998532|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
130009862|NCT01278745|467998533|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
130009863|NCT01278745|467998534|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
130009864|NCT01111851|467998535|FG000|Overall Study|All planned PET scans were not obtained.|2|||
130009865|NCT01111851|467998536|FG001|Overall Study|All planned PET scans were not obtained.|0|||
130009866|NCT01471015|467998538|FG000|Overall Study|Death|0|||
130009867|NCT01471015|467998539|FG001|Overall Study|Death|1|||
130009868|NCT01471015|467998540|FG002|Overall Study|Death|1|||
130009869|NCT01843842|467998541|FG000|Overall Study|Do not meet inclusion criteria|1|||
130009870|NCT01843842|467998542|FG001|Overall Study|Do not meet inclusion criteria|1|||
130009871|NCT02953340|467998543|FG000|Overall Study|Death|0|||
130009872|NCT02953340|467998544|FG001|Overall Study|Death|1|||
130009873|NCT02953340|467998543|FG000|Overall Study|Investigator Decision|3|||
130009874|NCT02953340|467998544|FG001|Overall Study|Investigator Decision|3|||
130009875|NCT02953340|467998543|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
130009876|NCT02953340|467998544|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
130009877|NCT02953340|467998543|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
130009878|NCT02953340|467998544|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
130009879|NCT02953340|467998543|FG000|Overall Study|Withdrawal by Subject|9|||
130009880|NCT02953340|467998544|FG001|Overall Study|Withdrawal by Subject|9|||
130009881|NCT02953340|467998543|FG000|Overall Study|Sponsor decision|0|||
130009882|NCT02953340|467998544|FG001|Overall Study|Sponsor decision|2|||
130009883|NCT02953340|467998543|FG000|Overall Study|Lost to Follow-up|3|||
130009884|NCT02953340|467998544|FG001|Overall Study|Lost to Follow-up|2|||
130009885|NCT02953340|467998543|FG000|Overall Study|Reason not specified|2|||
130009886|NCT02953340|467998544|FG001|Overall Study|Reason not specified|2|||
130009887|NCT02700412|467998547|FG000|Overall Study|Adverse Event|6|||
130009888|NCT02700412|467998547|FG000|Overall Study|Death|1|||
130009889|NCT02700412|467998547|FG000|Overall Study|Lack of Efficacy|19|||
130009890|NCT02700412|467998547|FG000|Overall Study|Protocol Violation|5|||
130009891|NCT02700412|467998547|FG000|Overall Study|Withdrawal by Subject|2|||
130009892|NCT01197521|467998550|FG000|Overall Study|Not reported|24|||
130009893|NCT01197521|467998551|FG001|Overall Study|Not reported|25|||
130009894|NCT01197521|467998552|FG002|Overall Study|Not reported|21|||
130009895|NCT01197521|467998550|FG000|Overall Study|Enrolment in long term extension|42|||
130009896|NCT01197521|467998551|FG001|Overall Study|Enrolment in long term extension|36|||
130009897|NCT01197521|467998552|FG002|Overall Study|Enrolment in long term extension|87|||
130009898|NCT01197521|467998550|FG000|Overall Study|Severe non-compliance to protocol|1|||
130009899|NCT01197521|467998551|FG001|Overall Study|Severe non-compliance to protocol|3|||
130009900|NCT01197521|467998552|FG002|Overall Study|Severe non-compliance to protocol|3|||
130009901|NCT01197521|467998550|FG000|Overall Study|Lack of therapeutic response|2|||
130009902|NCT01197521|467998551|FG001|Overall Study|Lack of therapeutic response|3|||
130009903|NCT01197521|467998552|FG002|Overall Study|Lack of therapeutic response|4|||
130009904|NCT01197521|467998550|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
130009905|NCT01197521|467998551|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
130343943|NCT01870076|469229189|FG003|Overall Study|Withdrawal by Subject|0|||
130343944|NCT00492063|469229190|FG000|Overall Study|Death|0|||
130343945|NCT00492063|469229191|FG001|Overall Study|Death|0|||
130343946|NCT00492063|469229192|FG002|Overall Study|Death|1|||
130343947|NCT00492063|469229193|FG003|Overall Study|Death|2|||
130343948|NCT00492063|469229190|FG000|Overall Study|Withdrawal by Subject|4|||
130343949|NCT00492063|469229191|FG001|Overall Study|Withdrawal by Subject|3|||
130343950|NCT00492063|469229192|FG002|Overall Study|Withdrawal by Subject|5|||
130343951|NCT00492063|469229193|FG003|Overall Study|Withdrawal by Subject|4|||
130343952|NCT00492063|469229190|FG000|Overall Study|Lost to Follow-up|6|||
130343953|NCT00492063|469229191|FG001|Overall Study|Lost to Follow-up|11|||
130343954|NCT00492063|469229192|FG002|Overall Study|Lost to Follow-up|5|||
130343955|NCT00492063|469229193|FG003|Overall Study|Lost to Follow-up|3|||
130343956|NCT00492063|469229190|FG000|Overall Study|Protocol Violation|0|||
130343957|NCT00492063|469229191|FG001|Overall Study|Protocol Violation|0|||
130343958|NCT00492063|469229192|FG002|Overall Study|Protocol Violation|0|||
130343959|NCT00492063|469229193|FG003|Overall Study|Protocol Violation|1|||
130009906|NCT01197521|467998552|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
130009907|NCT01197521|467998550|FG000|Overall Study|Lost to Follow-up|3|||
130009908|NCT01197521|467998551|FG001|Overall Study|Lost to Follow-up|2|||
130343960|NCT03041129|469229196|FG000|Overall Study|Withdrawal by Subject|2|||
130009909|NCT01197521|467998552|FG002|Overall Study|Lost to Follow-up|2|||
130009910|NCT01197521|467998550|FG000|Overall Study|Adverse Event|25|||
130009911|NCT01197521|467998551|FG001|Overall Study|Adverse Event|28|||
130009912|NCT01197521|467998552|FG002|Overall Study|Adverse Event|24|||
130009913|NCT01309659|467998553|FG000|Overall Study|Protocol Violation|0|||
130009914|NCT01309659|467998554|FG001|Overall Study|Protocol Violation|1|||
130343961|NCT03041129|469229197|FG001|Overall Study|Withdrawal by Subject|0|||
130343962|NCT03041129|469229198|FG002|Overall Study|Withdrawal by Subject|0|||
130009915|NCT02285777|467998558|FG000|Overall Study|Withdrawal by Subject|1|||
130009916|NCT02285777|467998559|FG001|Overall Study|Withdrawal by Subject|1|||
130009917|NCT02285777|467998558|FG000|Overall Study|Lost to Follow-up|4|||
130009918|NCT02285777|467998559|FG001|Overall Study|Lost to Follow-up|2|||
130009919|NCT03962101|467998563|FG000|Overall Study|Adverse Event|1|||
130009920|NCT03962101|467998563|FG000|Overall Study|Physician Decision|2|||
130009921|NCT03962101|467998563|FG000|Overall Study|Not related to medical events|1|||
130009922|NCT00271596|467998570|FG000|Overall Study|Protocol Violation|1|||
130009923|NCT00271596|467998571|FG001|Overall Study|Protocol Violation|0|||
130009924|NCT00271596|467998570|FG000|Overall Study|Withdrawal by Subject|0|||
130009925|NCT00271596|467998571|FG001|Overall Study|Withdrawal by Subject|1|||
130009926|NCT05003622|467998572|FG000|Overall Study|Progressive disease|2|||
130009927|NCT05003622|467998572|FG000|Overall Study|Withdrawal by Subject|1|||
130009928|NCT01045798|467998578|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
130009929|NCT01045798|467998579|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
130009930|NCT01045798|467998578|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
130009931|NCT01045798|467998579|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
130009932|NCT01045798|467998578|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
130009933|NCT01045798|467998579|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
130009934|NCT01045798|467998578|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
130009935|NCT01045798|467998579|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
130009936|NCT01484977|467998583|FG000|Overall Study|Adverse Event|8|||
130009937|NCT01484977|467998583|FG000|Overall Study|Lack of Efficacy|4|||
130009938|NCT01484977|467998583|FG000|Overall Study|Protocol Violation|6|||
130009939|NCT01484977|467998583|FG000|Overall Study|Lost to Follow-up|1|||
130009940|NCT01484977|467998583|FG000|Overall Study|Withdrawal by Subject|4|||
130009941|NCT01484977|467998583|FG000|Overall Study|Subject Protocol Non-compliant|1|||
130009942|NCT01484977|467998583|FG000|Overall Study|Moving Overseas|1|||
130009943|NCT01484977|467998583|FG000|Overall Study|Low White Blood Cell Count|1|||
130009944|NCT01484977|467998583|FG000|Overall Study|Lack of Compliance|1|||
130009945|NCT02269787|467998586|FG000|Overall Study|Lost to Follow-up|20|||
130009946|NCT02269787|467998587|FG001|Overall Study|Lost to Follow-up|6|||
130009947|NCT02269787|467998586|FG000|Overall Study|Death|2|||
130009948|NCT02269787|467998587|FG001|Overall Study|Death|3|||
130009949|NCT02269787|467998586|FG000|Overall Study|Incapacitated|0|||
130009950|NCT02269787|467998587|FG001|Overall Study|Incapacitated|1|||
130009951|NCT02228720|467998588|FG000|Open Label - Day 30|Lost to Follow-up|1|||
130009952|NCT05264740|467998595|FG000|Baseline|Withdrawal by Subject|0|||
130009953|NCT05264740|467998596|FG001|Baseline|Withdrawal by Subject|1|||
130009954|NCT05264740|467998595|FG000|Follow Up 1|Lost to Follow-up|1|||
130343963|NCT03041129|469229199|FG003|Overall Study|Withdrawal by Subject|0|||
130343964|NCT00510653|469229200|FG000|Overall Study|Withdrawal by Subject|8|||
130343965|NCT00510653|469229200|FG000|Overall Study|Monetary|3|||
130343966|NCT01947855|469229201|FG000|Overall Study|Withdrawal by Subject|1|||
130343967|NCT01947855|469229202|FG001|Overall Study|Withdrawal by Subject|0|||
130343968|NCT01947855|469229203|FG002|Overall Study|Withdrawal by Subject|0|||
130343969|NCT00821509|469229204|FG000|Overall Study|Withdrawal by Subject|12|||
130343970|NCT00821509|469229205|FG001|Overall Study|Withdrawal by Subject|11|||
130343971|NCT00821509|469229206|FG002|Overall Study|Withdrawal by Subject|34|||
130343972|NCT01246466|469230904|FG000|Overall Study|Death|1|||
130343973|NCT01246466|469230904|FG000|Overall Study|Withdrawal by Subject|1|||
130343974|NCT00877773|469230905|FG000|Overall Study|Disease Progression|44|||
130343975|NCT01012219|469230908|FG000|Period 1|Withdrawal by Subject|1|||
130343976|NCT01012219|469230908|FG000|Period 2|Withdrawal by Subject|1|||
130343977|NCT00003590|469230911|FG000|Overall Study|Ineligible Patient|1|||
130343978|NCT00003590|469230911|FG000|Overall Study|Adverse Event|7|||
130343979|NCT00003590|469230911|FG000|Overall Study|Withdrawal by Subject|1|||
130343980|NCT00003590|469230911|FG000|Overall Study|Lack of Efficacy|11|||
130009955|NCT05264740|467998596|FG001|Follow Up 1|Lost to Follow-up|1|||
130009956|NCT05264740|467998595|FG000|Follow Up 1|Withdrawal by Subject|0|||
130009957|NCT05264740|467998596|FG001|Follow Up 1|Withdrawal by Subject|1|||
130009958|NCT05264740|467998595|FG000|Follow Up 2|Lost to Follow-up|1|||
130009959|NCT05264740|467998596|FG001|Follow Up 2|Lost to Follow-up|4|||
130009960|NCT05264740|467998595|FG000|Follow Up 3|Lost to Follow-up|7|||
130009961|NCT05264740|467998596|FG001|Follow Up 3|Lost to Follow-up|4|||
130009962|NCT00597753|467998599|FG000|Overall Study|Adverse Event|6|||
130009963|NCT00597753|467998600|FG001|Overall Study|Adverse Event|2|||
130009964|NCT00597753|467998599|FG000|Overall Study|Death|55|||
130009965|NCT00597753|467998600|FG001|Overall Study|Death|29|||
130009966|NCT00597753|467998599|FG000|Overall Study|Lack of Efficacy|2|||
130343981|NCT00003590|469230911|FG000|Overall Study|Death|1|||
130009967|NCT00597753|467998600|FG001|Overall Study|Lack of Efficacy|0|||
130009968|NCT00597753|467998599|FG000|Overall Study|Lost to Follow-up|10|||
130009969|NCT00597753|467998600|FG001|Overall Study|Lost to Follow-up|3|||
130009970|NCT00597753|467998599|FG000|Overall Study|Physician Decision|5|||
130009971|NCT00597753|467998600|FG001|Overall Study|Physician Decision|1|||
130343982|NCT00003590|469230911|FG000|Overall Study|Physician Decision|1|||
130343983|NCT00883688|469230912|FG000|Overall Study|Ineligible|2|||
130009972|NCT00597753|467998599|FG000|Overall Study|Pregnancy|1|||
130009973|NCT00597753|467998600|FG001|Overall Study|Pregnancy|0|||
130009974|NCT00597753|467998599|FG000|Overall Study|Withdrawal by Subject|35|||
130009975|NCT00597753|467998600|FG001|Overall Study|Withdrawal by Subject|12|||
130009976|NCT00597753|467998599|FG000|Overall Study|Discontinued Dialysis|0|||
130009977|NCT00597753|467998600|FG001|Overall Study|Discontinued Dialysis|1|||
130009978|NCT00597753|467998599|FG000|Overall Study|Never dosed|2|||
130009979|NCT00597753|467998600|FG001|Overall Study|Never dosed|0|||
130009980|NCT00597753|467998599|FG000|Overall Study|Noncompliance|2|||
130009981|NCT00597753|467998600|FG001|Overall Study|Noncompliance|1|||
130009982|NCT00597753|467998599|FG000|Overall Study|Relocation|17|||
130009983|NCT00597753|467998600|FG001|Overall Study|Relocation|6|||
130009984|NCT00597753|467998599|FG000|Overall Study|Renal transplant|10|||
130009985|NCT00597753|467998600|FG001|Overall Study|Renal transplant|3|||
130009986|NCT00597753|467998599|FG000|Overall Study|Site closed by sponsor|19|||
130009987|NCT00597753|467998600|FG001|Overall Study|Site closed by sponsor|7|||
130009988|NCT00597753|467998599|FG000|Overall Study|Site elected to close|2|||
130009989|NCT00597753|467998600|FG001|Overall Study|Site elected to close|4|||
130009990|NCT03451851|467998601|FG000|PCP: Week 0 -16|Adverse Event|1|||
130009991|NCT03451851|467998602|FG001|PCP: Week 0 -16|Adverse Event|0|||
130009992|NCT03451851|467998603|FG002|PCP: Week 0 -16|Adverse Event|0|||
130009993|NCT03451851|467998604|FG003|PCP: Week 0 -16|Adverse Event|0|||
130009994|NCT03451851|467998605|FG004|PCP: Week 0 -16|Adverse Event|0|||
130009995|NCT03451851|467998606|FG005|PCP: Week 0 -16|Adverse Event|0|||
130009996|NCT03451851|467998607|FG006|PCP: Week 0 -16|Adverse Event|1|||
130009997|NCT03451851|467998608|FG007|PCP: Week 0 -16|Adverse Event|0|||
130009998|NCT03451851|467998601|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
130009999|NCT03451851|467998602|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
130010000|NCT03451851|467998603|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
130010001|NCT03451851|467998604|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
130010002|NCT03451851|467998605|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
130010003|NCT03451851|467998606|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
130010004|NCT03451851|467998607|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
130010005|NCT03451851|467998608|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
130010006|NCT03451851|467998601|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130010007|NCT03451851|467998602|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130216602|NCT05305989|468755618|FG002|Overall Study|Protocol Violation|0|||
130343984|NCT01350544|469230916|FG000|Overall Study|Administrative Withdrawal|0|||
130343985|NCT01350544|469230917|FG001|Overall Study|Administrative Withdrawal|1|||
130343986|NCT01350544|469230916|FG000|Overall Study|Death|1|||
130343987|NCT01350544|469230917|FG001|Overall Study|Death|2|||
130343988|NCT01350544|469230916|FG000|Overall Study|Moved out of LA County|2|||
130343989|NCT01350544|469230917|FG001|Overall Study|Moved out of LA County|2|||
130343990|NCT01350544|469230916|FG000|Overall Study|Medical Issues|1|||
130343991|NCT01350544|469230917|FG001|Overall Study|Medical Issues|1|||
130343992|NCT01350544|469230916|FG000|Overall Study|Withdrawal by Subject|0|||
130343993|NCT01350544|469230917|FG001|Overall Study|Withdrawal by Subject|1|||
130343994|NCT01350544|469230916|FG000|Overall Study|Incarceration|1|||
130343995|NCT01350544|469230917|FG001|Overall Study|Incarceration|0|||
130343996|NCT01350544|469230916|FG000|Overall Study|Lost to Follow-up|18|||
130343997|NCT01350544|469230917|FG001|Overall Study|Lost to Follow-up|15|||
130343998|NCT01444092|469230918|FG000|Overall Study|Adverse Event|8|||
130343999|NCT01444092|469230918|FG000|Overall Study|Protocol Violation|1|||
130344000|NCT01444092|469230918|FG000|Overall Study|Withdrawal by Subject|1|||
130344001|NCT01444092|469230918|FG000|Overall Study|Other Eligibility criteria|7|||
130344002|NCT03085914|469230923|FG000|Overall Study|Death|6|||
130344003|NCT03085914|469230924|FG001|Overall Study|Death|6|||
130344004|NCT03085914|469230925|FG002|Overall Study|Death|4|||
130344005|NCT03085914|469230926|FG003|Overall Study|Death|1|||
130344006|NCT03085914|469230927|FG004|Overall Study|Death|5|||
130344007|NCT03085914|469230928|FG005|Overall Study|Death|2|||
130344008|NCT03085914|469230929|FG006|Overall Study|Death|2|||
130010008|NCT03451851|467998603|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
130010009|NCT03451851|467998604|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130010010|NCT03451851|467998605|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130010011|NCT03451851|467998606|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130010012|NCT03451851|467998607|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130216603|NCT05305989|468755616|FG000|Overall Study|Investigator decision|1|||
130344009|NCT03085914|469230923|FG000|Overall Study|Withdrawal by Subject|1|||
130344010|NCT03085914|469230924|FG001|Overall Study|Withdrawal by Subject|1|||
130344011|NCT03085914|469230925|FG002|Overall Study|Withdrawal by Subject|2|||
130010013|NCT03451851|467998608|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
130010014|NCT03451851|467998601|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130344012|NCT03085914|469230926|FG003|Overall Study|Withdrawal by Subject|2|||
130344013|NCT03085914|469230927|FG004|Overall Study|Withdrawal by Subject|2|||
130344014|NCT03085914|469230928|FG005|Overall Study|Withdrawal by Subject|0|||
130344015|NCT03085914|469230929|FG006|Overall Study|Withdrawal by Subject|1|||
130010015|NCT03451851|467998602|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130010016|NCT03451851|467998603|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130010017|NCT03451851|467998604|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130010018|NCT03451851|467998605|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
130010019|NCT03451851|467998606|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
130010020|NCT03451851|467998607|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130010021|NCT03451851|467998608|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
130010022|NCT03451851|467998601|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010023|NCT03451851|467998602|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010024|NCT03451851|467998603|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010025|NCT03451851|467998604|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010026|NCT03451851|467998605|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
130344016|NCT03085914|469230923|FG000|Overall Study|Lost to Follow-up|0|||
130344017|NCT03085914|469230924|FG001|Overall Study|Lost to Follow-up|0|||
130344018|NCT03085914|469230925|FG002|Overall Study|Lost to Follow-up|1|||
130344019|NCT03085914|469230926|FG003|Overall Study|Lost to Follow-up|0|||
130344020|NCT03085914|469230927|FG004|Overall Study|Lost to Follow-up|0|||
130344021|NCT03085914|469230928|FG005|Overall Study|Lost to Follow-up|1|||
130344022|NCT03085914|469230929|FG006|Overall Study|Lost to Follow-up|1|||
130344023|NCT03085914|469230923|FG000|Overall Study|Reason was not specified,|2|||
130344024|NCT03085914|469230924|FG001|Overall Study|Reason was not specified,|2|||
130344025|NCT03085914|469230925|FG002|Overall Study|Reason was not specified,|2|||
130344026|NCT03085914|469230926|FG003|Overall Study|Reason was not specified,|3|||
130344027|NCT03085914|469230927|FG004|Overall Study|Reason was not specified,|3|||
130344028|NCT03085914|469230928|FG005|Overall Study|Reason was not specified,|3|||
130344029|NCT03085914|469230929|FG006|Overall Study|Reason was not specified,|6|||
130344030|NCT03085914|469230923|FG000|Overall Study|Progressive Disease|0|||
130344031|NCT03085914|469230924|FG001|Overall Study|Progressive Disease|0|||
130344032|NCT03085914|469230925|FG002|Overall Study|Progressive Disease|2|||
130344033|NCT03085914|469230926|FG003|Overall Study|Progressive Disease|2|||
130344034|NCT03085914|469230927|FG004|Overall Study|Progressive Disease|1|||
130344035|NCT03085914|469230928|FG005|Overall Study|Progressive Disease|1|||
130344036|NCT03085914|469230929|FG006|Overall Study|Progressive Disease|1|||
130344037|NCT03085914|469230923|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130344038|NCT03085914|469230924|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130344039|NCT03085914|469230925|FG002|Overall Study|Study Terminated by the Sponsor|0|||
129884408|NCT02771210|467536387|FG000|Period 1|Withdrawal by Subject|0|||
130344040|NCT03085914|469230926|FG003|Overall Study|Study Terminated by the Sponsor|1|||
130344041|NCT03085914|469230927|FG004|Overall Study|Study Terminated by the Sponsor|2|||
130344042|NCT03085914|469230928|FG005|Overall Study|Study Terminated by the Sponsor|1|||
130344043|NCT03085914|469230929|FG006|Overall Study|Study Terminated by the Sponsor|0|||
130344044|NCT01242813|469230930|FG000|Overall Study|Lost to Follow-up|2|||
130344045|NCT01252667|469230932|FG000|Overall Study|Transplant aborted post-conditioning|0|||
130344046|NCT01252667|469230933|FG001|Overall Study|Transplant aborted post-conditioning|0|||
130344047|NCT01252667|469230934|FG002|Overall Study|Transplant aborted post-conditioning|0|||
130344048|NCT01252667|469230935|FG003|Overall Study|Transplant aborted post-conditioning|0|||
130344049|NCT01252667|469230936|FG004|Overall Study|Transplant aborted post-conditioning|0|||
130344050|NCT01252667|469230937|FG005|Overall Study|Transplant aborted post-conditioning|1|||
130344051|NCT04644315|469230938|FG000|Overall Study|Subject withdrawal of consent|1|||
130344052|NCT01836276|469230939|FG000|Overall Study|Lost to Follow-up|28|||
130344053|NCT01836276|469230940|FG001|Overall Study|Lost to Follow-up|51|||
130344054|NCT00331552|469230943|FG000|Period 3: Phase II|Neurological Symptoms|1|||
130344055|NCT00331552|469230944|FG001|Period 3: Phase II|Neurological Symptoms|0|||
130344056|NCT00331552|469230943|FG000|Period 3: Phase II|Severe Nausea|1|||
130344057|NCT00331552|469230944|FG001|Period 3: Phase II|Severe Nausea|0|||
130344058|NCT01445548|469230945|FG000|Overall Study|Adverse Event|1|||
130344059|NCT02122783|469230952|FG000|Overall Study|Adverse Event|0|||
130344060|NCT02122783|469230953|FG001|Overall Study|Adverse Event|1|||
130344061|NCT02353143|469230959|FG000|Overall Study|Withdrawal by Subject|1|||
130344062|NCT02353143|469230960|FG001|Overall Study|Withdrawal by Subject|0|||
130344063|NCT02353143|469230961|FG002|Overall Study|Withdrawal by Subject|0|||
130344064|NCT02353143|469230962|FG003|Overall Study|Withdrawal by Subject|0|||
130344065|NCT02353143|469230963|FG004|Overall Study|Withdrawal by Subject|1|||
130344066|NCT02353143|469230964|FG005|Overall Study|Withdrawal by Subject|0|||
130344067|NCT02353143|469230965|FG006|Overall Study|Withdrawal by Subject|0|||
130344068|NCT02353143|469230966|FG007|Overall Study|Withdrawal by Subject|1|||
130344069|NCT02353143|469230967|FG008|Overall Study|Withdrawal by Subject|1|||
130344070|NCT02353143|469230959|FG000|Overall Study|Lack of Efficacy|2|||
130344071|NCT02353143|469230960|FG001|Overall Study|Lack of Efficacy|1|||
130344072|NCT02353143|469230961|FG002|Overall Study|Lack of Efficacy|2|||
130344073|NCT02353143|469230962|FG003|Overall Study|Lack of Efficacy|4|||
130344074|NCT02353143|469230963|FG004|Overall Study|Lack of Efficacy|13|||
130344075|NCT02353143|469230964|FG005|Overall Study|Lack of Efficacy|2|||
130344076|NCT02353143|469230965|FG006|Overall Study|Lack of Efficacy|2|||
130344077|NCT02353143|469230966|FG007|Overall Study|Lack of Efficacy|2|||
130344078|NCT02353143|469230967|FG008|Overall Study|Lack of Efficacy|1|||
130344079|NCT02353143|469230959|FG000|Overall Study|reason not specified|1|||
130344080|NCT02353143|469230960|FG001|Overall Study|reason not specified|2|||
130344081|NCT02353143|469230961|FG002|Overall Study|reason not specified|0|||
130344082|NCT02353143|469230962|FG003|Overall Study|reason not specified|0|||
130344083|NCT02353143|469230963|FG004|Overall Study|reason not specified|6|||
130344084|NCT02353143|469230964|FG005|Overall Study|reason not specified|1|||
130344085|NCT02353143|469230965|FG006|Overall Study|reason not specified|0|||
130344086|NCT02353143|469230966|FG007|Overall Study|reason not specified|3|||
130344087|NCT02353143|469230967|FG008|Overall Study|reason not specified|1|||
130344088|NCT02353143|469230959|FG000|Overall Study|Physician Decision|0|||
130344089|NCT02353143|469230960|FG001|Overall Study|Physician Decision|4|||
130344090|NCT02353143|469230961|FG002|Overall Study|Physician Decision|2|||
130344091|NCT02353143|469230962|FG003|Overall Study|Physician Decision|3|||
130344092|NCT02353143|469230963|FG004|Overall Study|Physician Decision|4|||
130344093|NCT02353143|469230964|FG005|Overall Study|Physician Decision|0|||
130344094|NCT02353143|469230965|FG006|Overall Study|Physician Decision|1|||
130344095|NCT02353143|469230966|FG007|Overall Study|Physician Decision|2|||
130344096|NCT02353143|469230967|FG008|Overall Study|Physician Decision|0|||
130344097|NCT02353143|469230959|FG000|Overall Study|Adverse Event|0|||
130344098|NCT02353143|469230960|FG001|Overall Study|Adverse Event|0|||
130344099|NCT02353143|469230961|FG002|Overall Study|Adverse Event|1|||
130344100|NCT02353143|469230962|FG003|Overall Study|Adverse Event|0|||
130344101|NCT02353143|469230963|FG004|Overall Study|Adverse Event|1|||
130344102|NCT02353143|469230964|FG005|Overall Study|Adverse Event|1|||
130344103|NCT02353143|469230965|FG006|Overall Study|Adverse Event|0|||
130344104|NCT02353143|469230966|FG007|Overall Study|Adverse Event|0|||
130344105|NCT02353143|469230967|FG008|Overall Study|Adverse Event|0|||
130344106|NCT02353143|469230959|FG000|Overall Study|patient receiving other treatment for AML|0|||
130344107|NCT02353143|469230960|FG001|Overall Study|patient receiving other treatment for AML|0|||
130344108|NCT02353143|469230961|FG002|Overall Study|patient receiving other treatment for AML|1|||
130344109|NCT02353143|469230962|FG003|Overall Study|patient receiving other treatment for AML|0|||
130344110|NCT02353143|469230963|FG004|Overall Study|patient receiving other treatment for AML|0|||
130344111|NCT02353143|469230964|FG005|Overall Study|patient receiving other treatment for AML|0|||
130344112|NCT02353143|469230965|FG006|Overall Study|patient receiving other treatment for AML|0|||
130344113|NCT02353143|469230966|FG007|Overall Study|patient receiving other treatment for AML|0|||
130344114|NCT02353143|469230967|FG008|Overall Study|patient receiving other treatment for AML|0|||
130344115|NCT02353143|469230959|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130344116|NCT02353143|469230960|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130344117|NCT02353143|469230961|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130344118|NCT02353143|469230962|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
130344119|NCT02353143|469230963|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
130344120|NCT02353143|469230964|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
130344121|NCT02353143|469230965|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130344122|NCT02353143|469230966|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130344123|NCT02353143|469230967|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
130344124|NCT02946931|469230976|FG000|Overall Study|Did not require collection of CRFs|588|||
130344125|NCT02946931|469230976|FG000|Overall Study|Other than listed|37|||
130344126|NCT02946931|469230976|FG000|Overall Study|Discharge from hospital|118|||
130344127|NCT02946931|469230976|FG000|Overall Study|Adverse Event|81|||
130344128|NCT02946931|469230976|FG000|Overall Study|CRFs not valid|1|||
130344129|NCT02946931|469230976|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
130344130|NCT03339297|469230977|FG000|Overall Study|Relapse of Hematologic Disease|1|||
130344131|NCT03339297|469230978|FG001|Overall Study|Relapse of Hematologic Disease|0|||
130344132|NCT03339297|469230977|FG000|Overall Study|Death|10|||
130344133|NCT03339297|469230978|FG001|Overall Study|Death|7|||
130344134|NCT03339297|469230977|FG000|Overall Study|Hepatic Candidosis|1|||
130344135|NCT03339297|469230978|FG001|Overall Study|Hepatic Candidosis|0|||
130344136|NCT03339297|469230977|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
130344137|NCT03339297|469230978|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
130344138|NCT03339297|469230977|FG000|Overall Study|Consent Withdrawn by Participant|3|||
130344139|NCT03339297|469230978|FG001|Overall Study|Consent Withdrawn by Participant|3|||
130344140|NCT03339297|469230977|FG000|Overall Study|Disease Relapse|2|||
130344141|NCT03339297|469230978|FG001|Overall Study|Disease Relapse|0|||
130344142|NCT03339297|469230977|FG000|Overall Study|Physician Decision|1|||
130344143|NCT03339297|469230978|FG001|Overall Study|Physician Decision|1|||
130344144|NCT03339297|469230977|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
130344145|NCT03339297|469230978|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
130344146|NCT03339297|469230977|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
130344147|NCT03339297|469230978|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
130344148|NCT03339297|469230977|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
130344149|NCT03339297|469230978|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
130344150|NCT03339297|469230977|FG000|Overall Study|Adverse Event, Non-fatal|1|||
130344151|NCT03339297|469230978|FG001|Overall Study|Adverse Event, Non-fatal|0|||
130344152|NCT03339297|469230977|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
130344153|NCT03339297|469230978|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
130344154|NCT03339297|469230977|FG000|Overall Study|Patient Was Not Eligible|1|||
130344155|NCT03339297|469230978|FG001|Overall Study|Patient Was Not Eligible|0|||
130344156|NCT02213133|469230979|FG000|Overall Study|Participant discontinued study therapy|2|||
130344157|NCT02213133|469230980|FG001|Overall Study|Participant discontinued study therapy|0|||
130344158|NCT02213133|469230981|FG002|Overall Study|Participant discontinued study therapy|0|||
130344159|NCT02213133|469230979|FG000|Overall Study|Participant withdrew informed consent|2|||
130344160|NCT02213133|469230980|FG001|Overall Study|Participant withdrew informed consent|1|||
130344161|NCT02213133|469230981|FG002|Overall Study|Participant withdrew informed consent|2|||
130344162|NCT02213133|469230979|FG000|Overall Study|Disease progression|11|||
130344163|NCT02213133|469230980|FG001|Overall Study|Disease progression|2|||
130344164|NCT02213133|469230981|FG002|Overall Study|Disease progression|0|||
130344165|NCT02213133|469230979|FG000|Overall Study|Adverse Event (AE)|1|||
130344166|NCT02213133|469230980|FG001|Overall Study|Adverse Event (AE)|0|||
130344167|NCT02213133|469230981|FG002|Overall Study|Adverse Event (AE)|0|||
130344168|NCT02213133|469230979|FG000|Overall Study|Death|16|||
130344169|NCT02213133|469230980|FG001|Overall Study|Death|2|||
130010027|NCT03451851|467998606|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010028|NCT03451851|467998607|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010029|NCT03451851|467998608|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
130010030|NCT03451851|467998601|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010031|NCT03451851|467998602|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010032|NCT03451851|467998603|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010033|NCT03451851|467998604|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010034|NCT03451851|467998605|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
130010035|NCT03451851|467998606|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010036|NCT03451851|467998607|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010037|NCT03451851|467998608|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
130010038|NCT05885737|467998609|FG000|DB Period|Adverse Event|4|||
130010039|NCT05885737|467998610|FG001|DB Period|Adverse Event|4|||
130010040|NCT05885737|467998609|FG000|DB Period|Lost to Follow-up|0|||
130010041|NCT05885737|467998610|FG001|DB Period|Lost to Follow-up|1|||
130010042|NCT05885737|467998609|FG000|DB Period|Physician Decision|2|||
130010043|NCT05885737|467998610|FG001|DB Period|Physician Decision|0|||
130010044|NCT05885737|467998609|FG000|DB Period|Withdrawal by Subject|12|||
130010045|NCT05885737|467998610|FG001|DB Period|Withdrawal by Subject|6|||
130010046|NCT05885737|467998609|FG000|DB Period|Other: Unspecified|2|||
130010047|NCT05885737|467998610|FG001|DB Period|Other: Unspecified|2|||
130010048|NCT05885737|467998609|FG000|OLE Period|Adverse Event|3|||
130010049|NCT05885737|467998610|FG001|OLE Period|Adverse Event|2|||
130010050|NCT05885737|467998609|FG000|OLE Period|Physician Decision|1|||
130010051|NCT05885737|467998610|FG001|OLE Period|Physician Decision|0|||
130010052|NCT05885737|467998609|FG000|OLE Period|Withdrawal by Subject|5|||
130010053|NCT05885737|467998610|FG001|OLE Period|Withdrawal by Subject|5|||
130010054|NCT05885737|467998609|FG000|OLE Period|Other: Unspecified|2|||
130010055|NCT05885737|467998610|FG001|OLE Period|Other: Unspecified|1|||
130010056|NCT00388973|467999887|FG000|Overall Study|Adverse Event|16|||
130010057|NCT00388973|467999888|FG001|Overall Study|Adverse Event|6|||
130010058|NCT00388973|467999887|FG000|Overall Study|Lack of Efficacy|1|||
130010059|NCT00388973|467999888|FG001|Overall Study|Lack of Efficacy|12|||
130010060|NCT00388973|467999887|FG000|Overall Study|Protocol Violation|3|||
130010061|NCT00388973|467999888|FG001|Overall Study|Protocol Violation|0|||
130010062|NCT00388973|467999887|FG000|Overall Study|Withdrawal by Subject|14|||
130010063|NCT00388973|467999888|FG001|Overall Study|Withdrawal by Subject|17|||
130344170|NCT02213133|469230981|FG002|Overall Study|Death|1|||
130344171|NCT02213133|469230979|FG000|Overall Study|Other|5|||
130344172|NCT02213133|469230980|FG001|Overall Study|Other|0|||
130344173|NCT02213133|469230981|FG002|Overall Study|Other|0|||
130344174|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
130344175|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
130344176|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
130344177|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
130344178|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130344179|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
130344180|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
130344181|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
130344182|NCT04740905|469230990|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
130344183|NCT04740905|469230991|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
130344184|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
130344185|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
130344186|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
130344187|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
130344188|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
130344189|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
130344190|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
130344191|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
130344192|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
130344193|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
130344194|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
130344195|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
130344196|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
130344197|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
130344198|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
130344199|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
130344200|NCT04740905|469230990|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
130344201|NCT04740905|469230991|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
130344202|NCT03051620|469230992|FG000|Overall Study|Lost to Follow-up|6|||
130344203|NCT03051620|469230992|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
130344204|NCT00393510|469230993|FG000|Overall Study|Physician Decision|3|||
130344205|NCT00393510|469230994|FG001|Overall Study|Physician Decision|9|||
130344206|NCT02412488|469230998|FG000|Overall Study|Lost to Follow-up|10|||
130344207|NCT02412488|469230998|FG000|Overall Study|Withdrawal by Subject|5|||
130344208|NCT02412488|469230998|FG000|Overall Study|Physician Decision|1|||
130344209|NCT02412488|469230998|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
130344210|NCT02412488|469230998|FG000|Overall Study|Reveal LINQ explant|1|||
130344211|NCT00796991|469230999|FG000|Overall Study|Adverse Event|0|||
130344212|NCT00796991|469231000|FG001|Overall Study|Adverse Event|0|||
129884409|NCT02771210|467536388|FG001|Period 1|Withdrawal by Subject|3|||
130010064|NCT00388973|467999887|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
130010065|NCT00388973|467999888|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
130010066|NCT00388973|467999887|FG000|Overall Study|Did not complete 61 days of treatment|5|||
130010067|NCT00388973|467999888|FG001|Overall Study|Did not complete 61 days of treatment|4|||
130344213|NCT00796991|469231001|FG002|Overall Study|Adverse Event|1|||
130344214|NCT00796991|469230999|FG000|Overall Study|Death|2|||
130344215|NCT00796991|469231000|FG001|Overall Study|Death|0|||
130344216|NCT00796991|469231001|FG002|Overall Study|Death|0|||
130344217|NCT00796991|469230999|FG000|Overall Study|Disease Progression|10|||
130010068|NCT00388973|467999887|FG000|Overall Study|Left region|0|||
130010069|NCT00388973|467999888|FG001|Overall Study|Left region|1|||
130010070|NCT00388973|467999887|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
130010071|NCT00388973|467999888|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
130010072|NCT00840086|467999895|FG000|Overall Study|Adverse Event|1|||
130344218|NCT00796991|469231000|FG001|Overall Study|Disease Progression|9|||
130344219|NCT00796991|469231001|FG002|Overall Study|Disease Progression|7|||
130344220|NCT00796991|469230999|FG000|Overall Study|Study Drug Toxicity|3|||
130344221|NCT00796991|469231000|FG001|Overall Study|Study Drug Toxicity|3|||
130344222|NCT00796991|469231001|FG002|Overall Study|Study Drug Toxicity|5|||
130344223|NCT00796991|469230999|FG000|Overall Study|Withdrawal by Subject|0|||
130344224|NCT00796991|469231000|FG001|Overall Study|Withdrawal by Subject|0|||
130344225|NCT00796991|469231001|FG002|Overall Study|Withdrawal by Subject|1|||
130344226|NCT00029146|469231002|FG000|Overall Study|Lost to Follow-up|2|||
130344227|NCT00029146|469231003|FG001|Overall Study|Lost to Follow-up|1|||
130344228|NCT00313781|469231004|FG000|Before Crossover|Death|22|||
130344229|NCT00313781|469231005|FG001|Before Crossover|Death|8|||
130344230|NCT00313781|469231006|FG002|Before Crossover|Death|0|||
130344231|NCT00313781|469231004|FG000|Before Crossover|Lost to Follow-up|0|||
130344232|NCT00313781|469231005|FG001|Before Crossover|Lost to Follow-up|3|||
130344233|NCT00313781|469231006|FG002|Before Crossover|Lost to Follow-up|0|||
130344234|NCT00313781|469231004|FG000|Before Crossover|Withdrawal by Subject|3|||
130344235|NCT00313781|469231005|FG001|Before Crossover|Withdrawal by Subject|1|||
130344236|NCT00313781|469231006|FG002|Before Crossover|Withdrawal by Subject|0|||
130344237|NCT00313781|469231004|FG000|Before Crossover|Other|45|||
130344238|NCT00313781|469231005|FG001|Before Crossover|Other|30|||
130344239|NCT00313781|469231006|FG002|Before Crossover|Other|0|||
130344240|NCT00313781|469231004|FG000|Before Crossover|Crossover|0|||
130344241|NCT00313781|469231005|FG001|Before Crossover|Crossover|37|||
130344242|NCT00313781|469231006|FG002|Before Crossover|Crossover|0|||
130344243|NCT00313781|469231004|FG000|Before Crossover|Randomized, not treated|5|||
130344244|NCT00313781|469231005|FG001|Before Crossover|Randomized, not treated|0|||
130344245|NCT00313781|469231006|FG002|Before Crossover|Randomized, not treated|0|||
130344246|NCT00313781|469231004|FG000|After Crossover|Death|0|||
130344247|NCT00313781|469231005|FG001|After Crossover|Death|0|||
130344248|NCT00313781|469231006|FG002|After Crossover|Death|6|||
130344249|NCT00313781|469231004|FG000|After Crossover|Withdrawal by Subject|0|||
130344250|NCT00313781|469231005|FG001|After Crossover|Withdrawal by Subject|0|||
130344251|NCT00313781|469231006|FG002|After Crossover|Withdrawal by Subject|3|||
130344252|NCT00313781|469231004|FG000|After Crossover|Other|0|||
130344253|NCT00313781|469231005|FG001|After Crossover|Other|0|||
130344254|NCT00313781|469231006|FG002|After Crossover|Other|18|||
130344255|NCT03567343|469231007|FG000|Overall Study|Lost to Follow-up|2|||
130344256|NCT03567343|469231008|FG001|Overall Study|Lost to Follow-up|1|||
130344257|NCT03567343|469231007|FG000|Overall Study|No longer eligible|2|||
130344258|NCT03567343|469231008|FG001|Overall Study|No longer eligible|1|||
130344259|NCT03567343|469231007|FG000|Overall Study|Adverse Event|1|||
130344260|NCT03567343|469231008|FG001|Overall Study|Adverse Event|0|||
130344261|NCT03567343|469231007|FG000|Overall Study|Protocol Violation|1|||
130344262|NCT03567343|469231008|FG001|Overall Study|Protocol Violation|1|||
130344263|NCT00834080|469231009|FG000|Overall Study|Adverse Event|7|||
130344264|NCT00834080|469231009|FG000|Overall Study|Lost to Follow-up|7|||
130344265|NCT00834080|469231009|FG000|Overall Study|Withdrawal by Subject|5|||
130344266|NCT00834080|469231009|FG000|Overall Study|Other - Pregnancy|1|||
130344267|NCT00834080|469231009|FG000|Overall Study|Other - False positive tests of the UDS|1|||
130344268|NCT00834080|469231009|FG000|Overall Study|Physician Decision|1|||
130344269|NCT00834080|469231009|FG000|Overall Study|Subject Relocated|1|||
130344270|NCT00392379|469231012|FG000|Overall Study|Withdrawal by Subject|17|||
130344271|NCT00392379|469231013|FG001|Overall Study|Withdrawal by Subject|28|||
130344272|NCT00392379|469231012|FG000|Overall Study|Lost to Follow-up|4|||
130344273|NCT00392379|469231013|FG001|Overall Study|Lost to Follow-up|9|||
130344274|NCT00392379|469231012|FG000|Overall Study|Adverse Event|1|||
130344275|NCT00392379|469231013|FG001|Overall Study|Adverse Event|1|||
130344276|NCT02365233|469231017|FG000|Overall Study|IRB withheld the data|1|||
130010073|NCT00840086|467999895|FG000|Overall Study|Protocol Violation|2|||
130344277|NCT02365233|469231018|FG001|Overall Study|IRB withheld the data|2|||
130344278|NCT02365233|469231019|FG002|Overall Study|IRB withheld the data|2|||
130344279|NCT00827931|469231020|FG000|Overall Study|Death|3|||
130344280|NCT00827931|469231021|FG001|Overall Study|Death|5|||
130344281|NCT00827931|469231020|FG000|Overall Study|Adverse Event|1|||
130344282|NCT00827931|469231021|FG001|Overall Study|Adverse Event|0|||
130344283|NCT00827931|469231020|FG000|Overall Study|Lost to Follow-up|1|||
130344284|NCT00827931|469231021|FG001|Overall Study|Lost to Follow-up|0|||
130344285|NCT00827931|469231020|FG000|Overall Study|Withdrawal by Subject|0|||
130344286|NCT00827931|469231021|FG001|Overall Study|Withdrawal by Subject|1|||
130344287|NCT00827931|469231020|FG000|Overall Study|Other|1|||
130344288|NCT00827931|469231021|FG001|Overall Study|Other|0|||
130344289|NCT00995566|469231022|FG000|Overall Study|Adverse Event|2|||
130344290|NCT00995566|469231022|FG000|Overall Study|Early study termination|52|||
130344291|NCT00608569|469231023|FG000|Overall Study|Death|4|||
130010074|NCT00840086|467999895|FG000|Overall Study|Lost to Follow-up|1|||
130010075|NCT01444742|467999897|FG000|Overall Study|Death|1|||
130010076|NCT02535715|467999898|FG000|Overall Study|Withdrawal by Subject|0|||
130344292|NCT00608569|469231024|FG001|Overall Study|Death|3|||
130344293|NCT00608569|469231023|FG000|Overall Study|Lost to Follow-up|4|||
130344294|NCT00608569|469231024|FG001|Overall Study|Lost to Follow-up|5|||
130344295|NCT00608569|469231023|FG000|Overall Study|Withdrawal by Subject|1|||
130344296|NCT00608569|469231024|FG001|Overall Study|Withdrawal by Subject|0|||
130344297|NCT00608569|469231023|FG000|Overall Study|Adverse Event|1|||
130344298|NCT00608569|469231024|FG001|Overall Study|Adverse Event|0|||
130344299|NCT00608569|469231023|FG000|Overall Study|Unable to adhere with study requirements|0|||
130344300|NCT00608569|469231024|FG001|Overall Study|Unable to adhere with study requirements|1|||
130344301|NCT03011892|469231025|FG000|Double Blind (DB) Period|Adverse Event|0|||
130344302|NCT03011892|469231026|FG001|Double Blind (DB) Period|Adverse Event|1|||
130344303|NCT03011892|469231027|FG002|Double Blind (DB) Period|Adverse Event|1|||
130344304|NCT03011892|469231028|FG003|Double Blind (DB) Period|Adverse Event|0|||
130344305|NCT03011892|469231029|FG004|Double Blind (DB) Period|Adverse Event|0|||
130344306|NCT03011892|469231030|FG005|Double Blind (DB) Period|Adverse Event|0|||
130344307|NCT03011892|469231031|FG006|Double Blind (DB) Period|Adverse Event|0|||
130344308|NCT03011892|469231032|FG007|Double Blind (DB) Period|Adverse Event|0|||
130344309|NCT03011892|469231033|FG008|Double Blind (DB) Period|Adverse Event|0|||
130344310|NCT03011892|469231034|FG009|Double Blind (DB) Period|Adverse Event|0|||
130344311|NCT03011892|469231035|FG010|Double Blind (DB) Period|Adverse Event|0|||
130344312|NCT03011892|469231036|FG011|Double Blind (DB) Period|Adverse Event|0|||
130344313|NCT03011892|469231025|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
130344314|NCT03011892|469231026|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
130344315|NCT03011892|469231027|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
130344316|NCT03011892|469231028|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
130344317|NCT03011892|469231029|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
130344318|NCT03011892|469231030|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
130344319|NCT03011892|469231031|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
130344320|NCT03011892|469231032|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
130344321|NCT03011892|469231033|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
130344322|NCT03011892|469231034|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
130344323|NCT03011892|469231035|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
130344324|NCT03011892|469231036|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
130344325|NCT03011892|469231025|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
130344326|NCT03011892|469231026|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
130344327|NCT03011892|469231027|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
130344328|NCT03011892|469231028|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
130344329|NCT03011892|469231029|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
130344330|NCT03011892|469231030|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
130344331|NCT03011892|469231031|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
130344332|NCT03011892|469231032|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
130344333|NCT03011892|469231033|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
130344334|NCT03011892|469231034|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
130010077|NCT02535715|467999899|FG001|Overall Study|Withdrawal by Subject|0|||
130010078|NCT02535715|467999900|FG002|Overall Study|Withdrawal by Subject|1|||
130344335|NCT03011892|469231035|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
130344336|NCT03011892|469231036|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
130344337|NCT03011892|469231025|FG000|Double Blind (DB) Period|Other|1|||
130344338|NCT03011892|469231026|FG001|Double Blind (DB) Period|Other|1|||
130344339|NCT03011892|469231027|FG002|Double Blind (DB) Period|Other|1|||
130010079|NCT00909181|467999901|FG000|Overall Study|Lost to Follow-up|39|||
130010080|NCT00909181|467999902|FG001|Overall Study|Lost to Follow-up|18|||
130010081|NCT00909181|467999903|FG002|Overall Study|Lost to Follow-up|33|||
130344340|NCT03011892|469231028|FG003|Double Blind (DB) Period|Other|0|||
130344341|NCT03011892|469231029|FG004|Double Blind (DB) Period|Other|1|||
130344342|NCT03011892|469231030|FG005|Double Blind (DB) Period|Other|0|||
130344343|NCT03011892|469231031|FG006|Double Blind (DB) Period|Other|0|||
130344344|NCT03011892|469231032|FG007|Double Blind (DB) Period|Other|0|||
130344345|NCT03011892|469231033|FG008|Double Blind (DB) Period|Other|0|||
130344346|NCT03011892|469231034|FG009|Double Blind (DB) Period|Other|0|||
130344347|NCT03011892|469231035|FG010|Double Blind (DB) Period|Other|0|||
130344348|NCT03011892|469231036|FG011|Double Blind (DB) Period|Other|0|||
130344349|NCT03011892|469231025|FG000|Double Blind (DB) Period|Physician Decision|1|||
130344350|NCT03011892|469231026|FG001|Double Blind (DB) Period|Physician Decision|0|||
130344351|NCT03011892|469231027|FG002|Double Blind (DB) Period|Physician Decision|1|||
130344352|NCT03011892|469231028|FG003|Double Blind (DB) Period|Physician Decision|0|||
130344353|NCT03011892|469231029|FG004|Double Blind (DB) Period|Physician Decision|0|||
130344354|NCT03011892|469231030|FG005|Double Blind (DB) Period|Physician Decision|0|||
130344355|NCT03011892|469231031|FG006|Double Blind (DB) Period|Physician Decision|0|||
130344356|NCT03011892|469231032|FG007|Double Blind (DB) Period|Physician Decision|0|||
130344357|NCT03011892|469231033|FG008|Double Blind (DB) Period|Physician Decision|0|||
130344358|NCT03011892|469231034|FG009|Double Blind (DB) Period|Physician Decision|0|||
130344359|NCT03011892|469231035|FG010|Double Blind (DB) Period|Physician Decision|0|||
130344360|NCT03011892|469231036|FG011|Double Blind (DB) Period|Physician Decision|0|||
130344361|NCT03011892|469231025|FG000|Double Blind (DB) Period|Pregnancy|0|||
130344362|NCT03011892|469231026|FG001|Double Blind (DB) Period|Pregnancy|0|||
130344363|NCT03011892|469231027|FG002|Double Blind (DB) Period|Pregnancy|0|||
130344364|NCT03011892|469231028|FG003|Double Blind (DB) Period|Pregnancy|0|||
130344365|NCT03011892|469231029|FG004|Double Blind (DB) Period|Pregnancy|1|||
130344366|NCT03011892|469231030|FG005|Double Blind (DB) Period|Pregnancy|0|||
130344367|NCT03011892|469231031|FG006|Double Blind (DB) Period|Pregnancy|0|||
130344368|NCT03011892|469231032|FG007|Double Blind (DB) Period|Pregnancy|0|||
130344369|NCT03011892|469231033|FG008|Double Blind (DB) Period|Pregnancy|0|||
130344370|NCT03011892|469231034|FG009|Double Blind (DB) Period|Pregnancy|0|||
130344371|NCT03011892|469231035|FG010|Double Blind (DB) Period|Pregnancy|0|||
130344372|NCT03011892|469231036|FG011|Double Blind (DB) Period|Pregnancy|0|||
130344373|NCT03011892|469231025|FG000|Double Blind (DB) Period|Protocol Violation|1|||
130344374|NCT03011892|469231026|FG001|Double Blind (DB) Period|Protocol Violation|0|||
130344375|NCT03011892|469231027|FG002|Double Blind (DB) Period|Protocol Violation|0|||
130344376|NCT03011892|469231028|FG003|Double Blind (DB) Period|Protocol Violation|0|||
130344377|NCT03011892|469231029|FG004|Double Blind (DB) Period|Protocol Violation|0|||
130344378|NCT03011892|469231030|FG005|Double Blind (DB) Period|Protocol Violation|0|||
130344379|NCT03011892|469231031|FG006|Double Blind (DB) Period|Protocol Violation|0|||
130344380|NCT03011892|469231032|FG007|Double Blind (DB) Period|Protocol Violation|0|||
130344381|NCT03011892|469231033|FG008|Double Blind (DB) Period|Protocol Violation|0|||
130344382|NCT03011892|469231034|FG009|Double Blind (DB) Period|Protocol Violation|0|||
130344383|NCT03011892|469231035|FG010|Double Blind (DB) Period|Protocol Violation|0|||
130344384|NCT03011892|469231036|FG011|Double Blind (DB) Period|Protocol Violation|0|||
130344385|NCT03011892|469231025|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
130344386|NCT03011892|469231026|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
130344387|NCT03011892|469231027|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
130344388|NCT03011892|469231028|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
130344389|NCT03011892|469231029|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
130344390|NCT03011892|469231030|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
130344391|NCT03011892|469231031|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344392|NCT03011892|469231032|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344393|NCT03011892|469231033|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344394|NCT03011892|469231034|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344395|NCT03011892|469231035|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344396|NCT03011892|469231036|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
130344397|NCT03011892|469231025|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
130344398|NCT03011892|469231026|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
130344399|NCT03011892|469231027|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
130344400|NCT03011892|469231028|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
130344401|NCT03011892|469231029|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
130344402|NCT03011892|469231030|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
130344403|NCT03011892|469231031|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
130344404|NCT03011892|469231032|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
130344405|NCT03011892|469231033|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
130344406|NCT03011892|469231034|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
130010082|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
130010083|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
130344407|NCT03011892|469231035|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
130344408|NCT03011892|469231036|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
130344409|NCT03011892|469231025|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
130344410|NCT03011892|469231026|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
130344411|NCT03011892|469231027|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
130344412|NCT03011892|469231028|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
130344413|NCT03011892|469231029|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
130344414|NCT03011892|469231030|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
130344415|NCT03011892|469231031|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
130344416|NCT03011892|469231032|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
130344417|NCT03011892|469231033|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
130344418|NCT03011892|469231034|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
130344419|NCT03011892|469231035|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
130344420|NCT03011892|469231036|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
130344421|NCT03011892|469231025|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
130344422|NCT03011892|469231026|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
130344423|NCT03011892|469231027|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
130344424|NCT03011892|469231028|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
130344425|NCT03011892|469231029|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
130344426|NCT03011892|469231030|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
130344427|NCT03011892|469231031|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
130344428|NCT03011892|469231032|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
130344429|NCT03011892|469231033|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
130344430|NCT03011892|469231034|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
130344431|NCT03011892|469231035|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
130344432|NCT03011892|469231036|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
130344433|NCT03011892|469231025|FG000|Open Label (OL) Period|Reason not specified|0|||
130344434|NCT03011892|469231026|FG001|Open Label (OL) Period|Reason not specified|0|||
130344435|NCT03011892|469231027|FG002|Open Label (OL) Period|Reason not specified|0|||
130344436|NCT03011892|469231028|FG003|Open Label (OL) Period|Reason not specified|0|||
130344437|NCT03011892|469231029|FG004|Open Label (OL) Period|Reason not specified|0|||
130344438|NCT03011892|469231030|FG005|Open Label (OL) Period|Reason not specified|0|||
130344439|NCT03011892|469231031|FG006|Open Label (OL) Period|Reason not specified|0|||
130344440|NCT03011892|469231032|FG007|Open Label (OL) Period|Reason not specified|1|||
130344441|NCT03011892|469231033|FG008|Open Label (OL) Period|Reason not specified|0|||
130344442|NCT03011892|469231034|FG009|Open Label (OL) Period|Reason not specified|0|||
130344443|NCT03011892|469231035|FG010|Open Label (OL) Period|Reason not specified|0|||
130344444|NCT03011892|469231036|FG011|Open Label (OL) Period|Reason not specified|0|||
130344445|NCT02282293|469231037|FG000|Overall Study|Lost to Follow-up|2|||
130344446|NCT02282293|469231038|FG001|Overall Study|Lost to Follow-up|2|||
130344447|NCT02282293|469231037|FG000|Overall Study|Unable to comply with study procedures|1|||
130344448|NCT02282293|469231038|FG001|Overall Study|Unable to comply with study procedures|0|||
130344449|NCT02282293|469231037|FG000|Overall Study|Moved out of study area|0|||
130344450|NCT02282293|469231038|FG001|Overall Study|Moved out of study area|1|||
130344451|NCT02312687|469231040|FG000|Overall Study|Other, Not Specified|1|||
130344452|NCT00384111|469231041|FG000|Overall Study|Disease Progression|3|||
130344453|NCT00384111|469231041|FG000|Overall Study|Adverse Event|1|||
130344454|NCT00384111|469231041|FG000|Overall Study|Investigator Decision|3|||
130344455|NCT00384111|469231041|FG000|Overall Study|Study Terminated by the Sponsor|19|||
130344456|NCT03612856|469231042|FG000|Pre-dose Period|Physician Decision|0|||
130344457|NCT03612856|469231043|FG001|Pre-dose Period|Physician Decision|1|||
130344458|NCT03612856|469231044|FG002|Pre-dose Period|Physician Decision|1|||
130344459|NCT03612856|469231042|FG000|Pre-dose Period|Withdrawal by Subject|0|||
130344460|NCT03612856|469231043|FG001|Pre-dose Period|Withdrawal by Subject|1|||
130344461|NCT03612856|469231044|FG002|Pre-dose Period|Withdrawal by Subject|0|||
130344462|NCT03720652|469231047|FG000|Overall Study|Withdrawal by Subject|2|||
130344463|NCT03720652|469231048|FG001|Overall Study|Withdrawal by Subject|7|||
130344464|NCT03720652|469231047|FG000|Overall Study|Lost to Follow-up|0|||
130344465|NCT03720652|469231048|FG001|Overall Study|Lost to Follow-up|4|||
130344466|NCT01454778|469231053|FG000|Overall Study|Lost to Follow-up|2|||
130344467|NCT01454778|469231053|FG000|Overall Study|Death|1|||
130344468|NCT00348881|469231054|FG000|Overall Study|Lost to Follow-up|12|||
130344469|NCT00348881|469231055|FG001|Overall Study|Lost to Follow-up|6|||
130344470|NCT00348881|469231054|FG000|Overall Study|Withdrawal by Subject|3|||
130344471|NCT00348881|469231055|FG001|Overall Study|Withdrawal by Subject|4|||
130010084|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
130344472|NCT00348881|469231054|FG000|Overall Study|Adverse Event|2|||
130344473|NCT00348881|469231055|FG001|Overall Study|Adverse Event|0|||
130344474|NCT00348881|469231054|FG000|Overall Study|Serious Adverse Event|0|||
130344475|NCT00348881|469231055|FG001|Overall Study|Serious Adverse Event|2|||
130344476|NCT03658876|469232929|FG000|Overall Study|Protocol Violation|3|||
130344477|NCT03658876|469232930|FG001|Overall Study|Protocol Violation|2|||
130010085|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
130010086|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
130010087|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
130010088|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
130010089|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
130010090|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
130010091|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
130010092|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
130010093|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
130010094|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
130344478|NCT03658876|469232929|FG000|Overall Study|Withdrawal by Subject|2|||
130344479|NCT03658876|469232930|FG001|Overall Study|Withdrawal by Subject|0|||
130344480|NCT03658876|469232929|FG000|Overall Study|Death|0|||
130344481|NCT03658876|469232930|FG001|Overall Study|Death|1|||
130344482|NCT03658876|469232929|FG000|Overall Study|Intercurrent illness|6|||
130344483|NCT03658876|469232930|FG001|Overall Study|Intercurrent illness|4|||
130344484|NCT03658876|469232929|FG000|Overall Study|Transplantation/other operation|1|||
130344485|NCT03658876|469232930|FG001|Overall Study|Transplantation/other operation|5|||
130344486|NCT01330017|469232931|FG000|Overall Study|Adverse Event|0|||
130344487|NCT01330017|469232932|FG001|Overall Study|Adverse Event|1|||
130344488|NCT01330017|469232933|FG002|Overall Study|Adverse Event|1|||
130344489|NCT01330017|469232934|FG003|Overall Study|Adverse Event|4|||
130344490|NCT01330017|469232935|FG004|Overall Study|Adverse Event|0|||
130344491|NCT01330017|469232931|FG000|Overall Study|Withdrawal by Subject|0|||
130344492|NCT01330017|469232932|FG001|Overall Study|Withdrawal by Subject|0|||
130344493|NCT01330017|469232933|FG002|Overall Study|Withdrawal by Subject|1|||
130344494|NCT01330017|469232934|FG003|Overall Study|Withdrawal by Subject|0|||
130344495|NCT01330017|469232935|FG004|Overall Study|Withdrawal by Subject|1|||
130344496|NCT01330017|469232931|FG000|Overall Study|Lost to Follow-up|0|||
130344497|NCT01330017|469232932|FG001|Overall Study|Lost to Follow-up|0|||
130344498|NCT01330017|469232933|FG002|Overall Study|Lost to Follow-up|1|||
130344499|NCT01330017|469232934|FG003|Overall Study|Lost to Follow-up|0|||
130344500|NCT01330017|469232935|FG004|Overall Study|Lost to Follow-up|0|||
130344501|NCT01330017|469232931|FG000|Overall Study|Protocol Violation|0|||
130344502|NCT01330017|469232932|FG001|Overall Study|Protocol Violation|0|||
130344503|NCT01330017|469232933|FG002|Overall Study|Protocol Violation|0|||
130344504|NCT01330017|469232934|FG003|Overall Study|Protocol Violation|1|||
130344505|NCT01330017|469232935|FG004|Overall Study|Protocol Violation|0|||
130344506|NCT01330017|469232931|FG000|Overall Study|Unknown Reason|5|||
130344507|NCT01330017|469232932|FG001|Overall Study|Unknown Reason|3|||
130344508|NCT01330017|469232933|FG002|Overall Study|Unknown Reason|5|||
130344509|NCT01330017|469232934|FG003|Overall Study|Unknown Reason|7|||
130344510|NCT01330017|469232935|FG004|Overall Study|Unknown Reason|2|||
130344511|NCT02616146|469232937|FG000|Overall Study|Adverse Event|64|||
130344512|NCT02616146|469232938|FG001|Overall Study|Adverse Event|24|||
130344513|NCT02616146|469232937|FG000|Overall Study|Lost to Follow-up|23|||
130344514|NCT02616146|469232938|FG001|Overall Study|Lost to Follow-up|13|||
130344515|NCT02616146|469232937|FG000|Overall Study|Non-compliance with study protocol|2|||
130344516|NCT02616146|469232938|FG001|Overall Study|Non-compliance with study protocol|0|||
130344517|NCT02616146|469232937|FG000|Overall Study|Non-compliance with study drug|4|||
130344518|NCT02616146|469232938|FG001|Overall Study|Non-compliance with study drug|2|||
130344519|NCT02616146|469232937|FG000|Overall Study|Pregnancy|2|||
130344520|NCT02616146|469232938|FG001|Overall Study|Pregnancy|2|||
130344521|NCT02616146|469232937|FG000|Overall Study|Pregnancy wish|3|||
130344522|NCT02616146|469232938|FG001|Overall Study|Pregnancy wish|0|||
130344523|NCT02616146|469232937|FG000|Overall Study|Protocol Violation|6|||
130344524|NCT02616146|469232938|FG001|Overall Study|Protocol Violation|3|||
130344525|NCT02616146|469232937|FG000|Overall Study|Study terminated by sponsor|1372|||
130344526|NCT02616146|469232938|FG001|Overall Study|Study terminated by sponsor|432|||
130344527|NCT02616146|469232937|FG000|Overall Study|Participant moved|4|||
130010095|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
130010096|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
130344528|NCT02616146|469232938|FG001|Overall Study|Participant moved|3|||
130344529|NCT02616146|469232937|FG000|Overall Study|Withdrawal by Subject|30|||
130344530|NCT02616146|469232938|FG001|Overall Study|Withdrawal by Subject|24|||
130344531|NCT02616146|469232937|FG000|Overall Study|Physician Decision|2|||
130344532|NCT02616146|469232938|FG001|Overall Study|Physician Decision|1|||
130344533|NCT01221272|469232939|FG000|Period 1|Adverse Event|2|||
130344534|NCT01221272|469232940|FG001|Period 1|Adverse Event|0|||
130344535|NCT01221272|469232939|FG000|Period 1|Consent Withdrawal|0|||
130344536|NCT01221272|469232940|FG001|Period 1|Consent Withdrawal|1|||
130344537|NCT01221272|469232939|FG000|Period 1|Significant Dosing Noncompliance|0|||
130216604|NCT05305989|468755617|FG001|Overall Study|Investigator decision|2|||
130216605|NCT05305989|468755618|FG002|Overall Study|Investigator decision|0|||
130216606|NCT05305989|468755616|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
130344538|NCT01221272|469232940|FG001|Period 1|Significant Dosing Noncompliance|1|||
130344539|NCT01221272|469232939|FG000|Period 2|Adverse Event|0|||
130344540|NCT01221272|469232940|FG001|Period 2|Adverse Event|2|||
130344541|NCT01106092|469232943|FG000|Overall Study|Withdrawal by Subject|0|||
130344542|NCT01106092|469232944|FG001|Overall Study|Withdrawal by Subject|0|||
130344543|NCT01106092|469232945|FG002|Overall Study|Withdrawal by Subject|0|||
130344544|NCT01106092|469232946|FG003|Overall Study|Withdrawal by Subject|1|||
130344545|NCT04839562|469232953|FG000|Overall Study|Withdrawal by Subject|0|||
130344546|NCT04839562|469232954|FG001|Overall Study|Withdrawal by Subject|1|||
130344547|NCT04839562|469232953|FG000|Overall Study|Physician Decision|0|||
130344548|NCT04839562|469232954|FG001|Overall Study|Physician Decision|1|||
130344549|NCT00730028|469232955|FG000|Overall Study|Adverse Event|23|||
130344550|NCT00730028|469232956|FG001|Overall Study|Adverse Event|26|||
130344551|NCT00730028|469232957|FG002|Overall Study|Adverse Event|16|||
130344552|NCT00730028|469232958|FG003|Overall Study|Adverse Event|20|||
130344553|NCT00730028|469232959|FG004|Overall Study|Adverse Event|43|||
130344554|NCT00730028|469232955|FG000|Overall Study|Lost to Follow-up|13|||
130344555|NCT00730028|469232956|FG001|Overall Study|Lost to Follow-up|26|||
130344556|NCT00730028|469232957|FG002|Overall Study|Lost to Follow-up|22|||
130344557|NCT00730028|469232958|FG003|Overall Study|Lost to Follow-up|26|||
130344558|NCT00730028|469232959|FG004|Overall Study|Lost to Follow-up|25|||
130344559|NCT00730028|469232955|FG000|Overall Study|Protocol Violation|6|||
130344560|NCT00730028|469232956|FG001|Overall Study|Protocol Violation|1|||
130344561|NCT00730028|469232957|FG002|Overall Study|Protocol Violation|1|||
130344562|NCT00730028|469232958|FG003|Overall Study|Protocol Violation|2|||
130344563|NCT00730028|469232959|FG004|Overall Study|Protocol Violation|0|||
130344564|NCT00730028|469232955|FG000|Overall Study|Withdrawal by Subject|9|||
130344565|NCT00730028|469232956|FG001|Overall Study|Withdrawal by Subject|5|||
130344566|NCT00730028|469232957|FG002|Overall Study|Withdrawal by Subject|4|||
130344567|NCT00730028|469232958|FG003|Overall Study|Withdrawal by Subject|5|||
130344568|NCT00730028|469232959|FG004|Overall Study|Withdrawal by Subject|9|||
130344569|NCT00730028|469232955|FG000|Overall Study|Physician Decision|3|||
130344570|NCT00730028|469232956|FG001|Overall Study|Physician Decision|3|||
130344571|NCT00730028|469232957|FG002|Overall Study|Physician Decision|2|||
130344572|NCT00730028|469232958|FG003|Overall Study|Physician Decision|3|||
130344573|NCT00730028|469232959|FG004|Overall Study|Physician Decision|2|||
130344574|NCT00730028|469232955|FG000|Overall Study|Treatment Failure|5|||
130344575|NCT00730028|469232956|FG001|Overall Study|Treatment Failure|5|||
130344576|NCT00730028|469232957|FG002|Overall Study|Treatment Failure|0|||
130344577|NCT00730028|469232958|FG003|Overall Study|Treatment Failure|0|||
130344578|NCT00730028|469232959|FG004|Overall Study|Treatment Failure|1|||
130344579|NCT00730028|469232955|FG000|Overall Study|Randomization Error|1|||
130344580|NCT00730028|469232956|FG001|Overall Study|Randomization Error|0|||
130344581|NCT00730028|469232957|FG002|Overall Study|Randomization Error|0|||
130344582|NCT00730028|469232958|FG003|Overall Study|Randomization Error|0|||
130344583|NCT00730028|469232959|FG004|Overall Study|Randomization Error|2|||
130344584|NCT00003472|469232960|FG000|Overall Study|Not evaluable|3|||
130344585|NCT00528970|469232961|FG000|Overall Study|Adverse Event|6|||
130344586|NCT00528970|469232962|FG001|Overall Study|Adverse Event|8|||
130344587|NCT00528970|469232963|FG002|Overall Study|Adverse Event|5|||
130344588|NCT00528970|469232961|FG000|Overall Study|Lost to Follow-up|0|||
130344589|NCT00528970|469232962|FG001|Overall Study|Lost to Follow-up|0|||
130344590|NCT00528970|469232963|FG002|Overall Study|Lost to Follow-up|1|||
130344591|NCT00528970|469232961|FG000|Overall Study|Other than specified|2|||
130344592|NCT00528970|469232962|FG001|Overall Study|Other than specified|3|||
130344593|NCT00528970|469232963|FG002|Overall Study|Other than specified|3|||
130344594|NCT00528970|469232961|FG000|Overall Study|Protocol Violation|2|||
130344595|NCT00528970|469232962|FG001|Overall Study|Protocol Violation|1|||
130344596|NCT00528970|469232963|FG002|Overall Study|Protocol Violation|4|||
130344597|NCT00528970|469232961|FG000|Overall Study|Lack of Efficacy|0|||
130344598|NCT00528970|469232962|FG001|Overall Study|Lack of Efficacy|0|||
130344599|NCT00528970|469232963|FG002|Overall Study|Lack of Efficacy|1|||
130344600|NCT00528970|469232961|FG000|Overall Study|Withdrawal by Subject|4|||
130344601|NCT00528970|469232962|FG001|Overall Study|Withdrawal by Subject|3|||
130344602|NCT00528970|469232963|FG002|Overall Study|Withdrawal by Subject|5|||
130344603|NCT00528970|469232961|FG000|Overall Study|Randomized but not treated|0|||
130344604|NCT00528970|469232962|FG001|Overall Study|Randomized but not treated|0|||
130344605|NCT00528970|469232963|FG002|Overall Study|Randomized but not treated|1|||
130344606|NCT03316911|469232969|FG000|Overall Study|Lost to Follow-up|33|||
130344607|NCT03316911|469232970|FG001|Overall Study|Lost to Follow-up|29|||
130344608|NCT01119937|469232971|FG000|Overall Study|Adverse Event|11|||
130344609|NCT01119937|469232972|FG001|Overall Study|Adverse Event|5|||
130344610|NCT01119937|469232971|FG000|Overall Study|Protocol deviation|3|||
130344611|NCT01119937|469232972|FG001|Overall Study|Protocol deviation|1|||
130344612|NCT01119937|469232971|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130216607|NCT05305989|468755617|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
130216608|NCT05305989|468755618|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
130216609|NCT05305989|468755616|FG000|Overall Study|Adverse Event|1|||
130344613|NCT01119937|469232972|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130344614|NCT01119937|469232971|FG000|Overall Study|Withdrawal by Subject|2|||
130344615|NCT01119937|469232972|FG001|Overall Study|Withdrawal by Subject|1|||
130344616|NCT02536404|469232974|FG000|Overall Study|Adverse Event|5|||
130344617|NCT02536404|469232975|FG001|Overall Study|Adverse Event|0|||
130344618|NCT02536404|469232974|FG000|Overall Study|Withdrawal by Subject|4|||
130344619|NCT02536404|469232975|FG001|Overall Study|Withdrawal by Subject|1|||
130344620|NCT02536404|469232974|FG000|Overall Study|Physician Decision|10|||
130344621|NCT02536404|469232975|FG001|Overall Study|Physician Decision|0|||
130344622|NCT02536404|469232974|FG000|Overall Study|Sponsor decision|1|||
130344623|NCT02536404|469232975|FG001|Overall Study|Sponsor decision|0|||
130010097|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
130010098|NCT00094770|467999905|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
130010099|NCT00094770|467999906|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
130010100|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
130010101|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
130010102|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
130010103|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
130010104|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
130010105|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
130010106|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
130010107|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
130010108|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
130010109|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
130010110|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
130010111|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
130010112|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
130010113|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
130344624|NCT00770146|469232976|FG000|Treatment Period|Withdrawal by Subject|6|||
130344625|NCT00770146|469232977|FG001|Treatment Period|Withdrawal by Subject|13|||
130344626|NCT00770146|469232976|FG000|Treatment Period|Adverse Event|2|||
130344627|NCT00770146|469232977|FG001|Treatment Period|Adverse Event|26|||
130344628|NCT00770146|469232976|FG000|Treatment Period|Other|1|||
130344629|NCT00770146|469232977|FG001|Treatment Period|Other|5|||
130344630|NCT00770146|469232976|FG000|Treatment Period|Protocol non-compliance|0|||
130344631|NCT00770146|469232977|FG001|Treatment Period|Protocol non-compliance|1|||
130344632|NCT00770146|469232976|FG000|Follow-up Period|Withdrawal by Subject|7|||
130344633|NCT00770146|469232977|FG001|Follow-up Period|Withdrawal by Subject|13|||
130344634|NCT00770146|469232976|FG000|Follow-up Period|Adverse Event|0|||
130344635|NCT00770146|469232977|FG001|Follow-up Period|Adverse Event|2|||
130344636|NCT00770146|469232976|FG000|Follow-up Period|Other|4|||
130344637|NCT00770146|469232977|FG001|Follow-up Period|Other|5|||
130344638|NCT00816023|469232981|FG000|Overall Study|Lost to Follow-up|1|||
130344639|NCT00816023|469232982|FG001|Overall Study|Lost to Follow-up|1|||
130344640|NCT00816023|469232983|FG002|Overall Study|Lost to Follow-up|0|||
130344641|NCT00816023|469232984|FG003|Overall Study|Lost to Follow-up|0|||
130344642|NCT00816023|469232981|FG000|Overall Study|Withdrawal by Subject|1|||
130344643|NCT00816023|469232982|FG001|Overall Study|Withdrawal by Subject|0|||
130344644|NCT00816023|469232983|FG002|Overall Study|Withdrawal by Subject|0|||
130344645|NCT00816023|469232984|FG003|Overall Study|Withdrawal by Subject|0|||
130344646|NCT00816023|469232981|FG000|Overall Study|Physician Decision|0|||
130344647|NCT00816023|469232982|FG001|Overall Study|Physician Decision|0|||
130344648|NCT00816023|469232983|FG002|Overall Study|Physician Decision|1|||
130344649|NCT00816023|469232984|FG003|Overall Study|Physician Decision|0|||
130344650|NCT00816023|469232981|FG000|Overall Study|assessments complete prior to window|1|||
130344651|NCT00816023|469232982|FG001|Overall Study|assessments complete prior to window|1|||
130344652|NCT00816023|469232983|FG002|Overall Study|assessments complete prior to window|2|||
130344653|NCT00816023|469232984|FG003|Overall Study|assessments complete prior to window|1|||
130344654|NCT00816023|469232981|FG000|Overall Study|Randomized Not Treated|6|||
130344655|NCT00816023|469232982|FG001|Overall Study|Randomized Not Treated|4|||
130344656|NCT00816023|469232983|FG002|Overall Study|Randomized Not Treated|6|||
130344657|NCT00816023|469232984|FG003|Overall Study|Randomized Not Treated|11|||
130344658|NCT01525901|469232985|FG000|Period 2: 12 Weeks|Adverse Event|0|||
130344659|NCT01525901|469232986|FG001|Period 2: 12 Weeks|Adverse Event|1|||
130344660|NCT01525901|469232987|FG002|Period 2: 12 Weeks|Adverse Event|0|||
130344661|NCT01525901|469232988|FG003|Period 2: 12 Weeks|Adverse Event|0|||
130344662|NCT05027971|469232993|FG000|Overall Study|Physician Decision|7|||
130344663|NCT05027971|469232994|FG001|Overall Study|Physician Decision|3|||
130344664|NCT05027971|469232993|FG000|Overall Study|Lost to Follow-up|1|||
130344665|NCT05027971|469232994|FG001|Overall Study|Lost to Follow-up|1|||
130344666|NCT05027971|469232993|FG000|Overall Study|Withdrawal by Subject|0|||
130344667|NCT05027971|469232994|FG001|Overall Study|Withdrawal by Subject|2|||
130344668|NCT05027971|469232993|FG000|Overall Study|Non-study fiber used.|0|||
130344669|NCT05027971|469232994|FG001|Overall Study|Non-study fiber used.|1|||
130344670|NCT05027971|469232993|FG000|Overall Study|Protocol Violation|0|||
130344671|NCT05027971|469232994|FG001|Overall Study|Protocol Violation|2|||
130344672|NCT02486627|469232995|FG000|Overall Study|Death|1|||
130344673|NCT02486627|469232996|FG001|Overall Study|Death|0|||
130344674|NCT02486627|469232995|FG000|Overall Study|Other Unspecified|0|||
130344675|NCT02486627|469232996|FG001|Overall Study|Other Unspecified|2|||
130344676|NCT02486627|469232995|FG000|Overall Study|Consent Withdrawn by Participant|4|||
130344677|NCT02486627|469232996|FG001|Overall Study|Consent Withdrawn by Participant|3|||
130344678|NCT02486627|469232995|FG000|Overall Study|Significant Participant Noncompliance|1|||
130344679|NCT02486627|469232996|FG001|Overall Study|Significant Participant Noncompliance|1|||
130344680|NCT02486627|469232995|FG000|Overall Study|Lost to Follow-up|1|||
130344681|NCT02486627|469232996|FG001|Overall Study|Lost to Follow-up|3|||
130344682|NCT01073462|469232998|FG000|Overall Study|Death|14|||
130344683|NCT01073462|469232998|FG000|Overall Study|Kidney transplant|10|||
130344684|NCT01073462|469232998|FG000|Overall Study|Low parathyroid hormone levels|8|||
130344685|NCT01073462|469232998|FG000|Overall Study|Serious adverse event|2|||
130344686|NCT01073462|469232998|FG000|Overall Study|Lost to Follow-up|7|||
130344687|NCT01238588|469232999|FG000|Overall Study|Withdrawal by Subject|1|||
130344688|NCT01238588|469232999|FG000|Overall Study|Physician Decision|2|||
130344689|NCT05395091|469233002|FG000|Baseline to Month 12|Adverse Event|7|||
130344690|NCT05395091|469233003|FG001|Baseline to Month 12|Adverse Event|2|||
130344691|NCT05395091|469233004|FG002|Baseline to Month 12|Adverse Event|0|||
130344692|NCT05395091|469233002|FG000|Baseline to Month 12|Death|3|||
130344693|NCT05395091|469233003|FG001|Baseline to Month 12|Death|1|||
130344694|NCT05395091|469233004|FG002|Baseline to Month 12|Death|0|||
130344695|NCT05395091|469233002|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
130344696|NCT05395091|469233003|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
130344697|NCT05395091|469233004|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
130344698|NCT05395091|469233002|FG000|Baseline to Month 12|Protocol Violation|2|||
130344699|NCT05395091|469233003|FG001|Baseline to Month 12|Protocol Violation|3|||
130344700|NCT05395091|469233004|FG002|Baseline to Month 12|Protocol Violation|0|||
130344701|NCT05395091|469233002|FG000|Baseline to Month 12|Physician Decision|1|||
130344702|NCT05395091|469233003|FG001|Baseline to Month 12|Physician Decision|0|||
130344703|NCT05395091|469233004|FG002|Baseline to Month 12|Physician Decision|0|||
130344704|NCT05395091|469233002|FG000|Month 12 to Month 18|Death|1|||
130344705|NCT05395091|469233003|FG001|Month 12 to Month 18|Death|0|||
130344706|NCT05395091|469233004|FG002|Month 12 to Month 18|Death|0|||
130344707|NCT05395091|469233002|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
130344708|NCT05395091|469233003|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
130344709|NCT05395091|469233004|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
130344710|NCT05395091|469233002|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
130344711|NCT05395091|469233003|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
130344712|NCT05395091|469233004|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
130344713|NCT05395091|469233002|FG000|Month 12 to Month 18|Other reasons|0|||
130344714|NCT05395091|469233003|FG001|Month 12 to Month 18|Other reasons|0|||
130344715|NCT05395091|469233004|FG002|Month 12 to Month 18|Other reasons|1|||
130344716|NCT03554486|469233005|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
130344717|NCT03554486|469233006|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
130344718|NCT03554486|469233007|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
130344719|NCT03554486|469233005|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
130344720|NCT03554486|469233006|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
130344721|NCT03554486|469233007|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
130344722|NCT03554486|469233005|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130344723|NCT03554486|469233006|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130344724|NCT03554486|469233007|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130344725|NCT01509053|469233008|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
130344726|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
130344727|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
130344728|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
130344729|NCT01509053|469233008|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
130344730|NCT01509053|469233008|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
130344731|NCT01915303|469233009|FG000|Core Phase|Adverse Event|7|||
130344732|NCT01915303|469233009|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
130344733|NCT01915303|469233009|FG000|Core Phase|Death|2|||
130344734|NCT01915303|469233009|FG000|Core Phase|Protocol Violation|2|||
130344735|NCT01915303|469233009|FG000|Core Phase|Abnormal lab value|1|||
130344736|NCT01915303|469233009|FG000|Core Phase|Withdrawal by Subject|1|||
130344737|NCT01915303|469233009|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
130344738|NCT01915303|469233009|FG000|Extension Phase|Withdrawal by Subject|4|||
130344739|NCT01915303|469233009|FG000|Extension Phase|Adverse Event|3|||
130344740|NCT01915303|469233009|FG000|Extension Phase|Death|1|||
130344741|NCT01915303|469233009|FG000|Extension Phase|Protocol Violation|1|||
130344742|NCT02925338|469233010|FG000|Overall Study|Death|0|||
130344743|NCT02925338|469233011|FG001|Overall Study|Death|2|||
130344744|NCT02925338|469233012|FG002|Overall Study|Death|1|||
130344745|NCT02925338|469233013|FG003|Overall Study|Death|0|||
130344746|NCT02925338|469233014|FG004|Overall Study|Death|0|||
130344747|NCT02925338|469233010|FG000|Overall Study|Lost to Follow-up|30|||
130344748|NCT02925338|469233011|FG001|Overall Study|Lost to Follow-up|10|||
130344749|NCT02925338|469233012|FG002|Overall Study|Lost to Follow-up|1|||
130344750|NCT02925338|469233013|FG003|Overall Study|Lost to Follow-up|16|||
130344751|NCT02925338|469233014|FG004|Overall Study|Lost to Follow-up|3|||
130344752|NCT02925338|469233010|FG000|Overall Study|Withdrawal by Subject|3|||
130344753|NCT02925338|469233011|FG001|Overall Study|Withdrawal by Subject|0|||
130344754|NCT02925338|469233012|FG002|Overall Study|Withdrawal by Subject|3|||
130344755|NCT02925338|469233013|FG003|Overall Study|Withdrawal by Subject|2|||
130344756|NCT02925338|469233014|FG004|Overall Study|Withdrawal by Subject|2|||
130344757|NCT02925338|469233010|FG000|Overall Study|Missing|38|||
130344758|NCT02925338|469233011|FG001|Overall Study|Missing|27|||
130344759|NCT02925338|469233012|FG002|Overall Study|Missing|0|||
130344760|NCT02925338|469233013|FG003|Overall Study|Missing|3|||
130344761|NCT02925338|469233014|FG004|Overall Study|Missing|2|||
130344762|NCT02925338|469233010|FG000|Overall Study|Participant's Decision|11|||
130344763|NCT02925338|469233011|FG001|Overall Study|Participant's Decision|7|||
130344764|NCT02925338|469233012|FG002|Overall Study|Participant's Decision|3|||
130344765|NCT02925338|469233013|FG003|Overall Study|Participant's Decision|8|||
130344766|NCT02925338|469233014|FG004|Overall Study|Participant's Decision|1|||
130344767|NCT02925338|469233010|FG000|Overall Study|Treatment Discontinuation|144|||
130344768|NCT02925338|469233011|FG001|Overall Study|Treatment Discontinuation|65|||
130344769|NCT02925338|469233012|FG002|Overall Study|Treatment Discontinuation|56|||
130344770|NCT02925338|469233013|FG003|Overall Study|Treatment Discontinuation|131|||
130344771|NCT02925338|469233014|FG004|Overall Study|Treatment Discontinuation|22|||
130010114|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
130010115|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
130010116|NCT00094770|467999905|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
130010117|NCT00094770|467999906|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
130010118|NCT00914927|467999907|FG000|Overall Study|Adverse Event|0|||
130010119|NCT00914927|467999908|FG001|Overall Study|Adverse Event|0|||
130010120|NCT00914927|467999909|FG002|Overall Study|Adverse Event|0|||
130010121|NCT00914927|467999910|FG003|Overall Study|Adverse Event|0|||
130010122|NCT00914927|467999911|FG004|Overall Study|Adverse Event|1|||
130010123|NCT00914927|467999912|FG005|Overall Study|Adverse Event|0|||
130010124|NCT00914927|467999913|FG006|Overall Study|Adverse Event|0|||
130010125|NCT00914927|467999907|FG000|Overall Study|Withdrawal by Subject|0|||
130010126|NCT00914927|467999908|FG001|Overall Study|Withdrawal by Subject|1|||
130344772|NCT00636363|469233017|FG000|Overall Study|Conjunctivitis|0|||
130344773|NCT00636363|469233018|FG001|Overall Study|Conjunctivitis|0|||
130344774|NCT00636363|469233019|FG002|Overall Study|Conjunctivitis|1|||
130344775|NCT00636363|469233017|FG000|Overall Study|Adverse Event|0|||
130344776|NCT00636363|469233018|FG001|Overall Study|Adverse Event|0|||
130344777|NCT00636363|469233019|FG002|Overall Study|Adverse Event|1|||
130344778|NCT00636363|469233017|FG000|Overall Study|Positive slit lamp finding|0|||
130344779|NCT00636363|469233018|FG001|Overall Study|Positive slit lamp finding|2|||
130344780|NCT00636363|469233019|FG002|Overall Study|Positive slit lamp finding|1|||
130344781|NCT00636363|469233017|FG000|Overall Study|Study related symptoms/complaints|8|||
130344782|NCT00636363|469233018|FG001|Overall Study|Study related symptoms/complaints|7|||
130344783|NCT00636363|469233019|FG002|Overall Study|Study related symptoms/complaints|4|||
130344784|NCT00636363|469233017|FG000|Overall Study|Met ineligibility criteria|0|||
130344785|NCT00636363|469233018|FG001|Overall Study|Met ineligibility criteria|0|||
130344786|NCT00636363|469233019|FG002|Overall Study|Met ineligibility criteria|3|||
130344787|NCT00636363|469233017|FG000|Overall Study|Missed > 1 visit|0|||
130344788|NCT00636363|469233018|FG001|Overall Study|Missed > 1 visit|1|||
130344789|NCT00636363|469233019|FG002|Overall Study|Missed > 1 visit|3|||
130344790|NCT00636363|469233017|FG000|Overall Study|Lack of motivation|1|||
130344791|NCT00636363|469233018|FG001|Overall Study|Lack of motivation|0|||
130344792|NCT00636363|469233019|FG002|Overall Study|Lack of motivation|1|||
130344793|NCT00636363|469233017|FG000|Overall Study|Protocol Violation|0|||
130344794|NCT00636363|469233018|FG001|Overall Study|Protocol Violation|3|||
130344795|NCT00636363|469233019|FG002|Overall Study|Protocol Violation|0|||
130344796|NCT00636363|469233017|FG000|Overall Study|Lost to Follow-up|3|||
130344797|NCT00636363|469233018|FG001|Overall Study|Lost to Follow-up|4|||
130344798|NCT00636363|469233019|FG002|Overall Study|Lost to Follow-up|2|||
130344799|NCT00636363|469233017|FG000|Overall Study|Withdrawal by Subject|1|||
130344800|NCT00636363|469233018|FG001|Overall Study|Withdrawal by Subject|3|||
130344801|NCT00636363|469233019|FG002|Overall Study|Withdrawal by Subject|2|||
130344802|NCT00280748|469233021|FG000|Overall Study|Decline in performance|3|||
130344803|NCT00280748|469233021|FG000|Overall Study|Extra-cranial disease progression|1|||
130344804|NCT01433250|469233023|FG000|Overall Study|Protocol Violation|0|||
130344805|NCT01433250|469233024|FG001|Overall Study|Protocol Violation|1|||
130344806|NCT01433250|469233023|FG000|Overall Study|Withdrawal by Subject|3|||
130344807|NCT01433250|469233024|FG001|Overall Study|Withdrawal by Subject|2|||
130344808|NCT00321646|469233028|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
130344809|NCT00321646|469233028|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
130344810|NCT00321646|469233028|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
130344811|NCT02730793|469233029|FG000|Overall Study|Physician Decision|0|||
130344812|NCT02730793|469233030|FG001|Overall Study|Physician Decision|1|||
130344813|NCT02730793|469233029|FG000|Overall Study|Withdrawal by Subject|0|||
130344814|NCT02730793|469233030|FG001|Overall Study|Withdrawal by Subject|1|||
130344815|NCT00534313|469233032|FG000|Short-term Period|Adverse Event|1|||
130344816|NCT00534313|469233033|FG001|Short-term Period|Adverse Event|2|||
130344817|NCT00534313|469233034|FG002|Short-term Period|Adverse Event|1|||
130344818|NCT00534313|469233035|FG003|Short-term Period|Adverse Event|3|||
130344819|NCT00534313|469233032|FG000|Short-term Period|Lack of Efficacy|3|||
130344820|NCT00534313|469233033|FG001|Short-term Period|Lack of Efficacy|4|||
130344821|NCT00534313|469233034|FG002|Short-term Period|Lack of Efficacy|0|||
130344822|NCT00534313|469233035|FG003|Short-term Period|Lack of Efficacy|3|||
130344823|NCT00534313|469233032|FG000|Short-term Period|Participant not meeting study criteria|0|||
130344824|NCT00534313|469233033|FG001|Short-term Period|Participant not meeting study criteria|0|||
130344825|NCT00534313|469233034|FG002|Short-term Period|Participant not meeting study criteria|0|||
130344826|NCT00534313|469233035|FG003|Short-term Period|Participant not meeting study criteria|1|||
130344827|NCT00534313|469233032|FG000|Short-term Period|Participant withdrew consent|2|||
130344828|NCT00534313|469233033|FG001|Short-term Period|Participant withdrew consent|0|||
130344829|NCT00534313|469233034|FG002|Short-term Period|Participant withdrew consent|0|||
130344830|NCT00534313|469233035|FG003|Short-term Period|Participant withdrew consent|2|||
130010127|NCT00914927|467999909|FG002|Overall Study|Withdrawal by Subject|0|||
130010128|NCT00914927|467999910|FG003|Overall Study|Withdrawal by Subject|1|||
130010129|NCT00914927|467999911|FG004|Overall Study|Withdrawal by Subject|0|||
130010130|NCT00914927|467999912|FG005|Overall Study|Withdrawal by Subject|0|||
130010131|NCT00914927|467999913|FG006|Overall Study|Withdrawal by Subject|0|||
130010132|NCT00914927|467999907|FG000|Overall Study|Lost to Follow-up|0|||
130010133|NCT00914927|467999908|FG001|Overall Study|Lost to Follow-up|0|||
130010134|NCT00914927|467999909|FG002|Overall Study|Lost to Follow-up|0|||
130010135|NCT00914927|467999910|FG003|Overall Study|Lost to Follow-up|1|||
130010136|NCT00914927|467999911|FG004|Overall Study|Lost to Follow-up|0|||
130010137|NCT00914927|467999912|FG005|Overall Study|Lost to Follow-up|0|||
130010138|NCT00914927|467999913|FG006|Overall Study|Lost to Follow-up|0|||
130010139|NCT00914927|467999907|FG000|Overall Study|Administrative/Other|2|||
130010140|NCT00914927|467999908|FG001|Overall Study|Administrative/Other|1|||
130010141|NCT00914927|467999909|FG002|Overall Study|Administrative/Other|0|||
130010142|NCT00914927|467999910|FG003|Overall Study|Administrative/Other|0|||
130010143|NCT00914927|467999911|FG004|Overall Study|Administrative/Other|1|||
130344831|NCT00534313|469233032|FG000|Short-term Period|Pregnancy|0|||
130344832|NCT00534313|469233033|FG001|Short-term Period|Pregnancy|0|||
130344833|NCT00534313|469233034|FG002|Short-term Period|Pregnancy|1|||
130344834|NCT00534313|469233035|FG003|Short-term Period|Pregnancy|0|||
130344835|NCT00534313|469233032|FG000|Long-term Period|Adverse Event|2|||
130344836|NCT00534313|469233033|FG001|Long-term Period|Adverse Event|1|||
130344837|NCT00534313|469233034|FG002|Long-term Period|Adverse Event|0|||
130344838|NCT00534313|469233035|FG003|Long-term Period|Adverse Event|1|||
130344839|NCT00534313|469233032|FG000|Long-term Period|Lack of Efficacy|14|||
130344840|NCT00534313|469233033|FG001|Long-term Period|Lack of Efficacy|10|||
130344841|NCT00534313|469233034|FG002|Long-term Period|Lack of Efficacy|14|||
130344842|NCT00534313|469233035|FG003|Long-term Period|Lack of Efficacy|12|||
130344843|NCT00534313|469233032|FG000|Long-term Period|Lost to Follow-up|1|||
130344844|NCT00534313|469233033|FG001|Long-term Period|Lost to Follow-up|2|||
130344845|NCT00534313|469233034|FG002|Long-term Period|Lost to Follow-up|0|||
130344846|NCT00534313|469233035|FG003|Long-term Period|Lost to Follow-up|0|||
130344847|NCT00534313|469233032|FG000|Long-term Period|Withdrawal by Subject|2|||
130344848|NCT00534313|469233033|FG001|Long-term Period|Withdrawal by Subject|2|||
130344849|NCT00534313|469233034|FG002|Long-term Period|Withdrawal by Subject|0|||
130344850|NCT00534313|469233035|FG003|Long-term Period|Withdrawal by Subject|0|||
130344851|NCT00534313|469233032|FG000|Long-term Period|No longer meets study criteria|0|||
130344852|NCT00534313|469233033|FG001|Long-term Period|No longer meets study criteria|1|||
130344853|NCT00534313|469233034|FG002|Long-term Period|No longer meets study criteria|0|||
130344854|NCT00534313|469233035|FG003|Long-term Period|No longer meets study criteria|0|||
130344855|NCT00534313|469233032|FG000|Long-term Period|Poor compliance/noncompliance|0|||
130344856|NCT00534313|469233033|FG001|Long-term Period|Poor compliance/noncompliance|1|||
130344857|NCT00534313|469233034|FG002|Long-term Period|Poor compliance/noncompliance|1|||
130344858|NCT00534313|469233035|FG003|Long-term Period|Poor compliance/noncompliance|0|||
130344859|NCT00534313|469233032|FG000|Long-term Period|Administrative reason by sponsor|17|||
130344860|NCT00534313|469233033|FG001|Long-term Period|Administrative reason by sponsor|15|||
130344861|NCT00534313|469233034|FG002|Long-term Period|Administrative reason by sponsor|26|||
130344862|NCT00534313|469233035|FG003|Long-term Period|Administrative reason by sponsor|18|||
130344863|NCT00534313|469233032|FG000|Long-term Period|Other|1|||
130344864|NCT00534313|469233033|FG001|Long-term Period|Other|2|||
130344865|NCT00534313|469233034|FG002|Long-term Period|Other|2|||
130344866|NCT00534313|469233035|FG003|Long-term Period|Other|2|||
130344867|NCT00927940|469233037|FG000|Overall Study|Death|1|||
130344868|NCT03007888|469233038|FG000|First Intervention (14 Days)|Adverse Event|1|||
130344869|NCT03007888|469233039|FG001|First Intervention (14 Days)|Adverse Event|0|||
130344870|NCT00043550|469233042|FG000|Overall Study|Withdrawal by Subject|22|||
130344871|NCT00043550|469233043|FG001|Overall Study|Withdrawal by Subject|12|||
130344872|NCT00043550|469233044|FG002|Overall Study|Withdrawal by Subject|20|||
130344873|NCT00436501|469233048|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
130344874|NCT00436501|469233049|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
130344875|NCT00436501|469233048|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
130344876|NCT00436501|469233049|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
130344877|NCT00217464|469233053|FG000|Overall Study|Progression|15|||
130344878|NCT00217464|469233053|FG000|Overall Study|Other|2|||
130010144|NCT00914927|467999912|FG005|Overall Study|Administrative/Other|0|||
130010145|NCT00914927|467999913|FG006|Overall Study|Administrative/Other|0|||
130216610|NCT05305989|468755617|FG001|Overall Study|Adverse Event|1|||
130344879|NCT01089361|469233054|FG000|Overall Study|Death|1|||
130344880|NCT01089361|469233055|FG001|Overall Study|Death|0|||
130344881|NCT01576159|469233056|FG000|Overall Study|Withdrawal by Subject|0|||
130344882|NCT01576159|469233057|FG001|Overall Study|Withdrawal by Subject|1|||
130344883|NCT01576159|469233058|FG002|Overall Study|Withdrawal by Subject|0|||
130344884|NCT01576159|469233059|FG003|Overall Study|Withdrawal by Subject|0|||
130010146|NCT04773106|467999914|FG000|Overall Study|Withdrawal by Subject|3|||
130010147|NCT04773106|467999914|FG000|Overall Study|Death|1|||
130010148|NCT01648790|467999915|FG000|Treatment 3|Withdrawal by Subject|0|||
130344885|NCT01576159|469233056|FG000|Overall Study|Physician Decision|0|||
130344886|NCT01576159|469233057|FG001|Overall Study|Physician Decision|0|||
130344887|NCT01576159|469233058|FG002|Overall Study|Physician Decision|1|||
130010149|NCT01648790|467999916|FG001|Treatment 3|Withdrawal by Subject|0|||
130010150|NCT01648790|467999917|FG002|Treatment 3|Withdrawal by Subject|0|||
130010151|NCT01648790|467999918|FG003|Treatment 3|Withdrawal by Subject|1|||
130010152|NCT01648790|467999919|FG004|Treatment 3|Withdrawal by Subject|0|||
130010153|NCT03374189|467999930|FG000|Overall Study|Lost to Follow-up|1|||
130010154|NCT03374189|467999931|FG001|Overall Study|Lost to Follow-up|0|||
130010155|NCT02375724|467999932|FG000|Overall Study|Lack of Efficacy|1|||
130010156|NCT02375724|467999933|FG001|Overall Study|Lack of Efficacy|1|||
130010157|NCT02375724|467999932|FG000|Overall Study|Withdrawal by Subject|1|||
130010158|NCT02375724|467999933|FG001|Overall Study|Withdrawal by Subject|1|||
130010159|NCT02375724|467999932|FG000|Overall Study|Lost to Follow-up|1|||
130010160|NCT02375724|467999933|FG001|Overall Study|Lost to Follow-up|0|||
130010161|NCT02375724|467999932|FG000|Overall Study|Protocol Violation|1|||
130010162|NCT02375724|467999933|FG001|Overall Study|Protocol Violation|0|||
130010163|NCT02375724|467999932|FG000|Overall Study|Adverse Event|2|||
130010164|NCT02375724|467999933|FG001|Overall Study|Adverse Event|4|||
130010165|NCT03462576|467999934|FG000|Overall Study|Protocol Violation|5|||
130010166|NCT03462576|467999935|FG001|Overall Study|Protocol Violation|11|||
130010167|NCT03462576|467999936|FG002|Overall Study|Protocol Violation|7|||
130010168|NCT03462576|467999934|FG000|Overall Study|Device Malfunction|0|||
130010169|NCT03462576|467999935|FG001|Overall Study|Device Malfunction|0|||
130010170|NCT03462576|467999936|FG002|Overall Study|Device Malfunction|1|||
130010171|NCT04707157|467999937|FG000|Overall Study|Adverse Event|12|||
130010172|NCT04707157|467999938|FG001|Overall Study|Adverse Event|3|||
130010173|NCT04707157|467999937|FG000|Overall Study|Lost to Follow-up|2|||
130010174|NCT04707157|467999938|FG001|Overall Study|Lost to Follow-up|0|||
130010175|NCT04707157|467999937|FG000|Overall Study|Sponsor's decision|1|||
130010176|NCT04707157|467999938|FG001|Overall Study|Sponsor's decision|0|||
130010177|NCT04707157|467999937|FG000|Overall Study|Physician Decision|8|||
130010178|NCT04707157|467999938|FG001|Overall Study|Physician Decision|5|||
130010179|NCT04707157|467999937|FG000|Overall Study|Protocol Deviation|1|||
130010180|NCT04707157|467999938|FG001|Overall Study|Protocol Deviation|0|||
130010181|NCT04707157|467999937|FG000|Overall Study|Withdrawal by Subject|1|||
130010182|NCT04707157|467999938|FG001|Overall Study|Withdrawal by Subject|1|||
130010183|NCT01069172|467999940|FG000|Overall Study|Withdrawal by Subject|1|||
130010184|NCT01069172|467999941|FG001|Overall Study|Withdrawal by Subject|0|||
130010185|NCT04206605|467999942|FG000|Overall Study|Adverse Event|0|||
130010186|NCT04206605|467999943|FG001|Overall Study|Adverse Event|1|||
130010187|NCT04206605|467999942|FG000|Overall Study|Withdrawal by Subject|1|||
130010188|NCT04206605|467999943|FG001|Overall Study|Withdrawal by Subject|0|||
130010189|NCT03901079|467999946|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
130010190|NCT04995055|467999949|FG000|Period 1|COVID-19 Related|1|||
130010191|NCT04995055|467999950|FG001|Period 1|COVID-19 Related|0|||
130010192|NCT04995055|467999949|FG000|Period 1|Withdrawal by Subject|0|||
130010193|NCT04995055|467999950|FG001|Period 1|Withdrawal by Subject|1|||
130010194|NCT04995055|467999949|FG000|Period 1|Subject discontinued due to timing|4|||
130010195|NCT04995055|467999950|FG001|Period 1|Subject discontinued due to timing|4|||
130010196|NCT01066585|467999951|FG000|Overall Study|Protocol Violation|1|||
130344888|NCT01576159|469233059|FG003|Overall Study|Physician Decision|0|||
130344889|NCT01576159|469233056|FG000|Overall Study|Lost to Follow-up|0|||
130344890|NCT01576159|469233057|FG001|Overall Study|Lost to Follow-up|0|||
130344891|NCT01576159|469233058|FG002|Overall Study|Lost to Follow-up|0|||
130344892|NCT01576159|469233059|FG003|Overall Study|Lost to Follow-up|1|||
130344893|NCT01576159|469233056|FG000|Overall Study|Protocol Violation|1|||
130344894|NCT01576159|469233057|FG001|Overall Study|Protocol Violation|0|||
130344895|NCT01576159|469233058|FG002|Overall Study|Protocol Violation|0|||
130344896|NCT01576159|469233059|FG003|Overall Study|Protocol Violation|0|||
130344897|NCT00169442|469233060|FG000|Overall Study|Withdrawal by Subject|0|||
130344898|NCT00169442|469233061|FG001|Overall Study|Withdrawal by Subject|0|||
130344899|NCT00169442|469233062|FG002|Overall Study|Withdrawal by Subject|1|||
130344900|NCT00169442|469233063|FG003|Overall Study|Withdrawal by Subject|0|||
130344901|NCT00169442|469233064|FG004|Overall Study|Withdrawal by Subject|0|||
130344902|NCT00169442|469233065|FG005|Overall Study|Withdrawal by Subject|0|||
130344903|NCT00169442|469233060|FG000|Overall Study|Migrated/moved from study area|0|||
130344904|NCT00169442|469233061|FG001|Overall Study|Migrated/moved from study area|0|||
130344905|NCT00169442|469233062|FG002|Overall Study|Migrated/moved from study area|0|||
130344906|NCT00169442|469233063|FG003|Overall Study|Migrated/moved from study area|0|||
130344907|NCT00169442|469233064|FG004|Overall Study|Migrated/moved from study area|0|||
130344908|NCT00169442|469233065|FG005|Overall Study|Migrated/moved from study area|2|||
130344909|NCT00169442|469233060|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344910|NCT00169442|469233061|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344911|NCT00169442|469233062|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344912|NCT00169442|469233063|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344913|NCT00169442|469233064|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
130344914|NCT00169442|469233065|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
130344915|NCT00169442|469233060|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344916|NCT00169442|469233061|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
130344917|NCT00169442|469233062|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344918|NCT00169442|469233063|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344919|NCT00169442|469233064|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344920|NCT00169442|469233065|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
130344921|NCT01426789|469233066|FG000|Part 1|Protocol deviation|0|||
130344922|NCT01426789|469233067|FG001|Part 1|Protocol deviation|1|||
130344923|NCT01426789|469233068|FG002|Part 1|Protocol deviation|0|||
130344924|NCT01426789|469233069|FG003|Part 1|Protocol deviation|0|||
130344925|NCT01426789|469233070|FG004|Part 1|Protocol deviation|0|||
130344926|NCT01426789|469233071|FG005|Part 1|Protocol deviation|0|||
130344927|NCT01426789|469233066|FG000|Part 1|Lost to Follow-up|1|||
130344928|NCT01426789|469233067|FG001|Part 1|Lost to Follow-up|2|||
130344929|NCT01426789|469233068|FG002|Part 1|Lost to Follow-up|0|||
130344930|NCT01426789|469233069|FG003|Part 1|Lost to Follow-up|0|||
130344931|NCT01426789|469233070|FG004|Part 1|Lost to Follow-up|0|||
130344932|NCT01426789|469233071|FG005|Part 1|Lost to Follow-up|0|||
130344933|NCT01426789|469233066|FG000|Part 1|Lack of Efficacy|2|||
130344934|NCT01426789|469233067|FG001|Part 1|Lack of Efficacy|1|||
130344935|NCT01426789|469233068|FG002|Part 1|Lack of Efficacy|0|||
130344936|NCT01426789|469233069|FG003|Part 1|Lack of Efficacy|0|||
130344937|NCT01426789|469233070|FG004|Part 1|Lack of Efficacy|0|||
130344938|NCT01426789|469233071|FG005|Part 1|Lack of Efficacy|0|||
130344939|NCT01426789|469233066|FG000|Part 1|Adverse Event|3|||
130344940|NCT01426789|469233067|FG001|Part 1|Adverse Event|0|||
130344941|NCT01426789|469233068|FG002|Part 1|Adverse Event|0|||
130344942|NCT01426789|469233069|FG003|Part 1|Adverse Event|0|||
130344943|NCT01426789|469233070|FG004|Part 1|Adverse Event|0|||
130344944|NCT01426789|469233071|FG005|Part 1|Adverse Event|0|||
130344945|NCT01426789|469233066|FG000|Part 2|Protocol deviation|0|||
130010197|NCT01066585|467999952|FG001|Overall Study|Protocol Violation|0|||
130010198|NCT01066585|467999951|FG000|Overall Study|Withdrawal by Subject|0|||
130344946|NCT01426789|469233067|FG001|Part 2|Protocol deviation|0|||
130344947|NCT01426789|469233068|FG002|Part 2|Protocol deviation|1|||
130344948|NCT01426789|469233069|FG003|Part 2|Protocol deviation|0|||
130344949|NCT01426789|469233070|FG004|Part 2|Protocol deviation|0|||
130344950|NCT01426789|469233071|FG005|Part 2|Protocol deviation|0|||
130344951|NCT01426789|469233066|FG000|Part 2|Death|0|||
130010199|NCT01066585|467999952|FG001|Overall Study|Withdrawal by Subject|3|||
130010200|NCT00884273|467999953|FG000|Overall Study|Adverse Event|0|||
130010201|NCT00884273|467999954|FG001|Overall Study|Adverse Event|2|||
130010202|NCT00884273|467999953|FG000|Overall Study|Protocol Violation|1|||
130010203|NCT00884273|467999954|FG001|Overall Study|Protocol Violation|3|||
130010204|NCT00884273|467999953|FG000|Overall Study|Practical reasons|1|||
130010205|NCT00884273|467999954|FG001|Overall Study|Practical reasons|0|||
130010206|NCT00578136|467999957|FG000|Overall Study|Not given intervention|1|||
130010207|NCT00578136|467999958|FG001|Overall Study|Not given intervention|1|||
130010208|NCT02047253|467999959|FG000|Overall Study|Lost to Follow-up|8|||
130010209|NCT01987960|467999961|FG000|Period 1|Adverse Event|24|||
130010210|NCT01987960|467999962|FG001|Period 1|Adverse Event|0|||
130010211|NCT01987960|467999963|FG002|Period 1|Adverse Event|0|||
130010212|NCT01987960|467999964|FG003|Period 1|Adverse Event|0|||
130010213|NCT01987960|467999961|FG000|Period 1|Lack of Efficacy|4|||
130010214|NCT01987960|467999962|FG001|Period 1|Lack of Efficacy|0|||
130010215|NCT01987960|467999963|FG002|Period 1|Lack of Efficacy|0|||
130010216|NCT01987960|467999964|FG003|Period 1|Lack of Efficacy|0|||
130010217|NCT01987960|467999961|FG000|Period 1|Non-compliance with IMP|6|||
130010218|NCT01987960|467999962|FG001|Period 1|Non-compliance with IMP|0|||
130010219|NCT01987960|467999963|FG002|Period 1|Non-compliance with IMP|0|||
130010220|NCT01987960|467999964|FG003|Period 1|Non-compliance with IMP|0|||
130010221|NCT01987960|467999961|FG000|Period 1|Protocol Violation|12|||
130010222|NCT01987960|467999962|FG001|Period 1|Protocol Violation|0|||
130010223|NCT01987960|467999963|FG002|Period 1|Protocol Violation|0|||
130010224|NCT01987960|467999964|FG003|Period 1|Protocol Violation|0|||
130010225|NCT01987960|467999961|FG000|Period 1|Withdrawal by Subject|21|||
130010226|NCT01987960|467999962|FG001|Period 1|Withdrawal by Subject|0|||
130010227|NCT01987960|467999963|FG002|Period 1|Withdrawal by Subject|0|||
130010228|NCT01987960|467999964|FG003|Period 1|Withdrawal by Subject|0|||
130216611|NCT05305989|468755618|FG002|Overall Study|Adverse Event|0|||
130010229|NCT01987960|467999961|FG000|Period 1|Lost to Follow-up|40|||
130010230|NCT01987960|467999962|FG001|Period 1|Lost to Follow-up|0|||
130010231|NCT01987960|467999963|FG002|Period 1|Lost to Follow-up|0|||
130010232|NCT01987960|467999964|FG003|Period 1|Lost to Follow-up|0|||
130010233|NCT01987960|467999961|FG000|Period 1|administrative or other reason|75|||
130010234|NCT01987960|467999962|FG001|Period 1|administrative or other reason|0|||
130010235|NCT01987960|467999963|FG002|Period 1|administrative or other reason|0|||
130010236|NCT01987960|467999964|FG003|Period 1|administrative or other reason|0|||
130010237|NCT01987960|467999961|FG000|Period 1|Withdrawal of consent before treatment|4|||
130010238|NCT01987960|467999962|FG001|Period 1|Withdrawal of consent before treatment|0|||
130010239|NCT01987960|467999963|FG002|Period 1|Withdrawal of consent before treatment|0|||
130010240|NCT01987960|467999964|FG003|Period 1|Withdrawal of consent before treatment|0|||
130010241|NCT01987960|467999961|FG000|Period 2|Adverse Event|0|||
130010242|NCT01987960|467999962|FG001|Period 2|Adverse Event|0|||
130010243|NCT01987960|467999963|FG002|Period 2|Adverse Event|1|||
130010244|NCT01987960|467999964|FG003|Period 2|Adverse Event|0|||
130010245|NCT01987960|467999961|FG000|Period 2|Withdrawal by Subject|0|||
130010246|NCT01987960|467999962|FG001|Period 2|Withdrawal by Subject|0|||
130010247|NCT01987960|467999963|FG002|Period 2|Withdrawal by Subject|1|||
130010248|NCT01987960|467999964|FG003|Period 2|Withdrawal by Subject|0|||
130010249|NCT01987960|467999961|FG000|Period 2|Administrative or other reason|0|||
130010250|NCT01987960|467999962|FG001|Period 2|Administrative or other reason|5|||
130010251|NCT01987960|467999963|FG002|Period 2|Administrative or other reason|7|||
130344952|NCT01426789|469233067|FG001|Part 2|Death|0|||
130344953|NCT01426789|469233068|FG002|Part 2|Death|1|||
130344954|NCT01426789|469233069|FG003|Part 2|Death|0|||
130344955|NCT01426789|469233070|FG004|Part 2|Death|1|||
130344956|NCT01426789|469233071|FG005|Part 2|Death|0|||
130344957|NCT01426789|469233066|FG000|Part 2|Administrative problems|0|||
130344958|NCT01426789|469233067|FG001|Part 2|Administrative problems|0|||
130344959|NCT01426789|469233068|FG002|Part 2|Administrative problems|2|||
130344960|NCT01426789|469233069|FG003|Part 2|Administrative problems|0|||
130344961|NCT01426789|469233070|FG004|Part 2|Administrative problems|1|||
130344962|NCT01426789|469233071|FG005|Part 2|Administrative problems|0|||
130344963|NCT01426789|469233066|FG000|Part 2|Lost to Follow-up|0|||
130344964|NCT01426789|469233067|FG001|Part 2|Lost to Follow-up|0|||
130344965|NCT01426789|469233068|FG002|Part 2|Lost to Follow-up|4|||
130344966|NCT01426789|469233069|FG003|Part 2|Lost to Follow-up|0|||
130344967|NCT01426789|469233070|FG004|Part 2|Lost to Follow-up|1|||
130344968|NCT01426789|469233071|FG005|Part 2|Lost to Follow-up|0|||
130344969|NCT01426789|469233066|FG000|Part 2|Withdrawal by Subject|0|||
130344970|NCT01426789|469233067|FG001|Part 2|Withdrawal by Subject|0|||
130344971|NCT01426789|469233068|FG002|Part 2|Withdrawal by Subject|0|||
130344972|NCT01426789|469233069|FG003|Part 2|Withdrawal by Subject|1|||
130344973|NCT01426789|469233070|FG004|Part 2|Withdrawal by Subject|2|||
130344974|NCT01426789|469233071|FG005|Part 2|Withdrawal by Subject|0|||
130344975|NCT01426789|469233066|FG000|Part 2|Lack of Efficacy|0|||
130344976|NCT01426789|469233067|FG001|Part 2|Lack of Efficacy|0|||
130344977|NCT01426789|469233068|FG002|Part 2|Lack of Efficacy|5|||
130344978|NCT01426789|469233069|FG003|Part 2|Lack of Efficacy|0|||
130344979|NCT01426789|469233070|FG004|Part 2|Lack of Efficacy|2|||
130344980|NCT01426789|469233071|FG005|Part 2|Lack of Efficacy|0|||
130344981|NCT01426789|469233066|FG000|Part 2|Adverse Event|0|||
130344982|NCT01426789|469233067|FG001|Part 2|Adverse Event|0|||
130344983|NCT01426789|469233068|FG002|Part 2|Adverse Event|2|||
130344984|NCT01426789|469233069|FG003|Part 2|Adverse Event|0|||
130010252|NCT01987960|467999964|FG003|Period 2|Administrative or other reason|0|||
130010253|NCT01987960|467999961|FG000|Period 3|Adverse Event|0|||
130010254|NCT01987960|467999962|FG001|Period 3|Adverse Event|0|||
130010255|NCT01987960|467999963|FG002|Period 3|Adverse Event|0|||
130010256|NCT01987960|467999964|FG003|Period 3|Adverse Event|7|||
130010257|NCT01987960|467999961|FG000|Period 3|Non-compliance with IMP|0|||
130010258|NCT01987960|467999962|FG001|Period 3|Non-compliance with IMP|0|||
130010259|NCT01987960|467999963|FG002|Period 3|Non-compliance with IMP|0|||
130010260|NCT01987960|467999964|FG003|Period 3|Non-compliance with IMP|1|||
130010261|NCT01987960|467999961|FG000|Period 3|Protocol Violation|0|||
130010262|NCT01987960|467999962|FG001|Period 3|Protocol Violation|0|||
130010263|NCT01987960|467999963|FG002|Period 3|Protocol Violation|0|||
130010264|NCT01987960|467999964|FG003|Period 3|Protocol Violation|6|||
130010265|NCT01987960|467999961|FG000|Period 3|Withdrawal by Subject|0|||
130010266|NCT01987960|467999962|FG001|Period 3|Withdrawal by Subject|0|||
130010267|NCT01987960|467999963|FG002|Period 3|Withdrawal by Subject|0|||
130010268|NCT01987960|467999964|FG003|Period 3|Withdrawal by Subject|9|||
130010269|NCT01987960|467999961|FG000|Period 3|Lost to Follow-up|0|||
130010270|NCT01987960|467999962|FG001|Period 3|Lost to Follow-up|0|||
130010271|NCT01987960|467999963|FG002|Period 3|Lost to Follow-up|0|||
130344985|NCT01426789|469233070|FG004|Part 2|Adverse Event|1|||
130344986|NCT01426789|469233071|FG005|Part 2|Adverse Event|0|||
130344987|NCT01181986|469233072|FG000|Phase 1|Lost to Follow-up|0|||
130344988|NCT01181986|469233073|FG001|Phase 1|Lost to Follow-up|1|||
130344989|NCT01181986|469233074|FG002|Phase 1|Lost to Follow-up|1|||
130344990|NCT01181986|469233072|FG000|Phase 1|Adverse Event|0|||
130344991|NCT01181986|469233073|FG001|Phase 1|Adverse Event|0|||
130344992|NCT01181986|469233074|FG002|Phase 1|Adverse Event|1|||
130344993|NCT01181986|469233072|FG000|Phase 1|Protocol Violation|1|||
130344994|NCT01181986|469233073|FG001|Phase 1|Protocol Violation|0|||
130344995|NCT01181986|469233074|FG002|Phase 1|Protocol Violation|0|||
130344996|NCT01181986|469233072|FG000|Phase 2|Adverse Event|0|||
130344997|NCT01181986|469233073|FG001|Phase 2|Adverse Event|3|||
130344998|NCT01181986|469233074|FG002|Phase 2|Adverse Event|0|||
130344999|NCT01181986|469233072|FG000|Phase 2|Medical condition|0|||
130345000|NCT01181986|469233073|FG001|Phase 2|Medical condition|1|||
130345001|NCT01181986|469233074|FG002|Phase 2|Medical condition|0|||
130345002|NCT00311584|469233077|FG000|Overall Study|Death|1|||
130345003|NCT00311584|469233078|FG001|Overall Study|Death|0|||
130345004|NCT00311584|469233077|FG000|Overall Study|Lack of Efficacy|12|||
130345005|NCT00311584|469233078|FG001|Overall Study|Lack of Efficacy|15|||
130345006|NCT00311584|469233077|FG000|Overall Study|Physician Decision|4|||
130345007|NCT00311584|469233078|FG001|Overall Study|Physician Decision|5|||
130345008|NCT00311584|469233077|FG000|Overall Study|Withdrawal by Subject|1|||
130345009|NCT00311584|469233078|FG001|Overall Study|Withdrawal by Subject|1|||
130345010|NCT00311584|469233077|FG000|Overall Study|ineligible|2|||
130345011|NCT00311584|469233078|FG001|Overall Study|ineligible|2|||
130345012|NCT03073733|469233079|FG000|Overall Study|Lost to Follow-up|1|||
130345013|NCT03073733|469233080|FG001|Overall Study|Lost to Follow-up|0|||
130345014|NCT03073733|469233081|FG002|Overall Study|Lost to Follow-up|0|||
130345015|NCT03073733|469233079|FG000|Overall Study|Physician Decision|0|||
130345016|NCT03073733|469233080|FG001|Overall Study|Physician Decision|1|||
130345017|NCT03073733|469233081|FG002|Overall Study|Physician Decision|0|||
130345018|NCT03073733|469233079|FG000|Overall Study|Withdrawal by Subject|0|||
130345019|NCT03073733|469233080|FG001|Overall Study|Withdrawal by Subject|0|||
130345020|NCT03073733|469233081|FG002|Overall Study|Withdrawal by Subject|1|||
130345021|NCT00835731|469233082|FG000|Overall Study|Withdrawal by Subject|1|||
130345022|NCT00835731|469233083|FG001|Overall Study|Withdrawal by Subject|0|||
130345023|NCT00835731|469233082|FG000|Overall Study|Physician Decision|1|||
130345024|NCT00835731|469233083|FG001|Overall Study|Physician Decision|1|||
130345025|NCT01155167|469233084|FG000|Overall Study|Insufficient ultrasound data|2|||
130345026|NCT01155167|469233085|FG001|Overall Study|Insufficient ultrasound data|0|||
130345027|NCT01155167|469233084|FG000|Overall Study|Access site changed to femoral artery|1|||
130345028|NCT01155167|469233085|FG001|Overall Study|Access site changed to femoral artery|0|||
130345029|NCT00167778|469233086|FG000|Overall Study|Withdrawal by Subject|1|||
130345030|NCT02654717|469233087|FG000|Overall Study|Adverse Event|2|||
130345031|NCT02654717|469233088|FG001|Overall Study|Adverse Event|2|||
130345032|NCT02654717|469233087|FG000|Overall Study|Protocol Violation|1|||
130345033|NCT02654717|469233088|FG001|Overall Study|Protocol Violation|2|||
130345034|NCT02654717|469233087|FG000|Overall Study|Withdrawal by Subject|0|||
130345035|NCT02654717|469233088|FG001|Overall Study|Withdrawal by Subject|1|||
130010272|NCT01987960|467999964|FG003|Period 3|Lost to Follow-up|5|||
130010273|NCT01987960|467999961|FG000|Period 3|Administrative or other reason|0|||
130345036|NCT02654717|469233087|FG000|Overall Study|Non-permitted medication|3|||
130345037|NCT02654717|469233088|FG001|Overall Study|Non-permitted medication|0|||
130345038|NCT02880956|469233090|FG000|Overall Study|Adverse Event|3|||
130010274|NCT01987960|467999962|FG001|Period 3|Administrative or other reason|0|||
130010275|NCT01987960|467999963|FG002|Period 3|Administrative or other reason|0|||
130010276|NCT01987960|467999964|FG003|Period 3|Administrative or other reason|43|||
130010277|NCT00932360|467999965|FG000|Washout (One Week)|Withdrawal by Subject|0|||
130010278|NCT00932360|467999966|FG001|Washout (One Week)|Withdrawal by Subject|0|||
130010279|NCT00932360|467999967|FG002|Washout (One Week)|Withdrawal by Subject|0|||
130010280|NCT00932360|467999968|FG003|Washout (One Week)|Withdrawal by Subject|0|||
130010281|NCT00932360|467999969|FG004|Washout (One Week)|Withdrawal by Subject|2|||
130010282|NCT00932360|467999970|FG005|Washout (One Week)|Withdrawal by Subject|0|||
130010283|NCT02536313|467999973|FG000|Overall Study|Lack of Efficacy|0|||
130010284|NCT02536313|467999974|FG001|Overall Study|Lack of Efficacy|1|||
130010285|NCT00993265|467999985|FG000|Overall Study|Adverse Event|1|||
130010286|NCT00993265|467999986|FG001|Overall Study|Adverse Event|0|||
130010287|NCT00993265|467999985|FG000|Overall Study|Changed dose of concomitant drug|2|||
130010288|NCT00993265|467999986|FG001|Overall Study|Changed dose of concomitant drug|0|||
130010289|NCT00993265|467999985|FG000|Overall Study|Non-compliant with study medication|1|||
130010290|NCT00993265|467999986|FG001|Overall Study|Non-compliant with study medication|0|||
130010291|NCT00807742|467999988|FG000|Overall Study|Death|9|||
130010292|NCT00807742|467999989|FG001|Overall Study|Death|2|||
130010293|NCT00807742|467999988|FG000|Overall Study|Withdrawal by Subject|2|||
130010294|NCT00807742|467999989|FG001|Overall Study|Withdrawal by Subject|1|||
130010295|NCT00807742|467999988|FG000|Overall Study|Lost to Follow-up|35|||
130010296|NCT00807742|467999989|FG001|Overall Study|Lost to Follow-up|51|||
130010297|NCT00492752|467999990|FG000|Double Blind Treatment|Death|13|||
130010298|NCT00492752|467999991|FG001|Double Blind Treatment|Death|0|||
130010299|NCT00492752|467999992|FG002|Double Blind Treatment|Death|2|||
130010300|NCT00492752|467999993|FG003|Double Blind Treatment|Death|0|||
130010301|NCT00492752|467999990|FG000|Double Blind Treatment|Adverse Event|1|||
130010302|NCT00492752|467999991|FG001|Double Blind Treatment|Adverse Event|0|||
130010303|NCT00492752|467999992|FG002|Double Blind Treatment|Adverse Event|0|||
130010304|NCT00492752|467999993|FG003|Double Blind Treatment|Adverse Event|0|||
130010305|NCT00492752|467999990|FG000|Double Blind Treatment|Protocol Violation|0|||
130216612|NCT05305989|468755616|FG000|Overall Study|Enrolled but never dosed|3|||
130216613|NCT05305989|468755617|FG001|Overall Study|Enrolled but never dosed|2|||
130010306|NCT00492752|467999991|FG001|Double Blind Treatment|Protocol Violation|0|||
130010307|NCT00492752|467999992|FG002|Double Blind Treatment|Protocol Violation|1|||
130010308|NCT00492752|467999993|FG003|Double Blind Treatment|Protocol Violation|0|||
130010309|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
130216614|NCT05305989|468755618|FG002|Overall Study|Enrolled but never dosed|1|||
130010310|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
130010311|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
130010312|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
130010313|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
130010314|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
130010315|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
130010316|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
130010317|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
130010318|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
130010319|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
130010320|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
130010321|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
130010322|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
130010323|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
130010324|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
130010325|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
130010326|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
130010327|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
130010328|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
130010329|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
130010330|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
130010331|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
130010332|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
130010333|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
130010334|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
130010335|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
130010336|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
130010337|NCT00492752|467999990|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
130010338|NCT00492752|467999991|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
130010339|NCT00492752|467999992|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
130010340|NCT00492752|467999993|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
130010341|NCT01357655|467999994|FG000|Overall Study|Administrative Reason by Sponsor|45|||
130010342|NCT01357655|467999995|FG001|Overall Study|Administrative Reason by Sponsor|0|||
130010343|NCT01357655|467999994|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130010344|NCT01357655|467999995|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130010345|NCT01357655|467999994|FG000|Overall Study|Disease Progression|1|||
130010346|NCT01357655|467999995|FG001|Overall Study|Disease Progression|0|||
130010347|NCT01357655|467999994|FG000|Overall Study|Lost to Follow-up|2|||
130010348|NCT01357655|467999995|FG001|Overall Study|Lost to Follow-up|0|||
130010349|NCT01357655|467999994|FG000|Overall Study|Maximum Clinical Benefit|2|||
130010350|NCT01357655|467999995|FG001|Overall Study|Maximum Clinical Benefit|0|||
130010351|NCT01357655|467999994|FG000|Overall Study|Reason Unspecified|1|||
130010352|NCT01357655|467999995|FG001|Overall Study|Reason Unspecified|0|||
130010353|NCT01357655|467999994|FG000|Overall Study|Study Drug Toxicity|11|||
130010354|NCT01357655|467999995|FG001|Overall Study|Study Drug Toxicity|0|||
130010355|NCT01357655|467999994|FG000|Overall Study|Subject Withdrew Consent|1|||
130010356|NCT01357655|467999995|FG001|Overall Study|Subject Withdrew Consent|0|||
130010357|NCT00219284|467999996|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
130010358|NCT00219284|467999997|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
130010359|NCT00219284|467999996|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
130010360|NCT00219284|467999997|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
130010361|NCT00219284|467999996|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
130010362|NCT00219284|467999997|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
130010363|NCT00219284|467999996|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
130010364|NCT00219284|467999997|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
130010365|NCT00219284|467999996|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
130010366|NCT00219284|467999997|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
130010367|NCT00219284|467999996|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
130010368|NCT00219284|467999997|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
130010369|NCT00219284|467999996|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
130010370|NCT00219284|467999997|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
130010371|NCT00219284|467999996|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
130010372|NCT00219284|467999997|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
130010373|NCT00219284|467999996|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
130345039|NCT02880956|469233091|FG001|Overall Study|Adverse Event|6|||
130010374|NCT00219284|467999997|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
130010375|NCT00609986|467999998|FG000|Overall Study|Did not receive transplant or treatment|8|||
130010376|NCT00609986|467999999|FG001|Overall Study|Did not receive transplant or treatment|3|||
130010377|NCT04722042|468000001|FG000|Overall Study|Withdrawal by Subject|2|||
130345040|NCT02880956|469233092|FG002|Overall Study|Adverse Event|5|||
130345041|NCT02880956|469233093|FG003|Overall Study|Adverse Event|4|||
130345042|NCT02880956|469233090|FG000|Overall Study|Withdrawal by Subject|9|||
130345043|NCT02880956|469233091|FG001|Overall Study|Withdrawal by Subject|4|||
130345044|NCT02880956|469233092|FG002|Overall Study|Withdrawal by Subject|6|||
130345045|NCT02880956|469233093|FG003|Overall Study|Withdrawal by Subject|11|||
130345046|NCT02880956|469233090|FG000|Overall Study|Lost to Follow-up|0|||
130345047|NCT02880956|469233091|FG001|Overall Study|Lost to Follow-up|1|||
130345048|NCT02880956|469233092|FG002|Overall Study|Lost to Follow-up|0|||
130345049|NCT02880956|469233093|FG003|Overall Study|Lost to Follow-up|0|||
130345050|NCT02880956|469233090|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130345051|NCT02880956|469233091|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
130345052|NCT02880956|469233092|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130345053|NCT02880956|469233093|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
130345054|NCT02880956|469233090|FG000|Overall Study|Other, Not Specified|4|||
130345055|NCT02880956|469233091|FG001|Overall Study|Other, Not Specified|2|||
130345056|NCT02880956|469233092|FG002|Overall Study|Other, Not Specified|0|||
130345057|NCT02880956|469233093|FG003|Overall Study|Other, Not Specified|3|||
130345058|NCT00576420|469235274|FG000|Overall Study|Death|0|||
130345059|NCT00576420|469235275|FG001|Overall Study|Death|0|||
130345060|NCT00576420|469235276|FG002|Overall Study|Death|1|||
130345061|NCT01340872|469235278|FG000|Double-blind Phase|Adverse Event|6|||
130345062|NCT01340872|469235279|FG001|Double-blind Phase|Adverse Event|4|||
130345063|NCT01340872|469235280|FG002|Double-blind Phase|Adverse Event|0|||
130345064|NCT01340872|469235281|FG003|Double-blind Phase|Adverse Event|0|||
130345065|NCT01340872|469235278|FG000|Double-blind Phase|Withdrawal by Subject|3|||
130345066|NCT01340872|469235279|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130345067|NCT01340872|469235280|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130345068|NCT01340872|469235281|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130345069|NCT01340872|469235278|FG000|Double-blind Phase|Lost to Follow-up|0|||
130345070|NCT01340872|469235279|FG001|Double-blind Phase|Lost to Follow-up|1|||
130345071|NCT01340872|469235280|FG002|Double-blind Phase|Lost to Follow-up|0|||
130345072|NCT01340872|469235281|FG003|Double-blind Phase|Lost to Follow-up|0|||
130345073|NCT01340872|469235278|FG000|Double-blind Phase|Protocol Violation|0|||
130345074|NCT01340872|469235279|FG001|Double-blind Phase|Protocol Violation|1|||
130345075|NCT01340872|469235280|FG002|Double-blind Phase|Protocol Violation|0|||
130345076|NCT01340872|469235281|FG003|Double-blind Phase|Protocol Violation|0|||
130345077|NCT01340872|469235278|FG000|Open-label Phase|Physician Decision|0|||
130345078|NCT01340872|469235279|FG001|Open-label Phase|Physician Decision|0|||
130345079|NCT01340872|469235280|FG002|Open-label Phase|Physician Decision|2|||
130345080|NCT01340872|469235281|FG003|Open-label Phase|Physician Decision|1|||
130345081|NCT01340872|469235278|FG000|Open-label Phase|Pregnancy|0|||
130345082|NCT01340872|469235279|FG001|Open-label Phase|Pregnancy|0|||
130345083|NCT01340872|469235280|FG002|Open-label Phase|Pregnancy|1|||
130345084|NCT01340872|469235281|FG003|Open-label Phase|Pregnancy|0|||
130345085|NCT01340872|469235278|FG000|Open-label Phase|Adverse Event|0|||
130345086|NCT01340872|469235279|FG001|Open-label Phase|Adverse Event|0|||
130345087|NCT01340872|469235280|FG002|Open-label Phase|Adverse Event|8|||
130345088|NCT01340872|469235281|FG003|Open-label Phase|Adverse Event|4|||
130345089|NCT01340872|469235278|FG000|Open-label Phase|Withdrawal by Subject|0|||
130345090|NCT01340872|469235279|FG001|Open-label Phase|Withdrawal by Subject|0|||
130345091|NCT01340872|469235280|FG002|Open-label Phase|Withdrawal by Subject|1|||
130345092|NCT01340872|469235281|FG003|Open-label Phase|Withdrawal by Subject|6|||
130345093|NCT01340872|469235278|FG000|Open-label Phase|Worsening of IBD|0|||
130345094|NCT01340872|469235279|FG001|Open-label Phase|Worsening of IBD|0|||
130345095|NCT01340872|469235280|FG002|Open-label Phase|Worsening of IBD|1|||
130345096|NCT01340872|469235281|FG003|Open-label Phase|Worsening of IBD|0|||
130345097|NCT01771809|469235284|FG000|Overall Study|Adverse Event|4|||
130345098|NCT01771809|469235285|FG001|Overall Study|Adverse Event|12|||
130345099|NCT01771809|469235284|FG000|Overall Study|Protocol Violation|0|||
130345100|NCT01771809|469235285|FG001|Overall Study|Protocol Violation|1|||
130345101|NCT01771809|469235284|FG000|Overall Study|Withdrawal by Subject|34|||
130345102|NCT01771809|469235285|FG001|Overall Study|Withdrawal by Subject|42|||
130345103|NCT01771809|469235284|FG000|Overall Study|Lost to Follow-up|1|||
130345104|NCT01771809|469235285|FG001|Overall Study|Lost to Follow-up|3|||
130345105|NCT01771809|469235284|FG000|Overall Study|Other (Insufficient clinical response)|22|||
130010378|NCT04722042|468000002|FG001|Overall Study|Withdrawal by Subject|1|||
130345106|NCT01771809|469235285|FG001|Overall Study|Other (Insufficient clinical response)|20|||
130345107|NCT01771809|469235284|FG000|Overall Study|Death|1|||
130345108|NCT01771809|469235285|FG001|Overall Study|Death|0|||
130345109|NCT01771809|469235284|FG000|Overall Study|Other (other)|9|||
130345110|NCT01771809|469235285|FG001|Overall Study|Other (other)|5|||
130345111|NCT01142089|469235297|FG000|Overall Study|Physician Decision|1|||
130345112|NCT01142089|469235298|FG001|Overall Study|Physician Decision|0|||
130345113|NCT01142089|469235297|FG000|Overall Study|Withdrawal by Subject|1|||
130345114|NCT01142089|469235298|FG001|Overall Study|Withdrawal by Subject|2|||
130010379|NCT04722042|468000003|FG002|Overall Study|Withdrawal by Subject|0|||
130010380|NCT02090413|468000006|FG000|Overall Study|Adverse Event|11|||
130010381|NCT02090413|468000007|FG001|Overall Study|Adverse Event|15|||
130010382|NCT02090413|468000008|FG002|Overall Study|Adverse Event|20|||
130010383|NCT02090413|468000006|FG000|Overall Study|Flushing event|2|||
130010384|NCT02090413|468000007|FG001|Overall Study|Flushing event|0|||
130010385|NCT02090413|468000008|FG002|Overall Study|Flushing event|1|||
130010386|NCT02090413|468000006|FG000|Overall Study|Withdrawal by Subject|2|||
130010387|NCT02090413|468000007|FG001|Overall Study|Withdrawal by Subject|2|||
130010388|NCT02090413|468000008|FG002|Overall Study|Withdrawal by Subject|2|||
130010389|NCT02090413|468000006|FG000|Overall Study|Investigator Decision|1|||
130010390|NCT02090413|468000007|FG001|Overall Study|Investigator Decision|1|||
130010391|NCT02090413|468000008|FG002|Overall Study|Investigator Decision|0|||
130010392|NCT02090413|468000006|FG000|Overall Study|Other|2|||
130010393|NCT02090413|468000007|FG001|Overall Study|Other|1|||
130010394|NCT02090413|468000008|FG002|Overall Study|Other|0|||
130010395|NCT02090413|468000006|FG000|Overall Study|Lost to Follow-up|1|||
130010396|NCT02090413|468000007|FG001|Overall Study|Lost to Follow-up|1|||
130345115|NCT01142089|469235297|FG000|Overall Study|Use of prohibited medications|0|||
130345116|NCT01142089|469235298|FG001|Overall Study|Use of prohibited medications|1|||
130345117|NCT01142089|469235297|FG000|Overall Study|Noncompliance with study procedures|2|||
130345118|NCT01142089|469235298|FG001|Overall Study|Noncompliance with study procedures|1|||
130345119|NCT01142089|469235297|FG000|Overall Study|Patient required rescue medication|8|||
130345120|NCT01142089|469235298|FG001|Overall Study|Patient required rescue medication|17|||
130345121|NCT02907892|469235303|FG000|Overall Study|Lost to Follow-up|27|||
130345122|NCT02907892|469235304|FG001|Overall Study|Lost to Follow-up|40|||
130345123|NCT01974765|469235305|FG000|Overall Study|Withdrawal by Subject|1|||
130345124|NCT01974765|469235305|FG000|Overall Study|Death|1|||
130345125|NCT01974765|469235305|FG000|Overall Study|Adverse Event|2|||
130345126|NCT03860935|469235309|FG000|Overall Study|Withdrawal of Consent|15|||
130345127|NCT03860935|469235310|FG001|Overall Study|Withdrawal of Consent|6|||
130345128|NCT03860935|469235309|FG000|Overall Study|Death|75|||
130345129|NCT03860935|469235310|FG001|Overall Study|Death|51|||
130345130|NCT03086967|469235311|FG000|Overall Study|Screen Failure|2|||
130345131|NCT03086967|469235312|FG001|Overall Study|Screen Failure|2|||
130345132|NCT01430754|469235315|FG000|Run-In Phase|Circadian Period Ineligible|24|||
130345133|NCT01430754|469235316|FG001|Run-In Phase|Circadian Period Ineligible|0|||
130345134|NCT01430754|469235315|FG000|Run-In Phase|Protocol Violation|6|||
130345135|NCT01430754|469235316|FG001|Run-In Phase|Protocol Violation|0|||
130345136|NCT01430754|469235315|FG000|Run-In Phase|Adverse Event|2|||
130345137|NCT01430754|469235316|FG001|Run-In Phase|Adverse Event|0|||
130345138|NCT01430754|469235315|FG000|Run-In Phase|Other|2|||
130345139|NCT01430754|469235316|FG001|Run-In Phase|Other|0|||
130345140|NCT01430754|469235315|FG000|Run-In Phase|Withdrawal by Subject|2|||
130345141|NCT01430754|469235316|FG001|Run-In Phase|Withdrawal by Subject|0|||
130345142|NCT01430754|469235315|FG000|Run-In Phase|Lost to Follow-up|1|||
130345143|NCT01430754|469235316|FG001|Run-In Phase|Lost to Follow-up|0|||
130345144|NCT02230527|469235318|FG000|Overall Study|Withdrawal by Subject|1|||
130345145|NCT02230527|469235319|FG001|Overall Study|Withdrawal by Subject|1|||
130345146|NCT02230527|469235318|FG000|Overall Study|Death|1|||
130345147|NCT02230527|469235319|FG001|Overall Study|Death|0|||
130345148|NCT02230527|469235318|FG000|Overall Study|Lost to Follow-up|2|||
130345149|NCT02230527|469235319|FG001|Overall Study|Lost to Follow-up|1|||
130345150|NCT02230527|469235318|FG000|Overall Study|Other|1|||
130345151|NCT02230527|469235319|FG001|Overall Study|Other|0|||
130345152|NCT04461600|469235320|FG000|Overall Study|Death|6|||
130345153|NCT04461600|469235321|FG001|Overall Study|Death|5|||
130345154|NCT04461600|469235320|FG000|Overall Study|Withdrawal by Subject|0|||
130345155|NCT04461600|469235321|FG001|Overall Study|Withdrawal by Subject|1|||
130345156|NCT00775203|469235327|FG000|Overall Study|Adverse Event|25|||
130345157|NCT00775203|469235328|FG001|Overall Study|Adverse Event|6|||
130345158|NCT00775203|469235327|FG000|Overall Study|Lack of Efficacy|8|||
130345159|NCT00775203|469235328|FG001|Overall Study|Lack of Efficacy|9|||
130345160|NCT00775203|469235327|FG000|Overall Study|Withdrawal by Subject|11|||
130345161|NCT00775203|469235328|FG001|Overall Study|Withdrawal by Subject|9|||
130345162|NCT00775203|469235327|FG000|Overall Study|Lost to Follow-up|11|||
130345163|NCT00775203|469235328|FG001|Overall Study|Lost to Follow-up|15|||
130345164|NCT00775203|469235327|FG000|Overall Study|Administrative reason|2|||
130345165|NCT00775203|469235328|FG001|Overall Study|Administrative reason|0|||
130345166|NCT00775203|469235327|FG000|Overall Study|Noncompliance|4|||
130345167|NCT00775203|469235328|FG001|Overall Study|Noncompliance|2|||
130345168|NCT00775203|469235327|FG000|Overall Study|Protocol Violation|0|||
130345169|NCT00775203|469235328|FG001|Overall Study|Protocol Violation|1|||
130345170|NCT00775203|469235327|FG000|Overall Study|Entered other study|1|||
130345171|NCT00775203|469235328|FG001|Overall Study|Entered other study|0|||
130345172|NCT00775203|469235327|FG000|Overall Study|Physician Decision|0|||
130345173|NCT00775203|469235328|FG001|Overall Study|Physician Decision|1|||
130010397|NCT02090413|468000008|FG002|Overall Study|Lost to Follow-up|0|||
130010398|NCT02321930|468000013|FG000|Overall Study|Lost to Follow-up|1|||
130345174|NCT00704522|469235329|FG000|Overall Study|Lack of Efficacy|65|||
130345175|NCT00704522|469235330|FG001|Overall Study|Lack of Efficacy|17|||
130345176|NCT00704522|469235329|FG000|Overall Study|Failure to appear again at hospital|56|||
130345177|NCT00704522|469235330|FG001|Overall Study|Failure to appear again at hospital|10|||
130345178|NCT00704522|469235329|FG000|Overall Study|Withdrawal by Subject|17|||
130345179|NCT00704522|469235330|FG001|Overall Study|Withdrawal by Subject|8|||
130345180|NCT00704522|469235329|FG000|Overall Study|Adverse Event|9|||
130010399|NCT05321069|468000014|FG000|Overall Study|Adverse Event|52|||
130010400|NCT05321069|468000015|FG001|Overall Study|Adverse Event|52|||
130345181|NCT00704522|469235330|FG001|Overall Study|Adverse Event|1|||
130345182|NCT00704522|469235329|FG000|Overall Study|Undefined causes|9|||
130345183|NCT00704522|469235330|FG001|Overall Study|Undefined causes|7|||
130345184|NCT00704522|469235329|FG000|Overall Study|No information on therapy end|27|||
130345185|NCT00704522|469235330|FG001|Overall Study|No information on therapy end|2|||
130010401|NCT05321069|468000016|FG002|Overall Study|Adverse Event|64|||
130010402|NCT05321069|468000014|FG000|Overall Study|Protocol Violation|1|||
130010403|NCT05321069|468000015|FG001|Overall Study|Protocol Violation|1|||
130010404|NCT05321069|468000016|FG002|Overall Study|Protocol Violation|0|||
130010405|NCT05321069|468000014|FG000|Overall Study|Withdrawal by Subject|23|||
130010406|NCT05321069|468000015|FG001|Overall Study|Withdrawal by Subject|18|||
130010407|NCT05321069|468000016|FG002|Overall Study|Withdrawal by Subject|12|||
130345186|NCT00701662|469235331|FG000|Overall Study|Lack of Efficacy|1|||
130345187|NCT00635024|469235332|FG000|Overall Study|Adverse Event|1|||
130345188|NCT01105065|469235333|FG000|Overall Study|Adverse Event|5|||
130345189|NCT01105065|469235333|FG000|Overall Study|Technical Problems|1|||
130345190|NCT02984943|469235334|FG000|Overall Study|Withdrawal by Subject|3|||
130345191|NCT02984943|469235334|FG000|Overall Study|Physician Decision|1|||
130345192|NCT04575597|469235337|FG000|Overall Study|Death|0|||
130345193|NCT04575597|469235338|FG001|Overall Study|Death|0|||
130345194|NCT04575597|469235339|FG002|Overall Study|Death|0|||
130345195|NCT04575597|469235340|FG003|Overall Study|Death|1|||
130345196|NCT04575597|469235341|FG004|Overall Study|Death|3|||
130345197|NCT04575597|469235342|FG005|Overall Study|Death|14|||
130345198|NCT04575597|469235337|FG000|Overall Study|Lost to Follow-up|2|||
130345199|NCT04575597|469235338|FG001|Overall Study|Lost to Follow-up|1|||
130345200|NCT04575597|469235339|FG002|Overall Study|Lost to Follow-up|1|||
130345201|NCT04575597|469235340|FG003|Overall Study|Lost to Follow-up|2|||
130345202|NCT04575597|469235341|FG004|Overall Study|Lost to Follow-up|10|||
130345203|NCT04575597|469235342|FG005|Overall Study|Lost to Follow-up|8|||
130345204|NCT04575597|469235337|FG000|Overall Study|Withdrawal by Subject|2|||
130345205|NCT04575597|469235338|FG001|Overall Study|Withdrawal by Subject|2|||
130345206|NCT04575597|469235339|FG002|Overall Study|Withdrawal by Subject|4|||
130345207|NCT04575597|469235340|FG003|Overall Study|Withdrawal by Subject|2|||
130345208|NCT04575597|469235341|FG004|Overall Study|Withdrawal by Subject|25|||
130345209|NCT04575597|469235342|FG005|Overall Study|Withdrawal by Subject|28|||
130345210|NCT04575597|469235337|FG000|Overall Study|Not Recorded|0|||
130345211|NCT04575597|469235338|FG001|Overall Study|Not Recorded|0|||
130345212|NCT04575597|469235339|FG002|Overall Study|Not Recorded|0|||
130345213|NCT04575597|469235340|FG003|Overall Study|Not Recorded|0|||
130345214|NCT04575597|469235341|FG004|Overall Study|Not Recorded|0|||
130345215|NCT04575597|469235342|FG005|Overall Study|Not Recorded|2|||
130345216|NCT04575597|469235337|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345217|NCT04575597|469235338|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345218|NCT04575597|469235339|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345219|NCT04575597|469235340|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130345220|NCT04575597|469235341|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
130345221|NCT04575597|469235342|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130345222|NCT01587898|469235356|FG000|Overall Study|Adverse Event|1|||
130345223|NCT01587898|469235357|FG001|Overall Study|Adverse Event|1|||
130345224|NCT01587898|469235358|FG002|Overall Study|Adverse Event|0|||
130345225|NCT01587898|469235359|FG003|Overall Study|Adverse Event|0|||
130345226|NCT01587898|469235356|FG000|Overall Study|Protocol Violation|0|||
130345227|NCT01587898|469235357|FG001|Overall Study|Protocol Violation|2|||
130345228|NCT01587898|469235358|FG002|Overall Study|Protocol Violation|1|||
130345229|NCT01587898|469235359|FG003|Overall Study|Protocol Violation|1|||
130345230|NCT01587898|469235356|FG000|Overall Study|Lost to Follow-up|0|||
130345231|NCT01587898|469235357|FG001|Overall Study|Lost to Follow-up|0|||
130345232|NCT01587898|469235358|FG002|Overall Study|Lost to Follow-up|0|||
130345233|NCT01587898|469235359|FG003|Overall Study|Lost to Follow-up|1|||
130345234|NCT01587898|469235356|FG000|Overall Study|Withdrawal by Subject|2|||
130345235|NCT01587898|469235357|FG001|Overall Study|Withdrawal by Subject|1|||
130345236|NCT01587898|469235358|FG002|Overall Study|Withdrawal by Subject|0|||
130345237|NCT01587898|469235359|FG003|Overall Study|Withdrawal by Subject|0|||
130345238|NCT01587898|469235356|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
130345239|NCT01587898|469235357|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
130345240|NCT01587898|469235358|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
130345241|NCT01587898|469235359|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
130345242|NCT01738477|469235360|FG000|Overall Study|Lost to Follow-up|1|||
130345243|NCT01738477|469235361|FG001|Overall Study|Lost to Follow-up|4|||
130345244|NCT02437110|469235362|FG000|Screening|Lost to Follow-up|3|||
130345245|NCT02437110|469235362|FG000|Screening|Physician Decision|1|||
130345246|NCT02437110|469235362|FG000|ART|Adverse Event|3|||
130010408|NCT05321069|468000014|FG000|Overall Study|Lost to Follow-up|1|||
130345247|NCT02437110|469235362|FG000|ART|Protocol Violation|3|||
130345248|NCT02437110|469235362|FG000|ART|Withdrawal by Subject|4|||
130345249|NCT02437110|469235362|FG000|ART|Lost to follow-up prior to start of intervention|1|||
130345250|NCT02437110|469235362|FG000|ART|Physician decision prior to start of intervention|2|||
130345251|NCT02437110|469235362|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
130345252|NCT02437110|469235362|FG000|Post-ART|Lost to Follow-up|3|||
130345253|NCT02437110|469235362|FG000|Post-ART|Protocol Violation|4|||
130345254|NCT02437110|469235362|FG000|Post-ART|Withdrawal by Subject|3|||
130345255|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
130345256|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
130010409|NCT05321069|468000015|FG001|Overall Study|Lost to Follow-up|0|||
130010410|NCT05321069|468000016|FG002|Overall Study|Lost to Follow-up|1|||
130010411|NCT05321069|468000014|FG000|Overall Study|No reason stated by the participants|23|||
130010412|NCT05321069|468000015|FG001|Overall Study|No reason stated by the participants|22|||
130010413|NCT05321069|468000016|FG002|Overall Study|No reason stated by the participants|16|||
130345257|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
130345258|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
130345259|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
130345260|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
130345261|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
130345262|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
130345263|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
130345264|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
130345265|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
130345266|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
130345267|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
130345268|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
130345269|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
130345270|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
130345271|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
130345272|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
130345273|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
130345274|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
130345275|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
130345276|NCT01227824|469235366|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
130345277|NCT01227824|469235367|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
130345278|NCT01227824|469235368|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
130345279|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
130345280|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
130345281|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
130345282|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
130345283|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
130345284|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
130345285|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
130345286|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
130345287|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
130345288|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
130345289|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
130010414|NCT05321069|468000014|FG000|Overall Study|Lack of Efficacy|1|||
130010415|NCT05321069|468000015|FG001|Overall Study|Lack of Efficacy|1|||
130345290|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
130345291|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
130345292|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
130345293|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
130345294|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
130345295|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
130345296|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
130345297|NCT01227824|469235366|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
130345298|NCT01227824|469235367|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
130345299|NCT01227824|469235368|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
130345300|NCT02576145|469235369|FG000|Overall Study|Adverse Event|1|||
130345301|NCT02576145|469235370|FG001|Overall Study|Adverse Event|0|||
130345302|NCT02576145|469235369|FG000|Overall Study|Withdrawal by Subject|1|||
130345303|NCT02576145|469235370|FG001|Overall Study|Withdrawal by Subject|0|||
130345304|NCT02576145|469235369|FG000|Overall Study|Acute rejection|1|||
130345305|NCT02576145|469235370|FG001|Overall Study|Acute rejection|0|||
130345306|NCT02576145|469235369|FG000|Overall Study|Tetanus Titers Decreased|0|||
130345307|NCT02576145|469235370|FG001|Overall Study|Tetanus Titers Decreased|1|||
130345308|NCT02660138|469235371|FG000|Overall Study|Adverse Event|0|||
130345309|NCT02660138|469235372|FG001|Overall Study|Adverse Event|3|||
130345310|NCT02660138|469235373|FG002|Overall Study|Adverse Event|2|||
130345311|NCT02660138|469235371|FG000|Overall Study|Lack of Efficacy|1|||
130345312|NCT02660138|469235372|FG001|Overall Study|Lack of Efficacy|2|||
130345313|NCT02660138|469235373|FG002|Overall Study|Lack of Efficacy|1|||
130345314|NCT02660138|469235371|FG000|Overall Study|Withdrawal by Subject|7|||
130345315|NCT02660138|469235372|FG001|Overall Study|Withdrawal by Subject|6|||
130345316|NCT02660138|469235373|FG002|Overall Study|Withdrawal by Subject|6|||
130345317|NCT02660138|469235371|FG000|Overall Study|Lost to Follow-up|4|||
130345318|NCT02660138|469235372|FG001|Overall Study|Lost to Follow-up|4|||
130345319|NCT02660138|469235373|FG002|Overall Study|Lost to Follow-up|1|||
130345320|NCT02660138|469235371|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
130345321|NCT02660138|469235372|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
130345322|NCT02660138|469235373|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
130345323|NCT02660138|469235371|FG000|Overall Study|Other|1|||
130345324|NCT02660138|469235372|FG001|Overall Study|Other|1|||
130345325|NCT02660138|469235373|FG002|Overall Study|Other|0|||
130345326|NCT02660138|469235371|FG000|Overall Study|Not treated|0|||
130345327|NCT02660138|469235372|FG001|Overall Study|Not treated|1|||
130345328|NCT02660138|469235373|FG002|Overall Study|Not treated|0|||
130345329|NCT00308581|469235378|FG000|Induction Phase|Adverse Event|0|||
130345330|NCT00308581|469235379|FG001|Induction Phase|Adverse Event|0|||
130010416|NCT05321069|468000016|FG002|Overall Study|Lack of Efficacy|0|||
130010417|NCT01293968|468000017|FG000|Overall Study|non-cooperation|3|||
130010418|NCT01293968|468000018|FG001|Overall Study|non-cooperation|3|||
130010419|NCT00853749|468000019|FG000|Overall Study|Lost to Follow-up|0|||
130010420|NCT00853749|468000020|FG001|Overall Study|Lost to Follow-up|1|||
130010421|NCT00798135|468000021|FG000|Overall Study|Disease progression, relapse|11|||
130345331|NCT00308581|469235380|FG002|Induction Phase|Adverse Event|37|||
130345332|NCT00308581|469235378|FG000|Induction Phase|Lack of Efficacy|0|||
130345333|NCT00308581|469235379|FG001|Induction Phase|Lack of Efficacy|0|||
130010422|NCT00798135|468000021|FG000|Overall Study|Disease progression, refractory|1|||
130345334|NCT00308581|469235380|FG002|Induction Phase|Lack of Efficacy|121|||
130345335|NCT00308581|469235378|FG000|Induction Phase|Withdrawal by Subject|0|||
130345336|NCT00308581|469235379|FG001|Induction Phase|Withdrawal by Subject|0|||
130345337|NCT00308581|469235380|FG002|Induction Phase|Withdrawal by Subject|5|||
130345338|NCT00308581|469235378|FG000|Induction Phase|Unknown reason|0|||
130345339|NCT00308581|469235379|FG001|Induction Phase|Unknown reason|0|||
130010423|NCT00798135|468000021|FG000|Overall Study|Physician Decision|1|||
130010424|NCT00687440|468000022|FG000|Overall Study|Adverse Event|3|||
130010425|NCT00687440|468000022|FG000|Overall Study|Lost to Follow-up|3|||
130010426|NCT00687440|468000022|FG000|Overall Study|Lack of Efficacy|2|||
130010427|NCT00687440|468000022|FG000|Overall Study|Death|2|||
130010428|NCT00687440|468000022|FG000|Overall Study|Other|1|||
130010429|NCT00687440|468000022|FG000|Overall Study|Missing|1|||
130010430|NCT01392677|468000025|FG000|Overall Study|Adverse Event|3|||
130010431|NCT01392677|468000026|FG001|Overall Study|Adverse Event|1|||
130010432|NCT01392677|468000025|FG000|Overall Study|Withdrawal by Subject|0|||
130010433|NCT01392677|468000026|FG001|Overall Study|Withdrawal by Subject|2|||
130010434|NCT01392677|468000025|FG000|Overall Study|Incorrect enrollment|2|||
130010435|NCT01392677|468000026|FG001|Overall Study|Incorrect enrollment|3|||
130010436|NCT01392677|468000025|FG000|Overall Study|Other reason|3|||
130010437|NCT01392677|468000026|FG001|Overall Study|Other reason|2|||
130010438|NCT03996876|468000027|FG000|Overall Study|Incomplete Data|2|||
130010439|NCT03996876|468000028|FG001|Overall Study|Incomplete Data|4|||
130010440|NCT03080883|468000029|FG000|Overall Study|Withdrawal by Subject|11|||
130010441|NCT03080883|468000030|FG001|Overall Study|Withdrawal by Subject|15|||
130010442|NCT03080883|468000029|FG000|Overall Study|Adverse Event|22|||
130010443|NCT03080883|468000030|FG001|Overall Study|Adverse Event|22|||
130010444|NCT03080883|468000029|FG000|Overall Study|Alternative Therapy|0|||
130010445|NCT03080883|468000030|FG001|Overall Study|Alternative Therapy|3|||
130010446|NCT03080883|468000029|FG000|Overall Study|Other Complicating Disease|9|||
130010447|NCT03080883|468000030|FG001|Overall Study|Other Complicating Disease|5|||
130010448|NCT03080883|468000029|FG000|Overall Study|Death|21|||
130010449|NCT03080883|468000030|FG001|Overall Study|Death|16|||
130010450|NCT03080883|468000029|FG000|Overall Study|Physician Decision|2|||
130010451|NCT03080883|468000030|FG001|Overall Study|Physician Decision|2|||
130010452|NCT03080883|468000029|FG000|Overall Study|Disease Progression|2|||
130010453|NCT03080883|468000030|FG001|Overall Study|Disease Progression|8|||
130010454|NCT03080883|468000029|FG000|Overall Study|Lost to Follow-up|1|||
130010455|NCT03080883|468000030|FG001|Overall Study|Lost to Follow-up|1|||
130010456|NCT04360551|468001434|FG000|Overall Study|Withdrawal by Subject|1|||
130010457|NCT04360551|468001435|FG001|Overall Study|Withdrawal by Subject|0|||
130010458|NCT00346073|468001444|FG000|Overall Study|Serious Adverse Event|2|||
130010459|NCT00346073|468001445|FG001|Overall Study|Serious Adverse Event|0|||
130010460|NCT00346073|468001444|FG000|Overall Study|Lost to Follow-up|39|||
130010461|NCT00346073|468001445|FG001|Overall Study|Lost to Follow-up|24|||
130010462|NCT03703882|468001450|FG000|Overall Study|Adverse Event|1|||
130010463|NCT03703882|468001451|FG001|Overall Study|Adverse Event|0|||
130010464|NCT03703882|468001450|FG000|Overall Study|Lost to Follow-up|0|||
130010465|NCT03703882|468001451|FG001|Overall Study|Lost to Follow-up|2|||
130010466|NCT03703882|468001450|FG000|Overall Study|Non-compliance with study drug|0|||
130010467|NCT03703882|468001451|FG001|Overall Study|Non-compliance with study drug|1|||
130010468|NCT03703882|468001450|FG000|Overall Study|Physician Decision|0|||
130010469|NCT03703882|468001451|FG001|Overall Study|Physician Decision|1|||
130010470|NCT03703882|468001450|FG000|Overall Study|Progressive disease|1|||
130010471|NCT03703882|468001451|FG001|Overall Study|Progressive disease|0|||
130010472|NCT03703882|468001450|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130010473|NCT03703882|468001451|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130010474|NCT03703882|468001450|FG000|Overall Study|Starting another treatment|0|||
130010475|NCT03703882|468001451|FG001|Overall Study|Starting another treatment|1|||
130010476|NCT03703882|468001450|FG000|Overall Study|noncompliance with study procedures|0|||
130345340|NCT00308581|469235380|FG002|Induction Phase|Unknown reason|3|||
130345341|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Adverse Event|10|||
130345342|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Adverse Event|17|||
130345343|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Adverse Event|0|||
130345344|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
130345345|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
130345346|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
130345347|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
130345348|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
130345349|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
130345350|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
130345351|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
130345352|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
130345353|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
130345354|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
130345355|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
130345356|NCT00308581|469235378|FG000|Randomized Maintenance Phase|Unknown reason|3|||
130345357|NCT00308581|469235379|FG001|Randomized Maintenance Phase|Unknown reason|0|||
130345358|NCT00308581|469235380|FG002|Randomized Maintenance Phase|Unknown reason|0|||
130345359|NCT00899353|469235381|FG000|Overall Study|Adverse Event|2|||
130345360|NCT00899353|469235381|FG000|Overall Study|Lost to Follow-up|1|||
130010477|NCT03703882|468001451|FG001|Overall Study|noncompliance with study procedures|1|||
130010478|NCT01617460|468001452|FG000|Overall Study|Adverse Event|10|||
130010479|NCT01617460|468001452|FG000|Overall Study|Physician Decision|16|||
130010480|NCT01617460|468001452|FG000|Overall Study|Protocol Violation|5|||
130010481|NCT01617460|468001452|FG000|Overall Study|Withdrawal by Subject|9|||
130010482|NCT00075023|468001459|FG000|Pilot Study|Physician Decision|1|||
130010483|NCT00075023|468001460|FG001|Pilot Study|Physician Decision|2|||
130010484|NCT00075023|468001459|FG000|Pilot Study|Withdrawal by Subject|1|||
130010485|NCT00075023|468001460|FG001|Pilot Study|Withdrawal by Subject|0|||
130010486|NCT03670953|468001461|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
130010487|NCT03670953|468001462|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
130010488|NCT03670953|468001463|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
130010489|NCT03670953|468001464|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
130010490|NCT03670953|468001461|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
130010491|NCT03670953|468001462|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
130010492|NCT03670953|468001463|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
130010493|NCT03670953|468001464|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
130010494|NCT03670953|468001461|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
130010495|NCT03670953|468001462|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
130010496|NCT03670953|468001463|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
130010497|NCT03670953|468001464|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
130010498|NCT03670953|468001461|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
130010499|NCT03670953|468001462|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
130010500|NCT03670953|468001463|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
130010501|NCT03670953|468001464|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
130010502|NCT03670953|468001461|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
130010503|NCT03670953|468001462|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
130010504|NCT03670953|468001463|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
130010505|NCT03670953|468001464|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
130010506|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
130010507|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
130010508|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
130010509|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
130010510|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
130010511|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
130010512|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
130010513|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
130010514|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
130010515|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
130010516|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
130010517|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
130010518|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
130010519|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
130010520|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
130010521|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
130010522|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130010523|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
130010524|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130010525|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
130010526|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
130010527|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
130010528|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
130010529|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
130010530|NCT03670953|468001461|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
130010531|NCT03670953|468001462|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
130010532|NCT03670953|468001463|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
130010533|NCT03670953|468001464|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
130010534|NCT03670953|468001461|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
130010535|NCT03670953|468001462|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
130010536|NCT03670953|468001463|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
130010537|NCT03670953|468001464|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
130010538|NCT03670953|468001461|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
130010539|NCT03670953|468001462|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
130010540|NCT03670953|468001463|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
130010541|NCT03670953|468001464|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
130010542|NCT03670953|468001461|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
130345361|NCT00899353|469235381|FG000|Overall Study|Withdrawal by Subject|2|||
130345362|NCT01284491|469235385|FG000|Overall Study|Study termination|13|||
130345363|NCT02694757|469235388|FG000|Overall Study|Lack of Efficacy|3|||
130345364|NCT02650921|469235389|FG000|Overall Study|Withdrawal by Subject|4|||
130345365|NCT02650921|469235389|FG000|Overall Study|Lost to Follow-up|2|||
130345366|NCT02650921|469235389|FG000|Overall Study|Adverse Event|1|||
130345367|NCT02650921|469235389|FG000|Overall Study|Due to Medical Condition|1|||
130345368|NCT00783302|469235390|FG000|Overall Study|Lost to Follow-up|17|||
130345369|NCT00783302|469235390|FG000|Overall Study|Technical Problems|11|||
130345370|NCT00783302|469235390|FG000|Overall Study|Protocol Violation|3|||
130345371|NCT00783302|469235390|FG000|Overall Study|Physician Decision|1|||
130345372|NCT00783302|469235390|FG000|Overall Study|Withdrawal by Subject|3|||
130345373|NCT04604132|469235391|FG000|Overall Study|Adverse Event|2|||
130345374|NCT04604132|469235392|FG001|Overall Study|Adverse Event|0|||
130345375|NCT04604132|469235393|FG002|Overall Study|Adverse Event|0|||
130345376|NCT04604132|469235394|FG003|Overall Study|Adverse Event|1|||
130345377|NCT04604132|469235395|FG004|Overall Study|Adverse Event|2|||
130345378|NCT04604132|469235391|FG000|Overall Study|Study terminated by sponsor|0|||
130345379|NCT04604132|469235392|FG001|Overall Study|Study terminated by sponsor|0|||
130345380|NCT04604132|469235393|FG002|Overall Study|Study terminated by sponsor|0|||
130345381|NCT04604132|469235394|FG003|Overall Study|Study terminated by sponsor|0|||
130345382|NCT04604132|469235395|FG004|Overall Study|Study terminated by sponsor|1|||
130345383|NCT04604132|469235391|FG000|Overall Study|Progressive disease: Clinical progression|0|||
130345384|NCT04604132|469235392|FG001|Overall Study|Progressive disease: Clinical progression|0|||
130345385|NCT04604132|469235393|FG002|Overall Study|Progressive disease: Clinical progression|1|||
130345386|NCT04604132|469235394|FG003|Overall Study|Progressive disease: Clinical progression|0|||
130345387|NCT04604132|469235395|FG004|Overall Study|Progressive disease: Clinical progression|0|||
130345388|NCT04604132|469235391|FG000|Overall Study|Progressive disease: Radiological progression|8|||
130345389|NCT04604132|469235392|FG001|Overall Study|Progressive disease: Radiological progression|7|||
130345390|NCT04604132|469235393|FG002|Overall Study|Progressive disease: Radiological progression|10|||
130345391|NCT04604132|469235394|FG003|Overall Study|Progressive disease: Radiological progression|4|||
130345392|NCT04604132|469235395|FG004|Overall Study|Progressive disease: Radiological progression|3|||
130345393|NCT04604132|469235391|FG000|Overall Study|Death|3|||
130345394|NCT04604132|469235392|FG001|Overall Study|Death|1|||
130345395|NCT04604132|469235393|FG002|Overall Study|Death|2|||
130345396|NCT04604132|469235394|FG003|Overall Study|Death|1|||
130345397|NCT04604132|469235395|FG004|Overall Study|Death|0|||
130345398|NCT00952380|469235396|FG000|Overall Study|Other|0|||
130345399|NCT00952380|469235397|FG001|Overall Study|Other|0|||
130345400|NCT00952380|469235398|FG002|Overall Study|Other|0|||
130345401|NCT00952380|469235399|FG003|Overall Study|Other|0|||
130345402|NCT00952380|469235400|FG004|Overall Study|Other|1|||
130345403|NCT00952380|469235396|FG000|Overall Study|Withdrawal by Subject|0|||
130345404|NCT00952380|469235397|FG001|Overall Study|Withdrawal by Subject|0|||
130345405|NCT00952380|469235398|FG002|Overall Study|Withdrawal by Subject|1|||
130345406|NCT00952380|469235399|FG003|Overall Study|Withdrawal by Subject|0|||
130345407|NCT00952380|469235400|FG004|Overall Study|Withdrawal by Subject|2|||
130345408|NCT00952380|469235396|FG000|Overall Study|Adverse Event|0|||
130345409|NCT00952380|469235397|FG001|Overall Study|Adverse Event|1|||
130345410|NCT00952380|469235398|FG002|Overall Study|Adverse Event|0|||
130345411|NCT00952380|469235399|FG003|Overall Study|Adverse Event|0|||
130345412|NCT00952380|469235400|FG004|Overall Study|Adverse Event|3|||
130345413|NCT00952380|469235396|FG000|Overall Study|Physician Decision|0|||
130345414|NCT00952380|469235397|FG001|Overall Study|Physician Decision|0|||
130345415|NCT00952380|469235398|FG002|Overall Study|Physician Decision|1|||
130345416|NCT00952380|469235399|FG003|Overall Study|Physician Decision|2|||
130345417|NCT00952380|469235400|FG004|Overall Study|Physician Decision|0|||
130345418|NCT00952380|469235396|FG000|Overall Study|Non-compliant to protocol|0|||
130345419|NCT00952380|469235397|FG001|Overall Study|Non-compliant to protocol|0|||
130345420|NCT00952380|469235398|FG002|Overall Study|Non-compliant to protocol|0|||
130345421|NCT00952380|469235399|FG003|Overall Study|Non-compliant to protocol|1|||
130345422|NCT00952380|469235400|FG004|Overall Study|Non-compliant to protocol|0|||
130345423|NCT03400956|469235401|FG000|Treatment Period 1|Adverse Event|0|||
130345424|NCT03400956|469235402|FG001|Treatment Period 1|Adverse Event|1|||
130345425|NCT03400956|469235403|FG002|Treatment Period 1|Adverse Event|0|||
130010543|NCT03670953|468001462|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
130010544|NCT03670953|468001463|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
130010545|NCT03670953|468001464|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
130010546|NCT03670953|468001461|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
130010547|NCT03670953|468001462|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
130010548|NCT03670953|468001463|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
130010549|NCT03670953|468001464|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
130010550|NCT03670953|468001461|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
130010551|NCT03670953|468001462|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
130010552|NCT03670953|468001463|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
130010553|NCT03670953|468001464|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
130010554|NCT03670953|468001461|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
130010555|NCT03670953|468001462|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
130010556|NCT03670953|468001463|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
130010557|NCT03670953|468001464|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
130010558|NCT04342871|468001465|FG000|Overall Study|Death|4|||
130345426|NCT03400956|469235401|FG000|Treatment Period 1|Lost to Follow-up|0|||
130345427|NCT03400956|469235402|FG001|Treatment Period 1|Lost to Follow-up|0|||
130345428|NCT03400956|469235403|FG002|Treatment Period 1|Lost to Follow-up|1|||
130345429|NCT03400956|469235401|FG000|Treatment Period 1|Protocol Violation|0|||
130345430|NCT03400956|469235402|FG001|Treatment Period 1|Protocol Violation|2|||
130345431|NCT03400956|469235403|FG002|Treatment Period 1|Protocol Violation|0|||
130345432|NCT03400956|469235401|FG000|Treatment Period 1|Study terminated by sponsor|3|||
130345433|NCT03400956|469235402|FG001|Treatment Period 1|Study terminated by sponsor|1|||
130345434|NCT03400956|469235403|FG002|Treatment Period 1|Study terminated by sponsor|1|||
130345435|NCT03400956|469235401|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130345436|NCT03400956|469235402|FG001|Treatment Period 1|Withdrawal by Subject|2|||
130345437|NCT03400956|469235403|FG002|Treatment Period 1|Withdrawal by Subject|4|||
130345438|NCT03400956|469235401|FG000|Treatment Period 1|Other|1|||
130345439|NCT03400956|469235402|FG001|Treatment Period 1|Other|2|||
130345440|NCT03400956|469235403|FG002|Treatment Period 1|Other|3|||
130345441|NCT03400956|469235401|FG000|Post-treatment Period 1|Adverse Event|0|||
130345442|NCT03400956|469235402|FG001|Post-treatment Period 1|Adverse Event|0|||
130345443|NCT03400956|469235403|FG002|Post-treatment Period 1|Adverse Event|1|||
130345444|NCT03400956|469235401|FG000|Post-treatment Period 1|Physician Decision|2|||
130345445|NCT03400956|469235402|FG001|Post-treatment Period 1|Physician Decision|3|||
130345446|NCT03400956|469235403|FG002|Post-treatment Period 1|Physician Decision|0|||
130345447|NCT03400956|469235401|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
130345448|NCT03400956|469235402|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
130345449|NCT03400956|469235403|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
130345450|NCT03400956|469235401|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
130345451|NCT03400956|469235402|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
130345452|NCT03400956|469235403|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
130345453|NCT03400956|469235401|FG000|Post-treatment Period 1|Other|4|||
130345454|NCT03400956|469235402|FG001|Post-treatment Period 1|Other|3|||
130345455|NCT03400956|469235403|FG002|Post-treatment Period 1|Other|4|||
130345456|NCT03400956|469235401|FG000|Treatment Period 2|Adverse Event|2|||
130345457|NCT03400956|469235402|FG001|Treatment Period 2|Adverse Event|1|||
130345458|NCT03400956|469235403|FG002|Treatment Period 2|Adverse Event|1|||
130345459|NCT03400956|469235401|FG000|Treatment Period 2|Lost to Follow-up|1|||
130345460|NCT03400956|469235402|FG001|Treatment Period 2|Lost to Follow-up|1|||
130345461|NCT03400956|469235403|FG002|Treatment Period 2|Lost to Follow-up|0|||
130345462|NCT03400956|469235401|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130345463|NCT03400956|469235402|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130345464|NCT03400956|469235403|FG002|Treatment Period 2|Withdrawal by Subject|3|||
130345465|NCT03400956|469235401|FG000|Treatment Period 2|Other|1|||
130345466|NCT03400956|469235402|FG001|Treatment Period 2|Other|1|||
130345467|NCT03400956|469235403|FG002|Treatment Period 2|Other|0|||
130345468|NCT03400956|469235401|FG000|Follow-up Period|Withdrawal by Subject|0|||
130345469|NCT03400956|469235402|FG001|Follow-up Period|Withdrawal by Subject|0|||
130345470|NCT03400956|469235403|FG002|Follow-up Period|Withdrawal by Subject|1|||
130345471|NCT03400956|469235401|FG000|Follow-up Period|Other|0|||
130345472|NCT03400956|469235402|FG001|Follow-up Period|Other|0|||
130345473|NCT03400956|469235403|FG002|Follow-up Period|Other|1|||
130345474|NCT00160667|469235404|FG000|Overall Study|Adverse Event|3|||
130345475|NCT00160667|469235405|FG001|Overall Study|Adverse Event|1|||
130345476|NCT00160667|469235406|FG002|Overall Study|Adverse Event|4|||
130345477|NCT00160667|469235404|FG000|Overall Study|Withdrawal by Subject|2|||
130345478|NCT00160667|469235405|FG001|Overall Study|Withdrawal by Subject|0|||
130345479|NCT00160667|469235406|FG002|Overall Study|Withdrawal by Subject|1|||
130345480|NCT00160667|469235404|FG000|Overall Study|Lack of Efficacy|0|||
130345481|NCT00160667|469235405|FG001|Overall Study|Lack of Efficacy|1|||
130345482|NCT00160667|469235406|FG002|Overall Study|Lack of Efficacy|0|||
130345483|NCT00160667|469235404|FG000|Overall Study|Protocol Violation|0|||
130010559|NCT04342871|468001465|FG000|Overall Study|Clinical deterioration/illness progression|2|||
130010560|NCT04342871|468001465|FG000|Overall Study|Did not complete baseline assessments|5|||
130010561|NCT04342871|468001465|FG000|Overall Study|Lost to Follow-up|13|||
130010562|NCT04179734|468001466|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
130010563|NCT04179734|468001467|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
130010564|NCT04179734|468001466|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
130010565|NCT04179734|468001467|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
130345484|NCT00160667|469235405|FG001|Overall Study|Protocol Violation|1|||
130345485|NCT00160667|469235406|FG002|Overall Study|Protocol Violation|0|||
130345486|NCT00160667|469235404|FG000|Overall Study|Patient decision|0|||
130345487|NCT00160667|469235405|FG001|Overall Study|Patient decision|0|||
130345488|NCT00160667|469235406|FG002|Overall Study|Patient decision|1|||
130345489|NCT01306929|469235411|FG000|Overall Study|Withdrawal by Subject|23|||
130345490|NCT01306929|469235411|FG000|Overall Study|Adverse Event|21|||
130345491|NCT01306929|469235411|FG000|Overall Study|Physician Decision|13|||
130345492|NCT01306929|469235411|FG000|Overall Study|Death|8|||
130345493|NCT01306929|469235411|FG000|Overall Study|Withdrawal by parent/guardian|5|||
130345494|NCT01306929|469235411|FG000|Overall Study|Protocol Violation|3|||
130345495|NCT01306929|469235411|FG000|Overall Study|Non-compliance with study drug|2|||
130345496|NCT01306929|469235411|FG000|Overall Study|Lost to Follow-up|2|||
130345497|NCT01306929|469235411|FG000|Overall Study|Various|17|||
130345498|NCT03709576|469235412|FG000|Overall Study|progression prior to enrollment|1|||
130345499|NCT00890045|469235418|FG000|Overall Study|Death|0|||
130345500|NCT00890045|469235419|FG001|Overall Study|Death|1|||
130345501|NCT00890045|469235418|FG000|Overall Study|Did not receive HeRO Graft|0|||
130345502|NCT00890045|469235419|FG001|Overall Study|Did not receive HeRO Graft|2|||
130345503|NCT00890045|469235418|FG000|Overall Study|Lost to Follow-up|5|||
130345504|NCT00890045|469235419|FG001|Overall Study|Lost to Follow-up|7|||
130345505|NCT00483756|469235424|FG000|Overall Study|Death|2|||
130345506|NCT00483756|469235425|FG001|Overall Study|Death|0|||
130345507|NCT00483756|469235426|FG002|Overall Study|Death|1|||
130345508|NCT00483756|469235424|FG000|Overall Study|Adverse Event|19|||
130345509|NCT00483756|469235425|FG001|Overall Study|Adverse Event|38|||
130010566|NCT00666458|468001469|FG000|Overall Study|Adverse Event|8|||
130010567|NCT00666458|468001470|FG001|Overall Study|Adverse Event|7|||
130010568|NCT00666458|468001469|FG000|Overall Study|Withdrawal by Subject|5|||
130010569|NCT00666458|468001470|FG001|Overall Study|Withdrawal by Subject|4|||
130010570|NCT00666458|468001469|FG000|Overall Study|Lost to Follow-up|0|||
130010571|NCT00666458|468001470|FG001|Overall Study|Lost to Follow-up|3|||
130010572|NCT00666458|468001469|FG000|Overall Study|Administrative reason by sponsor|1|||
130010573|NCT00666458|468001470|FG001|Overall Study|Administrative reason by sponsor|1|||
130010574|NCT00666458|468001469|FG000|Overall Study|Incorrect enrollment|7|||
130010575|NCT00666458|468001470|FG001|Overall Study|Incorrect enrollment|1|||
130010576|NCT00666458|468001469|FG000|Overall Study|Study specific discontinuation criteria|14|||
130010577|NCT00666458|468001470|FG001|Overall Study|Study specific discontinuation criteria|7|||
130216615|NCT03162328|468755619|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
130345510|NCT00483756|469235426|FG002|Overall Study|Adverse Event|40|||
130345511|NCT00483756|469235424|FG000|Overall Study|Lack of Efficacy|1|||
130345512|NCT00483756|469235425|FG001|Overall Study|Lack of Efficacy|0|||
130345513|NCT00483756|469235426|FG002|Overall Study|Lack of Efficacy|0|||
130345514|NCT00483756|469235424|FG000|Overall Study|Lost to Follow-up|3|||
130345515|NCT00483756|469235425|FG001|Overall Study|Lost to Follow-up|1|||
130345516|NCT00483756|469235426|FG002|Overall Study|Lost to Follow-up|0|||
130345517|NCT00483756|469235424|FG000|Overall Study|Withdrawal by Subject|5|||
130345518|NCT00483756|469235425|FG001|Overall Study|Withdrawal by Subject|3|||
130345519|NCT00483756|469235426|FG002|Overall Study|Withdrawal by Subject|4|||
130345520|NCT00483756|469235424|FG000|Overall Study|Other|2|||
130345521|NCT00483756|469235425|FG001|Overall Study|Other|4|||
130345522|NCT00483756|469235426|FG002|Overall Study|Other|3|||
130345523|NCT00483756|469235424|FG000|Overall Study|Randomized, Not Treated|1|||
130345524|NCT00483756|469235425|FG001|Overall Study|Randomized, Not Treated|4|||
130345525|NCT00483756|469235426|FG002|Overall Study|Randomized, Not Treated|4|||
130345526|NCT04463069|469235427|FG000|Overall Study|Withdrawal by Subject|2|||
130345527|NCT04463069|469235428|FG001|Overall Study|Withdrawal by Subject|10|||
130345528|NCT04463069|469235427|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
130345529|NCT04463069|469235428|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
130345530|NCT03603509|469237127|FG000|Overall Study|Lost to Follow-up|3|||
130345531|NCT03603509|469237128|FG001|Overall Study|Lost to Follow-up|4|||
130345532|NCT02656680|469237131|FG000|Overall Study|Lost to Follow-up|0|||
130345533|NCT02656680|469237132|FG001|Overall Study|Lost to Follow-up|1|||
130345534|NCT02656680|469237133|FG002|Overall Study|Lost to Follow-up|7|||
130345535|NCT04966910|469237134|FG000|Baseline|Participant did not complete measure|0|||
130345536|NCT04966910|469237135|FG001|Baseline|Participant did not complete measure|0|||
130345537|NCT04966910|469237136|FG002|Baseline|Participant did not complete measure|1|||
130345538|NCT04966910|469237137|FG003|Baseline|Participant did not complete measure|0|||
130345539|NCT04966910|469237134|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
130345540|NCT04966910|469237135|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
130345541|NCT04966910|469237136|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
130345542|NCT04966910|469237137|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
130345543|NCT04966910|469237134|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
130345544|NCT04966910|469237135|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
130345545|NCT04966910|469237136|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
130345546|NCT04966910|469237137|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
130345547|NCT04966910|469237134|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
130345548|NCT04966910|469237135|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
130345549|NCT04966910|469237136|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
130345550|NCT04966910|469237137|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
130345551|NCT04531462|469237141|FG000|Overall Study|Withdrawal by Subject|3|||
130345552|NCT04531462|469237142|FG001|Overall Study|Withdrawal by Subject|1|||
130345553|NCT04531462|469237141|FG000|Overall Study|Adverse Event|3|||
130345554|NCT04531462|469237142|FG001|Overall Study|Adverse Event|3|||
130345555|NCT00504582|469237143|FG000|Overall Study|Lost to Follow-up|1|||
130345556|NCT00504582|469237144|FG001|Overall Study|Lost to Follow-up|0|||
130345557|NCT00504582|469237145|FG002|Overall Study|Lost to Follow-up|0|||
130345558|NCT00348933|469237148|FG000|Overall Study|Withdrawal by Subject|10|||
130345559|NCT00348933|469237148|FG000|Overall Study|Lost to Follow-up|6|||
130345560|NCT00348933|469237148|FG000|Overall Study|Protocol Violation|2|||
130345561|NCT00348933|469237148|FG000|Overall Study|Adverse Event|7|||
130345562|NCT01489111|469237149|FG000|Overall Study|Withdrawal criterion|1|||
130345563|NCT00711516|469237155|FG000|Overall Study|Adverse Event|1|||
130345564|NCT00711516|469237156|FG001|Overall Study|Adverse Event|1|||
130345565|NCT00711516|469237155|FG000|Overall Study|Withdrawal by Subject|0|||
130345566|NCT00711516|469237156|FG001|Overall Study|Withdrawal by Subject|1|||
130345567|NCT00711516|469237155|FG000|Overall Study|Protocol Violation|0|||
130345568|NCT00711516|469237156|FG001|Overall Study|Protocol Violation|1|||
130010578|NCT00666458|468001469|FG000|Overall Study|Severe non-compliance to the protocol|1|||
130345569|NCT01029405|469237160|FG000|Overall Study|Withdrawal by Subject|0|||
130010579|NCT00666458|468001470|FG001|Overall Study|Severe non-compliance to the protocol|1|||
130010580|NCT00666458|468001469|FG000|Overall Study|Safety reasons|1|||
130010581|NCT00666458|468001470|FG001|Overall Study|Safety reasons|0|||
130010582|NCT00666458|468001469|FG000|Overall Study|Medical history of anemia|1|||
130010583|NCT00666458|468001470|FG001|Overall Study|Medical history of anemia|0|||
130010584|NCT02222207|468001472|FG000|Overall Study|Death|1|||
130010585|NCT02222207|468001472|FG000|Overall Study|Other reasons|2|||
130010586|NCT02222207|468001472|FG000|Overall Study|Adverse Event|1|||
130010587|NCT02982954|468001473|FG000|Overall Study|Death|55|||
130345570|NCT01029405|469237161|FG001|Overall Study|Withdrawal by Subject|1|||
130345571|NCT01029405|469237162|FG002|Overall Study|Withdrawal by Subject|2|||
130345572|NCT01029405|469237163|FG003|Overall Study|Withdrawal by Subject|0|||
130345573|NCT01029405|469237160|FG000|Overall Study|Protocol Violation|0|||
130345574|NCT01029405|469237161|FG001|Overall Study|Protocol Violation|0|||
130345575|NCT01029405|469237162|FG002|Overall Study|Protocol Violation|0|||
130345576|NCT01029405|469237163|FG003|Overall Study|Protocol Violation|1|||
130345577|NCT01029405|469237160|FG000|Overall Study|Adverse Event|0|||
130345578|NCT01029405|469237161|FG001|Overall Study|Adverse Event|0|||
130345579|NCT01029405|469237162|FG002|Overall Study|Adverse Event|1|||
130345580|NCT01029405|469237163|FG003|Overall Study|Adverse Event|1|||
130345581|NCT01029405|469237160|FG000|Overall Study|Lost to Follow-up|2|||
130345582|NCT01029405|469237161|FG001|Overall Study|Lost to Follow-up|1|||
130345583|NCT01029405|469237162|FG002|Overall Study|Lost to Follow-up|1|||
130345584|NCT01029405|469237163|FG003|Overall Study|Lost to Follow-up|2|||
130345585|NCT01029405|469237160|FG000|Overall Study|Other|0|||
130345586|NCT01029405|469237161|FG001|Overall Study|Other|1|||
130345587|NCT01029405|469237162|FG002|Overall Study|Other|0|||
130345588|NCT01029405|469237163|FG003|Overall Study|Other|1|||
130345589|NCT01534182|469237166|FG000|Overall Study|Administrative problems|1|||
130345590|NCT01534182|469237167|FG001|Overall Study|Administrative problems|0|||
130345591|NCT01534182|469237166|FG000|Overall Study|Withdrawal by Subject|4|||
130345592|NCT01534182|469237167|FG001|Overall Study|Withdrawal by Subject|7|||
130345593|NCT01534182|469237166|FG000|Overall Study|Adverse Event|7|||
130345594|NCT01534182|469237167|FG001|Overall Study|Adverse Event|3|||
130345595|NCT00924170|469237168|FG000|Overall Study|Refused further treatment|0|||
130345596|NCT00924170|469237169|FG001|Overall Study|Refused further treatment|1|||
130345597|NCT00924170|469237168|FG000|Overall Study|Physician Decision|0|||
130345598|NCT00924170|469237169|FG001|Overall Study|Physician Decision|1|||
130345599|NCT00924170|469237168|FG000|Overall Study|Progressive disease|3|||
130345600|NCT00924170|469237169|FG001|Overall Study|Progressive disease|6|||
130345601|NCT00924170|469237168|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
130345602|NCT00924170|469237169|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
130345603|NCT00924170|469237168|FG000|Overall Study|Death|1|||
130345604|NCT00924170|469237169|FG001|Overall Study|Death|0|||
130345605|NCT04449029|469237173|FG000|Overall Study|Adverse Event|0|||
130345606|NCT04449029|469237174|FG001|Overall Study|Adverse Event|1|||
130345607|NCT04449029|469237175|FG002|Overall Study|Adverse Event|1|||
130345608|NCT04449029|469237176|FG003|Overall Study|Adverse Event|0|||
130345609|NCT04449029|469237177|FG004|Overall Study|Adverse Event|1|||
130345610|NCT04449029|469237178|FG005|Overall Study|Adverse Event|0|||
130345611|NCT04449029|469237179|FG006|Overall Study|Adverse Event|1|||
130345612|NCT04449029|469237180|FG007|Overall Study|Adverse Event|0|||
130345613|NCT04449029|469237173|FG000|Overall Study|Lost to Follow-up|0|||
130345614|NCT04449029|469237174|FG001|Overall Study|Lost to Follow-up|1|||
130345615|NCT04449029|469237175|FG002|Overall Study|Lost to Follow-up|0|||
130345616|NCT04449029|469237176|FG003|Overall Study|Lost to Follow-up|0|||
130345617|NCT04449029|469237177|FG004|Overall Study|Lost to Follow-up|0|||
130345618|NCT04449029|469237178|FG005|Overall Study|Lost to Follow-up|0|||
130345619|NCT04449029|469237179|FG006|Overall Study|Lost to Follow-up|0|||
130345620|NCT04449029|469237180|FG007|Overall Study|Lost to Follow-up|0|||
130345621|NCT04449029|469237173|FG000|Overall Study|Protocol Violation|0|||
130345622|NCT04449029|469237174|FG001|Overall Study|Protocol Violation|1|||
130345623|NCT04449029|469237175|FG002|Overall Study|Protocol Violation|0|||
130345624|NCT04449029|469237176|FG003|Overall Study|Protocol Violation|0|||
130345625|NCT04449029|469237177|FG004|Overall Study|Protocol Violation|0|||
130345626|NCT04449029|469237178|FG005|Overall Study|Protocol Violation|0|||
130345627|NCT04449029|469237179|FG006|Overall Study|Protocol Violation|0|||
130345628|NCT04449029|469237180|FG007|Overall Study|Protocol Violation|0|||
130345629|NCT04449029|469237173|FG000|Overall Study|Physician Decision|0|||
130345630|NCT04449029|469237174|FG001|Overall Study|Physician Decision|0|||
130345631|NCT04449029|469237175|FG002|Overall Study|Physician Decision|0|||
130345632|NCT04449029|469237176|FG003|Overall Study|Physician Decision|0|||
130345633|NCT04449029|469237177|FG004|Overall Study|Physician Decision|0|||
130345634|NCT04449029|469237178|FG005|Overall Study|Physician Decision|1|||
130345635|NCT04449029|469237179|FG006|Overall Study|Physician Decision|0|||
130345636|NCT04449029|469237180|FG007|Overall Study|Physician Decision|0|||
130345637|NCT04449029|469237173|FG000|Overall Study|Withdrawal by Subject|3|||
130010588|NCT02982954|468001474|FG001|Overall Study|Death|29|||
130010589|NCT02982954|468001475|FG002|Overall Study|Death|15|||
130345638|NCT04449029|469237174|FG001|Overall Study|Withdrawal by Subject|0|||
130010590|NCT02982954|468001476|FG003|Overall Study|Death|20|||
130010591|NCT02982954|468001473|FG000|Overall Study|Lost to Follow-up|2|||
130010592|NCT02982954|468001474|FG001|Overall Study|Lost to Follow-up|1|||
130010593|NCT02982954|468001475|FG002|Overall Study|Lost to Follow-up|0|||
130010594|NCT02982954|468001476|FG003|Overall Study|Lost to Follow-up|0|||
130010595|NCT02982954|468001473|FG000|Overall Study|Participant withdrew consent|7|||
130010596|NCT02982954|468001474|FG001|Overall Study|Participant withdrew consent|5|||
130010597|NCT02982954|468001475|FG002|Overall Study|Participant withdrew consent|1|||
130010598|NCT02982954|468001476|FG003|Overall Study|Participant withdrew consent|1|||
130010599|NCT02982954|468001473|FG000|Overall Study|Other reasons|42|||
130010600|NCT02982954|468001474|FG001|Overall Study|Other reasons|17|||
130010601|NCT02982954|468001475|FG002|Overall Study|Other reasons|12|||
130010602|NCT02982954|468001476|FG003|Overall Study|Other reasons|3|||
130010603|NCT02982954|468001473|FG000|Overall Study|Premature site closure|0|||
130010604|NCT02982954|468001474|FG001|Overall Study|Premature site closure|0|||
130010605|NCT02982954|468001475|FG002|Overall Study|Premature site closure|0|||
130010606|NCT02982954|468001476|FG003|Overall Study|Premature site closure|1|||
130010607|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
130010608|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
130010609|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
130010610|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130010611|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130010612|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130010613|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Death|2|||
130010614|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Death|0|||
130010615|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
130010616|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
130010617|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
130010618|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130010619|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
130010620|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130010621|NCT02603120|468001477|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
130010622|NCT02603120|468001478|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
130010623|NCT02603120|468001477|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
130010624|NCT02603120|468001478|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
130010625|NCT02603120|468001477|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
130010626|NCT02603120|468001478|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
130010627|NCT02603120|468001477|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
130010628|NCT02603120|468001478|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
130010629|NCT02603120|468001477|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
130010630|NCT02603120|468001478|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
130010631|NCT02603120|468001477|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
130010632|NCT02603120|468001478|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
130010633|NCT02603120|468001477|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
130010634|NCT02603120|468001478|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
130010635|NCT00176605|468001481|FG000|Overall Study|Withdrawal by Subject|2|||
130010636|NCT01321710|468001482|FG000|Overall Study|Lost to Follow-up|4|||
130010637|NCT01321710|468001483|FG001|Overall Study|Lost to Follow-up|5|||
130010638|NCT01321710|468001484|FG002|Overall Study|Lost to Follow-up|0|||
130010639|NCT01227187|468001485|FG000|Overall Study|Physician Decision|0|||
130010640|NCT01227187|468001486|FG001|Overall Study|Physician Decision|0|||
130010641|NCT01227187|468001487|FG002|Overall Study|Physician Decision|0|||
130010642|NCT01227187|468001488|FG003|Overall Study|Physician Decision|1|||
130010643|NCT01761292|468001489|FG000|Part 1|Adverse Event|1|||
130010644|NCT01761292|468001489|FG000|Part 1|not receiving treatment in Part 1|1|||
130010645|NCT01761292|468001489|FG000|Extension 1|Withdrawal by Subject|1|||
130010646|NCT03332498|468001490|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
130010647|NCT03332498|468001491|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
130010648|NCT03332498|468001492|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
130010649|NCT04036708|468001493|FG000|Overall Study|Lost to Follow-up|14|||
130010650|NCT04036708|468001494|FG001|Overall Study|Lost to Follow-up|4|||
130010651|NCT04036708|468001495|FG002|Overall Study|Lost to Follow-up|14|||
130010652|NCT04036708|468001496|FG003|Overall Study|Lost to Follow-up|4|||
130010653|NCT03577730|468001498|FG000|Overall Study|Physician Decision|3|||
130010654|NCT03577730|468001499|FG001|Overall Study|Physician Decision|1|||
130010655|NCT03577730|468001498|FG000|Overall Study|Did not receive allocated intervention|1|||
130010656|NCT03577730|468001499|FG001|Overall Study|Did not receive allocated intervention|0|||
130010657|NCT02349048|468001501|FG000|Overall Study|Withdrawal by Subject|4|||
130010658|NCT02349048|468001502|FG001|Overall Study|Withdrawal by Subject|0|||
130010659|NCT02349048|468001501|FG000|Overall Study|Lost to Follow-up|1|||
130010660|NCT02349048|468001502|FG001|Overall Study|Lost to Follow-up|0|||
130010661|NCT01911442|468001505|FG000|Overall Study|Adverse Event|2|||
130010662|NCT01911442|468001506|FG001|Overall Study|Adverse Event|2|||
130010663|NCT01911442|468001507|FG002|Overall Study|Adverse Event|4|||
130010664|NCT01911442|468001505|FG000|Overall Study|Lack of Efficacy|1|||
130010665|NCT01911442|468001506|FG001|Overall Study|Lack of Efficacy|1|||
130010666|NCT01911442|468001507|FG002|Overall Study|Lack of Efficacy|1|||
130010667|NCT01911442|468001505|FG000|Overall Study|Lost to Follow-up|2|||
130010668|NCT01911442|468001506|FG001|Overall Study|Lost to Follow-up|0|||
130010669|NCT01911442|468001507|FG002|Overall Study|Lost to Follow-up|1|||
130010670|NCT01911442|468001505|FG000|Overall Study|Withdrawal by Subject|1|||
130010671|NCT01911442|468001506|FG001|Overall Study|Withdrawal by Subject|0|||
130010672|NCT01911442|468001507|FG002|Overall Study|Withdrawal by Subject|6|||
130010673|NCT01911442|468001505|FG000|Overall Study|Mother's Work Schedule|0|||
130010674|NCT01911442|468001506|FG001|Overall Study|Mother's Work Schedule|1|||
130010675|NCT01911442|468001507|FG002|Overall Study|Mother's Work Schedule|0|||
130010676|NCT00122681|468001511|FG000|Overall Study|Adverse Event|20|||
130010677|NCT00122681|468001512|FG001|Overall Study|Adverse Event|16|||
130010678|NCT00122681|468001511|FG000|Overall Study|Lost to Follow-up|1080|||
130010679|NCT00122681|468001512|FG001|Overall Study|Lost to Follow-up|1097|||
130010680|NCT00122681|468001511|FG000|Overall Study|Protocol Violation|7|||
130010681|NCT00122681|468001512|FG001|Overall Study|Protocol Violation|10|||
130010682|NCT00122681|468001511|FG000|Overall Study|Withdrawal by Subject|257|||
130010683|NCT00122681|468001512|FG001|Overall Study|Withdrawal by Subject|251|||
130010684|NCT00122681|468001511|FG000|Overall Study|Personal reasons|150|||
130010685|NCT00122681|468001512|FG001|Overall Study|Personal reasons|147|||
130010686|NCT01349465|468001513|FG000|Overall Study|Adverse Event|1|||
130010687|NCT01349465|468001514|FG001|Overall Study|Adverse Event|0|||
130010688|NCT01349465|468001513|FG000|Overall Study|Death|3|||
130010689|NCT01349465|468001514|FG001|Overall Study|Death|0|||
130010690|NCT01349465|468001513|FG000|Overall Study|Lost to Follow-up|10|||
130010691|NCT01349465|468001514|FG001|Overall Study|Lost to Follow-up|1|||
130010692|NCT01349465|468001513|FG000|Overall Study|Withdrawal by Subject|4|||
130010693|NCT01349465|468001514|FG001|Overall Study|Withdrawal by Subject|2|||
130010694|NCT01349465|468001513|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
130010695|NCT01349465|468001514|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
130010696|NCT01265615|468001515|FG000|Overall Study|Protocol Violation|2|||
130010697|NCT01265615|468001516|FG001|Overall Study|Protocol Violation|2|||
130010698|NCT01265615|468001517|FG002|Overall Study|Protocol Violation|4|||
130010699|NCT01265615|468001518|FG003|Overall Study|Protocol Violation|3|||
130010700|NCT03370120|468001522|FG000|Overall Study|Adverse event, non-fatal|24|||
130010701|NCT03370120|468001522|FG000|Overall Study|Withdrawal by Subject|6|||
130010702|NCT03370120|468001522|FG000|Overall Study|Lost to Follow-up|1|||
130010703|NCT03370120|468001522|FG000|Overall Study|Lack of Efficacy|37|||
130010704|NCT03370120|468001522|FG000|Overall Study|Per sponsor's instructions|1|||
130010705|NCT03370120|468001522|FG000|Overall Study|Study was terminated by parent company UCB|2|||
130010706|NCT03370120|468001522|FG000|Overall Study|The study was ended by the promoter|3|||
130010707|NCT03370120|468001522|FG000|Overall Study|Discontinuation of drug development|3|||
130010708|NCT03370120|468001522|FG000|Overall Study|End of project|2|||
130010709|NCT03370120|468001522|FG000|Overall Study|Premature study closure|2|||
130010710|NCT03370120|468001522|FG000|Overall Study|Premature program termination|1|||
130010711|NCT03370120|468001522|FG000|Overall Study|Premature study termination|7|||
130010712|NCT03370120|468001522|FG000|Overall Study|Trial terminated by sponsor|2|||
130010713|NCT03370120|468001522|FG000|Overall Study|Trial discontinued by sponsor|2|||
130010714|NCT03370120|468001522|FG000|Overall Study|Study ended|15|||
130010715|NCT03370120|468001522|FG000|Overall Study|Clinical trial has been cancelled|1|||
130010716|NCT03370120|468001522|FG000|Overall Study|End of study per sponsor decision|2|||
130010717|NCT03370120|468001522|FG000|Overall Study|Promoter's decision|2|||
130010718|NCT03370120|468001522|FG000|Overall Study|The trial has been suspended|3|||
130010719|NCT03370120|468001522|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
130010720|NCT03370120|468001522|FG000|Overall Study|Early termination by order of sponsor|2|||
130010721|NCT03370120|468001522|FG000|Overall Study|Discontinuation of the study|5|||
130010722|NCT03370120|468001522|FG000|Overall Study|End of clinical trial discontinuation|1|||
130010723|NCT03370120|468001522|FG000|Overall Study|Because the clinical trial ended halfway|4|||
130010724|NCT03370120|468001522|FG000|Overall Study|Development discontinued|5|||
130010725|NCT03370120|468001522|FG000|Overall Study|Padsenovil program closed|3|||
130010726|NCT03370120|468001522|FG000|Overall Study|End of project|2|||
130010727|NCT03370120|468001522|FG000|Overall Study|Termination of project|1|||
130010728|NCT03370120|468001522|FG000|Overall Study|The study was interrupted by sponsor|4|||
130010729|NCT03370120|468001522|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
130010730|NCT03370120|468001522|FG000|Overall Study|End of sponsor decision|1|||
130010731|NCT03370120|468001522|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
130010732|NCT03370120|468001522|FG000|Overall Study|Early termination of studies|5|||
130010733|NCT03370120|468001522|FG000|Overall Study|This study is ended early|1|||
130010734|NCT03370120|468001522|FG000|Overall Study|End of padsevonil program|2|||
130010735|NCT03370120|468001522|FG000|Overall Study|Decision of sponsor|6|||
130010736|NCT03370120|468001522|FG000|Overall Study|Asked by the sponsor|3|||
130010737|NCT03370120|468001522|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
130010738|NCT03370120|468001522|FG000|Overall Study|PI decision poor compliance from participant|1|||
130010739|NCT03370120|468001522|FG000|Overall Study|Promoter ended the study|3|||
130010740|NCT03370120|468001522|FG000|Overall Study|Premature study close by sponsor's decision|4|||
130010741|NCT03370120|468001522|FG000|Overall Study|Study terminated by sponsor|33|||
130010742|NCT03370120|468001522|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
130010743|NCT03370120|468001522|FG000|Overall Study|Sponsor decision to terminate study|63|||
130010744|NCT03370120|468001522|FG000|Overall Study|Program closure|3|||
130010745|NCT03370120|468001522|FG000|Overall Study|Study ended prematurely|1|||
130010746|NCT03370120|468001522|FG000|Overall Study|Study stopped by sponsor|2|||
130010747|NCT03370120|468001522|FG000|Overall Study|Program termination|55|||
130010748|NCT03370120|468001522|FG000|Overall Study|Sponsor decision|62|||
130010749|NCT03370120|468001522|FG000|Overall Study|Sponsor study closure|10|||
130010750|NCT00454857|468001524|FG000|Overall Study|Withdrawal by Subject|15|||
130010751|NCT00454857|468001524|FG000|Overall Study|Lost to Follow-up|16|||
130010752|NCT00454857|468001524|FG000|Overall Study|Noncompliance|6|||
130345639|NCT04449029|469237175|FG002|Overall Study|Withdrawal by Subject|1|||
130345640|NCT04449029|469237176|FG003|Overall Study|Withdrawal by Subject|1|||
130345641|NCT04449029|469237177|FG004|Overall Study|Withdrawal by Subject|5|||
130345642|NCT04449029|469237178|FG005|Overall Study|Withdrawal by Subject|1|||
130010753|NCT00454857|468001524|FG000|Overall Study|Death|5|||
130010754|NCT00454857|468001524|FG000|Overall Study|Other|11|||
130010755|NCT00454857|468001524|FG000|Overall Study|Reason unknown|1|||
130010756|NCT04206020|468001525|FG000|Overall Study|Adverse Event|1|||
130010757|NCT04206020|468001526|FG001|Overall Study|Adverse Event|4|||
130010758|NCT04206020|468001525|FG000|Overall Study|Protocol Violation|2|||
130345643|NCT04449029|469237179|FG006|Overall Study|Withdrawal by Subject|4|||
130010759|NCT04206020|468001526|FG001|Overall Study|Protocol Violation|0|||
130010760|NCT04206020|468001525|FG000|Overall Study|Withdrawal by Subject|2|||
130010761|NCT04206020|468001526|FG001|Overall Study|Withdrawal by Subject|0|||
130345644|NCT04449029|469237180|FG007|Overall Study|Withdrawal by Subject|0|||
130010762|NCT04206020|468001525|FG000|Overall Study|Lost to Follow-up|2|||
130345645|NCT02025556|469237181|FG000|Overall Study|Adverse Event|0|||
130345646|NCT02025556|469237182|FG001|Overall Study|Adverse Event|4|||
130345647|NCT02025556|469237183|FG002|Overall Study|Adverse Event|2|||
130345648|NCT02025556|469237181|FG000|Overall Study|Lack of Efficacy|2|||
130345649|NCT02025556|469237182|FG001|Overall Study|Lack of Efficacy|1|||
130345650|NCT02025556|469237183|FG002|Overall Study|Lack of Efficacy|0|||
130345651|NCT02025556|469237181|FG000|Overall Study|Protocol Violation|2|||
130345652|NCT02025556|469237182|FG001|Overall Study|Protocol Violation|1|||
130345653|NCT02025556|469237183|FG002|Overall Study|Protocol Violation|0|||
130345654|NCT02025556|469237181|FG000|Overall Study|Withdrawal by Subject|0|||
130345655|NCT02025556|469237182|FG001|Overall Study|Withdrawal by Subject|3|||
130345656|NCT02025556|469237183|FG002|Overall Study|Withdrawal by Subject|6|||
130345657|NCT02025556|469237181|FG000|Overall Study|Lost to Follow-up|2|||
130345658|NCT02025556|469237182|FG001|Overall Study|Lost to Follow-up|4|||
130345659|NCT02025556|469237183|FG002|Overall Study|Lost to Follow-up|0|||
130345660|NCT02025556|469237181|FG000|Overall Study|Reason not reported|0|||
130345661|NCT02025556|469237182|FG001|Overall Study|Reason not reported|0|||
130345662|NCT02025556|469237183|FG002|Overall Study|Reason not reported|1|||
130345663|NCT00627445|469237184|FG000|Overall Study|Adverse Event|3|||
130345664|NCT00627445|469237185|FG001|Overall Study|Adverse Event|3|||
130345665|NCT00627445|469237184|FG000|Overall Study|Lack of Efficacy|0|||
130345666|NCT00627445|469237185|FG001|Overall Study|Lack of Efficacy|1|||
130345667|NCT00627445|469237184|FG000|Overall Study|Other|6|||
130345668|NCT00627445|469237185|FG001|Overall Study|Other|8|||
130345669|NCT04098224|469237186|FG000|Overall Study|Adverse Event|1|||
130345670|NCT04098224|469237187|FG001|Overall Study|Adverse Event|0|||
130345671|NCT04098224|469237186|FG000|Overall Study|Physician Decision|1|||
130345672|NCT04098224|469237187|FG001|Overall Study|Physician Decision|0|||
130345673|NCT04098224|469237186|FG000|Overall Study|Patient not required enteral feeding|1|||
130345674|NCT04098224|469237187|FG001|Overall Study|Patient not required enteral feeding|0|||
130345675|NCT04098224|469237186|FG000|Overall Study|Patient failure nasogastric tube|1|||
130345676|NCT04098224|469237187|FG001|Overall Study|Patient failure nasogastric tube|0|||
130345677|NCT04098224|469237186|FG000|Overall Study|Patient early extubation|1|||
130345678|NCT04098224|469237187|FG001|Overall Study|Patient early extubation|3|||
130345679|NCT01203852|469237191|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
130345680|NCT01203852|469237191|FG000|Washout 2 Weeks|Physician Decision|46|||
130345681|NCT00247611|469237197|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
130345682|NCT00247611|469237198|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
130345683|NCT00247611|469237197|FG000|Baselined|Completed baseline only|9|||
130345684|NCT00247611|469237198|FG001|Baselined|Completed baseline only|8|||
130345685|NCT02395302|469237208|FG000|Overall Study|Screen Failure|3|||
130345686|NCT02395302|469237208|FG000|Overall Study|Run In Failure|7|||
130345687|NCT02395302|469237208|FG000|Overall Study|Withdrawal by Subject|2|||
130345688|NCT02395302|469237208|FG000|Overall Study|Physician Decision|2|||
130345689|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
130345690|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
130345691|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
130345692|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
130345693|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
130345694|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
130345695|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
130345696|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
130345697|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
130345698|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
130345699|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
130345700|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
130345701|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
130345702|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
130345703|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
130345704|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
130345705|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
130345706|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
130345707|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
130345708|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
130345709|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
130345710|NCT01087788|469237209|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
130345711|NCT01087788|469237210|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
130345712|NCT01087788|469237211|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
130345713|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
130345714|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
130345715|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
130345716|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
130345717|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
130345718|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
130345719|NCT01087788|469237209|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
130345720|NCT01087788|469237210|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
130345721|NCT01087788|469237211|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
130345722|NCT01087788|469237209|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
130345723|NCT01087788|469237210|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
130345724|NCT01087788|469237211|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
130345725|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
130345726|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
130345727|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
130345728|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
130345729|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
130345730|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
130345731|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
130345732|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
130345733|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
130345734|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
130345735|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
130345736|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
130345737|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
130345738|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
130345739|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
130345740|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
130345741|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
130345742|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
130345743|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
130345744|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
130345745|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
130345746|NCT01087788|469237209|FG000|24-weeks Dose-blind Period|Patient moved|0|||
130345747|NCT01087788|469237210|FG001|24-weeks Dose-blind Period|Patient moved|0|||
130345748|NCT01087788|469237211|FG002|24-weeks Dose-blind Period|Patient moved|1|||
130345749|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
130345750|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
130345751|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
130345752|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
130345753|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
130345754|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
130345755|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
130345756|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
130345757|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
130345758|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
130345759|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
130345760|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
130345761|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
130345762|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
130345763|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
130345764|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
130345765|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
130345766|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
130345767|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
130010763|NCT04206020|468001526|FG001|Overall Study|Lost to Follow-up|0|||
130010764|NCT04206020|468001525|FG000|Overall Study|Pregnancy|0|||
130010765|NCT04206020|468001526|FG001|Overall Study|Pregnancy|1|||
130010766|NCT04206020|468001525|FG000|Overall Study|Unable to attend visits|1|||
130010767|NCT04206020|468001526|FG001|Overall Study|Unable to attend visits|2|||
130010768|NCT00632099|468001527|FG000|Overall Study|Lost to Follow-up|3|||
130010769|NCT00632099|468001528|FG001|Overall Study|Lost to Follow-up|3|||
130010770|NCT02004262|468001537|FG000|Overall Study|Death|67|||
130010771|NCT02004262|468001538|FG001|Overall Study|Death|64|||
130010772|NCT02004262|468001539|FG002|Overall Study|Death|66|||
130010773|NCT02004262|468001540|FG003|Overall Study|Death|28|||
130010774|NCT02004262|468001541|FG004|Overall Study|Death|29|||
130010775|NCT02004262|468001542|FG005|Overall Study|Death|22|||
130010776|NCT02004262|468001537|FG000|Overall Study|Withdrawal by Subject|1|||
130010777|NCT02004262|468001538|FG001|Overall Study|Withdrawal by Subject|0|||
130010778|NCT02004262|468001539|FG002|Overall Study|Withdrawal by Subject|4|||
130010779|NCT02004262|468001540|FG003|Overall Study|Withdrawal by Subject|0|||
130010780|NCT02004262|468001541|FG004|Overall Study|Withdrawal by Subject|1|||
130010781|NCT02004262|468001542|FG005|Overall Study|Withdrawal by Subject|3|||
130010782|NCT02004262|468001537|FG000|Overall Study|Lost to Follow-up|1|||
130345768|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
130345769|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
130345770|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
130345771|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
130345772|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
130345773|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
130345774|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
130345775|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
130345776|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
130345777|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
130345778|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
130345779|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
130345780|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
130345781|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
130345782|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
130345783|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
130345784|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
130345785|NCT01087788|469237209|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
130345786|NCT01087788|469237210|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
130345787|NCT01087788|469237211|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
130345788|NCT03044574|469237219|FG000|Overall Study|Lost to Follow-up|37|||
130345789|NCT03044574|469237220|FG001|Overall Study|Lost to Follow-up|45|||
130345790|NCT00710762|469237221|FG000|Overall Study|Progressive disease|27|||
130345791|NCT00710762|469237222|FG001|Overall Study|Progressive disease|30|||
130345792|NCT00710762|469237221|FG000|Overall Study|Adverse Event other disease worsening|2|||
130345793|NCT00710762|469237222|FG001|Overall Study|Adverse Event other disease worsening|1|||
130345794|NCT00710762|469237221|FG000|Overall Study|Other Adverse Event|7|||
130345795|NCT00710762|469237222|FG001|Overall Study|Other Adverse Event|7|||
130345796|NCT00710762|469237221|FG000|Overall Study|Lost to Follow-up|1|||
130345797|NCT00710762|469237222|FG001|Overall Study|Lost to Follow-up|0|||
130345798|NCT00710762|469237221|FG000|Overall Study|Reason other than listed above|2|||
130345799|NCT00710762|469237222|FG001|Overall Study|Reason other than listed above|2|||
130345800|NCT00495040|469237224|FG000|Overall Study|Withdrawal by Subject|3|||
130345801|NCT00592774|469237228|FG000|Overall Study|Adverse Event|5|||
130345802|NCT00592774|469237229|FG001|Overall Study|Adverse Event|19|||
130345803|NCT00592774|469237230|FG002|Overall Study|Adverse Event|2|||
130345804|NCT00592774|469237231|FG003|Overall Study|Adverse Event|14|||
130345805|NCT00592774|469237232|FG004|Overall Study|Adverse Event|8|||
130345806|NCT00592774|469237228|FG000|Overall Study|Protocol Violation|0|||
130345807|NCT00592774|469237229|FG001|Overall Study|Protocol Violation|1|||
130345808|NCT00592774|469237230|FG002|Overall Study|Protocol Violation|0|||
130345809|NCT00592774|469237231|FG003|Overall Study|Protocol Violation|0|||
130345810|NCT00592774|469237232|FG004|Overall Study|Protocol Violation|1|||
130345811|NCT00592774|469237228|FG000|Overall Study|Withdrawal by Subject|3|||
130345812|NCT00592774|469237229|FG001|Overall Study|Withdrawal by Subject|7|||
130345813|NCT00592774|469237230|FG002|Overall Study|Withdrawal by Subject|0|||
130345814|NCT00592774|469237231|FG003|Overall Study|Withdrawal by Subject|0|||
130345815|NCT00592774|469237232|FG004|Overall Study|Withdrawal by Subject|0|||
130345816|NCT00592774|469237228|FG000|Overall Study|Lack of Efficacy|3|||
130345817|NCT00592774|469237229|FG001|Overall Study|Lack of Efficacy|3|||
130345818|NCT00592774|469237230|FG002|Overall Study|Lack of Efficacy|0|||
130345819|NCT00592774|469237231|FG003|Overall Study|Lack of Efficacy|0|||
130345820|NCT00592774|469237232|FG004|Overall Study|Lack of Efficacy|2|||
130345821|NCT00592774|469237228|FG000|Overall Study|Physician Decision|0|||
130345822|NCT00592774|469237229|FG001|Overall Study|Physician Decision|1|||
130010783|NCT02004262|468001538|FG001|Overall Study|Lost to Follow-up|1|||
130010784|NCT02004262|468001539|FG002|Overall Study|Lost to Follow-up|0|||
130010785|NCT02004262|468001540|FG003|Overall Study|Lost to Follow-up|0|||
130345823|NCT00592774|469237230|FG002|Overall Study|Physician Decision|1|||
130345824|NCT00592774|469237231|FG003|Overall Study|Physician Decision|0|||
130345825|NCT00592774|469237232|FG004|Overall Study|Physician Decision|1|||
130345826|NCT00592774|469237228|FG000|Overall Study|Other|0|||
130345827|NCT00592774|469237229|FG001|Overall Study|Other|1|||
130345828|NCT00592774|469237230|FG002|Overall Study|Other|1|||
130345829|NCT00592774|469237231|FG003|Overall Study|Other|0|||
130345830|NCT00592774|469237232|FG004|Overall Study|Other|2|||
130345831|NCT01700439|469237233|FG000|Overall Study|Lost to Follow-up|47|||
130345832|NCT01700439|469237233|FG000|Overall Study|Withdrawal by Subject|183|||
130345833|NCT01700439|469237233|FG000|Overall Study|Death|186|||
130345834|NCT01892384|469237234|FG000|Overall Study|Withdrawal by Subject|1|||
130345835|NCT01892384|469237235|FG001|Overall Study|Withdrawal by Subject|1|||
130345836|NCT01892384|469237236|FG002|Overall Study|Withdrawal by Subject|0|||
130345837|NCT01892384|469237237|FG003|Overall Study|Withdrawal by Subject|0|||
130345838|NCT00621621|469237248|FG000|Overall Study|Subjects were exited at EP study|30|||
130345839|NCT00621621|469237249|FG001|Overall Study|Subjects were exited at EP study|0|||
130345840|NCT01829243|469237250|FG000|First Intervention|Screen Failure|4|||
130345841|NCT01829243|469237251|FG001|First Intervention|Screen Failure|2|||
130345842|NCT00053898|469237271|FG000|Overall Study|No follow-up data from any source|9|||
130345843|NCT00053898|469237272|FG001|Overall Study|No follow-up data from any source|12|||
130345844|NCT00053898|469237271|FG000|Overall Study|Follow-up from telephone contact only|5|||
130345845|NCT00053898|469237272|FG001|Overall Study|Follow-up from telephone contact only|1|||
130345846|NCT01077375|469237277|FG000|Overall Study|Adverse Event|2|||
130345847|NCT01077375|469237278|FG001|Overall Study|Adverse Event|15|||
130345848|NCT01077375|469237277|FG000|Overall Study|Lack of Efficacy|6|||
130345849|NCT01077375|469237278|FG001|Overall Study|Lack of Efficacy|8|||
130345850|NCT01077375|469237277|FG000|Overall Study|Withdrawal by Subject|0|||
130345851|NCT01077375|469237278|FG001|Overall Study|Withdrawal by Subject|6|||
130345852|NCT01077375|469237277|FG000|Overall Study|Lost to Follow-up|2|||
130345853|NCT01077375|469237278|FG001|Overall Study|Lost to Follow-up|5|||
130345854|NCT01077375|469237277|FG000|Overall Study|Other Reason|0|||
130345855|NCT01077375|469237278|FG001|Overall Study|Other Reason|1|||
130345856|NCT01924429|469237281|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
130345857|NCT01924429|469237282|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
130345858|NCT00906971|469237283|FG000|Overall Study|Withdrawal by Subject|8|||
130345859|NCT00906971|469237284|FG001|Overall Study|Withdrawal by Subject|2|||
130345860|NCT00906971|469237283|FG000|Overall Study|Lost to Follow-up|0|||
130345861|NCT00906971|469237284|FG001|Overall Study|Lost to Follow-up|1|||
130345862|NCT00545129|469237285|FG000|Overall Study|Lack of Efficacy|2|||
130345863|NCT00545129|469237286|FG001|Overall Study|Lack of Efficacy|5|||
130345864|NCT00545129|469237285|FG000|Overall Study|Death|2|||
130345865|NCT00545129|469237286|FG001|Overall Study|Death|1|||
130345866|NCT00545129|469237285|FG000|Overall Study|Adverse Event|1|||
130345867|NCT00545129|469237286|FG001|Overall Study|Adverse Event|1|||
130345868|NCT00545129|469237285|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
130345869|NCT00545129|469237286|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
130345870|NCT00545129|469237285|FG000|Overall Study|Other|3|||
130345871|NCT00545129|469237286|FG001|Overall Study|Other|3|||
130345872|NCT01894568|469237287|FG000|Overall Study|Adverse Event|2|||
130345873|NCT01894568|469237288|FG001|Overall Study|Adverse Event|3|||
130345874|NCT01894568|469237287|FG000|Overall Study|Protocol required discontinuation|2|||
130345875|NCT01894568|469237288|FG001|Overall Study|Protocol required discontinuation|1|||
130345876|NCT01894568|469237287|FG000|Overall Study|Withdrawal by Subject|5|||
130345877|NCT01894568|469237288|FG001|Overall Study|Withdrawal by Subject|5|||
130345878|NCT01894568|469237287|FG000|Overall Study|Physician Decision|1|||
130345879|NCT01894568|469237288|FG001|Overall Study|Physician Decision|0|||
130345880|NCT01894568|469237287|FG000|Overall Study|Lost to Follow-up|0|||
130345881|NCT01894568|469237288|FG001|Overall Study|Lost to Follow-up|1|||
130345882|NCT00807573|469237289|FG000|Overall Study|Withdrawal by Subject|1|||
130345883|NCT00807573|469237289|FG000|Overall Study|Adverse Event|1|||
130345884|NCT01514370|469237292|FG000|Overall Study|Protocol Violation|2|||
130345885|NCT01514370|469237293|FG001|Overall Study|Protocol Violation|3|||
130345886|NCT01514370|469237292|FG000|Overall Study|Lost to Follow-up|0|||
130345887|NCT01514370|469237293|FG001|Overall Study|Lost to Follow-up|2|||
130345888|NCT01514370|469237292|FG000|Overall Study|Withdrawal by Subject|2|||
130010786|NCT02004262|468001541|FG004|Overall Study|Lost to Follow-up|0|||
130010787|NCT02004262|468001542|FG005|Overall Study|Lost to Follow-up|0|||
130010788|NCT02004262|468001537|FG000|Overall Study|Study Terminated by Sponsor|4|||
130010789|NCT02004262|468001538|FG001|Overall Study|Study Terminated by Sponsor|3|||
130010790|NCT02004262|468001539|FG002|Overall Study|Study Terminated by Sponsor|2|||
130010791|NCT02004262|468001540|FG003|Overall Study|Study Terminated by Sponsor|1|||
130010792|NCT02004262|468001541|FG004|Overall Study|Study Terminated by Sponsor|1|||
130010793|NCT02004262|468001542|FG005|Overall Study|Study Terminated by Sponsor|5|||
130010794|NCT01923285|468001543|FG000|Overall Study|Withdrawal by Subject|7|||
130010795|NCT01923285|468001544|FG001|Overall Study|Withdrawal by Subject|6|||
130010796|NCT03200366|468001548|FG000|Patient Navigation Intervention Given|Death|0|||
130345889|NCT01514370|469237293|FG001|Overall Study|Withdrawal by Subject|1|||
130345890|NCT01514370|469237292|FG000|Overall Study|Adverse Event|1|||
130345891|NCT01514370|469237293|FG001|Overall Study|Adverse Event|3|||
130345892|NCT01514370|469237292|FG000|Overall Study|Other|6|||
130345893|NCT01514370|469237293|FG001|Overall Study|Other|7|||
130345894|NCT01551420|469237294|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
130345895|NCT01551420|469237295|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
130345896|NCT01551420|469237294|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
130345897|NCT01551420|469237295|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
130345898|NCT01551420|469237294|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
130345899|NCT01551420|469237295|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
130345900|NCT01551420|469237294|FG000|Screened for Part B Eligibility|Declined participation|8|||
130345901|NCT01551420|469237295|FG001|Screened for Part B Eligibility|Declined participation|1|||
130345902|NCT01551420|469237294|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
130345903|NCT01551420|469237295|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
130345904|NCT01551420|469237294|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
130345905|NCT01551420|469237295|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
130345906|NCT01551420|469237294|FG000|Home Use (Part B)|Withdrawal by staff|0|||
130345907|NCT01551420|469237295|FG001|Home Use (Part B)|Withdrawal by staff|1|||
130345908|NCT04054947|469237296|FG000|Overall Study|Withdrawal by Subject|1|||
130345909|NCT04054947|469237297|FG001|Overall Study|Withdrawal by Subject|0|||
130345910|NCT04054947|469237296|FG000|Overall Study|Lost to Follow-up|2|||
130345911|NCT04054947|469237297|FG001|Overall Study|Lost to Follow-up|5|||
130345912|NCT00853970|469237302|FG000|Overall Study|Withdrawal by Subject|2|||
130345913|NCT00853970|469237303|FG001|Overall Study|Withdrawal by Subject|1|||
130345914|NCT00853970|469237302|FG000|Overall Study|Cancelled surgery|4|||
130345915|NCT00853970|469237303|FG001|Overall Study|Cancelled surgery|2|||
130345916|NCT02055365|469238779|FG000|Overall Study|Prematurely Withdrawn|1|||
130345917|NCT01258998|469238780|FG000|Overall Study|Ineligible|1|||
130345918|NCT01143389|469238781|FG000|Overall Study|Lost to Follow-up|26|||
130345919|NCT01143389|469238782|FG001|Overall Study|Lost to Follow-up|25|||
130345920|NCT02276027|469238785|FG000|Overall Study|Death|1|||
130345921|NCT02276027|469238786|FG001|Overall Study|Death|0|||
130345922|NCT02276027|469238787|FG002|Overall Study|Death|0|||
130345923|NCT02276027|469238788|FG003|Overall Study|Death|2|||
130345924|NCT02276027|469238785|FG000|Overall Study|Physician Decision|0|||
130345925|NCT02276027|469238786|FG001|Overall Study|Physician Decision|0|||
130345926|NCT02276027|469238787|FG002|Overall Study|Physician Decision|0|||
130345927|NCT02276027|469238788|FG003|Overall Study|Physician Decision|1|||
130345928|NCT02276027|469238785|FG000|Overall Study|Progressive disease|1|||
130345929|NCT02276027|469238786|FG001|Overall Study|Progressive disease|13|||
130345930|NCT02276027|469238787|FG002|Overall Study|Progressive disease|12|||
130345931|NCT02276027|469238788|FG003|Overall Study|Progressive disease|14|||
130345932|NCT02276027|469238785|FG000|Overall Study|Subject/guardian decision|0|||
130345933|NCT02276027|469238786|FG001|Overall Study|Subject/guardian decision|1|||
130345934|NCT02276027|469238787|FG002|Overall Study|Subject/guardian decision|0|||
130345935|NCT02276027|469238788|FG003|Overall Study|Subject/guardian decision|3|||
130345936|NCT02276027|469238785|FG000|Overall Study|Adverse Event|0|||
130345937|NCT02276027|469238786|FG001|Overall Study|Adverse Event|2|||
130345938|NCT02276027|469238787|FG002|Overall Study|Adverse Event|8|||
130345939|NCT02276027|469238788|FG003|Overall Study|Adverse Event|2|||
130345940|NCT03224598|469238789|FG000|Overall Study|Lost to Follow-up|0|||
130345941|NCT03224598|469238790|FG001|Overall Study|Lost to Follow-up|2|||
130345942|NCT03224598|469238791|FG002|Overall Study|Lost to Follow-up|0|||
130345943|NCT03224598|469238789|FG000|Overall Study|Other|0|||
130345944|NCT03224598|469238790|FG001|Overall Study|Other|1|||
130345945|NCT03224598|469238791|FG002|Overall Study|Other|0|||
130345946|NCT01527357|469238793|FG000|Overall Study|Death|8|||
130345947|NCT01527357|469238794|FG001|Overall Study|Death|2|||
130345948|NCT01527357|469238793|FG000|Overall Study|Lost to Follow-up|6|||
130345949|NCT01527357|469238794|FG001|Overall Study|Lost to Follow-up|4|||
130345950|NCT01527357|469238793|FG000|Overall Study|Withdrew Consent|1|||
130345951|NCT01527357|469238794|FG001|Overall Study|Withdrew Consent|1|||
130345952|NCT01527357|469238793|FG000|Overall Study|Non-compliance|0|||
130345953|NCT01527357|469238794|FG001|Overall Study|Non-compliance|1|||
130345954|NCT01527357|469238793|FG000|Overall Study|No Day 29 Visit|0|||
130345955|NCT01527357|469238794|FG001|Overall Study|No Day 29 Visit|1|||
130345956|NCT01527357|469238793|FG000|Overall Study|Did Not Receive Treatment|2|||
130345957|NCT01527357|469238794|FG001|Overall Study|Did Not Receive Treatment|0|||
130345958|NCT02446171|469238795|FG000|Overall Study|Withdrawal by Subject|0|||
130345959|NCT02446171|469238796|FG001|Overall Study|Withdrawal by Subject|0|||
130345960|NCT02446171|469238797|FG002|Overall Study|Withdrawal by Subject|2|||
130345961|NCT02446171|469238798|FG003|Overall Study|Withdrawal by Subject|0|||
130010797|NCT03200366|468001549|FG001|Patient Navigation Intervention Given|Death|2|||
130010798|NCT03200366|468001550|FG002|Patient Navigation Intervention Given|Death|0|||
130010799|NCT03200366|468001548|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
130010800|NCT03200366|468001549|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
130010801|NCT03200366|468001550|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
130010802|NCT03200366|468001548|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
130010803|NCT03200366|468001549|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
130010804|NCT03200366|468001550|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
130010805|NCT03200366|468001548|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
130010806|NCT03200366|468001549|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
130010807|NCT03200366|468001550|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
130010808|NCT03200366|468001548|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
130010809|NCT03200366|468001549|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
130010810|NCT03200366|468001550|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
130010811|NCT03200366|468001548|FG000|6 Month Post-Baseline Interview|Death|1|||
130010812|NCT03200366|468001549|FG001|6 Month Post-Baseline Interview|Death|1|||
130010813|NCT03200366|468001550|FG002|6 Month Post-Baseline Interview|Death|1|||
130010814|NCT03200366|468001548|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
130010815|NCT03200366|468001549|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
130010816|NCT03200366|468001550|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
130010817|NCT03200366|468001548|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
130010818|NCT03200366|468001549|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
130010819|NCT03200366|468001550|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
130010820|NCT03200366|468001548|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
130010821|NCT03200366|468001549|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
130010822|NCT03200366|468001550|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
130010823|NCT03200366|468001548|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
130010824|NCT03200366|468001549|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
130010825|NCT03200366|468001550|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
130010826|NCT03200366|468001548|FG000|9 Month Post-Baseline Interview|Death|1|||
130010827|NCT03200366|468001549|FG001|9 Month Post-Baseline Interview|Death|1|||
130010828|NCT03200366|468001550|FG002|9 Month Post-Baseline Interview|Death|1|||
130010829|NCT03200366|468001548|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
130345962|NCT03811093|469238800|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
130345963|NCT03811093|469238801|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
130345964|NCT03811093|469238800|FG000|Overall Study|Unable to measure body fat percentage|2|||
130345965|NCT03811093|469238801|FG001|Overall Study|Unable to measure body fat percentage|0|||
130345966|NCT00464490|469238802|FG000|Overall Study|Physician Decision|11|||
130345967|NCT00464490|469238803|FG001|Overall Study|Physician Decision|11|||
130345968|NCT03188042|469238804|FG000|Overall Study|Withdrawal by Subject|1|||
130345969|NCT03188042|469238805|FG001|Overall Study|Withdrawal by Subject|1|||
130345970|NCT00603590|469238806|FG000|Overall Study|Did not attend study clinic|39|||
130345971|NCT00603590|469238807|FG001|Overall Study|Did not attend study clinic|30|||
130345972|NCT00603590|469238806|FG000|Overall Study|Refused blood test|5|||
130345973|NCT00603590|469238807|FG001|Overall Study|Refused blood test|1|||
130345974|NCT00603590|469238806|FG000|Overall Study|Patient discontinued study drug|22|||
130345975|NCT00603590|469238807|FG001|Overall Study|Patient discontinued study drug|15|||
130345976|NCT00603590|469238806|FG000|Overall Study|Adverse Event|2|||
130345977|NCT00603590|469238807|FG001|Overall Study|Adverse Event|0|||
130345978|NCT00603590|469238806|FG000|Overall Study|Lost to Follow-up|8|||
130345979|NCT00603590|469238807|FG001|Overall Study|Lost to Follow-up|4|||
130345980|NCT00603590|469238806|FG000|Overall Study|Cardiovascular event|0|||
130345981|NCT00603590|469238807|FG001|Overall Study|Cardiovascular event|1|||
130345982|NCT01475071|469238811|FG000|Overall Study|Physician Decision|1|||
130345983|NCT01475071|469238811|FG000|Overall Study|Withdrawal by Subject|6|||
130345984|NCT01475071|469238811|FG000|Overall Study|Lost to Follow-up|1|||
130345985|NCT01343823|469238812|FG000|Overall Study|Study Terminated|1|||
130345986|NCT01343823|469238813|FG001|Overall Study|Study Terminated|0|||
130345987|NCT01343823|469238814|FG002|Overall Study|Study Terminated|0|||
130345988|NCT01343823|469238815|FG003|Overall Study|Study Terminated|1|||
130345989|NCT01343823|469238812|FG000|Overall Study|Withdrawal by Subject|1|||
130345990|NCT01343823|469238813|FG001|Overall Study|Withdrawal by Subject|0|||
130345991|NCT01343823|469238814|FG002|Overall Study|Withdrawal by Subject|0|||
130345992|NCT01343823|469238815|FG003|Overall Study|Withdrawal by Subject|0|||
130345993|NCT00923364|469238816|FG000|Overall Study|Death|3|||
130345994|NCT00923364|469238817|FG001|Overall Study|Death|0|||
130345995|NCT00923364|469238816|FG000|Overall Study|Did not go to transplant|1|||
130345996|NCT00923364|469238817|FG001|Overall Study|Did not go to transplant|0|||
130010830|NCT03200366|468001549|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
130010831|NCT03200366|468001550|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
130010832|NCT03200366|468001548|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
130010833|NCT03200366|468001549|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
130010834|NCT03200366|468001550|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
130010835|NCT03200366|468001548|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
130010836|NCT03200366|468001549|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
130010837|NCT03200366|468001550|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
130010838|NCT00552175|468001551|FG000|Overall Study|Lack of Efficacy|2|||
130010839|NCT00552175|468001552|FG001|Overall Study|Lack of Efficacy|0|||
130010840|NCT00552175|468001553|FG002|Overall Study|Lack of Efficacy|1|||
130010841|NCT00552175|468001551|FG000|Overall Study|Adverse Event|9|||
130010842|NCT00552175|468001552|FG001|Overall Study|Adverse Event|9|||
130010843|NCT00552175|468001553|FG002|Overall Study|Adverse Event|10|||
130010844|NCT00552175|468001551|FG000|Overall Study|Withdrawal by Subject|2|||
130010845|NCT00552175|468001552|FG001|Overall Study|Withdrawal by Subject|2|||
130010846|NCT00552175|468001553|FG002|Overall Study|Withdrawal by Subject|1|||
130010847|NCT00552175|468001551|FG000|Overall Study|Lost to Follow-up|0|||
130010848|NCT00552175|468001552|FG001|Overall Study|Lost to Follow-up|0|||
130010849|NCT00552175|468001553|FG002|Overall Study|Lost to Follow-up|1|||
130010850|NCT00552175|468001551|FG000|Overall Study|Entry Criteria Not Met|1|||
130010851|NCT00552175|468001552|FG001|Overall Study|Entry Criteria Not Met|1|||
130010852|NCT00552175|468001553|FG002|Overall Study|Entry Criteria Not Met|0|||
130010853|NCT00552175|468001551|FG000|Overall Study|Reason Not Specified|3|||
130010854|NCT00552175|468001552|FG001|Overall Study|Reason Not Specified|1|||
130010855|NCT00552175|468001553|FG002|Overall Study|Reason Not Specified|1|||
130010856|NCT01543828|468001554|FG000|Treatment 2|Lost to Follow-up|1|||
130010857|NCT01543828|468001555|FG001|Treatment 2|Lost to Follow-up|0|||
130010858|NCT02285998|468001556|FG000|Overall Study|Adverse Event|9|||
130010859|NCT02285998|468001557|FG001|Overall Study|Adverse Event|8|||
130010860|NCT02285998|468001556|FG000|Overall Study|Physician Decision|1|||
130010861|NCT02285998|468001557|FG001|Overall Study|Physician Decision|2|||
130010862|NCT02285998|468001556|FG000|Overall Study|Lost to Follow-up|176|||
130010863|NCT02285998|468001557|FG001|Overall Study|Lost to Follow-up|172|||
130010864|NCT02285998|468001556|FG000|Overall Study|Withdrawal by Subject|53|||
130010865|NCT02285998|468001557|FG001|Overall Study|Withdrawal by Subject|61|||
130010866|NCT02285998|468001556|FG000|Overall Study|Other Reasons|7|||
130010867|NCT02285998|468001557|FG001|Overall Study|Other Reasons|10|||
130010868|NCT01553188|468001560|FG000|Overall Study|Patient choice|1|||
130010869|NCT01553188|468001561|FG001|Overall Study|Patient choice|0|||
130010870|NCT01553188|468001562|FG002|Overall Study|Patient choice|0|||
130010871|NCT01553188|468001563|FG003|Overall Study|Patient choice|0|||
130010872|NCT01553188|468001560|FG000|Overall Study|Intercurrent illness and adverse event|0|||
130010873|NCT01553188|468001561|FG001|Overall Study|Intercurrent illness and adverse event|1|||
130010874|NCT01553188|468001562|FG002|Overall Study|Intercurrent illness and adverse event|2|||
130010875|NCT01553188|468001563|FG003|Overall Study|Intercurrent illness and adverse event|0|||
130010876|NCT04744207|468001567|FG000|Treatment|Withdrawal by Subject|2|||
130010877|NCT04744207|468001568|FG001|Treatment|Withdrawal by Subject|0|||
130010878|NCT04744207|468001567|FG000|Treatment|Adverse Event|1|||
130010879|NCT04744207|468001568|FG001|Treatment|Adverse Event|2|||
130010880|NCT00078325|468001576|FG000|Overall Study|Adverse Event|15|||
130010881|NCT00078325|468001577|FG001|Overall Study|Adverse Event|10|||
130010882|NCT00078325|468001578|FG002|Overall Study|Adverse Event|5|||
130010883|NCT00078325|468001576|FG000|Overall Study|Protocol Violation|2|||
130010884|NCT00078325|468001577|FG001|Overall Study|Protocol Violation|2|||
130010885|NCT00078325|468001578|FG002|Overall Study|Protocol Violation|0|||
130010886|NCT00078325|468001576|FG000|Overall Study|Withdrawal by Subject|1|||
130010887|NCT00078325|468001577|FG001|Overall Study|Withdrawal by Subject|5|||
130010888|NCT00078325|468001578|FG002|Overall Study|Withdrawal by Subject|3|||
130010889|NCT00078325|468001576|FG000|Overall Study|Lost to Follow-up|0|||
130010890|NCT00078325|468001577|FG001|Overall Study|Lost to Follow-up|1|||
130010891|NCT00078325|468001578|FG002|Overall Study|Lost to Follow-up|1|||
130010892|NCT00078325|468001576|FG000|Overall Study|Physician Decision|2|||
130010893|NCT00078325|468001577|FG001|Overall Study|Physician Decision|0|||
130010894|NCT00078325|468001578|FG002|Overall Study|Physician Decision|1|||
130010895|NCT00078325|468001576|FG000|Overall Study|Miscellaneous|1|||
130010896|NCT00078325|468001577|FG001|Overall Study|Miscellaneous|1|||
130010897|NCT00078325|468001578|FG002|Overall Study|Miscellaneous|1|||
130010898|NCT04126083|468001579|FG000|Overall Study|Withdrawal by Subject|1|||
130010899|NCT03710486|468001580|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
130010900|NCT03710486|468001581|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
130010901|NCT03710486|468001580|FG000|Overall Study|Missing|0|||
130010902|NCT03710486|468001581|FG001|Overall Study|Missing|2|||
130010903|NCT01279850|468001582|FG000|Overall Study|Protocol Violation|50|||
130010904|NCT01279850|468001582|FG000|Overall Study|No Drug Administration Information|7|||
130010905|NCT01279850|468001582|FG000|Overall Study|No Visit After Treatment|34|||
130010906|NCT01131520|468001583|FG000|Overall Study|Computer problem|1|||
130010907|NCT01131520|468001584|FG001|Overall Study|Computer problem|0|||
130010908|NCT01131520|468001583|FG000|Overall Study|Counselor not available|0|||
130010909|NCT01131520|468001584|FG001|Overall Study|Counselor not available|3|||
130010910|NCT01131520|468001583|FG000|Overall Study|Subject changed history after enrollment|0|||
130010911|NCT01131520|468001584|FG001|Overall Study|Subject changed history after enrollment|1|||
130010912|NCT02437864|468001587|FG000|Overall Study|Protocol Violation|4|||
130010913|NCT02437864|468001588|FG001|Overall Study|Protocol Violation|0|||
130010914|NCT01892163|468001589|FG000|Overall Study|Death|1|||
130010915|NCT01892163|468001590|FG001|Overall Study|Death|1|||
130010916|NCT01892163|468001589|FG000|Overall Study|Lost to Follow-up|1|||
130010917|NCT01892163|468001590|FG001|Overall Study|Lost to Follow-up|0|||
130010918|NCT03302975|468001591|FG000|Overall Study|Lost to Follow-up|4|||
130010919|NCT01924182|468001592|FG000|Overall Study|Withdrawal by Subject|1|||
130010920|NCT01924182|468001593|FG001|Overall Study|Withdrawal by Subject|0|||
130010921|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
130010922|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
130010923|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
130010924|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
130010925|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
130010926|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
130010927|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
130010928|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
130010929|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to death|4|||
130010930|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to death|3|||
130010931|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
130010932|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
130010933|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
130010934|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
130010935|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
130010936|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
130010937|NCT02258451|468001595|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
130010938|NCT02258451|468001596|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
130010939|NCT02258451|468001595|FG000|Overall Study|Other reason|1|||
130010940|NCT02258451|468001596|FG001|Overall Study|Other reason|1|||
130010941|NCT02258451|468001595|FG000|Overall Study|Never treated|2|||
130345997|NCT01011478|469238818|FG000|Overall Study|No follow up data|12|||
130345998|NCT01011478|469238819|FG001|Overall Study|No follow up data|7|||
130345999|NCT04352127|469238821|FG000|Overall Study|Unable to obtain readings|4|||
130346000|NCT04352127|469238822|FG001|Overall Study|Unable to obtain readings|1|||
130346001|NCT05338671|469238823|FG000|Overall Study|Lost to Follow-up|2|||
130346002|NCT05338671|469238824|FG001|Overall Study|Lost to Follow-up|2|||
130346003|NCT05338671|469238823|FG000|Overall Study|Root canal completed in a single visit|1|||
129884410|NCT02771210|467536387|FG000|Period 1|Withdrawal of informed consent|1|||
129884411|NCT02771210|467536388|FG001|Period 1|Withdrawal of informed consent|5|||
130346004|NCT05338671|469238824|FG001|Overall Study|Root canal completed in a single visit|0|||
130346005|NCT04456673|469238825|FG000|Overall Study|Adverse Event|7|||
130346006|NCT04456673|469238826|FG001|Overall Study|Adverse Event|14|||
130346007|NCT04456673|469238825|FG000|Overall Study|Poor compliance to protocol|1|||
130346008|NCT04456673|469238826|FG001|Overall Study|Poor compliance to protocol|0|||
130346009|NCT04456673|469238825|FG000|Overall Study|Withdrawal by Subject|31|||
130346010|NCT04456673|469238826|FG001|Overall Study|Withdrawal by Subject|23|||
130346011|NCT04456673|469238825|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
130346012|NCT04456673|469238826|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
130346013|NCT04391049|469238827|FG000|Overall Study|Protocol Violation|1|||
130346014|NCT03874429|469238828|FG000|Overall Study|Adverse Event|2|||
130346015|NCT03874429|469238829|FG001|Overall Study|Adverse Event|2|||
130346016|NCT03874429|469238828|FG000|Overall Study|Lack of Efficacy|0|||
130346017|NCT03874429|469238829|FG001|Overall Study|Lack of Efficacy|1|||
130346018|NCT03874429|469238828|FG000|Overall Study|Covid-19 pandemic|4|||
130346019|NCT03874429|469238829|FG001|Overall Study|Covid-19 pandemic|2|||
130346020|NCT00992589|469238833|FG000|Open-Label Phase|Adverse Event|4|||
130346021|NCT00992589|469238834|FG001|Open-Label Phase|Adverse Event|0|||
130346022|NCT00992589|469238835|FG002|Open-Label Phase|Adverse Event|0|||
130346023|NCT00992589|469238836|FG003|Open-Label Phase|Adverse Event|0|||
130346024|NCT00992589|469238833|FG000|Open-Label Phase|Withdrawal by Subject|20|||
130346025|NCT00992589|469238834|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130346026|NCT00992589|469238835|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130346027|NCT00992589|469238836|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130346028|NCT00992589|469238833|FG000|Open-Label Phase|Lost to Follow-up|1|||
130346029|NCT00992589|469238834|FG001|Open-Label Phase|Lost to Follow-up|0|||
130346030|NCT00992589|469238835|FG002|Open-Label Phase|Lost to Follow-up|0|||
130346031|NCT00992589|469238836|FG003|Open-Label Phase|Lost to Follow-up|0|||
130346032|NCT00992589|469238833|FG000|Open-Label Phase|Protocol Violation|3|||
130346033|NCT00992589|469238834|FG001|Open-Label Phase|Protocol Violation|0|||
130346034|NCT00992589|469238835|FG002|Open-Label Phase|Protocol Violation|0|||
130346035|NCT00992589|469238836|FG003|Open-Label Phase|Protocol Violation|0|||
130346036|NCT00992589|469238833|FG000|Open-Label Phase|Physician Decision|4|||
130346037|NCT00992589|469238834|FG001|Open-Label Phase|Physician Decision|0|||
130346038|NCT00992589|469238835|FG002|Open-Label Phase|Physician Decision|0|||
130346039|NCT00992589|469238836|FG003|Open-Label Phase|Physician Decision|0|||
130346040|NCT00992589|469238833|FG000|Open-Label Phase|Other|45|||
130346041|NCT00992589|469238834|FG001|Open-Label Phase|Other|0|||
130346042|NCT00992589|469238835|FG002|Open-Label Phase|Other|0|||
130346043|NCT00992589|469238836|FG003|Open-Label Phase|Other|0|||
130346044|NCT00992589|469238833|FG000|Double-Blind Phase|Adverse Event|0|||
130346045|NCT00992589|469238834|FG001|Double-Blind Phase|Adverse Event|6|||
130346046|NCT00992589|469238835|FG002|Double-Blind Phase|Adverse Event|2|||
130346047|NCT00992589|469238836|FG003|Double-Blind Phase|Adverse Event|3|||
130346048|NCT00992589|469238833|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130346049|NCT00992589|469238834|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130346050|NCT00992589|469238835|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
130346051|NCT00992589|469238836|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
130346052|NCT00992589|469238833|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130346053|NCT00992589|469238834|FG001|Double-Blind Phase|Lost to Follow-up|0|||
130346054|NCT00992589|469238835|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130346055|NCT00992589|469238836|FG003|Double-Blind Phase|Lost to Follow-up|2|||
130216616|NCT03162328|468755620|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
130346056|NCT00992589|469238833|FG000|Double-Blind Phase|Other|0|||
130346057|NCT00992589|469238834|FG001|Double-Blind Phase|Other|1|||
130346058|NCT00992589|469238835|FG002|Double-Blind Phase|Other|6|||
130346059|NCT00992589|469238836|FG003|Double-Blind Phase|Other|3|||
130346060|NCT01215916|469238837|FG000|Overall Study|Progressive Disease|0|||
130346061|NCT01215916|469238838|FG001|Overall Study|Progressive Disease|2|||
130346062|NCT01215916|469238839|FG002|Overall Study|Progressive Disease|1|||
130346063|NCT01215916|469238840|FG003|Overall Study|Progressive Disease|2|||
130346064|NCT01215916|469238841|FG004|Overall Study|Progressive Disease|5|||
130346065|NCT01215916|469238842|FG005|Overall Study|Progressive Disease|4|||
130010942|NCT02258451|468001596|FG001|Overall Study|Never treated|3|||
130010943|NCT01429584|468003321|FG000|Overall Study|Withdrawal by Subject|1|||
130010944|NCT01429584|468003322|FG001|Overall Study|Withdrawal by Subject|0|||
130010945|NCT01429584|468003321|FG000|Overall Study|Protocol Violation|0|||
130010946|NCT01429584|468003322|FG001|Overall Study|Protocol Violation|1|||
130010947|NCT03557281|468003326|FG000|Overall Study|Investigator discretion|0|||
130010948|NCT03557281|468003327|FG001|Overall Study|Investigator discretion|0|||
130010949|NCT03557281|468003328|FG002|Overall Study|Investigator discretion|1|||
130010950|NCT03557281|468003329|FG003|Overall Study|Investigator discretion|0|||
130010951|NCT03557281|468003330|FG004|Overall Study|Investigator discretion|0|||
130010952|NCT03557281|468003326|FG000|Overall Study|Withdrawal by Subject|0|||
130010953|NCT03557281|468003327|FG001|Overall Study|Withdrawal by Subject|1|||
130010954|NCT03557281|468003328|FG002|Overall Study|Withdrawal by Subject|1|||
130346066|NCT01215916|469238843|FG006|Overall Study|Progressive Disease|5|||
130346067|NCT01215916|469238844|FG007|Overall Study|Progressive Disease|3|||
130346068|NCT01215916|469238845|FG008|Overall Study|Progressive Disease|1|||
130346069|NCT01215916|469238837|FG000|Overall Study|Adverse Event|1|||
130346070|NCT01215916|469238838|FG001|Overall Study|Adverse Event|1|||
130346071|NCT01215916|469238839|FG002|Overall Study|Adverse Event|0|||
130346072|NCT01215916|469238840|FG003|Overall Study|Adverse Event|1|||
130346073|NCT01215916|469238841|FG004|Overall Study|Adverse Event|0|||
130346074|NCT01215916|469238842|FG005|Overall Study|Adverse Event|0|||
130346075|NCT01215916|469238843|FG006|Overall Study|Adverse Event|3|||
130346076|NCT01215916|469238844|FG007|Overall Study|Adverse Event|0|||
130346077|NCT01215916|469238845|FG008|Overall Study|Adverse Event|0|||
130346078|NCT01215916|469238837|FG000|Overall Study|Withdrawal by Subject|0|||
130346079|NCT01215916|469238838|FG001|Overall Study|Withdrawal by Subject|1|||
130346080|NCT01215916|469238839|FG002|Overall Study|Withdrawal by Subject|1|||
130346081|NCT01215916|469238840|FG003|Overall Study|Withdrawal by Subject|2|||
130346082|NCT01215916|469238841|FG004|Overall Study|Withdrawal by Subject|0|||
130346083|NCT01215916|469238842|FG005|Overall Study|Withdrawal by Subject|0|||
130346084|NCT01215916|469238843|FG006|Overall Study|Withdrawal by Subject|1|||
130346085|NCT01215916|469238844|FG007|Overall Study|Withdrawal by Subject|0|||
130346086|NCT01215916|469238845|FG008|Overall Study|Withdrawal by Subject|0|||
130346087|NCT01215916|469238837|FG000|Overall Study|Death|0|||
130346088|NCT01215916|469238838|FG001|Overall Study|Death|1|||
130346089|NCT01215916|469238839|FG002|Overall Study|Death|0|||
130346090|NCT01215916|469238840|FG003|Overall Study|Death|0|||
130346091|NCT01215916|469238841|FG004|Overall Study|Death|1|||
130346092|NCT01215916|469238842|FG005|Overall Study|Death|0|||
130346093|NCT01215916|469238843|FG006|Overall Study|Death|0|||
130346094|NCT01215916|469238844|FG007|Overall Study|Death|0|||
130346095|NCT01215916|469238845|FG008|Overall Study|Death|1|||
130346096|NCT01215916|469238837|FG000|Overall Study|Physician Decision|0|||
130346097|NCT01215916|469238838|FG001|Overall Study|Physician Decision|0|||
130346098|NCT01215916|469238839|FG002|Overall Study|Physician Decision|1|||
130346099|NCT01215916|469238840|FG003|Overall Study|Physician Decision|1|||
130346100|NCT01215916|469238841|FG004|Overall Study|Physician Decision|0|||
130346101|NCT01215916|469238842|FG005|Overall Study|Physician Decision|0|||
130346102|NCT01215916|469238843|FG006|Overall Study|Physician Decision|0|||
130346103|NCT01215916|469238844|FG007|Overall Study|Physician Decision|0|||
130346104|NCT01215916|469238845|FG008|Overall Study|Physician Decision|0|||
130010955|NCT03557281|468003329|FG003|Overall Study|Withdrawal by Subject|1|||
130010956|NCT03557281|468003330|FG004|Overall Study|Withdrawal by Subject|2|||
130346105|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
130346106|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346107|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346108|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346109|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346110|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346111|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346112|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346113|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
130346114|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Adverse Event|5|||
130346115|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Adverse Event|0|||
130346116|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Adverse Event|0|||
130346117|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Adverse Event|0|||
130346118|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Adverse Event|0|||
130346119|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Adverse Event|0|||
130010957|NCT03557281|468003326|FG000|Overall Study|Randomized, but did not receive treatment|0|||
130346120|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Adverse Event|0|||
130346121|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Adverse Event|0|||
130346122|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Adverse Event|0|||
130346123|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
130346124|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346125|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346126|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346127|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346128|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346129|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
130010958|NCT03557281|468003327|FG001|Overall Study|Randomized, but did not receive treatment|0|||
130010959|NCT03557281|468003328|FG002|Overall Study|Randomized, but did not receive treatment|0|||
130010960|NCT03557281|468003329|FG003|Overall Study|Randomized, but did not receive treatment|0|||
130010961|NCT03557281|468003330|FG004|Overall Study|Randomized, but did not receive treatment|1|||
130346130|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346131|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
130346132|NCT00045942|469238846|FG000|PKC412A2104 (Core)|Death|1|||
130346133|NCT00045942|469238847|FG001|PKC412A2104 (Core)|Death|0|||
130346134|NCT00045942|469238848|FG002|PKC412A2104 (Core)|Death|0|||
130346135|NCT00045942|469238849|FG003|PKC412A2104 (Core)|Death|0|||
130346136|NCT00045942|469238850|FG004|PKC412A2104 (Core)|Death|0|||
130346137|NCT00045942|469238851|FG005|PKC412A2104 (Core)|Death|0|||
130346138|NCT00045942|469238852|FG006|PKC412A2104 (Core)|Death|0|||
130346139|NCT00045942|469238853|FG007|PKC412A2104 (Core)|Death|0|||
130346140|NCT00045942|469238854|FG008|PKC412A2104 (Core)|Death|0|||
130346141|NCT00045942|469238846|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
130346142|NCT00045942|469238847|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
130346143|NCT00045942|469238848|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
130346144|NCT00045942|469238849|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
130346145|NCT00045942|469238850|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
130346146|NCT00045942|469238851|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
130346147|NCT00045942|469238852|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
130346148|NCT00045942|469238853|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
130346149|NCT00045942|469238854|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
130346150|NCT00045942|469238846|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
130346151|NCT00045942|469238847|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
130346152|NCT00045942|469238848|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
130346153|NCT00045942|469238849|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
130346154|NCT00045942|469238850|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
130346155|NCT00045942|469238851|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
130346156|NCT00045942|469238852|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
130346157|NCT00045942|469238853|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
130346158|NCT00045942|469238854|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
130346159|NCT00045942|469238846|FG000|PKC412A2104E1|Lack of Efficacy|0|||
130346160|NCT00045942|469238847|FG001|PKC412A2104E1|Lack of Efficacy|11|||
130346161|NCT00045942|469238848|FG002|PKC412A2104E1|Lack of Efficacy|11|||
130346162|NCT00045942|469238849|FG003|PKC412A2104E1|Lack of Efficacy|23|||
130346163|NCT00045942|469238850|FG004|PKC412A2104E1|Lack of Efficacy|17|||
130346164|NCT00045942|469238851|FG005|PKC412A2104E1|Lack of Efficacy|0|||
130346165|NCT00045942|469238852|FG006|PKC412A2104E1|Lack of Efficacy|0|||
130346166|NCT00045942|469238853|FG007|PKC412A2104E1|Lack of Efficacy|0|||
130346167|NCT00045942|469238854|FG008|PKC412A2104E1|Lack of Efficacy|0|||
130346168|NCT00045942|469238846|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
130346169|NCT00045942|469238847|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
130346170|NCT00045942|469238848|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
130346171|NCT00045942|469238849|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
130346172|NCT00045942|469238850|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
130346173|NCT00045942|469238851|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
130346174|NCT00045942|469238852|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
130346175|NCT00045942|469238853|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
130346176|NCT00045942|469238854|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
130346177|NCT00045942|469238846|FG000|PKC412A2104E1|Adverse Event|0|||
130346178|NCT00045942|469238847|FG001|PKC412A2104E1|Adverse Event|1|||
130346179|NCT00045942|469238848|FG002|PKC412A2104E1|Adverse Event|1|||
130346180|NCT00045942|469238849|FG003|PKC412A2104E1|Adverse Event|3|||
130346181|NCT00045942|469238850|FG004|PKC412A2104E1|Adverse Event|6|||
130346182|NCT00045942|469238851|FG005|PKC412A2104E1|Adverse Event|0|||
130346183|NCT00045942|469238852|FG006|PKC412A2104E1|Adverse Event|0|||
130346184|NCT00045942|469238853|FG007|PKC412A2104E1|Adverse Event|0|||
130346185|NCT00045942|469238854|FG008|PKC412A2104E1|Adverse Event|0|||
130010962|NCT01999465|468003333|FG000|Overall Study|Lost to Follow-up|0|||
130346186|NCT00045942|469238846|FG000|PKC412A2104E1|Death|0|||
130346187|NCT00045942|469238847|FG001|PKC412A2104E1|Death|4|||
130346188|NCT00045942|469238848|FG002|PKC412A2104E1|Death|1|||
130346189|NCT00045942|469238849|FG003|PKC412A2104E1|Death|1|||
130346190|NCT00045942|469238850|FG004|PKC412A2104E1|Death|1|||
130346191|NCT00045942|469238851|FG005|PKC412A2104E1|Death|0|||
130346192|NCT00045942|469238852|FG006|PKC412A2104E1|Death|0|||
130346193|NCT00045942|469238853|FG007|PKC412A2104E1|Death|0|||
130346194|NCT00045942|469238854|FG008|PKC412A2104E1|Death|0|||
130346195|NCT00045942|469238846|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346196|NCT00045942|469238847|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346197|NCT00045942|469238848|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
130346198|NCT00045942|469238849|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
130346199|NCT00045942|469238850|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346200|NCT00045942|469238851|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346201|NCT00045942|469238852|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130010963|NCT01999465|468003334|FG001|Overall Study|Lost to Follow-up|2|||
130010964|NCT01999465|468003333|FG000|Overall Study|Protocol Violation|0|||
130010965|NCT01999465|468003334|FG001|Overall Study|Protocol Violation|1|||
130010966|NCT02463409|468003337|FG000|Overall Study|Withdrawal by Subject|1|||
130010967|NCT02463409|468003337|FG000|Overall Study|Screen failure|1|||
130010968|NCT02819635|468003339|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
130010969|NCT02819635|468003340|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
130010970|NCT02819635|468003341|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
130346202|NCT00045942|469238853|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346203|NCT00045942|469238854|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
130346204|NCT00045942|469238846|FG000|PKC412A2104E2|Lost to Follow-up|0|||
130346205|NCT00045942|469238847|FG001|PKC412A2104E2|Lost to Follow-up|0|||
130346206|NCT00045942|469238848|FG002|PKC412A2104E2|Lost to Follow-up|0|||
130346207|NCT00045942|469238849|FG003|PKC412A2104E2|Lost to Follow-up|0|||
130346208|NCT00045942|469238850|FG004|PKC412A2104E2|Lost to Follow-up|0|||
130346209|NCT00045942|469238851|FG005|PKC412A2104E2|Lost to Follow-up|0|||
130346210|NCT00045942|469238852|FG006|PKC412A2104E2|Lost to Follow-up|0|||
130346211|NCT00045942|469238853|FG007|PKC412A2104E2|Lost to Follow-up|3|||
130346212|NCT00045942|469238854|FG008|PKC412A2104E2|Lost to Follow-up|0|||
130346213|NCT00045942|469238846|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
130346214|NCT00045942|469238847|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
130346215|NCT00045942|469238848|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
130346216|NCT00045942|469238849|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
130346217|NCT00045942|469238850|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
130346218|NCT00045942|469238851|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
130346219|NCT00045942|469238852|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
130346220|NCT00045942|469238853|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
130346221|NCT00045942|469238854|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
130346222|NCT00045942|469238846|FG000|PKC412A2104E2|Lack of Efficacy|0|||
130346223|NCT00045942|469238847|FG001|PKC412A2104E2|Lack of Efficacy|0|||
130346224|NCT00045942|469238848|FG002|PKC412A2104E2|Lack of Efficacy|0|||
130346225|NCT00045942|469238849|FG003|PKC412A2104E2|Lack of Efficacy|0|||
130346226|NCT00045942|469238850|FG004|PKC412A2104E2|Lack of Efficacy|0|||
130346227|NCT00045942|469238851|FG005|PKC412A2104E2|Lack of Efficacy|3|||
130346228|NCT00045942|469238852|FG006|PKC412A2104E2|Lack of Efficacy|2|||
130346229|NCT00045942|469238853|FG007|PKC412A2104E2|Lack of Efficacy|2|||
130346230|NCT00045942|469238854|FG008|PKC412A2104E2|Lack of Efficacy|6|||
130346231|NCT00045942|469238846|FG000|PKC412A2104E2|Adverse Event|0|||
130346232|NCT00045942|469238847|FG001|PKC412A2104E2|Adverse Event|0|||
130346233|NCT00045942|469238848|FG002|PKC412A2104E2|Adverse Event|0|||
130346234|NCT00045942|469238849|FG003|PKC412A2104E2|Adverse Event|0|||
130346235|NCT00045942|469238850|FG004|PKC412A2104E2|Adverse Event|0|||
130346236|NCT00045942|469238851|FG005|PKC412A2104E2|Adverse Event|4|||
130346237|NCT00045942|469238852|FG006|PKC412A2104E2|Adverse Event|3|||
130346238|NCT00045942|469238853|FG007|PKC412A2104E2|Adverse Event|1|||
130346239|NCT00045942|469238854|FG008|PKC412A2104E2|Adverse Event|0|||
130346240|NCT00045942|469238846|FG000|PKC412A2104E2|Death|0|||
130346241|NCT00045942|469238847|FG001|PKC412A2104E2|Death|0|||
130346242|NCT00045942|469238848|FG002|PKC412A2104E2|Death|0|||
130346243|NCT00045942|469238849|FG003|PKC412A2104E2|Death|0|||
130346244|NCT00045942|469238850|FG004|PKC412A2104E2|Death|0|||
130346245|NCT00045942|469238851|FG005|PKC412A2104E2|Death|1|||
130346246|NCT00045942|469238852|FG006|PKC412A2104E2|Death|2|||
130346247|NCT00045942|469238853|FG007|PKC412A2104E2|Death|0|||
130346248|NCT00045942|469238854|FG008|PKC412A2104E2|Death|0|||
130346249|NCT02142387|469238855|FG000|Overall Study|<19 years old|49|||
130346250|NCT02142387|469238856|FG001|Overall Study|<19 years old|326|||
130346251|NCT02142387|469238855|FG000|Overall Study|non-cardiac etiology|504|||
130346252|NCT02142387|469238856|FG001|Overall Study|non-cardiac etiology|3431|||
130346253|NCT02142387|469238855|FG000|Overall Study|CPR not performed|74|||
130346254|NCT02142387|469238856|FG001|Overall Study|CPR not performed|473|||
130346255|NCT02142387|469238855|FG000|Overall Study|witnessed by paramedic|139|||
130346256|NCT02142387|469238856|FG001|Overall Study|witnessed by paramedic|917|||
130346257|NCT02142387|469238855|FG000|Overall Study|incomplete data|1|||
130010971|NCT02819635|468003342|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
130010972|NCT02819635|468003343|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
130346258|NCT02142387|469238856|FG001|Overall Study|incomplete data|9|||
130346259|NCT02142387|469238855|FG000|Overall Study|occurred not at home|298|||
130346260|NCT02142387|469238856|FG001|Overall Study|occurred not at home|2474|||
130346261|NCT05028361|469238857|FG000|Overall Study|Withdrawal by Subject|1|||
130346262|NCT05028361|469238858|FG001|Overall Study|Withdrawal by Subject|0|||
130346263|NCT00779259|469238859|FG000|Quinine Alone|Adverse Event|2|||
130346264|NCT02047318|469238863|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
130346265|NCT02047318|469238863|FG000|Core Study Period|Adverse Event|1|||
130346266|NCT02047318|469238863|FG000|Core Study Period|Withdrawal by caregiver|3|||
130346267|NCT02047318|469238863|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
130346268|NCT02095132|469238864|FG000|Overall Study|Adverse Event|0|||
130346269|NCT02095132|469238865|FG001|Overall Study|Adverse Event|0|||
130346270|NCT02095132|469238866|FG002|Overall Study|Adverse Event|0|||
130010973|NCT02819635|468003344|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
130010974|NCT02819635|468003345|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
130010975|NCT02819635|468003346|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130010976|NCT02819635|468003347|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130010977|NCT02819635|468003348|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130010978|NCT02819635|468003349|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130010979|NCT02819635|468003350|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
130010980|NCT02819635|468003339|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010981|NCT02819635|468003340|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010982|NCT02819635|468003341|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010983|NCT02819635|468003342|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010984|NCT02819635|468003343|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
130010985|NCT02819635|468003344|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
130010986|NCT02819635|468003345|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
130010987|NCT02819635|468003346|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010988|NCT02819635|468003347|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010989|NCT02819635|468003348|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010990|NCT02819635|468003349|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010991|NCT02819635|468003350|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
130010992|NCT02819635|468003339|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130010993|NCT02819635|468003340|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130010994|NCT02819635|468003341|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130010995|NCT02819635|468003342|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130010996|NCT02819635|468003343|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130010997|NCT02819635|468003344|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
130010998|NCT02819635|468003345|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
130010999|NCT02819635|468003346|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130011000|NCT02819635|468003347|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130011001|NCT02819635|468003348|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130011002|NCT02819635|468003349|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130011003|NCT02819635|468003350|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
130011004|NCT02819635|468003339|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011005|NCT02819635|468003340|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011006|NCT02819635|468003341|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011007|NCT02819635|468003342|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011008|NCT02819635|468003343|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011009|NCT02819635|468003344|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011010|NCT02819635|468003345|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
130011011|NCT02819635|468003346|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011012|NCT02819635|468003347|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011013|NCT02819635|468003348|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011014|NCT02819635|468003349|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130346271|NCT02095132|469238867|FG003|Overall Study|Adverse Event|0|||
130346272|NCT02095132|469238868|FG004|Overall Study|Adverse Event|1|||
130346273|NCT02095132|469238869|FG005|Overall Study|Adverse Event|0|||
130346274|NCT02095132|469238870|FG006|Overall Study|Adverse Event|1|||
130011015|NCT02819635|468003350|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
130011016|NCT02819635|468003339|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
130011017|NCT02819635|468003340|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
130011018|NCT02819635|468003341|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
130011019|NCT02819635|468003342|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
130011020|NCT02819635|468003343|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
130346275|NCT02095132|469238871|FG007|Overall Study|Adverse Event|0|||
130346276|NCT02095132|469238872|FG008|Overall Study|Adverse Event|0|||
130346277|NCT02095132|469238864|FG000|Overall Study|Death|0|||
130346278|NCT02095132|469238865|FG001|Overall Study|Death|0|||
130346279|NCT02095132|469238866|FG002|Overall Study|Death|0|||
130346280|NCT02095132|469238867|FG003|Overall Study|Death|0|||
130346281|NCT02095132|469238868|FG004|Overall Study|Death|0|||
130346282|NCT02095132|469238869|FG005|Overall Study|Death|0|||
130346283|NCT02095132|469238870|FG006|Overall Study|Death|1|||
130346284|NCT02095132|469238871|FG007|Overall Study|Death|0|||
130346285|NCT02095132|469238872|FG008|Overall Study|Death|0|||
130346286|NCT02095132|469238864|FG000|Overall Study|Lack of Efficacy|3|||
130346287|NCT02095132|469238865|FG001|Overall Study|Lack of Efficacy|5|||
130346288|NCT02095132|469238866|FG002|Overall Study|Lack of Efficacy|2|||
130346289|NCT02095132|469238867|FG003|Overall Study|Lack of Efficacy|8|||
130346290|NCT02095132|469238868|FG004|Overall Study|Lack of Efficacy|3|||
130346291|NCT02095132|469238869|FG005|Overall Study|Lack of Efficacy|6|||
130011021|NCT02819635|468003344|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
130011022|NCT02819635|468003345|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
130011023|NCT02819635|468003346|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130011024|NCT02819635|468003347|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130346292|NCT02095132|469238870|FG006|Overall Study|Lack of Efficacy|10|||
130346293|NCT02095132|469238871|FG007|Overall Study|Lack of Efficacy|9|||
130346294|NCT02095132|469238872|FG008|Overall Study|Lack of Efficacy|8|||
130346295|NCT02095132|469238864|FG000|Overall Study|Physician Decision|1|||
130346296|NCT02095132|469238865|FG001|Overall Study|Physician Decision|0|||
130346297|NCT02095132|469238866|FG002|Overall Study|Physician Decision|0|||
130346298|NCT02095132|469238867|FG003|Overall Study|Physician Decision|0|||
130346299|NCT02095132|469238868|FG004|Overall Study|Physician Decision|0|||
130346300|NCT02095132|469238869|FG005|Overall Study|Physician Decision|0|||
130346301|NCT02095132|469238870|FG006|Overall Study|Physician Decision|1|||
130346302|NCT02095132|469238871|FG007|Overall Study|Physician Decision|0|||
130346303|NCT02095132|469238872|FG008|Overall Study|Physician Decision|2|||
130346304|NCT02095132|469238864|FG000|Overall Study|Withdrawal by Subject|0|||
130346305|NCT02095132|469238865|FG001|Overall Study|Withdrawal by Subject|0|||
130346306|NCT02095132|469238866|FG002|Overall Study|Withdrawal by Subject|2|||
130346307|NCT02095132|469238867|FG003|Overall Study|Withdrawal by Subject|2|||
130346308|NCT02095132|469238868|FG004|Overall Study|Withdrawal by Subject|3|||
130346309|NCT02095132|469238869|FG005|Overall Study|Withdrawal by Subject|0|||
130346310|NCT02095132|469238870|FG006|Overall Study|Withdrawal by Subject|5|||
130346311|NCT02095132|469238871|FG007|Overall Study|Withdrawal by Subject|0|||
130346312|NCT02095132|469238872|FG008|Overall Study|Withdrawal by Subject|0|||
130346313|NCT00409175|469238873|FG000|Overall Study|Adverse Event|4|||
130346314|NCT00409175|469238874|FG001|Overall Study|Adverse Event|3|||
130346315|NCT00409175|469238873|FG000|Overall Study|Withdrawal by Subject|1|||
130346316|NCT00409175|469238874|FG001|Overall Study|Withdrawal by Subject|2|||
130346317|NCT00409175|469238873|FG000|Overall Study|Negative genotype|0|||
130346318|NCT00409175|469238874|FG001|Overall Study|Negative genotype|1|||
130346319|NCT00409175|469238873|FG000|Overall Study|Liver transplantation|13|||
130346320|NCT00409175|469238874|FG001|Overall Study|Liver transplantation|13|||
130346321|NCT02108262|469238877|FG000|Overall Study|Non-compliance|0|||
130346322|NCT02108262|469238878|FG001|Overall Study|Non-compliance|2|||
130346323|NCT02108262|469238879|FG002|Overall Study|Non-compliance|1|||
130346324|NCT02108262|469238880|FG003|Overall Study|Non-compliance|1|||
130346325|NCT02108262|469238877|FG000|Overall Study|Randomized by error/screen failure|0|||
130346326|NCT02108262|469238878|FG001|Overall Study|Randomized by error/screen failure|0|||
130346327|NCT02108262|469238879|FG002|Overall Study|Randomized by error/screen failure|1|||
130346328|NCT02108262|469238880|FG003|Overall Study|Randomized by error/screen failure|0|||
130346329|NCT02108262|469238877|FG000|Overall Study|Distance to center|0|||
130346330|NCT02108262|469238878|FG001|Overall Study|Distance to center|1|||
130346331|NCT02108262|469238879|FG002|Overall Study|Distance to center|1|||
130346332|NCT02108262|469238880|FG003|Overall Study|Distance to center|0|||
130346333|NCT02108262|469238877|FG000|Overall Study|Adverse Event|0|||
130346334|NCT02108262|469238878|FG001|Overall Study|Adverse Event|11|||
130346335|NCT02108262|469238879|FG002|Overall Study|Adverse Event|6|||
130346336|NCT02108262|469238880|FG003|Overall Study|Adverse Event|12|||
130346337|NCT02108262|469238877|FG000|Overall Study|Death|0|||
130346338|NCT02108262|469238878|FG001|Overall Study|Death|2|||
130346339|NCT02108262|469238879|FG002|Overall Study|Death|2|||
130346340|NCT02108262|469238880|FG003|Overall Study|Death|1|||
130346341|NCT02108262|469238877|FG000|Overall Study|Lost to Follow-up|0|||
130346342|NCT02108262|469238878|FG001|Overall Study|Lost to Follow-up|0|||
130346343|NCT02108262|469238879|FG002|Overall Study|Lost to Follow-up|1|||
130346344|NCT02108262|469238880|FG003|Overall Study|Lost to Follow-up|0|||
130346345|NCT02108262|469238877|FG000|Overall Study|Physician Decision|0|||
130346346|NCT02108262|469238878|FG001|Overall Study|Physician Decision|0|||
130346347|NCT02108262|469238879|FG002|Overall Study|Physician Decision|2|||
130346348|NCT02108262|469238880|FG003|Overall Study|Physician Decision|0|||
130346349|NCT02108262|469238877|FG000|Overall Study|Withdrawal by Subject|0|||
130346350|NCT02108262|469238878|FG001|Overall Study|Withdrawal by Subject|7|||
130346351|NCT02108262|469238879|FG002|Overall Study|Withdrawal by Subject|3|||
130346352|NCT02108262|469238880|FG003|Overall Study|Withdrawal by Subject|4|||
130346353|NCT02108262|469238877|FG000|Overall Study|Due to key hepatic values|0|||
130346354|NCT02108262|469238878|FG001|Overall Study|Due to key hepatic values|1|||
130346355|NCT02108262|469238879|FG002|Overall Study|Due to key hepatic values|0|||
130346356|NCT02108262|469238880|FG003|Overall Study|Due to key hepatic values|0|||
130346357|NCT02108262|469238877|FG000|Overall Study|Unable to contact patient|0|||
130346358|NCT02108262|469238878|FG001|Overall Study|Unable to contact patient|3|||
130346359|NCT02108262|469238879|FG002|Overall Study|Unable to contact patient|1|||
130346360|NCT02108262|469238880|FG003|Overall Study|Unable to contact patient|2|||
130346361|NCT02108262|469238877|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
130346362|NCT02108262|469238878|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
130346363|NCT02108262|469238879|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
130346364|NCT02108262|469238880|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
130011025|NCT02819635|468003348|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130011026|NCT02819635|468003349|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130011027|NCT02819635|468003350|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
130011028|NCT02819635|468003339|FG000|Substudy 2, Part 2|Adverse Event|0|||
130011029|NCT02819635|468003340|FG001|Substudy 2, Part 2|Adverse Event|0|||
130011030|NCT02819635|468003341|FG002|Substudy 2, Part 2|Adverse Event|0|||
130011031|NCT02819635|468003342|FG003|Substudy 2, Part 2|Adverse Event|0|||
130011032|NCT02819635|468003343|FG004|Substudy 2, Part 2|Adverse Event|0|||
130011033|NCT02819635|468003344|FG005|Substudy 2, Part 2|Adverse Event|4|||
130011034|NCT02819635|468003345|FG006|Substudy 2, Part 2|Adverse Event|0|||
130011035|NCT02819635|468003346|FG007|Substudy 2, Part 2|Adverse Event|0|||
130011036|NCT02819635|468003347|FG008|Substudy 2, Part 2|Adverse Event|0|||
130011037|NCT02819635|468003348|FG009|Substudy 2, Part 2|Adverse Event|0|||
130346365|NCT02108262|469238877|FG000|Overall Study|Patient did not want another infusion|0|||
130346366|NCT02108262|469238878|FG001|Overall Study|Patient did not want another infusion|3|||
130346367|NCT02108262|469238879|FG002|Overall Study|Patient did not want another infusion|3|||
130346368|NCT02108262|469238880|FG003|Overall Study|Patient did not want another infusion|2|||
130346369|NCT02108262|469238877|FG000|Overall Study|Vacation|0|||
130346370|NCT02108262|469238878|FG001|Overall Study|Vacation|1|||
130346371|NCT02108262|469238879|FG002|Overall Study|Vacation|0|||
130346372|NCT02108262|469238880|FG003|Overall Study|Vacation|0|||
130346373|NCT02108262|469238877|FG000|Overall Study|Patient decision|0|||
130346374|NCT02108262|469238878|FG001|Overall Study|Patient decision|7|||
130346375|NCT02108262|469238879|FG002|Overall Study|Patient decision|9|||
130346376|NCT02108262|469238880|FG003|Overall Study|Patient decision|14|||
130346377|NCT02108262|469238877|FG000|Overall Study|Missed IV due to pharmacy error|0|||
130346378|NCT02108262|469238878|FG001|Overall Study|Missed IV due to pharmacy error|0|||
130346379|NCT02108262|469238879|FG002|Overall Study|Missed IV due to pharmacy error|1|||
130346380|NCT02108262|469238880|FG003|Overall Study|Missed IV due to pharmacy error|0|||
130346381|NCT01895361|469238881|FG000|Overall Study|Adverse Event|1|||
130346382|NCT01895361|469238882|FG001|Overall Study|Adverse Event|1|||
130346383|NCT01895361|469238883|FG002|Overall Study|Adverse Event|3|||
130346384|NCT01895361|469238881|FG000|Overall Study|Death|2|||
130346385|NCT01895361|469238882|FG001|Overall Study|Death|1|||
130346386|NCT01895361|469238883|FG002|Overall Study|Death|2|||
130346387|NCT01895361|469238881|FG000|Overall Study|Lost to Follow-up|4|||
130346388|NCT01895361|469238882|FG001|Overall Study|Lost to Follow-up|4|||
130346389|NCT01895361|469238883|FG002|Overall Study|Lost to Follow-up|6|||
130346390|NCT01895361|469238881|FG000|Overall Study|Non-compliance with study|1|||
130346391|NCT01895361|469238882|FG001|Overall Study|Non-compliance with study|3|||
130346392|NCT01895361|469238883|FG002|Overall Study|Non-compliance with study|1|||
130346393|NCT01895361|469238881|FG000|Overall Study|Physician Decision|2|||
130346394|NCT01895361|469238882|FG001|Overall Study|Physician Decision|2|||
130346395|NCT01895361|469238883|FG002|Overall Study|Physician Decision|2|||
130346396|NCT01895361|469238881|FG000|Overall Study|Withdrawal by Subject|7|||
130346397|NCT01895361|469238882|FG001|Overall Study|Withdrawal by Subject|6|||
130346398|NCT01895361|469238883|FG002|Overall Study|Withdrawal by Subject|6|||
130346399|NCT01895361|469238881|FG000|Overall Study|Lack of Efficacy|0|||
130346400|NCT01895361|469238882|FG001|Overall Study|Lack of Efficacy|1|||
130346401|NCT01895361|469238883|FG002|Overall Study|Lack of Efficacy|0|||
130346402|NCT01895361|469238881|FG000|Overall Study|Reasons different from categories above|7|||
130346403|NCT01895361|469238882|FG001|Overall Study|Reasons different from categories above|3|||
130346404|NCT01895361|469238883|FG002|Overall Study|Reasons different from categories above|4|||
130346405|NCT02586506|469238887|FG000|Overall Study|Protocol Violation|6|||
130346406|NCT02586506|469238887|FG000|Overall Study|Lost to Follow-up|1|||
130346407|NCT02586506|469238887|FG000|Overall Study|Other Reason|2|||
130346408|NCT00674154|469238888|FG000|Overall Study|Withdrawal by Subject|3|||
130346409|NCT00674154|469238889|FG001|Overall Study|Withdrawal by Subject|1|||
130346410|NCT00674154|469238888|FG000|Overall Study|Did not want parathyroidectomy|0|||
130346411|NCT00674154|469238889|FG001|Overall Study|Did not want parathyroidectomy|2|||
130011038|NCT02819635|468003349|FG010|Substudy 2, Part 2|Adverse Event|0|||
130011039|NCT02819635|468003350|FG011|Substudy 2, Part 2|Adverse Event|0|||
130011040|NCT02819635|468003339|FG000|Substudy 2, Part 2|Withdrew consent|0|||
130011041|NCT02819635|468003340|FG001|Substudy 2, Part 2|Withdrew consent|0|||
130346412|NCT05093790|469238890|FG000|Overall Study|Failure to meet continuation criteria|0|||
130011042|NCT02819635|468003341|FG002|Substudy 2, Part 2|Withdrew consent|0|||
130011043|NCT02819635|468003342|FG003|Substudy 2, Part 2|Withdrew consent|0|||
130011044|NCT02819635|468003343|FG004|Substudy 2, Part 2|Withdrew consent|0|||
130011045|NCT02819635|468003344|FG005|Substudy 2, Part 2|Withdrew consent|3|||
130346413|NCT05093790|469238891|FG001|Overall Study|Failure to meet continuation criteria|0|||
130346414|NCT05093790|469238892|FG002|Overall Study|Failure to meet continuation criteria|1|||
130346415|NCT05093790|469238893|FG003|Overall Study|Failure to meet continuation criteria|0|||
130346416|NCT05093790|469238890|FG000|Overall Study|Adverse Event|1|||
130011046|NCT02819635|468003345|FG006|Substudy 2, Part 2|Withdrew consent|1|||
130011047|NCT02819635|468003346|FG007|Substudy 2, Part 2|Withdrew consent|0|||
130011048|NCT02819635|468003347|FG008|Substudy 2, Part 2|Withdrew consent|0|||
130011049|NCT02819635|468003348|FG009|Substudy 2, Part 2|Withdrew consent|0|||
130011050|NCT02819635|468003349|FG010|Substudy 2, Part 2|Withdrew consent|0|||
130011051|NCT02819635|468003350|FG011|Substudy 2, Part 2|Withdrew consent|0|||
130011052|NCT02819635|468003339|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
130011053|NCT02819635|468003340|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
130011054|NCT02819635|468003341|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
130011055|NCT02819635|468003342|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
130011056|NCT02819635|468003343|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
130011057|NCT02819635|468003344|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
130011058|NCT02819635|468003345|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
130011059|NCT02819635|468003346|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
130011060|NCT02819635|468003347|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
130011061|NCT02819635|468003348|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
130011062|NCT02819635|468003349|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
130011063|NCT02819635|468003350|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
130011064|NCT02819635|468003339|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011065|NCT02819635|468003340|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011066|NCT02819635|468003341|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011067|NCT02819635|468003342|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011068|NCT02819635|468003343|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011069|NCT02819635|468003344|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011070|NCT02819635|468003345|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
130011071|NCT02819635|468003346|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011072|NCT02819635|468003347|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130346417|NCT05093790|469238891|FG001|Overall Study|Adverse Event|0|||
130346418|NCT05093790|469238892|FG002|Overall Study|Adverse Event|0|||
130346419|NCT05093790|469238893|FG003|Overall Study|Adverse Event|0|||
130346420|NCT01903252|469238895|FG000|Double-Blind Induction|Adverse Event|20|||
130346421|NCT01903252|469238896|FG001|Double-Blind Induction|Adverse Event|18|||
130346422|NCT01903252|469238897|FG002|Double-Blind Induction|Adverse Event|0|||
130346423|NCT01903252|469238898|FG003|Double-Blind Induction|Adverse Event|0|||
130346424|NCT01903252|469238899|FG004|Double-Blind Induction|Adverse Event|0|||
130346425|NCT01903252|469238900|FG005|Double-Blind Induction|Adverse Event|0|||
130346426|NCT01903252|469238895|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
130011073|NCT02819635|468003348|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011074|NCT02819635|468003349|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130011075|NCT02819635|468003350|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
130346427|NCT01903252|469238896|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
130346428|NCT01903252|469238897|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
130346429|NCT01903252|469238898|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
130346430|NCT01903252|469238899|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
130346431|NCT01903252|469238900|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
130346432|NCT01903252|469238895|FG000|Double-Blind Induction|Physician Decision|2|||
130346433|NCT01903252|469238896|FG001|Double-Blind Induction|Physician Decision|3|||
130346434|NCT01903252|469238897|FG002|Double-Blind Induction|Physician Decision|0|||
130346435|NCT01903252|469238898|FG003|Double-Blind Induction|Physician Decision|0|||
130346436|NCT01903252|469238899|FG004|Double-Blind Induction|Physician Decision|0|||
130346437|NCT01903252|469238900|FG005|Double-Blind Induction|Physician Decision|0|||
130346438|NCT01903252|469238895|FG000|Double-Blind Induction|non-compliance,|7|||
130346439|NCT01903252|469238896|FG001|Double-Blind Induction|non-compliance,|7|||
130346440|NCT01903252|469238897|FG002|Double-Blind Induction|non-compliance,|0|||
130346441|NCT01903252|469238898|FG003|Double-Blind Induction|non-compliance,|0|||
130346442|NCT01903252|469238899|FG004|Double-Blind Induction|non-compliance,|0|||
130346443|NCT01903252|469238900|FG005|Double-Blind Induction|non-compliance,|0|||
130346444|NCT01903252|469238895|FG000|Extended Induction, Open-Label|Adverse Event|0|||
130346445|NCT01903252|469238896|FG001|Extended Induction, Open-Label|Adverse Event|0|||
130346446|NCT01903252|469238897|FG002|Extended Induction, Open-Label|Adverse Event|17|||
130346447|NCT01903252|469238898|FG003|Extended Induction, Open-Label|Adverse Event|0|||
130346448|NCT01903252|469238899|FG004|Extended Induction, Open-Label|Adverse Event|0|||
130346449|NCT01903252|469238900|FG005|Extended Induction, Open-Label|Adverse Event|0|||
130346450|NCT01903252|469238895|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346451|NCT01903252|469238896|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346452|NCT01903252|469238897|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
130346453|NCT01903252|469238898|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346454|NCT01903252|469238899|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346455|NCT01903252|469238900|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
130346456|NCT01903252|469238895|FG000|Extended Induction, Open-Label|Physician Decision|0|||
130346457|NCT01903252|469238896|FG001|Extended Induction, Open-Label|Physician Decision|0|||
130346458|NCT01903252|469238897|FG002|Extended Induction, Open-Label|Physician Decision|1|||
130346459|NCT01903252|469238898|FG003|Extended Induction, Open-Label|Physician Decision|0|||
130346460|NCT01903252|469238899|FG004|Extended Induction, Open-Label|Physician Decision|0|||
130346461|NCT01903252|469238900|FG005|Extended Induction, Open-Label|Physician Decision|0|||
130346462|NCT01903252|469238895|FG000|Maintenance, Open-Label|Adverse Event|0|||
130346463|NCT01903252|469238896|FG001|Maintenance, Open-Label|Adverse Event|0|||
130346464|NCT01903252|469238897|FG002|Maintenance, Open-Label|Adverse Event|0|||
130346465|NCT01903252|469238898|FG003|Maintenance, Open-Label|Adverse Event|3|||
130346466|NCT01903252|469238899|FG004|Maintenance, Open-Label|Adverse Event|9|||
130346467|NCT01903252|469238900|FG005|Maintenance, Open-Label|Adverse Event|14|||
130346468|NCT01903252|469238895|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
130346469|NCT01903252|469238896|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
130346470|NCT01903252|469238897|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
130346471|NCT01903252|469238898|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
130346472|NCT01903252|469238899|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
130346473|NCT01903252|469238900|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
130346474|NCT01903252|469238895|FG000|Maintenance, Open-Label|Other|0|||
130346475|NCT01903252|469238896|FG001|Maintenance, Open-Label|Other|0|||
130346476|NCT01903252|469238897|FG002|Maintenance, Open-Label|Other|0|||
130346477|NCT01903252|469238898|FG003|Maintenance, Open-Label|Other|2|||
130346478|NCT01903252|469238899|FG004|Maintenance, Open-Label|Other|6|||
130346479|NCT01903252|469238900|FG005|Maintenance, Open-Label|Other|2|||
130346480|NCT01381562|469238901|FG000|Overall Study|Adverse Event|0|||
130346481|NCT01381562|469238902|FG001|Overall Study|Adverse Event|1|||
130346482|NCT01381562|469238903|FG002|Overall Study|Adverse Event|0|||
130346483|NCT01642732|469238904|FG000|Overall Study|Withdrawal by Subject|1|||
130346484|NCT01606878|469238907|FG000|Overall Study|Adverse Event|1|||
130346485|NCT01606878|469238908|FG001|Overall Study|Adverse Event|1|||
130346486|NCT01606878|469238909|FG002|Overall Study|Adverse Event|0|||
130346487|NCT01606878|469238910|FG003|Overall Study|Adverse Event|0|||
130346488|NCT01606878|469238911|FG004|Overall Study|Adverse Event|0|||
130346489|NCT01606878|469238912|FG005|Overall Study|Adverse Event|0|||
130346490|NCT01606878|469238913|FG006|Overall Study|Adverse Event|1|||
130346491|NCT01606878|469238914|FG007|Overall Study|Adverse Event|0|||
130346492|NCT01606878|469238915|FG008|Overall Study|Adverse Event|1|||
130346493|NCT01606878|469238916|FG009|Overall Study|Adverse Event|3|||
130346494|NCT01606878|469238917|FG010|Overall Study|Adverse Event|0|||
130346495|NCT01606878|469238907|FG000|Overall Study|Lack of Efficacy|1|||
130346496|NCT01606878|469238908|FG001|Overall Study|Lack of Efficacy|1|||
130346497|NCT01606878|469238909|FG002|Overall Study|Lack of Efficacy|1|||
130346498|NCT01606878|469238910|FG003|Overall Study|Lack of Efficacy|2|||
130346499|NCT01606878|469238911|FG004|Overall Study|Lack of Efficacy|1|||
130346500|NCT01606878|469238912|FG005|Overall Study|Lack of Efficacy|2|||
130346501|NCT01606878|469238913|FG006|Overall Study|Lack of Efficacy|1|||
130346502|NCT01606878|469238914|FG007|Overall Study|Lack of Efficacy|2|||
130011076|NCT02819635|468003339|FG000|Substudy 2, Part 2|Other, not specified|0|||
130011077|NCT02819635|468003340|FG001|Substudy 2, Part 2|Other, not specified|0|||
130011078|NCT02819635|468003341|FG002|Substudy 2, Part 2|Other, not specified|0|||
130011079|NCT02819635|468003342|FG003|Substudy 2, Part 2|Other, not specified|0|||
130011080|NCT02819635|468003343|FG004|Substudy 2, Part 2|Other, not specified|0|||
130011081|NCT02819635|468003344|FG005|Substudy 2, Part 2|Other, not specified|4|||
130011082|NCT02819635|468003345|FG006|Substudy 2, Part 2|Other, not specified|8|||
130011083|NCT02819635|468003346|FG007|Substudy 2, Part 2|Other, not specified|0|||
130011084|NCT02819635|468003347|FG008|Substudy 2, Part 2|Other, not specified|0|||
130011085|NCT02819635|468003348|FG009|Substudy 2, Part 2|Other, not specified|0|||
130011086|NCT02819635|468003349|FG010|Substudy 2, Part 2|Other, not specified|0|||
130346503|NCT01606878|469238915|FG008|Overall Study|Lack of Efficacy|2|||
130346504|NCT01606878|469238916|FG009|Overall Study|Lack of Efficacy|0|||
130346505|NCT01606878|469238917|FG010|Overall Study|Lack of Efficacy|1|||
130346506|NCT01606878|469238907|FG000|Overall Study|Physician Decision|1|||
130346507|NCT01606878|469238908|FG001|Overall Study|Physician Decision|0|||
130346508|NCT01606878|469238909|FG002|Overall Study|Physician Decision|2|||
130346509|NCT01606878|469238910|FG003|Overall Study|Physician Decision|1|||
130346510|NCT01606878|469238911|FG004|Overall Study|Physician Decision|1|||
130346511|NCT01606878|469238912|FG005|Overall Study|Physician Decision|1|||
130346512|NCT01606878|469238913|FG006|Overall Study|Physician Decision|2|||
130346513|NCT01606878|469238914|FG007|Overall Study|Physician Decision|0|||
130346514|NCT01606878|469238915|FG008|Overall Study|Physician Decision|1|||
130346515|NCT01606878|469238916|FG009|Overall Study|Physician Decision|0|||
130346516|NCT01606878|469238917|FG010|Overall Study|Physician Decision|0|||
130346517|NCT01606878|469238907|FG000|Overall Study|Withdrawal by Subject|3|||
130346518|NCT01606878|469238908|FG001|Overall Study|Withdrawal by Subject|2|||
130346519|NCT01606878|469238909|FG002|Overall Study|Withdrawal by Subject|2|||
130346520|NCT01606878|469238910|FG003|Overall Study|Withdrawal by Subject|0|||
130346521|NCT01606878|469238911|FG004|Overall Study|Withdrawal by Subject|1|||
130346522|NCT01606878|469238912|FG005|Overall Study|Withdrawal by Subject|1|||
130346523|NCT01606878|469238913|FG006|Overall Study|Withdrawal by Subject|2|||
130346524|NCT01606878|469238914|FG007|Overall Study|Withdrawal by Subject|1|||
130346525|NCT01606878|469238915|FG008|Overall Study|Withdrawal by Subject|2|||
130346526|NCT01606878|469238916|FG009|Overall Study|Withdrawal by Subject|0|||
130346527|NCT01606878|469238917|FG010|Overall Study|Withdrawal by Subject|2|||
130011087|NCT02819635|468003350|FG011|Substudy 2, Part 2|Other, not specified|0|||
130011088|NCT02819635|468003339|FG000|Substudy 3|Adverse Event|0|||
130011089|NCT02819635|468003340|FG001|Substudy 3|Adverse Event|0|||
130011090|NCT02819635|468003341|FG002|Substudy 3|Adverse Event|0|||
130011091|NCT02819635|468003342|FG003|Substudy 3|Adverse Event|0|||
130011092|NCT02819635|468003343|FG004|Substudy 3|Adverse Event|0|||
130011093|NCT02819635|468003344|FG005|Substudy 3|Adverse Event|0|||
130011094|NCT02819635|468003345|FG006|Substudy 3|Adverse Event|0|||
130011095|NCT02819635|468003346|FG007|Substudy 3|Adverse Event|0|||
130011096|NCT02819635|468003347|FG008|Substudy 3|Adverse Event|32|||
130011097|NCT02819635|468003348|FG009|Substudy 3|Adverse Event|3|||
130011098|NCT02819635|468003349|FG010|Substudy 3|Adverse Event|12|||
130011099|NCT02819635|468003350|FG011|Substudy 3|Adverse Event|18|||
130011100|NCT02819635|468003339|FG000|Substudy 3|Withdrew consent|0|||
130011101|NCT02819635|468003340|FG001|Substudy 3|Withdrew consent|0|||
130011102|NCT02819635|468003341|FG002|Substudy 3|Withdrew consent|0|||
130011103|NCT02819635|468003342|FG003|Substudy 3|Withdrew consent|0|||
130011104|NCT02819635|468003343|FG004|Substudy 3|Withdrew consent|0|||
130011105|NCT02819635|468003344|FG005|Substudy 3|Withdrew consent|0|||
130011106|NCT02819635|468003345|FG006|Substudy 3|Withdrew consent|0|||
130011107|NCT02819635|468003346|FG007|Substudy 3|Withdrew consent|0|||
130011108|NCT02819635|468003347|FG008|Substudy 3|Withdrew consent|11|||
130346528|NCT03039621|469240150|FG000|Overall Study|Violation of inclusion criteria|3|||
130346529|NCT03039621|469240151|FG001|Overall Study|Violation of inclusion criteria|2|||
130346530|NCT03039621|469240150|FG000|Overall Study|Non-compliance with protocol requirement|4|||
130346531|NCT03039621|469240151|FG001|Overall Study|Non-compliance with protocol requirement|5|||
130346532|NCT03039621|469240150|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
130346533|NCT03039621|469240151|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
130346534|NCT03039621|469240150|FG000|Overall Study|Violation of non-inclusion criteria|1|||
130346535|NCT03039621|469240151|FG001|Overall Study|Violation of non-inclusion criteria|2|||
130346536|NCT00002931|469240154|FG000|Overall Study|rapidly progressing disease during|2|||
130346537|NCT01879579|469240156|FG000|Overall Study|Phone incompatible with texting platform|3|||
130346538|NCT01879579|469240157|FG001|Overall Study|Phone incompatible with texting platform|0|||
130346539|NCT01879579|469240156|FG000|Overall Study|Did not enroll in texting platform|1|||
130346540|NCT01879579|469240157|FG001|Overall Study|Did not enroll in texting platform|0|||
130346541|NCT01879579|469240156|FG000|Overall Study|Did not initiate insulin treatment|1|||
130346542|NCT01879579|469240157|FG001|Overall Study|Did not initiate insulin treatment|0|||
130346543|NCT01879579|469240156|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
130346544|NCT01879579|469240157|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
130346545|NCT01879579|469240156|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
130346546|NCT01879579|469240157|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
130346547|NCT02292784|469240158|FG000|Overall Study|Lost to Follow-up|1|||
130346548|NCT02292784|469240159|FG001|Overall Study|Lost to Follow-up|17|||
130346549|NCT02292784|469240160|FG002|Overall Study|Lost to Follow-up|18|||
130346550|NCT02292784|469240158|FG000|Overall Study|Withdrawal by Subject|0|||
130346551|NCT02292784|469240159|FG001|Overall Study|Withdrawal by Subject|3|||
130346552|NCT02292784|469240160|FG002|Overall Study|Withdrawal by Subject|3|||
130346553|NCT01264081|469240161|FG000|Participants Screened|Screening failures|30|||
130346554|NCT01264081|469240161|FG000|Started Treatment|Withdrawal by Subject|1|||
130346555|NCT01264081|469240161|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
130346556|NCT00134784|469240162|FG000|Overall Study|Withdrawal by Subject|2|||
130346557|NCT00134784|469240163|FG001|Overall Study|Withdrawal by Subject|2|||
130346558|NCT00134784|469240164|FG002|Overall Study|Withdrawal by Subject|2|||
130346559|NCT00134784|469240165|FG003|Overall Study|Withdrawal by Subject|1|||
130346560|NCT02716896|469240166|FG000|Overall Study|Physician Decision|0|||
130346561|NCT02716896|469240167|FG001|Overall Study|Physician Decision|1|||
130346562|NCT03565367|469240171|FG000|Overall Study|No scan due to technical issues|4|||
130346563|NCT03565367|469240172|FG001|Overall Study|No scan due to technical issues|0|||
130346564|NCT03699475|469240178|FG000|Overall Study|Death|1|||
130346565|NCT00137839|469240179|FG000|Overall Study|Adverse Event|7|||
130346566|NCT00137839|469240179|FG000|Overall Study|Physician Decision|7|||
130346567|NCT00137839|469240179|FG000|Overall Study|Death|8|||
130346568|NCT00137839|469240179|FG000|Overall Study|Disease Progression|60|||
130346569|NCT00137839|469240179|FG000|Overall Study|Not Start Treatment|1|||
130346570|NCT00137839|469240179|FG000|Overall Study|Prolonged Treatment Delay|1|||
130346571|NCT02882152|469240184|FG000|Overall Study|Lost to Follow-up|1|||
130346572|NCT02882152|469240185|FG001|Overall Study|Lost to Follow-up|0|||
130346573|NCT01752036|469240188|FG000|Overall Study|Death|2|||
130346574|NCT03468543|469240189|FG000|Overall Study|Protocol stopping rules met|3|||
130346575|NCT01437995|469240190|FG000|Overall Study|Lost to Follow-up|11|||
130346576|NCT01437995|469240191|FG001|Overall Study|Lost to Follow-up|18|||
130346577|NCT01437995|469240192|FG002|Overall Study|Lost to Follow-up|20|||
130346578|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
130346579|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Adverse Event|9|||
130346580|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Death|4|||
130346581|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
130346582|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
130346583|NCT00159822|469240193|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
130346584|NCT00159822|469240193|FG000|Post-treatment Follow-up Period|Death|1|||
130346585|NCT00159822|469240193|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
130346586|NCT00159822|469240193|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
130346587|NCT00275821|469240195|FG000|Overall Study|Adverse Event|4|||
130346588|NCT00275821|469240196|FG001|Overall Study|Adverse Event|12|||
130346589|NCT00275821|469240197|FG002|Overall Study|Adverse Event|5|||
130346590|NCT00275821|469240195|FG000|Overall Study|Administrative problems|3|||
130346591|NCT00275821|469240196|FG001|Overall Study|Administrative problems|4|||
130346592|NCT00275821|469240197|FG002|Overall Study|Administrative problems|4|||
130346593|NCT00275821|469240195|FG000|Overall Study|Withdrawal by Subject|0|||
130346594|NCT00275821|469240196|FG001|Overall Study|Withdrawal by Subject|2|||
130346595|NCT00275821|469240197|FG002|Overall Study|Withdrawal by Subject|1|||
130346596|NCT00275821|469240195|FG000|Overall Study|Lost to Follow-up|0|||
130346597|NCT00275821|469240196|FG001|Overall Study|Lost to Follow-up|1|||
130346598|NCT00275821|469240197|FG002|Overall Study|Lost to Follow-up|1|||
130346599|NCT00275821|469240195|FG000|Overall Study|Death|0|||
130346600|NCT00275821|469240196|FG001|Overall Study|Death|2|||
130346601|NCT00275821|469240197|FG002|Overall Study|Death|1|||
130346602|NCT00275821|469240195|FG000|Overall Study|Lack of Efficacy|2|||
130011109|NCT02819635|468003348|FG009|Substudy 3|Withdrew consent|1|||
130011110|NCT02819635|468003349|FG010|Substudy 3|Withdrew consent|4|||
130011111|NCT02819635|468003350|FG011|Substudy 3|Withdrew consent|9|||
130011112|NCT02819635|468003339|FG000|Substudy 3|Lost to Follow-up|0|||
130011113|NCT02819635|468003340|FG001|Substudy 3|Lost to Follow-up|0|||
130011114|NCT02819635|468003341|FG002|Substudy 3|Lost to Follow-up|0|||
130011115|NCT02819635|468003342|FG003|Substudy 3|Lost to Follow-up|0|||
130011116|NCT02819635|468003343|FG004|Substudy 3|Lost to Follow-up|0|||
130011117|NCT02819635|468003344|FG005|Substudy 3|Lost to Follow-up|0|||
130011118|NCT02819635|468003345|FG006|Substudy 3|Lost to Follow-up|0|||
130011119|NCT02819635|468003346|FG007|Substudy 3|Lost to Follow-up|0|||
130011120|NCT02819635|468003347|FG008|Substudy 3|Lost to Follow-up|1|||
130011121|NCT02819635|468003348|FG009|Substudy 3|Lost to Follow-up|0|||
130011122|NCT02819635|468003349|FG010|Substudy 3|Lost to Follow-up|1|||
130011123|NCT02819635|468003350|FG011|Substudy 3|Lost to Follow-up|1|||
130011124|NCT02819635|468003339|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011125|NCT02819635|468003340|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011126|NCT02819635|468003341|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011127|NCT02819635|468003342|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011128|NCT02819635|468003343|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011129|NCT02819635|468003344|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011130|NCT02819635|468003345|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011131|NCT02819635|468003346|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011132|NCT02819635|468003347|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011133|NCT02819635|468003348|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011134|NCT02819635|468003349|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
130011135|NCT02819635|468003350|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
130011136|NCT02819635|468003339|FG000|Substudy 3|Other, not specified|0|||
130011137|NCT02819635|468003340|FG001|Substudy 3|Other, not specified|0|||
130011138|NCT02819635|468003341|FG002|Substudy 3|Other, not specified|0|||
130011139|NCT02819635|468003342|FG003|Substudy 3|Other, not specified|0|||
130011140|NCT02819635|468003343|FG004|Substudy 3|Other, not specified|0|||
130011141|NCT02819635|468003344|FG005|Substudy 3|Other, not specified|0|||
130011142|NCT02819635|468003345|FG006|Substudy 3|Other, not specified|0|||
130011143|NCT02819635|468003346|FG007|Substudy 3|Other, not specified|0|||
130011144|NCT02819635|468003347|FG008|Substudy 3|Other, not specified|202|||
130011145|NCT02819635|468003348|FG009|Substudy 3|Other, not specified|5|||
130011146|NCT02819635|468003349|FG010|Substudy 3|Other, not specified|89|||
130011147|NCT02819635|468003350|FG011|Substudy 3|Other, not specified|39|||
130011148|NCT03179891|468003352|FG000|First Intervention|Withdrawal by Subject|1|||
130011149|NCT03179891|468003353|FG001|First Intervention|Withdrawal by Subject|1|||
130011150|NCT03179891|468003352|FG000|First Intervention|Unspecified reason|1|||
130011151|NCT03179891|468003353|FG001|First Intervention|Unspecified reason|0|||
130011152|NCT03179891|468003352|FG000|First Intervention|Protocol Violation|0|||
130011153|NCT03179891|468003353|FG001|First Intervention|Protocol Violation|1|||
130011154|NCT03134599|468003354|FG000|Week 1|Lost to Follow-up|0|||
130011155|NCT03134599|468003355|FG001|Week 1|Lost to Follow-up|0|||
130011156|NCT03134599|468003356|FG002|Week 1|Lost to Follow-up|0|||
130011157|NCT03134599|468003357|FG003|Week 1|Lost to Follow-up|0|||
130011158|NCT03134599|468003358|FG004|Week 1|Lost to Follow-up|1|||
130011159|NCT03134599|468003359|FG005|Week 1|Lost to Follow-up|0|||
130011160|NCT03134599|468003354|FG000|Week 2|Lost to Follow-up|1|||
130011161|NCT03134599|468003355|FG001|Week 2|Lost to Follow-up|0|||
130011162|NCT03134599|468003356|FG002|Week 2|Lost to Follow-up|0|||
130011163|NCT03134599|468003357|FG003|Week 2|Lost to Follow-up|1|||
130011164|NCT03134599|468003358|FG004|Week 2|Lost to Follow-up|1|||
130011165|NCT03134599|468003359|FG005|Week 2|Lost to Follow-up|0|||
130011166|NCT03134599|468003354|FG000|Week 3|Lost to Follow-up|0|||
130011167|NCT03134599|468003355|FG001|Week 3|Lost to Follow-up|0|||
130011168|NCT03134599|468003356|FG002|Week 3|Lost to Follow-up|0|||
130011169|NCT03134599|468003357|FG003|Week 3|Lost to Follow-up|1|||
130346603|NCT00275821|469240196|FG001|Overall Study|Lack of Efficacy|1|||
130346604|NCT00275821|469240197|FG002|Overall Study|Lack of Efficacy|0|||
129884412|NCT02771210|467536387|FG000|Period 2|Adverse Event|1|||
130011170|NCT03134599|468003358|FG004|Week 3|Lost to Follow-up|0|||
130011171|NCT03134599|468003359|FG005|Week 3|Lost to Follow-up|1|||
130011172|NCT04416555|468003360|FG000|Overall Study|Withdrawal by Subject|0|||
130011173|NCT04416555|468003361|FG001|Overall Study|Withdrawal by Subject|3|||
130011174|NCT02018822|468003366|FG000|Overall Study|filling replaced by crown|0|||
130011175|NCT02018822|468003367|FG001|Overall Study|filling replaced by crown|1|||
130011176|NCT02018822|468003368|FG002|Overall Study|filling replaced by crown|0|||
130011177|NCT02018822|468003366|FG000|Overall Study|Physician Decision|0|||
130011178|NCT02018822|468003367|FG001|Overall Study|Physician Decision|1|||
130011179|NCT02018822|468003368|FG002|Overall Study|Physician Decision|1|||
130011180|NCT02018822|468003366|FG000|Overall Study|Lost to Follow-up|6|||
130011181|NCT02018822|468003367|FG001|Overall Study|Lost to Follow-up|6|||
130011182|NCT02018822|468003368|FG002|Overall Study|Lost to Follow-up|5|||
130011183|NCT03201458|468003369|FG000|Overall Study|No longer eligible|2|||
130011184|NCT03201458|468003370|FG001|Overall Study|No longer eligible|5|||
130011185|NCT03201458|468003369|FG000|Overall Study|Health event before starting|1|||
130011186|NCT03201458|468003370|FG001|Overall Study|Health event before starting|0|||
130011187|NCT03201458|468003369|FG000|Overall Study|Physician Decision|1|||
130011188|NCT03201458|468003370|FG001|Overall Study|Physician Decision|0|||
130011189|NCT00715026|468003373|FG000|Overall Study|Withdrawal by Subject|5|||
130011190|NCT00715026|468003373|FG000|Overall Study|Lost to Follow-up|3|||
130011191|NCT00715026|468003373|FG000|Overall Study|Protocol Violation|1|||
130011192|NCT00715026|468003373|FG000|Overall Study|Surgery done on non-study consented hip|1|||
130011193|NCT00750737|468003374|FG000|Overall Study|Withdrawal by Subject|3|||
130011194|NCT00750737|468003375|FG001|Overall Study|Withdrawal by Subject|3|||
130011195|NCT01389752|468003379|FG000|Study Period 1|Sponsor decision|0|||
130011196|NCT01389752|468003380|FG001|Study Period 1|Sponsor decision|2|||
130011197|NCT01389752|468003379|FG000|Study Period 2|Sponsor decision|1|||
130011198|NCT01389752|468003380|FG001|Study Period 2|Sponsor decision|0|||
130011199|NCT03975920|468003386|FG000|Overall Study|Lost to Follow-up|1|||
130011200|NCT03975920|468003387|FG001|Overall Study|Lost to Follow-up|2|||
130011201|NCT03975920|468003386|FG000|Overall Study|Protocol Violation|1|||
130011202|NCT03975920|468003387|FG001|Overall Study|Protocol Violation|1|||
130011203|NCT03975920|468003386|FG000|Overall Study|Did not complete survey|2|||
130011204|NCT03975920|468003387|FG001|Overall Study|Did not complete survey|1|||
130011205|NCT04251910|468003388|FG000|Overall Study|Covid 19 lockdown|0|||
130011206|NCT04251910|468003389|FG001|Overall Study|Covid 19 lockdown|5|||
130011207|NCT04251910|468003390|FG002|Overall Study|Covid 19 lockdown|0|||
130011208|NCT04251910|468003391|FG003|Overall Study|Covid 19 lockdown|4|||
130011209|NCT04251910|468003392|FG004|Overall Study|Covid 19 lockdown|0|||
130011210|NCT04251910|468003393|FG005|Overall Study|Covid 19 lockdown|0|||
130011211|NCT04251910|468003388|FG000|Overall Study|Assisted living facility was closed|0|||
130011212|NCT04251910|468003389|FG001|Overall Study|Assisted living facility was closed|0|||
130011213|NCT04251910|468003390|FG002|Overall Study|Assisted living facility was closed|0|||
130011214|NCT04251910|468003391|FG003|Overall Study|Assisted living facility was closed|0|||
130011215|NCT04251910|468003392|FG004|Overall Study|Assisted living facility was closed|1|||
130011216|NCT04251910|468003393|FG005|Overall Study|Assisted living facility was closed|0|||
130011217|NCT00804570|468003396|FG000|Overall Study|Adverse Event|14|||
130011218|NCT00804570|468003397|FG001|Overall Study|Adverse Event|7|||
130011219|NCT00804570|468003396|FG000|Overall Study|Lack of Efficacy|0|||
130011220|NCT00804570|468003397|FG001|Overall Study|Lack of Efficacy|1|||
130011221|NCT00804570|468003396|FG000|Overall Study|Lost to Follow-up|18|||
130011222|NCT00804570|468003397|FG001|Overall Study|Lost to Follow-up|21|||
130011223|NCT00804570|468003396|FG000|Overall Study|Entry criteria not met|5|||
130011224|NCT00804570|468003397|FG001|Overall Study|Entry criteria not met|5|||
130011225|NCT00804570|468003396|FG000|Overall Study|Protocol Violation|12|||
130011226|NCT00804570|468003397|FG001|Overall Study|Protocol Violation|16|||
130011227|NCT00804570|468003396|FG000|Overall Study|Physician Decision|1|||
130011228|NCT00804570|468003397|FG001|Overall Study|Physician Decision|2|||
130011229|NCT00804570|468003396|FG000|Overall Study|Sponsor decision|1|||
130011230|NCT00804570|468003397|FG001|Overall Study|Sponsor decision|4|||
130011231|NCT00804570|468003396|FG000|Overall Study|Withdrawal by Subject|21|||
130011232|NCT00804570|468003397|FG001|Overall Study|Withdrawal by Subject|38|||
130011233|NCT00290342|468003398|FG000|Overall Study|Other|0|||
130011234|NCT00290342|468003399|FG001|Overall Study|Other|1|||
130011235|NCT00290342|468003398|FG000|Overall Study|Withdrawal by Subject|6|||
130011236|NCT00290342|468003399|FG001|Overall Study|Withdrawal by Subject|4|||
130011237|NCT00290342|468003398|FG000|Overall Study|Lost to Follow-up|1|||
130011238|NCT00290342|468003399|FG001|Overall Study|Lost to Follow-up|0|||
130011239|NCT01056510|468003402|FG000|Overall Study|Dropout Before Start of Treatment|1|||
130011240|NCT01056510|468003403|FG001|Overall Study|Dropout Before Start of Treatment|1|||
130011241|NCT01056510|468003402|FG000|Overall Study|Withdrawal by Subject|4|||
129884413|NCT02771210|467536388|FG001|Period 2|Adverse Event|0|||
130011242|NCT01056510|468003403|FG001|Overall Study|Withdrawal by Subject|2|||
130011243|NCT01056510|468003402|FG000|Overall Study|Death|29|||
130011244|NCT01056510|468003403|FG001|Overall Study|Death|34|||
130011245|NCT01056510|468003402|FG000|Overall Study|Noncompliance|1|||
130011246|NCT01056510|468003403|FG001|Overall Study|Noncompliance|3|||
130011247|NCT01056510|468003402|FG000|Overall Study|Physician Decision|4|||
130011248|NCT01056510|468003403|FG001|Overall Study|Physician Decision|5|||
130011249|NCT01056510|468003402|FG000|Overall Study|Lost to Follow-up|5|||
130011250|NCT01056510|468003403|FG001|Overall Study|Lost to Follow-up|6|||
130011251|NCT01056510|468003402|FG000|Overall Study|Other|10|||
130011252|NCT01056510|468003403|FG001|Overall Study|Other|12|||
130011253|NCT01056510|468003402|FG000|Overall Study|Missing|0|||
130011254|NCT01056510|468003403|FG001|Overall Study|Missing|1|||
130011255|NCT00243386|468003404|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
130011256|NCT00243386|468003405|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
130011257|NCT00243386|468003406|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
130011258|NCT00243386|468003404|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
130011259|NCT00243386|468003405|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
130011260|NCT00243386|468003406|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
130011261|NCT00243386|468003404|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
130011262|NCT00243386|468003405|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
130011263|NCT00243386|468003406|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
130011264|NCT00243386|468003404|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
130011265|NCT00243386|468003405|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
130011266|NCT00243386|468003406|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
130011267|NCT00243386|468003404|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
130011268|NCT00243386|468003405|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
130011269|NCT00243386|468003406|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
130011270|NCT00243386|468003404|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
130011271|NCT00243386|468003405|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
130011272|NCT00243386|468003406|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
130011273|NCT00243386|468003404|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
130011274|NCT00243386|468003405|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
130011275|NCT00243386|468003406|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
130011276|NCT00243386|468003404|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
130011277|NCT00243386|468003405|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
130011278|NCT00243386|468003406|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
130011279|NCT00133991|468003407|FG000|Overall Study|Death|4|||
130011280|NCT03002155|468003408|FG000|Overall Study|Lost to Follow-up|1|||
130011281|NCT03002155|468003409|FG001|Overall Study|Lost to Follow-up|2|||
130011282|NCT03002155|468003408|FG000|Overall Study|Withdrawal by Subject|1|||
130011283|NCT03002155|468003409|FG001|Overall Study|Withdrawal by Subject|0|||
130011284|NCT03002155|468003408|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
130011285|NCT03002155|468003409|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
130011286|NCT00978029|468003410|FG000|Overall Study|Adverse Event|1|||
130011287|NCT00978029|468003411|FG001|Overall Study|Adverse Event|2|||
130011288|NCT00978029|468003412|FG002|Overall Study|Adverse Event|5|||
130011289|NCT00978029|468003410|FG000|Overall Study|Withdrawal by Subject|0|||
130011290|NCT00978029|468003411|FG001|Overall Study|Withdrawal by Subject|0|||
130011291|NCT00978029|468003412|FG002|Overall Study|Withdrawal by Subject|1|||
130011292|NCT00978029|468003410|FG000|Overall Study|Protocol Violation|0|||
130011293|NCT00978029|468003411|FG001|Overall Study|Protocol Violation|1|||
130011294|NCT00978029|468003412|FG002|Overall Study|Protocol Violation|0|||
130011295|NCT00545298|468003413|FG000|Overall Study|Issues with Standard of Care|2|||
130011296|NCT00545298|468003414|FG001|Overall Study|Issues with Standard of Care|0|||
130011297|NCT00545298|468003415|FG002|Overall Study|Issues with Standard of Care|1|||
130011298|NCT01820364|468003419|FG000|Part I: LGX818|Death|1|||
130011299|NCT01820364|468003420|FG001|Part I: LGX818|Death|0|||
130011300|NCT01820364|468003419|FG000|Part I: LGX818|Administrative Problems|3|||
130011301|NCT01820364|468003420|FG001|Part I: LGX818|Administrative Problems|0|||
130011302|NCT01820364|468003419|FG000|Part I: LGX818|Adverse Event|6|||
130011303|NCT01820364|468003420|FG001|Part I: LGX818|Adverse Event|0|||
130011304|NCT01820364|468003419|FG000|Part I: LGX818|Disease Progression|4|||
130011305|NCT01820364|468003420|FG001|Part I: LGX818|Disease Progression|0|||
130011306|NCT01820364|468003419|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
130011307|NCT01820364|468003420|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
130011308|NCT01793142|468003423|FG000|Overall Study|Randomized not treated|7|||
130011309|NCT03451084|468003429|FG000|Overall Study|Withdrawal by Subject|2|||
130011310|NCT03451084|468003430|FG001|Overall Study|Withdrawal by Subject|1|||
130011311|NCT03451084|468003431|FG002|Overall Study|Withdrawal by Subject|2|||
130011312|NCT03451084|468003432|FG003|Overall Study|Withdrawal by Subject|1|||
130011313|NCT03451084|468003429|FG000|Overall Study|Disease recurrence|0|||
130011314|NCT03451084|468003430|FG001|Overall Study|Disease recurrence|2|||
130011315|NCT03451084|468003431|FG002|Overall Study|Disease recurrence|0|||
130011316|NCT03451084|468003432|FG003|Overall Study|Disease recurrence|0|||
130011317|NCT03451084|468003429|FG000|Overall Study|Lack of Efficacy|0|||
130011318|NCT03451084|468003430|FG001|Overall Study|Lack of Efficacy|3|||
130011319|NCT03451084|468003431|FG002|Overall Study|Lack of Efficacy|0|||
130011320|NCT03451084|468003432|FG003|Overall Study|Lack of Efficacy|1|||
130011321|NCT03451084|468003429|FG000|Overall Study|Death|1|||
130011322|NCT03451084|468003430|FG001|Overall Study|Death|0|||
130011323|NCT03451084|468003431|FG002|Overall Study|Death|2|||
130011324|NCT03451084|468003432|FG003|Overall Study|Death|0|||
130011325|NCT03451084|468003429|FG000|Overall Study|Physician Decision|0|||
130011326|NCT03451084|468003430|FG001|Overall Study|Physician Decision|0|||
130011327|NCT03451084|468003431|FG002|Overall Study|Physician Decision|2|||
130011328|NCT03451084|468003432|FG003|Overall Study|Physician Decision|2|||
130011329|NCT03451084|468003429|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
130011330|NCT03451084|468003430|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
130011331|NCT03451084|468003431|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
130011332|NCT03451084|468003432|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
130011333|NCT03418129|468003433|FG000|Overall Study|Lost to Follow-up|11|||
130011334|NCT03418129|468003434|FG001|Overall Study|Lost to Follow-up|20|||
130011335|NCT03418129|468003435|FG002|Overall Study|Lost to Follow-up|15|||
130011336|NCT03418129|468003433|FG000|Overall Study|Withdrawal by Subject|3|||
130011337|NCT03418129|468003434|FG001|Overall Study|Withdrawal by Subject|6|||
130011338|NCT03418129|468003435|FG002|Overall Study|Withdrawal by Subject|4|||
130011339|NCT01617070|468003438|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
130011340|NCT05376215|468003439|FG000|Overall Study|Withdrawal by Subject|2|||
130011341|NCT05376215|468003440|FG001|Overall Study|Withdrawal by Subject|1|||
130346605|NCT00275821|469240195|FG000|Overall Study|Protocol Violation|5|||
130346606|NCT00275821|469240196|FG001|Overall Study|Protocol Violation|1|||
130346607|NCT00275821|469240197|FG002|Overall Study|Protocol Violation|0|||
130346608|NCT00329901|469240198|FG000|Overall Study|Withdrawal by Subject|4|||
130346609|NCT00329901|469240199|FG001|Overall Study|Withdrawal by Subject|3|||
130346610|NCT00329901|469240200|FG002|Overall Study|Withdrawal by Subject|2|||
130346611|NCT00329901|469240198|FG000|Overall Study|Lost to Follow-up|2|||
130346612|NCT00329901|469240199|FG001|Overall Study|Lost to Follow-up|0|||
130346613|NCT00329901|469240200|FG002|Overall Study|Lost to Follow-up|1|||
130346614|NCT00329901|469240198|FG000|Overall Study|Protocol Violation|1|||
130346615|NCT00329901|469240199|FG001|Overall Study|Protocol Violation|0|||
130346616|NCT00329901|469240200|FG002|Overall Study|Protocol Violation|1|||
130346617|NCT00329901|469240198|FG000|Overall Study|Unable to classify|2|||
130346618|NCT00329901|469240199|FG001|Overall Study|Unable to classify|2|||
130346619|NCT00329901|469240200|FG002|Overall Study|Unable to classify|0|||
130346620|NCT02296138|469240201|FG000|Overall Study|Adverse Event|348|||
130346621|NCT02296138|469240202|FG001|Overall Study|Adverse Event|259|||
130346622|NCT02296138|469240201|FG000|Overall Study|Lack of Efficacy|59|||
130346623|NCT02296138|469240202|FG001|Overall Study|Lack of Efficacy|37|||
130346624|NCT02296138|469240201|FG000|Overall Study|Protocol Violation|35|||
130346625|NCT02296138|469240202|FG001|Overall Study|Protocol Violation|36|||
130346626|NCT02296138|469240201|FG000|Overall Study|Lost to Follow-up|9|||
130346627|NCT02296138|469240202|FG001|Overall Study|Lost to Follow-up|12|||
130346628|NCT02296138|469240201|FG000|Overall Study|Withdrawal by Subject|184|||
130346629|NCT02296138|469240202|FG001|Overall Study|Withdrawal by Subject|131|||
130346630|NCT02296138|469240201|FG000|Overall Study|Not Treated|1|||
130346631|NCT02296138|469240202|FG001|Overall Study|Not Treated|1|||
130346632|NCT02296138|469240201|FG000|Overall Study|Patients with data irregularities|10|||
130346633|NCT02296138|469240202|FG001|Overall Study|Patients with data irregularities|11|||
130346634|NCT02296138|469240201|FG000|Overall Study|Other than specified|15|||
130346635|NCT02296138|469240202|FG001|Overall Study|Other than specified|13|||
130346636|NCT01209832|469240209|FG000|Period 1|Sponsor Decision and was not dosed|1|||
130346637|NCT01209832|469240209|FG000|Period 2|Sponsor Decision|1|||
130346638|NCT01268579|469240210|FG000|Overall Study|Adverse Event|1|||
130346639|NCT01268579|469240210|FG000|Overall Study|Withdrawal by Subject|2|||
130346640|NCT00761150|469240211|FG000|Open-label Period|Adverse Event|36|||
130346641|NCT00761150|469240212|FG001|Open-label Period|Adverse Event|0|||
130346642|NCT00761150|469240213|FG002|Open-label Period|Adverse Event|0|||
130346643|NCT00761150|469240211|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
130346644|NCT00761150|469240212|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
130346645|NCT00761150|469240213|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
130346646|NCT00761150|469240211|FG000|Open-label Period|Lost to Follow-up|7|||
130346647|NCT00761150|469240212|FG001|Open-label Period|Lost to Follow-up|0|||
130346648|NCT00761150|469240213|FG002|Open-label Period|Lost to Follow-up|0|||
130346649|NCT00761150|469240211|FG000|Open-label Period|Lack of Efficacy|4|||
130346650|NCT00761150|469240212|FG001|Open-label Period|Lack of Efficacy|0|||
130346651|NCT00761150|469240213|FG002|Open-label Period|Lack of Efficacy|0|||
130346652|NCT00761150|469240211|FG000|Open-label Period|Withdrawal by Subject|5|||
130346653|NCT00761150|469240212|FG001|Open-label Period|Withdrawal by Subject|0|||
130346654|NCT00761150|469240213|FG002|Open-label Period|Withdrawal by Subject|0|||
130346655|NCT00761150|469240211|FG000|Open-label Period|Noncompliance|2|||
130346656|NCT00761150|469240212|FG001|Open-label Period|Noncompliance|0|||
130346657|NCT00761150|469240213|FG002|Open-label Period|Noncompliance|0|||
130346658|NCT00761150|469240211|FG000|Open-label Period|Other|5|||
130346659|NCT00761150|469240212|FG001|Open-label Period|Other|0|||
130346660|NCT00761150|469240213|FG002|Open-label Period|Other|0|||
130346661|NCT00761150|469240211|FG000|Double-blind Period|Lack of Efficacy|0|||
130346662|NCT00761150|469240212|FG001|Double-blind Period|Lack of Efficacy|2|||
130346663|NCT00761150|469240213|FG002|Double-blind Period|Lack of Efficacy|19|||
130346664|NCT00761150|469240211|FG000|Double-blind Period|Adverse Event|0|||
130346665|NCT00761150|469240212|FG001|Double-blind Period|Adverse Event|3|||
130346666|NCT00761150|469240213|FG002|Double-blind Period|Adverse Event|3|||
130346667|NCT00761150|469240211|FG000|Double-blind Period|Withdrawal by Subject|0|||
130346668|NCT00761150|469240212|FG001|Double-blind Period|Withdrawal by Subject|3|||
130346669|NCT00761150|469240213|FG002|Double-blind Period|Withdrawal by Subject|2|||
130346670|NCT00761150|469240211|FG000|Double-blind Period|Lost to Follow-up|0|||
130346671|NCT00761150|469240212|FG001|Double-blind Period|Lost to Follow-up|2|||
130346672|NCT00761150|469240213|FG002|Double-blind Period|Lost to Follow-up|1|||
130346673|NCT00761150|469240211|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
130346674|NCT00761150|469240212|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
130346675|NCT00761150|469240213|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
130346676|NCT00761150|469240211|FG000|Double-blind Period|Noncompliance|0|||
130346677|NCT00761150|469240212|FG001|Double-blind Period|Noncompliance|1|||
130346678|NCT00761150|469240213|FG002|Double-blind Period|Noncompliance|0|||
130346679|NCT00761150|469240211|FG000|Double-blind Period|Other|0|||
130346680|NCT00761150|469240212|FG001|Double-blind Period|Other|3|||
130346681|NCT00761150|469240213|FG002|Double-blind Period|Other|3|||
130346682|NCT02692651|469240214|FG000|Study Treatment|Death|7|||
130346683|NCT02692651|469240215|FG001|Study Treatment|Death|3|||
130346684|NCT02692651|469240214|FG000|Study Treatment|comfort care|1|||
130346685|NCT02692651|469240215|FG001|Study Treatment|comfort care|1|||
130346686|NCT02692651|469240214|FG000|Study Treatment|Protocol violation per treating team preference|8|||
130346687|NCT02692651|469240215|FG001|Study Treatment|Protocol violation per treating team preference|6|||
130346688|NCT02692651|469240214|FG000|Post Study Treatment Follow-up|Death|4|||
130346689|NCT02692651|469240215|FG001|Post Study Treatment Follow-up|Death|4|||
130346690|NCT02480712|469240216|FG000|Overall Study|Enrolled but Never Treated|1|||
130346691|NCT02480712|469240216|FG000|Overall Study|Lost to Follow-up|5|||
130346692|NCT02480712|469240216|FG000|Overall Study|Withdrew Consent|3|||
130346693|NCT02480712|469240216|FG000|Overall Study|Death|1|||
130346694|NCT02480712|469240216|FG000|Overall Study|Lack of Efficacy|1|||
130346695|NCT00475423|469240217|FG000|Overall Study|Protocol Violation|5|||
130346696|NCT00475423|469240217|FG000|Overall Study|Adverse Event|4|||
130346697|NCT00475423|469240217|FG000|Overall Study|Withdrawal by Subject|6|||
130346698|NCT00475423|469240217|FG000|Overall Study|Lack of Efficacy|8|||
130346699|NCT00475423|469240217|FG000|Overall Study|Death|1|||
130346700|NCT00475423|469240217|FG000|Overall Study|Reason not specified|1|||
130346701|NCT00475423|469240217|FG000|Overall Study|Lost to Follow-up|7|||
130346702|NCT01860846|469240218|FG000|Overall Study|Lost to Follow-up|33|||
130346703|NCT05463198|469240219|FG000|Overall Study|Withdrawal by Subject|19|||
130346704|NCT05463198|469240219|FG000|Overall Study|Procedure Notes Missing|18|||
130346705|NCT02239120|469240222|FG000|Overall Study|Death|56|||
130346706|NCT02239120|469240223|FG001|Overall Study|Death|58|||
130346707|NCT02239120|469240222|FG000|Overall Study|Lost to Follow-up|19|||
130346708|NCT02239120|469240223|FG001|Overall Study|Lost to Follow-up|14|||
130346709|NCT00466687|469240224|FG000|Overall Study|Adverse Event|1|||
130346710|NCT00466687|469240224|FG000|Overall Study|Other complicating illness|3|||
130346711|NCT00466687|469240224|FG000|Overall Study|Withdrawal by Subject|1|||
130346712|NCT00466687|469240224|FG000|Overall Study|Disease progression|29|||
130346713|NCT01925989|469240225|FG000|Period 1|Sponsor Decision|1|||
130346714|NCT01925989|469240226|FG001|Period 1|Sponsor Decision|1|||
130346715|NCT01925989|469240227|FG002|Period 1|Sponsor Decision|0|||
130346716|NCT01925989|469240225|FG000|Period 1|Withdrawal by Subject|0|||
130346717|NCT01925989|469240226|FG001|Period 1|Withdrawal by Subject|1|||
130346718|NCT01925989|469240227|FG002|Period 1|Withdrawal by Subject|0|||
130346719|NCT00868517|469240232|FG000|Overall Study|Withdrawal by Subject|3|||
130346720|NCT00868517|469240233|FG001|Overall Study|Withdrawal by Subject|3|||
130346721|NCT00868517|469240234|FG002|Overall Study|Withdrawal by Subject|2|||
130346722|NCT00868517|469240232|FG000|Overall Study|Protocol Violation|1|||
130346723|NCT00868517|469240233|FG001|Overall Study|Protocol Violation|1|||
130346724|NCT00868517|469240234|FG002|Overall Study|Protocol Violation|0|||
130346725|NCT00420641|469240236|FG000|Overall Study|Adverse Event|3|||
130346726|NCT00420641|469240237|FG001|Overall Study|Adverse Event|25|||
130346727|NCT00420641|469240238|FG002|Overall Study|Adverse Event|10|||
130346728|NCT00420641|469240236|FG000|Overall Study|Lost to Follow-up|2|||
130346729|NCT00420641|469240237|FG001|Overall Study|Lost to Follow-up|4|||
130346730|NCT00420641|469240238|FG002|Overall Study|Lost to Follow-up|2|||
130346731|NCT00420641|469240236|FG000|Overall Study|Protocol Violation|8|||
130346732|NCT00420641|469240237|FG001|Overall Study|Protocol Violation|8|||
130346733|NCT00420641|469240238|FG002|Overall Study|Protocol Violation|7|||
130346734|NCT00420641|469240236|FG000|Overall Study|Withdrawal by Subject|15|||
130346735|NCT00420641|469240237|FG001|Overall Study|Withdrawal by Subject|21|||
130346736|NCT00420641|469240238|FG002|Overall Study|Withdrawal by Subject|14|||
130346737|NCT00420641|469240236|FG000|Overall Study|Lack of Efficacy|6|||
130346738|NCT00420641|469240237|FG001|Overall Study|Lack of Efficacy|5|||
130346739|NCT00420641|469240238|FG002|Overall Study|Lack of Efficacy|4|||
130011342|NCT05376215|468003439|FG000|Overall Study|Lost to Follow-up|0|||
130011343|NCT05376215|468003440|FG001|Overall Study|Lost to Follow-up|1|||
130011344|NCT01147744|468003454|FG000|Overall Study|Protocol Violation|1|||
130011345|NCT01147744|468003455|FG001|Overall Study|Protocol Violation|0|||
130011346|NCT01147744|468003456|FG002|Overall Study|Protocol Violation|1|||
130011347|NCT01147744|468003457|FG003|Overall Study|Protocol Violation|0|||
130011348|NCT01147744|468003458|FG004|Overall Study|Protocol Violation|1|||
130011349|NCT01147744|468003459|FG005|Overall Study|Protocol Violation|3|||
130011350|NCT01147744|468003460|FG006|Overall Study|Protocol Violation|1|||
130011351|NCT01147744|468003454|FG000|Overall Study|Physician Decision|0|||
130011352|NCT01147744|468003455|FG001|Overall Study|Physician Decision|1|||
130011353|NCT01147744|468003456|FG002|Overall Study|Physician Decision|1|||
130011354|NCT01147744|468003457|FG003|Overall Study|Physician Decision|0|||
130011355|NCT01147744|468003458|FG004|Overall Study|Physician Decision|0|||
130011356|NCT01147744|468003459|FG005|Overall Study|Physician Decision|0|||
130346740|NCT00420641|469240236|FG000|Overall Study|Non-compliance|7|||
130346741|NCT00420641|469240237|FG001|Overall Study|Non-compliance|5|||
130346742|NCT00420641|469240238|FG002|Overall Study|Non-compliance|4|||
130346743|NCT00420641|469240236|FG000|Overall Study|Other|4|||
130346744|NCT00420641|469240237|FG001|Overall Study|Other|4|||
130346745|NCT00420641|469240238|FG002|Overall Study|Other|3|||
130346746|NCT03459690|469240239|FG000|Overall Study|Lost to Follow-up|0|||
130346747|NCT03459690|469240240|FG001|Overall Study|Lost to Follow-up|1|||
130346748|NCT03459690|469240239|FG000|Overall Study|Withdrawal by Subject|1|||
130346749|NCT03459690|469240240|FG001|Overall Study|Withdrawal by Subject|1|||
130346750|NCT02815280|469240241|FG000|Double-Blind Phase|Adverse Event|1|||
130346751|NCT02815280|469240242|FG001|Double-Blind Phase|Adverse Event|1|||
130346752|NCT02815280|469240241|FG000|Double-Blind Phase|Lost to Follow-up|10|||
130346753|NCT02815280|469240242|FG001|Double-Blind Phase|Lost to Follow-up|9|||
130346754|NCT02815280|469240241|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
130346755|NCT02815280|469240242|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
130346756|NCT02815280|469240241|FG000|Double-Blind Phase|Protocol Violation|2|||
130346757|NCT02815280|469240242|FG001|Double-Blind Phase|Protocol Violation|2|||
130346758|NCT02815280|469240241|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
130346759|NCT02815280|469240242|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
130346760|NCT02815280|469240241|FG000|Open-Label Phase|Adverse Event|2|||
130346761|NCT02815280|469240242|FG001|Open-Label Phase|Adverse Event|3|||
130346762|NCT02815280|469240241|FG000|Open-Label Phase|Lost to Follow-up|18|||
130346763|NCT02815280|469240242|FG001|Open-Label Phase|Lost to Follow-up|9|||
130346764|NCT02815280|469240241|FG000|Open-Label Phase|Withdrawal by Subject|33|||
130346765|NCT02815280|469240242|FG001|Open-Label Phase|Withdrawal by Subject|18|||
130346766|NCT02815280|469240241|FG000|Open-Label Phase|Protocol Violation|3|||
130346767|NCT02815280|469240242|FG001|Open-Label Phase|Protocol Violation|0|||
130346768|NCT02815280|469240241|FG000|Open-Label Phase|Administrative|26|||
130346769|NCT02815280|469240242|FG001|Open-Label Phase|Administrative|12|||
130346770|NCT02815280|469240241|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
130346771|NCT02815280|469240242|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
130346772|NCT02514473|469240257|FG000|Overall Study|Adverse Event|0|||
130346773|NCT02514473|469240258|FG001|Overall Study|Adverse Event|2|||
130346774|NCT02514473|469240257|FG000|Overall Study|Withdrawal by Subject|2|||
130346775|NCT02514473|469240258|FG001|Overall Study|Withdrawal by Subject|1|||
130346776|NCT02514473|469240257|FG000|Overall Study|Lost to Follow-up|0|||
130346777|NCT02514473|469240258|FG001|Overall Study|Lost to Follow-up|1|||
130346778|NCT02514473|469240257|FG000|Overall Study|Other|1|||
130346779|NCT02514473|469240258|FG001|Overall Study|Other|1|||
130346780|NCT02158364|469240259|FG000|Overall Study|Case report forms uncollected|10|||
130346781|NCT02158364|469240259|FG000|Overall Study|Protocol Deviation|50|||
130346782|NCT01944839|469240260|FG000|Overall Study|Physician Decision|2|||
130346783|NCT01944839|469240261|FG001|Overall Study|Physician Decision|2|||
130346784|NCT01944839|469240260|FG000|Overall Study|Protocol Violation|0|||
130346785|NCT01944839|469240261|FG001|Overall Study|Protocol Violation|1|||
130346786|NCT01944839|469240260|FG000|Overall Study|Adverse Event|10|||
130011357|NCT01147744|468003460|FG006|Overall Study|Physician Decision|1|||
130011358|NCT01147744|468003454|FG000|Overall Study|Lack of Efficacy|11|||
130011359|NCT01147744|468003455|FG001|Overall Study|Lack of Efficacy|11|||
130346787|NCT01944839|469240261|FG001|Overall Study|Adverse Event|5|||
130346788|NCT01944839|469240260|FG000|Overall Study|Withdrawal by Subject|9|||
130346789|NCT01944839|469240261|FG001|Overall Study|Withdrawal by Subject|17|||
130346790|NCT01944839|469240260|FG000|Overall Study|Lost to Follow-up|1|||
130346791|NCT01944839|469240261|FG001|Overall Study|Lost to Follow-up|0|||
130346792|NCT01944839|469240260|FG000|Overall Study|Subject non-compliance|0|||
130346793|NCT01944839|469240261|FG001|Overall Study|Subject non-compliance|3|||
130011360|NCT01147744|468003456|FG002|Overall Study|Lack of Efficacy|9|||
130346794|NCT02217527|469240262|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
130346795|NCT02217527|469240263|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
130346796|NCT02217527|469240262|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
130011361|NCT01147744|468003457|FG003|Overall Study|Lack of Efficacy|11|||
130011362|NCT01147744|468003458|FG004|Overall Study|Lack of Efficacy|13|||
130011363|NCT01147744|468003459|FG005|Overall Study|Lack of Efficacy|8|||
130011364|NCT01147744|468003460|FG006|Overall Study|Lack of Efficacy|7|||
130011365|NCT01147744|468003454|FG000|Overall Study|Adverse Event|1|||
130011366|NCT01147744|468003455|FG001|Overall Study|Adverse Event|2|||
130011367|NCT01147744|468003456|FG002|Overall Study|Adverse Event|3|||
130011368|NCT01147744|468003457|FG003|Overall Study|Adverse Event|0|||
130011369|NCT01147744|468003458|FG004|Overall Study|Adverse Event|2|||
130011370|NCT01147744|468003459|FG005|Overall Study|Adverse Event|1|||
130011371|NCT01147744|468003460|FG006|Overall Study|Adverse Event|2|||
130011372|NCT01147744|468003454|FG000|Overall Study|Withdrawal by Subject|8|||
130011373|NCT01147744|468003455|FG001|Overall Study|Withdrawal by Subject|4|||
130011374|NCT01147744|468003456|FG002|Overall Study|Withdrawal by Subject|2|||
130011375|NCT01147744|468003457|FG003|Overall Study|Withdrawal by Subject|2|||
130011376|NCT01147744|468003458|FG004|Overall Study|Withdrawal by Subject|2|||
130011377|NCT01147744|468003459|FG005|Overall Study|Withdrawal by Subject|5|||
130011378|NCT01147744|468003460|FG006|Overall Study|Withdrawal by Subject|2|||
130011379|NCT01147744|468003454|FG000|Overall Study|Lost to Follow-up|0|||
130011380|NCT01147744|468003455|FG001|Overall Study|Lost to Follow-up|1|||
130011381|NCT01147744|468003456|FG002|Overall Study|Lost to Follow-up|0|||
130011382|NCT01147744|468003457|FG003|Overall Study|Lost to Follow-up|0|||
130011383|NCT01147744|468003458|FG004|Overall Study|Lost to Follow-up|0|||
130011384|NCT01147744|468003459|FG005|Overall Study|Lost to Follow-up|0|||
130011385|NCT01147744|468003460|FG006|Overall Study|Lost to Follow-up|0|||
130011386|NCT01147744|468003454|FG000|Overall Study|Sponsor decision to amend protocol|7|||
130011387|NCT01147744|468003455|FG001|Overall Study|Sponsor decision to amend protocol|4|||
130011388|NCT01147744|468003456|FG002|Overall Study|Sponsor decision to amend protocol|2|||
130011389|NCT01147744|468003457|FG003|Overall Study|Sponsor decision to amend protocol|5|||
130011390|NCT01147744|468003458|FG004|Overall Study|Sponsor decision to amend protocol|7|||
130011391|NCT01147744|468003459|FG005|Overall Study|Sponsor decision to amend protocol|2|||
130011392|NCT01147744|468003460|FG006|Overall Study|Sponsor decision to amend protocol|6|||
130011393|NCT01147744|468003454|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130011394|NCT01147744|468003455|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130011395|NCT01147744|468003456|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130011396|NCT01147744|468003457|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130011397|NCT01147744|468003458|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130011398|NCT01147744|468003459|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130011399|NCT01147744|468003460|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130011400|NCT01342484|468003461|FG000|Overall Study|Other Reasons|1|||
130011401|NCT01342484|468003462|FG001|Overall Study|Other Reasons|0|||
130011402|NCT01342484|468003463|FG002|Overall Study|Other Reasons|0|||
130011403|NCT01342484|468003461|FG000|Overall Study|Protocol Violation|0|||
130011404|NCT01342484|468003462|FG001|Overall Study|Protocol Violation|0|||
130011405|NCT01342484|468003463|FG002|Overall Study|Protocol Violation|1|||
130011406|NCT01342484|468003461|FG000|Overall Study|Withdrawal by Subject|1|||
130011407|NCT01342484|468003462|FG001|Overall Study|Withdrawal by Subject|0|||
130011408|NCT01342484|468003463|FG002|Overall Study|Withdrawal by Subject|0|||
130011409|NCT01840579|468003464|FG000|Overall Study|Status not recorded|0|||
130011410|NCT01840579|468003465|FG001|Overall Study|Status not recorded|0|||
130011411|NCT01840579|468003466|FG002|Overall Study|Status not recorded|2|||
130011412|NCT01840579|468003467|FG003|Overall Study|Status not recorded|3|||
130011413|NCT01840579|468003468|FG004|Overall Study|Status not recorded|4|||
130011414|NCT01840579|468003469|FG005|Overall Study|Status not recorded|3|||
130011415|NCT01840579|468003470|FG006|Overall Study|Status not recorded|0|||
130011416|NCT01840579|468003471|FG007|Overall Study|Status not recorded|3|||
130011417|NCT01840579|468003472|FG008|Overall Study|Status not recorded|3|||
130346797|NCT02217527|469240263|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
130346798|NCT01878149|469240264|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
130346799|NCT01878149|469240265|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
130346800|NCT00502203|469240273|FG000|Overall Study|Inevaluable|1|||
130346801|NCT02241889|469240276|FG000|Overall Study|device issues|0|||
130346802|NCT02241889|469240277|FG001|Overall Study|device issues|0|||
130011418|NCT01840579|468003473|FG009|Overall Study|Status not recorded|3|||
130011419|NCT01840579|468003464|FG000|Overall Study|Progressive disease|3|||
130011420|NCT01840579|468003465|FG001|Overall Study|Progressive disease|5|||
130011421|NCT01840579|468003466|FG002|Overall Study|Progressive disease|0|||
130011422|NCT01840579|468003467|FG003|Overall Study|Progressive disease|0|||
130011423|NCT01840579|468003468|FG004|Overall Study|Progressive disease|0|||
130011424|NCT01840579|468003469|FG005|Overall Study|Progressive disease|0|||
130011425|NCT01840579|468003470|FG006|Overall Study|Progressive disease|0|||
130011426|NCT01840579|468003471|FG007|Overall Study|Progressive disease|0|||
130011427|NCT01840579|468003472|FG008|Overall Study|Progressive disease|0|||
130011428|NCT01840579|468003473|FG009|Overall Study|Progressive disease|0|||
130011429|NCT01840579|468003464|FG000|Overall Study|Ongoing in study|0|||
130011430|NCT01840579|468003465|FG001|Overall Study|Ongoing in study|1|||
130011431|NCT01840579|468003466|FG002|Overall Study|Ongoing in study|0|||
130011432|NCT01840579|468003467|FG003|Overall Study|Ongoing in study|0|||
130011433|NCT01840579|468003468|FG004|Overall Study|Ongoing in study|0|||
130011434|NCT01840579|468003469|FG005|Overall Study|Ongoing in study|0|||
130011435|NCT01840579|468003470|FG006|Overall Study|Ongoing in study|0|||
130011436|NCT01840579|468003471|FG007|Overall Study|Ongoing in study|0|||
130011437|NCT01840579|468003472|FG008|Overall Study|Ongoing in study|0|||
130011438|NCT01840579|468003473|FG009|Overall Study|Ongoing in study|0|||
130011439|NCT01840579|468003464|FG000|Overall Study|Death|0|||
130011440|NCT01840579|468003465|FG001|Overall Study|Death|0|||
130011441|NCT01840579|468003466|FG002|Overall Study|Death|0|||
130011442|NCT01840579|468003467|FG003|Overall Study|Death|0|||
130011443|NCT01840579|468003468|FG004|Overall Study|Death|0|||
130011444|NCT01840579|468003469|FG005|Overall Study|Death|1|||
130011445|NCT01840579|468003470|FG006|Overall Study|Death|0|||
130011446|NCT01840579|468003471|FG007|Overall Study|Death|0|||
130011447|NCT01840579|468003472|FG008|Overall Study|Death|0|||
130011448|NCT01840579|468003473|FG009|Overall Study|Death|0|||
130011449|NCT01840579|468003464|FG000|Overall Study|Adverse Event|0|||
130011450|NCT01840579|468003465|FG001|Overall Study|Adverse Event|1|||
130011451|NCT01840579|468003466|FG002|Overall Study|Adverse Event|0|||
130011452|NCT01840579|468003467|FG003|Overall Study|Adverse Event|0|||
130011453|NCT01840579|468003468|FG004|Overall Study|Adverse Event|0|||
130011454|NCT01840579|468003469|FG005|Overall Study|Adverse Event|0|||
130011455|NCT01840579|468003470|FG006|Overall Study|Adverse Event|0|||
130011456|NCT01840579|468003471|FG007|Overall Study|Adverse Event|0|||
130011457|NCT01840579|468003472|FG008|Overall Study|Adverse Event|0|||
130011458|NCT01840579|468003473|FG009|Overall Study|Adverse Event|0|||
130011459|NCT01840579|468003464|FG000|Overall Study|Follow-up ended by Sponsor|0|||
130011460|NCT01840579|468003465|FG001|Overall Study|Follow-up ended by Sponsor|0|||
130011461|NCT01840579|468003466|FG002|Overall Study|Follow-up ended by Sponsor|0|||
130011462|NCT01840579|468003467|FG003|Overall Study|Follow-up ended by Sponsor|0|||
130011463|NCT01840579|468003468|FG004|Overall Study|Follow-up ended by Sponsor|0|||
130011464|NCT01840579|468003469|FG005|Overall Study|Follow-up ended by Sponsor|0|||
130346803|NCT02241889|469240278|FG002|Overall Study|device issues|1|||
130346804|NCT02241889|469240279|FG003|Overall Study|device issues|0|||
130346805|NCT02241889|469240280|FG004|Overall Study|device issues|0|||
130346806|NCT02241889|469240281|FG005|Overall Study|device issues|0|||
130346807|NCT02241889|469240276|FG000|Overall Study|Withdrawal by Subject|0|||
130346808|NCT02241889|469240277|FG001|Overall Study|Withdrawal by Subject|0|||
130346809|NCT02241889|469240278|FG002|Overall Study|Withdrawal by Subject|0|||
130346810|NCT02241889|469240279|FG003|Overall Study|Withdrawal by Subject|0|||
130346811|NCT02241889|469240280|FG004|Overall Study|Withdrawal by Subject|0|||
130346812|NCT02241889|469240281|FG005|Overall Study|Withdrawal by Subject|1|||
130346813|NCT03836001|469240282|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
130346814|NCT03836001|469240283|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
130346815|NCT03836001|469240284|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
130346816|NCT03836001|469240282|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
130346817|NCT03836001|469240283|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
130346818|NCT03836001|469240284|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
130346819|NCT03836001|469240282|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
130346820|NCT03836001|469240283|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
130346821|NCT03836001|469240284|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
130346822|NCT03836001|469240282|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
130346823|NCT03836001|469240283|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
130346824|NCT03836001|469240284|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
130346825|NCT03353740|469240296|FG000|Overall Study|Images for these participants not viable|52|||
130346826|NCT01395784|469240297|FG000|Overall Study|Lost to Follow-up|7|||
130346827|NCT01395784|469240297|FG000|Overall Study|Withdrawal by Subject|3|||
130011465|NCT01840579|468003470|FG006|Overall Study|Follow-up ended by Sponsor|2|||
130346828|NCT01395784|469240297|FG000|Overall Study|Physician Decision|5|||
130346829|NCT04268823|469240298|FG000|Overall Study|Adverse Event|1|||
130346830|NCT04268823|469240299|FG001|Overall Study|Adverse Event|0|||
130346831|NCT04268823|469240298|FG000|Overall Study|Participant Decision|1|||
130346832|NCT04268823|469240299|FG001|Overall Study|Participant Decision|0|||
130346833|NCT02519855|469241793|FG000|Overall Study|Adverse Event|0|||
130346834|NCT02519855|469241794|FG001|Overall Study|Adverse Event|1|||
130011466|NCT01840579|468003471|FG007|Overall Study|Follow-up ended by Sponsor|0|||
130011467|NCT01840579|468003472|FG008|Overall Study|Follow-up ended by Sponsor|0|||
130011468|NCT01840579|468003473|FG009|Overall Study|Follow-up ended by Sponsor|0|||
130011469|NCT05419128|468003475|FG000|Overall Study|Withdrawal by Subject|1|||
130011470|NCT05419128|468003476|FG001|Overall Study|Withdrawal by Subject|1|||
130346835|NCT02519855|469241793|FG000|Overall Study|Lost to Follow-up|3|||
130346836|NCT02519855|469241794|FG001|Overall Study|Lost to Follow-up|3|||
130346837|NCT00003830|469241808|FG000|Overall Study|No follow up data|3|||
130346838|NCT00003830|469241809|FG001|Overall Study|No follow up data|0|||
130346839|NCT00003830|469241808|FG000|Overall Study|Sentinel node positive patients|829|||
130346840|NCT00003830|469241809|FG001|Overall Study|Sentinel node positive patients|793|||
130011471|NCT05419128|468003477|FG002|Overall Study|Withdrawal by Subject|0|||
130011472|NCT05419128|468003478|FG003|Overall Study|Withdrawal by Subject|1|||
130011473|NCT05419128|468003479|FG004|Overall Study|Withdrawal by Subject|1|||
130011474|NCT05419128|468003480|FG005|Overall Study|Withdrawal by Subject|0|||
130011475|NCT05419128|468003475|FG000|Overall Study|Lost to Follow-up|0|||
130011476|NCT05419128|468003476|FG001|Overall Study|Lost to Follow-up|0|||
130011477|NCT05419128|468003477|FG002|Overall Study|Lost to Follow-up|1|||
130011478|NCT05419128|468003478|FG003|Overall Study|Lost to Follow-up|0|||
130011479|NCT05419128|468003479|FG004|Overall Study|Lost to Follow-up|0|||
130011480|NCT05419128|468003480|FG005|Overall Study|Lost to Follow-up|1|||
130011481|NCT03834519|468003481|FG000|Overall Study|Lost to Follow-up|2|||
130011482|NCT03834519|468003482|FG001|Overall Study|Lost to Follow-up|1|||
130011483|NCT03834519|468003481|FG000|Overall Study|Withdrawal by Subject|5|||
130011484|NCT03834519|468003482|FG001|Overall Study|Withdrawal by Subject|8|||
130011485|NCT03834519|468003481|FG000|Overall Study|Death|368|||
130011486|NCT03834519|468003482|FG001|Overall Study|Death|174|||
130011487|NCT03834519|468003481|FG000|Overall Study|Physician Decision|5|||
130011488|NCT03834519|468003482|FG001|Overall Study|Physician Decision|1|||
130011489|NCT03834519|468003481|FG000|Overall Study|Sponsor decision|149|||
130011490|NCT03834519|468003482|FG001|Overall Study|Sponsor decision|80|||
130011491|NCT04066491|468003483|FG000|Overall Study|Randomized, not treated|0|||
130011492|NCT04066491|468003484|FG001|Overall Study|Randomized, not treated|0|||
130011493|NCT04066491|468003485|FG002|Overall Study|Randomized, not treated|2|||
130011494|NCT04506086|468003486|FG000|Overall Study|Withdrawal by Subject|2|||
130011495|NCT00517751|468003487|FG000|Overall Study|Death|3|||
130011496|NCT00517751|468003487|FG000|Overall Study|Withdrawal by Subject|37|||
130011497|NCT00517751|468003487|FG000|Overall Study|Lost to Follow-up|4|||
130011498|NCT00517751|468003487|FG000|Overall Study|patient not over due|6|||
130011499|NCT00517751|468003487|FG000|Overall Study|Patient not due for visit|76|||
130011500|NCT00517751|468003487|FG000|Overall Study|Missing|3|||
130011501|NCT00495820|468003488|FG000|Overall Study|Adverse Event|1|||
130011502|NCT00495820|468003489|FG001|Overall Study|Adverse Event|1|||
130011503|NCT00820950|468003490|FG000|Overall Study|Scheduling Conflict|0|||
130011504|NCT00820950|468003491|FG001|Overall Study|Scheduling Conflict|0|||
130011505|NCT00820950|468003492|FG002|Overall Study|Scheduling Conflict|0|||
130011506|NCT00820950|468003493|FG003|Overall Study|Scheduling Conflict|0|||
130011507|NCT00820950|468003494|FG004|Overall Study|Scheduling Conflict|0|||
130011508|NCT00820950|468003495|FG005|Overall Study|Scheduling Conflict|0|||
130011509|NCT00820950|468003496|FG006|Overall Study|Scheduling Conflict|1|||
130011510|NCT00820950|468003497|FG007|Overall Study|Scheduling Conflict|1|||
130011511|NCT00820950|468003498|FG008|Overall Study|Scheduling Conflict|0|||
130011512|NCT00820950|468003499|FG009|Overall Study|Scheduling Conflict|0|||
130011513|NCT00820950|468003490|FG000|Overall Study|Protocol Violation|1|||
130011514|NCT00820950|468003491|FG001|Overall Study|Protocol Violation|1|||
130011515|NCT00820950|468003492|FG002|Overall Study|Protocol Violation|0|||
130011516|NCT00820950|468003493|FG003|Overall Study|Protocol Violation|0|||
130011517|NCT00820950|468003494|FG004|Overall Study|Protocol Violation|0|||
130011518|NCT00820950|468003495|FG005|Overall Study|Protocol Violation|0|||
130346841|NCT03739242|469241813|FG000|Overall Study|Withdrawal by Subject|1|||
130346842|NCT03739242|469241814|FG001|Overall Study|Withdrawal by Subject|1|||
130346843|NCT03739242|469241813|FG000|Overall Study|Protocol Violation|0|||
130346844|NCT03739242|469241814|FG001|Overall Study|Protocol Violation|1|||
130346845|NCT01992159|469241815|FG000|Overall Study|Withdrawal by Subject|4|||
130346846|NCT01992159|469241816|FG001|Overall Study|Withdrawal by Subject|7|||
130346847|NCT01992159|469241817|FG002|Overall Study|Withdrawal by Subject|0|||
130346848|NCT01992159|469241818|FG003|Overall Study|Withdrawal by Subject|3|||
130346849|NCT01992159|469241815|FG000|Overall Study|Adverse Event|0|||
130346850|NCT01992159|469241816|FG001|Overall Study|Adverse Event|1|||
130346851|NCT01992159|469241817|FG002|Overall Study|Adverse Event|0|||
130346852|NCT01992159|469241818|FG003|Overall Study|Adverse Event|1|||
130346853|NCT01992159|469241815|FG000|Overall Study|Death|0|||
130346854|NCT01992159|469241816|FG001|Overall Study|Death|0|||
130346855|NCT01992159|469241817|FG002|Overall Study|Death|1|||
130346856|NCT01992159|469241818|FG003|Overall Study|Death|0|||
130346857|NCT01205581|469241819|FG000|Overall Study|Withdrawal by Subject|1|||
130346858|NCT01205581|469241820|FG001|Overall Study|Withdrawal by Subject|0|||
130346859|NCT01205581|469241821|FG002|Overall Study|Withdrawal by Subject|0|||
130346860|NCT01205581|469241822|FG003|Overall Study|Withdrawal by Subject|0|||
130346861|NCT01205581|469241823|FG004|Overall Study|Withdrawal by Subject|0|||
130346862|NCT01205581|469241824|FG005|Overall Study|Withdrawal by Subject|0|||
130346863|NCT02278471|469241825|FG000|Overall Study|Lost to Follow-up|6|||
130346864|NCT02278471|469241826|FG001|Overall Study|Lost to Follow-up|15|||
130346865|NCT02278471|469241825|FG000|Overall Study|Death|2|||
130346866|NCT02278471|469241826|FG001|Overall Study|Death|2|||
130346867|NCT02278471|469241825|FG000|Overall Study|Withdrawal by Subject|0|||
130346868|NCT02278471|469241826|FG001|Overall Study|Withdrawal by Subject|3|||
130346869|NCT00640835|469241827|FG000|Overall Study|Adverse Event|5|||
130346870|NCT00640835|469241828|FG001|Overall Study|Adverse Event|3|||
130346871|NCT00640835|469241827|FG000|Overall Study|Withdrawal by Subject|12|||
130346872|NCT00640835|469241828|FG001|Overall Study|Withdrawal by Subject|14|||
130346873|NCT00640835|469241827|FG000|Overall Study|Physician Decision|10|||
130346874|NCT00640835|469241828|FG001|Overall Study|Physician Decision|14|||
130346875|NCT00640835|469241827|FG000|Overall Study|Sponsor's Decision|11|||
130346876|NCT00640835|469241828|FG001|Overall Study|Sponsor's Decision|7|||
130346877|NCT00640835|469241827|FG000|Overall Study|Protocol Violation|2|||
130346878|NCT00640835|469241828|FG001|Overall Study|Protocol Violation|2|||
130346879|NCT00640835|469241827|FG000|Overall Study|Lost to Follow-up|17|||
130346880|NCT00640835|469241828|FG001|Overall Study|Lost to Follow-up|13|||
130346881|NCT00640835|469241827|FG000|Overall Study|Other Reason|19|||
130346882|NCT00640835|469241828|FG001|Overall Study|Other Reason|4|||
130346883|NCT04535167|469241831|FG000|Treatment|Adverse Event|0|||
130346884|NCT04535167|469241832|FG001|Treatment|Adverse Event|0|||
130346885|NCT04535167|469241833|FG002|Treatment|Adverse Event|0|||
130011519|NCT00820950|468003496|FG006|Overall Study|Protocol Violation|0|||
130346886|NCT04535167|469241834|FG003|Treatment|Adverse Event|0|||
130346887|NCT04535167|469241835|FG004|Treatment|Adverse Event|0|||
130346888|NCT04535167|469241836|FG005|Treatment|Adverse Event|0|||
130011520|NCT00820950|468003497|FG007|Overall Study|Protocol Violation|0|||
130011521|NCT00820950|468003498|FG008|Overall Study|Protocol Violation|0|||
130346889|NCT04535167|469241837|FG006|Treatment|Adverse Event|1|||
130011522|NCT00820950|468003499|FG009|Overall Study|Protocol Violation|0|||
130011523|NCT03416153|468003500|FG000|Overall Study|Physician Decision|1|||
130011524|NCT03416153|468003501|FG001|Overall Study|Physician Decision|1|||
130011525|NCT03416153|468003500|FG000|Overall Study|Withdrawal by Subject|1|||
130346890|NCT04535167|469241831|FG000|Follow-Up|Death|0|||
130346891|NCT04535167|469241832|FG001|Follow-Up|Death|0|||
130346892|NCT04535167|469241833|FG002|Follow-Up|Death|0|||
130346893|NCT04535167|469241834|FG003|Follow-Up|Death|0|||
130346894|NCT04535167|469241835|FG004|Follow-Up|Death|0|||
130011526|NCT03416153|468003501|FG001|Overall Study|Withdrawal by Subject|0|||
130011527|NCT00980200|468005061|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
130011528|NCT00980200|468005062|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
130011529|NCT00980200|468005063|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
130011530|NCT00980200|468005064|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
130011531|NCT00980200|468005065|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
130011532|NCT00980200|468005061|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
130011533|NCT00980200|468005062|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
130011534|NCT00980200|468005063|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
130011535|NCT00980200|468005064|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
130011536|NCT00980200|468005065|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
130011537|NCT00457015|468005066|FG000|Overall Study|Left study site against medical advice|0|||
130011538|NCT00457015|468005067|FG001|Overall Study|Left study site against medical advice|1|||
130011539|NCT00747643|468005068|FG000|Overall Study|Withdrawal by Subject|36|||
130011540|NCT00747643|468005069|FG001|Overall Study|Withdrawal by Subject|27|||
130011541|NCT00750698|468005070|FG000|Overall Study|Withdrawal by Subject|1|||
130011542|NCT00750698|468005071|FG001|Overall Study|Withdrawal by Subject|0|||
130011543|NCT00750698|468005070|FG000|Overall Study|Progressive disease|5|||
130011544|NCT00750698|468005071|FG001|Overall Study|Progressive disease|2|||
130011545|NCT02263079|468005072|FG000|Overall Study|Physician Decision|1|||
130011546|NCT02263079|468005073|FG001|Overall Study|Physician Decision|0|||
130011547|NCT02263079|468005074|FG002|Overall Study|Physician Decision|0|||
130011548|NCT02263079|468005072|FG000|Overall Study|Withdrawal by Subject|2|||
130011549|NCT02263079|468005073|FG001|Overall Study|Withdrawal by Subject|8|||
130011550|NCT02263079|468005074|FG002|Overall Study|Withdrawal by Subject|0|||
130011551|NCT00402649|468005075|FG000|Overall Study|Lost to Follow-up|1|||
130011552|NCT00402649|468005075|FG000|Overall Study|Withdrawal by Subject|1|||
130011553|NCT01199042|468005076|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
130011554|NCT01199042|468005076|FG000|At Home (3 Months)|Lost to Follow-up|1|||
130011555|NCT02554019|468005080|FG000|Overall Study|Withdrawal by Subject|1|||
130011556|NCT02554019|468005081|FG001|Overall Study|Withdrawal by Subject|0|||
130011557|NCT02554019|468005082|FG002|Overall Study|Withdrawal by Subject|2|||
130011558|NCT02554019|468005080|FG000|Overall Study|Adverse Event|1|||
130011559|NCT02554019|468005081|FG001|Overall Study|Adverse Event|0|||
130011560|NCT02554019|468005082|FG002|Overall Study|Adverse Event|0|||
130011561|NCT01308008|468005083|FG000|4 Weeks|Illness, disinterest, time|9|||
130011562|NCT01308008|468005084|FG001|4 Weeks|Illness, disinterest, time|2|||
130011563|NCT01417195|468005085|FG000|Overall Study|Stimulation failure|1|||
130011564|NCT01417195|468005086|FG001|Overall Study|Stimulation failure|0|||
130011565|NCT01417195|468005085|FG000|Overall Study|No embryos for transfer|0|||
130011566|NCT01417195|468005086|FG001|Overall Study|No embryos for transfer|1|||
130011567|NCT01417195|468005085|FG000|Overall Study|No transfer due to risk of OHSS|1|||
130011568|NCT01417195|468005086|FG001|Overall Study|No transfer due to risk of OHSS|0|||
130011569|NCT01417195|468005085|FG000|Overall Study|No transfer due to elevated progesterone|1|||
130011570|NCT01417195|468005086|FG001|Overall Study|No transfer due to elevated progesterone|0|||
130011571|NCT03357731|468005087|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
130011572|NCT03357731|468005088|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
130011573|NCT03357731|468005089|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
130011574|NCT03357731|468005090|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
130011575|NCT03357731|468005091|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
130011576|NCT03357731|468005092|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
130011577|NCT03357731|468005087|FG000|Overall Study|Acute bradycardia and hypotension|0|||
130011578|NCT03357731|468005088|FG001|Overall Study|Acute bradycardia and hypotension|0|||
130011579|NCT03357731|468005089|FG002|Overall Study|Acute bradycardia and hypotension|0|||
130011580|NCT03357731|468005090|FG003|Overall Study|Acute bradycardia and hypotension|1|||
130011581|NCT03357731|468005091|FG004|Overall Study|Acute bradycardia and hypotension|0|||
130011582|NCT03357731|468005092|FG005|Overall Study|Acute bradycardia and hypotension|0|||
130011583|NCT03357731|468005087|FG000|Overall Study|Adverse Event|0|||
130011584|NCT03357731|468005088|FG001|Overall Study|Adverse Event|0|||
130011585|NCT03357731|468005089|FG002|Overall Study|Adverse Event|0|||
130011586|NCT03357731|468005090|FG003|Overall Study|Adverse Event|0|||
130011587|NCT03357731|468005091|FG004|Overall Study|Adverse Event|0|||
130011588|NCT03357731|468005092|FG005|Overall Study|Adverse Event|1|||
130011589|NCT03357731|468005087|FG000|Overall Study|Hypotension|0|||
130011590|NCT03357731|468005088|FG001|Overall Study|Hypotension|0|||
130011591|NCT03357731|468005089|FG002|Overall Study|Hypotension|1|||
130011592|NCT03357731|468005090|FG003|Overall Study|Hypotension|1|||
130011593|NCT03357731|468005091|FG004|Overall Study|Hypotension|0|||
130011594|NCT03357731|468005092|FG005|Overall Study|Hypotension|0|||
130011595|NCT03357731|468005087|FG000|Overall Study|Lost to Follow-up|0|||
130011596|NCT03357731|468005088|FG001|Overall Study|Lost to Follow-up|0|||
130011597|NCT03357731|468005089|FG002|Overall Study|Lost to Follow-up|0|||
130011598|NCT03357731|468005090|FG003|Overall Study|Lost to Follow-up|1|||
130011599|NCT03357731|468005091|FG004|Overall Study|Lost to Follow-up|0|||
130011600|NCT03357731|468005092|FG005|Overall Study|Lost to Follow-up|0|||
130011601|NCT00772954|468005093|FG000|Overall Study|Adverse Event|0|||
130346895|NCT04535167|469241836|FG005|Follow-Up|Death|0|||
130346896|NCT04535167|469241837|FG006|Follow-Up|Death|1|||
130346897|NCT04535167|469241831|FG000|Follow-Up|Lost to Follow-up|0|||
130346898|NCT04535167|469241832|FG001|Follow-Up|Lost to Follow-up|0|||
130346899|NCT04535167|469241833|FG002|Follow-Up|Lost to Follow-up|0|||
130346900|NCT04535167|469241834|FG003|Follow-Up|Lost to Follow-up|1|||
130346901|NCT04535167|469241835|FG004|Follow-Up|Lost to Follow-up|0|||
130346902|NCT04535167|469241836|FG005|Follow-Up|Lost to Follow-up|0|||
130346903|NCT04535167|469241837|FG006|Follow-Up|Lost to Follow-up|0|||
130346904|NCT00978432|469241838|FG000|Overall Study|Withdrawal by Subject|0|||
130346905|NCT00978432|469241839|FG001|Overall Study|Withdrawal by Subject|0|||
130346906|NCT00978432|469241840|FG002|Overall Study|Withdrawal by Subject|1|||
130346907|NCT00978432|469241838|FG000|Overall Study|Lack of Efficacy|1|||
130346908|NCT00978432|469241839|FG001|Overall Study|Lack of Efficacy|1|||
130346909|NCT00978432|469241840|FG002|Overall Study|Lack of Efficacy|3|||
130346910|NCT00978432|469241838|FG000|Overall Study|Adverse Event|2|||
130346911|NCT00978432|469241839|FG001|Overall Study|Adverse Event|0|||
130346912|NCT00978432|469241840|FG002|Overall Study|Adverse Event|1|||
130346913|NCT04618770|469241841|FG000|Overall Study|Censored from Analysis|12|||
130346914|NCT04618770|469241841|FG000|Overall Study|Early Termination|25|||
130346915|NCT04972630|469241844|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
130346916|NCT04972630|469241845|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
130346917|NCT04972630|469241846|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
130346918|NCT00075270|469241849|FG000|Overall Study|Withdrawal by Subject|28|||
130346919|NCT00075270|469241850|FG001|Overall Study|Withdrawal by Subject|21|||
130346920|NCT00075270|469241849|FG000|Overall Study|Lost to Follow-up|25|||
130346921|NCT00075270|469241850|FG001|Overall Study|Lost to Follow-up|28|||
130346922|NCT00075270|469241849|FG000|Overall Study|Protocol Violation|0|||
130346923|NCT00075270|469241850|FG001|Overall Study|Protocol Violation|2|||
130346924|NCT00075270|469241849|FG000|Overall Study|Death|198|||
130346925|NCT00075270|469241850|FG001|Overall Study|Death|215|||
130346926|NCT00075270|469241849|FG000|Overall Study|Other/Unknown|9|||
130346927|NCT00075270|469241850|FG001|Overall Study|Other/Unknown|5|||
130346928|NCT00075270|469241849|FG000|Overall Study|Missing|26|||
130346929|NCT00075270|469241850|FG001|Overall Study|Missing|13|||
130346930|NCT02160002|469241851|FG000|Overall Study|Withdrawal by Subject|2|||
130346931|NCT02160002|469241852|FG001|Overall Study|Withdrawal by Subject|1|||
130346932|NCT04896229|469241853|FG000|Overall Study|Lost to Follow-up|113|||
130346933|NCT04896229|469241854|FG001|Overall Study|Lost to Follow-up|113|||
130346934|NCT04418661|469241855|FG000|Overall Study|Adverse Event|0|||
130346935|NCT04418661|469241856|FG001|Overall Study|Adverse Event|1|||
130346936|NCT04418661|469241857|FG002|Overall Study|Adverse Event|5|||
130011602|NCT00772954|468005094|FG001|Overall Study|Adverse Event|0|||
130346937|NCT04418661|469241858|FG003|Overall Study|Adverse Event|3|||
130346938|NCT04418661|469241859|FG004|Overall Study|Adverse Event|0|||
130346939|NCT04418661|469241860|FG005|Overall Study|Adverse Event|2|||
130346940|NCT04418661|469241855|FG000|Overall Study|Progressive disease|4|||
130011603|NCT00772954|468005095|FG002|Overall Study|Adverse Event|1|||
130346941|NCT04418661|469241856|FG001|Overall Study|Progressive disease|11|||
130346942|NCT04418661|469241857|FG002|Overall Study|Progressive disease|6|||
130346943|NCT04418661|469241858|FG003|Overall Study|Progressive disease|11|||
130346944|NCT04418661|469241859|FG004|Overall Study|Progressive disease|1|||
130011604|NCT04640272|468005098|FG000|Overall Study|Subject moved out of area|1|||
130011605|NCT01438489|468005104|FG000|Overall Study|Lost to Follow-up|4|||
130011606|NCT01438489|468005105|FG001|Overall Study|Lost to Follow-up|2|||
130011607|NCT01438489|468005106|FG002|Overall Study|Lost to Follow-up|2|||
130011608|NCT01438489|468005104|FG000|Overall Study|Withdrawal by Subject|11|||
130011609|NCT01438489|468005105|FG001|Overall Study|Withdrawal by Subject|3|||
130011610|NCT01438489|468005106|FG002|Overall Study|Withdrawal by Subject|8|||
130011611|NCT01438489|468005104|FG000|Overall Study|Death|0|||
130011612|NCT01438489|468005105|FG001|Overall Study|Death|0|||
130011613|NCT01438489|468005106|FG002|Overall Study|Death|1|||
130011614|NCT01438489|468005104|FG000|Overall Study|Sponsor decision|4|||
130011615|NCT01438489|468005105|FG001|Overall Study|Sponsor decision|1|||
130011616|NCT01438489|468005106|FG002|Overall Study|Sponsor decision|4|||
130011617|NCT01438489|468005104|FG000|Overall Study|Subject choice/Subject moved|2|||
130011618|NCT01438489|468005105|FG001|Overall Study|Subject choice/Subject moved|1|||
130011619|NCT01438489|468005106|FG002|Overall Study|Subject choice/Subject moved|1|||
130011620|NCT01438489|468005104|FG000|Overall Study|Investigator decision|0|||
130011621|NCT01438489|468005105|FG001|Overall Study|Investigator decision|1|||
130011622|NCT01438489|468005106|FG002|Overall Study|Investigator decision|0|||
130011623|NCT01438489|468005104|FG000|Overall Study|AE/SAEs|2|||
130011624|NCT01438489|468005105|FG001|Overall Study|AE/SAEs|1|||
130011625|NCT01438489|468005106|FG002|Overall Study|AE/SAEs|1|||
130011626|NCT01438489|468005104|FG000|Overall Study|Received prohibited medication|1|||
130011627|NCT01438489|468005105|FG001|Overall Study|Received prohibited medication|0|||
130011628|NCT01438489|468005106|FG002|Overall Study|Received prohibited medication|0|||
130011629|NCT01438489|468005104|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
130011630|NCT01438489|468005105|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
130011631|NCT01438489|468005106|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
130011632|NCT01438489|468005104|FG000|Overall Study|Inadequate venous access|0|||
130011633|NCT01438489|468005105|FG001|Overall Study|Inadequate venous access|2|||
130011634|NCT01438489|468005106|FG002|Overall Study|Inadequate venous access|0|||
130011635|NCT00573430|468005107|FG000|Overall Study|Incorrect enrollment of randomization|0|||
130011636|NCT00573430|468005108|FG001|Overall Study|Incorrect enrollment of randomization|4|||
130011637|NCT00573430|468005109|FG002|Overall Study|Incorrect enrollment of randomization|3|||
130011638|NCT00573430|468005107|FG000|Overall Study|Adverse Event|0|||
130011639|NCT00573430|468005108|FG001|Overall Study|Adverse Event|0|||
130011640|NCT00573430|468005109|FG002|Overall Study|Adverse Event|2|||
130011641|NCT00573430|468005107|FG000|Overall Study|Withdrawal by Subject|1|||
130011642|NCT00573430|468005108|FG001|Overall Study|Withdrawal by Subject|0|||
130011643|NCT00573430|468005109|FG002|Overall Study|Withdrawal by Subject|1|||
130011644|NCT00573430|468005107|FG000|Overall Study|Protocol Violation|0|||
130011645|NCT00573430|468005108|FG001|Overall Study|Protocol Violation|1|||
130011646|NCT00573430|468005109|FG002|Overall Study|Protocol Violation|1|||
130011647|NCT00573430|468005107|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130011648|NCT00573430|468005108|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130011649|NCT00573430|468005109|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
130011650|NCT00751400|468005110|FG000|Overall Study|Lost to Follow-up|10|||
130011651|NCT01148537|468005116|FG000|Overall Study|Withdrawal by Subject|1|||
130011652|NCT01148537|468005117|FG001|Overall Study|Withdrawal by Subject|0|||
130011653|NCT01148537|468005118|FG002|Overall Study|Withdrawal by Subject|2|||
130011654|NCT01148537|468005116|FG000|Overall Study|Adverse Event|2|||
130011655|NCT01148537|468005117|FG001|Overall Study|Adverse Event|0|||
130011656|NCT01148537|468005118|FG002|Overall Study|Adverse Event|1|||
130011657|NCT01324232|468005119|FG000|Overall Study|Protocol Violation|0|||
130011658|NCT01324232|468005120|FG001|Overall Study|Protocol Violation|0|||
130011659|NCT01324232|468005121|FG002|Overall Study|Protocol Violation|0|||
130011660|NCT01324232|468005122|FG003|Overall Study|Protocol Violation|2|||
130011661|NCT01324232|468005119|FG000|Overall Study|Missing|0|||
130011662|NCT01324232|468005120|FG001|Overall Study|Missing|0|||
130011663|NCT01324232|468005121|FG002|Overall Study|Missing|1|||
130011664|NCT01324232|468005122|FG003|Overall Study|Missing|0|||
130011665|NCT01324232|468005119|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
130011666|NCT01324232|468005120|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
130011667|NCT01324232|468005121|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
130011668|NCT01324232|468005122|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
130011669|NCT01324232|468005119|FG000|Overall Study|Lack of Efficacy|2|||
130011670|NCT01324232|468005120|FG001|Overall Study|Lack of Efficacy|1|||
130011671|NCT01324232|468005121|FG002|Overall Study|Lack of Efficacy|2|||
130011672|NCT01324232|468005122|FG003|Overall Study|Lack of Efficacy|2|||
130011673|NCT01324232|468005119|FG000|Overall Study|Participant Refused Medication|0|||
130011674|NCT01324232|468005120|FG001|Overall Study|Participant Refused Medication|1|||
130011675|NCT01324232|468005121|FG002|Overall Study|Participant Refused Medication|0|||
130011676|NCT01324232|468005122|FG003|Overall Study|Participant Refused Medication|0|||
130011677|NCT01324232|468005119|FG000|Overall Study|Intercurrent illness|0|||
130011678|NCT01324232|468005120|FG001|Overall Study|Intercurrent illness|0|||
130011679|NCT01324232|468005121|FG002|Overall Study|Intercurrent illness|0|||
130011680|NCT01324232|468005122|FG003|Overall Study|Intercurrent illness|1|||
130011681|NCT01324232|468005119|FG000|Overall Study|Adverse Event|2|||
130011682|NCT01324232|468005120|FG001|Overall Study|Adverse Event|5|||
130011683|NCT01324232|468005121|FG002|Overall Study|Adverse Event|6|||
130011684|NCT01324232|468005122|FG003|Overall Study|Adverse Event|6|||
130011685|NCT01324232|468005119|FG000|Overall Study|Withdrawal by Subject|0|||
130011686|NCT01324232|468005120|FG001|Overall Study|Withdrawal by Subject|3|||
130011687|NCT01324232|468005121|FG002|Overall Study|Withdrawal by Subject|4|||
130011688|NCT01324232|468005122|FG003|Overall Study|Withdrawal by Subject|0|||
130011689|NCT01324232|468005119|FG000|Overall Study|Lost to Follow-up|1|||
130011690|NCT01324232|468005120|FG001|Overall Study|Lost to Follow-up|0|||
130011691|NCT01324232|468005121|FG002|Overall Study|Lost to Follow-up|0|||
130011692|NCT01324232|468005122|FG003|Overall Study|Lost to Follow-up|0|||
130011693|NCT00661531|468005123|FG000|Overall Study|Withdrawal by Subject|3|||
130011694|NCT01356407|468005125|FG000|Overall Study|Lost to Follow-up|2|||
130011695|NCT01356407|468005126|FG001|Overall Study|Lost to Follow-up|0|||
130011696|NCT01356407|468005125|FG000|Overall Study|Patient Withdrew Consent|2|||
130011697|NCT01356407|468005126|FG001|Overall Study|Patient Withdrew Consent|1|||
130011698|NCT01356407|468005125|FG000|Overall Study|Could not afford IMP administration|0|||
130011699|NCT01356407|468005126|FG001|Overall Study|Could not afford IMP administration|1|||
130011700|NCT01356407|468005125|FG000|Overall Study|Not complete Endoscopy|2|||
130011701|NCT01356407|468005126|FG001|Overall Study|Not complete Endoscopy|2|||
130011702|NCT02614859|468005127|FG000|Overall Study|Physician Decision|0|||
130011703|NCT02614859|468005128|FG001|Overall Study|Physician Decision|1|||
130011704|NCT00808236|468005142|FG000|Overall Study|Was not resuscitated|50|||
130011705|NCT00808236|468005143|FG001|Overall Study|Was not resuscitated|56|||
130011706|NCT00808236|468005142|FG000|Overall Study|Pre-defined exclusion|13|||
130011707|NCT00808236|468005143|FG001|Overall Study|Pre-defined exclusion|3|||
130011708|NCT00808236|468005142|FG000|Overall Study|Lost to Follow-up|1|||
130011709|NCT00808236|468005143|FG001|Overall Study|Lost to Follow-up|1|||
130011710|NCT00808236|468005142|FG000|Overall Study|Physician Decision|0|||
130011711|NCT00808236|468005143|FG001|Overall Study|Physician Decision|1|||
130011712|NCT00808236|468005142|FG000|Overall Study|Death|18|||
130011713|NCT00808236|468005143|FG001|Overall Study|Death|30|||
130011714|NCT02230384|468005144|FG000|Phase 1|Lost to Follow-up|1|||
130011715|NCT02230384|468005145|FG001|Phase 1|Lost to Follow-up|0|||
130011716|NCT02230384|468005144|FG000|Phase 1|Physician Decision|0|||
130011717|NCT02230384|468005145|FG001|Phase 1|Physician Decision|1|||
130011718|NCT02230384|468005144|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
130011719|NCT02230384|468005145|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
130011720|NCT02230384|468005144|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
130011721|NCT02230384|468005145|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
130011722|NCT02230384|468005144|FG000|Phase 2 - Switch|Adverse Event|2|||
130011723|NCT02230384|468005145|FG001|Phase 2 - Switch|Adverse Event|0|||
130011724|NCT00777101|468005146|FG000|Overall Study|Death|48|||
130011725|NCT00777101|468005147|FG001|Overall Study|Death|43|||
130011726|NCT00777101|468005146|FG000|Overall Study|Withdrawal by Subject|11|||
130011727|NCT00777101|468005147|FG001|Overall Study|Withdrawal by Subject|6|||
130011728|NCT00777101|468005146|FG000|Overall Study|Lost to Follow-up|2|||
130011729|NCT00777101|468005147|FG001|Overall Study|Lost to Follow-up|1|||
130011730|NCT00777101|468005146|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130011731|NCT00777101|468005147|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130011732|NCT00777101|468005146|FG000|Overall Study|Failed to Return|0|||
130011733|NCT00777101|468005147|FG001|Overall Study|Failed to Return|1|||
130011734|NCT00961220|468005148|FG000|Overall Study|Adverse Event|3|||
130011735|NCT00961220|468005148|FG000|Overall Study|Lack of Efficacy|1|||
130011736|NCT00961220|468005148|FG000|Overall Study|No IV access for O6BG|1|||
130011737|NCT00961220|468005148|FG000|Overall Study|O6BG no longer supplied|1|||
130011738|NCT00961220|468005148|FG000|Overall Study|Complete Response prior to 12 courses|1|||
130011739|NCT01301950|468005153|FG000|Overall Study|Surgery was cancelled by patient|0|||
130011740|NCT01301950|468005154|FG001|Overall Study|Surgery was cancelled by patient|1|||
130011741|NCT00825162|468005159|FG000|Overall Study|Withdrawal by Subject|11|||
130011742|NCT00825162|468005160|FG001|Overall Study|Withdrawal by Subject|13|||
130011743|NCT00825162|468005161|FG002|Overall Study|Withdrawal by Subject|3|||
130011744|NCT00825162|468005159|FG000|Overall Study|Lost to Follow-up|9|||
130011745|NCT00825162|468005160|FG001|Overall Study|Lost to Follow-up|6|||
130011746|NCT00825162|468005161|FG002|Overall Study|Lost to Follow-up|3|||
130011747|NCT00825162|468005159|FG000|Overall Study|Physician Decision|2|||
130011748|NCT00825162|468005160|FG001|Overall Study|Physician Decision|0|||
130011749|NCT00825162|468005161|FG002|Overall Study|Physician Decision|0|||
130011750|NCT00825162|468005159|FG000|Overall Study|Move away from the study area|1|||
130011751|NCT00825162|468005160|FG001|Overall Study|Move away from the study area|0|||
130011752|NCT00825162|468005161|FG002|Overall Study|Move away from the study area|0|||
130011753|NCT00825162|468005159|FG000|Overall Study|Unable to attend the study visit|5|||
130011754|NCT00825162|468005160|FG001|Overall Study|Unable to attend the study visit|2|||
130011755|NCT00825162|468005161|FG002|Overall Study|Unable to attend the study visit|0|||
130011756|NCT00964743|468005165|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
130011757|NCT00781911|468005166|FG000|Overall Study|Adverse Event|4|||
130011758|NCT00781911|468005167|FG001|Overall Study|Adverse Event|4|||
130011759|NCT00781911|468005166|FG000|Overall Study|Withdrawal by Subject|1|||
130346945|NCT04418661|469241860|FG005|Overall Study|Progressive disease|12|||
130346946|NCT04418661|469241855|FG000|Overall Study|Withdrawal by Subject|0|||
130346947|NCT04418661|469241856|FG001|Overall Study|Withdrawal by Subject|1|||
130346948|NCT04418661|469241857|FG002|Overall Study|Withdrawal by Subject|0|||
130346949|NCT04418661|469241858|FG003|Overall Study|Withdrawal by Subject|1|||
130346950|NCT04418661|469241859|FG004|Overall Study|Withdrawal by Subject|0|||
130346951|NCT04418661|469241860|FG005|Overall Study|Withdrawal by Subject|0|||
130346952|NCT04418661|469241855|FG000|Overall Study|Other|0|||
130346953|NCT04418661|469241856|FG001|Overall Study|Other|0|||
130346954|NCT04418661|469241857|FG002|Overall Study|Other|1|||
130346955|NCT04418661|469241858|FG003|Overall Study|Other|3|||
130346956|NCT04418661|469241859|FG004|Overall Study|Other|0|||
130346957|NCT04418661|469241860|FG005|Overall Study|Other|1|||
130346958|NCT00046891|469241863|FG000|Overall Study|Cancels|5|||
130346959|NCT00046891|469241864|FG001|Overall Study|Cancels|9|||
130346960|NCT00046891|469241863|FG000|Overall Study|Ineligible|1|||
130346961|NCT00046891|469241864|FG001|Overall Study|Ineligible|1|||
130346962|NCT00046891|469241863|FG000|Overall Study|Withdrawal by Subject|18|||
130346963|NCT00046891|469241864|FG001|Overall Study|Withdrawal by Subject|15|||
130346964|NCT00046891|469241863|FG000|Overall Study|Adverse Event|5|||
130346965|NCT00046891|469241864|FG001|Overall Study|Adverse Event|5|||
130346966|NCT02496676|469241865|FG000|Phase 1 - Period 1|Adverse Event|0|||
130346967|NCT02496676|469241866|FG001|Phase 1 - Period 1|Adverse Event|1|||
130346968|NCT02496676|469241865|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
130346969|NCT02496676|469241866|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
130346970|NCT04381988|469241877|FG000|Overall Study|The study was terminated|4|||
130346971|NCT04381988|469241878|FG001|Overall Study|The study was terminated|0|||
130346972|NCT01107379|469241879|FG000|Overall Study|Withdrawal by Subject|18|||
130346973|NCT01107379|469241879|FG000|Overall Study|Lost to Follow-up|3|||
130346974|NCT00609362|469241880|FG000|Overall Study|Withdrawal by Subject|2|||
130346975|NCT00609362|469241881|FG001|Overall Study|Withdrawal by Subject|1|||
130346976|NCT00609362|469241880|FG000|Overall Study|Adverse Event|1|||
130346977|NCT00609362|469241881|FG001|Overall Study|Adverse Event|0|||
130346978|NCT04559529|469241882|FG000|First Intervention (1 Day)|Adverse Event|0|||
130346979|NCT04559529|469241883|FG001|First Intervention (1 Day)|Adverse Event|0|||
130346980|NCT04559529|469241884|FG002|First Intervention (1 Day)|Adverse Event|0|||
130346981|NCT04559529|469241885|FG003|First Intervention (1 Day)|Adverse Event|1|||
130346982|NCT04559529|469241882|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130346983|NCT04559529|469241883|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130346984|NCT04559529|469241884|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
130346985|NCT04559529|469241885|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
130346986|NCT04559529|469241882|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
130346987|NCT04559529|469241883|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
130346988|NCT04559529|469241884|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
130346989|NCT04559529|469241885|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
130346990|NCT01009281|469241886|FG000|Overall Study|Administrative problems|7|||
130346991|NCT00548405|469241887|FG000|Overall Study|Adverse Event|6|||
130346992|NCT00548405|469241888|FG001|Overall Study|Adverse Event|2|||
130346993|NCT00548405|469241889|FG002|Overall Study|Adverse Event|0|||
130346994|NCT00548405|469241887|FG000|Overall Study|Lack of Efficacy|6|||
130011760|NCT00781911|468005167|FG001|Overall Study|Withdrawal by Subject|2|||
130011761|NCT00781911|468005166|FG000|Overall Study|Physician Decision|0|||
130011762|NCT00781911|468005167|FG001|Overall Study|Physician Decision|2|||
130011763|NCT00781911|468005166|FG000|Overall Study|Sponsor Decision|1|||
130011764|NCT00781911|468005167|FG001|Overall Study|Sponsor Decision|0|||
130011765|NCT03317795|468005170|FG000|Overall Study|IUD Expulsion|1|||
130011766|NCT03317795|468005171|FG001|Overall Study|IUD Expulsion|0|||
130011767|NCT03317795|468005170|FG000|Overall Study|Lost to Follow-up|1|||
130011768|NCT03317795|468005171|FG001|Overall Study|Lost to Follow-up|3|||
130011769|NCT03317795|468005170|FG000|Overall Study|Treatment change|0|||
130011770|NCT03317795|468005171|FG001|Overall Study|Treatment change|3|||
130011771|NCT03317795|468005170|FG000|Overall Study|Intolerance of medication|0|||
130011772|NCT03317795|468005171|FG001|Overall Study|Intolerance of medication|1|||
130346995|NCT00548405|469241888|FG001|Overall Study|Lack of Efficacy|0|||
130346996|NCT00548405|469241889|FG002|Overall Study|Lack of Efficacy|0|||
130346997|NCT00548405|469241887|FG000|Overall Study|Physician Decision|3|||
130346998|NCT00548405|469241888|FG001|Overall Study|Physician Decision|4|||
130346999|NCT00548405|469241889|FG002|Overall Study|Physician Decision|1|||
130347000|NCT00548405|469241887|FG000|Overall Study|Pregnancy|1|||
130011773|NCT01549002|468005172|FG000|Overall Study|Excessive pain|0|||
130011774|NCT01549002|468005173|FG001|Overall Study|Excessive pain|2|||
130011775|NCT01549002|468005172|FG000|Overall Study|Moderate sedation required|0|||
130011776|NCT01549002|468005173|FG001|Overall Study|Moderate sedation required|2|||
130347001|NCT00548405|469241888|FG001|Overall Study|Pregnancy|0|||
130347002|NCT00548405|469241889|FG002|Overall Study|Pregnancy|0|||
130347003|NCT00548405|469241887|FG000|Overall Study|Protocol Violation|1|||
130347004|NCT00548405|469241888|FG001|Overall Study|Protocol Violation|0|||
130347005|NCT00548405|469241889|FG002|Overall Study|Protocol Violation|0|||
130011777|NCT02424253|468005176|FG000|Overall Study|Other, unspecified|1|||
130011778|NCT02424253|468005177|FG001|Overall Study|Other, unspecified|0|||
130011779|NCT02424253|468005176|FG000|Overall Study|Compliance problems|1|||
130011780|NCT02424253|468005177|FG001|Overall Study|Compliance problems|0|||
130011781|NCT02424253|468005176|FG000|Overall Study|Physician Decision|2|||
130011782|NCT02424253|468005177|FG001|Overall Study|Physician Decision|0|||
130011783|NCT02424253|468005176|FG000|Overall Study|Lack of Efficacy|0|||
130011784|NCT02424253|468005177|FG001|Overall Study|Lack of Efficacy|7|||
130011785|NCT02424253|468005176|FG000|Overall Study|Adverse Event|2|||
130011786|NCT02424253|468005177|FG001|Overall Study|Adverse Event|0|||
130011787|NCT02424253|468005176|FG000|Overall Study|Consent withdrawn by subject|4|||
130011788|NCT02424253|468005177|FG001|Overall Study|Consent withdrawn by subject|1|||
130011789|NCT02424253|468005176|FG000|Overall Study|Lost to Follow-up|1|||
130011790|NCT02424253|468005177|FG001|Overall Study|Lost to Follow-up|1|||
130011791|NCT02290873|468005180|FG000|Overall Study|Withdrawal by Subject|0|||
130011792|NCT02290873|468005181|FG001|Overall Study|Withdrawal by Subject|1|||
130011793|NCT02290873|468005182|FG002|Overall Study|Withdrawal by Subject|1|||
130011794|NCT02290873|468005180|FG000|Overall Study|Nellcor device error|1|||
130011795|NCT02290873|468005181|FG001|Overall Study|Nellcor device error|0|||
130011796|NCT02290873|468005182|FG002|Overall Study|Nellcor device error|0|||
130011797|NCT02290873|468005180|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
130011798|NCT02290873|468005181|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
130011799|NCT02290873|468005182|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
130011800|NCT02290873|468005180|FG000|Overall Study|Protocol Violation|0|||
130011801|NCT02290873|468005181|FG001|Overall Study|Protocol Violation|0|||
130011802|NCT02290873|468005182|FG002|Overall Study|Protocol Violation|1|||
130011803|NCT01378104|468005183|FG000|Overall Study|Adverse Event|8|||
130011804|NCT01378104|468005184|FG001|Overall Study|Adverse Event|8|||
130011805|NCT01378104|468005183|FG000|Overall Study|Lack of Efficacy|7|||
130011806|NCT01378104|468005184|FG001|Overall Study|Lack of Efficacy|5|||
130011807|NCT01378104|468005183|FG000|Overall Study|Withdrawal by Subject|12|||
130011808|NCT01378104|468005184|FG001|Overall Study|Withdrawal by Subject|13|||
130011809|NCT01473563|468005185|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
130011810|NCT01519765|468005186|FG000|Overall Study|Adverse Event|0|||
130011811|NCT01519765|468005187|FG001|Overall Study|Adverse Event|1|||
130011812|NCT01519765|468005186|FG000|Overall Study|Lack of Efficacy|2|||
130347006|NCT00548405|469241887|FG000|Overall Study|Withdrawal by Subject|36|||
130347007|NCT00548405|469241888|FG001|Overall Study|Withdrawal by Subject|12|||
130347008|NCT00548405|469241889|FG002|Overall Study|Withdrawal by Subject|5|||
130347009|NCT00548405|469241887|FG000|Overall Study|Lost to Follow-up|1|||
130347010|NCT00548405|469241888|FG001|Overall Study|Lost to Follow-up|1|||
130347011|NCT00548405|469241889|FG002|Overall Study|Lost to Follow-up|2|||
130347012|NCT00548405|469241887|FG000|Overall Study|Death|0|||
130347013|NCT00548405|469241888|FG001|Overall Study|Death|1|||
130347014|NCT00548405|469241889|FG002|Overall Study|Death|1|||
130347015|NCT00548405|469241887|FG000|Overall Study|Sponsor decision|1|||
130347016|NCT00548405|469241888|FG001|Overall Study|Sponsor decision|0|||
130347017|NCT00548405|469241889|FG002|Overall Study|Sponsor decision|0|||
130347018|NCT00548405|469241887|FG000|Overall Study|Randomized but not treated|1|||
130347019|NCT00548405|469241888|FG001|Overall Study|Randomized but not treated|0|||
130347020|NCT00548405|469241889|FG002|Overall Study|Randomized but not treated|0|||
130347021|NCT02582684|469241891|FG000|Overall Study|Unable to contact subject/parent|4|||
130347022|NCT02582684|469241891|FG000|Overall Study|Subject not able to get to clinic|10|||
130347023|NCT02582684|469241891|FG000|Overall Study|Subject withdrew consent|1|||
130347024|NCT02582684|469241891|FG000|Overall Study|Found to be ineligible after enrollment|2|||
130347025|NCT03025035|469241892|FG000|Overall Study|Death|2|||
130347026|NCT03025035|469241892|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
130347027|NCT02048241|469241893|FG000|Overall Study|Withdrawal by Subject|0|||
130347028|NCT02048241|469241894|FG001|Overall Study|Withdrawal by Subject|1|||
130347029|NCT00402233|469241895|FG000|Overall Study|Adverse Event|1|||
130347030|NCT00402233|469241896|FG001|Overall Study|Adverse Event|7|||
130347031|NCT00402233|469241897|FG002|Overall Study|Adverse Event|9|||
130347032|NCT00402233|469241898|FG003|Overall Study|Adverse Event|9|||
130347033|NCT00402233|469241895|FG000|Overall Study|Protocol Violation|0|||
130347034|NCT00402233|469241896|FG001|Overall Study|Protocol Violation|1|||
130011813|NCT01519765|468005187|FG001|Overall Study|Lack of Efficacy|0|||
130011814|NCT01519765|468005186|FG000|Overall Study|Protocol Violation|1|||
130347035|NCT00402233|469241897|FG002|Overall Study|Protocol Violation|0|||
130347036|NCT00402233|469241898|FG003|Overall Study|Protocol Violation|0|||
130347037|NCT00402233|469241895|FG000|Overall Study|Withdrawal by Subject|2|||
130011815|NCT01519765|468005187|FG001|Overall Study|Protocol Violation|0|||
130011816|NCT01519765|468005186|FG000|Overall Study|Withdrawal by Subject|0|||
130011817|NCT01519765|468005187|FG001|Overall Study|Withdrawal by Subject|1|||
130011818|NCT03610724|468005188|FG000|Overall Study|Death|17|||
130011819|NCT03610724|468005188|FG000|Overall Study|Lost to Follow-up|1|||
130011820|NCT03610724|468005188|FG000|Overall Study|Physician Decision|1|||
130011821|NCT03610724|468005188|FG000|Overall Study|Died prior to infusion|1|||
130011822|NCT02354222|468005189|FG000|Overall Study|Adverse Event|0|||
130011823|NCT02354222|468005190|FG001|Overall Study|Adverse Event|3|||
130011824|NCT02354222|468005189|FG000|Overall Study|Physician Decision|1|||
130011825|NCT02354222|468005190|FG001|Overall Study|Physician Decision|1|||
130011826|NCT02354222|468005189|FG000|Overall Study|Pregnancy|1|||
130011827|NCT02354222|468005190|FG001|Overall Study|Pregnancy|0|||
130011828|NCT02354222|468005189|FG000|Overall Study|Withdrawal by Subject|2|||
130011829|NCT02354222|468005190|FG001|Overall Study|Withdrawal by Subject|3|||
130011830|NCT02354222|468005189|FG000|Overall Study|Conflict with the stopping criteria|0|||
130011831|NCT02354222|468005190|FG001|Overall Study|Conflict with the stopping criteria|4|||
130011832|NCT00786565|468005191|FG000|Enrollment Prior to Surgery|Site Closed|3|||
130011833|NCT00786565|468005191|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
130011834|NCT00786565|468005191|FG000|Post Surgery|Abnormal macular pucker|1|||
130011835|NCT00786565|468005191|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
130011836|NCT05248295|468005202|FG000|Overall Study|found ineligible|4|||
130011837|NCT05248295|468005203|FG001|Overall Study|found ineligible|1|||
130011838|NCT05248295|468005202|FG000|Overall Study|Withdrawal by Subject|0|||
130011839|NCT05248295|468005203|FG001|Overall Study|Withdrawal by Subject|1|||
130011840|NCT05248295|468005202|FG000|Overall Study|Data loss: audio recording error|1|||
130011841|NCT05248295|468005203|FG001|Overall Study|Data loss: audio recording error|1|||
130011842|NCT03021499|468005206|FG000|Overall Study|Adverse Event|1|||
130011843|NCT03021499|468005207|FG001|Overall Study|Adverse Event|0|||
130011844|NCT03021499|468005206|FG000|Overall Study|Death|1|||
130011845|NCT03021499|468005207|FG001|Overall Study|Death|5|||
130011846|NCT03021499|468005206|FG000|Overall Study|Lack of Efficacy|0|||
130011847|NCT03021499|468005207|FG001|Overall Study|Lack of Efficacy|1|||
130011848|NCT03021499|468005206|FG000|Overall Study|Lost to Follow-up|1|||
130011849|NCT03021499|468005207|FG001|Overall Study|Lost to Follow-up|3|||
130011850|NCT03021499|468005206|FG000|Overall Study|Physician Decision|2|||
130011851|NCT03021499|468005207|FG001|Overall Study|Physician Decision|3|||
130011852|NCT03021499|468005206|FG000|Overall Study|Pregnancy|1|||
130011853|NCT03021499|468005207|FG001|Overall Study|Pregnancy|0|||
130011854|NCT03021499|468005206|FG000|Overall Study|Withdrawal by Subject|7|||
130011855|NCT03021499|468005207|FG001|Overall Study|Withdrawal by Subject|14|||
130011856|NCT03021499|468005206|FG000|Overall Study|Prohibited medication required|1|||
130011857|NCT03021499|468005207|FG001|Overall Study|Prohibited medication required|0|||
130011858|NCT03021499|468005206|FG000|Overall Study|Protocol non-compliance|1|||
130011859|NCT03021499|468005207|FG001|Overall Study|Protocol non-compliance|1|||
130011860|NCT03021499|468005206|FG000|Overall Study|None of the above|0|||
130011861|NCT03021499|468005207|FG001|Overall Study|None of the above|4|||
130011862|NCT03021499|468005206|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
130011863|NCT03021499|468005207|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
130011864|NCT01210690|468005208|FG000|Overall Study|Adverse Event|7|||
130011865|NCT01210690|468005208|FG000|Overall Study|Lack of Efficacy|12|||
130011866|NCT01210690|468005208|FG000|Overall Study|Lost to Follow-up|3|||
130011867|NCT01210690|468005208|FG000|Overall Study|Disease Remission|1|||
130011868|NCT01210690|468005208|FG000|Overall Study|Withdrawal by Subject|1|||
130011869|NCT01210690|468005208|FG000|Overall Study|Patient refused to swallow|1|||
130011870|NCT01210690|468005208|FG000|Overall Study|Patient could not take glucose|1|||
130011871|NCT00470054|468005209|FG000|Overall Study|Ineligible|1|||
130011872|NCT04869345|468005216|FG000|Overall Study|Lost to Follow-up|8|||
130011873|NCT04869345|468005217|FG001|Overall Study|Lost to Follow-up|3|||
130011874|NCT00528021|468005221|FG000|Overall Study|Lack of Efficacy|17|||
130011875|NCT00528021|468005222|FG001|Overall Study|Lack of Efficacy|13|||
130011876|NCT00528021|468005223|FG002|Overall Study|Lack of Efficacy|7|||
130011877|NCT00528021|468005224|FG003|Overall Study|Lack of Efficacy|9|||
130011878|NCT04050982|468005225|FG000|Overall Study|Did not meet eligibility criteria|0|||
130011879|NCT04050982|468005226|FG001|Overall Study|Did not meet eligibility criteria|1|||
130011880|NCT04050982|468005227|FG002|Overall Study|Did not meet eligibility criteria|0|||
130011881|NCT04050982|468005225|FG000|Overall Study|Withdrawal by Subject|1|||
130011882|NCT04050982|468005226|FG001|Overall Study|Withdrawal by Subject|0|||
130011883|NCT04050982|468005227|FG002|Overall Study|Withdrawal by Subject|0|||
130011884|NCT04050982|468005225|FG000|Overall Study|Unable to enroll on platform|1|||
130011885|NCT04050982|468005226|FG001|Overall Study|Unable to enroll on platform|0|||
130011886|NCT04050982|468005227|FG002|Overall Study|Unable to enroll on platform|0|||
130011887|NCT05054114|468005228|FG000|Overall Study|Protocol Violation|13|||
130011888|NCT05054114|468005229|FG001|Overall Study|Protocol Violation|1|||
130011889|NCT05054114|468005228|FG000|Overall Study|Pregnancy|0|||
130011890|NCT05054114|468005229|FG001|Overall Study|Pregnancy|1|||
130011891|NCT01423851|468005233|FG000|Whole Study|Disease progression|2|||
130011892|NCT01423851|468005234|FG001|Whole Study|Disease progression|1|||
130011893|NCT01423851|468005235|FG002|Whole Study|Disease progression|1|||
130011894|NCT01423851|468005236|FG003|Whole Study|Disease progression|4|||
130011895|NCT01423851|468005237|FG004|Whole Study|Disease progression|1|||
130011896|NCT01423851|468005238|FG005|Whole Study|Disease progression|3|||
130011897|NCT01423851|468005239|FG006|Whole Study|Disease progression|1|||
130011898|NCT01423851|468005240|FG007|Whole Study|Disease progression|4|||
130011899|NCT01423851|468005241|FG008|Whole Study|Disease progression|0|||
130011900|NCT01423851|468005242|FG009|Whole Study|Disease progression|2|||
130011901|NCT01423851|468005243|FG010|Whole Study|Disease progression|10|||
130011902|NCT01423851|468005233|FG000|Whole Study|Physician Decision|0|||
130011903|NCT01423851|468005234|FG001|Whole Study|Physician Decision|1|||
130011904|NCT01423851|468005235|FG002|Whole Study|Physician Decision|2|||
130011905|NCT01423851|468005236|FG003|Whole Study|Physician Decision|0|||
130011906|NCT01423851|468005237|FG004|Whole Study|Physician Decision|2|||
130011907|NCT01423851|468005238|FG005|Whole Study|Physician Decision|0|||
130011908|NCT01423851|468005239|FG006|Whole Study|Physician Decision|2|||
130011909|NCT01423851|468005240|FG007|Whole Study|Physician Decision|1|||
130011910|NCT01423851|468005241|FG008|Whole Study|Physician Decision|3|||
130011911|NCT01423851|468005242|FG009|Whole Study|Physician Decision|4|||
130011912|NCT01423851|468005243|FG010|Whole Study|Physician Decision|12|||
130011913|NCT01423851|468005233|FG000|Whole Study|Withdrawal by Subject|1|||
130011914|NCT01423851|468005234|FG001|Whole Study|Withdrawal by Subject|1|||
130011915|NCT01423851|468005235|FG002|Whole Study|Withdrawal by Subject|0|||
130011916|NCT01423851|468005236|FG003|Whole Study|Withdrawal by Subject|0|||
130011917|NCT01423851|468005237|FG004|Whole Study|Withdrawal by Subject|0|||
130011918|NCT01423851|468005238|FG005|Whole Study|Withdrawal by Subject|0|||
130011919|NCT01423851|468005239|FG006|Whole Study|Withdrawal by Subject|0|||
130011920|NCT01423851|468005240|FG007|Whole Study|Withdrawal by Subject|0|||
130011921|NCT01423851|468005241|FG008|Whole Study|Withdrawal by Subject|2|||
130011922|NCT01423851|468005242|FG009|Whole Study|Withdrawal by Subject|0|||
130011923|NCT01423851|468005243|FG010|Whole Study|Withdrawal by Subject|4|||
130011924|NCT01423851|468005233|FG000|Whole Study|Adverse Event|0|||
130011925|NCT01423851|468005234|FG001|Whole Study|Adverse Event|0|||
130011926|NCT01423851|468005235|FG002|Whole Study|Adverse Event|0|||
130011927|NCT01423851|468005236|FG003|Whole Study|Adverse Event|2|||
130011928|NCT01423851|468005237|FG004|Whole Study|Adverse Event|0|||
130011929|NCT01423851|468005238|FG005|Whole Study|Adverse Event|0|||
130011930|NCT01423851|468005239|FG006|Whole Study|Adverse Event|0|||
130011931|NCT01423851|468005240|FG007|Whole Study|Adverse Event|3|||
130011932|NCT01423851|468005241|FG008|Whole Study|Adverse Event|3|||
130011933|NCT01423851|468005242|FG009|Whole Study|Adverse Event|2|||
130011934|NCT01423851|468005243|FG010|Whole Study|Adverse Event|3|||
130011935|NCT00916357|468007175|FG000|Period 1|Withdrawal by Subject|1|||
130011936|NCT00916357|468007176|FG001|Period 1|Withdrawal by Subject|0|||
130011937|NCT00916357|468007177|FG002|Period 1|Withdrawal by Subject|0|||
130011938|NCT00916357|468007178|FG003|Period 1|Withdrawal by Subject|0|||
130011939|NCT00916357|468007179|FG004|Period 1|Withdrawal by Subject|0|||
130011940|NCT00916357|468007180|FG005|Period 1|Withdrawal by Subject|0|||
130011941|NCT00916357|468007175|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
130011942|NCT00916357|468007176|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
130011943|NCT00916357|468007177|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
130011944|NCT00916357|468007178|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
130011945|NCT00916357|468007179|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
130011946|NCT00916357|468007180|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
130011947|NCT01773109|468007181|FG000|Overall Study|Symptomatic Progression|2|||
130011948|NCT01773109|468007181|FG000|Overall Study|Death|1|||
130011949|NCT01239342|468007182|FG000|Overall Study|Adverse Event|1|||
130011950|NCT01239342|468007183|FG001|Overall Study|Adverse Event|0|||
130011951|NCT01239342|468007182|FG000|Overall Study|Withdrawal by Subject|1|||
130011952|NCT01239342|468007183|FG001|Overall Study|Withdrawal by Subject|5|||
130011953|NCT01239342|468007182|FG000|Overall Study|Reason Unknown|1|||
130011954|NCT01239342|468007183|FG001|Overall Study|Reason Unknown|1|||
130011955|NCT02495844|468007184|FG000|Overall Study|Lack of Efficacy|1|||
130011956|NCT02495844|468007185|FG001|Overall Study|Lack of Efficacy|2|||
130011957|NCT02495844|468007184|FG000|Overall Study|AE, non-fatal|0|||
130011958|NCT02495844|468007185|FG001|Overall Study|AE, non-fatal|1|||
130011959|NCT02495844|468007184|FG000|Overall Study|Hepatitis Positivity|0|||
130011960|NCT02495844|468007185|FG001|Overall Study|Hepatitis Positivity|1|||
130011961|NCT02325219|468007188|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
130011962|NCT02325219|468007189|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
130011963|NCT02325219|468007190|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
130011964|NCT02325219|468007191|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
130347038|NCT00402233|469241896|FG001|Overall Study|Withdrawal by Subject|1|||
130347039|NCT00402233|469241897|FG002|Overall Study|Withdrawal by Subject|2|||
130347040|NCT00402233|469241898|FG003|Overall Study|Withdrawal by Subject|2|||
130347041|NCT00402233|469241895|FG000|Overall Study|Worsening of disease under study|2|||
130347042|NCT00402233|469241896|FG001|Overall Study|Worsening of disease under study|0|||
130347043|NCT00402233|469241897|FG002|Overall Study|Worsening of disease under study|0|||
130347044|NCT00402233|469241898|FG003|Overall Study|Worsening of disease under study|0|||
130347045|NCT00402233|469241895|FG000|Overall Study|Worsening of other pre-existing disease|0|||
130347046|NCT00402233|469241896|FG001|Overall Study|Worsening of other pre-existing disease|1|||
130347047|NCT00402233|469241897|FG002|Overall Study|Worsening of other pre-existing disease|0|||
130011965|NCT02325219|468007192|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
130011966|NCT02325219|468007188|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
130011967|NCT02325219|468007189|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
130011968|NCT02325219|468007190|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130011969|NCT02325219|468007191|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130011970|NCT02325219|468007192|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
130011971|NCT02325219|468007188|FG000|Controlled Period (Week 0 - 16)|Other|0|||
130011972|NCT02325219|468007189|FG001|Controlled Period (Week 0 - 16)|Other|0|||
130011973|NCT02325219|468007190|FG002|Controlled Period (Week 0 - 16)|Other|1|||
130011974|NCT02325219|468007191|FG003|Controlled Period (Week 0 - 16)|Other|0|||
130011975|NCT02325219|468007192|FG004|Controlled Period (Week 0 - 16)|Other|0|||
130011976|NCT02325219|468007188|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130011977|NCT02325219|468007189|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130347048|NCT00402233|469241898|FG003|Overall Study|Worsening of other pre-existing disease|0|||
130347049|NCT04658940|469241899|FG000|Overall Study|Withdrawal by Subject|1|||
130347050|NCT03579602|469241900|FG000|Overall Study|Subject unable to receive study drug|0|||
130347051|NCT03579602|469241901|FG001|Overall Study|Subject unable to receive study drug|2|||
130347052|NCT03579602|469241900|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
130347053|NCT03579602|469241901|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
130347054|NCT02518464|469241902|FG000|Overall Study|Adverse Event|2|||
130347055|NCT01120067|469241903|FG000|Overall Study|Lost to Follow-up|3|||
130347056|NCT01120067|469241904|FG001|Overall Study|Lost to Follow-up|1|||
130347057|NCT01120067|469241903|FG000|Overall Study|fail to engage >3 sessions|2|||
130347058|NCT01120067|469241904|FG001|Overall Study|fail to engage >3 sessions|0|||
130347059|NCT00266877|469241905|FG000|Overall Study|Death|1|||
130347060|NCT00266877|469241906|FG001|Overall Study|Death|1|||
130347061|NCT00266877|469241907|FG002|Overall Study|Death|1|||
130347062|NCT00266877|469241905|FG000|Overall Study|Adverse Event|6|||
130347063|NCT00266877|469241906|FG001|Overall Study|Adverse Event|4|||
130347064|NCT00266877|469241907|FG002|Overall Study|Adverse Event|1|||
130347065|NCT00266877|469241905|FG000|Overall Study|Physician Decision|2|||
130347066|NCT00266877|469241906|FG001|Overall Study|Physician Decision|1|||
130347067|NCT00266877|469241907|FG002|Overall Study|Physician Decision|1|||
130347068|NCT00266877|469241905|FG000|Overall Study|Withdrawal by Subject|3|||
130347069|NCT00266877|469241906|FG001|Overall Study|Withdrawal by Subject|1|||
130347070|NCT00266877|469241907|FG002|Overall Study|Withdrawal by Subject|1|||
130347071|NCT00266877|469241905|FG000|Overall Study|Disease Progression|72|||
130347072|NCT00266877|469241906|FG001|Overall Study|Disease Progression|37|||
130347073|NCT00266877|469241907|FG002|Overall Study|Disease Progression|23|||
130347074|NCT00266877|469241905|FG000|Overall Study|Symptomatic Deterioration|6|||
130347075|NCT00266877|469241906|FG001|Overall Study|Symptomatic Deterioration|3|||
130347076|NCT00266877|469241907|FG002|Overall Study|Symptomatic Deterioration|1|||
130347077|NCT00266877|469241905|FG000|Overall Study|Hospitalization|1|||
130347078|NCT00266877|469241906|FG001|Overall Study|Hospitalization|0|||
130347079|NCT00266877|469241907|FG002|Overall Study|Hospitalization|0|||
130347080|NCT00266877|469241905|FG000|Overall Study|Concomitant Radiotherapy|0|||
130011978|NCT02325219|468007190|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130011979|NCT02325219|468007191|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
130011980|NCT02325219|468007192|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
130011981|NCT02325219|468007188|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130011982|NCT02325219|468007189|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
130011983|NCT02325219|468007190|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130011984|NCT02325219|468007191|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130011985|NCT02325219|468007192|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
130011986|NCT02325219|468007188|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130011987|NCT02325219|468007189|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
130011988|NCT02325219|468007190|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130011989|NCT02325219|468007191|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130011990|NCT02325219|468007192|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
130011991|NCT02918864|468007193|FG000|Overall Study|Withdrawal by Subject|1|||
130011992|NCT02918864|468007194|FG001|Overall Study|Withdrawal by Subject|1|||
130011993|NCT02918864|468007193|FG000|Overall Study|Lost to Follow-up|3|||
130011994|NCT02918864|468007194|FG001|Overall Study|Lost to Follow-up|2|||
130011995|NCT04766021|468007195|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
130011996|NCT04766021|468007195|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
130011997|NCT02257372|468007199|FG000|Overall Study|Adverse Event|3|||
130011998|NCT02257372|468007200|FG001|Overall Study|Adverse Event|7|||
130011999|NCT02257372|468007199|FG000|Overall Study|Lack of Efficacy|2|||
130012000|NCT02257372|468007200|FG001|Overall Study|Lack of Efficacy|1|||
130012001|NCT02257372|468007199|FG000|Overall Study|Protocol Violation|1|||
130012002|NCT02257372|468007200|FG001|Overall Study|Protocol Violation|1|||
130012003|NCT02257372|468007199|FG000|Overall Study|Lost to Follow-up|0|||
130012004|NCT02257372|468007200|FG001|Overall Study|Lost to Follow-up|1|||
130012005|NCT02257372|468007199|FG000|Overall Study|Withdrew consent|1|||
130012006|NCT02257372|468007200|FG001|Overall Study|Withdrew consent|0|||
130012007|NCT00789529|468007201|FG000|Overall Study|Withdrawal by Subject|0|||
130012008|NCT00789529|468007202|FG001|Overall Study|Withdrawal by Subject|1|||
130012009|NCT00789529|468007201|FG000|Overall Study|Other Reason|1|||
130012010|NCT00789529|468007202|FG001|Overall Study|Other Reason|0|||
130012011|NCT02634151|468007203|FG000|Overall Study|Withdrawal by Subject|1|||
130012012|NCT02634151|468007204|FG001|Overall Study|Withdrawal by Subject|0|||
130012013|NCT02634151|468007203|FG000|Overall Study|Non-Compliance|0|||
130012014|NCT02634151|468007204|FG001|Overall Study|Non-Compliance|1|||
130012015|NCT02634151|468007203|FG000|Overall Study|Other|0|||
130012016|NCT02634151|468007204|FG001|Overall Study|Other|1|||
130012017|NCT02347098|468007205|FG000|Overall Study|Death|1|||
130012018|NCT02347098|468007206|FG001|Overall Study|Death|0|||
130012019|NCT02347098|468007205|FG000|Overall Study|Withdrawal by Subject|1|||
130012020|NCT02347098|468007206|FG001|Overall Study|Withdrawal by Subject|0|||
130012021|NCT02347098|468007205|FG000|Overall Study|Lost to Follow-up|2|||
130012022|NCT02347098|468007206|FG001|Overall Study|Lost to Follow-up|2|||
130012023|NCT02347098|468007205|FG000|Overall Study|Refuse Follow-up Visit|1|||
130012024|NCT02347098|468007206|FG001|Overall Study|Refuse Follow-up Visit|5|||
130012025|NCT02347098|468007205|FG000|Overall Study|no visit due to illness|2|||
130012026|NCT02347098|468007206|FG001|Overall Study|no visit due to illness|1|||
130012027|NCT02187172|468007207|FG000|Overall Study|Lost to Follow-up|1|||
130012028|NCT02187172|468007208|FG001|Overall Study|Lost to Follow-up|2|||
130012029|NCT02187172|468007207|FG000|Overall Study|Lack of Efficacy|1|||
130012030|NCT02187172|468007208|FG001|Overall Study|Lack of Efficacy|2|||
130012031|NCT02187172|468007207|FG000|Overall Study|Adverse Event|0|||
130012032|NCT02187172|468007208|FG001|Overall Study|Adverse Event|1|||
130012033|NCT02187172|468007207|FG000|Overall Study|Physician Decision|1|||
130012034|NCT02187172|468007208|FG001|Overall Study|Physician Decision|1|||
130012035|NCT00880399|468007209|FG000|Overall Study|Adverse Event|4|||
130012036|NCT00880399|468007210|FG001|Overall Study|Adverse Event|6|||
130012037|NCT00880399|468007211|FG002|Overall Study|Adverse Event|5|||
130012038|NCT00880399|468007209|FG000|Overall Study|Lack of Efficacy|1|||
130012039|NCT00880399|468007210|FG001|Overall Study|Lack of Efficacy|4|||
130012040|NCT00880399|468007211|FG002|Overall Study|Lack of Efficacy|2|||
130012041|NCT00880399|468007209|FG000|Overall Study|Protocol Violation|4|||
130012042|NCT00880399|468007210|FG001|Overall Study|Protocol Violation|4|||
130012043|NCT00880399|468007211|FG002|Overall Study|Protocol Violation|6|||
130012044|NCT00880399|468007209|FG000|Overall Study|Study closed/terminated|3|||
130012045|NCT00880399|468007210|FG001|Overall Study|Study closed/terminated|7|||
130012046|NCT00880399|468007211|FG002|Overall Study|Study closed/terminated|4|||
130012047|NCT00880399|468007209|FG000|Overall Study|Lost to Follow-up|8|||
130012048|NCT00880399|468007210|FG001|Overall Study|Lost to Follow-up|5|||
130012049|NCT00880399|468007211|FG002|Overall Study|Lost to Follow-up|3|||
130012050|NCT00880399|468007209|FG000|Overall Study|Physician Decision|5|||
130012051|NCT00880399|468007210|FG001|Overall Study|Physician Decision|0|||
130012052|NCT00880399|468007211|FG002|Overall Study|Physician Decision|3|||
130347081|NCT00266877|469241906|FG001|Overall Study|Concomitant Radiotherapy|1|||
130347082|NCT00266877|469241907|FG002|Overall Study|Concomitant Radiotherapy|0|||
130347083|NCT03985878|469241909|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
130347084|NCT03985878|469241909|FG000|Overall Study|Study Terminated by Sponsor|12|||
130347085|NCT03985878|469241909|FG000|Overall Study|Withdrawal by Subject|1|||
130347086|NCT00278915|469241912|FG000|Overall Study|Disease progression|1|||
130347087|NCT02520089|469241913|FG000|Overall Study|Lost to Follow-up|3|||
130347088|NCT02520089|469241914|FG001|Overall Study|Lost to Follow-up|4|||
130347089|NCT03473548|469241917|FG000|Overall Study|Did not attempt HST testing|3|||
130347090|NCT03473548|469241918|FG001|Overall Study|Did not attempt HST testing|0|||
130347091|NCT00129311|469241920|FG000|Overall Study|Withdrawal by Subject|12|||
130347092|NCT00129311|469241921|FG001|Overall Study|Withdrawal by Subject|19|||
130012053|NCT00880399|468007209|FG000|Overall Study|Withdrawal by Subject|6|||
130347093|NCT02232880|469241922|FG000|Overall Study|study stopped prior to randomization|1|||
130347094|NCT02545543|469241923|FG000|Overall Study|Lost to Follow-up|67|||
130347095|NCT02545543|469241924|FG001|Overall Study|Lost to Follow-up|25|||
130347096|NCT02545543|469241923|FG000|Overall Study|Physician Decision|3|||
130347097|NCT02545543|469241924|FG001|Overall Study|Physician Decision|0|||
130347098|NCT02545543|469241923|FG000|Overall Study|Withdrawal by Subject|9|||
130347099|NCT02545543|469241924|FG001|Overall Study|Withdrawal by Subject|8|||
130347100|NCT02545543|469241923|FG000|Overall Study|Noncomplaince|1|||
130347101|NCT02545543|469241924|FG001|Overall Study|Noncomplaince|0|||
130347102|NCT02545543|469241923|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
130347103|NCT02545543|469241924|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
130347104|NCT02829944|469241928|FG000|Overall Study|Physician Decision|0|||
130347105|NCT02829944|469241929|FG001|Overall Study|Physician Decision|1|||
130347106|NCT02829944|469241928|FG000|Overall Study|Screen Failure|2|||
130347107|NCT02829944|469241929|FG001|Overall Study|Screen Failure|2|||
130347108|NCT02829944|469241928|FG000|Overall Study|Inadequate Neuraxial Block|1|||
130347109|NCT02829944|469241929|FG001|Overall Study|Inadequate Neuraxial Block|1|||
130347110|NCT02829944|469241928|FG000|Overall Study|Withdrawal by Subject|2|||
130012054|NCT00880399|468007210|FG001|Overall Study|Withdrawal by Subject|3|||
130012055|NCT00880399|468007211|FG002|Overall Study|Withdrawal by Subject|3|||
130012056|NCT04353284|468007216|FG000|Overall Study|Adverse Event|1|||
130012057|NCT04353284|468007217|FG001|Overall Study|Adverse Event|1|||
130012058|NCT04353284|468007216|FG000|Overall Study|Lost to Follow-up|1|||
130012059|NCT04353284|468007217|FG001|Overall Study|Lost to Follow-up|0|||
130347111|NCT02829944|469241929|FG001|Overall Study|Withdrawal by Subject|1|||
130347112|NCT02829944|469241928|FG000|Overall Study|Catheter Displacement|1|||
130347113|NCT02829944|469241929|FG001|Overall Study|Catheter Displacement|0|||
130347114|NCT02829944|469241928|FG000|Overall Study|Catheter broke|0|||
130012060|NCT00766532|468007226|FG000|Overall Study|Protocol Violation|2|||
130347115|NCT02829944|469241929|FG001|Overall Study|Catheter broke|1|||
130347116|NCT02829944|469241928|FG000|Overall Study|Staff unavailable|0|||
130347117|NCT02829944|469241929|FG001|Overall Study|Staff unavailable|1|||
130347118|NCT00336583|469243525|FG000|Overall Study|Lost to Follow-up|1|||
130347119|NCT00336583|469243525|FG000|Overall Study|Death|1|||
130347120|NCT00910247|469243526|FG000|Overall Study|Adverse Event|15|||
130347121|NCT00910247|469243526|FG000|Overall Study|Death|2|||
130347122|NCT00910247|469243526|FG000|Overall Study|Lost to Follow-up|10|||
130347123|NCT00910247|469243526|FG000|Overall Study|Physician Decision|3|||
130347124|NCT00910247|469243526|FG000|Overall Study|Protocol Violation|10|||
130347125|NCT00910247|469243526|FG000|Overall Study|Withdrawal by Subject|25|||
130347126|NCT00910247|469243526|FG000|Overall Study|Not collected|4|||
130347127|NCT02927067|469243527|FG000|Overall Study|Withdrawn Consent|20|||
130347128|NCT02927067|469243528|FG001|Overall Study|Withdrawn Consent|12|||
130347129|NCT02927067|469243527|FG000|Overall Study|Death|18|||
130347130|NCT02927067|469243528|FG001|Overall Study|Death|31|||
130347131|NCT02927067|469243527|FG000|Overall Study|Adverse Event|13|||
130347132|NCT02927067|469243528|FG001|Overall Study|Adverse Event|10|||
130347133|NCT02927067|469243527|FG000|Overall Study|Noncompliance|5|||
130347134|NCT02927067|469243528|FG001|Overall Study|Noncompliance|2|||
130347135|NCT02927067|469243527|FG000|Overall Study|Reason not Specified|4|||
130012061|NCT02037295|468007230|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
130012062|NCT02037295|468007231|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
130012063|NCT02037295|468007232|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
130012064|NCT02037295|468007233|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
130012065|NCT00441974|468007234|FG000|Overall Study|Adverse Event|6|||
130012066|NCT00441974|468007234|FG000|Overall Study|Consent Withdrawn|35|||
130012067|NCT00441974|468007234|FG000|Overall Study|Lost to Follow-up|80|||
130012068|NCT00441974|468007234|FG000|Overall Study|Protocol Violation|7|||
130012069|NCT02770547|468007235|FG000|Overall Study|Patient non-compliant|1|||
130012070|NCT02770547|468007236|FG001|Overall Study|Patient non-compliant|0|||
130012071|NCT02770547|468007235|FG000|Overall Study|Adverse Event|0|||
130012072|NCT02770547|468007236|FG001|Overall Study|Adverse Event|1|||
130012073|NCT00393887|468007237|FG000|Overall Study|Physician Decision|5|||
130012074|NCT00393887|468007238|FG001|Overall Study|Physician Decision|0|||
130012075|NCT00393887|468007237|FG000|Overall Study|Lost to Follow-up|11|||
130012076|NCT00393887|468007238|FG001|Overall Study|Lost to Follow-up|9|||
130012077|NCT04962022|468007241|FG000|Period 1|Withdrawal by Subject|1|||
130012078|NCT04962022|468007242|FG001|Period 1|Withdrawal by Subject|0|||
130012079|NCT01146873|468007245|FG000|Overall Study|Transfer out|0|||
130012080|NCT01146873|468007246|FG001|Overall Study|Transfer out|6|||
130012081|NCT01967628|468007247|FG000|Overall Study|Withdrawal by Subject|2|||
130012082|NCT01967628|468007248|FG001|Overall Study|Withdrawal by Subject|0|||
130012083|NCT01967628|468007247|FG000|Overall Study|Unable to complete bronchoscopy|4|||
130012084|NCT01967628|468007248|FG001|Overall Study|Unable to complete bronchoscopy|6|||
130012085|NCT01967628|468007247|FG000|Overall Study|Lost to Follow-up|1|||
130012086|NCT01967628|468007248|FG001|Overall Study|Lost to Follow-up|0|||
130012087|NCT01967628|468007247|FG000|Overall Study|Low protein concentration in sample|20|||
130012088|NCT01967628|468007248|FG001|Overall Study|Low protein concentration in sample|25|||
130012089|NCT02055820|468007251|FG000|Phase I: Dose-Finding|Death|1|||
130012090|NCT02055820|468007252|FG001|Phase I: Dose-Finding|Death|0|||
130012091|NCT02055820|468007253|FG002|Phase I: Dose-Finding|Death|1|||
130012092|NCT02055820|468007254|FG003|Phase I: Dose-Finding|Death|2|||
130012093|NCT02055820|468007255|FG004|Phase I: Dose-Finding|Death|0|||
130012094|NCT02055820|468007256|FG005|Phase I: Dose-Finding|Death|1|||
130012095|NCT02055820|468007257|FG006|Phase I: Dose-Finding|Death|1|||
130012096|NCT02055820|468007258|FG007|Phase I: Dose-Finding|Death|0|||
130012097|NCT02055820|468007259|FG008|Phase I: Dose-Finding|Death|0|||
130012098|NCT02055820|468007260|FG009|Phase I: Dose-Finding|Death|0|||
130012099|NCT02055820|468007251|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012100|NCT02055820|468007252|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012101|NCT02055820|468007253|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012102|NCT02055820|468007254|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130347136|NCT02927067|469243528|FG001|Overall Study|Reason not Specified|6|||
130347137|NCT01727700|469243531|FG000|Overall Study|Adverse Event|0|||
130012103|NCT02055820|468007255|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012104|NCT02055820|468007256|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
130347138|NCT01727700|469243532|FG001|Overall Study|Adverse Event|7|||
130347139|NCT01727700|469243533|FG002|Overall Study|Adverse Event|1|||
130012105|NCT02055820|468007257|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012106|NCT02055820|468007258|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012107|NCT02055820|468007259|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012108|NCT02055820|468007260|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
130012109|NCT02055820|468007251|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
130347140|NCT01727700|469243531|FG000|Overall Study|Particpant withdrew consent|0|||
130347141|NCT01727700|469243532|FG001|Overall Study|Particpant withdrew consent|3|||
130347142|NCT01727700|469243533|FG002|Overall Study|Particpant withdrew consent|1|||
130012110|NCT02055820|468007252|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012111|NCT02055820|468007253|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012112|NCT02055820|468007254|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
130012113|NCT02055820|468007255|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012114|NCT02055820|468007256|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012115|NCT02055820|468007257|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
130012116|NCT02055820|468007258|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012117|NCT02055820|468007259|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012118|NCT02055820|468007260|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
130012119|NCT02055820|468007251|FG000|Phase II: Expansion|Death|0|||
130012120|NCT02055820|468007252|FG001|Phase II: Expansion|Death|0|||
130012121|NCT02055820|468007253|FG002|Phase II: Expansion|Death|0|||
130012122|NCT02055820|468007254|FG003|Phase II: Expansion|Death|0|||
130012123|NCT02055820|468007255|FG004|Phase II: Expansion|Death|33|||
130012124|NCT02055820|468007256|FG005|Phase II: Expansion|Death|0|||
130012125|NCT02055820|468007257|FG006|Phase II: Expansion|Death|0|||
130012126|NCT02055820|468007258|FG007|Phase II: Expansion|Death|0|||
130012127|NCT02055820|468007259|FG008|Phase II: Expansion|Death|0|||
130012128|NCT02055820|468007260|FG009|Phase II: Expansion|Death|0|||
130216617|NCT03162328|468755621|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
130347143|NCT01727700|469243531|FG000|Overall Study|Protocol Violation|2|||
130012129|NCT02055820|468007251|FG000|Phase II: Expansion|Lost to Follow-up|0|||
130347144|NCT01727700|469243532|FG001|Overall Study|Protocol Violation|0|||
130347145|NCT01727700|469243533|FG002|Overall Study|Protocol Violation|0|||
130347146|NCT01757691|469243537|FG000|Overall Study|Administrative problems|2|||
130347147|NCT01757691|469243538|FG001|Overall Study|Administrative problems|0|||
130347148|NCT02054481|469243541|FG000|Overall Study|Adverse Event|1|||
130347149|NCT02054481|469243542|FG001|Overall Study|Adverse Event|1|||
130347150|NCT02054481|469243543|FG002|Overall Study|Adverse Event|0|||
130347151|NCT02054481|469243544|FG003|Overall Study|Adverse Event|1|||
130347152|NCT02054481|469243541|FG000|Overall Study|Lost to Follow-up|1|||
130347153|NCT02054481|469243542|FG001|Overall Study|Lost to Follow-up|0|||
130347154|NCT02054481|469243543|FG002|Overall Study|Lost to Follow-up|0|||
130347155|NCT02054481|469243544|FG003|Overall Study|Lost to Follow-up|0|||
130347156|NCT02054481|469243541|FG000|Overall Study|Other reason|2|||
130347157|NCT02054481|469243542|FG001|Overall Study|Other reason|1|||
130347158|NCT02054481|469243543|FG002|Overall Study|Other reason|2|||
130347159|NCT02054481|469243544|FG003|Overall Study|Other reason|0|||
130347160|NCT02320903|469243545|FG000|Overall Study|Withdrawal by Subject|0|||
130347161|NCT02320903|469243546|FG001|Overall Study|Withdrawal by Subject|9|||
130347162|NCT02320903|469243547|FG002|Overall Study|Withdrawal by Subject|9|||
130347163|NCT02320903|469243545|FG000|Overall Study|Exited therapy; no longer eligible|8|||
130347164|NCT02320903|469243546|FG001|Overall Study|Exited therapy; no longer eligible|2|||
130347165|NCT02320903|469243547|FG002|Overall Study|Exited therapy; no longer eligible|2|||
130347166|NCT02320903|469243545|FG000|Overall Study|Lost to Follow-up|0|||
130347167|NCT02320903|469243546|FG001|Overall Study|Lost to Follow-up|5|||
130347168|NCT02320903|469243547|FG002|Overall Study|Lost to Follow-up|5|||
130347169|NCT01095094|469243551|FG000|Overall Study|Withdrawal by Subject|1|||
130347170|NCT01095094|469243551|FG000|Overall Study|Death|1|||
130347171|NCT01095094|469243551|FG000|Overall Study|Physician Decision|1|||
130347172|NCT05347147|469243552|FG000|Overall Study|Lost to Follow-up|0|||
130347173|NCT05347147|469243553|FG001|Overall Study|Lost to Follow-up|1|||
130347174|NCT05347147|469243552|FG000|Overall Study|Sponsor request|3|||
130347175|NCT05347147|469243553|FG001|Overall Study|Sponsor request|3|||
130347176|NCT05347147|469243552|FG000|Overall Study|Study termination|2|||
130347177|NCT05347147|469243553|FG001|Overall Study|Study termination|1|||
130347178|NCT01122394|469243558|FG000|Overall Study|Withdrawal by Subject|1|||
130347179|NCT01122394|469243559|FG001|Overall Study|Withdrawal by Subject|1|||
130347180|NCT01122394|469243558|FG000|Overall Study|Lost to Follow-up|2|||
130347181|NCT01122394|469243559|FG001|Overall Study|Lost to Follow-up|2|||
130347182|NCT01122394|469243558|FG000|Overall Study|Adverse Event|0|||
130347183|NCT01122394|469243559|FG001|Overall Study|Adverse Event|1|||
130347184|NCT02446743|469243560|FG000|Overall Study|Withdrawal by Subject|1|||
130347185|NCT02446743|469243561|FG001|Overall Study|Withdrawal by Subject|1|||
130347186|NCT02446743|469243560|FG000|Overall Study|Lost to Follow-up|1|||
130347187|NCT02446743|469243561|FG001|Overall Study|Lost to Follow-up|0|||
130347188|NCT02446743|469243560|FG000|Overall Study|Adverse Event|1|||
130347189|NCT02446743|469243561|FG001|Overall Study|Adverse Event|1|||
130347190|NCT02446743|469243560|FG000|Overall Study|Other|2|||
130347191|NCT02446743|469243561|FG001|Overall Study|Other|3|||
130347192|NCT03361176|469243562|FG000|Overall Study|Lost to Follow-up|1|||
130347193|NCT03361176|469243563|FG001|Overall Study|Lost to Follow-up|2|||
130347194|NCT03361176|469243562|FG000|Overall Study|Adverse Event|0|||
130347195|NCT03361176|469243563|FG001|Overall Study|Adverse Event|2|||
130347196|NCT03361176|469243562|FG000|Overall Study|Withdrawal by Subject|0|||
130347197|NCT03361176|469243563|FG001|Overall Study|Withdrawal by Subject|1|||
130347198|NCT03718299|469243564|FG000|Overall Study|Adverse Event|1|||
130347199|NCT03718299|469243564|FG000|Overall Study|Withdrawal by Subject|6|||
130347200|NCT03718299|469243564|FG000|Overall Study|Physician Decision|2|||
130347201|NCT03718299|469243564|FG000|Overall Study|Lost to Follow-up|1|||
130347202|NCT04389970|469243565|FG000|Overall Study|Lost to Follow-up|1|||
130347203|NCT01931670|469243567|FG000|Treatment Period|Exclusionary Medication Received|1|||
130347204|NCT01931670|469243568|FG001|Treatment Period|Exclusionary Medication Received|1|||
130347205|NCT01931670|469243569|FG002|Treatment Period|Exclusionary Medication Received|1|||
130347206|NCT01931670|469243567|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
130347207|NCT01931670|469243568|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
130347208|NCT01931670|469243569|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
130347209|NCT01931670|469243567|FG000|Treatment Period|Subject Noncompliant|4|||
130347210|NCT01931670|469243568|FG001|Treatment Period|Subject Noncompliant|9|||
130012130|NCT02055820|468007252|FG001|Phase II: Expansion|Lost to Follow-up|0|||
130012131|NCT02055820|468007253|FG002|Phase II: Expansion|Lost to Follow-up|0|||
130012132|NCT02055820|468007254|FG003|Phase II: Expansion|Lost to Follow-up|0|||
130012133|NCT02055820|468007255|FG004|Phase II: Expansion|Lost to Follow-up|4|||
130347211|NCT01931670|469243569|FG002|Treatment Period|Subject Noncompliant|5|||
130347212|NCT01931670|469243567|FG000|Treatment Period|Adverse Event|19|||
130347213|NCT01931670|469243568|FG001|Treatment Period|Adverse Event|8|||
130347214|NCT01931670|469243569|FG002|Treatment Period|Adverse Event|21|||
130347215|NCT01931670|469243567|FG000|Treatment Period|Lack of Efficacy|11|||
130347216|NCT01931670|469243568|FG001|Treatment Period|Lack of Efficacy|2|||
130347217|NCT01931670|469243569|FG002|Treatment Period|Lack of Efficacy|2|||
130347218|NCT01931670|469243567|FG000|Treatment Period|Pregnancy|7|||
130347219|NCT01931670|469243568|FG001|Treatment Period|Pregnancy|2|||
130347220|NCT01931670|469243569|FG002|Treatment Period|Pregnancy|0|||
130347221|NCT01931670|469243567|FG000|Treatment Period|Other|8|||
130347222|NCT01931670|469243568|FG001|Treatment Period|Other|7|||
130347223|NCT01931670|469243569|FG002|Treatment Period|Other|2|||
130347224|NCT01931670|469243567|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
130347225|NCT01931670|469243568|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
130347226|NCT01931670|469243569|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
130347227|NCT01931670|469243567|FG000|Treatment Period|Lost to Follow-up|19|||
130347228|NCT01931670|469243568|FG001|Treatment Period|Lost to Follow-up|5|||
130347229|NCT01931670|469243569|FG002|Treatment Period|Lost to Follow-up|7|||
130347230|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
130347231|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
130347232|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
130347233|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
130347234|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
130347235|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
130347236|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
130347237|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
130347238|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
130347239|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
130347240|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
130347241|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
130347242|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
130347243|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
130347244|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
130347245|NCT01931670|469243567|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
130012134|NCT02055820|468007256|FG005|Phase II: Expansion|Lost to Follow-up|0|||
130012135|NCT02055820|468007257|FG006|Phase II: Expansion|Lost to Follow-up|0|||
130012136|NCT02055820|468007258|FG007|Phase II: Expansion|Lost to Follow-up|0|||
130012137|NCT02055820|468007259|FG008|Phase II: Expansion|Lost to Follow-up|0|||
130012138|NCT02055820|468007260|FG009|Phase II: Expansion|Lost to Follow-up|0|||
130012139|NCT02055820|468007251|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
130012140|NCT02055820|468007252|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
130012141|NCT02055820|468007253|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
130347246|NCT01931670|469243568|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
130347247|NCT01931670|469243569|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
130347248|NCT00976508|469243570|FG000|Overall Study|Death|7|||
130347249|NCT00976508|469243571|FG001|Overall Study|Death|1|||
130347250|NCT00976508|469243570|FG000|Overall Study|Lost to Follow-up|1|||
130347251|NCT00976508|469243571|FG001|Overall Study|Lost to Follow-up|0|||
130347252|NCT00976508|469243570|FG000|Overall Study|Withdrawal by Subject|1|||
130347253|NCT00976508|469243571|FG001|Overall Study|Withdrawal by Subject|0|||
130347254|NCT00976508|469243570|FG000|Overall Study|Disease Progression|4|||
130012142|NCT02055820|468007254|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
130012143|NCT02055820|468007255|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
130347255|NCT00976508|469243571|FG001|Overall Study|Disease Progression|4|||
130347256|NCT00976508|469243570|FG000|Overall Study|Subject Enrolled in Hospice|1|||
130347257|NCT00976508|469243571|FG001|Overall Study|Subject Enrolled in Hospice|0|||
130347258|NCT00976508|469243570|FG000|Overall Study|Terminated by the Sponsor|0|||
130012144|NCT02055820|468007256|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
130012145|NCT02055820|468007257|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
130216618|NCT03162328|468755619|FG000|Screening Period|Withdrawal by Subject|1|||
130216619|NCT03162328|468755620|FG001|Screening Period|Withdrawal by Subject|0|||
130347259|NCT00976508|469243571|FG001|Overall Study|Terminated by the Sponsor|1|||
130347260|NCT03023046|469243575|FG000|Overall Study|Withdrawal by Subject|1|||
130347261|NCT00246571|469243578|FG000|Overall Study|Adverse Event|7|||
130347262|NCT00246571|469243579|FG001|Overall Study|Adverse Event|0|||
130347263|NCT00246571|469243578|FG000|Overall Study|Protocol Violation|0|||
130347264|NCT00246571|469243579|FG001|Overall Study|Protocol Violation|1|||
130347265|NCT00246571|469243578|FG000|Overall Study|Withdrawal by Subject|2|||
130347266|NCT00246571|469243579|FG001|Overall Study|Withdrawal by Subject|3|||
130347267|NCT00246571|469243578|FG000|Overall Study|Lack of Efficacy|84|||
130347268|NCT00246571|469243579|FG001|Overall Study|Lack of Efficacy|21|||
130347269|NCT00246571|469243578|FG000|Overall Study|Death|17|||
130347270|NCT00246571|469243579|FG001|Overall Study|Death|3|||
130347271|NCT00246571|469243578|FG000|Overall Study|Sponsor|0|||
130347272|NCT00246571|469243579|FG001|Overall Study|Sponsor|1|||
130347273|NCT00246571|469243578|FG000|Overall Study|Did not meet entrance criteria|2|||
130347274|NCT00246571|469243579|FG001|Overall Study|Did not meet entrance criteria|1|||
130347275|NCT00246571|469243578|FG000|Overall Study|Laboratory abnormalities|1|||
130347276|NCT00246571|469243579|FG001|Overall Study|Laboratory abnormalities|0|||
130347277|NCT00246571|469243578|FG000|Overall Study|Crossover participants|0|||
130347278|NCT00246571|469243579|FG001|Overall Study|Crossover participants|74|||
130347279|NCT00713310|469243586|FG000|Overall Study|Adverse Event|5|||
130347280|NCT00713310|469243587|FG001|Overall Study|Adverse Event|2|||
130347281|NCT00713310|469243586|FG000|Overall Study|Lack of Efficacy|0|||
130347282|NCT00713310|469243587|FG001|Overall Study|Lack of Efficacy|2|||
130347283|NCT00713310|469243586|FG000|Overall Study|Withdrawal by Subject|0|||
130347284|NCT00713310|469243587|FG001|Overall Study|Withdrawal by Subject|2|||
130347285|NCT00686634|469243592|FG000|Overall Study|Protocol Violation|6|||
130347286|NCT02361580|469243595|FG000|Overall Study|Lost to Follow-up|6|||
130347287|NCT02361580|469243596|FG001|Overall Study|Lost to Follow-up|3|||
130347288|NCT00924781|469243597|FG000|Overall Study|Study terminated by sponsor|12|||
130347289|NCT00924781|469243598|FG001|Overall Study|Study terminated by sponsor|10|||
130347290|NCT00708201|469243599|FG000|Overall Study|Adverse Event|4|||
130347291|NCT00708201|469243600|FG001|Overall Study|Adverse Event|4|||
130347292|NCT00708201|469243599|FG000|Overall Study|Withdrawal by Subject|1|||
130347293|NCT00708201|469243600|FG001|Overall Study|Withdrawal by Subject|1|||
130347294|NCT00708201|469243599|FG000|Overall Study|Lost to Follow-up|2|||
130347295|NCT00708201|469243600|FG001|Overall Study|Lost to Follow-up|0|||
130347296|NCT00708201|469243599|FG000|Overall Study|Protocol Violation|0|||
130347297|NCT00708201|469243600|FG001|Overall Study|Protocol Violation|1|||
130347298|NCT01653132|469243601|FG000|First Intervention|Protocol Violation|1|||
130347299|NCT01653132|469243602|FG001|First Intervention|Protocol Violation|0|||
130347300|NCT00761748|469243603|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
130347301|NCT00761748|469243604|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
130347302|NCT00761748|469243603|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
130347303|NCT00761748|469243604|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
130347304|NCT03312751|469243605|FG000|Overall Study|Death|7|||
130347305|NCT03312751|469243606|FG001|Overall Study|Death|9|||
130347306|NCT03312751|469243605|FG000|Overall Study|Study discontinuation due to other reason|0|||
130347307|NCT03312751|469243606|FG001|Overall Study|Study discontinuation due to other reason|1|||
130347308|NCT03490981|469243607|FG000|Overall Study|Lost to Follow-up|1|||
130347309|NCT03490981|469243608|FG001|Overall Study|Lost to Follow-up|2|||
130347310|NCT00282464|469243615|FG000|Overall Study|Adverse Event|26|||
130347311|NCT00282464|469243616|FG001|Overall Study|Adverse Event|20|||
130347312|NCT00282464|469243615|FG000|Overall Study|Lack of Efficacy|8|||
130347313|NCT00282464|469243616|FG001|Overall Study|Lack of Efficacy|8|||
130347314|NCT00282464|469243615|FG000|Overall Study|Lost to Follow-up|10|||
130347315|NCT00282464|469243616|FG001|Overall Study|Lost to Follow-up|10|||
130347316|NCT00282464|469243615|FG000|Overall Study|Withdrawal by Subject|24|||
130347317|NCT00282464|469243616|FG001|Overall Study|Withdrawal by Subject|10|||
130347318|NCT00282464|469243615|FG000|Overall Study|laboratory abnormality|1|||
130347319|NCT00282464|469243616|FG001|Overall Study|laboratory abnormality|2|||
130347320|NCT00282464|469243615|FG000|Overall Study|Protocol Violation|0|||
130347321|NCT00282464|469243616|FG001|Overall Study|Protocol Violation|7|||
130347322|NCT00282464|469243615|FG000|Overall Study|Patient moved|1|||
130347323|NCT00282464|469243616|FG001|Overall Study|Patient moved|0|||
130347324|NCT00282464|469243615|FG000|Overall Study|patient non-compliant|3|||
130347325|NCT00282464|469243616|FG001|Overall Study|patient non-compliant|0|||
130347326|NCT00282464|469243615|FG000|Overall Study|patient no show|0|||
129884414|NCT02771210|467536387|FG000|Period 2|Lack of Efficacy|0|||
130347327|NCT00282464|469243616|FG001|Overall Study|patient no show|1|||
130347328|NCT00282464|469243615|FG000|Overall Study|patient incarcerated|0|||
130347329|NCT00282464|469243616|FG001|Overall Study|patient incarcerated|1|||
130347330|NCT00282464|469243615|FG000|Overall Study|family crisis|0|||
130216620|NCT03162328|468755621|FG002|Screening Period|Withdrawal by Subject|0|||
130216621|NCT03162328|468755619|FG000|Study Period|Withdrawal by Subject|0|||
130216622|NCT03162328|468755620|FG001|Study Period|Withdrawal by Subject|0|||
130216623|NCT03162328|468755621|FG002|Study Period|Withdrawal by Subject|1|||
130216624|NCT00792116|468755622|FG000|Overall Study|Lost to Follow-up|0|||
130216625|NCT00792116|468755623|FG001|Overall Study|Lost to Follow-up|1|||
130216626|NCT00792116|468755622|FG000|Overall Study|Discontnued intervention|1|||
130216627|NCT00792116|468755623|FG001|Overall Study|Discontnued intervention|0|||
130216628|NCT00492232|468755624|FG000|Placebo Run-in|Adverse Event|0|||
130216629|NCT00492232|468755625|FG001|Placebo Run-in|Adverse Event|2|||
130216630|NCT00492232|468755624|FG000|Placebo Run-in|Protocol Violation|0|||
130216631|NCT00492232|468755625|FG001|Placebo Run-in|Protocol Violation|3|||
130216632|NCT00492232|468755624|FG000|Placebo Run-in|Lost to Follow-up|0|||
130216633|NCT00492232|468755625|FG001|Placebo Run-in|Lost to Follow-up|3|||
130216634|NCT00492232|468755624|FG000|Placebo Run-in|Withdrawal by Subject|0|||
130216635|NCT00492232|468755625|FG001|Placebo Run-in|Withdrawal by Subject|8|||
130216636|NCT00492232|468755624|FG000|Placebo Run-in|Pregnancy|0|||
130216637|NCT00492232|468755625|FG001|Placebo Run-in|Pregnancy|1|||
130216638|NCT00492232|468755624|FG000|Placebo Run-in|Entrance criteria not met|0|||
130216639|NCT00492232|468755625|FG001|Placebo Run-in|Entrance criteria not met|45|||
130216640|NCT00492232|468755624|FG000|Placebo Run-in|Other|0|||
130216641|NCT00492232|468755625|FG001|Placebo Run-in|Other|6|||
130216642|NCT00492232|468755624|FG000|Placebo Run-in|Missing|0|||
130216643|NCT00492232|468755625|FG001|Placebo Run-in|Missing|2|||
130216644|NCT00492232|468755624|FG000|Double-Blind Treatment|Adverse Event|1|||
130012146|NCT02055820|468007258|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
130012147|NCT02055820|468007259|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
130012148|NCT02055820|468007260|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
130012149|NCT01399788|468007262|FG000|First Intervention Period|Adverse Event|1|||
130012150|NCT01399788|468007263|FG001|First Intervention Period|Adverse Event|0|||
130012151|NCT01157364|468007264|FG000|Overall Study|Other Reasons|1|||
130012152|NCT01157364|468007265|FG001|Overall Study|Other Reasons|1|||
130012153|NCT01157364|468007266|FG002|Overall Study|Other Reasons|2|||
130012154|NCT01157364|468007267|FG003|Overall Study|Other Reasons|1|||
130012155|NCT01157364|468007268|FG004|Overall Study|Other Reasons|0|||
130012156|NCT01157364|468007269|FG005|Overall Study|Other Reasons|0|||
130012157|NCT01157364|468007264|FG000|Overall Study|Personal Reasons|0|||
130012158|NCT01157364|468007265|FG001|Overall Study|Personal Reasons|2|||
130012159|NCT01157364|468007266|FG002|Overall Study|Personal Reasons|0|||
130012160|NCT01157364|468007267|FG003|Overall Study|Personal Reasons|0|||
130012161|NCT01157364|468007268|FG004|Overall Study|Personal Reasons|1|||
130012162|NCT01157364|468007269|FG005|Overall Study|Personal Reasons|1|||
130012163|NCT01157364|468007264|FG000|Overall Study|Lost to Follow-up|1|||
130012164|NCT01157364|468007265|FG001|Overall Study|Lost to Follow-up|0|||
130012165|NCT01157364|468007266|FG002|Overall Study|Lost to Follow-up|1|||
130012166|NCT01157364|468007267|FG003|Overall Study|Lost to Follow-up|0|||
130012167|NCT01157364|468007268|FG004|Overall Study|Lost to Follow-up|0|||
130012168|NCT01157364|468007269|FG005|Overall Study|Lost to Follow-up|0|||
130012169|NCT01157364|468007264|FG000|Overall Study|Lack of Efficacy|0|||
130012170|NCT01157364|468007265|FG001|Overall Study|Lack of Efficacy|0|||
130012171|NCT01157364|468007266|FG002|Overall Study|Lack of Efficacy|0|||
130012172|NCT01157364|468007267|FG003|Overall Study|Lack of Efficacy|1|||
130012173|NCT01157364|468007268|FG004|Overall Study|Lack of Efficacy|0|||
130012174|NCT01157364|468007269|FG005|Overall Study|Lack of Efficacy|0|||
130012175|NCT01157364|468007264|FG000|Overall Study|Adverse Event|0|||
130012176|NCT01157364|468007265|FG001|Overall Study|Adverse Event|1|||
130012177|NCT01157364|468007266|FG002|Overall Study|Adverse Event|1|||
130012178|NCT01157364|468007267|FG003|Overall Study|Adverse Event|0|||
130012179|NCT01157364|468007268|FG004|Overall Study|Adverse Event|1|||
130012180|NCT01157364|468007269|FG005|Overall Study|Adverse Event|0|||
130012181|NCT00841568|468007271|FG000|Overall Study|Adverse Event|1|||
130012182|NCT00841568|468007271|FG000|Overall Study|Death|1|||
130216645|NCT00492232|468755625|FG001|Double-Blind Treatment|Adverse Event|2|||
130216646|NCT00492232|468755624|FG000|Double-Blind Treatment|Protocol Violation|3|||
130216647|NCT00492232|468755625|FG001|Double-Blind Treatment|Protocol Violation|7|||
130012183|NCT00841568|468007271|FG000|Overall Study|Withdrawal by Subject|2|||
130012184|NCT00841568|468007271|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
130012185|NCT01087775|468007272|FG000|Overall Study|failed inclusion criteria|2|||
130012186|NCT05289570|468007276|FG000|Overall Study|Physician Decision|1|||
130012187|NCT02370615|468007280|FG000|Overall Study|Adverse Event|1|||
130012188|NCT02370615|468007281|FG001|Overall Study|Adverse Event|0|||
130012189|NCT02700997|468007282|FG000|Overall Study|Did not undergo CT imaging|1|||
130216648|NCT00492232|468755624|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
130012190|NCT02700997|468007282|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
130012191|NCT00432042|468007283|FG000|Overall Study|Protocol Violation|2|||
130012192|NCT00432042|468007284|FG001|Overall Study|Protocol Violation|0|||
130012193|NCT00432042|468007285|FG002|Overall Study|Protocol Violation|0|||
130216649|NCT00492232|468755625|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
130012194|NCT00432042|468007283|FG000|Overall Study|Withdrawal by Subject|0|||
130012195|NCT00432042|468007284|FG001|Overall Study|Withdrawal by Subject|0|||
130216650|NCT00492232|468755624|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
130012196|NCT00432042|468007285|FG002|Overall Study|Withdrawal by Subject|2|||
130012197|NCT00432042|468007283|FG000|Overall Study|Lost to Follow-up|5|||
130012198|NCT00432042|468007284|FG001|Overall Study|Lost to Follow-up|1|||
130012199|NCT00432042|468007285|FG002|Overall Study|Lost to Follow-up|0|||
130012200|NCT01585272|468007286|FG000|Overall Study|Adverse Event|22|||
130012201|NCT01585272|468007286|FG000|Overall Study|Protocol Violation|7|||
130012202|NCT01585272|468007286|FG000|Overall Study|Withdrawal by Subject|10|||
130012203|NCT00645593|468007287|FG000|Overall Study|Later found to be ineligible|1|||
130012204|NCT00645593|468007288|FG001|Overall Study|Later found to be ineligible|0|||
130012205|NCT03765138|468007293|FG000|Overall Study|Lost to Follow-up|1|||
130012206|NCT03803059|468007295|FG000|Overall Study|Protocol Violation|2|||
130012207|NCT03803059|468007295|FG000|Overall Study|Lost to Follow-up|1|||
130012208|NCT04013529|468007298|FG000|Overall Study|Withdrawal by Subject|1|||
130012209|NCT04013529|468007299|FG001|Overall Study|Withdrawal by Subject|1|||
130012210|NCT03116698|468007300|FG000|Overall Study|Adverse Event|1|||
130012211|NCT03116698|468007301|FG001|Overall Study|Adverse Event|1|||
130347331|NCT00282464|469243616|FG001|Overall Study|family crisis|1|||
130347332|NCT00282464|469243615|FG000|Overall Study|dispensed wrong kit|0|||
130347333|NCT00282464|469243616|FG001|Overall Study|dispensed wrong kit|1|||
130347334|NCT00282464|469243615|FG000|Overall Study|dropped due to missed visits|0|||
130347335|NCT00282464|469243616|FG001|Overall Study|dropped due to missed visits|1|||
130347336|NCT01624870|469243617|FG000|Overall Study|Death|19|||
130347337|NCT01624870|469243617|FG000|Overall Study|Withdrawal by Subject|1|||
130347338|NCT01624870|469243617|FG000|Overall Study|CoreValve not implanted|6|||
130347339|NCT01624870|469243617|FG000|Overall Study|Lost to follow up|1|||
130347340|NCT04672252|469243621|FG000|Overall Study|Protocol Violation|1|||
130347341|NCT04672252|469243622|FG001|Overall Study|Protocol Violation|0|||
130347342|NCT04391569|469243623|FG000|Overall Study|Death|15|||
130347343|NCT04391569|469243624|FG001|Overall Study|Death|10|||
130347344|NCT04391569|469243623|FG000|Overall Study|Withdrawal by Subject|1|||
130347345|NCT04391569|469243624|FG001|Overall Study|Withdrawal by Subject|0|||
130347346|NCT04391569|469243623|FG000|Overall Study|Lost to Follow-up|3|||
130347347|NCT04391569|469243624|FG001|Overall Study|Lost to Follow-up|2|||
130347348|NCT04391569|469243623|FG000|Overall Study|Lack of Efficacy|0|||
130347349|NCT04391569|469243624|FG001|Overall Study|Lack of Efficacy|1|||
130347350|NCT04391569|469243623|FG000|Overall Study|Participant discharged to hospice facility|0|||
130347351|NCT04391569|469243624|FG001|Overall Study|Participant discharged to hospice facility|1|||
130347352|NCT04391569|469243623|FG000|Overall Study|Participant family decision|1|||
130347353|NCT04391569|469243624|FG001|Overall Study|Participant family decision|0|||
130347354|NCT04391569|469243623|FG000|Overall Study|Participant discharged prematurely|1|||
130347355|NCT04391569|469243624|FG001|Overall Study|Participant discharged prematurely|0|||
130347356|NCT00899392|469243625|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
130347357|NCT00899392|469243626|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
130347358|NCT01431638|469243633|FG000|Overall Study|Adverse Event|1|||
130347359|NCT01431638|469243634|FG001|Overall Study|Adverse Event|3|||
130347360|NCT01431638|469243635|FG002|Overall Study|Adverse Event|1|||
130347361|NCT01431638|469243633|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130347362|NCT01431638|469243634|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130347363|NCT01431638|469243635|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130347364|NCT01431638|469243633|FG000|Overall Study|Participants condition no longer requires study drug|0|||
130347365|NCT01431638|469243634|FG001|Overall Study|Participants condition no longer requires study drug|1|||
130347366|NCT01431638|469243635|FG002|Overall Study|Participants condition no longer requires study drug|0|||
130347367|NCT01431638|469243633|FG000|Overall Study|Participant withdrew consent|14|||
130347368|NCT01431638|469243634|FG001|Overall Study|Participant withdrew consent|5|||
130347369|NCT01431638|469243635|FG002|Overall Study|Participant withdrew consent|8|||
130347370|NCT01431638|469243633|FG000|Overall Study|Lost to Follow-up|7|||
130347371|NCT01431638|469243634|FG001|Overall Study|Lost to Follow-up|9|||
130347372|NCT01431638|469243635|FG002|Overall Study|Lost to Follow-up|7|||
130347373|NCT01431638|469243633|FG000|Overall Study|Administrative problems|1|||
130347374|NCT01431638|469243634|FG001|Overall Study|Administrative problems|4|||
130347375|NCT01431638|469243635|FG002|Overall Study|Administrative problems|6|||
130347376|NCT01431638|469243633|FG000|Overall Study|Death|1|||
130347377|NCT01431638|469243634|FG001|Overall Study|Death|0|||
130347378|NCT01431638|469243635|FG002|Overall Study|Death|0|||
130347379|NCT01431638|469243633|FG000|Overall Study|Protocol deviation|1|||
130347380|NCT01431638|469243634|FG001|Overall Study|Protocol deviation|1|||
130347381|NCT01431638|469243635|FG002|Overall Study|Protocol deviation|4|||
130012212|NCT03116698|468007302|FG002|Overall Study|Adverse Event|1|||
130012213|NCT03116698|468007303|FG003|Overall Study|Adverse Event|0|||
130216651|NCT00492232|468755625|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
130347382|NCT01431638|469243633|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
130347383|NCT01431638|469243634|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
130347384|NCT01431638|469243635|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
130347385|NCT01239732|469243636|FG000|Overall Study|Termination of study per protocol|667|||
130347386|NCT01239732|469243636|FG000|Overall Study|Death|226|||
130012214|NCT03116698|468007300|FG000|Overall Study|Withdrawal by Subject|1|||
130012215|NCT03116698|468007301|FG001|Overall Study|Withdrawal by Subject|4|||
130012216|NCT03116698|468007302|FG002|Overall Study|Withdrawal by Subject|5|||
130012217|NCT03116698|468007303|FG003|Overall Study|Withdrawal by Subject|2|||
130012218|NCT03116698|468007300|FG000|Overall Study|Lost to Follow-up|2|||
130012219|NCT03116698|468007301|FG001|Overall Study|Lost to Follow-up|0|||
130012220|NCT03116698|468007302|FG002|Overall Study|Lost to Follow-up|0|||
130012221|NCT03116698|468007303|FG003|Overall Study|Lost to Follow-up|0|||
130012222|NCT03116698|468007300|FG000|Overall Study|Physician Decision|1|||
130012223|NCT03116698|468007301|FG001|Overall Study|Physician Decision|1|||
130012224|NCT03116698|468007302|FG002|Overall Study|Physician Decision|0|||
130012225|NCT03116698|468007303|FG003|Overall Study|Physician Decision|0|||
130012226|NCT03116698|468007300|FG000|Overall Study|Protocol Violation|1|||
130012227|NCT03116698|468007301|FG001|Overall Study|Protocol Violation|0|||
130012228|NCT03116698|468007302|FG002|Overall Study|Protocol Violation|0|||
130012229|NCT03116698|468007303|FG003|Overall Study|Protocol Violation|0|||
130012230|NCT03116698|468007300|FG000|Overall Study|Death|0|||
130012231|NCT03116698|468007301|FG001|Overall Study|Death|0|||
130012232|NCT03116698|468007302|FG002|Overall Study|Death|2|||
130012233|NCT03116698|468007303|FG003|Overall Study|Death|0|||
130012234|NCT00788372|468007304|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
130012235|NCT00788372|468007304|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
130012236|NCT00788372|468007304|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
130012237|NCT00788372|468007304|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
130012238|NCT00788372|468007304|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
130012239|NCT00788372|468007304|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
130012240|NCT00788372|468007304|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
130012241|NCT03099187|468007311|FG000|Double-blind Treatment|Adverse Event|19|||
130012242|NCT03099187|468007312|FG001|Double-blind Treatment|Adverse Event|1|||
130012243|NCT03099187|468007313|FG002|Double-blind Treatment|Adverse Event|0|||
130012244|NCT03099187|468007314|FG003|Double-blind Treatment|Adverse Event|0|||
130012245|NCT03099187|468007311|FG000|Double-blind Treatment|Death|1|||
130012246|NCT03099187|468007312|FG001|Double-blind Treatment|Death|3|||
130012247|NCT03099187|468007313|FG002|Double-blind Treatment|Death|0|||
130012248|NCT03099187|468007314|FG003|Double-blind Treatment|Death|0|||
130012249|NCT03099187|468007311|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130012250|NCT03099187|468007312|FG001|Double-blind Treatment|Lack of Efficacy|0|||
130012251|NCT03099187|468007313|FG002|Double-blind Treatment|Lack of Efficacy|0|||
130012252|NCT03099187|468007314|FG003|Double-blind Treatment|Lack of Efficacy|0|||
130012253|NCT03099187|468007311|FG000|Double-blind Treatment|Physician Decision|2|||
130012254|NCT03099187|468007312|FG001|Double-blind Treatment|Physician Decision|1|||
130012255|NCT03099187|468007313|FG002|Double-blind Treatment|Physician Decision|0|||
130012256|NCT03099187|468007314|FG003|Double-blind Treatment|Physician Decision|0|||
130012257|NCT03099187|468007311|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
130012258|NCT03099187|468007312|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
130012259|NCT03099187|468007313|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
130012260|NCT03099187|468007314|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
130012261|NCT03099187|468007311|FG000|Double-blind Treatment|Lung transplantation|0|||
130012262|NCT03099187|468007312|FG001|Double-blind Treatment|Lung transplantation|1|||
130012263|NCT03099187|468007313|FG002|Double-blind Treatment|Lung transplantation|0|||
130012264|NCT03099187|468007314|FG003|Double-blind Treatment|Lung transplantation|0|||
130012265|NCT03099187|468007311|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
130012266|NCT03099187|468007312|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
130012267|NCT03099187|468007313|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
130012268|NCT03099187|468007314|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
130012269|NCT03099187|468007311|FG000|Double-blind Treatment|Disease progression|0|||
130012270|NCT03099187|468007312|FG001|Double-blind Treatment|Disease progression|1|||
130012271|NCT03099187|468007313|FG002|Double-blind Treatment|Disease progression|0|||
130012272|NCT03099187|468007314|FG003|Double-blind Treatment|Disease progression|0|||
130012273|NCT03099187|468007311|FG000|Double-blind Treatment|Randomization error|0|||
130012274|NCT03099187|468007312|FG001|Double-blind Treatment|Randomization error|2|||
130012275|NCT03099187|468007313|FG002|Double-blind Treatment|Randomization error|0|||
130012276|NCT03099187|468007314|FG003|Double-blind Treatment|Randomization error|0|||
130012277|NCT03099187|468007311|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
130012278|NCT03099187|468007312|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
130012279|NCT03099187|468007313|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
130012280|NCT03099187|468007314|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
130012281|NCT03099187|468007311|FG000|12-month Safety Follow-up|Adverse Event|0|||
130012282|NCT03099187|468007312|FG001|12-month Safety Follow-up|Adverse Event|0|||
130012283|NCT03099187|468007313|FG002|12-month Safety Follow-up|Adverse Event|5|||
130012284|NCT03099187|468007314|FG003|12-month Safety Follow-up|Adverse Event|12|||
130012285|NCT03099187|468007311|FG000|12-month Safety Follow-up|Death|0|||
130012286|NCT03099187|468007312|FG001|12-month Safety Follow-up|Death|0|||
130012287|NCT03099187|468007313|FG002|12-month Safety Follow-up|Death|7|||
130012288|NCT03099187|468007314|FG003|12-month Safety Follow-up|Death|9|||
130012289|NCT03099187|468007311|FG000|12-month Safety Follow-up|Lung transplantation|0|||
130012290|NCT03099187|468007312|FG001|12-month Safety Follow-up|Lung transplantation|0|||
130012291|NCT03099187|468007313|FG002|12-month Safety Follow-up|Lung transplantation|2|||
130012292|NCT03099187|468007314|FG003|12-month Safety Follow-up|Lung transplantation|1|||
130012293|NCT03099187|468007311|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
130012294|NCT03099187|468007312|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
130012295|NCT03099187|468007313|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
130012296|NCT03099187|468007314|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
130012297|NCT03099187|468007311|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
130012298|NCT03099187|468007312|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
130012299|NCT03099187|468007313|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
130012300|NCT03099187|468007314|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
130012301|NCT03099187|468007311|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
130012302|NCT03099187|468007312|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
130012303|NCT03099187|468007313|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
130012304|NCT03099187|468007314|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
130012305|NCT03099187|468007311|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
130012306|NCT03099187|468007312|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
130012307|NCT03099187|468007313|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
130012308|NCT03099187|468007314|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
130012309|NCT01246583|468007315|FG000|Overall Study|Lost to Follow-up|0|||
130012310|NCT01246583|468007316|FG001|Overall Study|Lost to Follow-up|0|||
130012311|NCT01246583|468007317|FG002|Overall Study|Lost to Follow-up|0|||
130012312|NCT01246583|468007318|FG003|Overall Study|Lost to Follow-up|1|||
130012313|NCT01246583|468007315|FG000|Overall Study|Protocol Violation|0|||
130012314|NCT01246583|468007316|FG001|Overall Study|Protocol Violation|0|||
130012315|NCT01246583|468007317|FG002|Overall Study|Protocol Violation|1|||
130012316|NCT01246583|468007318|FG003|Overall Study|Protocol Violation|0|||
130012317|NCT01246583|468007315|FG000|Overall Study|Withdrawal by Subject|1|||
130012318|NCT01246583|468007316|FG001|Overall Study|Withdrawal by Subject|0|||
130012319|NCT01246583|468007317|FG002|Overall Study|Withdrawal by Subject|0|||
130012320|NCT01246583|468007318|FG003|Overall Study|Withdrawal by Subject|0|||
130012321|NCT02116777|468007319|FG000|Overall Study|Adverse Event|0|||
130012322|NCT02116777|468007320|FG001|Overall Study|Adverse Event|0|||
130012323|NCT02116777|468007321|FG002|Overall Study|Adverse Event|0|||
130012324|NCT02116777|468007322|FG003|Overall Study|Adverse Event|0|||
130012325|NCT02116777|468007323|FG004|Overall Study|Adverse Event|2|||
130012326|NCT02116777|468007324|FG005|Overall Study|Adverse Event|2|||
130012327|NCT02116777|468007325|FG006|Overall Study|Adverse Event|0|||
130012328|NCT02116777|468007319|FG000|Overall Study|Death|0|||
130012329|NCT02116777|468007320|FG001|Overall Study|Death|0|||
130012330|NCT02116777|468007321|FG002|Overall Study|Death|0|||
130012331|NCT02116777|468007322|FG003|Overall Study|Death|1|||
130012332|NCT02116777|468007323|FG004|Overall Study|Death|0|||
130347387|NCT01239732|469243636|FG000|Overall Study|Withdrawal by Subject|87|||
130347388|NCT01239732|469243636|FG000|Overall Study|Adverse Event|6|||
130347389|NCT01239732|469243636|FG000|Overall Study|Protocol Violation|3|||
130012333|NCT02116777|468007324|FG005|Overall Study|Death|0|||
130012334|NCT02116777|468007325|FG006|Overall Study|Death|0|||
130012335|NCT02116777|468007319|FG000|Overall Study|Lack of Efficacy|3|||
130012336|NCT02116777|468007320|FG001|Overall Study|Lack of Efficacy|3|||
130347390|NCT01239732|469243636|FG000|Overall Study|Participant non compliance|5|||
130012337|NCT02116777|468007321|FG002|Overall Study|Lack of Efficacy|3|||
130012338|NCT02116777|468007322|FG003|Overall Study|Lack of Efficacy|8|||
130012339|NCT02116777|468007323|FG004|Overall Study|Lack of Efficacy|4|||
130012340|NCT02116777|468007324|FG005|Overall Study|Lack of Efficacy|1|||
130012341|NCT02116777|468007325|FG006|Overall Study|Lack of Efficacy|9|||
130012342|NCT02116777|468007319|FG000|Overall Study|Physician Decision|0|||
130012343|NCT02116777|468007320|FG001|Overall Study|Physician Decision|0|||
130012344|NCT02116777|468007321|FG002|Overall Study|Physician Decision|0|||
130012345|NCT02116777|468007322|FG003|Overall Study|Physician Decision|2|||
130012346|NCT02116777|468007323|FG004|Overall Study|Physician Decision|0|||
130012347|NCT02116777|468007324|FG005|Overall Study|Physician Decision|0|||
130012348|NCT02116777|468007325|FG006|Overall Study|Physician Decision|0|||
130012349|NCT02116777|468007319|FG000|Overall Study|Protocol Violation|0|||
130012350|NCT02116777|468007320|FG001|Overall Study|Protocol Violation|0|||
130012351|NCT02116777|468007321|FG002|Overall Study|Protocol Violation|0|||
130012352|NCT02116777|468007322|FG003|Overall Study|Protocol Violation|1|||
130012353|NCT02116777|468007323|FG004|Overall Study|Protocol Violation|0|||
130012354|NCT02116777|468007324|FG005|Overall Study|Protocol Violation|0|||
130012355|NCT02116777|468007325|FG006|Overall Study|Protocol Violation|0|||
130012356|NCT02116777|468007319|FG000|Overall Study|Withdrawal by Subject|0|||
130012357|NCT02116777|468007320|FG001|Overall Study|Withdrawal by Subject|0|||
130012358|NCT02116777|468007321|FG002|Overall Study|Withdrawal by Subject|0|||
130012359|NCT02116777|468007322|FG003|Overall Study|Withdrawal by Subject|1|||
130012360|NCT02116777|468007323|FG004|Overall Study|Withdrawal by Subject|0|||
130012361|NCT02116777|468007324|FG005|Overall Study|Withdrawal by Subject|0|||
130012362|NCT02116777|468007325|FG006|Overall Study|Withdrawal by Subject|0|||
130012363|NCT00733954|468007326|FG000|Overall Study|Lost to Follow-up|5|||
130012364|NCT00733954|468007327|FG001|Overall Study|Lost to Follow-up|2|||
130012365|NCT00733954|468007326|FG000|Overall Study|Protocol Violation|1|||
130012366|NCT00733954|468007327|FG001|Overall Study|Protocol Violation|0|||
130012367|NCT00733954|468007326|FG000|Overall Study|Withdrawal by Subject|2|||
130012368|NCT00733954|468007327|FG001|Overall Study|Withdrawal by Subject|0|||
130012369|NCT02663453|468007328|FG000|Overall Study|Death|4|||
130012370|NCT02663453|468007329|FG001|Overall Study|Death|4|||
130012371|NCT02663453|468007328|FG000|Overall Study|Withdrawal by Subject|1|||
130012372|NCT02663453|468007329|FG001|Overall Study|Withdrawal by Subject|0|||
130012373|NCT01611974|468008532|FG000|Overall Study|Death|10|||
130012374|NCT01611974|468008533|FG001|Overall Study|Death|12|||
130012375|NCT01611974|468008534|FG002|Overall Study|Death|10|||
130012376|NCT01611974|468008532|FG000|Overall Study|Lost to Follow-up|0|||
130012377|NCT01611974|468008533|FG001|Overall Study|Lost to Follow-up|1|||
130012378|NCT01611974|468008534|FG002|Overall Study|Lost to Follow-up|0|||
130012379|NCT01611974|468008532|FG000|Overall Study|Physician Decision|5|||
130012380|NCT01611974|468008533|FG001|Overall Study|Physician Decision|1|||
130012381|NCT01611974|468008534|FG002|Overall Study|Physician Decision|2|||
130012382|NCT01611974|468008532|FG000|Overall Study|Withdrawal by Subject|0|||
130012383|NCT01611974|468008533|FG001|Overall Study|Withdrawal by Subject|1|||
130012384|NCT01611974|468008534|FG002|Overall Study|Withdrawal by Subject|4|||
130012385|NCT01849874|468008539|FG000|Overall Study|Death|89|||
130012386|NCT01849874|468008540|FG001|Overall Study|Death|42|||
130012387|NCT01849874|468008539|FG000|Overall Study|Withdrawal by Subject|17|||
130012388|NCT01849874|468008540|FG001|Overall Study|Withdrawal by Subject|16|||
130012389|NCT01849874|468008539|FG000|Overall Study|Lost to Follow-up|3|||
130012390|NCT01849874|468008540|FG001|Overall Study|Lost to Follow-up|2|||
130012391|NCT01849874|468008539|FG000|Overall Study|Study Termination By Sponsor|93|||
130012392|NCT01849874|468008540|FG001|Overall Study|Study Termination By Sponsor|48|||
130012393|NCT01849874|468008539|FG000|Overall Study|Completed as per protocol amendment 6|3|||
130012394|NCT01849874|468008540|FG001|Overall Study|Completed as per protocol amendment 6|0|||
130012395|NCT01849874|468008539|FG000|Overall Study|Physician Decision|7|||
130012396|NCT01849874|468008540|FG001|Overall Study|Physician Decision|1|||
130012397|NCT01849874|468008539|FG000|Overall Study|Other|16|||
130012398|NCT01849874|468008540|FG001|Overall Study|Other|4|||
130012399|NCT02830880|468008545|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
130012400|NCT02830880|468008545|FG000|Overall Study|Death|1|||
130012401|NCT02830880|468008545|FG000|Overall Study|Physician Decision|1|||
130012402|NCT03551509|468008554|FG000|Overall Study|Lost to Follow-up|0|||
130012403|NCT03551509|468008555|FG001|Overall Study|Lost to Follow-up|1|||
130012404|NCT03551509|468008556|FG002|Overall Study|Lost to Follow-up|0|||
130012405|NCT01040351|468008557|FG000|Overall Study|poor ovarian response|1|||
130012406|NCT01040351|468008558|FG001|Overall Study|poor ovarian response|2|||
130012407|NCT01230307|468008559|FG000|Overall Study|LVAD Placement|0|||
130012408|NCT01230307|468008560|FG001|Overall Study|LVAD Placement|2|||
130012409|NCT00530894|468008564|FG000|Overall Study|Death|84|||
130012410|NCT00530894|468008565|FG001|Overall Study|Death|89|||
130012411|NCT00530894|468008566|FG002|Overall Study|Death|55|||
130012412|NCT00530894|468008567|FG003|Overall Study|Death|89|||
130012413|NCT00530894|468008564|FG000|Overall Study|Lost to Follow-up|1|||
130012414|NCT00530894|468008565|FG001|Overall Study|Lost to Follow-up|3|||
130012415|NCT00530894|468008566|FG002|Overall Study|Lost to Follow-up|0|||
130012416|NCT00530894|468008567|FG003|Overall Study|Lost to Follow-up|0|||
130012417|NCT00530894|468008564|FG000|Overall Study|Withdrawal by Subject|1|||
130012418|NCT00530894|468008565|FG001|Overall Study|Withdrawal by Subject|23|||
130012419|NCT00530894|468008566|FG002|Overall Study|Withdrawal by Subject|0|||
130216652|NCT00492232|468755624|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
130216653|NCT00492232|468755625|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
130012420|NCT00530894|468008567|FG003|Overall Study|Withdrawal by Subject|5|||
130012421|NCT00530894|468008564|FG000|Overall Study|Alive and censored prior to 1 year|2|||
130012422|NCT00530894|468008565|FG001|Overall Study|Alive and censored prior to 1 year|0|||
130012423|NCT00530894|468008566|FG002|Overall Study|Alive and censored prior to 1 year|0|||
130012424|NCT00530894|468008567|FG003|Overall Study|Alive and censored prior to 1 year|0|||
130216654|NCT00492232|468755624|FG000|Double-Blind Treatment|Other|6|||
130216655|NCT00492232|468755625|FG001|Double-Blind Treatment|Other|5|||
130216656|NCT00492232|468755624|FG000|Double-Blind Treatment|Randomized not treated|1|||
130216657|NCT00492232|468755625|FG001|Double-Blind Treatment|Randomized not treated|0|||
130012425|NCT02256540|468008568|FG000|Overall Study|Withdrawal by Subject|0|||
130012426|NCT02256540|468008569|FG001|Overall Study|Withdrawal by Subject|1|||
130012427|NCT02256540|468008570|FG002|Overall Study|Withdrawal by Subject|1|||
130012428|NCT02256540|468008568|FG000|Overall Study|Back pain preventing exercise|0|||
130012429|NCT02256540|468008569|FG001|Overall Study|Back pain preventing exercise|0|||
130012430|NCT02256540|468008570|FG002|Overall Study|Back pain preventing exercise|1|||
130012431|NCT01230242|468008571|FG000|Overall Study|Physician Decision|2|||
130012432|NCT01230242|468008571|FG000|Overall Study|Withdrawal by Subject|1|||
130012433|NCT04329702|468008578|FG000|Overall Study|illness|3|||
130012434|NCT04329702|468008579|FG001|Overall Study|illness|4|||
130012435|NCT04329702|468008580|FG002|Overall Study|illness|0|||
130012436|NCT04329702|468008578|FG000|Overall Study|Lost to Follow-up|0|||
130012437|NCT04329702|468008579|FG001|Overall Study|Lost to Follow-up|0|||
130012438|NCT04329702|468008580|FG002|Overall Study|Lost to Follow-up|2|||
130012439|NCT04329702|468008578|FG000|Overall Study|Death|0|||
130012440|NCT04329702|468008579|FG001|Overall Study|Death|2|||
130012441|NCT04329702|468008580|FG002|Overall Study|Death|0|||
130012442|NCT03719690|468008585|FG000|Overall Study|Withdrawal by Subject|5|||
130012443|NCT03719690|468008586|FG001|Overall Study|Withdrawal by Subject|10|||
130012444|NCT03719690|468008585|FG000|Overall Study|Death|40|||
130012445|NCT03719690|468008586|FG001|Overall Study|Death|149|||
130012446|NCT03719690|468008585|FG000|Overall Study|Miscellaneous|12|||
130012447|NCT03719690|468008586|FG001|Overall Study|Miscellaneous|56|||
130012448|NCT03719690|468008585|FG000|Overall Study|Lost to Follow-up|2|||
130012449|NCT03719690|468008586|FG001|Overall Study|Lost to Follow-up|18|||
130012450|NCT03719690|468008585|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
130012451|NCT03719690|468008586|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
130012452|NCT01918007|468008587|FG000|Overall Study|Baseline oximetry not acceptable|11|||
130012453|NCT01918007|468008588|FG001|Overall Study|Baseline oximetry not acceptable|7|||
130012454|NCT01918007|468008587|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
130012455|NCT01918007|468008588|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
130012456|NCT01918007|468008587|FG000|Overall Study|Lost to Follow-up|4|||
130012457|NCT01918007|468008588|FG001|Overall Study|Lost to Follow-up|7|||
130216658|NCT00492232|468755624|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
130216659|NCT00492232|468755625|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130216660|NCT01216332|468755626|FG000|Overall Study|Withdrawal by Subject|4|||
130012458|NCT01140451|468008590|FG000|Overall Study|Withdrawal by Subject|26|||
130012459|NCT01140451|468008591|FG001|Overall Study|Withdrawal by Subject|33|||
130012460|NCT01140451|468008590|FG000|Overall Study|Adverse Event|2|||
130012461|NCT01140451|468008591|FG001|Overall Study|Adverse Event|6|||
130012462|NCT01140451|468008590|FG000|Overall Study|Physician Decision|5|||
130216661|NCT01216332|468755627|FG001|Overall Study|Withdrawal by Subject|0|||
130216662|NCT00636636|468755628|FG000|Overall Study|Other reason|4|||
130216663|NCT00636636|468755629|FG001|Overall Study|Other reason|6|||
130216664|NCT00636636|468755628|FG000|Overall Study|Adverse Event|19|||
130216665|NCT00636636|468755629|FG001|Overall Study|Adverse Event|8|||
130216666|NCT00636636|468755628|FG000|Overall Study|Lack of Efficacy|7|||
130216667|NCT00636636|468755629|FG001|Overall Study|Lack of Efficacy|12|||
130216668|NCT00636636|468755628|FG000|Overall Study|Protocol Violation|2|||
130216669|NCT00636636|468755629|FG001|Overall Study|Protocol Violation|2|||
130216670|NCT00636636|468755628|FG000|Overall Study|Lost to Follow-up|0|||
130216671|NCT00636636|468755629|FG001|Overall Study|Lost to Follow-up|1|||
130216672|NCT00636636|468755628|FG000|Overall Study|Death|0|||
130216673|NCT00636636|468755629|FG001|Overall Study|Death|1|||
130216674|NCT00636636|468755628|FG000|Overall Study|Withdrawal by Subject|4|||
130216675|NCT00636636|468755629|FG001|Overall Study|Withdrawal by Subject|9|||
130216676|NCT00524173|468755630|FG000|Overall Study|Lost to Follow-up|0|||
130216677|NCT00524173|468755631|FG001|Overall Study|Lost to Follow-up|1|||
130216678|NCT00524173|468755630|FG000|Overall Study|Death|1|||
130216679|NCT00524173|468755631|FG001|Overall Study|Death|0|||
130216680|NCT00524173|468755630|FG000|Overall Study|Had not reached endpoint at study close|4|||
130216681|NCT00524173|468755631|FG001|Overall Study|Had not reached endpoint at study close|1|||
130216682|NCT01025284|468757178|FG000|Overall Study|Investigator Decision|0|||
130216683|NCT01025284|468757179|FG001|Overall Study|Investigator Decision|1|||
130216684|NCT01025284|468757180|FG002|Overall Study|Investigator Decision|0|||
130216685|NCT01025284|468757178|FG000|Overall Study|Withdrawal by Subject|0|||
130216686|NCT01025284|468757179|FG001|Overall Study|Withdrawal by Subject|1|||
130216687|NCT01025284|468757180|FG002|Overall Study|Withdrawal by Subject|0|||
130216688|NCT02753816|468757182|FG000|Overall Study|Protocol Violation|0|||
130216689|NCT02753816|468757183|FG001|Overall Study|Protocol Violation|1|||
130216690|NCT02753816|468757184|FG002|Overall Study|Protocol Violation|0|||
130216691|NCT01465230|468757185|FG000|Overall Study|Withdrawal by Subject|2|||
130216692|NCT00905567|468757186|FG000|Washout|Withdrawal by Subject|0|||
130216693|NCT00905567|468757187|FG001|Washout|Withdrawal by Subject|1|||
130216694|NCT02542397|468757188|FG000|Overall Study|Death|2|||
130216695|NCT02542397|468757188|FG000|Overall Study|Physician Decision|6|||
130216696|NCT02542397|468757188|FG000|Overall Study|Withdrawal by Subject|6|||
130216697|NCT02542397|468757188|FG000|Overall Study|Lost to Follow-up|2|||
130216698|NCT01738919|468757195|FG000|Overall Study|Lost to Follow-up|1|||
130012463|NCT01140451|468008591|FG001|Overall Study|Physician Decision|3|||
130012464|NCT01140451|468008590|FG000|Overall Study|Lost to Follow-up|2|||
130012465|NCT01140451|468008591|FG001|Overall Study|Lost to Follow-up|0|||
130012466|NCT01140451|468008590|FG000|Overall Study|Participants Planning Pregnancy|3|||
130012467|NCT01140451|468008591|FG001|Overall Study|Participants Planning Pregnancy|0|||
130012468|NCT02919436|468008593|FG000|Overall Study|Did not undergo surgery|16|||
130012469|NCT02919436|468008594|FG001|Overall Study|Did not undergo surgery|20|||
130012470|NCT02919436|468008593|FG000|Overall Study|Enrolled before trial registration|44|||
130216699|NCT01738919|468757196|FG001|Overall Study|Lost to Follow-up|0|||
130216700|NCT01738919|468757195|FG000|Overall Study|Immigrated|0|||
130216701|NCT01738919|468757196|FG001|Overall Study|Immigrated|1|||
130216702|NCT01738919|468757195|FG000|Overall Study|Withdrawal by Subject|0|||
130216703|NCT01738919|468757196|FG001|Overall Study|Withdrawal by Subject|1|||
130216704|NCT01738919|468757195|FG000|Overall Study|Not treated in accordance to guidelines|0|||
130216705|NCT01738919|468757196|FG001|Overall Study|Not treated in accordance to guidelines|1|||
130216706|NCT01473940|468757200|FG000|Induction Therapy|Death|0|||
130216707|NCT01473940|468757201|FG001|Induction Therapy|Death|0|||
130216708|NCT01473940|468757202|FG002|Induction Therapy|Death|1|||
130216709|NCT01473940|468757203|FG003|Induction Therapy|Death|1|||
130012471|NCT02919436|468008594|FG001|Overall Study|Enrolled before trial registration|33|||
130012472|NCT03699007|468008595|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
130012473|NCT03699007|468008596|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
130012474|NCT03699007|468008595|FG000|6-month Follow Up|Lost to Follow-up|2|||
130012475|NCT03699007|468008596|FG001|6-month Follow Up|Lost to Follow-up|3|||
130012476|NCT04718974|468008597|FG000|Overall Study|Death|0|||
130012477|NCT04718974|468008598|FG001|Overall Study|Death|2|||
130012478|NCT04718974|468008597|FG000|Overall Study|Lost to Follow-up|10|||
130216710|NCT01473940|468757200|FG000|Induction Therapy|Progressive Disease|0|||
130012479|NCT04718974|468008598|FG001|Overall Study|Lost to Follow-up|20|||
130012480|NCT04718974|468008597|FG000|Overall Study|Transferred out|2|||
130216711|NCT01473940|468757201|FG001|Induction Therapy|Progressive Disease|1|||
130216712|NCT01473940|468757202|FG002|Induction Therapy|Progressive Disease|1|||
130216713|NCT01473940|468757203|FG003|Induction Therapy|Progressive Disease|0|||
130347391|NCT01239732|469243636|FG000|Overall Study|Study termination by sponsor|2|||
130216714|NCT01473940|468757200|FG000|Maintenance Therapy|Progressive Disease|1|||
130216715|NCT01473940|468757201|FG001|Maintenance Therapy|Progressive Disease|2|||
130216716|NCT01473940|468757202|FG002|Maintenance Therapy|Progressive Disease|1|||
130012481|NCT04718974|468008598|FG001|Overall Study|Transferred out|4|||
130216717|NCT01473940|468757203|FG003|Maintenance Therapy|Progressive Disease|4|||
130216718|NCT00547248|468757204|FG000|Overall Study|Protocol Violation|0|||
130216719|NCT00547248|468757205|FG001|Overall Study|Protocol Violation|0|||
130216720|NCT00547248|468757206|FG002|Overall Study|Protocol Violation|1|||
130216721|NCT00547248|468757207|FG003|Overall Study|Protocol Violation|1|||
130216722|NCT00547248|468757204|FG000|Overall Study|Migrated/moved from study area|0|||
130216723|NCT00547248|468757205|FG001|Overall Study|Migrated/moved from study area|0|||
130216724|NCT00547248|468757206|FG002|Overall Study|Migrated/moved from study area|2|||
130216725|NCT00547248|468757207|FG003|Overall Study|Migrated/moved from study area|0|||
130216726|NCT00547248|468757204|FG000|Overall Study|Withdrawal by Subject|0|||
130216727|NCT00547248|468757205|FG001|Overall Study|Withdrawal by Subject|0|||
130216728|NCT00547248|468757206|FG002|Overall Study|Withdrawal by Subject|7|||
130216729|NCT00547248|468757207|FG003|Overall Study|Withdrawal by Subject|1|||
130216730|NCT00534248|468757210|FG000|Overall Study|Adverse Event|19|||
130216731|NCT00534248|468757211|FG001|Overall Study|Adverse Event|29|||
130216732|NCT00534248|468757210|FG000|Overall Study|Lost to Follow-up|353|||
130216733|NCT00534248|468757211|FG001|Overall Study|Lost to Follow-up|375|||
130216734|NCT00534248|468757210|FG000|Overall Study|Other protocol specified criteria|13|||
130216735|NCT00534248|468757211|FG001|Overall Study|Other protocol specified criteria|3|||
130216736|NCT00534248|468757210|FG000|Overall Study|Physician Decision|10|||
130216737|NCT00534248|468757211|FG001|Overall Study|Physician Decision|7|||
130216738|NCT00534248|468757210|FG000|Overall Study|Protocol Violation|3|||
130216739|NCT00534248|468757211|FG001|Overall Study|Protocol Violation|4|||
130216740|NCT00534248|468757210|FG000|Overall Study|Withdrawal by Subject|263|||
130216741|NCT00534248|468757211|FG001|Overall Study|Withdrawal by Subject|255|||
130216742|NCT02532257|468757212|FG000|Overall Study|Adverse Event|2|||
130216743|NCT02532257|468757212|FG000|Overall Study|Physician Decision|4|||
130216744|NCT02532257|468757212|FG000|Overall Study|Withdrawal by Subject|3|||
130216745|NCT02532257|468757212|FG000|Overall Study|Progressive Disease|10|||
130216746|NCT02849171|468757213|FG000|Overall Study|Withdrawal by Subject|1|||
130216747|NCT02849171|468757213|FG000|Overall Study|Not treated|1|||
130216748|NCT02259400|468757216|FG000|Overall Study|Death|0|||
130216749|NCT02259400|468757217|FG001|Overall Study|Death|2|||
130216750|NCT00697593|468757221|FG000|Overall Study|Adverse Event|3|||
130216751|NCT00697593|468757221|FG000|Overall Study|Protocol Violation|1|||
130216752|NCT00697593|468757221|FG000|Overall Study|Lack of Efficacy|3|||
130216753|NCT00697593|468757221|FG000|Overall Study|Suspension of the study by sponsor|12|||
130216754|NCT02964338|468757225|FG000|Overall Study|Sponsor terminated study for futility|12|||
130216755|NCT02964338|468757226|FG001|Overall Study|Sponsor terminated study for futility|15|||
130216756|NCT02964338|468757227|FG002|Overall Study|Sponsor terminated study for futility|14|||
130216757|NCT02964338|468757225|FG000|Overall Study|Lack of Efficacy|0|||
130216758|NCT02964338|468757226|FG001|Overall Study|Lack of Efficacy|3|||
130216759|NCT02964338|468757227|FG002|Overall Study|Lack of Efficacy|0|||
130216760|NCT02964338|468757225|FG000|Overall Study|Lost to Follow-up|1|||
130216761|NCT02964338|468757226|FG001|Overall Study|Lost to Follow-up|0|||
130216762|NCT02964338|468757227|FG002|Overall Study|Lost to Follow-up|3|||
130216763|NCT02964338|468757225|FG000|Overall Study|Protocol Violation|0|||
130216764|NCT02964338|468757226|FG001|Overall Study|Protocol Violation|1|||
130216765|NCT02964338|468757227|FG002|Overall Study|Protocol Violation|0|||
130216766|NCT02964338|468757225|FG000|Overall Study|Withdrawal by Subject|1|||
130216767|NCT02964338|468757226|FG001|Overall Study|Withdrawal by Subject|3|||
130216768|NCT02964338|468757227|FG002|Overall Study|Withdrawal by Subject|1|||
130216769|NCT02964338|468757225|FG000|Overall Study|Adverse Event|2|||
130216770|NCT02964338|468757226|FG001|Overall Study|Adverse Event|1|||
130216771|NCT02964338|468757227|FG002|Overall Study|Adverse Event|1|||
130216772|NCT02964338|468757225|FG000|Overall Study|Non-compliant with e-diary|0|||
130216773|NCT02964338|468757226|FG001|Overall Study|Non-compliant with e-diary|1|||
130216774|NCT02964338|468757227|FG002|Overall Study|Non-compliant with e-diary|0|||
130216775|NCT02964338|468757225|FG000|Overall Study|Did not meet criteria|1|||
130216776|NCT02964338|468757226|FG001|Overall Study|Did not meet criteria|0|||
130012482|NCT03259074|468008599|FG000|Overall Study|Adverse Event|9|||
130012483|NCT03259074|468008600|FG001|Overall Study|Adverse Event|12|||
130012484|NCT03259074|468008601|FG002|Overall Study|Adverse Event|8|||
130012485|NCT03259074|468008599|FG000|Overall Study|Death|1|||
130012486|NCT03259074|468008600|FG001|Overall Study|Death|1|||
130012487|NCT03259074|468008601|FG002|Overall Study|Death|3|||
130012488|NCT03259074|468008599|FG000|Overall Study|Lost to Follow-up|2|||
130012489|NCT03259074|468008600|FG001|Overall Study|Lost to Follow-up|4|||
130012490|NCT03259074|468008601|FG002|Overall Study|Lost to Follow-up|3|||
130012491|NCT03259074|468008599|FG000|Overall Study|New Therapy For Study Indication|1|||
130012492|NCT03259074|468008600|FG001|Overall Study|New Therapy For Study Indication|2|||
130216777|NCT02964338|468757227|FG002|Overall Study|Did not meet criteria|0|||
130216778|NCT02239640|468757230|FG000|Overall Study|Withdrawal by Subject|3|||
130216779|NCT02239640|468757230|FG000|Overall Study|Lost to Follow-up|72|||
130216780|NCT02239640|468757230|FG000|Overall Study|Death|142|||
130216781|NCT02630563|468757231|FG000|Overall Study|Administrative|1|||
130216782|NCT02372383|468757232|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
130216783|NCT02372383|468757233|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
130216784|NCT02372383|468757234|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
130216785|NCT00621257|468757235|FG000|Overall Study|Lost to Follow-up|4|||
130216786|NCT00621257|468757236|FG001|Overall Study|Lost to Follow-up|0|||
130012493|NCT03259074|468008601|FG002|Overall Study|New Therapy For Study Indication|2|||
130012494|NCT03259074|468008599|FG000|Overall Study|Physician Decision|4|||
130012495|NCT03259074|468008600|FG001|Overall Study|Physician Decision|12|||
130012496|NCT03259074|468008601|FG002|Overall Study|Physician Decision|10|||
130012497|NCT03259074|468008599|FG000|Overall Study|Pregnancy|1|||
130012498|NCT03259074|468008600|FG001|Overall Study|Pregnancy|1|||
130012499|NCT03259074|468008601|FG002|Overall Study|Pregnancy|0|||
130012500|NCT03259074|468008599|FG000|Overall Study|Progressive Disease|1|||
130012501|NCT03259074|468008600|FG001|Overall Study|Progressive Disease|0|||
130012502|NCT03259074|468008601|FG002|Overall Study|Progressive Disease|0|||
130012503|NCT03259074|468008599|FG000|Overall Study|Protocol Deviation|1|||
130012504|NCT03259074|468008600|FG001|Overall Study|Protocol Deviation|1|||
130012505|NCT03259074|468008601|FG002|Overall Study|Protocol Deviation|3|||
130012506|NCT03259074|468008599|FG000|Overall Study|Subject/Guardian Decision|13|||
130012507|NCT03259074|468008600|FG001|Overall Study|Subject/Guardian Decision|16|||
130012508|NCT03259074|468008601|FG002|Overall Study|Subject/Guardian Decision|14|||
130012509|NCT01780662|468008602|FG000|Overall Study|Adverse Event|1|||
130012510|NCT01780662|468008603|FG001|Overall Study|Adverse Event|0|||
130012511|NCT01780662|468008604|FG002|Overall Study|Adverse Event|2|||
130012512|NCT01780662|468008602|FG000|Overall Study|Physician Decision|0|||
130012513|NCT01780662|468008603|FG001|Overall Study|Physician Decision|5|||
130012514|NCT01780662|468008604|FG002|Overall Study|Physician Decision|7|||
130012515|NCT01780662|468008602|FG000|Overall Study|Protocol Violation|0|||
130012516|NCT01780662|468008603|FG001|Overall Study|Protocol Violation|1|||
130012517|NCT01780662|468008604|FG002|Overall Study|Protocol Violation|0|||
130012518|NCT01780662|468008602|FG000|Overall Study|Ineligible|0|||
130012519|NCT01780662|468008603|FG001|Overall Study|Ineligible|0|||
130012520|NCT01780662|468008604|FG002|Overall Study|Ineligible|1|||
130012521|NCT00053417|468008605|FG000|Overall Study|Adverse Event|1|||
130012522|NCT00053417|468008606|FG001|Overall Study|Adverse Event|0|||
130012523|NCT00053417|468008607|FG002|Overall Study|Adverse Event|1|||
130012524|NCT00053417|468008608|FG003|Overall Study|Adverse Event|5|||
130012525|NCT00053417|468008605|FG000|Overall Study|Non-Compliance|0|||
130012526|NCT00053417|468008606|FG001|Overall Study|Non-Compliance|0|||
130012527|NCT00053417|468008607|FG002|Overall Study|Non-Compliance|0|||
130012528|NCT00053417|468008608|FG003|Overall Study|Non-Compliance|1|||
130012529|NCT00053417|468008605|FG000|Overall Study|Withdrawal by Subject|0|||
130012530|NCT00053417|468008606|FG001|Overall Study|Withdrawal by Subject|1|||
130012531|NCT00053417|468008607|FG002|Overall Study|Withdrawal by Subject|0|||
130012532|NCT00053417|468008608|FG003|Overall Study|Withdrawal by Subject|0|||
130012533|NCT00053417|468008605|FG000|Overall Study|Lost to Follow-up|1|||
130012534|NCT00053417|468008606|FG001|Overall Study|Lost to Follow-up|1|||
130012535|NCT00053417|468008607|FG002|Overall Study|Lost to Follow-up|0|||
130012536|NCT00053417|468008608|FG003|Overall Study|Lost to Follow-up|0|||
130012537|NCT04081363|468008611|FG000|Overall Study|Withdrawal by Subject|1|||
130012538|NCT04081363|468008612|FG001|Overall Study|Withdrawal by Subject|0|||
130012539|NCT01227044|468008615|FG000|Overall Study|Lost to Follow-up|5|||
130012540|NCT01227044|468008616|FG001|Overall Study|Lost to Follow-up|7|||
130012541|NCT01227044|468008615|FG000|Overall Study|Discontinued Intervention|1|||
130012542|NCT01227044|468008616|FG001|Overall Study|Discontinued Intervention|2|||
130012543|NCT00583362|468008617|FG000|Overall Study|Adverse Event|44|||
130012544|NCT00583362|468008617|FG000|Overall Study|Lack of Efficacy|22|||
130012545|NCT00583362|468008617|FG000|Overall Study|Lost to Follow-up|4|||
130012546|NCT00583362|468008617|FG000|Overall Study|Non-compliance with study drug|28|||
130012547|NCT00583362|468008617|FG000|Overall Study|Pregnancy|7|||
130012548|NCT00583362|468008617|FG000|Overall Study|Miscommunication of visit window|5|||
130012549|NCT00583362|468008617|FG000|Overall Study|Current site closed|7|||
130347392|NCT01239732|469243636|FG000|Overall Study|Investigator's decision|4|||
130347393|NCT01239732|469243636|FG000|Overall Study|Treatment failure|2|||
130347394|NCT01239732|469243636|FG000|Overall Study|Other|19|||
130347395|NCT02216812|469243654|FG000|Overall Study|Lost to Follow-up|10|||
130347396|NCT02216812|469243655|FG001|Overall Study|Lost to Follow-up|5|||
130347397|NCT00527488|469243660|FG000|Overall Study|Withdrawn prior to dosing|0|||
130347398|NCT00527488|469243661|FG001|Overall Study|Withdrawn prior to dosing|1|||
130347399|NCT00527488|469243662|FG002|Overall Study|Withdrawn prior to dosing|1|||
130012550|NCT00583362|468008617|FG000|Overall Study|Subject not dosed in LBSL99|1|||
130012551|NCT00583362|468008617|FG000|Overall Study|Subject moved out of the country/state|2|||
130012552|NCT00583362|468008617|FG000|Overall Study|Missed visits due to staff changes|1|||
130012553|NCT00583362|468008617|FG000|Overall Study|Misunderstanding of protocol|1|||
130012554|NCT00583362|468008617|FG000|Overall Study|Behavioral problems and non-compliance|1|||
130012555|NCT00583362|468008617|FG000|Overall Study|Sponsor request due to missed doses|1|||
130012556|NCT00583362|468008617|FG000|Overall Study|Physician Decision|19|||
130012557|NCT00583362|468008617|FG000|Overall Study|Protocol Violation|2|||
130012558|NCT00583362|468008617|FG000|Overall Study|Withdrawal by Subject|57|||
130216787|NCT00621257|468757237|FG002|Overall Study|Lost to Follow-up|2|||
130012559|NCT01136655|468008625|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
130347400|NCT00527488|469243663|FG003|Overall Study|Withdrawn prior to dosing|0|||
130347401|NCT01958827|469243664|FG000|Overall Study|Adverse Event|3|||
130347402|NCT01958827|469243664|FG000|Overall Study|Lack of Efficacy|6|||
130216788|NCT00621257|468757238|FG003|Overall Study|Lost to Follow-up|4|||
130216789|NCT00621257|468757239|FG004|Overall Study|Lost to Follow-up|7|||
130216790|NCT00621257|468757235|FG000|Overall Study|Adverse Event|0|||
130216791|NCT00621257|468757236|FG001|Overall Study|Adverse Event|1|||
130216792|NCT00621257|468757237|FG002|Overall Study|Adverse Event|1|||
130216793|NCT00621257|468757238|FG003|Overall Study|Adverse Event|0|||
130216794|NCT00621257|468757239|FG004|Overall Study|Adverse Event|0|||
130012560|NCT01136655|468008625|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
130012561|NCT01136655|468008625|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
130012562|NCT01136655|468008625|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
130012563|NCT02287623|468008626|FG000|Overall Study|Protocol Violation|0|||
130216795|NCT00621257|468757235|FG000|Overall Study|Physician Decision|0|||
130216796|NCT00621257|468757236|FG001|Overall Study|Physician Decision|2|||
130216797|NCT00621257|468757237|FG002|Overall Study|Physician Decision|0|||
130216798|NCT00621257|468757238|FG003|Overall Study|Physician Decision|1|||
130347403|NCT01958827|469243664|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
130347404|NCT00604214|469243669|FG000|Baseline to Day 28|Death|223|||
130347405|NCT00604214|469243670|FG001|Baseline to Day 28|Death|202|||
130347406|NCT00604214|469243669|FG000|Baseline to Day 28|Lost to Follow-up|2|||
130347407|NCT00604214|469243670|FG001|Baseline to Day 28|Lost to Follow-up|4|||
130347408|NCT00604214|469243669|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
130347409|NCT00604214|469243670|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
130347410|NCT00604214|469243669|FG000|Day 29 to Day 90|Death|64|||
130347411|NCT00604214|469243670|FG001|Day 29 to Day 90|Death|67|||
130347412|NCT00604214|469243669|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
130347413|NCT00604214|469243670|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
130347414|NCT00604214|469243669|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
130347415|NCT00604214|469243670|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
130347416|NCT00604214|469243669|FG000|Day 91 to Day 180|Death|19|||
130347417|NCT00604214|469243670|FG001|Day 91 to Day 180|Death|23|||
130347418|NCT00604214|469243669|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
130347419|NCT00604214|469243670|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
130347420|NCT00604214|469243669|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
130347421|NCT00604214|469243670|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
130347422|NCT03939689|469246655|FG000|Overall Study|Radiographic progression|14|||
130347423|NCT03939689|469246656|FG001|Overall Study|Radiographic progression|17|||
130347424|NCT03939689|469246655|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
130347425|NCT03939689|469246656|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
130347426|NCT03939689|469246655|FG000|Overall Study|Adverse Event|1|||
130347427|NCT03939689|469246656|FG001|Overall Study|Adverse Event|8|||
130347428|NCT03939689|469246655|FG000|Overall Study|Unequivocal clinical progression|2|||
130347429|NCT03939689|469246656|FG001|Overall Study|Unequivocal clinical progression|5|||
130347430|NCT03939689|469246655|FG000|Overall Study|Other|1|||
130347431|NCT03939689|469246656|FG001|Overall Study|Other|4|||
130347432|NCT03939689|469246655|FG000|Overall Study|Death|0|||
130347433|NCT03939689|469246656|FG001|Overall Study|Death|3|||
130347434|NCT03939689|469246655|FG000|Overall Study|Participant decision|0|||
130347435|NCT03939689|469246656|FG001|Overall Study|Participant decision|3|||
130347436|NCT03939689|469246655|FG000|Overall Study|Withdrawal of consent|2|||
130347437|NCT03939689|469246656|FG001|Overall Study|Withdrawal of consent|1|||
130347438|NCT03939689|469246655|FG000|Overall Study|Investigator decision|1|||
130347439|NCT03939689|469246656|FG001|Overall Study|Investigator decision|0|||
130347440|NCT02964013|469246660|FG000|Overall Study|Death|58|||
130347441|NCT02964013|469246661|FG001|Overall Study|Death|239|||
130347442|NCT02964013|469246662|FG002|Overall Study|Death|38|||
130347443|NCT02964013|469246663|FG003|Overall Study|Death|10|||
130347444|NCT02964013|469246664|FG004|Overall Study|Death|33|||
130347445|NCT02964013|469246660|FG000|Overall Study|Lost to Follow-up|1|||
130347446|NCT02964013|469246661|FG001|Overall Study|Lost to Follow-up|4|||
130347447|NCT02964013|469246662|FG002|Overall Study|Lost to Follow-up|2|||
130347448|NCT02964013|469246663|FG003|Overall Study|Lost to Follow-up|0|||
130347449|NCT02964013|469246664|FG004|Overall Study|Lost to Follow-up|0|||
130347450|NCT02964013|469246660|FG000|Overall Study|Physician Decision|0|||
130347451|NCT02964013|469246661|FG001|Overall Study|Physician Decision|1|||
130347452|NCT02964013|469246662|FG002|Overall Study|Physician Decision|0|||
130347453|NCT02964013|469246663|FG003|Overall Study|Physician Decision|0|||
130347454|NCT02964013|469246664|FG004|Overall Study|Physician Decision|0|||
130347455|NCT02964013|469246660|FG000|Overall Study|Sponsor Decision|3|||
130347456|NCT02964013|469246661|FG001|Overall Study|Sponsor Decision|22|||
130347457|NCT02964013|469246662|FG002|Overall Study|Sponsor Decision|11|||
130347458|NCT02964013|469246663|FG003|Overall Study|Sponsor Decision|0|||
130347459|NCT02964013|469246664|FG004|Overall Study|Sponsor Decision|7|||
130347460|NCT02964013|469246660|FG000|Overall Study|Withdrawal by Subject|6|||
130347461|NCT02964013|469246661|FG001|Overall Study|Withdrawal by Subject|27|||
130347462|NCT02964013|469246662|FG002|Overall Study|Withdrawal by Subject|9|||
130347463|NCT02964013|469246663|FG003|Overall Study|Withdrawal by Subject|0|||
130347464|NCT02964013|469246664|FG004|Overall Study|Withdrawal by Subject|0|||
130347465|NCT02964013|469246660|FG000|Overall Study|Not Treated|0|||
130347466|NCT02964013|469246661|FG001|Overall Study|Not Treated|2|||
130012564|NCT02287623|468008627|FG001|Overall Study|Protocol Violation|1|||
130012565|NCT02577146|468008628|FG000|Overall Study|Lost to Follow-up|8|||
130012566|NCT02577146|468008628|FG000|Overall Study|Physician Decision|3|||
130012567|NCT02577146|468008628|FG000|Overall Study|Screen Failure|17|||
130347467|NCT02964013|469246662|FG002|Overall Study|Not Treated|0|||
130347468|NCT02964013|469246663|FG003|Overall Study|Not Treated|1|||
130347469|NCT02964013|469246664|FG004|Overall Study|Not Treated|0|||
130347470|NCT03595124|469246665|FG000|Overall Study|Physician Decision|1|||
130347471|NCT03595124|469246666|FG001|Overall Study|Physician Decision|1|||
130347472|NCT03595124|469246667|FG002|Overall Study|Physician Decision|1|||
130347473|NCT03595124|469246665|FG000|Overall Study|Ineligible|1|||
130347474|NCT03595124|469246666|FG001|Overall Study|Ineligible|1|||
130347475|NCT03595124|469246667|FG002|Overall Study|Ineligible|0|||
130347476|NCT03595124|469246665|FG000|Overall Study|Disease Progression|4|||
130347477|NCT03595124|469246666|FG001|Overall Study|Disease Progression|1|||
130347478|NCT03595124|469246667|FG002|Overall Study|Disease Progression|4|||
130347479|NCT04079868|469246671|FG000|Overall Study|Lost to Follow-up|100|||
130347480|NCT04079868|469246672|FG001|Overall Study|Lost to Follow-up|200|||
130347481|NCT04079868|469246671|FG000|Overall Study|Physician Decision|100|||
130347482|NCT04079868|469246672|FG001|Overall Study|Physician Decision|0|||
130347483|NCT05620108|469246677|FG000|Overall Study|Physician Decision|1|||
130347484|NCT05620108|469246678|FG001|Overall Study|Physician Decision|2|||
130347485|NCT03404960|469246680|FG000|Overall Study|Adverse Event|0|||
130347486|NCT03404960|469246681|FG001|Overall Study|Adverse Event|2|||
130347487|NCT03404960|469246680|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
130347488|NCT03404960|469246681|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
130347489|NCT03404960|469246680|FG000|Overall Study|Bowel obstruction|0|||
130347490|NCT03404960|469246681|FG001|Overall Study|Bowel obstruction|1|||
130347491|NCT03404960|469246680|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
130347492|NCT03404960|469246681|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
130347493|NCT04201288|469246684|FG000|Overall Study|Death|1|||
130347494|NCT04201288|469246685|FG001|Overall Study|Death|1|||
130347495|NCT04201288|469246684|FG000|Overall Study|Lost to Follow-up|5|||
130347496|NCT04201288|469246685|FG001|Overall Study|Lost to Follow-up|3|||
130347497|NCT04201288|469246684|FG000|Overall Study|Withdrawal by Subject|1|||
130347498|NCT04201288|469246685|FG001|Overall Study|Withdrawal by Subject|0|||
130347499|NCT02038842|469246686|FG000|Overall Study|Withdrawal by Subject|2|||
130347500|NCT02038842|469246687|FG001|Overall Study|Withdrawal by Subject|2|||
130347501|NCT02038842|469246688|FG002|Overall Study|Withdrawal by Subject|0|||
130347502|NCT02038842|469246689|FG003|Overall Study|Withdrawal by Subject|0|||
130347503|NCT02038842|469246686|FG000|Overall Study|Participant decision|0|||
130347504|NCT02038842|469246687|FG001|Overall Study|Participant decision|0|||
130347505|NCT02038842|469246688|FG002|Overall Study|Participant decision|2|||
130347506|NCT02038842|469246689|FG003|Overall Study|Participant decision|1|||
130347507|NCT02038842|469246686|FG000|Overall Study|Adverse Event|0|||
130347508|NCT02038842|469246687|FG001|Overall Study|Adverse Event|0|||
130347509|NCT02038842|469246688|FG002|Overall Study|Adverse Event|3|||
130347510|NCT02038842|469246689|FG003|Overall Study|Adverse Event|1|||
130347511|NCT02038842|469246686|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
130347512|NCT02038842|469246687|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
130347513|NCT02038842|469246688|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
130347514|NCT02038842|469246689|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
130347515|NCT03412773|469246690|FG000|Overall Study|Lost to Follow-up|0|||
130347516|NCT03412773|469246691|FG001|Overall Study|Lost to Follow-up|7|||
130347517|NCT03412773|469246692|FG002|Overall Study|Lost to Follow-up|6|||
130347518|NCT03412773|469246690|FG000|Overall Study|Withdrawal by Subject|0|||
130347519|NCT03412773|469246691|FG001|Overall Study|Withdrawal by Subject|15|||
130347520|NCT03412773|469246692|FG002|Overall Study|Withdrawal by Subject|19|||
130347521|NCT03412773|469246690|FG000|Overall Study|Study Closed By Sponsor|3|||
130347522|NCT03412773|469246691|FG001|Overall Study|Study Closed By Sponsor|46|||
130347523|NCT03412773|469246692|FG002|Overall Study|Study Closed By Sponsor|33|||
130347524|NCT03412773|469246690|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
130347525|NCT03412773|469246691|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
130347526|NCT03412773|469246692|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
130347527|NCT03412773|469246690|FG000|Overall Study|Death|7|||
130347528|NCT03412773|469246691|FG001|Overall Study|Death|259|||
130347529|NCT03412773|469246692|FG002|Overall Study|Death|273|||
130347530|NCT03412773|469246690|FG000|Overall Study|Physician Decision|0|||
130347531|NCT03412773|469246691|FG001|Overall Study|Physician Decision|0|||
130347532|NCT03412773|469246692|FG002|Overall Study|Physician Decision|1|||
130347533|NCT04395001|469246696|FG000|Overall Study|Lost to Follow-up|8|||
130347534|NCT04395001|469246697|FG001|Overall Study|Lost to Follow-up|9|||
130347535|NCT04395001|469246698|FG002|Overall Study|Lost to Follow-up|5|||
130347536|NCT04395001|469246696|FG000|Overall Study|Withdrawal by Subject|3|||
130347537|NCT04395001|469246697|FG001|Overall Study|Withdrawal by Subject|1|||
130347538|NCT04395001|469246698|FG002|Overall Study|Withdrawal by Subject|3|||
130347539|NCT04395001|469246696|FG000|Overall Study|missed appointment|7|||
130012568|NCT01970501|468008629|FG000|Overall Study|Discontinuation of study by sponsor|16|||
130012569|NCT01970501|468008630|FG001|Overall Study|Discontinuation of study by sponsor|14|||
130012570|NCT01970501|468008629|FG000|Overall Study|Withdrawal by Subject|6|||
130012571|NCT01970501|468008630|FG001|Overall Study|Withdrawal by Subject|7|||
130012572|NCT01970501|468008629|FG000|Overall Study|Adverse Event|2|||
130012573|NCT01970501|468008630|FG001|Overall Study|Adverse Event|4|||
130012574|NCT01970501|468008629|FG000|Overall Study|Death|1|||
130012575|NCT01970501|468008630|FG001|Overall Study|Death|3|||
130012576|NCT01970501|468008629|FG000|Overall Study|Physician Decision|2|||
130012577|NCT01970501|468008630|FG001|Overall Study|Physician Decision|0|||
130052077|NCT05137041|468147194|FG001|Overall Study|Withdrawal by Subject|2|||
130052078|NCT05137041|468147193|FG000|Overall Study|Reason not Specified|0|||
130052079|NCT05137041|468147194|FG001|Overall Study|Reason not Specified|1|||
130052080|NCT01605071|468147195|FG000|Overall Study|Withdrawal by Subject|3|||
130052081|NCT01605071|468147196|FG001|Overall Study|Withdrawal by Subject|2|||
130052082|NCT00392171|468147197|FG000|Overall Study|Did not meet inclusion criteria|4|||
130052083|NCT00392171|468147197|FG000|Overall Study|Disease progression|101|||
130052084|NCT00028002|468147201|FG000|Overall Study|Withdrawal by Subject|3|||
130052085|NCT00028002|468147201|FG000|Overall Study|Ineligible|8|||
130052086|NCT04907539|468147204|FG000|Overall Study|Consent withdrawn|1|||
130052087|NCT04907539|468147205|FG001|Overall Study|Consent withdrawn|0|||
130052088|NCT04907539|468147204|FG000|Overall Study|Death|14|||
130052089|NCT04907539|468147205|FG001|Overall Study|Death|3|||
130052090|NCT00051558|468147207|FG000|Overall Study|Adverse Event|30|||
130052091|NCT00051558|468147208|FG001|Overall Study|Adverse Event|18|||
130052092|NCT00051558|468147207|FG000|Overall Study|Withdrawal by Subject|29|||
130052093|NCT00051558|468147208|FG001|Overall Study|Withdrawal by Subject|42|||
130052094|NCT00051558|468147207|FG000|Overall Study|Death|9|||
130052095|NCT00051558|468147208|FG001|Overall Study|Death|15|||
130052096|NCT00051558|468147207|FG000|Overall Study|Lost to Follow-up|4|||
130347540|NCT04395001|469246697|FG001|Overall Study|missed appointment|4|||
130347541|NCT04395001|469246698|FG002|Overall Study|missed appointment|1|||
130347542|NCT05332912|469246703|FG000|Overall Study|Withdrawal by Subject|0|||
130347543|NCT05332912|469246704|FG001|Overall Study|Withdrawal by Subject|1|||
130347544|NCT05332912|469246705|FG002|Overall Study|Withdrawal by Subject|2|||
130347545|NCT05332912|469246706|FG003|Overall Study|Withdrawal by Subject|0|||
130347546|NCT05332912|469246703|FG000|Overall Study|Lost to Follow-up|0|||
130347547|NCT05332912|469246704|FG001|Overall Study|Lost to Follow-up|0|||
130347548|NCT05332912|469246705|FG002|Overall Study|Lost to Follow-up|1|||
130347549|NCT05332912|469246706|FG003|Overall Study|Lost to Follow-up|0|||
130347550|NCT04251156|469246709|FG000|Overall Study|Lost to Follow-up|1|||
130347551|NCT04251156|469246710|FG001|Overall Study|Lost to Follow-up|1|||
130347552|NCT04251156|469246709|FG000|Overall Study|Withdrawal by Subject|4|||
130347553|NCT04251156|469246710|FG001|Overall Study|Withdrawal by Subject|4|||
130347554|NCT02942004|469246711|FG000|Overall Study|Withdrawal by Subject|0|||
130347555|NCT02942004|469246712|FG001|Overall Study|Withdrawal by Subject|2|||
130347556|NCT02942004|469246713|FG002|Overall Study|Withdrawal by Subject|3|||
130347557|NCT02942004|469246711|FG000|Overall Study|Lost to Follow-up|1|||
130347558|NCT02942004|469246712|FG001|Overall Study|Lost to Follow-up|1|||
130347559|NCT02942004|469246713|FG002|Overall Study|Lost to Follow-up|2|||
130347560|NCT02942004|469246711|FG000|Overall Study|Randomized but not dosed|3|||
130347561|NCT02942004|469246712|FG001|Overall Study|Randomized but not dosed|9|||
130347562|NCT02942004|469246713|FG002|Overall Study|Randomized but not dosed|4|||
130347563|NCT04517669|469246714|FG000|Overall Study|Lost to Follow-up|2|||
130347564|NCT04517669|469246714|FG000|Overall Study|Withdrawal by Subject|3|||
130347565|NCT04517669|469246714|FG000|Overall Study|Drug withdrawn|44|||
130347566|NCT04517669|469246714|FG000|Overall Study|Other|1|||
130347567|NCT04517669|469246714|FG000|Overall Study|Eligibility criteria not met|4|||
130347568|NCT04517669|469246714|FG000|Overall Study|Did not receive treatment|3|||
130347569|NCT02455557|469246715|FG000|Overall Study|Withdrawal by Subject|2|||
130347570|NCT00807027|469246716|FG000|Overall Study|Withdrawal by Subject|13|||
130347571|NCT00807027|469246717|FG001|Overall Study|Withdrawal by Subject|14|||
130347572|NCT00807027|469246716|FG000|Overall Study|Protocol Violation|1|||
130347573|NCT00807027|469246717|FG001|Overall Study|Protocol Violation|1|||
130347574|NCT00807027|469246716|FG000|Overall Study|Adverse Event|2|||
130347575|NCT00807027|469246717|FG001|Overall Study|Adverse Event|2|||
130347576|NCT06133348|469246718|FG000|Overall Study|Death|3|||
129884415|NCT02771210|467536388|FG001|Period 2|Lack of Efficacy|1|||
130052097|NCT00051558|468147208|FG001|Overall Study|Lost to Follow-up|13|||
130052098|NCT00051558|468147207|FG000|Overall Study|Protocol Violation|3|||
130052099|NCT00051558|468147208|FG001|Overall Study|Protocol Violation|4|||
130052100|NCT00051558|468147207|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
130052101|NCT00051558|468147208|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
130052102|NCT00051558|468147207|FG000|Overall Study|Sponsor Decision|6|||
130347577|NCT06133348|469246718|FG000|Overall Study|Lost to Follow-up|1|||
130347578|NCT06133348|469246718|FG000|Overall Study|Physician Decision|1|||
130347579|NCT06133348|469246718|FG000|Overall Study|Withdrawal by Subject|5|||
130347580|NCT05508074|469246722|FG000|Overall Study|Death|2|||
130347581|NCT05508074|469246723|FG001|Overall Study|Death|5|||
130216799|NCT00621257|468757239|FG004|Overall Study|Physician Decision|1|||
130216800|NCT00621257|468757235|FG000|Overall Study|Withdrawal by Subject|0|||
130216801|NCT00621257|468757236|FG001|Overall Study|Withdrawal by Subject|0|||
130216802|NCT00621257|468757237|FG002|Overall Study|Withdrawal by Subject|0|||
130216803|NCT00621257|468757238|FG003|Overall Study|Withdrawal by Subject|1|||
130216804|NCT00621257|468757239|FG004|Overall Study|Withdrawal by Subject|1|||
130216805|NCT01255904|468757240|FG000|Overall Study|Physician Decision|1|||
130216806|NCT01255904|468757241|FG001|Overall Study|Physician Decision|4|||
130216807|NCT02061813|468757245|FG000|Overall Study|Withdrawal by Subject|1|||
130216808|NCT02061813|468757245|FG000|Overall Study|Protocol Violation|2|||
130216809|NCT01705080|468757248|FG000|Overall Study|Missed visit|10|||
130216810|NCT01705080|468757249|FG001|Overall Study|Missed visit|4|||
130216811|NCT01705080|468757250|FG002|Overall Study|Missed visit|1|||
130216812|NCT01705080|468757248|FG000|Overall Study|Death|4|||
130216813|NCT01705080|468757249|FG001|Overall Study|Death|4|||
130216814|NCT01705080|468757250|FG002|Overall Study|Death|6|||
130216815|NCT01705080|468757248|FG000|Overall Study|Withdrawal by Subject|61|||
130216816|NCT01705080|468757249|FG001|Overall Study|Withdrawal by Subject|44|||
130216817|NCT01705080|468757250|FG002|Overall Study|Withdrawal by Subject|9|||
130216818|NCT00206427|468757252|FG000|Overall Study|Adverse Event|2|||
130216819|NCT00741598|468757253|FG000|Overall Study|Lost to Follow-up|3|||
130216820|NCT00741598|468757254|FG001|Overall Study|Lost to Follow-up|4|||
130216821|NCT00741598|468757253|FG000|Overall Study|Lack of Efficacy|1|||
130216822|NCT00741598|468757254|FG001|Overall Study|Lack of Efficacy|2|||
130216823|NCT00741598|468757253|FG000|Overall Study|Physician Decision|1|||
130216824|NCT00741598|468757254|FG001|Overall Study|Physician Decision|1|||
130216825|NCT00741598|468757253|FG000|Overall Study|Pregnancy|1|||
130012578|NCT04218201|468010226|FG000|Overall Study|Death|0|||
130012579|NCT04218201|468010227|FG001|Overall Study|Death|0|||
130012580|NCT04218201|468010228|FG002|Overall Study|Death|2|||
130012581|NCT04218201|468010229|FG003|Overall Study|Death|0|||
130012582|NCT04218201|468010226|FG000|Overall Study|Unable to contact participant|4|||
130012583|NCT04218201|468010227|FG001|Overall Study|Unable to contact participant|0|||
130012584|NCT04218201|468010228|FG002|Overall Study|Unable to contact participant|3|||
130012585|NCT04218201|468010229|FG003|Overall Study|Unable to contact participant|0|||
130012586|NCT04218201|468010226|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
130012587|NCT04218201|468010227|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130012588|NCT04218201|468010228|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130012589|NCT04218201|468010229|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
130012590|NCT04218201|468010226|FG000|Overall Study|Withdrawal by Subject|2|||
130012591|NCT04218201|468010227|FG001|Overall Study|Withdrawal by Subject|0|||
130012592|NCT04218201|468010228|FG002|Overall Study|Withdrawal by Subject|0|||
130012593|NCT04218201|468010229|FG003|Overall Study|Withdrawal by Subject|0|||
130012594|NCT04218201|468010226|FG000|Overall Study|PCP plans to leave practice|0|||
130012595|NCT04218201|468010227|FG001|Overall Study|PCP plans to leave practice|8|||
130012596|NCT04218201|468010228|FG002|Overall Study|PCP plans to leave practice|0|||
130012597|NCT04218201|468010229|FG003|Overall Study|PCP plans to leave practice|5|||
130012598|NCT04218201|468010226|FG000|Overall Study|Reduced panel|0|||
130012599|NCT04218201|468010227|FG001|Overall Study|Reduced panel|0|||
130012600|NCT04218201|468010228|FG002|Overall Study|Reduced panel|0|||
130012601|NCT04218201|468010229|FG003|Overall Study|Reduced panel|1|||
130012602|NCT04218201|468010226|FG000|Overall Study|No longer interested in participating|0|||
130012603|NCT04218201|468010227|FG001|Overall Study|No longer interested in participating|1|||
130012604|NCT04218201|468010228|FG002|Overall Study|No longer interested in participating|0|||
130012605|NCT04218201|468010229|FG003|Overall Study|No longer interested in participating|0|||
130012606|NCT03723707|468010230|FG000|Overall Study|Death|32|||
130012607|NCT03723707|468010231|FG001|Overall Study|Death|32|||
130012608|NCT03723707|468010230|FG000|Overall Study|Admitted to long term care|12|||
130012609|NCT03723707|468010231|FG001|Overall Study|Admitted to long term care|12|||
130012610|NCT03723707|468010230|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
130012611|NCT03723707|468010231|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
130012612|NCT03723707|468010230|FG000|Overall Study|Lost to Follow-up|40|||
130216826|NCT00741598|468757254|FG001|Overall Study|Pregnancy|0|||
130216827|NCT00741598|468757253|FG000|Overall Study|Withdrawal by Subject|3|||
130216828|NCT00741598|468757254|FG001|Overall Study|Withdrawal by Subject|2|||
130216829|NCT00313586|468757255|FG000|Overall Study|Disease progression|14|||
130216830|NCT00313586|468757256|FG001|Overall Study|Disease progression|19|||
130216831|NCT00313586|468757257|FG002|Overall Study|Disease progression|10|||
130216832|NCT00313586|468757258|FG003|Overall Study|Disease progression|3|||
130012613|NCT03723707|468010231|FG001|Overall Study|Lost to Follow-up|22|||
130012614|NCT03723707|468010230|FG000|Overall Study|Discontinued after study closure|24|||
130012615|NCT03723707|468010231|FG001|Overall Study|Discontinued after study closure|12|||
130012616|NCT05121480|468010232|FG000|Overall Study|Lack of Efficacy|2|||
130012617|NCT05121480|468010233|FG001|Overall Study|Lack of Efficacy|2|||
130012618|NCT05121480|468010234|FG002|Overall Study|Lack of Efficacy|1|||
130012619|NCT05121480|468010235|FG003|Overall Study|Lack of Efficacy|4|||
130012620|NCT05121480|468010236|FG004|Overall Study|Lack of Efficacy|0|||
130012621|NCT05121480|468010237|FG005|Overall Study|Lack of Efficacy|1|||
130012622|NCT05121480|468010238|FG006|Overall Study|Lack of Efficacy|0|||
130012623|NCT05121480|468010239|FG007|Overall Study|Lack of Efficacy|2|||
130012624|NCT05121480|468010232|FG000|Overall Study|Treatment Failure|0|||
130012625|NCT05121480|468010233|FG001|Overall Study|Treatment Failure|2|||
130012626|NCT05121480|468010234|FG002|Overall Study|Treatment Failure|0|||
130216833|NCT00313586|468757255|FG000|Overall Study|Adverse Event|12|||
130216834|NCT00313586|468757256|FG001|Overall Study|Adverse Event|18|||
130216835|NCT00313586|468757257|FG002|Overall Study|Adverse Event|3|||
130012627|NCT05121480|468010235|FG003|Overall Study|Treatment Failure|1|||
130012628|NCT05121480|468010236|FG004|Overall Study|Treatment Failure|0|||
130012629|NCT05121480|468010237|FG005|Overall Study|Treatment Failure|0|||
130012630|NCT05121480|468010238|FG006|Overall Study|Treatment Failure|0|||
130012631|NCT05121480|468010239|FG007|Overall Study|Treatment Failure|0|||
130012632|NCT05121480|468010232|FG000|Overall Study|Adverse Event|0|||
130012633|NCT05121480|468010233|FG001|Overall Study|Adverse Event|1|||
130012634|NCT05121480|468010234|FG002|Overall Study|Adverse Event|0|||
130012635|NCT05121480|468010235|FG003|Overall Study|Adverse Event|5|||
130012636|NCT05121480|468010236|FG004|Overall Study|Adverse Event|3|||
130012637|NCT05121480|468010237|FG005|Overall Study|Adverse Event|2|||
130012638|NCT05121480|468010238|FG006|Overall Study|Adverse Event|0|||
130012639|NCT05121480|468010239|FG007|Overall Study|Adverse Event|4|||
130012640|NCT05121480|468010232|FG000|Overall Study|Withdrawal by Subject|4|||
130012641|NCT05121480|468010233|FG001|Overall Study|Withdrawal by Subject|9|||
130012642|NCT05121480|468010234|FG002|Overall Study|Withdrawal by Subject|1|||
130012643|NCT05121480|468010235|FG003|Overall Study|Withdrawal by Subject|8|||
130012644|NCT05121480|468010236|FG004|Overall Study|Withdrawal by Subject|0|||
130012645|NCT05121480|468010237|FG005|Overall Study|Withdrawal by Subject|9|||
130012646|NCT05121480|468010238|FG006|Overall Study|Withdrawal by Subject|0|||
130012647|NCT05121480|468010239|FG007|Overall Study|Withdrawal by Subject|4|||
130012648|NCT05121480|468010232|FG000|Overall Study|Non-compliance with the protocol|0|||
130012649|NCT05121480|468010233|FG001|Overall Study|Non-compliance with the protocol|0|||
130012650|NCT05121480|468010234|FG002|Overall Study|Non-compliance with the protocol|0|||
130012651|NCT05121480|468010235|FG003|Overall Study|Non-compliance with the protocol|0|||
130012652|NCT05121480|468010236|FG004|Overall Study|Non-compliance with the protocol|1|||
130012653|NCT05121480|468010237|FG005|Overall Study|Non-compliance with the protocol|6|||
130012654|NCT05121480|468010238|FG006|Overall Study|Non-compliance with the protocol|0|||
130012655|NCT05121480|468010239|FG007|Overall Study|Non-compliance with the protocol|1|||
130012656|NCT05121480|468010232|FG000|Overall Study|Lost to Follow-up|0|||
130012657|NCT05121480|468010233|FG001|Overall Study|Lost to Follow-up|4|||
130216836|NCT00313586|468757258|FG003|Overall Study|Adverse Event|10|||
130216837|NCT00313586|468757255|FG000|Overall Study|Death|11|||
130216838|NCT00313586|468757256|FG001|Overall Study|Death|8|||
130216839|NCT00313586|468757257|FG002|Overall Study|Death|1|||
130216840|NCT00313586|468757258|FG003|Overall Study|Death|7|||
130216841|NCT00313586|468757255|FG000|Overall Study|Withdrawal by Subject|13|||
130216842|NCT00313586|468757256|FG001|Overall Study|Withdrawal by Subject|6|||
130216843|NCT00313586|468757257|FG002|Overall Study|Withdrawal by Subject|6|||
130216844|NCT00313586|468757258|FG003|Overall Study|Withdrawal by Subject|2|||
130216845|NCT00313586|468757255|FG000|Overall Study|Alternative therapy|3|||
130012658|NCT05121480|468010234|FG002|Overall Study|Lost to Follow-up|1|||
130012659|NCT05121480|468010235|FG003|Overall Study|Lost to Follow-up|3|||
130012660|NCT05121480|468010236|FG004|Overall Study|Lost to Follow-up|1|||
130216846|NCT00313586|468757256|FG001|Overall Study|Alternative therapy|6|||
130216847|NCT00313586|468757257|FG002|Overall Study|Alternative therapy|2|||
130012661|NCT05121480|468010237|FG005|Overall Study|Lost to Follow-up|1|||
130012662|NCT05121480|468010238|FG006|Overall Study|Lost to Follow-up|1|||
130012663|NCT05121480|468010239|FG007|Overall Study|Lost to Follow-up|4|||
130012664|NCT05121480|468010232|FG000|Overall Study|Physician Decision|0|||
130216848|NCT00313586|468757258|FG003|Overall Study|Alternative therapy|0|||
130012665|NCT05121480|468010233|FG001|Overall Study|Physician Decision|0|||
130012666|NCT05121480|468010234|FG002|Overall Study|Physician Decision|0|||
130012667|NCT05121480|468010235|FG003|Overall Study|Physician Decision|0|||
130012668|NCT05121480|468010236|FG004|Overall Study|Physician Decision|0|||
130216849|NCT00313586|468757255|FG000|Overall Study|Other complicating disease|2|||
130216850|NCT00313586|468757256|FG001|Overall Study|Other complicating disease|2|||
130216851|NCT00313586|468757257|FG002|Overall Study|Other complicating disease|0|||
130012669|NCT05121480|468010237|FG005|Overall Study|Physician Decision|1|||
130012670|NCT05121480|468010238|FG006|Overall Study|Physician Decision|0|||
130012671|NCT05121480|468010239|FG007|Overall Study|Physician Decision|1|||
130216852|NCT00313586|468757258|FG003|Overall Study|Other complicating disease|0|||
130216853|NCT00313586|468757255|FG000|Overall Study|Did not achieve HI-major/better response|10|||
130216854|NCT00313586|468757256|FG001|Overall Study|Did not achieve HI-major/better response|7|||
130216855|NCT00313586|468757257|FG002|Overall Study|Did not achieve HI-major/better response|2|||
130216856|NCT00313586|468757258|FG003|Overall Study|Did not achieve HI-major/better response|1|||
130216857|NCT00313586|468757255|FG000|Overall Study|Physician Decision|2|||
130216858|NCT00313586|468757256|FG001|Overall Study|Physician Decision|1|||
130216859|NCT00313586|468757257|FG002|Overall Study|Physician Decision|0|||
130216860|NCT00313586|468757258|FG003|Overall Study|Physician Decision|0|||
130216861|NCT00313586|468757255|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
130216862|NCT00313586|468757256|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
130216863|NCT00313586|468757257|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
130216864|NCT00313586|468757258|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
130216865|NCT00313586|468757255|FG000|Overall Study|Lost insurance|0|||
130216866|NCT00313586|468757256|FG001|Overall Study|Lost insurance|1|||
130216867|NCT00313586|468757257|FG002|Overall Study|Lost insurance|0|||
130216868|NCT00313586|468757258|FG003|Overall Study|Lost insurance|0|||
130216869|NCT00313586|468757255|FG000|Overall Study|Moved|0|||
130216870|NCT00313586|468757256|FG001|Overall Study|Moved|1|||
130216871|NCT00313586|468757257|FG002|Overall Study|Moved|0|||
130216872|NCT00313586|468757258|FG003|Overall Study|Moved|0|||
130216873|NCT00313586|468757255|FG000|Overall Study|Death before starting treatment|1|||
130216874|NCT00313586|468757256|FG001|Overall Study|Death before starting treatment|0|||
130216875|NCT00313586|468757257|FG002|Overall Study|Death before starting treatment|0|||
130216876|NCT00313586|468757258|FG003|Overall Study|Death before starting treatment|0|||
130216877|NCT03076996|468757259|FG000|Overall Study|Withdrawal by Subject|2|||
130216878|NCT03076996|468757259|FG000|Overall Study|Lost to Follow-up|3|||
130216879|NCT03076996|468757259|FG000|Overall Study|Literacy precluded participation|1|||
130216880|NCT01247350|468757260|FG000|Overall Study|Adverse Event|0|||
130216881|NCT01247350|468757261|FG001|Overall Study|Adverse Event|0|||
130216882|NCT01247350|468757262|FG002|Overall Study|Adverse Event|1|||
130216883|NCT01247350|468757263|FG003|Overall Study|Adverse Event|0|||
130216884|NCT01247350|468757264|FG004|Overall Study|Adverse Event|0|||
130216885|NCT01247350|468757260|FG000|Overall Study|Withdrawal by Subject|0|||
130216886|NCT01247350|468757261|FG001|Overall Study|Withdrawal by Subject|0|||
130216887|NCT01247350|468757262|FG002|Overall Study|Withdrawal by Subject|0|||
130216888|NCT01247350|468757263|FG003|Overall Study|Withdrawal by Subject|1|||
130216889|NCT01247350|468757264|FG004|Overall Study|Withdrawal by Subject|0|||
130216890|NCT01247350|468757260|FG000|Overall Study|Entry criteria not met|0|||
130216891|NCT01247350|468757261|FG001|Overall Study|Entry criteria not met|0|||
130216892|NCT01247350|468757262|FG002|Overall Study|Entry criteria not met|0|||
130216893|NCT01247350|468757263|FG003|Overall Study|Entry criteria not met|0|||
130216894|NCT01247350|468757264|FG004|Overall Study|Entry criteria not met|1|||
130216895|NCT01398358|468757273|FG000|Overall Study|Lost to Follow-up|11|||
130216896|NCT01398358|468757274|FG001|Overall Study|Lost to Follow-up|21|||
130216897|NCT01398358|468757275|FG002|Overall Study|Lost to Follow-up|18|||
130216898|NCT01398358|468757273|FG000|Overall Study|Withdrawal by Subject|3|||
130012672|NCT05121480|468010232|FG000|Overall Study|Other Reason|0|||
130012673|NCT05121480|468010233|FG001|Overall Study|Other Reason|0|||
130012674|NCT05121480|468010234|FG002|Overall Study|Other Reason|0|||
130012675|NCT05121480|468010235|FG003|Overall Study|Other Reason|0|||
130012676|NCT05121480|468010236|FG004|Overall Study|Other Reason|0|||
130216899|NCT01398358|468757274|FG001|Overall Study|Withdrawal by Subject|2|||
130216900|NCT01398358|468757275|FG002|Overall Study|Withdrawal by Subject|2|||
130216901|NCT01398358|468757273|FG000|Overall Study|no longer eligible|1|||
130216902|NCT01398358|468757274|FG001|Overall Study|no longer eligible|0|||
130216903|NCT01398358|468757275|FG002|Overall Study|no longer eligible|1|||
130216904|NCT00003896|468757278|FG000|Overall Study|Adverse Event|16|||
130216905|NCT00003896|468757278|FG000|Overall Study|Withdrawal by Subject|1|||
130216906|NCT00003896|468757278|FG000|Overall Study|Lack of Efficacy|1|||
130216907|NCT00003896|468757278|FG000|Overall Study|Death|3|||
130216908|NCT00003896|468757278|FG000|Overall Study|not protocol specified|3|||
130216909|NCT00003896|468757278|FG000|Overall Study|ineligible|5|||
130216910|NCT00985686|468757280|FG000|Overall Study|Lost to Follow-up|1|||
130216911|NCT00985686|468757281|FG001|Overall Study|Lost to Follow-up|1|||
130216912|NCT00985686|468757282|FG002|Overall Study|Lost to Follow-up|0|||
130216913|NCT00985686|468757283|FG003|Overall Study|Lost to Follow-up|2|||
130216914|NCT01670045|468757284|FG000|Overall Study|Withdrawal by Subject|3|||
130216915|NCT01670045|468757284|FG000|Overall Study|Adverse Event|1|||
130216916|NCT01670045|468757284|FG000|Overall Study|Death|1|||
130216917|NCT01670045|468757284|FG000|Overall Study|Lost to Follow-up|11|||
130216918|NCT02559570|468757286|FG000|Overall Study|Adverse Event|0|||
130216919|NCT02559570|468757287|FG001|Overall Study|Adverse Event|2|||
130347582|NCT05508074|469246722|FG000|Overall Study|Withdrawal by Subject|1|||
130347583|NCT05508074|469246723|FG001|Overall Study|Withdrawal by Subject|2|||
130347584|NCT05508074|469246722|FG000|Overall Study|Adverse Event|0|||
130347585|NCT05508074|469246723|FG001|Overall Study|Adverse Event|1|||
130347586|NCT05508074|469246722|FG000|Overall Study|Physician Decision|0|||
130347587|NCT05508074|469246723|FG001|Overall Study|Physician Decision|1|||
130216920|NCT02559570|468757288|FG002|Overall Study|Adverse Event|0|||
130216921|NCT02559570|468757289|FG003|Overall Study|Adverse Event|1|||
130216922|NCT02559570|468757290|FG004|Overall Study|Adverse Event|0|||
130216923|NCT02559570|468757286|FG000|Overall Study|Withdrawal of Consent|0|||
130216924|NCT02559570|468757287|FG001|Overall Study|Withdrawal of Consent|0|||
130216925|NCT02559570|468757288|FG002|Overall Study|Withdrawal of Consent|1|||
130216926|NCT02559570|468757289|FG003|Overall Study|Withdrawal of Consent|2|||
130216927|NCT02559570|468757290|FG004|Overall Study|Withdrawal of Consent|1|||
130216928|NCT02559570|468757286|FG000|Overall Study|Lost to Follow-up|1|||
130216929|NCT02559570|468757287|FG001|Overall Study|Lost to Follow-up|0|||
130216930|NCT02559570|468757288|FG002|Overall Study|Lost to Follow-up|0|||
130216931|NCT02559570|468757289|FG003|Overall Study|Lost to Follow-up|0|||
130216932|NCT02559570|468757290|FG004|Overall Study|Lost to Follow-up|0|||
130216933|NCT02559570|468757286|FG000|Overall Study|Protocol Violation|1|||
130216934|NCT02559570|468757287|FG001|Overall Study|Protocol Violation|0|||
130216935|NCT02559570|468757288|FG002|Overall Study|Protocol Violation|0|||
130216936|NCT02559570|468757289|FG003|Overall Study|Protocol Violation|0|||
130216937|NCT02559570|468757290|FG004|Overall Study|Protocol Violation|1|||
130216938|NCT02559570|468757286|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130216939|NCT02559570|468757287|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130216940|NCT02559570|468757288|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130216941|NCT02559570|468757289|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130216942|NCT02559570|468757290|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130216943|NCT00420628|468757294|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
130216944|NCT00420628|468757295|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
130216945|NCT00420628|468757294|FG000|Overall Study|Lost to Follow-up|3|||
130216946|NCT00420628|468757295|FG001|Overall Study|Lost to Follow-up|2|||
130216947|NCT00420628|468757294|FG000|Overall Study|Adverse Event|1|||
130216948|NCT00420628|468757295|FG001|Overall Study|Adverse Event|0|||
130216949|NCT00396383|468757302|FG000|Overall Study|Death|2|||
130216950|NCT00396383|468757302|FG000|Overall Study|Lost to Follow-up|1|||
130216951|NCT00282152|468757303|FG000|Overall Study|Withdrawal by Subject|1|||
130216952|NCT00282152|468757304|FG001|Overall Study|Withdrawal by Subject|0|||
130216953|NCT00585325|468757305|FG000|Overall Study|Withdrawal by Subject|1|||
130216954|NCT00585325|468757306|FG001|Overall Study|Withdrawal by Subject|1|||
130216955|NCT03301831|468757307|FG000|Overall Study|Lost to Follow-up|5|||
130216956|NCT03301831|468757308|FG001|Overall Study|Lost to Follow-up|3|||
130216957|NCT03301831|468757307|FG000|Overall Study|Protocol Violation|4|||
130216958|NCT03301831|468757308|FG001|Overall Study|Protocol Violation|0|||
130216959|NCT03301831|468757307|FG000|Overall Study|Withdrawal by Subject|11|||
130216960|NCT03301831|468757308|FG001|Overall Study|Withdrawal by Subject|0|||
130216961|NCT03092791|468757309|FG000|Overall Study|Lost to Follow-up|0|||
130216962|NCT03092791|468757310|FG001|Overall Study|Lost to Follow-up|0|||
130216963|NCT03092791|468757311|FG002|Overall Study|Lost to Follow-up|0|||
130216964|NCT03092791|468757312|FG003|Overall Study|Lost to Follow-up|0|||
130216965|NCT03092791|468757313|FG004|Overall Study|Lost to Follow-up|0|||
130216966|NCT03092791|468757314|FG005|Overall Study|Lost to Follow-up|0|||
130216967|NCT03092791|468757315|FG006|Overall Study|Lost to Follow-up|1|||
130216968|NCT03092791|468757316|FG007|Overall Study|Lost to Follow-up|0|||
130216969|NCT03092791|468757309|FG000|Overall Study|Withdrawal of Consent|0|||
130216970|NCT03092791|468757310|FG001|Overall Study|Withdrawal of Consent|0|||
130216971|NCT03092791|468757311|FG002|Overall Study|Withdrawal of Consent|0|||
130216972|NCT03092791|468757312|FG003|Overall Study|Withdrawal of Consent|0|||
130216973|NCT03092791|468757313|FG004|Overall Study|Withdrawal of Consent|4|||
130216974|NCT03092791|468757314|FG005|Overall Study|Withdrawal of Consent|12|||
130216975|NCT03092791|468757315|FG006|Overall Study|Withdrawal of Consent|6|||
130216976|NCT03092791|468757316|FG007|Overall Study|Withdrawal of Consent|4|||
130216977|NCT03092791|468757309|FG000|Overall Study|Study Termination|0|||
130216978|NCT03092791|468757310|FG001|Overall Study|Study Termination|0|||
130216979|NCT03092791|468757311|FG002|Overall Study|Study Termination|0|||
130216980|NCT03092791|468757312|FG003|Overall Study|Study Termination|0|||
130216981|NCT03092791|468757313|FG004|Overall Study|Study Termination|55|||
130216982|NCT03092791|468757314|FG005|Overall Study|Study Termination|46|||
130216983|NCT03092791|468757315|FG006|Overall Study|Study Termination|53|||
130216984|NCT03092791|468757316|FG007|Overall Study|Study Termination|55|||
130012677|NCT05121480|468010237|FG005|Overall Study|Other Reason|1|||
130012678|NCT05121480|468010238|FG006|Overall Study|Other Reason|1|||
130216985|NCT03092791|468757309|FG000|Overall Study|Death|0|||
130216986|NCT03092791|468757310|FG001|Overall Study|Death|0|||
130216987|NCT03092791|468757311|FG002|Overall Study|Death|0|||
130216988|NCT03092791|468757312|FG003|Overall Study|Death|0|||
130216989|NCT03092791|468757313|FG004|Overall Study|Death|0|||
130216990|NCT03092791|468757314|FG005|Overall Study|Death|1|||
130216991|NCT03092791|468757315|FG006|Overall Study|Death|0|||
130012679|NCT05121480|468010239|FG007|Overall Study|Other Reason|1|||
130216992|NCT03092791|468757316|FG007|Overall Study|Death|1|||
130216993|NCT03092791|468757309|FG000|Overall Study|Reason Not Specified|0|||
130216994|NCT03092791|468757310|FG001|Overall Study|Reason Not Specified|0|||
130216995|NCT03092791|468757311|FG002|Overall Study|Reason Not Specified|0|||
130347588|NCT05508074|469246722|FG000|Overall Study|wrongly randomized|0|||
130347589|NCT05508074|469246723|FG001|Overall Study|wrongly randomized|1|||
130347590|NCT05508074|469246722|FG000|Overall Study|non-compliance|0|||
130347591|NCT05508074|469246723|FG001|Overall Study|non-compliance|1|||
130347592|NCT04638660|469246724|FG000|Overall Study|Withdrawal by Subject|2|||
130347593|NCT04638660|469246725|FG001|Overall Study|Withdrawal by Subject|0|||
130347594|NCT04638660|469246724|FG000|Overall Study|Lost to Follow-up|1|||
130347595|NCT04638660|469246725|FG001|Overall Study|Lost to Follow-up|0|||
130347596|NCT04481373|469246726|FG000|Overall Study|Protocol Violation|1|||
130347597|NCT04481373|469246727|FG001|Overall Study|Protocol Violation|0|||
130347598|NCT04481373|469246726|FG000|Overall Study|Viral load in hospital not over 1000|2|||
130347599|NCT04481373|469246727|FG001|Overall Study|Viral load in hospital not over 1000|1|||
130347600|NCT04481373|469246726|FG000|Overall Study|Death before hospital discharge|1|||
130347601|NCT04481373|469246727|FG001|Overall Study|Death before hospital discharge|0|||
130347602|NCT03199469|469246728|FG000|Overall Study|Randomized, not treated|0|||
130347603|NCT03199469|469246729|FG001|Overall Study|Randomized, not treated|3|||
130347604|NCT03199469|469246728|FG000|Overall Study|Withdrawal by Subject|1|||
130347605|NCT03199469|469246729|FG001|Overall Study|Withdrawal by Subject|0|||
130347606|NCT03199469|469246728|FG000|Overall Study|Death|1|||
130347607|NCT03199469|469246729|FG001|Overall Study|Death|3|||
130347608|NCT03199469|469246728|FG000|Overall Study|Ongoing|5|||
130347609|NCT03199469|469246729|FG001|Overall Study|Ongoing|14|||
130347610|NCT05040971|469246730|FG000|Overall Study|Withdrawal by Subject|0|||
130347611|NCT05040971|469246731|FG001|Overall Study|Withdrawal by Subject|2|||
130347612|NCT05040971|469246730|FG000|Overall Study|Lost to Follow-up|8|||
130347613|NCT05040971|469246731|FG001|Overall Study|Lost to Follow-up|3|||
130347614|NCT05040971|469246730|FG000|Overall Study|Death|2|||
130347615|NCT05040971|469246731|FG001|Overall Study|Death|0|||
130347616|NCT03842228|469246735|FG000|Overall Study|Adverse Event|1|||
130347617|NCT03842228|469246736|FG001|Overall Study|Adverse Event|1|||
130347618|NCT03842228|469246737|FG002|Overall Study|Adverse Event|1|||
130347619|NCT03842228|469246738|FG003|Overall Study|Adverse Event|0|||
130347620|NCT03842228|469246739|FG004|Overall Study|Adverse Event|0|||
130347621|NCT03842228|469246740|FG005|Overall Study|Adverse Event|0|||
130347622|NCT03842228|469246741|FG006|Overall Study|Adverse Event|0|||
130347623|NCT03842228|469246735|FG000|Overall Study|Death|0|||
130347624|NCT03842228|469246736|FG001|Overall Study|Death|1|||
130347625|NCT03842228|469246737|FG002|Overall Study|Death|0|||
130347626|NCT03842228|469246738|FG003|Overall Study|Death|0|||
130347627|NCT03842228|469246739|FG004|Overall Study|Death|0|||
130347628|NCT03842228|469246740|FG005|Overall Study|Death|0|||
130347629|NCT03842228|469246741|FG006|Overall Study|Death|0|||
130347630|NCT03842228|469246735|FG000|Overall Study|Withdrawal by Subject|0|||
130347631|NCT03842228|469246736|FG001|Overall Study|Withdrawal by Subject|0|||
130347632|NCT03842228|469246737|FG002|Overall Study|Withdrawal by Subject|2|||
130347633|NCT03842228|469246738|FG003|Overall Study|Withdrawal by Subject|1|||
130347634|NCT03842228|469246739|FG004|Overall Study|Withdrawal by Subject|0|||
130347635|NCT03842228|469246740|FG005|Overall Study|Withdrawal by Subject|0|||
130347636|NCT03842228|469246741|FG006|Overall Study|Withdrawal by Subject|2|||
130347637|NCT03842228|469246735|FG000|Overall Study|Progression|8|||
130347638|NCT03842228|469246736|FG001|Overall Study|Progression|1|||
130347639|NCT03842228|469246737|FG002|Overall Study|Progression|7|||
130347640|NCT03842228|469246738|FG003|Overall Study|Progression|5|||
130347641|NCT03842228|469246739|FG004|Overall Study|Progression|4|||
130347642|NCT03842228|469246740|FG005|Overall Study|Progression|2|||
130347643|NCT03842228|469246741|FG006|Overall Study|Progression|3|||
130347644|NCT04868539|469246743|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
130347645|NCT04868539|469246744|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
130347646|NCT03651700|469246747|FG000|Overall Study|Withdrawal by Subject|1|||
130347647|NCT03651700|469246748|FG001|Overall Study|Withdrawal by Subject|0|||
130347648|NCT04916730|469246754|FG000|Overall Study|Withdrawal by Subject|4|||
130347649|NCT04916730|469246755|FG001|Overall Study|Withdrawal by Subject|2|||
130347650|NCT04916730|469246754|FG000|Overall Study|Lost to Follow-up|0|||
130347651|NCT04916730|469246755|FG001|Overall Study|Lost to Follow-up|2|||
130347652|NCT04916730|469246754|FG000|Overall Study|Physician Decision|1|||
130347653|NCT04916730|469246755|FG001|Overall Study|Physician Decision|0|||
130347654|NCT05479734|469246758|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
130347655|NCT05479734|469246759|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
130347656|NCT05479734|469246758|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
130347657|NCT05479734|469246759|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
130347658|NCT05479734|469246758|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
130347659|NCT05479734|469246759|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
130347660|NCT05479734|469246758|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
130347661|NCT05479734|469246759|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
130347662|NCT03945825|469246760|FG000|Overall Study|Enrolled but treatment not administered|0|||
130347663|NCT03945825|469246761|FG001|Overall Study|Enrolled but treatment not administered|0|||
130052103|NCT00051558|468147208|FG001|Overall Study|Sponsor Decision|1|||
130216996|NCT03092791|468757312|FG003|Overall Study|Reason Not Specified|0|||
130216997|NCT03092791|468757313|FG004|Overall Study|Reason Not Specified|1|||
130216998|NCT03092791|468757314|FG005|Overall Study|Reason Not Specified|1|||
130216999|NCT03092791|468757315|FG006|Overall Study|Reason Not Specified|0|||
130217000|NCT03092791|468757316|FG007|Overall Study|Reason Not Specified|0|||
130217001|NCT00980655|468757318|FG000|Overall Study|Adverse Event|13|||
130217002|NCT00980655|468757319|FG001|Overall Study|Adverse Event|31|||
130217003|NCT00980655|468757318|FG000|Overall Study|Death|0|||
130217004|NCT00980655|468757319|FG001|Overall Study|Death|7|||
130217005|NCT00980655|468757318|FG000|Overall Study|Protocol Violation|2|||
130217006|NCT00980655|468757319|FG001|Overall Study|Protocol Violation|7|||
130012680|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
130012681|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
130012682|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
130012683|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
130012684|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
130012685|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
130012686|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
130012687|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130012688|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130012689|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
130012690|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
130012691|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
130012692|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
130012693|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
130012694|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
130012695|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
130012696|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
130012697|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
130012698|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
130012699|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
130012700|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
130012701|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
130012702|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130012703|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130012704|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
130012705|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
130012706|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
130012707|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
130012708|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
130012709|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
130012710|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
130012711|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
130012712|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
130012713|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
130347664|NCT03945825|469246762|FG002|Overall Study|Enrolled but treatment not administered|0|||
130347665|NCT03945825|469246763|FG003|Overall Study|Enrolled but treatment not administered|0|||
130347666|NCT03945825|469246764|FG004|Overall Study|Enrolled but treatment not administered|1|||
130347667|NCT03945825|469246765|FG005|Overall Study|Enrolled but treatment not administered|0|||
130217007|NCT00980655|468757318|FG000|Overall Study|Withdrawal by Subject|0|||
130347668|NCT03945825|469246760|FG000|Overall Study|Lost to Follow-up|1|||
130347669|NCT03945825|469246761|FG001|Overall Study|Lost to Follow-up|5|||
130347670|NCT03945825|469246762|FG002|Overall Study|Lost to Follow-up|0|||
130347671|NCT03945825|469246763|FG003|Overall Study|Lost to Follow-up|1|||
130347672|NCT03945825|469246764|FG004|Overall Study|Lost to Follow-up|2|||
130347673|NCT03945825|469246765|FG005|Overall Study|Lost to Follow-up|2|||
130347674|NCT03945825|469246760|FG000|Overall Study|Withdrawal by Subject|1|||
130347675|NCT03945825|469246761|FG001|Overall Study|Withdrawal by Subject|0|||
130347676|NCT03945825|469246762|FG002|Overall Study|Withdrawal by Subject|1|||
130347677|NCT03945825|469246763|FG003|Overall Study|Withdrawal by Subject|1|||
130347678|NCT03945825|469246764|FG004|Overall Study|Withdrawal by Subject|0|||
130012714|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
130347679|NCT03945825|469246765|FG005|Overall Study|Withdrawal by Subject|1|||
130347680|NCT03083665|469246768|FG000|Double-Blind Period|Adverse Event|5|||
130012715|NCT02831673|468010242|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
130012716|NCT02831673|468010243|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
130052104|NCT00051558|468147207|FG000|Overall Study|Other|2|||
130052105|NCT00051558|468147208|FG001|Overall Study|Other|1|||
130052106|NCT00051558|468147207|FG000|Overall Study|Significant Lab Value|2|||
130052107|NCT00051558|468147208|FG001|Overall Study|Significant Lab Value|0|||
130052108|NCT00051558|468147207|FG000|Overall Study|Physician Decision|5|||
130012717|NCT02831673|468010244|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
130012718|NCT02831673|468010245|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
130012719|NCT02831673|468010246|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
130012720|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130012721|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130012722|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
130012723|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
130012724|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130012725|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130012726|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130012727|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
130012728|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
130012729|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130347681|NCT03083665|469246769|FG001|Double-Blind Period|Adverse Event|4|||
130347682|NCT03083665|469246770|FG002|Double-Blind Period|Adverse Event|5|||
130347683|NCT03083665|469246771|FG003|Double-Blind Period|Adverse Event|0|||
130347684|NCT03083665|469246772|FG004|Double-Blind Period|Adverse Event|0|||
130347685|NCT03083665|469246773|FG005|Double-Blind Period|Adverse Event|0|||
130347686|NCT03083665|469246768|FG000|Double-Blind Period|Lack of Efficacy|0|||
130347687|NCT03083665|469246769|FG001|Double-Blind Period|Lack of Efficacy|0|||
130347688|NCT03083665|469246770|FG002|Double-Blind Period|Lack of Efficacy|1|||
130347689|NCT03083665|469246771|FG003|Double-Blind Period|Lack of Efficacy|0|||
130347690|NCT03083665|469246772|FG004|Double-Blind Period|Lack of Efficacy|0|||
130347691|NCT03083665|469246773|FG005|Double-Blind Period|Lack of Efficacy|0|||
130347692|NCT03083665|469246768|FG000|Double-Blind Period|Protocol Violation|1|||
130347693|NCT03083665|469246769|FG001|Double-Blind Period|Protocol Violation|0|||
130347694|NCT03083665|469246770|FG002|Double-Blind Period|Protocol Violation|1|||
130347695|NCT03083665|469246771|FG003|Double-Blind Period|Protocol Violation|0|||
130347696|NCT03083665|469246772|FG004|Double-Blind Period|Protocol Violation|0|||
130347697|NCT03083665|469246773|FG005|Double-Blind Period|Protocol Violation|0|||
130347698|NCT03083665|469246768|FG000|Double-Blind Period|Lost to Follow-up|1|||
130347699|NCT03083665|469246769|FG001|Double-Blind Period|Lost to Follow-up|0|||
130347700|NCT03083665|469246770|FG002|Double-Blind Period|Lost to Follow-up|1|||
130347701|NCT03083665|469246771|FG003|Double-Blind Period|Lost to Follow-up|0|||
130347702|NCT03083665|469246772|FG004|Double-Blind Period|Lost to Follow-up|0|||
130347703|NCT03083665|469246773|FG005|Double-Blind Period|Lost to Follow-up|0|||
130347704|NCT03083665|469246768|FG000|Double-Blind Period|Withdrawal by Subject|3|||
130347705|NCT03083665|469246769|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130347706|NCT03083665|469246770|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130347707|NCT03083665|469246771|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130347708|NCT03083665|469246772|FG004|Double-Blind Period|Withdrawal by Subject|0|||
130347709|NCT03083665|469246773|FG005|Double-Blind Period|Withdrawal by Subject|0|||
130347710|NCT03083665|469246768|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
130347711|NCT03083665|469246769|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130347712|NCT03083665|469246770|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130347713|NCT03083665|469246771|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130347714|NCT03083665|469246772|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130347715|NCT03083665|469246773|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
130347716|NCT03083665|469246768|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
130347717|NCT03083665|469246769|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
130347718|NCT03083665|469246770|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
130347719|NCT03083665|469246771|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
130347720|NCT03083665|469246772|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
130347721|NCT03083665|469246773|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
130347722|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130347723|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130012730|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130012731|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130012732|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130012733|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
130347724|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130347725|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
130347726|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130347727|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
130347728|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130347729|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130347730|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130347731|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130012734|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130012735|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
130012736|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
130012737|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
130012738|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
130012739|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
130012740|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130012741|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130012742|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
130012743|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
130012744|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130012745|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130012746|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130012747|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
130012748|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
130012749|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130012750|NCT02831673|468010242|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130012751|NCT02831673|468010243|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130012752|NCT02831673|468010244|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
130012753|NCT02831673|468010245|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
130012754|NCT02831673|468010246|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130012755|NCT02831673|468010242|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130012756|NCT02831673|468010243|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130012757|NCT02831673|468010244|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130012758|NCT02831673|468010245|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
130012759|NCT02831673|468010246|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
130012760|NCT02831673|468010242|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130012761|NCT02831673|468010243|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130012762|NCT02831673|468010244|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130012763|NCT02831673|468010245|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130012764|NCT02831673|468010246|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
130012765|NCT02831673|468010242|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130012766|NCT02831673|468010243|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130012767|NCT02831673|468010244|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130012768|NCT02831673|468010245|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130012769|NCT02831673|468010246|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
130012770|NCT02831673|468010242|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130012771|NCT02831673|468010243|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130012772|NCT02831673|468010244|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130012773|NCT02831673|468010245|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130012774|NCT02831673|468010246|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
130012775|NCT02831673|468010242|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130012776|NCT02831673|468010243|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130012777|NCT02831673|468010244|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130012778|NCT02831673|468010245|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130012779|NCT02831673|468010246|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
130012780|NCT02356562|468010247|FG000|Overall Study|Withdrawal by Subject|0|||
130012781|NCT02356562|468010248|FG001|Overall Study|Withdrawal by Subject|1|||
130012782|NCT02356562|468010247|FG000|Overall Study|Re-entered treatment in a previous study|1|||
130012783|NCT02356562|468010248|FG001|Overall Study|Re-entered treatment in a previous study|0|||
130012784|NCT02356562|468010247|FG000|Overall Study|site closure|1|||
130012785|NCT02356562|468010248|FG001|Overall Study|site closure|0|||
130012786|NCT00412750|468010250|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130012787|NCT00412750|468010251|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130012788|NCT00412750|468010252|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130012789|NCT00412750|468010250|FG000|Overall Study|Administrative problems|21|||
130012790|NCT00412750|468010251|FG001|Overall Study|Administrative problems|17|||
130012791|NCT00412750|468010252|FG002|Overall Study|Administrative problems|14|||
130012792|NCT00412750|468010250|FG000|Overall Study|Adverse Event|8|||
130012793|NCT00412750|468010251|FG001|Overall Study|Adverse Event|3|||
130012794|NCT00412750|468010252|FG002|Overall Study|Adverse Event|3|||
130012795|NCT00412750|468010250|FG000|Overall Study|Lost to Follow-up|1|||
130012796|NCT00412750|468010251|FG001|Overall Study|Lost to Follow-up|0|||
130217008|NCT00980655|468757319|FG001|Overall Study|Withdrawal by Subject|4|||
130012797|NCT00412750|468010252|FG002|Overall Study|Lost to Follow-up|1|||
130217009|NCT00980655|468757318|FG000|Overall Study|Lost to Follow-up|0|||
130217010|NCT00980655|468757319|FG001|Overall Study|Lost to Follow-up|1|||
130217011|NCT00980655|468757318|FG000|Overall Study|Parent/legal guardian request|1|||
130217012|NCT00980655|468757319|FG001|Overall Study|Parent/legal guardian request|0|||
130217013|NCT00980655|468757318|FG000|Overall Study|Other|0|||
130012798|NCT00412750|468010250|FG000|Overall Study|Withdrawal by Subject|0|||
130217014|NCT00980655|468757319|FG001|Overall Study|Other|1|||
130217015|NCT00845676|468757325|FG000|Overall Study|Virologic breakthrough at week 20|1|||
130217016|NCT00845676|468757325|FG000|Overall Study|Adverse Event|1|||
130217017|NCT00481767|468757327|FG000|Overall Study|Withdrawal by Subject|16|||
130217018|NCT00481767|468757328|FG001|Overall Study|Withdrawal by Subject|11|||
130217019|NCT00481767|468757327|FG000|Overall Study|Lost to Follow-up|16|||
130217020|NCT00481767|468757328|FG001|Overall Study|Lost to Follow-up|10|||
130217021|NCT01941537|468757329|FG000|Overall Study|Lack of Efficacy|1|||
130217022|NCT01941537|468757330|FG001|Overall Study|Lack of Efficacy|2|||
130217023|NCT01941537|468757329|FG000|Overall Study|Lost to Follow-up|1|||
130217024|NCT01941537|468757330|FG001|Overall Study|Lost to Follow-up|0|||
130217025|NCT01941537|468757329|FG000|Overall Study|Pregnancy|1|||
130217026|NCT01941537|468757330|FG001|Overall Study|Pregnancy|0|||
130217027|NCT01941537|468757329|FG000|Overall Study|Adverse Event|1|||
130217028|NCT01941537|468757330|FG001|Overall Study|Adverse Event|0|||
130217029|NCT01941537|468757329|FG000|Overall Study|Withdrawal by Subject|0|||
130217030|NCT01941537|468757330|FG001|Overall Study|Withdrawal by Subject|1|||
130217031|NCT02557516|468757332|FG000|Overall Study|Adverse Event|1|||
130217032|NCT02557516|468757333|FG001|Overall Study|Adverse Event|0|||
130217033|NCT02557516|468757334|FG002|Overall Study|Adverse Event|2|||
130217034|NCT02557516|468757335|FG003|Overall Study|Adverse Event|1|||
130217035|NCT02557516|468757332|FG000|Overall Study|Disease progression|0|||
130217036|NCT02557516|468757333|FG001|Overall Study|Disease progression|2|||
130217037|NCT02557516|468757334|FG002|Overall Study|Disease progression|0|||
130217038|NCT02557516|468757335|FG003|Overall Study|Disease progression|0|||
130217039|NCT02557516|468757332|FG000|Overall Study|Physician Decision|0|||
130217040|NCT02557516|468757333|FG001|Overall Study|Physician Decision|2|||
130217041|NCT02557516|468757334|FG002|Overall Study|Physician Decision|0|||
130217042|NCT02557516|468757335|FG003|Overall Study|Physician Decision|0|||
130217043|NCT02557516|468757332|FG000|Overall Study|Sponsor decision|0|||
130217044|NCT02557516|468757333|FG001|Overall Study|Sponsor decision|1|||
130217045|NCT02557516|468757334|FG002|Overall Study|Sponsor decision|2|||
130217046|NCT02557516|468757335|FG003|Overall Study|Sponsor decision|8|||
130217047|NCT00632125|468759436|FG000|Overall Study|Death|82|||
130217048|NCT00632125|468759436|FG000|Overall Study|Withdrawal by Subject|44|||
130217049|NCT00632125|468759436|FG000|Overall Study|Adverse Event|36|||
130217050|NCT00632125|468759436|FG000|Overall Study|Renal transplantation|17|||
130217051|NCT00632125|468759436|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
130217052|NCT00632125|468759436|FG000|Overall Study|Non-compliance|8|||
130217053|NCT00632125|468759436|FG000|Overall Study|Development of uncontrolled hypertension|5|||
130217054|NCT00632125|468759436|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
130217055|NCT03130959|468759449|FG000|Overall Study|Disease progression|19|||
130217056|NCT03130959|468759450|FG001|Overall Study|Disease progression|7|||
130217057|NCT03130959|468759451|FG002|Overall Study|Disease progression|12|||
130217058|NCT03130959|468759452|FG003|Overall Study|Disease progression|7|||
130217059|NCT03130959|468759453|FG004|Overall Study|Disease progression|12|||
130217060|NCT03130959|468759454|FG005|Overall Study|Disease progression|3|||
130217061|NCT03130959|468759455|FG006|Overall Study|Disease progression|6|||
130217062|NCT03130959|468759456|FG007|Overall Study|Disease progression|3|||
130217063|NCT03130959|468759457|FG008|Overall Study|Disease progression|15|||
130217064|NCT03130959|468759458|FG009|Overall Study|Disease progression|8|||
130217065|NCT03130959|468759449|FG000|Overall Study|Study drug toxicity|2|||
130012799|NCT00412750|468010251|FG001|Overall Study|Withdrawal by Subject|1|||
130012800|NCT00412750|468010252|FG002|Overall Study|Withdrawal by Subject|2|||
130012801|NCT00412750|468010250|FG000|Overall Study|Lack of Efficacy|0|||
130012802|NCT00412750|468010251|FG001|Overall Study|Lack of Efficacy|0|||
130012803|NCT00412750|468010252|FG002|Overall Study|Lack of Efficacy|3|||
130012804|NCT02646982|468010260|FG000|Overall Study|Adverse Event|1|||
130217066|NCT03130959|468759450|FG001|Overall Study|Study drug toxicity|2|||
130217067|NCT03130959|468759451|FG002|Overall Study|Study drug toxicity|1|||
130217068|NCT03130959|468759452|FG003|Overall Study|Study drug toxicity|2|||
130217069|NCT03130959|468759453|FG004|Overall Study|Study drug toxicity|1|||
130217070|NCT03130959|468759454|FG005|Overall Study|Study drug toxicity|1|||
130217071|NCT03130959|468759455|FG006|Overall Study|Study drug toxicity|3|||
130217072|NCT03130959|468759456|FG007|Overall Study|Study drug toxicity|0|||
130217073|NCT03130959|468759457|FG008|Overall Study|Study drug toxicity|3|||
130217074|NCT03130959|468759458|FG009|Overall Study|Study drug toxicity|3|||
130217075|NCT03130959|468759449|FG000|Overall Study|Other reasons|0|||
130217076|NCT03130959|468759450|FG001|Overall Study|Other reasons|0|||
130217077|NCT03130959|468759451|FG002|Overall Study|Other reasons|0|||
130217078|NCT03130959|468759452|FG003|Overall Study|Other reasons|0|||
130217079|NCT03130959|468759453|FG004|Overall Study|Other reasons|0|||
130217080|NCT03130959|468759454|FG005|Overall Study|Other reasons|1|||
130217081|NCT03130959|468759455|FG006|Overall Study|Other reasons|1|||
130217082|NCT03130959|468759456|FG007|Overall Study|Other reasons|0|||
130217083|NCT03130959|468759457|FG008|Overall Study|Other reasons|0|||
130217084|NCT03130959|468759458|FG009|Overall Study|Other reasons|0|||
130217085|NCT03130959|468759449|FG000|Overall Study|Subject request to discontinue therapy|0|||
130217086|NCT03130959|468759450|FG001|Overall Study|Subject request to discontinue therapy|0|||
130217087|NCT03130959|468759451|FG002|Overall Study|Subject request to discontinue therapy|1|||
130217088|NCT03130959|468759452|FG003|Overall Study|Subject request to discontinue therapy|1|||
130217089|NCT03130959|468759453|FG004|Overall Study|Subject request to discontinue therapy|0|||
130217090|NCT03130959|468759454|FG005|Overall Study|Subject request to discontinue therapy|0|||
130217091|NCT03130959|468759455|FG006|Overall Study|Subject request to discontinue therapy|1|||
130217092|NCT03130959|468759456|FG007|Overall Study|Subject request to discontinue therapy|1|||
130217093|NCT03130959|468759457|FG008|Overall Study|Subject request to discontinue therapy|0|||
130217094|NCT03130959|468759458|FG009|Overall Study|Subject request to discontinue therapy|0|||
130217095|NCT03130959|468759449|FG000|Overall Study|Not reported|0|||
130217096|NCT03130959|468759450|FG001|Overall Study|Not reported|0|||
130217097|NCT03130959|468759451|FG002|Overall Study|Not reported|0|||
130217098|NCT03130959|468759452|FG003|Overall Study|Not reported|1|||
130012805|NCT02646982|468010261|FG001|Overall Study|Adverse Event|1|||
130012806|NCT02646982|468010260|FG000|Overall Study|Withdrawal by Subject|2|||
130012807|NCT02646982|468010261|FG001|Overall Study|Withdrawal by Subject|1|||
130012808|NCT00713700|468010262|FG000|Overall Study|Lost to Follow-up|3|||
130012809|NCT00713700|468010262|FG000|Overall Study|Withdrawal by Subject|1|||
130012810|NCT03923426|468010264|FG000|Overall Study|Other|19|||
130012811|NCT03923426|468010264|FG000|Overall Study|Lost to Follow-up|16|||
130012812|NCT03923426|468010264|FG000|Overall Study|Death|107|||
130217099|NCT03130959|468759453|FG004|Overall Study|Not reported|0|||
130217100|NCT03130959|468759454|FG005|Overall Study|Not reported|1|||
130217101|NCT03130959|468759455|FG006|Overall Study|Not reported|0|||
130217102|NCT03130959|468759456|FG007|Overall Study|Not reported|0|||
130217103|NCT03130959|468759457|FG008|Overall Study|Not reported|0|||
130217104|NCT03130959|468759458|FG009|Overall Study|Not reported|1|||
130217105|NCT03130959|468759449|FG000|Overall Study|Adverse Event unrelated to drug|0|||
130217106|NCT03130959|468759450|FG001|Overall Study|Adverse Event unrelated to drug|0|||
130217107|NCT03130959|468759451|FG002|Overall Study|Adverse Event unrelated to drug|1|||
130217108|NCT03130959|468759452|FG003|Overall Study|Adverse Event unrelated to drug|1|||
130217109|NCT03130959|468759453|FG004|Overall Study|Adverse Event unrelated to drug|1|||
130217110|NCT03130959|468759454|FG005|Overall Study|Adverse Event unrelated to drug|0|||
130217111|NCT03130959|468759455|FG006|Overall Study|Adverse Event unrelated to drug|1|||
130217112|NCT03130959|468759456|FG007|Overall Study|Adverse Event unrelated to drug|0|||
130012813|NCT03923426|468010264|FG000|Overall Study|Incomplete response to question|13|||
130012814|NCT00769002|468010265|FG000|Overall Study|Study was not completed, no data|9|||
130012815|NCT00769002|468010266|FG001|Overall Study|Study was not completed, no data|9|||
130217113|NCT03130959|468759457|FG008|Overall Study|Adverse Event unrelated to drug|1|||
130217114|NCT03130959|468759458|FG009|Overall Study|Adverse Event unrelated to drug|1|||
130217115|NCT03130959|468759449|FG000|Overall Study|Participant withdrew consent|0|||
130217116|NCT03130959|468759450|FG001|Overall Study|Participant withdrew consent|1|||
130217117|NCT03130959|468759451|FG002|Overall Study|Participant withdrew consent|0|||
130217118|NCT03130959|468759452|FG003|Overall Study|Participant withdrew consent|2|||
130217119|NCT03130959|468759453|FG004|Overall Study|Participant withdrew consent|1|||
130217120|NCT03130959|468759454|FG005|Overall Study|Participant withdrew consent|0|||
130217121|NCT03130959|468759455|FG006|Overall Study|Participant withdrew consent|0|||
130012816|NCT00960661|468010270|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
130012817|NCT00960661|468010271|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
130012818|NCT00960661|468010272|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
130012819|NCT00960661|468010270|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
130012820|NCT00960661|468010271|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
130012821|NCT00960661|468010272|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
130012822|NCT00960661|468010270|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
130012823|NCT00960661|468010271|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
130012824|NCT00960661|468010272|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
130012825|NCT00960661|468010270|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
130012826|NCT00960661|468010271|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
130012827|NCT00960661|468010272|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
130012828|NCT00960661|468010270|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
130012829|NCT00960661|468010271|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
130012830|NCT00960661|468010272|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
130012831|NCT00960661|468010270|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
130012832|NCT00960661|468010271|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
130012833|NCT00960661|468010272|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
130012834|NCT00960661|468010270|FG000|Interventional Phase|Adverse Event|0|||
130012835|NCT00960661|468010271|FG001|Interventional Phase|Adverse Event|17|||
130012836|NCT00960661|468010272|FG002|Interventional Phase|Adverse Event|8|||
130012837|NCT00960661|468010270|FG000|Interventional Phase|Death|0|||
130012838|NCT00960661|468010271|FG001|Interventional Phase|Death|1|||
130012839|NCT00960661|468010272|FG002|Interventional Phase|Death|0|||
130012840|NCT00960661|468010270|FG000|Interventional Phase|Lost to Follow-up|0|||
130012841|NCT00960661|468010271|FG001|Interventional Phase|Lost to Follow-up|0|||
130012842|NCT00960661|468010272|FG002|Interventional Phase|Lost to Follow-up|2|||
130012843|NCT00960661|468010270|FG000|Interventional Phase|entry criteria not met|0|||
130012844|NCT00960661|468010271|FG001|Interventional Phase|entry criteria not met|3|||
130012845|NCT00960661|468010272|FG002|Interventional Phase|entry criteria not met|0|||
130012846|NCT00960661|468010270|FG000|Interventional Phase|Protocol Violation|0|||
130012847|NCT00960661|468010271|FG001|Interventional Phase|Protocol Violation|7|||
130012848|NCT00960661|468010272|FG002|Interventional Phase|Protocol Violation|2|||
130012849|NCT00960661|468010270|FG000|Interventional Phase|Withdrawal by Subject|0|||
130217122|NCT03130959|468759456|FG007|Overall Study|Participant withdrew consent|0|||
130217123|NCT03130959|468759457|FG008|Overall Study|Participant withdrew consent|0|||
130217124|NCT03130959|468759458|FG009|Overall Study|Participant withdrew consent|2|||
130217125|NCT03130959|468759449|FG000|Overall Study|Administrative reason by sponsor|1|||
130217126|NCT03130959|468759450|FG001|Overall Study|Administrative reason by sponsor|0|||
130217127|NCT03130959|468759451|FG002|Overall Study|Administrative reason by sponsor|1|||
130217128|NCT03130959|468759452|FG003|Overall Study|Administrative reason by sponsor|0|||
130217129|NCT03130959|468759453|FG004|Overall Study|Administrative reason by sponsor|0|||
130217130|NCT03130959|468759454|FG005|Overall Study|Administrative reason by sponsor|0|||
130217131|NCT03130959|468759455|FG006|Overall Study|Administrative reason by sponsor|0|||
130217132|NCT03130959|468759456|FG007|Overall Study|Administrative reason by sponsor|0|||
130217133|NCT03130959|468759457|FG008|Overall Study|Administrative reason by sponsor|0|||
130217134|NCT03130959|468759458|FG009|Overall Study|Administrative reason by sponsor|0|||
130217135|NCT03130959|468759449|FG000|Overall Study|Lost to Follow-up|1|||
130217136|NCT03130959|468759450|FG001|Overall Study|Lost to Follow-up|0|||
130217137|NCT03130959|468759451|FG002|Overall Study|Lost to Follow-up|0|||
130217138|NCT03130959|468759452|FG003|Overall Study|Lost to Follow-up|0|||
130217139|NCT03130959|468759453|FG004|Overall Study|Lost to Follow-up|0|||
130217140|NCT03130959|468759454|FG005|Overall Study|Lost to Follow-up|0|||
130217141|NCT03130959|468759455|FG006|Overall Study|Lost to Follow-up|0|||
130217142|NCT03130959|468759456|FG007|Overall Study|Lost to Follow-up|0|||
130217143|NCT03130959|468759457|FG008|Overall Study|Lost to Follow-up|0|||
130217144|NCT03130959|468759458|FG009|Overall Study|Lost to Follow-up|0|||
130217145|NCT02384538|468759459|FG000|Overall Study|Adverse Event|1|||
130217146|NCT02384538|468759460|FG001|Overall Study|Adverse Event|4|||
130217147|NCT02384538|468759459|FG000|Overall Study|Lack of Efficacy|4|||
130217148|NCT02384538|468759460|FG001|Overall Study|Lack of Efficacy|4|||
130217149|NCT02384538|468759459|FG000|Overall Study|Withdrew Consent|0|||
130217150|NCT02384538|468759460|FG001|Overall Study|Withdrew Consent|4|||
130217151|NCT02384538|468759459|FG000|Overall Study|Other|1|||
130217152|NCT02384538|468759460|FG001|Overall Study|Other|3|||
130217153|NCT03117361|468759464|FG000|Overall Study|Progressive disease|5|||
130217154|NCT03117361|468759464|FG000|Overall Study|Death|1|||
130012850|NCT00960661|468010271|FG001|Interventional Phase|Withdrawal by Subject|18|||
130012851|NCT00960661|468010272|FG002|Interventional Phase|Withdrawal by Subject|29|||
130012852|NCT00960661|468010270|FG000|Interventional Phase|Physician Decision|0|||
130012853|NCT00960661|468010271|FG001|Interventional Phase|Physician Decision|3|||
130217155|NCT03117361|468759464|FG000|Overall Study|Physician Decision|2|||
130217156|NCT03117361|468759464|FG000|Overall Study|On study treatment at the end of study|1|||
130217157|NCT03117361|468759464|FG000|Overall Study|Treatment-related adverse event|1|||
130217158|NCT00540644|468759468|FG000|Overall Study|Adverse Event|3|||
130217159|NCT00540644|468759469|FG001|Overall Study|Adverse Event|1|||
130217160|NCT00540644|468759468|FG000|Overall Study|Disease Progression|3|||
130217161|NCT00540644|468759469|FG001|Overall Study|Disease Progression|1|||
130217162|NCT00540644|468759468|FG000|Overall Study|Physician Decision|0|||
130217163|NCT00540644|468759469|FG001|Overall Study|Physician Decision|5|||
130217164|NCT00540644|468759468|FG000|Overall Study|Withdrawal by Subject|2|||
130217165|NCT00540644|468759469|FG001|Overall Study|Withdrawal by Subject|2|||
130217166|NCT00540644|468759468|FG000|Overall Study|Noncomplilance|1|||
130217167|NCT00540644|468759469|FG001|Overall Study|Noncomplilance|0|||
130217168|NCT03280056|468759470|FG000|Overall Study|Withdrawal by Subject|12|||
130217169|NCT03280056|468759471|FG001|Overall Study|Withdrawal by Subject|14|||
130217170|NCT03280056|468759470|FG000|Overall Study|Death|9|||
130217171|NCT03280056|468759471|FG001|Overall Study|Death|2|||
130217172|NCT03280056|468759470|FG000|Overall Study|Adverse Event|1|||
130217173|NCT03280056|468759471|FG001|Overall Study|Adverse Event|3|||
130217174|NCT03280056|468759470|FG000|Overall Study|Lost to Follow-up|1|||
130217175|NCT03280056|468759471|FG001|Overall Study|Lost to Follow-up|1|||
130217176|NCT03280056|468759470|FG000|Overall Study|Physician Decision|0|||
130012854|NCT00960661|468010272|FG002|Interventional Phase|Physician Decision|5|||
130217177|NCT03280056|468759471|FG001|Overall Study|Physician Decision|1|||
130217178|NCT03280056|468759470|FG000|Overall Study|Early Discontinuation|1|||
130012855|NCT00960661|468010270|FG000|Interventional Phase|sponsor decision|0|||
130012856|NCT00960661|468010271|FG001|Interventional Phase|sponsor decision|1|||
130012857|NCT00960661|468010272|FG002|Interventional Phase|sponsor decision|0|||
130012858|NCT00960661|468010270|FG000|Interventional Phase|Lack of Efficacy|0|||
130012859|NCT00960661|468010271|FG001|Interventional Phase|Lack of Efficacy|2|||
130012860|NCT00960661|468010272|FG002|Interventional Phase|Lack of Efficacy|0|||
130012861|NCT02699892|468010275|FG000|Overall Study|Other|36|||
130012862|NCT00847912|468010285|FG000|Overall Study|Protocol Violation|6|||
130012863|NCT00847912|468010286|FG001|Overall Study|Protocol Violation|7|||
130012864|NCT00847912|468010285|FG000|Overall Study|Withdrawal by Subject|3|||
130012865|NCT00847912|468010286|FG001|Overall Study|Withdrawal by Subject|6|||
130012866|NCT01732796|468010293|FG000|Overall Study|Adverse Event|16|||
130012867|NCT01732796|468010294|FG001|Overall Study|Adverse Event|16|||
130012868|NCT01732796|468010295|FG002|Overall Study|Adverse Event|4|||
130012869|NCT01732796|468010293|FG000|Overall Study|Lack of Efficacy|21|||
130012870|NCT01732796|468010294|FG001|Overall Study|Lack of Efficacy|18|||
130012871|NCT01732796|468010295|FG002|Overall Study|Lack of Efficacy|5|||
130012872|NCT01732796|468010293|FG000|Overall Study|Lost to Follow-up|2|||
130012873|NCT01732796|468010294|FG001|Overall Study|Lost to Follow-up|0|||
130012874|NCT01732796|468010295|FG002|Overall Study|Lost to Follow-up|0|||
130012875|NCT01732796|468010293|FG000|Overall Study|Withdrawal by Subject|6|||
130012876|NCT01732796|468010294|FG001|Overall Study|Withdrawal by Subject|8|||
130012877|NCT01732796|468010295|FG002|Overall Study|Withdrawal by Subject|2|||
130012878|NCT01732796|468010293|FG000|Overall Study|Other reason not defined above|1|||
130012879|NCT01732796|468010294|FG001|Overall Study|Other reason not defined above|0|||
130012880|NCT01732796|468010295|FG002|Overall Study|Other reason not defined above|2|||
130012881|NCT00530270|468010300|FG000|Overall Study|Protocol Violation|1|||
130012882|NCT00530270|468010301|FG001|Overall Study|Protocol Violation|0|||
130012883|NCT00838331|468010307|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
130012884|NCT03972969|468010309|FG000|3-month Follow-up|Death|1|||
130012885|NCT03972969|468010310|FG001|3-month Follow-up|Death|1|||
130012886|NCT03972969|468010311|FG002|3-month Follow-up|Death|0|||
130012887|NCT03972969|468010309|FG000|6-month Follow-up|Death|1|||
130012888|NCT03972969|468010310|FG001|6-month Follow-up|Death|1|||
130012889|NCT03972969|468010311|FG002|6-month Follow-up|Death|1|||
130012890|NCT03972969|468010309|FG000|6-month Follow-up|Lost to Follow-up|2|||
130012891|NCT03972969|468010310|FG001|6-month Follow-up|Lost to Follow-up|2|||
130012892|NCT03972969|468010311|FG002|6-month Follow-up|Lost to Follow-up|2|||
130012893|NCT00264875|468010312|FG000|Overall Study|Adverse Event|6|||
130217179|NCT03280056|468759471|FG001|Overall Study|Early Discontinuation|0|||
130217180|NCT02144077|468759472|FG000|Overall Study|Withdrawal by Subject|3|||
130217181|NCT02144077|468759473|FG001|Overall Study|Withdrawal by Subject|3|||
130217182|NCT02144077|468759472|FG000|Overall Study|Adverse Event|2|||
130012894|NCT00264875|468010312|FG000|Overall Study|Lost to Follow-up|6|||
130012895|NCT00264875|468010312|FG000|Overall Study|Protocol Violation|11|||
130012896|NCT00264875|468010312|FG000|Overall Study|Withdrawal by Subject|7|||
130012897|NCT00732303|468010313|FG000|Overall Study|Study Terminated|2|||
130012898|NCT01074190|468010314|FG000|Overall Study|Emergency Cesarean Delivery|1|||
130012899|NCT01074190|468010315|FG001|Overall Study|Emergency Cesarean Delivery|2|||
130012900|NCT01074190|468010316|FG002|Overall Study|Emergency Cesarean Delivery|1|||
130217183|NCT02144077|468759473|FG001|Overall Study|Adverse Event|3|||
130217184|NCT02144077|468759472|FG000|Overall Study|Lost to Follow-up|2|||
130012901|NCT01074190|468010314|FG000|Overall Study|Protocol Violation|2|||
130012902|NCT01074190|468010315|FG001|Overall Study|Protocol Violation|1|||
130217185|NCT02144077|468759473|FG001|Overall Study|Lost to Follow-up|2|||
130012903|NCT01074190|468010316|FG002|Overall Study|Protocol Violation|0|||
130217186|NCT02144077|468759472|FG000|Overall Study|Protocol Violation|1|||
130217187|NCT02144077|468759473|FG001|Overall Study|Protocol Violation|2|||
130217188|NCT02144077|468759472|FG000|Overall Study|Death|0|||
130217189|NCT02144077|468759473|FG001|Overall Study|Death|1|||
130217190|NCT02144077|468759472|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
130012904|NCT01074190|468010314|FG000|Overall Study|Delivered in under 90 minutes|0|||
130012905|NCT01074190|468010315|FG001|Overall Study|Delivered in under 90 minutes|2|||
130012906|NCT01074190|468010316|FG002|Overall Study|Delivered in under 90 minutes|1|||
130012907|NCT01074190|468010314|FG000|Overall Study|Subject withdrew consent|1|||
130012908|NCT01074190|468010315|FG001|Overall Study|Subject withdrew consent|1|||
130012909|NCT01074190|468010316|FG002|Overall Study|Subject withdrew consent|1|||
130012910|NCT00183274|468010320|FG000|Phase 1: Open-Label|Adverse Event|31|||
130012911|NCT00183274|468010321|FG001|Phase 1: Open-Label|Adverse Event|0|||
130217191|NCT02144077|468759473|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
130217192|NCT00610168|468759474|FG000|Overall Study|Withdrawal by Subject|2|||
130217193|NCT00610168|468759475|FG001|Overall Study|Withdrawal by Subject|0|||
130217194|NCT00943592|468759476|FG000|Overall Study|Death|3|||
130217195|NCT00169104|468759477|FG000|Overall Study|Withdrawal by Subject|2|||
130217196|NCT00169104|468759478|FG001|Overall Study|Withdrawal by Subject|0|||
130217197|NCT00169104|468759477|FG000|Overall Study|Protocol Violation|0|||
130217198|NCT00169104|468759478|FG001|Overall Study|Protocol Violation|1|||
130217199|NCT00169104|468759477|FG000|Overall Study|Physician Decision|0|||
130217200|NCT00169104|468759478|FG001|Overall Study|Physician Decision|1|||
130217201|NCT00715299|468759484|FG000|Overall Study|Withdrawal by Subject|1|||
130012912|NCT00183274|468010322|FG002|Phase 1: Open-Label|Adverse Event|0|||
130012913|NCT00183274|468010323|FG003|Phase 1: Open-Label|Adverse Event|0|||
130012914|NCT00183274|468010324|FG004|Phase 1: Open-Label|Adverse Event|0|||
130012915|NCT00183274|468010325|FG005|Phase 1: Open-Label|Adverse Event|0|||
130012916|NCT00183274|468010320|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
130012917|NCT00183274|468010321|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
130012918|NCT00183274|468010322|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
130012919|NCT00183274|468010323|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
130012920|NCT00183274|468010324|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
130012921|NCT00183274|468010325|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
130012922|NCT00183274|468010320|FG000|Phase 1: Open-Label|Protocol Violation|11|||
130012923|NCT00183274|468010321|FG001|Phase 1: Open-Label|Protocol Violation|0|||
130012924|NCT00183274|468010322|FG002|Phase 1: Open-Label|Protocol Violation|0|||
130217202|NCT00715299|468759484|FG000|Overall Study|Adverse Event|3|||
130217203|NCT00715299|468759484|FG000|Overall Study|failed the pre-screen exercise test|2|||
130217204|NCT01540981|468759485|FG000|Overall Study|Withdrawal by Subject|1|||
130217205|NCT01540981|468759486|FG001|Overall Study|Withdrawal by Subject|0|||
130217206|NCT00809094|468759488|FG000|Overall Study|Lost to Follow-up|0|||
130217207|NCT00809094|468759489|FG001|Overall Study|Lost to Follow-up|1|||
130217208|NCT00397189|468759490|FG000|3 Weeks Period|Lost to Follow-up|5|||
130217209|NCT00397189|468759491|FG001|3 Weeks Period|Lost to Follow-up|4|||
130217210|NCT00397189|468759490|FG000|3 Weeks Period|Adverse Event|3|||
130217211|NCT00397189|468759491|FG001|3 Weeks Period|Adverse Event|2|||
130217212|NCT00397189|468759490|FG000|3 Weeks Period|Withdrawal by Subject|13|||
130217213|NCT00397189|468759491|FG001|3 Weeks Period|Withdrawal by Subject|9|||
130217214|NCT00397189|468759490|FG000|3 Weeks Period|Physician Decision|0|||
130217215|NCT00397189|468759491|FG001|3 Weeks Period|Physician Decision|2|||
130217216|NCT00397189|468759490|FG000|3 Weeks Period|Protocol Violation|0|||
130217217|NCT00397189|468759491|FG001|3 Weeks Period|Protocol Violation|3|||
130217218|NCT00397189|468759490|FG000|3 Weeks Period|Other|0|||
130217219|NCT00397189|468759491|FG001|3 Weeks Period|Other|2|||
130217220|NCT01535443|468759494|FG000|Overall Study|Physician Decision|3|||
130217221|NCT00232557|468759495|FG000|Overall Study|Lost to Follow-up|3|||
130217222|NCT00232557|468759496|FG001|Overall Study|Lost to Follow-up|5|||
130217223|NCT01059773|468759497|FG000|Overall Study|Adverse Event|2|||
130217224|NCT01059773|468759498|FG001|Overall Study|Adverse Event|2|||
130217225|NCT01059773|468759497|FG000|Overall Study|Withdrawal by Subject|1|||
130217226|NCT01059773|468759498|FG001|Overall Study|Withdrawal by Subject|5|||
130217227|NCT01059773|468759497|FG000|Overall Study|Lost to Follow-up|1|||
130217228|NCT01059773|468759498|FG001|Overall Study|Lost to Follow-up|1|||
130217229|NCT01059773|468759497|FG000|Overall Study|Pregnancy|1|||
130217230|NCT01059773|468759498|FG001|Overall Study|Pregnancy|1|||
130217231|NCT01059773|468759497|FG000|Overall Study|Protocol Violation|6|||
130217232|NCT01059773|468759498|FG001|Overall Study|Protocol Violation|2|||
130012925|NCT00183274|468010323|FG003|Phase 1: Open-Label|Protocol Violation|0|||
130217233|NCT01059773|468759497|FG000|Overall Study|Physician Decision|5|||
130217234|NCT01059773|468759498|FG001|Overall Study|Physician Decision|4|||
130012926|NCT00183274|468010324|FG004|Phase 1: Open-Label|Protocol Violation|0|||
130012927|NCT00183274|468010325|FG005|Phase 1: Open-Label|Protocol Violation|0|||
130217235|NCT01059773|468759497|FG000|Overall Study|Lack of Efficacy|3|||
130217236|NCT01059773|468759498|FG001|Overall Study|Lack of Efficacy|3|||
130217237|NCT01059773|468759497|FG000|Overall Study|Death|0|||
130217238|NCT01059773|468759498|FG001|Overall Study|Death|1|||
130217239|NCT01059773|468759497|FG000|Overall Study|Malignancy including squamous cell skin|0|||
130217240|NCT01059773|468759498|FG001|Overall Study|Malignancy including squamous cell skin|1|||
130217241|NCT01059773|468759497|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
130217242|NCT01059773|468759498|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
130217243|NCT01059773|468759497|FG000|Overall Study|Other|1|||
130217244|NCT01059773|468759498|FG001|Overall Study|Other|3|||
130217245|NCT00141518|468759502|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
130217246|NCT00141518|468759503|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
130217247|NCT00141518|468759504|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
130217248|NCT00141518|468759502|FG000|Overall Study|Adverse Event|7|||
130217249|NCT00141518|468759503|FG001|Overall Study|Adverse Event|5|||
130217250|NCT00141518|468759504|FG002|Overall Study|Adverse Event|2|||
130217251|NCT00141518|468759502|FG000|Overall Study|Withdrawal by Subject|2|||
130217252|NCT00141518|468759503|FG001|Overall Study|Withdrawal by Subject|0|||
130217253|NCT00141518|468759504|FG002|Overall Study|Withdrawal by Subject|2|||
130217254|NCT00141518|468759502|FG000|Overall Study|Protocol Violation|1|||
130217255|NCT00141518|468759503|FG001|Overall Study|Protocol Violation|1|||
130217256|NCT00141518|468759504|FG002|Overall Study|Protocol Violation|2|||
130217257|NCT00141518|468759502|FG000|Overall Study|Lack of Efficacy|5|||
130217258|NCT00141518|468759503|FG001|Overall Study|Lack of Efficacy|0|||
130217259|NCT00141518|468759504|FG002|Overall Study|Lack of Efficacy|0|||
130217260|NCT01806168|468759506|FG000|Overall Study|Adverse Event|1|||
130217261|NCT01806168|468759507|FG001|Overall Study|Adverse Event|0|||
130217262|NCT01806168|468759508|FG002|Overall Study|Adverse Event|0|||
130217263|NCT01806168|468759506|FG000|Overall Study|Withdrawal by Subject|0|||
130217264|NCT01806168|468759507|FG001|Overall Study|Withdrawal by Subject|1|||
130217265|NCT01806168|468759508|FG002|Overall Study|Withdrawal by Subject|2|||
130217266|NCT01806168|468759506|FG000|Overall Study|Protocol Violation|0|||
130217267|NCT01806168|468759507|FG001|Overall Study|Protocol Violation|0|||
130217268|NCT01806168|468759508|FG002|Overall Study|Protocol Violation|1|||
130217269|NCT01029262|468759511|FG000|Overall Study|Adverse Event|9|||
130217270|NCT01029262|468759512|FG001|Overall Study|Adverse Event|52|||
130217271|NCT01029262|468759511|FG000|Overall Study|Lack of therapeutic effect|57|||
130217272|NCT01029262|468759512|FG001|Overall Study|Lack of therapeutic effect|76|||
130217273|NCT01029262|468759511|FG000|Overall Study|Withdrawal by Subject|10|||
130217274|NCT01029262|468759512|FG001|Overall Study|Withdrawal by Subject|17|||
130217275|NCT01029262|468759511|FG000|Overall Study|Protocol Violation|2|||
130217276|NCT01029262|468759512|FG001|Overall Study|Protocol Violation|3|||
130217277|NCT01029262|468759511|FG000|Overall Study|Miscellaneous|1|||
130217278|NCT01029262|468759512|FG001|Overall Study|Miscellaneous|9|||
130217279|NCT01029262|468759511|FG000|Overall Study|Death|0|||
130217280|NCT01029262|468759512|FG001|Overall Study|Death|3|||
130217281|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217282|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
130217283|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217284|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217285|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217286|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217287|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130012928|NCT00183274|468010320|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
130217288|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217289|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217290|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217291|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
130217292|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
130217293|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
130012929|NCT00183274|468010321|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
130012930|NCT00183274|468010322|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
130012931|NCT00183274|468010323|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
130012932|NCT00183274|468010324|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
130012933|NCT00183274|468010325|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
130012934|NCT00183274|468010320|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
130012935|NCT00183274|468010321|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
130012936|NCT00183274|468010322|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
130012937|NCT00183274|468010323|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
130217294|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217295|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217296|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217297|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217298|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217299|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217300|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217301|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130012938|NCT00183274|468010324|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
130012939|NCT00183274|468010325|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
130012940|NCT00183274|468010320|FG000|Phase 1: Open-Label|Other|9|||
130012941|NCT00183274|468010321|FG001|Phase 1: Open-Label|Other|0|||
130012942|NCT00183274|468010322|FG002|Phase 1: Open-Label|Other|0|||
130012943|NCT00183274|468010323|FG003|Phase 1: Open-Label|Other|0|||
130012944|NCT00183274|468010324|FG004|Phase 1: Open-Label|Other|0|||
130012945|NCT00183274|468010325|FG005|Phase 1: Open-Label|Other|0|||
130012946|NCT00183274|468010320|FG000|Phase 2: Double-Blind|Relapsed|0|||
130012947|NCT00183274|468010321|FG001|Phase 2: Double-Blind|Relapsed|8|||
130012948|NCT00183274|468010322|FG002|Phase 2: Double-Blind|Relapsed|29|||
130012949|NCT00183274|468010323|FG003|Phase 2: Double-Blind|Relapsed|0|||
130012950|NCT00183274|468010324|FG004|Phase 2: Double-Blind|Relapsed|0|||
130012951|NCT00183274|468010325|FG005|Phase 2: Double-Blind|Relapsed|0|||
130012952|NCT00183274|468010320|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130012953|NCT00183274|468010321|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
130012954|NCT00183274|468010322|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
130012955|NCT00183274|468010323|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130012956|NCT00183274|468010324|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130012957|NCT00183274|468010325|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
130012958|NCT00183274|468010320|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
130012959|NCT00183274|468010321|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
130012960|NCT00183274|468010322|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
130012961|NCT00183274|468010323|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
130012962|NCT00183274|468010324|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
130012963|NCT00183274|468010325|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
130012964|NCT00183274|468010320|FG000|Phase 3: Double-Blind|Relapsed|0|||
130012965|NCT00183274|468010321|FG001|Phase 3: Double-Blind|Relapsed|0|||
130012966|NCT00183274|468010322|FG002|Phase 3: Double-Blind|Relapsed|0|||
130012967|NCT00183274|468010323|FG003|Phase 3: Double-Blind|Relapsed|1|||
130012968|NCT00183274|468010324|FG004|Phase 3: Double-Blind|Relapsed|11|||
130012969|NCT00183274|468010325|FG005|Phase 3: Double-Blind|Relapsed|2|||
130012970|NCT02409290|468010328|FG000|Overall Study|Protocol Violation|3|||
130012971|NCT02409290|468010329|FG001|Overall Study|Protocol Violation|6|||
130012972|NCT02409290|468010330|FG002|Overall Study|Protocol Violation|9|||
130012973|NCT02409290|468010331|FG003|Overall Study|Protocol Violation|4|||
130012974|NCT02409290|468010328|FG000|Overall Study|No positive culture/no baseline sample|3|||
130012975|NCT02409290|468010329|FG001|Overall Study|No positive culture/no baseline sample|9|||
130012976|NCT02409290|468010330|FG002|Overall Study|No positive culture/no baseline sample|6|||
130012977|NCT02409290|468010331|FG003|Overall Study|No positive culture/no baseline sample|5|||
130012978|NCT02409290|468010328|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
130012979|NCT02409290|468010329|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
130012980|NCT02409290|468010330|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
130012981|NCT02409290|468010331|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
130012982|NCT00708500|468010332|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
130012983|NCT00708500|468010333|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
130012984|NCT00708500|468010334|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
130012985|NCT00708500|468010332|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
130012986|NCT00708500|468010333|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
130012987|NCT00708500|468010334|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
130012988|NCT00708500|468010332|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
130012989|NCT00708500|468010333|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
130012990|NCT00708500|468010334|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
130012991|NCT00708500|468010332|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
130012992|NCT00708500|468010333|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
130012993|NCT00708500|468010334|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
130012994|NCT00708500|468010332|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
130012995|NCT00708500|468010333|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
130012996|NCT00708500|468010334|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
130012997|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
130012998|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
130012999|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
130013000|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
130013001|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
130013002|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
130013003|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
130013004|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
130013005|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
130013006|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
130013007|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
130013008|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
130217302|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
130217303|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
130217304|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
130217305|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217306|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217307|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217308|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217309|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217310|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217311|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217312|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217313|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
130217314|NCT03410992|468759513|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
130217315|NCT03410992|468759514|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217316|NCT03410992|468759515|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217317|NCT03410992|468759516|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217318|NCT03410992|468759517|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217319|NCT03410992|468759518|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217320|NCT03410992|468759519|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217321|NCT03410992|468759520|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217322|NCT03410992|468759521|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217323|NCT03410992|468759522|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217324|NCT03410992|468759523|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
130217325|NCT03410992|468759513|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
130217326|NCT03410992|468759514|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
130217327|NCT03410992|468759515|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130013009|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
130013010|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
130217328|NCT03410992|468759516|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130013011|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
130013012|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
130013013|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
130013014|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
130013015|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
130013016|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
130013017|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
130013018|NCT00708500|468010332|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
130013019|NCT00708500|468010333|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
130013020|NCT00708500|468010334|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
130013021|NCT00708500|468010332|FG000|FOLLOWUP|Adverse Event|0|||
130013022|NCT00708500|468010333|FG001|FOLLOWUP|Adverse Event|1|||
130013023|NCT00708500|468010334|FG002|FOLLOWUP|Adverse Event|0|||
130013024|NCT00708500|468010332|FG000|FOLLOWUP|Lost to Follow-up|1|||
130013025|NCT00708500|468010333|FG001|FOLLOWUP|Lost to Follow-up|6|||
130013026|NCT00708500|468010334|FG002|FOLLOWUP|Lost to Follow-up|4|||
130013027|NCT00708500|468010332|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
130013028|NCT00708500|468010333|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
130013029|NCT00708500|468010334|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
130013030|NCT00708500|468010332|FG000|FOLLOWUP|Subject withdrew consent|31|||
130013031|NCT00708500|468010333|FG001|FOLLOWUP|Subject withdrew consent|4|||
130013032|NCT00708500|468010334|FG002|FOLLOWUP|Subject withdrew consent|5|||
130013033|NCT00708500|468010332|FG000|FOLLOWUP|Non-compliance with protocol|5|||
130013034|NCT00708500|468010333|FG001|FOLLOWUP|Non-compliance with protocol|0|||
130013035|NCT00708500|468010334|FG002|FOLLOWUP|Non-compliance with protocol|1|||
130013036|NCT00618410|468010339|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
130013037|NCT00618410|468010340|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
130013038|NCT00705783|468010346|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
130013039|NCT00705783|468010347|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
130013040|NCT00705783|468010348|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
130013041|NCT00705783|468010346|FG000|Conversion Phase|Lost to Follow-up|13|||
130013042|NCT00705783|468010347|FG001|Conversion Phase|Lost to Follow-up|0|||
130217329|NCT03410992|468759517|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130013043|NCT00705783|468010348|FG002|Conversion Phase|Lost to Follow-up|0|||
130013044|NCT00705783|468010346|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
130217330|NCT03410992|468759518|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217331|NCT03410992|468759519|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217332|NCT03410992|468759520|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217333|NCT03410992|468759521|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217334|NCT03410992|468759522|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217335|NCT03410992|468759523|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
130217336|NCT03410992|468759513|FG000|Week 16 Assessment|Incorrect escapers|0|||
130217337|NCT03410992|468759514|FG001|Week 16 Assessment|Incorrect escapers|6|||
130217338|NCT03410992|468759515|FG002|Week 16 Assessment|Incorrect escapers|0|||
130217339|NCT03410992|468759516|FG003|Week 16 Assessment|Incorrect escapers|0|||
130217340|NCT03410992|468759517|FG004|Week 16 Assessment|Incorrect escapers|0|||
130217341|NCT03410992|468759518|FG005|Week 16 Assessment|Incorrect escapers|0|||
130217342|NCT03410992|468759519|FG006|Week 16 Assessment|Incorrect escapers|0|||
130217343|NCT03410992|468759520|FG007|Week 16 Assessment|Incorrect escapers|0|||
130217344|NCT03410992|468759521|FG008|Week 16 Assessment|Incorrect escapers|0|||
130217345|NCT03410992|468759522|FG009|Week 16 Assessment|Incorrect escapers|0|||
130217346|NCT03410992|468759523|FG010|Week 16 Assessment|Incorrect escapers|0|||
130217347|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217348|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217349|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217350|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
130217351|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
130217352|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217353|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217354|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217355|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217356|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217357|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
130217358|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217359|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217360|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217361|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
130217362|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
130217363|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
130217364|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217365|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217366|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217367|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217368|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
130217369|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217370|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217371|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217372|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217373|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217374|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
130217375|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217376|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217377|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217378|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217379|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
130217380|NCT03410992|468759513|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217381|NCT03410992|468759514|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217382|NCT03410992|468759515|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217383|NCT03410992|468759516|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
130217384|NCT03410992|468759517|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
130217385|NCT03410992|468759518|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
130217386|NCT03410992|468759519|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217387|NCT03410992|468759520|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217388|NCT03410992|468759521|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217389|NCT03410992|468759522|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130013045|NCT00705783|468010347|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
130013046|NCT00705783|468010348|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
130013047|NCT00705783|468010346|FG000|Conversion Phase|Withdrawn by Investigator|4|||
130013048|NCT00705783|468010347|FG001|Conversion Phase|Withdrawn by Investigator|0|||
130013049|NCT00705783|468010348|FG002|Conversion Phase|Withdrawn by Investigator|0|||
130013050|NCT00705783|468010346|FG000|Conversion Phase|Withdrew Consent|24|||
130013051|NCT00705783|468010347|FG001|Conversion Phase|Withdrew Consent|0|||
130013052|NCT00705783|468010348|FG002|Conversion Phase|Withdrew Consent|0|||
130013053|NCT00705783|468010346|FG000|Conversion Phase|Protocol Deviation|2|||
130013054|NCT00705783|468010347|FG001|Conversion Phase|Protocol Deviation|0|||
130013055|NCT00705783|468010348|FG002|Conversion Phase|Protocol Deviation|0|||
130013056|NCT00705783|468010346|FG000|Conversion Phase|Adverse Event|11|||
130013057|NCT00705783|468010347|FG001|Conversion Phase|Adverse Event|0|||
130013058|NCT00705783|468010348|FG002|Conversion Phase|Adverse Event|0|||
130013059|NCT00705783|468010346|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
130013060|NCT00705783|468010347|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130013061|NCT00705783|468010348|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130013062|NCT00705783|468010346|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
130013063|NCT00705783|468010347|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130013064|NCT00705783|468010348|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
130013065|NCT00705783|468010346|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
130013066|NCT00705783|468010347|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
130013067|NCT00705783|468010348|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
130013068|NCT00705783|468010346|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
130013069|NCT00705783|468010347|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
130013070|NCT00705783|468010348|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
130013071|NCT00705783|468010346|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
130013072|NCT00705783|468010347|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130013073|NCT00705783|468010348|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
130013074|NCT00705783|468010346|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
130013075|NCT00705783|468010347|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130013076|NCT00705783|468010348|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130013077|NCT00705783|468010346|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
130013078|NCT00705783|468010347|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
130013079|NCT00705783|468010348|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
130013080|NCT00705783|468010346|FG000|Oral Stabilization Phase|Adverse Event|14|||
130013081|NCT00705783|468010347|FG001|Oral Stabilization Phase|Adverse Event|0|||
130013082|NCT00705783|468010348|FG002|Oral Stabilization Phase|Adverse Event|0|||
130013083|NCT00705783|468010346|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
130013084|NCT00705783|468010347|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130013085|NCT00705783|468010348|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130013086|NCT00705783|468010346|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
130013087|NCT00705783|468010347|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130013088|NCT00705783|468010348|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130013089|NCT00705783|468010346|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
130013090|NCT00705783|468010347|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
130013091|NCT00705783|468010348|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
130013092|NCT00705783|468010346|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
130013093|NCT00705783|468010347|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
130013094|NCT00705783|468010348|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
130013095|NCT00705783|468010346|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
130013096|NCT00705783|468010347|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
130217390|NCT03410992|468759523|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
130217391|NCT03410992|468759513|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217392|NCT03410992|468759514|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217393|NCT03410992|468759515|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
130013097|NCT00705783|468010348|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
130013098|NCT00705783|468010346|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
130013099|NCT00705783|468010347|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
130013100|NCT00705783|468010348|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
130013101|NCT00705783|468010346|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
130013102|NCT00705783|468010347|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
130013103|NCT00705783|468010348|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
130013104|NCT00705783|468010346|FG000|Depot Stabilization Phase|Adverse Event|17|||
130013105|NCT00705783|468010347|FG001|Depot Stabilization Phase|Adverse Event|0|||
130013106|NCT00705783|468010348|FG002|Depot Stabilization Phase|Adverse Event|0|||
130013107|NCT00705783|468010346|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
130013108|NCT00705783|468010347|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130013109|NCT00705783|468010348|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130013110|NCT00705783|468010346|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
130013111|NCT00705783|468010347|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130217394|NCT03410992|468759516|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217395|NCT03410992|468759517|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
130347732|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
130347733|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
130347734|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
130347735|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
130347736|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
130347737|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
130347738|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
130347739|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
130347740|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130347741|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130347742|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130347743|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130347744|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
130347745|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
130347746|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130347747|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130347748|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130347749|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
130347750|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130347751|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
130347752|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130347753|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130347754|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130347755|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130347756|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
130347757|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
130347758|NCT03083665|469246768|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130347759|NCT03083665|469246769|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130347760|NCT03083665|469246770|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130347761|NCT03083665|469246771|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130347762|NCT03083665|469246772|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
130347763|NCT03083665|469246773|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
130347764|NCT02720094|469246776|FG000|Overall Study|Ongoing|2210|||
130347765|NCT02720094|469246777|FG001|Overall Study|Ongoing|2203|||
130347766|NCT02720094|469246776|FG000|Overall Study|Scheduled exit visit/end of study|2|||
130347767|NCT02720094|469246777|FG001|Overall Study|Scheduled exit visit/end of study|1|||
130347768|NCT02720094|469246776|FG000|Overall Study|Death|4|||
130347769|NCT02720094|469246777|FG001|Overall Study|Death|7|||
130347770|NCT02720094|469246776|FG000|Overall Study|Withdrawal by Subject|55|||
130347771|NCT02720094|469246777|FG001|Overall Study|Withdrawal by Subject|56|||
130347772|NCT02720094|469246776|FG000|Overall Study|Lost to Follow-up|2|||
130347773|NCT02720094|469246777|FG001|Overall Study|Lost to Follow-up|7|||
130347774|NCT02720094|469246776|FG000|Overall Study|Physician Decision|1|||
130347775|NCT02720094|469246777|FG001|Overall Study|Physician Decision|3|||
130347776|NCT02720094|469246776|FG000|Overall Study|Inappropriate enrollment|1|||
130347777|NCT02720094|469246777|FG001|Overall Study|Inappropriate enrollment|3|||
130347778|NCT02720094|469246776|FG000|Overall Study|Relocation|1|||
130347779|NCT02720094|469246777|FG001|Overall Study|Relocation|1|||
130347780|NCT02519348|469246778|FG000|Overall Study|Death|31|||
130347781|NCT02519348|469246779|FG001|Overall Study|Death|74|||
130347782|NCT02519348|469246780|FG002|Overall Study|Death|47|||
130347783|NCT02519348|469246781|FG003|Overall Study|Death|54|||
130347784|NCT02519348|469246782|FG004|Overall Study|Death|63|||
130347785|NCT02519348|469246783|FG005|Overall Study|Death|18|||
130347786|NCT02519348|469246784|FG006|Overall Study|Death|2|||
130347787|NCT02519348|469246785|FG007|Overall Study|Death|5|||
130347788|NCT02519348|469246786|FG008|Overall Study|Death|5|||
130347789|NCT02519348|469246778|FG000|Overall Study|Withdrawal by Subject|4|||
130347790|NCT02519348|469246779|FG001|Overall Study|Withdrawal by Subject|7|||
130347791|NCT02519348|469246780|FG002|Overall Study|Withdrawal by Subject|4|||
130347792|NCT02519348|469246781|FG003|Overall Study|Withdrawal by Subject|3|||
130347793|NCT02519348|469246782|FG004|Overall Study|Withdrawal by Subject|3|||
130347794|NCT02519348|469246783|FG005|Overall Study|Withdrawal by Subject|2|||
130347795|NCT02519348|469246784|FG006|Overall Study|Withdrawal by Subject|0|||
130347796|NCT02519348|469246785|FG007|Overall Study|Withdrawal by Subject|0|||
130347797|NCT02519348|469246786|FG008|Overall Study|Withdrawal by Subject|1|||
130347798|NCT02519348|469246778|FG000|Overall Study|Lost to Follow-up|0|||
130217396|NCT03410992|468759518|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217397|NCT03410992|468759519|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217398|NCT03410992|468759520|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
130217399|NCT03410992|468759521|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217400|NCT03410992|468759522|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217401|NCT03410992|468759523|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
130217402|NCT03410992|468759513|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217403|NCT03410992|468759514|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217404|NCT03410992|468759515|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217405|NCT03410992|468759516|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130013112|NCT00705783|468010348|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
130013113|NCT00705783|468010346|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
130013114|NCT00705783|468010347|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
130013115|NCT00705783|468010348|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
130013116|NCT00705783|468010346|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
130217406|NCT03410992|468759517|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217407|NCT03410992|468759518|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217408|NCT03410992|468759519|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217409|NCT03410992|468759520|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217410|NCT03410992|468759521|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
130217411|NCT03410992|468759522|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217412|NCT03410992|468759523|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
130217413|NCT02438280|468759524|FG000|Overall Study|Physician Decision|1|||
130217414|NCT02438280|468759525|FG001|Overall Study|Physician Decision|0|||
130217415|NCT02260817|468759526|FG000|Overall Study|Lost to Follow-up|0|||
130217416|NCT02260817|468759527|FG001|Overall Study|Lost to Follow-up|14|||
130217417|NCT02260817|468759526|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
130217418|NCT02260817|468759527|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
130217419|NCT02260817|468759526|FG000|Overall Study|Observation, no biopsy|0|||
130217420|NCT02260817|468759527|FG001|Overall Study|Observation, no biopsy|1|||
130217421|NCT02260817|468759526|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
130217422|NCT02260817|468759527|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
130217423|NCT02260817|468759526|FG000|Overall Study|Protocol Violation|0|||
130217424|NCT02260817|468759527|FG001|Overall Study|Protocol Violation|14|||
130217425|NCT03299101|468759528|FG000|Overall Study|Lost to Follow-up|1|||
130217426|NCT03299101|468759528|FG000|Overall Study|Withdrawal by Subject|5|||
130217427|NCT03299101|468759528|FG000|Overall Study|Surgery was changed|3|||
130217428|NCT03299101|468759528|FG000|Overall Study|Not enough time to complete prehab|1|||
130217429|NCT01882803|468759530|FG000|Overall Study|Disease Progression|1|||
130217430|NCT01882803|468759530|FG000|Overall Study|Withdrawal by Subject|9|||
130217431|NCT01882803|468759530|FG000|Overall Study|Death|68|||
130013117|NCT00705783|468010347|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
130217432|NCT01882803|468759530|FG000|Overall Study|Physician Decision|3|||
130217433|NCT01882803|468759530|FG000|Overall Study|Lost to Follow-up|3|||
130217434|NCT01882803|468759530|FG000|Overall Study|Follow-up Completed|39|||
129884416|NCT02771210|467536387|FG000|Period 2|Withdrawal by Subject|1|||
129884417|NCT02771210|467536388|FG001|Period 2|Withdrawal by Subject|0|||
129884418|NCT02771210|467536387|FG000|Period 2|Withdrawal of informed consent|0|||
129884419|NCT02771210|467536388|FG001|Period 2|Withdrawal of informed consent|2|||
130013118|NCT00705783|468010348|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
130013119|NCT00705783|468010346|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
130013120|NCT00705783|468010347|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
130013121|NCT00705783|468010348|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
130347799|NCT02519348|469246779|FG001|Overall Study|Lost to Follow-up|0|||
130347800|NCT02519348|469246780|FG002|Overall Study|Lost to Follow-up|1|||
130347801|NCT02519348|469246781|FG003|Overall Study|Lost to Follow-up|0|||
130347802|NCT02519348|469246782|FG004|Overall Study|Lost to Follow-up|2|||
130347803|NCT02519348|469246783|FG005|Overall Study|Lost to Follow-up|1|||
129884420|NCT04012814|467536391|FG000|Overall Study|Lost to Follow-up|4|||
130013122|NCT00705783|468010346|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
130217435|NCT01882803|468759530|FG000|Overall Study|Study Terminated by the Sponsor|6|||
130217436|NCT01563913|468759531|FG000|Overall Study|Physician Decision|1|||
130217437|NCT01563913|468759532|FG001|Overall Study|Physician Decision|0|||
130217438|NCT01563913|468759531|FG000|Overall Study|Spouse Passed Away|1|||
130347804|NCT02519348|469246784|FG006|Overall Study|Lost to Follow-up|1|||
130347805|NCT02519348|469246785|FG007|Overall Study|Lost to Follow-up|0|||
130347806|NCT02519348|469246786|FG008|Overall Study|Lost to Follow-up|0|||
130347807|NCT02519348|469246778|FG000|Overall Study|Other|0|||
129884421|NCT04012814|467536391|FG000|Overall Study|Withdrawal by Subject|2|||
130217439|NCT01563913|468759532|FG001|Overall Study|Spouse Passed Away|0|||
130217440|NCT03066778|468759533|FG000|Overall Study|Death|195|||
130217441|NCT03066778|468759534|FG001|Overall Study|Death|205|||
130217442|NCT03066778|468759533|FG000|Overall Study|Withdrawal by Subject|5|||
130217443|NCT03066778|468759534|FG001|Overall Study|Withdrawal by Subject|7|||
130217444|NCT02091414|468759535|FG000|Overall Study|Withdrawal by Subject|2|||
130013123|NCT00705783|468010347|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
130013124|NCT00705783|468010348|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
130013125|NCT00705783|468010346|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
130013126|NCT00705783|468010347|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
130013127|NCT00705783|468010348|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
130013128|NCT00705783|468010346|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
130013129|NCT00705783|468010347|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
130013130|NCT00705783|468010348|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
130013131|NCT00705783|468010346|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
130013132|NCT00705783|468010347|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
130013133|NCT00705783|468010348|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
130013134|NCT00705783|468010346|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
130013135|NCT00705783|468010347|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
130013136|NCT00705783|468010348|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
130013137|NCT00705783|468010346|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
130013138|NCT00705783|468010347|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
130013139|NCT00705783|468010348|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
130013140|NCT02182687|468010349|FG000|Overall Study|Withdrawal by Subject|4|||
130013141|NCT02182687|468010350|FG001|Overall Study|Withdrawal by Subject|0|||
130013142|NCT02182687|468010349|FG000|Overall Study|Adverse Event|1|||
130013143|NCT02182687|468010350|FG001|Overall Study|Adverse Event|0|||
130013144|NCT02182687|468010349|FG000|Overall Study|Lost to Follow-up|0|||
130013145|NCT02182687|468010350|FG001|Overall Study|Lost to Follow-up|1|||
130013146|NCT02184195|468010353|FG000|Overall Study|Patient decision|5|||
130013147|NCT02184195|468010354|FG001|Overall Study|Patient decision|2|||
130013148|NCT02184195|468010353|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130013149|NCT02184195|468010354|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130013150|NCT02184195|468010353|FG000|Overall Study|Death|67|||
130013151|NCT02184195|468010354|FG001|Overall Study|Death|44|||
130013152|NCT02184195|468010353|FG000|Overall Study|Lost to Follow-up|1|||
130013153|NCT02184195|468010354|FG001|Overall Study|Lost to Follow-up|5|||
130013154|NCT02184195|468010353|FG000|Overall Study|Other|0|||
130013155|NCT02184195|468010354|FG001|Overall Study|Other|3|||
130013156|NCT00939783|468010357|FG000|Overall Study|Death|6|||
130013157|NCT00939783|468010357|FG000|Overall Study|Adverse Event|39|||
130013158|NCT00939783|468010357|FG000|Overall Study|Study Terminated by Sponsor|498|||
130013159|NCT00939783|468010357|FG000|Overall Study|Withdrawal by Subject|78|||
130013160|NCT00939783|468010357|FG000|Overall Study|Other|16|||
130013161|NCT00939783|468010357|FG000|Overall Study|Lost to Follow-up|8|||
130013162|NCT00939783|468010357|FG000|Overall Study|Protocol Violation|3|||
130013163|NCT00939783|468010357|FG000|Overall Study|Enrolled but not treated|1|||
130013164|NCT02255409|468010364|FG000|Overall Study|Administrative Reason|3|||
130013165|NCT02255409|468010365|FG001|Overall Study|Administrative Reason|7|||
130013166|NCT02255409|468010364|FG000|Overall Study|Withdrawal by Subject|1|||
130013167|NCT02255409|468010365|FG001|Overall Study|Withdrawal by Subject|5|||
130013168|NCT02255409|468010364|FG000|Overall Study|Lost to Follow-up|10|||
130013169|NCT02255409|468010365|FG001|Overall Study|Lost to Follow-up|19|||
130217445|NCT02091414|468759535|FG000|Overall Study|Death|2|||
130217446|NCT03665077|468759536|FG000|Overall Study|Lost to Follow-up|2|||
130217447|NCT03665077|468759536|FG000|Overall Study|Physician Decision|2|||
130217448|NCT00435461|468759539|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
130217449|NCT00435461|468759540|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
130217450|NCT00435461|468759541|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
130217451|NCT00435461|468759539|FG000|Overall Study|Protocol Violation|6|||
130217452|NCT00435461|468759540|FG001|Overall Study|Protocol Violation|9|||
130217453|NCT00435461|468759541|FG002|Overall Study|Protocol Violation|10|||
130217454|NCT00435461|468759539|FG000|Overall Study|Participant randomized(inadequate score)|1|||
130217455|NCT00435461|468759540|FG001|Overall Study|Participant randomized(inadequate score)|0|||
130217456|NCT00435461|468759541|FG002|Overall Study|Participant randomized(inadequate score)|0|||
130217457|NCT00435461|468759539|FG000|Overall Study|Compliance less than 80 percent|1|||
130217458|NCT00435461|468759540|FG001|Overall Study|Compliance less than 80 percent|0|||
130013170|NCT01251367|468010366|FG000|Overall Study|Protocol Violation|1|||
130013171|NCT01251367|468010366|FG000|Overall Study|Lack of Efficacy|2|||
130013172|NCT01251367|468010366|FG000|Overall Study|Adverse Event|19|||
130013173|NCT01251367|468010366|FG000|Overall Study|Withdrawal by Subject|36|||
130013174|NCT01251367|468010366|FG000|Overall Study|Lost to Follow-up|5|||
130013175|NCT01251367|468010366|FG000|Overall Study|Subject Required Alternative Treatment|7|||
130013176|NCT01251367|468010366|FG000|Overall Study|No Study Drug Available|1|||
130013177|NCT01251367|468010366|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
130013178|NCT01251367|468010366|FG000|Overall Study|End of Study Visit Performed in Error|1|||
130013179|NCT03775421|468010370|FG000|Overall Study|Lost to Follow-up|2|||
130013180|NCT03775421|468010370|FG000|Overall Study|Withdrawal by Subject|10|||
130217459|NCT00435461|468759541|FG002|Overall Study|Compliance less than 80 percent|0|||
130217460|NCT00435461|468759539|FG000|Overall Study|In error, two study medications switched|1|||
130217461|NCT00435461|468759540|FG001|Overall Study|In error, two study medications switched|0|||
130217462|NCT00435461|468759541|FG002|Overall Study|In error, two study medications switched|0|||
130217463|NCT00435461|468759539|FG000|Overall Study|Lack of Efficacy|2|||
130217464|NCT00435461|468759540|FG001|Overall Study|Lack of Efficacy|1|||
130217465|NCT00435461|468759541|FG002|Overall Study|Lack of Efficacy|0|||
130217466|NCT00435461|468759539|FG000|Overall Study|Withdrawal by Subject|1|||
130217467|NCT00435461|468759540|FG001|Overall Study|Withdrawal by Subject|0|||
130217468|NCT00435461|468759541|FG002|Overall Study|Withdrawal by Subject|2|||
130217469|NCT00435461|468759539|FG000|Overall Study|Randomized in error|1|||
130217470|NCT00435461|468759540|FG001|Overall Study|Randomized in error|0|||
130217471|NCT00435461|468759541|FG002|Overall Study|Randomized in error|0|||
130217472|NCT00435461|468759539|FG000|Overall Study|Participant could not tolerate symptoms|0|||
130217473|NCT00435461|468759540|FG001|Overall Study|Participant could not tolerate symptoms|0|||
130217474|NCT00435461|468759541|FG002|Overall Study|Participant could not tolerate symptoms|1|||
130217475|NCT00435461|468759539|FG000|Overall Study|Participant could not swallow capsule|0|||
130217476|NCT00435461|468759540|FG001|Overall Study|Participant could not swallow capsule|0|||
130217477|NCT00435461|468759541|FG002|Overall Study|Participant could not swallow capsule|1|||
130217478|NCT00435461|468759539|FG000|Overall Study|Pregnancy|2|||
130217479|NCT00435461|468759540|FG001|Overall Study|Pregnancy|0|||
130217480|NCT00435461|468759541|FG002|Overall Study|Pregnancy|0|||
130217481|NCT00435461|468759539|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
130217482|NCT00435461|468759540|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
130013181|NCT03775421|468010370|FG000|Overall Study|Physician Decision|3|||
130013182|NCT03775421|468010370|FG000|Overall Study|Death|1|||
130013183|NCT03775421|468010370|FG000|Overall Study|Study Terminated by Sponsor|94|||
130013184|NCT03917823|468010371|FG000|Overall Study|Lost to Follow-up|1|||
130013185|NCT03917823|468010372|FG001|Overall Study|Lost to Follow-up|1|||
130013186|NCT03917823|468010371|FG000|Overall Study|Withdrawal by Subject|0|||
130013187|NCT03917823|468010372|FG001|Overall Study|Withdrawal by Subject|1|||
130013188|NCT02016820|468010373|FG000|Overall Study|Lost to Follow-up|2|||
130013189|NCT02016820|468010374|FG001|Overall Study|Lost to Follow-up|4|||
130013190|NCT00135668|468010375|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
130013191|NCT00135668|468010376|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
130013192|NCT00135668|468010377|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
130013193|NCT00135668|468010378|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
130013194|NCT00473343|468010381|FG000|Overall Study|Adverse Event|9|||
130217483|NCT00435461|468759541|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
130217484|NCT00435461|468759539|FG000|Overall Study|Participant ended study one day early|1|||
130217485|NCT00435461|468759540|FG001|Overall Study|Participant ended study one day early|0|||
130217486|NCT00435461|468759541|FG002|Overall Study|Participant ended study one day early|0|||
130217487|NCT00435461|468759539|FG000|Overall Study|Noncompliance with study requirements|1|||
130217488|NCT00435461|468759540|FG001|Overall Study|Noncompliance with study requirements|1|||
130217489|NCT00435461|468759541|FG002|Overall Study|Noncompliance with study requirements|1|||
130217490|NCT00435461|468759539|FG000|Overall Study|Adverse Event|1|||
130217491|NCT00435461|468759540|FG001|Overall Study|Adverse Event|2|||
130217492|NCT00435461|468759541|FG002|Overall Study|Adverse Event|6|||
130217493|NCT00435461|468759539|FG000|Overall Study|Non-Compliance of diary|2|||
130217494|NCT00435461|468759540|FG001|Overall Study|Non-Compliance of diary|0|||
130217495|NCT00435461|468759541|FG002|Overall Study|Non-Compliance of diary|1|||
130217496|NCT00435461|468759539|FG000|Overall Study|Lost to Follow-up|1|||
130217497|NCT00435461|468759540|FG001|Overall Study|Lost to Follow-up|1|||
130217498|NCT00435461|468759541|FG002|Overall Study|Lost to Follow-up|2|||
130217499|NCT02306850|468759544|FG000|Overall Study|Lack of Efficacy|2|||
130217500|NCT00237692|468759545|FG000|Overall Study|Lost to Follow-up|9|||
130217501|NCT00237692|468759546|FG001|Overall Study|Lost to Follow-up|3|||
130013195|NCT00473343|468010381|FG000|Overall Study|Lost to Follow-up|8|||
130013196|NCT00473343|468010381|FG000|Overall Study|Treatment failure|27|||
130013197|NCT00473343|468010381|FG000|Overall Study|Withdrew consent|3|||
130013198|NCT00473343|468010381|FG000|Overall Study|Other un-specified reason|3|||
130013199|NCT04247061|468010384|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
130013200|NCT04247061|468010384|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
130217502|NCT00237692|468759547|FG002|Overall Study|Lost to Follow-up|5|||
130217503|NCT00237692|468759548|FG003|Overall Study|Lost to Follow-up|3|||
130217504|NCT00237692|468759545|FG000|Overall Study|Death|1|||
130217505|NCT00237692|468759546|FG001|Overall Study|Death|2|||
130217506|NCT00237692|468759547|FG002|Overall Study|Death|2|||
130217507|NCT00237692|468759548|FG003|Overall Study|Death|3|||
130217508|NCT00237692|468759545|FG000|Overall Study|Excluded - did not meet criteria|4|||
130217509|NCT00237692|468759546|FG001|Overall Study|Excluded - did not meet criteria|3|||
130217510|NCT00237692|468759547|FG002|Overall Study|Excluded - did not meet criteria|5|||
130217511|NCT00237692|468759548|FG003|Overall Study|Excluded - did not meet criteria|9|||
130217512|NCT00237692|468759545|FG000|Overall Study|Withdrawal by Subject|4|||
130217513|NCT00237692|468759546|FG001|Overall Study|Withdrawal by Subject|6|||
130217514|NCT00237692|468759547|FG002|Overall Study|Withdrawal by Subject|10|||
130217515|NCT00237692|468759548|FG003|Overall Study|Withdrawal by Subject|4|||
130217516|NCT02420262|468759549|FG000|Overall Study|Adverse Event|1|||
130052109|NCT00051558|468147208|FG001|Overall Study|Physician Decision|0|||
130217517|NCT02420262|468759550|FG001|Overall Study|Adverse Event|0|||
130217518|NCT02420262|468759549|FG000|Overall Study|Withdrawal by Subject|1|||
130217519|NCT02420262|468759550|FG001|Overall Study|Withdrawal by Subject|4|||
130217520|NCT02420262|468759549|FG000|Overall Study|Unclassified|0|||
130217521|NCT02420262|468759550|FG001|Overall Study|Unclassified|1|||
130217522|NCT05446142|468759566|FG000|Period 2|Adverse Event|1|||
130217523|NCT05446142|468759567|FG001|Period 2|Adverse Event|0|||
130217524|NCT05446142|468759568|FG002|Period 2|Adverse Event|0|||
130217525|NCT05446142|468759569|FG003|Period 2|Adverse Event|0|||
130217526|NCT05446142|468759570|FG004|Period 2|Adverse Event|0|||
130217527|NCT05446142|468759571|FG005|Period 2|Adverse Event|0|||
130217528|NCT02098395|468759572|FG000|Overall Study|Protocol Violation|2|||
130217529|NCT02098395|468759573|FG001|Overall Study|Protocol Violation|2|||
130217530|NCT02098395|468759574|FG002|Overall Study|Protocol Violation|0|||
130217531|NCT02098395|468759575|FG003|Overall Study|Protocol Violation|7|||
130217532|NCT02098395|468759572|FG000|Overall Study|Withdrawal by Subject|10|||
130217533|NCT02098395|468759573|FG001|Overall Study|Withdrawal by Subject|10|||
130217534|NCT02098395|468759574|FG002|Overall Study|Withdrawal by Subject|5|||
130217535|NCT02098395|468759575|FG003|Overall Study|Withdrawal by Subject|13|||
130217536|NCT02098395|468759572|FG000|Overall Study|Adverse Event|12|||
130217537|NCT02098395|468759573|FG001|Overall Study|Adverse Event|19|||
130217538|NCT02098395|468759574|FG002|Overall Study|Adverse Event|34|||
130217539|NCT02098395|468759575|FG003|Overall Study|Adverse Event|2|||
130217540|NCT02098395|468759572|FG000|Overall Study|Lost to Follow-up|2|||
130217541|NCT02098395|468759573|FG001|Overall Study|Lost to Follow-up|1|||
130217542|NCT02098395|468759574|FG002|Overall Study|Lost to Follow-up|0|||
130217543|NCT02098395|468759575|FG003|Overall Study|Lost to Follow-up|3|||
130217544|NCT02098395|468759572|FG000|Overall Study|Unclassified|0|||
130217545|NCT02098395|468759573|FG001|Overall Study|Unclassified|0|||
130217546|NCT02098395|468759574|FG002|Overall Study|Unclassified|3|||
130217547|NCT02098395|468759575|FG003|Overall Study|Unclassified|2|||
130217548|NCT00110357|468759578|FG000|Overall Study|Deterioration without progression|2|||
130217549|NCT00110357|468759579|FG001|Overall Study|Deterioration without progression|0|||
130217550|NCT00110357|468759578|FG000|Overall Study|Disease progression/relapse|20|||
130217551|NCT00110357|468759579|FG001|Overall Study|Disease progression/relapse|15|||
130217552|NCT00110357|468759578|FG000|Overall Study|Study Closure|1|||
130217553|NCT00110357|468759579|FG001|Overall Study|Study Closure|0|||
130217554|NCT00110357|468759578|FG000|Overall Study|Study Drug Toxicity|1|||
130217555|NCT00110357|468759579|FG001|Overall Study|Study Drug Toxicity|3|||
130217556|NCT00110357|468759578|FG000|Overall Study|Withdrawal by Subject|3|||
130217557|NCT00110357|468759579|FG001|Overall Study|Withdrawal by Subject|1|||
130217558|NCT03382418|468759580|FG000|Overall Study|Withdrawal by Subject|1|||
130217559|NCT03382418|468759581|FG001|Overall Study|Withdrawal by Subject|0|||
130217560|NCT03382418|468759582|FG002|Overall Study|Withdrawal by Subject|0|||
130217561|NCT03382418|468759580|FG000|Overall Study|Lost to Follow-up|2|||
130217562|NCT03382418|468759581|FG001|Overall Study|Lost to Follow-up|3|||
130217563|NCT03382418|468759582|FG002|Overall Study|Lost to Follow-up|0|||
130217564|NCT04633226|468759583|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130217565|NCT04633226|468759583|FG000|Overall Study|Randomized by mistake without study treatment|1|||
130217566|NCT01151345|468759584|FG000|First Intervention Period|Protocol Violation|0|||
130217567|NCT01151345|468759585|FG001|First Intervention Period|Protocol Violation|1|||
130217568|NCT01348100|468759588|FG000|Overall Study|Subject Withdrew Consent|0|||
130217569|NCT01348100|468759589|FG001|Overall Study|Subject Withdrew Consent|0|||
130347808|NCT02519348|469246779|FG001|Overall Study|Other|3|||
130347809|NCT02519348|469246780|FG002|Overall Study|Other|0|||
130347810|NCT02519348|469246781|FG003|Overall Study|Other|0|||
130347811|NCT02519348|469246782|FG004|Overall Study|Other|1|||
130347812|NCT02519348|469246783|FG005|Overall Study|Other|0|||
130347813|NCT02519348|469246784|FG006|Overall Study|Other|0|||
130347814|NCT02519348|469246785|FG007|Overall Study|Other|0|||
130347815|NCT02519348|469246786|FG008|Overall Study|Other|0|||
130347816|NCT02519348|469246778|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
130347817|NCT02519348|469246779|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
130347818|NCT02519348|469246780|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
130347819|NCT02519348|469246781|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
130347820|NCT02519348|469246782|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
130347821|NCT02519348|469246783|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
130347822|NCT02519348|469246784|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
130347823|NCT02519348|469246785|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
130347824|NCT02519348|469246786|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
130347825|NCT01302834|469246787|FG000|Overall Study|Protocol Violation|17|||
130347826|NCT01302834|469246788|FG001|Overall Study|Protocol Violation|23|||
130347827|NCT01302834|469246787|FG000|Overall Study|HIV positive|1|||
130347828|NCT01302834|469246788|FG001|Overall Study|HIV positive|3|||
130013201|NCT04247061|468010384|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
130013202|NCT00455013|468010388|FG000|Short Term Period|Adverse Event|2|||
130013203|NCT00455013|468010389|FG001|Short Term Period|Adverse Event|5|||
130013204|NCT00455013|468010390|FG002|Short Term Period|Adverse Event|0|||
130013205|NCT00455013|468010388|FG000|Short Term Period|Withdrawal by Subject|0|||
130013206|NCT00455013|468010389|FG001|Short Term Period|Withdrawal by Subject|0|||
130013207|NCT00455013|468010390|FG002|Short Term Period|Withdrawal by Subject|1|||
130013208|NCT00455013|468010388|FG000|Short Term Period|Lack of Efficacy|4|||
130013209|NCT00455013|468010389|FG001|Short Term Period|Lack of Efficacy|0|||
130013210|NCT00455013|468010390|FG002|Short Term Period|Lack of Efficacy|0|||
130013211|NCT00455013|468010388|FG000|Short Term Period|Other|0|||
130013212|NCT00455013|468010389|FG001|Short Term Period|Other|0|||
130013213|NCT00455013|468010390|FG002|Short Term Period|Other|1|||
130013214|NCT00455013|468010388|FG000|Long Term Extension (LTE)|Adverse Event|0|||
130013215|NCT00455013|468010389|FG001|Long Term Extension (LTE)|Adverse Event|1|||
130013216|NCT00455013|468010390|FG002|Long Term Extension (LTE)|Adverse Event|1|||
130013217|NCT00455013|468010388|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
130013218|NCT00455013|468010389|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
130013219|NCT00455013|468010390|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
130013220|NCT00455013|468010388|FG000|Long Term Extension (LTE)|Death|1|||
130013221|NCT00455013|468010389|FG001|Long Term Extension (LTE)|Death|1|||
130013222|NCT00455013|468010390|FG002|Long Term Extension (LTE)|Death|0|||
130013223|NCT00455013|468010388|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
130013224|NCT00455013|468010389|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
130013225|NCT00455013|468010390|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
130013226|NCT00455013|468010388|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
130013227|NCT00455013|468010389|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
130013228|NCT00455013|468010390|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
130013229|NCT00455013|468010388|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
130013230|NCT00455013|468010389|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
130013231|NCT00455013|468010390|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
130013232|NCT00455013|468010388|FG000|Long Term Extension (LTE)|non-specified|0|||
130013233|NCT00455013|468010389|FG001|Long Term Extension (LTE)|non-specified|0|||
130013234|NCT00455013|468010390|FG002|Long Term Extension (LTE)|non-specified|1|||
130013235|NCT02739620|468010393|FG000|Overall Study|Lost to Follow-up|3|||
130013236|NCT02739620|468010394|FG001|Overall Study|Lost to Follow-up|1|||
130013237|NCT02739620|468010393|FG000|Overall Study|Adverse Event|0|||
130013238|NCT02739620|468010394|FG001|Overall Study|Adverse Event|1|||
130013239|NCT01439555|468010395|FG000|Overall Study|Protocol Violation|1|||
130013240|NCT00102960|468010397|FG000|Overall Study|Death|23|||
130013241|NCT00102960|468010398|FG001|Overall Study|Death|11|||
130013242|NCT00102960|468010399|FG002|Overall Study|Death|11|||
130013243|NCT00102960|468010397|FG000|Overall Study|Lost to Follow-up|6|||
130013244|NCT00102960|468010398|FG001|Overall Study|Lost to Follow-up|12|||
130013245|NCT00102960|468010399|FG002|Overall Study|Lost to Follow-up|16|||
130013246|NCT00102960|468010397|FG000|Overall Study|Withdrawal by Subject|1|||
130013247|NCT00102960|468010398|FG001|Overall Study|Withdrawal by Subject|0|||
130013248|NCT00102960|468010399|FG002|Overall Study|Withdrawal by Subject|1|||
130013249|NCT01135498|468012171|FG000|Overall Study|Adverse Event|20|||
130013250|NCT01135498|468012171|FG000|Overall Study|Progressive disease|38|||
130013251|NCT01135498|468012171|FG000|Overall Study|Investigator judgement|25|||
130013252|NCT01135498|468012171|FG000|Overall Study|Withdrawal by Subject|4|||
130013253|NCT01135498|468012171|FG000|Overall Study|Death|1|||
130013254|NCT01135498|468012171|FG000|Overall Study|Ongoing at time of analysis|2|||
130013255|NCT02104583|468012172|FG000|Overall Study|New ICD or CRT-D implanted|2|||
130013256|NCT02104583|468012173|FG001|Overall Study|New ICD or CRT-D implanted|0|||
130013257|NCT02104583|468012174|FG002|Overall Study|New ICD or CRT-D implanted|1|||
130013258|NCT02104583|468012175|FG003|Overall Study|New ICD or CRT-D implanted|0|||
130013259|NCT02104583|468012176|FG004|Overall Study|New ICD or CRT-D implanted|0|||
130013260|NCT02104583|468012172|FG000|Overall Study|Death|2|||
130013261|NCT02104583|468012173|FG001|Overall Study|Death|1|||
130013262|NCT02104583|468012174|FG002|Overall Study|Death|3|||
130013263|NCT02104583|468012175|FG003|Overall Study|Death|3|||
130013264|NCT02104583|468012176|FG004|Overall Study|Death|5|||
130013265|NCT02104583|468012172|FG000|Overall Study|Subject required cardiac ablation|6|||
130013266|NCT02104583|468012173|FG001|Overall Study|Subject required cardiac ablation|4|||
130013267|NCT02104583|468012174|FG002|Overall Study|Subject required cardiac ablation|4|||
130013268|NCT02104583|468012175|FG003|Overall Study|Subject required cardiac ablation|5|||
130013269|NCT02104583|468012176|FG004|Overall Study|Subject required cardiac ablation|4|||
130013270|NCT02104583|468012172|FG000|Overall Study|Subject required prohibited medication|0|||
130013271|NCT02104583|468012173|FG001|Overall Study|Subject required prohibited medication|1|||
130013272|NCT02104583|468012174|FG002|Overall Study|Subject required prohibited medication|1|||
130013273|NCT02104583|468012175|FG003|Overall Study|Subject required prohibited medication|0|||
130013274|NCT02104583|468012176|FG004|Overall Study|Subject required prohibited medication|1|||
130013275|NCT02104583|468012172|FG000|Overall Study|Withdrew Consent|3|||
130013276|NCT02104583|468012173|FG001|Overall Study|Withdrew Consent|2|||
130217570|NCT01348100|468759590|FG002|Overall Study|Subject Withdrew Consent|2|||
130217571|NCT01348100|468759591|FG003|Overall Study|Subject Withdrew Consent|0|||
130217572|NCT01348100|468759592|FG004|Overall Study|Subject Withdrew Consent|1|||
130217573|NCT01348100|468759593|FG005|Overall Study|Subject Withdrew Consent|0|||
130217574|NCT01348100|468759594|FG006|Overall Study|Subject Withdrew Consent|1|||
130217575|NCT01348100|468759588|FG000|Overall Study|Protocol Deviation|0|||
130217576|NCT01348100|468759589|FG001|Overall Study|Protocol Deviation|0|||
130217577|NCT01348100|468759590|FG002|Overall Study|Protocol Deviation|0|||
130217578|NCT01348100|468759591|FG003|Overall Study|Protocol Deviation|1|||
130217579|NCT01348100|468759592|FG004|Overall Study|Protocol Deviation|0|||
130217580|NCT01348100|468759593|FG005|Overall Study|Protocol Deviation|0|||
130217581|NCT01348100|468759594|FG006|Overall Study|Protocol Deviation|0|||
130217582|NCT01348100|468759588|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217583|NCT01348100|468759589|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217584|NCT01348100|468759590|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217585|NCT01348100|468759591|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217586|NCT01348100|468759592|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217587|NCT01348100|468759593|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130217588|NCT01348100|468759594|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130217589|NCT01348100|468759588|FG000|Overall Study|Lost to Follow-up|0|||
130217590|NCT01348100|468759589|FG001|Overall Study|Lost to Follow-up|0|||
130217591|NCT01348100|468759590|FG002|Overall Study|Lost to Follow-up|0|||
130347829|NCT03735238|469246789|FG000|Overall Study|Did not want to participate in research|3|||
130347830|NCT03735238|469246789|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
130013277|NCT02104583|468012174|FG002|Overall Study|Withdrew Consent|0|||
130013278|NCT02104583|468012175|FG003|Overall Study|Withdrew Consent|2|||
130013279|NCT02104583|468012176|FG004|Overall Study|Withdrew Consent|1|||
130013280|NCT02104583|468012172|FG000|Overall Study|Investigator's Discretion|1|||
130013281|NCT02104583|468012173|FG001|Overall Study|Investigator's Discretion|0|||
130013282|NCT02104583|468012174|FG002|Overall Study|Investigator's Discretion|0|||
130013283|NCT02104583|468012175|FG003|Overall Study|Investigator's Discretion|0|||
130013284|NCT02104583|468012176|FG004|Overall Study|Investigator's Discretion|0|||
130013285|NCT02104583|468012172|FG000|Overall Study|Protocol Violation|0|||
130013286|NCT02104583|468012173|FG001|Overall Study|Protocol Violation|0|||
130013287|NCT02104583|468012174|FG002|Overall Study|Protocol Violation|1|||
130013288|NCT02104583|468012175|FG003|Overall Study|Protocol Violation|0|||
130013289|NCT02104583|468012176|FG004|Overall Study|Protocol Violation|0|||
130013290|NCT02104583|468012172|FG000|Overall Study|Adverse Event|3|||
130013291|NCT02104583|468012173|FG001|Overall Study|Adverse Event|3|||
130013292|NCT02104583|468012174|FG002|Overall Study|Adverse Event|6|||
130013293|NCT02104583|468012175|FG003|Overall Study|Adverse Event|6|||
130013294|NCT02104583|468012176|FG004|Overall Study|Adverse Event|1|||
130013295|NCT02104583|468012172|FG000|Overall Study|Lost to Follow-up|1|||
130013296|NCT02104583|468012173|FG001|Overall Study|Lost to Follow-up|0|||
130013297|NCT02104583|468012174|FG002|Overall Study|Lost to Follow-up|0|||
130013298|NCT02104583|468012175|FG003|Overall Study|Lost to Follow-up|0|||
130013299|NCT02104583|468012176|FG004|Overall Study|Lost to Follow-up|0|||
130013300|NCT02104583|468012172|FG000|Overall Study|Randomized but Never Treated|0|||
130013301|NCT02104583|468012173|FG001|Overall Study|Randomized but Never Treated|0|||
130347831|NCT06285240|469246790|FG000|Overall Study|Withdrawal by Subject|2|||
130347832|NCT06285240|469246791|FG001|Overall Study|Withdrawal by Subject|0|||
130347833|NCT06285240|469246792|FG002|Overall Study|Withdrawal by Subject|0|||
130347834|NCT06285240|469246793|FG003|Overall Study|Withdrawal by Subject|0|||
130347835|NCT06285240|469246790|FG000|Overall Study|Serious Adverse Event|0|||
130013302|NCT02104583|468012174|FG002|Overall Study|Randomized but Never Treated|0|||
130013303|NCT02104583|468012175|FG003|Overall Study|Randomized but Never Treated|1|||
130052110|NCT03952468|468147217|FG000|Overall Study|Death|0|||
130052111|NCT03952468|468147218|FG001|Overall Study|Death|1|||
130217592|NCT01348100|468759591|FG003|Overall Study|Lost to Follow-up|0|||
130217593|NCT01348100|468759592|FG004|Overall Study|Lost to Follow-up|0|||
130217594|NCT01348100|468759593|FG005|Overall Study|Lost to Follow-up|0|||
130013304|NCT02104583|468012176|FG004|Overall Study|Randomized but Never Treated|0|||
130013305|NCT01351389|468012177|FG000|Overall Study|Withdrawal by Subject|7|||
130013306|NCT01351389|468012178|FG001|Overall Study|Withdrawal by Subject|0|||
130013307|NCT01351389|468012177|FG000|Overall Study|did not complete intervention|23|||
130013308|NCT01351389|468012178|FG001|Overall Study|did not complete intervention|15|||
130013309|NCT00930761|468012179|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
130013310|NCT00930761|468012180|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
130013311|NCT00930761|468012179|FG000|Overall Study|less than 3 music therapy sessions|0|||
130013312|NCT00930761|468012180|FG001|Overall Study|less than 3 music therapy sessions|3|||
130013313|NCT01500278|468012187|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
130013314|NCT01500278|468012188|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
130013315|NCT01500278|468012187|FG000|Week 0 - Week 12|Protocol Violation|10|||
130013316|NCT01500278|468012188|FG001|Week 0 - Week 12|Protocol Violation|16|||
130013317|NCT01500278|468012187|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
130013318|NCT01500278|468012188|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
130013319|NCT01500278|468012187|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
130013320|NCT01500278|468012188|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
130013321|NCT01500278|468012187|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
130013322|NCT01500278|468012188|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
130013323|NCT01500278|468012187|FG000|Week 0 - Week 12|Patient decision|1|||
130013324|NCT01500278|468012188|FG001|Week 0 - Week 12|Patient decision|0|||
130013325|NCT01500278|468012187|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
130013326|NCT01500278|468012188|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
130013327|NCT01500278|468012187|FG000|Week 0 - Week 12|Investigator decision|1|||
130013328|NCT01500278|468012188|FG001|Week 0 - Week 12|Investigator decision|0|||
130013329|NCT01500278|468012187|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
130013330|NCT01500278|468012188|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
130013331|NCT01500278|468012187|FG000|Week 0 - Week 12|Sponsor decision|1|||
130013332|NCT01500278|468012188|FG001|Week 0 - Week 12|Sponsor decision|0|||
130013333|NCT01500278|468012187|FG000|Week 0 - Week 12|Personal reason|0|||
130013334|NCT01500278|468012188|FG001|Week 0 - Week 12|Personal reason|1|||
130013335|NCT01500278|468012187|FG000|Week 0 - Week 12|Other serious disease|0|||
130013336|NCT01500278|468012188|FG001|Week 0 - Week 12|Other serious disease|1|||
130013337|NCT01500278|468012187|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
130013338|NCT01500278|468012188|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
130013339|NCT01500278|468012187|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
130013340|NCT01500278|468012188|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
130013341|NCT01500278|468012187|FG000|Week 13 - Week 104|Protocol Violation|6|||
130013342|NCT01500278|468012188|FG001|Week 13 - Week 104|Protocol Violation|6|||
130013343|NCT01500278|468012187|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
130013344|NCT01500278|468012188|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
130013345|NCT01500278|468012187|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
130013346|NCT01500278|468012188|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
130013347|NCT01500278|468012187|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
130013348|NCT01500278|468012188|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
130013349|NCT01500278|468012187|FG000|Week 13 - Week 104|Non/bad compliance|7|||
130013350|NCT01500278|468012188|FG001|Week 13 - Week 104|Non/bad compliance|5|||
130013351|NCT01500278|468012187|FG000|Week 13 - Week 104|Recurrent infections|1|||
130013352|NCT01500278|468012188|FG001|Week 13 - Week 104|Recurrent infections|0|||
130013353|NCT01500278|468012187|FG000|Week 13 - Week 104|False positive test|1|||
130217595|NCT01348100|468759594|FG006|Overall Study|Lost to Follow-up|1|||
130217596|NCT01348100|468759588|FG000|Overall Study|Administrative Problems|0|||
130217597|NCT01348100|468759589|FG001|Overall Study|Administrative Problems|0|||
130217598|NCT01348100|468759590|FG002|Overall Study|Administrative Problems|0|||
130217599|NCT01348100|468759591|FG003|Overall Study|Administrative Problems|0|||
130217600|NCT01348100|468759592|FG004|Overall Study|Administrative Problems|0|||
130217601|NCT01348100|468759593|FG005|Overall Study|Administrative Problems|1|||
130217602|NCT01348100|468759594|FG006|Overall Study|Administrative Problems|1|||
130013354|NCT01500278|468012188|FG001|Week 13 - Week 104|False positive test|2|||
130013355|NCT01500278|468012187|FG000|Week 13 - Week 104|Sponsor request|4|||
130013356|NCT01500278|468012188|FG001|Week 13 - Week 104|Sponsor request|0|||
130013357|NCT01500278|468012187|FG000|Week 13 - Week 104|Withdrawn in error|1|||
130013358|NCT01500278|468012188|FG001|Week 13 - Week 104|Withdrawn in error|0|||
130013359|NCT01500278|468012187|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
130013360|NCT01500278|468012188|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
130217603|NCT03882957|468759597|FG000|Overall Study|Did not complete all three arms|1|||
130013361|NCT01500278|468012187|FG000|Week 13 - Week 104|Protocol deviation|1|||
130013362|NCT01500278|468012188|FG001|Week 13 - Week 104|Protocol deviation|0|||
130013363|NCT01500278|468012187|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
130013364|NCT01500278|468012188|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
130013365|NCT01500278|468012187|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
130013366|NCT01500278|468012188|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
130217604|NCT01134393|468759599|FG000|Overall Study|Adverse Event|18|||
130217605|NCT01134393|468759599|FG000|Overall Study|Lack of Efficacy|2|||
130217606|NCT01134393|468759599|FG000|Overall Study|Protocol Violation|12|||
130217607|NCT01134393|468759599|FG000|Overall Study|Lost to Follow-up|3|||
130217608|NCT01134393|468759599|FG000|Overall Study|Withdrawal by Subject|11|||
130217609|NCT01134393|468759599|FG000|Overall Study|Other|6|||
130217610|NCT03134911|468759600|FG000|Overall Study|Screen failure|31|||
130217611|NCT03134911|468759600|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
130217612|NCT02787083|468759606|FG000|Overall Study|Adverse Event|1|||
130217613|NCT02787083|468759607|FG001|Overall Study|Adverse Event|0|||
130217614|NCT02787083|468759606|FG000|Overall Study|Withdrawal by Subject|2|||
130217615|NCT02787083|468759607|FG001|Overall Study|Withdrawal by Subject|2|||
130217616|NCT02710084|468759608|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
130217617|NCT02710084|468759609|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
130217618|NCT02182830|468759610|FG000|Overall Study|Not Treated|1|||
130217619|NCT02182830|468759611|FG001|Overall Study|Not Treated|1|||
130217620|NCT02182830|468759610|FG000|Overall Study|Trial stopped, reason missing|3|||
130217621|NCT02182830|468759611|FG001|Overall Study|Trial stopped, reason missing|3|||
130217622|NCT02182830|468759610|FG000|Overall Study|Consent withdrawn|8|||
130217623|NCT02182830|468759611|FG001|Overall Study|Consent withdrawn|8|||
130217624|NCT02182830|468759610|FG000|Overall Study|Lost to Follow-up|3|||
130217625|NCT02182830|468759611|FG001|Overall Study|Lost to Follow-up|3|||
130217626|NCT00154375|468759612|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
130217627|NCT00154375|468759613|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
130217628|NCT00154375|468759612|FG000|Overall Study|Adverse Event|18|||
130217629|NCT00154375|468759613|FG001|Overall Study|Adverse Event|20|||
130217630|NCT00154375|468759612|FG000|Overall Study|Withdrawal by Subject|14|||
130217631|NCT00154375|468759613|FG001|Overall Study|Withdrawal by Subject|10|||
130217632|NCT00154375|468759612|FG000|Overall Study|Death|5|||
130217633|NCT00154375|468759613|FG001|Overall Study|Death|13|||
130217634|NCT00154375|468759612|FG000|Overall Study|Study drug no longer required|5|||
130217635|NCT00154375|468759613|FG001|Overall Study|Study drug no longer required|3|||
130217636|NCT00154375|468759612|FG000|Overall Study|Lost to Follow-up|2|||
130217637|NCT00154375|468759613|FG001|Overall Study|Lost to Follow-up|1|||
130217638|NCT00154375|468759612|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130217639|NCT00154375|468759613|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130217640|NCT00154375|468759612|FG000|Overall Study|Protocol Violation|0|||
130217641|NCT00154375|468759613|FG001|Overall Study|Protocol Violation|1|||
130217642|NCT00154375|468759612|FG000|Overall Study|Suspected progression of disease|44|||
130013367|NCT01500278|468012187|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
130013368|NCT01500278|468012188|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
130013369|NCT01500278|468012187|FG000|Week 13 - Week 104|Relocation|0|||
130013370|NCT01500278|468012188|FG001|Week 13 - Week 104|Relocation|1|||
130013371|NCT01500278|468012187|FG000|Week 13 - Week 104|Sponsor decision|0|||
130013372|NCT01500278|468012188|FG001|Week 13 - Week 104|Sponsor decision|2|||
130013373|NCT01500278|468012187|FG000|Week 13 - Week 104|Medical monitor decision|0|||
130013374|NCT01500278|468012188|FG001|Week 13 - Week 104|Medical monitor decision|2|||
130013375|NCT01500278|468012187|FG000|Week 13 - Week 104|Personal reason|0|||
130013376|NCT01500278|468012188|FG001|Week 13 - Week 104|Personal reason|1|||
130013377|NCT01500278|468012187|FG000|Week 13 - Week 104|Not completed|0|||
130013378|NCT01500278|468012188|FG001|Week 13 - Week 104|Not completed|1|||
130013379|NCT01500278|468012187|FG000|Week 13 - Week 104|Death|2|||
130013380|NCT01500278|468012188|FG001|Week 13 - Week 104|Death|4|||
130013381|NCT01500278|468012187|FG000|Week 13 - Week 104|Adverse Event|54|||
130013382|NCT01500278|468012188|FG001|Week 13 - Week 104|Adverse Event|54|||
130013383|NCT00283595|468012189|FG000|Overall Study|Withdrawal by Subject|1|||
130013384|NCT00283595|468012190|FG001|Overall Study|Withdrawal by Subject|2|||
130013385|NCT01709435|468012194|FG000|Overall Study|Adverse Event|1|||
130013386|NCT01709435|468012195|FG001|Overall Study|Adverse Event|1|||
130013387|NCT01709435|468012196|FG002|Overall Study|Adverse Event|1|||
130013388|NCT01709435|468012197|FG003|Overall Study|Adverse Event|0|||
130013389|NCT01709435|468012198|FG004|Overall Study|Adverse Event|0|||
130013390|NCT01709435|468012199|FG005|Overall Study|Adverse Event|1|||
130217643|NCT00154375|468759613|FG001|Overall Study|Suspected progression of disease|30|||
130217644|NCT02348008|468759614|FG000|Overall Study|Adverse Event|2|||
130217645|NCT02348008|468759615|FG001|Overall Study|Adverse Event|3|||
130217646|NCT02348008|468759616|FG002|Overall Study|Adverse Event|3|||
130217647|NCT02348008|468759614|FG000|Overall Study|Disease Progression|1|||
130217648|NCT02348008|468759615|FG001|Overall Study|Disease Progression|5|||
130217649|NCT02348008|468759616|FG002|Overall Study|Disease Progression|16|||
130013391|NCT01709435|468012194|FG000|Overall Study|Lack of Efficacy|5|||
130013392|NCT01709435|468012195|FG001|Overall Study|Lack of Efficacy|7|||
130013393|NCT01709435|468012196|FG002|Overall Study|Lack of Efficacy|2|||
130013394|NCT01709435|468012197|FG003|Overall Study|Lack of Efficacy|2|||
130013395|NCT01709435|468012198|FG004|Overall Study|Lack of Efficacy|6|||
130013396|NCT01709435|468012199|FG005|Overall Study|Lack of Efficacy|3|||
130013397|NCT01709435|468012194|FG000|Overall Study|Physician Decision|0|||
130013398|NCT01709435|468012195|FG001|Overall Study|Physician Decision|1|||
130013399|NCT01709435|468012196|FG002|Overall Study|Physician Decision|0|||
130013400|NCT01709435|468012197|FG003|Overall Study|Physician Decision|1|||
130013401|NCT01709435|468012198|FG004|Overall Study|Physician Decision|2|||
130013402|NCT01709435|468012199|FG005|Overall Study|Physician Decision|0|||
130013403|NCT01709435|468012194|FG000|Overall Study|Withdrawal by Subject|0|||
130013404|NCT01709435|468012195|FG001|Overall Study|Withdrawal by Subject|0|||
130013405|NCT01709435|468012196|FG002|Overall Study|Withdrawal by Subject|3|||
130013406|NCT01709435|468012197|FG003|Overall Study|Withdrawal by Subject|0|||
130013407|NCT01709435|468012198|FG004|Overall Study|Withdrawal by Subject|2|||
130013408|NCT01709435|468012199|FG005|Overall Study|Withdrawal by Subject|2|||
130013409|NCT01297270|468012203|FG000|Overall Study|Adverse Event|19|||
130013410|NCT01297270|468012204|FG001|Overall Study|Adverse Event|32|||
130013411|NCT01297270|468012205|FG002|Overall Study|Adverse Event|5|||
130013412|NCT01297270|468012203|FG000|Overall Study|Lack of Efficacy|15|||
130013413|NCT01297270|468012204|FG001|Overall Study|Lack of Efficacy|17|||
130013414|NCT01297270|468012205|FG002|Overall Study|Lack of Efficacy|15|||
130013415|NCT01297270|468012203|FG000|Overall Study|Lost to Follow-up|1|||
130013416|NCT01297270|468012204|FG001|Overall Study|Lost to Follow-up|2|||
130013417|NCT01297270|468012205|FG002|Overall Study|Lost to Follow-up|1|||
130013418|NCT01297270|468012203|FG000|Overall Study|Protocol Violation|0|||
130013419|NCT01297270|468012204|FG001|Overall Study|Protocol Violation|2|||
130013420|NCT01297270|468012205|FG002|Overall Study|Protocol Violation|0|||
130013421|NCT01297270|468012203|FG000|Overall Study|Withdrawal by Subject|7|||
130013422|NCT01297270|468012204|FG001|Overall Study|Withdrawal by Subject|15|||
130013423|NCT01297270|468012205|FG002|Overall Study|Withdrawal by Subject|7|||
130013424|NCT01297270|468012203|FG000|Overall Study|Other reason not defined above|3|||
130013425|NCT01297270|468012204|FG001|Overall Study|Other reason not defined above|3|||
130013426|NCT01297270|468012205|FG002|Overall Study|Other reason not defined above|1|||
130013427|NCT01297270|468012203|FG000|Overall Study|Not treated|0|||
130013428|NCT01297270|468012204|FG001|Overall Study|Not treated|1|||
130013429|NCT01297270|468012205|FG002|Overall Study|Not treated|0|||
130013430|NCT03882970|468012208|FG000|Overall Study|Adverse Event|5|||
130013431|NCT03882970|468012209|FG001|Overall Study|Adverse Event|7|||
130013432|NCT03882970|468012210|FG002|Overall Study|Adverse Event|3|||
130013433|NCT03882970|468012211|FG003|Overall Study|Adverse Event|1|||
130013434|NCT03882970|468012208|FG000|Overall Study|Death|1|||
130013435|NCT03882970|468012209|FG001|Overall Study|Death|2|||
130013436|NCT03882970|468012210|FG002|Overall Study|Death|1|||
130013437|NCT03882970|468012211|FG003|Overall Study|Death|1|||
130013438|NCT03882970|468012208|FG000|Overall Study|Lost to Follow-up|8|||
130013439|NCT03882970|468012209|FG001|Overall Study|Lost to Follow-up|9|||
130013440|NCT03882970|468012210|FG002|Overall Study|Lost to Follow-up|5|||
130013441|NCT03882970|468012211|FG003|Overall Study|Lost to Follow-up|5|||
130013442|NCT03882970|468012208|FG000|Overall Study|Physician Decision|0|||
130013443|NCT03882970|468012209|FG001|Overall Study|Physician Decision|2|||
130013444|NCT03882970|468012210|FG002|Overall Study|Physician Decision|2|||
130013445|NCT03882970|468012211|FG003|Overall Study|Physician Decision|2|||
130013446|NCT03882970|468012208|FG000|Overall Study|Protocol Violation|2|||
130013447|NCT03882970|468012209|FG001|Overall Study|Protocol Violation|0|||
130013448|NCT03882970|468012210|FG002|Overall Study|Protocol Violation|0|||
130013449|NCT03882970|468012211|FG003|Overall Study|Protocol Violation|0|||
130013450|NCT03882970|468012208|FG000|Overall Study|Withdrawal by Subject|8|||
130013451|NCT03882970|468012209|FG001|Overall Study|Withdrawal by Subject|17|||
130013452|NCT03882970|468012210|FG002|Overall Study|Withdrawal by Subject|7|||
130013453|NCT03882970|468012211|FG003|Overall Study|Withdrawal by Subject|22|||
130013454|NCT03882970|468012208|FG000|Overall Study|Personal Reason|2|||
130013455|NCT03882970|468012209|FG001|Overall Study|Personal Reason|3|||
130013456|NCT03882970|468012210|FG002|Overall Study|Personal Reason|1|||
130013457|NCT03882970|468012211|FG003|Overall Study|Personal Reason|3|||
130013458|NCT02863809|468012213|FG000|Overall Study|Adverse Event|8|||
130013459|NCT02863809|468012214|FG001|Overall Study|Adverse Event|8|||
130013460|NCT02863809|468012213|FG000|Overall Study|Withdrawal by Subject|0|||
130013461|NCT02863809|468012214|FG001|Overall Study|Withdrawal by Subject|1|||
130013462|NCT02863809|468012213|FG000|Overall Study|Lost to Follow-up|1|||
130013463|NCT02863809|468012214|FG001|Overall Study|Lost to Follow-up|1|||
130013464|NCT02863809|468012213|FG000|Overall Study|Death|1|||
130013465|NCT02863809|468012214|FG001|Overall Study|Death|0|||
130013466|NCT02830776|468012215|FG000|Overall Study|Lost to Follow-up|1|||
130013467|NCT03029143|468012216|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
130013468|NCT03029143|468012217|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
130013469|NCT03029143|468012218|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
130052112|NCT03952468|468147217|FG000|Overall Study|Adverse Event|0|||
130217650|NCT02348008|468759614|FG000|Overall Study|Withdrawal by Subject|0|||
130217651|NCT02348008|468759615|FG001|Overall Study|Withdrawal by Subject|1|||
130217652|NCT02348008|468759616|FG002|Overall Study|Withdrawal by Subject|0|||
130217653|NCT02348008|468759614|FG000|Overall Study|Symptomatic Deterioration|0|||
130217654|NCT02348008|468759615|FG001|Overall Study|Symptomatic Deterioration|1|||
130217655|NCT02348008|468759616|FG002|Overall Study|Symptomatic Deterioration|0|||
130217656|NCT00334295|468759621|FG000|Overall Study|Patients received fewer than 3 injection|5|||
130217657|NCT03268005|468759622|FG000|Overall Study|Death|2|||
130217658|NCT03268005|468759623|FG001|Overall Study|Death|1|||
130217659|NCT03268005|468759622|FG000|Overall Study|Lost to Follow-up|2|||
130217660|NCT03268005|468759623|FG001|Overall Study|Lost to Follow-up|2|||
130217661|NCT03268005|468759622|FG000|Overall Study|Withdrawal by Subject|11|||
130217662|NCT03268005|468759623|FG001|Overall Study|Withdrawal by Subject|11|||
130217663|NCT04378569|468761358|FG000|Overall Study|Adverse Event|0|||
130217664|NCT04378569|468761359|FG001|Overall Study|Adverse Event|0|||
130217665|NCT04378569|468761360|FG002|Overall Study|Adverse Event|2|||
130217666|NCT04378569|468761361|FG003|Overall Study|Adverse Event|0|||
130217667|NCT04378569|468761362|FG004|Overall Study|Adverse Event|3|||
130217668|NCT04378569|468761363|FG005|Overall Study|Adverse Event|3|||
130217669|NCT04378569|468761358|FG000|Overall Study|Lost to Follow-up|0|||
130217670|NCT04378569|468761359|FG001|Overall Study|Lost to Follow-up|3|||
130217671|NCT04378569|468761360|FG002|Overall Study|Lost to Follow-up|1|||
130217672|NCT04378569|468761361|FG003|Overall Study|Lost to Follow-up|0|||
130217673|NCT04378569|468761362|FG004|Overall Study|Lost to Follow-up|1|||
130217674|NCT04378569|468761363|FG005|Overall Study|Lost to Follow-up|1|||
130217675|NCT04378569|468761358|FG000|Overall Study|Protocol Violation|0|||
130217676|NCT04378569|468761359|FG001|Overall Study|Protocol Violation|0|||
130217677|NCT04378569|468761360|FG002|Overall Study|Protocol Violation|0|||
130217678|NCT04378569|468761361|FG003|Overall Study|Protocol Violation|0|||
130217679|NCT04378569|468761362|FG004|Overall Study|Protocol Violation|0|||
130217680|NCT04378569|468761363|FG005|Overall Study|Protocol Violation|1|||
130217681|NCT04378569|468761358|FG000|Overall Study|Withdrawal by Subject|0|||
130217682|NCT04378569|468761359|FG001|Overall Study|Withdrawal by Subject|6|||
130217683|NCT04378569|468761360|FG002|Overall Study|Withdrawal by Subject|7|||
130217684|NCT04378569|468761361|FG003|Overall Study|Withdrawal by Subject|4|||
130217685|NCT04378569|468761362|FG004|Overall Study|Withdrawal by Subject|5|||
130217686|NCT04378569|468761363|FG005|Overall Study|Withdrawal by Subject|4|||
130217687|NCT04378569|468761358|FG000|Overall Study|Lack of response|0|||
130217688|NCT04378569|468761359|FG001|Overall Study|Lack of response|0|||
130217689|NCT04378569|468761360|FG002|Overall Study|Lack of response|1|||
130217690|NCT04378569|468761361|FG003|Overall Study|Lack of response|0|||
130217691|NCT04378569|468761362|FG004|Overall Study|Lack of response|1|||
130217692|NCT04378569|468761363|FG005|Overall Study|Lack of response|1|||
130217693|NCT01962948|468761364|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
130217694|NCT01962948|468761365|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
130217695|NCT01962948|468761366|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
130316107|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
130013470|NCT03029143|468012216|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
130013471|NCT03029143|468012217|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
130013472|NCT03029143|468012218|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
130013473|NCT03029143|468012216|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
130013474|NCT03029143|468012217|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
130013475|NCT03029143|468012218|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
130013476|NCT03029143|468012216|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
130013477|NCT03029143|468012217|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
130013478|NCT03029143|468012218|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
130013479|NCT03029143|468012216|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
130013480|NCT03029143|468012217|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
130013481|NCT03029143|468012218|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
130013482|NCT03029143|468012216|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
130013483|NCT03029143|468012217|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
130013484|NCT03029143|468012218|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
130013485|NCT03029143|468012216|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
130013486|NCT03029143|468012217|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
130013487|NCT03029143|468012218|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
130013488|NCT03029143|468012216|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130013489|NCT03029143|468012217|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130013490|NCT03029143|468012218|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
130013491|NCT03029143|468012216|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
130013492|NCT03029143|468012217|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
130013493|NCT03029143|468012218|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
130013494|NCT03029143|468012216|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130013495|NCT03029143|468012217|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
130013496|NCT03029143|468012218|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
130013497|NCT03029143|468012216|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
130013498|NCT03029143|468012217|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
130013499|NCT03029143|468012218|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
130013500|NCT00607386|468012219|FG000|Overall Study|Physician Decision|1|||
130013501|NCT00974675|468012220|FG000|Overall Study|Adverse Event|2|||
130013502|NCT00974675|468012221|FG001|Overall Study|Adverse Event|1|||
130013503|NCT00974675|468012222|FG002|Overall Study|Adverse Event|1|||
130013504|NCT00974675|468012223|FG003|Overall Study|Adverse Event|1|||
130013505|NCT00974675|468012220|FG000|Overall Study|Physician Decision|0|||
130013506|NCT00974675|468012221|FG001|Overall Study|Physician Decision|0|||
130217696|NCT01962948|468761367|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
130013507|NCT00974675|468012222|FG002|Overall Study|Physician Decision|1|||
130013508|NCT00974675|468012223|FG003|Overall Study|Physician Decision|0|||
130013509|NCT00974675|468012220|FG000|Overall Study|Participant on holiday; unable to attend|0|||
130013510|NCT00974675|468012221|FG001|Overall Study|Participant on holiday; unable to attend|0|||
130013511|NCT00974675|468012222|FG002|Overall Study|Participant on holiday; unable to attend|0|||
130013512|NCT00974675|468012223|FG003|Overall Study|Participant on holiday; unable to attend|1|||
130013513|NCT02121262|468012226|FG000|Overall Study|Adverse Event|6|||
130013514|NCT02121262|468012227|FG001|Overall Study|Adverse Event|3|||
130013515|NCT02121262|468012226|FG000|Overall Study|Lack of Efficacy|3|||
130013516|NCT02121262|468012227|FG001|Overall Study|Lack of Efficacy|0|||
130013517|NCT02121262|468012226|FG000|Overall Study|Personal Reasons|19|||
130013518|NCT02121262|468012227|FG001|Overall Study|Personal Reasons|5|||
130217697|NCT00281697|468761372|FG000|Overall Study|> 60 days since last dose of study drug|4|||
130217698|NCT00281697|468761373|FG001|Overall Study|> 60 days since last dose of study drug|4|||
130217699|NCT00281697|468761372|FG000|Overall Study|Adverse Event|54|||
130217700|NCT00281697|468761373|FG001|Overall Study|Adverse Event|15|||
130217701|NCT00281697|468761372|FG000|Overall Study|Death|8|||
130217702|NCT00281697|468761373|FG001|Overall Study|Death|3|||
130217703|NCT00281697|468761372|FG000|Overall Study|Disease progression|279|||
130217704|NCT00281697|468761373|FG001|Overall Study|Disease progression|149|||
130217705|NCT00281697|468761372|FG000|Overall Study|Other|5|||
130217706|NCT00281697|468761373|FG001|Overall Study|Other|6|||
130217707|NCT00281697|468761372|FG000|Overall Study|Physician's decision to withdraw|15|||
130217708|NCT00281697|468761373|FG001|Overall Study|Physician's decision to withdraw|12|||
130217709|NCT00281697|468761372|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
130217710|NCT00281697|468761373|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
130217711|NCT00281697|468761372|FG000|Overall Study|Did not receive study drug|3|||
130217712|NCT00281697|468761373|FG001|Overall Study|Did not receive study drug|2|||
130217713|NCT04446429|468761374|FG000|Overall Study|Lost to Follow-up|6|||
130217714|NCT04446429|468761375|FG001|Overall Study|Lost to Follow-up|0|||
130217715|NCT02256917|468761376|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
130217716|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
130217717|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
130217718|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
130217719|NCT02256917|468761376|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
130217720|NCT01896193|468761380|FG000|Overall Study|Lack of Efficacy|20|||
130217721|NCT01896193|468761381|FG001|Overall Study|Lack of Efficacy|11|||
130217722|NCT01896193|468761380|FG000|Overall Study|Protocol Violation|0|||
130217723|NCT01896193|468761381|FG001|Overall Study|Protocol Violation|1|||
130217724|NCT01896193|468761380|FG000|Overall Study|Withdrew Consent|1|||
130217725|NCT01896193|468761381|FG001|Overall Study|Withdrew Consent|0|||
130217726|NCT01300247|468761383|FG000|Overall Study|Death|1|||
130217727|NCT01300247|468761384|FG001|Overall Study|Death|1|||
130217728|NCT01300247|468761383|FG000|Overall Study|Lost to Follow-up|2|||
130217729|NCT01300247|468761384|FG001|Overall Study|Lost to Follow-up|0|||
130217730|NCT01300247|468761383|FG000|Overall Study|Withdrawal by Subject|1|||
130217731|NCT01300247|468761384|FG001|Overall Study|Withdrawal by Subject|0|||
130217732|NCT01300247|468761383|FG000|Overall Study|Non-Compliance|0|||
130217733|NCT01300247|468761384|FG001|Overall Study|Non-Compliance|1|||
130217734|NCT05359952|468761385|FG000|Overall Study|Lost to Follow-up|1|||
130217735|NCT05359952|468761386|FG001|Overall Study|Lost to Follow-up|0|||
130217736|NCT01556932|468761387|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
130217737|NCT01556932|468761388|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
130217738|NCT02328937|468761389|FG000|Period 1|Lost to Follow-up|0|||
130217739|NCT02328937|468761390|FG001|Period 1|Lost to Follow-up|0|||
130217740|NCT02328937|468761391|FG002|Period 1|Lost to Follow-up|0|||
130217741|NCT02328937|468761392|FG003|Period 1|Lost to Follow-up|1|||
130217742|NCT02328937|468761393|FG004|Period 1|Lost to Follow-up|0|||
130217743|NCT02328937|468761394|FG005|Period 1|Lost to Follow-up|0|||
130217744|NCT02328937|468761389|FG000|Period 2|Adverse Event|0|||
130217745|NCT02328937|468761390|FG001|Period 2|Adverse Event|0|||
130217746|NCT02328937|468761391|FG002|Period 2|Adverse Event|1|||
130217747|NCT02328937|468761392|FG003|Period 2|Adverse Event|0|||
130013519|NCT02121262|468012226|FG000|Overall Study|Protocol Violation|1|||
130013520|NCT02121262|468012227|FG001|Overall Study|Protocol Violation|1|||
130013521|NCT02121262|468012226|FG000|Overall Study|Participant Dropped-out|0|||
130013522|NCT02121262|468012227|FG001|Overall Study|Participant Dropped-out|1|||
130013523|NCT02121262|468012226|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
130013524|NCT02121262|468012227|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
130013525|NCT02121262|468012226|FG000|Overall Study|Consent Withdrawn|1|||
130013526|NCT02121262|468012227|FG001|Overall Study|Consent Withdrawn|0|||
130013527|NCT02716987|468012228|FG000|Overall Study|Ligand synthesis failure|0|||
130013528|NCT02716987|468012229|FG001|Overall Study|Ligand synthesis failure|0|||
130013529|NCT02716987|468012230|FG002|Overall Study|Ligand synthesis failure|1|||
130013530|NCT02716987|468012231|FG003|Overall Study|Ligand synthesis failure|0|||
130013531|NCT02716987|468012232|FG004|Overall Study|Ligand synthesis failure|0|||
130013532|NCT02716987|468012233|FG005|Overall Study|Ligand synthesis failure|0|||
130013533|NCT02716987|468012228|FG000|Overall Study|Withdrawal by Subject|0|||
130013534|NCT02716987|468012229|FG001|Overall Study|Withdrawal by Subject|0|||
130013535|NCT02716987|468012230|FG002|Overall Study|Withdrawal by Subject|0|||
130013536|NCT02716987|468012231|FG003|Overall Study|Withdrawal by Subject|0|||
130013537|NCT02716987|468012232|FG004|Overall Study|Withdrawal by Subject|1|||
130013538|NCT02716987|468012233|FG005|Overall Study|Withdrawal by Subject|1|||
130013539|NCT02829138|468012234|FG000|Overall Study|Withdrawal by Subject|1|||
130013540|NCT02829138|468012235|FG001|Overall Study|Withdrawal by Subject|0|||
130013541|NCT01394627|468012236|FG000|First Intervention (1 Day)|poor intravenous access|0|||
130013542|NCT01394627|468012237|FG001|First Intervention (1 Day)|poor intravenous access|1|||
130013543|NCT01394627|468012236|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
130013544|NCT01394627|468012237|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
130013545|NCT01765920|468012243|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
130013546|NCT01765920|468012244|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
130013547|NCT01765920|468012243|FG000|Overall Study|Patient code disclosure|0|||
130013548|NCT01765920|468012244|FG001|Overall Study|Patient code disclosure|1|||
130013549|NCT03223428|468012245|FG000|Overall Study|No longer taking Xermelo|27|||
130013550|NCT03223428|468012245|FG000|Overall Study|Declined Consent|1|||
130347836|NCT06285240|469246791|FG001|Overall Study|Serious Adverse Event|0|||
130347837|NCT06285240|469246792|FG002|Overall Study|Serious Adverse Event|1|||
130347838|NCT06285240|469246793|FG003|Overall Study|Serious Adverse Event|0|||
130347839|NCT04428151|469246794|FG000|Overall Study|Death|100|||
130347840|NCT04428151|469246795|FG001|Overall Study|Death|86|||
130347841|NCT04428151|469246796|FG002|Overall Study|Death|57|||
130347842|NCT04428151|469246794|FG000|Overall Study|Lost to Follow-up|1|||
130347843|NCT04428151|469246795|FG001|Overall Study|Lost to Follow-up|1|||
130347844|NCT04428151|469246796|FG002|Overall Study|Lost to Follow-up|0|||
130347845|NCT04428151|469246794|FG000|Overall Study|Withdrawal by Subject|2|||
130347846|NCT04428151|469246795|FG001|Overall Study|Withdrawal by Subject|2|||
130347847|NCT04428151|469246796|FG002|Overall Study|Withdrawal by Subject|3|||
130347848|NCT04428151|469246794|FG000|Overall Study|Participant Ongoing in Study|41|||
130347849|NCT04428151|469246795|FG001|Overall Study|Participant Ongoing in Study|53|||
130347850|NCT04428151|469246796|FG002|Overall Study|Participant Ongoing in Study|28|||
130347851|NCT04844879|469246799|FG000|Overall Study|Death|1|||
130347852|NCT04844879|469246799|FG000|Overall Study|Withdrawal by Subject|1|||
130347853|NCT04844879|469246799|FG000|Overall Study|Adverse Event|1|||
130347854|NCT05214573|469246800|FG000|Overall Study|Physician Decision|5924|||
130347855|NCT05214573|469246801|FG001|Overall Study|Physician Decision|0|||
130347856|NCT06152224|469246802|FG000|Overall Study|Withdrawal by Subject|1|||
130347857|NCT06152224|469246803|FG001|Overall Study|Withdrawal by Subject|0|||
130347858|NCT06152224|469246802|FG000|Overall Study|Lost to Follow-up|0|||
130347859|NCT06152224|469246803|FG001|Overall Study|Lost to Follow-up|1|||
130347860|NCT06152224|469246802|FG000|Overall Study|On Follow Up|18|||
130347861|NCT06152224|469246803|FG001|Overall Study|On Follow Up|18|||
130347862|NCT02486718|469246810|FG000|Enrollment Phase|Death|19|||
130347863|NCT02486718|469246811|FG001|Enrollment Phase|Death|0|||
130347864|NCT02486718|469246812|FG002|Enrollment Phase|Death|0|||
130347865|NCT02486718|469246810|FG000|Enrollment Phase|Symptomatic deterioration|1|||
130347866|NCT02486718|469246811|FG001|Enrollment Phase|Symptomatic deterioration|0|||
130347867|NCT02486718|469246812|FG002|Enrollment Phase|Symptomatic deterioration|0|||
130347868|NCT02486718|469246810|FG000|Enrollment Phase|Withdrawal by Subject|86|||
130347869|NCT02486718|469246811|FG001|Enrollment Phase|Withdrawal by Subject|0|||
130347870|NCT02486718|469246812|FG002|Enrollment Phase|Withdrawal by Subject|0|||
130347871|NCT02486718|469246810|FG000|Enrollment Phase|Protocol Violation|18|||
130347872|NCT02486718|469246811|FG001|Enrollment Phase|Protocol Violation|0|||
130347873|NCT02486718|469246812|FG002|Enrollment Phase|Protocol Violation|0|||
130013551|NCT03223428|468012245|FG000|Overall Study|Non-responders|56|||
130347874|NCT02486718|469246810|FG000|Enrollment Phase|Physician Decision|18|||
130013552|NCT03223428|468012245|FG000|Overall Study|Withdrawal by Subject|14|||
130013553|NCT01081249|468012246|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
130013554|NCT01081249|468012247|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
130347875|NCT02486718|469246811|FG001|Enrollment Phase|Physician Decision|0|||
130013555|NCT02025907|468012248|FG000|Overall Study|Lack of Efficacy|1|||
130013556|NCT02025907|468012249|FG001|Overall Study|Lack of Efficacy|0|||
130013557|NCT02025907|468012248|FG000|Overall Study|Withdrawal by Subject|15|||
130013558|NCT02025907|468012249|FG001|Overall Study|Withdrawal by Subject|8|||
130013559|NCT02025907|468012248|FG000|Overall Study|Protocol Violation|2|||
130013560|NCT02025907|468012249|FG001|Overall Study|Protocol Violation|0|||
130013561|NCT02025907|468012248|FG000|Overall Study|Physician Decision|2|||
130217748|NCT02328937|468761393|FG004|Period 2|Adverse Event|0|||
129884422|NCT04012814|467536391|FG000|Overall Study|Protocol Violation|1|||
130013562|NCT02025907|468012249|FG001|Overall Study|Physician Decision|0|||
130013563|NCT02025907|468012248|FG000|Overall Study|Lost to Follow-up|2|||
130013564|NCT02025907|468012249|FG001|Overall Study|Lost to Follow-up|2|||
130013565|NCT02025907|468012248|FG000|Overall Study|Adverse Event|3|||
130013566|NCT02025907|468012249|FG001|Overall Study|Adverse Event|1|||
130013567|NCT02025907|468012248|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
130013568|NCT02025907|468012249|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
130013569|NCT02411539|468012250|FG000|Overall Study|Lost to Follow-up|2|||
130013570|NCT02411539|468012251|FG001|Overall Study|Lost to Follow-up|0|||
130013571|NCT02411539|468012250|FG000|Overall Study|Confounding medical condition|0|||
130013572|NCT02411539|468012251|FG001|Overall Study|Confounding medical condition|1|||
130013573|NCT00282334|468012252|FG000|Overall Study|Withdrawal by Subject|8|||
130013574|NCT00282334|468012253|FG001|Overall Study|Withdrawal by Subject|5|||
130013575|NCT03681119|468012255|FG000|Overall Study|No specific reason|4|||
130013576|NCT03681119|468012256|FG001|Overall Study|No specific reason|0|||
130013577|NCT03681119|468012255|FG000|Overall Study|Sickness|2|||
130013578|NCT03681119|468012256|FG001|Overall Study|Sickness|0|||
130013579|NCT04041284|468012259|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
130013580|NCT04041284|468012260|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
130013581|NCT04041284|468012259|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
130013582|NCT04041284|468012260|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
130013583|NCT04041284|468012259|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
130013584|NCT04041284|468012260|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
130013585|NCT04041284|468012259|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
130013586|NCT04041284|468012260|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
130013587|NCT04041284|468012259|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
130013588|NCT04041284|468012260|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
130013589|NCT04041284|468012259|FG000|DB Phase (12 Weeks)|Other than specified|1|||
130013590|NCT04041284|468012260|FG001|DB Phase (12 Weeks)|Other than specified|0|||
130013591|NCT04041284|468012259|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
130013592|NCT04041284|468012260|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
130013593|NCT04041284|468012259|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
130013594|NCT04041284|468012260|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
130013595|NCT04041284|468012259|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
130013596|NCT04041284|468012260|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
130013597|NCT04041284|468012259|FG000|OL Phase (12 Weeks)|Other than specified|6|||
130013598|NCT04041284|468012260|FG001|OL Phase (12 Weeks)|Other than specified|2|||
130013599|NCT00563186|468012261|FG000|Overall Study|LOS<48 hours|97|||
130013600|NCT00563186|468012262|FG001|Overall Study|LOS<48 hours|74|||
130013601|NCT00563186|468012261|FG000|Overall Study|Incomplete data|1|||
130013602|NCT00563186|468012262|FG001|Overall Study|Incomplete data|1|||
130013603|NCT00879645|468012267|FG000|Overall Study|Adverse Event|1|||
130013604|NCT00879645|468012268|FG001|Overall Study|Adverse Event|0|||
130013605|NCT00879645|468012269|FG002|Overall Study|Adverse Event|0|||
130013606|NCT00879645|468012270|FG003|Overall Study|Adverse Event|0|||
130013607|NCT03631732|468012271|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
130013608|NCT03631732|468012272|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
130013609|NCT03631732|468012271|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
130013610|NCT03631732|468012272|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
130013611|NCT03631732|468012271|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
130013612|NCT03631732|468012272|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
130013613|NCT03631732|468012271|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
130013614|NCT03631732|468012272|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
130013615|NCT03631732|468012271|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
130013616|NCT03631732|468012272|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
130013617|NCT03631732|468012271|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
130013618|NCT03631732|468012272|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
130013619|NCT03631732|468012271|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
130013620|NCT03631732|468012272|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
130013621|NCT03631732|468012271|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
130013622|NCT03631732|468012272|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
130013623|NCT03631732|468012271|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
130013624|NCT03631732|468012272|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
130013625|NCT03631732|468012271|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
130013626|NCT03631732|468012272|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
130013627|NCT00886600|468012273|FG000|Double-blind Monotherapy|Adverse Event|1|||
130013628|NCT00886600|468012274|FG001|Double-blind Monotherapy|Adverse Event|1|||
130013629|NCT00886600|468012275|FG002|Double-blind Monotherapy|Adverse Event|1|||
130013630|NCT00886600|468012276|FG003|Double-blind Monotherapy|Adverse Event|1|||
130013631|NCT00886600|468012273|FG000|Double-blind Monotherapy|Protocol Violation|0|||
130013632|NCT00886600|468012274|FG001|Double-blind Monotherapy|Protocol Violation|0|||
130013633|NCT00886600|468012275|FG002|Double-blind Monotherapy|Protocol Violation|0|||
130013634|NCT00886600|468012276|FG003|Double-blind Monotherapy|Protocol Violation|1|||
130013635|NCT00886600|468012273|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
130013636|NCT00886600|468012274|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
130013637|NCT00886600|468012275|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
130013638|NCT00886600|468012276|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
130013639|NCT00886600|468012273|FG000|Combination Therapy Period|Adverse Event|0|||
130013640|NCT00886600|468012274|FG001|Combination Therapy Period|Adverse Event|0|||
130013641|NCT00886600|468012275|FG002|Combination Therapy Period|Adverse Event|1|||
130013642|NCT00886600|468012276|FG003|Combination Therapy Period|Adverse Event|0|||
130013643|NCT00886600|468012273|FG000|Combination Therapy Period|Protocol Violation|0|||
130013644|NCT00886600|468012274|FG001|Combination Therapy Period|Protocol Violation|0|||
130013645|NCT00886600|468012275|FG002|Combination Therapy Period|Protocol Violation|1|||
130013646|NCT00886600|468012276|FG003|Combination Therapy Period|Protocol Violation|0|||
130013647|NCT01439204|468012277|FG000|Overall Study|Withdrawal by Subject|0|||
130013648|NCT01439204|468012278|FG001|Overall Study|Withdrawal by Subject|1|||
130013649|NCT01439204|468012277|FG000|Overall Study|Lost to Follow-up|0|||
130013650|NCT01439204|468012278|FG001|Overall Study|Lost to Follow-up|2|||
130013651|NCT01439204|468012277|FG000|Overall Study|No longer meets study criteria|1|||
130013652|NCT01439204|468012278|FG001|Overall Study|No longer meets study criteria|0|||
130013653|NCT01439204|468012277|FG000|Overall Study|poor/non-compliance|3|||
130013654|NCT01439204|468012278|FG001|Overall Study|poor/non-compliance|0|||
130013655|NCT04288154|468012279|FG000|Overall Study|Withdrawal by Subject|9|||
130013656|NCT04288154|468012280|FG001|Overall Study|Withdrawal by Subject|9|||
130013657|NCT02873936|468012282|FG000|Overall Study|Withdrew Consent|4|||
130013658|NCT02873936|468012283|FG001|Overall Study|Withdrew Consent|11|||
130013659|NCT02873936|468012284|FG002|Overall Study|Withdrew Consent|20|||
130013660|NCT02873936|468012282|FG000|Overall Study|Investigator's Discretion|3|||
130013661|NCT02873936|468012283|FG001|Overall Study|Investigator's Discretion|5|||
130013662|NCT02873936|468012284|FG002|Overall Study|Investigator's Discretion|4|||
130013663|NCT02873936|468012282|FG000|Overall Study|Adverse Event|3|||
130013664|NCT02873936|468012283|FG001|Overall Study|Adverse Event|5|||
130013665|NCT02873936|468012284|FG002|Overall Study|Adverse Event|3|||
130347876|NCT02486718|469246812|FG002|Enrollment Phase|Physician Decision|0|||
130347877|NCT02486718|469246810|FG000|Enrollment Phase|Reason not provided|41|||
130347878|NCT02486718|469246811|FG001|Enrollment Phase|Reason not provided|0|||
130347879|NCT02486718|469246812|FG002|Enrollment Phase|Reason not provided|0|||
130347880|NCT02486718|469246810|FG000|Enrollment Phase|Disease relapse|54|||
130347881|NCT02486718|469246811|FG001|Enrollment Phase|Disease relapse|0|||
130347882|NCT02486718|469246812|FG002|Enrollment Phase|Disease relapse|0|||
130347883|NCT02486718|469246810|FG000|Enrollment Phase|Lost to Follow-up|4|||
130347884|NCT02486718|469246811|FG001|Enrollment Phase|Lost to Follow-up|0|||
130347885|NCT02486718|469246812|FG002|Enrollment Phase|Lost to Follow-up|0|||
130347886|NCT02486718|469246810|FG000|Enrollment Phase|Adverse Event|34|||
130347887|NCT02486718|469246811|FG001|Enrollment Phase|Adverse Event|0|||
130347888|NCT02486718|469246812|FG002|Enrollment Phase|Adverse Event|0|||
130347889|NCT02486718|469246810|FG000|Randomized Phase|Withdrawal by Subject|0|||
130347890|NCT02486718|469246811|FG001|Randomized Phase|Withdrawal by Subject|44|||
130347891|NCT02486718|469246812|FG002|Randomized Phase|Withdrawal by Subject|47|||
130347892|NCT02486718|469246810|FG000|Randomized Phase|Protocol Violation|0|||
130347893|NCT02486718|469246811|FG001|Randomized Phase|Protocol Violation|2|||
130347894|NCT02486718|469246812|FG002|Randomized Phase|Protocol Violation|0|||
130347895|NCT02486718|469246810|FG000|Randomized Phase|Physician Decision|0|||
130347896|NCT02486718|469246811|FG001|Randomized Phase|Physician Decision|0|||
130347897|NCT02486718|469246812|FG002|Randomized Phase|Physician Decision|3|||
130347898|NCT02486718|469246810|FG000|Randomized Phase|Lost to Follow-up|0|||
130347899|NCT02486718|469246811|FG001|Randomized Phase|Lost to Follow-up|5|||
130347900|NCT02486718|469246812|FG002|Randomized Phase|Lost to Follow-up|11|||
130347901|NCT02486718|469246810|FG000|Randomized Phase|Disease Relapse|0|||
130347902|NCT02486718|469246811|FG001|Randomized Phase|Disease Relapse|1|||
130347903|NCT02486718|469246812|FG002|Randomized Phase|Disease Relapse|0|||
130347904|NCT02486718|469246810|FG000|Randomized Phase|Death|0|||
130347905|NCT02486718|469246811|FG001|Randomized Phase|Death|154|||
130347906|NCT02486718|469246812|FG002|Randomized Phase|Death|155|||
130013666|NCT02873936|468012282|FG000|Overall Study|Protocol Violation|0|||
130347907|NCT02486718|469246810|FG000|Randomized Phase|Ongoing|0|||
130347908|NCT02486718|469246811|FG001|Randomized Phase|Ongoing|301|||
130347909|NCT02486718|469246812|FG002|Randomized Phase|Ongoing|282|||
130347910|NCT04201262|469246814|FG000|Primary Treatment Period|Adverse Event|1|||
130347911|NCT04201262|469246815|FG001|Primary Treatment Period|Adverse Event|2|||
130347912|NCT04201262|469246814|FG000|Primary Treatment Period|Physician Decision|1|||
130217749|NCT02328937|468761394|FG005|Period 2|Adverse Event|0|||
130217750|NCT00996034|468761397|FG000|Overall Study|Lost to Follow-up|2|||
130217751|NCT00996034|468761397|FG000|Overall Study|withdrawn by PI|1|||
130217752|NCT03231306|468761398|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
130217753|NCT03231306|468761398|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
130217754|NCT03231306|468761398|FG000|Overall Study|Treatment delay > 21 days|2|||
130217755|NCT03231306|468761398|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
130217756|NCT03231306|468761398|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
130217757|NCT03231306|468761398|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
130217758|NCT03231306|468761398|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
130217759|NCT03231306|468761398|FG000|Overall Study|More than 1 Reason|2|||
130217760|NCT00685360|468761399|FG000|Overall Study|Lost to Follow-up|0|||
130217761|NCT00685360|468761400|FG001|Overall Study|Lost to Follow-up|1|||
130217762|NCT00685360|468761401|FG002|Overall Study|Lost to Follow-up|2|||
130217763|NCT00685360|468761399|FG000|Overall Study|Adverse Event|4|||
130217764|NCT00685360|468761400|FG001|Overall Study|Adverse Event|6|||
130217765|NCT00685360|468761401|FG002|Overall Study|Adverse Event|4|||
130217766|NCT00685360|468761399|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
130217767|NCT00685360|468761400|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
130217768|NCT00685360|468761401|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
130217769|NCT00685360|468761399|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
130347913|NCT04201262|469246815|FG001|Primary Treatment Period|Physician Decision|1|||
130013667|NCT02873936|468012283|FG001|Overall Study|Protocol Violation|1|||
130013668|NCT02873936|468012284|FG002|Overall Study|Protocol Violation|3|||
130013669|NCT02873936|468012282|FG000|Overall Study|Lost to Follow-up|1|||
130013670|NCT02873936|468012283|FG001|Overall Study|Lost to Follow-up|1|||
130013671|NCT02873936|468012284|FG002|Overall Study|Lost to Follow-up|1|||
130013672|NCT02873936|468012282|FG000|Overall Study|Non-compliance With Study Drug|1|||
130013673|NCT02873936|468012283|FG001|Overall Study|Non-compliance With Study Drug|0|||
130013674|NCT02873936|468012284|FG002|Overall Study|Non-compliance With Study Drug|1|||
130013675|NCT02873936|468012282|FG000|Overall Study|Randomized but not Dosed|1|||
130013676|NCT02873936|468012283|FG001|Overall Study|Randomized but not Dosed|0|||
130013677|NCT02873936|468012284|FG002|Overall Study|Randomized but not Dosed|0|||
130013678|NCT00754793|468012286|FG000|Overall Study|voluntary withdrawn from study|0|||
130013679|NCT00754793|468012287|FG001|Overall Study|voluntary withdrawn from study|1|||
130013680|NCT02943564|468012288|FG000|Overall Study|Miscellaneous Reasons|0|||
130013681|NCT02943564|468012289|FG001|Overall Study|Miscellaneous Reasons|0|||
130013682|NCT02943564|468012290|FG002|Overall Study|Miscellaneous Reasons|3|||
130013683|NCT02943564|468012288|FG000|Overall Study|Site terminated by sponsor|0|||
130013684|NCT02943564|468012289|FG001|Overall Study|Site terminated by sponsor|1|||
130013685|NCT02943564|468012290|FG002|Overall Study|Site terminated by sponsor|0|||
130013686|NCT02943564|468012288|FG000|Overall Study|Non-compliance with study drug|0|||
130013687|NCT02943564|468012289|FG001|Overall Study|Non-compliance with study drug|1|||
130013688|NCT02943564|468012290|FG002|Overall Study|Non-compliance with study drug|0|||
130013689|NCT02943564|468012288|FG000|Overall Study|Pregnancy|0|||
130013690|NCT02943564|468012289|FG001|Overall Study|Pregnancy|1|||
130013691|NCT02943564|468012290|FG002|Overall Study|Pregnancy|1|||
130013692|NCT02943564|468012288|FG000|Overall Study|Protocol Violation|2|||
130013693|NCT02943564|468012289|FG001|Overall Study|Protocol Violation|2|||
130013694|NCT02943564|468012290|FG002|Overall Study|Protocol Violation|2|||
130013695|NCT02943564|468012288|FG000|Overall Study|Lost to Follow-up|1|||
130013696|NCT02943564|468012289|FG001|Overall Study|Lost to Follow-up|0|||
130013697|NCT02943564|468012290|FG002|Overall Study|Lost to Follow-up|0|||
130013698|NCT02943564|468012288|FG000|Overall Study|Withdrawal by Subject|6|||
130013699|NCT02943564|468012289|FG001|Overall Study|Withdrawal by Subject|5|||
130013700|NCT02943564|468012290|FG002|Overall Study|Withdrawal by Subject|2|||
130013701|NCT02943564|468012288|FG000|Overall Study|Adverse Event|1|||
130013702|NCT02943564|468012289|FG001|Overall Study|Adverse Event|2|||
130013703|NCT02943564|468012290|FG002|Overall Study|Adverse Event|1|||
130013704|NCT02943564|468012288|FG000|Overall Study|Lack of Efficacy|0|||
130013705|NCT02943564|468012289|FG001|Overall Study|Lack of Efficacy|1|||
130013706|NCT02943564|468012290|FG002|Overall Study|Lack of Efficacy|0|||
130013707|NCT01073267|468012294|FG000|Overall Study|Disease Progression|3|||
130013708|NCT01225731|468012295|FG000|Part 1|Did not meet eligibility criteria|1|||
130013709|NCT01225731|468012296|FG001|Part 1|Did not meet eligibility criteria|0|||
130013710|NCT01225731|468012297|FG002|Part 1|Did not meet eligibility criteria|0|||
130013711|NCT01225731|468012298|FG003|Part 1|Did not meet eligibility criteria|0|||
130013712|NCT01225731|468012299|FG004|Part 1|Did not meet eligibility criteria|1|||
130013713|NCT01225731|468012300|FG005|Part 1|Did not meet eligibility criteria|0|||
130013714|NCT01225731|468012301|FG006|Part 1|Did not meet eligibility criteria|0|||
130013715|NCT01225731|468012302|FG007|Part 1|Did not meet eligibility criteria|0|||
130013716|NCT01225731|468012303|FG008|Part 1|Did not meet eligibility criteria|0|||
130013717|NCT01225731|468012304|FG009|Part 1|Did not meet eligibility criteria|0|||
130013718|NCT01225731|468012305|FG010|Part 1|Did not meet eligibility criteria|0|||
130013719|NCT01225731|468012306|FG011|Part 1|Did not meet eligibility criteria|0|||
130013720|NCT01225731|468012307|FG012|Part 1|Did not meet eligibility criteria|0|||
130013721|NCT01225731|468012295|FG000|Part 1|Adverse Event|1|||
130013722|NCT01225731|468012296|FG001|Part 1|Adverse Event|2|||
130013723|NCT01225731|468012297|FG002|Part 1|Adverse Event|1|||
130013724|NCT01225731|468012298|FG003|Part 1|Adverse Event|1|||
130013725|NCT01225731|468012299|FG004|Part 1|Adverse Event|1|||
130013726|NCT01225731|468012300|FG005|Part 1|Adverse Event|0|||
130013727|NCT01225731|468012301|FG006|Part 1|Adverse Event|0|||
130013728|NCT01225731|468012302|FG007|Part 1|Adverse Event|0|||
130013729|NCT01225731|468012303|FG008|Part 1|Adverse Event|0|||
130013730|NCT01225731|468012304|FG009|Part 1|Adverse Event|0|||
130013731|NCT01225731|468012305|FG010|Part 1|Adverse Event|0|||
130013732|NCT01225731|468012306|FG011|Part 1|Adverse Event|0|||
130013733|NCT01225731|468012307|FG012|Part 1|Adverse Event|0|||
130013734|NCT01225731|468012295|FG000|Part 1|Withdrawal by Subject|0|||
130013735|NCT01225731|468012296|FG001|Part 1|Withdrawal by Subject|3|||
130013736|NCT01225731|468012297|FG002|Part 1|Withdrawal by Subject|0|||
130013737|NCT01225731|468012298|FG003|Part 1|Withdrawal by Subject|0|||
130013738|NCT01225731|468012299|FG004|Part 1|Withdrawal by Subject|4|||
130217770|NCT00685360|468761400|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
130217771|NCT00685360|468761401|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
130217772|NCT00685360|468761399|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
130217773|NCT00685360|468761400|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
130217774|NCT00685360|468761401|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
130217775|NCT00685360|468761399|FG000|Overall Study|Protocol Deviation|0|||
130217776|NCT00685360|468761400|FG001|Overall Study|Protocol Deviation|1|||
130013739|NCT01225731|468012300|FG005|Part 1|Withdrawal by Subject|0|||
130013740|NCT01225731|468012301|FG006|Part 1|Withdrawal by Subject|0|||
130013741|NCT01225731|468012302|FG007|Part 1|Withdrawal by Subject|0|||
130217777|NCT00685360|468761401|FG002|Overall Study|Protocol Deviation|1|||
130013742|NCT01225731|468012303|FG008|Part 1|Withdrawal by Subject|0|||
130013743|NCT01225731|468012304|FG009|Part 1|Withdrawal by Subject|0|||
130217778|NCT04865419|468761402|FG000|Overall Study|Other|1|||
130217779|NCT04865419|468761403|FG001|Overall Study|Other|2|||
130217780|NCT04865419|468761404|FG002|Overall Study|Other|2|||
130217781|NCT04865419|468761405|FG003|Overall Study|Other|1|||
130217782|NCT04865419|468761406|FG004|Overall Study|Other|3|||
130013744|NCT01225731|468012305|FG010|Part 1|Withdrawal by Subject|0|||
130013745|NCT01225731|468012306|FG011|Part 1|Withdrawal by Subject|0|||
130013746|NCT01225731|468012307|FG012|Part 1|Withdrawal by Subject|0|||
130217783|NCT04865419|468761407|FG005|Overall Study|Other|0|||
130217784|NCT04865419|468761408|FG006|Overall Study|Other|0|||
130217785|NCT04865419|468761409|FG007|Overall Study|Other|1|||
130217786|NCT04865419|468761410|FG008|Overall Study|Other|0|||
130217787|NCT04865419|468761411|FG009|Overall Study|Other|0|||
130217788|NCT04865419|468761412|FG010|Overall Study|Other|0|||
130217789|NCT04865419|468761402|FG000|Overall Study|Withdrawal by Subject|0|||
130217790|NCT04865419|468761403|FG001|Overall Study|Withdrawal by Subject|1|||
130217791|NCT04865419|468761404|FG002|Overall Study|Withdrawal by Subject|1|||
130217792|NCT04865419|468761405|FG003|Overall Study|Withdrawal by Subject|0|||
130217793|NCT04865419|468761406|FG004|Overall Study|Withdrawal by Subject|0|||
130217794|NCT04865419|468761407|FG005|Overall Study|Withdrawal by Subject|0|||
130217795|NCT04865419|468761408|FG006|Overall Study|Withdrawal by Subject|0|||
130217796|NCT04865419|468761409|FG007|Overall Study|Withdrawal by Subject|1|||
130217797|NCT04865419|468761410|FG008|Overall Study|Withdrawal by Subject|2|||
130217798|NCT04865419|468761411|FG009|Overall Study|Withdrawal by Subject|1|||
130347914|NCT04201262|469246814|FG000|Long-term Extension Period|Death|1|||
130347915|NCT04201262|469246815|FG001|Long-term Extension Period|Death|0|||
130347916|NCT04803214|469246816|FG000|Overall Study|Adverse Event|1|||
130347917|NCT04803214|469246817|FG001|Overall Study|Adverse Event|0|||
130347918|NCT04803214|469246816|FG000|Overall Study|Withdrawal by Subject|1|||
130347919|NCT04803214|469246817|FG001|Overall Study|Withdrawal by Subject|2|||
130347920|NCT04803214|469246816|FG000|Overall Study|Lost to Follow-up|2|||
130347921|NCT04803214|469246817|FG001|Overall Study|Lost to Follow-up|4|||
130347922|NCT04803214|469246816|FG000|Overall Study|Physician Decision|1|||
130347923|NCT04803214|469246817|FG001|Overall Study|Physician Decision|1|||
130347924|NCT04803214|469246816|FG000|Overall Study|Missed 12 month visit|0|||
130347925|NCT04803214|469246817|FG001|Overall Study|Missed 12 month visit|3|||
130347926|NCT03307785|469246818|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
130347927|NCT03307785|469246819|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
130347928|NCT03307785|469246820|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
130347929|NCT03307785|469246821|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
130347930|NCT03307785|469246822|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
130347931|NCT03307785|469246823|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
130013747|NCT01225731|468012295|FG000|Part 1|Protocol Violation|0|||
130013748|NCT01225731|468012296|FG001|Part 1|Protocol Violation|0|||
130013749|NCT01225731|468012297|FG002|Part 1|Protocol Violation|0|||
130013750|NCT01225731|468012298|FG003|Part 1|Protocol Violation|1|||
130013751|NCT01225731|468012299|FG004|Part 1|Protocol Violation|0|||
130013752|NCT01225731|468012300|FG005|Part 1|Protocol Violation|0|||
130013753|NCT01225731|468012301|FG006|Part 1|Protocol Violation|0|||
130013754|NCT01225731|468012302|FG007|Part 1|Protocol Violation|0|||
130013755|NCT01225731|468012303|FG008|Part 1|Protocol Violation|0|||
130013756|NCT01225731|468012304|FG009|Part 1|Protocol Violation|0|||
130013757|NCT01225731|468012305|FG010|Part 1|Protocol Violation|0|||
130013758|NCT01225731|468012306|FG011|Part 1|Protocol Violation|0|||
130013759|NCT01225731|468012307|FG012|Part 1|Protocol Violation|0|||
130013760|NCT01225731|468012295|FG000|Part 2|Protocol Violation|0|||
130013761|NCT01225731|468012296|FG001|Part 2|Protocol Violation|0|||
130013762|NCT01225731|468012297|FG002|Part 2|Protocol Violation|0|||
130013763|NCT01225731|468012298|FG003|Part 2|Protocol Violation|0|||
130013764|NCT01225731|468012299|FG004|Part 2|Protocol Violation|0|||
130013765|NCT01225731|468012300|FG005|Part 2|Protocol Violation|1|||
130013766|NCT01225731|468012301|FG006|Part 2|Protocol Violation|0|||
130217799|NCT04865419|468761412|FG010|Overall Study|Withdrawal by Subject|0|||
130013767|NCT01225731|468012302|FG007|Part 2|Protocol Violation|0|||
130013768|NCT01225731|468012303|FG008|Part 2|Protocol Violation|1|||
130013769|NCT01225731|468012304|FG009|Part 2|Protocol Violation|0|||
130013770|NCT01225731|468012305|FG010|Part 2|Protocol Violation|0|||
130013771|NCT01225731|468012306|FG011|Part 2|Protocol Violation|0|||
130013772|NCT01225731|468012307|FG012|Part 2|Protocol Violation|0|||
130013773|NCT01225731|468012295|FG000|Part 2|Adverse Event|0|||
130013774|NCT01225731|468012296|FG001|Part 2|Adverse Event|0|||
130013775|NCT01225731|468012297|FG002|Part 2|Adverse Event|0|||
130013776|NCT01225731|468012298|FG003|Part 2|Adverse Event|0|||
130013777|NCT01225731|468012299|FG004|Part 2|Adverse Event|0|||
130013778|NCT01225731|468012300|FG005|Part 2|Adverse Event|0|||
130013779|NCT01225731|468012301|FG006|Part 2|Adverse Event|4|||
130013780|NCT01225731|468012302|FG007|Part 2|Adverse Event|4|||
130013781|NCT01225731|468012303|FG008|Part 2|Adverse Event|2|||
130013782|NCT01225731|468012304|FG009|Part 2|Adverse Event|0|||
130013783|NCT01225731|468012305|FG010|Part 2|Adverse Event|0|||
130013784|NCT01225731|468012306|FG011|Part 2|Adverse Event|0|||
130013785|NCT01225731|468012307|FG012|Part 2|Adverse Event|0|||
130013786|NCT01225731|468012295|FG000|Part 2|Lack of Efficacy|0|||
130013787|NCT01225731|468012296|FG001|Part 2|Lack of Efficacy|0|||
130013788|NCT01225731|468012297|FG002|Part 2|Lack of Efficacy|0|||
130013789|NCT01225731|468012298|FG003|Part 2|Lack of Efficacy|0|||
130013790|NCT01225731|468012299|FG004|Part 2|Lack of Efficacy|0|||
130013791|NCT01225731|468012300|FG005|Part 2|Lack of Efficacy|1|||
130013792|NCT01225731|468012301|FG006|Part 2|Lack of Efficacy|0|||
130013793|NCT01225731|468012302|FG007|Part 2|Lack of Efficacy|12|||
130013794|NCT01225731|468012303|FG008|Part 2|Lack of Efficacy|3|||
130013795|NCT01225731|468012304|FG009|Part 2|Lack of Efficacy|0|||
130013796|NCT01225731|468012305|FG010|Part 2|Lack of Efficacy|0|||
130013797|NCT01225731|468012306|FG011|Part 2|Lack of Efficacy|0|||
130013798|NCT01225731|468012307|FG012|Part 2|Lack of Efficacy|0|||
130013799|NCT01225731|468012295|FG000|Part 2|Pregnancy|0|||
130013800|NCT01225731|468012296|FG001|Part 2|Pregnancy|0|||
130013801|NCT01225731|468012297|FG002|Part 2|Pregnancy|0|||
130013802|NCT01225731|468012298|FG003|Part 2|Pregnancy|0|||
130013803|NCT01225731|468012299|FG004|Part 2|Pregnancy|0|||
130013804|NCT01225731|468012300|FG005|Part 2|Pregnancy|0|||
130013805|NCT01225731|468012301|FG006|Part 2|Pregnancy|1|||
130013806|NCT01225731|468012302|FG007|Part 2|Pregnancy|0|||
130013807|NCT01225731|468012303|FG008|Part 2|Pregnancy|1|||
130013808|NCT01225731|468012304|FG009|Part 2|Pregnancy|0|||
130013809|NCT01225731|468012305|FG010|Part 2|Pregnancy|0|||
130013810|NCT01225731|468012306|FG011|Part 2|Pregnancy|0|||
130013811|NCT01225731|468012307|FG012|Part 2|Pregnancy|0|||
130013812|NCT01225731|468012295|FG000|Part 2|Lost to Follow-up|0|||
130013813|NCT01225731|468012296|FG001|Part 2|Lost to Follow-up|0|||
130013814|NCT01225731|468012297|FG002|Part 2|Lost to Follow-up|0|||
130013815|NCT01225731|468012298|FG003|Part 2|Lost to Follow-up|0|||
130013816|NCT01225731|468012299|FG004|Part 2|Lost to Follow-up|0|||
130013817|NCT01225731|468012300|FG005|Part 2|Lost to Follow-up|0|||
130013818|NCT01225731|468012301|FG006|Part 2|Lost to Follow-up|0|||
130013819|NCT01225731|468012302|FG007|Part 2|Lost to Follow-up|3|||
130013820|NCT01225731|468012303|FG008|Part 2|Lost to Follow-up|1|||
130013821|NCT01225731|468012304|FG009|Part 2|Lost to Follow-up|0|||
130013822|NCT01225731|468012305|FG010|Part 2|Lost to Follow-up|0|||
130013823|NCT01225731|468012306|FG011|Part 2|Lost to Follow-up|0|||
130013824|NCT01225731|468012307|FG012|Part 2|Lost to Follow-up|0|||
130013825|NCT01225731|468012295|FG000|Part 2|Physician Decision|0|||
130013826|NCT01225731|468012296|FG001|Part 2|Physician Decision|0|||
130013827|NCT01225731|468012297|FG002|Part 2|Physician Decision|0|||
130013828|NCT01225731|468012298|FG003|Part 2|Physician Decision|0|||
130013829|NCT01225731|468012299|FG004|Part 2|Physician Decision|0|||
130013830|NCT01225731|468012300|FG005|Part 2|Physician Decision|0|||
130013831|NCT01225731|468012301|FG006|Part 2|Physician Decision|0|||
130013832|NCT01225731|468012302|FG007|Part 2|Physician Decision|2|||
130013833|NCT01225731|468012303|FG008|Part 2|Physician Decision|2|||
130013834|NCT01225731|468012304|FG009|Part 2|Physician Decision|0|||
130013835|NCT01225731|468012305|FG010|Part 2|Physician Decision|0|||
130013836|NCT01225731|468012306|FG011|Part 2|Physician Decision|0|||
130013837|NCT01225731|468012307|FG012|Part 2|Physician Decision|0|||
130013838|NCT01225731|468012295|FG000|Part 2|Withdrawal by Subject|0|||
130013839|NCT01225731|468012296|FG001|Part 2|Withdrawal by Subject|0|||
130013840|NCT01225731|468012297|FG002|Part 2|Withdrawal by Subject|0|||
130013841|NCT01225731|468012298|FG003|Part 2|Withdrawal by Subject|0|||
130013842|NCT01225731|468012299|FG004|Part 2|Withdrawal by Subject|0|||
130013843|NCT01225731|468012300|FG005|Part 2|Withdrawal by Subject|1|||
130013844|NCT01225731|468012301|FG006|Part 2|Withdrawal by Subject|3|||
130013845|NCT01225731|468012302|FG007|Part 2|Withdrawal by Subject|4|||
130013846|NCT01225731|468012303|FG008|Part 2|Withdrawal by Subject|1|||
130013847|NCT01225731|468012304|FG009|Part 2|Withdrawal by Subject|0|||
130013848|NCT01225731|468012305|FG010|Part 2|Withdrawal by Subject|0|||
130013849|NCT01225731|468012306|FG011|Part 2|Withdrawal by Subject|0|||
130013850|NCT01225731|468012307|FG012|Part 2|Withdrawal by Subject|0|||
130013851|NCT01225731|468012295|FG000|Part 3|Adverse Event|0|||
130013852|NCT01225731|468012296|FG001|Part 3|Adverse Event|0|||
130013853|NCT01225731|468012297|FG002|Part 3|Adverse Event|0|||
130013854|NCT01225731|468012298|FG003|Part 3|Adverse Event|0|||
130013855|NCT01225731|468012299|FG004|Part 3|Adverse Event|0|||
130013856|NCT01225731|468012300|FG005|Part 3|Adverse Event|0|||
130013857|NCT01225731|468012301|FG006|Part 3|Adverse Event|0|||
130013858|NCT01225731|468012302|FG007|Part 3|Adverse Event|0|||
130013859|NCT01225731|468012303|FG008|Part 3|Adverse Event|0|||
130013860|NCT01225731|468012304|FG009|Part 3|Adverse Event|0|||
130013861|NCT01225731|468012305|FG010|Part 3|Adverse Event|1|||
130013862|NCT01225731|468012306|FG011|Part 3|Adverse Event|1|||
130013863|NCT01225731|468012307|FG012|Part 3|Adverse Event|0|||
130013864|NCT01225731|468012295|FG000|Part 3|Lost to Follow-up|0|||
130013865|NCT01225731|468012296|FG001|Part 3|Lost to Follow-up|0|||
130013866|NCT01225731|468012297|FG002|Part 3|Lost to Follow-up|0|||
130013867|NCT01225731|468012298|FG003|Part 3|Lost to Follow-up|0|||
130013868|NCT01225731|468012299|FG004|Part 3|Lost to Follow-up|0|||
130013869|NCT01225731|468012300|FG005|Part 3|Lost to Follow-up|0|||
130013870|NCT01225731|468012301|FG006|Part 3|Lost to Follow-up|0|||
130013871|NCT01225731|468012302|FG007|Part 3|Lost to Follow-up|0|||
130013872|NCT01225731|468012303|FG008|Part 3|Lost to Follow-up|0|||
130013873|NCT01225731|468012304|FG009|Part 3|Lost to Follow-up|0|||
130013874|NCT01225731|468012305|FG010|Part 3|Lost to Follow-up|1|||
130013875|NCT01225731|468012306|FG011|Part 3|Lost to Follow-up|2|||
130013876|NCT01225731|468012307|FG012|Part 3|Lost to Follow-up|1|||
130013877|NCT01225731|468012295|FG000|Part 3|Physician Decision|0|||
130013878|NCT01225731|468012296|FG001|Part 3|Physician Decision|0|||
130013879|NCT01225731|468012297|FG002|Part 3|Physician Decision|0|||
130013880|NCT01225731|468012298|FG003|Part 3|Physician Decision|0|||
130013881|NCT01225731|468012299|FG004|Part 3|Physician Decision|0|||
130013882|NCT01225731|468012300|FG005|Part 3|Physician Decision|0|||
130013883|NCT01225731|468012301|FG006|Part 3|Physician Decision|0|||
130013884|NCT01225731|468012302|FG007|Part 3|Physician Decision|0|||
130013885|NCT01225731|468012303|FG008|Part 3|Physician Decision|0|||
130013886|NCT01225731|468012304|FG009|Part 3|Physician Decision|0|||
130013887|NCT01225731|468012305|FG010|Part 3|Physician Decision|0|||
130013888|NCT01225731|468012306|FG011|Part 3|Physician Decision|1|||
130013889|NCT01225731|468012307|FG012|Part 3|Physician Decision|2|||
130013890|NCT01225731|468012295|FG000|Part 3|Withdrawal by Subject|0|||
130013891|NCT01225731|468012296|FG001|Part 3|Withdrawal by Subject|0|||
130013892|NCT01225731|468012297|FG002|Part 3|Withdrawal by Subject|0|||
130013893|NCT01225731|468012298|FG003|Part 3|Withdrawal by Subject|0|||
130013894|NCT01225731|468012299|FG004|Part 3|Withdrawal by Subject|0|||
130013895|NCT01225731|468012300|FG005|Part 3|Withdrawal by Subject|0|||
130013896|NCT01225731|468012301|FG006|Part 3|Withdrawal by Subject|0|||
130013897|NCT01225731|468012302|FG007|Part 3|Withdrawal by Subject|0|||
130013898|NCT01225731|468012303|FG008|Part 3|Withdrawal by Subject|0|||
130013899|NCT01225731|468012304|FG009|Part 3|Withdrawal by Subject|0|||
130347932|NCT03307785|469246824|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
130347933|NCT03307785|469246825|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
130347934|NCT03307785|469246826|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
130347935|NCT03307785|469246827|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
130347936|NCT03307785|469246828|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
130347937|NCT03307785|469246818|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
130347938|NCT03307785|469246819|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
130347939|NCT03307785|469246820|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347940|NCT03307785|469246821|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347941|NCT03307785|469246822|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347942|NCT03307785|469246823|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347943|NCT03307785|469246824|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347944|NCT03307785|469246825|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347945|NCT03307785|469246826|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347946|NCT03307785|469246827|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347947|NCT03307785|469246828|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
130347948|NCT03307785|469246818|FG000|Part A: Up to 28.5 Months|Death|4|||
130347949|NCT03307785|469246819|FG001|Part A: Up to 28.5 Months|Death|4|||
130347950|NCT03307785|469246820|FG002|Part A: Up to 28.5 Months|Death|0|||
130347951|NCT03307785|469246821|FG003|Part A: Up to 28.5 Months|Death|0|||
130347952|NCT03307785|469246822|FG004|Part A: Up to 28.5 Months|Death|0|||
130347953|NCT03307785|469246823|FG005|Part A: Up to 28.5 Months|Death|0|||
130347954|NCT03307785|469246824|FG006|Part A: Up to 28.5 Months|Death|0|||
130347955|NCT03307785|469246825|FG007|Part A: Up to 28.5 Months|Death|0|||
130347956|NCT03307785|469246826|FG008|Part A: Up to 28.5 Months|Death|0|||
130347957|NCT03307785|469246827|FG009|Part A: Up to 28.5 Months|Death|0|||
130347958|NCT03307785|469246828|FG010|Part A: Up to 28.5 Months|Death|0|||
130347959|NCT03307785|469246818|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
130347960|NCT03307785|469246819|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
130013900|NCT01225731|468012305|FG010|Part 3|Withdrawal by Subject|4|||
130013901|NCT01225731|468012306|FG011|Part 3|Withdrawal by Subject|6|||
130013902|NCT01225731|468012307|FG012|Part 3|Withdrawal by Subject|4|||
130013903|NCT00577642|468012308|FG000|Overall Study|Clinical Disease Progression|1|||
130013904|NCT00917150|468012313|FG000|Overall Study|Adverse Event|12|||
130013905|NCT00917150|468012314|FG001|Overall Study|Adverse Event|7|||
130013906|NCT00917150|468012315|FG002|Overall Study|Adverse Event|12|||
130013907|NCT00917150|468012316|FG003|Overall Study|Adverse Event|11|||
130013908|NCT00917150|468012313|FG000|Overall Study|Death|1|||
130013909|NCT00917150|468012314|FG001|Overall Study|Death|4|||
130013910|NCT00917150|468012315|FG002|Overall Study|Death|3|||
130013911|NCT00917150|468012316|FG003|Overall Study|Death|2|||
130013912|NCT00917150|468012313|FG000|Overall Study|Lost to Follow-up|1|||
130013913|NCT00917150|468012314|FG001|Overall Study|Lost to Follow-up|0|||
130013914|NCT00917150|468012315|FG002|Overall Study|Lost to Follow-up|4|||
130013915|NCT00917150|468012316|FG003|Overall Study|Lost to Follow-up|2|||
130013916|NCT00917150|468012313|FG000|Overall Study|Physician Decision|0|||
130013917|NCT00917150|468012314|FG001|Overall Study|Physician Decision|2|||
130013918|NCT00917150|468012315|FG002|Overall Study|Physician Decision|0|||
130013919|NCT00917150|468012316|FG003|Overall Study|Physician Decision|1|||
130013920|NCT00917150|468012313|FG000|Overall Study|Protocol Violation|5|||
130013921|NCT00917150|468012314|FG001|Overall Study|Protocol Violation|5|||
130013922|NCT00917150|468012315|FG002|Overall Study|Protocol Violation|3|||
130013923|NCT00917150|468012316|FG003|Overall Study|Protocol Violation|5|||
130013924|NCT00917150|468012313|FG000|Overall Study|Withdrawal by Subject|15|||
130013925|NCT00917150|468012314|FG001|Overall Study|Withdrawal by Subject|16|||
130013926|NCT00917150|468012315|FG002|Overall Study|Withdrawal by Subject|18|||
130013927|NCT00917150|468012316|FG003|Overall Study|Withdrawal by Subject|11|||
130013928|NCT00917150|468012313|FG000|Overall Study|Other than specified|3|||
130013929|NCT00917150|468012314|FG001|Overall Study|Other than specified|3|||
130013930|NCT00917150|468012315|FG002|Overall Study|Other than specified|2|||
130013931|NCT00917150|468012316|FG003|Overall Study|Other than specified|2|||
130013932|NCT03891264|468012317|FG000|Overall Study|Adverse Event|1|||
130013933|NCT03891264|468012317|FG000|Overall Study|Withdrawal by Subject|2|||
130013934|NCT03891264|468012317|FG000|Overall Study|Physician Decision|2|||
130013935|NCT01505634|468012322|FG000|Overall Study|Withdrawal by Subject|2|||
130013936|NCT01505634|468012323|FG001|Overall Study|Withdrawal by Subject|5|||
130013937|NCT01505634|468012324|FG002|Overall Study|Withdrawal by Subject|1|||
130013938|NCT01505634|468012322|FG000|Overall Study|Physician Decision|1|||
130013939|NCT01505634|468012323|FG001|Overall Study|Physician Decision|1|||
130013940|NCT01505634|468012324|FG002|Overall Study|Physician Decision|0|||
130013941|NCT01505634|468012322|FG000|Overall Study|Adverse Event|1|||
130013942|NCT01505634|468012323|FG001|Overall Study|Adverse Event|0|||
130013943|NCT01505634|468012324|FG002|Overall Study|Adverse Event|0|||
130013944|NCT01505634|468012322|FG000|Overall Study|Insufficient supply of drug at site|1|||
130013945|NCT01505634|468012323|FG001|Overall Study|Insufficient supply of drug at site|0|||
130013946|NCT01505634|468012324|FG002|Overall Study|Insufficient supply of drug at site|0|||
130013947|NCT01505634|468012322|FG000|Overall Study|Protocol Violation|2|||
130013948|NCT01505634|468012323|FG001|Overall Study|Protocol Violation|0|||
130013949|NCT01505634|468012324|FG002|Overall Study|Protocol Violation|0|||
130013950|NCT01505634|468012322|FG000|Overall Study|Lost to Follow-up|1|||
130013951|NCT01505634|468012323|FG001|Overall Study|Lost to Follow-up|4|||
130013952|NCT01505634|468012324|FG002|Overall Study|Lost to Follow-up|4|||
130013953|NCT01505634|468012322|FG000|Overall Study|Death|1|||
130013954|NCT01505634|468012323|FG001|Overall Study|Death|0|||
130013955|NCT01505634|468012324|FG002|Overall Study|Death|0|||
130013956|NCT01505634|468012322|FG000|Overall Study|In a conflict zone|0|||
130013957|NCT01505634|468012323|FG001|Overall Study|In a conflict zone|0|||
130013958|NCT01505634|468012324|FG002|Overall Study|In a conflict zone|1|||
130013959|NCT02054897|468012325|FG000|Overall Study|Withdrawal by Subject|2|||
130013960|NCT02054897|468012326|FG001|Overall Study|Withdrawal by Subject|0|||
130013961|NCT02054897|468012327|FG002|Overall Study|Withdrawal by Subject|2|||
130013962|NCT02054897|468012325|FG000|Overall Study|Missing follow-up information|3|||
130013963|NCT02054897|468012326|FG001|Overall Study|Missing follow-up information|5|||
130013964|NCT02054897|468012327|FG002|Overall Study|Missing follow-up information|3|||
130013965|NCT02054897|468012325|FG000|Overall Study|Lost to Follow-up|4|||
130013966|NCT02054897|468012326|FG001|Overall Study|Lost to Follow-up|2|||
130013967|NCT02054897|468012327|FG002|Overall Study|Lost to Follow-up|7|||
130013968|NCT02054897|468012325|FG000|Overall Study|Randomized but not exposed|1|||
130013969|NCT02054897|468012326|FG001|Overall Study|Randomized but not exposed|0|||
130013970|NCT02054897|468012327|FG002|Overall Study|Randomized but not exposed|0|||
130013971|NCT00794157|468012328|FG000|Overall Study|Adverse Event|4|||
130013972|NCT00794157|468012329|FG001|Overall Study|Adverse Event|1|||
130217800|NCT04865419|468761402|FG000|Overall Study|Study terminated by Sponsor|0|||
130013973|NCT00794157|468012330|FG002|Overall Study|Adverse Event|8|||
130013974|NCT00794157|468012328|FG000|Overall Study|Subject withdrew consent|2|||
130013975|NCT00794157|468012329|FG001|Overall Study|Subject withdrew consent|0|||
130013976|NCT00794157|468012330|FG002|Overall Study|Subject withdrew consent|3|||
130013977|NCT00794157|468012328|FG000|Overall Study|Lost to Follow-up|2|||
130013978|NCT00794157|468012329|FG001|Overall Study|Lost to Follow-up|0|||
130013979|NCT00794157|468012330|FG002|Overall Study|Lost to Follow-up|1|||
130013980|NCT00794157|468012328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130013981|NCT00794157|468012329|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130013982|NCT00794157|468012330|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130013983|NCT00794157|468012328|FG000|Overall Study|Administrative problems|1|||
130013984|NCT00794157|468012329|FG001|Overall Study|Administrative problems|7|||
130013985|NCT00794157|468012330|FG002|Overall Study|Administrative problems|4|||
130013986|NCT00794157|468012328|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130013987|NCT00794157|468012329|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130013988|NCT00794157|468012330|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130013989|NCT00794157|468012328|FG000|Overall Study|Protocol deviation|0|||
130013990|NCT00794157|468012329|FG001|Overall Study|Protocol deviation|1|||
130013991|NCT00794157|468012330|FG002|Overall Study|Protocol deviation|1|||
130013992|NCT01692275|468012331|FG000|Overall Study|Lost to Follow-up|57|||
130013993|NCT01692275|468012332|FG001|Overall Study|Lost to Follow-up|48|||
130013994|NCT01692275|468012331|FG000|Overall Study|Withdrawal by Subject|9|||
130013995|NCT01692275|468012332|FG001|Overall Study|Withdrawal by Subject|11|||
130013996|NCT01624662|468012335|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
130013997|NCT01624662|468012336|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
130013998|NCT01624662|468012337|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
130013999|NCT01624662|468012338|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
130014000|NCT01624662|468012335|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
130014001|NCT01624662|468012336|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
130014002|NCT01624662|468012337|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130014003|NCT01624662|468012338|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130014004|NCT01624662|468012335|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130014005|NCT01624662|468012336|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
130014006|NCT01624662|468012337|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130014007|NCT01624662|468012338|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130347961|NCT03307785|469246820|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
130347962|NCT03307785|469246821|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
130347963|NCT03307785|469246822|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
130347964|NCT03307785|469246823|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
130347965|NCT03307785|469246824|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
130347966|NCT03307785|469246825|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
130347967|NCT03307785|469246826|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
130347968|NCT03307785|469246827|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
130347969|NCT03307785|469246828|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
130347970|NCT03307785|469246818|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347971|NCT03307785|469246819|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347972|NCT03307785|469246820|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
130347973|NCT03307785|469246821|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347974|NCT03307785|469246822|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347975|NCT03307785|469246823|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347976|NCT03307785|469246824|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347977|NCT03307785|469246825|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347978|NCT03307785|469246826|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347979|NCT03307785|469246827|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347980|NCT03307785|469246828|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
130347981|NCT03307785|469246818|FG000|Part B: Up to Approx. 66 Months|Death|0|||
130347982|NCT03307785|469246819|FG001|Part B: Up to Approx. 66 Months|Death|0|||
130347983|NCT03307785|469246820|FG002|Part B: Up to Approx. 66 Months|Death|7|||
130347984|NCT03307785|469246821|FG003|Part B: Up to Approx. 66 Months|Death|0|||
130347985|NCT03307785|469246822|FG004|Part B: Up to Approx. 66 Months|Death|0|||
130347986|NCT03307785|469246823|FG005|Part B: Up to Approx. 66 Months|Death|0|||
130347987|NCT03307785|469246824|FG006|Part B: Up to Approx. 66 Months|Death|0|||
130347988|NCT03307785|469246825|FG007|Part B: Up to Approx. 66 Months|Death|0|||
130347989|NCT03307785|469246826|FG008|Part B: Up to Approx. 66 Months|Death|0|||
130347990|NCT03307785|469246827|FG009|Part B: Up to Approx. 66 Months|Death|0|||
130347991|NCT03307785|469246828|FG010|Part B: Up to Approx. 66 Months|Death|0|||
130347992|NCT03307785|469246818|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130347993|NCT03307785|469246819|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130347994|NCT03307785|469246820|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
130347995|NCT03307785|469246821|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130347996|NCT03307785|469246822|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130014008|NCT01624662|468012335|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
130014009|NCT01624662|468012336|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
130014010|NCT01624662|468012337|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
130014011|NCT01624662|468012338|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
130347997|NCT03307785|469246823|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130347998|NCT03307785|469246824|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130347999|NCT03307785|469246825|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130348000|NCT03307785|469246826|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130348001|NCT03307785|469246827|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130348002|NCT03307785|469246828|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
130348003|NCT03307785|469246818|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348004|NCT03307785|469246819|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129884423|NCT04012814|467536391|FG000|Overall Study|Adverse Event|1|||
130014012|NCT01624662|468012335|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130014013|NCT01624662|468012336|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130348005|NCT03307785|469246820|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
130348006|NCT03307785|469246821|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348007|NCT03307785|469246822|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348008|NCT03307785|469246823|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348009|NCT03307785|469246824|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348010|NCT03307785|469246825|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348011|NCT03307785|469246826|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348012|NCT03307785|469246827|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348013|NCT03307785|469246828|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
130348014|NCT03307785|469246818|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348015|NCT03307785|469246819|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348016|NCT03307785|469246820|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
130348017|NCT03307785|469246821|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348018|NCT03307785|469246822|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348019|NCT03307785|469246823|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348020|NCT03307785|469246824|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348021|NCT03307785|469246825|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348022|NCT03307785|469246826|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348023|NCT03307785|469246827|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348024|NCT03307785|469246828|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
130348025|NCT03307785|469246818|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348026|NCT03307785|469246819|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348027|NCT03307785|469246820|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348028|NCT03307785|469246821|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
130348029|NCT03307785|469246822|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
130348030|NCT03307785|469246823|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348031|NCT03307785|469246824|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348032|NCT03307785|469246825|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348033|NCT03307785|469246826|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348034|NCT03307785|469246827|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348035|NCT03307785|469246828|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
130348036|NCT03307785|469246818|FG000|Part C: Up to Approx. 60 Months|Death|0|||
130348037|NCT03307785|469246819|FG001|Part C: Up to Approx. 60 Months|Death|0|||
130348038|NCT03307785|469246820|FG002|Part C: Up to Approx. 60 Months|Death|0|||
130348039|NCT03307785|469246821|FG003|Part C: Up to Approx. 60 Months|Death|2|||
130348040|NCT03307785|469246822|FG004|Part C: Up to Approx. 60 Months|Death|5|||
130348041|NCT03307785|469246823|FG005|Part C: Up to Approx. 60 Months|Death|0|||
130348042|NCT03307785|469246824|FG006|Part C: Up to Approx. 60 Months|Death|0|||
130348043|NCT03307785|469246825|FG007|Part C: Up to Approx. 60 Months|Death|0|||
130348044|NCT03307785|469246826|FG008|Part C: Up to Approx. 60 Months|Death|0|||
130348045|NCT03307785|469246827|FG009|Part C: Up to Approx. 60 Months|Death|0|||
130348046|NCT03307785|469246828|FG010|Part C: Up to Approx. 60 Months|Death|0|||
130348047|NCT03307785|469246818|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348048|NCT03307785|469246819|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348049|NCT03307785|469246820|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348050|NCT03307785|469246821|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
130348051|NCT03307785|469246822|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348052|NCT03307785|469246823|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348053|NCT03307785|469246824|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348054|NCT03307785|469246825|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348055|NCT03307785|469246826|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348056|NCT03307785|469246827|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348057|NCT03307785|469246828|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
130348058|NCT03307785|469246818|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348059|NCT03307785|469246819|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348060|NCT03307785|469246820|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348061|NCT03307785|469246821|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348062|NCT03307785|469246822|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
130348063|NCT03307785|469246823|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348064|NCT03307785|469246824|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348065|NCT03307785|469246825|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130014014|NCT01624662|468012337|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
130052113|NCT03952468|468147218|FG001|Overall Study|Adverse Event|1|||
130014015|NCT01624662|468012338|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130014016|NCT01624662|468012335|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130014017|NCT01624662|468012336|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
130014018|NCT01624662|468012337|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130014019|NCT01624662|468012338|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130014020|NCT01624662|468012335|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130014021|NCT01624662|468012336|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130014022|NCT01624662|468012337|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
130014023|NCT01624662|468012338|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130014024|NCT00361270|468012339|FG000|Overall Study|Death|0|||
130014025|NCT00361270|468012340|FG001|Overall Study|Death|0|||
130014026|NCT00361270|468012341|FG002|Overall Study|Death|0|||
130014027|NCT00361270|468012342|FG003|Overall Study|Death|2|||
130014028|NCT00361270|468012339|FG000|Overall Study|Lost to Follow-up|4|||
130014029|NCT00361270|468012340|FG001|Overall Study|Lost to Follow-up|1|||
130014030|NCT00361270|468012341|FG002|Overall Study|Lost to Follow-up|0|||
130014031|NCT00361270|468012342|FG003|Overall Study|Lost to Follow-up|0|||
130014032|NCT00361270|468012339|FG000|Overall Study|Physician Decision|0|||
130014033|NCT00361270|468012340|FG001|Overall Study|Physician Decision|0|||
130014034|NCT00361270|468012341|FG002|Overall Study|Physician Decision|1|||
130014035|NCT00361270|468012342|FG003|Overall Study|Physician Decision|0|||
130014036|NCT00361270|468012339|FG000|Overall Study|Protocol Violation|9|||
130014037|NCT00361270|468012340|FG001|Overall Study|Protocol Violation|4|||
130014038|NCT00361270|468012341|FG002|Overall Study|Protocol Violation|5|||
130014039|NCT00361270|468012342|FG003|Overall Study|Protocol Violation|4|||
130014040|NCT00361270|468012339|FG000|Overall Study|Withdrawal by Subject|6|||
130014041|NCT00361270|468012340|FG001|Overall Study|Withdrawal by Subject|6|||
130014042|NCT00361270|468012341|FG002|Overall Study|Withdrawal by Subject|3|||
130014043|NCT00361270|468012342|FG003|Overall Study|Withdrawal by Subject|7|||
130014044|NCT00361270|468012339|FG000|Overall Study|Afraid of Hypnosis|1|||
130014045|NCT00361270|468012340|FG001|Overall Study|Afraid of Hypnosis|2|||
130348066|NCT03307785|469246826|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348067|NCT03307785|469246827|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348068|NCT03307785|469246828|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
130348069|NCT03307785|469246818|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348070|NCT03307785|469246819|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348071|NCT03307785|469246820|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348072|NCT03307785|469246821|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348073|NCT03307785|469246822|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348074|NCT03307785|469246823|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
130348075|NCT03307785|469246824|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348076|NCT03307785|469246825|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348077|NCT03307785|469246826|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348078|NCT03307785|469246827|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348079|NCT03307785|469246828|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
130348080|NCT03307785|469246818|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
130348081|NCT03307785|469246819|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
130348082|NCT03307785|469246820|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
130348083|NCT03307785|469246821|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
130348084|NCT03307785|469246822|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
130348085|NCT03307785|469246823|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
130348086|NCT03307785|469246824|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
130348087|NCT03307785|469246825|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
130348088|NCT03307785|469246826|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
130348089|NCT03307785|469246827|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
130348090|NCT03307785|469246828|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
130348091|NCT03307785|469246818|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348092|NCT03307785|469246819|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348093|NCT03307785|469246820|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348094|NCT03307785|469246821|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348095|NCT03307785|469246822|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348096|NCT03307785|469246823|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
130348097|NCT03307785|469246824|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348098|NCT03307785|469246825|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348099|NCT03307785|469246826|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348100|NCT03307785|469246827|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348101|NCT03307785|469246828|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
130348102|NCT03307785|469246818|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348103|NCT03307785|469246819|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348104|NCT03307785|469246820|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348105|NCT03307785|469246821|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348106|NCT03307785|469246822|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348107|NCT03307785|469246823|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
130348108|NCT03307785|469246824|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348109|NCT03307785|469246825|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348110|NCT03307785|469246826|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348111|NCT03307785|469246827|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348112|NCT03307785|469246828|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
130348113|NCT03307785|469246818|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348114|NCT03307785|469246819|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348115|NCT03307785|469246820|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348116|NCT03307785|469246821|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348117|NCT03307785|469246822|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348118|NCT03307785|469246823|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
130348119|NCT03307785|469246824|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348120|NCT03307785|469246825|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348121|NCT03307785|469246826|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348122|NCT03307785|469246827|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348123|NCT03307785|469246828|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
130348124|NCT03307785|469246818|FG000|Part E: Up to 4.4 Months|Death|0|||
130348125|NCT03307785|469246819|FG001|Part E: Up to 4.4 Months|Death|0|||
130348126|NCT03307785|469246820|FG002|Part E: Up to 4.4 Months|Death|0|||
130348127|NCT03307785|469246821|FG003|Part E: Up to 4.4 Months|Death|0|||
130348128|NCT03307785|469246822|FG004|Part E: Up to 4.4 Months|Death|0|||
130348129|NCT03307785|469246823|FG005|Part E: Up to 4.4 Months|Death|0|||
130348130|NCT03307785|469246824|FG006|Part E: Up to 4.4 Months|Death|1|||
130014046|NCT00361270|468012341|FG002|Overall Study|Afraid of Hypnosis|0|||
130014047|NCT00361270|468012342|FG003|Overall Study|Afraid of Hypnosis|0|||
130014048|NCT00361270|468012339|FG000|Overall Study|Problems with Transportation|4|||
130014049|NCT00361270|468012340|FG001|Overall Study|Problems with Transportation|0|||
130014050|NCT00361270|468012341|FG002|Overall Study|Problems with Transportation|0|||
130014051|NCT00361270|468012342|FG003|Overall Study|Problems with Transportation|0|||
130014052|NCT00361270|468012339|FG000|Overall Study|Adverse Event|0|||
130014053|NCT00361270|468012340|FG001|Overall Study|Adverse Event|1|||
130014054|NCT00361270|468012341|FG002|Overall Study|Adverse Event|1|||
130014055|NCT00361270|468012342|FG003|Overall Study|Adverse Event|0|||
130014056|NCT01100437|468012346|FG000|Titration/Stabilization|Adverse Event|0|||
130014057|NCT01100437|468012347|FG001|Titration/Stabilization|Adverse Event|0|||
130014058|NCT01100437|468012348|FG002|Titration/Stabilization|Adverse Event|4|||
130014059|NCT01100437|468012346|FG000|Titration/Stabilization|Non-compliance|0|||
130014060|NCT01100437|468012347|FG001|Titration/Stabilization|Non-compliance|0|||
130014061|NCT01100437|468012348|FG002|Titration/Stabilization|Non-compliance|1|||
130014062|NCT01100437|468012346|FG000|Titration/Stabilization|Sponsor canceled study|0|||
130014063|NCT01100437|468012347|FG001|Titration/Stabilization|Sponsor canceled study|0|||
130014064|NCT01100437|468012348|FG002|Titration/Stabilization|Sponsor canceled study|1|||
130014065|NCT01100437|468012346|FG000|Maintenance|Withdrawal by Subject|0|||
130348131|NCT03307785|469246825|FG007|Part E: Up to 4.4 Months|Death|0|||
130348132|NCT03307785|469246826|FG008|Part E: Up to 4.4 Months|Death|0|||
130348133|NCT03307785|469246827|FG009|Part E: Up to 4.4 Months|Death|0|||
130348134|NCT03307785|469246828|FG010|Part E: Up to 4.4 Months|Death|0|||
130348135|NCT03307785|469246818|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
130348136|NCT03307785|469246819|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
130348137|NCT03307785|469246820|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
130348138|NCT03307785|469246821|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
130348139|NCT03307785|469246822|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
130348140|NCT03307785|469246823|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
130348141|NCT03307785|469246824|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
130348142|NCT03307785|469246825|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
130348143|NCT03307785|469246826|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
130348144|NCT03307785|469246827|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
130348145|NCT03307785|469246828|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
130348146|NCT03307785|469246818|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
130348147|NCT03307785|469246819|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
130348148|NCT03307785|469246820|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
130348149|NCT03307785|469246821|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
130348150|NCT03307785|469246822|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
130348151|NCT03307785|469246823|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
130348152|NCT03307785|469246824|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
130348153|NCT03307785|469246825|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
130348154|NCT03307785|469246826|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
130348155|NCT03307785|469246827|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
130348156|NCT03307785|469246828|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
130348157|NCT03370276|469246829|FG000|Overall Study|Death|0|||
130348158|NCT03370276|469246830|FG001|Overall Study|Death|2|||
130348159|NCT03370276|469246831|FG002|Overall Study|Death|5|||
130348160|NCT03217747|469246832|FG000|Overall Study|Adverse Event|0|||
130348161|NCT03217747|469246833|FG001|Overall Study|Adverse Event|1|||
130348162|NCT03217747|469246834|FG002|Overall Study|Adverse Event|0|||
130348163|NCT03217747|469246835|FG003|Overall Study|Adverse Event|0|||
130348164|NCT03217747|469246836|FG004|Overall Study|Adverse Event|0|||
130348165|NCT03217747|469246837|FG005|Overall Study|Adverse Event|0|||
130348166|NCT03217747|469246838|FG006|Overall Study|Adverse Event|0|||
130348167|NCT03217747|469246839|FG007|Overall Study|Adverse Event|0|||
130348168|NCT03217747|469246840|FG008|Overall Study|Adverse Event|0|||
130348169|NCT03217747|469246841|FG009|Overall Study|Adverse Event|0|||
130348170|NCT03217747|469246842|FG010|Overall Study|Adverse Event|0|||
130348171|NCT03217747|469246843|FG011|Overall Study|Adverse Event|0|||
130348172|NCT03217747|469246844|FG012|Overall Study|Adverse Event|1|||
130348173|NCT03217747|469246845|FG013|Overall Study|Adverse Event|1|||
130348174|NCT03217747|469246832|FG000|Overall Study|Death|0|||
130348175|NCT03217747|469246833|FG001|Overall Study|Death|0|||
130348176|NCT03217747|469246834|FG002|Overall Study|Death|0|||
130348177|NCT03217747|469246835|FG003|Overall Study|Death|0|||
130348178|NCT03217747|469246836|FG004|Overall Study|Death|0|||
130348179|NCT03217747|469246837|FG005|Overall Study|Death|0|||
130348180|NCT03217747|469246838|FG006|Overall Study|Death|0|||
130348181|NCT03217747|469246839|FG007|Overall Study|Death|0|||
130217801|NCT04865419|468761403|FG001|Overall Study|Study terminated by Sponsor|0|||
130348182|NCT03217747|469246840|FG008|Overall Study|Death|1|||
130348183|NCT03217747|469246841|FG009|Overall Study|Death|0|||
130348184|NCT03217747|469246842|FG010|Overall Study|Death|0|||
130348185|NCT03217747|469246843|FG011|Overall Study|Death|0|||
130348186|NCT03217747|469246844|FG012|Overall Study|Death|0|||
130348187|NCT03217747|469246845|FG013|Overall Study|Death|0|||
130348188|NCT03217747|469246832|FG000|Overall Study|Lack of Efficacy|12|||
130348189|NCT03217747|469246833|FG001|Overall Study|Lack of Efficacy|6|||
130348190|NCT03217747|469246834|FG002|Overall Study|Lack of Efficacy|15|||
130348191|NCT03217747|469246835|FG003|Overall Study|Lack of Efficacy|11|||
130348192|NCT03217747|469246836|FG004|Overall Study|Lack of Efficacy|3|||
130348193|NCT03217747|469246837|FG005|Overall Study|Lack of Efficacy|14|||
130014066|NCT01100437|468012347|FG001|Maintenance|Withdrawal by Subject|0|||
130014067|NCT01100437|468012348|FG002|Maintenance|Withdrawal by Subject|1|||
130348194|NCT03217747|469246838|FG006|Overall Study|Lack of Efficacy|10|||
130014068|NCT01100437|468012346|FG000|Maintenance|Sponsor termination of study|0|||
130014069|NCT01100437|468012347|FG001|Maintenance|Sponsor termination of study|0|||
130014070|NCT01100437|468012348|FG002|Maintenance|Sponsor termination of study|1|||
130014071|NCT01594853|468013829|FG000|Overall Study|Withdrawal by Subject|1|||
130014072|NCT01594853|468013830|FG001|Overall Study|Withdrawal by Subject|1|||
130014073|NCT01594853|468013829|FG000|Overall Study|Lost to Follow-up|1|||
130014074|NCT01594853|468013830|FG001|Overall Study|Lost to Follow-up|1|||
130014075|NCT01594853|468013829|FG000|Overall Study|noncompliance with exercise|0|||
130014076|NCT01594853|468013830|FG001|Overall Study|noncompliance with exercise|1|||
130014077|NCT03571646|468013831|FG000|Overall Study|Adverse Event|1|||
130014078|NCT03571646|468013832|FG001|Overall Study|Adverse Event|0|||
130014079|NCT03571646|468013831|FG000|Overall Study|Withdrawal by Subject|1|||
130014080|NCT03571646|468013832|FG001|Overall Study|Withdrawal by Subject|1|||
130014081|NCT03548935|468013833|FG000|Overall Study|Withdrawal by Subject|26|||
130014082|NCT03548935|468013834|FG001|Overall Study|Withdrawal by Subject|17|||
130014083|NCT03548935|468013833|FG000|Overall Study|Lost to Follow-up|39|||
130014084|NCT03548935|468013834|FG001|Overall Study|Lost to Follow-up|28|||
130014085|NCT03548935|468013833|FG000|Overall Study|Death|1|||
130014086|NCT03548935|468013834|FG001|Overall Study|Death|1|||
130014087|NCT04677959|468013835|FG000|Overall Study|Adverse Event|1|||
130014088|NCT04677959|468013836|FG001|Overall Study|Adverse Event|9|||
130014089|NCT04677959|468013835|FG000|Overall Study|Withdrawal by Subject|2|||
130014090|NCT04677959|468013836|FG001|Overall Study|Withdrawal by Subject|15|||
130014091|NCT04677959|468013835|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130014092|NCT04677959|468013836|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130014093|NCT04677959|468013835|FG000|Overall Study|Non-compliance with study drug|0|||
130014094|NCT04677959|468013836|FG001|Overall Study|Non-compliance with study drug|2|||
130014095|NCT04677959|468013835|FG000|Overall Study|Protocol deviation|0|||
130014096|NCT04677959|468013836|FG001|Overall Study|Protocol deviation|11|||
130014097|NCT04677959|468013835|FG000|Overall Study|Lost to Follow-up|9|||
130014098|NCT04677959|468013836|FG001|Overall Study|Lost to Follow-up|13|||
130014099|NCT04677959|468013835|FG000|Overall Study|Other than specified|0|||
130014100|NCT04677959|468013836|FG001|Overall Study|Other than specified|8|||
130014101|NCT00763815|468013837|FG000|Overall Study|Adverse Event|14|||
130014102|NCT00763815|468013838|FG001|Overall Study|Adverse Event|29|||
130014103|NCT00763815|468013837|FG000|Overall Study|Lack of Efficacy|10|||
130014104|NCT00763815|468013838|FG001|Overall Study|Lack of Efficacy|11|||
130014105|NCT00763815|468013837|FG000|Overall Study|Poor Compliance to Protocol|6|||
130014106|NCT00763815|468013838|FG001|Overall Study|Poor Compliance to Protocol|6|||
130014107|NCT00763815|468013837|FG000|Overall Study|Lost to Follow-up|2|||
130014108|NCT00763815|468013838|FG001|Overall Study|Lost to Follow-up|4|||
130014109|NCT00763815|468013837|FG000|Overall Study|Early Termination|1|||
130014110|NCT00763815|468013838|FG001|Overall Study|Early Termination|0|||
130348195|NCT03217747|469246839|FG007|Overall Study|Lack of Efficacy|4|||
130348196|NCT03217747|469246840|FG008|Overall Study|Lack of Efficacy|2|||
130348197|NCT03217747|469246841|FG009|Overall Study|Lack of Efficacy|7|||
130348198|NCT03217747|469246842|FG010|Overall Study|Lack of Efficacy|3|||
130348199|NCT03217747|469246843|FG011|Overall Study|Lack of Efficacy|1|||
130348200|NCT03217747|469246844|FG012|Overall Study|Lack of Efficacy|3|||
130348201|NCT03217747|469246845|FG013|Overall Study|Lack of Efficacy|1|||
130348202|NCT03217747|469246832|FG000|Overall Study|Withdrawal by Subject|2|||
130348203|NCT03217747|469246833|FG001|Overall Study|Withdrawal by Subject|1|||
130348204|NCT03217747|469246834|FG002|Overall Study|Withdrawal by Subject|1|||
130348205|NCT03217747|469246835|FG003|Overall Study|Withdrawal by Subject|1|||
130348206|NCT03217747|469246836|FG004|Overall Study|Withdrawal by Subject|1|||
130348207|NCT03217747|469246837|FG005|Overall Study|Withdrawal by Subject|2|||
130348208|NCT03217747|469246838|FG006|Overall Study|Withdrawal by Subject|1|||
130348209|NCT03217747|469246839|FG007|Overall Study|Withdrawal by Subject|0|||
130348210|NCT03217747|469246840|FG008|Overall Study|Withdrawal by Subject|0|||
130348211|NCT03217747|469246841|FG009|Overall Study|Withdrawal by Subject|0|||
130348212|NCT03217747|469246842|FG010|Overall Study|Withdrawal by Subject|0|||
130348213|NCT03217747|469246843|FG011|Overall Study|Withdrawal by Subject|1|||
130348214|NCT03217747|469246844|FG012|Overall Study|Withdrawal by Subject|0|||
130348215|NCT03217747|469246845|FG013|Overall Study|Withdrawal by Subject|1|||
130348216|NCT03217747|469246832|FG000|Overall Study|Toxicity and progression|1|||
130348217|NCT03217747|469246833|FG001|Overall Study|Toxicity and progression|0|||
130348218|NCT03217747|469246834|FG002|Overall Study|Toxicity and progression|0|||
130348219|NCT03217747|469246835|FG003|Overall Study|Toxicity and progression|0|||
130348220|NCT03217747|469246836|FG004|Overall Study|Toxicity and progression|0|||
130348221|NCT03217747|469246837|FG005|Overall Study|Toxicity and progression|0|||
130348222|NCT03217747|469246838|FG006|Overall Study|Toxicity and progression|0|||
130348223|NCT03217747|469246839|FG007|Overall Study|Toxicity and progression|0|||
130348224|NCT03217747|469246840|FG008|Overall Study|Toxicity and progression|0|||
130348225|NCT03217747|469246841|FG009|Overall Study|Toxicity and progression|0|||
130348226|NCT03217747|469246842|FG010|Overall Study|Toxicity and progression|0|||
130348227|NCT03217747|469246843|FG011|Overall Study|Toxicity and progression|0|||
130348228|NCT03217747|469246844|FG012|Overall Study|Toxicity and progression|0|||
130348229|NCT03217747|469246845|FG013|Overall Study|Toxicity and progression|0|||
130348230|NCT03217747|469246832|FG000|Overall Study|Removal of sole target lesion|1|||
130348231|NCT03217747|469246833|FG001|Overall Study|Removal of sole target lesion|0|||
130348232|NCT03217747|469246834|FG002|Overall Study|Removal of sole target lesion|0|||
130348233|NCT03217747|469246835|FG003|Overall Study|Removal of sole target lesion|0|||
130348234|NCT03217747|469246836|FG004|Overall Study|Removal of sole target lesion|0|||
130348235|NCT03217747|469246837|FG005|Overall Study|Removal of sole target lesion|0|||
130348236|NCT03217747|469246838|FG006|Overall Study|Removal of sole target lesion|0|||
130348237|NCT03217747|469246839|FG007|Overall Study|Removal of sole target lesion|0|||
130348238|NCT03217747|469246840|FG008|Overall Study|Removal of sole target lesion|0|||
130348239|NCT03217747|469246841|FG009|Overall Study|Removal of sole target lesion|0|||
130348240|NCT03217747|469246842|FG010|Overall Study|Removal of sole target lesion|0|||
130348241|NCT03217747|469246843|FG011|Overall Study|Removal of sole target lesion|0|||
130348242|NCT03217747|469246844|FG012|Overall Study|Removal of sole target lesion|0|||
130348243|NCT03217747|469246845|FG013|Overall Study|Removal of sole target lesion|0|||
130348244|NCT03217747|469246832|FG000|Overall Study|Stroke|0|||
130348245|NCT03217747|469246833|FG001|Overall Study|Stroke|0|||
130348246|NCT03217747|469246834|FG002|Overall Study|Stroke|0|||
130348247|NCT03217747|469246835|FG003|Overall Study|Stroke|0|||
130348248|NCT03217747|469246836|FG004|Overall Study|Stroke|0|||
130348249|NCT03217747|469246837|FG005|Overall Study|Stroke|1|||
130348250|NCT03217747|469246838|FG006|Overall Study|Stroke|0|||
130348251|NCT03217747|469246839|FG007|Overall Study|Stroke|0|||
130348252|NCT03217747|469246840|FG008|Overall Study|Stroke|0|||
130348253|NCT03217747|469246841|FG009|Overall Study|Stroke|0|||
130348254|NCT03217747|469246842|FG010|Overall Study|Stroke|0|||
130348255|NCT03217747|469246843|FG011|Overall Study|Stroke|1|||
130348256|NCT03217747|469246844|FG012|Overall Study|Stroke|0|||
130348257|NCT03217747|469246845|FG013|Overall Study|Stroke|0|||
130348258|NCT04103892|469246846|FG000|Overall Study|Adverse Event|0|||
130348259|NCT04103892|469246847|FG001|Overall Study|Adverse Event|0|||
130348260|NCT04103892|469246848|FG002|Overall Study|Adverse Event|0|||
130348261|NCT04103892|469246849|FG003|Overall Study|Adverse Event|3|||
130348262|NCT04103892|469246846|FG000|Overall Study|Lost to Follow-up|0|||
130348263|NCT04103892|469246847|FG001|Overall Study|Lost to Follow-up|0|||
130348264|NCT04103892|469246848|FG002|Overall Study|Lost to Follow-up|2|||
130348265|NCT04103892|469246849|FG003|Overall Study|Lost to Follow-up|0|||
130052114|NCT03952468|468147217|FG000|Overall Study|Physician Decision|1|||
130348266|NCT04103892|469246846|FG000|Overall Study|Protocol Violation|0|||
130014111|NCT00763815|468013837|FG000|Overall Study|Familial and Personal Reasons|9|||
130014112|NCT00763815|468013838|FG001|Overall Study|Familial and Personal Reasons|16|||
130014113|NCT00763815|468013837|FG000|Overall Study|Physician Decision|1|||
130014114|NCT00763815|468013838|FG001|Overall Study|Physician Decision|0|||
130014115|NCT00763815|468013837|FG000|Overall Study|Withdrawal by Subject|7|||
130014116|NCT00763815|468013838|FG001|Overall Study|Withdrawal by Subject|12|||
130014117|NCT00763815|468013837|FG000|Overall Study|Protocol Violation|2|||
130014118|NCT00763815|468013838|FG001|Overall Study|Protocol Violation|5|||
130014119|NCT00763815|468013837|FG000|Overall Study|Sponsor's Decision|0|||
130014120|NCT00763815|468013838|FG001|Overall Study|Sponsor's Decision|1|||
130014121|NCT01970995|468013839|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130014122|NCT01970995|468013840|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130014123|NCT01970995|468013841|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
130014124|NCT01970995|468013839|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
130014125|NCT01970995|468013840|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
130014126|NCT01970995|468013841|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
130014127|NCT01263639|468013842|FG000|Overall Study|Lost to Follow-up|66|||
130014128|NCT01263639|468013843|FG001|Overall Study|Lost to Follow-up|70|||
130014129|NCT01263639|468013842|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
130014130|NCT01263639|468013843|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
130014131|NCT01576549|468013844|FG000|Overall Study|Sponsor Decision|2|||
130014132|NCT00586495|468013845|FG000|Treatment Period|Adverse Event|11|||
130014133|NCT00586495|468013845|FG000|Treatment Period|Death|1|||
130014134|NCT00586495|468013845|FG000|Treatment Period|Protocol Violation|1|||
130014135|NCT00586495|468013845|FG000|Treatment Period|Withdrawal by Subject|1|||
130014136|NCT00586495|468013845|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
130014137|NCT00586495|468013845|FG000|Treatment Period|Switch to commercial drug|10|||
130014138|NCT00586495|468013845|FG000|Follow-up|Death|40|||
130014139|NCT00586495|468013845|FG000|Follow-up|Lost to Follow-up|1|||
130014140|NCT00586495|468013845|FG000|Follow-up|Withdrawal by Subject|4|||
130014141|NCT00586495|468013845|FG000|Follow-up|Protocol driven decision point|37|||
130014142|NCT00586495|468013845|FG000|Follow-up|Switch to commercial drug|10|||
130014143|NCT00440947|468013858|FG000|36-Week Induction Phase|Adverse Event|16|||
130014144|NCT00440947|468013859|FG001|36-Week Induction Phase|Adverse Event|0|||
130014145|NCT00440947|468013860|FG002|36-Week Induction Phase|Adverse Event|0|||
130014146|NCT00440947|468013861|FG003|36-Week Induction Phase|Adverse Event|0|||
130348267|NCT04103892|469246847|FG001|Overall Study|Protocol Violation|0|||
130348268|NCT04103892|469246848|FG002|Overall Study|Protocol Violation|1|||
130348269|NCT04103892|469246849|FG003|Overall Study|Protocol Violation|1|||
130348270|NCT04103892|469246846|FG000|Overall Study|Withdrawal by Subject|1|||
130348271|NCT04103892|469246847|FG001|Overall Study|Withdrawal by Subject|0|||
130348272|NCT04103892|469246848|FG002|Overall Study|Withdrawal by Subject|2|||
130348273|NCT04103892|469246849|FG003|Overall Study|Withdrawal by Subject|5|||
130348274|NCT04103892|469246846|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
130348275|NCT04103892|469246847|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
130348276|NCT04103892|469246848|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
130348277|NCT04103892|469246849|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
130348278|NCT05217641|469246851|FG000|Overall Study|Lost to Follow-up|1|||
130348279|NCT05217641|469246852|FG001|Overall Study|Lost to Follow-up|1|||
130348280|NCT05217641|469246853|FG002|Overall Study|Lost to Follow-up|0|||
130348281|NCT05217641|469246854|FG003|Overall Study|Lost to Follow-up|1|||
130348282|NCT05217641|469246855|FG004|Overall Study|Lost to Follow-up|1|||
130348283|NCT05217641|469246856|FG005|Overall Study|Lost to Follow-up|0|||
130348284|NCT05217641|469246851|FG000|Overall Study|Withdrawal by Subject|0|||
130348285|NCT05217641|469246852|FG001|Overall Study|Withdrawal by Subject|0|||
130348286|NCT05217641|469246853|FG002|Overall Study|Withdrawal by Subject|0|||
130348287|NCT05217641|469246854|FG003|Overall Study|Withdrawal by Subject|3|||
130348288|NCT05217641|469246855|FG004|Overall Study|Withdrawal by Subject|1|||
130348289|NCT05217641|469246856|FG005|Overall Study|Withdrawal by Subject|0|||
130348290|NCT05217641|469246851|FG000|Overall Study|Other: participant did not specify reason|0|||
130348291|NCT05217641|469246852|FG001|Overall Study|Other: participant did not specify reason|0|||
130348292|NCT05217641|469246853|FG002|Overall Study|Other: participant did not specify reason|0|||
130348293|NCT05217641|469246854|FG003|Overall Study|Other: participant did not specify reason|0|||
130348294|NCT05217641|469246855|FG004|Overall Study|Other: participant did not specify reason|1|||
130348295|NCT05217641|469246856|FG005|Overall Study|Other: participant did not specify reason|0|||
130348296|NCT05217641|469246851|FG000|Overall Study|Extended Follow up|1|||
130348297|NCT05217641|469246852|FG001|Overall Study|Extended Follow up|1|||
130348298|NCT05217641|469246853|FG002|Overall Study|Extended Follow up|0|||
130348299|NCT05217641|469246854|FG003|Overall Study|Extended Follow up|0|||
130348300|NCT05217641|469246855|FG004|Overall Study|Extended Follow up|1|||
130348301|NCT05217641|469246856|FG005|Overall Study|Extended Follow up|0|||
130348302|NCT04675151|469246857|FG000|Overall Study|Protocol Violation|1|||
130348303|NCT04675151|469246858|FG001|Overall Study|Protocol Violation|0|||
130348304|NCT04675151|469246859|FG002|Overall Study|Protocol Violation|0|||
130348305|NCT04675151|469246860|FG003|Overall Study|Protocol Violation|1|||
130348306|NCT04035486|469246861|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
130348307|NCT04035486|469246862|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
130348308|NCT04035486|469246863|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
130348309|NCT04035486|469246864|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
130348310|NCT04035486|469246861|FG000|Overall Study|Death|6|||
130348311|NCT04035486|469246862|FG001|Overall Study|Death|3|||
130348312|NCT04035486|469246863|FG002|Overall Study|Death|70|||
130348313|NCT04035486|469246864|FG003|Overall Study|Death|77|||
130348314|NCT04035486|469246861|FG000|Overall Study|Screen Failure|0|||
130014147|NCT00440947|468013862|FG004|36-Week Induction Phase|Adverse Event|0|||
130014148|NCT00440947|468013858|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
130348315|NCT04035486|469246862|FG001|Overall Study|Screen Failure|0|||
130348316|NCT04035486|469246863|FG002|Overall Study|Screen Failure|1|||
130348317|NCT04035486|469246864|FG003|Overall Study|Screen Failure|1|||
130348318|NCT04035486|469246861|FG000|Overall Study|Withdrawal by Subject|1|||
130348319|NCT04035486|469246862|FG001|Overall Study|Withdrawal by Subject|1|||
130014149|NCT00440947|468013859|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130014150|NCT00440947|468013860|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130014151|NCT00440947|468013861|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130014152|NCT00440947|468013862|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
130014153|NCT00440947|468013858|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
130014154|NCT00440947|468013859|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130014155|NCT00440947|468013860|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130014156|NCT00440947|468013861|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130014157|NCT00440947|468013862|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
130014158|NCT00440947|468013858|FG000|36-Week Induction Phase|Non-compliance|10|||
130014159|NCT00440947|468013859|FG001|36-Week Induction Phase|Non-compliance|0|||
130014160|NCT00440947|468013860|FG002|36-Week Induction Phase|Non-compliance|0|||
130014161|NCT00440947|468013861|FG003|36-Week Induction Phase|Non-compliance|0|||
130014162|NCT00440947|468013862|FG004|36-Week Induction Phase|Non-compliance|0|||
130014163|NCT00440947|468013858|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
130014164|NCT00440947|468013859|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
130014165|NCT00440947|468013860|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
130014166|NCT00440947|468013861|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
130014167|NCT00440947|468013862|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
130014168|NCT00440947|468013858|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
130014169|NCT00440947|468013859|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
130014170|NCT00440947|468013860|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
130014171|NCT00440947|468013861|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
130014172|NCT00440947|468013862|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
130014173|NCT00440947|468013858|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
130014174|NCT00440947|468013859|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130014175|NCT00440947|468013860|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130014176|NCT00440947|468013861|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130014177|NCT00440947|468013862|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
130014178|NCT00440947|468013858|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
130014179|NCT00440947|468013859|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
130014180|NCT00440947|468013860|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
130014181|NCT00440947|468013861|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
130014182|NCT00440947|468013862|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
130014183|NCT00440947|468013858|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
130014184|NCT00440947|468013859|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130014185|NCT00440947|468013860|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130014186|NCT00440947|468013861|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130014187|NCT00440947|468013862|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
130014188|NCT00440947|468013858|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
129884424|NCT01275196|467536392|FG000|Overall Study|Adverse Event|3|||
130014189|NCT00440947|468013859|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130014190|NCT00440947|468013860|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130014191|NCT00440947|468013861|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130014192|NCT00440947|468013862|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
130014193|NCT00440947|468013858|FG000|36-Week Induction Phase|Incarceration|3|||
130014194|NCT00440947|468013859|FG001|36-Week Induction Phase|Incarceration|0|||
130014195|NCT00440947|468013860|FG002|36-Week Induction Phase|Incarceration|0|||
130014196|NCT00440947|468013861|FG003|36-Week Induction Phase|Incarceration|0|||
130014197|NCT00440947|468013862|FG004|36-Week Induction Phase|Incarceration|0|||
130014198|NCT00440947|468013858|FG000|36-Week Induction Phase|Pregnancy|1|||
130014199|NCT00440947|468013859|FG001|36-Week Induction Phase|Pregnancy|0|||
130014200|NCT00440947|468013860|FG002|36-Week Induction Phase|Pregnancy|0|||
130014201|NCT00440947|468013861|FG003|36-Week Induction Phase|Pregnancy|0|||
130014202|NCT00440947|468013862|FG004|36-Week Induction Phase|Pregnancy|0|||
130014203|NCT00440947|468013858|FG000|48-Week Randomization Phase|Adverse Event|0|||
130014204|NCT00440947|468013859|FG001|48-Week Randomization Phase|Adverse Event|2|||
130014205|NCT00440947|468013860|FG002|48-Week Randomization Phase|Adverse Event|5|||
130348320|NCT04035486|469246863|FG002|Overall Study|Withdrawal by Subject|11|||
130348321|NCT04035486|469246864|FG003|Overall Study|Withdrawal by Subject|9|||
130348322|NCT01730937|469246865|FG000|Overall Study|Protocol Violation|5|||
130348323|NCT01730937|469246866|FG001|Overall Study|Protocol Violation|11|||
130348324|NCT03947684|469246869|FG000|Overall Study|Lost to Follow-up|13|||
130348325|NCT03947684|469246870|FG001|Overall Study|Lost to Follow-up|5|||
130348326|NCT03947684|469246871|FG002|Overall Study|Lost to Follow-up|1|||
130348327|NCT03947684|469246869|FG000|Overall Study|Withdrawal by Subject|11|||
130348328|NCT03947684|469246870|FG001|Overall Study|Withdrawal by Subject|4|||
130348329|NCT03947684|469246871|FG002|Overall Study|Withdrawal by Subject|0|||
130348330|NCT03947684|469246869|FG000|Overall Study|Physician Decision|1|||
130348331|NCT03947684|469246870|FG001|Overall Study|Physician Decision|0|||
130348332|NCT03947684|469246871|FG002|Overall Study|Physician Decision|0|||
130348333|NCT03947684|469246869|FG000|Overall Study|Lack of adherence to study protocol|2|||
130348334|NCT03947684|469246870|FG001|Overall Study|Lack of adherence to study protocol|0|||
130348335|NCT03947684|469246871|FG002|Overall Study|Lack of adherence to study protocol|0|||
130348336|NCT02367040|469246872|FG000|Overall Study|Lost to Follow-up|1|||
130348337|NCT02367040|469246873|FG001|Overall Study|Lost to Follow-up|1|||
130348338|NCT02367040|469246872|FG000|Overall Study|Lack of Efficacy|1|||
130348339|NCT02367040|469246873|FG001|Overall Study|Lack of Efficacy|0|||
130348340|NCT02367040|469246872|FG000|Overall Study|Additional primary malignancy|1|||
130348341|NCT02367040|469246873|FG001|Overall Study|Additional primary malignancy|1|||
130348342|NCT02367040|469246872|FG000|Overall Study|AE not associated with clinical disease progression|117|||
130348343|NCT02367040|469246873|FG001|Overall Study|AE not associated with clinical disease progression|12|||
130348344|NCT02367040|469246872|FG000|Overall Study|AE associated with clinical disease progression|1|||
130348345|NCT02367040|469246873|FG001|Overall Study|AE associated with clinical disease progression|4|||
130348346|NCT02367040|469246872|FG000|Overall Study|Physician Decision|2|||
130348347|NCT02367040|469246873|FG001|Overall Study|Physician Decision|8|||
130348348|NCT02367040|469246872|FG000|Overall Study|Non-compliance to study drug|1|||
130348349|NCT02367040|469246873|FG001|Overall Study|Non-compliance to study drug|0|||
130348350|NCT02367040|469246872|FG000|Overall Study|Failure to meet continuation criteria|1|||
130348351|NCT02367040|469246873|FG001|Overall Study|Failure to meet continuation criteria|0|||
130348352|NCT02367040|469246872|FG000|Overall Study|Switching to other therapy|2|||
130348353|NCT02367040|469246873|FG001|Overall Study|Switching to other therapy|0|||
130348354|NCT02367040|469246872|FG000|Overall Study|Withdrawal by Subject|51|||
130348355|NCT02367040|469246873|FG001|Overall Study|Withdrawal by Subject|16|||
130348356|NCT02367040|469246872|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
130348357|NCT02367040|469246873|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130348358|NCT02367040|469246872|FG000|Overall Study|Patient decision|40|||
130348359|NCT02367040|469246873|FG001|Overall Study|Patient decision|14|||
130348360|NCT02367040|469246872|FG000|Overall Study|Required procedure failed|1|||
130348361|NCT02367040|469246873|FG001|Overall Study|Required procedure failed|0|||
130348362|NCT02367040|469246872|FG000|Overall Study|Randomized by mistake with study treatment|1|||
130348363|NCT02367040|469246873|FG001|Overall Study|Randomized by mistake with study treatment|0|||
130348364|NCT02367040|469246872|FG000|Overall Study|Protocol Violation|1|||
130348365|NCT02367040|469246873|FG001|Overall Study|Protocol Violation|0|||
130348366|NCT02367040|469246872|FG000|Overall Study|Progressive disease - radiological progression|54|||
130348367|NCT02367040|469246873|FG001|Overall Study|Progressive disease - radiological progression|80|||
130348368|NCT02367040|469246872|FG000|Overall Study|Progressive disease - clinical progression|6|||
130348369|NCT02367040|469246873|FG001|Overall Study|Progressive disease - clinical progression|6|||
130348370|NCT02367040|469246872|FG000|Overall Study|Drug not administered|3|||
130348371|NCT02367040|469246873|FG001|Overall Study|Drug not administered|2|||
130348372|NCT02367040|469246872|FG000|Overall Study|Progressive disease|0|||
130014206|NCT00440947|468013861|FG003|48-Week Randomization Phase|Adverse Event|0|||
130014207|NCT00440947|468013862|FG004|48-Week Randomization Phase|Adverse Event|0|||
130052115|NCT03952468|468147218|FG001|Overall Study|Physician Decision|0|||
130014208|NCT00440947|468013858|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130014209|NCT00440947|468013859|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
130014210|NCT00440947|468013860|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
130014211|NCT00440947|468013861|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130014212|NCT00440947|468013862|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
130014213|NCT00440947|468013858|FG000|48-Week Randomization Phase|Non-compliance|0|||
130014214|NCT00440947|468013859|FG001|48-Week Randomization Phase|Non-compliance|3|||
130014215|NCT00440947|468013860|FG002|48-Week Randomization Phase|Non-compliance|4|||
130014216|NCT00440947|468013861|FG003|48-Week Randomization Phase|Non-compliance|0|||
130348373|NCT02367040|469246873|FG001|Overall Study|Progressive disease|1|||
130348374|NCT02367040|469246872|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
130348375|NCT02367040|469246873|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
130348376|NCT02367040|469246872|FG000|Overall Study|Death|2|||
130348377|NCT02367040|469246873|FG001|Overall Study|Death|0|||
130348378|NCT02367040|469246872|FG000|Overall Study|Study terminated by sponsor|19|||
130348379|NCT02367040|469246873|FG001|Overall Study|Study terminated by sponsor|2|||
130348380|NCT02477618|469246874|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
130348381|NCT02477618|469246875|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
130348382|NCT02477618|469246874|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
130348383|NCT02477618|469246875|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
130348384|NCT02477618|469246874|FG000|Overall Study|Adverse Event|1|||
130348385|NCT02477618|469246875|FG001|Overall Study|Adverse Event|1|||
130348386|NCT02477618|469246874|FG000|Overall Study|Transferred Away from Study Site|1|||
130348387|NCT02477618|469246875|FG001|Overall Study|Transferred Away from Study Site|0|||
130348388|NCT02477618|469246874|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
130348389|NCT02477618|469246875|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
130348390|NCT01892722|469246876|FG000|Overall Study|Protocol deviation|0|||
130348391|NCT01892722|469246877|FG001|Overall Study|Protocol deviation|1|||
130348392|NCT01892722|469246876|FG000|Overall Study|Administrative problems|0|||
130348393|NCT01892722|469246877|FG001|Overall Study|Administrative problems|1|||
130348394|NCT01892722|469246876|FG000|Overall Study|Patient/guardian decision|0|||
130348395|NCT01892722|469246877|FG001|Overall Study|Patient/guardian decision|2|||
130348396|NCT01892722|469246876|FG000|Overall Study|Physician Decision|1|||
130348397|NCT01892722|469246877|FG001|Overall Study|Physician Decision|2|||
130348398|NCT01892722|469246876|FG000|Overall Study|Adverse Event|3|||
130348399|NCT01892722|469246877|FG001|Overall Study|Adverse Event|2|||
130348400|NCT01892722|469246876|FG000|Overall Study|Lack of Efficacy|0|||
130348401|NCT01892722|469246877|FG001|Overall Study|Lack of Efficacy|7|||
130348402|NCT01892722|469246876|FG000|Overall Study|Withdrawal by Subject|3|||
130348403|NCT01892722|469246877|FG001|Overall Study|Withdrawal by Subject|5|||
130348404|NCT03007420|469246878|FG000|Overall Study|Withdrawal by Subject|0|||
130348405|NCT03007420|469246879|FG001|Overall Study|Withdrawal by Subject|2|||
130348406|NCT03007420|469246878|FG000|Overall Study|Physician Decision|0|||
130348407|NCT03007420|469246879|FG001|Overall Study|Physician Decision|1|||
130348408|NCT03875235|469246880|FG000|Overall Study|Ongoing study treatment|63|||
130348409|NCT03875235|469246881|FG001|Overall Study|Ongoing study treatment|20|||
130348410|NCT03875235|469246880|FG000|Overall Study|Off treatment|77|||
130348411|NCT03875235|469246881|FG001|Overall Study|Off treatment|91|||
130348412|NCT03875235|469246880|FG000|Overall Study|Withdrawal by Subject|3|||
130348413|NCT03875235|469246881|FG001|Overall Study|Withdrawal by Subject|10|||
130348414|NCT03875235|469246880|FG000|Overall Study|Death|198|||
130348415|NCT03875235|469246881|FG001|Overall Study|Death|223|||
130348416|NCT04526665|469246884|FG000|Overall Study|Withdrawal by Subject|6|||
130348417|NCT04526665|469246885|FG001|Overall Study|Withdrawal by Subject|3|||
130348418|NCT04526665|469246884|FG000|Overall Study|Adverse Event|4|||
130348419|NCT04526665|469246885|FG001|Overall Study|Adverse Event|1|||
130348420|NCT04526665|469246884|FG000|Overall Study|Physician Decision|2|||
130348421|NCT04526665|469246885|FG001|Overall Study|Physician Decision|2|||
130348422|NCT04526665|469246884|FG000|Overall Study|Death|2|||
130348423|NCT04526665|469246885|FG001|Overall Study|Death|0|||
130348424|NCT04526665|469246884|FG000|Overall Study|Other|0|||
130348425|NCT04526665|469246885|FG001|Overall Study|Other|1|||
130348426|NCT02994069|469247485|FG000|Overall Study|Death|7|||
130348427|NCT02994069|469247486|FG001|Overall Study|Death|13|||
130348428|NCT02994069|469247485|FG000|Overall Study|Adverse Event|1|||
130348429|NCT02994069|469247486|FG001|Overall Study|Adverse Event|0|||
130348430|NCT02994069|469247485|FG000|Overall Study|Other|2|||
130348431|NCT02994069|469247486|FG001|Overall Study|Other|0|||
130348432|NCT02994069|469247485|FG000|Overall Study|still on follow up/treatment|5|||
130348433|NCT02994069|469247486|FG001|Overall Study|still on follow up/treatment|6|||
130348434|NCT05212168|469247487|FG000|Overall Study|Lost to Follow-up|0|||
130014217|NCT00440947|468013862|FG004|48-Week Randomization Phase|Non-compliance|0|||
130014218|NCT00440947|468013858|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
130014219|NCT00440947|468013859|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
130014220|NCT00440947|468013860|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
130014221|NCT00440947|468013861|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
130348435|NCT05212168|469247488|FG001|Overall Study|Lost to Follow-up|3|||
130348436|NCT05212168|469247487|FG000|Overall Study|Study terminated by sponsor|30|||
130348437|NCT05212168|469247488|FG001|Overall Study|Study terminated by sponsor|27|||
130348438|NCT05212168|469247487|FG000|Overall Study|Other|4|||
130348439|NCT05212168|469247488|FG001|Overall Study|Other|7|||
130348440|NCT03587727|469247492|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
130348441|NCT03587727|469247492|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
130348442|NCT04102189|469247496|FG000|Overall Study|Withdrawal by Subject|1|||
130348443|NCT04102189|469247497|FG001|Overall Study|Withdrawal by Subject|2|||
130052116|NCT03952468|468147217|FG000|Overall Study|Lost to Follow-up|3|||
130014222|NCT00440947|468013862|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
130014223|NCT00440947|468013858|FG000|48-Week Randomization Phase|Protocol Violation|0|||
130014224|NCT00440947|468013859|FG001|48-Week Randomization Phase|Protocol Violation|0|||
130014225|NCT00440947|468013860|FG002|48-Week Randomization Phase|Protocol Violation|1|||
130014226|NCT00440947|468013861|FG003|48-Week Randomization Phase|Protocol Violation|0|||
130014227|NCT00440947|468013862|FG004|48-Week Randomization Phase|Protocol Violation|0|||
130014228|NCT00440947|468013858|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
130014229|NCT00440947|468013859|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
130014230|NCT00440947|468013860|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
130014231|NCT00440947|468013861|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
130014232|NCT00440947|468013862|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
130014233|NCT00440947|468013858|FG000|48-Week Randomization Phase|Pregnancy|0|||
130014234|NCT00440947|468013859|FG001|48-Week Randomization Phase|Pregnancy|0|||
130014235|NCT00440947|468013860|FG002|48-Week Randomization Phase|Pregnancy|1|||
130014236|NCT00440947|468013861|FG003|48-Week Randomization Phase|Pregnancy|0|||
130014237|NCT00440947|468013862|FG004|48-Week Randomization Phase|Pregnancy|0|||
130014238|NCT00440947|468013858|FG000|48-Week Randomization Phase|Incarceration|0|||
130348444|NCT04102189|469247496|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130348445|NCT04102189|469247497|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130348446|NCT04102189|469247496|FG000|Overall Study|Lost to Follow-up|1|||
130348447|NCT04102189|469247497|FG001|Overall Study|Lost to Follow-up|0|||
130348448|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
130348449|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
130348450|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
130348451|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
130348452|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
130348453|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
130348454|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
130348455|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
130348456|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
130348457|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
130348458|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
130348459|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
130348460|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130348461|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
130348462|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130348463|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130348464|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130348465|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
130348466|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130348467|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
130348468|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130348469|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130348470|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130348471|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
130348472|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130348473|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130348474|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
130348475|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130348476|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130348477|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
130348478|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130348479|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
130348480|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
130348481|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130348482|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130348483|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
130348484|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
130348485|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
130348486|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
130348487|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
130348488|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
130348489|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
130348490|NCT03524092|469247498|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
130348491|NCT03524092|469247499|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
130348492|NCT03524092|469247500|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
130348493|NCT03524092|469247501|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
130348494|NCT03524092|469247502|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
130014239|NCT00440947|468013859|FG001|48-Week Randomization Phase|Incarceration|3|||
130217802|NCT04865419|468761404|FG002|Overall Study|Study terminated by Sponsor|0|||
130348495|NCT03524092|469247503|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
130014240|NCT00440947|468013860|FG002|48-Week Randomization Phase|Incarceration|0|||
130014241|NCT00440947|468013861|FG003|48-Week Randomization Phase|Incarceration|0|||
130014242|NCT00440947|468013862|FG004|48-Week Randomization Phase|Incarceration|0|||
130014243|NCT00440947|468013858|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130014244|NCT00440947|468013859|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
130014245|NCT00440947|468013860|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130014246|NCT00440947|468013861|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130014247|NCT00440947|468013862|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
130014248|NCT00440947|468013858|FG000|48-Week Randomization Phase|Physician Decision|0|||
130014249|NCT00440947|468013859|FG001|48-Week Randomization Phase|Physician Decision|2|||
130014250|NCT00440947|468013860|FG002|48-Week Randomization Phase|Physician Decision|0|||
130014251|NCT00440947|468013861|FG003|48-Week Randomization Phase|Physician Decision|0|||
130014252|NCT00440947|468013862|FG004|48-Week Randomization Phase|Physician Decision|0|||
130014253|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
130014254|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
130014255|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
130014256|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
130014257|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
130014258|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
130014259|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
130014260|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
130014261|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
130014262|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
130014263|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
130014264|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
130014265|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
130014266|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
130014267|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
130014268|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
130014269|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
130014270|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
130014271|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
130014272|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
130014273|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
130014274|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
130014275|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
130014276|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
130014277|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
130014278|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
130014279|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
130014280|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
130014281|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
130014282|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
130014283|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
130014284|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
130014285|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
130014286|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
130014287|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
130014288|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
130014289|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
130014290|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
130014291|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
130014292|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
130014293|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
130348496|NCT03524092|469247498|FG000|Loss of Response Rescue Period|Adverse Event|0|||
130348497|NCT03524092|469247499|FG001|Loss of Response Rescue Period|Adverse Event|0|||
130348498|NCT03524092|469247500|FG002|Loss of Response Rescue Period|Adverse Event|0|||
130348499|NCT03524092|469247501|FG003|Loss of Response Rescue Period|Adverse Event|2|||
130348500|NCT03524092|469247502|FG004|Loss of Response Rescue Period|Adverse Event|0|||
130348501|NCT03524092|469247503|FG005|Loss of Response Rescue Period|Adverse Event|0|||
130348502|NCT03524092|469247498|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
130348503|NCT03524092|469247499|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
130348504|NCT03524092|469247500|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
130348505|NCT03524092|469247501|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
130348506|NCT03524092|469247502|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
130348507|NCT03524092|469247503|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
130348508|NCT03524092|469247498|FG000|Loss of Response Rescue Period|Pregnancy|0|||
130348509|NCT03524092|469247499|FG001|Loss of Response Rescue Period|Pregnancy|0|||
130348510|NCT03524092|469247500|FG002|Loss of Response Rescue Period|Pregnancy|0|||
130348511|NCT03524092|469247501|FG003|Loss of Response Rescue Period|Pregnancy|1|||
130348512|NCT03524092|469247502|FG004|Loss of Response Rescue Period|Pregnancy|0|||
130348513|NCT03524092|469247503|FG005|Loss of Response Rescue Period|Pregnancy|0|||
130348514|NCT03524092|469247498|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130348515|NCT03524092|469247499|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130348516|NCT03524092|469247500|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130348517|NCT03524092|469247501|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
130348518|NCT03524092|469247502|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130348519|NCT03524092|469247503|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
130014294|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
130348520|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130014295|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
130014296|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
130014297|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
130014298|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
130014299|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
130014300|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
130014301|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
130014302|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
130014303|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
130014304|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
130014305|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
130014306|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
130014307|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
130014308|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Other|0|||
130014309|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Other|0|||
130014310|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Other|0|||
130014311|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Other|1|||
130014312|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Other|0|||
130014313|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
130014314|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
130014315|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
130014316|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
130014317|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
130014318|NCT00440947|468013858|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130014319|NCT00440947|468013859|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130014320|NCT00440947|468013860|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130014321|NCT00440947|468013861|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
130014322|NCT00440947|468013862|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
130014323|NCT01834274|468013866|FG000|Overall Study|Study Termination|41|||
130014324|NCT01834274|468013867|FG001|Overall Study|Study Termination|38|||
130014325|NCT01834274|468013866|FG000|Overall Study|Withdrawal by Subject|1|||
130014326|NCT01834274|468013867|FG001|Overall Study|Withdrawal by Subject|1|||
130014327|NCT01834274|468013866|FG000|Overall Study|Lost to Follow-up|3|||
130014328|NCT01834274|468013867|FG001|Overall Study|Lost to Follow-up|1|||
130348521|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130348522|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130348523|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130348524|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
130348525|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
130348526|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130348527|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130348528|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130348529|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130348530|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
130348531|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
130348532|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130348533|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130348534|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130348535|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130348536|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
130348537|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
130348538|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130348539|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130348540|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130348541|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130348542|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
130348543|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
130348544|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130348545|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130348546|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130348547|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130348548|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
130348549|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
130348550|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130348551|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130348552|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130348553|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130348554|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
130348555|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
130348556|NCT03524092|469247498|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130348557|NCT03524092|469247499|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130348558|NCT03524092|469247500|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130348559|NCT03524092|469247501|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130348560|NCT03524092|469247502|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
130348561|NCT03524092|469247503|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
130014329|NCT01834274|468013866|FG000|Overall Study|Other|2|||
130014330|NCT01834274|468013867|FG001|Overall Study|Other|1|||
130014331|NCT02980224|468013878|FG000|Overall Study|Adverse Event|4|||
130014332|NCT02980224|468013879|FG001|Overall Study|Adverse Event|1|||
130052117|NCT03952468|468147218|FG001|Overall Study|Lost to Follow-up|4|||
130348562|NCT03524092|469247498|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130348563|NCT03524092|469247499|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130348564|NCT03524092|469247500|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130348565|NCT03524092|469247501|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130348566|NCT03524092|469247502|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
130348567|NCT03524092|469247503|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
130348568|NCT03524092|469247498|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130348569|NCT03524092|469247499|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130348570|NCT03524092|469247500|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130348571|NCT03524092|469247501|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130348572|NCT03524092|469247502|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
130348573|NCT03524092|469247503|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
130348574|NCT03524092|469247498|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130348575|NCT03524092|469247499|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130348576|NCT03524092|469247500|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130348577|NCT03524092|469247501|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130348578|NCT03524092|469247502|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
130348579|NCT03524092|469247503|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
130348580|NCT03524092|469247498|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130348581|NCT03524092|469247499|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130348582|NCT03524092|469247500|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130348583|NCT03524092|469247501|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130348584|NCT03524092|469247502|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
130348585|NCT03524092|469247503|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
130014333|NCT02980224|468013878|FG000|Overall Study|Withdrawal by Subject|0|||
130014334|NCT02980224|468013879|FG001|Overall Study|Withdrawal by Subject|2|||
130014335|NCT00606320|468013880|FG000|Overall Study|Adverse Event|3|||
130014336|NCT00606320|468013880|FG000|Overall Study|Lack of Efficacy|5|||
130014337|NCT00606320|468013880|FG000|Overall Study|Physician Decision|7|||
130014338|NCT00606320|468013880|FG000|Overall Study|Protocol Violation|8|||
130014339|NCT00606320|468013880|FG000|Overall Study|Withdrawal by Subject|10|||
130014340|NCT00606320|468013880|FG000|Overall Study|Progression to depressive phase|4|||
130014341|NCT02595723|468013881|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
130014342|NCT02595723|468013882|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
130014343|NCT02595723|468013883|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
130014344|NCT02595723|468013881|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
130014345|NCT02595723|468013882|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
130014346|NCT02595723|468013883|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
130014347|NCT01087905|468013884|FG000|Overall Study|Lost to Follow-up|24|||
130014348|NCT01087905|468013885|FG001|Overall Study|Lost to Follow-up|28|||
130014349|NCT01087905|468013886|FG002|Overall Study|Lost to Follow-up|18|||
130014350|NCT01087905|468013887|FG003|Overall Study|Lost to Follow-up|31|||
130014351|NCT01087905|468013888|FG004|Overall Study|Lost to Follow-up|27|||
130014352|NCT01087905|468013889|FG005|Overall Study|Lost to Follow-up|25|||
130014353|NCT01087905|468013890|FG006|Overall Study|Lost to Follow-up|20|||
130014354|NCT01087905|468013891|FG007|Overall Study|Lost to Follow-up|24|||
130014355|NCT01087905|468013884|FG000|Overall Study|Withdrawal by Subject|5|||
130014356|NCT01087905|468013885|FG001|Overall Study|Withdrawal by Subject|4|||
130014357|NCT01087905|468013886|FG002|Overall Study|Withdrawal by Subject|4|||
130014358|NCT01087905|468013887|FG003|Overall Study|Withdrawal by Subject|5|||
130014359|NCT01087905|468013888|FG004|Overall Study|Withdrawal by Subject|4|||
130014360|NCT01087905|468013889|FG005|Overall Study|Withdrawal by Subject|3|||
130014361|NCT01087905|468013890|FG006|Overall Study|Withdrawal by Subject|3|||
130014362|NCT01087905|468013891|FG007|Overall Study|Withdrawal by Subject|5|||
130014363|NCT02937818|468013892|FG000|Overall Study|Participants decision|2|||
130014364|NCT02937818|468013893|FG001|Overall Study|Participants decision|1|||
130014365|NCT02937818|468013894|FG002|Overall Study|Participants decision|1|||
130014366|NCT02937818|468013895|FG003|Overall Study|Participants decision|1|||
130014367|NCT02937818|468013892|FG000|Overall Study|Adverse Event|2|||
130014368|NCT02937818|468013893|FG001|Overall Study|Adverse Event|4|||
130014369|NCT02937818|468013894|FG002|Overall Study|Adverse Event|1|||
130014370|NCT02937818|468013895|FG003|Overall Study|Adverse Event|1|||
130014371|NCT02937818|468013892|FG000|Overall Study|Disease progression|17|||
130014372|NCT02937818|468013893|FG001|Overall Study|Disease progression|15|||
130014373|NCT02937818|468013894|FG002|Overall Study|Disease progression|7|||
130014374|NCT02937818|468013895|FG003|Overall Study|Disease progression|19|||
130014375|NCT02937818|468013892|FG000|Overall Study|Condition under investigation worsened|0|||
130014376|NCT02937818|468013893|FG001|Overall Study|Condition under investigation worsened|0|||
130014377|NCT02937818|468013894|FG002|Overall Study|Condition under investigation worsened|1|||
130014378|NCT02937818|468013895|FG003|Overall Study|Condition under investigation worsened|0|||
130014379|NCT05513625|468013896|FG000|Overall Study|Withdrawal by Subject|1|||
130014380|NCT01015768|468013897|FG000|Overall Study|Some subject data unuseable|4|||
130014381|NCT01015768|468013898|FG001|Overall Study|Some subject data unuseable|4|||
130014382|NCT00677014|468013899|FG000|Overall Study|Lost to Follow-up|20|||
130014383|NCT00677014|468013900|FG001|Overall Study|Lost to Follow-up|12|||
130014384|NCT00677014|468013901|FG002|Overall Study|Lost to Follow-up|24|||
130348586|NCT04303780|469247504|FG000|Overall Study|Death|104|||
130348587|NCT04303780|469247505|FG001|Overall Study|Death|85|||
130348588|NCT04303780|469247504|FG000|Overall Study|Lost to Follow-up|5|||
130348589|NCT04303780|469247505|FG001|Overall Study|Lost to Follow-up|2|||
130348590|NCT04303780|469247504|FG000|Overall Study|Withdrawal by Subject|12|||
130348591|NCT04303780|469247505|FG001|Overall Study|Withdrawal by Subject|39|||
130348592|NCT04303780|469247504|FG000|Overall Study|Ongoing in study|50|||
130348593|NCT04303780|469247505|FG001|Overall Study|Ongoing in study|45|||
130348594|NCT03576274|469247507|FG000|Overall Study|Lost to Follow-up|3|||
130348595|NCT03576274|469247508|FG001|Overall Study|Lost to Follow-up|2|||
130348596|NCT03576274|469247509|FG002|Overall Study|Lost to Follow-up|3|||
130348597|NCT03576274|469247510|FG003|Overall Study|Lost to Follow-up|1|||
130348598|NCT03576274|469247511|FG004|Overall Study|Lost to Follow-up|3|||
130348599|NCT03576274|469247507|FG000|Overall Study|Withdrawal by Subject|5|||
130348600|NCT03576274|469247508|FG001|Overall Study|Withdrawal by Subject|3|||
130348601|NCT03576274|469247509|FG002|Overall Study|Withdrawal by Subject|2|||
130348602|NCT03576274|469247510|FG003|Overall Study|Withdrawal by Subject|8|||
130348603|NCT03576274|469247511|FG004|Overall Study|Withdrawal by Subject|6|||
130348604|NCT03976323|469247512|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
130348605|NCT03976323|469247513|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130348606|NCT03976323|469247514|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130348607|NCT03976323|469247512|FG000|Induction Phase|Death|80|||
130348608|NCT03976323|469247513|FG001|Induction Phase|Death|0|||
130348609|NCT03976323|469247514|FG002|Induction Phase|Death|0|||
130348610|NCT03976323|469247512|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
130348611|NCT03976323|469247513|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
130348612|NCT03976323|469247514|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
130348613|NCT03976323|469247512|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130348614|NCT03976323|469247513|FG001|Maintenance Phase|Withdrawal by Subject|9|||
130348615|NCT03976323|469247514|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130348616|NCT03976323|469247512|FG000|Maintenance Phase|Physician Decision|0|||
130348617|NCT03976323|469247513|FG001|Maintenance Phase|Physician Decision|0|||
130348618|NCT03976323|469247514|FG002|Maintenance Phase|Physician Decision|1|||
130348619|NCT03976323|469247512|FG000|Maintenance Phase|Death|0|||
130348620|NCT03976323|469247513|FG001|Maintenance Phase|Death|228|||
130348621|NCT03976323|469247514|FG002|Maintenance Phase|Death|234|||
130348622|NCT07149155|469247515|FG000|Overall Study|Lost to Follow-up|10|||
130348623|NCT03345576|469247516|FG000|Overall Study|Withdrawal by Subject|2|||
130348624|NCT03345576|469247517|FG001|Overall Study|Withdrawal by Subject|2|||
130348625|NCT03345576|469247516|FG000|Overall Study|Adverse Event|1|||
130348626|NCT03345576|469247517|FG001|Overall Study|Adverse Event|0|||
130014385|NCT00677014|468013899|FG000|Overall Study|Death|6|||
130014386|NCT00677014|468013900|FG001|Overall Study|Death|15|||
130014387|NCT00677014|468013901|FG002|Overall Study|Death|7|||
130014388|NCT00677014|468013899|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
130014389|NCT00677014|468013900|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
130014390|NCT00677014|468013901|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
130014391|NCT00640328|468013902|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130014392|NCT00640328|468013903|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
130014393|NCT00640328|468013904|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130014394|NCT00640328|468013905|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130014395|NCT00640328|468013906|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
129884425|NCT01275196|467536393|FG001|Overall Study|Adverse Event|5|||
130014396|NCT00640328|468013907|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
130014397|NCT00640328|468013902|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130014398|NCT00640328|468013903|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130014399|NCT00640328|468013904|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130014400|NCT00640328|468013905|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130014401|NCT00640328|468013906|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
130014402|NCT00640328|468013907|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
130014403|NCT00640328|468013902|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130014404|NCT00640328|468013903|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130014405|NCT00640328|468013904|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
130014406|NCT00640328|468013905|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130014407|NCT00640328|468013906|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130014408|NCT00640328|468013907|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
130014409|NCT00640328|468013902|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130014410|NCT00640328|468013903|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
130014411|NCT00640328|468013904|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130052118|NCT03952468|468147217|FG000|Overall Study|Withdrawal by Subject|2|||
130014412|NCT00640328|468013905|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
130014413|NCT00640328|468013906|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130014414|NCT00640328|468013907|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
130014415|NCT02374099|468013908|FG000|Overall Study|Adverse Event|1|||
130014416|NCT02374099|468013909|FG001|Overall Study|Adverse Event|0|||
130014417|NCT02374099|468013908|FG000|Overall Study|Progressive Disease|35|||
130014418|NCT02374099|468013909|FG001|Overall Study|Progressive Disease|40|||
130014419|NCT02374099|468013908|FG000|Overall Study|Withdrawal by Subject|5|||
130014420|NCT02374099|468013909|FG001|Overall Study|Withdrawal by Subject|1|||
130014421|NCT02374099|468013908|FG000|Overall Study|Miscellaneous|2|||
130014422|NCT02374099|468013909|FG001|Overall Study|Miscellaneous|3|||
130014423|NCT02374099|468013908|FG000|Overall Study|Randomized, but not treated|2|||
130014424|NCT02374099|468013909|FG001|Overall Study|Randomized, but not treated|1|||
130014425|NCT02374099|468013908|FG000|Overall Study|Study Terminated by Sponsor|3|||
130014426|NCT02374099|468013909|FG001|Overall Study|Study Terminated by Sponsor|4|||
130014427|NCT01326546|468013910|FG000|Overall Study|Lost to Follow-up|8|||
130014428|NCT01326546|468013911|FG001|Overall Study|Lost to Follow-up|7|||
130014429|NCT01326546|468013910|FG000|Overall Study|Protocol Violation|3|||
130014430|NCT01326546|468013911|FG001|Overall Study|Protocol Violation|4|||
130014431|NCT01326546|468013910|FG000|Overall Study|Pregnancy|0|||
130014432|NCT01326546|468013911|FG001|Overall Study|Pregnancy|1|||
130014433|NCT01326546|468013910|FG000|Overall Study|Adverse Event|1|||
130014434|NCT01326546|468013911|FG001|Overall Study|Adverse Event|0|||
130014435|NCT01326546|468013910|FG000|Overall Study|Withdrawal by Subject|5|||
130014436|NCT01326546|468013911|FG001|Overall Study|Withdrawal by Subject|1|||
130014437|NCT01033825|468013912|FG000|Overall Study|Withdrawal by Subject|2|||
130014438|NCT01033825|468013913|FG001|Overall Study|Withdrawal by Subject|3|||
130014439|NCT01033825|468013914|FG002|Overall Study|Withdrawal by Subject|2|||
130014440|NCT01033825|468013915|FG003|Overall Study|Withdrawal by Subject|1|||
130014441|NCT01033825|468013916|FG004|Overall Study|Withdrawal by Subject|1|||
130014442|NCT01033825|468013917|FG005|Overall Study|Withdrawal by Subject|0|||
130014443|NCT01033825|468013918|FG006|Overall Study|Withdrawal by Subject|0|||
130014444|NCT01033825|468013912|FG000|Overall Study|Adverse Event|0|||
130014445|NCT01033825|468013913|FG001|Overall Study|Adverse Event|0|||
130014446|NCT01033825|468013914|FG002|Overall Study|Adverse Event|0|||
130014447|NCT01033825|468013915|FG003|Overall Study|Adverse Event|1|||
130014448|NCT01033825|468013916|FG004|Overall Study|Adverse Event|0|||
130014449|NCT01033825|468013917|FG005|Overall Study|Adverse Event|0|||
130014450|NCT01033825|468013918|FG006|Overall Study|Adverse Event|0|||
130014451|NCT01033825|468013912|FG000|Overall Study|Protocol Violation|1|||
130014452|NCT01033825|468013913|FG001|Overall Study|Protocol Violation|0|||
130014453|NCT01033825|468013914|FG002|Overall Study|Protocol Violation|0|||
130014454|NCT01033825|468013915|FG003|Overall Study|Protocol Violation|0|||
130014455|NCT01033825|468013916|FG004|Overall Study|Protocol Violation|0|||
130014456|NCT01033825|468013917|FG005|Overall Study|Protocol Violation|0|||
130014457|NCT01033825|468013918|FG006|Overall Study|Protocol Violation|0|||
130014458|NCT01033825|468013912|FG000|Overall Study|Other|0|||
130014459|NCT01033825|468013913|FG001|Overall Study|Other|0|||
130014460|NCT01033825|468013914|FG002|Overall Study|Other|0|||
130014461|NCT01033825|468013915|FG003|Overall Study|Other|0|||
130014462|NCT01033825|468013916|FG004|Overall Study|Other|1|||
130014463|NCT01033825|468013917|FG005|Overall Study|Other|0|||
130014464|NCT01033825|468013918|FG006|Overall Study|Other|0|||
130014465|NCT04294719|468013919|FG000|Overall Study|Withdrawal by Subject|1|||
130014466|NCT00081159|468013920|FG000|Overall Study|Withdrawal by Subject|0|||
130014467|NCT00081159|468013921|FG001|Overall Study|Withdrawal by Subject|3|||
130014468|NCT00081159|468013920|FG000|Overall Study|Myelosuppression prior to treatment|0|||
130014469|NCT00081159|468013921|FG001|Overall Study|Myelosuppression prior to treatment|1|||
130014470|NCT00081159|468013920|FG000|Overall Study|Lost to Follow-up|2|||
130014471|NCT00081159|468013921|FG001|Overall Study|Lost to Follow-up|1|||
130014472|NCT01714687|468013922|FG000|Overall Study|Withdrawal by Subject|1|||
130014473|NCT01714687|468013923|FG001|Overall Study|Withdrawal by Subject|0|||
130014474|NCT01714687|468013922|FG000|Overall Study|Lost to Follow-up|2|||
130014475|NCT01714687|468013923|FG001|Overall Study|Lost to Follow-up|4|||
130014476|NCT01553136|468013926|FG000|Overall Study|Adverse Event|3|||
130014477|NCT01553136|468013927|FG001|Overall Study|Adverse Event|2|||
130014478|NCT01553136|468013926|FG000|Overall Study|Withdrawal by Subject|2|||
130014479|NCT01553136|468013927|FG001|Overall Study|Withdrawal by Subject|3|||
130014480|NCT01553136|468013926|FG000|Overall Study|Lost to Follow-up|4|||
130014481|NCT01553136|468013927|FG001|Overall Study|Lost to Follow-up|10|||
130014482|NCT01553136|468013926|FG000|Overall Study|Physician Decision|2|||
130014483|NCT01553136|468013927|FG001|Overall Study|Physician Decision|3|||
130014484|NCT01553136|468013926|FG000|Overall Study|Scheduling Difficulties|5|||
130014485|NCT01553136|468013927|FG001|Overall Study|Scheduling Difficulties|4|||
130014486|NCT00894556|468013928|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
130014487|NCT00894556|468013929|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
130014488|NCT00894556|468013930|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
130014489|NCT00894556|468013931|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
130014490|NCT00894556|468013928|FG000|Treatment Phase|Lost to Follow-up|2|||
130014491|NCT00894556|468013929|FG001|Treatment Phase|Lost to Follow-up|3|||
130014492|NCT00894556|468013930|FG002|Treatment Phase|Lost to Follow-up|1|||
130014493|NCT00894556|468013931|FG003|Treatment Phase|Lost to Follow-up|0|||
130014494|NCT00894556|468013928|FG000|Treatment Phase|Lack of Qualifying Event|2|||
130014495|NCT00894556|468013929|FG001|Treatment Phase|Lack of Qualifying Event|1|||
130014496|NCT00894556|468013930|FG002|Treatment Phase|Lack of Qualifying Event|0|||
130014497|NCT00894556|468013931|FG003|Treatment Phase|Lack of Qualifying Event|0|||
130014498|NCT01979536|468013934|FG000|Overall Study|Physician Decision|2|||
130014499|NCT01979536|468013935|FG001|Overall Study|Physician Decision|3|||
130014500|NCT01979536|468013934|FG000|Overall Study|Withdrawal by Subject|0|||
130014501|NCT01979536|468013935|FG001|Overall Study|Withdrawal by Subject|1|||
130014502|NCT01979536|468013934|FG000|Overall Study|Refusal|0|||
130014503|NCT01979536|468013935|FG001|Overall Study|Refusal|1|||
130014504|NCT01979536|468013934|FG000|Overall Study|Relapse|0|||
130014505|NCT01979536|468013935|FG001|Overall Study|Relapse|1|||
130014506|NCT01979536|468013934|FG000|Overall Study|Study terminated by Sponsor|0|||
130014507|NCT01979536|468013935|FG001|Overall Study|Study terminated by Sponsor|1|||
130014508|NCT01979536|468013934|FG000|Overall Study|Did not start treatment|0|||
130014509|NCT01979536|468013935|FG001|Overall Study|Did not start treatment|1|||
130014510|NCT03077685|468013936|FG000|Overall Study|Lost to Follow-up|0|||
130014511|NCT03077685|468013937|FG001|Overall Study|Lost to Follow-up|0|||
130014512|NCT03077685|468013938|FG002|Overall Study|Lost to Follow-up|0|||
130014513|NCT03077685|468013939|FG003|Overall Study|Lost to Follow-up|0|||
130014514|NCT03077685|468013940|FG004|Overall Study|Lost to Follow-up|1|||
130014515|NCT03077685|468013936|FG000|Overall Study|Death|0|||
130014516|NCT03077685|468013937|FG001|Overall Study|Death|0|||
130014517|NCT03077685|468013938|FG002|Overall Study|Death|1|||
130014518|NCT03077685|468013939|FG003|Overall Study|Death|1|||
130014519|NCT03077685|468013940|FG004|Overall Study|Death|3|||
130014520|NCT03077685|468013936|FG000|Overall Study|Withdrawal by Subject|0|||
130014521|NCT03077685|468013937|FG001|Overall Study|Withdrawal by Subject|0|||
130014522|NCT03077685|468013938|FG002|Overall Study|Withdrawal by Subject|0|||
130014523|NCT03077685|468013939|FG003|Overall Study|Withdrawal by Subject|2|||
130014524|NCT03077685|468013940|FG004|Overall Study|Withdrawal by Subject|1|||
130014525|NCT03077685|468013936|FG000|Overall Study|Physician Decision|0|||
130014526|NCT03077685|468013937|FG001|Overall Study|Physician Decision|0|||
130014527|NCT03077685|468013938|FG002|Overall Study|Physician Decision|1|||
130014528|NCT03077685|468013939|FG003|Overall Study|Physician Decision|0|||
130014529|NCT03077685|468013940|FG004|Overall Study|Physician Decision|3|||
130014530|NCT03077685|468013936|FG000|Overall Study|Disease Progression|1|||
130014531|NCT03077685|468013937|FG001|Overall Study|Disease Progression|0|||
130014532|NCT03077685|468013938|FG002|Overall Study|Disease Progression|0|||
130014533|NCT03077685|468013939|FG003|Overall Study|Disease Progression|2|||
130014534|NCT03077685|468013940|FG004|Overall Study|Disease Progression|1|||
130014535|NCT03077685|468013936|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
130014536|NCT03077685|468013937|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
130014537|NCT03077685|468013938|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
130014538|NCT03077685|468013939|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
130014539|NCT03077685|468013940|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
130014540|NCT03077685|468013936|FG000|Overall Study|Subject entered hospice care|0|||
130014541|NCT03077685|468013937|FG001|Overall Study|Subject entered hospice care|0|||
130014542|NCT03077685|468013938|FG002|Overall Study|Subject entered hospice care|0|||
130014543|NCT03077685|468013939|FG003|Overall Study|Subject entered hospice care|0|||
130014544|NCT03077685|468013940|FG004|Overall Study|Subject entered hospice care|1|||
130014545|NCT02581202|468013956|FG000|Overall Study|Lack of Efficacy|2|||
130014546|NCT02581202|468013956|FG000|Overall Study|Withdrawal by Subject|4|||
130014547|NCT02581202|468013956|FG000|Overall Study|Lost to Follow-up|5|||
130014548|NCT02581202|468013956|FG000|Overall Study|Pregnancy|3|||
130014549|NCT01806779|468013957|FG000|Overall Study|Physician Decision|2|||
130014550|NCT01806779|468013958|FG001|Overall Study|Physician Decision|0|||
130014551|NCT01806779|468013959|FG002|Overall Study|Physician Decision|1|||
130014552|NCT01806779|468013957|FG000|Overall Study|Lack of Efficacy|1|||
130014553|NCT01806779|468013958|FG001|Overall Study|Lack of Efficacy|1|||
130014554|NCT01806779|468013959|FG002|Overall Study|Lack of Efficacy|0|||
130014555|NCT01806779|468013957|FG000|Overall Study|Lost to Follow-up|19|||
130014556|NCT01806779|468013958|FG001|Overall Study|Lost to Follow-up|20|||
130014557|NCT01806779|468013959|FG002|Overall Study|Lost to Follow-up|0|||
130014558|NCT01806779|468013957|FG000|Overall Study|Withdrawal by Subject|20|||
130014559|NCT01806779|468013958|FG001|Overall Study|Withdrawal by Subject|23|||
130014560|NCT01806779|468013959|FG002|Overall Study|Withdrawal by Subject|22|||
130014561|NCT02595450|468013962|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
130014562|NCT02595450|468013962|FG000|Overall Study|Enrolled, but not treated|8|||
130014563|NCT04294901|468013964|FG000|Overall Study|Death|86|||
130014564|NCT04294901|468013965|FG001|Overall Study|Death|110|||
130014565|NCT04294901|468013964|FG000|Overall Study|Provider did not have historical control patients|581|||
130014566|NCT04294901|468013965|FG001|Overall Study|Provider did not have historical control patients|0|||
130014567|NCT04294901|468013964|FG000|Overall Study|Provider did not have intervention patients|0|||
130014568|NCT04294901|468013965|FG001|Overall Study|Provider did not have intervention patients|98|||
130014569|NCT01934556|468013968|FG000|Overall Study|Withdrawal by Subject|0|||
130014570|NCT01934556|468013969|FG001|Overall Study|Withdrawal by Subject|1|||
130014571|NCT01934556|468013970|FG002|Overall Study|Withdrawal by Subject|1|||
130014572|NCT01934556|468013968|FG000|Overall Study|Lost to Follow-up|4|||
130014573|NCT01934556|468013969|FG001|Overall Study|Lost to Follow-up|10|||
130014574|NCT01934556|468013970|FG002|Overall Study|Lost to Follow-up|7|||
130014575|NCT01934556|468013968|FG000|Overall Study|Death|1|||
130014576|NCT01934556|468013969|FG001|Overall Study|Death|5|||
130014577|NCT01934556|468013970|FG002|Overall Study|Death|2|||
130014578|NCT05038020|468013974|FG000|Overall Study|Early Termination|3|||
130014579|NCT05038020|468013975|FG001|Overall Study|Early Termination|0|||
130014580|NCT03770260|468015366|FG000|Overall Study|Disease progression|0|||
130014581|NCT03770260|468015367|FG001|Overall Study|Disease progression|1|||
130014582|NCT03770260|468015368|FG002|Overall Study|Disease progression|0|||
130014583|NCT03770260|468015369|FG003|Overall Study|Disease progression|0|||
130014584|NCT02484911|468015370|FG000|Overall Study|Withdrawal by Subject|2|||
130014585|NCT02484911|468015371|FG001|Overall Study|Withdrawal by Subject|1|||
130014586|NCT02484911|468015370|FG000|Overall Study|Protocol Violation|2|||
130014587|NCT02484911|468015371|FG001|Overall Study|Protocol Violation|1|||
130014588|NCT01652885|468015376|FG000|Overall Study|Adverse Event|1|||
130014589|NCT00075400|468015377|FG000|Overall Study|Ineligible: wrong primary|1|||
130014590|NCT00075400|468015377|FG000|Overall Study|Never treated|2|||
130014591|NCT00490568|468015378|FG000|Overall Study|Adverse Event|116|||
130014592|NCT00490568|468015378|FG000|Overall Study|Lost to Follow-up|13|||
130014593|NCT00490568|468015378|FG000|Overall Study|Protocol Violation|45|||
130014594|NCT00490568|468015378|FG000|Overall Study|Withdrawal by Subject|135|||
130014595|NCT00490568|468015378|FG000|Overall Study|Still in the study at termination|974|||
130014596|NCT00490568|468015378|FG000|Overall Study|Other|1|||
130014597|NCT00490568|468015378|FG000|Overall Study|Exclusion criteria met|1|||
130014598|NCT00490568|468015378|FG000|Overall Study|Caregiver related|20|||
130014599|NCT00490568|468015378|FG000|Overall Study|Abnormal ECG|25|||
130014600|NCT00490568|468015378|FG000|Overall Study|Participant refused follow-up|9|||
130014601|NCT00490568|468015378|FG000|Overall Study|Legal representative withdrew consent|1|||
130014602|NCT00490568|468015378|FG000|Overall Study|Disease progression|4|||
130014603|NCT00490568|468015378|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
130014604|NCT00490568|468015378|FG000|Overall Study|Investigator decision|3|||
130014605|NCT00490568|468015378|FG000|Overall Study|Non-Compliance|7|||
130014606|NCT00490568|468015378|FG000|Overall Study|Efficacy related|3|||
130014607|NCT00490568|468015378|FG000|Overall Study|Participant died|1|||
130014608|NCT00490568|468015378|FG000|Overall Study|Participant withdrawal due to surgery|1|||
130014609|NCT01395394|468015379|FG000|Baseline Study Visit|Protocol Violation|1|||
130014610|NCT01395394|468015380|FG001|Baseline Study Visit|Protocol Violation|0|||
130014611|NCT01395394|468015381|FG002|Baseline Study Visit|Protocol Violation|0|||
130014612|NCT03451773|468015384|FG000|Overall Study|Death on study|1|||
130014613|NCT03451773|468015385|FG001|Overall Study|Death on study|5|||
130014614|NCT03451773|468015384|FG000|Overall Study|Death during follow-up period|0|||
130014615|NCT03451773|468015385|FG001|Overall Study|Death during follow-up period|1|||
130014616|NCT03468855|468015386|FG000|Overall Study|Adverse Event|2|||
130014617|NCT03468855|468015386|FG000|Overall Study|Lost to Follow-up|5|||
130014618|NCT03468855|468015386|FG000|Overall Study|Withdrawal by Subject|3|||
130014619|NCT03468855|468015386|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
130014620|NCT01908101|468015387|FG000|Overall Study|Physician Decision|1|||
130014621|NCT01908101|468015387|FG000|Overall Study|Withdrawal by Subject|1|||
130014622|NCT01908101|468015387|FG000|Overall Study|Incorrect Diagnosis|2|||
130014623|NCT01908101|468015387|FG000|Overall Study|Incorrect Starting Dose|1|||
130014624|NCT01908101|468015387|FG000|Overall Study|Did not complete the first cycle|4|||
130014625|NCT00477165|468015388|FG000|Overall Study|Adverse Event|7|||
130014626|NCT00477165|468015389|FG001|Overall Study|Adverse Event|2|||
130014627|NCT00105443|468015390|FG000|Double-Blind Treatment|Adverse Event|1|||
130014628|NCT00105443|468015391|FG001|Double-Blind Treatment|Adverse Event|0|||
130014629|NCT00105443|468015392|FG002|Double-Blind Treatment|Adverse Event|0|||
130014630|NCT00105443|468015393|FG003|Double-Blind Treatment|Adverse Event|0|||
130014631|NCT00105443|468015390|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
130014632|NCT00105443|468015391|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
130014633|NCT00105443|468015392|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
130014634|NCT00105443|468015393|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
130014635|NCT00105443|468015390|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
130014636|NCT00105443|468015391|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
130014637|NCT00105443|468015392|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
130014638|NCT00105443|468015393|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
130014639|NCT00105443|468015390|FG000|Double-Blind Treatment|Physician Decision|1|||
130014640|NCT00105443|468015391|FG001|Double-Blind Treatment|Physician Decision|0|||
130014641|NCT00105443|468015392|FG002|Double-Blind Treatment|Physician Decision|2|||
130014642|NCT00105443|468015393|FG003|Double-Blind Treatment|Physician Decision|0|||
130014643|NCT00105443|468015390|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
130014644|NCT00105443|468015391|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
130014645|NCT00105443|468015392|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
130014646|NCT00105443|468015393|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
130014647|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
130014648|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
130014649|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
130014650|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
130014651|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
130014652|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
130014653|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
130014654|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
130014655|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
130014656|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
130014657|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
130014658|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
130014659|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
130014660|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
130217803|NCT04865419|468761405|FG003|Overall Study|Study terminated by Sponsor|2|||
130014661|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
130217804|NCT04865419|468761406|FG004|Overall Study|Study terminated by Sponsor|2|||
130014662|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
130014663|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
130014664|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
130014665|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
130014666|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
130014667|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
130014668|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
130014669|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
130014670|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
130014671|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
130014672|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
130014673|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
130014674|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
130014675|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
130014676|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
130014677|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
130014678|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
130014679|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
130014680|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
130014681|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
130014682|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
130014683|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
130014684|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
130014685|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
130014686|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
130014687|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
130014688|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
130014689|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
130014690|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
130014691|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
130014692|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
130014693|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
130014694|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
130014695|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
130014696|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
130014697|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
130014698|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
130014699|NCT00105443|468015390|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
130014700|NCT00105443|468015391|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
130014701|NCT00105443|468015392|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
130014702|NCT00105443|468015393|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
130014703|NCT02135692|468015394|FG000|Overall Study|Adverse Event|3|||
130014704|NCT02135692|468015394|FG000|Overall Study|Lack of Efficacy|2|||
130014705|NCT02135692|468015394|FG000|Overall Study|Protocol Violation|2|||
130014706|NCT02135692|468015394|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
130014707|NCT02135692|468015394|FG000|Overall Study|Product commercially available|159|||
130014708|NCT02135692|468015394|FG000|Overall Study|Study closed/terminated|153|||
130014709|NCT02135692|468015394|FG000|Overall Study|Lost to Follow-up|4|||
130014710|NCT02135692|468015394|FG000|Overall Study|Withdrawal by Subject|15|||
130014711|NCT01157078|468015395|FG000|Overall Study|Withdrawal by Subject|12|||
130014712|NCT01157078|468015396|FG001|Overall Study|Withdrawal by Subject|14|||
130014713|NCT01157078|468015395|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130014714|NCT01157078|468015396|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130014715|NCT01157078|468015395|FG000|Overall Study|Adverse Event|6|||
130014716|NCT01157078|468015396|FG001|Overall Study|Adverse Event|6|||
130014717|NCT01157078|468015395|FG000|Overall Study|Severe non-compliance to protocol|2|||
130014718|NCT01157078|468015396|FG001|Overall Study|Severe non-compliance to protocol|4|||
130014719|NCT01157078|468015395|FG000|Overall Study|Condition under investigation worsened|0|||
130014720|NCT01157078|468015396|FG001|Overall Study|Condition under investigation worsened|1|||
130014721|NCT01157078|468015395|FG000|Overall Study|Lack of Efficacy|2|||
130014722|NCT01157078|468015396|FG001|Overall Study|Lack of Efficacy|0|||
130014723|NCT01157078|468015395|FG000|Overall Study|Study-specific withdrawal criteria|2|||
130014724|NCT01157078|468015396|FG001|Overall Study|Study-specific withdrawal criteria|2|||
130014725|NCT01157078|468015395|FG000|Overall Study|Lost to Follow-up|7|||
130014726|NCT01157078|468015396|FG001|Overall Study|Lost to Follow-up|5|||
130014727|NCT01157078|468015395|FG000|Overall Study|Other|2|||
130014728|NCT01157078|468015396|FG001|Overall Study|Other|4|||
130014729|NCT04429061|468015399|FG000|Overall Study|Lost to Follow-up|62|||
130014730|NCT04429061|468015400|FG001|Overall Study|Lost to Follow-up|87|||
130014731|NCT04429061|468015399|FG000|Overall Study|Withdrawal by Subject|3|||
130014732|NCT04429061|468015400|FG001|Overall Study|Withdrawal by Subject|4|||
130014733|NCT00879229|468015407|FG000|Overall Study|Study terminated by Sponsor|13|||
130014734|NCT00879229|468015408|FG001|Overall Study|Study terminated by Sponsor|12|||
130014735|NCT00879229|468015407|FG000|Overall Study|Death|4|||
130014736|NCT00879229|468015408|FG001|Overall Study|Death|2|||
130014737|NCT00879229|468015407|FG000|Overall Study|Adverse Event|2|||
130014738|NCT00879229|468015408|FG001|Overall Study|Adverse Event|0|||
130014739|NCT00879229|468015407|FG000|Overall Study|Withdrawal by Subject|1|||
130014740|NCT00879229|468015408|FG001|Overall Study|Withdrawal by Subject|0|||
130014741|NCT00879229|468015407|FG000|Overall Study|Clinical status did not improve|1|||
130014742|NCT00879229|468015408|FG001|Overall Study|Clinical status did not improve|0|||
130014743|NCT00879229|468015407|FG000|Overall Study|Other|1|||
130014744|NCT00879229|468015408|FG001|Overall Study|Other|0|||
130014745|NCT01097746|468015409|FG000|Overall Study|Adverse Event|4|||
130014746|NCT01097746|468015409|FG000|Overall Study|taken off study before any treatment given|1|||
130014747|NCT00631371|468015416|FG000|Overall Study|Lost to Follow-up|24|||
130014748|NCT00631371|468015417|FG001|Overall Study|Lost to Follow-up|19|||
130014749|NCT00631371|468015416|FG000|Overall Study|Other reason|5|||
130014750|NCT00631371|468015417|FG001|Overall Study|Other reason|12|||
130014751|NCT00631371|468015416|FG000|Overall Study|subject request|38|||
130014752|NCT00631371|468015417|FG001|Overall Study|subject request|45|||
130014753|NCT00631371|468015416|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
130014754|NCT00631371|468015417|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
130014755|NCT00631371|468015416|FG000|Overall Study|Death|263|||
130014756|NCT00631371|468015417|FG001|Overall Study|Death|239|||
130014757|NCT00390546|468015418|FG000|Overall Study|Renal impairment|1|||
130014758|NCT00390546|468015419|FG001|Overall Study|Renal impairment|0|||
130014759|NCT00390546|468015418|FG000|Overall Study|Physician Decision|5|||
130014760|NCT00390546|468015419|FG001|Overall Study|Physician Decision|5|||
130014761|NCT00812214|468015425|FG000|Overall Study|Lost to Follow-up|3|||
130014762|NCT00812214|468015426|FG001|Overall Study|Lost to Follow-up|1|||
130014763|NCT02145741|468015427|FG000|Overall Study|Progressive disease|3|||
130014764|NCT02145741|468015428|FG001|Overall Study|Progressive disease|6|||
130014765|NCT02145741|468015429|FG002|Overall Study|Progressive disease|6|||
130014766|NCT02145741|468015427|FG000|Overall Study|quality issue with the administered drug|3|||
130014767|NCT02145741|468015428|FG001|Overall Study|quality issue with the administered drug|0|||
130014768|NCT02145741|468015429|FG002|Overall Study|quality issue with the administered drug|0|||
130014769|NCT01192022|468015430|FG000|Overall Study|Withdrawal of Consent|3|||
130014770|NCT01192022|468015431|FG001|Overall Study|Withdrawal of Consent|1|||
130014771|NCT01192022|468015432|FG002|Overall Study|Withdrawal of Consent|0|||
130014772|NCT01192022|468015433|FG003|Overall Study|Withdrawal of Consent|0|||
130014773|NCT01192022|468015434|FG004|Overall Study|Withdrawal of Consent|0|||
130014774|NCT01192022|468015430|FG000|Overall Study|Lost to Follow-up|4|||
130014775|NCT01192022|468015431|FG001|Overall Study|Lost to Follow-up|2|||
130014776|NCT01192022|468015432|FG002|Overall Study|Lost to Follow-up|1|||
130014777|NCT01192022|468015433|FG003|Overall Study|Lost to Follow-up|1|||
130014778|NCT01192022|468015434|FG004|Overall Study|Lost to Follow-up|0|||
130014779|NCT01192022|468015430|FG000|Overall Study|Adverse Event|1|||
130014780|NCT01192022|468015431|FG001|Overall Study|Adverse Event|0|||
130014781|NCT01192022|468015432|FG002|Overall Study|Adverse Event|0|||
130014782|NCT01192022|468015433|FG003|Overall Study|Adverse Event|0|||
130014783|NCT01192022|468015434|FG004|Overall Study|Adverse Event|0|||
130014784|NCT01192022|468015430|FG000|Overall Study|Fatal Adverse Event|4|||
130014785|NCT01192022|468015431|FG001|Overall Study|Fatal Adverse Event|6|||
130014786|NCT01192022|468015432|FG002|Overall Study|Fatal Adverse Event|0|||
130014787|NCT01192022|468015433|FG003|Overall Study|Fatal Adverse Event|0|||
130014788|NCT01192022|468015434|FG004|Overall Study|Fatal Adverse Event|1|||
130014789|NCT01192022|468015430|FG000|Overall Study|Physician withdrew-patient hardship|1|||
130014790|NCT01192022|468015431|FG001|Overall Study|Physician withdrew-patient hardship|0|||
130014791|NCT01192022|468015432|FG002|Overall Study|Physician withdrew-patient hardship|0|||
130014792|NCT01192022|468015433|FG003|Overall Study|Physician withdrew-patient hardship|0|||
130014793|NCT01192022|468015434|FG004|Overall Study|Physician withdrew-patient hardship|0|||
130014794|NCT01192022|468015430|FG000|Overall Study|Patient too sick from chemotherapy|0|||
130014795|NCT01192022|468015431|FG001|Overall Study|Patient too sick from chemotherapy|1|||
130014796|NCT01192022|468015432|FG002|Overall Study|Patient too sick from chemotherapy|0|||
130014797|NCT01192022|468015433|FG003|Overall Study|Patient too sick from chemotherapy|0|||
130014798|NCT01192022|468015434|FG004|Overall Study|Patient too sick from chemotherapy|0|||
130014799|NCT01192022|468015430|FG000|Overall Study|Patient needed surgery|0|||
130014800|NCT01192022|468015431|FG001|Overall Study|Patient needed surgery|1|||
130014801|NCT01192022|468015432|FG002|Overall Study|Patient needed surgery|0|||
130014802|NCT01192022|468015433|FG003|Overall Study|Patient needed surgery|0|||
130014803|NCT01192022|468015434|FG004|Overall Study|Patient needed surgery|0|||
130014804|NCT01192022|468015430|FG000|Overall Study|Parents did not allow all follow up|0|||
130014805|NCT01192022|468015431|FG001|Overall Study|Parents did not allow all follow up|0|||
130014806|NCT01192022|468015432|FG002|Overall Study|Parents did not allow all follow up|0|||
130014807|NCT01192022|468015433|FG003|Overall Study|Parents did not allow all follow up|1|||
130014808|NCT01192022|468015434|FG004|Overall Study|Parents did not allow all follow up|0|||
130014809|NCT00129766|468015436|FG000|Overall Study|Death|3|||
130014810|NCT00129766|468015437|FG001|Overall Study|Death|8|||
130014811|NCT00129766|468015436|FG000|Overall Study|Withdrawal of consent|31|||
130014812|NCT00129766|468015437|FG001|Overall Study|Withdrawal of consent|30|||
130014813|NCT00129766|468015436|FG000|Overall Study|Lost to Follow-up|26|||
130014814|NCT00129766|468015437|FG001|Overall Study|Lost to Follow-up|21|||
130014815|NCT00781456|468015439|FG000|Overall Study|Adverse Event|3|||
130014816|NCT00781456|468015440|FG001|Overall Study|Adverse Event|3|||
130014817|NCT00781456|468015439|FG000|Overall Study|Withdrawal by Subject|3|||
130014818|NCT00781456|468015440|FG001|Overall Study|Withdrawal by Subject|5|||
130014819|NCT00781456|468015439|FG000|Overall Study|Protocol Violation|4|||
130014820|NCT00781456|468015440|FG001|Overall Study|Protocol Violation|1|||
130014821|NCT00781456|468015439|FG000|Overall Study|Noncompliance With Protocol|1|||
130014822|NCT00781456|468015440|FG001|Overall Study|Noncompliance With Protocol|1|||
130014823|NCT00781456|468015439|FG000|Overall Study|Lost to Follow-up|10|||
130014824|NCT00781456|468015440|FG001|Overall Study|Lost to Follow-up|5|||
130014825|NCT00781456|468015439|FG000|Overall Study|Other Reason, Unknown|0|||
130014826|NCT00781456|468015440|FG001|Overall Study|Other Reason, Unknown|1|||
130014827|NCT04091087|468015441|FG000|Overall Study|Not treated|1|||
130014828|NCT04091087|468015442|FG001|Overall Study|Not treated|0|||
130014829|NCT04091087|468015441|FG000|Overall Study|Adverse Event|4|||
130014830|NCT04091087|468015442|FG001|Overall Study|Adverse Event|4|||
130014831|NCT04091087|468015441|FG000|Overall Study|Protocol Violation|0|||
130014832|NCT04091087|468015442|FG001|Overall Study|Protocol Violation|1|||
130014833|NCT04091087|468015441|FG000|Overall Study|Withdrawal by Subject|5|||
130014834|NCT04091087|468015442|FG001|Overall Study|Withdrawal by Subject|2|||
130014835|NCT05440539|468015443|FG000|Overall Study|Lost to Follow-up|4|||
130014836|NCT05440539|468015444|FG001|Overall Study|Lost to Follow-up|4|||
130014837|NCT05440539|468015443|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
130014838|NCT05440539|468015444|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
130014839|NCT03808077|468015445|FG000|Overall Study|Physician Decision|2|||
130014840|NCT03808077|468015446|FG001|Overall Study|Physician Decision|3|||
130014841|NCT03808077|468015445|FG000|Overall Study|Withdrawal by Subject|1|||
130014842|NCT03808077|468015446|FG001|Overall Study|Withdrawal by Subject|0|||
130014843|NCT03808077|468015445|FG000|Overall Study|Equipment Issues|2|||
130014844|NCT03808077|468015446|FG001|Overall Study|Equipment Issues|1|||
130014845|NCT04152161|468015447|FG000|Overall Study|Death|0|||
130014846|NCT04152161|468015448|FG001|Overall Study|Death|1|||
130014847|NCT04152161|468015447|FG000|Overall Study|Physician Decision|0|||
130014848|NCT04152161|468015448|FG001|Overall Study|Physician Decision|1|||
130014849|NCT04152161|468015447|FG000|Overall Study|Lost to Follow-up|9|||
130014850|NCT04152161|468015448|FG001|Overall Study|Lost to Follow-up|3|||
130014851|NCT04152161|468015447|FG000|Overall Study|Protocol Violation|1|||
130014852|NCT04152161|468015448|FG001|Overall Study|Protocol Violation|0|||
130014853|NCT04152161|468015447|FG000|Overall Study|Withdrawal by Subject|29|||
130014854|NCT04152161|468015448|FG001|Overall Study|Withdrawal by Subject|28|||
130014855|NCT04152161|468015447|FG000|Overall Study|Sponsor termination of study|750|||
130014856|NCT04152161|468015448|FG001|Overall Study|Sponsor termination of study|755|||
130014857|NCT04152161|468015447|FG000|Overall Study|Other|20|||
130014858|NCT04152161|468015448|FG001|Overall Study|Other|18|||
130014859|NCT03246958|468015449|FG000|Overall Study|Withdrawal by Subject|0|||
130014860|NCT03246958|468015450|FG001|Overall Study|Withdrawal by Subject|1|||
130014861|NCT03246958|468015451|FG002|Overall Study|Withdrawal by Subject|0|||
130014862|NCT03246958|468015452|FG003|Overall Study|Withdrawal by Subject|0|||
130014863|NCT03246958|468015453|FG004|Overall Study|Withdrawal by Subject|0|||
130014864|NCT03246958|468015454|FG005|Overall Study|Withdrawal by Subject|1|||
130014865|NCT03246958|468015455|FG006|Overall Study|Withdrawal by Subject|0|||
130014866|NCT03246958|468015449|FG000|Overall Study|Progression|13|||
130014867|NCT03246958|468015450|FG001|Overall Study|Progression|9|||
130014868|NCT03246958|468015451|FG002|Overall Study|Progression|3|||
130014869|NCT03246958|468015452|FG003|Overall Study|Progression|2|||
130014870|NCT03246958|468015453|FG004|Overall Study|Progression|1|||
130014871|NCT03246958|468015454|FG005|Overall Study|Progression|2|||
130014872|NCT03246958|468015455|FG006|Overall Study|Progression|1|||
130014873|NCT03246958|468015449|FG000|Overall Study|Adverse Event|2|||
130014874|NCT03246958|468015450|FG001|Overall Study|Adverse Event|2|||
130014875|NCT03246958|468015451|FG002|Overall Study|Adverse Event|0|||
130014876|NCT03246958|468015452|FG003|Overall Study|Adverse Event|1|||
130014877|NCT03246958|468015453|FG004|Overall Study|Adverse Event|1|||
130014878|NCT03246958|468015454|FG005|Overall Study|Adverse Event|0|||
130014879|NCT03246958|468015455|FG006|Overall Study|Adverse Event|2|||
130014880|NCT03246958|468015449|FG000|Overall Study|Death|0|||
130014881|NCT03246958|468015450|FG001|Overall Study|Death|1|||
130014882|NCT03246958|468015451|FG002|Overall Study|Death|0|||
130014883|NCT03246958|468015452|FG003|Overall Study|Death|0|||
130014884|NCT03246958|468015453|FG004|Overall Study|Death|0|||
130014885|NCT03246958|468015454|FG005|Overall Study|Death|0|||
130014886|NCT03246958|468015455|FG006|Overall Study|Death|0|||
130014887|NCT03246958|468015449|FG000|Overall Study|Physician Decision|0|||
130014888|NCT03246958|468015450|FG001|Overall Study|Physician Decision|0|||
130014889|NCT03246958|468015451|FG002|Overall Study|Physician Decision|0|||
130014890|NCT03246958|468015452|FG003|Overall Study|Physician Decision|1|||
130014891|NCT03246958|468015453|FG004|Overall Study|Physician Decision|0|||
130014892|NCT03246958|468015454|FG005|Overall Study|Physician Decision|0|||
130014893|NCT03246958|468015455|FG006|Overall Study|Physician Decision|0|||
130014894|NCT03246958|468015449|FG000|Overall Study|Never start treatment|1|||
130014895|NCT03246958|468015450|FG001|Overall Study|Never start treatment|0|||
130014896|NCT03246958|468015451|FG002|Overall Study|Never start treatment|0|||
130014897|NCT03246958|468015452|FG003|Overall Study|Never start treatment|0|||
130014898|NCT03246958|468015453|FG004|Overall Study|Never start treatment|0|||
130014899|NCT03246958|468015454|FG005|Overall Study|Never start treatment|0|||
130014900|NCT03246958|468015455|FG006|Overall Study|Never start treatment|0|||
130014901|NCT03246958|468015449|FG000|Overall Study|Over enrollment|0|||
130014902|NCT03246958|468015450|FG001|Overall Study|Over enrollment|2|||
130014903|NCT03246958|468015451|FG002|Overall Study|Over enrollment|0|||
130014904|NCT03246958|468015452|FG003|Overall Study|Over enrollment|0|||
130014905|NCT03246958|468015453|FG004|Overall Study|Over enrollment|0|||
130014906|NCT03246958|468015454|FG005|Overall Study|Over enrollment|0|||
130014907|NCT03246958|468015455|FG006|Overall Study|Over enrollment|0|||
130014908|NCT01379274|468015456|FG000|Overall Study|funding withdrawn|1|||
130014909|NCT03287219|468015457|FG000|Overall Study|Protocol Violation|0|||
130014910|NCT03287219|468015458|FG001|Overall Study|Protocol Violation|2|||
130014911|NCT00631020|468015459|FG000|Overall Study|Lost to Follow-up|7|||
130014912|NCT00631020|468015459|FG000|Overall Study|Incarcerated|1|||
130014913|NCT03221751|468015460|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
130014914|NCT03221751|468015461|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
130014915|NCT01265797|468015462|FG000|Run-in Month|Withdrawal by Subject|0|||
130014916|NCT01265797|468015463|FG001|Run-in Month|Withdrawal by Subject|4|||
130014917|NCT01265797|468015462|FG000|Run-in Month|1st seizure during run-in month|0|||
130014918|NCT01265797|468015463|FG001|Run-in Month|1st seizure during run-in month|1|||
130014919|NCT01265797|468015462|FG000|Blinded Month|Lack of Efficacy|5|||
130014920|NCT01265797|468015463|FG001|Blinded Month|Lack of Efficacy|0|||
130014921|NCT01265797|468015462|FG000|Blinded Month|Lost to Follow-up|1|||
130014922|NCT01265797|468015463|FG001|Blinded Month|Lost to Follow-up|0|||
130014923|NCT01265797|468015462|FG000|Blinded Month|Protocol Violation|2|||
130014924|NCT01265797|468015463|FG001|Blinded Month|Protocol Violation|1|||
130014925|NCT01265797|468015462|FG000|Blinded Month|Adverse Event|2|||
130014926|NCT01265797|468015463|FG001|Blinded Month|Adverse Event|0|||
130014927|NCT01265797|468015462|FG000|Blinded Month|Diary data incomplete|0|||
130014928|NCT01265797|468015463|FG001|Blinded Month|Diary data incomplete|1|||
130014929|NCT01265797|468015462|FG000|Open Label Month|Lost to Follow-up|0|||
130014930|NCT01265797|468015463|FG001|Open Label Month|Lost to Follow-up|1|||
130014931|NCT02813694|468015464|FG000|Overall Study|Physician Decision|0|||
130014932|NCT02813694|468015465|FG001|Overall Study|Physician Decision|1|||
130014933|NCT02813694|468015464|FG000|Overall Study|Withdrawal by Subject|10|||
130014934|NCT02813694|468015465|FG001|Overall Study|Withdrawal by Subject|9|||
130014935|NCT02813694|468015464|FG000|Overall Study|Lost to Follow-up|1|||
130014936|NCT02813694|468015465|FG001|Overall Study|Lost to Follow-up|1|||
130014937|NCT02813694|468015464|FG000|Overall Study|Death|3|||
130014938|NCT02813694|468015465|FG001|Overall Study|Death|3|||
130014939|NCT02813694|468015464|FG000|Overall Study|Randomized- did not receive study drug|2|||
130014940|NCT02813694|468015465|FG001|Overall Study|Randomized- did not receive study drug|0|||
130014941|NCT02813694|468015464|FG000|Overall Study|Patient hospitalized|1|||
130014942|NCT02813694|468015465|FG001|Overall Study|Patient hospitalized|0|||
130014943|NCT01422915|468015466|FG000|Overall Study|Adverse Event|1|||
130014944|NCT01152021|468015467|FG000|Overall Study|Adverse Event|4|||
130014945|NCT01152021|468015468|FG001|Overall Study|Adverse Event|4|||
130014946|NCT01152021|468015467|FG000|Overall Study|Study drug had expired|1|||
130014947|NCT01152021|468015468|FG001|Overall Study|Study drug had expired|0|||
130014948|NCT01152021|468015467|FG000|Overall Study|Physician Decision|1|||
130014949|NCT01152021|468015468|FG001|Overall Study|Physician Decision|1|||
130014950|NCT01152021|468015467|FG000|Overall Study|No access to study drug in Pharmacy|0|||
130014951|NCT01152021|468015468|FG001|Overall Study|No access to study drug in Pharmacy|1|||
130014952|NCT04839380|468015469|FG000|Overall Study|Withdrawal by Subject|2|||
130014953|NCT04839380|468015469|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
130014954|NCT01347554|468015470|FG000|Overall Study|Lack of Efficacy|7|||
130014955|NCT01347554|468015471|FG001|Overall Study|Lack of Efficacy|11|||
130014956|NCT00004259|468015473|FG000|Overall Study|Protocol Violation|1|||
130014957|NCT00004259|468015474|FG001|Overall Study|Protocol Violation|2|||
130014958|NCT00004259|468015475|FG002|Overall Study|Protocol Violation|0|||
130014959|NCT00004259|468015476|FG003|Overall Study|Protocol Violation|0|||
130014960|NCT00004259|468015473|FG000|Overall Study|Withdrawal by Subject|0|||
130014961|NCT00004259|468015474|FG001|Overall Study|Withdrawal by Subject|2|||
130014962|NCT00004259|468015475|FG002|Overall Study|Withdrawal by Subject|0|||
130014963|NCT00004259|468015476|FG003|Overall Study|Withdrawal by Subject|0|||
130014964|NCT00996944|468015477|FG000|Double-blind Treatment Period|Adverse Event|2|||
130014965|NCT00996944|468015478|FG001|Double-blind Treatment Period|Adverse Event|1|||
130014966|NCT00996944|468015477|FG000|Double-blind Treatment Period|Protocol Violation|1|||
130014967|NCT00996944|468015478|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130014968|NCT00996944|468015477|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
130014969|NCT00996944|468015478|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
130014970|NCT00996944|468015477|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130014971|NCT00996944|468015478|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130014972|NCT00996944|468015477|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
130014973|NCT00996944|468015478|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
130014974|NCT00769184|468015479|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
130014975|NCT00769184|468015480|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
130014976|NCT00769184|468015479|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
130014977|NCT00769184|468015480|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
130014978|NCT00769184|468015479|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
130014979|NCT00769184|468015480|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
130014980|NCT00385255|468015481|FG000|Overall Study|Serious Adverse Event|1|||
130014981|NCT00385255|468015482|FG001|Overall Study|Serious Adverse Event|2|||
130014982|NCT00385255|468015481|FG000|Overall Study|Protocol Violation|0|||
130014983|NCT00385255|468015482|FG001|Overall Study|Protocol Violation|4|||
130014984|NCT00385255|468015481|FG000|Overall Study|Withdrawal by Subject|0|||
130014985|NCT00385255|468015482|FG001|Overall Study|Withdrawal by Subject|8|||
130014986|NCT00385255|468015481|FG000|Overall Study|Migrated/moved from study area|0|||
130014987|NCT00385255|468015482|FG001|Overall Study|Migrated/moved from study area|1|||
130014988|NCT00385255|468015481|FG000|Overall Study|Lost to Follow-up|20|||
130014989|NCT00385255|468015482|FG001|Overall Study|Lost to Follow-up|58|||
130014990|NCT02443883|468015483|FG000|Overall Study|Adverse Event|0|||
130014991|NCT02443883|468015484|FG001|Overall Study|Adverse Event|1|||
130014992|NCT02443883|468015485|FG002|Overall Study|Adverse Event|0|||
130014993|NCT02443883|468015486|FG003|Overall Study|Adverse Event|0|||
130014994|NCT02443883|468015483|FG000|Overall Study|Lost to Follow-up|3|||
130014995|NCT02443883|468015484|FG001|Overall Study|Lost to Follow-up|2|||
130014996|NCT02443883|468015485|FG002|Overall Study|Lost to Follow-up|1|||
130014997|NCT02443883|468015486|FG003|Overall Study|Lost to Follow-up|0|||
130014998|NCT02443883|468015483|FG000|Overall Study|Physician Decision|1|||
130014999|NCT02443883|468015484|FG001|Overall Study|Physician Decision|1|||
130015000|NCT02443883|468015485|FG002|Overall Study|Physician Decision|0|||
130015001|NCT02443883|468015486|FG003|Overall Study|Physician Decision|3|||
130015002|NCT02443883|468015483|FG000|Overall Study|Withdrawal by Subject|1|||
130015003|NCT02443883|468015484|FG001|Overall Study|Withdrawal by Subject|0|||
130015004|NCT02443883|468015485|FG002|Overall Study|Withdrawal by Subject|0|||
130015005|NCT02443883|468015486|FG003|Overall Study|Withdrawal by Subject|2|||
130015006|NCT02443883|468015483|FG000|Overall Study|Randomized, but never treated|1|||
130015007|NCT02443883|468015484|FG001|Overall Study|Randomized, but never treated|0|||
130015008|NCT02443883|468015485|FG002|Overall Study|Randomized, but never treated|0|||
130015009|NCT02443883|468015486|FG003|Overall Study|Randomized, but never treated|0|||
130015010|NCT00205855|468015502|FG000|Overall Study|Only received temporary implants|16|||
130015011|NCT00205855|468015502|FG000|Overall Study|Withdrawal by Subject|5|||
130015012|NCT00506883|468015505|FG000|Overall Study|Lost to Follow-up|1|||
130015013|NCT00506883|468015506|FG001|Overall Study|Lost to Follow-up|1|||
130015014|NCT00506883|468015507|FG002|Overall Study|Lost to Follow-up|1|||
130015015|NCT00506883|468015505|FG000|Overall Study|Withdrawal by Subject|1|||
130015016|NCT00506883|468015506|FG001|Overall Study|Withdrawal by Subject|0|||
130015017|NCT00506883|468015507|FG002|Overall Study|Withdrawal by Subject|1|||
130015018|NCT00506883|468015505|FG000|Overall Study|Lack of Efficacy|0|||
130015019|NCT00506883|468015506|FG001|Overall Study|Lack of Efficacy|1|||
130015020|NCT00506883|468015507|FG002|Overall Study|Lack of Efficacy|1|||
130015021|NCT00506883|468015505|FG000|Overall Study|Other|5|||
130015022|NCT00506883|468015506|FG001|Overall Study|Other|1|||
130015023|NCT00506883|468015507|FG002|Overall Study|Other|1|||
130015024|NCT01445951|468015508|FG000|Overall Study|Adverse Event|16|||
130015025|NCT01445951|468015509|FG001|Overall Study|Adverse Event|9|||
130015026|NCT01445951|468015510|FG002|Overall Study|Adverse Event|0|||
130015027|NCT01445951|468015508|FG000|Overall Study|Protocol Violation|2|||
130015028|NCT01445951|468015509|FG001|Overall Study|Protocol Violation|2|||
130015029|NCT01445951|468015510|FG002|Overall Study|Protocol Violation|2|||
130015030|NCT01445951|468015508|FG000|Overall Study|Withdrawal by Subject|21|||
130015031|NCT01445951|468015509|FG001|Overall Study|Withdrawal by Subject|16|||
130015032|NCT01445951|468015510|FG002|Overall Study|Withdrawal by Subject|8|||
130015033|NCT01445951|468015508|FG000|Overall Study|Physician Decision|3|||
130015034|NCT01445951|468015509|FG001|Overall Study|Physician Decision|1|||
130015035|NCT01445951|468015510|FG002|Overall Study|Physician Decision|0|||
130015036|NCT01445951|468015508|FG000|Overall Study|Lost to Follow-up|1|||
130015037|NCT01445951|468015509|FG001|Overall Study|Lost to Follow-up|2|||
130015038|NCT01445951|468015510|FG002|Overall Study|Lost to Follow-up|4|||
130015039|NCT01445951|468015508|FG000|Overall Study|Pregnancy|0|||
130015040|NCT01445951|468015509|FG001|Overall Study|Pregnancy|1|||
130015041|NCT01445951|468015510|FG002|Overall Study|Pregnancy|4|||
130015042|NCT01445951|468015508|FG000|Overall Study|Death|0|||
130015043|NCT01445951|468015509|FG001|Overall Study|Death|0|||
130015044|NCT01445951|468015510|FG002|Overall Study|Death|1|||
130015045|NCT01445951|468015508|FG000|Overall Study|Non-compliance with study drug|1|||
130015046|NCT01445951|468015509|FG001|Overall Study|Non-compliance with study drug|2|||
130098747|NCT03426995|468319293|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130015047|NCT01445951|468015510|FG002|Overall Study|Non-compliance with study drug|0|||
130015048|NCT01445951|468015508|FG000|Overall Study|Non-compliance with protocol|0|||
130015049|NCT01445951|468015509|FG001|Overall Study|Non-compliance with protocol|1|||
130015050|NCT01445951|468015510|FG002|Overall Study|Non-compliance with protocol|0|||
130015051|NCT01445951|468015508|FG000|Overall Study|Sponsor decision - subject travel|0|||
130015052|NCT01445951|468015509|FG001|Overall Study|Sponsor decision - subject travel|1|||
130015053|NCT01445951|468015510|FG002|Overall Study|Sponsor decision - subject travel|0|||
130015054|NCT01445951|468015508|FG000|Overall Study|Cough|0|||
130015055|NCT01445951|468015509|FG001|Overall Study|Cough|1|||
130015056|NCT01445951|468015510|FG002|Overall Study|Cough|0|||
130015057|NCT01627860|468015511|FG000|Overall Study|Adverse Event|9|||
130015058|NCT01627860|468015512|FG001|Overall Study|Adverse Event|4|||
130015059|NCT01627860|468015511|FG000|Overall Study|Withdrawal by Subject|2|||
130015060|NCT01627860|468015512|FG001|Overall Study|Withdrawal by Subject|1|||
130015061|NCT01627860|468015511|FG000|Overall Study|Seizure frequency doubled|0|||
130015062|NCT01627860|468015512|FG001|Overall Study|Seizure frequency doubled|1|||
130015063|NCT01627860|468015511|FG000|Overall Study|Protocol Violation|1|||
130015064|NCT01627860|468015512|FG001|Overall Study|Protocol Violation|0|||
130015065|NCT04194528|468015522|FG000|Overall Study|Adverse Event|1|||
130015066|NCT03921424|468015524|FG000|Overall Study|Lost to Follow-up|0|||
130015067|NCT03921424|468015525|FG001|Overall Study|Lost to Follow-up|1|||
130015068|NCT03921424|468015524|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130015069|NCT03921424|468015525|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
130015070|NCT04649255|468017660|FG000|Overall Study|Death|9|||
130015071|NCT04649255|468017660|FG000|Overall Study|Withdrawal by Subject|1|||
130015072|NCT04129528|468017661|FG000|Overall Study|Adverse Event|1|||
130015073|NCT04129528|468017662|FG001|Overall Study|Adverse Event|0|||
130015074|NCT04129528|468017661|FG000|Overall Study|Physician Decision|1|||
130015075|NCT04129528|468017662|FG001|Overall Study|Physician Decision|1|||
130015076|NCT04129528|468017661|FG000|Overall Study|Withdrawal by Subject|1|||
130015077|NCT04129528|468017662|FG001|Overall Study|Withdrawal by Subject|1|||
130015078|NCT01964352|468017663|FG000|Overall Study|Adverse Event|13|||
130015079|NCT01964352|468017664|FG001|Overall Study|Adverse Event|3|||
130015080|NCT01964352|468017665|FG002|Overall Study|Adverse Event|4|||
130015081|NCT01964352|468017666|FG003|Overall Study|Adverse Event|3|||
130015082|NCT01964352|468017663|FG000|Overall Study|Lack of Efficacy|6|||
130015083|NCT01964352|468017664|FG001|Overall Study|Lack of Efficacy|0|||
130015084|NCT01964352|468017665|FG002|Overall Study|Lack of Efficacy|0|||
130015085|NCT01964352|468017666|FG003|Overall Study|Lack of Efficacy|0|||
130015086|NCT01964352|468017663|FG000|Overall Study|Protocol Violation|2|||
130015087|NCT01964352|468017664|FG001|Overall Study|Protocol Violation|4|||
130015088|NCT01964352|468017665|FG002|Overall Study|Protocol Violation|0|||
130015089|NCT01964352|468017666|FG003|Overall Study|Protocol Violation|2|||
130015090|NCT01964352|468017663|FG000|Overall Study|Lost to Follow-up|1|||
130015091|NCT01964352|468017664|FG001|Overall Study|Lost to Follow-up|0|||
130015092|NCT01964352|468017665|FG002|Overall Study|Lost to Follow-up|0|||
130015093|NCT01964352|468017666|FG003|Overall Study|Lost to Follow-up|1|||
130015094|NCT01964352|468017663|FG000|Overall Study|Withdrawal by Subject|4|||
130015095|NCT01964352|468017664|FG001|Overall Study|Withdrawal by Subject|2|||
130015096|NCT01964352|468017665|FG002|Overall Study|Withdrawal by Subject|1|||
130015097|NCT01964352|468017666|FG003|Overall Study|Withdrawal by Subject|0|||
130015098|NCT01964352|468017663|FG000|Overall Study|Other than stated above|0|||
130015099|NCT01964352|468017664|FG001|Overall Study|Other than stated above|2|||
130015100|NCT01964352|468017665|FG002|Overall Study|Other than stated above|1|||
130015101|NCT01964352|468017666|FG003|Overall Study|Other than stated above|2|||
130015102|NCT04682405|468017671|FG000|Overall Study|Adverse Event|0|||
130015103|NCT04682405|468017672|FG001|Overall Study|Adverse Event|1|||
130015104|NCT00522431|468017673|FG000|Overall Study|Adverse Event|5|||
130015105|NCT00522431|468017673|FG000|Overall Study|Protocol Violation|2|||
130015106|NCT00522431|468017673|FG000|Overall Study|Withdrawal by Subject|2|||
130015107|NCT00522431|468017673|FG000|Overall Study|Subject non-compliance|1|||
130015108|NCT00522431|468017673|FG000|Overall Study|Other/unknown|1|||
130015109|NCT00513409|468017679|FG000|Overall Study|Adverse Event|0|||
130015110|NCT00513409|468017680|FG001|Overall Study|Adverse Event|1|||
130015111|NCT00513409|468017679|FG000|Overall Study|Withdrawal by Subject|0|||
130015112|NCT00513409|468017680|FG001|Overall Study|Withdrawal by Subject|2|||
130015113|NCT00513409|468017679|FG000|Overall Study|Lost to Follow-up|0|||
130015114|NCT00513409|468017680|FG001|Overall Study|Lost to Follow-up|1|||
130015115|NCT00513409|468017679|FG000|Overall Study|Physician Decision|1|||
130015116|NCT00513409|468017680|FG001|Overall Study|Physician Decision|0|||
130015117|NCT00513409|468017679|FG000|Overall Study|Visit 3 not done|1|||
130015118|NCT00513409|468017680|FG001|Overall Study|Visit 3 not done|2|||
130015119|NCT01049035|468017681|FG000|Overall Study|Serious adverse event|0|||
130015120|NCT01049035|468017682|FG001|Overall Study|Serious adverse event|1|||
130015121|NCT01049035|468017683|FG002|Overall Study|Serious adverse event|1|||
130015122|NCT01049035|468017684|FG003|Overall Study|Serious adverse event|2|||
130015123|NCT01049035|468017685|FG004|Overall Study|Serious adverse event|0|||
130015124|NCT01049035|468017686|FG005|Overall Study|Serious adverse event|0|||
130015125|NCT01049035|468017687|FG006|Overall Study|Serious adverse event|0|||
130015126|NCT01049035|468017681|FG000|Overall Study|Other adverse event (AE)|0|||
130015127|NCT01049035|468017682|FG001|Overall Study|Other adverse event (AE)|0|||
130015128|NCT01049035|468017683|FG002|Overall Study|Other adverse event (AE)|0|||
130015129|NCT01049035|468017684|FG003|Overall Study|Other adverse event (AE)|1|||
130015130|NCT01049035|468017685|FG004|Overall Study|Other adverse event (AE)|0|||
130015131|NCT01049035|468017686|FG005|Overall Study|Other adverse event (AE)|0|||
130015132|NCT01049035|468017687|FG006|Overall Study|Other adverse event (AE)|0|||
130015133|NCT01049035|468017681|FG000|Overall Study|Non-compliance with the protocol|12|||
130015134|NCT01049035|468017682|FG001|Overall Study|Non-compliance with the protocol|6|||
130015135|NCT01049035|468017683|FG002|Overall Study|Non-compliance with the protocol|14|||
130015136|NCT01049035|468017684|FG003|Overall Study|Non-compliance with the protocol|5|||
130015137|NCT01049035|468017685|FG004|Overall Study|Non-compliance with the protocol|3|||
130015138|NCT01049035|468017686|FG005|Overall Study|Non-compliance with the protocol|4|||
130015139|NCT01049035|468017687|FG006|Overall Study|Non-compliance with the protocol|10|||
130015140|NCT01049035|468017681|FG000|Overall Study|Lost to Follow-up|5|||
130015141|NCT01049035|468017682|FG001|Overall Study|Lost to Follow-up|4|||
130015142|NCT01049035|468017683|FG002|Overall Study|Lost to Follow-up|4|||
130015143|NCT01049035|468017684|FG003|Overall Study|Lost to Follow-up|1|||
130015144|NCT01049035|468017685|FG004|Overall Study|Lost to Follow-up|0|||
130015145|NCT01049035|468017686|FG005|Overall Study|Lost to Follow-up|3|||
130015146|NCT01049035|468017687|FG006|Overall Study|Lost to Follow-up|3|||
130015147|NCT01049035|468017681|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
130015148|NCT01049035|468017682|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
130015149|NCT01049035|468017683|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
130015150|NCT01049035|468017684|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
130015151|NCT01049035|468017685|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
130015152|NCT01049035|468017686|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
130015153|NCT01049035|468017687|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
130015154|NCT03189446|468017689|FG000|Overall Study|Adverse Event|2|||
130015155|NCT03189446|468017689|FG000|Overall Study|Withdrawal by Subject|2|||
130015156|NCT03189446|468017689|FG000|Overall Study|Physician Decision|1|||
130015157|NCT05634577|468017690|FG000|Overall Study|Lost to Follow-up|1|||
130015158|NCT05634577|468017690|FG000|Overall Study|Withdrawal by Subject|1|||
130015159|NCT04839978|468017691|FG000|Overall Study|Lost to Follow-up|135|||
130015160|NCT04839978|468017692|FG001|Overall Study|Lost to Follow-up|147|||
130015161|NCT03865706|468017693|FG000|Overall Study|Death|0|||
130015162|NCT03865706|468017694|FG001|Overall Study|Death|3|||
130015163|NCT03865706|468017695|FG002|Overall Study|Death|1|||
130015164|NCT02095535|468017696|FG000|Recruitment|Protocol Violation|2|||
130015165|NCT00623480|468017697|FG000|Overall Study|Lost to Follow-up|0|||
130015166|NCT00623480|468017698|FG001|Overall Study|Lost to Follow-up|1|||
130015167|NCT00623480|468017697|FG000|Overall Study|Withdrawal by Subject|2|||
130015168|NCT00623480|468017698|FG001|Overall Study|Withdrawal by Subject|4|||
130015169|NCT00623480|468017697|FG000|Overall Study|Lack of Efficacy|1|||
130015170|NCT00623480|468017698|FG001|Overall Study|Lack of Efficacy|0|||
130015171|NCT00623480|468017697|FG000|Overall Study|Non-compliant with study medication|4|||
130015172|NCT00623480|468017698|FG001|Overall Study|Non-compliant with study medication|0|||
130015173|NCT00623480|468017697|FG000|Overall Study|Protocol Violation|0|||
130015174|NCT00623480|468017698|FG001|Overall Study|Protocol Violation|1|||
130015175|NCT00623480|468017697|FG000|Overall Study|Site closed by sponsor|0|||
130015176|NCT00623480|468017698|FG001|Overall Study|Site closed by sponsor|1|||
130015177|NCT03709654|468017699|FG000|Overall Study|Lost to Follow-up|1|||
130015178|NCT03709654|468017700|FG001|Overall Study|Lost to Follow-up|1|||
130015179|NCT03709654|468017699|FG000|Overall Study|Withdrawal by Subject|1|||
130015180|NCT03709654|468017700|FG001|Overall Study|Withdrawal by Subject|1|||
130015181|NCT03709654|468017699|FG000|Overall Study|Adverse Event|1|||
130015182|NCT03709654|468017700|FG001|Overall Study|Adverse Event|0|||
130015183|NCT01902966|468017701|FG000|Overall Study|Death|1|||
130015184|NCT01902966|468017701|FG000|Overall Study|Physician Decision|1|||
130015185|NCT01902966|468017701|FG000|Overall Study|Withdrawal by Subject|1|||
130015186|NCT02631200|468017704|FG000|First Period|Death|1|||
130015187|NCT02631200|468017705|FG001|First Period|Death|2|||
130015188|NCT02631200|468017704|FG000|First Period|Patient ill-health|2|||
130015189|NCT02631200|468017705|FG001|First Period|Patient ill-health|4|||
130015190|NCT02631200|468017704|FG000|First Period|Withdrawal by Subject|4|||
130015191|NCT02631200|468017705|FG001|First Period|Withdrawal by Subject|1|||
130015192|NCT02631200|468017704|FG000|Deferred Period|Death|0|||
130015193|NCT02631200|468017705|FG001|Deferred Period|Death|1|||
130015194|NCT02631200|468017704|FG000|Deferred Period|Received kidney transplant|0|||
130015195|NCT02631200|468017705|FG001|Deferred Period|Received kidney transplant|1|||
130015196|NCT02631200|468017704|FG000|Deferred Period|Withdrawal by Subject|0|||
130015197|NCT02631200|468017705|FG001|Deferred Period|Withdrawal by Subject|2|||
130015198|NCT02631200|468017704|FG000|Deferred Period|Lost to Follow-up|0|||
130015199|NCT02631200|468017705|FG001|Deferred Period|Lost to Follow-up|1|||
130015200|NCT01081912|468017707|FG000|Conversion/Titration|Adverse Event|47|||
130015201|NCT01081912|468017708|FG001|Conversion/Titration|Adverse Event|0|||
130015202|NCT01081912|468017709|FG002|Conversion/Titration|Adverse Event|0|||
130015203|NCT01081912|468017707|FG000|Conversion/Titration|Lack of Efficacy|17|||
130015204|NCT01081912|468017708|FG001|Conversion/Titration|Lack of Efficacy|0|||
130015205|NCT01081912|468017709|FG002|Conversion/Titration|Lack of Efficacy|0|||
130015206|NCT01081912|468017707|FG000|Conversion/Titration|Lost to Follow-up|5|||
130015207|NCT01081912|468017708|FG001|Conversion/Titration|Lost to Follow-up|0|||
130015208|NCT01081912|468017709|FG002|Conversion/Titration|Lost to Follow-up|0|||
130015209|NCT01081912|468017707|FG000|Conversion/Titration|Physician Decision|2|||
130015210|NCT01081912|468017708|FG001|Conversion/Titration|Physician Decision|0|||
130015211|NCT01081912|468017709|FG002|Conversion/Titration|Physician Decision|0|||
130015212|NCT01081912|468017707|FG000|Conversion/Titration|Protocol Violation|67|||
130015213|NCT01081912|468017708|FG001|Conversion/Titration|Protocol Violation|0|||
130015214|NCT01081912|468017709|FG002|Conversion/Titration|Protocol Violation|0|||
130015215|NCT01081912|468017707|FG000|Conversion/Titration|Withdrawal by Subject|23|||
130015216|NCT01081912|468017708|FG001|Conversion/Titration|Withdrawal by Subject|0|||
130015217|NCT01081912|468017709|FG002|Conversion/Titration|Withdrawal by Subject|0|||
130015218|NCT01081912|468017707|FG000|Conversion/Titration|Non-Compliance|47|||
130015219|NCT01081912|468017708|FG001|Conversion/Titration|Non-Compliance|0|||
130015220|NCT01081912|468017709|FG002|Conversion/Titration|Non-Compliance|0|||
130015221|NCT01081912|468017707|FG000|Maintenance Treatment|Adverse Event|0|||
130015222|NCT01081912|468017708|FG001|Maintenance Treatment|Adverse Event|2|||
130015223|NCT01081912|468017709|FG002|Maintenance Treatment|Adverse Event|12|||
130015224|NCT01081912|468017707|FG000|Maintenance Treatment|Lack of Efficacy|0|||
130015225|NCT01081912|468017708|FG001|Maintenance Treatment|Lack of Efficacy|14|||
130015226|NCT01081912|468017709|FG002|Maintenance Treatment|Lack of Efficacy|64|||
130015227|NCT01081912|468017707|FG000|Maintenance Treatment|Lost to Follow-up|0|||
130015228|NCT01081912|468017708|FG001|Maintenance Treatment|Lost to Follow-up|1|||
130015229|NCT01081912|468017709|FG002|Maintenance Treatment|Lost to Follow-up|0|||
130015230|NCT01081912|468017707|FG000|Maintenance Treatment|Physician Decision|0|||
130015231|NCT01081912|468017708|FG001|Maintenance Treatment|Physician Decision|0|||
130015232|NCT01081912|468017709|FG002|Maintenance Treatment|Physician Decision|1|||
130015233|NCT01081912|468017707|FG000|Maintenance Treatment|Protocol Violation|0|||
130015234|NCT01081912|468017708|FG001|Maintenance Treatment|Protocol Violation|1|||
130015235|NCT01081912|468017709|FG002|Maintenance Treatment|Protocol Violation|2|||
130015236|NCT01081912|468017707|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
130015237|NCT01081912|468017708|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
130015238|NCT01081912|468017709|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
130015239|NCT01081912|468017707|FG000|Maintenance Treatment|Non-Compliance|0|||
130015240|NCT01081912|468017708|FG001|Maintenance Treatment|Non-Compliance|4|||
130015241|NCT01081912|468017709|FG002|Maintenance Treatment|Non-Compliance|7|||
130015242|NCT01081912|468017707|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
130015243|NCT01081912|468017708|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
130015244|NCT01081912|468017709|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
130015245|NCT04677712|468017711|FG000|Overall Study|Lost to Follow-up|0|||
130015246|NCT04677712|468017712|FG001|Overall Study|Lost to Follow-up|1|||
130015247|NCT04677712|468017713|FG002|Overall Study|Lost to Follow-up|0|||
130015248|NCT04677712|468017714|FG003|Overall Study|Lost to Follow-up|0|||
130015249|NCT04677712|468017715|FG004|Overall Study|Lost to Follow-up|0|||
130015250|NCT04677712|468017716|FG005|Overall Study|Lost to Follow-up|0|||
130015251|NCT00711100|468017717|FG000|Overall Study|Lack of Efficacy|5|||
130015252|NCT00711100|468017717|FG000|Overall Study|Withdrawal by Subject|8|||
130015253|NCT00783094|468017718|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
130015254|NCT00783094|468017719|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
130015255|NCT00783094|468017720|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
130015256|NCT00783094|468017718|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
130015257|NCT00783094|468017719|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
130015258|NCT00783094|468017720|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
130015259|NCT00783094|468017718|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
130015260|NCT00783094|468017719|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
130015261|NCT00783094|468017720|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
130015262|NCT00783094|468017718|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
130015263|NCT00783094|468017719|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
130015264|NCT00783094|468017720|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
130015265|NCT00783094|468017718|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
130015266|NCT00783094|468017719|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
130015267|NCT00783094|468017720|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
130015268|NCT00783094|468017718|FG000|Open-Label Extension Period|Adverse Event|12|||
130015269|NCT00783094|468017719|FG001|Open-Label Extension Period|Adverse Event|7|||
130015270|NCT00783094|468017720|FG002|Open-Label Extension Period|Adverse Event|16|||
130015271|NCT00783094|468017718|FG000|Open-Label Extension Period|Death|0|||
130015272|NCT00783094|468017719|FG001|Open-Label Extension Period|Death|0|||
130015273|NCT00783094|468017720|FG002|Open-Label Extension Period|Death|1|||
130015274|NCT00783094|468017718|FG000|Open-Label Extension Period|Protocol Violation|4|||
130217805|NCT04865419|468761407|FG005|Overall Study|Study terminated by Sponsor|0|||
130015275|NCT00783094|468017719|FG001|Open-Label Extension Period|Protocol Violation|5|||
130015276|NCT00783094|468017720|FG002|Open-Label Extension Period|Protocol Violation|7|||
130015277|NCT00783094|468017718|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
130015278|NCT00783094|468017719|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
130217806|NCT04865419|468761408|FG006|Overall Study|Study terminated by Sponsor|0|||
130015279|NCT00783094|468017720|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
130015280|NCT00783094|468017718|FG000|Open-Label Extension Period|Physician Decision|4|||
130015281|NCT00783094|468017719|FG001|Open-Label Extension Period|Physician Decision|2|||
130015282|NCT00783094|468017720|FG002|Open-Label Extension Period|Physician Decision|3|||
130015283|NCT00783094|468017718|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
130015284|NCT00783094|468017719|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
130015285|NCT00783094|468017720|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
130015286|NCT02513329|468017721|FG000|Overall Study|Lost to Follow-up|5|||
130015287|NCT02513329|468017722|FG001|Overall Study|Lost to Follow-up|2|||
130015288|NCT01294670|468017723|FG000|Overall Study|Not treated|1|||
130015289|NCT01294670|468017724|FG001|Overall Study|Not treated|0|||
130015290|NCT01294670|468017725|FG002|Overall Study|Not treated|0|||
130015291|NCT01294670|468017726|FG003|Overall Study|Not treated|0|||
130015292|NCT01294670|468017727|FG004|Overall Study|Not treated|0|||
130015293|NCT02083380|468017731|FG000|Overall Study|Lack of Efficacy|68|||
130015294|NCT02083380|468017732|FG001|Overall Study|Lack of Efficacy|79|||
130015295|NCT02083380|468017733|FG002|Overall Study|Lack of Efficacy|64|||
130015296|NCT02083380|468017731|FG000|Overall Study|Withdrawal by Subject|9|||
130015297|NCT02083380|468017732|FG001|Overall Study|Withdrawal by Subject|3|||
130015298|NCT02083380|468017733|FG002|Overall Study|Withdrawal by Subject|7|||
130015299|NCT02083380|468017731|FG000|Overall Study|Physician Decision|1|||
130015300|NCT02083380|468017732|FG001|Overall Study|Physician Decision|6|||
130015301|NCT02083380|468017733|FG002|Overall Study|Physician Decision|3|||
130015302|NCT02083380|468017731|FG000|Overall Study|Adverse Event|0|||
130015303|NCT02083380|468017732|FG001|Overall Study|Adverse Event|0|||
130015304|NCT02083380|468017733|FG002|Overall Study|Adverse Event|1|||
130015305|NCT02083380|468017731|FG000|Overall Study|Lost to Follow-up|5|||
130015306|NCT02083380|468017732|FG001|Overall Study|Lost to Follow-up|3|||
130015307|NCT02083380|468017733|FG002|Overall Study|Lost to Follow-up|3|||
130015308|NCT02083380|468017731|FG000|Overall Study|Other|8|||
130015309|NCT02083380|468017732|FG001|Overall Study|Other|4|||
130015310|NCT02083380|468017733|FG002|Overall Study|Other|6|||
130015311|NCT00001379|468017734|FG000|Initial Treatment|Disease progression|21|||
130015312|NCT00001379|468017735|FG001|Initial Treatment|Disease progression|3|||
130015313|NCT00001379|468017736|FG002|Initial Treatment|Disease progression|0|||
130015314|NCT00001379|468017737|FG003|Initial Treatment|Disease progression|0|||
130015315|NCT00001379|468017734|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
130015316|NCT00001379|468017735|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
130015317|NCT00001379|468017736|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
130015318|NCT00001379|468017737|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
130015319|NCT00001379|468017734|FG000|Initial Treatment|Received alternative treatment|2|||
130015320|NCT00001379|468017735|FG001|Initial Treatment|Received alternative treatment|1|||
130015321|NCT00001379|468017736|FG002|Initial Treatment|Received alternative treatment|0|||
130015322|NCT00001379|468017737|FG003|Initial Treatment|Received alternative treatment|0|||
130015323|NCT00001379|468017734|FG000|Initial Treatment|Refused further treatment|2|||
130015324|NCT00001379|468017735|FG001|Initial Treatment|Refused further treatment|0|||
130015325|NCT00001379|468017736|FG002|Initial Treatment|Refused further treatment|0|||
130015326|NCT00001379|468017737|FG003|Initial Treatment|Refused further treatment|0|||
130015327|NCT00001379|468017734|FG000|Initial Treatment|Did not receive protocol treatment|0|||
130015328|NCT00001379|468017735|FG001|Initial Treatment|Did not receive protocol treatment|0|||
130015329|NCT00001379|468017736|FG002|Initial Treatment|Did not receive protocol treatment|5|||
130015330|NCT00001379|468017737|FG003|Initial Treatment|Did not receive protocol treatment|0|||
130015331|NCT00001379|468017734|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
130015332|NCT00001379|468017735|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
130015333|NCT00001379|468017736|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
130015334|NCT00001379|468017737|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
130015335|NCT00001379|468017734|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
130015336|NCT00001379|468017735|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
130015337|NCT00001379|468017736|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
130015338|NCT00001379|468017737|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
130015339|NCT00001379|468017734|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
130015340|NCT00001379|468017735|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
130015341|NCT00001379|468017736|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
130015342|NCT00001379|468017737|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
130015343|NCT00001379|468017734|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
130015344|NCT00001379|468017735|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
130015345|NCT00001379|468017736|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
130015346|NCT00001379|468017737|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
130015347|NCT00001379|468017734|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
130015348|NCT00001379|468017735|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
130015349|NCT00001379|468017736|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
130015350|NCT00001379|468017737|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
130015351|NCT03703102|468017743|FG000|Overall Study|Adverse Event|4|||
130015352|NCT03703102|468017744|FG001|Overall Study|Adverse Event|3|||
130015353|NCT03703102|468017745|FG002|Overall Study|Adverse Event|7|||
130015354|NCT03703102|468017746|FG003|Overall Study|Adverse Event|3|||
130015355|NCT03703102|468017747|FG004|Overall Study|Adverse Event|13|||
130015356|NCT03703102|468017743|FG000|Overall Study|Lack of Efficacy|4|||
130015357|NCT03703102|468017744|FG001|Overall Study|Lack of Efficacy|0|||
130015358|NCT03703102|468017745|FG002|Overall Study|Lack of Efficacy|1|||
130015359|NCT03703102|468017746|FG003|Overall Study|Lack of Efficacy|4|||
130015360|NCT03703102|468017747|FG004|Overall Study|Lack of Efficacy|1|||
130015361|NCT03703102|468017743|FG000|Overall Study|Lost to Follow-up|0|||
130015362|NCT03703102|468017744|FG001|Overall Study|Lost to Follow-up|0|||
130015363|NCT03703102|468017745|FG002|Overall Study|Lost to Follow-up|1|||
130015364|NCT03703102|468017746|FG003|Overall Study|Lost to Follow-up|2|||
130015365|NCT03703102|468017747|FG004|Overall Study|Lost to Follow-up|2|||
130015366|NCT03703102|468017743|FG000|Overall Study|Physician Decision|2|||
130015367|NCT03703102|468017744|FG001|Overall Study|Physician Decision|2|||
130015368|NCT03703102|468017745|FG002|Overall Study|Physician Decision|2|||
130015369|NCT03703102|468017746|FG003|Overall Study|Physician Decision|2|||
130015370|NCT03703102|468017747|FG004|Overall Study|Physician Decision|4|||
130015371|NCT03703102|468017743|FG000|Overall Study|Withdrawal by Subject|7|||
130015372|NCT03703102|468017744|FG001|Overall Study|Withdrawal by Subject|5|||
130015373|NCT03703102|468017745|FG002|Overall Study|Withdrawal by Subject|5|||
130015374|NCT03703102|468017746|FG003|Overall Study|Withdrawal by Subject|5|||
130015375|NCT03703102|468017747|FG004|Overall Study|Withdrawal by Subject|9|||
130015376|NCT03703102|468017743|FG000|Overall Study|Ineligibility|0|||
130015377|NCT03703102|468017744|FG001|Overall Study|Ineligibility|0|||
130015378|NCT03703102|468017745|FG002|Overall Study|Ineligibility|1|||
130015379|NCT03703102|468017746|FG003|Overall Study|Ineligibility|0|||
130015380|NCT03703102|468017747|FG004|Overall Study|Ineligibility|0|||
130015381|NCT03703102|468017743|FG000|Overall Study|Protocol Deviation|4|||
130015382|NCT03703102|468017744|FG001|Overall Study|Protocol Deviation|4|||
130015383|NCT03703102|468017745|FG002|Overall Study|Protocol Deviation|3|||
130015384|NCT03703102|468017746|FG003|Overall Study|Protocol Deviation|0|||
130015385|NCT03703102|468017747|FG004|Overall Study|Protocol Deviation|0|||
130015386|NCT03703102|468017743|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130015387|NCT03703102|468017744|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130015388|NCT03703102|468017745|FG002|Overall Study|Non-Compliance with Study Drug|2|||
130015389|NCT03703102|468017746|FG003|Overall Study|Non-Compliance with Study Drug|1|||
130015390|NCT03703102|468017747|FG004|Overall Study|Non-Compliance with Study Drug|4|||
130015391|NCT00876187|468017748|FG000|Overall Study|Adverse Event|14|||
130015392|NCT00876187|468017749|FG001|Overall Study|Adverse Event|12|||
130015393|NCT00876187|468017750|FG002|Overall Study|Adverse Event|19|||
130015394|NCT00876187|468017751|FG003|Overall Study|Adverse Event|29|||
130015395|NCT00876187|468017752|FG004|Overall Study|Adverse Event|10|||
130015396|NCT00876187|468017748|FG000|Overall Study|Lack of Efficacy|59|||
130015397|NCT00876187|468017749|FG001|Overall Study|Lack of Efficacy|34|||
130015398|NCT00876187|468017750|FG002|Overall Study|Lack of Efficacy|45|||
130015399|NCT00876187|468017751|FG003|Overall Study|Lack of Efficacy|34|||
130015400|NCT00876187|468017752|FG004|Overall Study|Lack of Efficacy|59|||
130015401|NCT00876187|468017748|FG000|Overall Study|Lost to Follow-up|9|||
130015402|NCT00876187|468017749|FG001|Overall Study|Lost to Follow-up|10|||
130015403|NCT00876187|468017750|FG002|Overall Study|Lost to Follow-up|8|||
130015404|NCT00876187|468017751|FG003|Overall Study|Lost to Follow-up|8|||
130015405|NCT00876187|468017752|FG004|Overall Study|Lost to Follow-up|11|||
130015406|NCT00876187|468017748|FG000|Overall Study|Protocol Violation|6|||
130015407|NCT00876187|468017749|FG001|Overall Study|Protocol Violation|7|||
130015408|NCT00876187|468017750|FG002|Overall Study|Protocol Violation|7|||
130015409|NCT00876187|468017751|FG003|Overall Study|Protocol Violation|6|||
130015410|NCT00876187|468017752|FG004|Overall Study|Protocol Violation|3|||
130015411|NCT00876187|468017748|FG000|Overall Study|Withdrawal by Subject|16|||
130015412|NCT00876187|468017749|FG001|Overall Study|Withdrawal by Subject|26|||
130015413|NCT00876187|468017750|FG002|Overall Study|Withdrawal by Subject|32|||
130015414|NCT00876187|468017751|FG003|Overall Study|Withdrawal by Subject|38|||
130015415|NCT00876187|468017752|FG004|Overall Study|Withdrawal by Subject|37|||
130015416|NCT00876187|468017748|FG000|Overall Study|Entered extension study|101|||
130015417|NCT00876187|468017749|FG001|Overall Study|Entered extension study|120|||
130015418|NCT00876187|468017750|FG002|Overall Study|Entered extension study|156|||
130015419|NCT00876187|468017751|FG003|Overall Study|Entered extension study|151|||
130015420|NCT00876187|468017752|FG004|Overall Study|Entered extension study|144|||
130015421|NCT00876187|468017748|FG000|Overall Study|Randomized but not treated|3|||
130015422|NCT00876187|468017749|FG001|Overall Study|Randomized but not treated|1|||
130015423|NCT00876187|468017750|FG002|Overall Study|Randomized but not treated|3|||
130015424|NCT00876187|468017751|FG003|Overall Study|Randomized but not treated|2|||
130015425|NCT00876187|468017752|FG004|Overall Study|Randomized but not treated|3|||
130015426|NCT00876187|468017748|FG000|Overall Study|Other|2|||
130015427|NCT00876187|468017749|FG001|Overall Study|Other|5|||
130015428|NCT00876187|468017750|FG002|Overall Study|Other|9|||
130015429|NCT00876187|468017751|FG003|Overall Study|Other|7|||
130015430|NCT00876187|468017752|FG004|Overall Study|Other|4|||
130015431|NCT00405067|468017753|FG000|Overall Study|Adverse Event|4|||
130015432|NCT00405067|468017754|FG001|Overall Study|Adverse Event|9|||
130015433|NCT00405067|468017755|FG002|Overall Study|Adverse Event|4|||
130015434|NCT00405067|468017753|FG000|Overall Study|Lost to Follow-up|0|||
130015435|NCT00405067|468017754|FG001|Overall Study|Lost to Follow-up|0|||
130015436|NCT00405067|468017755|FG002|Overall Study|Lost to Follow-up|1|||
130015437|NCT01650636|468017756|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
130015438|NCT01650636|468017757|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
130015439|NCT01650636|468017756|FG000|Washout up to 5 Months|Physician Decision|2|||
130015440|NCT01650636|468017757|FG001|Washout up to 5 Months|Physician Decision|2|||
130015441|NCT01650636|468017756|FG000|Washout up to 5 Months|Death|1|||
130015442|NCT01650636|468017757|FG001|Washout up to 5 Months|Death|0|||
130015443|NCT01650636|468017756|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
130015444|NCT01650636|468017757|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
130015445|NCT01650636|468017756|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
130015446|NCT01650636|468017757|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
130015447|NCT01650636|468017756|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
130015448|NCT01650636|468017757|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
130015449|NCT01560780|468017759|FG000|Overall Study|Death|2|||
130015450|NCT01560780|468017760|FG001|Overall Study|Death|1|||
130015451|NCT01560780|468017759|FG000|Overall Study|Patient Preference|11|||
130015452|NCT01560780|468017760|FG001|Overall Study|Patient Preference|11|||
130015453|NCT01032915|468017761|FG000|Overall Study|Adverse Event|2|||
130015454|NCT01032915|468017762|FG001|Overall Study|Adverse Event|2|||
130015455|NCT01032915|468017763|FG002|Overall Study|Adverse Event|1|||
130015456|NCT01032915|468017764|FG003|Overall Study|Adverse Event|1|||
130015457|NCT01032915|468017761|FG000|Overall Study|Abnormal test procedure result|0|||
130015458|NCT01032915|468017762|FG001|Overall Study|Abnormal test procedure result|0|||
130015459|NCT01032915|468017763|FG002|Overall Study|Abnormal test procedure result|1|||
130015460|NCT01032915|468017764|FG003|Overall Study|Abnormal test procedure result|0|||
130015461|NCT01032915|468017761|FG000|Overall Study|Withdrawal by Subject|0|||
130015462|NCT01032915|468017762|FG001|Overall Study|Withdrawal by Subject|3|||
130015463|NCT01032915|468017763|FG002|Overall Study|Withdrawal by Subject|1|||
130015464|NCT01032915|468017764|FG003|Overall Study|Withdrawal by Subject|1|||
130015465|NCT01032915|468017761|FG000|Overall Study|Administrative reasons|5|||
130015466|NCT01032915|468017762|FG001|Overall Study|Administrative reasons|6|||
130015467|NCT01032915|468017763|FG002|Overall Study|Administrative reasons|4|||
130015468|NCT01032915|468017764|FG003|Overall Study|Administrative reasons|4|||
130015469|NCT01032915|468017761|FG000|Overall Study|Protocol Violation|1|||
130015470|NCT01032915|468017762|FG001|Overall Study|Protocol Violation|0|||
130015471|NCT01032915|468017763|FG002|Overall Study|Protocol Violation|0|||
130015472|NCT01032915|468017764|FG003|Overall Study|Protocol Violation|1|||
130015473|NCT03363321|468017765|FG000|Overall Study|Withdrawal by Subject|0|||
130015474|NCT03363321|468017766|FG001|Overall Study|Withdrawal by Subject|1|||
130015475|NCT03363321|468017767|FG002|Overall Study|Withdrawal by Subject|0|||
130015476|NCT03363321|468017768|FG003|Overall Study|Withdrawal by Subject|1|||
130015477|NCT03363321|468017769|FG004|Overall Study|Withdrawal by Subject|0|||
130015478|NCT01577186|468017770|FG000|Overall Study|Adverse Event|23|||
130015479|NCT01577186|468017770|FG000|Overall Study|Death|1|||
130015480|NCT01577186|468017770|FG000|Overall Study|Lost to Follow-up|28|||
130015481|NCT01577186|468017770|FG000|Overall Study|Withdrawal by Subject|35|||
130015482|NCT01577186|468017770|FG000|Overall Study|Insufficient Response|18|||
130015483|NCT01577186|468017770|FG000|Overall Study|Ineligible to Continue|15|||
130015484|NCT01577186|468017770|FG000|Overall Study|Non-Compliant|8|||
130015485|NCT01577186|468017770|FG000|Overall Study|Other|2|||
130015486|NCT02915523|468017774|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
130015487|NCT02915523|468017775|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
130015488|NCT02915523|468017776|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
130015489|NCT02915523|468017777|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
130015490|NCT02915523|468017774|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
130015491|NCT02915523|468017775|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
130015492|NCT02915523|468017776|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
130015493|NCT02915523|468017777|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
130015494|NCT02915523|468017774|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
130015495|NCT02915523|468017775|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
130015496|NCT02915523|468017776|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
130015497|NCT02915523|468017777|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
130015498|NCT02915523|468017774|FG000|Expansion Phase (Phase 2)|Death|0|||
130015499|NCT02915523|468017775|FG001|Expansion Phase (Phase 2)|Death|0|||
130015500|NCT02915523|468017776|FG002|Expansion Phase (Phase 2)|Death|26|||
130015501|NCT02915523|468017777|FG003|Expansion Phase (Phase 2)|Death|53|||
130015502|NCT02915523|468017774|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
130015503|NCT02915523|468017775|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
130015504|NCT02915523|468017776|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
130015505|NCT02915523|468017777|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
130015506|NCT02915523|468017774|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
130015507|NCT02915523|468017775|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
130015508|NCT02915523|468017776|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
130015509|NCT02915523|468017777|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
130015510|NCT02915523|468017774|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
130015511|NCT02915523|468017775|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
130015512|NCT02915523|468017776|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
130015513|NCT02915523|468017777|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
130015514|NCT00957008|468017778|FG000|Overall Study|Withdrawal by Subject|13|||
130015515|NCT00957008|468017779|FG001|Overall Study|Withdrawal by Subject|10|||
130015516|NCT00957008|468017780|FG002|Overall Study|Withdrawal by Subject|12|||
130015517|NCT00957008|468017781|FG003|Overall Study|Withdrawal by Subject|16|||
130015518|NCT00957008|468017778|FG000|Overall Study|Lost to Follow-up|3|||
130015519|NCT00957008|468017779|FG001|Overall Study|Lost to Follow-up|1|||
130015520|NCT00957008|468017780|FG002|Overall Study|Lost to Follow-up|3|||
130015521|NCT00957008|468017781|FG003|Overall Study|Lost to Follow-up|4|||
130015522|NCT00957008|468017778|FG000|Overall Study|Physician Decision|1|||
130015523|NCT00957008|468017779|FG001|Overall Study|Physician Decision|0|||
130015524|NCT00957008|468017780|FG002|Overall Study|Physician Decision|1|||
130015525|NCT00957008|468017781|FG003|Overall Study|Physician Decision|1|||
130015526|NCT00957008|468017778|FG000|Overall Study|Relocated; Family conflict|4|||
130015527|NCT00957008|468017779|FG001|Overall Study|Relocated; Family conflict|1|||
130015528|NCT00957008|468017780|FG002|Overall Study|Relocated; Family conflict|1|||
130015529|NCT00957008|468017781|FG003|Overall Study|Relocated; Family conflict|3|||
130015530|NCT00915681|468017782|FG000|Overall Study|Screening failures|46|||
130015531|NCT00811135|468017783|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
130015532|NCT00811135|468017783|FG000|Overall Study|Death|3|||
130015533|NCT00811135|468017783|FG000|Overall Study|Protocol Violation|2|||
130015534|NCT00811135|468017783|FG000|Overall Study|Violation of Selection Criteria|1|||
130015535|NCT00811135|468017783|FG000|Overall Study|Refused Treatment|1|||
130015536|NCT00811135|468017783|FG000|Overall Study|Withdrawal by Subject|3|||
130015537|NCT00811135|468017783|FG000|Overall Study|Administrative/Other Unspecified|11|||
130015538|NCT00811135|468017783|FG000|Overall Study|Ongoing|59|||
130015539|NCT01118351|468017784|FG000|Overall Study|Adverse Event|3|||
130015540|NCT01118351|468017784|FG000|Overall Study|Withdrawal by Subject|1|||
130015541|NCT05630937|468017796|FG000|Overall Study|Study terminated by sponsor|1|||
130015542|NCT05630937|468017797|FG001|Overall Study|Study terminated by sponsor|1|||
130015543|NCT05630937|468017798|FG002|Overall Study|Study terminated by sponsor|8|||
130015544|NCT05630937|468017799|FG003|Overall Study|Study terminated by sponsor|0|||
130015545|NCT05630937|468017796|FG000|Overall Study|Lost to Follow-up|0|||
130015546|NCT05630937|468017797|FG001|Overall Study|Lost to Follow-up|0|||
130015547|NCT05630937|468017798|FG002|Overall Study|Lost to Follow-up|1|||
130015548|NCT05630937|468017799|FG003|Overall Study|Lost to Follow-up|0|||
130015549|NCT05630937|468017796|FG000|Overall Study|Enrolled but not treated|0|||
130015550|NCT05630937|468017797|FG001|Overall Study|Enrolled but not treated|0|||
130015551|NCT05630937|468017798|FG002|Overall Study|Enrolled but not treated|0|||
130015552|NCT05630937|468017799|FG003|Overall Study|Enrolled but not treated|1|||
130015553|NCT01604265|468017803|FG000|Overall Study|Adverse Event|1|||
130015554|NCT01604265|468017804|FG001|Overall Study|Adverse Event|0|||
130015555|NCT01604265|468017803|FG000|Overall Study|Withdrawal by Subject|1|||
130015556|NCT01604265|468017804|FG001|Overall Study|Withdrawal by Subject|0|||
130015557|NCT02706873|468017805|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
130015558|NCT02706873|468017806|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
130015559|NCT02706873|468017807|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
130015560|NCT02706873|468017808|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
130015561|NCT02706873|468017805|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
130015562|NCT02706873|468017806|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
130015563|NCT02706873|468017807|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
130015564|NCT02706873|468017808|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
130015565|NCT02706873|468017805|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
130015566|NCT02706873|468017806|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130015567|NCT02706873|468017807|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
130015568|NCT02706873|468017808|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
130015569|NCT02706873|468017805|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
130015570|NCT02706873|468017806|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
130015571|NCT02706873|468017807|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
130015572|NCT02706873|468017808|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
130015573|NCT02706873|468017805|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
130015574|NCT02706873|468017806|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
130015575|NCT02706873|468017807|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
130015576|NCT02706873|468017808|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
130015577|NCT02706873|468017805|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
130015578|NCT02706873|468017806|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
130015579|NCT02706873|468017807|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
130015580|NCT02706873|468017808|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
130015581|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
130015582|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
130015583|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
130015584|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
130015585|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
130015586|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
130015587|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
130015588|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
130015589|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
130015590|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
130015591|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
130015592|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
130015593|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
130015594|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
130015595|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
130015596|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
130015597|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
130015598|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
130015599|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
130015600|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
130015601|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
130015602|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
130015603|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
130015604|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
130015605|NCT02706873|468017805|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
130015606|NCT02706873|468017806|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
130015607|NCT02706873|468017807|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
130015608|NCT02706873|468017808|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
130015609|NCT00464334|468017814|FG000|Overall Study|Adverse Event|0|||
130015610|NCT00464334|468017815|FG001|Overall Study|Adverse Event|0|||
130015611|NCT00464334|468017816|FG002|Overall Study|Adverse Event|0|||
130015612|NCT00464334|468017817|FG003|Overall Study|Adverse Event|1|||
130015613|NCT00464334|468017818|FG004|Overall Study|Adverse Event|1|||
130015614|NCT00464334|468017819|FG005|Overall Study|Adverse Event|1|||
130015615|NCT00464334|468017820|FG006|Overall Study|Adverse Event|0|||
130015616|NCT00464334|468017821|FG007|Overall Study|Adverse Event|0|||
130015617|NCT00464334|468017822|FG008|Overall Study|Adverse Event|2|||
130015618|NCT00464334|468017823|FG009|Overall Study|Adverse Event|1|||
130015619|NCT00464334|468017824|FG010|Overall Study|Adverse Event|2|||
130015620|NCT00464334|468017814|FG000|Overall Study|Lack of Efficacy|0|||
130015621|NCT00464334|468017815|FG001|Overall Study|Lack of Efficacy|1|||
130015622|NCT00464334|468017816|FG002|Overall Study|Lack of Efficacy|0|||
130015623|NCT00464334|468017817|FG003|Overall Study|Lack of Efficacy|0|||
130015624|NCT00464334|468017818|FG004|Overall Study|Lack of Efficacy|0|||
130015625|NCT00464334|468017819|FG005|Overall Study|Lack of Efficacy|0|||
130015626|NCT00464334|468017820|FG006|Overall Study|Lack of Efficacy|0|||
130015627|NCT00464334|468017821|FG007|Overall Study|Lack of Efficacy|0|||
130015628|NCT00464334|468017822|FG008|Overall Study|Lack of Efficacy|0|||
130015629|NCT00464334|468017823|FG009|Overall Study|Lack of Efficacy|0|||
130015630|NCT00464334|468017824|FG010|Overall Study|Lack of Efficacy|0|||
130015631|NCT00464334|468017814|FG000|Overall Study|Lost to Follow-up|0|||
130015632|NCT00464334|468017815|FG001|Overall Study|Lost to Follow-up|0|||
130015633|NCT00464334|468017816|FG002|Overall Study|Lost to Follow-up|1|||
130015634|NCT00464334|468017817|FG003|Overall Study|Lost to Follow-up|0|||
130015635|NCT00464334|468017818|FG004|Overall Study|Lost to Follow-up|1|||
130015636|NCT00464334|468017819|FG005|Overall Study|Lost to Follow-up|0|||
130015637|NCT00464334|468017820|FG006|Overall Study|Lost to Follow-up|1|||
130015638|NCT00464334|468017821|FG007|Overall Study|Lost to Follow-up|0|||
130015639|NCT00464334|468017822|FG008|Overall Study|Lost to Follow-up|0|||
130015640|NCT00464334|468017823|FG009|Overall Study|Lost to Follow-up|0|||
130015641|NCT00464334|468017824|FG010|Overall Study|Lost to Follow-up|2|||
130015642|NCT00464334|468017814|FG000|Overall Study|Progressive Disease|0|||
130015643|NCT00464334|468017815|FG001|Overall Study|Progressive Disease|0|||
130015644|NCT00464334|468017816|FG002|Overall Study|Progressive Disease|0|||
130015645|NCT00464334|468017817|FG003|Overall Study|Progressive Disease|0|||
130015646|NCT00464334|468017818|FG004|Overall Study|Progressive Disease|0|||
130015647|NCT00464334|468017819|FG005|Overall Study|Progressive Disease|1|||
130015648|NCT00464334|468017820|FG006|Overall Study|Progressive Disease|0|||
130015649|NCT00464334|468017821|FG007|Overall Study|Progressive Disease|0|||
130015650|NCT00464334|468017822|FG008|Overall Study|Progressive Disease|1|||
130015651|NCT00464334|468017823|FG009|Overall Study|Progressive Disease|0|||
130015652|NCT00464334|468017824|FG010|Overall Study|Progressive Disease|0|||
130015653|NCT00464334|468017814|FG000|Overall Study|Study Terminated by Sponsor|0|||
130015654|NCT00464334|468017815|FG001|Overall Study|Study Terminated by Sponsor|0|||
130015655|NCT00464334|468017816|FG002|Overall Study|Study Terminated by Sponsor|0|||
130015656|NCT00464334|468017817|FG003|Overall Study|Study Terminated by Sponsor|1|||
130015657|NCT00464334|468017818|FG004|Overall Study|Study Terminated by Sponsor|0|||
130015658|NCT00464334|468017819|FG005|Overall Study|Study Terminated by Sponsor|0|||
130015659|NCT00464334|468017820|FG006|Overall Study|Study Terminated by Sponsor|0|||
130015660|NCT00464334|468017821|FG007|Overall Study|Study Terminated by Sponsor|0|||
130015661|NCT00464334|468017822|FG008|Overall Study|Study Terminated by Sponsor|0|||
130015662|NCT00464334|468017823|FG009|Overall Study|Study Terminated by Sponsor|0|||
130015663|NCT00464334|468017824|FG010|Overall Study|Study Terminated by Sponsor|0|||
130015664|NCT00464334|468017814|FG000|Overall Study|Withdrawal by Subject|1|||
130015665|NCT00464334|468017815|FG001|Overall Study|Withdrawal by Subject|7|||
130015666|NCT00464334|468017816|FG002|Overall Study|Withdrawal by Subject|4|||
130015667|NCT00464334|468017817|FG003|Overall Study|Withdrawal by Subject|2|||
130015668|NCT00464334|468017818|FG004|Overall Study|Withdrawal by Subject|2|||
130015669|NCT00464334|468017819|FG005|Overall Study|Withdrawal by Subject|2|||
130015670|NCT00464334|468017820|FG006|Overall Study|Withdrawal by Subject|2|||
130015671|NCT00464334|468017821|FG007|Overall Study|Withdrawal by Subject|1|||
130015672|NCT00464334|468017822|FG008|Overall Study|Withdrawal by Subject|3|||
130015673|NCT00464334|468017823|FG009|Overall Study|Withdrawal by Subject|0|||
130015674|NCT00464334|468017824|FG010|Overall Study|Withdrawal by Subject|0|||
130015675|NCT00794677|468017833|FG000|First Intervention|Withdrawal by Subject|2|||
130015676|NCT00794677|468017834|FG001|First Intervention|Withdrawal by Subject|0|||
130015677|NCT00889265|468017835|FG000|Overall Study|Adverse Event|1|||
130015678|NCT00889265|468017835|FG000|Overall Study|Lost to Follow-up|5|||
130015679|NCT00889265|468017835|FG000|Overall Study|Protocol Violation|1|||
130015680|NCT00531752|468017839|FG000|First Double-blind Intervention Period|Adverse Event|2|||
130015681|NCT00531752|468017840|FG001|First Double-blind Intervention Period|Adverse Event|0|||
130015682|NCT00531752|468017841|FG002|First Double-blind Intervention Period|Adverse Event|1|||
130015683|NCT00531752|468017842|FG003|First Double-blind Intervention Period|Adverse Event|1|||
130015684|NCT00531752|468017839|FG000|First Double-blind Intervention Period|Other|1|||
130015685|NCT00531752|468017840|FG001|First Double-blind Intervention Period|Other|4|||
130015686|NCT00531752|468017841|FG002|First Double-blind Intervention Period|Other|4|||
130015687|NCT00531752|468017842|FG003|First Double-blind Intervention Period|Other|0|||
130015688|NCT00531752|468017839|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
130015689|NCT00531752|468017840|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
130015690|NCT00531752|468017841|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
130015691|NCT00531752|468017842|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
130015692|NCT00531752|468017839|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
130015693|NCT00531752|468017840|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
130015694|NCT00531752|468017841|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
130015695|NCT00531752|468017842|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
130015696|NCT00531752|468017839|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
130015697|NCT00531752|468017840|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
130015698|NCT00531752|468017841|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
130015699|NCT00531752|468017842|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
130015700|NCT00531752|468017839|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
130015701|NCT00531752|468017840|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
130015702|NCT00531752|468017841|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
130015703|NCT00531752|468017842|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
130015704|NCT00531752|468017839|FG000|Second Double-blind Intervention Period|Other|1|||
130015705|NCT00531752|468017840|FG001|Second Double-blind Intervention Period|Other|1|||
130015706|NCT00531752|468017841|FG002|Second Double-blind Intervention Period|Other|0|||
130015707|NCT00531752|468017842|FG003|Second Double-blind Intervention Period|Other|0|||
130015708|NCT00531752|468017839|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130015709|NCT00531752|468017840|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130015710|NCT00531752|468017841|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130015711|NCT00531752|468017842|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
130015712|NCT00531752|468017839|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130015713|NCT00531752|468017840|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130015714|NCT00531752|468017841|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130015715|NCT00531752|468017842|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
130015716|NCT00401375|468017843|FG000|Overall Study|Protocol Violation|2|||
130015717|NCT00401375|468017844|FG001|Overall Study|Protocol Violation|2|||
130015718|NCT00401375|468017845|FG002|Overall Study|Protocol Violation|1|||
130015719|NCT00401375|468017843|FG000|Overall Study|Adverse Event|6|||
130015720|NCT00401375|468017844|FG001|Overall Study|Adverse Event|11|||
130015721|NCT00401375|468017845|FG002|Overall Study|Adverse Event|10|||
130015722|NCT00401375|468017843|FG000|Overall Study|Withdrawal by Subject|9|||
130015723|NCT00401375|468017844|FG001|Overall Study|Withdrawal by Subject|7|||
130015724|NCT00401375|468017845|FG002|Overall Study|Withdrawal by Subject|7|||
130015725|NCT00401375|468017843|FG000|Overall Study|Lost to Follow-up|0|||
130015726|NCT00401375|468017844|FG001|Overall Study|Lost to Follow-up|1|||
130015727|NCT00401375|468017845|FG002|Overall Study|Lost to Follow-up|1|||
130015728|NCT00401375|468017843|FG000|Overall Study|Other than specified|2|||
130015729|NCT00401375|468017844|FG001|Overall Study|Other than specified|1|||
130015730|NCT00401375|468017845|FG002|Overall Study|Other than specified|3|||
130015731|NCT00401375|468017843|FG000|Overall Study|Randomized but not treated|3|||
130015732|NCT00401375|468017844|FG001|Overall Study|Randomized but not treated|3|||
130015733|NCT00401375|468017845|FG002|Overall Study|Randomized but not treated|3|||
130015734|NCT00950664|468017846|FG000|First Intervention|Lost to Follow-up|1|||
130015735|NCT00950664|468017847|FG001|First Intervention|Lost to Follow-up|3|||
130015736|NCT00950664|468017846|FG000|First Intervention|Withdrawal by Subject|2|||
130015737|NCT00950664|468017847|FG001|First Intervention|Withdrawal by Subject|2|||
130015738|NCT02821715|468017848|FG000|Overall Study|Protocol Violation|1|||
130015739|NCT02821715|468017849|FG001|Overall Study|Protocol Violation|0|||
130015740|NCT02821715|468017850|FG002|Overall Study|Protocol Violation|0|||
130015741|NCT02821715|468017851|FG003|Overall Study|Protocol Violation|0|||
130015742|NCT02821715|468017852|FG004|Overall Study|Protocol Violation|0|||
130015743|NCT02821715|468017853|FG005|Overall Study|Protocol Violation|0|||
130015744|NCT03152019|468017854|FG000|Overall Study|Adverse Event|0|||
130015745|NCT03152019|468017855|FG001|Overall Study|Adverse Event|1|||
130015746|NCT00254501|468017861|FG000|Overall Study|Lost to Follow-up|1|||
130015747|NCT00254501|468017862|FG001|Overall Study|Lost to Follow-up|1|||
130015748|NCT00923130|468017863|FG000|Overall Study|Stopped treatment due to progression|17|||
130015749|NCT00923130|468017863|FG000|Overall Study|Death|1|||
130015750|NCT00923130|468017863|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
130015751|NCT00923130|468017863|FG000|Overall Study|Switched to alternative treatment|2|||
130015752|NCT00923130|468017863|FG000|Overall Study|Refused further treatment|2|||
130015753|NCT00609791|468019094|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
130015754|NCT01394939|468019099|FG000|Overall Study|Adverse Event|1|||
130015755|NCT01394939|468019100|FG001|Overall Study|Adverse Event|3|||
130015756|NCT01394939|468019101|FG002|Overall Study|Adverse Event|0|||
130015757|NCT01394939|468019102|FG003|Overall Study|Adverse Event|2|||
130015758|NCT01394939|468019099|FG000|Overall Study|Death|0|||
130015759|NCT01394939|468019100|FG001|Overall Study|Death|2|||
130015760|NCT01394939|468019101|FG002|Overall Study|Death|0|||
130015761|NCT01394939|468019102|FG003|Overall Study|Death|0|||
130015762|NCT01394939|468019099|FG000|Overall Study|Physician Decision|0|||
130015763|NCT01394939|468019100|FG001|Overall Study|Physician Decision|1|||
130015764|NCT01394939|468019101|FG002|Overall Study|Physician Decision|0|||
130015765|NCT01394939|468019102|FG003|Overall Study|Physician Decision|0|||
130015766|NCT01394939|468019099|FG000|Overall Study|Withdrawal by Subject|0|||
130015767|NCT01394939|468019100|FG001|Overall Study|Withdrawal by Subject|2|||
130015768|NCT01394939|468019101|FG002|Overall Study|Withdrawal by Subject|0|||
130015769|NCT01394939|468019102|FG003|Overall Study|Withdrawal by Subject|2|||
130015770|NCT01394939|468019099|FG000|Overall Study|Others|0|||
130015771|NCT01394939|468019100|FG001|Overall Study|Others|2|||
130015772|NCT01394939|468019101|FG002|Overall Study|Others|0|||
130015773|NCT01394939|468019102|FG003|Overall Study|Others|3|||
130015774|NCT00150592|468019105|FG000|Overall Study|Adverse Event|4|||
130015775|NCT00150592|468019106|FG001|Overall Study|Adverse Event|1|||
130015776|NCT00150592|468019105|FG000|Overall Study|Protocol Violation|1|||
130015777|NCT00150592|468019106|FG001|Overall Study|Protocol Violation|0|||
130015778|NCT00150592|468019105|FG000|Overall Study|Withdrawal by Subject|1|||
130015779|NCT00150592|468019106|FG001|Overall Study|Withdrawal by Subject|2|||
130015780|NCT00150592|468019105|FG000|Overall Study|Non-compliance|1|||
130015781|NCT00150592|468019106|FG001|Overall Study|Non-compliance|0|||
130015782|NCT00874120|468019111|FG000|First Intervention|Adverse Event|0|||
130015783|NCT00874120|468019112|FG001|First Intervention|Adverse Event|1|||
130015784|NCT00874120|468019111|FG000|First Intervention|Withdrawal by Subject|2|||
130015785|NCT00874120|468019112|FG001|First Intervention|Withdrawal by Subject|0|||
130015786|NCT00874120|468019111|FG000|First Intervention|Lost to Follow-up|0|||
130015787|NCT00874120|468019112|FG001|First Intervention|Lost to Follow-up|1|||
130015788|NCT00874120|468019111|FG000|First Intervention|Protocol Violation|3|||
130015789|NCT00874120|468019112|FG001|First Intervention|Protocol Violation|0|||
130015790|NCT00874120|468019111|FG000|First Intervention|positive drug test|1|||
130015791|NCT00874120|468019112|FG001|First Intervention|positive drug test|0|||
130015792|NCT00874120|468019111|FG000|Second Intervention|Withdrawal by Subject|1|||
130015793|NCT00874120|468019112|FG001|Second Intervention|Withdrawal by Subject|0|||
130015794|NCT00874120|468019111|FG000|Second Intervention|Protocol Violation|1|||
130015795|NCT00874120|468019112|FG001|Second Intervention|Protocol Violation|0|||
130015796|NCT01823679|468019113|FG000|Overall Study|Death|1|||
130015797|NCT03927105|468019114|FG000|Overall Study|Death|1|||
130015798|NCT03927105|468019114|FG000|Overall Study|In observation for potential re-treatment|2|||
130015799|NCT03927105|468019114|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
130015800|NCT05594173|468019118|FG000|Overall Study|Adverse Event|1|||
130015801|NCT05594173|468019118|FG000|Overall Study|COVID-19 Pandemic|2|||
130015802|NCT00647556|468019119|FG000|Overall Study|Adverse Event|0|||
130015803|NCT00647556|468019120|FG001|Overall Study|Adverse Event|1|||
130015804|NCT00647556|468019119|FG000|Overall Study|Lost to Follow-up|1|||
130015805|NCT00647556|468019120|FG001|Overall Study|Lost to Follow-up|0|||
130015806|NCT00647556|468019119|FG000|Overall Study|Protocol Violation|0|||
130015807|NCT00647556|468019120|FG001|Overall Study|Protocol Violation|1|||
130015808|NCT00647556|468019119|FG000|Overall Study|Withdrawal by Subject|1|||
130015809|NCT00647556|468019120|FG001|Overall Study|Withdrawal by Subject|0|||
130015810|NCT00647556|468019119|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
130015811|NCT00647556|468019120|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
130015812|NCT01877187|468019121|FG000|Overall Study|Death|2|||
130015813|NCT01877187|468019121|FG000|Overall Study|Withdrawal by Subject|4|||
130015814|NCT01877187|468019121|FG000|Overall Study|Lost to Follow-up|3|||
130015815|NCT01877187|468019121|FG000|Overall Study|Declining clinical status|11|||
130015816|NCT01877187|468019121|FG000|Overall Study|Liver transplant|2|||
130015817|NCT03776175|468019123|FG000|Treatment Period (42 Days)|Adverse Event|0|||
130015818|NCT03776175|468019124|FG001|Treatment Period (42 Days)|Adverse Event|1|||
130015819|NCT03776175|468019125|FG002|Treatment Period (42 Days)|Adverse Event|1|||
130015820|NCT03776175|468019126|FG003|Treatment Period (42 Days)|Adverse Event|0|||
130015821|NCT03776175|468019123|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
130015822|NCT03776175|468019124|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
130015823|NCT03776175|468019125|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
130015824|NCT03776175|468019126|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
130015825|NCT03776175|468019123|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
130015826|NCT03776175|468019124|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
130015827|NCT03776175|468019125|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
130015828|NCT03776175|468019126|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
130015829|NCT03776175|468019123|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
130015830|NCT03776175|468019124|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
130015831|NCT03776175|468019125|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
130015832|NCT03776175|468019126|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
130015833|NCT03776175|468019123|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
130015834|NCT03776175|468019124|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
130015835|NCT03776175|468019125|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
130015836|NCT03776175|468019126|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
130015837|NCT03776175|468019123|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
130015838|NCT03776175|468019124|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
130015839|NCT03776175|468019125|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
130015840|NCT03776175|468019126|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
130015841|NCT02412787|468019127|FG000|Overall Study|Withdrawal by Subject|9|||
130015842|NCT02412787|468019127|FG000|Overall Study|Participation Terminated by Investigator|1|||
130015843|NCT02412787|468019127|FG000|Overall Study|Site Terminated by Sponsor|21|||
130015844|NCT02412787|468019127|FG000|Overall Study|Technical Problems|1|||
130015845|NCT02412787|468019127|FG000|Overall Study|Reason Not Specified|1|||
130015846|NCT02311153|468019128|FG000|Overall Study|Lost to Follow-up|5|||
130015847|NCT02311153|468019129|FG001|Overall Study|Lost to Follow-up|7|||
130015848|NCT00414453|468019138|FG000|Overall Study|Abnormal lab work|16|||
130015849|NCT00845728|468019139|FG000|Overall Study|Abnormal laboratory value (s)|2|||
130015850|NCT00845728|468019140|FG001|Overall Study|Abnormal laboratory value (s)|2|||
130015851|NCT00845728|468019139|FG000|Overall Study|Patient's inability to use the device|4|||
130015852|NCT00845728|468019140|FG001|Overall Study|Patient's inability to use the device|6|||
130015853|NCT00845728|468019139|FG000|Overall Study|Abnormal test procedure result (s)|7|||
130015854|NCT00845728|468019140|FG001|Overall Study|Abnormal test procedure result (s)|2|||
130015855|NCT00845728|468019139|FG000|Overall Study|Lost to Follow-up|22|||
130015856|NCT00845728|468019140|FG001|Overall Study|Lost to Follow-up|13|||
130015857|NCT00845728|468019139|FG000|Overall Study|Death|24|||
130015858|NCT00845728|468019140|FG001|Overall Study|Death|26|||
130015859|NCT00845728|468019139|FG000|Overall Study|Administrative Problems|34|||
130015860|NCT00845728|468019140|FG001|Overall Study|Administrative Problems|26|||
130015861|NCT00845728|468019139|FG000|Overall Study|Protocol Violation|36|||
130015862|NCT00845728|468019140|FG001|Overall Study|Protocol Violation|24|||
130015863|NCT00845728|468019139|FG000|Overall Study|Lack of Efficacy|51|||
130015864|NCT00845728|468019140|FG001|Overall Study|Lack of Efficacy|39|||
130098748|NCT03426995|468319294|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098749|NCT03426995|468319295|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098750|NCT03426995|468319296|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
130098751|NCT03426995|468319297|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
130098752|NCT03426995|468319298|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098753|NCT03426995|468319299|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098754|NCT03426995|468319300|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130015865|NCT00845728|468019139|FG000|Overall Study|Adverse Event|101|||
130015866|NCT00845728|468019140|FG001|Overall Study|Adverse Event|96|||
130015867|NCT00845728|468019139|FG000|Overall Study|Withdrawal by Subject|105|||
130015868|NCT00845728|468019140|FG001|Overall Study|Withdrawal by Subject|108|||
130015869|NCT04951037|468019143|FG000|Overall Study|Lost to Follow-up|16|||
130015870|NCT04951037|468019143|FG000|Overall Study|Withdrawal by Subject|5|||
130015871|NCT04951037|468019143|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
130015872|NCT02599961|468019147|FG000|Overall Study|Withdrawal by Subject|1|||
130098755|NCT03426995|468319301|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098756|NCT03426995|468319302|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098757|NCT03426995|468319303|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098758|NCT03426995|468319304|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098759|NCT03426995|468319305|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098760|NCT03426995|468319306|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098761|NCT03426995|468319307|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098762|NCT03426995|468319308|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098763|NCT03426995|468319309|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098764|NCT03426995|468319310|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
130098765|NCT03426995|468319292|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130098766|NCT03426995|468319293|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130015873|NCT02599961|468019147|FG000|Overall Study|Subject Non-Compliance|2|||
130015874|NCT02599961|468019147|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
130098767|NCT03426995|468319294|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130015875|NCT02599961|468019147|FG000|Overall Study|Other, Not Specified|3|||
130015876|NCT00143312|468019148|FG000|Overall Study|Death|11|||
130015877|NCT00143312|468019148|FG000|Overall Study|Adverse Event|2|||
130015878|NCT00143312|468019148|FG000|Overall Study|Lost to Follow-up|1|||
130015879|NCT00143312|468019148|FG000|Overall Study|Other|1|||
130015880|NCT00143312|468019148|FG000|Overall Study|Withdrawal by Subject|1|||
130015881|NCT01029366|468019149|FG000|Overall Study|Withdrawal by Subject|1|||
130015882|NCT01029366|468019150|FG001|Overall Study|Withdrawal by Subject|0|||
130015883|NCT01029366|468019149|FG000|Overall Study|Death|1|||
130015884|NCT01029366|468019150|FG001|Overall Study|Death|1|||
130015885|NCT01029366|468019149|FG000|Overall Study|disease progression|2|||
130015886|NCT01029366|468019150|FG001|Overall Study|disease progression|0|||
130015887|NCT01029366|468019149|FG000|Overall Study|manufacturing failure|0|||
130015888|NCT01029366|468019150|FG001|Overall Study|manufacturing failure|1|||
130015889|NCT00906087|468019156|FG000|Initial Washout|Withdrawal by Subject|1|||
130015890|NCT00906087|468019156|FG000|Initial Washout|Physician Decision|1|||
130015891|NCT00513500|468019170|FG000|Overall Study|Lost to Follow-up|35|||
130015892|NCT00513500|468019171|FG001|Overall Study|Lost to Follow-up|39|||
130015893|NCT00513500|468019170|FG000|Overall Study|Death|2|||
130015894|NCT00513500|468019171|FG001|Overall Study|Death|1|||
130015895|NCT00513500|468019170|FG000|Overall Study|Hospitalized|4|||
130015896|NCT00513500|468019171|FG001|Overall Study|Hospitalized|14|||
130015897|NCT00749996|468019174|FG000|Overall Study|Lost to Follow-up|7|||
130015898|NCT00749996|468019175|FG001|Overall Study|Lost to Follow-up|4|||
130015899|NCT00749996|468019174|FG000|Overall Study|Withdrawal by Subject|5|||
130015900|NCT00749996|468019175|FG001|Overall Study|Withdrawal by Subject|4|||
130015901|NCT00749996|468019174|FG000|Overall Study|Protocol Violation|2|||
130015902|NCT00749996|468019175|FG001|Overall Study|Protocol Violation|3|||
130015903|NCT00749996|468019174|FG000|Overall Study|Physician Decision|2|||
130015904|NCT00749996|468019175|FG001|Overall Study|Physician Decision|0|||
130015905|NCT00749996|468019174|FG000|Overall Study|Pregnancy|0|||
130015906|NCT00749996|468019175|FG001|Overall Study|Pregnancy|2|||
130015907|NCT00749996|468019174|FG000|Overall Study|Adverse Event|1|||
130015908|NCT00749996|468019175|FG001|Overall Study|Adverse Event|0|||
130015909|NCT00749996|468019174|FG000|Overall Study|Death|1|||
130015910|NCT00749996|468019175|FG001|Overall Study|Death|0|||
130015911|NCT00517829|468019176|FG000|Overall Study|Adverse Event|22|||
130015912|NCT00517829|468019177|FG001|Overall Study|Adverse Event|34|||
130015913|NCT00517829|468019176|FG000|Overall Study|Disease Progression|39|||
130015914|NCT00517829|468019177|FG001|Overall Study|Disease Progression|32|||
130015915|NCT00517829|468019176|FG000|Overall Study|Patient Request|6|||
130015916|NCT00517829|468019177|FG001|Overall Study|Patient Request|5|||
130015917|NCT00517829|468019176|FG000|Overall Study|Investigator Request|5|||
130015918|NCT00517829|468019177|FG001|Overall Study|Investigator Request|3|||
130015919|NCT00517829|468019176|FG000|Overall Study|Other|3|||
130015920|NCT00517829|468019177|FG001|Overall Study|Other|1|||
130015921|NCT00606086|468019178|FG000|Overall Study|Adverse Event|1|||
130015922|NCT00606086|468019179|FG001|Overall Study|Adverse Event|1|||
130015923|NCT00606086|468019178|FG000|Overall Study|Lost to Follow-up|4|||
130015924|NCT00606086|468019179|FG001|Overall Study|Lost to Follow-up|8|||
130015925|NCT00606086|468019178|FG000|Overall Study|Protocol Violation|1|||
130015926|NCT00606086|468019179|FG001|Overall Study|Protocol Violation|0|||
130015927|NCT00606086|468019178|FG000|Overall Study|Withdrawal by Subject|5|||
130015928|NCT00606086|468019179|FG001|Overall Study|Withdrawal by Subject|3|||
130015929|NCT00606086|468019178|FG000|Overall Study|Non-compliance|0|||
130015930|NCT00606086|468019179|FG001|Overall Study|Non-compliance|1|||
130015931|NCT00606086|468019178|FG000|Overall Study|Randomized, not treated|1|||
130015932|NCT00606086|468019179|FG001|Overall Study|Randomized, not treated|2|||
130015933|NCT00796315|468019186|FG000|Overall Study|Protocol Violation|0|||
130015934|NCT00796315|468019187|FG001|Overall Study|Protocol Violation|1|||
130015935|NCT00796315|468019188|FG002|Overall Study|Protocol Violation|0|||
130015936|NCT00689871|468019195|FG000|Overall Study|Lost to Follow-up|123|||
130015937|NCT00689871|468019196|FG001|Overall Study|Lost to Follow-up|13|||
130015938|NCT00689871|468019197|FG002|Overall Study|Lost to Follow-up|37|||
130015939|NCT00689871|468019198|FG003|Overall Study|Lost to Follow-up|1|||
130015940|NCT00689871|468019195|FG000|Overall Study|Explanted of All Study Devices|36|||
130015941|NCT00689871|468019196|FG001|Overall Study|Explanted of All Study Devices|25|||
130015942|NCT00689871|468019197|FG002|Overall Study|Explanted of All Study Devices|29|||
130015943|NCT00689871|468019198|FG003|Overall Study|Explanted of All Study Devices|3|||
130015944|NCT00689871|468019195|FG000|Overall Study|Withdrawal by Subject|13|||
130015945|NCT00689871|468019196|FG001|Overall Study|Withdrawal by Subject|3|||
130015946|NCT00689871|468019197|FG002|Overall Study|Withdrawal by Subject|4|||
130015947|NCT00689871|468019198|FG003|Overall Study|Withdrawal by Subject|1|||
130015948|NCT00689871|468019195|FG000|Overall Study|Death|1|||
130015949|NCT00689871|468019196|FG001|Overall Study|Death|10|||
130015950|NCT00689871|468019197|FG002|Overall Study|Death|2|||
130015951|NCT00689871|468019198|FG003|Overall Study|Death|2|||
130015952|NCT00689871|468019195|FG000|Overall Study|Physician Decision|2|||
130015953|NCT00689871|468019196|FG001|Overall Study|Physician Decision|1|||
130098768|NCT03426995|468319295|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130015954|NCT00689871|468019197|FG002|Overall Study|Physician Decision|1|||
130015955|NCT00689871|468019198|FG003|Overall Study|Physician Decision|0|||
130098769|NCT03426995|468319296|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130015956|NCT00542269|468019201|FG000|Overall Study|Adverse Event|10|||
130015957|NCT00542269|468019202|FG001|Overall Study|Adverse Event|4|||
130015958|NCT00542269|468019203|FG002|Overall Study|Adverse Event|5|||
130015959|NCT00542269|468019201|FG000|Overall Study|Protocol Violation|1|||
130015960|NCT00542269|468019202|FG001|Overall Study|Protocol Violation|1|||
130015961|NCT00542269|468019203|FG002|Overall Study|Protocol Violation|0|||
130015962|NCT00542269|468019201|FG000|Overall Study|Withdrawal by Subject|1|||
130015963|NCT00542269|468019202|FG001|Overall Study|Withdrawal by Subject|0|||
130015964|NCT00542269|468019203|FG002|Overall Study|Withdrawal by Subject|0|||
130015965|NCT00542269|468019201|FG000|Overall Study|Administrative problems|1|||
130015966|NCT00542269|468019202|FG001|Overall Study|Administrative problems|1|||
130015967|NCT00542269|468019203|FG002|Overall Study|Administrative problems|1|||
130015968|NCT00845650|468019208|FG000|Overall Study|Withdrawal by Subject|0|||
130015969|NCT00845650|468019209|FG001|Overall Study|Withdrawal by Subject|0|||
130015970|NCT00845650|468019210|FG002|Overall Study|Withdrawal by Subject|0|||
130015971|NCT00845650|468019211|FG003|Overall Study|Withdrawal by Subject|0|||
130015972|NCT00845650|468019212|FG004|Overall Study|Withdrawal by Subject|2|||
130015973|NCT00845650|468019213|FG005|Overall Study|Withdrawal by Subject|0|||
130015974|NCT00845650|468019208|FG000|Overall Study|Lost to Follow-up|0|||
130015975|NCT00845650|468019209|FG001|Overall Study|Lost to Follow-up|0|||
130015976|NCT00845650|468019210|FG002|Overall Study|Lost to Follow-up|3|||
130015977|NCT00845650|468019211|FG003|Overall Study|Lost to Follow-up|1|||
130015978|NCT00845650|468019212|FG004|Overall Study|Lost to Follow-up|0|||
130015979|NCT00845650|468019213|FG005|Overall Study|Lost to Follow-up|1|||
130015980|NCT00845650|468019208|FG000|Overall Study|Sponsor hold on dosing|0|||
130015981|NCT00845650|468019209|FG001|Overall Study|Sponsor hold on dosing|0|||
130015982|NCT00845650|468019210|FG002|Overall Study|Sponsor hold on dosing|0|||
130015983|NCT00845650|468019211|FG003|Overall Study|Sponsor hold on dosing|0|||
130015984|NCT00845650|468019212|FG004|Overall Study|Sponsor hold on dosing|1|||
130015985|NCT00845650|468019213|FG005|Overall Study|Sponsor hold on dosing|1|||
130015986|NCT00845650|468019208|FG000|Overall Study|Unable to access IV line|1|||
130015987|NCT00845650|468019209|FG001|Overall Study|Unable to access IV line|0|||
130015988|NCT00845650|468019210|FG002|Overall Study|Unable to access IV line|0|||
130015989|NCT00845650|468019211|FG003|Overall Study|Unable to access IV line|0|||
130015990|NCT00845650|468019212|FG004|Overall Study|Unable to access IV line|0|||
130015991|NCT00845650|468019213|FG005|Overall Study|Unable to access IV line|0|||
130015992|NCT00814892|468019214|FG000|Overall Study|Disease Progression|1|||
130015993|NCT00814892|468019214|FG000|Overall Study|Study Termination|1|||
130015994|NCT00159861|468019215|FG000|Core Study - 16 Weeks|Death|3|||
130015995|NCT00159861|468019216|FG001|Core Study - 16 Weeks|Death|0|||
130015996|NCT00159861|468019215|FG000|Core Study - 16 Weeks|Adverse Event|12|||
130015997|NCT00159861|468019216|FG001|Core Study - 16 Weeks|Adverse Event|6|||
130015998|NCT00159861|468019215|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
130015999|NCT00159861|468019216|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
130016000|NCT00159861|468019215|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
130016001|NCT00159861|468019216|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
130016002|NCT00159861|468019215|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
130016003|NCT00159861|468019216|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
130016004|NCT00159861|468019215|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
130016005|NCT00159861|468019216|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
130016006|NCT00159861|468019215|FG000|Extension Study - up to 3 Years|Death|24|||
130016007|NCT00159861|468019216|FG001|Extension Study - up to 3 Years|Death|28|||
130016008|NCT00159861|468019215|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
130016009|NCT00159861|468019216|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
130016010|NCT00159861|468019215|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
130016011|NCT00159861|468019216|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
130016012|NCT00159861|468019215|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
130016013|NCT00159861|468019216|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
130016014|NCT00159861|468019215|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
130016015|NCT00159861|468019216|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
130016016|NCT04489888|468019217|FG000|Overall Study|Death|75|||
130016017|NCT04489888|468019217|FG000|Overall Study|Sponsor Decision|26|||
130016018|NCT03349099|468019218|FG000|Overall Study|Physician Decision|3|||
130016019|NCT03349099|468019219|FG001|Overall Study|Physician Decision|4|||
130016020|NCT03349099|468019218|FG000|Overall Study|Stone migrated from the kidney|1|||
130016021|NCT03349099|468019219|FG001|Overall Study|Stone migrated from the kidney|0|||
130016022|NCT00278993|468019220|FG000|Overall Study|Adverse Event|24|||
130016023|NCT00278993|468019220|FG000|Overall Study|Withdrawal by Subject|5|||
130016024|NCT00278993|468019220|FG000|Overall Study|Progressive Disease|65|||
130016025|NCT00278993|468019220|FG000|Overall Study|Physician Decision|9|||
130016026|NCT00278993|468019220|FG000|Overall Study|Not Otherwise Specified|4|||
130016027|NCT01430455|468019222|FG000|Overall Study|Withdrawal by Subject|1|||
130016028|NCT01430455|468019222|FG000|Overall Study|Switched to follow-up phase|1|||
130016029|NCT03829657|468019224|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
130016030|NCT03829657|468019225|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
130016031|NCT03829657|468019226|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
130016032|NCT03829657|468019227|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
130016033|NCT03829657|468019228|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
130016034|NCT03829657|468019224|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
130016035|NCT03829657|468019225|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130016036|NCT03829657|468019226|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130016037|NCT03829657|468019227|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130016038|NCT03829657|468019228|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
130016039|NCT03829657|468019224|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
130098770|NCT03426995|468319297|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130098771|NCT03426995|468319298|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130016040|NCT03829657|468019225|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
130016041|NCT03829657|468019226|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
130016042|NCT03829657|468019227|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
130016043|NCT03829657|468019228|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
130016044|NCT03829657|468019224|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
130016045|NCT03829657|468019225|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
130016046|NCT03829657|468019226|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
130016047|NCT03829657|468019227|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
130016048|NCT03829657|468019228|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
130016049|NCT03829657|468019224|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
130016050|NCT03829657|468019225|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
130016051|NCT03829657|468019226|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
130016052|NCT03829657|468019227|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
130016053|NCT03829657|468019228|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
130016054|NCT03829657|468019224|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
130016055|NCT03829657|468019225|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
130016056|NCT03829657|468019226|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
130016057|NCT03829657|468019227|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
130016058|NCT03829657|468019228|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
130016059|NCT03829657|468019224|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130016060|NCT03829657|468019225|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130016061|NCT03829657|468019226|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130016062|NCT03829657|468019227|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
130016063|NCT03829657|468019228|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
130016064|NCT03829657|468019224|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
130016065|NCT03829657|468019225|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
130016066|NCT03829657|468019226|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
130016067|NCT03829657|468019227|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
130016068|NCT03829657|468019228|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
130016069|NCT03829657|468019224|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
130016070|NCT03829657|468019225|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
130016071|NCT03829657|468019226|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
130016072|NCT03829657|468019227|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
130016073|NCT03829657|468019228|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
130016074|NCT03829657|468019224|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130016075|NCT03829657|468019225|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130016076|NCT03829657|468019226|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130016077|NCT03829657|468019227|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
130016078|NCT03829657|468019228|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
130016079|NCT01014689|468019229|FG000|Overall Study|Lack of Efficacy|0|||
130016080|NCT01014689|468019230|FG001|Overall Study|Lack of Efficacy|1|||
130016081|NCT01014689|468019229|FG000|Overall Study|Adverse Event|3|||
130016082|NCT01014689|468019230|FG001|Overall Study|Adverse Event|0|||
130016083|NCT01014689|468019229|FG000|Overall Study|Withdrawal by Subject|5|||
130016084|NCT01014689|468019230|FG001|Overall Study|Withdrawal by Subject|4|||
130016085|NCT01014689|468019229|FG000|Overall Study|Protocol Violation|1|||
130016086|NCT01014689|468019230|FG001|Overall Study|Protocol Violation|1|||
130016087|NCT01014689|468019229|FG000|Overall Study|Lost to Follow-up|3|||
130016088|NCT01014689|468019230|FG001|Overall Study|Lost to Follow-up|7|||
130016089|NCT01014689|468019229|FG000|Overall Study|Pregnancy|1|||
130016090|NCT01014689|468019230|FG001|Overall Study|Pregnancy|0|||
130016091|NCT00290433|468020771|FG000|Overall Study|Disease Progression|13|||
130016092|NCT00290433|468020771|FG000|Overall Study|Adverse Event|14|||
130016093|NCT00290433|468020771|FG000|Overall Study|Withdrawal by Subject|1|||
130016094|NCT00290433|468020771|FG000|Overall Study|Non-Compliance|1|||
130016095|NCT00290433|468020771|FG000|Overall Study|Congestive Heart Failure|1|||
130016096|NCT00290433|468020771|FG000|Overall Study|Transplant in CR|5|||
130016097|NCT00290433|468020771|FG000|Overall Study|Unrelated Infection/Death|1|||
130016098|NCT03031301|468020773|FG000|Overall Study|Protocol Violation|4|||
130016099|NCT03031301|468020774|FG001|Overall Study|Protocol Violation|8|||
130016100|NCT03031301|468020773|FG000|Overall Study|Withdrawal by Subject|7|||
130016101|NCT03031301|468020774|FG001|Overall Study|Withdrawal by Subject|4|||
130016102|NCT03031301|468020773|FG000|Overall Study|Lost to Follow-up|4|||
130016103|NCT03031301|468020774|FG001|Overall Study|Lost to Follow-up|12|||
130016104|NCT03031301|468020773|FG000|Overall Study|Noncompliance|1|||
130016105|NCT03031301|468020774|FG001|Overall Study|Noncompliance|3|||
130016106|NCT03031301|468020773|FG000|Overall Study|Technical issue|1|||
130016107|NCT03031301|468020774|FG001|Overall Study|Technical issue|1|||
130016108|NCT03031301|468020773|FG000|Overall Study|Adverse Event|1|||
130016109|NCT03031301|468020774|FG001|Overall Study|Adverse Event|0|||
130016110|NCT02429414|468020775|FG000|Overall Study|Physician Decision|0|||
130016111|NCT02429414|468020776|FG001|Overall Study|Physician Decision|1|||
130016112|NCT03245450|468020777|FG000|Overall Study|Radiological disease progression|3|||
130016113|NCT03245450|468020778|FG001|Overall Study|Radiological disease progression|3|||
130016114|NCT03245450|468020779|FG002|Overall Study|Radiological disease progression|2|||
130016115|NCT03245450|468020780|FG003|Overall Study|Radiological disease progression|2|||
130016116|NCT03245450|468020781|FG004|Overall Study|Radiological disease progression|7|||
130016117|NCT03245450|468020782|FG005|Overall Study|Radiological disease progression|6|||
130016118|NCT03245450|468020783|FG006|Overall Study|Radiological disease progression|6|||
130016119|NCT03245450|468020777|FG000|Overall Study|Clinical disease progression|0|||
130016120|NCT03245450|468020778|FG001|Overall Study|Clinical disease progression|0|||
130016121|NCT03245450|468020779|FG002|Overall Study|Clinical disease progression|1|||
130016122|NCT03245450|468020780|FG003|Overall Study|Clinical disease progression|0|||
130016123|NCT03245450|468020781|FG004|Overall Study|Clinical disease progression|0|||
130016124|NCT03245450|468020782|FG005|Overall Study|Clinical disease progression|2|||
130217807|NCT04865419|468761409|FG007|Overall Study|Study terminated by Sponsor|0|||
130217808|NCT04865419|468761410|FG008|Overall Study|Study terminated by Sponsor|0|||
130217809|NCT04865419|468761411|FG009|Overall Study|Study terminated by Sponsor|0|||
130217810|NCT04865419|468761412|FG010|Overall Study|Study terminated by Sponsor|1|||
130016125|NCT03245450|468020783|FG006|Overall Study|Clinical disease progression|0|||
130016126|NCT03245450|468020777|FG000|Overall Study|Other|0|||
130016127|NCT03245450|468020778|FG001|Overall Study|Other|0|||
130016128|NCT03245450|468020779|FG002|Overall Study|Other|0|||
130016129|NCT03245450|468020780|FG003|Overall Study|Other|1|||
130016130|NCT03245450|468020781|FG004|Overall Study|Other|1|||
130016131|NCT03245450|468020782|FG005|Overall Study|Other|1|||
130016132|NCT03245450|468020783|FG006|Overall Study|Other|1|||
130016133|NCT03245450|468020777|FG000|Overall Study|Withdrawal by Subject|0|||
130016134|NCT03245450|468020778|FG001|Overall Study|Withdrawal by Subject|1|||
130016135|NCT03245450|468020779|FG002|Overall Study|Withdrawal by Subject|0|||
130016136|NCT03245450|468020780|FG003|Overall Study|Withdrawal by Subject|0|||
130016137|NCT03245450|468020781|FG004|Overall Study|Withdrawal by Subject|0|||
130016138|NCT03245450|468020782|FG005|Overall Study|Withdrawal by Subject|0|||
130016139|NCT03245450|468020783|FG006|Overall Study|Withdrawal by Subject|0|||
130016140|NCT03245450|468020777|FG000|Overall Study|Adverse Event|0|||
130016141|NCT03245450|468020778|FG001|Overall Study|Adverse Event|0|||
130016142|NCT03245450|468020779|FG002|Overall Study|Adverse Event|0|||
130016143|NCT03245450|468020780|FG003|Overall Study|Adverse Event|0|||
130016144|NCT03245450|468020781|FG004|Overall Study|Adverse Event|1|||
130016145|NCT03245450|468020782|FG005|Overall Study|Adverse Event|0|||
130016146|NCT03245450|468020783|FG006|Overall Study|Adverse Event|2|||
130016147|NCT01784861|468020788|FG000|Overall Study|Adverse Event|0|||
130016148|NCT01784861|468020789|FG001|Overall Study|Adverse Event|0|||
130016149|NCT01784861|468020790|FG002|Overall Study|Adverse Event|1|||
130016150|NCT01784861|468020791|FG003|Overall Study|Adverse Event|2|||
130016151|NCT01784861|468020792|FG004|Overall Study|Adverse Event|1|||
130016152|NCT01784861|468020793|FG005|Overall Study|Adverse Event|0|||
130016153|NCT01784861|468020788|FG000|Overall Study|Withdrawal by Subject|0|||
130016154|NCT01784861|468020789|FG001|Overall Study|Withdrawal by Subject|0|||
130016155|NCT01784861|468020790|FG002|Overall Study|Withdrawal by Subject|0|||
130016156|NCT01784861|468020791|FG003|Overall Study|Withdrawal by Subject|1|||
130016157|NCT01784861|468020792|FG004|Overall Study|Withdrawal by Subject|0|||
130016158|NCT01784861|468020793|FG005|Overall Study|Withdrawal by Subject|0|||
130016159|NCT01784861|468020788|FG000|Overall Study|Physician Decision|0|||
130016160|NCT01784861|468020789|FG001|Overall Study|Physician Decision|0|||
130016161|NCT01784861|468020790|FG002|Overall Study|Physician Decision|0|||
130016162|NCT01784861|468020791|FG003|Overall Study|Physician Decision|2|||
130016163|NCT01784861|468020792|FG004|Overall Study|Physician Decision|0|||
130016164|NCT01784861|468020793|FG005|Overall Study|Physician Decision|1|||
130016165|NCT03948178|468020796|FG000|Overall Study|Protocol Violation|1|||
130016166|NCT03948178|468020796|FG000|Overall Study|Lost to Follow-up|2|||
130016167|NCT03948178|468020796|FG000|Overall Study|Withdrawal by Subject|2|||
130016168|NCT03948178|468020796|FG000|Overall Study|Reason not known|2|||
130016169|NCT03948178|468020796|FG000|Overall Study|Personal reason|14|||
130016170|NCT03948178|468020796|FG000|Overall Study|Disease progression|30|||
130016171|NCT03948178|468020796|FG000|Overall Study|Adverse Event|12|||
130016172|NCT03948178|468020796|FG000|Overall Study|Sponsor terminated study|164|||
130016173|NCT02432235|468020797|FG000|Overall Study|Death|1|||
130016174|NCT02432235|468020798|FG001|Overall Study|Death|1|||
130016175|NCT02432235|468020799|FG002|Overall Study|Death|2|||
130016176|NCT02432235|468020800|FG003|Overall Study|Death|2|||
130016177|NCT02432235|468020801|FG004|Overall Study|Death|1|||
130016178|NCT02432235|468020802|FG005|Overall Study|Death|3|||
130016179|NCT02432235|468020803|FG006|Overall Study|Death|11|||
130016180|NCT02432235|468020804|FG007|Overall Study|Death|15|||
130016181|NCT02432235|468020805|FG008|Overall Study|Death|15|||
130016182|NCT02432235|468020806|FG009|Overall Study|Death|3|||
130016183|NCT02432235|468020807|FG010|Overall Study|Death|1|||
130016184|NCT02432235|468020808|FG011|Overall Study|Death|0|||
130016185|NCT02432235|468020797|FG000|Overall Study|Withdrawal by Subject|0|||
130016186|NCT02432235|468020798|FG001|Overall Study|Withdrawal by Subject|1|||
130016187|NCT02432235|468020799|FG002|Overall Study|Withdrawal by Subject|0|||
130016188|NCT02432235|468020800|FG003|Overall Study|Withdrawal by Subject|0|||
130016189|NCT02432235|468020801|FG004|Overall Study|Withdrawal by Subject|0|||
130016190|NCT02432235|468020802|FG005|Overall Study|Withdrawal by Subject|2|||
130016191|NCT02432235|468020803|FG006|Overall Study|Withdrawal by Subject|5|||
130016192|NCT02432235|468020804|FG007|Overall Study|Withdrawal by Subject|3|||
130016193|NCT02432235|468020805|FG008|Overall Study|Withdrawal by Subject|1|||
130016194|NCT02432235|468020806|FG009|Overall Study|Withdrawal by Subject|0|||
130016195|NCT02432235|468020807|FG010|Overall Study|Withdrawal by Subject|0|||
130016196|NCT02432235|468020808|FG011|Overall Study|Withdrawal by Subject|0|||
130016197|NCT02432235|468020797|FG000|Overall Study|Lost to Follow-up|0|||
130016198|NCT02432235|468020798|FG001|Overall Study|Lost to Follow-up|0|||
130016199|NCT02432235|468020799|FG002|Overall Study|Lost to Follow-up|0|||
130016200|NCT02432235|468020800|FG003|Overall Study|Lost to Follow-up|0|||
130016201|NCT02432235|468020801|FG004|Overall Study|Lost to Follow-up|0|||
130016202|NCT02432235|468020802|FG005|Overall Study|Lost to Follow-up|1|||
130016203|NCT02432235|468020803|FG006|Overall Study|Lost to Follow-up|0|||
130016204|NCT02432235|468020804|FG007|Overall Study|Lost to Follow-up|0|||
130016205|NCT02432235|468020805|FG008|Overall Study|Lost to Follow-up|1|||
130016206|NCT02432235|468020806|FG009|Overall Study|Lost to Follow-up|0|||
130016207|NCT02432235|468020807|FG010|Overall Study|Lost to Follow-up|0|||
130016208|NCT02432235|468020808|FG011|Overall Study|Lost to Follow-up|0|||
130016209|NCT02432235|468020797|FG000|Overall Study|Miscellaneous|0|||
130016210|NCT02432235|468020798|FG001|Overall Study|Miscellaneous|0|||
130016211|NCT02432235|468020799|FG002|Overall Study|Miscellaneous|0|||
130016212|NCT02432235|468020800|FG003|Overall Study|Miscellaneous|0|||
130016213|NCT02432235|468020801|FG004|Overall Study|Miscellaneous|1|||
130016214|NCT02432235|468020802|FG005|Overall Study|Miscellaneous|6|||
130016215|NCT02432235|468020803|FG006|Overall Study|Miscellaneous|2|||
130016216|NCT02432235|468020804|FG007|Overall Study|Miscellaneous|2|||
130016217|NCT02432235|468020805|FG008|Overall Study|Miscellaneous|4|||
130016218|NCT02432235|468020806|FG009|Overall Study|Miscellaneous|0|||
130016219|NCT02432235|468020807|FG010|Overall Study|Miscellaneous|0|||
130016220|NCT02432235|468020808|FG011|Overall Study|Miscellaneous|1|||
130016221|NCT00382993|468020809|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
130016222|NCT00382993|468020810|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
130016223|NCT00382993|468020809|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
130016224|NCT00382993|468020810|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
130016225|NCT00382993|468020809|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
130016226|NCT00382993|468020810|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
130016227|NCT00382993|468020809|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
130016228|NCT00382993|468020810|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
130016229|NCT00382993|468020809|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
130016230|NCT00382993|468020810|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
130016231|NCT00382993|468020809|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
130016232|NCT00382993|468020810|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
130016233|NCT00382993|468020809|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
130016234|NCT00382993|468020810|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
130016235|NCT00382993|468020809|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
130016236|NCT00382993|468020810|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
130016237|NCT00382993|468020809|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
130016238|NCT00382993|468020810|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
130016239|NCT00382993|468020809|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
130016240|NCT00382993|468020810|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
130016241|NCT01965262|468020823|FG000|Second Intervention (7 Days)|Discontinued|0|||
130016242|NCT01965262|468020824|FG001|Second Intervention (7 Days)|Discontinued|1|||
130016243|NCT01965262|468020823|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
130016244|NCT01965262|468020824|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
130016245|NCT01965262|468020823|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
130016246|NCT01965262|468020824|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
130016247|NCT02898259|468020825|FG000|Overall Study|Adverse Event|0|||
130016248|NCT02898259|468020826|FG001|Overall Study|Adverse Event|0|||
130016249|NCT02898259|468020827|FG002|Overall Study|Adverse Event|1|||
130016250|NCT02898259|468020828|FG003|Overall Study|Adverse Event|0|||
130016251|NCT02898259|468020829|FG004|Overall Study|Adverse Event|0|||
130016252|NCT02898259|468020825|FG000|Overall Study|Lack of Efficacy|1|||
130016253|NCT02898259|468020826|FG001|Overall Study|Lack of Efficacy|1|||
130016254|NCT02898259|468020827|FG002|Overall Study|Lack of Efficacy|3|||
130016255|NCT02898259|468020828|FG003|Overall Study|Lack of Efficacy|0|||
130016256|NCT02898259|468020829|FG004|Overall Study|Lack of Efficacy|0|||
130016257|NCT02898259|468020825|FG000|Overall Study|Lost to Follow-up|0|||
130016258|NCT02898259|468020826|FG001|Overall Study|Lost to Follow-up|0|||
130016259|NCT02898259|468020827|FG002|Overall Study|Lost to Follow-up|1|||
130016260|NCT02898259|468020828|FG003|Overall Study|Lost to Follow-up|0|||
130016261|NCT02898259|468020829|FG004|Overall Study|Lost to Follow-up|0|||
130016262|NCT02898259|468020825|FG000|Overall Study|Transformation before study began|0|||
130016263|NCT02898259|468020826|FG001|Overall Study|Transformation before study began|0|||
130016264|NCT02898259|468020827|FG002|Overall Study|Transformation before study began|0|||
130016265|NCT02898259|468020828|FG003|Overall Study|Transformation before study began|1|||
130016266|NCT02898259|468020829|FG004|Overall Study|Transformation before study began|0|||
130217811|NCT04865419|468761402|FG000|Overall Study|Death|3|||
130217812|NCT04865419|468761403|FG001|Overall Study|Death|1|||
130016267|NCT01046877|468020830|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
130016268|NCT01046877|468020830|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
130016269|NCT03016325|468020831|FG000|Treatment Period|Participant withdrew consent|0|||
130016270|NCT03016325|468020832|FG001|Treatment Period|Participant withdrew consent|1|||
130016271|NCT03016325|468020833|FG002|Treatment Period|Participant withdrew consent|0|||
130016272|NCT03016325|468020834|FG003|Treatment Period|Participant withdrew consent|0|||
130016273|NCT03016325|468020835|FG004|Treatment Period|Participant withdrew consent|0|||
130016274|NCT03016325|468020836|FG005|Treatment Period|Participant withdrew consent|0|||
130016275|NCT03016325|468020837|FG006|Treatment Period|Participant withdrew consent|0|||
130016276|NCT03016325|468020838|FG007|Treatment Period|Participant withdrew consent|0|||
130016277|NCT03016325|468020831|FG000|Treatment Period|Death|0|||
130016278|NCT03016325|468020832|FG001|Treatment Period|Death|0|||
130016279|NCT03016325|468020833|FG002|Treatment Period|Death|0|||
130016280|NCT03016325|468020834|FG003|Treatment Period|Death|0|||
130016281|NCT03016325|468020835|FG004|Treatment Period|Death|2|||
130016282|NCT03016325|468020836|FG005|Treatment Period|Death|0|||
130016283|NCT03016325|468020837|FG006|Treatment Period|Death|0|||
130016284|NCT03016325|468020838|FG007|Treatment Period|Death|0|||
130016285|NCT03016325|468020831|FG000|Treatment Period|Participant refuses assessments|0|||
130016286|NCT03016325|468020832|FG001|Treatment Period|Participant refuses assessments|0|||
130016287|NCT03016325|468020833|FG002|Treatment Period|Participant refuses assessments|1|||
130016288|NCT03016325|468020834|FG003|Treatment Period|Participant refuses assessments|0|||
130016289|NCT03016325|468020835|FG004|Treatment Period|Participant refuses assessments|0|||
130016290|NCT03016325|468020836|FG005|Treatment Period|Participant refuses assessments|0|||
130016291|NCT03016325|468020837|FG006|Treatment Period|Participant refuses assessments|0|||
130016292|NCT03016325|468020838|FG007|Treatment Period|Participant refuses assessments|0|||
130016293|NCT03016325|468020831|FG000|32-Day Follow-Up Period|Death|2|||
130016294|NCT03016325|468020832|FG001|32-Day Follow-Up Period|Death|0|||
130016295|NCT03016325|468020833|FG002|32-Day Follow-Up Period|Death|5|||
130016296|NCT03016325|468020834|FG003|32-Day Follow-Up Period|Death|6|||
130016297|NCT03016325|468020835|FG004|32-Day Follow-Up Period|Death|3|||
130016298|NCT03016325|468020836|FG005|32-Day Follow-Up Period|Death|0|||
130016299|NCT03016325|468020837|FG006|32-Day Follow-Up Period|Death|0|||
130016300|NCT03016325|468020838|FG007|32-Day Follow-Up Period|Death|0|||
130016301|NCT03016325|468020831|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
130016302|NCT03016325|468020832|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
130016303|NCT03016325|468020833|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
130016304|NCT03016325|468020834|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
130016305|NCT03016325|468020835|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
130016306|NCT03016325|468020836|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
130016307|NCT03016325|468020837|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
130016308|NCT03016325|468020838|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
130016309|NCT03016325|468020831|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
130016310|NCT03016325|468020832|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
130016311|NCT03016325|468020833|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
130016312|NCT03016325|468020834|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
130016313|NCT03016325|468020835|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
130016314|NCT03016325|468020836|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
130016315|NCT03016325|468020837|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
130016316|NCT03016325|468020838|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
130016317|NCT03016325|468020831|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
130016318|NCT03016325|468020832|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
130016319|NCT03016325|468020833|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
130016320|NCT03016325|468020834|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
130016321|NCT03016325|468020835|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
130016322|NCT03016325|468020836|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
130016323|NCT03016325|468020837|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
130016324|NCT03016325|468020838|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
130016325|NCT03016325|468020831|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
130016326|NCT03016325|468020832|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
130016327|NCT03016325|468020833|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
130016328|NCT03016325|468020834|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
130016329|NCT03016325|468020835|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
130016330|NCT03016325|468020836|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
130016331|NCT03016325|468020837|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
130016332|NCT03016325|468020838|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
130016333|NCT03016325|468020831|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016334|NCT03016325|468020832|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016335|NCT03016325|468020833|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
130016336|NCT03016325|468020834|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016337|NCT03016325|468020835|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016338|NCT03016325|468020836|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016339|NCT03016325|468020837|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016340|NCT03016325|468020838|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
130016341|NCT03016325|468020831|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016342|NCT03016325|468020832|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
130016343|NCT03016325|468020833|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016344|NCT03016325|468020834|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016345|NCT03016325|468020835|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016346|NCT03016325|468020836|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016347|NCT03016325|468020837|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016348|NCT03016325|468020838|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
130016349|NCT03016325|468020831|FG000|182-Day Follow-Up Period|Death|3|||
130016350|NCT03016325|468020832|FG001|182-Day Follow-Up Period|Death|3|||
130016351|NCT03016325|468020833|FG002|182-Day Follow-Up Period|Death|11|||
130016352|NCT03016325|468020834|FG003|182-Day Follow-Up Period|Death|12|||
130016353|NCT03016325|468020835|FG004|182-Day Follow-Up Period|Death|9|||
130016354|NCT03016325|468020836|FG005|182-Day Follow-Up Period|Death|0|||
130016355|NCT03016325|468020837|FG006|182-Day Follow-Up Period|Death|0|||
130016356|NCT03016325|468020838|FG007|182-Day Follow-Up Period|Death|1|||
130016357|NCT03016325|468020831|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
130016358|NCT03016325|468020832|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016359|NCT03016325|468020833|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016360|NCT03016325|468020834|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016361|NCT03016325|468020835|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016362|NCT03016325|468020836|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016363|NCT03016325|468020837|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016364|NCT03016325|468020838|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
130016365|NCT03016325|468020831|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
130016366|NCT03016325|468020832|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
130016367|NCT03016325|468020833|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
130016368|NCT03016325|468020834|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
130016369|NCT03016325|468020835|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
130016370|NCT03016325|468020836|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
130016371|NCT03016325|468020837|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
130016372|NCT03016325|468020838|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
130016373|NCT03016325|468020831|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016374|NCT03016325|468020832|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016375|NCT03016325|468020833|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016376|NCT03016325|468020834|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016377|NCT03016325|468020835|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
130016378|NCT03016325|468020836|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016379|NCT03016325|468020837|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016380|NCT03016325|468020838|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
130016381|NCT03016325|468020831|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016382|NCT03016325|468020832|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016383|NCT03016325|468020833|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016384|NCT03016325|468020834|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016385|NCT03016325|468020835|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
130016386|NCT03016325|468020836|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016387|NCT03016325|468020837|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016388|NCT03016325|468020838|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
130016389|NCT03016325|468020831|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016390|NCT03016325|468020832|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016391|NCT03016325|468020833|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016392|NCT03016325|468020834|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
130016393|NCT03016325|468020835|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016394|NCT03016325|468020836|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016395|NCT03016325|468020837|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016396|NCT03016325|468020838|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
130016397|NCT03016325|468020831|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016398|NCT03016325|468020832|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
130016399|NCT03016325|468020833|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016400|NCT03016325|468020834|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016401|NCT03016325|468020835|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016402|NCT03016325|468020836|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016403|NCT03016325|468020837|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016404|NCT03016325|468020838|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
130016405|NCT03016325|468020831|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130016406|NCT03016325|468020832|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130016407|NCT03016325|468020833|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130016408|NCT03016325|468020834|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130016409|NCT03016325|468020835|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
130016410|NCT03016325|468020836|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
130016411|NCT03016325|468020837|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
130016412|NCT03016325|468020838|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
130016413|NCT02970292|468020839|FG000|Overall Study|Physician Decision|1|||
130016414|NCT02970292|468020840|FG001|Overall Study|Physician Decision|1|||
130016415|NCT02970292|468020839|FG000|Overall Study|Withdrawal by Subject|11|||
130016416|NCT02970292|468020840|FG001|Overall Study|Withdrawal by Subject|5|||
130016417|NCT02970292|468020839|FG000|Overall Study|Noncompliance with study drug|2|||
130016418|NCT02970292|468020840|FG001|Overall Study|Noncompliance with study drug|2|||
130016419|NCT02970292|468020839|FG000|Overall Study|Adverse Event|5|||
130016420|NCT02970292|468020840|FG001|Overall Study|Adverse Event|0|||
130016421|NCT02970292|468020839|FG000|Overall Study|Lack of Efficacy|1|||
130016422|NCT02970292|468020840|FG001|Overall Study|Lack of Efficacy|0|||
130016423|NCT02970292|468020839|FG000|Overall Study|Lost to Follow-up|1|||
130016424|NCT02970292|468020840|FG001|Overall Study|Lost to Follow-up|0|||
130016425|NCT02970292|468020839|FG000|Overall Study|Protocol Violation|2|||
130016426|NCT02970292|468020840|FG001|Overall Study|Protocol Violation|0|||
130016427|NCT02970292|468020839|FG000|Overall Study|Other|1|||
130016428|NCT02970292|468020840|FG001|Overall Study|Other|0|||
130016429|NCT01902290|468020843|FG000|Overall Study|Withdrawal by Subject|19|||
130016430|NCT01902290|468020844|FG001|Overall Study|Withdrawal by Subject|27|||
130016431|NCT01902290|468020843|FG000|Overall Study|Lost to Follow-up|2|||
130016432|NCT01902290|468020844|FG001|Overall Study|Lost to Follow-up|2|||
130016433|NCT01902290|468020843|FG000|Overall Study|Death|1|||
130098772|NCT03426995|468319299|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130098773|NCT03426995|468319300|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130016434|NCT01902290|468020844|FG001|Overall Study|Death|0|||
130016435|NCT01902290|468020843|FG000|Overall Study|Sponsor Decision|26|||
130016436|NCT01902290|468020844|FG001|Overall Study|Sponsor Decision|24|||
130016437|NCT03436862|468020846|FG000|Overall Study|Adverse Event|4|||
130016438|NCT03436862|468020846|FG000|Overall Study|Progressive Disease|2|||
130016439|NCT00391222|468020848|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
130016440|NCT00391222|468020849|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
130016441|NCT00391222|468020850|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
130016442|NCT00391222|468020851|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
130016443|NCT00391222|468020848|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
130016444|NCT00391222|468020849|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
130016445|NCT00391222|468020850|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
130016446|NCT00391222|468020851|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
130016447|NCT00391222|468020848|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
130016448|NCT00391222|468020849|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
130016449|NCT00391222|468020850|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
130016450|NCT00391222|468020851|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
130016451|NCT00391222|468020848|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
130016452|NCT00391222|468020849|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
130016453|NCT00391222|468020850|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
130016454|NCT00391222|468020851|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
130016455|NCT00391222|468020848|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
130016456|NCT00391222|468020849|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
130016457|NCT00391222|468020850|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
130016458|NCT00391222|468020851|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
130016459|NCT00391222|468020848|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
130016460|NCT00391222|468020849|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
130016461|NCT00391222|468020850|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
130016462|NCT00391222|468020851|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
130016463|NCT00391222|468020848|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
130016464|NCT00391222|468020849|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
130016465|NCT00391222|468020850|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
130016466|NCT00391222|468020851|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
130016467|NCT00391222|468020848|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
130016468|NCT00391222|468020849|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
130016469|NCT00391222|468020850|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
130016470|NCT00391222|468020851|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
130016471|NCT00391222|468020848|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
130016472|NCT00391222|468020849|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
130016473|NCT00391222|468020850|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
130016474|NCT00391222|468020851|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
130016475|NCT00391222|468020848|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
130016476|NCT00391222|468020849|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
130016477|NCT00391222|468020850|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
130016478|NCT00391222|468020851|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
130016479|NCT00391222|468020848|FG000|Period III (Double-Blind Treatment)|Other|6|||
130016480|NCT00391222|468020849|FG001|Period III (Double-Blind Treatment)|Other|1|||
130016481|NCT00391222|468020850|FG002|Period III (Double-Blind Treatment)|Other|6|||
130016482|NCT00391222|468020851|FG003|Period III (Double-Blind Treatment)|Other|0|||
130016483|NCT03215771|468020852|FG000|Overall Study|Withdrawal by Subject|2|||
130016484|NCT03215771|468020852|FG000|Overall Study|Physician Decision|1|||
130016485|NCT02039375|468020853|FG000|Overall Study|Lost to Follow-up|2|||
130016486|NCT04770389|468020854|FG000|Overall Study|Adverse Event|1|||
130016487|NCT04770389|468020855|FG001|Overall Study|Adverse Event|2|||
130016488|NCT04770389|468020856|FG002|Overall Study|Adverse Event|0|||
130016489|NCT04770389|468020857|FG003|Overall Study|Adverse Event|1|||
130016490|NCT04770389|468020854|FG000|Overall Study|Withdrawal by Subject|0|||
130016491|NCT04770389|468020855|FG001|Overall Study|Withdrawal by Subject|2|||
130016492|NCT04770389|468020856|FG002|Overall Study|Withdrawal by Subject|1|||
130016493|NCT04770389|468020857|FG003|Overall Study|Withdrawal by Subject|0|||
130016494|NCT04770389|468020854|FG000|Overall Study|Failed attempt to draw blood|1|||
130016495|NCT04770389|468020855|FG001|Overall Study|Failed attempt to draw blood|0|||
130016496|NCT04770389|468020856|FG002|Overall Study|Failed attempt to draw blood|0|||
130016497|NCT04770389|468020857|FG003|Overall Study|Failed attempt to draw blood|0|||
130016498|NCT04770389|468020854|FG000|Overall Study|Left the country|0|||
130016499|NCT04770389|468020855|FG001|Overall Study|Left the country|0|||
130016500|NCT04770389|468020856|FG002|Overall Study|Left the country|1|||
130016501|NCT04770389|468020857|FG003|Overall Study|Left the country|2|||
130016502|NCT04770389|468020854|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
130016503|NCT04770389|468020855|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
130016504|NCT04770389|468020856|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
130016505|NCT04770389|468020857|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
130016506|NCT04770389|468020854|FG000|Overall Study|Lost to Follow-up|0|||
130016507|NCT04770389|468020855|FG001|Overall Study|Lost to Follow-up|0|||
130016508|NCT04770389|468020856|FG002|Overall Study|Lost to Follow-up|0|||
130016509|NCT04770389|468020857|FG003|Overall Study|Lost to Follow-up|1|||
130016510|NCT04770389|468020854|FG000|Overall Study|Moved away from study site|0|||
130016511|NCT04770389|468020855|FG001|Overall Study|Moved away from study site|1|||
130016512|NCT04770389|468020856|FG002|Overall Study|Moved away from study site|0|||
130016513|NCT04770389|468020857|FG003|Overall Study|Moved away from study site|0|||
130016514|NCT03873714|468020861|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
130016515|NCT03028870|468020862|FG000|Overall Study|Adverse Event|7|||
130016516|NCT03028870|468020863|FG001|Overall Study|Adverse Event|4|||
130016517|NCT03028870|468020864|FG002|Overall Study|Adverse Event|3|||
130016518|NCT03028870|468020865|FG003|Overall Study|Adverse Event|3|||
130016519|NCT03028870|468020862|FG000|Overall Study|Withdrawal by Subject|1|||
130016520|NCT03028870|468020863|FG001|Overall Study|Withdrawal by Subject|1|||
130016521|NCT03028870|468020864|FG002|Overall Study|Withdrawal by Subject|1|||
130016522|NCT03028870|468020865|FG003|Overall Study|Withdrawal by Subject|2|||
130016523|NCT03028870|468020862|FG000|Overall Study|Lost to Follow-up|1|||
130016524|NCT03028870|468020863|FG001|Overall Study|Lost to Follow-up|0|||
130016525|NCT03028870|468020864|FG002|Overall Study|Lost to Follow-up|0|||
130016526|NCT03028870|468020865|FG003|Overall Study|Lost to Follow-up|0|||
130016527|NCT03028870|468020862|FG000|Overall Study|Lack of Efficacy|3|||
130016528|NCT03028870|468020863|FG001|Overall Study|Lack of Efficacy|0|||
130016529|NCT03028870|468020864|FG002|Overall Study|Lack of Efficacy|0|||
130016530|NCT03028870|468020865|FG003|Overall Study|Lack of Efficacy|0|||
130016531|NCT03028870|468020862|FG000|Overall Study|Administrative|5|||
130016532|NCT03028870|468020863|FG001|Overall Study|Administrative|5|||
130016533|NCT03028870|468020864|FG002|Overall Study|Administrative|12|||
130016534|NCT03028870|468020865|FG003|Overall Study|Administrative|4|||
130016535|NCT00708123|468020866|FG000|Period 1|Protocol Violation|0|||
130016536|NCT00708123|468020867|FG001|Period 1|Protocol Violation|1|||
130016537|NCT00708123|468020868|FG002|Period 1|Protocol Violation|0|||
130016538|NCT00708123|468020869|FG003|Period 1|Protocol Violation|1|||
130016539|NCT00708123|468020870|FG004|Period 1|Protocol Violation|0|||
130016540|NCT00708123|468020866|FG000|Period 1|Adverse Event|0|||
130016541|NCT00708123|468020867|FG001|Period 1|Adverse Event|0|||
130016542|NCT00708123|468020868|FG002|Period 1|Adverse Event|1|||
130016543|NCT00708123|468020869|FG003|Period 1|Adverse Event|0|||
130016544|NCT00708123|468020870|FG004|Period 1|Adverse Event|0|||
130016545|NCT00708123|468020866|FG000|Period 2|Protocol Violation|0|||
130016546|NCT00708123|468020867|FG001|Period 2|Protocol Violation|0|||
130016547|NCT00708123|468020868|FG002|Period 2|Protocol Violation|0|||
130016548|NCT00708123|468020869|FG003|Period 2|Protocol Violation|1|||
130016549|NCT00708123|468020870|FG004|Period 2|Protocol Violation|0|||
130016550|NCT00708123|468020866|FG000|Period 2|Other Reason|1|||
130016551|NCT00708123|468020867|FG001|Period 2|Other Reason|0|||
130016552|NCT00708123|468020868|FG002|Period 2|Other Reason|0|||
130016553|NCT00708123|468020869|FG003|Period 2|Other Reason|0|||
130016554|NCT00708123|468020870|FG004|Period 2|Other Reason|0|||
130016555|NCT00708123|468020866|FG000|Period 3|Lost to Follow-up|0|||
130016556|NCT00708123|468020867|FG001|Period 3|Lost to Follow-up|0|||
130016557|NCT00708123|468020868|FG002|Period 3|Lost to Follow-up|1|||
130016558|NCT00708123|468020869|FG003|Period 3|Lost to Follow-up|1|||
130016559|NCT00708123|468020870|FG004|Period 3|Lost to Follow-up|0|||
130016560|NCT00708123|468020866|FG000|Period 4|Protocol Violation|0|||
130016561|NCT00708123|468020867|FG001|Period 4|Protocol Violation|1|||
130016562|NCT00708123|468020868|FG002|Period 4|Protocol Violation|0|||
130016563|NCT00708123|468020869|FG003|Period 4|Protocol Violation|0|||
130016564|NCT00708123|468020870|FG004|Period 4|Protocol Violation|0|||
130016565|NCT04486950|468020871|FG000|Overall Study|Lost to Follow-up|0|||
130016566|NCT04486950|468020872|FG001|Overall Study|Lost to Follow-up|0|||
130016567|NCT04486950|468020873|FG002|Overall Study|Lost to Follow-up|0|||
130016568|NCT04486950|468020874|FG003|Overall Study|Lost to Follow-up|0|||
130016569|NCT04486950|468020875|FG004|Overall Study|Lost to Follow-up|0|||
130016570|NCT04486950|468020876|FG005|Overall Study|Lost to Follow-up|1|||
130016571|NCT04486950|468020877|FG006|Overall Study|Lost to Follow-up|0|||
130016572|NCT00317109|468020882|FG000|Overall Study|Withdrawal by Subject|2|||
130016573|NCT00317109|468020883|FG001|Overall Study|Withdrawal by Subject|0|||
130016574|NCT00317109|468020882|FG000|Overall Study|Migated/moved from study area|1|||
130016575|NCT00317109|468020883|FG001|Overall Study|Migated/moved from study area|0|||
130016576|NCT03693625|468020884|FG000|Overall Study|Adverse Event|2|||
130016577|NCT03693625|468020885|FG001|Overall Study|Adverse Event|0|||
130016578|NCT03693625|468020884|FG000|Overall Study|Study Terminated By Sponsor|20|||
130016579|NCT03693625|468020885|FG001|Overall Study|Study Terminated By Sponsor|7|||
130016580|NCT03693625|468020884|FG000|Overall Study|Withdrawal by Subject|1|||
130016581|NCT03693625|468020885|FG001|Overall Study|Withdrawal by Subject|1|||
130016582|NCT01508702|468020886|FG000|Overall Study|Adverse Event|7|||
130016583|NCT01508702|468020887|FG001|Overall Study|Adverse Event|3|||
130016584|NCT01508702|468020886|FG000|Overall Study|Gout flare|2|||
130016585|NCT01508702|468020887|FG001|Overall Study|Gout flare|0|||
130016586|NCT01508702|468020886|FG000|Overall Study|Protocol Violation|2|||
130016587|NCT01508702|468020887|FG001|Overall Study|Protocol Violation|1|||
130016588|NCT01508702|468020886|FG000|Overall Study|Lost to Follow-up|1|||
130016589|NCT01508702|468020887|FG001|Overall Study|Lost to Follow-up|2|||
130016590|NCT01508702|468020886|FG000|Overall Study|Withdrawal by Subject|11|||
130016591|NCT01508702|468020887|FG001|Overall Study|Withdrawal by Subject|7|||
130016592|NCT00250835|468020889|FG000|Overall Study|Withdrawal by Subject|1|||
130016593|NCT01187953|468020890|FG000|Overall Study|Death|11|||
130016594|NCT01187953|468020891|FG001|Overall Study|Death|13|||
130016595|NCT01187953|468020890|FG000|Overall Study|Adverse Event|1|||
130016596|NCT01187953|468020891|FG001|Overall Study|Adverse Event|2|||
130016597|NCT01187953|468020890|FG000|Overall Study|Lost to Follow-up|0|||
130016598|NCT01187953|468020891|FG001|Overall Study|Lost to Follow-up|3|||
130016599|NCT01187953|468020890|FG000|Overall Study|Withdrawal by Subject|3|||
130016600|NCT01187953|468020891|FG001|Overall Study|Withdrawal by Subject|3|||
130016601|NCT01464307|468020895|FG000|Main Period|Death|0|||
130016602|NCT01464307|468020896|FG001|Main Period|Death|1|||
130016603|NCT01464307|468020895|FG000|Main Period|Adverse Event|6|||
130016604|NCT01464307|468020896|FG001|Main Period|Adverse Event|1|||
130016605|NCT01464307|468020895|FG000|Main Period|Lack of Efficacy|2|||
130016606|NCT01464307|468020896|FG001|Main Period|Lack of Efficacy|0|||
130016607|NCT01464307|468020895|FG000|Main Period|Withdrawal by Subject|5|||
130016608|NCT01464307|468020896|FG001|Main Period|Withdrawal by Subject|2|||
130016609|NCT01464307|468020895|FG000|Main Period|Predefined discontinuation criteria|2|||
130016610|NCT01464307|468020896|FG001|Main Period|Predefined discontinuation criteria|1|||
130016611|NCT01464307|468020895|FG000|Open-Label Extension Period|Adverse Event|15|||
130016612|NCT01464307|468020896|FG001|Open-Label Extension Period|Adverse Event|0|||
130016613|NCT01464307|468020895|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
130016614|NCT01464307|468020896|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
130016615|NCT01464307|468020895|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
130016616|NCT01464307|468020896|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
130016617|NCT01464307|468020895|FG000|Open-Label Extension Period|Death|1|||
130016618|NCT01464307|468020896|FG001|Open-Label Extension Period|Death|0|||
130016619|NCT01464307|468020895|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130016620|NCT01464307|468020896|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
130016621|NCT01464307|468020895|FG000|Open-Label Extension Period|Non-compliance|9|||
130016622|NCT01464307|468020896|FG001|Open-Label Extension Period|Non-compliance|0|||
130016623|NCT01464307|468020895|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
130016624|NCT01464307|468020896|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
130016625|NCT02457637|468020899|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
130016626|NCT04942925|468020902|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
130016627|NCT04942925|468020903|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
130016628|NCT04942925|468020902|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
130016629|NCT04942925|468020903|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
130016630|NCT01273883|468020904|FG000|First Intervention|Adverse Event|2|||
130016631|NCT01273883|468020905|FG001|First Intervention|Adverse Event|1|||
130016632|NCT01273883|468020904|FG000|Second Intervention|Lost to Follow-up|1|||
130016633|NCT01273883|468020905|FG001|Second Intervention|Lost to Follow-up|1|||
130016634|NCT01273883|468020904|FG000|Second Intervention|Lack of Efficacy|1|||
130016635|NCT01273883|468020905|FG001|Second Intervention|Lack of Efficacy|0|||
130016636|NCT00333359|468020910|FG000|Overall Study|Adverse Event|29|||
130016637|NCT00333359|468020911|FG001|Overall Study|Adverse Event|35|||
130016638|NCT00333359|468020910|FG000|Overall Study|Withdrawal by Subject|19|||
130016639|NCT00333359|468020911|FG001|Overall Study|Withdrawal by Subject|37|||
130016640|NCT00333359|468020910|FG000|Overall Study|Physician Decision|2|||
130016641|NCT00333359|468020911|FG001|Overall Study|Physician Decision|2|||
130016642|NCT00333359|468020910|FG000|Overall Study|Protocol Non-compliance|2|||
130016643|NCT00333359|468020911|FG001|Overall Study|Protocol Non-compliance|8|||
130016644|NCT00333359|468020910|FG000|Overall Study|Lost to Follow-up|15|||
130016645|NCT00333359|468020911|FG001|Overall Study|Lost to Follow-up|25|||
130016646|NCT00333359|468020910|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
130016647|NCT00333359|468020911|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
130016648|NCT00333359|468020910|FG000|Overall Study|Treatment Failure|3|||
130016649|NCT00333359|468020911|FG001|Overall Study|Treatment Failure|8|||
130016650|NCT00333359|468020910|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
130016651|NCT00333359|468020911|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
130016652|NCT02867995|468020913|FG000|Overall Study|Withdrawal by Subject|0|||
130016653|NCT02867995|468020914|FG001|Overall Study|Withdrawal by Subject|1|||
130016654|NCT02867995|468020913|FG000|Overall Study|Lost to Follow-up|0|||
130016655|NCT02867995|468020914|FG001|Overall Study|Lost to Follow-up|2|||
130016656|NCT04099251|468024279|FG000|Pre-Treatment|Other reasons|1|||
130016657|NCT04099251|468024280|FG001|Pre-Treatment|Other reasons|0|||
130016658|NCT04099251|468024279|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
130016659|NCT04099251|468024280|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
130016660|NCT04099251|468024279|FG000|Blinded Treatment Phase|Other reasons|16|||
130016661|NCT04099251|468024280|FG001|Blinded Treatment Phase|Other reasons|7|||
130016662|NCT04099251|468024279|FG000|Blinded Treatment Phase|Disease recurrence|26|||
130016663|NCT04099251|468024280|FG001|Blinded Treatment Phase|Disease recurrence|41|||
130016664|NCT04099251|468024279|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
130016665|NCT04099251|468024280|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
130016666|NCT04099251|468024279|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
130016667|NCT04099251|468024280|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
130016668|NCT04099251|468024279|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
130016669|NCT04099251|468024280|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
130016670|NCT04099251|468024279|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
130016671|NCT04099251|468024280|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
130016672|NCT04099251|468024279|FG000|Blinded Treatment Phase|Death|6|||
130016673|NCT04099251|468024280|FG001|Blinded Treatment Phase|Death|2|||
130016674|NCT04099251|468024279|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
130016675|NCT04099251|468024280|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
130016676|NCT04099251|468024279|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
130016677|NCT04099251|468024280|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
130016678|NCT04099251|468024279|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
130016679|NCT04099251|468024280|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
130016680|NCT04099251|468024279|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
130016681|NCT04099251|468024280|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
130016682|NCT04099251|468024279|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
130016683|NCT04099251|468024280|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
130016684|NCT04099251|468024279|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
130016685|NCT04099251|468024280|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
130016686|NCT04099251|468024279|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
130052119|NCT03952468|468147218|FG001|Overall Study|Withdrawal by Subject|1|||
130016687|NCT04099251|468024280|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
130016688|NCT04099251|468024279|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
130016689|NCT04099251|468024280|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
130016690|NCT04099251|468024279|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
130016691|NCT04099251|468024280|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
130016692|NCT05032157|468024281|FG000|Overall Study|Adverse Event|12|||
130016693|NCT05032157|468024282|FG001|Overall Study|Adverse Event|7|||
130016694|NCT05032157|468024281|FG000|Overall Study|Pregnancy|0|||
130016695|NCT05032157|468024282|FG001|Overall Study|Pregnancy|2|||
130016696|NCT05032157|468024281|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130016697|NCT05032157|468024282|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
130016698|NCT05032157|468024281|FG000|Overall Study|Protocol Deviation|8|||
130016699|NCT05032157|468024282|FG001|Overall Study|Protocol Deviation|4|||
130016700|NCT05032157|468024281|FG000|Overall Study|Lost to Follow-up|1|||
130016701|NCT05032157|468024282|FG001|Overall Study|Lost to Follow-up|3|||
130016702|NCT05032157|468024281|FG000|Overall Study|Physician Decision|7|||
130016703|NCT05032157|468024282|FG001|Overall Study|Physician Decision|2|||
130016704|NCT05032157|468024281|FG000|Overall Study|Patient Decision|38|||
130016705|NCT05032157|468024282|FG001|Overall Study|Patient Decision|19|||
130016706|NCT03047980|468024283|FG000|Overall Study|Adverse Event|1|||
130016707|NCT00880893|468024284|FG000|Overall Study|Protocol Violation|13|||
130016708|NCT00880893|468024285|FG001|Overall Study|Protocol Violation|1|||
130016709|NCT00880893|468024284|FG000|Overall Study|Withdrawal by Subject|15|||
130016710|NCT00880893|468024285|FG001|Overall Study|Withdrawal by Subject|11|||
130016711|NCT00880893|468024284|FG000|Overall Study|Lost to Follow-up|76|||
130016712|NCT00880893|468024285|FG001|Overall Study|Lost to Follow-up|33|||
130016713|NCT00880893|468024284|FG000|Overall Study|Serious adverse event|3|||
130016714|NCT00880893|468024285|FG001|Overall Study|Serious adverse event|0|||
130016715|NCT02164981|468024286|FG000|Started|Withdrawal by Subject|2|||
130016716|NCT02164981|468024287|FG001|Started|Withdrawal by Subject|1|||
130016717|NCT02164981|468024288|FG002|Started|Withdrawal by Subject|0|||
130016718|NCT02164981|468024286|FG000|Started|Protocol Violation|2|||
130016719|NCT02164981|468024287|FG001|Started|Protocol Violation|0|||
130016720|NCT02164981|468024288|FG002|Started|Protocol Violation|0|||
130016721|NCT02164981|468024286|FG000|Started|Adverse Event|1|||
130016722|NCT02164981|468024287|FG001|Started|Adverse Event|2|||
130016723|NCT02164981|468024288|FG002|Started|Adverse Event|0|||
130016724|NCT02164981|468024286|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
130016725|NCT02164981|468024287|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
130016726|NCT02164981|468024288|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
130016727|NCT02164981|468024286|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
130016728|NCT02164981|468024287|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
130016729|NCT02164981|468024288|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
130016730|NCT02164981|468024286|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
130016731|NCT02164981|468024287|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
130016732|NCT02164981|468024288|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
130016733|NCT01783678|468024289|FG000|Overall Study|Randomized but Not Treated|0|||
130016734|NCT01783678|468024290|FG001|Overall Study|Randomized but Not Treated|0|||
130016735|NCT01783678|468024291|FG002|Overall Study|Randomized but Not Treated|0|||
130016736|NCT01783678|468024292|FG003|Overall Study|Randomized but Not Treated|1|||
130016737|NCT01783678|468024293|FG004|Overall Study|Randomized but Not Treated|0|||
130016738|NCT01783678|468024294|FG005|Overall Study|Randomized but Not Treated|0|||
130016739|NCT01783678|468024289|FG000|Overall Study|Lack of Efficacy|1|||
130016740|NCT01783678|468024290|FG001|Overall Study|Lack of Efficacy|13|||
130016741|NCT01783678|468024291|FG002|Overall Study|Lack of Efficacy|1|||
130016742|NCT01783678|468024292|FG003|Overall Study|Lack of Efficacy|3|||
130016743|NCT01783678|468024293|FG004|Overall Study|Lack of Efficacy|6|||
130016744|NCT01783678|468024294|FG005|Overall Study|Lack of Efficacy|5|||
130016745|NCT01783678|468024289|FG000|Overall Study|Lost to Follow-up|0|||
130016746|NCT01783678|468024290|FG001|Overall Study|Lost to Follow-up|4|||
130016747|NCT01783678|468024291|FG002|Overall Study|Lost to Follow-up|0|||
130016748|NCT01783678|468024292|FG003|Overall Study|Lost to Follow-up|2|||
130016749|NCT01783678|468024293|FG004|Overall Study|Lost to Follow-up|1|||
130016750|NCT01783678|468024294|FG005|Overall Study|Lost to Follow-up|0|||
130016751|NCT01783678|468024289|FG000|Overall Study|Withdrew Consent|1|||
130016752|NCT01783678|468024290|FG001|Overall Study|Withdrew Consent|1|||
130016753|NCT01783678|468024291|FG002|Overall Study|Withdrew Consent|0|||
130016754|NCT01783678|468024292|FG003|Overall Study|Withdrew Consent|2|||
130016755|NCT01783678|468024293|FG004|Overall Study|Withdrew Consent|0|||
130016756|NCT01783678|468024294|FG005|Overall Study|Withdrew Consent|0|||
130016757|NCT02404103|468024295|FG000|Overall Study|Adverse Event|1|||
130016758|NCT02404103|468024296|FG001|Overall Study|Adverse Event|0|||
130016759|NCT02404103|468024295|FG000|Overall Study|Lost to Follow-up|3|||
130016760|NCT02404103|468024296|FG001|Overall Study|Lost to Follow-up|3|||
130217813|NCT04865419|468761404|FG002|Overall Study|Death|4|||
130217814|NCT04865419|468761405|FG003|Overall Study|Death|2|||
130217815|NCT04865419|468761406|FG004|Overall Study|Death|5|||
130217816|NCT04865419|468761407|FG005|Overall Study|Death|2|||
130217817|NCT04865419|468761408|FG006|Overall Study|Death|1|||
130217818|NCT04865419|468761409|FG007|Overall Study|Death|1|||
130217819|NCT04865419|468761410|FG008|Overall Study|Death|2|||
130217820|NCT04865419|468761411|FG009|Overall Study|Death|2|||
130217821|NCT04865419|468761412|FG010|Overall Study|Death|1|||
130217822|NCT04865419|468761402|FG000|Overall Study|Lost to Follow-up|0|||
130217823|NCT04865419|468761403|FG001|Overall Study|Lost to Follow-up|0|||
130217824|NCT04865419|468761404|FG002|Overall Study|Lost to Follow-up|0|||
130217825|NCT04865419|468761405|FG003|Overall Study|Lost to Follow-up|0|||
130217826|NCT04865419|468761406|FG004|Overall Study|Lost to Follow-up|0|||
130217827|NCT04865419|468761407|FG005|Overall Study|Lost to Follow-up|0|||
130217828|NCT04865419|468761408|FG006|Overall Study|Lost to Follow-up|0|||
130217829|NCT04865419|468761409|FG007|Overall Study|Lost to Follow-up|0|||
130217830|NCT04865419|468761410|FG008|Overall Study|Lost to Follow-up|0|||
130217831|NCT04865419|468761411|FG009|Overall Study|Lost to Follow-up|1|||
130217832|NCT04865419|468761412|FG010|Overall Study|Lost to Follow-up|0|||
130217833|NCT00547157|468761413|FG000|Overall Study|Other|1|||
130217834|NCT00547157|468761414|FG001|Overall Study|Other|0|||
130217835|NCT00547157|468761413|FG000|Overall Study|Death|38|||
130217836|NCT00547157|468761414|FG001|Overall Study|Death|18|||
130217837|NCT00547157|468761413|FG000|Overall Study|Withdrawal by Subject|3|||
130217838|NCT00547157|468761414|FG001|Overall Study|Withdrawal by Subject|1|||
130217839|NCT00547157|468761413|FG000|Overall Study|Administrative decision|3|||
130217840|NCT00547157|468761414|FG001|Overall Study|Administrative decision|2|||
130217841|NCT00547157|468761413|FG000|Overall Study|Lost to Follow-up|4|||
130016761|NCT01995071|468024297|FG000|Overall Study|Adverse Event|0|||
130016762|NCT01995071|468024298|FG001|Overall Study|Adverse Event|0|||
130016763|NCT01995071|468024299|FG002|Overall Study|Adverse Event|0|||
130016764|NCT01995071|468024300|FG003|Overall Study|Adverse Event|0|||
130016765|NCT01995071|468024301|FG004|Overall Study|Adverse Event|0|||
130016766|NCT01995071|468024302|FG005|Overall Study|Adverse Event|0|||
130016767|NCT01995071|468024303|FG006|Overall Study|Adverse Event|1|||
130016768|NCT01995071|468024304|FG007|Overall Study|Adverse Event|0|||
130016769|NCT01995071|468024305|FG008|Overall Study|Adverse Event|0|||
130016770|NCT01995071|468024306|FG009|Overall Study|Adverse Event|0|||
130016771|NCT01995071|468024307|FG010|Overall Study|Adverse Event|0|||
130016772|NCT01995071|468024308|FG011|Overall Study|Adverse Event|0|||
130016773|NCT01995071|468024297|FG000|Overall Study|Moved|0|||
130016774|NCT01995071|468024298|FG001|Overall Study|Moved|0|||
130016775|NCT01995071|468024299|FG002|Overall Study|Moved|1|||
130016776|NCT01995071|468024300|FG003|Overall Study|Moved|0|||
130016777|NCT01995071|468024301|FG004|Overall Study|Moved|1|||
130016778|NCT01995071|468024302|FG005|Overall Study|Moved|0|||
130016779|NCT01995071|468024303|FG006|Overall Study|Moved|0|||
130016780|NCT01995071|468024304|FG007|Overall Study|Moved|0|||
130016781|NCT01995071|468024305|FG008|Overall Study|Moved|0|||
130016782|NCT01995071|468024306|FG009|Overall Study|Moved|0|||
130016783|NCT01995071|468024307|FG010|Overall Study|Moved|1|||
130016784|NCT01995071|468024308|FG011|Overall Study|Moved|0|||
130016785|NCT01995071|468024297|FG000|Overall Study|Lost to Follow-up|1|||
130016786|NCT01995071|468024298|FG001|Overall Study|Lost to Follow-up|0|||
130016787|NCT01995071|468024299|FG002|Overall Study|Lost to Follow-up|0|||
130016788|NCT01995071|468024300|FG003|Overall Study|Lost to Follow-up|0|||
130016789|NCT01995071|468024301|FG004|Overall Study|Lost to Follow-up|0|||
130016790|NCT01995071|468024302|FG005|Overall Study|Lost to Follow-up|0|||
130016791|NCT01995071|468024303|FG006|Overall Study|Lost to Follow-up|0|||
130016792|NCT01995071|468024304|FG007|Overall Study|Lost to Follow-up|1|||
130016793|NCT01995071|468024305|FG008|Overall Study|Lost to Follow-up|1|||
130016794|NCT01995071|468024306|FG009|Overall Study|Lost to Follow-up|0|||
130016795|NCT01995071|468024307|FG010|Overall Study|Lost to Follow-up|0|||
130016796|NCT01995071|468024308|FG011|Overall Study|Lost to Follow-up|0|||
130016797|NCT01995071|468024297|FG000|Overall Study|Incarcerated|0|||
130016798|NCT01995071|468024298|FG001|Overall Study|Incarcerated|0|||
130016799|NCT01995071|468024299|FG002|Overall Study|Incarcerated|0|||
130016800|NCT01995071|468024300|FG003|Overall Study|Incarcerated|0|||
130016801|NCT01995071|468024301|FG004|Overall Study|Incarcerated|0|||
130016802|NCT01995071|468024302|FG005|Overall Study|Incarcerated|0|||
130016803|NCT01995071|468024303|FG006|Overall Study|Incarcerated|0|||
130016804|NCT01995071|468024304|FG007|Overall Study|Incarcerated|1|||
130016805|NCT01995071|468024305|FG008|Overall Study|Incarcerated|0|||
130016806|NCT01995071|468024306|FG009|Overall Study|Incarcerated|0|||
130016807|NCT01995071|468024307|FG010|Overall Study|Incarcerated|0|||
130016808|NCT01995071|468024308|FG011|Overall Study|Incarcerated|0|||
130016809|NCT00328627|468024309|FG000|Overall Study|Hyperglycemic Rescue|41|||
130016810|NCT00328627|468024310|FG001|Overall Study|Hyperglycemic Rescue|18|||
130016811|NCT00328627|468024311|FG002|Overall Study|Hyperglycemic Rescue|16|||
130016812|NCT00328627|468024312|FG003|Overall Study|Hyperglycemic Rescue|13|||
130016813|NCT00328627|468024313|FG004|Overall Study|Hyperglycemic Rescue|6|||
130016814|NCT00328627|468024314|FG005|Overall Study|Hyperglycemic Rescue|5|||
130016815|NCT00328627|468024315|FG006|Overall Study|Hyperglycemic Rescue|19|||
130016816|NCT00328627|468024316|FG007|Overall Study|Hyperglycemic Rescue|6|||
130016817|NCT00328627|468024317|FG008|Overall Study|Hyperglycemic Rescue|6|||
130016818|NCT00328627|468024318|FG009|Overall Study|Hyperglycemic Rescue|11|||
130016819|NCT00328627|468024319|FG010|Overall Study|Hyperglycemic Rescue|3|||
130016820|NCT00328627|468024320|FG011|Overall Study|Hyperglycemic Rescue|2|||
130016821|NCT00328627|468024309|FG000|Overall Study|Adverse Event|3|||
130016822|NCT00328627|468024310|FG001|Overall Study|Adverse Event|1|||
130016823|NCT00328627|468024311|FG002|Overall Study|Adverse Event|2|||
130016824|NCT00328627|468024312|FG003|Overall Study|Adverse Event|3|||
130016825|NCT00328627|468024313|FG004|Overall Study|Adverse Event|1|||
130016826|NCT00328627|468024314|FG005|Overall Study|Adverse Event|2|||
130016827|NCT00328627|468024315|FG006|Overall Study|Adverse Event|1|||
130016828|NCT00328627|468024316|FG007|Overall Study|Adverse Event|2|||
130016829|NCT00328627|468024317|FG008|Overall Study|Adverse Event|0|||
130016830|NCT00328627|468024318|FG009|Overall Study|Adverse Event|7|||
130016831|NCT00328627|468024319|FG010|Overall Study|Adverse Event|5|||
130016832|NCT00328627|468024320|FG011|Overall Study|Adverse Event|4|||
130016833|NCT00328627|468024309|FG000|Overall Study|Protocol Violation|2|||
130016834|NCT00328627|468024310|FG001|Overall Study|Protocol Violation|2|||
130016835|NCT00328627|468024311|FG002|Overall Study|Protocol Violation|2|||
130016836|NCT00328627|468024312|FG003|Overall Study|Protocol Violation|8|||
130016837|NCT00328627|468024313|FG004|Overall Study|Protocol Violation|5|||
130016838|NCT00328627|468024314|FG005|Overall Study|Protocol Violation|5|||
130016839|NCT00328627|468024315|FG006|Overall Study|Protocol Violation|6|||
130217842|NCT00547157|468761414|FG001|Overall Study|Lost to Follow-up|2|||
130217843|NCT01383018|468761415|FG000|Overall Study|Adverse Event|14|||
130217844|NCT01383018|468761415|FG000|Overall Study|Death|10|||
130217845|NCT01383018|468761415|FG000|Overall Study|Lost to Follow-up|5|||
130217846|NCT01383018|468761415|FG000|Overall Study|Physician Decision|5|||
130217847|NCT01383018|468761415|FG000|Overall Study|Withdrawal by Subject|9|||
130217848|NCT01383018|468761415|FG000|Overall Study|Subject not implanted|76|||
130217849|NCT01383018|468761415|FG000|Overall Study|Missed Visit|247|||
130217850|NCT01383018|468761415|FG000|Overall Study|Site closed early-not compliance related|7|||
130217851|NCT01383018|468761415|FG000|Overall Study|Patient moved away from site|1|||
130217852|NCT01383018|468761415|FG000|Overall Study|Subject Incarcerated|1|||
130217853|NCT01765569|468761417|FG000|Period B|Withdrawal by Subject|1|||
130217854|NCT01765569|468761417|FG000|Period C|Death|1|||
130217855|NCT04208412|468761418|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
130217856|NCT04208412|468761419|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
130217857|NCT04208412|468761418|FG000|Overall Study|Withdrawal by Subject|1|||
130217858|NCT04208412|468761419|FG001|Overall Study|Withdrawal by Subject|0|||
130217859|NCT04208412|468761418|FG000|Overall Study|Lost to Follow-up|0|||
130217860|NCT04208412|468761419|FG001|Overall Study|Lost to Follow-up|1|||
130217861|NCT05415462|468761422|FG000|Overall Study|Death|18|||
130217862|NCT05415462|468761423|FG001|Overall Study|Death|10|||
130217863|NCT05415462|468761422|FG000|Overall Study|Lost to Follow-up|72|||
130217864|NCT05415462|468761423|FG001|Overall Study|Lost to Follow-up|64|||
130217865|NCT05415462|468761422|FG000|Overall Study|Physician Decision|5|||
130217866|NCT05415462|468761423|FG001|Overall Study|Physician Decision|5|||
130217867|NCT05415462|468761422|FG000|Overall Study|Protocol Deviation|1|||
130217868|NCT05415462|468761423|FG001|Overall Study|Protocol Deviation|0|||
130217869|NCT05415462|468761422|FG000|Overall Study|Withdrawal by Subject|129|||
130217870|NCT05415462|468761423|FG001|Overall Study|Withdrawal by Subject|101|||
130217871|NCT05415462|468761422|FG000|Overall Study|Other Than Specified|8|||
130217872|NCT05415462|468761423|FG001|Overall Study|Other Than Specified|8|||
130217873|NCT04186221|468761426|FG000|Overall Study|Death|1|||
130217874|NCT01904032|468761433|FG000|Overall Study|Adverse Event|3|||
130217875|NCT01904032|468761434|FG001|Overall Study|Adverse Event|1|||
130217876|NCT01904032|468761433|FG000|Overall Study|Lost to Follow-up|4|||
130217877|NCT01904032|468761434|FG001|Overall Study|Lost to Follow-up|2|||
130217878|NCT00531947|468761435|FG000|Overall Study|Adverse Event|5|||
130217879|NCT00531947|468761436|FG001|Overall Study|Adverse Event|10|||
130217880|NCT00531947|468761435|FG000|Overall Study|Lost to Follow-up|12|||
130217881|NCT00531947|468761436|FG001|Overall Study|Lost to Follow-up|9|||
130217882|NCT00531947|468761435|FG000|Overall Study|Withdrawal by Subject|14|||
130217883|NCT00531947|468761436|FG001|Overall Study|Withdrawal by Subject|19|||
130217884|NCT00531947|468761435|FG000|Overall Study|Protocol Violation|2|||
130217885|NCT00531947|468761436|FG001|Overall Study|Protocol Violation|1|||
130016840|NCT00328627|468024316|FG007|Overall Study|Protocol Violation|2|||
130016841|NCT00328627|468024317|FG008|Overall Study|Protocol Violation|1|||
130016842|NCT00328627|468024318|FG009|Overall Study|Protocol Violation|4|||
130016843|NCT00328627|468024319|FG010|Overall Study|Protocol Violation|6|||
130016844|NCT00328627|468024320|FG011|Overall Study|Protocol Violation|2|||
130016845|NCT00328627|468024309|FG000|Overall Study|Lost to Follow-up|4|||
130016846|NCT00328627|468024310|FG001|Overall Study|Lost to Follow-up|2|||
130016847|NCT00328627|468024311|FG002|Overall Study|Lost to Follow-up|2|||
130016848|NCT00328627|468024312|FG003|Overall Study|Lost to Follow-up|4|||
130016849|NCT00328627|468024313|FG004|Overall Study|Lost to Follow-up|0|||
130016850|NCT00328627|468024314|FG005|Overall Study|Lost to Follow-up|2|||
130016851|NCT00328627|468024315|FG006|Overall Study|Lost to Follow-up|3|||
130016852|NCT00328627|468024316|FG007|Overall Study|Lost to Follow-up|0|||
130016853|NCT00328627|468024317|FG008|Overall Study|Lost to Follow-up|3|||
130016854|NCT00328627|468024318|FG009|Overall Study|Lost to Follow-up|2|||
130016855|NCT00328627|468024319|FG010|Overall Study|Lost to Follow-up|0|||
130016856|NCT00328627|468024320|FG011|Overall Study|Lost to Follow-up|1|||
130016857|NCT00328627|468024309|FG000|Overall Study|Withdrawal by Subject|5|||
130016858|NCT00328627|468024310|FG001|Overall Study|Withdrawal by Subject|4|||
130016859|NCT00328627|468024311|FG002|Overall Study|Withdrawal by Subject|5|||
130098774|NCT03426995|468319301|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130217886|NCT00531947|468761435|FG000|Overall Study|Non-Compliance|4|||
130217887|NCT00531947|468761436|FG001|Overall Study|Non-Compliance|7|||
130217888|NCT00531947|468761435|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
130016860|NCT00328627|468024312|FG003|Overall Study|Withdrawal by Subject|6|||
130016861|NCT00328627|468024313|FG004|Overall Study|Withdrawal by Subject|2|||
130217889|NCT00531947|468761436|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
130217890|NCT01087203|468761441|FG000|Overall Study|Lost to Follow-up|2|||
130217891|NCT01087203|468761442|FG001|Overall Study|Lost to Follow-up|0|||
130217892|NCT01087203|468761441|FG000|Overall Study|Withdrawal by Subject|2|||
130217893|NCT01087203|468761442|FG001|Overall Study|Withdrawal by Subject|6|||
130217894|NCT01087203|468761441|FG000|Overall Study|Lack of Efficacy|1|||
130217895|NCT01087203|468761442|FG001|Overall Study|Lack of Efficacy|2|||
130217896|NCT01087203|468761441|FG000|Overall Study|Study terminated by sponsor|27|||
130217897|NCT01087203|468761442|FG001|Overall Study|Study terminated by sponsor|27|||
130217898|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
130217899|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
130217900|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
130217901|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
130217902|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
130217903|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
130217904|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
130217905|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
130217906|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
130217907|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
130217908|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217909|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217910|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217911|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
130217912|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217913|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217914|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
130217915|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
130217916|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217917|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
130217918|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217919|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217920|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
130217921|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217922|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217923|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217924|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217925|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217926|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217927|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
130217928|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217929|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217930|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217931|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217932|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217933|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
130217934|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217935|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
130016862|NCT00328627|468024314|FG005|Overall Study|Withdrawal by Subject|5|||
130016863|NCT00328627|468024315|FG006|Overall Study|Withdrawal by Subject|4|||
130016864|NCT00328627|468024316|FG007|Overall Study|Withdrawal by Subject|4|||
130016865|NCT00328627|468024317|FG008|Overall Study|Withdrawal by Subject|4|||
130016866|NCT00328627|468024318|FG009|Overall Study|Withdrawal by Subject|5|||
130016867|NCT00328627|468024319|FG010|Overall Study|Withdrawal by Subject|2|||
130016868|NCT00328627|468024320|FG011|Overall Study|Withdrawal by Subject|7|||
130016869|NCT00328627|468024309|FG000|Overall Study|Pregnancy|0|||
130016870|NCT00328627|468024310|FG001|Overall Study|Pregnancy|1|||
130016871|NCT00328627|468024311|FG002|Overall Study|Pregnancy|0|||
130016872|NCT00328627|468024312|FG003|Overall Study|Pregnancy|0|||
130016873|NCT00328627|468024313|FG004|Overall Study|Pregnancy|0|||
130016874|NCT00328627|468024314|FG005|Overall Study|Pregnancy|0|||
130016875|NCT00328627|468024315|FG006|Overall Study|Pregnancy|0|||
130016876|NCT00328627|468024316|FG007|Overall Study|Pregnancy|0|||
130016877|NCT00328627|468024317|FG008|Overall Study|Pregnancy|0|||
130016878|NCT00328627|468024318|FG009|Overall Study|Pregnancy|0|||
130016879|NCT00328627|468024319|FG010|Overall Study|Pregnancy|0|||
130016880|NCT00328627|468024320|FG011|Overall Study|Pregnancy|0|||
130016881|NCT00328627|468024309|FG000|Overall Study|Physician Decision|4|||
130016882|NCT00328627|468024310|FG001|Overall Study|Physician Decision|3|||
130016883|NCT00328627|468024311|FG002|Overall Study|Physician Decision|1|||
130016884|NCT00328627|468024312|FG003|Overall Study|Physician Decision|2|||
130016885|NCT00328627|468024313|FG004|Overall Study|Physician Decision|1|||
130016886|NCT00328627|468024314|FG005|Overall Study|Physician Decision|1|||
130016887|NCT00328627|468024315|FG006|Overall Study|Physician Decision|1|||
130016888|NCT00328627|468024316|FG007|Overall Study|Physician Decision|0|||
130016889|NCT00328627|468024317|FG008|Overall Study|Physician Decision|3|||
130016890|NCT00328627|468024318|FG009|Overall Study|Physician Decision|2|||
130016891|NCT00328627|468024319|FG010|Overall Study|Physician Decision|1|||
130016892|NCT00328627|468024320|FG011|Overall Study|Physician Decision|0|||
130016893|NCT00328627|468024309|FG000|Overall Study|Other|0|||
130016894|NCT00328627|468024310|FG001|Overall Study|Other|0|||
130016895|NCT00328627|468024311|FG002|Overall Study|Other|0|||
130016896|NCT00328627|468024312|FG003|Overall Study|Other|1|||
130016897|NCT00328627|468024313|FG004|Overall Study|Other|0|||
130016898|NCT00328627|468024314|FG005|Overall Study|Other|0|||
130016899|NCT00328627|468024315|FG006|Overall Study|Other|1|||
130016900|NCT00328627|468024316|FG007|Overall Study|Other|0|||
130016901|NCT00328627|468024317|FG008|Overall Study|Other|0|||
130016902|NCT00328627|468024318|FG009|Overall Study|Other|1|||
130016903|NCT00328627|468024319|FG010|Overall Study|Other|1|||
130016904|NCT00328627|468024320|FG011|Overall Study|Other|0|||
130016905|NCT03311711|468024321|FG000|Overall Study|Death|1|||
130016906|NCT03311711|468024322|FG001|Overall Study|Death|0|||
130016907|NCT03311711|468024323|FG002|Overall Study|Death|0|||
130016908|NCT03311711|468024324|FG003|Overall Study|Death|0|||
130016909|NCT03311711|468024325|FG004|Overall Study|Death|0|||
130016910|NCT03311711|468024326|FG005|Overall Study|Death|0|||
130016911|NCT03311711|468024327|FG006|Overall Study|Death|1|||
130016912|NCT03311711|468024328|FG007|Overall Study|Death|0|||
130016913|NCT03311711|468024329|FG008|Overall Study|Death|1|||
130016914|NCT03311711|468024330|FG009|Overall Study|Death|0|||
130016915|NCT03311711|468024321|FG000|Overall Study|Death of dyad partner|0|||
130016916|NCT03311711|468024322|FG001|Overall Study|Death of dyad partner|1|||
130016917|NCT03311711|468024323|FG002|Overall Study|Death of dyad partner|0|||
130016918|NCT03311711|468024324|FG003|Overall Study|Death of dyad partner|0|||
130016919|NCT03311711|468024325|FG004|Overall Study|Death of dyad partner|0|||
130016920|NCT03311711|468024326|FG005|Overall Study|Death of dyad partner|0|||
130016921|NCT03311711|468024327|FG006|Overall Study|Death of dyad partner|0|||
130016922|NCT03311711|468024328|FG007|Overall Study|Death of dyad partner|1|||
130016923|NCT03311711|468024329|FG008|Overall Study|Death of dyad partner|0|||
130016924|NCT03311711|468024330|FG009|Overall Study|Death of dyad partner|1|||
130016925|NCT03311711|468024321|FG000|Overall Study|Lost to Follow-up|2|||
130016926|NCT03311711|468024322|FG001|Overall Study|Lost to Follow-up|2|||
130016927|NCT03311711|468024323|FG002|Overall Study|Lost to Follow-up|0|||
130016928|NCT03311711|468024324|FG003|Overall Study|Lost to Follow-up|0|||
130016929|NCT03311711|468024325|FG004|Overall Study|Lost to Follow-up|0|||
130016930|NCT03311711|468024326|FG005|Overall Study|Lost to Follow-up|0|||
130016931|NCT03311711|468024327|FG006|Overall Study|Lost to Follow-up|1|||
130016932|NCT03311711|468024328|FG007|Overall Study|Lost to Follow-up|1|||
130016933|NCT03311711|468024329|FG008|Overall Study|Lost to Follow-up|0|||
130016934|NCT03311711|468024330|FG009|Overall Study|Lost to Follow-up|0|||
130016935|NCT03311711|468024321|FG000|Overall Study|Withdrawal by Subject|1|||
130016936|NCT03311711|468024322|FG001|Overall Study|Withdrawal by Subject|1|||
130016937|NCT03311711|468024323|FG002|Overall Study|Withdrawal by Subject|0|||
130016938|NCT03311711|468024324|FG003|Overall Study|Withdrawal by Subject|0|||
130016939|NCT03311711|468024325|FG004|Overall Study|Withdrawal by Subject|0|||
130016940|NCT03311711|468024326|FG005|Overall Study|Withdrawal by Subject|0|||
130016941|NCT03311711|468024327|FG006|Overall Study|Withdrawal by Subject|3|||
130016942|NCT03311711|468024328|FG007|Overall Study|Withdrawal by Subject|3|||
130016943|NCT03311711|468024329|FG008|Overall Study|Withdrawal by Subject|0|||
130016944|NCT03311711|468024330|FG009|Overall Study|Withdrawal by Subject|0|||
130016945|NCT01623271|468024335|FG000|Overall Study|Withdrawal by Subject|2|||
130016946|NCT01339559|468024337|FG000|Overall Study|Adverse Event|92|||
130016947|NCT01339559|468024337|FG000|Overall Study|Death|5|||
130016948|NCT01339559|468024337|FG000|Overall Study|Lack of Efficacy|164|||
130016949|NCT01339559|468024337|FG000|Overall Study|Lost to Follow-up|22|||
130217936|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217937|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
130217938|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217939|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217940|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217941|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217942|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
130217943|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
130217944|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217945|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217946|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130217947|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
130016950|NCT01339559|468024337|FG000|Overall Study|Subject choice|89|||
130217948|NCT04074330|468761454|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217949|NCT04074330|468761455|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217950|NCT04074330|468761456|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217951|NCT04074330|468761457|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217952|NCT04074330|468761458|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217953|NCT04074330|468761459|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
130217954|NCT04074330|468761460|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217955|NCT04074330|468761461|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217956|NCT04074330|468761462|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217957|NCT04074330|468761463|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
130217958|NCT04074330|468761454|FG000|Dose Expansion (up to 42 Months)|Death|0|||
130217959|NCT04074330|468761455|FG001|Dose Expansion (up to 42 Months)|Death|0|||
130217960|NCT04074330|468761456|FG002|Dose Expansion (up to 42 Months)|Death|0|||
130217961|NCT04074330|468761457|FG003|Dose Expansion (up to 42 Months)|Death|0|||
130217962|NCT04074330|468761458|FG004|Dose Expansion (up to 42 Months)|Death|0|||
130016951|NCT01339559|468024337|FG000|Overall Study|Protocol Violation|15|||
130016952|NCT01339559|468024337|FG000|Overall Study|Study closure at site|1|||
130016953|NCT01339559|468024337|FG000|Overall Study|Incarcerated|2|||
130016954|NCT01339559|468024337|FG000|Overall Study|Epilepsy surgery|1|||
130016955|NCT01339559|468024337|FG000|Overall Study|Pregnancy planned|2|||
130016956|NCT01339559|468024337|FG000|Overall Study|Left the country|1|||
130016957|NCT01339559|468024337|FG000|Overall Study|Investigator decision|2|||
130016958|NCT01339559|468024337|FG000|Overall Study|Patient didn't wish to continue|1|||
130016959|NCT01339559|468024337|FG000|Overall Study|PI decision|1|||
130016960|NCT01137773|468024338|FG000|Overall Study|Death|3|||
130016961|NCT01137773|468024339|FG001|Overall Study|Death|3|||
130016962|NCT01137773|468024338|FG000|Overall Study|Lost to Follow-up|6|||
130016963|NCT01137773|468024339|FG001|Overall Study|Lost to Follow-up|0|||
130016964|NCT03548051|468024340|FG000|Overall Study|Death|1|||
130016965|NCT03548051|468024341|FG001|Overall Study|Death|1|||
130016966|NCT03548051|468024340|FG000|Overall Study|Withdrawal by Subject|1|||
130016967|NCT03548051|468024341|FG001|Overall Study|Withdrawal by Subject|0|||
130016968|NCT01745146|468024342|FG000|Overall Study|Withdrawal by Subject|1|||
130016969|NCT01745146|468024343|FG001|Overall Study|Withdrawal by Subject|3|||
130016970|NCT01745146|468024342|FG000|Overall Study|Lost to Follow-up|2|||
130016971|NCT01745146|468024343|FG001|Overall Study|Lost to Follow-up|0|||
130016972|NCT00488982|468024346|FG000|Course 1|Physician Decision|0|||
130016973|NCT00488982|468024347|FG001|Course 1|Physician Decision|2|||
130217963|NCT04074330|468761459|FG005|Dose Expansion (up to 42 Months)|Death|0|||
130217964|NCT04074330|468761460|FG006|Dose Expansion (up to 42 Months)|Death|0|||
130217965|NCT04074330|468761461|FG007|Dose Expansion (up to 42 Months)|Death|0|||
130217966|NCT04074330|468761462|FG008|Dose Expansion (up to 42 Months)|Death|1|||
130217967|NCT04074330|468761463|FG009|Dose Expansion (up to 42 Months)|Death|0|||
130217968|NCT04074330|468761454|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217969|NCT04074330|468761455|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217970|NCT04074330|468761456|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217971|NCT04074330|468761457|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217972|NCT04074330|468761458|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217973|NCT04074330|468761459|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217974|NCT04074330|468761460|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217975|NCT04074330|468761461|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
130217976|NCT04074330|468761462|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
130217977|NCT04074330|468761463|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
130217978|NCT00184093|468761464|FG000|Overall Study|Adverse Event|3|||
130217979|NCT00184093|468761464|FG000|Overall Study|Lost to Follow-up|3|||
130217980|NCT00184093|468761464|FG000|Overall Study|Physician Decision|1|||
130217981|NCT00184093|468761464|FG000|Overall Study|Withdrawal by Subject|2|||
130217982|NCT05095311|468761467|FG000|Overall Study|Lost to Follow-up|7|||
130217983|NCT05095311|468761468|FG001|Overall Study|Lost to Follow-up|0|||
130217984|NCT05095311|468761469|FG002|Overall Study|Lost to Follow-up|0|||
130016974|NCT00488982|468024348|FG002|Course 1|Physician Decision|4|||
130016975|NCT00488982|468024346|FG000|Course 1|Withdrawal by Subject|0|||
130016976|NCT00488982|468024347|FG001|Course 1|Withdrawal by Subject|8|||
130016977|NCT00488982|468024348|FG002|Course 1|Withdrawal by Subject|2|||
130016978|NCT00488982|468024346|FG000|Course 1|nonprotocol therapy|0|||
130016979|NCT00488982|468024347|FG001|Course 1|nonprotocol therapy|2|||
130016980|NCT00488982|468024348|FG002|Course 1|nonprotocol therapy|2|||
130016981|NCT00488982|468024346|FG000|Course 1|Adverse Event|0|||
130016982|NCT00488982|468024347|FG001|Course 1|Adverse Event|0|||
130016983|NCT00488982|468024348|FG002|Course 1|Adverse Event|6|||
130016984|NCT03548558|468024349|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
130016985|NCT03548558|468024350|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
130016986|NCT03548558|468024351|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130016987|NCT03548558|468024352|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
130016988|NCT03548558|468024353|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130016989|NCT03548558|468024354|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130016990|NCT03548558|468024355|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
130016991|NCT03548558|468024349|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
130016992|NCT03548558|468024350|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
130016993|NCT03548558|468024351|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
130016994|NCT03548558|468024352|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
130016995|NCT03548558|468024353|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
130016996|NCT03548558|468024354|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
130016997|NCT03548558|468024355|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
130016998|NCT03548558|468024349|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
130016999|NCT03548558|468024350|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
130017000|NCT03548558|468024351|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
130017001|NCT03548558|468024352|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
130017002|NCT03548558|468024353|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
130017003|NCT03548558|468024354|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
130017004|NCT03548558|468024355|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
130017005|NCT03548558|468024349|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130017006|NCT03548558|468024350|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130017007|NCT03548558|468024351|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130017008|NCT03548558|468024352|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
130017009|NCT03548558|468024353|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
130017010|NCT03548558|468024354|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
130017011|NCT03548558|468024355|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
130017012|NCT03548558|468024349|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130017013|NCT03548558|468024350|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130017014|NCT03548558|468024351|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130017015|NCT03548558|468024352|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
130017016|NCT03548558|468024353|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
130017017|NCT03548558|468024354|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
130017018|NCT03548558|468024355|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
130017019|NCT03548558|468024349|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130017020|NCT03548558|468024350|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130017021|NCT03548558|468024351|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130017022|NCT03548558|468024352|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
130017023|NCT03548558|468024353|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
130017024|NCT03548558|468024354|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
130017025|NCT03548558|468024355|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
130017026|NCT03273166|468024361|FG000|Overall Study|Withdrawn prior to Completion|31|||
130017027|NCT02669017|468024362|FG000|Overall Study|Death|1|||
130017028|NCT02669017|468024363|FG001|Overall Study|Death|2|||
130017029|NCT02669017|468024364|FG002|Overall Study|Death|2|||
130017030|NCT02669017|468024365|FG003|Overall Study|Death|3|||
130017031|NCT02669017|468024366|FG004|Overall Study|Death|8|||
130017032|NCT02669017|468024367|FG005|Overall Study|Death|18|||
130017033|NCT02669017|468024368|FG006|Overall Study|Death|10|||
130017034|NCT02669017|468024369|FG007|Overall Study|Death|47|||
130017035|NCT02669017|468024370|FG008|Overall Study|Death|20|||
130017036|NCT02669017|468024362|FG000|Overall Study|Withdrawal by Subject|0|||
130017037|NCT02669017|468024363|FG001|Overall Study|Withdrawal by Subject|0|||
130017038|NCT02669017|468024364|FG002|Overall Study|Withdrawal by Subject|0|||
130017039|NCT02669017|468024365|FG003|Overall Study|Withdrawal by Subject|1|||
130017040|NCT02669017|468024366|FG004|Overall Study|Withdrawal by Subject|2|||
130017041|NCT02669017|468024367|FG005|Overall Study|Withdrawal by Subject|0|||
130017042|NCT02669017|468024368|FG006|Overall Study|Withdrawal by Subject|0|||
130017043|NCT02669017|468024369|FG007|Overall Study|Withdrawal by Subject|2|||
130017044|NCT02669017|468024370|FG008|Overall Study|Withdrawal by Subject|2|||
130017045|NCT02669017|468024362|FG000|Overall Study|Lost to Follow-up|0|||
130017046|NCT02669017|468024363|FG001|Overall Study|Lost to Follow-up|0|||
130017047|NCT02669017|468024364|FG002|Overall Study|Lost to Follow-up|0|||
130017048|NCT02669017|468024365|FG003|Overall Study|Lost to Follow-up|0|||
130017049|NCT02669017|468024366|FG004|Overall Study|Lost to Follow-up|0|||
130017050|NCT02669017|468024367|FG005|Overall Study|Lost to Follow-up|0|||
130017051|NCT02669017|468024368|FG006|Overall Study|Lost to Follow-up|0|||
130017052|NCT02669017|468024369|FG007|Overall Study|Lost to Follow-up|0|||
130017053|NCT02669017|468024370|FG008|Overall Study|Lost to Follow-up|1|||
130017054|NCT02669017|468024362|FG000|Overall Study|Miscellaneous|0|||
130017055|NCT02669017|468024363|FG001|Overall Study|Miscellaneous|0|||
130017056|NCT02669017|468024364|FG002|Overall Study|Miscellaneous|0|||
130017057|NCT02669017|468024365|FG003|Overall Study|Miscellaneous|0|||
130017058|NCT02669017|468024366|FG004|Overall Study|Miscellaneous|2|||
130017059|NCT02669017|468024367|FG005|Overall Study|Miscellaneous|1|||
130017060|NCT02669017|468024368|FG006|Overall Study|Miscellaneous|1|||
130017061|NCT02669017|468024369|FG007|Overall Study|Miscellaneous|13|||
130017062|NCT02669017|468024370|FG008|Overall Study|Miscellaneous|2|||
130017063|NCT03509350|468024372|FG000|Overall Study|Withdrawal by Subject|0|||
130017064|NCT03509350|468024373|FG001|Overall Study|Withdrawal by Subject|2|||
130017065|NCT01425203|468024374|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
130017066|NCT01425203|468024375|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
130017067|NCT01425203|468024376|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
130017068|NCT01425203|468024374|FG000|Treatment Phase|Failure at futility timepoint|8|||
130017069|NCT01425203|468024375|FG001|Treatment Phase|Failure at futility timepoint|27|||
130017070|NCT01425203|468024376|FG002|Treatment Phase|Failure at futility timepoint|0|||
130017071|NCT01425203|468024374|FG000|Treatment Phase|Other virologic failure criteria|5|||
130017072|NCT01425203|468024375|FG001|Treatment Phase|Other virologic failure criteria|3|||
130017073|NCT01425203|468024376|FG002|Treatment Phase|Other virologic failure criteria|0|||
130017074|NCT01425203|468024374|FG000|Treatment Phase|Unidentified reasons|11|||
130017075|NCT01425203|468024375|FG001|Treatment Phase|Unidentified reasons|5|||
130017076|NCT01425203|468024376|FG002|Treatment Phase|Unidentified reasons|0|||
130017077|NCT01425203|468024374|FG000|Treatment Phase|Did not receive treatment|0|||
130017078|NCT01425203|468024375|FG001|Treatment Phase|Did not receive treatment|1|||
130017079|NCT01425203|468024376|FG002|Treatment Phase|Did not receive treatment|0|||
130017080|NCT01425203|468024374|FG000|Crossover Phase|Failure at futility timepoint|0|||
130017081|NCT01425203|468024375|FG001|Crossover Phase|Failure at futility timepoint|0|||
130017082|NCT01425203|468024376|FG002|Crossover Phase|Failure at futility timepoint|3|||
130017083|NCT01425203|468024374|FG000|Crossover Phase|Other virologic failure criteria|0|||
130017084|NCT01425203|468024375|FG001|Crossover Phase|Other virologic failure criteria|0|||
130017085|NCT01425203|468024376|FG002|Crossover Phase|Other virologic failure criteria|3|||
130017086|NCT00535132|468024379|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
130017087|NCT00535132|468024380|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
130017088|NCT00535132|468024379|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
130017089|NCT00535132|468024380|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
130017090|NCT02559687|468024388|FG000|Overall Study|Death|112|||
130017091|NCT02559687|468024388|FG000|Overall Study|Sponsor Decision|5|||
130017092|NCT02559687|468024388|FG000|Overall Study|Withdrawal by Subject|4|||
130017093|NCT01780831|468024393|FG000|Overall Study|Withdrawal by Subject|0|||
130017094|NCT01780831|468024394|FG001|Overall Study|Withdrawal by Subject|0|||
130017095|NCT01780831|468024395|FG002|Overall Study|Withdrawal by Subject|4|||
130017096|NCT01780831|468024396|FG003|Overall Study|Withdrawal by Subject|0|||
130017097|NCT01780831|468024393|FG000|Overall Study|Lost to Follow-up|0|||
130017098|NCT01780831|468024394|FG001|Overall Study|Lost to Follow-up|0|||
130017099|NCT01780831|468024395|FG002|Overall Study|Lost to Follow-up|0|||
130017100|NCT01780831|468024396|FG003|Overall Study|Lost to Follow-up|1|||
130217985|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
130217986|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
130217987|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
130217988|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
130217989|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
130217990|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
130217991|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
130217992|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
130217993|NCT00972283|468761471|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
130217994|NCT00972283|468761472|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
130217995|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
130217996|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
130217997|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
130217998|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
130217999|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
130218000|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
130218001|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
130218002|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
130218003|NCT00972283|468761471|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
130218004|NCT00972283|468761472|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
130218005|NCT01868165|468761476|FG000|Overall Study|Withdrawal by Subject|36|||
130218006|NCT01868165|468761476|FG000|Overall Study|Physician Decision|2|||
130218007|NCT01868165|468761476|FG000|Overall Study|Lost to Follow-up|3|||
130218008|NCT01868165|468761476|FG000|Overall Study|Death|4|||
130218009|NCT02588664|468761479|FG000|Overall Study|Death|56|||
130218010|NCT02588664|468761480|FG001|Overall Study|Death|55|||
130218011|NCT02588664|468761479|FG000|Overall Study|Lost to Follow-up|1305|||
130218012|NCT02588664|468761480|FG001|Overall Study|Lost to Follow-up|990|||
130218013|NCT01429298|468761481|FG000|Overall Study|Protocol Violation|4|||
130218014|NCT01429298|468761482|FG001|Overall Study|Protocol Violation|6|||
130218015|NCT02903420|468761483|FG000|Overall Study|Death|3|||
130218016|NCT01124292|468761487|FG000|Overall Study|Lost to Follow-up|2|||
130218017|NCT01124292|468761488|FG001|Overall Study|Lost to Follow-up|4|||
130218018|NCT01124292|468761489|FG002|Overall Study|Lost to Follow-up|3|||
130218019|NCT01124292|468761487|FG000|Overall Study|Physician Decision|0|||
130218020|NCT01124292|468761488|FG001|Overall Study|Physician Decision|3|||
130218021|NCT01124292|468761489|FG002|Overall Study|Physician Decision|2|||
130218022|NCT01124292|468761487|FG000|Overall Study|Withdrawal by Subject|0|||
130218023|NCT01124292|468761488|FG001|Overall Study|Withdrawal by Subject|6|||
130218024|NCT01124292|468761489|FG002|Overall Study|Withdrawal by Subject|2|||
130218025|NCT01124292|468761487|FG000|Overall Study|medical issue unrelated to the study|0|||
130218026|NCT01124292|468761488|FG001|Overall Study|medical issue unrelated to the study|0|||
130218027|NCT01124292|468761489|FG002|Overall Study|medical issue unrelated to the study|2|||
130218028|NCT01124292|468761487|FG000|Overall Study|piercing track closed|0|||
130218029|NCT01124292|468761488|FG001|Overall Study|piercing track closed|2|||
130218030|NCT01124292|468761489|FG002|Overall Study|piercing track closed|1|||
130218031|NCT03373461|468761490|FG000|Part 2|Adverse Event|0|||
130218032|NCT03373461|468761491|FG001|Part 2|Adverse Event|1|||
130218033|NCT03373461|468761492|FG002|Part 2|Adverse Event|0|||
130218034|NCT03373461|468761493|FG003|Part 2|Adverse Event|0|||
130218035|NCT03373461|468761494|FG004|Part 2|Adverse Event|1|||
130218036|NCT03300180|468761495|FG000|Baseline|Withdrawal by Subject|4|||
130218037|NCT03300180|468761496|FG001|Baseline|Withdrawal by Subject|6|||
130218038|NCT03300180|468761497|FG002|Baseline|Withdrawal by Subject|4|||
130218039|NCT03300180|468761495|FG000|6 Month Outcome|Withdrawal by Subject|12|||
130218040|NCT03300180|468761496|FG001|6 Month Outcome|Withdrawal by Subject|12|||
130218041|NCT03300180|468761497|FG002|6 Month Outcome|Withdrawal by Subject|19|||
130218042|NCT03300180|468761495|FG000|6 Month Outcome|Death|2|||
130218043|NCT03300180|468761496|FG001|6 Month Outcome|Death|4|||
130218044|NCT03300180|468761497|FG002|6 Month Outcome|Death|3|||
130218045|NCT03300180|468761495|FG000|6 Month Outcome|Missed Assessment|43|||
130218046|NCT03300180|468761496|FG001|6 Month Outcome|Missed Assessment|52|||
130218047|NCT03300180|468761497|FG002|6 Month Outcome|Missed Assessment|46|||
130218048|NCT03300180|468761495|FG000|12 Month Outcome|Withdrawal by Subject|3|||
130218049|NCT03300180|468761496|FG001|12 Month Outcome|Withdrawal by Subject|6|||
130218050|NCT03300180|468761497|FG002|12 Month Outcome|Withdrawal by Subject|6|||
130218051|NCT03300180|468761495|FG000|12 Month Outcome|Death|9|||
130218052|NCT03300180|468761496|FG001|12 Month Outcome|Death|6|||
130218053|NCT03300180|468761497|FG002|12 Month Outcome|Death|6|||
130218054|NCT03300180|468761495|FG000|12 Month Outcome|Missed Assessment|62|||
130218055|NCT03300180|468761496|FG001|12 Month Outcome|Missed Assessment|59|||
130218056|NCT03300180|468761497|FG002|12 Month Outcome|Missed Assessment|58|||
130218057|NCT03300180|468761495|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
130218058|NCT03300180|468761496|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
130218059|NCT03300180|468761497|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
130218060|NCT03300180|468761495|FG000|18 Month Outcome Assessment|Death|8|||
130218061|NCT03300180|468761496|FG001|18 Month Outcome Assessment|Death|5|||
130218062|NCT03300180|468761497|FG002|18 Month Outcome Assessment|Death|5|||
130218063|NCT03300180|468761495|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
130218064|NCT03300180|468761496|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
130218065|NCT03300180|468761497|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
130218066|NCT03300180|468761495|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
130218067|NCT03300180|468761496|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
130218068|NCT03300180|468761497|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
130218069|NCT03300180|468761495|FG000|24 Month Outcome Assessment|Death|13|||
130218070|NCT03300180|468761496|FG001|24 Month Outcome Assessment|Death|13|||
130218071|NCT03300180|468761497|FG002|24 Month Outcome Assessment|Death|3|||
130218072|NCT03300180|468761495|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
130218073|NCT03300180|468761496|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
130218074|NCT03300180|468761497|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
130218075|NCT03654729|468763327|FG000|Overall Study|Death|9|||
130218076|NCT03654729|468763328|FG001|Overall Study|Death|9|||
130218077|NCT03654729|468763329|FG002|Overall Study|Death|16|||
130218078|NCT03654729|468763327|FG000|Overall Study|Withdrawal by Subject|8|||
130218079|NCT03654729|468763328|FG001|Overall Study|Withdrawal by Subject|6|||
130218080|NCT03654729|468763329|FG002|Overall Study|Withdrawal by Subject|4|||
130218081|NCT03654729|468763327|FG000|Overall Study|Study terminated by Sponsor|3|||
130218082|NCT03654729|468763328|FG001|Overall Study|Study terminated by Sponsor|5|||
130218083|NCT03654729|468763329|FG002|Overall Study|Study terminated by Sponsor|4|||
130218084|NCT03654729|468763327|FG000|Overall Study|Not reported|2|||
130218085|NCT03654729|468763328|FG001|Overall Study|Not reported|4|||
130218086|NCT03654729|468763329|FG002|Overall Study|Not reported|5|||
130218087|NCT03654729|468763327|FG000|Overall Study|Progressive disease|3|||
130218088|NCT03654729|468763328|FG001|Overall Study|Progressive disease|0|||
130218089|NCT03654729|468763329|FG002|Overall Study|Progressive disease|0|||
130218090|NCT03654729|468763327|FG000|Overall Study|Lost to Follow-up|2|||
130218091|NCT03654729|468763328|FG001|Overall Study|Lost to Follow-up|0|||
130218092|NCT03654729|468763329|FG002|Overall Study|Lost to Follow-up|0|||
130218093|NCT03654729|468763327|FG000|Overall Study|Physician Decision|2|||
130218094|NCT03654729|468763328|FG001|Overall Study|Physician Decision|0|||
130218095|NCT03654729|468763329|FG002|Overall Study|Physician Decision|0|||
130218096|NCT03654729|468763327|FG000|Overall Study|Protocol Violation|1|||
130218097|NCT03654729|468763328|FG001|Overall Study|Protocol Violation|1|||
130218098|NCT03654729|468763329|FG002|Overall Study|Protocol Violation|0|||
130218099|NCT03654729|468763327|FG000|Overall Study|Non-compliance with study drug|0|||
130218100|NCT03654729|468763328|FG001|Overall Study|Non-compliance with study drug|1|||
130218101|NCT03654729|468763329|FG002|Overall Study|Non-compliance with study drug|0|||
130218102|NCT03654729|468763327|FG000|Overall Study|Site terminated by Sponsor|1|||
130218103|NCT03654729|468763328|FG001|Overall Study|Site terminated by Sponsor|0|||
130218104|NCT03654729|468763329|FG002|Overall Study|Site terminated by Sponsor|0|||
130218105|NCT04530838|468763330|FG000|Overall Study|Other|2|||
130218106|NCT04530838|468763331|FG001|Overall Study|Other|1|||
130218107|NCT04530838|468763332|FG002|Overall Study|Other|0|||
130218108|NCT04530838|468763330|FG000|Overall Study|Physician Decision|0|||
130218109|NCT04530838|468763331|FG001|Overall Study|Physician Decision|0|||
130218110|NCT04530838|468763332|FG002|Overall Study|Physician Decision|1|||
130218111|NCT04530838|468763330|FG000|Overall Study|Death|0|||
130218112|NCT04530838|468763331|FG001|Overall Study|Death|0|||
130218113|NCT04530838|468763332|FG002|Overall Study|Death|1|||
130218114|NCT04530838|468763330|FG000|Overall Study|Adverse Event|0|||
130218115|NCT04530838|468763331|FG001|Overall Study|Adverse Event|1|||
130218116|NCT04530838|468763332|FG002|Overall Study|Adverse Event|0|||
130218117|NCT04530838|468763330|FG000|Overall Study|No longer meets eligibility criteria|1|||
130218118|NCT04530838|468763331|FG001|Overall Study|No longer meets eligibility criteria|0|||
130218119|NCT04530838|468763332|FG002|Overall Study|No longer meets eligibility criteria|2|||
130218120|NCT04530838|468763330|FG000|Overall Study|Withdrawal by parent/guardian|5|||
130218121|NCT04530838|468763331|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130218122|NCT04530838|468763332|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130218123|NCT00803712|468763333|FG000|Overall Study|Noncompliance|3|||
130218124|NCT00803712|468763334|FG001|Overall Study|Noncompliance|0|||
130218125|NCT00803712|468763333|FG000|Overall Study|Adverse Event|5|||
130218126|NCT00803712|468763334|FG001|Overall Study|Adverse Event|0|||
130218127|NCT00803712|468763333|FG000|Overall Study|Death|8|||
130218128|NCT00803712|468763334|FG001|Overall Study|Death|7|||
130218129|NCT00803712|468763333|FG000|Overall Study|Lost to Follow-up|3|||
130218130|NCT00803712|468763334|FG001|Overall Study|Lost to Follow-up|1|||
130218131|NCT00803712|468763333|FG000|Overall Study|Withdrawal by Subject|2|||
130218132|NCT00803712|468763334|FG001|Overall Study|Withdrawal by Subject|4|||
130218133|NCT00803712|468763333|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
130218134|NCT00803712|468763334|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
130218135|NCT00803712|468763333|FG000|Overall Study|Protocol criteria (other)|0|||
130218136|NCT00803712|468763334|FG001|Overall Study|Protocol criteria (other)|2|||
130218137|NCT00803712|468763333|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
130218138|NCT00803712|468763334|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
130218139|NCT00803712|468763333|FG000|Overall Study|Administrative decision|2|||
130218140|NCT00803712|468763334|FG001|Overall Study|Administrative decision|3|||
130218141|NCT00803712|468763333|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
130218142|NCT00803712|468763334|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
130218143|NCT01919164|468763345|FG000|Overall Study|Adverse Event|6|||
130218144|NCT01919164|468763346|FG001|Overall Study|Adverse Event|4|||
130218145|NCT01919164|468763347|FG002|Overall Study|Adverse Event|9|||
130218146|NCT01919164|468763348|FG003|Overall Study|Adverse Event|3|||
130218147|NCT01919164|468763349|FG004|Overall Study|Adverse Event|2|||
130218148|NCT01919164|468763345|FG000|Overall Study|Lost to Follow-up|2|||
130218149|NCT01919164|468763346|FG001|Overall Study|Lost to Follow-up|2|||
130218150|NCT01919164|468763347|FG002|Overall Study|Lost to Follow-up|2|||
130218151|NCT01919164|468763348|FG003|Overall Study|Lost to Follow-up|0|||
130218152|NCT01919164|468763349|FG004|Overall Study|Lost to Follow-up|4|||
130218153|NCT01919164|468763345|FG000|Overall Study|Death|1|||
130218154|NCT01919164|468763346|FG001|Overall Study|Death|0|||
130218155|NCT01919164|468763347|FG002|Overall Study|Death|0|||
130218156|NCT01919164|468763348|FG003|Overall Study|Death|0|||
130218157|NCT01919164|468763349|FG004|Overall Study|Death|0|||
130218158|NCT01919164|468763345|FG000|Overall Study|Protocol Violation|6|||
130218159|NCT01919164|468763346|FG001|Overall Study|Protocol Violation|0|||
130218160|NCT01919164|468763347|FG002|Overall Study|Protocol Violation|3|||
130218161|NCT01919164|468763348|FG003|Overall Study|Protocol Violation|2|||
130218162|NCT01919164|468763349|FG004|Overall Study|Protocol Violation|2|||
130218163|NCT01919164|468763345|FG000|Overall Study|Disease progression|2|||
130218164|NCT01919164|468763346|FG001|Overall Study|Disease progression|2|||
130218165|NCT01919164|468763347|FG002|Overall Study|Disease progression|1|||
130218166|NCT01919164|468763348|FG003|Overall Study|Disease progression|2|||
130218167|NCT01919164|468763349|FG004|Overall Study|Disease progression|1|||
130218168|NCT01919164|468763345|FG000|Overall Study|Withdrew consent|13|||
130218169|NCT01919164|468763346|FG001|Overall Study|Withdrew consent|13|||
130218170|NCT01919164|468763347|FG002|Overall Study|Withdrew consent|14|||
130218171|NCT01919164|468763348|FG003|Overall Study|Withdrew consent|14|||
130218172|NCT01919164|468763349|FG004|Overall Study|Withdrew consent|9|||
130218173|NCT01919164|468763345|FG000|Overall Study|Other Un-specified|13|||
130218174|NCT01919164|468763346|FG001|Overall Study|Other Un-specified|9|||
130218175|NCT01919164|468763347|FG002|Overall Study|Other Un-specified|8|||
130218176|NCT01919164|468763348|FG003|Overall Study|Other Un-specified|7|||
130218177|NCT01919164|468763349|FG004|Overall Study|Other Un-specified|15|||
130218178|NCT00588146|468763351|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
130218179|NCT00588146|468763352|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
130218180|NCT02100839|468763353|FG000|Multiple Ascending Dose|Adverse Event|2|||
130218181|NCT02100839|468763354|FG001|Multiple Ascending Dose|Adverse Event|0|||
130218182|NCT02100839|468763353|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
130218183|NCT02100839|468763354|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
130218184|NCT02823470|468763355|FG000|Overall Study|Adverse Event|1|||
130218185|NCT02823470|468763356|FG001|Overall Study|Adverse Event|0|||
130218186|NCT02823470|468763355|FG000|Overall Study|Study terminated by sponsor|8|||
130218187|NCT02823470|468763356|FG001|Overall Study|Study terminated by sponsor|15|||
130218188|NCT00463801|468763362|FG000|Overall Study|Protocol Violation|1|||
130218189|NCT00463801|468763362|FG000|Overall Study|Lack of Efficacy|2|||
130218190|NCT00463801|468763362|FG000|Overall Study|Adverse Event|4|||
130218191|NCT00463801|468763362|FG000|Overall Study|Lost to Follow-up|5|||
130017101|NCT01827670|468024400|FG000|Overall Study|Withdrawal of Consent|3|||
130017102|NCT01827670|468024401|FG001|Overall Study|Withdrawal of Consent|2|||
130017103|NCT01827670|468024400|FG000|Overall Study|Lost to Follow-up|0|||
130218192|NCT00463801|468763362|FG000|Overall Study|No longer require therapy|1|||
130218193|NCT00669318|468763363|FG000|Overall Study|Withdrawal by Subject|2|||
130218194|NCT02315664|468763364|FG000|Overall Study|Lost to Follow-up|1|||
130218195|NCT02315664|468763365|FG001|Overall Study|Lost to Follow-up|1|||
130218196|NCT02315664|468763364|FG000|Overall Study|Withdrawal by Subject|0|||
130218197|NCT02315664|468763365|FG001|Overall Study|Withdrawal by Subject|3|||
130218198|NCT02501161|468763366|FG000|Overall Study|Adverse Event|2|||
130218199|NCT02501161|468763367|FG001|Overall Study|Adverse Event|6|||
130218200|NCT02501161|468763366|FG000|Overall Study|Lost to Follow-up|7|||
130218201|NCT02501161|468763367|FG001|Overall Study|Lost to Follow-up|4|||
130218202|NCT02501161|468763366|FG000|Overall Study|Withdrawal by Subject|10|||
130218203|NCT02501161|468763367|FG001|Overall Study|Withdrawal by Subject|15|||
130218204|NCT02501161|468763366|FG000|Overall Study|Other|3|||
130218205|NCT02501161|468763367|FG001|Overall Study|Other|0|||
130218206|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
130218207|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
130218208|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
130218209|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
130218210|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130218211|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130218212|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
130218213|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
130218214|NCT00667992|468763370|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130218215|NCT00667992|468763371|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130218216|NCT00667992|468763370|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
130218217|NCT00667992|468763371|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
130218218|NCT00667992|468763370|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
130218219|NCT00667992|468763371|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
130218220|NCT00667992|468763370|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
130218221|NCT00667992|468763371|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
130218222|NCT00667992|468763370|FG000|Wash-out|Not within one doubling dilution|4|||
130218223|NCT00667992|468763371|FG001|Wash-out|Not within one doubling dilution|3|||
130218224|NCT00667992|468763370|FG000|Wash-out|Failure to wash-out|2|||
130218225|NCT00667992|468763371|FG001|Wash-out|Failure to wash-out|2|||
130218226|NCT00667992|468763370|FG000|Wash-out|Withdrawal by Subject|1|||
130218227|NCT00667992|468763371|FG001|Wash-out|Withdrawal by Subject|0|||
130218228|NCT00667992|468763370|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
130218229|NCT00667992|468763371|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
130218230|NCT00667992|468763370|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
130218231|NCT00667992|468763371|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
130218232|NCT02748057|468763375|FG000|Overall Study|Adverse Event|1|||
130218233|NCT02748057|468763376|FG001|Overall Study|Adverse Event|0|||
130218234|NCT02748057|468763375|FG000|Overall Study|Physician Decision|0|||
130218235|NCT02748057|468763376|FG001|Overall Study|Physician Decision|1|||
130218236|NCT02748057|468763375|FG000|Overall Study|Protocol Violation|2|||
130218237|NCT02748057|468763376|FG001|Overall Study|Protocol Violation|1|||
130218238|NCT02748057|468763375|FG000|Overall Study|Participant Moved|1|||
130218239|NCT02748057|468763376|FG001|Overall Study|Participant Moved|0|||
130218240|NCT02748057|468763375|FG000|Overall Study|Withdrawal by Subject|1|||
130218241|NCT02748057|468763376|FG001|Overall Study|Withdrawal by Subject|0|||
130218242|NCT01990573|468763377|FG000|Overall Study|Physician Decision|0|||
130017104|NCT01827670|468024401|FG001|Overall Study|Lost to Follow-up|1|||
130017105|NCT02941627|468024402|FG000|Overall Study|Death|1|||
130017106|NCT02941627|468024402|FG000|Overall Study|Surgical failure|1|||
130218243|NCT01990573|468763378|FG001|Overall Study|Physician Decision|0|||
130218244|NCT01990573|468763379|FG002|Overall Study|Physician Decision|1|||
130218245|NCT03335813|468763384|FG000|Overall Study|Withdrawal by Subject|1|||
130218246|NCT00524771|468763387|FG000|Overall Study|Protocol Violation|220|||
130218247|NCT00524771|468763388|FG001|Overall Study|Protocol Violation|585|||
130218248|NCT02492165|468763389|FG000|Overall Study|Withdrawal by Subject|0|||
130218249|NCT02492165|468763390|FG001|Overall Study|Withdrawal by Subject|1|||
130218250|NCT02492165|468763391|FG002|Overall Study|Withdrawal by Subject|0|||
130218251|NCT02492165|468763392|FG003|Overall Study|Withdrawal by Subject|0|||
130218252|NCT01957579|468763394|FG000|Overall Study|Withdrawal of concent|0|||
130218253|NCT01957579|468763395|FG001|Overall Study|Withdrawal of concent|1|||
130218254|NCT01957579|468763396|FG002|Overall Study|Withdrawal of concent|0|||
130218255|NCT01957579|468763397|FG003|Overall Study|Withdrawal of concent|0|||
130218256|NCT01957579|468763394|FG000|Overall Study|Death|0|||
130218257|NCT01957579|468763395|FG001|Overall Study|Death|0|||
130218258|NCT01957579|468763396|FG002|Overall Study|Death|2|||
130218259|NCT01957579|468763397|FG003|Overall Study|Death|0|||
130218260|NCT01000974|468763398|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
130218261|NCT01000974|468763399|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
130218262|NCT01000974|468763400|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
130218263|NCT01000974|468763398|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
130218264|NCT01000974|468763399|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
130218265|NCT01000974|468763400|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
130218266|NCT01000974|468763398|FG000|Primary Vaccination Phase|Protocol Violation|40|||
130218267|NCT01000974|468763399|FG001|Primary Vaccination Phase|Protocol Violation|3|||
130218268|NCT01000974|468763400|FG002|Primary Vaccination Phase|Protocol Violation|2|||
130218269|NCT01000974|468763398|FG000|Primary Vaccination Phase|Adverse Event|14|||
130218270|NCT01000974|468763399|FG001|Primary Vaccination Phase|Adverse Event|2|||
130218271|NCT01000974|468763400|FG002|Primary Vaccination Phase|Adverse Event|2|||
130218272|NCT01000974|468763398|FG000|Primary Vaccination Phase|Other|4|||
130218273|NCT01000974|468763399|FG001|Primary Vaccination Phase|Other|9|||
130218274|NCT01000974|468763400|FG002|Primary Vaccination Phase|Other|12|||
130218275|NCT01000974|468763398|FG000|Booster Vaccination Phase|Protocol Violation|0|||
130218276|NCT01000974|468763399|FG001|Booster Vaccination Phase|Protocol Violation|0|||
130218277|NCT01000974|468763400|FG002|Booster Vaccination Phase|Protocol Violation|2|||
130218278|NCT01000974|468763398|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
130218279|NCT01000974|468763399|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
130218280|NCT01000974|468763400|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
130218281|NCT01000974|468763398|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
130218282|NCT01000974|468763399|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
130218283|NCT01000974|468763400|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
130218284|NCT01000974|468763398|FG000|Booster Vaccination Phase|Other|24|||
130218285|NCT01000974|468763399|FG001|Booster Vaccination Phase|Other|6|||
130218286|NCT01000974|468763400|FG002|Booster Vaccination Phase|Other|4|||
130218287|NCT01639144|468763403|FG000|Overall Study|Withdrawal by Subject|4|||
130218288|NCT01639144|468763404|FG001|Overall Study|Withdrawal by Subject|2|||
130218289|NCT01639144|468763403|FG000|Overall Study|Physician Decision|2|||
130218290|NCT01639144|468763404|FG001|Overall Study|Physician Decision|0|||
130218291|NCT01639144|468763403|FG000|Overall Study|Met postoperative exclusion criteria|4|||
130218292|NCT01639144|468763404|FG001|Overall Study|Met postoperative exclusion criteria|3|||
130218293|NCT02750332|468763405|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130218294|NCT02750332|468763406|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130218295|NCT02485483|468763411|FG000|Overall Study|Depression at baseline|15|||
130218296|NCT02485483|468763412|FG001|Overall Study|Depression at baseline|0|||
130218297|NCT02485483|468763411|FG000|Overall Study|Discontinued after baseline|39|||
130218298|NCT02485483|468763412|FG001|Overall Study|Discontinued after baseline|0|||
130218299|NCT01724177|468763414|FG000|Overall Study|Adverse Event|8|||
130218300|NCT01724177|468763414|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
130218301|NCT01724177|468763414|FG000|Overall Study|Nervous participant|1|||
130218302|NCT01724177|468763414|FG000|Overall Study|Serious Adverse Event Related|1|||
130218303|NCT02982863|468763419|FG000|Overall Study|Not eligible patients|809|||
130218304|NCT02982863|468763420|FG001|Overall Study|Not eligible patients|4261|||
130218305|NCT02982863|468763421|FG002|Overall Study|Not eligible patients|1852|||
130218306|NCT02982863|468763422|FG003|Overall Study|Not eligible patients|1400|||
130218307|NCT02982863|468763423|FG004|Overall Study|Not eligible patients|492|||
130218308|NCT02457195|468763424|FG000|Overall Study|Adverse Event|3|||
130218309|NCT02457195|468763424|FG000|Overall Study|Protocol Violation|2|||
130218310|NCT02457195|468763424|FG000|Overall Study|Withdrawal by Subject|4|||
130218311|NCT00158262|468763427|FG000|Overall Study|Lost to Follow-up|1|||
130218312|NCT00158262|468763428|FG001|Overall Study|Lost to Follow-up|1|||
130218313|NCT02959918|468763429|FG000|Overall Study|Adverse Event|1|||
130218314|NCT02959918|468763430|FG001|Overall Study|Adverse Event|1|||
130218315|NCT02959918|468763431|FG002|Overall Study|Adverse Event|2|||
130218316|NCT02959918|468763432|FG003|Overall Study|Adverse Event|0|||
130218317|NCT02959918|468763433|FG004|Overall Study|Adverse Event|0|||
130218318|NCT02959918|468763434|FG005|Overall Study|Adverse Event|2|||
130218319|NCT02959918|468763435|FG006|Overall Study|Adverse Event|2|||
130218320|NCT02959918|468763436|FG007|Overall Study|Adverse Event|1|||
130218321|NCT02959918|468763437|FG008|Overall Study|Adverse Event|2|||
130218322|NCT02959918|468763438|FG009|Overall Study|Adverse Event|1|||
130218323|NCT02959918|468763439|FG010|Overall Study|Adverse Event|1|||
130218324|NCT02959918|468763440|FG011|Overall Study|Adverse Event|3|||
130218325|NCT02959918|468763441|FG012|Overall Study|Adverse Event|2|||
130218326|NCT02959918|468763442|FG013|Overall Study|Adverse Event|4|||
130218327|NCT02959918|468763429|FG000|Overall Study|Lost to Follow-up|0|||
130218328|NCT02959918|468763430|FG001|Overall Study|Lost to Follow-up|0|||
130218329|NCT02959918|468763431|FG002|Overall Study|Lost to Follow-up|0|||
130218330|NCT02959918|468763432|FG003|Overall Study|Lost to Follow-up|0|||
130218331|NCT02959918|468763433|FG004|Overall Study|Lost to Follow-up|0|||
130218332|NCT02959918|468763434|FG005|Overall Study|Lost to Follow-up|0|||
130218333|NCT02959918|468763435|FG006|Overall Study|Lost to Follow-up|0|||
130218334|NCT02959918|468763436|FG007|Overall Study|Lost to Follow-up|0|||
130218335|NCT02959918|468763437|FG008|Overall Study|Lost to Follow-up|0|||
130218336|NCT02959918|468763438|FG009|Overall Study|Lost to Follow-up|1|||
130218337|NCT02959918|468763439|FG010|Overall Study|Lost to Follow-up|0|||
130218338|NCT02959918|468763440|FG011|Overall Study|Lost to Follow-up|0|||
130218339|NCT02959918|468763441|FG012|Overall Study|Lost to Follow-up|1|||
130218340|NCT02959918|468763442|FG013|Overall Study|Lost to Follow-up|0|||
130218341|NCT02959918|468763429|FG000|Overall Study|Withdrawal by Subject|0|||
130218342|NCT02959918|468763430|FG001|Overall Study|Withdrawal by Subject|0|||
130218343|NCT02959918|468763431|FG002|Overall Study|Withdrawal by Subject|1|||
130218344|NCT02959918|468763432|FG003|Overall Study|Withdrawal by Subject|2|||
130218345|NCT02959918|468763433|FG004|Overall Study|Withdrawal by Subject|0|||
130218346|NCT02959918|468763434|FG005|Overall Study|Withdrawal by Subject|0|||
130218347|NCT02959918|468763435|FG006|Overall Study|Withdrawal by Subject|1|||
130218348|NCT02959918|468763436|FG007|Overall Study|Withdrawal by Subject|0|||
130218349|NCT02959918|468763437|FG008|Overall Study|Withdrawal by Subject|1|||
130218350|NCT02959918|468763438|FG009|Overall Study|Withdrawal by Subject|1|||
130218351|NCT02959918|468763439|FG010|Overall Study|Withdrawal by Subject|2|||
130218352|NCT02959918|468763440|FG011|Overall Study|Withdrawal by Subject|3|||
130218353|NCT02959918|468763441|FG012|Overall Study|Withdrawal by Subject|1|||
130218354|NCT02959918|468763442|FG013|Overall Study|Withdrawal by Subject|1|||
130218355|NCT02959918|468763429|FG000|Overall Study|Protocol Violation|0|||
130218356|NCT02959918|468763430|FG001|Overall Study|Protocol Violation|0|||
130218357|NCT02959918|468763431|FG002|Overall Study|Protocol Violation|1|||
130218358|NCT02959918|468763432|FG003|Overall Study|Protocol Violation|0|||
130218359|NCT02959918|468763433|FG004|Overall Study|Protocol Violation|0|||
130218360|NCT02959918|468763434|FG005|Overall Study|Protocol Violation|1|||
130218361|NCT02959918|468763435|FG006|Overall Study|Protocol Violation|0|||
130218362|NCT02959918|468763436|FG007|Overall Study|Protocol Violation|0|||
130218363|NCT02959918|468763437|FG008|Overall Study|Protocol Violation|2|||
130218364|NCT02959918|468763438|FG009|Overall Study|Protocol Violation|1|||
130218365|NCT02959918|468763439|FG010|Overall Study|Protocol Violation|0|||
130218366|NCT02959918|468763440|FG011|Overall Study|Protocol Violation|1|||
130218367|NCT02959918|468763441|FG012|Overall Study|Protocol Violation|1|||
130218368|NCT02959918|468763442|FG013|Overall Study|Protocol Violation|0|||
130218369|NCT02959918|468763429|FG000|Overall Study|Stopping Rule Met|1|||
130218370|NCT02959918|468763430|FG001|Overall Study|Stopping Rule Met|0|||
130218371|NCT02959918|468763431|FG002|Overall Study|Stopping Rule Met|3|||
130218372|NCT02959918|468763432|FG003|Overall Study|Stopping Rule Met|4|||
130218373|NCT02959918|468763433|FG004|Overall Study|Stopping Rule Met|5|||
130218374|NCT02959918|468763434|FG005|Overall Study|Stopping Rule Met|3|||
130218375|NCT02959918|468763435|FG006|Overall Study|Stopping Rule Met|2|||
130218376|NCT02959918|468763436|FG007|Overall Study|Stopping Rule Met|4|||
130218377|NCT02959918|468763437|FG008|Overall Study|Stopping Rule Met|1|||
130218378|NCT02959918|468763438|FG009|Overall Study|Stopping Rule Met|1|||
130218379|NCT02959918|468763439|FG010|Overall Study|Stopping Rule Met|3|||
130218380|NCT02959918|468763440|FG011|Overall Study|Stopping Rule Met|5|||
130218381|NCT02959918|468763441|FG012|Overall Study|Stopping Rule Met|2|||
130218382|NCT02959918|468763442|FG013|Overall Study|Stopping Rule Met|1|||
130218383|NCT02959918|468763429|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
130218384|NCT02959918|468763430|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
130218385|NCT02959918|468763431|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
130218386|NCT02959918|468763432|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
130218387|NCT02959918|468763433|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218388|NCT02959918|468763434|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218389|NCT02959918|468763435|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218390|NCT02959918|468763436|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218391|NCT02959918|468763437|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218392|NCT02959918|468763438|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218393|NCT02959918|468763439|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218394|NCT02959918|468763440|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218395|NCT02959918|468763441|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218396|NCT02959918|468763442|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
130218397|NCT02959918|468763429|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218398|NCT02959918|468763430|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218399|NCT02959918|468763431|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218400|NCT02959918|468763432|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218401|NCT02959918|468763433|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218402|NCT02959918|468763434|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218403|NCT02959918|468763435|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218404|NCT02959918|468763436|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
130218405|NCT02959918|468763437|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218406|NCT02959918|468763438|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218407|NCT02959918|468763439|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218408|NCT02959918|468763440|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218409|NCT02959918|468763441|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218410|NCT02959918|468763442|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
130218411|NCT02959918|468763429|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218412|NCT02959918|468763430|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218413|NCT02959918|468763431|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218414|NCT02959918|468763432|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218415|NCT02959918|468763433|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218416|NCT02959918|468763434|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218417|NCT02959918|468763435|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218418|NCT02959918|468763436|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218419|NCT02959918|468763437|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
130218420|NCT02959918|468763438|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218421|NCT02959918|468763439|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218422|NCT02959918|468763440|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218423|NCT02959918|468763441|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218424|NCT02959918|468763442|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
130218425|NCT02959918|468763429|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218426|NCT02959918|468763430|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218427|NCT02959918|468763431|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218428|NCT02959918|468763432|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218429|NCT02959918|468763433|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218430|NCT02959918|468763434|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218431|NCT02959918|468763435|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218432|NCT02959918|468763436|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218433|NCT02959918|468763437|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218434|NCT02959918|468763438|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
130218435|NCT02959918|468763439|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218436|NCT02959918|468763440|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218437|NCT02959918|468763441|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218438|NCT02959918|468763442|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
130218439|NCT02585713|468763444|FG000|Overall Study|Withdrew prior to treatment|2|||
130218440|NCT02585713|468763445|FG001|Overall Study|Withdrew prior to treatment|7|||
130218441|NCT02585713|468763444|FG000|Overall Study|Other|3|||
130218442|NCT02585713|468763445|FG001|Overall Study|Other|1|||
130218443|NCT03173456|468763450|FG000|Baseline|Medication dispensing system malfunction'|0|||
130218444|NCT03173456|468763451|FG001|Baseline|Medication dispensing system malfunction'|1|||
130218445|NCT03173456|468763452|FG002|Baseline|Medication dispensing system malfunction'|0|||
130017107|NCT02941627|468024402|FG000|Overall Study|cholesteatoma prevented implantation|1|||
130017108|NCT00790907|468024407|FG000|Overall Study|Adverse Event|9|||
130017109|NCT00790907|468024408|FG001|Overall Study|Adverse Event|7|||
130017110|NCT00790907|468024409|FG002|Overall Study|Adverse Event|6|||
130218446|NCT03173456|468763453|FG003|Baseline|Medication dispensing system malfunction'|0|||
130218447|NCT03173456|468763454|FG004|Baseline|Medication dispensing system malfunction'|2|||
130218448|NCT03173456|468763450|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
130218449|NCT03173456|468763451|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
130218450|NCT03173456|468763452|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
130218451|NCT03173456|468763453|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
130218452|NCT03173456|468763454|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
130218453|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
130218454|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
130218455|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
130218456|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
130218457|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
130218458|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
130218459|NCT01733121|468763455|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130218460|NCT01733121|468763456|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
130218461|NCT04501952|468763465|FG000|Overall Study|Adverse Event|0|||
130218462|NCT04501952|468763466|FG001|Overall Study|Adverse Event|3|||
130218463|NCT04501952|468763465|FG000|Overall Study|Investigator's Discretion|0|||
130218464|NCT04501952|468763466|FG001|Overall Study|Investigator's Discretion|1|||
130218465|NCT04501952|468763465|FG000|Overall Study|Protocol Violation|1|||
130218466|NCT04501952|468763466|FG001|Overall Study|Protocol Violation|1|||
130218467|NCT04501952|468763465|FG000|Overall Study|Withdrew Consent|5|||
130218468|NCT04501952|468763466|FG001|Overall Study|Withdrew Consent|4|||
130218469|NCT04501952|468763465|FG000|Overall Study|Lost to Follow-up|7|||
130218470|NCT04501952|468763466|FG001|Overall Study|Lost to Follow-up|2|||
130218471|NCT04501952|468763465|FG000|Overall Study|Randomized and Never Treated|13|||
130218472|NCT04501952|468763466|FG001|Overall Study|Randomized and Never Treated|9|||
130218473|NCT00941304|468763467|FG000|Overall Study|Lost to Follow-up|1|||
130218474|NCT00941304|468763468|FG001|Overall Study|Lost to Follow-up|0|||
130218475|NCT00941304|468763469|FG002|Overall Study|Lost to Follow-up|0|||
130218476|NCT00941304|468763470|FG003|Overall Study|Lost to Follow-up|0|||
130218477|NCT00941304|468763471|FG004|Overall Study|Lost to Follow-up|0|||
130218478|NCT00784719|468763472|FG000|Overall Study|Adverse Event|0|||
130218479|NCT00784719|468763473|FG001|Overall Study|Adverse Event|2|||
130218480|NCT00784719|468763474|FG002|Overall Study|Adverse Event|0|||
130218481|NCT00784719|468763475|FG003|Overall Study|Adverse Event|0|||
130218482|NCT00784719|468763476|FG004|Overall Study|Adverse Event|1|||
130218483|NCT00784719|468763477|FG005|Overall Study|Adverse Event|1|||
130218484|NCT00784719|468763478|FG006|Overall Study|Adverse Event|1|||
130218485|NCT00784719|468763472|FG000|Overall Study|Lost to Follow-up|0|||
130218486|NCT00784719|468763473|FG001|Overall Study|Lost to Follow-up|0|||
130218487|NCT00784719|468763474|FG002|Overall Study|Lost to Follow-up|0|||
130218488|NCT00784719|468763475|FG003|Overall Study|Lost to Follow-up|0|||
130218489|NCT00784719|468763476|FG004|Overall Study|Lost to Follow-up|1|||
130218490|NCT00784719|468763477|FG005|Overall Study|Lost to Follow-up|1|||
130218491|NCT00784719|468763478|FG006|Overall Study|Lost to Follow-up|0|||
130218492|NCT00784719|468763472|FG000|Overall Study|Other|2|||
130218493|NCT00784719|468763473|FG001|Overall Study|Other|1|||
130218494|NCT00784719|468763474|FG002|Overall Study|Other|1|||
130218495|NCT00784719|468763475|FG003|Overall Study|Other|0|||
130218496|NCT00784719|468763476|FG004|Overall Study|Other|2|||
130017111|NCT00790907|468024407|FG000|Overall Study|Physician Decision|304|||
130218497|NCT00784719|468763477|FG005|Overall Study|Other|1|||
130218498|NCT00784719|468763478|FG006|Overall Study|Other|3|||
130218499|NCT00784719|468763472|FG000|Overall Study|Withdrawal by Subject|1|||
130218500|NCT00784719|468763473|FG001|Overall Study|Withdrawal by Subject|0|||
130218501|NCT00784719|468763474|FG002|Overall Study|Withdrawal by Subject|0|||
130218502|NCT00784719|468763475|FG003|Overall Study|Withdrawal by Subject|0|||
130218503|NCT00784719|468763476|FG004|Overall Study|Withdrawal by Subject|2|||
130218504|NCT00784719|468763477|FG005|Overall Study|Withdrawal by Subject|0|||
130218505|NCT00784719|468763478|FG006|Overall Study|Withdrawal by Subject|1|||
130218506|NCT01408901|468763479|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
130218507|NCT01408901|468763480|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
130218508|NCT01408901|468763481|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
130218509|NCT01408901|468763482|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
130218510|NCT01408901|468763479|FG000|6-Week Follow-Up|Death|1|||
130218511|NCT01408901|468763480|FG001|6-Week Follow-Up|Death|0|||
130218512|NCT01408901|468763481|FG002|6-Week Follow-Up|Death|0|||
130218513|NCT01408901|468763482|FG003|6-Week Follow-Up|Death|0|||
130218514|NCT01408901|468763479|FG000|6-Week Follow-Up|Cancelled visit|0|||
130218515|NCT01408901|468763480|FG001|6-Week Follow-Up|Cancelled visit|1|||
130218516|NCT01408901|468763481|FG002|6-Week Follow-Up|Cancelled visit|0|||
130218517|NCT01408901|468763482|FG003|6-Week Follow-Up|Cancelled visit|2|||
130218518|NCT01408901|468763479|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130218519|NCT01408901|468763480|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130218520|NCT01408901|468763481|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
130218521|NCT01408901|468763482|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
130218522|NCT01408901|468763479|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
130218523|NCT01408901|468763480|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130218524|NCT01408901|468763481|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130218525|NCT01408901|468763482|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
130218526|NCT01408901|468763479|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
130218527|NCT01408901|468763480|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
130218528|NCT01408901|468763481|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
130218529|NCT01408901|468763482|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
130218530|NCT01408901|468763479|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
130218531|NCT01408901|468763480|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
130218532|NCT01408901|468763481|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
130218533|NCT01408901|468763482|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
130218534|NCT01408901|468763479|FG000|26-Week Follow-Up|Death|0|||
130218535|NCT01408901|468763480|FG001|26-Week Follow-Up|Death|1|||
130218536|NCT01408901|468763481|FG002|26-Week Follow-Up|Death|0|||
130218537|NCT01408901|468763482|FG003|26-Week Follow-Up|Death|0|||
130218538|NCT04004260|468763489|FG000|Overall Study|Withdrawal by Subject|7|||
130218539|NCT04004260|468763490|FG001|Overall Study|Withdrawal by Subject|3|||
130218540|NCT04004260|468763489|FG000|Overall Study|Lost to Follow-up|22|||
130218541|NCT04004260|468763490|FG001|Overall Study|Lost to Follow-up|12|||
130218542|NCT04004260|468763489|FG000|Overall Study|Did not engage in intervention|13|||
130218543|NCT04004260|468763490|FG001|Overall Study|Did not engage in intervention|17|||
130218544|NCT05464420|468763491|FG000|Overall Study|Death|0|||
130218545|NCT05464420|468763492|FG001|Overall Study|Death|0|||
130218546|NCT05464420|468763493|FG002|Overall Study|Death|0|||
130218547|NCT05464420|468763494|FG003|Overall Study|Death|1|||
130218548|NCT05464420|468763491|FG000|Overall Study|Lost to Follow-up|16|||
130218549|NCT05464420|468763492|FG001|Overall Study|Lost to Follow-up|11|||
130218550|NCT05464420|468763493|FG002|Overall Study|Lost to Follow-up|11|||
130218551|NCT05464420|468763494|FG003|Overall Study|Lost to Follow-up|11|||
130218552|NCT05464420|468763491|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
130218553|NCT05464420|468763492|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
130218554|NCT05464420|468763493|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
130218555|NCT05464420|468763494|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
130218556|NCT05464420|468763491|FG000|Overall Study|Withdrawal by Subject|4|||
130218557|NCT05464420|468763492|FG001|Overall Study|Withdrawal by Subject|8|||
130218558|NCT05464420|468763493|FG002|Overall Study|Withdrawal by Subject|3|||
130218559|NCT05464420|468763494|FG003|Overall Study|Withdrawal by Subject|1|||
130218560|NCT05464420|468763491|FG000|Overall Study|Protocol Violation|0|||
130218561|NCT05464420|468763492|FG001|Overall Study|Protocol Violation|0|||
130218562|NCT05464420|468763493|FG002|Overall Study|Protocol Violation|1|||
130218563|NCT05464420|468763494|FG003|Overall Study|Protocol Violation|1|||
130218564|NCT05464420|468763491|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
130218565|NCT05464420|468763492|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
130218566|NCT05464420|468763493|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
130218567|NCT05464420|468763494|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
130218568|NCT03414229|468763495|FG000|Overall Study|Adverse Event|1|||
130218569|NCT03414229|468763496|FG001|Overall Study|Adverse Event|0|||
130218570|NCT03414229|468763497|FG002|Overall Study|Adverse Event|2|||
130218571|NCT03414229|468763498|FG003|Overall Study|Adverse Event|1|||
130218572|NCT03414229|468763495|FG000|Overall Study|Lack of Efficacy|7|||
130218573|NCT03414229|468763496|FG001|Overall Study|Lack of Efficacy|4|||
130218574|NCT03414229|468763497|FG002|Overall Study|Lack of Efficacy|1|||
130218575|NCT03414229|468763498|FG003|Overall Study|Lack of Efficacy|9|||
130218576|NCT03414229|468763495|FG000|Overall Study|Change in therapy|1|||
130017112|NCT00790907|468024408|FG001|Overall Study|Physician Decision|271|||
130218577|NCT03414229|468763496|FG001|Overall Study|Change in therapy|0|||
130218578|NCT03414229|468763497|FG002|Overall Study|Change in therapy|0|||
130218579|NCT03414229|468763498|FG003|Overall Study|Change in therapy|0|||
130218580|NCT03414229|468763495|FG000|Overall Study|Pregnancy|0|||
130218581|NCT03414229|468763496|FG001|Overall Study|Pregnancy|0|||
130218582|NCT03414229|468763497|FG002|Overall Study|Pregnancy|1|||
130218583|NCT03414229|468763498|FG003|Overall Study|Pregnancy|0|||
130218584|NCT03414229|468763495|FG000|Overall Study|Withdrawal by Subject|0|||
130218585|NCT03414229|468763496|FG001|Overall Study|Withdrawal by Subject|1|||
130218586|NCT03414229|468763497|FG002|Overall Study|Withdrawal by Subject|1|||
130218587|NCT03414229|468763498|FG003|Overall Study|Withdrawal by Subject|0|||
130218588|NCT04533438|468763499|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
130218589|NCT04533438|468763500|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
130017113|NCT00790907|468024409|FG002|Overall Study|Physician Decision|255|||
130017114|NCT00790907|468024407|FG000|Overall Study|Withdrawal by Subject|1|||
130017115|NCT00790907|468024408|FG001|Overall Study|Withdrawal by Subject|7|||
130017116|NCT00790907|468024409|FG002|Overall Study|Withdrawal by Subject|5|||
130017117|NCT00790907|468024407|FG000|Overall Study|Bleeding Event|11|||
130017118|NCT00790907|468024408|FG001|Overall Study|Bleeding Event|16|||
130017119|NCT00790907|468024409|FG002|Overall Study|Bleeding Event|21|||
130017120|NCT00790907|468024407|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
130017121|NCT00790907|468024408|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
130017122|NCT00790907|468024409|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
130218590|NCT02716584|468763505|FG000|Overall Study|Lost to Follow-up|8|||
130218591|NCT02716584|468763506|FG001|Overall Study|Lost to Follow-up|5|||
130218592|NCT01903993|468763507|FG000|Overall Study|Death|118|||
130218593|NCT01903993|468763508|FG001|Overall Study|Death|121|||
130218594|NCT01903993|468763507|FG000|Overall Study|Withdrawal by Subject|15|||
130218595|NCT01903993|468763508|FG001|Overall Study|Withdrawal by Subject|4|||
130218596|NCT01903993|468763507|FG000|Overall Study|Lost to Follow-up|2|||
130017123|NCT00790907|468024407|FG000|Overall Study|Qualifying Condition Not Present|29|||
130017124|NCT00790907|468024408|FG001|Overall Study|Qualifying Condition Not Present|14|||
130017125|NCT00790907|468024409|FG002|Overall Study|Qualifying Condition Not Present|16|||
130017126|NCT00790907|468024407|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
130017127|NCT00790907|468024408|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
130017128|NCT00790907|468024409|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
130017129|NCT00790907|468024407|FG000|Overall Study|Did Not Receive Study Drug|10|||
130017130|NCT00790907|468024408|FG001|Overall Study|Did Not Receive Study Drug|0|||
130017131|NCT00790907|468024409|FG002|Overall Study|Did Not Receive Study Drug|0|||
130017132|NCT01888640|468024410|FG000|Overall Study|Lost to Follow-up|1|||
130017133|NCT01888640|468024411|FG001|Overall Study|Lost to Follow-up|2|||
130017134|NCT01888640|468024412|FG002|Overall Study|Lost to Follow-up|0|||
130017135|NCT01888640|468024410|FG000|Overall Study|Withdrawal by Subject|15|||
130017136|NCT01888640|468024411|FG001|Overall Study|Withdrawal by Subject|11|||
130017137|NCT01888640|468024412|FG002|Overall Study|Withdrawal by Subject|4|||
130017138|NCT01888640|468024410|FG000|Overall Study|Minimum dose not met|10|||
130017139|NCT01888640|468024411|FG001|Overall Study|Minimum dose not met|16|||
130017140|NCT01888640|468024412|FG002|Overall Study|Minimum dose not met|0|||
130017141|NCT01888640|468024410|FG000|Overall Study|Given wrong unit (placebo)|1|||
130017142|NCT01888640|468024411|FG001|Overall Study|Given wrong unit (placebo)|0|||
130017143|NCT01888640|468024412|FG002|Overall Study|Given wrong unit (placebo)|0|||
130017144|NCT01888640|468024410|FG000|Overall Study|Excluded for prior TENS|0|||
130017145|NCT01888640|468024411|FG001|Overall Study|Excluded for prior TENS|1|||
130017146|NCT01888640|468024412|FG002|Overall Study|Excluded for prior TENS|0|||
130017147|NCT01888640|468024410|FG000|Overall Study|Researcher Termination of Participant|0|||
130017148|NCT01888640|468024411|FG001|Overall Study|Researcher Termination of Participant|1|||
130017149|NCT01888640|468024412|FG002|Overall Study|Researcher Termination of Participant|1|||
130017150|NCT00109707|468024413|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
130017151|NCT00109707|468024414|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
130017152|NCT00109707|468024415|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
130017153|NCT00109707|468024413|FG000|Overall Study|Abnormal laboratory values|1|||
130017154|NCT00109707|468024414|FG001|Overall Study|Abnormal laboratory values|0|||
130017155|NCT00109707|468024415|FG002|Overall Study|Abnormal laboratory values|0|||
130017156|NCT00109707|468024413|FG000|Overall Study|Administrative problems|2|||
130218597|NCT01903993|468763508|FG001|Overall Study|Lost to Follow-up|3|||
130218598|NCT01903993|468763507|FG000|Overall Study|Study Terminated by Sponsor|8|||
130017157|NCT00109707|468024414|FG001|Overall Study|Administrative problems|0|||
130017158|NCT00109707|468024415|FG002|Overall Study|Administrative problems|1|||
130017159|NCT00109707|468024413|FG000|Overall Study|Adverse Event|10|||
130218599|NCT01903993|468763508|FG001|Overall Study|Study Terminated by Sponsor|14|||
130017160|NCT00109707|468024414|FG001|Overall Study|Adverse Event|2|||
130218600|NCT01903993|468763507|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
130218601|NCT01903993|468763508|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
130218602|NCT01588405|468763509|FG000|Overall Study|Adverse Event|1|||
130218603|NCT01588405|468763509|FG000|Overall Study|Clinical Worsening|1|||
130218604|NCT01243177|468763512|FG000|Overall Study|Lack of Efficacy|47|||
130218605|NCT01243177|468763513|FG001|Overall Study|Lack of Efficacy|31|||
130218606|NCT01243177|468763512|FG000|Overall Study|Protocol Violation|11|||
130218607|NCT01243177|468763513|FG001|Overall Study|Protocol Violation|10|||
130218608|NCT01243177|468763512|FG000|Overall Study|Lost to Follow-up|15|||
130218609|NCT01243177|468763513|FG001|Overall Study|Lost to Follow-up|18|||
130218610|NCT01243177|468763512|FG000|Overall Study|Withdrawal by Subject|46|||
130218611|NCT01243177|468763513|FG001|Overall Study|Withdrawal by Subject|38|||
130218612|NCT01243177|468763512|FG000|Overall Study|AE, serious fatal|0|||
130017161|NCT00109707|468024415|FG002|Overall Study|Adverse Event|3|||
130017162|NCT00109707|468024413|FG000|Overall Study|Death|4|||
130218613|NCT01243177|468763513|FG001|Overall Study|AE, serious fatal|1|||
130017163|NCT00109707|468024414|FG001|Overall Study|Death|0|||
130017164|NCT00109707|468024415|FG002|Overall Study|Death|0|||
130218614|NCT01243177|468763512|FG000|Overall Study|SAE, non-fatal|7|||
130218615|NCT01243177|468763513|FG001|Overall Study|SAE, non-fatal|9|||
130218616|NCT01243177|468763512|FG000|Overall Study|AE, non-serious non-fatal|40|||
130218617|NCT01243177|468763513|FG001|Overall Study|AE, non-serious non-fatal|58|||
130218618|NCT01243177|468763512|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
130218619|NCT01243177|468763513|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
130218620|NCT01243177|468763512|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130218621|NCT01243177|468763513|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130218622|NCT01243177|468763512|FG000|Overall Study|Other Reason|11|||
130218623|NCT01243177|468763513|FG001|Overall Study|Other Reason|12|||
130218624|NCT01073163|468765012|FG000|Overall Study|Adverse Event|1|||
130218625|NCT01073163|468765012|FG000|Overall Study|Disease Progression|1|||
130218626|NCT01073163|468765012|FG000|Overall Study|Early termination|1|||
130218627|NCT00703677|468765013|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
130218628|NCT00940888|468765014|FG000|Overall Study|Unsuccessful Implant|4|||
130218629|NCT00940888|468765014|FG000|Overall Study|Death|461|||
130218630|NCT00940888|468765014|FG000|Overall Study|Withdrawn - Non-Death|364|||
130218631|NCT00940888|468765014|FG000|Overall Study|Lost to Follow-up|6|||
130218632|NCT04441788|468765017|FG000|Overall Study|Voluntary Withdrawl|0|||
130218633|NCT04441788|468765018|FG001|Overall Study|Voluntary Withdrawl|1|||
130218634|NCT04441788|468765019|FG002|Overall Study|Voluntary Withdrawl|0|||
130218635|NCT04441788|468765017|FG000|Overall Study|Ineligibility|1|||
130218636|NCT04441788|468765018|FG001|Overall Study|Ineligibility|0|||
130218637|NCT04441788|468765019|FG002|Overall Study|Ineligibility|0|||
130218638|NCT04441788|468765017|FG000|Overall Study|Adverse Event|0|||
130218639|NCT04441788|468765018|FG001|Overall Study|Adverse Event|0|||
130218640|NCT04441788|468765019|FG002|Overall Study|Adverse Event|4|||
130218641|NCT04441788|468765017|FG000|Overall Study|Study Terminated by Sponsor|16|||
130218642|NCT04441788|468765018|FG001|Overall Study|Study Terminated by Sponsor|16|||
130218643|NCT04441788|468765019|FG002|Overall Study|Study Terminated by Sponsor|12|||
130218644|NCT03859648|468765024|FG000|Overall Study|Lost to Follow-up|1|||
130218645|NCT03859648|468765024|FG000|Overall Study|Adverse Event|1|||
130218646|NCT01677182|468765025|FG000|Overall Study|Adverse Event|2|||
130218647|NCT01677182|468765026|FG001|Overall Study|Adverse Event|1|||
130218648|NCT01677182|468765027|FG002|Overall Study|Adverse Event|8|||
130218649|NCT01677182|468765025|FG000|Overall Study|Protocol Violation|5|||
130218650|NCT01677182|468765026|FG001|Overall Study|Protocol Violation|1|||
130218651|NCT01677182|468765027|FG002|Overall Study|Protocol Violation|4|||
130218652|NCT01677182|468765025|FG000|Overall Study|Lost to Follow-up|4|||
130218653|NCT01677182|468765026|FG001|Overall Study|Lost to Follow-up|0|||
130218654|NCT01677182|468765027|FG002|Overall Study|Lost to Follow-up|3|||
130218655|NCT01677182|468765025|FG000|Overall Study|Withdrawal by Subject|7|||
130218656|NCT01677182|468765026|FG001|Overall Study|Withdrawal by Subject|12|||
130218657|NCT01677182|468765027|FG002|Overall Study|Withdrawal by Subject|10|||
130218658|NCT01677182|468765025|FG000|Overall Study|Study termination|12|||
130218659|NCT01677182|468765026|FG001|Overall Study|Study termination|9|||
130218660|NCT01677182|468765027|FG002|Overall Study|Study termination|11|||
130218661|NCT01677182|468765025|FG000|Overall Study|Lack of Efficacy|3|||
130218662|NCT01677182|468765026|FG001|Overall Study|Lack of Efficacy|0|||
130218663|NCT01677182|468765027|FG002|Overall Study|Lack of Efficacy|1|||
130218664|NCT01677182|468765025|FG000|Overall Study|Other reasons|1|||
130218665|NCT01677182|468765026|FG001|Overall Study|Other reasons|5|||
130218666|NCT01677182|468765027|FG002|Overall Study|Other reasons|2|||
130218667|NCT00762762|468765032|FG000|Overall Study|Did not return for appointments|6|||
130218668|NCT00762762|468765033|FG001|Overall Study|Did not return for appointments|8|||
130218669|NCT02489448|468765034|FG000|Overall Study|Death|3|||
130218670|NCT02489448|468765034|FG000|Overall Study|Withdrawal by Subject|2|||
130218671|NCT01239394|468765043|FG000|Overall Study|Adverse Event|1|||
130218672|NCT02861664|468765044|FG000|Overall Study|Withdrawal of Consent|0|||
130218673|NCT02861664|468765045|FG001|Overall Study|Withdrawal of Consent|1|||
130218674|NCT02781818|468765047|FG000|Overall Study|Lost to Follow-up|4|||
130218675|NCT02781818|468765048|FG001|Overall Study|Lost to Follow-up|2|||
130218676|NCT02781818|468765049|FG002|Overall Study|Lost to Follow-up|1|||
130218677|NCT01223404|468765050|FG000|First Intervention (1 Day)|Adverse Event|0|||
130218678|NCT01223404|468765051|FG001|First Intervention (1 Day)|Adverse Event|0|||
130218679|NCT01223404|468765052|FG002|First Intervention (1 Day)|Adverse Event|0|||
130218680|NCT01223404|468765053|FG003|First Intervention (1 Day)|Adverse Event|1|||
130218681|NCT01223404|468765054|FG004|First Intervention (1 Day)|Adverse Event|0|||
130218682|NCT01223404|468765055|FG005|First Intervention (1 Day)|Adverse Event|0|||
130218683|NCT01223404|468765050|FG000|Second Intervention (1 Day)|Adverse Event|1|||
130218684|NCT01223404|468765051|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130218685|NCT01223404|468765052|FG002|Second Intervention (1 Day)|Adverse Event|0|||
130218686|NCT01223404|468765053|FG003|Second Intervention (1 Day)|Adverse Event|0|||
130218687|NCT01223404|468765054|FG004|Second Intervention (1 Day)|Adverse Event|0|||
130218688|NCT01223404|468765055|FG005|Second Intervention (1 Day)|Adverse Event|0|||
130218689|NCT01223404|468765050|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218690|NCT01223404|468765051|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218691|NCT01223404|468765052|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218692|NCT01223404|468765053|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
130218693|NCT01223404|468765054|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218694|NCT01223404|468765055|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
130218695|NCT00707057|468765056|FG000|Overall Study|Withdrawal by Subject|8|||
130218696|NCT00707057|468765057|FG001|Overall Study|Withdrawal by Subject|3|||
130218697|NCT00707057|468765056|FG000|Overall Study|Dosed incorrectly|0|||
130218698|NCT00707057|468765057|FG001|Overall Study|Dosed incorrectly|1|||
130218699|NCT00577772|468765063|FG000|Overall Study|Lost to Follow-up|0|||
130218700|NCT00577772|468765064|FG001|Overall Study|Lost to Follow-up|1|||
130218701|NCT00572455|468765065|FG000|Stage I (14 Days)|Adverse Event|0|||
130218702|NCT00572455|468765066|FG001|Stage I (14 Days)|Adverse Event|0|||
130218703|NCT00572455|468765067|FG002|Stage I (14 Days)|Adverse Event|0|||
130218704|NCT00572455|468765068|FG003|Stage I (14 Days)|Adverse Event|0|||
130218705|NCT00572455|468765069|FG004|Stage I (14 Days)|Adverse Event|0|||
130218706|NCT00572455|468765070|FG005|Stage I (14 Days)|Adverse Event|3|||
130218707|NCT00572455|468765071|FG006|Stage I (14 Days)|Adverse Event|0|||
130218708|NCT00572455|468765072|FG007|Stage I (14 Days)|Adverse Event|0|||
130218709|NCT00572455|468765073|FG008|Stage I (14 Days)|Adverse Event|0|||
130218710|NCT00572455|468765074|FG009|Stage I (14 Days)|Adverse Event|0|||
130218711|NCT00572455|468765075|FG010|Stage I (14 Days)|Adverse Event|0|||
130218712|NCT00572455|468765076|FG011|Stage I (14 Days)|Adverse Event|0|||
130218713|NCT00572455|468765077|FG012|Stage I (14 Days)|Adverse Event|0|||
130218714|NCT00572455|468765078|FG013|Stage I (14 Days)|Adverse Event|0|||
130218715|NCT00572455|468765065|FG000|Stage I (14 Days)|Other|0|||
130218716|NCT00572455|468765066|FG001|Stage I (14 Days)|Other|0|||
130218717|NCT00572455|468765067|FG002|Stage I (14 Days)|Other|0|||
130218718|NCT00572455|468765068|FG003|Stage I (14 Days)|Other|0|||
130218719|NCT00572455|468765069|FG004|Stage I (14 Days)|Other|1|||
130218720|NCT00572455|468765070|FG005|Stage I (14 Days)|Other|0|||
130218721|NCT00572455|468765071|FG006|Stage I (14 Days)|Other|0|||
130218722|NCT00572455|468765072|FG007|Stage I (14 Days)|Other|0|||
130218723|NCT00572455|468765073|FG008|Stage I (14 Days)|Other|0|||
130218724|NCT00572455|468765074|FG009|Stage I (14 Days)|Other|0|||
130218725|NCT00572455|468765075|FG010|Stage I (14 Days)|Other|0|||
130218726|NCT00572455|468765076|FG011|Stage I (14 Days)|Other|0|||
130218727|NCT00572455|468765077|FG012|Stage I (14 Days)|Other|0|||
130218728|NCT00572455|468765078|FG013|Stage I (14 Days)|Other|0|||
130218729|NCT00572455|468765065|FG000|Stage II (28 Days)|Adverse Event|0|||
130218730|NCT00572455|468765066|FG001|Stage II (28 Days)|Adverse Event|0|||
130218731|NCT00572455|468765067|FG002|Stage II (28 Days)|Adverse Event|0|||
130218732|NCT00572455|468765068|FG003|Stage II (28 Days)|Adverse Event|0|||
130218733|NCT00572455|468765069|FG004|Stage II (28 Days)|Adverse Event|0|||
130218734|NCT00572455|468765070|FG005|Stage II (28 Days)|Adverse Event|0|||
130218735|NCT00572455|468765071|FG006|Stage II (28 Days)|Adverse Event|0|||
130218736|NCT00572455|468765072|FG007|Stage II (28 Days)|Adverse Event|0|||
130218737|NCT00572455|468765073|FG008|Stage II (28 Days)|Adverse Event|1|||
130218738|NCT00572455|468765074|FG009|Stage II (28 Days)|Adverse Event|3|||
130218739|NCT00572455|468765075|FG010|Stage II (28 Days)|Adverse Event|3|||
130218740|NCT00572455|468765076|FG011|Stage II (28 Days)|Adverse Event|4|||
130218741|NCT00572455|468765077|FG012|Stage II (28 Days)|Adverse Event|5|||
130218742|NCT00572455|468765078|FG013|Stage II (28 Days)|Adverse Event|1|||
130218743|NCT00572455|468765065|FG000|Stage II (28 Days)|Death|0|||
130218744|NCT00572455|468765066|FG001|Stage II (28 Days)|Death|0|||
130218745|NCT00572455|468765067|FG002|Stage II (28 Days)|Death|0|||
130218746|NCT00572455|468765068|FG003|Stage II (28 Days)|Death|0|||
130218747|NCT00572455|468765069|FG004|Stage II (28 Days)|Death|0|||
130218748|NCT00572455|468765070|FG005|Stage II (28 Days)|Death|0|||
130218749|NCT00572455|468765071|FG006|Stage II (28 Days)|Death|0|||
130218750|NCT00572455|468765072|FG007|Stage II (28 Days)|Death|0|||
130218751|NCT00572455|468765073|FG008|Stage II (28 Days)|Death|1|||
130218752|NCT00572455|468765074|FG009|Stage II (28 Days)|Death|0|||
130218753|NCT00572455|468765075|FG010|Stage II (28 Days)|Death|0|||
130218754|NCT00572455|468765076|FG011|Stage II (28 Days)|Death|0|||
130218755|NCT00572455|468765077|FG012|Stage II (28 Days)|Death|0|||
130218756|NCT00572455|468765078|FG013|Stage II (28 Days)|Death|0|||
130218757|NCT00572455|468765065|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
130218758|NCT00572455|468765066|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
130218759|NCT00572455|468765067|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
130218760|NCT00572455|468765068|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
130218761|NCT00572455|468765069|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
130218762|NCT00572455|468765070|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
130218763|NCT00572455|468765071|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
130218764|NCT00572455|468765072|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
130218765|NCT00572455|468765073|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
130218766|NCT00572455|468765074|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
130218767|NCT00572455|468765075|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
130218768|NCT00572455|468765076|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
130218769|NCT00572455|468765077|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
130218770|NCT00572455|468765078|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
130218771|NCT00572455|468765065|FG000|Stage II (28 Days)|Other|0|||
130218772|NCT00572455|468765066|FG001|Stage II (28 Days)|Other|0|||
130218773|NCT00572455|468765067|FG002|Stage II (28 Days)|Other|0|||
130218774|NCT00572455|468765068|FG003|Stage II (28 Days)|Other|0|||
130218775|NCT00572455|468765069|FG004|Stage II (28 Days)|Other|0|||
130218776|NCT00572455|468765070|FG005|Stage II (28 Days)|Other|0|||
130218777|NCT00572455|468765071|FG006|Stage II (28 Days)|Other|0|||
130218778|NCT00572455|468765072|FG007|Stage II (28 Days)|Other|0|||
130218779|NCT00572455|468765073|FG008|Stage II (28 Days)|Other|1|||
130218780|NCT00572455|468765074|FG009|Stage II (28 Days)|Other|0|||
130218781|NCT00572455|468765075|FG010|Stage II (28 Days)|Other|0|||
130218782|NCT00572455|468765076|FG011|Stage II (28 Days)|Other|0|||
130218783|NCT00572455|468765077|FG012|Stage II (28 Days)|Other|0|||
130218784|NCT00572455|468765078|FG013|Stage II (28 Days)|Other|0|||
130218785|NCT00572455|468765065|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
130218786|NCT00572455|468765066|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
130218787|NCT00572455|468765067|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
130218788|NCT00572455|468765068|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
130218789|NCT00572455|468765069|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
130218790|NCT00572455|468765070|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
130218791|NCT00572455|468765071|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
130017165|NCT00109707|468024413|FG000|Overall Study|Disease progression|12|||
130218792|NCT00572455|468765072|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
130218793|NCT00572455|468765073|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
130218794|NCT00572455|468765074|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
130218795|NCT00572455|468765075|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
130218796|NCT00572455|468765076|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
130218797|NCT00572455|468765077|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
130218798|NCT00572455|468765078|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
130218799|NCT02821416|468765081|FG000|Overall Study|Adverse Event|0|||
130218800|NCT02821416|468765082|FG001|Overall Study|Adverse Event|1|||
130218801|NCT02821416|468765081|FG000|Overall Study|Withdrawal by Subject|2|||
130218802|NCT02821416|468765082|FG001|Overall Study|Withdrawal by Subject|0|||
130218803|NCT02821416|468765081|FG000|Overall Study|Lost to Follow-up|1|||
130218804|NCT02821416|468765082|FG001|Overall Study|Lost to Follow-up|0|||
130218805|NCT04152083|468765083|FG000|Overall Study|Lost to Follow-up|2|||
130218806|NCT04152083|468765084|FG001|Overall Study|Lost to Follow-up|1|||
130218807|NCT04152083|468765083|FG000|Overall Study|Adverse Event|1|||
130218808|NCT04152083|468765084|FG001|Overall Study|Adverse Event|0|||
130218809|NCT04152083|468765083|FG000|Overall Study|Randomized but not treated|3|||
130218810|NCT04152083|468765084|FG001|Overall Study|Randomized but not treated|2|||
130218811|NCT00856999|468765085|FG000|Overall Study|Withdrawal by Subject|5|||
130218812|NCT00872521|468765086|FG000|Completed PAD Induction|Patient choice|0|||
130218813|NCT00872521|468765087|FG001|Completed PAD Induction|Patient choice|1|||
130218814|NCT00872521|468765088|FG002|Completed PAD Induction|Patient choice|0|||
130218815|NCT00872521|468765086|FG000|Completed PAD Induction|Disease progression|0|||
130218816|NCT00872521|468765087|FG001|Completed PAD Induction|Disease progression|2|||
130218817|NCT00872521|468765088|FG002|Completed PAD Induction|Disease progression|0|||
130218818|NCT00872521|468765086|FG000|Completed PAD Induction|Adverse Event|4|||
130218819|NCT00872521|468765087|FG001|Completed PAD Induction|Adverse Event|0|||
130218820|NCT00872521|468765088|FG002|Completed PAD Induction|Adverse Event|0|||
130218821|NCT00872521|468765086|FG000|Completed PAD Induction|Death|1|||
130218822|NCT00872521|468765087|FG001|Completed PAD Induction|Death|1|||
130218823|NCT00872521|468765088|FG002|Completed PAD Induction|Death|0|||
130218824|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Other|1|||
130218825|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Other|2|||
130218826|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Other|0|||
130218827|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Patient choice|0|||
130218828|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Patient choice|1|||
130218829|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Patient choice|0|||
130218830|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
130218831|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
130218832|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
130218833|NCT00872521|468765086|FG000|Primary Endpoint Analysis|Patient response missing|0|||
130218834|NCT00872521|468765087|FG001|Primary Endpoint Analysis|Patient response missing|0|||
130218835|NCT00872521|468765088|FG002|Primary Endpoint Analysis|Patient response missing|1|||
130218836|NCT00872521|468765086|FG000|Completed 3-month Follow up|Other|0|||
130218837|NCT00872521|468765087|FG001|Completed 3-month Follow up|Other|2|||
130218838|NCT00872521|468765088|FG002|Completed 3-month Follow up|Other|0|||
130218839|NCT00872521|468765086|FG000|Completed 3-month Follow up|Physician Decision|0|||
130218840|NCT00872521|468765087|FG001|Completed 3-month Follow up|Physician Decision|1|||
130218841|NCT00872521|468765088|FG002|Completed 3-month Follow up|Physician Decision|0|||
130218842|NCT00872521|468765086|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
130218843|NCT00872521|468765087|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
130218844|NCT00872521|468765088|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
130218845|NCT04819438|468765089|FG000|Overall Study|Withdrawal by Subject|1|||
130218846|NCT04819438|468765090|FG001|Overall Study|Withdrawal by Subject|0|||
130218847|NCT04819438|468765089|FG000|Overall Study|Adverse Event|0|||
130218848|NCT04819438|468765090|FG001|Overall Study|Adverse Event|1|||
130218849|NCT04819438|468765089|FG000|Overall Study|Protocol Violation|0|||
130218850|NCT04819438|468765090|FG001|Overall Study|Protocol Violation|1|||
130218851|NCT03465709|468765091|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
130218852|NCT03465709|468765091|FG000|Overall Study|Withdrawal by Subject|3|||
130218853|NCT03060291|468765092|FG000|3-month Follow-up|Declined to respond|8|||
130218854|NCT03060291|468765093|FG001|3-month Follow-up|Declined to respond|10|||
130218855|NCT03060291|468765094|FG002|3-month Follow-up|Declined to respond|2|||
130218856|NCT03060291|468765092|FG000|6-month Follow-up|Declined to respond|7|||
130218857|NCT03060291|468765093|FG001|6-month Follow-up|Declined to respond|13|||
130218858|NCT03060291|468765094|FG002|6-month Follow-up|Declined to respond|4|||
130218859|NCT03060291|468765092|FG000|12-month Follow-up|Declined to respond|7|||
130218860|NCT03060291|468765093|FG001|12-month Follow-up|Declined to respond|16|||
130218861|NCT03060291|468765094|FG002|12-month Follow-up|Declined to respond|6|||
130218862|NCT01720524|468765095|FG000|Part A|Insufficient Clinical Response|2|||
130218863|NCT01720524|468765096|FG001|Part A|Insufficient Clinical Response|4|||
130218864|NCT01720524|468765095|FG000|Part A|Adverse Event|2|||
130218865|NCT01720524|468765096|FG001|Part A|Adverse Event|2|||
130218866|NCT01720524|468765095|FG000|Part A|Death|2|||
130218867|NCT01720524|468765096|FG001|Part A|Death|1|||
130218868|NCT01720524|468765095|FG000|Part A|Lost to Follow-up|0|||
130218869|NCT01720524|468765096|FG001|Part A|Lost to Follow-up|1|||
130218870|NCT01720524|468765095|FG000|Part A|Missed 28 day follow-up visit|1|||
130218871|NCT01720524|468765096|FG001|Part A|Missed 28 day follow-up visit|1|||
130218872|NCT01720524|468765095|FG000|Part A|Withdrawal by Subject|0|||
130218873|NCT01720524|468765096|FG001|Part A|Withdrawal by Subject|1|||
130218874|NCT01720524|468765095|FG000|Part A|Other|0|||
130218875|NCT01720524|468765096|FG001|Part A|Other|1|||
130218876|NCT01720524|468765095|FG000|Part A|Lost to Follow-up|0|||
130218877|NCT01720524|468765096|FG001|Part A|Lost to Follow-up|1|||
130218878|NCT01720524|468765095|FG000|Part B|No longer willing to participate in study|1|||
130218879|NCT01720524|468765096|FG001|Part B|No longer willing to participate in study|4|||
130218880|NCT01720524|468765095|FG000|Part B|Other|2|||
130218881|NCT01720524|468765096|FG001|Part B|Other|0|||
130218882|NCT01720524|468765095|FG000|Part B|Lost to Follow-up|2|||
130218883|NCT01720524|468765096|FG001|Part B|Lost to Follow-up|3|||
130218884|NCT01720524|468765095|FG000|Part B|Death|0|||
130218885|NCT01720524|468765096|FG001|Part B|Death|2|||
130218886|NCT02105285|468765102|FG000|Overall Study|Adverse Event|1|||
130218887|NCT02105285|468765103|FG001|Overall Study|Adverse Event|1|||
130218888|NCT02105285|468765104|FG002|Overall Study|Adverse Event|0|||
130218889|NCT02105285|468765102|FG000|Overall Study|Protocol Violation|0|||
130218890|NCT02105285|468765103|FG001|Overall Study|Protocol Violation|1|||
130218891|NCT02105285|468765104|FG002|Overall Study|Protocol Violation|0|||
130218892|NCT02105285|468765102|FG000|Overall Study|Withdrawal by Subject|1|||
130218893|NCT02105285|468765103|FG001|Overall Study|Withdrawal by Subject|0|||
130017166|NCT00109707|468024414|FG001|Overall Study|Disease progression|4|||
130218894|NCT02105285|468765104|FG002|Overall Study|Withdrawal by Subject|0|||
130218895|NCT01421641|468765105|FG000|Overall Study|Protocol Violation|2|||
130218896|NCT01421641|468765106|FG001|Overall Study|Protocol Violation|2|||
130218897|NCT03061188|468765108|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
130218898|NCT03061188|468765109|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
130218899|NCT03061188|468765110|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
130218900|NCT03061188|468765111|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
130218901|NCT03061188|468765108|FG000|On Follow-up for 3 Years|Death|0|||
130218902|NCT03061188|468765109|FG001|On Follow-up for 3 Years|Death|3|||
130218903|NCT03061188|468765110|FG002|On Follow-up for 3 Years|Death|5|||
130218904|NCT03061188|468765111|FG003|On Follow-up for 3 Years|Death|4|||
130218905|NCT03061188|468765108|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130218906|NCT03061188|468765109|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130218907|NCT03061188|468765110|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
130218908|NCT03061188|468765111|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
130218909|NCT02609984|468765112|FG000|Overall Study|Death|29|||
130218910|NCT02609984|468765113|FG001|Overall Study|Death|26|||
130218911|NCT02609984|468765112|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
130218912|NCT02609984|468765113|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
130218913|NCT02609984|468765112|FG000|Overall Study|Lost to Follow-up|1|||
130218914|NCT02609984|468765113|FG001|Overall Study|Lost to Follow-up|2|||
130218915|NCT02609984|468765112|FG000|Overall Study|Withdrawal by Subject|0|||
130218916|NCT02609984|468765113|FG001|Overall Study|Withdrawal by Subject|1|||
130218917|NCT02609984|468765112|FG000|Overall Study|Disease Progression|2|||
130218918|NCT02609984|468765113|FG001|Overall Study|Disease Progression|0|||
130218919|NCT02504320|468765114|FG000|Treatment Period 1|Positive Drug Screen|0|||
130218920|NCT02504320|468765115|FG001|Treatment Period 1|Positive Drug Screen|0|||
130218921|NCT02504320|468765116|FG002|Treatment Period 1|Positive Drug Screen|1|||
130218922|NCT02504320|468765117|FG003|Treatment Period 1|Positive Drug Screen|0|||
130218923|NCT02504320|468765114|FG000|Treatment Period 2|Positive Drug Screen|0|||
130218924|NCT02504320|468765115|FG001|Treatment Period 2|Positive Drug Screen|1|||
130218925|NCT02504320|468765116|FG002|Treatment Period 2|Positive Drug Screen|0|||
130218926|NCT02504320|468765117|FG003|Treatment Period 2|Positive Drug Screen|0|||
130218927|NCT02504320|468765114|FG000|Treatment Period 3|Positive Drug Screen|0|||
130218928|NCT02504320|468765115|FG001|Treatment Period 3|Positive Drug Screen|0|||
130218929|NCT02504320|468765116|FG002|Treatment Period 3|Positive Drug Screen|0|||
130218930|NCT02504320|468765117|FG003|Treatment Period 3|Positive Drug Screen|1|||
130218931|NCT02504320|468765114|FG000|Treatment Period 3|Adverse Event|0|||
130218932|NCT02504320|468765115|FG001|Treatment Period 3|Adverse Event|0|||
130218933|NCT02504320|468765116|FG002|Treatment Period 3|Adverse Event|1|||
130218934|NCT02504320|468765117|FG003|Treatment Period 3|Adverse Event|0|||
130218935|NCT01210222|468765118|FG000|Overall Study|Ineligible|2|||
130218936|NCT01210222|468765118|FG000|Overall Study|Never treated|1|||
130218937|NCT03293394|468765119|FG000|Follow-up (6 Months)|Adverse Event|4|||
130218938|NCT03293394|468765120|FG001|Follow-up (6 Months)|Adverse Event|2|||
130218939|NCT00436826|468765123|FG000|Double Blind Period (DBP)|Adverse Event|2|||
130218940|NCT00436826|468765124|FG001|Double Blind Period (DBP)|Adverse Event|0|||
130218941|NCT00436826|468765125|FG002|Double Blind Period (DBP)|Adverse Event|0|||
130218942|NCT00436826|468765126|FG003|Double Blind Period (DBP)|Adverse Event|0|||
130218943|NCT00436826|468765127|FG004|Double Blind Period (DBP)|Adverse Event|0|||
130218944|NCT00436826|468765128|FG005|Double Blind Period (DBP)|Adverse Event|0|||
130218945|NCT00436826|468765123|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
130218946|NCT00436826|468765124|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
130218947|NCT00436826|468765125|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
130218948|NCT00436826|468765126|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
130218949|NCT00436826|468765127|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
130017167|NCT00109707|468024415|FG002|Overall Study|Disease progression|3|||
130218950|NCT00436826|468765128|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
130218951|NCT00436826|468765123|FG000|Double Blind Period (DBP)|Other|10|||
130017168|NCT00109707|468024413|FG000|Overall Study|Lost to Follow-up|3|||
130017169|NCT00109707|468024414|FG001|Overall Study|Lost to Follow-up|0|||
130017170|NCT00109707|468024415|FG002|Overall Study|Lost to Follow-up|0|||
130017171|NCT00109707|468024413|FG000|Overall Study|Protocol Violation|1|||
130017172|NCT00109707|468024414|FG001|Overall Study|Protocol Violation|0|||
130017173|NCT00109707|468024415|FG002|Overall Study|Protocol Violation|0|||
130017174|NCT00109707|468024413|FG000|Overall Study|Patient withdrew consent|6|||
130218952|NCT00436826|468765124|FG001|Double Blind Period (DBP)|Other|11|||
130017175|NCT00109707|468024414|FG001|Overall Study|Patient withdrew consent|1|||
130017176|NCT00109707|468024415|FG002|Overall Study|Patient withdrew consent|0|||
130218953|NCT00436826|468765125|FG002|Double Blind Period (DBP)|Other|0|||
130218954|NCT00436826|468765126|FG003|Double Blind Period (DBP)|Other|0|||
130218955|NCT00436826|468765127|FG004|Double Blind Period (DBP)|Other|0|||
130218956|NCT00436826|468765128|FG005|Double Blind Period (DBP)|Other|0|||
130218957|NCT00436826|468765123|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218958|NCT00436826|468765124|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218959|NCT00436826|468765125|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218960|NCT00436826|468765126|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
130218961|NCT00436826|468765127|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218962|NCT00436826|468765128|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
130218963|NCT00436826|468765123|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218964|NCT00436826|468765124|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218965|NCT00436826|468765125|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
130218966|NCT00436826|468765126|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
130218967|NCT00436826|468765127|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218968|NCT00436826|468765128|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
130218969|NCT00436826|468765123|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218970|NCT00436826|468765124|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218971|NCT00436826|468765125|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218972|NCT00436826|468765126|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
130218973|NCT00436826|468765127|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
130218974|NCT00436826|468765128|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
130218975|NCT04978337|468765129|FG000|Overall Study|Withdrawal by Subject|0|||
130218976|NCT04978337|468765130|FG001|Overall Study|Withdrawal by Subject|1|||
130218977|NCT01436227|468765132|FG000|Overall Study|Adverse Event|7|||
130218978|NCT01436227|468765132|FG000|Overall Study|Death|1|||
130218979|NCT01436227|468765132|FG000|Overall Study|Lack of Efficacy|1|||
130218980|NCT01436227|468765132|FG000|Overall Study|Lost to Follow-up|3|||
130218981|NCT01436227|468765132|FG000|Overall Study|Physician Decision|1|||
130218982|NCT01436227|468765132|FG000|Overall Study|Withdrawal by Subject|7|||
130218983|NCT01436227|468765132|FG000|Overall Study|Disease progression, relapse|6|||
130218984|NCT00869128|468765138|FG000|Overall Study|lack of Compliance|6|||
130218985|NCT00869128|468765139|FG001|Overall Study|lack of Compliance|6|||
130218986|NCT02282163|468765151|FG000|Overall Study|Protocol Violation|1|||
130218987|NCT01603407|468765152|FG000|Overall Study|Adverse Event|1|||
130218988|NCT01603407|468765153|FG001|Overall Study|Adverse Event|1|||
130218989|NCT01603407|468765154|FG002|Overall Study|Adverse Event|1|||
130218990|NCT01603407|468765152|FG000|Overall Study|Protocol Violation|2|||
130218991|NCT01603407|468765153|FG001|Overall Study|Protocol Violation|2|||
130218992|NCT01603407|468765154|FG002|Overall Study|Protocol Violation|0|||
130218993|NCT01603407|468765152|FG000|Overall Study|Withdrawal by Subject|8|||
130218994|NCT01603407|468765153|FG001|Overall Study|Withdrawal by Subject|5|||
130218995|NCT01603407|468765154|FG002|Overall Study|Withdrawal by Subject|7|||
130218996|NCT01603407|468765152|FG000|Overall Study|Lost to Follow-up|0|||
130218997|NCT01603407|468765153|FG001|Overall Study|Lost to Follow-up|3|||
130218998|NCT01603407|468765154|FG002|Overall Study|Lost to Follow-up|2|||
130218999|NCT02500719|468765155|FG000|Overall Study|Lost to Follow-up|2|||
130219000|NCT02500719|468765156|FG001|Overall Study|Lost to Follow-up|3|||
130098775|NCT03426995|468319302|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
130219001|NCT02500719|468765155|FG000|Overall Study|Trauma history|1|||
130219002|NCT02500719|468765156|FG001|Overall Study|Trauma history|0|||
130219003|NCT02500719|468765155|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
130219004|NCT02500719|468765156|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
130219005|NCT02500719|468765155|FG000|Overall Study|Did not meet criteria for PTSD|0|||
130219006|NCT02500719|468765156|FG001|Overall Study|Did not meet criteria for PTSD|1|||
130219007|NCT02500719|468765155|FG000|Overall Study|Claustrophobia|0|||
130219008|NCT02500719|468765156|FG001|Overall Study|Claustrophobia|1|||
130219009|NCT02500719|468765155|FG000|Overall Study|History of head trauma|0|||
130219010|NCT02500719|468765156|FG001|Overall Study|History of head trauma|1|||
130219011|NCT01990768|468765157|FG000|Intervention Started|Found to be ineligible|14|||
130219012|NCT01990768|468765158|FG001|Intervention Started|Found to be ineligible|13|||
130219013|NCT01990768|468765159|FG002|Intervention Started|Found to be ineligible|11|||
130219014|NCT01990768|468765157|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
130219015|NCT01990768|468765158|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
130219016|NCT01990768|468765159|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
130219017|NCT01990768|468765157|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
130219018|NCT01990768|468765158|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
130219019|NCT01990768|468765159|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
130219020|NCT01990768|468765157|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
130219021|NCT01990768|468765158|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
130017177|NCT02250274|468024417|FG000|Overall Study|Insufficient blood draw amount|7|||
130219022|NCT01990768|468765159|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
130219023|NCT01990768|468765157|FG000|Intervention Started|Patient care priority|1|||
130219024|NCT01990768|468765158|FG001|Intervention Started|Patient care priority|2|||
130219025|NCT01990768|468765159|FG002|Intervention Started|Patient care priority|3|||
130219026|NCT01990768|468765157|FG000|Intervention Started|IV lost|2|||
130219027|NCT01990768|468765158|FG001|Intervention Started|IV lost|2|||
130219028|NCT01990768|468765159|FG002|Intervention Started|IV lost|2|||
130219029|NCT01990768|468765157|FG000|Intervention Started|Required CPR|1|||
130219030|NCT01990768|468765158|FG001|Intervention Started|Required CPR|1|||
130219031|NCT01990768|468765159|FG002|Intervention Started|Required CPR|0|||
130219032|NCT01990768|468765157|FG000|Intervention Started|Seizure or hx of seizure|0|||
130219033|NCT01990768|468765158|FG001|Intervention Started|Seizure or hx of seizure|0|||
130219034|NCT01990768|468765159|FG002|Intervention Started|Seizure or hx of seizure|2|||
130219035|NCT01990768|468765157|FG000|Intervention Started|Discovered to be pregnant|0|||
130219036|NCT01990768|468765158|FG001|Intervention Started|Discovered to be pregnant|1|||
130219037|NCT01990768|468765159|FG002|Intervention Started|Discovered to be pregnant|0|||
130219038|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
130219039|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
130219040|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
130219041|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
130219042|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
130219043|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
130219044|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
130219045|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
130219046|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
130219047|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
130219048|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
130219049|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
130219050|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Death|3|||
130219051|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Death|1|||
130219052|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Death|1|||
130219053|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Discharged|2|||
130219054|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Discharged|1|||
130219055|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Discharged|0|||
130219056|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
130219057|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
130219058|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
130219059|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
130219060|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
130219061|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
130219062|NCT01990768|468765157|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
130219063|NCT01990768|468765158|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
130219064|NCT01990768|468765159|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
130219065|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
130219066|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
130219067|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
130219068|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
130219069|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
130219070|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
130219071|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
130219072|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
130219073|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
130219074|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
130219075|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
130219076|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
130219077|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
130219078|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
130219079|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
130219080|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
130219081|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
130219082|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
130219083|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
130219084|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
130219085|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
130219086|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
130219087|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
130219088|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
130219089|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
130219090|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
130219091|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
130219092|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
130219093|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
130219094|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
130219095|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130219096|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130219097|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
130219098|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
130219099|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
130219100|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
130219101|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
130219102|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
130219103|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
130219104|NCT01990768|468765157|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
130219105|NCT01990768|468765158|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
130219106|NCT01990768|468765159|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
130219107|NCT01990768|468765157|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
130219108|NCT01990768|468765158|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
130219109|NCT01990768|468765159|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
130219110|NCT01990768|468765157|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
130219111|NCT01990768|468765158|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
130219112|NCT01990768|468765159|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
130219113|NCT01990768|468765157|FG000|6-Month Follow-up|No contact information|5|||
130219114|NCT01990768|468765158|FG001|6-Month Follow-up|No contact information|6|||
130219115|NCT01990768|468765159|FG002|6-Month Follow-up|No contact information|5|||
130219116|NCT01990768|468765157|FG000|6-Month Follow-up|Homeless|4|||
130219117|NCT01990768|468765158|FG001|6-Month Follow-up|Homeless|3|||
130219118|NCT01990768|468765159|FG002|6-Month Follow-up|Homeless|6|||
130219119|NCT01990768|468765157|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
130219120|NCT01990768|468765158|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
130219121|NCT01990768|468765159|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
130219122|NCT01990768|468765157|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
130219123|NCT01990768|468765158|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
130219124|NCT01990768|468765159|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
130219125|NCT01990768|468765157|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
130219126|NCT01990768|468765158|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
130219127|NCT01990768|468765159|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
130219128|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
130219129|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130219130|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130219131|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
130219132|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
130219133|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130219134|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130219135|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
130219136|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
130219137|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130219138|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130219139|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
130219140|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
130219141|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130219142|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130219143|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
130219144|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
130219145|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130219146|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130219147|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
130219148|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
130219149|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130219150|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130219151|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
130219152|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
130219153|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130219154|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130219155|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
130219156|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
130219157|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130219158|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130219159|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
130219160|NCT03538691|468765160|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
130219161|NCT03538691|468765161|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130219162|NCT03538691|468765162|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130219163|NCT03538691|468765163|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
130219164|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130219165|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
130219166|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130219167|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
130219168|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130219169|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
130219170|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130219171|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
130219172|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130219173|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
130219174|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130219175|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
130219176|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130219177|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
130219178|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130219179|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
130219180|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130219181|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
130219182|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130219183|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
130219184|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130219185|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
130219186|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130219187|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
130219188|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130219189|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
130219190|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130219191|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
130219192|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130219193|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
130219194|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130219195|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
130219196|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130219197|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
130219198|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130219199|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
130219200|NCT03538691|468765160|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219201|NCT03538691|468765161|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
130219202|NCT03538691|468765162|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219203|NCT03538691|468765163|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219204|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
130219205|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
130219206|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
130219207|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
130219208|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
130219209|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
130219210|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
130219211|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
130219212|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
130219213|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
130219214|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
130219215|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
130219216|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
130219217|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
130219218|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
130017178|NCT02250274|468024418|FG001|Overall Study|Insufficient blood draw amount|6|||
130017179|NCT01277549|468024419|FG000|Overall Study|Failed to meet eligibility criteria|13|||
130017180|NCT01277549|468024420|FG001|Overall Study|Failed to meet eligibility criteria|9|||
130017181|NCT01277549|468024419|FG000|Overall Study|Withdrawal by Subject|1|||
130219219|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
130219220|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
130219221|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
130219222|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
130219223|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
130219224|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130219225|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130219226|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
130219227|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
130219228|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
130219229|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
130219230|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
130219231|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
130219232|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130219233|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130219234|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
130219235|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
130219236|NCT03538691|468765160|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219237|NCT03538691|468765161|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
130219238|NCT03538691|468765162|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
130219239|NCT03538691|468765163|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
130219240|NCT06597084|468765164|FG000|Overall Study|Withdrawal by Subject|4|||
130219241|NCT06597084|468765165|FG001|Overall Study|Withdrawal by Subject|9|||
130219242|NCT06597084|468765164|FG000|Overall Study|Consent was not given by the patient until V2|0|||
130219243|NCT06597084|468765165|FG001|Overall Study|Consent was not given by the patient until V2|3|||
130219244|NCT06597084|468765164|FG000|Overall Study|Physician Decision|1|||
130219245|NCT06597084|468765165|FG001|Overall Study|Physician Decision|0|||
130219246|NCT06597084|468765164|FG000|Overall Study|Adverse Event|3|||
130219247|NCT06597084|468765165|FG001|Overall Study|Adverse Event|2|||
130219248|NCT06597084|468765164|FG000|Overall Study|Death|4|||
130219249|NCT06597084|468765165|FG001|Overall Study|Death|0|||
130219250|NCT06597084|468765164|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
130219251|NCT06597084|468765165|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
130219252|NCT06597084|468765164|FG000|Overall Study|Lost to Follow-up|4|||
130219253|NCT06597084|468765165|FG001|Overall Study|Lost to Follow-up|2|||
130219254|NCT06597084|468765164|FG000|Overall Study|Other. Not specified|1|||
130219255|NCT06597084|468765165|FG001|Overall Study|Other. Not specified|0|||
130219256|NCT02029274|468765171|FG000|Overall Study|Adverse Event|1|||
130219257|NCT02029274|468765172|FG001|Overall Study|Adverse Event|0|||
130219258|NCT02029274|468765173|FG002|Overall Study|Adverse Event|2|||
130219259|NCT02029274|468765174|FG003|Overall Study|Adverse Event|2|||
130219260|NCT05251233|468766829|FG000|Overall Study|Disease progression - did not start treatment|0|||
130219261|NCT05251233|468766830|FG001|Overall Study|Disease progression - did not start treatment|0|||
130219262|NCT05251233|468766831|FG002|Overall Study|Disease progression - did not start treatment|5|||
130219263|NCT05251233|468766829|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
130219264|NCT05251233|468766830|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
130219265|NCT05251233|468766831|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
130219266|NCT05251233|468766829|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
130219267|NCT05251233|468766830|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
130219268|NCT05251233|468766831|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
130219269|NCT05251233|468766829|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
130219270|NCT05251233|468766830|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
130219271|NCT05251233|468766831|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
130219272|NCT05251233|468766829|FG000|Overall Study|Death - did not start treatment|3|||
130219273|NCT05251233|468766830|FG001|Overall Study|Death - did not start treatment|0|||
130219274|NCT05251233|468766831|FG002|Overall Study|Death - did not start treatment|0|||
130219275|NCT05251233|468766829|FG000|Overall Study|Withdrawal by Subject|2|||
130219276|NCT05251233|468766830|FG001|Overall Study|Withdrawal by Subject|2|||
130219277|NCT05251233|468766831|FG002|Overall Study|Withdrawal by Subject|0|||
130219278|NCT05251233|468766829|FG000|Overall Study|Other complicating disease|2|||
130219279|NCT05251233|468766830|FG001|Overall Study|Other complicating disease|1|||
130219280|NCT05251233|468766831|FG002|Overall Study|Other complicating disease|0|||
130219281|NCT05251233|468766829|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
130219282|NCT05251233|468766830|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
130219283|NCT05251233|468766831|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
130219284|NCT05251233|468766829|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
130219285|NCT05251233|468766830|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
130219286|NCT05251233|468766831|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
130219287|NCT03272347|468766836|FG000|Overall Study|Death|0|||
130219288|NCT03272347|468766837|FG001|Overall Study|Death|0|||
130219289|NCT03272347|468766838|FG002|Overall Study|Death|0|||
130219290|NCT03272347|468766839|FG003|Overall Study|Death|1|||
130219291|NCT03272347|468766836|FG000|Overall Study|Lost to Follow-up|1|||
130219292|NCT03272347|468766837|FG001|Overall Study|Lost to Follow-up|3|||
130219293|NCT03272347|468766838|FG002|Overall Study|Lost to Follow-up|5|||
130219294|NCT03272347|468766839|FG003|Overall Study|Lost to Follow-up|1|||
130219295|NCT03272347|468766836|FG000|Overall Study|Physician Decision|4|||
130219296|NCT03272347|468766837|FG001|Overall Study|Physician Decision|2|||
130219297|NCT03272347|468766838|FG002|Overall Study|Physician Decision|5|||
130219298|NCT03272347|468766839|FG003|Overall Study|Physician Decision|4|||
130219299|NCT03272347|468766836|FG000|Overall Study|Screen Failure|1|||
130219300|NCT03272347|468766837|FG001|Overall Study|Screen Failure|0|||
130219301|NCT03272347|468766838|FG002|Overall Study|Screen Failure|0|||
130219302|NCT03272347|468766839|FG003|Overall Study|Screen Failure|0|||
130219303|NCT03272347|468766836|FG000|Overall Study|Withdrawal by Subject|5|||
130219304|NCT03272347|468766837|FG001|Overall Study|Withdrawal by Subject|1|||
130219305|NCT03272347|468766838|FG002|Overall Study|Withdrawal by Subject|2|||
130219306|NCT03272347|468766839|FG003|Overall Study|Withdrawal by Subject|1|||
130219307|NCT00391872|468766842|FG000|Overall Study|Protocol Violation|7|||
130219308|NCT00391872|468766843|FG001|Overall Study|Protocol Violation|2|||
130219309|NCT00391872|468766842|FG000|Overall Study|Withdrawal by Subject|296|||
130219310|NCT00391872|468766843|FG001|Overall Study|Withdrawal by Subject|249|||
130219311|NCT00391872|468766842|FG000|Overall Study|Reason unknown|2|||
130219312|NCT00391872|468766843|FG001|Overall Study|Reason unknown|4|||
130219313|NCT00391872|468766842|FG000|Overall Study|Lost to Follow-up|2|||
130219314|NCT00391872|468766843|FG001|Overall Study|Lost to Follow-up|0|||
130219315|NCT00905632|468766845|FG000|Overall Study|Adverse Event|0|||
130219316|NCT00905632|468766846|FG001|Overall Study|Adverse Event|0|||
130219317|NCT00905632|468766847|FG002|Overall Study|Adverse Event|0|||
130219318|NCT00905632|468766848|FG003|Overall Study|Adverse Event|0|||
130219319|NCT00905632|468766849|FG004|Overall Study|Adverse Event|0|||
130219320|NCT00905632|468766850|FG005|Overall Study|Adverse Event|1|||
130219321|NCT00905632|468766851|FG006|Overall Study|Adverse Event|4|||
130219322|NCT01307891|468766853|FG000|Overall Study|Progressive Disease|3|||
130219323|NCT01307891|468766854|FG001|Overall Study|Progressive Disease|1|||
130219324|NCT02937740|468766855|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
130219325|NCT02937740|468766856|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
130219326|NCT02937740|468766855|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
130219327|NCT02937740|468766856|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
130219328|NCT02937740|468766855|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
130219329|NCT02937740|468766856|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
130219330|NCT02937740|468766855|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
130219331|NCT02937740|468766856|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
130219332|NCT02937740|468766855|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
130219333|NCT02937740|468766856|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
130219334|NCT02937740|468766855|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
130219335|NCT02937740|468766856|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
130219336|NCT00305227|468766859|FG000|Overall Study|Lost to Follow-up|7|||
130219337|NCT00305227|468766860|FG001|Overall Study|Lost to Follow-up|6|||
130017182|NCT01277549|468024420|FG001|Overall Study|Withdrawal by Subject|3|||
130017183|NCT01277549|468024419|FG000|Overall Study|Protocol Violation|10|||
130219338|NCT04085601|468766861|FG000|Overall Study|Lost to Follow-up|1|||
130219339|NCT04085601|468766862|FG001|Overall Study|Lost to Follow-up|0|||
130219340|NCT04085601|468766861|FG000|Overall Study|Death|1|||
130219341|NCT04085601|468766862|FG001|Overall Study|Death|1|||
130219342|NCT03492437|468766863|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130017184|NCT01277549|468024420|FG001|Overall Study|Protocol Violation|1|||
130219343|NCT03492437|468766864|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130219344|NCT02915159|468766866|FG000|Overall Study|Participant no longer meets criteria|2|||
130219345|NCT02915159|468766867|FG001|Overall Study|Participant no longer meets criteria|0|||
130219346|NCT02915159|468766866|FG000|Overall Study|poor/non-compliance|1|||
130219347|NCT02915159|468766867|FG001|Overall Study|poor/non-compliance|0|||
130219348|NCT02915159|468766866|FG000|Overall Study|Participant withdrew consent|5|||
130219349|NCT02915159|468766867|FG001|Overall Study|Participant withdrew consent|1|||
130219350|NCT02915159|468766866|FG000|Overall Study|Request to discontinue treatment|1|||
130219351|NCT02915159|468766867|FG001|Overall Study|Request to discontinue treatment|2|||
130219352|NCT02915159|468766866|FG000|Overall Study|Adverse Event|2|||
130219353|NCT02915159|468766867|FG001|Overall Study|Adverse Event|2|||
130219354|NCT02915159|468766866|FG000|Overall Study|Lack of Efficacy|0|||
130219355|NCT02915159|468766867|FG001|Overall Study|Lack of Efficacy|3|||
130219356|NCT04534517|468766868|FG000|Overall Study|Adverse Event|1|||
130219357|NCT04534517|468766868|FG000|Overall Study|Withdrawal by Subject|1|||
130219358|NCT04534517|468766868|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130219359|NCT04534517|468766868|FG000|Overall Study|COVID-19 Related|1|||
130219360|NCT03872843|468766869|FG000|Overall Study|Lost to Follow-up|5|||
130219361|NCT03872843|468766870|FG001|Overall Study|Lost to Follow-up|7|||
130219362|NCT00823264|468766871|FG000|Overall Study|Protocol Violation|2|||
130219363|NCT00823264|468766872|FG001|Overall Study|Protocol Violation|0|||
130219364|NCT05133323|468766873|FG000|Overall Study|Lack of Efficacy|0|||
130219365|NCT05133323|468766874|FG001|Overall Study|Lack of Efficacy|0|||
130219366|NCT05133323|468766875|FG002|Overall Study|Lack of Efficacy|1|||
130219367|NCT05133323|468766873|FG000|Overall Study|Withdrawal by Subject|2|||
130219368|NCT05133323|468766874|FG001|Overall Study|Withdrawal by Subject|1|||
130219369|NCT05133323|468766875|FG002|Overall Study|Withdrawal by Subject|0|||
130219370|NCT00113295|468766876|FG000|Overall Study|Adverse Event|4|||
130219371|NCT00113295|468766877|FG001|Overall Study|Adverse Event|1|||
130219372|NCT00113295|468766876|FG000|Overall Study|Unrelated Medical Illness|1|||
130219373|NCT00113295|468766877|FG001|Overall Study|Unrelated Medical Illness|0|||
130219374|NCT01714544|468766878|FG000|Overall Study|Lost to Follow-up|1|||
130219375|NCT01714544|468766878|FG000|Overall Study|Physician Decision|1|||
130219376|NCT01714544|468766878|FG000|Overall Study|Withdrawal by Subject|1|||
130219377|NCT02824224|468766887|FG000|Overall Study|Discontinued, IUS expulsion|0|||
130219378|NCT02824224|468766888|FG001|Overall Study|Discontinued, IUS expulsion|1|||
130219379|NCT02824224|468766887|FG000|Overall Study|Did not show up for allocation visit|2|||
130219380|NCT02824224|468766888|FG001|Overall Study|Did not show up for allocation visit|0|||
130219381|NCT02465437|468766895|FG000|Overall Study|Physician Decision|0|||
130219382|NCT02465437|468766896|FG001|Overall Study|Physician Decision|0|||
130219383|NCT02465437|468766897|FG002|Overall Study|Physician Decision|1|||
130219384|NCT02465437|468766898|FG003|Overall Study|Physician Decision|0|||
130219385|NCT02465437|468766895|FG000|Overall Study|Withdrawal by Subject|1|||
130219386|NCT02465437|468766896|FG001|Overall Study|Withdrawal by Subject|0|||
130219387|NCT02465437|468766897|FG002|Overall Study|Withdrawal by Subject|0|||
130219388|NCT02465437|468766898|FG003|Overall Study|Withdrawal by Subject|1|||
130219389|NCT02465437|468766895|FG000|Overall Study|Adverse Event|0|||
130219390|NCT02465437|468766896|FG001|Overall Study|Adverse Event|1|||
130219391|NCT02465437|468766897|FG002|Overall Study|Adverse Event|0|||
130219392|NCT02465437|468766898|FG003|Overall Study|Adverse Event|0|||
130219393|NCT00003483|468766899|FG000|Overall Study|Not evaluable|1|||
130219394|NCT02609386|468766902|FG000|Overall Study|Withdrawal by Subject|6|||
130219395|NCT02609386|468766903|FG001|Overall Study|Withdrawal by Subject|1|||
130219396|NCT02609386|468766902|FG000|Overall Study|Lost to Follow-up|3|||
130219397|NCT02609386|468766903|FG001|Overall Study|Lost to Follow-up|5|||
130219398|NCT02609386|468766902|FG000|Overall Study|Death|19|||
130219399|NCT02609386|468766903|FG001|Overall Study|Death|9|||
130219400|NCT02609386|468766902|FG000|Overall Study|Physician Decision|0|||
130219401|NCT02609386|468766903|FG001|Overall Study|Physician Decision|2|||
130219402|NCT01001520|468766913|FG000|Medication Period 1|Withdrawal by Subject|2|||
130219403|NCT01001520|468766914|FG001|Medication Period 1|Withdrawal by Subject|2|||
130219404|NCT01001520|468766913|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
130219405|NCT01001520|468766914|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
130219406|NCT01001520|468766913|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
130219407|NCT01001520|468766914|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
130219408|NCT01001520|468766913|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
130219409|NCT01001520|468766914|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
130219410|NCT01001520|468766913|FG000|Washout Period|Withdrawal by Subject|2|||
130219411|NCT01001520|468766914|FG001|Washout Period|Withdrawal by Subject|1|||
130219412|NCT01001520|468766913|FG000|Medication Period 2|Withdrawal by Subject|0|||
130219413|NCT01001520|468766914|FG001|Medication Period 2|Withdrawal by Subject|3|||
130219414|NCT00878800|468766930|FG000|Overall Study|Adverse Event|0|||
130219415|NCT00878800|468766931|FG001|Overall Study|Adverse Event|0|||
130219416|NCT00878800|468766932|FG002|Overall Study|Adverse Event|2|||
130219417|NCT00878800|468766933|FG003|Overall Study|Adverse Event|0|||
130219418|NCT00878800|468766934|FG004|Overall Study|Adverse Event|1|||
130219419|NCT00878800|468766930|FG000|Overall Study|Progressive disease|1|||
130219420|NCT00878800|468766931|FG001|Overall Study|Progressive disease|5|||
130219421|NCT00878800|468766932|FG002|Overall Study|Progressive disease|6|||
130219422|NCT00878800|468766933|FG003|Overall Study|Progressive disease|5|||
130219423|NCT00878800|468766934|FG004|Overall Study|Progressive disease|13|||
130219424|NCT00878800|468766930|FG000|Overall Study|Withdrew consent|1|||
130219425|NCT00878800|468766931|FG001|Overall Study|Withdrew consent|1|||
130219426|NCT00878800|468766932|FG002|Overall Study|Withdrew consent|0|||
130219427|NCT00878800|468766933|FG003|Overall Study|Withdrew consent|1|||
130219428|NCT00878800|468766934|FG004|Overall Study|Withdrew consent|1|||
130219429|NCT00878800|468766930|FG000|Overall Study|Death|0|||
130219430|NCT00878800|468766931|FG001|Overall Study|Death|0|||
130219431|NCT00878800|468766932|FG002|Overall Study|Death|1|||
130219432|NCT00878800|468766933|FG003|Overall Study|Death|0|||
130219433|NCT00878800|468766934|FG004|Overall Study|Death|0|||
130219434|NCT00878800|468766930|FG000|Overall Study|Other|1|||
130219435|NCT00878800|468766931|FG001|Overall Study|Other|1|||
130219436|NCT00878800|468766932|FG002|Overall Study|Other|0|||
130219437|NCT00878800|468766933|FG003|Overall Study|Other|0|||
130219438|NCT00878800|468766934|FG004|Overall Study|Other|1|||
130219439|NCT00613821|468766935|FG000|Overall Study|Withdrawal by Subject|1|||
130219440|NCT00613821|468766936|FG001|Overall Study|Withdrawal by Subject|0|||
130219441|NCT00613821|468766935|FG000|Overall Study|Physician Decision|1|||
130219442|NCT00613821|468766936|FG001|Overall Study|Physician Decision|1|||
130219443|NCT03318003|468766937|FG000|Overall Study|Withdrawal by Subject|1|||
130219444|NCT03318003|468766938|FG001|Overall Study|Withdrawal by Subject|1|||
130219445|NCT03318003|468766937|FG000|Overall Study|fetal loss|0|||
130219446|NCT03318003|468766938|FG001|Overall Study|fetal loss|1|||
130219447|NCT02302846|468766940|FG000|Overall Study|Withdrawal by Subject|1|||
130219448|NCT01468454|468766941|FG000|Overall Study|Did not have surgery after PET|9|||
130219449|NCT04435808|468766942|FG000|Overall Study|Study stopped by DSMB|0|||
130219450|NCT04435808|468766943|FG001|Overall Study|Study stopped by DSMB|1|||
130219451|NCT02620787|468766944|FG000|Overall Study|Adverse Event|1|||
130219452|NCT02620787|468766945|FG001|Overall Study|Adverse Event|0|||
130219453|NCT02620787|468766944|FG000|Overall Study|Eligibility Criteria Not Met|1|||
130219454|NCT02620787|468766945|FG001|Overall Study|Eligibility Criteria Not Met|0|||
130219455|NCT00807612|468766948|FG000|Overall Study|Death|8|||
130219456|NCT00807612|468766948|FG000|Overall Study|Study early termination|5|||
130219457|NCT00807612|468766948|FG000|Overall Study|Withdrawal by Subject|1|||
130219458|NCT02028507|468766950|FG000|Overall Study|Progressive Disease|122|||
130219459|NCT02028507|468766951|FG001|Overall Study|Progressive Disease|90|||
130219460|NCT02028507|468766952|FG002|Overall Study|Progressive Disease|102|||
130219461|NCT02028507|468766953|FG003|Overall Study|Progressive Disease|89|||
130219462|NCT02028507|468766950|FG000|Overall Study|Adverse Event|8|||
130219463|NCT02028507|468766951|FG001|Overall Study|Adverse Event|25|||
130219464|NCT02028507|468766952|FG002|Overall Study|Adverse Event|3|||
130219465|NCT02028507|468766953|FG003|Overall Study|Adverse Event|16|||
130219466|NCT02028507|468766950|FG000|Overall Study|Withdrawal by Subject|6|||
130219467|NCT02028507|468766951|FG001|Overall Study|Withdrawal by Subject|8|||
130219468|NCT02028507|468766952|FG002|Overall Study|Withdrawal by Subject|5|||
130219469|NCT02028507|468766953|FG003|Overall Study|Withdrawal by Subject|9|||
130219470|NCT02028507|468766950|FG000|Overall Study|Protocol Violation|2|||
130219471|NCT02028507|468766951|FG001|Overall Study|Protocol Violation|4|||
130219472|NCT02028507|468766952|FG002|Overall Study|Protocol Violation|1|||
130219473|NCT02028507|468766953|FG003|Overall Study|Protocol Violation|3|||
130219474|NCT02028507|468766950|FG000|Overall Study|Physician Decision|0|||
130219475|NCT02028507|468766951|FG001|Overall Study|Physician Decision|4|||
130017185|NCT01277549|468024419|FG000|Overall Study|Physician Decision|2|||
130219476|NCT02028507|468766952|FG002|Overall Study|Physician Decision|0|||
130219477|NCT02028507|468766953|FG003|Overall Study|Physician Decision|0|||
130219478|NCT02028507|468766950|FG000|Overall Study|Death|1|||
130219479|NCT02028507|468766951|FG001|Overall Study|Death|0|||
130219480|NCT02028507|468766952|FG002|Overall Study|Death|1|||
130219481|NCT02028507|468766953|FG003|Overall Study|Death|3|||
130219482|NCT02028507|468766950|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
130219483|NCT02028507|468766951|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
130219484|NCT02028507|468766952|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
130219485|NCT02028507|468766953|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
130219486|NCT02028507|468766950|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
130219487|NCT02028507|468766951|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
130219488|NCT02028507|468766952|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
130219489|NCT02028507|468766953|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
130219490|NCT02028507|468766950|FG000|Overall Study|Randomized But Not Treated|3|||
130219491|NCT02028507|468766951|FG001|Overall Study|Randomized But Not Treated|6|||
130219492|NCT02028507|468766952|FG002|Overall Study|Randomized But Not Treated|0|||
130219493|NCT02028507|468766953|FG003|Overall Study|Randomized But Not Treated|4|||
130219494|NCT02028507|468766950|FG000|Overall Study|Enzyme defect|0|||
130219495|NCT02028507|468766951|FG001|Overall Study|Enzyme defect|0|||
130219496|NCT02028507|468766952|FG002|Overall Study|Enzyme defect|0|||
130219497|NCT02028507|468766953|FG003|Overall Study|Enzyme defect|1|||
130219498|NCT02028507|468766950|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130219499|NCT02028507|468766951|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130219500|NCT02028507|468766952|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
130219501|NCT02028507|468766953|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
130219502|NCT02028507|468766950|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
130219503|NCT02028507|468766951|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
130219504|NCT02028507|468766952|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
130219505|NCT02028507|468766953|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
130219506|NCT02258659|468766954|FG000|Overall Study|Withdrawal by Subject|1|||
130219507|NCT04892446|468766955|FG000|Overall Study|Death|4|||
130219508|NCT04892446|468766956|FG001|Overall Study|Death|4|||
130219509|NCT04892446|468766957|FG002|Overall Study|Death|0|||
130219510|NCT04892446|468766955|FG000|Overall Study|Withdrew consent|3|||
130219511|NCT04892446|468766956|FG001|Overall Study|Withdrew consent|0|||
130219512|NCT04892446|468766957|FG002|Overall Study|Withdrew consent|1|||
130219513|NCT04892446|468766955|FG000|Overall Study|Investigator's discretion|1|||
130219514|NCT04892446|468766956|FG001|Overall Study|Investigator's discretion|1|||
130219515|NCT04892446|468766957|FG002|Overall Study|Investigator's discretion|0|||
130219516|NCT04892446|468766955|FG000|Overall Study|Study terminated by sponsor|0|||
130219517|NCT04892446|468766956|FG001|Overall Study|Study terminated by sponsor|0|||
130219518|NCT04892446|468766957|FG002|Overall Study|Study terminated by sponsor|2|||
130219519|NCT00272844|468766958|FG000|Overall Study|Withdrawal by Subject|5|||
130219520|NCT00705341|468766962|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
130219521|NCT00705341|468766963|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
130219522|NCT00705341|468766964|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
130219523|NCT00705341|468766965|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
130219524|NCT00705341|468766962|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130219525|NCT00705341|468766963|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130219526|NCT00705341|468766964|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
130219527|NCT00705341|468766965|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
130219528|NCT00791700|468766966|FG000|Overall Study|Insufficient clinical response|1|||
130219529|NCT00791700|468766967|FG001|Overall Study|Insufficient clinical response|4|||
130219530|NCT00791700|468766968|FG002|Overall Study|Insufficient clinical response|1|||
130219531|NCT00791700|468766969|FG003|Overall Study|Insufficient clinical response|8|||
130219532|NCT00791700|468766966|FG000|Overall Study|No longer willing to participate|1|||
130219533|NCT00791700|468766967|FG001|Overall Study|No longer willing to participate|1|||
130219534|NCT00791700|468766968|FG002|Overall Study|No longer willing to participate|0|||
130219535|NCT00791700|468766969|FG003|Overall Study|No longer willing to participate|8|||
130219536|NCT00791700|468766966|FG000|Overall Study|Non-compliance with study treatment|0|||
130219537|NCT00791700|468766967|FG001|Overall Study|Non-compliance with study treatment|2|||
130219538|NCT00791700|468766968|FG002|Overall Study|Non-compliance with study treatment|0|||
130219539|NCT00791700|468766969|FG003|Overall Study|Non-compliance with study treatment|4|||
130219540|NCT00791700|468766966|FG000|Overall Study|Withdrawn due to pregnancy|0|||
130219541|NCT00791700|468766967|FG001|Overall Study|Withdrawn due to pregnancy|0|||
130219542|NCT00791700|468766968|FG002|Overall Study|Withdrawn due to pregnancy|0|||
130219543|NCT00791700|468766969|FG003|Overall Study|Withdrawn due to pregnancy|1|||
130219544|NCT00791700|468766966|FG000|Overall Study|Other|0|||
130219545|NCT00791700|468766967|FG001|Overall Study|Other|1|||
130219546|NCT00791700|468766968|FG002|Overall Study|Other|0|||
130219547|NCT00791700|468766969|FG003|Overall Study|Other|1|||
130219548|NCT00791700|468766966|FG000|Overall Study|Death|0|||
130219549|NCT00791700|468766967|FG001|Overall Study|Death|0|||
130098776|NCT03426995|468319303|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130219550|NCT00791700|468766968|FG002|Overall Study|Death|0|||
130219551|NCT00791700|468766969|FG003|Overall Study|Death|1|||
130219552|NCT00791700|468766966|FG000|Overall Study|Lost to Follow-up|4|||
130219553|NCT00791700|468766967|FG001|Overall Study|Lost to Follow-up|3|||
130219554|NCT00791700|468766968|FG002|Overall Study|Lost to Follow-up|4|||
130219555|NCT00791700|468766969|FG003|Overall Study|Lost to Follow-up|6|||
130219556|NCT00791700|468766966|FG000|Overall Study|Adverse Event|0|||
130219557|NCT00791700|468766967|FG001|Overall Study|Adverse Event|0|||
130219558|NCT00791700|468766968|FG002|Overall Study|Adverse Event|1|||
130219559|NCT00791700|468766969|FG003|Overall Study|Adverse Event|1|||
130219560|NCT00527826|468766972|FG000|Overall Study|Adverse Event|10|||
130219561|NCT00527826|468766973|FG001|Overall Study|Adverse Event|10|||
130219562|NCT00527826|468766972|FG000|Overall Study|Lost to Follow-up|3|||
130219563|NCT00527826|468766973|FG001|Overall Study|Lost to Follow-up|2|||
130219564|NCT00527826|468766972|FG000|Overall Study|Withdrawal by Subject|5|||
130219565|NCT00527826|468766973|FG001|Overall Study|Withdrawal by Subject|8|||
130219566|NCT00527826|468766972|FG000|Overall Study|Inclusion Criteria Not Met|3|||
130219567|NCT00527826|468766973|FG001|Overall Study|Inclusion Criteria Not Met|3|||
130219568|NCT00527826|468766972|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
130219569|NCT00527826|468766973|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
130219570|NCT00527826|468766972|FG000|Overall Study|Additional Intake of Viani forte|0|||
130219571|NCT00527826|468766973|FG001|Overall Study|Additional Intake of Viani forte|1|||
130219572|NCT00527826|468766972|FG000|Overall Study|Participant moved away|0|||
130219573|NCT00527826|468766973|FG001|Overall Study|Participant moved away|1|||
130219574|NCT01808261|468766974|FG000|Overall Study|Physician Decision|0|||
130219575|NCT01808261|468766975|FG001|Overall Study|Physician Decision|2|||
130219576|NCT01808261|468766974|FG000|Overall Study|Study Closed/Terminated|25|||
130219577|NCT01808261|468766975|FG001|Overall Study|Study Closed/Terminated|23|||
130219578|NCT01808261|468766974|FG000|Overall Study|Adverse event, non-fatal|2|||
130219579|NCT01808261|468766975|FG001|Overall Study|Adverse event, non-fatal|0|||
130219580|NCT01808261|468766974|FG000|Overall Study|Consent withdrawn by subject|6|||
130219581|NCT01808261|468766975|FG001|Overall Study|Consent withdrawn by subject|7|||
130219582|NCT01808261|468766974|FG000|Overall Study|Lost to Follow-up|3|||
130219583|NCT01808261|468766975|FG001|Overall Study|Lost to Follow-up|1|||
130219584|NCT01737879|468766980|FG000|Overall Study|Death|1|||
130219585|NCT01737879|468766980|FG000|Overall Study|Sponsor decision|40|||
130219586|NCT02497404|468766981|FG000|Overall Study|Adverse Event|1|||
130219587|NCT05568797|468766988|FG000|Overall Study|Adverse Event|0|||
130219588|NCT05568797|468766989|FG001|Overall Study|Adverse Event|8|||
130219589|NCT05568797|468766988|FG000|Overall Study|Lost to Follow-up|2|||
130219590|NCT05568797|468766989|FG001|Overall Study|Lost to Follow-up|3|||
130219591|NCT05568797|468766988|FG000|Overall Study|Withdrawal by Subject|1|||
130219592|NCT05568797|468766989|FG001|Overall Study|Withdrawal by Subject|10|||
130219593|NCT05568797|468766988|FG000|Overall Study|Other|2|||
130219594|NCT05568797|468766989|FG001|Overall Study|Other|2|||
130219595|NCT03131687|468766990|FG000|Overall Study|Adverse Event|0|||
130219596|NCT03131687|468766991|FG001|Overall Study|Adverse Event|1|||
130219597|NCT03131687|468766992|FG002|Overall Study|Adverse Event|0|||
130219598|NCT03131687|468766993|FG003|Overall Study|Adverse Event|1|||
130219599|NCT03131687|468766994|FG004|Overall Study|Adverse Event|2|||
130219600|NCT03131687|468766995|FG005|Overall Study|Adverse Event|2|||
130219601|NCT03131687|468766990|FG000|Overall Study|Death|1|||
130219602|NCT03131687|468766991|FG001|Overall Study|Death|0|||
130219603|NCT03131687|468766992|FG002|Overall Study|Death|0|||
130219604|NCT03131687|468766993|FG003|Overall Study|Death|0|||
130219605|NCT03131687|468766994|FG004|Overall Study|Death|0|||
130219606|NCT03131687|468766995|FG005|Overall Study|Death|0|||
130219607|NCT03131687|468766990|FG000|Overall Study|Withdrawal by Subject|3|||
130219608|NCT03131687|468766991|FG001|Overall Study|Withdrawal by Subject|3|||
130219609|NCT03131687|468766992|FG002|Overall Study|Withdrawal by Subject|3|||
130219610|NCT03131687|468766993|FG003|Overall Study|Withdrawal by Subject|1|||
130219611|NCT03131687|468766994|FG004|Overall Study|Withdrawal by Subject|2|||
130219612|NCT03131687|468766995|FG005|Overall Study|Withdrawal by Subject|1|||
130219613|NCT03131687|468766990|FG000|Overall Study|Lost to Follow-up|1|||
130219614|NCT03131687|468766991|FG001|Overall Study|Lost to Follow-up|4|||
130219615|NCT03131687|468766992|FG002|Overall Study|Lost to Follow-up|0|||
130219616|NCT03131687|468766993|FG003|Overall Study|Lost to Follow-up|1|||
130219617|NCT03131687|468766994|FG004|Overall Study|Lost to Follow-up|4|||
130219618|NCT03131687|468766995|FG005|Overall Study|Lost to Follow-up|2|||
130219619|NCT03131687|468766990|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
130219620|NCT03131687|468766991|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
130219621|NCT03131687|468766992|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
130219622|NCT03131687|468766993|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
130219623|NCT03131687|468766994|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
130219624|NCT03131687|468766995|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
130219625|NCT03131687|468766990|FG000|Overall Study|Principle Investigator Decision|0|||
130219626|NCT03131687|468766991|FG001|Overall Study|Principle Investigator Decision|1|||
130219627|NCT03131687|468766992|FG002|Overall Study|Principle Investigator Decision|0|||
130219628|NCT03131687|468766993|FG003|Overall Study|Principle Investigator Decision|0|||
130219629|NCT03131687|468766994|FG004|Overall Study|Principle Investigator Decision|0|||
130219630|NCT03131687|468766995|FG005|Overall Study|Principle Investigator Decision|0|||
130219631|NCT03131687|468766990|FG000|Overall Study|Inadvertent Enrollment|0|||
130219632|NCT03131687|468766991|FG001|Overall Study|Inadvertent Enrollment|0|||
130219633|NCT03131687|468766992|FG002|Overall Study|Inadvertent Enrollment|0|||
130219634|NCT03131687|468766993|FG003|Overall Study|Inadvertent Enrollment|1|||
130219635|NCT03131687|468766994|FG004|Overall Study|Inadvertent Enrollment|0|||
130219636|NCT03131687|468766995|FG005|Overall Study|Inadvertent Enrollment|0|||
130219637|NCT02998996|468766996|FG000|Overall Study|Lost to Follow-up|0|||
130219638|NCT02998996|468766997|FG001|Overall Study|Lost to Follow-up|0|||
130219639|NCT02998996|468766998|FG002|Overall Study|Lost to Follow-up|1|||
130219640|NCT02998996|468766999|FG003|Overall Study|Lost to Follow-up|0|||
130219641|NCT02998996|468767000|FG004|Overall Study|Lost to Follow-up|0|||
130219642|NCT02998996|468767001|FG005|Overall Study|Lost to Follow-up|0|||
130219643|NCT02998996|468766996|FG000|Overall Study|Pregnancy|0|||
130219644|NCT02998996|468766997|FG001|Overall Study|Pregnancy|1|||
130219645|NCT02998996|468766998|FG002|Overall Study|Pregnancy|0|||
130219646|NCT02998996|468766999|FG003|Overall Study|Pregnancy|0|||
130219647|NCT02998996|468767000|FG004|Overall Study|Pregnancy|0|||
130219648|NCT02998996|468767001|FG005|Overall Study|Pregnancy|0|||
130219649|NCT02998996|468766996|FG000|Overall Study|Family reasons|0|||
130219650|NCT02998996|468766997|FG001|Overall Study|Family reasons|0|||
130219651|NCT02998996|468766998|FG002|Overall Study|Family reasons|0|||
130219652|NCT02998996|468766999|FG003|Overall Study|Family reasons|0|||
130219653|NCT02998996|468767000|FG004|Overall Study|Family reasons|1|||
130219654|NCT02998996|468767001|FG005|Overall Study|Family reasons|0|||
130219655|NCT01118663|468767002|FG000|Overall Study|Adverse Event|2|||
130219656|NCT01118663|468767003|FG001|Overall Study|Adverse Event|1|||
130219657|NCT01118663|468767002|FG000|Overall Study|Withdrawal by Subject|0|||
130219658|NCT01118663|468767003|FG001|Overall Study|Withdrawal by Subject|1|||
130219659|NCT05279131|468767004|FG000|Overall Study|Lost to Follow-up|1|||
130219660|NCT05279131|468767004|FG000|Overall Study|Death|1|||
130219661|NCT05279131|468767004|FG000|Overall Study|Physician Decision|1|||
130219662|NCT01066871|468767007|FG000|Overall Study|Lost to Follow-up|0|||
130219663|NCT01066871|468767008|FG001|Overall Study|Lost to Follow-up|2|||
130219664|NCT01066871|468767009|FG002|Overall Study|Lost to Follow-up|2|||
130219665|NCT01066871|468767010|FG003|Overall Study|Lost to Follow-up|0|||
130219666|NCT01066871|468767007|FG000|Overall Study|Protocol Violation|1|||
130219667|NCT01066871|468767008|FG001|Overall Study|Protocol Violation|0|||
130219668|NCT01066871|468767009|FG002|Overall Study|Protocol Violation|3|||
130219669|NCT01066871|468767010|FG003|Overall Study|Protocol Violation|2|||
130219670|NCT01066871|468767007|FG000|Overall Study|Lack of Efficacy|0|||
130219671|NCT01066871|468767008|FG001|Overall Study|Lack of Efficacy|0|||
130219672|NCT01066871|468767009|FG002|Overall Study|Lack of Efficacy|0|||
130219673|NCT01066871|468767010|FG003|Overall Study|Lack of Efficacy|1|||
130219674|NCT01066871|468767007|FG000|Overall Study|Withdrawal by Subject|3|||
130219675|NCT01066871|468767008|FG001|Overall Study|Withdrawal by Subject|1|||
130219676|NCT01066871|468767009|FG002|Overall Study|Withdrawal by Subject|0|||
130219677|NCT01066871|468767010|FG003|Overall Study|Withdrawal by Subject|0|||
130219678|NCT01066871|468767007|FG000|Overall Study|Other|0|||
130219679|NCT01066871|468767008|FG001|Overall Study|Other|2|||
130219680|NCT01066871|468767009|FG002|Overall Study|Other|1|||
130219681|NCT01066871|468767010|FG003|Overall Study|Other|2|||
130219682|NCT00954122|468768585|FG000|Overall Study|Withdrawal by Subject|5|||
130219683|NCT00954122|468768585|FG000|Overall Study|Adverse Event|1|||
130219684|NCT00954122|468768585|FG000|Overall Study|Safety Reason|1|||
130219685|NCT03365934|468768587|FG000|Overall Study|Adverse Event|1|||
130219686|NCT03365934|468768587|FG000|Overall Study|Withdrawal by Subject|1|||
130219687|NCT02121795|468768596|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
130219688|NCT02121795|468768597|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
130219689|NCT02121795|468768596|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
130219690|NCT02121795|468768597|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
130219691|NCT02121795|468768596|FG000|Double-Blind Phase|Lost to Follow-up|7|||
130219692|NCT02121795|468768597|FG001|Double-Blind Phase|Lost to Follow-up|4|||
130219693|NCT02121795|468768596|FG000|Double-Blind Phase|Physician Decision|2|||
130219694|NCT02121795|468768597|FG001|Double-Blind Phase|Physician Decision|5|||
130219695|NCT02121795|468768596|FG000|Double-Blind Phase|Adverse Event|5|||
130219696|NCT02121795|468768597|FG001|Double-Blind Phase|Adverse Event|0|||
130219697|NCT02121795|468768596|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130219698|NCT02121795|468768597|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130219699|NCT02121795|468768596|FG000|Double-Blind Phase|Protocol Violation|0|||
130219700|NCT02121795|468768597|FG001|Double-Blind Phase|Protocol Violation|3|||
130219701|NCT02121795|468768596|FG000|Double-Blind Phase|Death|1|||
130219702|NCT02121795|468768597|FG001|Double-Blind Phase|Death|1|||
130219703|NCT02121795|468768596|FG000|Open-Label Phase|Physician Decision|8|||
130219704|NCT02121795|468768597|FG001|Open-Label Phase|Physician Decision|8|||
130219705|NCT02121795|468768596|FG000|Open-Label Phase|Withdrawal by Subject|3|||
130219706|NCT02121795|468768597|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130219707|NCT02121795|468768596|FG000|Open-Label Phase|Lost to Follow-up|1|||
130219708|NCT02121795|468768597|FG001|Open-Label Phase|Lost to Follow-up|0|||
130219709|NCT00666211|468768598|FG000|Overall Study|Withdrawal by Subject|10|||
130219710|NCT00666211|468768599|FG001|Overall Study|Withdrawal by Subject|13|||
130219711|NCT00666211|468768598|FG000|Overall Study|went off medication, no more pain|1|||
130219712|NCT00666211|468768599|FG001|Overall Study|went off medication, no more pain|0|||
130219713|NCT00666211|468768598|FG000|Overall Study|patient non-compliant|6|||
130219714|NCT00666211|468768599|FG001|Overall Study|patient non-compliant|6|||
130219715|NCT00666211|468768598|FG000|Overall Study|disease progression|1|||
130219716|NCT00666211|468768599|FG001|Overall Study|disease progression|8|||
130219717|NCT00666211|468768598|FG000|Overall Study|Lost to Follow-up|2|||
130219718|NCT00666211|468768599|FG001|Overall Study|Lost to Follow-up|0|||
130219719|NCT00666211|468768598|FG000|Overall Study|toxicity|0|||
130219720|NCT00666211|468768599|FG001|Overall Study|toxicity|2|||
130219721|NCT00666211|468768598|FG000|Overall Study|hospital admission|0|||
130219722|NCT00666211|468768599|FG001|Overall Study|hospital admission|5|||
130219723|NCT00666211|468768598|FG000|Overall Study|Death|0|||
130219724|NCT00666211|468768599|FG001|Overall Study|Death|2|||
130219725|NCT00666211|468768598|FG000|Overall Study|off tx for other complicating disease|0|||
130219726|NCT00666211|468768599|FG001|Overall Study|off tx for other complicating disease|1|||
130219727|NCT00666211|468768598|FG000|Overall Study|Physician Decision|0|||
130219728|NCT00666211|468768599|FG001|Overall Study|Physician Decision|1|||
130219729|NCT02299388|468768600|FG000|Overall Study|Withdrawal by Subject|0|||
130219730|NCT02299388|468768601|FG001|Overall Study|Withdrawal by Subject|1|||
130219731|NCT03334188|468768604|FG000|Overall Study|Withdrawal by Subject|0|||
130219732|NCT03334188|468768605|FG001|Overall Study|Withdrawal by Subject|1|||
130219733|NCT03334188|468768604|FG000|Overall Study|Death|1|||
130219734|NCT03334188|468768605|FG001|Overall Study|Death|0|||
130219735|NCT03334188|468768604|FG000|Overall Study|Never had qualifying clinic visit|7|||
130219736|NCT03334188|468768605|FG001|Overall Study|Never had qualifying clinic visit|7|||
130219737|NCT03373760|468768606|FG000|Overall Study|Adverse Event|8|||
130219738|NCT03373760|468768606|FG000|Overall Study|Disease Progression|46|||
130219739|NCT03373760|468768606|FG000|Overall Study|Death|4|||
130219740|NCT01093586|468768609|FG000|Overall Study|Failed to engraft|3|||
130219741|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
130219742|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
130219743|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
130219744|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
130219745|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
130219746|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
130219747|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
130219748|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
130219749|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
130219750|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
130219751|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
130219752|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
130219753|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
130219754|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
130219755|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Death|1|||
130219756|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Death|0|||
130219757|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
130219758|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
130219759|NCT00105989|468768610|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
130219760|NCT00105989|468768611|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
130219761|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
130219762|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
130219763|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
130219764|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
130219765|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
130219766|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
130219767|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
130219768|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
130219769|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
130219770|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
130219771|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
130219772|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
130219773|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
130219774|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
130219775|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Death|0|||
130219776|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Death|0|||
130219777|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
130219778|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
130219779|NCT00105989|468768610|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
130219780|NCT00105989|468768611|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
130219781|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
130219782|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
130219783|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
130219784|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
130219785|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
130219786|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
130219787|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
130219788|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
130219789|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
130219790|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
130219791|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
130219792|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
130219793|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
130219794|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
130219795|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
130219796|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
130219797|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
130219798|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
130219799|NCT00105989|468768610|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
130219800|NCT00105989|468768611|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
130219801|NCT03442088|468768612|FG000|Overall Study|Adverse Event|1|||
130219802|NCT03442088|468768612|FG000|Overall Study|Lack of Efficacy|2|||
130219803|NCT03442088|468768612|FG000|Overall Study|Lost to Follow-up|2|||
130219804|NCT00357877|468768613|FG000|Overall Study|Death|2|||
130219805|NCT00357877|468768614|FG001|Overall Study|Death|1|||
130219806|NCT00357877|468768613|FG000|Overall Study|Lost to Follow-up|20|||
130219807|NCT00357877|468768614|FG001|Overall Study|Lost to Follow-up|23|||
130219808|NCT00357877|468768613|FG000|Overall Study|Withdrawal by Subject|3|||
130219809|NCT00357877|468768614|FG001|Overall Study|Withdrawal by Subject|3|||
130219810|NCT00357877|468768613|FG000|Overall Study|Administrative withdrawal|1|||
130219811|NCT00357877|468768614|FG001|Overall Study|Administrative withdrawal|1|||
130219812|NCT00357877|468768613|FG000|Overall Study|Other|0|||
130219813|NCT00357877|468768614|FG001|Overall Study|Other|2|||
130219814|NCT04668209|468768615|FG000|Overall Study|Withdrawal by Subject|2|||
130219815|NCT04668209|468768616|FG001|Overall Study|Withdrawal by Subject|2|||
130219816|NCT04668209|468768615|FG000|Overall Study|Lost to Follow-up|3|||
130219817|NCT04668209|468768616|FG001|Overall Study|Lost to Follow-up|4|||
130219818|NCT04668209|468768615|FG000|Overall Study|Subject Expired|2|||
130219819|NCT04668209|468768616|FG001|Overall Study|Subject Expired|0|||
130219820|NCT04668209|468768615|FG000|Overall Study|Withdrawn from study|0|||
130219821|NCT04668209|468768616|FG001|Overall Study|Withdrawn from study|1|||
130219822|NCT04668209|468768615|FG000|Overall Study|Adverse Event|0|||
130219823|NCT04668209|468768616|FG001|Overall Study|Adverse Event|1|||
130219824|NCT01869777|468768623|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
130219825|NCT00613366|468768626|FG000|Overall Study|Withdrawal by Subject|3|||
130219826|NCT00613366|468768627|FG001|Overall Study|Withdrawal by Subject|2|||
130219827|NCT00766597|468768628|FG000|Overall Study|Unexpected closure of study|4|||
130219828|NCT00766597|468768628|FG000|Overall Study|Without CCR5-tropic virus|5|||
130219829|NCT01135524|468768629|FG000|Overall Study|Withdrawal by Subject|14|||
130219830|NCT01135524|468768629|FG000|Overall Study|Adverse Event|20|||
130219831|NCT01135524|468768629|FG000|Overall Study|Lost to Follow-up|3|||
130219832|NCT01135524|468768629|FG000|Overall Study|Administrative|151|||
130219833|NCT01135524|468768629|FG000|Overall Study|Lack of Efficacy|8|||
130219834|NCT02907463|468768630|FG000|Overall Study|Lost to Follow-up|17|||
130219835|NCT02907463|468768630|FG000|Overall Study|Death|10|||
130219836|NCT02907463|468768630|FG000|Overall Study|Withdrawal by Subject|4|||
130219837|NCT02907463|468768630|FG000|Overall Study|MIS Approach was not used|2|||
130219838|NCT02907463|468768630|FG000|Overall Study|Not Implanted with Study Device|2|||
130219839|NCT02907463|468768630|FG000|Overall Study|Device Explanted|1|||
130219840|NCT02907463|468768630|FG000|Overall Study|Missing Exit Form|1|||
130219841|NCT01266824|468768631|FG000|Overall Study|Study terminated prior to completion|2|||
130219842|NCT01266824|468768632|FG001|Overall Study|Study terminated prior to completion|3|||
130219843|NCT00411450|468768633|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
130219844|NCT01716663|468768634|FG000|Overall Study|Withdrawn prior to procedure|4|||
130219845|NCT01716663|468768634|FG000|Overall Study|Treated with non-study catheter|2|||
130219846|NCT02254772|468768637|FG000|Overall Study|Ineligible|1|||
130219847|NCT02254772|468768637|FG000|Overall Study|Withdrawal by Subject|1|||
130219848|NCT05225558|468768638|FG000|Overall Study|Withdrawal by Subject|4|||
130219849|NCT05225558|468768639|FG001|Overall Study|Withdrawal by Subject|3|||
130219850|NCT05225558|468768638|FG000|Overall Study|Adverse Event|1|||
130219851|NCT05225558|468768639|FG001|Overall Study|Adverse Event|0|||
130219852|NCT05225558|468768638|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
130219853|NCT05225558|468768639|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
130219854|NCT05225558|468768638|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
130219855|NCT05225558|468768639|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
130219856|NCT01001910|468768640|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
130219857|NCT00614874|468768641|FG000|Overall Study|Protocol Violation|1|||
130219858|NCT00614874|468768641|FG000|Overall Study|Withdrawal by Subject|1|||
130219859|NCT03006562|468768642|FG000|Overall Study|Lost to Follow-up|0|||
130017186|NCT01277549|468024420|FG001|Overall Study|Physician Decision|1|||
130017187|NCT00446511|468024423|FG000|Overall Study|Adverse Event|7|||
130219860|NCT03006562|468768643|FG001|Overall Study|Lost to Follow-up|1|||
130219861|NCT02427841|468768645|FG000|Overall Study|Lack of Efficacy|5|||
130219862|NCT02427841|468768645|FG000|Overall Study|Physician Decision|2|||
130219863|NCT02427841|468768645|FG000|Overall Study|Withdrawal by Subject|1|||
130219864|NCT00511810|468768646|FG000|Overall Study|Lost to Follow-up|1|||
130219865|NCT00511810|468768647|FG001|Overall Study|Lost to Follow-up|2|||
130219866|NCT00511810|468768646|FG000|Overall Study|Lack of Efficacy|0|||
130219867|NCT00511810|468768647|FG001|Overall Study|Lack of Efficacy|2|||
130219868|NCT00511810|468768646|FG000|Overall Study|Refused second scn|0|||
130219869|NCT00511810|468768647|FG001|Overall Study|Refused second scn|1|||
130219870|NCT01502033|468768650|FG000|Overall Study|1 participant had scalp discomfort|1|||
130219871|NCT01502033|468768650|FG000|Overall Study|1 participant had worsening depression|1|||
130219872|NCT01502033|468768650|FG000|Overall Study|1 participant went back to school|1|||
130219873|NCT05285787|468768652|FG000|Overall Study|Withdrawal by Subject|1|||
130219874|NCT02360280|468768656|FG000|Overall Study|Withdrawal by Subject|2|||
130219875|NCT02360280|468768657|FG001|Overall Study|Withdrawal by Subject|0|||
130219876|NCT02360280|468768656|FG000|Overall Study|Adverse Event|0|||
130219877|NCT02360280|468768657|FG001|Overall Study|Adverse Event|1|||
130219878|NCT02360280|468768656|FG000|Overall Study|Lost to Follow-up|1|||
130219879|NCT02360280|468768657|FG001|Overall Study|Lost to Follow-up|0|||
130219880|NCT02472886|468768658|FG000|Overall Study|Lack of Efficacy|0|||
130219881|NCT02472886|468768659|FG001|Overall Study|Lack of Efficacy|2|||
130219882|NCT02472886|468768660|FG002|Overall Study|Lack of Efficacy|1|||
130219883|NCT00320788|468768661|FG000|Overall Study|Adverse Event|0|||
130219884|NCT00320788|468768662|FG001|Overall Study|Adverse Event|0|||
130219885|NCT00320788|468768663|FG002|Overall Study|Adverse Event|0|||
130219886|NCT00320788|468768664|FG003|Overall Study|Adverse Event|1|||
130219887|NCT00320788|468768665|FG004|Overall Study|Adverse Event|0|||
130219888|NCT00320788|468768661|FG000|Overall Study|Death|0|||
130219889|NCT00320788|468768662|FG001|Overall Study|Death|0|||
130219890|NCT00320788|468768663|FG002|Overall Study|Death|1|||
130219891|NCT00320788|468768664|FG003|Overall Study|Death|0|||
130219892|NCT00320788|468768665|FG004|Overall Study|Death|1|||
130219893|NCT00320788|468768661|FG000|Overall Study|Lost to Follow-up|0|||
130219894|NCT00320788|468768662|FG001|Overall Study|Lost to Follow-up|2|||
130219895|NCT00320788|468768663|FG002|Overall Study|Lost to Follow-up|1|||
130219896|NCT00320788|468768664|FG003|Overall Study|Lost to Follow-up|0|||
130219897|NCT00320788|468768665|FG004|Overall Study|Lost to Follow-up|0|||
130219898|NCT00320788|468768661|FG000|Overall Study|Decision by the Sponsor|1|||
130017188|NCT00446511|468024424|FG001|Overall Study|Adverse Event|2|||
130017189|NCT00446511|468024425|FG002|Overall Study|Adverse Event|3|||
130219899|NCT00320788|468768662|FG001|Overall Study|Decision by the Sponsor|1|||
130219900|NCT00320788|468768663|FG002|Overall Study|Decision by the Sponsor|0|||
130219901|NCT00320788|468768664|FG003|Overall Study|Decision by the Sponsor|0|||
130219902|NCT00320788|468768665|FG004|Overall Study|Decision by the Sponsor|1|||
130219903|NCT00320788|468768661|FG000|Overall Study|Other|1|||
130219904|NCT00320788|468768662|FG001|Overall Study|Other|2|||
130219905|NCT00320788|468768663|FG002|Overall Study|Other|1|||
130219906|NCT00320788|468768664|FG003|Overall Study|Other|1|||
130219907|NCT00320788|468768665|FG004|Overall Study|Other|1|||
130219908|NCT00320788|468768661|FG000|Overall Study|Physician Decision|1|||
130219909|NCT00320788|468768662|FG001|Overall Study|Physician Decision|1|||
130219910|NCT00320788|468768663|FG002|Overall Study|Physician Decision|0|||
130219911|NCT00320788|468768664|FG003|Overall Study|Physician Decision|0|||
130219912|NCT00320788|468768665|FG004|Overall Study|Physician Decision|0|||
130219913|NCT00320788|468768661|FG000|Overall Study|Protocol Violation|0|||
130219914|NCT00320788|468768662|FG001|Overall Study|Protocol Violation|0|||
130219915|NCT00320788|468768663|FG002|Overall Study|Protocol Violation|0|||
130219916|NCT00320788|468768664|FG003|Overall Study|Protocol Violation|0|||
130219917|NCT00320788|468768665|FG004|Overall Study|Protocol Violation|1|||
130219918|NCT00320788|468768661|FG000|Overall Study|Withdrawal by Subject|3|||
130219919|NCT00320788|468768662|FG001|Overall Study|Withdrawal by Subject|0|||
130219920|NCT00320788|468768663|FG002|Overall Study|Withdrawal by Subject|0|||
130219921|NCT00320788|468768664|FG003|Overall Study|Withdrawal by Subject|3|||
130219922|NCT00320788|468768665|FG004|Overall Study|Withdrawal by Subject|1|||
130219923|NCT02797678|468768686|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
130219924|NCT02797678|468768687|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130219925|NCT02797678|468768688|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130219926|NCT02797678|468768689|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
130219927|NCT02797678|468768686|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
130219928|NCT02797678|468768687|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
130219929|NCT02797678|468768688|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
130219930|NCT02797678|468768689|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
130219931|NCT02797678|468768686|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130219932|NCT02797678|468768687|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130219933|NCT02797678|468768688|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
130219934|NCT02797678|468768689|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
130219935|NCT02401035|468768690|FG000|Overall Study|Withdrawal by Subject|1|||
130219936|NCT02401035|468768691|FG001|Overall Study|Withdrawal by Subject|0|||
130219937|NCT03046953|468768693|FG000|Overall Study|Relapse/progressive disease|21|||
130219938|NCT03046953|468768693|FG000|Overall Study|Death|2|||
130219939|NCT03046953|468768693|FG000|Overall Study|Withdrawal by Subject|3|||
130219940|NCT04039204|468768694|FG000|Overall Study|Withdrawal by Subject|0|||
130219941|NCT04039204|468768695|FG001|Overall Study|Withdrawal by Subject|2|||
130219942|NCT01189461|468768696|FG000|Overall Study|Lack of Efficacy|13|||
130219943|NCT01189461|468768696|FG000|Overall Study|Lost to Follow-up|1|||
130219944|NCT01189461|468768696|FG000|Overall Study|Withdrawal by Subject|6|||
130219945|NCT01189461|468768696|FG000|Overall Study|Protocol Violation|1|||
130219946|NCT01189461|468768696|FG000|Overall Study|Adverse Event|2|||
130219947|NCT01189461|468768696|FG000|Overall Study|Did not meet entrance criteria|3|||
130219948|NCT01189461|468768696|FG000|Overall Study|Other|8|||
130219949|NCT00656175|468768698|FG000|Overall Study|Adverse Event|1|||
130219950|NCT00656175|468768699|FG001|Overall Study|Adverse Event|0|||
130219951|NCT00656175|468768698|FG000|Overall Study|Transportation issues|0|||
130219952|NCT00656175|468768699|FG001|Overall Study|Transportation issues|1|||
130219953|NCT00534638|468768708|FG000|Overall Study|Withdrawal by Subject|3|||
130219954|NCT00534638|468768709|FG001|Overall Study|Withdrawal by Subject|4|||
130219955|NCT00534638|468768708|FG000|Overall Study|Migrated/moved from study area|13|||
130219956|NCT00534638|468768709|FG001|Overall Study|Migrated/moved from study area|11|||
130219957|NCT00534638|468768708|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
130219958|NCT00534638|468768709|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
130219959|NCT00534638|468768708|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
130219960|NCT00534638|468768709|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
130219961|NCT00534638|468768708|FG000|Overall Study|Other|1685|||
130219962|NCT00534638|468768709|FG001|Overall Study|Other|902|||
130219963|NCT04162795|468768712|FG000|Overall Study|Other|16|||
130219964|NCT04162795|468768712|FG000|Overall Study|Screen failures|10|||
130219965|NCT05259163|468770069|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
130219966|NCT05259163|468770070|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
130219967|NCT01381926|468770073|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
130219968|NCT01381926|468770074|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
130219969|NCT01381926|468770073|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
130219970|NCT01381926|468770074|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
130219971|NCT02624947|468770075|FG000|Maternal Participants|Adverse Event|5|||
130219972|NCT02624947|468770076|FG001|Maternal Participants|Adverse Event|0|||
130219973|NCT02624947|468770075|FG000|Maternal Participants|Investigator Decision|5|||
130219974|NCT02624947|468770076|FG001|Maternal Participants|Investigator Decision|3|||
130219975|NCT02624947|468770075|FG000|Maternal Participants|Lost to Follow-up|54|||
130219976|NCT02624947|468770076|FG001|Maternal Participants|Lost to Follow-up|24|||
130219977|NCT02624947|468770075|FG000|Maternal Participants|Non Compliance|8|||
130219978|NCT02624947|468770076|FG001|Maternal Participants|Non Compliance|5|||
130219979|NCT02624947|468770075|FG000|Maternal Participants|Sponsor Request|1|||
130219980|NCT02624947|468770076|FG001|Maternal Participants|Sponsor Request|1|||
130219981|NCT02624947|468770075|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
130219982|NCT02624947|468770076|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
130219983|NCT02624947|468770075|FG000|Maternal Participants|Miscellaneous|23|||
130219984|NCT02624947|468770076|FG001|Maternal Participants|Miscellaneous|15|||
130219985|NCT02624947|468770075|FG000|Infant Participants|Adverse Event|18|||
130219986|NCT02624947|468770076|FG001|Infant Participants|Adverse Event|11|||
130219987|NCT02624947|468770075|FG000|Infant Participants|Investigator Decision|5|||
130219988|NCT02624947|468770076|FG001|Infant Participants|Investigator Decision|4|||
130219989|NCT02624947|468770075|FG000|Infant Participants|Lost to Follow-up|93|||
130219990|NCT02624947|468770076|FG001|Infant Participants|Lost to Follow-up|58|||
130219991|NCT02624947|468770075|FG000|Infant Participants|Non Compliance|17|||
130219992|NCT02624947|468770076|FG001|Infant Participants|Non Compliance|7|||
130219993|NCT02624947|468770075|FG000|Infant Participants|Sponsor Request|0|||
130219994|NCT02624947|468770076|FG001|Infant Participants|Sponsor Request|1|||
130219995|NCT02624947|468770075|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
130219996|NCT02624947|468770076|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
130219997|NCT02624947|468770075|FG000|Infant Participants|Miscellaneous|50|||
130219998|NCT02624947|468770076|FG001|Infant Participants|Miscellaneous|26|||
130219999|NCT01971567|468770090|FG000|Overall Study|Withdrawal by Subject|3|||
130220000|NCT01971567|468770091|FG001|Overall Study|Withdrawal by Subject|2|||
130220001|NCT01971567|468770090|FG000|Overall Study|Lost to Follow-up|1|||
130220002|NCT01971567|468770091|FG001|Overall Study|Lost to Follow-up|0|||
130220003|NCT01409915|468770092|FG000|Overall Study|Adverse Event|0|||
130220004|NCT01409915|468770093|FG001|Overall Study|Adverse Event|2|||
130220005|NCT01409915|468770092|FG000|Overall Study|Withdrawal by Subject|0|||
130220006|NCT01409915|468770093|FG001|Overall Study|Withdrawal by Subject|1|||
130220007|NCT01409915|468770092|FG000|Overall Study|Protocol Violation|1|||
130220008|NCT01409915|468770093|FG001|Overall Study|Protocol Violation|0|||
130220009|NCT04826484|468770094|FG000|Overall Study|Lost to Follow-up|2|||
130220010|NCT04826484|468770095|FG001|Overall Study|Lost to Follow-up|0|||
130220011|NCT02250300|468770099|FG000|Expansion Phase|Death|6|||
130220012|NCT02250300|468770100|FG001|Expansion Phase|Death|7|||
130220013|NCT02250300|468770101|FG002|Expansion Phase|Death|0|||
130220014|NCT02250300|468770102|FG003|Expansion Phase|Death|0|||
130220015|NCT00215644|468770103|FG000|Overall Study|Disease Progression|28|||
130220016|NCT00215644|468770104|FG001|Overall Study|Disease Progression|10|||
130220017|NCT00215644|468770103|FG000|Overall Study|Adverse Event|2|||
130220018|NCT00215644|468770104|FG001|Overall Study|Adverse Event|9|||
130220019|NCT00215644|468770103|FG000|Overall Study|Death|1|||
130220020|NCT00215644|468770104|FG001|Overall Study|Death|2|||
130220021|NCT00215644|468770103|FG000|Overall Study|Withdrawal by Subject|1|||
130220022|NCT00215644|468770104|FG001|Overall Study|Withdrawal by Subject|0|||
130220023|NCT00215644|468770103|FG000|Overall Study|Other|3|||
130220024|NCT00215644|468770104|FG001|Overall Study|Other|15|||
130220025|NCT00215644|468770103|FG000|Overall Study|Randomized but Not Treated|1|||
130220026|NCT00215644|468770104|FG001|Overall Study|Randomized but Not Treated|0|||
130220027|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
130220028|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
130220029|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
130220030|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
130220031|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
130220032|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
130220033|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
130220034|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
130220035|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
130220036|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
130220037|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
130220038|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
130220039|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
130220040|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
130220041|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
130220042|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
130220043|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
130220044|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
130220045|NCT03569098|468770105|FG000|Double-Blind Treatment Cycle 1|Other|1|||
130220046|NCT03569098|468770106|FG001|Double-Blind Treatment Cycle 1|Other|0|||
130220047|NCT03569098|468770107|FG002|Double-Blind Treatment Cycle 1|Other|1|||
130220048|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
130220049|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
130220050|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
130220051|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
130220052|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
130220053|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
130220054|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
130220055|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
130220056|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
130220057|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
130220058|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
130220059|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
130220060|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
130220061|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
130220062|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
130220063|NCT03569098|468770105|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
130220064|NCT03569098|468770106|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
130220065|NCT03569098|468770107|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
130220066|NCT00758498|468770108|FG000|Overall Study|Adverse Event|2|||
130220067|NCT00758498|468770109|FG001|Overall Study|Adverse Event|2|||
130220068|NCT00758498|468770110|FG002|Overall Study|Adverse Event|3|||
130220069|NCT00758498|468770108|FG000|Overall Study|Subject legally detained out of state|1|||
130220070|NCT00758498|468770109|FG001|Overall Study|Subject legally detained out of state|0|||
130220071|NCT00758498|468770110|FG002|Overall Study|Subject legally detained out of state|0|||
130220072|NCT00758498|468770108|FG000|Overall Study|Withdrawal by Subject|0|||
130220073|NCT00758498|468770109|FG001|Overall Study|Withdrawal by Subject|0|||
130220074|NCT00758498|468770110|FG002|Overall Study|Withdrawal by Subject|1|||
130220075|NCT00758498|468770108|FG000|Overall Study|Noncompliance to study procedures|0|||
130220076|NCT00758498|468770109|FG001|Overall Study|Noncompliance to study procedures|0|||
130220077|NCT00758498|468770110|FG002|Overall Study|Noncompliance to study procedures|1|||
130220078|NCT01516736|468770115|FG000|Overall Study|Withdrawal by Subject|10|||
130220079|NCT01516736|468770116|FG001|Overall Study|Withdrawal by Subject|4|||
130220080|NCT01516736|468770115|FG000|Overall Study|Adverse Event|4|||
130220081|NCT01516736|468770116|FG001|Overall Study|Adverse Event|5|||
130220082|NCT01516736|468770115|FG000|Overall Study|Death|3|||
130220083|NCT01516736|468770116|FG001|Overall Study|Death|1|||
130220084|NCT01516736|468770115|FG000|Overall Study|Physician Decision|2|||
130220085|NCT01516736|468770116|FG001|Overall Study|Physician Decision|1|||
130220086|NCT01516736|468770115|FG000|Overall Study|Lack of Efficacy|1|||
130220087|NCT01516736|468770116|FG001|Overall Study|Lack of Efficacy|0|||
130220088|NCT01516736|468770115|FG000|Overall Study|Protocol Violation|0|||
130220089|NCT01516736|468770116|FG001|Overall Study|Protocol Violation|1|||
130220090|NCT01516736|468770115|FG000|Overall Study|Other (not specified)|0|||
130220091|NCT01516736|468770116|FG001|Overall Study|Other (not specified)|1|||
130220092|NCT01697800|468770117|FG000|Overall Study|Death|0|||
130220093|NCT01697800|468770118|FG001|Overall Study|Death|1|||
130220094|NCT04194489|468770124|FG000|Overall Study|Withdrawal by Subject|5|||
130220095|NCT04194489|468770124|FG000|Overall Study|Lost to Follow-up|48|||
130220096|NCT00522548|468770125|FG000|Overall Study|Adverse Event|2|||
130220097|NCT00522548|468770126|FG001|Overall Study|Adverse Event|2|||
130017190|NCT00446511|468024426|FG003|Overall Study|Adverse Event|1|||
130017191|NCT00446511|468024423|FG000|Overall Study|Protocol Violation|0|||
130017192|NCT00446511|468024424|FG001|Overall Study|Protocol Violation|0|||
130017193|NCT00446511|468024425|FG002|Overall Study|Protocol Violation|0|||
130017194|NCT00446511|468024426|FG003|Overall Study|Protocol Violation|1|||
130017195|NCT00446511|468024423|FG000|Overall Study|Withdrawal by Subject|0|||
130017196|NCT00446511|468024424|FG001|Overall Study|Withdrawal by Subject|0|||
130220098|NCT00522548|468770125|FG000|Overall Study|Withdrawal by Subject|0|||
130220099|NCT00522548|468770126|FG001|Overall Study|Withdrawal by Subject|2|||
130220100|NCT04147247|468770127|FG000|Overall Study|Progressive disease|3|||
130220101|NCT04147247|468770128|FG001|Overall Study|Progressive disease|3|||
130017197|NCT00446511|468024425|FG002|Overall Study|Withdrawal by Subject|0|||
130017198|NCT00446511|468024426|FG003|Overall Study|Withdrawal by Subject|3|||
130017199|NCT00446511|468024423|FG000|Overall Study|Administrative Problems|3|||
130017200|NCT00446511|468024424|FG001|Overall Study|Administrative Problems|0|||
130017201|NCT00446511|468024425|FG002|Overall Study|Administrative Problems|4|||
130017202|NCT00446511|468024426|FG003|Overall Study|Administrative Problems|1|||
130017203|NCT01618214|468024427|FG000|Overall Study|Adverse Event|3|||
130017204|NCT01618214|468024428|FG001|Overall Study|Adverse Event|1|||
130017205|NCT01618214|468024427|FG000|Overall Study|Lack of Efficacy|1|||
130017206|NCT01618214|468024428|FG001|Overall Study|Lack of Efficacy|1|||
130017207|NCT01618214|468024427|FG000|Overall Study|Protocol Violation|1|||
130017208|NCT01618214|468024428|FG001|Overall Study|Protocol Violation|4|||
130220102|NCT04147247|468770129|FG002|Overall Study|Progressive disease|4|||
130017209|NCT01618214|468024427|FG000|Overall Study|Withdrawal Criteria|1|||
130220103|NCT04147247|468770130|FG003|Overall Study|Progressive disease|4|||
130017210|NCT01618214|468024428|FG001|Overall Study|Withdrawal Criteria|2|||
130017211|NCT01618214|468024427|FG000|Overall Study|Unclassified|4|||
130017212|NCT01618214|468024428|FG001|Overall Study|Unclassified|5|||
130017213|NCT02228590|468024429|FG000|Overall Study|Withdrawal by Subject|1|||
130017214|NCT00550680|468024430|FG000|Overall Study|Administrative Reasons|1|||
130017215|NCT00550680|468024430|FG000|Overall Study|Adverse Event|5|||
130017216|NCT00550680|468024430|FG000|Overall Study|Death|3|||
130017217|NCT00550680|468024430|FG000|Overall Study|Early Improvement|1|||
130017218|NCT00550680|468024430|FG000|Overall Study|Lost to Follow-up|3|||
130017219|NCT00550680|468024430|FG000|Overall Study|Lack of Efficacy|1|||
130017220|NCT00550680|468024430|FG000|Overall Study|Other|10|||
130017221|NCT00550680|468024430|FG000|Overall Study|Protocol Violation|7|||
130017222|NCT00550680|468024430|FG000|Overall Study|Refused Treatment|19|||
130017223|NCT00550680|468024430|FG000|Overall Study|Screen Failure|6|||
130017224|NCT01119248|468024431|FG000|Overall Study|Physician Decision|5|||
130017225|NCT00562354|468024432|FG000|Overall Study|Physician Decision|0|||
130017226|NCT00562354|468024433|FG001|Overall Study|Physician Decision|1|||
130017227|NCT00562354|468024432|FG000|Overall Study|Lost to Follow-up|0|||
130017228|NCT00562354|468024433|FG001|Overall Study|Lost to Follow-up|1|||
130017229|NCT01883635|468024435|FG000|Overall Study|Withdrawal by Subject|4|||
130017230|NCT01883635|468024436|FG001|Overall Study|Withdrawal by Subject|0|||
130220104|NCT04147247|468770131|FG004|Overall Study|Progressive disease|3|||
130220105|NCT04147247|468770127|FG000|Overall Study|Physician Decision|0|||
130220106|NCT04147247|468770128|FG001|Overall Study|Physician Decision|1|||
130220107|NCT04147247|468770129|FG002|Overall Study|Physician Decision|0|||
130220108|NCT04147247|468770130|FG003|Overall Study|Physician Decision|0|||
130220109|NCT04147247|468770131|FG004|Overall Study|Physician Decision|0|||
130220110|NCT04147247|468770127|FG000|Overall Study|Clinical Disease Progression|0|||
130220111|NCT04147247|468770128|FG001|Overall Study|Clinical Disease Progression|0|||
130220112|NCT04147247|468770129|FG002|Overall Study|Clinical Disease Progression|0|||
130220113|NCT04147247|468770130|FG003|Overall Study|Clinical Disease Progression|0|||
130220114|NCT04147247|468770131|FG004|Overall Study|Clinical Disease Progression|1|||
130220115|NCT04147247|468770127|FG000|Overall Study|Adverse Event|0|||
130220116|NCT04147247|468770128|FG001|Overall Study|Adverse Event|0|||
130220117|NCT04147247|468770129|FG002|Overall Study|Adverse Event|1|||
130220118|NCT04147247|468770130|FG003|Overall Study|Adverse Event|0|||
130220119|NCT04147247|468770131|FG004|Overall Study|Adverse Event|1|||
130220120|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
130220121|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220122|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220123|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220124|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
130220125|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
130220126|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220127|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220128|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220129|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
130220130|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
130220131|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220132|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220133|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220134|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
130220135|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
130220136|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220137|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220138|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220139|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
130220140|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
130220141|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220142|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220143|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220144|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
130220145|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
130220146|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220147|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220148|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220149|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
130220150|NCT01111565|468770132|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
130220151|NCT01111565|468770133|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130017231|NCT00761514|468024437|FG000|Overall Study|Adverse Event|1|||
130017232|NCT00761514|468024437|FG000|Overall Study|Withdrawal by Subject|2|||
130017233|NCT00761514|468024437|FG000|Overall Study|Lost to Follow-up|1|||
130220152|NCT01111565|468770134|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130220153|NCT01111565|468770135|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130220154|NCT01111565|468770136|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
130220155|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130017234|NCT00761514|468024437|FG000|Overall Study|Health insurance didn't cover study drug|1|||
130017235|NCT00761514|468024437|FG000|Overall Study|Problem complying with study visit|1|||
130017236|NCT00761514|468024437|FG000|Overall Study|Unable to pay for medications|1|||
130017237|NCT02124564|468024441|FG000|Treatment Period|Adverse Event|2|||
130017238|NCT02124564|468024441|FG000|Treatment Period|Lack of Efficacy|3|||
130017239|NCT02124564|468024441|FG000|Treatment Period|Withdrawal by Subject|2|||
130017240|NCT03885089|468024442|FG000|Overall Study|No informed consent for publication of study results|2|||
130017241|NCT02043548|468024448|FG000|Overall Study|Lack of Efficacy|1|||
130017242|NCT02043548|468024449|FG001|Overall Study|Lack of Efficacy|0|||
130017243|NCT02043548|468024448|FG000|Overall Study|Adverse Event|0|||
130017244|NCT02043548|468024449|FG001|Overall Study|Adverse Event|1|||
130017245|NCT01425008|468024458|FG000|Dose Escalation Phase|Progressive Disease|2|||
130017246|NCT01425008|468024459|FG001|Dose Escalation Phase|Progressive Disease|3|||
130017247|NCT01425008|468024460|FG002|Dose Escalation Phase|Progressive Disease|2|||
130017248|NCT01425008|468024461|FG003|Dose Escalation Phase|Progressive Disease|3|||
130017249|NCT01425008|468024462|FG004|Dose Escalation Phase|Progressive Disease|5|||
130017250|NCT01425008|468024463|FG005|Dose Escalation Phase|Progressive Disease|4|||
130017251|NCT01425008|468024464|FG006|Dose Escalation Phase|Progressive Disease|0|||
130017252|NCT01425008|468024465|FG007|Dose Escalation Phase|Progressive Disease|2|||
130017253|NCT01425008|468024466|FG008|Dose Escalation Phase|Progressive Disease|6|||
130017254|NCT01425008|468024467|FG009|Dose Escalation Phase|Progressive Disease|2|||
130017255|NCT01425008|468024468|FG010|Dose Escalation Phase|Progressive Disease|0|||
130017256|NCT01425008|468024469|FG011|Dose Escalation Phase|Progressive Disease|0|||
130017257|NCT01425008|468024470|FG012|Dose Escalation Phase|Progressive Disease|0|||
130017258|NCT01425008|468024471|FG013|Dose Escalation Phase|Progressive Disease|0|||
130017259|NCT01425008|468024472|FG014|Dose Escalation Phase|Progressive Disease|0|||
130017260|NCT01425008|468024473|FG015|Dose Escalation Phase|Progressive Disease|0|||
130017261|NCT01425008|468024474|FG016|Dose Escalation Phase|Progressive Disease|0|||
130017262|NCT01425008|468024475|FG017|Dose Escalation Phase|Progressive Disease|0|||
130017263|NCT01425008|468024476|FG018|Dose Escalation Phase|Progressive Disease|0|||
130017264|NCT01425008|468024458|FG000|Dose Escalation Phase|Adverse Event|2|||
130017265|NCT01425008|468024459|FG001|Dose Escalation Phase|Adverse Event|0|||
130017266|NCT01425008|468024460|FG002|Dose Escalation Phase|Adverse Event|0|||
130220156|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130220157|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130098777|NCT03426995|468319304|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130098778|NCT03426995|468319305|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130098779|NCT03426995|468319306|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130220158|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130220159|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130017267|NCT01425008|468024461|FG003|Dose Escalation Phase|Adverse Event|0|||
130220160|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220161|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220162|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
130220163|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220164|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130220165|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130220166|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
130220167|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130220168|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
130220169|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130220170|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220171|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220172|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220173|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
130220174|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
130220175|NCT01111565|468770132|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220176|NCT01111565|468770133|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220177|NCT01111565|468770134|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220178|NCT01111565|468770135|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
130220179|NCT01111565|468770136|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
130220180|NCT02683239|468770137|FG000|Overall Study|Protocol Violation|35|||
130220181|NCT02683239|468770138|FG001|Overall Study|Protocol Violation|23|||
130220182|NCT02683239|468770139|FG002|Overall Study|Protocol Violation|26|||
130220183|NCT02683239|468770140|FG003|Overall Study|Protocol Violation|4|||
130220184|NCT02683239|468770141|FG004|Overall Study|Protocol Violation|35|||
130220185|NCT02683239|468770142|FG005|Overall Study|Protocol Violation|4|||
130220186|NCT02683239|468770143|FG006|Overall Study|Protocol Violation|5|||
130220187|NCT02683239|468770137|FG000|Overall Study|Adverse Event|64|||
130220188|NCT02683239|468770138|FG001|Overall Study|Adverse Event|39|||
130220189|NCT02683239|468770139|FG002|Overall Study|Adverse Event|42|||
130220190|NCT02683239|468770140|FG003|Overall Study|Adverse Event|16|||
130017268|NCT01425008|468024462|FG004|Dose Escalation Phase|Adverse Event|0|||
130017269|NCT01425008|468024463|FG005|Dose Escalation Phase|Adverse Event|2|||
130220191|NCT02683239|468770141|FG004|Overall Study|Adverse Event|189|||
130220192|NCT02683239|468770142|FG005|Overall Study|Adverse Event|9|||
130220193|NCT02683239|468770143|FG006|Overall Study|Adverse Event|9|||
130220194|NCT02683239|468770137|FG000|Overall Study|Physician Decision|38|||
130220195|NCT02683239|468770138|FG001|Overall Study|Physician Decision|19|||
130220196|NCT02683239|468770139|FG002|Overall Study|Physician Decision|14|||
130220197|NCT02683239|468770140|FG003|Overall Study|Physician Decision|73|||
130220198|NCT02683239|468770141|FG004|Overall Study|Physician Decision|143|||
130220199|NCT02683239|468770142|FG005|Overall Study|Physician Decision|14|||
130220200|NCT02683239|468770143|FG006|Overall Study|Physician Decision|15|||
130220201|NCT02683239|468770137|FG000|Overall Study|Withdrawal by Subject|187|||
129884426|NCT01275196|467536392|FG000|Overall Study|Withdrawal by Subject|4|||
129884427|NCT01275196|467536393|FG001|Overall Study|Withdrawal by Subject|5|||
129884428|NCT01275196|467536392|FG000|Overall Study|Lost to Follow-up|1|||
129884429|NCT01275196|467536393|FG001|Overall Study|Lost to Follow-up|0|||
129884430|NCT01275196|467536392|FG000|Overall Study|Disease Progression|6|||
129884431|NCT01275196|467536393|FG001|Overall Study|Disease Progression|5|||
129884432|NCT01275196|467536392|FG000|Overall Study|Protocol Violation|1|||
130220202|NCT02683239|468770138|FG001|Overall Study|Withdrawal by Subject|99|||
130220203|NCT02683239|468770139|FG002|Overall Study|Withdrawal by Subject|91|||
130220204|NCT02683239|468770140|FG003|Overall Study|Withdrawal by Subject|18|||
130220205|NCT02683239|468770141|FG004|Overall Study|Withdrawal by Subject|248|||
130220206|NCT02683239|468770142|FG005|Overall Study|Withdrawal by Subject|22|||
130220207|NCT02683239|468770143|FG006|Overall Study|Withdrawal by Subject|28|||
130220208|NCT02683239|468770137|FG000|Overall Study|Lost to Follow-up|77|||
130220209|NCT02683239|468770138|FG001|Overall Study|Lost to Follow-up|24|||
130220210|NCT02683239|468770139|FG002|Overall Study|Lost to Follow-up|25|||
130220211|NCT02683239|468770140|FG003|Overall Study|Lost to Follow-up|7|||
130220212|NCT02683239|468770141|FG004|Overall Study|Lost to Follow-up|88|||
130220213|NCT02683239|468770142|FG005|Overall Study|Lost to Follow-up|8|||
130220214|NCT02683239|468770143|FG006|Overall Study|Lost to Follow-up|11|||
130220215|NCT02683239|468770137|FG000|Overall Study|Death|9|||
130220216|NCT02683239|468770138|FG001|Overall Study|Death|5|||
130220217|NCT02683239|468770139|FG002|Overall Study|Death|8|||
130220218|NCT02683239|468770140|FG003|Overall Study|Death|0|||
130220219|NCT02683239|468770141|FG004|Overall Study|Death|12|||
130220220|NCT02683239|468770142|FG005|Overall Study|Death|1|||
130220221|NCT02683239|468770143|FG006|Overall Study|Death|0|||
130220222|NCT02683239|468770137|FG000|Overall Study|Lack of Efficacy|50|||
130220223|NCT02683239|468770138|FG001|Overall Study|Lack of Efficacy|23|||
130220224|NCT02683239|468770139|FG002|Overall Study|Lack of Efficacy|12|||
130220225|NCT02683239|468770140|FG003|Overall Study|Lack of Efficacy|2|||
130220226|NCT02683239|468770141|FG004|Overall Study|Lack of Efficacy|29|||
130220227|NCT02683239|468770142|FG005|Overall Study|Lack of Efficacy|2|||
130220228|NCT02683239|468770143|FG006|Overall Study|Lack of Efficacy|3|||
130220229|NCT02683239|468770137|FG000|Overall Study|Missing data|0|||
130220230|NCT02683239|468770138|FG001|Overall Study|Missing data|1|||
130220231|NCT02683239|468770139|FG002|Overall Study|Missing data|1|||
130220232|NCT02683239|468770140|FG003|Overall Study|Missing data|0|||
130220233|NCT02683239|468770141|FG004|Overall Study|Missing data|1|||
130220234|NCT02683239|468770142|FG005|Overall Study|Missing data|0|||
130220235|NCT02683239|468770143|FG006|Overall Study|Missing data|0|||
130220236|NCT04131712|468770146|FG000|Overall Study|COVID related|0|||
130220237|NCT04131712|468770147|FG001|Overall Study|COVID related|0|||
130220238|NCT04131712|468770148|FG002|Overall Study|COVID related|2|||
130220239|NCT04131712|468770149|FG003|Overall Study|COVID related|0|||
130220240|NCT04131712|468770146|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130220241|NCT04131712|468770147|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130220242|NCT04131712|468770148|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
130220243|NCT04131712|468770149|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
130220244|NCT00873730|468770150|FG000|Overall Study|Protocol Deviation|5|||
130220245|NCT00873730|468770151|FG001|Overall Study|Protocol Deviation|2|||
130220246|NCT00873730|468770150|FG000|Overall Study|Adverse Event|0|||
130220247|NCT00873730|468770151|FG001|Overall Study|Adverse Event|2|||
130220248|NCT00873730|468770150|FG000|Overall Study|Withdrawal by Subject|0|||
130220249|NCT00873730|468770151|FG001|Overall Study|Withdrawal by Subject|1|||
130220250|NCT00873730|468770150|FG000|Overall Study|Sponsor decision|1|||
130220251|NCT00873730|468770151|FG001|Overall Study|Sponsor decision|0|||
130220252|NCT00103662|468770152|FG000|Overall Study|Entered Rescue Procedure|0|||
130220253|NCT00103662|468770153|FG001|Overall Study|Entered Rescue Procedure|7|||
130220254|NCT00103662|468770152|FG000|Overall Study|Death|7|||
130220255|NCT00103662|468770153|FG001|Overall Study|Death|7|||
130220256|NCT00103662|468770152|FG000|Overall Study|Elective Withdrawal|5|||
130220257|NCT00103662|468770153|FG001|Overall Study|Elective Withdrawal|5|||
130220258|NCT00103662|468770152|FG000|Overall Study|Lost to Follow-up|0|||
130220259|NCT00103662|468770153|FG001|Overall Study|Lost to Follow-up|1|||
130220260|NCT00103662|468770152|FG000|Overall Study|Other|6|||
130220261|NCT00103662|468770153|FG001|Overall Study|Other|9|||
130220262|NCT00103662|468770152|FG000|Overall Study|Failed mobilization|0|||
130220263|NCT00103662|468770153|FG001|Overall Study|Failed mobilization|4|||
130220264|NCT00103662|468770152|FG000|Overall Study|Intercurrent illness|1|||
130220265|NCT00103662|468770153|FG001|Overall Study|Intercurrent illness|0|||
130220266|NCT00943397|468770154|FG000|Overall Study|Adverse Event|0|||
130220267|NCT00943397|468770155|FG001|Overall Study|Adverse Event|6|||
130220268|NCT00943397|468770154|FG000|Overall Study|Lost to Follow-up|0|||
130220269|NCT00943397|468770155|FG001|Overall Study|Lost to Follow-up|4|||
130220270|NCT00943397|468770154|FG000|Overall Study|Protocol Violation|2|||
130220271|NCT00943397|468770155|FG001|Overall Study|Protocol Violation|5|||
130220272|NCT00943397|468770154|FG000|Overall Study|Withdrawal by Subject|1|||
130220273|NCT00943397|468770155|FG001|Overall Study|Withdrawal by Subject|1|||
130220274|NCT00943397|468770154|FG000|Overall Study|Site terminated and other|12|||
130220275|NCT00943397|468770155|FG001|Overall Study|Site terminated and other|56|||
130220276|NCT04878055|468770156|FG000|Overall Study|Patient transferred in another department|0|||
130220277|NCT04878055|468770157|FG001|Overall Study|Patient transferred in another department|2|||
130220278|NCT04878055|468770156|FG000|Overall Study|Physician Decision|1|||
130220279|NCT04878055|468770157|FG001|Overall Study|Physician Decision|1|||
130220280|NCT04878055|468770156|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
130220281|NCT04878055|468770157|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
130220282|NCT04878055|468770156|FG000|Overall Study|Adverse Event|12|||
130220283|NCT04878055|468770157|FG001|Overall Study|Adverse Event|7|||
130220284|NCT04878055|468770156|FG000|Overall Study|Other|5|||
130220285|NCT04878055|468770157|FG001|Overall Study|Other|0|||
130220286|NCT04878055|468770156|FG000|Overall Study|Withdrawal by Subject|7|||
130220287|NCT04878055|468770157|FG001|Overall Study|Withdrawal by Subject|3|||
130220288|NCT04878055|468770156|FG000|Overall Study|Lost to Follow-up|10|||
130220289|NCT04878055|468770157|FG001|Overall Study|Lost to Follow-up|1|||
130220290|NCT01968811|468770158|FG000|Overall Study|Protocol Violation|4|||
130220291|NCT01968811|468770158|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
130220292|NCT03904420|468770163|FG000|Overall Study|Study terminated|2|||
130220293|NCT03904420|468770164|FG001|Overall Study|Study terminated|2|||
130220294|NCT01089127|468770169|FG000|Overall Study|Adverse Event|5|||
130220295|NCT01089127|468770170|FG001|Overall Study|Adverse Event|1|||
130220296|NCT01089127|468770171|FG002|Overall Study|Adverse Event|1|||
130220297|NCT01089127|468770172|FG003|Overall Study|Adverse Event|0|||
130220298|NCT01089127|468770173|FG004|Overall Study|Adverse Event|0|||
130220299|NCT01089127|468770174|FG005|Overall Study|Adverse Event|1|||
130220300|NCT01089127|468770169|FG000|Overall Study|Subject withdrew consent|0|||
130220301|NCT01089127|468770170|FG001|Overall Study|Subject withdrew consent|1|||
130220302|NCT01089127|468770171|FG002|Overall Study|Subject withdrew consent|1|||
130220303|NCT01089127|468770172|FG003|Overall Study|Subject withdrew consent|1|||
130220304|NCT01089127|468770173|FG004|Overall Study|Subject withdrew consent|0|||
130220305|NCT01089127|468770174|FG005|Overall Study|Subject withdrew consent|2|||
130220306|NCT01089127|468770169|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130220307|NCT01089127|468770170|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130220308|NCT01089127|468770171|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130220309|NCT01089127|468770172|FG003|Overall Study|Abnormal test procedure result(s)|0|||
130220310|NCT01089127|468770173|FG004|Overall Study|Abnormal test procedure result(s)|0|||
130220311|NCT01089127|468770174|FG005|Overall Study|Abnormal test procedure result(s)|0|||
130220312|NCT01089127|468770169|FG000|Overall Study|Lost to Follow-up|1|||
130220313|NCT01089127|468770170|FG001|Overall Study|Lost to Follow-up|1|||
130220314|NCT01089127|468770171|FG002|Overall Study|Lost to Follow-up|0|||
130220315|NCT01089127|468770172|FG003|Overall Study|Lost to Follow-up|0|||
130220316|NCT01089127|468770173|FG004|Overall Study|Lost to Follow-up|1|||
130220317|NCT01089127|468770174|FG005|Overall Study|Lost to Follow-up|0|||
130220318|NCT01089127|468770169|FG000|Overall Study|Protocol deviation|0|||
130220319|NCT01089127|468770170|FG001|Overall Study|Protocol deviation|1|||
130220320|NCT01089127|468770171|FG002|Overall Study|Protocol deviation|0|||
130220321|NCT01089127|468770172|FG003|Overall Study|Protocol deviation|0|||
130220322|NCT01089127|468770173|FG004|Overall Study|Protocol deviation|1|||
130220323|NCT01089127|468770174|FG005|Overall Study|Protocol deviation|0|||
130220324|NCT01841970|468770177|FG000|Overall Study|Withdrawal by Subject|1|||
130220325|NCT01841970|468770177|FG000|Overall Study|Physician Decision|2|||
130220326|NCT01841970|468770177|FG000|Overall Study|Lost to Follow-up|8|||
130220327|NCT02592447|468770178|FG000|Overall Study|Lost to Follow-up|1|||
130220328|NCT02592447|468770179|FG001|Overall Study|Lost to Follow-up|0|||
130220329|NCT02592447|468770178|FG000|Overall Study|Ineligible after randomization|1|||
130220330|NCT02592447|468770179|FG001|Overall Study|Ineligible after randomization|0|||
130220331|NCT02592447|468770178|FG000|Overall Study|Withdrawal by Subject|0|||
130220332|NCT02592447|468770179|FG001|Overall Study|Withdrawal by Subject|1|||
130220333|NCT01048541|468770188|FG000|Overall Study|Withdrawal by Subject|1|||
130220334|NCT01048541|468770189|FG001|Overall Study|Withdrawal by Subject|0|||
130220335|NCT00627497|468770190|FG000|Overall Study|Lost to Follow-up|1|||
130220336|NCT00627497|468770191|FG001|Overall Study|Lost to Follow-up|1|||
130220337|NCT00627497|468770192|FG002|Overall Study|Lost to Follow-up|0|||
130220338|NCT00627497|468770193|FG003|Overall Study|Lost to Follow-up|0|||
130220339|NCT00327717|468770194|FG000|Overall Study|Adverse Event|6|||
130220340|NCT00327717|468770195|FG001|Overall Study|Adverse Event|6|||
130220341|NCT00327717|468770194|FG000|Overall Study|Lack of Efficacy|0|||
130220342|NCT00327717|468770195|FG001|Overall Study|Lack of Efficacy|1|||
130220343|NCT00327717|468770194|FG000|Overall Study|Withdrawal by Subject|3|||
130220344|NCT00327717|468770195|FG001|Overall Study|Withdrawal by Subject|7|||
130220345|NCT02080364|468770196|FG000|Baseline Period|Protocol Violation|2|||
130220346|NCT02080364|468770197|FG001|Baseline Period|Protocol Violation|1|||
130220347|NCT02080364|468770198|FG002|Baseline Period|Protocol Violation|0|||
130220348|NCT02080364|468770199|FG003|Baseline Period|Protocol Violation|0|||
130220349|NCT02080364|468770196|FG000|Baseline Period|Other|0|||
130220350|NCT02080364|468770197|FG001|Baseline Period|Other|1|||
130220351|NCT02080364|468770198|FG002|Baseline Period|Other|1|||
130220352|NCT02080364|468770199|FG003|Baseline Period|Other|0|||
130220353|NCT02080364|468770196|FG000|Treatment Period|Adverse Event|10|||
130220354|NCT02080364|468770197|FG001|Treatment Period|Adverse Event|15|||
130220355|NCT02080364|468770198|FG002|Treatment Period|Adverse Event|11|||
130220356|NCT02080364|468770199|FG003|Treatment Period|Adverse Event|14|||
130220357|NCT02080364|468770196|FG000|Treatment Period|Lost to Follow-up|2|||
130220358|NCT02080364|468770197|FG001|Treatment Period|Lost to Follow-up|3|||
130220359|NCT02080364|468770198|FG002|Treatment Period|Lost to Follow-up|5|||
130220360|NCT02080364|468770199|FG003|Treatment Period|Lost to Follow-up|0|||
130220361|NCT02080364|468770196|FG000|Treatment Period|Protocol Violation|5|||
130220362|NCT02080364|468770197|FG001|Treatment Period|Protocol Violation|3|||
130220363|NCT02080364|468770198|FG002|Treatment Period|Protocol Violation|5|||
130220364|NCT02080364|468770199|FG003|Treatment Period|Protocol Violation|1|||
130220365|NCT02080364|468770196|FG000|Treatment Period|Withdrawal by Subject|16|||
130220366|NCT02080364|468770197|FG001|Treatment Period|Withdrawal by Subject|16|||
130220367|NCT02080364|468770198|FG002|Treatment Period|Withdrawal by Subject|15|||
130220368|NCT02080364|468770199|FG003|Treatment Period|Withdrawal by Subject|10|||
130220369|NCT02080364|468770196|FG000|Treatment Period|Study Terminated by Sponsor|0|||
130220370|NCT02080364|468770197|FG001|Treatment Period|Study Terminated by Sponsor|0|||
130220371|NCT02080364|468770198|FG002|Treatment Period|Study Terminated by Sponsor|180|||
130220372|NCT02080364|468770199|FG003|Treatment Period|Study Terminated by Sponsor|183|||
130220373|NCT02080364|468770196|FG000|Treatment Period|Other|14|||
130220374|NCT02080364|468770197|FG001|Treatment Period|Other|12|||
130220375|NCT02080364|468770198|FG002|Treatment Period|Other|21|||
130220376|NCT02080364|468770199|FG003|Treatment Period|Other|16|||
130220377|NCT00571662|468770201|FG000|Overall Study|Withdrawal by Subject|2|||
130220378|NCT00571662|468770201|FG000|Overall Study|psychiatric instability|1|||
130220379|NCT00571662|468770201|FG000|Overall Study|Adverse Event|5|||
130220380|NCT00964028|468770202|FG000|Overall Study|Withdrawal by Subject|0|||
130220381|NCT00964028|468770203|FG001|Overall Study|Withdrawal by Subject|1|||
130220382|NCT03472521|468770204|FG000|Overall Study|Lost to Follow-up|3|||
130220383|NCT03472521|468770205|FG001|Overall Study|Lost to Follow-up|2|||
130220384|NCT03472521|468770204|FG000|Overall Study|Discontinued intervention|3|||
130220385|NCT03472521|468770205|FG001|Overall Study|Discontinued intervention|1|||
130220386|NCT02385110|468770206|FG000|Overall Study|Early Death|1|||
130220387|NCT02385110|468770207|FG001|Overall Study|Early Death|0|||
130220388|NCT00181883|468770212|FG000|Overall Study|Lack of Efficacy|2|||
130220389|NCT00181883|468770212|FG000|Overall Study|Treatment Limiting AEs|3|||
130220390|NCT00181883|468770212|FG000|Overall Study|Withdrawal by Subject|4|||
130220391|NCT00181883|468770212|FG000|Overall Study|Lost to Follow-up|1|||
130220392|NCT00765817|468770213|FG000|Overall Study|Adverse Event|13|||
130220393|NCT00765817|468770214|FG001|Overall Study|Adverse Event|1|||
130220394|NCT00765817|468770213|FG000|Overall Study|Death|0|||
130017270|NCT01425008|468024464|FG006|Dose Escalation Phase|Adverse Event|0|||
130220395|NCT00765817|468770214|FG001|Overall Study|Death|1|||
130220396|NCT00765817|468770213|FG000|Overall Study|Entry criteria not met|2|||
130220397|NCT00765817|468770214|FG001|Overall Study|Entry criteria not met|2|||
130220398|NCT00765817|468770213|FG000|Overall Study|Loss of glucose control|0|||
130220399|NCT00765817|468770214|FG001|Overall Study|Loss of glucose control|2|||
130220400|NCT00765817|468770213|FG000|Overall Study|Lost to Follow-up|1|||
130220401|NCT00765817|468770214|FG001|Overall Study|Lost to Follow-up|3|||
130220402|NCT00765817|468770213|FG000|Overall Study|Physician Decision|2|||
130220403|NCT00765817|468770214|FG001|Overall Study|Physician Decision|1|||
130220404|NCT00765817|468770213|FG000|Overall Study|Protocol Violation|1|||
130220405|NCT00765817|468770214|FG001|Overall Study|Protocol Violation|1|||
130220406|NCT00765817|468770213|FG000|Overall Study|Subject decision|7|||
130220407|NCT00765817|468770214|FG001|Overall Study|Subject decision|11|||
130220408|NCT00103285|468772167|FG000|Induction|Adverse Event|14|||
130220409|NCT00103285|468772168|FG001|Induction|Adverse Event|0|||
130220410|NCT00103285|468772169|FG002|Induction|Adverse Event|0|||
130220411|NCT00103285|468772170|FG003|Induction|Adverse Event|0|||
130220412|NCT00103285|468772171|FG004|Induction|Adverse Event|0|||
130220413|NCT00103285|468772172|FG005|Induction|Adverse Event|0|||
130220414|NCT00103285|468772173|FG006|Induction|Adverse Event|0|||
130220415|NCT00103285|468772174|FG007|Induction|Adverse Event|0|||
130220416|NCT00103285|468772167|FG000|Induction|Death|24|||
130220417|NCT00103285|468772168|FG001|Induction|Death|0|||
130220418|NCT00103285|468772169|FG002|Induction|Death|0|||
130220419|NCT00103285|468772170|FG003|Induction|Death|0|||
130220420|NCT00103285|468772171|FG004|Induction|Death|0|||
130220421|NCT00103285|468772172|FG005|Induction|Death|0|||
130220422|NCT00103285|468772173|FG006|Induction|Death|0|||
130220423|NCT00103285|468772174|FG007|Induction|Death|0|||
130220424|NCT00103285|468772167|FG000|Induction|Physician Decision|103|||
130220425|NCT00103285|468772168|FG001|Induction|Physician Decision|0|||
130220426|NCT00103285|468772169|FG002|Induction|Physician Decision|0|||
130220427|NCT00103285|468772170|FG003|Induction|Physician Decision|0|||
130220428|NCT00103285|468772171|FG004|Induction|Physician Decision|0|||
129884433|NCT01275196|467536393|FG001|Overall Study|Protocol Violation|0|||
130220429|NCT00103285|468772172|FG005|Induction|Physician Decision|0|||
129884434|NCT01275196|467536392|FG000|Overall Study|Suboptimal response/treatment failure|5|||
129884435|NCT01275196|467536393|FG001|Overall Study|Suboptimal response/treatment failure|6|||
130017271|NCT01425008|468024465|FG007|Dose Escalation Phase|Adverse Event|0|||
130017272|NCT01425008|468024466|FG008|Dose Escalation Phase|Adverse Event|2|||
130017273|NCT01425008|468024467|FG009|Dose Escalation Phase|Adverse Event|0|||
130017274|NCT01425008|468024468|FG010|Dose Escalation Phase|Adverse Event|0|||
130017275|NCT01425008|468024469|FG011|Dose Escalation Phase|Adverse Event|0|||
130017276|NCT01425008|468024470|FG012|Dose Escalation Phase|Adverse Event|0|||
130017277|NCT01425008|468024471|FG013|Dose Escalation Phase|Adverse Event|0|||
130017278|NCT01425008|468024472|FG014|Dose Escalation Phase|Adverse Event|0|||
130017279|NCT01425008|468024473|FG015|Dose Escalation Phase|Adverse Event|0|||
130017280|NCT01425008|468024474|FG016|Dose Escalation Phase|Adverse Event|0|||
130017281|NCT01425008|468024475|FG017|Dose Escalation Phase|Adverse Event|0|||
130017282|NCT01425008|468024476|FG018|Dose Escalation Phase|Adverse Event|0|||
130220430|NCT00103285|468772173|FG006|Induction|Physician Decision|0|||
130220431|NCT00103285|468772174|FG007|Induction|Physician Decision|0|||
130220432|NCT00103285|468772167|FG000|Induction|Withdrawal by Subject|1|||
130220433|NCT00103285|468772168|FG001|Induction|Withdrawal by Subject|0|||
130220434|NCT00103285|468772169|FG002|Induction|Withdrawal by Subject|0|||
130220435|NCT00103285|468772170|FG003|Induction|Withdrawal by Subject|0|||
130220436|NCT00103285|468772171|FG004|Induction|Withdrawal by Subject|0|||
130220437|NCT00103285|468772172|FG005|Induction|Withdrawal by Subject|0|||
130220438|NCT00103285|468772173|FG006|Induction|Withdrawal by Subject|0|||
130220439|NCT00103285|468772174|FG007|Induction|Withdrawal by Subject|0|||
130220440|NCT00103285|468772167|FG000|Induction|Ineligible|43|||
130220441|NCT00103285|468772168|FG001|Induction|Ineligible|0|||
130220442|NCT00103285|468772169|FG002|Induction|Ineligible|0|||
130220443|NCT00103285|468772170|FG003|Induction|Ineligible|0|||
130220444|NCT00103285|468772171|FG004|Induction|Ineligible|0|||
130220445|NCT00103285|468772172|FG005|Induction|Ineligible|0|||
130220446|NCT00103285|468772173|FG006|Induction|Ineligible|0|||
130220447|NCT00103285|468772174|FG007|Induction|Ineligible|0|||
130220448|NCT00103285|468772167|FG000|Induction|Refusal|906|||
130220449|NCT00103285|468772168|FG001|Induction|Refusal|0|||
130220450|NCT00103285|468772169|FG002|Induction|Refusal|0|||
130220451|NCT00103285|468772170|FG003|Induction|Refusal|0|||
130220452|NCT00103285|468772171|FG004|Induction|Refusal|0|||
130220453|NCT00103285|468772172|FG005|Induction|Refusal|0|||
130220454|NCT00103285|468772173|FG006|Induction|Refusal|0|||
130220455|NCT00103285|468772174|FG007|Induction|Refusal|0|||
130220456|NCT00103285|468772167|FG000|Induction|Other|258|||
130220457|NCT00103285|468772168|FG001|Induction|Other|0|||
130220458|NCT00103285|468772169|FG002|Induction|Other|0|||
130220459|NCT00103285|468772170|FG003|Induction|Other|0|||
130220460|NCT00103285|468772171|FG004|Induction|Other|0|||
130220461|NCT00103285|468772172|FG005|Induction|Other|0|||
130220462|NCT00103285|468772173|FG006|Induction|Other|0|||
130220463|NCT00103285|468772174|FG007|Induction|Other|0|||
130220464|NCT00103285|468772167|FG000|Response Assignment|Adverse Event|0|||
130220465|NCT00103285|468772168|FG001|Response Assignment|Adverse Event|8|||
130220466|NCT00103285|468772169|FG002|Response Assignment|Adverse Event|3|||
130220467|NCT00103285|468772170|FG003|Response Assignment|Adverse Event|2|||
130220468|NCT00103285|468772171|FG004|Response Assignment|Adverse Event|3|||
130220469|NCT00103285|468772172|FG005|Response Assignment|Adverse Event|1|||
130220470|NCT00103285|468772173|FG006|Response Assignment|Adverse Event|1|||
130220471|NCT00103285|468772174|FG007|Response Assignment|Adverse Event|2|||
130220472|NCT00103285|468772167|FG000|Response Assignment|Death|0|||
130220473|NCT00103285|468772168|FG001|Response Assignment|Death|5|||
130220474|NCT00103285|468772169|FG002|Response Assignment|Death|2|||
130220475|NCT00103285|468772170|FG003|Response Assignment|Death|2|||
130220476|NCT00103285|468772171|FG004|Response Assignment|Death|3|||
130220477|NCT00103285|468772172|FG005|Response Assignment|Death|1|||
130220478|NCT00103285|468772173|FG006|Response Assignment|Death|0|||
130220479|NCT00103285|468772174|FG007|Response Assignment|Death|8|||
130220480|NCT00103285|468772167|FG000|Response Assignment|Lost to Follow-up|0|||
130220481|NCT00103285|468772168|FG001|Response Assignment|Lost to Follow-up|9|||
129884436|NCT02572817|467536394|FG000|Overall Study|Death|6|||
130220482|NCT00103285|468772169|FG002|Response Assignment|Lost to Follow-up|5|||
130220483|NCT00103285|468772170|FG003|Response Assignment|Lost to Follow-up|5|||
130220484|NCT00103285|468772171|FG004|Response Assignment|Lost to Follow-up|1|||
130220485|NCT00103285|468772172|FG005|Response Assignment|Lost to Follow-up|2|||
130220486|NCT00103285|468772173|FG006|Response Assignment|Lost to Follow-up|2|||
130220487|NCT00103285|468772174|FG007|Response Assignment|Lost to Follow-up|5|||
130220488|NCT00103285|468772167|FG000|Response Assignment|Physician Decision|0|||
130220489|NCT00103285|468772168|FG001|Response Assignment|Physician Decision|13|||
130220490|NCT00103285|468772169|FG002|Response Assignment|Physician Decision|14|||
130220491|NCT00103285|468772170|FG003|Response Assignment|Physician Decision|9|||
130220492|NCT00103285|468772171|FG004|Response Assignment|Physician Decision|13|||
130220493|NCT00103285|468772172|FG005|Response Assignment|Physician Decision|7|||
130220494|NCT00103285|468772173|FG006|Response Assignment|Physician Decision|4|||
130017283|NCT01425008|468024458|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017284|NCT01425008|468024459|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130220495|NCT00103285|468772174|FG007|Response Assignment|Physician Decision|35|||
130220496|NCT00103285|468772167|FG000|Response Assignment|Protocol Violation|0|||
130220497|NCT00103285|468772168|FG001|Response Assignment|Protocol Violation|2|||
130220498|NCT00103285|468772169|FG002|Response Assignment|Protocol Violation|0|||
130220499|NCT00103285|468772170|FG003|Response Assignment|Protocol Violation|0|||
130220500|NCT00103285|468772171|FG004|Response Assignment|Protocol Violation|0|||
130220501|NCT00103285|468772172|FG005|Response Assignment|Protocol Violation|0|||
130220502|NCT00103285|468772173|FG006|Response Assignment|Protocol Violation|0|||
130017285|NCT01425008|468024460|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017286|NCT01425008|468024461|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017287|NCT01425008|468024462|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130017288|NCT01425008|468024463|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017289|NCT01425008|468024464|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
130017290|NCT01425008|468024465|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130017291|NCT01425008|468024466|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130017292|NCT01425008|468024467|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017293|NCT01425008|468024468|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130220503|NCT00103285|468772174|FG007|Response Assignment|Protocol Violation|0|||
130220504|NCT00103285|468772167|FG000|Response Assignment|Withdrawal by Subject|0|||
130220505|NCT00103285|468772168|FG001|Response Assignment|Withdrawal by Subject|4|||
130220506|NCT00103285|468772169|FG002|Response Assignment|Withdrawal by Subject|1|||
130220507|NCT00103285|468772170|FG003|Response Assignment|Withdrawal by Subject|1|||
130220508|NCT00103285|468772171|FG004|Response Assignment|Withdrawal by Subject|2|||
130220509|NCT00103285|468772172|FG005|Response Assignment|Withdrawal by Subject|2|||
130220510|NCT00103285|468772173|FG006|Response Assignment|Withdrawal by Subject|0|||
130220511|NCT00103285|468772174|FG007|Response Assignment|Withdrawal by Subject|2|||
130220512|NCT00103285|468772167|FG000|Response Assignment|Ineligible|0|||
130220513|NCT00103285|468772168|FG001|Response Assignment|Ineligible|8|||
130220514|NCT00103285|468772169|FG002|Response Assignment|Ineligible|6|||
130220515|NCT00103285|468772170|FG003|Response Assignment|Ineligible|2|||
130220516|NCT00103285|468772171|FG004|Response Assignment|Ineligible|0|||
130220517|NCT00103285|468772172|FG005|Response Assignment|Ineligible|3|||
130220518|NCT00103285|468772173|FG006|Response Assignment|Ineligible|1|||
130220519|NCT00103285|468772174|FG007|Response Assignment|Ineligible|5|||
130220520|NCT00103285|468772167|FG000|Response Assignment|Refusal|0|||
130017294|NCT01425008|468024469|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130220521|NCT00103285|468772168|FG001|Response Assignment|Refusal|53|||
130220522|NCT00103285|468772169|FG002|Response Assignment|Refusal|5|||
130220523|NCT00103285|468772170|FG003|Response Assignment|Refusal|3|||
130220524|NCT00103285|468772171|FG004|Response Assignment|Refusal|25|||
130220525|NCT00103285|468772172|FG005|Response Assignment|Refusal|15|||
130220526|NCT00103285|468772173|FG006|Response Assignment|Refusal|30|||
130220527|NCT00103285|468772174|FG007|Response Assignment|Refusal|10|||
130220528|NCT00103285|468772167|FG000|Response Assignment|Other|0|||
130220529|NCT00103285|468772168|FG001|Response Assignment|Other|30|||
130220530|NCT00103285|468772169|FG002|Response Assignment|Other|48|||
130220531|NCT00103285|468772170|FG003|Response Assignment|Other|38|||
130220532|NCT00103285|468772171|FG004|Response Assignment|Other|37|||
130220533|NCT00103285|468772172|FG005|Response Assignment|Other|17|||
130220534|NCT00103285|468772173|FG006|Response Assignment|Other|11|||
130220535|NCT00103285|468772174|FG007|Response Assignment|Other|53|||
130220536|NCT00452439|468772176|FG000|Overall Study|Lost to Follow-up|1|||
130220537|NCT00452439|468772177|FG001|Overall Study|Lost to Follow-up|1|||
130220538|NCT00452439|468772176|FG000|Overall Study|Refused Treatment|4|||
130220539|NCT00452439|468772177|FG001|Overall Study|Refused Treatment|3|||
130220540|NCT00452439|468772176|FG000|Overall Study|Death|3|||
130220541|NCT00452439|468772177|FG001|Overall Study|Death|1|||
130220542|NCT00452439|468772176|FG000|Overall Study|Bone Marrow Transplant|0|||
130220543|NCT00452439|468772177|FG001|Overall Study|Bone Marrow Transplant|1|||
130220544|NCT00452439|468772176|FG000|Overall Study|Too Ill to Continue|0|||
130220545|NCT00452439|468772177|FG001|Overall Study|Too Ill to Continue|1|||
130220546|NCT00452439|468772176|FG000|Overall Study|Failed to achieve complete response|2|||
130220547|NCT00452439|468772177|FG001|Overall Study|Failed to achieve complete response|0|||
130220548|NCT00452439|468772176|FG000|Overall Study|Relapse|3|||
130220549|NCT00452439|468772177|FG001|Overall Study|Relapse|0|||
130220550|NCT00452439|468772176|FG000|Overall Study|Fracture|1|||
130220551|NCT00452439|468772177|FG001|Overall Study|Fracture|0|||
130220552|NCT01302418|468772179|FG000|Overall Study|Protocol Violation|9|||
130220553|NCT01302418|468772179|FG000|Overall Study|Non-evaluable|9|||
130220554|NCT00377637|468772180|FG000|Induction Phase|Adverse Event|12|||
130220555|NCT00377637|468772181|FG001|Induction Phase|Adverse Event|21|||
130220556|NCT00377637|468772182|FG002|Induction Phase|Adverse Event|0|||
130220557|NCT00377637|468772183|FG003|Induction Phase|Adverse Event|0|||
130220558|NCT00377637|468772180|FG000|Induction Phase|Deterioration/serum creatinine|2|||
130220559|NCT00377637|468772181|FG001|Induction Phase|Deterioration/serum creatinine|0|||
130220560|NCT00377637|468772182|FG002|Induction Phase|Deterioration/serum creatinine|0|||
130220561|NCT00377637|468772183|FG003|Induction Phase|Deterioration/serum creatinine|0|||
130220562|NCT00377637|468772180|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130220563|NCT00377637|468772181|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
130220564|NCT00377637|468772182|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130220565|NCT00377637|468772183|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
130220566|NCT00377637|468772180|FG000|Induction Phase|Lost to Follow-up|2|||
130220567|NCT00377637|468772181|FG001|Induction Phase|Lost to Follow-up|1|||
130220568|NCT00377637|468772182|FG002|Induction Phase|Lost to Follow-up|0|||
130220569|NCT00377637|468772183|FG003|Induction Phase|Lost to Follow-up|0|||
130220570|NCT00377637|468772180|FG000|Induction Phase|Death|1|||
130220571|NCT00377637|468772181|FG001|Induction Phase|Death|3|||
130220572|NCT00377637|468772182|FG002|Induction Phase|Death|0|||
130220573|NCT00377637|468772183|FG003|Induction Phase|Death|0|||
130220574|NCT00377637|468772180|FG000|Induction Phase|Withdrawal by Subject|5|||
130220575|NCT00377637|468772181|FG001|Induction Phase|Withdrawal by Subject|6|||
130220576|NCT00377637|468772182|FG002|Induction Phase|Withdrawal by Subject|0|||
130220577|NCT00377637|468772183|FG003|Induction Phase|Withdrawal by Subject|0|||
130220578|NCT00377637|468772180|FG000|Induction Phase|Physician Decision|3|||
130220579|NCT00377637|468772181|FG001|Induction Phase|Physician Decision|1|||
130220580|NCT00377637|468772182|FG002|Induction Phase|Physician Decision|0|||
130220581|NCT00377637|468772183|FG003|Induction Phase|Physician Decision|0|||
130220582|NCT00377637|468772180|FG000|Induction Phase|Sponsor decision|1|||
130220583|NCT00377637|468772181|FG001|Induction Phase|Sponsor decision|2|||
130220584|NCT00377637|468772182|FG002|Induction Phase|Sponsor decision|0|||
130220585|NCT00377637|468772183|FG003|Induction Phase|Sponsor decision|0|||
130220586|NCT00377637|468772180|FG000|Induction Phase|Non-Compliance|1|||
130220587|NCT00377637|468772181|FG001|Induction Phase|Non-Compliance|0|||
130220588|NCT00377637|468772182|FG002|Induction Phase|Non-Compliance|0|||
130220589|NCT00377637|468772183|FG003|Induction Phase|Non-Compliance|0|||
130220590|NCT00377637|468772180|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
130220591|NCT00377637|468772181|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
130220592|NCT00377637|468772182|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
130220593|NCT00377637|468772183|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
130220594|NCT00377637|468772180|FG000|Maintenance Phase|Adverse Event|0|||
130220595|NCT00377637|468772181|FG001|Maintenance Phase|Adverse Event|0|||
130220596|NCT00377637|468772182|FG002|Maintenance Phase|Adverse Event|29|||
130220597|NCT00377637|468772183|FG003|Maintenance Phase|Adverse Event|43|||
130220598|NCT00377637|468772180|FG000|Maintenance Phase|Physician Decision|0|||
130220599|NCT00377637|468772181|FG001|Maintenance Phase|Physician Decision|0|||
130220600|NCT00377637|468772182|FG002|Maintenance Phase|Physician Decision|5|||
130220601|NCT00377637|468772183|FG003|Maintenance Phase|Physician Decision|4|||
130220602|NCT00377637|468772180|FG000|Maintenance Phase|Lost to Follow-up|0|||
130220603|NCT00377637|468772181|FG001|Maintenance Phase|Lost to Follow-up|0|||
130220604|NCT00377637|468772182|FG002|Maintenance Phase|Lost to Follow-up|3|||
130220605|NCT00377637|468772183|FG003|Maintenance Phase|Lost to Follow-up|1|||
130220606|NCT00377637|468772180|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130220607|NCT00377637|468772181|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130220608|NCT00377637|468772182|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130220609|NCT00377637|468772183|FG003|Maintenance Phase|Withdrawal by Subject|3|||
130220610|NCT00377637|468772180|FG000|Maintenance Phase|Sponsor decision|0|||
130220611|NCT00377637|468772181|FG001|Maintenance Phase|Sponsor decision|0|||
130220612|NCT00377637|468772182|FG002|Maintenance Phase|Sponsor decision|2|||
130220613|NCT00377637|468772183|FG003|Maintenance Phase|Sponsor decision|3|||
130220614|NCT00377637|468772180|FG000|Maintenance Phase|Non-compliance|0|||
130220615|NCT00377637|468772181|FG001|Maintenance Phase|Non-compliance|0|||
130220616|NCT00377637|468772182|FG002|Maintenance Phase|Non-compliance|1|||
130220617|NCT00377637|468772183|FG003|Maintenance Phase|Non-compliance|1|||
130220618|NCT00377637|468772180|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
130220619|NCT00377637|468772181|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
130220620|NCT00377637|468772182|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
130220621|NCT00377637|468772183|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
130220622|NCT00377637|468772180|FG000|Maintenance Phase|Death|0|||
130220623|NCT00377637|468772181|FG001|Maintenance Phase|Death|0|||
130220624|NCT00377637|468772182|FG002|Maintenance Phase|Death|0|||
130220625|NCT00377637|468772183|FG003|Maintenance Phase|Death|1|||
130220626|NCT00994110|468772185|FG000|Overall Study|Withdrawal by Subject|9|||
130220627|NCT00994110|468772186|FG001|Overall Study|Withdrawal by Subject|9|||
130220628|NCT00994110|468772185|FG000|Overall Study|Not Treated|4|||
130220629|NCT00994110|468772186|FG001|Overall Study|Not Treated|8|||
130220630|NCT00994110|468772185|FG000|Overall Study|Adverse Event|1|||
130220631|NCT00994110|468772186|FG001|Overall Study|Adverse Event|0|||
130220632|NCT00994110|468772185|FG000|Overall Study|Patient not resected|41|||
130220633|NCT00994110|468772186|FG001|Overall Study|Patient not resected|52|||
130220634|NCT00994110|468772185|FG000|Overall Study|Pt not eligible|10|||
130220635|NCT00994110|468772186|FG001|Overall Study|Pt not eligible|5|||
130220636|NCT00368108|468772187|FG000|Overall Study|Adverse Event|38|||
130220637|NCT00368108|468772188|FG001|Overall Study|Adverse Event|26|||
130220638|NCT00368108|468772189|FG002|Overall Study|Adverse Event|44|||
130220639|NCT00368108|468772187|FG000|Overall Study|Abnormal Laboratory Value|0|||
130220640|NCT00368108|468772188|FG001|Overall Study|Abnormal Laboratory Value|0|||
130220641|NCT00368108|468772189|FG002|Overall Study|Abnormal Laboratory Value|3|||
130220642|NCT00368108|468772187|FG000|Overall Study|Protocol Violation|5|||
130220643|NCT00368108|468772188|FG001|Overall Study|Protocol Violation|9|||
130220644|NCT00368108|468772189|FG002|Overall Study|Protocol Violation|9|||
130220645|NCT00368108|468772187|FG000|Overall Study|Withdrawal by Subject|9|||
130220646|NCT00368108|468772188|FG001|Overall Study|Withdrawal by Subject|3|||
130220647|NCT00368108|468772189|FG002|Overall Study|Withdrawal by Subject|5|||
130220648|NCT00368108|468772187|FG000|Overall Study|Lack of Efficacy|7|||
130220649|NCT00368108|468772188|FG001|Overall Study|Lack of Efficacy|8|||
130220650|NCT00368108|468772189|FG002|Overall Study|Lack of Efficacy|5|||
130220651|NCT00368108|468772187|FG000|Overall Study|Physician Decision|2|||
130220652|NCT00368108|468772188|FG001|Overall Study|Physician Decision|0|||
130220653|NCT00368108|468772189|FG002|Overall Study|Physician Decision|1|||
130220654|NCT00368108|468772187|FG000|Overall Study|Other|3|||
130220655|NCT00368108|468772188|FG001|Overall Study|Other|7|||
130220656|NCT00368108|468772189|FG002|Overall Study|Other|1|||
130220657|NCT00130689|468772190|FG000|Overall Study|Progressive Disease|29|||
130220658|NCT00130689|468772190|FG000|Overall Study|Death|1|||
130220659|NCT00130689|468772190|FG000|Overall Study|Clinical Deterioration|4|||
130220660|NCT00130689|468772190|FG000|Overall Study|Withdrawal by Subject|3|||
130220661|NCT00130689|468772190|FG000|Overall Study|Ineligible|6|||
130220662|NCT01254656|468772191|FG000|Overall Study|Discontinued due to termination of study|40|||
130220663|NCT01254656|468772192|FG001|Overall Study|Discontinued due to termination of study|39|||
130220664|NCT01254656|468772193|FG002|Overall Study|Discontinued due to termination of study|13|||
130220665|NCT01254656|468772191|FG000|Overall Study|Lack of Efficacy|3|||
130220666|NCT01254656|468772192|FG001|Overall Study|Lack of Efficacy|0|||
130220667|NCT01254656|468772193|FG002|Overall Study|Lack of Efficacy|0|||
130220668|NCT01254656|468772191|FG000|Overall Study|Lost to Follow-up|1|||
130220669|NCT01254656|468772192|FG001|Overall Study|Lost to Follow-up|0|||
130220670|NCT01254656|468772193|FG002|Overall Study|Lost to Follow-up|2|||
130220671|NCT01254656|468772191|FG000|Overall Study|Withdrawal by Subject|2|||
130220672|NCT01254656|468772192|FG001|Overall Study|Withdrawal by Subject|2|||
130220673|NCT01254656|468772193|FG002|Overall Study|Withdrawal by Subject|1|||
130220674|NCT01254656|468772191|FG000|Overall Study|Pregnancy|0|||
130220675|NCT01254656|468772192|FG001|Overall Study|Pregnancy|0|||
130220676|NCT01254656|468772193|FG002|Overall Study|Pregnancy|2|||
130220677|NCT01254656|468772191|FG000|Overall Study|Adverse Event|1|||
130220678|NCT01254656|468772192|FG001|Overall Study|Adverse Event|1|||
130220679|NCT01254656|468772193|FG002|Overall Study|Adverse Event|0|||
130220680|NCT01254656|468772191|FG000|Overall Study|Death|0|||
130220681|NCT01254656|468772192|FG001|Overall Study|Death|1|||
130220682|NCT01254656|468772193|FG002|Overall Study|Death|0|||
130220683|NCT03200548|468772198|FG000|Overall Study|Withdrawal by Subject|5|||
130220684|NCT03200548|468772199|FG001|Overall Study|Withdrawal by Subject|11|||
130220685|NCT03200548|468772200|FG002|Overall Study|Withdrawal by Subject|7|||
130220686|NCT03200548|468772201|FG003|Overall Study|Withdrawal by Subject|6|||
130220687|NCT00716456|468772202|FG000|Overall Study|Adverse Event|0|||
130220688|NCT00716456|468772203|FG001|Overall Study|Adverse Event|2|||
130220689|NCT00716456|468772204|FG002|Overall Study|Adverse Event|0|||
130220690|NCT00447772|468772205|FG000|Overall Study|Lack of Efficacy|3|||
130220691|NCT00447772|468772205|FG000|Overall Study|Insufficient compliance|6|||
130220692|NCT00447772|468772205|FG000|Overall Study|Discontinuation of drug therapy|1|||
130220693|NCT00447772|468772205|FG000|Overall Study|Lost to Follow-up|9|||
130220694|NCT00447772|468772205|FG000|Overall Study|Withdrawal by Subject|1|||
130220695|NCT00447772|468772205|FG000|Overall Study|Unable to attend all study visits|2|||
130220696|NCT00447772|468772205|FG000|Overall Study|Adverse Event|1|||
130220697|NCT00447772|468772205|FG000|Overall Study|Patient relocated|1|||
130220698|NCT00447772|468772205|FG000|Overall Study|Incomplete documentation at visit 1|1|||
130220699|NCT00447772|468772205|FG000|Overall Study|Chemotherapy for lung cancer|1|||
130220700|NCT00447772|468772205|FG000|Overall Study|Premature re-injection required|1|||
130220701|NCT00875563|468772210|FG000|Overall Study|Death|4|||
130220702|NCT00875563|468772210|FG000|Overall Study|Withdrawal by Subject|7|||
130220703|NCT00875563|468772210|FG000|Overall Study|No long-term (3-5 year) consent|6|||
130220704|NCT00875563|468772210|FG000|Overall Study|Still be eligible for follow-up|7|||
130220705|NCT02896569|468772213|FG000|Overall Study|Lost to Follow-up|2|||
130220706|NCT02896569|468772214|FG001|Overall Study|Lost to Follow-up|1|||
130220707|NCT02896569|468772213|FG000|Overall Study|Physician Decision|1|||
130220708|NCT02896569|468772214|FG001|Overall Study|Physician Decision|3|||
130220709|NCT02896569|468772213|FG000|Overall Study|Adverse Event|0|||
130220710|NCT02896569|468772214|FG001|Overall Study|Adverse Event|1|||
130220711|NCT02896569|468772213|FG000|Overall Study|Withdrawal by Subject|1|||
130220712|NCT02896569|468772214|FG001|Overall Study|Withdrawal by Subject|0|||
130220713|NCT01462630|468772215|FG000|Overall Study|Did not initiate therapy|3|||
130220714|NCT01462630|468772215|FG000|Overall Study|Death|1|||
130220715|NCT01462630|468772215|FG000|Overall Study|Protocol Violation|2|||
130220716|NCT01462630|468772215|FG000|Overall Study|Adverse Event|1|||
130220717|NCT03257436|468772216|FG000|Overall Study|Withdrawal by Subject|76|||
130220718|NCT03257436|468772216|FG000|Overall Study|Death|19|||
130220719|NCT00970489|468772219|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
130220720|NCT00970489|468772220|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
130220721|NCT05417412|468772221|FG000|Overall Study|Lost to Follow-up|2|||
130220722|NCT03478371|468772224|FG000|Overall Study|non-compliance|1|||
130220723|NCT03478371|468772224|FG000|Overall Study|Lost to Follow-up|4|||
130220724|NCT02849743|468772225|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
130220725|NCT02849743|468772226|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
130220726|NCT02849743|468772225|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130220727|NCT02849743|468772226|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130220728|NCT03874013|468772231|FG000|Overall Study|Adverse Event|0|||
130220729|NCT03874013|468772232|FG001|Overall Study|Adverse Event|1|||
130220730|NCT01096160|468772234|FG000|Overall Study|Adverse Event|0|||
130220731|NCT01096160|468772235|FG001|Overall Study|Adverse Event|0|||
130220732|NCT01096160|468772236|FG002|Overall Study|Adverse Event|1|||
130220733|NCT01096160|468772237|FG003|Overall Study|Adverse Event|0|||
130220734|NCT01096160|468772238|FG004|Overall Study|Adverse Event|0|||
130220735|NCT01096160|468772239|FG005|Overall Study|Adverse Event|0|||
130220736|NCT01096160|468772240|FG006|Overall Study|Adverse Event|0|||
130220737|NCT01096160|468772241|FG007|Overall Study|Adverse Event|0|||
130220738|NCT01096160|468772242|FG008|Overall Study|Adverse Event|0|||
130220739|NCT01096160|468772243|FG009|Overall Study|Adverse Event|1|||
130220740|NCT01096160|468772234|FG000|Overall Study|Met stopping criteria per protocol|0|||
130220741|NCT01096160|468772235|FG001|Overall Study|Met stopping criteria per protocol|0|||
130220742|NCT01096160|468772236|FG002|Overall Study|Met stopping criteria per protocol|0|||
130220743|NCT01096160|468772237|FG003|Overall Study|Met stopping criteria per protocol|0|||
130220744|NCT01096160|468772238|FG004|Overall Study|Met stopping criteria per protocol|1|||
130220745|NCT01096160|468772239|FG005|Overall Study|Met stopping criteria per protocol|0|||
130220746|NCT01096160|468772240|FG006|Overall Study|Met stopping criteria per protocol|2|||
130220747|NCT01096160|468772241|FG007|Overall Study|Met stopping criteria per protocol|0|||
130220748|NCT01096160|468772242|FG008|Overall Study|Met stopping criteria per protocol|2|||
130220749|NCT01096160|468772243|FG009|Overall Study|Met stopping criteria per protocol|0|||
130220750|NCT00922116|468772245|FG000|Overall Study|Adverse Event|4|||
130220751|NCT00922116|468772245|FG000|Overall Study|Death|1|||
130220752|NCT00922116|468772245|FG000|Overall Study|Lost to Follow-up|1|||
130220753|NCT00922116|468772245|FG000|Overall Study|Withdrawal by Subject|4|||
130220754|NCT00922116|468772245|FG000|Overall Study|Other|5|||
130220755|NCT04607135|468772246|FG000|Overall Study|Physician Decision|1|||
130220756|NCT04607135|468772246|FG000|Overall Study|Withdrawal by Subject|1|||
130220757|NCT04607135|468772246|FG000|Overall Study|Equipment not working|3|||
130220758|NCT06060496|468772247|FG000|Overall Study|Withdrawal by Subject|2|||
130220759|NCT06060496|468772247|FG000|Overall Study|Lost to Follow-up|2|||
130220760|NCT03990051|468772248|FG000|Masked Period|Lost to Follow-up|1|||
130220761|NCT03990051|468772249|FG001|Masked Period|Lost to Follow-up|0|||
130220762|NCT03990051|468772248|FG000|Long Term Period|Death|1|||
130220763|NCT03990051|468772249|FG001|Long Term Period|Death|1|||
130220764|NCT03990051|468772248|FG000|Long Term Period|Lost to Follow-up|7|||
130220765|NCT03990051|468772249|FG001|Long Term Period|Lost to Follow-up|2|||
130220766|NCT00618826|468772250|FG000|Overall Study|Adverse Event|1|||
130220767|NCT03193047|468772252|FG000|Overall Study|Physician Decision|1|||
130220768|NCT03193047|468772253|FG001|Overall Study|Physician Decision|0|||
130220769|NCT03193047|468772252|FG000|Overall Study|Participant Left State|1|||
130220770|NCT03193047|468772253|FG001|Overall Study|Participant Left State|0|||
130220771|NCT01509664|468772256|FG000|Overall Study|Lost to Follow-up|15|||
130220772|NCT01509664|468772257|FG001|Overall Study|Lost to Follow-up|21|||
130220773|NCT00149396|468772264|FG000|Overall Study|Death|15|||
130220774|NCT00149396|468772264|FG000|Overall Study|Withdrawal by Subject|1|||
130220775|NCT00149396|468772264|FG000|Overall Study|Subject noncompliance|2|||
130220776|NCT00149396|468772264|FG000|Overall Study|other treatment|5|||
130220777|NCT02364388|468772265|FG000|Overall Study|Protocol Violation|1|||
130220778|NCT02364388|468772265|FG000|Overall Study|Technical Failure|3|||
130220779|NCT02364388|468772265|FG000|Overall Study|No OA/US data|2|||
130220780|NCT02364388|468772265|FG000|Overall Study|No Biopsy|2|||
130220781|NCT00186485|468772268|FG000|Overall Study|Lost to Follow-up|3|||
130220782|NCT00905424|468772269|FG000|Overall Study|Lost to Follow-up|3|||
130220783|NCT00905424|468772270|FG001|Overall Study|Lost to Follow-up|3|||
130220784|NCT00905424|468772269|FG000|Overall Study|Withdrawal by Subject|1|||
130220785|NCT00905424|468772270|FG001|Overall Study|Withdrawal by Subject|2|||
130220786|NCT00905424|468772269|FG000|Overall Study|Adverse Event|4|||
130220787|NCT00905424|468772270|FG001|Overall Study|Adverse Event|2|||
130220788|NCT00905424|468772269|FG000|Overall Study|Non-compliance with study medication|2|||
130220789|NCT00905424|468772270|FG001|Overall Study|Non-compliance with study medication|0|||
130220790|NCT00905424|468772269|FG000|Overall Study|Sponsor decision|1|||
130220791|NCT00905424|468772270|FG001|Overall Study|Sponsor decision|0|||
130220792|NCT00905424|468772269|FG000|Overall Study|Positive urine drug screen|0|||
130220793|NCT00905424|468772270|FG001|Overall Study|Positive urine drug screen|1|||
130220794|NCT00905424|468772269|FG000|Overall Study|Non-adherence to visit schedule|0|||
130220795|NCT00905424|468772270|FG001|Overall Study|Non-adherence to visit schedule|1|||
130220796|NCT00379899|468772271|FG000|Overall Study|Adverse Event|7|||
130220797|NCT00379899|468772272|FG001|Overall Study|Adverse Event|3|||
130220798|NCT00379899|468772271|FG000|Overall Study|Death|10|||
130220799|NCT00379899|468772272|FG001|Overall Study|Death|10|||
130220800|NCT00379899|468772271|FG000|Overall Study|Lost to Follow-up|2|||
130220801|NCT00379899|468772272|FG001|Overall Study|Lost to Follow-up|4|||
130220802|NCT00379899|468772271|FG000|Overall Study|Physician Decision|3|||
130220803|NCT00379899|468772272|FG001|Overall Study|Physician Decision|4|||
130220804|NCT00379899|468772271|FG000|Overall Study|Withdrawal by Subject|5|||
130220805|NCT00379899|468772272|FG001|Overall Study|Withdrawal by Subject|5|||
130220806|NCT00379899|468772271|FG000|Overall Study|Ineligibility determined|0|||
130220807|NCT00379899|468772272|FG001|Overall Study|Ineligibility determined|1|||
130220808|NCT00379899|468772271|FG000|Overall Study|Noncompliance|1|||
130220809|NCT00379899|468772272|FG001|Overall Study|Noncompliance|1|||
130220810|NCT00379899|468772271|FG000|Overall Study|Parathyroidectomy|0|||
130220811|NCT00379899|468772272|FG001|Overall Study|Parathyroidectomy|2|||
130220812|NCT00379899|468772271|FG000|Overall Study|Renal transplantation|5|||
130220813|NCT00379899|468772272|FG001|Overall Study|Renal transplantation|4|||
130220814|NCT00379899|468772271|FG000|Overall Study|Coronary artery bypass graft|1|||
130220815|NCT00379899|468772272|FG001|Overall Study|Coronary artery bypass graft|1|||
130220816|NCT00379899|468772271|FG000|Overall Study|Other protocol-specified criteria|3|||
130220817|NCT00379899|468772272|FG001|Overall Study|Other protocol-specified criteria|4|||
130220818|NCT00379899|468772271|FG000|Overall Study|Other|3|||
130220819|NCT00379899|468772272|FG001|Overall Study|Other|1|||
130220820|NCT05225389|468772273|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
130220821|NCT03311841|468772274|FG000|14-day Wash-out|Adverse Event|0|||
130220822|NCT03311841|468772275|FG001|14-day Wash-out|Adverse Event|1|||
130220823|NCT03311841|468772276|FG002|14-day Wash-out|Adverse Event|0|||
130220824|NCT03311841|468772277|FG003|14-day Wash-out|Adverse Event|0|||
130220825|NCT03311841|468772278|FG004|14-day Wash-out|Adverse Event|0|||
130220826|NCT03311841|468772274|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220827|NCT03311841|468772275|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220828|NCT03311841|468772276|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220829|NCT03311841|468772277|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
130220830|NCT03311841|468772278|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
130220831|NCT01026948|468772279|FG000|Overall Study|Physician Decision|8|||
130220832|NCT00627926|468772280|FG000|Overall Study|Adverse Event|26|||
130220833|NCT00627926|468772281|FG001|Overall Study|Adverse Event|37|||
130220834|NCT00627926|468772282|FG002|Overall Study|Adverse Event|36|||
130220835|NCT00627926|468772280|FG000|Overall Study|Death|1|||
130220836|NCT00627926|468772281|FG001|Overall Study|Death|0|||
130220837|NCT00627926|468772282|FG002|Overall Study|Death|0|||
130220838|NCT00627926|468772280|FG000|Overall Study|Lost to Follow-up|4|||
130220839|NCT00627926|468772281|FG001|Overall Study|Lost to Follow-up|3|||
130220840|NCT00627926|468772282|FG002|Overall Study|Lost to Follow-up|4|||
130220841|NCT00627926|468772280|FG000|Overall Study|Withdrawal by Subject|2|||
130220842|NCT00627926|468772281|FG001|Overall Study|Withdrawal by Subject|1|||
130220843|NCT00627926|468772282|FG002|Overall Study|Withdrawal by Subject|0|||
130220844|NCT00627926|468772280|FG000|Overall Study|Lack of Efficacy|118|||
130220845|NCT00627926|468772281|FG001|Overall Study|Lack of Efficacy|40|||
130220846|NCT00627926|468772282|FG002|Overall Study|Lack of Efficacy|38|||
130220847|NCT00627926|468772280|FG000|Overall Study|Noncompliance/unspecified|8|||
130220848|NCT00627926|468772281|FG001|Overall Study|Noncompliance/unspecified|23|||
130220849|NCT00627926|468772282|FG002|Overall Study|Noncompliance/unspecified|17|||
130220850|NCT03360019|468772290|FG000|Overall Study|Withdrawal by Subject|2|||
130017295|NCT01425008|468024470|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017296|NCT01425008|468024471|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017297|NCT01425008|468024472|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017298|NCT01425008|468024473|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017299|NCT01425008|468024474|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017300|NCT01425008|468024475|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017301|NCT01425008|468024476|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130017302|NCT01425008|468024458|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130017303|NCT01425008|468024459|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130017304|NCT01425008|468024460|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130017305|NCT01425008|468024461|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130017306|NCT01425008|468024462|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
130017307|NCT01425008|468024463|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
130017308|NCT01425008|468024464|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
130017309|NCT01425008|468024465|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
130017310|NCT01425008|468024466|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
130017311|NCT01425008|468024467|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
130017312|NCT01425008|468024468|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
130017313|NCT01425008|468024469|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
130017314|NCT01425008|468024470|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
130017315|NCT01425008|468024471|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
130017316|NCT01425008|468024472|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
130017317|NCT01425008|468024473|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
130017318|NCT01425008|468024474|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
130017319|NCT01425008|468024475|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
130017320|NCT01425008|468024476|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
130017321|NCT01425008|468024458|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017322|NCT01425008|468024459|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017323|NCT01425008|468024460|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
130220851|NCT03360019|468772291|FG001|Overall Study|Withdrawal by Subject|0|||
130220852|NCT03360019|468772292|FG002|Overall Study|Withdrawal by Subject|0|||
130017324|NCT01425008|468024461|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017325|NCT01425008|468024462|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017326|NCT01425008|468024463|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
130220853|NCT03360019|468772290|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
130220854|NCT03360019|468772291|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
130220855|NCT03360019|468772292|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
130220856|NCT01462110|468772293|FG000|Overall Study|Adverse Event|1|||
130220857|NCT01462110|468772294|FG001|Overall Study|Adverse Event|0|||
130220858|NCT00753675|468772295|FG000|Overall Study|other reason|11|||
130220859|NCT00753675|468772296|FG001|Overall Study|other reason|12|||
130220860|NCT00753675|468772297|FG002|Overall Study|other reason|13|||
130220861|NCT00753675|468772295|FG000|Overall Study|Death|1|||
130220862|NCT00753675|468772296|FG001|Overall Study|Death|2|||
130220863|NCT00753675|468772297|FG002|Overall Study|Death|4|||
130220864|NCT00753675|468772295|FG000|Overall Study|Adverse Event|11|||
130220865|NCT00753675|468772296|FG001|Overall Study|Adverse Event|9|||
130220866|NCT00753675|468772297|FG002|Overall Study|Adverse Event|4|||
130220867|NCT00753675|468772295|FG000|Overall Study|Objective progression of disease|35|||
130220868|NCT00753675|468772296|FG001|Overall Study|Objective progression of disease|35|||
130220869|NCT00753675|468772297|FG002|Overall Study|Objective progression of disease|35|||
130220870|NCT00753675|468772295|FG000|Overall Study|Withdrawal by Subject|0|||
130220871|NCT00753675|468772296|FG001|Overall Study|Withdrawal by Subject|1|||
130220872|NCT00753675|468772297|FG002|Overall Study|Withdrawal by Subject|0|||
130220873|NCT00753675|468772295|FG000|Overall Study|Lost to Follow-up|1|||
130220874|NCT00753675|468772296|FG001|Overall Study|Lost to Follow-up|0|||
130220875|NCT00753675|468772297|FG002|Overall Study|Lost to Follow-up|0|||
130220876|NCT02149264|468772303|FG000|Overall Study|Withdrawal by Subject|9|||
130220877|NCT02149264|468772303|FG000|Overall Study|Adverse Event|7|||
130220878|NCT02149264|468772303|FG000|Overall Study|Physician Decision|3|||
130220879|NCT02149264|468772303|FG000|Overall Study|Protocol Violation|1|||
130220880|NCT03283930|468772304|FG000|Overall Study|Scheduling conflict|8|||
130220881|NCT03283930|468772305|FG001|Overall Study|Scheduling conflict|10|||
130220882|NCT03283930|468772304|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
130220883|NCT03283930|468772305|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
130220884|NCT03283930|468772304|FG000|Overall Study|Technical software issue|2|||
130220885|NCT03283930|468772305|FG001|Overall Study|Technical software issue|2|||
130220886|NCT00805129|468772306|FG000|Overall Study|Not treated|1|||
130220887|NCT02499120|468772310|FG000|Overall Study|Death|52|||
130220888|NCT02499120|468772311|FG001|Overall Study|Death|43|||
130220889|NCT02499120|468772310|FG000|Overall Study|Lost to Follow-up|1|||
130220890|NCT02499120|468772311|FG001|Overall Study|Lost to Follow-up|2|||
130220891|NCT02499120|468772310|FG000|Overall Study|Participant refused further follow-up|1|||
130220892|NCT02499120|468772311|FG001|Overall Study|Participant refused further follow-up|0|||
130220893|NCT02499120|468772310|FG000|Overall Study|Withdrawal by Subject|2|||
130220894|NCT02499120|468772311|FG001|Overall Study|Withdrawal by Subject|5|||
130220895|NCT02499120|468772310|FG000|Overall Study|Other|9|||
130220896|NCT02499120|468772311|FG001|Overall Study|Other|10|||
130220897|NCT01839916|468772320|FG000|Overall Study|Death|9|||
130220898|NCT01839916|468772320|FG000|Overall Study|Physician Decision|17|||
130220899|NCT01839916|468772320|FG000|Overall Study|Relapse|12|||
130220900|NCT01839916|468772320|FG000|Overall Study|GVHD|2|||
130220901|NCT01839916|468772320|FG000|Overall Study|Graft Failure|1|||
130220902|NCT04235504|468772325|FG000|Study Phase|Withdrawal by Subject|5|||
130220903|NCT04235504|468772326|FG001|Study Phase|Withdrawal by Subject|2|||
130220904|NCT04235504|468772327|FG002|Study Phase|Withdrawal by Subject|0|||
130220905|NCT04235504|468772328|FG003|Study Phase|Withdrawal by Subject|0|||
130220906|NCT04235504|468772325|FG000|Continuation Phase|Withdrawal by Subject|0|||
130220907|NCT04235504|468772326|FG001|Continuation Phase|Withdrawal by Subject|4|||
130220908|NCT04235504|468772327|FG002|Continuation Phase|Withdrawal by Subject|0|||
130220909|NCT04235504|468772328|FG003|Continuation Phase|Withdrawal by Subject|0|||
130220910|NCT04235504|468772325|FG000|Continuation Phase|Adverse Event|0|||
130220911|NCT04235504|468772326|FG001|Continuation Phase|Adverse Event|1|||
130220912|NCT04235504|468772327|FG002|Continuation Phase|Adverse Event|0|||
130220913|NCT04235504|468772328|FG003|Continuation Phase|Adverse Event|0|||
130220914|NCT04235504|468772325|FG000|Continuation Phase|Physician Decision|1|||
130220915|NCT04235504|468772326|FG001|Continuation Phase|Physician Decision|2|||
130220916|NCT04235504|468772327|FG002|Continuation Phase|Physician Decision|1|||
130220917|NCT04235504|468772328|FG003|Continuation Phase|Physician Decision|0|||
130220918|NCT02106351|468772335|FG000|Treatment Cycle 1|Adverse Event|2|||
130220919|NCT02106351|468772336|FG001|Treatment Cycle 1|Adverse Event|0|||
130220920|NCT02106351|468772337|FG002|Treatment Cycle 1|Adverse Event|0|||
130220921|NCT02106351|468772335|FG000|Treatment Cycle 1|Consent withdrawn|1|||
130220922|NCT02106351|468772336|FG001|Treatment Cycle 1|Consent withdrawn|0|||
130220923|NCT02106351|468772337|FG002|Treatment Cycle 1|Consent withdrawn|2|||
130220924|NCT02106351|468772335|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130220925|NCT02106351|468772336|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
130220926|NCT02106351|468772337|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
130220927|NCT02106351|468772335|FG000|Treatment Cycle 1|Other|0|||
130220928|NCT02106351|468772336|FG001|Treatment Cycle 1|Other|3|||
130220929|NCT02106351|468772337|FG002|Treatment Cycle 1|Other|1|||
130220930|NCT02106351|468772335|FG000|Treatment Cycle 1|Randomised but not treated|1|||
130220931|NCT02106351|468772336|FG001|Treatment Cycle 1|Randomised but not treated|0|||
130220932|NCT02106351|468772337|FG002|Treatment Cycle 1|Randomised but not treated|1|||
130220933|NCT02106351|468772335|FG000|Treatment Cycle 2|Adverse Event|0|||
130220934|NCT02106351|468772336|FG001|Treatment Cycle 2|Adverse Event|2|||
130220935|NCT02106351|468772337|FG002|Treatment Cycle 2|Adverse Event|0|||
130220936|NCT02106351|468772335|FG000|Treatment Cycle 2|Consent withdrawn|0|||
130220937|NCT02106351|468772336|FG001|Treatment Cycle 2|Consent withdrawn|1|||
130220938|NCT02106351|468772337|FG002|Treatment Cycle 2|Consent withdrawn|1|||
130220939|NCT02106351|468772335|FG000|Treatment Cycle 2|Other|0|||
130220940|NCT02106351|468772336|FG001|Treatment Cycle 2|Other|2|||
130220941|NCT02106351|468772337|FG002|Treatment Cycle 2|Other|2|||
130220942|NCT02106351|468772335|FG000|Treatment Cycle 3|Adverse Event|0|||
130220943|NCT02106351|468772336|FG001|Treatment Cycle 3|Adverse Event|1|||
130220944|NCT02106351|468772337|FG002|Treatment Cycle 3|Adverse Event|0|||
130220945|NCT02106351|468772335|FG000|Treatment Cycle 3|Consent withdrawn|0|||
130220946|NCT02106351|468772336|FG001|Treatment Cycle 3|Consent withdrawn|0|||
130220947|NCT02106351|468772337|FG002|Treatment Cycle 3|Consent withdrawn|2|||
130220948|NCT02106351|468772335|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
130220949|NCT02106351|468772336|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
130220950|NCT02106351|468772337|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
130220951|NCT02106351|468772335|FG000|Treatment Cycle 3|Other|0|||
130220952|NCT02106351|468772336|FG001|Treatment Cycle 3|Other|2|||
130220953|NCT02106351|468772337|FG002|Treatment Cycle 3|Other|3|||
130220954|NCT02106351|468772335|FG000|Treatment Cycle 4|Consent withdrawn|0|||
130220955|NCT02106351|468772336|FG001|Treatment Cycle 4|Consent withdrawn|0|||
130220956|NCT02106351|468772337|FG002|Treatment Cycle 4|Consent withdrawn|2|||
130220957|NCT02106351|468772335|FG000|Treatment Cycle 4|Other|0|||
130220958|NCT02106351|468772336|FG001|Treatment Cycle 4|Other|1|||
130220959|NCT02106351|468772337|FG002|Treatment Cycle 4|Other|0|||
130220960|NCT00101868|468772338|FG000|Overall Study|Death|10|||
130220961|NCT00101868|468772339|FG001|Overall Study|Death|10|||
130220962|NCT00101868|468772338|FG000|Overall Study|Withdrawal by Subject|8|||
130220963|NCT00101868|468772339|FG001|Overall Study|Withdrawal by Subject|9|||
130220964|NCT00101868|468772338|FG000|Overall Study|Protocol Violation|3|||
130220965|NCT00101868|468772339|FG001|Overall Study|Protocol Violation|0|||
130220966|NCT00101868|468772338|FG000|Overall Study|Lost to Follow-up|8|||
130220967|NCT00101868|468772339|FG001|Overall Study|Lost to Follow-up|13|||
130220968|NCT00069823|468772340|FG000|Overall Study|Did not have follow-up diary cards|6|||
130220969|NCT00069823|468772341|FG001|Overall Study|Did not have follow-up diary cards|3|||
130220970|NCT00520039|468772342|FG000|Overall Study|Exclusion criteria met at first visit|7|||
130220971|NCT00520039|468772343|FG001|Overall Study|Exclusion criteria met at first visit|5|||
130220972|NCT02329327|468772344|FG000|Overall Study|Death|78|||
130220973|NCT02329327|468772345|FG001|Overall Study|Death|0|||
130220974|NCT02329327|468772344|FG000|Overall Study|Withdrawal by Subject|3|||
130220975|NCT02329327|468772345|FG001|Overall Study|Withdrawal by Subject|0|||
130220976|NCT02329327|468772344|FG000|Overall Study|Lost to Follow-up|4|||
130220977|NCT02329327|468772345|FG001|Overall Study|Lost to Follow-up|0|||
130220978|NCT03560869|468772346|FG000|Overall Study|Withdrawal by Subject|3|||
130220979|NCT03560869|468772347|FG001|Overall Study|Withdrawal by Subject|4|||
130220980|NCT03560869|468772346|FG000|Overall Study|Screening failure|4|||
130220981|NCT03560869|468772347|FG001|Overall Study|Screening failure|4|||
130220982|NCT03560869|468772346|FG000|Overall Study|Withdrawal by PI|0|||
130220983|NCT03560869|468772347|FG001|Overall Study|Withdrawal by PI|1|||
130220984|NCT01801111|468772348|FG000|Overall Study|Adverse Event|12|||
130220985|NCT01801111|468772348|FG000|Overall Study|Death|8|||
130220986|NCT01801111|468772348|FG000|Overall Study|Physician Decision|5|||
130220987|NCT01801111|468772348|FG000|Overall Study|Other|1|||
130220988|NCT01801111|468772348|FG000|Overall Study|Withdrawal by Subject|4|||
130220989|NCT01801111|468772348|FG000|Overall Study|Study Terminated by Sponsor|27|||
130220990|NCT01801111|468772348|FG000|Overall Study|Progressive Disease|81|||
130220991|NCT01210482|468772349|FG000|Overall Study|Protocol Violation|1|||
130220992|NCT01210482|468772349|FG000|Overall Study|Case Report Forms were not collected|18|||
130220993|NCT01210482|468772349|FG000|Overall Study|Duplicated|2|||
130220994|NCT01210482|468772349|FG000|Overall Study|No Drug Administration|28|||
130220995|NCT01223937|468772350|FG000|Overall Study|Withdrawal by Subject|3|||
130220996|NCT01223937|468772351|FG001|Overall Study|Withdrawal by Subject|2|||
130220997|NCT01223937|468772350|FG000|Overall Study|Lost to Follow-up|1|||
130220998|NCT01223937|468772351|FG001|Overall Study|Lost to Follow-up|4|||
130220999|NCT01223937|468772350|FG000|Overall Study|Adverse Event|1|||
130221000|NCT01223937|468772351|FG001|Overall Study|Adverse Event|4|||
130221001|NCT01223937|468772350|FG000|Overall Study|Protocol Violation|8|||
130221002|NCT01223937|468772351|FG001|Overall Study|Protocol Violation|7|||
130221003|NCT01223937|468772350|FG000|Overall Study|Other|4|||
130221004|NCT01223937|468772351|FG001|Overall Study|Other|1|||
130221005|NCT03284853|468772353|FG000|Overall Study|Adverse Event|40|||
130221006|NCT03284853|468772354|FG001|Overall Study|Adverse Event|4|||
130221007|NCT03284853|468772353|FG000|Overall Study|Withdrawal by Subject|5|||
130221008|NCT03284853|468772354|FG001|Overall Study|Withdrawal by Subject|1|||
130221009|NCT03284853|468772353|FG000|Overall Study|Lost to Follow-up|1|||
130221010|NCT03284853|468772354|FG001|Overall Study|Lost to Follow-up|0|||
130221011|NCT03284853|468772353|FG000|Overall Study|Lack of Efficacy|1|||
130221012|NCT03284853|468772354|FG001|Overall Study|Lack of Efficacy|0|||
130221013|NCT03284853|468772353|FG000|Overall Study|Disallowed Concurrent Medication|1|||
130221014|NCT03284853|468772354|FG001|Overall Study|Disallowed Concurrent Medication|1|||
130221015|NCT03284853|468772353|FG000|Overall Study|Protocol Violation|3|||
130221016|NCT03284853|468772354|FG001|Overall Study|Protocol Violation|3|||
130221017|NCT03284853|468772353|FG000|Overall Study|Death|0|||
130221018|NCT03284853|468772354|FG001|Overall Study|Death|1|||
130221019|NCT03284853|468772353|FG000|Overall Study|Other - Reason not reported in CSR|4|||
130221020|NCT03284853|468772354|FG001|Overall Study|Other - Reason not reported in CSR|3|||
130221021|NCT05176717|468772355|FG000|Overall Study|Sponsor Decision|1|||
130221022|NCT05176717|468772356|FG001|Overall Study|Sponsor Decision|2|||
130221023|NCT05176717|468772357|FG002|Overall Study|Sponsor Decision|2|||
130221024|NCT02308228|468772359|FG000|Overall Study|Adverse Event|3|||
130221025|NCT02308228|468772360|FG001|Overall Study|Adverse Event|4|||
130221026|NCT02308228|468772359|FG000|Overall Study|Withdrawal by Subject|5|||
130221027|NCT02308228|468772360|FG001|Overall Study|Withdrawal by Subject|3|||
130221028|NCT03999749|468772363|FG000|Overall Study|Toxicity|16|||
130221029|NCT03999749|468772363|FG000|Overall Study|Withdrawal by Subject|3|||
130221030|NCT03999749|468772363|FG000|Overall Study|Disease progression|26|||
130221031|NCT03999749|468772363|FG000|Overall Study|Physician Decision|4|||
130221032|NCT03999749|468772363|FG000|Overall Study|Death|5|||
130221033|NCT03999749|468772363|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
130221034|NCT00255164|468772364|FG000|Overall Study|Adverse Event|10|||
130221035|NCT00255164|468772365|FG001|Overall Study|Adverse Event|6|||
130221036|NCT00255164|468772366|FG002|Overall Study|Adverse Event|9|||
130221037|NCT00255164|468772364|FG000|Overall Study|Lost to Follow-up|4|||
130221038|NCT00255164|468772365|FG001|Overall Study|Lost to Follow-up|3|||
130221039|NCT00255164|468772366|FG002|Overall Study|Lost to Follow-up|4|||
130221040|NCT00255164|468772364|FG000|Overall Study|Withdrawal by Subject|18|||
130221041|NCT00255164|468772365|FG001|Overall Study|Withdrawal by Subject|17|||
130221042|NCT00255164|468772366|FG002|Overall Study|Withdrawal by Subject|8|||
130221043|NCT00255164|468772364|FG000|Overall Study|Noncompliance|0|||
130221044|NCT00255164|468772365|FG001|Overall Study|Noncompliance|1|||
130221045|NCT00255164|468772366|FG002|Overall Study|Noncompliance|2|||
130221046|NCT00255164|468772364|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
130221047|NCT00255164|468772365|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
130221048|NCT00255164|468772366|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
130221049|NCT00255164|468772364|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
130221050|NCT00255164|468772365|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
130221051|NCT00255164|468772366|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
130221052|NCT00255164|468772364|FG000|Overall Study|Possible Barrett's Esophagus|1|||
130221053|NCT00255164|468772365|FG001|Overall Study|Possible Barrett's Esophagus|3|||
130221054|NCT00255164|468772366|FG002|Overall Study|Possible Barrett's Esophagus|8|||
130221055|NCT00255164|468772364|FG000|Overall Study|Esophageal Stricture|0|||
130221056|NCT00255164|468772365|FG001|Overall Study|Esophageal Stricture|0|||
130221057|NCT00255164|468772366|FG002|Overall Study|Esophageal Stricture|1|||
130221058|NCT00255164|468772364|FG000|Overall Study|Therapeutic Failure|11|||
130221059|NCT00255164|468772365|FG001|Overall Study|Therapeutic Failure|2|||
130017327|NCT01425008|468024464|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017328|NCT01425008|468024465|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017329|NCT01425008|468024466|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
130017330|NCT01425008|468024467|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
130017331|NCT01425008|468024468|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017332|NCT01425008|468024469|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017333|NCT01425008|468024470|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017334|NCT01425008|468024471|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017335|NCT01425008|468024472|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017336|NCT01425008|468024473|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017337|NCT01425008|468024474|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017338|NCT01425008|468024475|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017339|NCT01425008|468024476|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
130017340|NCT01425008|468024458|FG000|Dose Escalation Phase|Other|0|||
130017341|NCT01425008|468024459|FG001|Dose Escalation Phase|Other|0|||
130017342|NCT01425008|468024460|FG002|Dose Escalation Phase|Other|0|||
130017343|NCT01425008|468024461|FG003|Dose Escalation Phase|Other|0|||
130017344|NCT01425008|468024462|FG004|Dose Escalation Phase|Other|0|||
130017345|NCT01425008|468024463|FG005|Dose Escalation Phase|Other|0|||
130017346|NCT01425008|468024464|FG006|Dose Escalation Phase|Other|0|||
130017347|NCT01425008|468024465|FG007|Dose Escalation Phase|Other|0|||
130017348|NCT01425008|468024466|FG008|Dose Escalation Phase|Other|1|||
130017349|NCT01425008|468024467|FG009|Dose Escalation Phase|Other|0|||
130017350|NCT01425008|468024468|FG010|Dose Escalation Phase|Other|0|||
130017351|NCT01425008|468024469|FG011|Dose Escalation Phase|Other|0|||
130017352|NCT01425008|468024470|FG012|Dose Escalation Phase|Other|0|||
130017353|NCT01425008|468024471|FG013|Dose Escalation Phase|Other|0|||
130017354|NCT01425008|468024472|FG014|Dose Escalation Phase|Other|0|||
130017355|NCT01425008|468024473|FG015|Dose Escalation Phase|Other|0|||
130017356|NCT01425008|468024474|FG016|Dose Escalation Phase|Other|0|||
130017357|NCT01425008|468024475|FG017|Dose Escalation Phase|Other|0|||
130017358|NCT01425008|468024476|FG018|Dose Escalation Phase|Other|0|||
130017359|NCT01425008|468024458|FG000|Dose Expansion Phase|Progressive Disease|0|||
130017360|NCT01425008|468024459|FG001|Dose Expansion Phase|Progressive Disease|0|||
130221060|NCT00255164|468772366|FG002|Overall Study|Therapeutic Failure|3|||
130221061|NCT05219968|468772367|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
130017361|NCT01425008|468024460|FG002|Dose Expansion Phase|Progressive Disease|0|||
130017362|NCT01425008|468024461|FG003|Dose Expansion Phase|Progressive Disease|0|||
130017363|NCT01425008|468024462|FG004|Dose Expansion Phase|Progressive Disease|0|||
130017364|NCT01425008|468024463|FG005|Dose Expansion Phase|Progressive Disease|0|||
130017365|NCT01425008|468024464|FG006|Dose Expansion Phase|Progressive Disease|0|||
130017366|NCT01425008|468024465|FG007|Dose Expansion Phase|Progressive Disease|0|||
130017367|NCT01425008|468024466|FG008|Dose Expansion Phase|Progressive Disease|0|||
130017368|NCT01425008|468024467|FG009|Dose Expansion Phase|Progressive Disease|0|||
130017369|NCT01425008|468024468|FG010|Dose Expansion Phase|Progressive Disease|10|||
130017370|NCT01425008|468024469|FG011|Dose Expansion Phase|Progressive Disease|4|||
130017371|NCT01425008|468024470|FG012|Dose Expansion Phase|Progressive Disease|12|||
130017372|NCT01425008|468024471|FG013|Dose Expansion Phase|Progressive Disease|1|||
130017373|NCT01425008|468024472|FG014|Dose Expansion Phase|Progressive Disease|5|||
130221062|NCT05219968|468772368|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221063|NCT05219968|468772369|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221064|NCT05219968|468772370|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221065|NCT05219968|468772371|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
130221066|NCT05219968|468772367|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
130221067|NCT05219968|468772368|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221068|NCT05219968|468772369|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221069|NCT05219968|468772370|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221070|NCT05219968|468772371|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
130221071|NCT05219968|468772367|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
130221072|NCT05219968|468772368|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
130221073|NCT05219968|468772369|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
130221074|NCT05219968|468772370|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
130221075|NCT05219968|468772371|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
130221076|NCT05219968|468772367|FG000|Week 24 Treatment Period|Adverse Event|3|||
130221077|NCT05219968|468772368|FG001|Week 24 Treatment Period|Adverse Event|0|||
130221078|NCT05219968|468772369|FG002|Week 24 Treatment Period|Adverse Event|0|||
130221079|NCT05219968|468772370|FG003|Week 24 Treatment Period|Adverse Event|0|||
130221080|NCT05219968|468772371|FG004|Week 24 Treatment Period|Adverse Event|0|||
130221081|NCT05219968|468772367|FG000|Week 24 Treatment Period|Physician Decision|0|||
130221082|NCT05219968|468772368|FG001|Week 24 Treatment Period|Physician Decision|1|||
130221083|NCT05219968|468772369|FG002|Week 24 Treatment Period|Physician Decision|0|||
130221084|NCT05219968|468772370|FG003|Week 24 Treatment Period|Physician Decision|0|||
130221085|NCT05219968|468772371|FG004|Week 24 Treatment Period|Physician Decision|0|||
130221086|NCT05219968|468772367|FG000|Week 24 Treatment Period|Other, not specified|3|||
130221087|NCT05219968|468772368|FG001|Week 24 Treatment Period|Other, not specified|0|||
130221088|NCT05219968|468772369|FG002|Week 24 Treatment Period|Other, not specified|0|||
130221089|NCT05219968|468772370|FG003|Week 24 Treatment Period|Other, not specified|0|||
130221090|NCT05219968|468772371|FG004|Week 24 Treatment Period|Other, not specified|0|||
130221091|NCT05219968|468772367|FG000|Safety Extension Period|Treatment administration failure|0|||
130221092|NCT05219968|468772368|FG001|Safety Extension Period|Treatment administration failure|0|||
130221093|NCT05219968|468772369|FG002|Safety Extension Period|Treatment administration failure|0|||
130221094|NCT05219968|468772370|FG003|Safety Extension Period|Treatment administration failure|1|||
130221095|NCT05219968|468772371|FG004|Safety Extension Period|Treatment administration failure|4|||
130221096|NCT05219968|468772367|FG000|Safety Extension Period|Bilateral dislodgement|0|||
130221097|NCT05219968|468772368|FG001|Safety Extension Period|Bilateral dislodgement|0|||
130221098|NCT05219968|468772369|FG002|Safety Extension Period|Bilateral dislodgement|4|||
130221099|NCT05219968|468772370|FG003|Safety Extension Period|Bilateral dislodgement|0|||
130221100|NCT05219968|468772371|FG004|Safety Extension Period|Bilateral dislodgement|1|||
130221101|NCT05219968|468772367|FG000|Safety Extension Period|Withdrawal by Subject|0|||
130221102|NCT05219968|468772368|FG001|Safety Extension Period|Withdrawal by Subject|0|||
130221103|NCT05219968|468772369|FG002|Safety Extension Period|Withdrawal by Subject|2|||
130221104|NCT05219968|468772370|FG003|Safety Extension Period|Withdrawal by Subject|0|||
130221105|NCT05219968|468772371|FG004|Safety Extension Period|Withdrawal by Subject|4|||
130221106|NCT05219968|468772367|FG000|Safety Extension Period|Adverse Event|0|||
130221107|NCT05219968|468772368|FG001|Safety Extension Period|Adverse Event|0|||
130221108|NCT05219968|468772369|FG002|Safety Extension Period|Adverse Event|2|||
130221109|NCT05219968|468772370|FG003|Safety Extension Period|Adverse Event|1|||
130221110|NCT05219968|468772371|FG004|Safety Extension Period|Adverse Event|1|||
130221111|NCT05219968|468772367|FG000|Safety Extension Period|Lost to Follow-up|0|||
130221112|NCT05219968|468772368|FG001|Safety Extension Period|Lost to Follow-up|0|||
130221113|NCT05219968|468772369|FG002|Safety Extension Period|Lost to Follow-up|0|||
130221114|NCT05219968|468772370|FG003|Safety Extension Period|Lost to Follow-up|1|||
130221115|NCT05219968|468772371|FG004|Safety Extension Period|Lost to Follow-up|0|||
130221116|NCT04587336|468772372|FG000|Overall Study|Lost to Follow-up|1|||
130221117|NCT04587336|468772373|FG001|Overall Study|Lost to Follow-up|0|||
130221118|NCT03512353|468774323|FG000|Overall Study|Sponsor Decision|3|||
130221119|NCT03512353|468774323|FG000|Overall Study|Death|1|||
130221120|NCT01845597|468774324|FG000|Overall Study|Death|8|||
130221121|NCT01845597|468774324|FG000|Overall Study|Lost to Follow-up|22|||
130221122|NCT02581488|468774328|FG000|Overall Study|Adverse Event|6|||
130221123|NCT02581488|468774329|FG001|Overall Study|Adverse Event|7|||
130221124|NCT02581488|468774328|FG000|Overall Study|Lost to Follow-up|1|||
130221125|NCT02581488|468774329|FG001|Overall Study|Lost to Follow-up|0|||
130221126|NCT02581488|468774328|FG000|Overall Study|Withdrawal by Subject|1|||
130221127|NCT02581488|468774329|FG001|Overall Study|Withdrawal by Subject|0|||
130221128|NCT02581488|468774328|FG000|Overall Study|Non-Compliance|1|||
130221129|NCT02581488|468774329|FG001|Overall Study|Non-Compliance|0|||
130221130|NCT02581488|468774328|FG000|Overall Study|Protocol Violation|0|||
130221131|NCT02581488|468774329|FG001|Overall Study|Protocol Violation|4|||
130221132|NCT01877668|468774330|FG000|Overall Study|Death|0|||
130221133|NCT01877668|468774331|FG001|Overall Study|Death|0|||
130221134|NCT01877668|468774332|FG002|Overall Study|Death|0|||
130221135|NCT01877668|468774333|FG003|Overall Study|Death|1|||
130221136|NCT01877668|468774334|FG004|Overall Study|Death|0|||
130221137|NCT01877668|468774330|FG000|Overall Study|No longer met study criteria|1|||
130221138|NCT01877668|468774331|FG001|Overall Study|No longer met study criteria|0|||
130221139|NCT01877668|468774332|FG002|Overall Study|No longer met study criteria|1|||
130221140|NCT01877668|468774333|FG003|Overall Study|No longer met study criteria|0|||
130221141|NCT01877668|468774334|FG004|Overall Study|No longer met study criteria|0|||
130221142|NCT01877668|468774330|FG000|Overall Study|Insufficient clinical response|0|||
130221143|NCT01877668|468774331|FG001|Overall Study|Insufficient clinical response|1|||
130221144|NCT01877668|468774332|FG002|Overall Study|Insufficient clinical response|2|||
130221145|NCT01877668|468774333|FG003|Overall Study|Insufficient clinical response|2|||
130221146|NCT01877668|468774334|FG004|Overall Study|Insufficient clinical response|0|||
130221147|NCT01877668|468774330|FG000|Overall Study|Lost to Follow-up|0|||
130221148|NCT01877668|468774331|FG001|Overall Study|Lost to Follow-up|2|||
130221149|NCT01877668|468774332|FG002|Overall Study|Lost to Follow-up|1|||
130221150|NCT01877668|468774333|FG003|Overall Study|Lost to Follow-up|0|||
130221151|NCT01877668|468774334|FG004|Overall Study|Lost to Follow-up|0|||
130221152|NCT01877668|468774330|FG000|Overall Study|Withdrawal by Subject|2|||
130221153|NCT01877668|468774331|FG001|Overall Study|Withdrawal by Subject|0|||
130221154|NCT01877668|468774332|FG002|Overall Study|Withdrawal by Subject|3|||
130221155|NCT01877668|468774333|FG003|Overall Study|Withdrawal by Subject|2|||
130221156|NCT01877668|468774334|FG004|Overall Study|Withdrawal by Subject|2|||
130221157|NCT01877668|468774330|FG000|Overall Study|Other|1|||
130221158|NCT01877668|468774331|FG001|Overall Study|Other|1|||
130221159|NCT01877668|468774332|FG002|Overall Study|Other|1|||
130221160|NCT01877668|468774333|FG003|Overall Study|Other|1|||
130221161|NCT01877668|468774334|FG004|Overall Study|Other|3|||
130221162|NCT01877668|468774330|FG000|Overall Study|Protocol Violation|1|||
130221163|NCT01877668|468774331|FG001|Overall Study|Protocol Violation|1|||
130221164|NCT01877668|468774332|FG002|Overall Study|Protocol Violation|0|||
130221165|NCT01877668|468774333|FG003|Overall Study|Protocol Violation|0|||
130221166|NCT01877668|468774334|FG004|Overall Study|Protocol Violation|3|||
130221167|NCT01877668|468774330|FG000|Overall Study|Adverse event related to study drug|2|||
130221168|NCT01877668|468774331|FG001|Overall Study|Adverse event related to study drug|2|||
130221169|NCT01877668|468774332|FG002|Overall Study|Adverse event related to study drug|2|||
130221170|NCT01877668|468774333|FG003|Overall Study|Adverse event related to study drug|2|||
130221171|NCT01877668|468774334|FG004|Overall Study|Adverse event related to study drug|1|||
130221172|NCT01877668|468774330|FG000|Overall Study|Adverse event unrelated to study drug|4|||
130221173|NCT01877668|468774331|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130221174|NCT01877668|468774332|FG002|Overall Study|Adverse event unrelated to study drug|2|||
130221175|NCT01877668|468774333|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130221176|NCT01877668|468774334|FG004|Overall Study|Adverse event unrelated to study drug|1|||
130221177|NCT03286218|468774365|FG000|Qualification Phase Period 1|Adverse Event|1|||
130221178|NCT03286218|468774366|FG001|Qualification Phase Period 1|Adverse Event|0|||
130221179|NCT03286218|468774367|FG002|Qualification Phase Period 1|Adverse Event|0|||
130221180|NCT03286218|468774368|FG003|Qualification Phase Period 1|Adverse Event|0|||
130221181|NCT03286218|468774369|FG004|Qualification Phase Period 1|Adverse Event|0|||
130221182|NCT03286218|468774370|FG005|Qualification Phase Period 1|Adverse Event|0|||
130221183|NCT03286218|468774371|FG006|Qualification Phase Period 1|Adverse Event|0|||
130221184|NCT03286218|468774372|FG007|Qualification Phase Period 1|Adverse Event|0|||
130221185|NCT03286218|468774373|FG008|Qualification Phase Period 1|Adverse Event|0|||
130221186|NCT03286218|468774374|FG009|Qualification Phase Period 1|Adverse Event|0|||
130221187|NCT03286218|468774375|FG010|Qualification Phase Period 1|Adverse Event|0|||
130221188|NCT03286218|468774376|FG011|Qualification Phase Period 1|Adverse Event|0|||
130221189|NCT03286218|468774365|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221190|NCT03286218|468774366|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
130221191|NCT03286218|468774367|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221192|NCT03286218|468774368|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221193|NCT03286218|468774369|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221194|NCT03286218|468774370|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221195|NCT03286218|468774371|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221196|NCT03286218|468774372|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221197|NCT03286218|468774373|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221198|NCT03286218|468774374|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221199|NCT03286218|468774375|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221200|NCT03286218|468774376|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
130221201|NCT03286218|468774365|FG000|Qualification Phase Period 2|Adverse Event|0|||
130221202|NCT03286218|468774366|FG001|Qualification Phase Period 2|Adverse Event|1|||
130221203|NCT03286218|468774367|FG002|Qualification Phase Period 2|Adverse Event|0|||
130221204|NCT03286218|468774368|FG003|Qualification Phase Period 2|Adverse Event|0|||
130221205|NCT03286218|468774369|FG004|Qualification Phase Period 2|Adverse Event|0|||
130221206|NCT03286218|468774370|FG005|Qualification Phase Period 2|Adverse Event|0|||
130221207|NCT03286218|468774371|FG006|Qualification Phase Period 2|Adverse Event|0|||
130221208|NCT03286218|468774372|FG007|Qualification Phase Period 2|Adverse Event|0|||
130221209|NCT03286218|468774373|FG008|Qualification Phase Period 2|Adverse Event|0|||
130221210|NCT03286218|468774374|FG009|Qualification Phase Period 2|Adverse Event|0|||
130221211|NCT03286218|468774375|FG010|Qualification Phase Period 2|Adverse Event|0|||
130221212|NCT03286218|468774376|FG011|Qualification Phase Period 2|Adverse Event|0|||
130221213|NCT03286218|468774365|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
130221214|NCT03286218|468774366|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
130221215|NCT03286218|468774367|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221216|NCT03286218|468774368|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221217|NCT03286218|468774369|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221218|NCT03286218|468774370|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221219|NCT03286218|468774371|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221220|NCT03286218|468774372|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221221|NCT03286218|468774373|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221222|NCT03286218|468774374|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221223|NCT03286218|468774375|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221224|NCT03286218|468774376|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
130221225|NCT03286218|468774365|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
130221226|NCT03286218|468774366|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
130221227|NCT03286218|468774367|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
130221228|NCT03286218|468774368|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
130221229|NCT03286218|468774369|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
130221230|NCT03286218|468774370|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
130221231|NCT03286218|468774371|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
130221232|NCT03286218|468774372|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
130221233|NCT03286218|468774373|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
130221234|NCT03286218|468774374|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
130221235|NCT03286218|468774375|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
130221236|NCT03286218|468774376|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
130221237|NCT03286218|468774365|FG000|Qualification Phase Period 2|Protocol Violation|2|||
130221238|NCT03286218|468774366|FG001|Qualification Phase Period 2|Protocol Violation|0|||
130221239|NCT03286218|468774367|FG002|Qualification Phase Period 2|Protocol Violation|0|||
130221240|NCT03286218|468774368|FG003|Qualification Phase Period 2|Protocol Violation|0|||
130221241|NCT03286218|468774369|FG004|Qualification Phase Period 2|Protocol Violation|0|||
130221242|NCT03286218|468774370|FG005|Qualification Phase Period 2|Protocol Violation|0|||
130221243|NCT03286218|468774371|FG006|Qualification Phase Period 2|Protocol Violation|0|||
130221244|NCT03286218|468774372|FG007|Qualification Phase Period 2|Protocol Violation|0|||
130221245|NCT03286218|468774373|FG008|Qualification Phase Period 2|Protocol Violation|0|||
130221246|NCT03286218|468774374|FG009|Qualification Phase Period 2|Protocol Violation|0|||
130221247|NCT03286218|468774375|FG010|Qualification Phase Period 2|Protocol Violation|0|||
130221248|NCT03286218|468774376|FG011|Qualification Phase Period 2|Protocol Violation|0|||
130221249|NCT03286218|468774365|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
130221250|NCT03286218|468774366|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
130221251|NCT03286218|468774367|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221252|NCT03286218|468774368|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221253|NCT03286218|468774369|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221254|NCT03286218|468774370|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221255|NCT03286218|468774371|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221256|NCT03286218|468774372|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221257|NCT03286218|468774373|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221258|NCT03286218|468774374|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221259|NCT03286218|468774375|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221260|NCT03286218|468774376|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
130221261|NCT03286218|468774365|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221262|NCT03286218|468774366|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221263|NCT03286218|468774367|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221264|NCT03286218|468774368|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221265|NCT03286218|468774369|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221266|NCT03286218|468774370|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221267|NCT03286218|468774371|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221268|NCT03286218|468774372|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
130017374|NCT01425008|468024473|FG015|Dose Expansion Phase|Progressive Disease|8|||
130017375|NCT01425008|468024474|FG016|Dose Expansion Phase|Progressive Disease|9|||
130017376|NCT01425008|468024475|FG017|Dose Expansion Phase|Progressive Disease|2|||
130017377|NCT01425008|468024476|FG018|Dose Expansion Phase|Progressive Disease|10|||
130017378|NCT01425008|468024458|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
130017379|NCT01425008|468024459|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
130017380|NCT01425008|468024460|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
130017381|NCT01425008|468024461|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
130017382|NCT01425008|468024462|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
130017383|NCT01425008|468024463|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
130017384|NCT01425008|468024464|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
130017385|NCT01425008|468024465|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
130017386|NCT01425008|468024466|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
130017387|NCT01425008|468024467|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
130017388|NCT01425008|468024468|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
130017389|NCT01425008|468024469|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
130017390|NCT01425008|468024470|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
130017391|NCT01425008|468024471|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
130017392|NCT01425008|468024472|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
130017393|NCT01425008|468024473|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
130017394|NCT01425008|468024474|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
130017395|NCT01425008|468024475|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
130017396|NCT01425008|468024476|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
130017397|NCT01425008|468024458|FG000|Dose Expansion Phase|Other|0|||
130017398|NCT01425008|468024459|FG001|Dose Expansion Phase|Other|0|||
130017399|NCT01425008|468024460|FG002|Dose Expansion Phase|Other|0|||
130017400|NCT01425008|468024461|FG003|Dose Expansion Phase|Other|0|||
130017401|NCT01425008|468024462|FG004|Dose Expansion Phase|Other|0|||
130017402|NCT01425008|468024463|FG005|Dose Expansion Phase|Other|0|||
130017403|NCT01425008|468024464|FG006|Dose Expansion Phase|Other|0|||
130017404|NCT01425008|468024465|FG007|Dose Expansion Phase|Other|0|||
130017405|NCT01425008|468024466|FG008|Dose Expansion Phase|Other|0|||
130221269|NCT03286218|468774373|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221270|NCT03286218|468774374|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221271|NCT03286218|468774375|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
130221272|NCT03286218|468774376|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
130221273|NCT03286218|468774365|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221274|NCT03286218|468774366|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221275|NCT03286218|468774367|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221276|NCT03286218|468774368|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221277|NCT03286218|468774369|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221278|NCT03286218|468774370|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221279|NCT03286218|468774371|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221280|NCT03286218|468774372|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221281|NCT03286218|468774373|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221282|NCT03286218|468774374|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221283|NCT03286218|468774375|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
130221284|NCT03286218|468774376|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
130221285|NCT02532374|468774379|FG000|Overall Study|Withdrawal by Subject|1|||
130221286|NCT02532374|468774379|FG000|Overall Study|Physician Decision|1|||
130221287|NCT02762084|468774380|FG000|Overall Study|Withdrawal by Subject|1|||
130221288|NCT02762084|468774381|FG001|Overall Study|Withdrawal by Subject|0|||
130221289|NCT02762084|468774382|FG002|Overall Study|Withdrawal by Subject|0|||
130221290|NCT02762084|468774380|FG000|Overall Study|Adverse Event|0|||
130221291|NCT02762084|468774381|FG001|Overall Study|Adverse Event|0|||
130221292|NCT02762084|468774382|FG002|Overall Study|Adverse Event|1|||
130221293|NCT01348139|468774383|FG000|Period 1|Adverse Event|1|||
130221294|NCT01348139|468774384|FG001|Period 1|Adverse Event|0|||
130221295|NCT01348139|468774385|FG002|Period 1|Adverse Event|0|||
130221296|NCT01348139|468774386|FG003|Period 1|Adverse Event|0|||
130221297|NCT01348139|468774387|FG004|Period 1|Adverse Event|0|||
130221298|NCT01348139|468774388|FG005|Period 1|Adverse Event|0|||
130221299|NCT01781962|468774391|FG000|Overall Study|Other Miscellaneous Reasons|5|||
130221300|NCT01765296|468774392|FG000|Overall Study|Protocol Violation|0|||
130221301|NCT01765296|468774393|FG001|Overall Study|Protocol Violation|5|||
130221302|NCT01765296|468774394|FG002|Overall Study|Protocol Violation|4|||
130221303|NCT01765296|468774392|FG000|Overall Study|Withdrawal by Subject|4|||
130221304|NCT01765296|468774393|FG001|Overall Study|Withdrawal by Subject|2|||
130221305|NCT01765296|468774394|FG002|Overall Study|Withdrawal by Subject|2|||
130221306|NCT01765296|468774392|FG000|Overall Study|Adverse Event|1|||
130221307|NCT01765296|468774393|FG001|Overall Study|Adverse Event|13|||
130221308|NCT01765296|468774394|FG002|Overall Study|Adverse Event|5|||
130221309|NCT01765296|468774392|FG000|Overall Study|Lack of Efficacy|0|||
130221310|NCT01765296|468774393|FG001|Overall Study|Lack of Efficacy|0|||
130221311|NCT01765296|468774394|FG002|Overall Study|Lack of Efficacy|2|||
130221312|NCT01619852|468774395|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
130221313|NCT01619852|468774396|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
130221314|NCT01619852|468774395|FG000|3 Month Follow up|Lost to Follow-up|31|||
130221315|NCT01619852|468774396|FG001|3 Month Follow up|Lost to Follow-up|34|||
130221316|NCT03933449|468774397|FG000|Overall Study|Adverse Event|6|||
130221317|NCT03933449|468774398|FG001|Overall Study|Adverse Event|4|||
130221318|NCT03933449|468774397|FG000|Overall Study|Death|55|||
130221319|NCT03933449|468774398|FG001|Overall Study|Death|57|||
130221320|NCT03933449|468774397|FG000|Overall Study|Sponsor Decision|1|||
130221321|NCT03933449|468774398|FG001|Overall Study|Sponsor Decision|0|||
130221322|NCT02659943|468774399|FG000|Overall Study|Switched to alternative treatment|1|||
130221323|NCT02659943|468774400|FG001|Overall Study|Switched to alternative treatment|1|||
130221324|NCT02659943|468774401|FG002|Overall Study|Switched to alternative treatment|0|||
130221325|NCT02659943|468774402|FG003|Overall Study|Switched to alternative treatment|2|||
130221326|NCT02659943|468774403|FG004|Overall Study|Switched to alternative treatment|1|||
130221327|NCT02659943|468774404|FG005|Overall Study|Switched to alternative treatment|0|||
130221328|NCT02659943|468774405|FG006|Overall Study|Switched to alternative treatment|1|||
130221329|NCT02659943|468774399|FG000|Overall Study|Disease progression on study|0|||
130221330|NCT02659943|468774400|FG001|Overall Study|Disease progression on study|1|||
130221331|NCT02659943|468774401|FG002|Overall Study|Disease progression on study|1|||
130221332|NCT02659943|468774402|FG003|Overall Study|Disease progression on study|1|||
130221333|NCT02659943|468774403|FG004|Overall Study|Disease progression on study|1|||
130221334|NCT02659943|468774404|FG005|Overall Study|Disease progression on study|4|||
130221335|NCT02659943|468774405|FG006|Overall Study|Disease progression on study|0|||
130221336|NCT02659943|468774399|FG000|Overall Study|Patient's condition per principal investigator|0|||
130221337|NCT02659943|468774400|FG001|Overall Study|Patient's condition per principal investigator|0|||
130221338|NCT02659943|468774401|FG002|Overall Study|Patient's condition per principal investigator|0|||
130221339|NCT02659943|468774402|FG003|Overall Study|Patient's condition per principal investigator|0|||
130221340|NCT02659943|468774403|FG004|Overall Study|Patient's condition per principal investigator|0|||
130221341|NCT02659943|468774404|FG005|Overall Study|Patient's condition per principal investigator|1|||
130221342|NCT02659943|468774405|FG006|Overall Study|Patient's condition per principal investigator|0|||
130221343|NCT02659943|468774399|FG000|Overall Study|Ineligible|0|||
130221344|NCT02659943|468774400|FG001|Overall Study|Ineligible|0|||
130221345|NCT02659943|468774401|FG002|Overall Study|Ineligible|0|||
130221346|NCT02659943|468774402|FG003|Overall Study|Ineligible|0|||
130221347|NCT02659943|468774403|FG004|Overall Study|Ineligible|0|||
130221348|NCT02659943|468774404|FG005|Overall Study|Ineligible|0|||
130221349|NCT02659943|468774405|FG006|Overall Study|Ineligible|1|||
130221350|NCT02659943|468774399|FG000|Overall Study|No longer meets eligibility|0|||
130221351|NCT02659943|468774400|FG001|Overall Study|No longer meets eligibility|0|||
130221352|NCT02659943|468774401|FG002|Overall Study|No longer meets eligibility|0|||
130221353|NCT02659943|468774402|FG003|Overall Study|No longer meets eligibility|0|||
130221354|NCT02659943|468774403|FG004|Overall Study|No longer meets eligibility|0|||
130221355|NCT02659943|468774404|FG005|Overall Study|No longer meets eligibility|0|||
130221356|NCT02659943|468774405|FG006|Overall Study|No longer meets eligibility|1|||
130221357|NCT02659943|468774399|FG000|Overall Study|No treatment, per protocol|0|||
130221358|NCT02659943|468774400|FG001|Overall Study|No treatment, per protocol|0|||
130221359|NCT02659943|468774401|FG002|Overall Study|No treatment, per protocol|0|||
130221360|NCT02659943|468774402|FG003|Overall Study|No treatment, per protocol|0|||
130221361|NCT02659943|468774403|FG004|Overall Study|No treatment, per protocol|0|||
130221362|NCT02659943|468774404|FG005|Overall Study|No treatment, per protocol|0|||
130221363|NCT02659943|468774405|FG006|Overall Study|No treatment, per protocol|3|||
130221364|NCT01576575|468774406|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
130221365|NCT01576575|468774406|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
130221366|NCT01576575|468774406|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
130221367|NCT01723072|468774407|FG000|Overall Study|Withdrawal by Subject|7|||
130221368|NCT01723072|468774408|FG001|Overall Study|Withdrawal by Subject|13|||
130221369|NCT01723072|468774407|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
130221370|NCT01723072|468774408|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
130221371|NCT01723072|468774407|FG000|Overall Study|Other|4|||
130221372|NCT01723072|468774408|FG001|Overall Study|Other|3|||
130221373|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
130221374|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221375|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
130221376|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
130221377|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221378|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221379|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221380|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221381|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221382|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221383|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221384|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221385|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221386|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221387|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221388|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221389|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221390|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221391|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
130221392|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
130221393|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
130221394|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
130221395|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
130221396|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221397|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221398|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221399|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221400|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221401|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221402|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221403|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221404|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221405|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221406|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221407|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221408|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221409|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221410|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
130221411|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221412|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
130221413|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
130221414|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221415|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221416|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221417|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221418|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221419|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221420|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221421|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221422|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221423|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221424|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221425|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221426|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221427|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221428|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221429|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
130221430|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
130221431|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221432|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221433|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221434|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221435|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221436|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221437|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221438|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221439|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221440|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221441|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221442|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221443|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221444|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221445|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221446|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221447|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221448|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
130221449|NCT03428100|468774409|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221450|NCT03428100|468774410|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
130221451|NCT03428100|468774411|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221452|NCT03428100|468774412|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221453|NCT03428100|468774413|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221454|NCT03428100|468774414|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221455|NCT03428100|468774415|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221456|NCT03428100|468774416|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221457|NCT03428100|468774417|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221458|NCT03428100|468774418|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221459|NCT03428100|468774419|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221460|NCT03428100|468774420|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221461|NCT03428100|468774421|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221462|NCT03428100|468774422|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221463|NCT03428100|468774423|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221464|NCT03428100|468774424|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221465|NCT03428100|468774425|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221466|NCT03428100|468774426|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221467|NCT03428100|468774427|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
130221468|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221469|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221470|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221471|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221472|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221473|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
130221474|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221475|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
130221476|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221477|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221478|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221479|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221480|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
130221481|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221482|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221483|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
130221484|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
130221485|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221486|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
130221487|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
130221488|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
130221489|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
130221490|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
130221491|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
130221492|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
130221493|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
130221494|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
130221495|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
130221496|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
130221497|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
130017406|NCT01425008|468024467|FG009|Dose Expansion Phase|Other|0|||
130017407|NCT01425008|468024468|FG010|Dose Expansion Phase|Other|0|||
130221498|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
130221499|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
130221500|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
130221501|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
130221502|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
130221503|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
130221504|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
130221505|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
130017408|NCT01425008|468024469|FG011|Dose Expansion Phase|Other|0|||
130017409|NCT01425008|468024470|FG012|Dose Expansion Phase|Other|1|||
130017410|NCT01425008|468024471|FG013|Dose Expansion Phase|Other|0|||
130017411|NCT01425008|468024472|FG014|Dose Expansion Phase|Other|0|||
130017412|NCT01425008|468024473|FG015|Dose Expansion Phase|Other|0|||
130017413|NCT01425008|468024474|FG016|Dose Expansion Phase|Other|2|||
130017414|NCT01425008|468024475|FG017|Dose Expansion Phase|Other|0|||
130017415|NCT01425008|468024476|FG018|Dose Expansion Phase|Other|4|||
130017416|NCT01425008|468024458|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017417|NCT01425008|468024459|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017418|NCT01425008|468024460|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017419|NCT01425008|468024461|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017420|NCT01425008|468024462|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017421|NCT01425008|468024463|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017422|NCT01425008|468024464|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017423|NCT01425008|468024465|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017424|NCT01425008|468024466|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017425|NCT01425008|468024467|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017426|NCT01425008|468024468|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
130017427|NCT01425008|468024469|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
130017428|NCT01425008|468024470|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017429|NCT01425008|468024471|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017430|NCT01425008|468024472|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017431|NCT01425008|468024473|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
130017432|NCT01425008|468024474|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
130017433|NCT01425008|468024475|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
130017434|NCT01425008|468024476|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
130017435|NCT01425008|468024458|FG000|Dose Expansion Phase|Adverse Event|0|||
130017436|NCT01425008|468024459|FG001|Dose Expansion Phase|Adverse Event|0|||
130017437|NCT01425008|468024460|FG002|Dose Expansion Phase|Adverse Event|0|||
130017438|NCT01425008|468024461|FG003|Dose Expansion Phase|Adverse Event|0|||
130017439|NCT01425008|468024462|FG004|Dose Expansion Phase|Adverse Event|0|||
130017440|NCT01425008|468024463|FG005|Dose Expansion Phase|Adverse Event|0|||
130017441|NCT01425008|468024464|FG006|Dose Expansion Phase|Adverse Event|0|||
130017442|NCT01425008|468024465|FG007|Dose Expansion Phase|Adverse Event|0|||
130017443|NCT01425008|468024466|FG008|Dose Expansion Phase|Adverse Event|0|||
130017444|NCT01425008|468024467|FG009|Dose Expansion Phase|Adverse Event|0|||
129884437|NCT02572817|467536395|FG001|Overall Study|Death|3|||
130017445|NCT01425008|468024468|FG010|Dose Expansion Phase|Adverse Event|2|||
130017446|NCT01425008|468024469|FG011|Dose Expansion Phase|Adverse Event|3|||
130017447|NCT01425008|468024470|FG012|Dose Expansion Phase|Adverse Event|3|||
130017448|NCT01425008|468024471|FG013|Dose Expansion Phase|Adverse Event|0|||
130017449|NCT01425008|468024472|FG014|Dose Expansion Phase|Adverse Event|1|||
130017450|NCT01425008|468024473|FG015|Dose Expansion Phase|Adverse Event|1|||
130017451|NCT01425008|468024474|FG016|Dose Expansion Phase|Adverse Event|5|||
130017452|NCT01425008|468024475|FG017|Dose Expansion Phase|Adverse Event|0|||
130017453|NCT01425008|468024476|FG018|Dose Expansion Phase|Adverse Event|3|||
130017454|NCT01425008|468024458|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
130017455|NCT01425008|468024459|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
130017456|NCT01425008|468024460|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
130017457|NCT01425008|468024461|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
130017458|NCT01425008|468024462|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
130017459|NCT01425008|468024463|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
130017460|NCT01425008|468024464|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
130017461|NCT01425008|468024465|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
130017462|NCT01425008|468024466|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
130017463|NCT01425008|468024467|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
130017464|NCT01425008|468024468|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
130017465|NCT01425008|468024469|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
130017466|NCT01425008|468024470|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
130017467|NCT01425008|468024471|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
130017468|NCT01425008|468024472|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
130017469|NCT01425008|468024473|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
130017470|NCT01425008|468024474|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
130017471|NCT01425008|468024475|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
130017472|NCT01425008|468024476|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
130017473|NCT01425008|468024458|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017474|NCT01425008|468024459|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017475|NCT01425008|468024460|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017476|NCT01425008|468024461|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017477|NCT01425008|468024462|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017478|NCT01425008|468024463|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017479|NCT01425008|468024464|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017480|NCT01425008|468024465|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017481|NCT01425008|468024466|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017482|NCT01425008|468024467|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017483|NCT01425008|468024468|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017484|NCT01425008|468024469|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130221506|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221507|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130017485|NCT01425008|468024470|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017486|NCT01425008|468024471|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017487|NCT01425008|468024472|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129884438|NCT02572817|467536394|FG000|Overall Study|Lost to Follow-up|3|||
130221508|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221509|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221510|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
130221511|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
130221512|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
130221513|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221514|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221515|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221516|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221517|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
130221518|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
130221519|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
130221520|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
130221521|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
130221522|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221523|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
130221524|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
130221525|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221526|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221527|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130017488|NCT01425008|468024473|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017489|NCT01425008|468024474|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017490|NCT01425008|468024475|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130017491|NCT01425008|468024476|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
130017492|NCT00805480|468024479|FG000|Overall Study|Withdrawal by Subject|13|||
130017493|NCT00805480|468024480|FG001|Overall Study|Withdrawal by Subject|5|||
130017494|NCT00805480|468024481|FG002|Overall Study|Withdrawal by Subject|11|||
130017495|NCT00805480|468024482|FG003|Overall Study|Withdrawal by Subject|5|||
130017496|NCT00805480|468024479|FG000|Overall Study|Lost to Follow-up|1|||
130017497|NCT00805480|468024480|FG001|Overall Study|Lost to Follow-up|2|||
130017498|NCT00805480|468024481|FG002|Overall Study|Lost to Follow-up|0|||
130017499|NCT00805480|468024482|FG003|Overall Study|Lost to Follow-up|0|||
130017500|NCT00805480|468024479|FG000|Overall Study|Adverse Event|0|||
130017501|NCT00805480|468024480|FG001|Overall Study|Adverse Event|0|||
130017502|NCT00805480|468024481|FG002|Overall Study|Adverse Event|1|||
130017503|NCT00805480|468024482|FG003|Overall Study|Adverse Event|0|||
130017504|NCT00562588|468024483|FG000|Overall Study|Adverse Event|40|||
130017505|NCT00562588|468024484|FG001|Overall Study|Adverse Event|58|||
130017506|NCT00562588|468024483|FG000|Overall Study|Protocol Violation|30|||
130017507|NCT00562588|468024484|FG001|Overall Study|Protocol Violation|26|||
130017508|NCT00562588|468024483|FG000|Overall Study|Lost to Follow-up|12|||
130017509|NCT00562588|468024484|FG001|Overall Study|Lost to Follow-up|4|||
130017510|NCT00562588|468024483|FG000|Overall Study|Withdrawal by Subject|10|||
130017511|NCT00562588|468024484|FG001|Overall Study|Withdrawal by Subject|9|||
130017512|NCT00562588|468024483|FG000|Overall Study|Other|0|||
130017513|NCT00562588|468024484|FG001|Overall Study|Other|2|||
130017514|NCT03315871|468024488|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
130017515|NCT03315871|468024489|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
130017516|NCT03315871|468024490|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
130017517|NCT03315871|468024488|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
130017518|NCT03315871|468024489|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
130017519|NCT03315871|468024490|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
130017520|NCT03315871|468024488|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
130017521|NCT03315871|468024489|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
130017522|NCT03315871|468024490|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
130017523|NCT03315871|468024488|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
130017524|NCT03315871|468024489|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
130017525|NCT03315871|468024490|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
130017526|NCT03315871|468024488|FG000|PROSTVAC + CV301|Progressive disease|0|||
130017527|NCT03315871|468024489|FG001|PROSTVAC + CV301|Progressive disease|0|||
130017528|NCT03315871|468024490|FG002|PROSTVAC + CV301|Progressive disease|1|||
130017529|NCT03315871|468024488|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
130017530|NCT03315871|468024489|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
130017531|NCT03315871|468024490|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
130017532|NCT00112905|468026360|FG000|Overall Study|Adverse Event|4|||
130017533|NCT00112905|468026360|FG000|Overall Study|Death|1|||
130017534|NCT00112905|468026360|FG000|Overall Study|Ineligibility|5|||
130017535|NCT00112905|468026360|FG000|Overall Study|Alternative treatment|1|||
130017536|NCT00112905|468026360|FG000|Overall Study|performance status was deteiorating|1|||
130017537|NCT02600507|468026361|FG000|Overall Study|Adverse Event|3|||
130017538|NCT02600507|468026362|FG001|Overall Study|Adverse Event|15|||
130017539|NCT02600507|468026363|FG002|Overall Study|Adverse Event|5|||
130017540|NCT02600507|468026361|FG000|Overall Study|Lack of Efficacy|3|||
130017541|NCT02600507|468026362|FG001|Overall Study|Lack of Efficacy|8|||
130017542|NCT02600507|468026363|FG002|Overall Study|Lack of Efficacy|5|||
130017543|NCT02600507|468026361|FG000|Overall Study|Lost to Follow-up|3|||
130017544|NCT02600507|468026362|FG001|Overall Study|Lost to Follow-up|5|||
130017545|NCT02600507|468026363|FG002|Overall Study|Lost to Follow-up|2|||
130017546|NCT02600507|468026361|FG000|Overall Study|Protocol Violation|12|||
130017547|NCT02600507|468026362|FG001|Overall Study|Protocol Violation|4|||
130017548|NCT02600507|468026363|FG002|Overall Study|Protocol Violation|4|||
130017549|NCT02600507|468026361|FG000|Overall Study|Physician Decision|1|||
130017550|NCT02600507|468026362|FG001|Overall Study|Physician Decision|0|||
130017551|NCT02600507|468026363|FG002|Overall Study|Physician Decision|1|||
130017552|NCT02600507|468026361|FG000|Overall Study|Withdrawal by Subject|7|||
130017553|NCT02600507|468026362|FG001|Overall Study|Withdrawal by Subject|11|||
130017554|NCT02600507|468026363|FG002|Overall Study|Withdrawal by Subject|7|||
130017555|NCT02600507|468026361|FG000|Overall Study|Other|0|||
130017556|NCT02600507|468026362|FG001|Overall Study|Other|1|||
130017557|NCT02600507|468026363|FG002|Overall Study|Other|1|||
130017558|NCT00621504|468026369|FG000|Overall Study|Adverse Event|1|||
130017559|NCT00621504|468026370|FG001|Overall Study|Adverse Event|3|||
130017560|NCT00621504|468026369|FG000|Overall Study|At the request of sponsor/investigator|1|||
130017561|NCT00621504|468026370|FG001|Overall Study|At the request of sponsor/investigator|0|||
130017562|NCT00621504|468026369|FG000|Overall Study|Withdrew consent|9|||
130017563|NCT00621504|468026370|FG001|Overall Study|Withdrew consent|6|||
130017564|NCT00621504|468026369|FG000|Overall Study|Lost to Follow-up|8|||
130017565|NCT00621504|468026370|FG001|Overall Study|Lost to Follow-up|10|||
130017566|NCT00621504|468026369|FG000|Overall Study|Other|1|||
130017567|NCT00621504|468026370|FG001|Overall Study|Other|0|||
130017568|NCT00621504|468026369|FG000|Overall Study|Death|6|||
130017569|NCT00621504|468026370|FG001|Overall Study|Death|6|||
130017570|NCT00605085|468026371|FG000|Overall Study|Withdrawal by Subject|8|||
130017571|NCT00605085|468026372|FG001|Overall Study|Withdrawal by Subject|5|||
130221528|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221529|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221530|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221531|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221532|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130221533|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221534|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221535|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221536|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
130221537|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130221538|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221539|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
130221540|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221541|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221542|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
130221543|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
130221544|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
130221545|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
130221546|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
130221547|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
130221548|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
130221549|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
130221550|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
130221551|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
130221552|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
130221553|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
130221554|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
130221555|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
130221556|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
130221557|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
130221558|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
130221559|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
130221560|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
130221561|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
130017572|NCT00605085|468026371|FG000|Overall Study|Adverse Event|9|||
130017573|NCT00605085|468026372|FG001|Overall Study|Adverse Event|5|||
130017574|NCT00605085|468026371|FG000|Overall Study|Pregnancy|2|||
130017575|NCT00605085|468026372|FG001|Overall Study|Pregnancy|0|||
130017576|NCT00605085|468026371|FG000|Overall Study|Protocol Violation|3|||
130017577|NCT00605085|468026372|FG001|Overall Study|Protocol Violation|2|||
130017578|NCT00605085|468026371|FG000|Overall Study|Lost to Follow-up|10|||
130017579|NCT00605085|468026372|FG001|Overall Study|Lost to Follow-up|5|||
130017580|NCT00605085|468026371|FG000|Overall Study|administrative reasons|18|||
130017581|NCT00605085|468026372|FG001|Overall Study|administrative reasons|8|||
130017582|NCT03257267|468026377|FG000|Overall Study|Adverse Event|17|||
130017583|NCT03257267|468026378|FG001|Overall Study|Adverse Event|7|||
130017584|NCT03257267|468026377|FG000|Overall Study|Death|96|||
130017585|NCT03257267|468026378|FG001|Overall Study|Death|98|||
130017586|NCT03257267|468026377|FG000|Overall Study|Lost to Follow-up|2|||
130017587|NCT03257267|468026378|FG001|Overall Study|Lost to Follow-up|2|||
130017588|NCT03257267|468026377|FG000|Overall Study|Non-compliance with Study Drug|0|||
130017589|NCT03257267|468026378|FG001|Overall Study|Non-compliance with Study Drug|2|||
130017590|NCT03257267|468026377|FG000|Overall Study|Participant Decision|35|||
130017591|NCT03257267|468026378|FG001|Overall Study|Participant Decision|43|||
130017592|NCT03257267|468026377|FG000|Overall Study|Sponsor Decision|1|||
130017593|NCT03257267|468026378|FG001|Overall Study|Sponsor Decision|0|||
130221562|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
130221563|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130017594|NCT03257267|468026377|FG000|Overall Study|Physician Decision|1|||
130017595|NCT03257267|468026378|FG001|Overall Study|Physician Decision|3|||
130221564|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130017596|NCT03257267|468026377|FG000|Overall Study|Disease Progression|109|||
130221565|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130017597|NCT03257267|468026378|FG001|Overall Study|Disease Progression|121|||
130017598|NCT03257267|468026377|FG000|Overall Study|Withdrawal by Subject|8|||
130221566|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221567|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221568|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221569|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
130221570|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221571|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221572|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221573|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221574|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221575|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221576|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221577|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221578|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221579|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221580|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
130221581|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
130221582|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221583|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221584|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221585|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
130221586|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
130221587|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
130221588|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130221589|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130221590|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
130221591|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
130221592|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
130221593|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
130221594|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
130221595|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
130221596|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
130221597|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
130221598|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
130221599|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
130221600|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
130221601|NCT03428100|468774409|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221602|NCT03428100|468774410|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221603|NCT03428100|468774411|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221604|NCT03428100|468774412|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221605|NCT03428100|468774413|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221606|NCT03428100|468774414|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221607|NCT03428100|468774415|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130221608|NCT03428100|468774416|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221609|NCT03428100|468774417|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221610|NCT03428100|468774418|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
130221611|NCT03428100|468774419|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
130221612|NCT03428100|468774420|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130221613|NCT03428100|468774421|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221614|NCT03428100|468774422|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
130221615|NCT03428100|468774423|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
130221616|NCT03428100|468774424|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221617|NCT03428100|468774425|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
130221618|NCT03428100|468774426|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
130221619|NCT03428100|468774427|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
130221620|NCT04556760|468774428|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221621|NCT04556760|468774429|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
130221622|NCT04556760|468774430|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221623|NCT04556760|468774431|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221624|NCT04556760|468774432|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221625|NCT04556760|468774433|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
130221626|NCT04556760|468774428|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221627|NCT04556760|468774429|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221628|NCT04556760|468774430|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221629|NCT04556760|468774431|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
130221630|NCT04556760|468774432|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221631|NCT04556760|468774433|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
130221632|NCT02168491|468774435|FG000|Overall Study|Withdrawal by Subject|1|||
130221633|NCT01610037|468774437|FG000|All Patients|Adverse Event|27|||
130221634|NCT01610037|468774438|FG001|All Patients|Adverse Event|22|||
130221635|NCT01610037|468774439|FG002|All Patients|Adverse Event|26|||
130221636|NCT01610037|468774437|FG000|All Patients|Withdrawal by Subject|12|||
130221637|NCT01610037|468774438|FG001|All Patients|Withdrawal by Subject|10|||
130221638|NCT01610037|468774439|FG002|All Patients|Withdrawal by Subject|20|||
130221639|NCT01610037|468774437|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
130221640|NCT01610037|468774438|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
130221641|NCT01610037|468774439|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
130221642|NCT01610037|468774437|FG000|All Patients|Death|4|||
130221643|NCT01610037|468774438|FG001|All Patients|Death|2|||
130221644|NCT01610037|468774439|FG002|All Patients|Death|1|||
130221645|NCT01610037|468774437|FG000|All Patients|Protocol deviation|4|||
130221646|NCT01610037|468774438|FG001|All Patients|Protocol deviation|3|||
130221647|NCT01610037|468774439|FG002|All Patients|Protocol deviation|3|||
130221648|NCT01610037|468774437|FG000|All Patients|Abnormal laboratory value|1|||
130221649|NCT01610037|468774438|FG001|All Patients|Abnormal laboratory value|1|||
130221650|NCT01610037|468774439|FG002|All Patients|Abnormal laboratory value|0|||
130221651|NCT01610037|468774437|FG000|All Patients|Administrative problems|1|||
130221652|NCT01610037|468774438|FG001|All Patients|Administrative problems|4|||
130221653|NCT01610037|468774439|FG002|All Patients|Administrative problems|4|||
130221654|NCT01610037|468774437|FG000|All Patients|Lost to Follow-up|1|||
130221655|NCT01610037|468774438|FG001|All Patients|Lost to Follow-up|0|||
130221656|NCT01610037|468774439|FG002|All Patients|Lost to Follow-up|0|||
130221657|NCT01610037|468774437|FG000|All Patients|Abnormal test procedure result(s)|0|||
130221658|NCT01610037|468774438|FG001|All Patients|Abnormal test procedure result(s)|1|||
130221659|NCT01610037|468774439|FG002|All Patients|Abnormal test procedure result(s)|3|||
130221660|NCT01610037|468774437|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
130221661|NCT01610037|468774438|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
130221662|NCT01610037|468774439|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
130221663|NCT01610037|468774437|FG000|Treatment and Follow up Period|Death|10|||
130221664|NCT01610037|468774438|FG001|Treatment and Follow up Period|Death|5|||
130221665|NCT01610037|468774439|FG002|Treatment and Follow up Period|Death|4|||
130221666|NCT01610037|468774437|FG000|Treatment and Follow up Period|Administrative problems|1|||
130221667|NCT01610037|468774438|FG001|Treatment and Follow up Period|Administrative problems|3|||
130221668|NCT01610037|468774439|FG002|Treatment and Follow up Period|Administrative problems|2|||
130221669|NCT01610037|468774437|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
130221670|NCT01610037|468774438|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
130221671|NCT01610037|468774439|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
130221672|NCT00705757|468774440|FG000|Overall Study|Lack of Efficacy|5|||
130221673|NCT00705757|468774441|FG001|Overall Study|Lack of Efficacy|1|||
130221674|NCT00705757|468774442|FG002|Overall Study|Lack of Efficacy|3|||
130221675|NCT00705757|468774440|FG000|Overall Study|Lost to Follow-up|7|||
130221676|NCT00705757|468774441|FG001|Overall Study|Lost to Follow-up|6|||
130221677|NCT00705757|468774442|FG002|Overall Study|Lost to Follow-up|6|||
130221678|NCT00705757|468774440|FG000|Overall Study|Withdrawal by Subject|1|||
130221679|NCT00705757|468774441|FG001|Overall Study|Withdrawal by Subject|1|||
130221680|NCT00705757|468774442|FG002|Overall Study|Withdrawal by Subject|2|||
130221681|NCT01411852|468774443|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
129884439|NCT02572817|467536395|FG001|Overall Study|Lost to Follow-up|3|||
129884440|NCT02111213|467536399|FG000|Overall Study|Withdrawal by Subject|3|||
129884441|NCT02111213|467536400|FG001|Overall Study|Withdrawal by Subject|2|||
129884442|NCT02111213|467536399|FG000|Overall Study|Lost to Follow-up|3|||
129884443|NCT02111213|467536400|FG001|Overall Study|Lost to Follow-up|4|||
130017599|NCT03257267|468026378|FG001|Overall Study|Withdrawal by Subject|26|||
130017600|NCT03257267|468026377|FG000|Overall Study|Other|0|||
130017601|NCT03257267|468026378|FG001|Overall Study|Other|2|||
130017602|NCT01979523|468026379|FG000|Overall Study|Withdrawal by Subject|1|||
130017603|NCT01979523|468026380|FG001|Overall Study|Withdrawal by Subject|0|||
130017604|NCT00706134|468026381|FG000|Overall Study|Adverse Event|8|||
130017605|NCT00706134|468026382|FG001|Overall Study|Adverse Event|7|||
130017606|NCT00706134|468026383|FG002|Overall Study|Adverse Event|2|||
130017607|NCT00706134|468026384|FG003|Overall Study|Adverse Event|3|||
130017608|NCT00706134|468026381|FG000|Overall Study|Lost to Follow-up|0|||
130017609|NCT00706134|468026382|FG001|Overall Study|Lost to Follow-up|1|||
130017610|NCT00706134|468026383|FG002|Overall Study|Lost to Follow-up|0|||
130017611|NCT00706134|468026384|FG003|Overall Study|Lost to Follow-up|0|||
130017612|NCT00706134|468026381|FG000|Overall Study|Protocol Violation|0|||
130017613|NCT00706134|468026382|FG001|Overall Study|Protocol Violation|6|||
130017614|NCT00706134|468026383|FG002|Overall Study|Protocol Violation|0|||
130017615|NCT00706134|468026384|FG003|Overall Study|Protocol Violation|3|||
130017616|NCT00706134|468026381|FG000|Overall Study|Withdrawal by Subject|1|||
130017617|NCT00706134|468026382|FG001|Overall Study|Withdrawal by Subject|2|||
130017618|NCT00706134|468026383|FG002|Overall Study|Withdrawal by Subject|1|||
130017619|NCT00706134|468026384|FG003|Overall Study|Withdrawal by Subject|0|||
130017620|NCT00706134|468026381|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
130017621|NCT00706134|468026382|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130017622|NCT00706134|468026383|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130017623|NCT00706134|468026384|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
130017624|NCT00706134|468026381|FG000|Overall Study|Did not meet study criteria|2|||
130017625|NCT00706134|468026382|FG001|Overall Study|Did not meet study criteria|0|||
130017626|NCT00706134|468026383|FG002|Overall Study|Did not meet study criteria|0|||
130017627|NCT00706134|468026384|FG003|Overall Study|Did not meet study criteria|0|||
130017628|NCT01982292|468026385|FG000|Overall Study|Adverse Event|2|||
130017629|NCT01982292|468026386|FG001|Overall Study|Adverse Event|0|||
130017630|NCT01982292|468026385|FG000|Overall Study|Death|1|||
130017631|NCT01982292|468026386|FG001|Overall Study|Death|0|||
130017632|NCT01982292|468026385|FG000|Overall Study|Lost to Follow-up|2|||
130017633|NCT01982292|468026386|FG001|Overall Study|Lost to Follow-up|0|||
130017634|NCT01982292|468026385|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
130017635|NCT01982292|468026386|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
130017636|NCT01982292|468026385|FG000|Overall Study|Protocol Deviation|1|||
130017637|NCT01982292|468026386|FG001|Overall Study|Protocol Deviation|0|||
130017638|NCT01982292|468026385|FG000|Overall Study|Patient/Guardian Decision|3|||
130017639|NCT01982292|468026386|FG001|Overall Study|Patient/Guardian Decision|1|||
130017640|NCT01982292|468026385|FG000|Overall Study|Technical Problems|2|||
130017641|NCT01982292|468026386|FG001|Overall Study|Technical Problems|0|||
130017642|NCT00746252|468026389|FG000|Overall Study|weight gain >7.5 %|1|||
130017643|NCT00746252|468026390|FG001|Overall Study|weight gain >7.5 %|2|||
130017644|NCT00082888|468026391|FG000|Overall Study|Ineligible|1|||
130017645|NCT00082888|468026392|FG001|Overall Study|Ineligible|0|||
130017646|NCT00082888|468026393|FG002|Overall Study|Ineligible|0|||
130017647|NCT01659320|468026395|FG000|Overall Study|Withdrawal by Subject|2|||
130017648|NCT01659320|468026395|FG000|Overall Study|Physician Decision|1|||
130017649|NCT01870401|468026396|FG000|Overall Study|Death|48|||
130017650|NCT01870401|468026397|FG001|Overall Study|Death|24|||
130017651|NCT01870401|468026396|FG000|Overall Study|Withdrawal by Subject|39|||
130017652|NCT01870401|468026397|FG001|Overall Study|Withdrawal by Subject|26|||
130017653|NCT01870401|468026396|FG000|Overall Study|Lost to Follow-up|19|||
130017654|NCT01870401|468026397|FG001|Overall Study|Lost to Follow-up|14|||
129884444|NCT00210119|467536401|FG000|Overall Study|Protocol Violation|1|||
129884445|NCT00210119|467536401|FG000|Overall Study|Withdrawal by Subject|1|||
130017655|NCT01870401|468026396|FG000|Overall Study|Other|9|||
130017656|NCT01870401|468026397|FG001|Overall Study|Other|7|||
130017657|NCT01870401|468026396|FG000|Overall Study|On-going in the Study|35|||
130017658|NCT01870401|468026397|FG001|Overall Study|On-going in the Study|25|||
129884446|NCT01830881|467536402|FG000|Overall Study|Changed decision to have an abortion|0|||
129884447|NCT01830881|467536403|FG001|Overall Study|Changed decision to have an abortion|1|||
130017659|NCT02684981|468026398|FG000|Overall Study|Permanently discontinued the treatment|157|||
130017660|NCT02684981|468026399|FG001|Overall Study|Permanently discontinued the treatment|161|||
129884448|NCT00119262|467536404|FG000|Overall Study|Lack of Efficacy|0|||
130017661|NCT02684981|468026400|FG002|Overall Study|Permanently discontinued the treatment|110|||
130017662|NCT02684981|468026398|FG000|Overall Study|Other|83|||
130017663|NCT02684981|468026399|FG001|Overall Study|Other|49|||
130017664|NCT02684981|468026400|FG002|Overall Study|Other|17|||
130017665|NCT04623242|468026401|FG000|Overall Study|Withdrawal by Subject|7|||
129884449|NCT00119262|467536405|FG001|Overall Study|Lack of Efficacy|3|||
130017666|NCT04623242|468026402|FG001|Overall Study|Withdrawal by Subject|12|||
130017667|NCT04623242|468026403|FG002|Overall Study|Withdrawal by Subject|5|||
130017668|NCT04623242|468026404|FG003|Overall Study|Withdrawal by Subject|7|||
130017669|NCT04623242|468026405|FG004|Overall Study|Withdrawal by Subject|0|||
130017670|NCT04623242|468026401|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
130017671|NCT04623242|468026402|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
130017672|NCT04623242|468026403|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
130017673|NCT04623242|468026404|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
130017674|NCT04623242|468026405|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
130017675|NCT04623242|468026401|FG000|Overall Study|Subject unblinded to mutation status|0|||
130017676|NCT04623242|468026402|FG001|Overall Study|Subject unblinded to mutation status|0|||
130017677|NCT04623242|468026403|FG002|Overall Study|Subject unblinded to mutation status|0|||
130017678|NCT04623242|468026404|FG003|Overall Study|Subject unblinded to mutation status|13|||
130017679|NCT04623242|468026405|FG004|Overall Study|Subject unblinded to mutation status|0|||
130221682|NCT01411852|468774444|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
130221683|NCT01411852|468774443|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
130221684|NCT01411852|468774444|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
130221685|NCT01411852|468774443|FG000|Prehospital Intervention Phase|Found to be under age|0|||
130221686|NCT01411852|468774444|FG001|Prehospital Intervention Phase|Found to be under age|1|||
130221687|NCT01411852|468774443|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
130221688|NCT01411852|468774444|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
130221689|NCT01411852|468774443|FG000|Hospital Intervention Phase|Severe head injury|5|||
130221690|NCT01411852|468774444|FG001|Hospital Intervention Phase|Severe head injury|4|||
130221691|NCT01411852|468774443|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
130221692|NCT01411852|468774444|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
130221693|NCT01411852|468774443|FG000|Hospital Intervention Phase|Miscommunication error|1|||
130221694|NCT01411852|468774444|FG001|Hospital Intervention Phase|Miscommunication error|2|||
130221695|NCT01411852|468774443|FG000|Hospital Intervention Phase|CPR administered|3|||
130221696|NCT01411852|468774444|FG001|Hospital Intervention Phase|CPR administered|1|||
130221697|NCT01411852|468774443|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
130221698|NCT01411852|468774444|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
130221699|NCT01411852|468774443|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
130221700|NCT01411852|468774444|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
130221701|NCT01411852|468774443|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
130221702|NCT01411852|468774444|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
130221703|NCT01411852|468774443|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
130221704|NCT01411852|468774444|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
130221705|NCT01411852|468774443|FG000|Hospital Intervention Phase|Other ineligible|2|||
130221706|NCT01411852|468774444|FG001|Hospital Intervention Phase|Other ineligible|2|||
130221707|NCT01411852|468774443|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
130221708|NCT01411852|468774444|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
130221709|NCT01411852|468774443|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
130221710|NCT01411852|468774444|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
130221711|NCT01411852|468774443|FG000|Hospital Intervention Phase|Vascular access failed|1|||
130221712|NCT01411852|468774444|FG001|Hospital Intervention Phase|Vascular access failed|0|||
130221713|NCT03743025|468774445|FG000|Overall Study|Surgery was cancelled|2|||
130221714|NCT03743025|468774446|FG001|Overall Study|Surgery was cancelled|1|||
130221715|NCT02420119|468774447|FG000|Overall Study|insufficient laboratory data|5|||
130221716|NCT00807885|468774448|FG000|Overall Study|Lost to Follow-up|0|||
130221717|NCT00807885|468774449|FG001|Overall Study|Lost to Follow-up|0|||
130221718|NCT00807885|468774450|FG002|Overall Study|Lost to Follow-up|0|||
130221719|NCT00807885|468774451|FG003|Overall Study|Lost to Follow-up|0|||
130221720|NCT00807885|468774452|FG004|Overall Study|Lost to Follow-up|0|||
130221721|NCT00807885|468774453|FG005|Overall Study|Lost to Follow-up|1|||
130221722|NCT00807885|468774454|FG006|Overall Study|Lost to Follow-up|0|||
130221723|NCT00807885|468774455|FG007|Overall Study|Lost to Follow-up|0|||
130221724|NCT00807885|468774456|FG008|Overall Study|Lost to Follow-up|0|||
130221725|NCT03126786|468774457|FG000|Overall Study|Adverse Event|3|||
130221726|NCT03126786|468774458|FG001|Overall Study|Adverse Event|0|||
130017680|NCT00820898|468026406|FG000|Overall Study|Inelgible - wrong primary site|1|||
130221727|NCT03126786|468774457|FG000|Overall Study|Lost to Follow-up|0|||
130221728|NCT03126786|468774458|FG001|Overall Study|Lost to Follow-up|1|||
130221729|NCT03126786|468774457|FG000|Overall Study|Withdrawal by Subject|3|||
130221730|NCT03126786|468774458|FG001|Overall Study|Withdrawal by Subject|1|||
130221731|NCT00227539|468774459|FG000|Overall Study|Protocol Violation|1|||
130221732|NCT00991289|468774460|FG000|Overall Study|Adverse Event|1|||
130221733|NCT00991289|468774460|FG000|Overall Study|Physician Decision|2|||
130221734|NCT00991289|468774460|FG000|Overall Study|Withdrawal by Subject|3|||
129884450|NCT00119262|467536404|FG000|Overall Study|Withdrawal by Subject|12|||
129884451|NCT00119262|467536405|FG001|Overall Study|Withdrawal by Subject|11|||
129884452|NCT00119262|467536404|FG000|Overall Study|Adverse Event|33|||
129884453|NCT00119262|467536405|FG001|Overall Study|Adverse Event|35|||
129884454|NCT00119262|467536404|FG000|Overall Study|other disease|0|||
129884455|NCT00119262|467536405|FG001|Overall Study|other disease|2|||
129884456|NCT00119262|467536404|FG000|Overall Study|ineligble|1|||
129884457|NCT00119262|467536405|FG001|Overall Study|ineligble|2|||
129884458|NCT00119262|467536404|FG000|Overall Study|others|0|||
129884459|NCT00119262|467536405|FG001|Overall Study|others|5|||
129884460|NCT00734214|467536406|FG000|Overall Study|Withdrawal by Subject|3|||
130017681|NCT00493870|468026409|FG000|Overall Study|Lost to Follow-up|12|||
130017682|NCT00493870|468026410|FG001|Overall Study|Lost to Follow-up|15|||
130017683|NCT00272038|468026411|FG000|Overall Study|withdrew before they received 2 cycles|7|||
130017684|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
130017685|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
130017686|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
130017687|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
130017688|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
130017689|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
130017690|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
130017691|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
130017692|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
130017693|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
130017694|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
130017695|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
130017696|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
130017697|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
130017698|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
130017699|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
130017700|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
130017701|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
130017702|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
129884461|NCT00734214|467536407|FG001|Overall Study|Withdrawal by Subject|4|||
130221735|NCT00991289|468774460|FG000|Overall Study|Lost to Follow-up|4|||
130221736|NCT00991289|468774460|FG000|Overall Study|Protocol Violation|2|||
130221737|NCT00426764|468774461|FG000|Overall Study|Protocol Violation|1|||
130221738|NCT00426764|468774461|FG000|Overall Study|Withdrawal by Subject|4|||
130221739|NCT00426764|468774461|FG000|Overall Study|Physician Decision|6|||
130221740|NCT00426764|468774461|FG000|Overall Study|Compassionate Use|1|||
130221741|NCT00426764|468774461|FG000|Overall Study|Progressive Disease|83|||
130221742|NCT00426764|468774461|FG000|Overall Study|Adverse Event|24|||
130221743|NCT00426764|468774461|FG000|Overall Study|Other|1|||
130221744|NCT00426764|468774461|FG000|Overall Study|Death|1|||
130221745|NCT00426764|468774461|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
130221746|NCT03804268|468774464|FG000|Overall Study|Adverse Event|2|||
130221747|NCT03804268|468774465|FG001|Overall Study|Adverse Event|2|||
130221748|NCT03804268|468774464|FG000|Overall Study|Withdrawal by Subject|2|||
130221749|NCT03804268|468774465|FG001|Overall Study|Withdrawal by Subject|0|||
130221750|NCT03804268|468774464|FG000|Overall Study|Lost to Follow-up|1|||
130221751|NCT03804268|468774465|FG001|Overall Study|Lost to Follow-up|0|||
130221752|NCT03804268|468774464|FG000|Overall Study|Physician Decision|2|||
130221753|NCT03804268|468774465|FG001|Overall Study|Physician Decision|0|||
130221754|NCT02716779|468774466|FG000|Monotherapy|Adverse Event|0|||
130221755|NCT02716779|468774467|FG001|Monotherapy|Adverse Event|1|||
130221756|NCT02716779|468774468|FG002|Monotherapy|Adverse Event|1|||
130221757|NCT02716779|468774466|FG000|Combination Therapy|Adverse Event|0|||
130221758|NCT02716779|468774467|FG001|Combination Therapy|Adverse Event|2|||
130221759|NCT02716779|468774468|FG002|Combination Therapy|Adverse Event|1|||
130221760|NCT01843803|468774471|FG000|Overall Study|not a Veteran, did not see provider|1|||
130221761|NCT01843803|468774472|FG001|Overall Study|not a Veteran, did not see provider|3|||
130221762|NCT01051817|468774480|FG000|Overall Study|Adverse Event|0|||
130221763|NCT01051817|468774481|FG001|Overall Study|Adverse Event|2|||
130221764|NCT01051817|468774480|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
130221765|NCT01051817|468774481|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
130221766|NCT01051817|468774480|FG000|Overall Study|Withdrawal by Subject|3|||
130221767|NCT01051817|468774481|FG001|Overall Study|Withdrawal by Subject|5|||
130221768|NCT01051817|468774480|FG000|Overall Study|Protocol Violation|0|||
130221769|NCT01051817|468774481|FG001|Overall Study|Protocol Violation|1|||
130221770|NCT02989402|468774482|FG000|Overall Study|Adverse event, or serious adverse event|4|||
130221771|NCT02989402|468774482|FG000|Overall Study|Death|2|||
130221772|NCT02989402|468774482|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
130221773|NCT02989402|468774482|FG000|Overall Study|Lost to Follow-up|8|||
130221774|NCT02989402|468774482|FG000|Overall Study|Patient no longer on monotherapy|1|||
130221775|NCT02989402|468774482|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
130221776|NCT02989402|468774482|FG000|Overall Study|Withdrawal by Subject|7|||
130221777|NCT02989402|468774482|FG000|Overall Study|Other|2|||
130221778|NCT02686164|468774484|FG000|Overall Study|Adverse Event|1|||
130221779|NCT02686164|468774484|FG000|Overall Study|Withdrawal of consent|1|||
130221780|NCT02686164|468774484|FG000|Overall Study|Clinical progression|1|||
130221781|NCT02824627|468774487|FG000|Overall Study|Adverse Event|1|||
130221782|NCT02824627|468774488|FG001|Overall Study|Adverse Event|2|||
130221783|NCT02824627|468774487|FG000|Overall Study|Lost to Follow-up|2|||
130221784|NCT02824627|468774488|FG001|Overall Study|Lost to Follow-up|1|||
130221785|NCT00672633|468774489|FG000|Overall Study|Withdrawal by Subject|0|||
130221786|NCT00672633|468774490|FG001|Overall Study|Withdrawal by Subject|1|||
130221787|NCT01938846|468774491|FG000|Overall Study|Progressive disease|26|||
130221788|NCT01938846|468774492|FG001|Overall Study|Progressive disease|18|||
130221789|NCT01938846|468774493|FG002|Overall Study|Progressive disease|16|||
130221790|NCT01938846|468774491|FG000|Overall Study|Adverse Event|8|||
130221791|NCT01938846|468774492|FG001|Overall Study|Adverse Event|4|||
130221792|NCT01938846|468774493|FG002|Overall Study|Adverse Event|3|||
130221793|NCT01938846|468774491|FG000|Overall Study|Withdrawal by Subject|2|||
130221794|NCT01938846|468774492|FG001|Overall Study|Withdrawal by Subject|2|||
130221795|NCT01938846|468774493|FG002|Overall Study|Withdrawal by Subject|1|||
130221796|NCT01938846|468774491|FG000|Overall Study|Other than listed|5|||
130221797|NCT01938846|468774492|FG001|Overall Study|Other than listed|1|||
130221798|NCT01938846|468774493|FG002|Overall Study|Other than listed|4|||
130221799|NCT02324361|468774496|FG000|Overall Study|Lost to Follow-up|5|||
130221800|NCT02324361|468774497|FG001|Overall Study|Lost to Follow-up|2|||
130221801|NCT01519817|468776158|FG000|Overall Study|Withdrawal by Subject|1|||
130221802|NCT01519817|468776159|FG001|Overall Study|Withdrawal by Subject|0|||
130221803|NCT01519817|468776160|FG002|Overall Study|Withdrawal by Subject|0|||
130221804|NCT01519817|468776161|FG003|Overall Study|Withdrawal by Subject|0|||
130221805|NCT01519817|468776158|FG000|Overall Study|Off study due to infection|0|||
130221806|NCT01519817|468776159|FG001|Overall Study|Off study due to infection|0|||
130221807|NCT01519817|468776160|FG002|Overall Study|Off study due to infection|0|||
130221808|NCT01519817|468776161|FG003|Overall Study|Off study due to infection|1|||
130221809|NCT02922153|468776162|FG000|Overall Study|Death|8|||
130221810|NCT02922153|468776163|FG001|Overall Study|Death|1|||
130221811|NCT02922153|468776162|FG000|Overall Study|Lost to Follow-up|1|||
130221812|NCT02922153|468776163|FG001|Overall Study|Lost to Follow-up|0|||
130221813|NCT02922153|468776162|FG000|Overall Study|Physician Decision|1|||
130221814|NCT02922153|468776163|FG001|Overall Study|Physician Decision|1|||
130221815|NCT02692586|468776168|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
130221816|NCT02692586|468776168|FG000|Overall Study|Received adjunctive thrombolytics|2|||
130221817|NCT03234036|468776170|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
130221818|NCT03234036|468776171|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
130221819|NCT03234036|468776172|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
130221820|NCT03234036|468776173|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
130221821|NCT02999789|468776174|FG000|Overall Study|Withdrawal by Subject|0|||
130221822|NCT02999789|468776175|FG001|Overall Study|Withdrawal by Subject|1|||
130221823|NCT02999789|468776174|FG000|Overall Study|Became ineligible|1|||
130221824|NCT02999789|468776175|FG001|Overall Study|Became ineligible|2|||
130221825|NCT04613739|468776178|FG000|Overall Study|Lost to Follow-up|6|||
130221826|NCT04613739|468776179|FG001|Overall Study|Lost to Follow-up|9|||
130221827|NCT04613739|468776178|FG000|Overall Study|potentially duplicative/fraudulent|1|||
130221828|NCT04613739|468776179|FG001|Overall Study|potentially duplicative/fraudulent|3|||
130221829|NCT01447407|468776180|FG000|Overall Study|Withdrawal by Subject|2|||
130221830|NCT01447407|468776181|FG001|Overall Study|Withdrawal by Subject|0|||
130221831|NCT01447407|468776182|FG002|Overall Study|Withdrawal by Subject|0|||
130221832|NCT01447407|468776183|FG003|Overall Study|Withdrawal by Subject|1|||
130221833|NCT01447407|468776180|FG000|Overall Study|Physician Decision|0|||
130221834|NCT01447407|468776181|FG001|Overall Study|Physician Decision|0|||
130221835|NCT01447407|468776182|FG002|Overall Study|Physician Decision|1|||
130221836|NCT01447407|468776183|FG003|Overall Study|Physician Decision|1|||
130221837|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
130221838|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
130221839|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
130221840|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Death|0|||
130221841|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Death|1|||
130221842|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Death|0|||
130221843|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
130221844|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
130221845|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
130221846|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
130221847|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
130221848|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
130221849|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130221850|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130221851|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130221852|NCT01064414|468776184|FG000|Core Period: Baseline to Week 26|Other|4|||
130221853|NCT01064414|468776185|FG001|Core Period: Baseline to Week 26|Other|7|||
130221854|NCT01064414|468776186|FG002|Core Period: Baseline to Week 26|Other|2|||
130098780|NCT03426995|468319307|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130221855|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130221856|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130098781|NCT03426995|468319308|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130221857|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130221858|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Death|0|||
130221859|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Death|1|||
130221860|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130221861|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130221862|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130221863|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130221864|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130221865|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130221866|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130221867|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130221868|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130221869|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130221870|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
130221871|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130017703|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
130017704|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
130017705|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
130017706|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
130017707|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
130017708|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
130017709|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
130017710|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
130017711|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
130017712|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
130017713|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
130017714|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
130017715|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
130017716|NCT03605680|468026412|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
130017717|NCT03605680|468026413|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130017718|NCT03605680|468026414|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130017719|NCT03605680|468026415|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
130017720|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
130052120|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
130017721|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
130017722|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
130017723|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
130017724|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
130017725|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
130017726|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
130017727|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
130017728|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130017729|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130017730|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130017731|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130017732|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
130017733|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130017734|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
130017735|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130017736|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
130017737|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
130017738|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
130017739|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
130017740|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
130017741|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
130017742|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
130017743|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
130017744|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
130017745|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130017746|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
130017747|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
130017748|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
130017749|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
130017750|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
130017751|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
130017752|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
130017753|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
130017754|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
130017755|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
130017756|NCT03605680|468026412|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
130017757|NCT03605680|468026413|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
130017758|NCT03605680|468026414|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
130017759|NCT03605680|468026415|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
130017760|NCT01289015|468026420|FG000|Overall Study|Protocol Violation|12|||
130017761|NCT01289015|468026421|FG001|Overall Study|Protocol Violation|9|||
130017762|NCT01289015|468026420|FG000|Overall Study|Adverse Event|3|||
130017763|NCT01289015|468026421|FG001|Overall Study|Adverse Event|0|||
130017764|NCT01289015|468026420|FG000|Overall Study|Lost to Follow-up|33|||
130017765|NCT01289015|468026421|FG001|Overall Study|Lost to Follow-up|17|||
130017766|NCT01289015|468026420|FG000|Overall Study|Withdrawal by Subject|17|||
130017767|NCT01289015|468026421|FG001|Overall Study|Withdrawal by Subject|8|||
130017768|NCT01289015|468026420|FG000|Overall Study|Disease progression|1|||
130017769|NCT01289015|468026421|FG001|Overall Study|Disease progression|0|||
130017770|NCT01289015|468026420|FG000|Overall Study|Negative baseline culture and others|33|||
130017771|NCT01289015|468026421|FG001|Overall Study|Negative baseline culture and others|20|||
130017772|NCT02590588|468026429|FG000|Overall Study|Adverse Event|1|||
130221872|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
130221873|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130221874|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130221875|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130221876|NCT01064414|468776184|FG000|Extension Period: Week 26 to Week 52|Other|5|||
130221877|NCT01064414|468776185|FG001|Extension Period: Week 26 to Week 52|Other|2|||
130221878|NCT01064414|468776186|FG002|Extension Period: Week 26 to Week 52|Other|1|||
130221879|NCT00249873|468776187|FG000|Overall Study|Not treated|7|||
130221880|NCT00249873|468776188|FG001|Overall Study|Not treated|8|||
130221881|NCT00249873|468776187|FG000|Overall Study|Significant thrombocytopenia|9|||
130221882|NCT00249873|468776188|FG001|Overall Study|Significant thrombocytopenia|8|||
130221883|NCT00249873|468776187|FG000|Overall Study|Severe allergic reaction|8|||
130221884|NCT00249873|468776188|FG001|Overall Study|Severe allergic reaction|1|||
130221885|NCT00249873|468776187|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
130221886|NCT00249873|468776188|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
130221887|NCT00249873|468776187|FG000|Overall Study|Other Serious Adverse Event|86|||
130221888|NCT00249873|468776188|FG001|Overall Study|Other Serious Adverse Event|97|||
130221889|NCT00249873|468776187|FG000|Overall Study|Qualifying condition not present|20|||
130221890|NCT00249873|468776188|FG001|Overall Study|Qualifying condition not present|23|||
130221891|NCT00249873|468776187|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
130221892|NCT00249873|468776188|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
130221893|NCT00249873|468776187|FG000|Overall Study|Withdrawal by Subject|504|||
130221894|NCT00249873|468776188|FG001|Overall Study|Withdrawal by Subject|466|||
130221895|NCT00249873|468776187|FG000|Overall Study|Lost to Follow-up|4|||
130221896|NCT00249873|468776188|FG001|Overall Study|Lost to Follow-up|7|||
130221897|NCT00249873|468776187|FG000|Overall Study|Minor bleeding|99|||
130221898|NCT00249873|468776188|FG001|Overall Study|Minor bleeding|37|||
130221899|NCT00249873|468776187|FG000|Overall Study|Non-compliance|41|||
130221900|NCT00249873|468776188|FG001|Overall Study|Non-compliance|46|||
130221901|NCT00249873|468776187|FG000|Overall Study|Other non serious Adverse Event|112|||
130221902|NCT00249873|468776188|FG001|Overall Study|Other non serious Adverse Event|108|||
130221903|NCT00249873|468776187|FG000|Overall Study|Other contraindicated medication|1|||
130221904|NCT00249873|468776188|FG001|Overall Study|Other contraindicated medication|0|||
130221905|NCT00249873|468776187|FG000|Overall Study|Patient not wish to continue after May08|3|||
130221906|NCT00249873|468776188|FG001|Overall Study|Patient not wish to continue after May08|4|||
130221907|NCT00249873|468776187|FG000|Overall Study|Physician withdrew consent|59|||
130221908|NCT00249873|468776188|FG001|Overall Study|Physician withdrew consent|60|||
130221909|NCT00249873|468776187|FG000|Overall Study|Open label clopidogrel required|31|||
130221910|NCT00249873|468776188|FG001|Overall Study|Open label clopidogrel required|42|||
130221911|NCT00249873|468776187|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
130221912|NCT00249873|468776188|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
130221913|NCT00249873|468776187|FG000|Overall Study|Oral anticoagulant required|159|||
130221914|NCT00249873|468776188|FG001|Overall Study|Oral anticoagulant required|157|||
130221915|NCT00249873|468776187|FG000|Overall Study|Study drug intolerance|5|||
130221916|NCT00249873|468776188|FG001|Overall Study|Study drug intolerance|0|||
130221917|NCT00249873|468776187|FG000|Overall Study|Surgery/ procedure|9|||
130221918|NCT00249873|468776188|FG001|Overall Study|Surgery/ procedure|9|||
130221919|NCT00249873|468776187|FG000|Overall Study|Event related to cardiac condition|12|||
130221920|NCT00249873|468776188|FG001|Overall Study|Event related to cardiac condition|21|||
130221921|NCT00249873|468776187|FG000|Overall Study|Thromboembolic/outcome event|82|||
130017773|NCT00267748|468026432|FG000|Non-randomized Period|Progressive disease|10|||
130221922|NCT00249873|468776188|FG001|Overall Study|Thromboembolic/outcome event|122|||
130221923|NCT03131167|468776189|FG000|Overall Study|Other (Unspecified)|0|||
130221924|NCT03131167|468776190|FG001|Overall Study|Other (Unspecified)|0|||
130221925|NCT03131167|468776191|FG002|Overall Study|Other (Unspecified)|0|||
130221926|NCT03131167|468776192|FG003|Overall Study|Other (Unspecified)|0|||
130017774|NCT00267748|468026433|FG001|Non-randomized Period|Progressive disease|0|||
130221927|NCT03131167|468776193|FG004|Overall Study|Other (Unspecified)|0|||
130221928|NCT03131167|468776194|FG005|Overall Study|Other (Unspecified)|1|||
130221929|NCT03131167|468776195|FG006|Overall Study|Other (Unspecified)|0|||
130221930|NCT03131167|468776196|FG007|Overall Study|Other (Unspecified)|0|||
130221931|NCT03131167|468776197|FG008|Overall Study|Other (Unspecified)|0|||
130221932|NCT03131167|468776198|FG009|Overall Study|Other (Unspecified)|0|||
130221933|NCT03131167|468776199|FG010|Overall Study|Other (Unspecified)|0|||
130221934|NCT03131167|468776200|FG011|Overall Study|Other (Unspecified)|0|||
130221935|NCT03131167|468776201|FG012|Overall Study|Other (Unspecified)|0|||
130221936|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Death|20|||
130221937|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Death|26|||
130221938|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
130221939|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
130221940|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
130221941|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
130221942|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
130221943|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
130221944|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
130221945|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
130221946|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
130221947|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
130221948|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
130221949|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
130221950|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
130221951|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
130221952|NCT00643201|468776202|FG000|Randomized, Completed 6 Months of Study|Other|107|||
130221953|NCT00643201|468776203|FG001|Randomized, Completed 6 Months of Study|Other|107|||
130221954|NCT00643201|468776202|FG000|Completed Study Follow Up|Death|28|||
130221955|NCT00643201|468776203|FG001|Completed Study Follow Up|Death|34|||
130221956|NCT00643201|468776202|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
130221957|NCT00643201|468776203|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
130221958|NCT00643201|468776202|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
130221959|NCT00643201|468776203|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
130221960|NCT00643201|468776202|FG000|Completed Study Follow Up|non-specified|1|||
130221961|NCT00643201|468776203|FG001|Completed Study Follow Up|non-specified|0|||
130221962|NCT00165503|468776204|FG000|Overall Study|Death|1|||
130221963|NCT00165503|468776204|FG000|Overall Study|Lost to Follow-up|12|||
130221964|NCT00165503|468776204|FG000|Overall Study|Unresectable|3|||
130221965|NCT02976519|468776205|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221966|NCT02976519|468776206|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
130221967|NCT02976519|468776207|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221968|NCT02976519|468776208|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221969|NCT02976519|468776209|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221970|NCT02976519|468776210|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221971|NCT02976519|468776211|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
130221972|NCT02976519|468776205|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221973|NCT02976519|468776206|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221974|NCT02976519|468776207|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221975|NCT02976519|468776208|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
130221976|NCT02976519|468776209|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221977|NCT02976519|468776210|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221978|NCT02976519|468776211|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
130221979|NCT02976519|468776205|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221980|NCT02976519|468776206|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221981|NCT02976519|468776207|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221982|NCT02976519|468776208|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221983|NCT02976519|468776209|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221984|NCT02976519|468776210|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
130221985|NCT02976519|468776211|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
130221986|NCT02976519|468776205|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221987|NCT02976519|468776206|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221988|NCT02976519|468776207|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221989|NCT02976519|468776208|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221990|NCT02976519|468776209|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221991|NCT02976519|468776210|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
130221992|NCT02976519|468776211|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
130221993|NCT02976519|468776205|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221994|NCT02976519|468776206|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221995|NCT02976519|468776207|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221996|NCT02976519|468776208|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221997|NCT02976519|468776209|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221998|NCT02976519|468776210|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
130221999|NCT02976519|468776211|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
130222000|NCT02346708|468776212|FG000|Overall Study|Adverse Event|2|||
130222001|NCT02346708|468776213|FG001|Overall Study|Adverse Event|0|||
130222002|NCT02346708|468776212|FG000|Overall Study|Protocol Violation|0|||
130222003|NCT02346708|468776213|FG001|Overall Study|Protocol Violation|1|||
130222004|NCT00928434|468776214|FG000|Overall Study|Adverse Event|14|||
130222005|NCT00928434|468776215|FG001|Overall Study|Adverse Event|5|||
130222006|NCT00928434|468776216|FG002|Overall Study|Adverse Event|18|||
130222007|NCT00928434|468776214|FG000|Overall Study|Protocol Violation|5|||
130222008|NCT00928434|468776215|FG001|Overall Study|Protocol Violation|0|||
130222009|NCT00928434|468776216|FG002|Overall Study|Protocol Violation|8|||
130222010|NCT00928434|468776214|FG000|Overall Study|Physician Decision|2|||
130222011|NCT00928434|468776215|FG001|Overall Study|Physician Decision|0|||
130222012|NCT00928434|468776216|FG002|Overall Study|Physician Decision|3|||
130222013|NCT00928434|468776214|FG000|Overall Study|Lost to Follow-up|1|||
130222014|NCT00928434|468776215|FG001|Overall Study|Lost to Follow-up|0|||
130222015|NCT00928434|468776216|FG002|Overall Study|Lost to Follow-up|3|||
130222016|NCT00928434|468776214|FG000|Overall Study|Withdrawal by Subject|5|||
130222017|NCT00928434|468776215|FG001|Overall Study|Withdrawal by Subject|3|||
130222018|NCT00928434|468776216|FG002|Overall Study|Withdrawal by Subject|2|||
130222019|NCT00928434|468776214|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
130222020|NCT00928434|468776215|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
130222021|NCT00928434|468776216|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
130222022|NCT00928434|468776214|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
130222023|NCT00928434|468776215|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
130222024|NCT00928434|468776216|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
130222025|NCT00928434|468776214|FG000|Overall Study|Other (not meeting above criteria)|5|||
130222026|NCT00928434|468776215|FG001|Overall Study|Other (not meeting above criteria)|1|||
130222027|NCT00928434|468776216|FG002|Overall Study|Other (not meeting above criteria)|2|||
130222028|NCT01278342|468776219|FG000|Overall Study|Physician Decision|0|||
130222029|NCT01278342|468776220|FG001|Overall Study|Physician Decision|1|||
130222030|NCT01278342|468776221|FG002|Overall Study|Physician Decision|0|||
130222031|NCT01278342|468776219|FG000|Overall Study|Lost to Follow-up|1|||
130222032|NCT01278342|468776220|FG001|Overall Study|Lost to Follow-up|0|||
130222033|NCT01278342|468776221|FG002|Overall Study|Lost to Follow-up|0|||
130222034|NCT01278342|468776219|FG000|Overall Study|Administrative problems|2|||
130222035|NCT01278342|468776220|FG001|Overall Study|Administrative problems|0|||
130222036|NCT01278342|468776221|FG002|Overall Study|Administrative problems|0|||
130222037|NCT01278342|468776219|FG000|Overall Study|Other|1|||
130222038|NCT01278342|468776220|FG001|Overall Study|Other|0|||
130222039|NCT01278342|468776221|FG002|Overall Study|Other|0|||
130222040|NCT00313846|468776227|FG000|Overall Study|Withdrawal by Subject|2|||
130222041|NCT00313846|468776228|FG001|Overall Study|Withdrawal by Subject|0|||
130222042|NCT00313846|468776227|FG000|Overall Study|Adverse Event|1|||
130222043|NCT00313846|468776228|FG001|Overall Study|Adverse Event|8|||
130222044|NCT00313846|468776227|FG000|Overall Study|Administrative|2|||
130222045|NCT00313846|468776228|FG001|Overall Study|Administrative|3|||
130222046|NCT02221648|468776232|FG000|Overall Study|Withdrawal by Subject|3|||
130222047|NCT02221648|468776233|FG001|Overall Study|Withdrawal by Subject|3|||
130222048|NCT01922258|468776239|FG000|Overall Study|Lost to Follow-up|1|||
130222049|NCT01922258|468776240|FG001|Overall Study|Lost to Follow-up|1|||
130222050|NCT01922258|468776239|FG000|Overall Study|Adverse Event|9|||
130222051|NCT01922258|468776240|FG001|Overall Study|Adverse Event|2|||
130222052|NCT01922258|468776239|FG000|Overall Study|Met Withdrawal Criteria|0|||
130222053|NCT01922258|468776240|FG001|Overall Study|Met Withdrawal Criteria|4|||
130222054|NCT01922258|468776239|FG000|Overall Study|Withdrawn by the Investigator|1|||
130222055|NCT01922258|468776240|FG001|Overall Study|Withdrawn by the Investigator|4|||
130222056|NCT01922258|468776239|FG000|Overall Study|Withdrawal by participant|5|||
130222057|NCT01922258|468776240|FG001|Overall Study|Withdrawal by participant|5|||
130222058|NCT00673257|468776241|FG000|Overall Study|Withdrawal by Subject|4|||
130222059|NCT00673257|468776241|FG000|Overall Study|Unable to obtain specimen|1|||
130222060|NCT04552132|468776242|FG000|Overall Study|Lost to Follow-up|4|||
130222061|NCT04552132|468776243|FG001|Overall Study|Lost to Follow-up|3|||
130222062|NCT04552132|468776242|FG000|Overall Study|Protocol Violation|1|||
130222063|NCT04552132|468776243|FG001|Overall Study|Protocol Violation|0|||
130222064|NCT02256839|468776244|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
130222065|NCT02256839|468776245|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
130222066|NCT01951417|468776260|FG000|Overall Study|Withdrawal by Subject|1|||
130222067|NCT01951417|468776260|FG000|Overall Study|Protocol Violation|2|||
130222068|NCT01951417|468776260|FG000|Overall Study|Lost to Follow-up|6|||
130222069|NCT01497067|468776261|FG000|Overall Study|Lost to Follow-up|56|||
130222070|NCT01497067|468776261|FG000|Overall Study|Adverse Event|3|||
130222071|NCT01497067|468776261|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
130222072|NCT01497067|468776261|FG000|Overall Study|Other|13|||
130222073|NCT01598610|468776266|FG000|Overall Study|Adverse Event|1|||
130222074|NCT04346199|468776267|FG000|Overall Study|Death|8|||
130222075|NCT04346199|468776268|FG001|Overall Study|Death|9|||
130222076|NCT04346199|468776267|FG000|Overall Study|Lost to Follow-up|0|||
130222077|NCT04346199|468776268|FG001|Overall Study|Lost to Follow-up|1|||
130222078|NCT04346199|468776267|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
130222079|NCT04346199|468776268|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
130222080|NCT04346199|468776267|FG000|Overall Study|Withdrawal by Subject|5|||
130222081|NCT04346199|468776268|FG001|Overall Study|Withdrawal by Subject|1|||
130222082|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
130222083|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
130222084|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Adverse Event|57|||
130222085|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Adverse Event|49|||
130222086|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
130222087|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
130222088|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Site closure|3|||
130222089|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Site closure|2|||
130222090|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
130222091|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
130222092|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Physician Decision|48|||
130222093|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Physician Decision|38|||
130222094|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
130222095|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
130222096|NCT01705977|468776271|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
130222097|NCT01705977|468776272|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
130222098|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
130222099|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
130222100|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
130222101|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
130222102|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
130222103|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
130222104|NCT01705977|468776271|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
130222105|NCT01705977|468776272|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
130222106|NCT03066830|468776273|FG000|Overall Study|At the Participant's own Request|16|||
130222107|NCT03066830|468776274|FG001|Overall Study|At the Participant's own Request|17|||
130222108|NCT03066830|468776273|FG000|Overall Study|Other|3|||
130222109|NCT03066830|468776274|FG001|Overall Study|Other|0|||
130222110|NCT03066830|468776273|FG000|Overall Study|Poor Compliance to Protocol|1|||
130222111|NCT03066830|468776274|FG001|Overall Study|Poor Compliance to Protocol|0|||
130222112|NCT03066830|468776273|FG000|Overall Study|Adverse Event|2|||
130222113|NCT03066830|468776274|FG001|Overall Study|Adverse Event|2|||
130222114|NCT03066830|468776273|FG000|Overall Study|Lost to Follow-up|11|||
130222115|NCT03066830|468776274|FG001|Overall Study|Lost to Follow-up|3|||
130222116|NCT02039778|468776275|FG000|Overall Study|Death|2|||
130222117|NCT02039778|468776275|FG000|Overall Study|Withdrawal by Subject|1|||
130222118|NCT02039778|468776275|FG000|Overall Study|Never started the protocol treatment|1|||
130222119|NCT00096538|468776285|FG000|Overall Study|Withdrawal by Subject|1|||
130222120|NCT01827592|468776288|FG000|Overall Study|Adverse Event|11|||
130222121|NCT01827592|468776289|FG001|Overall Study|Adverse Event|9|||
130222122|NCT01827592|468776290|FG002|Overall Study|Adverse Event|2|||
130222123|NCT01827592|468776288|FG000|Overall Study|Physician Decision|0|||
130222124|NCT01827592|468776289|FG001|Overall Study|Physician Decision|2|||
130222125|NCT01827592|468776290|FG002|Overall Study|Physician Decision|1|||
130222126|NCT01827592|468776288|FG000|Overall Study|Protocol Violation|2|||
130222127|NCT01827592|468776289|FG001|Overall Study|Protocol Violation|1|||
130222128|NCT01827592|468776290|FG002|Overall Study|Protocol Violation|0|||
130222129|NCT01827592|468776288|FG000|Overall Study|Lost to Follow-up|1|||
130222130|NCT01827592|468776289|FG001|Overall Study|Lost to Follow-up|2|||
130222131|NCT01827592|468776290|FG002|Overall Study|Lost to Follow-up|2|||
130222132|NCT01827592|468776288|FG000|Overall Study|Withdrawal by Subject|12|||
130222133|NCT01827592|468776289|FG001|Overall Study|Withdrawal by Subject|11|||
130222134|NCT01827592|468776290|FG002|Overall Study|Withdrawal by Subject|11|||
130222135|NCT01827592|468776288|FG000|Overall Study|Patient's substantial non-compliance|1|||
130222136|NCT01827592|468776289|FG001|Overall Study|Patient's substantial non-compliance|1|||
130222137|NCT01827592|468776290|FG002|Overall Study|Patient's substantial non-compliance|6|||
130222138|NCT01827592|468776288|FG000|Overall Study|Trial terminated by Sponsor|47|||
130222139|NCT01827592|468776289|FG001|Overall Study|Trial terminated by Sponsor|53|||
130222140|NCT01827592|468776290|FG002|Overall Study|Trial terminated by Sponsor|51|||
130222141|NCT01827592|468776288|FG000|Overall Study|Others|0|||
130222142|NCT01827592|468776289|FG001|Overall Study|Others|1|||
130222143|NCT01827592|468776290|FG002|Overall Study|Others|3|||
130222144|NCT01931397|468776299|FG000|Overall Study|Physician Decision|2|||
130222145|NCT01931397|468776299|FG000|Overall Study|Withdrawal by Subject|8|||
130222146|NCT01931397|468776299|FG000|Overall Study|moved out of state|1|||
130222147|NCT02058589|468776303|FG000|Overall Study|Serious Adverse Event|1|||
130222148|NCT02058589|468776304|FG001|Overall Study|Serious Adverse Event|1|||
130222149|NCT02058589|468776303|FG000|Overall Study|Non-Serious Adverse Event|1|||
130222150|NCT02058589|468776304|FG001|Overall Study|Non-Serious Adverse Event|0|||
130017775|NCT00267748|468026434|FG002|Non-randomized Period|Progressive disease|0|||
130017776|NCT00267748|468026432|FG000|Non-randomized Period|Adverse Event|8|||
130017777|NCT00267748|468026433|FG001|Non-randomized Period|Adverse Event|0|||
130017778|NCT00267748|468026434|FG002|Non-randomized Period|Adverse Event|0|||
130017779|NCT00267748|468026432|FG000|Non-randomized Period|Death|1|||
130017780|NCT00267748|468026433|FG001|Non-randomized Period|Death|0|||
130017781|NCT00267748|468026434|FG002|Non-randomized Period|Death|0|||
130222151|NCT02058589|468776303|FG000|Overall Study|Withdrawal by Subject|0|||
130222152|NCT02058589|468776304|FG001|Overall Study|Withdrawal by Subject|1|||
130222153|NCT02143024|468776305|FG000|Overall Study|Lost to Follow-up|1|||
130222154|NCT02143024|468776306|FG001|Overall Study|Lost to Follow-up|1|||
130222155|NCT02143024|468776305|FG000|Overall Study|Withdrawal by Subject|1|||
130222156|NCT02143024|468776306|FG001|Overall Study|Withdrawal by Subject|0|||
130222157|NCT01945944|468776307|FG000|Overall Study|Adverse Event|0|||
130017782|NCT00267748|468026432|FG000|Non-randomized Period|Participant not willing to participate|1|||
130017783|NCT00267748|468026433|FG001|Non-randomized Period|Participant not willing to participate|0|||
130222158|NCT01945944|468776308|FG001|Overall Study|Adverse Event|2|||
130222159|NCT01945944|468776307|FG000|Overall Study|Physician Decision|1|||
130222160|NCT01945944|468776308|FG001|Overall Study|Physician Decision|0|||
130222161|NCT01945944|468776307|FG000|Overall Study|Withdrawal by Subject|0|||
130222162|NCT01945944|468776308|FG001|Overall Study|Withdrawal by Subject|1|||
130222163|NCT01212094|468778198|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
130222164|NCT01212094|468778199|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
130017784|NCT00267748|468026434|FG002|Non-randomized Period|Participant not willing to participate|0|||
130017785|NCT00267748|468026432|FG000|Non-randomized Period|Other|3|||
130017786|NCT00267748|468026433|FG001|Non-randomized Period|Other|0|||
130017787|NCT00267748|468026434|FG002|Non-randomized Period|Other|0|||
130017788|NCT00267748|468026432|FG000|Randomized Period|Death|0|||
130017789|NCT00267748|468026433|FG001|Randomized Period|Death|2|||
130017790|NCT00267748|468026434|FG002|Randomized Period|Death|3|||
130017791|NCT00267748|468026432|FG000|Randomized Period|Adverse Event|0|||
130017792|NCT00267748|468026433|FG001|Randomized Period|Adverse Event|23|||
130017793|NCT00267748|468026434|FG002|Randomized Period|Adverse Event|25|||
130017794|NCT00267748|468026432|FG000|Randomized Period|Global deterioration of health status|0|||
130017795|NCT00267748|468026433|FG001|Randomized Period|Global deterioration of health status|6|||
130017796|NCT00267748|468026434|FG002|Randomized Period|Global deterioration of health status|7|||
130017797|NCT00267748|468026432|FG000|Randomized Period|Lost to Follow-up|0|||
129884462|NCT00734214|467536406|FG000|Overall Study|MD withdrawal|1|||
130017798|NCT00267748|468026433|FG001|Randomized Period|Lost to Follow-up|1|||
130017799|NCT00267748|468026434|FG002|Randomized Period|Lost to Follow-up|0|||
130017800|NCT00267748|468026432|FG000|Randomized Period|Objective progression or relapse|0|||
130017801|NCT00267748|468026433|FG001|Randomized Period|Objective progression or relapse|77|||
130222165|NCT01212094|468778200|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
130222166|NCT01212094|468778198|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
130222167|NCT01212094|468778199|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
130222168|NCT01212094|468778200|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
130222169|NCT01212094|468778198|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
130222170|NCT01212094|468778199|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
130222171|NCT01212094|468778200|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
130222172|NCT01212094|468778198|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
130222173|NCT01212094|468778199|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
130222174|NCT01212094|468778200|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
130222175|NCT01212094|468778198|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
130222176|NCT01212094|468778199|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
130222177|NCT01212094|468778200|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
130222178|NCT01212094|468778198|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
130222179|NCT01212094|468778199|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
130222180|NCT01212094|468778200|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
130222181|NCT02019550|468778207|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130222182|NCT02019550|468778208|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
130222183|NCT04771013|468778212|FG000|Overall Study|Withdrawal by Subject|2|||
130222184|NCT04771013|468778213|FG001|Overall Study|Withdrawal by Subject|0|||
130222185|NCT04771013|468778212|FG000|Overall Study|Death|0|||
130222186|NCT04771013|468778213|FG001|Overall Study|Death|5|||
130222187|NCT04771013|468778212|FG000|Overall Study|Referred to another hospital before day 20|0|||
130222188|NCT04771013|468778213|FG001|Overall Study|Referred to another hospital before day 20|1|||
130222189|NCT00823134|468778214|FG000|Overall Study|Invalid measurement|1|||
130222190|NCT02291029|468778218|FG000|Overall Study|Withdrawal by Subject|0|||
130222191|NCT02291029|468778219|FG001|Overall Study|Withdrawal by Subject|0|||
130222192|NCT02291029|468778220|FG002|Overall Study|Withdrawal by Subject|1|||
130222193|NCT02291029|468778221|FG003|Overall Study|Withdrawal by Subject|0|||
130222194|NCT02291029|468778222|FG004|Overall Study|Withdrawal by Subject|0|||
130222195|NCT02291029|468778223|FG005|Overall Study|Withdrawal by Subject|0|||
130222196|NCT02291029|468778218|FG000|Overall Study|Adverse Event|0|||
130222197|NCT02291029|468778219|FG001|Overall Study|Adverse Event|1|||
130222198|NCT02291029|468778220|FG002|Overall Study|Adverse Event|0|||
130222199|NCT02291029|468778221|FG003|Overall Study|Adverse Event|0|||
130222200|NCT02291029|468778222|FG004|Overall Study|Adverse Event|0|||
130222201|NCT02291029|468778223|FG005|Overall Study|Adverse Event|0|||
130222202|NCT00419757|468778224|FG000|Overall Study|Adverse Event|1|||
130222203|NCT00419757|468778225|FG001|Overall Study|Adverse Event|4|||
130222204|NCT00419757|468778224|FG000|Overall Study|Lost to Follow-up|1|||
130222205|NCT00419757|468778225|FG001|Overall Study|Lost to Follow-up|4|||
130222206|NCT00419757|468778224|FG000|Overall Study|Withdrawal by Subject|7|||
130222207|NCT00419757|468778225|FG001|Overall Study|Withdrawal by Subject|1|||
130222208|NCT00419757|468778224|FG000|Overall Study|Protocol Violation|2|||
130222209|NCT00419757|468778225|FG001|Overall Study|Protocol Violation|3|||
130222210|NCT00419757|468778224|FG000|Overall Study|Study specific discontinuation criteria|4|||
130222211|NCT00419757|468778225|FG001|Overall Study|Study specific discontinuation criteria|8|||
130222212|NCT00419757|468778224|FG000|Overall Study|Multiple reasons|3|||
130222213|NCT00419757|468778225|FG001|Overall Study|Multiple reasons|1|||
130222214|NCT00493012|468778226|FG000|Overall Study|Lost to Follow-up|18|||
130222215|NCT00493012|468778227|FG001|Overall Study|Lost to Follow-up|17|||
130222216|NCT01128296|468778228|FG000|Overall Study|Physician Decision|0|||
130222217|NCT01128296|468778229|FG001|Overall Study|Physician Decision|0|||
130222218|NCT01128296|468778230|FG002|Overall Study|Physician Decision|0|||
130222219|NCT01128296|468778231|FG003|Overall Study|Physician Decision|0|||
130222220|NCT01128296|468778232|FG004|Overall Study|Physician Decision|0|||
130222221|NCT01128296|468778233|FG005|Overall Study|Physician Decision|3|||
130222222|NCT01128296|468778228|FG000|Overall Study|Withdrawal by Subject|0|||
130222223|NCT01128296|468778229|FG001|Overall Study|Withdrawal by Subject|0|||
130222224|NCT01128296|468778230|FG002|Overall Study|Withdrawal by Subject|0|||
130222225|NCT01128296|468778231|FG003|Overall Study|Withdrawal by Subject|0|||
130222226|NCT01128296|468778232|FG004|Overall Study|Withdrawal by Subject|0|||
130222227|NCT01128296|468778233|FG005|Overall Study|Withdrawal by Subject|2|||
130222228|NCT04155463|468778234|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
130222229|NCT04155463|468778235|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
130222230|NCT01914393|468778236|FG000|Overall Study|Protocol Violation|11|||
130222231|NCT01914393|468778237|FG001|Overall Study|Protocol Violation|3|||
130222232|NCT01914393|468778238|FG002|Overall Study|Protocol Violation|19|||
130222233|NCT01914393|468778236|FG000|Overall Study|Lack of Efficacy|11|||
130222234|NCT01914393|468778237|FG001|Overall Study|Lack of Efficacy|16|||
130222235|NCT01914393|468778238|FG002|Overall Study|Lack of Efficacy|5|||
130222236|NCT01914393|468778236|FG000|Overall Study|no reason given|14|||
130222237|NCT01914393|468778237|FG001|Overall Study|no reason given|8|||
130222238|NCT01914393|468778238|FG002|Overall Study|no reason given|16|||
130222239|NCT01914393|468778236|FG000|Overall Study|Adverse Event|29|||
130222240|NCT01914393|468778237|FG001|Overall Study|Adverse Event|18|||
130222241|NCT01914393|468778238|FG002|Overall Study|Adverse Event|31|||
130222242|NCT01914393|468778236|FG000|Overall Study|Withdrawal by Subject|38|||
130222243|NCT01914393|468778237|FG001|Overall Study|Withdrawal by Subject|20|||
130222244|NCT01914393|468778238|FG002|Overall Study|Withdrawal by Subject|47|||
130222245|NCT01914393|468778236|FG000|Overall Study|Lost to Follow-up|12|||
130222246|NCT01914393|468778237|FG001|Overall Study|Lost to Follow-up|6|||
130222247|NCT01914393|468778238|FG002|Overall Study|Lost to Follow-up|19|||
130222248|NCT01914393|468778236|FG000|Overall Study|subject never dosed|0|||
130222249|NCT01914393|468778237|FG001|Overall Study|subject never dosed|0|||
130222250|NCT01914393|468778238|FG002|Overall Study|subject never dosed|1|||
130222251|NCT04547140|468778241|FG000|Overall Study|Adverse Event|0|||
130222252|NCT04547140|468778242|FG001|Overall Study|Adverse Event|1|||
130222253|NCT04547140|468778241|FG000|Overall Study|Withdrawal by Subject|0|||
130222254|NCT04547140|468778242|FG001|Overall Study|Withdrawal by Subject|1|||
130222255|NCT04547140|468778241|FG000|Overall Study|Lost to Follow-up|3|||
130222256|NCT04547140|468778242|FG001|Overall Study|Lost to Follow-up|1|||
130222257|NCT04547140|468778241|FG000|Overall Study|Death|2|||
130222258|NCT04547140|468778242|FG001|Overall Study|Death|1|||
130222259|NCT04547140|468778241|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
130222260|NCT04547140|468778242|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
130222261|NCT04547140|468778241|FG000|Overall Study|Pregnancy|1|||
130222262|NCT04547140|468778242|FG001|Overall Study|Pregnancy|0|||
130222263|NCT04547140|468778241|FG000|Overall Study|Reason Not Specified|4|||
130222264|NCT04547140|468778242|FG001|Overall Study|Reason Not Specified|1|||
130222265|NCT00003537|468778243|FG000|Overall Study|Not evalauable|1|||
130222266|NCT01051557|468778244|FG000|Overall Study|Physician Decision|1|||
130017802|NCT00267748|468026434|FG002|Randomized Period|Objective progression or relapse|86|||
130017803|NCT00267748|468026432|FG000|Randomized Period|Withdrawal by Subject|0|||
130017804|NCT00267748|468026433|FG001|Randomized Period|Withdrawal by Subject|9|||
130017805|NCT00267748|468026434|FG002|Randomized Period|Withdrawal by Subject|2|||
130017806|NCT00267748|468026432|FG000|Randomized Period|Other|0|||
130017807|NCT00267748|468026433|FG001|Randomized Period|Other|9|||
130017808|NCT00267748|468026434|FG002|Randomized Period|Other|6|||
130017809|NCT00267748|468026432|FG000|Randomized Period|randomized but not treated|0|||
130222267|NCT01051557|468778245|FG001|Overall Study|Physician Decision|0|||
130222268|NCT01051557|468778246|FG002|Overall Study|Physician Decision|0|||
130222269|NCT01051557|468778247|FG003|Overall Study|Physician Decision|0|||
130222270|NCT01051557|468778248|FG004|Overall Study|Physician Decision|0|||
130222271|NCT01051557|468778249|FG005|Overall Study|Physician Decision|0|||
130222272|NCT01051557|468778250|FG006|Overall Study|Physician Decision|0|||
130222273|NCT01051557|468778244|FG000|Overall Study|disease progression|3|||
130222274|NCT01051557|468778245|FG001|Overall Study|disease progression|3|||
130222275|NCT01051557|468778246|FG002|Overall Study|disease progression|5|||
130222276|NCT01051557|468778247|FG003|Overall Study|disease progression|2|||
130222277|NCT01051557|468778248|FG004|Overall Study|disease progression|4|||
130222278|NCT01051557|468778249|FG005|Overall Study|disease progression|3|||
130222279|NCT01051557|468778250|FG006|Overall Study|disease progression|1|||
130222280|NCT01051557|468778244|FG000|Overall Study|Withdrawal by Subject|0|||
130222281|NCT01051557|468778245|FG001|Overall Study|Withdrawal by Subject|0|||
130222282|NCT01051557|468778246|FG002|Overall Study|Withdrawal by Subject|1|||
130222283|NCT01051557|468778247|FG003|Overall Study|Withdrawal by Subject|0|||
130222284|NCT01051557|468778248|FG004|Overall Study|Withdrawal by Subject|2|||
130222285|NCT01051557|468778249|FG005|Overall Study|Withdrawal by Subject|0|||
130222286|NCT01051557|468778250|FG006|Overall Study|Withdrawal by Subject|1|||
130222287|NCT01051557|468778244|FG000|Overall Study|Adverse Event|0|||
130222288|NCT01051557|468778245|FG001|Overall Study|Adverse Event|0|||
130222289|NCT01051557|468778246|FG002|Overall Study|Adverse Event|0|||
130222290|NCT01051557|468778247|FG003|Overall Study|Adverse Event|1|||
130222291|NCT01051557|468778248|FG004|Overall Study|Adverse Event|1|||
130222292|NCT01051557|468778249|FG005|Overall Study|Adverse Event|3|||
130222293|NCT01051557|468778250|FG006|Overall Study|Adverse Event|4|||
130222294|NCT04110314|468778252|FG000|Overall Study|Did not meet inclusion criteria|35255|||
130222295|NCT04110314|468778253|FG001|Overall Study|Did not meet inclusion criteria|35104|||
130222296|NCT04110314|468778254|FG002|Overall Study|Did not meet inclusion criteria|35636|||
130222297|NCT04110314|468778255|FG003|Overall Study|Did not meet inclusion criteria|35135|||
130222298|NCT04110314|468778256|FG004|Overall Study|Did not meet inclusion criteria|35247|||
130222299|NCT04110314|468778257|FG005|Overall Study|Did not meet inclusion criteria|35727|||
130222300|NCT01178125|468778266|FG000|Overall Study|Lost to Follow-up|397|||
130222301|NCT01178125|468778266|FG000|Overall Study|Adverse Event|244|||
130222302|NCT01178125|468778266|FG000|Overall Study|Withdrawal by Subject|209|||
130222303|NCT01178125|468778266|FG000|Overall Study|Noncompliance|184|||
130222304|NCT01178125|468778266|FG000|Overall Study|Pregnancy|55|||
130222305|NCT01178125|468778266|FG000|Overall Study|Other Reason|39|||
130222306|NCT01178125|468778266|FG000|Overall Study|Sponsor Decision|28|||
130222307|NCT01178125|468778266|FG000|Overall Study|Protocol Violation|17|||
130222308|NCT01178125|468778266|FG000|Overall Study|Investigator Decision|5|||
130222309|NCT02948829|468778267|FG000|Overall Study|Lost to Follow-up|2|||
130222310|NCT02948829|468778267|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
130222311|NCT02948829|468778267|FG000|Overall Study|Pregnancy|1|||
130222312|NCT02948829|468778267|FG000|Overall Study|Other: Reason not Specified|8|||
130222313|NCT01004978|468778268|FG000|Overall Study|Disease progression|31|||
130222314|NCT01004978|468778269|FG001|Overall Study|Disease progression|48|||
130222315|NCT01004978|468778268|FG000|Overall Study|Adverse Event|42|||
130222316|NCT01004978|468778269|FG001|Overall Study|Adverse Event|22|||
130222317|NCT01004978|468778268|FG000|Overall Study|Death|3|||
130222318|NCT01004978|468778269|FG001|Overall Study|Death|2|||
130222319|NCT01004978|468778268|FG000|Overall Study|Withdrawal by Subject|16|||
130222320|NCT01004978|468778269|FG001|Overall Study|Withdrawal by Subject|16|||
130017810|NCT00267748|468026433|FG001|Randomized Period|randomized but not treated|0|||
130017811|NCT00267748|468026434|FG002|Randomized Period|randomized but not treated|3|||
130222321|NCT01004978|468778268|FG000|Overall Study|Alternative therapy|4|||
130222322|NCT01004978|468778269|FG001|Overall Study|Alternative therapy|8|||
130222323|NCT01004978|468778268|FG000|Overall Study|Physician Decision|6|||
130222324|NCT01004978|468778269|FG001|Overall Study|Physician Decision|3|||
130222325|NCT01004978|468778268|FG000|Overall Study|Other complicating disease|2|||
130222326|NCT01004978|468778269|FG001|Overall Study|Other complicating disease|2|||
130222327|NCT01004978|468778268|FG000|Overall Study|Protocol Violation|2|||
130222328|NCT01004978|468778269|FG001|Overall Study|Protocol Violation|3|||
130222329|NCT01004978|468778268|FG000|Overall Study|Non-compliance|3|||
130222330|NCT01004978|468778269|FG001|Overall Study|Non-compliance|2|||
130222331|NCT01004978|468778268|FG000|Overall Study|Ineligible|1|||
130222332|NCT01004978|468778269|FG001|Overall Study|Ineligible|0|||
130222333|NCT01004978|468778268|FG000|Overall Study|Unblinded|0|||
130222334|NCT01004978|468778269|FG001|Overall Study|Unblinded|1|||
130222335|NCT01004978|468778268|FG000|Overall Study|Performance status worsening|0|||
130222336|NCT01004978|468778269|FG001|Overall Study|Performance status worsening|1|||
130222337|NCT01004978|468778268|FG000|Overall Study|Never started treatment|8|||
130222338|NCT01004978|468778269|FG001|Overall Study|Never started treatment|9|||
130222339|NCT00369915|468778270|FG000|Overall Study|expected side effects|2|||
130222340|NCT00369915|468778271|FG001|Overall Study|expected side effects|1|||
130222341|NCT00369915|468778270|FG000|Overall Study|Withdrawal by Subject|4|||
130222342|NCT00369915|468778271|FG001|Overall Study|Withdrawal by Subject|1|||
130222343|NCT00369915|468778270|FG000|Overall Study|W/drawl by investigators|0|||
130222344|NCT00369915|468778271|FG001|Overall Study|W/drawl by investigators|1|||
130222345|NCT01711983|468778272|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
130222346|NCT01711983|468778272|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
130222347|NCT01711983|468778272|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
130222348|NCT01711983|468778272|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
130222349|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222350|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
130222351|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130222352|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222353|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222354|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222355|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222356|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222357|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222358|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222359|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222360|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222361|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222362|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222363|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130222364|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130222365|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
130222366|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222367|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222368|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222369|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222370|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222371|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130017812|NCT01294800|468026435|FG000|Overall Study|Adverse Event|7|||
130017813|NCT01294800|468026436|FG001|Overall Study|Adverse Event|6|||
130017814|NCT01294800|468026437|FG002|Overall Study|Adverse Event|12|||
130017815|NCT01294800|468026438|FG003|Overall Study|Adverse Event|5|||
130017816|NCT01294800|468026435|FG000|Overall Study|Subject Withdrew Consent|2|||
130017817|NCT01294800|468026436|FG001|Overall Study|Subject Withdrew Consent|2|||
130017818|NCT01294800|468026437|FG002|Overall Study|Subject Withdrew Consent|2|||
130017819|NCT01294800|468026438|FG003|Overall Study|Subject Withdrew Consent|11|||
130017820|NCT01294800|468026435|FG000|Overall Study|Lost to Follow-up|0|||
130017821|NCT01294800|468026436|FG001|Overall Study|Lost to Follow-up|0|||
130017822|NCT01294800|468026437|FG002|Overall Study|Lost to Follow-up|1|||
130017823|NCT01294800|468026438|FG003|Overall Study|Lost to Follow-up|0|||
130017824|NCT01294800|468026435|FG000|Overall Study|Non-compliance With Protocol|0|||
130017825|NCT01294800|468026436|FG001|Overall Study|Non-compliance With Protocol|1|||
130017826|NCT01294800|468026437|FG002|Overall Study|Non-compliance With Protocol|1|||
130017827|NCT01294800|468026438|FG003|Overall Study|Non-compliance With Protocol|0|||
130017828|NCT01294800|468026435|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
130017829|NCT01294800|468026436|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
130017830|NCT01294800|468026437|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
130017831|NCT01294800|468026438|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
130017832|NCT03594227|468026440|FG000|Overall Study|Adverse Event|2|||
130017833|NCT03594227|468026441|FG001|Overall Study|Adverse Event|1|||
130017834|NCT03594227|468026442|FG002|Overall Study|Adverse Event|0|||
130017835|NCT03594227|468026443|FG003|Overall Study|Adverse Event|2|||
130017836|NCT03594227|468026440|FG000|Overall Study|Lost to Follow-up|1|||
130017837|NCT03594227|468026441|FG001|Overall Study|Lost to Follow-up|1|||
130017838|NCT03594227|468026442|FG002|Overall Study|Lost to Follow-up|1|||
130017839|NCT03594227|468026443|FG003|Overall Study|Lost to Follow-up|0|||
130017840|NCT03594227|468026440|FG000|Overall Study|Withdrawal by Subject|1|||
130017841|NCT03594227|468026441|FG001|Overall Study|Withdrawal by Subject|1|||
130017842|NCT03594227|468026442|FG002|Overall Study|Withdrawal by Subject|1|||
130017843|NCT03594227|468026443|FG003|Overall Study|Withdrawal by Subject|1|||
130017844|NCT03594227|468026440|FG000|Overall Study|Pregnancy|0|||
130017845|NCT03594227|468026441|FG001|Overall Study|Pregnancy|1|||
130017846|NCT03594227|468026442|FG002|Overall Study|Pregnancy|0|||
130017847|NCT03594227|468026443|FG003|Overall Study|Pregnancy|0|||
130017848|NCT03594227|468026440|FG000|Overall Study|Sponsor Decision|0|||
130017849|NCT03594227|468026441|FG001|Overall Study|Sponsor Decision|0|||
130017850|NCT03594227|468026442|FG002|Overall Study|Sponsor Decision|0|||
130017851|NCT03594227|468026443|FG003|Overall Study|Sponsor Decision|1|||
130017852|NCT03594227|468026440|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
130222372|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222373|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222374|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222375|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222376|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130017853|NCT03594227|468026441|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
130017854|NCT03594227|468026442|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
130017855|NCT03594227|468026443|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
130017856|NCT02199080|468026450|FG000|Overall Study|Protocol Violation|12|||
130017857|NCT01097863|468026453|FG000|Overall Study|Discomfort|1|||
130017858|NCT01097863|468026454|FG001|Overall Study|Discomfort|0|||
130222377|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222378|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130222379|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
130222380|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
130222381|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130222382|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222383|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222384|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222385|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222386|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222387|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222388|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222389|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222390|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222391|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222392|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222393|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130222394|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222395|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222396|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
130222397|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222398|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222399|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222400|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222401|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222402|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222403|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222404|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222405|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222406|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222407|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222408|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
130222409|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222410|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129884463|NCT00734214|467536407|FG001|Overall Study|MD withdrawal|0|||
130222411|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
130222412|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222413|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222414|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222415|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222416|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222417|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222418|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222419|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222420|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222421|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222422|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222423|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
130222424|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222425|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222426|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
130222427|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222428|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222429|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222430|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222431|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222432|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130316108|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
130017859|NCT01097863|468026455|FG002|Overall Study|Discomfort|1|||
130017860|NCT01097863|468026453|FG000|Overall Study|Did not return for final visit|0|||
130017861|NCT01097863|468026454|FG001|Overall Study|Did not return for final visit|0|||
130222433|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222434|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222435|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222436|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222437|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222438|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
130222439|NCT02326272|468778273|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222440|NCT02326272|468778274|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222441|NCT02326272|468778275|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
130222442|NCT02326272|468778276|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222443|NCT02326272|468778277|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222444|NCT02326272|468778278|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222445|NCT02326272|468778279|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222446|NCT02326272|468778280|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222447|NCT02326272|468778281|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222448|NCT02326272|468778282|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222449|NCT02326272|468778283|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222450|NCT02326272|468778284|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222451|NCT02326272|468778285|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222452|NCT02326272|468778286|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222453|NCT02326272|468778287|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
130222454|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222455|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222456|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130017862|NCT01097863|468026455|FG002|Overall Study|Did not return for final visit|1|||
130017863|NCT00574275|468026456|FG000|Overall Study|Randomized but not treated|2|||
130017864|NCT00574275|468026457|FG001|Overall Study|Randomized but not treated|3|||
130017865|NCT00574275|468026456|FG000|Overall Study|Adverse Event|32|||
130017866|NCT00574275|468026457|FG001|Overall Study|Adverse Event|76|||
130017867|NCT00574275|468026456|FG000|Overall Study|Disease progression|160|||
130017868|NCT00574275|468026457|FG001|Overall Study|Disease progression|146|||
130017869|NCT00574275|468026456|FG000|Overall Study|Lost to Follow-up|2|||
130017870|NCT00574275|468026457|FG001|Overall Study|Lost to Follow-up|1|||
130017871|NCT00574275|468026456|FG000|Overall Study|Study stopped based on DMC decision|62|||
130017872|NCT00574275|468026457|FG001|Overall Study|Study stopped based on DMC decision|23|||
130017873|NCT00574275|468026456|FG000|Overall Study|Withdrawal by Subject|15|||
130017874|NCT00574275|468026457|FG001|Overall Study|Withdrawal by Subject|17|||
130017875|NCT00574275|468026456|FG000|Overall Study|Error calculating tumor measurement|1|||
130017876|NCT00574275|468026457|FG001|Overall Study|Error calculating tumor measurement|0|||
130017877|NCT00574275|468026456|FG000|Overall Study|Physician Decision|1|||
130017878|NCT00574275|468026457|FG001|Overall Study|Physician Decision|1|||
130017879|NCT00574275|468026456|FG000|Overall Study|Protocol Violation|0|||
130017880|NCT00574275|468026457|FG001|Overall Study|Protocol Violation|1|||
130017881|NCT00574275|468026456|FG000|Overall Study|Patient and Investigator decision|0|||
130017882|NCT00574275|468026457|FG001|Overall Study|Patient and Investigator decision|1|||
130017883|NCT00574275|468026456|FG000|Overall Study|Insurance change|0|||
130017884|NCT00574275|468026457|FG001|Overall Study|Insurance change|1|||
130017885|NCT00574275|468026456|FG000|Overall Study|Operation for curative intent|0|||
130017886|NCT00574275|468026457|FG001|Overall Study|Operation for curative intent|1|||
130017887|NCT02703311|468026459|FG000|Overall Study|Death|5|||
130017888|NCT02703311|468026459|FG000|Overall Study|Withdrawal by Subject|3|||
130017889|NCT00960843|468026460|FG000|Overall Study|Lost to Follow-up|2|||
130017890|NCT00960843|468026461|FG001|Overall Study|Lost to Follow-up|0|||
130017891|NCT00960843|468026460|FG000|Overall Study|Protocol Violation|0|||
130017892|NCT00960843|468026461|FG001|Overall Study|Protocol Violation|4|||
129884464|NCT02038764|467536408|FG000|Overall Study|Adverse Event|0|||
130017893|NCT00960843|468026460|FG000|Overall Study|Repeated needle dislodgment|0|||
130017894|NCT00960843|468026461|FG001|Overall Study|Repeated needle dislodgment|1|||
130017895|NCT00652366|468026462|FG000|Overall Study|Adverse Event|8|||
130017896|NCT00652366|468026463|FG001|Overall Study|Adverse Event|4|||
130017897|NCT00652366|468026464|FG002|Overall Study|Adverse Event|7|||
130222457|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222458|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130222459|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
130222460|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
130222461|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
130222462|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130222463|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222464|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222465|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222466|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222467|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222468|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130222469|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222470|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222471|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222472|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222473|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222474|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
130222475|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130222476|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222477|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130222478|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
130222479|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222480|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222481|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222482|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222483|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
130222484|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222485|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222486|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222487|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222488|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222489|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130222490|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222491|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130222492|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222493|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222494|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222495|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222496|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222497|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222498|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130222499|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222500|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222501|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222502|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222503|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222504|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
130222505|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222506|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222507|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222508|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130222509|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222510|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222511|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222512|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222513|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130222514|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130017898|NCT00652366|468026465|FG003|Overall Study|Adverse Event|17|||
130222515|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222516|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222517|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222518|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222519|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222520|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222521|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
130017899|NCT00652366|468026466|FG004|Overall Study|Adverse Event|13|||
130017900|NCT00652366|468026462|FG000|Overall Study|Death|5|||
130017901|NCT00652366|468026463|FG001|Overall Study|Death|4|||
130017902|NCT00652366|468026464|FG002|Overall Study|Death|1|||
130017903|NCT00652366|468026465|FG003|Overall Study|Death|8|||
130017904|NCT00652366|468026466|FG004|Overall Study|Death|5|||
130017905|NCT00652366|468026462|FG000|Overall Study|Lack of Efficacy|84|||
130017906|NCT00652366|468026463|FG001|Overall Study|Lack of Efficacy|58|||
130017907|NCT00652366|468026464|FG002|Overall Study|Lack of Efficacy|53|||
130017908|NCT00652366|468026465|FG003|Overall Study|Lack of Efficacy|133|||
130017909|NCT00652366|468026466|FG004|Overall Study|Lack of Efficacy|13|||
130017910|NCT00652366|468026462|FG000|Overall Study|Violation of Selection Criteria|0|||
130017911|NCT00652366|468026463|FG001|Overall Study|Violation of Selection Criteria|0|||
130017912|NCT00652366|468026464|FG002|Overall Study|Violation of Selection Criteria|1|||
130017913|NCT00652366|468026465|FG003|Overall Study|Violation of Selection Criteria|0|||
130017914|NCT00652366|468026466|FG004|Overall Study|Violation of Selection Criteria|0|||
130017915|NCT00652366|468026462|FG000|Overall Study|Protocol Violation|1|||
130017916|NCT00652366|468026463|FG001|Overall Study|Protocol Violation|0|||
130017917|NCT00652366|468026464|FG002|Overall Study|Protocol Violation|0|||
130017918|NCT00652366|468026465|FG003|Overall Study|Protocol Violation|0|||
130017919|NCT00652366|468026466|FG004|Overall Study|Protocol Violation|0|||
130017920|NCT00652366|468026462|FG000|Overall Study|Refused treatment|3|||
130017921|NCT00652366|468026463|FG001|Overall Study|Refused treatment|7|||
130017922|NCT00652366|468026464|FG002|Overall Study|Refused treatment|6|||
130017923|NCT00652366|468026465|FG003|Overall Study|Refused treatment|17|||
130017924|NCT00652366|468026466|FG004|Overall Study|Refused treatment|5|||
130017925|NCT00652366|468026462|FG000|Overall Study|Other|5|||
130017926|NCT00652366|468026463|FG001|Overall Study|Other|2|||
130017927|NCT00652366|468026464|FG002|Overall Study|Other|3|||
130017928|NCT00652366|468026465|FG003|Overall Study|Other|4|||
130017929|NCT00652366|468026466|FG004|Overall Study|Other|0|||
130017930|NCT02069899|468026471|FG000|Overall Study|Adverse Event|6|||
130017931|NCT02069899|468026472|FG001|Overall Study|Adverse Event|0|||
130017932|NCT02069899|468026473|FG002|Overall Study|Adverse Event|1|||
130017933|NCT02069899|468026471|FG000|Overall Study|Withdrawal by Participant|2|||
130017934|NCT02069899|468026472|FG001|Overall Study|Withdrawal by Participant|0|||
130017935|NCT02069899|468026473|FG002|Overall Study|Withdrawal by Participant|0|||
130017936|NCT02069899|468026471|FG000|Overall Study|Lost to Follow-up|1|||
130017937|NCT02069899|468026472|FG001|Overall Study|Lost to Follow-up|0|||
130017938|NCT02069899|468026473|FG002|Overall Study|Lost to Follow-up|1|||
130017939|NCT02069899|468026471|FG000|Overall Study|Other|4|||
130017940|NCT02069899|468026472|FG001|Overall Study|Other|0|||
130017941|NCT02069899|468026473|FG002|Overall Study|Other|0|||
130017942|NCT02069899|468026471|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
130017943|NCT02069899|468026472|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
130017944|NCT02069899|468026473|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
130017945|NCT02069899|468026471|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
130017946|NCT02069899|468026472|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
130017947|NCT02069899|468026473|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
130017948|NCT00490451|468026476|FG000|Overall Study|Adverse Event|3|||
130017949|NCT00490451|468026477|FG001|Overall Study|Adverse Event|3|||
130017950|NCT00490451|468026476|FG000|Overall Study|Death|3|||
130017951|NCT00490451|468026477|FG001|Overall Study|Death|1|||
130017952|NCT00490451|468026476|FG000|Overall Study|Withdrawal by Subject|2|||
130017953|NCT00490451|468026477|FG001|Overall Study|Withdrawal by Subject|0|||
130017954|NCT00490451|468026476|FG000|Overall Study|Investigator Decision|1|||
130017955|NCT00490451|468026477|FG001|Overall Study|Investigator Decision|0|||
130017956|NCT00490451|468026476|FG000|Overall Study|Protocol Violation|1|||
130017957|NCT00490451|468026477|FG001|Overall Study|Protocol Violation|0|||
130017958|NCT00490451|468026476|FG000|Overall Study|Progressive Disease|53|||
130017959|NCT00490451|468026477|FG001|Overall Study|Progressive Disease|34|||
130222522|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222523|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222524|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222525|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222526|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222527|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222528|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
130222529|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222530|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222531|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222532|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222533|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222534|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222535|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
130222536|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222537|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222538|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222539|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222540|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222541|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222542|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222543|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130222544|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222545|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222546|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222547|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222548|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222549|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222550|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222551|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222552|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
130222553|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222554|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222555|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222556|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222557|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222558|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
130222559|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222560|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222561|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222562|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222563|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222564|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
130222565|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
130222566|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
130222567|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
130222568|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222569|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222570|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222571|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222572|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222573|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
130222574|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222575|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222576|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222577|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222578|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222579|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
130222580|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222581|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130098782|NCT03426995|468319309|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130098783|NCT03426995|468319310|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
130222582|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222583|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222584|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222585|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222586|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222587|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222588|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
130222589|NCT02326272|468778273|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222590|NCT02326272|468778274|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222591|NCT02326272|468778275|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222592|NCT02326272|468778276|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222593|NCT02326272|468778277|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222594|NCT02326272|468778278|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222595|NCT02326272|468778279|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
130222596|NCT02326272|468778280|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222597|NCT02326272|468778281|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222598|NCT02326272|468778282|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222599|NCT02326272|468778283|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222600|NCT02326272|468778284|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222601|NCT02326272|468778285|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222602|NCT02326272|468778286|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222603|NCT02326272|468778287|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
130222604|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
130222605|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
130222606|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
130222607|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
130222608|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
130222609|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
130222610|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
130222611|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
130222612|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
130222613|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
130222614|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
130222615|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
130222616|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
130222617|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
130222618|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
130222619|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222620|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222621|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222622|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222623|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222624|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222625|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222626|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222627|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222628|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222629|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
130222630|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
130222631|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130222632|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130222633|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
130222634|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222635|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222636|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222637|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222638|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222639|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222640|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222641|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222642|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130017960|NCT01181011|468026478|FG000|Overall Study|Adverse Event|2|||
130017961|NCT01181011|468026478|FG000|Overall Study|Lost to Follow-up|1|||
130017962|NCT00137111|468026479|FG000|Total Therapy|Death|35|||
129884465|NCT02038764|467536409|FG001|Overall Study|Adverse Event|0|||
129884466|NCT02038764|467536410|FG002|Overall Study|Adverse Event|1|||
129884467|NCT02038764|467536411|FG003|Overall Study|Adverse Event|0|||
130017963|NCT00137111|468026480|FG001|Total Therapy|Death|0|||
130017964|NCT00137111|468026481|FG002|Total Therapy|Death|0|||
130017965|NCT00137111|468026482|FG003|Total Therapy|Death|0|||
130017966|NCT00137111|468026479|FG000|Total Therapy|Non Compliance|5|||
130222643|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222644|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130222645|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222646|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130222647|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222648|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130222649|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222650|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222651|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222652|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222653|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222654|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222655|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222656|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222657|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222658|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222659|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222660|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
130222661|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222662|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222663|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130222664|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222665|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222666|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222667|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222668|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222669|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222670|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222671|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222672|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222673|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222674|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
130222675|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222676|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
130222677|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130222678|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130222679|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222680|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222681|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222682|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222683|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222684|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222685|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222686|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222687|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222688|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222689|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222690|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
130222691|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222692|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130222693|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
130017967|NCT00137111|468026480|FG001|Total Therapy|Non Compliance|0|||
130017968|NCT00137111|468026481|FG002|Total Therapy|Non Compliance|0|||
130222694|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222695|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222696|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222697|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222698|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222699|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222700|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222701|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222702|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222703|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222704|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222705|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
130222706|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130222707|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130222708|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130222709|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222710|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222711|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222712|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222713|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222714|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222715|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222716|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222717|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222718|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222719|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222720|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
130222721|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222722|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222723|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
130222724|NCT02326272|468778273|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222725|NCT02326272|468778274|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222726|NCT02326272|468778275|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222727|NCT02326272|468778276|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222728|NCT02326272|468778277|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222729|NCT02326272|468778278|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222730|NCT02326272|468778279|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222731|NCT02326272|468778280|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222732|NCT02326272|468778281|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222733|NCT02326272|468778282|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222734|NCT02326272|468778283|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222735|NCT02326272|468778284|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222736|NCT02326272|468778285|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
130222737|NCT02326272|468778286|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222738|NCT02326272|468778287|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
130222739|NCT00737100|468778292|FG000|Overall Study|Adverse Event|6|||
130222740|NCT00737100|468778293|FG001|Overall Study|Adverse Event|5|||
130222741|NCT00737100|468778294|FG002|Overall Study|Adverse Event|3|||
130222742|NCT00737100|468778292|FG000|Overall Study|Lost to Follow-up|0|||
130222743|NCT00737100|468778293|FG001|Overall Study|Lost to Follow-up|1|||
130222744|NCT00737100|468778294|FG002|Overall Study|Lost to Follow-up|0|||
130222745|NCT00737100|468778292|FG000|Overall Study|Withdrawal by Subject|0|||
130222746|NCT00737100|468778293|FG001|Overall Study|Withdrawal by Subject|0|||
130222747|NCT00737100|468778294|FG002|Overall Study|Withdrawal by Subject|3|||
130222748|NCT00737100|468778292|FG000|Overall Study|Reason discontinued not explained above|1|||
130222749|NCT00737100|468778293|FG001|Overall Study|Reason discontinued not explained above|1|||
130222750|NCT00737100|468778294|FG002|Overall Study|Reason discontinued not explained above|1|||
130222751|NCT00735943|468778297|FG000|Overall Study|Lost to Follow-up|1|||
130222752|NCT00735943|468778297|FG000|Overall Study|Adverse Event|1|||
130222753|NCT01265394|468778298|FG000|Overall Study|Subjects withdrawn|37|||
130222754|NCT00268983|468778303|FG000|Overall Study|Death|3|||
130222755|NCT00268983|468778304|FG001|Overall Study|Death|0|||
130222756|NCT01719380|468778305|FG000|Overall Study|Adverse Event|0|||
130222757|NCT01719380|468778306|FG001|Overall Study|Adverse Event|0|||
130222758|NCT01719380|468778307|FG002|Overall Study|Adverse Event|1|||
130222759|NCT01719380|468778308|FG003|Overall Study|Adverse Event|2|||
130222760|NCT01719380|468778309|FG004|Overall Study|Adverse Event|0|||
130222761|NCT01719380|468778310|FG005|Overall Study|Adverse Event|1|||
130222762|NCT01719380|468778311|FG006|Overall Study|Adverse Event|0|||
130222763|NCT01719380|468778312|FG007|Overall Study|Adverse Event|1|||
130222764|NCT01719380|468778313|FG008|Overall Study|Adverse Event|4|||
130222765|NCT01719380|468778314|FG009|Overall Study|Adverse Event|3|||
130222766|NCT01719380|468778305|FG000|Overall Study|Death|0|||
130222767|NCT01719380|468778306|FG001|Overall Study|Death|1|||
130222768|NCT01719380|468778307|FG002|Overall Study|Death|0|||
130222769|NCT01719380|468778308|FG003|Overall Study|Death|0|||
130222770|NCT01719380|468778309|FG004|Overall Study|Death|0|||
130222771|NCT01719380|468778310|FG005|Overall Study|Death|0|||
130222772|NCT01719380|468778311|FG006|Overall Study|Death|0|||
130222773|NCT01719380|468778312|FG007|Overall Study|Death|0|||
130222774|NCT01719380|468778313|FG008|Overall Study|Death|3|||
130222775|NCT01719380|468778314|FG009|Overall Study|Death|3|||
130222776|NCT01719380|468778305|FG000|Overall Study|Participant/Guardian Decision|0|||
130222777|NCT01719380|468778306|FG001|Overall Study|Participant/Guardian Decision|0|||
130222778|NCT01719380|468778307|FG002|Overall Study|Participant/Guardian Decision|1|||
130222779|NCT01719380|468778308|FG003|Overall Study|Participant/Guardian Decision|0|||
130222780|NCT01719380|468778309|FG004|Overall Study|Participant/Guardian Decision|0|||
130222781|NCT01719380|468778310|FG005|Overall Study|Participant/Guardian Decision|0|||
130222782|NCT01719380|468778311|FG006|Overall Study|Participant/Guardian Decision|0|||
130222783|NCT01719380|468778312|FG007|Overall Study|Participant/Guardian Decision|0|||
130222784|NCT01719380|468778313|FG008|Overall Study|Participant/Guardian Decision|2|||
130222785|NCT01719380|468778314|FG009|Overall Study|Participant/Guardian Decision|2|||
130222786|NCT01719380|468778305|FG000|Overall Study|Physician Decision|0|||
130017969|NCT00137111|468026482|FG003|Total Therapy|Non Compliance|0|||
130017970|NCT04703075|468026483|FG000|Overall Study|Adverse Event|11|||
130222787|NCT01719380|468778306|FG001|Overall Study|Physician Decision|0|||
130222788|NCT01719380|468778307|FG002|Overall Study|Physician Decision|2|||
130222789|NCT01719380|468778308|FG003|Overall Study|Physician Decision|0|||
130222790|NCT01719380|468778309|FG004|Overall Study|Physician Decision|0|||
130222791|NCT01719380|468778310|FG005|Overall Study|Physician Decision|0|||
130222792|NCT01719380|468778311|FG006|Overall Study|Physician Decision|0|||
130222793|NCT01719380|468778312|FG007|Overall Study|Physician Decision|0|||
130222794|NCT01719380|468778313|FG008|Overall Study|Physician Decision|1|||
130222795|NCT01719380|468778314|FG009|Overall Study|Physician Decision|1|||
130222796|NCT01719380|468778305|FG000|Overall Study|Lack of Efficacy|2|||
130222797|NCT01719380|468778306|FG001|Overall Study|Lack of Efficacy|6|||
130222798|NCT01719380|468778307|FG002|Overall Study|Lack of Efficacy|5|||
130222799|NCT01719380|468778308|FG003|Overall Study|Lack of Efficacy|6|||
130222800|NCT01719380|468778309|FG004|Overall Study|Lack of Efficacy|3|||
130222801|NCT01719380|468778310|FG005|Overall Study|Lack of Efficacy|7|||
130222802|NCT01719380|468778311|FG006|Overall Study|Lack of Efficacy|10|||
130222803|NCT01719380|468778312|FG007|Overall Study|Lack of Efficacy|6|||
130222804|NCT01719380|468778313|FG008|Overall Study|Lack of Efficacy|39|||
130222805|NCT01719380|468778314|FG009|Overall Study|Lack of Efficacy|42|||
130222806|NCT01719380|468778305|FG000|Overall Study|Progressive Disease|0|||
130222807|NCT01719380|468778306|FG001|Overall Study|Progressive Disease|0|||
130222808|NCT01719380|468778307|FG002|Overall Study|Progressive Disease|0|||
130222809|NCT01719380|468778308|FG003|Overall Study|Progressive Disease|0|||
130222810|NCT01719380|468778309|FG004|Overall Study|Progressive Disease|0|||
130222811|NCT01719380|468778310|FG005|Overall Study|Progressive Disease|0|||
130222812|NCT01719380|468778311|FG006|Overall Study|Progressive Disease|0|||
130222813|NCT01719380|468778312|FG007|Overall Study|Progressive Disease|0|||
130222814|NCT01719380|468778313|FG008|Overall Study|Progressive Disease|1|||
130222815|NCT01719380|468778314|FG009|Overall Study|Progressive Disease|0|||
130222816|NCT00321906|468778322|FG000|Overall Study|Adverse Event|36|||
130222817|NCT00321906|468778323|FG001|Overall Study|Adverse Event|44|||
130222818|NCT00321906|468778322|FG000|Overall Study|Death|9|||
130222819|NCT00321906|468778323|FG001|Overall Study|Death|6|||
130222820|NCT00321906|468778322|FG000|Overall Study|Lost to Follow-up|1|||
130222821|NCT00321906|468778323|FG001|Overall Study|Lost to Follow-up|2|||
130222822|NCT00321906|468778322|FG000|Overall Study|Withdrawal by Subject|0|||
130222823|NCT00321906|468778323|FG001|Overall Study|Withdrawal by Subject|4|||
130222824|NCT00838097|468778326|FG000|Overall Study|Ineligibility determined|6|||
130222825|NCT00838097|468778326|FG000|Overall Study|Adverse Event|2|||
130222826|NCT00838097|468778326|FG000|Overall Study|Withdrawal by Subject|3|||
130222827|NCT00838097|468778326|FG000|Overall Study|Requirement for alternative therapy|2|||
130222828|NCT00838097|468778326|FG000|Overall Study|Physician Decision|4|||
130222829|NCT00838097|468778326|FG000|Overall Study|Lost to Follow-up|11|||
130222830|NCT00838097|468778326|FG000|Overall Study|Death|6|||
130222831|NCT00838097|468778326|FG000|Overall Study|Protocol-specified criteria|142|||
130222832|NCT00871234|468778327|FG000|Overall Study|Adverse Event|2|||
130017971|NCT04703075|468026484|FG001|Overall Study|Adverse Event|7|||
130017972|NCT04703075|468026483|FG000|Overall Study|Lost to Follow-up|6|||
130017973|NCT04703075|468026484|FG001|Overall Study|Lost to Follow-up|12|||
130017974|NCT04703075|468026483|FG000|Overall Study|Physician Decision|3|||
130017975|NCT04703075|468026484|FG001|Overall Study|Physician Decision|0|||
130222833|NCT00871234|468778327|FG000|Overall Study|Lost to Follow-up|3|||
130222834|NCT03380377|468778330|FG000|Overall Study|Physician Decision|1|||
130222835|NCT03380377|468778330|FG000|Overall Study|Withdrawal by Subject|1|||
130222836|NCT02600923|468778333|FG000|Overall Study|Death|10|||
130222837|NCT02600923|468778333|FG000|Overall Study|Adverse Event|3|||
130222838|NCT02600923|468778333|FG000|Overall Study|Global deterioration of health status|2|||
130222839|NCT02600923|468778333|FG000|Overall Study|Insufficient clinical response|6|||
129884468|NCT02038764|467536412|FG004|Overall Study|Adverse Event|0|||
130222840|NCT02600923|468778333|FG000|Overall Study|Lost to Follow-up|1|||
130222841|NCT02600923|468778333|FG000|Overall Study|Withdrawal by Subject|5|||
130222842|NCT02600923|468778333|FG000|Overall Study|Objective progression or relapse|50|||
130222843|NCT02600923|468778333|FG000|Overall Study|Study terminated by Sponsor|53|||
130222844|NCT02600923|468778333|FG000|Overall Study|Not treated|1|||
130222845|NCT00792909|468778334|FG000|Overall Study|Withdrawal by Subject|0|||
130222846|NCT00792909|468778335|FG001|Overall Study|Withdrawal by Subject|1|||
130222847|NCT00792909|468778336|FG002|Overall Study|Withdrawal by Subject|0|||
130222848|NCT00128661|468778339|FG000|Overall Study|Adverse Event|14|||
130017976|NCT04703075|468026483|FG000|Overall Study|Moved|0|||
130017977|NCT04703075|468026484|FG001|Overall Study|Moved|2|||
130017978|NCT04703075|468026483|FG000|Overall Study|Index INH Resistant|0|||
130222849|NCT00128661|468778340|FG001|Overall Study|Adverse Event|11|||
130222850|NCT00128661|468778339|FG000|Overall Study|Lost to Follow-up|10|||
130222851|NCT00128661|468778340|FG001|Overall Study|Lost to Follow-up|7|||
130222852|NCT00128661|468778339|FG000|Overall Study|Withdrawal by Subject|243|||
130222853|NCT00128661|468778340|FG001|Overall Study|Withdrawal by Subject|232|||
130222854|NCT00128661|468778339|FG000|Overall Study|Other|7|||
130222855|NCT00128661|468778340|FG001|Overall Study|Other|8|||
130222856|NCT01261390|468778342|FG000|Overall Study|Significant Concurrent Illness|1|||
130222857|NCT01261390|468778343|FG001|Overall Study|Significant Concurrent Illness|0|||
130222858|NCT01261390|468778344|FG002|Overall Study|Significant Concurrent Illness|1|||
130222859|NCT01261390|468778345|FG003|Overall Study|Significant Concurrent Illness|0|||
130222860|NCT01261390|468778342|FG000|Overall Study|Dissatisfaction with Treatment|2|||
130222861|NCT01261390|468778343|FG001|Overall Study|Dissatisfaction with Treatment|1|||
130222862|NCT01261390|468778344|FG002|Overall Study|Dissatisfaction with Treatment|1|||
130017979|NCT04703075|468026484|FG001|Overall Study|Index INH Resistant|1|||
130222863|NCT01261390|468778345|FG003|Overall Study|Dissatisfaction with Treatment|2|||
130017980|NCT04703075|468026483|FG000|Overall Study|Lack of Efficacy|6|||
130017981|NCT04703075|468026484|FG001|Overall Study|Lack of Efficacy|18|||
130017982|NCT01967550|468026485|FG000|Overall Study|Withdrawal by Subject|1|||
130017983|NCT01967550|468026486|FG001|Overall Study|Withdrawal by Subject|0|||
130017984|NCT01967550|468026485|FG000|Overall Study|Adverse Event|2|||
130017985|NCT01967550|468026486|FG001|Overall Study|Adverse Event|0|||
130017986|NCT01967550|468026485|FG000|Overall Study|Protocol Violation|2|||
130017987|NCT01967550|468026486|FG001|Overall Study|Protocol Violation|1|||
130017988|NCT01967550|468026485|FG000|Overall Study|Non Compliance|0|||
130017989|NCT01967550|468026486|FG001|Overall Study|Non Compliance|1|||
130017990|NCT02425826|468026491|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
130017991|NCT02425826|468026492|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
130017992|NCT02425826|468026493|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
130017993|NCT02425826|468026491|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
130017994|NCT02425826|468026492|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
130017995|NCT02425826|468026493|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
130017996|NCT02425826|468026491|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
130017997|NCT02425826|468026492|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
130017998|NCT02425826|468026493|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
130017999|NCT02425826|468026491|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
130018000|NCT02425826|468026492|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
130018001|NCT02425826|468026493|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
130018002|NCT02425826|468026491|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
130018003|NCT02425826|468026492|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
130018004|NCT02425826|468026493|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
130018005|NCT02425826|468026491|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
130018006|NCT02425826|468026492|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
130018007|NCT02425826|468026493|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
130018008|NCT02425826|468026491|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
130018009|NCT02425826|468026492|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
130018010|NCT02425826|468026493|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
130018011|NCT02425826|468026491|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
130018012|NCT02425826|468026492|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
130018013|NCT02425826|468026493|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
130018014|NCT02425826|468026491|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
130018015|NCT02425826|468026492|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
130018016|NCT02425826|468026493|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
130018017|NCT02425826|468026491|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
130018018|NCT02425826|468026492|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
130018019|NCT02425826|468026493|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
130018020|NCT02500121|468026497|FG000|Overall Study|Lost to Follow-up|0|||
130018021|NCT02500121|468026498|FG001|Overall Study|Lost to Follow-up|1|||
130018022|NCT02500121|468026497|FG000|Overall Study|Withdrawal by Subject|1|||
130018023|NCT02500121|468026498|FG001|Overall Study|Withdrawal by Subject|1|||
130018024|NCT02500121|468026497|FG000|Overall Study|Death|26|||
130018025|NCT02500121|468026498|FG001|Overall Study|Death|24|||
130018026|NCT00852995|468026499|FG000|Overall Study|Adverse Event|1|||
130018027|NCT00852995|468026500|FG001|Overall Study|Adverse Event|0|||
130018028|NCT00852995|468026501|FG002|Overall Study|Adverse Event|4|||
130018029|NCT00852995|468026502|FG003|Overall Study|Adverse Event|0|||
130018030|NCT00852995|468026503|FG004|Overall Study|Adverse Event|0|||
130018031|NCT00852995|468026499|FG000|Overall Study|Lost to Follow-up|0|||
130018032|NCT00852995|468026500|FG001|Overall Study|Lost to Follow-up|1|||
130018033|NCT00852995|468026501|FG002|Overall Study|Lost to Follow-up|1|||
130018034|NCT00852995|468026502|FG003|Overall Study|Lost to Follow-up|0|||
130222864|NCT01261390|468778342|FG000|Overall Study|Relocation|0|||
130222865|NCT01261390|468778343|FG001|Overall Study|Relocation|1|||
130222866|NCT01261390|468778344|FG002|Overall Study|Relocation|0|||
130222867|NCT01261390|468778345|FG003|Overall Study|Relocation|0|||
130222868|NCT01261390|468778342|FG000|Overall Study|Loss of Interest in the Study|3|||
130222869|NCT01261390|468778343|FG001|Overall Study|Loss of Interest in the Study|1|||
130222870|NCT01261390|468778344|FG002|Overall Study|Loss of Interest in the Study|0|||
130222871|NCT01261390|468778345|FG003|Overall Study|Loss of Interest in the Study|0|||
130222872|NCT01261390|468778342|FG000|Overall Study|Lost to Follow-up|1|||
130222873|NCT01261390|468778343|FG001|Overall Study|Lost to Follow-up|6|||
130222874|NCT01261390|468778344|FG002|Overall Study|Lost to Follow-up|5|||
130222875|NCT01261390|468778345|FG003|Overall Study|Lost to Follow-up|6|||
130222876|NCT00977613|468778351|FG000|Overall Study|Lost to Follow-up|16|||
130222877|NCT01691378|468778355|FG000|Overall Study|Withdrawal by Subject|2|||
130222878|NCT01691378|468778356|FG001|Overall Study|Withdrawal by Subject|0|||
130222879|NCT01691378|468778355|FG000|Overall Study|Lost to Follow-up|5|||
130222880|NCT01691378|468778356|FG001|Overall Study|Lost to Follow-up|2|||
130222881|NCT00808067|468778359|FG000|Overall Study|Major/minor bleed|30|||
130222882|NCT00808067|468778360|FG001|Overall Study|Major/minor bleed|44|||
130222883|NCT00808067|468778359|FG000|Overall Study|Outcome event - other|33|||
130222884|NCT00808067|468778360|FG001|Overall Study|Outcome event - other|25|||
130222885|NCT00808067|468778359|FG000|Overall Study|Adverse Event|111|||
130222886|NCT00808067|468778360|FG001|Overall Study|Adverse Event|121|||
130222887|NCT00808067|468778359|FG000|Overall Study|Hospitalization (not including surgery)|18|||
130222888|NCT00808067|468778360|FG001|Overall Study|Hospitalization (not including surgery)|17|||
130222889|NCT00808067|468778359|FG000|Overall Study|Hospitalization due to surgery|37|||
130222890|NCT00808067|468778360|FG001|Overall Study|Hospitalization due to surgery|40|||
130222891|NCT00808067|468778359|FG000|Overall Study|Reduced creatinine clearance|53|||
130222892|NCT00808067|468778360|FG001|Overall Study|Reduced creatinine clearance|55|||
130222893|NCT00808067|468778359|FG000|Overall Study|Elevated LFT results|7|||
130222894|NCT00808067|468778360|FG001|Overall Study|Elevated LFT results|3|||
130222895|NCT00808067|468778359|FG000|Overall Study|Patient refused to take study medication|65|||
130222896|NCT00808067|468778360|FG001|Overall Study|Patient refused to take study medication|76|||
130222897|NCT00808067|468778359|FG000|Overall Study|Missing|1|||
130222898|NCT00808067|468778360|FG001|Overall Study|Missing|0|||
130222899|NCT00808067|468778359|FG000|Overall Study|Death|1|||
130222900|NCT00808067|468778360|FG001|Overall Study|Death|1|||
130222901|NCT00808067|468778359|FG000|Overall Study|Procedure|6|||
130222902|NCT00808067|468778360|FG001|Overall Study|Procedure|7|||
130222903|NCT00808067|468778359|FG000|Overall Study|Withdrawal by Subject|21|||
130222904|NCT00808067|468778360|FG001|Overall Study|Withdrawal by Subject|25|||
130222905|NCT00808067|468778359|FG000|Overall Study|Site closed|4|||
130222906|NCT00808067|468778360|FG001|Overall Study|Site closed|3|||
130222907|NCT00808067|468778359|FG000|Overall Study|Physician Decision|47|||
130222908|NCT00808067|468778360|FG001|Overall Study|Physician Decision|38|||
130222909|NCT00808067|468778359|FG000|Overall Study|Protocol Violation|3|||
130222910|NCT00808067|468778360|FG001|Overall Study|Protocol Violation|11|||
130222911|NCT00808067|468778359|FG000|Overall Study|Patient elected|7|||
130222912|NCT00808067|468778360|FG001|Overall Study|Patient elected|9|||
130222913|NCT00808067|468778359|FG000|Overall Study|Site closed for cause|19|||
130222914|NCT00808067|468778360|FG001|Overall Study|Site closed for cause|19|||
130222915|NCT00808067|468778359|FG000|Overall Study|Other reason not defined above|5|||
130222916|NCT00808067|468778360|FG001|Overall Study|Other reason not defined above|5|||
130222917|NCT00808067|468778359|FG000|Overall Study|Excluded from analysis|13|||
130222918|NCT00808067|468778360|FG001|Overall Study|Excluded from analysis|19|||
130222919|NCT02532283|468778361|FG000|Overall Study|Adverse Event|0|||
130222920|NCT02532283|468778362|FG001|Overall Study|Adverse Event|1|||
130222921|NCT02532283|468778361|FG000|Overall Study|Death|1|||
130222922|NCT02532283|468778362|FG001|Overall Study|Death|0|||
130222923|NCT02532283|468778361|FG000|Overall Study|Lost to Follow-up|0|||
130222924|NCT02532283|468778362|FG001|Overall Study|Lost to Follow-up|1|||
130222925|NCT02532283|468778361|FG000|Overall Study|Withdrawal by Subject|8|||
130222926|NCT02532283|468778362|FG001|Overall Study|Withdrawal by Subject|3|||
130018035|NCT00852995|468026503|FG004|Overall Study|Lost to Follow-up|0|||
130018036|NCT00852995|468026499|FG000|Overall Study|Withdrawal by Subject|4|||
130018037|NCT00852995|468026500|FG001|Overall Study|Withdrawal by Subject|0|||
130018038|NCT00852995|468026501|FG002|Overall Study|Withdrawal by Subject|0|||
130018039|NCT00852995|468026502|FG003|Overall Study|Withdrawal by Subject|1|||
130018040|NCT00852995|468026503|FG004|Overall Study|Withdrawal by Subject|2|||
130018041|NCT00852995|468026499|FG000|Overall Study|Non-Compliance|0|||
130018042|NCT00852995|468026500|FG001|Overall Study|Non-Compliance|0|||
130018043|NCT00852995|468026501|FG002|Overall Study|Non-Compliance|0|||
130018044|NCT00852995|468026502|FG003|Overall Study|Non-Compliance|2|||
130018045|NCT00852995|468026503|FG004|Overall Study|Non-Compliance|0|||
130018046|NCT00852995|468026499|FG000|Overall Study|Progressive Disease|1|||
130018047|NCT00852995|468026500|FG001|Overall Study|Progressive Disease|0|||
130018048|NCT00852995|468026501|FG002|Overall Study|Progressive Disease|0|||
130018049|NCT00852995|468026502|FG003|Overall Study|Progressive Disease|2|||
130018050|NCT00852995|468026503|FG004|Overall Study|Progressive Disease|1|||
130018051|NCT00852995|468026499|FG000|Overall Study|Physician Decision|1|||
130018052|NCT00852995|468026500|FG001|Overall Study|Physician Decision|0|||
130018053|NCT00852995|468026501|FG002|Overall Study|Physician Decision|0|||
130018054|NCT00852995|468026502|FG003|Overall Study|Physician Decision|0|||
130018055|NCT00852995|468026503|FG004|Overall Study|Physician Decision|0|||
130018056|NCT00852995|468026499|FG000|Overall Study|Protocol Violation|0|||
130018057|NCT00852995|468026500|FG001|Overall Study|Protocol Violation|0|||
130018058|NCT00852995|468026501|FG002|Overall Study|Protocol Violation|0|||
130018059|NCT00852995|468026502|FG003|Overall Study|Protocol Violation|0|||
130018060|NCT00852995|468026503|FG004|Overall Study|Protocol Violation|1|||
130018061|NCT00852995|468026499|FG000|Overall Study|Moved Out of Area|1|||
130098784|NCT03426995|468319292|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098785|NCT03426995|468319293|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130018062|NCT00852995|468026500|FG001|Overall Study|Moved Out of Area|0|||
130018063|NCT00852995|468026501|FG002|Overall Study|Moved Out of Area|0|||
130018064|NCT00852995|468026502|FG003|Overall Study|Moved Out of Area|0|||
130018065|NCT00852995|468026503|FG004|Overall Study|Moved Out of Area|0|||
130018066|NCT01836783|468026505|FG000|Overall Study|Withdrawal by Subject|0|||
130018067|NCT01836783|468026506|FG001|Overall Study|Withdrawal by Subject|2|||
130018068|NCT04518462|468026508|FG000|Overall Study|Withdrawal by Subject|0|||
130018069|NCT04518462|468026509|FG001|Overall Study|Withdrawal by Subject|0|||
130018070|NCT04518462|468026510|FG002|Overall Study|Withdrawal by Subject|1|||
130018071|NCT04518462|468026508|FG000|Overall Study|Physician Decision|1|||
130018072|NCT04518462|468026509|FG001|Overall Study|Physician Decision|1|||
130018073|NCT04518462|468026510|FG002|Overall Study|Physician Decision|0|||
130018074|NCT04418076|468026514|FG000|Overall Study|Death|1|||
130018075|NCT04418076|468026515|FG001|Overall Study|Death|0|||
130018076|NCT04418076|468026516|FG002|Overall Study|Death|0|||
130018077|NCT04418076|468026517|FG003|Overall Study|Death|0|||
130018078|NCT04418076|468026514|FG000|Overall Study|Lost to Follow-up|2|||
130018079|NCT04418076|468026515|FG001|Overall Study|Lost to Follow-up|5|||
130018080|NCT04418076|468026516|FG002|Overall Study|Lost to Follow-up|1|||
130018081|NCT04418076|468026517|FG003|Overall Study|Lost to Follow-up|2|||
130018082|NCT04418076|468026514|FG000|Overall Study|Withdrawal by Subject|1|||
130018083|NCT04418076|468026515|FG001|Overall Study|Withdrawal by Subject|0|||
130018084|NCT04418076|468026516|FG002|Overall Study|Withdrawal by Subject|1|||
130018085|NCT04418076|468026517|FG003|Overall Study|Withdrawal by Subject|1|||
130018086|NCT04418076|468026514|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
130018087|NCT04418076|468026515|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
130018088|NCT04418076|468026516|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
130018089|NCT04418076|468026517|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
130018090|NCT01471782|468026518|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
130018091|NCT01471782|468026519|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
130018092|NCT01471782|468026520|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
130018093|NCT01471782|468026521|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
130018094|NCT01471782|468026522|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
130018095|NCT01471782|468026523|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
130018096|NCT01471782|468026518|FG000|Overall Study|Lack of Efficacy|1|||
130018097|NCT01471782|468026519|FG001|Overall Study|Lack of Efficacy|2|||
130018098|NCT01471782|468026520|FG002|Overall Study|Lack of Efficacy|1|||
130018099|NCT01471782|468026521|FG003|Overall Study|Lack of Efficacy|1|||
130018100|NCT01471782|468026522|FG004|Overall Study|Lack of Efficacy|5|||
130018101|NCT01471782|468026523|FG005|Overall Study|Lack of Efficacy|18|||
130222927|NCT00490971|468778365|FG000|Acute/Continuation|Adverse Event|62|||
130222928|NCT00490971|468778366|FG001|Acute/Continuation|Adverse Event|13|||
130222929|NCT00490971|468778367|FG002|Acute/Continuation|Adverse Event|0|||
130222930|NCT00490971|468778368|FG003|Acute/Continuation|Adverse Event|0|||
130222931|NCT00490971|468778369|FG004|Acute/Continuation|Adverse Event|0|||
130222932|NCT00490971|468778365|FG000|Acute/Continuation|Death|2|||
130222933|NCT00490971|468778366|FG001|Acute/Continuation|Death|0|||
130222934|NCT00490971|468778367|FG002|Acute/Continuation|Death|0|||
130222935|NCT00490971|468778368|FG003|Acute/Continuation|Death|0|||
130222936|NCT00490971|468778369|FG004|Acute/Continuation|Death|0|||
130222937|NCT00490971|468778365|FG000|Acute/Continuation|Lack of Efficacy|106|||
130222938|NCT00490971|468778366|FG001|Acute/Continuation|Lack of Efficacy|12|||
130222939|NCT00490971|468778367|FG002|Acute/Continuation|Lack of Efficacy|0|||
130222940|NCT00490971|468778368|FG003|Acute/Continuation|Lack of Efficacy|0|||
130222941|NCT00490971|468778369|FG004|Acute/Continuation|Lack of Efficacy|0|||
130222942|NCT00490971|468778365|FG000|Acute/Continuation|Lost to Follow-up|23|||
130222943|NCT00490971|468778366|FG001|Acute/Continuation|Lost to Follow-up|7|||
130222944|NCT00490971|468778367|FG002|Acute/Continuation|Lost to Follow-up|0|||
130222945|NCT00490971|468778368|FG003|Acute/Continuation|Lost to Follow-up|0|||
130222946|NCT00490971|468778369|FG004|Acute/Continuation|Lost to Follow-up|0|||
130222947|NCT00490971|468778365|FG000|Acute/Continuation|Protocol Violation|10|||
130018102|NCT01471782|468026518|FG000|Overall Study|Adverse Event|1|||
130222948|NCT00490971|468778366|FG001|Acute/Continuation|Protocol Violation|2|||
130222949|NCT00490971|468778367|FG002|Acute/Continuation|Protocol Violation|0|||
130222950|NCT00490971|468778368|FG003|Acute/Continuation|Protocol Violation|0|||
130222951|NCT00490971|468778369|FG004|Acute/Continuation|Protocol Violation|0|||
130222952|NCT00490971|468778365|FG000|Acute/Continuation|Withdrawal by Subject|92|||
130222953|NCT00490971|468778366|FG001|Acute/Continuation|Withdrawal by Subject|24|||
130222954|NCT00490971|468778367|FG002|Acute/Continuation|Withdrawal by Subject|0|||
130222955|NCT00490971|468778368|FG003|Acute/Continuation|Withdrawal by Subject|0|||
130222956|NCT00490971|468778369|FG004|Acute/Continuation|Withdrawal by Subject|0|||
130222957|NCT00490971|468778365|FG000|Acute/Continuation|Other|11|||
130222958|NCT00490971|468778366|FG001|Acute/Continuation|Other|4|||
130222959|NCT00490971|468778367|FG002|Acute/Continuation|Other|0|||
130222960|NCT00490971|468778368|FG003|Acute/Continuation|Other|0|||
130222961|NCT00490971|468778369|FG004|Acute/Continuation|Other|0|||
130222962|NCT00490971|468778365|FG000|Maintenance|Adverse Event|0|||
130222963|NCT00490971|468778366|FG001|Maintenance|Adverse Event|0|||
130222964|NCT00490971|468778367|FG002|Maintenance|Adverse Event|4|||
130222965|NCT00490971|468778368|FG003|Maintenance|Adverse Event|5|||
130222966|NCT00490971|468778369|FG004|Maintenance|Adverse Event|7|||
130222967|NCT00490971|468778365|FG000|Maintenance|Death|0|||
130222968|NCT00490971|468778366|FG001|Maintenance|Death|0|||
130222969|NCT00490971|468778367|FG002|Maintenance|Death|0|||
130222970|NCT00490971|468778368|FG003|Maintenance|Death|2|||
130222971|NCT00490971|468778369|FG004|Maintenance|Death|0|||
130222972|NCT00490971|468778365|FG000|Maintenance|Lost to Follow-up|0|||
130222973|NCT00490971|468778366|FG001|Maintenance|Lost to Follow-up|0|||
130222974|NCT00490971|468778367|FG002|Maintenance|Lost to Follow-up|5|||
130222975|NCT00490971|468778368|FG003|Maintenance|Lost to Follow-up|8|||
130222976|NCT00490971|468778369|FG004|Maintenance|Lost to Follow-up|10|||
130222977|NCT00490971|468778365|FG000|Maintenance|Pregnancy|0|||
130222978|NCT00490971|468778366|FG001|Maintenance|Pregnancy|0|||
130222979|NCT00490971|468778367|FG002|Maintenance|Pregnancy|1|||
130222980|NCT00490971|468778368|FG003|Maintenance|Pregnancy|0|||
130222981|NCT00490971|468778369|FG004|Maintenance|Pregnancy|0|||
130222982|NCT00490971|468778365|FG000|Maintenance|Protocol Violation|0|||
130222983|NCT00490971|468778366|FG001|Maintenance|Protocol Violation|0|||
130222984|NCT00490971|468778367|FG002|Maintenance|Protocol Violation|4|||
130222985|NCT00490971|468778368|FG003|Maintenance|Protocol Violation|1|||
130222986|NCT00490971|468778369|FG004|Maintenance|Protocol Violation|1|||
130222987|NCT00490971|468778365|FG000|Maintenance|Withdrawal by Subject|0|||
130222988|NCT00490971|468778366|FG001|Maintenance|Withdrawal by Subject|0|||
130222989|NCT00490971|468778367|FG002|Maintenance|Withdrawal by Subject|26|||
130222990|NCT00490971|468778368|FG003|Maintenance|Withdrawal by Subject|28|||
130222991|NCT00490971|468778369|FG004|Maintenance|Withdrawal by Subject|18|||
130222992|NCT00490971|468778365|FG000|Maintenance|Other|0|||
130222993|NCT00490971|468778366|FG001|Maintenance|Other|0|||
130222994|NCT00490971|468778367|FG002|Maintenance|Other|11|||
130222995|NCT00490971|468778368|FG003|Maintenance|Other|9|||
130222996|NCT00490971|468778369|FG004|Maintenance|Other|3|||
130222997|NCT04888494|468778371|FG000|Overall Study|Lost to Follow-up|2|||
130222998|NCT04888494|468778372|FG001|Overall Study|Lost to Follow-up|3|||
130222999|NCT04888494|468778371|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
130223000|NCT04888494|468778372|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
130223001|NCT00565604|468778378|FG000|Overall Study|Failure to treat|2|||
130223002|NCT00565604|468778378|FG000|Overall Study|Lost to Follow-up|2|||
130223003|NCT04754542|468778379|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
130223004|NCT04754542|468778380|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
130223005|NCT02317991|468779935|FG000|Overall Study|Adverse Event|12|||
130223006|NCT02317991|468779935|FG000|Overall Study|Death|4|||
130223007|NCT02317991|468779935|FG000|Overall Study|Withdrawal by Subject|8|||
130223008|NCT02317991|468779935|FG000|Overall Study|Progressive Disease|41|||
130018103|NCT01471782|468026519|FG001|Overall Study|Adverse Event|1|||
130223009|NCT00327340|468779936|FG000|Overall Study|Withdrawal by Subject|1|||
130223010|NCT00327340|468779937|FG001|Overall Study|Withdrawal by Subject|5|||
130223011|NCT00327340|468779936|FG000|Overall Study|Physician Decision|1|||
130223012|NCT00327340|468779937|FG001|Overall Study|Physician Decision|1|||
130223013|NCT00327340|468779936|FG000|Overall Study|Disease Progression|10|||
130223014|NCT00327340|468779937|FG001|Overall Study|Disease Progression|19|||
130223015|NCT00327340|468779936|FG000|Overall Study|Symptomatic Disease|0|||
130223016|NCT00327340|468779937|FG001|Overall Study|Symptomatic Disease|2|||
130223017|NCT00327340|468779936|FG000|Overall Study|Adverse Event|3|||
130223018|NCT00327340|468779937|FG001|Overall Study|Adverse Event|3|||
130223019|NCT01716806|468779942|FG000|Overall Study|Patient withdrawal of consent|4|||
130223020|NCT01716806|468779943|FG001|Overall Study|Patient withdrawal of consent|2|||
130223021|NCT01716806|468779944|FG002|Overall Study|Patient withdrawal of consent|4|||
130223022|NCT01716806|468779945|FG003|Overall Study|Patient withdrawal of consent|3|||
130223023|NCT01716806|468779946|FG004|Overall Study|Patient withdrawal of consent|2|||
130223024|NCT01716806|468779947|FG005|Overall Study|Patient withdrawal of consent|0|||
130223025|NCT01716806|468779942|FG000|Overall Study|Lost to Follow-up|3|||
130223026|NCT01716806|468779943|FG001|Overall Study|Lost to Follow-up|3|||
130223027|NCT01716806|468779944|FG002|Overall Study|Lost to Follow-up|0|||
130223028|NCT01716806|468779945|FG003|Overall Study|Lost to Follow-up|2|||
130223029|NCT01716806|468779946|FG004|Overall Study|Lost to Follow-up|1|||
130223030|NCT01716806|468779947|FG005|Overall Study|Lost to Follow-up|0|||
130223031|NCT01716806|468779942|FG000|Overall Study|Death|13|||
130223032|NCT01716806|468779943|FG001|Overall Study|Death|9|||
130223033|NCT01716806|468779944|FG002|Overall Study|Death|12|||
130223034|NCT01716806|468779945|FG003|Overall Study|Death|4|||
130223035|NCT01716806|468779946|FG004|Overall Study|Death|10|||
130223036|NCT01716806|468779947|FG005|Overall Study|Death|5|||
130223037|NCT01716806|468779942|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223038|NCT01716806|468779943|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223039|NCT01716806|468779944|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223040|NCT01716806|468779945|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
130223041|NCT01716806|468779946|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
130223042|NCT01716806|468779947|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
130223043|NCT01716806|468779942|FG000|Overall Study|PI decision|0|||
130223044|NCT01716806|468779943|FG001|Overall Study|PI decision|0|||
130223045|NCT01716806|468779944|FG002|Overall Study|PI decision|0|||
130223046|NCT01716806|468779945|FG003|Overall Study|PI decision|0|||
130223047|NCT01716806|468779946|FG004|Overall Study|PI decision|1|||
130223048|NCT01716806|468779947|FG005|Overall Study|PI decision|0|||
130223049|NCT01716806|468779942|FG000|Overall Study|Change in performance status|1|||
130223050|NCT01716806|468779943|FG001|Overall Study|Change in performance status|0|||
130223051|NCT01716806|468779944|FG002|Overall Study|Change in performance status|0|||
130223052|NCT01716806|468779945|FG003|Overall Study|Change in performance status|0|||
130223053|NCT01716806|468779946|FG004|Overall Study|Change in performance status|0|||
130223054|NCT01716806|468779947|FG005|Overall Study|Change in performance status|0|||
130223055|NCT01716806|468779942|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223056|NCT01716806|468779943|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223057|NCT01716806|468779944|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
130223058|NCT01716806|468779945|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223059|NCT01716806|468779946|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223060|NCT01716806|468779947|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
130223061|NCT01716806|468779942|FG000|Overall Study|Sponsor direction|7|||
130223062|NCT01716806|468779943|FG001|Overall Study|Sponsor direction|8|||
130223063|NCT01716806|468779944|FG002|Overall Study|Sponsor direction|5|||
130223064|NCT01716806|468779945|FG003|Overall Study|Sponsor direction|12|||
130223065|NCT01716806|468779946|FG004|Overall Study|Sponsor direction|16|||
130223066|NCT01716806|468779947|FG005|Overall Study|Sponsor direction|1|||
130223067|NCT03506438|468779948|FG000|Overall Study|Lost to Follow-up|8|||
130223068|NCT03506438|468779949|FG001|Overall Study|Lost to Follow-up|7|||
130223069|NCT03506438|468779950|FG002|Overall Study|Lost to Follow-up|8|||
130223070|NCT03506438|468779951|FG003|Overall Study|Lost to Follow-up|7|||
130223071|NCT03506438|468779952|FG004|Overall Study|Lost to Follow-up|0|||
130223072|NCT03506438|468779953|FG005|Overall Study|Lost to Follow-up|0|||
130223073|NCT03527277|468779954|FG000|Overall Study|Withdrawal by Subject|5|||
130223074|NCT03527277|468779955|FG001|Overall Study|Withdrawal by Subject|0|||
130223075|NCT03527277|468779954|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
130223076|NCT03527277|468779955|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
130223077|NCT03527277|468779954|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
130018104|NCT01471782|468026520|FG002|Overall Study|Adverse Event|2|||
130018105|NCT01471782|468026521|FG003|Overall Study|Adverse Event|2|||
130018106|NCT01471782|468026522|FG004|Overall Study|Adverse Event|3|||
130018107|NCT01471782|468026523|FG005|Overall Study|Adverse Event|1|||
130223078|NCT03527277|468779955|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
130223079|NCT03316586|468779958|FG000|Overall Study|Adverse Event|2|||
130223080|NCT03316586|468779958|FG000|Overall Study|Physician Decision|3|||
130018108|NCT01471782|468026518|FG000|Overall Study|Other|0|||
130223081|NCT03316586|468779958|FG000|Overall Study|Lack of Efficacy|10|||
130223082|NCT03316586|468779958|FG000|Overall Study|still on treatment|1|||
130223083|NCT03316586|468779958|FG000|Overall Study|Patient needed radiation therapy|1|||
130223084|NCT03316586|468779958|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
130223085|NCT03934216|468779961|FG000|Overall Study|Other Reasons|5|||
130223086|NCT03934216|468779962|FG001|Overall Study|Other Reasons|5|||
130223087|NCT03934216|468779961|FG000|Overall Study|Adverse Event|22|||
130223088|NCT03934216|468779962|FG001|Overall Study|Adverse Event|11|||
130223089|NCT03934216|468779961|FG000|Overall Study|Lack of Efficacy|8|||
130223090|NCT03934216|468779962|FG001|Overall Study|Lack of Efficacy|7|||
130223091|NCT03934216|468779961|FG000|Overall Study|Lost to Follow-up|2|||
130223092|NCT03934216|468779962|FG001|Overall Study|Lost to Follow-up|0|||
130223093|NCT03934216|468779961|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130223094|NCT03934216|468779962|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130223095|NCT03934216|468779961|FG000|Overall Study|Pregnancy|1|||
130223096|NCT03934216|468779962|FG001|Overall Study|Pregnancy|0|||
130223097|NCT03934216|468779961|FG000|Overall Study|Withdrawal by Subject|18|||
130223098|NCT03934216|468779962|FG001|Overall Study|Withdrawal by Subject|6|||
130223099|NCT03934216|468779961|FG000|Overall Study|Randomized but not treated|1|||
130223100|NCT03934216|468779962|FG001|Overall Study|Randomized but not treated|1|||
130223101|NCT01396083|468779965|FG000|Overall Study|Adverse Event|2|||
130223102|NCT01396083|468779966|FG001|Overall Study|Adverse Event|28|||
130223103|NCT01396083|468779965|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130223104|NCT01396083|468779966|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130223105|NCT01396083|468779965|FG000|Overall Study|Consent withdrawn|4|||
130223106|NCT01396083|468779966|FG001|Overall Study|Consent withdrawn|5|||
130223107|NCT01396083|468779965|FG000|Overall Study|Protocol deviation(s)|0|||
130223108|NCT01396083|468779966|FG001|Overall Study|Protocol deviation(s)|1|||
130223109|NCT01396083|468779965|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130223110|NCT01396083|468779966|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130223111|NCT01396083|468779965|FG000|Overall Study|Administrative problems|1|||
130223112|NCT01396083|468779966|FG001|Overall Study|Administrative problems|0|||
130223113|NCT01396083|468779965|FG000|Overall Study|Lost to Follow-up|1|||
130223114|NCT01396083|468779966|FG001|Overall Study|Lost to Follow-up|0|||
130223115|NCT02806713|468779967|FG000|Overall Study|Urethral injury during procedure|1|||
130223116|NCT02806713|468779968|FG001|Overall Study|Urethral injury during procedure|0|||
130223117|NCT02806713|468779967|FG000|Overall Study|cancelled surgery|1|||
130223118|NCT02806713|468779968|FG001|Overall Study|cancelled surgery|2|||
130223119|NCT00735709|468779969|FG000|Overall Study|Adverse Event|2|||
130223120|NCT00735709|468779970|FG001|Overall Study|Adverse Event|3|||
130223121|NCT00735709|468779971|FG002|Overall Study|Adverse Event|1|||
130223122|NCT00735709|468779972|FG003|Overall Study|Adverse Event|5|||
130223123|NCT00735709|468779969|FG000|Overall Study|Lack of Efficacy|8|||
130223124|NCT00735709|468779970|FG001|Overall Study|Lack of Efficacy|4|||
130223125|NCT00735709|468779971|FG002|Overall Study|Lack of Efficacy|2|||
130223126|NCT00735709|468779972|FG003|Overall Study|Lack of Efficacy|3|||
130223127|NCT00735709|468779969|FG000|Overall Study|Noncompliance|0|||
130223128|NCT00735709|468779970|FG001|Overall Study|Noncompliance|0|||
130018109|NCT01471782|468026519|FG001|Overall Study|Other|0|||
130018110|NCT01471782|468026520|FG002|Overall Study|Other|1|||
130018111|NCT01471782|468026521|FG003|Overall Study|Other|1|||
130018112|NCT01471782|468026522|FG004|Overall Study|Other|6|||
130018113|NCT01471782|468026523|FG005|Overall Study|Other|5|||
130018114|NCT01471782|468026518|FG000|Overall Study|Change of Chemotherapy|1|||
130018115|NCT01471782|468026519|FG001|Overall Study|Change of Chemotherapy|1|||
130018116|NCT01471782|468026520|FG002|Overall Study|Change of Chemotherapy|0|||
130018117|NCT01471782|468026521|FG003|Overall Study|Change of Chemotherapy|0|||
130018118|NCT01471782|468026522|FG004|Overall Study|Change of Chemotherapy|1|||
130018119|NCT01471782|468026523|FG005|Overall Study|Change of Chemotherapy|4|||
130018120|NCT01471782|468026518|FG000|Overall Study|Disease Relapse|0|||
130018121|NCT01471782|468026519|FG001|Overall Study|Disease Relapse|0|||
130018122|NCT01471782|468026520|FG002|Overall Study|Disease Relapse|0|||
130018123|NCT01471782|468026521|FG003|Overall Study|Disease Relapse|1|||
130018124|NCT01471782|468026522|FG004|Overall Study|Disease Relapse|2|||
130018125|NCT01471782|468026523|FG005|Overall Study|Disease Relapse|1|||
130018126|NCT01471782|468026518|FG000|Overall Study|Physician Decision|0|||
130018127|NCT01471782|468026519|FG001|Overall Study|Physician Decision|0|||
130018128|NCT01471782|468026520|FG002|Overall Study|Physician Decision|0|||
130018129|NCT01471782|468026521|FG003|Overall Study|Physician Decision|0|||
130223129|NCT00735709|468779971|FG002|Overall Study|Noncompliance|1|||
130018130|NCT01471782|468026522|FG004|Overall Study|Physician Decision|3|||
130098786|NCT03426995|468319294|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129884469|NCT02038764|467536408|FG000|Overall Study|Lost to Follow-up|0|||
130018131|NCT01471782|468026523|FG005|Overall Study|Physician Decision|8|||
130018132|NCT01471782|468026518|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130223130|NCT00735709|468779972|FG003|Overall Study|Noncompliance|0|||
130223131|NCT00735709|468779969|FG000|Overall Study|Protocol deviations|1|||
130223132|NCT00735709|468779970|FG001|Overall Study|Protocol deviations|2|||
130223133|NCT00735709|468779971|FG002|Overall Study|Protocol deviations|1|||
130223134|NCT00735709|468779972|FG003|Overall Study|Protocol deviations|1|||
130223135|NCT00735709|468779969|FG000|Overall Study|Voluntary Withdrawal|1|||
130223136|NCT00735709|468779970|FG001|Overall Study|Voluntary Withdrawal|3|||
130223137|NCT00735709|468779971|FG002|Overall Study|Voluntary Withdrawal|5|||
130223138|NCT00735709|468779972|FG003|Overall Study|Voluntary Withdrawal|7|||
130223139|NCT00735709|468779969|FG000|Overall Study|Lost to Follow-up|0|||
130223140|NCT00735709|468779970|FG001|Overall Study|Lost to Follow-up|1|||
130018133|NCT01471782|468026519|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130018134|NCT01471782|468026520|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130018135|NCT01471782|468026521|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130018136|NCT01471782|468026522|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
130018137|NCT01471782|468026523|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130018138|NCT01471782|468026518|FG000|Overall Study|Death|0|||
130018139|NCT01471782|468026519|FG001|Overall Study|Death|0|||
130018140|NCT01471782|468026520|FG002|Overall Study|Death|0|||
130018141|NCT01471782|468026521|FG003|Overall Study|Death|0|||
129884470|NCT02038764|467536409|FG001|Overall Study|Lost to Follow-up|1|||
130018142|NCT01471782|468026522|FG004|Overall Study|Death|0|||
130018143|NCT01471782|468026523|FG005|Overall Study|Death|1|||
130018144|NCT01314716|468026524|FG000|Double-Blind Phase|Randomized but not treated|1|||
130018145|NCT01314716|468026525|FG001|Double-Blind Phase|Randomized but not treated|1|||
130223141|NCT00735709|468779971|FG002|Overall Study|Lost to Follow-up|1|||
130223142|NCT00735709|468779972|FG003|Overall Study|Lost to Follow-up|1|||
130223143|NCT00735709|468779969|FG000|Overall Study|Excluded medication|1|||
130223144|NCT00735709|468779970|FG001|Overall Study|Excluded medication|0|||
130223145|NCT00735709|468779971|FG002|Overall Study|Excluded medication|0|||
130223146|NCT00735709|468779972|FG003|Overall Study|Excluded medication|1|||
130223147|NCT01165307|468779973|FG000|Overall Study|Lost to Follow-up|11|||
130223148|NCT01165307|468779974|FG001|Overall Study|Lost to Follow-up|3|||
130223149|NCT01165307|468779973|FG000|Overall Study|Withdrawal by Subject|2|||
130223150|NCT01165307|468779974|FG001|Overall Study|Withdrawal by Subject|0|||
130223151|NCT01165307|468779973|FG000|Overall Study|Subject not available for contact|1|||
130223152|NCT01165307|468779974|FG001|Overall Study|Subject not available for contact|0|||
130223153|NCT03113968|468779986|FG000|Overall Study|Withdrawal by Subject|31|||
130223154|NCT03113968|468779987|FG001|Overall Study|Withdrawal by Subject|4|||
130223155|NCT04805671|468779990|FG000|Overall Study|Death|2|||
130223156|NCT04805671|468779991|FG001|Overall Study|Death|7|||
130223157|NCT04805671|468779990|FG000|Overall Study|Lost to Follow-up|1|||
130223158|NCT04805671|468779991|FG001|Overall Study|Lost to Follow-up|0|||
130223159|NCT04805671|468779990|FG000|Overall Study|Withdrawal by Subject|9|||
130223160|NCT04805671|468779991|FG001|Overall Study|Withdrawal by Subject|7|||
130223161|NCT04805671|468779990|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
130223162|NCT04805671|468779991|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
130223163|NCT02111174|468779992|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
130223164|NCT02111174|468779993|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
130223165|NCT02111174|468779992|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
130223166|NCT02111174|468779993|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
130223167|NCT02111174|468779992|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
130223168|NCT02111174|468779993|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
130223169|NCT02111174|468779992|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
130223170|NCT02111174|468779993|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
130223171|NCT01657162|468779998|FG000|Overall Study|Adverse Event|26|||
130223172|NCT01657162|468779999|FG001|Overall Study|Adverse Event|36|||
130223173|NCT01657162|468779998|FG000|Overall Study|Withdrawal by Subject|13|||
130223174|NCT01657162|468779999|FG001|Overall Study|Withdrawal by Subject|13|||
130223175|NCT01657162|468779998|FG000|Overall Study|Continuing Significant Deterioration|9|||
130223176|NCT01657162|468779999|FG001|Overall Study|Continuing Significant Deterioration|3|||
130223177|NCT01657162|468779998|FG000|Overall Study|Refusal of Treatment|4|||
130223178|NCT01657162|468779999|FG001|Overall Study|Refusal of Treatment|6|||
130223179|NCT01657162|468779998|FG000|Overall Study|Lost to Follow-up|3|||
130223180|NCT01657162|468779999|FG001|Overall Study|Lost to Follow-up|4|||
130223181|NCT01657162|468779998|FG000|Overall Study|Death|2|||
130223182|NCT01657162|468779999|FG001|Overall Study|Death|3|||
130223183|NCT01657162|468779998|FG000|Overall Study|Inability to Complete Study Procedures|1|||
130223184|NCT01657162|468779999|FG001|Overall Study|Inability to Complete Study Procedures|7|||
130223185|NCT01657162|468779998|FG000|Overall Study|Protocol Violation|1|||
130223186|NCT01657162|468779999|FG001|Overall Study|Protocol Violation|0|||
130223187|NCT01657162|468779998|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
130223188|NCT01657162|468779999|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
130223189|NCT01657162|468779998|FG000|Overall Study|Other than Specified|0|||
130223190|NCT01657162|468779999|FG001|Overall Study|Other than Specified|2|||
130223191|NCT00901342|468780000|FG000|Overall Study|Adverse Event|1|||
130223192|NCT00901342|468780000|FG000|Overall Study|Death|4|||
130223193|NCT00901342|468780000|FG000|Overall Study|Disease progression|1|||
130223194|NCT00901342|468780000|FG000|Overall Study|Withdrawal by Subject|9|||
130223195|NCT00751140|468780009|FG000|Overall Study|benign angioma excluded from analysis|1|||
130223196|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
130223197|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
130223198|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
130223199|NCT04001803|468780010|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
130223200|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
130223201|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
130223202|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
130223203|NCT04001803|468780010|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
130098787|NCT03426995|468319295|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130223204|NCT04001803|468780010|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
130223205|NCT04001803|468780010|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
130223206|NCT02493517|468780011|FG000|Overall Study|Protocol Violation|1|||
130223207|NCT02493517|468780012|FG001|Overall Study|Protocol Violation|2|||
130223208|NCT02493517|468780011|FG000|Overall Study|Withdrawal by Subject|1|||
130223209|NCT02493517|468780012|FG001|Overall Study|Withdrawal by Subject|2|||
130223210|NCT02493517|468780011|FG000|Overall Study|Adverse Event|0|||
130223211|NCT02493517|468780012|FG001|Overall Study|Adverse Event|2|||
130223212|NCT02493517|468780011|FG000|Overall Study|Missed study visit|0|||
130223213|NCT02493517|468780012|FG001|Overall Study|Missed study visit|1|||
130223214|NCT03718429|468780013|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
130223215|NCT03718429|468780014|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
130223216|NCT03718429|468780015|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
130223217|NCT03718429|468780016|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
130223218|NCT05404711|468780019|FG000|Completed Study Visit|Withdrawal by Subject|1|||
130223219|NCT05404711|468780019|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
130223220|NCT05404711|468780019|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
130223221|NCT05404711|468780019|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
130223222|NCT05404711|468780019|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
130223223|NCT05404711|468780019|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
130223224|NCT00325819|468780020|FG000|Overall Study|Study product lost in mail|2|||
130223225|NCT00325819|468780021|FG001|Overall Study|Study product lost in mail|1|||
130223226|NCT00325819|468780020|FG000|Overall Study|Did not take a dose of study product|4|||
130223227|NCT00325819|468780021|FG001|Overall Study|Did not take a dose of study product|9|||
130223228|NCT00325819|468780020|FG000|Overall Study|Lost to Follow-up|3|||
130223229|NCT00325819|468780021|FG001|Overall Study|Lost to Follow-up|3|||
130223230|NCT02346877|468780022|FG000|Overall Study|Adverse Event|1|||
130223231|NCT02346877|468780023|FG001|Overall Study|Adverse Event|0|||
130223232|NCT02346877|468780022|FG000|Overall Study|Administrative Decision|1|||
130223233|NCT02346877|468780023|FG001|Overall Study|Administrative Decision|0|||
130223234|NCT02346877|468780022|FG000|Overall Study|Sponsor Decision|12|||
130223235|NCT02346877|468780023|FG001|Overall Study|Sponsor Decision|0|||
130223236|NCT02346877|468780022|FG000|Overall Study|Missing|5|||
130223237|NCT02346877|468780023|FG001|Overall Study|Missing|0|||
130223244|NCT04376515|468780032|FG000|Overall Study|Found to have been vaccinated before study start|6|||
130223245|NCT04376515|468780033|FG001|Overall Study|Found to have been vaccinated before study start|6|||
130223246|NCT03811821|468780034|FG000|Overall Study|Adverse Event|1|||
130223247|NCT03811821|468780035|FG001|Overall Study|Adverse Event|1|||
130223248|NCT03811821|468780034|FG000|Overall Study|Withdrawal by Subject|5|||
130223249|NCT03811821|468780035|FG001|Overall Study|Withdrawal by Subject|4|||
130223250|NCT03811821|468780034|FG000|Overall Study|Lost to Follow-up|2|||
130223251|NCT03811821|468780035|FG001|Overall Study|Lost to Follow-up|2|||
130223252|NCT03811821|468780034|FG000|Overall Study|Contraindication for treatment|0|||
130223253|NCT03811821|468780035|FG001|Overall Study|Contraindication for treatment|1|||
130223254|NCT03811821|468780034|FG000|Overall Study|Tolerability|0|||
130223255|NCT03811821|468780035|FG001|Overall Study|Tolerability|3|||
130223256|NCT03811821|468780034|FG000|Overall Study|Comorbidities|0|||
130223257|NCT03811821|468780035|FG001|Overall Study|Comorbidities|2|||
130223258|NCT01683604|468780037|FG000|Overall Study|Adverse Event|2|||
130223259|NCT01683604|468780037|FG000|Overall Study|Lack of Efficacy|1|||
130223260|NCT01683604|468780037|FG000|Overall Study|Other|2|||
130223261|NCT03430856|468780043|FG000|Overall Study|Adverse Event|0|||
130223262|NCT03430856|468780044|FG001|Overall Study|Adverse Event|1|||
130223263|NCT03430856|468780045|FG002|Overall Study|Adverse Event|0|||
130223264|NCT03430856|468780043|FG000|Overall Study|Rescue criteria|1|||
130223265|NCT03430856|468780044|FG001|Overall Study|Rescue criteria|1|||
130018146|NCT01314716|468026524|FG000|Double-Blind Phase|Adverse Event|10|||
130223266|NCT03430856|468780045|FG002|Overall Study|Rescue criteria|0|||
130223267|NCT03430856|468780043|FG000|Overall Study|Voluntary withdrawal of consent|1|||
130018147|NCT01314716|468026525|FG001|Double-Blind Phase|Adverse Event|4|||
130223268|NCT03430856|468780044|FG001|Overall Study|Voluntary withdrawal of consent|1|||
130223269|NCT03430856|468780045|FG002|Overall Study|Voluntary withdrawal of consent|1|||
130223270|NCT01949142|468780046|FG000|Overall Study|Withdrawal of consent|1|||
130223271|NCT01949142|468780047|FG001|Overall Study|Withdrawal of consent|0|||
130223272|NCT01949142|468780046|FG000|Overall Study|Lost to Follow-up|1|||
130223273|NCT01949142|468780047|FG001|Overall Study|Lost to Follow-up|1|||
130223274|NCT01949142|468780046|FG000|Overall Study|Parent changed their mind|1|||
130223275|NCT01949142|468780047|FG001|Overall Study|Parent changed their mind|0|||
130223276|NCT01395810|468780048|FG000|Overall Study|Adverse Event|0|||
130098788|NCT03426995|468319296|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130223277|NCT01395810|468780049|FG001|Overall Study|Adverse Event|1|||
130223278|NCT01395810|468780050|FG002|Overall Study|Adverse Event|0|||
130223279|NCT01395810|468780051|FG003|Overall Study|Adverse Event|0|||
130223280|NCT01395810|468780048|FG000|Overall Study|Lack of Efficacy|0|||
130223281|NCT01395810|468780049|FG001|Overall Study|Lack of Efficacy|1|||
130223282|NCT01395810|468780050|FG002|Overall Study|Lack of Efficacy|0|||
130223283|NCT01395810|468780051|FG003|Overall Study|Lack of Efficacy|0|||
130223284|NCT01395810|468780048|FG000|Overall Study|Withdrawal criteria|0|||
130223285|NCT01395810|468780049|FG001|Overall Study|Withdrawal criteria|2|||
130223286|NCT01395810|468780050|FG002|Overall Study|Withdrawal criteria|0|||
130223287|NCT01395810|468780051|FG003|Overall Study|Withdrawal criteria|0|||
130223288|NCT01395810|468780048|FG000|Overall Study|Unclassified|2|||
130223289|NCT01395810|468780049|FG001|Overall Study|Unclassified|0|||
130223290|NCT01395810|468780050|FG002|Overall Study|Unclassified|0|||
130223291|NCT01395810|468780051|FG003|Overall Study|Unclassified|0|||
130223292|NCT05027815|468780054|FG000|Overall Study|Death|2|||
130223293|NCT05027815|468780055|FG001|Overall Study|Death|1|||
130223294|NCT03677869|468780059|FG000|Overall Study|Withdrawal by Subject|1|||
130223295|NCT04265261|468780061|FG000|Overall Study|Adverse Event|2|||
130223296|NCT04265261|468780062|FG001|Overall Study|Adverse Event|0|||
130223297|NCT04265261|468780063|FG002|Overall Study|Adverse Event|0|||
130223298|NCT04265261|468780061|FG000|Overall Study|Death|1|||
130223299|NCT04265261|468780062|FG001|Overall Study|Death|0|||
130223300|NCT04265261|468780063|FG002|Overall Study|Death|0|||
130223301|NCT04265261|468780061|FG000|Overall Study|Lost to Follow-up|4|||
130223302|NCT04265261|468780062|FG001|Overall Study|Lost to Follow-up|1|||
130223303|NCT04265261|468780063|FG002|Overall Study|Lost to Follow-up|3|||
130223304|NCT04265261|468780061|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130223305|NCT04265261|468780062|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130223306|NCT04265261|468780063|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130223307|NCT04265261|468780061|FG000|Overall Study|Physician Decision|0|||
130098789|NCT03426995|468319297|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130223308|NCT04265261|468780062|FG001|Overall Study|Physician Decision|0|||
130223309|NCT04265261|468780063|FG002|Overall Study|Physician Decision|1|||
130223310|NCT04265261|468780061|FG000|Overall Study|Protocol Deviation|0|||
130223311|NCT04265261|468780062|FG001|Overall Study|Protocol Deviation|2|||
130223312|NCT04265261|468780063|FG002|Overall Study|Protocol Deviation|0|||
130223313|NCT04265261|468780061|FG000|Overall Study|Withdrawal by Subject|2|||
130223314|NCT04265261|468780062|FG001|Overall Study|Withdrawal by Subject|1|||
130223315|NCT04265261|468780063|FG002|Overall Study|Withdrawal by Subject|4|||
130223316|NCT03877224|468780064|FG000|Overall Study|Death|3|||
130223317|NCT03877224|468780065|FG001|Overall Study|Death|2|||
130223318|NCT03877224|468780064|FG000|Overall Study|Withdrawal by Subject|1|||
129884471|NCT02038764|467536410|FG002|Overall Study|Lost to Follow-up|0|||
129884472|NCT02038764|467536411|FG003|Overall Study|Lost to Follow-up|0|||
129884473|NCT02038764|467536412|FG004|Overall Study|Lost to Follow-up|0|||
129884474|NCT02038764|467536408|FG000|Overall Study|Withdrawal by Subject|0|||
129884475|NCT02038764|467536409|FG001|Overall Study|Withdrawal by Subject|0|||
129884476|NCT02038764|467536410|FG002|Overall Study|Withdrawal by Subject|0|||
129884477|NCT02038764|467536411|FG003|Overall Study|Withdrawal by Subject|0|||
129884478|NCT02038764|467536412|FG004|Overall Study|Withdrawal by Subject|1|||
129884479|NCT02038764|467536408|FG000|Overall Study|Other|1|||
129884480|NCT02038764|467536409|FG001|Overall Study|Other|0|||
129884481|NCT02038764|467536410|FG002|Overall Study|Other|1|||
129884482|NCT02038764|467536411|FG003|Overall Study|Other|0|||
129884483|NCT02038764|467536412|FG004|Overall Study|Other|0|||
129884484|NCT04844918|467536415|FG000|Overall Study|Adverse Event|7|||
130018148|NCT01314716|468026524|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
130018149|NCT01314716|468026525|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130018150|NCT01314716|468026524|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130018151|NCT01314716|468026525|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130018152|NCT01314716|468026524|FG000|Double-Blind Phase|Sponsor request|1|||
130018153|NCT01314716|468026525|FG001|Double-Blind Phase|Sponsor request|2|||
130018154|NCT01314716|468026524|FG000|Double-Blind Phase|Physician Decision|0|||
130018155|NCT01314716|468026525|FG001|Double-Blind Phase|Physician Decision|1|||
130018156|NCT01314716|468026524|FG000|Open-Label Phase|Adverse Event|4|||
130018157|NCT01314716|468026525|FG001|Open-Label Phase|Adverse Event|6|||
130018158|NCT01314716|468026524|FG000|Open-Label Phase|Withdrawal by Subject|1|||
130018159|NCT01314716|468026525|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130018160|NCT01314716|468026524|FG000|Open-Label Phase|Physician Decision|5|||
130018161|NCT01314716|468026525|FG001|Open-Label Phase|Physician Decision|4|||
130018162|NCT04311502|468028011|FG000|Overall Study|Death|1|||
130018163|NCT04311502|468028012|FG001|Overall Study|Death|1|||
130018164|NCT04311502|468028013|FG002|Overall Study|Death|1|||
130018165|NCT04311502|468028011|FG000|Overall Study|Lost to Follow-up|2|||
130018166|NCT04311502|468028012|FG001|Overall Study|Lost to Follow-up|3|||
130018167|NCT04311502|468028013|FG002|Overall Study|Lost to Follow-up|0|||
130018168|NCT04311502|468028011|FG000|Overall Study|Participant is in prison|1|||
130018169|NCT04311502|468028012|FG001|Overall Study|Participant is in prison|0|||
130018170|NCT04311502|468028013|FG002|Overall Study|Participant is in prison|0|||
130018171|NCT04311502|468028011|FG000|Overall Study|Participant moved out of country|1|||
130018172|NCT04311502|468028012|FG001|Overall Study|Participant moved out of country|0|||
130018173|NCT04311502|468028013|FG002|Overall Study|Participant moved out of country|0|||
130018174|NCT04311502|468028011|FG000|Overall Study|Withdrawal by Subject|2|||
130018175|NCT04311502|468028012|FG001|Overall Study|Withdrawal by Subject|0|||
130018176|NCT04311502|468028013|FG002|Overall Study|Withdrawal by Subject|0|||
130018177|NCT04311502|468028011|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
130018178|NCT04311502|468028012|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
130018179|NCT04311502|468028013|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
130018180|NCT03040999|468028014|FG000|Overall Study|Lost to Follow-up|2|||
130018181|NCT03040999|468028015|FG001|Overall Study|Lost to Follow-up|2|||
130018182|NCT03040999|468028014|FG000|Overall Study|Withdrawal by Subject|12|||
130018183|NCT03040999|468028015|FG001|Overall Study|Withdrawal by Subject|13|||
130018184|NCT03040999|468028014|FG000|Overall Study|Death|155|||
130018185|NCT03040999|468028015|FG001|Overall Study|Death|171|||
130018186|NCT03040999|468028014|FG000|Overall Study|Physician Decision|0|||
130018187|NCT03040999|468028015|FG001|Overall Study|Physician Decision|3|||
130018188|NCT03657043|468028016|FG000|Overall Study|Withdrawal by Subject|1|||
130018189|NCT03657043|468028017|FG001|Overall Study|Withdrawal by Subject|1|||
130018190|NCT03657043|468028018|FG002|Overall Study|Withdrawal by Subject|0|||
130018191|NCT03657043|468028019|FG003|Overall Study|Withdrawal by Subject|0|||
130018192|NCT03657043|468028020|FG004|Overall Study|Withdrawal by Subject|4|||
130018193|NCT03657043|468028016|FG000|Overall Study|Study closure by Sponsor|0|||
130018194|NCT03657043|468028017|FG001|Overall Study|Study closure by Sponsor|2|||
130018195|NCT03657043|468028018|FG002|Overall Study|Study closure by Sponsor|0|||
130018196|NCT03657043|468028019|FG003|Overall Study|Study closure by Sponsor|0|||
130018197|NCT03657043|468028020|FG004|Overall Study|Study closure by Sponsor|17|||
130018198|NCT03657043|468028016|FG000|Overall Study|Lost to Follow-up|0|||
129884485|NCT04844918|467536416|FG001|Overall Study|Adverse Event|8|||
129884486|NCT04844918|467536417|FG002|Overall Study|Adverse Event|5|||
129884487|NCT04844918|467536415|FG000|Overall Study|Physician Decision|0|||
130018199|NCT03657043|468028017|FG001|Overall Study|Lost to Follow-up|0|||
130018200|NCT03657043|468028018|FG002|Overall Study|Lost to Follow-up|0|||
130018201|NCT03657043|468028019|FG003|Overall Study|Lost to Follow-up|0|||
130018202|NCT03657043|468028020|FG004|Overall Study|Lost to Follow-up|4|||
130018203|NCT03657043|468028016|FG000|Overall Study|Death|6|||
130018204|NCT03657043|468028017|FG001|Overall Study|Death|5|||
130018205|NCT03657043|468028018|FG002|Overall Study|Death|0|||
130018206|NCT03657043|468028019|FG003|Overall Study|Death|0|||
130018207|NCT03657043|468028020|FG004|Overall Study|Death|53|||
130018208|NCT03657043|468028016|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
130223319|NCT03877224|468780065|FG001|Overall Study|Withdrawal by Subject|6|||
130223320|NCT03877224|468780064|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
130223321|NCT03877224|468780065|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
130223322|NCT00447902|468780066|FG000|Overall Study|Adverse Event|0|||
130223323|NCT00447902|468780067|FG001|Overall Study|Adverse Event|3|||
130223324|NCT00447902|468780066|FG000|Overall Study|Protocol Violation|1|||
130223325|NCT00447902|468780067|FG001|Overall Study|Protocol Violation|0|||
130223326|NCT00447902|468780066|FG000|Overall Study|Withdrawal by Subject|0|||
130223327|NCT00447902|468780067|FG001|Overall Study|Withdrawal by Subject|1|||
130223328|NCT00447902|468780066|FG000|Overall Study|included patients who discontinued|1|||
130223329|NCT00447902|468780067|FG001|Overall Study|included patients who discontinued|1|||
130223330|NCT00447902|468780066|FG000|Overall Study|Lack of Efficacy|2|||
130223331|NCT00447902|468780067|FG001|Overall Study|Lack of Efficacy|1|||
130223332|NCT00379834|468781626|FG000|Overall Study|Time constraints|2|||
130223333|NCT01001429|468781627|FG000|Overall Study|surgery cancelled|0|||
130223334|NCT01001429|468781628|FG001|Overall Study|surgery cancelled|1|||
130223335|NCT00956839|468781629|FG000|Overall Study|Lost to Follow-up|3|||
130223336|NCT00956839|468781630|FG001|Overall Study|Lost to Follow-up|0|||
130223337|NCT00956839|468781631|FG002|Overall Study|Lost to Follow-up|3|||
130223338|NCT02163395|468781636|FG000|Overall Study|Withdrawal by Subject|1|||
130223339|NCT02163395|468781636|FG000|Overall Study|Lost to Follow-up|3|||
130223340|NCT02163395|468781636|FG000|Overall Study|Adverse Event|1|||
130223341|NCT00521365|468781640|FG000|Overall Study|Adverse Event|3|||
130223342|NCT00521365|468781640|FG000|Overall Study|Lost to Follow-up|6|||
130223343|NCT00521365|468781640|FG000|Overall Study|Protocol deviation|2|||
130223344|NCT00521365|468781640|FG000|Overall Study|Drug compliance|3|||
130223345|NCT00521365|468781640|FG000|Overall Study|Usage of not allowed drugs|6|||
130223346|NCT03627832|468781641|FG000|Overall Study|Withdrawal by Subject|10|||
130223347|NCT03627832|468781642|FG001|Overall Study|Withdrawal by Subject|1|||
130223348|NCT03150082|468781643|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
130223349|NCT03150082|468781644|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
130223350|NCT01718483|468781645|FG000|Overall Study|Withdrawal by Subject|14|||
130223351|NCT01718483|468781646|FG001|Overall Study|Withdrawal by Subject|12|||
130223352|NCT01718483|468781645|FG000|Overall Study|Adverse Event|5|||
130223353|NCT01718483|468781646|FG001|Overall Study|Adverse Event|12|||
130223354|NCT01718483|468781645|FG000|Overall Study|Lost to Follow-up|8|||
130223355|NCT01718483|468781646|FG001|Overall Study|Lost to Follow-up|3|||
130223356|NCT01718483|468781645|FG000|Overall Study|Protocol Violation|4|||
130223357|NCT01718483|468781646|FG001|Overall Study|Protocol Violation|2|||
130223358|NCT01718483|468781645|FG000|Overall Study|Other|1|||
130223359|NCT01718483|468781646|FG001|Overall Study|Other|4|||
130223360|NCT01718483|468781645|FG000|Overall Study|Pregnancy|1|||
130223361|NCT01718483|468781646|FG001|Overall Study|Pregnancy|1|||
130223362|NCT01718483|468781645|FG000|Overall Study|Lack of Efficacy|1|||
130223363|NCT01718483|468781646|FG001|Overall Study|Lack of Efficacy|0|||
130223364|NCT01831427|468781650|FG000|Overall Study|Adverse Event|0|||
130223365|NCT01831427|468781651|FG001|Overall Study|Adverse Event|1|||
130223366|NCT01831427|468781652|FG002|Overall Study|Adverse Event|0|||
130223367|NCT01831427|468781653|FG003|Overall Study|Adverse Event|0|||
130223368|NCT01831427|468781654|FG004|Overall Study|Adverse Event|0|||
130223369|NCT01831427|468781655|FG005|Overall Study|Adverse Event|1|||
130223370|NCT01831427|468781656|FG006|Overall Study|Adverse Event|0|||
130223371|NCT01831427|468781657|FG007|Overall Study|Adverse Event|1|||
130223372|NCT01831427|468781658|FG008|Overall Study|Adverse Event|0|||
130223373|NCT01831427|468781659|FG009|Overall Study|Adverse Event|0|||
130223374|NCT01831427|468781660|FG010|Overall Study|Adverse Event|2|||
130223375|NCT01831427|468781650|FG000|Overall Study|Investigator's Discretion|0|||
130223376|NCT01831427|468781651|FG001|Overall Study|Investigator's Discretion|0|||
130223377|NCT01831427|468781652|FG002|Overall Study|Investigator's Discretion|0|||
130223378|NCT01831427|468781653|FG003|Overall Study|Investigator's Discretion|1|||
130223379|NCT01831427|468781654|FG004|Overall Study|Investigator's Discretion|0|||
130223380|NCT01831427|468781655|FG005|Overall Study|Investigator's Discretion|0|||
130223381|NCT01831427|468781656|FG006|Overall Study|Investigator's Discretion|0|||
130223382|NCT01831427|468781657|FG007|Overall Study|Investigator's Discretion|0|||
130223383|NCT01831427|468781658|FG008|Overall Study|Investigator's Discretion|0|||
130223384|NCT01831427|468781659|FG009|Overall Study|Investigator's Discretion|0|||
130223385|NCT01831427|468781660|FG010|Overall Study|Investigator's Discretion|0|||
130223386|NCT01831427|468781650|FG000|Overall Study|Withdrew Consent|0|||
130223387|NCT01831427|468781651|FG001|Overall Study|Withdrew Consent|0|||
130018209|NCT03657043|468028017|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
130018210|NCT03657043|468028018|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
130018211|NCT03657043|468028019|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
130018212|NCT03657043|468028020|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
130018213|NCT03657043|468028016|FG000|Overall Study|Adverse Event|0|||
130018214|NCT03657043|468028017|FG001|Overall Study|Adverse Event|0|||
130223388|NCT01831427|468781652|FG002|Overall Study|Withdrew Consent|0|||
130223389|NCT01831427|468781653|FG003|Overall Study|Withdrew Consent|0|||
130223390|NCT01831427|468781654|FG004|Overall Study|Withdrew Consent|0|||
130223391|NCT01831427|468781655|FG005|Overall Study|Withdrew Consent|0|||
130223392|NCT01831427|468781656|FG006|Overall Study|Withdrew Consent|2|||
130223393|NCT01831427|468781657|FG007|Overall Study|Withdrew Consent|0|||
130223394|NCT01831427|468781658|FG008|Overall Study|Withdrew Consent|0|||
130223395|NCT01831427|468781659|FG009|Overall Study|Withdrew Consent|1|||
130223396|NCT01831427|468781660|FG010|Overall Study|Withdrew Consent|1|||
130223397|NCT00536510|468781661|FG000|Overall Study|Adverse Event|27|||
130223398|NCT00536510|468781662|FG001|Overall Study|Adverse Event|4|||
130223399|NCT00536510|468781661|FG000|Overall Study|Lost to Follow-up|11|||
130223400|NCT00536510|468781662|FG001|Overall Study|Lost to Follow-up|8|||
130223401|NCT00536510|468781661|FG000|Overall Study|Protocol Violation|4|||
130223402|NCT00536510|468781662|FG001|Overall Study|Protocol Violation|5|||
130223403|NCT00536510|468781661|FG000|Overall Study|Withdrawal by Subject|16|||
130223404|NCT00536510|468781662|FG001|Overall Study|Withdrawal by Subject|9|||
130223405|NCT00536510|468781661|FG000|Overall Study|Flushing with Product|20|||
130223406|NCT00536510|468781662|FG001|Overall Study|Flushing with Product|0|||
130223407|NCT00536510|468781661|FG000|Overall Study|Laboratory Adverse Event|2|||
130223408|NCT00536510|468781662|FG001|Overall Study|Laboratory Adverse Event|1|||
130223409|NCT00536510|468781661|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
130223410|NCT00536510|468781662|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
130223411|NCT02169505|468781663|FG000|Overall Study|Withdrawal by Subject|1|||
130223412|NCT00048035|468781664|FG000|Core Period|Early Withdrawals|4|||
130018215|NCT03657043|468028018|FG002|Overall Study|Adverse Event|0|||
130223413|NCT00048035|468781665|FG001|Core Period|Early Withdrawals|2|||
130223414|NCT00048035|468781666|FG002|Core Period|Early Withdrawals|1|||
130223415|NCT00048035|468781667|FG003|Core Period|Early Withdrawals|1|||
129800202|NCT00764504|467236235|FG002|Overall Study|Withdrawal by Subject|4|||
129800203|NCT00764504|467236233|FG000|Overall Study|Lost to Follow-up|40|||
129800204|NCT00764504|467236234|FG001|Overall Study|Lost to Follow-up|34|||
129800205|NCT00764504|467236235|FG002|Overall Study|Lost to Follow-up|72|||
129800206|NCT01638819|467236246|FG000|Overall Study|Lost to Follow-up|1|||
129800207|NCT01638819|467236247|FG001|Overall Study|Lost to Follow-up|0|||
129800208|NCT03538431|467236248|FG000|Overall Study|Physician Decision|0|||
129800209|NCT03538431|467236249|FG001|Overall Study|Physician Decision|1|||
129800210|NCT03538431|467236248|FG000|Overall Study|Withdrawal by Subject|1|||
129800211|NCT03538431|467236249|FG001|Overall Study|Withdrawal by Subject|0|||
129800212|NCT03911154|467236250|FG000|Overall Study|Withdrawal by Subject|1|||
129800213|NCT01278160|467236254|FG000|Overall Study|Adverse Event|1|||
129800214|NCT01278160|467236255|FG001|Overall Study|Adverse Event|1|||
129800215|NCT01278160|467236254|FG000|Overall Study|Lost to Follow-up|0|||
129800216|NCT01278160|467236255|FG001|Overall Study|Lost to Follow-up|1|||
129800217|NCT01278160|467236254|FG000|Overall Study|Withdrawal by Subject|3|||
129800218|NCT01278160|467236255|FG001|Overall Study|Withdrawal by Subject|2|||
129800219|NCT01278160|467236254|FG000|Overall Study|Unclassified|1|||
129800220|NCT01278160|467236255|FG001|Overall Study|Unclassified|2|||
129800221|NCT02898116|467236259|FG000|Overall Study|Adverse Event|1|||
129800222|NCT02898116|467236259|FG000|Overall Study|Progressive disease|1|||
129800223|NCT02891161|467236266|FG000|Study Treatment|Disease Progression|2|||
129800224|NCT02891161|467236267|FG001|Study Treatment|Disease Progression|4|||
129800225|NCT02891161|467236266|FG000|Study Treatment|AE/Side Effects/Complications|1|||
129800226|NCT02891161|467236267|FG001|Study Treatment|AE/Side Effects/Complications|5|||
129800227|NCT02891161|467236266|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
129800228|NCT02891161|467236267|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
130223416|NCT00048035|468781668|FG004|Core Period|Early Withdrawals|1|||
130223417|NCT00048035|468781669|FG005|Core Period|Early Withdrawals|1|||
130223418|NCT00048035|468781670|FG006|Core Period|Early Withdrawals|0|||
130223419|NCT00048035|468781671|FG007|Core Period|Early Withdrawals|0|||
130018216|NCT03657043|468028019|FG003|Overall Study|Adverse Event|0|||
130018217|NCT03657043|468028020|FG004|Overall Study|Adverse Event|2|||
130018218|NCT03657043|468028016|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
130018219|NCT03657043|468028017|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
130018220|NCT03657043|468028018|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
130018221|NCT03657043|468028019|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
130018222|NCT03657043|468028020|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
130018223|NCT03657043|468028016|FG000|Overall Study|Withdrawal - declined follow-up|0|||
130223420|NCT00048035|468781664|FG000|Extension Year 1|Early Withdrawals|0|||
130223421|NCT00048035|468781665|FG001|Extension Year 1|Early Withdrawals|0|||
130223422|NCT00048035|468781666|FG002|Extension Year 1|Early Withdrawals|0|||
130223423|NCT00048035|468781667|FG003|Extension Year 1|Early Withdrawals|0|||
130223424|NCT00048035|468781668|FG004|Extension Year 1|Early Withdrawals|0|||
130223425|NCT00048035|468781669|FG005|Extension Year 1|Early Withdrawals|0|||
130223426|NCT00048035|468781670|FG006|Extension Year 1|Early Withdrawals|11|||
130223427|NCT00048035|468781671|FG007|Extension Year 1|Early Withdrawals|11|||
130223428|NCT00048035|468781664|FG000|Extension Year 2|Early Withdrawals|0|||
130223429|NCT00048035|468781665|FG001|Extension Year 2|Early Withdrawals|0|||
130223430|NCT00048035|468781666|FG002|Extension Year 2|Early Withdrawals|0|||
130223431|NCT00048035|468781667|FG003|Extension Year 2|Early Withdrawals|0|||
130223432|NCT00048035|468781668|FG004|Extension Year 2|Early Withdrawals|0|||
130223433|NCT00048035|468781669|FG005|Extension Year 2|Early Withdrawals|0|||
130223434|NCT00048035|468781670|FG006|Extension Year 2|Early Withdrawals|3|||
130223435|NCT00048035|468781671|FG007|Extension Year 2|Early Withdrawals|3|||
130223436|NCT05137717|468781672|FG000|Overall Study|Death|2|||
130223437|NCT05137717|468781672|FG000|Overall Study|Withdrawal by Subject|6|||
130223438|NCT02035553|468781673|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
130223439|NCT02035553|468781674|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
130223440|NCT02035553|468781673|FG000|Overall Study|Adverse Event|10|||
130223441|NCT02035553|468781674|FG001|Overall Study|Adverse Event|6|||
130223442|NCT02035553|468781673|FG000|Overall Study|Physician Decision|3|||
130223443|NCT02035553|468781674|FG001|Overall Study|Physician Decision|2|||
130223444|NCT02035553|468781673|FG000|Overall Study|Lack of Efficacy|1|||
130223445|NCT02035553|468781674|FG001|Overall Study|Lack of Efficacy|1|||
130223446|NCT02035553|468781673|FG000|Overall Study|Withdrawal by Subject|4|||
130223447|NCT02035553|468781674|FG001|Overall Study|Withdrawal by Subject|7|||
130223448|NCT02035553|468781673|FG000|Overall Study|Non-compliance with Study Drug|0|||
130223449|NCT02035553|468781674|FG001|Overall Study|Non-compliance with Study Drug|1|||
130223450|NCT02035553|468781673|FG000|Overall Study|Lost to Follow-up|0|||
130223451|NCT02035553|468781674|FG001|Overall Study|Lost to Follow-up|1|||
130223452|NCT02035553|468781673|FG000|Overall Study|Other Reason|0|||
130223453|NCT02035553|468781674|FG001|Overall Study|Other Reason|4|||
130223454|NCT02735980|468781676|FG000|Overall Study|Adverse Event|0|||
130223455|NCT02735980|468781677|FG001|Overall Study|Adverse Event|4|||
130223456|NCT02735980|468781678|FG002|Overall Study|Adverse Event|1|||
130223457|NCT02735980|468781676|FG000|Overall Study|Death|5|||
130223458|NCT02735980|468781677|FG001|Overall Study|Death|4|||
130223459|NCT02735980|468781678|FG002|Overall Study|Death|0|||
130223460|NCT02735980|468781676|FG000|Overall Study|Physician Decision|3|||
130223461|NCT02735980|468781677|FG001|Overall Study|Physician Decision|1|||
130223462|NCT02735980|468781678|FG002|Overall Study|Physician Decision|0|||
130223463|NCT02735980|468781676|FG000|Overall Study|Screen failure|1|||
130223464|NCT02735980|468781677|FG001|Overall Study|Screen failure|0|||
130223465|NCT02735980|468781678|FG002|Overall Study|Screen failure|0|||
130223466|NCT02735980|468781676|FG000|Overall Study|Withdrawal by Subject|1|||
130223467|NCT02735980|468781677|FG001|Overall Study|Withdrawal by Subject|2|||
130223468|NCT02735980|468781678|FG002|Overall Study|Withdrawal by Subject|0|||
130223469|NCT00509899|468781679|FG000|Overall Study|Progressive disease|1|||
130223470|NCT00509899|468781680|FG001|Overall Study|Progressive disease|3|||
130223471|NCT00509899|468781681|FG002|Overall Study|Progressive disease|5|||
130223472|NCT00509899|468781682|FG003|Overall Study|Progressive disease|1|||
130223473|NCT00509899|468781683|FG004|Overall Study|Progressive disease|0|||
130223474|NCT00509899|468781684|FG005|Overall Study|Progressive disease|1|||
130223475|NCT00509899|468781685|FG006|Overall Study|Progressive disease|0|||
130223476|NCT00509899|468781686|FG007|Overall Study|Progressive disease|0|||
130223477|NCT00509899|468781679|FG000|Overall Study|Unacceptable Toxicity|1|||
130223478|NCT00509899|468781680|FG001|Overall Study|Unacceptable Toxicity|0|||
130223479|NCT00509899|468781681|FG002|Overall Study|Unacceptable Toxicity|0|||
130223480|NCT00509899|468781682|FG003|Overall Study|Unacceptable Toxicity|2|||
130223481|NCT00509899|468781683|FG004|Overall Study|Unacceptable Toxicity|0|||
130223482|NCT00509899|468781684|FG005|Overall Study|Unacceptable Toxicity|0|||
130223483|NCT00509899|468781685|FG006|Overall Study|Unacceptable Toxicity|0|||
130018224|NCT03657043|468028017|FG001|Overall Study|Withdrawal - declined follow-up|0|||
130018225|NCT03657043|468028018|FG002|Overall Study|Withdrawal - declined follow-up|0|||
130018226|NCT03657043|468028019|FG003|Overall Study|Withdrawal - declined follow-up|0|||
130018227|NCT03657043|468028020|FG004|Overall Study|Withdrawal - declined follow-up|1|||
130018228|NCT02627495|468028023|FG000|Overall Study|Withdrawal by Subject|4|||
130018229|NCT01736579|468028024|FG000|Overall Study|Termination of Study by Sponsor|2|||
130018230|NCT01736579|468028025|FG001|Overall Study|Termination of Study by Sponsor|2|||
130018231|NCT02543528|468028033|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130018232|NCT02543528|468028034|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130018233|NCT02543528|468028035|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130018234|NCT02543528|468028036|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
130018235|NCT02543528|468028037|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
130018236|NCT02543528|468028033|FG000|Adaptation Period|Lens Handling Difficultes|0|||
130223484|NCT00509899|468781686|FG007|Overall Study|Unacceptable Toxicity|0|||
130223485|NCT00509899|468781679|FG000|Overall Study|Withdrawal by Subject|6|||
130223486|NCT00509899|468781680|FG001|Overall Study|Withdrawal by Subject|2|||
130223487|NCT00509899|468781681|FG002|Overall Study|Withdrawal by Subject|3|||
130223488|NCT00509899|468781682|FG003|Overall Study|Withdrawal by Subject|0|||
130223489|NCT00509899|468781683|FG004|Overall Study|Withdrawal by Subject|3|||
130223490|NCT00509899|468781684|FG005|Overall Study|Withdrawal by Subject|2|||
130223491|NCT00509899|468781685|FG006|Overall Study|Withdrawal by Subject|0|||
130223492|NCT00509899|468781686|FG007|Overall Study|Withdrawal by Subject|0|||
130223493|NCT00509899|468781679|FG000|Overall Study|Physician Decision|4|||
130223494|NCT00509899|468781680|FG001|Overall Study|Physician Decision|2|||
130223495|NCT00509899|468781681|FG002|Overall Study|Physician Decision|7|||
130223496|NCT00509899|468781682|FG003|Overall Study|Physician Decision|0|||
130223497|NCT00509899|468781683|FG004|Overall Study|Physician Decision|1|||
130223498|NCT00509899|468781684|FG005|Overall Study|Physician Decision|4|||
130223499|NCT00509899|468781685|FG006|Overall Study|Physician Decision|0|||
130223500|NCT00509899|468781686|FG007|Overall Study|Physician Decision|0|||
130223501|NCT00509899|468781679|FG000|Overall Study|Intercurrent Illness|1|||
130223502|NCT00509899|468781680|FG001|Overall Study|Intercurrent Illness|0|||
130223503|NCT00509899|468781681|FG002|Overall Study|Intercurrent Illness|0|||
130223504|NCT00509899|468781682|FG003|Overall Study|Intercurrent Illness|1|||
130223505|NCT00509899|468781683|FG004|Overall Study|Intercurrent Illness|0|||
130223506|NCT00509899|468781684|FG005|Overall Study|Intercurrent Illness|1|||
130223507|NCT00509899|468781685|FG006|Overall Study|Intercurrent Illness|0|||
130223508|NCT00509899|468781686|FG007|Overall Study|Intercurrent Illness|0|||
130223509|NCT00509899|468781679|FG000|Overall Study|Death|2|||
130223510|NCT00509899|468781680|FG001|Overall Study|Death|2|||
130223511|NCT00509899|468781681|FG002|Overall Study|Death|3|||
130223512|NCT00509899|468781682|FG003|Overall Study|Death|0|||
130223513|NCT00509899|468781683|FG004|Overall Study|Death|1|||
130223514|NCT00509899|468781684|FG005|Overall Study|Death|1|||
130223515|NCT00509899|468781685|FG006|Overall Study|Death|1|||
130223516|NCT00509899|468781686|FG007|Overall Study|Death|1|||
130223517|NCT00509899|468781679|FG000|Overall Study|Lack of Efficacy|1|||
130223518|NCT00509899|468781680|FG001|Overall Study|Lack of Efficacy|0|||
130223519|NCT00509899|468781681|FG002|Overall Study|Lack of Efficacy|2|||
130223520|NCT00509899|468781682|FG003|Overall Study|Lack of Efficacy|0|||
130223521|NCT00509899|468781683|FG004|Overall Study|Lack of Efficacy|0|||
130223522|NCT00509899|468781684|FG005|Overall Study|Lack of Efficacy|1|||
130223523|NCT00509899|468781685|FG006|Overall Study|Lack of Efficacy|0|||
130223524|NCT00509899|468781686|FG007|Overall Study|Lack of Efficacy|0|||
130223525|NCT03713684|468781687|FG000|Overall Study|Adverse Event|1|||
130223526|NCT03713684|468781688|FG001|Overall Study|Adverse Event|3|||
130223527|NCT03713684|468781689|FG002|Overall Study|Adverse Event|1|||
130223528|NCT03713684|468781690|FG003|Overall Study|Adverse Event|0|||
130223529|NCT03713684|468781687|FG000|Overall Study|Poor compliance to protocol|2|||
130223530|NCT03713684|468781688|FG001|Overall Study|Poor compliance to protocol|1|||
130223531|NCT03713684|468781689|FG002|Overall Study|Poor compliance to protocol|0|||
130223532|NCT03713684|468781690|FG003|Overall Study|Poor compliance to protocol|1|||
130223533|NCT03713684|468781687|FG000|Overall Study|Withdrawal by Subject|14|||
130223534|NCT03713684|468781688|FG001|Overall Study|Withdrawal by Subject|6|||
130223535|NCT03713684|468781689|FG002|Overall Study|Withdrawal by Subject|14|||
130223536|NCT03713684|468781690|FG003|Overall Study|Withdrawal by Subject|16|||
130223537|NCT03713684|468781687|FG000|Overall Study|Other than specified|69|||
130223538|NCT03713684|468781688|FG001|Overall Study|Other than specified|77|||
130223539|NCT03713684|468781689|FG002|Overall Study|Other than specified|73|||
130223540|NCT03713684|468781690|FG003|Overall Study|Other than specified|70|||
130223541|NCT02185417|468781691|FG000|Overall Study|Death|448|||
130223542|NCT02185417|468781692|FG001|Overall Study|Death|446|||
130223543|NCT02185417|468781693|FG002|Overall Study|Death|0|||
130223544|NCT02185417|468781691|FG000|Overall Study|Withdrawal by Subject|7|||
130223545|NCT02185417|468781692|FG001|Overall Study|Withdrawal by Subject|12|||
130223546|NCT02185417|468781693|FG002|Overall Study|Withdrawal by Subject|0|||
130223547|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
130223548|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
130223549|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Death|561|||
130223550|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Death|298|||
130223551|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
130223552|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
130223553|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
130223554|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
130223555|NCT00974311|468781694|FG000|DB Phase (up to 24 Months)|Other|1|||
130018237|NCT02543528|468028034|FG001|Adaptation Period|Lens Handling Difficultes|0|||
130018238|NCT02543528|468028035|FG002|Adaptation Period|Lens Handling Difficultes|0|||
130018239|NCT02543528|468028036|FG003|Adaptation Period|Lens Handling Difficultes|0|||
130018240|NCT02543528|468028037|FG004|Adaptation Period|Lens Handling Difficultes|8|||
130018241|NCT02543528|468028033|FG000|Adaptation Period|Lost to Follow-up|0|||
130018242|NCT02543528|468028034|FG001|Adaptation Period|Lost to Follow-up|0|||
130018243|NCT02543528|468028035|FG002|Adaptation Period|Lost to Follow-up|0|||
130018244|NCT02543528|468028036|FG003|Adaptation Period|Lost to Follow-up|0|||
130018245|NCT02543528|468028037|FG004|Adaptation Period|Lost to Follow-up|14|||
130018246|NCT02543528|468028033|FG000|Adaptation Period|Adverse Event|0|||
130018247|NCT02543528|468028034|FG001|Adaptation Period|Adverse Event|0|||
130018248|NCT02543528|468028035|FG002|Adaptation Period|Adverse Event|0|||
130018249|NCT02543528|468028036|FG003|Adaptation Period|Adverse Event|0|||
130018250|NCT02543528|468028037|FG004|Adaptation Period|Adverse Event|2|||
130018251|NCT02543528|468028033|FG000|Extended Wear Period|Adverse Event|17|||
130018252|NCT02543528|468028034|FG001|Extended Wear Period|Adverse Event|11|||
130018253|NCT02543528|468028035|FG002|Extended Wear Period|Adverse Event|16|||
130018254|NCT02543528|468028036|FG003|Extended Wear Period|Adverse Event|3|||
130018255|NCT02543528|468028037|FG004|Extended Wear Period|Adverse Event|0|||
130018256|NCT02543528|468028033|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
130018257|NCT02543528|468028034|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
130018258|NCT02543528|468028035|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
130018259|NCT02543528|468028036|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
130018260|NCT02543528|468028037|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
130018261|NCT02543528|468028033|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
130018262|NCT02543528|468028034|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130018263|NCT02543528|468028035|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130018264|NCT02543528|468028036|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130018265|NCT02543528|468028037|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
130018266|NCT02543528|468028033|FG000|Extended Wear Period|Lost to Follow-up|0|||
130018267|NCT02543528|468028034|FG001|Extended Wear Period|Lost to Follow-up|1|||
130018268|NCT02543528|468028035|FG002|Extended Wear Period|Lost to Follow-up|2|||
130018269|NCT02543528|468028036|FG003|Extended Wear Period|Lost to Follow-up|1|||
130018270|NCT02543528|468028037|FG004|Extended Wear Period|Lost to Follow-up|0|||
130018271|NCT02543528|468028033|FG000|Extended Wear Period|Withdrawal by Subject|10|||
130018272|NCT02543528|468028034|FG001|Extended Wear Period|Withdrawal by Subject|9|||
130018273|NCT02543528|468028035|FG002|Extended Wear Period|Withdrawal by Subject|4|||
130018274|NCT02543528|468028036|FG003|Extended Wear Period|Withdrawal by Subject|5|||
130018275|NCT02543528|468028037|FG004|Extended Wear Period|Withdrawal by Subject|0|||
130018276|NCT02049944|468028038|FG000|Overall Study|Protocol Violation|2|||
130018277|NCT01408147|468028039|FG000|Overall Study|Withdrawal by Subject|0|||
130018278|NCT01408147|468028040|FG001|Overall Study|Withdrawal by Subject|1|||
130018279|NCT01765673|468028041|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
130018280|NCT01042600|468028042|FG000|Overall Study|Ineligible|1|||
130018281|NCT01042600|468028043|FG001|Overall Study|Ineligible|0|||
130018282|NCT04541004|468028044|FG000|Overall Study|Adverse Event|2|||
130018283|NCT05048719|468028045|FG000|Overall Study|Withdrawal by Subject|2|||
130018284|NCT05048719|468028046|FG001|Overall Study|Withdrawal by Subject|1|||
130018285|NCT05048719|468028047|FG002|Overall Study|Withdrawal by Subject|3|||
130018286|NCT05048719|468028048|FG003|Overall Study|Withdrawal by Subject|1|||
130018287|NCT05048719|468028049|FG004|Overall Study|Withdrawal by Subject|0|||
130018288|NCT05048719|468028050|FG005|Overall Study|Withdrawal by Subject|2|||
130018289|NCT05048719|468028051|FG006|Overall Study|Withdrawal by Subject|1|||
130018290|NCT05048719|468028052|FG007|Overall Study|Withdrawal by Subject|1|||
130018291|NCT05048719|468028053|FG008|Overall Study|Withdrawal by Subject|0|||
130223556|NCT00974311|468781695|FG001|DB Phase (up to 24 Months)|Other|0|||
130223557|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Death|14|||
130223558|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Death|21|||
130223559|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
130223560|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
130223561|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Other|15|||
130223562|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Other|2|||
130223563|NCT00974311|468781694|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
130223564|NCT00974311|468781695|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
130223565|NCT02595502|468781696|FG000|Period 1|Adverse Event|0|||
130223566|NCT02595502|468781697|FG001|Period 1|Adverse Event|1|||
130223567|NCT02595502|468781696|FG000|Period 1|Withdrawal by Subject|1|||
130223568|NCT02595502|468781697|FG001|Period 1|Withdrawal by Subject|0|||
130223569|NCT02595502|468781696|FG000|Period 1|Lost to Follow-up|0|||
130223570|NCT02595502|468781697|FG001|Period 1|Lost to Follow-up|1|||
130223571|NCT02595502|468781696|FG000|Period 2|Adverse Event|1|||
130223572|NCT02595502|468781697|FG001|Period 2|Adverse Event|1|||
130223573|NCT02595502|468781696|FG000|Period 2|Received incorrect lens at Period 1|0|||
130223574|NCT02595502|468781697|FG001|Period 2|Received incorrect lens at Period 1|1|||
130223575|NCT02595502|468781696|FG000|Period 3|Protocol Violation|0|||
130223576|NCT02595502|468781697|FG001|Period 3|Protocol Violation|1|||
130223577|NCT02595502|468781696|FG000|Period 3|Lost to Follow-up|1|||
130223578|NCT02595502|468781697|FG001|Period 3|Lost to Follow-up|0|||
130223579|NCT02595502|468781696|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
130223580|NCT02595502|468781697|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
130223581|NCT05556148|468781698|FG000|Overall Study|Early Termination|29|||
130223582|NCT05556148|468781698|FG000|Overall Study|Baseline Tasks Expired|4|||
130223583|NCT05556148|468781698|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
130223584|NCT05556148|468781698|FG000|Overall Study|No Longer Wished to Participate|1|||
130223585|NCT05556148|468781698|FG000|Overall Study|Bacterial Conjunctivitis|1|||
130223586|NCT00458003|468781699|FG000|Overall Study|Non protocol spinal anesthesia|1|||
130223587|NCT00458003|468781700|FG001|Overall Study|Non protocol spinal anesthesia|1|||
130223588|NCT00809445|468781701|FG000|1 Month Follow-up|Lost contact|1|||
130223589|NCT00809445|468781702|FG001|1 Month Follow-up|Lost contact|2|||
130223590|NCT00809445|468781703|FG002|1 Month Follow-up|Lost contact|1|||
130223591|NCT00809445|468781701|FG000|1 Month Follow-up|Withdrew consent|1|||
130223592|NCT00809445|468781702|FG001|1 Month Follow-up|Withdrew consent|1|||
130223593|NCT00809445|468781703|FG002|1 Month Follow-up|Withdrew consent|1|||
130223594|NCT00809445|468781701|FG000|1 Month Follow-up|Death|0|||
130223595|NCT00809445|468781702|FG001|1 Month Follow-up|Death|1|||
130223596|NCT00809445|468781703|FG002|1 Month Follow-up|Death|1|||
130223597|NCT00809445|468781701|FG000|1 Month Follow-up|Incarcerated|0|||
130223598|NCT00809445|468781702|FG001|1 Month Follow-up|Incarcerated|0|||
130223599|NCT00809445|468781703|FG002|1 Month Follow-up|Incarcerated|1|||
130223600|NCT00809445|468781701|FG000|6 Month Follow-up|Lost contact|16|||
130223601|NCT00809445|468781702|FG001|6 Month Follow-up|Lost contact|14|||
130223602|NCT00809445|468781703|FG002|6 Month Follow-up|Lost contact|14|||
130223603|NCT00809445|468781701|FG000|6 Month Follow-up|Death|2|||
130223604|NCT00809445|468781702|FG001|6 Month Follow-up|Death|1|||
130223605|NCT00809445|468781703|FG002|6 Month Follow-up|Death|1|||
130223606|NCT00809445|468781701|FG000|6 Month Follow-up|Incarcerated|6|||
130223607|NCT00809445|468781702|FG001|6 Month Follow-up|Incarcerated|8|||
130223608|NCT00809445|468781703|FG002|6 Month Follow-up|Incarcerated|8|||
130223609|NCT00809445|468781701|FG000|6 Month Follow-up|Withdrew consent|0|||
130223610|NCT00809445|468781702|FG001|6 Month Follow-up|Withdrew consent|0|||
130223611|NCT00809445|468781703|FG002|6 Month Follow-up|Withdrew consent|1|||
130223612|NCT02048722|468781704|FG000|2 Cycles of Treatment|Adverse Event|2|||
130223613|NCT02048722|468781704|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
130223614|NCT02048722|468781704|FG000|2 Cycles of Treatment|Progressive Disease|2|||
130223615|NCT02048722|468781704|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
130223616|NCT02048722|468781704|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
130223617|NCT02048722|468781704|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
130223618|NCT04144322|468781705|FG000|Overall Study|Lack of Efficacy|2|||
130223619|NCT04144322|468781706|FG001|Overall Study|Lack of Efficacy|2|||
130223620|NCT01272908|468781710|FG000|Initial Treatment Period|Adverse Event|1|||
130223621|NCT01272908|468781710|FG000|Initial Treatment Period|Lack of Efficacy|5|||
130223622|NCT01272908|468781710|FG000|Initial Treatment Period|Protocol Violation|1|||
130223623|NCT01272908|468781710|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
130223624|NCT01272908|468781710|FG000|Re-Treatment Period|Adverse Event|2|||
130223625|NCT01272908|468781710|FG000|Re-Treatment Period|Lack of Efficacy|3|||
130223626|NCT01272908|468781710|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
130223627|NCT02131064|468781711|FG000|Overall Study|Death|5|||
130223628|NCT02131064|468781712|FG001|Overall Study|Death|6|||
130223629|NCT02131064|468781711|FG000|Overall Study|Lost to Follow-up|4|||
130223630|NCT02131064|468781712|FG001|Overall Study|Lost to Follow-up|8|||
130223631|NCT02131064|468781711|FG000|Overall Study|Withdrawal by Subject|14|||
130223632|NCT02131064|468781712|FG001|Overall Study|Withdrawal by Subject|18|||
130223633|NCT02131064|468781711|FG000|Overall Study|Other|2|||
130223634|NCT02131064|468781712|FG001|Overall Study|Other|2|||
130223635|NCT03489343|468781715|FG000|Overall Study|Documented progressive disease|1|||
130223636|NCT03489343|468781716|FG001|Overall Study|Documented progressive disease|0|||
130223637|NCT03489343|468781717|FG002|Overall Study|Documented progressive disease|3|||
130223638|NCT03489343|468781718|FG003|Overall Study|Documented progressive disease|1|||
130223639|NCT03489343|468781719|FG004|Overall Study|Documented progressive disease|3|||
130223640|NCT03489343|468781720|FG005|Overall Study|Documented progressive disease|5|||
130223641|NCT03489343|468781721|FG006|Overall Study|Documented progressive disease|4|||
130223642|NCT03489343|468781715|FG000|Overall Study|Adverse Event|0|||
130223643|NCT03489343|468781716|FG001|Overall Study|Adverse Event|1|||
130223644|NCT03489343|468781717|FG002|Overall Study|Adverse Event|0|||
130223645|NCT03489343|468781718|FG003|Overall Study|Adverse Event|0|||
130223646|NCT03489343|468781719|FG004|Overall Study|Adverse Event|0|||
130223647|NCT03489343|468781720|FG005|Overall Study|Adverse Event|1|||
130223648|NCT03489343|468781721|FG006|Overall Study|Adverse Event|0|||
130223649|NCT03489343|468781715|FG000|Overall Study|Withdrawal by Subject|0|||
130223650|NCT03489343|468781716|FG001|Overall Study|Withdrawal by Subject|0|||
130223651|NCT03489343|468781717|FG002|Overall Study|Withdrawal by Subject|0|||
130223652|NCT03489343|468781718|FG003|Overall Study|Withdrawal by Subject|1|||
130223653|NCT03489343|468781719|FG004|Overall Study|Withdrawal by Subject|0|||
130223654|NCT03489343|468781720|FG005|Overall Study|Withdrawal by Subject|1|||
130223655|NCT03489343|468781721|FG006|Overall Study|Withdrawal by Subject|1|||
130223656|NCT03489343|468781715|FG000|Overall Study|Clinical progression|0|||
130223657|NCT03489343|468781716|FG001|Overall Study|Clinical progression|0|||
130223658|NCT03489343|468781717|FG002|Overall Study|Clinical progression|0|||
130223659|NCT03489343|468781718|FG003|Overall Study|Clinical progression|1|||
130223660|NCT03489343|468781719|FG004|Overall Study|Clinical progression|0|||
130223661|NCT03489343|468781720|FG005|Overall Study|Clinical progression|0|||
130223662|NCT03489343|468781721|FG006|Overall Study|Clinical progression|1|||
130223663|NCT01158261|468781722|FG000|Overall Study|Lost to Follow-up|9|||
130223664|NCT01158261|468781722|FG000|Overall Study|Death|7|||
130223665|NCT01158261|468781722|FG000|Overall Study|Withdrawal by Subject|1|||
130223666|NCT03143101|468781723|FG000|Overall Study|Withdrawal by Subject|0|||
130223667|NCT03143101|468781724|FG001|Overall Study|Withdrawal by Subject|1|||
130223668|NCT03143101|468781725|FG002|Overall Study|Withdrawal by Subject|0|||
130223669|NCT03143101|468781723|FG000|Overall Study|Lost to Follow-up|2|||
130223670|NCT03143101|468781724|FG001|Overall Study|Lost to Follow-up|2|||
130223671|NCT03143101|468781725|FG002|Overall Study|Lost to Follow-up|0|||
130223672|NCT01630135|468781729|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
130223673|NCT01630135|468781730|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
130223674|NCT02899065|468781732|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
130223675|NCT02899065|468781733|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
130223676|NCT02899065|468781732|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
130223677|NCT02899065|468781733|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
130223678|NCT02899065|468781732|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
130223679|NCT02899065|468781733|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
130223680|NCT00971867|468781734|FG000|Overall Study|Adverse Event|4|||
130223681|NCT00971867|468781734|FG000|Overall Study|Participant Withdrew Consent|1|||
130223682|NCT00971867|468781734|FG000|Overall Study|Disease Progression|6|||
130223683|NCT05227118|468781738|FG000|Overall Study|Adverse Event|0|||
130223684|NCT05227118|468781739|FG001|Overall Study|Adverse Event|0|||
130223685|NCT05227118|468781740|FG002|Overall Study|Adverse Event|1|||
130223686|NCT05227118|468781741|FG003|Overall Study|Adverse Event|0|||
130223687|NCT05227118|468781738|FG000|Overall Study|Withdrawal by Subject|0|||
130223688|NCT05227118|468781739|FG001|Overall Study|Withdrawal by Subject|0|||
130223689|NCT05227118|468781740|FG002|Overall Study|Withdrawal by Subject|2|||
130223690|NCT05227118|468781741|FG003|Overall Study|Withdrawal by Subject|0|||
130223691|NCT03727841|468781747|FG000|Overall Study|Physician Decision|3|||
130223692|NCT03727841|468781748|FG001|Overall Study|Physician Decision|1|||
130223693|NCT01601496|468781749|FG000|Overall Study|Physician Decision|1|||
130223694|NCT01601496|468781749|FG000|Overall Study|Withdrawal by Subject|1|||
130223695|NCT01601496|468781749|FG000|Overall Study|Lost to Follow-up|6|||
130223696|NCT01601496|468781749|FG000|Overall Study|Death|4|||
130223697|NCT01601496|468781749|FG000|Overall Study|Other: patient refusal to continue|3|||
130223698|NCT03243305|468781750|FG000|Overall Study|Lost to Follow-up|250|||
130223699|NCT03243305|468781750|FG000|Overall Study|Withdrawal by Subject|170|||
130223700|NCT03243305|468781750|FG000|Overall Study|Pregnancy|104|||
130223701|NCT03243305|468781750|FG000|Overall Study|Non-Compliance with Study Drug|38|||
130223702|NCT03243305|468781750|FG000|Overall Study|Adverse Event|23|||
130223703|NCT03243305|468781750|FG000|Overall Study|No sexually active|26|||
130223704|NCT03243305|468781750|FG000|Overall Study|Physician Decision|22|||
130223705|NCT03243305|468781750|FG000|Overall Study|Protocol Violation|22|||
130223706|NCT03243305|468781750|FG000|Overall Study|Study method no longer primary method|12|||
130223707|NCT03243305|468781750|FG000|Overall Study|Study Terminated by Sponsor|1|||
130223708|NCT03243305|468781750|FG000|Overall Study|Early terminations|267|||
130223709|NCT02689804|468781751|FG000|Overall Study|Withdrawal by Subject|2|||
130223710|NCT02689804|468781752|FG001|Overall Study|Withdrawal by Subject|0|||
130223711|NCT01166750|468781760|FG000|Overall Study|Lost to Follow-up|1|||
130223712|NCT01166750|468781761|FG001|Overall Study|Lost to Follow-up|0|||
130223713|NCT01585246|468781762|FG000|Overall Study|Lost to Follow-up|0|||
130223714|NCT01585246|468781763|FG001|Overall Study|Lost to Follow-up|0|||
130223715|NCT01585246|468781764|FG002|Overall Study|Lost to Follow-up|2|||
130223716|NCT01585246|468781765|FG003|Overall Study|Lost to Follow-up|1|||
130223717|NCT01585246|468781766|FG004|Overall Study|Lost to Follow-up|0|||
130223718|NCT01585246|468781762|FG000|Overall Study|Protocol Violation|0|||
130223719|NCT01585246|468781763|FG001|Overall Study|Protocol Violation|0|||
130223720|NCT01585246|468781764|FG002|Overall Study|Protocol Violation|0|||
130223721|NCT01585246|468781765|FG003|Overall Study|Protocol Violation|0|||
130018292|NCT05048719|468028045|FG000|Overall Study|Death|1|||
130223722|NCT01585246|468781766|FG004|Overall Study|Protocol Violation|1|||
130223723|NCT01585246|468781762|FG000|Overall Study|Withdrawal by Subject|0|||
130223724|NCT01585246|468781763|FG001|Overall Study|Withdrawal by Subject|0|||
130223725|NCT01585246|468781764|FG002|Overall Study|Withdrawal by Subject|1|||
130223726|NCT01585246|468781765|FG003|Overall Study|Withdrawal by Subject|2|||
130223727|NCT01585246|468781766|FG004|Overall Study|Withdrawal by Subject|1|||
130223728|NCT01585246|468781762|FG000|Overall Study|Other|0|||
130018293|NCT05048719|468028046|FG001|Overall Study|Death|0|||
130223729|NCT01585246|468781763|FG001|Overall Study|Other|1|||
130223730|NCT01585246|468781764|FG002|Overall Study|Other|1|||
130223731|NCT01585246|468781765|FG003|Overall Study|Other|1|||
130223732|NCT01585246|468781766|FG004|Overall Study|Other|0|||
130223733|NCT04396626|468781767|FG000|Overall Study|Premature termination of study|975|||
130223734|NCT02417753|468781768|FG000|Overall Study|Death|1|||
130223735|NCT03771963|468781771|FG000|Overall Study|Lost to Follow-up|22|||
130223736|NCT03771963|468781771|FG000|Overall Study|Withdrawal of Consent|10|||
130223737|NCT03014206|468781772|FG000|Overall Study|Registration Violation|12|||
130223738|NCT02998151|468781777|FG000|Overall Study|Withdrawal by Subject|3|||
130223739|NCT02998151|468781777|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
130223740|NCT02998151|468781777|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
130223741|NCT02155985|468781778|FG000|Overall Study|Withdrawal by Subject|0|||
130223742|NCT02155985|468781779|FG001|Overall Study|Withdrawal by Subject|0|||
130223743|NCT02155985|468781780|FG002|Overall Study|Withdrawal by Subject|1|||
130223744|NCT02155985|468781778|FG000|Overall Study|Lost to Follow-up|1|||
130223745|NCT02155985|468781779|FG001|Overall Study|Lost to Follow-up|0|||
130223746|NCT02155985|468781780|FG002|Overall Study|Lost to Follow-up|0|||
130223747|NCT02573259|468781781|FG000|Overall Study|Death|1|||
130223748|NCT02573259|468781782|FG001|Overall Study|Death|6|||
130223749|NCT02573259|468781783|FG002|Overall Study|Death|5|||
130223750|NCT02573259|468781784|FG003|Overall Study|Death|6|||
130223751|NCT02573259|468781785|FG004|Overall Study|Death|9|||
130223752|NCT02573259|468781786|FG005|Overall Study|Death|32|||
130223753|NCT02573259|468781787|FG006|Overall Study|Death|21|||
130223754|NCT02573259|468781781|FG000|Overall Study|Lost to Follow-up|0|||
130223755|NCT02573259|468781782|FG001|Overall Study|Lost to Follow-up|0|||
130223756|NCT02573259|468781783|FG002|Overall Study|Lost to Follow-up|0|||
130223757|NCT02573259|468781784|FG003|Overall Study|Lost to Follow-up|0|||
130223758|NCT02573259|468781785|FG004|Overall Study|Lost to Follow-up|0|||
130223759|NCT02573259|468781786|FG005|Overall Study|Lost to Follow-up|2|||
130223760|NCT02573259|468781787|FG006|Overall Study|Lost to Follow-up|1|||
130223761|NCT02573259|468781781|FG000|Overall Study|Participant refused further follow-up|0|||
130223762|NCT02573259|468781782|FG001|Overall Study|Participant refused further follow-up|2|||
130223763|NCT02573259|468781783|FG002|Overall Study|Participant refused further follow-up|1|||
130223764|NCT02573259|468781784|FG003|Overall Study|Participant refused further follow-up|0|||
130223765|NCT02573259|468781785|FG004|Overall Study|Participant refused further follow-up|3|||
129884488|NCT04844918|467536416|FG001|Overall Study|Physician Decision|1|||
130223766|NCT02573259|468781786|FG005|Overall Study|Participant refused further follow-up|20|||
130223767|NCT02573259|468781787|FG006|Overall Study|Participant refused further follow-up|7|||
130223768|NCT02573259|468781781|FG000|Overall Study|Other|0|||
130223769|NCT02573259|468781782|FG001|Overall Study|Other|0|||
130223770|NCT02573259|468781783|FG002|Overall Study|Other|0|||
130223771|NCT02573259|468781784|FG003|Overall Study|Other|0|||
130223772|NCT02573259|468781785|FG004|Overall Study|Other|1|||
130223773|NCT02573259|468781786|FG005|Overall Study|Other|4|||
130223774|NCT02573259|468781787|FG006|Overall Study|Other|5|||
130223775|NCT01367249|468781793|FG000|Overall Study|Withdrawal by Subject|6|||
130223776|NCT01367249|468781794|FG001|Overall Study|Withdrawal by Subject|6|||
130223777|NCT01367249|468781793|FG000|Overall Study|Other|3|||
130223778|NCT01367249|468781794|FG001|Overall Study|Other|10|||
130223779|NCT01817075|468781795|FG000|Overall Study|Adverse Event|7|||
130223780|NCT01817075|468781796|FG001|Overall Study|Adverse Event|5|||
130223781|NCT01817075|468781795|FG000|Overall Study|Physician Decision|9|||
130223782|NCT01817075|468781796|FG001|Overall Study|Physician Decision|12|||
130223783|NCT01817075|468781795|FG000|Overall Study|Withdrawal by Subject|31|||
130223784|NCT01817075|468781796|FG001|Overall Study|Withdrawal by Subject|15|||
130223785|NCT01817075|468781795|FG000|Overall Study|Received Sorafenib after enrollment|0|||
130223786|NCT01817075|468781796|FG001|Overall Study|Received Sorafenib after enrollment|1|||
130223787|NCT01817075|468781795|FG000|Overall Study|Ineligible|0|||
130223788|NCT01817075|468781796|FG001|Overall Study|Ineligible|2|||
130223789|NCT02358031|468784300|FG000|Overall Study|Death|253|||
130223790|NCT02358031|468784301|FG001|Overall Study|Death|237|||
130223791|NCT02358031|468784302|FG002|Overall Study|Death|266|||
130223792|NCT02358031|468784300|FG000|Overall Study|Lost to Follow-up|1|||
130223793|NCT02358031|468784301|FG001|Overall Study|Lost to Follow-up|1|||
130223794|NCT02358031|468784302|FG002|Overall Study|Lost to Follow-up|0|||
130223795|NCT02358031|468784300|FG000|Overall Study|Withdrawal by Subject|19|||
130223796|NCT02358031|468784301|FG001|Overall Study|Withdrawal by Subject|14|||
130223797|NCT02358031|468784302|FG002|Overall Study|Withdrawal by Subject|18|||
130223798|NCT02358031|468784300|FG000|Overall Study|Sponsor Decision|26|||
130223799|NCT02358031|468784301|FG001|Overall Study|Sponsor Decision|28|||
130223800|NCT02358031|468784302|FG002|Overall Study|Sponsor Decision|16|||
130223801|NCT05664581|468784303|FG000|Overall Study|Withdrawal by Subject|2|||
130223802|NCT02787304|468784304|FG000|Overall Study|Adverse Event|9|||
130223803|NCT02787304|468784305|FG001|Overall Study|Adverse Event|3|||
130223804|NCT02787304|468784306|FG002|Overall Study|Adverse Event|8|||
130223805|NCT02787304|468784307|FG003|Overall Study|Adverse Event|1|||
130223806|NCT02787304|468784304|FG000|Overall Study|Withdrawal by Subject|1|||
130223807|NCT02787304|468784305|FG001|Overall Study|Withdrawal by Subject|4|||
130223808|NCT02787304|468784306|FG002|Overall Study|Withdrawal by Subject|0|||
130223809|NCT02787304|468784307|FG003|Overall Study|Withdrawal by Subject|0|||
130223810|NCT02787304|468784304|FG000|Overall Study|Lost to Follow-up|1|||
130223811|NCT02787304|468784305|FG001|Overall Study|Lost to Follow-up|0|||
130223812|NCT02787304|468784306|FG002|Overall Study|Lost to Follow-up|0|||
130223813|NCT02787304|468784307|FG003|Overall Study|Lost to Follow-up|1|||
130223814|NCT02787304|468784304|FG000|Overall Study|Noncompliance with study drug|0|||
130223815|NCT02787304|468784305|FG001|Overall Study|Noncompliance with study drug|0|||
130223816|NCT02787304|468784306|FG002|Overall Study|Noncompliance with study drug|1|||
130223817|NCT02787304|468784307|FG003|Overall Study|Noncompliance with study drug|0|||
130223818|NCT02787304|468784304|FG000|Overall Study|Physician Decision|0|||
130223819|NCT02787304|468784305|FG001|Overall Study|Physician Decision|0|||
130223820|NCT02787304|468784306|FG002|Overall Study|Physician Decision|1|||
130223821|NCT02787304|468784307|FG003|Overall Study|Physician Decision|0|||
130223822|NCT02787304|468784304|FG000|Overall Study|Study terminated by sponsor|25|||
130223823|NCT02787304|468784305|FG001|Overall Study|Study terminated by sponsor|31|||
130223824|NCT02787304|468784306|FG002|Overall Study|Study terminated by sponsor|31|||
130223825|NCT02787304|468784307|FG003|Overall Study|Study terminated by sponsor|32|||
130223826|NCT01051921|468784308|FG000|Overall Study|Physician Decision|9|||
130223827|NCT01051921|468784308|FG000|Overall Study|Adverse Event|8|||
130223828|NCT01051921|468784308|FG000|Overall Study|Withdrawal by Subject|7|||
130223829|NCT01051921|468784308|FG000|Overall Study|Lost to Follow-up|4|||
130018294|NCT05048719|468028047|FG002|Overall Study|Death|0|||
130018295|NCT05048719|468028048|FG003|Overall Study|Death|0|||
130223830|NCT01051921|468784308|FG000|Overall Study|virological failure|1|||
130223831|NCT01051921|468784308|FG000|Overall Study|patient moved|1|||
130018296|NCT05048719|468028049|FG004|Overall Study|Death|0|||
130018297|NCT05048719|468028050|FG005|Overall Study|Death|0|||
130223832|NCT01325350|468784311|FG000|Overall Study|Adverse Event|3|||
130223833|NCT01325350|468784312|FG001|Overall Study|Adverse Event|3|||
130018298|NCT05048719|468028051|FG006|Overall Study|Death|0|||
130223834|NCT01325350|468784313|FG002|Overall Study|Adverse Event|3|||
130223835|NCT01325350|468784314|FG003|Overall Study|Adverse Event|1|||
130223836|NCT01325350|468784315|FG004|Overall Study|Adverse Event|2|||
130223837|NCT01325350|468784311|FG000|Overall Study|Pregnancy|0|||
130223838|NCT01325350|468784312|FG001|Overall Study|Pregnancy|0|||
130223839|NCT01325350|468784313|FG002|Overall Study|Pregnancy|1|||
130223840|NCT01325350|468784314|FG003|Overall Study|Pregnancy|0|||
130223841|NCT01325350|468784315|FG004|Overall Study|Pregnancy|1|||
130223842|NCT01325350|468784311|FG000|Overall Study|Lost to Follow-up|1|||
130223843|NCT01325350|468784312|FG001|Overall Study|Lost to Follow-up|0|||
130223844|NCT01325350|468784313|FG002|Overall Study|Lost to Follow-up|5|||
130018299|NCT05048719|468028052|FG007|Overall Study|Death|0|||
130223845|NCT01325350|468784314|FG003|Overall Study|Lost to Follow-up|1|||
130223846|NCT01325350|468784315|FG004|Overall Study|Lost to Follow-up|5|||
130223847|NCT01325350|468784311|FG000|Overall Study|Personal Reasons|2|||
130223848|NCT01325350|468784312|FG001|Overall Study|Personal Reasons|1|||
130223849|NCT01325350|468784313|FG002|Overall Study|Personal Reasons|6|||
130223850|NCT01325350|468784314|FG003|Overall Study|Personal Reasons|5|||
130223851|NCT01325350|468784315|FG004|Overall Study|Personal Reasons|3|||
130223852|NCT01325350|468784311|FG000|Overall Study|Protocol Violation|0|||
130223853|NCT01325350|468784312|FG001|Overall Study|Protocol Violation|0|||
130223854|NCT01325350|468784313|FG002|Overall Study|Protocol Violation|0|||
130223855|NCT01325350|468784314|FG003|Overall Study|Protocol Violation|1|||
130223856|NCT01325350|468784315|FG004|Overall Study|Protocol Violation|0|||
130223857|NCT01325350|468784311|FG000|Overall Study|Withdrawal by Subject|0|||
130223858|NCT01325350|468784312|FG001|Overall Study|Withdrawal by Subject|0|||
130223859|NCT01325350|468784313|FG002|Overall Study|Withdrawal by Subject|1|||
130223860|NCT01325350|468784314|FG003|Overall Study|Withdrawal by Subject|1|||
130223861|NCT01325350|468784315|FG004|Overall Study|Withdrawal by Subject|0|||
130223862|NCT01325350|468784311|FG000|Overall Study|Did Not Receive Treatment|0|||
130223863|NCT01325350|468784312|FG001|Overall Study|Did Not Receive Treatment|1|||
130223864|NCT01325350|468784313|FG002|Overall Study|Did Not Receive Treatment|1|||
130223865|NCT01325350|468784314|FG003|Overall Study|Did Not Receive Treatment|0|||
130223866|NCT01325350|468784315|FG004|Overall Study|Did Not Receive Treatment|1|||
130223867|NCT01053741|468784318|FG000|2nd Study Intervention|Physician Decision|0|||
130223868|NCT01053741|468784319|FG001|2nd Study Intervention|Physician Decision|1|||
130223869|NCT00619827|468784321|FG000|Overall Study|Adverse Event|1|||
130223870|NCT00619827|468784322|FG001|Overall Study|Adverse Event|2|||
130223871|NCT00619827|468784321|FG000|Overall Study|Withdrawal by Subject|2|||
130223872|NCT00619827|468784322|FG001|Overall Study|Withdrawal by Subject|2|||
130223873|NCT01063855|468784323|FG000|Overall Study|Adverse Event|4|||
130223874|NCT01063855|468784324|FG001|Overall Study|Adverse Event|4|||
130223875|NCT01063855|468784323|FG000|Overall Study|Death|0|||
130223876|NCT01063855|468784324|FG001|Overall Study|Death|1|||
130223877|NCT01063855|468784323|FG000|Overall Study|Lost to Follow-up|8|||
130223878|NCT01063855|468784324|FG001|Overall Study|Lost to Follow-up|4|||
130223879|NCT01063855|468784323|FG000|Overall Study|Pregnancy|1|||
130223880|NCT01063855|468784324|FG001|Overall Study|Pregnancy|0|||
130223881|NCT01063855|468784323|FG000|Overall Study|Lack of Efficacy|0|||
130223882|NCT01063855|468784324|FG001|Overall Study|Lack of Efficacy|1|||
130223883|NCT01063855|468784323|FG000|Overall Study|Withdrawal by Subject|11|||
130223884|NCT01063855|468784324|FG001|Overall Study|Withdrawal by Subject|8|||
130223885|NCT01063855|468784323|FG000|Overall Study|Reason not specified|13|||
130223886|NCT01063855|468784324|FG001|Overall Study|Reason not specified|11|||
130223887|NCT02619617|468784346|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
130223888|NCT02619617|468784347|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
130223889|NCT02619617|468784346|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
130223890|NCT02619617|468784347|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
130223891|NCT01854697|468784348|FG000|Overall Study|Adverse Event|1|||
130223892|NCT01854697|468784349|FG001|Overall Study|Adverse Event|0|||
130223893|NCT01854697|468784350|FG002|Overall Study|Adverse Event|0|||
130223894|NCT01854697|468784351|FG003|Overall Study|Adverse Event|0|||
130223895|NCT01854697|468784352|FG004|Overall Study|Adverse Event|1|||
130223896|NCT01854697|468784348|FG000|Overall Study|Lost to Follow-up|4|||
130223897|NCT01854697|468784349|FG001|Overall Study|Lost to Follow-up|1|||
130223898|NCT01854697|468784350|FG002|Overall Study|Lost to Follow-up|1|||
130223899|NCT01854697|468784351|FG003|Overall Study|Lost to Follow-up|2|||
130223900|NCT01854697|468784352|FG004|Overall Study|Lost to Follow-up|0|||
130223901|NCT01854697|468784348|FG000|Overall Study|To enter another AbbVie study|1|||
130018300|NCT05048719|468028053|FG008|Overall Study|Death|0|||
130018301|NCT05048719|468028045|FG000|Overall Study|Adverse Event|0|||
130018302|NCT05048719|468028046|FG001|Overall Study|Adverse Event|1|||
130018303|NCT05048719|468028047|FG002|Overall Study|Adverse Event|2|||
130018304|NCT05048719|468028048|FG003|Overall Study|Adverse Event|0|||
130018305|NCT05048719|468028049|FG004|Overall Study|Adverse Event|1|||
130018306|NCT05048719|468028050|FG005|Overall Study|Adverse Event|0|||
130018307|NCT05048719|468028051|FG006|Overall Study|Adverse Event|0|||
130018308|NCT05048719|468028052|FG007|Overall Study|Adverse Event|0|||
130018309|NCT05048719|468028053|FG008|Overall Study|Adverse Event|0|||
130018310|NCT05048719|468028045|FG000|Overall Study|Lost to Follow-up|0|||
130018311|NCT05048719|468028046|FG001|Overall Study|Lost to Follow-up|0|||
130018312|NCT05048719|468028047|FG002|Overall Study|Lost to Follow-up|1|||
130018313|NCT05048719|468028048|FG003|Overall Study|Lost to Follow-up|3|||
130018314|NCT05048719|468028049|FG004|Overall Study|Lost to Follow-up|1|||
130018315|NCT05048719|468028050|FG005|Overall Study|Lost to Follow-up|1|||
130018316|NCT05048719|468028051|FG006|Overall Study|Lost to Follow-up|1|||
130018317|NCT05048719|468028052|FG007|Overall Study|Lost to Follow-up|1|||
130018318|NCT05048719|468028053|FG008|Overall Study|Lost to Follow-up|0|||
130018319|NCT05048719|468028045|FG000|Overall Study|Physician Decision|0|||
130018320|NCT05048719|468028046|FG001|Overall Study|Physician Decision|0|||
130018321|NCT05048719|468028047|FG002|Overall Study|Physician Decision|0|||
130018322|NCT05048719|468028048|FG003|Overall Study|Physician Decision|0|||
130018323|NCT05048719|468028049|FG004|Overall Study|Physician Decision|0|||
130018324|NCT05048719|468028050|FG005|Overall Study|Physician Decision|0|||
130018325|NCT05048719|468028051|FG006|Overall Study|Physician Decision|0|||
130018326|NCT05048719|468028052|FG007|Overall Study|Physician Decision|1|||
130018327|NCT05048719|468028053|FG008|Overall Study|Physician Decision|1|||
130223902|NCT01854697|468784349|FG001|Overall Study|To enter another AbbVie study|0|||
130223903|NCT01854697|468784350|FG002|Overall Study|To enter another AbbVie study|0|||
130223904|NCT01854697|468784351|FG003|Overall Study|To enter another AbbVie study|0|||
130223905|NCT01854697|468784352|FG004|Overall Study|To enter another AbbVie study|1|||
130018328|NCT05048719|468028045|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
130018329|NCT05048719|468028046|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130018330|NCT05048719|468028047|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129800229|NCT02891161|467236266|FG000|Follow up|Death|4|||
130018331|NCT05048719|468028048|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130018332|NCT05048719|468028049|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130223906|NCT01854697|468784348|FG000|Overall Study|Withdrew Consent|0|||
130223907|NCT01854697|468784349|FG001|Overall Study|Withdrew Consent|1|||
130223908|NCT01854697|468784350|FG002|Overall Study|Withdrew Consent|0|||
130223909|NCT01854697|468784351|FG003|Overall Study|Withdrew Consent|1|||
130223910|NCT01854697|468784352|FG004|Overall Study|Withdrew Consent|0|||
130223911|NCT01854697|468784348|FG000|Overall Study|Other|0|||
130223912|NCT01854697|468784349|FG001|Overall Study|Other|1|||
130223913|NCT01854697|468784350|FG002|Overall Study|Other|1|||
130223914|NCT01854697|468784351|FG003|Overall Study|Other|0|||
130223915|NCT01854697|468784352|FG004|Overall Study|Other|0|||
130223916|NCT00115778|468784356|FG000|Overall Study|Withdrawal by Subject|0|||
130223917|NCT00115778|468784357|FG001|Overall Study|Withdrawal by Subject|1|||
130223918|NCT00528424|468784360|FG000|Overall Study|Lost to Follow-up|13|||
130223919|NCT00528424|468784360|FG000|Overall Study|Withdrew consent|2|||
130223920|NCT00528424|468784360|FG000|Overall Study|Administrative reason|2|||
130223921|NCT00528424|468784360|FG000|Overall Study|Other|12|||
130223922|NCT02515630|468784361|FG000|Overall Study|Withdrawal by Subject|5|||
130223923|NCT02515630|468784361|FG000|Overall Study|Adverse Event|4|||
130223924|NCT02515630|468784361|FG000|Overall Study|Physician Decision|4|||
130223925|NCT02515630|468784361|FG000|Overall Study|Death|2|||
130223926|NCT02515630|468784361|FG000|Overall Study|Disease Progression|1|||
130223927|NCT00483652|468784362|FG000|Double-blind Treatment Period|Protocol Violation|2|||
130223928|NCT00483652|468784363|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130223929|NCT00483652|468784362|FG000|Double-blind Treatment Period|Adverse Event|3|||
130223930|NCT00483652|468784363|FG001|Double-blind Treatment Period|Adverse Event|4|||
130223931|NCT00483652|468784362|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
130223932|NCT00483652|468784363|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
130223933|NCT00483652|468784362|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
130223934|NCT00483652|468784363|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
130223935|NCT00468585|468784364|FG000|Overall Study|Patient not treated|1|||
130223936|NCT00468585|468784365|FG001|Overall Study|Patient not treated|0|||
130223937|NCT00468585|468784366|FG002|Overall Study|Patient not treated|1|||
130223938|NCT00468585|468784367|FG003|Overall Study|Patient not treated|0|||
130223939|NCT00468585|468784364|FG000|Overall Study|Patient found to be ineligible|0|||
130223940|NCT00468585|468784365|FG001|Overall Study|Patient found to be ineligible|0|||
130223941|NCT00468585|468784366|FG002|Overall Study|Patient found to be ineligible|1|||
130223942|NCT00468585|468784367|FG003|Overall Study|Patient found to be ineligible|0|||
130223943|NCT00468585|468784364|FG000|Overall Study|Adverse Event|0|||
130223944|NCT00468585|468784365|FG001|Overall Study|Adverse Event|0|||
130223945|NCT00468585|468784366|FG002|Overall Study|Adverse Event|1|||
130223946|NCT00468585|468784367|FG003|Overall Study|Adverse Event|0|||
130223947|NCT00468585|468784364|FG000|Overall Study|Withdrawal by Subject|0|||
130223948|NCT00468585|468784365|FG001|Overall Study|Withdrawal by Subject|0|||
130223949|NCT00468585|468784366|FG002|Overall Study|Withdrawal by Subject|2|||
130223950|NCT00468585|468784367|FG003|Overall Study|Withdrawal by Subject|1|||
130223951|NCT02154139|468784372|FG000|Overall Study|Injection not administered|2|||
130223952|NCT02154139|468784372|FG000|Overall Study|Other|2|||
130223953|NCT02154139|468784372|FG000|Overall Study|Investigator transferred|3|||
130223954|NCT02087774|468784373|FG000|Overall Study|Were absent day of data collection|8|||
130223955|NCT02087774|468784374|FG001|Overall Study|Were absent day of data collection|20|||
130223956|NCT02157519|468784382|FG000|Overall Study|Death|3|||
130223957|NCT02157519|468784383|FG001|Overall Study|Death|1|||
130223958|NCT02157519|468784382|FG000|Overall Study|Withdrawal by Subject|7|||
130223959|NCT02157519|468784383|FG001|Overall Study|Withdrawal by Subject|0|||
130223960|NCT02157519|468784382|FG000|Overall Study|Lost to Follow-up|1|||
130223961|NCT02157519|468784383|FG001|Overall Study|Lost to Follow-up|0|||
130223962|NCT01656395|468784384|FG000|Overall Study|Adverse Event|1|||
130223963|NCT01656395|468784385|FG001|Overall Study|Adverse Event|14|||
130223964|NCT01656395|468784386|FG002|Overall Study|Adverse Event|5|||
130223965|NCT01656395|468784387|FG003|Overall Study|Adverse Event|4|||
130223966|NCT01656395|468784388|FG004|Overall Study|Adverse Event|5|||
130223967|NCT01656395|468784389|FG005|Overall Study|Adverse Event|7|||
130223968|NCT01656395|468784390|FG006|Overall Study|Adverse Event|0|||
130223969|NCT01656395|468784391|FG007|Overall Study|Adverse Event|0|||
130223970|NCT01656395|468784384|FG000|Overall Study|Lack of Efficacy|1|||
130223971|NCT01656395|468784385|FG001|Overall Study|Lack of Efficacy|8|||
130223972|NCT01656395|468784386|FG002|Overall Study|Lack of Efficacy|6|||
130223973|NCT01656395|468784387|FG003|Overall Study|Lack of Efficacy|1|||
130223974|NCT01656395|468784388|FG004|Overall Study|Lack of Efficacy|1|||
130223975|NCT01656395|468784389|FG005|Overall Study|Lack of Efficacy|6|||
130223976|NCT01656395|468784390|FG006|Overall Study|Lack of Efficacy|0|||
130223977|NCT01656395|468784391|FG007|Overall Study|Lack of Efficacy|0|||
130223978|NCT01656395|468784384|FG000|Overall Study|Lost to Follow-up|1|||
130223979|NCT01656395|468784385|FG001|Overall Study|Lost to Follow-up|0|||
130223980|NCT01656395|468784386|FG002|Overall Study|Lost to Follow-up|0|||
130223981|NCT01656395|468784387|FG003|Overall Study|Lost to Follow-up|0|||
130223982|NCT01656395|468784388|FG004|Overall Study|Lost to Follow-up|0|||
130223983|NCT01656395|468784389|FG005|Overall Study|Lost to Follow-up|0|||
130223984|NCT01656395|468784390|FG006|Overall Study|Lost to Follow-up|0|||
130223985|NCT01656395|468784391|FG007|Overall Study|Lost to Follow-up|0|||
130223986|NCT01656395|468784384|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130223987|NCT01656395|468784385|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130223988|NCT01656395|468784386|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130223989|NCT01656395|468784387|FG003|Overall Study|Non-Compliance with Study Drug|0|||
130223990|NCT01656395|468784388|FG004|Overall Study|Non-Compliance with Study Drug|1|||
130223991|NCT01656395|468784389|FG005|Overall Study|Non-Compliance with Study Drug|1|||
130223992|NCT01656395|468784390|FG006|Overall Study|Non-Compliance with Study Drug|0|||
130223993|NCT01656395|468784391|FG007|Overall Study|Non-Compliance with Study Drug|0|||
130223994|NCT01656395|468784384|FG000|Overall Study|Other|0|||
130223995|NCT01656395|468784385|FG001|Overall Study|Other|0|||
130223996|NCT01656395|468784386|FG002|Overall Study|Other|1|||
130223997|NCT01656395|468784387|FG003|Overall Study|Other|0|||
130223998|NCT01656395|468784388|FG004|Overall Study|Other|0|||
130223999|NCT01656395|468784389|FG005|Overall Study|Other|1|||
130224000|NCT01656395|468784390|FG006|Overall Study|Other|0|||
130224001|NCT01656395|468784391|FG007|Overall Study|Other|0|||
130018333|NCT05048719|468028050|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130224002|NCT01656395|468784384|FG000|Overall Study|Physician Decision|2|||
130224003|NCT01656395|468784385|FG001|Overall Study|Physician Decision|3|||
129884489|NCT04844918|467536417|FG002|Overall Study|Physician Decision|0|||
130224004|NCT01656395|468784386|FG002|Overall Study|Physician Decision|3|||
130224005|NCT01656395|468784387|FG003|Overall Study|Physician Decision|2|||
130224006|NCT01656395|468784388|FG004|Overall Study|Physician Decision|3|||
130224007|NCT01656395|468784389|FG005|Overall Study|Physician Decision|3|||
130224008|NCT01656395|468784390|FG006|Overall Study|Physician Decision|0|||
130224009|NCT01656395|468784391|FG007|Overall Study|Physician Decision|0|||
130224010|NCT01656395|468784384|FG000|Overall Study|Pregnancy|0|||
130224011|NCT01656395|468784385|FG001|Overall Study|Pregnancy|0|||
130224012|NCT01656395|468784386|FG002|Overall Study|Pregnancy|1|||
130224013|NCT01656395|468784387|FG003|Overall Study|Pregnancy|0|||
130224014|NCT01656395|468784388|FG004|Overall Study|Pregnancy|0|||
130224015|NCT01656395|468784389|FG005|Overall Study|Pregnancy|0|||
130224016|NCT01656395|468784390|FG006|Overall Study|Pregnancy|0|||
130224017|NCT01656395|468784391|FG007|Overall Study|Pregnancy|0|||
130224018|NCT01656395|468784384|FG000|Overall Study|Progressive Disease|0|||
130224019|NCT01656395|468784385|FG001|Overall Study|Progressive Disease|0|||
130224020|NCT01656395|468784386|FG002|Overall Study|Progressive Disease|0|||
130224021|NCT01656395|468784387|FG003|Overall Study|Progressive Disease|0|||
130224022|NCT01656395|468784388|FG004|Overall Study|Progressive Disease|0|||
130224023|NCT01656395|468784389|FG005|Overall Study|Progressive Disease|1|||
130224024|NCT01656395|468784390|FG006|Overall Study|Progressive Disease|0|||
130018334|NCT05048719|468028051|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130018335|NCT05048719|468028052|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130224025|NCT01656395|468784391|FG007|Overall Study|Progressive Disease|0|||
130224026|NCT01656395|468784384|FG000|Overall Study|Protocol Violation|6|||
130224027|NCT01656395|468784385|FG001|Overall Study|Protocol Violation|6|||
130224028|NCT01656395|468784386|FG002|Overall Study|Protocol Violation|9|||
130224029|NCT01656395|468784387|FG003|Overall Study|Protocol Violation|2|||
130224030|NCT01656395|468784388|FG004|Overall Study|Protocol Violation|4|||
130224031|NCT01656395|468784389|FG005|Overall Study|Protocol Violation|10|||
130224032|NCT01656395|468784390|FG006|Overall Study|Protocol Violation|0|||
130224033|NCT01656395|468784391|FG007|Overall Study|Protocol Violation|0|||
130224034|NCT01656395|468784384|FG000|Overall Study|Screen Failure|2|||
130224035|NCT01656395|468784385|FG001|Overall Study|Screen Failure|1|||
130224036|NCT01656395|468784386|FG002|Overall Study|Screen Failure|7|||
130224037|NCT01656395|468784387|FG003|Overall Study|Screen Failure|1|||
130224038|NCT01656395|468784388|FG004|Overall Study|Screen Failure|0|||
130224039|NCT01656395|468784389|FG005|Overall Study|Screen Failure|8|||
130224040|NCT01656395|468784390|FG006|Overall Study|Screen Failure|0|||
130224041|NCT01656395|468784391|FG007|Overall Study|Screen Failure|0|||
130224042|NCT01656395|468784384|FG000|Overall Study|Withdrawal by Subject|3|||
130224043|NCT01656395|468784385|FG001|Overall Study|Withdrawal by Subject|1|||
130224044|NCT01656395|468784386|FG002|Overall Study|Withdrawal by Subject|4|||
130224045|NCT01656395|468784387|FG003|Overall Study|Withdrawal by Subject|2|||
130224046|NCT01656395|468784388|FG004|Overall Study|Withdrawal by Subject|0|||
130224047|NCT01656395|468784389|FG005|Overall Study|Withdrawal by Subject|3|||
130224048|NCT01656395|468784390|FG006|Overall Study|Withdrawal by Subject|0|||
130224049|NCT01656395|468784391|FG007|Overall Study|Withdrawal by Subject|0|||
130224050|NCT03075267|468784392|FG000|Overall Study|Protocol Violation|1|||
130224051|NCT03075267|468784393|FG001|Overall Study|Protocol Violation|0|||
130224052|NCT03075267|468784394|FG002|Overall Study|Protocol Violation|0|||
130224053|NCT00676403|468784395|FG000|Overall Study|Adverse Event|1|||
130224054|NCT00676403|468784396|FG001|Overall Study|Adverse Event|2|||
130224055|NCT00676403|468784397|FG002|Overall Study|Adverse Event|0|||
130224056|NCT00676403|468784398|FG003|Overall Study|Adverse Event|5|||
130224057|NCT00676403|468784399|FG004|Overall Study|Adverse Event|1|||
130224058|NCT00676403|468784400|FG005|Overall Study|Adverse Event|2|||
130224059|NCT00676403|468784395|FG000|Overall Study|Lost to Follow-up|0|||
130224060|NCT00676403|468784396|FG001|Overall Study|Lost to Follow-up|0|||
130224061|NCT00676403|468784397|FG002|Overall Study|Lost to Follow-up|0|||
130224062|NCT00676403|468784398|FG003|Overall Study|Lost to Follow-up|0|||
130224063|NCT00676403|468784399|FG004|Overall Study|Lost to Follow-up|0|||
130224064|NCT00676403|468784400|FG005|Overall Study|Lost to Follow-up|1|||
130224065|NCT00676403|468784395|FG000|Overall Study|Reason Unspecified|1|||
130224066|NCT00676403|468784396|FG001|Overall Study|Reason Unspecified|0|||
130224067|NCT00676403|468784397|FG002|Overall Study|Reason Unspecified|1|||
130224068|NCT00676403|468784398|FG003|Overall Study|Reason Unspecified|0|||
130224069|NCT00676403|468784399|FG004|Overall Study|Reason Unspecified|0|||
130224070|NCT00676403|468784400|FG005|Overall Study|Reason Unspecified|1|||
130224071|NCT00676403|468784395|FG000|Overall Study|Withdrawal by Subject|0|||
130224072|NCT00676403|468784396|FG001|Overall Study|Withdrawal by Subject|0|||
130224073|NCT00676403|468784397|FG002|Overall Study|Withdrawal by Subject|0|||
130224074|NCT00676403|468784398|FG003|Overall Study|Withdrawal by Subject|0|||
130224075|NCT00676403|468784399|FG004|Overall Study|Withdrawal by Subject|0|||
130224076|NCT00676403|468784400|FG005|Overall Study|Withdrawal by Subject|1|||
130224077|NCT01746862|468784404|FG000|Overall Study|Withdrawal by Subject|1|||
130224078|NCT01746862|468784405|FG001|Overall Study|Withdrawal by Subject|1|||
130224079|NCT01746862|468784404|FG000|Overall Study|Protocol Violation|1|||
130224080|NCT01746862|468784405|FG001|Overall Study|Protocol Violation|0|||
130224081|NCT01746862|468784404|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
130224082|NCT01746862|468784405|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
130224083|NCT01746862|468784404|FG000|Overall Study|Entered puberty during the study|1|||
130224084|NCT01746862|468784405|FG001|Overall Study|Entered puberty during the study|0|||
130224085|NCT04742673|468784406|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
130224086|NCT04742673|468784407|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
130224087|NCT06058390|468784409|FG000|Overall Study|Lost to Follow-up|0|||
130224088|NCT06058390|468784410|FG001|Overall Study|Lost to Follow-up|0|||
130224089|NCT06058390|468784411|FG002|Overall Study|Lost to Follow-up|2|||
130224090|NCT06058390|468784412|FG003|Overall Study|Lost to Follow-up|1|||
130224091|NCT06058390|468784409|FG000|Overall Study|Physician Decision|0|||
130224092|NCT06058390|468784410|FG001|Overall Study|Physician Decision|0|||
130224093|NCT06058390|468784411|FG002|Overall Study|Physician Decision|0|||
130224094|NCT06058390|468784412|FG003|Overall Study|Physician Decision|1|||
130224095|NCT06058390|468784409|FG000|Overall Study|Participants did not receive any study intervention|0|||
130224096|NCT06058390|468784410|FG001|Overall Study|Participants did not receive any study intervention|0|||
130224097|NCT06058390|468784411|FG002|Overall Study|Participants did not receive any study intervention|0|||
130224098|NCT06058390|468784412|FG003|Overall Study|Participants did not receive any study intervention|1|||
130224099|NCT03361306|468784413|FG000|Overall Study|Death|6|||
130224100|NCT04073303|468784414|FG000|Overall Study|Adverse Event|0|||
130224101|NCT04073303|468784415|FG001|Overall Study|Adverse Event|2|||
130224102|NCT04073303|468784414|FG000|Overall Study|Withdrawal by Subject|16|||
130224103|NCT04073303|468784415|FG001|Overall Study|Withdrawal by Subject|36|||
130224104|NCT04073303|468784414|FG000|Overall Study|Lost to Follow-up|6|||
130224105|NCT04073303|468784415|FG001|Overall Study|Lost to Follow-up|1|||
130224106|NCT04073303|468784414|FG000|Overall Study|Protocol Deviation|0|||
130224107|NCT04073303|468784415|FG001|Overall Study|Protocol Deviation|4|||
130224108|NCT04073303|468784414|FG000|Overall Study|Other|1|||
130224109|NCT04073303|468784415|FG001|Overall Study|Other|1|||
130224110|NCT03589807|468784423|FG000|Overall Study|Lost to Follow-up|0|||
130224111|NCT03589807|468784424|FG001|Overall Study|Lost to Follow-up|2|||
130224112|NCT03589807|468784425|FG002|Overall Study|Lost to Follow-up|2|||
130224113|NCT03589807|468784426|FG003|Overall Study|Lost to Follow-up|3|||
130224114|NCT03589807|468784427|FG004|Overall Study|Lost to Follow-up|1|||
130224115|NCT03589807|468784428|FG005|Overall Study|Lost to Follow-up|1|||
130224116|NCT03589807|468784423|FG000|Overall Study|Withdrawal by Subject|0|||
130224117|NCT03589807|468784424|FG001|Overall Study|Withdrawal by Subject|5|||
130224118|NCT03589807|468784425|FG002|Overall Study|Withdrawal by Subject|0|||
130224119|NCT03589807|468784426|FG003|Overall Study|Withdrawal by Subject|0|||
130224120|NCT03589807|468784427|FG004|Overall Study|Withdrawal by Subject|0|||
130224121|NCT03589807|468784428|FG005|Overall Study|Withdrawal by Subject|0|||
130224122|NCT03589807|468784423|FG000|Overall Study|Protocol Violation|0|||
130224123|NCT03589807|468784424|FG001|Overall Study|Protocol Violation|0|||
130224124|NCT03589807|468784425|FG002|Overall Study|Protocol Violation|0|||
130224125|NCT03589807|468784426|FG003|Overall Study|Protocol Violation|1|||
130224126|NCT03589807|468784427|FG004|Overall Study|Protocol Violation|0|||
130224127|NCT03589807|468784428|FG005|Overall Study|Protocol Violation|0|||
130224128|NCT03589807|468784423|FG000|Overall Study|Enrolled but treatment not administered|0|||
130224129|NCT03589807|468784424|FG001|Overall Study|Enrolled but treatment not administered|0|||
130224130|NCT03589807|468784425|FG002|Overall Study|Enrolled but treatment not administered|0|||
130018336|NCT05048719|468028053|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
130224131|NCT03589807|468784426|FG003|Overall Study|Enrolled but treatment not administered|0|||
130224132|NCT03589807|468784427|FG004|Overall Study|Enrolled but treatment not administered|1|||
130224133|NCT03589807|468784428|FG005|Overall Study|Enrolled but treatment not administered|0|||
130018337|NCT05048719|468028045|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130224134|NCT00810069|468784429|FG000|Lead-in Period I|Adverse Event|43|||
130224135|NCT00810069|468784430|FG001|Lead-in Period I|Adverse Event|0|||
130224136|NCT00810069|468784431|FG002|Lead-in Period I|Adverse Event|0|||
130224137|NCT00810069|468784429|FG000|Lead-in Period I|Lack of Efficacy|1|||
130224138|NCT00810069|468784430|FG001|Lead-in Period I|Lack of Efficacy|0|||
130224139|NCT00810069|468784431|FG002|Lead-in Period I|Lack of Efficacy|0|||
130224140|NCT00810069|468784429|FG000|Lead-in Period I|Lost to Follow-up|19|||
130224141|NCT00810069|468784430|FG001|Lead-in Period I|Lost to Follow-up|0|||
130224142|NCT00810069|468784431|FG002|Lead-in Period I|Lost to Follow-up|0|||
130224143|NCT00810069|468784429|FG000|Lead-in Period I|Physician Decision|1|||
130224144|NCT00810069|468784430|FG001|Lead-in Period I|Physician Decision|0|||
130224145|NCT00810069|468784431|FG002|Lead-in Period I|Physician Decision|0|||
130224146|NCT00810069|468784429|FG000|Lead-in Period I|Protocol Violation|1|||
130224147|NCT00810069|468784430|FG001|Lead-in Period I|Protocol Violation|0|||
130224148|NCT00810069|468784431|FG002|Lead-in Period I|Protocol Violation|0|||
130224149|NCT00810069|468784429|FG000|Lead-in Period I|Withdrawal by Subject|46|||
130224150|NCT00810069|468784430|FG001|Lead-in Period I|Withdrawal by Subject|0|||
130224151|NCT00810069|468784431|FG002|Lead-in Period I|Withdrawal by Subject|0|||
130224152|NCT00810069|468784429|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
130224153|NCT00810069|468784430|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
130224154|NCT00810069|468784431|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
130224155|NCT00810069|468784429|FG000|Lead-in Period I|Randomization criteria not met|158|||
130224156|NCT00810069|468784430|FG001|Lead-in Period I|Randomization criteria not met|0|||
130224157|NCT00810069|468784431|FG002|Lead-in Period I|Randomization criteria not met|0|||
130224158|NCT00810069|468784429|FG000|Double-Blind Period II|Adverse Event|0|||
130224159|NCT00810069|468784430|FG001|Double-Blind Period II|Adverse Event|9|||
130224160|NCT00810069|468784431|FG002|Double-Blind Period II|Adverse Event|8|||
130224161|NCT00810069|468784429|FG000|Double-Blind Period II|Lack of Efficacy|0|||
130224162|NCT00810069|468784430|FG001|Double-Blind Period II|Lack of Efficacy|7|||
130224163|NCT00810069|468784431|FG002|Double-Blind Period II|Lack of Efficacy|12|||
130224164|NCT00810069|468784429|FG000|Double-Blind Period II|Lost to Follow-up|0|||
130224165|NCT00810069|468784430|FG001|Double-Blind Period II|Lost to Follow-up|9|||
130224166|NCT00810069|468784431|FG002|Double-Blind Period II|Lost to Follow-up|9|||
130224167|NCT00810069|468784429|FG000|Double-Blind Period II|Physician Decision|0|||
130224168|NCT00810069|468784430|FG001|Double-Blind Period II|Physician Decision|0|||
130224169|NCT00810069|468784431|FG002|Double-Blind Period II|Physician Decision|1|||
130224170|NCT00810069|468784429|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
130224171|NCT00810069|468784430|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
130224172|NCT00810069|468784431|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
130224173|NCT00810069|468784429|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
130224174|NCT00810069|468784430|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
130224175|NCT00810069|468784431|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
130224176|NCT00810069|468784429|FG000|Double-Blind Period II|Clinical relapse|0|||
130224177|NCT00810069|468784430|FG001|Double-Blind Period II|Clinical relapse|3|||
130224178|NCT00810069|468784431|FG002|Double-Blind Period II|Clinical relapse|0|||
130224179|NCT00810069|468784429|FG000|Double-Blind Period II|Protocol Violation|0|||
130224180|NCT00810069|468784430|FG001|Double-Blind Period II|Protocol Violation|7|||
130224181|NCT00810069|468784431|FG002|Double-Blind Period II|Protocol Violation|6|||
129884490|NCT04844918|467536415|FG000|Overall Study|Withdrawal by Subject|6|||
130018338|NCT05048719|468028046|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
130224182|NCT04767373|468784434|FG000|Overall Study|Death|6|||
130224183|NCT04767373|468784435|FG001|Overall Study|Death|3|||
130224184|NCT04767373|468784434|FG000|Overall Study|Lost to Follow-up|67|||
130018339|NCT05048719|468028047|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130224185|NCT04767373|468784435|FG001|Overall Study|Lost to Follow-up|35|||
130224186|NCT04767373|468784434|FG000|Overall Study|Physician Decision|15|||
130224187|NCT04767373|468784435|FG001|Overall Study|Physician Decision|4|||
130224188|NCT04767373|468784434|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130224189|NCT04767373|468784435|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130224190|NCT04767373|468784434|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
130224191|NCT04767373|468784435|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
130224192|NCT04767373|468784434|FG000|Overall Study|Other|1|||
130224193|NCT04767373|468784435|FG001|Overall Study|Other|2|||
130224194|NCT00593918|468784436|FG000|Overall Study|Withdrawal by Subject|5|||
130224195|NCT00593918|468784437|FG001|Overall Study|Withdrawal by Subject|24|||
130224196|NCT02983045|468784438|FG000|Overall Study|Withdrawal by Subject|0|||
130224197|NCT02983045|468784439|FG001|Overall Study|Withdrawal by Subject|1|||
130018340|NCT05048719|468028048|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130052121|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
130224198|NCT02983045|468784440|FG002|Overall Study|Withdrawal by Subject|0|||
130224199|NCT02983045|468784441|FG003|Overall Study|Withdrawal by Subject|5|||
130224200|NCT02983045|468784442|FG004|Overall Study|Withdrawal by Subject|0|||
130224201|NCT02983045|468784443|FG005|Overall Study|Withdrawal by Subject|72|||
130224202|NCT02983045|468784444|FG006|Overall Study|Withdrawal by Subject|0|||
130224203|NCT02983045|468784445|FG007|Overall Study|Withdrawal by Subject|0|||
130224204|NCT02983045|468784446|FG008|Overall Study|Withdrawal by Subject|0|||
130224205|NCT02983045|468784447|FG009|Overall Study|Withdrawal by Subject|2|||
130224206|NCT02983045|468784438|FG000|Overall Study|Lost to Follow-up|0|||
130224207|NCT02983045|468784439|FG001|Overall Study|Lost to Follow-up|0|||
130224208|NCT02983045|468784440|FG002|Overall Study|Lost to Follow-up|0|||
130224209|NCT02983045|468784441|FG003|Overall Study|Lost to Follow-up|0|||
130224210|NCT02983045|468784442|FG004|Overall Study|Lost to Follow-up|0|||
130224211|NCT02983045|468784443|FG005|Overall Study|Lost to Follow-up|10|||
130224212|NCT02983045|468784444|FG006|Overall Study|Lost to Follow-up|0|||
130224213|NCT02983045|468784445|FG007|Overall Study|Lost to Follow-up|0|||
130224214|NCT02983045|468784446|FG008|Overall Study|Lost to Follow-up|0|||
130224215|NCT02983045|468784447|FG009|Overall Study|Lost to Follow-up|0|||
130224216|NCT02658669|468784448|FG000|Overall Study|Lost to Follow-up|7|||
130018341|NCT05048719|468028049|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130052122|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130224217|NCT02658669|468784449|FG001|Overall Study|Lost to Follow-up|5|||
130224218|NCT03421379|468784451|FG000|Period 1|Withdrawal by Subject|0|||
130224219|NCT03421379|468784452|FG001|Period 1|Withdrawal by Subject|1|||
130018342|NCT05048719|468028050|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130018343|NCT05048719|468028051|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130018344|NCT05048719|468028052|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130018345|NCT05048719|468028053|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
130018346|NCT05048719|468028045|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018347|NCT05048719|468028046|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
130018348|NCT05048719|468028047|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018349|NCT05048719|468028048|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018350|NCT05048719|468028049|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018351|NCT05048719|468028050|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018352|NCT05048719|468028051|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018353|NCT05048719|468028052|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018354|NCT05048719|468028053|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
130018355|NCT05048719|468028045|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018356|NCT05048719|468028046|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018357|NCT05048719|468028047|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018358|NCT05048719|468028048|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
130018359|NCT05048719|468028049|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018360|NCT05048719|468028050|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018361|NCT05048719|468028051|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018362|NCT05048719|468028052|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018363|NCT05048719|468028053|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
130018364|NCT05048719|468028045|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018365|NCT05048719|468028046|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018366|NCT05048719|468028047|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018367|NCT05048719|468028048|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018368|NCT05048719|468028049|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018369|NCT05048719|468028050|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
130018370|NCT05048719|468028051|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018371|NCT05048719|468028052|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018372|NCT05048719|468028053|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
130018373|NCT02721355|468028054|FG000|Overall Study|Lost to Follow-up|6|||
130018374|NCT02721355|468028055|FG001|Overall Study|Lost to Follow-up|1|||
130224220|NCT03421379|468784451|FG000|Period 1|Physician Decision|1|||
130224221|NCT03421379|468784452|FG001|Period 1|Physician Decision|1|||
130224222|NCT03421379|468784451|FG000|Period 1|Did not receive treatment|1|||
130224223|NCT03421379|468784452|FG001|Period 1|Did not receive treatment|2|||
130224224|NCT02782741|468784453|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
130224225|NCT02782741|468784454|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
130224226|NCT02782741|468784455|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
130224227|NCT02782741|468784453|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
130224228|NCT02782741|468784454|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
130224229|NCT02782741|468784455|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
130224230|NCT02782741|468784453|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
130224231|NCT02782741|468784454|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
130224232|NCT02782741|468784455|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
130224233|NCT02782741|468784453|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
130224234|NCT02782741|468784454|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
130224235|NCT02782741|468784455|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
130224236|NCT02782741|468784453|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
130224237|NCT02782741|468784454|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
130224238|NCT02782741|468784455|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
130018375|NCT01652287|468028056|FG000|Overall Study|Withdrawal by Subject|2|||
130018376|NCT01652287|468028057|FG001|Overall Study|Withdrawal by Subject|0|||
130018377|NCT00527605|468028058|FG000|Overall Study|Adverse Event|3|||
130018378|NCT00527605|468028059|FG001|Overall Study|Adverse Event|0|||
130018379|NCT00527605|468028058|FG000|Overall Study|Withdrawal by Subject|3|||
130018380|NCT00527605|468028059|FG001|Overall Study|Withdrawal by Subject|7|||
130018381|NCT00527605|468028058|FG000|Overall Study|Lost to Follow-up|6|||
130018382|NCT00527605|468028059|FG001|Overall Study|Lost to Follow-up|2|||
130018383|NCT00527605|468028058|FG000|Overall Study|Protocol Violation|1|||
130018384|NCT00527605|468028059|FG001|Overall Study|Protocol Violation|2|||
130018385|NCT00763139|468028060|FG000|Overall Study|Adverse Event|4|||
130018386|NCT00763139|468028061|FG001|Overall Study|Adverse Event|2|||
130018387|NCT00763139|468028060|FG000|Overall Study|Withdrawal by Subject|0|||
130018388|NCT00763139|468028061|FG001|Overall Study|Withdrawal by Subject|1|||
130018389|NCT00763139|468028060|FG000|Overall Study|med change not allowed by protocol|1|||
130018390|NCT00763139|468028061|FG001|Overall Study|med change not allowed by protocol|0|||
130018391|NCT01592760|468028062|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
130018392|NCT01592760|468028063|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
130018393|NCT01592760|468028064|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
130224239|NCT04157088|468784456|FG000|Overall Study|Study terminated by sponsor|23|||
130224240|NCT04157088|468784456|FG000|Overall Study|Withdrawal by Subject|4|||
130224241|NCT04157088|468784456|FG000|Overall Study|Lost to Follow-up|2|||
130224242|NCT04157088|468784456|FG000|Overall Study|Death|1|||
130224243|NCT00196105|468784459|FG000|Overall Study|Lost to Follow-up|4|||
130224244|NCT00196105|468784460|FG001|Overall Study|Lost to Follow-up|5|||
130224245|NCT00196105|468784461|FG002|Overall Study|Lost to Follow-up|7|||
130224246|NCT04863872|468784462|FG000|Overall Study|Withdrawal by Subject|4|||
130224247|NCT04863872|468784463|FG001|Overall Study|Withdrawal by Subject|15|||
130224248|NCT04863872|468784462|FG000|Overall Study|Death|5|||
130224249|NCT04863872|468784463|FG001|Overall Study|Death|2|||
130224250|NCT04863872|468784462|FG000|Overall Study|Lost to Follow-up|2|||
130224251|NCT04863872|468784463|FG001|Overall Study|Lost to Follow-up|1|||
130224252|NCT04058028|468784464|FG000|Overall Study|Withdrawal of Consent from Study|12|||
130224253|NCT04058028|468784465|FG001|Overall Study|Withdrawal of Consent from Study|8|||
130224254|NCT04058028|468784466|FG002|Overall Study|Withdrawal of Consent from Study|6|||
130224255|NCT04058028|468784467|FG003|Overall Study|Withdrawal of Consent from Study|7|||
130224256|NCT04058028|468784464|FG000|Overall Study|Decision by Sponsor|13|||
130224257|NCT04058028|468784465|FG001|Overall Study|Decision by Sponsor|4|||
130224258|NCT04058028|468784466|FG002|Overall Study|Decision by Sponsor|1|||
130224259|NCT04058028|468784467|FG003|Overall Study|Decision by Sponsor|35|||
130224260|NCT04058028|468784464|FG000|Overall Study|Lost to Follow-up|1|||
130224261|NCT04058028|468784465|FG001|Overall Study|Lost to Follow-up|1|||
130224262|NCT04058028|468784466|FG002|Overall Study|Lost to Follow-up|1|||
130224263|NCT04058028|468784467|FG003|Overall Study|Lost to Follow-up|0|||
130224264|NCT04058028|468784464|FG000|Overall Study|Death|0|||
130224265|NCT04058028|468784465|FG001|Overall Study|Death|1|||
130224266|NCT04058028|468784466|FG002|Overall Study|Death|0|||
130224267|NCT04058028|468784467|FG003|Overall Study|Death|0|||
130224268|NCT00485069|468784468|FG000|Overall Study|Adverse Event|10|||
130224269|NCT00485069|468784469|FG001|Overall Study|Adverse Event|4|||
130224270|NCT00485069|468784468|FG000|Overall Study|Lack of Efficacy|2|||
130224271|NCT00485069|468784469|FG001|Overall Study|Lack of Efficacy|1|||
130224272|NCT00485069|468784468|FG000|Overall Study|Protocol Violation|0|||
130224273|NCT00485069|468784469|FG001|Overall Study|Protocol Violation|1|||
130224274|NCT00485069|468784468|FG000|Overall Study|Withdrawal by Subject|6|||
130224275|NCT00485069|468784469|FG001|Overall Study|Withdrawal by Subject|6|||
130224276|NCT00992017|468784471|FG000|Overall Study|Lost to Follow-up|2|||
130224277|NCT00992017|468784471|FG000|Overall Study|Withdrawal by Subject|2|||
130224278|NCT00992017|468784471|FG000|Overall Study|Unable to get to clinic|5|||
130224279|NCT00992017|468784471|FG000|Overall Study|Not adhere to study requirements|1|||
130224280|NCT02864407|468784472|FG000|Overall Study|Protocol Violation|3|||
130224281|NCT02864407|468784472|FG000|Overall Study|Lost to Follow-up|115|||
130224282|NCT02864407|468784472|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
130224283|NCT02864407|468784472|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
130224284|NCT02864407|468784472|FG000|Overall Study|Consent prior to the contract date|1|||
129800230|NCT02891161|467236267|FG001|Follow up|Death|8|||
130018394|NCT04312009|468028065|FG000|Overall Study|Withdrawal by Subject|2|||
130018395|NCT04312009|468028066|FG001|Overall Study|Withdrawal by Subject|1|||
130018396|NCT00179309|468028075|FG000|Treatment|Toxicity|2|||
130018397|NCT00179309|468028076|FG001|Treatment|Toxicity|3|||
130018398|NCT00179309|468028075|FG000|Treatment|Withdrawal by Subject|1|||
130018399|NCT00179309|468028076|FG001|Treatment|Withdrawal by Subject|2|||
130018400|NCT00179309|468028075|FG000|Treatment|Allergy|1|||
130224285|NCT04577794|468784480|FG000|Overall Study|Adverse Event|1|||
130224286|NCT04577794|468784481|FG001|Overall Study|Adverse Event|1|||
130224287|NCT02849080|468784482|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
130018401|NCT00179309|468028076|FG001|Treatment|Allergy|0|||
130018402|NCT01678144|468028079|FG000|Stage 1: MAR Classic|Adverse Event|1|||
130224288|NCT02849080|468784483|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
130224289|NCT02849080|468784484|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
130224290|NCT02849080|468784485|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
130224291|NCT02849080|468784482|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
130224292|NCT02849080|468784483|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
130224293|NCT02849080|468784484|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
130224294|NCT02849080|468784485|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
130098790|NCT03426995|468319298|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130224295|NCT02849080|468784482|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
130224296|NCT02849080|468784483|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
130224297|NCT02849080|468784484|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
130224298|NCT02849080|468784485|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
130224299|NCT02849080|468784482|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
130224300|NCT02849080|468784483|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130224301|NCT02849080|468784484|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130224302|NCT02849080|468784485|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
130224303|NCT02849080|468784482|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
130224304|NCT02849080|468784483|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
130224305|NCT02849080|468784484|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
130224306|NCT02849080|468784485|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
130224307|NCT02849080|468784482|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
130224308|NCT02849080|468784483|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130224309|NCT02849080|468784484|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130224310|NCT02849080|468784485|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
130224311|NCT01819727|468784486|FG000|Overall Study|Adverse Event|8|||
130224312|NCT01819727|468784487|FG001|Overall Study|Adverse Event|9|||
130224313|NCT01819727|468784486|FG000|Overall Study|Death|1|||
130224314|NCT01819727|468784487|FG001|Overall Study|Death|0|||
130224315|NCT01819727|468784486|FG000|Overall Study|Lost to Follow-up|1|||
130224316|NCT01819727|468784487|FG001|Overall Study|Lost to Follow-up|1|||
130224317|NCT01819727|468784486|FG000|Overall Study|Physician Decision|3|||
130224318|NCT01819727|468784487|FG001|Overall Study|Physician Decision|2|||
130224319|NCT01819727|468784486|FG000|Overall Study|Pregnancy|1|||
130224320|NCT01819727|468784487|FG001|Overall Study|Pregnancy|0|||
130224321|NCT01819727|468784486|FG000|Overall Study|Protocol Violation|0|||
130224322|NCT01819727|468784487|FG001|Overall Study|Protocol Violation|2|||
130224323|NCT01819727|468784486|FG000|Overall Study|Study Terminated by Sponsor|0|||
130224324|NCT01819727|468784487|FG001|Overall Study|Study Terminated by Sponsor|1|||
130018403|NCT01709149|468028083|FG000|Open-label Lead-in Phase|Adverse Event|109|||
130018404|NCT01709149|468028084|FG001|Open-label Lead-in Phase|Adverse Event|0|||
130018405|NCT01709149|468028085|FG002|Open-label Lead-in Phase|Adverse Event|0|||
130018406|NCT01709149|468028083|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
130018407|NCT01709149|468028084|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
130018408|NCT01709149|468028085|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
130018409|NCT01709149|468028083|FG000|Open-label Lead-in Phase|Death|1|||
130018410|NCT01709149|468028084|FG001|Open-label Lead-in Phase|Death|0|||
130018411|NCT01709149|468028085|FG002|Open-label Lead-in Phase|Death|0|||
130018412|NCT01709149|468028083|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
130018413|NCT01709149|468028084|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
130018414|NCT01709149|468028085|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
130018415|NCT01709149|468028083|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
130018416|NCT01709149|468028084|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
130018417|NCT01709149|468028085|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
130018418|NCT01709149|468028083|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130018419|NCT01709149|468028084|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
130018420|NCT01709149|468028085|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
130018421|NCT01709149|468028083|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
130018422|NCT01709149|468028084|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
130224325|NCT01819727|468784486|FG000|Overall Study|Withdrawal by Subject|6|||
130224326|NCT01819727|468784487|FG001|Overall Study|Withdrawal by Subject|11|||
130224327|NCT01819727|468784486|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
130224328|NCT01819727|468784487|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
130224329|NCT01819727|468784486|FG000|Overall Study|Quit due to lack of health benifits|0|||
130224330|NCT01819727|468784487|FG001|Overall Study|Quit due to lack of health benifits|1|||
130224331|NCT03839394|468784491|FG000|Overall Study|Lost to Follow-up|6|||
130224332|NCT03839394|468784492|FG001|Overall Study|Lost to Follow-up|8|||
130224333|NCT03839394|468784491|FG000|Overall Study|Withdrawal by Subject|0|||
130018423|NCT01709149|468028085|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
130018424|NCT01709149|468028083|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
130018425|NCT01709149|468028084|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
130018426|NCT01709149|468028085|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
130018427|NCT01709149|468028083|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
130018428|NCT01709149|468028084|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
130018429|NCT01709149|468028085|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
130018430|NCT01709149|468028083|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130018431|NCT01709149|468028084|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
130018432|NCT01709149|468028085|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130018433|NCT02797808|468028086|FG000|Overall Study|Withdrawal by Subject|1|||
130018434|NCT02797808|468028087|FG001|Overall Study|Withdrawal by Subject|1|||
130018435|NCT02797808|468028086|FG000|Overall Study|Physician Decision|6|||
130018436|NCT02797808|468028087|FG001|Overall Study|Physician Decision|2|||
130018437|NCT02192827|468028088|FG000|Overall Study|Lost to Follow-up|25|||
130018438|NCT02192827|468028089|FG001|Overall Study|Lost to Follow-up|27|||
130018439|NCT02192827|468028088|FG000|Overall Study|Given additional steroids with admission|13|||
130018440|NCT02192827|468028089|FG001|Overall Study|Given additional steroids with admission|11|||
130018441|NCT05098041|468028092|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
130018442|NCT00797732|468028099|FG000|Overall Study|Withdrawal by Subject|3|||
130018443|NCT00797732|468028100|FG001|Overall Study|Withdrawal by Subject|3|||
130018444|NCT00797732|468028101|FG002|Overall Study|Withdrawal by Subject|0|||
130018445|NCT00797732|468028099|FG000|Overall Study|Lost to Follow-up|1|||
130018446|NCT00797732|468028100|FG001|Overall Study|Lost to Follow-up|0|||
130018447|NCT00797732|468028101|FG002|Overall Study|Lost to Follow-up|0|||
130018448|NCT00797732|468028099|FG000|Overall Study|Death|1|||
130018449|NCT00797732|468028100|FG001|Overall Study|Death|0|||
130018450|NCT00797732|468028101|FG002|Overall Study|Death|0|||
130018451|NCT00797732|468028099|FG000|Overall Study|Not meet inclusion criteria|0|||
130018452|NCT00797732|468028100|FG001|Overall Study|Not meet inclusion criteria|0|||
130018453|NCT00797732|468028101|FG002|Overall Study|Not meet inclusion criteria|7|||
130018454|NCT00797732|468028099|FG000|Overall Study|Excluded due to time constraints|0|||
130018455|NCT00797732|468028100|FG001|Overall Study|Excluded due to time constraints|0|||
130018456|NCT00797732|468028101|FG002|Overall Study|Excluded due to time constraints|24|||
130018457|NCT00797732|468028099|FG000|Overall Study|Refused to Participate|0|||
130018458|NCT00797732|468028100|FG001|Overall Study|Refused to Participate|0|||
130018459|NCT00797732|468028101|FG002|Overall Study|Refused to Participate|123|||
130018460|NCT00401752|468028102|FG000|Overall Study|Adverse Event|2|||
130018461|NCT00401752|468028103|FG001|Overall Study|Adverse Event|5|||
130018462|NCT00401752|468028102|FG000|Overall Study|Withdrawal by Subject|2|||
130018463|NCT00401752|468028103|FG001|Overall Study|Withdrawal by Subject|6|||
130018464|NCT00401752|468028102|FG000|Overall Study|Lost to Follow-up|1|||
130224334|NCT03839394|468784492|FG001|Overall Study|Withdrawal by Subject|2|||
130224335|NCT03101150|468785798|FG000|Overall Study|Lost to Follow-up|2|||
130018465|NCT00401752|468028103|FG001|Overall Study|Lost to Follow-up|4|||
130018466|NCT00401752|468028102|FG000|Overall Study|Development of any exclusion criteria|4|||
130018467|NCT00401752|468028103|FG001|Overall Study|Development of any exclusion criteria|2|||
130018468|NCT00401752|468028102|FG000|Overall Study|Physician Decision|1|||
130018469|NCT00401752|468028103|FG001|Overall Study|Physician Decision|1|||
130018470|NCT01895322|468028104|FG000|Overall Study|Adverse Event|1|||
130018471|NCT01895322|468028104|FG000|Overall Study|Withdrawal by Subject|2|||
130018472|NCT01895322|468028104|FG000|Overall Study|Protocol Violation|10|||
130224336|NCT03101150|468785799|FG001|Overall Study|Lost to Follow-up|4|||
130224337|NCT03101150|468785798|FG000|Overall Study|Miscarriage|3|||
130224338|NCT03101150|468785799|FG001|Overall Study|Miscarriage|6|||
130224339|NCT00611806|468785800|FG000|Overall Study|Withdrawal by Subject|8|||
130224340|NCT00611806|468785801|FG001|Overall Study|Withdrawal by Subject|2|||
130224341|NCT00611806|468785800|FG000|Overall Study|Adverse Event|2|||
130224342|NCT00611806|468785801|FG001|Overall Study|Adverse Event|1|||
130224343|NCT00611806|468785800|FG000|Overall Study|Lost to Follow-up|6|||
130224344|NCT00611806|468785801|FG001|Overall Study|Lost to Follow-up|0|||
130224345|NCT00715559|468785802|FG000|Overall Study|medication not tolerated - nausea|1|||
130224346|NCT02063672|468785805|FG000|Overall Study|Ongoing Follow-up|27|||
130224347|NCT02063672|468785806|FG001|Overall Study|Ongoing Follow-up|14|||
130224348|NCT02063672|468785805|FG000|Overall Study|Death|5|||
130224349|NCT02063672|468785806|FG001|Overall Study|Death|3|||
130224350|NCT02063672|468785805|FG000|Overall Study|Lost to Follow-up|1|||
130224351|NCT02063672|468785806|FG001|Overall Study|Lost to Follow-up|3|||
130224352|NCT02063672|468785805|FG000|Overall Study|Withdrawal by Subject|2|||
130224353|NCT02063672|468785806|FG001|Overall Study|Withdrawal by Subject|2|||
130224354|NCT02498678|468785807|FG000|Overall Study|interference from the surgical team|0|||
130224355|NCT02498678|468785808|FG001|Overall Study|interference from the surgical team|2|||
130224356|NCT00230048|468785813|FG000|Overall Study|Lost to Follow-up|13|||
130224357|NCT00230048|468785814|FG001|Overall Study|Lost to Follow-up|18|||
130224358|NCT01566604|468785815|FG000|Overall Study|Patient's inability to use the device|1|||
130224359|NCT01566604|468785816|FG001|Overall Study|Patient's inability to use the device|0|||
130224360|NCT01566604|468785815|FG000|Overall Study|Administrative problems|1|||
129884491|NCT04844918|467536416|FG001|Overall Study|Withdrawal by Subject|3|||
130224361|NCT01566604|468785816|FG001|Overall Study|Administrative problems|0|||
130224362|NCT01566604|468785815|FG000|Overall Study|Lack of Efficacy|1|||
129884492|NCT04844918|467536417|FG002|Overall Study|Withdrawal by Subject|3|||
130224363|NCT01566604|468785816|FG001|Overall Study|Lack of Efficacy|2|||
130224364|NCT01566604|468785815|FG000|Overall Study|Protocol deviation|2|||
130224365|NCT01566604|468785816|FG001|Overall Study|Protocol deviation|0|||
130224366|NCT01566604|468785815|FG000|Overall Study|Abnormal laboratory value|2|||
130224367|NCT01566604|468785816|FG001|Overall Study|Abnormal laboratory value|0|||
130224368|NCT01566604|468785815|FG000|Overall Study|Death|4|||
130224369|NCT01566604|468785816|FG001|Overall Study|Death|1|||
130224370|NCT01566604|468785815|FG000|Overall Study|Adverse Event|4|||
130224371|NCT01566604|468785816|FG001|Overall Study|Adverse Event|2|||
130224372|NCT01566604|468785815|FG000|Overall Study|Withdrawal by Subject|9|||
130224373|NCT01566604|468785816|FG001|Overall Study|Withdrawal by Subject|6|||
130224374|NCT03225170|468785817|FG000|Overall Study|Lost to Follow-up|4|||
130224375|NCT03225170|468785818|FG001|Overall Study|Lost to Follow-up|4|||
130224376|NCT03225170|468785819|FG002|Overall Study|Lost to Follow-up|0|||
130224377|NCT03225170|468785817|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
130224378|NCT03225170|468785818|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
130224379|NCT03225170|468785819|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
130224380|NCT00661089|468785826|FG000|Overall Study|1 subject withdrawal|0|||
130224381|NCT00661089|468785827|FG001|Overall Study|1 subject withdrawal|1|||
130224382|NCT00661089|468785826|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
130224383|NCT00661089|468785827|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
130224384|NCT00274742|468785828|FG000|Overall Study|Adverse Event|0|||
130018473|NCT02275338|468028105|FG000|Overall Study|Adverse Event|15|||
130018474|NCT02275338|468028105|FG000|Overall Study|Lack of Efficacy|3|||
130018475|NCT02275338|468028105|FG000|Overall Study|Withdrawal by Subject|4|||
130018476|NCT02275338|468028105|FG000|Overall Study|Disease progression (death)|1|||
130018477|NCT02275338|468028105|FG000|Overall Study|Ineligible to start Phase 2|4|||
130018478|NCT02275338|468028105|FG000|Overall Study|Reason not specified|5|||
130018479|NCT02275338|468028105|FG000|Overall Study|Does not meet entry criteria|1|||
130018480|NCT01857869|468028108|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
130018481|NCT01857869|468028109|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
130018482|NCT01857869|468028110|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
130018483|NCT01857869|468028111|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
130018484|NCT01857869|468028112|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
130224385|NCT00274742|468785829|FG001|Overall Study|Adverse Event|4|||
130224386|NCT00274742|468785830|FG002|Overall Study|Adverse Event|1|||
130224387|NCT00274742|468785831|FG003|Overall Study|Adverse Event|4|||
130224388|NCT00274742|468785832|FG004|Overall Study|Adverse Event|12|||
130224389|NCT00274742|468785833|FG005|Overall Study|Adverse Event|3|||
130224390|NCT00274742|468785828|FG000|Overall Study|Lost to Follow-up|0|||
130224391|NCT00274742|468785829|FG001|Overall Study|Lost to Follow-up|0|||
130224392|NCT00274742|468785830|FG002|Overall Study|Lost to Follow-up|0|||
130224393|NCT00274742|468785831|FG003|Overall Study|Lost to Follow-up|0|||
130018485|NCT01857869|468028113|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
130018486|NCT01857869|468028114|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
130018487|NCT01857869|468028115|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
130018488|NCT01857869|468028116|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
130018489|NCT01857869|468028117|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
130018490|NCT01857869|468028108|FG000|Primary/Challenge Phase|Pregnancy|1|||
130018491|NCT01857869|468028109|FG001|Primary/Challenge Phase|Pregnancy|0|||
130018492|NCT01857869|468028110|FG002|Primary/Challenge Phase|Pregnancy|0|||
130018493|NCT01857869|468028111|FG003|Primary/Challenge Phase|Pregnancy|0|||
130018494|NCT01857869|468028112|FG004|Primary/Challenge Phase|Pregnancy|0|||
130018495|NCT01857869|468028113|FG005|Primary/Challenge Phase|Pregnancy|0|||
130018496|NCT01857869|468028114|FG006|Primary/Challenge Phase|Pregnancy|0|||
130018497|NCT01857869|468028115|FG007|Primary/Challenge Phase|Pregnancy|0|||
130018498|NCT01857869|468028116|FG008|Primary/Challenge Phase|Pregnancy|0|||
130018499|NCT01857869|468028117|FG009|Primary/Challenge Phase|Pregnancy|0|||
130018500|NCT01857869|468028108|FG000|Primary/Challenge Phase|Protocol Violation|1|||
130018501|NCT01857869|468028109|FG001|Primary/Challenge Phase|Protocol Violation|0|||
130224394|NCT00274742|468785832|FG004|Overall Study|Lost to Follow-up|1|||
130224395|NCT00274742|468785833|FG005|Overall Study|Lost to Follow-up|0|||
130224396|NCT00274742|468785828|FG000|Overall Study|End of Study|0|||
130224397|NCT00274742|468785829|FG001|Overall Study|End of Study|0|||
130098791|NCT03426995|468319299|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
130018502|NCT01857869|468028110|FG002|Primary/Challenge Phase|Protocol Violation|0|||
130018503|NCT01857869|468028111|FG003|Primary/Challenge Phase|Protocol Violation|0|||
130018504|NCT01857869|468028112|FG004|Primary/Challenge Phase|Protocol Violation|0|||
130018505|NCT01857869|468028113|FG005|Primary/Challenge Phase|Protocol Violation|0|||
130018506|NCT01857869|468028114|FG006|Primary/Challenge Phase|Protocol Violation|0|||
130018507|NCT01857869|468028115|FG007|Primary/Challenge Phase|Protocol Violation|0|||
130018508|NCT01857869|468028116|FG008|Primary/Challenge Phase|Protocol Violation|0|||
130224398|NCT00274742|468785830|FG002|Overall Study|End of Study|0|||
130224399|NCT00274742|468785831|FG003|Overall Study|End of Study|1|||
130224400|NCT00274742|468785832|FG004|Overall Study|End of Study|0|||
130224401|NCT00274742|468785833|FG005|Overall Study|End of Study|0|||
130018509|NCT01857869|468028117|FG009|Primary/Challenge Phase|Protocol Violation|0|||
130224402|NCT00274742|468785828|FG000|Overall Study|Disease Progression|0|||
130018510|NCT01857869|468028108|FG000|Primary/Challenge Phase|Other|1|||
130018511|NCT01857869|468028109|FG001|Primary/Challenge Phase|Other|1|||
130018512|NCT01857869|468028110|FG002|Primary/Challenge Phase|Other|0|||
130018513|NCT01857869|468028111|FG003|Primary/Challenge Phase|Other|0|||
130018514|NCT01857869|468028112|FG004|Primary/Challenge Phase|Other|0|||
130018515|NCT01857869|468028113|FG005|Primary/Challenge Phase|Other|0|||
130018516|NCT01857869|468028114|FG006|Primary/Challenge Phase|Other|0|||
130018517|NCT01857869|468028115|FG007|Primary/Challenge Phase|Other|0|||
130018518|NCT01857869|468028116|FG008|Primary/Challenge Phase|Other|0|||
130018519|NCT01857869|468028117|FG009|Primary/Challenge Phase|Other|0|||
130018520|NCT01857869|468028108|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018521|NCT01857869|468028109|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018522|NCT01857869|468028110|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018523|NCT01857869|468028111|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
130018524|NCT01857869|468028112|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018525|NCT01857869|468028113|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018526|NCT01857869|468028114|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018527|NCT01857869|468028115|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018528|NCT01857869|468028116|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018529|NCT01857869|468028117|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
130018530|NCT01857869|468028108|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018531|NCT01857869|468028109|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018532|NCT01857869|468028110|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018533|NCT01857869|468028111|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
130018534|NCT01857869|468028112|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018535|NCT01857869|468028113|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018536|NCT01857869|468028114|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018537|NCT01857869|468028115|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018538|NCT01857869|468028116|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018539|NCT01857869|468028117|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
130018540|NCT04607733|468028123|FG000|Overall Study|Lost to Follow-up|1|||
130018541|NCT04607733|468028124|FG001|Overall Study|Lost to Follow-up|0|||
130018542|NCT04607733|468028125|FG002|Overall Study|Lost to Follow-up|0|||
130018543|NCT04607733|468028126|FG003|Overall Study|Lost to Follow-up|1|||
130018544|NCT04607733|468028127|FG004|Overall Study|Lost to Follow-up|1|||
130224403|NCT00274742|468785829|FG001|Overall Study|Disease Progression|1|||
130224404|NCT00274742|468785830|FG002|Overall Study|Disease Progression|1|||
130224405|NCT00274742|468785831|FG003|Overall Study|Disease Progression|0|||
130224406|NCT00274742|468785832|FG004|Overall Study|Disease Progression|1|||
130224407|NCT00274742|468785833|FG005|Overall Study|Disease Progression|0|||
130224408|NCT00274742|468785828|FG000|Overall Study|Other|0|||
130224409|NCT00274742|468785829|FG001|Overall Study|Other|3|||
130224410|NCT00274742|468785830|FG002|Overall Study|Other|0|||
130224411|NCT00274742|468785831|FG003|Overall Study|Other|0|||
130224412|NCT00274742|468785832|FG004|Overall Study|Other|2|||
130224413|NCT00274742|468785833|FG005|Overall Study|Other|0|||
130224414|NCT01529606|468785837|FG000|Overall Study|Lost to Follow-up|21|||
130224415|NCT01529606|468785838|FG001|Overall Study|Lost to Follow-up|18|||
130224416|NCT01900444|468785842|FG000|Overall Study|Protocol Violation|2|||
130224417|NCT01900444|468785842|FG000|Overall Study|Lost to Follow-up|1|||
130224418|NCT00072384|468785845|FG000|Overall Study|Physician Decision|1|||
130224419|NCT00072384|468785845|FG000|Overall Study|Ineligible|8|||
130224420|NCT01825200|468785846|FG000|Overall Study|Lost to Follow-up|5|||
130224421|NCT01825200|468785847|FG001|Overall Study|Lost to Follow-up|6|||
130224422|NCT01825200|468785846|FG000|Overall Study|Withdrawal by Subject|0|||
130224423|NCT01825200|468785847|FG001|Overall Study|Withdrawal by Subject|1|||
130224424|NCT00490035|468785848|FG000|Overall Study|AE, non-serious non-fatal|3|||
130224425|NCT00490035|468785849|FG001|Overall Study|AE, non-serious non-fatal|4|||
130224426|NCT00490035|468785850|FG002|Overall Study|AE, non-serious non-fatal|4|||
130224427|NCT00490035|468785851|FG003|Overall Study|AE, non-serious non-fatal|5|||
130224428|NCT00490035|468785848|FG000|Overall Study|Lost to Follow-up|2|||
130224429|NCT00490035|468785849|FG001|Overall Study|Lost to Follow-up|0|||
130224430|NCT00490035|468785850|FG002|Overall Study|Lost to Follow-up|1|||
130224431|NCT00490035|468785851|FG003|Overall Study|Lost to Follow-up|0|||
130224432|NCT00490035|468785848|FG000|Overall Study|Withdrawal by Subject|2|||
130224433|NCT00490035|468785849|FG001|Overall Study|Withdrawal by Subject|1|||
130224434|NCT00490035|468785850|FG002|Overall Study|Withdrawal by Subject|1|||
130224435|NCT00490035|468785851|FG003|Overall Study|Withdrawal by Subject|0|||
130224436|NCT00490035|468785848|FG000|Overall Study|Other reason|0|||
130224437|NCT00490035|468785849|FG001|Overall Study|Other reason|1|||
130224438|NCT00490035|468785850|FG002|Overall Study|Other reason|3|||
130224439|NCT00490035|468785851|FG003|Overall Study|Other reason|1|||
130224440|NCT00490035|468785848|FG000|Overall Study|AE, serious fatal|1|||
130224441|NCT00490035|468785849|FG001|Overall Study|AE, serious fatal|0|||
130224442|NCT00490035|468785850|FG002|Overall Study|AE, serious fatal|0|||
130224443|NCT00490035|468785851|FG003|Overall Study|AE, serious fatal|0|||
130224444|NCT00490035|468785848|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130224445|NCT00490035|468785849|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130224446|NCT00490035|468785850|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
130224447|NCT00490035|468785851|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
130224448|NCT00490035|468785848|FG000|Overall Study|AE of unknown type|0|||
130224449|NCT00490035|468785849|FG001|Overall Study|AE of unknown type|0|||
130224450|NCT00490035|468785850|FG002|Overall Study|AE of unknown type|2|||
130224451|NCT00490035|468785851|FG003|Overall Study|AE of unknown type|0|||
130224452|NCT00731822|468785855|FG000|Overall Study|Adverse Event|2|||
130224453|NCT00731822|468785856|FG001|Overall Study|Adverse Event|1|||
130224454|NCT00731822|468785855|FG000|Overall Study|Protocol Violation|1|||
130224455|NCT00731822|468785856|FG001|Overall Study|Protocol Violation|0|||
130224456|NCT00731822|468785855|FG000|Overall Study|Lost to Follow-up|1|||
130224457|NCT00731822|468785856|FG001|Overall Study|Lost to Follow-up|0|||
130018545|NCT04607733|468028128|FG005|Overall Study|Lost to Follow-up|0|||
130018546|NCT04607733|468028123|FG000|Overall Study|Withdrawal by Subject|0|||
130018547|NCT04607733|468028124|FG001|Overall Study|Withdrawal by Subject|0|||
130018548|NCT04607733|468028125|FG002|Overall Study|Withdrawal by Subject|0|||
130224458|NCT05209880|468785863|FG000|1-Month Follow-up|Spoke with Doctor|5|||
130224459|NCT05209880|468785864|FG001|1-Month Follow-up|Spoke with Doctor|5|||
130224460|NCT05209880|468785863|FG000|1-Month Follow-up|Lost to Follow-up|7|||
130224461|NCT05209880|468785864|FG001|1-Month Follow-up|Lost to Follow-up|9|||
130224462|NCT05209880|468785863|FG000|1-Month Follow-up|Discontinued|0|||
130224463|NCT05209880|468785864|FG001|1-Month Follow-up|Discontinued|1|||
130224464|NCT05209880|468785863|FG000|3-Month Follow-up|Spoke with Doctor|17|||
130224465|NCT05209880|468785864|FG001|3-Month Follow-up|Spoke with Doctor|7|||
130224466|NCT05209880|468785863|FG000|3-Month Follow-up|Lost to Follow-up|8|||
130224467|NCT05209880|468785864|FG001|3-Month Follow-up|Lost to Follow-up|10|||
130224468|NCT05209880|468785863|FG000|3-Month Follow-up|Discontinued|1|||
130224469|NCT05209880|468785864|FG001|3-Month Follow-up|Discontinued|3|||
130224470|NCT05209880|468785863|FG000|6-Month Follow-up|Spoke with Doctor|25|||
130224471|NCT05209880|468785864|FG001|6-Month Follow-up|Spoke with Doctor|14|||
130224472|NCT05209880|468785863|FG000|6-Month Follow-up|Lost to Follow-up|9|||
130224473|NCT05209880|468785864|FG001|6-Month Follow-up|Lost to Follow-up|14|||
130224474|NCT05209880|468785863|FG000|6-Month Follow-up|Discontinued|1|||
130224475|NCT05209880|468785864|FG001|6-Month Follow-up|Discontinued|3|||
130224476|NCT04817332|468785865|FG000|Overall Study|Lost to Follow-up|3|||
130224477|NCT04817332|468785866|FG001|Overall Study|Lost to Follow-up|3|||
130224478|NCT04817332|468785865|FG000|Overall Study|Protocol Violation|2|||
130224479|NCT04817332|468785866|FG001|Overall Study|Protocol Violation|0|||
130224480|NCT04795466|468785872|FG000|Overall Study|Adverse Event|3|||
130224481|NCT04795466|468785873|FG001|Overall Study|Adverse Event|1|||
130224482|NCT04795466|468785872|FG000|Overall Study|Physician Decision|1|||
130224483|NCT04795466|468785873|FG001|Overall Study|Physician Decision|0|||
130224484|NCT04795466|468785872|FG000|Overall Study|Withdrawal by Subject|2|||
130224485|NCT04795466|468785873|FG001|Overall Study|Withdrawal by Subject|1|||
130224486|NCT05635045|468785874|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130224487|NCT05635045|468785875|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130224488|NCT05635045|468785876|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
130224489|NCT05635045|468785877|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
130224490|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
130224491|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
130224492|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
130224493|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
130224494|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
130224495|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
130224496|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
130224497|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224498|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224499|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224500|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224501|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
130224502|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
130224503|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224504|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224505|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224506|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224507|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
130224508|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
130224509|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224510|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224511|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224512|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224513|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
130224514|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
130224515|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224516|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224517|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224518|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224519|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224520|NCT01435759|468785881|FG000|Antidepressant Lead-in Phase|Other|119|||
130224521|NCT01435759|468785882|FG001|Antidepressant Lead-in Phase|Other|0|||
130224522|NCT01435759|468785883|FG002|Antidepressant Lead-in Phase|Other|0|||
130224523|NCT01435759|468785884|FG003|Antidepressant Lead-in Phase|Other|0|||
130224524|NCT01435759|468785885|FG004|Antidepressant Lead-in Phase|Other|0|||
130018549|NCT04607733|468028126|FG003|Overall Study|Withdrawal by Subject|0|||
130018550|NCT04607733|468028127|FG004|Overall Study|Withdrawal by Subject|1|||
130018551|NCT04607733|468028128|FG005|Overall Study|Withdrawal by Subject|0|||
130018552|NCT03603496|468028163|FG000|Overall Study|Death|19|||
130018553|NCT03603496|468028164|FG001|Overall Study|Death|24|||
130018554|NCT03603496|468028163|FG000|Overall Study|Lost to Follow-up|141|||
130018555|NCT03603496|468028164|FG001|Overall Study|Lost to Follow-up|141|||
130018556|NCT03603496|468028163|FG000|Overall Study|Withdrawal by Subject|26|||
130018557|NCT03603496|468028164|FG001|Overall Study|Withdrawal by Subject|20|||
130224525|NCT01435759|468785886|FG005|Antidepressant Lead-in Phase|Other|0|||
130224526|NCT01435759|468785881|FG000|Double-blind Phase|Adverse Event|7|||
130224527|NCT01435759|468785882|FG001|Double-blind Phase|Adverse Event|0|||
130224528|NCT01435759|468785883|FG002|Double-blind Phase|Adverse Event|1|||
130224529|NCT01435759|468785884|FG003|Double-blind Phase|Adverse Event|1|||
130224530|NCT01435759|468785885|FG004|Double-blind Phase|Adverse Event|1|||
130224531|NCT01435759|468785886|FG005|Double-blind Phase|Adverse Event|3|||
130224532|NCT01435759|468785881|FG000|Double-blind Phase|Protocol Violation|2|||
130224533|NCT01435759|468785882|FG001|Double-blind Phase|Protocol Violation|0|||
130224534|NCT01435759|468785883|FG002|Double-blind Phase|Protocol Violation|1|||
130224535|NCT01435759|468785884|FG003|Double-blind Phase|Protocol Violation|2|||
130224536|NCT01435759|468785885|FG004|Double-blind Phase|Protocol Violation|0|||
130224537|NCT01435759|468785886|FG005|Double-blind Phase|Protocol Violation|1|||
130224538|NCT01435759|468785881|FG000|Double-blind Phase|Withdrawal by Subject|17|||
130224539|NCT01435759|468785882|FG001|Double-blind Phase|Withdrawal by Subject|4|||
130224540|NCT01435759|468785883|FG002|Double-blind Phase|Withdrawal by Subject|3|||
130224541|NCT01435759|468785884|FG003|Double-blind Phase|Withdrawal by Subject|4|||
130224542|NCT01435759|468785885|FG004|Double-blind Phase|Withdrawal by Subject|2|||
130224543|NCT01435759|468785886|FG005|Double-blind Phase|Withdrawal by Subject|2|||
130224544|NCT01435759|468785881|FG000|Double-blind Phase|Lost to Follow-up|31|||
130224545|NCT01435759|468785882|FG001|Double-blind Phase|Lost to Follow-up|1|||
130224546|NCT01435759|468785883|FG002|Double-blind Phase|Lost to Follow-up|2|||
130224547|NCT01435759|468785884|FG003|Double-blind Phase|Lost to Follow-up|0|||
130224548|NCT01435759|468785885|FG004|Double-blind Phase|Lost to Follow-up|3|||
130224549|NCT01435759|468785886|FG005|Double-blind Phase|Lost to Follow-up|3|||
130224550|NCT01435759|468785881|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
130224551|NCT01435759|468785882|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224552|NCT01435759|468785883|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224553|NCT01435759|468785884|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224554|NCT01435759|468785885|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
130224555|NCT01435759|468785886|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
130224556|NCT01435759|468785881|FG000|Double-blind Phase|Other|8|||
130224557|NCT01435759|468785882|FG001|Double-blind Phase|Other|2|||
130224558|NCT01435759|468785883|FG002|Double-blind Phase|Other|0|||
130224559|NCT01435759|468785884|FG003|Double-blind Phase|Other|2|||
130224560|NCT01435759|468785885|FG004|Double-blind Phase|Other|0|||
130224561|NCT01435759|468785886|FG005|Double-blind Phase|Other|0|||
130224562|NCT02849587|468785889|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
130224563|NCT02849587|468785890|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
130224564|NCT02849587|468785891|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
130224565|NCT02849587|468785889|FG000|Overall Study|Withdrawal by Subject|0|||
130224566|NCT02849587|468785890|FG001|Overall Study|Withdrawal by Subject|1|||
130224567|NCT02849587|468785891|FG002|Overall Study|Withdrawal by Subject|0|||
130224568|NCT02421419|468785893|FG000|Overall Study|Physician Decision|0|||
130224569|NCT02421419|468785894|FG001|Overall Study|Physician Decision|0|||
130224570|NCT02421419|468785895|FG002|Overall Study|Physician Decision|1|||
130224571|NCT01365130|468785899|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
130224572|NCT00810199|468785901|FG000|Overall Study|Adverse Event|24|||
130224573|NCT00810199|468785902|FG001|Overall Study|Adverse Event|26|||
130224574|NCT00810199|468785901|FG000|Overall Study|Death|4|||
130224575|NCT00810199|468785902|FG001|Overall Study|Death|6|||
130224576|NCT00810199|468785901|FG000|Overall Study|Withdrew consent|9|||
130224577|NCT00810199|468785902|FG001|Overall Study|Withdrew consent|12|||
130224578|NCT00810199|468785901|FG000|Overall Study|Insufficient therapeutic response|5|||
130224579|NCT00810199|468785902|FG001|Overall Study|Insufficient therapeutic response|14|||
130224580|NCT00810199|468785901|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
130224581|NCT00810199|468785902|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
130224582|NCT00810199|468785901|FG000|Overall Study|Administrative/Other|5|||
130224583|NCT00810199|468785902|FG001|Overall Study|Administrative/Other|6|||
130224584|NCT00810199|468785901|FG000|Overall Study|Protocol Violation|2|||
130224585|NCT00810199|468785902|FG001|Overall Study|Protocol Violation|6|||
130224586|NCT00810199|468785901|FG000|Overall Study|Failure to return|1|||
130224587|NCT00810199|468785902|FG001|Overall Study|Failure to return|4|||
130224588|NCT00810199|468785901|FG000|Overall Study|Did not receive study drug|2|||
130224589|NCT00810199|468785902|FG001|Overall Study|Did not receive study drug|1|||
130224590|NCT05502302|468785903|FG000|Overall Study|Lost to Follow-up|6|||
130224591|NCT05502302|468785903|FG000|Overall Study|Death|2|||
130224592|NCT01628848|468785907|FG000|Overall Study|Adverse Event|9|||
130224593|NCT01628848|468785908|FG001|Overall Study|Adverse Event|7|||
130224594|NCT01628848|468785907|FG000|Overall Study|Lack of Efficacy|0|||
130224595|NCT01628848|468785908|FG001|Overall Study|Lack of Efficacy|4|||
130224596|NCT01628848|468785907|FG000|Overall Study|Withdrawal by Subject|0|||
130224597|NCT01628848|468785908|FG001|Overall Study|Withdrawal by Subject|2|||
130224598|NCT01628848|468785907|FG000|Overall Study|Physician Decision|3|||
130224599|NCT01628848|468785908|FG001|Overall Study|Physician Decision|1|||
130224600|NCT00003471|468785909|FG000|Overall Study|Not evaluable|4|||
130224601|NCT02104895|468785910|FG000|Overall Study|Withdrawal by Subject|0|||
130224602|NCT02104895|468785911|FG001|Overall Study|Withdrawal by Subject|14|||
130224603|NCT01107925|468785913|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
130224604|NCT01107925|468785914|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224605|NCT01107925|468785915|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224606|NCT01107925|468785916|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224607|NCT01107925|468785917|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
130224608|NCT01107925|468785918|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
130224609|NCT01107925|468785913|FG000|Period 2|Withdrawal by Subject|0|||
130224610|NCT01107925|468785914|FG001|Period 2|Withdrawal by Subject|1|||
130224611|NCT01107925|468785915|FG002|Period 2|Withdrawal by Subject|0|||
130224612|NCT01107925|468785916|FG003|Period 2|Withdrawal by Subject|0|||
130224613|NCT01107925|468785917|FG004|Period 2|Withdrawal by Subject|0|||
130224614|NCT01107925|468785918|FG005|Period 2|Withdrawal by Subject|1|||
130224615|NCT03311945|468785919|FG000|Overall Study|Adverse Event|2|||
130224616|NCT03311945|468785919|FG000|Overall Study|Lack of Efficacy|1|||
130224617|NCT01619878|468785920|FG000|6 Week Follow-up Phase|Adverse Event|1|||
130224618|NCT01619878|468785920|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
130224619|NCT01619878|468785920|FG000|Follow-up at 12 Months of Age|Death|2|||
130224620|NCT02895295|468785923|FG000|Overall Study|Survey Non-response|71|||
130224621|NCT02895295|468785924|FG001|Overall Study|Survey Non-response|94|||
130224622|NCT02895295|468785925|FG002|Overall Study|Survey Non-response|92|||
130224623|NCT04821830|468785926|FG000|Overall Study|Withdrawal by Subject|1|||
130224624|NCT04821830|468785927|FG001|Overall Study|Withdrawal by Subject|0|||
130224625|NCT00960804|468785928|FG000|Overall Study|Adverse Event|1|||
130224626|NCT00960804|468785929|FG001|Overall Study|Adverse Event|0|||
130224627|NCT00960804|468785930|FG002|Overall Study|Adverse Event|0|||
130224628|NCT00960804|468785928|FG000|Overall Study|Withdrawal by Subject|1|||
130224629|NCT00960804|468785929|FG001|Overall Study|Withdrawal by Subject|0|||
130224630|NCT00960804|468785930|FG002|Overall Study|Withdrawal by Subject|0|||
130224631|NCT00960804|468785928|FG000|Overall Study|Study terminated by the sponsor|5|||
130224632|NCT00960804|468785929|FG001|Overall Study|Study terminated by the sponsor|4|||
130224633|NCT00960804|468785930|FG002|Overall Study|Study terminated by the sponsor|10|||
130224634|NCT03810456|468785931|FG000|Treatment|Urgent Family Matters|3|||
130224635|NCT03810456|468785932|FG001|Treatment|Urgent Family Matters|0|||
130224636|NCT03810456|468785933|FG002|Treatment|Urgent Family Matters|0|||
130224637|NCT03810456|468785931|FG000|Treatment|Scheduling Conflicts|0|||
130224638|NCT03810456|468785932|FG001|Treatment|Scheduling Conflicts|11|||
130224639|NCT03810456|468785933|FG002|Treatment|Scheduling Conflicts|0|||
130224640|NCT03810456|468785931|FG000|Treatment|No Longer Interested|0|||
130224641|NCT03810456|468785932|FG001|Treatment|No Longer Interested|12|||
130224642|NCT03810456|468785933|FG002|Treatment|No Longer Interested|0|||
130224643|NCT03810456|468785931|FG000|Treatment|Transportation Issues|0|||
130224644|NCT03810456|468785932|FG001|Treatment|Transportation Issues|1|||
130224645|NCT03810456|468785933|FG002|Treatment|Transportation Issues|0|||
130224646|NCT03810456|468785931|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
130224647|NCT03810456|468785932|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
130224648|NCT03810456|468785933|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
130224649|NCT03810456|468785931|FG000|1 Month Follow-Up|Relocated to Different State|1|||
130224650|NCT03810456|468785932|FG001|1 Month Follow-Up|Relocated to Different State|0|||
130224651|NCT03810456|468785933|FG002|1 Month Follow-Up|Relocated to Different State|1|||
130224652|NCT03810456|468785931|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
130224653|NCT03810456|468785932|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
130224654|NCT03810456|468785933|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
130224655|NCT03810456|468785931|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
130224656|NCT03810456|468785932|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
130224657|NCT03810456|468785933|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
130224658|NCT03810456|468785931|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
130224659|NCT03810456|468785932|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
130224660|NCT03810456|468785933|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
130224661|NCT03810456|468785931|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
130224662|NCT03810456|468785932|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
130224663|NCT03810456|468785933|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
130224664|NCT03810456|468785931|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
130224665|NCT03810456|468785932|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
130224666|NCT03810456|468785933|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
130224667|NCT00490919|468785934|FG000|Open-label Run-in Period|Adverse Event|239|||
130224668|NCT00490919|468785935|FG001|Open-label Run-in Period|Adverse Event|0|||
130098792|NCT03426995|468319300|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130224669|NCT00490919|468785936|FG002|Open-label Run-in Period|Adverse Event|0|||
130224670|NCT00490919|468785934|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
130224671|NCT00490919|468785935|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130224672|NCT00490919|468785936|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130224673|NCT00490919|468785934|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
130224674|NCT00490919|468785935|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130224675|NCT00490919|468785936|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130224676|NCT00490919|468785934|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
130224677|NCT00490919|468785935|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130224678|NCT00490919|468785936|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130224679|NCT00490919|468785934|FG000|Open-label Run-in Period|Administrative|40|||
130224680|NCT00490919|468785935|FG001|Open-label Run-in Period|Administrative|0|||
130224681|NCT00490919|468785936|FG002|Open-label Run-in Period|Administrative|0|||
130224682|NCT00490919|468785934|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
130224683|NCT00490919|468785935|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
130224684|NCT00490919|468785936|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
130224685|NCT00490919|468785934|FG000|Double-blind Phase|Adverse Event|0|||
130224686|NCT00490919|468785935|FG001|Double-blind Phase|Adverse Event|40|||
130224687|NCT00490919|468785936|FG002|Double-blind Phase|Adverse Event|20|||
130224688|NCT00490919|468785934|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130224689|NCT00490919|468785935|FG001|Double-blind Phase|Withdrawal by Subject|10|||
130224690|NCT00490919|468785936|FG002|Double-blind Phase|Withdrawal by Subject|11|||
130224691|NCT00490919|468785934|FG000|Double-blind Phase|Lost to Follow-up|0|||
130224692|NCT00490919|468785935|FG001|Double-blind Phase|Lost to Follow-up|8|||
130224693|NCT00490919|468785936|FG002|Double-blind Phase|Lost to Follow-up|11|||
130224694|NCT00490919|468785934|FG000|Double-blind Phase|Lack of Efficacy|0|||
130224695|NCT00490919|468785935|FG001|Double-blind Phase|Lack of Efficacy|22|||
130224696|NCT00490919|468785936|FG002|Double-blind Phase|Lack of Efficacy|36|||
130224697|NCT00490919|468785934|FG000|Double-blind Phase|Administrative|0|||
130224698|NCT00490919|468785935|FG001|Double-blind Phase|Administrative|6|||
130224699|NCT00490919|468785936|FG002|Double-blind Phase|Administrative|6|||
130224700|NCT03163446|468787918|FG000|Overall Study|Unable to return for Day 180 visit|2|||
130224701|NCT03163446|468787919|FG001|Overall Study|Unable to return for Day 180 visit|0|||
130224702|NCT03163446|468787918|FG000|Overall Study|Withdrawal by Subject|2|||
130224703|NCT03163446|468787919|FG001|Overall Study|Withdrawal by Subject|6|||
130224704|NCT03163446|468787918|FG000|Overall Study|Death|16|||
130224705|NCT03163446|468787919|FG001|Overall Study|Death|5|||
130224706|NCT03163446|468787918|FG000|Overall Study|Lost to Follow-up|6|||
130224707|NCT03163446|468787919|FG001|Overall Study|Lost to Follow-up|5|||
130224708|NCT03163446|468787918|FG000|Overall Study|Physician Decision|1|||
130224709|NCT03163446|468787919|FG001|Overall Study|Physician Decision|1|||
130224710|NCT03163446|468787918|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
130224711|NCT03163446|468787919|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
130224712|NCT01317641|468787920|FG000|Overall Study|Not treated|0|||
130224713|NCT01317641|468787921|FG001|Overall Study|Not treated|0|||
130224714|NCT01317641|468787922|FG002|Overall Study|Not treated|0|||
130224715|NCT01317641|468787923|FG003|Overall Study|Not treated|0|||
130224716|NCT01317641|468787924|FG004|Overall Study|Not treated|0|||
130224717|NCT01317641|468787925|FG005|Overall Study|Not treated|0|||
130224718|NCT01317641|468787926|FG006|Overall Study|Not treated|0|||
130224719|NCT01317641|468787927|FG007|Overall Study|Not treated|1|||
130224720|NCT01317641|468787928|FG008|Overall Study|Not treated|1|||
130224721|NCT01317641|468787920|FG000|Overall Study|Adverse Event|0|||
130224722|NCT01317641|468787921|FG001|Overall Study|Adverse Event|1|||
130224723|NCT01317641|468787922|FG002|Overall Study|Adverse Event|0|||
130224724|NCT01317641|468787923|FG003|Overall Study|Adverse Event|1|||
130224725|NCT01317641|468787924|FG004|Overall Study|Adverse Event|0|||
130224726|NCT01317641|468787925|FG005|Overall Study|Adverse Event|0|||
130224727|NCT01317641|468787926|FG006|Overall Study|Adverse Event|2|||
130224728|NCT01317641|468787927|FG007|Overall Study|Adverse Event|1|||
130224729|NCT01317641|468787928|FG008|Overall Study|Adverse Event|0|||
130224730|NCT01317641|468787920|FG000|Overall Study|Protocol Violation|1|||
130224731|NCT01317641|468787921|FG001|Overall Study|Protocol Violation|0|||
130224732|NCT01317641|468787922|FG002|Overall Study|Protocol Violation|0|||
130224733|NCT01317641|468787923|FG003|Overall Study|Protocol Violation|0|||
130224734|NCT01317641|468787924|FG004|Overall Study|Protocol Violation|0|||
130224735|NCT01317641|468787925|FG005|Overall Study|Protocol Violation|0|||
130224736|NCT01317641|468787926|FG006|Overall Study|Protocol Violation|0|||
130224737|NCT01317641|468787927|FG007|Overall Study|Protocol Violation|0|||
130224738|NCT01317641|468787928|FG008|Overall Study|Protocol Violation|0|||
130224739|NCT01317641|468787920|FG000|Overall Study|Disease progression|0|||
130224740|NCT01317641|468787921|FG001|Overall Study|Disease progression|0|||
130224741|NCT01317641|468787922|FG002|Overall Study|Disease progression|0|||
130224742|NCT01317641|468787923|FG003|Overall Study|Disease progression|0|||
130224743|NCT01317641|468787924|FG004|Overall Study|Disease progression|0|||
130224744|NCT01317641|468787925|FG005|Overall Study|Disease progression|0|||
130224745|NCT01317641|468787926|FG006|Overall Study|Disease progression|0|||
130224746|NCT01317641|468787927|FG007|Overall Study|Disease progression|3|||
130224747|NCT01317641|468787928|FG008|Overall Study|Disease progression|4|||
130224748|NCT01317641|468787920|FG000|Overall Study|Withdrawal by Subject|0|||
130224749|NCT01317641|468787921|FG001|Overall Study|Withdrawal by Subject|0|||
130224750|NCT01317641|468787922|FG002|Overall Study|Withdrawal by Subject|0|||
130224751|NCT01317641|468787923|FG003|Overall Study|Withdrawal by Subject|0|||
130224752|NCT01317641|468787924|FG004|Overall Study|Withdrawal by Subject|0|||
130224753|NCT01317641|468787925|FG005|Overall Study|Withdrawal by Subject|0|||
130224754|NCT01317641|468787926|FG006|Overall Study|Withdrawal by Subject|1|||
130224755|NCT01317641|468787927|FG007|Overall Study|Withdrawal by Subject|0|||
130224756|NCT01317641|468787928|FG008|Overall Study|Withdrawal by Subject|0|||
130224757|NCT01228591|468787929|FG000|Baseline|Lack of Efficacy|1|||
130224758|NCT01228591|468787930|FG001|Baseline|Lack of Efficacy|2|||
130224759|NCT01921517|468787931|FG000|Overall Study|Lost to Follow-up|5|||
130224760|NCT01921517|468787932|FG001|Overall Study|Lost to Follow-up|0|||
130224761|NCT01921517|468787931|FG000|Overall Study|Newly diagnosed health concern|2|||
130224762|NCT01921517|468787932|FG001|Overall Study|Newly diagnosed health concern|0|||
130224763|NCT01921517|468787931|FG000|Overall Study|Physician Decision|0|||
130224764|NCT01921517|468787932|FG001|Overall Study|Physician Decision|2|||
130224765|NCT01921517|468787931|FG000|Overall Study|Withdrawal by Subject|7|||
130224766|NCT01921517|468787932|FG001|Overall Study|Withdrawal by Subject|3|||
130224767|NCT01921517|468787931|FG000|Overall Study|Subject missed final imaging|1|||
130224768|NCT01921517|468787932|FG001|Overall Study|Subject missed final imaging|4|||
130224769|NCT03110354|468787938|FG000|Overall Study|Death|1|||
130224770|NCT03110354|468787939|FG001|Overall Study|Death|0|||
130224771|NCT03110354|468787940|FG002|Overall Study|Death|0|||
130224772|NCT03110354|468787941|FG003|Overall Study|Death|1|||
130224773|NCT03110354|468787942|FG004|Overall Study|Death|0|||
130224774|NCT03110354|468787938|FG000|Overall Study|Start of new therapy|0|||
130224775|NCT03110354|468787939|FG001|Overall Study|Start of new therapy|0|||
130224776|NCT03110354|468787940|FG002|Overall Study|Start of new therapy|0|||
130224777|NCT03110354|468787941|FG003|Overall Study|Start of new therapy|0|||
130224778|NCT03110354|468787942|FG004|Overall Study|Start of new therapy|1|||
130224779|NCT03110354|468787938|FG000|Overall Study|Failure to achieve response|2|||
130224780|NCT03110354|468787939|FG001|Overall Study|Failure to achieve response|3|||
130224781|NCT03110354|468787940|FG002|Overall Study|Failure to achieve response|0|||
130224782|NCT03110354|468787941|FG003|Overall Study|Failure to achieve response|2|||
130224783|NCT03110354|468787942|FG004|Overall Study|Failure to achieve response|1|||
130224784|NCT03110354|468787938|FG000|Overall Study|Progressive disease|1|||
130224785|NCT03110354|468787939|FG001|Overall Study|Progressive disease|1|||
130224786|NCT03110354|468787940|FG002|Overall Study|Progressive disease|3|||
130224787|NCT03110354|468787941|FG003|Overall Study|Progressive disease|4|||
130224788|NCT03110354|468787942|FG004|Overall Study|Progressive disease|2|||
130224789|NCT03110354|468787938|FG000|Overall Study|Adverse Event|0|||
130224790|NCT03110354|468787939|FG001|Overall Study|Adverse Event|0|||
130224791|NCT03110354|468787940|FG002|Overall Study|Adverse Event|0|||
130224792|NCT03110354|468787941|FG003|Overall Study|Adverse Event|2|||
130224793|NCT03110354|468787942|FG004|Overall Study|Adverse Event|2|||
130224794|NCT03110354|468787938|FG000|Overall Study|Other|0|||
130224795|NCT03110354|468787939|FG001|Overall Study|Other|0|||
130224796|NCT03110354|468787940|FG002|Overall Study|Other|0|||
130224797|NCT03110354|468787941|FG003|Overall Study|Other|1|||
130224798|NCT03110354|468787942|FG004|Overall Study|Other|1|||
130224799|NCT00116688|468787948|FG000|Overall Study|Protocol deviation|1|||
130224800|NCT00116688|468787949|FG001|Overall Study|Protocol deviation|0|||
130224801|NCT00116688|468787948|FG000|Overall Study|Noncompliance|3|||
130224802|NCT00116688|468787949|FG001|Overall Study|Noncompliance|1|||
130224803|NCT00116688|468787948|FG000|Overall Study|Adverse Event|11|||
130224804|NCT00116688|468787949|FG001|Overall Study|Adverse Event|0|||
130224805|NCT00116688|468787948|FG000|Overall Study|Withdrawal by Subject|26|||
130224806|NCT00116688|468787949|FG001|Overall Study|Withdrawal by Subject|2|||
130224807|NCT00116688|468787948|FG000|Overall Study|Requirement for alternative therapy|11|||
130224808|NCT00116688|468787949|FG001|Overall Study|Requirement for alternative therapy|1|||
130224809|NCT00116688|468787948|FG000|Overall Study|Physician Decision|7|||
130224810|NCT00116688|468787949|FG001|Overall Study|Physician Decision|0|||
130224811|NCT00116688|468787948|FG000|Overall Study|Lost to Follow-up|3|||
130224812|NCT00116688|468787949|FG001|Overall Study|Lost to Follow-up|0|||
130224813|NCT00116688|468787948|FG000|Overall Study|Death|15|||
130224814|NCT00116688|468787949|FG001|Overall Study|Death|0|||
130018558|NCT00774345|468028165|FG000|Pre-treatment|Other reasons|2|||
130018559|NCT00774345|468028166|FG001|Pre-treatment|Other reasons|0|||
130018560|NCT00774345|468028165|FG000|Treatment|Adverse Event|61|||
130018561|NCT00774345|468028166|FG001|Treatment|Adverse Event|15|||
130018562|NCT00774345|468028165|FG000|Treatment|Progressive Disease without histologic transformation|51|||
130018563|NCT00774345|468028166|FG001|Treatment|Progressive Disease without histologic transformation|111|||
130018564|NCT00774345|468028165|FG000|Treatment|Progressive Disease with histologic transformation|4|||
130018565|NCT00774345|468028166|FG001|Treatment|Progressive Disease with histologic transformation|2|||
130018566|NCT00774345|468028165|FG000|Treatment|Withdrawal by Subject|5|||
130018567|NCT00774345|468028166|FG001|Treatment|Withdrawal by Subject|2|||
130018568|NCT00774345|468028165|FG000|Treatment|Lost to Follow-up|1|||
130018569|NCT00774345|468028166|FG001|Treatment|Lost to Follow-up|1|||
130018570|NCT00774345|468028165|FG000|Treatment|Death|4|||
130018571|NCT00774345|468028166|FG001|Treatment|Death|0|||
130018572|NCT00774345|468028165|FG000|Treatment|Other Reasons|32|||
130018573|NCT00774345|468028166|FG001|Treatment|Other Reasons|26|||
130018574|NCT00835237|468028167|FG000|Overall Study|Lost to Follow-up|4|||
130018575|NCT00835237|468028168|FG001|Overall Study|Lost to Follow-up|0|||
130018576|NCT00835237|468028167|FG000|Overall Study|Withdrawal by Subject|2|||
130018577|NCT00835237|468028168|FG001|Overall Study|Withdrawal by Subject|0|||
130018578|NCT01265550|468028169|FG000|Pre Randomization|Withdrawal by Subject|0|||
130018579|NCT01265550|468028170|FG001|Pre Randomization|Withdrawal by Subject|0|||
130018580|NCT01265550|468028171|FG002|Pre Randomization|Withdrawal by Subject|0|||
130018581|NCT01265550|468028172|FG003|Pre Randomization|Withdrawal by Subject|70|||
130018582|NCT01265550|468028169|FG000|Pre Randomization|Technical Exclusions|0|||
130018583|NCT01265550|468028170|FG001|Pre Randomization|Technical Exclusions|0|||
130018584|NCT01265550|468028171|FG002|Pre Randomization|Technical Exclusions|0|||
130018585|NCT01265550|468028172|FG003|Pre Randomization|Technical Exclusions|54|||
130018586|NCT01265550|468028169|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
130018587|NCT01265550|468028170|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
130018588|NCT01265550|468028171|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
130018589|NCT01265550|468028172|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
130018590|NCT01265550|468028169|FG000|Pre Randomization|Non-GERD organic disorders|0|||
130018591|NCT01265550|468028170|FG001|Pre Randomization|Non-GERD organic disorders|0|||
130018592|NCT01265550|468028171|FG002|Pre Randomization|Non-GERD organic disorders|0|||
130018593|NCT01265550|468028172|FG003|Pre Randomization|Non-GERD organic disorders|23|||
130018594|NCT01265550|468028169|FG000|Pre Randomization|Functional heartburn|0|||
130018595|NCT01265550|468028170|FG001|Pre Randomization|Functional heartburn|0|||
130018596|NCT01265550|468028171|FG002|Pre Randomization|Functional heartburn|0|||
130018597|NCT01265550|468028172|FG003|Pre Randomization|Functional heartburn|99|||
130018598|NCT00623428|468028175|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
130018599|NCT00623428|468028176|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
130018600|NCT00623428|468028175|FG000|Treatment Period|Death|0|||
130018601|NCT00623428|468028176|FG001|Treatment Period|Death|1|||
130018602|NCT00623428|468028175|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
130018603|NCT00623428|468028176|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
130018604|NCT00623428|468028175|FG000|Treatment Period|Insufficient therapeutic response|0|||
130018605|NCT00623428|468028176|FG001|Treatment Period|Insufficient therapeutic response|2|||
130018606|NCT00623428|468028175|FG000|Treatment Period|Other|0|||
130018607|NCT00623428|468028176|FG001|Treatment Period|Other|1|||
130018608|NCT00623428|468028175|FG000|Treatment Period|Withdrawal by Subject|0|||
130018609|NCT00623428|468028176|FG001|Treatment Period|Withdrawal by Subject|1|||
130018610|NCT00623428|468028175|FG000|Follow-up Period|Relapse post-treatment|11|||
130018611|NCT00623428|468028176|FG001|Follow-up Period|Relapse post-treatment|3|||
130018612|NCT00623428|468028175|FG000|Follow-up Period|Failure to return|10|||
130018613|NCT00623428|468028176|FG001|Follow-up Period|Failure to return|2|||
130018614|NCT00623428|468028175|FG000|Follow-up Period|Patient withdrew consent|5|||
130018615|NCT00623428|468028176|FG001|Follow-up Period|Patient withdrew consent|4|||
130018616|NCT00623428|468028175|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
130018617|NCT00623428|468028176|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
130018618|NCT00623428|468028175|FG000|Follow-up Period|Did not cooperate|0|||
130018619|NCT00623428|468028176|FG001|Follow-up Period|Did not cooperate|3|||
130018620|NCT00623428|468028175|FG000|Follow-up Period|Reason not specified|1|||
129884493|NCT04844918|467536415|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
130018621|NCT00623428|468028176|FG001|Follow-up Period|Reason not specified|1|||
130018622|NCT00623428|468028175|FG000|Follow-up Period|Death|0|||
130018623|NCT00623428|468028176|FG001|Follow-up Period|Death|1|||
130018624|NCT01929408|468028179|FG000|Overall Study|received HCT as initial treatment|8|||
130018625|NCT02788747|468028180|FG000|Overall Study|Adverse Event|1|||
130018626|NCT02788747|468028181|FG001|Overall Study|Adverse Event|0|||
130018627|NCT02788747|468028182|FG002|Overall Study|Adverse Event|0|||
130018628|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
130018629|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
130018630|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
130224815|NCT00116688|468787948|FG000|Overall Study|Protocol-specified criteria|3|||
130224816|NCT00116688|468787949|FG001|Overall Study|Protocol-specified criteria|0|||
130224817|NCT00116688|468787948|FG000|Overall Study|Pregnancy|1|||
130224818|NCT00116688|468787949|FG001|Overall Study|Pregnancy|0|||
130224819|NCT00116688|468787948|FG000|Overall Study|Other|11|||
130224820|NCT00116688|468787949|FG001|Overall Study|Other|0|||
130224821|NCT01775670|468787954|FG000|Overall Study|Lost to Follow-up|1|||
130224822|NCT01775670|468787955|FG001|Overall Study|Lost to Follow-up|1|||
130224823|NCT01298700|468787956|FG000|Overall Study|Adverse Event|50|||
130224824|NCT01298700|468787957|FG001|Overall Study|Adverse Event|51|||
130224825|NCT01298700|468787956|FG000|Overall Study|Lack of Efficacy|9|||
130224826|NCT01298700|468787957|FG001|Overall Study|Lack of Efficacy|14|||
130224827|NCT01298700|468787956|FG000|Overall Study|Lost to Follow-up|5|||
130224828|NCT01298700|468787957|FG001|Overall Study|Lost to Follow-up|2|||
130224829|NCT01298700|468787956|FG000|Overall Study|Withdrawal by Subject|12|||
130224830|NCT01298700|468787957|FG001|Overall Study|Withdrawal by Subject|9|||
130224831|NCT01298700|468787956|FG000|Overall Study|Protocol Violation|6|||
130224832|NCT01298700|468787957|FG001|Overall Study|Protocol Violation|4|||
130224833|NCT01298700|468787956|FG000|Overall Study|Other Miscellaneous Reasons|16|||
130224834|NCT01298700|468787957|FG001|Overall Study|Other Miscellaneous Reasons|15|||
130224835|NCT01298700|468787956|FG000|Overall Study|Did not Receive Study Drug|3|||
130224836|NCT01298700|468787957|FG001|Overall Study|Did not Receive Study Drug|5|||
130224837|NCT04006145|468787960|FG000|Overall Study|Lost to Follow-up|0|||
130224838|NCT04006145|468787961|FG001|Overall Study|Lost to Follow-up|1|||
130224839|NCT04006145|468787960|FG000|Overall Study|Other|1|||
130224840|NCT04006145|468787961|FG001|Overall Study|Other|2|||
130224841|NCT00010257|468787964|FG000|Overall Study|Withdrawal by Subject|1|||
130224842|NCT00010257|468787965|FG001|Overall Study|Withdrawal by Subject|0|||
130224843|NCT00643760|468787966|FG000|Overall Study|Adverse Event|11|||
130224844|NCT00643760|468787967|FG001|Overall Study|Adverse Event|5|||
130224845|NCT00643760|468787968|FG002|Overall Study|Adverse Event|12|||
130224846|NCT00643760|468787969|FG003|Overall Study|Adverse Event|21|||
130224847|NCT00643760|468787970|FG004|Overall Study|Adverse Event|6|||
130224848|NCT00643760|468787966|FG000|Overall Study|Lack of Efficacy|3|||
130224849|NCT00643760|468787967|FG001|Overall Study|Lack of Efficacy|1|||
130224850|NCT00643760|468787968|FG002|Overall Study|Lack of Efficacy|0|||
130224851|NCT00643760|468787969|FG003|Overall Study|Lack of Efficacy|4|||
130224852|NCT00643760|468787970|FG004|Overall Study|Lack of Efficacy|3|||
130224853|NCT00643760|468787966|FG000|Overall Study|Protocol Violation|7|||
130224854|NCT00643760|468787967|FG001|Overall Study|Protocol Violation|6|||
130224855|NCT00643760|468787968|FG002|Overall Study|Protocol Violation|4|||
130224856|NCT00643760|468787969|FG003|Overall Study|Protocol Violation|4|||
130224857|NCT00643760|468787970|FG004|Overall Study|Protocol Violation|6|||
130224858|NCT00643760|468787966|FG000|Overall Study|Lost to Follow-up|6|||
130224859|NCT00643760|468787967|FG001|Overall Study|Lost to Follow-up|2|||
130224860|NCT00643760|468787968|FG002|Overall Study|Lost to Follow-up|1|||
130224861|NCT00643760|468787969|FG003|Overall Study|Lost to Follow-up|3|||
130224862|NCT00643760|468787970|FG004|Overall Study|Lost to Follow-up|3|||
130224863|NCT00643760|468787966|FG000|Overall Study|Investigator Discretion|0|||
130224864|NCT00643760|468787967|FG001|Overall Study|Investigator Discretion|0|||
130224865|NCT00643760|468787968|FG002|Overall Study|Investigator Discretion|0|||
130224866|NCT00643760|468787969|FG003|Overall Study|Investigator Discretion|2|||
130224867|NCT00643760|468787970|FG004|Overall Study|Investigator Discretion|0|||
130224868|NCT00643760|468787966|FG000|Overall Study|Withdrawal by Subject|3|||
130224869|NCT00643760|468787967|FG001|Overall Study|Withdrawal by Subject|1|||
130224870|NCT00643760|468787968|FG002|Overall Study|Withdrawal by Subject|2|||
130224871|NCT00643760|468787969|FG003|Overall Study|Withdrawal by Subject|4|||
130224872|NCT00643760|468787970|FG004|Overall Study|Withdrawal by Subject|1|||
130224873|NCT00104052|468787974|FG000|Overall Study|Adverse Event|1|||
130224874|NCT00104052|468787974|FG000|Overall Study|Lack of Efficacy|26|||
130224875|NCT00104052|468787974|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
130224876|NCT01241279|468787979|FG000|Overall Study|Lost to Follow-up|0|||
130224877|NCT01241279|468787980|FG001|Overall Study|Lost to Follow-up|1|||
130224878|NCT00239720|468787981|FG000|Overall Study|Adverse Event|1|||
130224879|NCT00239720|468787982|FG001|Overall Study|Adverse Event|0|||
130224880|NCT00239720|468787981|FG000|Overall Study|Lost to Follow-up|0|||
130224881|NCT00239720|468787982|FG001|Overall Study|Lost to Follow-up|1|||
130224882|NCT01145482|468787983|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130224883|NCT01145482|468787984|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
130224884|NCT01405560|468787987|FG000|Overall Study|Physician Decision|1|||
130224885|NCT01699750|468787989|FG000|Overall Study|Withdrew Consent|0|||
130224886|NCT01699750|468787990|FG001|Overall Study|Withdrew Consent|1|||
130224887|NCT01699750|468787989|FG000|Overall Study|Other|0|||
130224888|NCT01699750|468787990|FG001|Overall Study|Other|2|||
130224889|NCT01484951|468787991|FG000|Overall Study|Adverse Event|3|||
130224890|NCT01484951|468787991|FG000|Overall Study|Personal Reasons|1|||
130224891|NCT01484951|468787991|FG000|Overall Study|Non-Compliance|1|||
130224892|NCT02119299|468787992|FG000|Overall Study|Withdrawal by Subject|7|||
130224893|NCT02119299|468787992|FG000|Overall Study|Lack of Efficacy|1|||
130224894|NCT02119299|468787992|FG000|Overall Study|Pregnancy|1|||
130224895|NCT02452047|468787993|FG000|Overall Study|Adverse Event|0|||
130224896|NCT02452047|468787994|FG001|Overall Study|Adverse Event|1|||
130224897|NCT02452047|468787995|FG002|Overall Study|Adverse Event|1|||
130224898|NCT02452047|468787993|FG000|Overall Study|Death|1|||
130224899|NCT02452047|468787994|FG001|Overall Study|Death|3|||
130224900|NCT02452047|468787995|FG002|Overall Study|Death|1|||
130224901|NCT02452047|468787993|FG000|Overall Study|Physician Decision|1|||
130224902|NCT02452047|468787994|FG001|Overall Study|Physician Decision|0|||
130224903|NCT02452047|468787995|FG002|Overall Study|Physician Decision|0|||
130224904|NCT02452047|468787993|FG000|Overall Study|Lost to Follow-up|1|||
130224905|NCT02452047|468787994|FG001|Overall Study|Lost to Follow-up|1|||
130224906|NCT02452047|468787995|FG002|Overall Study|Lost to Follow-up|0|||
130224907|NCT02452047|468787993|FG000|Overall Study|Withdrawal by Subject|1|||
130224908|NCT02452047|468787994|FG001|Overall Study|Withdrawal by Subject|0|||
130224909|NCT02452047|468787995|FG002|Overall Study|Withdrawal by Subject|0|||
130224910|NCT01249417|468787996|FG000|Randomised Population|Study treatment not received|0|||
130224911|NCT01249417|468787997|FG001|Randomised Population|Study treatment not received|0|||
130224912|NCT01249417|468787998|FG002|Randomised Population|Study treatment not received|2|||
130224913|NCT01249417|468787996|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
130224914|NCT01249417|468787997|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
130224915|NCT01249417|468787998|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
130224916|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Other|0|||
130224917|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Other|0|||
130224918|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Other|1|||
130224919|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
130224920|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
130224921|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
130224922|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
130224923|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
130224924|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
130224925|NCT01249417|468787996|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
130224926|NCT01249417|468787997|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
130224927|NCT01249417|468787998|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
130224928|NCT00917124|468787999|FG000|Overall Study|Protocol Violation|4|||
130224929|NCT00917124|468788000|FG001|Overall Study|Protocol Violation|6|||
130224930|NCT00126594|468788002|FG000|Overall Study|Ineligible|2|||
130224931|NCT00126594|468788003|FG001|Overall Study|Ineligible|0|||
130224932|NCT00126594|468788002|FG000|Overall Study|Withdrawal by Subject|0|||
130224933|NCT00126594|468788003|FG001|Overall Study|Withdrawal by Subject|4|||
130224934|NCT00126594|468788002|FG000|Overall Study|Physician Decision|1|||
130224935|NCT00126594|468788003|FG001|Overall Study|Physician Decision|3|||
130224936|NCT00126594|468788002|FG000|Overall Study|Adverse Event|7|||
130224937|NCT00126594|468788003|FG001|Overall Study|Adverse Event|5|||
130224938|NCT00126594|468788002|FG000|Overall Study|Non-compliance|0|||
130224939|NCT00126594|468788003|FG001|Overall Study|Non-compliance|1|||
130224940|NCT00126594|468788002|FG000|Overall Study|Disease Progression|29|||
130224941|NCT00126594|468788003|FG001|Overall Study|Disease Progression|24|||
130224942|NCT03769649|468788004|FG000|Overall Study|Lost to Follow-up|4|||
130224943|NCT01290718|468788007|FG000|Overall Study|Early termination of the study|4|||
130224944|NCT00473655|468788008|FG000|Overall Study|Lost to Follow-up|9|||
130018631|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
130018632|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
130018633|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
130224945|NCT00473655|468788009|FG001|Overall Study|Lost to Follow-up|5|||
130224946|NCT00473655|468788010|FG002|Overall Study|Lost to Follow-up|8|||
130224947|NCT00243919|468788011|FG000|Overall Study|Death|3|||
130224948|NCT00243919|468788012|FG001|Overall Study|Death|4|||
130224949|NCT00243919|468788013|FG002|Overall Study|Death|6|||
130224950|NCT00243919|468788011|FG000|Overall Study|Withdrawal by Subject|6|||
130224951|NCT00243919|468788012|FG001|Overall Study|Withdrawal by Subject|6|||
130224952|NCT00243919|468788013|FG002|Overall Study|Withdrawal by Subject|2|||
130224953|NCT00243919|468788011|FG000|Overall Study|Lost to Follow-up|6|||
130224954|NCT00243919|468788012|FG001|Overall Study|Lost to Follow-up|7|||
130224955|NCT00243919|468788013|FG002|Overall Study|Lost to Follow-up|3|||
130224956|NCT00243919|468788011|FG000|Overall Study|Administrative Error|1|||
130224957|NCT00243919|468788012|FG001|Overall Study|Administrative Error|0|||
130224958|NCT00243919|468788013|FG002|Overall Study|Administrative Error|0|||
130224959|NCT00243919|468788011|FG000|Overall Study|Physician Decision|1|||
130224960|NCT00243919|468788012|FG001|Overall Study|Physician Decision|1|||
130224961|NCT00243919|468788013|FG002|Overall Study|Physician Decision|0|||
130224962|NCT01268267|468788014|FG000|Overall Study|Protocol Violation|1|||
130224963|NCT04176939|468788015|FG000|Overall Study|Withdrawal by Subject|5|||
130224964|NCT04176939|468788015|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
130224965|NCT04176939|468788015|FG000|Overall Study|Lost to Follow-up|2|||
130224966|NCT04176939|468788015|FG000|Overall Study|Unspecified reason|4|||
130224967|NCT04176939|468788015|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
130224968|NCT04919317|468788022|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
130224969|NCT04919317|468788023|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
130224970|NCT04919317|468788022|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
130224971|NCT04919317|468788023|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
130224972|NCT02869789|468788024|FG000|Overall Study|Disease progression|184|||
130224973|NCT02869789|468788025|FG001|Overall Study|Disease progression|109|||
130224974|NCT02869789|468788026|FG002|Overall Study|Disease progression|260|||
130224975|NCT02869789|468788027|FG003|Overall Study|Disease progression|19|||
130224976|NCT02869789|468788024|FG000|Overall Study|Study drug toxicity|90|||
130224977|NCT02869789|468788025|FG001|Overall Study|Study drug toxicity|32|||
130224978|NCT02869789|468788026|FG002|Overall Study|Study drug toxicity|55|||
130224979|NCT02869789|468788027|FG003|Overall Study|Study drug toxicity|14|||
130224980|NCT02869789|468788024|FG000|Overall Study|Death|7|||
130224981|NCT02869789|468788025|FG001|Overall Study|Death|3|||
130224982|NCT02869789|468788026|FG002|Overall Study|Death|5|||
130224983|NCT02869789|468788027|FG003|Overall Study|Death|1|||
130224984|NCT02869789|468788024|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
130224985|NCT02869789|468788025|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
130224986|NCT02869789|468788026|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
130224987|NCT02869789|468788027|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
130224988|NCT02869789|468788024|FG000|Overall Study|Participant request to discontinue study treatment|10|||
130224989|NCT02869789|468788025|FG001|Overall Study|Participant request to discontinue study treatment|5|||
130224990|NCT02869789|468788026|FG002|Overall Study|Participant request to discontinue study treatment|5|||
130224991|NCT02869789|468788027|FG003|Overall Study|Participant request to discontinue study treatment|3|||
130224992|NCT02869789|468788024|FG000|Overall Study|Withdrawal by Subject|5|||
130224993|NCT02869789|468788025|FG001|Overall Study|Withdrawal by Subject|2|||
130224994|NCT02869789|468788026|FG002|Overall Study|Withdrawal by Subject|7|||
130224995|NCT02869789|468788027|FG003|Overall Study|Withdrawal by Subject|2|||
130224996|NCT02869789|468788024|FG000|Overall Study|Lost to Follow-up|0|||
130224997|NCT02869789|468788025|FG001|Overall Study|Lost to Follow-up|0|||
130224998|NCT02869789|468788026|FG002|Overall Study|Lost to Follow-up|2|||
130224999|NCT02869789|468788027|FG003|Overall Study|Lost to Follow-up|0|||
130225000|NCT02869789|468788024|FG000|Overall Study|Maximum clinical benefit|5|||
130225001|NCT02869789|468788025|FG001|Overall Study|Maximum clinical benefit|2|||
130225002|NCT02869789|468788026|FG002|Overall Study|Maximum clinical benefit|1|||
130225003|NCT02869789|468788027|FG003|Overall Study|Maximum clinical benefit|0|||
130225004|NCT02869789|468788024|FG000|Overall Study|Poor/Non-compliance|0|||
130225005|NCT02869789|468788025|FG001|Overall Study|Poor/Non-compliance|2|||
130225006|NCT02869789|468788026|FG002|Overall Study|Poor/Non-compliance|1|||
130225007|NCT02869789|468788027|FG003|Overall Study|Poor/Non-compliance|0|||
130225008|NCT02869789|468788024|FG000|Overall Study|Participant no longer meets study criteria|0|||
130225009|NCT02869789|468788025|FG001|Overall Study|Participant no longer meets study criteria|1|||
130225010|NCT02869789|468788026|FG002|Overall Study|Participant no longer meets study criteria|1|||
130225011|NCT02869789|468788027|FG003|Overall Study|Participant no longer meets study criteria|0|||
130225012|NCT02869789|468788024|FG000|Overall Study|Administrative reason by sponsor|0|||
130225013|NCT02869789|468788025|FG001|Overall Study|Administrative reason by sponsor|0|||
130225014|NCT02869789|468788026|FG002|Overall Study|Administrative reason by sponsor|1|||
130225015|NCT02869789|468788027|FG003|Overall Study|Administrative reason by sponsor|0|||
130225016|NCT02869789|468788024|FG000|Overall Study|Other reasons|4|||
130225017|NCT02869789|468788025|FG001|Overall Study|Other reasons|8|||
130225018|NCT02869789|468788026|FG002|Overall Study|Other reasons|6|||
130225019|NCT02869789|468788027|FG003|Overall Study|Other reasons|0|||
130225020|NCT02127658|468788042|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
130225021|NCT02127658|468788043|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
130225022|NCT02127658|468788042|FG000|Overall Study|Withdrawal by Subject|0|||
130225023|NCT02127658|468788043|FG001|Overall Study|Withdrawal by Subject|2|||
130225024|NCT02127658|468788042|FG000|Overall Study|Physician Decision|0|||
130225025|NCT02127658|468788043|FG001|Overall Study|Physician Decision|1|||
130225026|NCT01443858|468788044|FG000|Overall Study|Withdrawal by Subject|9|||
130225027|NCT01443858|468788045|FG001|Overall Study|Withdrawal by Subject|8|||
130018634|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
130018635|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
130018636|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
130018637|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
130018638|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
130018639|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
130018640|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
130018641|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
130018642|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
130018643|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
130018644|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
130018645|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
130018646|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
130018647|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
130018648|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
130225028|NCT01443858|468788046|FG002|Overall Study|Withdrawal by Subject|5|||
130225029|NCT01443858|468788044|FG000|Overall Study|Lack of Efficacy|1|||
130018649|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
130018650|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
130018651|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
130018652|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
130018653|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
130018654|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
130018655|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
130018656|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
130018657|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
130018658|NCT00784654|468028183|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
130018659|NCT00784654|468028184|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
130018660|NCT00784654|468028185|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
130018661|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
130018662|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
130018663|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
130018664|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
130018665|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
130018666|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
130018667|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130018668|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
130018669|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
130018670|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
130018671|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
130018672|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
130018673|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Adverse Event|0|||
130018674|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Adverse Event|1|||
130018675|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Adverse Event|1|||
130018676|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
130018677|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
130018678|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
130018679|NCT00784654|468028183|FG000|Randomized Withdrawal Period|Family reasons|0|||
130018680|NCT00784654|468028184|FG001|Randomized Withdrawal Period|Family reasons|0|||
130098793|NCT03426995|468319301|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098794|NCT03426995|468319302|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098795|NCT03426995|468319303|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098796|NCT03426995|468319304|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098797|NCT03426995|468319305|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098798|NCT03426995|468319306|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098799|NCT03426995|468319307|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130018681|NCT00784654|468028185|FG002|Randomized Withdrawal Period|Family reasons|1|||
130018682|NCT00262873|468028186|FG000|Overall Study|Adverse Event|3|||
130018683|NCT00262873|468028186|FG000|Overall Study|Withdrawal by Subject|5|||
130018684|NCT00844753|468028187|FG000|Overall Study|Lack of Efficacy|1|||
130018685|NCT00844753|468028188|FG001|Overall Study|Lack of Efficacy|0|||
130018686|NCT00844753|468028189|FG002|Overall Study|Lack of Efficacy|2|||
130018687|NCT00844753|468028190|FG003|Overall Study|Lack of Efficacy|2|||
130018688|NCT00844753|468028187|FG000|Overall Study|Adverse Event|3|||
130018689|NCT00844753|468028188|FG001|Overall Study|Adverse Event|2|||
130018690|NCT00844753|468028189|FG002|Overall Study|Adverse Event|5|||
130018691|NCT00844753|468028190|FG003|Overall Study|Adverse Event|5|||
130018692|NCT00844753|468028187|FG000|Overall Study|Lost to Follow-up|1|||
130018693|NCT00844753|468028188|FG001|Overall Study|Lost to Follow-up|1|||
130018694|NCT00844753|468028189|FG002|Overall Study|Lost to Follow-up|0|||
130018695|NCT00844753|468028190|FG003|Overall Study|Lost to Follow-up|1|||
130018696|NCT00844753|468028187|FG000|Overall Study|could not swallow medication|2|||
130018697|NCT00844753|468028188|FG001|Overall Study|could not swallow medication|0|||
130018698|NCT00844753|468028189|FG002|Overall Study|could not swallow medication|0|||
130018699|NCT00844753|468028190|FG003|Overall Study|could not swallow medication|0|||
130018700|NCT00844753|468028187|FG000|Overall Study|Withdrawal by Subject|1|||
130018701|NCT00844753|468028188|FG001|Overall Study|Withdrawal by Subject|0|||
130018702|NCT00844753|468028189|FG002|Overall Study|Withdrawal by Subject|0|||
130018703|NCT00844753|468028190|FG003|Overall Study|Withdrawal by Subject|3|||
130018704|NCT01452152|468028191|FG000|Overall Study|Study termination by sponsor|5|||
130018705|NCT01452152|468028192|FG001|Overall Study|Study termination by sponsor|0|||
130018706|NCT01452152|468028193|FG002|Overall Study|Study termination by sponsor|4|||
130018707|NCT02068547|468029396|FG000|Overall Study|Lost to Follow-up|3|||
130018708|NCT02068547|468029397|FG001|Overall Study|Lost to Follow-up|3|||
130018709|NCT02068547|468029396|FG000|Overall Study|Physician Decision|1|||
130018710|NCT02068547|468029397|FG001|Overall Study|Physician Decision|0|||
130018711|NCT02229552|468029399|FG000|Baseline|Withdrawal by Subject|6|||
130018712|NCT02229552|468029399|FG000|1-year Follow up|Withdrawal by Subject|7|||
130018713|NCT02229552|468029399|FG000|1-year Follow up|Lost to Follow-up|18|||
130018714|NCT02229552|468029399|FG000|2-Year Follow up|Withdrawal by Subject|9|||
130018715|NCT02229552|468029399|FG000|2-Year Follow up|Lost to Follow-up|17|||
130018716|NCT04872101|468029400|FG000|Overall Study|Withdrawal by Subject|10|||
130018717|NCT04872101|468029401|FG001|Overall Study|Withdrawal by Subject|16|||
130018718|NCT04872101|468029400|FG000|Overall Study|Lack of Efficacy|6|||
130018719|NCT04872101|468029401|FG001|Overall Study|Lack of Efficacy|14|||
130018720|NCT04872101|468029400|FG000|Overall Study|Adverse Event|1|||
130018721|NCT04872101|468029401|FG001|Overall Study|Adverse Event|6|||
130018722|NCT04872101|468029400|FG000|Overall Study|Lost to Follow-up|2|||
130018723|NCT04872101|468029401|FG001|Overall Study|Lost to Follow-up|1|||
130018724|NCT04872101|468029400|FG000|Overall Study|Pregnancy|2|||
130018725|NCT04872101|468029401|FG001|Overall Study|Pregnancy|0|||
130018726|NCT04872101|468029400|FG000|Overall Study|Prohibited Medication|1|||
130018727|NCT04872101|468029401|FG001|Overall Study|Prohibited Medication|0|||
130018728|NCT04872101|468029400|FG000|Overall Study|Not dosed|1|||
130018729|NCT04872101|468029401|FG001|Overall Study|Not dosed|0|||
130018730|NCT00971945|468029402|FG000|Overall Study|Progressive Disease|3|||
130018731|NCT00971945|468029402|FG000|Overall Study|Change in treatment policy|1|||
130018732|NCT00971945|468029402|FG000|Overall Study|Other reasons|2|||
130018733|NCT03354663|468029403|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
130018734|NCT03354663|468029403|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
130018735|NCT03354663|468029403|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
130018736|NCT03354663|468029403|FG000|Completed 30-day Visit|Missed Visit|1|||
130018737|NCT03691974|468029404|FG000|Overall Study|Physician Decision|1|||
130018738|NCT03691974|468029405|FG001|Overall Study|Physician Decision|0|||
130018739|NCT03691974|468029404|FG000|Overall Study|Adverse Event|1|||
130018740|NCT03691974|468029405|FG001|Overall Study|Adverse Event|0|||
130018741|NCT03691974|468029404|FG000|Overall Study|Withdrawal by Subject|11|||
130018742|NCT03691974|468029405|FG001|Overall Study|Withdrawal by Subject|9|||
130018743|NCT03691974|468029404|FG000|Overall Study|Protocol Violation|1|||
130018744|NCT03691974|468029405|FG001|Overall Study|Protocol Violation|0|||
130018745|NCT03691974|468029404|FG000|Overall Study|Lost to Follow-up|8|||
130018746|NCT03691974|468029405|FG001|Overall Study|Lost to Follow-up|7|||
130018747|NCT01391000|468029406|FG000|Overall Study|Lost to Follow-up|2|||
130018748|NCT01391000|468029407|FG001|Overall Study|Lost to Follow-up|0|||
130018749|NCT00817531|468029408|FG000|Overall Study|Adverse Event|1|||
130018750|NCT00817531|468029408|FG000|Overall Study|Lack of Efficacy|1|||
130018751|NCT02239939|468029409|FG000|Overall Study|Adverse Event|1|||
130018752|NCT02239939|468029410|FG001|Overall Study|Adverse Event|0|||
130018753|NCT02239939|468029409|FG000|Overall Study|Withdrawal by Subject|1|||
130018754|NCT02239939|468029410|FG001|Overall Study|Withdrawal by Subject|1|||
130018755|NCT02239939|468029409|FG000|Overall Study|Lost to Follow-up|0|||
130018756|NCT02239939|468029410|FG001|Overall Study|Lost to Follow-up|1|||
130018757|NCT03325673|468029420|FG000|Overall Study|Adverse Event|4|||
130018758|NCT03325673|468029421|FG001|Overall Study|Adverse Event|0|||
130018759|NCT01514682|468029422|FG000|Overall Study|Withdrawal by Subject|2|||
130018760|NCT01514682|468029423|FG001|Overall Study|Withdrawal by Subject|3|||
130018761|NCT01514682|468029422|FG000|Overall Study|Physician Decision|4|||
130018762|NCT01514682|468029423|FG001|Overall Study|Physician Decision|3|||
130018763|NCT00590590|468029424|FG000|Overall Study|Lack of Efficacy|1|||
130018764|NCT00590590|468029425|FG001|Overall Study|Lack of Efficacy|2|||
130018765|NCT00590590|468029426|FG002|Overall Study|Lack of Efficacy|0|||
130018766|NCT00590590|468029424|FG000|Overall Study|Adverse Event|1|||
130018767|NCT00590590|468029425|FG001|Overall Study|Adverse Event|0|||
130018768|NCT00590590|468029426|FG002|Overall Study|Adverse Event|0|||
130018769|NCT00590590|468029424|FG000|Overall Study|Protocol Violation|0|||
130018770|NCT00590590|468029425|FG001|Overall Study|Protocol Violation|0|||
130018771|NCT00590590|468029426|FG002|Overall Study|Protocol Violation|2|||
130018772|NCT00590590|468029424|FG000|Overall Study|Lost to Follow-up|4|||
130018773|NCT00590590|468029425|FG001|Overall Study|Lost to Follow-up|1|||
130018774|NCT00590590|468029426|FG002|Overall Study|Lost to Follow-up|2|||
130018775|NCT00590590|468029424|FG000|Overall Study|Withdrawal by Subject|0|||
130018776|NCT00590590|468029425|FG001|Overall Study|Withdrawal by Subject|1|||
130018777|NCT00590590|468029426|FG002|Overall Study|Withdrawal by Subject|1|||
130018778|NCT00590590|468029424|FG000|Overall Study|Did not complete due to study closure|1|||
130018779|NCT00590590|468029425|FG001|Overall Study|Did not complete due to study closure|1|||
130018780|NCT00590590|468029426|FG002|Overall Study|Did not complete due to study closure|1|||
130018781|NCT00590590|468029424|FG000|Overall Study|Did not complete study|0|||
130018782|NCT00590590|468029425|FG001|Overall Study|Did not complete study|1|||
130018783|NCT00590590|468029426|FG002|Overall Study|Did not complete study|0|||
130018784|NCT00132132|468029429|FG000|Overall Study|Lost to Follow-up|7|||
130018785|NCT00132132|468029430|FG001|Overall Study|Lost to Follow-up|2|||
130018786|NCT02105454|468029435|FG000|Overall Study|Withdrawal by Subject|1|||
130018787|NCT00356278|468029436|FG000|Overall Study|Withdrawal by Subject|25|||
130018788|NCT00356278|468029437|FG001|Overall Study|Withdrawal by Subject|15|||
130018789|NCT00356278|468029438|FG002|Overall Study|Withdrawal by Subject|19|||
130018790|NCT00883337|468029441|FG000|Core Treatment Period|Adverse Event|9|||
130018791|NCT00883337|468029442|FG001|Core Treatment Period|Adverse Event|12|||
130018792|NCT00883337|468029443|FG002|Core Treatment Period|Adverse Event|22|||
130018793|NCT00883337|468029441|FG000|Core Treatment Period|Lack of Efficacy|7|||
130018794|NCT00883337|468029442|FG001|Core Treatment Period|Lack of Efficacy|4|||
130018795|NCT00883337|468029443|FG002|Core Treatment Period|Lack of Efficacy|2|||
130018796|NCT00883337|468029441|FG000|Core Treatment Period|Lost to Follow-up|1|||
130018797|NCT00883337|468029442|FG001|Core Treatment Period|Lost to Follow-up|1|||
130018798|NCT00883337|468029443|FG002|Core Treatment Period|Lost to Follow-up|0|||
130018799|NCT00883337|468029441|FG000|Core Treatment Period|Withdrawal by Subject|2|||
130018800|NCT00883337|468029442|FG001|Core Treatment Period|Withdrawal by Subject|2|||
130018801|NCT00883337|468029443|FG002|Core Treatment Period|Withdrawal by Subject|6|||
130018802|NCT00883337|468029441|FG000|Core Treatment Period|Wish to be pregnant|1|||
130018803|NCT00883337|468029442|FG001|Core Treatment Period|Wish to be pregnant|2|||
130018804|NCT00883337|468029443|FG002|Core Treatment Period|Wish to be pregnant|1|||
130018805|NCT00883337|468029441|FG000|Core Treatment Period|Poor compliance to protocol|0|||
130018806|NCT00883337|468029442|FG001|Core Treatment Period|Poor compliance to protocol|0|||
130018807|NCT00883337|468029443|FG002|Core Treatment Period|Poor compliance to protocol|1|||
130018808|NCT00883337|468029441|FG000|Core Treatment Period|Other than above|0|||
130018809|NCT00883337|468029442|FG001|Core Treatment Period|Other than above|1|||
130018810|NCT00883337|468029443|FG002|Core Treatment Period|Other than above|1|||
130018811|NCT00883337|468029441|FG000|Extension Treatment Period|Adverse Event|8|||
130018812|NCT00883337|468029442|FG001|Extension Treatment Period|Adverse Event|5|||
130098800|NCT03426995|468319308|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130225030|NCT01443858|468788045|FG001|Overall Study|Lack of Efficacy|0|||
130225031|NCT01443858|468788046|FG002|Overall Study|Lack of Efficacy|0|||
130225032|NCT01443858|468788044|FG000|Overall Study|Lost to Follow-up|5|||
130018813|NCT00883337|468029443|FG002|Extension Treatment Period|Adverse Event|5|||
130018814|NCT00883337|468029441|FG000|Extension Treatment Period|Lack of Efficacy|8|||
130018815|NCT00883337|468029442|FG001|Extension Treatment Period|Lack of Efficacy|8|||
130018816|NCT00883337|468029443|FG002|Extension Treatment Period|Lack of Efficacy|8|||
130018817|NCT00883337|468029441|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
130018818|NCT00883337|468029442|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
130018819|NCT00883337|468029443|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
130018820|NCT00883337|468029441|FG000|Extension Treatment Period|Lost to Follow-up|1|||
130018821|NCT00883337|468029442|FG001|Extension Treatment Period|Lost to Follow-up|0|||
130018822|NCT00883337|468029443|FG002|Extension Treatment Period|Lost to Follow-up|0|||
130018823|NCT00883337|468029441|FG000|Extension Treatment Period|Other than above|10|||
130018824|NCT00883337|468029442|FG001|Extension Treatment Period|Other than above|9|||
130018825|NCT00883337|468029443|FG002|Extension Treatment Period|Other than above|5|||
130018826|NCT03468309|468029446|FG000|Overall Study|Lost to Follow-up|4|||
130018827|NCT03468309|468029446|FG000|Overall Study|Withdrawal by Subject|2|||
130018828|NCT02363686|468029452|FG000|Overall Study|Withdrawal by Subject|22|||
130018829|NCT02363686|468029452|FG000|Overall Study|incomplete FEES examinations|13|||
130018830|NCT01496885|468029456|FG000|Overall Study|Lost to Follow-up|13|||
130018831|NCT01496885|468029456|FG000|Overall Study|Withdrawal by Subject|7|||
130018832|NCT01496885|468029456|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
130018833|NCT01496885|468029456|FG000|Overall Study|Death|1|||
130018834|NCT03446885|468029457|FG000|Overall Study|Lost to Follow-up|1|||
130018835|NCT03446885|468029458|FG001|Overall Study|Lost to Follow-up|0|||
130018836|NCT03446885|468029457|FG000|Overall Study|Did not complete entire visit|1|||
130018837|NCT03446885|468029458|FG001|Overall Study|Did not complete entire visit|0|||
130018838|NCT01485627|468029461|FG000|Overall Study|Patient withdrew|6|||
130018839|NCT01485627|468029462|FG001|Overall Study|Patient withdrew|5|||
130018840|NCT01485627|468029461|FG000|Overall Study|Patient died|3|||
130018841|NCT01485627|468029462|FG001|Overall Study|Patient died|1|||
130018842|NCT01485627|468029461|FG000|Overall Study|Patient lost to followup|0|||
130018843|NCT01485627|468029462|FG001|Overall Study|Patient lost to followup|1|||
130018844|NCT01485627|468029461|FG000|Overall Study|Caregiver withdrew|3|||
130018845|NCT01485627|468029462|FG001|Overall Study|Caregiver withdrew|3|||
130018846|NCT01485627|468029461|FG000|Overall Study|Caregiver lost to follow up|11|||
130018847|NCT01485627|468029462|FG001|Overall Study|Caregiver lost to follow up|12|||
130018848|NCT01485627|468029461|FG000|Overall Study|Caregiver died|1|||
130018849|NCT01485627|468029462|FG001|Overall Study|Caregiver died|0|||
130018850|NCT01485627|468029461|FG000|Overall Study|caregiver was not bereaved|42|||
130018851|NCT01485627|468029462|FG001|Overall Study|caregiver was not bereaved|35|||
130018852|NCT02264990|468029467|FG000|Overall Study|Death|255|||
130018853|NCT02264990|468029468|FG001|Overall Study|Death|250|||
130018854|NCT02264990|468029467|FG000|Overall Study|Withdrawal by Subject|4|||
130018855|NCT02264990|468029468|FG001|Overall Study|Withdrawal by Subject|5|||
130018856|NCT02264990|468029467|FG000|Overall Study|Lost to Follow-up|1|||
130018857|NCT02264990|468029468|FG001|Overall Study|Lost to Follow-up|3|||
130018858|NCT02264990|468029467|FG000|Overall Study|Other|0|||
130018859|NCT02264990|468029468|FG001|Overall Study|Other|1|||
130018860|NCT01662895|468029477|FG000|Overall Study|Lost to Follow-up|0|||
130018861|NCT01662895|468029478|FG001|Overall Study|Lost to Follow-up|1|||
130018862|NCT00075504|468029486|FG000|Overall Study|Withdrawal by Subject|9|||
130018863|NCT00075504|468029487|FG001|Overall Study|Withdrawal by Subject|7|||
130018864|NCT01692301|468029489|FG000|Overall Study|Adverse Event|15|||
130018865|NCT01692301|468029490|FG001|Overall Study|Adverse Event|12|||
130018866|NCT01692301|468029489|FG000|Overall Study|Death|1|||
130018867|NCT01692301|468029490|FG001|Overall Study|Death|2|||
130018868|NCT01692301|468029489|FG000|Overall Study|Lack of Efficacy|0|||
130018869|NCT01692301|468029490|FG001|Overall Study|Lack of Efficacy|5|||
130018870|NCT01692301|468029489|FG000|Overall Study|Non-compliance with study treatment|1|||
130018871|NCT01692301|468029490|FG001|Overall Study|Non-compliance with study treatment|2|||
130018872|NCT01692301|468029489|FG000|Overall Study|Protocol deviation|9|||
130018873|NCT01692301|468029490|FG001|Overall Study|Protocol deviation|2|||
130018874|NCT01692301|468029489|FG000|Overall Study|Patient/guardian decision|16|||
130225033|NCT01443858|468788045|FG001|Overall Study|Lost to Follow-up|5|||
130018875|NCT01692301|468029490|FG001|Overall Study|Patient/guardian decision|15|||
130018876|NCT01692301|468029489|FG000|Overall Study|Technical problems|0|||
130018877|NCT01692301|468029490|FG001|Overall Study|Technical problems|1|||
130018878|NCT01692301|468029489|FG000|Overall Study|Physician Decision|2|||
130018879|NCT01692301|468029490|FG001|Overall Study|Physician Decision|2|||
130018880|NCT01692301|468029489|FG000|Overall Study|Lost to Follow-up|1|||
130018881|NCT01692301|468029490|FG001|Overall Study|Lost to Follow-up|1|||
130018882|NCT01142726|468029491|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
130018883|NCT01142726|468029492|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
130225034|NCT01443858|468788046|FG002|Overall Study|Lost to Follow-up|2|||
130225035|NCT01867008|468788047|FG000|Overall Study|Withdrawal by Subject|1|||
130018884|NCT01142726|468029493|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
130018885|NCT01142726|468029491|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
130018886|NCT01142726|468029492|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
130018887|NCT01142726|468029493|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
130018888|NCT01142726|468029491|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
130018889|NCT01142726|468029492|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
130018890|NCT01142726|468029493|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
130018891|NCT01142726|468029491|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
130018892|NCT01142726|468029492|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
130018893|NCT01142726|468029493|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
130018894|NCT01142726|468029491|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
130018895|NCT01142726|468029492|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
130018896|NCT01142726|468029493|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
130018897|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
130018898|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
130018899|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
130018900|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
130018901|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
130018902|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
130018903|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
130018904|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
130018905|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
130018906|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
130018907|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
130018908|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
130018909|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
130018910|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
130018911|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
130018912|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
130018913|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
130018914|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
130018915|NCT01142726|468029491|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
130018916|NCT01142726|468029492|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
130018917|NCT01142726|468029493|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
130018918|NCT01142726|468029491|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
130018919|NCT01142726|468029492|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
130018920|NCT01142726|468029493|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
130018921|NCT01142726|468029491|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
130018922|NCT01142726|468029492|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
130018923|NCT01142726|468029493|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
130018924|NCT01142726|468029491|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
130018925|NCT01142726|468029492|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
130018926|NCT01142726|468029493|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
130018927|NCT01142726|468029491|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
130018928|NCT01142726|468029492|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
130018929|NCT01142726|468029493|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
130018930|NCT01568593|468029494|FG000|Overall Study|Lack of Efficacy|4|||
130018931|NCT01568593|468029495|FG001|Overall Study|Lack of Efficacy|1|||
130018932|NCT01568593|468029494|FG000|Overall Study|Adverse Event|3|||
130018933|NCT01568593|468029495|FG001|Overall Study|Adverse Event|2|||
130018934|NCT02109484|468029496|FG000|Overall Study|Lost to Follow-up|0|||
130018935|NCT02109484|468029497|FG001|Overall Study|Lost to Follow-up|0|||
130018936|NCT02109484|468029498|FG002|Overall Study|Lost to Follow-up|0|||
130018937|NCT02109484|468029499|FG003|Overall Study|Lost to Follow-up|1|||
130018938|NCT02109484|468029500|FG004|Overall Study|Lost to Follow-up|1|||
130018939|NCT02109484|468029501|FG005|Overall Study|Lost to Follow-up|0|||
130018940|NCT02109484|468029502|FG006|Overall Study|Lost to Follow-up|1|||
130018941|NCT02109484|468029503|FG007|Overall Study|Lost to Follow-up|0|||
130018942|NCT02109484|468029496|FG000|Overall Study|Withdrawal by Subject|0|||
130018943|NCT02109484|468029497|FG001|Overall Study|Withdrawal by Subject|0|||
130018944|NCT02109484|468029498|FG002|Overall Study|Withdrawal by Subject|0|||
130018945|NCT02109484|468029499|FG003|Overall Study|Withdrawal by Subject|0|||
130018946|NCT02109484|468029500|FG004|Overall Study|Withdrawal by Subject|1|||
130225036|NCT01534273|468788048|FG000|Period 1|Physician Decision|0|||
130018947|NCT02109484|468029501|FG005|Overall Study|Withdrawal by Subject|1|||
130018948|NCT02109484|468029502|FG006|Overall Study|Withdrawal by Subject|1|||
130225037|NCT01534273|468788049|FG001|Period 1|Physician Decision|0|||
130018949|NCT02109484|468029503|FG007|Overall Study|Withdrawal by Subject|0|||
130018950|NCT02109484|468029496|FG000|Overall Study|Physician Decision|0|||
130018951|NCT02109484|468029497|FG001|Overall Study|Physician Decision|0|||
130018952|NCT02109484|468029498|FG002|Overall Study|Physician Decision|0|||
130018953|NCT02109484|468029499|FG003|Overall Study|Physician Decision|0|||
130018954|NCT02109484|468029500|FG004|Overall Study|Physician Decision|2|||
130018955|NCT02109484|468029501|FG005|Overall Study|Physician Decision|0|||
130018956|NCT02109484|468029502|FG006|Overall Study|Physician Decision|0|||
130018957|NCT02109484|468029503|FG007|Overall Study|Physician Decision|0|||
130018958|NCT02109484|468029496|FG000|Overall Study|Death|0|||
130018959|NCT02109484|468029497|FG001|Overall Study|Death|0|||
130018960|NCT02109484|468029498|FG002|Overall Study|Death|0|||
130018961|NCT02109484|468029499|FG003|Overall Study|Death|0|||
130018962|NCT02109484|468029500|FG004|Overall Study|Death|0|||
130018963|NCT02109484|468029501|FG005|Overall Study|Death|0|||
130018964|NCT02109484|468029502|FG006|Overall Study|Death|0|||
130018965|NCT02109484|468029503|FG007|Overall Study|Death|2|||
130018966|NCT02109484|468029496|FG000|Overall Study|Moved away from study area|0|||
130018967|NCT02109484|468029497|FG001|Overall Study|Moved away from study area|0|||
130018968|NCT02109484|468029498|FG002|Overall Study|Moved away from study area|0|||
130018969|NCT02109484|468029499|FG003|Overall Study|Moved away from study area|0|||
130018970|NCT02109484|468029500|FG004|Overall Study|Moved away from study area|0|||
130018971|NCT02109484|468029501|FG005|Overall Study|Moved away from study area|0|||
130018972|NCT02109484|468029502|FG006|Overall Study|Moved away from study area|1|||
130018973|NCT02109484|468029503|FG007|Overall Study|Moved away from study area|1|||
130018974|NCT02111993|468029508|FG000|Overall Study|Physician Decision|5|||
130018975|NCT02111993|468029509|FG001|Overall Study|Physician Decision|4|||
130018976|NCT00293579|468029510|FG000|Overall Study|Withdrawal by Subject|1|||
130018977|NCT01180660|468029517|FG000|Overall Study|Changed to open surgery|1|||
130018978|NCT01180660|468029518|FG001|Overall Study|Changed to open surgery|0|||
130018979|NCT01318109|468029521|FG000|Overall Study|Adverse Event|0|||
130018980|NCT01318109|468029522|FG001|Overall Study|Adverse Event|2|||
130018981|NCT01318109|468029523|FG002|Overall Study|Adverse Event|0|||
130018982|NCT01318109|468029521|FG000|Overall Study|Withdrawal by Subject|1|||
130018983|NCT01318109|468029522|FG001|Overall Study|Withdrawal by Subject|0|||
130018984|NCT01318109|468029523|FG002|Overall Study|Withdrawal by Subject|0|||
130018985|NCT01318109|468029521|FG000|Overall Study|Schedule Conflict|0|||
130018986|NCT01318109|468029522|FG001|Overall Study|Schedule Conflict|1|||
130018987|NCT01318109|468029523|FG002|Overall Study|Schedule Conflict|0|||
130018988|NCT01328951|468029524|FG000|Overall Study|Disease Progression|17|||
130018989|NCT01328951|468029525|FG001|Overall Study|Disease Progression|14|||
130018990|NCT01328951|468029524|FG000|Overall Study|Adverse Event|2|||
130018991|NCT01328951|468029525|FG001|Overall Study|Adverse Event|0|||
130018992|NCT01328951|468029524|FG000|Overall Study|Death|243|||
130018993|NCT01328951|468029525|FG001|Overall Study|Death|258|||
130018994|NCT01328951|468029524|FG000|Overall Study|Lost to Follow-up|6|||
130018995|NCT01328951|468029525|FG001|Overall Study|Lost to Follow-up|7|||
130018996|NCT01328951|468029524|FG000|Overall Study|Withdrawal by Subject|6|||
130018997|NCT01328951|468029525|FG001|Overall Study|Withdrawal by Subject|6|||
130018998|NCT01328951|468029524|FG000|Overall Study|Study Closed by the Sponsor|36|||
130018999|NCT01328951|468029525|FG001|Overall Study|Study Closed by the Sponsor|31|||
130019000|NCT01328951|468029524|FG000|Overall Study|Other|11|||
130019001|NCT01328951|468029525|FG001|Overall Study|Other|6|||
130019002|NCT04042103|468029528|FG000|Overall Study|Lost to Follow-up|1|||
130019003|NCT04042103|468029528|FG000|Overall Study|Withdrawal by Subject|1|||
130019004|NCT01003210|468029529|FG000|Overall Study|Lost to Follow-up|1|||
130019005|NCT01003210|468029530|FG001|Overall Study|Lost to Follow-up|3|||
130019006|NCT00271817|468029531|FG000|Part 1|Adverse Event|68|||
130019007|NCT00271817|468029532|FG001|Part 1|Adverse Event|25|||
130019008|NCT00271817|468029533|FG002|Part 1|Adverse Event|156|||
130019009|NCT00271817|468029531|FG000|Part 1|Lost to Follow-up|6|||
130019010|NCT00271817|468029532|FG001|Part 1|Lost to Follow-up|8|||
130019011|NCT00271817|468029533|FG002|Part 1|Lost to Follow-up|24|||
130019012|NCT00271817|468029531|FG000|Part 1|Protocol Violation|5|||
130019013|NCT00271817|468029532|FG001|Part 1|Protocol Violation|4|||
130019014|NCT00271817|468029533|FG002|Part 1|Protocol Violation|7|||
130019015|NCT00271817|468029531|FG000|Part 1|Patient Moved|3|||
130019016|NCT00271817|468029532|FG001|Part 1|Patient Moved|1|||
130019017|NCT00271817|468029533|FG002|Part 1|Patient Moved|5|||
130019018|NCT00271817|468029531|FG000|Part 1|Withdrawal by Subject|23|||
130019019|NCT00271817|468029532|FG001|Part 1|Withdrawal by Subject|17|||
130019020|NCT00271817|468029533|FG002|Part 1|Withdrawal by Subject|45|||
130019021|NCT00271817|468029531|FG000|Part 1|LDL < 50 mg/dL|1|||
130019022|NCT00271817|468029532|FG001|Part 1|LDL < 50 mg/dL|4|||
130019023|NCT00271817|468029533|FG002|Part 1|LDL < 50 mg/dL|48|||
130019024|NCT00271817|468029531|FG000|Part 2|Adverse Event|0|||
130019025|NCT00271817|468029532|FG001|Part 2|Adverse Event|17|||
130019026|NCT00271817|468029533|FG002|Part 2|Adverse Event|33|||
130019027|NCT00271817|468029531|FG000|Part 2|Lack of Efficacy|0|||
130019028|NCT00271817|468029532|FG001|Part 2|Lack of Efficacy|1|||
130019029|NCT00271817|468029533|FG002|Part 2|Lack of Efficacy|6|||
130019030|NCT00271817|468029531|FG000|Part 2|Lost to Follow-up|0|||
130019031|NCT00271817|468029532|FG001|Part 2|Lost to Follow-up|6|||
130019032|NCT00271817|468029533|FG002|Part 2|Lost to Follow-up|18|||
130019033|NCT00271817|468029531|FG000|Part 2|Protocol Violation|0|||
130019034|NCT00271817|468029532|FG001|Part 2|Protocol Violation|3|||
130019035|NCT00271817|468029533|FG002|Part 2|Protocol Violation|5|||
130019036|NCT00271817|468029531|FG000|Part 2|Patient Moved|0|||
130019037|NCT00271817|468029532|FG001|Part 2|Patient Moved|0|||
130019038|NCT00271817|468029533|FG002|Part 2|Patient Moved|5|||
130019039|NCT00271817|468029531|FG000|Part 2|Withdrawal by Subject|0|||
130019040|NCT00271817|468029532|FG001|Part 2|Withdrawal by Subject|2|||
130019041|NCT00271817|468029533|FG002|Part 2|Withdrawal by Subject|13|||
130019042|NCT00271817|468029531|FG000|Part 2|LDL < 50 mg/dL|0|||
130019043|NCT00271817|468029532|FG001|Part 2|LDL < 50 mg/dL|3|||
130225038|NCT01534273|468788050|FG002|Period 1|Physician Decision|0|||
130225039|NCT01534273|468788051|FG003|Period 1|Physician Decision|1|||
130019044|NCT00271817|468029533|FG002|Part 2|LDL < 50 mg/dL|4|||
130019045|NCT03124563|468029534|FG000|Overall Study|Lost to Follow-up|1|||
130019046|NCT03124563|468029535|FG001|Overall Study|Lost to Follow-up|1|||
130019047|NCT03124563|468029534|FG000|Overall Study|Withdrawal by Subject|1|||
130019048|NCT03124563|468029535|FG001|Overall Study|Withdrawal by Subject|1|||
130019049|NCT03368170|468031265|FG000|Overall Study|Adverse Event|2|||
130019050|NCT03368170|468031266|FG001|Overall Study|Adverse Event|1|||
130019051|NCT01662440|468031267|FG000|Overall Study|Adverse Event|1|||
130019052|NCT01662440|468031268|FG001|Overall Study|Adverse Event|0|||
130019053|NCT01662440|468031269|FG002|Overall Study|Adverse Event|0|||
130019054|NCT01662440|468031270|FG003|Overall Study|Adverse Event|1|||
130019055|NCT01662440|468031267|FG000|Overall Study|Death|0|||
130019056|NCT01662440|468031268|FG001|Overall Study|Death|1|||
130019057|NCT01662440|468031269|FG002|Overall Study|Death|0|||
130019058|NCT01662440|468031270|FG003|Overall Study|Death|0|||
130019059|NCT01662440|468031267|FG000|Overall Study|Lost to Follow-up|2|||
130019060|NCT01662440|468031268|FG001|Overall Study|Lost to Follow-up|2|||
130019061|NCT01662440|468031269|FG002|Overall Study|Lost to Follow-up|4|||
130019062|NCT01662440|468031270|FG003|Overall Study|Lost to Follow-up|1|||
130019063|NCT01662440|468031267|FG000|Overall Study|Subject moved to another country.|0|||
130019064|NCT01662440|468031268|FG001|Overall Study|Subject moved to another country.|1|||
130019065|NCT01662440|468031269|FG002|Overall Study|Subject moved to another country.|0|||
130019066|NCT01662440|468031270|FG003|Overall Study|Subject moved to another country.|0|||
130019067|NCT01662440|468031267|FG000|Overall Study|Protocol Violation|1|||
130019068|NCT01662440|468031268|FG001|Overall Study|Protocol Violation|0|||
130019069|NCT01662440|468031269|FG002|Overall Study|Protocol Violation|0|||
130019070|NCT01662440|468031270|FG003|Overall Study|Protocol Violation|0|||
130019071|NCT01662440|468031267|FG000|Overall Study|Withdrawal by Subject|5|||
130019072|NCT01662440|468031268|FG001|Overall Study|Withdrawal by Subject|2|||
130019073|NCT01662440|468031269|FG002|Overall Study|Withdrawal by Subject|2|||
130019074|NCT01662440|468031270|FG003|Overall Study|Withdrawal by Subject|2|||
130019075|NCT01661140|468031271|FG000|Open-Label Period|Adverse Event|44|||
130019076|NCT01661140|468031272|FG001|Open-Label Period|Adverse Event|0|||
130019077|NCT01661140|468031273|FG002|Open-Label Period|Adverse Event|0|||
130019078|NCT01661140|468031271|FG000|Open-Label Period|Protocol Violation|3|||
130019079|NCT01661140|468031272|FG001|Open-Label Period|Protocol Violation|0|||
130019080|NCT01661140|468031273|FG002|Open-Label Period|Protocol Violation|0|||
130019081|NCT01661140|468031271|FG000|Open-Label Period|Withdrawal by Subject|5|||
130019082|NCT01661140|468031272|FG001|Open-Label Period|Withdrawal by Subject|0|||
130019083|NCT01661140|468031273|FG002|Open-Label Period|Withdrawal by Subject|0|||
130019084|NCT01661140|468031271|FG000|Open-Label Period|Investigator Decision|3|||
130019085|NCT01661140|468031272|FG001|Open-Label Period|Investigator Decision|0|||
130019086|NCT01661140|468031273|FG002|Open-Label Period|Investigator Decision|0|||
130019087|NCT01661140|468031271|FG000|Open-Label Period|Death|1|||
130019088|NCT01661140|468031272|FG001|Open-Label Period|Death|0|||
130019089|NCT01661140|468031273|FG002|Open-Label Period|Death|0|||
130019090|NCT01661140|468031271|FG000|Open-Label Period|Administrative/Other|1|||
130098801|NCT03426995|468319309|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098802|NCT03426995|468319310|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
130098803|NCT03426995|468319292|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098804|NCT03426995|468319293|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098805|NCT03426995|468319294|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098806|NCT03426995|468319295|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098807|NCT03426995|468319296|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098808|NCT03426995|468319297|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098809|NCT03426995|468319298|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098810|NCT03426995|468319299|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098811|NCT03426995|468319300|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098812|NCT03426995|468319301|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098813|NCT03426995|468319302|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098814|NCT03426995|468319303|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098815|NCT03426995|468319304|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098816|NCT03426995|468319305|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098817|NCT03426995|468319306|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
130098818|NCT03426995|468319307|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
130098819|NCT03426995|468319308|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098820|NCT03426995|468319309|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098821|NCT03426995|468319310|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
130098822|NCT03426995|468319292|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098823|NCT03426995|468319293|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098824|NCT03426995|468319294|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098825|NCT03426995|468319295|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098826|NCT03426995|468319296|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098827|NCT03426995|468319297|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098828|NCT03426995|468319298|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098829|NCT03426995|468319299|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098830|NCT03426995|468319300|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098831|NCT03426995|468319301|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098832|NCT03426995|468319302|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098833|NCT03426995|468319303|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098834|NCT03426995|468319304|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130225040|NCT01534273|468788052|FG004|Period 1|Physician Decision|0|||
130019091|NCT01661140|468031272|FG001|Open-Label Period|Administrative/Other|0|||
130019092|NCT01661140|468031273|FG002|Open-Label Period|Administrative/Other|0|||
130019093|NCT01661140|468031271|FG000|Open-Label Period|Sponsor termination|16|||
130019094|NCT01661140|468031272|FG001|Open-Label Period|Sponsor termination|0|||
130019095|NCT01661140|468031273|FG002|Open-Label Period|Sponsor termination|0|||
130019096|NCT01661140|468031271|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
130019097|NCT01661140|468031272|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
130019098|NCT01661140|468031273|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
130019099|NCT01661140|468031271|FG000|Open-Label Period|Lost to Follow-up|2|||
130019100|NCT01661140|468031272|FG001|Open-Label Period|Lost to Follow-up|0|||
130019101|NCT01661140|468031273|FG002|Open-Label Period|Lost to Follow-up|0|||
130019102|NCT01661140|468031271|FG000|Double-Blind Period|Refused Treatment|0|||
130019103|NCT01661140|468031272|FG001|Double-Blind Period|Refused Treatment|0|||
130019104|NCT01661140|468031273|FG002|Double-Blind Period|Refused Treatment|1|||
130019105|NCT01661140|468031271|FG000|Double-Blind Period|Adverse Event|0|||
130019106|NCT01661140|468031272|FG001|Double-Blind Period|Adverse Event|16|||
130019107|NCT01661140|468031273|FG002|Double-Blind Period|Adverse Event|18|||
130019108|NCT01661140|468031271|FG000|Double-Blind Period|Protocol Violation|0|||
130019109|NCT01661140|468031272|FG001|Double-Blind Period|Protocol Violation|2|||
130019110|NCT01661140|468031273|FG002|Double-Blind Period|Protocol Violation|3|||
130019111|NCT01661140|468031271|FG000|Double-Blind Period|Withdrawal by Subject|0|||
130019112|NCT01661140|468031272|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130019113|NCT01661140|468031273|FG002|Double-Blind Period|Withdrawal by Subject|3|||
130019114|NCT01661140|468031271|FG000|Double-Blind Period|Investigator's Decision|0|||
130019115|NCT01661140|468031272|FG001|Double-Blind Period|Investigator's Decision|1|||
130019116|NCT01661140|468031273|FG002|Double-Blind Period|Investigator's Decision|2|||
130019117|NCT01661140|468031271|FG000|Double-Blind Period|Sponsor Termination|0|||
130019118|NCT01661140|468031272|FG001|Double-Blind Period|Sponsor Termination|14|||
130019119|NCT01661140|468031273|FG002|Double-Blind Period|Sponsor Termination|17|||
130019120|NCT01661140|468031271|FG000|Double-Blind Period|Administrative/Other|0|||
130019121|NCT01661140|468031272|FG001|Double-Blind Period|Administrative/Other|7|||
130019122|NCT01661140|468031273|FG002|Double-Blind Period|Administrative/Other|6|||
130019123|NCT02787850|468031276|FG000|Overall Study|Withdrawal by Subject|0|||
130019124|NCT02787850|468031277|FG001|Overall Study|Withdrawal by Subject|1|||
130098835|NCT03426995|468319305|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098836|NCT03426995|468319306|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
130225041|NCT01534273|468788053|FG005|Period 1|Physician Decision|0|||
130225042|NCT01534273|468788054|FG006|Period 1|Physician Decision|0|||
130225043|NCT03586050|468788055|FG000|Overall Study|Death|3|||
130225044|NCT03586050|468788055|FG000|Overall Study|Withdrawal by Subject|2|||
130225045|NCT01211145|468788056|FG000|Overall Study|Reason not specified|3|||
130225046|NCT01211145|468788057|FG001|Overall Study|Reason not specified|2|||
130225047|NCT01211145|468788058|FG002|Overall Study|Reason not specified|2|||
130225048|NCT01211145|468788059|FG003|Overall Study|Reason not specified|1|||
130098837|NCT03426995|468319307|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
130098838|NCT03426995|468319308|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098839|NCT03426995|468319309|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098840|NCT03426995|468319310|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
130098841|NCT05939388|468319311|FG000|Overall Study|Lost to Follow-up|1|||
130098842|NCT00602667|468319312|FG000|Overall Study|Still on Therapy|0|||
130098843|NCT00602667|468319313|FG001|Overall Study|Still on Therapy|2|||
130098844|NCT00602667|468319314|FG002|Overall Study|Still on Therapy|2|||
130098845|NCT00602667|468319312|FG000|Overall Study|Death|0|||
130098846|NCT00602667|468319313|FG001|Overall Study|Death|1|||
130098847|NCT00602667|468319314|FG002|Overall Study|Death|1|||
130098848|NCT00602667|468319312|FG000|Overall Study|Family request|3|||
130098849|NCT00602667|468319313|FG001|Overall Study|Family request|25|||
130098850|NCT00602667|468319314|FG002|Overall Study|Family request|6|||
130098851|NCT00602667|468319312|FG000|Overall Study|Excessive toxicity|1|||
130098852|NCT00602667|468319313|FG001|Overall Study|Excessive toxicity|1|||
130098853|NCT00602667|468319314|FG002|Overall Study|Excessive toxicity|0|||
130098854|NCT00602667|468319312|FG000|Overall Study|Second malignancy|0|||
130098855|NCT00602667|468319313|FG001|Overall Study|Second malignancy|1|||
130098856|NCT00602667|468319314|FG002|Overall Study|Second malignancy|0|||
130098857|NCT00602667|468319312|FG000|Overall Study|Physician Decision|2|||
130098858|NCT00602667|468319313|FG001|Overall Study|Physician Decision|3|||
130098859|NCT00602667|468319314|FG002|Overall Study|Physician Decision|8|||
130098860|NCT00602667|468319312|FG000|Overall Study|Progressive disease|13|||
130098861|NCT00602667|468319313|FG001|Overall Study|Progressive disease|48|||
130098862|NCT00602667|468319314|FG002|Overall Study|Progressive disease|45|||
130098863|NCT00602667|468319312|FG000|Overall Study|Progressive disease prior to therapy|0|||
130225049|NCT01211145|468788056|FG000|Overall Study|Lost to Follow-up|3|||
130225050|NCT01211145|468788057|FG001|Overall Study|Lost to Follow-up|2|||
130225051|NCT01211145|468788058|FG002|Overall Study|Lost to Follow-up|1|||
130019125|NCT00494091|468031280|FG000|Overall Study|Death|5|||
130019126|NCT00494091|468031281|FG001|Overall Study|Death|54|||
130019127|NCT00494091|468031280|FG000|Overall Study|Lost to Follow-up|0|||
130019128|NCT00494091|468031281|FG001|Overall Study|Lost to Follow-up|4|||
130019129|NCT00494091|468031280|FG000|Overall Study|Other|1|||
130098864|NCT00602667|468319313|FG001|Overall Study|Progressive disease prior to therapy|0|||
130098865|NCT00602667|468319314|FG002|Overall Study|Progressive disease prior to therapy|1|||
130098866|NCT04410978|468319320|FG000|Overall Study|Poor compliance to protocol|2|||
130098867|NCT04410978|468319321|FG001|Overall Study|Poor compliance to protocol|4|||
130098868|NCT04410978|468319320|FG000|Overall Study|Withdrawal by Subject|64|||
130098869|NCT04410978|468319321|FG001|Overall Study|Withdrawal by Subject|66|||
130098870|NCT04410978|468319320|FG000|Overall Study|Other|6|||
130098871|NCT04410978|468319321|FG001|Overall Study|Other|7|||
130098872|NCT04410978|468319320|FG000|Overall Study|Missing study status|1|||
130098873|NCT04410978|468319321|FG001|Overall Study|Missing study status|0|||
130098874|NCT05153629|468319323|FG000|Overall Study|Withdrawal by Subject|0|||
130098875|NCT05153629|468319324|FG001|Overall Study|Withdrawal by Subject|2|||
130098876|NCT03743571|468319330|FG000|Overall Study|Withdrawal by Subject|1|||
130098877|NCT03743571|468319331|FG001|Overall Study|Withdrawal by Subject|1|||
130098878|NCT03743571|468319330|FG000|Overall Study|Lost to Follow-up|1|||
130098879|NCT03743571|468319331|FG001|Overall Study|Lost to Follow-up|2|||
130098880|NCT04115488|468319332|FG000|Overall Study|Adverse Event|8|||
130098881|NCT04115488|468319333|FG001|Overall Study|Adverse Event|4|||
130098882|NCT04115488|468319332|FG000|Overall Study|Withdrawal by Subject|3|||
130098883|NCT04115488|468319333|FG001|Overall Study|Withdrawal by Subject|6|||
130098884|NCT04115488|468319332|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
130098885|NCT04115488|468319333|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
130098886|NCT04115488|468319332|FG000|Overall Study|Patient 's location change|1|||
130098887|NCT04115488|468319333|FG001|Overall Study|Patient 's location change|0|||
130098888|NCT04115488|468319332|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
130225052|NCT01211145|468788059|FG003|Overall Study|Lost to Follow-up|2|||
130019130|NCT00494091|468031281|FG001|Overall Study|Other|11|||
130019131|NCT00494091|468031280|FG000|Overall Study|Withdrawal by Subject|0|||
130019132|NCT00494091|468031281|FG001|Overall Study|Withdrawal by Subject|7|||
130019133|NCT02921971|468031282|FG000|Overall Study|Adverse Event|1|||
130019134|NCT02921971|468031283|FG001|Overall Study|Adverse Event|2|||
130019135|NCT02921971|468031282|FG000|Overall Study|Lack of Efficacy|3|||
130019136|NCT02921971|468031283|FG001|Overall Study|Lack of Efficacy|1|||
130019137|NCT02921971|468031282|FG000|Overall Study|Other than specified above|2|||
130019138|NCT02921971|468031283|FG001|Overall Study|Other than specified above|1|||
130019139|NCT00452699|468031284|FG000|Overall Study|Adverse Event|10|||
130019140|NCT00452699|468031285|FG001|Overall Study|Adverse Event|3|||
130019141|NCT00452699|468031284|FG000|Overall Study|Lack of Efficacy|6|||
130019142|NCT00452699|468031285|FG001|Overall Study|Lack of Efficacy|4|||
130019143|NCT00452699|468031284|FG000|Overall Study|Lost to Follow-up|6|||
130019144|NCT00452699|468031285|FG001|Overall Study|Lost to Follow-up|9|||
130019145|NCT00452699|468031284|FG000|Overall Study|Protocol Violation|21|||
130019146|NCT00452699|468031285|FG001|Overall Study|Protocol Violation|25|||
130019147|NCT00452699|468031284|FG000|Overall Study|Withdrawal by Subject|26|||
130019148|NCT00452699|468031285|FG001|Overall Study|Withdrawal by Subject|25|||
130019149|NCT00452699|468031284|FG000|Overall Study|Other|12|||
130019150|NCT00452699|468031285|FG001|Overall Study|Other|7|||
130019151|NCT00326898|468031286|FG000|Overall Study|Disease progression|52|||
130019152|NCT00326898|468031287|FG001|Overall Study|Disease progression|54|||
130019153|NCT00326898|468031288|FG002|Overall Study|Disease progression|102|||
130019154|NCT00326898|468031286|FG000|Overall Study|Adverse Event|124|||
130019155|NCT00326898|468031287|FG001|Overall Study|Adverse Event|128|||
130019156|NCT00326898|468031288|FG002|Overall Study|Adverse Event|33|||
130019157|NCT00326898|468031286|FG000|Overall Study|Death|2|||
130019158|NCT00326898|468031287|FG001|Overall Study|Death|0|||
130019159|NCT00326898|468031288|FG002|Overall Study|Death|0|||
130019160|NCT00326898|468031286|FG000|Overall Study|Withdrawal by Subject|134|||
130019161|NCT00326898|468031287|FG001|Overall Study|Withdrawal by Subject|128|||
130019162|NCT00326898|468031288|FG002|Overall Study|Withdrawal by Subject|32|||
130019163|NCT00326898|468031286|FG000|Overall Study|Alternative therapy|1|||
130019164|NCT00326898|468031287|FG001|Overall Study|Alternative therapy|0|||
130019165|NCT00326898|468031288|FG002|Overall Study|Alternative therapy|0|||
130019166|NCT00326898|468031286|FG000|Overall Study|Other complicating disease|5|||
130019167|NCT00326898|468031287|FG001|Overall Study|Other complicating disease|5|||
130019168|NCT00326898|468031288|FG002|Overall Study|Other complicating disease|4|||
130019169|NCT00326898|468031286|FG000|Overall Study|Other/Missing/Unknown|33|||
130019170|NCT00326898|468031287|FG001|Overall Study|Other/Missing/Unknown|28|||
130019171|NCT00326898|468031288|FG002|Overall Study|Other/Missing/Unknown|32|||
130019172|NCT03847987|468031289|FG000|Overall Study|Lost to Follow-up|1|||
130019173|NCT03847987|468031290|FG001|Overall Study|Lost to Follow-up|0|||
130019174|NCT03847987|468031289|FG000|Overall Study|Adverse Event|2|||
130019175|NCT03847987|468031290|FG001|Overall Study|Adverse Event|0|||
130019176|NCT01637142|468031297|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
130019177|NCT02111564|468031298|FG000|Overall Study|Death|109|||
130019178|NCT02111564|468031299|FG001|Overall Study|Death|120|||
130019179|NCT02111564|468031298|FG000|Overall Study|Lost to Follow-up|2|||
130019180|NCT02111564|468031299|FG001|Overall Study|Lost to Follow-up|3|||
130019181|NCT02111564|468031298|FG000|Overall Study|Withdrawal by Subject|20|||
130019182|NCT02111564|468031299|FG001|Overall Study|Withdrawal by Subject|20|||
130019183|NCT00687362|468031300|FG000|Overall Study|Protocol Violation|2|||
130019184|NCT00687362|468031300|FG000|Overall Study|Withdrawal by Subject|1|||
130019185|NCT04986202|468031305|FG000|Overall Study|Death|10|||
130019186|NCT04986202|468031306|FG001|Overall Study|Death|3|||
130019187|NCT04986202|468031307|FG002|Overall Study|Death|10|||
130019188|NCT04986202|468031305|FG000|Overall Study|Physician Decision|3|||
130019189|NCT04986202|468031306|FG001|Overall Study|Physician Decision|1|||
130019190|NCT04986202|468031307|FG002|Overall Study|Physician Decision|2|||
130019191|NCT04986202|468031305|FG000|Overall Study|Withdrawal by Subject|4|||
130019192|NCT04986202|468031306|FG001|Overall Study|Withdrawal by Subject|2|||
130019193|NCT04986202|468031307|FG002|Overall Study|Withdrawal by Subject|4|||
130019194|NCT05131204|468031308|FG000|Overall Study|Sponsor request|2|||
130019195|NCT05131204|468031309|FG001|Overall Study|Sponsor request|1|||
130019196|NCT00252057|468031314|FG000|Overall Study|Withdrawal by Subject|2|||
130019197|NCT00252057|468031315|FG001|Overall Study|Withdrawal by Subject|5|||
130019198|NCT00252057|468031314|FG000|Overall Study|Death|1|||
130019199|NCT00252057|468031315|FG001|Overall Study|Death|2|||
130019200|NCT00252057|468031314|FG000|Overall Study|Participant previously enrolled|0|||
130019201|NCT00252057|468031315|FG001|Overall Study|Participant previously enrolled|1|||
130019202|NCT01098071|468031316|FG000|Overall Study|Surgery (adenoidectomy)|2|||
130019203|NCT01098071|468031316|FG000|Overall Study|Lost to Follow-up|13|||
130019204|NCT01665807|468031321|FG000|Overall Study|Withdrawal by Subject|2|||
130019205|NCT01665807|468031322|FG001|Overall Study|Withdrawal by Subject|0|||
130019206|NCT01665807|468031323|FG002|Overall Study|Withdrawal by Subject|1|||
130019207|NCT02728830|468031324|FG000|Overall Study|Exclusionary Surgery|9|||
130019208|NCT02728830|468031324|FG000|Overall Study|Exclusionary Pathology|6|||
130019209|NCT02728830|468031324|FG000|Overall Study|Physician Decision|3|||
130019210|NCT02728830|468031324|FG000|Overall Study|Withdrawal by Subject|2|||
130019211|NCT02728830|468031324|FG000|Overall Study|Lost to Follow-up|1|||
130019212|NCT02728830|468031324|FG000|Overall Study|Exclusionary Lab Values|1|||
130019213|NCT02728830|468031324|FG000|Overall Study|Contraindicated Illness|1|||
130019214|NCT02728830|468031324|FG000|Overall Study|Language Barrier|1|||
130019215|NCT01081795|468031325|FG000|Overall Study|Adverse Event|18|||
130019216|NCT01081795|468031326|FG001|Overall Study|Adverse Event|23|||
130019217|NCT01081795|468031327|FG002|Overall Study|Adverse Event|6|||
130019218|NCT01081795|468031325|FG000|Overall Study|Lack of Efficacy|7|||
130019219|NCT01081795|468031326|FG001|Overall Study|Lack of Efficacy|5|||
130225053|NCT01211145|468788056|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130225054|NCT01211145|468788057|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130225055|NCT01211145|468788058|FG002|Overall Study|Study-specific withdrawal criteria|0|||
130225056|NCT01211145|468788059|FG003|Overall Study|Study-specific withdrawal criteria|0|||
130225057|NCT01211145|468788056|FG000|Overall Study|Severe noncompliance to protocol|1|||
130225058|NCT01211145|468788057|FG001|Overall Study|Severe noncompliance to protocol|0|||
129884494|NCT04844918|467536416|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
129884495|NCT04844918|467536417|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
129884496|NCT01266993|467536428|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
129884497|NCT01266993|467536429|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
129884498|NCT01266993|467536428|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
129884499|NCT01266993|467536429|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
129884500|NCT02293837|467536432|FG000|Overall Study|Lost to Follow-up|0|||
129884501|NCT02293837|467536433|FG001|Overall Study|Lost to Follow-up|2|||
130019220|NCT01081795|468031327|FG002|Overall Study|Lack of Efficacy|19|||
130019221|NCT01081795|468031325|FG000|Overall Study|Subject's schedule|1|||
130019222|NCT01081795|468031326|FG001|Overall Study|Subject's schedule|1|||
129884502|NCT02293837|467536434|FG002|Overall Study|Lost to Follow-up|1|||
129884503|NCT02293837|467536435|FG003|Overall Study|Lost to Follow-up|0|||
130019223|NCT01081795|468031327|FG002|Overall Study|Subject's schedule|2|||
130019224|NCT01081795|468031325|FG000|Overall Study|Revocation of informed consent|2|||
130019225|NCT01081795|468031326|FG001|Overall Study|Revocation of informed consent|0|||
130019226|NCT01081795|468031327|FG002|Overall Study|Revocation of informed consent|0|||
130019227|NCT01081795|468031325|FG000|Overall Study|Ineligible for participation|1|||
130019228|NCT01081795|468031326|FG001|Overall Study|Ineligible for participation|0|||
130019229|NCT01081795|468031327|FG002|Overall Study|Ineligible for participation|0|||
130019230|NCT01081795|468031325|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
130019231|NCT01081795|468031326|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
130019232|NCT01081795|468031327|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
130019233|NCT01081795|468031325|FG000|Overall Study|Using drug with restricted days of use|2|||
130019234|NCT01081795|468031326|FG001|Overall Study|Using drug with restricted days of use|3|||
130019235|NCT01081795|468031327|FG002|Overall Study|Using drug with restricted days of use|2|||
130019236|NCT01081795|468031325|FG000|Overall Study|Other|1|||
130019237|NCT01081795|468031326|FG001|Overall Study|Other|2|||
130019238|NCT01081795|468031327|FG002|Overall Study|Other|0|||
130019239|NCT00143455|468031328|FG000|Cohort 1|Adverse Event|8|||
130019240|NCT00143455|468031329|FG001|Cohort 1|Adverse Event|4|||
130019241|NCT00143455|468031330|FG002|Cohort 1|Adverse Event|0|||
130019242|NCT00143455|468031331|FG003|Cohort 1|Adverse Event|0|||
130019243|NCT00143455|468031328|FG000|Cohort 1|Death|5|||
130019244|NCT00143455|468031329|FG001|Cohort 1|Death|2|||
130019245|NCT00143455|468031330|FG002|Cohort 1|Death|0|||
130019246|NCT00143455|468031331|FG003|Cohort 1|Death|0|||
130019247|NCT00143455|468031328|FG000|Cohort 1|Progressive Disease|0|||
130019248|NCT00143455|468031329|FG001|Cohort 1|Progressive Disease|6|||
130019249|NCT00143455|468031330|FG002|Cohort 1|Progressive Disease|0|||
130019250|NCT00143455|468031331|FG003|Cohort 1|Progressive Disease|0|||
130019251|NCT00143455|468031328|FG000|Cohort 1|Withdrawal by Subject|1|||
130019252|NCT00143455|468031329|FG001|Cohort 1|Withdrawal by Subject|4|||
130019253|NCT00143455|468031330|FG002|Cohort 1|Withdrawal by Subject|0|||
130019254|NCT00143455|468031331|FG003|Cohort 1|Withdrawal by Subject|0|||
130019255|NCT00143455|468031328|FG000|Cohort 1|Randomized But Not Treated|0|||
130019256|NCT00143455|468031329|FG001|Cohort 1|Randomized But Not Treated|1|||
130019257|NCT00143455|468031330|FG002|Cohort 1|Randomized But Not Treated|0|||
130019258|NCT00143455|468031331|FG003|Cohort 1|Randomized But Not Treated|0|||
130019259|NCT00143455|468031328|FG000|Cohort 2|Adverse Event|0|||
130019260|NCT00143455|468031329|FG001|Cohort 2|Adverse Event|0|||
130019261|NCT00143455|468031330|FG002|Cohort 2|Adverse Event|42|||
130019262|NCT00143455|468031331|FG003|Cohort 2|Adverse Event|30|||
130019263|NCT00143455|468031328|FG000|Cohort 2|No Longer Required Study Treatment|0|||
130019264|NCT00143455|468031329|FG001|Cohort 2|No Longer Required Study Treatment|0|||
130019265|NCT00143455|468031330|FG002|Cohort 2|No Longer Required Study Treatment|1|||
130019266|NCT00143455|468031331|FG003|Cohort 2|No Longer Required Study Treatment|0|||
130019267|NCT00143455|468031328|FG000|Cohort 2|Protocol Violation|0|||
130019268|NCT00143455|468031329|FG001|Cohort 2|Protocol Violation|0|||
130019269|NCT00143455|468031330|FG002|Cohort 2|Protocol Violation|1|||
130019270|NCT00143455|468031331|FG003|Cohort 2|Protocol Violation|1|||
130019271|NCT00143455|468031328|FG000|Cohort 2|Lost to Follow-up|0|||
130019272|NCT00143455|468031329|FG001|Cohort 2|Lost to Follow-up|0|||
130019273|NCT00143455|468031330|FG002|Cohort 2|Lost to Follow-up|1|||
130019274|NCT00143455|468031331|FG003|Cohort 2|Lost to Follow-up|4|||
130019275|NCT00143455|468031328|FG000|Cohort 2|Death|0|||
130019276|NCT00143455|468031329|FG001|Cohort 2|Death|0|||
130019277|NCT00143455|468031330|FG002|Cohort 2|Death|20|||
130019278|NCT00143455|468031331|FG003|Cohort 2|Death|12|||
130019279|NCT00143455|468031328|FG000|Cohort 2|Progressive Disease|0|||
130019280|NCT00143455|468031329|FG001|Cohort 2|Progressive Disease|0|||
130019281|NCT00143455|468031330|FG002|Cohort 2|Progressive Disease|20|||
130019282|NCT00143455|468031331|FG003|Cohort 2|Progressive Disease|27|||
130019283|NCT00143455|468031328|FG000|Cohort 2|Withdrawal by Subject|0|||
130019284|NCT00143455|468031329|FG001|Cohort 2|Withdrawal by Subject|0|||
130019285|NCT00143455|468031330|FG002|Cohort 2|Withdrawal by Subject|13|||
130019286|NCT00143455|468031331|FG003|Cohort 2|Withdrawal by Subject|12|||
130019287|NCT00143455|468031328|FG000|Cohort 2|Other|0|||
130019288|NCT00143455|468031329|FG001|Cohort 2|Other|0|||
130019289|NCT00143455|468031330|FG002|Cohort 2|Other|7|||
130019290|NCT00143455|468031331|FG003|Cohort 2|Other|6|||
130019291|NCT00143455|468031328|FG000|Cohort 2|Randomized But Not Treated|0|||
130019292|NCT00143455|468031329|FG001|Cohort 2|Randomized But Not Treated|0|||
130019293|NCT00143455|468031330|FG002|Cohort 2|Randomized But Not Treated|1|||
130019294|NCT00143455|468031331|FG003|Cohort 2|Randomized But Not Treated|1|||
130019295|NCT03713944|468031332|FG000|Study Treatment|Patient non-compliance|1|||
130019296|NCT03713944|468031332|FG000|Study Treatment|Alternative Cancer Therapy|3|||
130019297|NCT03713944|468031332|FG000|Study Treatment|Disease Progression|18|||
130019298|NCT03713944|468031332|FG000|Study Treatment|AE/Side Effects/Complications|2|||
130019299|NCT03713944|468031332|FG000|Study Treatment|Death|2|||
130019300|NCT03713944|468031332|FG000|Study Treatment|Withdrawal by Subject|1|||
130019301|NCT03713944|468031332|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
130019302|NCT03713944|468031332|FG000|Study Treatment|Symptomatic Deterioration|2|||
130019303|NCT03713944|468031332|FG000|Follow up|Withdrawal by Subject|2|||
130019304|NCT03713944|468031332|FG000|Follow up|Death|11|||
130019305|NCT03713944|468031332|FG000|Follow up|Study Terminated|3|||
130019306|NCT00419380|468031335|FG000|Overall Study|Lack of Efficacy|1|||
130019307|NCT00419380|468031336|FG001|Overall Study|Lack of Efficacy|7|||
130019308|NCT00419380|468031335|FG000|Overall Study|Physician Decision|0|||
130019309|NCT00419380|468031336|FG001|Overall Study|Physician Decision|1|||
130019310|NCT00419380|468031335|FG000|Overall Study|Lost to Follow-up|0|||
130019311|NCT00419380|468031336|FG001|Overall Study|Lost to Follow-up|1|||
130019312|NCT00419380|468031335|FG000|Overall Study|Withdrawal by Subject|0|||
130019313|NCT00419380|468031336|FG001|Overall Study|Withdrawal by Subject|1|||
130019314|NCT03127384|468031339|FG000|Overall Study|Lost to Follow-up|4|||
130019315|NCT03127384|468031339|FG000|Overall Study|Subject request|2|||
130019316|NCT01026831|468031341|FG000|Overall Study|Adverse Event|4|||
130019317|NCT01026831|468031342|FG001|Overall Study|Adverse Event|3|||
130019318|NCT01026831|468031341|FG000|Overall Study|Lost to Follow-up|2|||
130019319|NCT01026831|468031342|FG001|Overall Study|Lost to Follow-up|0|||
130019320|NCT01026831|468031341|FG000|Overall Study|Physician Decision|1|||
130019321|NCT01026831|468031342|FG001|Overall Study|Physician Decision|1|||
130019322|NCT01026831|468031341|FG000|Overall Study|Protocol Violation|0|||
130019323|NCT01026831|468031342|FG001|Overall Study|Protocol Violation|2|||
130019324|NCT01026831|468031341|FG000|Overall Study|Withdrawal by Subject|7|||
130019325|NCT01026831|468031342|FG001|Overall Study|Withdrawal by Subject|5|||
130019326|NCT04417894|468031343|FG000|Overall Study|Lost to Follow-up|3|||
130019327|NCT04417894|468031344|FG001|Overall Study|Lost to Follow-up|0|||
130019328|NCT04417894|468031343|FG000|Overall Study|Withdrawal by Subject|7|||
130019329|NCT04417894|468031344|FG001|Overall Study|Withdrawal by Subject|6|||
130019330|NCT04417894|468031343|FG000|Overall Study|Lack of Efficacy|3|||
130019331|NCT04417894|468031344|FG001|Overall Study|Lack of Efficacy|1|||
130019332|NCT03861559|468031345|FG000|Overall Study|Adverse Event|0|||
130019333|NCT03861559|468031346|FG001|Overall Study|Adverse Event|2|||
130019334|NCT03861559|468031345|FG000|Overall Study|Treatment failure|0|||
130019335|NCT03861559|468031346|FG001|Overall Study|Treatment failure|2|||
130019336|NCT03861559|468031345|FG000|Overall Study|Noncompliance|1|||
130019337|NCT03861559|468031346|FG001|Overall Study|Noncompliance|1|||
130019338|NCT03861559|468031345|FG000|Overall Study|Did not meet eligibility requirements|1|||
130019339|NCT03861559|468031346|FG001|Overall Study|Did not meet eligibility requirements|0|||
130019340|NCT03652662|468031347|FG000|Overall Study|Withdrawal by Subject|2|||
130019341|NCT03652662|468031348|FG001|Overall Study|Withdrawal by Subject|1|||
130019342|NCT03652662|468031347|FG000|Overall Study|Lost to Follow-up|1|||
130019343|NCT03652662|468031348|FG001|Overall Study|Lost to Follow-up|0|||
130019344|NCT00487539|468031349|FG000|Overall Study|Adverse Event|3|||
130019345|NCT00487539|468031350|FG001|Overall Study|Adverse Event|2|||
130019346|NCT00487539|468031351|FG002|Overall Study|Adverse Event|1|||
130019347|NCT00487539|468031352|FG003|Overall Study|Adverse Event|1|||
130019348|NCT00487539|468031349|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130019349|NCT00487539|468031350|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130019350|NCT00487539|468031351|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130019351|NCT00487539|468031352|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
130019352|NCT00487539|468031349|FG000|Overall Study|Other|3|||
130019353|NCT00487539|468031350|FG001|Overall Study|Other|1|||
130019354|NCT00487539|468031351|FG002|Overall Study|Other|2|||
130019355|NCT00487539|468031352|FG003|Overall Study|Other|2|||
130019356|NCT03440814|468031353|FG000|Overall Study|Adverse Event|2|||
130019357|NCT03440814|468031354|FG001|Overall Study|Adverse Event|1|||
130019358|NCT03440814|468031353|FG000|Overall Study|Lost to Follow-up|2|||
130019359|NCT03440814|468031354|FG001|Overall Study|Lost to Follow-up|0|||
130019360|NCT03440814|468031353|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
130019361|NCT03440814|468031354|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
130019362|NCT00879697|468031355|FG000|Overall Study|Physician Decision|2|||
130019363|NCT00879697|468031356|FG001|Overall Study|Physician Decision|2|||
130019364|NCT02751502|468031357|FG000|Overall Study|Lack of funding|4|||
130098889|NCT04115488|468319333|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
130019365|NCT00088374|468031358|FG000|Overall Study|patient did not receive any 17AAG|1|||
130019366|NCT00088374|468031358|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
130019367|NCT02678390|468031359|FG000|AE (1 Day)|Withdrawal by Subject|0|||
130019368|NCT02678390|468031360|FG001|AE (1 Day)|Withdrawal by Subject|1|||
130019369|NCT03499028|468031361|FG000|Overall Study|Lost to Follow-up|12|||
130019370|NCT03499028|468031362|FG001|Overall Study|Lost to Follow-up|9|||
130019371|NCT03499028|468031361|FG000|Overall Study|Withdrawal by Subject|5|||
130019372|NCT03499028|468031362|FG001|Overall Study|Withdrawal by Subject|8|||
130019373|NCT03499028|468031361|FG000|Overall Study|Unplanned SNF discharge|5|||
130019374|NCT03499028|468031362|FG001|Overall Study|Unplanned SNF discharge|8|||
130019375|NCT00498173|468031363|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
130019376|NCT00498173|468031364|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
130019377|NCT00498173|468031365|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
130019378|NCT03595553|468031366|FG000|Overall Study|Withdrawal by Subject|20|||
130019379|NCT03595553|468031367|FG001|Overall Study|Withdrawal by Subject|8|||
130019380|NCT03595553|468031366|FG000|Overall Study|Physician Decision|3|||
130019381|NCT03595553|468031367|FG001|Overall Study|Physician Decision|2|||
130019382|NCT03595553|468031366|FG000|Overall Study|Adverse Event|2|||
130019383|NCT03595553|468031367|FG001|Overall Study|Adverse Event|5|||
130019384|NCT03595553|468031366|FG000|Overall Study|Death|24|||
130019385|NCT03595553|468031367|FG001|Overall Study|Death|22|||
130019386|NCT03595553|468031366|FG000|Overall Study|Lost to Follow-up|6|||
130019387|NCT03595553|468031367|FG001|Overall Study|Lost to Follow-up|7|||
130019388|NCT03595553|468031366|FG000|Overall Study|Other as indicated in CSR|3|||
130019389|NCT03595553|468031367|FG001|Overall Study|Other as indicated in CSR|3|||
130019390|NCT03595553|468031366|FG000|Overall Study|Sponsor Decision|0|||
130019391|NCT03595553|468031367|FG001|Overall Study|Sponsor Decision|1|||
130019392|NCT01110200|468031368|FG000|Overall Study|Adverse Event|28|||
130019393|NCT01110200|468031369|FG001|Overall Study|Adverse Event|28|||
130019394|NCT01110200|468031368|FG000|Overall Study|Withdrawal by Subject|25|||
130019395|NCT01110200|468031369|FG001|Overall Study|Withdrawal by Subject|32|||
130019396|NCT01110200|468031368|FG000|Overall Study|Lack of Efficacy|16|||
130019397|NCT01110200|468031369|FG001|Overall Study|Lack of Efficacy|25|||
130019398|NCT01110200|468031368|FG000|Overall Study|Protocol Violation|14|||
130019399|NCT01110200|468031369|FG001|Overall Study|Protocol Violation|12|||
130019400|NCT01110200|468031368|FG000|Overall Study|Physician Decision|13|||
130019401|NCT01110200|468031369|FG001|Overall Study|Physician Decision|17|||
130019402|NCT01110200|468031368|FG000|Overall Study|Lost to Follow-up|10|||
130019403|NCT01110200|468031369|FG001|Overall Study|Lost to Follow-up|7|||
130019404|NCT01437397|468031370|FG000|Overall Study|Lost to Follow-up|9|||
130019405|NCT01437397|468031371|FG001|Overall Study|Lost to Follow-up|4|||
130019406|NCT01437397|468031372|FG002|Overall Study|Lost to Follow-up|2|||
130019407|NCT01437397|468031373|FG003|Overall Study|Lost to Follow-up|4|||
130019408|NCT01437397|468031374|FG004|Overall Study|Lost to Follow-up|5|||
130019409|NCT01437397|468031370|FG000|Overall Study|Withdrawal by Subject|11|||
130019410|NCT01437397|468031371|FG001|Overall Study|Withdrawal by Subject|12|||
130019411|NCT01437397|468031372|FG002|Overall Study|Withdrawal by Subject|24|||
130098890|NCT00885677|468319334|FG000|Overall Study|Death|40|||
130019412|NCT01437397|468031373|FG003|Overall Study|Withdrawal by Subject|11|||
130019413|NCT01437397|468031374|FG004|Overall Study|Withdrawal by Subject|22|||
130019414|NCT01437397|468031370|FG000|Overall Study|Protocol Violation|10|||
130098891|NCT00885677|468319335|FG001|Overall Study|Death|34|||
130098892|NCT00885677|468319334|FG000|Overall Study|Lost to Follow-up|15|||
130098893|NCT00885677|468319335|FG001|Overall Study|Lost to Follow-up|13|||
130098894|NCT00885677|468319334|FG000|Overall Study|Protocol Violation|54|||
130098895|NCT00885677|468319335|FG001|Overall Study|Protocol Violation|54|||
130098896|NCT00885677|468319334|FG000|Overall Study|premature study closure|41|||
130098897|NCT00885677|468319335|FG001|Overall Study|premature study closure|44|||
130098898|NCT00885677|468319334|FG000|Overall Study|device/lead revision or replacement|7|||
130098899|NCT00885677|468319335|FG001|Overall Study|device/lead revision or replacement|6|||
130098900|NCT00885677|468319334|FG000|Overall Study|Heart transplantation|1|||
130098901|NCT00885677|468319335|FG001|Overall Study|Heart transplantation|0|||
130098902|NCT00885677|468319334|FG000|Overall Study|Inclusion/exclusion not met|25|||
130098903|NCT00885677|468319335|FG001|Overall Study|Inclusion/exclusion not met|27|||
130098904|NCT00972309|468319336|FG000|Overall Study|Switched to alternative treatment|0|||
130098905|NCT00972309|468319337|FG001|Overall Study|Switched to alternative treatment|2|||
130098906|NCT00972309|468319336|FG000|Overall Study|Refused further treatment|0|||
130019415|NCT01437397|468031371|FG001|Overall Study|Protocol Violation|12|||
130019416|NCT01437397|468031372|FG002|Overall Study|Protocol Violation|13|||
130019417|NCT01437397|468031373|FG003|Overall Study|Protocol Violation|21|||
130019418|NCT01437397|468031374|FG004|Overall Study|Protocol Violation|19|||
130019419|NCT01437397|468031370|FG000|Overall Study|Lack of Efficacy|5|||
130019420|NCT01437397|468031371|FG001|Overall Study|Lack of Efficacy|4|||
130019421|NCT01437397|468031372|FG002|Overall Study|Lack of Efficacy|8|||
130019422|NCT01437397|468031373|FG003|Overall Study|Lack of Efficacy|10|||
130019423|NCT01437397|468031374|FG004|Overall Study|Lack of Efficacy|20|||
130019424|NCT01437397|468031370|FG000|Overall Study|Adverse Event|21|||
130019425|NCT01437397|468031371|FG001|Overall Study|Adverse Event|22|||
130019426|NCT01437397|468031372|FG002|Overall Study|Adverse Event|16|||
130019427|NCT01437397|468031373|FG003|Overall Study|Adverse Event|14|||
130019428|NCT01437397|468031374|FG004|Overall Study|Adverse Event|21|||
130019429|NCT01437397|468031370|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
130019430|NCT01437397|468031371|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
130019431|NCT01437397|468031372|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
130019432|NCT01437397|468031373|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
130019433|NCT01437397|468031374|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
130019434|NCT00903175|468031375|FG000|Period 1 - First Line|Adverse Event|36|||
130019435|NCT00903175|468031376|FG001|Period 1 - First Line|Adverse Event|50|||
130019436|NCT00903175|468031375|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
130019437|NCT00903175|468031376|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
130019438|NCT00903175|468031375|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
130019439|NCT00903175|468031376|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
130019440|NCT00903175|468031375|FG000|Period 1 - First Line|Protocol Violation|3|||
130019441|NCT00903175|468031376|FG001|Period 1 - First Line|Protocol Violation|3|||
130019442|NCT00903175|468031375|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
130019443|NCT00903175|468031376|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
130019444|NCT00903175|468031375|FG000|Period 1 - First Line|Administrative problems|12|||
130019445|NCT00903175|468031376|FG001|Period 1 - First Line|Administrative problems|13|||
130019446|NCT00903175|468031375|FG000|Period 1 - First Line|Death|17|||
130019447|NCT00903175|468031376|FG001|Period 1 - First Line|Death|10|||
130019448|NCT00903175|468031375|FG000|Period 2 - Second Line|Missing|1|||
130019449|NCT00903175|468031376|FG001|Period 2 - Second Line|Missing|0|||
130019450|NCT00903175|468031375|FG000|Period 2 - Second Line|Adverse Event|16|||
130019451|NCT00903175|468031376|FG001|Period 2 - Second Line|Adverse Event|20|||
130019452|NCT00903175|468031375|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
130019453|NCT00903175|468031376|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
130019454|NCT00903175|468031375|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
130019455|NCT00903175|468031376|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
130019456|NCT00903175|468031375|FG000|Period 2 - Second Line|Administrative problems|19|||
130019457|NCT00903175|468031376|FG001|Period 2 - Second Line|Administrative problems|9|||
130019458|NCT00903175|468031375|FG000|Period 2 - Second Line|Death|5|||
130019459|NCT00903175|468031376|FG001|Period 2 - Second Line|Death|2|||
130019460|NCT01687712|468031377|FG000|Cycle 1|Not Biochemically Pregnant|386|||
130019461|NCT01687712|468031378|FG001|Cycle 1|Not Biochemically Pregnant|348|||
130019462|NCT01687712|468031377|FG000|Cycle 1|Early Pregnancy Loss|43|||
130019463|NCT01687712|468031378|FG001|Cycle 1|Early Pregnancy Loss|60|||
130019464|NCT01687712|468031377|FG000|Cycle 1|Ectopic Pregnancy|5|||
130019465|NCT01687712|468031378|FG001|Cycle 1|Ectopic Pregnancy|5|||
130019466|NCT01687712|468031377|FG000|Cycle 1|Heterotropic Pregnancy|1|||
130019467|NCT01687712|468031378|FG001|Cycle 1|Heterotropic Pregnancy|0|||
130019468|NCT01687712|468031377|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
130019469|NCT01687712|468031378|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
130019470|NCT01687712|468031377|FG000|Cycle 1|Abortion|3|||
130019471|NCT01687712|468031378|FG001|Cycle 1|Abortion|0|||
130019472|NCT01687712|468031377|FG000|Cycle 1|Intrauterine Fetal Death|0|||
130019473|NCT01687712|468031378|FG001|Cycle 1|Intrauterine Fetal Death|1|||
130019474|NCT01687712|468031377|FG000|Cycle 1|Lost to Follow-up|1|||
130019475|NCT01687712|468031378|FG001|Cycle 1|Lost to Follow-up|1|||
130019476|NCT01687712|468031377|FG000|Cycle 2|Not Biochemically Pregnant|74|||
130019477|NCT01687712|468031378|FG001|Cycle 2|Not Biochemically Pregnant|77|||
130019478|NCT01687712|468031377|FG000|Cycle 2|Early Pregnancy Loss|18|||
130019479|NCT01687712|468031378|FG001|Cycle 2|Early Pregnancy Loss|16|||
130019480|NCT01687712|468031377|FG000|Cycle 2|Ectopic Pregnancy|0|||
130019481|NCT01687712|468031378|FG001|Cycle 2|Ectopic Pregnancy|1|||
130019482|NCT01687712|468031377|FG000|Cycle 2|Still Birth|1|||
130019483|NCT01687712|468031378|FG001|Cycle 2|Still Birth|0|||
130019484|NCT01687712|468031377|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
130019485|NCT01687712|468031378|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
130019486|NCT01687712|468031377|FG000|Cycle 3|Not Biochemically Pregnant|21|||
130019487|NCT01687712|468031378|FG001|Cycle 3|Not Biochemically Pregnant|22|||
130019488|NCT01687712|468031377|FG000|Cycle 3|Early Pregnancy Loss|1|||
130019489|NCT01687712|468031378|FG001|Cycle 3|Early Pregnancy Loss|2|||
130019490|NCT01687712|468031377|FG000|Cycle 3|Ectopic Pregnancy|1|||
130019491|NCT01687712|468031378|FG001|Cycle 3|Ectopic Pregnancy|0|||
130019492|NCT01687712|468031377|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
130019493|NCT01687712|468031378|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
130098907|NCT00972309|468319337|FG001|Overall Study|Refused further treatment|1|||
130019494|NCT03074474|468031383|FG000|Overall Study|Lost to Follow-up|10|||
130019495|NCT03074474|468031383|FG000|Overall Study|Withdrawal by Subject|10|||
130019496|NCT03074474|468031383|FG000|Overall Study|Death|4|||
130019497|NCT03074474|468031383|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
130019498|NCT01035905|468031386|FG000|Overall Study|Lack of Efficacy|1|||
130019499|NCT01035905|468031387|FG001|Overall Study|Lack of Efficacy|1|||
130019500|NCT00371865|468031388|FG000|Overall Study|Lack of Efficacy|0|||
130019501|NCT00371865|468031389|FG001|Overall Study|Lack of Efficacy|2|||
130019502|NCT00371865|468031388|FG000|Overall Study|Protocol Violation|3|||
130019503|NCT00371865|468031389|FG001|Overall Study|Protocol Violation|2|||
130019504|NCT00371865|468031388|FG000|Overall Study|Withdrawal by Subject|12|||
130019505|NCT00371865|468031389|FG001|Overall Study|Withdrawal by Subject|10|||
130019506|NCT02508194|468031390|FG000|Overall Study|Death|5|||
130019507|NCT02508194|468031391|FG001|Overall Study|Death|3|||
130019508|NCT02508194|468031390|FG000|Overall Study|Lost to Follow-up|25|||
130019509|NCT02508194|468031391|FG001|Overall Study|Lost to Follow-up|18|||
130019510|NCT02508194|468031390|FG000|Overall Study|Withdrawal by Subject|20|||
130019511|NCT02508194|468031391|FG001|Overall Study|Withdrawal by Subject|18|||
130019512|NCT02508194|468031390|FG000|Overall Study|Error in Randomization|1|||
130019513|NCT02508194|468031391|FG001|Overall Study|Error in Randomization|3|||
130019514|NCT02508194|468031390|FG000|Overall Study|Principal Investigator Decision|1|||
130019515|NCT02508194|468031391|FG001|Overall Study|Principal Investigator Decision|2|||
130019516|NCT01632566|468031393|FG000|Overall Study|Withdrawal by Subject|0|||
130019517|NCT01632566|468031394|FG001|Overall Study|Withdrawal by Subject|1|||
130019518|NCT01632566|468031395|FG002|Overall Study|Withdrawal by Subject|0|||
130019519|NCT01632566|468031396|FG003|Overall Study|Withdrawal by Subject|0|||
130019520|NCT01632566|468031397|FG004|Overall Study|Withdrawal by Subject|0|||
130019521|NCT01632566|468031393|FG000|Overall Study|Sponsor Decision|0|||
130019522|NCT01632566|468031394|FG001|Overall Study|Sponsor Decision|2|||
130019523|NCT01632566|468031395|FG002|Overall Study|Sponsor Decision|9|||
130019524|NCT01632566|468031396|FG003|Overall Study|Sponsor Decision|2|||
130019525|NCT01632566|468031397|FG004|Overall Study|Sponsor Decision|2|||
130019526|NCT02158091|468031399|FG000|Overall Study|DLT|2|||
130019527|NCT02158091|468031400|FG001|Overall Study|DLT|1|||
130019528|NCT02158091|468031401|FG002|Overall Study|DLT|0|||
130019529|NCT03977467|468031402|FG000|Overall Study|Disease Progression|1|||
130019530|NCT03977467|468031403|FG001|Overall Study|Disease Progression|1|||
130019531|NCT03977467|468031404|FG002|Overall Study|Disease Progression|30|||
130019532|NCT03977467|468031405|FG003|Overall Study|Disease Progression|0|||
130019533|NCT03977467|468031402|FG000|Overall Study|Adverse Event|0|||
130019534|NCT03977467|468031403|FG001|Overall Study|Adverse Event|1|||
130019535|NCT03977467|468031404|FG002|Overall Study|Adverse Event|0|||
130019536|NCT03977467|468031405|FG003|Overall Study|Adverse Event|0|||
130019537|NCT03977467|468031402|FG000|Overall Study|Death|0|||
130019538|NCT03977467|468031403|FG001|Overall Study|Death|0|||
130019539|NCT03977467|468031404|FG002|Overall Study|Death|3|||
130019540|NCT03977467|468031405|FG003|Overall Study|Death|0|||
130019541|NCT03977467|468031402|FG000|Overall Study|Lack of Efficacy|0|||
130019542|NCT03977467|468031403|FG001|Overall Study|Lack of Efficacy|0|||
130019543|NCT03977467|468031404|FG002|Overall Study|Lack of Efficacy|1|||
130019544|NCT03977467|468031405|FG003|Overall Study|Lack of Efficacy|0|||
130019545|NCT03977467|468031402|FG000|Overall Study|Withdrawal by Subject|2|||
130019546|NCT03977467|468031403|FG001|Overall Study|Withdrawal by Subject|1|||
130019547|NCT03977467|468031404|FG002|Overall Study|Withdrawal by Subject|4|||
130019548|NCT03977467|468031405|FG003|Overall Study|Withdrawal by Subject|0|||
130019549|NCT03977467|468031402|FG000|Overall Study|Study Terminated|1|||
130019550|NCT03977467|468031403|FG001|Overall Study|Study Terminated|0|||
130019551|NCT03977467|468031404|FG002|Overall Study|Study Terminated|0|||
130019552|NCT03977467|468031405|FG003|Overall Study|Study Terminated|1|||
130019553|NCT05913232|468031406|FG000|Overall Study|Adverse Event|0|||
130019554|NCT05913232|468031407|FG001|Overall Study|Adverse Event|2|||
130019555|NCT05913232|468031408|FG002|Overall Study|Adverse Event|1|||
130019556|NCT05913232|468031409|FG003|Overall Study|Adverse Event|1|||
130019557|NCT04153188|468031413|FG000|Overall Study|Lost to Follow-up|1|||
130019558|NCT04153188|468031414|FG001|Overall Study|Lost to Follow-up|1|||
130019559|NCT04153188|468031413|FG000|Overall Study|Withdrawal by Subject|2|||
130019560|NCT04153188|468031414|FG001|Overall Study|Withdrawal by Subject|0|||
130019561|NCT04153188|468031413|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
130019562|NCT04153188|468031414|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
130019563|NCT00264238|468031416|FG000|Overall Study|Protocol Violation|1|||
130019564|NCT00700271|468031417|FG000|Overall Study|Adverse Event|4|||
130019565|NCT00700271|468031418|FG001|Overall Study|Adverse Event|6|||
130019566|NCT00700271|468031417|FG000|Overall Study|Protocol Violation|1|||
130019567|NCT00700271|468031418|FG001|Overall Study|Protocol Violation|0|||
130019568|NCT00700271|468031417|FG000|Overall Study|Administrative Reasons|1|||
130019569|NCT00700271|468031418|FG001|Overall Study|Administrative Reasons|0|||
130019570|NCT00700271|468031417|FG000|Overall Study|Withdrawal by Subject|6|||
130019571|NCT00700271|468031418|FG001|Overall Study|Withdrawal by Subject|4|||
130019572|NCT00700271|468031417|FG000|Overall Study|Lost to Follow-up|2|||
130019573|NCT00700271|468031418|FG001|Overall Study|Lost to Follow-up|2|||
130019574|NCT00861744|468031419|FG000|Overall Study|Adverse Event|0|||
130019575|NCT00861744|468031420|FG001|Overall Study|Adverse Event|0|||
130019576|NCT00861744|468031421|FG002|Overall Study|Adverse Event|0|||
130019577|NCT00861744|468031422|FG003|Overall Study|Adverse Event|1|||
130019578|NCT00861744|468031419|FG000|Overall Study|Lost to Follow-up|7|||
130019579|NCT00861744|468031420|FG001|Overall Study|Lost to Follow-up|19|||
130019580|NCT00861744|468031421|FG002|Overall Study|Lost to Follow-up|17|||
130019581|NCT00861744|468031422|FG003|Overall Study|Lost to Follow-up|12|||
130019582|NCT00861744|468031419|FG000|Overall Study|Withdrawal by Subject|10|||
130019583|NCT00861744|468031420|FG001|Overall Study|Withdrawal by Subject|6|||
130019584|NCT00861744|468031421|FG002|Overall Study|Withdrawal by Subject|6|||
130019585|NCT00861744|468031422|FG003|Overall Study|Withdrawal by Subject|19|||
130019586|NCT00861744|468031419|FG000|Overall Study|Protocol Violation|0|||
130019587|NCT00861744|468031420|FG001|Overall Study|Protocol Violation|1|||
130019588|NCT00861744|468031421|FG002|Overall Study|Protocol Violation|0|||
130019589|NCT00861744|468031422|FG003|Overall Study|Protocol Violation|0|||
130019590|NCT00861744|468031419|FG000|Overall Study|Migration from study area|0|||
130019591|NCT00861744|468031420|FG001|Overall Study|Migration from study area|3|||
130019592|NCT00861744|468031421|FG002|Overall Study|Migration from study area|1|||
130019593|NCT00861744|468031422|FG003|Overall Study|Migration from study area|0|||
130019594|NCT00861744|468031419|FG000|Overall Study|Blood draws|0|||
130019595|NCT00861744|468031420|FG001|Overall Study|Blood draws|0|||
130019596|NCT00861744|468031421|FG002|Overall Study|Blood draws|0|||
130019597|NCT00861744|468031422|FG003|Overall Study|Blood draws|1|||
130225059|NCT01211145|468788058|FG002|Overall Study|Severe noncompliance to protocol|0|||
130225060|NCT01211145|468788059|FG003|Overall Study|Severe noncompliance to protocol|0|||
130098908|NCT00972309|468319336|FG000|Overall Study|Late determination of ineligibility|0|||
130098909|NCT00972309|468319337|FG001|Overall Study|Late determination of ineligibility|1|||
130098910|NCT00972309|468319336|FG000|Overall Study|Second malignancy|1|||
130098911|NCT00972309|468319337|FG001|Overall Study|Second malignancy|1|||
130098912|NCT00972309|468319336|FG000|Overall Study|Visa issues|0|||
130098913|NCT00972309|468319337|FG001|Overall Study|Visa issues|1|||
130098914|NCT00972309|468319336|FG000|Overall Study|Secondary cancer (SCC)|0|||
130098915|NCT00972309|468319337|FG001|Overall Study|Secondary cancer (SCC)|1|||
130098916|NCT00972309|468319336|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
130098917|NCT00972309|468319337|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
130098918|NCT00972309|468319336|FG000|Overall Study|Lost to Follow-up|1|||
130098919|NCT00972309|468319337|FG001|Overall Study|Lost to Follow-up|1|||
130098920|NCT00972309|468319336|FG000|Overall Study|Disease progression on study|10|||
130098921|NCT00972309|468319337|FG001|Overall Study|Disease progression on study|4|||
130098922|NCT00948896|468319339|FG000|Randomization to 24 Months of Age|Death|1|||
130098923|NCT00948896|468319340|FG001|Randomization to 24 Months of Age|Death|0|||
130098924|NCT00948896|468319341|FG002|Randomization to 24 Months of Age|Death|0|||
130098925|NCT00948896|468319342|FG003|Randomization to 24 Months of Age|Death|0|||
130098926|NCT00948896|468319343|FG004|Randomization to 24 Months of Age|Death|2|||
130019598|NCT05107765|468031423|FG000|Overall Study|Lost to Follow-up|4|||
130019599|NCT05107765|468031424|FG001|Overall Study|Lost to Follow-up|1|||
130098927|NCT00948896|468319344|FG005|Randomization to 24 Months of Age|Death|1|||
130098928|NCT00948896|468319345|FG006|Randomization to 24 Months of Age|Death|2|||
130098929|NCT00948896|468319346|FG007|Randomization to 24 Months of Age|Death|1|||
130098930|NCT00948896|468319339|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
130019600|NCT05107765|468031423|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
130019601|NCT05107765|468031424|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
130019602|NCT05107765|468031423|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
130019603|NCT05107765|468031424|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
130019604|NCT01411085|468031427|FG000|Overall Study|Physician Decision|1|||
130019605|NCT01411085|468031427|FG000|Overall Study|Protocol Violation|1|||
130019606|NCT01411085|468031427|FG000|Overall Study|Adverse Event|1|||
130019607|NCT03809611|468031428|FG000|Overall Study|Withdrawal by Subject|1|||
130019608|NCT03809611|468031429|FG001|Overall Study|Withdrawal by Subject|1|||
130019609|NCT02193074|468031430|FG000|Overall Study|Withdrawal by Subject|1|||
130019610|NCT02193074|468031431|FG001|Overall Study|Withdrawal by Subject|2|||
130019611|NCT02193074|468031430|FG000|Overall Study|Adverse Event|16|||
130019612|NCT02193074|468031431|FG001|Overall Study|Adverse Event|13|||
130019613|NCT01534533|468031432|FG000|Overall Study|Lost to Follow-up|3|||
130019614|NCT01534533|468031433|FG001|Overall Study|Lost to Follow-up|0|||
130019615|NCT01534533|468031434|FG002|Overall Study|Lost to Follow-up|4|||
130019616|NCT01534533|468031435|FG003|Overall Study|Lost to Follow-up|3|||
130019617|NCT01534533|468031432|FG000|Overall Study|Withdrawal by Subject|5|||
130019618|NCT01534533|468031433|FG001|Overall Study|Withdrawal by Subject|3|||
130019619|NCT01534533|468031434|FG002|Overall Study|Withdrawal by Subject|4|||
130019620|NCT01534533|468031435|FG003|Overall Study|Withdrawal by Subject|1|||
130019621|NCT02615990|468032842|FG000|Overall Study|study terminated|1|||
130019622|NCT02615990|468032843|FG001|Overall Study|study terminated|1|||
130019623|NCT01363986|468032844|FG000|Overall Study|Disease progression|1|||
130019624|NCT00130832|468032845|FG000|Overall Study|Adverse Event|1|||
130019625|NCT00130832|468032846|FG001|Overall Study|Adverse Event|1|||
130019626|NCT00130832|468032845|FG000|Overall Study|Lost to Follow-up|1|||
130019627|NCT00130832|468032846|FG001|Overall Study|Lost to Follow-up|2|||
130019628|NCT00130832|468032845|FG000|Overall Study|Protocol Violation|6|||
130019629|NCT00130832|468032846|FG001|Overall Study|Protocol Violation|8|||
130019630|NCT00130832|468032845|FG000|Overall Study|Withdrawal by Subject|6|||
130019631|NCT00130832|468032846|FG001|Overall Study|Withdrawal by Subject|1|||
130019632|NCT00130832|468032845|FG000|Overall Study|Moved|2|||
130019633|NCT00130832|468032846|FG001|Overall Study|Moved|2|||
130019634|NCT00130832|468032845|FG000|Overall Study|Other|0|||
130019635|NCT00130832|468032846|FG001|Overall Study|Other|3|||
130019636|NCT03905863|468032847|FG000|Overall Study|Adverse Event|2|||
130019637|NCT03905863|468032848|FG001|Overall Study|Adverse Event|4|||
130019638|NCT03905863|468032847|FG000|Overall Study|Withdrawal by Subject|2|||
130019639|NCT03905863|468032848|FG001|Overall Study|Withdrawal by Subject|2|||
130019640|NCT03905863|468032847|FG000|Overall Study|Physician Decision|0|||
130019641|NCT03905863|468032848|FG001|Overall Study|Physician Decision|3|||
130019642|NCT03905863|468032847|FG000|Overall Study|Lost to Follow-up|1|||
130019643|NCT03905863|468032848|FG001|Overall Study|Lost to Follow-up|0|||
130019644|NCT03905863|468032847|FG000|Overall Study|Protocol Violation|0|||
130019645|NCT03905863|468032848|FG001|Overall Study|Protocol Violation|2|||
130019646|NCT03905863|468032847|FG000|Overall Study|Death|0|||
130019647|NCT03905863|468032848|FG001|Overall Study|Death|1|||
130019648|NCT02354703|468032849|FG000|Overall Study|Withdrawal by Subject|1|||
130019649|NCT02354703|468032850|FG001|Overall Study|Withdrawal by Subject|1|||
130019650|NCT02354703|468032851|FG002|Overall Study|Withdrawal by Subject|1|||
130019651|NCT02354703|468032852|FG003|Overall Study|Withdrawal by Subject|1|||
130019652|NCT02354703|468032849|FG000|Overall Study|Lost to Follow-up|2|||
130019653|NCT02354703|468032850|FG001|Overall Study|Lost to Follow-up|7|||
130019654|NCT02354703|468032851|FG002|Overall Study|Lost to Follow-up|9|||
130019655|NCT02354703|468032852|FG003|Overall Study|Lost to Follow-up|2|||
130019656|NCT02354703|468032849|FG000|Overall Study|Adverse Event|0|||
130019657|NCT02354703|468032850|FG001|Overall Study|Adverse Event|0|||
130019658|NCT02354703|468032851|FG002|Overall Study|Adverse Event|1|||
130019659|NCT02354703|468032852|FG003|Overall Study|Adverse Event|0|||
130019660|NCT05499559|468032853|FG000|Overall Study|Lost to Follow-up|467|||
130019661|NCT04681170|468032854|FG000|Stratified Enrolment & run-in|Death|1|||
130019662|NCT04681170|468032855|FG001|Stratified Enrolment & run-in|Death|0|||
130019663|NCT04681170|468032854|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
130019664|NCT04681170|468032855|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
130019665|NCT04681170|468032854|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
130019666|NCT04681170|468032855|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
130019667|NCT04681170|468032854|FG000|Open Label Efficacy Phase|Adverse Event|0|||
130019668|NCT04681170|468032855|FG001|Open Label Efficacy Phase|Adverse Event|2|||
130098931|NCT00948896|468319340|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
130098932|NCT00948896|468319341|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
130098933|NCT00948896|468319342|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
130098934|NCT00948896|468319343|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130098935|NCT00948896|468319344|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
130098936|NCT00948896|468319345|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130098937|NCT00948896|468319346|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
130019669|NCT04681170|468032854|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
130019670|NCT04681170|468032855|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
130098938|NCT00948896|468319339|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
130019671|NCT04681170|468032854|FG000|Open Label Safety Phase|AEs and none compliance|0|||
130019672|NCT04681170|468032855|FG001|Open Label Safety Phase|AEs and none compliance|1|||
130019673|NCT02468648|468032856|FG000|Overall Study|Death|1|||
130019674|NCT02118792|468032857|FG000|Overall Study|Withdrawal by Subject|6|||
130019675|NCT02118792|468032858|FG001|Overall Study|Withdrawal by Subject|3|||
130019676|NCT02118792|468032857|FG000|Overall Study|Lost to Follow-up|4|||
130019677|NCT02118792|468032858|FG001|Overall Study|Lost to Follow-up|4|||
130019678|NCT02118792|468032857|FG000|Overall Study|Adverse Event|5|||
130019679|NCT02118792|468032858|FG001|Overall Study|Adverse Event|4|||
130019680|NCT02118792|468032857|FG000|Overall Study|Withdrawal by parent/guardian|14|||
130019681|NCT02118792|468032858|FG001|Overall Study|Withdrawal by parent/guardian|20|||
130019682|NCT02118792|468032857|FG000|Overall Study|Other|1|||
130019683|NCT02118792|468032858|FG001|Overall Study|Other|6|||
130019684|NCT02118792|468032857|FG000|Overall Study|Randomised but not treated|1|||
130019685|NCT02118792|468032858|FG001|Overall Study|Randomised but not treated|0|||
130019686|NCT02787863|468032859|FG000|Overall Study|Death|1|||
130019687|NCT02787863|468032860|FG001|Overall Study|Death|0|||
130019688|NCT02787863|468032861|FG002|Overall Study|Death|1|||
130019689|NCT02787863|468032862|FG003|Overall Study|Death|0|||
130019690|NCT02787863|468032863|FG004|Overall Study|Death|0|||
130019691|NCT02787863|468032864|FG005|Overall Study|Death|0|||
130019692|NCT02787863|468032865|FG006|Overall Study|Death|0|||
130019693|NCT02787863|468032866|FG007|Overall Study|Death|0|||
130019694|NCT02787863|468032859|FG000|Overall Study|Withdrawal by Subject|0|||
130019695|NCT02787863|468032860|FG001|Overall Study|Withdrawal by Subject|1|||
130019696|NCT02787863|468032861|FG002|Overall Study|Withdrawal by Subject|1|||
130019697|NCT02787863|468032862|FG003|Overall Study|Withdrawal by Subject|0|||
130019698|NCT02787863|468032863|FG004|Overall Study|Withdrawal by Subject|0|||
130019699|NCT02787863|468032864|FG005|Overall Study|Withdrawal by Subject|0|||
130019700|NCT02787863|468032865|FG006|Overall Study|Withdrawal by Subject|0|||
130019701|NCT02787863|468032866|FG007|Overall Study|Withdrawal by Subject|0|||
130019702|NCT01368835|468032867|FG000|Overall Study|Inclusion criteria/photography quality|22|||
130019703|NCT01368835|468032867|FG000|Overall Study|Lost to Follow-up|11|||
130019704|NCT02754726|468032868|FG000|Overall Study|Progressive Disease by RECIST|13|||
130019705|NCT02754726|468032868|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
130019706|NCT02754726|468032868|FG000|Overall Study|Clinical Disease Progression|5|||
130019707|NCT02754726|468032868|FG000|Overall Study|Adverse Event|3|||
130019708|NCT02754726|468032868|FG000|Overall Study|Withdrawal by Subject|1|||
130019709|NCT02754726|468032868|FG000|Overall Study|Tolerability|1|||
130019710|NCT01415752|468032880|FG000|Induction (Step 1)|Ineligible|4|||
130019711|NCT01415752|468032881|FG001|Induction (Step 1)|Ineligible|3|||
130019712|NCT01415752|468032882|FG002|Induction (Step 1)|Ineligible|4|||
130019713|NCT01415752|468032883|FG003|Induction (Step 1)|Ineligible|4|||
130019714|NCT01415752|468032880|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
130019715|NCT01415752|468032881|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
130019716|NCT01415752|468032882|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
130019717|NCT01415752|468032883|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
130019718|NCT01415752|468032880|FG000|Maintenance (Step 2)|Adverse Event|3|||
130019719|NCT01415752|468032881|FG001|Maintenance (Step 2)|Adverse Event|4|||
130019720|NCT01415752|468032882|FG002|Maintenance (Step 2)|Adverse Event|9|||
130019721|NCT01415752|468032883|FG003|Maintenance (Step 2)|Adverse Event|6|||
130019722|NCT01415752|468032880|FG000|Maintenance (Step 2)|Death|1|||
130019723|NCT01415752|468032881|FG001|Maintenance (Step 2)|Death|1|||
130019724|NCT01415752|468032882|FG002|Maintenance (Step 2)|Death|2|||
130019725|NCT01415752|468032883|FG003|Maintenance (Step 2)|Death|0|||
130019726|NCT01415752|468032880|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
130019727|NCT01415752|468032881|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
130019728|NCT01415752|468032882|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
130019729|NCT01415752|468032883|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
130019730|NCT01415752|468032880|FG000|Maintenance (Step 2)|Alternative therapy|0|||
130019731|NCT01415752|468032881|FG001|Maintenance (Step 2)|Alternative therapy|1|||
130019732|NCT01415752|468032882|FG002|Maintenance (Step 2)|Alternative therapy|0|||
130019733|NCT01415752|468032883|FG003|Maintenance (Step 2)|Alternative therapy|0|||
130019734|NCT01415752|468032880|FG000|Maintenance (Step 2)|Other reasons|3|||
130019735|NCT01415752|468032881|FG001|Maintenance (Step 2)|Other reasons|6|||
130019736|NCT01415752|468032882|FG002|Maintenance (Step 2)|Other reasons|4|||
130019737|NCT01415752|468032883|FG003|Maintenance (Step 2)|Other reasons|6|||
130225061|NCT01211145|468788056|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
130225062|NCT01211145|468788057|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
130019738|NCT01415752|468032880|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
130019739|NCT01415752|468032881|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
130019740|NCT01415752|468032882|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
130019741|NCT01415752|468032883|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
130019742|NCT01415752|468032880|FG000|Maintenance (Step 2)|ineligible|1|||
130019743|NCT01415752|468032881|FG001|Maintenance (Step 2)|ineligible|1|||
130019744|NCT01415752|468032882|FG002|Maintenance (Step 2)|ineligible|1|||
130019745|NCT01415752|468032883|FG003|Maintenance (Step 2)|ineligible|0|||
130019746|NCT01415752|468032880|FG000|Maintenance (Step 2)|Missing|4|||
130225063|NCT01211145|468788058|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
130019747|NCT01415752|468032881|FG001|Maintenance (Step 2)|Missing|1|||
130019748|NCT01415752|468032882|FG002|Maintenance (Step 2)|Missing|4|||
130019749|NCT01415752|468032883|FG003|Maintenance (Step 2)|Missing|3|||
130019750|NCT01903837|468032885|FG000|Part A|Withdrawal by Subject|4|||
130019751|NCT01903837|468032886|FG001|Part A|Withdrawal by Subject|9|||
130019752|NCT01903837|468032887|FG002|Part A|Withdrawal by Subject|8|||
130019753|NCT01903837|468032888|FG003|Part A|Withdrawal by Subject|5|||
130019754|NCT01903837|468032885|FG000|Part A|Adverse Event|3|||
130019755|NCT01903837|468032886|FG001|Part A|Adverse Event|6|||
130019756|NCT01903837|468032887|FG002|Part A|Adverse Event|9|||
130019757|NCT01903837|468032888|FG003|Part A|Adverse Event|6|||
130019758|NCT01903837|468032885|FG000|Part A|Lost to Follow-up|9|||
130019759|NCT01903837|468032886|FG001|Part A|Lost to Follow-up|7|||
130019760|NCT01903837|468032887|FG002|Part A|Lost to Follow-up|7|||
130019761|NCT01903837|468032888|FG003|Part A|Lost to Follow-up|2|||
130019762|NCT01903837|468032885|FG000|Part A|Non-compliance with study drug|1|||
130019763|NCT01903837|468032886|FG001|Part A|Non-compliance with study drug|4|||
130019764|NCT01903837|468032887|FG002|Part A|Non-compliance with study drug|4|||
130019765|NCT01903837|468032888|FG003|Part A|Non-compliance with study drug|0|||
130019766|NCT01903837|468032885|FG000|Part A|Physician Decision|1|||
130019767|NCT01903837|468032886|FG001|Part A|Physician Decision|1|||
130019768|NCT01903837|468032887|FG002|Part A|Physician Decision|0|||
130019769|NCT01903837|468032888|FG003|Part A|Physician Decision|0|||
130019770|NCT01903837|468032885|FG000|Part A|Protocol Violation|1|||
130019771|NCT01903837|468032886|FG001|Part A|Protocol Violation|1|||
130019772|NCT01903837|468032887|FG002|Part A|Protocol Violation|0|||
130019773|NCT01903837|468032888|FG003|Part A|Protocol Violation|0|||
130019774|NCT01903837|468032885|FG000|Part B|Lost to Follow-up|0|||
130019775|NCT01903837|468032886|FG001|Part B|Lost to Follow-up|3|||
130019776|NCT01903837|468032887|FG002|Part B|Lost to Follow-up|3|||
130019777|NCT01903837|468032888|FG003|Part B|Lost to Follow-up|4|||
130019778|NCT01903837|468032885|FG000|Part B|Withdrawal by Subject|1|||
130019779|NCT01903837|468032886|FG001|Part B|Withdrawal by Subject|2|||
130019780|NCT01903837|468032887|FG002|Part B|Withdrawal by Subject|0|||
130019781|NCT01903837|468032888|FG003|Part B|Withdrawal by Subject|3|||
130019782|NCT01903837|468032885|FG000|Part B|Adverse Event|3|||
130019783|NCT01903837|468032886|FG001|Part B|Adverse Event|0|||
130019784|NCT01903837|468032887|FG002|Part B|Adverse Event|2|||
130019785|NCT01903837|468032888|FG003|Part B|Adverse Event|0|||
130019786|NCT01903837|468032885|FG000|Part B|Non-compliance with study drug|2|||
130019787|NCT01903837|468032886|FG001|Part B|Non-compliance with study drug|0|||
130019788|NCT01903837|468032887|FG002|Part B|Non-compliance with study drug|0|||
130019789|NCT01903837|468032888|FG003|Part B|Non-compliance with study drug|1|||
130019790|NCT01903837|468032885|FG000|Part B|Incarceration|2|||
130225064|NCT01211145|468788059|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
130019791|NCT01903837|468032886|FG001|Part B|Incarceration|0|||
130019792|NCT01903837|468032887|FG002|Part B|Incarceration|0|||
130019793|NCT01903837|468032888|FG003|Part B|Incarceration|1|||
130019794|NCT01903837|468032885|FG000|Part B|Physician Decision|1|||
130019795|NCT01903837|468032886|FG001|Part B|Physician Decision|0|||
130019796|NCT01903837|468032887|FG002|Part B|Physician Decision|0|||
130225065|NCT01211145|468788056|FG000|Overall Study|Patient decision|2|||
130225066|NCT01211145|468788057|FG001|Overall Study|Patient decision|1|||
130019797|NCT01903837|468032888|FG003|Part B|Physician Decision|2|||
130019798|NCT01903837|468032885|FG000|Part B|Lack of Efficacy|0|||
130019799|NCT01903837|468032886|FG001|Part B|Lack of Efficacy|1|||
130225067|NCT01211145|468788058|FG002|Overall Study|Patient decision|0|||
130019800|NCT01903837|468032887|FG002|Part B|Lack of Efficacy|0|||
130019801|NCT01903837|468032888|FG003|Part B|Lack of Efficacy|0|||
130225068|NCT01211145|468788059|FG003|Overall Study|Patient decision|2|||
130019802|NCT00705939|468032890|FG000|Overall Study|Protocol Violation|0|||
130225069|NCT00570401|468788060|FG000|Overall Study|Adverse Event|2|||
130019803|NCT00705939|468032891|FG001|Overall Study|Protocol Violation|0|||
130019804|NCT00705939|468032892|FG002|Overall Study|Protocol Violation|1|||
130019805|NCT00705939|468032890|FG000|Overall Study|Withdrawal by Subject|0|||
130019806|NCT00705939|468032891|FG001|Overall Study|Withdrawal by Subject|1|||
130019807|NCT00705939|468032892|FG002|Overall Study|Withdrawal by Subject|3|||
130019808|NCT00705939|468032890|FG000|Overall Study|Physician Decision|0|||
130019809|NCT00705939|468032891|FG001|Overall Study|Physician Decision|1|||
130019810|NCT00705939|468032892|FG002|Overall Study|Physician Decision|0|||
130019811|NCT05048342|468032893|FG000|Overall Study|Adverse Event|1|||
130019812|NCT05048342|468032893|FG000|Overall Study|Subject decision|2|||
130019813|NCT01441063|468032894|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
130019814|NCT01441063|468032894|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
130019815|NCT04372927|468032895|FG000|Overall Study|Death|1|||
130019816|NCT00661271|468032896|FG000|Overall Study|Lost to Follow-up|28|||
130225070|NCT00385918|468788065|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
130225071|NCT00385918|468788066|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
130225072|NCT00385918|468788067|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
130225073|NCT00385918|468788065|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
130225074|NCT00385918|468788066|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
130019817|NCT00661271|468032897|FG001|Overall Study|Lost to Follow-up|25|||
130019818|NCT01707693|468032899|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
130019819|NCT01707693|468032900|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
130019820|NCT01707693|468032899|FG000|Overall Study Allocation|Protocol Violation|4|||
130019821|NCT01707693|468032900|FG001|Overall Study Allocation|Protocol Violation|3|||
130019822|NCT01707693|468032899|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
130019823|NCT01707693|468032900|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
130019824|NCT01707693|468032899|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
130019825|NCT01707693|468032900|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
130019826|NCT01325428|468032901|FG000|Part A|Progressive disease according to RECIST|9|||
130019827|NCT01325428|468032901|FG000|Part A|Clinical signs, symptoms of progression|2|||
130019828|NCT01325428|468032901|FG000|Part A|Other adverse event|1|||
130019829|NCT01325428|468032901|FG000|Part A|Refused continue taking trial medication|2|||
130019830|NCT01325428|468032901|FG000|Part A|Other reason not defined above|2|||
130019831|NCT01325428|468032901|FG000|Part B|Refused continue taking trial medication|2|||
130019832|NCT01325428|468032901|FG000|Part B|Other reason not defined above|1|||
130019833|NCT03847610|468032902|FG000|Overall Study|Withdrawal by Subject|1|||
130019834|NCT03099707|468032903|FG000|Overall Study|Withdrawal by Subject|0|||
130019835|NCT03099707|468032904|FG001|Overall Study|Withdrawal by Subject|3|||
130019836|NCT03099707|468032903|FG000|Overall Study|Lost to Follow-up|0|||
130019837|NCT03099707|468032904|FG001|Overall Study|Lost to Follow-up|1|||
130019838|NCT01445769|468032905|FG000|Overall Study|Consent Withdrawn|2|||
130019839|NCT01445769|468032905|FG000|Overall Study|Disease Progression|1|||
130019840|NCT01445769|468032905|FG000|Overall Study|Lost to Follow-up|5|||
130019841|NCT00343889|468032928|FG000|Overall Study|Lost to Follow-up|2|||
130019842|NCT00343889|468032929|FG001|Overall Study|Lost to Follow-up|0|||
130019843|NCT00343889|468032928|FG000|Overall Study|Withdrawal by Subject|0|||
130019844|NCT00343889|468032929|FG001|Overall Study|Withdrawal by Subject|1|||
130019845|NCT00343889|468032928|FG000|Overall Study|Protocol Violation|1|||
130019846|NCT00343889|468032929|FG001|Overall Study|Protocol Violation|0|||
130019847|NCT01294579|468032932|FG000|Overall Study|Disease progression|12|||
130019848|NCT01294579|468032932|FG000|Overall Study|Adverse Event|11|||
130019849|NCT01294579|468032932|FG000|Overall Study|Study closed/terminated|3|||
130019850|NCT01294579|468032932|FG000|Overall Study|Lost to Follow-up|1|||
130019851|NCT01294579|468032932|FG000|Overall Study|Physician Decision|3|||
130019852|NCT01294579|468032932|FG000|Overall Study|Withdrawal by Subject|5|||
130019853|NCT01967537|468032935|FG000|Overall Study|Withdrawal by Subject|52|||
130019854|NCT01967537|468032935|FG000|Overall Study|Refuse treatment|2|||
130019855|NCT01967537|468032935|FG000|Overall Study|Lost to Follow-up|6|||
130019856|NCT01079182|468032936|FG000|Overall Study|Lost to Follow-up|1634|||
130019857|NCT01079182|468032936|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
130019858|NCT01079182|468032936|FG000|Overall Study|Lack of Efficacy|514|||
130019859|NCT01079182|468032936|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
130019860|NCT01079182|468032936|FG000|Overall Study|Reasons not Evaluated|271|||
130019861|NCT05130463|468032937|FG000|Overall Study|Unspecified reasons|2|||
130019862|NCT05130463|468032937|FG000|Overall Study|off-label indication dose|435|||
130019863|NCT03461757|468032938|FG000|Overall Study|Adverse Event|1|||
130019864|NCT03461757|468032939|FG001|Overall Study|Adverse Event|0|||
130019865|NCT03461757|468032938|FG000|Overall Study|Lost to Follow-up|13|||
130019866|NCT03461757|468032939|FG001|Overall Study|Lost to Follow-up|7|||
130019867|NCT03461757|468032938|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
130019868|NCT03461757|468032939|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
130019869|NCT03461757|468032938|FG000|Overall Study|Non-compliance with study treatment|0|||
130019870|NCT03461757|468032939|FG001|Overall Study|Non-compliance with study treatment|1|||
130019871|NCT03461757|468032938|FG000|Overall Study|Pregnancy|2|||
130019872|NCT03461757|468032939|FG001|Overall Study|Pregnancy|0|||
130019873|NCT03461757|468032938|FG000|Overall Study|Protocol Violation|1|||
130019874|NCT03461757|468032939|FG001|Overall Study|Protocol Violation|1|||
130019875|NCT03461757|468032938|FG000|Overall Study|Withdrawal by Subject|7|||
130019876|NCT03461757|468032939|FG001|Overall Study|Withdrawal by Subject|7|||
130019877|NCT03461757|468032938|FG000|Overall Study|Other Reasons|1|||
130019878|NCT03461757|468032939|FG001|Overall Study|Other Reasons|4|||
130019879|NCT00720109|468032945|FG000|Induction Period|Did not meet eligibility criteria|3|||
130019880|NCT00720109|468032946|FG001|Induction Period|Did not meet eligibility criteria|0|||
130019881|NCT00720109|468032947|FG002|Induction Period|Did not meet eligibility criteria|0|||
130019882|NCT00720109|468032945|FG000|Induction Period|Bone Marrow Transplant|2|||
130019883|NCT00720109|468032946|FG001|Induction Period|Bone Marrow Transplant|0|||
130019884|NCT00720109|468032947|FG002|Induction Period|Bone Marrow Transplant|0|||
130019885|NCT00720109|468032945|FG000|Induction Period|Physician Decision|1|||
130019886|NCT00720109|468032946|FG001|Induction Period|Physician Decision|0|||
130019887|NCT00720109|468032947|FG002|Induction Period|Physician Decision|0|||
130019888|NCT00720109|468032945|FG000|Risk Stratification Period|Adverse Event|0|||
130019889|NCT00720109|468032946|FG001|Risk Stratification Period|Adverse Event|1|||
130019890|NCT00720109|468032947|FG002|Risk Stratification Period|Adverse Event|0|||
130019891|NCT00720109|468032945|FG000|Risk Stratification Period|Physician Decision|0|||
130019892|NCT00720109|468032946|FG001|Risk Stratification Period|Physician Decision|2|||
130019893|NCT00720109|468032947|FG002|Risk Stratification Period|Physician Decision|1|||
130019894|NCT00720109|468032945|FG000|Risk Stratification Period|Bone marrow transplant|0|||
130019895|NCT00720109|468032946|FG001|Risk Stratification Period|Bone marrow transplant|9|||
130019896|NCT00720109|468032947|FG002|Risk Stratification Period|Bone marrow transplant|7|||
130019897|NCT00720109|468032945|FG000|Risk Stratification Period|Disease progression or relapse|0|||
130019898|NCT00720109|468032946|FG001|Risk Stratification Period|Disease progression or relapse|2|||
130019899|NCT00720109|468032947|FG002|Risk Stratification Period|Disease progression or relapse|0|||
130019900|NCT00720109|468032945|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
130019901|NCT00720109|468032946|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
130019902|NCT00720109|468032947|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
130019903|NCT00903929|468032948|FG000|Overall Study|Withdrawal by Subject|0|||
130019904|NCT00903929|468032949|FG001|Overall Study|Withdrawal by Subject|0|||
130019905|NCT00903929|468032950|FG002|Overall Study|Withdrawal by Subject|1|||
130019906|NCT00903929|468032951|FG003|Overall Study|Withdrawal by Subject|2|||
130019907|NCT00903929|468032948|FG000|Overall Study|Adverse Event|0|||
130019908|NCT00903929|468032949|FG001|Overall Study|Adverse Event|0|||
130019909|NCT00903929|468032950|FG002|Overall Study|Adverse Event|0|||
130019910|NCT00903929|468032951|FG003|Overall Study|Adverse Event|1|||
130019911|NCT00512798|468032952|FG000|Overall Study|Death|0|||
130019912|NCT00512798|468032953|FG001|Overall Study|Death|3|||
130019913|NCT00512798|468032952|FG000|Overall Study|Adverse Event|2|||
130019914|NCT00512798|468032953|FG001|Overall Study|Adverse Event|4|||
130019915|NCT00512798|468032952|FG000|Overall Study|Progression of disease|14|||
130019916|NCT00512798|468032953|FG001|Overall Study|Progression of disease|20|||
130019917|NCT00512798|468032952|FG000|Overall Study|Withdrawal by Subject|3|||
130019918|NCT00512798|468032953|FG001|Overall Study|Withdrawal by Subject|0|||
130019919|NCT04899232|468032961|FG000|Screening Period|Physician Decision|1|||
130019920|NCT04899232|468032962|FG001|Screening Period|Physician Decision|0|||
130019921|NCT04899232|468032963|FG002|Screening Period|Physician Decision|0|||
130019922|NCT04899232|468032961|FG000|Screening Period|Withdrawal by Subject|1|||
130019923|NCT04899232|468032962|FG001|Screening Period|Withdrawal by Subject|0|||
130019924|NCT04899232|468032963|FG002|Screening Period|Withdrawal by Subject|0|||
130019925|NCT04899232|468032961|FG000|Screening Period|Participant discharged before receiving intervention|3|||
130019926|NCT04899232|468032962|FG001|Screening Period|Participant discharged before receiving intervention|0|||
130019927|NCT04899232|468032963|FG002|Screening Period|Participant discharged before receiving intervention|0|||
130019928|NCT03110224|468032964|FG000|Overall Study|Death|3|||
130019929|NCT03110224|468032964|FG000|Overall Study|Lost to Follow-up|132|||
130019930|NCT03110224|468032964|FG000|Overall Study|Physician Decision|2|||
130019931|NCT03110224|468032964|FG000|Overall Study|Site Closed by Physician|35|||
130019932|NCT03110224|468032964|FG000|Overall Study|Site Closed by Sponsor|202|||
130019933|NCT03110224|468032964|FG000|Overall Study|Withdrawal by Subject|9|||
130019934|NCT01564862|468032965|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
130019935|NCT01564862|468032966|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
130019936|NCT01564862|468032967|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130019937|NCT01564862|468032965|FG000|Overall Study|Major Protocol Deviation|3|||
130019938|NCT01564862|468032966|FG001|Overall Study|Major Protocol Deviation|3|||
130019939|NCT01564862|468032967|FG002|Overall Study|Major Protocol Deviation|4|||
130019940|NCT01564862|468032965|FG000|Overall Study|Lost to Follow-up|10|||
130019941|NCT01564862|468032966|FG001|Overall Study|Lost to Follow-up|8|||
130019942|NCT01564862|468032967|FG002|Overall Study|Lost to Follow-up|6|||
130019943|NCT01564862|468032965|FG000|Overall Study|Voluntary Withdrawal|9|||
130019944|NCT01564862|468032966|FG001|Overall Study|Voluntary Withdrawal|6|||
130019945|NCT01564862|468032967|FG002|Overall Study|Voluntary Withdrawal|8|||
130019946|NCT01564862|468032965|FG000|Overall Study|Lack of Efficacy|1|||
130019947|NCT01564862|468032966|FG001|Overall Study|Lack of Efficacy|5|||
130019948|NCT01564862|468032967|FG002|Overall Study|Lack of Efficacy|6|||
130019949|NCT01564862|468032965|FG000|Overall Study|Other reason(s)|1|||
130019950|NCT01564862|468032966|FG001|Overall Study|Other reason(s)|0|||
130019951|NCT01564862|468032967|FG002|Overall Study|Other reason(s)|0|||
130019952|NCT02926950|468032968|FG000|Overall Study|Adverse Event|4|||
130019953|NCT02926950|468032969|FG001|Overall Study|Adverse Event|6|||
130019954|NCT02926950|468032968|FG000|Overall Study|At the participant's own request|21|||
130019955|NCT02926950|468032969|FG001|Overall Study|At the participant's own request|25|||
130019956|NCT02926950|468032968|FG000|Overall Study|Reason not Specified|17|||
130019957|NCT02926950|468032969|FG001|Overall Study|Reason not Specified|9|||
130019958|NCT02926950|468032968|FG000|Overall Study|Lost to Follow-up|7|||
130019959|NCT02926950|468032969|FG001|Overall Study|Lost to Follow-up|8|||
130019960|NCT02028455|468032970|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130019961|NCT02028455|468032971|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130019962|NCT02028455|468032972|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130019963|NCT02028455|468032973|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130019964|NCT02028455|468032974|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130019965|NCT02028455|468032975|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
130019966|NCT02028455|468032976|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
130019967|NCT02028455|468032977|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
130019968|NCT02028455|468032970|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
130019969|NCT02028455|468032971|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
130019970|NCT02028455|468032972|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
130019971|NCT02028455|468032973|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
130019972|NCT02028455|468032974|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
130019973|NCT02028455|468032975|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
130019974|NCT02028455|468032976|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
130019975|NCT02028455|468032977|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
130019976|NCT02028455|468032970|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130019977|NCT02028455|468032971|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130019978|NCT02028455|468032972|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130019979|NCT02028455|468032973|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130019980|NCT02028455|468032974|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130019981|NCT02028455|468032975|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
130019982|NCT02028455|468032976|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
130225075|NCT00385918|468788067|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
130225076|NCT00385918|468788065|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
130225077|NCT00385918|468788066|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
130225078|NCT00385918|468788067|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
130225079|NCT00385918|468788065|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
130098939|NCT00948896|468319340|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
130098940|NCT00948896|468319341|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
130098941|NCT00948896|468319342|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
130098942|NCT00948896|468319343|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
130098943|NCT00948896|468319344|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
130098944|NCT00948896|468319345|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
130098945|NCT00948896|468319346|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
130098946|NCT00948896|468319339|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
130098947|NCT00948896|468319340|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
130098948|NCT00948896|468319341|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
130098949|NCT00948896|468319342|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
130098950|NCT00948896|468319343|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
130098951|NCT00948896|468319344|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
130098952|NCT00948896|468319345|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
130098953|NCT00948896|468319346|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
130098954|NCT00948896|468319339|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130098955|NCT00948896|468319340|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
130098956|NCT00948896|468319341|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
130098957|NCT00948896|468319342|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
130098958|NCT00948896|468319343|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130098959|NCT00948896|468319344|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
130098960|NCT00948896|468319345|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130098961|NCT00948896|468319346|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
130098962|NCT00948896|468319339|FG000|24 Months of Age to 36 Months of Age|Death|0|||
130098963|NCT00948896|468319340|FG001|24 Months of Age to 36 Months of Age|Death|2|||
130098964|NCT00948896|468319341|FG002|24 Months of Age to 36 Months of Age|Death|2|||
130098965|NCT00948896|468319342|FG003|24 Months of Age to 36 Months of Age|Death|0|||
130098966|NCT00948896|468319343|FG004|24 Months of Age to 36 Months of Age|Death|0|||
130098967|NCT00948896|468319344|FG005|24 Months of Age to 36 Months of Age|Death|1|||
130098968|NCT00948896|468319345|FG006|24 Months of Age to 36 Months of Age|Death|0|||
130098969|NCT00948896|468319346|FG007|24 Months of Age to 36 Months of Age|Death|0|||
130098970|NCT00948896|468319339|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
130098971|NCT00948896|468319340|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130098972|NCT00948896|468319341|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
130098973|NCT00948896|468319342|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
130098974|NCT00948896|468319343|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130098975|NCT00948896|468319344|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130098976|NCT00948896|468319345|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130098977|NCT00948896|468319346|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
130098978|NCT00948896|468319339|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
130098979|NCT00948896|468319340|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130098980|NCT00948896|468319341|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
130098981|NCT00948896|468319342|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130098982|NCT00948896|468319343|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
130098983|NCT00948896|468319344|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130098984|NCT00948896|468319345|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130098985|NCT00948896|468319346|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
130098986|NCT00948896|468319339|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130098987|NCT00948896|468319340|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130098988|NCT00948896|468319341|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
130098989|NCT00948896|468319342|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130098990|NCT00948896|468319343|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130098991|NCT00948896|468319344|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
130098992|NCT00948896|468319345|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130098993|NCT00948896|468319346|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
130098994|NCT00948896|468319339|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130098995|NCT00948896|468319340|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130098996|NCT00948896|468319341|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130098997|NCT00948896|468319342|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
130098998|NCT00948896|468319343|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130098999|NCT00948896|468319344|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130099000|NCT00948896|468319345|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130225080|NCT00385918|468788066|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
130019983|NCT02028455|468032977|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
130019984|NCT02028455|468032970|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130019985|NCT02028455|468032971|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130019986|NCT02028455|468032972|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
130019987|NCT02028455|468032973|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
130019988|NCT02028455|468032974|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130019989|NCT02028455|468032975|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
130019990|NCT02028455|468032976|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
130019991|NCT02028455|468032977|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
130019992|NCT02396589|468032978|FG000|Intervention|Lost to Follow-up|1|||
130019993|NCT02396589|468032979|FG001|Intervention|Lost to Follow-up|0|||
130019994|NCT02396589|468032978|FG000|6 Month Follow-up|change in health status|0|||
130019995|NCT02396589|468032979|FG001|6 Month Follow-up|change in health status|1|||
130019996|NCT02396589|468032978|FG000|9 Month Follow-up|Death|0|||
130019997|NCT02396589|468032979|FG001|9 Month Follow-up|Death|1|||
130019998|NCT02396589|468032978|FG000|12 Month Follow up|Lost to Follow-up|0|||
130019999|NCT02396589|468032979|FG001|12 Month Follow up|Lost to Follow-up|2|||
130020000|NCT04341948|468032980|FG000|Overall Study|Adverse Event|0|||
130020001|NCT04341948|468032981|FG001|Overall Study|Adverse Event|1|||
130020002|NCT04341948|468032980|FG000|Overall Study|Lost to Follow-up|6|||
130020003|NCT04341948|468032981|FG001|Overall Study|Lost to Follow-up|1|||
130020004|NCT04341948|468032980|FG000|Overall Study|Physician Decision|1|||
130020005|NCT04341948|468032981|FG001|Overall Study|Physician Decision|2|||
130020006|NCT04341948|468032980|FG000|Overall Study|Withdrawal by Participant|6|||
130020007|NCT04341948|468032981|FG001|Overall Study|Withdrawal by Participant|3|||
130020008|NCT04341948|468032980|FG000|Overall Study|Lack of compliance by Participant|1|||
130020009|NCT04341948|468032981|FG001|Overall Study|Lack of compliance by Participant|0|||
130020010|NCT04705051|468034651|FG000|Overall Study|Enrolled but not treated|1|||
130020011|NCT04705051|468034651|FG000|Overall Study|Study terminated by sponsor|23|||
130020012|NCT01761266|468034655|FG000|Overall Study|Death|415|||
130020013|NCT01761266|468034656|FG001|Overall Study|Death|402|||
130020014|NCT01761266|468034655|FG000|Overall Study|Lost to Follow-up|8|||
130020015|NCT01761266|468034656|FG001|Overall Study|Lost to Follow-up|12|||
130020016|NCT01761266|468034655|FG000|Overall Study|Withdrawal by Subject|14|||
130020017|NCT01761266|468034656|FG001|Overall Study|Withdrawal by Subject|10|||
130020018|NCT01761266|468034655|FG000|Overall Study|Sponsor Decision|41|||
130020019|NCT01761266|468034656|FG001|Overall Study|Sponsor Decision|52|||
130020020|NCT01284114|468034657|FG000|Overall Study|viral infection|1|||
130020021|NCT01284114|468034657|FG000|Overall Study|From the results of ALLTITUDE study|1|||
130020022|NCT01284114|468034657|FG000|Overall Study|Symptomatic hypotension|1|||
130020023|NCT01284114|468034657|FG000|Overall Study|dizziness|1|||
130020024|NCT03445000|468034659|FG000|Overall Study|Disease progression|8|||
130020025|NCT03445000|468034659|FG000|Overall Study|Adverse Event|3|||
130020026|NCT03445000|468034659|FG000|Overall Study|Death|2|||
130020027|NCT03445000|468034659|FG000|Overall Study|Physician Decision|1|||
130020028|NCT03409744|468034660|FG000|Overall Study|Death|2|||
130225081|NCT00385918|468788067|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
130225082|NCT00385918|468788065|FG000|Intervention Phase After Randomization|Physician Decision|1|||
130225083|NCT00385918|468788066|FG001|Intervention Phase After Randomization|Physician Decision|0|||
130225084|NCT00385918|468788067|FG002|Intervention Phase After Randomization|Physician Decision|0|||
130225085|NCT00385918|468788065|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
130020029|NCT03409744|468034660|FG000|Overall Study|Physician Decision|5|||
130020030|NCT03409744|468034660|FG000|Overall Study|Pregnancy|1|||
130020031|NCT03409744|468034660|FG000|Overall Study|Lost to Follow-up|1|||
130020032|NCT03409744|468034660|FG000|Overall Study|Protocol Violation|1|||
130020033|NCT00264004|468034662|FG000|Overall Study|Adverse Event|2|||
130020034|NCT00264004|468034663|FG001|Overall Study|Adverse Event|3|||
130020035|NCT00264004|468034664|FG002|Overall Study|Adverse Event|6|||
130020036|NCT00264004|468034665|FG003|Overall Study|Adverse Event|4|||
130020037|NCT00264004|468034662|FG000|Overall Study|Withdrawal by Subject|0|||
130020038|NCT00264004|468034663|FG001|Overall Study|Withdrawal by Subject|1|||
130020039|NCT00264004|468034664|FG002|Overall Study|Withdrawal by Subject|2|||
130020040|NCT00264004|468034665|FG003|Overall Study|Withdrawal by Subject|2|||
130020041|NCT00264004|468034662|FG000|Overall Study|Other|2|||
130020042|NCT00264004|468034663|FG001|Overall Study|Other|2|||
130020043|NCT00264004|468034664|FG002|Overall Study|Other|0|||
130020044|NCT00264004|468034665|FG003|Overall Study|Other|3|||
130020045|NCT00264004|468034662|FG000|Overall Study|Development study specific disc. crit.|1|||
130225086|NCT00385918|468788066|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
130225087|NCT00385918|468788067|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
130225088|NCT01676701|468788068|FG000|Overall Study|Protocol Violation|1|||
130225089|NCT01676701|468788069|FG001|Overall Study|Protocol Violation|0|||
130225090|NCT01676701|468788068|FG000|Overall Study|Sponsor Decision|3|||
130225091|NCT01676701|468788069|FG001|Overall Study|Sponsor Decision|4|||
130225092|NCT00549549|468788079|FG000|Overall Study|Adverse Event|5|||
130225093|NCT00549549|468788080|FG001|Overall Study|Adverse Event|3|||
130099001|NCT00948896|468319346|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
130099002|NCT03795233|468319347|FG000|Overall Study|Withdrawal by Subject|2|||
130099003|NCT03795233|468319348|FG001|Overall Study|Withdrawal by Subject|1|||
130099004|NCT03795233|468319347|FG000|Overall Study|Lost to Follow-up|1|||
130099005|NCT03795233|468319348|FG001|Overall Study|Lost to Follow-up|0|||
130099006|NCT03795233|468319347|FG000|Overall Study|Death|1|||
130099007|NCT03795233|468319348|FG001|Overall Study|Death|0|||
130099008|NCT01869959|468319361|FG000|Randomization Period|Physician Decision|0|||
130099009|NCT01869959|468319362|FG001|Randomization Period|Physician Decision|0|||
130099010|NCT01869959|468319363|FG002|Randomization Period|Physician Decision|0|||
130099011|NCT01869959|468319364|FG003|Randomization Period|Physician Decision|0|||
130099012|NCT01869959|468319365|FG004|Randomization Period|Physician Decision|1|||
130099013|NCT01869959|468319361|FG000|Treatment Period|Adverse Event|1|||
130099014|NCT01869959|468319362|FG001|Treatment Period|Adverse Event|0|||
130099015|NCT01869959|468319363|FG002|Treatment Period|Adverse Event|3|||
130099016|NCT01869959|468319364|FG003|Treatment Period|Adverse Event|1|||
130099017|NCT01869959|468319365|FG004|Treatment Period|Adverse Event|0|||
130099018|NCT01869959|468319361|FG000|Treatment Period|Sponsor decision|0|||
130099019|NCT01869959|468319362|FG001|Treatment Period|Sponsor decision|1|||
130099020|NCT01869959|468319363|FG002|Treatment Period|Sponsor decision|0|||
130099021|NCT01869959|468319364|FG003|Treatment Period|Sponsor decision|1|||
130099022|NCT01869959|468319365|FG004|Treatment Period|Sponsor decision|0|||
130099023|NCT01869959|468319361|FG000|Treatment Period|Withdrawal by Subject|0|||
130099024|NCT01869959|468319362|FG001|Treatment Period|Withdrawal by Subject|1|||
130099025|NCT01869959|468319363|FG002|Treatment Period|Withdrawal by Subject|0|||
130099026|NCT01869959|468319364|FG003|Treatment Period|Withdrawal by Subject|0|||
130099027|NCT01869959|468319365|FG004|Treatment Period|Withdrawal by Subject|0|||
130099028|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
130099029|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
130099030|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
130099031|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
130099032|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
130099033|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
130099034|NCT00828009|468319366|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
130099035|NCT00828009|468319366|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
130099036|NCT00828009|468319366|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
130099037|NCT00828009|468319366|FG000|Step 2 - Maintenance Therapy|Death|1|||
130099038|NCT00828009|468319366|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
130099039|NCT00828009|468319366|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
130099040|NCT00828009|468319366|FG000|Step 2 - Maintenance Therapy|Other|1|||
130099041|NCT02576951|468319368|FG000|Overall Study|Lost to Follow-up|0|||
130099042|NCT02576951|468319369|FG001|Overall Study|Lost to Follow-up|0|||
130099043|NCT02576951|468319370|FG002|Overall Study|Lost to Follow-up|2|||
130099044|NCT02576951|468319371|FG003|Overall Study|Lost to Follow-up|2|||
130225094|NCT00549549|468788081|FG002|Overall Study|Adverse Event|1|||
130225095|NCT00549549|468788082|FG003|Overall Study|Adverse Event|9|||
129884504|NCT02293837|467536432|FG000|Overall Study|Withdrawal by Subject|2|||
130099045|NCT02576951|468319368|FG000|Overall Study|Withdrawal by Subject|1|||
130099046|NCT02576951|468319369|FG001|Overall Study|Withdrawal by Subject|0|||
130099047|NCT02576951|468319370|FG002|Overall Study|Withdrawal by Subject|0|||
130099048|NCT02576951|468319371|FG003|Overall Study|Withdrawal by Subject|2|||
130099049|NCT02576951|468319368|FG000|Overall Study|Protocol Violation|0|||
130099050|NCT02576951|468319369|FG001|Overall Study|Protocol Violation|0|||
130099051|NCT02576951|468319370|FG002|Overall Study|Protocol Violation|0|||
130225096|NCT00549549|468788079|FG000|Overall Study|Lack of Efficacy|9|||
130225097|NCT00549549|468788080|FG001|Overall Study|Lack of Efficacy|6|||
130225098|NCT00549549|468788081|FG002|Overall Study|Lack of Efficacy|4|||
130020046|NCT00264004|468034663|FG001|Overall Study|Development study specific disc. crit.|0|||
130020047|NCT00264004|468034664|FG002|Overall Study|Development study specific disc. crit.|1|||
130020048|NCT00264004|468034665|FG003|Overall Study|Development study specific disc. crit.|0|||
130020049|NCT00264004|468034662|FG000|Overall Study|Cond. under inv. worsened|9|||
130020050|NCT00264004|468034663|FG001|Overall Study|Cond. under inv. worsened|5|||
130020051|NCT00264004|468034664|FG002|Overall Study|Cond. under inv. worsened|3|||
130020052|NCT00264004|468034665|FG003|Overall Study|Cond. under inv. worsened|4|||
130020053|NCT00264004|468034662|FG000|Overall Study|Not treated|3|||
130225099|NCT00549549|468788082|FG003|Overall Study|Lack of Efficacy|2|||
130020054|NCT00264004|468034663|FG001|Overall Study|Not treated|0|||
130225100|NCT00549549|468788079|FG000|Overall Study|Lost to Follow-up|1|||
130020055|NCT00264004|468034664|FG002|Overall Study|Not treated|2|||
130020056|NCT00264004|468034665|FG003|Overall Study|Not treated|2|||
130020057|NCT00691483|468034666|FG000|Overall Study|Adverse Event|14|||
130020058|NCT00691483|468034667|FG001|Overall Study|Adverse Event|6|||
130020059|NCT00691483|468034666|FG000|Overall Study|Lost to Follow-up|17|||
130020060|NCT00691483|468034667|FG001|Overall Study|Lost to Follow-up|10|||
130020061|NCT00691483|468034666|FG000|Overall Study|Withdrawal by Subject|24|||
130020062|NCT00691483|468034667|FG001|Overall Study|Withdrawal by Subject|7|||
130020063|NCT00691483|468034666|FG000|Overall Study|Other known cause|6|||
130020064|NCT00691483|468034667|FG001|Overall Study|Other known cause|1|||
130020065|NCT00691483|468034666|FG000|Overall Study|Randomized by not treated|7|||
130020066|NCT00691483|468034667|FG001|Overall Study|Randomized by not treated|1|||
130020067|NCT00049673|468034669|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
130020068|NCT00049673|468034670|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
130020069|NCT02475681|468034671|FG000|Overall Study|Death|16|||
130020070|NCT02475681|468034672|FG001|Overall Study|Death|6|||
130020071|NCT02475681|468034673|FG002|Overall Study|Death|9|||
130020072|NCT02475681|468034671|FG000|Overall Study|Physician Decision|0|||
130020073|NCT02475681|468034672|FG001|Overall Study|Physician Decision|3|||
130020074|NCT02475681|468034673|FG002|Overall Study|Physician Decision|1|||
130020075|NCT02475681|468034671|FG000|Overall Study|Withdrawal by Subject|12|||
130020076|NCT02475681|468034672|FG001|Overall Study|Withdrawal by Subject|6|||
130020077|NCT02475681|468034673|FG002|Overall Study|Withdrawal by Subject|9|||
130020078|NCT02475681|468034671|FG000|Overall Study|Lost to Follow-up|2|||
130020079|NCT02475681|468034672|FG001|Overall Study|Lost to Follow-up|1|||
130020080|NCT02475681|468034673|FG002|Overall Study|Lost to Follow-up|3|||
130020081|NCT02475681|468034671|FG000|Overall Study|Ongoing in Study|0|||
130020082|NCT02475681|468034672|FG001|Overall Study|Ongoing in Study|163|||
130020083|NCT02475681|468034673|FG002|Overall Study|Ongoing in Study|157|||
130020084|NCT02475681|468034671|FG000|Overall Study|Reasons other than above listed|2|||
130020085|NCT02475681|468034672|FG001|Overall Study|Reasons other than above listed|0|||
130020086|NCT02475681|468034673|FG002|Overall Study|Reasons other than above listed|0|||
130020087|NCT01535729|468034674|FG000|Overall Study|Withdrawal by Subject|2|||
130020088|NCT01535729|468034674|FG000|Overall Study|Disease progression|230|||
130020089|NCT01535729|468034674|FG000|Overall Study|Discontinued treatment|25|||
130020090|NCT01535729|468034674|FG000|Overall Study|Lost to Follow-up|8|||
130020091|NCT01535729|468034674|FG000|Overall Study|Death|52|||
130020092|NCT01535729|468034674|FG000|Overall Study|Other|19|||
130020093|NCT01535729|468034674|FG000|Overall Study|Did not sign informed consent|1|||
130020094|NCT01535729|468034674|FG000|Overall Study|No previous chemotherapy|33|||
130020095|NCT01535729|468034674|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
130020096|NCT01535729|468034674|FG000|Overall Study|Protocol Violation|11|||
130225101|NCT00549549|468788080|FG001|Overall Study|Lost to Follow-up|0|||
130020097|NCT01535729|468034674|FG000|Overall Study|Screening failure|1|||
130020098|NCT01535729|468034674|FG000|Overall Study|Not treated|9|||
130020099|NCT01535729|468034674|FG000|Overall Study|No participant record available|5|||
130020100|NCT01262365|468034677|FG000|Overall Study|Lack of Efficacy|35|||
130020101|NCT01262365|468034678|FG001|Overall Study|Lack of Efficacy|30|||
130020102|NCT01262365|468034679|FG002|Overall Study|Lack of Efficacy|47|||
130020103|NCT01262365|468034677|FG000|Overall Study|Protocol Violation|3|||
130020104|NCT01262365|468034678|FG001|Overall Study|Protocol Violation|1|||
130020105|NCT01262365|468034679|FG002|Overall Study|Protocol Violation|1|||
130020106|NCT01262365|468034677|FG000|Overall Study|Lost to Follow-up|3|||
130020107|NCT01262365|468034678|FG001|Overall Study|Lost to Follow-up|7|||
130020108|NCT01262365|468034679|FG002|Overall Study|Lost to Follow-up|6|||
130020109|NCT01262365|468034677|FG000|Overall Study|Withdrawal by Subject|17|||
130020110|NCT01262365|468034678|FG001|Overall Study|Withdrawal by Subject|22|||
130020111|NCT01262365|468034679|FG002|Overall Study|Withdrawal by Subject|22|||
130020112|NCT01262365|468034677|FG000|Overall Study|Death|1|||
130020113|NCT01262365|468034678|FG001|Overall Study|Death|2|||
130225102|NCT00549549|468788081|FG002|Overall Study|Lost to Follow-up|1|||
130020114|NCT01262365|468034679|FG002|Overall Study|Death|1|||
130020115|NCT01262365|468034677|FG000|Overall Study|Adverse Event|26|||
130020116|NCT01262365|468034678|FG001|Overall Study|Adverse Event|16|||
130020117|NCT01262365|468034679|FG002|Overall Study|Adverse Event|11|||
130020118|NCT01262365|468034677|FG000|Overall Study|sponsor decision|1|||
130020119|NCT01262365|468034678|FG001|Overall Study|sponsor decision|1|||
130020120|NCT01262365|468034679|FG002|Overall Study|sponsor decision|0|||
130020121|NCT01262365|468034677|FG000|Overall Study|Randomization error|1|||
130020122|NCT01262365|468034678|FG001|Overall Study|Randomization error|0|||
130020123|NCT01262365|468034679|FG002|Overall Study|Randomization error|2|||
130020124|NCT01262365|468034677|FG000|Overall Study|Non-compliance|1|||
130020125|NCT01262365|468034678|FG001|Overall Study|Non-compliance|0|||
130020126|NCT01262365|468034679|FG002|Overall Study|Non-compliance|2|||
130020127|NCT01262365|468034677|FG000|Overall Study|Suspected pregnancy|1|||
130020128|NCT01262365|468034678|FG001|Overall Study|Suspected pregnancy|0|||
130020129|NCT01262365|468034679|FG002|Overall Study|Suspected pregnancy|0|||
130020130|NCT01262365|468034677|FG000|Overall Study|Patient pregnant|1|||
130020131|NCT01262365|468034678|FG001|Overall Study|Patient pregnant|0|||
130020132|NCT01262365|468034679|FG002|Overall Study|Patient pregnant|1|||
130020133|NCT01262365|468034677|FG000|Overall Study|Toxicity related to study drug|0|||
130020134|NCT01262365|468034678|FG001|Overall Study|Toxicity related to study drug|1|||
130020135|NCT01262365|468034679|FG002|Overall Study|Toxicity related to study drug|0|||
130020136|NCT01262365|468034677|FG000|Overall Study|Cannot tolerate the protocol|0|||
130225103|NCT00549549|468788082|FG003|Overall Study|Lost to Follow-up|2|||
130225104|NCT00549549|468788079|FG000|Overall Study|Withdrawal by Subject|0|||
130020137|NCT01262365|468034678|FG001|Overall Study|Cannot tolerate the protocol|1|||
130020138|NCT01262365|468034679|FG002|Overall Study|Cannot tolerate the protocol|0|||
130020139|NCT01262365|468034677|FG000|Overall Study|Patient unavailable|0|||
130020140|NCT01262365|468034678|FG001|Overall Study|Patient unavailable|0|||
130020141|NCT01262365|468034679|FG002|Overall Study|Patient unavailable|1|||
130020142|NCT02322710|468034680|FG000|Overall Study|No efficacy assessment post-baseline|0|||
130020143|NCT02322710|468034681|FG001|Overall Study|No efficacy assessment post-baseline|1|||
130020144|NCT02322710|468034680|FG000|Overall Study|Protocol Violation|20|||
130020145|NCT02322710|468034681|FG001|Overall Study|Protocol Violation|25|||
130020146|NCT04161131|468034682|FG000|Overall Study|Ineligible|2|||
130020147|NCT04161131|468034682|FG000|Overall Study|Lost to Follow-up|4|||
130020148|NCT03733392|468034683|FG000|Overall Study|Withdrawal by Subject|11|||
130020149|NCT03733392|468034684|FG001|Overall Study|Withdrawal by Subject|1|||
130020150|NCT03733392|468034683|FG000|Overall Study|Death|1|||
130020151|NCT03733392|468034684|FG001|Overall Study|Death|0|||
130020152|NCT03733392|468034683|FG000|Overall Study|Lost to Follow-up|5|||
130020153|NCT03733392|468034684|FG001|Overall Study|Lost to Follow-up|0|||
130020154|NCT03733392|468034683|FG000|Overall Study|Protocol Violation|0|||
130020155|NCT03733392|468034684|FG001|Overall Study|Protocol Violation|1|||
130020156|NCT03733392|468034683|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
130020157|NCT03733392|468034684|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
130020158|NCT03733392|468034683|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
130020159|NCT03733392|468034684|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
130020160|NCT03733392|468034683|FG000|Overall Study|Patient Non-Compliance|2|||
130020161|NCT03733392|468034684|FG001|Overall Study|Patient Non-Compliance|1|||
130020162|NCT03733392|468034683|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
130020163|NCT03733392|468034684|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
130020164|NCT03733392|468034683|FG000|Overall Study|Withdrawal prior to procedure|5|||
130020165|NCT03733392|468034684|FG001|Overall Study|Withdrawal prior to procedure|2|||
130020166|NCT02740478|468034685|FG000|Overall Study|Withdrawal by Subject|1|||
130020167|NCT02944448|468034687|FG000|Overall Study|Adverse Event|37|||
130020168|NCT02944448|468034688|FG001|Overall Study|Adverse Event|6|||
130020169|NCT02944448|468034687|FG000|Overall Study|Lack of Efficacy|8|||
130020170|NCT02944448|468034688|FG001|Overall Study|Lack of Efficacy|5|||
130020171|NCT02944448|468034687|FG000|Overall Study|Lost to Follow-up|3|||
130020172|NCT02944448|468034688|FG001|Overall Study|Lost to Follow-up|1|||
130020173|NCT02944448|468034687|FG000|Overall Study|Protocol Violation|25|||
130020174|NCT02944448|468034688|FG001|Overall Study|Protocol Violation|7|||
130020175|NCT02944448|468034687|FG000|Overall Study|Withdrawal by Subject|14|||
130020176|NCT02944448|468034688|FG001|Overall Study|Withdrawal by Subject|4|||
130020177|NCT02944448|468034687|FG000|Overall Study|Sponsor did not supply drug in time|0|||
130020178|NCT02944448|468034688|FG001|Overall Study|Sponsor did not supply drug in time|1|||
130020179|NCT02944448|468034687|FG000|Overall Study|Noncompliant with dosing|1|||
130020180|NCT02944448|468034688|FG001|Overall Study|Noncompliant with dosing|0|||
130020181|NCT02944448|468034687|FG000|Overall Study|Abnormal laboratory values|1|||
130020182|NCT02944448|468034688|FG001|Overall Study|Abnormal laboratory values|0|||
130020183|NCT00925015|468034691|FG000|Overall Study|Adverse Event|1|||
130020184|NCT00925015|468034692|FG001|Overall Study|Adverse Event|2|||
130020185|NCT00925015|468034693|FG002|Overall Study|Adverse Event|1|||
130020186|NCT00925015|468034691|FG000|Overall Study|Physician Decision|0|||
130020187|NCT00925015|468034692|FG001|Overall Study|Physician Decision|1|||
130020188|NCT00925015|468034693|FG002|Overall Study|Physician Decision|0|||
130020189|NCT00925015|468034691|FG000|Overall Study|Progressive Disease|7|||
130020190|NCT00925015|468034692|FG001|Overall Study|Progressive Disease|3|||
130020191|NCT00925015|468034693|FG002|Overall Study|Progressive Disease|4|||
130020192|NCT00925015|468034691|FG000|Overall Study|Withdrawal by Subject|0|||
130020193|NCT00925015|468034692|FG001|Overall Study|Withdrawal by Subject|0|||
130020194|NCT00925015|468034693|FG002|Overall Study|Withdrawal by Subject|1|||
130020195|NCT03118297|468034694|FG000|Overall Study|Lost to Follow-up|0|||
130020196|NCT03118297|468034695|FG001|Overall Study|Lost to Follow-up|2|||
130020197|NCT01885000|468034696|FG000|Overall Study|Adverse Event|1|||
130020198|NCT01885000|468034697|FG001|Overall Study|Adverse Event|0|||
130020199|NCT01885000|468034696|FG000|Overall Study|Withdrawal by Subject|1|||
130020200|NCT01885000|468034697|FG001|Overall Study|Withdrawal by Subject|1|||
130020201|NCT01885000|468034696|FG000|Overall Study|Protocol Violation|0|||
130020202|NCT01885000|468034697|FG001|Overall Study|Protocol Violation|1|||
130020203|NCT03124784|468034698|FG000|Overall Study|Adverse Event|1|||
130020204|NCT03124784|468034698|FG000|Overall Study|Computer/Equip Malfunction|1|||
130020205|NCT01777152|468034702|FG000|Overall Study|Withdrawal by Subject|22|||
130020206|NCT01777152|468034703|FG001|Overall Study|Withdrawal by Subject|16|||
130020207|NCT01777152|468034702|FG000|Overall Study|Lost to Follow-up|3|||
130020208|NCT01777152|468034703|FG001|Overall Study|Lost to Follow-up|5|||
130020209|NCT01777152|468034702|FG000|Overall Study|Death|68|||
130020210|NCT01777152|468034703|FG001|Overall Study|Death|89|||
130020211|NCT01777152|468034702|FG000|Overall Study|Not eligible, no study drug received|1|||
130020212|NCT01777152|468034703|FG001|Overall Study|Not eligible, no study drug received|0|||
130020213|NCT01777152|468034702|FG000|Overall Study|Change of diagnosis|1|||
130020214|NCT01777152|468034703|FG001|Overall Study|Change of diagnosis|0|||
130020215|NCT02469090|468034706|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
130020216|NCT02469090|468034707|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
130020217|NCT02469090|468034708|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
130020218|NCT02469090|468034706|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
130020219|NCT02469090|468034707|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
130020220|NCT02469090|468034708|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
130020221|NCT02469090|468034706|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
130020222|NCT02469090|468034707|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
130020223|NCT02469090|468034708|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
130020224|NCT02469090|468034706|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
130020225|NCT02469090|468034707|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
130020226|NCT02469090|468034708|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
130020227|NCT02469090|468034706|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
130020228|NCT02469090|468034707|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
130020229|NCT02469090|468034708|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
130020230|NCT02469090|468034706|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
130020231|NCT02469090|468034707|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
130020232|NCT02469090|468034708|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
130020233|NCT02469090|468034706|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
130020234|NCT02469090|468034707|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
130020235|NCT02469090|468034708|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
130020236|NCT02469090|468034706|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
130020237|NCT02469090|468034707|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
130020238|NCT02469090|468034708|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
130020239|NCT01391507|468034709|FG000|Overall Study|Death|0|||
130020240|NCT01391507|468034710|FG001|Overall Study|Death|0|||
130020241|NCT01391507|468034711|FG002|Overall Study|Death|0|||
130020242|NCT01391507|468034712|FG003|Overall Study|Death|1|||
130020243|NCT01391507|468034709|FG000|Overall Study|Adverse Event|1|||
130020244|NCT01391507|468034710|FG001|Overall Study|Adverse Event|1|||
130020245|NCT01391507|468034711|FG002|Overall Study|Adverse Event|2|||
130020246|NCT01391507|468034712|FG003|Overall Study|Adverse Event|2|||
130020247|NCT01391507|468034709|FG000|Overall Study|Withdrawal by Subject|1|||
130020248|NCT01391507|468034710|FG001|Overall Study|Withdrawal by Subject|2|||
130020249|NCT01391507|468034711|FG002|Overall Study|Withdrawal by Subject|1|||
130020250|NCT01391507|468034712|FG003|Overall Study|Withdrawal by Subject|1|||
130020251|NCT01391507|468034709|FG000|Overall Study|Lack of Efficacy|0|||
130020252|NCT01391507|468034710|FG001|Overall Study|Lack of Efficacy|0|||
130020253|NCT01391507|468034711|FG002|Overall Study|Lack of Efficacy|0|||
130020254|NCT01391507|468034712|FG003|Overall Study|Lack of Efficacy|1|||
130020255|NCT01391507|468034709|FG000|Overall Study|Protocol Violation|2|||
130020256|NCT01391507|468034710|FG001|Overall Study|Protocol Violation|1|||
130020257|NCT01391507|468034711|FG002|Overall Study|Protocol Violation|1|||
130020258|NCT01391507|468034712|FG003|Overall Study|Protocol Violation|2|||
130020259|NCT02926209|468034716|FG000|Study Cohort|Poor Bowel Preparation|1|||
130020260|NCT02926209|468034717|FG001|Study Cohort|Poor Bowel Preparation|0|||
130020261|NCT01926782|468034718|FG000|Overall Study|Participant moved|2|||
130020262|NCT01926782|468034719|FG001|Overall Study|Participant moved|0|||
130020263|NCT01926782|468034720|FG002|Overall Study|Participant moved|1|||
130020264|NCT01926782|468034721|FG003|Overall Study|Participant moved|1|||
130020265|NCT01926782|468034722|FG004|Overall Study|Participant moved|0|||
130225105|NCT00549549|468788080|FG001|Overall Study|Withdrawal by Subject|4|||
130020266|NCT01926782|468034723|FG005|Overall Study|Participant moved|3|||
130020267|NCT01926782|468034718|FG000|Overall Study|Physician Decision|0|||
130020268|NCT01926782|468034719|FG001|Overall Study|Physician Decision|2|||
130020269|NCT01926782|468034720|FG002|Overall Study|Physician Decision|1|||
130020270|NCT01926782|468034721|FG003|Overall Study|Physician Decision|1|||
130020271|NCT01926782|468034722|FG004|Overall Study|Physician Decision|0|||
130020272|NCT01926782|468034723|FG005|Overall Study|Physician Decision|0|||
130020273|NCT01926782|468034718|FG000|Overall Study|Other than specified|2|||
130020274|NCT01926782|468034719|FG001|Overall Study|Other than specified|3|||
130020275|NCT01926782|468034720|FG002|Overall Study|Other than specified|5|||
130020276|NCT01926782|468034721|FG003|Overall Study|Other than specified|12|||
130020277|NCT01926782|468034722|FG004|Overall Study|Other than specified|4|||
130020278|NCT01926782|468034723|FG005|Overall Study|Other than specified|11|||
130020279|NCT01926782|468034718|FG000|Overall Study|Adverse Event|13|||
130020280|NCT01926782|468034719|FG001|Overall Study|Adverse Event|4|||
130020281|NCT01926782|468034720|FG002|Overall Study|Adverse Event|17|||
130020282|NCT01926782|468034721|FG003|Overall Study|Adverse Event|4|||
130020283|NCT01926782|468034722|FG004|Overall Study|Adverse Event|3|||
130020284|NCT01926782|468034723|FG005|Overall Study|Adverse Event|14|||
130020285|NCT01926782|468034718|FG000|Overall Study|Poor compliance to protocol|5|||
130020286|NCT01926782|468034719|FG001|Overall Study|Poor compliance to protocol|3|||
130020287|NCT01926782|468034720|FG002|Overall Study|Poor compliance to protocol|8|||
130020288|NCT01926782|468034721|FG003|Overall Study|Poor compliance to protocol|0|||
130020289|NCT01926782|468034722|FG004|Overall Study|Poor compliance to protocol|1|||
130020290|NCT01926782|468034723|FG005|Overall Study|Poor compliance to protocol|6|||
130020291|NCT01926782|468034718|FG000|Overall Study|Randomized and not treated|0|||
130020292|NCT01926782|468034719|FG001|Overall Study|Randomized and not treated|0|||
130020293|NCT01926782|468034720|FG002|Overall Study|Randomized and not treated|0|||
130020294|NCT01926782|468034721|FG003|Overall Study|Randomized and not treated|1|||
130020295|NCT01926782|468034722|FG004|Overall Study|Randomized and not treated|0|||
130020296|NCT01926782|468034723|FG005|Overall Study|Randomized and not treated|0|||
130020297|NCT01926782|468034718|FG000|Overall Study|Withdrawal by Subject|6|||
130020298|NCT01926782|468034719|FG001|Overall Study|Withdrawal by Subject|1|||
130020299|NCT01926782|468034720|FG002|Overall Study|Withdrawal by Subject|8|||
130020300|NCT01926782|468034721|FG003|Overall Study|Withdrawal by Subject|1|||
130020301|NCT01926782|468034722|FG004|Overall Study|Withdrawal by Subject|0|||
130020302|NCT01926782|468034723|FG005|Overall Study|Withdrawal by Subject|5|||
130020303|NCT01926782|468034718|FG000|Overall Study|Related to study drug administration|0|||
130020304|NCT01926782|468034719|FG001|Overall Study|Related to study drug administration|0|||
130020305|NCT01926782|468034720|FG002|Overall Study|Related to study drug administration|0|||
130020306|NCT01926782|468034721|FG003|Overall Study|Related to study drug administration|0|||
130020307|NCT01926782|468034722|FG004|Overall Study|Related to study drug administration|0|||
130020308|NCT01926782|468034723|FG005|Overall Study|Related to study drug administration|2|||
130020309|NCT02462473|468034726|FG000|Overall Study|Death|1|||
130020310|NCT02462473|468034726|FG000|Overall Study|Other|3|||
130020311|NCT00430508|468034727|FG000|Overall Study|Adverse Event|2|||
130020312|NCT00430508|468034728|FG001|Overall Study|Adverse Event|3|||
130020313|NCT00430508|468034729|FG002|Overall Study|Adverse Event|5|||
130020314|NCT00430508|468034730|FG003|Overall Study|Adverse Event|3|||
130020315|NCT00430508|468034727|FG000|Overall Study|Withdrawal by Subject|0|||
130020316|NCT00430508|468034728|FG001|Overall Study|Withdrawal by Subject|1|||
130020317|NCT00430508|468034729|FG002|Overall Study|Withdrawal by Subject|1|||
130020318|NCT00430508|468034730|FG003|Overall Study|Withdrawal by Subject|1|||
130020319|NCT00430508|468034727|FG000|Overall Study|responder at visit 4|0|||
130020320|NCT00430508|468034728|FG001|Overall Study|responder at visit 4|0|||
130020321|NCT00430508|468034729|FG002|Overall Study|responder at visit 4|2|||
130020322|NCT00430508|468034730|FG003|Overall Study|responder at visit 4|0|||
130020323|NCT00430508|468034727|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
130020324|NCT00430508|468034728|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
130020325|NCT00430508|468034729|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
130020326|NCT00430508|468034730|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
130020327|NCT00430508|468034727|FG000|Overall Study|Other|1|||
130020328|NCT00430508|468034728|FG001|Overall Study|Other|1|||
130020329|NCT00430508|468034729|FG002|Overall Study|Other|3|||
130020330|NCT00430508|468034730|FG003|Overall Study|Other|0|||
130020331|NCT04673786|468034736|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
130020332|NCT04673786|468034737|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
130020333|NCT04673786|468034738|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
130020334|NCT04673786|468034736|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
130020335|NCT04673786|468034737|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
130020336|NCT04673786|468034738|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
130020337|NCT04673786|468034736|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
130020338|NCT04673786|468034737|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
130020339|NCT04673786|468034738|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
130020340|NCT04673786|468034736|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
130020341|NCT04673786|468034737|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
130020342|NCT04673786|468034738|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
130020343|NCT04673786|468034736|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
130020344|NCT04673786|468034737|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
130020345|NCT04673786|468034738|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
130020346|NCT04673786|468034736|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
130020347|NCT04673786|468034737|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
130020348|NCT04673786|468034738|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
130020349|NCT03298022|468034739|FG000|Overall Study|Lack of Efficacy|4|||
130020350|NCT03298022|468034739|FG000|Overall Study|Withdrawal by Subject|7|||
130020351|NCT03298022|468034739|FG000|Overall Study|Adverse Event|1|||
130020352|NCT03298022|468034739|FG000|Overall Study|disease relapse|1|||
130020353|NCT01422239|468034742|FG000|Overall Study|Lost to Follow-up|4|||
130020354|NCT01422239|468034743|FG001|Overall Study|Lost to Follow-up|3|||
130020355|NCT01400451|468034744|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
130020356|NCT01400451|468034745|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
130020357|NCT01400451|468034746|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
130020358|NCT01400451|468034744|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
130020359|NCT01400451|468034745|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
130020360|NCT01400451|468034746|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
130020361|NCT01400451|468034744|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
130020362|NCT01400451|468034745|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
130020363|NCT01400451|468034746|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
130020364|NCT01400451|468034744|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
130020365|NCT01400451|468034745|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
130020366|NCT01400451|468034746|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
130020367|NCT01400451|468034744|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
130020368|NCT01400451|468034745|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
130020369|NCT01400451|468034746|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
130020370|NCT02573155|468034749|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
130020371|NCT02573155|468034750|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
130020372|NCT02573155|468034749|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
130020373|NCT02573155|468034750|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
130020374|NCT02573155|468034749|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
130020375|NCT02573155|468034750|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
130020376|NCT02573155|468034749|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
130020377|NCT02573155|468034750|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
130020378|NCT02573155|468034749|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
130020379|NCT02573155|468034750|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
130020380|NCT02573155|468034749|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
130020381|NCT02573155|468034750|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
130020382|NCT02573155|468034749|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
130020383|NCT02573155|468034750|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
130020384|NCT02573155|468034749|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
130020385|NCT02573155|468034750|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
130020386|NCT00516737|468034756|FG000|Overall Study|Lost to Follow-up|2|||
130020387|NCT00516737|468034757|FG001|Overall Study|Lost to Follow-up|0|||
130020388|NCT00516737|468034756|FG000|Overall Study|Physician Decision|0|||
130020389|NCT00516737|468034757|FG001|Overall Study|Physician Decision|1|||
130020390|NCT00516737|468034756|FG000|Overall Study|Withdrawal by Subject|0|||
130020391|NCT00516737|468034757|FG001|Overall Study|Withdrawal by Subject|1|||
130020392|NCT00516737|468034756|FG000|Overall Study|Lack of Qualifying Event|9|||
130020393|NCT00516737|468034757|FG001|Overall Study|Lack of Qualifying Event|6|||
130020394|NCT01844895|468034758|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
130020395|NCT01844895|468034758|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
130020396|NCT01844895|468034758|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
130020397|NCT01844895|468034758|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
130020398|NCT01844895|468034758|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
130020399|NCT01844895|468034758|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
130020400|NCT01844895|468034758|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
130020401|NCT00454805|468034762|FG000|Overall Study|Withdrawal by Subject|9|||
130020402|NCT00454805|468034763|FG001|Overall Study|Withdrawal by Subject|2|||
130020403|NCT00454805|468034762|FG000|Overall Study|Death|0|||
130020404|NCT00454805|468034763|FG001|Overall Study|Death|2|||
130020405|NCT00454805|468034762|FG000|Overall Study|Disease progression|16|||
130020406|NCT00454805|468034763|FG001|Overall Study|Disease progression|19|||
130020407|NCT00454805|468034762|FG000|Overall Study|In order to begin radiotherapy|1|||
130020408|NCT00454805|468034763|FG001|Overall Study|In order to begin radiotherapy|0|||
130020409|NCT01627899|468034774|FG000|Overall Study|Study terminated early by sponsor.|5|||
130020410|NCT01358864|468034782|FG000|Overall Study|Adverse Event|0|||
130020411|NCT01358864|468034783|FG001|Overall Study|Adverse Event|6|||
130020412|NCT01358864|468034784|FG002|Overall Study|Adverse Event|9|||
130020413|NCT01358864|468034785|FG003|Overall Study|Adverse Event|0|||
130020414|NCT01358864|468034786|FG004|Overall Study|Adverse Event|4|||
130020415|NCT01358864|468034787|FG005|Overall Study|Adverse Event|8|||
130020416|NCT01358864|468034788|FG006|Overall Study|Adverse Event|12|||
130020417|NCT01358864|468034789|FG007|Overall Study|Adverse Event|7|||
130020418|NCT01358864|468034782|FG000|Overall Study|Lack of Efficacy|26|||
130020419|NCT01358864|468034783|FG001|Overall Study|Lack of Efficacy|3|||
130020420|NCT01358864|468034784|FG002|Overall Study|Lack of Efficacy|4|||
130020421|NCT01358864|468034785|FG003|Overall Study|Lack of Efficacy|19|||
130020422|NCT01358864|468034786|FG004|Overall Study|Lack of Efficacy|7|||
130020423|NCT01358864|468034787|FG005|Overall Study|Lack of Efficacy|4|||
130020424|NCT01358864|468034788|FG006|Overall Study|Lack of Efficacy|49|||
130020425|NCT01358864|468034789|FG007|Overall Study|Lack of Efficacy|44|||
130020426|NCT01358864|468034782|FG000|Overall Study|Lost to Follow-up|0|||
130020427|NCT01358864|468034783|FG001|Overall Study|Lost to Follow-up|0|||
130020428|NCT01358864|468034784|FG002|Overall Study|Lost to Follow-up|1|||
130020429|NCT01358864|468034785|FG003|Overall Study|Lost to Follow-up|0|||
130020430|NCT01358864|468034786|FG004|Overall Study|Lost to Follow-up|0|||
130020431|NCT01358864|468034787|FG005|Overall Study|Lost to Follow-up|0|||
130020432|NCT01358864|468034788|FG006|Overall Study|Lost to Follow-up|0|||
130020433|NCT01358864|468034789|FG007|Overall Study|Lost to Follow-up|1|||
130020434|NCT01358864|468034782|FG000|Overall Study|Withdrawal by Subject|3|||
130020435|NCT01358864|468034783|FG001|Overall Study|Withdrawal by Subject|4|||
130020436|NCT01358864|468034784|FG002|Overall Study|Withdrawal by Subject|2|||
130020437|NCT01358864|468034785|FG003|Overall Study|Withdrawal by Subject|0|||
130020438|NCT01358864|468034786|FG004|Overall Study|Withdrawal by Subject|0|||
130020439|NCT01358864|468034787|FG005|Overall Study|Withdrawal by Subject|1|||
130020440|NCT01358864|468034788|FG006|Overall Study|Withdrawal by Subject|1|||
130020441|NCT01358864|468034789|FG007|Overall Study|Withdrawal by Subject|3|||
130020442|NCT01358864|468034782|FG000|Overall Study|Other reason not defined above|2|||
130020443|NCT01358864|468034783|FG001|Overall Study|Other reason not defined above|0|||
130020444|NCT01358864|468034784|FG002|Overall Study|Other reason not defined above|0|||
130020445|NCT01358864|468034785|FG003|Overall Study|Other reason not defined above|0|||
130020446|NCT01358864|468034786|FG004|Overall Study|Other reason not defined above|0|||
130020447|NCT01358864|468034787|FG005|Overall Study|Other reason not defined above|0|||
130020448|NCT01358864|468034788|FG006|Overall Study|Other reason not defined above|2|||
130020449|NCT01358864|468034789|FG007|Overall Study|Other reason not defined above|0|||
130020450|NCT01358864|468034782|FG000|Overall Study|Not treated|0|||
130020451|NCT01358864|468034783|FG001|Overall Study|Not treated|0|||
130020452|NCT01358864|468034784|FG002|Overall Study|Not treated|0|||
130020453|NCT01358864|468034785|FG003|Overall Study|Not treated|0|||
130020454|NCT01358864|468034786|FG004|Overall Study|Not treated|0|||
130020455|NCT01358864|468034787|FG005|Overall Study|Not treated|0|||
130020456|NCT01358864|468034788|FG006|Overall Study|Not treated|1|||
130020457|NCT01358864|468034789|FG007|Overall Study|Not treated|0|||
130020458|NCT04158648|468034793|FG000|Overall Study|Ongoing in the Study|69|||
130020459|NCT04158648|468034793|FG000|Overall Study|Withdrawal by Subject|4|||
130020460|NCT04209855|468034794|FG000|Overall Study|Death|161|||
130020461|NCT04209855|468034795|FG001|Overall Study|Death|177|||
130020462|NCT04209855|468034794|FG000|Overall Study|PI Discretion|1|||
130020463|NCT04209855|468034795|FG001|Overall Study|PI Discretion|1|||
130020464|NCT04209855|468034794|FG000|Overall Study|Lost to Follow-up|5|||
130020465|NCT04209855|468034795|FG001|Overall Study|Lost to Follow-up|2|||
130020466|NCT04209855|468034794|FG000|Overall Study|Withdrew consent|10|||
130020467|NCT04209855|468034795|FG001|Overall Study|Withdrew consent|24|||
130020468|NCT04209855|468034794|FG000|Overall Study|Sponsor decision|44|||
130020469|NCT04209855|468034795|FG001|Overall Study|Sponsor decision|18|||
130020470|NCT04209855|468034794|FG000|Overall Study|Other than specified|6|||
130020471|NCT04209855|468034795|FG001|Overall Study|Other than specified|4|||
130020472|NCT02289950|468034796|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
130020473|NCT02289950|468034797|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
130020474|NCT02289950|468034796|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
130020475|NCT02289950|468034797|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
130020476|NCT02289950|468034796|FG000|Overall Study|Lost to Follow-up|1|||
130020477|NCT02289950|468034797|FG001|Overall Study|Lost to Follow-up|0|||
130020478|NCT02289950|468034796|FG000|Overall Study|Physician Decision|9|||
130020479|NCT02289950|468034797|FG001|Overall Study|Physician Decision|3|||
130020480|NCT02289950|468034796|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
130225106|NCT00549549|468788081|FG002|Overall Study|Withdrawal by Subject|1|||
130225107|NCT00549549|468788082|FG003|Overall Study|Withdrawal by Subject|0|||
130020481|NCT02289950|468034797|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
130020482|NCT02289950|468034796|FG000|Overall Study|Withdrawal by Subject|1|||
130020483|NCT02289950|468034797|FG001|Overall Study|Withdrawal by Subject|3|||
130020484|NCT02289950|468034796|FG000|Overall Study|Test article held for greater than 28 days|0|||
130020485|NCT02289950|468034797|FG001|Overall Study|Test article held for greater than 28 days|1|||
130020486|NCT02289950|468034796|FG000|Overall Study|Adverse Event|11|||
129884505|NCT02293837|467536433|FG001|Overall Study|Withdrawal by Subject|1|||
130020487|NCT02289950|468034797|FG001|Overall Study|Adverse Event|3|||
130020488|NCT02289950|468034796|FG000|Overall Study|Death|1|||
130020489|NCT02289950|468034797|FG001|Overall Study|Death|1|||
130020490|NCT02289950|468034796|FG000|Overall Study|Other|5|||
130020491|NCT02289950|468034797|FG001|Overall Study|Other|2|||
130020492|NCT02289950|468034796|FG000|Overall Study|Not Treated|2|||
130020493|NCT02289950|468034797|FG001|Overall Study|Not Treated|1|||
130020494|NCT01250379|468034800|FG000|Overall Study|Death|141|||
130020495|NCT01250379|468034801|FG001|Overall Study|Death|148|||
130020496|NCT01250379|468034800|FG000|Overall Study|Withdrawal by Subject|32|||
130020497|NCT01250379|468034801|FG001|Overall Study|Withdrawal by Subject|20|||
130020498|NCT01250379|468034800|FG000|Overall Study|Physician Decision|11|||
130020499|NCT01250379|468034801|FG001|Overall Study|Physician Decision|3|||
130020500|NCT01250379|468034800|FG000|Overall Study|Protocol Violation|2|||
130020501|NCT01250379|468034801|FG001|Overall Study|Protocol Violation|8|||
130020502|NCT01250379|468034800|FG000|Overall Study|Lost to Follow-up|9|||
130020503|NCT01250379|468034801|FG001|Overall Study|Lost to Follow-up|6|||
130020504|NCT01250379|468034800|FG000|Overall Study|Adverse Event|5|||
130020505|NCT01250379|468034801|FG001|Overall Study|Adverse Event|4|||
130020506|NCT01250379|468034800|FG000|Overall Study|Other|0|||
130020507|NCT01250379|468034801|FG001|Overall Study|Other|4|||
130020508|NCT01250379|468034800|FG000|Overall Study|Participant noncompliance|2|||
130020509|NCT01250379|468034801|FG001|Overall Study|Participant noncompliance|0|||
130020510|NCT05902364|468034802|FG000|Overall Study|Adverse Event|1|||
130020511|NCT05902364|468034803|FG001|Overall Study|Adverse Event|0|||
130020512|NCT01489527|468034807|FG000|Overall Study|Pregnancy|9|||
130020513|NCT01489527|468034808|FG001|Overall Study|Pregnancy|14|||
130020514|NCT01489527|468034807|FG000|Overall Study|Participant moved|6|||
130020515|NCT01489527|468034808|FG001|Overall Study|Participant moved|7|||
130020516|NCT01489527|468034807|FG000|Overall Study|Withdrawal by Subject|0|||
130020517|NCT01489527|468034808|FG001|Overall Study|Withdrawal by Subject|4|||
130020518|NCT01489527|468034807|FG000|Overall Study|Lost to Follow-up|5|||
130020519|NCT01489527|468034808|FG001|Overall Study|Lost to Follow-up|1|||
130020520|NCT01489527|468034807|FG000|Overall Study|Procedures|1|||
130020521|NCT01489527|468034808|FG001|Overall Study|Procedures|0|||
130020522|NCT01489527|468034807|FG000|Overall Study|Not compliant|1|||
130020523|NCT01489527|468034808|FG001|Overall Study|Not compliant|0|||
130020524|NCT01984268|468034809|FG000|Overall Study|Study Terminated|15|||
130020525|NCT01344876|468034811|FG000|Overall Study|Adverse Event|0|||
130020526|NCT01344876|468034812|FG001|Overall Study|Adverse Event|0|||
130020527|NCT01344876|468034813|FG002|Overall Study|Adverse Event|0|||
130020528|NCT01344876|468034814|FG003|Overall Study|Adverse Event|0|||
130020529|NCT01344876|468034815|FG004|Overall Study|Adverse Event|1|||
130020530|NCT01344876|468034811|FG000|Overall Study|Withdrawal by Subject|0|||
130020531|NCT01344876|468034812|FG001|Overall Study|Withdrawal by Subject|0|||
130020532|NCT01344876|468034813|FG002|Overall Study|Withdrawal by Subject|1|||
130020533|NCT01344876|468034814|FG003|Overall Study|Withdrawal by Subject|0|||
130020534|NCT01344876|468034815|FG004|Overall Study|Withdrawal by Subject|0|||
130020535|NCT01344876|468034811|FG000|Overall Study|Definite progression of primary disease|1|||
130020536|NCT01344876|468034812|FG001|Overall Study|Definite progression of primary disease|0|||
130020537|NCT01344876|468034813|FG002|Overall Study|Definite progression of primary disease|0|||
129884506|NCT02293837|467536434|FG002|Overall Study|Withdrawal by Subject|2|||
130020538|NCT01344876|468034814|FG003|Overall Study|Definite progression of primary disease|3|||
130020539|NCT01344876|468034815|FG004|Overall Study|Definite progression of primary disease|0|||
130020540|NCT04818593|468034816|FG000|Overall Study|Low Oocyte Yield|8|||
130020541|NCT04818593|468034817|FG001|Overall Study|Low Oocyte Yield|8|||
130020542|NCT04818593|468034816|FG000|Overall Study|Not ICSI Insemination|7|||
130020543|NCT04818593|468034817|FG001|Overall Study|Not ICSI Insemination|7|||
130020544|NCT04818593|468034816|FG000|Overall Study|Poor Sperm Quality|2|||
130020545|NCT04818593|468034817|FG001|Overall Study|Poor Sperm Quality|2|||
130020546|NCT04818593|468034816|FG000|Overall Study|Withdrawal by Subject|2|||
130020547|NCT04818593|468034817|FG001|Overall Study|Withdrawal by Subject|2|||
130020548|NCT04818593|468034816|FG000|Overall Study|Conversion to IUI due to low response|1|||
130020549|NCT04818593|468034817|FG001|Overall Study|Conversion to IUI due to low response|1|||
130020550|NCT02968810|468036661|FG000|Overall Study|Lost to Follow-up|1|||
130020551|NCT02968810|468036662|FG001|Overall Study|Lost to Follow-up|0|||
130020552|NCT02968810|468036661|FG000|Overall Study|Physician Decision|1|||
130020553|NCT02968810|468036662|FG001|Overall Study|Physician Decision|0|||
130020554|NCT02968810|468036661|FG000|Overall Study|Withdrawal by Subject|1|||
130020555|NCT02968810|468036662|FG001|Overall Study|Withdrawal by Subject|3|||
130020556|NCT02968810|468036661|FG000|Overall Study|Disease Progression|0|||
130020557|NCT02968810|468036662|FG001|Overall Study|Disease Progression|1|||
130020558|NCT04316585|468036666|FG000|Overall Study|Adverse Event|2|||
130020559|NCT04316585|468036667|FG001|Overall Study|Adverse Event|1|||
130020560|NCT04316585|468036666|FG000|Overall Study|Lost to Follow-up|1|||
130020561|NCT04316585|468036667|FG001|Overall Study|Lost to Follow-up|0|||
130020562|NCT04316585|468036666|FG000|Overall Study|Withdrawal by Subject|2|||
130020563|NCT04316585|468036667|FG001|Overall Study|Withdrawal by Subject|3|||
130020564|NCT04316585|468036666|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130020565|NCT04316585|468036667|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
130020566|NCT04316585|468036666|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
130020567|NCT04316585|468036667|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
130020568|NCT02889796|468036675|FG000|Overall Study|Withdrew Consent|18|||
130020569|NCT02889796|468036676|FG001|Overall Study|Withdrew Consent|29|||
130020570|NCT02889796|468036677|FG002|Overall Study|Withdrew Consent|20|||
130020571|NCT02889796|468036678|FG003|Overall Study|Withdrew Consent|1|||
130020572|NCT02889796|468036679|FG004|Overall Study|Withdrew Consent|2|||
130020573|NCT02889796|468036680|FG005|Overall Study|Withdrew Consent|35|||
130020574|NCT02889796|468036675|FG000|Overall Study|Investigator's Discretion|10|||
130020575|NCT02889796|468036676|FG001|Overall Study|Investigator's Discretion|9|||
130020576|NCT02889796|468036677|FG002|Overall Study|Investigator's Discretion|10|||
130020577|NCT02889796|468036678|FG003|Overall Study|Investigator's Discretion|3|||
130020578|NCT02889796|468036679|FG004|Overall Study|Investigator's Discretion|0|||
130020579|NCT02889796|468036680|FG005|Overall Study|Investigator's Discretion|15|||
130020580|NCT02889796|468036675|FG000|Overall Study|Adverse Event|17|||
130020581|NCT02889796|468036676|FG001|Overall Study|Adverse Event|8|||
130020582|NCT02889796|468036677|FG002|Overall Study|Adverse Event|8|||
130020583|NCT02889796|468036678|FG003|Overall Study|Adverse Event|4|||
130020584|NCT02889796|468036679|FG004|Overall Study|Adverse Event|1|||
130020585|NCT02889796|468036680|FG005|Overall Study|Adverse Event|7|||
130020586|NCT02889796|468036675|FG000|Overall Study|Lost to Follow-up|5|||
130020587|NCT02889796|468036676|FG001|Overall Study|Lost to Follow-up|7|||
130020588|NCT02889796|468036677|FG002|Overall Study|Lost to Follow-up|2|||
130020589|NCT02889796|468036678|FG003|Overall Study|Lost to Follow-up|0|||
130020590|NCT02889796|468036679|FG004|Overall Study|Lost to Follow-up|2|||
130020591|NCT02889796|468036680|FG005|Overall Study|Lost to Follow-up|6|||
130020592|NCT02889796|468036675|FG000|Overall Study|Protocol Violation|0|||
130020593|NCT02889796|468036676|FG001|Overall Study|Protocol Violation|1|||
130020594|NCT02889796|468036677|FG002|Overall Study|Protocol Violation|3|||
130020595|NCT02889796|468036678|FG003|Overall Study|Protocol Violation|0|||
130020596|NCT02889796|468036679|FG004|Overall Study|Protocol Violation|0|||
130020597|NCT02889796|468036680|FG005|Overall Study|Protocol Violation|4|||
130020598|NCT02889796|468036675|FG000|Overall Study|Non-compliance With Study Drug|0|||
130020599|NCT02889796|468036676|FG001|Overall Study|Non-compliance With Study Drug|2|||
130020600|NCT02889796|468036677|FG002|Overall Study|Non-compliance With Study Drug|0|||
130020601|NCT02889796|468036678|FG003|Overall Study|Non-compliance With Study Drug|0|||
130020602|NCT02889796|468036679|FG004|Overall Study|Non-compliance With Study Drug|1|||
130020603|NCT02889796|468036680|FG005|Overall Study|Non-compliance With Study Drug|2|||
130020604|NCT02889796|468036675|FG000|Overall Study|Death|1|||
130020605|NCT02889796|468036676|FG001|Overall Study|Death|1|||
130020606|NCT02889796|468036677|FG002|Overall Study|Death|0|||
130020607|NCT02889796|468036678|FG003|Overall Study|Death|1|||
130020608|NCT02889796|468036679|FG004|Overall Study|Death|0|||
130020609|NCT02889796|468036680|FG005|Overall Study|Death|1|||
130020610|NCT02889796|468036675|FG000|Overall Study|Pregnancy|0|||
130020611|NCT02889796|468036676|FG001|Overall Study|Pregnancy|1|||
130020612|NCT02889796|468036677|FG002|Overall Study|Pregnancy|1|||
130020613|NCT02889796|468036678|FG003|Overall Study|Pregnancy|0|||
130020614|NCT02889796|468036679|FG004|Overall Study|Pregnancy|0|||
130020615|NCT02889796|468036680|FG005|Overall Study|Pregnancy|0|||
130020616|NCT02889796|468036675|FG000|Overall Study|Randomized but not Dosed|2|||
130020617|NCT02889796|468036676|FG001|Overall Study|Randomized but not Dosed|0|||
130020618|NCT02889796|468036677|FG002|Overall Study|Randomized but not Dosed|0|||
130020619|NCT02889796|468036678|FG003|Overall Study|Randomized but not Dosed|0|||
130020620|NCT02889796|468036679|FG004|Overall Study|Randomized but not Dosed|0|||
130020621|NCT02889796|468036680|FG005|Overall Study|Randomized but not Dosed|2|||
130020622|NCT01407926|468036686|FG000|Overall Study|Lost to Follow-up|55|||
130020623|NCT02814565|468036687|FG000|Overall Study|Lack of Efficacy|0|||
130020624|NCT02814565|468036688|FG001|Overall Study|Lack of Efficacy|1|||
130020625|NCT02814565|468036687|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
130020626|NCT02814565|468036688|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
130020627|NCT04656652|468036689|FG000|Overall Study|Lost to Follow-up|2|||
130020628|NCT04656652|468036690|FG001|Overall Study|Lost to Follow-up|2|||
130020629|NCT04656652|468036689|FG000|Overall Study|Death|213|||
130020630|NCT04656652|468036690|FG001|Overall Study|Death|212|||
130020631|NCT04656652|468036689|FG000|Overall Study|Other|1|||
130020632|NCT04656652|468036690|FG001|Overall Study|Other|0|||
130020633|NCT04656652|468036689|FG000|Overall Study|Withdrawal by Subject|15|||
130020634|NCT04656652|468036690|FG001|Overall Study|Withdrawal by Subject|29|||
130020635|NCT02792842|468036693|FG000|Overall Study|Adverse Event|4|||
130020636|NCT02792842|468036694|FG001|Overall Study|Adverse Event|2|||
130020637|NCT02792842|468036695|FG002|Overall Study|Adverse Event|3|||
130020638|NCT02792842|468036693|FG000|Overall Study|Withdrawal by Subject|0|||
130020639|NCT02792842|468036694|FG001|Overall Study|Withdrawal by Subject|1|||
130020640|NCT02792842|468036695|FG002|Overall Study|Withdrawal by Subject|2|||
130020641|NCT02792842|468036693|FG000|Overall Study|Lost to Follow-up|0|||
130020642|NCT02792842|468036694|FG001|Overall Study|Lost to Follow-up|0|||
130020643|NCT02792842|468036695|FG002|Overall Study|Lost to Follow-up|1|||
130020644|NCT02792842|468036693|FG000|Overall Study|Schedule delay|0|||
130020645|NCT02792842|468036694|FG001|Overall Study|Schedule delay|1|||
130020646|NCT02792842|468036695|FG002|Overall Study|Schedule delay|1|||
130020647|NCT00493038|468036704|FG000|Treatment|Adverse Event|8|||
130020648|NCT00493038|468036705|FG001|Treatment|Adverse Event|4|||
130020649|NCT00493038|468036704|FG000|Treatment|Lost to Follow-up|5|||
130020650|NCT00493038|468036705|FG001|Treatment|Lost to Follow-up|3|||
130020651|NCT00493038|468036704|FG000|Treatment|Withdrawal by Subject|11|||
130020652|NCT00493038|468036705|FG001|Treatment|Withdrawal by Subject|12|||
130020653|NCT00493038|468036704|FG000|Treatment|Other|0|||
130020654|NCT00493038|468036705|FG001|Treatment|Other|1|||
130020655|NCT00493038|468036704|FG000|Follow-up|Lost to Follow-up|1|||
130020656|NCT00493038|468036705|FG001|Follow-up|Lost to Follow-up|0|||
130020657|NCT03345472|468036706|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
130020658|NCT03345472|468036706|FG000|Implant to 3 Months|Physician Decision|1|||
130020659|NCT03345472|468036706|FG000|Implant to 3 Months|Adverse Event|1|||
130020660|NCT03345472|468036706|FG000|3 Months to 12 Months|Physician Decision|3|||
130020661|NCT03345472|468036706|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
130020662|NCT03345472|468036706|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
130020663|NCT03345472|468036706|FG000|3 Months to 12 Months|Adverse Event|1|||
130020664|NCT03345472|468036706|FG000|3 Months to 12 Months|Death|1|||
130020665|NCT00577993|468036709|FG000|Overall Study|Adverse Event|1|||
130020666|NCT00577993|468036710|FG001|Overall Study|Adverse Event|0|||
130020667|NCT00577993|468036711|FG002|Overall Study|Adverse Event|0|||
130020668|NCT00577993|468036709|FG000|Overall Study|Death|0|||
130020669|NCT00577993|468036710|FG001|Overall Study|Death|1|||
130020670|NCT00577993|468036711|FG002|Overall Study|Death|1|||
130020671|NCT00577993|468036709|FG000|Overall Study|Lack of Efficacy|0|||
130020672|NCT00577993|468036710|FG001|Overall Study|Lack of Efficacy|1|||
130020673|NCT00577993|468036711|FG002|Overall Study|Lack of Efficacy|0|||
130020674|NCT00577993|468036709|FG000|Overall Study|Protocol Violation|2|||
130020675|NCT00577993|468036710|FG001|Overall Study|Protocol Violation|3|||
130020676|NCT00577993|468036711|FG002|Overall Study|Protocol Violation|0|||
130020677|NCT00577993|468036709|FG000|Overall Study|Withdrawal by Subject|1|||
130020678|NCT00577993|468036710|FG001|Overall Study|Withdrawal by Subject|0|||
130020679|NCT00577993|468036711|FG002|Overall Study|Withdrawal by Subject|2|||
130020680|NCT00577993|468036709|FG000|Overall Study|Conversion|2|||
130020681|NCT00577993|468036710|FG001|Overall Study|Conversion|5|||
130020682|NCT00577993|468036711|FG002|Overall Study|Conversion|0|||
130020683|NCT00577993|468036709|FG000|Overall Study|Uninsured|1|||
130020684|NCT00577993|468036710|FG001|Overall Study|Uninsured|0|||
130020685|NCT00577993|468036711|FG002|Overall Study|Uninsured|0|||
130020686|NCT01847885|468036712|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
130020687|NCT01847885|468036713|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
130020688|NCT01847885|468036714|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
130020689|NCT01847885|468036712|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
130020690|NCT01847885|468036713|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
130020691|NCT01847885|468036714|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
130020692|NCT01847885|468036712|FG000|Initial Enrollment (Consented)|Screen failure|39|||
130020693|NCT01847885|468036713|FG001|Initial Enrollment (Consented)|Screen failure|0|||
130020694|NCT01847885|468036714|FG002|Initial Enrollment (Consented)|Screen failure|0|||
130020695|NCT01847885|468036712|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
130020696|NCT01847885|468036713|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
130020697|NCT01847885|468036714|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
130020698|NCT01847885|468036712|FG000|Randomization|Protocol Violation|0|||
130020699|NCT01847885|468036713|FG001|Randomization|Protocol Violation|1|||
130020700|NCT01847885|468036714|FG002|Randomization|Protocol Violation|0|||
130020701|NCT01847885|468036712|FG000|Randomization|Withdrawal by Subject|0|||
130020702|NCT01847885|468036713|FG001|Randomization|Withdrawal by Subject|0|||
130020703|NCT01847885|468036714|FG002|Randomization|Withdrawal by Subject|2|||
130020704|NCT01847885|468036712|FG000|Randomization|Screen Failure|0|||
130020705|NCT01847885|468036713|FG001|Randomization|Screen Failure|3|||
130020706|NCT01847885|468036714|FG002|Randomization|Screen Failure|0|||
130020707|NCT04029519|468036716|FG000|Overall Study|Protocol Violation|1|||
130020708|NCT04029519|468036716|FG000|Overall Study|Withdrawal by Subject|3|||
130020709|NCT04029519|468036716|FG000|Overall Study|Lost to Follow-up|1|||
130020710|NCT00070941|468036719|FG000|Overall Study|Adverse Event|10|||
130020711|NCT00070941|468036720|FG001|Overall Study|Adverse Event|8|||
130225108|NCT00549549|468788079|FG000|Overall Study|Other|9|||
130225109|NCT00549549|468788080|FG001|Overall Study|Other|9|||
130020712|NCT00070941|468036721|FG002|Overall Study|Adverse Event|4|||
130020713|NCT00094055|468036722|FG000|Overall Study|Adverse Event|11|||
130020714|NCT00094055|468036722|FG000|Overall Study|Death|4|||
130020715|NCT00094055|468036722|FG000|Overall Study|Lack of Efficacy|17|||
130020716|NCT00094055|468036722|FG000|Overall Study|Lost to Follow-up|2|||
130020717|NCT00094055|468036722|FG000|Overall Study|progressive disease|2|||
130020718|NCT00094055|468036722|FG000|Overall Study|clinical progression|1|||
130020719|NCT00094055|468036722|FG000|Overall Study|roll-over to another study|14|||
130020720|NCT00094055|468036722|FG000|Overall Study|Withdrawal by Subject|9|||
130020721|NCT00411554|468036726|FG000|Overall Study|Adverse Event|2|||
130020722|NCT00411554|468036727|FG001|Overall Study|Adverse Event|4|||
130020723|NCT00411554|468036726|FG000|Overall Study|Lack of Efficacy|2|||
130020724|NCT00411554|468036727|FG001|Overall Study|Lack of Efficacy|5|||
130020725|NCT00411554|468036726|FG000|Overall Study|Withdrawal by Subject|3|||
130020726|NCT00411554|468036727|FG001|Overall Study|Withdrawal by Subject|0|||
130020727|NCT00411554|468036726|FG000|Overall Study|Patient Moved|1|||
130020728|NCT00411554|468036727|FG001|Overall Study|Patient Moved|0|||
130020729|NCT00699907|468036728|FG000|Overall Study|Withdrawal by Subject|2|||
130020730|NCT00699907|468036729|FG001|Overall Study|Withdrawal by Subject|1|||
130020731|NCT00699907|468036730|FG002|Overall Study|Withdrawal by Subject|0|||
130099052|NCT02576951|468319371|FG003|Overall Study|Protocol Violation|1|||
130020732|NCT00699907|468036728|FG000|Overall Study|No usable sample|0|||
130099053|NCT03280628|468320860|FG000|Overall Study|Lost to Follow-up|8|||
130099054|NCT03280628|468320861|FG001|Overall Study|Lost to Follow-up|6|||
130099055|NCT03280628|468320862|FG002|Overall Study|Lost to Follow-up|11|||
130099056|NCT01361308|468320865|FG000|Overall Study|Withdrawal by Subject|9|||
130099057|NCT01361308|468320866|FG001|Overall Study|Withdrawal by Subject|13|||
130099058|NCT01361308|468320865|FG000|Overall Study|Physician Decision|3|||
130099059|NCT01361308|468320866|FG001|Overall Study|Physician Decision|3|||
130099060|NCT01361308|468320865|FG000|Overall Study|Lack of Efficacy|2|||
130099061|NCT01361308|468320866|FG001|Overall Study|Lack of Efficacy|0|||
130099062|NCT01361308|468320865|FG000|Overall Study|Protocol Violation|1|||
130099063|NCT01361308|468320866|FG001|Overall Study|Protocol Violation|0|||
130099064|NCT01361308|468320865|FG000|Overall Study|Lost to Follow-up|5|||
130099065|NCT01361308|468320866|FG001|Overall Study|Lost to Follow-up|4|||
130099066|NCT01361308|468320865|FG000|Overall Study|Adverse Event|8|||
130099067|NCT01361308|468320866|FG001|Overall Study|Adverse Event|4|||
130099068|NCT01361308|468320865|FG000|Overall Study|Eligibility Criteria Not Met|2|||
130099069|NCT01361308|468320866|FG001|Overall Study|Eligibility Criteria Not Met|3|||
130099070|NCT01361308|468320865|FG000|Overall Study|Failed C-SSRS|5|||
130099071|NCT01361308|468320866|FG001|Overall Study|Failed C-SSRS|2|||
130099072|NCT01361308|468320865|FG000|Overall Study|Other|0|||
130099073|NCT01361308|468320866|FG001|Overall Study|Other|1|||
130099074|NCT03839693|468320871|FG000|Overall Study|Lost to Follow-up|0|||
130099075|NCT03839693|468320872|FG001|Overall Study|Lost to Follow-up|2|||
130099076|NCT03839693|468320873|FG002|Overall Study|Lost to Follow-up|2|||
130099077|NCT03839693|468320871|FG000|Overall Study|Withdrawal by Subject|1|||
130099078|NCT03839693|468320872|FG001|Overall Study|Withdrawal by Subject|0|||
130099079|NCT03839693|468320873|FG002|Overall Study|Withdrawal by Subject|2|||
130099080|NCT03839693|468320871|FG000|Overall Study|subject moved out of the area|1|||
130099081|NCT03839693|468320872|FG001|Overall Study|subject moved out of the area|0|||
130099082|NCT03839693|468320873|FG002|Overall Study|subject moved out of the area|0|||
130099083|NCT00700115|468320882|FG000|Overall Study|Withdrawal by Subject|1|||
130099084|NCT00700115|468320883|FG001|Overall Study|Withdrawal by Subject|0|||
130099085|NCT00700115|468320882|FG000|Overall Study|Lost to Follow-up|0|||
130099086|NCT00700115|468320883|FG001|Overall Study|Lost to Follow-up|1|||
130099087|NCT02503215|468320884|FG000|Overall Study|Unable to wear compression stockings|1|||
130099088|NCT02503215|468320884|FG000|Overall Study|Unable to use positive airway pressure|2|||
130099089|NCT02983305|468320889|FG000|Overall Study|incomplete data|2|||
130020733|NCT00699907|468036729|FG001|Overall Study|No usable sample|9|||
130020734|NCT00699907|468036730|FG002|Overall Study|No usable sample|8|||
130020735|NCT02161211|468036731|FG000|Overall Study|Lost to Follow-up|21|||
130020736|NCT02161211|468036732|FG001|Overall Study|Lost to Follow-up|27|||
130020737|NCT02161211|468036733|FG002|Overall Study|Lost to Follow-up|21|||
130020738|NCT02161211|468036731|FG000|Overall Study|Dropped|12|||
130020739|NCT02161211|468036732|FG001|Overall Study|Dropped|5|||
130099090|NCT02983305|468320890|FG001|Overall Study|incomplete data|0|||
130099091|NCT00822237|468320891|FG000|Dose 1 Vaccination|Not vaccinated|3|||
130225110|NCT00549549|468788081|FG002|Overall Study|Other|9|||
130020740|NCT02161211|468036733|FG002|Overall Study|Dropped|9|||
130020741|NCT03728309|468036734|FG000|Overall Study|Randomized but not Treated|0|||
130020742|NCT03728309|468036735|FG001|Overall Study|Randomized but not Treated|1|||
130225111|NCT00549549|468788082|FG003|Overall Study|Other|11|||
130020743|NCT03728309|468036734|FG000|Overall Study|Adverse Event|0|||
130020744|NCT03728309|468036735|FG001|Overall Study|Adverse Event|1|||
130020745|NCT03728309|468036734|FG000|Overall Study|Withdrawal by Subject|2|||
130020746|NCT03728309|468036735|FG001|Overall Study|Withdrawal by Subject|8|||
130020747|NCT03728309|468036734|FG000|Overall Study|Lost to Follow-up|9|||
130020748|NCT03728309|468036735|FG001|Overall Study|Lost to Follow-up|10|||
130020749|NCT03728309|468036734|FG000|Overall Study|Protocol Deviation|0|||
130020750|NCT03728309|468036735|FG001|Overall Study|Protocol Deviation|1|||
130020751|NCT03728309|468036734|FG000|Overall Study|Due to COVID|1|||
130020752|NCT03728309|468036735|FG001|Overall Study|Due to COVID|3|||
130020753|NCT00953758|468036738|FG000|Overall Study|Death|2|||
130020754|NCT00953758|468036739|FG001|Overall Study|Death|0|||
130020755|NCT00953758|468036740|FG002|Overall Study|Death|1|||
130225112|NCT00549549|468788079|FG000|Overall Study|Randomized but not treated|0|||
130020756|NCT00953758|468036741|FG003|Overall Study|Death|1|||
130099092|NCT00822237|468320892|FG001|Dose 1 Vaccination|Not vaccinated|0|||
130225113|NCT00549549|468788080|FG001|Overall Study|Randomized but not treated|0|||
130020757|NCT00953758|468036742|FG004|Overall Study|Death|1|||
130020758|NCT00953758|468036743|FG005|Overall Study|Death|1|||
130020759|NCT00953758|468036744|FG006|Overall Study|Death|1|||
130020760|NCT00953758|468036745|FG007|Overall Study|Death|3|||
130020761|NCT00953758|468036746|FG008|Overall Study|Death|1|||
130020762|NCT00953758|468036747|FG009|Overall Study|Death|0|||
130020763|NCT00953758|468036738|FG000|Overall Study|Participant refused further follow-up|0|||
130020764|NCT00953758|468036739|FG001|Overall Study|Participant refused further follow-up|0|||
130020765|NCT00953758|468036740|FG002|Overall Study|Participant refused further follow-up|1|||
130020766|NCT00953758|468036741|FG003|Overall Study|Participant refused further follow-up|0|||
130020767|NCT00953758|468036742|FG004|Overall Study|Participant refused further follow-up|3|||
130020768|NCT00953758|468036743|FG005|Overall Study|Participant refused further follow-up|0|||
130020769|NCT00953758|468036744|FG006|Overall Study|Participant refused further follow-up|0|||
130020770|NCT00953758|468036745|FG007|Overall Study|Participant refused further follow-up|0|||
130020771|NCT00953758|468036746|FG008|Overall Study|Participant refused further follow-up|1|||
130020772|NCT00953758|468036747|FG009|Overall Study|Participant refused further follow-up|0|||
130020773|NCT00953758|468036738|FG000|Overall Study|Lost to Follow-up|0|||
130020774|NCT00953758|468036739|FG001|Overall Study|Lost to Follow-up|0|||
130020775|NCT00953758|468036740|FG002|Overall Study|Lost to Follow-up|0|||
130020776|NCT00953758|468036741|FG003|Overall Study|Lost to Follow-up|1|||
130020777|NCT00953758|468036742|FG004|Overall Study|Lost to Follow-up|0|||
130020778|NCT00953758|468036743|FG005|Overall Study|Lost to Follow-up|0|||
130020779|NCT00953758|468036744|FG006|Overall Study|Lost to Follow-up|0|||
130020780|NCT00953758|468036745|FG007|Overall Study|Lost to Follow-up|1|||
130020781|NCT00953758|468036746|FG008|Overall Study|Lost to Follow-up|0|||
130020782|NCT00953758|468036747|FG009|Overall Study|Lost to Follow-up|1|||
130020783|NCT00953758|468036738|FG000|Overall Study|Physician Decision|0|||
130020784|NCT00953758|468036739|FG001|Overall Study|Physician Decision|0|||
130020785|NCT00953758|468036740|FG002|Overall Study|Physician Decision|0|||
130020786|NCT00953758|468036741|FG003|Overall Study|Physician Decision|0|||
130020787|NCT00953758|468036742|FG004|Overall Study|Physician Decision|1|||
130020788|NCT00953758|468036743|FG005|Overall Study|Physician Decision|0|||
130020789|NCT00953758|468036744|FG006|Overall Study|Physician Decision|0|||
130020790|NCT00953758|468036745|FG007|Overall Study|Physician Decision|0|||
130020791|NCT00953758|468036746|FG008|Overall Study|Physician Decision|0|||
130020792|NCT00953758|468036747|FG009|Overall Study|Physician Decision|0|||
130020793|NCT00953758|468036738|FG000|Overall Study|Disease progression|0|||
130020794|NCT00953758|468036739|FG001|Overall Study|Disease progression|0|||
130020795|NCT00953758|468036740|FG002|Overall Study|Disease progression|0|||
130020796|NCT00953758|468036741|FG003|Overall Study|Disease progression|0|||
130020797|NCT00953758|468036742|FG004|Overall Study|Disease progression|1|||
130020798|NCT00953758|468036743|FG005|Overall Study|Disease progression|0|||
130020799|NCT00953758|468036744|FG006|Overall Study|Disease progression|0|||
130020800|NCT00953758|468036745|FG007|Overall Study|Disease progression|0|||
130020801|NCT00953758|468036746|FG008|Overall Study|Disease progression|0|||
130020802|NCT00953758|468036747|FG009|Overall Study|Disease progression|0|||
130020803|NCT00953758|468036738|FG000|Overall Study|Participant went for transplant|0|||
130020804|NCT00953758|468036739|FG001|Overall Study|Participant went for transplant|0|||
130020805|NCT00953758|468036740|FG002|Overall Study|Participant went for transplant|0|||
130020806|NCT00953758|468036741|FG003|Overall Study|Participant went for transplant|0|||
130020807|NCT00953758|468036742|FG004|Overall Study|Participant went for transplant|0|||
130020808|NCT00953758|468036743|FG005|Overall Study|Participant went for transplant|0|||
130020809|NCT00953758|468036744|FG006|Overall Study|Participant went for transplant|0|||
130020810|NCT00953758|468036745|FG007|Overall Study|Participant went for transplant|0|||
130020811|NCT00953758|468036746|FG008|Overall Study|Participant went for transplant|1|||
130020812|NCT00953758|468036747|FG009|Overall Study|Participant went for transplant|0|||
130020813|NCT01536860|468036748|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
130020814|NCT01536860|468036749|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
130020815|NCT01536860|468036750|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
130020816|NCT01164722|468036751|FG000|Overall Study|Adverse Event|0|||
130020817|NCT01164722|468036752|FG001|Overall Study|Adverse Event|1|||
130020818|NCT01164722|468036751|FG000|Overall Study|Withdrawal by Subject|3|||
130020819|NCT01164722|468036752|FG001|Overall Study|Withdrawal by Subject|4|||
130020820|NCT01164722|468036751|FG000|Overall Study|Lost to Follow-up|3|||
130020821|NCT01164722|468036752|FG001|Overall Study|Lost to Follow-up|6|||
130020822|NCT01164722|468036751|FG000|Overall Study|met protocol criteria for non-treatment|11|||
130020823|NCT01164722|468036752|FG001|Overall Study|met protocol criteria for non-treatment|1|||
130099093|NCT00822237|468320891|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
130020824|NCT01164722|468036751|FG000|Overall Study|enrolled on other study, concomitant med|1|||
130020825|NCT01164722|468036752|FG001|Overall Study|enrolled on other study, concomitant med|3|||
130020826|NCT02682901|468036753|FG000|Overall Study|Adverse Event|10|||
130020827|NCT02682901|468036754|FG001|Overall Study|Adverse Event|3|||
130020828|NCT02682901|468036753|FG000|Overall Study|Lack of Efficacy|0|||
130020829|NCT02682901|468036754|FG001|Overall Study|Lack of Efficacy|1|||
130020830|NCT03167073|468036755|FG000|Overall Study|Stillbirth|1|||
130020831|NCT03167073|468036756|FG001|Overall Study|Stillbirth|0|||
130020832|NCT01276236|468036757|FG000|Overall Study|Lack of Efficacy|2|||
130020833|NCT01276236|468036757|FG000|Overall Study|Withdrawal by Subject|4|||
130020834|NCT00044512|468036758|FG000|Follow Up|Lost to Follow-up|2|||
130020835|NCT02799069|468036760|FG000|Overall Study|Adverse Event|0|||
130020836|NCT02799069|468036761|FG001|Overall Study|Adverse Event|2|||
130020837|NCT02799069|468036762|FG002|Overall Study|Adverse Event|2|||
130020838|NCT02799069|468036760|FG000|Overall Study|Lack of Efficacy|2|||
130020839|NCT02799069|468036761|FG001|Overall Study|Lack of Efficacy|0|||
130020840|NCT02799069|468036762|FG002|Overall Study|Lack of Efficacy|0|||
130020841|NCT02799069|468036760|FG000|Overall Study|Lost to Follow-up|1|||
130020842|NCT02799069|468036761|FG001|Overall Study|Lost to Follow-up|1|||
130020843|NCT02799069|468036762|FG002|Overall Study|Lost to Follow-up|0|||
130020844|NCT02799069|468036760|FG000|Overall Study|Withdrawal by Subject|4|||
130020845|NCT02799069|468036761|FG001|Overall Study|Withdrawal by Subject|4|||
130020846|NCT02799069|468036762|FG002|Overall Study|Withdrawal by Subject|3|||
130020847|NCT02799069|468036760|FG000|Overall Study|Protocol Violation|1|||
130020848|NCT02799069|468036761|FG001|Overall Study|Protocol Violation|0|||
130020849|NCT02799069|468036762|FG002|Overall Study|Protocol Violation|2|||
130020850|NCT00357500|468036779|FG000|Overall Study|Adverse Event|3|||
130020851|NCT00357500|468036779|FG000|Overall Study|Withdrawal by Subject|5|||
130020852|NCT00357500|468036779|FG000|Overall Study|Progressive Disease|65|||
130020853|NCT00357500|468036779|FG000|Overall Study|Not Started Protocol Therapy|4|||
130020854|NCT02695628|468036780|FG000|Overall Study|Withdrawal by Subject|1|||
130020855|NCT01681433|468036781|FG000|Overall Study|Lack of Efficacy|23|||
130020856|NCT01681433|468036782|FG001|Overall Study|Lack of Efficacy|23|||
130020857|NCT01681433|468036781|FG000|Overall Study|Withdrawal by Subject|5|||
130020858|NCT01681433|468036782|FG001|Overall Study|Withdrawal by Subject|5|||
130020859|NCT01681433|468036781|FG000|Overall Study|Protocol Violation|2|||
130020860|NCT01681433|468036782|FG001|Overall Study|Protocol Violation|0|||
130020861|NCT01681433|468036781|FG000|Overall Study|Adverse Event|2|||
130020862|NCT01681433|468036782|FG001|Overall Study|Adverse Event|4|||
130020863|NCT01681433|468036781|FG000|Overall Study|Lost to Follow-up|0|||
130020864|NCT01681433|468036782|FG001|Overall Study|Lost to Follow-up|1|||
130020865|NCT00511355|468036783|FG000|Overall Study|Adverse Event|4|||
130020866|NCT00511355|468036784|FG001|Overall Study|Adverse Event|4|||
130020867|NCT00511355|468036783|FG000|Overall Study|Pregnancy Wish|1|||
130020868|NCT00511355|468036784|FG001|Overall Study|Pregnancy Wish|0|||
130020869|NCT00511355|468036783|FG000|Overall Study|Lost to Follow-up|2|||
130020870|NCT00511355|468036784|FG001|Overall Study|Lost to Follow-up|1|||
130020871|NCT00511355|468036783|FG000|Overall Study|Other Reason|0|||
130020872|NCT00511355|468036784|FG001|Overall Study|Other Reason|1|||
130020873|NCT00511355|468036783|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
130020874|NCT00511355|468036784|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
130020875|NCT00511355|468036783|FG000|Overall Study|Withdrawal of informed consent|0|||
130020876|NCT00511355|468036784|FG001|Overall Study|Withdrawal of informed consent|1|||
130020877|NCT00511355|468036783|FG000|Overall Study|Other reason pre-treatment|0|||
130020878|NCT00511355|468036784|FG001|Overall Study|Other reason pre-treatment|1|||
130020879|NCT04770779|468036787|FG000|Overall Study|Randomized, never treated|0|||
130020880|NCT04770779|468036788|FG001|Overall Study|Randomized, never treated|1|||
130020881|NCT04770779|468036787|FG000|Overall Study|Adverse Event|9|||
130020882|NCT04770779|468036788|FG001|Overall Study|Adverse Event|1|||
130020883|NCT04770779|468036787|FG000|Overall Study|Withdrawal by Subject|7|||
130020884|NCT04770779|468036788|FG001|Overall Study|Withdrawal by Subject|1|||
130020885|NCT04770779|468036787|FG000|Overall Study|Pregnancy|0|||
130020886|NCT04770779|468036788|FG001|Overall Study|Pregnancy|1|||
130020887|NCT03692052|468036789|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
130020888|NCT03692052|468036789|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
130020889|NCT03692052|468036789|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
130020890|NCT03692052|468036789|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
130020891|NCT05600309|468036790|FG000|Overall Study|Death|41|||
130020892|NCT05600309|468036791|FG001|Overall Study|Death|38|||
130020893|NCT05600309|468036790|FG000|Overall Study|Sponsor Decision|9|||
130020894|NCT05600309|468036791|FG001|Overall Study|Sponsor Decision|6|||
130020895|NCT00644787|468036792|FG000|Period 1: Titration Phase|Adverse Event|11|||
130020896|NCT00644787|468036793|FG001|Period 1: Titration Phase|Adverse Event|0|||
130020897|NCT00644787|468036794|FG002|Period 1: Titration Phase|Adverse Event|0|||
130020898|NCT00644787|468036792|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
130020899|NCT00644787|468036793|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
130020900|NCT00644787|468036794|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
130020901|NCT00644787|468036792|FG000|Period 1: Titration Phase|Physician Decision|1|||
130020902|NCT00644787|468036793|FG001|Period 1: Titration Phase|Physician Decision|0|||
130020903|NCT00644787|468036794|FG002|Period 1: Titration Phase|Physician Decision|0|||
130020904|NCT00644787|468036792|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
130020905|NCT00644787|468036793|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
130020906|NCT00644787|468036794|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
130020907|NCT00644787|468036792|FG000|Period 1: Titration Phase|Worsening of complications|1|||
130020908|NCT00644787|468036793|FG001|Period 1: Titration Phase|Worsening of complications|0|||
130020909|NCT00644787|468036794|FG002|Period 1: Titration Phase|Worsening of complications|0|||
130020910|NCT00644787|468036792|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
130020911|NCT00644787|468036793|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
130020912|NCT00644787|468036794|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
130020913|NCT00644787|468036792|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
130020914|NCT00644787|468036793|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
130020915|NCT00644787|468036794|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
130020916|NCT00644787|468036792|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
130020917|NCT00644787|468036793|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
130020918|NCT00644787|468036794|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
130020919|NCT00644787|468036792|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
130020920|NCT00644787|468036793|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
130020921|NCT00644787|468036794|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
130020922|NCT00644787|468036792|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
130020923|NCT00644787|468036793|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
130020924|NCT00644787|468036794|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
130020925|NCT00644787|468036792|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
130020926|NCT00644787|468036793|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
130020927|NCT00644787|468036794|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
130020928|NCT00644787|468036792|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
130020929|NCT00644787|468036793|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
130020930|NCT00644787|468036794|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
130020931|NCT00936208|468036795|FG000|Overall Study|Protocol Violation|37|||
130020932|NCT00936208|468036796|FG001|Overall Study|Protocol Violation|22|||
130020933|NCT04428424|468036799|FG000|Overall Study|Does not meet entrance criteria|132|||
130020934|NCT04428424|468036799|FG000|Overall Study|Lost to Follow-up|115|||
130020935|NCT05036083|468036803|FG000|Overall Study|Physician Decision|1|||
130020936|NCT05036083|468036803|FG000|Overall Study|Withdrawal by Subject|1|||
130020937|NCT05036083|468036803|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
130020938|NCT05036083|468036803|FG000|Overall Study|IV not sustainable|1|||
130020939|NCT04622046|468036804|FG000|Intervention Period|Adverse Event|1|||
130020940|NCT04622046|468036804|FG000|Intervention Period|Withdrawal by Subject|2|||
130020941|NCT04622046|468036804|FG000|Extension Period|Ongoing in the Extension Period|21|||
130020942|NCT01844986|468036805|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
130020943|NCT01844986|468036806|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
130020944|NCT01844986|468036805|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
130020945|NCT01844986|468036806|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
130020946|NCT01844986|468036805|FG000|Overall Study (Global Cohort)|Death|55|||
130020947|NCT01844986|468036806|FG001|Overall Study (Global Cohort)|Death|26|||
130020948|NCT01844986|468036805|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
130020949|NCT01844986|468036806|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
130020950|NCT01844986|468036805|FG000|Overall Study (China Cohort)|Death|10|||
130020951|NCT01844986|468036806|FG001|Overall Study (China Cohort)|Death|6|||
130020952|NCT01790503|468038033|FG000|Overall Study|Adverse Event|1|||
130020953|NCT01790503|468038034|FG001|Overall Study|Adverse Event|0|||
130020954|NCT01790503|468038035|FG002|Overall Study|Adverse Event|0|||
130020955|NCT01790503|468038036|FG003|Overall Study|Adverse Event|0|||
130020956|NCT01790503|468038037|FG004|Overall Study|Adverse Event|0|||
130020957|NCT01790503|468038038|FG005|Overall Study|Adverse Event|2|||
130020958|NCT01790503|468038039|FG006|Overall Study|Adverse Event|0|||
130020959|NCT01790503|468038040|FG007|Overall Study|Adverse Event|0|||
130020960|NCT01790503|468038041|FG008|Overall Study|Adverse Event|2|||
130020961|NCT01790503|468038042|FG009|Overall Study|Adverse Event|4|||
130020962|NCT01790503|468038043|FG010|Overall Study|Adverse Event|7|||
130020963|NCT01790503|468038033|FG000|Overall Study|Withdrawal by Subject|0|||
130020964|NCT01790503|468038034|FG001|Overall Study|Withdrawal by Subject|0|||
130020965|NCT01790503|468038035|FG002|Overall Study|Withdrawal by Subject|1|||
130020966|NCT01790503|468038036|FG003|Overall Study|Withdrawal by Subject|1|||
130020967|NCT01790503|468038037|FG004|Overall Study|Withdrawal by Subject|1|||
130020968|NCT01790503|468038038|FG005|Overall Study|Withdrawal by Subject|2|||
130020969|NCT01790503|468038039|FG006|Overall Study|Withdrawal by Subject|1|||
130020970|NCT01790503|468038040|FG007|Overall Study|Withdrawal by Subject|0|||
130020971|NCT01790503|468038041|FG008|Overall Study|Withdrawal by Subject|0|||
130020972|NCT01790503|468038042|FG009|Overall Study|Withdrawal by Subject|0|||
130020973|NCT01790503|468038043|FG010|Overall Study|Withdrawal by Subject|1|||
130020974|NCT01790503|468038033|FG000|Overall Study|Disease progression|2|||
130020975|NCT01790503|468038034|FG001|Overall Study|Disease progression|1|||
130020976|NCT01790503|468038035|FG002|Overall Study|Disease progression|0|||
130020977|NCT01790503|468038036|FG003|Overall Study|Disease progression|1|||
130020978|NCT01790503|468038037|FG004|Overall Study|Disease progression|2|||
130020979|NCT01790503|468038038|FG005|Overall Study|Disease progression|1|||
130020980|NCT01790503|468038039|FG006|Overall Study|Disease progression|0|||
130020981|NCT01790503|468038040|FG007|Overall Study|Disease progression|1|||
130020982|NCT01790503|468038041|FG008|Overall Study|Disease progression|0|||
130020983|NCT01790503|468038042|FG009|Overall Study|Disease progression|17|||
130020984|NCT01790503|468038043|FG010|Overall Study|Disease progression|7|||
130020985|NCT01790503|468038033|FG000|Overall Study|Protocol Violation|0|||
130020986|NCT01790503|468038034|FG001|Overall Study|Protocol Violation|0|||
130020987|NCT01790503|468038035|FG002|Overall Study|Protocol Violation|0|||
130020988|NCT01790503|468038036|FG003|Overall Study|Protocol Violation|0|||
130020989|NCT01790503|468038037|FG004|Overall Study|Protocol Violation|0|||
130020990|NCT01790503|468038038|FG005|Overall Study|Protocol Violation|0|||
130020991|NCT01790503|468038039|FG006|Overall Study|Protocol Violation|0|||
130020992|NCT01790503|468038040|FG007|Overall Study|Protocol Violation|0|||
130020993|NCT01790503|468038041|FG008|Overall Study|Protocol Violation|0|||
130020994|NCT01790503|468038042|FG009|Overall Study|Protocol Violation|1|||
130020995|NCT01790503|468038043|FG010|Overall Study|Protocol Violation|0|||
130020996|NCT01790503|468038033|FG000|Overall Study|Physician Decision|0|||
130020997|NCT01790503|468038034|FG001|Overall Study|Physician Decision|0|||
130020998|NCT01790503|468038035|FG002|Overall Study|Physician Decision|0|||
130020999|NCT01790503|468038036|FG003|Overall Study|Physician Decision|0|||
130021000|NCT01790503|468038037|FG004|Overall Study|Physician Decision|0|||
130021001|NCT01790503|468038038|FG005|Overall Study|Physician Decision|0|||
130021002|NCT01790503|468038039|FG006|Overall Study|Physician Decision|0|||
130021003|NCT01790503|468038040|FG007|Overall Study|Physician Decision|0|||
130021004|NCT01790503|468038041|FG008|Overall Study|Physician Decision|0|||
130021005|NCT01790503|468038042|FG009|Overall Study|Physician Decision|1|||
130021006|NCT01790503|468038043|FG010|Overall Study|Physician Decision|1|||
130021007|NCT01790503|468038033|FG000|Overall Study|Death|0|||
130021008|NCT01790503|468038034|FG001|Overall Study|Death|0|||
130021009|NCT01790503|468038035|FG002|Overall Study|Death|0|||
130021010|NCT01790503|468038036|FG003|Overall Study|Death|0|||
130021011|NCT01790503|468038037|FG004|Overall Study|Death|0|||
130021012|NCT01790503|468038038|FG005|Overall Study|Death|0|||
130021013|NCT01790503|468038039|FG006|Overall Study|Death|0|||
130021014|NCT01790503|468038040|FG007|Overall Study|Death|0|||
130021015|NCT01790503|468038041|FG008|Overall Study|Death|0|||
130021016|NCT01790503|468038042|FG009|Overall Study|Death|1|||
130021017|NCT01790503|468038043|FG010|Overall Study|Death|0|||
130021018|NCT01790503|468038033|FG000|Overall Study|Non Compliance|0|||
130021019|NCT01790503|468038034|FG001|Overall Study|Non Compliance|0|||
130021020|NCT01790503|468038035|FG002|Overall Study|Non Compliance|0|||
130021021|NCT01790503|468038036|FG003|Overall Study|Non Compliance|0|||
130021022|NCT01790503|468038037|FG004|Overall Study|Non Compliance|1|||
130021023|NCT01790503|468038038|FG005|Overall Study|Non Compliance|0|||
130021024|NCT01790503|468038039|FG006|Overall Study|Non Compliance|0|||
130021025|NCT01790503|468038040|FG007|Overall Study|Non Compliance|0|||
130021026|NCT01790503|468038041|FG008|Overall Study|Non Compliance|0|||
130021027|NCT01790503|468038042|FG009|Overall Study|Non Compliance|0|||
130021028|NCT01790503|468038043|FG010|Overall Study|Non Compliance|0|||
130021029|NCT01790503|468038033|FG000|Overall Study|Other|0|||
130021030|NCT01790503|468038034|FG001|Overall Study|Other|0|||
130021031|NCT01790503|468038035|FG002|Overall Study|Other|0|||
130021032|NCT01790503|468038036|FG003|Overall Study|Other|0|||
130021033|NCT01790503|468038037|FG004|Overall Study|Other|1|||
130021034|NCT01790503|468038038|FG005|Overall Study|Other|0|||
130021035|NCT01790503|468038039|FG006|Overall Study|Other|0|||
130021036|NCT01790503|468038040|FG007|Overall Study|Other|0|||
130021037|NCT01790503|468038041|FG008|Overall Study|Other|1|||
130021038|NCT01790503|468038042|FG009|Overall Study|Other|2|||
130021039|NCT01790503|468038043|FG010|Overall Study|Other|0|||
130021040|NCT02605642|468038044|FG000|Overall Study|Other|11|||
130021041|NCT02605642|468038045|FG001|Overall Study|Other|1|||
130021042|NCT02605642|468038044|FG000|Overall Study|Participant non-compliance|2|||
130021043|NCT02605642|468038045|FG001|Overall Study|Participant non-compliance|4|||
130021044|NCT02605642|468038044|FG000|Overall Study|Physician Decision|10|||
130021045|NCT02605642|468038045|FG001|Overall Study|Physician Decision|0|||
130021046|NCT02605642|468038044|FG000|Overall Study|Lost to Follow-up|12|||
130021047|NCT02605642|468038045|FG001|Overall Study|Lost to Follow-up|1|||
130021048|NCT02605642|468038044|FG000|Overall Study|Adverse Event|14|||
130021049|NCT02605642|468038045|FG001|Overall Study|Adverse Event|2|||
130021050|NCT02605642|468038044|FG000|Overall Study|Withdrawal by Subject|23|||
130021051|NCT02605642|468038045|FG001|Overall Study|Withdrawal by Subject|2|||
130021052|NCT02605642|468038044|FG000|Overall Study|Lack of response|24|||
130021053|NCT02605642|468038045|FG001|Overall Study|Lack of response|11|||
130021054|NCT00984204|468038054|FG000|Overall Study|Death|1|||
130021055|NCT00984204|468038054|FG000|Overall Study|Lost to Follow-up|4|||
130021056|NCT00984204|468038054|FG000|Overall Study|Lack of Efficacy|10|||
130021057|NCT00699348|468038055|FG000|Overall Study|Death|6|||
130021058|NCT00699348|468038055|FG000|Overall Study|Adverse Event|15|||
130021059|NCT00699348|468038055|FG000|Overall Study|Withdrawal by Subject|11|||
130021060|NCT00699348|468038055|FG000|Overall Study|Protocol Violation|10|||
130021061|NCT00699348|468038055|FG000|Overall Study|Lack of Efficacy|8|||
130021062|NCT00699348|468038055|FG000|Overall Study|Failure to return|1|||
130021063|NCT00699348|468038055|FG000|Overall Study|Blood transfusion|24|||
130021064|NCT00699348|468038055|FG000|Overall Study|Renal transplantation|10|||
130021065|NCT00699348|468038055|FG000|Overall Study|Other|5|||
130021066|NCT03269344|468038056|FG000|Overall Study|Protocol Violation|4|||
130021067|NCT03269344|468038057|FG001|Overall Study|Protocol Violation|3|||
130021068|NCT02597855|468038058|FG000|Overall Study|Lost to Follow-up|2|||
130021069|NCT02597855|468038059|FG001|Overall Study|Lost to Follow-up|1|||
130021070|NCT01449708|468038060|FG000|Overall Study|Protocol Violation|0|||
130021071|NCT01449708|468038061|FG001|Overall Study|Protocol Violation|1|||
130021072|NCT01449708|468038060|FG000|Overall Study|surgical complication|1|||
130021073|NCT01449708|468038061|FG001|Overall Study|surgical complication|2|||
130021074|NCT01449708|468038060|FG000|Overall Study|respiratory failure|1|||
130021075|NCT01449708|468038061|FG001|Overall Study|respiratory failure|0|||
130021076|NCT03704194|468038067|FG000|Overall Study|Withdrawal by Subject|0|||
130021077|NCT03704194|468038068|FG001|Overall Study|Withdrawal by Subject|1|||
130021078|NCT00223496|468038069|FG000|Overall Study|screen failure|9|||
130021079|NCT00223496|468038069|FG000|Overall Study|Lost to Follow-up|4|||
130021080|NCT00223496|468038069|FG000|Overall Study|Lack of Efficacy|6|||
130021081|NCT00223496|468038069|FG000|Overall Study|Withdrawal by Subject|1|||
130021082|NCT00223496|468038069|FG000|Overall Study|Physician Decision|2|||
130021083|NCT00559507|468038070|FG000|Overall Study|Not treated, patient ineligible|3|||
130099094|NCT00822237|468320892|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
130099095|NCT00822237|468320891|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
130099096|NCT00822237|468320892|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
130099097|NCT00822237|468320891|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
130099098|NCT00822237|468320892|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
130099099|NCT00822237|468320891|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
130099100|NCT00822237|468320892|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
130099101|NCT03433482|468320893|FG000|Overall Study|Lost to Follow-up|1|||
130099102|NCT03433482|468320894|FG001|Overall Study|Lost to Follow-up|0|||
130099103|NCT03433482|468320895|FG002|Overall Study|Lost to Follow-up|1|||
130099104|NCT03433482|468320896|FG003|Overall Study|Lost to Follow-up|1|||
130099105|NCT03433482|468320893|FG000|Overall Study|Withdrawal by Subject|0|||
130099106|NCT03433482|468320894|FG001|Overall Study|Withdrawal by Subject|0|||
130099107|NCT03433482|468320895|FG002|Overall Study|Withdrawal by Subject|1|||
130099108|NCT03433482|468320896|FG003|Overall Study|Withdrawal by Subject|0|||
130021084|NCT01414257|468038071|FG000|Overall Study|No Visit After First Day of Treatment|12|||
130021085|NCT01414257|468038071|FG000|Overall Study|Protocol Violation|10|||
130021086|NCT02479802|468038072|FG000|Overall Study|Lost to Follow-up|1|||
130099109|NCT03433482|468320893|FG000|Overall Study|Unknown reason|0|||
130099110|NCT03433482|468320894|FG001|Overall Study|Unknown reason|0|||
130021087|NCT02479802|468038072|FG000|Overall Study|Adverse Event|1|||
130021088|NCT01882907|468038073|FG000|Overall Study|Adverse Event|3|||
130021089|NCT01882907|468038074|FG001|Overall Study|Adverse Event|1|||
130021090|NCT01882907|468038073|FG000|Overall Study|Lack of Efficacy|0|||
130021091|NCT01882907|468038074|FG001|Overall Study|Lack of Efficacy|3|||
130021092|NCT01882907|468038073|FG000|Overall Study|Lost to Follow-up|1|||
130021093|NCT01882907|468038074|FG001|Overall Study|Lost to Follow-up|4|||
130021094|NCT01882907|468038073|FG000|Overall Study|Protocol Violation|10|||
130021095|NCT01882907|468038074|FG001|Overall Study|Protocol Violation|14|||
130021096|NCT01882907|468038073|FG000|Overall Study|Withdrawal by Subject|0|||
130021097|NCT01882907|468038074|FG001|Overall Study|Withdrawal by Subject|6|||
130021098|NCT01978093|468038075|FG000|Overall Study|Death|1|||
130021099|NCT01978093|468038076|FG001|Overall Study|Death|0|||
130021100|NCT01978093|468038075|FG000|Overall Study|Adverse Event|0|||
130021101|NCT01978093|468038076|FG001|Overall Study|Adverse Event|5|||
130021102|NCT01978093|468038075|FG000|Overall Study|Protocol Violation|8|||
130021103|NCT01978093|468038076|FG001|Overall Study|Protocol Violation|2|||
130021104|NCT01978093|468038075|FG000|Overall Study|Withdrawal by Subject|29|||
130021105|NCT01978093|468038076|FG001|Overall Study|Withdrawal by Subject|25|||
130021106|NCT01978093|468038075|FG000|Overall Study|Lost to Follow-up|11|||
130021107|NCT01978093|468038076|FG001|Overall Study|Lost to Follow-up|15|||
130021108|NCT01978093|468038075|FG000|Overall Study|Migrated/moved from study area|11|||
130021109|NCT01978093|468038076|FG001|Overall Study|Migrated/moved from study area|13|||
130021110|NCT01978093|468038075|FG000|Overall Study|Loss of kaiser coverage|4|||
130021111|NCT01978093|468038076|FG001|Overall Study|Loss of kaiser coverage|10|||
130021112|NCT01978093|468038075|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
130021113|NCT01978093|468038076|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
130021114|NCT01978093|468038075|FG000|Overall Study|Mother lost custody of child|0|||
130021115|NCT01978093|468038076|FG001|Overall Study|Mother lost custody of child|1|||
130021116|NCT01978093|468038075|FG000|Overall Study|Child was in care of grandmother|0|||
130021117|NCT01978093|468038076|FG001|Overall Study|Child was in care of grandmother|1|||
130021118|NCT01978093|468038075|FG000|Overall Study|N/A for vaccine administration|0|||
130021119|NCT01978093|468038076|FG001|Overall Study|N/A for vaccine administration|1|||
130021120|NCT05702515|468038077|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
130021121|NCT01784965|468038081|FG000|Overall Study|Withdrawal by Subject|6|||
130021122|NCT01784965|468038082|FG001|Overall Study|Withdrawal by Subject|3|||
130021123|NCT01784965|468038081|FG000|Overall Study|Adverse Event|0|||
130021124|NCT01784965|468038082|FG001|Overall Study|Adverse Event|8|||
130021125|NCT03757988|468038083|FG000|Overall Study|Withdrawal by Subject|1|||
130021126|NCT01491178|468038086|FG000|Overall Study|Adverse Event|1016|||
130021127|NCT01491178|468038086|FG000|Overall Study|Improvement of NVAF|210|||
130021128|NCT01491178|468038086|FG000|Overall Study|To conduct invasive treatment|59|||
130021129|NCT01491178|468038086|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
130021130|NCT01491178|468038086|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
130021131|NCT01491178|468038086|FG000|Overall Study|To take a contraindication|20|||
130021132|NCT01491178|468038086|FG000|Overall Study|Other than specified above|657|||
130021133|NCT01604512|468038087|FG000|Overall Study|Withdrawal by Subject|3|||
130021134|NCT01604512|468038087|FG000|Overall Study|Not treated|4|||
130021135|NCT03132636|468038088|FG000|Overall Study|Adverse Event|1|||
130021136|NCT03132636|468038089|FG001|Overall Study|Adverse Event|2|||
130021137|NCT03132636|468038088|FG000|Overall Study|Death|4|||
130021138|NCT03132636|468038089|FG001|Overall Study|Death|7|||
130021139|NCT03132636|468038088|FG000|Overall Study|Lost to Follow-up|3|||
130021140|NCT03132636|468038089|FG001|Overall Study|Lost to Follow-up|2|||
130021141|NCT03132636|468038088|FG000|Overall Study|Non compliance with protocol by participant|1|||
130021142|NCT03132636|468038089|FG001|Overall Study|Non compliance with protocol by participant|1|||
130021143|NCT03132636|468038088|FG000|Overall Study|Subject decision|1|||
130021144|NCT03132636|468038089|FG001|Overall Study|Subject decision|9|||
130021145|NCT03132636|468038088|FG000|Overall Study|Sponsor decision|0|||
130021146|NCT03132636|468038089|FG001|Overall Study|Sponsor decision|1|||
130021147|NCT03132636|468038088|FG000|Overall Study|Physician Decision|1|||
130021148|NCT03132636|468038089|FG001|Overall Study|Physician Decision|0|||
130021149|NCT03132636|468038088|FG000|Overall Study|Progressive disease|33|||
130021150|NCT03132636|468038089|FG001|Overall Study|Progressive disease|36|||
130021151|NCT03132636|468038088|FG000|Overall Study|Withdrawal of consent|2|||
130021152|NCT03132636|468038089|FG001|Overall Study|Withdrawal of consent|5|||
130021153|NCT03132636|468038088|FG000|Overall Study|Did not re-consent|1|||
130021154|NCT03132636|468038089|FG001|Overall Study|Did not re-consent|0|||
130021155|NCT03132636|468038088|FG000|Overall Study|Lost insurance coverage|1|||
130021156|NCT03132636|468038089|FG001|Overall Study|Lost insurance coverage|0|||
130021157|NCT03132636|468038088|FG000|Overall Study|Related to radiological outcomes|0|||
130099111|NCT03433482|468320895|FG002|Overall Study|Unknown reason|2|||
130099112|NCT03433482|468320896|FG003|Overall Study|Unknown reason|0|||
130099113|NCT01646268|468320897|FG000|Overall Study|Adverse Event|6|||
130099114|NCT01646268|468320898|FG001|Overall Study|Adverse Event|7|||
130099115|NCT01646268|468320897|FG000|Overall Study|Lack of Efficacy|1|||
130099116|NCT01646268|468320898|FG001|Overall Study|Lack of Efficacy|3|||
130099117|NCT01646268|468320897|FG000|Overall Study|Protocol Violation|0|||
130021158|NCT03132636|468038089|FG001|Overall Study|Related to radiological outcomes|1|||
130021159|NCT03132636|468038088|FG000|Overall Study|Unable to come to site for continued visits|0|||
130021160|NCT03132636|468038089|FG001|Overall Study|Unable to come to site for continued visits|1|||
130021161|NCT01100944|468038096|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
130021162|NCT01100944|468038097|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
130099118|NCT01646268|468320898|FG001|Overall Study|Protocol Violation|1|||
130021163|NCT01100944|468038098|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
130021164|NCT01100944|468038096|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
130099119|NCT01646268|468320897|FG000|Overall Study|Withdrawal by Subject|2|||
130021165|NCT01100944|468038097|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
130021166|NCT01100944|468038098|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
130021167|NCT01100944|468038096|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
130021168|NCT01100944|468038097|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
130021169|NCT01100944|468038098|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
130021170|NCT01100944|468038096|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
130021171|NCT01100944|468038097|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
130021172|NCT01100944|468038098|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
130021173|NCT00999908|468038099|FG000|Treatment Period 1|Subject withdrew consent|2|||
130021174|NCT00999908|468038100|FG001|Treatment Period 1|Subject withdrew consent|0|||
130021175|NCT00999908|468038101|FG002|Treatment Period 1|Subject withdrew consent|0|||
130021176|NCT00999908|468038099|FG000|Treatment Period 2|Protocol Violation|1|||
130021177|NCT00999908|468038100|FG001|Treatment Period 2|Protocol Violation|0|||
130021178|NCT00999908|468038101|FG002|Treatment Period 2|Protocol Violation|0|||
130021179|NCT01543087|468038106|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
130021180|NCT01543087|468038107|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
130021181|NCT01543087|468038108|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
130021182|NCT01543087|468038109|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
130021183|NCT01543087|468038110|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
130021184|NCT01543087|468038111|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
130021185|NCT01543087|468038106|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
130021186|NCT01543087|468038107|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
130021187|NCT01543087|468038108|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
130021188|NCT01543087|468038109|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
130021189|NCT01543087|468038110|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
130021190|NCT01543087|468038111|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
130021191|NCT01543087|468038106|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
130021192|NCT01543087|468038107|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
130021193|NCT01543087|468038108|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
130021194|NCT01543087|468038109|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
130021195|NCT01543087|468038110|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
130021196|NCT01543087|468038111|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
130021197|NCT01543087|468038106|FG000|Stage 1 (48 Months)|Other than specified|5|||
130021198|NCT01543087|468038107|FG001|Stage 1 (48 Months)|Other than specified|0|||
130021199|NCT01543087|468038108|FG002|Stage 1 (48 Months)|Other than specified|9|||
130021200|NCT01543087|468038109|FG003|Stage 1 (48 Months)|Other than specified|0|||
130021201|NCT01543087|468038110|FG004|Stage 1 (48 Months)|Other than specified|0|||
130021202|NCT01543087|468038111|FG005|Stage 1 (48 Months)|Other than specified|0|||
130021203|NCT01543087|468038106|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
130021204|NCT01543087|468038107|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
130021205|NCT01543087|468038108|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
130021206|NCT01543087|468038109|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
130021207|NCT01543087|468038110|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
130021208|NCT01543087|468038111|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
130021209|NCT01543087|468038106|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130099120|NCT01646268|468320898|FG001|Overall Study|Withdrawal by Subject|5|||
130021210|NCT01543087|468038107|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
130021211|NCT01543087|468038108|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130021212|NCT01543087|468038109|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130021213|NCT01543087|468038110|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
130021214|NCT01543087|468038111|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
130021215|NCT01543087|468038106|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
130021216|NCT01543087|468038107|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
130021217|NCT01543087|468038108|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
130021218|NCT01543087|468038109|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
130021219|NCT01543087|468038110|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
130021220|NCT01543087|468038111|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
130021221|NCT00706030|468038112|FG000|Overall Study|Disease Progression|4|||
130021222|NCT00706030|468038113|FG001|Overall Study|Disease Progression|6|||
130021223|NCT00706030|468038114|FG002|Overall Study|Disease Progression|46|||
130021224|NCT00706030|468038115|FG003|Overall Study|Disease Progression|12|||
130021225|NCT00706030|468038112|FG000|Overall Study|Adverse Event|1|||
130021226|NCT00706030|468038113|FG001|Overall Study|Adverse Event|0|||
130021227|NCT00706030|468038114|FG002|Overall Study|Adverse Event|4|||
130021228|NCT00706030|468038115|FG003|Overall Study|Adverse Event|2|||
130021229|NCT00706030|468038112|FG000|Overall Study|Withdrawal by Subject|1|||
130021230|NCT00706030|468038113|FG001|Overall Study|Withdrawal by Subject|0|||
130021231|NCT00706030|468038114|FG002|Overall Study|Withdrawal by Subject|2|||
130021232|NCT00706030|468038115|FG003|Overall Study|Withdrawal by Subject|0|||
130021233|NCT00706030|468038112|FG000|Overall Study|Physician Decision|0|||
130021234|NCT00706030|468038113|FG001|Overall Study|Physician Decision|0|||
130021235|NCT00706030|468038114|FG002|Overall Study|Physician Decision|2|||
130021236|NCT00706030|468038115|FG003|Overall Study|Physician Decision|0|||
130021237|NCT00706030|468038112|FG000|Overall Study|Not recorded|0|||
130021238|NCT00706030|468038113|FG001|Overall Study|Not recorded|0|||
130021239|NCT00706030|468038114|FG002|Overall Study|Not recorded|2|||
130021240|NCT00706030|468038115|FG003|Overall Study|Not recorded|0|||
130021241|NCT00706030|468038112|FG000|Overall Study|Protocol Violation|0|||
130021242|NCT00706030|468038113|FG001|Overall Study|Protocol Violation|0|||
130021243|NCT00706030|468038114|FG002|Overall Study|Protocol Violation|1|||
130021244|NCT00706030|468038115|FG003|Overall Study|Protocol Violation|1|||
130021245|NCT00706030|468038112|FG000|Overall Study|Failed to return|0|||
130021246|NCT00706030|468038113|FG001|Overall Study|Failed to return|0|||
130021247|NCT00706030|468038114|FG002|Overall Study|Failed to return|1|||
130021248|NCT00706030|468038115|FG003|Overall Study|Failed to return|0|||
130021249|NCT00706030|468038112|FG000|Overall Study|Symptomatic Deterioration|0|||
130021250|NCT00706030|468038113|FG001|Overall Study|Symptomatic Deterioration|0|||
130021251|NCT00706030|468038114|FG002|Overall Study|Symptomatic Deterioration|1|||
130021252|NCT00706030|468038115|FG003|Overall Study|Symptomatic Deterioration|0|||
130021253|NCT00706030|468038112|FG000|Overall Study|No treatment received|0|||
130021254|NCT00706030|468038113|FG001|Overall Study|No treatment received|0|||
130021255|NCT00706030|468038114|FG002|Overall Study|No treatment received|0|||
130021256|NCT00706030|468038115|FG003|Overall Study|No treatment received|1|||
130021257|NCT00706030|468038112|FG000|Overall Study|Death|0|||
130021258|NCT00706030|468038113|FG001|Overall Study|Death|0|||
130021259|NCT00706030|468038114|FG002|Overall Study|Death|1|||
130021260|NCT00706030|468038115|FG003|Overall Study|Death|0|||
130021261|NCT05779072|468038117|FG000|Overall Study|Lost to Follow-up|0|||
130021262|NCT05779072|468038118|FG001|Overall Study|Lost to Follow-up|1|||
130021263|NCT05779072|468038117|FG000|Overall Study|Withdrawal by Subject|1|||
130021264|NCT05779072|468038118|FG001|Overall Study|Withdrawal by Subject|5|||
130021265|NCT03870555|468038119|FG000|Period 3 (2 Days)|Adverse Event|1|||
130021266|NCT03870555|468038120|FG001|Period 3 (2 Days)|Adverse Event|0|||
130021267|NCT03870555|468038121|FG002|Period 3 (2 Days)|Adverse Event|0|||
130021268|NCT03694925|468038122|FG000|Overall Study|Inadequate laboratory testing|0|||
130099121|NCT01646268|468320897|FG000|Overall Study|Other|2|||
130099122|NCT01646268|468320898|FG001|Overall Study|Other|0|||
130099123|NCT01519635|468320903|FG000|Overall Study|Withdrawal by Subject|0|||
130099124|NCT01519635|468320904|FG001|Overall Study|Withdrawal by Subject|1|||
130099125|NCT01519635|468320903|FG000|Overall Study|No possibility to put a catheter|1|||
130099126|NCT01519635|468320904|FG001|Overall Study|No possibility to put a catheter|2|||
130099127|NCT02325414|468320905|FG000|Overall Study|Withdrawal by Subject|3|||
130021269|NCT03694925|468038123|FG001|Overall Study|Inadequate laboratory testing|3|||
130021270|NCT03694925|468038124|FG002|Overall Study|Inadequate laboratory testing|0|||
130021271|NCT02301403|468038130|FG000|Overall Study|Withdrawal by Subject|28|||
130021272|NCT02301403|468038131|FG001|Overall Study|Withdrawal by Subject|41|||
130021273|NCT00730639|468038132|FG000|Overall Study|Adverse Event|3|||
130021274|NCT00730639|468038133|FG001|Overall Study|Adverse Event|0|||
130021275|NCT00730639|468038134|FG002|Overall Study|Adverse Event|9|||
130021276|NCT00730639|468038135|FG003|Overall Study|Adverse Event|8|||
130021277|NCT00730639|468038136|FG004|Overall Study|Adverse Event|23|||
130021278|NCT00730639|468038132|FG000|Overall Study|Complete Response|0|||
130021279|NCT00730639|468038133|FG001|Overall Study|Complete Response|0|||
129884507|NCT02293837|467536435|FG003|Overall Study|Withdrawal by Subject|1|||
130021280|NCT00730639|468038134|FG002|Overall Study|Complete Response|2|||
130021281|NCT00730639|468038135|FG003|Overall Study|Complete Response|2|||
130021282|NCT00730639|468038136|FG004|Overall Study|Complete Response|1|||
130021283|NCT00730639|468038132|FG000|Overall Study|Completed Maximum Cycles|0|||
130021284|NCT00730639|468038133|FG001|Overall Study|Completed Maximum Cycles|0|||
130021285|NCT00730639|468038134|FG002|Overall Study|Completed Maximum Cycles|11|||
130021286|NCT00730639|468038135|FG003|Overall Study|Completed Maximum Cycles|3|||
130021287|NCT00730639|468038136|FG004|Overall Study|Completed Maximum Cycles|6|||
130021288|NCT00730639|468038132|FG000|Overall Study|Death|0|||
130021289|NCT00730639|468038133|FG001|Overall Study|Death|0|||
130021290|NCT00730639|468038134|FG002|Overall Study|Death|0|||
130021291|NCT00730639|468038135|FG003|Overall Study|Death|0|||
130021292|NCT00730639|468038136|FG004|Overall Study|Death|2|||
130021293|NCT00730639|468038132|FG000|Overall Study|Disease Progression|12|||
130021294|NCT00730639|468038133|FG001|Overall Study|Disease Progression|13|||
130021295|NCT00730639|468038134|FG002|Overall Study|Disease Progression|48|||
130021296|NCT00730639|468038135|FG003|Overall Study|Disease Progression|32|||
130021297|NCT00730639|468038136|FG004|Overall Study|Disease Progression|88|||
130021298|NCT00730639|468038132|FG000|Overall Study|non-specified|0|||
130021299|NCT00730639|468038133|FG001|Overall Study|non-specified|0|||
130021300|NCT00730639|468038134|FG002|Overall Study|non-specified|4|||
130021301|NCT00730639|468038135|FG003|Overall Study|non-specified|2|||
130021302|NCT00730639|468038136|FG004|Overall Study|non-specified|3|||
130021303|NCT00730639|468038132|FG000|Overall Study|Protocol Violation|0|||
130021304|NCT00730639|468038133|FG001|Overall Study|Protocol Violation|0|||
130021305|NCT00730639|468038134|FG002|Overall Study|Protocol Violation|1|||
130021306|NCT00730639|468038135|FG003|Overall Study|Protocol Violation|0|||
130021307|NCT00730639|468038136|FG004|Overall Study|Protocol Violation|0|||
130021308|NCT00730639|468038132|FG000|Overall Study|Withdrawal by Subject|0|||
130021309|NCT00730639|468038133|FG001|Overall Study|Withdrawal by Subject|0|||
130021310|NCT00730639|468038134|FG002|Overall Study|Withdrawal by Subject|6|||
130021311|NCT00730639|468038135|FG003|Overall Study|Withdrawal by Subject|3|||
130021312|NCT00730639|468038136|FG004|Overall Study|Withdrawal by Subject|4|||
130021313|NCT00730639|468038132|FG000|Overall Study|Treatment on-going|2|||
130021314|NCT00730639|468038133|FG001|Overall Study|Treatment on-going|5|||
130021315|NCT00730639|468038134|FG002|Overall Study|Treatment on-going|5|||
130021316|NCT00730639|468038135|FG003|Overall Study|Treatment on-going|4|||
130021317|NCT00730639|468038136|FG004|Overall Study|Treatment on-going|4|||
130021318|NCT02665286|468038137|FG000|Overall Study|Lost to Follow-up|3|||
130021319|NCT02665286|468038138|FG001|Overall Study|Lost to Follow-up|2|||
130021320|NCT02665286|468038139|FG002|Overall Study|Lost to Follow-up|1|||
130021321|NCT03064841|468038140|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
130021322|NCT03064841|468038140|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
130021323|NCT03064841|468038140|FG000|Overall Study|Screen failure|2|||
130021324|NCT03434977|468038141|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
130021325|NCT03434977|468038142|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
130021326|NCT00217087|468038143|FG000|Overall Study|decided to have esophagectomy|1|||
130021327|NCT00217087|468038144|FG001|Overall Study|decided to have esophagectomy|2|||
130021328|NCT00217087|468038143|FG000|Overall Study|completed less than 12 months return|10|||
130021329|NCT00217087|468038144|FG001|Overall Study|completed less than 12 months return|18|||
130021330|NCT03920670|468038145|FG000|Overall Study|Protocol Violation|2|||
130021331|NCT03920670|468038146|FG001|Overall Study|Protocol Violation|2|||
130021332|NCT03920670|468038145|FG000|Overall Study|Adverse Event|1|||
130021333|NCT03920670|468038146|FG001|Overall Study|Adverse Event|0|||
130021334|NCT03208231|468038152|FG000|Overall Study|Death|1|||
130021335|NCT03208231|468038153|FG001|Overall Study|Death|2|||
130021336|NCT03208231|468038152|FG000|Overall Study|Moved and unable to get to clinic|1|||
130021337|NCT03208231|468038153|FG001|Overall Study|Moved and unable to get to clinic|0|||
130021338|NCT03208231|468038152|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
130021339|NCT03208231|468038153|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
130021340|NCT04347239|468038167|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
130021341|NCT04347239|468038168|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
130021342|NCT04347239|468038169|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
130021343|NCT04347239|468038167|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
130021344|NCT04347239|468038168|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
130021345|NCT04347239|468038169|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
130021346|NCT02270242|468038171|FG000|Overall Study|Withdrawal by Subject|18|||
130021347|NCT02270242|468038172|FG001|Overall Study|Withdrawal by Subject|25|||
130021348|NCT02270242|468038171|FG000|Overall Study|Lost to Follow-up|41|||
130021349|NCT02270242|468038172|FG001|Overall Study|Lost to Follow-up|27|||
130021350|NCT02270242|468038171|FG000|Overall Study|Physician Decision|0|||
130021351|NCT02270242|468038172|FG001|Overall Study|Physician Decision|1|||
130021352|NCT02321436|468038173|FG000|Overall Study|Withdrawal by Subject|1|||
130021353|NCT02321436|468038174|FG001|Overall Study|Withdrawal by Subject|0|||
130021354|NCT02321436|468038173|FG000|Overall Study|Lost to Follow-up|0|||
130021355|NCT02321436|468038174|FG001|Overall Study|Lost to Follow-up|1|||
130021356|NCT03355300|468038175|FG000|Overall Study|Physician Decision|0|||
130021357|NCT03355300|468038176|FG001|Overall Study|Physician Decision|1|||
130021358|NCT03355300|468038175|FG000|Overall Study|Lack of Efficacy|2|||
130021359|NCT03355300|468038176|FG001|Overall Study|Lack of Efficacy|1|||
130021360|NCT03355300|468038175|FG000|Overall Study|Other reason|1|||
130021361|NCT03355300|468038176|FG001|Overall Study|Other reason|0|||
130021362|NCT03048422|468038177|FG000|Overall Study|Death|1|||
130021363|NCT03048422|468038178|FG001|Overall Study|Death|0|||
130021364|NCT03048422|468038179|FG002|Overall Study|Death|0|||
130021365|NCT03048422|468038177|FG000|Overall Study|Lost to Follow-up|5|||
130225114|NCT00549549|468788081|FG002|Overall Study|Randomized but not treated|1|||
130225115|NCT00549549|468788082|FG003|Overall Study|Randomized but not treated|1|||
130099128|NCT02325414|468320906|FG001|Overall Study|Withdrawal by Subject|1|||
130099129|NCT02325414|468320905|FG000|Overall Study|Lost to Follow-up|5|||
130021366|NCT03048422|468038178|FG001|Overall Study|Lost to Follow-up|0|||
130021367|NCT03048422|468038179|FG002|Overall Study|Lost to Follow-up|1|||
130021368|NCT03048422|468038177|FG000|Overall Study|Withdrawal by Subject|5|||
130021369|NCT03048422|468038178|FG001|Overall Study|Withdrawal by Subject|7|||
130021370|NCT03048422|468038179|FG002|Overall Study|Withdrawal by Subject|4|||
130021371|NCT03048422|468038177|FG000|Overall Study|Moved|3|||
130021372|NCT03048422|468038178|FG001|Overall Study|Moved|2|||
130021373|NCT03048422|468038179|FG002|Overall Study|Moved|2|||
130021374|NCT03048422|468038177|FG000|Overall Study|Noncompliant with Study Requirements|2|||
130021375|NCT03048422|468038178|FG001|Overall Study|Noncompliant with Study Requirements|1|||
130021376|NCT03048422|468038179|FG002|Overall Study|Noncompliant with Study Requirements|2|||
130021377|NCT03048422|468038177|FG000|Overall Study|Not Able to Get to Clinic|1|||
130021378|NCT03048422|468038178|FG001|Overall Study|Not Able to Get to Clinic|0|||
130021379|NCT03048422|468038179|FG002|Overall Study|Not Able to Get to Clinic|0|||
130021380|NCT03266016|468040553|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
130021381|NCT03266016|468040554|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130021382|NCT03266016|468040555|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130021383|NCT03266016|468040556|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
130021384|NCT03266016|468040553|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
130021385|NCT03266016|468040554|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
130021386|NCT03266016|468040555|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
130021387|NCT03266016|468040556|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
130021388|NCT01241708|468040557|FG000|Overall Study|Withdrawal by Subject|6|||
130021389|NCT01241708|468040557|FG000|Overall Study|Screen Failure|6|||
130099130|NCT02325414|468320906|FG001|Overall Study|Lost to Follow-up|5|||
130099131|NCT00347776|468320907|FG000|1.5 Month Follow-up|Death|2|||
130099132|NCT00347776|468320908|FG001|1.5 Month Follow-up|Death|0|||
130099133|NCT00347776|468320909|FG002|1.5 Month Follow-up|Death|0|||
130099134|NCT00347776|468320907|FG000|1.5 Month Follow-up|reached the endpoint|12|||
130099135|NCT00347776|468320908|FG001|1.5 Month Follow-up|reached the endpoint|8|||
130099136|NCT00347776|468320909|FG002|1.5 Month Follow-up|reached the endpoint|12|||
130099137|NCT00347776|468320907|FG000|6 Month Follow-up|Death|2|||
130021390|NCT01241708|468040557|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
130021391|NCT01241708|468040557|FG000|Overall Study|Lost to Follow-up|5|||
130021392|NCT04137887|468040558|FG000|Overall Study|Death|102|||
130021393|NCT04137887|468040559|FG001|Overall Study|Death|92|||
130021394|NCT04137887|468040558|FG000|Overall Study|Withdrawal by Subject|2|||
130021395|NCT04137887|468040559|FG001|Overall Study|Withdrawal by Subject|3|||
130021396|NCT04137887|468040558|FG000|Overall Study|Randomized but not treated|0|||
130021397|NCT04137887|468040559|FG001|Overall Study|Randomized but not treated|1|||
130021398|NCT04183335|468040560|FG000|Overall Study|Adverse Event|1|||
130021399|NCT04183335|468040561|FG001|Overall Study|Adverse Event|0|||
130021400|NCT04183335|468040560|FG000|Overall Study|Withdrawal by Subject|12|||
130021401|NCT04183335|468040561|FG001|Overall Study|Withdrawal by Subject|3|||
130021402|NCT01268293|468040569|FG000|Overall Study|Disease progression|7|||
130021403|NCT01268293|468040569|FG000|Overall Study|Adverse Event|1|||
130021404|NCT01268293|468040569|FG000|Overall Study|Subject choice|1|||
130021405|NCT01396005|468040574|FG000|Overall Study|Withdrawal by Subject|0|||
130021406|NCT01396005|468040575|FG001|Overall Study|Withdrawal by Subject|1|||
130021407|NCT01396005|468040574|FG000|Overall Study|Non-compliance with protocol|0|||
130021408|NCT01396005|468040575|FG001|Overall Study|Non-compliance with protocol|1|||
130021409|NCT03823391|468040576|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
130021410|NCT03823391|468040577|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
130021411|NCT03823391|468040576|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
130021412|NCT03823391|468040577|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
130021413|NCT05689047|468040578|FG000|Overall Study|Lost to Follow-up|0|||
130021414|NCT05689047|468040579|FG001|Overall Study|Lost to Follow-up|1|||
130021415|NCT05689047|468040578|FG000|Overall Study|Protocol Deviation|1|||
130099138|NCT00347776|468320908|FG001|6 Month Follow-up|Death|1|||
130099139|NCT00347776|468320909|FG002|6 Month Follow-up|Death|3|||
130021416|NCT05689047|468040579|FG001|Overall Study|Protocol Deviation|0|||
130021417|NCT03286842|468040580|FG000|Overall Study|Patients rolled over to another study|80|||
130021418|NCT03178487|468040581|FG000|Period 1|Adverse Event|1|||
130021419|NCT03178487|468040582|FG001|Period 1|Adverse Event|2|||
130099140|NCT00347776|468320907|FG000|6 Month Follow-up|reached endpont|20|||
130225116|NCT02155699|468788083|FG000|Overall Study|Withdrawal by Subject|0|||
130021420|NCT03178487|468040581|FG000|Period 1|Withdrawal by Subject|2|||
130021421|NCT03178487|468040582|FG001|Period 1|Withdrawal by Subject|1|||
130021422|NCT03178487|468040581|FG000|Period 1|Lost to Follow-up|1|||
130021423|NCT03178487|468040582|FG001|Period 1|Lost to Follow-up|0|||
130021424|NCT03178487|468040581|FG000|Period 1|Other|0|||
130021425|NCT03178487|468040582|FG001|Period 1|Other|1|||
130099141|NCT00347776|468320908|FG001|6 Month Follow-up|reached endpont|12|||
130225117|NCT02155699|468788084|FG001|Overall Study|Withdrawal by Subject|3|||
130225118|NCT02155699|468788085|FG002|Overall Study|Withdrawal by Subject|6|||
130225119|NCT02155699|468788086|FG003|Overall Study|Withdrawal by Subject|1|||
130225120|NCT02155699|468788083|FG000|Overall Study|Lost to Follow-up|0|||
130225121|NCT02155699|468788084|FG001|Overall Study|Lost to Follow-up|0|||
130225122|NCT02155699|468788085|FG002|Overall Study|Lost to Follow-up|0|||
130225123|NCT02155699|468788086|FG003|Overall Study|Lost to Follow-up|3|||
130225124|NCT02155699|468788083|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
130225125|NCT02155699|468788084|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
130225126|NCT02155699|468788085|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
130225127|NCT02155699|468788086|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
130225128|NCT02227784|468788087|FG000|Double-Blind Phase|Adverse Event|3|||
130225129|NCT02227784|468788088|FG001|Double-Blind Phase|Adverse Event|2|||
130225130|NCT02227784|468788089|FG002|Double-Blind Phase|Adverse Event|1|||
130225131|NCT02227784|468788090|FG003|Double-Blind Phase|Adverse Event|3|||
130225132|NCT02227784|468788091|FG004|Double-Blind Phase|Adverse Event|0|||
130225133|NCT02227784|468788087|FG000|Double-Blind Phase|Physician Decision|1|||
130225134|NCT02227784|468788088|FG001|Double-Blind Phase|Physician Decision|0|||
130225135|NCT02227784|468788089|FG002|Double-Blind Phase|Physician Decision|0|||
130225136|NCT02227784|468788090|FG003|Double-Blind Phase|Physician Decision|1|||
130225137|NCT02227784|468788091|FG004|Double-Blind Phase|Physician Decision|0|||
130225138|NCT02227784|468788087|FG000|Double-Blind Phase|Protocol Violation|0|||
130225139|NCT02227784|468788088|FG001|Double-Blind Phase|Protocol Violation|0|||
130225140|NCT02227784|468788089|FG002|Double-Blind Phase|Protocol Violation|1|||
130225141|NCT02227784|468788090|FG003|Double-Blind Phase|Protocol Violation|1|||
130225142|NCT02227784|468788091|FG004|Double-Blind Phase|Protocol Violation|0|||
130021426|NCT03178487|468040581|FG000|Period 2|Adverse Event|4|||
130021427|NCT03178487|468040582|FG001|Period 2|Adverse Event|4|||
130021428|NCT03178487|468040581|FG000|Period 2|Withdrawal by Subject|6|||
130021429|NCT03178487|468040582|FG001|Period 2|Withdrawal by Subject|6|||
130021430|NCT03178487|468040581|FG000|Period 2|Lost to Follow-up|2|||
130225143|NCT02227784|468788087|FG000|Double-Blind Phase|Sponsor Decision|34|||
130225144|NCT02227784|468788088|FG001|Double-Blind Phase|Sponsor Decision|15|||
130225145|NCT02227784|468788089|FG002|Double-Blind Phase|Sponsor Decision|14|||
130225146|NCT02227784|468788090|FG003|Double-Blind Phase|Sponsor Decision|32|||
130225147|NCT02227784|468788091|FG004|Double-Blind Phase|Sponsor Decision|0|||
130225148|NCT02227784|468788087|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130225149|NCT02227784|468788088|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130225150|NCT02227784|468788089|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
130225151|NCT02227784|468788090|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
130225152|NCT02227784|468788091|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130225153|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130225154|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130021431|NCT03178487|468040582|FG001|Period 2|Lost to Follow-up|2|||
130021432|NCT03178487|468040581|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
130021433|NCT03178487|468040582|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
130021434|NCT03178487|468040581|FG000|Period 2|Other|8|||
130021435|NCT03178487|468040582|FG001|Period 2|Other|7|||
130021436|NCT01453855|468040583|FG000|Overall Study|Adverse Event|3|||
130021437|NCT01453855|468040584|FG001|Overall Study|Adverse Event|4|||
130021438|NCT01453855|468040583|FG000|Overall Study|Lost to Follow-up|2|||
130021439|NCT01453855|468040584|FG001|Overall Study|Lost to Follow-up|1|||
130021440|NCT01453855|468040583|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
130021441|NCT01453855|468040584|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
130021442|NCT01453855|468040583|FG000|Overall Study|Noncompliance|1|||
130021443|NCT01453855|468040584|FG001|Overall Study|Noncompliance|0|||
130021444|NCT01453855|468040583|FG000|Overall Study|Inadequate Control of IOP|1|||
130021445|NCT01453855|468040584|FG001|Overall Study|Inadequate Control of IOP|5|||
130021446|NCT01453855|468040583|FG000|Overall Study|Other|0|||
130021447|NCT01453855|468040584|FG001|Overall Study|Other|1|||
130021448|NCT01562548|468040587|FG000|Overall Study|Lost to Follow-up|0|||
130021449|NCT01562548|468040588|FG001|Overall Study|Lost to Follow-up|0|||
130021450|NCT01562548|468040589|FG002|Overall Study|Lost to Follow-up|1|||
130021451|NCT01562548|468040590|FG003|Overall Study|Lost to Follow-up|0|||
130021452|NCT01496066|468040591|FG000|Overall Study|Lost to Follow-up|8|||
130021453|NCT01496066|468040592|FG001|Overall Study|Lost to Follow-up|5|||
130021454|NCT01496066|468040591|FG000|Overall Study|Explant|3|||
130021455|NCT01496066|468040592|FG001|Overall Study|Explant|0|||
130225155|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130225156|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
130225157|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
130225158|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Death|0|||
130225159|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Death|0|||
130225160|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Death|0|||
130225161|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Death|0|||
130225162|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Death|1|||
130225163|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225164|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225165|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225166|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130225167|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
130225168|NCT02227784|468788087|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225169|NCT02227784|468788088|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225170|NCT02227784|468788089|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225171|NCT02227784|468788090|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
130225172|NCT02227784|468788091|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
130225173|NCT02688933|468788096|FG000|Overall Study|Adverse Event|3|||
130225174|NCT02688933|468788097|FG001|Overall Study|Adverse Event|1|||
130225175|NCT02688933|468788096|FG000|Overall Study|Lack of Efficacy|2|||
130225176|NCT02688933|468788097|FG001|Overall Study|Lack of Efficacy|2|||
130225177|NCT02688933|468788096|FG000|Overall Study|Poor compliance to protocol|7|||
130225178|NCT02688933|468788097|FG001|Overall Study|Poor compliance to protocol|4|||
130225179|NCT02688933|468788096|FG000|Overall Study|Hypoglycemia|2|||
130225180|NCT02688933|468788097|FG001|Overall Study|Hypoglycemia|0|||
130225181|NCT02688933|468788096|FG000|Overall Study|Other than Specified|14|||
130225182|NCT02688933|468788097|FG001|Overall Study|Other than Specified|25|||
130225183|NCT02688933|468788096|FG000|Overall Study|Lost to Follow-up|1|||
130225184|NCT02688933|468788097|FG001|Overall Study|Lost to Follow-up|5|||
130225185|NCT00248651|468788098|FG000|Overall Study|Withdrawal by Subject|28|||
130225186|NCT00248651|468788099|FG001|Overall Study|Withdrawal by Subject|40|||
130225187|NCT00248651|468788100|FG002|Overall Study|Withdrawal by Subject|32|||
130225188|NCT01275144|468788101|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
130225189|NCT01275144|468788102|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
130225190|NCT00828113|468788103|FG000|Overall Study|Withdrawal by Subject|27|||
130225191|NCT00828113|468788104|FG001|Overall Study|Withdrawal by Subject|26|||
130225192|NCT00828113|468788103|FG000|Overall Study|Lost to Follow-up|3|||
130225193|NCT00828113|468788104|FG001|Overall Study|Lost to Follow-up|5|||
130225194|NCT05607576|468788105|FG000|Overall Study|immediate sensor error|2|||
130225195|NCT05607576|468788105|FG000|Overall Study|Physician Decision|2|||
130225196|NCT01091246|468788106|FG000|Overall Study|Lost to Follow-up|23|||
130225197|NCT01091246|468788107|FG001|Overall Study|Lost to Follow-up|11|||
130021456|NCT01496066|468040591|FG000|Overall Study|Death|1|||
130225198|NCT01091246|468788108|FG002|Overall Study|Lost to Follow-up|7|||
130225199|NCT01091246|468788106|FG000|Overall Study|Adverse Event|1|||
130225200|NCT01091246|468788107|FG001|Overall Study|Adverse Event|0|||
130225201|NCT01091246|468788108|FG002|Overall Study|Adverse Event|1|||
130225202|NCT01091246|468788106|FG000|Overall Study|Withdrawal by Subject|9|||
130225203|NCT01091246|468788107|FG001|Overall Study|Withdrawal by Subject|5|||
130225204|NCT01091246|468788108|FG002|Overall Study|Withdrawal by Subject|4|||
130225205|NCT01091246|468788106|FG000|Overall Study|Subject not dosed|2|||
130021457|NCT01496066|468040592|FG001|Overall Study|Death|4|||
130021458|NCT03237065|468040593|FG000|Overall Study|Adverse Event|0|||
130021459|NCT03237065|468040594|FG001|Overall Study|Adverse Event|2|||
130021460|NCT03237065|468040593|FG000|Overall Study|Protocol Violation|0|||
130021461|NCT03237065|468040594|FG001|Overall Study|Protocol Violation|1|||
130021462|NCT03237065|468040593|FG000|Overall Study|Withdrawal by Subject|3|||
130021463|NCT03237065|468040594|FG001|Overall Study|Withdrawal by Subject|0|||
130021464|NCT03237065|468040593|FG000|Overall Study|Lost to Follow-up|1|||
130021465|NCT03237065|468040594|FG001|Overall Study|Lost to Follow-up|0|||
130021466|NCT03237065|468040593|FG000|Overall Study|Unable to obtain venous access|0|||
130021467|NCT03237065|468040594|FG001|Overall Study|Unable to obtain venous access|1|||
130021468|NCT00209339|468040595|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
130021469|NCT00209339|468040595|FG000|At 12 Months Follow-up|Death|1|||
130021470|NCT00209339|468040595|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
130021471|NCT00209339|468040595|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
130021472|NCT00209339|468040595|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
130021473|NCT00209339|468040595|FG000|At 24 Months Follow-up|Death|1|||
130021474|NCT00209339|468040595|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
130021475|NCT00209339|468040595|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
130021476|NCT00209339|468040595|FG000|At 4 Years Follow-up|Death|1|||
130021477|NCT00209339|468040595|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
130021478|NCT00209339|468040595|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
130021479|NCT00209339|468040595|FG000|At 5 Years Follow-up|Death|1|||
130021480|NCT01587079|468040596|FG000|Overall Study|Protocol-specified criteria|9|||
130021481|NCT01587079|468040596|FG000|Overall Study|Protocol Violation|5|||
130021482|NCT01587079|468040596|FG000|Overall Study|Lost to Follow-up|2|||
130021483|NCT01587079|468040596|FG000|Overall Study|Physician Decision|2|||
130021484|NCT01587079|468040596|FG000|Overall Study|Withdrawal by Subject|7|||
130225206|NCT01091246|468788107|FG001|Overall Study|Subject not dosed|0|||
130225207|NCT01091246|468788108|FG002|Overall Study|Subject not dosed|1|||
130225208|NCT02700048|468788111|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
130225209|NCT02700048|468788112|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
130225210|NCT02175225|468788113|FG000|Overall Study|Withdrawal by Subject|1|||
130225211|NCT02175225|468788114|FG001|Overall Study|Withdrawal by Subject|2|||
130225212|NCT02175225|468788113|FG000|Overall Study|Lost to Follow-up|6|||
130225213|NCT02175225|468788114|FG001|Overall Study|Lost to Follow-up|7|||
130225214|NCT02175225|468788113|FG000|Overall Study|Study drug not administered|1|||
130225215|NCT02175225|468788114|FG001|Overall Study|Study drug not administered|2|||
130225216|NCT02668640|468788115|FG000|Overall Study|Lost to Follow-up|13|||
130225217|NCT02668640|468788115|FG000|Overall Study|Other, not specified|1|||
130225218|NCT04877990|468788116|FG000|Treatment|Other reasons|3|||
130225219|NCT04877990|468788117|FG001|Treatment|Other reasons|1|||
130225220|NCT04877990|468788116|FG000|Treatment|Administrative reasons by sponsor|17|||
130225221|NCT04877990|468788117|FG001|Treatment|Administrative reasons by sponsor|33|||
130225222|NCT04877990|468788116|FG000|Treatment|Withdrawal by Subject|2|||
130225223|NCT04877990|468788117|FG001|Treatment|Withdrawal by Subject|6|||
130225224|NCT04877990|468788116|FG000|Treatment|Adverse Event|2|||
130225225|NCT04877990|468788117|FG001|Treatment|Adverse Event|1|||
130225226|NCT01121263|468788118|FG000|Overall Study|Death|3|||
130225227|NCT01121263|468788119|FG001|Overall Study|Death|2|||
130225228|NCT01121263|468788118|FG000|Overall Study|Lost to Follow-up|22|||
130225229|NCT01121263|468788119|FG001|Overall Study|Lost to Follow-up|12|||
130225230|NCT01121263|468788118|FG000|Overall Study|Withdrawal by Subject|0|||
130225231|NCT01121263|468788119|FG001|Overall Study|Withdrawal by Subject|1|||
130225232|NCT02007720|468788120|FG000|Overall Study|Withdrawal by Subject|9|||
130225233|NCT02007720|468788121|FG001|Overall Study|Withdrawal by Subject|11|||
130225234|NCT02007720|468788120|FG000|Overall Study|study terminated by sponsor|58|||
130225235|NCT02007720|468788121|FG001|Overall Study|study terminated by sponsor|54|||
130021485|NCT01587079|468040596|FG000|Overall Study|Adverse Event|14|||
130021486|NCT01764633|468040597|FG000|Overall Study|Withdrawal by Subject|105|||
130021487|NCT01764633|468040598|FG001|Overall Study|Withdrawal by Subject|88|||
130021488|NCT01764633|468040597|FG000|Overall Study|Lost to Follow-up|13|||
130021489|NCT01764633|468040598|FG001|Overall Study|Lost to Follow-up|5|||
130021490|NCT02268058|468040599|FG000|Overall Study|Protocol Violation|1|||
130225236|NCT02007720|468788120|FG000|Overall Study|technical problem|4|||
130225237|NCT02007720|468788121|FG001|Overall Study|technical problem|2|||
130225238|NCT02007720|468788120|FG000|Overall Study|patient followd less than 165 days|11|||
130021491|NCT02268058|468040600|FG001|Overall Study|Protocol Violation|0|||
130021492|NCT02268058|468040601|FG002|Overall Study|Protocol Violation|0|||
130021493|NCT02268058|468040602|FG003|Overall Study|Protocol Violation|0|||
130021494|NCT00704964|468040608|FG000|Overall Study|Not completed on time|328|||
130021495|NCT04781816|468040609|FG000|Overall Study|Adverse Event|0|||
130225239|NCT02007720|468788121|FG001|Overall Study|patient followd less than 165 days|5|||
130021496|NCT04781816|468040610|FG001|Overall Study|Adverse Event|1|||
130021497|NCT04781816|468040609|FG000|Overall Study|Withdrawal by Subject|1|||
130021498|NCT04781816|468040610|FG001|Overall Study|Withdrawal by Subject|1|||
130225240|NCT01386606|468789891|FG000|Overall Study|Adverse Event|0|||
130225241|NCT01386606|468789892|FG001|Overall Study|Adverse Event|1|||
130225242|NCT01386606|468789893|FG002|Overall Study|Adverse Event|0|||
130225243|NCT01386606|468789894|FG003|Overall Study|Adverse Event|0|||
130225244|NCT01386606|468789891|FG000|Overall Study|Withdrawal by Subject|0|||
130225245|NCT01386606|468789892|FG001|Overall Study|Withdrawal by Subject|1|||
130225246|NCT01386606|468789893|FG002|Overall Study|Withdrawal by Subject|1|||
130225247|NCT01386606|468789894|FG003|Overall Study|Withdrawal by Subject|0|||
130225248|NCT01386606|468789891|FG000|Overall Study|Protocol Violation|1|||
130225249|NCT01386606|468789892|FG001|Overall Study|Protocol Violation|0|||
130225250|NCT01386606|468789893|FG002|Overall Study|Protocol Violation|1|||
130225251|NCT01386606|468789894|FG003|Overall Study|Protocol Violation|1|||
130225252|NCT01386606|468789891|FG000|Overall Study|Lost to Follow-up|2|||
130225253|NCT01386606|468789892|FG001|Overall Study|Lost to Follow-up|0|||
130225254|NCT01386606|468789893|FG002|Overall Study|Lost to Follow-up|0|||
130225255|NCT01386606|468789894|FG003|Overall Study|Lost to Follow-up|0|||
130225256|NCT01386606|468789891|FG000|Overall Study|Subject incarcerated|0|||
130225257|NCT01386606|468789892|FG001|Overall Study|Subject incarcerated|1|||
130225258|NCT01386606|468789893|FG002|Overall Study|Subject incarcerated|0|||
130225259|NCT01386606|468789894|FG003|Overall Study|Subject incarcerated|0|||
130225260|NCT01386606|468789891|FG000|Overall Study|Unable to draw PK|1|||
130225261|NCT01386606|468789892|FG001|Overall Study|Unable to draw PK|0|||
130225262|NCT01386606|468789893|FG002|Overall Study|Unable to draw PK|0|||
130225263|NCT01386606|468789894|FG003|Overall Study|Unable to draw PK|0|||
130225264|NCT01386606|468789891|FG000|Overall Study|T levels too high|0|||
130225265|NCT01386606|468789892|FG001|Overall Study|T levels too high|1|||
130225266|NCT01386606|468789893|FG002|Overall Study|T levels too high|1|||
130225267|NCT01386606|468789894|FG003|Overall Study|T levels too high|0|||
130225268|NCT04980014|468789895|FG000|Overall Study|Participants who are Duplicated|1|||
130225269|NCT04980014|468789895|FG000|Overall Study|Follow-up Failure|13|||
130225270|NCT04980014|468789895|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
130225271|NCT04980014|468789895|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
130225272|NCT04980014|468789895|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
130225273|NCT01965327|468789900|FG000|Overall Study|Physician Decision|2|||
130225274|NCT03964207|468789902|FG000|First Treatment|Withdrawal by Subject|1|||
130225275|NCT03964207|468789903|FG001|First Treatment|Withdrawal by Subject|2|||
130225276|NCT03964207|468789902|FG000|First Treatment|Protocol Violation|1|||
130225277|NCT03964207|468789903|FG001|First Treatment|Protocol Violation|0|||
130225278|NCT03964207|468789902|FG000|First Treatment|Lost to Follow-up|1|||
130225279|NCT03964207|468789903|FG001|First Treatment|Lost to Follow-up|0|||
130225280|NCT03964207|468789902|FG000|Second Treatment|Lost to Follow-up|0|||
130225281|NCT03964207|468789903|FG001|Second Treatment|Lost to Follow-up|1|||
130225282|NCT03964207|468789902|FG000|Second Treatment|Adverse Event|1|||
130225283|NCT03964207|468789903|FG001|Second Treatment|Adverse Event|2|||
130021499|NCT04781816|468040609|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
130099142|NCT00347776|468320909|FG002|6 Month Follow-up|reached endpont|15|||
130099143|NCT00347776|468320907|FG000|12 Month Follow-up|Lost to Follow-up|7|||
130099144|NCT00347776|468320908|FG001|12 Month Follow-up|Lost to Follow-up|6|||
130021500|NCT04781816|468040610|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
130021501|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
130021502|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
130021503|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
130021504|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
130021505|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
130021506|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
130099145|NCT00347776|468320909|FG002|12 Month Follow-up|Lost to Follow-up|6|||
130099146|NCT00347776|468320907|FG000|12 Month Follow-up|Death|3|||
130099147|NCT00347776|468320908|FG001|12 Month Follow-up|Death|4|||
130099148|NCT00347776|468320909|FG002|12 Month Follow-up|Death|4|||
130099149|NCT00347776|468320907|FG000|12 Month Follow-up|Reached endpoint|13|||
130021507|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
130099150|NCT00347776|468320908|FG001|12 Month Follow-up|Reached endpoint|6|||
130099151|NCT00347776|468320909|FG002|12 Month Follow-up|Reached endpoint|9|||
130099152|NCT00594568|468320910|FG000|Initial Treatment|Adverse Event|51|||
130099153|NCT00594568|468320911|FG001|Initial Treatment|Adverse Event|121|||
130099154|NCT00594568|468320912|FG002|Initial Treatment|Adverse Event|144|||
130099155|NCT00594568|468320910|FG000|Initial Treatment|Death|6|||
130099156|NCT00594568|468320911|FG001|Initial Treatment|Death|11|||
130099157|NCT00594568|468320912|FG002|Initial Treatment|Death|15|||
130225284|NCT01294423|468789904|FG000|Overall Study|Adverse Event|1|||
130225285|NCT01294423|468789905|FG001|Overall Study|Adverse Event|2|||
130225286|NCT01294423|468789906|FG002|Overall Study|Adverse Event|3|||
130225287|NCT01294423|468789904|FG000|Overall Study|Withdrawal by Subject|1|||
130225288|NCT01294423|468789905|FG001|Overall Study|Withdrawal by Subject|2|||
130225289|NCT01294423|468789906|FG002|Overall Study|Withdrawal by Subject|2|||
130225290|NCT01294423|468789904|FG000|Overall Study|subject no longer meets study criteria|2|||
130225291|NCT01294423|468789905|FG001|Overall Study|subject no longer meets study criteria|5|||
130099158|NCT00594568|468320910|FG000|Initial Treatment|Lost to Follow-up|4|||
130099159|NCT00594568|468320911|FG001|Initial Treatment|Lost to Follow-up|1|||
130099160|NCT00594568|468320912|FG002|Initial Treatment|Lost to Follow-up|4|||
130021508|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
130021509|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
130021510|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
130021511|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
130021512|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
130021513|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
130021514|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
130021515|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
130021516|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
130021517|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
130021518|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
130021519|NCT04418765|468040611|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
130021520|NCT04418765|468040612|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
130021521|NCT04418765|468040613|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
130021522|NCT04418765|468040611|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
130021523|NCT04418765|468040612|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
130021524|NCT04418765|468040613|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
130021525|NCT04418765|468040611|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
130021526|NCT04418765|468040612|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
130021527|NCT04418765|468040613|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
130021528|NCT04418765|468040611|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
130021529|NCT04418765|468040612|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
130021530|NCT04418765|468040613|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
130021531|NCT04418765|468040611|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
130021532|NCT04418765|468040612|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
130021533|NCT04418765|468040613|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
130021534|NCT04418765|468040611|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
130021535|NCT04418765|468040612|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
130021536|NCT04418765|468040613|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
130021537|NCT04418765|468040611|FG000|Extension Period (48 Weeks)|Other than specified|0|||
130021538|NCT04418765|468040612|FG001|Extension Period (48 Weeks)|Other than specified|5|||
130021539|NCT04418765|468040613|FG002|Extension Period (48 Weeks)|Other than specified|2|||
130021540|NCT01789970|468040614|FG000|Open-label Titration Period|Adverse Event|68|||
130021541|NCT01789970|468040615|FG001|Open-label Titration Period|Adverse Event|0|||
130021542|NCT01789970|468040616|FG002|Open-label Titration Period|Adverse Event|0|||
130021543|NCT01789970|468040614|FG000|Open-label Titration Period|Lack of Efficacy|31|||
130021544|NCT01789970|468040615|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130021545|NCT01789970|468040616|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130021546|NCT01789970|468040614|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
130021547|NCT01789970|468040615|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130021548|NCT01789970|468040616|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130021549|NCT01789970|468040614|FG000|Open-label Titration Period|Protocol Violation|18|||
130021550|NCT01789970|468040615|FG001|Open-label Titration Period|Protocol Violation|0|||
130021551|NCT01789970|468040616|FG002|Open-label Titration Period|Protocol Violation|0|||
130021552|NCT01789970|468040614|FG000|Open-label Titration Period|Lost to Follow-up|5|||
130021553|NCT01789970|468040615|FG001|Open-label Titration Period|Lost to Follow-up|0|||
130021554|NCT01789970|468040616|FG002|Open-label Titration Period|Lost to Follow-up|0|||
130021555|NCT01789970|468040614|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
130021556|NCT01789970|468040615|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
130021557|NCT01789970|468040616|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
130021558|NCT01789970|468040614|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
130021559|NCT01789970|468040615|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
130021560|NCT01789970|468040616|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
130021561|NCT01789970|468040614|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
130021562|NCT01789970|468040615|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
130021563|NCT01789970|468040616|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
130021564|NCT01789970|468040614|FG000|Open-label Titration Period|Pregnancy|2|||
130021565|NCT01789970|468040615|FG001|Open-label Titration Period|Pregnancy|0|||
130021566|NCT01789970|468040616|FG002|Open-label Titration Period|Pregnancy|0|||
130021567|NCT01789970|468040614|FG000|Open-label Titration Period|Other|76|||
130021568|NCT01789970|468040615|FG001|Open-label Titration Period|Other|0|||
130021569|NCT01789970|468040616|FG002|Open-label Titration Period|Other|0|||
130225292|NCT01294423|468789906|FG002|Overall Study|subject no longer meets study criteria|2|||
130225293|NCT01294423|468789904|FG000|Overall Study|poor/non-compliance|1|||
130225294|NCT01294423|468789905|FG001|Overall Study|poor/non-compliance|0|||
130225295|NCT01294423|468789906|FG002|Overall Study|poor/non-compliance|1|||
130225296|NCT00301834|468789909|FG000|Overall Study|Death|1|||
130225297|NCT02026141|468789911|FG000|Overall Study|Protocol Violation|0|||
130225298|NCT02026141|468789912|FG001|Overall Study|Protocol Violation|1|||
130225299|NCT05081388|468789913|FG000|Overall Study|Adverse Event|1|||
130225300|NCT05081388|468789914|FG001|Overall Study|Adverse Event|0|||
130225301|NCT05081388|468789915|FG002|Overall Study|Adverse Event|0|||
130225302|NCT05081388|468789916|FG003|Overall Study|Adverse Event|0|||
130225303|NCT05081388|468789917|FG004|Overall Study|Adverse Event|0|||
130225304|NCT05081388|468789913|FG000|Overall Study|Lost to Follow-up|0|||
130225305|NCT05081388|468789914|FG001|Overall Study|Lost to Follow-up|1|||
130099161|NCT00594568|468320910|FG000|Initial Treatment|Physician Decision|3|||
130099162|NCT00594568|468320911|FG001|Initial Treatment|Physician Decision|2|||
130099163|NCT00594568|468320912|FG002|Initial Treatment|Physician Decision|4|||
130099164|NCT00594568|468320910|FG000|Initial Treatment|Protocol Violation|2|||
130099165|NCT00594568|468320911|FG001|Initial Treatment|Protocol Violation|2|||
130099166|NCT00594568|468320912|FG002|Initial Treatment|Protocol Violation|5|||
130099167|NCT00594568|468320910|FG000|Initial Treatment|Withdrawal by Subject|25|||
130099168|NCT00594568|468320911|FG001|Initial Treatment|Withdrawal by Subject|31|||
130099169|NCT00594568|468320912|FG002|Initial Treatment|Withdrawal by Subject|46|||
130099170|NCT00594568|468320910|FG000|Initial Treatment|Sponsor decision|193|||
130099171|NCT00594568|468320911|FG001|Initial Treatment|Sponsor decision|142|||
130099172|NCT00594568|468320912|FG002|Initial Treatment|Sponsor decision|147|||
130099173|NCT00594568|468320910|FG000|Initial Treatment|Caregiver decision|21|||
130099174|NCT00594568|468320911|FG001|Initial Treatment|Caregiver decision|36|||
130099175|NCT00594568|468320912|FG002|Initial Treatment|Caregiver decision|36|||
130099176|NCT00594568|468320910|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
130099177|NCT00594568|468320911|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
130099178|NCT00594568|468320912|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
130099179|NCT00594568|468320910|FG000|Initial Treatment|Entry criteria exclusion|0|||
130099180|NCT00594568|468320911|FG001|Initial Treatment|Entry criteria exclusion|1|||
130099181|NCT00594568|468320912|FG002|Initial Treatment|Entry criteria exclusion|1|||
130099182|NCT00594568|468320910|FG000|Delayed Start|Death|0|||
130099183|NCT00594568|468320911|FG001|Delayed Start|Death|0|||
130099184|NCT00594568|468320912|FG002|Delayed Start|Death|1|||
130099185|NCT00594568|468320910|FG000|Delayed Start|Adverse Event|12|||
130099186|NCT00594568|468320911|FG001|Delayed Start|Adverse Event|2|||
130099187|NCT00594568|468320912|FG002|Delayed Start|Adverse Event|2|||
130099188|NCT00594568|468320910|FG000|Delayed Start|Withdrawal by Subject|4|||
130099189|NCT00594568|468320911|FG001|Delayed Start|Withdrawal by Subject|3|||
130099190|NCT00594568|468320912|FG002|Delayed Start|Withdrawal by Subject|0|||
130099191|NCT00594568|468320910|FG000|Delayed Start|Physician Decision|0|||
130099192|NCT00594568|468320911|FG001|Delayed Start|Physician Decision|0|||
130099193|NCT00594568|468320912|FG002|Delayed Start|Physician Decision|1|||
130099194|NCT00594568|468320910|FG000|Delayed Start|Lost to Follow-up|0|||
130099195|NCT00594568|468320911|FG001|Delayed Start|Lost to Follow-up|0|||
130099196|NCT00594568|468320912|FG002|Delayed Start|Lost to Follow-up|1|||
130099197|NCT00594568|468320910|FG000|Delayed Start|Caregiver Decision|5|||
130099198|NCT00594568|468320911|FG001|Delayed Start|Caregiver Decision|6|||
130099199|NCT00594568|468320912|FG002|Delayed Start|Caregiver Decision|2|||
130099200|NCT00594568|468320910|FG000|Delayed Start|Sponsor Decision|77|||
130099201|NCT00594568|468320911|FG001|Delayed Start|Sponsor Decision|66|||
130099202|NCT00594568|468320912|FG002|Delayed Start|Sponsor Decision|59|||
130099203|NCT00594568|468320910|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
130099204|NCT00594568|468320911|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
130099205|NCT00594568|468320912|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
130099206|NCT00594568|468320910|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
130099207|NCT00594568|468320911|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130099208|NCT00594568|468320912|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130099209|NCT00594568|468320910|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
130099210|NCT00594568|468320911|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
130099211|NCT00594568|468320912|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
130225306|NCT05081388|468789915|FG002|Overall Study|Lost to Follow-up|0|||
130099212|NCT00594568|468320910|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
130099213|NCT00594568|468320911|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
130099214|NCT00594568|468320912|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
130099215|NCT00594568|468320910|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
130225307|NCT05081388|468789916|FG003|Overall Study|Lost to Follow-up|0|||
130225308|NCT05081388|468789917|FG004|Overall Study|Lost to Follow-up|0|||
130225309|NCT05081388|468789913|FG000|Overall Study|Subject decision|0|||
130099216|NCT00594568|468320911|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
130225310|NCT05081388|468789914|FG001|Overall Study|Subject decision|0|||
130225311|NCT05081388|468789915|FG002|Overall Study|Subject decision|0|||
130225312|NCT05081388|468789916|FG003|Overall Study|Subject decision|1|||
130225313|NCT05081388|468789917|FG004|Overall Study|Subject decision|0|||
130225314|NCT02059239|468789918|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
130225315|NCT02059239|468789919|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
130225316|NCT02059239|468789918|FG000|Overall Study|Physician Decision|1|||
130225317|NCT02059239|468789919|FG001|Overall Study|Physician Decision|0|||
130225318|NCT02219685|468789920|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
130225319|NCT02219685|468789921|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
130225320|NCT02219685|468789920|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
130225321|NCT02219685|468789921|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
130225322|NCT04202497|468789922|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
130225323|NCT04202497|468789923|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130225324|NCT04202497|468789924|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130225325|NCT04202497|468789925|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
130225326|NCT02115607|468789932|FG000|Overall Study|Withdrawal by Subject|1|||
130225327|NCT00102596|468789936|FG000|Part A|Screen failures|6|||
130225328|NCT00102596|468789937|FG001|Part A|Screen failures|0|||
130225329|NCT00102596|468789936|FG000|Part A|Adverse Event|1|||
130225330|NCT00102596|468789937|FG001|Part A|Adverse Event|0|||
130225331|NCT00069264|468789939|FG000|Overall Study|Adverse Event|3|||
130225332|NCT00069264|468789939|FG000|Overall Study|Progressive Disease|23|||
130225333|NCT00069264|468789939|FG000|Overall Study|Withdrawal by Subject|3|||
130225334|NCT00069264|468789939|FG000|Overall Study|Discon Therapy|3|||
130225335|NCT05547386|468789940|FG000|Overall Study|Withdrawal by Subject|7|||
130225336|NCT04622969|468789941|FG000|Overall Study|Withdrawal by Subject|2|||
130225337|NCT04622969|468789942|FG001|Overall Study|Withdrawal by Subject|3|||
130225338|NCT04467515|468789943|FG000|Overall Study|Lost to Follow-up|1|||
130225339|NCT04467515|468789944|FG001|Overall Study|Lost to Follow-up|0|||
130225340|NCT04467515|468789945|FG002|Overall Study|Lost to Follow-up|0|||
130225341|NCT04467515|468789943|FG000|Overall Study|Withdrawal by Subject|1|||
130225342|NCT04467515|468789944|FG001|Overall Study|Withdrawal by Subject|0|||
130225343|NCT04467515|468789945|FG002|Overall Study|Withdrawal by Subject|1|||
130225344|NCT04467515|468789943|FG000|Overall Study|Progressive Disease|0|||
130225345|NCT04467515|468789944|FG001|Overall Study|Progressive Disease|1|||
130225346|NCT04467515|468789945|FG002|Overall Study|Progressive Disease|3|||
130225347|NCT04467515|468789943|FG000|Overall Study|Death|0|||
130225348|NCT04467515|468789944|FG001|Overall Study|Death|1|||
130225349|NCT04467515|468789945|FG002|Overall Study|Death|0|||
130225350|NCT05616013|468789948|FG000|Overall Study|Adverse Event|6|||
130225351|NCT05616013|468789949|FG001|Overall Study|Adverse Event|12|||
130225352|NCT05616013|468789950|FG002|Overall Study|Adverse Event|8|||
130225353|NCT05616013|468789951|FG003|Overall Study|Adverse Event|4|||
130225354|NCT05616013|468789952|FG004|Overall Study|Adverse Event|6|||
130021570|NCT01789970|468040614|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
130225355|NCT05616013|468789953|FG005|Overall Study|Adverse Event|8|||
130225356|NCT05616013|468789954|FG006|Overall Study|Adverse Event|3|||
130225357|NCT05616013|468789955|FG007|Overall Study|Adverse Event|6|||
130225358|NCT05616013|468789956|FG008|Overall Study|Adverse Event|1|||
130225359|NCT05616013|468789948|FG000|Overall Study|Lost to Follow-up|5|||
130225360|NCT05616013|468789949|FG001|Overall Study|Lost to Follow-up|4|||
130225361|NCT05616013|468789950|FG002|Overall Study|Lost to Follow-up|3|||
130225362|NCT05616013|468789951|FG003|Overall Study|Lost to Follow-up|2|||
130225363|NCT05616013|468789952|FG004|Overall Study|Lost to Follow-up|0|||
130225364|NCT05616013|468789953|FG005|Overall Study|Lost to Follow-up|5|||
130225365|NCT05616013|468789954|FG006|Overall Study|Lost to Follow-up|2|||
130225366|NCT05616013|468789955|FG007|Overall Study|Lost to Follow-up|1|||
130225367|NCT05616013|468789956|FG008|Overall Study|Lost to Follow-up|2|||
130225368|NCT05616013|468789948|FG000|Overall Study|Non-compliance with study requirements|2|||
130225369|NCT05616013|468789949|FG001|Overall Study|Non-compliance with study requirements|2|||
130225370|NCT05616013|468789950|FG002|Overall Study|Non-compliance with study requirements|2|||
130225371|NCT05616013|468789951|FG003|Overall Study|Non-compliance with study requirements|3|||
130225372|NCT05616013|468789952|FG004|Overall Study|Non-compliance with study requirements|0|||
130225373|NCT05616013|468789953|FG005|Overall Study|Non-compliance with study requirements|2|||
130225374|NCT05616013|468789954|FG006|Overall Study|Non-compliance with study requirements|1|||
130225375|NCT05616013|468789955|FG007|Overall Study|Non-compliance with study requirements|1|||
130225376|NCT05616013|468789956|FG008|Overall Study|Non-compliance with study requirements|4|||
130225377|NCT05616013|468789948|FG000|Overall Study|Withdrawal by Subject|11|||
130225378|NCT05616013|468789949|FG001|Overall Study|Withdrawal by Subject|9|||
130225379|NCT05616013|468789950|FG002|Overall Study|Withdrawal by Subject|8|||
130225380|NCT05616013|468789951|FG003|Overall Study|Withdrawal by Subject|6|||
130225381|NCT05616013|468789952|FG004|Overall Study|Withdrawal by Subject|3|||
130225382|NCT05616013|468789953|FG005|Overall Study|Withdrawal by Subject|4|||
130021571|NCT01789970|468040615|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
130021572|NCT01789970|468040616|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
130021573|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
130021574|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
130021575|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
130021576|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130021577|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
130021578|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
130021579|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130021580|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
130021581|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
130021582|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130021583|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
130021584|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
130021585|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
130021586|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
130021587|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
130021588|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
130021589|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
130021590|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
130021591|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130021592|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130021593|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
130021594|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
130021595|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
130021596|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
130021597|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
130021598|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
130021599|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
130099217|NCT00594568|468320912|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
130225383|NCT05616013|468789954|FG006|Overall Study|Withdrawal by Subject|6|||
130225384|NCT05616013|468789955|FG007|Overall Study|Withdrawal by Subject|5|||
130225385|NCT05616013|468789956|FG008|Overall Study|Withdrawal by Subject|4|||
130225386|NCT05616013|468789948|FG000|Overall Study|Physician Decision|0|||
130225387|NCT05616013|468789949|FG001|Overall Study|Physician Decision|0|||
129884508|NCT02293837|467536432|FG000|Overall Study|COVID-19 Related|1|||
130021600|NCT01789970|468040614|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
130021601|NCT01789970|468040615|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
130021602|NCT01789970|468040616|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
130021603|NCT01121393|468040617|FG000|Overall Study|Progressive disease|201|||
130021604|NCT01121393|468040618|FG001|Overall Study|Progressive disease|20|||
130021605|NCT01121393|468040617|FG000|Overall Study|Other Adverse events|24|||
130021606|NCT01121393|468040618|FG001|Overall Study|Other Adverse events|45|||
130021607|NCT01121393|468040617|FG000|Overall Study|Non-compliant with protocol|0|||
130021608|NCT01121393|468040618|FG001|Overall Study|Non-compliant with protocol|3|||
130021609|NCT01121393|468040617|FG000|Overall Study|Lost to Follow-up|1|||
130021610|NCT01121393|468040618|FG001|Overall Study|Lost to Follow-up|0|||
130021611|NCT01121393|468040617|FG000|Overall Study|Refused cont. medication|7|||
130021612|NCT01121393|468040618|FG001|Overall Study|Refused cont. medication|7|||
130021613|NCT01121393|468040617|FG000|Overall Study|Not treated|3|||
130021614|NCT01121393|468040618|FG001|Overall Study|Not treated|9|||
130021615|NCT01121393|468040617|FG000|Overall Study|Other than listed|6|||
130021616|NCT01121393|468040618|FG001|Overall Study|Other than listed|0|||
130021617|NCT02296242|468040621|FG000|Overall Study|Death|1|||
130021618|NCT02296242|468040622|FG001|Overall Study|Death|1|||
130021619|NCT02296242|468040623|FG002|Overall Study|Death|1|||
130021620|NCT02296242|468040624|FG003|Overall Study|Death|1|||
130021621|NCT02296242|468040625|FG004|Overall Study|Death|1|||
130021622|NCT02296242|468040621|FG000|Overall Study|Withdrawal by Subject|0|||
130021623|NCT02296242|468040622|FG001|Overall Study|Withdrawal by Subject|0|||
130021624|NCT02296242|468040623|FG002|Overall Study|Withdrawal by Subject|1|||
130021625|NCT02296242|468040624|FG003|Overall Study|Withdrawal by Subject|1|||
130021626|NCT02296242|468040625|FG004|Overall Study|Withdrawal by Subject|3|||
130021627|NCT02296242|468040621|FG000|Overall Study|Disease Progression|1|||
130021628|NCT02296242|468040622|FG001|Overall Study|Disease Progression|3|||
130021629|NCT02296242|468040623|FG002|Overall Study|Disease Progression|2|||
130021630|NCT02296242|468040624|FG003|Overall Study|Disease Progression|8|||
130021631|NCT02296242|468040625|FG004|Overall Study|Disease Progression|11|||
130021632|NCT02296242|468040621|FG000|Overall Study|Unacceptable Toxicity|0|||
130021633|NCT02296242|468040622|FG001|Overall Study|Unacceptable Toxicity|0|||
130021634|NCT02296242|468040623|FG002|Overall Study|Unacceptable Toxicity|0|||
130021635|NCT02296242|468040624|FG003|Overall Study|Unacceptable Toxicity|0|||
130021636|NCT02296242|468040625|FG004|Overall Study|Unacceptable Toxicity|1|||
130021637|NCT02296242|468040621|FG000|Overall Study|Patient Condition Changed|0|||
130021638|NCT02296242|468040622|FG001|Overall Study|Patient Condition Changed|0|||
130021639|NCT02296242|468040623|FG002|Overall Study|Patient Condition Changed|2|||
130021640|NCT02296242|468040624|FG003|Overall Study|Patient Condition Changed|0|||
130021641|NCT02296242|468040625|FG004|Overall Study|Patient Condition Changed|1|||
130021642|NCT02296242|468040621|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
130021643|NCT02296242|468040622|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
130021644|NCT02296242|468040623|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
130021645|NCT02296242|468040624|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
130021646|NCT02296242|468040625|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
130021647|NCT02296242|468040621|FG000|Overall Study|Lost to Follow-up|1|||
130021648|NCT02296242|468040622|FG001|Overall Study|Lost to Follow-up|0|||
130021649|NCT02296242|468040623|FG002|Overall Study|Lost to Follow-up|0|||
130021650|NCT02296242|468040624|FG003|Overall Study|Lost to Follow-up|0|||
130021651|NCT02296242|468040625|FG004|Overall Study|Lost to Follow-up|0|||
130021652|NCT02296242|468040621|FG000|Overall Study|Need for Hydroxyurea|2|||
130021653|NCT02296242|468040622|FG001|Overall Study|Need for Hydroxyurea|0|||
130021654|NCT02296242|468040623|FG002|Overall Study|Need for Hydroxyurea|0|||
130021655|NCT02296242|468040624|FG003|Overall Study|Need for Hydroxyurea|0|||
130225388|NCT05616013|468789950|FG002|Overall Study|Physician Decision|1|||
130225389|NCT05616013|468789951|FG003|Overall Study|Physician Decision|0|||
130225390|NCT05616013|468789952|FG004|Overall Study|Physician Decision|0|||
130225391|NCT05616013|468789953|FG005|Overall Study|Physician Decision|1|||
130225392|NCT05616013|468789954|FG006|Overall Study|Physician Decision|3|||
130225393|NCT05616013|468789955|FG007|Overall Study|Physician Decision|0|||
130225394|NCT05616013|468789956|FG008|Overall Study|Physician Decision|0|||
130225395|NCT05616013|468789948|FG000|Overall Study|Protocol Violation|0|||
130225396|NCT05616013|468789949|FG001|Overall Study|Protocol Violation|0|||
130225397|NCT05616013|468789950|FG002|Overall Study|Protocol Violation|0|||
130225398|NCT05616013|468789951|FG003|Overall Study|Protocol Violation|0|||
130225399|NCT05616013|468789952|FG004|Overall Study|Protocol Violation|0|||
130225400|NCT05616013|468789953|FG005|Overall Study|Protocol Violation|0|||
130099218|NCT00594568|468320910|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
130225401|NCT05616013|468789954|FG006|Overall Study|Protocol Violation|1|||
130225402|NCT05616013|468789955|FG007|Overall Study|Protocol Violation|0|||
130225403|NCT05616013|468789956|FG008|Overall Study|Protocol Violation|2|||
130225404|NCT05616013|468789948|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
130225405|NCT05616013|468789949|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
130099219|NCT00594568|468320911|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
130099220|NCT00594568|468320912|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
130099221|NCT00299546|468320913|FG000|Overall Study|Death|3|||
130225406|NCT05616013|468789950|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225407|NCT05616013|468789951|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225408|NCT05616013|468789952|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225409|NCT05616013|468789953|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
130099222|NCT00299546|468320914|FG001|Overall Study|Death|2|||
130099223|NCT00299546|468320915|FG002|Overall Study|Death|0|||
130099224|NCT00299546|468320913|FG000|Overall Study|Lost to Follow-up|2|||
130099225|NCT00299546|468320914|FG001|Overall Study|Lost to Follow-up|2|||
130099226|NCT00299546|468320915|FG002|Overall Study|Lost to Follow-up|5|||
130099227|NCT00299546|468320913|FG000|Overall Study|Adverse Event|37|||
130099228|NCT00299546|468320914|FG001|Overall Study|Adverse Event|22|||
130099229|NCT00299546|468320915|FG002|Overall Study|Adverse Event|27|||
130099230|NCT00299546|468320913|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
130099231|NCT00299546|468320914|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
130099232|NCT00299546|468320915|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
130099233|NCT00299546|468320913|FG000|Overall Study|Other|24|||
130099234|NCT00299546|468320914|FG001|Overall Study|Other|26|||
130099235|NCT00299546|468320915|FG002|Overall Study|Other|19|||
130099236|NCT00299546|468320913|FG000|Overall Study|Not treated|0|||
130099237|NCT00299546|468320914|FG001|Overall Study|Not treated|1|||
130099238|NCT00299546|468320915|FG002|Overall Study|Not treated|1|||
130099239|NCT03099265|468320916|FG000|Overall Study|Adverse Event|1|||
130099240|NCT00518531|468320920|FG000|Treatment Period 1|Adverse Event|5|||
130099241|NCT00518531|468320921|FG001|Treatment Period 1|Adverse Event|0|||
130099242|NCT00518531|468320920|FG000|Treatment Period 1|Lost to Follow-up|5|||
130225410|NCT05616013|468789954|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225411|NCT05616013|468789955|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
130225412|NCT05616013|468789956|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
130316109|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
130225413|NCT05616013|468789948|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
130225414|NCT05616013|468789949|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225415|NCT05616013|468789950|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225416|NCT05616013|468789951|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225417|NCT05616013|468789952|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225418|NCT05616013|468789953|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225419|NCT05616013|468789954|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225420|NCT05616013|468789955|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225421|NCT05616013|468789956|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
130225422|NCT05616013|468789948|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
130225423|NCT05616013|468789949|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225424|NCT05616013|468789950|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225425|NCT05616013|468789951|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225426|NCT05616013|468789952|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225427|NCT05616013|468789953|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225428|NCT05616013|468789954|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225429|NCT05616013|468789955|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225430|NCT05616013|468789956|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
130225431|NCT05616013|468789948|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225432|NCT05616013|468789949|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
130225433|NCT05616013|468789950|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225434|NCT05616013|468789951|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225435|NCT05616013|468789952|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225436|NCT05616013|468789953|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225437|NCT05616013|468789954|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225438|NCT05616013|468789955|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225439|NCT05616013|468789956|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
130225440|NCT05616013|468789948|FG000|Overall Study|Participant Decision, Time Constraints|0|||
130225441|NCT05616013|468789949|FG001|Overall Study|Participant Decision, Time Constraints|1|||
130225442|NCT05616013|468789950|FG002|Overall Study|Participant Decision, Time Constraints|0|||
130225443|NCT05616013|468789951|FG003|Overall Study|Participant Decision, Time Constraints|0|||
130225444|NCT05616013|468789952|FG004|Overall Study|Participant Decision, Time Constraints|0|||
130225445|NCT05616013|468789953|FG005|Overall Study|Participant Decision, Time Constraints|0|||
130225446|NCT05616013|468789954|FG006|Overall Study|Participant Decision, Time Constraints|0|||
130225447|NCT05616013|468789955|FG007|Overall Study|Participant Decision, Time Constraints|0|||
130225448|NCT05616013|468789956|FG008|Overall Study|Participant Decision, Time Constraints|0|||
130225449|NCT05616013|468789948|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130225450|NCT05616013|468789949|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130225451|NCT05616013|468789950|FG002|Overall Study|Prohibited Concomitant Medication|1|||
130225452|NCT05616013|468789951|FG003|Overall Study|Prohibited Concomitant Medication|0|||
130225453|NCT05616013|468789952|FG004|Overall Study|Prohibited Concomitant Medication|0|||
130225454|NCT05616013|468789953|FG005|Overall Study|Prohibited Concomitant Medication|0|||
130225455|NCT05616013|468789954|FG006|Overall Study|Prohibited Concomitant Medication|0|||
130225456|NCT05616013|468789955|FG007|Overall Study|Prohibited Concomitant Medication|0|||
130225457|NCT05616013|468789956|FG008|Overall Study|Prohibited Concomitant Medication|0|||
130021656|NCT02296242|468040625|FG004|Overall Study|Need for Hydroxyurea|0|||
130021657|NCT02296242|468040621|FG000|Overall Study|Screened for Other Protocol|0|||
130021658|NCT02296242|468040622|FG001|Overall Study|Screened for Other Protocol|1|||
130021659|NCT02296242|468040623|FG002|Overall Study|Screened for Other Protocol|0|||
130021660|NCT02296242|468040624|FG003|Overall Study|Screened for Other Protocol|0|||
130021661|NCT02296242|468040625|FG004|Overall Study|Screened for Other Protocol|0|||
130021662|NCT02296242|468040621|FG000|Overall Study|Physician Decision|0|||
130021663|NCT02296242|468040622|FG001|Overall Study|Physician Decision|1|||
130021664|NCT02296242|468040623|FG002|Overall Study|Physician Decision|0|||
130021665|NCT02296242|468040624|FG003|Overall Study|Physician Decision|1|||
130021666|NCT02296242|468040625|FG004|Overall Study|Physician Decision|0|||
130021667|NCT02296242|468040621|FG000|Overall Study|Alternative Treatment|0|||
130021668|NCT02296242|468040622|FG001|Overall Study|Alternative Treatment|0|||
130021669|NCT02296242|468040623|FG002|Overall Study|Alternative Treatment|0|||
130021670|NCT02296242|468040624|FG003|Overall Study|Alternative Treatment|1|||
130021671|NCT02296242|468040625|FG004|Overall Study|Alternative Treatment|0|||
130021672|NCT02296242|468040621|FG000|Overall Study|Adverse Event|0|||
130021673|NCT02296242|468040622|FG001|Overall Study|Adverse Event|0|||
130021674|NCT02296242|468040623|FG002|Overall Study|Adverse Event|0|||
130021675|NCT02296242|468040624|FG003|Overall Study|Adverse Event|1|||
130021676|NCT02296242|468040625|FG004|Overall Study|Adverse Event|0|||
130021677|NCT02296242|468040621|FG000|Overall Study|Lack of Efficacy|0|||
130021678|NCT02296242|468040622|FG001|Overall Study|Lack of Efficacy|0|||
130021679|NCT02296242|468040623|FG002|Overall Study|Lack of Efficacy|0|||
130021680|NCT02296242|468040624|FG003|Overall Study|Lack of Efficacy|0|||
130021681|NCT02296242|468040625|FG004|Overall Study|Lack of Efficacy|3|||
130021682|NCT02217566|468040626|FG000|Overall Study|Lost to Follow-up|2|||
130021683|NCT02217566|468040626|FG000|Overall Study|Death|3|||
130021684|NCT02217566|468040626|FG000|Overall Study|Early study termination|6|||
130021685|NCT00608985|468040634|FG000|Overall Study|Adverse Event|2|||
130021686|NCT00608985|468040635|FG001|Overall Study|Adverse Event|7|||
130021687|NCT00608985|468040636|FG002|Overall Study|Adverse Event|4|||
130021688|NCT00608985|468040637|FG003|Overall Study|Adverse Event|6|||
130021689|NCT00608985|468040634|FG000|Overall Study|Administrative/Other|7|||
130021690|NCT00608985|468040635|FG001|Overall Study|Administrative/Other|4|||
130021691|NCT00608985|468040636|FG002|Overall Study|Administrative/Other|1|||
130021692|NCT00608985|468040637|FG003|Overall Study|Administrative/Other|2|||
130021693|NCT00608985|468040634|FG000|Overall Study|Withdrawal of Consent|5|||
130021694|NCT00608985|468040635|FG001|Overall Study|Withdrawal of Consent|1|||
130021695|NCT00608985|468040636|FG002|Overall Study|Withdrawal of Consent|1|||
130021696|NCT00608985|468040637|FG003|Overall Study|Withdrawal of Consent|1|||
130021697|NCT00608985|468040634|FG000|Overall Study|Lost to Follow-up|2|||
130021698|NCT00608985|468040635|FG001|Overall Study|Lost to Follow-up|1|||
130021699|NCT00608985|468040636|FG002|Overall Study|Lost to Follow-up|0|||
130021700|NCT00608985|468040637|FG003|Overall Study|Lost to Follow-up|0|||
130021701|NCT03033745|468040638|FG000|Overall Study|Protocol Violation|0|||
130021702|NCT03033745|468040639|FG001|Overall Study|Protocol Violation|0|||
130021703|NCT03033745|468040640|FG002|Overall Study|Protocol Violation|1|||
130021704|NCT03033745|468040638|FG000|Overall Study|Adverse Event|1|||
130021705|NCT03033745|468040639|FG001|Overall Study|Adverse Event|0|||
130021706|NCT03033745|468040640|FG002|Overall Study|Adverse Event|1|||
130021707|NCT03033745|468040638|FG000|Overall Study|Withdrawal by Subject|0|||
130021708|NCT03033745|468040639|FG001|Overall Study|Withdrawal by Subject|1|||
130021709|NCT03033745|468040640|FG002|Overall Study|Withdrawal by Subject|0|||
130021710|NCT02574637|468040641|FG000|Double-blind Period|Adverse Event|1|||
130021711|NCT02574637|468040642|FG001|Double-blind Period|Adverse Event|0|||
130021712|NCT02574637|468040643|FG002|Double-blind Period|Adverse Event|0|||
130021713|NCT02574637|468040644|FG003|Double-blind Period|Adverse Event|0|||
130021714|NCT02574637|468040645|FG004|Double-blind Period|Adverse Event|0|||
130021715|NCT02574637|468040646|FG005|Double-blind Period|Adverse Event|0|||
130021716|NCT02574637|468040647|FG006|Double-blind Period|Adverse Event|0|||
130021717|NCT02574637|468040648|FG007|Double-blind Period|Adverse Event|0|||
130021718|NCT02574637|468040649|FG008|Double-blind Period|Adverse Event|0|||
130021719|NCT02574637|468040650|FG009|Double-blind Period|Adverse Event|0|||
130021720|NCT02574637|468040641|FG000|Double-blind Period|Lack of Efficacy|0|||
130021721|NCT02574637|468040642|FG001|Double-blind Period|Lack of Efficacy|0|||
130021722|NCT02574637|468040643|FG002|Double-blind Period|Lack of Efficacy|2|||
130021723|NCT02574637|468040644|FG003|Double-blind Period|Lack of Efficacy|0|||
130021724|NCT02574637|468040645|FG004|Double-blind Period|Lack of Efficacy|0|||
130021725|NCT02574637|468040646|FG005|Double-blind Period|Lack of Efficacy|0|||
130021726|NCT02574637|468040647|FG006|Double-blind Period|Lack of Efficacy|0|||
130021727|NCT02574637|468040648|FG007|Double-blind Period|Lack of Efficacy|0|||
130021728|NCT02574637|468040649|FG008|Double-blind Period|Lack of Efficacy|0|||
130021729|NCT02574637|468040650|FG009|Double-blind Period|Lack of Efficacy|0|||
130021730|NCT02574637|468040641|FG000|Double-blind Period|Protocol Deviation|1|||
130021731|NCT02574637|468040642|FG001|Double-blind Period|Protocol Deviation|0|||
130021732|NCT02574637|468040643|FG002|Double-blind Period|Protocol Deviation|0|||
130225458|NCT05616013|468789948|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225459|NCT05616013|468789949|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225460|NCT05616013|468789950|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
130225461|NCT05616013|468789951|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225462|NCT05616013|468789952|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225463|NCT05616013|468789953|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225464|NCT05616013|468789954|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225465|NCT05616013|468789955|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225466|NCT05616013|468789956|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
130225467|NCT05616013|468789948|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225468|NCT05616013|468789949|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225469|NCT05616013|468789950|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225470|NCT05616013|468789951|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
130225471|NCT05616013|468789952|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225472|NCT05616013|468789953|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225473|NCT05616013|468789954|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225474|NCT05616013|468789955|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225475|NCT05616013|468789956|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
130225476|NCT05616013|468789948|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225477|NCT05616013|468789949|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225478|NCT05616013|468789950|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225479|NCT05616013|468789951|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225480|NCT05616013|468789952|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225481|NCT05616013|468789953|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225482|NCT05616013|468789954|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
130225483|NCT05616013|468789955|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225484|NCT05616013|468789956|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
130225485|NCT05616013|468789948|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225486|NCT05616013|468789949|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225487|NCT05616013|468789950|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225488|NCT05616013|468789951|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225489|NCT05616013|468789952|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225490|NCT05616013|468789953|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225491|NCT05616013|468789954|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225492|NCT05616013|468789955|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
130225493|NCT05616013|468789956|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
130225494|NCT05616013|468789948|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225495|NCT05616013|468789949|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225496|NCT05616013|468789950|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225497|NCT05616013|468789951|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225498|NCT05616013|468789952|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225499|NCT05616013|468789953|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225500|NCT05616013|468789954|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225501|NCT05616013|468789955|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
130225502|NCT05616013|468789956|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
130225503|NCT05116202|468789957|FG000|Overall Study|Study Terminated by Sponsor|21|||
130225504|NCT05116202|468789958|FG001|Overall Study|Study Terminated by Sponsor|38|||
130225505|NCT05116202|468789959|FG002|Overall Study|Study Terminated by Sponsor|17|||
130225506|NCT05116202|468789960|FG003|Overall Study|Study Terminated by Sponsor|18|||
130225507|NCT05116202|468789961|FG004|Overall Study|Study Terminated by Sponsor|0|||
130225508|NCT05116202|468789957|FG000|Overall Study|Withdrawal by Subject|0|||
130225509|NCT05116202|468789958|FG001|Overall Study|Withdrawal by Subject|1|||
130225510|NCT05116202|468789959|FG002|Overall Study|Withdrawal by Subject|1|||
130225511|NCT05116202|468789960|FG003|Overall Study|Withdrawal by Subject|1|||
130225512|NCT05116202|468789961|FG004|Overall Study|Withdrawal by Subject|1|||
130225513|NCT05116202|468789957|FG000|Overall Study|Lost to Follow-up|0|||
130225514|NCT05116202|468789958|FG001|Overall Study|Lost to Follow-up|0|||
130225515|NCT05116202|468789959|FG002|Overall Study|Lost to Follow-up|0|||
130225516|NCT05116202|468789960|FG003|Overall Study|Lost to Follow-up|0|||
129800231|NCT02891161|467236266|FG000|Follow up|Refused to Follow up|0|||
130021733|NCT02574637|468040644|FG003|Double-blind Period|Protocol Deviation|0|||
130021734|NCT02574637|468040645|FG004|Double-blind Period|Protocol Deviation|0|||
130021735|NCT02574637|468040646|FG005|Double-blind Period|Protocol Deviation|0|||
130021736|NCT02574637|468040647|FG006|Double-blind Period|Protocol Deviation|0|||
130021737|NCT02574637|468040648|FG007|Double-blind Period|Protocol Deviation|0|||
130021738|NCT02574637|468040649|FG008|Double-blind Period|Protocol Deviation|0|||
130021739|NCT02574637|468040650|FG009|Double-blind Period|Protocol Deviation|0|||
130021740|NCT02574637|468040641|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
130021741|NCT02574637|468040642|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
130021742|NCT02574637|468040643|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
130021743|NCT02574637|468040644|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
130021744|NCT02574637|468040645|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
130021745|NCT02574637|468040646|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
130021746|NCT02574637|468040647|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
130021747|NCT02574637|468040648|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
130021748|NCT02574637|468040649|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
130021749|NCT02574637|468040650|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
130021750|NCT02574637|468040641|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
130021751|NCT02574637|468040642|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
130021752|NCT02574637|468040643|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
130021753|NCT02574637|468040644|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
130021754|NCT02574637|468040645|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
130021755|NCT02574637|468040646|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
130021756|NCT02574637|468040647|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
130021757|NCT02574637|468040648|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
130021758|NCT02574637|468040649|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
130021759|NCT02574637|468040650|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
130021760|NCT02574637|468040641|FG000|Double-blind Period|Reason Not Specified|0|||
130021761|NCT02574637|468040642|FG001|Double-blind Period|Reason Not Specified|0|||
130021762|NCT02574637|468040643|FG002|Double-blind Period|Reason Not Specified|0|||
130021763|NCT02574637|468040644|FG003|Double-blind Period|Reason Not Specified|1|||
130021764|NCT02574637|468040645|FG004|Double-blind Period|Reason Not Specified|0|||
130021765|NCT02574637|468040646|FG005|Double-blind Period|Reason Not Specified|0|||
130021766|NCT02574637|468040647|FG006|Double-blind Period|Reason Not Specified|0|||
130021767|NCT02574637|468040648|FG007|Double-blind Period|Reason Not Specified|0|||
130021768|NCT02574637|468040649|FG008|Double-blind Period|Reason Not Specified|0|||
130021769|NCT02574637|468040650|FG009|Double-blind Period|Reason Not Specified|0|||
130021770|NCT02574637|468040641|FG000|Open-label (OL) Period|Adverse Event|0|||
130021771|NCT02574637|468040642|FG001|Open-label (OL) Period|Adverse Event|0|||
130021772|NCT02574637|468040643|FG002|Open-label (OL) Period|Adverse Event|0|||
130021773|NCT02574637|468040644|FG003|Open-label (OL) Period|Adverse Event|0|||
130021774|NCT02574637|468040645|FG004|Open-label (OL) Period|Adverse Event|0|||
130021775|NCT02574637|468040646|FG005|Open-label (OL) Period|Adverse Event|0|||
130021776|NCT02574637|468040647|FG006|Open-label (OL) Period|Adverse Event|0|||
130021777|NCT02574637|468040648|FG007|Open-label (OL) Period|Adverse Event|0|||
130021778|NCT02574637|468040649|FG008|Open-label (OL) Period|Adverse Event|1|||
130021779|NCT02574637|468040650|FG009|Open-label (OL) Period|Adverse Event|0|||
130021780|NCT02574637|468040641|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
130021781|NCT02574637|468040642|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
130021782|NCT02574637|468040643|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
130021783|NCT02574637|468040644|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
130021784|NCT02574637|468040645|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
130021785|NCT02574637|468040646|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
130021786|NCT02574637|468040647|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
130099243|NCT00518531|468320921|FG001|Treatment Period 1|Lost to Follow-up|3|||
130099244|NCT00518531|468320920|FG000|Treatment Period 1|Physician Decision|1|||
130099245|NCT00518531|468320921|FG001|Treatment Period 1|Physician Decision|0|||
130099246|NCT00518531|468320920|FG000|Treatment Period 1|Protocol Violation|2|||
130099247|NCT00518531|468320921|FG001|Treatment Period 1|Protocol Violation|0|||
130099248|NCT00518531|468320920|FG000|Treatment Period 1|Withdrawal by Subject|4|||
130099249|NCT00518531|468320921|FG001|Treatment Period 1|Withdrawal by Subject|6|||
129884509|NCT02293837|467536433|FG001|Overall Study|COVID-19 Related|1|||
130021787|NCT02574637|468040648|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
130021788|NCT02574637|468040649|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
130021789|NCT02574637|468040650|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
130021790|NCT02574637|468040641|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130021791|NCT02574637|468040642|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130021792|NCT02574637|468040643|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130021793|NCT02574637|468040644|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130099250|NCT00518531|468320920|FG000|Treatment Period 1|Early crossover|1|||
130099251|NCT00518531|468320921|FG001|Treatment Period 1|Early crossover|3|||
130225517|NCT05116202|468789961|FG004|Overall Study|Lost to Follow-up|2|||
130225518|NCT05116202|468789957|FG000|Overall Study|Death|1|||
130225519|NCT05116202|468789958|FG001|Overall Study|Death|1|||
130225520|NCT05116202|468789959|FG002|Overall Study|Death|2|||
130225521|NCT05116202|468789960|FG003|Overall Study|Death|1|||
130225522|NCT05116202|468789961|FG004|Overall Study|Death|5|||
130225523|NCT03834506|468789962|FG000|Overall Study|Death|336|||
130225524|NCT03834506|468789963|FG001|Overall Study|Death|326|||
130225525|NCT03834506|468789962|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130225526|NCT03834506|468789963|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130225527|NCT03834506|468789962|FG000|Overall Study|Withdrawal by Subject|10|||
130225528|NCT03834506|468789963|FG001|Overall Study|Withdrawal by Subject|8|||
130225529|NCT03834506|468789962|FG000|Overall Study|Sponsor decision|165|||
130225530|NCT03834506|468789963|FG001|Overall Study|Sponsor decision|178|||
130225531|NCT03834506|468789962|FG000|Overall Study|Physician Decision|3|||
130225532|NCT03834506|468789963|FG001|Overall Study|Physician Decision|1|||
130225533|NCT03834506|468789962|FG000|Overall Study|Lost to Follow-up|0|||
130225534|NCT03834506|468789963|FG001|Overall Study|Lost to Follow-up|1|||
130225535|NCT05067972|468789964|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225536|NCT05067972|468789965|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
130225537|NCT05067972|468789966|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225538|NCT05067972|468789967|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
130225539|NCT05067972|468789968|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225540|NCT05067972|468789969|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
130225541|NCT05067972|468789970|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
130225542|NCT05067972|468789964|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
130225543|NCT05067972|468789965|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
130225544|NCT05067972|468789966|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
130225545|NCT05067972|468789967|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
130225546|NCT05067972|468789968|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
130225547|NCT05067972|468789969|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
130225548|NCT05067972|468789970|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
130225549|NCT05067972|468789964|FG000|Part 1: Treatment|Progressive Disease|3|||
130225550|NCT05067972|468789965|FG001|Part 1: Treatment|Progressive Disease|3|||
130225551|NCT05067972|468789966|FG002|Part 1: Treatment|Progressive Disease|4|||
130225552|NCT05067972|468789967|FG003|Part 1: Treatment|Progressive Disease|2|||
130225553|NCT05067972|468789968|FG004|Part 1: Treatment|Progressive Disease|3|||
130225554|NCT05067972|468789969|FG005|Part 1: Treatment|Progressive Disease|0|||
130225555|NCT05067972|468789970|FG006|Part 1: Treatment|Progressive Disease|2|||
130225556|NCT05067972|468789964|FG000|Part 1: Treatment|Physician Decision|0|||
130225557|NCT05067972|468789965|FG001|Part 1: Treatment|Physician Decision|0|||
130225558|NCT05067972|468789966|FG002|Part 1: Treatment|Physician Decision|0|||
130225559|NCT05067972|468789967|FG003|Part 1: Treatment|Physician Decision|1|||
130225560|NCT05067972|468789968|FG004|Part 1: Treatment|Physician Decision|0|||
130225561|NCT05067972|468789969|FG005|Part 1: Treatment|Physician Decision|0|||
130225562|NCT05067972|468789970|FG006|Part 1: Treatment|Physician Decision|0|||
130225563|NCT05067972|468789964|FG000|Part 1: Treatment|Death|0|||
130225564|NCT05067972|468789965|FG001|Part 1: Treatment|Death|0|||
130225565|NCT05067972|468789966|FG002|Part 1: Treatment|Death|0|||
130225566|NCT05067972|468789967|FG003|Part 1: Treatment|Death|2|||
130225567|NCT05067972|468789968|FG004|Part 1: Treatment|Death|0|||
130225568|NCT05067972|468789969|FG005|Part 1: Treatment|Death|0|||
130225569|NCT05067972|468789970|FG006|Part 1: Treatment|Death|0|||
130225570|NCT05067972|468789964|FG000|Part 1: Treatment|Adverse Event|0|||
130225571|NCT05067972|468789965|FG001|Part 1: Treatment|Adverse Event|0|||
130225572|NCT05067972|468789966|FG002|Part 1: Treatment|Adverse Event|0|||
130225573|NCT05067972|468789967|FG003|Part 1: Treatment|Adverse Event|0|||
130225574|NCT05067972|468789968|FG004|Part 1: Treatment|Adverse Event|0|||
130225575|NCT05067972|468789969|FG005|Part 1: Treatment|Adverse Event|2|||
130225576|NCT05067972|468789970|FG006|Part 1: Treatment|Adverse Event|1|||
130225577|NCT05067972|468789964|FG000|Part 1: Follow-up|Adverse Event|0|||
130021794|NCT02574637|468040645|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130021795|NCT02574637|468040646|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
130021796|NCT02574637|468040647|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
130021797|NCT02574637|468040648|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
130021798|NCT02574637|468040649|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
130225578|NCT05067972|468789965|FG001|Part 1: Follow-up|Adverse Event|0|||
130225579|NCT05067972|468789966|FG002|Part 1: Follow-up|Adverse Event|0|||
130225580|NCT05067972|468789967|FG003|Part 1: Follow-up|Adverse Event|0|||
130225581|NCT05067972|468789968|FG004|Part 1: Follow-up|Adverse Event|0|||
130225582|NCT05067972|468789969|FG005|Part 1: Follow-up|Adverse Event|1|||
130225583|NCT05067972|468789970|FG006|Part 1: Follow-up|Adverse Event|0|||
130225584|NCT05067972|468789964|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
130225585|NCT05067972|468789965|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
130225586|NCT05067972|468789966|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
130225587|NCT05067972|468789967|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
130225588|NCT05067972|468789968|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
130225589|NCT05067972|468789969|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
130225590|NCT05067972|468789970|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
130225591|NCT05067972|468789964|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225592|NCT05067972|468789965|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225593|NCT05067972|468789966|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225594|NCT05067972|468789967|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225595|NCT05067972|468789968|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225596|NCT05067972|468789969|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
130225597|NCT05067972|468789970|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
130225598|NCT05067972|468789964|FG000|Part 1: Follow-up|Physician Decision|0|||
130225599|NCT05067972|468789965|FG001|Part 1: Follow-up|Physician Decision|0|||
130225600|NCT05067972|468789966|FG002|Part 1: Follow-up|Physician Decision|0|||
130225601|NCT05067972|468789967|FG003|Part 1: Follow-up|Physician Decision|1|||
130225602|NCT05067972|468789968|FG004|Part 1: Follow-up|Physician Decision|0|||
130225603|NCT05067972|468789969|FG005|Part 1: Follow-up|Physician Decision|0|||
130225604|NCT05067972|468789970|FG006|Part 1: Follow-up|Physician Decision|0|||
130225605|NCT05067972|468789964|FG000|Part 1: Follow-up|Death|1|||
130225606|NCT05067972|468789965|FG001|Part 1: Follow-up|Death|2|||
130225607|NCT05067972|468789966|FG002|Part 1: Follow-up|Death|1|||
130225608|NCT05067972|468789967|FG003|Part 1: Follow-up|Death|0|||
130225609|NCT05067972|468789968|FG004|Part 1: Follow-up|Death|1|||
130225610|NCT05067972|468789969|FG005|Part 1: Follow-up|Death|0|||
130225611|NCT05067972|468789970|FG006|Part 1: Follow-up|Death|1|||
130225612|NCT04391842|468789971|FG000|Overall Study|Withdrawal by Subject|2|||
130225613|NCT02287038|468789972|FG000|Overall Study|Stopped attending appointments|3|||
130225614|NCT02287038|468789973|FG001|Overall Study|Stopped attending appointments|2|||
130225615|NCT02287038|468789972|FG000|Overall Study|Anxiety after starting medication|0|||
130021799|NCT02574637|468040650|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
130021800|NCT04016311|468040651|FG000|Overall Study|Withdrawal by Subject|1|||
130021801|NCT04016311|468040652|FG001|Overall Study|Withdrawal by Subject|0|||
130021802|NCT02064387|468040655|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021803|NCT02064387|468040656|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021804|NCT02064387|468040657|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021805|NCT02064387|468040658|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021806|NCT02064387|468040659|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021807|NCT02064387|468040660|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021808|NCT02064387|468040661|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021809|NCT02064387|468040662|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
130021810|NCT02064387|468040663|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021811|NCT02064387|468040664|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
130021812|NCT02064387|468040665|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021813|NCT02064387|468040666|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
130021814|NCT02064387|468040655|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021815|NCT02064387|468040656|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021816|NCT02064387|468040657|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021817|NCT02064387|468040658|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021818|NCT02064387|468040659|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021819|NCT02064387|468040660|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021820|NCT02064387|468040661|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021821|NCT02064387|468040662|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
130021822|NCT02064387|468040663|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021823|NCT02064387|468040664|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021824|NCT02064387|468040665|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021825|NCT02064387|468040666|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
130021826|NCT02064387|468040655|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021827|NCT02064387|468040656|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021828|NCT02064387|468040657|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021829|NCT02064387|468040658|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021830|NCT02064387|468040659|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130225616|NCT02287038|468789973|FG001|Overall Study|Anxiety after starting medication|1|||
130225617|NCT02287038|468789972|FG000|Overall Study|Nausea after starting medication|1|||
130225618|NCT02287038|468789973|FG001|Overall Study|Nausea after starting medication|0|||
130225619|NCT02287038|468789972|FG000|Overall Study|Abnormal ECG after starting medication|1|||
130225620|NCT02287038|468789973|FG001|Overall Study|Abnormal ECG after starting medication|0|||
130225621|NCT01676012|468789979|FG000|Overall Study|Adverse Event|2|||
130225622|NCT01676012|468789979|FG000|Overall Study|incomplete set of videos|1|||
130225623|NCT02667301|468790000|FG000|Overall Study|Adverse Event|1|||
130225624|NCT02667301|468790000|FG000|Overall Study|Lack of Efficacy|1|||
130225625|NCT02283658|468790001|FG000|Overall Study|Withdrawal by Subject|1|||
130225626|NCT03528551|468790003|FG000|Overall Study|Lost to Follow-up|0|||
130225627|NCT03528551|468790004|FG001|Overall Study|Lost to Follow-up|1|||
130225628|NCT03528551|468790005|FG002|Overall Study|Lost to Follow-up|0|||
130225629|NCT03528551|468790003|FG000|Overall Study|Transferred to other arm/group|2|||
130225630|NCT03528551|468790004|FG001|Overall Study|Transferred to other arm/group|3|||
130225631|NCT03528551|468790005|FG002|Overall Study|Transferred to other arm/group|0|||
130225632|NCT03528551|468790003|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130225633|NCT03528551|468790004|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130225634|NCT03528551|468790005|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130225635|NCT03528551|468790003|FG000|Overall Study|Protocol Violation|0|||
130099252|NCT00518531|468320920|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130099253|NCT00518531|468320921|FG001|Treatment Period 2|Withdrawal by Subject|8|||
130099254|NCT00518531|468320920|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
130099255|NCT00518531|468320921|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
130099256|NCT00518531|468320920|FG000|Treatment Period 2|Adverse Event|1|||
130099257|NCT00518531|468320921|FG001|Treatment Period 2|Adverse Event|7|||
130099258|NCT00518531|468320920|FG000|Treatment Period 2|Protocol-specified criteria|0|||
130099259|NCT00518531|468320921|FG001|Treatment Period 2|Protocol-specified criteria|1|||
130099260|NCT00518531|468320920|FG000|Treatment Period 2|Non-compliance|1|||
130099261|NCT00518531|468320921|FG001|Treatment Period 2|Non-compliance|2|||
130099262|NCT00602927|468320924|FG000|Period 1: 13 Days|Protocol Violation|2|||
130099263|NCT00602927|468320925|FG001|Period 1: 13 Days|Protocol Violation|4|||
130099264|NCT00602927|468320924|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
130099265|NCT00602927|468320925|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
130099266|NCT00602927|468320924|FG000|Period 1: 13 Days|Time|1|||
130099267|NCT00602927|468320925|FG001|Period 1: 13 Days|Time|0|||
130099268|NCT00602927|468320924|FG000|Period 1: 13 Days|Claustrophobia|0|||
130099269|NCT00602927|468320925|FG001|Period 1: 13 Days|Claustrophobia|1|||
130099270|NCT00602927|468320924|FG000|Period 2: 14 Days|Protocol Violation|0|||
130099271|NCT00602927|468320925|FG001|Period 2: 14 Days|Protocol Violation|2|||
130099272|NCT00602927|468320924|FG000|Period 3: 13 Days|Protocol Violation|0|||
130099273|NCT00602927|468320925|FG001|Period 3: 13 Days|Protocol Violation|1|||
130099274|NCT00602927|468320924|FG000|Period 3: 13 Days|MRI data quality|2|||
130099275|NCT00602927|468320925|FG001|Period 3: 13 Days|MRI data quality|2|||
130099276|NCT04311411|468320929|FG000|Overall Study|Adverse Event|2|||
130099277|NCT04311411|468320930|FG001|Overall Study|Adverse Event|3|||
130099278|NCT04311411|468320931|FG002|Overall Study|Adverse Event|2|||
130099279|NCT04311411|468320929|FG000|Overall Study|Withdrawal by Subject|3|||
130099280|NCT04311411|468320930|FG001|Overall Study|Withdrawal by Subject|3|||
130099281|NCT04311411|468320931|FG002|Overall Study|Withdrawal by Subject|0|||
130099282|NCT03722849|468320935|FG000|Overall Study|Withdrawal by Subject|1|||
130099283|NCT03722849|468320936|FG001|Overall Study|Withdrawal by Subject|1|||
130099284|NCT05644756|468320937|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
130099285|NCT05644756|468320937|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
130099286|NCT03985982|468320938|FG000|Double-Blind Phase|Lost to Follow-up|4|||
130099287|NCT03985982|468320939|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130099288|NCT03985982|468320940|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130099289|NCT03985982|468320938|FG000|Double-Blind Phase|Physician Decision|1|||
130099290|NCT03985982|468320939|FG001|Double-Blind Phase|Physician Decision|0|||
130099291|NCT03985982|468320940|FG002|Double-Blind Phase|Physician Decision|0|||
130099292|NCT03985982|468320938|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
130099293|NCT03985982|468320939|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130099294|NCT03985982|468320940|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130099295|NCT03985982|468320938|FG000|Double-Blind Phase|COVID-19|1|||
130099296|NCT03985982|468320939|FG001|Double-Blind Phase|COVID-19|0|||
130099297|NCT03985982|468320940|FG002|Double-Blind Phase|COVID-19|0|||
130099298|NCT03985982|468320938|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
130099299|NCT03985982|468320939|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
130099300|NCT03985982|468320940|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
130099301|NCT03985982|468320938|FG000|Open-Label Phase|Lost to Follow-up|0|||
130099302|NCT03985982|468320939|FG001|Open-Label Phase|Lost to Follow-up|0|||
130225636|NCT03528551|468790004|FG001|Overall Study|Protocol Violation|3|||
130225637|NCT03528551|468790005|FG002|Overall Study|Protocol Violation|0|||
130225638|NCT03528551|468790003|FG000|Overall Study|Withdrawal by Subject|0|||
130099303|NCT03985982|468320940|FG002|Open-Label Phase|Lost to Follow-up|13|||
130099304|NCT03985982|468320938|FG000|Open-Label Phase|Physician Decision|0|||
130099305|NCT03985982|468320939|FG001|Open-Label Phase|Physician Decision|0|||
130099306|NCT03985982|468320940|FG002|Open-Label Phase|Physician Decision|2|||
130099307|NCT03985982|468320938|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130099308|NCT03985982|468320939|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130225639|NCT03528551|468790004|FG001|Overall Study|Withdrawal by Subject|7|||
130225640|NCT03528551|468790005|FG002|Overall Study|Withdrawal by Subject|0|||
130225641|NCT00689338|468790006|FG000|Overall Study|Death|65|||
130225642|NCT00689338|468790006|FG000|Overall Study|Adverse Event|13|||
130225643|NCT00689338|468790006|FG000|Overall Study|Insufficient Clinical Response|1|||
130225644|NCT00689338|468790006|FG000|Overall Study|Lack of Efficacy|6|||
130225645|NCT00689338|468790006|FG000|Overall Study|Other|8|||
130225646|NCT00689338|468790006|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
130225647|NCT00689338|468790006|FG000|Overall Study|Lost to Follow-up|5|||
130225648|NCT00689338|468790006|FG000|Overall Study|Withdrawal by Subject|3|||
130225649|NCT00689338|468790006|FG000|Overall Study|Protocol Violation|15|||
130225650|NCT00846586|468790007|FG000|Overall Study|Adverse Event|20|||
130225651|NCT00846586|468790008|FG001|Overall Study|Adverse Event|10|||
130225652|NCT00846586|468790007|FG000|Overall Study|Subject withdrew consent|8|||
130225653|NCT00846586|468790008|FG001|Overall Study|Subject withdrew consent|10|||
130225654|NCT00846586|468790007|FG000|Overall Study|Administrative problems|5|||
130225655|NCT00846586|468790008|FG001|Overall Study|Administrative problems|4|||
130225656|NCT00846586|468790007|FG000|Overall Study|Death|2|||
130225657|NCT00846586|468790008|FG001|Overall Study|Death|0|||
130225658|NCT00846586|468790007|FG000|Overall Study|Protocol deviation|2|||
130225659|NCT00846586|468790008|FG001|Overall Study|Protocol deviation|6|||
130225660|NCT00846586|468790007|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130225661|NCT00846586|468790008|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130225662|NCT00846586|468790007|FG000|Overall Study|Lost to Follow-up|1|||
130225663|NCT00846586|468790008|FG001|Overall Study|Lost to Follow-up|4|||
130225664|NCT00846586|468790007|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130225665|NCT00846586|468790008|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130225666|NCT01061606|468790009|FG000|Overall Study|Adverse Event|1|||
130225667|NCT01061606|468790009|FG000|Overall Study|Death|1|||
130225668|NCT01061606|468790009|FG000|Overall Study|Disease Progression|4|||
130225669|NCT01061606|468790009|FG000|Overall Study|alternative therapy|2|||
130225670|NCT00735007|468790010|FG000|Overall Study|Adverse Event|4|||
130225671|NCT00735007|468790010|FG000|Overall Study|Protocol Violation|1|||
130225672|NCT00715403|468790011|FG000|Overall Study|Progressive disease|0|||
130225673|NCT00715403|468790012|FG001|Overall Study|Progressive disease|1|||
130225674|NCT00715403|468790013|FG002|Overall Study|Progressive disease|3|||
130225675|NCT00715403|468790014|FG003|Overall Study|Progressive disease|9|||
130225676|NCT00715403|468790015|FG004|Overall Study|Progressive disease|5|||
130225677|NCT00715403|468790016|FG005|Overall Study|Progressive disease|14|||
130225678|NCT00715403|468790017|FG006|Overall Study|Progressive disease|1|||
130225679|NCT00715403|468790011|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225680|NCT00715403|468790012|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225681|NCT00715403|468790013|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225682|NCT00715403|468790014|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225683|NCT00715403|468790015|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
130021831|NCT02064387|468040660|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021832|NCT02064387|468040661|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021833|NCT02064387|468040662|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021834|NCT02064387|468040663|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
130225684|NCT00715403|468790016|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
130225685|NCT00715403|468790017|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
130225686|NCT00715403|468790011|FG000|Overall Study|Other Adverse Event than DLT|1|||
130225687|NCT00715403|468790012|FG001|Overall Study|Other Adverse Event than DLT|0|||
130021835|NCT02064387|468040664|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021836|NCT02064387|468040665|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130021837|NCT02064387|468040666|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
130225688|NCT00715403|468790013|FG002|Overall Study|Other Adverse Event than DLT|0|||
130225689|NCT00715403|468790014|FG003|Overall Study|Other Adverse Event than DLT|0|||
130225690|NCT00715403|468790015|FG004|Overall Study|Other Adverse Event than DLT|0|||
130225691|NCT00715403|468790016|FG005|Overall Study|Other Adverse Event than DLT|2|||
130021838|NCT02064387|468040655|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
130021839|NCT02064387|468040656|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
130021840|NCT02064387|468040657|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
130021841|NCT02064387|468040658|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
130021842|NCT02064387|468040659|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
130021843|NCT02064387|468040660|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
130021844|NCT02064387|468040661|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
130021845|NCT02064387|468040662|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
130021846|NCT02064387|468040663|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
130021847|NCT02064387|468040664|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
130021848|NCT02064387|468040665|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
130021849|NCT02064387|468040666|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
130021850|NCT02064387|468040655|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130099309|NCT03985982|468320940|FG002|Open-Label Phase|Withdrawal by Subject|11|||
130099310|NCT00478933|468320941|FG000|Overall Study|Protocol Violation|22|||
130099311|NCT00478933|468320941|FG000|Overall Study|Informed consent not verified|3|||
130099312|NCT00478933|468320941|FG000|Overall Study|Inadequate data available|53|||
130099313|NCT03772574|468320942|FG000|Overall Study|Protocol Violation|2|||
130099314|NCT03772574|468320943|FG001|Overall Study|Protocol Violation|0|||
130099315|NCT03772574|468320944|FG002|Overall Study|Protocol Violation|0|||
130099316|NCT03772574|468320942|FG000|Overall Study|Discomfort|0|||
130099317|NCT03772574|468320943|FG001|Overall Study|Discomfort|5|||
130099318|NCT03772574|468320944|FG002|Overall Study|Discomfort|4|||
130099319|NCT00348348|468320952|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
130099320|NCT00348348|468320953|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
130099321|NCT00348348|468320952|FG000|Overall Study|Lack of Efficacy|1|||
130099322|NCT00348348|468320953|FG001|Overall Study|Lack of Efficacy|1|||
130099323|NCT00348348|468320952|FG000|Overall Study|Lost to Follow-up|8|||
130099324|NCT00348348|468320953|FG001|Overall Study|Lost to Follow-up|10|||
130099325|NCT00348348|468320952|FG000|Overall Study|Withdrawal by Subject|4|||
130099326|NCT00348348|468320953|FG001|Overall Study|Withdrawal by Subject|1|||
130099327|NCT00348348|468320952|FG000|Overall Study|Other|7|||
130099328|NCT00348348|468320953|FG001|Overall Study|Other|4|||
130099329|NCT00348348|468320952|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
130099330|NCT00348348|468320953|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
130099331|NCT00348348|468320952|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
130099332|NCT00348348|468320953|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
130099333|NCT00348348|468320952|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
130099334|NCT00348348|468320953|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
130099335|NCT00348348|468320952|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
130099336|NCT00348348|468320953|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
130099337|NCT00348348|468320952|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
130099338|NCT00348348|468320953|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
130099339|NCT00348348|468320952|FG000|Overall Study|Adverse event probably related to study|1|||
130099340|NCT00348348|468320953|FG001|Overall Study|Adverse event probably related to study|0|||
130099341|NCT01298362|468320954|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
130099342|NCT01298362|468320955|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
130099343|NCT04983589|468320960|FG000|Overall Study|Withdrawal by Subject|0|||
130099344|NCT04983589|468320961|FG001|Overall Study|Withdrawal by Subject|3|||
130099345|NCT04983589|468320960|FG000|Overall Study|COVID-19 Infection|1|||
130099346|NCT04983589|468320961|FG001|Overall Study|COVID-19 Infection|0|||
130099347|NCT04983589|468320960|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
130099348|NCT04983589|468320961|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
130099349|NCT00924820|468320962|FG000|Overall Study|Death|2|||
130099350|NCT00924820|468320962|FG000|Overall Study|Ineligible, Screen Failure|5|||
130099351|NCT00762073|468320967|FG000|Overall Study|Lack of Efficacy|1|||
130099352|NCT00762073|468320968|FG001|Overall Study|Lack of Efficacy|1|||
130099353|NCT00762073|468320969|FG002|Overall Study|Lack of Efficacy|0|||
130099354|NCT00762073|468320970|FG003|Overall Study|Lack of Efficacy|0|||
130099355|NCT00762073|468320967|FG000|Overall Study|Adverse Event|1|||
130099356|NCT00762073|468320968|FG001|Overall Study|Adverse Event|0|||
130099357|NCT00762073|468320969|FG002|Overall Study|Adverse Event|1|||
130099358|NCT00762073|468320970|FG003|Overall Study|Adverse Event|1|||
130021851|NCT02064387|468040656|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021852|NCT02064387|468040657|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130099359|NCT00762073|468320967|FG000|Overall Study|Significant Subject Noncompliance|0|||
130099360|NCT00762073|468320968|FG001|Overall Study|Significant Subject Noncompliance|1|||
130099361|NCT00762073|468320969|FG002|Overall Study|Significant Subject Noncompliance|0|||
130099362|NCT00762073|468320970|FG003|Overall Study|Significant Subject Noncompliance|1|||
130099363|NCT00762073|468320967|FG000|Overall Study|Withdrawal by Subject|1|||
130099364|NCT00762073|468320968|FG001|Overall Study|Withdrawal by Subject|2|||
130099365|NCT00762073|468320969|FG002|Overall Study|Withdrawal by Subject|1|||
130099366|NCT00762073|468320970|FG003|Overall Study|Withdrawal by Subject|1|||
130225692|NCT00715403|468790017|FG006|Overall Study|Other Adverse Event than DLT|0|||
130225693|NCT00715403|468790011|FG000|Overall Study|Protocol Violation|0|||
130225694|NCT00715403|468790012|FG001|Overall Study|Protocol Violation|0|||
130225695|NCT00715403|468790013|FG002|Overall Study|Protocol Violation|0|||
130225696|NCT00715403|468790014|FG003|Overall Study|Protocol Violation|0|||
130225697|NCT00715403|468790015|FG004|Overall Study|Protocol Violation|0|||
130225698|NCT00715403|468790016|FG005|Overall Study|Protocol Violation|1|||
130225699|NCT00715403|468790017|FG006|Overall Study|Protocol Violation|0|||
130225700|NCT00715403|468790011|FG000|Overall Study|Other reason not defined above|0|||
130225701|NCT00715403|468790012|FG001|Overall Study|Other reason not defined above|0|||
130225702|NCT00715403|468790013|FG002|Overall Study|Other reason not defined above|1|||
130225703|NCT00715403|468790014|FG003|Overall Study|Other reason not defined above|0|||
130225704|NCT00715403|468790015|FG004|Overall Study|Other reason not defined above|1|||
130225705|NCT00715403|468790016|FG005|Overall Study|Other reason not defined above|1|||
130225706|NCT00715403|468790017|FG006|Overall Study|Other reason not defined above|0|||
130225707|NCT01789047|468790018|FG000|Overall Study|Adverse Event|3|||
130225708|NCT01789047|468790019|FG001|Overall Study|Adverse Event|2|||
130225709|NCT01789047|468790018|FG000|Overall Study|Withdrawal by Subject|1|||
130225710|NCT01789047|468790019|FG001|Overall Study|Withdrawal by Subject|2|||
130225711|NCT03644017|468790020|FG000|Overall Study|Access Abandonment|5|||
130225712|NCT03644017|468790020|FG000|Overall Study|Kidney Transplant|2|||
130225713|NCT02340000|468790023|FG000|Time Period 1|Withdrawal by Subject|6|||
130225714|NCT02340000|468790024|FG001|Time Period 1|Withdrawal by Subject|8|||
130225715|NCT02340000|468790023|FG000|Time Period 1|Lost to Follow-up|6|||
130225716|NCT02340000|468790024|FG001|Time Period 1|Lost to Follow-up|7|||
130225717|NCT02340000|468790023|FG000|Time Period 2|Withdrawal by Subject|9|||
130225718|NCT02340000|468790024|FG001|Time Period 2|Withdrawal by Subject|7|||
130225719|NCT02340000|468790023|FG000|Time Period 2|Lost to Follow-up|10|||
130225720|NCT02340000|468790024|FG001|Time Period 2|Lost to Follow-up|8|||
130225721|NCT01883895|468790029|FG000|Overall Study|Lost to Follow-up|2|||
130225722|NCT00073918|468790030|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
130225723|NCT00073918|468790030|FG000|Overall Study|Rapid disease progression|2|||
130225724|NCT00073918|468790030|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
130225725|NCT00919633|468790033|FG000|Overall Study|Adverse Event|1|||
130225726|NCT00919633|468790034|FG001|Overall Study|Adverse Event|9|||
130225727|NCT00919633|468790035|FG002|Overall Study|Adverse Event|12|||
130225728|NCT00919633|468790036|FG003|Overall Study|Adverse Event|10|||
130225729|NCT00919633|468790033|FG000|Overall Study|Death|0|||
130225730|NCT00919633|468790034|FG001|Overall Study|Death|0|||
130225731|NCT00919633|468790035|FG002|Overall Study|Death|2|||
130225732|NCT00919633|468790036|FG003|Overall Study|Death|0|||
130225733|NCT00919633|468790033|FG000|Overall Study|Lack of Efficacy|17|||
130225734|NCT00919633|468790034|FG001|Overall Study|Lack of Efficacy|3|||
130225735|NCT00919633|468790035|FG002|Overall Study|Lack of Efficacy|2|||
130225736|NCT00919633|468790036|FG003|Overall Study|Lack of Efficacy|3|||
130225737|NCT00919633|468790033|FG000|Overall Study|Withdrawal by Subject|1|||
130225738|NCT00919633|468790034|FG001|Overall Study|Withdrawal by Subject|2|||
130225739|NCT00919633|468790035|FG002|Overall Study|Withdrawal by Subject|4|||
130225740|NCT00919633|468790036|FG003|Overall Study|Withdrawal by Subject|3|||
130225741|NCT00919633|468790033|FG000|Overall Study|Lost to Follow-up|3|||
130225742|NCT00919633|468790034|FG001|Overall Study|Lost to Follow-up|1|||
130225743|NCT00919633|468790035|FG002|Overall Study|Lost to Follow-up|0|||
130225744|NCT00919633|468790036|FG003|Overall Study|Lost to Follow-up|2|||
130225745|NCT00919633|468790033|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
130225746|NCT00919633|468790034|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
130021853|NCT02064387|468040658|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021854|NCT02064387|468040659|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130225747|NCT00919633|468790035|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
130225748|NCT00919633|468790036|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
130225749|NCT00919633|468790033|FG000|Overall Study|Protocol Violation|0|||
130225750|NCT00919633|468790034|FG001|Overall Study|Protocol Violation|0|||
130225751|NCT00919633|468790035|FG002|Overall Study|Protocol Violation|0|||
130225752|NCT00919633|468790036|FG003|Overall Study|Protocol Violation|1|||
130225753|NCT00919633|468790033|FG000|Overall Study|Physician Decision|0|||
130225754|NCT00919633|468790034|FG001|Overall Study|Physician Decision|0|||
130225755|NCT00919633|468790035|FG002|Overall Study|Physician Decision|0|||
130225756|NCT00919633|468790036|FG003|Overall Study|Physician Decision|1|||
130225757|NCT00919633|468790033|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
130225758|NCT00919633|468790034|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
130225759|NCT00919633|468790035|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
130225760|NCT00919633|468790036|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
130225761|NCT00919633|468790033|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
130225762|NCT00919633|468790034|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
130225763|NCT00919633|468790035|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
130225764|NCT00919633|468790036|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
130225765|NCT02481050|468791699|FG000|Overall Study|Adverse Event|1|||
130225766|NCT02481050|468791699|FG000|Overall Study|Disease Progression|47|||
130225767|NCT02481050|468791699|FG000|Overall Study|Withdrawal by Subject|7|||
130225768|NCT02481050|468791699|FG000|Overall Study|Other|3|||
130225769|NCT03246347|468791702|FG000|Overall Study|On Study|23|||
130225770|NCT02188160|468791703|FG000|Overall Study|Adverse Event|1|||
130225771|NCT02188160|468791704|FG001|Overall Study|Adverse Event|0|||
130225772|NCT02188160|468791703|FG000|Overall Study|Use of an excluded medication|0|||
130225773|NCT02188160|468791704|FG001|Overall Study|Use of an excluded medication|1|||
130225774|NCT04113694|468791705|FG000|Overall Study|Adverse Event|2|||
130225775|NCT04113694|468791705|FG000|Overall Study|Lost to Follow-up|2|||
130225776|NCT04113694|468791705|FG000|Overall Study|Withdrawal by Subject|6|||
130225777|NCT04113694|468791705|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
130225778|NCT01022203|468791712|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
130225779|NCT01022203|468791713|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
130225780|NCT01022203|468791712|FG000|Post Treatment Assessment|Physician Decision|2|||
130225781|NCT01022203|468791713|FG001|Post Treatment Assessment|Physician Decision|0|||
130225782|NCT01022203|468791712|FG000|Post Treatment Assessment|Adverse Event|0|||
130225783|NCT01022203|468791713|FG001|Post Treatment Assessment|Adverse Event|2|||
130225784|NCT01022203|468791712|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
130225785|NCT01022203|468791713|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
130225786|NCT03638128|468791716|FG000|Overall Study|Withdrawal by Subject|1|||
130225787|NCT03638128|468791717|FG001|Overall Study|Withdrawal by Subject|7|||
130225788|NCT03638128|468791718|FG002|Overall Study|Withdrawal by Subject|6|||
130225789|NCT03638128|468791716|FG000|Overall Study|Sponsor Decision|15|||
130225790|NCT03638128|468791717|FG001|Overall Study|Sponsor Decision|12|||
130225791|NCT03638128|468791718|FG002|Overall Study|Sponsor Decision|19|||
130225792|NCT03638128|468791716|FG000|Overall Study|Lost to Follow-up|0|||
130225793|NCT03638128|468791717|FG001|Overall Study|Lost to Follow-up|0|||
130225794|NCT03638128|468791718|FG002|Overall Study|Lost to Follow-up|1|||
130225795|NCT00903201|468791720|FG000|Overall Study|Adverse Event|1|||
130225796|NCT00903201|468791721|FG001|Overall Study|Adverse Event|4|||
130225797|NCT00903201|468791722|FG002|Overall Study|Adverse Event|0|||
130225798|NCT00903201|468791720|FG000|Overall Study|Protocol Violation|2|||
130225799|NCT00903201|468791721|FG001|Overall Study|Protocol Violation|1|||
130225800|NCT00903201|468791722|FG002|Overall Study|Protocol Violation|0|||
130225801|NCT00903201|468791720|FG000|Overall Study|Lost to Follow-up|0|||
130225802|NCT00903201|468791721|FG001|Overall Study|Lost to Follow-up|1|||
130225803|NCT00903201|468791722|FG002|Overall Study|Lost to Follow-up|0|||
130225804|NCT00903201|468791720|FG000|Overall Study|Physician Decision|1|||
130225805|NCT00903201|468791721|FG001|Overall Study|Physician Decision|0|||
130225806|NCT00903201|468791722|FG002|Overall Study|Physician Decision|1|||
130225807|NCT00903201|468791720|FG000|Overall Study|Withdrawal by Subject|1|||
130225808|NCT00903201|468791721|FG001|Overall Study|Withdrawal by Subject|0|||
130225809|NCT00903201|468791722|FG002|Overall Study|Withdrawal by Subject|1|||
130225810|NCT00329108|468791723|FG000|Overall Study|Adverse Event|2|||
130225811|NCT00329108|468791724|FG001|Overall Study|Adverse Event|2|||
130225812|NCT00329108|468791723|FG000|Overall Study|Lack of Efficacy|3|||
130225813|NCT00329108|468791724|FG001|Overall Study|Lack of Efficacy|3|||
130225814|NCT00329108|468791723|FG000|Overall Study|Withdrawal by Subject|0|||
130225815|NCT00329108|468791724|FG001|Overall Study|Withdrawal by Subject|2|||
130099367|NCT00762073|468320967|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
130099368|NCT00762073|468320968|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
130099369|NCT00762073|468320969|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
130099370|NCT00762073|468320970|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
130099371|NCT00491322|468320972|FG000|Overall Study|Protocol Violation|1|||
130099372|NCT00491322|468320973|FG001|Overall Study|Protocol Violation|0|||
130099373|NCT00491322|468320972|FG000|Overall Study|Pregnancy|0|||
130099374|NCT00491322|468320973|FG001|Overall Study|Pregnancy|1|||
130099375|NCT00455923|468320974|FG000|Overall Study|Pregnancy|0|||
130099376|NCT00455923|468320975|FG001|Overall Study|Pregnancy|2|||
130225816|NCT00329108|468791723|FG000|Overall Study|symptomatic deterioration|1|||
130225817|NCT00329108|468791724|FG001|Overall Study|symptomatic deterioration|1|||
130225818|NCT00329108|468791723|FG000|Overall Study|Subject no longer willing to participate|2|||
130225819|NCT00329108|468791724|FG001|Overall Study|Subject no longer willing to participate|2|||
130225820|NCT00329108|468791723|FG000|Overall Study|study terminated by sponsor|1|||
130225821|NCT00329108|468791724|FG001|Overall Study|study terminated by sponsor|0|||
130225822|NCT00329108|468791723|FG000|Overall Study|withdrew patient after SAE resolved|1|||
130225823|NCT00329108|468791724|FG001|Overall Study|withdrew patient after SAE resolved|0|||
130099377|NCT00455923|468320974|FG000|Overall Study|Other|3|||
130225824|NCT00329108|468791723|FG000|Overall Study|Protocol Violation|0|||
130225825|NCT00329108|468791724|FG001|Overall Study|Protocol Violation|2|||
130225826|NCT01094288|468791727|FG000|Overall Study|Adverse Event|0|||
130225827|NCT01094288|468791728|FG001|Overall Study|Adverse Event|3|||
130225828|NCT01094288|468791729|FG002|Overall Study|Adverse Event|1|||
130225829|NCT01094288|468791730|FG003|Overall Study|Adverse Event|1|||
130225830|NCT01094288|468791731|FG004|Overall Study|Adverse Event|0|||
130225831|NCT01094288|468791732|FG005|Overall Study|Adverse Event|0|||
130225832|NCT01094288|468791733|FG006|Overall Study|Adverse Event|0|||
130225833|NCT01094288|468791734|FG007|Overall Study|Adverse Event|0|||
130225834|NCT01094288|468791727|FG000|Overall Study|Withdrawal by Subject|0|||
130225835|NCT01094288|468791728|FG001|Overall Study|Withdrawal by Subject|1|||
130225836|NCT01094288|468791729|FG002|Overall Study|Withdrawal by Subject|2|||
130225837|NCT01094288|468791730|FG003|Overall Study|Withdrawal by Subject|0|||
130225838|NCT01094288|468791731|FG004|Overall Study|Withdrawal by Subject|0|||
130225839|NCT01094288|468791732|FG005|Overall Study|Withdrawal by Subject|0|||
130225840|NCT01094288|468791733|FG006|Overall Study|Withdrawal by Subject|0|||
130225841|NCT01094288|468791734|FG007|Overall Study|Withdrawal by Subject|2|||
130225842|NCT01094288|468791727|FG000|Overall Study|Initiation of Alternative Therapy|0|||
130225843|NCT01094288|468791728|FG001|Overall Study|Initiation of Alternative Therapy|0|||
130225844|NCT01094288|468791729|FG002|Overall Study|Initiation of Alternative Therapy|1|||
130225845|NCT01094288|468791730|FG003|Overall Study|Initiation of Alternative Therapy|0|||
130225846|NCT01094288|468791731|FG004|Overall Study|Initiation of Alternative Therapy|0|||
130225847|NCT01094288|468791732|FG005|Overall Study|Initiation of Alternative Therapy|0|||
130225848|NCT01094288|468791733|FG006|Overall Study|Initiation of Alternative Therapy|0|||
130225849|NCT01094288|468791734|FG007|Overall Study|Initiation of Alternative Therapy|0|||
130225850|NCT01094288|468791727|FG000|Overall Study|Reason not Specified|2|||
130225851|NCT01094288|468791728|FG001|Overall Study|Reason not Specified|3|||
130225852|NCT01094288|468791729|FG002|Overall Study|Reason not Specified|0|||
130225853|NCT01094288|468791730|FG003|Overall Study|Reason not Specified|1|||
130225854|NCT01094288|468791731|FG004|Overall Study|Reason not Specified|0|||
130021855|NCT02064387|468040660|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021856|NCT02064387|468040661|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021857|NCT02064387|468040662|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021858|NCT02064387|468040663|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021859|NCT02064387|468040664|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021860|NCT02064387|468040665|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
130021861|NCT02064387|468040666|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
130021862|NCT02706730|468040667|FG000|Overall Study|Adverse Event|3|||
130021863|NCT02706730|468040667|FG000|Overall Study|Lack of Efficacy|5|||
130021864|NCT02706730|468040667|FG000|Overall Study|Withdrawal by Subject|11|||
130021865|NCT02706730|468040667|FG000|Overall Study|Study Terminated by Sponsor|11|||
130021866|NCT02706730|468040667|FG000|Overall Study|Subject chose not to receive injection|3|||
130021867|NCT02499029|468040672|FG000|Overall Study|Lost to Follow-up|2|||
130021868|NCT02499029|468040673|FG001|Overall Study|Lost to Follow-up|2|||
130021869|NCT02499029|468040672|FG000|Overall Study|Physician Decision|2|||
130021870|NCT02499029|468040673|FG001|Overall Study|Physician Decision|1|||
130021871|NCT02499029|468040672|FG000|Overall Study|Death|1|||
130021872|NCT02499029|468040673|FG001|Overall Study|Death|0|||
130021873|NCT01999582|468040674|FG000|Overall Study|Withdrawal by Subject|0|||
130021874|NCT01999582|468040675|FG001|Overall Study|Withdrawal by Subject|0|||
130021875|NCT01999582|468040676|FG002|Overall Study|Withdrawal by Subject|0|||
130021876|NCT01999582|468040677|FG003|Overall Study|Withdrawal by Subject|1|||
130021877|NCT01999582|468040678|FG004|Overall Study|Withdrawal by Subject|0|||
130099378|NCT00455923|468320975|FG001|Overall Study|Other|1|||
130099379|NCT02331680|468320977|FG000|Overall Study|Adverse Event|3|||
130099380|NCT02331680|468320978|FG001|Overall Study|Adverse Event|0|||
130099381|NCT02331680|468320979|FG002|Overall Study|Adverse Event|2|||
130099382|NCT02331680|468320977|FG000|Overall Study|Physician Decision|1|||
130099383|NCT02331680|468320978|FG001|Overall Study|Physician Decision|1|||
130099384|NCT02331680|468320979|FG002|Overall Study|Physician Decision|2|||
130099385|NCT02331680|468320977|FG000|Overall Study|Withdrawal by Subject|0|||
130099386|NCT02331680|468320978|FG001|Overall Study|Withdrawal by Subject|1|||
130021878|NCT01999582|468040679|FG005|Overall Study|Withdrawal by Subject|0|||
130099387|NCT02331680|468320979|FG002|Overall Study|Withdrawal by Subject|2|||
130099388|NCT02331680|468320977|FG000|Overall Study|Met withdrawal criteria|2|||
130099389|NCT02331680|468320978|FG001|Overall Study|Met withdrawal criteria|2|||
130099390|NCT02331680|468320979|FG002|Overall Study|Met withdrawal criteria|5|||
130021879|NCT01999582|468040674|FG000|Overall Study|Adverse Event|0|||
130099391|NCT02331680|468320977|FG000|Overall Study|Non-compliance with study drug|0|||
130099392|NCT02331680|468320978|FG001|Overall Study|Non-compliance with study drug|0|||
130225855|NCT01094288|468791732|FG005|Overall Study|Reason not Specified|0|||
130225856|NCT01094288|468791733|FG006|Overall Study|Reason not Specified|0|||
130225857|NCT01094288|468791734|FG007|Overall Study|Reason not Specified|0|||
130225858|NCT01094288|468791727|FG000|Overall Study|Ongoing Participants|0|||
130225859|NCT01094288|468791728|FG001|Overall Study|Ongoing Participants|3|||
130225860|NCT01094288|468791729|FG002|Overall Study|Ongoing Participants|0|||
130225861|NCT01094288|468791730|FG003|Overall Study|Ongoing Participants|0|||
130225862|NCT01094288|468791731|FG004|Overall Study|Ongoing Participants|0|||
130225863|NCT01094288|468791732|FG005|Overall Study|Ongoing Participants|0|||
130225864|NCT01094288|468791733|FG006|Overall Study|Ongoing Participants|0|||
130225865|NCT01094288|468791734|FG007|Overall Study|Ongoing Participants|0|||
130225866|NCT02611882|468791735|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
130225867|NCT02611882|468791736|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
130225868|NCT02611882|468791737|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
130225869|NCT01389232|468791738|FG000|Overall Study|Had scaffold removed|15|||
130225870|NCT01389232|468791738|FG000|Overall Study|Personal reasons|2|||
130225871|NCT01389232|468791738|FG000|Overall Study|Adverse Event|1|||
130225872|NCT01389232|468791738|FG000|Overall Study|Death|1|||
130225873|NCT01317940|468791739|FG000|Overall Study|Death|1|||
130225874|NCT01317940|468791740|FG001|Overall Study|Death|0|||
130225875|NCT01317940|468791741|FG002|Overall Study|Death|1|||
130225876|NCT01317940|468791742|FG003|Overall Study|Death|0|||
130225877|NCT01317940|468791743|FG004|Overall Study|Death|0|||
130225878|NCT01317940|468791744|FG005|Overall Study|Death|0|||
130225879|NCT01317940|468791739|FG000|Overall Study|Lost to Follow-up|0|||
130225880|NCT01317940|468791740|FG001|Overall Study|Lost to Follow-up|0|||
130225881|NCT01317940|468791741|FG002|Overall Study|Lost to Follow-up|1|||
130225882|NCT01317940|468791742|FG003|Overall Study|Lost to Follow-up|1|||
130225883|NCT01317940|468791743|FG004|Overall Study|Lost to Follow-up|1|||
130225884|NCT01317940|468791744|FG005|Overall Study|Lost to Follow-up|0|||
130225885|NCT01317940|468791739|FG000|Overall Study|Change in therapy plan|0|||
130225886|NCT01317940|468791740|FG001|Overall Study|Change in therapy plan|0|||
130225887|NCT01317940|468791741|FG002|Overall Study|Change in therapy plan|3|||
130225888|NCT01317940|468791742|FG003|Overall Study|Change in therapy plan|0|||
130225889|NCT01317940|468791743|FG004|Overall Study|Change in therapy plan|0|||
130225890|NCT01317940|468791744|FG005|Overall Study|Change in therapy plan|0|||
130225891|NCT02371616|468791746|FG000|Overall Study|Protocol Violation|2|||
130225892|NCT02371616|468791747|FG001|Overall Study|Protocol Violation|1|||
130225893|NCT02371616|468791746|FG000|Overall Study|Adverse Event|0|||
130225894|NCT02371616|468791747|FG001|Overall Study|Adverse Event|1|||
130225895|NCT02371616|468791746|FG000|Overall Study|Withdrawal of Consent|1|||
130225896|NCT02371616|468791747|FG001|Overall Study|Withdrawal of Consent|0|||
130225897|NCT02371616|468791746|FG000|Overall Study|Other (Not specified)|1|||
130225898|NCT02371616|468791747|FG001|Overall Study|Other (Not specified)|5|||
130225899|NCT00754741|468791748|FG000|Overall Study|Died or disenrolled|57|||
130225900|NCT00754741|468791749|FG001|Overall Study|Died or disenrolled|69|||
130225901|NCT00754741|468791750|FG002|Overall Study|Died or disenrolled|54|||
130225902|NCT04152200|468791752|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
130225903|NCT04152200|468791753|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
130225904|NCT00593814|468791754|FG000|Overall Study|Death|7|||
130225905|NCT00593814|468791755|FG001|Overall Study|Death|0|||
130225906|NCT00593814|468791754|FG000|Overall Study|Withdrawal by Subject|7|||
130225907|NCT00593814|468791755|FG001|Overall Study|Withdrawal by Subject|0|||
130225908|NCT00593814|468791754|FG000|Overall Study|Lost to Follow-up|7|||
130225909|NCT00593814|468791755|FG001|Overall Study|Lost to Follow-up|0|||
130225910|NCT00593814|468791754|FG000|Overall Study|Physician Decision|3|||
130225911|NCT00593814|468791755|FG001|Overall Study|Physician Decision|0|||
130225912|NCT02699996|468791756|FG000|Overall Study|Withdrawal by Subject|5|||
130225913|NCT02699996|468791757|FG001|Overall Study|Withdrawal by Subject|2|||
130225914|NCT04069715|468791758|FG000|Overall Study|Lost to Follow-up|1|||
130225915|NCT04069715|468791759|FG001|Overall Study|Lost to Follow-up|1|||
130225916|NCT04069715|468791758|FG000|Overall Study|Physician Decision|1|||
130225917|NCT04069715|468791759|FG001|Overall Study|Physician Decision|1|||
130225918|NCT04069715|468791758|FG000|Overall Study|Withdrawal by Subject|3|||
130021880|NCT01999582|468040675|FG001|Overall Study|Adverse Event|0|||
130225919|NCT04069715|468791759|FG001|Overall Study|Withdrawal by Subject|3|||
130225920|NCT03205150|468791760|FG000|Overall Study|Protocol deviation|1|||
130225921|NCT03205150|468791761|FG001|Overall Study|Protocol deviation|3|||
130225922|NCT03205150|468791762|FG002|Overall Study|Protocol deviation|0|||
130225923|NCT03205150|468791760|FG000|Overall Study|Patient/guardian decision|0|||
130021881|NCT01999582|468040676|FG002|Overall Study|Adverse Event|3|||
130225924|NCT03205150|468791761|FG001|Overall Study|Patient/guardian decision|3|||
130225925|NCT03205150|468791762|FG002|Overall Study|Patient/guardian decision|0|||
130021882|NCT01999582|468040677|FG003|Overall Study|Adverse Event|0|||
130225926|NCT03205150|468791760|FG000|Overall Study|Adverse Event|1|||
130225927|NCT03205150|468791761|FG001|Overall Study|Adverse Event|1|||
130225928|NCT03205150|468791762|FG002|Overall Study|Adverse Event|1|||
130225929|NCT03205150|468791760|FG000|Overall Study|Lost to Follow-up|0|||
130225930|NCT03205150|468791761|FG001|Overall Study|Lost to Follow-up|0|||
130225931|NCT03205150|468791762|FG002|Overall Study|Lost to Follow-up|1|||
130225932|NCT02723188|468791763|FG000|Overall Study|Withdrawal by Subject|1|||
130225933|NCT02723188|468791764|FG001|Overall Study|Withdrawal by Subject|0|||
130225934|NCT02723188|468791765|FG002|Overall Study|Withdrawal by Subject|0|||
130225935|NCT01095835|468791766|FG000|Overall Study|Adverse Event|8|||
130225936|NCT01095835|468791767|FG001|Overall Study|Adverse Event|6|||
130225937|NCT01095835|468791768|FG002|Overall Study|Adverse Event|6|||
130225938|NCT01095835|468791766|FG000|Overall Study|Lack of Efficacy|0|||
130225939|NCT01095835|468791767|FG001|Overall Study|Lack of Efficacy|1|||
130225940|NCT01095835|468791768|FG002|Overall Study|Lack of Efficacy|0|||
130225941|NCT01095835|468791766|FG000|Overall Study|Physician Decision|0|||
130225942|NCT01095835|468791767|FG001|Overall Study|Physician Decision|0|||
130225943|NCT01095835|468791768|FG002|Overall Study|Physician Decision|1|||
130225944|NCT01095835|468791766|FG000|Overall Study|Withdrawal by Subject|1|||
130225945|NCT01095835|468791767|FG001|Overall Study|Withdrawal by Subject|3|||
130225946|NCT01095835|468791768|FG002|Overall Study|Withdrawal by Subject|0|||
130225947|NCT01095835|468791766|FG000|Overall Study|Non study compliance|0|||
130225948|NCT01095835|468791767|FG001|Overall Study|Non study compliance|0|||
130225949|NCT01095835|468791768|FG002|Overall Study|Non study compliance|1|||
130225950|NCT01095835|468791766|FG000|Overall Study|Protocol Violation|1|||
130225951|NCT01095835|468791767|FG001|Overall Study|Protocol Violation|2|||
130225952|NCT01095835|468791768|FG002|Overall Study|Protocol Violation|0|||
130225953|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
130225954|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
130225955|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
130225956|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
130225957|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
130225958|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
130225959|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
130225960|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
130225961|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
130225962|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
130225963|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
130225964|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
130225965|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
130225966|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
130225967|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
130225968|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
130225969|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
130225970|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
130225971|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
130225972|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
130225973|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
130225974|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
130225975|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
130225976|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
130225977|NCT01198002|468791771|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
130225978|NCT01198002|468791772|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
130225979|NCT01198002|468791773|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
130225980|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
130225981|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
130225982|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
130225983|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
130225984|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
130225985|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
130225986|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
130225987|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
130225988|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
130099393|NCT02331680|468320979|FG002|Overall Study|Non-compliance with study drug|1|||
130099394|NCT02331680|468320977|FG000|Overall Study|Protocol Violation|0|||
130099395|NCT02331680|468320978|FG001|Overall Study|Protocol Violation|0|||
130099396|NCT02331680|468320979|FG002|Overall Study|Protocol Violation|3|||
130225989|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
130225990|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
130225991|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
130225992|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
130225993|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
130225994|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
130225995|NCT01198002|468791771|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
130225996|NCT01198002|468791772|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
130225997|NCT01198002|468791773|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
130225998|NCT00789321|468791777|FG000|Overall Study|Adverse Event|0|||
130225999|NCT00789321|468791778|FG001|Overall Study|Adverse Event|1|||
130226000|NCT03652818|468791782|FG000|Overall Study|Adverse Event|1|||
130226001|NCT03652818|468791783|FG001|Overall Study|Adverse Event|0|||
130226002|NCT03652818|468791784|FG002|Overall Study|Adverse Event|0|||
130226003|NCT03652818|468791785|FG003|Overall Study|Adverse Event|0|||
130226004|NCT03652818|468791786|FG004|Overall Study|Adverse Event|0|||
130226005|NCT03652818|468791782|FG000|Overall Study|Physician Decision|1|||
130226006|NCT03652818|468791783|FG001|Overall Study|Physician Decision|0|||
130226007|NCT03652818|468791784|FG002|Overall Study|Physician Decision|0|||
130226008|NCT03652818|468791785|FG003|Overall Study|Physician Decision|0|||
130226009|NCT03652818|468791786|FG004|Overall Study|Physician Decision|0|||
130226010|NCT03652818|468791782|FG000|Overall Study|Lost to Follow-up|0|||
130226011|NCT03652818|468791783|FG001|Overall Study|Lost to Follow-up|1|||
130226012|NCT03652818|468791784|FG002|Overall Study|Lost to Follow-up|2|||
130226013|NCT03652818|468791785|FG003|Overall Study|Lost to Follow-up|1|||
130226014|NCT03652818|468791786|FG004|Overall Study|Lost to Follow-up|1|||
130226015|NCT01930539|468791791|FG000|Overall Study|Withdrawal by Subject|2|||
130226016|NCT01930539|468791792|FG001|Overall Study|Withdrawal by Subject|2|||
130226017|NCT00830219|468791793|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130226018|NCT00830219|468791794|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130226019|NCT01811732|468791795|FG000|Overall Study|Lost to Follow-up|24|||
130226020|NCT01811732|468791796|FG001|Overall Study|Lost to Follow-up|30|||
130226021|NCT01811732|468791795|FG000|Overall Study|Withdrawal by Subject|16|||
130226022|NCT01811732|468791796|FG001|Overall Study|Withdrawal by Subject|10|||
130226023|NCT01811732|468791795|FG000|Overall Study|Adverse Event|3|||
130226024|NCT01811732|468791796|FG001|Overall Study|Adverse Event|9|||
130226025|NCT01811732|468791795|FG000|Overall Study|Lack of Efficacy|3|||
130226026|NCT01811732|468791796|FG001|Overall Study|Lack of Efficacy|1|||
130226027|NCT01811732|468791795|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
130226028|NCT01811732|468791796|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
130226029|NCT01811732|468791795|FG000|Overall Study|Physician Decision|2|||
130226030|NCT01811732|468791796|FG001|Overall Study|Physician Decision|0|||
130226031|NCT01811732|468791795|FG000|Overall Study|Death|1|||
130226032|NCT01811732|468791796|FG001|Overall Study|Death|1|||
130226033|NCT01811732|468791795|FG000|Overall Study|Insufficient venous access|0|||
130226034|NCT01811732|468791796|FG001|Overall Study|Insufficient venous access|1|||
130226035|NCT01811732|468791795|FG000|Overall Study|Protocol Violation|0|||
130226036|NCT01811732|468791796|FG001|Overall Study|Protocol Violation|1|||
130226037|NCT01811732|468791795|FG000|Overall Study|Subject incarcerated|1|||
130226038|NCT01811732|468791796|FG001|Overall Study|Subject incarcerated|2|||
130226039|NCT01811732|468791795|FG000|Overall Study|Admitted to another facility|1|||
130226040|NCT01811732|468791796|FG001|Overall Study|Admitted to another facility|0|||
130226041|NCT01811732|468791795|FG000|Overall Study|Correct study drug not available on site|1|||
130226042|NCT01811732|468791796|FG001|Overall Study|Correct study drug not available on site|0|||
130226043|NCT00288912|468791799|FG000|Overall Study|Developed exclusion criterion|4|||
130226044|NCT00288912|468791800|FG001|Overall Study|Developed exclusion criterion|6|||
130226045|NCT00288912|468791801|FG002|Overall Study|Developed exclusion criterion|7|||
130226046|NCT00288912|468791799|FG000|Overall Study|Lost to Follow-up|9|||
130226047|NCT00288912|468791800|FG001|Overall Study|Lost to Follow-up|6|||
130226048|NCT00288912|468791801|FG002|Overall Study|Lost to Follow-up|9|||
130226049|NCT00288912|468791799|FG000|Overall Study|Withdrawal by Subject|4|||
130226050|NCT00288912|468791800|FG001|Overall Study|Withdrawal by Subject|5|||
130226051|NCT00288912|468791801|FG002|Overall Study|Withdrawal by Subject|12|||
130226052|NCT01868646|468791802|FG000|Overall Study|Do not meet inclusion criteria|3|||
130226053|NCT01868646|468791803|FG001|Overall Study|Do not meet inclusion criteria|5|||
130226054|NCT01783743|468791808|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
130226055|NCT01783743|468791809|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
130226056|NCT01783743|468791808|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
130226057|NCT01783743|468791809|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
130226058|NCT01783743|468791808|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
130226059|NCT01783743|468791809|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
130226060|NCT01607593|468791810|FG000|Overall Study|Adverse Event|15|||
130226061|NCT01607593|468791810|FG000|Overall Study|Lack of Efficacy|16|||
130226062|NCT01607593|468791810|FG000|Overall Study|Lost to Follow-up|25|||
130226063|NCT01607593|468791810|FG000|Overall Study|Continuation|33|||
130226064|NCT01607593|468791810|FG000|Overall Study|Other|4|||
130226065|NCT02771275|468791811|FG000|Overall Study|Reoperation|3|||
130226066|NCT02771275|468791811|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
130226067|NCT00728494|468791824|FG000|Overall Study|Adverse Event|7|||
130226068|NCT00728494|468791825|FG001|Overall Study|Adverse Event|0|||
130226069|NCT00728494|468791824|FG000|Overall Study|Withdrawal by Subject|0|||
130226070|NCT00728494|468791825|FG001|Overall Study|Withdrawal by Subject|2|||
130226071|NCT00728494|468791824|FG000|Overall Study|Lack of Efficacy|2|||
130226072|NCT00728494|468791825|FG001|Overall Study|Lack of Efficacy|4|||
130226073|NCT00728494|468791824|FG000|Overall Study|No data available|0|||
130226074|NCT00728494|468791825|FG001|Overall Study|No data available|1|||
130226075|NCT03439137|468791826|FG000|Overall Study|Adverse Event|16|||
130226076|NCT03439137|468791827|FG001|Overall Study|Adverse Event|12|||
130226077|NCT03439137|468791826|FG000|Overall Study|Physician Decision|0|||
130226078|NCT03439137|468791827|FG001|Overall Study|Physician Decision|5|||
130226079|NCT03439137|468791826|FG000|Overall Study|Withdrawal by Subject|14|||
130226080|NCT03439137|468791827|FG001|Overall Study|Withdrawal by Subject|4|||
130226081|NCT03439137|468791826|FG000|Overall Study|Conducting rescue therapy|2|||
130226082|NCT03439137|468791827|FG001|Overall Study|Conducting rescue therapy|1|||
130226083|NCT03439137|468791826|FG000|Overall Study|Difficult to control Hb|10|||
130226084|NCT03439137|468791827|FG001|Overall Study|Difficult to control Hb|2|||
130226085|NCT03439137|468791826|FG000|Overall Study|Initiation of a renal transplant|0|||
130226086|NCT03439137|468791827|FG001|Overall Study|Initiation of a renal transplant|2|||
130226087|NCT01240382|468791829|FG000|Overall Study|Adverse Event|2|||
130226088|NCT01240382|468791830|FG001|Overall Study|Adverse Event|1|||
130226089|NCT01240382|468791829|FG000|Overall Study|Lack of Efficacy|0|||
130226090|NCT01240382|468791830|FG001|Overall Study|Lack of Efficacy|2|||
130226091|NCT01240382|468791829|FG000|Overall Study|Fear of adverse events|0|||
130226092|NCT01240382|468791830|FG001|Overall Study|Fear of adverse events|1|||
130226093|NCT02456727|468791831|FG000|Overall Study|Lost to Follow-up|63|||
130226094|NCT02456727|468791832|FG001|Overall Study|Lost to Follow-up|65|||
130226095|NCT02456727|468791831|FG000|Overall Study|Death|2|||
130226096|NCT02456727|468791832|FG001|Overall Study|Death|1|||
130226097|NCT02456727|468791831|FG000|Overall Study|Withdrawal by Subject|1|||
130226098|NCT02456727|468791832|FG001|Overall Study|Withdrawal by Subject|10|||
130226099|NCT02456727|468791831|FG000|Overall Study|Never Initiated Treatment|43|||
130226100|NCT02456727|468791832|FG001|Overall Study|Never Initiated Treatment|30|||
130226101|NCT02643693|468791833|FG000|Overall Study|Physician Decision|0|||
130226102|NCT02643693|468791834|FG001|Overall Study|Physician Decision|1|||
130226103|NCT02643693|468791835|FG002|Overall Study|Physician Decision|0|||
130226104|NCT02643693|468791836|FG003|Overall Study|Physician Decision|0|||
130226105|NCT02643693|468791837|FG004|Overall Study|Physician Decision|0|||
130226106|NCT02643693|468791838|FG005|Overall Study|Physician Decision|0|||
130226107|NCT02643693|468791833|FG000|Overall Study|Withdrawal by Subject|0|||
130226108|NCT02643693|468791834|FG001|Overall Study|Withdrawal by Subject|1|||
130226109|NCT02643693|468791835|FG002|Overall Study|Withdrawal by Subject|0|||
130226110|NCT02643693|468791836|FG003|Overall Study|Withdrawal by Subject|0|||
130226111|NCT02643693|468791837|FG004|Overall Study|Withdrawal by Subject|0|||
130226112|NCT02643693|468791838|FG005|Overall Study|Withdrawal by Subject|0|||
130226113|NCT02643693|468791833|FG000|Overall Study|Protocol Adherence Issues|2|||
130226114|NCT02643693|468791834|FG001|Overall Study|Protocol Adherence Issues|0|||
130226115|NCT02643693|468791835|FG002|Overall Study|Protocol Adherence Issues|1|||
130226116|NCT02643693|468791836|FG003|Overall Study|Protocol Adherence Issues|0|||
130226117|NCT02643693|468791837|FG004|Overall Study|Protocol Adherence Issues|0|||
130226118|NCT02643693|468791838|FG005|Overall Study|Protocol Adherence Issues|1|||
130226119|NCT00888654|468791839|FG000|Overall Study|Problems swallowing oral meds.|1|||
130226120|NCT00888654|468791839|FG000|Overall Study|Not enough oral meds before surgery|3|||
130226121|NCT00888654|468791839|FG000|Overall Study|Surgery aborted|2|||
130226122|NCT00888654|468791839|FG000|Overall Study|Withdrawal by Subject|1|||
130226123|NCT00888654|468791839|FG000|Overall Study|Inelig. due to contraindication of med|1|||
130226124|NCT00888654|468791839|FG000|Overall Study|Change in surg date|1|||
130226125|NCT00888654|468791839|FG000|Overall Study|Stopped meds due to headaches|1|||
130226126|NCT03829462|468791843|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
130226127|NCT03829462|468791844|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
130226128|NCT03829462|468791843|FG000|Overall Study|No treatment due to progression disease|0|||
130226129|NCT03829462|468791844|FG001|Overall Study|No treatment due to progression disease|1|||
130226130|NCT00791999|468791846|FG000|Overall Study|Protocol planed withdrawal|14|||
130226131|NCT00791999|468791847|FG001|Overall Study|Protocol planed withdrawal|11|||
130226132|NCT00791999|468791848|FG002|Overall Study|Protocol planed withdrawal|11|||
130226133|NCT00791999|468791849|FG003|Overall Study|Protocol planed withdrawal|45|||
130226134|NCT00791999|468791846|FG000|Overall Study|Withdrawal by Subject|0|||
130226135|NCT00791999|468791847|FG001|Overall Study|Withdrawal by Subject|1|||
130226136|NCT00791999|468791848|FG002|Overall Study|Withdrawal by Subject|0|||
130226137|NCT00791999|468791849|FG003|Overall Study|Withdrawal by Subject|2|||
130226138|NCT00791999|468791846|FG000|Overall Study|Protocol Violation|3|||
130226139|NCT00791999|468791847|FG001|Overall Study|Protocol Violation|0|||
130226140|NCT00791999|468791848|FG002|Overall Study|Protocol Violation|1|||
130226141|NCT00791999|468791849|FG003|Overall Study|Protocol Violation|0|||
130226142|NCT00791999|468791846|FG000|Overall Study|Adverse Event|3|||
130226143|NCT00791999|468791847|FG001|Overall Study|Adverse Event|3|||
130226144|NCT00791999|468791848|FG002|Overall Study|Adverse Event|7|||
130226145|NCT00791999|468791849|FG003|Overall Study|Adverse Event|3|||
130226146|NCT00791999|468791846|FG000|Overall Study|Lack of Efficacy|0|||
130226147|NCT00791999|468791847|FG001|Overall Study|Lack of Efficacy|1|||
130226148|NCT00791999|468791848|FG002|Overall Study|Lack of Efficacy|0|||
130226149|NCT00791999|468791849|FG003|Overall Study|Lack of Efficacy|2|||
130226150|NCT00791999|468791846|FG000|Overall Study|Reason other than those above|1|||
130226151|NCT00791999|468791847|FG001|Overall Study|Reason other than those above|0|||
130226152|NCT00791999|468791848|FG002|Overall Study|Reason other than those above|1|||
130226153|NCT00791999|468791849|FG003|Overall Study|Reason other than those above|0|||
130226154|NCT00427908|468791850|FG000|Primary Phase|Lost to Follow-up|4|||
130226155|NCT00427908|468791851|FG001|Primary Phase|Lost to Follow-up|0|||
130226156|NCT00427908|468791852|FG002|Primary Phase|Lost to Follow-up|2|||
130226157|NCT00427908|468791853|FG003|Primary Phase|Lost to Follow-up|0|||
130226158|NCT00427908|468791850|FG000|Primary Phase|Withdrawal by Subject|1|||
130226159|NCT00427908|468791851|FG001|Primary Phase|Withdrawal by Subject|2|||
130226160|NCT00427908|468791852|FG002|Primary Phase|Withdrawal by Subject|1|||
130226161|NCT00427908|468791853|FG003|Primary Phase|Withdrawal by Subject|0|||
130226162|NCT00427908|468791850|FG000|Primary Phase|Adverse Event|0|||
130226163|NCT00427908|468791851|FG001|Primary Phase|Adverse Event|1|||
130226164|NCT00427908|468791852|FG002|Primary Phase|Adverse Event|0|||
130226165|NCT00427908|468791853|FG003|Primary Phase|Adverse Event|0|||
130226166|NCT01710020|468791854|FG000|Period 1|Protocol Violation|1|||
130226167|NCT01190813|468791855|FG000|Overall Study|Lost to Follow-up|1|||
130226168|NCT01190813|468791856|FG001|Overall Study|Lost to Follow-up|2|||
130226169|NCT01190813|468791855|FG000|Overall Study|Withdrawal by Subject|2|||
130226170|NCT01190813|468791856|FG001|Overall Study|Withdrawal by Subject|1|||
130226171|NCT01190813|468791855|FG000|Overall Study|Refused study treatment after randomized|1|||
130226172|NCT01190813|468791856|FG001|Overall Study|Refused study treatment after randomized|0|||
130226173|NCT01190813|468791855|FG000|Overall Study|Adverse Event|0|||
130226174|NCT01190813|468791856|FG001|Overall Study|Adverse Event|1|||
130226175|NCT04194814|468791857|FG000|Overall Study|Physician Decision|3|||
130226176|NCT04194814|468791858|FG001|Overall Study|Physician Decision|0|||
130226177|NCT04194814|468791857|FG000|Overall Study|Withdrawal by Subject|0|||
130226178|NCT04194814|468791858|FG001|Overall Study|Withdrawal by Subject|2|||
130226179|NCT02737358|468793556|FG000|Overall Study|Withdrawal by Subject|7|||
130226180|NCT02737358|468793557|FG001|Overall Study|Withdrawal by Subject|12|||
130226181|NCT02737358|468793556|FG000|Overall Study|Lost to Follow-up|2|||
130226182|NCT02737358|468793557|FG001|Overall Study|Lost to Follow-up|3|||
130226183|NCT03191799|468793562|FG000|Overall Study|Withdrawal by Subject|4|||
130226184|NCT03191799|468793562|FG000|Overall Study|Physician Decision|2|||
130226185|NCT03191799|468793562|FG000|Overall Study|Lost to Follow-up|1|||
130226186|NCT03191799|468793562|FG000|Overall Study|Death|2|||
130021883|NCT01999582|468040678|FG004|Overall Study|Adverse Event|1|||
130021884|NCT01999582|468040679|FG005|Overall Study|Adverse Event|0|||
130021885|NCT01999582|468040674|FG000|Overall Study|Other Reasons|1|||
130021886|NCT01999582|468040675|FG001|Overall Study|Other Reasons|0|||
130021887|NCT01999582|468040676|FG002|Overall Study|Other Reasons|3|||
130021888|NCT01999582|468040677|FG003|Overall Study|Other Reasons|1|||
130021889|NCT01999582|468040678|FG004|Overall Study|Other Reasons|1|||
130226187|NCT00748241|468793568|FG000|Overall Study|Implant failure|1|||
130226188|NCT00748241|468793568|FG000|Overall Study|Lost to Follow-up|5|||
130226189|NCT00748241|468793568|FG000|Overall Study|Death|2|||
130226190|NCT02974868|468793578|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
130226191|NCT02974868|468793579|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
130226192|NCT02974868|468793580|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
130226193|NCT02974868|468793581|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
130226194|NCT02974868|468793578|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
130226195|NCT02974868|468793579|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
130226196|NCT02974868|468793580|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
130226197|NCT02974868|468793581|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
130226198|NCT02974868|468793578|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
130226199|NCT02974868|468793579|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
130226200|NCT02974868|468793580|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
130021890|NCT01999582|468040679|FG005|Overall Study|Other Reasons|2|||
130021891|NCT01999582|468040674|FG000|Overall Study|Protocol Violation|1|||
130226201|NCT02974868|468793581|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
130226202|NCT02974868|468793578|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
130226203|NCT02974868|468793579|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
130226204|NCT02974868|468793580|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
130226205|NCT02974868|468793581|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
130226206|NCT00706004|468793582|FG000|Overall Study|Did not meet eligibility criteria|2|||
130226207|NCT00297648|468793585|FG000|Overall Study|Adverse Event|13|||
130226208|NCT00297648|468793585|FG000|Overall Study|Lack of Efficacy|18|||
130226209|NCT00297648|468793585|FG000|Overall Study|Lost to Follow-up|1|||
130226210|NCT00297648|468793585|FG000|Overall Study|Withdrawal by Subject|3|||
130226211|NCT00297648|468793585|FG000|Overall Study|Other: Incompliance|1|||
130226212|NCT03575702|468793586|FG000|Overall Study|Withdrawal by Subject|1|||
130226213|NCT03575702|468793587|FG001|Overall Study|Withdrawal by Subject|1|||
130226214|NCT03575702|468793586|FG000|Overall Study|Lost to Follow-up|1|||
130226215|NCT03575702|468793587|FG001|Overall Study|Lost to Follow-up|2|||
130226216|NCT03575702|468793586|FG000|Overall Study|Protocol Violation|0|||
130226217|NCT03575702|468793587|FG001|Overall Study|Protocol Violation|1|||
130226218|NCT03575702|468793586|FG000|Overall Study|Patient non compliance|4|||
130226219|NCT03575702|468793587|FG001|Overall Study|Patient non compliance|0|||
130226220|NCT03903172|468793588|FG000|Overall Study|screen fail|4|||
130226221|NCT03903172|468793589|FG001|Overall Study|screen fail|1|||
130226222|NCT01545388|468793590|FG000|Overall Study|Adverse Event|2|||
130226223|NCT01545388|468793591|FG001|Overall Study|Adverse Event|4|||
130226224|NCT01545388|468793592|FG002|Overall Study|Adverse Event|1|||
130226225|NCT01545388|468793590|FG000|Overall Study|Lack of Efficacy|3|||
130226226|NCT01545388|468793591|FG001|Overall Study|Lack of Efficacy|2|||
130226227|NCT01545388|468793592|FG002|Overall Study|Lack of Efficacy|5|||
130226228|NCT01545388|468793590|FG000|Overall Study|Participant moved or relocated|1|||
130226229|NCT01545388|468793591|FG001|Overall Study|Participant moved or relocated|0|||
130226230|NCT01545388|468793592|FG002|Overall Study|Participant moved or relocated|0|||
130226231|NCT01545388|468793590|FG000|Overall Study|Withdrawal by Subject|1|||
130226232|NCT01545388|468793591|FG001|Overall Study|Withdrawal by Subject|4|||
130226233|NCT01545388|468793592|FG002|Overall Study|Withdrawal by Subject|2|||
130226234|NCT01545388|468793590|FG000|Overall Study|Other|1|||
130226235|NCT01545388|468793591|FG001|Overall Study|Other|1|||
130226236|NCT01545388|468793592|FG002|Overall Study|Other|0|||
130226237|NCT01255163|468793593|FG000|Overall Study|Withdrawal by Subject|1|||
130226238|NCT01255163|468793594|FG001|Overall Study|Withdrawal by Subject|0|||
130226239|NCT01255163|468793593|FG000|Overall Study|Lost to Follow-up|2|||
130226240|NCT01255163|468793594|FG001|Overall Study|Lost to Follow-up|0|||
130226241|NCT01255163|468793593|FG000|Overall Study|Adverse Event|0|||
130226242|NCT01255163|468793594|FG001|Overall Study|Adverse Event|2|||
130226243|NCT01255163|468793593|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
130226244|NCT01255163|468793594|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
130226245|NCT02495389|468793595|FG000|Overall Study|Withdrawal by Subject|40|||
130226246|NCT01802385|468793599|FG000|Overall Study|Death|106|||
130226247|NCT01802385|468793600|FG001|Overall Study|Death|120|||
130226248|NCT03834493|468793601|FG000|Overall Study|Participants Ongoing|311|||
130226249|NCT03834493|468793602|FG001|Overall Study|Participants Ongoing|324|||
130226250|NCT03834493|468793601|FG000|Overall Study|Withdrawal by Subject|20|||
130226251|NCT03834493|468793602|FG001|Overall Study|Withdrawal by Subject|17|||
130226252|NCT03834493|468793601|FG000|Overall Study|Physician Decision|1|||
130226253|NCT03834493|468793602|FG001|Overall Study|Physician Decision|0|||
130226254|NCT03834493|468793601|FG000|Overall Study|Death|289|||
130226255|NCT03834493|468793602|FG001|Overall Study|Death|282|||
130226256|NCT05559905|468793603|FG000|Overall Study|Withdrawal by Subject|1|||
130226257|NCT05559905|468793604|FG001|Overall Study|Withdrawal by Subject|0|||
130226258|NCT05559905|468793605|FG002|Overall Study|Withdrawal by Subject|0|||
130099397|NCT02279888|468320980|FG000|Overall Study|Death|326|||
130099398|NCT02279888|468320980|FG000|Overall Study|Withdrawal by Subject|38|||
130099399|NCT02279888|468320980|FG000|Overall Study|Lost to Follow-up|21|||
130099400|NCT02279888|468320980|FG000|Overall Study|Physician Decision|62|||
130099401|NCT02279888|468320980|FG000|Overall Study|Subject Non-compliance|43|||
130099402|NCT02279888|468320980|FG000|Overall Study|Not implanted|14|||
130226259|NCT05559905|468793603|FG000|Overall Study|Not Reported|1|||
130226260|NCT05559905|468793604|FG001|Overall Study|Not Reported|0|||
130226261|NCT05559905|468793605|FG002|Overall Study|Not Reported|0|||
130226262|NCT04003103|468793606|FG000|Overall Study|Death|1|||
130226263|NCT04003103|468793607|FG001|Overall Study|Death|0|||
130226264|NCT04003103|468793608|FG002|Overall Study|Death|0|||
130226265|NCT04003103|468793606|FG000|Overall Study|Lost to Follow-up|4|||
130226266|NCT04003103|468793607|FG001|Overall Study|Lost to Follow-up|3|||
130226267|NCT04003103|468793608|FG002|Overall Study|Lost to Follow-up|2|||
130226268|NCT04003103|468793606|FG000|Overall Study|Withdrawal by Subject|10|||
130226269|NCT04003103|468793607|FG001|Overall Study|Withdrawal by Subject|1|||
130226270|NCT04003103|468793608|FG002|Overall Study|Withdrawal by Subject|1|||
130099403|NCT02279888|468320980|FG000|Overall Study|Visit not performed|26|||
130226271|NCT04003103|468793606|FG000|Overall Study|Status not recorded|0|||
130226272|NCT04003103|468793607|FG001|Overall Study|Status not recorded|2|||
130226273|NCT04003103|468793608|FG002|Overall Study|Status not recorded|0|||
130226274|NCT02277028|468793610|FG000|Overall Study|Lost to Follow-up|1|||
130226275|NCT02277028|468793611|FG001|Overall Study|Lost to Follow-up|0|||
130021892|NCT01999582|468040675|FG001|Overall Study|Protocol Violation|0|||
130021893|NCT01999582|468040676|FG002|Overall Study|Protocol Violation|0|||
130021894|NCT01999582|468040677|FG003|Overall Study|Protocol Violation|0|||
130021895|NCT01999582|468040678|FG004|Overall Study|Protocol Violation|0|||
130021896|NCT01999582|468040679|FG005|Overall Study|Protocol Violation|1|||
130021897|NCT01999582|468040674|FG000|Overall Study|Lack of Efficacy|1|||
130021898|NCT01999582|468040675|FG001|Overall Study|Lack of Efficacy|3|||
130021899|NCT01999582|468040676|FG002|Overall Study|Lack of Efficacy|0|||
130021900|NCT01999582|468040677|FG003|Overall Study|Lack of Efficacy|1|||
130021901|NCT01999582|468040678|FG004|Overall Study|Lack of Efficacy|0|||
130021902|NCT01999582|468040679|FG005|Overall Study|Lack of Efficacy|0|||
130226276|NCT02277028|468793610|FG000|Overall Study|Withdrawal by Subject|0|||
130226277|NCT02277028|468793611|FG001|Overall Study|Withdrawal by Subject|1|||
130226278|NCT02718911|468793612|FG000|Overall Study|Adverse Event|0|||
130226279|NCT02718911|468793613|FG001|Overall Study|Adverse Event|0|||
130226280|NCT02718911|468793614|FG002|Overall Study|Adverse Event|0|||
130226281|NCT02718911|468793615|FG003|Overall Study|Adverse Event|0|||
130226282|NCT02718911|468793616|FG004|Overall Study|Adverse Event|0|||
130226283|NCT02718911|468793617|FG005|Overall Study|Adverse Event|0|||
130226284|NCT02718911|468793618|FG006|Overall Study|Adverse Event|0|||
130226285|NCT02718911|468793619|FG007|Overall Study|Adverse Event|0|||
130226286|NCT02718911|468793620|FG008|Overall Study|Adverse Event|0|||
130226287|NCT02718911|468793621|FG009|Overall Study|Adverse Event|2|||
130226288|NCT02718911|468793612|FG000|Overall Study|Death|2|||
130226289|NCT02718911|468793613|FG001|Overall Study|Death|3|||
130226290|NCT02718911|468793614|FG002|Overall Study|Death|1|||
130226291|NCT02718911|468793615|FG003|Overall Study|Death|0|||
130226292|NCT02718911|468793616|FG004|Overall Study|Death|1|||
130226293|NCT02718911|468793617|FG005|Overall Study|Death|3|||
130226294|NCT02718911|468793618|FG006|Overall Study|Death|1|||
130226295|NCT02718911|468793619|FG007|Overall Study|Death|1|||
130226296|NCT02718911|468793620|FG008|Overall Study|Death|4|||
130226297|NCT02718911|468793621|FG009|Overall Study|Death|3|||
130226298|NCT02718911|468793612|FG000|Overall Study|Lost to Follow-up|0|||
130226299|NCT02718911|468793613|FG001|Overall Study|Lost to Follow-up|0|||
130226300|NCT02718911|468793614|FG002|Overall Study|Lost to Follow-up|0|||
130226301|NCT02718911|468793615|FG003|Overall Study|Lost to Follow-up|0|||
130226302|NCT02718911|468793616|FG004|Overall Study|Lost to Follow-up|0|||
130226303|NCT02718911|468793617|FG005|Overall Study|Lost to Follow-up|0|||
130226304|NCT02718911|468793618|FG006|Overall Study|Lost to Follow-up|0|||
130226305|NCT02718911|468793619|FG007|Overall Study|Lost to Follow-up|0|||
130226306|NCT02718911|468793620|FG008|Overall Study|Lost to Follow-up|1|||
130226307|NCT02718911|468793621|FG009|Overall Study|Lost to Follow-up|0|||
130226308|NCT02718911|468793612|FG000|Overall Study|Physician Decision|2|||
130226309|NCT02718911|468793613|FG001|Overall Study|Physician Decision|0|||
130226310|NCT02718911|468793614|FG002|Overall Study|Physician Decision|1|||
130226311|NCT02718911|468793615|FG003|Overall Study|Physician Decision|1|||
130226312|NCT02718911|468793616|FG004|Overall Study|Physician Decision|0|||
130226313|NCT02718911|468793617|FG005|Overall Study|Physician Decision|0|||
130226314|NCT02718911|468793618|FG006|Overall Study|Physician Decision|0|||
130226315|NCT02718911|468793619|FG007|Overall Study|Physician Decision|1|||
130226316|NCT02718911|468793620|FG008|Overall Study|Physician Decision|2|||
130226317|NCT02718911|468793621|FG009|Overall Study|Physician Decision|1|||
130226318|NCT02718911|468793612|FG000|Overall Study|Withdrawal by Subject|0|||
130226319|NCT02718911|468793613|FG001|Overall Study|Withdrawal by Subject|0|||
130226320|NCT02718911|468793614|FG002|Overall Study|Withdrawal by Subject|0|||
130226321|NCT02718911|468793615|FG003|Overall Study|Withdrawal by Subject|0|||
130226322|NCT02718911|468793616|FG004|Overall Study|Withdrawal by Subject|1|||
130226323|NCT02718911|468793617|FG005|Overall Study|Withdrawal by Subject|0|||
130226324|NCT02718911|468793618|FG006|Overall Study|Withdrawal by Subject|0|||
130226325|NCT02718911|468793619|FG007|Overall Study|Withdrawal by Subject|0|||
130021903|NCT03889639|468040688|FG000|Overall Study|Withdrawal by Subject|0|||
130021904|NCT03889639|468040689|FG001|Overall Study|Withdrawal by Subject|0|||
130226326|NCT02718911|468793620|FG008|Overall Study|Withdrawal by Subject|1|||
130226327|NCT02718911|468793621|FG009|Overall Study|Withdrawal by Subject|4|||
130226328|NCT02718911|468793612|FG000|Overall Study|Reason Not Collected|0|||
130226329|NCT02718911|468793613|FG001|Overall Study|Reason Not Collected|0|||
130226330|NCT02718911|468793614|FG002|Overall Study|Reason Not Collected|1|||
130226331|NCT02718911|468793615|FG003|Overall Study|Reason Not Collected|0|||
130021905|NCT03889639|468040690|FG002|Overall Study|Withdrawal by Subject|0|||
130021906|NCT03889639|468040691|FG003|Overall Study|Withdrawal by Subject|0|||
130021907|NCT03889639|468040692|FG004|Overall Study|Withdrawal by Subject|0|||
130226332|NCT02718911|468793616|FG004|Overall Study|Reason Not Collected|0|||
130226333|NCT02718911|468793617|FG005|Overall Study|Reason Not Collected|0|||
130226334|NCT02718911|468793618|FG006|Overall Study|Reason Not Collected|2|||
130226335|NCT02718911|468793619|FG007|Overall Study|Reason Not Collected|1|||
130226336|NCT02718911|468793620|FG008|Overall Study|Reason Not Collected|4|||
130226337|NCT02718911|468793621|FG009|Overall Study|Reason Not Collected|9|||
130226338|NCT05002972|468793622|FG000|Overall Study|Withdrawal by Subject|2|||
130226339|NCT01172873|468793626|FG000|Overall Study|Withdrawal by Subject|3|||
130226340|NCT01172873|468793627|FG001|Overall Study|Withdrawal by Subject|2|||
130226341|NCT00983372|468793628|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
130226342|NCT00983372|468793628|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
130226343|NCT00983372|468793628|FG000|Diltiazem ER Alone|Adverse Event|1|||
130226344|NCT05518539|468793631|FG000|Overall Study|Lost to Follow-up|6|||
130226345|NCT02053493|468793636|FG000|Overall Study|Withdrawal by Subject|1|||
130226346|NCT02053493|468793637|FG001|Overall Study|Withdrawal by Subject|1|||
130226347|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130226348|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130226349|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130226350|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130226351|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Adverse Event|0|||
130226352|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Adverse Event|1|||
130226353|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
130226354|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
130226355|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
130226356|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
130226357|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
130226358|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
130226359|NCT04613518|468793640|FG000|Double-Blind Treatment Period|Other Reasons|2|||
130226360|NCT04613518|468793641|FG001|Double-Blind Treatment Period|Other Reasons|0|||
130226361|NCT04613518|468793642|FG002|Double-Blind Treatment Period|Other Reasons|0|||
130226362|NCT04613518|468793640|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
130226363|NCT04613518|468793641|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
130226364|NCT04613518|468793642|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130226365|NCT04613518|468793640|FG000|Open-Label Treatment Period|Adverse Event|1|||
130226366|NCT04613518|468793641|FG001|Open-Label Treatment Period|Adverse Event|0|||
130226367|NCT04613518|468793642|FG002|Open-Label Treatment Period|Adverse Event|3|||
130226368|NCT04613518|468793640|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
130226369|NCT04613518|468793641|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
130226370|NCT04613518|468793642|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
130226371|NCT04613518|468793640|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
130226372|NCT04613518|468793641|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
130226373|NCT04613518|468793642|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
130226374|NCT04613518|468793640|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
130226375|NCT04613518|468793641|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
130226376|NCT04613518|468793642|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
130226377|NCT04613518|468793640|FG000|Open-Label Treatment Period|Other reasons|1|||
130226378|NCT04613518|468793641|FG001|Open-Label Treatment Period|Other reasons|0|||
130226379|NCT04613518|468793642|FG002|Open-Label Treatment Period|Other reasons|0|||
130226380|NCT01619865|468793643|FG000|Overall Study|Adverse Event|1|||
130226381|NCT01619865|468793643|FG000|Overall Study|Death|2|||
130226382|NCT01619865|468793643|FG000|Overall Study|subject not able to comply|1|||
130226383|NCT01494818|468793644|FG000|Overall Study|Relocation|1|||
130226384|NCT01494818|468793645|FG001|Overall Study|Relocation|2|||
130226385|NCT01494818|468793644|FG000|Overall Study|Lost to Follow-up|1|||
130226386|NCT01494818|468793645|FG001|Overall Study|Lost to Follow-up|0|||
130226387|NCT01077323|468793646|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
130226388|NCT01077323|468793647|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
130226389|NCT01077323|468793648|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
130226390|NCT01077323|468793646|FG000|Overall Study|Dispensing of drug in baseline period|0|||
130226391|NCT01077323|468793647|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
130226392|NCT01077323|468793648|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
130226393|NCT01077323|468793646|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
130021908|NCT03889639|468040693|FG005|Overall Study|Withdrawal by Subject|0|||
130021909|NCT03889639|468040694|FG006|Overall Study|Withdrawal by Subject|0|||
130021910|NCT03889639|468040695|FG007|Overall Study|Withdrawal by Subject|1|||
130021911|NCT01703858|468040696|FG000|Overall Study|Withdrawal by Subject|0|||
130021912|NCT01703858|468040697|FG001|Overall Study|Withdrawal by Subject|1|||
130021913|NCT01703858|468040698|FG002|Overall Study|Withdrawal by Subject|0|||
130021914|NCT00927095|468040699|FG000|Overall Study|Adverse Event|3|||
130021915|NCT00927095|468040700|FG001|Overall Study|Adverse Event|1|||
130021916|NCT00927095|468040701|FG002|Overall Study|Adverse Event|0|||
130099404|NCT01891669|468320981|FG000|Overall Study|Death|0|||
130226394|NCT01077323|468793647|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
130226395|NCT01077323|468793648|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
130226396|NCT00617357|468793649|FG000|Overall Study|Lost to Follow-up|7|||
130226397|NCT00617357|468793649|FG000|Overall Study|Death|5|||
130226398|NCT00617357|468793649|FG000|Overall Study|insurance concerns|2|||
130226399|NCT00617357|468793649|FG000|Overall Study|Withdrawal by Subject|1|||
130226400|NCT00617357|468793649|FG000|Overall Study|Physician Decision|1|||
130226401|NCT02153918|468793650|FG000|Overall Study|Refused further treatment|1|||
130226402|NCT01764841|468793651|FG000|Overall Study|Logistical Difficulties|0|||
130226403|NCT01764841|468793652|FG001|Overall Study|Logistical Difficulties|1|||
130226404|NCT01764841|468793653|FG002|Overall Study|Logistical Difficulties|0|||
130226405|NCT01764841|468793654|FG003|Overall Study|Logistical Difficulties|0|||
130226406|NCT01764841|468793651|FG000|Overall Study|Death|3|||
130226407|NCT01764841|468793652|FG001|Overall Study|Death|0|||
130226408|NCT01764841|468793653|FG002|Overall Study|Death|1|||
130226409|NCT01764841|468793654|FG003|Overall Study|Death|4|||
130226410|NCT01764841|468793651|FG000|Overall Study|No Follow Up|1|||
130226411|NCT01764841|468793652|FG001|Overall Study|No Follow Up|0|||
130226412|NCT01764841|468793653|FG002|Overall Study|No Follow Up|1|||
130226413|NCT01764841|468793654|FG003|Overall Study|No Follow Up|0|||
130226414|NCT01764841|468793651|FG000|Overall Study|Protocol Violation|0|||
130226415|NCT01764841|468793652|FG001|Overall Study|Protocol Violation|1|||
130226416|NCT01764841|468793653|FG002|Overall Study|Protocol Violation|0|||
130226417|NCT01764841|468793654|FG003|Overall Study|Protocol Violation|0|||
130226418|NCT01764841|468793651|FG000|Overall Study|Withdrawal by Subject|16|||
130226419|NCT01764841|468793652|FG001|Overall Study|Withdrawal by Subject|24|||
130226420|NCT01764841|468793653|FG002|Overall Study|Withdrawal by Subject|11|||
130226421|NCT01764841|468793654|FG003|Overall Study|Withdrawal by Subject|15|||
130226422|NCT01764841|468793651|FG000|Overall Study|Lost to Follow-up|3|||
130226423|NCT01764841|468793652|FG001|Overall Study|Lost to Follow-up|0|||
130226424|NCT01764841|468793653|FG002|Overall Study|Lost to Follow-up|1|||
130226425|NCT01764841|468793654|FG003|Overall Study|Lost to Follow-up|0|||
130226426|NCT02616783|468793655|FG000|Overall Study|Randomized but Not Treated|1|||
130226427|NCT02616783|468793656|FG001|Overall Study|Randomized but Not Treated|0|||
130226428|NCT02616783|468793655|FG000|Overall Study|Adverse Event|1|||
130226429|NCT02616783|468793656|FG001|Overall Study|Adverse Event|0|||
130226430|NCT02616783|468793655|FG000|Overall Study|Death|1|||
130226431|NCT02616783|468793656|FG001|Overall Study|Death|0|||
130226432|NCT02616783|468793655|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130226433|NCT02616783|468793656|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130226434|NCT02616783|468793655|FG000|Overall Study|Protocol Violation|1|||
130226435|NCT02616783|468793656|FG001|Overall Study|Protocol Violation|1|||
130226436|NCT02616783|468793655|FG000|Overall Study|Withdrew Consent|1|||
130226437|NCT02616783|468793656|FG001|Overall Study|Withdrew Consent|1|||
130226438|NCT04344301|468793657|FG000|Overall Study|Withdrawal by Subject|1|||
130226439|NCT04344301|468793658|FG001|Overall Study|Withdrawal by Subject|0|||
130226440|NCT04344301|468793657|FG000|Overall Study|Death|0|||
130226441|NCT04344301|468793658|FG001|Overall Study|Death|1|||
130226442|NCT05214118|468793661|FG000|Overall Study|Lost to Follow-up|0|||
130226443|NCT05214118|468793662|FG001|Overall Study|Lost to Follow-up|2|||
130226444|NCT05214118|468793661|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
130226445|NCT05214118|468793662|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
130226446|NCT05214118|468793661|FG000|Overall Study|moved|1|||
130226447|NCT05214118|468793662|FG001|Overall Study|moved|0|||
130226448|NCT04010461|468793663|FG000|Overall Study|COVID based withdrawal|5|||
130226449|NCT04010461|468793663|FG000|Overall Study|Withdrawal by Subject|5|||
130226450|NCT04010461|468793663|FG000|Overall Study|Adverse Event|1|||
130226451|NCT04010461|468793663|FG000|Overall Study|No Motor Threshold obtainable|1|||
130226452|NCT04010461|468793663|FG000|Overall Study|Physician Decision|1|||
130226453|NCT03797898|468793664|FG000|Overall Study|Lost to Follow-up|60|||
130226454|NCT03797898|468793665|FG001|Overall Study|Lost to Follow-up|69|||
130226455|NCT03797898|468793664|FG000|Overall Study|Withdrawal by Subject|9|||
130226456|NCT03797898|468793665|FG001|Overall Study|Withdrawal by Subject|7|||
130226457|NCT03797898|468793664|FG000|Overall Study|Became ineligible|5|||
130226458|NCT03797898|468793665|FG001|Overall Study|Became ineligible|2|||
130226459|NCT00086190|468793666|FG000|Overall Study|Adverse Event|6|||
130226460|NCT00086190|468793667|FG001|Overall Study|Adverse Event|2|||
130226461|NCT00086190|468793668|FG002|Overall Study|Adverse Event|2|||
130226462|NCT00086190|468793666|FG000|Overall Study|Withdrawal by Subject|0|||
130226463|NCT00086190|468793667|FG001|Overall Study|Withdrawal by Subject|2|||
130021917|NCT00927095|468040699|FG000|Overall Study|Withdrawal by Subject|2|||
130226464|NCT00086190|468793668|FG002|Overall Study|Withdrawal by Subject|2|||
130226465|NCT00086190|468793666|FG000|Overall Study|Protocol Violation|1|||
130226466|NCT00086190|468793667|FG001|Overall Study|Protocol Violation|0|||
130226467|NCT00086190|468793668|FG002|Overall Study|Protocol Violation|0|||
130226468|NCT00086190|468793666|FG000|Overall Study|Moved|1|||
130226469|NCT00086190|468793667|FG001|Overall Study|Moved|0|||
130226470|NCT00086190|468793668|FG002|Overall Study|Moved|0|||
130226471|NCT00086190|468793666|FG000|Overall Study|Worsening depression|0|||
130226472|NCT00086190|468793667|FG001|Overall Study|Worsening depression|0|||
130226473|NCT00086190|468793668|FG002|Overall Study|Worsening depression|2|||
130226474|NCT03902613|468793669|FG000|Overall Study|Physician Decision|1|||
130226475|NCT02027025|468793673|FG000|Overall Study|Adverse Event|0|||
130226476|NCT02027025|468793674|FG001|Overall Study|Adverse Event|1|||
130226477|NCT02027025|468793675|FG002|Overall Study|Adverse Event|1|||
130226478|NCT02027025|468793673|FG000|Overall Study|Protocol Violation|1|||
130226479|NCT02027025|468793674|FG001|Overall Study|Protocol Violation|0|||
130226480|NCT02027025|468793675|FG002|Overall Study|Protocol Violation|0|||
130226481|NCT02027025|468793673|FG000|Overall Study|Lost to Follow-up|0|||
130226482|NCT02027025|468793674|FG001|Overall Study|Lost to Follow-up|2|||
130226483|NCT02027025|468793675|FG002|Overall Study|Lost to Follow-up|0|||
130226484|NCT02027025|468793673|FG000|Overall Study|Withdrawal by Subject|0|||
130226485|NCT02027025|468793674|FG001|Overall Study|Withdrawal by Subject|1|||
130226486|NCT02027025|468793675|FG002|Overall Study|Withdrawal by Subject|0|||
130226487|NCT02027025|468793673|FG000|Overall Study|Sponsor's decision|0|||
130226488|NCT02027025|468793674|FG001|Overall Study|Sponsor's decision|1|||
130226489|NCT02027025|468793675|FG002|Overall Study|Sponsor's decision|0|||
130226490|NCT00732069|468793676|FG000|Washout After First Study Drug|Adverse Event|1|||
130226491|NCT00732069|468793677|FG001|Washout After First Study Drug|Adverse Event|0|||
130226492|NCT00732069|468793678|FG002|Washout After First Study Drug|Adverse Event|0|||
130226493|NCT00732069|468793679|FG003|Washout After First Study Drug|Adverse Event|0|||
130226494|NCT00732069|468793680|FG004|Washout After First Study Drug|Adverse Event|0|||
130226495|NCT00732069|468793681|FG005|Washout After First Study Drug|Adverse Event|0|||
130226496|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Early discharge|5|||
130226497|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Early discharge|5|||
130226498|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
130226499|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
130226500|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
130226501|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
130226502|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
130226503|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
130226504|NCT04460326|468793682|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
130226505|NCT04460326|468793683|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
130226506|NCT04460326|468793682|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
130226507|NCT04460326|468793683|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
130226508|NCT00577317|468793684|FG000|Overall Study|Study Terminated|0|||
130226509|NCT00577317|468793685|FG001|Overall Study|Study Terminated|2|||
130226510|NCT04794751|468793686|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
130226511|NCT04794751|468793687|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
130226512|NCT04794751|468793686|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
130226513|NCT04794751|468793687|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
130226514|NCT04794751|468793686|FG000|Period 1|Protocol Violation|0|||
130226515|NCT04794751|468793687|FG001|Period 1|Protocol Violation|2|||
130021918|NCT00927095|468040700|FG001|Overall Study|Withdrawal by Subject|1|||
130021919|NCT00927095|468040701|FG002|Overall Study|Withdrawal by Subject|1|||
130021920|NCT00927095|468040699|FG000|Overall Study|Physician Decision|1|||
130021921|NCT00927095|468040700|FG001|Overall Study|Physician Decision|2|||
130021922|NCT00927095|468040701|FG002|Overall Study|Physician Decision|1|||
130021923|NCT01290692|468040702|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
130021924|NCT02556255|468040703|FG000|Overall Study|Lost to Follow-up|4|||
130021925|NCT00993031|468040707|FG000|Overall Study|Death|0|||
130021926|NCT00993031|468040708|FG001|Overall Study|Death|1|||
130021927|NCT00993031|468040707|FG000|Overall Study|Physician Decision|0|||
130021928|NCT00993031|468040708|FG001|Overall Study|Physician Decision|2|||
130021929|NCT00993031|468040707|FG000|Overall Study|Withdrawal by Subject|3|||
130021930|NCT00993031|468040708|FG001|Overall Study|Withdrawal by Subject|3|||
130021931|NCT00993031|468040707|FG000|Overall Study|Lost to Follow-up|19|||
130021932|NCT00993031|468040708|FG001|Overall Study|Lost to Follow-up|13|||
130021933|NCT03115151|468040709|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
130021934|NCT03115151|468040710|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
130021935|NCT03115151|468040709|FG000|Overall Study|Epidural catheter removal|1|||
130021936|NCT03115151|468040710|FG001|Overall Study|Epidural catheter removal|0|||
130021937|NCT03115151|468040709|FG000|Overall Study|Withdrawal by Subject|0|||
130226516|NCT04794751|468793686|FG000|Period 1|Withdrawal by Subject|0|||
130226517|NCT04794751|468793687|FG001|Period 1|Withdrawal by Subject|1|||
130226518|NCT04794751|468793686|FG000|Period 2|Withdrawal by Subject|0|||
130226519|NCT04794751|468793687|FG001|Period 2|Withdrawal by Subject|1|||
130226520|NCT04794751|468793686|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
130226521|NCT04794751|468793687|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
130226522|NCT04794751|468793686|FG000|Period 2|Protocol Violation|1|||
130226523|NCT04794751|468793687|FG001|Period 2|Protocol Violation|0|||
130226524|NCT03669588|468793690|FG000|Overall Study|Adverse Event|1|||
130226525|NCT03669588|468793691|FG001|Overall Study|Adverse Event|0|||
130226526|NCT03669588|468793690|FG000|Overall Study|Physician Decision|0|||
130226527|NCT03669588|468793691|FG001|Overall Study|Physician Decision|1|||
130226528|NCT03669588|468793690|FG000|Overall Study|Protocol Violation|1|||
130226529|NCT03669588|468793691|FG001|Overall Study|Protocol Violation|0|||
130226530|NCT03669588|468793690|FG000|Overall Study|Sponsor Decision|1|||
130226531|NCT03669588|468793691|FG001|Overall Study|Sponsor Decision|1|||
130226532|NCT03669588|468793690|FG000|Overall Study|Withdrawal by Subject|1|||
130226533|NCT03669588|468793691|FG001|Overall Study|Withdrawal by Subject|4|||
130226534|NCT03669588|468793690|FG000|Overall Study|Rescue Therapy Needed|0|||
130226535|NCT03669588|468793691|FG001|Overall Study|Rescue Therapy Needed|1|||
130226536|NCT00369343|468793694|FG000|Double-blind Phase|Adverse Event|19|||
130226537|NCT00369343|468793695|FG001|Double-blind Phase|Adverse Event|4|||
130226538|NCT00369343|468793694|FG000|Double-blind Phase|Failed to return|2|||
130226539|NCT00369343|468793695|FG001|Double-blind Phase|Failed to return|0|||
130226540|NCT00369343|468793694|FG000|Double-blind Phase|Lost to Follow-up|9|||
130226541|NCT00369343|468793695|FG001|Double-blind Phase|Lost to Follow-up|2|||
130226542|NCT00369343|468793694|FG000|Double-blind Phase|Protocol Violation|2|||
130226543|NCT00369343|468793695|FG001|Double-blind Phase|Protocol Violation|0|||
130226544|NCT00369343|468793694|FG000|Double-blind Phase|Withdrawal by Subject|8|||
130226545|NCT00369343|468793695|FG001|Double-blind Phase|Withdrawal by Subject|6|||
130021938|NCT03115151|468040710|FG001|Overall Study|Withdrawal by Subject|1|||
130226546|NCT00369343|468793694|FG000|Double-blind Phase|Lack of Efficacy|0|||
130226547|NCT00369343|468793695|FG001|Double-blind Phase|Lack of Efficacy|4|||
130226548|NCT00369343|468793694|FG000|Double-blind Phase|Protocol deviation|4|||
130226549|NCT00369343|468793695|FG001|Double-blind Phase|Protocol deviation|0|||
130226550|NCT00369343|468793694|FG000|Open-label Phase|Adverse Event|19|||
130226551|NCT00369343|468793695|FG001|Open-label Phase|Adverse Event|7|||
130226552|NCT00369343|468793694|FG000|Open-label Phase|Failed to return|4|||
130226553|NCT00369343|468793695|FG001|Open-label Phase|Failed to return|0|||
130226554|NCT00369343|468793694|FG000|Open-label Phase|Physician Decision|2|||
130226555|NCT00369343|468793695|FG001|Open-label Phase|Physician Decision|0|||
130226556|NCT00369343|468793694|FG000|Open-label Phase|Lost to Follow-up|5|||
130226557|NCT00369343|468793695|FG001|Open-label Phase|Lost to Follow-up|3|||
130226558|NCT00369343|468793694|FG000|Open-label Phase|inadvertently reported study completers|3|||
130226559|NCT00369343|468793695|FG001|Open-label Phase|inadvertently reported study completers|2|||
130226560|NCT00369343|468793694|FG000|Open-label Phase|Protocol Violation|1|||
130226561|NCT00369343|468793695|FG001|Open-label Phase|Protocol Violation|3|||
130226562|NCT00369343|468793694|FG000|Open-label Phase|Withdrawal by Subject|15|||
130226563|NCT00369343|468793695|FG001|Open-label Phase|Withdrawal by Subject|6|||
130226564|NCT00369343|468793694|FG000|Open-label Phase|Lack of Efficacy|4|||
130226565|NCT00369343|468793695|FG001|Open-label Phase|Lack of Efficacy|3|||
130226566|NCT00369343|468793694|FG000|Open-label Phase|Lack of continuance tolerability|3|||
130226567|NCT00369343|468793695|FG001|Open-label Phase|Lack of continuance tolerability|4|||
130226568|NCT00369343|468793694|FG000|Open-label Phase|did not take study drug|1|||
130226569|NCT00369343|468793695|FG001|Open-label Phase|did not take study drug|2|||
130226570|NCT01100502|468793696|FG000|Overall Study|Withdrawal by Subject|18|||
130226571|NCT01100502|468793697|FG001|Overall Study|Withdrawal by Subject|25|||
130226572|NCT01100502|468793696|FG000|Overall Study|Lost to Follow-up|13|||
130226573|NCT01100502|468793697|FG001|Overall Study|Lost to Follow-up|28|||
130226574|NCT01100502|468793696|FG000|Overall Study|Site request to end participation in study|0|||
130226575|NCT01100502|468793697|FG001|Overall Study|Site request to end participation in study|1|||
130226576|NCT01100502|468793696|FG000|Overall Study|Death|45|||
130226577|NCT01100502|468793697|FG001|Overall Study|Death|40|||
130226578|NCT02322749|468793698|FG000|Period 2|Adverse Event|0|||
130226579|NCT02322749|468793699|FG001|Period 2|Adverse Event|0|||
130226580|NCT02322749|468793700|FG002|Period 2|Adverse Event|0|||
130226581|NCT02322749|468793701|FG003|Period 2|Adverse Event|1|||
130226582|NCT02322749|468793702|FG004|Period 2|Adverse Event|0|||
130226583|NCT02322749|468793703|FG005|Period 2|Adverse Event|0|||
130226584|NCT02322749|468793698|FG000|Period 2|Withdrawal by Subject|0|||
130226585|NCT02322749|468793699|FG001|Period 2|Withdrawal by Subject|0|||
130226586|NCT02322749|468793700|FG002|Period 2|Withdrawal by Subject|0|||
130226587|NCT02322749|468793701|FG003|Period 2|Withdrawal by Subject|1|||
130226588|NCT02322749|468793702|FG004|Period 2|Withdrawal by Subject|0|||
130226589|NCT02322749|468793703|FG005|Period 2|Withdrawal by Subject|0|||
130226590|NCT02322749|468793698|FG000|Period 3|Withdrawal by Subject|0|||
130226591|NCT02322749|468793699|FG001|Period 3|Withdrawal by Subject|0|||
130226592|NCT02322749|468793700|FG002|Period 3|Withdrawal by Subject|1|||
130226593|NCT02322749|468793701|FG003|Period 3|Withdrawal by Subject|0|||
130226594|NCT02322749|468793702|FG004|Period 3|Withdrawal by Subject|0|||
130226595|NCT02322749|468793703|FG005|Period 3|Withdrawal by Subject|0|||
130226596|NCT05158140|468793714|FG000|Overall Study|Death|0|||
130226597|NCT05158140|468793715|FG001|Overall Study|Death|0|||
130226598|NCT05158140|468793716|FG002|Overall Study|Death|0|||
130226599|NCT05158140|468793717|FG003|Overall Study|Death|1|||
130226600|NCT05158140|468793714|FG000|Overall Study|Lost to Follow-up|3|||
130226601|NCT05158140|468793715|FG001|Overall Study|Lost to Follow-up|6|||
130226602|NCT05158140|468793716|FG002|Overall Study|Lost to Follow-up|4|||
130226603|NCT05158140|468793717|FG003|Overall Study|Lost to Follow-up|3|||
130226604|NCT05158140|468793714|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130226605|NCT05158140|468793715|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130226606|NCT05158140|468793716|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
130226607|NCT05158140|468793717|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130226608|NCT05158140|468793714|FG000|Overall Study|Withdrawal by Subject|3|||
130226609|NCT05158140|468793715|FG001|Overall Study|Withdrawal by Subject|7|||
130226610|NCT05158140|468793716|FG002|Overall Study|Withdrawal by Subject|3|||
130226611|NCT05158140|468793717|FG003|Overall Study|Withdrawal by Subject|7|||
130226612|NCT04414787|468793722|FG000|Overall Study|Patient Death|18|||
130226613|NCT04414787|468793723|FG001|Overall Study|Patient Death|18|||
130226614|NCT04414787|468793724|FG002|Overall Study|Patient Death|15|||
130226615|NCT04414787|468793725|FG003|Overall Study|Patient Death|15|||
130226616|NCT04414787|468793722|FG000|Overall Study|Patient Hospitalization|1|||
130226617|NCT04414787|468793723|FG001|Overall Study|Patient Hospitalization|1|||
130226618|NCT04414787|468793724|FG002|Overall Study|Patient Hospitalization|2|||
130226619|NCT04414787|468793725|FG003|Overall Study|Patient Hospitalization|2|||
130226620|NCT04414787|468793722|FG000|Overall Study|Lost to Follow-up|7|||
130226621|NCT04414787|468793723|FG001|Overall Study|Lost to Follow-up|7|||
130226622|NCT04414787|468793724|FG002|Overall Study|Lost to Follow-up|5|||
130226623|NCT04414787|468793725|FG003|Overall Study|Lost to Follow-up|5|||
130226624|NCT04414787|468793722|FG000|Overall Study|Residence in post-acute care facility|3|||
130226625|NCT04414787|468793723|FG001|Overall Study|Residence in post-acute care facility|3|||
130226626|NCT04414787|468793724|FG002|Overall Study|Residence in post-acute care facility|5|||
130226627|NCT04414787|468793725|FG003|Overall Study|Residence in post-acute care facility|5|||
130226628|NCT00807365|468793726|FG000|Overall Study|Study Terminated|5|||
130226629|NCT01526785|468793727|FG000|Overall Study|Study Terminated by Sponsor|8|||
130021939|NCT03115151|468040709|FG000|Overall Study|Intervention not received according to the protocol.|1|||
130021940|NCT03115151|468040710|FG001|Overall Study|Intervention not received according to the protocol.|1|||
130021941|NCT03115151|468040709|FG000|Overall Study|Physician Decision|1|||
130021942|NCT03115151|468040710|FG001|Overall Study|Physician Decision|0|||
130021943|NCT03115151|468040709|FG000|Overall Study|Randomization not applied|1|||
130021944|NCT03115151|468040710|FG001|Overall Study|Randomization not applied|1|||
130021945|NCT04820309|468040728|FG000|Overall Study|Adverse Event|96|||
130021946|NCT04820309|468040728|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
130021947|NCT04820309|468040728|FG000|Overall Study|Consent Withdrawn|93|||
130021948|NCT04820309|468040728|FG000|Overall Study|failure to adhere to protocol|32|||
130021949|NCT04820309|468040728|FG000|Overall Study|alcohol or drug use|6|||
130021950|NCT04820309|468040728|FG000|Overall Study|Lost to Follow-up|46|||
130021951|NCT04820309|468040728|FG000|Overall Study|Death|2|||
130021952|NCT04820309|468040728|FG000|Overall Study|Pregnancy|1|||
130021953|NCT04820309|468040728|FG000|Overall Study|Other reasons|12|||
130021954|NCT00980538|468040735|FG000|Overall Study|Lost to Follow-up|20|||
130021955|NCT00980538|468040735|FG000|Overall Study|Sponsor's Decision|4|||
130021956|NCT00980538|468040735|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
130021957|NCT00980538|468040735|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
130021958|NCT00980538|468040735|FG000|Overall Study|Switch to Commercially Available Medication|25|||
130021959|NCT00980538|468040735|FG000|Overall Study|Participant Non-Compliant|9|||
130021960|NCT00980538|468040735|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
130021961|NCT00980538|468040735|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
130021962|NCT00980538|468040735|FG000|Overall Study|Other|60|||
130021963|NCT00980538|468040735|FG000|Overall Study|Other|1|||
130021964|NCT02482129|468040736|FG000|Overall Study|Adverse Event-prior to treatment|0|||
130021965|NCT02482129|468040737|FG001|Overall Study|Adverse Event-prior to treatment|1|||
130021966|NCT02482129|468040736|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
130021967|NCT02482129|468040737|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
130021968|NCT02482129|468040736|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
130021969|NCT02482129|468040737|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
130021970|NCT02482129|468040736|FG000|Overall Study|Criteria not met-prior to treatment|1|||
130021971|NCT02482129|468040737|FG001|Overall Study|Criteria not met-prior to treatment|0|||
130021972|NCT02482129|468040736|FG000|Overall Study|Adverse Event|1|||
130021973|NCT02482129|468040737|FG001|Overall Study|Adverse Event|0|||
130021974|NCT02482129|468040736|FG000|Overall Study|Withdrawal by Subject|2|||
130021975|NCT02482129|468040737|FG001|Overall Study|Withdrawal by Subject|0|||
130021976|NCT02482129|468040736|FG000|Overall Study|Criteria not met|1|||
130021977|NCT02482129|468040737|FG001|Overall Study|Criteria not met|0|||
130021978|NCT03505021|468040738|FG000|Overall Study|Protocol Violation|1|||
130021979|NCT03505021|468040739|FG001|Overall Study|Protocol Violation|0|||
130021980|NCT03505021|468040738|FG000|Overall Study|Death|9|||
130021981|NCT03505021|468040739|FG001|Overall Study|Death|8|||
130021982|NCT03505021|468040738|FG000|Overall Study|Consent withdrawn by subject|6|||
130021983|NCT03505021|468040739|FG001|Overall Study|Consent withdrawn by subject|1|||
130021984|NCT03505021|468040738|FG000|Overall Study|Lost to Follow-up|5|||
130021985|NCT03505021|468040739|FG001|Overall Study|Lost to Follow-up|3|||
130021986|NCT03505021|468040738|FG000|Overall Study|Adverse Event|26|||
130021987|NCT03505021|468040739|FG001|Overall Study|Adverse Event|9|||
130021988|NCT03505021|468040738|FG000|Overall Study|Disease progression|33|||
130021989|NCT03505021|468040739|FG001|Overall Study|Disease progression|17|||
130021990|NCT03505021|468040738|FG000|Overall Study|Other|11|||
130021991|NCT03505021|468040739|FG001|Overall Study|Other|5|||
130021992|NCT03505021|468040738|FG000|Overall Study|Personal reason|21|||
130021993|NCT03505021|468040739|FG001|Overall Study|Personal reason|12|||
130021994|NCT03087955|468042574|FG000|Overall Study|Death|4|||
130021995|NCT03087955|468042575|FG001|Overall Study|Death|0|||
130021996|NCT03087955|468042574|FG000|Overall Study|Lack of Efficacy|2|||
130099405|NCT01891669|468320982|FG001|Overall Study|Death|0|||
129884510|NCT02293837|467536434|FG002|Overall Study|COVID-19 Related|0|||
130021997|NCT03087955|468042575|FG001|Overall Study|Lack of Efficacy|0|||
130021998|NCT03087955|468042574|FG000|Overall Study|Lost to Follow-up|1|||
130021999|NCT03087955|468042575|FG001|Overall Study|Lost to Follow-up|0|||
130022000|NCT02392429|468042576|FG000|Screening|Screen failure|15|||
130022001|NCT02392429|468042576|FG000|Enrolled Participants|Ineligible due to disease|3|||
130022002|NCT02392429|468042576|FG000|Enrolled Participants|Withdrawal by Subject|4|||
130022003|NCT02392429|468042576|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
130022004|NCT02392429|468042576|FG000|Evaluable|Death|5|||
130022005|NCT02392429|468042576|FG000|Evaluable|Withdrawal by Subject|1|||
130022006|NCT02392429|468042576|FG000|Evaluable|Adverse Event|1|||
130022007|NCT02392429|468042576|FG000|Evaluable|remission bone marrow biopsy|3|||
130022008|NCT00482014|468042577|FG000|Overall Study|Withdrawal by Subject|1|||
130022009|NCT00482014|468042578|FG001|Overall Study|Withdrawal by Subject|2|||
130022010|NCT00482014|468042579|FG002|Overall Study|Withdrawal by Subject|3|||
130099406|NCT01891669|468320983|FG002|Overall Study|Death|0|||
130099407|NCT01891669|468320984|FG003|Overall Study|Death|0|||
130022011|NCT00482014|468042580|FG003|Overall Study|Withdrawal by Subject|4|||
130022012|NCT00482014|468042577|FG000|Overall Study|Adverse Event|3|||
130022013|NCT00482014|468042578|FG001|Overall Study|Adverse Event|0|||
130022014|NCT00482014|468042579|FG002|Overall Study|Adverse Event|2|||
130022015|NCT00482014|468042580|FG003|Overall Study|Adverse Event|8|||
130022016|NCT00482014|468042577|FG000|Overall Study|Death|1|||
130022017|NCT00482014|468042578|FG001|Overall Study|Death|2|||
130022018|NCT00482014|468042579|FG002|Overall Study|Death|1|||
130022019|NCT00482014|468042580|FG003|Overall Study|Death|4|||
130022020|NCT00482014|468042577|FG000|Overall Study|Lack of Efficacy|1|||
130022021|NCT00482014|468042578|FG001|Overall Study|Lack of Efficacy|0|||
130022022|NCT00482014|468042579|FG002|Overall Study|Lack of Efficacy|4|||
130022023|NCT00482014|468042580|FG003|Overall Study|Lack of Efficacy|6|||
130022024|NCT00482014|468042577|FG000|Overall Study|Sponsor Decision|1|||
130022025|NCT00482014|468042578|FG001|Overall Study|Sponsor Decision|2|||
130022026|NCT00482014|468042579|FG002|Overall Study|Sponsor Decision|1|||
130022027|NCT00482014|468042580|FG003|Overall Study|Sponsor Decision|1|||
130022028|NCT03686397|468042581|FG000|Overall Study|Lack of Efficacy|3|||
130022029|NCT03686397|468042582|FG001|Overall Study|Lack of Efficacy|5|||
130022030|NCT03686397|468042581|FG000|Overall Study|Adverse Event|0|||
130022031|NCT03686397|468042582|FG001|Overall Study|Adverse Event|1|||
130022032|NCT03686397|468042581|FG000|Overall Study|Protocol Violation|0|||
130022033|NCT03686397|468042582|FG001|Overall Study|Protocol Violation|1|||
130022034|NCT03686397|468042581|FG000|Overall Study|Withdrawal by Subject|0|||
130022035|NCT03686397|468042582|FG001|Overall Study|Withdrawal by Subject|1|||
130022036|NCT03686397|468042581|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
130022037|NCT03686397|468042582|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
130022038|NCT00598975|468042585|FG000|Overall Study|Adverse Event|1|||
130022039|NCT00598975|468042586|FG001|Overall Study|Adverse Event|1|||
130022040|NCT00598975|468042585|FG000|Overall Study|Brain metastases|1|||
130022041|NCT00598975|468042586|FG001|Overall Study|Brain metastases|0|||
130022042|NCT00598975|468042585|FG000|Overall Study|Withdrawal by Subject|1|||
130022043|NCT00598975|468042586|FG001|Overall Study|Withdrawal by Subject|1|||
130022044|NCT00598975|468042585|FG000|Overall Study|Withdrawal of consent|0|||
130022045|NCT00598975|468042586|FG001|Overall Study|Withdrawal of consent|1|||
130022046|NCT00598975|468042585|FG000|Overall Study|Disease progression|8|||
130022047|NCT00598975|468042586|FG001|Overall Study|Disease progression|3|||
130022048|NCT00598975|468042585|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
130022049|NCT00598975|468042586|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
130022050|NCT01178138|468042587|FG000|Overall Study|Lost to Follow-up|8|||
130022051|NCT01178138|468042587|FG000|Overall Study|Withdrawal by Subject|7|||
130022052|NCT01178138|468042587|FG000|Overall Study|Physician Decision|8|||
130022053|NCT00424827|468042591|FG000|Overall Study|Adverse Event|1|||
130022054|NCT03806127|468042592|FG000|Overall Study|Withdrawal by Subject|4|||
130022055|NCT03806127|468042593|FG001|Overall Study|Withdrawal by Subject|5|||
130022056|NCT03806127|468042592|FG000|Overall Study|Protocol Violation|3|||
130022057|NCT03806127|468042593|FG001|Overall Study|Protocol Violation|1|||
130022058|NCT03806127|468042592|FG000|Overall Study|Adverse Event|3|||
130022059|NCT03806127|468042593|FG001|Overall Study|Adverse Event|0|||
130022060|NCT03806127|468042592|FG000|Overall Study|Unable to Complete Procedures|0|||
130022061|NCT03806127|468042593|FG001|Overall Study|Unable to Complete Procedures|1|||
130022062|NCT03806127|468042592|FG000|Overall Study|Pregnancy|0|||
130226630|NCT01526785|468793727|FG000|Overall Study|Death|2|||
130226631|NCT01526785|468793727|FG000|Overall Study|Physician Decision|1|||
130226632|NCT01526785|468793727|FG000|Overall Study|Withdrawal by Subject|2|||
130226633|NCT04350827|468793734|FG000|Overall Study|Lost to Follow-up|1|||
130099408|NCT01891669|468320985|FG004|Overall Study|Death|0|||
130099409|NCT01891669|468320986|FG005|Overall Study|Death|0|||
130022063|NCT03806127|468042593|FG001|Overall Study|Pregnancy|1|||
130022064|NCT03806127|468042592|FG000|Overall Study|Lost to Follow-up|5|||
130022065|NCT03806127|468042593|FG001|Overall Study|Lost to Follow-up|1|||
130022066|NCT03806127|468042592|FG000|Overall Study|Physician Decision|1|||
130022067|NCT03806127|468042593|FG001|Overall Study|Physician Decision|1|||
130022068|NCT03806127|468042592|FG000|Overall Study|Could Not Come Due to Covid|1|||
130022069|NCT03806127|468042593|FG001|Overall Study|Could Not Come Due to Covid|0|||
130022070|NCT03806127|468042592|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
130022071|NCT03806127|468042593|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
130022072|NCT03806127|468042592|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
130022073|NCT03806127|468042593|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
130022074|NCT03806127|468042592|FG000|Overall Study|Covid 19 Restrictions|2|||
130022075|NCT03806127|468042593|FG001|Overall Study|Covid 19 Restrictions|0|||
130022076|NCT03806127|468042592|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
130022077|NCT03806127|468042593|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
130022078|NCT03806127|468042592|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
130022079|NCT03806127|468042593|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
130099410|NCT01891669|468320987|FG006|Overall Study|Death|0|||
130226634|NCT04350827|468793735|FG001|Overall Study|Lost to Follow-up|2|||
130226635|NCT00916578|468795422|FG000|Overall Study|Physician Decision|2|||
130226636|NCT00916578|468795422|FG000|Overall Study|Withdrawal by Subject|3|||
130226637|NCT00916578|468795422|FG000|Overall Study|Insurance Denial|2|||
130226638|NCT00945243|468795427|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
130226639|NCT03256578|468795428|FG000|Overall Study|Excluded Post Randomization|66|||
130226640|NCT03256578|468795429|FG001|Overall Study|Excluded Post Randomization|56|||
130226641|NCT03028142|468795430|FG000|Overall Study|Adverse Event|1|||
130226642|NCT03028142|468795431|FG001|Overall Study|Adverse Event|1|||
130226643|NCT03028142|468795432|FG002|Overall Study|Adverse Event|0|||
130226644|NCT03028142|468795433|FG003|Overall Study|Adverse Event|0|||
130226645|NCT03028142|468795434|FG004|Overall Study|Adverse Event|0|||
130226646|NCT03028142|468795435|FG005|Overall Study|Adverse Event|1|||
130226647|NCT03028142|468795430|FG000|Overall Study|Withdrawal by Subject|0|||
130226648|NCT03028142|468795431|FG001|Overall Study|Withdrawal by Subject|0|||
130226649|NCT03028142|468795432|FG002|Overall Study|Withdrawal by Subject|0|||
130226650|NCT03028142|468795433|FG003|Overall Study|Withdrawal by Subject|0|||
130226651|NCT03028142|468795434|FG004|Overall Study|Withdrawal by Subject|1|||
130226652|NCT03028142|468795435|FG005|Overall Study|Withdrawal by Subject|0|||
130226653|NCT02810418|468795436|FG000|Arm A Dose Escalation|Adverse Event|2|||
130226654|NCT02810418|468795437|FG001|Arm A Dose Escalation|Adverse Event|1|||
130226655|NCT02810418|468795438|FG002|Arm A Dose Escalation|Adverse Event|0|||
130226656|NCT02810418|468795439|FG003|Arm A Dose Escalation|Adverse Event|0|||
130226657|NCT02810418|468795440|FG004|Arm A Dose Escalation|Adverse Event|0|||
130226658|NCT02810418|468795441|FG005|Arm A Dose Escalation|Adverse Event|0|||
130226659|NCT02810418|468795442|FG006|Arm A Dose Escalation|Adverse Event|0|||
130226660|NCT02810418|468795436|FG000|Dose Expansion|Adverse Event|0|||
130226661|NCT02810418|468795437|FG001|Dose Expansion|Adverse Event|1|||
130226662|NCT02810418|468795438|FG002|Dose Expansion|Adverse Event|1|||
130226663|NCT02810418|468795439|FG003|Dose Expansion|Adverse Event|0|||
130226664|NCT02810418|468795440|FG004|Dose Expansion|Adverse Event|0|||
130226665|NCT02810418|468795441|FG005|Dose Expansion|Adverse Event|0|||
130226666|NCT02810418|468795442|FG006|Dose Expansion|Adverse Event|0|||
130226667|NCT02810418|468795436|FG000|Dose Expansion|Physician Decision|0|||
130226668|NCT02810418|468795437|FG001|Dose Expansion|Physician Decision|0|||
130226669|NCT02810418|468795438|FG002|Dose Expansion|Physician Decision|2|||
130226670|NCT02810418|468795439|FG003|Dose Expansion|Physician Decision|0|||
130226671|NCT02810418|468795440|FG004|Dose Expansion|Physician Decision|0|||
130226672|NCT02810418|468795441|FG005|Dose Expansion|Physician Decision|0|||
130226673|NCT02810418|468795442|FG006|Dose Expansion|Physician Decision|0|||
130226674|NCT02810418|468795436|FG000|Arm B Dose Escalation|Adverse Event|0|||
130226675|NCT02810418|468795437|FG001|Arm B Dose Escalation|Adverse Event|0|||
130226676|NCT02810418|468795438|FG002|Arm B Dose Escalation|Adverse Event|0|||
130226677|NCT02810418|468795439|FG003|Arm B Dose Escalation|Adverse Event|0|||
130226678|NCT02810418|468795440|FG004|Arm B Dose Escalation|Adverse Event|1|||
130226679|NCT02810418|468795441|FG005|Arm B Dose Escalation|Adverse Event|2|||
130226680|NCT02810418|468795442|FG006|Arm B Dose Escalation|Adverse Event|0|||
130226681|NCT01162343|468795446|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
130226682|NCT01162343|468795446|FG000|Overall Study|Refused psychiatrist assessment|12|||
130226683|NCT04635839|468795460|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
130226684|NCT04635839|468795461|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
130226685|NCT02870868|468795462|FG000|Overall Study|Withdrawal by Subject|2|||
130226686|NCT02870868|468795463|FG001|Overall Study|Withdrawal by Subject|1|||
130226687|NCT00744939|468795464|FG000|Overall Study|Withdrawal by Subject|9|||
130226688|NCT00744939|468795464|FG000|Overall Study|Protocol Violation|13|||
130226689|NCT00744939|468795464|FG000|Overall Study|Death|24|||
130226690|NCT00744939|468795464|FG000|Overall Study|distance|4|||
130226691|NCT00744939|468795464|FG000|Overall Study|Lost to Follow-up|12|||
130226692|NCT00744939|468795464|FG000|Overall Study|Medical history exclusionary|1|||
130226693|NCT00744939|468795464|FG000|Overall Study|Did not receive Magnevist|7|||
130226694|NCT00744939|468795464|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
130226695|NCT00744939|468795464|FG000|Overall Study|coma|1|||
130226696|NCT00744939|468795464|FG000|Overall Study|incorrect race|1|||
130226697|NCT01674725|468795466|FG000|Overall Study|Adverse Event|1|||
130022080|NCT01467492|468042596|FG000|Overall Study|Withdrawal by Subject|6|||
130226698|NCT01674725|468795467|FG001|Overall Study|Adverse Event|0|||
130226699|NCT01674725|468795466|FG000|Overall Study|Did not receive study drug|1|||
130226700|NCT01674725|468795467|FG001|Overall Study|Did not receive study drug|0|||
130226701|NCT01674725|468795466|FG000|Overall Study|Withdrawal by Subject|1|||
130226702|NCT01674725|468795467|FG001|Overall Study|Withdrawal by Subject|0|||
130226703|NCT01674725|468795466|FG000|Overall Study|Lost to Follow-up|0|||
130226704|NCT01674725|468795467|FG001|Overall Study|Lost to Follow-up|1|||
130226705|NCT02900352|468795468|FG000|Overall Study|Lost to Follow-up|28|||
130226706|NCT02900352|468795469|FG001|Overall Study|Lost to Follow-up|17|||
130226707|NCT03074695|468795470|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
130226708|NCT03074695|468795471|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
130226709|NCT03074695|468795470|FG000|Overall Study|Research staff not available|1|||
130226710|NCT03074695|468795471|FG001|Overall Study|Research staff not available|2|||
130226711|NCT03074695|468795470|FG000|Overall Study|Did not receive neuraxial block|2|||
130226712|NCT03074695|468795471|FG001|Overall Study|Did not receive neuraxial block|2|||
130226713|NCT01774981|468795472|FG000|Overall Study|Adverse Event|0|||
130226714|NCT01774981|468795473|FG001|Overall Study|Adverse Event|0|||
130226715|NCT01774981|468795474|FG002|Overall Study|Adverse Event|0|||
130226716|NCT01774981|468795475|FG003|Overall Study|Adverse Event|0|||
130226717|NCT01774981|468795476|FG004|Overall Study|Adverse Event|0|||
130226718|NCT01774981|468795477|FG005|Overall Study|Adverse Event|1|||
130226719|NCT01774981|468795478|FG006|Overall Study|Adverse Event|0|||
130226720|NCT01774981|468795479|FG007|Overall Study|Adverse Event|0|||
130226721|NCT01774981|468795472|FG000|Overall Study|Withdrawal by Subject|0|||
130226722|NCT01774981|468795473|FG001|Overall Study|Withdrawal by Subject|0|||
130226723|NCT01774981|468795474|FG002|Overall Study|Withdrawal by Subject|0|||
130226724|NCT01774981|468795475|FG003|Overall Study|Withdrawal by Subject|0|||
130226725|NCT01774981|468795476|FG004|Overall Study|Withdrawal by Subject|0|||
130226726|NCT01774981|468795477|FG005|Overall Study|Withdrawal by Subject|0|||
130226727|NCT01774981|468795478|FG006|Overall Study|Withdrawal by Subject|0|||
130226728|NCT01774981|468795479|FG007|Overall Study|Withdrawal by Subject|1|||
130226729|NCT01774981|468795472|FG000|Overall Study|Death|0|||
130226730|NCT01774981|468795473|FG001|Overall Study|Death|0|||
130226731|NCT01774981|468795474|FG002|Overall Study|Death|0|||
130226732|NCT01774981|468795475|FG003|Overall Study|Death|0|||
130226733|NCT01774981|468795476|FG004|Overall Study|Death|1|||
130226734|NCT01774981|468795477|FG005|Overall Study|Death|0|||
130226735|NCT01774981|468795478|FG006|Overall Study|Death|0|||
130226736|NCT01774981|468795479|FG007|Overall Study|Death|0|||
130226737|NCT00960193|468795480|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
130226738|NCT01239797|468795481|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
130226739|NCT01239797|468795482|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
130226740|NCT01239797|468795481|FG000|Randomized Participants|Participant withdrew consent|1|||
130226741|NCT01239797|468795482|FG001|Randomized Participants|Participant withdrew consent|7|||
130226742|NCT01239797|468795481|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
130226743|NCT01239797|468795482|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
130226744|NCT01239797|468795481|FG000|Treated Participants|Disease progression|185|||
130226745|NCT01239797|468795482|FG001|Treated Participants|Disease progression|185|||
130226746|NCT01239797|468795481|FG000|Treated Participants|Study drug toxicity|39|||
130226747|NCT01239797|468795482|FG001|Treated Participants|Study drug toxicity|45|||
130226748|NCT01239797|468795481|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
130226749|NCT01239797|468795482|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
130226750|NCT01239797|468795481|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
130226751|NCT01239797|468795482|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
130226752|NCT01239797|468795481|FG000|Treated Participants|Administrative reason by sponsor|13|||
130226753|NCT01239797|468795482|FG001|Treated Participants|Administrative reason by sponsor|4|||
130226754|NCT01239797|468795481|FG000|Treated Participants|Other reasons|14|||
130226755|NCT01239797|468795482|FG001|Treated Participants|Other reasons|14|||
130226756|NCT01239797|468795481|FG000|Treated Participants|Participant withdrew consent|6|||
130226757|NCT01239797|468795482|FG001|Treated Participants|Participant withdrew consent|11|||
130226758|NCT01239797|468795481|FG000|Treated Participants|Death|1|||
130226759|NCT01239797|468795482|FG001|Treated Participants|Death|1|||
130226760|NCT01239797|468795481|FG000|Treated Participants|Participant no longer meets study criteria|1|||
130226761|NCT01239797|468795482|FG001|Treated Participants|Participant no longer meets study criteria|1|||
130226762|NCT01239797|468795481|FG000|Treated Participants|Poor/non-compliance|0|||
130226763|NCT01239797|468795482|FG001|Treated Participants|Poor/non-compliance|1|||
130226764|NCT02631941|468795487|FG000|Overall Study|Physician Decision|0|||
130226765|NCT02631941|468795488|FG001|Overall Study|Physician Decision|1|||
130226766|NCT02631941|468795489|FG002|Overall Study|Physician Decision|0|||
130226767|NCT02631941|468795490|FG003|Overall Study|Physician Decision|0|||
130226768|NCT02631941|468795491|FG004|Overall Study|Physician Decision|0|||
130226769|NCT02631941|468795492|FG005|Overall Study|Physician Decision|0|||
130226770|NCT02631941|468795493|FG006|Overall Study|Physician Decision|0|||
130226771|NCT02631941|468795494|FG007|Overall Study|Physician Decision|0|||
130226772|NCT02631941|468795495|FG008|Overall Study|Physician Decision|0|||
130226773|NCT02631941|468795496|FG009|Overall Study|Physician Decision|0|||
130226774|NCT02631941|468795487|FG000|Overall Study|Adverse Event|0|||
130226775|NCT02631941|468795488|FG001|Overall Study|Adverse Event|1|||
130226776|NCT02631941|468795489|FG002|Overall Study|Adverse Event|0|||
130226777|NCT02631941|468795490|FG003|Overall Study|Adverse Event|0|||
130226778|NCT02631941|468795491|FG004|Overall Study|Adverse Event|0|||
130226779|NCT02631941|468795492|FG005|Overall Study|Adverse Event|0|||
130226780|NCT02631941|468795493|FG006|Overall Study|Adverse Event|0|||
130226781|NCT02631941|468795494|FG007|Overall Study|Adverse Event|0|||
130226782|NCT02631941|468795495|FG008|Overall Study|Adverse Event|0|||
130226783|NCT02631941|468795496|FG009|Overall Study|Adverse Event|0|||
130226784|NCT02631941|468795487|FG000|Overall Study|Withdrawal by Subject|0|||
130226785|NCT02631941|468795488|FG001|Overall Study|Withdrawal by Subject|0|||
130226786|NCT02631941|468795489|FG002|Overall Study|Withdrawal by Subject|0|||
130022081|NCT01467492|468042597|FG001|Overall Study|Withdrawal by Subject|4|||
130022082|NCT01467492|468042596|FG000|Overall Study|Study Terminated by Sponsor|6|||
130226787|NCT02631941|468795490|FG003|Overall Study|Withdrawal by Subject|0|||
130226788|NCT02631941|468795491|FG004|Overall Study|Withdrawal by Subject|1|||
130226789|NCT02631941|468795492|FG005|Overall Study|Withdrawal by Subject|0|||
130226790|NCT02631941|468795493|FG006|Overall Study|Withdrawal by Subject|0|||
130226791|NCT02631941|468795494|FG007|Overall Study|Withdrawal by Subject|1|||
130226792|NCT02631941|468795495|FG008|Overall Study|Withdrawal by Subject|0|||
130226793|NCT02631941|468795496|FG009|Overall Study|Withdrawal by Subject|0|||
130226794|NCT02631941|468795487|FG000|Overall Study|Lost to Follow-up|0|||
130226795|NCT02631941|468795488|FG001|Overall Study|Lost to Follow-up|0|||
130226796|NCT02631941|468795489|FG002|Overall Study|Lost to Follow-up|0|||
130226797|NCT02631941|468795490|FG003|Overall Study|Lost to Follow-up|0|||
130226798|NCT02631941|468795491|FG004|Overall Study|Lost to Follow-up|0|||
130226799|NCT02631941|468795492|FG005|Overall Study|Lost to Follow-up|0|||
130226800|NCT02631941|468795493|FG006|Overall Study|Lost to Follow-up|0|||
130226801|NCT02631941|468795494|FG007|Overall Study|Lost to Follow-up|0|||
130226802|NCT02631941|468795495|FG008|Overall Study|Lost to Follow-up|1|||
130226803|NCT02631941|468795496|FG009|Overall Study|Lost to Follow-up|0|||
130226804|NCT02915835|468795497|FG000|Overall Study|Physician Decision|1|||
130226805|NCT02915835|468795498|FG001|Overall Study|Physician Decision|0|||
130226806|NCT02915835|468795497|FG000|Overall Study|Withdrawal by Subject|0|||
130226807|NCT02915835|468795498|FG001|Overall Study|Withdrawal by Subject|1|||
130226808|NCT03722576|468795499|FG000|Overall Study|Withdrawal by Subject|3|||
130226809|NCT03722576|468795499|FG000|Overall Study|Adverse Event|2|||
130226810|NCT03722576|468795499|FG000|Overall Study|Physician Decision|1|||
130226811|NCT03722576|468795499|FG000|Overall Study|Lost to Follow-up|1|||
130226812|NCT02513550|468795502|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
130226813|NCT02513550|468795503|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
130226814|NCT02513550|468795504|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
130226815|NCT02513550|468795505|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
130226816|NCT02513550|468795506|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130226817|NCT02513550|468795507|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
130226818|NCT02513550|468795502|FG000|Double Blind Treatment Period|Adverse Event|5|||
130226819|NCT02513550|468795503|FG001|Double Blind Treatment Period|Adverse Event|13|||
130226820|NCT02513550|468795504|FG002|Double Blind Treatment Period|Adverse Event|17|||
130226821|NCT02513550|468795505|FG003|Double Blind Treatment Period|Adverse Event|0|||
130226822|NCT02513550|468795506|FG004|Double Blind Treatment Period|Adverse Event|1|||
130226823|NCT02513550|468795507|FG005|Double Blind Treatment Period|Adverse Event|0|||
130226824|NCT02513550|468795502|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
130226825|NCT02513550|468795503|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
130226826|NCT02513550|468795504|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
130226827|NCT02513550|468795505|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
130226828|NCT02513550|468795506|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
130226829|NCT02513550|468795507|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
130226830|NCT02513550|468795502|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
130226831|NCT02513550|468795503|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
130226832|NCT02513550|468795504|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
130022083|NCT01467492|468042597|FG001|Overall Study|Study Terminated by Sponsor|4|||
130022084|NCT01467492|468042596|FG000|Overall Study|Adverse Event|4|||
130226833|NCT02513550|468795505|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130226834|NCT02513550|468795506|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130226835|NCT02513550|468795507|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
130226836|NCT02513550|468795502|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130226837|NCT02513550|468795503|FG001|Double Blind Treatment Period|Protocol Violation|1|||
130226838|NCT02513550|468795504|FG002|Double Blind Treatment Period|Protocol Violation|4|||
129884511|NCT02293837|467536435|FG003|Overall Study|COVID-19 Related|0|||
129884512|NCT02293837|467536432|FG000|Overall Study|Participant ill and could not be infused|0|||
130226839|NCT02513550|468795505|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130022085|NCT01467492|468042597|FG001|Overall Study|Adverse Event|3|||
130022086|NCT01467492|468042596|FG000|Overall Study|Lost to Follow-up|3|||
130022087|NCT01467492|468042597|FG001|Overall Study|Lost to Follow-up|2|||
130022088|NCT01467492|468042596|FG000|Overall Study|Undefined|2|||
130022089|NCT01467492|468042597|FG001|Overall Study|Undefined|0|||
130022090|NCT01467492|468042596|FG000|Overall Study|Enrolled But Not Treated|1|||
130022091|NCT01467492|468042597|FG001|Overall Study|Enrolled But Not Treated|0|||
130022092|NCT02450487|468042599|FG000|Overall Study|Lost to Follow-up|3|||
130022093|NCT01790048|468042600|FG000|Overall Study|Incorrect Age|9|||
130022094|NCT01790048|468042601|FG001|Overall Study|Incorrect Age|14|||
130022095|NCT01790048|468042600|FG000|Overall Study|data entry error|0|||
130022096|NCT01790048|468042601|FG001|Overall Study|data entry error|1|||
130022097|NCT01790048|468042600|FG000|Overall Study|Other|0|||
130022098|NCT01790048|468042601|FG001|Overall Study|Other|2|||
130022099|NCT01790048|468042600|FG000|Overall Study|SAM at Enrollment|2|||
130022100|NCT01790048|468042601|FG001|Overall Study|SAM at Enrollment|0|||
130022101|NCT01790048|468042600|FG000|Overall Study|Measurement error|1|||
130022102|NCT01790048|468042601|FG001|Overall Study|Measurement error|0|||
130022103|NCT00159432|468042602|FG000|Overall Study|Adverse Event|1|||
130022104|NCT00159432|468042602|FG000|Overall Study|Death|1|||
130022105|NCT00159432|468042602|FG000|Overall Study|Lack of Efficacy|8|||
130022106|NCT04537208|468042605|FG000|Overall Study|Adverse Event|0|||
130022107|NCT04537208|468042606|FG001|Overall Study|Adverse Event|0|||
130022108|NCT04537208|468042607|FG002|Overall Study|Adverse Event|0|||
130022109|NCT04537208|468042608|FG003|Overall Study|Adverse Event|0|||
130022110|NCT04537208|468042609|FG004|Overall Study|Adverse Event|0|||
130022111|NCT04537208|468042610|FG005|Overall Study|Adverse Event|0|||
130022112|NCT04537208|468042611|FG006|Overall Study|Adverse Event|0|||
130022113|NCT04537208|468042612|FG007|Overall Study|Adverse Event|0|||
130022114|NCT04537208|468042613|FG008|Overall Study|Adverse Event|1|||
130022115|NCT04537208|468042614|FG009|Overall Study|Adverse Event|0|||
130022116|NCT04537208|468042615|FG010|Overall Study|Adverse Event|0|||
130022117|NCT04537208|468042605|FG000|Overall Study|Protocol deviation|0|||
130022118|NCT04537208|468042606|FG001|Overall Study|Protocol deviation|0|||
130022119|NCT04537208|468042607|FG002|Overall Study|Protocol deviation|2|||
130022120|NCT04537208|468042608|FG003|Overall Study|Protocol deviation|0|||
130022121|NCT04537208|468042609|FG004|Overall Study|Protocol deviation|0|||
130022122|NCT04537208|468042610|FG005|Overall Study|Protocol deviation|2|||
130022123|NCT04537208|468042611|FG006|Overall Study|Protocol deviation|4|||
130022124|NCT04537208|468042612|FG007|Overall Study|Protocol deviation|0|||
130022125|NCT04537208|468042613|FG008|Overall Study|Protocol deviation|1|||
130022126|NCT04537208|468042614|FG009|Overall Study|Protocol deviation|0|||
130022127|NCT04537208|468042615|FG010|Overall Study|Protocol deviation|2|||
130022128|NCT04537208|468042605|FG000|Overall Study|Withdrawal by Subject|4|||
130022129|NCT04537208|468042606|FG001|Overall Study|Withdrawal by Subject|2|||
130022130|NCT04537208|468042607|FG002|Overall Study|Withdrawal by Subject|1|||
130022131|NCT04537208|468042608|FG003|Overall Study|Withdrawal by Subject|3|||
130022132|NCT04537208|468042609|FG004|Overall Study|Withdrawal by Subject|5|||
130022133|NCT04537208|468042610|FG005|Overall Study|Withdrawal by Subject|1|||
130022134|NCT04537208|468042611|FG006|Overall Study|Withdrawal by Subject|6|||
130022135|NCT04537208|468042612|FG007|Overall Study|Withdrawal by Subject|1|||
130022136|NCT04537208|468042613|FG008|Overall Study|Withdrawal by Subject|7|||
130022137|NCT04537208|468042614|FG009|Overall Study|Withdrawal by Subject|2|||
130022138|NCT04537208|468042615|FG010|Overall Study|Withdrawal by Subject|4|||
130022139|NCT04537208|468042605|FG000|Overall Study|Lost to Follow-up|4|||
130022140|NCT04537208|468042606|FG001|Overall Study|Lost to Follow-up|1|||
130022141|NCT04537208|468042607|FG002|Overall Study|Lost to Follow-up|3|||
130022142|NCT04537208|468042608|FG003|Overall Study|Lost to Follow-up|4|||
130022143|NCT04537208|468042609|FG004|Overall Study|Lost to Follow-up|3|||
130022144|NCT04537208|468042610|FG005|Overall Study|Lost to Follow-up|2|||
130022145|NCT04537208|468042611|FG006|Overall Study|Lost to Follow-up|3|||
130022146|NCT04537208|468042612|FG007|Overall Study|Lost to Follow-up|2|||
130022147|NCT04537208|468042613|FG008|Overall Study|Lost to Follow-up|7|||
130022148|NCT04537208|468042614|FG009|Overall Study|Lost to Follow-up|2|||
130022149|NCT04537208|468042615|FG010|Overall Study|Lost to Follow-up|2|||
130022150|NCT05030311|468042616|FG000|Overall Study|Technical problems|0|||
130022151|NCT05030311|468042617|FG001|Overall Study|Technical problems|1|||
130022152|NCT05030311|468042616|FG000|Overall Study|Withdrawal by Subject|31|||
130022153|NCT05030311|468042617|FG001|Overall Study|Withdrawal by Subject|17|||
130022154|NCT05030311|468042616|FG000|Overall Study|Adverse Event|13|||
130022155|NCT05030311|468042617|FG001|Overall Study|Adverse Event|5|||
130022156|NCT05030311|468042616|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130022157|NCT05030311|468042617|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130022158|NCT05030311|468042616|FG000|Overall Study|Physician Decision|5|||
130022159|NCT05030311|468042617|FG001|Overall Study|Physician Decision|2|||
130022160|NCT05030311|468042616|FG000|Overall Study|Lost to Follow-up|5|||
130022161|NCT05030311|468042617|FG001|Overall Study|Lost to Follow-up|1|||
130022162|NCT05030311|468042616|FG000|Overall Study|Protocol Violation|4|||
130022163|NCT05030311|468042617|FG001|Overall Study|Protocol Violation|4|||
130022164|NCT03042468|468042619|FG000|Overall Study|Death|0|||
130226840|NCT02513550|468795506|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130226841|NCT02513550|468795507|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130226842|NCT02513550|468795502|FG000|Double Blind Treatment Period|Physician Decision|2|||
130226843|NCT02513550|468795503|FG001|Double Blind Treatment Period|Physician Decision|0|||
130226844|NCT02513550|468795504|FG002|Double Blind Treatment Period|Physician Decision|4|||
130226845|NCT02513550|468795505|FG003|Double Blind Treatment Period|Physician Decision|0|||
130226846|NCT02513550|468795506|FG004|Double Blind Treatment Period|Physician Decision|0|||
130226847|NCT02513550|468795507|FG005|Double Blind Treatment Period|Physician Decision|0|||
130226848|NCT02513550|468795502|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
130226849|NCT02513550|468795503|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
130226850|NCT02513550|468795504|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
130226851|NCT02513550|468795505|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
130226852|NCT02513550|468795506|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
130226853|NCT02513550|468795507|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
130226854|NCT02513550|468795502|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226855|NCT02513550|468795503|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226856|NCT02513550|468795504|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
130226857|NCT02513550|468795505|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226858|NCT02513550|468795506|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226859|NCT02513550|468795507|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
130226860|NCT02513550|468795502|FG000|Double Blind Treatment Period|Due to personal business|2|||
130226861|NCT02513550|468795503|FG001|Double Blind Treatment Period|Due to personal business|0|||
130226862|NCT02513550|468795504|FG002|Double Blind Treatment Period|Due to personal business|1|||
130226863|NCT02513550|468795505|FG003|Double Blind Treatment Period|Due to personal business|0|||
130226864|NCT02513550|468795506|FG004|Double Blind Treatment Period|Due to personal business|0|||
130226865|NCT02513550|468795507|FG005|Double Blind Treatment Period|Due to personal business|0|||
130226866|NCT02513550|468795502|FG000|Double Blind Treatment Period|Death|1|||
130226867|NCT02513550|468795503|FG001|Double Blind Treatment Period|Death|0|||
130226868|NCT02513550|468795504|FG002|Double Blind Treatment Period|Death|2|||
130226869|NCT02513550|468795505|FG003|Double Blind Treatment Period|Death|0|||
130226870|NCT02513550|468795506|FG004|Double Blind Treatment Period|Death|0|||
130226871|NCT02513550|468795507|FG005|Double Blind Treatment Period|Death|0|||
130226872|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
130226873|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
130226874|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
130226875|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130226876|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130226877|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
130226878|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
130226879|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
130226880|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
130226881|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130226882|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130226883|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
130226884|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
130226885|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
130226886|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
130226887|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130226888|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130226889|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
130226890|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
130226891|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
130226892|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
130022165|NCT03042468|468042620|FG001|Overall Study|Death|1|||
130022166|NCT03042468|468042621|FG002|Overall Study|Death|1|||
130226893|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
130226894|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
130226895|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
130226896|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
130226897|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
130226898|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
130226899|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
130226900|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
130226901|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
130226902|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Death|0|||
130226903|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Death|0|||
130226904|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Death|1|||
130226905|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Death|0|||
130226906|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Death|0|||
130226907|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Death|0|||
130226908|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226909|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226910|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
130226911|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226912|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226913|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
130226914|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226915|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226916|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
130226917|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226918|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226919|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
130226920|NCT02513550|468795502|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226921|NCT02513550|468795503|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226922|NCT02513550|468795504|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
130226923|NCT02513550|468795505|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226924|NCT02513550|468795506|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226925|NCT02513550|468795507|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
130226926|NCT00192114|468795511|FG000|Overall Study|Objective Tumor Progression|19|||
130226927|NCT00192114|468795511|FG000|Overall Study|Adverse Event|2|||
130226928|NCT00192114|468795511|FG000|Overall Study|Clinical Progression|2|||
130226929|NCT00192114|468795511|FG000|Overall Study|Death|1|||
130226930|NCT00492297|468795512|FG000|Treatment|Death|2|||
130226931|NCT00492297|468795512|FG000|Treatment|Study terminated by sponsor|3|||
130226932|NCT00492297|468795512|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
130226933|NCT00492297|468795512|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
130226934|NCT00492297|468795512|FG000|Survival Only Follow-up|Death|46|||
130226935|NCT00492297|468795512|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
130226936|NCT00492297|468795512|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
130226937|NCT01408706|468795514|FG000|Overall Study|Physician Decision|1|||
130226938|NCT01408706|468795515|FG001|Overall Study|Physician Decision|0|||
130226939|NCT00113607|468795516|FG000|Overall Study|Adverse Event|40|||
130226940|NCT00113607|468795517|FG001|Overall Study|Adverse Event|71|||
130226941|NCT00113607|468795516|FG000|Overall Study|Death|8|||
130226942|NCT00113607|468795517|FG001|Overall Study|Death|8|||
130226943|NCT00113607|468795516|FG000|Overall Study|Withdrawal by Subject|50|||
130226944|NCT00113607|468795517|FG001|Overall Study|Withdrawal by Subject|58|||
130226945|NCT00113607|468795516|FG000|Overall Study|Lost to Follow-up|0|||
130226946|NCT00113607|468795517|FG001|Overall Study|Lost to Follow-up|2|||
130226947|NCT00113607|468795516|FG000|Overall Study|Disease Progression|180|||
130226948|NCT00113607|468795517|FG001|Overall Study|Disease Progression|142|||
130226949|NCT00113607|468795516|FG000|Overall Study|Complete Response (Confirmed)|14|||
130226950|NCT00113607|468795517|FG001|Overall Study|Complete Response (Confirmed)|24|||
130226951|NCT00113607|468795516|FG000|Overall Study|Other|43|||
130226952|NCT00113607|468795517|FG001|Overall Study|Other|32|||
130226953|NCT01222104|468795518|FG000|Overall Study|Lost to Follow-up|37|||
130226954|NCT01222104|468795518|FG000|Overall Study|Death|10|||
130226955|NCT01418339|468795520|FG000|Overall Study|Adverse Event|5|||
130226956|NCT01418339|468795521|FG001|Overall Study|Adverse Event|2|||
130226957|NCT01418339|468795520|FG000|Overall Study|Subject Withdrew Consent|1|||
130226958|NCT01418339|468795521|FG001|Overall Study|Subject Withdrew Consent|2|||
130226959|NCT01418339|468795520|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
130226960|NCT01418339|468795521|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
130226961|NCT03885908|468795522|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
130226962|NCT03885908|468795523|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
130226963|NCT03885908|468795522|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
130226964|NCT03885908|468795523|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
130226965|NCT03885908|468795522|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
130226966|NCT03885908|468795523|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
130226967|NCT03885908|468795522|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
130226968|NCT03885908|468795523|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
130226969|NCT02204917|468795524|FG000|Overall Study|Protocol Violation|1|||
130226970|NCT03669549|468795525|FG000|Overall Study|Adverse Event|4|||
130226971|NCT03669549|468795525|FG000|Overall Study|Withdrawal by Subject|1|||
130226972|NCT03669549|468795525|FG000|Overall Study|Study terminated by the Sponsor|1|||
130226973|NCT00909844|468795526|FG000|Overall Study|Adverse Event|1|||
130226974|NCT00909844|468795526|FG000|Overall Study|Withdrawal by Subject|1|||
130226975|NCT00909844|468795526|FG000|Overall Study|Lost to Follow-up|2|||
130226976|NCT00698815|468795527|FG000|Overall Study|Death|1|||
130226977|NCT00698815|468795528|FG001|Overall Study|Death|2|||
130226978|NCT00698815|468795529|FG002|Overall Study|Death|4|||
130226979|NCT00698815|468795527|FG000|Overall Study|Withdrawal by Subject|6|||
130226980|NCT00698815|468795528|FG001|Overall Study|Withdrawal by Subject|3|||
130226981|NCT00698815|468795529|FG002|Overall Study|Withdrawal by Subject|2|||
130226982|NCT00698815|468795527|FG000|Overall Study|MD discretion|2|||
130226983|NCT00698815|468795528|FG001|Overall Study|MD discretion|7|||
130226984|NCT00698815|468795529|FG002|Overall Study|MD discretion|2|||
130226985|NCT00698815|468795527|FG000|Overall Study|Did not receive protocol treatment|1|||
130226986|NCT00698815|468795528|FG001|Overall Study|Did not receive protocol treatment|2|||
130226987|NCT00698815|468795529|FG002|Overall Study|Did not receive protocol treatment|2|||
130226988|NCT01064479|468795530|FG000|Overall Study|Death|10|||
130226989|NCT01064479|468795531|FG001|Overall Study|Death|11|||
130226990|NCT01064479|468795530|FG000|Overall Study|Withdrawal by Subject|2|||
130226991|NCT01064479|468795531|FG001|Overall Study|Withdrawal by Subject|2|||
130226992|NCT01064479|468795530|FG000|Overall Study|Disease progression|1|||
130226993|NCT01064479|468795531|FG001|Overall Study|Disease progression|1|||
130226994|NCT01064479|468795530|FG000|Overall Study|Toxicity|1|||
130226995|NCT01064479|468795531|FG001|Overall Study|Toxicity|1|||
130226996|NCT01064479|468795530|FG000|Overall Study|Other|1|||
130226997|NCT01064479|468795531|FG001|Overall Study|Other|2|||
130226998|NCT01663402|468795536|FG000|Overall Study|Randomized but not treated|19|||
130226999|NCT01663402|468795537|FG001|Overall Study|Randomized but not treated|11|||
130227000|NCT01663402|468795536|FG000|Overall Study|Adverse Event|347|||
130227001|NCT01663402|468795537|FG001|Overall Study|Adverse Event|362|||
130227002|NCT01663402|468795536|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
130227003|NCT01663402|468795537|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
130227004|NCT01663402|468795536|FG000|Overall Study|Poor compliance to protocol|529|||
130227005|NCT01663402|468795537|FG001|Overall Study|Poor compliance to protocol|454|||
130227006|NCT01663402|468795536|FG000|Overall Study|Physician Decision|77|||
130227007|NCT01663402|468795537|FG001|Overall Study|Physician Decision|62|||
130227008|NCT01663402|468795536|FG000|Overall Study|Site terminated by sponsor|1|||
130227009|NCT01663402|468795537|FG001|Overall Study|Site terminated by sponsor|3|||
130227010|NCT01663402|468795536|FG000|Overall Study|Participant moved|139|||
130227011|NCT01663402|468795537|FG001|Overall Study|Participant moved|104|||
130227012|NCT01663402|468795536|FG000|Overall Study|Withdrawal by Subject|118|||
130227013|NCT01663402|468795537|FG001|Overall Study|Withdrawal by Subject|91|||
130227014|NCT01663402|468795536|FG000|Overall Study|Related to study drug administration|96|||
130227015|NCT01663402|468795537|FG001|Overall Study|Related to study drug administration|105|||
130227016|NCT01663402|468795536|FG000|Overall Study|Lost to Follow-up|17|||
130227017|NCT01663402|468795537|FG001|Overall Study|Lost to Follow-up|15|||
130227018|NCT01663402|468795536|FG000|Overall Study|Other than specified above|172|||
130227019|NCT01663402|468795537|FG001|Overall Study|Other than specified above|147|||
130022167|NCT03042468|468042622|FG003|Overall Study|Death|0|||
130227020|NCT02984982|468795551|FG000|Overall Study|Adverse Event|2|||
130227021|NCT02984982|468795552|FG001|Overall Study|Adverse Event|5|||
130227022|NCT02984982|468795551|FG000|Overall Study|Poor Compliance to Protocol|4|||
130227023|NCT02984982|468795552|FG001|Overall Study|Poor Compliance to Protocol|4|||
130227024|NCT02984982|468795551|FG000|Overall Study|Withdrawal by Subject|2|||
130227025|NCT02984982|468795552|FG001|Overall Study|Withdrawal by Subject|0|||
130227026|NCT02984982|468795551|FG000|Overall Study|Randomized but not treated|0|||
130227027|NCT02984982|468795552|FG001|Overall Study|Randomized but not treated|1|||
130227028|NCT01747499|468795554|FG000|Overall Study|Steroid refractory aGvHD|1|||
130227029|NCT01747499|468795555|FG001|Overall Study|Steroid refractory aGvHD|0|||
130022168|NCT03042468|468042623|FG004|Overall Study|Death|0|||
130022169|NCT03042468|468042624|FG005|Overall Study|Death|0|||
130022170|NCT03042468|468042619|FG000|Overall Study|Withdrawal by Subject|0|||
130022171|NCT03042468|468042620|FG001|Overall Study|Withdrawal by Subject|0|||
130022172|NCT03042468|468042621|FG002|Overall Study|Withdrawal by Subject|0|||
130022173|NCT03042468|468042622|FG003|Overall Study|Withdrawal by Subject|0|||
130022174|NCT03042468|468042623|FG004|Overall Study|Withdrawal by Subject|0|||
130022175|NCT03042468|468042624|FG005|Overall Study|Withdrawal by Subject|1|||
130022176|NCT03042468|468042619|FG000|Overall Study|Lost to Follow-up|0|||
130022177|NCT03042468|468042620|FG001|Overall Study|Lost to Follow-up|0|||
130022178|NCT03042468|468042621|FG002|Overall Study|Lost to Follow-up|0|||
130022179|NCT03042468|468042622|FG003|Overall Study|Lost to Follow-up|0|||
130022180|NCT03042468|468042623|FG004|Overall Study|Lost to Follow-up|1|||
130022181|NCT03042468|468042624|FG005|Overall Study|Lost to Follow-up|1|||
130022182|NCT00253630|468042625|FG000|Overall Study|ineligible|2|||
130022183|NCT00429858|468042626|FG000|Overall Study|Withdrawal by Subject|1|||
130022184|NCT00429858|468042626|FG000|Overall Study|Study Termination|1|||
130227030|NCT01747499|468795556|FG002|Overall Study|Steroid refractory aGvHD|0|||
130227031|NCT01747499|468795557|FG003|Overall Study|Steroid refractory aGvHD|1|||
130227032|NCT01747499|468795558|FG004|Overall Study|Steroid refractory aGvHD|4|||
130227033|NCT01747499|468795554|FG000|Overall Study|Physician Decision|0|||
130227034|NCT01747499|468795555|FG001|Overall Study|Physician Decision|1|||
130227035|NCT01747499|468795556|FG002|Overall Study|Physician Decision|0|||
130227036|NCT01747499|468795557|FG003|Overall Study|Physician Decision|0|||
130227037|NCT01747499|468795558|FG004|Overall Study|Physician Decision|2|||
130227038|NCT01747499|468795554|FG000|Overall Study|Death|0|||
130227039|NCT01747499|468795555|FG001|Overall Study|Death|0|||
130227040|NCT01747499|468795556|FG002|Overall Study|Death|0|||
130227041|NCT01747499|468795557|FG003|Overall Study|Death|1|||
130227042|NCT01747499|468795558|FG004|Overall Study|Death|1|||
130227043|NCT01747499|468795554|FG000|Overall Study|Withdrawal by Subject|0|||
130227044|NCT01747499|468795555|FG001|Overall Study|Withdrawal by Subject|0|||
130227045|NCT01747499|468795556|FG002|Overall Study|Withdrawal by Subject|0|||
130227046|NCT01747499|468795557|FG003|Overall Study|Withdrawal by Subject|0|||
130227047|NCT01747499|468795558|FG004|Overall Study|Withdrawal by Subject|6|||
130227048|NCT01747499|468795554|FG000|Overall Study|Developed AML and death|0|||
130227049|NCT01747499|468795555|FG001|Overall Study|Developed AML and death|0|||
130227050|NCT01747499|468795556|FG002|Overall Study|Developed AML and death|0|||
130227051|NCT01747499|468795557|FG003|Overall Study|Developed AML and death|0|||
130227052|NCT01747499|468795558|FG004|Overall Study|Developed AML and death|1|||
130227053|NCT01747499|468795554|FG000|Overall Study|Determined not to be eligible|0|||
130227054|NCT01747499|468795555|FG001|Overall Study|Determined not to be eligible|0|||
130227055|NCT01747499|468795556|FG002|Overall Study|Determined not to be eligible|0|||
130227056|NCT01747499|468795557|FG003|Overall Study|Determined not to be eligible|0|||
130227057|NCT01747499|468795558|FG004|Overall Study|Determined not to be eligible|1|||
130227058|NCT01103323|468795559|FG000|Without/Before Drug Switch|Adverse Event|50|||
130227059|NCT01103323|468795560|FG001|Without/Before Drug Switch|Adverse Event|7|||
130227060|NCT01103323|468795559|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
130227061|NCT01103323|468795560|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
130227062|NCT01103323|468795559|FG000|Without/Before Drug Switch|Protocol Violation|2|||
130227063|NCT01103323|468795560|FG001|Without/Before Drug Switch|Protocol Violation|0|||
130227064|NCT01103323|468795559|FG000|Without/Before Drug Switch|Physician Decision|2|||
130227065|NCT01103323|468795560|FG001|Without/Before Drug Switch|Physician Decision|0|||
130227066|NCT01103323|468795559|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
130227067|NCT01103323|468795560|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
130227068|NCT01103323|468795559|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
130099411|NCT01891669|468320988|FG007|Overall Study|Death|1|||
130099412|NCT01891669|468320989|FG008|Overall Study|Death|0|||
130099413|NCT01891669|468320990|FG009|Overall Study|Death|1|||
130099414|NCT01891669|468320981|FG000|Overall Study|Withdrawal by Subject|1|||
130099415|NCT01891669|468320982|FG001|Overall Study|Withdrawal by Subject|1|||
130099416|NCT01891669|468320983|FG002|Overall Study|Withdrawal by Subject|0|||
130099417|NCT01891669|468320984|FG003|Overall Study|Withdrawal by Subject|0|||
130099418|NCT01891669|468320985|FG004|Overall Study|Withdrawal by Subject|0|||
130099419|NCT01891669|468320986|FG005|Overall Study|Withdrawal by Subject|0|||
130099420|NCT01891669|468320987|FG006|Overall Study|Withdrawal by Subject|1|||
130099421|NCT01891669|468320988|FG007|Overall Study|Withdrawal by Subject|2|||
130099422|NCT01891669|468320989|FG008|Overall Study|Withdrawal by Subject|1|||
130099423|NCT01891669|468320990|FG009|Overall Study|Withdrawal by Subject|1|||
130099424|NCT01891669|468320981|FG000|Overall Study|Other|1|||
130099425|NCT01891669|468320982|FG001|Overall Study|Other|0|||
130099426|NCT01891669|468320983|FG002|Overall Study|Other|0|||
130099427|NCT01891669|468320984|FG003|Overall Study|Other|0|||
130099428|NCT01891669|468320985|FG004|Overall Study|Other|0|||
130099429|NCT01891669|468320986|FG005|Overall Study|Other|0|||
130099430|NCT01891669|468320987|FG006|Overall Study|Other|0|||
130099431|NCT01891669|468320988|FG007|Overall Study|Other|1|||
130099432|NCT01891669|468320989|FG008|Overall Study|Other|0|||
130099433|NCT01891669|468320990|FG009|Overall Study|Other|0|||
130099434|NCT02856282|468322668|FG000|Overall Study|Withdrawal by Subject|1|||
130099435|NCT00057330|468322669|FG000|Overall Study|Adverse Event|9|||
130099436|NCT00057330|468322670|FG001|Overall Study|Adverse Event|12|||
130099437|NCT00057330|468322669|FG000|Overall Study|Death|1|||
130099438|NCT00057330|468322670|FG001|Overall Study|Death|0|||
130099439|NCT00057330|468322669|FG000|Overall Study|Protocol Violation|1|||
130099440|NCT00057330|468322670|FG001|Overall Study|Protocol Violation|1|||
130099441|NCT00057330|468322669|FG000|Overall Study|Withdrawal by Subject|115|||
130099442|NCT00057330|468322670|FG001|Overall Study|Withdrawal by Subject|84|||
130099443|NCT00057330|468322669|FG000|Overall Study|Lost to Follow-up|745|||
130227069|NCT01103323|468795560|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
130227070|NCT01103323|468795559|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
130227071|NCT01103323|468795560|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
130227072|NCT00372424|468795561|FG000|Overall Study|Adverse Event|2|||
130227073|NCT00372424|468795561|FG000|Overall Study|Withdrawal by Subject|1|||
130099444|NCT00057330|468322670|FG001|Overall Study|Lost to Follow-up|617|||
130099445|NCT00057330|468322669|FG000|Overall Study|Physician Decision|1|||
130099446|NCT00057330|468322670|FG001|Overall Study|Physician Decision|0|||
130099447|NCT00057330|468322669|FG000|Overall Study|Other|260|||
130099448|NCT00057330|468322670|FG001|Overall Study|Other|206|||
130099449|NCT02074982|468322671|FG000|Overall Study|Adverse Event|15|||
130099450|NCT02074982|468322672|FG001|Overall Study|Adverse Event|7|||
130227074|NCT00372424|468795561|FG000|Overall Study|Death|1|||
130227075|NCT00372424|468795561|FG000|Overall Study|Objective Progression or Relapse|14|||
130227076|NCT00372424|468795561|FG000|Overall Study|Other|7|||
130227077|NCT00372424|468795561|FG000|Overall Study|Enrolled, Not Treated|1|||
130227078|NCT00072410|468795562|FG000|Overall Study|Progressive disease|0|||
130227079|NCT00072410|468795563|FG001|Overall Study|Progressive disease|3|||
130227080|NCT03160716|468795565|FG000|Overall Study|Lost to Follow-up|1|||
130227081|NCT00875810|468795569|FG000|Overall Study|Withdrawal by Subject|1|||
130227082|NCT00875810|468795569|FG000|Overall Study|Physician Decision|3|||
130227083|NCT00875810|468795569|FG000|Overall Study|Lost to Follow-up|39|||
130227084|NCT00875810|468795569|FG000|Overall Study|Patient enroled but not implanted|2|||
130227085|NCT00875810|468795569|FG000|Overall Study|Device explanted|1|||
130227086|NCT00780975|468795572|FG000|Overall Study|Progressive disease|3|||
130227087|NCT00780975|468795572|FG000|Overall Study|Toxicity|5|||
130227088|NCT01939314|468795573|FG000|Overall Study|Withdrawal by Subject|3|||
130227089|NCT01939314|468795574|FG001|Overall Study|Withdrawal by Subject|1|||
130227090|NCT01939314|468795573|FG000|Overall Study|Protocol Violation|1|||
130227091|NCT01939314|468795574|FG001|Overall Study|Protocol Violation|0|||
130227092|NCT01939314|468795573|FG000|Overall Study|Pregnancy|0|||
130227093|NCT01939314|468795574|FG001|Overall Study|Pregnancy|1|||
130227094|NCT01939314|468795573|FG000|Overall Study|Lost to Follow-up|5|||
130227095|NCT01939314|468795574|FG001|Overall Study|Lost to Follow-up|6|||
130227096|NCT00969228|468795578|FG000|Overall Study|Adverse Event|1|||
130227097|NCT00969228|468795579|FG001|Overall Study|Adverse Event|0|||
130227098|NCT00969228|468795578|FG000|Overall Study|Withdrawal by Subject|4|||
130022185|NCT01239160|468042628|FG000|Overall Study|Lost to Follow-up|3|||
130022186|NCT01239160|468042629|FG001|Overall Study|Lost to Follow-up|5|||
130227099|NCT00969228|468795579|FG001|Overall Study|Withdrawal by Subject|0|||
130022187|NCT01239160|468042630|FG002|Overall Study|Lost to Follow-up|0|||
130227100|NCT00969228|468795578|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
130227101|NCT00969228|468795579|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
130227102|NCT02563899|468795580|FG000|Overall Study|Protocol Violation|1|||
130227103|NCT02563899|468795581|FG001|Overall Study|Protocol Violation|0|||
130227104|NCT02563899|468795582|FG002|Overall Study|Protocol Violation|0|||
130227105|NCT02563899|468795583|FG003|Overall Study|Protocol Violation|0|||
130227106|NCT02563899|468795580|FG000|Overall Study|Withdrawal by Subject|0|||
130227107|NCT02563899|468795581|FG001|Overall Study|Withdrawal by Subject|0|||
130022188|NCT01239160|468042628|FG000|Overall Study|Withdrawal by Subject|17|||
130022189|NCT01239160|468042629|FG001|Overall Study|Withdrawal by Subject|6|||
130022190|NCT01239160|468042630|FG002|Overall Study|Withdrawal by Subject|2|||
130022191|NCT01239160|468042628|FG000|Overall Study|Physician Decision|5|||
130022192|NCT01239160|468042629|FG001|Overall Study|Physician Decision|7|||
130022193|NCT01239160|468042630|FG002|Overall Study|Physician Decision|2|||
130022194|NCT01239160|468042628|FG000|Overall Study|Early Termination Due to Study Closure|0|||
130022195|NCT01239160|468042629|FG001|Overall Study|Early Termination Due to Study Closure|1|||
130022196|NCT01239160|468042630|FG002|Overall Study|Early Termination Due to Study Closure|6|||
130022197|NCT01639833|468042633|FG000|Overall Study|Death|4|||
130227108|NCT02563899|468795582|FG002|Overall Study|Withdrawal by Subject|1|||
130227109|NCT02563899|468795583|FG003|Overall Study|Withdrawal by Subject|0|||
130227110|NCT00794664|468795584|FG000|Treatment Period|Withdrawal by Subject|0|||
130227111|NCT00794664|468795585|FG001|Treatment Period|Withdrawal by Subject|2|||
130227112|NCT00794664|468795584|FG000|Treatment Period|Protocol non-compliance|0|||
130227113|NCT00794664|468795585|FG001|Treatment Period|Protocol non-compliance|1|||
130227114|NCT00794664|468795584|FG000|Treatment Period|Other|0|||
130227115|NCT00794664|468795585|FG001|Treatment Period|Other|1|||
130227116|NCT00794664|468795584|FG000|Treatment Period|Adverse Event|1|||
130227117|NCT00794664|468795585|FG001|Treatment Period|Adverse Event|8|||
130227118|NCT00794664|468795584|FG000|Follow-up Period|Other|1|||
130227119|NCT00794664|468795585|FG001|Follow-up Period|Other|2|||
130227120|NCT00794664|468795584|FG000|Follow-up Period|Withdrawal by Subject|0|||
130227121|NCT00794664|468795585|FG001|Follow-up Period|Withdrawal by Subject|2|||
130022198|NCT01639833|468042634|FG001|Overall Study|Death|2|||
130022199|NCT01639833|468042633|FG000|Overall Study|Withdrawal by Subject|2|||
130022200|NCT01639833|468042634|FG001|Overall Study|Withdrawal by Subject|2|||
130227122|NCT00794664|468795584|FG000|Follow-up Period|Protocol non-compliance|0|||
130227123|NCT00794664|468795585|FG001|Follow-up Period|Protocol non-compliance|1|||
130227124|NCT01305564|468795590|FG000|Overall Study|Death|21|||
130227125|NCT01305564|468795590|FG000|Overall Study|Lost to Follow-up|12|||
130227126|NCT01305564|468795590|FG000|Overall Study|Withdrawal by Subject|1|||
130022201|NCT02436876|468042637|FG000|Overall Study|Lost to Follow-up|0|||
130227127|NCT01305564|468795590|FG000|Overall Study|Physician Decision|3|||
130022202|NCT02436876|468042638|FG001|Overall Study|Lost to Follow-up|1|||
130022203|NCT02436876|468042639|FG002|Overall Study|Lost to Follow-up|1|||
130227128|NCT01814007|468795595|FG000|Overall Study|Withdrawal by Subject|1|||
130022204|NCT02436876|468042640|FG003|Overall Study|Lost to Follow-up|1|||
130227129|NCT01655901|468798022|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227130|NCT01655901|468798023|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227131|NCT01655901|468798024|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227132|NCT01655901|468798025|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
130227133|NCT01655901|468798026|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
130227134|NCT01655901|468798027|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
130227135|NCT00922636|468798030|FG000|Overall Study|Adverse Event|3|||
130227136|NCT00922636|468798031|FG001|Overall Study|Adverse Event|3|||
130227137|NCT00922636|468798032|FG002|Overall Study|Adverse Event|2|||
130227138|NCT00922636|468798033|FG003|Overall Study|Adverse Event|3|||
130227139|NCT00922636|468798034|FG004|Overall Study|Adverse Event|2|||
130227140|NCT00922636|468798030|FG000|Overall Study|Lack of Efficacy|1|||
130227141|NCT00922636|468798031|FG001|Overall Study|Lack of Efficacy|7|||
130227142|NCT00922636|468798032|FG002|Overall Study|Lack of Efficacy|3|||
130227143|NCT00922636|468798033|FG003|Overall Study|Lack of Efficacy|2|||
130227144|NCT00922636|468798034|FG004|Overall Study|Lack of Efficacy|4|||
130227145|NCT00922636|468798030|FG000|Overall Study|Sponsor Decision|0|||
130227146|NCT00922636|468798031|FG001|Overall Study|Sponsor Decision|0|||
130227147|NCT00922636|468798032|FG002|Overall Study|Sponsor Decision|2|||
130022205|NCT02436876|468042637|FG000|Overall Study|Withdrawal by Subject|1|||
130022206|NCT02436876|468042638|FG001|Overall Study|Withdrawal by Subject|0|||
130227148|NCT00922636|468798033|FG003|Overall Study|Sponsor Decision|0|||
130227149|NCT00922636|468798034|FG004|Overall Study|Sponsor Decision|0|||
130227150|NCT00922636|468798030|FG000|Overall Study|Withdrawal by Subject|0|||
130227151|NCT00922636|468798031|FG001|Overall Study|Withdrawal by Subject|0|||
130227152|NCT00922636|468798032|FG002|Overall Study|Withdrawal by Subject|5|||
130227153|NCT00922636|468798033|FG003|Overall Study|Withdrawal by Subject|2|||
130227154|NCT00922636|468798034|FG004|Overall Study|Withdrawal by Subject|4|||
130227155|NCT00922636|468798030|FG000|Overall Study|Protocol Violation|0|||
130227156|NCT00922636|468798031|FG001|Overall Study|Protocol Violation|0|||
130227157|NCT00922636|468798032|FG002|Overall Study|Protocol Violation|2|||
130227158|NCT00922636|468798033|FG003|Overall Study|Protocol Violation|2|||
130227159|NCT00922636|468798034|FG004|Overall Study|Protocol Violation|0|||
130227160|NCT00922636|468798030|FG000|Overall Study|Entry Criteria Not Met|0|||
130227161|NCT00922636|468798031|FG001|Overall Study|Entry Criteria Not Met|0|||
130227162|NCT00922636|468798032|FG002|Overall Study|Entry Criteria Not Met|1|||
130227163|NCT00922636|468798033|FG003|Overall Study|Entry Criteria Not Met|1|||
130227164|NCT00922636|468798034|FG004|Overall Study|Entry Criteria Not Met|0|||
130227165|NCT00922636|468798030|FG000|Overall Study|Parent/Caregiver Decision|2|||
130227166|NCT00922636|468798031|FG001|Overall Study|Parent/Caregiver Decision|4|||
130227167|NCT00922636|468798032|FG002|Overall Study|Parent/Caregiver Decision|3|||
130227168|NCT00922636|468798033|FG003|Overall Study|Parent/Caregiver Decision|5|||
130227169|NCT00922636|468798034|FG004|Overall Study|Parent/Caregiver Decision|2|||
130227170|NCT00922636|468798030|FG000|Overall Study|Lost to Follow-up|1|||
130227171|NCT00922636|468798031|FG001|Overall Study|Lost to Follow-up|2|||
130227172|NCT00922636|468798032|FG002|Overall Study|Lost to Follow-up|2|||
130227173|NCT00922636|468798033|FG003|Overall Study|Lost to Follow-up|2|||
130227174|NCT00922636|468798034|FG004|Overall Study|Lost to Follow-up|4|||
130227175|NCT04969289|468798035|FG000|Overall Study|Lost to Follow-up|13|||
130227176|NCT04969289|468798036|FG001|Overall Study|Lost to Follow-up|9|||
130227177|NCT00557466|468798037|FG000|Overall Study|Adverse Event|3|||
130227178|NCT00557466|468798038|FG001|Overall Study|Adverse Event|1|||
130227179|NCT00557466|468798039|FG002|Overall Study|Adverse Event|4|||
130022207|NCT02436876|468042639|FG002|Overall Study|Withdrawal by Subject|0|||
130022208|NCT02436876|468042640|FG003|Overall Study|Withdrawal by Subject|1|||
130022209|NCT02436876|468042637|FG000|Overall Study|Physician Decision|0|||
130022210|NCT02436876|468042638|FG001|Overall Study|Physician Decision|2|||
130022211|NCT02436876|468042639|FG002|Overall Study|Physician Decision|1|||
130022212|NCT02436876|468042640|FG003|Overall Study|Physician Decision|0|||
130022213|NCT02436876|468042637|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
130022214|NCT02436876|468042638|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
130022215|NCT02436876|468042639|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
130022216|NCT02436876|468042640|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
130022217|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
130022218|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
130022219|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
130022220|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
130022221|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130022222|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130022223|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
130022224|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130022225|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
130022226|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130227180|NCT00557466|468798040|FG003|Overall Study|Adverse Event|1|||
130227181|NCT00557466|468798041|FG004|Overall Study|Adverse Event|2|||
130227182|NCT00557466|468798042|FG005|Overall Study|Adverse Event|4|||
130227183|NCT00557466|468798037|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130227184|NCT00557466|468798038|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130227185|NCT00557466|468798039|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130227186|NCT00557466|468798040|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130227187|NCT00557466|468798041|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130227188|NCT00557466|468798042|FG005|Overall Study|Abnormal laboratory value(s)|0|||
130227189|NCT00557466|468798037|FG000|Overall Study|Protocol deviation|0|||
130227190|NCT00557466|468798038|FG001|Overall Study|Protocol deviation|1|||
130227191|NCT00557466|468798039|FG002|Overall Study|Protocol deviation|0|||
130227192|NCT00557466|468798040|FG003|Overall Study|Protocol deviation|2|||
130227193|NCT00557466|468798041|FG004|Overall Study|Protocol deviation|0|||
130227194|NCT00557466|468798042|FG005|Overall Study|Protocol deviation|0|||
130227195|NCT00557466|468798037|FG000|Overall Study|Subject withdrew consent|0|||
130227196|NCT00557466|468798038|FG001|Overall Study|Subject withdrew consent|0|||
130227197|NCT00557466|468798039|FG002|Overall Study|Subject withdrew consent|0|||
130227198|NCT00557466|468798040|FG003|Overall Study|Subject withdrew consent|0|||
130227199|NCT00557466|468798041|FG004|Overall Study|Subject withdrew consent|1|||
130227200|NCT00557466|468798042|FG005|Overall Study|Subject withdrew consent|2|||
130227201|NCT00557466|468798037|FG000|Overall Study|Administrative problems|0|||
130227202|NCT00557466|468798038|FG001|Overall Study|Administrative problems|1|||
130227203|NCT00557466|468798039|FG002|Overall Study|Administrative problems|1|||
130227204|NCT00557466|468798040|FG003|Overall Study|Administrative problems|0|||
130227205|NCT00557466|468798041|FG004|Overall Study|Administrative problems|0|||
130227206|NCT00557466|468798042|FG005|Overall Study|Administrative problems|0|||
130227207|NCT00557466|468798037|FG000|Overall Study|Abnormal test procedure results|0|||
130227208|NCT00557466|468798038|FG001|Overall Study|Abnormal test procedure results|0|||
130227209|NCT00557466|468798039|FG002|Overall Study|Abnormal test procedure results|1|||
130227210|NCT00557466|468798040|FG003|Overall Study|Abnormal test procedure results|0|||
130227211|NCT00557466|468798041|FG004|Overall Study|Abnormal test procedure results|0|||
130227212|NCT00557466|468798042|FG005|Overall Study|Abnormal test procedure results|0|||
130227213|NCT00557466|468798037|FG000|Overall Study|Lost to Follow-up|0|||
130227214|NCT00557466|468798038|FG001|Overall Study|Lost to Follow-up|0|||
130227215|NCT00557466|468798039|FG002|Overall Study|Lost to Follow-up|0|||
130227216|NCT00557466|468798040|FG003|Overall Study|Lost to Follow-up|1|||
130227217|NCT00557466|468798041|FG004|Overall Study|Lost to Follow-up|0|||
130227218|NCT00557466|468798042|FG005|Overall Study|Lost to Follow-up|0|||
130227219|NCT01251952|468798045|FG000|Overall Study|Adverse Event|1|||
130227220|NCT02486692|468798046|FG000|Overall Study|did not login for randomization|4|||
130227221|NCT02486692|468798047|FG001|Overall Study|did not login for randomization|7|||
130227222|NCT00496769|468798048|FG000|Double Blind|>=1 reason assigned per patient|558|||
130227223|NCT00496769|468798049|FG001|Double Blind|>=1 reason assigned per patient|649|||
130227224|NCT00496769|468798050|FG002|Double Blind|>=1 reason assigned per patient|0|||
130227225|NCT00496769|468798048|FG000|Open Label|>=1 reason assigned per patient|0|||
130227226|NCT00496769|468798049|FG001|Open Label|>=1 reason assigned per patient|0|||
130227227|NCT00496769|468798050|FG002|Open Label|>=1 reason assigned per patient|1011|||
130227228|NCT02224625|468798053|FG000|Irritation|Adverse Event|6|||
130227229|NCT02224625|468798053|FG000|Sensitization|Adverse Event|55|||
130227230|NCT02812186|468798054|FG000|Period 1|Post randomization screen failure|5|||
130227231|NCT02812186|468798055|FG001|Period 1|Post randomization screen failure|9|||
130227232|NCT02812186|468798054|FG000|Period 1|nonevaluable data sets|6|||
130227233|NCT02812186|468798055|FG001|Period 1|nonevaluable data sets|6|||
130227234|NCT01307787|468798058|FG000|Overall Study|Withdrawal by Subject|2|||
130227235|NCT01307787|468798059|FG001|Overall Study|Withdrawal by Subject|0|||
130227236|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
130227237|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
130227238|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
130227239|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
130227240|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
130227241|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
130227242|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
130227243|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
130227244|NCT01573000|468798060|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
130099451|NCT02074982|468322671|FG000|Overall Study|Lack of Efficacy|6|||
130099452|NCT02074982|468322672|FG001|Overall Study|Lack of Efficacy|1|||
130099453|NCT02074982|468322671|FG000|Overall Study|Lost to Follow-up|9|||
130099454|NCT02074982|468322672|FG001|Overall Study|Lost to Follow-up|10|||
130099455|NCT02074982|468322671|FG000|Overall Study|Non-compliance with study treatment|0|||
130227245|NCT01573000|468798061|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
130227246|NCT01573000|468798060|FG000|Crossover Phase|Lack of Efficacy|0|||
130227247|NCT01573000|468798061|FG001|Crossover Phase|Lack of Efficacy|13|||
130227248|NCT01573000|468798060|FG000|Crossover Phase|Lost to Follow-up|0|||
130227249|NCT01573000|468798061|FG001|Crossover Phase|Lost to Follow-up|2|||
130227250|NCT01573000|468798060|FG000|Crossover Phase|Death|0|||
130227251|NCT01573000|468798061|FG001|Crossover Phase|Death|3|||
130227252|NCT01573000|468798060|FG000|Long-Term Follow-Up|Death|3|||
130227253|NCT01573000|468798061|FG001|Long-Term Follow-Up|Death|0|||
130227254|NCT01573000|468798060|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
130227255|NCT01573000|468798061|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
130227256|NCT03353792|468798062|FG000|Overall Study|Lost to Follow-up|1|||
130227257|NCT03353792|468798063|FG001|Overall Study|Lost to Follow-up|0|||
130227258|NCT03353792|468798062|FG000|Overall Study|Participant Unable to Manage Device|1|||
130227259|NCT03353792|468798063|FG001|Overall Study|Participant Unable to Manage Device|0|||
130227260|NCT03342001|468798069|FG000|Overall Study|Adverse Event|1|||
130227261|NCT03342001|468798069|FG000|Overall Study|Lost to Follow-up|1|||
130227262|NCT01433159|468798071|FG000|Overall Study|Adverse Event|1|||
130227263|NCT01433159|468798072|FG001|Overall Study|Adverse Event|0|||
130227264|NCT01433159|468798071|FG000|Overall Study|Physician Decision|1|||
130227265|NCT01433159|468798072|FG001|Overall Study|Physician Decision|0|||
130227266|NCT01433159|468798071|FG000|Overall Study|Protocol Violation|0|||
130227267|NCT01433159|468798072|FG001|Overall Study|Protocol Violation|1|||
130227268|NCT01100853|468798073|FG000|Overall Study|Lost to Follow-up|11|||
130227269|NCT01100853|468798074|FG001|Overall Study|Lost to Follow-up|6|||
130227270|NCT01100853|468798073|FG000|Overall Study|Received <4 study injections|10|||
130227271|NCT01100853|468798074|FG001|Overall Study|Received <4 study injections|13|||
130227272|NCT01100853|468798073|FG000|Overall Study|Withdrawal by Subject|6|||
130227273|NCT01100853|468798074|FG001|Overall Study|Withdrawal by Subject|4|||
130227274|NCT04161391|468798079|FG000|Overall Study|Adverse Event|0|||
130227275|NCT04161391|468798080|FG001|Overall Study|Adverse Event|1|||
130227276|NCT04161391|468798081|FG002|Overall Study|Adverse Event|0|||
130227277|NCT04161391|468798082|FG003|Overall Study|Adverse Event|1|||
130227278|NCT04161391|468798083|FG004|Overall Study|Adverse Event|0|||
130227279|NCT04161391|468798084|FG005|Overall Study|Adverse Event|0|||
130227280|NCT04161391|468798085|FG006|Overall Study|Adverse Event|0|||
130227281|NCT04161391|468798086|FG007|Overall Study|Adverse Event|3|||
130227282|NCT04161391|468798087|FG008|Overall Study|Adverse Event|0|||
130227283|NCT04161391|468798079|FG000|Overall Study|Death|0|||
130227284|NCT04161391|468798080|FG001|Overall Study|Death|0|||
130227285|NCT04161391|468798081|FG002|Overall Study|Death|0|||
130227286|NCT04161391|468798082|FG003|Overall Study|Death|0|||
130227287|NCT04161391|468798083|FG004|Overall Study|Death|0|||
130227288|NCT04161391|468798084|FG005|Overall Study|Death|0|||
130227289|NCT04161391|468798085|FG006|Overall Study|Death|0|||
130227290|NCT04161391|468798086|FG007|Overall Study|Death|1|||
130227291|NCT04161391|468798087|FG008|Overall Study|Death|0|||
130227292|NCT04161391|468798079|FG000|Overall Study|Physician Decision|0|||
130227293|NCT04161391|468798080|FG001|Overall Study|Physician Decision|0|||
130227294|NCT04161391|468798081|FG002|Overall Study|Physician Decision|1|||
130227295|NCT04161391|468798082|FG003|Overall Study|Physician Decision|2|||
130227296|NCT04161391|468798083|FG004|Overall Study|Physician Decision|0|||
130227297|NCT04161391|468798084|FG005|Overall Study|Physician Decision|0|||
130227298|NCT04161391|468798085|FG006|Overall Study|Physician Decision|2|||
130227299|NCT04161391|468798086|FG007|Overall Study|Physician Decision|0|||
130227300|NCT04161391|468798087|FG008|Overall Study|Physician Decision|0|||
130227301|NCT04161391|468798079|FG000|Overall Study|Progressive Disease|4|||
130227302|NCT04161391|468798080|FG001|Overall Study|Progressive Disease|3|||
130227303|NCT04161391|468798081|FG002|Overall Study|Progressive Disease|3|||
130227304|NCT04161391|468798082|FG003|Overall Study|Progressive Disease|5|||
130227305|NCT04161391|468798083|FG004|Overall Study|Progressive Disease|3|||
130227306|NCT04161391|468798084|FG005|Overall Study|Progressive Disease|3|||
130227307|NCT04161391|468798085|FG006|Overall Study|Progressive Disease|5|||
130227308|NCT04161391|468798086|FG007|Overall Study|Progressive Disease|2|||
130227309|NCT04161391|468798087|FG008|Overall Study|Progressive Disease|2|||
130227310|NCT02579629|468798088|FG000|Overall Study|Withdrawal by Subject|0|||
130227311|NCT02579629|468798089|FG001|Overall Study|Withdrawal by Subject|1|||
130227312|NCT02579629|468798090|FG002|Overall Study|Withdrawal by Subject|0|||
130227313|NCT02579629|468798088|FG000|Overall Study|Screen Failure|2|||
130227314|NCT02579629|468798089|FG001|Overall Study|Screen Failure|0|||
130227315|NCT02579629|468798090|FG002|Overall Study|Screen Failure|2|||
130227316|NCT01190891|468798091|FG000|Overall Study|Protocol Violation|1|||
130227317|NCT01190891|468798092|FG001|Overall Study|Protocol Violation|0|||
130227318|NCT01190891|468798091|FG000|Overall Study|Withdrawal by Subject|5|||
130022227|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130022228|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130227319|NCT01190891|468798092|FG001|Overall Study|Withdrawal by Subject|0|||
130227320|NCT00266708|468798093|FG000|Overall Study|No renal function|1|||
130227321|NCT00266708|468798094|FG001|Overall Study|No renal function|1|||
130227322|NCT00266708|468798093|FG000|Overall Study|Refused biopsy|3|||
130227323|NCT00266708|468798094|FG001|Overall Study|Refused biopsy|6|||
130227324|NCT00266708|468798093|FG000|Overall Study|Asthma|0|||
130227325|NCT00266708|468798094|FG001|Overall Study|Asthma|2|||
130227326|NCT01926028|468798095|FG000|Overall Study|Lost to Follow-up|7|||
130227327|NCT01926028|468798096|FG001|Overall Study|Lost to Follow-up|6|||
130227328|NCT01926028|468798097|FG002|Overall Study|Lost to Follow-up|0|||
130022229|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
130022230|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
130022231|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
130022232|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
130022233|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
130022234|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
130022235|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
130022236|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
130022237|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130022238|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130022239|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130022240|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
130022241|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
130022242|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130022243|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130022244|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130022245|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130022246|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
130022247|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130022248|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
130022249|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130022250|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130022251|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130022252|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
130022253|NCT03403205|468042642|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
130022254|NCT03403205|468042643|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
130022255|NCT03403205|468042644|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
130022256|NCT03403205|468042645|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
130022257|NCT03403205|468042646|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
130022258|NCT03403205|468042647|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
130022259|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
130022260|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
130022261|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
130022262|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
130022263|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
130022264|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
130022265|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
130022266|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
130022267|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
130022268|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
130022269|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
130022270|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
130022271|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Death|1|||
130022272|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Death|0|||
130022273|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Death|0|||
130022274|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Death|0|||
130022275|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Death|0|||
130022276|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Death|0|||
130022277|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
130022278|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130022279|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130022280|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130022281|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130022282|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
130022283|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
130022284|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
130022285|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
130022286|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
130022287|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
130022288|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
130227329|NCT01926028|468798095|FG000|Overall Study|Physician Decision|1|||
130227330|NCT01926028|468798096|FG001|Overall Study|Physician Decision|5|||
130227331|NCT01926028|468798097|FG002|Overall Study|Physician Decision|0|||
130227332|NCT01926028|468798095|FG000|Overall Study|Withdrawal by Subject|9|||
130227333|NCT01926028|468798096|FG001|Overall Study|Withdrawal by Subject|9|||
130227334|NCT01926028|468798097|FG002|Overall Study|Withdrawal by Subject|2|||
130227335|NCT01926028|468798095|FG000|Overall Study|Non compliance or other reasons|4|||
130227336|NCT01926028|468798096|FG001|Overall Study|Non compliance or other reasons|2|||
130227337|NCT01926028|468798097|FG002|Overall Study|Non compliance or other reasons|0|||
130227338|NCT01130272|468798098|FG000|Overall Study|Adverse Event|2|||
130227339|NCT01130272|468798099|FG001|Overall Study|Adverse Event|5|||
130227340|NCT01130272|468798100|FG002|Overall Study|Adverse Event|6|||
130227341|NCT01130272|468798101|FG003|Overall Study|Adverse Event|22|||
130227342|NCT01130272|468798102|FG004|Overall Study|Adverse Event|7|||
130227343|NCT01130272|468798098|FG000|Overall Study|IVRS-confirmed constipation|0|||
130227344|NCT01130272|468798099|FG001|Overall Study|IVRS-confirmed constipation|1|||
130227345|NCT01130272|468798100|FG002|Overall Study|IVRS-confirmed constipation|1|||
130227346|NCT01130272|468798101|FG003|Overall Study|IVRS-confirmed constipation|2|||
130227347|NCT01130272|468798102|FG004|Overall Study|IVRS-confirmed constipation|0|||
130227348|NCT01130272|468798098|FG000|Overall Study|Rescue medications due to diarrhea|3|||
130227349|NCT01130272|468798099|FG001|Overall Study|Rescue medications due to diarrhea|5|||
130227350|NCT01130272|468798100|FG002|Overall Study|Rescue medications due to diarrhea|8|||
130227351|NCT01130272|468798101|FG003|Overall Study|Rescue medications due to diarrhea|8|||
130227352|NCT01130272|468798102|FG004|Overall Study|Rescue medications due to diarrhea|6|||
130227353|NCT01130272|468798098|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
130227354|NCT01130272|468798099|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
130227355|NCT01130272|468798100|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
130227356|NCT01130272|468798101|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
130227357|NCT01130272|468798102|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
130227358|NCT01130272|468798098|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227359|NCT01130272|468798099|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227360|NCT01130272|468798100|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227361|NCT01130272|468798101|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
130227362|NCT01130272|468798102|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
130227363|NCT01130272|468798098|FG000|Overall Study|Protocol Violation|0|||
130227364|NCT01130272|468798099|FG001|Overall Study|Protocol Violation|0|||
130227365|NCT01130272|468798100|FG002|Overall Study|Protocol Violation|3|||
130227366|NCT01130272|468798101|FG003|Overall Study|Protocol Violation|5|||
130227367|NCT01130272|468798102|FG004|Overall Study|Protocol Violation|5|||
130227368|NCT01130272|468798098|FG000|Overall Study|Lost to Follow-up|4|||
130227369|NCT01130272|468798099|FG001|Overall Study|Lost to Follow-up|3|||
130227370|NCT01130272|468798100|FG002|Overall Study|Lost to Follow-up|4|||
130227371|NCT01130272|468798101|FG003|Overall Study|Lost to Follow-up|7|||
130227372|NCT01130272|468798102|FG004|Overall Study|Lost to Follow-up|6|||
130227373|NCT01130272|468798098|FG000|Overall Study|Withdrawal by Subject|4|||
130227374|NCT01130272|468798099|FG001|Overall Study|Withdrawal by Subject|11|||
130227375|NCT01130272|468798100|FG002|Overall Study|Withdrawal by Subject|10|||
130227376|NCT01130272|468798101|FG003|Overall Study|Withdrawal by Subject|9|||
130227377|NCT01130272|468798102|FG004|Overall Study|Withdrawal by Subject|8|||
130227378|NCT01130272|468798098|FG000|Overall Study|Physician Decision|1|||
130227379|NCT01130272|468798099|FG001|Overall Study|Physician Decision|1|||
130227380|NCT01130272|468798100|FG002|Overall Study|Physician Decision|0|||
130227381|NCT01130272|468798101|FG003|Overall Study|Physician Decision|1|||
130227382|NCT01130272|468798102|FG004|Overall Study|Physician Decision|2|||
130227383|NCT01130272|468798098|FG000|Overall Study|Sponsor decision|6|||
130227384|NCT01130272|468798099|FG001|Overall Study|Sponsor decision|15|||
130227385|NCT01130272|468798100|FG002|Overall Study|Sponsor decision|16|||
130227386|NCT01130272|468798101|FG003|Overall Study|Sponsor decision|13|||
130227387|NCT01130272|468798102|FG004|Overall Study|Sponsor decision|16|||
130227388|NCT01130272|468798098|FG000|Overall Study|Study arm discontinued|38|||
130227389|NCT01130272|468798099|FG001|Overall Study|Study arm discontinued|0|||
130227390|NCT01130272|468798100|FG002|Overall Study|Study arm discontinued|0|||
130227391|NCT01130272|468798101|FG003|Overall Study|Study arm discontinued|0|||
130227392|NCT01130272|468798102|FG004|Overall Study|Study arm discontinued|0|||
130227393|NCT01548404|468798103|FG000|Overall Study|Adverse Event|3|||
130227394|NCT01548404|468798104|FG001|Overall Study|Adverse Event|1|||
130227395|NCT01548404|468798103|FG000|Overall Study|Physician Decision|2|||
130227396|NCT01548404|468798104|FG001|Overall Study|Physician Decision|1|||
130227397|NCT01548404|468798103|FG000|Overall Study|Inadequate response to study treatment|23|||
130227398|NCT01548404|468798104|FG001|Overall Study|Inadequate response to study treatment|7|||
130227399|NCT01548404|468798103|FG000|Overall Study|Lost to Follow-up|2|||
130227400|NCT01548404|468798104|FG001|Overall Study|Lost to Follow-up|0|||
130227401|NCT01548404|468798103|FG000|Overall Study|Withdrawal by Subject|0|||
130227402|NCT01548404|468798104|FG001|Overall Study|Withdrawal by Subject|3|||
130227403|NCT01548404|468798103|FG000|Overall Study|Other than specified above|0|||
130227404|NCT01548404|468798104|FG001|Overall Study|Other than specified above|2|||
130227405|NCT00641056|468798105|FG000|Overall Study|Adverse Event|12|||
130227406|NCT00641056|468798106|FG001|Overall Study|Adverse Event|2|||
130227407|NCT00641056|468798105|FG000|Overall Study|Lost to Follow-up|2|||
130227408|NCT00641056|468798106|FG001|Overall Study|Lost to Follow-up|1|||
130227409|NCT00641056|468798105|FG000|Overall Study|Physician Decision|3|||
130227410|NCT00641056|468798106|FG001|Overall Study|Physician Decision|1|||
130227411|NCT00641056|468798105|FG000|Overall Study|Protocol Violation|2|||
130227412|NCT00641056|468798106|FG001|Overall Study|Protocol Violation|0|||
130227413|NCT00641056|468798105|FG000|Overall Study|Entry Criteria Not Met|3|||
130227414|NCT00641056|468798106|FG001|Overall Study|Entry Criteria Not Met|0|||
130227415|NCT00641056|468798105|FG000|Overall Study|Subject Decision|6|||
130227416|NCT00641056|468798106|FG001|Overall Study|Subject Decision|19|||
130227417|NCT00641056|468798105|FG000|Overall Study|Sponsor Decision|1|||
130227418|NCT00641056|468798106|FG001|Overall Study|Sponsor Decision|2|||
130227419|NCT00737048|468798107|FG000|Overall Study|Physician Decision|0|||
130227420|NCT00737048|468798108|FG001|Overall Study|Physician Decision|0|||
130227421|NCT00737048|468798109|FG002|Overall Study|Physician Decision|1|||
129800232|NCT02891161|467236267|FG001|Follow up|Refused to Follow up|2|||
129800233|NCT02891161|467236266|FG000|Follow up|Symptomatic deterioration|0|||
130227422|NCT00737048|468798107|FG000|Overall Study|Adverse Event|0|||
130227423|NCT00737048|468798108|FG001|Overall Study|Adverse Event|1|||
130227424|NCT00737048|468798109|FG002|Overall Study|Adverse Event|0|||
130227425|NCT00737048|468798107|FG000|Overall Study|Worsening of the symptoms|3|||
130227426|NCT00737048|468798108|FG001|Overall Study|Worsening of the symptoms|5|||
130227427|NCT00737048|468798109|FG002|Overall Study|Worsening of the symptoms|3|||
130227428|NCT02351934|468798110|FG000|Allocation|POD weight<pre-op weight|3|||
130227429|NCT02351934|468798111|FG001|Allocation|POD weight<pre-op weight|0|||
130227430|NCT02351934|468798110|FG000|Allocation|Hypotension preventing administration|2|||
130227431|NCT02351934|468798111|FG001|Allocation|Hypotension preventing administration|0|||
130227432|NCT02351934|468798110|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
130227433|NCT02351934|468798111|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
130227434|NCT02351934|468798110|FG000|Follow-Up|POD weight<pre-op weight|3|||
130227435|NCT02351934|468798111|FG001|Follow-Up|POD weight<pre-op weight|0|||
130227436|NCT02351934|468798110|FG000|Follow-Up|Acute Kidney Injury|1|||
130227437|NCT02351934|468798111|FG001|Follow-Up|Acute Kidney Injury|0|||
130227438|NCT02351934|468798110|FG000|Follow-Up|Early dismissal|3|||
130227439|NCT02351934|468798111|FG001|Follow-Up|Early dismissal|0|||
130227440|NCT02351934|468798110|FG000|Follow-Up|Hypotension|3|||
130227441|NCT02351934|468798111|FG001|Follow-Up|Hypotension|0|||
130227442|NCT02351934|468798110|FG000|Follow-Up|No documentation|2|||
130227443|NCT02351934|468798111|FG001|Follow-Up|No documentation|0|||
130227444|NCT02351934|468798110|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
130227445|NCT02351934|468798111|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
130227446|NCT02351934|468798110|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
130227447|NCT02351934|468798111|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
130227448|NCT00896493|468798112|FG000|Overall Study|Early disease relapse|3|||
130227449|NCT01739335|468798114|FG000|Overall Study|Lost to Follow-up|7|||
130227450|NCT01739335|468798115|FG001|Overall Study|Lost to Follow-up|4|||
130227451|NCT01739335|468798114|FG000|Overall Study|Ineligible patient randomized|0|||
130227452|NCT01739335|468798115|FG001|Overall Study|Ineligible patient randomized|1|||
130227453|NCT04040439|468798121|FG000|Overall Study|Invalid registration|11|||
130227454|NCT04040439|468798121|FG000|Overall Study|No IC* on publication of study results|2|||
130227455|NCT01309386|468798122|FG000|Overall Study|Other|2|||
130227456|NCT01309386|468798123|FG001|Overall Study|Other|0|||
130227457|NCT01309386|468798122|FG000|Overall Study|Withdrawal by Subject|2|||
130227458|NCT01309386|468798123|FG001|Overall Study|Withdrawal by Subject|0|||
130227459|NCT01309386|468798122|FG000|Overall Study|Progressive disease|9|||
130227460|NCT01309386|468798123|FG001|Overall Study|Progressive disease|11|||
130227461|NCT01309386|468798122|FG000|Overall Study|Physician Decision|1|||
130227462|NCT01309386|468798123|FG001|Overall Study|Physician Decision|1|||
130227463|NCT01309386|468798122|FG000|Overall Study|Lack of Efficacy|3|||
130227464|NCT01309386|468798123|FG001|Overall Study|Lack of Efficacy|1|||
130227465|NCT01309386|468798122|FG000|Overall Study|Adverse Event|5|||
130227466|NCT01309386|468798123|FG001|Overall Study|Adverse Event|8|||
130227467|NCT02062437|468798124|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
130227468|NCT02062437|468798124|FG000|Overall Study|Patient not available for the 2y visit|18|||
130227469|NCT02062437|468798124|FG000|Overall Study|Death|2|||
130227470|NCT02062437|468798124|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
130227471|NCT00752089|468798125|FG000|Overall Study|Adverse Event|1|||
130227472|NCT00752089|468798125|FG000|Overall Study|Protocol Deviation|2|||
130227473|NCT00752089|468798125|FG000|Overall Study|Could not attend visit 9|1|||
130227474|NCT00752089|468798125|FG000|Overall Study|Not capable of wearing partial denture|1|||
130227475|NCT00752089|468798125|FG000|Overall Study|Cannot continue the study|1|||
130227476|NCT01324102|468798126|FG000|Overall Study|illness|1|||
130227477|NCT01324102|468798127|FG001|Overall Study|illness|6|||
130227478|NCT00386334|468798132|FG000|Double Blind Period|Adverse Event|9|||
130227479|NCT00386334|468798133|FG001|Double Blind Period|Adverse Event|14|||
130227480|NCT00386334|468798132|FG000|Double Blind Period|Protocol Violation|1|||
130227481|NCT00386334|468798133|FG001|Double Blind Period|Protocol Violation|1|||
130227482|NCT00386334|468798132|FG000|Double Blind Period|Withdrawal by Subject|9|||
130227483|NCT00386334|468798133|FG001|Double Blind Period|Withdrawal by Subject|13|||
130227484|NCT00386334|468798132|FG000|Double Blind Period|Lack of Efficacy|20|||
130227485|NCT00386334|468798133|FG001|Double Blind Period|Lack of Efficacy|11|||
130227486|NCT00386334|468798132|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
130099456|NCT02074982|468322672|FG001|Overall Study|Non-compliance with study treatment|2|||
130099457|NCT02074982|468322671|FG000|Overall Study|Physician Decision|1|||
130099458|NCT02074982|468322672|FG001|Overall Study|Physician Decision|1|||
130099459|NCT02074982|468322671|FG000|Overall Study|Pregnancy|1|||
130099460|NCT02074982|468322672|FG001|Overall Study|Pregnancy|2|||
130099461|NCT02074982|468322671|FG000|Overall Study|Protocol deviation|4|||
130099462|NCT02074982|468322672|FG001|Overall Study|Protocol deviation|3|||
130099463|NCT02074982|468322671|FG000|Overall Study|Technical problems|0|||
130099464|NCT02074982|468322672|FG001|Overall Study|Technical problems|2|||
130099465|NCT02074982|468322671|FG000|Overall Study|Subject/guardian decision|15|||
130099466|NCT02074982|468322672|FG001|Overall Study|Subject/guardian decision|24|||
130099467|NCT02074982|468322671|FG000|Overall Study|Death|0|||
130099468|NCT02074982|468322672|FG001|Overall Study|Death|2|||
130227487|NCT00386334|468798133|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
130227488|NCT00386334|468798132|FG000|Double Blind Period|Other|3|||
130099469|NCT00183170|468322687|FG000|First Intervention|Did not complete study|1|||
130099470|NCT00183170|468322688|FG001|First Intervention|Did not complete study|0|||
130227489|NCT00386334|468798133|FG001|Double Blind Period|Other|3|||
130227490|NCT00386334|468798132|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
130227491|NCT00386334|468798133|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
130227492|NCT00902577|468798136|FG000|Overall Study|Withdrawal by Subject|6|||
130227493|NCT00902577|468798136|FG000|Overall Study|FMISO production failure|2|||
130227494|NCT00785356|468798139|FG000|Overall Study|Study prematurely terminated|8|||
130227495|NCT01232790|468798141|FG000|Randomization|Withdrawal by Subject|2|||
130227496|NCT01232790|468798142|FG001|Randomization|Withdrawal by Subject|0|||
130227497|NCT01232790|468798141|FG000|Randomization|Protocol Violation|0|||
130227498|NCT01232790|468798142|FG001|Randomization|Protocol Violation|1|||
130227499|NCT01232790|468798141|FG000|Randomization|Physician Decision|0|||
130227500|NCT01232790|468798142|FG001|Randomization|Physician Decision|1|||
130227501|NCT01232790|468798141|FG000|Initial Assessment|Withdrawal by Subject|0|||
130227502|NCT01232790|468798142|FG001|Initial Assessment|Withdrawal by Subject|1|||
130227503|NCT01232790|468798141|FG000|First Crossover|Withdrawal by Subject|1|||
130227504|NCT01232790|468798142|FG001|First Crossover|Withdrawal by Subject|0|||
130227505|NCT01232790|468798141|FG000|Second Crossover|Withdrawal by Subject|1|||
130227506|NCT01232790|468798142|FG001|Second Crossover|Withdrawal by Subject|2|||
130227507|NCT03238417|468798143|FG000|Overall|non-response|955|||
130227508|NCT03238417|468798144|FG001|Overall|non-response|1920|||
130227509|NCT03238417|468798143|FG000|Overall|partial completion|48|||
130227510|NCT03238417|468798144|FG001|Overall|partial completion|68|||
130227511|NCT03238417|468798143|FG000|Baseline|Partial completion|17|||
130227512|NCT03238417|468798144|FG001|Baseline|Partial completion|48|||
130227513|NCT03238417|468798143|FG000|Baseline|non-response|372|||
130227514|NCT03238417|468798144|FG001|Baseline|non-response|669|||
130227515|NCT03238417|468798143|FG000|12-month|non-response|296|||
130227516|NCT03238417|468798144|FG001|12-month|non-response|669|||
130227517|NCT03238417|468798143|FG000|12-month|partial completion|23|||
130227518|NCT03238417|468798144|FG001|12-month|partial completion|37|||
130227519|NCT03238417|468798143|FG000|24-month|non-response|287|||
130227520|NCT03238417|468798144|FG001|24-month|non-response|594|||
130227521|NCT03238417|468798143|FG000|24-month|partial completion|8|||
130227522|NCT03238417|468798144|FG001|24-month|partial completion|31|||
130227523|NCT00083915|468798145|FG000|Overall Study|Death|6|||
130227524|NCT00083915|468798146|FG001|Overall Study|Death|3|||
130227525|NCT00083915|468798145|FG000|Overall Study|Physician Decision|11|||
130227526|NCT00083915|468798146|FG001|Overall Study|Physician Decision|6|||
130227527|NCT00083915|468798145|FG000|Overall Study|Withdrawal by Subject|8|||
130227528|NCT00083915|468798146|FG001|Overall Study|Withdrawal by Subject|3|||
130227529|NCT00083915|468798145|FG000|Overall Study|disease progression|18|||
130227530|NCT00083915|468798146|FG001|Overall Study|disease progression|23|||
130227531|NCT00083915|468798145|FG000|Overall Study|Failure to collect|3|||
130227532|NCT00083915|468798146|FG001|Overall Study|Failure to collect|0|||
130227533|NCT00083915|468798145|FG000|Overall Study|No response|3|||
130227534|NCT00083915|468798146|FG001|Overall Study|No response|1|||
130227535|NCT00083915|468798145|FG000|Overall Study|Insurance issues|1|||
130227536|NCT00083915|468798146|FG001|Overall Study|Insurance issues|1|||
130227537|NCT00853762|468798150|FG000|Overall Study|Premature Termination|16|||
130227538|NCT00853762|468798151|FG001|Overall Study|Premature Termination|15|||
130227539|NCT00853762|468798152|FG002|Overall Study|Premature Termination|14|||
130227540|NCT00853762|468798153|FG003|Overall Study|Premature Termination|21|||
130227541|NCT00853762|468798150|FG000|Overall Study|Protocol Violation|0|||
130227542|NCT00853762|468798151|FG001|Overall Study|Protocol Violation|0|||
130227543|NCT00853762|468798152|FG002|Overall Study|Protocol Violation|0|||
130227544|NCT00853762|468798153|FG003|Overall Study|Protocol Violation|1|||
130227545|NCT00853762|468798150|FG000|Overall Study|Withdrawal by Subject|0|||
130227546|NCT00853762|468798151|FG001|Overall Study|Withdrawal by Subject|0|||
130227547|NCT00853762|468798152|FG002|Overall Study|Withdrawal by Subject|1|||
130227548|NCT00853762|468798153|FG003|Overall Study|Withdrawal by Subject|0|||
130227549|NCT00853762|468798150|FG000|Overall Study|Other|0|||
130099471|NCT00183170|468322687|FG000|First Intervention|Did not meet targeted BrAC|1|||
130099472|NCT00183170|468322688|FG001|First Intervention|Did not meet targeted BrAC|0|||
130099473|NCT00183170|468322687|FG000|Washout 1 Week|Did not complete study|6|||
130099474|NCT00183170|468322688|FG001|Washout 1 Week|Did not complete study|8|||
130099475|NCT00183170|468322687|FG000|Second Intervention|Did not complete study|1|||
130099476|NCT00183170|468322688|FG001|Second Intervention|Did not complete study|0|||
130099477|NCT00183170|468322687|FG000|Second Intervention|Did not meet targeted BrAC|0|||
130227550|NCT00853762|468798151|FG001|Overall Study|Other|2|||
130227551|NCT00853762|468798152|FG002|Overall Study|Other|0|||
130227552|NCT00853762|468798153|FG003|Overall Study|Other|0|||
130227553|NCT00853762|468798150|FG000|Overall Study|Randomised but not Treated|0|||
130227554|NCT00853762|468798151|FG001|Overall Study|Randomised but not Treated|2|||
130227555|NCT00853762|468798152|FG002|Overall Study|Randomised but not Treated|2|||
130227556|NCT00853762|468798153|FG003|Overall Study|Randomised but not Treated|0|||
130227557|NCT02000921|468798156|FG000|Overall Study|Withdrawal by Subject|3|||
130227558|NCT02000921|468798157|FG001|Overall Study|Withdrawal by Subject|10|||
130227559|NCT02000921|468798158|FG002|Overall Study|Withdrawal by Subject|5|||
130227560|NCT02000921|468798156|FG000|Overall Study|Lost to Follow-up|2|||
130227561|NCT02000921|468798157|FG001|Overall Study|Lost to Follow-up|4|||
130227562|NCT02000921|468798158|FG002|Overall Study|Lost to Follow-up|5|||
130227563|NCT02000921|468798156|FG000|Overall Study|Physician Decision|0|||
130227564|NCT02000921|468798157|FG001|Overall Study|Physician Decision|2|||
130227565|NCT02000921|468798158|FG002|Overall Study|Physician Decision|0|||
130227566|NCT02051296|468798159|FG000|Overall Study|Lost to Follow-up|1|||
130227567|NCT02051296|468798160|FG001|Overall Study|Lost to Follow-up|2|||
130227568|NCT02051296|468798159|FG000|Overall Study|withdraw prior to treatment|7|||
130227569|NCT02051296|468798160|FG001|Overall Study|withdraw prior to treatment|7|||
130227570|NCT00106002|468798161|FG000|Overall Study|Did not take any study drug|1|||
130227571|NCT00106002|468798161|FG000|Overall Study|Ineligible after Registration|1|||
130227572|NCT01245101|468798164|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
130227573|NCT01245101|468798165|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
130227574|NCT01245101|468798164|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
130227575|NCT01245101|468798165|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
130227576|NCT01245101|468798164|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
130227577|NCT01245101|468798165|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
130227578|NCT01225549|468798168|FG000|Period 4 - Washout|Disallowed medication|0|||
130227579|NCT01225549|468798169|FG001|Period 4 - Washout|Disallowed medication|1|||
130227580|NCT01225549|468798170|FG002|Period 4 - Washout|Disallowed medication|0|||
130227581|NCT01225549|468798171|FG003|Period 4 - Washout|Disallowed medication|0|||
130227582|NCT01225549|468798172|FG004|Period 4 - Washout|Disallowed medication|0|||
130227583|NCT01225549|468798173|FG005|Period 4 - Washout|Disallowed medication|0|||
130227584|NCT01225549|468798174|FG006|Period 4 - Washout|Disallowed medication|0|||
130227585|NCT01225549|468798175|FG007|Period 4 - Washout|Disallowed medication|0|||
130227586|NCT01225549|468798176|FG008|Period 4 - Washout|Disallowed medication|0|||
130227587|NCT01225549|468798177|FG009|Period 4 - Washout|Disallowed medication|0|||
130227588|NCT01225549|468798168|FG000|Period 6 - Washout|Disallowed medication|0|||
130227589|NCT01225549|468798169|FG001|Period 6 - Washout|Disallowed medication|0|||
130227590|NCT01225549|468798170|FG002|Period 6 - Washout|Disallowed medication|0|||
130227591|NCT01225549|468798171|FG003|Period 6 - Washout|Disallowed medication|1|||
130227592|NCT01225549|468798172|FG004|Period 6 - Washout|Disallowed medication|0|||
130227593|NCT01225549|468798173|FG005|Period 6 - Washout|Disallowed medication|0|||
130227594|NCT01225549|468798174|FG006|Period 6 - Washout|Disallowed medication|0|||
130227595|NCT01225549|468798175|FG007|Period 6 - Washout|Disallowed medication|0|||
130227596|NCT01225549|468798176|FG008|Period 6 - Washout|Disallowed medication|0|||
130227597|NCT01225549|468798177|FG009|Period 6 - Washout|Disallowed medication|0|||
130227598|NCT04456686|468798178|FG000|Overall Study|Adverse Event|2|||
130227599|NCT04456686|468798179|FG001|Overall Study|Adverse Event|1|||
130227600|NCT04456686|468798178|FG000|Overall Study|Lack of Efficacy|3|||
130227601|NCT04456686|468798179|FG001|Overall Study|Lack of Efficacy|1|||
130227602|NCT04456686|468798178|FG000|Overall Study|Withdrew consent|3|||
130227603|NCT04456686|468798179|FG001|Overall Study|Withdrew consent|1|||
130227604|NCT04456686|468798178|FG000|Overall Study|Physician Decision|2|||
130227605|NCT04456686|468798179|FG001|Overall Study|Physician Decision|2|||
130227606|NCT04456686|468798178|FG000|Overall Study|Withdrawal by Subject|5|||
130227607|NCT04456686|468798179|FG001|Overall Study|Withdrawal by Subject|1|||
130227608|NCT04456686|468798178|FG000|Overall Study|Protocol Violation|0|||
130227609|NCT04456686|468798179|FG001|Overall Study|Protocol Violation|1|||
130227610|NCT00891813|468798181|FG000|Overall Study|Adverse Event|3|||
130227611|NCT00891813|468798181|FG000|Overall Study|Withdrawal by Subject|1|||
130227612|NCT00891813|468798181|FG000|Overall Study|Patient Noncompliance|6|||
130227613|NCT00891813|468798181|FG000|Overall Study|Protocol Violation|2|||
130227614|NCT00473083|468798186|FG000|Overall Study|Adverse Event|1|||
130227615|NCT00473083|468798187|FG001|Overall Study|Adverse Event|0|||
130227616|NCT00473083|468798188|FG002|Overall Study|Adverse Event|0|||
130227617|NCT02858401|468798189|FG000|Overall Study|Withdrew Consent|0|||
130227618|NCT02858401|468798190|FG001|Overall Study|Withdrew Consent|0|||
130227619|NCT02858401|468798191|FG002|Overall Study|Withdrew Consent|0|||
130227620|NCT02858401|468798192|FG003|Overall Study|Withdrew Consent|0|||
130227621|NCT02858401|468798193|FG004|Overall Study|Withdrew Consent|0|||
130227622|NCT02858401|468798194|FG005|Overall Study|Withdrew Consent|1|||
130227623|NCT02858401|468798195|FG006|Overall Study|Withdrew Consent|0|||
130227624|NCT02858401|468798189|FG000|Overall Study|Lost to Follow-up|0|||
130227625|NCT02858401|468798190|FG001|Overall Study|Lost to Follow-up|1|||
130227626|NCT02858401|468798191|FG002|Overall Study|Lost to Follow-up|0|||
130227627|NCT02858401|468798192|FG003|Overall Study|Lost to Follow-up|0|||
130022289|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
130022290|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130022291|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130022292|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130227628|NCT02858401|468798193|FG004|Overall Study|Lost to Follow-up|0|||
130227629|NCT02858401|468798194|FG005|Overall Study|Lost to Follow-up|0|||
130227630|NCT02858401|468798195|FG006|Overall Study|Lost to Follow-up|0|||
130227631|NCT00749398|468798196|FG000|Overall Study|Lack of Efficacy|7|||
130227632|NCT00749398|468798196|FG000|Overall Study|Adverse Event|4|||
130227633|NCT00749398|468798196|FG000|Overall Study|Serious adverse event|11|||
130227634|NCT00749398|468798196|FG000|Overall Study|Withdrawal by Subject|17|||
130227635|NCT00749398|468798196|FG000|Overall Study|Lost to Follow-up|11|||
130227636|NCT00749398|468798196|FG000|Overall Study|Reason not specified|2|||
130227637|NCT00749398|468798196|FG000|Overall Study|Unknown reason|1|||
130227638|NCT03093181|468798197|FG000|Overall Study|Withdrawal by Subject|2|||
130227639|NCT03093181|468798198|FG001|Overall Study|Withdrawal by Subject|1|||
130227640|NCT03093181|468798199|FG002|Overall Study|Withdrawal by Subject|2|||
130227641|NCT03093181|468798197|FG000|Overall Study|Other (Not specified)|1|||
130227642|NCT03093181|468798198|FG001|Overall Study|Other (Not specified)|0|||
130227643|NCT03093181|468798199|FG002|Overall Study|Other (Not specified)|0|||
130227644|NCT03093181|468798197|FG000|Overall Study|Adverse Event|0|||
130227645|NCT03093181|468798198|FG001|Overall Study|Adverse Event|1|||
130227646|NCT03093181|468798199|FG002|Overall Study|Adverse Event|0|||
130227647|NCT03093181|468798197|FG000|Overall Study|Other (Protocol violation)|0|||
130227648|NCT03093181|468798198|FG001|Overall Study|Other (Protocol violation)|0|||
130227649|NCT03093181|468798199|FG002|Overall Study|Other (Protocol violation)|1|||
130227650|NCT04210986|468798200|FG000|Overall Study|Lost to Follow-up|5|||
130227651|NCT04210986|468798201|FG001|Overall Study|Lost to Follow-up|2|||
130227652|NCT04210986|468798200|FG000|Overall Study|Withdrawal by Subject|3|||
130227653|NCT04210986|468798201|FG001|Overall Study|Withdrawal by Subject|1|||
130227654|NCT04210986|468798200|FG000|Overall Study|Protocol Violation|1|||
130227655|NCT04210986|468798201|FG001|Overall Study|Protocol Violation|1|||
130227656|NCT04210986|468798200|FG000|Overall Study|Physician Decision|0|||
130227657|NCT04210986|468798201|FG001|Overall Study|Physician Decision|1|||
130227658|NCT04233879|468798202|FG000|Overall Study|Death|2|||
130227659|NCT04233879|468798203|FG001|Overall Study|Death|0|||
130227660|NCT04233879|468798202|FG000|Overall Study|Lost to Follow-up|3|||
130227661|NCT04233879|468798203|FG001|Overall Study|Lost to Follow-up|8|||
130227662|NCT04233879|468798202|FG000|Overall Study|Physician Decision|4|||
130227663|NCT04233879|468798203|FG001|Overall Study|Physician Decision|4|||
130022293|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130227664|NCT04233879|468798202|FG000|Overall Study|Withdrawal by Subject|7|||
130227665|NCT04233879|468798203|FG001|Overall Study|Withdrawal by Subject|10|||
130227666|NCT04233879|468798202|FG000|Overall Study|Other|281|||
130227667|NCT04233879|468798203|FG001|Overall Study|Other|279|||
130227668|NCT03585270|468798206|FG000|Overall Study|Withdrawal by Subject|2|||
130227669|NCT03585270|468798207|FG001|Overall Study|Withdrawal by Subject|6|||
130227670|NCT03585270|468798206|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
130022294|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
130227671|NCT03585270|468798207|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
130227672|NCT03585270|468798206|FG000|Overall Study|Adverse Event|5|||
130022295|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
130022296|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
130022297|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
130022298|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
130022299|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
130022300|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
130022301|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
130022302|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
130022303|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
130022304|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
130022305|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
130022306|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
130022307|NCT03403205|468042642|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
130022308|NCT03403205|468042643|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
130022309|NCT03403205|468042644|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
130022310|NCT03403205|468042645|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
130022311|NCT03403205|468042646|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
130022312|NCT03403205|468042647|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
130022313|NCT01834729|468042648|FG000|Overall Study|Did not return bowel diaries|0|||
130022314|NCT01834729|468042649|FG001|Overall Study|Did not return bowel diaries|0|||
130022315|NCT01834729|468042650|FG002|Overall Study|Did not return bowel diaries|3|||
130022316|NCT01834729|468042651|FG003|Overall Study|Did not return bowel diaries|0|||
130022317|NCT01834729|468042648|FG000|Overall Study|Withdrawal by Subject|1|||
130022318|NCT01834729|468042649|FG001|Overall Study|Withdrawal by Subject|1|||
130022319|NCT01834729|468042650|FG002|Overall Study|Withdrawal by Subject|0|||
130022320|NCT01834729|468042651|FG003|Overall Study|Withdrawal by Subject|0|||
130022321|NCT01834729|468042648|FG000|Overall Study|Adverse Event|0|||
130022322|NCT01834729|468042649|FG001|Overall Study|Adverse Event|0|||
130022323|NCT01834729|468042650|FG002|Overall Study|Adverse Event|0|||
130022324|NCT01834729|468042651|FG003|Overall Study|Adverse Event|2|||
130022325|NCT02971670|468042652|FG000|Overall Study|Withdrawal by Subject|4|||
130022326|NCT02971670|468042653|FG001|Overall Study|Withdrawal by Subject|1|||
130022327|NCT02971670|468042654|FG002|Overall Study|Withdrawal by Subject|1|||
130022328|NCT02971670|468042655|FG003|Overall Study|Withdrawal by Subject|2|||
130022329|NCT00288080|468042656|FG000|Overall Study|Withdrawal by Subject|1|||
130022330|NCT00288080|468042657|FG001|Overall Study|Withdrawal by Subject|3|||
130022331|NCT00288080|468042656|FG000|Overall Study|Protocol Violation|25|||
130022332|NCT00288080|468042657|FG001|Overall Study|Protocol Violation|20|||
130022333|NCT02387580|468042661|FG000|Overall Study|Withdrawal by Subject|0|||
130022334|NCT02387580|468042662|FG001|Overall Study|Withdrawal by Subject|0|||
130022335|NCT02387580|468042663|FG002|Overall Study|Withdrawal by Subject|0|||
130022336|NCT02387580|468042664|FG003|Overall Study|Withdrawal by Subject|1|||
130022337|NCT02387580|468042665|FG004|Overall Study|Withdrawal by Subject|0|||
130022338|NCT02387580|468042666|FG005|Overall Study|Withdrawal by Subject|0|||
130022339|NCT02340663|468042668|FG000|Overall Study|Lost to Follow-up|1|||
130022340|NCT02340663|468042669|FG001|Overall Study|Lost to Follow-up|0|||
130022341|NCT02340663|468042668|FG000|Overall Study|Protocol Violation|1|||
130022342|NCT02340663|468042669|FG001|Overall Study|Protocol Violation|0|||
130022343|NCT02340663|468042668|FG000|Overall Study|Withdrawal by Subject|3|||
130022344|NCT02340663|468042669|FG001|Overall Study|Withdrawal by Subject|1|||
130022345|NCT02979431|468042670|FG000|Overall Study|Parent/guardian withdrew consent|2|||
130022346|NCT02979431|468042671|FG001|Overall Study|Parent/guardian withdrew consent|1|||
130099478|NCT00183170|468322688|FG001|Second Intervention|Did not meet targeted BrAC|2|||
130099479|NCT00761969|468322689|FG000|Overall Study|Death|112|||
130022347|NCT02979431|468042672|FG002|Overall Study|Parent/guardian withdrew consent|1|||
130022348|NCT02979431|468042673|FG003|Overall Study|Parent/guardian withdrew consent|1|||
130022349|NCT02979431|468042670|FG000|Overall Study|Randomized but received no study drug|1|||
130022350|NCT02979431|468042671|FG001|Overall Study|Randomized but received no study drug|1|||
130099480|NCT00761969|468322690|FG001|Overall Study|Death|47|||
130099481|NCT00761969|468322689|FG000|Overall Study|Lost to Follow-up|88|||
130099482|NCT00761969|468322690|FG001|Overall Study|Lost to Follow-up|93|||
130099483|NCT00585468|468322691|FG000|First Intervention|Withdrawal by Subject|1|||
130099484|NCT00585468|468322692|FG001|First Intervention|Withdrawal by Subject|1|||
130099485|NCT01353586|468322693|FG000|Overall Study|Procedure terminated prior to ablation|3|||
130099486|NCT01353586|468322694|FG001|Overall Study|Procedure terminated prior to ablation|0|||
130099487|NCT01353586|468322693|FG000|Overall Study|Never had insertion of study catheter|4|||
130099488|NCT01353586|468322694|FG001|Overall Study|Never had insertion of study catheter|1|||
130227673|NCT03585270|468798207|FG001|Overall Study|Adverse Event|2|||
130022351|NCT02979431|468042672|FG002|Overall Study|Randomized but received no study drug|0|||
130022352|NCT02979431|468042673|FG003|Overall Study|Randomized but received no study drug|0|||
130022353|NCT02979431|468042670|FG000|Overall Study|Adverse Event|0|||
130227674|NCT03585270|468798206|FG000|Overall Study|Lost to Follow-up|1|||
130227675|NCT03585270|468798207|FG001|Overall Study|Lost to Follow-up|4|||
130227676|NCT03585270|468798206|FG000|Overall Study|Death|5|||
130227677|NCT03585270|468798207|FG001|Overall Study|Death|3|||
130227678|NCT03585270|468798206|FG000|Overall Study|Other reasons|2|||
130227679|NCT03585270|468798207|FG001|Overall Study|Other reasons|2|||
130227680|NCT01076543|468798210|FG000|Overall Study|Withdrawal by Subject|2|||
130227681|NCT01076543|468798211|FG001|Overall Study|Withdrawal by Subject|0|||
130227682|NCT01076543|468798212|FG002|Overall Study|Withdrawal by Subject|0|||
130227683|NCT01076543|468798213|FG003|Overall Study|Withdrawal by Subject|0|||
130227684|NCT01076543|468798214|FG004|Overall Study|Withdrawal by Subject|0|||
130227685|NCT01076543|468798215|FG005|Overall Study|Withdrawal by Subject|0|||
130227686|NCT05222880|468798216|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130227687|NCT05222880|468798216|FG000|Overall Study|Withdrew Consent during Study|1|||
130227688|NCT05222880|468798216|FG000|Overall Study|COVID-19 Related|1|||
130227689|NCT01791985|468798217|FG000|Overall Study|Adverse Event|7|||
130227690|NCT01791985|468798217|FG000|Overall Study|Withdrawal by Subject|1|||
130227691|NCT03217591|468798233|FG000|Overall Study|Adverse Event|1|||
130227692|NCT03217591|468798234|FG001|Overall Study|Adverse Event|2|||
130227693|NCT03217591|468798235|FG002|Overall Study|Adverse Event|6|||
130227694|NCT03217591|468798233|FG000|Overall Study|Withdrawal by Subject|0|||
130227695|NCT03217591|468798234|FG001|Overall Study|Withdrawal by Subject|1|||
130227696|NCT03217591|468798235|FG002|Overall Study|Withdrawal by Subject|3|||
130227697|NCT03217591|468798233|FG000|Overall Study|Lost to Follow-up|1|||
130227698|NCT03217591|468798234|FG001|Overall Study|Lost to Follow-up|0|||
130227699|NCT03217591|468798235|FG002|Overall Study|Lost to Follow-up|0|||
130227700|NCT03217591|468798233|FG000|Overall Study|Protocol Violation|1|||
130227701|NCT03217591|468798234|FG001|Overall Study|Protocol Violation|0|||
130227702|NCT03217591|468798235|FG002|Overall Study|Protocol Violation|1|||
130227703|NCT02357459|468799902|FG000|Overall Study|Adverse Event|0|||
130227704|NCT02357459|468799903|FG001|Overall Study|Adverse Event|1|||
130227705|NCT02357459|468799904|FG002|Overall Study|Adverse Event|1|||
130227706|NCT02357459|468799902|FG000|Overall Study|Withdrawal by Subject|5|||
130227707|NCT02357459|468799903|FG001|Overall Study|Withdrawal by Subject|3|||
130227708|NCT02357459|468799904|FG002|Overall Study|Withdrawal by Subject|3|||
130227709|NCT02357459|468799902|FG000|Overall Study|Physician Decision|0|||
130227710|NCT02357459|468799903|FG001|Overall Study|Physician Decision|2|||
130227711|NCT02357459|468799904|FG002|Overall Study|Physician Decision|0|||
130227712|NCT02357459|468799902|FG000|Overall Study|Protocol Violation|1|||
130227713|NCT02357459|468799903|FG001|Overall Study|Protocol Violation|1|||
130227714|NCT02357459|468799904|FG002|Overall Study|Protocol Violation|0|||
130227715|NCT02357459|468799902|FG000|Overall Study|Lost to Follow-up|1|||
130227716|NCT02357459|468799903|FG001|Overall Study|Lost to Follow-up|3|||
130227717|NCT02357459|468799904|FG002|Overall Study|Lost to Follow-up|0|||
130227718|NCT02357459|468799902|FG000|Overall Study|Lack of Efficacy|7|||
130227719|NCT02357459|468799903|FG001|Overall Study|Lack of Efficacy|4|||
130227720|NCT02357459|468799904|FG002|Overall Study|Lack of Efficacy|4|||
130227721|NCT02357459|468799902|FG000|Overall Study|Patient Relocated|2|||
130227722|NCT02357459|468799903|FG001|Overall Study|Patient Relocated|0|||
130227723|NCT02357459|468799904|FG002|Overall Study|Patient Relocated|0|||
130227724|NCT02357459|468799902|FG000|Overall Study|Instruction from PCP|1|||
130227725|NCT02357459|468799903|FG001|Overall Study|Instruction from PCP|0|||
130227726|NCT02357459|468799904|FG002|Overall Study|Instruction from PCP|0|||
130227727|NCT02357459|468799902|FG000|Overall Study|Incarceration|0|||
130227728|NCT02357459|468799903|FG001|Overall Study|Incarceration|0|||
130227729|NCT02357459|468799904|FG002|Overall Study|Incarceration|1|||
130227730|NCT02357459|468799902|FG000|Overall Study|Pre-planned Knee surgery|0|||
130227731|NCT02357459|468799903|FG001|Overall Study|Pre-planned Knee surgery|0|||
130227732|NCT02357459|468799904|FG002|Overall Study|Pre-planned Knee surgery|2|||
130099489|NCT01353586|468322693|FG000|Overall Study|Neurological exam not done|0|||
130099490|NCT01353586|468322694|FG001|Overall Study|Neurological exam not done|1|||
130099491|NCT00978120|468322695|FG000|Overall Study|Death|0|||
130099492|NCT00978120|468322696|FG001|Overall Study|Death|0|||
130099493|NCT00978120|468322697|FG002|Overall Study|Death|0|||
130099494|NCT00978120|468322698|FG003|Overall Study|Death|1|||
130099495|NCT00978120|468322695|FG000|Overall Study|Lost to Follow-up|0|||
130099496|NCT00978120|468322696|FG001|Overall Study|Lost to Follow-up|0|||
130099497|NCT00978120|468322697|FG002|Overall Study|Lost to Follow-up|3|||
130227733|NCT02357459|468799902|FG000|Overall Study|Job Commitments|0|||
130227734|NCT02357459|468799903|FG001|Overall Study|Job Commitments|0|||
130227735|NCT02357459|468799904|FG002|Overall Study|Job Commitments|1|||
130227736|NCT01548599|468799905|FG000|Overall Study|Lost to Follow-up|0|||
130227737|NCT01548599|468799906|FG001|Overall Study|Lost to Follow-up|1|||
130227738|NCT01548599|468799905|FG000|Overall Study|Withdrawal by Subject|4|||
130227739|NCT01548599|468799906|FG001|Overall Study|Withdrawal by Subject|0|||
130227740|NCT01548599|468799905|FG000|Overall Study|Death|2|||
130227741|NCT01548599|468799906|FG001|Overall Study|Death|1|||
130227742|NCT05630196|468799907|FG000|Overall Study|Adverse Event|2|||
130227743|NCT05630196|468799908|FG001|Overall Study|Adverse Event|1|||
130227744|NCT05630196|468799907|FG000|Overall Study|Lost to Follow-up|1|||
130227745|NCT05630196|468799908|FG001|Overall Study|Lost to Follow-up|1|||
130227746|NCT05630196|468799907|FG000|Overall Study|Protocol Violation|2|||
130227747|NCT05630196|468799908|FG001|Overall Study|Protocol Violation|3|||
130227748|NCT05630196|468799907|FG000|Overall Study|Physician Decision|1|||
130227749|NCT05630196|468799908|FG001|Overall Study|Physician Decision|0|||
130227750|NCT05630196|468799907|FG000|Overall Study|Withdrawal by Subject|3|||
130227751|NCT05630196|468799908|FG001|Overall Study|Withdrawal by Subject|4|||
130227752|NCT00352118|468799910|FG000|Overall Study|Physician Decision|4|||
130227753|NCT02990000|468799911|FG000|Overall Study|Failed to provide data beyond baseline|36|||
130227754|NCT02990000|468799912|FG001|Overall Study|Failed to provide data beyond baseline|34|||
130227755|NCT02308046|468799913|FG000|Overall Study|Negative yeast culture at Baseline|32|||
130227756|NCT02308046|468799914|FG001|Overall Study|Negative yeast culture at Baseline|33|||
130227757|NCT02308046|468799913|FG000|Overall Study|Positive for STD at Baseline|1|||
130227758|NCT02308046|468799914|FG001|Overall Study|Positive for STD at Baseline|2|||
130227759|NCT02308046|468799913|FG000|Overall Study|Lost to Follow-up|1|||
130227760|NCT02308046|468799914|FG001|Overall Study|Lost to Follow-up|3|||
130227761|NCT00883181|468799915|FG000|Overall Study|Hematological Adverse Event|26|||
130227762|NCT00883181|468799915|FG000|Overall Study|Non-hematological Adverse Event|55|||
130227763|NCT00883181|468799915|FG000|Overall Study|Disease Progression|94|||
130227764|NCT00883181|468799915|FG000|Overall Study|Administrative Reason|24|||
130227765|NCT00883181|468799915|FG000|Overall Study|Withdrawal by Subject|4|||
130227766|NCT00883181|468799915|FG000|Overall Study|Death|31|||
130227767|NCT00883181|468799915|FG000|Overall Study|Other|38|||
130227768|NCT00883181|468799915|FG000|Overall Study|Protocol Deviation|3|||
130227769|NCT00883181|468799915|FG000|Overall Study|Noncompliance|3|||
130227770|NCT01587885|468799918|FG000|Treatment Period 1|Failure to Return|0|||
130227771|NCT01587885|468799919|FG001|Treatment Period 1|Failure to Return|1|||
130227772|NCT01587885|468799918|FG000|Treatment Period 1|Protocol Violation|0|||
130227773|NCT01587885|468799919|FG001|Treatment Period 1|Protocol Violation|2|||
130227774|NCT00001566|468799924|FG000|Overall Study|patients' choice to discontinue protocol|3|||
130227775|NCT00001566|468799924|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
130227776|NCT00001566|468799924|FG000|Overall Study|Death|13|||
130227777|NCT00001566|468799924|FG000|Overall Study|Lost to Follow-up|1|||
130227778|NCT00001566|468799924|FG000|Overall Study|unable to complete initial apheresis|1|||
130227779|NCT02914834|468799925|FG000|Overall Study|Study halted due to COVID|1|||
130227780|NCT02914834|468799926|FG001|Overall Study|Study halted due to COVID|1|||
130227781|NCT02914834|468799925|FG000|Overall Study|1 subject withdrew|0|||
130227782|NCT02914834|468799926|FG001|Overall Study|1 subject withdrew|1|||
130227783|NCT00975416|468799929|FG000|Overall Study|early discharge from tx|3|||
130227784|NCT00975416|468799930|FG001|Overall Study|early discharge from tx|5|||
130227785|NCT01249131|468799935|FG000|Washout Period of 10 Days|Adverse Event|0|||
130227786|NCT01249131|468799936|FG001|Washout Period of 10 Days|Adverse Event|0|||
130227787|NCT01249131|468799937|FG002|Washout Period of 10 Days|Adverse Event|0|||
130227788|NCT01249131|468799938|FG003|Washout Period of 10 Days|Adverse Event|0|||
130227789|NCT01249131|468799939|FG004|Washout Period of 10 Days|Adverse Event|1|||
130227790|NCT01249131|468799940|FG005|Washout Period of 10 Days|Adverse Event|0|||
130227791|NCT02378662|468799941|FG000|Overall Study|Early Discontinuation|2|||
130227792|NCT02378662|468799942|FG001|Overall Study|Early Discontinuation|0|||
130227793|NCT01774591|468799943|FG000|Overall Study|Physician Decision|1|||
130227794|NCT01774591|468799944|FG001|Overall Study|Physician Decision|1|||
130227795|NCT01774591|468799943|FG000|Overall Study|Withdrawal by Subject|0|||
130227796|NCT01774591|468799944|FG001|Overall Study|Withdrawal by Subject|1|||
130227797|NCT01774591|468799943|FG000|Overall Study|Adverse Event|0|||
130227798|NCT01774591|468799944|FG001|Overall Study|Adverse Event|2|||
130227799|NCT01701245|468799945|FG000|Overall Study|Protocol Violation|1|||
130022354|NCT02979431|468042671|FG001|Overall Study|Adverse Event|0|||
130022355|NCT02979431|468042672|FG002|Overall Study|Adverse Event|1|||
130227800|NCT01701245|468799946|FG001|Overall Study|Protocol Violation|3|||
130227801|NCT01701245|468799945|FG000|Overall Study|Did not complete the open label period|11|||
130227802|NCT01701245|468799946|FG001|Overall Study|Did not complete the open label period|12|||
130227803|NCT01159574|468799947|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
130227804|NCT01159574|468799947|FG000|Treatment Phase|Adverse Event|3|||
130227805|NCT01159574|468799947|FG000|Treatment Phase|Death|6|||
130227806|NCT01159574|468799947|FG000|Treatment Phase|Physician Decision|2|||
130227807|NCT01159574|468799947|FG000|Treatment Phase|Withdrawal by Subject|7|||
130227808|NCT01159574|468799947|FG000|Treatment Phase|still on treatment|2|||
130227809|NCT01159574|468799947|FG000|Follow Up Phase|Lost to Follow-up|2|||
130022356|NCT02979431|468042673|FG003|Overall Study|Adverse Event|0|||
130227810|NCT01159574|468799947|FG000|Follow Up Phase|still being followed for overall surviva|18|||
130227811|NCT03555149|468799952|FG000|Overall Study|Death|18|||
130227812|NCT03555149|468799953|FG001|Overall Study|Death|15|||
130227813|NCT03555149|468799954|FG002|Overall Study|Death|15|||
130227814|NCT03555149|468799955|FG003|Overall Study|Death|4|||
130227815|NCT03555149|468799956|FG004|Overall Study|Death|4|||
130227816|NCT03555149|468799957|FG005|Overall Study|Death|11|||
130227817|NCT03555149|468799958|FG006|Overall Study|Death|12|||
130227818|NCT03555149|468799959|FG007|Overall Study|Death|1|||
130227819|NCT03555149|468799952|FG000|Overall Study|Lost to Follow-up|1|||
130227820|NCT03555149|468799953|FG001|Overall Study|Lost to Follow-up|0|||
130227821|NCT03555149|468799954|FG002|Overall Study|Lost to Follow-up|0|||
130227822|NCT03555149|468799955|FG003|Overall Study|Lost to Follow-up|0|||
130227823|NCT03555149|468799956|FG004|Overall Study|Lost to Follow-up|0|||
130227824|NCT03555149|468799957|FG005|Overall Study|Lost to Follow-up|1|||
130227825|NCT03555149|468799958|FG006|Overall Study|Lost to Follow-up|0|||
130227826|NCT03555149|468799959|FG007|Overall Study|Lost to Follow-up|0|||
130227827|NCT03555149|468799952|FG000|Overall Study|Physician Decision|1|||
130227828|NCT03555149|468799953|FG001|Overall Study|Physician Decision|0|||
130227829|NCT03555149|468799954|FG002|Overall Study|Physician Decision|0|||
130227830|NCT03555149|468799955|FG003|Overall Study|Physician Decision|0|||
130227831|NCT03555149|468799956|FG004|Overall Study|Physician Decision|0|||
130227832|NCT03555149|468799957|FG005|Overall Study|Physician Decision|0|||
130227833|NCT03555149|468799958|FG006|Overall Study|Physician Decision|0|||
130099498|NCT00978120|468322698|FG003|Overall Study|Lost to Follow-up|0|||
130099499|NCT00978120|468322695|FG000|Overall Study|Withdrawal by Subject|2|||
130099500|NCT00978120|468322696|FG001|Overall Study|Withdrawal by Subject|0|||
130099501|NCT00978120|468322697|FG002|Overall Study|Withdrawal by Subject|0|||
130099502|NCT00978120|468322698|FG003|Overall Study|Withdrawal by Subject|0|||
130099503|NCT00978120|468322695|FG000|Overall Study|Moved out of state|0|||
130227834|NCT03555149|468799959|FG007|Overall Study|Physician Decision|0|||
130227835|NCT03555149|468799952|FG000|Overall Study|Study Terminated By Sponsor|1|||
130227836|NCT03555149|468799953|FG001|Overall Study|Study Terminated By Sponsor|0|||
130227837|NCT03555149|468799954|FG002|Overall Study|Study Terminated By Sponsor|0|||
130227838|NCT03555149|468799955|FG003|Overall Study|Study Terminated By Sponsor|0|||
130227839|NCT03555149|468799956|FG004|Overall Study|Study Terminated By Sponsor|0|||
130227840|NCT03555149|468799957|FG005|Overall Study|Study Terminated By Sponsor|2|||
130227841|NCT03555149|468799958|FG006|Overall Study|Study Terminated By Sponsor|3|||
130227842|NCT03555149|468799959|FG007|Overall Study|Study Terminated By Sponsor|1|||
130227843|NCT03555149|468799952|FG000|Overall Study|Withdrawal by Subject|3|||
130227844|NCT03555149|468799953|FG001|Overall Study|Withdrawal by Subject|0|||
130227845|NCT03555149|468799954|FG002|Overall Study|Withdrawal by Subject|0|||
130227846|NCT03555149|468799955|FG003|Overall Study|Withdrawal by Subject|2|||
130227847|NCT03555149|468799956|FG004|Overall Study|Withdrawal by Subject|0|||
130227848|NCT03555149|468799957|FG005|Overall Study|Withdrawal by Subject|1|||
130227849|NCT03555149|468799958|FG006|Overall Study|Withdrawal by Subject|0|||
130227850|NCT03555149|468799959|FG007|Overall Study|Withdrawal by Subject|0|||
130227851|NCT02666222|468799961|FG000|Overall Study|Death|2|||
130227852|NCT01474486|468799963|FG000|Overall Study|Death|2|||
130227853|NCT01474486|468799963|FG000|Overall Study|Withdrawal by Subject|4|||
130227854|NCT01474486|468799963|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
130227855|NCT03504917|468799967|FG000|Blinded Treatment Period|Protocol Violation|1|||
130227856|NCT03504917|468799968|FG001|Blinded Treatment Period|Protocol Violation|0|||
130227857|NCT03504917|468799967|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
130099504|NCT00978120|468322696|FG001|Overall Study|Moved out of state|0|||
130099505|NCT00978120|468322697|FG002|Overall Study|Moved out of state|0|||
130099506|NCT00978120|468322698|FG003|Overall Study|Moved out of state|1|||
130227858|NCT03504917|468799968|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
130227859|NCT03504917|468799967|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
130227860|NCT03504917|468799968|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
130227861|NCT03504917|468799967|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
130227862|NCT03504917|468799968|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
130099507|NCT01068418|468322707|FG000|Overall Study|Physician Decision|12|||
130099508|NCT03155269|468322708|FG000|Overall Study|Withdrawal by Subject|4|||
130099509|NCT03155269|468322709|FG001|Overall Study|Withdrawal by Subject|5|||
130099510|NCT03155269|468322708|FG000|Overall Study|Lost to Follow-up|1|||
130099511|NCT03155269|468322709|FG001|Overall Study|Lost to Follow-up|2|||
130227863|NCT03504917|468799967|FG000|Blinded Treatment Period|Adverse Event|4|||
130227864|NCT03504917|468799968|FG001|Blinded Treatment Period|Adverse Event|4|||
130227865|NCT03504917|468799967|FG000|Blinded Treatment Period|Physician Decision|1|||
130227866|NCT03504917|468799968|FG001|Blinded Treatment Period|Physician Decision|0|||
130227867|NCT03504917|468799967|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
130227868|NCT03504917|468799968|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
130227869|NCT03504917|468799967|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
130227870|NCT03504917|468799968|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
130227871|NCT03504917|468799967|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
130227872|NCT03504917|468799968|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
130227873|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
130227874|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
130227875|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
130227876|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
130227877|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
130227878|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
130227879|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
130227880|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
130227881|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
130227882|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
130227883|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
130227884|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
130227885|NCT03504917|468799967|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
130227886|NCT03504917|468799968|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
130227887|NCT04219189|468799969|FG000|Overall Study|Withdrawal by Subject|1|||
130227888|NCT04219189|468799970|FG001|Overall Study|Withdrawal by Subject|2|||
130227889|NCT04219189|468799969|FG000|Overall Study|Protocol Violation|0|||
130227890|NCT04219189|468799970|FG001|Overall Study|Protocol Violation|1|||
130227891|NCT04219189|468799969|FG000|Overall Study|Lost to Follow-up|0|||
130227892|NCT04219189|468799970|FG001|Overall Study|Lost to Follow-up|1|||
130227893|NCT04219189|468799969|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
130227894|NCT04219189|468799970|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
130227895|NCT03101020|468799971|FG000|Overall Study|Lack of time to participate|1|||
130227896|NCT03101020|468799972|FG001|Overall Study|Lack of time to participate|0|||
130227897|NCT03101020|468799971|FG000|Overall Study|Ran over by a car|0|||
130227898|NCT03101020|468799972|FG001|Overall Study|Ran over by a car|1|||
130227899|NCT03101020|468799971|FG000|Overall Study|Withdrawal by Subject|0|||
130227900|NCT03101020|468799972|FG001|Overall Study|Withdrawal by Subject|2|||
130227901|NCT05817669|468799973|FG000|Overall Study|Prohibited medication used|1|||
130227902|NCT05817669|468799974|FG001|Overall Study|Prohibited medication used|2|||
130227903|NCT05817669|468799973|FG000|Overall Study|Adverse Event|1|||
130227904|NCT05817669|468799974|FG001|Overall Study|Adverse Event|0|||
130227905|NCT05817669|468799973|FG000|Overall Study|Withdrawal by Subject|1|||
130227906|NCT05817669|468799974|FG001|Overall Study|Withdrawal by Subject|2|||
130227907|NCT03292016|468799975|FG000|Second Washout|Adverse Event|0|||
130227908|NCT03292016|468799976|FG001|Second Washout|Adverse Event|1|||
130227909|NCT03292016|468799977|FG002|Second Washout|Adverse Event|0|||
130227910|NCT03292016|468799978|FG003|Second Washout|Adverse Event|0|||
130227911|NCT03292016|468799979|FG004|Second Washout|Adverse Event|0|||
130227912|NCT03292016|468799980|FG005|Second Washout|Adverse Event|0|||
130227913|NCT03786380|468799981|FG000|Overall Study|Adverse Event|1|||
130227914|NCT03786380|468799982|FG001|Overall Study|Adverse Event|0|||
130227915|NCT03786380|468799983|FG002|Overall Study|Adverse Event|0|||
130227916|NCT03786380|468799984|FG003|Overall Study|Adverse Event|3|||
130227917|NCT03786380|468799985|FG004|Overall Study|Adverse Event|1|||
130227918|NCT03786380|468799981|FG000|Overall Study|Lack of Efficacy|0|||
130227919|NCT03786380|468799982|FG001|Overall Study|Lack of Efficacy|0|||
130099512|NCT00943826|468322710|FG000|Concurrent Phase|Adverse Event|50|||
130099513|NCT00943826|468322711|FG001|Concurrent Phase|Adverse Event|27|||
130099514|NCT00943826|468322710|FG000|Concurrent Phase|Withdrew consent|3|||
130099515|NCT00943826|468322711|FG001|Concurrent Phase|Withdrew consent|7|||
130099516|NCT00943826|468322710|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
130099517|NCT00943826|468322711|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
130099518|NCT00943826|468322710|FG000|Concurrent Phase|Administrative reasons|2|||
130099519|NCT00943826|468322711|FG001|Concurrent Phase|Administrative reasons|1|||
130099520|NCT00943826|468322710|FG000|Concurrent Phase|Protocol Violation|1|||
129884513|NCT02293837|467536433|FG001|Overall Study|Participant ill and could not be infused|0|||
130227920|NCT03786380|468799983|FG002|Overall Study|Lack of Efficacy|0|||
130227921|NCT03786380|468799984|FG003|Overall Study|Lack of Efficacy|0|||
130227922|NCT03786380|468799985|FG004|Overall Study|Lack of Efficacy|1|||
130227923|NCT03786380|468799981|FG000|Overall Study|Withdrawal by Subject|1|||
130227924|NCT03786380|468799982|FG001|Overall Study|Withdrawal by Subject|2|||
130227925|NCT03786380|468799983|FG002|Overall Study|Withdrawal by Subject|2|||
130227926|NCT03786380|468799984|FG003|Overall Study|Withdrawal by Subject|1|||
130099521|NCT00943826|468322711|FG001|Concurrent Phase|Protocol Violation|0|||
130099522|NCT00943826|468322710|FG000|Maintenance Phase|Adverse Event|31|||
130227927|NCT03786380|468799985|FG004|Overall Study|Withdrawal by Subject|2|||
129884514|NCT02293837|467536434|FG002|Overall Study|Participant ill and could not be infused|1|||
130227928|NCT03786380|468799981|FG000|Overall Study|Lost to Follow-up|3|||
130227929|NCT03786380|468799982|FG001|Overall Study|Lost to Follow-up|0|||
130227930|NCT03786380|468799983|FG002|Overall Study|Lost to Follow-up|1|||
130227931|NCT03786380|468799984|FG003|Overall Study|Lost to Follow-up|2|||
130227932|NCT03786380|468799985|FG004|Overall Study|Lost to Follow-up|0|||
130227933|NCT03786380|468799981|FG000|Overall Study|Physician Decision|0|||
130227934|NCT03786380|468799982|FG001|Overall Study|Physician Decision|0|||
130227935|NCT03786380|468799983|FG002|Overall Study|Physician Decision|1|||
130227936|NCT03786380|468799984|FG003|Overall Study|Physician Decision|0|||
130227937|NCT03786380|468799985|FG004|Overall Study|Physician Decision|0|||
130227938|NCT03786380|468799981|FG000|Overall Study|Study Terminated by the Sponsor|30|||
130227939|NCT03786380|468799982|FG001|Overall Study|Study Terminated by the Sponsor|20|||
130227940|NCT03786380|468799983|FG002|Overall Study|Study Terminated by the Sponsor|50|||
130227941|NCT03786380|468799984|FG003|Overall Study|Study Terminated by the Sponsor|57|||
130227942|NCT03786380|468799985|FG004|Overall Study|Study Terminated by the Sponsor|23|||
130227943|NCT03786380|468799981|FG000|Overall Study|Reason Not Specified|0|||
130227944|NCT03786380|468799982|FG001|Overall Study|Reason Not Specified|0|||
130227945|NCT03786380|468799983|FG002|Overall Study|Reason Not Specified|0|||
130227946|NCT03786380|468799984|FG003|Overall Study|Reason Not Specified|0|||
130227947|NCT03786380|468799985|FG004|Overall Study|Reason Not Specified|1|||
130227948|NCT01664091|468799988|FG000|Overall Study|Death|1|||
130227949|NCT01664091|468799988|FG000|Overall Study|Disease Progression|2|||
130227950|NCT01664091|468799988|FG000|Overall Study|Lost to Follow-up|2|||
130227951|NCT01664091|468799988|FG000|Overall Study|Withdrawal by Subject|1|||
130227952|NCT01909804|468799991|FG000|Overall Study|Randomized but Never Treated|0|||
130227953|NCT01909804|468799992|FG001|Overall Study|Randomized but Never Treated|0|||
130227954|NCT01909804|468799993|FG002|Overall Study|Randomized but Never Treated|0|||
130227955|NCT01909804|468799994|FG003|Overall Study|Randomized but Never Treated|0|||
130227956|NCT01909804|468799995|FG004|Overall Study|Randomized but Never Treated|0|||
130227957|NCT01909804|468799996|FG005|Overall Study|Randomized but Never Treated|0|||
130227958|NCT01909804|468799997|FG006|Overall Study|Randomized but Never Treated|1|||
130227959|NCT01909804|468799998|FG007|Overall Study|Randomized but Never Treated|0|||
130227960|NCT01909804|468799999|FG008|Overall Study|Randomized but Never Treated|0|||
130227961|NCT01909804|468800000|FG009|Overall Study|Randomized but Never Treated|0|||
130227962|NCT01909804|468800001|FG010|Overall Study|Randomized but Never Treated|0|||
130227963|NCT01909804|468800002|FG011|Overall Study|Randomized but Never Treated|1|||
130227964|NCT01909804|468799991|FG000|Overall Study|Death|0|||
130227965|NCT01909804|468799992|FG001|Overall Study|Death|0|||
130227966|NCT01909804|468799993|FG002|Overall Study|Death|0|||
130227967|NCT01909804|468799994|FG003|Overall Study|Death|0|||
130022357|NCT02979431|468042670|FG000|Overall Study|Subject left country after Day14|1|||
130022358|NCT02979431|468042671|FG001|Overall Study|Subject left country after Day14|0|||
130022359|NCT02979431|468042672|FG002|Overall Study|Subject left country after Day14|0|||
130022360|NCT02979431|468042673|FG003|Overall Study|Subject left country after Day14|0|||
130022361|NCT01656434|468042674|FG000|Overall Study|Adverse Event|199|||
130022362|NCT01656434|468042675|FG001|Overall Study|Adverse Event|63|||
130022363|NCT01656434|468042674|FG000|Overall Study|Enrollment terminated at trial site|2|||
130022364|NCT01656434|468042675|FG001|Overall Study|Enrollment terminated at trial site|0|||
130022365|NCT01656434|468042674|FG000|Overall Study|Lost to Follow-up|309|||
130022366|NCT01656434|468042675|FG001|Overall Study|Lost to Follow-up|76|||
130227968|NCT01909804|468799995|FG004|Overall Study|Death|0|||
130227969|NCT01909804|468799996|FG005|Overall Study|Death|0|||
130227970|NCT01909804|468799997|FG006|Overall Study|Death|0|||
130099523|NCT00943826|468322711|FG001|Maintenance Phase|Adverse Event|30|||
130099524|NCT00943826|468322710|FG000|Maintenance Phase|Withdrew consent|2|||
130099525|NCT00943826|468322711|FG001|Maintenance Phase|Withdrew consent|4|||
130099526|NCT00943826|468322710|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
130099527|NCT00943826|468322711|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
130099528|NCT00943826|468322710|FG000|Maintenance Phase|Administrative reasons|4|||
130099529|NCT00943826|468322711|FG001|Maintenance Phase|Administrative reasons|1|||
130099530|NCT00943826|468322710|FG000|Maintenance Phase|Failure to return|0|||
130099531|NCT00943826|468322711|FG001|Maintenance Phase|Failure to return|1|||
130099532|NCT00943826|468322710|FG000|Monotherapy Phase|Adverse Event|42|||
130099533|NCT00943826|468322711|FG001|Monotherapy Phase|Adverse Event|5|||
130099534|NCT00943826|468322710|FG000|Monotherapy Phase|Administrative reasons|11|||
130099535|NCT00943826|468322711|FG001|Monotherapy Phase|Administrative reasons|5|||
130099536|NCT00943826|468322710|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
130227971|NCT01909804|468799998|FG007|Overall Study|Death|0|||
130227972|NCT01909804|468799999|FG008|Overall Study|Death|0|||
130099537|NCT00943826|468322711|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
130227973|NCT01909804|468800000|FG009|Overall Study|Death|0|||
130227974|NCT01909804|468800001|FG010|Overall Study|Death|1|||
130227975|NCT01909804|468800002|FG011|Overall Study|Death|0|||
130227976|NCT01909804|468799991|FG000|Overall Study|Lack of Efficacy|4|||
130227977|NCT01909804|468799992|FG001|Overall Study|Lack of Efficacy|1|||
130022367|NCT01656434|468042674|FG000|Overall Study|Site discontinued study participation|24|||
130227978|NCT01909804|468799993|FG002|Overall Study|Lack of Efficacy|0|||
130227979|NCT01909804|468799994|FG003|Overall Study|Lack of Efficacy|0|||
130227980|NCT01909804|468799995|FG004|Overall Study|Lack of Efficacy|7|||
130227981|NCT01909804|468799996|FG005|Overall Study|Lack of Efficacy|3|||
130227982|NCT01909804|468799997|FG006|Overall Study|Lack of Efficacy|1|||
130227983|NCT01909804|468799998|FG007|Overall Study|Lack of Efficacy|1|||
130227984|NCT01909804|468799999|FG008|Overall Study|Lack of Efficacy|0|||
130227985|NCT01909804|468800000|FG009|Overall Study|Lack of Efficacy|1|||
130227986|NCT01909804|468800001|FG010|Overall Study|Lack of Efficacy|0|||
130227987|NCT01909804|468800002|FG011|Overall Study|Lack of Efficacy|1|||
130227988|NCT01909804|468799991|FG000|Overall Study|Withdrew Consent|0|||
130227989|NCT01909804|468799992|FG001|Overall Study|Withdrew Consent|0|||
130227990|NCT01909804|468799993|FG002|Overall Study|Withdrew Consent|0|||
130227991|NCT01909804|468799994|FG003|Overall Study|Withdrew Consent|0|||
130227992|NCT01909804|468799995|FG004|Overall Study|Withdrew Consent|1|||
130227993|NCT01909804|468799996|FG005|Overall Study|Withdrew Consent|1|||
130227994|NCT01909804|468799997|FG006|Overall Study|Withdrew Consent|0|||
130227995|NCT01909804|468799998|FG007|Overall Study|Withdrew Consent|0|||
130227996|NCT01909804|468799999|FG008|Overall Study|Withdrew Consent|0|||
130227997|NCT01909804|468800000|FG009|Overall Study|Withdrew Consent|0|||
130227998|NCT01909804|468800001|FG010|Overall Study|Withdrew Consent|0|||
130227999|NCT01909804|468800002|FG011|Overall Study|Withdrew Consent|0|||
130228000|NCT01909804|468799991|FG000|Overall Study|Protocol Violation|0|||
130228001|NCT01909804|468799992|FG001|Overall Study|Protocol Violation|0|||
130228002|NCT01909804|468799993|FG002|Overall Study|Protocol Violation|0|||
130228003|NCT01909804|468799994|FG003|Overall Study|Protocol Violation|0|||
130228004|NCT01909804|468799995|FG004|Overall Study|Protocol Violation|0|||
130228005|NCT01909804|468799996|FG005|Overall Study|Protocol Violation|0|||
130228006|NCT01909804|468799997|FG006|Overall Study|Protocol Violation|0|||
130228007|NCT01909804|468799998|FG007|Overall Study|Protocol Violation|0|||
130228008|NCT01909804|468799999|FG008|Overall Study|Protocol Violation|0|||
130228009|NCT01909804|468800000|FG009|Overall Study|Protocol Violation|0|||
130228010|NCT01909804|468800001|FG010|Overall Study|Protocol Violation|0|||
130228011|NCT01909804|468800002|FG011|Overall Study|Protocol Violation|1|||
130228012|NCT01038687|468800003|FG000|Overall Study|Adverse Event|0|||
130228013|NCT01038687|468800004|FG001|Overall Study|Adverse Event|2|||
130228014|NCT01038687|468800005|FG002|Overall Study|Adverse Event|1|||
130228015|NCT00338741|468800007|FG000|Overall Study|Lost to Follow-up|2|||
130228016|NCT00338741|468800008|FG001|Overall Study|Lost to Follow-up|0|||
130228017|NCT02144701|468800009|FG000|Overall Study|development of relapse, GVHD or death|9|||
130228018|NCT02144701|468800010|FG001|Overall Study|development of relapse, GVHD or death|3|||
130228019|NCT01218802|468800012|FG000|Overall Study|Lost to Follow-up|5|||
130228020|NCT01218802|468800013|FG001|Overall Study|Lost to Follow-up|6|||
130228021|NCT01218802|468800012|FG000|Overall Study|Withdrawal by Subject|3|||
130228022|NCT01218802|468800013|FG001|Overall Study|Withdrawal by Subject|10|||
130228023|NCT01218802|468800012|FG000|Overall Study|Adverse Event|0|||
130228024|NCT01218802|468800013|FG001|Overall Study|Adverse Event|2|||
130228025|NCT01218802|468800012|FG000|Overall Study|Incarcerated|2|||
130228026|NCT01218802|468800013|FG001|Overall Study|Incarcerated|0|||
130228027|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228028|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228029|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130022368|NCT01656434|468042675|FG001|Overall Study|Site discontinued study participation|9|||
130022369|NCT01656434|468042674|FG000|Overall Study|Screen failure|2|||
130022370|NCT01656434|468042675|FG001|Overall Study|Screen failure|0|||
130022371|NCT01656434|468042674|FG000|Overall Study|Protocol Violation|7|||
130022372|NCT01656434|468042675|FG001|Overall Study|Protocol Violation|0|||
130228030|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228031|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228032|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
130228033|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Refused|0|||
130228034|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Refused|0|||
130228035|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Refused|0|||
130228036|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Refused|0|||
130228037|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Refused|1|||
130228038|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Refused|0|||
130228039|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228040|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
130228041|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228042|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228043|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228044|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
130228045|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|Death|0|||
130228046|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|Death|0|||
130228047|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|Death|0|||
130228048|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|Death|0|||
130228049|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|Death|1|||
130228050|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|Death|0|||
130228051|NCT03327324|468800014|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228052|NCT03327324|468800015|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228053|NCT03327324|468800016|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228054|NCT03327324|468800017|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228055|NCT03327324|468800018|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228056|NCT03327324|468800019|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
130228057|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228058|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228059|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228060|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228061|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228062|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228063|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
130228064|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130228065|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130228066|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
130228067|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
130228068|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
130228069|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
130228070|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228071|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228072|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228073|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228074|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
130228075|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|Death|1|||
130022373|NCT01656434|468042674|FG000|Overall Study|Pregnancy wish|18|||
130022374|NCT01656434|468042675|FG001|Overall Study|Pregnancy wish|6|||
130022375|NCT01656434|468042674|FG000|Overall Study|Pregnancy|45|||
130022376|NCT01656434|468042675|FG001|Overall Study|Pregnancy|10|||
130022377|NCT01656434|468042674|FG000|Overall Study|Physician Decision|7|||
130022378|NCT01656434|468042675|FG001|Overall Study|Physician Decision|2|||
130022379|NCT01656434|468042674|FG000|Overall Study|Non-compliance with study drug|48|||
130022380|NCT01656434|468042675|FG001|Overall Study|Non-compliance with study drug|9|||
130022381|NCT01656434|468042674|FG000|Overall Study|Study terminated by sponsor|1501|||
130022382|NCT01656434|468042675|FG001|Overall Study|Study terminated by sponsor|348|||
130022383|NCT01656434|468042674|FG000|Overall Study|Participant discontinued; drug related|13|||
130022384|NCT01656434|468042675|FG001|Overall Study|Participant discontinued; drug related|4|||
130022385|NCT01656434|468042674|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
130022386|NCT01656434|468042675|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
130099538|NCT00943826|468322710|FG000|Monotherapy Phase|Withdrew Consent|2|||
130099539|NCT00943826|468322711|FG001|Monotherapy Phase|Withdrew Consent|3|||
130099540|NCT00943826|468322710|FG000|Monotherapy Phase|Failure to return|2|||
130099541|NCT00943826|468322711|FG001|Monotherapy Phase|Failure to return|1|||
130099542|NCT00943826|468322710|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
130099543|NCT00943826|468322711|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
130099544|NCT00943826|468322710|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
130099545|NCT00943826|468322711|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
130099546|NCT00943826|468322710|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
130099547|NCT00943826|468322711|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
130099548|NCT00943826|468322710|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
130099549|NCT00943826|468322711|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
130022387|NCT01656434|468042674|FG000|Overall Study|Non-compliance with protocol|39|||
130228076|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|Death|0|||
130228077|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|Death|1|||
130228078|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|Death|1|||
130228079|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|Death|1|||
130228080|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|Death|0|||
130228081|NCT03327324|468800014|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228082|NCT03327324|468800015|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228083|NCT03327324|468800016|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228084|NCT03327324|468800017|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228085|NCT03327324|468800018|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228086|NCT03327324|468800019|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
130228087|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
130228088|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228089|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228090|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228091|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228092|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
130228093|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
130228094|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
130228095|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228096|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228097|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228098|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
130228099|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130228100|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130228101|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
130228102|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130228103|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130228104|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
130228105|NCT03327324|468800014|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228106|NCT03327324|468800015|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228107|NCT03327324|468800016|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228108|NCT03327324|468800017|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
130228109|NCT03327324|468800018|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
130228110|NCT03327324|468800019|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
130228111|NCT03327324|468800014|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
130228112|NCT03327324|468800015|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228113|NCT03327324|468800016|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228114|NCT03327324|468800017|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228115|NCT03327324|468800018|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228116|NCT03327324|468800019|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
130228117|NCT03327324|468800014|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
130228118|NCT03327324|468800015|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228119|NCT03327324|468800016|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228120|NCT03327324|468800017|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228121|NCT03327324|468800018|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228122|NCT03327324|468800019|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
130228123|NCT02314728|468800023|FG000|Overall Study|Protocol Violation|1|||
130228124|NCT02314728|468800024|FG001|Overall Study|Protocol Violation|0|||
130228125|NCT02314728|468800023|FG000|Overall Study|Lost to Follow-up|0|||
130228126|NCT02314728|468800024|FG001|Overall Study|Lost to Follow-up|1|||
130228127|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
130228128|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228129|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130099550|NCT00326625|468322712|FG000|Overall Study|Adverse Event|20|||
130099551|NCT00326625|468322713|FG001|Overall Study|Adverse Event|9|||
130099552|NCT00326625|468322712|FG000|Overall Study|Withdrawal by Subject|15|||
130099553|NCT00326625|468322713|FG001|Overall Study|Withdrawal by Subject|12|||
130228130|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228131|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228132|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228133|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
130228134|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
130228135|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228136|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228137|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228138|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228139|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228140|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
130228141|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228142|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
130228143|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228144|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228145|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228146|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228147|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
130228148|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228149|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228150|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
130228151|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228152|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228153|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228154|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
130228155|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228156|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228157|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
130228158|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228159|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228160|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228161|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
130228162|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228163|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228164|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
130228165|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130099554|NCT00326625|468322712|FG000|Overall Study|Death|18|||
130099555|NCT00326625|468322713|FG001|Overall Study|Death|16|||
130099556|NCT00326625|468322712|FG000|Overall Study|Lost to Follow-up|1|||
130228166|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228167|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228168|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
130228169|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228170|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228171|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228172|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
130228173|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228174|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228175|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
130228176|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228177|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228178|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228179|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
130228180|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228181|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228182|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
130228183|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228184|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228185|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228186|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228187|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
130228188|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228189|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
130228190|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228191|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228192|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228193|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228194|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
130228195|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228196|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
130228197|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228198|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228199|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228200|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228201|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
130228202|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228203|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
130228204|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228205|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228206|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228207|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228208|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
130228209|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228210|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
130228211|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228212|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228213|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228214|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228215|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228216|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
130228217|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
130228218|NCT01791595|468800025|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228219|NCT01791595|468800026|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228220|NCT01791595|468800027|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228221|NCT01791595|468800028|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228222|NCT01791595|468800029|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130228223|NCT01791595|468800030|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
130228224|NCT01791595|468800031|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
130022388|NCT01656434|468042675|FG001|Overall Study|Non-compliance with protocol|15|||
130022389|NCT01656434|468042674|FG000|Overall Study|Participant moved|40|||
130022390|NCT01656434|468042675|FG001|Overall Study|Participant moved|12|||
130022391|NCT01656434|468042674|FG000|Overall Study|Participant withdrew consent|28|||
130022392|NCT01656434|468042675|FG001|Overall Study|Participant withdrew consent|9|||
130022393|NCT01656434|468042674|FG000|Overall Study|Withdrawal by Subject|64|||
130022394|NCT01656434|468042675|FG001|Overall Study|Withdrawal by Subject|7|||
130022395|NCT06098729|468042685|FG000|Overall Study|Withdrawal by Subject|1|||
130022396|NCT03033875|468042691|FG000|Overall Study|Withdrawal by Subject|5|||
130022397|NCT03033875|468042692|FG001|Overall Study|Withdrawal by Subject|9|||
130022398|NCT03033875|468042693|FG002|Overall Study|Withdrawal by Subject|4|||
130022399|NCT03033875|468042691|FG000|Overall Study|Other|14|||
130022400|NCT03033875|468042692|FG001|Overall Study|Other|15|||
130022401|NCT03033875|468042693|FG002|Overall Study|Other|8|||
130022402|NCT04925752|468042697|FG000|Overall Study|Still on Study|1826|||
130022403|NCT04925752|468042698|FG001|Overall Study|Still on Study|926|||
130022404|NCT04925752|468042697|FG000|Overall Study|Withdrew Consent|128|||
130022405|NCT04925752|468042698|FG001|Overall Study|Withdrew Consent|59|||
130022406|NCT04925752|468042697|FG000|Overall Study|Lost to Follow-up|73|||
130022407|NCT04925752|468042698|FG001|Overall Study|Lost to Follow-up|47|||
130022408|NCT04925752|468042697|FG000|Overall Study|Randomized but Never Treated|12|||
130022409|NCT04925752|468042698|FG001|Overall Study|Randomized but Never Treated|9|||
130022410|NCT04925752|468042697|FG000|Overall Study|Hiv-1 Infection|6|||
130022411|NCT04925752|468042698|FG001|Overall Study|Hiv-1 Infection|7|||
130022412|NCT04925752|468042697|FG000|Overall Study|Investigator's discretion|8|||
130022413|NCT04925752|468042698|FG001|Overall Study|Investigator's discretion|5|||
130022414|NCT04925752|468042697|FG000|Overall Study|Non-compliance with Study Drug|8|||
130022415|NCT04925752|468042698|FG001|Overall Study|Non-compliance with Study Drug|5|||
130022416|NCT04925752|468042697|FG000|Overall Study|Adverse Event|5|||
130022417|NCT04925752|468042698|FG001|Overall Study|Adverse Event|2|||
130099557|NCT00326625|468322713|FG001|Overall Study|Lost to Follow-up|0|||
130022418|NCT04925752|468042697|FG000|Overall Study|Death|4|||
130022419|NCT04925752|468042698|FG001|Overall Study|Death|2|||
130022420|NCT04925752|468042697|FG000|Overall Study|Protocol Violation|1|||
130022421|NCT04925752|468042698|FG001|Overall Study|Protocol Violation|3|||
130022422|NCT04925752|468042697|FG000|Overall Study|Withdrew Assent|1|||
130022423|NCT04925752|468042698|FG001|Overall Study|Withdrew Assent|0|||
130022424|NCT03467958|468042699|FG000|Overall Study|Adverse Event|20|||
130022425|NCT03467958|468042700|FG001|Overall Study|Adverse Event|32|||
130022426|NCT03467958|468042701|FG002|Overall Study|Adverse Event|5|||
130022427|NCT03467958|468042702|FG003|Overall Study|Adverse Event|3|||
130022428|NCT03467958|468042703|FG004|Overall Study|Adverse Event|3|||
130099558|NCT00326625|468322712|FG000|Overall Study|prescheduled medical intervention|0|||
130099559|NCT00326625|468322713|FG001|Overall Study|prescheduled medical intervention|1|||
130099560|NCT01265875|468322718|FG000|Overall Study|Uncooperative/unreliable|1|||
130099561|NCT05275673|468322719|FG000|Overall Study|Study Termination by Sponsor|2|||
130099562|NCT05275673|468322720|FG001|Overall Study|Study Termination by Sponsor|3|||
130099563|NCT05275673|468322719|FG000|Overall Study|Death|1|||
130099564|NCT05275673|468322720|FG001|Overall Study|Death|0|||
130099565|NCT05275673|468322719|FG000|Overall Study|Withdrawal by Subject|1|||
130099566|NCT05275673|468322720|FG001|Overall Study|Withdrawal by Subject|0|||
130099567|NCT02335411|468322723|FG000|Overall Study|Death|223|||
130099568|NCT02335411|468322724|FG001|Overall Study|Death|22|||
130099569|NCT02335411|468322725|FG002|Overall Study|Death|26|||
130099570|NCT02335411|468322723|FG000|Overall Study|Physician Decision|3|||
130099571|NCT02335411|468322724|FG001|Overall Study|Physician Decision|0|||
130099572|NCT02335411|468322725|FG002|Overall Study|Physician Decision|0|||
130099573|NCT02335411|468322723|FG000|Overall Study|Protocol Violation|1|||
130099574|NCT02335411|468322724|FG001|Overall Study|Protocol Violation|0|||
130099575|NCT02335411|468322725|FG002|Overall Study|Protocol Violation|0|||
130099576|NCT02335411|468322723|FG000|Overall Study|Withdrawal by Subject|11|||
130099577|NCT02335411|468322724|FG001|Overall Study|Withdrawal by Subject|0|||
130099578|NCT02335411|468322725|FG002|Overall Study|Withdrawal by Subject|3|||
130099579|NCT02335411|468322723|FG000|Overall Study|Sponsor Decision|12|||
130099580|NCT02335411|468322724|FG001|Overall Study|Sponsor Decision|3|||
130099581|NCT02335411|468322725|FG002|Overall Study|Sponsor Decision|2|||
130099582|NCT02335411|468322723|FG000|Overall Study|Adverse Event|9|||
130099583|NCT02335411|468322724|FG001|Overall Study|Adverse Event|0|||
130022429|NCT03467958|468042704|FG005|Overall Study|Adverse Event|3|||
130099584|NCT02335411|468322725|FG002|Overall Study|Adverse Event|0|||
130099585|NCT03075826|468322726|FG000|Overall Study|Withdrawal by Subject|1|||
130099586|NCT03075826|468322726|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
130099587|NCT00650806|468322727|FG000|Overall Study|Adverse Event|0|||
130099588|NCT00650806|468322728|FG001|Overall Study|Adverse Event|5|||
130022430|NCT03467958|468042705|FG006|Overall Study|Adverse Event|6|||
130022431|NCT03467958|468042706|FG007|Overall Study|Adverse Event|5|||
130022432|NCT03467958|468042707|FG008|Overall Study|Adverse Event|0|||
130022433|NCT03467958|468042699|FG000|Overall Study|Lack of Efficacy|59|||
130022434|NCT03467958|468042700|FG001|Overall Study|Lack of Efficacy|120|||
130022435|NCT03467958|468042701|FG002|Overall Study|Lack of Efficacy|6|||
130099589|NCT00650806|468322729|FG002|Overall Study|Adverse Event|3|||
130228225|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228226|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228227|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228228|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228229|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228230|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
130228231|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
130228232|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228233|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228234|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228235|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228236|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228237|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
130228238|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
130228239|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228240|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228241|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228242|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228243|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228244|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
130228245|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
130228246|NCT01791595|468800025|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228247|NCT01791595|468800026|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228248|NCT01791595|468800027|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228249|NCT01791595|468800028|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228250|NCT01791595|468800029|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228251|NCT01791595|468800030|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
130228252|NCT01791595|468800031|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
130228253|NCT03118934|468800032|FG000|Overall Study|Adverse Event|0|||
130228254|NCT03118934|468800033|FG001|Overall Study|Adverse Event|0|||
130228255|NCT03118934|468800034|FG002|Overall Study|Adverse Event|0|||
130228256|NCT03118934|468800035|FG003|Overall Study|Adverse Event|0|||
130228257|NCT03118934|468800036|FG004|Overall Study|Adverse Event|0|||
130228258|NCT03118934|468800037|FG005|Overall Study|Adverse Event|1|||
130228259|NCT03118934|468800032|FG000|Overall Study|Physician Decision|0|||
130228260|NCT03118934|468800033|FG001|Overall Study|Physician Decision|0|||
130228261|NCT03118934|468800034|FG002|Overall Study|Physician Decision|0|||
130228262|NCT03118934|468800035|FG003|Overall Study|Physician Decision|0|||
130228263|NCT03118934|468800036|FG004|Overall Study|Physician Decision|0|||
130228264|NCT03118934|468800037|FG005|Overall Study|Physician Decision|1|||
130228265|NCT03118934|468800032|FG000|Overall Study|Discontinued prior to exposure|0|||
130228266|NCT03118934|468800033|FG001|Overall Study|Discontinued prior to exposure|1|||
130228267|NCT03118934|468800034|FG002|Overall Study|Discontinued prior to exposure|1|||
130228268|NCT03118934|468800035|FG003|Overall Study|Discontinued prior to exposure|1|||
130228269|NCT03118934|468800036|FG004|Overall Study|Discontinued prior to exposure|2|||
130228270|NCT03118934|468800037|FG005|Overall Study|Discontinued prior to exposure|0|||
130228271|NCT01614470|468800038|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
130228272|NCT01614470|468800039|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130228273|NCT01614470|468800040|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
130228274|NCT01614470|468800038|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
130228275|NCT01614470|468800039|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
130228276|NCT01614470|468800040|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
130228277|NCT00249834|468800041|FG000|Overall Study|Ovarian stimulation failed|1|||
130228278|NCT00249834|468800042|FG001|Overall Study|Ovarian stimulation failed|0|||
130228279|NCT00249834|468800043|FG002|Overall Study|Ovarian stimulation failed|0|||
130228280|NCT00249834|468800044|FG003|Overall Study|Ovarian stimulation failed|0|||
130099590|NCT00650806|468322730|FG003|Overall Study|Adverse Event|4|||
130228281|NCT00249834|468800045|FG004|Overall Study|Ovarian stimulation failed|0|||
130228282|NCT00249834|468800046|FG005|Overall Study|Ovarian stimulation failed|0|||
130228283|NCT00249834|468800047|FG006|Overall Study|Ovarian stimulation failed|0|||
130228284|NCT00249834|468800048|FG007|Overall Study|Ovarian stimulation failed|0|||
130228285|NCT00249834|468800041|FG000|Overall Study|Failure of down-regulation|0|||
130228286|NCT00249834|468800042|FG001|Overall Study|Failure of down-regulation|0|||
130228287|NCT00249834|468800043|FG002|Overall Study|Failure of down-regulation|0|||
130228288|NCT00249834|468800044|FG003|Overall Study|Failure of down-regulation|0|||
130228289|NCT00249834|468800045|FG004|Overall Study|Failure of down-regulation|0|||
130228290|NCT00249834|468800046|FG005|Overall Study|Failure of down-regulation|0|||
130228291|NCT00249834|468800047|FG006|Overall Study|Failure of down-regulation|1|||
130228292|NCT00249834|468800048|FG007|Overall Study|Failure of down-regulation|0|||
130228293|NCT00249834|468800041|FG000|Overall Study|Protocol Violation|0|||
130228294|NCT00249834|468800042|FG001|Overall Study|Protocol Violation|19|||
130228295|NCT00249834|468800043|FG002|Overall Study|Protocol Violation|14|||
130228296|NCT00249834|468800044|FG003|Overall Study|Protocol Violation|8|||
130228297|NCT00249834|468800045|FG004|Overall Study|Protocol Violation|5|||
130228298|NCT00249834|468800046|FG005|Overall Study|Protocol Violation|2|||
130228299|NCT00249834|468800047|FG006|Overall Study|Protocol Violation|0|||
130228300|NCT00249834|468800048|FG007|Overall Study|Protocol Violation|0|||
130228301|NCT02895347|468800049|FG000|Overall Study|Withdrawal by Subject|3|||
130228302|NCT02895347|468800050|FG001|Overall Study|Withdrawal by Subject|1|||
130228303|NCT03177148|468800054|FG000|Overall Study|Lost to Follow-up|50|||
130228304|NCT03177148|468800055|FG001|Overall Study|Lost to Follow-up|1|||
130228305|NCT03177148|468800054|FG000|Overall Study|Death|1|||
130228306|NCT03177148|468800055|FG001|Overall Study|Death|0|||
130228307|NCT02848664|468800058|FG000|Overall Study|Withdrawal by Subject|2|||
130228308|NCT02848664|468800058|FG000|Overall Study|Adverse Event|1|||
130228309|NCT02848664|468800058|FG000|Overall Study|no assistance for device training|1|||
130228310|NCT01204671|468800059|FG000|Overall Study|Adverse Event|4|||
130228311|NCT01204671|468800060|FG001|Overall Study|Adverse Event|3|||
130228312|NCT01204671|468800061|FG002|Overall Study|Adverse Event|3|||
130228313|NCT01204671|468800062|FG003|Overall Study|Adverse Event|3|||
130228314|NCT01204671|468800063|FG004|Overall Study|Adverse Event|1|||
130228315|NCT01204671|468800059|FG000|Overall Study|Withdrawal by Subject|2|||
130228316|NCT01204671|468800060|FG001|Overall Study|Withdrawal by Subject|3|||
130228317|NCT01204671|468800061|FG002|Overall Study|Withdrawal by Subject|4|||
130228318|NCT01204671|468800062|FG003|Overall Study|Withdrawal by Subject|5|||
130022436|NCT03467958|468042702|FG003|Overall Study|Lack of Efficacy|9|||
130022437|NCT03467958|468042703|FG004|Overall Study|Lack of Efficacy|8|||
130228319|NCT01204671|468800063|FG004|Overall Study|Withdrawal by Subject|3|||
130228320|NCT01204671|468800059|FG000|Overall Study|Lost to Follow-up|7|||
130228321|NCT01204671|468800060|FG001|Overall Study|Lost to Follow-up|8|||
130228322|NCT01204671|468800061|FG002|Overall Study|Lost to Follow-up|6|||
130228323|NCT01204671|468800062|FG003|Overall Study|Lost to Follow-up|4|||
130228324|NCT01204671|468800063|FG004|Overall Study|Lost to Follow-up|0|||
130228325|NCT01204671|468800059|FG000|Overall Study|Unknown Completion Status|1|||
130228326|NCT01204671|468800060|FG001|Overall Study|Unknown Completion Status|1|||
130228327|NCT01204671|468800061|FG002|Overall Study|Unknown Completion Status|0|||
130228328|NCT01204671|468800062|FG003|Overall Study|Unknown Completion Status|0|||
130228329|NCT01204671|468800063|FG004|Overall Study|Unknown Completion Status|0|||
130228330|NCT01204671|468800059|FG000|Overall Study|Physician Decision|0|||
130228331|NCT01204671|468800060|FG001|Overall Study|Physician Decision|0|||
130228332|NCT01204671|468800061|FG002|Overall Study|Physician Decision|0|||
130228333|NCT01204671|468800062|FG003|Overall Study|Physician Decision|1|||
130228334|NCT01204671|468800063|FG004|Overall Study|Physician Decision|0|||
130228335|NCT00492726|468800068|FG000|Overall Study|Adverse Event|10|||
130228336|NCT00492726|468800069|FG001|Overall Study|Adverse Event|6|||
130228337|NCT00492726|468800068|FG000|Overall Study|Death|7|||
130228338|NCT00492726|468800069|FG001|Overall Study|Death|2|||
130228339|NCT00492726|468800068|FG000|Overall Study|Lack of Efficacy|0|||
130228340|NCT00492726|468800069|FG001|Overall Study|Lack of Efficacy|2|||
130228341|NCT00492726|468800068|FG000|Overall Study|Lost to Follow-up|27|||
130228342|NCT00492726|468800069|FG001|Overall Study|Lost to Follow-up|19|||
130228343|NCT00492726|468800068|FG000|Overall Study|Physician Decision|0|||
130228344|NCT00492726|468800069|FG001|Overall Study|Physician Decision|1|||
130228345|NCT00492726|468800068|FG000|Overall Study|Withdrawal by Subject|6|||
130228346|NCT00492726|468800069|FG001|Overall Study|Withdrawal by Subject|3|||
130228347|NCT00492726|468800068|FG000|Overall Study|Non compliant with study medication|0|||
130228348|NCT00492726|468800069|FG001|Overall Study|Non compliant with study medication|3|||
130228349|NCT04386902|468800070|FG000|Overall Study|Withdrawal by Subject|5|||
130228350|NCT04386902|468800070|FG000|Overall Study|Technical problems in the recording|5|||
130228351|NCT02404545|468800071|FG000|Overall Study|Sponsor Termination|6|||
130228352|NCT02404545|468800072|FG001|Overall Study|Sponsor Termination|6|||
130228353|NCT01712516|468801556|FG000|Overall Study|Technical problems|0|||
130022438|NCT03467958|468042704|FG005|Overall Study|Lack of Efficacy|9|||
130228354|NCT01712516|468801557|FG001|Overall Study|Technical problems|0|||
130228355|NCT01712516|468801558|FG002|Overall Study|Technical problems|0|||
130228356|NCT01712516|468801559|FG003|Overall Study|Technical problems|2|||
130228357|NCT01712516|468801556|FG000|Overall Study|Lost to Follow-up|0|||
130228358|NCT01712516|468801557|FG001|Overall Study|Lost to Follow-up|0|||
130228359|NCT01712516|468801558|FG002|Overall Study|Lost to Follow-up|2|||
130228360|NCT01712516|468801559|FG003|Overall Study|Lost to Follow-up|1|||
130228361|NCT01712516|468801556|FG000|Overall Study|Death|0|||
130228362|NCT01712516|468801557|FG001|Overall Study|Death|1|||
130228363|NCT01712516|468801558|FG002|Overall Study|Death|0|||
130022439|NCT03467958|468042705|FG006|Overall Study|Lack of Efficacy|11|||
130228364|NCT01712516|468801559|FG003|Overall Study|Death|0|||
130228365|NCT01712516|468801556|FG000|Overall Study|Protocol deviation|1|||
130228366|NCT01712516|468801557|FG001|Overall Study|Protocol deviation|0|||
130228367|NCT01712516|468801558|FG002|Overall Study|Protocol deviation|1|||
130228368|NCT01712516|468801559|FG003|Overall Study|Protocol deviation|0|||
130228369|NCT01712516|468801556|FG000|Overall Study|Physician Decision|2|||
130228370|NCT01712516|468801557|FG001|Overall Study|Physician Decision|0|||
130228371|NCT01712516|468801558|FG002|Overall Study|Physician Decision|0|||
130228372|NCT01712516|468801559|FG003|Overall Study|Physician Decision|1|||
130228373|NCT01712516|468801556|FG000|Overall Study|Withdrawal by Subject|3|||
130228374|NCT01712516|468801557|FG001|Overall Study|Withdrawal by Subject|9|||
130228375|NCT01712516|468801558|FG002|Overall Study|Withdrawal by Subject|3|||
130228376|NCT01712516|468801559|FG003|Overall Study|Withdrawal by Subject|9|||
130228377|NCT01181167|468801560|FG000|Overall Study|Adverse Event|11|||
130228378|NCT01181167|468801561|FG001|Overall Study|Adverse Event|21|||
130228379|NCT01181167|468801560|FG000|Overall Study|Lost to Follow-up|1|||
130228380|NCT01181167|468801561|FG001|Overall Study|Lost to Follow-up|0|||
130228381|NCT01181167|468801560|FG000|Overall Study|Physician Decision|2|||
130228382|NCT01181167|468801561|FG001|Overall Study|Physician Decision|3|||
130228383|NCT01181167|468801560|FG000|Overall Study|Protocol Violation|3|||
130228384|NCT01181167|468801561|FG001|Overall Study|Protocol Violation|0|||
130228385|NCT01181167|468801560|FG000|Overall Study|Withdrawal by Subject|6|||
130228386|NCT01181167|468801561|FG001|Overall Study|Withdrawal by Subject|8|||
130228387|NCT00161213|468801562|FG000|Overall Study|Withdrawal by Subject|1|||
130228388|NCT00161213|468801562|FG000|Overall Study|Evaluable for toxicity but not response|1|||
130228389|NCT03103503|468801563|FG000|Overall Study|Death|64|||
130228390|NCT03103503|468801563|FG000|Overall Study|Physician Decision|57|||
130228391|NCT03103503|468801563|FG000|Overall Study|Withdrawal by Subject|10|||
130228392|NCT03103503|468801563|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
130228393|NCT03103503|468801563|FG000|Overall Study|Lost to Follow-up|3|||
130228394|NCT03103503|468801563|FG000|Overall Study|Study Closure|757|||
130228395|NCT02683109|468801565|FG000|Overall Study|Adverse Event|1|||
130228396|NCT02683109|468801566|FG001|Overall Study|Adverse Event|0|||
130228397|NCT00183430|468801567|FG000|Overall Study|Adverse Event|1|||
130228398|NCT00183430|468801568|FG001|Overall Study|Adverse Event|0|||
130228399|NCT00183430|468801567|FG000|Overall Study|Lost to Follow-up|3|||
130228400|NCT00183430|468801568|FG001|Overall Study|Lost to Follow-up|0|||
130228401|NCT00183430|468801567|FG000|Overall Study|did not meet inclusion criteria|1|||
130228402|NCT00183430|468801568|FG001|Overall Study|did not meet inclusion criteria|0|||
130228403|NCT00183430|468801567|FG000|Overall Study|Withdrawal by Subject|1|||
130228404|NCT00183430|468801568|FG001|Overall Study|Withdrawal by Subject|0|||
130228405|NCT03322293|468801571|FG000|Overall Study|Lost to Follow-up|0|||
130228406|NCT03322293|468801572|FG001|Overall Study|Lost to Follow-up|0|||
130228407|NCT03322293|468801573|FG002|Overall Study|Lost to Follow-up|1|||
130228408|NCT01178294|468801574|FG000|Overall Study|Adverse Event|4|||
130228409|NCT01178294|468801574|FG000|Overall Study|Lost to Follow-up|2|||
130228410|NCT01178294|468801574|FG000|Overall Study|Lack of Efficacy|1|||
130228411|NCT01178294|468801574|FG000|Overall Study|Death|1|||
130228412|NCT01178294|468801574|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
130228413|NCT01178294|468801574|FG000|Overall Study|Subject status is terminal|1|||
130228414|NCT01178294|468801574|FG000|Overall Study|Completion status could not be verified|1|||
130228415|NCT02089347|468801575|FG000|Overall Study|Protocol Violation|1|||
130228416|NCT02089347|468801576|FG001|Overall Study|Protocol Violation|0|||
130228417|NCT00551369|468801577|FG000|Overall Study|Protocol Violation|5|||
130228418|NCT00551369|468801577|FG000|Overall Study|Withdrawal by Subject|1|||
130228419|NCT00551369|468801577|FG000|Overall Study|Not treated per protocol and re|1|||
130228420|NCT00719901|468801578|FG000|Overall Study|Adverse Event|5|||
130228421|NCT00719901|468801578|FG000|Overall Study|Withdrawal by Subject|1|||
130228422|NCT00719901|468801578|FG000|Overall Study|Alternate Treatment|1|||
130022440|NCT03467958|468042706|FG007|Overall Study|Lack of Efficacy|9|||
130022441|NCT03467958|468042707|FG008|Overall Study|Lack of Efficacy|3|||
130022442|NCT03467958|468042699|FG000|Overall Study|Lost to Follow-up|1|||
130022443|NCT03467958|468042700|FG001|Overall Study|Lost to Follow-up|2|||
130022444|NCT03467958|468042701|FG002|Overall Study|Lost to Follow-up|1|||
130022445|NCT03467958|468042702|FG003|Overall Study|Lost to Follow-up|0|||
130228423|NCT00719901|468801578|FG000|Overall Study|Disease Progression|3|||
130228424|NCT00719901|468801578|FG000|Overall Study|Availability of Study Drug|1|||
130228425|NCT01122173|468801579|FG000|Overall Study|Lost to Follow-up|3|||
130228426|NCT01122173|468801579|FG000|Overall Study|Withdrawal by Subject|3|||
130228427|NCT01122173|468801579|FG000|Overall Study|Left study for other reasons|3|||
130228428|NCT01184872|468801580|FG000|Overall Study|Adverse Event|3|||
130228429|NCT01184872|468801581|FG001|Overall Study|Adverse Event|4|||
130228430|NCT01184872|468801580|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130228431|NCT01184872|468801581|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130228432|NCT01184872|468801580|FG000|Overall Study|Withdrawal by Subject|2|||
130228433|NCT01184872|468801581|FG001|Overall Study|Withdrawal by Subject|0|||
130228434|NCT01184872|468801580|FG000|Overall Study|Lost to Follow-up|0|||
130228435|NCT01184872|468801581|FG001|Overall Study|Lost to Follow-up|1|||
130022446|NCT03467958|468042703|FG004|Overall Study|Lost to Follow-up|4|||
130022447|NCT03467958|468042704|FG005|Overall Study|Lost to Follow-up|0|||
130022448|NCT03467958|468042705|FG006|Overall Study|Lost to Follow-up|0|||
130228436|NCT01184872|468801580|FG000|Overall Study|Administrative problems|1|||
130228437|NCT01184872|468801581|FG001|Overall Study|Administrative problems|1|||
130228438|NCT01184872|468801580|FG000|Overall Study|Protocol deviation|1|||
130228439|NCT01184872|468801581|FG001|Overall Study|Protocol deviation|0|||
130228440|NCT02674516|468801582|FG000|Overall Study|Lost to Follow-up|3|||
130228441|NCT02674516|468801583|FG001|Overall Study|Lost to Follow-up|0|||
130228442|NCT02674516|468801582|FG000|Overall Study|Protocol Violation|0|||
130228443|NCT02674516|468801583|FG001|Overall Study|Protocol Violation|4|||
130228444|NCT02674516|468801582|FG000|Overall Study|Knowledge of study hypothesis|1|||
130228445|NCT02674516|468801583|FG001|Overall Study|Knowledge of study hypothesis|0|||
130228446|NCT02662569|468801585|FG000|Overall Study|Withdrawal by Subject|6|||
130228447|NCT02662569|468801586|FG001|Overall Study|Withdrawal by Subject|1|||
130228448|NCT02662569|468801587|FG002|Overall Study|Withdrawal by Subject|6|||
130228449|NCT02662569|468801588|FG003|Overall Study|Withdrawal by Subject|4|||
130228450|NCT02662569|468801585|FG000|Overall Study|Lost to Follow-up|1|||
130228451|NCT02662569|468801586|FG001|Overall Study|Lost to Follow-up|0|||
130228452|NCT02662569|468801587|FG002|Overall Study|Lost to Follow-up|0|||
130228453|NCT02662569|468801588|FG003|Overall Study|Lost to Follow-up|0|||
130228454|NCT04076917|468801589|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
130228455|NCT04076917|468801589|FG000|Overall Study|Study closure|13|||
130228456|NCT04076917|468801589|FG000|Overall Study|Physician Decision|3|||
130228457|NCT04076917|468801589|FG000|Overall Study|Death|1|||
130228458|NCT04076917|468801589|FG000|Overall Study|Lost to Follow-up|1|||
130228459|NCT04076917|468801589|FG000|Overall Study|Withdrawal by Subject|1|||
130228460|NCT04076917|468801589|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
130228461|NCT03863353|468801593|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
130228462|NCT03863353|468801594|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
130228463|NCT01299584|468801595|FG000|Overall Study|Protocol Violation|9|||
130228464|NCT02747927|468801596|FG000|Overall Study|Adverse Event|5|||
130228465|NCT02747927|468801597|FG001|Overall Study|Adverse Event|14|||
130228466|NCT02747927|468801596|FG000|Overall Study|Lost to Follow-up|22|||
130228467|NCT02747927|468801597|FG001|Overall Study|Lost to Follow-up|43|||
130228468|NCT02747927|468801596|FG000|Overall Study|Pregnancy|34|||
130228469|NCT02747927|468801597|FG001|Overall Study|Pregnancy|66|||
130228470|NCT02747927|468801596|FG000|Overall Study|Protocol Violation|2|||
130228471|NCT02747927|468801597|FG001|Overall Study|Protocol Violation|4|||
130228472|NCT02747927|468801596|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
130228473|NCT02747927|468801597|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
130228474|NCT02747927|468801596|FG000|Overall Study|Reason not Specified|11|||
130228475|NCT02747927|468801597|FG001|Overall Study|Reason not Specified|27|||
130228476|NCT03810183|468801601|FG000|Overall Study|Study terminated by Sponsor|2|||
130228477|NCT03810183|468801602|FG001|Overall Study|Study terminated by Sponsor|1|||
130228478|NCT00323063|468801603|FG000|Overall Study|Adverse Event|1|||
130228479|NCT00323063|468801604|FG001|Overall Study|Adverse Event|0|||
130228480|NCT00323063|468801603|FG000|Overall Study|brain mets discovered prior to treatment|1|||
130228481|NCT00323063|468801604|FG001|Overall Study|brain mets discovered prior to treatment|0|||
130228482|NCT00423046|468801605|FG000|Overall Study|Other|340|||
130228483|NCT00423046|468801606|FG001|Overall Study|Other|345|||
130228484|NCT00830128|468801607|FG000|Overall Study|Adverse Event|5|||
130228485|NCT00830128|468801607|FG000|Overall Study|Lack of Efficacy|7|||
130228486|NCT00830128|468801607|FG000|Overall Study|Protocol Violation|1|||
130228487|NCT00830128|468801607|FG000|Overall Study|Withdrawal by Subject|2|||
130228488|NCT00830128|468801607|FG000|Overall Study|Family obligation|1|||
130228489|NCT00830128|468801607|FG000|Overall Study|Relocation|1|||
130228490|NCT00830128|468801607|FG000|Overall Study|Work obligation|1|||
130228491|NCT00830128|468801607|FG000|Overall Study|Operating a vehicle|1|||
130228492|NCT04249427|468801612|FG000|Overall Study|Adverse Event|3|||
130228493|NCT04249427|468801613|FG001|Overall Study|Adverse Event|1|||
130228494|NCT04249427|468801612|FG000|Overall Study|Lack of Efficacy|0|||
130228495|NCT04249427|468801613|FG001|Overall Study|Lack of Efficacy|1|||
130228496|NCT04249427|468801612|FG000|Overall Study|Withdrawal by Subject|1|||
130228497|NCT04249427|468801613|FG001|Overall Study|Withdrawal by Subject|2|||
130228498|NCT01673178|468801614|FG000|Overall Study|Lost to Follow-up|0|||
130228499|NCT01673178|468801615|FG001|Overall Study|Lost to Follow-up|1|||
130228500|NCT01673178|468801616|FG002|Overall Study|Lost to Follow-up|0|||
130228501|NCT01673178|468801617|FG003|Overall Study|Lost to Follow-up|0|||
130228502|NCT01673178|468801618|FG004|Overall Study|Lost to Follow-up|0|||
130228503|NCT01673178|468801614|FG000|Overall Study|Withdrawal by Subject|0|||
130228504|NCT01673178|468801615|FG001|Overall Study|Withdrawal by Subject|0|||
130228505|NCT01673178|468801616|FG002|Overall Study|Withdrawal by Subject|1|||
130228506|NCT01673178|468801617|FG003|Overall Study|Withdrawal by Subject|4|||
130228507|NCT01673178|468801618|FG004|Overall Study|Withdrawal by Subject|2|||
130022449|NCT03467958|468042706|FG007|Overall Study|Lost to Follow-up|0|||
130022450|NCT03467958|468042707|FG008|Overall Study|Lost to Follow-up|0|||
130022451|NCT03467958|468042699|FG000|Overall Study|Other reasons|8|||
130228508|NCT01673178|468801614|FG000|Overall Study|Protocol Violation|1|||
130228509|NCT01673178|468801615|FG001|Overall Study|Protocol Violation|1|||
130228510|NCT01673178|468801616|FG002|Overall Study|Protocol Violation|0|||
130022452|NCT03467958|468042700|FG001|Overall Study|Other reasons|14|||
130022453|NCT03467958|468042701|FG002|Overall Study|Other reasons|2|||
130022454|NCT03467958|468042702|FG003|Overall Study|Other reasons|1|||
130022455|NCT03467958|468042703|FG004|Overall Study|Other reasons|4|||
130022456|NCT03467958|468042704|FG005|Overall Study|Other reasons|0|||
130022457|NCT03467958|468042705|FG006|Overall Study|Other reasons|1|||
130022458|NCT03467958|468042706|FG007|Overall Study|Other reasons|0|||
130022459|NCT03467958|468042707|FG008|Overall Study|Other reasons|1|||
130022460|NCT03467958|468042699|FG000|Overall Study|Pregnancy|1|||
130022461|NCT03467958|468042700|FG001|Overall Study|Pregnancy|0|||
130022462|NCT03467958|468042701|FG002|Overall Study|Pregnancy|0|||
130022463|NCT03467958|468042702|FG003|Overall Study|Pregnancy|0|||
130022464|NCT03467958|468042703|FG004|Overall Study|Pregnancy|0|||
130022465|NCT03467958|468042704|FG005|Overall Study|Pregnancy|1|||
130022466|NCT03467958|468042705|FG006|Overall Study|Pregnancy|0|||
130022467|NCT03467958|468042706|FG007|Overall Study|Pregnancy|0|||
130022468|NCT03467958|468042707|FG008|Overall Study|Pregnancy|0|||
130022469|NCT03467958|468042699|FG000|Overall Study|Study terminated by sponsor|65|||
130022470|NCT03467958|468042700|FG001|Overall Study|Study terminated by sponsor|117|||
130022471|NCT03467958|468042701|FG002|Overall Study|Study terminated by sponsor|45|||
130022472|NCT03467958|468042702|FG003|Overall Study|Study terminated by sponsor|64|||
130022473|NCT03467958|468042703|FG004|Overall Study|Study terminated by sponsor|66|||
130022474|NCT03467958|468042704|FG005|Overall Study|Study terminated by sponsor|17|||
130022475|NCT03467958|468042705|FG006|Overall Study|Study terminated by sponsor|11|||
130022476|NCT03467958|468042706|FG007|Overall Study|Study terminated by sponsor|5|||
130022477|NCT03467958|468042707|FG008|Overall Study|Study terminated by sponsor|5|||
130022478|NCT03467958|468042699|FG000|Overall Study|Withdrawal by Subject|25|||
130022479|NCT03467958|468042700|FG001|Overall Study|Withdrawal by Subject|44|||
130022480|NCT03467958|468042701|FG002|Overall Study|Withdrawal by Subject|7|||
130022481|NCT03467958|468042702|FG003|Overall Study|Withdrawal by Subject|8|||
130022482|NCT03467958|468042703|FG004|Overall Study|Withdrawal by Subject|6|||
130022483|NCT03467958|468042704|FG005|Overall Study|Withdrawal by Subject|8|||
130022484|NCT03467958|468042705|FG006|Overall Study|Withdrawal by Subject|4|||
130022485|NCT03467958|468042706|FG007|Overall Study|Withdrawal by Subject|1|||
130022486|NCT03467958|468042707|FG008|Overall Study|Withdrawal by Subject|4|||
130022487|NCT02925156|468042709|FG000|Overall Study|Lost to Follow-up|27|||
130022488|NCT02925156|468042710|FG001|Overall Study|Lost to Follow-up|53|||
130022489|NCT02925156|468042711|FG002|Overall Study|Lost to Follow-up|51|||
130022490|NCT02925156|468042712|FG003|Overall Study|Lost to Follow-up|59|||
130022491|NCT02925156|468042713|FG004|Overall Study|Lost to Follow-up|89|||
130022492|NCT02925156|468042714|FG005|Overall Study|Lost to Follow-up|107|||
130022493|NCT02925156|468042715|FG006|Overall Study|Lost to Follow-up|34|||
130022494|NCT02925156|468042716|FG007|Overall Study|Lost to Follow-up|36|||
130022495|NCT02925156|468042717|FG008|Overall Study|Lost to Follow-up|73|||
130022496|NCT02925156|468042718|FG009|Overall Study|Lost to Follow-up|34|||
130022497|NCT00866307|468042719|FG000|Induction|Adverse Event|5|||
130022498|NCT00866307|468042720|FG001|Induction|Adverse Event|0|||
130022499|NCT00866307|468042721|FG002|Induction|Adverse Event|0|||
130022500|NCT00866307|468042719|FG000|Induction|Death|2|||
130022501|NCT00866307|468042720|FG001|Induction|Death|0|||
130022502|NCT00866307|468042721|FG002|Induction|Death|0|||
130022503|NCT00866307|468042719|FG000|Induction|Physician Decision|5|||
130022504|NCT00866307|468042720|FG001|Induction|Physician Decision|0|||
130022505|NCT00866307|468042721|FG002|Induction|Physician Decision|0|||
130022506|NCT00866307|468042719|FG000|Induction|Progressive Disease|1|||
130022507|NCT00866307|468042720|FG001|Induction|Progressive Disease|0|||
130022508|NCT00866307|468042721|FG002|Induction|Progressive Disease|0|||
130022509|NCT00866307|468042719|FG000|Induction|Identification of Patients with Day 29 M|3|||
130022510|NCT00866307|468042720|FG001|Induction|Identification of Patients with Day 29 M|0|||
130022511|NCT00866307|468042721|FG002|Induction|Identification of Patients with Day 29 M|0|||
130022512|NCT00866307|468042719|FG000|Induction|Inadequate cytognetic samples th|1|||
130022513|NCT00866307|468042720|FG001|Induction|Inadequate cytognetic samples th|0|||
130022514|NCT00866307|468042721|FG002|Induction|Inadequate cytognetic samples th|0|||
130022515|NCT00866307|468042719|FG000|Induction|Improper post-induction consent|2|||
130022516|NCT00866307|468042720|FG001|Induction|Improper post-induction consent|0|||
130022517|NCT00866307|468042721|FG002|Induction|Improper post-induction consent|0|||
130022518|NCT00866307|468042719|FG000|Induction|Study was closed at the time|1|||
130022519|NCT00866307|468042720|FG001|Induction|Study was closed at the time|0|||
130022520|NCT00866307|468042721|FG002|Induction|Study was closed at the time|0|||
130022521|NCT00866307|468042719|FG000|Consolidation/Maintenance|Adverse Event|0|||
130022522|NCT00866307|468042720|FG001|Consolidation/Maintenance|Adverse Event|0|||
130022523|NCT00866307|468042721|FG002|Consolidation/Maintenance|Adverse Event|8|||
130228511|NCT01673178|468801617|FG003|Overall Study|Protocol Violation|1|||
130228512|NCT01673178|468801618|FG004|Overall Study|Protocol Violation|0|||
130228513|NCT01673178|468801614|FG000|Overall Study|Adverse Event|1|||
130228514|NCT01673178|468801615|FG001|Overall Study|Adverse Event|0|||
130228515|NCT01673178|468801616|FG002|Overall Study|Adverse Event|0|||
130228516|NCT01673178|468801617|FG003|Overall Study|Adverse Event|2|||
130228517|NCT01673178|468801618|FG004|Overall Study|Adverse Event|0|||
130228518|NCT01673178|468801614|FG000|Overall Study|Other|1|||
130228519|NCT01673178|468801615|FG001|Overall Study|Other|0|||
130228520|NCT01673178|468801616|FG002|Overall Study|Other|2|||
130228521|NCT01673178|468801617|FG003|Overall Study|Other|1|||
130228522|NCT01673178|468801618|FG004|Overall Study|Other|0|||
130228523|NCT01419314|468801619|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
130228524|NCT01419314|468801620|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
130228525|NCT01419314|468801619|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
130228526|NCT01419314|468801620|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
130228527|NCT01419314|468801619|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
130228528|NCT01419314|468801620|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
130228529|NCT00402727|468801624|FG000|Overall Study|Adverse Event|10|||
130228530|NCT00402727|468801625|FG001|Overall Study|Adverse Event|6|||
130228531|NCT00402727|468801624|FG000|Overall Study|Death|1|||
130228532|NCT00402727|468801625|FG001|Overall Study|Death|0|||
130228533|NCT00402727|468801624|FG000|Overall Study|Lack of Efficacy|1|||
130228534|NCT00402727|468801625|FG001|Overall Study|Lack of Efficacy|3|||
130228535|NCT00402727|468801624|FG000|Overall Study|Lost to Follow-up|24|||
130228536|NCT00402727|468801625|FG001|Overall Study|Lost to Follow-up|11|||
130228537|NCT00402727|468801624|FG000|Overall Study|Physician Decision|1|||
130228538|NCT00402727|468801625|FG001|Overall Study|Physician Decision|1|||
130228539|NCT00402727|468801624|FG000|Overall Study|Protocol Violation|0|||
130228540|NCT00402727|468801625|FG001|Overall Study|Protocol Violation|4|||
130228541|NCT00402727|468801624|FG000|Overall Study|Withdrawal by Subject|3|||
130228542|NCT00402727|468801625|FG001|Overall Study|Withdrawal by Subject|7|||
130228543|NCT00402727|468801624|FG000|Overall Study|supply problems|2|||
130228544|NCT00402727|468801625|FG001|Overall Study|supply problems|1|||
130228545|NCT00402727|468801624|FG000|Overall Study|non-compliance|0|||
130228546|NCT00402727|468801625|FG001|Overall Study|non-compliance|1|||
130228547|NCT01405898|468801626|FG000|Overall Study|Withdrawal by Subject|2|||
130228548|NCT01405898|468801627|FG001|Overall Study|Withdrawal by Subject|2|||
130228549|NCT03188055|468801628|FG000|Overall Study|Unavailable for training|0|||
130228550|NCT03188055|468801629|FG001|Overall Study|Unavailable for training|0|||
130228551|NCT03188055|468801630|FG002|Overall Study|Unavailable for training|19|||
130228552|NCT03188055|468801631|FG003|Overall Study|Unavailable for training|0|||
130228553|NCT03188055|468801632|FG004|Overall Study|Unavailable for training|0|||
130228554|NCT03188055|468801633|FG005|Overall Study|Unavailable for training|0|||
130228555|NCT03188055|468801628|FG000|Overall Study|Lost to Follow-up|0|||
130228556|NCT03188055|468801629|FG001|Overall Study|Lost to Follow-up|18|||
130228557|NCT03188055|468801630|FG002|Overall Study|Lost to Follow-up|0|||
130228558|NCT03188055|468801631|FG003|Overall Study|Lost to Follow-up|11|||
130228559|NCT03188055|468801632|FG004|Overall Study|Lost to Follow-up|0|||
130228560|NCT03188055|468801633|FG005|Overall Study|Lost to Follow-up|0|||
130228561|NCT03188055|468801628|FG000|Overall Study|Withdrawal by Subject|0|||
130228562|NCT03188055|468801629|FG001|Overall Study|Withdrawal by Subject|1|||
130228563|NCT03188055|468801630|FG002|Overall Study|Withdrawal by Subject|0|||
130228564|NCT03188055|468801631|FG003|Overall Study|Withdrawal by Subject|1|||
130228565|NCT03188055|468801632|FG004|Overall Study|Withdrawal by Subject|0|||
130228566|NCT03188055|468801633|FG005|Overall Study|Withdrawal by Subject|0|||
130228567|NCT00887484|468801646|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
130228568|NCT00887484|468801646|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
130228569|NCT00887484|468801646|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
130228570|NCT03044314|468801647|FG000|Overall Study|Physician Decision|2|||
130228571|NCT03044314|468801647|FG000|Overall Study|Withdrawal by Subject|1|||
130228572|NCT03044314|468801647|FG000|Overall Study|Connector tubing not available|1|||
130228573|NCT01316224|468801648|FG000|Overall Study|Protocol Violation|3|||
130228574|NCT01316224|468801648|FG000|Overall Study|Adverse Event|3|||
130228575|NCT01316224|468801648|FG000|Overall Study|Lack of Efficacy|1|||
130228576|NCT01316224|468801648|FG000|Overall Study|Withdrawal by Subject|1|||
130228577|NCT01316224|468801648|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
130228578|NCT01316224|468801648|FG000|Overall Study|Other|1|||
130228579|NCT00264147|468801649|FG000|Treatment I Period|Adverse Event|3|||
130228580|NCT00264147|468801650|FG001|Treatment I Period|Adverse Event|6|||
130228581|NCT00264147|468801651|FG002|Treatment I Period|Adverse Event|3|||
130022524|NCT00866307|468042719|FG000|Consolidation/Maintenance|Death|0|||
130022525|NCT00866307|468042720|FG001|Consolidation/Maintenance|Death|0|||
130022526|NCT00866307|468042721|FG002|Consolidation/Maintenance|Death|1|||
130022527|NCT00866307|468042719|FG000|Consolidation/Maintenance|Physician Decision|0|||
130022528|NCT00866307|468042720|FG001|Consolidation/Maintenance|Physician Decision|3|||
130022529|NCT00866307|468042721|FG002|Consolidation/Maintenance|Physician Decision|2|||
130022530|NCT00866307|468042719|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
130022531|NCT00866307|468042720|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
130022532|NCT00866307|468042721|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
130022533|NCT00866307|468042719|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
130022534|NCT00866307|468042720|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
130022535|NCT00866307|468042721|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
130022536|NCT00866307|468042719|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
130022537|NCT00866307|468042720|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
130022538|NCT00866307|468042721|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
130022539|NCT00866307|468042719|FG000|Consolidation/Maintenance|Therapy error|0|||
130022540|NCT00866307|468042720|FG001|Consolidation/Maintenance|Therapy error|1|||
130022541|NCT00866307|468042721|FG002|Consolidation/Maintenance|Therapy error|0|||
130022542|NCT00866307|468042719|FG000|Consolidation/Maintenance|Non-compliance|0|||
130022543|NCT00866307|468042720|FG001|Consolidation/Maintenance|Non-compliance|0|||
130022544|NCT00866307|468042721|FG002|Consolidation/Maintenance|Non-compliance|1|||
130022545|NCT00866307|468042719|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
130022546|NCT00866307|468042720|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
130022547|NCT00866307|468042721|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
130022548|NCT02286947|468042724|FG000|Overall Study|Withdrawal by Subject|2|||
130022549|NCT01060059|468042727|FG000|Overall Study|Adverse Event|1|||
130022550|NCT01060059|468042728|FG001|Overall Study|Adverse Event|1|||
130022551|NCT01060059|468042727|FG000|Overall Study|Death|2|||
130022552|NCT01060059|468042728|FG001|Overall Study|Death|3|||
130022553|NCT01060059|468042727|FG000|Overall Study|Lost to Follow-up|18|||
130022554|NCT01060059|468042728|FG001|Overall Study|Lost to Follow-up|34|||
130022555|NCT01060059|468042727|FG000|Overall Study|entry criteria not met|4|||
130022556|NCT01060059|468042728|FG001|Overall Study|entry criteria not met|3|||
130022557|NCT01060059|468042727|FG000|Overall Study|Withdrawal by Subject|35|||
130022558|NCT01060059|468042728|FG001|Overall Study|Withdrawal by Subject|23|||
130022559|NCT01060059|468042727|FG000|Overall Study|lack of glycemic control|2|||
130022560|NCT01060059|468042728|FG001|Overall Study|lack of glycemic control|1|||
130022561|NCT01060059|468042727|FG000|Overall Study|lack of compliance|5|||
130022562|NCT01060059|468042728|FG001|Overall Study|lack of compliance|2|||
130022563|NCT01614093|468042729|FG000|Overall Study|Withdrawal by Subject|1|||
130022564|NCT00848354|468042730|FG000|Phase 1|Adverse Event|5|||
130022565|NCT00848354|468042731|FG001|Phase 1|Adverse Event|4|||
130022566|NCT00848354|468042730|FG000|Phase 1|Discontinuation of study by sponsor|2|||
130022567|NCT00848354|468042731|FG001|Phase 1|Discontinuation of study by sponsor|1|||
130022568|NCT00848354|468042730|FG000|Phase 1|Failed to return|0|||
130022569|NCT00848354|468042731|FG001|Phase 1|Failed to return|1|||
130022570|NCT00848354|468042730|FG000|Phase 1|Lost to Follow-up|1|||
130022571|NCT00848354|468042731|FG001|Phase 1|Lost to Follow-up|1|||
130022572|NCT00848354|468042730|FG000|Phase 1|Unspecified Reason|1|||
130022573|NCT00848354|468042731|FG001|Phase 1|Unspecified Reason|1|||
130022574|NCT00848354|468042730|FG000|Phase 1|Protocol Violation|1|||
130022575|NCT00848354|468042731|FG001|Phase 1|Protocol Violation|1|||
130022576|NCT00848354|468042730|FG000|Phase 1|Withdrawal by Subject|2|||
130022577|NCT00848354|468042731|FG001|Phase 1|Withdrawal by Subject|4|||
130022578|NCT00848354|468042730|FG000|Phase 1|Lack of Efficacy|0|||
130022579|NCT00848354|468042731|FG001|Phase 1|Lack of Efficacy|1|||
130022580|NCT00848354|468042730|FG000|Phase 2 Year 1|Adverse Event|7|||
130022581|NCT00848354|468042731|FG001|Phase 2 Year 1|Adverse Event|2|||
130022582|NCT00848354|468042730|FG000|Phase 2 Year 1|Death|1|||
130022583|NCT00848354|468042731|FG001|Phase 2 Year 1|Death|0|||
130022584|NCT00848354|468042730|FG000|Phase 2 Year 1|Failed to Return|1|||
130022585|NCT00848354|468042731|FG001|Phase 2 Year 1|Failed to Return|1|||
130022586|NCT00848354|468042730|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
130022587|NCT00848354|468042731|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
130022588|NCT00848354|468042730|FG000|Phase 2 Year 1|Unspecified Reason|3|||
130022589|NCT00848354|468042731|FG001|Phase 2 Year 1|Unspecified Reason|0|||
130022590|NCT00848354|468042730|FG000|Phase 2 Year 1|Protocol Violation|4|||
130022591|NCT00848354|468042731|FG001|Phase 2 Year 1|Protocol Violation|1|||
130099591|NCT00650806|468322727|FG000|Overall Study|Lost to Follow-up|7|||
130099592|NCT00650806|468322728|FG001|Overall Study|Lost to Follow-up|6|||
130099593|NCT00650806|468322729|FG002|Overall Study|Lost to Follow-up|11|||
130099594|NCT00650806|468322730|FG003|Overall Study|Lost to Follow-up|10|||
130099595|NCT00650806|468322727|FG000|Overall Study|Protocol Violation|0|||
130099596|NCT00650806|468322728|FG001|Overall Study|Protocol Violation|0|||
130099597|NCT00650806|468322729|FG002|Overall Study|Protocol Violation|0|||
130099598|NCT00650806|468322730|FG003|Overall Study|Protocol Violation|1|||
130099599|NCT00650806|468322727|FG000|Overall Study|Pregnancy|0|||
130099600|NCT00650806|468322728|FG001|Overall Study|Pregnancy|0|||
130099601|NCT00650806|468322729|FG002|Overall Study|Pregnancy|0|||
130099602|NCT00650806|468322730|FG003|Overall Study|Pregnancy|1|||
130099603|NCT00650806|468322727|FG000|Overall Study|Withdrawal by Subject|7|||
130099604|NCT00650806|468322728|FG001|Overall Study|Withdrawal by Subject|5|||
130099605|NCT00650806|468322729|FG002|Overall Study|Withdrawal by Subject|8|||
130099606|NCT00650806|468322730|FG003|Overall Study|Withdrawal by Subject|6|||
129884515|NCT02293837|467536435|FG003|Overall Study|Participant ill and could not be infused|0|||
130022592|NCT00848354|468042730|FG000|Phase 2 Year 1|Subject Request|1|||
130022593|NCT00848354|468042731|FG001|Phase 2 Year 1|Subject Request|2|||
130099607|NCT00650806|468322727|FG000|Overall Study|Noncompliance with study drug regimen|1|||
130099608|NCT00650806|468322728|FG001|Overall Study|Noncompliance with study drug regimen|1|||
130099609|NCT00650806|468322729|FG002|Overall Study|Noncompliance with study drug regimen|0|||
130099610|NCT00650806|468322730|FG003|Overall Study|Noncompliance with study drug regimen|0|||
130022594|NCT00848354|468042730|FG000|Phase 2 Year 2|Adverse Event|12|||
130022595|NCT00848354|468042731|FG001|Phase 2 Year 2|Adverse Event|2|||
130022596|NCT00848354|468042730|FG000|Phase 2 Year 2|Death|2|||
130022597|NCT00848354|468042731|FG001|Phase 2 Year 2|Death|0|||
130022598|NCT00848354|468042730|FG000|Phase 2 Year 2|Failed to return|3|||
130228582|NCT00264147|468801652|FG003|Treatment I Period|Adverse Event|5|||
130228583|NCT00264147|468801653|FG004|Treatment I Period|Adverse Event|7|||
130228584|NCT00264147|468801654|FG005|Treatment I Period|Adverse Event|0|||
130228585|NCT00264147|468801649|FG000|Treatment I Period|Laboratory Adverse Event|0|||
130228586|NCT00264147|468801650|FG001|Treatment I Period|Laboratory Adverse Event|0|||
130228587|NCT00264147|468801651|FG002|Treatment I Period|Laboratory Adverse Event|0|||
130228588|NCT00264147|468801652|FG003|Treatment I Period|Laboratory Adverse Event|1|||
130228589|NCT00264147|468801653|FG004|Treatment I Period|Laboratory Adverse Event|0|||
130228590|NCT00264147|468801654|FG005|Treatment I Period|Laboratory Adverse Event|0|||
130228591|NCT00264147|468801649|FG000|Treatment I Period|Lack of Efficacy|6|||
130228592|NCT00264147|468801650|FG001|Treatment I Period|Lack of Efficacy|2|||
130228593|NCT00264147|468801651|FG002|Treatment I Period|Lack of Efficacy|8|||
130228594|NCT00264147|468801652|FG003|Treatment I Period|Lack of Efficacy|0|||
130228595|NCT00264147|468801653|FG004|Treatment I Period|Lack of Efficacy|1|||
130228596|NCT00264147|468801654|FG005|Treatment I Period|Lack of Efficacy|0|||
130228597|NCT00264147|468801649|FG000|Treatment I Period|Lost to Follow-up|1|||
130228598|NCT00264147|468801650|FG001|Treatment I Period|Lost to Follow-up|0|||
130228599|NCT00264147|468801651|FG002|Treatment I Period|Lost to Follow-up|0|||
130228600|NCT00264147|468801652|FG003|Treatment I Period|Lost to Follow-up|1|||
130228601|NCT00264147|468801653|FG004|Treatment I Period|Lost to Follow-up|1|||
130228602|NCT00264147|468801654|FG005|Treatment I Period|Lost to Follow-up|0|||
130228603|NCT00264147|468801649|FG000|Treatment I Period|Protocol Violation|2|||
130228604|NCT00264147|468801650|FG001|Treatment I Period|Protocol Violation|2|||
130228605|NCT00264147|468801651|FG002|Treatment I Period|Protocol Violation|0|||
130228606|NCT00264147|468801652|FG003|Treatment I Period|Protocol Violation|0|||
130228607|NCT00264147|468801653|FG004|Treatment I Period|Protocol Violation|0|||
130228608|NCT00264147|468801654|FG005|Treatment I Period|Protocol Violation|0|||
130022599|NCT00848354|468042731|FG001|Phase 2 Year 2|Failed to return|0|||
130022600|NCT00848354|468042730|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
130022601|NCT00848354|468042731|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
130022602|NCT00848354|468042730|FG000|Phase 2 Year 2|Unspecified Reason|1|||
130022603|NCT00848354|468042731|FG001|Phase 2 Year 2|Unspecified Reason|0|||
130022604|NCT00848354|468042730|FG000|Phase 2 Year 2|Protocol Violation|1|||
130022605|NCT00848354|468042731|FG001|Phase 2 Year 2|Protocol Violation|1|||
130022606|NCT00848354|468042730|FG000|Phase 2 Year 2|Subject Request|1|||
130022607|NCT00848354|468042731|FG001|Phase 2 Year 2|Subject Request|1|||
130022608|NCT00848354|468042730|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
130022609|NCT00848354|468042731|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
130022610|NCT01972074|468042734|FG000|Overall Study|Adverse Event|4|||
130022611|NCT01972074|468042735|FG001|Overall Study|Adverse Event|1|||
130022612|NCT01972074|468042736|FG002|Overall Study|Adverse Event|0|||
130022613|NCT01972074|468042734|FG000|Overall Study|Lack of Efficacy|1|||
130022614|NCT01972074|468042735|FG001|Overall Study|Lack of Efficacy|1|||
130022615|NCT01972074|468042736|FG002|Overall Study|Lack of Efficacy|0|||
130022616|NCT01972074|468042734|FG000|Overall Study|Lost to Follow-up|0|||
130022617|NCT01972074|468042735|FG001|Overall Study|Lost to Follow-up|1|||
130022618|NCT01972074|468042736|FG002|Overall Study|Lost to Follow-up|1|||
130022619|NCT01972074|468042734|FG000|Overall Study|Withdrawal by Subject|1|||
130022620|NCT01972074|468042735|FG001|Overall Study|Withdrawal by Subject|1|||
130022621|NCT01972074|468042736|FG002|Overall Study|Withdrawal by Subject|1|||
130022622|NCT01972074|468042734|FG000|Overall Study|Scanner Unavailable|0|||
130022623|NCT01972074|468042735|FG001|Overall Study|Scanner Unavailable|0|||
130022624|NCT01972074|468042736|FG002|Overall Study|Scanner Unavailable|1|||
130022625|NCT05574062|468042737|FG000|Pre Run-In|Screening failure|3|||
130022626|NCT05574062|468042738|FG001|Pre Run-In|Screening failure|0|||
130022627|NCT05574062|468042739|FG002|Pre Run-In|Screening failure|0|||
130022628|NCT05574062|468042740|FG003|Pre Run-In|Screening failure|0|||
130022629|NCT05574062|468042741|FG004|Pre Run-In|Screening failure|0|||
130022630|NCT05574062|468042737|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
130022631|NCT05574062|468042738|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
130022632|NCT05574062|468042739|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
130228609|NCT00264147|468801649|FG000|Treatment I Period|Withdrawal by Subject|2|||
130228610|NCT00264147|468801650|FG001|Treatment I Period|Withdrawal by Subject|0|||
130228611|NCT00264147|468801651|FG002|Treatment I Period|Withdrawal by Subject|0|||
130228612|NCT00264147|468801652|FG003|Treatment I Period|Withdrawal by Subject|2|||
130228613|NCT00264147|468801653|FG004|Treatment I Period|Withdrawal by Subject|2|||
130228614|NCT00264147|468801654|FG005|Treatment I Period|Withdrawal by Subject|0|||
130228615|NCT00264147|468801649|FG000|Treatment I Period|Patient out of town for an extended time|0|||
130022633|NCT05574062|468042740|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
130022634|NCT05574062|468042741|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
130022635|NCT05574062|468042737|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
130022636|NCT05574062|468042738|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
130022637|NCT05574062|468042739|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
130022638|NCT05574062|468042740|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
130022639|NCT05574062|468042741|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
130022640|NCT05574062|468042737|FG000|Continuation Phase Period 1|Physician Decision|1|||
130022641|NCT05574062|468042738|FG001|Continuation Phase Period 1|Physician Decision|0|||
130022642|NCT05574062|468042739|FG002|Continuation Phase Period 1|Physician Decision|0|||
130022643|NCT05574062|468042740|FG003|Continuation Phase Period 1|Physician Decision|0|||
130022644|NCT05574062|468042741|FG004|Continuation Phase Period 1|Physician Decision|0|||
130022645|NCT05574062|468042737|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
130228616|NCT00264147|468801650|FG001|Treatment I Period|Patient out of town for an extended time|1|||
130022646|NCT05574062|468042738|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
130022647|NCT05574062|468042739|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
130228617|NCT00264147|468801651|FG002|Treatment I Period|Patient out of town for an extended time|0|||
130228618|NCT00264147|468801652|FG003|Treatment I Period|Patient out of town for an extended time|0|||
130228619|NCT00264147|468801653|FG004|Treatment I Period|Patient out of town for an extended time|0|||
130228620|NCT00264147|468801654|FG005|Treatment I Period|Patient out of town for an extended time|0|||
130228621|NCT00264147|468801649|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130022648|NCT05574062|468042740|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
130022649|NCT05574062|468042741|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
130228622|NCT00264147|468801650|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228623|NCT00264147|468801651|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
130228624|NCT00264147|468801652|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228625|NCT00264147|468801653|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228626|NCT00264147|468801654|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
130228627|NCT00264147|468801649|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
130022650|NCT05574062|468042737|FG000|Continuation Phase Period 1|Adverse Event|1|||
130022651|NCT05574062|468042738|FG001|Continuation Phase Period 1|Adverse Event|0|||
130022652|NCT05574062|468042739|FG002|Continuation Phase Period 1|Adverse Event|0|||
130022653|NCT05574062|468042740|FG003|Continuation Phase Period 1|Adverse Event|0|||
130022654|NCT05574062|468042741|FG004|Continuation Phase Period 1|Adverse Event|0|||
130022655|NCT05574062|468042737|FG000|Continuation Phase Period 1|Death|1|||
130099611|NCT00650806|468322727|FG000|Overall Study|Study terminated by sponsor|2|||
130099612|NCT00650806|468322728|FG001|Overall Study|Study terminated by sponsor|3|||
130099613|NCT00650806|468322729|FG002|Overall Study|Study terminated by sponsor|5|||
130099614|NCT00650806|468322730|FG003|Overall Study|Study terminated by sponsor|4|||
130099615|NCT00650806|468322727|FG000|Overall Study|Other|1|||
130099616|NCT00650806|468322728|FG001|Overall Study|Other|1|||
130022656|NCT05574062|468042738|FG001|Continuation Phase Period 1|Death|0|||
130099617|NCT00650806|468322729|FG002|Overall Study|Other|2|||
130099618|NCT00650806|468322730|FG003|Overall Study|Other|0|||
130099619|NCT04456998|468322731|FG000|Overall Study|Adverse Event|0|||
130099620|NCT04456998|468322732|FG001|Overall Study|Adverse Event|4|||
130099621|NCT04456998|468322731|FG000|Overall Study|Protocol Deviation|0|||
130099622|NCT04456998|468322732|FG001|Overall Study|Protocol Deviation|1|||
130099623|NCT04456998|468322731|FG000|Overall Study|Withdrawal by Subject|0|||
130099624|NCT04456998|468322732|FG001|Overall Study|Withdrawal by Subject|1|||
130099625|NCT04882085|468322736|FG000|Overall Study|Death|6|||
130099626|NCT04882085|468322737|FG001|Overall Study|Death|9|||
130099627|NCT04882085|468322736|FG000|Overall Study|Withdrawal by Subject|0|||
130099628|NCT04882085|468322737|FG001|Overall Study|Withdrawal by Subject|3|||
130099629|NCT04882085|468322736|FG000|Overall Study|Randomized not treated|1|||
130099630|NCT04882085|468322737|FG001|Overall Study|Randomized not treated|0|||
130099631|NCT04455620|468322738|FG000|Overall Study|Withdrawal by Subject|0|||
130099632|NCT04455620|468322739|FG001|Overall Study|Withdrawal by Subject|0|||
130099633|NCT04455620|468322740|FG002|Overall Study|Withdrawal by Subject|2|||
130099634|NCT04455620|468322741|FG003|Overall Study|Withdrawal by Subject|0|||
130099635|NCT04455620|468322742|FG004|Overall Study|Withdrawal by Subject|1|||
130022657|NCT05574062|468042739|FG002|Continuation Phase Period 1|Death|0|||
130022658|NCT05574062|468042740|FG003|Continuation Phase Period 1|Death|0|||
130022659|NCT05574062|468042741|FG004|Continuation Phase Period 1|Death|0|||
130022660|NCT05574062|468042737|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
130022661|NCT05574062|468042738|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
130022662|NCT05574062|468042739|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
130022663|NCT05574062|468042740|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
130022664|NCT05574062|468042741|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
130022665|NCT01777581|468042742|FG000|Overall Study|Lost to Follow-up|1|||
130022666|NCT01777581|468042743|FG001|Overall Study|Lost to Follow-up|1|||
130022667|NCT01777581|468042742|FG000|Overall Study|Adverse Event|2|||
130022668|NCT01777581|468042743|FG001|Overall Study|Adverse Event|0|||
130022669|NCT01777581|468042742|FG000|Overall Study|Lack of Efficacy|0|||
130022670|NCT01777581|468042743|FG001|Overall Study|Lack of Efficacy|1|||
130022671|NCT04202679|468042748|FG000|Overall Study|Adverse Event|2|||
130022672|NCT04202679|468042749|FG001|Overall Study|Adverse Event|0|||
130022673|NCT04202679|468042748|FG000|Overall Study|Poor compliance to protocol|1|||
130022674|NCT04202679|468042749|FG001|Overall Study|Poor compliance to protocol|0|||
130022675|NCT04202679|468042748|FG000|Overall Study|Withdrawal by Subject|23|||
130022676|NCT04202679|468042749|FG001|Overall Study|Withdrawal by Subject|6|||
130022677|NCT03864653|468042750|FG000|Overall Study|Withdrawal by Subject|1|||
130022678|NCT00546052|468042753|FG000|Overall Study|Adverse Event|47|||
130022679|NCT00546052|468042753|FG000|Overall Study|Lost to Follow-up|144|||
130022680|NCT00546052|468042753|FG000|Overall Study|Protocol Violation|9|||
130022681|NCT00546052|468042753|FG000|Overall Study|Withdrawal by Subject|20|||
130022682|NCT00546052|468042753|FG000|Overall Study|Non Compliance|7|||
130022683|NCT01928381|468042754|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
130022684|NCT01928381|468042755|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130022685|NCT01928381|468042756|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130022686|NCT01928381|468042757|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130022687|NCT01928381|468042758|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130022688|NCT01928381|468042759|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130022689|NCT01928381|468042760|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
130022690|NCT01928381|468042754|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
130022691|NCT01928381|468042755|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
130022692|NCT01928381|468042756|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
130022693|NCT01928381|468042757|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
130022694|NCT01928381|468042758|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
130022695|NCT01928381|468042759|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
130099636|NCT04455620|468322738|FG000|Overall Study|Lost to Follow-up|0|||
130099637|NCT04455620|468322739|FG001|Overall Study|Lost to Follow-up|0|||
130099638|NCT04455620|468322740|FG002|Overall Study|Lost to Follow-up|1|||
129800234|NCT02891161|467236267|FG001|Follow up|Symptomatic deterioration|1|||
130099639|NCT04455620|468322741|FG003|Overall Study|Lost to Follow-up|1|||
130099640|NCT04455620|468322742|FG004|Overall Study|Lost to Follow-up|0|||
130099641|NCT04455620|468322738|FG000|Overall Study|Death|1|||
130099642|NCT04455620|468322739|FG001|Overall Study|Death|6|||
130099643|NCT04455620|468322740|FG002|Overall Study|Death|20|||
130022696|NCT01928381|468042760|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
130022697|NCT01928381|468042754|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
130022698|NCT01928381|468042755|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
130022699|NCT01928381|468042756|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
130022700|NCT01928381|468042757|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
130022701|NCT01928381|468042758|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
130022702|NCT01928381|468042759|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
130022703|NCT01928381|468042760|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
130022704|NCT01928381|468042754|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
130022705|NCT01928381|468042755|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
130022706|NCT01928381|468042756|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
130022707|NCT01928381|468042757|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
130022708|NCT01928381|468042758|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
130022709|NCT01928381|468042759|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
130022710|NCT01928381|468042760|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
130022711|NCT01928381|468042754|FG000|Part 1 - Pain Training|Protocol Violation|1|||
130022712|NCT01928381|468042755|FG001|Part 1 - Pain Training|Protocol Violation|0|||
130022713|NCT01928381|468042756|FG002|Part 1 - Pain Training|Protocol Violation|0|||
130022714|NCT01928381|468042757|FG003|Part 1 - Pain Training|Protocol Violation|0|||
130022715|NCT01928381|468042758|FG004|Part 1 - Pain Training|Protocol Violation|0|||
130022716|NCT01928381|468042759|FG005|Part 1 - Pain Training|Protocol Violation|0|||
130022717|NCT01928381|468042760|FG006|Part 1 - Pain Training|Protocol Violation|0|||
130022718|NCT01928381|468042754|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
130022719|NCT01928381|468042755|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130022720|NCT01928381|468042756|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130099644|NCT04455620|468322741|FG003|Overall Study|Death|1|||
130022721|NCT01928381|468042757|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130022722|NCT01928381|468042758|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130022723|NCT01928381|468042759|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130022724|NCT01928381|468042760|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
130022725|NCT01928381|468042754|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
130022726|NCT01928381|468042755|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130022727|NCT01928381|468042756|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130022728|NCT01928381|468042757|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130022729|NCT01928381|468042758|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130022730|NCT01928381|468042759|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130022731|NCT01928381|468042760|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
130022732|NCT01928381|468042754|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
130022733|NCT01928381|468042755|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130022734|NCT01928381|468042756|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130022735|NCT01928381|468042757|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130099645|NCT04455620|468322742|FG004|Overall Study|Death|7|||
130099646|NCT04455620|468322738|FG000|Overall Study|Study Termination|0|||
130099647|NCT04455620|468322739|FG001|Overall Study|Study Termination|2|||
130099648|NCT04455620|468322740|FG002|Overall Study|Study Termination|1|||
130099649|NCT04455620|468322741|FG003|Overall Study|Study Termination|0|||
130099650|NCT04455620|468322742|FG004|Overall Study|Study Termination|6|||
130099651|NCT00400985|468322743|FG000|Overall Study|Withdrawal by Subject|5|||
130099652|NCT00400985|468322743|FG000|Overall Study|system modification|8|||
130099653|NCT00400985|468322743|FG000|Overall Study|Death|30|||
130099654|NCT00400985|468322743|FG000|Overall Study|Lost to Follow-up|9|||
130099655|NCT00965562|468322744|FG000|Overall Study|Lost to Follow-up|1|||
130099656|NCT00965562|468322745|FG001|Overall Study|Lost to Follow-up|2|||
130099657|NCT00965562|468322746|FG002|Overall Study|Lost to Follow-up|3|||
130099658|NCT00965562|468322744|FG000|Overall Study|Withdrawal by Subject|2|||
130099659|NCT00965562|468322745|FG001|Overall Study|Withdrawal by Subject|2|||
130099660|NCT00965562|468322746|FG002|Overall Study|Withdrawal by Subject|0|||
130099661|NCT03792633|468322751|FG000|Overall Study|Alternative Treatment|17|||
130099662|NCT03792633|468322752|FG001|Overall Study|Alternative Treatment|19|||
130099663|NCT03792633|468322751|FG000|Overall Study|Death|2|||
130022736|NCT01928381|468042758|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130099664|NCT03792633|468322752|FG001|Overall Study|Death|0|||
130099665|NCT03792633|468322751|FG000|Overall Study|Disease progression|8|||
130099666|NCT03792633|468322752|FG001|Overall Study|Disease progression|9|||
130099667|NCT03792633|468322751|FG000|Overall Study|Lost to Follow-up|1|||
130099668|NCT03792633|468322752|FG001|Overall Study|Lost to Follow-up|1|||
130099669|NCT03792633|468322751|FG000|Overall Study|Screen fail|1|||
130099670|NCT03792633|468322752|FG001|Overall Study|Screen fail|0|||
130099671|NCT03792633|468322751|FG000|Overall Study|Second malignancy|0|||
130099672|NCT03792633|468322752|FG001|Overall Study|Second malignancy|1|||
130099673|NCT03179462|468322755|FG000|Overall Study|screening failure|1|||
130228628|NCT00264147|468801650|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
130228629|NCT00264147|468801651|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
130228630|NCT00264147|468801652|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
130228631|NCT00264147|468801653|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
130228632|NCT00264147|468801654|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
130228633|NCT00264147|468801649|FG000|Treatment II Period|Adverse Event|0|||
130228634|NCT00264147|468801650|FG001|Treatment II Period|Adverse Event|0|||
130228635|NCT00264147|468801651|FG002|Treatment II Period|Adverse Event|0|||
130228636|NCT00264147|468801652|FG003|Treatment II Period|Adverse Event|0|||
130228637|NCT00264147|468801653|FG004|Treatment II Period|Adverse Event|9|||
130228638|NCT00264147|468801654|FG005|Treatment II Period|Adverse Event|9|||
130228639|NCT00264147|468801649|FG000|Treatment II Period|Laboratory Adverse Event|0|||
130228640|NCT00264147|468801650|FG001|Treatment II Period|Laboratory Adverse Event|0|||
130228641|NCT00264147|468801651|FG002|Treatment II Period|Laboratory Adverse Event|0|||
130228642|NCT00264147|468801652|FG003|Treatment II Period|Laboratory Adverse Event|0|||
130228643|NCT00264147|468801653|FG004|Treatment II Period|Laboratory Adverse Event|0|||
130228644|NCT00264147|468801654|FG005|Treatment II Period|Laboratory Adverse Event|1|||
130228645|NCT00264147|468801649|FG000|Treatment II Period|Lack of Efficacy|0|||
130228646|NCT00264147|468801650|FG001|Treatment II Period|Lack of Efficacy|0|||
130228647|NCT00264147|468801651|FG002|Treatment II Period|Lack of Efficacy|0|||
130228648|NCT00264147|468801652|FG003|Treatment II Period|Lack of Efficacy|0|||
130228649|NCT00264147|468801653|FG004|Treatment II Period|Lack of Efficacy|20|||
130228650|NCT00264147|468801654|FG005|Treatment II Period|Lack of Efficacy|19|||
130228651|NCT00264147|468801649|FG000|Treatment II Period|Lost to Follow-up|0|||
130228652|NCT00264147|468801650|FG001|Treatment II Period|Lost to Follow-up|0|||
130228653|NCT00264147|468801651|FG002|Treatment II Period|Lost to Follow-up|0|||
130228654|NCT00264147|468801652|FG003|Treatment II Period|Lost to Follow-up|0|||
130228655|NCT00264147|468801653|FG004|Treatment II Period|Lost to Follow-up|1|||
130228656|NCT00264147|468801654|FG005|Treatment II Period|Lost to Follow-up|1|||
130228657|NCT00264147|468801649|FG000|Treatment II Period|Withdrawal by Subject|0|||
130228658|NCT00264147|468801650|FG001|Treatment II Period|Withdrawal by Subject|0|||
130228659|NCT00264147|468801651|FG002|Treatment II Period|Withdrawal by Subject|0|||
130228660|NCT00264147|468801652|FG003|Treatment II Period|Withdrawal by Subject|0|||
130228661|NCT00264147|468801653|FG004|Treatment II Period|Withdrawal by Subject|3|||
130228662|NCT00264147|468801654|FG005|Treatment II Period|Withdrawal by Subject|2|||
130228663|NCT00264147|468801649|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228664|NCT00264147|468801650|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228665|NCT00264147|468801651|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228666|NCT00264147|468801652|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228667|NCT00264147|468801653|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
130228668|NCT00264147|468801654|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
130228669|NCT03234465|468801655|FG000|Overall Study|Adverse Event|4|||
130228670|NCT03234465|468801656|FG001|Overall Study|Adverse Event|2|||
130228671|NCT03234465|468801655|FG000|Overall Study|Death|0|||
130228672|NCT03234465|468801656|FG001|Overall Study|Death|1|||
130228673|NCT03234465|468801655|FG000|Overall Study|Lost to Follow-up|1|||
130228674|NCT03234465|468801656|FG001|Overall Study|Lost to Follow-up|1|||
130228675|NCT03234465|468801655|FG000|Overall Study|Withdrawal by Subject|12|||
130228676|NCT03234465|468801656|FG001|Overall Study|Withdrawal by Subject|27|||
130228677|NCT03234465|468801655|FG000|Overall Study|Symptomatic deterioration|0|||
130228678|NCT03234465|468801656|FG001|Overall Study|Symptomatic deterioration|1|||
130228679|NCT03234465|468801655|FG000|Overall Study|Non-compliance|2|||
130228680|NCT03234465|468801656|FG001|Overall Study|Non-compliance|0|||
130228681|NCT03234465|468801655|FG000|Overall Study|Other|14|||
130228682|NCT03234465|468801656|FG001|Overall Study|Other|8|||
130228683|NCT00449163|468801657|FG000|Overall Study|Physician Decision|3|||
130228684|NCT03106077|468801658|FG000|Overall Study|Screen Failure|94|||
130228685|NCT03106077|468801659|FG001|Overall Study|Screen Failure|0|||
130228686|NCT00606307|468801662|FG000|Overall Study|Adverse Event|2|||
130228687|NCT00606307|468801662|FG000|Overall Study|Withdrawal by Subject|2|||
130228688|NCT00606307|468801662|FG000|Overall Study|Disease progression|6|||
130228689|NCT00606307|468801662|FG000|Overall Study|QTc prolongation|1|||
130228690|NCT01274533|468801663|FG000|Overall Study|Withdrawal by Subject|1|||
130228691|NCT01274533|468801663|FG000|Overall Study|Non-compliance|1|||
130228692|NCT01274533|468801663|FG000|Overall Study|Disease progression|2|||
129800235|NCT02891161|467236266|FG000|Follow up|Study terminated|0|||
130228693|NCT02008526|468801673|FG000|Overall Study|Death|0|||
130228694|NCT02008526|468801674|FG001|Overall Study|Death|2|||
130228695|NCT02008526|468801675|FG002|Overall Study|Death|1|||
130228696|NCT02008526|468801673|FG000|Overall Study|Withdrawal by Subject|3|||
130228697|NCT02008526|468801674|FG001|Overall Study|Withdrawal by Subject|3|||
130228698|NCT02008526|468801675|FG002|Overall Study|Withdrawal by Subject|2|||
130228699|NCT02008526|468801673|FG000|Overall Study|Lost to Follow-up|5|||
130228700|NCT02008526|468801674|FG001|Overall Study|Lost to Follow-up|9|||
130228701|NCT02008526|468801675|FG002|Overall Study|Lost to Follow-up|6|||
130228702|NCT01118052|468801676|FG000|Overall Study|Never treated|2|||
130228703|NCT02949947|468801677|FG000|Overall Study|Non Compliance|0|||
130228704|NCT02949947|468801678|FG001|Overall Study|Non Compliance|1|||
130228705|NCT02949947|468801677|FG000|Overall Study|Insurance change|1|||
130228706|NCT02949947|468801678|FG001|Overall Study|Insurance change|0|||
130228707|NCT00828711|468801680|FG000|Overall Study|Lost to Follow-up|1|||
130228708|NCT00828711|468801681|FG001|Overall Study|Lost to Follow-up|0|||
130228709|NCT00828711|468801682|FG002|Overall Study|Lost to Follow-up|0|||
130228710|NCT01618968|468801683|FG000|Overall Study|Adverse Event|1|||
130228711|NCT01618968|468801684|FG001|Overall Study|Adverse Event|0|||
130228712|NCT01618968|468801685|FG002|Overall Study|Adverse Event|0|||
130228713|NCT01618968|468801686|FG003|Overall Study|Adverse Event|0|||
130228714|NCT01618968|468801683|FG000|Overall Study|Death|0|||
130228715|NCT01618968|468801684|FG001|Overall Study|Death|0|||
130228716|NCT01618968|468801685|FG002|Overall Study|Death|0|||
130228717|NCT01618968|468801686|FG003|Overall Study|Death|1|||
130228718|NCT02230891|468801687|FG000|Baseline|Did not meet inclusion|0|||
130228719|NCT02230891|468801688|FG001|Baseline|Did not meet inclusion|1|||
130228720|NCT02230891|468801689|FG002|Baseline|Did not meet inclusion|1|||
130228721|NCT02230891|468801687|FG000|2 Week|Withdrawal by Subject|2|||
130228722|NCT02230891|468801688|FG001|2 Week|Withdrawal by Subject|2|||
130228723|NCT02230891|468801689|FG002|2 Week|Withdrawal by Subject|0|||
130228724|NCT02230891|468801687|FG000|2 Week|Consent withdrawn|1|||
130228725|NCT02230891|468801688|FG001|2 Week|Consent withdrawn|0|||
130228726|NCT02230891|468801689|FG002|2 Week|Consent withdrawn|0|||
130228727|NCT02230891|468801687|FG000|6 Month|Withdrawal by Subject|1|||
130228728|NCT02230891|468801688|FG001|6 Month|Withdrawal by Subject|1|||
130228729|NCT02230891|468801689|FG002|6 Month|Withdrawal by Subject|1|||
130228730|NCT02230891|468801687|FG000|6 Month|Physician Decision|0|||
130228731|NCT02230891|468801688|FG001|6 Month|Physician Decision|2|||
130228732|NCT02230891|468801689|FG002|6 Month|Physician Decision|0|||
130228733|NCT02230891|468801687|FG000|12 Month|Death|1|||
130228734|NCT02230891|468801688|FG001|12 Month|Death|0|||
130228735|NCT02230891|468801689|FG002|12 Month|Death|0|||
130228736|NCT02230891|468801687|FG000|12 Month|Lost to Follow-up|0|||
130228737|NCT02230891|468801688|FG001|12 Month|Lost to Follow-up|1|||
130228738|NCT02230891|468801689|FG002|12 Month|Lost to Follow-up|0|||
130228739|NCT02230891|468801687|FG000|12 Month|Withdrawal by Subject|0|||
130228740|NCT02230891|468801688|FG001|12 Month|Withdrawal by Subject|2|||
130228741|NCT02230891|468801689|FG002|12 Month|Withdrawal by Subject|0|||
130228742|NCT02230891|468801687|FG000|18 Month End of Study|Death|0|||
130228743|NCT02230891|468801688|FG001|18 Month End of Study|Death|0|||
130228744|NCT02230891|468801689|FG002|18 Month End of Study|Death|1|||
130228745|NCT02230891|468801687|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
130228746|NCT02230891|468801688|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
130228747|NCT02230891|468801689|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
130228748|NCT02370511|468801692|FG000|Overall Study|Death|10|||
130228749|NCT02370511|468801693|FG001|Overall Study|Death|7|||
130228750|NCT02370511|468801694|FG002|Overall Study|Death|1|||
130228751|NCT02370511|468801692|FG000|Overall Study|Withdrawal by Subject|2|||
130228752|NCT02370511|468801693|FG001|Overall Study|Withdrawal by Subject|0|||
130228753|NCT02370511|468801694|FG002|Overall Study|Withdrawal by Subject|0|||
130228754|NCT02370511|468801692|FG000|Overall Study|Lost to Follow-up|0|||
130228755|NCT02370511|468801693|FG001|Overall Study|Lost to Follow-up|4|||
130228756|NCT02370511|468801694|FG002|Overall Study|Lost to Follow-up|0|||
130228757|NCT03882918|468801702|FG000|Overall Study|Study terminated by sponsor|98|||
130228758|NCT03882918|468801702|FG000|Overall Study|Protocol Violation|1|||
130228759|NCT03882918|468801702|FG000|Overall Study|Other|9|||
130228760|NCT03882918|468801702|FG000|Overall Study|Lack of Efficacy|14|||
130228761|NCT03882918|468801702|FG000|Overall Study|Adverse Event|13|||
130228762|NCT03882918|468801702|FG000|Overall Study|Withdrawal by Subject|5|||
130228763|NCT02100124|468801708|FG000|Overall Study|Lost to Follow-up|5|||
130228764|NCT02100124|468801709|FG001|Overall Study|Lost to Follow-up|11|||
130228765|NCT02100124|468801710|FG002|Overall Study|Lost to Follow-up|3|||
130228766|NCT02100124|468801708|FG000|Overall Study|Withdrawal by Subject|1|||
130228767|NCT02100124|468801709|FG001|Overall Study|Withdrawal by Subject|0|||
130228768|NCT02100124|468801710|FG002|Overall Study|Withdrawal by Subject|0|||
130228769|NCT00870727|468803588|FG000|Overall Study|Lost to Follow-up|0|||
130228770|NCT00870727|468803589|FG001|Overall Study|Lost to Follow-up|1|||
130228771|NCT00870727|468803588|FG000|Overall Study|Lack of Efficacy|1|||
130228772|NCT00870727|468803589|FG001|Overall Study|Lack of Efficacy|3|||
130228773|NCT00870727|468803588|FG000|Overall Study|Adverse Event|0|||
130228774|NCT00870727|468803589|FG001|Overall Study|Adverse Event|1|||
130228775|NCT01384877|468803593|FG000|Treatment 2|Lost to Follow-up|2|||
130228776|NCT01384877|468803594|FG001|Treatment 2|Lost to Follow-up|2|||
130228777|NCT03630393|468803595|FG000|Overall Study|Death|1|||
130228778|NCT03630393|468803596|FG001|Overall Study|Death|0|||
130228779|NCT00408499|468803597|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228780|NCT00408499|468803598|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228781|NCT00408499|468803599|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
130228782|NCT00408499|468803600|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228783|NCT00408499|468803601|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
130228784|NCT00408499|468803597|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
130228785|NCT00408499|468803598|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
130228786|NCT00408499|468803599|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130228787|NCT00408499|468803600|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130228788|NCT00408499|468803601|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
130228789|NCT00408499|468803597|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
130228790|NCT00408499|468803598|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
130228791|NCT00408499|468803599|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130228792|NCT00408499|468803600|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130228793|NCT00408499|468803601|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
130228794|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Adverse Event|0|||
130228795|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Adverse Event|0|||
130228796|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Adverse Event|0|||
130228797|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Adverse Event|0|||
130228798|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Adverse Event|9|||
130228799|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Death|0|||
130228800|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Death|0|||
130228801|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Death|0|||
130228802|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Death|0|||
130228803|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Death|2|||
130228804|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Physician Decision|0|||
130228805|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Physician Decision|0|||
130228806|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Physician Decision|0|||
130228807|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Physician Decision|0|||
130228808|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Physician Decision|1|||
130228809|NCT00408499|468803597|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228810|NCT00408499|468803598|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228811|NCT00408499|468803599|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228812|NCT00408499|468803600|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
130228813|NCT00408499|468803601|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
130228814|NCT00408499|468803597|FG000|Phase II- MTD Expansion|treatment delay|0|||
130228815|NCT00408499|468803598|FG001|Phase II- MTD Expansion|treatment delay|0|||
130228816|NCT00408499|468803599|FG002|Phase II- MTD Expansion|treatment delay|0|||
130228817|NCT00408499|468803600|FG003|Phase II- MTD Expansion|treatment delay|0|||
130228818|NCT00408499|468803601|FG004|Phase II- MTD Expansion|treatment delay|3|||
130228819|NCT01586195|468803602|FG000|Overall Study|Death|11|||
130228820|NCT01586195|468803602|FG000|Overall Study|Withdrawal of Consent|5|||
130228821|NCT01586195|468803602|FG000|Overall Study|Started new anti-melanoma therapy|1|||
130228822|NCT01586195|468803602|FG000|Overall Study|Reason not specified|9|||
130228823|NCT00997334|468803603|FG000|Overall Study|still on therapy|12|||
130228824|NCT00997334|468803603|FG000|Overall Study|Adverse Event|3|||
130022737|NCT01928381|468042759|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130022738|NCT01928381|468042760|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
130022739|NCT01928381|468042754|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
130022740|NCT01928381|468042755|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130022741|NCT01928381|468042756|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130022742|NCT01928381|468042757|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130022743|NCT01928381|468042758|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130228825|NCT00997334|468803603|FG000|Overall Study|Patient non-compliance|1|||
130228826|NCT00997334|468803603|FG000|Overall Study|Withdrawal by Subject|3|||
130228827|NCT00997334|468803603|FG000|Overall Study|Death|2|||
130228828|NCT00997334|468803603|FG000|Overall Study|Urgent Palliative Care|2|||
130228829|NCT00997334|468803603|FG000|Overall Study|No lesion amenable|1|||
130228830|NCT00997334|468803603|FG000|Overall Study|Ineligible|1|||
130228831|NCT04745351|468803615|FG000|Overall Study|Death|51|||
130228832|NCT04745351|468803616|FG001|Overall Study|Death|25|||
130228833|NCT04745351|468803615|FG000|Overall Study|Lost to Follow-up|9|||
130228834|NCT04745351|468803616|FG001|Overall Study|Lost to Follow-up|3|||
130228835|NCT04745351|468803615|FG000|Overall Study|Randomized but Never Treated|3|||
130228836|NCT04745351|468803616|FG001|Overall Study|Randomized but Never Treated|3|||
130228837|NCT04745351|468803615|FG000|Overall Study|Adverse Event|4|||
130228838|NCT04745351|468803616|FG001|Overall Study|Adverse Event|0|||
130228839|NCT04745351|468803615|FG000|Overall Study|Withdrew Consent|1|||
130228840|NCT04745351|468803616|FG001|Overall Study|Withdrew Consent|2|||
130228841|NCT04745351|468803615|FG000|Overall Study|Investigator's Discretion|2|||
130228842|NCT04745351|468803616|FG001|Overall Study|Investigator's Discretion|0|||
130228843|NCT04745351|468803615|FG000|Overall Study|Protocol Violation|1|||
130228844|NCT04745351|468803616|FG001|Overall Study|Protocol Violation|0|||
130228845|NCT01863771|468803619|FG000|Induction Phase|Adverse Event|9|||
130228846|NCT01863771|468803620|FG001|Induction Phase|Adverse Event|0|||
130228847|NCT01863771|468803621|FG002|Induction Phase|Adverse Event|0|||
130228848|NCT01863771|468803622|FG003|Induction Phase|Adverse Event|0|||
130228849|NCT01863771|468803619|FG000|Induction Phase|Lack of Efficacy|10|||
130228850|NCT01863771|468803620|FG001|Induction Phase|Lack of Efficacy|0|||
130228851|NCT01863771|468803621|FG002|Induction Phase|Lack of Efficacy|0|||
130228852|NCT01863771|468803622|FG003|Induction Phase|Lack of Efficacy|0|||
130228853|NCT01863771|468803619|FG000|Induction Phase|Withdrawal by Subject|2|||
130228854|NCT01863771|468803620|FG001|Induction Phase|Withdrawal by Subject|0|||
130228855|NCT01863771|468803621|FG002|Induction Phase|Withdrawal by Subject|0|||
130228856|NCT01863771|468803622|FG003|Induction Phase|Withdrawal by Subject|0|||
130228857|NCT01863771|468803619|FG000|Maintenance Phase|Adverse Event|0|||
130228858|NCT01863771|468803620|FG001|Maintenance Phase|Adverse Event|0|||
130228859|NCT01863771|468803621|FG002|Maintenance Phase|Adverse Event|1|||
130228860|NCT01863771|468803622|FG003|Maintenance Phase|Adverse Event|1|||
130228861|NCT01863771|468803619|FG000|Maintenance Phase|Lack of Efficacy|0|||
130228862|NCT01863771|468803620|FG001|Maintenance Phase|Lack of Efficacy|3|||
130228863|NCT01863771|468803621|FG002|Maintenance Phase|Lack of Efficacy|7|||
130228864|NCT01863771|468803622|FG003|Maintenance Phase|Lack of Efficacy|38|||
130228865|NCT01863771|468803619|FG000|Maintenance Phase|Physician Decision|0|||
130228866|NCT01863771|468803620|FG001|Maintenance Phase|Physician Decision|0|||
130228867|NCT01863771|468803621|FG002|Maintenance Phase|Physician Decision|2|||
130228868|NCT01863771|468803622|FG003|Maintenance Phase|Physician Decision|1|||
130228869|NCT01863771|468803619|FG000|Maintenance Phase|Pregnancy|0|||
130228870|NCT01863771|468803620|FG001|Maintenance Phase|Pregnancy|1|||
130228871|NCT01863771|468803621|FG002|Maintenance Phase|Pregnancy|0|||
130228872|NCT01863771|468803622|FG003|Maintenance Phase|Pregnancy|0|||
130228873|NCT01863771|468803619|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130228874|NCT01863771|468803620|FG001|Maintenance Phase|Withdrawal by Subject|1|||
130228875|NCT01863771|468803621|FG002|Maintenance Phase|Withdrawal by Subject|2|||
130099674|NCT03179462|468322756|FG001|Overall Study|screening failure|2|||
130099675|NCT03179462|468322757|FG002|Overall Study|screening failure|0|||
130099676|NCT04636437|468322758|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
130099677|NCT04636437|468322759|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
130099678|NCT04636437|468322760|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
130099679|NCT04636437|468322758|FG000|Overall Study|Started weight loss drug/program|2|||
130099680|NCT04636437|468322759|FG001|Overall Study|Started weight loss drug/program|1|||
130099681|NCT04636437|468322760|FG002|Overall Study|Started weight loss drug/program|1|||
130099682|NCT04636437|468322758|FG000|Overall Study|Lost to Follow-up|3|||
130099683|NCT04636437|468322759|FG001|Overall Study|Lost to Follow-up|1|||
130228876|NCT01863771|468803622|FG003|Maintenance Phase|Withdrawal by Subject|3|||
130228877|NCT01248455|468803627|FG000|Overall Study|switched to alternate treatment|1|||
130228878|NCT00426270|468803628|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
130228879|NCT00426270|468803628|FG000|Overall Study|Adverse Event|5|||
130228880|NCT01117870|468803630|FG000|Overall Study|Inability to place needle|1|||
130228881|NCT01117870|468803631|FG001|Overall Study|Inability to place needle|0|||
130228882|NCT03102762|468803632|FG000|Overall Study|Lost to Follow-up|1|||
130228883|NCT03102762|468803633|FG001|Overall Study|Lost to Follow-up|0|||
130099684|NCT04636437|468322760|FG002|Overall Study|Lost to Follow-up|4|||
130228884|NCT00958074|468803634|FG000|Overall Study|Withdrawal by Subject|0|||
130228885|NCT00958074|468803635|FG001|Overall Study|Withdrawal by Subject|1|||
130228886|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
130228887|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130099685|NCT04636437|468322758|FG000|Overall Study|Participant or physician decision|3|||
130228888|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130228889|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130228890|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
130228891|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
130228892|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228893|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228894|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228895|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
130228896|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
130228897|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228898|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228899|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228900|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
130228901|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
130228902|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228903|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228904|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228905|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
130228906|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
130228907|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228908|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228909|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228910|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
130228911|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
130228912|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228913|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228914|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228915|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
130228916|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
130228917|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228918|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228919|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228920|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
130228921|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
130228922|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228923|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228924|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228925|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
130228926|NCT02709746|468803636|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
130228927|NCT02709746|468803637|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228928|NCT02709746|468803638|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228929|NCT02709746|468803639|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228930|NCT02709746|468803640|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
130228931|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130228932|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
130228933|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130228934|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
130228935|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
130228936|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
130228937|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
130228938|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
130228939|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
130228940|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
130228941|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
130228942|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
130228943|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
130228944|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
130228945|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
130228946|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
130228947|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
130228948|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
130228949|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
130228950|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
130022744|NCT01928381|468042759|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130228951|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
130228952|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
130228953|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
130228954|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
130228955|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
130228956|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
130228957|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130228958|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130228959|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
130228960|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
130228961|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228962|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228963|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
130228964|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228965|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
130228966|NCT02709746|468803636|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
130228967|NCT02709746|468803637|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
130228968|NCT02709746|468803638|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
130228969|NCT02709746|468803639|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
130228970|NCT02709746|468803640|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
130228971|NCT03426345|468803650|FG000|Overall Study|Adverse Event|4|||
130228972|NCT03426345|468803651|FG001|Overall Study|Adverse Event|4|||
130228973|NCT03426345|468803650|FG000|Overall Study|Lack of Efficacy|1|||
130228974|NCT03426345|468803651|FG001|Overall Study|Lack of Efficacy|0|||
130228975|NCT03426345|468803650|FG000|Overall Study|Withdrawal by Subject|5|||
130228976|NCT03426345|468803651|FG001|Overall Study|Withdrawal by Subject|6|||
130228977|NCT03426345|468803650|FG000|Overall Study|Lost to Follow-up|3|||
130228978|NCT03426345|468803651|FG001|Overall Study|Lost to Follow-up|1|||
130228979|NCT03426345|468803650|FG000|Overall Study|Protocol Deviation|3|||
130228980|NCT03426345|468803651|FG001|Overall Study|Protocol Deviation|4|||
130228981|NCT03426345|468803650|FG000|Overall Study|Reason Not Specified|1|||
130228982|NCT03426345|468803651|FG001|Overall Study|Reason Not Specified|2|||
130228983|NCT03426345|468803650|FG000|Overall Study|Missing Completion Status|1|||
130228984|NCT03426345|468803651|FG001|Overall Study|Missing Completion Status|0|||
130228985|NCT02446691|468803652|FG000|Overall Study|Withdrawal by Subject|2|||
130228986|NCT02446691|468803652|FG000|Overall Study|Lost to Follow-up|8|||
130228987|NCT02446691|468803652|FG000|Overall Study|Protocol Violation|1|||
130228988|NCT02497469|468803653|FG000|Overall Study|Randomized but not Treated|0|||
130228989|NCT02497469|468803654|FG001|Overall Study|Randomized but not Treated|2|||
130228990|NCT02497469|468803653|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
130228991|NCT02497469|468803654|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
130228992|NCT02497469|468803653|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
130228993|NCT02497469|468803654|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
130228994|NCT02497469|468803653|FG000|Overall Study|Significant Protocol Deviation|4|||
130228995|NCT02497469|468803654|FG001|Overall Study|Significant Protocol Deviation|5|||
130228996|NCT02497469|468803653|FG000|Overall Study|Lost to Follow-up|14|||
130228997|NCT02497469|468803654|FG001|Overall Study|Lost to Follow-up|4|||
130228998|NCT02497469|468803653|FG000|Overall Study|Voluntary Withdrawal|39|||
130228999|NCT02497469|468803654|FG001|Overall Study|Voluntary Withdrawal|41|||
130229000|NCT02497469|468803653|FG000|Overall Study|Pregnancy|1|||
130229001|NCT02497469|468803654|FG001|Overall Study|Pregnancy|1|||
130229002|NCT02497469|468803653|FG000|Overall Study|Lack of Efficacy|86|||
130229003|NCT02497469|468803654|FG001|Overall Study|Lack of Efficacy|40|||
130229004|NCT02497469|468803653|FG000|Overall Study|Reason not Specified|6|||
130229005|NCT02497469|468803654|FG001|Overall Study|Reason not Specified|6|||
130229006|NCT01026493|468803656|FG000|Overall Study|Protocol Violation|0|||
130229007|NCT01026493|468803657|FG001|Overall Study|Protocol Violation|1|||
130229008|NCT01026493|468803658|FG002|Overall Study|Protocol Violation|0|||
130229009|NCT01026493|468803659|FG003|Overall Study|Protocol Violation|0|||
130229010|NCT01026493|468803660|FG004|Overall Study|Protocol Violation|2|||
130229011|NCT01026493|468803661|FG005|Overall Study|Protocol Violation|3|||
130229012|NCT01026493|468803662|FG006|Overall Study|Protocol Violation|4|||
130229013|NCT01026493|468803663|FG007|Overall Study|Protocol Violation|1|||
130229014|NCT00630916|468803667|FG000|Overall Study|Death|110|||
130229015|NCT00630916|468803667|FG000|Overall Study|Explant|8|||
130229016|NCT00630916|468803667|FG000|Overall Study|Lost to Follow-up|5|||
130229017|NCT00630916|468803667|FG000|Overall Study|Withdrawal by Subject|30|||
130229018|NCT00630916|468803667|FG000|Overall Study|Protocol Violation|7|||
130229019|NCT00630916|468803667|FG000|Overall Study|Physician Decision|47|||
130229020|NCT00630916|468803667|FG000|Overall Study|Lack of Efficacy|3|||
130229021|NCT02295644|468803674|FG000|Overall Study|Did not meet inclusion criterion|0|||
130229022|NCT02295644|468803675|FG001|Overall Study|Did not meet inclusion criterion|0|||
130229023|NCT02295644|468803676|FG002|Overall Study|Did not meet inclusion criterion|1|||
130229024|NCT02295644|468803677|FG003|Overall Study|Did not meet inclusion criterion|2|||
130229025|NCT00324155|468803678|FG000|Enrolled and Randomized|No longer met study criteria|3|||
130229026|NCT00324155|468803679|FG001|Enrolled and Randomized|No longer met study criteria|0|||
130229027|NCT00324155|468803678|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
130229028|NCT00324155|468803679|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
130229029|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
130229030|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
130229031|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
130229032|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
130229033|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Death|8|||
130229034|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Death|15|||
130229035|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
130229036|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
130022745|NCT01928381|468042760|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
130022746|NCT01928381|468042754|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
130022747|NCT01928381|468042755|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
130022748|NCT01928381|468042756|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
130022749|NCT01928381|468042757|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
130022750|NCT01928381|468042758|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
130022751|NCT01928381|468042759|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
130022752|NCT01928381|468042760|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
130022753|NCT01928381|468042754|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130022754|NCT01928381|468042755|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130022755|NCT01928381|468042756|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
130022756|NCT01928381|468042757|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130022757|NCT01928381|468042758|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130022758|NCT01928381|468042759|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130022759|NCT01928381|468042760|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
130022760|NCT01928381|468042754|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
130022761|NCT01928381|468042755|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
130022762|NCT01928381|468042756|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
130022763|NCT01928381|468042757|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
130022764|NCT01928381|468042758|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
130022765|NCT01928381|468042759|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
130022766|NCT01928381|468042760|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
130022767|NCT01928381|468042754|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
130022768|NCT01928381|468042755|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
130022769|NCT01928381|468042756|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
130022770|NCT01928381|468042757|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
130022771|NCT01928381|468042758|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
130022772|NCT01928381|468042759|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
130022773|NCT01928381|468042760|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
130022774|NCT01928381|468042754|FG000|Washout First Intervention|Protocol Violation|0|||
130229037|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
130022775|NCT01928381|468042755|FG001|Washout First Intervention|Protocol Violation|0|||
130022776|NCT01928381|468042756|FG002|Washout First Intervention|Protocol Violation|0|||
130229038|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
130229039|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
130229040|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
130229041|NCT00324155|468803678|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
130229042|NCT00324155|468803679|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
130229043|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
130229044|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
130229045|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
130229046|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
130229047|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
130229048|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
130229049|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
130229050|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
130229051|NCT00324155|468803678|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
130229052|NCT00324155|468803679|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
130229053|NCT00324155|468803678|FG000|Follow-up Phase|On-going participants still on drug|11|||
130229054|NCT00324155|468803679|FG001|Follow-up Phase|On-going participants still on drug|6|||
130229055|NCT05412134|468803680|FG000|Overall Study|Lost to Follow-up|2|||
130229056|NCT05412134|468803681|FG001|Overall Study|Lost to Follow-up|0|||
130229057|NCT03167242|468803682|FG000|Overall Study|Patient/Guardian Decision|0|||
130229058|NCT03167242|468803683|FG001|Overall Study|Patient/Guardian Decision|1|||
130229059|NCT03167242|468803684|FG002|Overall Study|Patient/Guardian Decision|2|||
130229060|NCT03167242|468803685|FG003|Overall Study|Patient/Guardian Decision|1|||
130229061|NCT03167242|468803686|FG004|Overall Study|Patient/Guardian Decision|1|||
130229062|NCT03167242|468803687|FG005|Overall Study|Patient/Guardian Decision|1|||
130229063|NCT03167242|468803688|FG006|Overall Study|Patient/Guardian Decision|0|||
130229064|NCT03167242|468803689|FG007|Overall Study|Patient/Guardian Decision|0|||
130229065|NCT03167242|468803690|FG008|Overall Study|Patient/Guardian Decision|0|||
130229066|NCT03167242|468803691|FG009|Overall Study|Patient/Guardian Decision|0|||
130229067|NCT03167242|468803692|FG010|Overall Study|Patient/Guardian Decision|1|||
130229068|NCT03167242|468803693|FG011|Overall Study|Patient/Guardian Decision|0|||
130229069|NCT03167242|468803682|FG000|Overall Study|Lost to Follow-up|0|||
130229070|NCT03167242|468803683|FG001|Overall Study|Lost to Follow-up|0|||
130229071|NCT03167242|468803684|FG002|Overall Study|Lost to Follow-up|1|||
130229072|NCT03167242|468803685|FG003|Overall Study|Lost to Follow-up|0|||
130229073|NCT03167242|468803686|FG004|Overall Study|Lost to Follow-up|0|||
130229074|NCT03167242|468803687|FG005|Overall Study|Lost to Follow-up|1|||
130229075|NCT03167242|468803688|FG006|Overall Study|Lost to Follow-up|2|||
130229076|NCT03167242|468803689|FG007|Overall Study|Lost to Follow-up|1|||
130229077|NCT03167242|468803690|FG008|Overall Study|Lost to Follow-up|0|||
130229078|NCT03167242|468803691|FG009|Overall Study|Lost to Follow-up|0|||
130229079|NCT03167242|468803692|FG010|Overall Study|Lost to Follow-up|1|||
130229080|NCT03167242|468803693|FG011|Overall Study|Lost to Follow-up|1|||
130229081|NCT03167242|468803682|FG000|Overall Study|Reason not provided|0|||
130229082|NCT03167242|468803683|FG001|Overall Study|Reason not provided|0|||
130229083|NCT03167242|468803684|FG002|Overall Study|Reason not provided|0|||
130229084|NCT03167242|468803685|FG003|Overall Study|Reason not provided|0|||
130229085|NCT03167242|468803686|FG004|Overall Study|Reason not provided|0|||
130229086|NCT03167242|468803687|FG005|Overall Study|Reason not provided|0|||
130229087|NCT03167242|468803688|FG006|Overall Study|Reason not provided|0|||
130229088|NCT03167242|468803689|FG007|Overall Study|Reason not provided|0|||
130229089|NCT03167242|468803690|FG008|Overall Study|Reason not provided|1|||
130229090|NCT03167242|468803691|FG009|Overall Study|Reason not provided|0|||
130229091|NCT03167242|468803692|FG010|Overall Study|Reason not provided|0|||
130229092|NCT03167242|468803693|FG011|Overall Study|Reason not provided|0|||
130229093|NCT05401565|468803698|FG000|Overall Study|Lost to Follow-up|1|||
130229094|NCT05401565|468803699|FG001|Overall Study|Lost to Follow-up|0|||
130229095|NCT05401565|468803698|FG000|Overall Study|Adverse Event|2|||
130229096|NCT05401565|468803699|FG001|Overall Study|Adverse Event|0|||
130229097|NCT00726609|468803702|FG000|Overall Study|Adverse Event|10|||
130229098|NCT00726609|468803702|FG000|Overall Study|Withdrawal by Subject|2|||
130229099|NCT00726609|468803702|FG000|Overall Study|Lack of Efficacy|25|||
130229100|NCT00726609|468803702|FG000|Overall Study|Other|16|||
130229101|NCT00726609|468803702|FG000|Overall Study|Missing|42|||
130229102|NCT00726609|468803702|FG000|Overall Study|Other|3|||
130229103|NCT03080935|468803712|FG000|Overall Study|Death|34|||
130229104|NCT03080935|468803713|FG001|Overall Study|Death|50|||
130229105|NCT03080935|468803712|FG000|Overall Study|Lost to Follow-up|5|||
130229106|NCT03080935|468803713|FG001|Overall Study|Lost to Follow-up|4|||
130229107|NCT03080935|468803712|FG000|Overall Study|Withdrawal by Subject|11|||
130229108|NCT03080935|468803713|FG001|Overall Study|Withdrawal by Subject|15|||
130229109|NCT02175121|468803714|FG000|Overall Study|Lack of Efficacy|1|||
130229110|NCT02175121|468803715|FG001|Overall Study|Lack of Efficacy|0|||
130229111|NCT02175121|468803716|FG002|Overall Study|Lack of Efficacy|0|||
130229112|NCT02175121|468803717|FG003|Overall Study|Lack of Efficacy|0|||
130229113|NCT02175121|468803718|FG004|Overall Study|Lack of Efficacy|0|||
130229114|NCT02175121|468803714|FG000|Overall Study|Lost to Follow-up|0|||
130229115|NCT02175121|468803715|FG001|Overall Study|Lost to Follow-up|1|||
130229116|NCT02175121|468803716|FG002|Overall Study|Lost to Follow-up|0|||
130229117|NCT02175121|468803717|FG003|Overall Study|Lost to Follow-up|1|||
130229118|NCT02175121|468803718|FG004|Overall Study|Lost to Follow-up|0|||
130229119|NCT02175121|468803714|FG000|Overall Study|Personal emergency|0|||
130229120|NCT02175121|468803715|FG001|Overall Study|Personal emergency|0|||
130229121|NCT02175121|468803716|FG002|Overall Study|Personal emergency|0|||
130229122|NCT02175121|468803717|FG003|Overall Study|Personal emergency|0|||
130229123|NCT02175121|468803718|FG004|Overall Study|Personal emergency|1|||
130229124|NCT02175121|468803714|FG000|Overall Study|Schedule conflict|0|||
130229125|NCT02175121|468803715|FG001|Overall Study|Schedule conflict|0|||
130229126|NCT02175121|468803716|FG002|Overall Study|Schedule conflict|1|||
130229127|NCT02175121|468803717|FG003|Overall Study|Schedule conflict|0|||
130229128|NCT02175121|468803718|FG004|Overall Study|Schedule conflict|0|||
130229129|NCT02175121|468803714|FG000|Overall Study|Time issues|0|||
130229130|NCT02175121|468803715|FG001|Overall Study|Time issues|0|||
130229131|NCT02175121|468803716|FG002|Overall Study|Time issues|1|||
130229132|NCT02175121|468803717|FG003|Overall Study|Time issues|0|||
130229133|NCT02175121|468803718|FG004|Overall Study|Time issues|0|||
130229134|NCT03329885|468803719|FG000|Overall Study|Sponsor discontinued the study early|0|||
130229135|NCT03329885|468803720|FG001|Overall Study|Sponsor discontinued the study early|0|||
130229136|NCT03329885|468803721|FG002|Overall Study|Sponsor discontinued the study early|0|||
130229137|NCT03329885|468803722|FG003|Overall Study|Sponsor discontinued the study early|0|||
130229138|NCT03329885|468803723|FG004|Overall Study|Sponsor discontinued the study early|0|||
130229139|NCT03329885|468803724|FG005|Overall Study|Sponsor discontinued the study early|0|||
130229140|NCT03329885|468803725|FG006|Overall Study|Sponsor discontinued the study early|1|||
129884516|NCT04779242|467536436|FG000|Overall Study|Adverse Event|1|||
130229141|NCT03329885|468803726|FG007|Overall Study|Sponsor discontinued the study early|1|||
130229142|NCT03329885|468803727|FG008|Overall Study|Sponsor discontinued the study early|0|||
130229143|NCT00269152|468803734|FG000|Overall Study|Adverse Event|9|||
130229144|NCT00269152|468803735|FG001|Overall Study|Adverse Event|3|||
130229145|NCT00269152|468803734|FG000|Overall Study|Withdrawal by Subject|7|||
130229146|NCT00269152|468803735|FG001|Overall Study|Withdrawal by Subject|3|||
130229147|NCT00269152|468803734|FG000|Overall Study|Physician Decision|2|||
130229148|NCT00269152|468803735|FG001|Overall Study|Physician Decision|3|||
130229149|NCT00269152|468803734|FG000|Overall Study|Protocol Violation|0|||
130229150|NCT00269152|468803735|FG001|Overall Study|Protocol Violation|1|||
130229151|NCT03886272|468803736|FG000|Period 1|Withdrawal by Subject|0|||
130229152|NCT03886272|468803737|FG001|Period 1|Withdrawal by Subject|0|||
130229153|NCT03886272|468803738|FG002|Period 1|Withdrawal by Subject|0|||
130229154|NCT03886272|468803739|FG003|Period 1|Withdrawal by Subject|0|||
130229155|NCT03886272|468803740|FG004|Period 1|Withdrawal by Subject|0|||
130229156|NCT03886272|468803741|FG005|Period 1|Withdrawal by Subject|1|||
130229157|NCT03886272|468803742|FG006|Period 1|Withdrawal by Subject|0|||
130229158|NCT02557399|468803743|FG000|Overall Study|Adverse Event|6|||
130229159|NCT02557399|468803744|FG001|Overall Study|Adverse Event|5|||
130229160|NCT02557399|468803743|FG000|Overall Study|Protocol Violation|0|||
130229161|NCT02557399|468803744|FG001|Overall Study|Protocol Violation|1|||
130229162|NCT02557399|468803743|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130229163|NCT02557399|468803744|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130229164|NCT02557399|468803743|FG000|Overall Study|Withdrawal by Subject|1|||
130229165|NCT02557399|468803744|FG001|Overall Study|Withdrawal by Subject|1|||
130229166|NCT00931632|468803745|FG000|Overall Study|Withdrawal by Subject|2|||
130229167|NCT00931632|468803746|FG001|Overall Study|Withdrawal by Subject|3|||
130229168|NCT00931632|468803745|FG000|Overall Study|Adverse Event|19|||
130229169|NCT00931632|468803746|FG001|Overall Study|Adverse Event|15|||
130229170|NCT01687218|468803749|FG000|Overall Study|Withdrawal by Subject|2|||
130229171|NCT01687218|468803750|FG001|Overall Study|Withdrawal by Subject|3|||
130229172|NCT01687218|468803751|FG002|Overall Study|Withdrawal by Subject|0|||
130229173|NCT01687218|468803752|FG003|Overall Study|Withdrawal by Subject|1|||
130229174|NCT01687218|468803753|FG004|Overall Study|Withdrawal by Subject|1|||
130229175|NCT01687218|468803754|FG005|Overall Study|Withdrawal by Subject|0|||
130229176|NCT01687218|468803749|FG000|Overall Study|Relocated, no follow-up planned|1|||
130229177|NCT01687218|468803750|FG001|Overall Study|Relocated, no follow-up planned|0|||
130229178|NCT01687218|468803751|FG002|Overall Study|Relocated, no follow-up planned|1|||
130229179|NCT01687218|468803752|FG003|Overall Study|Relocated, no follow-up planned|1|||
130229180|NCT01687218|468803753|FG004|Overall Study|Relocated, no follow-up planned|0|||
130229181|NCT01687218|468803754|FG005|Overall Study|Relocated, no follow-up planned|0|||
130229182|NCT03139552|468803760|FG000|Overall Study|unable to attend tasting due to schedule|3|||
130229183|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
130229184|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
130229185|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
130229186|NCT03368807|468803769|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
130229187|NCT01973218|468803770|FG000|Overall Study|Adverse Event|1|||
130229188|NCT01973218|468803771|FG001|Overall Study|Adverse Event|0|||
130229189|NCT01973218|468803770|FG000|Overall Study|Withdrawal by Subject|1|||
130229190|NCT01973218|468803771|FG001|Overall Study|Withdrawal by Subject|0|||
130229191|NCT02247466|468803772|FG000|Overall Study|Procedure changed to open surgery|0|||
130229192|NCT02247466|468803773|FG001|Overall Study|Procedure changed to open surgery|3|||
130229193|NCT02033759|468803776|FG000|Overall Study|Withdrawal by Subject|2|||
130229194|NCT02033759|468803777|FG001|Overall Study|Withdrawal by Subject|1|||
130229195|NCT02033759|468803776|FG000|Overall Study|Protocol Violation|1|||
130229196|NCT02033759|468803777|FG001|Overall Study|Protocol Violation|1|||
130229197|NCT04356937|468803780|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
130229198|NCT04356937|468803781|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
130229199|NCT03533751|468803782|FG000|Overall Study|Withdrawal by Subject|12|||
130022777|NCT01928381|468042757|FG003|Washout First Intervention|Protocol Violation|0|||
130022778|NCT01928381|468042758|FG004|Washout First Intervention|Protocol Violation|1|||
130022779|NCT01928381|468042759|FG005|Washout First Intervention|Protocol Violation|0|||
130022780|NCT01928381|468042760|FG006|Washout First Intervention|Protocol Violation|0|||
130229200|NCT03533751|468803783|FG001|Overall Study|Withdrawal by Subject|6|||
130229201|NCT03533751|468803784|FG002|Overall Study|Withdrawal by Subject|11|||
130229202|NCT03533751|468803785|FG003|Overall Study|Withdrawal by Subject|9|||
130229203|NCT03533751|468803786|FG004|Overall Study|Withdrawal by Subject|10|||
130229204|NCT03533751|468803782|FG000|Overall Study|Adverse Event|4|||
130229205|NCT03533751|468803783|FG001|Overall Study|Adverse Event|7|||
130229206|NCT03533751|468803784|FG002|Overall Study|Adverse Event|2|||
130229207|NCT03533751|468803785|FG003|Overall Study|Adverse Event|4|||
130229208|NCT03533751|468803786|FG004|Overall Study|Adverse Event|5|||
130229209|NCT03533751|468803782|FG000|Overall Study|Physician Decision|0|||
130229210|NCT03533751|468803783|FG001|Overall Study|Physician Decision|2|||
130229211|NCT03533751|468803784|FG002|Overall Study|Physician Decision|1|||
130229212|NCT03533751|468803785|FG003|Overall Study|Physician Decision|2|||
130229213|NCT03533751|468803786|FG004|Overall Study|Physician Decision|1|||
130229214|NCT03533751|468803782|FG000|Overall Study|Sponsor Decision|0|||
130229215|NCT03533751|468803783|FG001|Overall Study|Sponsor Decision|0|||
130229216|NCT03533751|468803784|FG002|Overall Study|Sponsor Decision|1|||
130229217|NCT03533751|468803785|FG003|Overall Study|Sponsor Decision|1|||
130229218|NCT03533751|468803786|FG004|Overall Study|Sponsor Decision|0|||
130229219|NCT03533751|468803782|FG000|Overall Study|Lost to Follow-up|3|||
130229220|NCT03533751|468803783|FG001|Overall Study|Lost to Follow-up|7|||
130229221|NCT03533751|468803784|FG002|Overall Study|Lost to Follow-up|6|||
130229222|NCT03533751|468803785|FG003|Overall Study|Lost to Follow-up|4|||
130229223|NCT03533751|468803786|FG004|Overall Study|Lost to Follow-up|3|||
130229224|NCT03533751|468803782|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
130229225|NCT03533751|468803783|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
130229226|NCT03533751|468803784|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
130229227|NCT03533751|468803785|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
130229228|NCT03533751|468803786|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
130229229|NCT03533751|468803782|FG000|Overall Study|Other|0|||
130229230|NCT03533751|468803783|FG001|Overall Study|Other|2|||
130229231|NCT03533751|468803784|FG002|Overall Study|Other|1|||
130229232|NCT03533751|468803785|FG003|Overall Study|Other|0|||
130229233|NCT03533751|468803786|FG004|Overall Study|Other|3|||
130229234|NCT05117060|468803787|FG000|Overall Study|Adverse Event|3|||
130229235|NCT05117060|468803788|FG001|Overall Study|Adverse Event|5|||
130229236|NCT05117060|468803789|FG002|Overall Study|Adverse Event|6|||
130229237|NCT05117060|468803790|FG003|Overall Study|Adverse Event|1|||
130229238|NCT05117060|468803787|FG000|Overall Study|Lost to Follow-up|0|||
130229239|NCT05117060|468803788|FG001|Overall Study|Lost to Follow-up|0|||
130229240|NCT05117060|468803789|FG002|Overall Study|Lost to Follow-up|0|||
130229241|NCT05117060|468803790|FG003|Overall Study|Lost to Follow-up|1|||
130229242|NCT05117060|468803787|FG000|Overall Study|Lack of Efficacy|4|||
130229243|NCT05117060|468803788|FG001|Overall Study|Lack of Efficacy|5|||
130229244|NCT05117060|468803789|FG002|Overall Study|Lack of Efficacy|2|||
130229245|NCT05117060|468803790|FG003|Overall Study|Lack of Efficacy|6|||
130229246|NCT05117060|468803787|FG000|Overall Study|Withdrawal by Subject|8|||
130229247|NCT05117060|468803788|FG001|Overall Study|Withdrawal by Subject|5|||
130229248|NCT05117060|468803789|FG002|Overall Study|Withdrawal by Subject|5|||
130229249|NCT05117060|468803790|FG003|Overall Study|Withdrawal by Subject|6|||
130229250|NCT05117060|468803787|FG000|Overall Study|Other|2|||
130022781|NCT01928381|468042754|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
130022782|NCT01928381|468042755|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
130022783|NCT01928381|468042756|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
130022784|NCT01928381|468042757|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
130229251|NCT05117060|468803788|FG001|Overall Study|Other|1|||
130229252|NCT05117060|468803789|FG002|Overall Study|Other|3|||
130229253|NCT05117060|468803790|FG003|Overall Study|Other|1|||
130229254|NCT01419535|468803791|FG000|Overall Study|could not maintain iv line|1|||
130229255|NCT01419535|468803792|FG001|Overall Study|could not maintain iv line|1|||
130229256|NCT01419535|468803791|FG000|Overall Study|Withdrawal by Subject|0|||
130229257|NCT01419535|468803792|FG001|Overall Study|Withdrawal by Subject|1|||
130229258|NCT02873689|468805844|FG000|Overall Study|Lack of Efficacy|1|||
130229259|NCT02873689|468805845|FG001|Overall Study|Lack of Efficacy|0|||
130022785|NCT01928381|468042758|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
130022786|NCT01928381|468042759|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
130022787|NCT01928381|468042760|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
130022788|NCT01928381|468042754|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
130022789|NCT01928381|468042755|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
130022790|NCT01928381|468042756|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
130022791|NCT01928381|468042757|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
130022792|NCT01928381|468042758|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
130022793|NCT01928381|468042759|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
130022794|NCT01928381|468042760|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
130022795|NCT03406897|468042762|FG000|Overall Study|Lost to Follow-up|1|||
130022796|NCT03406897|468042763|FG001|Overall Study|Lost to Follow-up|2|||
130022797|NCT03406897|468042762|FG000|Overall Study|Withdrawal by Subject|4|||
130022798|NCT03406897|468042763|FG001|Overall Study|Withdrawal by Subject|4|||
130022799|NCT03406897|468042762|FG000|Overall Study|Physician Decision|0|||
130022800|NCT03406897|468042763|FG001|Overall Study|Physician Decision|1|||
130022801|NCT04441905|468044959|FG000|Overall Study|Lost to Follow-up|1|||
130022802|NCT04441905|468044960|FG001|Overall Study|Lost to Follow-up|0|||
130022803|NCT04441905|468044961|FG002|Overall Study|Lost to Follow-up|0|||
130022804|NCT04441905|468044962|FG003|Overall Study|Lost to Follow-up|0|||
130022805|NCT04441905|468044963|FG004|Overall Study|Lost to Follow-up|0|||
130022806|NCT04441905|468044964|FG005|Overall Study|Lost to Follow-up|0|||
130022807|NCT04441905|468044959|FG000|Overall Study|Enrolled but treatment not administered|0|||
130022808|NCT04441905|468044960|FG001|Overall Study|Enrolled but treatment not administered|1|||
130022809|NCT04441905|468044961|FG002|Overall Study|Enrolled but treatment not administered|0|||
130022810|NCT04441905|468044962|FG003|Overall Study|Enrolled but treatment not administered|0|||
130022811|NCT04441905|468044963|FG004|Overall Study|Enrolled but treatment not administered|0|||
130022812|NCT04441905|468044964|FG005|Overall Study|Enrolled but treatment not administered|0|||
130022813|NCT04441905|468044959|FG000|Overall Study|Became ineligible after enrollment|0|||
130022814|NCT04441905|468044960|FG001|Overall Study|Became ineligible after enrollment|0|||
130022815|NCT04441905|468044961|FG002|Overall Study|Became ineligible after enrollment|0|||
130022816|NCT04441905|468044962|FG003|Overall Study|Became ineligible after enrollment|0|||
130022817|NCT04441905|468044963|FG004|Overall Study|Became ineligible after enrollment|1|||
130022818|NCT04441905|468044964|FG005|Overall Study|Became ineligible after enrollment|0|||
130022819|NCT04770753|468044965|FG000|Overall Study|Randomized, never treated|1|||
130022820|NCT04770753|468044966|FG001|Overall Study|Randomized, never treated|1|||
130022821|NCT04770753|468044965|FG000|Overall Study|Withdrawal by Subject|3|||
130022822|NCT04770753|468044966|FG001|Overall Study|Withdrawal by Subject|1|||
130022823|NCT04770753|468044965|FG000|Overall Study|Adverse Event|2|||
130022824|NCT04770753|468044966|FG001|Overall Study|Adverse Event|0|||
130022825|NCT04770753|468044965|FG000|Overall Study|Pregnancy|1|||
130022826|NCT04770753|468044966|FG001|Overall Study|Pregnancy|0|||
130022827|NCT04770753|468044965|FG000|Overall Study|Other un-specified|1|||
130022828|NCT04770753|468044966|FG001|Overall Study|Other un-specified|0|||
130022829|NCT02775851|468044967|FG000|Overall Study|Adverse Event|1|||
130022830|NCT02775851|468044968|FG001|Overall Study|Adverse Event|10|||
130022831|NCT02775851|468044967|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
130022832|NCT02775851|468044968|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
130022833|NCT02775851|468044967|FG000|Overall Study|Progression/Relapse|0|||
130022834|NCT02775851|468044968|FG001|Overall Study|Progression/Relapse|4|||
130022835|NCT02775851|468044967|FG000|Overall Study|Other - Not Protocol Specified|0|||
130022836|NCT02775851|468044968|FG001|Overall Study|Other - Not Protocol Specified|7|||
130022837|NCT02775851|468044967|FG000|Overall Study|Withdrawal by Subject|1|||
130022838|NCT02775851|468044968|FG001|Overall Study|Withdrawal by Subject|0|||
130022839|NCT01934140|468044970|FG000|Persistence Phase (Year 6-10)|Other|24|||
130022840|NCT01934140|468044971|FG001|Persistence Phase (Year 6-10)|Other|6|||
130022841|NCT01934140|468044970|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
130022842|NCT01934140|468044971|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
130022843|NCT01934140|468044970|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
130022844|NCT01934140|468044971|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
130099686|NCT04636437|468322759|FG001|Overall Study|Participant or physician decision|1|||
130099687|NCT04636437|468322760|FG002|Overall Study|Participant or physician decision|1|||
130229260|NCT02873689|468805844|FG000|Overall Study|Withdrawal by Subject|2|||
130229261|NCT02873689|468805845|FG001|Overall Study|Withdrawal by Subject|2|||
130229262|NCT02873689|468805844|FG000|Overall Study|Protocol Violation|1|||
130022845|NCT01934140|468044970|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
130099688|NCT00816166|468322761|FG000|Overall Study|Lost to Follow-up|6|||
130022846|NCT01934140|468044971|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
130022847|NCT01934140|468044970|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
130099689|NCT00816166|468322762|FG001|Overall Study|Lost to Follow-up|10|||
130229263|NCT02873689|468805845|FG001|Overall Study|Protocol Violation|0|||
130022848|NCT01934140|468044971|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
130022849|NCT01934140|468044970|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
130022850|NCT01934140|468044971|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
130022851|NCT01934140|468044970|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
130022852|NCT01934140|468044971|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
130022853|NCT01934140|468044970|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
130022854|NCT01934140|468044971|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
130022855|NCT00618748|468044977|FG000|Overall Study|Adverse Event|4|||
130022856|NCT00618748|468044978|FG001|Overall Study|Adverse Event|3|||
130022857|NCT00618748|468044979|FG002|Overall Study|Adverse Event|8|||
130022858|NCT00618748|468044977|FG000|Overall Study|Physician Decision|3|||
130022859|NCT00618748|468044978|FG001|Overall Study|Physician Decision|1|||
130022860|NCT00618748|468044979|FG002|Overall Study|Physician Decision|1|||
130022861|NCT00618748|468044977|FG000|Overall Study|Withdrawal by Subject|4|||
130022862|NCT00618748|468044978|FG001|Overall Study|Withdrawal by Subject|1|||
130022863|NCT00618748|468044979|FG002|Overall Study|Withdrawal by Subject|5|||
130022864|NCT00200850|468044984|FG000|Overall Study|relocation|1|||
130022865|NCT00200850|468044985|FG001|Overall Study|relocation|0|||
130022866|NCT00200850|468044986|FG002|Overall Study|relocation|1|||
130022867|NCT00200850|468044984|FG000|Overall Study|too busy|1|||
130022868|NCT00200850|468044985|FG001|Overall Study|too busy|0|||
130022869|NCT00200850|468044986|FG002|Overall Study|too busy|0|||
130022870|NCT00200850|468044984|FG000|Overall Study|Pregnancy|0|||
130022871|NCT00200850|468044985|FG001|Overall Study|Pregnancy|0|||
130022872|NCT00200850|468044986|FG002|Overall Study|Pregnancy|1|||
130022873|NCT00200850|468044984|FG000|Overall Study|Poor adherence|0|||
130022874|NCT00200850|468044985|FG001|Overall Study|Poor adherence|0|||
130022875|NCT00200850|468044986|FG002|Overall Study|Poor adherence|1|||
130022876|NCT00200850|468044984|FG000|Overall Study|optic neuritis|0|||
130022877|NCT00200850|468044985|FG001|Overall Study|optic neuritis|0|||
130022878|NCT00200850|468044986|FG002|Overall Study|optic neuritis|1|||
130022879|NCT00200850|468044984|FG000|Overall Study|Adverse Event|1|||
130022880|NCT00200850|468044985|FG001|Overall Study|Adverse Event|1|||
130022881|NCT00200850|468044986|FG002|Overall Study|Adverse Event|2|||
130022882|NCT02595879|468044987|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
130022883|NCT02595879|468044988|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
130022884|NCT04294459|468044989|FG000|Overall Study|Adverse Event|0|||
130022885|NCT04294459|468044990|FG001|Overall Study|Adverse Event|1|||
130022886|NCT01534676|468044991|FG000|Overall Study|Study closed due to poor enrollment|2|||
130022887|NCT01534676|468044992|FG001|Overall Study|Study closed due to poor enrollment|1|||
130022888|NCT02908880|468044994|FG000|Overall Study|Lost to Follow-up|4|||
130022889|NCT02908880|468044994|FG000|Overall Study|Explantation of the device|1|||
130022890|NCT02908880|468044994|FG000|Overall Study|Withdrawal by Subject|17|||
130022891|NCT02908880|468044994|FG000|Overall Study|Death|5|||
130022892|NCT02421887|468044995|FG000|Overall Study|Lost to Follow-up|5|||
130022893|NCT02421887|468044996|FG001|Overall Study|Lost to Follow-up|0|||
130022894|NCT02421887|468044995|FG000|Overall Study|Withdrawal by Subject|8|||
130022895|NCT02421887|468044996|FG001|Overall Study|Withdrawal by Subject|5|||
130022896|NCT02421887|468044995|FG000|Overall Study|Physician Decision|2|||
130022897|NCT02421887|468044996|FG001|Overall Study|Physician Decision|4|||
130022898|NCT02421887|468044995|FG000|Overall Study|Adverse Event|2|||
130022899|NCT02421887|468044996|FG001|Overall Study|Adverse Event|0|||
130022900|NCT03946670|468045002|FG000|Overall Study|Progressive Disease|26|||
130022901|NCT03946670|468045003|FG001|Overall Study|Progressive Disease|23|||
130022902|NCT03946670|468045002|FG000|Overall Study|Adverse Event|7|||
130022903|NCT03946670|468045003|FG001|Overall Study|Adverse Event|9|||
130022904|NCT03946670|468045002|FG000|Overall Study|Death|5|||
130022905|NCT03946670|468045003|FG001|Overall Study|Death|6|||
130022906|NCT03946670|468045002|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
130022907|NCT03946670|468045003|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
130022908|NCT03946670|468045002|FG000|Overall Study|Subject Decision|4|||
130022909|NCT03946670|468045003|FG001|Overall Study|Subject Decision|4|||
130022910|NCT03946670|468045002|FG000|Overall Study|Physician Decision|3|||
130022911|NCT03946670|468045003|FG001|Overall Study|Physician Decision|3|||
130022912|NCT03946670|468045002|FG000|Overall Study|New Therapy for Study Indication|1|||
130022913|NCT03946670|468045003|FG001|Overall Study|New Therapy for Study Indication|0|||
130022914|NCT03946670|468045002|FG000|Overall Study|Not treated|1|||
130022915|NCT03946670|468045003|FG001|Overall Study|Not treated|1|||
130022916|NCT03083886|468045004|FG000|Overall Study|Withdrawal by Subject|51|||
130229264|NCT02873689|468805844|FG000|Overall Study|Adverse Event|2|||
130229265|NCT02873689|468805845|FG001|Overall Study|Adverse Event|2|||
130229266|NCT02873689|468805844|FG000|Overall Study|Randomized but not Treated|1|||
130229267|NCT02873689|468805845|FG001|Overall Study|Randomized but not Treated|1|||
130229268|NCT00350545|468805846|FG000|Overall Study|Withdrawal by Subject|2|||
130229269|NCT00720278|468805853|FG000|Overall Study|Adverse Event|5|||
130229270|NCT00720278|468805854|FG001|Overall Study|Adverse Event|3|||
130229271|NCT00720278|468805855|FG002|Overall Study|Adverse Event|4|||
130229272|NCT00720278|468805853|FG000|Overall Study|Withdrawal by Subject|0|||
130229273|NCT00720278|468805854|FG001|Overall Study|Withdrawal by Subject|1|||
130229274|NCT00720278|468805855|FG002|Overall Study|Withdrawal by Subject|0|||
130229275|NCT00720278|468805853|FG000|Overall Study|Lost to Follow-up|0|||
130229276|NCT00720278|468805854|FG001|Overall Study|Lost to Follow-up|0|||
130229277|NCT00720278|468805855|FG002|Overall Study|Lost to Follow-up|1|||
130229278|NCT00720278|468805853|FG000|Overall Study|Non-compliance|1|||
130229279|NCT00720278|468805854|FG001|Overall Study|Non-compliance|0|||
130229280|NCT00720278|468805855|FG002|Overall Study|Non-compliance|0|||
130229281|NCT00720278|468805853|FG000|Overall Study|eligibility criteria violation|1|||
130229282|NCT00720278|468805854|FG001|Overall Study|eligibility criteria violation|0|||
130229283|NCT00720278|468805855|FG002|Overall Study|eligibility criteria violation|1|||
130229284|NCT00368251|468805858|FG000|Overall Study|SAE, non-fatal|1|||
130229285|NCT00368251|468805859|FG001|Overall Study|SAE, non-fatal|0|||
130229286|NCT00368251|468805860|FG002|Overall Study|SAE, non-fatal|0|||
130229287|NCT00368251|468805858|FG000|Overall Study|AE, non-serious non-fatal|0|||
130229288|NCT00368251|468805859|FG001|Overall Study|AE, non-serious non-fatal|0|||
129884517|NCT04779242|467536437|FG001|Overall Study|Adverse Event|1|||
129884518|NCT04779242|467536436|FG000|Overall Study|Lost to Follow-up|2|||
130229289|NCT00368251|468805860|FG002|Overall Study|AE, non-serious non-fatal|1|||
130229290|NCT03312738|468805861|FG000|Overall Study|Progressive disease|58|||
130229291|NCT03312738|468805862|FG001|Overall Study|Progressive disease|67|||
130229292|NCT03312738|468805861|FG000|Overall Study|Patient/guardian decision|13|||
130229293|NCT03312738|468805862|FG001|Overall Study|Patient/guardian decision|5|||
130229294|NCT03312738|468805861|FG000|Overall Study|Adverse Event|5|||
130229295|NCT03312738|468805862|FG001|Overall Study|Adverse Event|3|||
130229296|NCT03312738|468805861|FG000|Overall Study|Protocol deviation|2|||
130229297|NCT03312738|468805862|FG001|Overall Study|Protocol deviation|0|||
130229298|NCT03312738|468805861|FG000|Overall Study|Technical problems|0|||
130229299|NCT03312738|468805862|FG001|Overall Study|Technical problems|1|||
130229300|NCT03312738|468805861|FG000|Overall Study|Physician Decision|2|||
130229301|NCT03312738|468805862|FG001|Overall Study|Physician Decision|3|||
130229302|NCT02466399|468805866|FG000|Overall Study|Adverse Event|1|||
130229303|NCT02466399|468805867|FG001|Overall Study|Adverse Event|0|||
130229304|NCT02466399|468805866|FG000|Overall Study|Early exit due to family emergency|1|||
130229305|NCT02466399|468805867|FG001|Overall Study|Early exit due to family emergency|0|||
130229306|NCT00607893|468805868|FG000|Overall Study|Lost to Follow-up|4|||
130229307|NCT00607893|468805869|FG001|Overall Study|Lost to Follow-up|0|||
130229308|NCT00607893|468805868|FG000|Overall Study|withdrew due to loss of interest|0|||
130229309|NCT00607893|468805869|FG001|Overall Study|withdrew due to loss of interest|1|||
130229310|NCT00607893|468805868|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
130229311|NCT00607893|468805869|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
130229312|NCT00607893|468805868|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
130229313|NCT00607893|468805869|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
130229314|NCT00607893|468805868|FG000|Overall Study|Declined to be treated|1|||
130229315|NCT00607893|468805869|FG001|Overall Study|Declined to be treated|0|||
130229316|NCT00607893|468805868|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
130229317|NCT00607893|468805869|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
130229318|NCT02669849|468805870|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130229319|NCT02669849|468805871|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130229320|NCT02669849|468805872|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130229321|NCT02669849|468805870|FG000|Overall Study|Lost to Follow-up|1|||
130229322|NCT02669849|468805871|FG001|Overall Study|Lost to Follow-up|0|||
130229323|NCT02669849|468805872|FG002|Overall Study|Lost to Follow-up|3|||
130229324|NCT02669849|468805870|FG000|Overall Study|Death|1|||
130229325|NCT02669849|468805871|FG001|Overall Study|Death|1|||
130229326|NCT02669849|468805872|FG002|Overall Study|Death|2|||
130229327|NCT02669849|468805870|FG000|Overall Study|Study terminated by sponsor|16|||
130229328|NCT02669849|468805871|FG001|Overall Study|Study terminated by sponsor|1|||
130229329|NCT02669849|468805872|FG002|Overall Study|Study terminated by sponsor|14|||
130229330|NCT02669849|468805870|FG000|Overall Study|Other|0|||
130022917|NCT03083886|468045005|FG001|Overall Study|Withdrawal by Subject|73|||
130022918|NCT03083886|468045006|FG002|Overall Study|Withdrawal by Subject|104|||
130022919|NCT03083886|468045004|FG000|Overall Study|Missing Baseline data|43|||
130229331|NCT02669849|468805871|FG001|Overall Study|Other|0|||
130229332|NCT02669849|468805872|FG002|Overall Study|Other|2|||
130229333|NCT03408899|468805873|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
130229334|NCT00606008|468805874|FG000|Overall Study|Adverse Event|1|||
130229335|NCT00606008|468805874|FG000|Overall Study|Withdrawal by Subject|4|||
130022920|NCT03083886|468045005|FG001|Overall Study|Missing Baseline data|42|||
130022921|NCT03083886|468045006|FG002|Overall Study|Missing Baseline data|31|||
130022922|NCT03083886|468045004|FG000|Overall Study|Investigator terminated|1|||
130022923|NCT03083886|468045005|FG001|Overall Study|Investigator terminated|6|||
130022924|NCT03083886|468045006|FG002|Overall Study|Investigator terminated|3|||
130022925|NCT04161495|468045007|FG000|Overall Study|Withdrawal by Subject|3|||
130022926|NCT04161495|468045008|FG001|Overall Study|Withdrawal by Subject|0|||
130022927|NCT04161495|468045007|FG000|Overall Study|Protocol Violation|1|||
130022928|NCT04161495|468045008|FG001|Overall Study|Protocol Violation|0|||
130022929|NCT04161495|468045007|FG000|Overall Study|Prohibited concomitant medication|3|||
130022930|NCT04161495|468045008|FG001|Overall Study|Prohibited concomitant medication|0|||
130022931|NCT04161495|468045007|FG000|Overall Study|Adverse Event|1|||
130022932|NCT04161495|468045008|FG001|Overall Study|Adverse Event|0|||
130022933|NCT04161495|468045007|FG000|Overall Study|Other - Unspecified|1|||
130022934|NCT04161495|468045008|FG001|Overall Study|Other - Unspecified|0|||
130022935|NCT04161495|468045007|FG000|Overall Study|Death|0|||
130022936|NCT04161495|468045008|FG001|Overall Study|Death|1|||
130022937|NCT03655756|468045009|FG000|Overall Study|Death|1|||
130022938|NCT02062658|468045010|FG000|Overall Study|Withdrawal by Subject|1|||
130022939|NCT02062658|468045010|FG000|Overall Study|Lack of Efficacy|1|||
130022940|NCT02161562|468045011|FG000|Overall Study|Withdrawal by Subject|5|||
130022941|NCT02161562|468045012|FG001|Overall Study|Withdrawal by Subject|8|||
130022942|NCT02161562|468045011|FG000|Overall Study|Protocol Violation|9|||
130022943|NCT02161562|468045012|FG001|Overall Study|Protocol Violation|4|||
130022944|NCT02161562|468045011|FG000|Overall Study|Pregnancy|1|||
130022945|NCT02161562|468045012|FG001|Overall Study|Pregnancy|2|||
130022946|NCT02161562|468045011|FG000|Overall Study|Lost to Follow-up|3|||
130022947|NCT02161562|468045012|FG001|Overall Study|Lost to Follow-up|1|||
130022948|NCT02161562|468045011|FG000|Overall Study|Lack of Efficacy|4|||
130022949|NCT02161562|468045012|FG001|Overall Study|Lack of Efficacy|1|||
130022950|NCT02161562|468045011|FG000|Overall Study|Adverse Event|1|||
130022951|NCT02161562|468045012|FG001|Overall Study|Adverse Event|1|||
130022952|NCT02161562|468045011|FG000|Overall Study|Participant moved back to home country|1|||
130022953|NCT02161562|468045012|FG001|Overall Study|Participant moved back to home country|0|||
130022954|NCT02161562|468045011|FG000|Overall Study|Withdrew due to being out of the country|1|||
130022955|NCT02161562|468045012|FG001|Overall Study|Withdrew due to being out of the country|0|||
130022956|NCT02161562|468045011|FG000|Overall Study|Participant moved out of province|1|||
130022957|NCT02161562|468045012|FG001|Overall Study|Participant moved out of province|0|||
130022958|NCT02475655|468045013|FG000|Overall Study|Lost to Follow-up|0|||
130022959|NCT02475655|468045014|FG001|Overall Study|Lost to Follow-up|1|||
130022960|NCT00643994|468045016|FG000|Overall Study|Death|24|||
130022961|NCT00643994|468045016|FG000|Overall Study|Lost to Follow-up|72|||
130022962|NCT00257010|468045035|FG000|Overall Study|Lack of Efficacy|11|||
130022963|NCT00257010|468045035|FG000|Overall Study|Lost to Follow-up|53|||
130022964|NCT00257010|468045035|FG000|Overall Study|Withdrawal by Subject|34|||
130022965|NCT00257010|468045035|FG000|Overall Study|Adverse Event|10|||
130022966|NCT00257010|468045035|FG000|Overall Study|various|11|||
130022967|NCT00257010|468045035|FG000|Overall Study|no headache reported|9|||
130022968|NCT00323557|468045036|FG000|Overall Study|Physician Decision|1|||
130022969|NCT00323557|468045037|FG001|Overall Study|Physician Decision|0|||
130022970|NCT00197054|468045038|FG000|Overall Study|Withdrawal by Subject|9|||
130022971|NCT00197054|468045039|FG001|Overall Study|Withdrawal by Subject|3|||
130022972|NCT00197054|468045040|FG002|Overall Study|Withdrawal by Subject|3|||
130022973|NCT00197054|468045038|FG000|Overall Study|Moved from area|7|||
130022974|NCT00197054|468045039|FG001|Overall Study|Moved from area|14|||
130022975|NCT00197054|468045040|FG002|Overall Study|Moved from area|9|||
130022976|NCT00197054|468045038|FG000|Overall Study|Lost to Follow-up|1|||
130022977|NCT00197054|468045039|FG001|Overall Study|Lost to Follow-up|4|||
130022978|NCT00197054|468045040|FG002|Overall Study|Lost to Follow-up|0|||
130022979|NCT02450578|468045043|FG000|Overall Study|ECG abnormality so not treated|1|||
130022980|NCT02450578|468045044|FG001|Overall Study|ECG abnormality so not treated|0|||
130022981|NCT02450578|468045045|FG002|Overall Study|ECG abnormality so not treated|0|||
130022982|NCT02450578|468045046|FG003|Overall Study|ECG abnormality so not treated|0|||
130022983|NCT00662792|468045047|FG000|Period 1|Personal Reasons|0|||
130022984|NCT00662792|468045048|FG001|Period 1|Personal Reasons|0|||
130229336|NCT02014272|468805878|FG000|Intervention Period 1|Withdrawal by Subject|1|||
130229337|NCT02014272|468805879|FG001|Intervention Period 1|Withdrawal by Subject|0|||
130229338|NCT02014272|468805878|FG000|Intervention Period 1|Adverse Event|0|||
130229339|NCT02014272|468805879|FG001|Intervention Period 1|Adverse Event|1|||
130229340|NCT03499795|468805880|FG000|Overall Study|Adverse Event|1|||
130229341|NCT03499795|468805880|FG000|Overall Study|Lost to Follow-up|1|||
130229342|NCT03636256|468805881|FG000|Overall Study|Lost to Follow-up|3|||
130229343|NCT03636256|468805882|FG001|Overall Study|Lost to Follow-up|0|||
130229344|NCT03636256|468805883|FG002|Overall Study|Lost to Follow-up|2|||
130229345|NCT03636256|468805884|FG003|Overall Study|Lost to Follow-up|1|||
130229346|NCT03636256|468805885|FG004|Overall Study|Lost to Follow-up|0|||
130229347|NCT03636256|468805886|FG005|Overall Study|Lost to Follow-up|4|||
130229348|NCT03636256|468805887|FG006|Overall Study|Lost to Follow-up|2|||
130229349|NCT03636256|468805888|FG007|Overall Study|Lost to Follow-up|0|||
130229350|NCT03636256|468805889|FG008|Overall Study|Lost to Follow-up|4|||
130229351|NCT03636256|468805881|FG000|Overall Study|Withdrawal by Subject|0|||
130229352|NCT03636256|468805882|FG001|Overall Study|Withdrawal by Subject|0|||
130229353|NCT03636256|468805883|FG002|Overall Study|Withdrawal by Subject|0|||
130229354|NCT03636256|468805884|FG003|Overall Study|Withdrawal by Subject|0|||
130229355|NCT03636256|468805885|FG004|Overall Study|Withdrawal by Subject|0|||
130229356|NCT03636256|468805886|FG005|Overall Study|Withdrawal by Subject|0|||
130229357|NCT03636256|468805887|FG006|Overall Study|Withdrawal by Subject|0|||
130229358|NCT03636256|468805888|FG007|Overall Study|Withdrawal by Subject|0|||
130229359|NCT03636256|468805889|FG008|Overall Study|Withdrawal by Subject|1|||
130229360|NCT01218308|468805892|FG000|Overall Study|Adverse Event|1|||
130229361|NCT01218308|468805893|FG001|Overall Study|Adverse Event|2|||
130229362|NCT01218308|468805892|FG000|Overall Study|Protocol Violation|0|||
130229363|NCT01218308|468805893|FG001|Overall Study|Protocol Violation|2|||
130229364|NCT01218308|468805892|FG000|Overall Study|Withdrawal by Subject|61|||
130229365|NCT01218308|468805893|FG001|Overall Study|Withdrawal by Subject|64|||
130229366|NCT01218308|468805892|FG000|Overall Study|Lost to Follow-up|27|||
130229367|NCT01218308|468805893|FG001|Overall Study|Lost to Follow-up|31|||
130229368|NCT01218308|468805892|FG000|Overall Study|Other|14|||
130229369|NCT01218308|468805893|FG001|Overall Study|Other|21|||
130229370|NCT00547339|468805896|FG000|Overall Study|Physician Decision|0|||
130229371|NCT00547339|468805897|FG001|Overall Study|Physician Decision|0|||
130229372|NCT00547339|468805898|FG002|Overall Study|Physician Decision|1|||
130229373|NCT00547339|468805899|FG003|Overall Study|Physician Decision|0|||
130229374|NCT01516216|468805900|FG000|Overall Study|Adverse Event|2|||
130229375|NCT01516216|468805901|FG001|Overall Study|Adverse Event|4|||
130229376|NCT01516216|468805900|FG000|Overall Study|Disease Progression|38|||
130229377|NCT01516216|468805901|FG001|Overall Study|Disease Progression|34|||
130229378|NCT01516216|468805900|FG000|Overall Study|Withdrawal by Subject|9|||
130229379|NCT01516216|468805901|FG001|Overall Study|Withdrawal by Subject|11|||
130229380|NCT01516216|468805900|FG000|Overall Study|Potentially Curative Resection|6|||
130229381|NCT01516216|468805901|FG001|Overall Study|Potentially Curative Resection|12|||
130229382|NCT01516216|468805900|FG000|Overall Study|Nonadherence|2|||
130229383|NCT01516216|468805901|FG001|Overall Study|Nonadherence|3|||
130229384|NCT01516216|468805900|FG000|Overall Study|Physician Decision|6|||
130229385|NCT01516216|468805901|FG001|Overall Study|Physician Decision|3|||
130229386|NCT01516216|468805900|FG000|Overall Study|Prolonged Treatment Delay|5|||
130229387|NCT01516216|468805901|FG001|Overall Study|Prolonged Treatment Delay|1|||
130229388|NCT01516216|468805900|FG000|Overall Study|Intercurrent Illness|1|||
130229389|NCT01516216|468805901|FG001|Overall Study|Intercurrent Illness|0|||
130229390|NCT01516216|468805900|FG000|Overall Study|Death|1|||
130229391|NCT01516216|468805901|FG001|Overall Study|Death|1|||
130229392|NCT01458587|468805902|FG000|Overall Study|Withdrawal by Subject|1|||
130229393|NCT01458587|468805903|FG001|Overall Study|Withdrawal by Subject|0|||
129800236|NCT02891161|467236267|FG001|Follow up|Study terminated|6|||
130229394|NCT01603602|468805904|FG000|Overall Study|Adverse Event|1|||
130229395|NCT01603602|468805905|FG001|Overall Study|Adverse Event|0|||
130229396|NCT01603602|468805906|FG002|Overall Study|Adverse Event|0|||
130229397|NCT01603602|468805904|FG000|Overall Study|Personal Reasons|1|||
130229398|NCT01603602|468805905|FG001|Overall Study|Personal Reasons|0|||
130229399|NCT01603602|468805906|FG002|Overall Study|Personal Reasons|1|||
130229400|NCT01079780|468805907|FG000|Overall Study|Disease progression|43|||
130229401|NCT01079780|468805908|FG001|Overall Study|Disease progression|7|||
130229402|NCT01079780|468805909|FG002|Overall Study|Disease progression|31|||
130229403|NCT01079780|468805907|FG000|Overall Study|Adverse Event|13|||
130229404|NCT01079780|468805908|FG001|Overall Study|Adverse Event|5|||
130229405|NCT01079780|468805909|FG002|Overall Study|Adverse Event|7|||
130229406|NCT01079780|468805907|FG000|Overall Study|Death|2|||
130229407|NCT01079780|468805908|FG001|Overall Study|Death|0|||
130229408|NCT01079780|468805909|FG002|Overall Study|Death|2|||
130229409|NCT01079780|468805907|FG000|Overall Study|Withdrawal by Subject|6|||
130229410|NCT01079780|468805908|FG001|Overall Study|Withdrawal by Subject|4|||
130229411|NCT01079780|468805909|FG002|Overall Study|Withdrawal by Subject|4|||
130229412|NCT01079780|468805907|FG000|Overall Study|Alternative therapy|2|||
130229413|NCT01079780|468805908|FG001|Overall Study|Alternative therapy|0|||
130229414|NCT01079780|468805909|FG002|Overall Study|Alternative therapy|2|||
130229415|NCT01079780|468805907|FG000|Overall Study|Physician Decision|1|||
130229416|NCT01079780|468805908|FG001|Overall Study|Physician Decision|0|||
130229417|NCT01079780|468805909|FG002|Overall Study|Physician Decision|1|||
130229418|NCT01079780|468805907|FG000|Overall Study|Error made in lesion measurement|1|||
130229419|NCT01079780|468805908|FG001|Overall Study|Error made in lesion measurement|0|||
130229420|NCT01079780|468805909|FG002|Overall Study|Error made in lesion measurement|0|||
130229421|NCT01079780|468805907|FG000|Overall Study|Patient had surgery|1|||
130229422|NCT01079780|468805908|FG001|Overall Study|Patient had surgery|0|||
130229423|NCT01079780|468805909|FG002|Overall Study|Patient had surgery|0|||
130229424|NCT01079780|468805907|FG000|Overall Study|Treatment cycle delay|0|||
130229425|NCT01079780|468805908|FG001|Overall Study|Treatment cycle delay|0|||
130229426|NCT01079780|468805909|FG002|Overall Study|Treatment cycle delay|1|||
130229427|NCT01079780|468805907|FG000|Overall Study|Never started treatment|1|||
130229428|NCT01079780|468805908|FG001|Overall Study|Never started treatment|0|||
130229429|NCT01079780|468805909|FG002|Overall Study|Never started treatment|2|||
130229430|NCT02783066|468805910|FG000|Overall Study|Withdrawal by Subject|13|||
130229431|NCT05379920|468805915|FG000|Overall Study|Lost to Follow-up|0|||
130229432|NCT05379920|468805916|FG001|Overall Study|Lost to Follow-up|5|||
130229433|NCT05379920|468805917|FG002|Overall Study|Lost to Follow-up|0|||
130229434|NCT05379920|468805918|FG003|Overall Study|Lost to Follow-up|0|||
130229435|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
130229436|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
130229437|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
130229438|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
130229439|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
130229440|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229441|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
130229442|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229443|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229444|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
130229445|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
130229446|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
130229447|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
130229448|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130229449|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130229450|NCT03176771|468805919|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229451|NCT03176771|468805920|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229452|NCT03176771|468805921|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
130229453|NCT03176771|468805922|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229454|NCT03176771|468805923|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
130229455|NCT03176771|468805919|FG000|Double-Blind Extension Period|Adverse Event|0|||
130229456|NCT03176771|468805920|FG001|Double-Blind Extension Period|Adverse Event|0|||
130229457|NCT03176771|468805921|FG002|Double-Blind Extension Period|Adverse Event|0|||
130229458|NCT03176771|468805922|FG003|Double-Blind Extension Period|Adverse Event|15|||
130229459|NCT03176771|468805923|FG004|Double-Blind Extension Period|Adverse Event|18|||
130229460|NCT03176771|468805919|FG000|Double-Blind Extension Period|Death|0|||
130229461|NCT03176771|468805920|FG001|Double-Blind Extension Period|Death|0|||
130229462|NCT03176771|468805921|FG002|Double-Blind Extension Period|Death|0|||
130229463|NCT03176771|468805922|FG003|Double-Blind Extension Period|Death|3|||
130229464|NCT03176771|468805923|FG004|Double-Blind Extension Period|Death|4|||
130229465|NCT03176771|468805919|FG000|Double-Blind Extension Period|Physician Decision|0|||
130229466|NCT03176771|468805920|FG001|Double-Blind Extension Period|Physician Decision|0|||
130229467|NCT03176771|468805921|FG002|Double-Blind Extension Period|Physician Decision|0|||
130229468|NCT03176771|468805922|FG003|Double-Blind Extension Period|Physician Decision|3|||
130229469|NCT03176771|468805923|FG004|Double-Blind Extension Period|Physician Decision|1|||
130229470|NCT03176771|468805919|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
130229471|NCT03176771|468805920|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
130229472|NCT03176771|468805921|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
130229473|NCT03176771|468805922|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
130229474|NCT03176771|468805923|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
130229475|NCT03530293|468805924|FG000|Pre-randomization|Adverse Event|12|||
130229476|NCT03530293|468805925|FG001|Pre-randomization|Adverse Event|0|||
130229477|NCT03530293|468805926|FG002|Pre-randomization|Adverse Event|0|||
130229478|NCT03530293|468805924|FG000|Pre-randomization|Protocol Violation|2|||
130229479|NCT03530293|468805925|FG001|Pre-randomization|Protocol Violation|0|||
130229480|NCT03530293|468805926|FG002|Pre-randomization|Protocol Violation|0|||
130229481|NCT03530293|468805924|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
130229482|NCT03530293|468805925|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
130229483|NCT03530293|468805926|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
130229484|NCT03530293|468805924|FG000|Pre-randomization|Withdrawal by Subject|5|||
130229485|NCT03530293|468805925|FG001|Pre-randomization|Withdrawal by Subject|0|||
130229486|NCT03530293|468805926|FG002|Pre-randomization|Withdrawal by Subject|0|||
130229487|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
130229488|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
130229489|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
130229490|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
130229491|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
130229492|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
130229493|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
130229494|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
130229495|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
130229496|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
130229497|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
130229498|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
130229499|NCT03530293|468805924|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
130229500|NCT03530293|468805925|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
130229501|NCT03530293|468805926|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
130229502|NCT02732639|468805928|FG000|Overall Study|Lost to Follow-up|1|||
130229503|NCT02265510|468805931|FG000|Overall Study|Withdrawal by Subject|1|||
130229504|NCT02265510|468805932|FG001|Overall Study|Withdrawal by Subject|1|||
130229505|NCT02265510|468805933|FG002|Overall Study|Withdrawal by Subject|2|||
130229506|NCT02265510|468805934|FG003|Overall Study|Withdrawal by Subject|1|||
130229507|NCT02265510|468805935|FG004|Overall Study|Withdrawal by Subject|0|||
130229508|NCT02265510|468805936|FG005|Overall Study|Withdrawal by Subject|2|||
130229509|NCT02265510|468805937|FG006|Overall Study|Withdrawal by Subject|0|||
130229510|NCT02265510|468805938|FG007|Overall Study|Withdrawal by Subject|2|||
130229511|NCT02265510|468805939|FG008|Overall Study|Withdrawal by Subject|0|||
130229512|NCT02265510|468805940|FG009|Overall Study|Withdrawal by Subject|0|||
130229513|NCT02265510|468805941|FG010|Overall Study|Withdrawal by Subject|0|||
130229514|NCT02265510|468805942|FG011|Overall Study|Withdrawal by Subject|0|||
130229515|NCT02265510|468805943|FG012|Overall Study|Withdrawal by Subject|1|||
130229516|NCT02265510|468805944|FG013|Overall Study|Withdrawal by Subject|0|||
130229517|NCT02265510|468805931|FG000|Overall Study|Disease Progression|0|||
130229518|NCT02265510|468805932|FG001|Overall Study|Disease Progression|1|||
130229519|NCT02265510|468805933|FG002|Overall Study|Disease Progression|2|||
130229520|NCT02265510|468805934|FG003|Overall Study|Disease Progression|1|||
130229521|NCT02265510|468805935|FG004|Overall Study|Disease Progression|1|||
130229522|NCT02265510|468805936|FG005|Overall Study|Disease Progression|0|||
130229523|NCT02265510|468805937|FG006|Overall Study|Disease Progression|0|||
130229524|NCT02265510|468805938|FG007|Overall Study|Disease Progression|0|||
130229525|NCT02265510|468805939|FG008|Overall Study|Disease Progression|0|||
130229526|NCT02265510|468805940|FG009|Overall Study|Disease Progression|0|||
130229527|NCT02265510|468805941|FG010|Overall Study|Disease Progression|0|||
130229528|NCT02265510|468805942|FG011|Overall Study|Disease Progression|0|||
130229529|NCT02265510|468805943|FG012|Overall Study|Disease Progression|0|||
130229530|NCT02265510|468805944|FG013|Overall Study|Disease Progression|0|||
130229531|NCT02265510|468805931|FG000|Overall Study|Death|2|||
130229532|NCT02265510|468805932|FG001|Overall Study|Death|0|||
130229533|NCT02265510|468805933|FG002|Overall Study|Death|2|||
130229534|NCT02265510|468805934|FG003|Overall Study|Death|2|||
130229535|NCT02265510|468805935|FG004|Overall Study|Death|1|||
130229536|NCT02265510|468805936|FG005|Overall Study|Death|3|||
130229537|NCT02265510|468805937|FG006|Overall Study|Death|2|||
130229538|NCT02265510|468805938|FG007|Overall Study|Death|1|||
130229539|NCT02265510|468805939|FG008|Overall Study|Death|3|||
130229540|NCT02265510|468805940|FG009|Overall Study|Death|3|||
130229541|NCT02265510|468805941|FG010|Overall Study|Death|4|||
130229542|NCT02265510|468805942|FG011|Overall Study|Death|12|||
130229543|NCT02265510|468805943|FG012|Overall Study|Death|7|||
130229544|NCT02265510|468805944|FG013|Overall Study|Death|6|||
130229545|NCT02265510|468805931|FG000|Overall Study|Lost to Follow-up|0|||
130229546|NCT02265510|468805932|FG001|Overall Study|Lost to Follow-up|0|||
130229547|NCT02265510|468805933|FG002|Overall Study|Lost to Follow-up|0|||
130229548|NCT02265510|468805934|FG003|Overall Study|Lost to Follow-up|0|||
130229549|NCT02265510|468805935|FG004|Overall Study|Lost to Follow-up|1|||
130229550|NCT02265510|468805936|FG005|Overall Study|Lost to Follow-up|0|||
130229551|NCT02265510|468805937|FG006|Overall Study|Lost to Follow-up|0|||
130229552|NCT02265510|468805938|FG007|Overall Study|Lost to Follow-up|0|||
130229553|NCT02265510|468805939|FG008|Overall Study|Lost to Follow-up|0|||
130229554|NCT02265510|468805940|FG009|Overall Study|Lost to Follow-up|2|||
130229555|NCT02265510|468805941|FG010|Overall Study|Lost to Follow-up|0|||
130229556|NCT02265510|468805942|FG011|Overall Study|Lost to Follow-up|0|||
130229557|NCT02265510|468805943|FG012|Overall Study|Lost to Follow-up|0|||
130229558|NCT02265510|468805944|FG013|Overall Study|Lost to Follow-up|2|||
130229559|NCT02265510|468805931|FG000|Overall Study|Other|0|||
130229560|NCT02265510|468805932|FG001|Overall Study|Other|1|||
130229561|NCT02265510|468805933|FG002|Overall Study|Other|0|||
130229562|NCT02265510|468805934|FG003|Overall Study|Other|0|||
130229563|NCT02265510|468805935|FG004|Overall Study|Other|0|||
130229564|NCT02265510|468805936|FG005|Overall Study|Other|0|||
130229565|NCT02265510|468805937|FG006|Overall Study|Other|0|||
130229566|NCT02265510|468805938|FG007|Overall Study|Other|0|||
130229567|NCT02265510|468805939|FG008|Overall Study|Other|0|||
130229568|NCT02265510|468805940|FG009|Overall Study|Other|0|||
130229569|NCT02265510|468805941|FG010|Overall Study|Other|0|||
130229570|NCT02265510|468805942|FG011|Overall Study|Other|0|||
130229571|NCT02265510|468805943|FG012|Overall Study|Other|0|||
130229572|NCT02265510|468805944|FG013|Overall Study|Other|0|||
130229573|NCT02265510|468805931|FG000|Overall Study|Study Terminated by Sponsor|0|||
130229574|NCT02265510|468805932|FG001|Overall Study|Study Terminated by Sponsor|0|||
130229575|NCT02265510|468805933|FG002|Overall Study|Study Terminated by Sponsor|0|||
130229576|NCT02265510|468805934|FG003|Overall Study|Study Terminated by Sponsor|0|||
130229577|NCT02265510|468805935|FG004|Overall Study|Study Terminated by Sponsor|0|||
130229578|NCT02265510|468805936|FG005|Overall Study|Study Terminated by Sponsor|1|||
130229579|NCT02265510|468805937|FG006|Overall Study|Study Terminated by Sponsor|1|||
130229580|NCT02265510|468805938|FG007|Overall Study|Study Terminated by Sponsor|1|||
130229581|NCT02265510|468805939|FG008|Overall Study|Study Terminated by Sponsor|1|||
130229582|NCT02265510|468805940|FG009|Overall Study|Study Terminated by Sponsor|2|||
130229583|NCT02265510|468805941|FG010|Overall Study|Study Terminated by Sponsor|1|||
130229584|NCT02265510|468805942|FG011|Overall Study|Study Terminated by Sponsor|4|||
130229585|NCT02265510|468805943|FG012|Overall Study|Study Terminated by Sponsor|1|||
130229586|NCT02265510|468805944|FG013|Overall Study|Study Terminated by Sponsor|2|||
130229587|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
130229588|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130229589|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130229590|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
130229591|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
130229592|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130229593|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130229594|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
130229595|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
130229596|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
130229597|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
130229598|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
130229599|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
130229600|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130229601|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130229602|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
130229603|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
130229604|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
130229605|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
130229606|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
130229607|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
130229608|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130229609|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130229610|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
130229611|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
130229612|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130229613|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130229614|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
130229615|NCT01668797|468805945|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
130229616|NCT01668797|468805946|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130229617|NCT01668797|468805947|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130229618|NCT01668797|468805948|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
130229619|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130229620|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
130229621|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130229622|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
130229623|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130229624|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
130229625|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130229626|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
130229627|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
130229628|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
130229629|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
130229630|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
130229631|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130229632|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
130229633|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130229634|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
130229635|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
130229636|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
130229637|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
130229638|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
130229639|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130229640|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
130229641|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130229642|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
130229643|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130229644|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
130229645|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130229646|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
130229647|NCT01668797|468805945|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130229648|NCT01668797|468805946|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
130229649|NCT01668797|468805947|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130229650|NCT01668797|468805948|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
130229651|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
130229652|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
130229653|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
130229654|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
130229655|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
130229656|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
130229657|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
130229658|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
130229659|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
130229660|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
130229661|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
130229662|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
130229663|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
130229664|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
130229665|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
130229666|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
130229667|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130229668|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130229669|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
130229670|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
130229671|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
130229672|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
130229673|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
130229674|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
130229675|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
130229676|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
130229677|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
130229678|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
130229679|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
130229680|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
130229681|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
130229682|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
129884519|NCT04779242|467536437|FG001|Overall Study|Lost to Follow-up|4|||
130229683|NCT01668797|468805945|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
130229684|NCT01668797|468805946|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
130229685|NCT01668797|468805947|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
130229686|NCT01668797|468805948|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
130229687|NCT01004614|468805949|FG000|Washout|Withdrawal by Subject|0|||
130229688|NCT01004614|468805950|FG001|Washout|Withdrawal by Subject|1|||
130229689|NCT01004614|468805951|FG002|Washout|Withdrawal by Subject|0|||
130229690|NCT01004614|468805952|FG003|Washout|Withdrawal by Subject|0|||
130229691|NCT02530385|468805953|FG000|Overall Study|Withdrawal by Subject|0|||
130229692|NCT02530385|468805954|FG001|Overall Study|Withdrawal by Subject|1|||
130229693|NCT01569022|468805956|FG000|First Intervention|Lost to Follow-up|2|||
130229694|NCT01569022|468805957|FG001|First Intervention|Lost to Follow-up|1|||
130229695|NCT01569022|468805956|FG000|Second Intervention|Lost to Follow-up|2|||
130229696|NCT01569022|468805957|FG001|Second Intervention|Lost to Follow-up|2|||
130229697|NCT02111083|468805962|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
130229698|NCT02111083|468805963|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
130229699|NCT00116142|468805964|FG000|Overall Study|Adverse Event|8|||
130229700|NCT00116142|468805965|FG001|Overall Study|Adverse Event|7|||
130229701|NCT00116142|468805964|FG000|Overall Study|Protocol Violation|2|||
130229702|NCT00116142|468805965|FG001|Overall Study|Protocol Violation|1|||
130229703|NCT00116142|468805964|FG000|Overall Study|Withdrawal by Subject|5|||
130229704|NCT00116142|468805965|FG001|Overall Study|Withdrawal by Subject|5|||
130229705|NCT00116142|468805964|FG000|Overall Study|Physician Decision|3|||
130229706|NCT00116142|468805965|FG001|Overall Study|Physician Decision|1|||
130229707|NCT00116142|468805964|FG000|Overall Study|Delayed Radiation Therapy|1|||
130229708|NCT00116142|468805965|FG001|Overall Study|Delayed Radiation Therapy|0|||
130229709|NCT00116142|468805964|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
130229710|NCT00116142|468805965|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
130229711|NCT00116142|468805964|FG000|Overall Study|Patient stopped due to depression|0|||
130229712|NCT00116142|468805965|FG001|Overall Study|Patient stopped due to depression|1|||
130229713|NCT00116142|468805964|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
130229714|NCT00116142|468805965|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
130229715|NCT00116142|468805964|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
130229716|NCT00116142|468805965|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
130229717|NCT00116142|468805964|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
130229718|NCT00116142|468805965|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
130229719|NCT00433836|468805966|FG000|Overall Study|Adverse Event|7|||
130229720|NCT00433836|468805967|FG001|Overall Study|Adverse Event|0|||
130229721|NCT00433836|468805966|FG000|Overall Study|Lost to Follow-up|3|||
130229722|NCT00433836|468805967|FG001|Overall Study|Lost to Follow-up|0|||
130229723|NCT00433836|468805966|FG000|Overall Study|Withdrawal by Subject|2|||
130229724|NCT00433836|468805967|FG001|Overall Study|Withdrawal by Subject|1|||
130229725|NCT00433836|468805966|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130229726|NCT00433836|468805967|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130229727|NCT00433836|468805966|FG000|Overall Study|Protocol Violation|0|||
130229728|NCT00433836|468805967|FG001|Overall Study|Protocol Violation|2|||
130229729|NCT00433836|468805966|FG000|Overall Study|Condition no longer requires study drug|0|||
130229730|NCT00433836|468805967|FG001|Overall Study|Condition no longer requires study drug|1|||
130229731|NCT00433836|468805966|FG000|Overall Study|Abnormal laboratory values|0|||
130229732|NCT00433836|468805967|FG001|Overall Study|Abnormal laboratory values|1|||
130229733|NCT00644059|468805968|FG000|Overall Study|Lost to Follow-up|37|||
130229734|NCT00644059|468805969|FG001|Overall Study|Lost to Follow-up|34|||
130229735|NCT00644059|468805970|FG002|Overall Study|Lost to Follow-up|16|||
130229736|NCT00644059|468805968|FG000|Overall Study|Withdrawal by Subject|52|||
130229737|NCT00644059|468805969|FG001|Overall Study|Withdrawal by Subject|60|||
130229738|NCT00644059|468805970|FG002|Overall Study|Withdrawal by Subject|30|||
130229739|NCT00644059|468805968|FG000|Overall Study|Adverse Event|8|||
130229740|NCT00644059|468805969|FG001|Overall Study|Adverse Event|5|||
130229741|NCT00644059|468805970|FG002|Overall Study|Adverse Event|1|||
130229742|NCT00644059|468805968|FG000|Overall Study|Inappropriate Enrollment|1|||
130229743|NCT00644059|468805969|FG001|Overall Study|Inappropriate Enrollment|3|||
130229744|NCT00644059|468805970|FG002|Overall Study|Inappropriate Enrollment|0|||
130229745|NCT00644059|468805968|FG000|Overall Study|Protocol Deviation/violation|20|||
130229746|NCT00644059|468805969|FG001|Overall Study|Protocol Deviation/violation|19|||
130229747|NCT00644059|468805970|FG002|Overall Study|Protocol Deviation/violation|15|||
130229748|NCT00644059|468805968|FG000|Overall Study|Unable to classify|6|||
130229749|NCT00644059|468805969|FG001|Overall Study|Unable to classify|2|||
130229750|NCT00644059|468805970|FG002|Overall Study|Unable to classify|3|||
130229751|NCT02133508|468805971|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
130229752|NCT02133508|468805971|FG000|Overall Study|Death|12|||
130229753|NCT02133508|468805971|FG000|Overall Study|Lost to Follow-up|2|||
130229754|NCT00472420|468805978|FG000|Induction Treatment Period|Physician Decision|9|||
130229755|NCT00472420|468805978|FG000|Induction Treatment Period|Adverse Event|3|||
130229756|NCT00472420|468805978|FG000|Induction Treatment Period|Non-compliance|1|||
130229757|NCT00472420|468805978|FG000|Induction Treatment Period|Death|3|||
130229758|NCT00472420|468805978|FG000|Follow-up Period|Death|5|||
130229759|NCT00472420|468805978|FG000|Follow-up Period|Physician Decision|9|||
130229760|NCT00472420|468805978|FG000|Follow-up Period|Lost to Follow-up|2|||
130229761|NCT00472420|468805978|FG000|Follow-up Period|Protocol Violation|1|||
130229762|NCT01787552|468805984|FG000|Overall Study|Withdrawal by Subject|2|||
130229763|NCT01787552|468805985|FG001|Overall Study|Withdrawal by Subject|0|||
130229764|NCT01787552|468805986|FG002|Overall Study|Withdrawal by Subject|0|||
130229765|NCT01787552|468805987|FG003|Overall Study|Withdrawal by Subject|4|||
130229766|NCT01787552|468805984|FG000|Overall Study|Physician Decision|2|||
130229767|NCT01787552|468805985|FG001|Overall Study|Physician Decision|2|||
130229768|NCT01787552|468805986|FG002|Overall Study|Physician Decision|1|||
130229769|NCT01787552|468805987|FG003|Overall Study|Physician Decision|2|||
130229770|NCT01787552|468805984|FG000|Overall Study|Death|0|||
130229771|NCT01787552|468805985|FG001|Overall Study|Death|0|||
130229772|NCT01787552|468805986|FG002|Overall Study|Death|0|||
130229773|NCT01787552|468805987|FG003|Overall Study|Death|1|||
130229774|NCT01787552|468805984|FG000|Overall Study|Adverse Event|2|||
130229775|NCT01787552|468805985|FG001|Overall Study|Adverse Event|5|||
130229776|NCT01787552|468805986|FG002|Overall Study|Adverse Event|2|||
130229777|NCT01787552|468805987|FG003|Overall Study|Adverse Event|16|||
130229778|NCT01787552|468805984|FG000|Overall Study|Study terminated by Sponsor|0|||
130229779|NCT01787552|468805985|FG001|Overall Study|Study terminated by Sponsor|0|||
130229780|NCT01787552|468805986|FG002|Overall Study|Study terminated by Sponsor|1|||
130229781|NCT01787552|468805987|FG003|Overall Study|Study terminated by Sponsor|3|||
130229782|NCT01787552|468805984|FG000|Overall Study|Progressive Disease|2|||
130229783|NCT01787552|468805985|FG001|Overall Study|Progressive Disease|2|||
130229784|NCT01787552|468805986|FG002|Overall Study|Progressive Disease|1|||
130229785|NCT01787552|468805987|FG003|Overall Study|Progressive Disease|1|||
130229786|NCT04079790|468805989|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
130229787|NCT04079790|468805990|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130229788|NCT04079790|468805991|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130229789|NCT04079790|468805992|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
130229790|NCT04079790|468805989|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130229791|NCT04079790|468805990|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130229792|NCT04079790|468805991|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
130229793|NCT04079790|468805992|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
130229794|NCT04079790|468805989|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130229795|NCT04079790|468805990|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130229796|NCT04079790|468805991|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
130229797|NCT04079790|468805992|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
130229798|NCT00390689|468805993|FG000|Overall Study|Adverse Event|2|||
130229799|NCT00390689|468805994|FG001|Overall Study|Adverse Event|5|||
130229800|NCT00390689|468805995|FG002|Overall Study|Adverse Event|2|||
130229801|NCT00390689|468805993|FG000|Overall Study|Lack of Efficacy|0|||
130229802|NCT00390689|468805994|FG001|Overall Study|Lack of Efficacy|0|||
130229803|NCT00390689|468805995|FG002|Overall Study|Lack of Efficacy|1|||
130229804|NCT00390689|468805993|FG000|Overall Study|Protocol Violation|1|||
130229805|NCT00390689|468805994|FG001|Overall Study|Protocol Violation|0|||
130229806|NCT00390689|468805995|FG002|Overall Study|Protocol Violation|0|||
130229807|NCT00390689|468805993|FG000|Overall Study|Investigator's judgement|2|||
130022985|NCT00662792|468045049|FG002|Period 1|Personal Reasons|1|||
130022986|NCT00662792|468045050|FG003|Period 1|Personal Reasons|0|||
130022987|NCT00662792|468045047|FG000|Period 1|Refused continuing medication|0|||
130022988|NCT00662792|468045048|FG001|Period 1|Refused continuing medication|1|||
130229808|NCT00390689|468805994|FG001|Overall Study|Investigator's judgement|0|||
130229809|NCT00390689|468805995|FG002|Overall Study|Investigator's judgement|0|||
130229810|NCT01253161|468805996|FG000|Overall Study|Adverse Event|1|||
130229811|NCT01924533|468805998|FG000|Overall Study|Death|181|||
130229812|NCT01924533|468805999|FG001|Overall Study|Death|200|||
130229813|NCT01924533|468805998|FG000|Overall Study|Lost to Follow-up|0|||
130229814|NCT01924533|468805999|FG001|Overall Study|Lost to Follow-up|1|||
130229815|NCT01924533|468805998|FG000|Overall Study|Withdrawal by Subject|7|||
130229816|NCT01924533|468805999|FG001|Overall Study|Withdrawal by Subject|3|||
130229817|NCT01924533|468805998|FG000|Overall Study|Other Eligibility criteria|1|||
130229818|NCT01924533|468805999|FG001|Overall Study|Other Eligibility criteria|1|||
130229819|NCT03307174|468806001|FG000|Overall Study|Unplanned ICU Administrion|5|||
130229820|NCT03307174|468806002|FG001|Overall Study|Unplanned ICU Administrion|3|||
130022989|NCT00662792|468045049|FG002|Period 1|Refused continuing medication|1|||
130229821|NCT03307174|468806001|FG000|Overall Study|Aborted Surgery|1|||
130229822|NCT03307174|468806002|FG001|Overall Study|Aborted Surgery|2|||
130229823|NCT03307174|468806001|FG000|Overall Study|Hypotension|6|||
130229824|NCT03307174|468806002|FG001|Overall Study|Hypotension|0|||
130229825|NCT03307174|468806001|FG000|Overall Study|Nonfunctional epidural|1|||
130229826|NCT03307174|468806002|FG001|Overall Study|Nonfunctional epidural|1|||
130229827|NCT03307174|468806001|FG000|Overall Study|Planned epidural removal|1|||
130229828|NCT03307174|468806002|FG001|Overall Study|Planned epidural removal|0|||
130229829|NCT03307174|468806001|FG000|Overall Study|Intrathecal catheter placement|0|||
130229830|NCT03307174|468806002|FG001|Overall Study|Intrathecal catheter placement|1|||
130229831|NCT04275336|468806003|FG000|Overall Study|First venipuncture failed|4|||
130229832|NCT04275336|468806004|FG001|Overall Study|First venipuncture failed|6|||
130229833|NCT04275336|468806005|FG002|Overall Study|First venipuncture failed|5|||
130229834|NCT04275336|468806003|FG000|Overall Study|Unscheduled venipuncture|9|||
130229835|NCT04275336|468806004|FG001|Overall Study|Unscheduled venipuncture|13|||
130229836|NCT04275336|468806005|FG002|Overall Study|Unscheduled venipuncture|7|||
130229837|NCT04275336|468806003|FG000|Overall Study|Failed specimen of saliva|4|||
130229838|NCT04275336|468806004|FG001|Overall Study|Failed specimen of saliva|3|||
130229839|NCT04275336|468806005|FG002|Overall Study|Failed specimen of saliva|4|||
130229840|NCT03055936|468806006|FG000|Overall Study|Adverse Event|0|||
130229841|NCT03055936|468806007|FG001|Overall Study|Adverse Event|1|||
130229842|NCT03055936|468806008|FG002|Overall Study|Adverse Event|1|||
130229843|NCT03055936|468806009|FG003|Overall Study|Adverse Event|1|||
130229844|NCT03055936|468806006|FG000|Overall Study|Personal reason|2|||
130229845|NCT03055936|468806007|FG001|Overall Study|Personal reason|0|||
130229846|NCT03055936|468806008|FG002|Overall Study|Personal reason|1|||
130229847|NCT03055936|468806009|FG003|Overall Study|Personal reason|0|||
130229848|NCT03372798|468806018|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
130229849|NCT03372798|468806019|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
130229850|NCT03372798|468806018|FG000|Overall Study|Failure of imaging probe|0|||
130229851|NCT03372798|468806019|FG001|Overall Study|Failure of imaging probe|1|||
130229852|NCT00721799|468806038|FG000|Overall Study|Withdrawal by Subject|7|||
130229853|NCT00721799|468806038|FG000|Overall Study|withdraw by subject after scan 1|1|||
130229854|NCT03141359|468806039|FG000|Overall Study|Death|32|||
130229855|NCT03141359|468806039|FG000|Overall Study|Still On Study (in follow up)|29|||
130229856|NCT01081626|468806040|FG000|Overall Study|Dosing error|1|||
130229857|NCT01081626|468806041|FG001|Overall Study|Dosing error|1|||
130229858|NCT01081626|468806040|FG000|Overall Study|Missing Estradiol|25|||
130229859|NCT01081626|468806041|FG001|Overall Study|Missing Estradiol|28|||
130229860|NCT01081626|468806040|FG000|Overall Study|Low antral follicle count|1|||
130229861|NCT01081626|468806041|FG001|Overall Study|Low antral follicle count|0|||
130229862|NCT01081626|468806040|FG000|Overall Study|Overstimulation|0|||
130229863|NCT01081626|468806041|FG001|Overall Study|Overstimulation|1|||
130229864|NCT01081626|468806040|FG000|Overall Study|Lost to Follow-up|0|||
130229865|NCT01081626|468806041|FG001|Overall Study|Lost to Follow-up|1|||
130229866|NCT01081626|468806040|FG000|Overall Study|Other|33|||
130229867|NCT01081626|468806041|FG001|Overall Study|Other|30|||
130229868|NCT04158219|468806042|FG000|Overall Study|Lost to Follow-up|1|||
130229869|NCT02074514|468806043|FG000|Overall Study|Lack of Efficacy|3|||
130229870|NCT02074514|468806044|FG001|Overall Study|Lack of Efficacy|2|||
130229871|NCT02074514|468806043|FG000|Overall Study|Lost to Follow-up|0|||
130229872|NCT02074514|468806044|FG001|Overall Study|Lost to Follow-up|1|||
130229873|NCT02074514|468806043|FG000|Overall Study|Withdrew Consent|0|||
130229874|NCT02074514|468806044|FG001|Overall Study|Withdrew Consent|1|||
130229875|NCT02337764|468807349|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
130229876|NCT02337764|468807349|FG000|Overall Study|Voluntary Withdrawal|12|||
130229877|NCT02337764|468807349|FG000|Overall Study|Lack of Efficacy|2|||
130229878|NCT04748718|468807352|FG000|Overall Study|Lost to Follow-up|50|||
130229879|NCT01065818|468807353|FG000|Overall Study|Withdrawal by Subject|1|||
130229880|NCT01065818|468807353|FG000|Overall Study|Not a candidate for surgery|1|||
130229881|NCT01450813|468807354|FG000|Overall Study|Physician Decision|1|||
130229882|NCT01450813|468807355|FG001|Overall Study|Physician Decision|1|||
130229883|NCT01450813|468807356|FG002|Overall Study|Physician Decision|0|||
130229884|NCT01450813|468807357|FG003|Overall Study|Physician Decision|3|||
130229885|NCT01935089|468807359|FG000|Overall Study|Adverse Event|2|||
130229886|NCT01935089|468807359|FG000|Overall Study|Withdrawal by Subject|1|||
130229887|NCT02337491|468807363|FG000|Overall Study|Death|1|||
130229888|NCT02337491|468807364|FG001|Overall Study|Death|1|||
130229889|NCT02337491|468807363|FG000|Overall Study|Adverse Event|0|||
130229890|NCT02337491|468807364|FG001|Overall Study|Adverse Event|1|||
130229891|NCT02337491|468807363|FG000|Overall Study|Withdrawal by Subject|3|||
130229892|NCT02337491|468807364|FG001|Overall Study|Withdrawal by Subject|0|||
130229893|NCT02337491|468807363|FG000|Overall Study|Progressive Disease|44|||
130229894|NCT02337491|468807364|FG001|Overall Study|Progressive Disease|28|||
130229895|NCT02337491|468807363|FG000|Overall Study|On Treatment|2|||
130229896|NCT02337491|468807364|FG001|Overall Study|On Treatment|0|||
130229897|NCT00723229|468807365|FG000|First Intervention|Lost to Follow-up|7|||
130229898|NCT00723229|468807366|FG001|First Intervention|Lost to Follow-up|3|||
130229899|NCT01483118|468807371|FG000|Overall Study|Lost to Follow-up|12|||
130229900|NCT01483118|468807372|FG001|Overall Study|Lost to Follow-up|16|||
130229901|NCT03435055|468807374|FG000|Screening|Physician Decision|2|||
130229902|NCT03435055|468807374|FG000|Received Intervention|Did not complete nitrous administration|3|||
130229903|NCT03712280|468807375|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
130229904|NCT03712280|468807376|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
130229905|NCT03712280|468807377|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
130229906|NCT03712280|468807378|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
130229907|NCT03712280|468807375|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
130229908|NCT03712280|468807376|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
130229909|NCT03712280|468807377|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
130229910|NCT03712280|468807378|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
130229911|NCT03712280|468807375|FG000|Overall Study|Adverse Event|0|||
130229912|NCT03712280|468807376|FG001|Overall Study|Adverse Event|0|||
130229913|NCT03712280|468807377|FG002|Overall Study|Adverse Event|1|||
130229914|NCT03712280|468807378|FG003|Overall Study|Adverse Event|0|||
130229915|NCT01302899|468807381|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
130229916|NCT01302899|468807382|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
130229917|NCT01302899|468807381|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
130229918|NCT01302899|468807382|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
130229919|NCT02834975|468807383|FG000|Overall Study|Physician Decision|2|||
130229920|NCT02834975|468807383|FG000|Overall Study|Adverse Event|1|||
130229921|NCT02834975|468807383|FG000|Overall Study|Withdrawal by Subject|1|||
130229922|NCT02834975|468807383|FG000|Overall Study|Lack of Efficacy|1|||
130229923|NCT03558516|468807384|FG000|Overall Study|Protocol Violation|2|||
130229924|NCT03558516|468807385|FG001|Overall Study|Protocol Violation|2|||
130229925|NCT00929669|468807386|FG000|Overall Study|elevated glucose levels|1|||
130229926|NCT04494646|468807391|FG000|Overall Study|Adverse Event|0|||
130229927|NCT04494646|468807392|FG001|Overall Study|Adverse Event|1|||
130229928|NCT04494646|468807391|FG000|Overall Study|Withdrawal by Subject|0|||
130229929|NCT04494646|468807392|FG001|Overall Study|Withdrawal by Subject|1|||
130229930|NCT02785939|468807395|FG000|Overall Study|Progression|25|||
130229931|NCT02785939|468807396|FG001|Overall Study|Progression|8|||
130229932|NCT02785939|468807395|FG000|Overall Study|Adverse Event|3|||
130229933|NCT02785939|468807396|FG001|Overall Study|Adverse Event|1|||
130229934|NCT02785939|468807395|FG000|Overall Study|Death|1|||
130229935|NCT02785939|468807396|FG001|Overall Study|Death|0|||
130229936|NCT02785939|468807395|FG000|Overall Study|Refusal|1|||
130229937|NCT02785939|468807396|FG001|Overall Study|Refusal|0|||
130229938|NCT02785939|468807395|FG000|Overall Study|Deteriorating health|1|||
130229939|NCT02785939|468807396|FG001|Overall Study|Deteriorating health|0|||
130229940|NCT02785939|468807395|FG000|Overall Study|Not protocol specified|0|||
130229941|NCT02785939|468807396|FG001|Overall Study|Not protocol specified|1|||
130229942|NCT02147626|468807399|FG000|Overall Study|Lost to Follow-up|4|||
130229943|NCT02147626|468807400|FG001|Overall Study|Lost to Follow-up|4|||
130229944|NCT02147626|468807399|FG000|Overall Study|Pregnancy|1|||
130229945|NCT02147626|468807400|FG001|Overall Study|Pregnancy|2|||
130229946|NCT02147626|468807399|FG000|Overall Study|Withdrawal by Subject|0|||
130229947|NCT02147626|468807400|FG001|Overall Study|Withdrawal by Subject|1|||
130229948|NCT00572832|468807401|FG000|Overall Study|Lost to Follow-up|0|||
130229949|NCT00572832|468807402|FG001|Overall Study|Lost to Follow-up|11|||
130229950|NCT00572832|468807401|FG000|Overall Study|Pregnancy|0|||
130229951|NCT00572832|468807402|FG001|Overall Study|Pregnancy|1|||
130229952|NCT01704261|468807406|FG000|Overall Study|Withdrawal by Subject|12|||
130229953|NCT01704261|468807407|FG001|Overall Study|Withdrawal by Subject|15|||
130229954|NCT01704261|468807406|FG000|Overall Study|Lost to Follow-up|1|||
130229955|NCT01704261|468807407|FG001|Overall Study|Lost to Follow-up|0|||
130229956|NCT02722967|468807408|FG000|Overall Study|Adverse Event|1|||
130229957|NCT02722967|468807409|FG001|Overall Study|Adverse Event|0|||
130229958|NCT02722967|468807410|FG002|Overall Study|Adverse Event|0|||
130229959|NCT02722967|468807408|FG000|Overall Study|Lost to Follow-up|0|||
130229960|NCT02722967|468807409|FG001|Overall Study|Lost to Follow-up|1|||
130229961|NCT02722967|468807410|FG002|Overall Study|Lost to Follow-up|0|||
130229962|NCT02722967|468807408|FG000|Overall Study|Non-compliance with patch wearing|2|||
130229963|NCT02722967|468807409|FG001|Overall Study|Non-compliance with patch wearing|1|||
130229964|NCT02722967|468807410|FG002|Overall Study|Non-compliance with patch wearing|1|||
130229965|NCT02722967|468807408|FG000|Overall Study|Withdrawal by Subject|1|||
130229966|NCT02722967|468807409|FG001|Overall Study|Withdrawal by Subject|0|||
130229967|NCT02722967|468807410|FG002|Overall Study|Withdrawal by Subject|1|||
130229968|NCT02722967|468807408|FG000|Overall Study|Physician Decision|1|||
130229969|NCT02722967|468807409|FG001|Overall Study|Physician Decision|0|||
130229970|NCT02722967|468807410|FG002|Overall Study|Physician Decision|0|||
130229971|NCT02722967|468807408|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
130229972|NCT02722967|468807409|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
130229973|NCT02722967|468807410|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
130229974|NCT00846053|468807413|FG000|Overall Study|Physician Decision|3|||
130229975|NCT00846053|468807414|FG001|Overall Study|Physician Decision|0|||
130229976|NCT00111761|468807415|FG000|Part 1|Physician Decision|0|||
130229977|NCT00111761|468807416|FG001|Part 1|Physician Decision|1|||
130229978|NCT00111761|468807415|FG000|Part 1|Death|0|||
130229979|NCT00111761|468807416|FG001|Part 1|Death|2|||
130229980|NCT00111761|468807415|FG000|Part 1|Other|0|||
130229981|NCT00111761|468807416|FG001|Part 1|Other|1|||
130229982|NCT00111761|468807415|FG000|Part 1|Withdrawal by Subject|0|||
130229983|NCT00111761|468807416|FG001|Part 1|Withdrawal by Subject|1|||
130229984|NCT00111761|468807415|FG000|Part 2|Adverse Event|1|||
130229985|NCT00111761|468807416|FG001|Part 2|Adverse Event|0|||
130229986|NCT00111761|468807415|FG000|Part 2|Physician Decision|1|||
130229987|NCT00111761|468807416|FG001|Part 2|Physician Decision|0|||
130229988|NCT00111761|468807415|FG000|Part 2|Death|1|||
130229989|NCT00111761|468807416|FG001|Part 2|Death|0|||
130229990|NCT00111761|468807415|FG000|Part 2|Disease progression|3|||
130229991|NCT00111761|468807416|FG001|Part 2|Disease progression|0|||
130229992|NCT00111761|468807415|FG000|Part 2|Protocol-specified criteria|1|||
130229993|NCT00111761|468807416|FG001|Part 2|Protocol-specified criteria|0|||
130229994|NCT00111761|468807415|FG000|Part 2|Other|1|||
130229995|NCT00111761|468807416|FG001|Part 2|Other|0|||
130229996|NCT00467519|468807420|FG000|Overall Study|Protocol Violation|8|||
130229997|NCT00467519|468807421|FG001|Overall Study|Protocol Violation|4|||
130229998|NCT00467519|468807420|FG000|Overall Study|Lost to Follow-up|2|||
130229999|NCT00467519|468807421|FG001|Overall Study|Lost to Follow-up|9|||
130230000|NCT00467519|468807420|FG000|Overall Study|Withdrawal by Subject|4|||
130230001|NCT00467519|468807421|FG001|Overall Study|Withdrawal by Subject|10|||
130230002|NCT00843492|468807428|FG000|Overall Study|Adverse Event|0|||
130230003|NCT00843492|468807429|FG001|Overall Study|Adverse Event|3|||
130230004|NCT00843492|468807428|FG000|Overall Study|Lost to Follow-up|4|||
130230005|NCT00843492|468807429|FG001|Overall Study|Lost to Follow-up|4|||
130230006|NCT00843492|468807428|FG000|Overall Study|Withdrawal by Subject|0|||
130230007|NCT00843492|468807429|FG001|Overall Study|Withdrawal by Subject|4|||
130230008|NCT00843492|468807428|FG000|Overall Study|Immobilization Stopped|1|||
130230009|NCT00843492|468807429|FG001|Overall Study|Immobilization Stopped|0|||
130230010|NCT00843492|468807428|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
130230011|NCT00843492|468807429|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
130230012|NCT00843492|468807428|FG000|Overall Study|Orthopedic Surgery|0|||
130230013|NCT00843492|468807429|FG001|Overall Study|Orthopedic Surgery|2|||
130230014|NCT00843492|468807428|FG000|Overall Study|Visit Not Performed|1|||
130230015|NCT00843492|468807429|FG001|Overall Study|Visit Not Performed|0|||
130230016|NCT00843492|468807428|FG000|Overall Study|Deep-vein Thrombosis|1|||
130230017|NCT00843492|468807429|FG001|Overall Study|Deep-vein Thrombosis|0|||
130022990|NCT00662792|468045050|FG003|Period 1|Refused continuing medication|0|||
130230018|NCT01677741|468807430|FG000|Overall Study|Death|0|||
130230019|NCT01677741|468807431|FG001|Overall Study|Death|0|||
130230020|NCT01677741|468807432|FG002|Overall Study|Death|0|||
130230021|NCT01677741|468807433|FG003|Overall Study|Death|1|||
130230022|NCT01677741|468807434|FG004|Overall Study|Death|0|||
130230023|NCT01677741|468807435|FG005|Overall Study|Death|1|||
130230024|NCT01677741|468807436|FG006|Overall Study|Death|0|||
130230025|NCT01677741|468807437|FG007|Overall Study|Death|0|||
130230026|NCT01677741|468807430|FG000|Overall Study|Withdrawal by Subject|2|||
130230027|NCT01677741|468807431|FG001|Overall Study|Withdrawal by Subject|7|||
130230028|NCT01677741|468807432|FG002|Overall Study|Withdrawal by Subject|5|||
130230029|NCT01677741|468807433|FG003|Overall Study|Withdrawal by Subject|4|||
130022991|NCT00662792|468045047|FG000|Period 1|Lost to Follow-up|1|||
130230030|NCT01677741|468807434|FG004|Overall Study|Withdrawal by Subject|11|||
130230031|NCT01677741|468807435|FG005|Overall Study|Withdrawal by Subject|20|||
130230032|NCT01677741|468807436|FG006|Overall Study|Withdrawal by Subject|4|||
130230033|NCT01677741|468807437|FG007|Overall Study|Withdrawal by Subject|2|||
130230034|NCT01677741|468807430|FG000|Overall Study|Enrolled in a rollover study|0|||
130230035|NCT01677741|468807431|FG001|Overall Study|Enrolled in a rollover study|3|||
130230036|NCT01677741|468807432|FG002|Overall Study|Enrolled in a rollover study|2|||
130230037|NCT01677741|468807433|FG003|Overall Study|Enrolled in a rollover study|1|||
130230038|NCT01677741|468807434|FG004|Overall Study|Enrolled in a rollover study|6|||
130022992|NCT00662792|468045048|FG001|Period 1|Lost to Follow-up|0|||
130022993|NCT00662792|468045049|FG002|Period 1|Lost to Follow-up|0|||
130022994|NCT00662792|468045050|FG003|Period 1|Lost to Follow-up|0|||
130022995|NCT00662792|468045047|FG000|Period 1|Other adverse event (AE)|0|||
130022996|NCT00662792|468045048|FG001|Period 1|Other adverse event (AE)|2|||
130022997|NCT00662792|468045049|FG002|Period 1|Other adverse event (AE)|0|||
130022998|NCT00662792|468045050|FG003|Period 1|Other adverse event (AE)|0|||
130022999|NCT00662792|468045047|FG000|Period 1|Worsening of disease under study (AE)|1|||
130023000|NCT00662792|468045048|FG001|Period 1|Worsening of disease under study (AE)|3|||
130023001|NCT00662792|468045049|FG002|Period 1|Worsening of disease under study (AE)|2|||
130023002|NCT00662792|468045050|FG003|Period 1|Worsening of disease under study (AE)|0|||
130023003|NCT00662792|468045047|FG000|Period 1|Not treated|0|||
130023004|NCT00662792|468045048|FG001|Period 1|Not treated|1|||
130023005|NCT00662792|468045049|FG002|Period 1|Not treated|0|||
130023006|NCT00662792|468045050|FG003|Period 1|Not treated|0|||
130023007|NCT00662792|468045047|FG000|Period 2|Worsening of disease under study|1|||
130230039|NCT01677741|468807435|FG005|Overall Study|Enrolled in a rollover study|6|||
130230040|NCT01677741|468807436|FG006|Overall Study|Enrolled in a rollover study|7|||
130023008|NCT00662792|468045048|FG001|Period 2|Worsening of disease under study|0|||
130023009|NCT00662792|468045049|FG002|Period 2|Worsening of disease under study|0|||
130023010|NCT00662792|468045050|FG003|Period 2|Worsening of disease under study|3|||
130023011|NCT00662792|468045047|FG000|Period 3|Refused continuing medication|1|||
130023012|NCT00662792|468045048|FG001|Period 3|Refused continuing medication|0|||
130023013|NCT00662792|468045049|FG002|Period 3|Refused continuing medication|1|||
130023014|NCT00662792|468045050|FG003|Period 3|Refused continuing medication|0|||
130023015|NCT00662792|468045047|FG000|Period 3|Other adverse event (AE)|0|||
130023016|NCT00662792|468045048|FG001|Period 3|Other adverse event (AE)|0|||
130023017|NCT00662792|468045049|FG002|Period 3|Other adverse event (AE)|1|||
130230041|NCT01677741|468807437|FG007|Overall Study|Enrolled in a rollover study|0|||
130230042|NCT01677741|468807430|FG000|Overall Study|Progressive disease|1|||
130230043|NCT01677741|468807431|FG001|Overall Study|Progressive disease|0|||
130230044|NCT01677741|468807432|FG002|Overall Study|Progressive disease|1|||
130230045|NCT01677741|468807433|FG003|Overall Study|Progressive disease|0|||
130230046|NCT01677741|468807434|FG004|Overall Study|Progressive disease|0|||
130023018|NCT00662792|468045050|FG003|Period 3|Other adverse event (AE)|1|||
130023019|NCT00662792|468045047|FG000|Period 4|Refused continuing medication|0|||
130230047|NCT01677741|468807435|FG005|Overall Study|Progressive disease|1|||
130230048|NCT01677741|468807436|FG006|Overall Study|Progressive disease|0|||
130230049|NCT01677741|468807437|FG007|Overall Study|Progressive disease|0|||
130230050|NCT00720499|468807438|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
130230051|NCT00720499|468807439|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
130230052|NCT00720499|468807438|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
130023020|NCT00662792|468045048|FG001|Period 4|Refused continuing medication|1|||
130230053|NCT00720499|468807439|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
130230054|NCT00720499|468807438|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
130023021|NCT00662792|468045049|FG002|Period 4|Refused continuing medication|0|||
130023022|NCT00662792|468045050|FG003|Period 4|Refused continuing medication|0|||
130023023|NCT00662792|468045047|FG000|Period 4|Other adverse event (AE)|1|||
130230055|NCT00720499|468807439|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
130230056|NCT03641508|468807451|FG000|First Injection|Lost to Follow-up|2|||
130230057|NCT03641508|468807452|FG001|First Injection|Lost to Follow-up|0|||
130230058|NCT03642990|468807453|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
130230059|NCT03642990|468807453|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
130230060|NCT00855218|468807454|FG000|Overall Study|Adverse Event|43|||
130230061|NCT00855218|468807455|FG001|Overall Study|Adverse Event|27|||
130230062|NCT00855218|468807454|FG000|Overall Study|Withdrawal by Subject|10|||
130230063|NCT00855218|468807455|FG001|Overall Study|Withdrawal by Subject|6|||
130230064|NCT00855218|468807454|FG000|Overall Study|Physician Decision|18|||
130023024|NCT00662792|468045048|FG001|Period 4|Other adverse event (AE)|0|||
130023025|NCT00662792|468045049|FG002|Period 4|Other adverse event (AE)|0|||
130023026|NCT00662792|468045050|FG003|Period 4|Other adverse event (AE)|0|||
130023027|NCT00662792|468045047|FG000|Period 4|Worsening of disease under study (AE)|0|||
130023028|NCT00662792|468045048|FG001|Period 4|Worsening of disease under study (AE)|0|||
130023029|NCT00662792|468045049|FG002|Period 4|Worsening of disease under study (AE)|0|||
130023030|NCT00662792|468045050|FG003|Period 4|Worsening of disease under study (AE)|1|||
130023031|NCT01699087|468045052|FG000|Overall Study|Lost to Follow-up|7|||
130230065|NCT00855218|468807455|FG001|Overall Study|Physician Decision|11|||
130230066|NCT00855218|468807454|FG000|Overall Study|Lost to Follow-up|0|||
130023032|NCT01699087|468045052|FG000|Overall Study|Screen failure (prior to treatment)|15|||
130023033|NCT01699087|468045052|FG000|Overall Study|Unable to make future visits|2|||
130230067|NCT00855218|468807455|FG001|Overall Study|Lost to Follow-up|1|||
130230068|NCT00855218|468807454|FG000|Overall Study|Protocol Violation|5|||
130230069|NCT00855218|468807455|FG001|Overall Study|Protocol Violation|9|||
130230070|NCT00855218|468807454|FG000|Overall Study|non-compliant with study drug|3|||
130230071|NCT00855218|468807455|FG001|Overall Study|non-compliant with study drug|1|||
130230072|NCT00855218|468807454|FG000|Overall Study|patient convenience|2|||
130230073|NCT00855218|468807455|FG001|Overall Study|patient convenience|0|||
130230074|NCT00855218|468807454|FG000|Overall Study|technical problems|2|||
130230075|NCT00855218|468807455|FG001|Overall Study|technical problems|1|||
130230076|NCT00855218|468807454|FG000|Overall Study|Still treated with study medication|0|||
130230077|NCT00855218|468807455|FG001|Overall Study|Still treated with study medication|1|||
130230078|NCT00855218|468807454|FG000|Overall Study|Untreatable disease progression|54|||
130230079|NCT00855218|468807455|FG001|Overall Study|Untreatable disease progression|67|||
130230080|NCT00855218|468807454|FG000|Overall Study|Second malignancy|0|||
130230081|NCT00855218|468807455|FG001|Overall Study|Second malignancy|1|||
130230082|NCT00855218|468807454|FG000|Overall Study|Progression measurement proven|7|||
130230083|NCT00855218|468807455|FG001|Overall Study|Progression measurement proven|15|||
130230084|NCT00855218|468807454|FG000|Overall Study|Clinical endpoint reached|10|||
130230085|NCT00855218|468807455|FG001|Overall Study|Clinical endpoint reached|13|||
130230086|NCT00764790|468807456|FG000|Overall Study|Protocol Violation|0|||
130230087|NCT00764790|468807457|FG001|Overall Study|Protocol Violation|0|||
130230088|NCT00764790|468807458|FG002|Overall Study|Protocol Violation|1|||
130230089|NCT00764790|468807456|FG000|Overall Study|Withdrawal by Subject|10|||
130230090|NCT00764790|468807457|FG001|Overall Study|Withdrawal by Subject|12|||
130230091|NCT00764790|468807458|FG002|Overall Study|Withdrawal by Subject|6|||
130230092|NCT00764790|468807456|FG000|Overall Study|Lost to Follow-up|28|||
130230093|NCT00764790|468807457|FG001|Overall Study|Lost to Follow-up|29|||
130230094|NCT00764790|468807458|FG002|Overall Study|Lost to Follow-up|23|||
130230095|NCT03191552|468807459|FG000|Overall Study|Lost to Follow-up|1|||
130230096|NCT03191552|468807460|FG001|Overall Study|Lost to Follow-up|0|||
130230097|NCT03191552|468807461|FG002|Overall Study|Lost to Follow-up|0|||
130230098|NCT03191552|468807459|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
130230099|NCT03191552|468807460|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
130230100|NCT03191552|468807461|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
130230101|NCT01441973|468807462|FG000|Overall Study|Disease progression|8|||
130230102|NCT01441973|468807463|FG001|Overall Study|Disease progression|6|||
130230103|NCT01441973|468807462|FG000|Overall Study|Adverse event unrelated to study drug|3|||
130230104|NCT01441973|468807463|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130230105|NCT01441973|468807462|FG000|Overall Study|Participant request to discontinue|1|||
130230106|NCT01441973|468807463|FG001|Overall Study|Participant request to discontinue|1|||
130230107|NCT01441973|468807462|FG000|Overall Study|Poor compliance/noncompliance|0|||
130230108|NCT01441973|468807463|FG001|Overall Study|Poor compliance/noncompliance|1|||
130230109|NCT01441973|468807462|FG000|Overall Study|Administrative reason by sponsor|3|||
130230110|NCT01441973|468807463|FG001|Overall Study|Administrative reason by sponsor|5|||
130230111|NCT01441973|468807462|FG000|Overall Study|Participant withdrew consent|0|||
130230112|NCT01441973|468807463|FG001|Overall Study|Participant withdrew consent|1|||
130230113|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
130230114|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130230115|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130230116|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
130230117|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
130230118|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130230119|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130230120|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
130230121|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
130230122|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130230123|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130230124|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130230125|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
130230126|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
130230127|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
130230128|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
130230129|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
130230130|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130230131|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130230132|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130230133|NCT01149655|468807464|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
130230134|NCT01149655|468807465|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130230135|NCT01149655|468807466|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130230136|NCT01149655|468807467|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
130230137|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130230138|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
130230139|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130230140|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
130230141|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130230142|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
130230143|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130230144|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
130230145|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
130230146|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
130230147|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
130230148|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
130230149|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130230150|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
130230151|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130230152|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
130230153|NCT01149655|468807464|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130230154|NCT01149655|468807465|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
130230155|NCT01149655|468807466|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130230156|NCT01149655|468807467|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
130230157|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
130230158|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
130230159|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
130230160|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
130230161|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
130230162|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
130230163|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
130230164|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
130230165|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
130230166|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
130230167|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
130230168|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
130230169|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
130230170|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
130230171|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
130230172|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
130230173|NCT01149655|468807464|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
130230174|NCT01149655|468807465|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
130230175|NCT01149655|468807466|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
130230176|NCT01149655|468807467|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
130230177|NCT05079321|468807468|FG000|Overall Study|Withdrawal by Subject|2|||
130230178|NCT05079321|468807469|FG001|Overall Study|Withdrawal by Subject|2|||
130230179|NCT05079321|468807468|FG000|Overall Study|Lost to Follow-up|0|||
130230180|NCT05079321|468807469|FG001|Overall Study|Lost to Follow-up|1|||
130230181|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Other than specified|2|||
130230182|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Other than specified|4|||
130230183|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
130230184|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
130230185|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Pregnancy|0|||
130230186|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Pregnancy|2|||
130230187|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Physician Decision|1|||
130230188|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Physician Decision|1|||
130230189|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
130230190|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
130230191|NCT02003144|468807470|FG000|Open Label Maintenance Phase|Adverse Event|2|||
130230192|NCT02003144|468807471|FG001|Open Label Maintenance Phase|Adverse Event|1|||
130230193|NCT05965752|468807472|FG000|Overall Study|Adverse Event|0|||
130230194|NCT05965752|468807473|FG001|Overall Study|Adverse Event|1|||
130230195|NCT05965752|468807474|FG002|Overall Study|Adverse Event|0|||
130230196|NCT05965752|468807475|FG003|Overall Study|Adverse Event|1|||
130230197|NCT05965752|468807476|FG004|Overall Study|Adverse Event|3|||
130230198|NCT05965752|468807472|FG000|Overall Study|Lost to Follow-up|2|||
130230199|NCT05965752|468807473|FG001|Overall Study|Lost to Follow-up|0|||
130230200|NCT05965752|468807474|FG002|Overall Study|Lost to Follow-up|1|||
130230201|NCT05965752|468807475|FG003|Overall Study|Lost to Follow-up|1|||
130230202|NCT05965752|468807476|FG004|Overall Study|Lost to Follow-up|1|||
130230203|NCT05965752|468807472|FG000|Overall Study|Withdrawal by Subject|2|||
130230204|NCT05965752|468807473|FG001|Overall Study|Withdrawal by Subject|2|||
130230205|NCT05965752|468807474|FG002|Overall Study|Withdrawal by Subject|1|||
130230206|NCT05965752|468807475|FG003|Overall Study|Withdrawal by Subject|5|||
130230207|NCT05965752|468807476|FG004|Overall Study|Withdrawal by Subject|0|||
130230208|NCT05965752|468807472|FG000|Overall Study|Disease Relapse|1|||
130230209|NCT05965752|468807473|FG001|Overall Study|Disease Relapse|0|||
130230210|NCT05965752|468807474|FG002|Overall Study|Disease Relapse|1|||
130230211|NCT05965752|468807475|FG003|Overall Study|Disease Relapse|0|||
130230212|NCT05965752|468807476|FG004|Overall Study|Disease Relapse|0|||
130230213|NCT05965752|468807472|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130230214|NCT05965752|468807473|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
130230215|NCT05965752|468807474|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130230216|NCT05965752|468807475|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
130230217|NCT05965752|468807476|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130230218|NCT05965752|468807472|FG000|Overall Study|Unable to Return for Study Visits|0|||
130230219|NCT05965752|468807473|FG001|Overall Study|Unable to Return for Study Visits|1|||
130230220|NCT05965752|468807474|FG002|Overall Study|Unable to Return for Study Visits|0|||
130230221|NCT05965752|468807475|FG003|Overall Study|Unable to Return for Study Visits|3|||
130230222|NCT05965752|468807476|FG004|Overall Study|Unable to Return for Study Visits|1|||
130230223|NCT05965752|468807472|FG000|Overall Study|Early Termination|0|||
130230224|NCT05965752|468807473|FG001|Overall Study|Early Termination|0|||
130230225|NCT05965752|468807474|FG002|Overall Study|Early Termination|1|||
130230226|NCT05965752|468807475|FG003|Overall Study|Early Termination|0|||
130230227|NCT05965752|468807476|FG004|Overall Study|Early Termination|0|||
130230228|NCT05965752|468807472|FG000|Overall Study|Reported Unwanted Symptoms|0|||
130230229|NCT05965752|468807473|FG001|Overall Study|Reported Unwanted Symptoms|0|||
130230230|NCT05965752|468807474|FG002|Overall Study|Reported Unwanted Symptoms|0|||
130230231|NCT05965752|468807475|FG003|Overall Study|Reported Unwanted Symptoms|0|||
130230232|NCT05965752|468807476|FG004|Overall Study|Reported Unwanted Symptoms|1|||
130230233|NCT05965752|468807472|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230234|NCT05965752|468807473|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230235|NCT05965752|468807474|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230236|NCT05965752|468807475|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
130230237|NCT05965752|468807476|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
130230238|NCT01324947|468807477|FG000|Overall Study|Adverse Event|7|||
130230239|NCT01324947|468807477|FG000|Overall Study|Death|10|||
130230240|NCT01324947|468807477|FG000|Overall Study|Other|3|||
130230241|NCT01324947|468807477|FG000|Overall Study|Progressive Disease|50|||
130230242|NCT01324947|468807477|FG000|Overall Study|Withdrawal by Subject|3|||
130230243|NCT01324947|468807477|FG000|Overall Study|1 discontinued before starting drug|1|||
130230244|NCT01274351|468807478|FG000|Overall Study|Lost to Follow-up|1|||
130230245|NCT01274351|468807478|FG000|Overall Study|patient not compliant with the protocol|1|||
130230246|NCT01274351|468807478|FG000|Overall Study|Pregnancy|1|||
130230247|NCT01274351|468807478|FG000|Overall Study|Death|2|||
130230248|NCT01274351|468807478|FG000|Overall Study|Withdrawal by Subject|3|||
130230249|NCT01274351|468807478|FG000|Overall Study|Adverse Event|8|||
130230250|NCT01274351|468807478|FG000|Overall Study|progression of disease|3|||
130230251|NCT01274351|468807478|FG000|Overall Study|hospitalization|1|||
130230252|NCT01296412|468807482|FG000|Overall Study|Adverse Event|8|||
130230253|NCT01296412|468807483|FG001|Overall Study|Adverse Event|29|||
130230254|NCT01296412|468807482|FG000|Overall Study|Lack of Efficacy|1|||
130230255|NCT01296412|468807483|FG001|Overall Study|Lack of Efficacy|0|||
130230256|NCT01296412|468807482|FG000|Overall Study|Lost to Follow-up|10|||
130230257|NCT01296412|468807483|FG001|Overall Study|Lost to Follow-up|7|||
130230258|NCT01296412|468807482|FG000|Overall Study|Non-compliance with study drug|1|||
130230259|NCT01296412|468807483|FG001|Overall Study|Non-compliance with study drug|2|||
130230260|NCT01296412|468807482|FG000|Overall Study|Other reason not specified|20|||
130230261|NCT01296412|468807483|FG001|Overall Study|Other reason not specified|15|||
130230262|NCT01296412|468807482|FG000|Overall Study|Physician Decision|1|||
130230263|NCT01296412|468807483|FG001|Overall Study|Physician Decision|3|||
130230264|NCT01296412|468807482|FG000|Overall Study|Pregnancy|0|||
130230265|NCT01296412|468807483|FG001|Overall Study|Pregnancy|1|||
130230266|NCT01296412|468807482|FG000|Overall Study|Withdrawal by Subject|10|||
130230267|NCT01296412|468807483|FG001|Overall Study|Withdrawal by Subject|13|||
130230268|NCT02160626|468807484|FG000|Overall Study|Adverse Event|1|||
130230269|NCT02160626|468807485|FG001|Overall Study|Adverse Event|0|||
130230270|NCT02160626|468807486|FG002|Overall Study|Adverse Event|0|||
130230271|NCT02160626|468807484|FG000|Overall Study|Schedule not conducive to study visits|0|||
130230272|NCT02160626|468807485|FG001|Overall Study|Schedule not conducive to study visits|0|||
130230273|NCT02160626|468807486|FG002|Overall Study|Schedule not conducive to study visits|1|||
130230274|NCT02160626|468807484|FG000|Overall Study|Withdrawal by Subject|0|||
130230275|NCT02160626|468807485|FG001|Overall Study|Withdrawal by Subject|1|||
130230276|NCT02160626|468807486|FG002|Overall Study|Withdrawal by Subject|0|||
130230277|NCT04239924|468807489|FG000|Overall Study|Lost to Follow-up|2|||
130230278|NCT00434252|468809599|FG000|Overall Study|Lack of Efficacy|50|||
130230279|NCT00434252|468809600|FG001|Overall Study|Lack of Efficacy|100|||
130230280|NCT00434252|468809599|FG000|Overall Study|Adverse Event|6|||
130230281|NCT00434252|468809600|FG001|Overall Study|Adverse Event|13|||
130230282|NCT00434252|468809599|FG000|Overall Study|Death|1|||
130230283|NCT00434252|468809600|FG001|Overall Study|Death|2|||
130230284|NCT00434252|468809599|FG000|Overall Study|Lost to Follow-up|0|||
130230285|NCT00434252|468809600|FG001|Overall Study|Lost to Follow-up|1|||
130230286|NCT00434252|468809599|FG000|Overall Study|Physician Decision|4|||
130230287|NCT00434252|468809600|FG001|Overall Study|Physician Decision|8|||
130230288|NCT00434252|468809599|FG000|Overall Study|Withdrawal by Subject|3|||
130230289|NCT00434252|468809600|FG001|Overall Study|Withdrawal by Subject|7|||
130230290|NCT02997163|468809602|FG000|Overall Study|Adverse Event|1|||
130230291|NCT02997163|468809603|FG001|Overall Study|Adverse Event|0|||
130230292|NCT02997163|468809604|FG002|Overall Study|Adverse Event|0|||
130230293|NCT02997163|468809605|FG003|Overall Study|Adverse Event|1|||
130230294|NCT01855958|468809620|FG000|Overall Study|Withdrawal by Subject|1|||
130230295|NCT01855958|468809621|FG001|Overall Study|Withdrawal by Subject|0|||
130230296|NCT00296244|468809622|FG000|Overall Study|Underwent retransplant|0|||
130230297|NCT00296244|468809623|FG001|Overall Study|Underwent retransplant|1|||
130230298|NCT00427934|468809624|FG000|Overall Study|Adverse Event|1|||
130230299|NCT00427934|468809625|FG001|Overall Study|Adverse Event|0|||
130230300|NCT00427934|468809626|FG002|Overall Study|Adverse Event|5|||
130230301|NCT00427934|468809627|FG003|Overall Study|Adverse Event|4|||
130230302|NCT00427934|468809624|FG000|Overall Study|Lack of Efficacy|0|||
130230303|NCT00427934|468809625|FG001|Overall Study|Lack of Efficacy|0|||
130230304|NCT00427934|468809626|FG002|Overall Study|Lack of Efficacy|5|||
130230305|NCT00427934|468809627|FG003|Overall Study|Lack of Efficacy|2|||
130230306|NCT00427934|468809624|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
130230307|NCT00427934|468809625|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
130230308|NCT00427934|468809626|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
130230309|NCT00427934|468809627|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
130230310|NCT00427934|468809624|FG000|Overall Study|Other|0|||
130230311|NCT00427934|468809625|FG001|Overall Study|Other|0|||
130230312|NCT00427934|468809626|FG002|Overall Study|Other|11|||
130230313|NCT00427934|468809627|FG003|Overall Study|Other|5|||
130230314|NCT00427934|468809624|FG000|Overall Study|Withdrawal by Subject|0|||
130230315|NCT00427934|468809625|FG001|Overall Study|Withdrawal by Subject|0|||
130230316|NCT00427934|468809626|FG002|Overall Study|Withdrawal by Subject|1|||
130230317|NCT00427934|468809627|FG003|Overall Study|Withdrawal by Subject|3|||
130230318|NCT00499122|468809628|FG000|Overall Study|Withdrawal by Subject|2|||
130230319|NCT00903968|468809631|FG000|Overall Study|Adverse Event|0|||
130230320|NCT00903968|468809632|FG001|Overall Study|Adverse Event|0|||
130230321|NCT00903968|468809633|FG002|Overall Study|Adverse Event|0|||
130230322|NCT00903968|468809634|FG003|Overall Study|Adverse Event|0|||
130230323|NCT00903968|468809635|FG004|Overall Study|Adverse Event|0|||
130230324|NCT00903968|468809636|FG005|Overall Study|Adverse Event|0|||
130230325|NCT00903968|468809637|FG006|Overall Study|Adverse Event|1|||
130230326|NCT00903968|468809638|FG007|Overall Study|Adverse Event|8|||
130230327|NCT00903968|468809631|FG000|Overall Study|DLT|0|||
130230328|NCT00903968|468809632|FG001|Overall Study|DLT|0|||
130230329|NCT00903968|468809633|FG002|Overall Study|DLT|0|||
130230330|NCT00903968|468809634|FG003|Overall Study|DLT|0|||
130230331|NCT00903968|468809635|FG004|Overall Study|DLT|0|||
130230332|NCT00903968|468809636|FG005|Overall Study|DLT|0|||
130230333|NCT00903968|468809637|FG006|Overall Study|DLT|2|||
130230334|NCT00903968|468809638|FG007|Overall Study|DLT|0|||
130230335|NCT00903968|468809631|FG000|Overall Study|Withdrawal by Subject|1|||
130230336|NCT00903968|468809632|FG001|Overall Study|Withdrawal by Subject|0|||
130230337|NCT00903968|468809633|FG002|Overall Study|Withdrawal by Subject|1|||
130230338|NCT00903968|468809634|FG003|Overall Study|Withdrawal by Subject|0|||
130230339|NCT00903968|468809635|FG004|Overall Study|Withdrawal by Subject|1|||
130230340|NCT00903968|468809636|FG005|Overall Study|Withdrawal by Subject|1|||
130230341|NCT00903968|468809637|FG006|Overall Study|Withdrawal by Subject|0|||
130230342|NCT00903968|468809638|FG007|Overall Study|Withdrawal by Subject|4|||
130230343|NCT00903968|468809631|FG000|Overall Study|Non-Compliance|0|||
130230344|NCT00903968|468809632|FG001|Overall Study|Non-Compliance|0|||
130230345|NCT00903968|468809633|FG002|Overall Study|Non-Compliance|0|||
130230346|NCT00903968|468809634|FG003|Overall Study|Non-Compliance|0|||
130230347|NCT00903968|468809635|FG004|Overall Study|Non-Compliance|0|||
130230348|NCT00903968|468809636|FG005|Overall Study|Non-Compliance|1|||
130230349|NCT00903968|468809637|FG006|Overall Study|Non-Compliance|0|||
130230350|NCT00903968|468809638|FG007|Overall Study|Non-Compliance|0|||
130230351|NCT00903968|468809631|FG000|Overall Study|Physician Decision|0|||
130230352|NCT00903968|468809632|FG001|Overall Study|Physician Decision|0|||
130230353|NCT00903968|468809633|FG002|Overall Study|Physician Decision|0|||
130230354|NCT00903968|468809634|FG003|Overall Study|Physician Decision|0|||
130230355|NCT00903968|468809635|FG004|Overall Study|Physician Decision|0|||
130230356|NCT00903968|468809636|FG005|Overall Study|Physician Decision|1|||
130230357|NCT00903968|468809637|FG006|Overall Study|Physician Decision|0|||
130230358|NCT00903968|468809638|FG007|Overall Study|Physician Decision|0|||
130230359|NCT00903968|468809631|FG000|Overall Study|Progressive Disease|2|||
130230360|NCT00903968|468809632|FG001|Overall Study|Progressive Disease|3|||
130230361|NCT00903968|468809633|FG002|Overall Study|Progressive Disease|2|||
130230362|NCT00903968|468809634|FG003|Overall Study|Progressive Disease|3|||
130230363|NCT00903968|468809635|FG004|Overall Study|Progressive Disease|3|||
130230364|NCT00903968|468809636|FG005|Overall Study|Progressive Disease|3|||
130230365|NCT00903968|468809637|FG006|Overall Study|Progressive Disease|0|||
130230366|NCT00903968|468809638|FG007|Overall Study|Progressive Disease|18|||
130230367|NCT00903968|468809631|FG000|Overall Study|Lack of Efficacy|0|||
130230368|NCT00903968|468809632|FG001|Overall Study|Lack of Efficacy|0|||
130230369|NCT00903968|468809633|FG002|Overall Study|Lack of Efficacy|0|||
130230370|NCT00903968|468809634|FG003|Overall Study|Lack of Efficacy|0|||
130230371|NCT00903968|468809635|FG004|Overall Study|Lack of Efficacy|0|||
130230372|NCT00903968|468809636|FG005|Overall Study|Lack of Efficacy|0|||
130230373|NCT00903968|468809637|FG006|Overall Study|Lack of Efficacy|0|||
130230374|NCT00903968|468809638|FG007|Overall Study|Lack of Efficacy|3|||
130230375|NCT04539275|468809639|FG000|Overall Study|Death|2|||
130230376|NCT04539275|468809640|FG001|Overall Study|Death|4|||
130230377|NCT04539275|468809639|FG000|Overall Study|Lost to Follow-up|1|||
130230378|NCT04539275|468809640|FG001|Overall Study|Lost to Follow-up|1|||
130230379|NCT04539275|468809639|FG000|Overall Study|Withdrawal by Subject|3|||
130230380|NCT04539275|468809640|FG001|Overall Study|Withdrawal by Subject|0|||
130230381|NCT01373164|468809641|FG000|Overall Study|Lost to Follow-up|0|||
130230382|NCT01373164|468809642|FG001|Overall Study|Lost to Follow-up|0|||
130230383|NCT01373164|468809643|FG002|Overall Study|Lost to Follow-up|1|||
130230384|NCT01373164|468809644|FG003|Overall Study|Lost to Follow-up|2|||
130230385|NCT01373164|468809645|FG004|Overall Study|Lost to Follow-up|0|||
130230386|NCT01373164|468809641|FG000|Overall Study|Withdrawal by Subject|0|||
130230387|NCT01373164|468809642|FG001|Overall Study|Withdrawal by Subject|1|||
130230388|NCT01373164|468809643|FG002|Overall Study|Withdrawal by Subject|0|||
130230389|NCT01373164|468809644|FG003|Overall Study|Withdrawal by Subject|10|||
130230390|NCT01373164|468809645|FG004|Overall Study|Withdrawal by Subject|2|||
130230391|NCT01799941|468809650|FG000|Overall Study|Adverse Event|34|||
130230392|NCT01799941|468809650|FG000|Overall Study|Withdrawal by Subject|21|||
130230393|NCT01799941|468809650|FG000|Overall Study|Death|2|||
130230394|NCT01799941|468809650|FG000|Overall Study|Investigator Decision|4|||
130230395|NCT01799941|468809650|FG000|Overall Study|Lack of Efficacy|3|||
130230396|NCT01799941|468809650|FG000|Overall Study|Lost to Follow-up|17|||
130230397|NCT01799941|468809650|FG000|Overall Study|Other|15|||
130230398|NCT03736967|468809666|FG000|Overall Study|Withdrawal by Subject|26|||
130230399|NCT03736967|468809667|FG001|Overall Study|Withdrawal by Subject|25|||
130230400|NCT03736967|468809668|FG002|Overall Study|Withdrawal by Subject|23|||
130230401|NCT03736967|468809669|FG003|Overall Study|Withdrawal by Subject|26|||
130230402|NCT03736967|468809666|FG000|Overall Study|Lost to Follow-up|3|||
130230403|NCT03736967|468809667|FG001|Overall Study|Lost to Follow-up|2|||
130230404|NCT03736967|468809668|FG002|Overall Study|Lost to Follow-up|1|||
130230405|NCT03736967|468809669|FG003|Overall Study|Lost to Follow-up|1|||
130230406|NCT03736967|468809666|FG000|Overall Study|Physician Decision|1|||
130230407|NCT03736967|468809667|FG001|Overall Study|Physician Decision|0|||
130230408|NCT03736967|468809668|FG002|Overall Study|Physician Decision|0|||
130230409|NCT03736967|468809669|FG003|Overall Study|Physician Decision|1|||
130230410|NCT03736967|468809666|FG000|Overall Study|Adverse Event|0|||
130230411|NCT03736967|468809667|FG001|Overall Study|Adverse Event|1|||
130230412|NCT03736967|468809668|FG002|Overall Study|Adverse Event|0|||
130230413|NCT03736967|468809669|FG003|Overall Study|Adverse Event|1|||
130230414|NCT03736967|468809666|FG000|Overall Study|Death|0|||
130230415|NCT03736967|468809667|FG001|Overall Study|Death|0|||
130230416|NCT03736967|468809668|FG002|Overall Study|Death|0|||
130230417|NCT03736967|468809669|FG003|Overall Study|Death|1|||
130230418|NCT03736967|468809666|FG000|Overall Study|Randomized but never treated|1|||
130230419|NCT03736967|468809667|FG001|Overall Study|Randomized but never treated|0|||
130230420|NCT03736967|468809668|FG002|Overall Study|Randomized but never treated|0|||
130230421|NCT03736967|468809669|FG003|Overall Study|Randomized but never treated|0|||
130230422|NCT02419807|468809670|FG000|Overall Study|Withdrawal by Subject|4|||
130230423|NCT02419807|468809670|FG000|Overall Study|Physician Decision|1|||
130230424|NCT02419807|468809670|FG000|Overall Study|Protocol Violation|5|||
130230425|NCT01006629|468809671|FG000|Overall Study|Adverse Event|1|||
130230426|NCT01006629|468809671|FG000|Overall Study|Parent refused to continue participation|1|||
130230427|NCT01006629|468809671|FG000|Overall Study|Parent unable to perform site visit|4|||
130230428|NCT03157089|468809672|FG000|Overall Study|Treated only with pembrolizumab|1|||
130230429|NCT03157089|468809673|FG001|Overall Study|Treated only with pembrolizumab|0|||
130230430|NCT03157089|468809672|FG000|Overall Study|Adverse Event|5|||
130230431|NCT03157089|468809673|FG001|Overall Study|Adverse Event|4|||
130230432|NCT03157089|468809672|FG000|Overall Study|Progressive disease|6|||
130230433|NCT03157089|468809673|FG001|Overall Study|Progressive disease|8|||
130230434|NCT02932943|468809674|FG000|Overall Study|Lost to Follow-up|0|||
130230435|NCT02932943|468809675|FG001|Overall Study|Lost to Follow-up|2|||
130230436|NCT02932943|468809674|FG000|Overall Study|Adverse Event|2|||
130230437|NCT02932943|468809675|FG001|Overall Study|Adverse Event|2|||
130230438|NCT02932943|468809674|FG000|Overall Study|Withdrawal by Subject|3|||
130230439|NCT02932943|468809675|FG001|Overall Study|Withdrawal by Subject|3|||
130230440|NCT02300610|468809678|FG000|Overall Study|Withdrawal by Subject|1|||
130230441|NCT02300610|468809679|FG001|Overall Study|Withdrawal by Subject|0|||
130230442|NCT02300610|468809680|FG002|Overall Study|Withdrawal by Subject|1|||
130230443|NCT00095979|468809681|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
130230444|NCT01663623|468809684|FG000|Overall Study|Adverse Event|3|||
130230445|NCT01663623|468809685|FG001|Overall Study|Adverse Event|7|||
130230446|NCT01663623|468809684|FG000|Overall Study|Lack of Efficacy|5|||
130230447|NCT01663623|468809685|FG001|Overall Study|Lack of Efficacy|6|||
130230448|NCT01663623|468809684|FG000|Overall Study|Protocol Violation|0|||
130230449|NCT01663623|468809685|FG001|Overall Study|Protocol Violation|1|||
130230450|NCT01663623|468809684|FG000|Overall Study|Other-Study closed/terminated|1|||
130230451|NCT01663623|468809685|FG001|Overall Study|Other-Study closed/terminated|1|||
130230452|NCT01663623|468809684|FG000|Overall Study|Physician Decision|1|||
130230453|NCT01663623|468809685|FG001|Overall Study|Physician Decision|4|||
130230454|NCT01663623|468809684|FG000|Overall Study|Withdrawal by Subject|2|||
130230455|NCT01663623|468809685|FG001|Overall Study|Withdrawal by Subject|1|||
130230456|NCT02251275|468809686|FG000|Overall Study|Adverse Event|23|||
130230457|NCT02251275|468809687|FG001|Overall Study|Adverse Event|60|||
130230458|NCT02251275|468809688|FG002|Overall Study|Adverse Event|28|||
130230459|NCT02251275|468809689|FG003|Overall Study|Adverse Event|0|||
130230460|NCT02251275|468809690|FG004|Overall Study|Adverse Event|0|||
130230461|NCT02251275|468809686|FG000|Overall Study|Lost to Follow-up|5|||
130230462|NCT02251275|468809687|FG001|Overall Study|Lost to Follow-up|6|||
130230463|NCT02251275|468809688|FG002|Overall Study|Lost to Follow-up|4|||
130230464|NCT02251275|468809689|FG003|Overall Study|Lost to Follow-up|0|||
130230465|NCT02251275|468809690|FG004|Overall Study|Lost to Follow-up|0|||
130230466|NCT02251275|468809686|FG000|Overall Study|Physician Decision|19|||
130230467|NCT02251275|468809687|FG001|Overall Study|Physician Decision|30|||
130230468|NCT02251275|468809688|FG002|Overall Study|Physician Decision|26|||
130230469|NCT02251275|468809689|FG003|Overall Study|Physician Decision|0|||
130230470|NCT02251275|468809690|FG004|Overall Study|Physician Decision|1|||
130230471|NCT02251275|468809686|FG000|Overall Study|Protocol Deviation|0|||
130230472|NCT02251275|468809687|FG001|Overall Study|Protocol Deviation|0|||
130230473|NCT02251275|468809688|FG002|Overall Study|Protocol Deviation|1|||
130230474|NCT02251275|468809689|FG003|Overall Study|Protocol Deviation|0|||
130230475|NCT02251275|468809690|FG004|Overall Study|Protocol Deviation|0|||
130230476|NCT02251275|468809686|FG000|Overall Study|Withdrawal by Subject|25|||
130230477|NCT02251275|468809687|FG001|Overall Study|Withdrawal by Subject|51|||
130230478|NCT02251275|468809688|FG002|Overall Study|Withdrawal by Subject|35|||
130230479|NCT02251275|468809689|FG003|Overall Study|Withdrawal by Subject|1|||
130230480|NCT02251275|468809690|FG004|Overall Study|Withdrawal by Subject|0|||
130230481|NCT00856180|468809694|FG000|Overall Study|Adverse Event|4|||
130023034|NCT03021642|468045055|FG000|Washout Period (21 Days)|Adverse Event|1|||
130023035|NCT03021642|468045056|FG001|Washout Period (21 Days)|Adverse Event|1|||
130023036|NCT00756938|468045057|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
130023037|NCT00756938|468045058|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
130023038|NCT00756938|468045059|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
130023039|NCT00756938|468045060|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
130023040|NCT00756938|468045057|FG000|12-week Base Study|Protocol Violation|0|||
130023041|NCT00756938|468045058|FG001|12-week Base Study|Protocol Violation|0|||
130023042|NCT00756938|468045059|FG002|12-week Base Study|Protocol Violation|1|||
130023043|NCT00756938|468045060|FG003|12-week Base Study|Protocol Violation|0|||
130023044|NCT00756938|468045057|FG000|12-week Base Study|Lost to Follow-up|1|||
130023045|NCT00756938|468045058|FG001|12-week Base Study|Lost to Follow-up|0|||
130023046|NCT00756938|468045059|FG002|12-week Base Study|Lost to Follow-up|0|||
130023047|NCT00756938|468045060|FG003|12-week Base Study|Lost to Follow-up|0|||
130023048|NCT00756938|468045057|FG000|Optional Extension|Lack of Efficacy|0|||
130023049|NCT00756938|468045058|FG001|Optional Extension|Lack of Efficacy|0|||
130023050|NCT00756938|468045059|FG002|Optional Extension|Lack of Efficacy|0|||
130023051|NCT00756938|468045060|FG003|Optional Extension|Lack of Efficacy|1|||
130023052|NCT00756938|468045057|FG000|Optional Extension|End of Study|0|||
130023053|NCT00756938|468045058|FG001|Optional Extension|End of Study|0|||
130023054|NCT00756938|468045059|FG002|Optional Extension|End of Study|0|||
130023055|NCT00756938|468045060|FG003|Optional Extension|End of Study|11|||
130023056|NCT00756938|468045057|FG000|Optional Extension|Protocol-specific criteria met|0|||
130023057|NCT00756938|468045058|FG001|Optional Extension|Protocol-specific criteria met|0|||
130023058|NCT00756938|468045059|FG002|Optional Extension|Protocol-specific criteria met|0|||
130023059|NCT00756938|468045060|FG003|Optional Extension|Protocol-specific criteria met|9|||
130023060|NCT00756938|468045057|FG000|Optional Extension|Physician Decision|0|||
130023061|NCT00756938|468045058|FG001|Optional Extension|Physician Decision|0|||
130023062|NCT00756938|468045059|FG002|Optional Extension|Physician Decision|0|||
130023063|NCT00756938|468045060|FG003|Optional Extension|Physician Decision|3|||
130023064|NCT00756938|468045057|FG000|Optional Extension|Lost to Follow-up|0|||
130023065|NCT00756938|468045058|FG001|Optional Extension|Lost to Follow-up|0|||
130023066|NCT00756938|468045059|FG002|Optional Extension|Lost to Follow-up|0|||
130023067|NCT00756938|468045060|FG003|Optional Extension|Lost to Follow-up|1|||
130023068|NCT00756938|468045057|FG000|Optional Extension|Protocol Violation|0|||
130023069|NCT00756938|468045058|FG001|Optional Extension|Protocol Violation|0|||
130023070|NCT00756938|468045059|FG002|Optional Extension|Protocol Violation|0|||
130023071|NCT00756938|468045060|FG003|Optional Extension|Protocol Violation|1|||
130023072|NCT00756938|468045057|FG000|Optional Extension|Withdrawal by Subject|0|||
130023073|NCT00756938|468045058|FG001|Optional Extension|Withdrawal by Subject|0|||
130023074|NCT00756938|468045059|FG002|Optional Extension|Withdrawal by Subject|0|||
130023075|NCT00756938|468045060|FG003|Optional Extension|Withdrawal by Subject|10|||
130023076|NCT00756938|468045057|FG000|Optional Extension|Adverse Event|0|||
130023077|NCT00756938|468045058|FG001|Optional Extension|Adverse Event|0|||
130023078|NCT00756938|468045059|FG002|Optional Extension|Adverse Event|0|||
130023079|NCT00756938|468045060|FG003|Optional Extension|Adverse Event|1|||
130023080|NCT00441545|468045061|FG000|First Intervention|Adverse Event|6|||
130023081|NCT00441545|468045062|FG001|First Intervention|Adverse Event|5|||
130023082|NCT00441545|468045061|FG000|First Intervention|Protocol Violation|2|||
130023083|NCT00441545|468045062|FG001|First Intervention|Protocol Violation|2|||
130023084|NCT00441545|468045061|FG000|First Intervention|Withdrawal by Subject|3|||
130023085|NCT00441545|468045062|FG001|First Intervention|Withdrawal by Subject|3|||
130023086|NCT00441545|468045061|FG000|First Intervention|Kidney transplant|1|||
130023087|NCT00441545|468045062|FG001|First Intervention|Kidney transplant|1|||
130023088|NCT00441545|468045061|FG000|First Intervention|Lack of Efficacy|2|||
130023089|NCT00441545|468045062|FG001|First Intervention|Lack of Efficacy|0|||
130023090|NCT00441545|468045061|FG000|First Intervention|Subject exceeded safety criteria|0|||
130023091|NCT00441545|468045062|FG001|First Intervention|Subject exceeded safety criteria|1|||
130023092|NCT00441545|468045061|FG000|First Intervention|Subject met an exclusionary criteria|1|||
130023093|NCT00441545|468045062|FG001|First Intervention|Subject met an exclusionary criteria|0|||
130023094|NCT00441545|468045061|FG000|First Intervention|Extended hospitalization|1|||
130023095|NCT00441545|468045062|FG001|First Intervention|Extended hospitalization|0|||
130023096|NCT00441545|468045061|FG000|First Intervention|Site error|1|||
130023097|NCT00441545|468045062|FG001|First Intervention|Site error|0|||
130023098|NCT00441545|468045061|FG000|First Intervention|Sponsor's request|1|||
130023099|NCT00441545|468045062|FG001|First Intervention|Sponsor's request|0|||
130023100|NCT00441545|468045061|FG000|Second Intervention|Adverse Event|5|||
130023101|NCT00441545|468045062|FG001|Second Intervention|Adverse Event|2|||
130023102|NCT00441545|468045061|FG000|Second Intervention|Protocol Violation|4|||
130023103|NCT00441545|468045062|FG001|Second Intervention|Protocol Violation|1|||
130023104|NCT00441545|468045061|FG000|Second Intervention|Withdrawal by Subject|1|||
130023105|NCT00441545|468045062|FG001|Second Intervention|Withdrawal by Subject|1|||
130023106|NCT00441545|468045061|FG000|Second Intervention|Kidney Transplant|1|||
130023107|NCT00441545|468045062|FG001|Second Intervention|Kidney Transplant|1|||
130023108|NCT00441545|468045061|FG000|Second Intervention|Lack of Efficacy|0|||
130230482|NCT00856180|468809694|FG000|Overall Study|Progressive Disease|16|||
130230483|NCT00686972|468809695|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
130230484|NCT01462942|468809698|FG000|Overall Study|Adverse Event|7|||
130230485|NCT01462942|468809699|FG001|Overall Study|Adverse Event|12|||
130230486|NCT01462942|468809700|FG002|Overall Study|Adverse Event|10|||
130230487|NCT01462942|468809701|FG003|Overall Study|Adverse Event|11|||
130230488|NCT01462942|468809702|FG004|Overall Study|Adverse Event|11|||
130230489|NCT01462942|468809698|FG000|Overall Study|Other, including COPD exacerbation|3|||
130230490|NCT01462942|468809699|FG001|Overall Study|Other, including COPD exacerbation|5|||
130230491|NCT01462942|468809700|FG002|Overall Study|Other, including COPD exacerbation|2|||
130230492|NCT01462942|468809701|FG003|Overall Study|Other, including COPD exacerbation|8|||
130230493|NCT01462942|468809702|FG004|Overall Study|Other, including COPD exacerbation|5|||
130230494|NCT01462942|468809698|FG000|Overall Study|Withdrawal by Subject|14|||
130230495|NCT01462942|468809699|FG001|Overall Study|Withdrawal by Subject|10|||
130230496|NCT01462942|468809700|FG002|Overall Study|Withdrawal by Subject|14|||
130230497|NCT01462942|468809701|FG003|Overall Study|Withdrawal by Subject|16|||
130230498|NCT01462942|468809702|FG004|Overall Study|Withdrawal by Subject|19|||
130230499|NCT01462942|468809698|FG000|Overall Study|Lack of Efficacy|6|||
130230500|NCT01462942|468809699|FG001|Overall Study|Lack of Efficacy|0|||
130230501|NCT01462942|468809700|FG002|Overall Study|Lack of Efficacy|4|||
130230502|NCT01462942|468809701|FG003|Overall Study|Lack of Efficacy|5|||
130230503|NCT01462942|468809702|FG004|Overall Study|Lack of Efficacy|3|||
130230504|NCT01462942|468809698|FG000|Overall Study|Lost to Follow-up|0|||
130230505|NCT01462942|468809699|FG001|Overall Study|Lost to Follow-up|1|||
130230506|NCT01462942|468809700|FG002|Overall Study|Lost to Follow-up|1|||
130230507|NCT01462942|468809701|FG003|Overall Study|Lost to Follow-up|1|||
130230508|NCT01462942|468809702|FG004|Overall Study|Lost to Follow-up|1|||
130230509|NCT01462942|468809698|FG000|Overall Study|Protocol Violation|4|||
130230510|NCT01462942|468809699|FG001|Overall Study|Protocol Violation|6|||
130230511|NCT01462942|468809700|FG002|Overall Study|Protocol Violation|9|||
130230512|NCT01462942|468809701|FG003|Overall Study|Protocol Violation|9|||
130230513|NCT01462942|468809702|FG004|Overall Study|Protocol Violation|6|||
130230514|NCT01027845|468809703|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
130230515|NCT01027845|468809704|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
130230516|NCT01027845|468809705|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
130230517|NCT01027845|468809706|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
130230518|NCT01027845|468809703|FG000|Primary Vaccination Phase|Adverse Event|1|||
130230519|NCT01027845|468809704|FG001|Primary Vaccination Phase|Adverse Event|0|||
130230520|NCT01027845|468809705|FG002|Primary Vaccination Phase|Adverse Event|0|||
130230521|NCT01027845|468809706|FG003|Primary Vaccination Phase|Adverse Event|0|||
130230522|NCT01027845|468809703|FG000|Primary Vaccination Phase|Protocol Violation|1|||
130230523|NCT01027845|468809704|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130230524|NCT01027845|468809705|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130230525|NCT01027845|468809706|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130230526|NCT01027845|468809703|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
130230527|NCT01027845|468809704|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
130230528|NCT01027845|468809705|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
130230529|NCT01027845|468809706|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
130230530|NCT01027845|468809703|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
130230531|NCT01027845|468809704|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130230532|NCT01027845|468809705|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
130230533|NCT01027845|468809706|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
130230534|NCT01027845|468809703|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
130230535|NCT01027845|468809704|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
130230536|NCT01027845|468809705|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
130230537|NCT01027845|468809706|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
130230538|NCT00368550|468809707|FG000|Overall Study|Adverse Event|7|||
130230539|NCT00368550|468809708|FG001|Overall Study|Adverse Event|4|||
130023109|NCT00441545|468045062|FG001|Second Intervention|Lack of Efficacy|1|||
130023110|NCT00441545|468045061|FG000|Second Intervention|Subject exceeded safety criteria|1|||
130230540|NCT00368550|468809707|FG000|Overall Study|Lack of Efficacy|4|||
130230541|NCT00368550|468809708|FG001|Overall Study|Lack of Efficacy|9|||
130230542|NCT00368550|468809707|FG000|Overall Study|Withdrawal by Subject|17|||
130230543|NCT00368550|468809708|FG001|Overall Study|Withdrawal by Subject|10|||
130230544|NCT00486044|468809709|FG000|Overall Study|Withdrawal by Subject|2|||
130230545|NCT00486044|468809710|FG001|Overall Study|Withdrawal by Subject|1|||
130230546|NCT00486044|468809709|FG000|Overall Study|Adverse Event|0|||
130023111|NCT00441545|468045062|FG001|Second Intervention|Subject exceeded safety criteria|0|||
130230547|NCT00486044|468809710|FG001|Overall Study|Adverse Event|1|||
130230548|NCT00486044|468809709|FG000|Overall Study|Lost to Follow-up|0|||
130230549|NCT00486044|468809710|FG001|Overall Study|Lost to Follow-up|1|||
130230550|NCT01670292|468809714|FG000|Overall Study|Lost to Follow-up|14|||
130230551|NCT03154086|468809720|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230552|NCT03154086|468809721|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230553|NCT03154086|468809722|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230554|NCT03154086|468809723|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
130230555|NCT03154086|468809724|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230556|NCT03154086|468809725|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230557|NCT03154086|468809726|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230558|NCT03154086|468809727|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230559|NCT03154086|468809728|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230560|NCT03154086|468809729|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230561|NCT03154086|468809730|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230562|NCT03154086|468809731|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230563|NCT03154086|468809732|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230564|NCT03154086|468809733|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230565|NCT03154086|468809734|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
130230566|NCT03154086|468809720|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230567|NCT03154086|468809721|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
130230568|NCT03154086|468809722|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230569|NCT03154086|468809723|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230570|NCT03154086|468809724|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230571|NCT03154086|468809725|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230572|NCT03154086|468809726|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230573|NCT03154086|468809727|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230574|NCT03154086|468809728|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230575|NCT03154086|468809729|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230576|NCT03154086|468809730|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230577|NCT03154086|468809731|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230578|NCT03154086|468809732|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230579|NCT03154086|468809733|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230580|NCT03154086|468809734|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
130230581|NCT03154086|468809720|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230582|NCT03154086|468809721|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230583|NCT03154086|468809722|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
130230584|NCT03154086|468809723|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230585|NCT03154086|468809724|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230586|NCT03154086|468809725|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230587|NCT03154086|468809726|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230588|NCT03154086|468809727|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230589|NCT03154086|468809728|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230590|NCT03154086|468809729|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230591|NCT03154086|468809730|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230592|NCT03154086|468809731|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230593|NCT03154086|468809732|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230594|NCT03154086|468809733|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230595|NCT03154086|468809734|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
130230596|NCT03154086|468809720|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
130230597|NCT03154086|468809721|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230598|NCT03154086|468809722|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230599|NCT03154086|468809723|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230600|NCT03154086|468809724|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230601|NCT03154086|468809725|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230602|NCT03154086|468809726|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230603|NCT03154086|468809727|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230604|NCT03154086|468809728|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130023112|NCT00441545|468045061|FG000|Second Intervention|Subject moved|0|||
130023113|NCT00441545|468045062|FG001|Second Intervention|Subject moved|1|||
130023114|NCT02347176|468045063|FG000|Overall Study|Lost to Follow-up|2|||
130023115|NCT02347176|468045064|FG001|Overall Study|Lost to Follow-up|3|||
130023116|NCT02347176|468045065|FG002|Overall Study|Lost to Follow-up|1|||
130023117|NCT02347176|468045066|FG003|Overall Study|Lost to Follow-up|1|||
130023118|NCT02347176|468045063|FG000|Overall Study|Withdrawal by Subject|9|||
130023119|NCT02347176|468045064|FG001|Overall Study|Withdrawal by Subject|5|||
130023120|NCT02347176|468045065|FG002|Overall Study|Withdrawal by Subject|5|||
130023121|NCT02347176|468045066|FG003|Overall Study|Withdrawal by Subject|3|||
130023122|NCT02347176|468045063|FG000|Overall Study|Other|1|||
130023123|NCT02347176|468045064|FG001|Overall Study|Other|2|||
130023124|NCT02347176|468045065|FG002|Overall Study|Other|2|||
130023125|NCT02347176|468045066|FG003|Overall Study|Other|0|||
130023126|NCT02474082|468045067|FG000|Overall Study|Adverse Event|2|||
130023127|NCT02474082|468045068|FG001|Overall Study|Adverse Event|32|||
130023128|NCT02474082|468045067|FG000|Overall Study|Withdrawal of informed consent|1|||
130023129|NCT02474082|468045068|FG001|Overall Study|Withdrawal of informed consent|11|||
130023130|NCT02474082|468045067|FG000|Overall Study|Lost to Follow-up|2|||
130023131|NCT02474082|468045068|FG001|Overall Study|Lost to Follow-up|2|||
130023132|NCT02474082|468045067|FG000|Overall Study|Dose tapering not achieved|0|||
130023133|NCT02474082|468045068|FG001|Overall Study|Dose tapering not achieved|4|||
130023134|NCT02474082|468045067|FG000|Overall Study|Participant/guardian decision|1|||
130023135|NCT02474082|468045068|FG001|Overall Study|Participant/guardian decision|2|||
130023136|NCT02474082|468045067|FG000|Overall Study|Non-compliance with study treatment|0|||
130023137|NCT02474082|468045068|FG001|Overall Study|Non-compliance with study treatment|2|||
130023138|NCT02474082|468045067|FG000|Overall Study|Protocol deviation|0|||
130023139|NCT02474082|468045068|FG001|Overall Study|Protocol deviation|1|||
130023140|NCT00797823|468045073|FG000|First Period (Initial Randomization)|Physician Decision|1|||
130023141|NCT00797823|468045074|FG001|First Period (Initial Randomization)|Physician Decision|0|||
130023142|NCT00797823|468045075|FG002|First Period (Initial Randomization)|Physician Decision|0|||
130023143|NCT00523991|468045076|FG000|Overall Study|Adverse Event|6|||
130023144|NCT00523991|468045077|FG001|Overall Study|Adverse Event|5|||
130023145|NCT00523991|468045076|FG000|Overall Study|Protocol Violation|1|||
130023146|NCT00523991|468045077|FG001|Overall Study|Protocol Violation|4|||
130023147|NCT00523991|468045076|FG000|Overall Study|Lost to Follow-up|4|||
130023148|NCT00523991|468045077|FG001|Overall Study|Lost to Follow-up|1|||
130023149|NCT00523991|468045076|FG000|Overall Study|Withdrawal by Subject|7|||
130023150|NCT00523991|468045077|FG001|Overall Study|Withdrawal by Subject|17|||
130023151|NCT00523991|468045076|FG000|Overall Study|Other reason (not specified)|3|||
130023152|NCT00523991|468045077|FG001|Overall Study|Other reason (not specified)|0|||
130023153|NCT00193063|468045078|FG000|Overall Study|Lack of Efficacy|3|||
130023154|NCT00193063|468045078|FG000|Overall Study|Adverse Event|1|||
130023155|NCT00744874|468045081|FG000|Overall Study|Lost to Follow-up|1|||
130023156|NCT00744874|468045081|FG000|Overall Study|Withdrawal by Subject|1|||
130023157|NCT00744874|468045081|FG000|Overall Study|Study Device not available at procedure|1|||
130023158|NCT00744874|468045081|FG000|Overall Study|Unable to accomodate schedule|1|||
130023159|NCT01127165|468045087|FG000|Overall Study|Adverse Event|2|||
130023160|NCT01127165|468045088|FG001|Overall Study|Adverse Event|2|||
130023161|NCT01127165|468045087|FG000|Overall Study|Lack of Efficacy|10|||
130023162|NCT01127165|468045088|FG001|Overall Study|Lack of Efficacy|8|||
130023163|NCT01127165|468045087|FG000|Overall Study|Lost to Follow-up|3|||
130023164|NCT01127165|468045088|FG001|Overall Study|Lost to Follow-up|5|||
130023165|NCT01127165|468045087|FG000|Overall Study|Withdrawal by Subject|1|||
130023166|NCT01127165|468045088|FG001|Overall Study|Withdrawal by Subject|3|||
130023167|NCT01127165|468045087|FG000|Overall Study|Protocol Violation|0|||
130023168|NCT01127165|468045088|FG001|Overall Study|Protocol Violation|1|||
130023169|NCT00763321|468045089|FG000|Open-label Period|Adverse Event|24|||
130023170|NCT00763321|468045090|FG001|Open-label Period|Adverse Event|0|||
130230605|NCT03154086|468809729|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230606|NCT03154086|468809730|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230607|NCT03154086|468809731|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230608|NCT03154086|468809732|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230609|NCT03154086|468809733|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230610|NCT03154086|468809734|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
130230611|NCT03154086|468809720|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230612|NCT03154086|468809721|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230613|NCT03154086|468809722|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230614|NCT03154086|468809723|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230615|NCT03154086|468809724|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230616|NCT03154086|468809725|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230617|NCT03154086|468809726|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230618|NCT03154086|468809727|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230619|NCT03154086|468809728|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
130230620|NCT03154086|468809729|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230621|NCT03154086|468809730|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230622|NCT03154086|468809731|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230623|NCT03154086|468809732|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230624|NCT03154086|468809733|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230625|NCT03154086|468809734|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
130230626|NCT03154086|468809720|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230627|NCT03154086|468809721|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230628|NCT03154086|468809722|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230629|NCT03154086|468809723|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230630|NCT03154086|468809724|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230631|NCT03154086|468809725|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230632|NCT03154086|468809726|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230633|NCT03154086|468809727|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
130230634|NCT03154086|468809728|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230635|NCT03154086|468809729|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230636|NCT03154086|468809730|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230637|NCT03154086|468809731|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230638|NCT03154086|468809732|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230639|NCT03154086|468809733|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230640|NCT03154086|468809734|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
130230641|NCT03154086|468809720|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
130230642|NCT03154086|468809721|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
130230643|NCT03154086|468809722|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
130230644|NCT03154086|468809723|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
130230645|NCT03154086|468809724|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
130230646|NCT03154086|468809725|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
130230647|NCT03154086|468809726|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
130023171|NCT00763321|468045091|FG002|Open-label Period|Adverse Event|0|||
129884520|NCT04779242|467536436|FG000|Overall Study|Withdrawal by Subject|7|||
130230648|NCT03154086|468809727|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
130230649|NCT03154086|468809728|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
130230650|NCT03154086|468809729|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
130230651|NCT03154086|468809730|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
130230652|NCT03154086|468809731|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
130230653|NCT03154086|468809732|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
130230654|NCT03154086|468809733|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
130230655|NCT03154086|468809734|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
130230656|NCT01603277|468809735|FG000|Overall Study|Adverse Event|1|||
130230657|NCT01603277|468809736|FG001|Overall Study|Adverse Event|2|||
130230658|NCT01603277|468809735|FG000|Overall Study|Physician Decision|0|||
130230659|NCT01603277|468809736|FG001|Overall Study|Physician Decision|1|||
130230660|NCT01603277|468809735|FG000|Overall Study|Protocol Violation|6|||
130230661|NCT01603277|468809736|FG001|Overall Study|Protocol Violation|10|||
130230662|NCT01603277|468809735|FG000|Overall Study|Withdrawal by Subject|5|||
130230663|NCT01603277|468809736|FG001|Overall Study|Withdrawal by Subject|4|||
130230664|NCT01603277|468809735|FG000|Overall Study|Non-Compliance|2|||
130230665|NCT01603277|468809736|FG001|Overall Study|Non-Compliance|1|||
130230666|NCT04465422|468809739|FG000|Overall Study|Lost to Follow-up|0|||
130230667|NCT04465422|468809740|FG001|Overall Study|Lost to Follow-up|2|||
130230668|NCT02391337|468809741|FG000|6 Months Follow-up|Death|5|||
130230669|NCT02391337|468809742|FG001|6 Months Follow-up|Death|4|||
130230670|NCT02391337|468809741|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
130230671|NCT02391337|468809742|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
130230672|NCT02391337|468809741|FG000|12 Months Follow-up|Death|2|||
130230673|NCT02391337|468809742|FG001|12 Months Follow-up|Death|0|||
130230674|NCT02391337|468809741|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
130230675|NCT02391337|468809742|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
130230676|NCT02391337|468809741|FG000|12 Months Follow-up|Lost to Follow-up|0|||
130230677|NCT02391337|468809742|FG001|12 Months Follow-up|Lost to Follow-up|2|||
130230678|NCT00746551|468809743|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
130230679|NCT00746551|468809744|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
130230680|NCT00746551|468809743|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
130230681|NCT00746551|468809744|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
130230682|NCT00746551|468809743|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
130230683|NCT00746551|468809744|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
130230684|NCT00062166|468809745|FG000|Overall Study|Withdrawal by Subject|6|||
130230685|NCT00833755|468809746|FG000|Overall Study|Physician Decision|4|||
130230686|NCT00833755|468809747|FG001|Overall Study|Physician Decision|4|||
130230687|NCT00833755|468809748|FG002|Overall Study|Physician Decision|2|||
130230688|NCT00833755|468809749|FG003|Overall Study|Physician Decision|6|||
130230689|NCT00833755|468809746|FG000|Overall Study|Subject had scheduling issues|0|||
130230690|NCT00833755|468809747|FG001|Overall Study|Subject had scheduling issues|1|||
130230691|NCT00833755|468809748|FG002|Overall Study|Subject had scheduling issues|0|||
130230692|NCT00833755|468809749|FG003|Overall Study|Subject had scheduling issues|0|||
130230693|NCT01776554|468809752|FG000|Overall Study|Adverse Event|1|||
130230694|NCT01776554|468809753|FG001|Overall Study|Adverse Event|0|||
130230695|NCT01776554|468809752|FG000|Overall Study|Withdrawal by Subject|3|||
130230696|NCT01776554|468809753|FG001|Overall Study|Withdrawal by Subject|8|||
130230697|NCT01776554|468809752|FG000|Overall Study|Lost to Follow-up|6|||
130230698|NCT01776554|468809753|FG001|Overall Study|Lost to Follow-up|9|||
130230699|NCT01776554|468809752|FG000|Overall Study|Administrative Reason|2|||
130230700|NCT01776554|468809753|FG001|Overall Study|Administrative Reason|5|||
130230701|NCT01776554|468809752|FG000|Overall Study|Protocol Violation|1|||
130230702|NCT01776554|468809753|FG001|Overall Study|Protocol Violation|0|||
130230703|NCT01776554|468809752|FG000|Overall Study|Unclassified|4|||
130230704|NCT01776554|468809753|FG001|Overall Study|Unclassified|1|||
130230705|NCT02475369|468809754|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
130230706|NCT02475369|468809755|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
130230707|NCT03608826|468809757|FG000|Overall Study|Death|3|||
130230708|NCT03608826|468809757|FG000|Overall Study|Heart Transplant|3|||
130230709|NCT03608826|468809757|FG000|Overall Study|Physician Decision|4|||
130230710|NCT03122171|468809758|FG000|Overall Study|Withdrawal by Subject|1|||
130230711|NCT00617279|468809770|FG000|Overall Study|Study terminated by Sponsor|10|||
130230712|NCT00617279|468809771|FG001|Overall Study|Study terminated by Sponsor|15|||
130230713|NCT00617279|468809770|FG000|Overall Study|Graft abandonment|2|||
130230714|NCT00617279|468809771|FG001|Overall Study|Graft abandonment|0|||
130230715|NCT00617279|468809770|FG000|Overall Study|Lost to Follow-up|1|||
130230716|NCT00617279|468809771|FG001|Overall Study|Lost to Follow-up|0|||
130230717|NCT00617279|468809770|FG000|Overall Study|Death|1|||
130230718|NCT00617279|468809771|FG001|Overall Study|Death|2|||
130230719|NCT00921024|468809774|FG000|Overall Study|Lost to Follow-up|2|||
130230720|NCT00921024|468809775|FG001|Overall Study|Lost to Follow-up|0|||
130230721|NCT00921024|468809774|FG000|Overall Study|Received concomittant therapy|2|||
130230722|NCT00921024|468809775|FG001|Overall Study|Received concomittant therapy|0|||
130230723|NCT00921024|468809774|FG000|Overall Study|Withdrawal by Subject|0|||
130230724|NCT00921024|468809775|FG001|Overall Study|Withdrawal by Subject|3|||
130230725|NCT03415178|468809777|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
130230726|NCT03415178|468809778|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
130230727|NCT03415178|468809777|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
130230728|NCT03415178|468809778|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
130230729|NCT00753519|468811472|FG000|Overall Study|Withdrawal by Subject|0|||
130230730|NCT00753519|468811473|FG001|Overall Study|Withdrawal by Subject|2|||
130230731|NCT02807259|468811474|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
130230732|NCT02807259|468811475|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
130230733|NCT02807259|468811474|FG000|Midline (3 Months)|migration, refusal, not available|30|||
130230734|NCT02807259|468811475|FG001|Midline (3 Months)|migration, refusal, not available|34|||
130230735|NCT02807259|468811474|FG000|Endline (3 Months)|migration, refusal, not available|35|||
130230736|NCT02807259|468811475|FG001|Endline (3 Months)|migration, refusal, not available|87|||
130230737|NCT03861039|468811476|FG000|Overall Study|Adverse Event|2|||
130230738|NCT03861039|468811477|FG001|Overall Study|Adverse Event|5|||
130230739|NCT03861039|468811478|FG002|Overall Study|Adverse Event|11|||
130230740|NCT03861039|468811476|FG000|Overall Study|Withdrawal by Subject|1|||
130230741|NCT03861039|468811477|FG001|Overall Study|Withdrawal by Subject|3|||
130230742|NCT03861039|468811478|FG002|Overall Study|Withdrawal by Subject|4|||
130230743|NCT02791269|468811494|FG000|Overall Study|Lost to Follow-up|0|||
130230744|NCT02791269|468811495|FG001|Overall Study|Lost to Follow-up|1|||
130230745|NCT00420745|468811496|FG000|Overall Study|Adverse Event|2|||
130230746|NCT00420745|468811497|FG001|Overall Study|Adverse Event|2|||
130230747|NCT00420745|468811496|FG000|Overall Study|Lost to Follow-up|10|||
130230748|NCT00420745|468811497|FG001|Overall Study|Lost to Follow-up|2|||
130230749|NCT00420745|468811496|FG000|Overall Study|Protocol Violation|1|||
130230750|NCT00420745|468811497|FG001|Overall Study|Protocol Violation|0|||
130230751|NCT00420745|468811496|FG000|Overall Study|Physician Decision|1|||
130230752|NCT00420745|468811497|FG001|Overall Study|Physician Decision|1|||
130230753|NCT00420745|468811496|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
130230754|NCT00420745|468811497|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
130230755|NCT00420745|468811496|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
130230756|NCT00420745|468811497|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
130230757|NCT01125930|468811498|FG000|Overall Study|Adverse Event|0|||
130230758|NCT01125930|468811499|FG001|Overall Study|Adverse Event|1|||
130230759|NCT01125930|468811498|FG000|Overall Study|Withdrawal by Subject|1|||
130230760|NCT01125930|468811499|FG001|Overall Study|Withdrawal by Subject|6|||
130230761|NCT01125930|468811498|FG000|Overall Study|Protocol Violation|0|||
130230762|NCT01125930|468811499|FG001|Overall Study|Protocol Violation|1|||
130230763|NCT01125930|468811498|FG000|Overall Study|Lost to Follow-up|0|||
130230764|NCT01125930|468811499|FG001|Overall Study|Lost to Follow-up|2|||
130023172|NCT00763321|468045089|FG000|Open-label Period|Lost to Follow-up|14|||
130023173|NCT00763321|468045090|FG001|Open-label Period|Lost to Follow-up|0|||
130023174|NCT00763321|468045091|FG002|Open-label Period|Lost to Follow-up|0|||
130023175|NCT00763321|468045089|FG000|Open-label Period|Withdrawal by Subject|7|||
130023176|NCT00763321|468045090|FG001|Open-label Period|Withdrawal by Subject|0|||
130023177|NCT00763321|468045091|FG002|Open-label Period|Withdrawal by Subject|0|||
130023178|NCT00763321|468045089|FG000|Open-label Period|Subject noncompliant|7|||
130023179|NCT00763321|468045090|FG001|Open-label Period|Subject noncompliant|0|||
130023180|NCT00763321|468045091|FG002|Open-label Period|Subject noncompliant|0|||
130023181|NCT00763321|468045089|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
130023182|NCT00763321|468045090|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
130023183|NCT00763321|468045091|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
130230765|NCT03098979|468811500|FG000|Overall Study|Adverse Event|1|||
130230766|NCT03098979|468811501|FG001|Overall Study|Adverse Event|0|||
130230767|NCT03098979|468811502|FG002|Overall Study|Adverse Event|1|||
130230768|NCT03098979|468811503|FG003|Overall Study|Adverse Event|4|||
130230769|NCT03098979|468811504|FG004|Overall Study|Adverse Event|6|||
130230770|NCT03098979|468811505|FG005|Overall Study|Adverse Event|1|||
130230771|NCT03098979|468811500|FG000|Overall Study|Withdrawal by Subject|2|||
130230772|NCT03098979|468811501|FG001|Overall Study|Withdrawal by Subject|1|||
130230773|NCT03098979|468811502|FG002|Overall Study|Withdrawal by Subject|1|||
130230774|NCT03098979|468811503|FG003|Overall Study|Withdrawal by Subject|1|||
130230775|NCT03098979|468811504|FG004|Overall Study|Withdrawal by Subject|2|||
130230776|NCT03098979|468811505|FG005|Overall Study|Withdrawal by Subject|1|||
130230777|NCT03098979|468811500|FG000|Overall Study|Death|1|||
130230778|NCT03098979|468811501|FG001|Overall Study|Death|0|||
130230779|NCT03098979|468811502|FG002|Overall Study|Death|2|||
130023184|NCT00763321|468045089|FG000|Open-label Period|Lack of Efficacy|2|||
130023185|NCT00763321|468045090|FG001|Open-label Period|Lack of Efficacy|0|||
130023186|NCT00763321|468045091|FG002|Open-label Period|Lack of Efficacy|0|||
130230780|NCT03098979|468811503|FG003|Overall Study|Death|0|||
130230781|NCT03098979|468811504|FG004|Overall Study|Death|1|||
130230782|NCT03098979|468811505|FG005|Overall Study|Death|0|||
130230783|NCT03098979|468811500|FG000|Overall Study|Physician Decision|2|||
130230784|NCT03098979|468811501|FG001|Overall Study|Physician Decision|1|||
130230785|NCT03098979|468811502|FG002|Overall Study|Physician Decision|0|||
130230786|NCT03098979|468811503|FG003|Overall Study|Physician Decision|0|||
130230787|NCT03098979|468811504|FG004|Overall Study|Physician Decision|0|||
130230788|NCT03098979|468811505|FG005|Overall Study|Physician Decision|0|||
130230789|NCT03098979|468811500|FG000|Overall Study|Non-compliance|0|||
130230790|NCT03098979|468811501|FG001|Overall Study|Non-compliance|0|||
130230791|NCT03098979|468811502|FG002|Overall Study|Non-compliance|0|||
130230792|NCT03098979|468811503|FG003|Overall Study|Non-compliance|0|||
130230793|NCT03098979|468811504|FG004|Overall Study|Non-compliance|0|||
130230794|NCT03098979|468811505|FG005|Overall Study|Non-compliance|1|||
130230795|NCT03098979|468811500|FG000|Overall Study|Protocol Violation|0|||
130230796|NCT03098979|468811501|FG001|Overall Study|Protocol Violation|0|||
130230797|NCT03098979|468811502|FG002|Overall Study|Protocol Violation|0|||
130230798|NCT03098979|468811503|FG003|Overall Study|Protocol Violation|0|||
130230799|NCT03098979|468811504|FG004|Overall Study|Protocol Violation|0|||
130230800|NCT03098979|468811505|FG005|Overall Study|Protocol Violation|1|||
130230801|NCT02426684|468811506|FG000|Overall Study|Physician Decision|1|||
130230802|NCT02369653|468811507|FG000|Overall Study|Lost to Follow-up|0|||
130230803|NCT02369653|468811508|FG001|Overall Study|Lost to Follow-up|1|||
130230804|NCT02369653|468811507|FG000|Overall Study|Administrative reason by sponsor|0|||
130230805|NCT02369653|468811508|FG001|Overall Study|Administrative reason by sponsor|1|||
130230806|NCT02369653|468811507|FG000|Overall Study|Death|1|||
130230807|NCT02369653|468811508|FG001|Overall Study|Death|2|||
130230808|NCT02369653|468811507|FG000|Overall Study|Participant withdrew consent|13|||
130230809|NCT02369653|468811508|FG001|Overall Study|Participant withdrew consent|3|||
130230810|NCT03587636|468811509|FG000|Overall Study|Lost to Follow-up|2|||
130230811|NCT03587636|468811510|FG001|Overall Study|Lost to Follow-up|5|||
130230812|NCT03248037|468811511|FG000|Overall Study|Withdrawal by Subject|6|||
130230813|NCT03248037|468811512|FG001|Overall Study|Withdrawal by Subject|9|||
130230814|NCT03248037|468811511|FG000|Overall Study|Adverse Event|15|||
130230815|NCT03248037|468811512|FG001|Overall Study|Adverse Event|0|||
130230816|NCT02897349|468811513|FG000|Overall Study|Lost to Follow-up|2|||
130230817|NCT02897349|468811514|FG001|Overall Study|Lost to Follow-up|2|||
130230818|NCT02897349|468811513|FG000|Overall Study|Adverse Event|3|||
130230819|NCT02897349|468811514|FG001|Overall Study|Adverse Event|3|||
130230820|NCT02897349|468811513|FG000|Overall Study|Other than listed above|0|||
130230821|NCT02897349|468811514|FG001|Overall Study|Other than listed above|1|||
130230822|NCT00671749|468811521|FG000|Overall Study|Adverse Event|2|||
130230823|NCT00671749|468811521|FG000|Overall Study|Withdrawal by Subject|4|||
130230824|NCT00671749|468811521|FG000|Overall Study|Protocol Violation|1|||
130230825|NCT00671749|468811521|FG000|Overall Study|Lost to Follow-up|1|||
130230826|NCT02515227|468811522|FG000|Overall Study|Adverse Event|0|||
130230827|NCT02515227|468811523|FG001|Overall Study|Adverse Event|2|||
130230828|NCT02515227|468811522|FG000|Overall Study|Progressive disease|2|||
130230829|NCT02515227|468811523|FG001|Overall Study|Progressive disease|9|||
130230830|NCT01259245|468811524|FG000|Overall Study|Withdrawal by Subject|27|||
130230831|NCT01259245|468811525|FG001|Overall Study|Withdrawal by Subject|24|||
130230832|NCT01259245|468811524|FG000|Overall Study|Death|1|||
130230833|NCT01259245|468811525|FG001|Overall Study|Death|2|||
130230834|NCT03363906|468811535|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
130230835|NCT03363906|468811536|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
130230836|NCT03363906|468811535|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
130230837|NCT03363906|468811536|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
130230838|NCT03363906|468811535|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
130099690|NCT00816166|468322761|FG000|Overall Study|Death|4|||
130230839|NCT03363906|468811536|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
130230840|NCT03363906|468811535|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
130230841|NCT03363906|468811536|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
130230842|NCT02714153|468811538|FG000|Overall Study|Death|1|||
130230843|NCT00087178|468811541|FG000|Overall Study|No follow up data|5|||
130230844|NCT00087178|468811542|FG001|Overall Study|No follow up data|15|||
130230845|NCT00087178|468811541|FG000|Overall Study|No clinical assessment|1|||
130230846|NCT00087178|468811542|FG001|Overall Study|No clinical assessment|2|||
130230847|NCT00087178|468811541|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
130230848|NCT00087178|468811542|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
130230849|NCT01692119|468811557|FG000|Overall Study|Protocol Violation|3|||
130230850|NCT01692119|468811558|FG001|Overall Study|Protocol Violation|1|||
130230851|NCT01692119|468811557|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
130230852|NCT01692119|468811558|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
130230853|NCT00997893|468811559|FG000|Overall Study|Adverse Event|1|||
130230854|NCT00997893|468811560|FG001|Overall Study|Adverse Event|0|||
130230855|NCT00997893|468811561|FG002|Overall Study|Adverse Event|0|||
130230856|NCT00997893|468811559|FG000|Overall Study|Unable to meet study timelines|1|||
130230857|NCT00997893|468811560|FG001|Overall Study|Unable to meet study timelines|0|||
130230858|NCT00997893|468811561|FG002|Overall Study|Unable to meet study timelines|0|||
130230859|NCT00997893|468811559|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
130230860|NCT00997893|468811560|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
130230861|NCT00997893|468811561|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
130230862|NCT01142336|468811564|FG000|Overall Study|Adverse Event|1|||
130230863|NCT01142336|468811565|FG001|Overall Study|Adverse Event|1|||
130230864|NCT01142336|468811564|FG000|Overall Study|Lost to Follow-up|0|||
130230865|NCT01142336|468811565|FG001|Overall Study|Lost to Follow-up|1|||
130230866|NCT02029417|468811566|FG000|Overall Study|Death|1|||
130230867|NCT02029417|468811566|FG000|Overall Study|Adverse Event|1|||
130230868|NCT05219162|468811569|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
130230869|NCT05219162|468811569|FG000|Overall Study|Withdrawal by Subject|23|||
130230870|NCT00171249|468811572|FG000|Overall Study|Withdrawal by Subject|2|||
130230871|NCT00171249|468811573|FG001|Overall Study|Withdrawal by Subject|0|||
130230872|NCT00171249|468811574|FG002|Overall Study|Withdrawal by Subject|0|||
130230873|NCT00171249|468811575|FG003|Overall Study|Withdrawal by Subject|6|||
130230874|NCT00171249|468811576|FG004|Overall Study|Withdrawal by Subject|0|||
130230875|NCT00171249|468811577|FG005|Overall Study|Withdrawal by Subject|0|||
130230876|NCT00171249|468811578|FG006|Overall Study|Withdrawal by Subject|0|||
130230877|NCT00171249|468811572|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
130230878|NCT00171249|468811573|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130230879|NCT00171249|468811574|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
130230880|NCT00171249|468811575|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
130230881|NCT00171249|468811576|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130230882|NCT00171249|468811577|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
130230883|NCT00171249|468811578|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
130230884|NCT00171249|468811572|FG000|Overall Study|Death|7|||
130230885|NCT00171249|468811573|FG001|Overall Study|Death|1|||
130230886|NCT00171249|468811574|FG002|Overall Study|Death|0|||
130230887|NCT00171249|468811575|FG003|Overall Study|Death|4|||
130230888|NCT00171249|468811576|FG004|Overall Study|Death|0|||
130230889|NCT00171249|468811577|FG005|Overall Study|Death|3|||
130230890|NCT00171249|468811578|FG006|Overall Study|Death|1|||
130230891|NCT00171249|468811572|FG000|Overall Study|Other|10|||
130230892|NCT00171249|468811573|FG001|Overall Study|Other|0|||
130230893|NCT00171249|468811574|FG002|Overall Study|Other|0|||
130023187|NCT00763321|468045089|FG000|Open-label Period|Other|4|||
130023188|NCT00763321|468045090|FG001|Open-label Period|Other|0|||
130023189|NCT00763321|468045091|FG002|Open-label Period|Other|0|||
130023190|NCT00763321|468045089|FG000|Double-blind Period|Lack of Efficacy|0|||
130023191|NCT00763321|468045090|FG001|Double-blind Period|Lack of Efficacy|9|||
130023192|NCT00763321|468045091|FG002|Double-blind Period|Lack of Efficacy|17|||
130023193|NCT00763321|468045089|FG000|Double-blind Period|Adverse Event|0|||
130023194|NCT00763321|468045090|FG001|Double-blind Period|Adverse Event|4|||
130023195|NCT00763321|468045091|FG002|Double-blind Period|Adverse Event|4|||
130023196|NCT00763321|468045089|FG000|Double-blind Period|Lost to Follow-up|0|||
130023197|NCT00763321|468045090|FG001|Double-blind Period|Lost to Follow-up|4|||
130230894|NCT00171249|468811575|FG003|Overall Study|Other|43|||
130023198|NCT00763321|468045091|FG002|Double-blind Period|Lost to Follow-up|2|||
130023199|NCT00763321|468045089|FG000|Double-blind Period|Withdrawal by Subject|0|||
130023200|NCT00763321|468045090|FG001|Double-blind Period|Withdrawal by Subject|2|||
130023201|NCT00763321|468045091|FG002|Double-blind Period|Withdrawal by Subject|3|||
130023202|NCT00763321|468045089|FG000|Double-blind Period|Other|0|||
130230895|NCT00171249|468811576|FG004|Overall Study|Other|0|||
130230896|NCT00171249|468811577|FG005|Overall Study|Other|2|||
130230897|NCT00171249|468811578|FG006|Overall Study|Other|0|||
130230898|NCT00171249|468811572|FG000|Overall Study|No Longer Requires Study Drug|4|||
130023203|NCT00763321|468045090|FG001|Double-blind Period|Other|2|||
130230899|NCT00171249|468811573|FG001|Overall Study|No Longer Requires Study Drug|0|||
130230900|NCT00171249|468811574|FG002|Overall Study|No Longer Requires Study Drug|0|||
130230901|NCT00171249|468811575|FG003|Overall Study|No Longer Requires Study Drug|3|||
130230902|NCT00171249|468811576|FG004|Overall Study|No Longer Requires Study Drug|0|||
130230903|NCT00171249|468811577|FG005|Overall Study|No Longer Requires Study Drug|5|||
130023204|NCT00763321|468045091|FG002|Double-blind Period|Other|3|||
130023205|NCT03175549|468045092|FG000|Overall Study|Lost to Follow-up|2|||
130023206|NCT03175549|468045093|FG001|Overall Study|Lost to Follow-up|2|||
130023207|NCT03175549|468045092|FG000|Overall Study|Medication non-compliance|2|||
130023208|NCT03175549|468045093|FG001|Overall Study|Medication non-compliance|2|||
130023209|NCT02435849|468045094|FG000|Overall Study|Death|23|||
130023210|NCT02435849|468045095|FG001|Overall Study|Death|0|||
130023211|NCT02435849|468045094|FG000|Overall Study|Lack of Efficacy|10|||
130023212|NCT02435849|468045095|FG001|Overall Study|Lack of Efficacy|0|||
130023213|NCT02435849|468045094|FG000|Overall Study|New therapy for study indication|8|||
130023214|NCT02435849|468045095|FG001|Overall Study|New therapy for study indication|0|||
130023215|NCT02435849|468045094|FG000|Overall Study|Subject/guardian decision|5|||
130023216|NCT02435849|468045095|FG001|Overall Study|Subject/guardian decision|1|||
130023217|NCT02435849|468045094|FG000|Overall Study|Lost to Follow-up|1|||
130023218|NCT02435849|468045095|FG001|Overall Study|Lost to Follow-up|0|||
130230904|NCT00171249|468811578|FG006|Overall Study|No Longer Requires Study Drug|0|||
130230905|NCT00171249|468811572|FG000|Overall Study|Administrative Problems|1|||
130230906|NCT00171249|468811573|FG001|Overall Study|Administrative Problems|0|||
130230907|NCT00171249|468811574|FG002|Overall Study|Administrative Problems|0|||
130230908|NCT00171249|468811575|FG003|Overall Study|Administrative Problems|2|||
130230909|NCT00171249|468811576|FG004|Overall Study|Administrative Problems|0|||
130023219|NCT02435849|468045094|FG000|Overall Study|Physician Decision|1|||
130023220|NCT02435849|468045095|FG001|Overall Study|Physician Decision|0|||
130023221|NCT02486757|468045096|FG000|Overall Study|Lost to Follow-up|1|||
130023222|NCT01064167|468045097|FG000|Overall Study|Protocol Violation|14|||
130023223|NCT01064167|468045098|FG001|Overall Study|Protocol Violation|15|||
130023224|NCT00725075|468045099|FG000|Overall Study|Use of Excluded Medication|0|||
130023225|NCT00725075|468045100|FG001|Overall Study|Use of Excluded Medication|1|||
130023226|NCT00725075|468045101|FG002|Overall Study|Use of Excluded Medication|0|||
130023227|NCT00725075|468045099|FG000|Overall Study|Protocol Violation|0|||
130230910|NCT00171249|468811577|FG005|Overall Study|Administrative Problems|0|||
130230911|NCT00171249|468811578|FG006|Overall Study|Administrative Problems|0|||
130023228|NCT00725075|468045100|FG001|Overall Study|Protocol Violation|0|||
130023229|NCT00725075|468045101|FG002|Overall Study|Protocol Violation|1|||
130023230|NCT00725075|468045099|FG000|Overall Study|Lost to Follow-up|1|||
130023231|NCT00725075|468045100|FG001|Overall Study|Lost to Follow-up|0|||
130023232|NCT00725075|468045101|FG002|Overall Study|Lost to Follow-up|0|||
130023233|NCT00725075|468045099|FG000|Overall Study|Withdrawal by Subject|4|||
130023234|NCT00725075|468045100|FG001|Overall Study|Withdrawal by Subject|5|||
130023235|NCT00725075|468045101|FG002|Overall Study|Withdrawal by Subject|4|||
130023236|NCT00725075|468045099|FG000|Overall Study|Adverse Event|2|||
130023237|NCT00725075|468045100|FG001|Overall Study|Adverse Event|1|||
130023238|NCT00725075|468045101|FG002|Overall Study|Adverse Event|1|||
130023239|NCT00725075|468045099|FG000|Overall Study|Worsening of Disease|2|||
130023240|NCT00725075|468045100|FG001|Overall Study|Worsening of Disease|1|||
130023241|NCT00725075|468045101|FG002|Overall Study|Worsening of Disease|2|||
130023242|NCT00725075|468045099|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
130023243|NCT00725075|468045100|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
130023244|NCT00725075|468045101|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
130023245|NCT00725075|468045099|FG000|Overall Study|Other|1|||
130023246|NCT00725075|468045100|FG001|Overall Study|Other|0|||
130023247|NCT00725075|468045101|FG002|Overall Study|Other|0|||
130023248|NCT03984305|468045102|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
130023249|NCT03984305|468045103|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
130023250|NCT03984305|468045102|FG000|Overall Study|Withdrawal by Subject|3|||
130023251|NCT03984305|468045103|FG001|Overall Study|Withdrawal by Subject|3|||
130023252|NCT03984305|468045102|FG000|Overall Study|Lost to Follow-up|1|||
130023253|NCT03984305|468045103|FG001|Overall Study|Lost to Follow-up|0|||
130023254|NCT00087646|468045104|FG000|Overall Study|Adverse Event|37|||
130023255|NCT00087646|468045105|FG001|Overall Study|Adverse Event|6|||
130230912|NCT00171249|468811572|FG000|Overall Study|Adverse Event|3|||
130230913|NCT00171249|468811573|FG001|Overall Study|Adverse Event|1|||
130023256|NCT00087646|468045106|FG002|Overall Study|Adverse Event|18|||
130023257|NCT00087646|468045107|FG003|Overall Study|Adverse Event|20|||
130023258|NCT00087646|468045104|FG000|Overall Study|Death|0|||
130023259|NCT00087646|468045105|FG001|Overall Study|Death|1|||
130023260|NCT00087646|468045106|FG002|Overall Study|Death|0|||
130023261|NCT00087646|468045107|FG003|Overall Study|Death|0|||
130230914|NCT00171249|468811574|FG002|Overall Study|Adverse Event|0|||
130023262|NCT00087646|468045104|FG000|Overall Study|Withdrawal by Subject|6|||
130023263|NCT00087646|468045105|FG001|Overall Study|Withdrawal by Subject|1|||
130023264|NCT00087646|468045106|FG002|Overall Study|Withdrawal by Subject|2|||
130023265|NCT00087646|468045107|FG003|Overall Study|Withdrawal by Subject|2|||
130023266|NCT00087646|468045104|FG000|Overall Study|Insufficient therapeutic response|64|||
130023267|NCT00087646|468045105|FG001|Overall Study|Insufficient therapeutic response|24|||
130023268|NCT00087646|468045106|FG002|Overall Study|Insufficient therapeutic response|38|||
130023269|NCT00087646|468045107|FG003|Overall Study|Insufficient therapeutic response|51|||
130023270|NCT00087646|468045104|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
130023271|NCT00087646|468045105|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
130023272|NCT00087646|468045106|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
130023273|NCT00087646|468045107|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
130023274|NCT00087646|468045104|FG000|Overall Study|Failure to Return|5|||
130023275|NCT00087646|468045105|FG001|Overall Study|Failure to Return|2|||
130023276|NCT00087646|468045106|FG002|Overall Study|Failure to Return|2|||
130023277|NCT00087646|468045107|FG003|Overall Study|Failure to Return|3|||
130023278|NCT00087646|468045104|FG000|Overall Study|Administrative/Other|6|||
130023279|NCT00087646|468045105|FG001|Overall Study|Administrative/Other|1|||
130023280|NCT00087646|468045106|FG002|Overall Study|Administrative/Other|1|||
130023281|NCT00087646|468045107|FG003|Overall Study|Administrative/Other|2|||
130023282|NCT00087646|468045104|FG000|Overall Study|Other Protocol Violation|3|||
130023283|NCT00087646|468045105|FG001|Overall Study|Other Protocol Violation|1|||
130023284|NCT00087646|468045106|FG002|Overall Study|Other Protocol Violation|0|||
130023285|NCT00087646|468045107|FG003|Overall Study|Other Protocol Violation|0|||
130023286|NCT00087646|468045104|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
130230915|NCT00171249|468811575|FG003|Overall Study|Adverse Event|15|||
130230916|NCT00171249|468811576|FG004|Overall Study|Adverse Event|0|||
130230917|NCT00171249|468811577|FG005|Overall Study|Adverse Event|2|||
130230918|NCT00171249|468811578|FG006|Overall Study|Adverse Event|0|||
130230919|NCT00171249|468811572|FG000|Overall Study|Lost to Follow-up|5|||
130230920|NCT00171249|468811573|FG001|Overall Study|Lost to Follow-up|0|||
130230921|NCT00171249|468811574|FG002|Overall Study|Lost to Follow-up|0|||
130230922|NCT00171249|468811575|FG003|Overall Study|Lost to Follow-up|9|||
130230923|NCT00171249|468811576|FG004|Overall Study|Lost to Follow-up|0|||
130230924|NCT00171249|468811577|FG005|Overall Study|Lost to Follow-up|0|||
130230925|NCT00171249|468811578|FG006|Overall Study|Lost to Follow-up|0|||
130230926|NCT01041859|468811579|FG000|Open-Label Titration|Adverse Event|69|||
130230927|NCT01041859|468811580|FG001|Open-Label Titration|Adverse Event|0|||
130230928|NCT01041859|468811581|FG002|Open-Label Titration|Adverse Event|0|||
130230929|NCT01041859|468811579|FG000|Open-Label Titration|Lack of Efficacy|3|||
130230930|NCT01041859|468811580|FG001|Open-Label Titration|Lack of Efficacy|0|||
130230931|NCT01041859|468811581|FG002|Open-Label Titration|Lack of Efficacy|0|||
130023287|NCT00087646|468045105|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
130023288|NCT00087646|468045106|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
130023289|NCT00087646|468045107|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
130230932|NCT01041859|468811579|FG000|Open-Label Titration|Lost to Follow-up|1|||
130023290|NCT01235962|468045108|FG000|Overall Study|Withdrawal by Subject|20|||
130230933|NCT01041859|468811580|FG001|Open-Label Titration|Lost to Follow-up|0|||
130230934|NCT01041859|468811581|FG002|Open-Label Titration|Lost to Follow-up|0|||
130230935|NCT01041859|468811579|FG000|Open-Label Titration|Physician Decision|1|||
130230936|NCT01041859|468811580|FG001|Open-Label Titration|Physician Decision|0|||
130230937|NCT01041859|468811581|FG002|Open-Label Titration|Physician Decision|0|||
130230938|NCT01041859|468811579|FG000|Open-Label Titration|Protocol Violation|1|||
130230939|NCT01041859|468811580|FG001|Open-Label Titration|Protocol Violation|0|||
130230940|NCT01041859|468811581|FG002|Open-Label Titration|Protocol Violation|0|||
130230941|NCT01041859|468811579|FG000|Open-Label Titration|Other|7|||
130230942|NCT01041859|468811580|FG001|Open-Label Titration|Other|0|||
130230943|NCT01041859|468811581|FG002|Open-Label Titration|Other|0|||
130230944|NCT01041859|468811579|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
130230945|NCT01041859|468811580|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
130230946|NCT01041859|468811581|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
130230947|NCT01041859|468811579|FG000|Open-Label Titration|Withdrawal by Subject|11|||
130230948|NCT01041859|468811580|FG001|Open-Label Titration|Withdrawal by Subject|0|||
130230949|NCT01041859|468811581|FG002|Open-Label Titration|Withdrawal by Subject|0|||
130230950|NCT01041859|468811579|FG000|Double-Blind Maintenance|Adverse Event|0|||
130230951|NCT01041859|468811580|FG001|Double-Blind Maintenance|Adverse Event|23|||
130230952|NCT01041859|468811581|FG002|Double-Blind Maintenance|Adverse Event|13|||
130230953|NCT01041859|468811579|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
130230954|NCT01041859|468811580|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
130230955|NCT01041859|468811581|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
130230956|NCT01041859|468811579|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
130230957|NCT01041859|468811580|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
130230958|NCT01041859|468811581|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
130230959|NCT01041859|468811579|FG000|Double-Blind Maintenance|Physician Decision|0|||
130230960|NCT01041859|468811580|FG001|Double-Blind Maintenance|Physician Decision|2|||
130230961|NCT01041859|468811581|FG002|Double-Blind Maintenance|Physician Decision|1|||
130023291|NCT01235962|468045109|FG001|Overall Study|Withdrawal by Subject|19|||
130230962|NCT01041859|468811579|FG000|Double-Blind Maintenance|Protocol Violation|0|||
130230963|NCT01041859|468811580|FG001|Double-Blind Maintenance|Protocol Violation|1|||
130230964|NCT01041859|468811581|FG002|Double-Blind Maintenance|Protocol Violation|3|||
130023292|NCT01235962|468045110|FG002|Overall Study|Withdrawal by Subject|62|||
130023293|NCT01235962|468045111|FG003|Overall Study|Withdrawal by Subject|49|||
130023294|NCT01235962|468045108|FG000|Overall Study|Lost to Follow-up|21|||
130023295|NCT01235962|468045109|FG001|Overall Study|Lost to Follow-up|16|||
130023296|NCT01235962|468045110|FG002|Overall Study|Lost to Follow-up|47|||
130023297|NCT01235962|468045111|FG003|Overall Study|Lost to Follow-up|32|||
130023298|NCT01235962|468045108|FG000|Overall Study|Physician Decision|5|||
130023299|NCT01235962|468045109|FG001|Overall Study|Physician Decision|0|||
130023300|NCT01235962|468045110|FG002|Overall Study|Physician Decision|9|||
130023301|NCT01235962|468045111|FG003|Overall Study|Physician Decision|5|||
130023302|NCT01580397|468045112|FG000|Overall Study|Lack of Efficacy|14|||
130023303|NCT02902120|468045114|FG000|Overall Study|Lack of Efficacy|1|||
130023304|NCT02004873|468045115|FG000|Overall Study|Implant unsuccessful|6|||
130023305|NCT02004873|468045115|FG000|Overall Study|Awaiting 6-month visit|390|||
130023306|NCT02004873|468045115|FG000|Overall Study|Missed 6-month visit|4|||
130023307|NCT02004873|468045115|FG000|Overall Study|Death|23|||
130023308|NCT02004873|468045115|FG000|Overall Study|Withdrawal by Subject|1|||
130023309|NCT01353703|468045116|FG000|Overall Study|Migrated/moved from study area|1|||
130230965|NCT01041859|468811579|FG000|Double-Blind Maintenance|Other|0|||
130230966|NCT01041859|468811580|FG001|Double-Blind Maintenance|Other|6|||
130230967|NCT01041859|468811581|FG002|Double-Blind Maintenance|Other|2|||
130230968|NCT01041859|468811579|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
130230969|NCT01041859|468811580|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
130230970|NCT01041859|468811581|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
130230971|NCT01041859|468811579|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
130230972|NCT01041859|468811580|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
130230973|NCT01041859|468811581|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
130230974|NCT02908347|468811587|FG000|Overall Study|Adverse Event|0|||
130023310|NCT01353703|468045117|FG001|Overall Study|Migrated/moved from study area|0|||
130023311|NCT03718143|468046706|FG000|Overall Study|Death|1|||
130023312|NCT03718143|468046707|FG001|Overall Study|Death|0|||
130023313|NCT03718143|468046708|FG002|Overall Study|Death|0|||
130023314|NCT03718143|468046706|FG000|Overall Study|Progression of Disease|1|||
130023315|NCT03718143|468046707|FG001|Overall Study|Progression of Disease|0|||
130023316|NCT03718143|468046708|FG002|Overall Study|Progression of Disease|0|||
130023317|NCT03718143|468046706|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130023318|NCT03718143|468046707|FG001|Overall Study|Withdrawal of Informed Consent|2|||
130023319|NCT03718143|468046708|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130023320|NCT05064059|468046709|FG000|Overall Study|Death|199|||
130023321|NCT05064059|468046710|FG001|Overall Study|Death|196|||
130023322|NCT05064059|468046709|FG000|Overall Study|Physician Decision|4|||
130023323|NCT05064059|468046710|FG001|Overall Study|Physician Decision|2|||
130023324|NCT05064059|468046709|FG000|Overall Study|Sponsor Decision|14|||
130023325|NCT05064059|468046710|FG001|Overall Study|Sponsor Decision|11|||
130023326|NCT05064059|468046709|FG000|Overall Study|Withdrawal by Subject|4|||
130023327|NCT05064059|468046710|FG001|Overall Study|Withdrawal by Subject|11|||
130023328|NCT00805740|468046711|FG000|Overall Study|Death|7|||
130023329|NCT00805740|468046712|FG001|Overall Study|Death|4|||
130023330|NCT00805740|468046711|FG000|Overall Study|Withdrawal by Subject|1|||
130023331|NCT00805740|468046712|FG001|Overall Study|Withdrawal by Subject|0|||
130023332|NCT00805740|468046711|FG000|Overall Study|Lost to Follow-up|1|||
130023333|NCT00805740|468046712|FG001|Overall Study|Lost to Follow-up|0|||
130099691|NCT00816166|468322762|FG001|Overall Study|Death|2|||
130099692|NCT00352664|468322763|FG000|Overall Study|Withdrawal by Subject|7|||
130230975|NCT02908347|468811588|FG001|Overall Study|Adverse Event|1|||
130230976|NCT02908347|468811587|FG000|Overall Study|Lost to Follow-up|1|||
130230977|NCT02908347|468811588|FG001|Overall Study|Lost to Follow-up|0|||
130023334|NCT00805740|468046711|FG000|Overall Study|Randomized, but not treated|2|||
130023335|NCT00805740|468046712|FG001|Overall Study|Randomized, but not treated|0|||
130023336|NCT05227690|468046718|FG000|Overall Study|Adverse Event|5|||
130023337|NCT05227690|468046719|FG001|Overall Study|Adverse Event|6|||
130023338|NCT05227690|468046720|FG002|Overall Study|Adverse Event|10|||
130230978|NCT01326871|468811589|FG000|Overall Study|Major surgery|0|||
130230979|NCT01326871|468811590|FG001|Overall Study|Major surgery|1|||
130230980|NCT01326871|468811591|FG002|Overall Study|Major surgery|0|||
130230981|NCT01326871|468811589|FG000|Overall Study|SAE and death|0|||
130230982|NCT01326871|468811590|FG001|Overall Study|SAE and death|2|||
130230983|NCT01326871|468811591|FG002|Overall Study|SAE and death|0|||
130230984|NCT01326871|468811589|FG000|Overall Study|Physician decision and decreased performance status|0|||
130230985|NCT01326871|468811590|FG001|Overall Study|Physician decision and decreased performance status|1|||
130230986|NCT01326871|468811591|FG002|Overall Study|Physician decision and decreased performance status|0|||
130230987|NCT01326871|468811589|FG000|Overall Study|Disease progression|0|||
130230988|NCT01326871|468811590|FG001|Overall Study|Disease progression|11|||
130230989|NCT01326871|468811591|FG002|Overall Study|Disease progression|5|||
130230990|NCT01326871|468811589|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
130230991|NCT01326871|468811590|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
130230992|NCT01326871|468811591|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
130230993|NCT01326871|468811589|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
130230994|NCT01326871|468811590|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
130230995|NCT01326871|468811591|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
130230996|NCT01326871|468811589|FG000|Overall Study|Withdrawal by Subject|0|||
130023339|NCT05227690|468046718|FG000|Overall Study|Lack of Efficacy|2|||
130023340|NCT05227690|468046719|FG001|Overall Study|Lack of Efficacy|4|||
130023341|NCT05227690|468046720|FG002|Overall Study|Lack of Efficacy|1|||
130023342|NCT05227690|468046718|FG000|Overall Study|Physician Decision|6|||
130023343|NCT05227690|468046719|FG001|Overall Study|Physician Decision|0|||
130230997|NCT01326871|468811590|FG001|Overall Study|Withdrawal by Subject|1|||
130230998|NCT01326871|468811591|FG002|Overall Study|Withdrawal by Subject|0|||
130230999|NCT01326871|468811589|FG000|Overall Study|DLT|0|||
130231000|NCT01326871|468811590|FG001|Overall Study|DLT|2|||
130231001|NCT01326871|468811591|FG002|Overall Study|DLT|0|||
130231002|NCT01326871|468811589|FG000|Overall Study|SAE, disease progression and subject decision|0|||
130231003|NCT01326871|468811590|FG001|Overall Study|SAE, disease progression and subject decision|1|||
130023344|NCT05227690|468046720|FG002|Overall Study|Physician Decision|4|||
130231004|NCT01326871|468811591|FG002|Overall Study|SAE, disease progression and subject decision|0|||
130023345|NCT05227690|468046718|FG000|Overall Study|Withdrawal of consent|28|||
130231005|NCT01326871|468811589|FG000|Overall Study|Death|0|||
130231006|NCT01326871|468811590|FG001|Overall Study|Death|1|||
130231007|NCT01326871|468811591|FG002|Overall Study|Death|0|||
130231008|NCT01326871|468811589|FG000|Overall Study|Other|0|||
130231009|NCT01326871|468811590|FG001|Overall Study|Other|3|||
130231010|NCT01326871|468811591|FG002|Overall Study|Other|0|||
130231011|NCT01326871|468811589|FG000|Overall Study|SAE and disease progression|0|||
130023346|NCT05227690|468046719|FG001|Overall Study|Withdrawal of consent|27|||
130023347|NCT05227690|468046720|FG002|Overall Study|Withdrawal of consent|21|||
130023348|NCT05227690|468046718|FG000|Overall Study|Other, not specified|2|||
130023349|NCT05227690|468046719|FG001|Overall Study|Other, not specified|2|||
130023350|NCT05227690|468046720|FG002|Overall Study|Other, not specified|1|||
130023351|NCT02770326|468046723|FG000|Overall Study|Death|3|||
130023352|NCT02770326|468046723|FG000|Overall Study|Lost to Follow-up|1|||
130023353|NCT02971202|468046724|FG000|Overall Study|Pregnancy|1|||
130023354|NCT02971202|468046725|FG001|Overall Study|Pregnancy|0|||
130231012|NCT01326871|468811590|FG001|Overall Study|SAE and disease progression|0|||
130231013|NCT01326871|468811591|FG002|Overall Study|SAE and disease progression|1|||
130231014|NCT01326871|468811589|FG000|Overall Study|SAE and physician decision|0|||
130231015|NCT01326871|468811590|FG001|Overall Study|SAE and physician decision|0|||
130023355|NCT02971202|468046726|FG002|Overall Study|Pregnancy|0|||
130023356|NCT02971202|468046724|FG000|Overall Study|screen fail after consent|1|||
130231016|NCT01326871|468811591|FG002|Overall Study|SAE and physician decision|1|||
130231017|NCT01326871|468811589|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
130231018|NCT01326871|468811590|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
130231019|NCT01326871|468811591|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
130023357|NCT02971202|468046725|FG001|Overall Study|screen fail after consent|0|||
130023358|NCT02971202|468046726|FG002|Overall Study|screen fail after consent|1|||
130099693|NCT00352664|468322764|FG001|Overall Study|Withdrawal by Subject|0|||
130099694|NCT01233284|468322765|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
130099695|NCT01233284|468322766|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130099696|NCT01233284|468322767|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130099697|NCT01233284|468322768|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130099698|NCT01233284|468322769|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
130099699|NCT01233284|468322765|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130099700|NCT01233284|468322766|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
130099701|NCT01233284|468322767|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130099702|NCT01233284|468322768|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130099703|NCT01233284|468322769|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
130099704|NCT01233284|468322765|FG000|Period 1 (4 Weeks)|Other|0|||
130099705|NCT01233284|468322766|FG001|Period 1 (4 Weeks)|Other|0|||
130099706|NCT01233284|468322767|FG002|Period 1 (4 Weeks)|Other|1|||
130099707|NCT01233284|468322768|FG003|Period 1 (4 Weeks)|Other|0|||
130099708|NCT01233284|468322769|FG004|Period 1 (4 Weeks)|Other|0|||
130099709|NCT01233284|468322765|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130099710|NCT01233284|468322766|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130099711|NCT01233284|468322767|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
130099712|NCT01233284|468322768|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130099713|NCT01233284|468322769|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
130099714|NCT01233284|468322765|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130099715|NCT01233284|468322766|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130099716|NCT01233284|468322767|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
130099717|NCT01233284|468322768|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130099718|NCT01233284|468322769|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130099719|NCT01233284|468322765|FG000|Period 3 (4 Weeks)|Other|0|||
130099720|NCT01233284|468322766|FG001|Period 3 (4 Weeks)|Other|0|||
130099721|NCT01233284|468322767|FG002|Period 3 (4 Weeks)|Other|0|||
130099722|NCT01233284|468322768|FG003|Period 3 (4 Weeks)|Other|1|||
130099723|NCT01233284|468322769|FG004|Period 3 (4 Weeks)|Other|0|||
130099724|NCT01233284|468322765|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
130099725|NCT01233284|468322766|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
130099726|NCT01233284|468322767|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
130099727|NCT01233284|468322768|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
130099728|NCT01233284|468322769|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
130099729|NCT01233284|468322765|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130099730|NCT01233284|468322766|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130099731|NCT01233284|468322767|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130099732|NCT01233284|468322768|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
130099733|NCT01233284|468322769|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
130099734|NCT01058707|468322770|FG000|Overall Study|Disease Progression|15|||
130099735|NCT01058707|468322771|FG001|Overall Study|Disease Progression|20|||
130099736|NCT01058707|468322772|FG002|Overall Study|Disease Progression|20|||
130099737|NCT01058707|468322773|FG003|Overall Study|Disease Progression|15|||
130099738|NCT01058707|468322774|FG004|Overall Study|Disease Progression|23|||
130099739|NCT01058707|468322775|FG005|Overall Study|Disease Progression|10|||
130231020|NCT01326871|468811589|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
130231021|NCT01326871|468811590|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
130231022|NCT01326871|468811591|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
130231023|NCT01326871|468811589|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
130231024|NCT01326871|468811590|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
130231025|NCT01326871|468811591|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
130231026|NCT01326871|468811589|FG000|Overall Study|Physician Decision|0|||
130231027|NCT01326871|468811590|FG001|Overall Study|Physician Decision|0|||
130231028|NCT01326871|468811591|FG002|Overall Study|Physician Decision|1|||
130231029|NCT01326871|468811589|FG000|Overall Study|SAE|0|||
130231030|NCT01326871|468811590|FG001|Overall Study|SAE|0|||
130231031|NCT01326871|468811591|FG002|Overall Study|SAE|1|||
130231032|NCT01326871|468811589|FG000|Overall Study|Disease progression and death|0|||
130231033|NCT01326871|468811590|FG001|Overall Study|Disease progression and death|0|||
130231034|NCT01326871|468811591|FG002|Overall Study|Disease progression and death|1|||
130231035|NCT01326871|468811589|FG000|Overall Study|Subject decision|0|||
130099740|NCT01058707|468322776|FG006|Overall Study|Disease Progression|12|||
130099741|NCT01058707|468322770|FG000|Overall Study|Adverse Event|11|||
130099742|NCT01058707|468322771|FG001|Overall Study|Adverse Event|4|||
130099743|NCT01058707|468322772|FG002|Overall Study|Adverse Event|7|||
130099744|NCT01058707|468322773|FG003|Overall Study|Adverse Event|6|||
130099745|NCT01058707|468322774|FG004|Overall Study|Adverse Event|7|||
130099746|NCT01058707|468322775|FG005|Overall Study|Adverse Event|3|||
130099747|NCT01058707|468322776|FG006|Overall Study|Adverse Event|1|||
130099748|NCT01058707|468322770|FG000|Overall Study|Subject Decision|5|||
130099749|NCT01058707|468322771|FG001|Overall Study|Subject Decision|3|||
130231036|NCT01326871|468811590|FG001|Overall Study|Subject decision|0|||
130023359|NCT04033367|468046727|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
130023360|NCT04033367|468046728|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
130023361|NCT04033367|468046727|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
130023362|NCT04033367|468046728|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130023363|NCT04033367|468046727|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
130023364|NCT04033367|468046728|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
130023365|NCT04033367|468046727|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
130023366|NCT04033367|468046728|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
130023367|NCT02723201|468046729|FG000|Second Intervention Period|Protocol Violation|1|||
130023368|NCT02723201|468046730|FG001|Second Intervention Period|Protocol Violation|0|||
130023369|NCT02723201|468046731|FG002|Second Intervention Period|Protocol Violation|0|||
130023370|NCT02723201|468046729|FG000|Second Intervention Period|Adverse Event|1|||
130023371|NCT02723201|468046730|FG001|Second Intervention Period|Adverse Event|0|||
130023372|NCT02723201|468046731|FG002|Second Intervention Period|Adverse Event|0|||
130023373|NCT03472560|468046732|FG000|Overall Study|Subject transfer to continuation protocol|0|||
130023374|NCT03472560|468046733|FG001|Overall Study|Subject transfer to continuation protocol|1|||
130023375|NCT03472560|468046732|FG000|Overall Study|Withdrawal by Subject|4|||
130023376|NCT03472560|468046733|FG001|Overall Study|Withdrawal by Subject|0|||
130023377|NCT03472560|468046732|FG000|Overall Study|Progressive disease|24|||
130023378|NCT03472560|468046733|FG001|Overall Study|Progressive disease|8|||
130023379|NCT03472560|468046732|FG000|Overall Study|Physician Decision|1|||
130023380|NCT03472560|468046733|FG001|Overall Study|Physician Decision|0|||
130023381|NCT03472560|468046732|FG000|Overall Study|Death|7|||
130023382|NCT03472560|468046733|FG001|Overall Study|Death|4|||
130231037|NCT01326871|468811591|FG002|Overall Study|Subject decision|1|||
130231038|NCT01200329|468811592|FG000|Overall Study|Lack of financial coverage|2|||
130231039|NCT01200329|468811592|FG000|Overall Study|Progressive disease|1|||
130231040|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
130231041|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
130231042|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
130231043|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
130231044|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
130231045|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
130231046|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
130023383|NCT03472560|468046732|FG000|Overall Study|Adverse Event|5|||
130023384|NCT03472560|468046733|FG001|Overall Study|Adverse Event|3|||
130023385|NCT03472560|468046732|FG000|Overall Study|Global deterioration of health status|0|||
130023386|NCT03472560|468046733|FG001|Overall Study|Global deterioration of health status|4|||
130023387|NCT01946178|468046734|FG000|Overall Study|Pregnancy|1|||
130099750|NCT01058707|468322772|FG002|Overall Study|Subject Decision|3|||
130099751|NCT01058707|468322773|FG003|Overall Study|Subject Decision|1|||
130231047|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130231048|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130231049|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
130231050|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
130231051|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
130231052|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130231053|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130231054|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
130231055|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
130231056|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
130231057|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130023388|NCT01946178|468046734|FG000|Overall Study|Lost to Follow-up|1|||
130099752|NCT01058707|468322774|FG004|Overall Study|Subject Decision|2|||
130099753|NCT01058707|468322775|FG005|Overall Study|Subject Decision|3|||
130099754|NCT01058707|468322776|FG006|Overall Study|Subject Decision|6|||
130099755|NCT01058707|468322770|FG000|Overall Study|Lost to Follow-up|0|||
130099756|NCT01058707|468322771|FG001|Overall Study|Lost to Follow-up|0|||
130023389|NCT02634580|468046735|FG000|Double-blind Treatment Period|Subject Request|1|||
130023390|NCT02634580|468046736|FG001|Double-blind Treatment Period|Subject Request|0|||
130023391|NCT02634580|468046737|FG002|Double-blind Treatment Period|Subject Request|1|||
130023392|NCT02634580|468046738|FG003|Double-blind Treatment Period|Subject Request|1|||
130023393|NCT02634580|468046735|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130099757|NCT01058707|468322772|FG002|Overall Study|Lost to Follow-up|1|||
130099758|NCT01058707|468322773|FG003|Overall Study|Lost to Follow-up|0|||
130099759|NCT01058707|468322774|FG004|Overall Study|Lost to Follow-up|0|||
130099760|NCT01058707|468322775|FG005|Overall Study|Lost to Follow-up|0|||
130023394|NCT02634580|468046736|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
130023395|NCT02634580|468046737|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
130023396|NCT02634580|468046738|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
130023397|NCT00491179|468046739|FG000|Overall Study|Adverse Event|5|||
130023398|NCT00491179|468046740|FG001|Overall Study|Adverse Event|1|||
130023399|NCT00491179|468046739|FG000|Overall Study|Withdrawal by Subject|2|||
130023400|NCT00491179|468046740|FG001|Overall Study|Withdrawal by Subject|1|||
130023401|NCT01505894|468046741|FG000|Overall Study|Adverse Event|1|||
130023402|NCT01505894|468046742|FG001|Overall Study|Adverse Event|0|||
130023403|NCT01505894|468046743|FG002|Overall Study|Adverse Event|0|||
130023404|NCT01505894|468046744|FG003|Overall Study|Adverse Event|0|||
130023405|NCT01505894|468046745|FG004|Overall Study|Adverse Event|0|||
130023406|NCT01505894|468046746|FG005|Overall Study|Adverse Event|0|||
130023407|NCT01505894|468046747|FG006|Overall Study|Adverse Event|0|||
130023408|NCT01505894|468046748|FG007|Overall Study|Adverse Event|0|||
130023409|NCT01505894|468046749|FG008|Overall Study|Adverse Event|0|||
130023410|NCT01505894|468046741|FG000|Overall Study|Other than specified|0|||
130023411|NCT01505894|468046742|FG001|Overall Study|Other than specified|0|||
130023412|NCT01505894|468046743|FG002|Overall Study|Other than specified|0|||
130023413|NCT01505894|468046744|FG003|Overall Study|Other than specified|0|||
130023414|NCT01505894|468046745|FG004|Overall Study|Other than specified|1|||
130023415|NCT01505894|468046746|FG005|Overall Study|Other than specified|0|||
130023416|NCT01505894|468046747|FG006|Overall Study|Other than specified|0|||
130023417|NCT01505894|468046748|FG007|Overall Study|Other than specified|0|||
130023418|NCT01505894|468046749|FG008|Overall Study|Other than specified|0|||
130023419|NCT01001702|468046750|FG000|Overall Study|Lost to Follow-up|7|||
130023420|NCT01001702|468046750|FG000|Overall Study|Adverse Event|7|||
130023421|NCT01001702|468046750|FG000|Overall Study|Sponsor Discontinued Study|4|||
130023422|NCT01001702|468046750|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
130023423|NCT01001702|468046750|FG000|Overall Study|Investigator withdrew Subject|10|||
130023424|NCT01001702|468046750|FG000|Overall Study|Withdrawal by Subject|19|||
130023425|NCT01001702|468046750|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
130023426|NCT04269395|468046751|FG000|Overall Study|Lost to Follow-up|1|||
130023427|NCT04269395|468046752|FG001|Overall Study|Lost to Follow-up|0|||
130023428|NCT04269395|468046751|FG000|Overall Study|Study terminated by Sponsor|13|||
130023429|NCT04269395|468046752|FG001|Overall Study|Study terminated by Sponsor|10|||
130023430|NCT00584233|468046753|FG000|Overall Study|Withdrawal by Subject|5|||
130023431|NCT00584233|468046753|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
130023432|NCT02222714|468046754|FG000|Overall Study|Death|0|||
130023433|NCT02222714|468046755|FG001|Overall Study|Death|2|||
130023434|NCT02222714|468046756|FG002|Overall Study|Death|3|||
130023435|NCT02222714|468046757|FG003|Overall Study|Death|4|||
130023436|NCT02222714|468046758|FG004|Overall Study|Death|6|||
130023437|NCT02222714|468046754|FG000|Overall Study|Withdrawal by Subject|0|||
130023438|NCT02222714|468046755|FG001|Overall Study|Withdrawal by Subject|0|||
130023439|NCT02222714|468046756|FG002|Overall Study|Withdrawal by Subject|1|||
130023440|NCT02222714|468046757|FG003|Overall Study|Withdrawal by Subject|0|||
130023441|NCT02222714|468046758|FG004|Overall Study|Withdrawal by Subject|1|||
130023442|NCT01285908|468046759|FG000|Baseline Measurement|unable to insert catheter|1|||
130023443|NCT01285908|468046760|FG001|Baseline Measurement|unable to insert catheter|0|||
130023444|NCT01285908|468046761|FG002|Baseline Measurement|unable to insert catheter|0|||
130023445|NCT01285908|468046759|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
130023446|NCT01285908|468046760|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
130023447|NCT01285908|468046761|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
130023448|NCT01285908|468046759|FG000|Baseline Measurement|unable to tolerate procedure|1|||
130023449|NCT01285908|468046760|FG001|Baseline Measurement|unable to tolerate procedure|0|||
130023450|NCT01285908|468046761|FG002|Baseline Measurement|unable to tolerate procedure|0|||
130023451|NCT03529773|468046762|FG000|Overall Study|Adverse Event|0|||
130023452|NCT03529773|468046763|FG001|Overall Study|Adverse Event|0|||
130023453|NCT03529773|468046764|FG002|Overall Study|Adverse Event|0|||
130023454|NCT03529773|468046765|FG003|Overall Study|Adverse Event|0|||
130023455|NCT03529773|468046766|FG004|Overall Study|Adverse Event|0|||
130023456|NCT03529773|468046767|FG005|Overall Study|Adverse Event|0|||
130023457|NCT03529773|468046768|FG006|Overall Study|Adverse Event|0|||
130023458|NCT03529773|468046769|FG007|Overall Study|Adverse Event|0|||
130023459|NCT03529773|468046770|FG008|Overall Study|Adverse Event|0|||
130023460|NCT03529773|468046771|FG009|Overall Study|Adverse Event|0|||
130023461|NCT03529773|468046772|FG010|Overall Study|Adverse Event|0|||
130023462|NCT03529773|468046773|FG011|Overall Study|Adverse Event|0|||
130023463|NCT03529773|468046774|FG012|Overall Study|Adverse Event|0|||
130023464|NCT03529773|468046775|FG013|Overall Study|Adverse Event|0|||
130023465|NCT03529773|468046776|FG014|Overall Study|Adverse Event|0|||
130023466|NCT03529773|468046777|FG015|Overall Study|Adverse Event|0|||
130023467|NCT03529773|468046778|FG016|Overall Study|Adverse Event|0|||
130023468|NCT03529773|468046779|FG017|Overall Study|Adverse Event|0|||
130023469|NCT03529773|468046780|FG018|Overall Study|Adverse Event|0|||
130023470|NCT03529773|468046781|FG019|Overall Study|Adverse Event|0|||
130023471|NCT03529773|468046782|FG020|Overall Study|Adverse Event|0|||
130023472|NCT03529773|468046783|FG021|Overall Study|Adverse Event|0|||
130023473|NCT03529773|468046784|FG022|Overall Study|Adverse Event|0|||
130023474|NCT03529773|468046785|FG023|Overall Study|Adverse Event|0|||
130023475|NCT03529773|468046786|FG024|Overall Study|Adverse Event|0|||
130023476|NCT03529773|468046787|FG025|Overall Study|Adverse Event|0|||
130023477|NCT03529773|468046788|FG026|Overall Study|Adverse Event|0|||
130023478|NCT03529773|468046789|FG027|Overall Study|Adverse Event|0|||
130023479|NCT03529773|468046790|FG028|Overall Study|Adverse Event|0|||
130023480|NCT03529773|468046791|FG029|Overall Study|Adverse Event|0|||
130023481|NCT03529773|468046792|FG030|Overall Study|Adverse Event|1|||
130023482|NCT03529773|468046793|FG031|Overall Study|Adverse Event|0|||
130023483|NCT03529773|468046794|FG032|Overall Study|Adverse Event|0|||
130023484|NCT03529773|468046795|FG033|Overall Study|Adverse Event|0|||
130023485|NCT03529773|468046796|FG034|Overall Study|Adverse Event|0|||
130023486|NCT03529773|468046797|FG035|Overall Study|Adverse Event|1|||
130023487|NCT03529773|468046798|FG036|Overall Study|Adverse Event|0|||
130023488|NCT03529773|468046799|FG037|Overall Study|Adverse Event|0|||
130023489|NCT03529773|468046800|FG038|Overall Study|Adverse Event|1|||
130023490|NCT03529773|468046801|FG039|Overall Study|Adverse Event|1|||
130023491|NCT03529773|468046762|FG000|Overall Study|Death|0|||
130023492|NCT03529773|468046763|FG001|Overall Study|Death|0|||
130023493|NCT03529773|468046764|FG002|Overall Study|Death|0|||
130023494|NCT03529773|468046765|FG003|Overall Study|Death|0|||
130023495|NCT03529773|468046766|FG004|Overall Study|Death|0|||
130023496|NCT03529773|468046767|FG005|Overall Study|Death|0|||
130023497|NCT03529773|468046768|FG006|Overall Study|Death|0|||
130023498|NCT03529773|468046769|FG007|Overall Study|Death|0|||
130023499|NCT03529773|468046770|FG008|Overall Study|Death|0|||
130023500|NCT03529773|468046771|FG009|Overall Study|Death|0|||
130023501|NCT03529773|468046772|FG010|Overall Study|Death|0|||
130023502|NCT03529773|468046773|FG011|Overall Study|Death|0|||
130023503|NCT03529773|468046774|FG012|Overall Study|Death|1|||
130023504|NCT03529773|468046775|FG013|Overall Study|Death|0|||
130023505|NCT03529773|468046776|FG014|Overall Study|Death|0|||
130023506|NCT03529773|468046777|FG015|Overall Study|Death|0|||
130023507|NCT03529773|468046778|FG016|Overall Study|Death|0|||
130023508|NCT03529773|468046779|FG017|Overall Study|Death|0|||
130023509|NCT03529773|468046780|FG018|Overall Study|Death|0|||
130023510|NCT03529773|468046781|FG019|Overall Study|Death|1|||
130023511|NCT03529773|468046782|FG020|Overall Study|Death|0|||
130023512|NCT03529773|468046783|FG021|Overall Study|Death|0|||
130023513|NCT03529773|468046784|FG022|Overall Study|Death|1|||
130023514|NCT03529773|468046785|FG023|Overall Study|Death|0|||
130023515|NCT03529773|468046786|FG024|Overall Study|Death|0|||
130023516|NCT03529773|468046787|FG025|Overall Study|Death|0|||
130023517|NCT03529773|468046788|FG026|Overall Study|Death|0|||
130023518|NCT03529773|468046789|FG027|Overall Study|Death|0|||
130023519|NCT03529773|468046790|FG028|Overall Study|Death|0|||
130023520|NCT03529773|468046791|FG029|Overall Study|Death|0|||
130023521|NCT03529773|468046792|FG030|Overall Study|Death|0|||
130023522|NCT03529773|468046793|FG031|Overall Study|Death|0|||
130023523|NCT03529773|468046794|FG032|Overall Study|Death|0|||
130023524|NCT03529773|468046795|FG033|Overall Study|Death|1|||
130023525|NCT03529773|468046796|FG034|Overall Study|Death|1|||
130023526|NCT03529773|468046797|FG035|Overall Study|Death|0|||
130023527|NCT03529773|468046798|FG036|Overall Study|Death|1|||
130023528|NCT03529773|468046799|FG037|Overall Study|Death|0|||
130023529|NCT03529773|468046800|FG038|Overall Study|Death|0|||
130023530|NCT03529773|468046801|FG039|Overall Study|Death|0|||
130023531|NCT03529773|468046762|FG000|Overall Study|Lost to Follow-up|0|||
130023532|NCT03529773|468046763|FG001|Overall Study|Lost to Follow-up|0|||
130023533|NCT03529773|468046764|FG002|Overall Study|Lost to Follow-up|1|||
130023534|NCT03529773|468046765|FG003|Overall Study|Lost to Follow-up|0|||
130023535|NCT03529773|468046766|FG004|Overall Study|Lost to Follow-up|1|||
130023536|NCT03529773|468046767|FG005|Overall Study|Lost to Follow-up|1|||
130023537|NCT03529773|468046768|FG006|Overall Study|Lost to Follow-up|0|||
130023538|NCT03529773|468046769|FG007|Overall Study|Lost to Follow-up|0|||
130023539|NCT03529773|468046770|FG008|Overall Study|Lost to Follow-up|0|||
130023540|NCT03529773|468046771|FG009|Overall Study|Lost to Follow-up|0|||
130023541|NCT03529773|468046772|FG010|Overall Study|Lost to Follow-up|0|||
130023542|NCT03529773|468046773|FG011|Overall Study|Lost to Follow-up|0|||
130023543|NCT03529773|468046774|FG012|Overall Study|Lost to Follow-up|0|||
130023544|NCT03529773|468046775|FG013|Overall Study|Lost to Follow-up|1|||
130023545|NCT03529773|468046776|FG014|Overall Study|Lost to Follow-up|4|||
130023546|NCT03529773|468046777|FG015|Overall Study|Lost to Follow-up|1|||
130023547|NCT03529773|468046778|FG016|Overall Study|Lost to Follow-up|1|||
130023548|NCT03529773|468046779|FG017|Overall Study|Lost to Follow-up|0|||
130023549|NCT03529773|468046780|FG018|Overall Study|Lost to Follow-up|1|||
130023550|NCT03529773|468046781|FG019|Overall Study|Lost to Follow-up|1|||
130023551|NCT03529773|468046782|FG020|Overall Study|Lost to Follow-up|2|||
130023552|NCT03529773|468046783|FG021|Overall Study|Lost to Follow-up|4|||
130099761|NCT01058707|468322776|FG006|Overall Study|Lost to Follow-up|0|||
130099762|NCT01058707|468322770|FG000|Overall Study|Reason Not Specified|0|||
130099763|NCT01058707|468322771|FG001|Overall Study|Reason Not Specified|3|||
130099764|NCT01058707|468322772|FG002|Overall Study|Reason Not Specified|2|||
130099765|NCT01058707|468322773|FG003|Overall Study|Reason Not Specified|0|||
130099766|NCT01058707|468322774|FG004|Overall Study|Reason Not Specified|7|||
130099767|NCT01058707|468322775|FG005|Overall Study|Reason Not Specified|1|||
130099768|NCT01058707|468322776|FG006|Overall Study|Reason Not Specified|7|||
130023553|NCT03529773|468046784|FG022|Overall Study|Lost to Follow-up|3|||
130099769|NCT01821391|468322777|FG000|Overall Study|Adverse Event|1|||
130099770|NCT01821391|468322778|FG001|Overall Study|Adverse Event|0|||
130099771|NCT02146365|468322779|FG000|Overall Study|Lost to Follow-up|2|||
130099772|NCT02146365|468322780|FG001|Overall Study|Lost to Follow-up|1|||
130099773|NCT02146365|468322781|FG002|Overall Study|Lost to Follow-up|3|||
130099774|NCT02146365|468322782|FG003|Overall Study|Lost to Follow-up|3|||
130099775|NCT02146365|468322783|FG004|Overall Study|Lost to Follow-up|1|||
130099776|NCT02146365|468322784|FG005|Overall Study|Lost to Follow-up|1|||
130099777|NCT02146365|468322785|FG006|Overall Study|Lost to Follow-up|0|||
130099778|NCT02146365|468322786|FG007|Overall Study|Lost to Follow-up|1|||
130099779|NCT02146365|468322779|FG000|Overall Study|Withdrawal by Subject|1|||
130099780|NCT02146365|468322780|FG001|Overall Study|Withdrawal by Subject|2|||
130099781|NCT02146365|468322781|FG002|Overall Study|Withdrawal by Subject|1|||
130099782|NCT02146365|468322782|FG003|Overall Study|Withdrawal by Subject|5|||
130099783|NCT02146365|468322783|FG004|Overall Study|Withdrawal by Subject|1|||
130099784|NCT02146365|468322784|FG005|Overall Study|Withdrawal by Subject|0|||
130099785|NCT02146365|468322785|FG006|Overall Study|Withdrawal by Subject|0|||
130099786|NCT02146365|468322786|FG007|Overall Study|Withdrawal by Subject|0|||
130099787|NCT02146365|468322779|FG000|Overall Study|Unable to Comply with Protocol|0|||
130099788|NCT02146365|468322780|FG001|Overall Study|Unable to Comply with Protocol|1|||
130099789|NCT02146365|468322781|FG002|Overall Study|Unable to Comply with Protocol|1|||
130099790|NCT02146365|468322782|FG003|Overall Study|Unable to Comply with Protocol|0|||
130099791|NCT02146365|468322783|FG004|Overall Study|Unable to Comply with Protocol|0|||
130099792|NCT02146365|468322784|FG005|Overall Study|Unable to Comply with Protocol|0|||
130099793|NCT02146365|468322785|FG006|Overall Study|Unable to Comply with Protocol|0|||
130099794|NCT02146365|468322786|FG007|Overall Study|Unable to Comply with Protocol|0|||
130099795|NCT02146365|468322779|FG000|Overall Study|Other|1|||
130099796|NCT02146365|468322780|FG001|Overall Study|Other|0|||
130099797|NCT02146365|468322781|FG002|Overall Study|Other|2|||
130099798|NCT02146365|468322782|FG003|Overall Study|Other|1|||
130231058|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130231059|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
130231060|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
130023554|NCT03529773|468046785|FG023|Overall Study|Lost to Follow-up|4|||
130023555|NCT03529773|468046786|FG024|Overall Study|Lost to Follow-up|3|||
130023556|NCT03529773|468046787|FG025|Overall Study|Lost to Follow-up|5|||
130023557|NCT03529773|468046788|FG026|Overall Study|Lost to Follow-up|5|||
130023558|NCT03529773|468046789|FG027|Overall Study|Lost to Follow-up|0|||
130023559|NCT03529773|468046790|FG028|Overall Study|Lost to Follow-up|0|||
130023560|NCT03529773|468046791|FG029|Overall Study|Lost to Follow-up|0|||
130023561|NCT03529773|468046792|FG030|Overall Study|Lost to Follow-up|1|||
130023562|NCT03529773|468046793|FG031|Overall Study|Lost to Follow-up|0|||
130023563|NCT03529773|468046794|FG032|Overall Study|Lost to Follow-up|0|||
130023564|NCT03529773|468046795|FG033|Overall Study|Lost to Follow-up|1|||
130023565|NCT03529773|468046796|FG034|Overall Study|Lost to Follow-up|1|||
130023566|NCT03529773|468046797|FG035|Overall Study|Lost to Follow-up|0|||
130023567|NCT03529773|468046798|FG036|Overall Study|Lost to Follow-up|0|||
130023568|NCT03529773|468046799|FG037|Overall Study|Lost to Follow-up|3|||
130023569|NCT03529773|468046800|FG038|Overall Study|Lost to Follow-up|1|||
130023570|NCT03529773|468046801|FG039|Overall Study|Lost to Follow-up|1|||
130099799|NCT02146365|468322783|FG004|Overall Study|Other|0|||
130099800|NCT02146365|468322784|FG005|Overall Study|Other|0|||
130231061|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
130231062|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130231063|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130099801|NCT02146365|468322785|FG006|Overall Study|Other|0|||
130023571|NCT03529773|468046762|FG000|Overall Study|No longer meets eligibility criteria|0|||
130023572|NCT03529773|468046763|FG001|Overall Study|No longer meets eligibility criteria|0|||
130023573|NCT03529773|468046764|FG002|Overall Study|No longer meets eligibility criteria|0|||
130023574|NCT03529773|468046765|FG003|Overall Study|No longer meets eligibility criteria|0|||
130099802|NCT02146365|468322786|FG007|Overall Study|Other|0|||
130099803|NCT01843660|468322788|FG000|Overall Study|Other|30|||
130099804|NCT01977482|468322789|FG000|Overall Study|Adverse Event|0|||
130023575|NCT03529773|468046766|FG004|Overall Study|No longer meets eligibility criteria|0|||
130023576|NCT03529773|468046767|FG005|Overall Study|No longer meets eligibility criteria|0|||
130023577|NCT03529773|468046768|FG006|Overall Study|No longer meets eligibility criteria|0|||
130023578|NCT03529773|468046769|FG007|Overall Study|No longer meets eligibility criteria|0|||
130023579|NCT03529773|468046770|FG008|Overall Study|No longer meets eligibility criteria|0|||
130023580|NCT03529773|468046771|FG009|Overall Study|No longer meets eligibility criteria|0|||
130023581|NCT03529773|468046772|FG010|Overall Study|No longer meets eligibility criteria|0|||
130023582|NCT03529773|468046773|FG011|Overall Study|No longer meets eligibility criteria|0|||
130023583|NCT03529773|468046774|FG012|Overall Study|No longer meets eligibility criteria|0|||
130023584|NCT03529773|468046775|FG013|Overall Study|No longer meets eligibility criteria|0|||
130023585|NCT03529773|468046776|FG014|Overall Study|No longer meets eligibility criteria|0|||
130023586|NCT03529773|468046777|FG015|Overall Study|No longer meets eligibility criteria|0|||
130023587|NCT03529773|468046778|FG016|Overall Study|No longer meets eligibility criteria|0|||
130023588|NCT03529773|468046779|FG017|Overall Study|No longer meets eligibility criteria|0|||
130023589|NCT03529773|468046780|FG018|Overall Study|No longer meets eligibility criteria|0|||
130023590|NCT03529773|468046781|FG019|Overall Study|No longer meets eligibility criteria|0|||
130023591|NCT03529773|468046782|FG020|Overall Study|No longer meets eligibility criteria|0|||
130023592|NCT03529773|468046783|FG021|Overall Study|No longer meets eligibility criteria|0|||
130023593|NCT03529773|468046784|FG022|Overall Study|No longer meets eligibility criteria|1|||
130023594|NCT03529773|468046785|FG023|Overall Study|No longer meets eligibility criteria|0|||
130023595|NCT03529773|468046786|FG024|Overall Study|No longer meets eligibility criteria|0|||
130023596|NCT03529773|468046787|FG025|Overall Study|No longer meets eligibility criteria|0|||
130023597|NCT03529773|468046788|FG026|Overall Study|No longer meets eligibility criteria|0|||
130023598|NCT03529773|468046789|FG027|Overall Study|No longer meets eligibility criteria|0|||
130023599|NCT03529773|468046790|FG028|Overall Study|No longer meets eligibility criteria|0|||
130023600|NCT03529773|468046791|FG029|Overall Study|No longer meets eligibility criteria|0|||
130023601|NCT03529773|468046792|FG030|Overall Study|No longer meets eligibility criteria|0|||
130023602|NCT03529773|468046793|FG031|Overall Study|No longer meets eligibility criteria|0|||
130023603|NCT03529773|468046794|FG032|Overall Study|No longer meets eligibility criteria|0|||
130023604|NCT03529773|468046795|FG033|Overall Study|No longer meets eligibility criteria|0|||
130023605|NCT03529773|468046796|FG034|Overall Study|No longer meets eligibility criteria|0|||
130023606|NCT03529773|468046797|FG035|Overall Study|No longer meets eligibility criteria|0|||
130023607|NCT03529773|468046798|FG036|Overall Study|No longer meets eligibility criteria|0|||
130023608|NCT03529773|468046799|FG037|Overall Study|No longer meets eligibility criteria|0|||
130023609|NCT03529773|468046800|FG038|Overall Study|No longer meets eligibility criteria|1|||
130023610|NCT03529773|468046801|FG039|Overall Study|No longer meets eligibility criteria|0|||
130023611|NCT03529773|468046762|FG000|Overall Study|Other|0|||
130023612|NCT03529773|468046763|FG001|Overall Study|Other|0|||
130023613|NCT03529773|468046764|FG002|Overall Study|Other|0|||
130023614|NCT03529773|468046765|FG003|Overall Study|Other|0|||
130023615|NCT03529773|468046766|FG004|Overall Study|Other|0|||
130023616|NCT03529773|468046767|FG005|Overall Study|Other|0|||
130023617|NCT03529773|468046768|FG006|Overall Study|Other|0|||
130023618|NCT03529773|468046769|FG007|Overall Study|Other|0|||
130023619|NCT03529773|468046770|FG008|Overall Study|Other|0|||
130023620|NCT03529773|468046771|FG009|Overall Study|Other|0|||
130023621|NCT03529773|468046772|FG010|Overall Study|Other|0|||
130023622|NCT03529773|468046773|FG011|Overall Study|Other|0|||
130023623|NCT03529773|468046774|FG012|Overall Study|Other|1|||
130023624|NCT03529773|468046775|FG013|Overall Study|Other|0|||
130023625|NCT03529773|468046776|FG014|Overall Study|Other|2|||
130023626|NCT03529773|468046777|FG015|Overall Study|Other|0|||
130023627|NCT03529773|468046778|FG016|Overall Study|Other|0|||
130023628|NCT03529773|468046779|FG017|Overall Study|Other|3|||
130023629|NCT03529773|468046780|FG018|Overall Study|Other|0|||
130023630|NCT03529773|468046781|FG019|Overall Study|Other|0|||
130023631|NCT03529773|468046782|FG020|Overall Study|Other|1|||
130023632|NCT03529773|468046783|FG021|Overall Study|Other|0|||
130099805|NCT01977482|468322790|FG001|Overall Study|Adverse Event|1|||
130099806|NCT01977482|468322791|FG002|Overall Study|Adverse Event|1|||
130231064|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
130231065|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
130099807|NCT01977482|468322792|FG003|Overall Study|Adverse Event|0|||
130099808|NCT01977482|468322793|FG004|Overall Study|Adverse Event|2|||
130099809|NCT01977482|468322794|FG005|Overall Study|Adverse Event|0|||
130099810|NCT01977482|468322789|FG000|Overall Study|Lost to Follow-up|1|||
130023633|NCT03529773|468046784|FG022|Overall Study|Other|1|||
130023634|NCT03529773|468046785|FG023|Overall Study|Other|0|||
130023635|NCT03529773|468046786|FG024|Overall Study|Other|3|||
130231066|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
130231067|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130023636|NCT03529773|468046787|FG025|Overall Study|Other|2|||
130023637|NCT03529773|468046788|FG026|Overall Study|Other|2|||
130023638|NCT03529773|468046789|FG027|Overall Study|Other|0|||
130023639|NCT03529773|468046790|FG028|Overall Study|Other|0|||
130023640|NCT03529773|468046791|FG029|Overall Study|Other|0|||
130023641|NCT03529773|468046792|FG030|Overall Study|Other|0|||
130023642|NCT03529773|468046793|FG031|Overall Study|Other|0|||
130023643|NCT03529773|468046794|FG032|Overall Study|Other|0|||
130023644|NCT03529773|468046795|FG033|Overall Study|Other|0|||
130023645|NCT03529773|468046796|FG034|Overall Study|Other|1|||
130023646|NCT03529773|468046797|FG035|Overall Study|Other|1|||
130023647|NCT03529773|468046798|FG036|Overall Study|Other|0|||
130023648|NCT03529773|468046799|FG037|Overall Study|Other|0|||
130023649|NCT03529773|468046800|FG038|Overall Study|Other|0|||
130023650|NCT03529773|468046801|FG039|Overall Study|Other|0|||
130023651|NCT03529773|468046762|FG000|Overall Study|Physician Decision|0|||
130023652|NCT03529773|468046763|FG001|Overall Study|Physician Decision|0|||
130023653|NCT03529773|468046764|FG002|Overall Study|Physician Decision|0|||
130023654|NCT03529773|468046765|FG003|Overall Study|Physician Decision|0|||
130023655|NCT03529773|468046766|FG004|Overall Study|Physician Decision|0|||
130023656|NCT03529773|468046767|FG005|Overall Study|Physician Decision|0|||
130023657|NCT03529773|468046768|FG006|Overall Study|Physician Decision|0|||
130023658|NCT03529773|468046769|FG007|Overall Study|Physician Decision|0|||
130023659|NCT03529773|468046770|FG008|Overall Study|Physician Decision|0|||
130023660|NCT03529773|468046771|FG009|Overall Study|Physician Decision|0|||
130023661|NCT03529773|468046772|FG010|Overall Study|Physician Decision|0|||
130023662|NCT03529773|468046773|FG011|Overall Study|Physician Decision|0|||
130023663|NCT03529773|468046774|FG012|Overall Study|Physician Decision|0|||
130023664|NCT03529773|468046775|FG013|Overall Study|Physician Decision|0|||
130023665|NCT03529773|468046776|FG014|Overall Study|Physician Decision|0|||
130023666|NCT03529773|468046777|FG015|Overall Study|Physician Decision|0|||
130023667|NCT03529773|468046778|FG016|Overall Study|Physician Decision|0|||
130023668|NCT03529773|468046779|FG017|Overall Study|Physician Decision|0|||
130023669|NCT03529773|468046780|FG018|Overall Study|Physician Decision|0|||
130023670|NCT03529773|468046781|FG019|Overall Study|Physician Decision|1|||
130023671|NCT03529773|468046782|FG020|Overall Study|Physician Decision|1|||
130023672|NCT03529773|468046783|FG021|Overall Study|Physician Decision|0|||
130023673|NCT03529773|468046784|FG022|Overall Study|Physician Decision|0|||
130023674|NCT03529773|468046785|FG023|Overall Study|Physician Decision|0|||
130023675|NCT03529773|468046786|FG024|Overall Study|Physician Decision|0|||
130023676|NCT03529773|468046787|FG025|Overall Study|Physician Decision|0|||
130023677|NCT03529773|468046788|FG026|Overall Study|Physician Decision|0|||
130023678|NCT03529773|468046789|FG027|Overall Study|Physician Decision|0|||
130023679|NCT03529773|468046790|FG028|Overall Study|Physician Decision|0|||
130023680|NCT03529773|468046791|FG029|Overall Study|Physician Decision|0|||
130023681|NCT03529773|468046792|FG030|Overall Study|Physician Decision|0|||
130023682|NCT03529773|468046793|FG031|Overall Study|Physician Decision|0|||
130023683|NCT03529773|468046794|FG032|Overall Study|Physician Decision|0|||
130023684|NCT03529773|468046795|FG033|Overall Study|Physician Decision|0|||
130023685|NCT03529773|468046796|FG034|Overall Study|Physician Decision|0|||
130023686|NCT03529773|468046797|FG035|Overall Study|Physician Decision|0|||
130023687|NCT03529773|468046798|FG036|Overall Study|Physician Decision|0|||
130023688|NCT03529773|468046799|FG037|Overall Study|Physician Decision|0|||
130023689|NCT03529773|468046800|FG038|Overall Study|Physician Decision|0|||
130023690|NCT03529773|468046801|FG039|Overall Study|Physician Decision|0|||
130023691|NCT03529773|468046762|FG000|Overall Study|Protocol Violation|0|||
130023692|NCT03529773|468046763|FG001|Overall Study|Protocol Violation|0|||
130023693|NCT03529773|468046764|FG002|Overall Study|Protocol Violation|0|||
130023694|NCT03529773|468046765|FG003|Overall Study|Protocol Violation|0|||
130023695|NCT03529773|468046766|FG004|Overall Study|Protocol Violation|0|||
130023696|NCT03529773|468046767|FG005|Overall Study|Protocol Violation|0|||
130023697|NCT03529773|468046768|FG006|Overall Study|Protocol Violation|0|||
130023698|NCT03529773|468046769|FG007|Overall Study|Protocol Violation|0|||
130023699|NCT03529773|468046770|FG008|Overall Study|Protocol Violation|0|||
130023700|NCT03529773|468046771|FG009|Overall Study|Protocol Violation|0|||
130023701|NCT03529773|468046772|FG010|Overall Study|Protocol Violation|0|||
130023702|NCT03529773|468046773|FG011|Overall Study|Protocol Violation|0|||
130023703|NCT03529773|468046774|FG012|Overall Study|Protocol Violation|0|||
130023704|NCT03529773|468046775|FG013|Overall Study|Protocol Violation|0|||
130023705|NCT03529773|468046776|FG014|Overall Study|Protocol Violation|0|||
130023706|NCT03529773|468046777|FG015|Overall Study|Protocol Violation|0|||
130023707|NCT03529773|468046778|FG016|Overall Study|Protocol Violation|0|||
130023708|NCT03529773|468046779|FG017|Overall Study|Protocol Violation|0|||
130023709|NCT03529773|468046780|FG018|Overall Study|Protocol Violation|0|||
130023710|NCT03529773|468046781|FG019|Overall Study|Protocol Violation|0|||
130023711|NCT03529773|468046782|FG020|Overall Study|Protocol Violation|0|||
130023712|NCT03529773|468046783|FG021|Overall Study|Protocol Violation|0|||
130023713|NCT03529773|468046784|FG022|Overall Study|Protocol Violation|0|||
130023714|NCT03529773|468046785|FG023|Overall Study|Protocol Violation|0|||
130023715|NCT03529773|468046786|FG024|Overall Study|Protocol Violation|0|||
130023716|NCT03529773|468046787|FG025|Overall Study|Protocol Violation|0|||
130023717|NCT03529773|468046788|FG026|Overall Study|Protocol Violation|0|||
130023718|NCT03529773|468046789|FG027|Overall Study|Protocol Violation|0|||
130023719|NCT03529773|468046790|FG028|Overall Study|Protocol Violation|0|||
130023720|NCT03529773|468046791|FG029|Overall Study|Protocol Violation|0|||
130023721|NCT03529773|468046792|FG030|Overall Study|Protocol Violation|1|||
130023722|NCT03529773|468046793|FG031|Overall Study|Protocol Violation|0|||
130023723|NCT03529773|468046794|FG032|Overall Study|Protocol Violation|0|||
130023724|NCT03529773|468046795|FG033|Overall Study|Protocol Violation|0|||
130023725|NCT03529773|468046796|FG034|Overall Study|Protocol Violation|0|||
130023726|NCT03529773|468046797|FG035|Overall Study|Protocol Violation|0|||
130023727|NCT03529773|468046798|FG036|Overall Study|Protocol Violation|0|||
130023728|NCT03529773|468046799|FG037|Overall Study|Protocol Violation|0|||
130023729|NCT03529773|468046800|FG038|Overall Study|Protocol Violation|0|||
130023730|NCT03529773|468046801|FG039|Overall Study|Protocol Violation|0|||
130023731|NCT03529773|468046762|FG000|Overall Study|Withdrawal by Subject|0|||
130023732|NCT03529773|468046763|FG001|Overall Study|Withdrawal by Subject|0|||
130023733|NCT03529773|468046764|FG002|Overall Study|Withdrawal by Subject|0|||
130023734|NCT03529773|468046765|FG003|Overall Study|Withdrawal by Subject|0|||
130023735|NCT03529773|468046766|FG004|Overall Study|Withdrawal by Subject|0|||
130023736|NCT03529773|468046767|FG005|Overall Study|Withdrawal by Subject|0|||
130023737|NCT03529773|468046768|FG006|Overall Study|Withdrawal by Subject|0|||
130023738|NCT03529773|468046769|FG007|Overall Study|Withdrawal by Subject|1|||
130023739|NCT03529773|468046770|FG008|Overall Study|Withdrawal by Subject|0|||
130023740|NCT03529773|468046771|FG009|Overall Study|Withdrawal by Subject|1|||
130023741|NCT03529773|468046772|FG010|Overall Study|Withdrawal by Subject|1|||
130023742|NCT03529773|468046773|FG011|Overall Study|Withdrawal by Subject|0|||
130023743|NCT03529773|468046774|FG012|Overall Study|Withdrawal by Subject|0|||
130023744|NCT03529773|468046775|FG013|Overall Study|Withdrawal by Subject|0|||
130023745|NCT03529773|468046776|FG014|Overall Study|Withdrawal by Subject|0|||
130023746|NCT03529773|468046777|FG015|Overall Study|Withdrawal by Subject|3|||
130023747|NCT03529773|468046778|FG016|Overall Study|Withdrawal by Subject|0|||
130023748|NCT03529773|468046779|FG017|Overall Study|Withdrawal by Subject|2|||
130023749|NCT03529773|468046780|FG018|Overall Study|Withdrawal by Subject|3|||
130023750|NCT03529773|468046781|FG019|Overall Study|Withdrawal by Subject|1|||
130023751|NCT03529773|468046782|FG020|Overall Study|Withdrawal by Subject|3|||
130023752|NCT03529773|468046783|FG021|Overall Study|Withdrawal by Subject|1|||
130023753|NCT03529773|468046784|FG022|Overall Study|Withdrawal by Subject|1|||
130023754|NCT03529773|468046785|FG023|Overall Study|Withdrawal by Subject|2|||
130023755|NCT03529773|468046786|FG024|Overall Study|Withdrawal by Subject|2|||
130023756|NCT03529773|468046787|FG025|Overall Study|Withdrawal by Subject|4|||
130023757|NCT03529773|468046788|FG026|Overall Study|Withdrawal by Subject|2|||
130023758|NCT03529773|468046789|FG027|Overall Study|Withdrawal by Subject|1|||
130023759|NCT03529773|468046790|FG028|Overall Study|Withdrawal by Subject|1|||
130023760|NCT03529773|468046791|FG029|Overall Study|Withdrawal by Subject|0|||
130023761|NCT03529773|468046792|FG030|Overall Study|Withdrawal by Subject|0|||
130023762|NCT03529773|468046793|FG031|Overall Study|Withdrawal by Subject|0|||
130023763|NCT03529773|468046794|FG032|Overall Study|Withdrawal by Subject|0|||
130023764|NCT03529773|468046795|FG033|Overall Study|Withdrawal by Subject|0|||
130023765|NCT03529773|468046796|FG034|Overall Study|Withdrawal by Subject|1|||
130023766|NCT03529773|468046797|FG035|Overall Study|Withdrawal by Subject|2|||
130023767|NCT03529773|468046798|FG036|Overall Study|Withdrawal by Subject|0|||
130023768|NCT03529773|468046799|FG037|Overall Study|Withdrawal by Subject|2|||
130023769|NCT03529773|468046800|FG038|Overall Study|Withdrawal by Subject|1|||
130023770|NCT03529773|468046801|FG039|Overall Study|Withdrawal by Subject|1|||
130023771|NCT03529773|468046762|FG000|Overall Study|Screen Failure|0|||
130023772|NCT03529773|468046763|FG001|Overall Study|Screen Failure|0|||
130023773|NCT03529773|468046764|FG002|Overall Study|Screen Failure|0|||
129884521|NCT04779242|467536437|FG001|Overall Study|Withdrawal by Subject|9|||
130023774|NCT03529773|468046765|FG003|Overall Study|Screen Failure|0|||
130023775|NCT03529773|468046766|FG004|Overall Study|Screen Failure|0|||
130023776|NCT03529773|468046767|FG005|Overall Study|Screen Failure|0|||
130023777|NCT03529773|468046768|FG006|Overall Study|Screen Failure|0|||
130023778|NCT03529773|468046769|FG007|Overall Study|Screen Failure|0|||
130023779|NCT03529773|468046770|FG008|Overall Study|Screen Failure|0|||
130023780|NCT03529773|468046771|FG009|Overall Study|Screen Failure|0|||
130023781|NCT03529773|468046772|FG010|Overall Study|Screen Failure|0|||
130023782|NCT03529773|468046773|FG011|Overall Study|Screen Failure|0|||
130023783|NCT03529773|468046774|FG012|Overall Study|Screen Failure|0|||
130023784|NCT03529773|468046775|FG013|Overall Study|Screen Failure|0|||
130023785|NCT03529773|468046776|FG014|Overall Study|Screen Failure|0|||
130023786|NCT03529773|468046777|FG015|Overall Study|Screen Failure|0|||
130099811|NCT01977482|468322790|FG001|Overall Study|Lost to Follow-up|0|||
130099812|NCT01977482|468322791|FG002|Overall Study|Lost to Follow-up|0|||
130099813|NCT01977482|468322792|FG003|Overall Study|Lost to Follow-up|0|||
130099814|NCT01977482|468322793|FG004|Overall Study|Lost to Follow-up|0|||
130099815|NCT01977482|468322794|FG005|Overall Study|Lost to Follow-up|0|||
130099816|NCT01977482|468322789|FG000|Overall Study|Physician Decision|0|||
130099817|NCT01977482|468322790|FG001|Overall Study|Physician Decision|1|||
130099818|NCT01977482|468322791|FG002|Overall Study|Physician Decision|0|||
130099819|NCT01977482|468322792|FG003|Overall Study|Physician Decision|0|||
130099820|NCT01977482|468322793|FG004|Overall Study|Physician Decision|0|||
130099821|NCT01977482|468322794|FG005|Overall Study|Physician Decision|0|||
130099822|NCT01977482|468322789|FG000|Overall Study|Protocol Violation|0|||
130099823|NCT01977482|468322790|FG001|Overall Study|Protocol Violation|0|||
130099824|NCT01977482|468322791|FG002|Overall Study|Protocol Violation|1|||
130099825|NCT01977482|468322792|FG003|Overall Study|Protocol Violation|0|||
130099826|NCT01977482|468322793|FG004|Overall Study|Protocol Violation|0|||
130099827|NCT01977482|468322794|FG005|Overall Study|Protocol Violation|0|||
130099828|NCT01977482|468322789|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
130099829|NCT01977482|468322790|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
130099830|NCT01977482|468322791|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
130099831|NCT01977482|468322792|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
130099832|NCT01977482|468322793|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
130099833|NCT01977482|468322794|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
130099834|NCT01977482|468322789|FG000|Overall Study|Withdrawal by Subject|2|||
130099835|NCT01977482|468322790|FG001|Overall Study|Withdrawal by Subject|4|||
130099836|NCT01977482|468322791|FG002|Overall Study|Withdrawal by Subject|1|||
130099837|NCT01977482|468322792|FG003|Overall Study|Withdrawal by Subject|3|||
130099838|NCT01977482|468322793|FG004|Overall Study|Withdrawal by Subject|1|||
130099839|NCT01977482|468322794|FG005|Overall Study|Withdrawal by Subject|5|||
130099840|NCT00209560|468322795|FG000|Overall Study|Lack of Efficacy|1|||
130099841|NCT00209560|468322796|FG001|Overall Study|Lack of Efficacy|0|||
130099842|NCT00795886|468322797|FG000|Overall Study|Death|10|||
130099843|NCT05554471|468322807|FG000|Overall Study|Physician Decision|2|||
130099844|NCT05554471|468322808|FG001|Overall Study|Physician Decision|1|||
130099845|NCT05554471|468322807|FG000|Overall Study|Lost to Follow-up|2|||
130099846|NCT05554471|468322808|FG001|Overall Study|Lost to Follow-up|1|||
130099847|NCT05554471|468322807|FG000|Overall Study|Death|0|||
130099848|NCT05554471|468322808|FG001|Overall Study|Death|1|||
130099849|NCT04880850|468322809|FG000|Overall Study|Death|2|||
130099850|NCT04880850|468322810|FG001|Overall Study|Death|1|||
130099851|NCT04880850|468322809|FG000|Overall Study|Lost to Follow-up|3|||
130099852|NCT04880850|468322810|FG001|Overall Study|Lost to Follow-up|6|||
130099853|NCT04880850|468322809|FG000|Overall Study|Physician Decision|2|||
130099854|NCT04880850|468322810|FG001|Overall Study|Physician Decision|1|||
130099855|NCT04880850|468322809|FG000|Overall Study|Withdrawal by Subject|9|||
130099856|NCT04880850|468322810|FG001|Overall Study|Withdrawal by Subject|10|||
130099857|NCT01608321|468322811|FG000|Overall Study|Withdrawal by Subject|1|||
130099858|NCT01608321|468322812|FG001|Overall Study|Withdrawal by Subject|0|||
130099859|NCT03417102|468322813|FG000|Overall Study|Adverse Event|0|||
130099860|NCT03417102|468322814|FG001|Overall Study|Adverse Event|1|||
130099861|NCT03417102|468322813|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
130099862|NCT03417102|468322814|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
130099863|NCT03417102|468322813|FG000|Overall Study|Other|0|||
130099864|NCT03417102|468322814|FG001|Overall Study|Other|1|||
130099865|NCT02062385|468322815|FG000|Overall Study|Adverse Event|19|||
130099866|NCT02062385|468322816|FG001|Overall Study|Adverse Event|13|||
130099867|NCT02062385|468322817|FG002|Overall Study|Adverse Event|1|||
130099868|NCT02062385|468322818|FG003|Overall Study|Adverse Event|0|||
130099869|NCT02062385|468322815|FG000|Overall Study|Protocol Violation|1|||
130099870|NCT02062385|468322816|FG001|Overall Study|Protocol Violation|0|||
130099871|NCT02062385|468322817|FG002|Overall Study|Protocol Violation|0|||
130099872|NCT02062385|468322818|FG003|Overall Study|Protocol Violation|0|||
130099873|NCT02062385|468322815|FG000|Overall Study|Incomplete EPI by database lock|2|||
130099874|NCT02062385|468322816|FG001|Overall Study|Incomplete EPI by database lock|0|||
130099875|NCT02062385|468322817|FG002|Overall Study|Incomplete EPI by database lock|0|||
130099876|NCT02062385|468322818|FG003|Overall Study|Incomplete EPI by database lock|0|||
130099877|NCT02062385|468322815|FG000|Overall Study|Moved|10|||
130099878|NCT02062385|468322816|FG001|Overall Study|Moved|11|||
130023787|NCT03529773|468046778|FG016|Overall Study|Screen Failure|0|||
130023788|NCT03529773|468046779|FG017|Overall Study|Screen Failure|0|||
130023789|NCT03529773|468046780|FG018|Overall Study|Screen Failure|0|||
130023790|NCT03529773|468046781|FG019|Overall Study|Screen Failure|0|||
130023791|NCT03529773|468046782|FG020|Overall Study|Screen Failure|0|||
130023792|NCT03529773|468046783|FG021|Overall Study|Screen Failure|0|||
130023793|NCT03529773|468046784|FG022|Overall Study|Screen Failure|0|||
130023794|NCT03529773|468046785|FG023|Overall Study|Screen Failure|0|||
130023795|NCT03529773|468046786|FG024|Overall Study|Screen Failure|0|||
130023796|NCT03529773|468046787|FG025|Overall Study|Screen Failure|0|||
130023797|NCT03529773|468046788|FG026|Overall Study|Screen Failure|0|||
130023798|NCT03529773|468046789|FG027|Overall Study|Screen Failure|0|||
130023799|NCT03529773|468046790|FG028|Overall Study|Screen Failure|0|||
130023800|NCT03529773|468046791|FG029|Overall Study|Screen Failure|0|||
130023801|NCT03529773|468046792|FG030|Overall Study|Screen Failure|0|||
130023802|NCT03529773|468046793|FG031|Overall Study|Screen Failure|0|||
130023803|NCT03529773|468046794|FG032|Overall Study|Screen Failure|0|||
130023804|NCT03529773|468046795|FG033|Overall Study|Screen Failure|0|||
130231068|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130231069|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
130231070|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
130231071|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
130231072|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130231073|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130231074|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
130231075|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
130231076|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
130231077|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130231078|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130231079|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
130231080|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
130231081|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130231082|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130316110|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316111|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
130023805|NCT03529773|468046796|FG034|Overall Study|Screen Failure|0|||
130023806|NCT03529773|468046797|FG035|Overall Study|Screen Failure|0|||
130023807|NCT03529773|468046798|FG036|Overall Study|Screen Failure|1|||
130023808|NCT03529773|468046799|FG037|Overall Study|Screen Failure|1|||
130023809|NCT03529773|468046800|FG038|Overall Study|Screen Failure|0|||
130023810|NCT03529773|468046801|FG039|Overall Study|Screen Failure|1|||
130023811|NCT03529773|468046762|FG000|Overall Study|Randomized but not vaccinated|0|||
130023812|NCT03529773|468046763|FG001|Overall Study|Randomized but not vaccinated|0|||
130023813|NCT03529773|468046764|FG002|Overall Study|Randomized but not vaccinated|0|||
130023814|NCT03529773|468046765|FG003|Overall Study|Randomized but not vaccinated|0|||
130023815|NCT03529773|468046766|FG004|Overall Study|Randomized but not vaccinated|0|||
130023816|NCT03529773|468046767|FG005|Overall Study|Randomized but not vaccinated|0|||
130023817|NCT03529773|468046768|FG006|Overall Study|Randomized but not vaccinated|0|||
130023818|NCT03529773|468046769|FG007|Overall Study|Randomized but not vaccinated|0|||
130023819|NCT03529773|468046770|FG008|Overall Study|Randomized but not vaccinated|0|||
130023820|NCT03529773|468046771|FG009|Overall Study|Randomized but not vaccinated|0|||
130023821|NCT03529773|468046772|FG010|Overall Study|Randomized but not vaccinated|0|||
130023822|NCT03529773|468046773|FG011|Overall Study|Randomized but not vaccinated|0|||
130023823|NCT03529773|468046774|FG012|Overall Study|Randomized but not vaccinated|0|||
130023824|NCT03529773|468046775|FG013|Overall Study|Randomized but not vaccinated|0|||
130023825|NCT03529773|468046776|FG014|Overall Study|Randomized but not vaccinated|0|||
130023826|NCT03529773|468046777|FG015|Overall Study|Randomized but not vaccinated|0|||
130023827|NCT03529773|468046778|FG016|Overall Study|Randomized but not vaccinated|0|||
130023828|NCT03529773|468046779|FG017|Overall Study|Randomized but not vaccinated|1|||
130023829|NCT03529773|468046780|FG018|Overall Study|Randomized but not vaccinated|0|||
130023830|NCT03529773|468046781|FG019|Overall Study|Randomized but not vaccinated|0|||
130023831|NCT03529773|468046782|FG020|Overall Study|Randomized but not vaccinated|0|||
130023832|NCT03529773|468046783|FG021|Overall Study|Randomized but not vaccinated|0|||
130316112|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
130023833|NCT03529773|468046784|FG022|Overall Study|Randomized but not vaccinated|0|||
130023834|NCT03529773|468046785|FG023|Overall Study|Randomized but not vaccinated|0|||
130023835|NCT03529773|468046786|FG024|Overall Study|Randomized but not vaccinated|0|||
130023836|NCT03529773|468046787|FG025|Overall Study|Randomized but not vaccinated|0|||
130023837|NCT03529773|468046788|FG026|Overall Study|Randomized but not vaccinated|0|||
130023838|NCT03529773|468046789|FG027|Overall Study|Randomized but not vaccinated|1|||
130023839|NCT03529773|468046790|FG028|Overall Study|Randomized but not vaccinated|0|||
130023840|NCT03529773|468046791|FG029|Overall Study|Randomized but not vaccinated|0|||
130023841|NCT03529773|468046792|FG030|Overall Study|Randomized but not vaccinated|0|||
130023842|NCT03529773|468046793|FG031|Overall Study|Randomized but not vaccinated|0|||
130023843|NCT03529773|468046794|FG032|Overall Study|Randomized but not vaccinated|0|||
130023844|NCT03529773|468046795|FG033|Overall Study|Randomized but not vaccinated|0|||
130023845|NCT03529773|468046796|FG034|Overall Study|Randomized but not vaccinated|0|||
130023846|NCT03529773|468046797|FG035|Overall Study|Randomized but not vaccinated|0|||
130023847|NCT03529773|468046798|FG036|Overall Study|Randomized but not vaccinated|0|||
130023848|NCT03529773|468046799|FG037|Overall Study|Randomized but not vaccinated|0|||
130023849|NCT03529773|468046800|FG038|Overall Study|Randomized but not vaccinated|0|||
130023850|NCT03529773|468046801|FG039|Overall Study|Randomized but not vaccinated|0|||
130023851|NCT01340209|468046802|FG000|Overall Study|Adverse Event|1|||
130023852|NCT01340209|468046803|FG001|Overall Study|Adverse Event|1|||
130023853|NCT01340209|468046804|FG002|Overall Study|Adverse Event|2|||
130023854|NCT01340209|468046802|FG000|Overall Study|Protocol Violation|1|||
130023855|NCT01340209|468046803|FG001|Overall Study|Protocol Violation|2|||
130023856|NCT01340209|468046804|FG002|Overall Study|Protocol Violation|1|||
130023857|NCT01340209|468046802|FG000|Overall Study|Withdrawal by Subject|0|||
130023858|NCT01340209|468046803|FG001|Overall Study|Withdrawal by Subject|0|||
130023859|NCT01340209|468046804|FG002|Overall Study|Withdrawal by Subject|1|||
130023860|NCT01340209|468046802|FG000|Overall Study|Other reason not defined above|3|||
130023861|NCT01340209|468046803|FG001|Overall Study|Other reason not defined above|5|||
130023862|NCT01340209|468046804|FG002|Overall Study|Other reason not defined above|4|||
130023863|NCT01537211|468046807|FG000|Overall Study|Lost to Follow-up|0|||
130023864|NCT01537211|468046808|FG001|Overall Study|Lost to Follow-up|1|||
130023865|NCT04142983|468046809|FG000|Overall Study|Lost to Follow-up|73|||
130023866|NCT04142983|468046809|FG000|Overall Study|Withdrawal by Subject|10|||
130023867|NCT04142983|468046809|FG000|Overall Study|Physician Decision|1|||
130023868|NCT04142983|468046809|FG000|Overall Study|Adverse Event|1|||
130023869|NCT04142983|468046809|FG000|Overall Study|No longer eligible|4|||
130023870|NCT04142983|468046809|FG000|Overall Study|Screen Failure|10|||
130023871|NCT00090545|468046812|FG000|Overall Study|Disease progression on study|21|||
130023872|NCT00090545|468046813|FG001|Overall Study|Disease progression on study|17|||
130023873|NCT00090545|468046812|FG000|Overall Study|Refused further treatment|1|||
130023874|NCT00090545|468046813|FG001|Overall Study|Refused further treatment|4|||
130023875|NCT00090545|468046812|FG000|Overall Study|Death|0|||
130023876|NCT00090545|468046813|FG001|Overall Study|Death|1|||
130023877|NCT00090545|468046812|FG000|Overall Study|Adverse Event|0|||
130023878|NCT00090545|468046813|FG001|Overall Study|Adverse Event|2|||
130023879|NCT02809833|468046817|FG000|Overall Study|Death|3|||
130023880|NCT02809833|468046817|FG000|Overall Study|Intolerance|54|||
130023881|NCT02809833|468046817|FG000|Overall Study|Lack of Efficacy|89|||
130023882|NCT02809833|468046817|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
130023883|NCT02809833|468046817|FG000|Overall Study|Noncompliance|1|||
130023884|NCT02809833|468046817|FG000|Overall Study|Withdrawal by Subject|34|||
130023885|NCT02809833|468046817|FG000|Overall Study|Lost to Follow-up|35|||
130023886|NCT02809833|468046817|FG000|Overall Study|Adverse Event (AE)|24|||
130023887|NCT02809833|468046817|FG000|Overall Study|Other|5|||
130023888|NCT02809833|468046817|FG000|Overall Study|Missing Information|52|||
130023889|NCT01017952|468046818|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
130023890|NCT01017952|468046819|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130023891|NCT01017952|468046820|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130023892|NCT01017952|468046821|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130023893|NCT01017952|468046822|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130023894|NCT01017952|468046818|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
130023895|NCT01017952|468046819|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
130023896|NCT01017952|468046820|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
130023897|NCT01017952|468046821|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
130023898|NCT01017952|468046822|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
130023899|NCT01017952|468046818|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
130023900|NCT01017952|468046819|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130023901|NCT01017952|468046820|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130023902|NCT01017952|468046821|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130023903|NCT01017952|468046822|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
130023904|NCT01017952|468046818|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
130023905|NCT01017952|468046819|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130023906|NCT01017952|468046820|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130023907|NCT01017952|468046821|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130023908|NCT01017952|468046822|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130023909|NCT01017952|468046818|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
130023910|NCT01017952|468046819|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
130023911|NCT01017952|468046820|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
130023912|NCT01017952|468046821|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
130023913|NCT01017952|468046822|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
130023914|NCT01017952|468046818|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
130023915|NCT01017952|468046819|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130023916|NCT01017952|468046820|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130023917|NCT01017952|468046821|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130023918|NCT01017952|468046822|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130023919|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
130023920|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
130023921|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
130023922|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
130023923|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
130023924|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130023925|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
130023926|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
130023927|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
130023928|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
130023929|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130099879|NCT02062385|468322817|FG002|Overall Study|Moved|1|||
130099880|NCT02062385|468322818|FG003|Overall Study|Moved|0|||
130099881|NCT02062385|468322815|FG000|Overall Study|Withdrawn by parent/guardian|46|||
130099882|NCT02062385|468322816|FG001|Overall Study|Withdrawn by parent/guardian|41|||
130099883|NCT02062385|468322817|FG002|Overall Study|Withdrawn by parent/guardian|9|||
130231083|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130231084|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
130231085|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
130231086|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
130231087|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
130231088|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
130231089|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
130231090|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
130231091|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
130231092|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
130231093|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
130231094|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
130231095|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
130231096|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231097|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231098|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231099|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
130231100|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
130231101|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231102|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231103|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231104|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
130231105|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231106|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
130231107|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231108|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231109|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
130231110|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
130231111|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
130231112|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
130231113|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
130023930|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
130023931|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
130023932|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
130023933|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
130099884|NCT02062385|468322818|FG003|Overall Study|Withdrawn by parent/guardian|8|||
130099885|NCT02062385|468322815|FG000|Overall Study|Death|0|||
130099886|NCT02062385|468322816|FG001|Overall Study|Death|0|||
130099887|NCT02062385|468322817|FG002|Overall Study|Death|0|||
130099888|NCT02062385|468322818|FG003|Overall Study|Death|1|||
130023934|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
130023935|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
130023936|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
130023937|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
130023938|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
130023939|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130023940|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
130023941|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130023942|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
130023943|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
130023944|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130023945|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
130023946|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
130023947|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130023948|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130023949|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130023950|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
130023951|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
130023952|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
130023953|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
130023954|NCT01017952|468046818|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
130023955|NCT01017952|468046819|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
130023956|NCT01017952|468046820|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
130023957|NCT01017952|468046821|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
130023958|NCT01017952|468046822|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
130023959|NCT01298492|468046823|FG000|Overall Study|Death|2|||
130023960|NCT01298492|468046823|FG000|Overall Study|Insufficient Clinical Response|22|||
130023961|NCT01298492|468046823|FG000|Overall Study|Lost to Follow-up|12|||
130023962|NCT01298492|468046823|FG000|Overall Study|Withdrawal by Subject|47|||
130023963|NCT01298492|468046823|FG000|Overall Study|Other (Unspecified)|7|||
130023964|NCT01298492|468046823|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
130023965|NCT01298492|468046823|FG000|Overall Study|Protocol Violation|2|||
130023966|NCT01298492|468046823|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
130023967|NCT01298492|468046823|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
130023968|NCT00352105|468046824|FG000|Overall Study|Death|5|||
130023969|NCT00352105|468046824|FG000|Overall Study|Withdrawal by Subject|5|||
130023970|NCT00352105|468046824|FG000|Overall Study|Lack of Efficacy|9|||
130023971|NCT00352105|468046824|FG000|Overall Study|Adverse Event|19|||
130023972|NCT00352105|468046824|FG000|Overall Study|Protocol Violation|2|||
130023973|NCT01405053|468046825|FG000|Overall Study|Adverse Event|3|||
130023974|NCT01405053|468046826|FG001|Overall Study|Adverse Event|0|||
130023975|NCT01405053|468046825|FG000|Overall Study|Lost to Follow-up|0|||
130023976|NCT01405053|468046826|FG001|Overall Study|Lost to Follow-up|1|||
130023977|NCT01405053|468046825|FG000|Overall Study|Participant choice|2|||
130023978|NCT01405053|468046826|FG001|Overall Study|Participant choice|1|||
130023979|NCT01405053|468046825|FG000|Overall Study|Inadequate therapeutic effect|2|||
130023980|NCT01405053|468046826|FG001|Overall Study|Inadequate therapeutic effect|1|||
130023981|NCT01405053|468046825|FG000|Overall Study|Withdrawal by Subject|3|||
130023982|NCT01405053|468046826|FG001|Overall Study|Withdrawal by Subject|4|||
130023983|NCT01405053|468046825|FG000|Overall Study|Other|0|||
130023984|NCT01405053|468046826|FG001|Overall Study|Other|1|||
130023985|NCT02175680|468046830|FG000|Overall Study|non-compliance|1|||
130023986|NCT02175680|468046830|FG000|Overall Study|other non-medical reason|1|||
130023987|NCT01913483|468046835|FG000|Overall Study|Withdrawal by Subject|1|||
130023988|NCT01913483|468046836|FG001|Overall Study|Withdrawal by Subject|2|||
130023989|NCT01913483|468046835|FG000|Overall Study|Lost to Follow-up|6|||
130023990|NCT01913483|468046836|FG001|Overall Study|Lost to Follow-up|3|||
130023991|NCT01913483|468046835|FG000|Overall Study|Death|14|||
130023992|NCT01913483|468046836|FG001|Overall Study|Death|17|||
130023993|NCT02302963|468046837|FG000|Overall Study|Withdrawal by Subject|2|||
130023994|NCT02302963|468046838|FG001|Overall Study|Withdrawal by Subject|1|||
130023995|NCT02302963|468046837|FG000|Overall Study|Steroid injection|0|||
130023996|NCT02302963|468046838|FG001|Overall Study|Steroid injection|1|||
130023997|NCT02302963|468046837|FG000|Overall Study|Physician Decision|1|||
130023998|NCT02302963|468046838|FG001|Overall Study|Physician Decision|0|||
130023999|NCT01816243|468046839|FG000|Overall Study|Adverse Event|6|||
130024000|NCT01816243|468046839|FG000|Overall Study|Lost to Follow-up|1|||
130024001|NCT01816243|468046839|FG000|Overall Study|Lack of Efficacy|1|||
130231114|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
130024002|NCT01816243|468046839|FG000|Overall Study|Not eligible for the study|1|||
130024003|NCT01816243|468046839|FG000|Overall Study|Amputation|3|||
130024004|NCT00915343|468046840|FG000|Part B - Open Label Period|Treatment switch|0|||
130231115|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130231116|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
130024005|NCT00915343|468046841|FG001|Part B - Open Label Period|Treatment switch|0|||
130024006|NCT00915343|468046842|FG002|Part B - Open Label Period|Treatment switch|1|||
130231117|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130231118|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130231119|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
130024007|NCT00915343|468046840|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
130024008|NCT00915343|468046841|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
130024009|NCT00915343|468046842|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
130024010|NCT01920711|468046843|FG000|Overall Study|Death|347|||
130024011|NCT01920711|468046844|FG001|Overall Study|Death|356|||
130024012|NCT01920711|468046843|FG000|Overall Study|Lost to Follow-up|13|||
130024013|NCT01920711|468046844|FG001|Overall Study|Lost to Follow-up|14|||
130024014|NCT01920711|468046843|FG000|Overall Study|Withdrawal by Subject|4|||
130024015|NCT01920711|468046844|FG001|Overall Study|Withdrawal by Subject|3|||
130024016|NCT01145066|468046847|FG000|Overall Study|To resume NSAIDs|2|||
130024017|NCT01145066|468046848|FG001|Overall Study|To resume NSAIDs|2|||
130024018|NCT01145066|468046849|FG002|Overall Study|To resume NSAIDs|1|||
130024019|NCT01145066|468046847|FG000|Overall Study|Non-related surgery|0|||
130024020|NCT01145066|468046848|FG001|Overall Study|Non-related surgery|0|||
130024021|NCT01145066|468046849|FG002|Overall Study|Non-related surgery|1|||
130024022|NCT01145066|468046847|FG000|Overall Study|Withdrawal by Subject|0|||
130024023|NCT01145066|468046848|FG001|Overall Study|Withdrawal by Subject|0|||
130024024|NCT01145066|468046849|FG002|Overall Study|Withdrawal by Subject|2|||
130024025|NCT01145066|468046847|FG000|Overall Study|To start new med|1|||
130024026|NCT01145066|468046848|FG001|Overall Study|To start new med|0|||
130024027|NCT01145066|468046849|FG002|Overall Study|To start new med|0|||
130024028|NCT01145066|468046847|FG000|Overall Study|problems swallowing capsule|1|||
130024029|NCT01145066|468046848|FG001|Overall Study|problems swallowing capsule|0|||
130024030|NCT01145066|468046849|FG002|Overall Study|problems swallowing capsule|0|||
130024031|NCT01145066|468046847|FG000|Overall Study|Abdominal discomfort|0|||
130024032|NCT01145066|468046848|FG001|Overall Study|Abdominal discomfort|1|||
130024033|NCT01145066|468046849|FG002|Overall Study|Abdominal discomfort|0|||
130024034|NCT01145066|468046847|FG000|Overall Study|Low platelet count|0|||
130024035|NCT01145066|468046848|FG001|Overall Study|Low platelet count|1|||
130024036|NCT01145066|468046849|FG002|Overall Study|Low platelet count|0|||
130024037|NCT03687502|468046854|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
130024038|NCT03687502|468046854|FG000|Overall Study|Lumason not available|1|||
130024039|NCT01724528|468046858|FG000|Overall Study|Death|3|||
130024040|NCT01724528|468046859|FG001|Overall Study|Death|0|||
130024041|NCT01724528|468046858|FG000|Overall Study|Withdrawal by Subject|0|||
130024042|NCT01724528|468046859|FG001|Overall Study|Withdrawal by Subject|2|||
130024043|NCT01724528|468046858|FG000|Overall Study|Protocol Violation|0|||
130024044|NCT01724528|468046859|FG001|Overall Study|Protocol Violation|1|||
130231120|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
130231121|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231122|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231123|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231124|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
130231125|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231126|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
130231127|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231128|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231129|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
130231130|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
130231131|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130231132|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130231133|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130231134|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
130024045|NCT01724528|468046858|FG000|Overall Study|Patient refused to attend last visit|1|||
130024046|NCT01724528|468046859|FG001|Overall Study|Patient refused to attend last visit|0|||
130024047|NCT01634555|468046863|FG000|Overall Study|Adverse Event|3|||
130024048|NCT01634555|468046863|FG000|Overall Study|Physician Decision|1|||
130024049|NCT06228586|468046864|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
130024050|NCT06228586|468046865|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
130024051|NCT01227902|468048164|FG000|Overall Study|Adverse Event|12|||
130024052|NCT01227902|468048165|FG001|Overall Study|Adverse Event|8|||
130024053|NCT01227902|468048166|FG002|Overall Study|Adverse Event|11|||
130024054|NCT01227902|468048167|FG003|Overall Study|Adverse Event|4|||
130024055|NCT01227902|468048164|FG000|Overall Study|Lack of Efficacy|1|||
130024056|NCT01227902|468048165|FG001|Overall Study|Lack of Efficacy|2|||
130024057|NCT01227902|468048166|FG002|Overall Study|Lack of Efficacy|2|||
130024058|NCT01227902|468048167|FG003|Overall Study|Lack of Efficacy|1|||
130024059|NCT01227902|468048164|FG000|Overall Study|Protocol Violation|1|||
130024060|NCT01227902|468048165|FG001|Overall Study|Protocol Violation|0|||
130024061|NCT01227902|468048166|FG002|Overall Study|Protocol Violation|0|||
130024062|NCT01227902|468048167|FG003|Overall Study|Protocol Violation|0|||
130024063|NCT01227902|468048164|FG000|Overall Study|Lost to Follow-up|0|||
130024064|NCT01227902|468048165|FG001|Overall Study|Lost to Follow-up|0|||
130024065|NCT01227902|468048166|FG002|Overall Study|Lost to Follow-up|1|||
130024066|NCT01227902|468048167|FG003|Overall Study|Lost to Follow-up|2|||
130024067|NCT01227902|468048164|FG000|Overall Study|Physician Decision|0|||
130024068|NCT01227902|468048165|FG001|Overall Study|Physician Decision|1|||
130024069|NCT01227902|468048166|FG002|Overall Study|Physician Decision|1|||
130024070|NCT01227902|468048167|FG003|Overall Study|Physician Decision|0|||
130024071|NCT01227902|468048164|FG000|Overall Study|Withdrawal by Subject|4|||
130024072|NCT01227902|468048165|FG001|Overall Study|Withdrawal by Subject|2|||
130024073|NCT01227902|468048166|FG002|Overall Study|Withdrawal by Subject|4|||
130024074|NCT01227902|468048167|FG003|Overall Study|Withdrawal by Subject|3|||
130024075|NCT01299766|468048169|FG000|Overall Study|Death|5|||
130024076|NCT01299766|468048170|FG001|Overall Study|Death|4|||
130024077|NCT01299766|468048169|FG000|Overall Study|Withdrawal by Subject|29|||
130024078|NCT01299766|468048170|FG001|Overall Study|Withdrawal by Subject|19|||
130024079|NCT00403260|468048175|FG000|Overall Study|Adverse Event|5|||
130024080|NCT00403260|468048176|FG001|Overall Study|Adverse Event|4|||
130024081|NCT00403260|468048175|FG000|Overall Study|Withdrawal by Subject|5|||
130024082|NCT00403260|468048176|FG001|Overall Study|Withdrawal by Subject|6|||
130024083|NCT00403260|468048175|FG000|Overall Study|Lost to Follow-up|49|||
130231135|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231136|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
130231137|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231138|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231139|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
130231140|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
130231141|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231142|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231143|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231144|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
130231145|NCT02717195|468811595|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
130231146|NCT02717195|468811596|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231147|NCT02717195|468811597|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231148|NCT02717195|468811598|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231149|NCT02717195|468811599|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
130231150|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
130231151|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
130231152|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
130231153|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
130231154|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
130231155|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
130231156|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
130231157|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
130231158|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
130231159|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
130231160|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
130231161|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
130231162|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
130024084|NCT00403260|468048176|FG001|Overall Study|Lost to Follow-up|25|||
130024085|NCT00403260|468048175|FG000|Overall Study|Re-appearance of P. falciparum|34|||
130024086|NCT00403260|468048176|FG001|Overall Study|Re-appearance of P. falciparum|25|||
130024087|NCT00403260|468048175|FG000|Overall Study|P. vivax infection|26|||
130024088|NCT00403260|468048176|FG001|Overall Study|P. vivax infection|4|||
130024089|NCT00403260|468048175|FG000|Overall Study|Mixed infection with P. vivax|2|||
130024090|NCT00403260|468048176|FG001|Overall Study|Mixed infection with P. vivax|0|||
130024091|NCT00403260|468048175|FG000|Overall Study|Mixed infection with P. falciparum|1|||
130024092|NCT00403260|468048176|FG001|Overall Study|Mixed infection with P. falciparum|0|||
130024093|NCT00403260|468048175|FG000|Overall Study|P. vivax infection at screening|1|||
130024094|NCT00403260|468048176|FG001|Overall Study|P. vivax infection at screening|0|||
130024095|NCT00403260|468048175|FG000|Overall Study|P. ovale infection|1|||
130231163|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
130231164|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
130231165|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130231166|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130231167|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
130231168|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
130231169|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
130231170|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130231171|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130231172|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
130231173|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
130024096|NCT00403260|468048176|FG001|Overall Study|P. ovale infection|0|||
130024097|NCT00403260|468048175|FG000|Overall Study|Gametocyte re-appearance|1|||
130024098|NCT00403260|468048176|FG001|Overall Study|Gametocyte re-appearance|1|||
130024099|NCT00403260|468048175|FG000|Overall Study|Withdrawn from study accidentally|0|||
130024100|NCT00403260|468048176|FG001|Overall Study|Withdrawn from study accidentally|1|||
130024101|NCT01354028|468048177|FG000|Overall Study|Physician Decision|0|||
130024102|NCT01354028|468048178|FG001|Overall Study|Physician Decision|2|||
130024103|NCT01354028|468048177|FG000|Overall Study|Discharged before study start|2|||
130024104|NCT01354028|468048178|FG001|Overall Study|Discharged before study start|2|||
130024105|NCT01354028|468048177|FG000|Overall Study|No quiet alert state|0|||
130024106|NCT01354028|468048178|FG001|Overall Study|No quiet alert state|1|||
130024107|NCT00935883|468048181|FG000|Treatment Period|Physician Decision|1|||
130024108|NCT00935883|468048182|FG001|Treatment Period|Physician Decision|0|||
130024109|NCT00935883|468048181|FG000|Treatment Period|Withdrawal by Subject|0|||
130024110|NCT00935883|468048182|FG001|Treatment Period|Withdrawal by Subject|2|||
130024111|NCT01622569|468048191|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
130024112|NCT01622569|468048192|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
130024113|NCT01622569|468048193|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
130024114|NCT01622569|468048194|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
130024115|NCT01622569|468048191|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130024116|NCT01622569|468048192|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130024117|NCT01622569|468048193|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
130024118|NCT01622569|468048194|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
130024119|NCT01622569|468048191|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
130024120|NCT01622569|468048192|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
130024121|NCT01622569|468048193|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
130024122|NCT01622569|468048194|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
130024123|NCT01622569|468048191|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130024124|NCT01622569|468048192|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
130024125|NCT01622569|468048193|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
130024126|NCT01622569|468048194|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
130231174|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
130231175|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130024127|NCT01622569|468048191|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
130024128|NCT01622569|468048192|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
130024129|NCT01622569|468048193|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
130024130|NCT01622569|468048194|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
130024131|NCT01622569|468048191|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
130024132|NCT01622569|468048192|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
130024133|NCT01622569|468048193|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
130024134|NCT01622569|468048194|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
130024135|NCT01622569|468048191|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
130024136|NCT01622569|468048192|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
130024137|NCT01622569|468048193|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
130024138|NCT01622569|468048194|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
130024139|NCT01622569|468048191|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130024140|NCT01622569|468048192|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130024141|NCT01622569|468048193|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
130024142|NCT01622569|468048194|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
130024143|NCT01940484|468048197|FG000|Overall Study|Withdrawal by Subject|3|||
130024144|NCT01940484|468048197|FG000|Overall Study|Underwent transplantation|4|||
130024145|NCT01940484|468048197|FG000|Overall Study|Death|2|||
130024146|NCT01940484|468048197|FG000|Overall Study|Adverse Event|1|||
130024147|NCT00634569|468048202|FG000|Overall Study|Withdrawal by Subject|0|||
130024148|NCT00634569|468048203|FG001|Overall Study|Withdrawal by Subject|4|||
130024149|NCT00634569|468048202|FG000|Overall Study|Physician Decision|0|||
130024150|NCT00634569|468048203|FG001|Overall Study|Physician Decision|1|||
130024151|NCT01163786|468048204|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
130024152|NCT01163786|468048204|FG000|Treatment With Bortezomib|Adverse Event|2|||
130024153|NCT01163786|468048204|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
130024154|NCT02918019|468048205|FG000|Overall Study|Death|0|||
130024155|NCT02918019|468048206|FG001|Overall Study|Death|0|||
130024156|NCT02918019|468048207|FG002|Overall Study|Death|1|||
130024157|NCT02918019|468048208|FG003|Overall Study|Death|0|||
130024158|NCT02918019|468048205|FG000|Overall Study|Lost to Follow-up|1|||
130024159|NCT02918019|468048206|FG001|Overall Study|Lost to Follow-up|1|||
130024160|NCT02918019|468048207|FG002|Overall Study|Lost to Follow-up|0|||
130024161|NCT02918019|468048208|FG003|Overall Study|Lost to Follow-up|1|||
130024162|NCT02918019|468048205|FG000|Overall Study|Principal investigator request|0|||
130024163|NCT02918019|468048206|FG001|Overall Study|Principal investigator request|0|||
130024164|NCT02918019|468048207|FG002|Overall Study|Principal investigator request|0|||
130024165|NCT02918019|468048208|FG003|Overall Study|Principal investigator request|1|||
130024166|NCT02918019|468048205|FG000|Overall Study|Physician Decision|1|||
130024167|NCT02918019|468048206|FG001|Overall Study|Physician Decision|3|||
130024168|NCT02918019|468048207|FG002|Overall Study|Physician Decision|2|||
130024169|NCT02918019|468048208|FG003|Overall Study|Physician Decision|0|||
130024170|NCT02918019|468048205|FG000|Overall Study|Protocol deviation|1|||
130024171|NCT02918019|468048206|FG001|Overall Study|Protocol deviation|1|||
130024172|NCT02918019|468048207|FG002|Overall Study|Protocol deviation|0|||
130024173|NCT02918019|468048208|FG003|Overall Study|Protocol deviation|2|||
130024174|NCT02918019|468048205|FG000|Overall Study|Withdrawal by Subject|3|||
130024175|NCT02918019|468048206|FG001|Overall Study|Withdrawal by Subject|4|||
130024176|NCT02918019|468048207|FG002|Overall Study|Withdrawal by Subject|6|||
130024177|NCT02918019|468048208|FG003|Overall Study|Withdrawal by Subject|4|||
130024178|NCT02918019|468048205|FG000|Overall Study|Adverse Event|0|||
130024179|NCT02918019|468048206|FG001|Overall Study|Adverse Event|1|||
130024180|NCT02918019|468048207|FG002|Overall Study|Adverse Event|0|||
130024181|NCT02918019|468048208|FG003|Overall Study|Adverse Event|1|||
130024182|NCT01212185|468048209|FG000|Overall Study|Protocol Violation|2|||
130024183|NCT01212185|468048210|FG001|Overall Study|Protocol Violation|1|||
130024184|NCT00094757|468048211|FG000|Overall Study|Adverse Event|11|||
130024185|NCT00094757|468048212|FG001|Overall Study|Adverse Event|9|||
130024186|NCT00094757|468048213|FG002|Overall Study|Adverse Event|6|||
130024187|NCT00094757|468048211|FG000|Overall Study|Lack of Efficacy|11|||
130024188|NCT00094757|468048212|FG001|Overall Study|Lack of Efficacy|15|||
130024189|NCT00094757|468048213|FG002|Overall Study|Lack of Efficacy|8|||
130024190|NCT00094757|468048211|FG000|Overall Study|Lost to Follow-up|3|||
130024191|NCT00094757|468048212|FG001|Overall Study|Lost to Follow-up|5|||
130024192|NCT00094757|468048213|FG002|Overall Study|Lost to Follow-up|6|||
130024193|NCT00094757|468048211|FG000|Overall Study|Patient Moved|2|||
130024194|NCT00094757|468048212|FG001|Overall Study|Patient Moved|1|||
130024195|NCT00094757|468048213|FG002|Overall Study|Patient Moved|1|||
130024196|NCT00094757|468048211|FG000|Overall Study|Protocol Violation|8|||
130024197|NCT00094757|468048212|FG001|Overall Study|Protocol Violation|5|||
130024198|NCT00094757|468048213|FG002|Overall Study|Protocol Violation|3|||
130024199|NCT00094757|468048211|FG000|Overall Study|Withdrawal by Subject|14|||
130024200|NCT00094757|468048212|FG001|Overall Study|Withdrawal by Subject|21|||
130024201|NCT00094757|468048213|FG002|Overall Study|Withdrawal by Subject|5|||
130024202|NCT00094757|468048211|FG000|Overall Study|Other|3|||
130024203|NCT00094757|468048212|FG001|Overall Study|Other|3|||
130024204|NCT00094757|468048213|FG002|Overall Study|Other|1|||
130024205|NCT00094757|468048211|FG000|Overall Study|Protocol specified discontinuation|1|||
130024206|NCT00094757|468048212|FG001|Overall Study|Protocol specified discontinuation|3|||
130024207|NCT00094757|468048213|FG002|Overall Study|Protocol specified discontinuation|0|||
130024208|NCT04317274|468048214|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
130024209|NCT04317274|468048215|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
130024210|NCT04317274|468048216|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
130024211|NCT04317274|468048217|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
130024212|NCT02568046|468048218|FG000|Overall Study|Adverse Event|0|||
130024213|NCT02568046|468048219|FG001|Overall Study|Adverse Event|1|||
130024214|NCT02568046|468048218|FG000|Overall Study|Death|2|||
130024215|NCT02568046|468048219|FG001|Overall Study|Death|0|||
130024216|NCT02568046|468048218|FG000|Overall Study|Progressive Disease|1|||
130024217|NCT02568046|468048219|FG001|Overall Study|Progressive Disease|0|||
130024218|NCT02568046|468048218|FG000|Overall Study|Withdrawal by Subject|2|||
130024219|NCT02568046|468048219|FG001|Overall Study|Withdrawal by Subject|1|||
130024220|NCT02568046|468048218|FG000|Overall Study|Other Events|0|||
130024221|NCT02568046|468048219|FG001|Overall Study|Other Events|1|||
130024222|NCT03403192|468048220|FG000|Overall Study|Lost to Follow-up|1|||
130024223|NCT03403192|468048221|FG001|Overall Study|Lost to Follow-up|2|||
130024224|NCT03403192|468048222|FG002|Overall Study|Lost to Follow-up|0|||
130024225|NCT03403192|468048223|FG003|Overall Study|Lost to Follow-up|0|||
130024226|NCT03403192|468048220|FG000|Overall Study|Unable to respond|0|||
130024227|NCT03403192|468048221|FG001|Overall Study|Unable to respond|1|||
130024228|NCT03403192|468048222|FG002|Overall Study|Unable to respond|0|||
130024229|NCT03403192|468048223|FG003|Overall Study|Unable to respond|0|||
130024230|NCT03403192|468048220|FG000|Overall Study|Incomplete|3|||
130024231|NCT03403192|468048221|FG001|Overall Study|Incomplete|1|||
130024232|NCT03403192|468048222|FG002|Overall Study|Incomplete|3|||
130024233|NCT03403192|468048223|FG003|Overall Study|Incomplete|6|||
130024234|NCT00379795|468048224|FG000|Overall Study|Death|31|||
130024235|NCT00379795|468048225|FG001|Overall Study|Death|8|||
130024236|NCT00379795|468048226|FG002|Overall Study|Death|6|||
130024237|NCT00379795|468048227|FG003|Overall Study|Death|4|||
130024238|NCT00379795|468048228|FG004|Overall Study|Death|7|||
130024239|NCT00379795|468048224|FG000|Overall Study|Adverse Event|17|||
130024240|NCT00379795|468048225|FG001|Overall Study|Adverse Event|3|||
130024241|NCT00379795|468048226|FG002|Overall Study|Adverse Event|3|||
130024242|NCT00379795|468048227|FG003|Overall Study|Adverse Event|1|||
130024243|NCT00379795|468048228|FG004|Overall Study|Adverse Event|4|||
130024244|NCT00379795|468048224|FG000|Overall Study|Lost to Follow-up|8|||
130024245|NCT00379795|468048225|FG001|Overall Study|Lost to Follow-up|1|||
130024246|NCT00379795|468048226|FG002|Overall Study|Lost to Follow-up|2|||
130024247|NCT00379795|468048227|FG003|Overall Study|Lost to Follow-up|1|||
130024248|NCT00379795|468048228|FG004|Overall Study|Lost to Follow-up|4|||
130024249|NCT00379795|468048224|FG000|Overall Study|Physician Decision|25|||
130024250|NCT00379795|468048225|FG001|Overall Study|Physician Decision|0|||
130024251|NCT00379795|468048226|FG002|Overall Study|Physician Decision|2|||
130024252|NCT00379795|468048227|FG003|Overall Study|Physician Decision|2|||
130024253|NCT00379795|468048228|FG004|Overall Study|Physician Decision|2|||
130024254|NCT00379795|468048224|FG000|Overall Study|Withdrawal by Subject|94|||
130024255|NCT00379795|468048225|FG001|Overall Study|Withdrawal by Subject|11|||
130024256|NCT00379795|468048226|FG002|Overall Study|Withdrawal by Subject|19|||
130024257|NCT00379795|468048227|FG003|Overall Study|Withdrawal by Subject|7|||
130024258|NCT00379795|468048228|FG004|Overall Study|Withdrawal by Subject|14|||
130024259|NCT00379795|468048224|FG000|Overall Study|Subject non-compliance|7|||
130024260|NCT00379795|468048225|FG001|Overall Study|Subject non-compliance|2|||
130024261|NCT00379795|468048226|FG002|Overall Study|Subject non-compliance|0|||
130024262|NCT00379795|468048227|FG003|Overall Study|Subject non-compliance|0|||
130024263|NCT00379795|468048228|FG004|Overall Study|Subject non-compliance|1|||
130024264|NCT00379795|468048224|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
130024265|NCT00379795|468048225|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
130024266|NCT00379795|468048226|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
130024267|NCT00379795|468048227|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
130024268|NCT00379795|468048228|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
130024269|NCT00379795|468048224|FG000|Overall Study|Subjects condition mandated intervention|34|||
130024270|NCT00379795|468048225|FG001|Overall Study|Subjects condition mandated intervention|9|||
130024271|NCT00379795|468048226|FG002|Overall Study|Subjects condition mandated intervention|7|||
130024272|NCT00379795|468048227|FG003|Overall Study|Subjects condition mandated intervention|5|||
130024273|NCT00379795|468048228|FG004|Overall Study|Subjects condition mandated intervention|7|||
130024274|NCT00379795|468048224|FG000|Overall Study|Sponsor's decision|257|||
130099889|NCT02062385|468322815|FG000|Overall Study|Lost to Follow-up|0|||
130024275|NCT00379795|468048225|FG001|Overall Study|Sponsor's decision|17|||
130024276|NCT00379795|468048226|FG002|Overall Study|Sponsor's decision|54|||
130024277|NCT00379795|468048227|FG003|Overall Study|Sponsor's decision|47|||
130024278|NCT00379795|468048228|FG004|Overall Study|Sponsor's decision|10|||
130024279|NCT04849780|468048229|FG000|Period 1|Covid-19 Related|1|||
130024280|NCT04849780|468048230|FG001|Period 1|Covid-19 Related|0|||
130024281|NCT04849780|468048229|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
130024282|NCT04849780|468048230|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
130024283|NCT04849780|468048229|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
130024284|NCT04849780|468048230|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
130024285|NCT02551159|468048231|FG000|Overall Study|Death|352|||
130024286|NCT02551159|468048232|FG001|Overall Study|Death|174|||
130024287|NCT02551159|468048233|FG002|Overall Study|Death|161|||
130024288|NCT02551159|468048231|FG000|Overall Study|Withdrawal by Subject|8|||
130024289|NCT02551159|468048232|FG001|Overall Study|Withdrawal by Subject|5|||
130024290|NCT02551159|468048233|FG002|Overall Study|Withdrawal by Subject|16|||
130024291|NCT02551159|468048231|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
130024292|NCT02551159|468048232|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
130024293|NCT02551159|468048233|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
130024294|NCT00268242|468048234|FG000|Overall Study|Death|1|||
130024295|NCT00993928|468048235|FG000|Overall Study|Withdrawal by Subject|4|||
130024296|NCT00993928|468048236|FG001|Overall Study|Withdrawal by Subject|7|||
130024297|NCT00993928|468048235|FG000|Overall Study|ineligible|1|||
130024298|NCT00993928|468048236|FG001|Overall Study|ineligible|0|||
130024299|NCT01665144|468048237|FG000|Core Part|Withdrawal by Subject|96|||
130024300|NCT01665144|468048238|FG001|Core Part|Withdrawal by Subject|77|||
130024301|NCT01665144|468048239|FG002|Core Part|Withdrawal by Subject|0|||
130024302|NCT01665144|468048237|FG000|Core Part|Adverse Event|45|||
130024303|NCT01665144|468048238|FG001|Core Part|Adverse Event|18|||
130024304|NCT01665144|468048239|FG002|Core Part|Adverse Event|0|||
130024305|NCT01665144|468048237|FG000|Core Part|Lack of Efficacy|16|||
130024306|NCT01665144|468048238|FG001|Core Part|Lack of Efficacy|11|||
130024307|NCT01665144|468048239|FG002|Core Part|Lack of Efficacy|0|||
130024308|NCT01665144|468048237|FG000|Core Part|Lost to Follow-up|9|||
130024309|NCT01665144|468048238|FG001|Core Part|Lost to Follow-up|8|||
130024310|NCT01665144|468048239|FG002|Core Part|Lost to Follow-up|0|||
130024311|NCT01665144|468048237|FG000|Core Part|Physician Decision|13|||
130024312|NCT01665144|468048238|FG001|Core Part|Physician Decision|1|||
130024313|NCT01665144|468048239|FG002|Core Part|Physician Decision|0|||
130024314|NCT01665144|468048237|FG000|Core Part|Progressive disease|8|||
130024315|NCT01665144|468048238|FG001|Core Part|Progressive disease|4|||
130024316|NCT01665144|468048239|FG002|Core Part|Progressive disease|0|||
130024317|NCT01665144|468048237|FG000|Core Part|Non-compliance with study treatment|5|||
130024318|NCT01665144|468048238|FG001|Core Part|Non-compliance with study treatment|0|||
130024319|NCT01665144|468048239|FG002|Core Part|Non-compliance with study treatment|0|||
130024320|NCT01665144|468048237|FG000|Core Part|Death|3|||
130024321|NCT01665144|468048238|FG001|Core Part|Death|1|||
130024322|NCT01665144|468048239|FG002|Core Part|Death|0|||
130024323|NCT01665144|468048237|FG000|Core Part|Protocol deviation|3|||
130024324|NCT01665144|468048238|FG001|Core Part|Protocol deviation|1|||
130024325|NCT01665144|468048239|FG002|Core Part|Protocol deviation|0|||
130024326|NCT01665144|468048237|FG000|Core Part|New therapy for study indication|2|||
130024327|NCT01665144|468048238|FG001|Core Part|New therapy for study indication|1|||
130024328|NCT01665144|468048239|FG002|Core Part|New therapy for study indication|0|||
130024329|NCT01665144|468048237|FG000|Core Part|Technical problems|2|||
130024330|NCT01665144|468048238|FG001|Core Part|Technical problems|0|||
130024331|NCT01665144|468048239|FG002|Core Part|Technical problems|0|||
130099890|NCT02062385|468322816|FG001|Overall Study|Lost to Follow-up|0|||
130231176|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130024332|NCT01665144|468048237|FG000|Extension Part|Patient/guardian decision|180|||
130024333|NCT01665144|468048238|FG001|Extension Part|Patient/guardian decision|0|||
130024334|NCT01665144|468048239|FG002|Extension Part|Patient/guardian decision|98|||
130024335|NCT01665144|468048237|FG000|Extension Part|Adverse Event|104|||
130024336|NCT01665144|468048238|FG001|Extension Part|Adverse Event|0|||
130024337|NCT01665144|468048239|FG002|Extension Part|Adverse Event|59|||
130024338|NCT01665144|468048237|FG000|Extension Part|Study closed early|42|||
130024339|NCT01665144|468048238|FG001|Extension Part|Study closed early|0|||
130024340|NCT01665144|468048239|FG002|Extension Part|Study closed early|19|||
130024341|NCT01665144|468048237|FG000|Extension Part|Progressive disease|36|||
130231177|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
130099891|NCT02062385|468322817|FG002|Overall Study|Lost to Follow-up|1|||
130099892|NCT02062385|468322818|FG003|Overall Study|Lost to Follow-up|0|||
130024342|NCT01665144|468048238|FG001|Extension Part|Progressive disease|0|||
130024343|NCT01665144|468048239|FG002|Extension Part|Progressive disease|14|||
130024344|NCT01665144|468048237|FG000|Extension Part|Lack of Efficacy|37|||
130024345|NCT01665144|468048238|FG001|Extension Part|Lack of Efficacy|0|||
130024346|NCT01665144|468048239|FG002|Extension Part|Lack of Efficacy|12|||
130024347|NCT01665144|468048237|FG000|Extension Part|Physician Decision|29|||
130024348|NCT01665144|468048238|FG001|Extension Part|Physician Decision|0|||
130024349|NCT01665144|468048239|FG002|Extension Part|Physician Decision|13|||
130024350|NCT01665144|468048237|FG000|Extension Part|Technical problems|20|||
130024351|NCT01665144|468048238|FG001|Extension Part|Technical problems|0|||
130024352|NCT01665144|468048239|FG002|Extension Part|Technical problems|8|||
130024353|NCT01665144|468048237|FG000|Extension Part|Death|20|||
130024354|NCT01665144|468048238|FG001|Extension Part|Death|0|||
130024355|NCT01665144|468048239|FG002|Extension Part|Death|4|||
130024356|NCT01665144|468048237|FG000|Extension Part|Missing|12|||
130024357|NCT01665144|468048238|FG001|Extension Part|Missing|0|||
130024358|NCT01665144|468048239|FG002|Extension Part|Missing|6|||
130024359|NCT01665144|468048237|FG000|Extension Part|Lost to Follow-up|9|||
130024360|NCT01665144|468048238|FG001|Extension Part|Lost to Follow-up|0|||
130024361|NCT01665144|468048239|FG002|Extension Part|Lost to Follow-up|5|||
130024362|NCT01665144|468048237|FG000|Extension Part|New therapy for study indication|3|||
130024363|NCT01665144|468048238|FG001|Extension Part|New therapy for study indication|0|||
130024364|NCT01665144|468048239|FG002|Extension Part|New therapy for study indication|2|||
130024365|NCT01665144|468048237|FG000|Extension Part|Protocol deviation|3|||
130024366|NCT01665144|468048238|FG001|Extension Part|Protocol deviation|0|||
130024367|NCT01665144|468048239|FG002|Extension Part|Protocol deviation|0|||
130024368|NCT03551743|468048242|FG000|Overall Study|Adverse Event|1|||
130024369|NCT03551743|468048243|FG001|Overall Study|Adverse Event|0|||
130024370|NCT03551743|468048244|FG002|Overall Study|Adverse Event|0|||
130024371|NCT03551743|468048245|FG003|Overall Study|Adverse Event|0|||
130024372|NCT03551743|468048242|FG000|Overall Study|Withdrawal by Subject|1|||
130024373|NCT03551743|468048243|FG001|Overall Study|Withdrawal by Subject|0|||
130024374|NCT03551743|468048244|FG002|Overall Study|Withdrawal by Subject|0|||
130024375|NCT03551743|468048245|FG003|Overall Study|Withdrawal by Subject|0|||
130024376|NCT02317562|468048246|FG000|Overall Study|Physician Decision|1|||
130024377|NCT02317562|468048246|FG000|Overall Study|early termination of the study|8|||
130024378|NCT02317562|468048246|FG000|Overall Study|Lack of Efficacy|4|||
130024379|NCT02317562|468048246|FG000|Overall Study|Withdrawal by Subject|1|||
130024380|NCT00911989|468048247|FG000|Overall Study|Adverse Event|1|||
130024381|NCT02937350|468048249|FG000|Overall Study|Withdrawal by Subject|0|||
130024382|NCT02937350|468048250|FG001|Overall Study|Withdrawal by Subject|1|||
130024383|NCT02937350|468048251|FG002|Overall Study|Withdrawal by Subject|0|||
130024384|NCT00803179|468048255|FG000|Overall Study|Lost to Follow-up|3|||
130024385|NCT04811716|468048256|FG000|Overall Study|Withdrawal by Subject|2|||
130024386|NCT04811716|468048257|FG001|Overall Study|Withdrawal by Subject|0|||
130024387|NCT01877083|468048261|FG000|Treatment Phase|Disease Progression|10|||
130024388|NCT01877083|468048261|FG000|Treatment Phase|Clinical Progression|1|||
130024389|NCT01877083|468048261|FG000|Treatment Phase|Adverse Event|6|||
130024390|NCT01877083|468048261|FG000|Treatment Phase|Withdrawal by Subject|2|||
130024391|NCT01877083|468048261|FG000|Treatment Phase|Lost to Follow-up|1|||
130024392|NCT01877083|468048261|FG000|Extension Phase|Disease Progression|3|||
130024393|NCT01877083|468048261|FG000|Extension Phase|Adverse Event|2|||
130024394|NCT00429585|468048264|FG000|Overall Study|Death|1|||
130024395|NCT00429585|468048265|FG001|Overall Study|Death|0|||
130024396|NCT00429585|468048264|FG000|Overall Study|Lost to Follow-up|27|||
130024397|NCT00429585|468048265|FG001|Overall Study|Lost to Follow-up|20|||
130024398|NCT00429585|468048264|FG000|Overall Study|Physician Decision|2|||
130024399|NCT00429585|468048265|FG001|Overall Study|Physician Decision|0|||
130024400|NCT01582308|468048266|FG000|Period 1|Withdrawal by Subject|0|||
130024401|NCT01582308|468048267|FG001|Period 1|Withdrawal by Subject|0|||
130024402|NCT01582308|468048268|FG002|Period 1|Withdrawal by Subject|0|||
130024403|NCT01582308|468048269|FG003|Period 1|Withdrawal by Subject|0|||
130024404|NCT01582308|468048270|FG004|Period 1|Withdrawal by Subject|0|||
130024405|NCT01582308|468048271|FG005|Period 1|Withdrawal by Subject|0|||
130024406|NCT01582308|468048272|FG006|Period 1|Withdrawal by Subject|1|||
130024407|NCT01582308|468048273|FG007|Period 1|Withdrawal by Subject|0|||
130024408|NCT01582308|468048274|FG008|Period 1|Withdrawal by Subject|0|||
130024409|NCT01582308|468048275|FG009|Period 1|Withdrawal by Subject|0|||
130024410|NCT01582308|468048266|FG000|10-day Washout Following Period 1|Physician Decision|0|||
130024411|NCT01582308|468048267|FG001|10-day Washout Following Period 1|Physician Decision|0|||
130024412|NCT01582308|468048268|FG002|10-day Washout Following Period 1|Physician Decision|0|||
130024413|NCT01582308|468048269|FG003|10-day Washout Following Period 1|Physician Decision|0|||
130024414|NCT01582308|468048270|FG004|10-day Washout Following Period 1|Physician Decision|1|||
130024415|NCT01582308|468048271|FG005|10-day Washout Following Period 1|Physician Decision|0|||
130024416|NCT01582308|468048272|FG006|10-day Washout Following Period 1|Physician Decision|0|||
130024417|NCT01582308|468048273|FG007|10-day Washout Following Period 1|Physician Decision|0|||
130024418|NCT01582308|468048274|FG008|10-day Washout Following Period 1|Physician Decision|0|||
130024419|NCT01582308|468048275|FG009|10-day Washout Following Period 1|Physician Decision|0|||
130024420|NCT01582308|468048266|FG000|Period 4|Physician Decision|1|||
130024421|NCT01582308|468048267|FG001|Period 4|Physician Decision|0|||
130024422|NCT01582308|468048268|FG002|Period 4|Physician Decision|0|||
130024423|NCT01582308|468048269|FG003|Period 4|Physician Decision|0|||
130024424|NCT01582308|468048270|FG004|Period 4|Physician Decision|0|||
130024425|NCT01582308|468048271|FG005|Period 4|Physician Decision|1|||
130024426|NCT01582308|468048272|FG006|Period 4|Physician Decision|0|||
130024427|NCT01582308|468048273|FG007|Period 4|Physician Decision|0|||
130024428|NCT01582308|468048274|FG008|Period 4|Physician Decision|0|||
130024429|NCT01582308|468048275|FG009|Period 4|Physician Decision|1|||
130024430|NCT05280756|468050326|FG000|Overall Study|Lost to Follow-up|1|||
130024431|NCT05280756|468050327|FG001|Overall Study|Lost to Follow-up|1|||
130024432|NCT02527707|468050333|FG000|Overall Study|Adverse Event|1|||
130024433|NCT02527707|468050333|FG000|Overall Study|Adverse Event|1|||
130024434|NCT00930059|468050334|FG000|Overall Study|Death|1|||
130024435|NCT00930059|468050335|FG001|Overall Study|Death|0|||
130024436|NCT00930059|468050334|FG000|Overall Study|Did not meet entrance criteria|1|||
130024437|NCT00930059|468050335|FG001|Overall Study|Did not meet entrance criteria|1|||
130024438|NCT00930059|468050334|FG000|Overall Study|Withdrawal by Subject|3|||
130024439|NCT00930059|468050335|FG001|Overall Study|Withdrawal by Subject|4|||
130024440|NCT00930059|468050334|FG000|Overall Study|Other|1|||
130024441|NCT00930059|468050335|FG001|Overall Study|Other|0|||
130024442|NCT00930059|468050334|FG000|Overall Study|1 site terminated by sponsor|1|||
130024443|NCT00930059|468050335|FG001|Overall Study|1 site terminated by sponsor|1|||
130024444|NCT00930059|468050334|FG000|Overall Study|Adverse Event|1|||
130024445|NCT00930059|468050335|FG001|Overall Study|Adverse Event|6|||
130024446|NCT04002310|468050338|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
130024447|NCT04002310|468050339|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
130024448|NCT04002310|468050340|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
130024449|NCT04002310|468050341|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
130024450|NCT04002310|468050342|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
130024451|NCT00542997|468050343|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
130024452|NCT00542997|468050343|FG000|Wash in / Wash Out Period|Adverse Event|3|||
130024453|NCT00542997|468050343|FG000|Efficacy Period|Adverse Event|3|||
130024454|NCT03064763|468050347|FG000|Overall Study|Lost to Follow-up|1|||
130024455|NCT03064763|468050347|FG000|Overall Study|Death|8|||
130024456|NCT02002975|468050348|FG000|Overall Study|Case Report Forms Uncollected|135|||
130024457|NCT02002975|468050348|FG000|Overall Study|Protocol Deviation|437|||
130024458|NCT01072344|468050351|FG000|Overall Study|Relasped-reached end point|7|||
130024459|NCT01072344|468050352|FG001|Overall Study|Relasped-reached end point|12|||
130024460|NCT01072344|468050351|FG000|Overall Study|Protocol Violation|1|||
130024461|NCT01072344|468050352|FG001|Overall Study|Protocol Violation|2|||
130024462|NCT01072344|468050351|FG000|Overall Study|Lost to Follow-up|3|||
130024463|NCT01072344|468050352|FG001|Overall Study|Lost to Follow-up|4|||
130024464|NCT00808444|468050359|FG000|Overall Study|Withdrawal by Subject|1|||
130024465|NCT00808444|468050360|FG001|Overall Study|Withdrawal by Subject|0|||
130024466|NCT00808444|468050359|FG000|Overall Study|Lost to Follow-up|0|||
130024467|NCT00808444|468050360|FG001|Overall Study|Lost to Follow-up|1|||
130024468|NCT01461044|468050361|FG000|Overall Study|Death|58|||
130024469|NCT01461044|468050362|FG001|Overall Study|Death|35|||
130024470|NCT01461044|468050361|FG000|Overall Study|Lost to Follow-up|12|||
130024471|NCT01461044|468050362|FG001|Overall Study|Lost to Follow-up|5|||
130024472|NCT00716976|468050363|FG000|Overall Study|Adverse Event|2|||
130024473|NCT00716976|468050364|FG001|Overall Study|Adverse Event|0|||
130024474|NCT00716976|468050363|FG000|Overall Study|Death|1|||
130024475|NCT00716976|468050364|FG001|Overall Study|Death|0|||
130024476|NCT00716976|468050363|FG000|Overall Study|Physician Decision|2|||
130024477|NCT00716976|468050364|FG001|Overall Study|Physician Decision|2|||
130024478|NCT00716976|468050363|FG000|Overall Study|Withdrawal by Subject|5|||
130024479|NCT00716976|468050364|FG001|Overall Study|Withdrawal by Subject|1|||
130024480|NCT00716976|468050363|FG000|Overall Study|Premature discontinuation cisplatin|5|||
130024481|NCT00716976|468050364|FG001|Overall Study|Premature discontinuation cisplatin|4|||
130024482|NCT00716976|468050363|FG000|Overall Study|Radiation during protocol|1|||
130024483|NCT00716976|468050364|FG001|Overall Study|Radiation during protocol|0|||
130024484|NCT00716976|468050363|FG000|Overall Study|Ineligibles|4|||
130024485|NCT00716976|468050364|FG001|Overall Study|Ineligibles|2|||
130024486|NCT00122135|468050365|FG000|Overall Study|Withdrawal by Subject|3|||
130024487|NCT00122135|468050366|FG001|Overall Study|Withdrawal by Subject|0|||
130024488|NCT03068325|468050367|FG000|Overall Study|Lost to Follow-up|5|||
130024489|NCT00975156|468050368|FG000|Overall Study|Protocol Violation|0|||
130024490|NCT00975156|468050369|FG001|Overall Study|Protocol Violation|1|||
130024491|NCT00454779|468050374|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
130024492|NCT00454779|468050375|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
130024493|NCT00454779|468050374|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
130024494|NCT00454779|468050375|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
130024495|NCT00454779|468050374|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
130024496|NCT00454779|468050375|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
130024497|NCT00454779|468050374|FG000|First-line Treatment Phase|Protocol Violation|0|||
130024498|NCT00454779|468050375|FG001|First-line Treatment Phase|Protocol Violation|1|||
130024499|NCT00454779|468050374|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
130024500|NCT00454779|468050375|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
130024501|NCT00454779|468050374|FG000|First-line Treatment Phase|Ongoing|1|||
130024502|NCT00454779|468050375|FG001|First-line Treatment Phase|Ongoing|0|||
130024503|NCT00454779|468050374|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
130024504|NCT00454779|468050375|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
130024505|NCT00454779|468050374|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
130024506|NCT00454779|468050375|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
130024507|NCT00454779|468050374|FG000|Second-line Treatment Phase|Ongoing|0|||
130024508|NCT00454779|468050375|FG001|Second-line Treatment Phase|Ongoing|1|||
130024509|NCT05425563|468050378|FG000|Overall Study|Withdrawal by Subject|17|||
130024510|NCT00168831|468050379|FG000|Overall Study|Adverse Event|36|||
130024511|NCT00168831|468050380|FG001|Overall Study|Adverse Event|47|||
130024512|NCT00168831|468050381|FG002|Overall Study|Adverse Event|74|||
130024513|NCT00168831|468050379|FG000|Overall Study|Lost to Follow-up|5|||
130024514|NCT00168831|468050380|FG001|Overall Study|Lost to Follow-up|6|||
130024515|NCT00168831|468050381|FG002|Overall Study|Lost to Follow-up|4|||
130024516|NCT00168831|468050379|FG000|Overall Study|Withdrawal by Subject|7|||
130024517|NCT00168831|468050380|FG001|Overall Study|Withdrawal by Subject|14|||
130024518|NCT00168831|468050381|FG002|Overall Study|Withdrawal by Subject|19|||
130024519|NCT00168831|468050379|FG000|Overall Study|Protocol Violation|6|||
130024520|NCT00168831|468050380|FG001|Overall Study|Protocol Violation|11|||
130024521|NCT00168831|468050381|FG002|Overall Study|Protocol Violation|11|||
130024522|NCT00168831|468050379|FG000|Overall Study|Other|6|||
130024523|NCT00168831|468050380|FG001|Overall Study|Other|3|||
130024524|NCT00168831|468050381|FG002|Overall Study|Other|6|||
130024525|NCT02009878|468050385|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
130024526|NCT02009878|468050386|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130231178|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
130024527|NCT02009878|468050387|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
130024528|NCT00343512|468050390|FG000|Overall Study|Withdrawal by Subject|2|||
130024529|NCT00684515|468050391|FG000|Overall Study|Adverse Event|3|||
130024530|NCT00684515|468050392|FG001|Overall Study|Adverse Event|3|||
130024531|NCT00684515|468050393|FG002|Overall Study|Adverse Event|1|||
130024532|NCT00684515|468050391|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
130024533|NCT00684515|468050392|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
130024534|NCT00684515|468050393|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
130024535|NCT04428411|468050394|FG000|Overall Study|Lost to Follow-up|114|||
130024536|NCT00272987|468050395|FG000|Overall Study|Adverse Event|1|||
130024537|NCT00272987|468050396|FG001|Overall Study|Adverse Event|0|||
130024538|NCT00272987|468050397|FG002|Overall Study|Adverse Event|0|||
130024539|NCT00272987|468050395|FG000|Overall Study|Lost to Follow-up|3|||
130231179|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
130231180|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130231181|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130231182|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
130231183|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130024540|NCT00272987|468050396|FG001|Overall Study|Lost to Follow-up|1|||
130024541|NCT00272987|468050397|FG002|Overall Study|Lost to Follow-up|1|||
130024542|NCT00272987|468050395|FG000|Overall Study|Withdrawal by Subject|1|||
130024543|NCT00272987|468050396|FG001|Overall Study|Withdrawal by Subject|0|||
130024544|NCT00272987|468050397|FG002|Overall Study|Withdrawal by Subject|3|||
130024545|NCT00272987|468050395|FG000|Overall Study|Sponsor Terminated study|0|||
130024546|NCT00272987|468050396|FG001|Overall Study|Sponsor Terminated study|1|||
130024547|NCT00272987|468050397|FG002|Overall Study|Sponsor Terminated study|1|||
130024548|NCT00272987|468050395|FG000|Overall Study|Disease progression|1|||
130024549|NCT00272987|468050396|FG001|Overall Study|Disease progression|1|||
130024550|NCT00272987|468050397|FG002|Overall Study|Disease progression|2|||
130024551|NCT00272987|468050395|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
130024552|NCT00272987|468050396|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
130024553|NCT00272987|468050397|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
130024554|NCT00272987|468050395|FG000|Overall Study|Death|1|||
130024555|NCT00272987|468050396|FG001|Overall Study|Death|0|||
130024556|NCT00272987|468050397|FG002|Overall Study|Death|0|||
130024557|NCT03222349|468050398|FG000|Overall Study|Treatment B not done|5|||
130024558|NCT03222349|468050399|FG001|Overall Study|Treatment B not done|0|||
130024559|NCT03222349|468050398|FG000|Overall Study|Lost to Follow-up|1|||
130024560|NCT03222349|468050399|FG001|Overall Study|Lost to Follow-up|2|||
130024561|NCT03222349|468050398|FG000|Overall Study|Withdrawal by Subject|1|||
130024562|NCT03222349|468050399|FG001|Overall Study|Withdrawal by Subject|0|||
130024563|NCT03222349|468050398|FG000|Overall Study|Treatment A not done|0|||
130024564|NCT03222349|468050399|FG001|Overall Study|Treatment A not done|5|||
130024565|NCT03222349|468050398|FG000|Overall Study|Study terminated by sponsor|1|||
130024566|NCT03222349|468050399|FG001|Overall Study|Study terminated by sponsor|0|||
130024567|NCT01808612|468050406|FG000|Treatment Period|Adverse Event|8|||
130024568|NCT01808612|468050407|FG001|Treatment Period|Adverse Event|4|||
130024569|NCT01808612|468050408|FG002|Treatment Period|Adverse Event|3|||
130024570|NCT01808612|468050406|FG000|Treatment Period|Lost to Follow-up|2|||
130024571|NCT01808612|468050407|FG001|Treatment Period|Lost to Follow-up|2|||
130024572|NCT01808612|468050408|FG002|Treatment Period|Lost to Follow-up|1|||
130024573|NCT01808612|468050406|FG000|Treatment Period|Protocol Violation|1|||
130024574|NCT01808612|468050407|FG001|Treatment Period|Protocol Violation|0|||
130024575|NCT01808612|468050408|FG002|Treatment Period|Protocol Violation|0|||
130024576|NCT01808612|468050406|FG000|Treatment Period|Withdrawal by Subject|1|||
130024577|NCT01808612|468050407|FG001|Treatment Period|Withdrawal by Subject|0|||
130024578|NCT01808612|468050408|FG002|Treatment Period|Withdrawal by Subject|4|||
130024579|NCT01808612|468050406|FG000|Treatment Period|Physician Decision|1|||
130024580|NCT01808612|468050407|FG001|Treatment Period|Physician Decision|0|||
130024581|NCT01808612|468050408|FG002|Treatment Period|Physician Decision|4|||
130024582|NCT01808612|468050406|FG000|Treatment Period|Sponsor Decision|1|||
130024583|NCT01808612|468050407|FG001|Treatment Period|Sponsor Decision|0|||
130024584|NCT01808612|468050408|FG002|Treatment Period|Sponsor Decision|0|||
130024585|NCT01808612|468050406|FG000|Treatment Period|Lack of Efficacy|1|||
130024586|NCT01808612|468050407|FG001|Treatment Period|Lack of Efficacy|1|||
130024587|NCT01808612|468050408|FG002|Treatment Period|Lack of Efficacy|2|||
130024588|NCT01808612|468050406|FG000|Discontinuation Period|Adverse Event|1|||
130024589|NCT01808612|468050407|FG001|Discontinuation Period|Adverse Event|0|||
130024590|NCT01808612|468050408|FG002|Discontinuation Period|Adverse Event|0|||
130024591|NCT01808612|468050406|FG000|Discontinuation Period|Physician Decision|1|||
130024592|NCT01808612|468050407|FG001|Discontinuation Period|Physician Decision|0|||
130024593|NCT01808612|468050408|FG002|Discontinuation Period|Physician Decision|0|||
130024594|NCT01808612|468050406|FG000|Discontinuation Period|Lost to Follow-up|0|||
130024595|NCT01808612|468050407|FG001|Discontinuation Period|Lost to Follow-up|1|||
130024596|NCT01808612|468050408|FG002|Discontinuation Period|Lost to Follow-up|0|||
130024597|NCT04823949|468050409|FG000|Overall Study|Withdrawal by Subject|0|||
130024598|NCT04823949|468050410|FG001|Overall Study|Withdrawal by Subject|4|||
130024599|NCT04823949|468050409|FG000|Overall Study|Physician Decision|0|||
130024600|NCT04823949|468050410|FG001|Overall Study|Physician Decision|1|||
130024601|NCT00939692|468050412|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
130024602|NCT00939692|468050413|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
130024603|NCT00939692|468050412|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
130024604|NCT00939692|468050413|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
130024605|NCT01700192|468050414|FG000|Overall Study|Adverse Event|73|||
130024606|NCT01700192|468050415|FG001|Overall Study|Adverse Event|18|||
130024607|NCT01700192|468050414|FG000|Overall Study|Lack of Efficacy|1|||
130024608|NCT01700192|468050415|FG001|Overall Study|Lack of Efficacy|0|||
130024609|NCT01700192|468050414|FG000|Overall Study|Lost to Follow-up|42|||
130024610|NCT01700192|468050415|FG001|Overall Study|Lost to Follow-up|29|||
130024611|NCT01700192|468050414|FG000|Overall Study|Noncompliance with study drug|0|||
130024612|NCT01700192|468050415|FG001|Overall Study|Noncompliance with study drug|5|||
130099893|NCT00526227|468322819|FG000|Overall Study|Device not implanted|1|||
130024613|NCT01700192|468050414|FG000|Overall Study|Physician Decision|2|||
130024614|NCT01700192|468050415|FG001|Overall Study|Physician Decision|3|||
130024615|NCT01700192|468050414|FG000|Overall Study|Pregnancy|1|||
130024616|NCT01700192|468050415|FG001|Overall Study|Pregnancy|4|||
130099894|NCT00526227|468322819|FG000|Overall Study|Death|1|||
130024617|NCT01700192|468050414|FG000|Overall Study|Progressive disease|1|||
130024618|NCT01700192|468050415|FG001|Overall Study|Progressive disease|0|||
130024619|NCT01700192|468050414|FG000|Overall Study|Protocol Violation|3|||
130024620|NCT01700192|468050415|FG001|Overall Study|Protocol Violation|4|||
130024621|NCT01700192|468050414|FG000|Overall Study|Technical problems|0|||
130024622|NCT01700192|468050415|FG001|Overall Study|Technical problems|1|||
130024623|NCT01700192|468050414|FG000|Overall Study|Withdrawal by Subject|56|||
130024624|NCT01700192|468050415|FG001|Overall Study|Withdrawal by Subject|64|||
130024625|NCT01700192|468050414|FG000|Overall Study|Never received study drug|1|||
130024626|NCT01700192|468050415|FG001|Overall Study|Never received study drug|0|||
130024627|NCT02793232|468050416|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130231184|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
130231185|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
130231186|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
130231187|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
130231188|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
130231189|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
130231190|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130231191|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130231192|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
130231193|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
130231194|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
130231195|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231196|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231197|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231198|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
130231199|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
130231200|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
130231201|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
130231202|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
130231203|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
130231204|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
130231205|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130231206|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130231207|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130024628|NCT02793232|468050417|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130024629|NCT02793232|468050418|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130024630|NCT02793232|468050419|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130024631|NCT02793232|468050420|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
130024632|NCT02793232|468050421|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130024633|NCT02793232|468050422|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
130024634|NCT02793232|468050423|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130024635|NCT02793232|468050424|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
130024636|NCT03979274|468050431|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130024637|NCT03979274|468050432|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130024638|NCT02319044|468050433|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
130024639|NCT02319044|468050434|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
130024640|NCT02319044|468050435|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
130024641|NCT02319044|468050433|FG000|Overall Study|Withdrawal by Subject|3|||
130024642|NCT02319044|468050434|FG001|Overall Study|Withdrawal by Subject|3|||
130024643|NCT02319044|468050435|FG002|Overall Study|Withdrawal by Subject|6|||
130024644|NCT02319044|468050433|FG000|Overall Study|Condition under investigation worsened|100|||
130024645|NCT02319044|468050434|FG001|Overall Study|Condition under investigation worsened|50|||
130024646|NCT02319044|468050435|FG002|Overall Study|Condition under investigation worsened|46|||
130024647|NCT02319044|468050433|FG000|Overall Study|Adverse Event|17|||
130024648|NCT02319044|468050434|FG001|Overall Study|Adverse Event|2|||
130024649|NCT02319044|468050435|FG002|Overall Study|Adverse Event|8|||
130024650|NCT02319044|468050433|FG000|Overall Study|Study specific discontinuation criteria|2|||
130024651|NCT02319044|468050434|FG001|Overall Study|Study specific discontinuation criteria|2|||
130024652|NCT02319044|468050435|FG002|Overall Study|Study specific discontinuation criteria|1|||
130024653|NCT02319044|468050433|FG000|Overall Study|Not treated|0|||
130024654|NCT02319044|468050434|FG001|Overall Study|Not treated|2|||
130231208|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
130231209|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
130231210|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130231211|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130024655|NCT02319044|468050435|FG002|Overall Study|Not treated|2|||
130024656|NCT00626093|468050436|FG000|Overall Study|Lost to Follow-up|5|||
130024657|NCT00626093|468050436|FG000|Overall Study|Death|1|||
130231212|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
130231213|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130231214|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
130231215|NCT02717195|468811595|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130231216|NCT02717195|468811596|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130231217|NCT02717195|468811597|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
130231218|NCT02717195|468811598|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
130231219|NCT02717195|468811599|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
130231220|NCT03087058|468811600|FG000|Overall Study|Withdrawal by Subject|2|||
130231221|NCT03087058|468811601|FG001|Overall Study|Withdrawal by Subject|0|||
130231222|NCT03087058|468811602|FG002|Overall Study|Withdrawal by Subject|0|||
130231223|NCT02577029|468811603|FG000|Overall Study|Adverse Event|1|||
130231224|NCT02577029|468811604|FG001|Overall Study|Adverse Event|0|||
130231225|NCT02577029|468811605|FG002|Overall Study|Adverse Event|2|||
130231226|NCT02577029|468811606|FG003|Overall Study|Adverse Event|0|||
130231227|NCT02577029|468811607|FG004|Overall Study|Adverse Event|1|||
130231228|NCT02577029|468811608|FG005|Overall Study|Adverse Event|0|||
130231229|NCT02577029|468811609|FG006|Overall Study|Adverse Event|0|||
130231230|NCT02577029|468811610|FG007|Overall Study|Adverse Event|0|||
130231231|NCT02577029|468811603|FG000|Overall Study|Withdrawal by Subject|0|||
130231232|NCT02577029|468811604|FG001|Overall Study|Withdrawal by Subject|0|||
130231233|NCT02577029|468811605|FG002|Overall Study|Withdrawal by Subject|0|||
130231234|NCT02577029|468811606|FG003|Overall Study|Withdrawal by Subject|0|||
130231235|NCT02577029|468811607|FG004|Overall Study|Withdrawal by Subject|0|||
130231236|NCT02577029|468811608|FG005|Overall Study|Withdrawal by Subject|1|||
130231237|NCT02577029|468811609|FG006|Overall Study|Withdrawal by Subject|0|||
130231238|NCT02577029|468811610|FG007|Overall Study|Withdrawal by Subject|0|||
130231239|NCT02577029|468811603|FG000|Overall Study|Sponsor Termination of the Study|9|||
130231240|NCT02577029|468811604|FG001|Overall Study|Sponsor Termination of the Study|2|||
130231241|NCT02577029|468811605|FG002|Overall Study|Sponsor Termination of the Study|5|||
130231242|NCT02577029|468811606|FG003|Overall Study|Sponsor Termination of the Study|12|||
130231243|NCT02577029|468811607|FG004|Overall Study|Sponsor Termination of the Study|10|||
130231244|NCT02577029|468811608|FG005|Overall Study|Sponsor Termination of the Study|12|||
130231245|NCT02577029|468811609|FG006|Overall Study|Sponsor Termination of the Study|12|||
130231246|NCT02577029|468811610|FG007|Overall Study|Sponsor Termination of the Study|12|||
130231247|NCT02078817|468811611|FG000|Overall Study|Withdrawal by Subject|1|||
130231248|NCT01420536|468811612|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
130231249|NCT01420536|468811613|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
130231250|NCT01265498|468811618|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
130231251|NCT01265498|468811619|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
130231252|NCT01652690|468811621|FG000|Overall Study|Withdrawal by Subject|16|||
130231253|NCT01652690|468811622|FG001|Overall Study|Withdrawal by Subject|4|||
130231254|NCT01652690|468811621|FG000|Overall Study|Other|8|||
130231255|NCT01652690|468811622|FG001|Overall Study|Other|9|||
130231256|NCT01652690|468811621|FG000|Overall Study|Lost to Follow-up|6|||
130024658|NCT00626093|468050436|FG000|Overall Study|Physician Decision|4|||
130024659|NCT00626093|468050436|FG000|Overall Study|Withdrawal by Subject|6|||
130024660|NCT00626093|468050436|FG000|Overall Study|Protocol Violation|1|||
130231257|NCT01652690|468811622|FG001|Overall Study|Lost to Follow-up|6|||
130231258|NCT01652690|468811621|FG000|Overall Study|Death|5|||
130231259|NCT01652690|468811622|FG001|Overall Study|Death|2|||
130231260|NCT03225287|468811623|FG000|Overall Study|Adverse Event|0|||
130231261|NCT03225287|468811624|FG001|Overall Study|Adverse Event|0|||
130024661|NCT00626093|468050436|FG000|Overall Study|One of the required devices not implante|6|||
130231262|NCT03225287|468811625|FG002|Overall Study|Adverse Event|1|||
130231263|NCT03225287|468811623|FG000|Overall Study|Protocol non-compliance|0|||
130231264|NCT03225287|468811624|FG001|Overall Study|Protocol non-compliance|0|||
130231265|NCT03225287|468811625|FG002|Overall Study|Protocol non-compliance|1|||
130231266|NCT03225287|468811623|FG000|Overall Study|Subject withdraws consent|3|||
130231267|NCT03225287|468811624|FG001|Overall Study|Subject withdraws consent|0|||
130231268|NCT03225287|468811625|FG002|Overall Study|Subject withdraws consent|0|||
130231269|NCT03225287|468811623|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
130231270|NCT03225287|468811624|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
130231271|NCT03225287|468811625|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
130231272|NCT03225287|468811623|FG000|Overall Study|Trial drug not effective|0|||
130231273|NCT03225287|468811624|FG001|Overall Study|Trial drug not effective|1|||
130231274|NCT03225287|468811625|FG002|Overall Study|Trial drug not effective|0|||
130231275|NCT03225287|468811623|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
130231276|NCT03225287|468811624|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
130231277|NCT03225287|468811625|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
130231278|NCT03225287|468811623|FG000|Overall Study|Stem cell transplantation|0|||
130231279|NCT03225287|468811624|FG001|Overall Study|Stem cell transplantation|1|||
130231280|NCT03225287|468811625|FG002|Overall Study|Stem cell transplantation|0|||
130231281|NCT06996301|468811627|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
130231282|NCT06996301|468811628|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
130231283|NCT06996301|468811627|FG000|Overall Study|Patients with discordant diagnostic results|107|||
130231284|NCT06996301|468811628|FG001|Overall Study|Patients with discordant diagnostic results|90|||
130231285|NCT06996301|468811627|FG000|Overall Study|Lost to Follow-up|31|||
130231286|NCT06996301|468811628|FG001|Overall Study|Lost to Follow-up|56|||
130231287|NCT06996301|468811627|FG000|Overall Study|Withdrawal by Subject|12|||
130231288|NCT06996301|468811628|FG001|Overall Study|Withdrawal by Subject|7|||
130231289|NCT04030598|468811629|FG000|Overall Study|Voluntary Withdrawal|0|||
130231290|NCT04030598|468811630|FG001|Overall Study|Voluntary Withdrawal|1|||
130231291|NCT04030598|468811631|FG002|Overall Study|Voluntary Withdrawal|0|||
130231292|NCT02097823|468811634|FG000|Overall Study|Withdrawal by Subject|1|||
130024662|NCT00603915|468050437|FG000|Overall Study|Physician Decision|1|||
130024663|NCT03891901|468050438|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
130024664|NCT03891901|468050439|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024665|NCT03891901|468050440|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024666|NCT03891901|468050441|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024667|NCT03891901|468050442|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024668|NCT03891901|468050443|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024669|NCT03891901|468050444|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024670|NCT03891901|468050445|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024671|NCT03891901|468050446|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
130024672|NCT03891901|468050438|FG000|Overall Study|Adverse Event|2|||
130024673|NCT03891901|468050439|FG001|Overall Study|Adverse Event|2|||
130024674|NCT03891901|468050440|FG002|Overall Study|Adverse Event|0|||
130024675|NCT03891901|468050441|FG003|Overall Study|Adverse Event|0|||
130024676|NCT03891901|468050442|FG004|Overall Study|Adverse Event|0|||
130024677|NCT03891901|468050443|FG005|Overall Study|Adverse Event|0|||
130024678|NCT03891901|468050444|FG006|Overall Study|Adverse Event|0|||
130024679|NCT03891901|468050445|FG007|Overall Study|Adverse Event|0|||
130024680|NCT03891901|468050446|FG008|Overall Study|Adverse Event|0|||
130024681|NCT03891901|468050438|FG000|Overall Study|Poor venous access|1|||
130024682|NCT03891901|468050439|FG001|Overall Study|Poor venous access|0|||
130024683|NCT03891901|468050440|FG002|Overall Study|Poor venous access|0|||
130024684|NCT03891901|468050441|FG003|Overall Study|Poor venous access|0|||
130024685|NCT03891901|468050442|FG004|Overall Study|Poor venous access|0|||
130024686|NCT03891901|468050443|FG005|Overall Study|Poor venous access|0|||
130024687|NCT03891901|468050444|FG006|Overall Study|Poor venous access|0|||
130024688|NCT03891901|468050445|FG007|Overall Study|Poor venous access|0|||
130024689|NCT03891901|468050446|FG008|Overall Study|Poor venous access|0|||
130024690|NCT03891901|468050438|FG000|Overall Study|Withdrawal by Subject|0|||
130231293|NCT02097823|468811635|FG001|Overall Study|Withdrawal by Subject|1|||
130231294|NCT00959751|468813466|FG000|Overall Study|Lost to Follow-up|2|||
130231295|NCT00959751|468813467|FG001|Overall Study|Lost to Follow-up|3|||
130231296|NCT00959751|468813466|FG000|Overall Study|Consent Withdrawn|0|||
130024691|NCT03891901|468050439|FG001|Overall Study|Withdrawal by Subject|2|||
130024692|NCT03891901|468050440|FG002|Overall Study|Withdrawal by Subject|0|||
130231297|NCT00959751|468813467|FG001|Overall Study|Consent Withdrawn|1|||
130231298|NCT00959751|468813466|FG000|Overall Study|Non-compliance to Study Procedures|0|||
130231299|NCT00959751|468813467|FG001|Overall Study|Non-compliance to Study Procedures|1|||
130231300|NCT00959751|468813466|FG000|Overall Study|No migraine headache without aura|7|||
130231301|NCT00959751|468813467|FG001|Overall Study|No migraine headache without aura|7|||
130231302|NCT00900562|468813470|FG000|Overall Study|Progressive disease|9|||
130231303|NCT00900562|468813471|FG001|Overall Study|Progressive disease|5|||
130231304|NCT00900562|468813470|FG000|Overall Study|Toxicity|1|||
130231305|NCT00900562|468813471|FG001|Overall Study|Toxicity|0|||
130231306|NCT00900562|468813470|FG000|Overall Study|Death|1|||
130231307|NCT00900562|468813471|FG001|Overall Study|Death|1|||
130231308|NCT00900562|468813470|FG000|Overall Study|Withdrawal by Subject|0|||
130231309|NCT00900562|468813471|FG001|Overall Study|Withdrawal by Subject|1|||
130231310|NCT00900562|468813470|FG000|Overall Study|Unrelated adverse event|1|||
130231311|NCT00900562|468813471|FG001|Overall Study|Unrelated adverse event|0|||
130231312|NCT04459338|468813472|FG000|Overall Study|Loss of IV during study|1|||
130231313|NCT04459338|468813473|FG001|Overall Study|Loss of IV during study|0|||
130231314|NCT01454284|468813474|FG000|Overall Study|Adverse Event|20|||
130231315|NCT01454284|468813475|FG001|Overall Study|Adverse Event|7|||
130231316|NCT01454284|468813474|FG000|Overall Study|Death|0|||
130231317|NCT01454284|468813475|FG001|Overall Study|Death|3|||
130231318|NCT01454284|468813474|FG000|Overall Study|Lost to Follow-up|13|||
130231319|NCT01454284|468813475|FG001|Overall Study|Lost to Follow-up|8|||
130231320|NCT01454284|468813474|FG000|Overall Study|Protocol Violation|9|||
130231321|NCT01454284|468813475|FG001|Overall Study|Protocol Violation|6|||
130231322|NCT01454284|468813474|FG000|Overall Study|Withdrawal by Subject|58|||
130231323|NCT01454284|468813475|FG001|Overall Study|Withdrawal by Subject|36|||
130231324|NCT01454284|468813474|FG000|Overall Study|Physician Decision|16|||
130231325|NCT01454284|468813475|FG001|Overall Study|Physician Decision|11|||
130231326|NCT01454284|468813474|FG000|Overall Study|Sponsor Decision|0|||
130231327|NCT01454284|468813475|FG001|Overall Study|Sponsor Decision|2|||
130231328|NCT02665117|468813476|FG000|Overall Study|Physician Decision|1|||
130231329|NCT02665117|468813477|FG001|Overall Study|Physician Decision|0|||
130231330|NCT03817528|468813483|FG000|Overall Study|Withdrawal by Subject|1|||
130231331|NCT03817528|468813483|FG000|Overall Study|Adverse Event|2|||
130231332|NCT03451071|468813489|FG000|First Vaccine|Withdrawal by Subject|1|||
130231333|NCT03451071|468813489|FG000|Second Vaccine|Lost to Follow-up|19|||
130231334|NCT03451071|468813489|FG000|Third Vaccine|Lost to Follow-up|22|||
130231335|NCT03451071|468813489|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
130231336|NCT02065557|468813490|FG000|Induction Period|Withdrawal by Subject|2|||
130231337|NCT02065557|468813491|FG001|Induction Period|Withdrawal by Subject|1|||
130231338|NCT02065557|468813492|FG002|Induction Period|Withdrawal by Subject|0|||
130231339|NCT02065557|468813493|FG003|Induction Period|Withdrawal by Subject|0|||
130231340|NCT02065557|468813494|FG004|Induction Period|Withdrawal by Subject|0|||
130231341|NCT02065557|468813495|FG005|Induction Period|Withdrawal by Subject|0|||
130231342|NCT02065557|468813490|FG000|Induction Period|Lack of Efficacy|2|||
130231343|NCT02065557|468813491|FG001|Induction Period|Lack of Efficacy|1|||
130231344|NCT02065557|468813492|FG002|Induction Period|Lack of Efficacy|1|||
130231345|NCT02065557|468813493|FG003|Induction Period|Lack of Efficacy|0|||
130231346|NCT02065557|468813494|FG004|Induction Period|Lack of Efficacy|0|||
130231347|NCT02065557|468813495|FG005|Induction Period|Lack of Efficacy|0|||
130231348|NCT02065557|468813490|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130231349|NCT02065557|468813491|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130231350|NCT02065557|468813492|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
130231351|NCT02065557|468813493|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130231352|NCT02065557|468813494|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130231353|NCT02065557|468813495|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
130231354|NCT02065557|468813490|FG000|Induction Period|Non-Responder at Week 8|4|||
130231355|NCT02065557|468813491|FG001|Induction Period|Non-Responder at Week 8|4|||
130231356|NCT02065557|468813492|FG002|Induction Period|Non-Responder at Week 8|0|||
130231357|NCT02065557|468813493|FG003|Induction Period|Non-Responder at Week 8|0|||
130231358|NCT02065557|468813494|FG004|Induction Period|Non-Responder at Week 8|0|||
130231359|NCT02065557|468813495|FG005|Induction Period|Non-Responder at Week 8|0|||
130231360|NCT02065557|468813490|FG000|Induction Period|Adverse Event|1|||
130231361|NCT02065557|468813491|FG001|Induction Period|Adverse Event|1|||
130231362|NCT02065557|468813492|FG002|Induction Period|Adverse Event|0|||
130231363|NCT02065557|468813493|FG003|Induction Period|Adverse Event|0|||
130231364|NCT02065557|468813494|FG004|Induction Period|Adverse Event|0|||
130231365|NCT02065557|468813495|FG005|Induction Period|Adverse Event|0|||
130231366|NCT02065557|468813490|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231367|NCT02065557|468813491|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231368|NCT02065557|468813492|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231369|NCT02065557|468813493|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
130231370|NCT02065557|468813494|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
130231371|NCT02065557|468813495|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
130231372|NCT02065557|468813490|FG000|Maintenance Period|Withdrawal by Subject|0|||
130231373|NCT02065557|468813491|FG001|Maintenance Period|Withdrawal by Subject|0|||
130231374|NCT02065557|468813492|FG002|Maintenance Period|Withdrawal by Subject|0|||
130231375|NCT02065557|468813493|FG003|Maintenance Period|Withdrawal by Subject|0|||
130231376|NCT02065557|468813494|FG004|Maintenance Period|Withdrawal by Subject|2|||
130231377|NCT02065557|468813495|FG005|Maintenance Period|Withdrawal by Subject|1|||
130231378|NCT02065557|468813490|FG000|Maintenance Period|Lack of Efficacy|0|||
130231379|NCT02065557|468813491|FG001|Maintenance Period|Lack of Efficacy|0|||
130231380|NCT02065557|468813492|FG002|Maintenance Period|Lack of Efficacy|0|||
130231381|NCT02065557|468813493|FG003|Maintenance Period|Lack of Efficacy|0|||
130231382|NCT02065557|468813494|FG004|Maintenance Period|Lack of Efficacy|5|||
130231383|NCT02065557|468813495|FG005|Maintenance Period|Lack of Efficacy|2|||
130231384|NCT02065557|468813490|FG000|Maintenance Period|Subject Non-Compliance|0|||
130231385|NCT02065557|468813491|FG001|Maintenance Period|Subject Non-Compliance|0|||
130231386|NCT02065557|468813492|FG002|Maintenance Period|Subject Non-Compliance|0|||
130231387|NCT02065557|468813493|FG003|Maintenance Period|Subject Non-Compliance|0|||
130231388|NCT02065557|468813494|FG004|Maintenance Period|Subject Non-Compliance|0|||
130231389|NCT02065557|468813495|FG005|Maintenance Period|Subject Non-Compliance|1|||
130231390|NCT00250588|468813496|FG000|Overall Study|Withdrawal by Subject|3|||
130231391|NCT00250588|468813497|FG001|Overall Study|Withdrawal by Subject|6|||
130231392|NCT00250588|468813498|FG002|Overall Study|Withdrawal by Subject|0|||
130231393|NCT00250588|468813496|FG000|Overall Study|Lost to Follow-up|6|||
130231394|NCT00250588|468813497|FG001|Overall Study|Lost to Follow-up|13|||
130231395|NCT00250588|468813498|FG002|Overall Study|Lost to Follow-up|13|||
130231396|NCT03502798|468813499|FG000|Overall Study|equipment failure|0|||
130231397|NCT03502798|468813500|FG001|Overall Study|equipment failure|7|||
130231398|NCT00485303|468813501|FG000|Overall Study|Adverse Event|5|||
130231399|NCT00485303|468813501|FG000|Overall Study|Progressive Disease|44|||
130231400|NCT00485303|468813501|FG000|Overall Study|Other|3|||
130231401|NCT00485303|468813501|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
130231402|NCT00485303|468813501|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
130231403|NCT00296335|468813504|FG000|Overall Study|Recurrence|3|||
130231404|NCT00296335|468813505|FG001|Overall Study|Recurrence|51|||
130231405|NCT00296335|468813504|FG000|Overall Study|Adverse Event|17|||
130231406|NCT00296335|468813505|FG001|Overall Study|Adverse Event|27|||
130231407|NCT00296335|468813504|FG000|Overall Study|Lost to Follow-up|7|||
130231408|NCT00296335|468813505|FG001|Overall Study|Lost to Follow-up|33|||
130231409|NCT00296335|468813504|FG000|Overall Study|Physician Decision|3|||
130231410|NCT00296335|468813505|FG001|Overall Study|Physician Decision|11|||
130231411|NCT01401322|468813506|FG000|Overall Study|Withdrawal by Subject|1|||
130231412|NCT01401322|468813506|FG000|Overall Study|Physician Decision|1|||
130231413|NCT02737722|468813507|FG000|Overall Study|Physician Decision|0|||
130231414|NCT02737722|468813508|FG001|Overall Study|Physician Decision|0|||
130231415|NCT02737722|468813509|FG002|Overall Study|Physician Decision|1|||
130231416|NCT02737722|468813510|FG003|Overall Study|Physician Decision|0|||
130231417|NCT00112957|468813517|FG000|Overall Study|Progressive disease|18|||
130231418|NCT00112957|468813517|FG000|Overall Study|Physician Decision|1|||
130231419|NCT03444584|468813525|FG000|Overall Study|Withdrawal by Subject|0|||
130231420|NCT03444584|468813526|FG001|Overall Study|Withdrawal by Subject|1|||
130231421|NCT03444584|468813525|FG000|Overall Study|Other|0|||
130231422|NCT03444584|468813526|FG001|Overall Study|Other|1|||
130231423|NCT03451045|468813527|FG000|Overall Study|Lack of Efficacy|3|||
130231424|NCT03451045|468813528|FG001|Overall Study|Lack of Efficacy|2|||
130231425|NCT03451045|468813529|FG002|Overall Study|Lack of Efficacy|2|||
130231426|NCT03451045|468813527|FG000|Overall Study|Physician Decision|1|||
130231427|NCT03451045|468813528|FG001|Overall Study|Physician Decision|1|||
130231428|NCT03451045|468813529|FG002|Overall Study|Physician Decision|1|||
130231429|NCT03451045|468813527|FG000|Overall Study|Withdrawal by Subject|4|||
130231430|NCT03451045|468813528|FG001|Overall Study|Withdrawal by Subject|0|||
130231431|NCT03451045|468813529|FG002|Overall Study|Withdrawal by Subject|5|||
130231432|NCT03451045|468813527|FG000|Overall Study|Pregnancy|0|||
130024693|NCT03891901|468050441|FG003|Overall Study|Withdrawal by Subject|0|||
130024694|NCT03891901|468050442|FG004|Overall Study|Withdrawal by Subject|0|||
130231433|NCT03451045|468813528|FG001|Overall Study|Pregnancy|0|||
130231434|NCT03451045|468813529|FG002|Overall Study|Pregnancy|2|||
130231435|NCT03451045|468813527|FG000|Overall Study|Adverse Event|7|||
130024695|NCT03891901|468050443|FG005|Overall Study|Withdrawal by Subject|0|||
130024696|NCT03891901|468050444|FG006|Overall Study|Withdrawal by Subject|0|||
130024697|NCT03891901|468050445|FG007|Overall Study|Withdrawal by Subject|0|||
130024698|NCT03891901|468050446|FG008|Overall Study|Withdrawal by Subject|0|||
130231436|NCT03451045|468813528|FG001|Overall Study|Adverse Event|1|||
130231437|NCT03451045|468813529|FG002|Overall Study|Adverse Event|3|||
130231438|NCT03451045|468813527|FG000|Overall Study|Non-compliance with study|2|||
130231439|NCT03451045|468813528|FG001|Overall Study|Non-compliance with study|0|||
130231440|NCT03451045|468813529|FG002|Overall Study|Non-compliance with study|1|||
130231441|NCT03451045|468813527|FG000|Overall Study|any other reason|10|||
130231442|NCT03451045|468813528|FG001|Overall Study|any other reason|2|||
130231443|NCT03451045|468813529|FG002|Overall Study|any other reason|13|||
130231444|NCT00863707|468813530|FG000|Overall Study|Randomized, but drug not received|4|||
130231445|NCT00863707|468813531|FG001|Overall Study|Randomized, but drug not received|3|||
130231446|NCT03704064|468813532|FG000|Overall Study|Lost to Follow-up|8|||
130231447|NCT03704064|468813533|FG001|Overall Study|Lost to Follow-up|4|||
130231448|NCT03704064|468813532|FG000|Overall Study|Withdrawal by Subject|1|||
130231449|NCT03704064|468813533|FG001|Overall Study|Withdrawal by Subject|1|||
130231450|NCT03704064|468813532|FG000|Overall Study|No longer available for study visits|0|||
130231451|NCT03704064|468813533|FG001|Overall Study|No longer available for study visits|1|||
130231452|NCT03704064|468813532|FG000|Overall Study|Censoring event|1|||
130231453|NCT03704064|468813533|FG001|Overall Study|Censoring event|0|||
130231454|NCT04142242|468813534|FG000|Stage I|Non-compliance with the protocol|1|||
130231455|NCT04142242|468813535|FG001|Stage I|Non-compliance with the protocol|0|||
130231456|NCT04142242|468813536|FG002|Stage I|Non-compliance with the protocol|0|||
130231457|NCT04142242|468813537|FG003|Stage I|Non-compliance with the protocol|0|||
130231458|NCT04142242|468813538|FG004|Stage I|Non-compliance with the protocol|0|||
130231459|NCT04142242|468813539|FG005|Stage I|Non-compliance with the protocol|1|||
130231460|NCT04142242|468813534|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231461|NCT04142242|468813535|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
130231462|NCT04142242|468813536|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231463|NCT04142242|468813537|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231464|NCT04142242|468813538|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231465|NCT04142242|468813539|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
130231466|NCT04142242|468813534|FG000|Stage II|Non-compliance with the protocol|0|||
130231467|NCT04142242|468813535|FG001|Stage II|Non-compliance with the protocol|0|||
130231468|NCT04142242|468813536|FG002|Stage II|Non-compliance with the protocol|0|||
130231469|NCT04142242|468813537|FG003|Stage II|Non-compliance with the protocol|2|||
130231470|NCT04142242|468813538|FG004|Stage II|Non-compliance with the protocol|0|||
130231471|NCT04142242|468813539|FG005|Stage II|Non-compliance with the protocol|0|||
130231472|NCT04142242|468813534|FG000|Stage II|Lost to Follow-up|0|||
130231473|NCT04142242|468813535|FG001|Stage II|Lost to Follow-up|0|||
130231474|NCT04142242|468813536|FG002|Stage II|Lost to Follow-up|1|||
130231475|NCT04142242|468813537|FG003|Stage II|Lost to Follow-up|2|||
130231476|NCT04142242|468813538|FG004|Stage II|Lost to Follow-up|0|||
130231477|NCT04142242|468813539|FG005|Stage II|Lost to Follow-up|0|||
130231478|NCT04142242|468813534|FG000|Stage II|Withdrawal by Subject|0|||
130231479|NCT04142242|468813535|FG001|Stage II|Withdrawal by Subject|0|||
130231480|NCT04142242|468813536|FG002|Stage II|Withdrawal by Subject|5|||
130231481|NCT04142242|468813537|FG003|Stage II|Withdrawal by Subject|9|||
130231482|NCT04142242|468813538|FG004|Stage II|Withdrawal by Subject|0|||
130231483|NCT04142242|468813539|FG005|Stage II|Withdrawal by Subject|0|||
130231484|NCT00289276|468813542|FG000|Second Part of FAST Study (Expansion)|Death|0|||
130231485|NCT00289276|468813543|FG001|Second Part of FAST Study (Expansion)|Death|2|||
130231486|NCT00289276|468813542|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
130231487|NCT00289276|468813543|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
130231488|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
130231489|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
130231490|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
130231491|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
130231492|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
130231493|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
130231494|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
130231495|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
130231496|NCT03040726|468813544|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
130231497|NCT03040726|468813545|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
130231498|NCT02783911|468813546|FG000|Overall Study|Lost to Follow-up|3|||
130231499|NCT02783911|468813547|FG001|Overall Study|Lost to Follow-up|32|||
130231500|NCT00071981|468813548|FG000|Overall Study|Lack of Efficacy|37|||
130231501|NCT00071981|468813549|FG001|Overall Study|Lack of Efficacy|29|||
130231502|NCT00071981|468813550|FG002|Overall Study|Lack of Efficacy|30|||
130231503|NCT00071981|468813551|FG003|Overall Study|Lack of Efficacy|43|||
130231504|NCT00071981|468813548|FG000|Overall Study|Adverse Event|4|||
130231505|NCT00071981|468813549|FG001|Overall Study|Adverse Event|4|||
130231506|NCT00071981|468813550|FG002|Overall Study|Adverse Event|3|||
130231507|NCT00071981|468813551|FG003|Overall Study|Adverse Event|1|||
130231508|NCT00071981|468813548|FG000|Overall Study|Death|0|||
130231509|NCT00071981|468813549|FG001|Overall Study|Death|0|||
130231510|NCT00071981|468813550|FG002|Overall Study|Death|1|||
130231511|NCT00071981|468813551|FG003|Overall Study|Death|1|||
130231512|NCT00071981|468813548|FG000|Overall Study|Withdrawal by Subject|3|||
130231513|NCT00071981|468813549|FG001|Overall Study|Withdrawal by Subject|1|||
130231514|NCT00071981|468813550|FG002|Overall Study|Withdrawal by Subject|0|||
130231515|NCT00071981|468813551|FG003|Overall Study|Withdrawal by Subject|0|||
130231516|NCT00071981|468813548|FG000|Overall Study|No protocol therapy|2|||
130231517|NCT00071981|468813549|FG001|Overall Study|No protocol therapy|5|||
130231518|NCT00071981|468813550|FG002|Overall Study|No protocol therapy|1|||
130231519|NCT00071981|468813551|FG003|Overall Study|No protocol therapy|0|||
130231520|NCT00071981|468813548|FG000|Overall Study|others (not specified in the study)|0|||
130231521|NCT00071981|468813549|FG001|Overall Study|others (not specified in the study)|2|||
130231522|NCT00071981|468813550|FG002|Overall Study|others (not specified in the study)|2|||
130231523|NCT00071981|468813551|FG003|Overall Study|others (not specified in the study)|0|||
130231524|NCT01123655|468813552|FG000|Overall Study|Medication for RA had to be changed|1|||
130231525|NCT01123655|468813553|FG001|Overall Study|Medication for RA had to be changed|0|||
130231526|NCT01123655|468813554|FG002|Overall Study|Medication for RA had to be changed|0|||
130231527|NCT01123655|468813552|FG000|Overall Study|new illness|0|||
130231528|NCT01123655|468813553|FG001|Overall Study|new illness|1|||
130231529|NCT01123655|468813554|FG002|Overall Study|new illness|0|||
130231530|NCT01123655|468813552|FG000|Overall Study|began prohibitive drug|0|||
130231531|NCT01123655|468813553|FG001|Overall Study|began prohibitive drug|0|||
130231532|NCT01123655|468813554|FG002|Overall Study|began prohibitive drug|1|||
130231533|NCT00885118|468813557|FG000|Overall Study|Adverse Event|1|||
130231534|NCT00885118|468813558|FG001|Overall Study|Adverse Event|0|||
130231535|NCT00885118|468813559|FG002|Overall Study|Adverse Event|0|||
130231536|NCT00885118|468813560|FG003|Overall Study|Adverse Event|0|||
130231537|NCT00885118|468813561|FG004|Overall Study|Adverse Event|0|||
130231538|NCT00885118|468813557|FG000|Overall Study|Withdrawal by Subject|0|||
130231539|NCT00885118|468813558|FG001|Overall Study|Withdrawal by Subject|0|||
130231540|NCT00885118|468813559|FG002|Overall Study|Withdrawal by Subject|0|||
130231541|NCT00885118|468813560|FG003|Overall Study|Withdrawal by Subject|0|||
130231542|NCT00885118|468813561|FG004|Overall Study|Withdrawal by Subject|1|||
130231543|NCT00885118|468813557|FG000|Overall Study|Other reason not defined above|0|||
130231544|NCT00885118|468813558|FG001|Overall Study|Other reason not defined above|0|||
130231545|NCT00885118|468813559|FG002|Overall Study|Other reason not defined above|1|||
130231546|NCT00885118|468813560|FG003|Overall Study|Other reason not defined above|0|||
130231547|NCT00885118|468813561|FG004|Overall Study|Other reason not defined above|0|||
130231548|NCT02814526|468813566|FG000|Overall Study|Adverse Event|4|||
130231549|NCT02814526|468813567|FG001|Overall Study|Adverse Event|3|||
130231550|NCT02814526|468813566|FG000|Overall Study|Death|1|||
130231551|NCT02814526|468813567|FG001|Overall Study|Death|1|||
130024699|NCT03434379|468050447|FG000|Global Period|Lost to Follow-up|3|||
130231552|NCT02814526|468813566|FG000|Overall Study|Lost to Follow-up|3|||
130231553|NCT02814526|468813567|FG001|Overall Study|Lost to Follow-up|4|||
130231554|NCT02814526|468813566|FG000|Overall Study|non site physician decision|1|||
130231555|NCT02814526|468813567|FG001|Overall Study|non site physician decision|0|||
130231556|NCT02814526|468813566|FG000|Overall Study|participant noncompliance|1|||
130231557|NCT02814526|468813567|FG001|Overall Study|participant noncompliance|1|||
130231558|NCT02814526|468813566|FG000|Overall Study|Withdrawal by Subject|20|||
130231559|NCT02814526|468813567|FG001|Overall Study|Withdrawal by Subject|14|||
130231560|NCT02814526|468813566|FG000|Overall Study|safety risk|2|||
130231561|NCT02814526|468813567|FG001|Overall Study|safety risk|1|||
130231562|NCT02814526|468813566|FG000|Overall Study|early termination-study terminated|1|||
130231563|NCT02814526|468813567|FG001|Overall Study|early termination-study terminated|2|||
130024700|NCT03434379|468050448|FG001|Global Period|Lost to Follow-up|6|||
130231564|NCT02814526|468813566|FG000|Overall Study|Other|0|||
130231565|NCT02814526|468813567|FG001|Overall Study|Other|4|||
130231566|NCT03883386|468813568|FG000|First Assignment|Lost to Follow-up|1|||
130231567|NCT03883386|468813569|FG001|First Assignment|Lost to Follow-up|0|||
130231568|NCT03883386|468813568|FG000|First Assignment|Withdrawal by Subject|1|||
130231569|NCT03883386|468813569|FG001|First Assignment|Withdrawal by Subject|1|||
130231570|NCT00251758|468813570|FG000|Overall Study|Adverse Event|7|||
130231571|NCT00251758|468813571|FG001|Overall Study|Adverse Event|9|||
130231572|NCT00251758|468813572|FG002|Overall Study|Adverse Event|11|||
130231573|NCT00251758|468813570|FG000|Overall Study|Lost to Follow-up|4|||
130231574|NCT00251758|468813571|FG001|Overall Study|Lost to Follow-up|2|||
130231575|NCT00251758|468813572|FG002|Overall Study|Lost to Follow-up|5|||
130231576|NCT00251758|468813570|FG000|Overall Study|Withdrawal by Subject|13|||
130231577|NCT00251758|468813571|FG001|Overall Study|Withdrawal by Subject|7|||
130231578|NCT00251758|468813572|FG002|Overall Study|Withdrawal by Subject|3|||
130231579|NCT00251758|468813570|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130231580|NCT00251758|468813571|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
130231581|NCT00251758|468813572|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130231582|NCT00251758|468813570|FG000|Overall Study|Lack of Efficacy|3|||
130231583|NCT00251758|468813571|FG001|Overall Study|Lack of Efficacy|0|||
130231584|NCT00251758|468813572|FG002|Overall Study|Lack of Efficacy|0|||
130024701|NCT03434379|468050449|FG002|Global Period|Lost to Follow-up|0|||
130231585|NCT00251758|468813570|FG000|Overall Study|Noncompliant|0|||
130231586|NCT00251758|468813571|FG001|Overall Study|Noncompliant|2|||
130231587|NCT00251758|468813572|FG002|Overall Study|Noncompliant|2|||
130231588|NCT00251758|468813570|FG000|Overall Study|Pregnancy|0|||
130231589|NCT00251758|468813571|FG001|Overall Study|Pregnancy|1|||
130231590|NCT00251758|468813572|FG002|Overall Study|Pregnancy|0|||
130231591|NCT00251758|468813570|FG000|Overall Study|Per Subject Request|0|||
130231592|NCT00251758|468813571|FG001|Overall Study|Per Subject Request|0|||
130231593|NCT00251758|468813572|FG002|Overall Study|Per Subject Request|1|||
130231594|NCT00251758|468813570|FG000|Overall Study|Per Investigator Request|1|||
130231595|NCT00251758|468813571|FG001|Overall Study|Per Investigator Request|0|||
130231596|NCT00251758|468813572|FG002|Overall Study|Per Investigator Request|0|||
130231597|NCT01387269|468813573|FG000|Overall Study|Death|38|||
130231598|NCT01387269|468813574|FG001|Overall Study|Death|20|||
130231599|NCT01387269|468813573|FG000|Overall Study|Other|8|||
130231600|NCT01387269|468813574|FG001|Overall Study|Other|7|||
130231601|NCT01387269|468813573|FG000|Overall Study|Unrelated AE|12|||
130231602|NCT01387269|468813574|FG001|Overall Study|Unrelated AE|3|||
130231603|NCT01387269|468813573|FG000|Overall Study|Withdrawal by patient|32|||
130231604|NCT01387269|468813574|FG001|Overall Study|Withdrawal by patient|10|||
130231605|NCT01387269|468813573|FG000|Overall Study|Study drug-related AE|1|||
130231606|NCT01387269|468813574|FG001|Overall Study|Study drug-related AE|0|||
130231607|NCT01387269|468813573|FG000|Overall Study|Lost to Follow-up|1|||
130231608|NCT01387269|468813574|FG001|Overall Study|Lost to Follow-up|0|||
130231609|NCT03054428|468813577|FG000|Overall Study|Physician Decision|0|||
130231610|NCT03054428|468813578|FG001|Overall Study|Physician Decision|1|||
130231611|NCT03054428|468813579|FG002|Overall Study|Physician Decision|1|||
130231612|NCT03054428|468813577|FG000|Overall Study|Lack of Efficacy|3|||
130231613|NCT03054428|468813578|FG001|Overall Study|Lack of Efficacy|1|||
130231614|NCT03054428|468813579|FG002|Overall Study|Lack of Efficacy|0|||
130231615|NCT03054428|468813577|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
130231616|NCT03054428|468813578|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
130231617|NCT03054428|468813579|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
130231618|NCT03054428|468813577|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
130231619|NCT03054428|468813578|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
130231620|NCT03054428|468813579|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
130231621|NCT03054428|468813577|FG000|Overall Study|Transitioned to OLE study|76|||
130231622|NCT03054428|468813578|FG001|Overall Study|Transitioned to OLE study|76|||
130231623|NCT03054428|468813579|FG002|Overall Study|Transitioned to OLE study|73|||
130231624|NCT03054428|468813577|FG000|Overall Study|Withdrawal by Subject|3|||
130231625|NCT03054428|468813578|FG001|Overall Study|Withdrawal by Subject|2|||
130231626|NCT03054428|468813579|FG002|Overall Study|Withdrawal by Subject|3|||
130231627|NCT03054428|468813577|FG000|Overall Study|Lost to Follow-up|0|||
130231628|NCT03054428|468813578|FG001|Overall Study|Lost to Follow-up|0|||
130231629|NCT03054428|468813579|FG002|Overall Study|Lost to Follow-up|1|||
130099895|NCT03222856|468322822|FG000|Overall Study|Adverse Event|6|||
130231630|NCT03092752|468813580|FG000|Overall Study|Aged <40 years|14209|||
130231631|NCT03092752|468813580|FG000|Overall Study|At least one claim with T2DM|61299|||
130231632|NCT03092752|468813580|FG000|Overall Study|Having no claim of study drugs|29282|||
130231633|NCT03092752|468813580|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
130099896|NCT03222856|468322822|FG000|Overall Study|Death|1|||
130231634|NCT03092752|468813580|FG000|Overall Study|<6 month history|245900|||
130231635|NCT01499810|468813588|FG000|Overall Study|Lost to Follow-up|10|||
130231636|NCT01499810|468813588|FG000|Overall Study|Protocol Violation|1|||
130231637|NCT01499810|468813588|FG000|Overall Study|Withdrawal by Subject|1|||
130231638|NCT01884597|468813589|FG000|Overall Study|Adverse Event|0|||
130231639|NCT01884597|468813590|FG001|Overall Study|Adverse Event|0|||
130024702|NCT03434379|468050450|FG003|Global Period|Lost to Follow-up|0|||
130024703|NCT03434379|468050447|FG000|Global Period|Death|115|||
130024704|NCT03434379|468050448|FG001|Global Period|Death|228|||
130024705|NCT03434379|468050449|FG002|Global Period|Death|0|||
130024706|NCT03434379|468050450|FG003|Global Period|Death|0|||
130024707|NCT03434379|468050447|FG000|Global Period|Withdrawal by Subject|20|||
130024708|NCT03434379|468050448|FG001|Global Period|Withdrawal by Subject|21|||
130024709|NCT03434379|468050449|FG002|Global Period|Withdrawal by Subject|0|||
130024710|NCT03434379|468050450|FG003|Global Period|Withdrawal by Subject|0|||
130024711|NCT03434379|468050447|FG000|Global Period|Reason Unspecified|0|||
130024712|NCT03434379|468050448|FG001|Global Period|Reason Unspecified|1|||
130024713|NCT03434379|468050449|FG002|Global Period|Reason Unspecified|0|||
130024714|NCT03434379|468050450|FG003|Global Period|Reason Unspecified|0|||
130024715|NCT03434379|468050447|FG000|Global Period|Study Ended by Sponsor|26|||
130024716|NCT03434379|468050448|FG001|Global Period|Study Ended by Sponsor|80|||
130024717|NCT03434379|468050449|FG002|Global Period|Study Ended by Sponsor|0|||
130024718|NCT03434379|468050450|FG003|Global Period|Study Ended by Sponsor|0|||
130024719|NCT03434379|468050447|FG000|Global Period|Physician Decision|1|||
130024720|NCT03434379|468050448|FG001|Global Period|Physician Decision|0|||
130024721|NCT03434379|468050449|FG002|Global Period|Physician Decision|0|||
130024722|NCT03434379|468050450|FG003|Global Period|Physician Decision|0|||
130024723|NCT03434379|468050447|FG000|China Extension Period|Lost to Follow-up|0|||
130024724|NCT03434379|468050448|FG001|China Extension Period|Lost to Follow-up|0|||
130024725|NCT03434379|468050449|FG002|China Extension Period|Lost to Follow-up|2|||
130024726|NCT03434379|468050450|FG003|China Extension Period|Lost to Follow-up|3|||
130024727|NCT03434379|468050447|FG000|China Extension Period|Death|0|||
130024728|NCT03434379|468050448|FG001|China Extension Period|Death|0|||
130024729|NCT03434379|468050449|FG002|China Extension Period|Death|46|||
130024730|NCT03434379|468050450|FG003|China Extension Period|Death|88|||
130024731|NCT03434379|468050447|FG000|China Extension Period|Withdrawal by Subject|0|||
130024732|NCT03434379|468050448|FG001|China Extension Period|Withdrawal by Subject|0|||
130024733|NCT03434379|468050449|FG002|China Extension Period|Withdrawal by Subject|8|||
130024734|NCT03434379|468050450|FG003|China Extension Period|Withdrawal by Subject|6|||
130024735|NCT03434379|468050447|FG000|China Extension Period|Study Ended by Sponsor|0|||
130024736|NCT03434379|468050448|FG001|China Extension Period|Study Ended by Sponsor|0|||
130024737|NCT03434379|468050449|FG002|China Extension Period|Study Ended by Sponsor|5|||
130024738|NCT03434379|468050450|FG003|China Extension Period|Study Ended by Sponsor|36|||
130024739|NCT02026063|468050453|FG000|Overall Study|Physician Decision|0|||
130024740|NCT02026063|468050454|FG001|Overall Study|Physician Decision|10|||
130024741|NCT02026063|468050453|FG000|Overall Study|Noncompliance with Study Drug|1|||
130024742|NCT02026063|468050454|FG001|Overall Study|Noncompliance with Study Drug|1|||
130024743|NCT02026063|468050453|FG000|Overall Study|Withdrawal of Consent|1|||
130024744|NCT02026063|468050454|FG001|Overall Study|Withdrawal of Consent|6|||
130024745|NCT02026063|468050453|FG000|Overall Study|Adverse Event|5|||
130024746|NCT02026063|468050454|FG001|Overall Study|Adverse Event|20|||
130024747|NCT02026063|468050453|FG000|Overall Study|Lack of Efficacy|0|||
130024748|NCT02026063|468050454|FG001|Overall Study|Lack of Efficacy|4|||
130024749|NCT02026063|468050453|FG000|Overall Study|Lost to Follow-up|0|||
130024750|NCT02026063|468050454|FG001|Overall Study|Lost to Follow-up|1|||
130024751|NCT02026063|468050453|FG000|Overall Study|Reason not Specified|2|||
130024752|NCT02026063|468050454|FG001|Overall Study|Reason not Specified|7|||
130024753|NCT02154087|468050455|FG000|Overall Study|Study Termination|1|||
130024754|NCT01116544|468050457|FG000|Overall Study|Protocol Violation|1|||
130024755|NCT01116544|468050458|FG001|Overall Study|Protocol Violation|0|||
130024756|NCT01116544|468050457|FG000|Overall Study|Withdrawal by Subject|1|||
130024757|NCT01116544|468050458|FG001|Overall Study|Withdrawal by Subject|1|||
130024758|NCT00486278|468050459|FG000|Overall Study|Adverse Event|5|||
130024759|NCT00486278|468050459|FG000|Overall Study|Withdrawal by Subject|2|||
130024760|NCT00486278|468050459|FG000|Overall Study|Physician Decision|2|||
130024761|NCT04556617|468050464|FG000|Overall Study|progressive disease|0|||
130024762|NCT04556617|468050465|FG001|Overall Study|progressive disease|2|||
130024763|NCT04556617|468050466|FG002|Overall Study|progressive disease|2|||
130024764|NCT04556617|468050467|FG003|Overall Study|progressive disease|1|||
130024765|NCT04556617|468050468|FG004|Overall Study|progressive disease|1|||
130024766|NCT04556617|468050464|FG000|Overall Study|Physician Decision|0|||
130024767|NCT04556617|468050465|FG001|Overall Study|Physician Decision|0|||
130024768|NCT04556617|468050466|FG002|Overall Study|Physician Decision|2|||
130024769|NCT04556617|468050467|FG003|Overall Study|Physician Decision|0|||
130024770|NCT04556617|468050468|FG004|Overall Study|Physician Decision|0|||
130024771|NCT04556617|468050464|FG000|Overall Study|Adverse Event|0|||
130024772|NCT04556617|468050465|FG001|Overall Study|Adverse Event|0|||
130231640|NCT01884597|468813591|FG002|Overall Study|Adverse Event|1|||
130231641|NCT01884597|468813589|FG000|Overall Study|Lack of Efficacy|1|||
130231642|NCT01884597|468813590|FG001|Overall Study|Lack of Efficacy|0|||
130231643|NCT01884597|468813591|FG002|Overall Study|Lack of Efficacy|0|||
130231644|NCT01884597|468813589|FG000|Overall Study|Death|0|||
130231645|NCT01884597|468813590|FG001|Overall Study|Death|1|||
130231646|NCT01884597|468813591|FG002|Overall Study|Death|0|||
130231647|NCT01093846|468813592|FG000|Overall Study|Adverse Event|0|||
130231648|NCT01093846|468813593|FG001|Overall Study|Adverse Event|0|||
130231649|NCT01093846|468813594|FG002|Overall Study|Adverse Event|1|||
130231650|NCT01093846|468813592|FG000|Overall Study|Lack of Efficacy|0|||
130231651|NCT01093846|468813593|FG001|Overall Study|Lack of Efficacy|0|||
130231652|NCT01093846|468813594|FG002|Overall Study|Lack of Efficacy|4|||
130231653|NCT01093846|468813592|FG000|Overall Study|Condition no longer required study drug|1|||
130231654|NCT01093846|468813593|FG001|Overall Study|Condition no longer required study drug|1|||
130231655|NCT01093846|468813594|FG002|Overall Study|Condition no longer required study drug|1|||
130231656|NCT01093846|468813592|FG000|Overall Study|Administrative Problems|18|||
130231657|NCT01093846|468813593|FG001|Overall Study|Administrative Problems|17|||
130231658|NCT01093846|468813594|FG002|Overall Study|Administrative Problems|15|||
130231659|NCT03082729|468813595|FG000|Overall Study|Lost to Follow-up|7|||
130231660|NCT03082729|468813595|FG000|Overall Study|Physician Decision|2|||
130231661|NCT03082729|468813595|FG000|Overall Study|Withdrawal by Subject|1|||
130231662|NCT03082729|468813595|FG000|Overall Study|Lack of Efficacy|9|||
130231663|NCT03082729|468813595|FG000|Overall Study|Adverse Event|4|||
130231664|NCT03082729|468813595|FG000|Overall Study|Protocol Violation|6|||
130231665|NCT03082729|468813595|FG000|Overall Study|Fear of study procedure|1|||
130231666|NCT03082729|468813595|FG000|Overall Study|Scheduling conflict|1|||
130231667|NCT03321721|468813598|FG000|Overall Study|Lost to Follow-up|4|||
130231668|NCT03321721|468813599|FG001|Overall Study|Lost to Follow-up|8|||
130231669|NCT03321721|468813600|FG002|Overall Study|Lost to Follow-up|11|||
130231670|NCT00666237|468813601|FG000|Overall Study|Death|5|||
130231671|NCT00666237|468813602|FG001|Overall Study|Death|5|||
130231672|NCT00666237|468813601|FG000|Overall Study|Lost to Follow-up|29|||
130231673|NCT00666237|468813602|FG001|Overall Study|Lost to Follow-up|25|||
130231674|NCT01416571|468813603|FG000|Overall Study|Lost to Follow-up|2|||
130231675|NCT03353220|468813604|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
130231676|NCT03353220|468813605|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
130231677|NCT01673386|468815429|FG000|Overall Study|Study terminated by sponsor|16|||
130231678|NCT01673386|468815430|FG001|Overall Study|Study terminated by sponsor|22|||
130231679|NCT01673386|468815429|FG000|Overall Study|Adverse Event|5|||
130231680|NCT01673386|468815430|FG001|Overall Study|Adverse Event|2|||
130231681|NCT01673386|468815429|FG000|Overall Study|Progressive disease|4|||
130231682|NCT01673386|468815430|FG001|Overall Study|Progressive disease|1|||
130231683|NCT01673386|468815429|FG000|Overall Study|Withdrawal by Subject|0|||
130231684|NCT01673386|468815430|FG001|Overall Study|Withdrawal by Subject|2|||
130231685|NCT00336544|468815434|FG000|Overall Study|Lack of Efficacy|8|||
130231686|NCT00336544|468815435|FG001|Overall Study|Lack of Efficacy|5|||
130231687|NCT00336544|468815434|FG000|Overall Study|Adverse Event|4|||
130231688|NCT00336544|468815435|FG001|Overall Study|Adverse Event|9|||
130231689|NCT00336544|468815434|FG000|Overall Study|Withdrawal by Subject|4|||
130231690|NCT00336544|468815435|FG001|Overall Study|Withdrawal by Subject|3|||
130231691|NCT00336544|468815434|FG000|Overall Study|Other|3|||
130231692|NCT00336544|468815435|FG001|Overall Study|Other|5|||
130231693|NCT01649765|468815436|FG000|Overall Study|Adverse Event|5|||
130231694|NCT01649765|468815437|FG001|Overall Study|Adverse Event|3|||
130231695|NCT01649765|468815436|FG000|Overall Study|Lack of Efficacy|1|||
130231696|NCT01649765|468815437|FG001|Overall Study|Lack of Efficacy|1|||
130231697|NCT01649765|468815436|FG000|Overall Study|Physician Decision|0|||
130231698|NCT01649765|468815437|FG001|Overall Study|Physician Decision|3|||
130231699|NCT01649765|468815436|FG000|Overall Study|Protocol Violation|1|||
130231700|NCT01649765|468815437|FG001|Overall Study|Protocol Violation|0|||
130231701|NCT01649765|468815436|FG000|Overall Study|Withdrawal by Subject|2|||
130231702|NCT01649765|468815437|FG001|Overall Study|Withdrawal by Subject|1|||
130231703|NCT01648764|468815438|FG000|Overall Study|Progressive Disease|0|||
130231704|NCT01648764|468815439|FG001|Overall Study|Progressive Disease|1|||
130231705|NCT01648764|468815440|FG002|Overall Study|Progressive Disease|0|||
130231706|NCT01648764|468815441|FG003|Overall Study|Progressive Disease|0|||
130231707|NCT01648764|468815442|FG004|Overall Study|Progressive Disease|0|||
130231708|NCT01648764|468815443|FG005|Overall Study|Progressive Disease|1|||
130231709|NCT01648764|468815444|FG006|Overall Study|Progressive Disease|1|||
130231710|NCT01648764|468815445|FG007|Overall Study|Progressive Disease|0|||
130231711|NCT01648764|468815446|FG008|Overall Study|Progressive Disease|0|||
130231712|NCT01648764|468815447|FG009|Overall Study|Progressive Disease|2|||
130231713|NCT01648764|468815448|FG010|Overall Study|Progressive Disease|0|||
130231714|NCT01648764|468815449|FG011|Overall Study|Progressive Disease|1|||
130231715|NCT01648764|468815450|FG012|Overall Study|Progressive Disease|2|||
130231716|NCT01648764|468815451|FG013|Overall Study|Progressive Disease|1|||
130024773|NCT04556617|468050466|FG002|Overall Study|Adverse Event|2|||
130024774|NCT04556617|468050467|FG003|Overall Study|Adverse Event|3|||
130024775|NCT04556617|468050468|FG004|Overall Study|Adverse Event|0|||
130024776|NCT04556617|468050464|FG000|Overall Study|Withdrawal by Subject|0|||
130024777|NCT04556617|468050465|FG001|Overall Study|Withdrawal by Subject|2|||
130024778|NCT04556617|468050466|FG002|Overall Study|Withdrawal by Subject|1|||
130024779|NCT04556617|468050467|FG003|Overall Study|Withdrawal by Subject|1|||
130024780|NCT04556617|468050468|FG004|Overall Study|Withdrawal by Subject|0|||
130024781|NCT04556617|468050464|FG000|Overall Study|PSA increase|0|||
130024782|NCT04556617|468050465|FG001|Overall Study|PSA increase|1|||
130024783|NCT04556617|468050466|FG002|Overall Study|PSA increase|0|||
130024784|NCT04556617|468050467|FG003|Overall Study|PSA increase|0|||
130024785|NCT04556617|468050468|FG004|Overall Study|PSA increase|0|||
130024786|NCT04556617|468050464|FG000|Overall Study|Sponsor study termination|1|||
130024787|NCT04556617|468050465|FG001|Overall Study|Sponsor study termination|0|||
130024788|NCT04556617|468050466|FG002|Overall Study|Sponsor study termination|0|||
130024789|NCT04556617|468050467|FG003|Overall Study|Sponsor study termination|0|||
130024790|NCT04556617|468050468|FG004|Overall Study|Sponsor study termination|0|||
130024791|NCT04949841|468050469|FG000|Overall Study|Adverse Event|7|||
130024792|NCT04949841|468050469|FG000|Overall Study|Death|1|||
130024793|NCT04949841|468050469|FG000|Overall Study|Withdrawal by Subject|52|||
130024794|NCT04949841|468050469|FG000|Overall Study|Pregnancy|4|||
130024795|NCT04949841|468050469|FG000|Overall Study|Lost to Follow-up|9|||
130024796|NCT04949841|468050469|FG000|Overall Study|Lack of Efficacy|55|||
130024797|NCT04949841|468050469|FG000|Overall Study|Various reasons|9|||
130024798|NCT03179436|468050470|FG000|Overall Study|Withdrawal by Subject|1|||
130024799|NCT03179436|468050471|FG001|Overall Study|Withdrawal by Subject|0|||
130024800|NCT03179436|468050472|FG002|Overall Study|Withdrawal by Subject|0|||
130024801|NCT03179436|468050473|FG003|Overall Study|Withdrawal by Subject|4|||
130024802|NCT03179436|468050474|FG004|Overall Study|Withdrawal by Subject|2|||
130024803|NCT03179436|468050475|FG005|Overall Study|Withdrawal by Subject|2|||
130024804|NCT03179436|468050476|FG006|Overall Study|Withdrawal by Subject|5|||
130024805|NCT03179436|468050477|FG007|Overall Study|Withdrawal by Subject|0|||
130024806|NCT03179436|468050478|FG008|Overall Study|Withdrawal by Subject|3|||
130024807|NCT03179436|468050479|FG009|Overall Study|Withdrawal by Subject|0|||
130024808|NCT03179436|468050480|FG010|Overall Study|Withdrawal by Subject|0|||
130024809|NCT03179436|468050481|FG011|Overall Study|Withdrawal by Subject|0|||
130024810|NCT03179436|468050470|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130024811|NCT03179436|468050471|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130024812|NCT03179436|468050472|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130024813|NCT03179436|468050473|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130024814|NCT03179436|468050474|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130024815|NCT03179436|468050475|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130024816|NCT03179436|468050476|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130024817|NCT03179436|468050477|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
130024818|NCT03179436|468050478|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
130024819|NCT03179436|468050479|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
130024820|NCT03179436|468050480|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
130024821|NCT03179436|468050481|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
130024822|NCT03179436|468050470|FG000|Overall Study|Sponsor Decision|0|||
130024823|NCT03179436|468050471|FG001|Overall Study|Sponsor Decision|0|||
130024824|NCT03179436|468050472|FG002|Overall Study|Sponsor Decision|1|||
130024825|NCT03179436|468050473|FG003|Overall Study|Sponsor Decision|3|||
130024826|NCT03179436|468050474|FG004|Overall Study|Sponsor Decision|9|||
130024827|NCT03179436|468050475|FG005|Overall Study|Sponsor Decision|7|||
130024828|NCT03179436|468050476|FG006|Overall Study|Sponsor Decision|2|||
130231717|NCT01648764|468815438|FG000|Overall Study|Adverse Event|0|||
130231718|NCT01648764|468815439|FG001|Overall Study|Adverse Event|0|||
130024829|NCT03179436|468050477|FG007|Overall Study|Sponsor Decision|4|||
130024830|NCT03179436|468050478|FG008|Overall Study|Sponsor Decision|23|||
130024831|NCT03179436|468050479|FG009|Overall Study|Sponsor Decision|6|||
130231719|NCT01648764|468815440|FG002|Overall Study|Adverse Event|0|||
130024832|NCT03179436|468050480|FG010|Overall Study|Sponsor Decision|7|||
130024833|NCT03179436|468050481|FG011|Overall Study|Sponsor Decision|5|||
130024834|NCT03179436|468050470|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024835|NCT03179436|468050471|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
130024836|NCT03179436|468050472|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024837|NCT03179436|468050473|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024838|NCT03179436|468050474|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
130231720|NCT01648764|468815441|FG003|Overall Study|Adverse Event|0|||
130231721|NCT01648764|468815442|FG004|Overall Study|Adverse Event|0|||
130231722|NCT01648764|468815443|FG005|Overall Study|Adverse Event|1|||
130231723|NCT01648764|468815444|FG006|Overall Study|Adverse Event|0|||
130231724|NCT01648764|468815445|FG007|Overall Study|Adverse Event|0|||
130231725|NCT01648764|468815446|FG008|Overall Study|Adverse Event|0|||
130231726|NCT01648764|468815447|FG009|Overall Study|Adverse Event|1|||
130231727|NCT01648764|468815448|FG010|Overall Study|Adverse Event|0|||
130231728|NCT01648764|468815449|FG011|Overall Study|Adverse Event|3|||
130231729|NCT01648764|468815450|FG012|Overall Study|Adverse Event|1|||
130231730|NCT01648764|468815451|FG013|Overall Study|Adverse Event|1|||
130231731|NCT01648764|468815438|FG000|Overall Study|Death|0|||
130231732|NCT01648764|468815439|FG001|Overall Study|Death|0|||
130231733|NCT01648764|468815440|FG002|Overall Study|Death|0|||
130231734|NCT01648764|468815441|FG003|Overall Study|Death|0|||
130231735|NCT01648764|468815442|FG004|Overall Study|Death|0|||
130231736|NCT01648764|468815443|FG005|Overall Study|Death|0|||
130231737|NCT01648764|468815444|FG006|Overall Study|Death|1|||
130231738|NCT01648764|468815445|FG007|Overall Study|Death|0|||
130231739|NCT01648764|468815446|FG008|Overall Study|Death|0|||
130231740|NCT01648764|468815447|FG009|Overall Study|Death|0|||
130231741|NCT01648764|468815448|FG010|Overall Study|Death|0|||
130231742|NCT01648764|468815449|FG011|Overall Study|Death|0|||
130231743|NCT01648764|468815450|FG012|Overall Study|Death|0|||
130231744|NCT01648764|468815451|FG013|Overall Study|Death|1|||
130231745|NCT01648764|468815438|FG000|Overall Study|Withdrawal by Subject|0|||
130231746|NCT01648764|468815439|FG001|Overall Study|Withdrawal by Subject|0|||
130231747|NCT01648764|468815440|FG002|Overall Study|Withdrawal by Subject|0|||
130231748|NCT01648764|468815441|FG003|Overall Study|Withdrawal by Subject|0|||
130231749|NCT01648764|468815442|FG004|Overall Study|Withdrawal by Subject|0|||
130231750|NCT01648764|468815443|FG005|Overall Study|Withdrawal by Subject|0|||
130231751|NCT01648764|468815444|FG006|Overall Study|Withdrawal by Subject|2|||
130231752|NCT01648764|468815445|FG007|Overall Study|Withdrawal by Subject|0|||
130231753|NCT01648764|468815446|FG008|Overall Study|Withdrawal by Subject|0|||
130231754|NCT01648764|468815447|FG009|Overall Study|Withdrawal by Subject|0|||
130231755|NCT01648764|468815448|FG010|Overall Study|Withdrawal by Subject|0|||
130231756|NCT01648764|468815449|FG011|Overall Study|Withdrawal by Subject|0|||
130231757|NCT01648764|468815450|FG012|Overall Study|Withdrawal by Subject|1|||
130231758|NCT01648764|468815451|FG013|Overall Study|Withdrawal by Subject|0|||
130231759|NCT01648764|468815438|FG000|Overall Study|Investigator Decision|0|||
130231760|NCT01648764|468815439|FG001|Overall Study|Investigator Decision|0|||
130231761|NCT01648764|468815440|FG002|Overall Study|Investigator Decision|0|||
130231762|NCT01648764|468815441|FG003|Overall Study|Investigator Decision|0|||
130231763|NCT01648764|468815442|FG004|Overall Study|Investigator Decision|0|||
130231764|NCT01648764|468815443|FG005|Overall Study|Investigator Decision|0|||
130231765|NCT01648764|468815444|FG006|Overall Study|Investigator Decision|1|||
130231766|NCT01648764|468815445|FG007|Overall Study|Investigator Decision|0|||
130231767|NCT01648764|468815446|FG008|Overall Study|Investigator Decision|0|||
130231768|NCT01648764|468815447|FG009|Overall Study|Investigator Decision|0|||
130231769|NCT01648764|468815448|FG010|Overall Study|Investigator Decision|0|||
130231770|NCT01648764|468815449|FG011|Overall Study|Investigator Decision|1|||
130231771|NCT01648764|468815450|FG012|Overall Study|Investigator Decision|0|||
130231772|NCT01648764|468815451|FG013|Overall Study|Investigator Decision|0|||
130231773|NCT00715208|468815452|FG000|Overall Study|Withdrawal by Subject|1|||
130231774|NCT00715208|468815453|FG001|Overall Study|Withdrawal by Subject|1|||
130231775|NCT00715208|468815452|FG000|Overall Study|Adverse Event|0|||
130231776|NCT00715208|468815453|FG001|Overall Study|Adverse Event|6|||
130231777|NCT00715208|468815452|FG000|Overall Study|Lack of Efficacy|0|||
130231778|NCT00715208|468815453|FG001|Overall Study|Lack of Efficacy|2|||
130231779|NCT01715831|468815454|FG000|Overall Study|Adverse Event|1|||
130231780|NCT00316004|468815455|FG000|Overall Study|Subject was not given study fluid.|14|||
130231781|NCT00316004|468815456|FG001|Overall Study|Subject was not given study fluid.|14|||
130231782|NCT00316004|468815457|FG002|Overall Study|Subject was not given study fluid.|21|||
130231783|NCT01118299|468815460|FG000|Overall Study|Death|7|||
130231784|NCT01118299|468815461|FG001|Overall Study|Death|5|||
130231785|NCT01118299|468815460|FG000|Overall Study|Withdrawal by Subject|8|||
130231786|NCT01118299|468815461|FG001|Overall Study|Withdrawal by Subject|8|||
130231787|NCT01118299|468815460|FG000|Overall Study|Lost to Follow-up|2|||
130231788|NCT01118299|468815461|FG001|Overall Study|Lost to Follow-up|1|||
130231789|NCT01118299|468815460|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
130231790|NCT01118299|468815461|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
130231791|NCT00784875|468815462|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
130231792|NCT00784875|468815463|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
130231793|NCT00784875|468815464|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
130231794|NCT00784875|468815465|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
130231795|NCT00784875|468815462|FG000|Period A - Baseline|Adverse Event|0|||
130231796|NCT00784875|468815463|FG001|Period A - Baseline|Adverse Event|0|||
130231797|NCT00784875|468815464|FG002|Period A - Baseline|Adverse Event|0|||
130231798|NCT00784875|468815465|FG003|Period A - Baseline|Adverse Event|8|||
130024839|NCT03179436|468050475|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
130231799|NCT00784875|468815462|FG000|Period A - Baseline|Protocol Violation|0|||
130231800|NCT00784875|468815463|FG001|Period A - Baseline|Protocol Violation|0|||
130231801|NCT00784875|468815464|FG002|Period A - Baseline|Protocol Violation|0|||
130231802|NCT00784875|468815465|FG003|Period A - Baseline|Protocol Violation|25|||
130231803|NCT00784875|468815462|FG000|Period A - Baseline|Withdrawal by Subject|0|||
130231804|NCT00784875|468815463|FG001|Period A - Baseline|Withdrawal by Subject|0|||
130231805|NCT00784875|468815464|FG002|Period A - Baseline|Withdrawal by Subject|0|||
130231806|NCT00784875|468815465|FG003|Period A - Baseline|Withdrawal by Subject|27|||
130231807|NCT00784875|468815462|FG000|Period A - Baseline|Physician Decision|0|||
130231808|NCT00784875|468815463|FG001|Period A - Baseline|Physician Decision|0|||
130231809|NCT00784875|468815464|FG002|Period A - Baseline|Physician Decision|0|||
130231810|NCT00784875|468815465|FG003|Period A - Baseline|Physician Decision|2|||
130231811|NCT00784875|468815462|FG000|Period A - Baseline|Sponsor Decision|0|||
130231812|NCT00784875|468815463|FG001|Period A - Baseline|Sponsor Decision|0|||
130231813|NCT00784875|468815464|FG002|Period A - Baseline|Sponsor Decision|0|||
130231814|NCT00784875|468815465|FG003|Period A - Baseline|Sponsor Decision|113|||
130231815|NCT00784875|468815462|FG000|Period A - Baseline|Lost to Follow-up|0|||
130231816|NCT00784875|468815463|FG001|Period A - Baseline|Lost to Follow-up|0|||
130231817|NCT00784875|468815464|FG002|Period A - Baseline|Lost to Follow-up|0|||
130231818|NCT00784875|468815465|FG003|Period A - Baseline|Lost to Follow-up|2|||
130231819|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
130231820|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
130231821|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
130231822|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
130231823|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
130231824|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
130231825|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
130231826|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
130231827|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
130231828|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
130231829|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
130231830|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
130231831|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130231832|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
130231833|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130024840|NCT03179436|468050476|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024841|NCT03179436|468050477|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024842|NCT03179436|468050478|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024843|NCT03179436|468050479|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024844|NCT03179436|468050480|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024845|NCT03179436|468050481|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
130024846|NCT03179436|468050470|FG000|Overall Study|Lost to Follow-up|1|||
130024847|NCT03179436|468050471|FG001|Overall Study|Lost to Follow-up|0|||
130024848|NCT03179436|468050472|FG002|Overall Study|Lost to Follow-up|0|||
130024849|NCT03179436|468050473|FG003|Overall Study|Lost to Follow-up|1|||
130024850|NCT03179436|468050474|FG004|Overall Study|Lost to Follow-up|0|||
130024851|NCT03179436|468050475|FG005|Overall Study|Lost to Follow-up|1|||
130231834|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
130231835|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
130231836|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
130024852|NCT03179436|468050476|FG006|Overall Study|Lost to Follow-up|0|||
130024853|NCT03179436|468050477|FG007|Overall Study|Lost to Follow-up|0|||
130231837|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
130099897|NCT01721369|468322823|FG000|Overall Study|Not initial etiological diagnosis|12|||
130024854|NCT03179436|468050478|FG008|Overall Study|Lost to Follow-up|1|||
130231838|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
130231839|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
130231840|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
130231841|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
130231842|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
130231843|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
130231844|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
130231845|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
130231846|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
130231847|NCT00784875|468815462|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130231848|NCT00784875|468815463|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130231849|NCT00784875|468815464|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
130231850|NCT00784875|468815465|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
130231851|NCT00784875|468815462|FG000|Period C|Adverse Event|1|||
130231852|NCT00784875|468815463|FG001|Period C|Adverse Event|0|||
130231853|NCT00784875|468815464|FG002|Period C|Adverse Event|4|||
130231854|NCT00784875|468815465|FG003|Period C|Adverse Event|2|||
130231855|NCT00784875|468815462|FG000|Period C|Protocol Violation|0|||
130231856|NCT00784875|468815463|FG001|Period C|Protocol Violation|0|||
130231857|NCT00784875|468815464|FG002|Period C|Protocol Violation|1|||
130231858|NCT00784875|468815465|FG003|Period C|Protocol Violation|2|||
130231859|NCT00784875|468815462|FG000|Period C|Lack of Efficacy|0|||
130231860|NCT00784875|468815463|FG001|Period C|Lack of Efficacy|0|||
130231861|NCT00784875|468815464|FG002|Period C|Lack of Efficacy|1|||
130231862|NCT00784875|468815465|FG003|Period C|Lack of Efficacy|0|||
130231863|NCT00784875|468815462|FG000|Period C|Withdrawal by Subject|1|||
130231864|NCT00784875|468815463|FG001|Period C|Withdrawal by Subject|1|||
130231865|NCT00784875|468815464|FG002|Period C|Withdrawal by Subject|2|||
130231866|NCT00784875|468815465|FG003|Period C|Withdrawal by Subject|0|||
130231867|NCT00784875|468815462|FG000|Period C|Physician Decision|0|||
130231868|NCT00784875|468815463|FG001|Period C|Physician Decision|0|||
130231869|NCT00784875|468815464|FG002|Period C|Physician Decision|1|||
130231870|NCT00784875|468815465|FG003|Period C|Physician Decision|1|||
130231871|NCT00784875|468815462|FG000|Period C|Sponsor Decision|5|||
130024855|NCT03179436|468050479|FG009|Overall Study|Lost to Follow-up|1|||
130024856|NCT03179436|468050480|FG010|Overall Study|Lost to Follow-up|0|||
130231872|NCT00784875|468815463|FG001|Period C|Sponsor Decision|5|||
130231873|NCT00784875|468815464|FG002|Period C|Sponsor Decision|4|||
130231874|NCT00784875|468815465|FG003|Period C|Sponsor Decision|2|||
130231875|NCT00784875|468815462|FG000|Period D|Adverse Event|0|||
130231876|NCT00784875|468815463|FG001|Period D|Adverse Event|2|||
130024857|NCT03179436|468050481|FG011|Overall Study|Lost to Follow-up|0|||
130231877|NCT00784875|468815464|FG002|Period D|Adverse Event|2|||
130231878|NCT00784875|468815465|FG003|Period D|Adverse Event|0|||
130231879|NCT00784875|468815462|FG000|Period D|Protocol Violation|1|||
130231880|NCT00784875|468815463|FG001|Period D|Protocol Violation|0|||
130231881|NCT00784875|468815464|FG002|Period D|Protocol Violation|0|||
130231882|NCT00784875|468815465|FG003|Period D|Protocol Violation|0|||
130231883|NCT00784875|468815462|FG000|Period D|Withdrawal by Subject|2|||
130231884|NCT00784875|468815463|FG001|Period D|Withdrawal by Subject|0|||
130231885|NCT00784875|468815464|FG002|Period D|Withdrawal by Subject|2|||
130231886|NCT00784875|468815465|FG003|Period D|Withdrawal by Subject|0|||
130231887|NCT00784875|468815462|FG000|Period D|Physician Decision|0|||
130231888|NCT00784875|468815463|FG001|Period D|Physician Decision|1|||
130231889|NCT00784875|468815464|FG002|Period D|Physician Decision|0|||
130231890|NCT00784875|468815465|FG003|Period D|Physician Decision|0|||
130231891|NCT00784875|468815462|FG000|Period D|Sponsor Decision|1|||
130231892|NCT00784875|468815463|FG001|Period D|Sponsor Decision|1|||
130231893|NCT00784875|468815464|FG002|Period D|Sponsor Decision|1|||
130231894|NCT00784875|468815465|FG003|Period D|Sponsor Decision|0|||
130231895|NCT00784875|468815462|FG000|Period D|Lost to Follow-up|1|||
130231896|NCT00784875|468815463|FG001|Period D|Lost to Follow-up|0|||
130231897|NCT00784875|468815464|FG002|Period D|Lost to Follow-up|1|||
130231898|NCT00784875|468815465|FG003|Period D|Lost to Follow-up|1|||
130231899|NCT01829347|468815468|FG000|VTI-210|Death|5|||
130231900|NCT01829347|468815469|FG001|VTI-210|Death|3|||
130231901|NCT01829347|468815468|FG000|VTI-210|Withdrawal by Subject|1|||
130231902|NCT01829347|468815469|FG001|VTI-210|Withdrawal by Subject|0|||
130231903|NCT01829347|468815468|FG000|VTI-210E|Death|2|||
130231904|NCT01829347|468815469|FG001|VTI-210E|Death|1|||
130231905|NCT01829347|468815468|FG000|VTI-210E|Study terminated prematurely|1|||
130231906|NCT01829347|468815469|FG001|VTI-210E|Study terminated prematurely|5|||
130231907|NCT04018066|468815470|FG000|Overall Study|participants started taking medications during the study period|3|||
130231908|NCT04018066|468815470|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
130231909|NCT01027949|468815471|FG000|Overall Study|Death|174|||
130231910|NCT01027949|468815471|FG000|Overall Study|Progressive Disease|163|||
130231911|NCT01027949|468815471|FG000|Overall Study|Adverse Event|172|||
130231912|NCT01027949|468815471|FG000|Overall Study|Withdrawal by Subject|113|||
130231913|NCT01027949|468815471|FG000|Overall Study|Lost to Follow-up|17|||
130231914|NCT01027949|468815471|FG000|Overall Study|Protocol Violation|13|||
130231915|NCT01027949|468815471|FG000|Overall Study|PI Decision|8|||
130231916|NCT01027949|468815471|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
130231917|NCT01027949|468815471|FG000|Overall Study|Non-compliance with Study Procedures|7|||
130231918|NCT01027949|468815471|FG000|Overall Study|Lung Transplant|5|||
130231919|NCT01027949|468815471|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
130231920|NCT01027949|468815471|FG000|Overall Study|Use of Excluded Medication|2|||
130231921|NCT01027949|468815471|FG000|Overall Study|Patient Self-discontinuation|1|||
130231922|NCT01027949|468815471|FG000|Overall Study|Pregnancy|1|||
130231923|NCT01027949|468815471|FG000|Overall Study|Surgery|1|||
130231924|NCT02152007|468815483|FG000|Overall Study|Withdrawal by Subject|1|||
130231925|NCT00706797|468815486|FG000|Overall Study|Lack of Efficacy|3|||
130231926|NCT00706797|468815487|FG001|Overall Study|Lack of Efficacy|0|||
130231927|NCT00706797|468815486|FG000|Overall Study|Adverse Event|0|||
130231928|NCT00706797|468815487|FG001|Overall Study|Adverse Event|3|||
130231929|NCT00706797|468815486|FG000|Overall Study|Withdrawal by Subject|8|||
130231930|NCT00706797|468815487|FG001|Overall Study|Withdrawal by Subject|1|||
130231931|NCT00706797|468815486|FG000|Overall Study|Death|1|||
130231932|NCT00706797|468815487|FG001|Overall Study|Death|0|||
130231933|NCT00706797|468815486|FG000|Overall Study|Discontinuation of study by sponsor|52|||
130231934|NCT00706797|468815487|FG001|Overall Study|Discontinuation of study by sponsor|63|||
130231935|NCT00706797|468815486|FG000|Overall Study|Protocol Violation|3|||
130231936|NCT00706797|468815487|FG001|Overall Study|Protocol Violation|2|||
130231937|NCT00706797|468815486|FG000|Overall Study|Lost to Follow-up|1|||
130231938|NCT00706797|468815487|FG001|Overall Study|Lost to Follow-up|2|||
130231939|NCT00706797|468815486|FG000|Overall Study|Other|1|||
130231940|NCT00706797|468815487|FG001|Overall Study|Other|0|||
130231941|NCT02309359|468815490|FG000|Overall Study|Adverse Event|4|||
130231942|NCT02309359|468815491|FG001|Overall Study|Adverse Event|5|||
130231943|NCT02309359|468815492|FG002|Overall Study|Adverse Event|5|||
130231944|NCT02309359|468815493|FG003|Overall Study|Adverse Event|4|||
130231945|NCT02309359|468815494|FG004|Overall Study|Adverse Event|4|||
130231946|NCT02309359|468815490|FG000|Overall Study|Death|1|||
130231947|NCT02309359|468815491|FG001|Overall Study|Death|0|||
130231948|NCT02309359|468815492|FG002|Overall Study|Death|0|||
130231949|NCT02309359|468815493|FG003|Overall Study|Death|0|||
130231950|NCT02309359|468815494|FG004|Overall Study|Death|0|||
130231951|NCT02309359|468815490|FG000|Overall Study|Withdrawal by Subject|2|||
130231952|NCT02309359|468815491|FG001|Overall Study|Withdrawal by Subject|2|||
130231953|NCT02309359|468815492|FG002|Overall Study|Withdrawal by Subject|4|||
130231954|NCT02309359|468815493|FG003|Overall Study|Withdrawal by Subject|4|||
130231955|NCT02309359|468815494|FG004|Overall Study|Withdrawal by Subject|0|||
130231956|NCT02309359|468815490|FG000|Overall Study|Lack of Efficacy|3|||
130231957|NCT02309359|468815491|FG001|Overall Study|Lack of Efficacy|1|||
130231958|NCT02309359|468815492|FG002|Overall Study|Lack of Efficacy|0|||
130231959|NCT02309359|468815493|FG003|Overall Study|Lack of Efficacy|0|||
130231960|NCT02309359|468815494|FG004|Overall Study|Lack of Efficacy|3|||
130231961|NCT02309359|468815490|FG000|Overall Study|Lost to Follow-up|0|||
130231962|NCT02309359|468815491|FG001|Overall Study|Lost to Follow-up|0|||
130231963|NCT02309359|468815492|FG002|Overall Study|Lost to Follow-up|0|||
130231964|NCT02309359|468815493|FG003|Overall Study|Lost to Follow-up|1|||
130231965|NCT02309359|468815494|FG004|Overall Study|Lost to Follow-up|0|||
130231966|NCT02309359|468815490|FG000|Overall Study|Other|2|||
130231967|NCT02309359|468815491|FG001|Overall Study|Other|0|||
130231968|NCT02309359|468815492|FG002|Overall Study|Other|2|||
130231969|NCT02309359|468815493|FG003|Overall Study|Other|3|||
130231970|NCT02309359|468815494|FG004|Overall Study|Other|2|||
130231971|NCT05144945|468815496|FG000|Overall Study|Withdrawal by Subject|1|||
130231972|NCT05144945|468815497|FG001|Overall Study|Withdrawal by Subject|0|||
130231973|NCT00284856|468815498|FG000|Overall Study|Adverse Event|3|||
130231974|NCT00284856|468815499|FG001|Overall Study|Adverse Event|3|||
130231975|NCT00284856|468815500|FG002|Overall Study|Adverse Event|3|||
130231976|NCT00284856|468815498|FG000|Overall Study|Lack of Efficacy|2|||
130231977|NCT00284856|468815499|FG001|Overall Study|Lack of Efficacy|1|||
130231978|NCT00284856|468815500|FG002|Overall Study|Lack of Efficacy|8|||
130231979|NCT00284856|468815498|FG000|Overall Study|Lost to Follow-up|25|||
130231980|NCT00284856|468815499|FG001|Overall Study|Lost to Follow-up|21|||
130231981|NCT00284856|468815500|FG002|Overall Study|Lost to Follow-up|22|||
130231982|NCT00284856|468815498|FG000|Overall Study|Protocol Violation|5|||
130231983|NCT00284856|468815499|FG001|Overall Study|Protocol Violation|4|||
130231984|NCT00284856|468815500|FG002|Overall Study|Protocol Violation|5|||
130231985|NCT00284856|468815498|FG000|Overall Study|Withdrawal by Subject|12|||
130231986|NCT00284856|468815499|FG001|Overall Study|Withdrawal by Subject|16|||
130231987|NCT00284856|468815500|FG002|Overall Study|Withdrawal by Subject|18|||
130231988|NCT00284856|468815498|FG000|Overall Study|Other|4|||
130231989|NCT00284856|468815499|FG001|Overall Study|Other|5|||
130231990|NCT00284856|468815500|FG002|Overall Study|Other|4|||
130231991|NCT01192815|468815501|FG000|Overall Study|Withdrawal by Subject|1|||
130231992|NCT01192815|468815501|FG000|Overall Study|Lack of Efficacy|1|||
130231993|NCT01394276|468815502|FG000|Overall Study|Related Adverse event (AEs)|15|||
130231994|NCT01394276|468815502|FG000|Overall Study|Not related AEs|9|||
130231995|NCT01394276|468815502|FG000|Overall Study|Remission of disease|2|||
130231996|NCT01394276|468815502|FG000|Overall Study|Insufficient therapeutic effect|17|||
130231997|NCT01394276|468815502|FG000|Overall Study|Insufficient compliance|9|||
130231998|NCT01394276|468815502|FG000|Overall Study|Lost to Follow-up|5|||
130231999|NCT01394276|468815502|FG000|Overall Study|Participant moved to another site|1|||
130232000|NCT01394276|468815502|FG000|Overall Study|Pregnancy|1|||
130232001|NCT01394276|468815502|FG000|Overall Study|unavailability of drug at the Hospital|2|||
130232002|NCT01394276|468815502|FG000|Overall Study|Symptoms of concurrent diseases|1|||
130232003|NCT00465179|468815503|FG000|Overall Study|Adverse Event|4|||
130232004|NCT00465179|468815503|FG000|Overall Study|Withdrawal by Subject|2|||
130232005|NCT00465179|468815503|FG000|Overall Study|Progression of Disease|47|||
130099898|NCT00706901|468324038|FG000|Overall Study|Lost to Follow-up|2|||
130099899|NCT00706901|468324039|FG001|Overall Study|Lost to Follow-up|3|||
130099900|NCT00706901|468324040|FG002|Overall Study|Lost to Follow-up|2|||
130099901|NCT00706901|468324038|FG000|Overall Study|Withdrawal by Subject|4|||
130099902|NCT00706901|468324039|FG001|Overall Study|Withdrawal by Subject|2|||
130099903|NCT00706901|468324040|FG002|Overall Study|Withdrawal by Subject|5|||
130232006|NCT00262925|468815506|FG000|Overall Study|Lack of Efficacy|3|||
130232007|NCT00262925|468815506|FG000|Overall Study|Adverse Event|4|||
130232008|NCT00262925|468815506|FG000|Overall Study|Death|2|||
130232009|NCT00262925|468815506|FG000|Overall Study|alternative therapy|1|||
130232010|NCT00262925|468815506|FG000|Overall Study|Other|1|||
130232011|NCT04682301|468815507|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
130232012|NCT04682301|468815507|FG000|Overall Study|Death|2|||
130232013|NCT00560404|468815508|FG000|Overall Study|Adverse Event|2|||
130232014|NCT00560404|468815509|FG001|Overall Study|Adverse Event|3|||
130232015|NCT00560404|468815508|FG000|Overall Study|Death|3|||
130232016|NCT00560404|468815509|FG001|Overall Study|Death|3|||
130232017|NCT00560404|468815508|FG000|Overall Study|Protocol Violation|12|||
130232018|NCT00560404|468815509|FG001|Overall Study|Protocol Violation|7|||
130232019|NCT00560404|468815508|FG000|Overall Study|Administrative Reasons|1|||
130232020|NCT00560404|468815509|FG001|Overall Study|Administrative Reasons|1|||
130232021|NCT00560404|468815508|FG000|Overall Study|Withdrew Consent|4|||
130099904|NCT00706901|468324038|FG000|Overall Study|In Jail|1|||
130232022|NCT00560404|468815509|FG001|Overall Study|Withdrew Consent|0|||
130099905|NCT00706901|468324039|FG001|Overall Study|In Jail|0|||
130099906|NCT00706901|468324040|FG002|Overall Study|In Jail|1|||
130099907|NCT00706901|468324038|FG000|Overall Study|Death|1|||
130099908|NCT00706901|468324039|FG001|Overall Study|Death|0|||
130099909|NCT00706901|468324040|FG002|Overall Study|Death|0|||
130099910|NCT04478994|468324041|FG000|Overall Study|Withdrawal by Subject|1|||
130099911|NCT04478994|468324042|FG001|Overall Study|Withdrawal by Subject|1|||
130099912|NCT01100073|468324043|FG000|Overall Study|Lack of Efficacy|4|||
130099913|NCT01100073|468324043|FG000|Overall Study|Insufficient Tolerability|21|||
130099914|NCT01100073|468324043|FG000|Overall Study|Withdrawal by Subject|13|||
130099915|NCT01100073|468324043|FG000|Overall Study|Lost to Follow-up|39|||
130099916|NCT01100073|468324043|FG000|Overall Study|Lack of effect + patient's wish|2|||
130099917|NCT01100073|468324043|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
130099918|NCT01100073|468324043|FG000|Overall Study|Other|8|||
130099919|NCT01100073|468324043|FG000|Overall Study|Missing|5|||
130099920|NCT01656850|468324044|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
130099921|NCT01656850|468324045|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
130099922|NCT01118949|468324048|FG000|Overall Study|Adverse Event|5|||
130099923|NCT01118949|468324048|FG000|Overall Study|Withdrawal by Subject|4|||
130099924|NCT00685763|468324058|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
130099925|NCT00685763|468324058|FG000|Overall Study|Protocol Violation|1|||
130099926|NCT01741259|468324059|FG000|Overall Study|Protocol Violation|6|||
130099927|NCT01741259|468324060|FG001|Overall Study|Protocol Violation|4|||
130099928|NCT01741259|468324059|FG000|Overall Study|Withdrawal by Subject|0|||
130099929|NCT01741259|468324060|FG001|Overall Study|Withdrawal by Subject|2|||
130099930|NCT00698009|468324061|FG000|Overall Study|Withdrawal by Subject|1|||
130099931|NCT02094573|468324062|FG000|Overall Study|Adverse Event|4|||
130099932|NCT02094573|468324063|FG001|Overall Study|Adverse Event|14|||
130232023|NCT00560404|468815508|FG000|Overall Study|Failure to return|1|||
130232024|NCT00560404|468815509|FG001|Overall Study|Failure to return|2|||
130232025|NCT00560404|468815508|FG000|Overall Study|Other withdrawal reason|13|||
130232026|NCT00560404|468815509|FG001|Overall Study|Other withdrawal reason|5|||
130232027|NCT02187783|468815510|FG000|Overall Study|Adverse Event|8|||
130099933|NCT02094573|468324062|FG000|Overall Study|Clinical Progressive Disease|9|||
130099934|NCT02094573|468324063|FG001|Overall Study|Clinical Progressive Disease|13|||
130099935|NCT02094573|468324062|FG000|Overall Study|Death|11|||
130099936|NCT02094573|468324063|FG001|Overall Study|Death|3|||
130099937|NCT02094573|468324062|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
130099938|NCT02094573|468324063|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
130099939|NCT02094573|468324062|FG000|Overall Study|Non-compliance with Study Drug|1|||
130099940|NCT02094573|468324063|FG001|Overall Study|Non-compliance with Study Drug|1|||
130099941|NCT02094573|468324062|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
130099942|NCT02094573|468324063|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
130099943|NCT02094573|468324062|FG000|Overall Study|Physician Decision|4|||
130099944|NCT02094573|468324063|FG001|Overall Study|Physician Decision|4|||
130099945|NCT02094573|468324062|FG000|Overall Study|Site Terminated by Sponsor|10|||
130099946|NCT02094573|468324063|FG001|Overall Study|Site Terminated by Sponsor|17|||
130099947|NCT02094573|468324062|FG000|Overall Study|Withdrawal by Subject|6|||
130099948|NCT02094573|468324063|FG001|Overall Study|Withdrawal by Subject|8|||
130099949|NCT02094573|468324062|FG000|Overall Study|Randomized but not Treated|3|||
130099950|NCT02094573|468324063|FG001|Overall Study|Randomized but not Treated|0|||
130099951|NCT04633434|468324070|FG000|Overall Study|Lost to Follow-up|32|||
130099952|NCT04633434|468324071|FG001|Overall Study|Lost to Follow-up|32|||
130099953|NCT01605370|468324081|FG000|Overall Study|Adverse Event|1|||
130099954|NCT01605370|468324082|FG001|Overall Study|Adverse Event|0|||
130099955|NCT00627094|468324087|FG000|Overall Study|Adverse Event|8|||
130099956|NCT00627094|468324088|FG001|Overall Study|Adverse Event|7|||
130099957|NCT00627094|468324087|FG000|Overall Study|Lost to Follow-up|1|||
130099958|NCT00627094|468324088|FG001|Overall Study|Lost to Follow-up|0|||
130099959|NCT00627094|468324087|FG000|Overall Study|Withdrawal by Subject|1|||
130099960|NCT00627094|468324088|FG001|Overall Study|Withdrawal by Subject|1|||
130232028|NCT02187783|468815510|FG000|Overall Study|Death|3|||
130232029|NCT02187783|468815510|FG000|Overall Study|Progressive disease|80|||
130232030|NCT02187783|468815510|FG000|Overall Study|Protocol Violation|3|||
130099961|NCT00627094|468324087|FG000|Overall Study|ulcer healed|1|||
130099962|NCT00627094|468324088|FG001|Overall Study|ulcer healed|7|||
130099963|NCT00627094|468324087|FG000|Overall Study|Other reason|1|||
130099964|NCT00627094|468324088|FG001|Overall Study|Other reason|0|||
130232031|NCT02187783|468815510|FG000|Overall Study|Physician Decision|2|||
130232032|NCT02187783|468815510|FG000|Overall Study|Withdrawal by Subject|9|||
130232033|NCT02187783|468815510|FG000|Overall Study|Study terminated by sponsor|1|||
130232034|NCT00471497|468815511|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
130099965|NCT03733301|468324098|FG000|Overall Study|Screen Fail|1|||
130099966|NCT03733301|468324099|FG001|Overall Study|Screen Fail|0|||
130099967|NCT03733301|468324100|FG002|Overall Study|Screen Fail|0|||
130099968|NCT03733301|468324098|FG000|Overall Study|Non-compliance|1|||
130099969|NCT03733301|468324099|FG001|Overall Study|Non-compliance|0|||
130024858|NCT03179436|468050470|FG000|Overall Study|Death|12|||
130024859|NCT03179436|468050471|FG001|Overall Study|Death|17|||
130024860|NCT03179436|468050472|FG002|Overall Study|Death|7|||
130024861|NCT03179436|468050473|FG003|Overall Study|Death|32|||
130024862|NCT03179436|468050474|FG004|Overall Study|Death|29|||
130024863|NCT03179436|468050475|FG005|Overall Study|Death|30|||
130024864|NCT03179436|468050476|FG006|Overall Study|Death|33|||
130024865|NCT03179436|468050477|FG007|Overall Study|Death|9|||
130024866|NCT03179436|468050478|FG008|Overall Study|Death|84|||
130024867|NCT03179436|468050479|FG009|Overall Study|Death|33|||
130024868|NCT03179436|468050480|FG010|Overall Study|Death|22|||
130024869|NCT03179436|468050481|FG011|Overall Study|Death|15|||
130024870|NCT05168267|468050482|FG000|Overall Study|Withdrawal by Subject|2|||
130024871|NCT05168267|468050483|FG001|Overall Study|Withdrawal by Subject|1|||
130024872|NCT05168267|468050482|FG000|Overall Study|Withdrawn by Therapist|1|||
130024873|NCT05168267|468050483|FG001|Overall Study|Withdrawn by Therapist|1|||
130024874|NCT05168267|468050482|FG000|Overall Study|Left Facility|1|||
130024875|NCT05168267|468050483|FG001|Overall Study|Left Facility|0|||
130024876|NCT05702736|468050484|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
130024877|NCT05702736|468050485|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
130024878|NCT05702736|468050484|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
130024879|NCT05702736|468050485|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
130024880|NCT00500682|468050488|FG000|Overall Study|Adverse Event|37|||
130024881|NCT00500682|468050489|FG001|Overall Study|Adverse Event|29|||
130024882|NCT00500682|468050488|FG000|Overall Study|Death|25|||
130024883|NCT00500682|468050489|FG001|Overall Study|Death|16|||
130024884|NCT00500682|468050488|FG000|Overall Study|Lost to Follow-up|11|||
130024885|NCT00500682|468050489|FG001|Overall Study|Lost to Follow-up|11|||
130024886|NCT00500682|468050488|FG000|Overall Study|Physician Decision|6|||
130024887|NCT00500682|468050489|FG001|Overall Study|Physician Decision|10|||
130024888|NCT00500682|468050488|FG000|Overall Study|Pregnancy|2|||
130024889|NCT00500682|468050489|FG001|Overall Study|Pregnancy|0|||
130024890|NCT00500682|468050488|FG000|Overall Study|Protocol Violation|1|||
130024891|NCT00500682|468050489|FG001|Overall Study|Protocol Violation|3|||
130024892|NCT00500682|468050488|FG000|Overall Study|Withdrawal by Subject|80|||
130024893|NCT00500682|468050489|FG001|Overall Study|Withdrawal by Subject|74|||
130024894|NCT00500682|468050488|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
130024895|NCT00500682|468050489|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
130024896|NCT00772668|468050493|FG000|Overall Study|Physician Decision|3|||
130024897|NCT01182428|468050494|FG000|Overall Study|Physician Decision|1|||
130024898|NCT01182428|468050495|FG001|Overall Study|Physician Decision|0|||
130024899|NCT01182428|468050494|FG000|Overall Study|Lost to Follow-up|9|||
130024900|NCT01182428|468050495|FG001|Overall Study|Lost to Follow-up|1|||
130024901|NCT01182428|468050494|FG000|Overall Study|Withdrawal by Subject|1|||
130024902|NCT01182428|468050495|FG001|Overall Study|Withdrawal by Subject|0|||
130024903|NCT00684957|468050500|FG000|Overall Study|Withdrawal by Subject|1|||
130024904|NCT00684957|468050501|FG001|Overall Study|Withdrawal by Subject|1|||
130024905|NCT00684957|468050500|FG000|Overall Study|Lost to Follow-up|1|||
130024906|NCT00684957|468050501|FG001|Overall Study|Lost to Follow-up|0|||
130024907|NCT04484285|468052139|FG000|Overall Study|Unable to operate stimulator|3|||
130024908|NCT04484285|468052140|FG001|Overall Study|Unable to operate stimulator|0|||
130024909|NCT00768898|468052141|FG000|Overall Study|Unrelated injury|1|||
130024910|NCT00768898|468052141|FG000|Overall Study|Headache|1|||
130024911|NCT02949128|468052142|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
130024912|NCT02949128|468052142|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
130024913|NCT02949128|468052142|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
130024914|NCT02949128|468052142|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
130024915|NCT02949128|468052142|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
130024916|NCT02949128|468052142|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
130024917|NCT02949128|468052142|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
130024918|NCT02949128|468052142|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
130099970|NCT03733301|468324100|FG002|Overall Study|Non-compliance|0|||
130024919|NCT02949128|468052142|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
130024920|NCT02949128|468052142|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
130024921|NCT03160560|468052145|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
130024922|NCT03160560|468052146|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130024923|NCT03160560|468052147|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130024924|NCT03160560|468052148|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130024925|NCT03160560|468052145|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130024926|NCT03160560|468052146|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130024927|NCT03160560|468052147|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130024928|NCT03160560|468052148|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130024929|NCT00667576|468052149|FG000|Overall Study|Withdrawal by Subject|1|||
130024930|NCT00667576|468052150|FG001|Overall Study|Withdrawal by Subject|0|||
130024931|NCT00667576|468052151|FG002|Overall Study|Withdrawal by Subject|1|||
130232035|NCT00471497|468815512|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
130232036|NCT00471497|468815513|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
130232037|NCT00471497|468815511|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
130232038|NCT00471497|468815512|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
130232039|NCT00471497|468815513|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
130232040|NCT00471497|468815511|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
130232041|NCT00471497|468815512|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
130232042|NCT00471497|468815513|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
130232043|NCT00471497|468815511|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
130232044|NCT00471497|468815512|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
130232045|NCT00471497|468815513|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
130232046|NCT00471497|468815511|FG000|Core Treatment Phase|Lost to Follow-up|6|||
130232047|NCT00471497|468815512|FG001|Core Treatment Phase|Lost to Follow-up|6|||
130232048|NCT00471497|468815513|FG002|Core Treatment Phase|Lost to Follow-up|3|||
130232049|NCT00471497|468815511|FG000|Core Treatment Phase|Death|3|||
130232050|NCT00471497|468815512|FG001|Core Treatment Phase|Death|9|||
130232051|NCT00471497|468815513|FG002|Core Treatment Phase|Death|3|||
130232052|NCT00471497|468815511|FG000|Core Treatment Phase|Disease Progression|10|||
130232053|NCT00471497|468815512|FG001|Core Treatment Phase|Disease Progression|2|||
130232054|NCT00471497|468815513|FG002|Core Treatment Phase|Disease Progression|4|||
130232055|NCT00471497|468815511|FG000|Core Treatment Phase|Protocol Violation|6|||
130232056|NCT00471497|468815512|FG001|Core Treatment Phase|Protocol Violation|15|||
130232057|NCT00471497|468815513|FG002|Core Treatment Phase|Protocol Violation|11|||
130232058|NCT00471497|468815511|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
130232059|NCT00471497|468815512|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
130232060|NCT00471497|468815513|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
130232061|NCT00471497|468815511|FG000|Core Treatment Phase|Administrative problems|14|||
130232062|NCT00471497|468815512|FG001|Core Treatment Phase|Administrative problems|14|||
130232063|NCT00471497|468815513|FG002|Core Treatment Phase|Administrative problems|12|||
130232064|NCT00471497|468815511|FG000|Core Treatment Phase|Adverse Event|43|||
130232065|NCT00471497|468815512|FG001|Core Treatment Phase|Adverse Event|53|||
130232066|NCT00471497|468815513|FG002|Core Treatment Phase|Adverse Event|89|||
130232067|NCT00471497|468815511|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
130232068|NCT00471497|468815512|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
130232069|NCT00471497|468815513|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
130232070|NCT00471497|468815511|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
130232071|NCT00471497|468815512|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
130232072|NCT00471497|468815513|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
130232073|NCT00471497|468815511|FG000|Extension Phase|Adverse Event|9|||
130232074|NCT00471497|468815512|FG001|Extension Phase|Adverse Event|5|||
130232075|NCT00471497|468815513|FG002|Extension Phase|Adverse Event|1|||
130232076|NCT00471497|468815511|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
130232077|NCT00471497|468815512|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
130232078|NCT00471497|468815513|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130232079|NCT00471497|468815511|FG000|Extension Phase|Withdrawal by Subject|3|||
130232080|NCT00471497|468815512|FG001|Extension Phase|Withdrawal by Subject|1|||
130232081|NCT00471497|468815513|FG002|Extension Phase|Withdrawal by Subject|0|||
130232082|NCT00471497|468815511|FG000|Extension Phase|Lost to Follow-up|2|||
130232083|NCT00471497|468815512|FG001|Extension Phase|Lost to Follow-up|0|||
130232084|NCT00471497|468815513|FG002|Extension Phase|Lost to Follow-up|0|||
130232085|NCT00471497|468815511|FG000|Extension Phase|Death|1|||
130232086|NCT00471497|468815512|FG001|Extension Phase|Death|0|||
130232087|NCT00471497|468815513|FG002|Extension Phase|Death|0|||
130232088|NCT00471497|468815511|FG000|Extension Phase|Disease progression|2|||
130232089|NCT00471497|468815512|FG001|Extension Phase|Disease progression|0|||
130024932|NCT00667576|468052152|FG003|Overall Study|Withdrawal by Subject|1|||
130024933|NCT00667576|468052153|FG004|Overall Study|Withdrawal by Subject|1|||
130232090|NCT00471497|468815513|FG002|Extension Phase|Disease progression|0|||
130232091|NCT00471497|468815511|FG000|Extension Phase|Protocol Violation|2|||
130232092|NCT00471497|468815512|FG001|Extension Phase|Protocol Violation|2|||
130232093|NCT00471497|468815513|FG002|Extension Phase|Protocol Violation|0|||
130232094|NCT00392223|468815514|FG000|Overall Study|Adverse Event|5|||
130024934|NCT00667576|468052149|FG000|Overall Study|Adverse Event|1|||
130232095|NCT00392223|468815515|FG001|Overall Study|Adverse Event|4|||
130232096|NCT00392223|468815514|FG000|Overall Study|Lost to Follow-up|1|||
130232097|NCT00392223|468815515|FG001|Overall Study|Lost to Follow-up|4|||
130232098|NCT00392223|468815514|FG000|Overall Study|Protocol Violation|0|||
130232099|NCT00392223|468815515|FG001|Overall Study|Protocol Violation|3|||
130024935|NCT00667576|468052150|FG001|Overall Study|Adverse Event|1|||
130232100|NCT00392223|468815514|FG000|Overall Study|Withdrawal by Subject|3|||
130232101|NCT00392223|468815515|FG001|Overall Study|Withdrawal by Subject|2|||
130232102|NCT00402831|468815518|FG000|Overall Study|Lost to Follow-up|1|||
130232103|NCT00402831|468815519|FG001|Overall Study|Lost to Follow-up|2|||
130232104|NCT00402831|468815518|FG000|Overall Study|Non-compliance with protocol|0|||
130232105|NCT00402831|468815519|FG001|Overall Study|Non-compliance with protocol|1|||
130232106|NCT01114724|468815522|FG000|Overall Study|Death|8|||
130232107|NCT01114724|468815522|FG000|Overall Study|Lost to Follow-up|1|||
130232108|NCT01114724|468815522|FG000|Overall Study|Withdrawal by Subject|1|||
130232109|NCT01981616|468815531|FG000|Overall Study|Adverse Event|0|||
130232110|NCT01981616|468815532|FG001|Overall Study|Adverse Event|1|||
130232111|NCT01981616|468815531|FG000|Overall Study|Protocol Violation|1|||
130232112|NCT01981616|468815532|FG001|Overall Study|Protocol Violation|0|||
130232113|NCT01020123|468815533|FG000|Main Period|Withdrawal by Subject|6|||
130232114|NCT01020123|468815534|FG001|Main Period|Withdrawal by Subject|5|||
130232115|NCT01020123|468815535|FG002|Main Period|Withdrawal by Subject|3|||
130232116|NCT01020123|468815536|FG003|Main Period|Withdrawal by Subject|1|||
130232117|NCT01020123|468815537|FG004|Main Period|Withdrawal by Subject|6|||
130232118|NCT01020123|468815538|FG005|Main Period|Withdrawal by Subject|3|||
130232119|NCT01020123|468815539|FG006|Main Period|Withdrawal by Subject|2|||
130232120|NCT01020123|468815533|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
130232121|NCT01020123|468815534|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
130232122|NCT01020123|468815535|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
130232123|NCT01020123|468815536|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
130232124|NCT01020123|468815537|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
130232125|NCT01020123|468815538|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
130232126|NCT01020123|468815539|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
130232127|NCT01020123|468815533|FG000|Main Period|Adverse Event|5|||
130232128|NCT01020123|468815534|FG001|Main Period|Adverse Event|2|||
130232129|NCT01020123|468815535|FG002|Main Period|Adverse Event|2|||
130232130|NCT01020123|468815536|FG003|Main Period|Adverse Event|1|||
130232131|NCT01020123|468815537|FG004|Main Period|Adverse Event|1|||
130232132|NCT01020123|468815538|FG005|Main Period|Adverse Event|2|||
130232133|NCT01020123|468815539|FG006|Main Period|Adverse Event|1|||
130232134|NCT01020123|468815533|FG000|Main Period|Protocol Violation|4|||
130232135|NCT01020123|468815534|FG001|Main Period|Protocol Violation|4|||
130232136|NCT01020123|468815535|FG002|Main Period|Protocol Violation|2|||
130232137|NCT01020123|468815536|FG003|Main Period|Protocol Violation|5|||
130232138|NCT01020123|468815537|FG004|Main Period|Protocol Violation|2|||
130232139|NCT01020123|468815538|FG005|Main Period|Protocol Violation|3|||
130232140|NCT01020123|468815539|FG006|Main Period|Protocol Violation|2|||
130232141|NCT01020123|468815533|FG000|Main Period|Lost to Follow-up|0|||
130232142|NCT01020123|468815534|FG001|Main Period|Lost to Follow-up|2|||
130232143|NCT01020123|468815535|FG002|Main Period|Lost to Follow-up|0|||
130232144|NCT01020123|468815536|FG003|Main Period|Lost to Follow-up|0|||
130232145|NCT01020123|468815537|FG004|Main Period|Lost to Follow-up|0|||
130232146|NCT01020123|468815538|FG005|Main Period|Lost to Follow-up|0|||
130232147|NCT01020123|468815539|FG006|Main Period|Lost to Follow-up|0|||
130232148|NCT01020123|468815533|FG000|Main Period|Unclasified|2|||
130232149|NCT01020123|468815534|FG001|Main Period|Unclasified|0|||
130232150|NCT01020123|468815535|FG002|Main Period|Unclasified|1|||
130232151|NCT01020123|468815536|FG003|Main Period|Unclasified|0|||
130232152|NCT01020123|468815537|FG004|Main Period|Unclasified|1|||
130232153|NCT01020123|468815538|FG005|Main Period|Unclasified|3|||
130232154|NCT01020123|468815539|FG006|Main Period|Unclasified|6|||
130232155|NCT01020123|468815533|FG000|Extention Period|Withdrawal by Subject|2|||
130232156|NCT01020123|468815534|FG001|Extention Period|Withdrawal by Subject|1|||
130232157|NCT01020123|468815535|FG002|Extention Period|Withdrawal by Subject|1|||
130232158|NCT01020123|468815536|FG003|Extention Period|Withdrawal by Subject|0|||
130232159|NCT01020123|468815537|FG004|Extention Period|Withdrawal by Subject|0|||
130232160|NCT01020123|468815538|FG005|Extention Period|Withdrawal by Subject|0|||
130232161|NCT01020123|468815539|FG006|Extention Period|Withdrawal by Subject|0|||
130232162|NCT01020123|468815533|FG000|Extention Period|Adverse Event|0|||
130232163|NCT01020123|468815534|FG001|Extention Period|Adverse Event|0|||
130232164|NCT01020123|468815535|FG002|Extention Period|Adverse Event|0|||
130232165|NCT01020123|468815536|FG003|Extention Period|Adverse Event|1|||
130232166|NCT01020123|468815537|FG004|Extention Period|Adverse Event|0|||
130232167|NCT01020123|468815538|FG005|Extention Period|Adverse Event|0|||
130232168|NCT01020123|468815539|FG006|Extention Period|Adverse Event|0|||
130232169|NCT01020123|468815533|FG000|Extention Period|Protocol Violation|1|||
130232170|NCT01020123|468815534|FG001|Extention Period|Protocol Violation|1|||
130232171|NCT01020123|468815535|FG002|Extention Period|Protocol Violation|1|||
130232172|NCT01020123|468815536|FG003|Extention Period|Protocol Violation|0|||
130232173|NCT01020123|468815537|FG004|Extention Period|Protocol Violation|0|||
130232174|NCT01020123|468815538|FG005|Extention Period|Protocol Violation|0|||
130232175|NCT01020123|468815539|FG006|Extention Period|Protocol Violation|1|||
130232176|NCT01020123|468815533|FG000|Extention Period|Lost to Follow-up|0|||
130232177|NCT01020123|468815534|FG001|Extention Period|Lost to Follow-up|0|||
130232178|NCT01020123|468815535|FG002|Extention Period|Lost to Follow-up|0|||
130232179|NCT01020123|468815536|FG003|Extention Period|Lost to Follow-up|0|||
130232180|NCT01020123|468815537|FG004|Extention Period|Lost to Follow-up|0|||
130232181|NCT01020123|468815538|FG005|Extention Period|Lost to Follow-up|2|||
130232182|NCT01020123|468815539|FG006|Extention Period|Lost to Follow-up|0|||
130232183|NCT00094445|468815540|FG000|Overall Study|Withdrawal by Subject|3|||
130232184|NCT00094445|468815540|FG000|Overall Study|Lost to Follow-up|1|||
130232185|NCT00094445|468815540|FG000|Overall Study|Progressive Disease|2|||
130232186|NCT00769561|468815545|FG000|Overall Study|Withdrawal by Subject|2|||
130232187|NCT00769561|468815546|FG001|Overall Study|Withdrawal by Subject|2|||
130232188|NCT00769561|468815545|FG000|Overall Study|Lost to Follow-up|1|||
130232189|NCT00769561|468815546|FG001|Overall Study|Lost to Follow-up|3|||
130232190|NCT04711005|468815547|FG000|Overall Study|Withdrawal by Subject|0|||
130232191|NCT04711005|468815548|FG001|Overall Study|Withdrawal by Subject|0|||
130232192|NCT04711005|468815549|FG002|Overall Study|Withdrawal by Subject|0|||
130232193|NCT04711005|468815550|FG003|Overall Study|Withdrawal by Subject|0|||
130232194|NCT04711005|468815551|FG004|Overall Study|Withdrawal by Subject|0|||
130232195|NCT04711005|468815552|FG005|Overall Study|Withdrawal by Subject|0|||
130232196|NCT04711005|468815553|FG006|Overall Study|Withdrawal by Subject|0|||
130232197|NCT04711005|468815554|FG007|Overall Study|Withdrawal by Subject|1|||
130232198|NCT04711005|468815555|FG008|Overall Study|Withdrawal by Subject|0|||
130232199|NCT04711005|468815556|FG009|Overall Study|Withdrawal by Subject|0|||
130232200|NCT04711005|468815547|FG000|Overall Study|Physician Decision|0|||
130232201|NCT04711005|468815548|FG001|Overall Study|Physician Decision|0|||
130232202|NCT04711005|468815549|FG002|Overall Study|Physician Decision|0|||
130232203|NCT04711005|468815550|FG003|Overall Study|Physician Decision|0|||
130232204|NCT04711005|468815551|FG004|Overall Study|Physician Decision|0|||
130232205|NCT04711005|468815552|FG005|Overall Study|Physician Decision|0|||
130232206|NCT04711005|468815553|FG006|Overall Study|Physician Decision|0|||
130232207|NCT04711005|468815554|FG007|Overall Study|Physician Decision|2|||
130232208|NCT04711005|468815555|FG008|Overall Study|Physician Decision|1|||
130232209|NCT04711005|468815556|FG009|Overall Study|Physician Decision|0|||
130232210|NCT03824561|468815564|FG000|Overall Study|Protocol Violation|19|||
130232211|NCT01773928|468815565|FG000|Overall Study|Adverse Event|0|||
130232212|NCT01773928|468815566|FG001|Overall Study|Adverse Event|0|||
130232213|NCT01773928|468815567|FG002|Overall Study|Adverse Event|0|||
130232214|NCT01773928|468815568|FG003|Overall Study|Adverse Event|0|||
130232215|NCT01773928|468815569|FG004|Overall Study|Adverse Event|0|||
130232216|NCT01773928|468815570|FG005|Overall Study|Adverse Event|0|||
130232217|NCT01773928|468815571|FG006|Overall Study|Adverse Event|0|||
130232218|NCT01773928|468815572|FG007|Overall Study|Adverse Event|1|||
130232219|NCT01773928|468815573|FG008|Overall Study|Adverse Event|0|||
130232220|NCT01773928|468815565|FG000|Overall Study|Physician Decision|0|||
130232221|NCT01773928|468815566|FG001|Overall Study|Physician Decision|0|||
130232222|NCT01773928|468815567|FG002|Overall Study|Physician Decision|0|||
130232223|NCT01773928|468815568|FG003|Overall Study|Physician Decision|1|||
130232224|NCT01773928|468815569|FG004|Overall Study|Physician Decision|0|||
130232225|NCT01773928|468815570|FG005|Overall Study|Physician Decision|0|||
130232226|NCT01773928|468815571|FG006|Overall Study|Physician Decision|0|||
130232227|NCT01773928|468815572|FG007|Overall Study|Physician Decision|0|||
130232228|NCT01773928|468815573|FG008|Overall Study|Physician Decision|0|||
130232229|NCT01773928|468815565|FG000|Overall Study|Withdrawal by Subject|5|||
130232230|NCT01773928|468815566|FG001|Overall Study|Withdrawal by Subject|4|||
130232231|NCT01773928|468815567|FG002|Overall Study|Withdrawal by Subject|4|||
130232232|NCT01773928|468815568|FG003|Overall Study|Withdrawal by Subject|4|||
130232233|NCT01773928|468815569|FG004|Overall Study|Withdrawal by Subject|7|||
130232234|NCT01773928|468815570|FG005|Overall Study|Withdrawal by Subject|1|||
130232235|NCT01773928|468815571|FG006|Overall Study|Withdrawal by Subject|0|||
130232236|NCT01773928|468815572|FG007|Overall Study|Withdrawal by Subject|0|||
130232237|NCT01773928|468815573|FG008|Overall Study|Withdrawal by Subject|1|||
130232238|NCT01773928|468815565|FG000|Overall Study|Lost to Follow-up|0|||
130024936|NCT00667576|468052151|FG002|Overall Study|Adverse Event|0|||
130024937|NCT00667576|468052152|FG003|Overall Study|Adverse Event|0|||
130024938|NCT00667576|468052153|FG004|Overall Study|Adverse Event|0|||
130232239|NCT01773928|468815566|FG001|Overall Study|Lost to Follow-up|0|||
130232240|NCT01773928|468815567|FG002|Overall Study|Lost to Follow-up|0|||
130232241|NCT01773928|468815568|FG003|Overall Study|Lost to Follow-up|0|||
130232242|NCT01773928|468815569|FG004|Overall Study|Lost to Follow-up|0|||
130232243|NCT01773928|468815570|FG005|Overall Study|Lost to Follow-up|1|||
130232244|NCT01773928|468815571|FG006|Overall Study|Lost to Follow-up|0|||
130232245|NCT01773928|468815572|FG007|Overall Study|Lost to Follow-up|0|||
130232246|NCT01773928|468815573|FG008|Overall Study|Lost to Follow-up|0|||
130232247|NCT01773928|468815565|FG000|Overall Study|Subject misrepresented age|0|||
130232248|NCT01773928|468815566|FG001|Overall Study|Subject misrepresented age|1|||
130024939|NCT00667576|468052149|FG000|Overall Study|Lost to Follow-up|0|||
130232249|NCT01773928|468815567|FG002|Overall Study|Subject misrepresented age|0|||
130232250|NCT01773928|468815568|FG003|Overall Study|Subject misrepresented age|0|||
130232251|NCT01773928|468815569|FG004|Overall Study|Subject misrepresented age|0|||
130232252|NCT01773928|468815570|FG005|Overall Study|Subject misrepresented age|0|||
130232253|NCT01773928|468815571|FG006|Overall Study|Subject misrepresented age|0|||
130232254|NCT01773928|468815572|FG007|Overall Study|Subject misrepresented age|0|||
130232255|NCT01773928|468815573|FG008|Overall Study|Subject misrepresented age|0|||
130232256|NCT01773928|468815565|FG000|Overall Study|Subject met exclusion criteria|0|||
130232257|NCT01773928|468815566|FG001|Overall Study|Subject met exclusion criteria|0|||
130232258|NCT01773928|468815567|FG002|Overall Study|Subject met exclusion criteria|0|||
130232259|NCT01773928|468815568|FG003|Overall Study|Subject met exclusion criteria|0|||
130232260|NCT01773928|468815569|FG004|Overall Study|Subject met exclusion criteria|0|||
130232261|NCT01773928|468815570|FG005|Overall Study|Subject met exclusion criteria|0|||
130232262|NCT01773928|468815571|FG006|Overall Study|Subject met exclusion criteria|0|||
130232263|NCT01773928|468815572|FG007|Overall Study|Subject met exclusion criteria|0|||
130232264|NCT01773928|468815573|FG008|Overall Study|Subject met exclusion criteria|1|||
130232265|NCT01773928|468815565|FG000|Overall Study|Randomized, had to leave, never returned|0|||
130232266|NCT01773928|468815566|FG001|Overall Study|Randomized, had to leave, never returned|0|||
130232267|NCT01773928|468815567|FG002|Overall Study|Randomized, had to leave, never returned|0|||
130232268|NCT01773928|468815568|FG003|Overall Study|Randomized, had to leave, never returned|1|||
130232269|NCT01773928|468815569|FG004|Overall Study|Randomized, had to leave, never returned|0|||
130232270|NCT01773928|468815570|FG005|Overall Study|Randomized, had to leave, never returned|0|||
130232271|NCT01773928|468815571|FG006|Overall Study|Randomized, had to leave, never returned|0|||
130232272|NCT01773928|468815572|FG007|Overall Study|Randomized, had to leave, never returned|0|||
130232273|NCT01773928|468815573|FG008|Overall Study|Randomized, had to leave, never returned|0|||
130232274|NCT01773928|468815565|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
130232275|NCT01773928|468815566|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
130232276|NCT01773928|468815567|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
130232277|NCT01773928|468815568|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
130232278|NCT01773928|468815569|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
130232279|NCT01773928|468815570|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
130232280|NCT01773928|468815571|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
130232281|NCT01773928|468815572|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
130232282|NCT01773928|468815573|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
130232283|NCT03573297|468815575|FG000|Open Label Treatment Period|Adverse Event|67|||
130232284|NCT03573297|468815576|FG001|Open Label Treatment Period|Adverse Event|0|||
130232285|NCT03573297|468815577|FG002|Open Label Treatment Period|Adverse Event|0|||
130232286|NCT03573297|468815578|FG003|Open Label Treatment Period|Adverse Event|0|||
130232287|NCT03573297|468815575|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
130232288|NCT03573297|468815576|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
130232289|NCT03573297|468815577|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
130232290|NCT03573297|468815578|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
130232291|NCT03573297|468815575|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
130232292|NCT03573297|468815576|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
130232293|NCT03573297|468815577|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
130232294|NCT03573297|468815578|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
130232295|NCT03573297|468815575|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
130232296|NCT03573297|468815576|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
130232297|NCT03573297|468815577|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
130232298|NCT03573297|468815578|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
130232299|NCT03573297|468815575|FG000|Open Label Treatment Period|Pregnancy|1|||
130232300|NCT03573297|468815576|FG001|Open Label Treatment Period|Pregnancy|0|||
130232301|NCT03573297|468815577|FG002|Open Label Treatment Period|Pregnancy|0|||
130232302|NCT03573297|468815578|FG003|Open Label Treatment Period|Pregnancy|0|||
130232303|NCT03573297|468815575|FG000|Open Label Treatment Period|Protocol Violation|17|||
130232304|NCT03573297|468815576|FG001|Open Label Treatment Period|Protocol Violation|0|||
130232305|NCT03573297|468815577|FG002|Open Label Treatment Period|Protocol Violation|0|||
130232306|NCT03573297|468815578|FG003|Open Label Treatment Period|Protocol Violation|0|||
130232307|NCT03573297|468815575|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
130232308|NCT03573297|468815576|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130232309|NCT03573297|468815577|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130232310|NCT03573297|468815578|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
130232311|NCT03573297|468815575|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
130232312|NCT03573297|468815576|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130232313|NCT03573297|468815577|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130232314|NCT03573297|468815578|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
130232315|NCT03573297|468815575|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
130024940|NCT00667576|468052150|FG001|Overall Study|Lost to Follow-up|0|||
130232316|NCT03573297|468815576|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130232317|NCT03573297|468815577|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130232318|NCT03573297|468815578|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
130024941|NCT00667576|468052151|FG002|Overall Study|Lost to Follow-up|1|||
130024942|NCT00667576|468052152|FG003|Overall Study|Lost to Follow-up|0|||
130232319|NCT03573297|468815575|FG000|Open Label Treatment Period|Other, Not Specified|7|||
130232320|NCT03573297|468815576|FG001|Open Label Treatment Period|Other, Not Specified|0|||
130024943|NCT00667576|468052153|FG004|Overall Study|Lost to Follow-up|0|||
130024944|NCT00667576|468052149|FG000|Overall Study|Protocol Violation|0|||
130024945|NCT00667576|468052150|FG001|Overall Study|Protocol Violation|0|||
130024946|NCT00667576|468052151|FG002|Overall Study|Protocol Violation|0|||
130024947|NCT00667576|468052152|FG003|Overall Study|Protocol Violation|1|||
130024948|NCT00667576|468052153|FG004|Overall Study|Protocol Violation|0|||
130024949|NCT00667576|468052149|FG000|Overall Study|Physician Decision|0|||
130024950|NCT00667576|468052150|FG001|Overall Study|Physician Decision|0|||
130024951|NCT00667576|468052151|FG002|Overall Study|Physician Decision|0|||
130024952|NCT00667576|468052152|FG003|Overall Study|Physician Decision|1|||
130024953|NCT00667576|468052153|FG004|Overall Study|Physician Decision|0|||
130024954|NCT00667576|468052149|FG000|Overall Study|Missed Visit|0|||
130024955|NCT00667576|468052150|FG001|Overall Study|Missed Visit|0|||
130024956|NCT00667576|468052151|FG002|Overall Study|Missed Visit|0|||
130024957|NCT00667576|468052152|FG003|Overall Study|Missed Visit|1|||
130024958|NCT00667576|468052153|FG004|Overall Study|Missed Visit|0|||
130024959|NCT01390389|468052154|FG000|Overall Study|Withdrawal by Subject|2|||
130024960|NCT01390389|468052155|FG001|Overall Study|Withdrawal by Subject|0|||
130024961|NCT01390389|468052154|FG000|Overall Study|Screen Fail|2|||
130024962|NCT01390389|468052155|FG001|Overall Study|Screen Fail|1|||
130024963|NCT01430442|468052158|FG000|Overall Study|Subject Withdrew Consent|3|||
130024964|NCT01430442|468052159|FG001|Overall Study|Subject Withdrew Consent|0|||
130232321|NCT03573297|468815577|FG002|Open Label Treatment Period|Other, Not Specified|0|||
130232322|NCT03573297|468815578|FG003|Open Label Treatment Period|Other, Not Specified|0|||
130232323|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
130232324|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
130232325|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
130024965|NCT01430442|468052160|FG002|Overall Study|Subject Withdrew Consent|1|||
130024966|NCT01430442|468052161|FG003|Overall Study|Subject Withdrew Consent|0|||
130232326|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
130232327|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130024967|NCT01430442|468052162|FG004|Overall Study|Subject Withdrew Consent|2|||
130024968|NCT01430442|468052163|FG005|Overall Study|Subject Withdrew Consent|1|||
130024969|NCT01430442|468052164|FG006|Overall Study|Subject Withdrew Consent|5|||
130024970|NCT01430442|468052165|FG007|Overall Study|Subject Withdrew Consent|2|||
130024971|NCT01430442|468052158|FG000|Overall Study|Lost to Follow-up|2|||
130024972|NCT01430442|468052159|FG001|Overall Study|Lost to Follow-up|0|||
130099971|NCT03733301|468324098|FG000|Overall Study|Lack of Efficacy|2|||
130232328|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130232329|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Adverse Event|5|||
130232330|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Adverse Event|1|||
130232331|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130232332|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130232333|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130232334|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
130232335|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130232336|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
130232337|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
130232338|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
130232339|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130232340|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
130232341|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
130232342|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
130099972|NCT03733301|468324099|FG001|Overall Study|Lack of Efficacy|3|||
130099973|NCT03733301|468324100|FG002|Overall Study|Lack of Efficacy|0|||
130024973|NCT01430442|468052160|FG002|Overall Study|Lost to Follow-up|1|||
130024974|NCT01430442|468052161|FG003|Overall Study|Lost to Follow-up|2|||
130024975|NCT01430442|468052162|FG004|Overall Study|Lost to Follow-up|2|||
130024976|NCT01430442|468052163|FG005|Overall Study|Lost to Follow-up|1|||
130024977|NCT01430442|468052164|FG006|Overall Study|Lost to Follow-up|5|||
130024978|NCT01430442|468052165|FG007|Overall Study|Lost to Follow-up|1|||
130024979|NCT01430442|468052158|FG000|Overall Study|Pregnancy|1|||
130024980|NCT01430442|468052159|FG001|Overall Study|Pregnancy|0|||
130024981|NCT01430442|468052160|FG002|Overall Study|Pregnancy|0|||
130099974|NCT03733301|468324098|FG000|Overall Study|Adverse Event|0|||
130232343|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130232344|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
130232345|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
130232346|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
130232347|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
130232348|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
130232349|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
130232350|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
130232351|NCT03573297|468815575|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
130024982|NCT01430442|468052161|FG003|Overall Study|Pregnancy|0|||
130024983|NCT01430442|468052162|FG004|Overall Study|Pregnancy|0|||
130024984|NCT01430442|468052163|FG005|Overall Study|Pregnancy|1|||
130024985|NCT01430442|468052164|FG006|Overall Study|Pregnancy|0|||
130024986|NCT01430442|468052165|FG007|Overall Study|Pregnancy|0|||
130024987|NCT01430442|468052158|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
130024988|NCT01430442|468052159|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
130232352|NCT03573297|468815576|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
130232353|NCT03573297|468815577|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
130232354|NCT03573297|468815578|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
130232355|NCT02273167|468815581|FG000|Overall Study|Adverse Event|1|||
130232356|NCT02273167|468815582|FG001|Overall Study|Adverse Event|0|||
130232357|NCT02273167|468815583|FG002|Overall Study|Adverse Event|0|||
130232358|NCT02273167|468815581|FG000|Overall Study|Protocol Violation|3|||
130232359|NCT02273167|468815582|FG001|Overall Study|Protocol Violation|1|||
130232360|NCT02273167|468815583|FG002|Overall Study|Protocol Violation|1|||
130232361|NCT02273167|468815581|FG000|Overall Study|Lost to Follow-up|0|||
130232362|NCT02273167|468815582|FG001|Overall Study|Lost to Follow-up|1|||
130232363|NCT02273167|468815583|FG002|Overall Study|Lost to Follow-up|1|||
130232364|NCT02273167|468815581|FG000|Overall Study|Withdrawal by Subject|10|||
130232365|NCT02273167|468815582|FG001|Overall Study|Withdrawal by Subject|12|||
130232366|NCT02273167|468815583|FG002|Overall Study|Withdrawal by Subject|11|||
130232367|NCT02273167|468815581|FG000|Overall Study|Various|10|||
130232368|NCT02273167|468815582|FG001|Overall Study|Various|9|||
130024989|NCT01430442|468052160|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
130024990|NCT01430442|468052161|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
130024991|NCT01430442|468052162|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
130024992|NCT01430442|468052163|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
130024993|NCT01430442|468052164|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
130024994|NCT01430442|468052165|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
130232369|NCT02273167|468815583|FG002|Overall Study|Various|8|||
130232370|NCT02781324|468815584|FG000|Overall Study|Withdrawal by Subject|1|||
130232371|NCT02781324|468815585|FG001|Overall Study|Withdrawal by Subject|0|||
130232372|NCT02781324|468815584|FG000|Overall Study|Physician Decision|1|||
130232373|NCT02781324|468815585|FG001|Overall Study|Physician Decision|2|||
130232374|NCT00661388|468815589|FG000|Overall Study|Adverse Event|14|||
130232375|NCT00661388|468815589|FG000|Overall Study|Protocol Violation|7|||
130099975|NCT03733301|468324099|FG001|Overall Study|Adverse Event|1|||
130232376|NCT00661388|468815589|FG000|Overall Study|Renal transplantation|1|||
130232377|NCT00661388|468815589|FG000|Overall Study|Dialysis initiation|1|||
130232378|NCT00661388|468815589|FG000|Overall Study|Administrative reasons|1|||
130232379|NCT03370172|468817739|FG000|Overall Study|Withdrawal by Subject|0|||
130024995|NCT01641939|468052166|FG000|Overall Study|Death|90|||
130024996|NCT01641939|468052167|FG001|Overall Study|Death|187|||
130024997|NCT01641939|468052168|FG002|Overall Study|Death|61|||
130024998|NCT01641939|468052166|FG000|Overall Study|Lost to Follow-up|3|||
130024999|NCT01641939|468052167|FG001|Overall Study|Lost to Follow-up|2|||
130025000|NCT01641939|468052168|FG002|Overall Study|Lost to Follow-up|1|||
130025001|NCT01641939|468052166|FG000|Overall Study|Withdrawal by Subject|14|||
130232380|NCT03370172|468817740|FG001|Overall Study|Withdrawal by Subject|1|||
130232381|NCT01171534|468817747|FG000|Overall Study|Lost to Follow-up|0|||
130232382|NCT01171534|468817748|FG001|Overall Study|Lost to Follow-up|2|||
130232383|NCT01171534|468817747|FG000|Overall Study|screen failure|0|||
130232384|NCT01171534|468817748|FG001|Overall Study|screen failure|1|||
130232385|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
130232386|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
130232387|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
130232388|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
130232389|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
130232390|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
130232391|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
130232392|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
130232393|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
130232394|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
130232395|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
130232396|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
130232397|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
130232398|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
130232399|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
130232400|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
130232401|NCT00849056|468817749|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130232402|NCT00849056|468817750|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
130232403|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130232404|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
130232405|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
130232406|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
130232407|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
130232408|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
130232409|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
130232410|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
130232411|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130232412|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130232413|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
130232414|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
130232415|NCT00849056|468817749|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
130232416|NCT00849056|468817750|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
130232417|NCT02934178|468817754|FG000|Received Vaccination 2|Death|0|||
130232418|NCT02934178|468817755|FG001|Received Vaccination 2|Death|1|||
130232419|NCT02934178|468817754|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
130232420|NCT02934178|468817755|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
130232421|NCT01898078|468817759|FG000|Overall Study|Progressive Disease|1|||
130025002|NCT01641939|468052167|FG001|Overall Study|Withdrawal by Subject|11|||
130025003|NCT01641939|468052168|FG002|Overall Study|Withdrawal by Subject|5|||
130025004|NCT01641939|468052166|FG000|Overall Study|Study Terminated by Sponsor|10|||
130025005|NCT01641939|468052167|FG001|Overall Study|Study Terminated by Sponsor|28|||
130025006|NCT01641939|468052168|FG002|Overall Study|Study Terminated by Sponsor|3|||
130025007|NCT00772629|468052169|FG000|Overall Study|Subject was not vaccinated|1|||
130025008|NCT00772629|468052170|FG001|Overall Study|Subject was not vaccinated|0|||
130232422|NCT01898078|468817760|FG001|Overall Study|Progressive Disease|5|||
130232423|NCT01898078|468817759|FG000|Overall Study|Adverse Event|2|||
130232424|NCT01898078|468817760|FG001|Overall Study|Adverse Event|1|||
130232425|NCT01898078|468817759|FG000|Overall Study|Withdrawal by Subject|1|||
130232426|NCT01898078|468817760|FG001|Overall Study|Withdrawal by Subject|1|||
130232427|NCT01898078|468817759|FG000|Overall Study|Symptomatic Deterioration|2|||
130232428|NCT01898078|468817760|FG001|Overall Study|Symptomatic Deterioration|0|||
130025009|NCT05162066|468052174|FG000|Overall Study|Adverse Event|1|||
130025010|NCT05162066|468052175|FG001|Overall Study|Adverse Event|0|||
130025011|NCT05162066|468052176|FG002|Overall Study|Adverse Event|0|||
130025012|NCT05162066|468052174|FG000|Overall Study|Perceived lack of efficacy|1|||
130025013|NCT05162066|468052175|FG001|Overall Study|Perceived lack of efficacy|0|||
130099976|NCT03733301|468324100|FG002|Overall Study|Adverse Event|3|||
130232429|NCT01898078|468817759|FG000|Overall Study|Reason not Specified|0|||
130232430|NCT01898078|468817760|FG001|Overall Study|Reason not Specified|1|||
130232431|NCT01075048|468817761|FG000|Overall Study|Death|4|||
130232432|NCT01075048|468817762|FG001|Overall Study|Death|17|||
130232433|NCT01075048|468817763|FG002|Overall Study|Death|12|||
130232434|NCT01075048|468817761|FG000|Overall Study|Start of other or new therapy|4|||
130232435|NCT01075048|468817762|FG001|Overall Study|Start of other or new therapy|36|||
130232436|NCT01075048|468817763|FG002|Overall Study|Start of other or new therapy|46|||
130232437|NCT01075048|468817761|FG000|Overall Study|Withdrawal by Subject|1|||
130232438|NCT01075048|468817762|FG001|Overall Study|Withdrawal by Subject|6|||
130232439|NCT01075048|468817763|FG002|Overall Study|Withdrawal by Subject|3|||
130232440|NCT01075048|468817761|FG000|Overall Study|Lost to Follow-up|0|||
130232441|NCT01075048|468817762|FG001|Overall Study|Lost to Follow-up|1|||
130232442|NCT01075048|468817763|FG002|Overall Study|Lost to Follow-up|1|||
130232443|NCT01287936|468817764|FG000|Overall Study|Lost to Follow-up|0|||
130232444|NCT01287936|468817765|FG001|Overall Study|Lost to Follow-up|1|||
130232445|NCT01287936|468817766|FG002|Overall Study|Lost to Follow-up|1|||
130232446|NCT01140906|468817767|FG000|Overall Study|Adverse Event|7|||
130232447|NCT01140906|468817768|FG001|Overall Study|Adverse Event|10|||
130232448|NCT01140906|468817769|FG002|Overall Study|Adverse Event|17|||
130232449|NCT01140906|468817770|FG003|Overall Study|Adverse Event|7|||
130232450|NCT01140906|468817767|FG000|Overall Study|Lack of Efficacy|6|||
130232451|NCT01140906|468817768|FG001|Overall Study|Lack of Efficacy|8|||
130232452|NCT01140906|468817769|FG002|Overall Study|Lack of Efficacy|2|||
130232453|NCT01140906|468817770|FG003|Overall Study|Lack of Efficacy|1|||
130232454|NCT01140906|468817767|FG000|Overall Study|Non-compliance|0|||
130232455|NCT01140906|468817768|FG001|Overall Study|Non-compliance|1|||
130232456|NCT01140906|468817769|FG002|Overall Study|Non-compliance|0|||
130232457|NCT01140906|468817770|FG003|Overall Study|Non-compliance|1|||
130232458|NCT01140906|468817767|FG000|Overall Study|Protocol Violation|5|||
130232459|NCT01140906|468817768|FG001|Overall Study|Protocol Violation|3|||
130232460|NCT01140906|468817769|FG002|Overall Study|Protocol Violation|2|||
130232461|NCT01140906|468817770|FG003|Overall Study|Protocol Violation|1|||
130232462|NCT01140906|468817767|FG000|Overall Study|Withdrawal of consent|6|||
130232463|NCT01140906|468817768|FG001|Overall Study|Withdrawal of consent|6|||
130232464|NCT01140906|468817769|FG002|Overall Study|Withdrawal of consent|2|||
130232465|NCT01140906|468817770|FG003|Overall Study|Withdrawal of consent|2|||
130232466|NCT01140906|468817767|FG000|Overall Study|Lost to Follow-up|1|||
130232467|NCT01140906|468817768|FG001|Overall Study|Lost to Follow-up|1|||
130232468|NCT01140906|468817769|FG002|Overall Study|Lost to Follow-up|0|||
130232469|NCT01140906|468817770|FG003|Overall Study|Lost to Follow-up|2|||
130232470|NCT01140906|468817767|FG000|Overall Study|Administrative or other reason|0|||
130232471|NCT01140906|468817768|FG001|Overall Study|Administrative or other reason|5|||
130232472|NCT01140906|468817769|FG002|Overall Study|Administrative or other reason|3|||
130232473|NCT01140906|468817770|FG003|Overall Study|Administrative or other reason|2|||
130232474|NCT00703534|468817771|FG000|Overall Study|Adverse Event|14|||
130232475|NCT00703534|468817772|FG001|Overall Study|Adverse Event|3|||
130232476|NCT00703534|468817771|FG000|Overall Study|Withdrawal by Subject|8|||
130232477|NCT00703534|468817772|FG001|Overall Study|Withdrawal by Subject|7|||
130232478|NCT00703534|468817771|FG000|Overall Study|Incorrect Enrollment|6|||
130099977|NCT03733301|468324098|FG000|Overall Study|Withdrawal by Subject|3|||
130099978|NCT03733301|468324099|FG001|Overall Study|Withdrawal by Subject|5|||
130099979|NCT03733301|468324100|FG002|Overall Study|Withdrawal by Subject|1|||
130099980|NCT04637815|468324101|FG000|Overall Study|Death|1|||
130099981|NCT04637815|468324102|FG001|Overall Study|Death|0|||
130099982|NCT04637815|468324101|FG000|Overall Study|Lost to Follow-up|5|||
130099983|NCT04637815|468324102|FG001|Overall Study|Lost to Follow-up|2|||
130232479|NCT00703534|468817772|FG001|Overall Study|Incorrect Enrollment|6|||
130232480|NCT00703534|468817771|FG000|Overall Study|Lost to Follow-up|1|||
129884522|NCT04779242|467536436|FG000|Overall Study|Death|6|||
130232481|NCT00703534|468817772|FG001|Overall Study|Lost to Follow-up|4|||
130232482|NCT00703534|468817771|FG000|Overall Study|Severe Non Compliance|1|||
130232483|NCT00703534|468817772|FG001|Overall Study|Severe Non Compliance|5|||
130232484|NCT01316614|468817773|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
130232485|NCT01316614|468817773|FG000|Overall Study|Cytology slides not available for review|4|||
129884523|NCT04779242|467536437|FG001|Overall Study|Death|6|||
130099984|NCT00320801|468324103|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
130232486|NCT01316614|468817773|FG000|Overall Study|Cystic lesion|5|||
130232487|NCT01316614|468817773|FG000|Overall Study|Inadequate number of passes|2|||
130232488|NCT01316614|468817773|FG000|Overall Study|Medically unstable|1|||
130232489|NCT03427411|468817774|FG000|Overall Study|Screen failure - platelets too low|0|||
130232490|NCT03427411|468817775|FG001|Overall Study|Screen failure - platelets too low|1|||
130232491|NCT00076570|468817776|FG000|Overall Study|Drug intolerance|8|||
130232492|NCT00076570|468817777|FG001|Overall Study|Drug intolerance|8|||
130232493|NCT04889040|468817778|FG000|Overall Study|Withdrawal by Subject|3|||
130232494|NCT04889040|468817779|FG001|Overall Study|Withdrawal by Subject|3|||
130232495|NCT04889040|468817778|FG000|Overall Study|Lost to Follow-up|0|||
130232496|NCT04889040|468817779|FG001|Overall Study|Lost to Follow-up|1|||
130232497|NCT04889040|468817778|FG000|Overall Study|Adverse Event|2|||
130232498|NCT04889040|468817779|FG001|Overall Study|Adverse Event|1|||
130232499|NCT02058095|468817780|FG000|Overall Study|Adverse Event|1|||
130232500|NCT02058095|468817781|FG001|Overall Study|Adverse Event|0|||
130232501|NCT00998946|468817782|FG000|Overall Study|Lost to Follow-up|1|||
130232502|NCT00998946|468817782|FG000|Overall Study|Withdrawal by Subject|1|||
130232503|NCT00998946|468817782|FG000|Overall Study|Death|2|||
130232504|NCT00998946|468817782|FG000|Overall Study|Reason Unspecified|3|||
130232505|NCT00998946|468817782|FG000|Overall Study|Enrolled but not Dosed|2|||
130232506|NCT00977197|468817785|FG000|Overall Study|Withdrawal by Subject|3|||
130232507|NCT00977197|468817786|FG001|Overall Study|Withdrawal by Subject|4|||
130232508|NCT00977197|468817785|FG000|Overall Study|Adverse Event|3|||
130232509|NCT00977197|468817786|FG001|Overall Study|Adverse Event|1|||
130232510|NCT00977197|468817785|FG000|Overall Study|Lack of Efficacy|1|||
130232511|NCT00977197|468817786|FG001|Overall Study|Lack of Efficacy|0|||
130232512|NCT00977197|468817785|FG000|Overall Study|Lost to Follow-up|1|||
130232513|NCT00977197|468817786|FG001|Overall Study|Lost to Follow-up|3|||
130232514|NCT00977197|468817785|FG000|Overall Study|Nonadherence|1|||
130232515|NCT00977197|468817786|FG001|Overall Study|Nonadherence|1|||
130232516|NCT01432951|468817787|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
130232517|NCT00853385|468817788|FG000|Overall Study|Death|0|||
130232518|NCT00853385|468817789|FG001|Overall Study|Death|0|||
130232519|NCT00853385|468817790|FG002|Overall Study|Death|0|||
130232520|NCT00853385|468817791|FG003|Overall Study|Death|0|||
130232521|NCT00853385|468817792|FG004|Overall Study|Death|1|||
130232522|NCT00853385|468817788|FG000|Overall Study|Adverse Event|24|||
130232523|NCT00853385|468817789|FG001|Overall Study|Adverse Event|24|||
130232524|NCT00853385|468817790|FG002|Overall Study|Adverse Event|2|||
130232525|NCT00853385|468817791|FG003|Overall Study|Adverse Event|5|||
130232526|NCT00853385|468817792|FG004|Overall Study|Adverse Event|22|||
130232527|NCT00853385|468817788|FG000|Overall Study|Lack of Efficacy|6|||
130232528|NCT00853385|468817789|FG001|Overall Study|Lack of Efficacy|7|||
130232529|NCT00853385|468817790|FG002|Overall Study|Lack of Efficacy|3|||
130232530|NCT00853385|468817791|FG003|Overall Study|Lack of Efficacy|3|||
130232531|NCT00853385|468817792|FG004|Overall Study|Lack of Efficacy|6|||
130232532|NCT00853385|468817788|FG000|Overall Study|Lost to Follow-up|2|||
130232533|NCT00853385|468817789|FG001|Overall Study|Lost to Follow-up|1|||
130232534|NCT00853385|468817790|FG002|Overall Study|Lost to Follow-up|0|||
130232535|NCT00853385|468817791|FG003|Overall Study|Lost to Follow-up|0|||
130232536|NCT00853385|468817792|FG004|Overall Study|Lost to Follow-up|0|||
130232537|NCT00853385|468817788|FG000|Overall Study|Withdrawal by Subject|4|||
130232538|NCT00853385|468817789|FG001|Overall Study|Withdrawal by Subject|2|||
130232539|NCT00853385|468817790|FG002|Overall Study|Withdrawal by Subject|0|||
130232540|NCT00853385|468817791|FG003|Overall Study|Withdrawal by Subject|1|||
130232541|NCT00853385|468817792|FG004|Overall Study|Withdrawal by Subject|1|||
130232542|NCT00853385|468817788|FG000|Overall Study|Other|18|||
130232543|NCT00853385|468817789|FG001|Overall Study|Other|9|||
130232544|NCT00853385|468817790|FG002|Overall Study|Other|4|||
130232545|NCT00853385|468817791|FG003|Overall Study|Other|4|||
130232546|NCT00853385|468817792|FG004|Overall Study|Other|12|||
130232547|NCT02842866|468817795|FG000|Overall Study|Serious Adverse Event|0|||
130232548|NCT02842866|468817796|FG001|Overall Study|Serious Adverse Event|1|||
130232549|NCT02842866|468817795|FG000|Overall Study|Protocol Violation|4|||
130232550|NCT02842866|468817796|FG001|Overall Study|Protocol Violation|2|||
130232551|NCT02842866|468817795|FG000|Overall Study|Lost to Follow-up|2|||
130232552|NCT02842866|468817796|FG001|Overall Study|Lost to Follow-up|0|||
130232553|NCT02842866|468817795|FG000|Overall Study|Withdrawal by Subject|1|||
130232554|NCT02842866|468817796|FG001|Overall Study|Withdrawal by Subject|0|||
130232555|NCT00577408|468817797|FG000|Overall Study|Stopped attending study visits|9|||
130232556|NCT00577408|468817798|FG001|Overall Study|Stopped attending study visits|11|||
130232557|NCT00577408|468817797|FG000|Overall Study|Continued opioid use|3|||
130232558|NCT00577408|468817798|FG001|Overall Study|Continued opioid use|2|||
130232559|NCT00577408|468817797|FG000|Overall Study|Non-compliance with study meds|0|||
130232560|NCT00577408|468817798|FG001|Overall Study|Non-compliance with study meds|3|||
130232561|NCT00577408|468817797|FG000|Overall Study|Refused Oral Naltrexone|0|||
130232562|NCT00577408|468817798|FG001|Overall Study|Refused Oral Naltrexone|1|||
130232563|NCT00577408|468817797|FG000|Overall Study|Moved out of state|0|||
130232564|NCT00577408|468817798|FG001|Overall Study|Moved out of state|1|||
130232565|NCT00577408|468817797|FG000|Overall Study|Scheduling Issues|0|||
130232566|NCT00577408|468817798|FG001|Overall Study|Scheduling Issues|3|||
130232567|NCT00577408|468817797|FG000|Overall Study|Death|0|||
130232568|NCT00577408|468817798|FG001|Overall Study|Death|1|||
130232569|NCT00577408|468817797|FG000|Overall Study|Psychiatric hospitalization|0|||
130232570|NCT00577408|468817798|FG001|Overall Study|Psychiatric hospitalization|1|||
130232571|NCT00656617|468817799|FG000|Overall Study|Adverse Event|1|||
130232572|NCT00656617|468817799|FG000|Overall Study|Death|2|||
130232573|NCT00656617|468817799|FG000|Overall Study|Insurance Issues|2|||
130232574|NCT00656617|468817799|FG000|Overall Study|Move to different clinical trial|2|||
130232575|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
130232576|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
130232577|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
130232578|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
130232579|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
130232580|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
130232581|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
130232582|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
130232583|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130232584|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130232585|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
130232586|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
130232587|NCT02349386|468817808|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130232588|NCT02349386|468817809|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130232589|NCT02349386|468817810|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
130232590|NCT02349386|468817811|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
130232591|NCT02349386|468817808|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
130232592|NCT02349386|468817809|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
130232593|NCT02349386|468817810|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
130232594|NCT02349386|468817811|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
130232595|NCT02349386|468817808|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130232596|NCT02349386|468817809|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130232597|NCT02349386|468817810|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
130232598|NCT02349386|468817811|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
130232599|NCT00676143|468817812|FG000|Overall Study|Adverse Event|34|||
130232600|NCT00676143|468817813|FG001|Overall Study|Adverse Event|60|||
130232601|NCT00676143|468817812|FG000|Overall Study|Death|4|||
130232602|NCT00676143|468817813|FG001|Overall Study|Death|4|||
130232603|NCT00676143|468817812|FG000|Overall Study|Lack of Efficacy|0|||
130232604|NCT00676143|468817813|FG001|Overall Study|Lack of Efficacy|6|||
130232605|NCT00676143|468817812|FG000|Overall Study|Lost to Follow-up|0|||
130232606|NCT00676143|468817813|FG001|Overall Study|Lost to Follow-up|13|||
130232607|NCT00676143|468817812|FG000|Overall Study|Physician Decision|5|||
130232608|NCT00676143|468817813|FG001|Overall Study|Physician Decision|8|||
130232609|NCT00676143|468817812|FG000|Overall Study|Protocol Violation|4|||
130232610|NCT00676143|468817813|FG001|Overall Study|Protocol Violation|8|||
130232611|NCT00676143|468817812|FG000|Overall Study|Withdrawal by Subject|24|||
130232612|NCT00676143|468817813|FG001|Overall Study|Withdrawal by Subject|42|||
130232613|NCT00676143|468817812|FG000|Overall Study|Discontinuation of study by sponsor|65|||
130232614|NCT00676143|468817813|FG001|Overall Study|Discontinuation of study by sponsor|88|||
130232615|NCT00676143|468817812|FG000|Overall Study|Failed to return|2|||
130232616|NCT00676143|468817813|FG001|Overall Study|Failed to return|1|||
130232617|NCT00676143|468817812|FG000|Overall Study|Loss of caregiver|5|||
130232618|NCT00676143|468817813|FG001|Overall Study|Loss of caregiver|3|||
130232619|NCT00676143|468817812|FG000|Overall Study|Other|11|||
130232620|NCT00676143|468817813|FG001|Overall Study|Other|20|||
130232621|NCT00676143|468817812|FG000|Overall Study|Participant participation unknown|1|||
130232622|NCT00676143|468817813|FG001|Overall Study|Participant participation unknown|4|||
130232623|NCT00676143|468817812|FG000|Overall Study|Vasogenic edema recurrence|1|||
130232624|NCT00676143|468817813|FG001|Overall Study|Vasogenic edema recurrence|3|||
130232625|NCT01901185|468817814|FG000|Overall Study|Withdrawal by Subject|2|||
130232626|NCT00701363|468817817|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
130232627|NCT00701363|468817818|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130232628|NCT00701363|468817819|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130232629|NCT00701363|468817820|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
130232630|NCT00701363|468817817|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
130025014|NCT05162066|468052176|FG002|Overall Study|Perceived lack of efficacy|0|||
130025015|NCT01871090|468052177|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
130025016|NCT01871090|468052178|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
130232631|NCT00701363|468817818|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
130232632|NCT00701363|468817819|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
130232633|NCT00701363|468817820|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
130232634|NCT00701363|468817817|FG000|Treatment Phase 1|Adverse Event|7|||
130232635|NCT00701363|468817818|FG001|Treatment Phase 1|Adverse Event|0|||
130232636|NCT00701363|468817819|FG002|Treatment Phase 1|Adverse Event|0|||
130232637|NCT00701363|468817820|FG003|Treatment Phase 1|Adverse Event|0|||
130232638|NCT00701363|468817817|FG000|Treatment Phase 1|Protocol Violation|1|||
130232639|NCT00701363|468817818|FG001|Treatment Phase 1|Protocol Violation|0|||
130232640|NCT00701363|468817819|FG002|Treatment Phase 1|Protocol Violation|0|||
130232641|NCT00701363|468817820|FG003|Treatment Phase 1|Protocol Violation|0|||
130232642|NCT00701363|468817817|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
130232643|NCT00701363|468817818|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
130232644|NCT00701363|468817819|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
130232645|NCT00701363|468817820|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
130232646|NCT00701363|468817817|FG000|Treatment Phase 1|Lack of Efficacy|1|||
130232647|NCT00701363|468817818|FG001|Treatment Phase 1|Lack of Efficacy|0|||
130232648|NCT00701363|468817819|FG002|Treatment Phase 1|Lack of Efficacy|0|||
130232649|NCT00701363|468817820|FG003|Treatment Phase 1|Lack of Efficacy|0|||
130232650|NCT00701363|468817817|FG000|Treatment Phase 2|Adverse Event|0|||
130232651|NCT00701363|468817818|FG001|Treatment Phase 2|Adverse Event|0|||
130232652|NCT00701363|468817819|FG002|Treatment Phase 2|Adverse Event|1|||
130232653|NCT00701363|468817820|FG003|Treatment Phase 2|Adverse Event|0|||
130232654|NCT00701363|468817817|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
130232655|NCT00701363|468817818|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
130232656|NCT00701363|468817819|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
130232657|NCT00701363|468817820|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
130232658|NCT04759131|468817821|FG000|Overall Study|Investigator's discretion|1|||
130232659|NCT04759131|468817822|FG001|Overall Study|Investigator's discretion|0|||
130232660|NCT04759131|468817821|FG000|Overall Study|Subject withdrawal|1|||
130232661|NCT04759131|468817822|FG001|Overall Study|Subject withdrawal|0|||
130232662|NCT03692949|468817823|FG000|Overall Study|Lost to Follow-up|0|||
130232663|NCT03692949|468817824|FG001|Overall Study|Lost to Follow-up|0|||
130232664|NCT03692949|468817825|FG002|Overall Study|Lost to Follow-up|0|||
130232665|NCT03692949|468817826|FG003|Overall Study|Lost to Follow-up|0|||
130232666|NCT03692949|468817827|FG004|Overall Study|Lost to Follow-up|0|||
130232667|NCT03692949|468817828|FG005|Overall Study|Lost to Follow-up|0|||
130232668|NCT03692949|468817829|FG006|Overall Study|Lost to Follow-up|0|||
130232669|NCT03692949|468817830|FG007|Overall Study|Lost to Follow-up|1|||
130232670|NCT02592824|468817838|FG000|Overall Study|Protocol Violation|5|||
130232671|NCT02592824|468817839|FG001|Overall Study|Protocol Violation|3|||
130232672|NCT02592824|468817838|FG000|Overall Study|Lost to Follow-up|2|||
130232673|NCT02592824|468817839|FG001|Overall Study|Lost to Follow-up|1|||
130232674|NCT03426878|468817840|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
130232675|NCT03426878|468817840|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
130232676|NCT03426878|468817840|FG000|Overall Study|Declined to receive results|3|||
130232677|NCT03426878|468817840|FG000|Overall Study|Received negative results by mailed letter|65|||
130232678|NCT03426878|468817840|FG000|Overall Study|Lost to Follow-up|177|||
130232679|NCT01286129|468817841|FG000|Overall Study|Withdrawal by Subject|4|||
130232680|NCT01286129|468817842|FG001|Overall Study|Withdrawal by Subject|1|||
130232681|NCT01286129|468817841|FG000|Overall Study|Could not comply with study requirements|4|||
130232682|NCT01286129|468817842|FG001|Overall Study|Could not comply with study requirements|4|||
130232683|NCT05233761|468817847|FG000|Treatment Period A|Withdrawal by Subject|12|||
130232684|NCT05233761|468817848|FG001|Treatment Period A|Withdrawal by Subject|10|||
130232685|NCT05233761|468817847|FG000|Treatment Period A|Lost to Follow-up|6|||
130232686|NCT05233761|468817848|FG001|Treatment Period A|Lost to Follow-up|12|||
130232687|NCT05233761|468817847|FG000|Treatment Period A|Protocol Violation|8|||
130232688|NCT05233761|468817848|FG001|Treatment Period A|Protocol Violation|15|||
130232689|NCT01604785|468817849|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
130232690|NCT01604785|468817850|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
130232691|NCT00869960|468817851|FG000|Overall Study|Lost to Follow-up|2|||
130232692|NCT01654276|468817861|FG000|Overall Study|Lack of Efficacy|1|||
130232693|NCT01654276|468817861|FG000|Overall Study|Lost to Follow-up|4|||
130232694|NCT01654276|468817861|FG000|Overall Study|Withdrawal by Subject|1|||
130232695|NCT01991795|468817862|FG000|Overall Study|Lost to Follow-up|6|||
130232696|NCT01991795|468817863|FG001|Overall Study|Lost to Follow-up|4|||
130232697|NCT01991795|468817862|FG000|Overall Study|Withdrawal by Subject|117|||
130232698|NCT01991795|468817863|FG001|Overall Study|Withdrawal by Subject|94|||
130232699|NCT01991795|468817862|FG000|Overall Study|Site prematurely closed by sponsor|26|||
130232700|NCT01991795|468817863|FG001|Overall Study|Site prematurely closed by sponsor|25|||
130232701|NCT03344757|468817864|FG000|Overall Study|Withdrawal by Subject|18|||
130232702|NCT03344757|468817865|FG001|Overall Study|Withdrawal by Subject|16|||
130232703|NCT03344757|468817864|FG000|Overall Study|Lost to Follow-up|0|||
130232704|NCT03344757|468817865|FG001|Overall Study|Lost to Follow-up|2|||
130232705|NCT04798027|468817871|FG000|Overall Study|Protocol Violation|0|||
130232706|NCT04798027|468817872|FG001|Overall Study|Protocol Violation|0|||
130232707|NCT04798027|468817873|FG002|Overall Study|Protocol Violation|0|||
130232708|NCT04798027|468817874|FG003|Overall Study|Protocol Violation|0|||
130232709|NCT04798027|468817875|FG004|Overall Study|Protocol Violation|1|||
130232710|NCT04798027|468817876|FG005|Overall Study|Protocol Violation|0|||
130232711|NCT04798027|468817877|FG006|Overall Study|Protocol Violation|0|||
130232712|NCT04798027|468817878|FG007|Overall Study|Protocol Violation|1|||
130232713|NCT04798027|468817879|FG008|Overall Study|Protocol Violation|0|||
130232714|NCT04798027|468817871|FG000|Overall Study|Withdrawal by Subject|1|||
130232715|NCT04798027|468817872|FG001|Overall Study|Withdrawal by Subject|0|||
130232716|NCT04798027|468817873|FG002|Overall Study|Withdrawal by Subject|1|||
130232717|NCT04798027|468817874|FG003|Overall Study|Withdrawal by Subject|1|||
130025017|NCT01871090|468052177|FG000|Overall Study|Interrogation not completed correctly|1|||
130025018|NCT01871090|468052178|FG001|Overall Study|Interrogation not completed correctly|0|||
130025019|NCT01871090|468052177|FG000|Overall Study|Subject Non-Compliance|0|||
130025020|NCT01871090|468052178|FG001|Overall Study|Subject Non-Compliance|1|||
130232718|NCT04798027|468817875|FG004|Overall Study|Withdrawal by Subject|1|||
130232719|NCT04798027|468817876|FG005|Overall Study|Withdrawal by Subject|1|||
130232720|NCT04798027|468817877|FG006|Overall Study|Withdrawal by Subject|3|||
130232721|NCT04798027|468817878|FG007|Overall Study|Withdrawal by Subject|2|||
130232722|NCT04798027|468817879|FG008|Overall Study|Withdrawal by Subject|2|||
130025021|NCT00804687|468052179|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
130232723|NCT04798027|468817871|FG000|Overall Study|Lost to Follow-up|1|||
130232724|NCT04798027|468817872|FG001|Overall Study|Lost to Follow-up|3|||
130232725|NCT04798027|468817873|FG002|Overall Study|Lost to Follow-up|0|||
130232726|NCT04798027|468817874|FG003|Overall Study|Lost to Follow-up|0|||
130232727|NCT04798027|468817875|FG004|Overall Study|Lost to Follow-up|0|||
130025022|NCT00804687|468052180|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
130025023|NCT00804687|468052181|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
130025024|NCT00804687|468052182|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
130025025|NCT00804687|468052183|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
130025026|NCT00804687|468052184|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
130025027|NCT00804687|468052179|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
130025028|NCT00804687|468052180|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
130025029|NCT00804687|468052181|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
130099985|NCT00320801|468324104|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
130099986|NCT00320801|468324105|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
130099987|NCT00320801|468324106|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
130099988|NCT00320801|468324103|FG000|Open-label Run-in Period|Adverse Event|33|||
130232728|NCT04798027|468817876|FG005|Overall Study|Lost to Follow-up|1|||
130232729|NCT04798027|468817877|FG006|Overall Study|Lost to Follow-up|0|||
130232730|NCT04798027|468817878|FG007|Overall Study|Lost to Follow-up|0|||
130232731|NCT04798027|468817879|FG008|Overall Study|Lost to Follow-up|1|||
130232732|NCT04798027|468817871|FG000|Overall Study|Withdrawal by Sponsor|8|||
130232733|NCT04798027|468817872|FG001|Overall Study|Withdrawal by Sponsor|22|||
130232734|NCT04798027|468817873|FG002|Overall Study|Withdrawal by Sponsor|9|||
130232735|NCT04798027|468817874|FG003|Overall Study|Withdrawal by Sponsor|26|||
130232736|NCT04798027|468817875|FG004|Overall Study|Withdrawal by Sponsor|24|||
130232737|NCT04798027|468817876|FG005|Overall Study|Withdrawal by Sponsor|11|||
130232738|NCT04798027|468817877|FG006|Overall Study|Withdrawal by Sponsor|25|||
130232739|NCT04798027|468817878|FG007|Overall Study|Withdrawal by Sponsor|26|||
130232740|NCT04798027|468817879|FG008|Overall Study|Withdrawal by Sponsor|11|||
130232741|NCT03104374|468817880|FG000|Period 1|Adverse Event|7|||
130232742|NCT03104374|468817881|FG001|Period 1|Adverse Event|7|||
130232743|NCT03104374|468817882|FG002|Period 1|Adverse Event|12|||
130232744|NCT03104374|468817883|FG003|Period 1|Adverse Event|14|||
130232745|NCT03104374|468817880|FG000|Period 1|Withdrawal by Subject|18|||
130232746|NCT03104374|468817881|FG001|Period 1|Withdrawal by Subject|9|||
130232747|NCT03104374|468817882|FG002|Period 1|Withdrawal by Subject|10|||
130232748|NCT03104374|468817883|FG003|Period 1|Withdrawal by Subject|17|||
130232749|NCT03104374|468817880|FG000|Period 1|Lost to Follow-up|4|||
130232750|NCT03104374|468817881|FG001|Period 1|Lost to Follow-up|4|||
130232751|NCT03104374|468817882|FG002|Period 1|Lost to Follow-up|6|||
130232752|NCT03104374|468817883|FG003|Period 1|Lost to Follow-up|8|||
130232753|NCT03104374|468817880|FG000|Period 1|Lack of Efficacy|6|||
130232754|NCT03104374|468817881|FG001|Period 1|Lack of Efficacy|7|||
130232755|NCT03104374|468817882|FG002|Period 1|Lack of Efficacy|12|||
130232756|NCT03104374|468817883|FG003|Period 1|Lack of Efficacy|6|||
130232757|NCT03104374|468817880|FG000|Period 1|Other|2|||
130232758|NCT03104374|468817881|FG001|Period 1|Other|2|||
130232759|NCT03104374|468817882|FG002|Period 1|Other|4|||
130232760|NCT03104374|468817883|FG003|Period 1|Other|7|||
130232761|NCT03104374|468817880|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130232762|NCT03104374|468817881|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130232763|NCT03104374|468817882|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
130232764|NCT03104374|468817883|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
130232765|NCT03104374|468817880|FG000|Period 2|Adverse Event|4|||
130232766|NCT03104374|468817881|FG001|Period 2|Adverse Event|7|||
130232767|NCT03104374|468817882|FG002|Period 2|Adverse Event|10|||
130232768|NCT03104374|468817883|FG003|Period 2|Adverse Event|10|||
130232769|NCT03104374|468817880|FG000|Period 2|Withdrawal by Subject|3|||
130232770|NCT03104374|468817881|FG001|Period 2|Withdrawal by Subject|7|||
130232771|NCT03104374|468817882|FG002|Period 2|Withdrawal by Subject|13|||
130232772|NCT03104374|468817883|FG003|Period 2|Withdrawal by Subject|16|||
130232773|NCT03104374|468817880|FG000|Period 2|Lost to Follow-up|2|||
130232774|NCT03104374|468817881|FG001|Period 2|Lost to Follow-up|2|||
130232775|NCT03104374|468817882|FG002|Period 2|Lost to Follow-up|3|||
130232776|NCT03104374|468817883|FG003|Period 2|Lost to Follow-up|5|||
130232777|NCT03104374|468817880|FG000|Period 2|Lack of Efficacy|2|||
130232778|NCT03104374|468817881|FG001|Period 2|Lack of Efficacy|4|||
130232779|NCT03104374|468817882|FG002|Period 2|Lack of Efficacy|7|||
130232780|NCT03104374|468817883|FG003|Period 2|Lack of Efficacy|4|||
130232781|NCT03104374|468817880|FG000|Period 2|COVID-19 Infection|0|||
130232782|NCT03104374|468817881|FG001|Period 2|COVID-19 Infection|0|||
130232783|NCT03104374|468817882|FG002|Period 2|COVID-19 Infection|1|||
130232784|NCT03104374|468817883|FG003|Period 2|COVID-19 Infection|0|||
130232785|NCT03104374|468817880|FG000|Period 2|Other|3|||
130232786|NCT03104374|468817881|FG001|Period 2|Other|2|||
130232787|NCT03104374|468817882|FG002|Period 2|Other|2|||
130232788|NCT03104374|468817883|FG003|Period 2|Other|4|||
130232789|NCT02121210|468817886|FG000|Overall Study|Adverse Event|5|||
130232790|NCT02121210|468817887|FG001|Overall Study|Adverse Event|7|||
130232791|NCT02121210|468817886|FG000|Overall Study|Lack of Efficacy|2|||
130232792|NCT02121210|468817887|FG001|Overall Study|Lack of Efficacy|0|||
130025030|NCT00804687|468052182|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
130025031|NCT00804687|468052183|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
130025032|NCT00804687|468052184|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
130025033|NCT00804687|468052179|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
130025034|NCT00804687|468052180|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
130025035|NCT00804687|468052181|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
130232793|NCT02121210|468817886|FG000|Overall Study|Other than specified above|0|||
130232794|NCT02121210|468817887|FG001|Overall Study|Other than specified above|2|||
130232795|NCT04609514|468817888|FG000|Overall Study|Lost to Follow-up|5|||
130232796|NCT04609514|468817889|FG001|Overall Study|Lost to Follow-up|4|||
130232797|NCT04609514|468817888|FG000|Overall Study|Withdrawal by PI|0|||
130232798|NCT04609514|468817889|FG001|Overall Study|Withdrawal by PI|2|||
130232799|NCT00909870|468817890|FG000|Overall Study|Adverse Event|13|||
130232800|NCT00909870|468817891|FG001|Overall Study|Adverse Event|7|||
130232801|NCT00909870|468817890|FG000|Overall Study|Protocol Violation|1|||
130232802|NCT00909870|468817891|FG001|Overall Study|Protocol Violation|2|||
130232803|NCT00909870|468817890|FG000|Overall Study|Withdrawal by Subject|5|||
130232804|NCT00909870|468817891|FG001|Overall Study|Withdrawal by Subject|8|||
130232805|NCT00909870|468817890|FG000|Overall Study|Lost to Follow-up|3|||
130232806|NCT00909870|468817891|FG001|Overall Study|Lost to Follow-up|3|||
130232807|NCT00909870|468817890|FG000|Overall Study|Physician Decision|0|||
130232808|NCT00909870|468817891|FG001|Overall Study|Physician Decision|2|||
130232809|NCT00909870|468817890|FG000|Overall Study|Other|1|||
130232810|NCT00909870|468817891|FG001|Overall Study|Other|5|||
130232811|NCT01316575|468817892|FG000|Overall Study|Withdrawal by Subject|2|||
130025036|NCT00804687|468052182|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
130025037|NCT00804687|468052183|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
130025038|NCT00804687|468052184|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
130025039|NCT00804687|468052179|FG000|Period 5: Treatment Period|Positive drug test|1|||
130025040|NCT00804687|468052180|FG001|Period 5: Treatment Period|Positive drug test|0|||
130025041|NCT00804687|468052181|FG002|Period 5: Treatment Period|Positive drug test|0|||
130025042|NCT00804687|468052182|FG003|Period 5: Treatment Period|Positive drug test|0|||
130025043|NCT00804687|468052183|FG004|Period 5: Treatment Period|Positive drug test|0|||
130025044|NCT00804687|468052184|FG005|Period 5: Treatment Period|Positive drug test|0|||
130025045|NCT01220414|468052185|FG000|Overall Study|Withdrawal by Subject|1|||
130232812|NCT01316575|468817893|FG001|Overall Study|Withdrawal by Subject|0|||
130025046|NCT01220414|468052186|FG001|Overall Study|Withdrawal by Subject|0|||
130232813|NCT01316575|468817892|FG000|Overall Study|Required alternate treatment|0|||
130232814|NCT01316575|468817893|FG001|Overall Study|Required alternate treatment|1|||
130232815|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
130232816|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
130232817|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130025047|NCT01220414|468052187|FG002|Overall Study|Withdrawal by Subject|0|||
130025048|NCT01220414|468052188|FG003|Overall Study|Withdrawal by Subject|1|||
130025049|NCT02415712|468052195|FG000|Overall Study|Protocol Violation|16|||
130025050|NCT02658448|468052199|FG000|Overall Study|Lost to Follow-up|1|||
130025051|NCT03106779|468052200|FG000|Overall Study|Lack of Efficacy|33|||
130025052|NCT03106779|468052201|FG001|Overall Study|Lack of Efficacy|24|||
130025053|NCT03106779|468052200|FG000|Overall Study|Adverse Event|8|||
130025054|NCT03106779|468052201|FG001|Overall Study|Adverse Event|16|||
130025055|NCT03106779|468052200|FG000|Overall Study|Physician Decision|10|||
130025056|NCT03106779|468052201|FG001|Overall Study|Physician Decision|6|||
130025057|NCT03106779|468052200|FG000|Overall Study|Patient/guardian decision|4|||
130025058|NCT03106779|468052201|FG001|Overall Study|Patient/guardian decision|3|||
130025059|NCT03106779|468052200|FG000|Overall Study|Progressive disease|1|||
130025060|NCT03106779|468052201|FG001|Overall Study|Progressive disease|3|||
130025061|NCT03106779|468052200|FG000|Overall Study|Lost to Follow-up|1|||
130025062|NCT03106779|468052201|FG001|Overall Study|Lost to Follow-up|2|||
130232818|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232819|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232820|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232821|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232822|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232823|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232824|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
130232825|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
130232826|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
130232827|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232828|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232829|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232830|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232831|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232832|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232833|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232834|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
130232835|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
130232836|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130025063|NCT03106779|468052200|FG000|Overall Study|Death|1|||
130025064|NCT03106779|468052201|FG001|Overall Study|Death|0|||
130232837|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232838|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232839|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232840|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130025065|NCT03106779|468052200|FG000|Overall Study|Protocol Violation|1|||
130025066|NCT03106779|468052201|FG001|Overall Study|Protocol Violation|0|||
130232841|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232842|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232843|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232844|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
130232845|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
130232846|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
130232847|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232848|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232849|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232850|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232851|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232852|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130025067|NCT03106779|468052200|FG000|Overall Study|Not treated|1|||
130025068|NCT03106779|468052201|FG001|Overall Study|Not treated|0|||
130025069|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
130025070|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
130025071|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
130025072|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
130025073|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
130025074|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
130025075|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
130025076|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
130025077|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
130025078|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
130025079|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
130025080|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
130025081|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
130025082|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
130025083|NCT02288247|468052202|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
130025084|NCT02288247|468052203|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
130025085|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
130025086|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
130025087|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
130025088|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
130025089|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
130025090|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
130025091|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
130025092|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
130025093|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
130025094|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
130025095|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
130025096|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
130025097|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
130025098|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
130025099|NCT02288247|468052202|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
130025100|NCT02288247|468052203|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
130025101|NCT04093531|468052204|FG000|Overall Study|failed screening|4|||
130025102|NCT03634800|468052205|FG000|Overall Study|Adverse Event|1|||
130025103|NCT03634800|468052205|FG000|Overall Study|Disease Progression|4|||
130025104|NCT03634800|468052205|FG000|Overall Study|Withdrawal by Subject|1|||
130025105|NCT00132730|468052218|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
130232853|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232854|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
130232855|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
130232856|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
130232857|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232858|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232859|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232860|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232861|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232862|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130025106|NCT00132730|468052219|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
130025107|NCT00132730|468052220|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
130025108|NCT00132730|468052221|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
130025109|NCT00132730|468052222|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
130025110|NCT00132730|468052223|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
130025111|NCT00132730|468052218|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
130025112|NCT00132730|468052219|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
130025113|NCT00132730|468052220|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130025114|NCT00132730|468052221|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130025115|NCT00132730|468052222|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130025116|NCT00132730|468052223|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
130025117|NCT00132730|468052218|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
130232863|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232864|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
130232865|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
130232866|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
130232867|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232868|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130025118|NCT00132730|468052219|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
130025119|NCT00132730|468052220|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
130025120|NCT00132730|468052221|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
130025121|NCT00132730|468052222|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
130025122|NCT00132730|468052223|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
130025123|NCT00132730|468052218|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130025124|NCT00132730|468052219|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130025125|NCT00132730|468052220|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
130025126|NCT00132730|468052221|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
130025127|NCT00132730|468052222|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130025128|NCT00132730|468052223|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
130025129|NCT00132730|468052218|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130025130|NCT00132730|468052219|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130025131|NCT00132730|468052220|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
130025132|NCT00132730|468052221|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
130025133|NCT00132730|468052222|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130025134|NCT00132730|468052223|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
130025135|NCT00132730|468052218|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130025136|NCT00132730|468052219|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130025137|NCT00132730|468052220|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130025138|NCT00132730|468052221|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
130025139|NCT00132730|468052222|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130025140|NCT00132730|468052223|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
130025141|NCT00132730|468052218|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130025142|NCT00132730|468052219|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130025143|NCT00132730|468052220|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
130025144|NCT00132730|468052221|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
130025145|NCT00132730|468052222|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130025146|NCT00132730|468052223|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
130025147|NCT00132730|468052218|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130025148|NCT00132730|468052219|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130025149|NCT00132730|468052220|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130025150|NCT00132730|468052221|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
130025151|NCT00132730|468052222|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
130025152|NCT00132730|468052223|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
130025153|NCT00132730|468052218|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130025154|NCT00132730|468052219|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130025155|NCT00132730|468052220|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130025156|NCT00132730|468052221|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130025157|NCT00132730|468052222|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
130025158|NCT00132730|468052223|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
130025159|NCT00132730|468052218|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130025160|NCT00132730|468052219|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130025161|NCT00132730|468052220|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130025162|NCT00132730|468052221|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130025163|NCT00132730|468052222|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
130025164|NCT00132730|468052223|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
130025165|NCT00132730|468052218|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130025166|NCT00132730|468052219|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130025167|NCT00132730|468052220|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130025168|NCT00132730|468052221|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130025169|NCT00132730|468052222|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
130232869|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232870|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232871|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232872|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232873|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232874|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
130232875|NCT01232283|468817894|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
130232876|NCT01232283|468817895|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
130232877|NCT01232283|468817896|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232878|NCT01232283|468817897|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232879|NCT01232283|468817898|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232880|NCT01232283|468817899|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232881|NCT01232283|468817900|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232882|NCT01232283|468817901|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232883|NCT01232283|468817902|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232884|NCT01232283|468817903|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
130232885|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232886|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232887|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
130232888|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
130232889|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232890|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232891|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129884524|NCT04779242|467536436|FG000|Overall Study|COVID-19 related reasons|2|||
130099989|NCT00320801|468324104|FG001|Open-label Run-in Period|Adverse Event|0|||
130099990|NCT00320801|468324105|FG002|Open-label Run-in Period|Adverse Event|0|||
130099991|NCT00320801|468324106|FG003|Open-label Run-in Period|Adverse Event|0|||
130232892|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130025170|NCT00132730|468052223|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
130025171|NCT00132730|468052218|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130025172|NCT00132730|468052219|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130025173|NCT00132730|468052220|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130025174|NCT00132730|468052221|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
130025175|NCT00132730|468052222|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
130025176|NCT00132730|468052223|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
130025177|NCT01554579|468052224|FG000|Overall Study|Adverse Event|6|||
130025178|NCT01554579|468052225|FG001|Overall Study|Adverse Event|25|||
130025179|NCT01554579|468052224|FG000|Overall Study|Lack of Efficacy|2|||
130025180|NCT01554579|468052225|FG001|Overall Study|Lack of Efficacy|1|||
130025181|NCT01554579|468052224|FG000|Overall Study|Withdrawal by Subject|2|||
130025182|NCT01554579|468052225|FG001|Overall Study|Withdrawal by Subject|1|||
130025183|NCT01192347|468052226|FG000|Overall Study|Death|3|||
130025184|NCT01192347|468052226|FG000|Overall Study|Lost to Follow-up|3|||
130025185|NCT01192347|468052226|FG000|Overall Study|Withdrawal by Subject|1|||
130232893|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232894|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
130232895|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232896|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130025186|NCT01192347|468052226|FG000|Overall Study|Adverse Event|1|||
130025187|NCT01192347|468052226|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
130025188|NCT01192347|468052226|FG000|Overall Study|Patient seen in different hospital|1|||
130025189|NCT01192347|468052226|FG000|Overall Study|Patient not visiting hospital regularly|1|||
130025190|NCT01192347|468052226|FG000|Overall Study|Patient did not show up for visits|1|||
130025191|NCT01463098|468052227|FG000|Part A (11 Days)|Participant Choice|2|||
130025192|NCT01463098|468052228|FG001|Part A (11 Days)|Participant Choice|0|||
130025193|NCT01463098|468052229|FG002|Part A (11 Days)|Participant Choice|0|||
130025194|NCT01463098|468052230|FG003|Part A (11 Days)|Participant Choice|0|||
130025195|NCT01463098|468052231|FG004|Part A (11 Days)|Participant Choice|0|||
130025196|NCT01463098|468052232|FG005|Part A (11 Days)|Participant Choice|0|||
130025197|NCT01463098|468052233|FG006|Part A (11 Days)|Participant Choice|0|||
130025198|NCT01463098|468052234|FG007|Part A (11 Days)|Participant Choice|0|||
130025199|NCT01463098|468052235|FG008|Part A (11 Days)|Participant Choice|1|||
130025200|NCT01463098|468052236|FG009|Part A (11 Days)|Participant Choice|0|||
130025201|NCT01463098|468052237|FG010|Part A (11 Days)|Participant Choice|0|||
130025202|NCT01463098|468052238|FG011|Part A (11 Days)|Participant Choice|0|||
130025203|NCT01463098|468052239|FG012|Part A (11 Days)|Participant Choice|0|||
130025204|NCT01463098|468052240|FG013|Part A (11 Days)|Participant Choice|0|||
130025205|NCT01463098|468052227|FG000|Part A (11 Days)|Lost to Follow-up|0|||
130025206|NCT01463098|468052228|FG001|Part A (11 Days)|Lost to Follow-up|0|||
130025207|NCT01463098|468052229|FG002|Part A (11 Days)|Lost to Follow-up|0|||
130025208|NCT01463098|468052230|FG003|Part A (11 Days)|Lost to Follow-up|0|||
130025209|NCT01463098|468052231|FG004|Part A (11 Days)|Lost to Follow-up|1|||
130025210|NCT01463098|468052232|FG005|Part A (11 Days)|Lost to Follow-up|0|||
130025211|NCT01463098|468052233|FG006|Part A (11 Days)|Lost to Follow-up|0|||
130025212|NCT01463098|468052234|FG007|Part A (11 Days)|Lost to Follow-up|0|||
130025213|NCT01463098|468052235|FG008|Part A (11 Days)|Lost to Follow-up|0|||
130025214|NCT01463098|468052236|FG009|Part A (11 Days)|Lost to Follow-up|0|||
130025215|NCT01463098|468052237|FG010|Part A (11 Days)|Lost to Follow-up|0|||
130025216|NCT01463098|468052238|FG011|Part A (11 Days)|Lost to Follow-up|0|||
130025217|NCT01463098|468052239|FG012|Part A (11 Days)|Lost to Follow-up|0|||
130025218|NCT01463098|468052240|FG013|Part A (11 Days)|Lost to Follow-up|0|||
130025219|NCT01463098|468052227|FG000|Part B (11 Days)|Participant Choice|0|||
130025220|NCT01463098|468052228|FG001|Part B (11 Days)|Participant Choice|0|||
130025221|NCT01463098|468052229|FG002|Part B (11 Days)|Participant Choice|0|||
130025222|NCT01463098|468052230|FG003|Part B (11 Days)|Participant Choice|0|||
130025223|NCT01463098|468052231|FG004|Part B (11 Days)|Participant Choice|0|||
130025224|NCT01463098|468052232|FG005|Part B (11 Days)|Participant Choice|0|||
130025225|NCT01463098|468052233|FG006|Part B (11 Days)|Participant Choice|0|||
130232897|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
130025226|NCT01463098|468052234|FG007|Part B (11 Days)|Participant Choice|0|||
130025227|NCT01463098|468052235|FG008|Part B (11 Days)|Participant Choice|0|||
130025228|NCT01463098|468052236|FG009|Part B (11 Days)|Participant Choice|0|||
130025229|NCT01463098|468052237|FG010|Part B (11 Days)|Participant Choice|0|||
130025230|NCT01463098|468052238|FG011|Part B (11 Days)|Participant Choice|1|||
130025231|NCT01463098|468052239|FG012|Part B (11 Days)|Participant Choice|0|||
130025232|NCT01463098|468052240|FG013|Part B (11 Days)|Participant Choice|0|||
130025233|NCT01528787|468052245|FG000|Overall Study|Withdrawal by Subject|0|||
130025234|NCT01528787|468052246|FG001|Overall Study|Withdrawal by Subject|0|||
130025235|NCT01528787|468052247|FG002|Overall Study|Withdrawal by Subject|0|||
130025236|NCT01528787|468052248|FG003|Overall Study|Withdrawal by Subject|1|||
130025237|NCT01528787|468052245|FG000|Overall Study|Family Emergency|0|||
130025238|NCT01528787|468052246|FG001|Overall Study|Family Emergency|0|||
130232898|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
130232899|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232900|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232901|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232902|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232903|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130025239|NCT01528787|468052247|FG002|Overall Study|Family Emergency|1|||
130025240|NCT01528787|468052248|FG003|Overall Study|Family Emergency|0|||
130025241|NCT03433781|468052254|FG000|Overall Study|Progression of Disease|1|||
130025242|NCT03433781|468052255|FG001|Overall Study|Progression of Disease|0|||
130025243|NCT03433781|468052256|FG002|Overall Study|Progression of Disease|0|||
130025244|NCT03433781|468052254|FG000|Overall Study|Physician Decision|0|||
130025245|NCT03433781|468052255|FG001|Overall Study|Physician Decision|1|||
130025246|NCT03433781|468052256|FG002|Overall Study|Physician Decision|0|||
130025247|NCT00408694|468052257|FG000|Overall Study|Ineligible|1|||
130025248|NCT00408694|468052257|FG000|Overall Study|No protocol treatment|1|||
130025249|NCT03543410|468052263|FG000|Overall Study|Adverse Event|10|||
130025250|NCT03543410|468052264|FG001|Overall Study|Adverse Event|8|||
130025251|NCT03543410|468052265|FG002|Overall Study|Adverse Event|2|||
130025252|NCT03543410|468052263|FG000|Overall Study|Lack of Efficacy|0|||
130025253|NCT03543410|468052264|FG001|Overall Study|Lack of Efficacy|1|||
130025254|NCT03543410|468052265|FG002|Overall Study|Lack of Efficacy|0|||
130025255|NCT03543410|468052263|FG000|Overall Study|Lost to Follow-up|0|||
130025256|NCT03543410|468052264|FG001|Overall Study|Lost to Follow-up|1|||
130025257|NCT03543410|468052265|FG002|Overall Study|Lost to Follow-up|0|||
130025258|NCT03543410|468052263|FG000|Overall Study|Withdrawal by Subject|5|||
130025259|NCT03543410|468052264|FG001|Overall Study|Withdrawal by Subject|2|||
130025260|NCT03543410|468052265|FG002|Overall Study|Withdrawal by Subject|8|||
130025261|NCT03543410|468052263|FG000|Overall Study|Protocol Violation|0|||
130025262|NCT03543410|468052264|FG001|Overall Study|Protocol Violation|1|||
130025263|NCT03543410|468052265|FG002|Overall Study|Protocol Violation|0|||
130025264|NCT03543410|468052263|FG000|Overall Study|Due to COVID-19|4|||
130025265|NCT03543410|468052264|FG001|Overall Study|Due to COVID-19|0|||
130025266|NCT03543410|468052265|FG002|Overall Study|Due to COVID-19|2|||
130025267|NCT03543410|468052263|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
130025268|NCT03543410|468052264|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
130025269|NCT03543410|468052265|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
130025270|NCT03543410|468052263|FG000|Overall Study|Not Due to COVID-19|2|||
130025271|NCT03543410|468052264|FG001|Overall Study|Not Due to COVID-19|0|||
130025272|NCT03543410|468052265|FG002|Overall Study|Not Due to COVID-19|1|||
130025273|NCT02883244|468052266|FG000|Overall Study|Lost to Follow-up|0|||
130232904|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
130232905|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232906|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232907|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
130025274|NCT02883244|468052267|FG001|Overall Study|Lost to Follow-up|1|||
130232908|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130025275|NCT02435914|468052268|FG000|Overall Study|Ocular Adverse Event|1|||
130025276|NCT02435914|468052269|FG001|Overall Study|Ocular Adverse Event|0|||
130025277|NCT02435914|468052270|FG002|Overall Study|Ocular Adverse Event|0|||
130025278|NCT02435914|468052271|FG003|Overall Study|Ocular Adverse Event|0|||
130025279|NCT02435914|468052268|FG000|Overall Study|Withdrawal by Subject|0|||
130232909|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232910|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232911|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232912|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232913|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232914|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
130232915|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232916|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232917|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
130232918|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
130232919|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130025280|NCT02435914|468052269|FG001|Overall Study|Withdrawal by Subject|1|||
130025281|NCT02435914|468052270|FG002|Overall Study|Withdrawal by Subject|0|||
130025282|NCT02435914|468052271|FG003|Overall Study|Withdrawal by Subject|0|||
130025283|NCT02435914|468052268|FG000|Overall Study|Other Miscellaneous Reason|0|||
130025284|NCT02435914|468052269|FG001|Overall Study|Other Miscellaneous Reason|0|||
130025285|NCT02435914|468052270|FG002|Overall Study|Other Miscellaneous Reason|1|||
130025286|NCT02435914|468052271|FG003|Overall Study|Other Miscellaneous Reason|0|||
130025287|NCT00880256|468052277|FG000|Overall Study|Lost to Follow-up|28|||
130025288|NCT04871711|468052280|FG000|Overall Study|Withdrawal by Subject|11|||
130025289|NCT04871711|468052281|FG001|Overall Study|Withdrawal by Subject|5|||
130025290|NCT04871711|468052280|FG000|Overall Study|Lack of Efficacy|5|||
130025291|NCT04871711|468052281|FG001|Overall Study|Lack of Efficacy|7|||
130025292|NCT04871711|468052280|FG000|Overall Study|Adverse Event|2|||
130025293|NCT04871711|468052281|FG001|Overall Study|Adverse Event|6|||
130232920|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232921|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232922|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232923|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232924|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
130232925|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232926|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232927|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
130232928|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
130025294|NCT04871711|468052280|FG000|Overall Study|Various reasons|2|||
130025295|NCT04871711|468052281|FG001|Overall Study|Various reasons|1|||
130025296|NCT04871711|468052280|FG000|Overall Study|Lost to Follow-up|0|||
130025297|NCT04871711|468052281|FG001|Overall Study|Lost to Follow-up|2|||
130025298|NCT00573794|468052295|FG000|Overall Study|Adverse Event|81|||
130025299|NCT00573794|468052295|FG000|Overall Study|Withdrew Consent|90|||
130025300|NCT00573794|468052295|FG000|Overall Study|Lost to Follow-up|13|||
130025301|NCT00573794|468052295|FG000|Overall Study|Protocol Violation|6|||
130232929|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232930|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232931|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232932|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232933|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232934|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
130232935|NCT01232283|468817894|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
130232936|NCT01232283|468817895|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
130232937|NCT01232283|468817896|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
130232938|NCT01232283|468817897|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
130232939|NCT01232283|468817898|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
130232940|NCT01232283|468817899|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
130232941|NCT01232283|468817900|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
130232942|NCT01232283|468817901|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
130232943|NCT01232283|468817902|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
130232944|NCT01232283|468817903|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
130232945|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232946|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232947|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232948|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232949|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
130232950|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
130232951|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232952|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
130232953|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232954|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
130232955|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232956|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232957|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232958|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232959|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
130232960|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232961|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
130232962|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
130232963|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232964|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
130232965|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232966|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130025302|NCT00573794|468052295|FG000|Overall Study|Lack of Efficacy|94|||
130025303|NCT00573794|468052295|FG000|Overall Study|Other|46|||
130025304|NCT02183519|468052296|FG000|Overall Study|computer error|3|||
130025305|NCT02183519|468052297|FG001|Overall Study|computer error|0|||
130025306|NCT02183519|468052296|FG000|Overall Study|Did not respond to cough inducter|0|||
130025307|NCT02183519|468052297|FG001|Overall Study|Did not respond to cough inducter|3|||
130025308|NCT00695565|468052302|FG000|Overall Study|Lost to Follow-up|4|||
130025309|NCT00695565|468052303|FG001|Overall Study|Lost to Follow-up|4|||
130025310|NCT00695565|468052302|FG000|Overall Study|Adverse Event|3|||
130025311|NCT00695565|468052303|FG001|Overall Study|Adverse Event|1|||
130025312|NCT00695565|468052302|FG000|Overall Study|Protocol Violation|3|||
130025313|NCT00695565|468052303|FG001|Overall Study|Protocol Violation|1|||
130232967|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232968|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232969|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130232970|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130232971|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
130025314|NCT00695565|468052302|FG000|Overall Study|Withdrawal by Subject|1|||
130025315|NCT00695565|468052303|FG001|Overall Study|Withdrawal by Subject|1|||
130025316|NCT00695565|468052302|FG000|Overall Study|Lack of Efficacy|1|||
130025317|NCT00695565|468052303|FG001|Overall Study|Lack of Efficacy|1|||
130025318|NCT00695565|468052302|FG000|Overall Study|Subject did not follow instructions|1|||
130025319|NCT00695565|468052303|FG001|Overall Study|Subject did not follow instructions|1|||
130025320|NCT02419508|468052306|FG000|Overall Study|Adverse Event|9|||
130025321|NCT02419508|468052307|FG001|Overall Study|Adverse Event|3|||
130025322|NCT02419508|468052306|FG000|Overall Study|Withdrawal by Subject|1|||
130025323|NCT02419508|468052307|FG001|Overall Study|Withdrawal by Subject|0|||
130025324|NCT02419508|468052306|FG000|Overall Study|Other - Reason not specified|0|||
130025325|NCT02419508|468052307|FG001|Overall Study|Other - Reason not specified|1|||
130025326|NCT03110900|468052308|FG000|Overall Study|Sponsor withdrew|1|||
130025327|NCT03110900|468052309|FG001|Overall Study|Sponsor withdrew|1|||
130025328|NCT02531646|468052319|FG000|Overall Study|equip. image processing issue|5|||
130025329|NCT02531646|468052320|FG001|Overall Study|equip. image processing issue|1|||
130025330|NCT02531646|468052321|FG002|Overall Study|equip. image processing issue|0|||
130025331|NCT02320487|468052322|FG000|Overall Study|Reason not Specified|1|||
130025332|NCT02320487|468052322|FG000|Overall Study|Physician Decision|5|||
130025333|NCT02320487|468052322|FG000|Overall Study|Withdrawal by Subject|1|||
130025334|NCT02320487|468052322|FG000|Overall Study|Death|3|||
130025335|NCT02320487|468052322|FG000|Overall Study|Adverse Event|11|||
130025336|NCT04439175|468054100|FG000|Overall Study|Never started treatment|4|||
130025337|NCT04439175|468054100|FG000|Overall Study|Ineligible|5|||
130025338|NCT04439175|468054100|FG000|Overall Study|Adverse Event|6|||
130025339|NCT04439175|468054100|FG000|Overall Study|Death|4|||
130025340|NCT04439175|468054100|FG000|Overall Study|Disease progression|44|||
130025341|NCT04439175|468054100|FG000|Overall Study|Withdrawal by Subject|4|||
130025342|NCT04439175|468054100|FG000|Overall Study|Alternative Therapy|1|||
130025343|NCT04439175|468054100|FG000|Overall Study|Other|2|||
130025344|NCT02363478|468054101|FG000|Overall Study|Lost to Follow-up|4|||
130232972|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
130025345|NCT02363478|468054101|FG000|Overall Study|Adverse Event|4|||
130025346|NCT02152345|468054102|FG000|Overall Study|Case Cancellations|2|||
130025347|NCT02152345|468054103|FG001|Overall Study|Case Cancellations|4|||
130025348|NCT02152345|468054102|FG000|Overall Study|Withdrawal by Subject|2|||
130232973|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232974|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
130232975|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232976|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232977|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130025349|NCT02152345|468054103|FG001|Overall Study|Withdrawal by Subject|1|||
130232978|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130025350|NCT02554929|468054104|FG000|Overall Study|Lost to Follow-up|4|||
130025351|NCT02554929|468054105|FG001|Overall Study|Lost to Follow-up|4|||
130025352|NCT02554929|468054104|FG000|Overall Study|Withdrawal by Subject|2|||
130025353|NCT02554929|468054105|FG001|Overall Study|Withdrawal by Subject|8|||
130025354|NCT01916980|468054106|FG000|Overall Study|Adverse Event|4|||
130025355|NCT01916980|468054107|FG001|Overall Study|Adverse Event|2|||
130025356|NCT01916980|468054106|FG000|Overall Study|Lack of Efficacy|2|||
130025357|NCT01916980|468054107|FG001|Overall Study|Lack of Efficacy|2|||
130025358|NCT01916980|468054106|FG000|Overall Study|Withdrawal by Subject|1|||
130025359|NCT01916980|468054107|FG001|Overall Study|Withdrawal by Subject|0|||
130025360|NCT02324270|468054108|FG000|Overall Study|Withdrawal by Subject|0|||
130025361|NCT02324270|468054109|FG001|Overall Study|Withdrawal by Subject|1|||
130025362|NCT02324270|468054110|FG002|Overall Study|Withdrawal by Subject|0|||
130025363|NCT02324270|468054108|FG000|Overall Study|Lost to Follow-up|4|||
130025364|NCT02324270|468054109|FG001|Overall Study|Lost to Follow-up|3|||
130025365|NCT02324270|468054110|FG002|Overall Study|Lost to Follow-up|4|||
130025366|NCT02324270|468054108|FG000|Overall Study|Protocol Violation|0|||
130025367|NCT02324270|468054109|FG001|Overall Study|Protocol Violation|1|||
130025368|NCT02324270|468054110|FG002|Overall Study|Protocol Violation|1|||
130025369|NCT02324270|468054108|FG000|Overall Study|Non Compliance with Study Drug|1|||
130025370|NCT02324270|468054109|FG001|Overall Study|Non Compliance with Study Drug|2|||
130025371|NCT02324270|468054110|FG002|Overall Study|Non Compliance with Study Drug|0|||
130232979|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
130232980|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232981|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130025372|NCT00546364|468054111|FG000|Overall Study|Disease progression|5|||
130025373|NCT00546364|468054112|FG001|Overall Study|Disease progression|11|||
130025374|NCT00546364|468054113|FG002|Overall Study|Disease progression|8|||
130025375|NCT00546364|468054111|FG000|Overall Study|Completed and off treatment|1|||
130025376|NCT00546364|468054112|FG001|Overall Study|Completed and off treatment|0|||
130025377|NCT00546364|468054113|FG002|Overall Study|Completed and off treatment|2|||
130025378|NCT00546364|468054111|FG000|Overall Study|Administrative reason by sponsor|1|||
130025379|NCT00546364|468054112|FG001|Overall Study|Administrative reason by sponsor|0|||
130025380|NCT00546364|468054113|FG002|Overall Study|Administrative reason by sponsor|0|||
130025381|NCT00546364|468054111|FG000|Overall Study|Poor compliance/noncompliance|0|||
130025382|NCT00546364|468054112|FG001|Overall Study|Poor compliance/noncompliance|0|||
130025383|NCT00546364|468054113|FG002|Overall Study|Poor compliance/noncompliance|1|||
130025384|NCT00546364|468054111|FG000|Overall Study|No longer meets study criteria|1|||
130025385|NCT00546364|468054112|FG001|Overall Study|No longer meets study criteria|1|||
130025386|NCT00546364|468054113|FG002|Overall Study|No longer meets study criteria|0|||
130025387|NCT00546364|468054111|FG000|Overall Study|Withdrawal by Subject|5|||
130025388|NCT00546364|468054112|FG001|Overall Study|Withdrawal by Subject|6|||
130025389|NCT00546364|468054113|FG002|Overall Study|Withdrawal by Subject|3|||
130025390|NCT00546364|468054111|FG000|Overall Study|Prior taxotere|1|||
130025391|NCT00546364|468054112|FG001|Overall Study|Prior taxotere|0|||
130025392|NCT00546364|468054113|FG002|Overall Study|Prior taxotere|0|||
130025393|NCT00546364|468054111|FG000|Overall Study|Mixed response|1|||
130025394|NCT00546364|468054112|FG001|Overall Study|Mixed response|0|||
130232982|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130025395|NCT00546364|468054113|FG002|Overall Study|Mixed response|0|||
130025396|NCT00546364|468054111|FG000|Overall Study|Palliative treatment|1|||
130025397|NCT00546364|468054112|FG001|Overall Study|Palliative treatment|0|||
130025398|NCT00546364|468054113|FG002|Overall Study|Palliative treatment|1|||
130025399|NCT00546364|468054111|FG000|Overall Study|Target lesions resected|1|||
130025400|NCT00546364|468054112|FG001|Overall Study|Target lesions resected|0|||
130025401|NCT00546364|468054113|FG002|Overall Study|Target lesions resected|0|||
130025402|NCT00546364|468054111|FG000|Overall Study|Physician Decision|0|||
130025403|NCT00546364|468054112|FG001|Overall Study|Physician Decision|0|||
130025404|NCT00546364|468054113|FG002|Overall Study|Physician Decision|1|||
130025405|NCT00546364|468054111|FG000|Overall Study|Sponsor decision|0|||
130025406|NCT00546364|468054112|FG001|Overall Study|Sponsor decision|0|||
130025407|NCT00546364|468054113|FG002|Overall Study|Sponsor decision|1|||
130025408|NCT03786432|468054114|FG000|Overall Study|Screen Failure after consent|1|||
130025409|NCT03786432|468054114|FG000|Overall Study|Lost to Follow-up|4|||
130025410|NCT03786432|468054114|FG000|Overall Study|did not complete 12 month CT scan|1|||
130025411|NCT03968419|468054116|FG000|Treatment Period|Adverse Event|0|||
130025412|NCT03968419|468054117|FG001|Treatment Period|Adverse Event|0|||
130025413|NCT03968419|468054118|FG002|Treatment Period|Adverse Event|1|||
130025414|NCT03968419|468054116|FG000|Safety Follow-up Period|Death|3|||
130025415|NCT03968419|468054117|FG001|Safety Follow-up Period|Death|2|||
130025416|NCT03968419|468054118|FG002|Safety Follow-up Period|Death|1|||
130025417|NCT03968419|468054116|FG000|Safety Follow-up Period|Subject Decision|2|||
130025418|NCT03968419|468054117|FG001|Safety Follow-up Period|Subject Decision|1|||
130025419|NCT03968419|468054118|FG002|Safety Follow-up Period|Subject Decision|0|||
130025420|NCT03593915|468054119|FG000|Overall Study|Adverse Event|0|||
130025421|NCT03593915|468054120|FG001|Overall Study|Adverse Event|0|||
130025422|NCT03593915|468054121|FG002|Overall Study|Adverse Event|0|||
130025423|NCT03593915|468054122|FG003|Overall Study|Adverse Event|1|||
130025424|NCT03593915|468054123|FG004|Overall Study|Adverse Event|0|||
130025425|NCT03593915|468054124|FG005|Overall Study|Adverse Event|0|||
130232983|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130025426|NCT03593915|468054119|FG000|Overall Study|Physician Decision|0|||
130025427|NCT03593915|468054120|FG001|Overall Study|Physician Decision|0|||
130025428|NCT03593915|468054121|FG002|Overall Study|Physician Decision|0|||
130025429|NCT03593915|468054122|FG003|Overall Study|Physician Decision|0|||
130025430|NCT03593915|468054123|FG004|Overall Study|Physician Decision|0|||
130025431|NCT03593915|468054124|FG005|Overall Study|Physician Decision|1|||
130232984|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
130232985|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232986|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232987|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232988|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232989|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
130232990|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232991|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
130232992|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
130232993|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232994|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
130232995|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130232996|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130232997|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130232998|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130025432|NCT02894840|468054125|FG000|Overall Study|Lost to Follow-up|1|||
130025433|NCT02894840|468054126|FG001|Overall Study|Lost to Follow-up|0|||
130025434|NCT02894840|468054127|FG002|Overall Study|Lost to Follow-up|3|||
130025435|NCT02894840|468054128|FG003|Overall Study|Lost to Follow-up|0|||
130232999|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233000|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130025436|NCT00167245|468054130|FG000|Overall Study|Lost to Follow-up|20|||
130025437|NCT00167245|468054131|FG001|Overall Study|Lost to Follow-up|31|||
130025438|NCT00167245|468054130|FG000|Overall Study|Withdrawal by Subject|5|||
130025439|NCT00167245|468054131|FG001|Overall Study|Withdrawal by Subject|8|||
130025440|NCT00167245|468054130|FG000|Overall Study|Incarcerated|3|||
130025441|NCT00167245|468054131|FG001|Overall Study|Incarcerated|2|||
130025442|NCT00167245|468054130|FG000|Overall Study|Drowsy|1|||
130025443|NCT00167245|468054131|FG001|Overall Study|Drowsy|0|||
130025444|NCT00688909|468054136|FG000|Overall Study|Adverse Event|28|||
130025445|NCT00688909|468054136|FG000|Overall Study|Patient withdrew consent|2|||
130025446|NCT00688909|468054136|FG000|Overall Study|Administrative problems|1|||
130025447|NCT00688909|468054136|FG000|Overall Study|Protocol Violation|2|||
130025448|NCT00700180|468054137|FG000|Overall Study|Death|99|||
130025449|NCT00700180|468054138|FG001|Overall Study|Death|114|||
130025450|NCT00700180|468054137|FG000|Overall Study|Alive on treatment|5|||
130025451|NCT00700180|468054138|FG001|Overall Study|Alive on treatment|3|||
130025452|NCT00700180|468054137|FG000|Overall Study|Alive in follow-up|46|||
130233001|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233002|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
130233003|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233004|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
130233005|NCT01232283|468817894|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233006|NCT01232283|468817895|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233007|NCT01232283|468817896|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233008|NCT01232283|468817897|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233009|NCT01232283|468817898|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233010|NCT01232283|468817899|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
130025453|NCT00700180|468054138|FG001|Overall Study|Alive in follow-up|27|||
130025454|NCT00700180|468054137|FG000|Overall Study|Lost to Follow-up|4|||
130025455|NCT00700180|468054138|FG001|Overall Study|Lost to Follow-up|5|||
130025456|NCT03569202|468054142|FG000|Part 3|Physician Decision|1|||
130025457|NCT03569202|468054143|FG001|Part 3|Physician Decision|0|||
130025458|NCT03569202|468054142|FG000|Part 3|Other|1|||
130025459|NCT03569202|468054143|FG001|Part 3|Other|1|||
130025460|NCT01668654|468054144|FG000|Overall Study|Study Closed/Terminated|3|||
130025461|NCT01668654|468054144|FG000|Overall Study|Withdrawal by Subject|1|||
130025462|NCT04557384|468054145|FG000|Overall Study|Study Terminated by Sponsor|1|||
130025463|NCT04557384|468054145|FG000|Overall Study|Death|1|||
130025464|NCT02397473|468054147|FG000|Treatment Phase|Adverse Event|1|||
130025465|NCT02397473|468054148|FG001|Treatment Phase|Adverse Event|2|||
130025466|NCT02397473|468054147|FG000|Treatment Phase|Lack of Efficacy|8|||
130025467|NCT02397473|468054148|FG001|Treatment Phase|Lack of Efficacy|1|||
130025468|NCT02397473|468054147|FG000|Treatment Phase|Lost to Follow-up|1|||
130025469|NCT02397473|468054148|FG001|Treatment Phase|Lost to Follow-up|0|||
130025470|NCT02397473|468054147|FG000|Treatment Phase|Withdrawal by Subject|2|||
130025471|NCT02397473|468054148|FG001|Treatment Phase|Withdrawal by Subject|1|||
130025472|NCT02397473|468054147|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
130025473|NCT02397473|468054148|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
130025474|NCT02397473|468054147|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
130099992|NCT00320801|468324103|FG000|Open-label Run-in Period|Administrative|10|||
130099993|NCT00320801|468324104|FG001|Open-label Run-in Period|Administrative|0|||
130099994|NCT00320801|468324105|FG002|Open-label Run-in Period|Administrative|0|||
130099995|NCT00320801|468324106|FG003|Open-label Run-in Period|Administrative|0|||
130233011|NCT01232283|468817900|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130025475|NCT02397473|468054148|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
130025476|NCT02397473|468054147|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
130025477|NCT02397473|468054148|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130025478|NCT02397473|468054147|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
130025479|NCT02397473|468054148|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
130025480|NCT02397473|468054147|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130025481|NCT02397473|468054148|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130025482|NCT00254566|468054150|FG000|Overall Study|Death|1|||
130025483|NCT00254566|468054151|FG001|Overall Study|Death|0|||
130025484|NCT00254566|468054150|FG000|Overall Study|Adverse Event|5|||
130025485|NCT00254566|468054151|FG001|Overall Study|Adverse Event|4|||
130025486|NCT00254566|468054150|FG000|Overall Study|Lack of Efficacy|12|||
130025487|NCT00254566|468054151|FG001|Overall Study|Lack of Efficacy|9|||
130025488|NCT00254566|468054150|FG000|Overall Study|Other|1|||
130025489|NCT00254566|468054151|FG001|Overall Study|Other|5|||
130025490|NCT00254566|468054150|FG000|Overall Study|Withdrawal by Subject|5|||
130025491|NCT00254566|468054151|FG001|Overall Study|Withdrawal by Subject|6|||
130025492|NCT00254566|468054150|FG000|Overall Study|Lost to Follow-up|7|||
130025493|NCT00254566|468054151|FG001|Overall Study|Lost to Follow-up|2|||
130025494|NCT00059202|468054152|FG000|Overall Study|Withdrawal by Subject|5|||
130025495|NCT00059202|468054153|FG001|Overall Study|Withdrawal by Subject|9|||
130025496|NCT00059202|468054152|FG000|Overall Study|Protocol Violation|1|||
130025497|NCT00059202|468054153|FG001|Overall Study|Protocol Violation|3|||
130025498|NCT00059202|468054152|FG000|Overall Study|drug toxicity|0|||
130025499|NCT00059202|468054153|FG001|Overall Study|drug toxicity|3|||
130025500|NCT04652804|468054158|FG000|Overall Study|Ineligible post randomization|1|||
130025501|NCT04652804|468054159|FG001|Overall Study|Ineligible post randomization|0|||
130025502|NCT04652804|468054160|FG002|Overall Study|Ineligible post randomization|1|||
130025503|NCT04652804|468054161|FG003|Overall Study|Ineligible post randomization|0|||
130025504|NCT04652804|468054162|FG004|Overall Study|Ineligible post randomization|1|||
130025505|NCT04652804|468054163|FG005|Overall Study|Ineligible post randomization|1|||
130025506|NCT04652804|468054158|FG000|Overall Study|Missing SVR lab results|2|||
130025507|NCT04652804|468054159|FG001|Overall Study|Missing SVR lab results|0|||
130233012|NCT01232283|468817901|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130233013|NCT01232283|468817902|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130025508|NCT04652804|468054160|FG002|Overall Study|Missing SVR lab results|0|||
130025509|NCT04652804|468054161|FG003|Overall Study|Missing SVR lab results|0|||
130233014|NCT01232283|468817903|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
130025510|NCT04652804|468054162|FG004|Overall Study|Missing SVR lab results|0|||
130025511|NCT04652804|468054163|FG005|Overall Study|Missing SVR lab results|0|||
130025512|NCT00364689|468054167|FG000|Overall Study|Lost to Follow-up|1|||
130025513|NCT00191451|468054168|FG000|Overall Study|Withdrawal by Subject|2|||
130025514|NCT00191451|468054169|FG001|Overall Study|Withdrawal by Subject|3|||
130025515|NCT00191451|468054170|FG002|Overall Study|Withdrawal by Subject|5|||
130025516|NCT00191451|468054168|FG000|Overall Study|Physician Decision|2|||
130025517|NCT00191451|468054169|FG001|Overall Study|Physician Decision|9|||
130025518|NCT00191451|468054170|FG002|Overall Study|Physician Decision|6|||
130025519|NCT00191451|468054168|FG000|Overall Study|Sponsor Decision|1|||
130025520|NCT00191451|468054169|FG001|Overall Study|Sponsor Decision|0|||
130025521|NCT00191451|468054170|FG002|Overall Study|Sponsor Decision|0|||
130025522|NCT00191451|468054168|FG000|Overall Study|Ineligible|0|||
130025523|NCT00191451|468054169|FG001|Overall Study|Ineligible|1|||
130025524|NCT00191451|468054170|FG002|Overall Study|Ineligible|0|||
130233015|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233016|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233017|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130025525|NCT00191451|468054168|FG000|Overall Study|Reason Not Specified|2|||
130025526|NCT00191451|468054169|FG001|Overall Study|Reason Not Specified|1|||
130025527|NCT00191451|468054170|FG002|Overall Study|Reason Not Specified|3|||
130025528|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
130025529|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
130025530|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
130025531|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
130025532|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
130025533|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
130025534|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
130025535|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
130025536|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
130025537|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
130025538|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
130025539|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
130025540|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
130025541|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
130025542|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
130025543|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
130025544|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
130025545|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
130025546|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
130025547|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
130025548|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
130025549|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
130025550|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
130025551|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
130025552|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Death|2|||
130025553|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Death|1|||
130025554|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Death|2|||
130025555|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Graft loss|0|||
130025556|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Graft loss|2|||
130025557|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Graft loss|0|||
130233018|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233019|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233020|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233021|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233022|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
130233023|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
130233024|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
130233025|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130025558|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
130025559|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
130233026|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233027|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233028|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130025560|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
130025561|NCT01114529|468054171|FG000|Completed Study Medication at Month 24|Missing|2|||
130025562|NCT01114529|468054172|FG001|Completed Study Medication at Month 24|Missing|0|||
129884525|NCT04779242|467536437|FG001|Overall Study|COVID-19 related reasons|1|||
129884526|NCT04779242|467536436|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
129884527|NCT04779242|467536437|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
129884528|NCT04779242|467536436|FG000|Overall Study|Martial Law in Ukraine|2|||
129884529|NCT04779242|467536437|FG001|Overall Study|Martial Law in Ukraine|3|||
129884530|NCT01680458|467536441|FG000|Overall Study|Protocol Violation|3|||
129884531|NCT03012061|467536450|FG000|Overall Study|Withdrawal by Subject|1|||
129884532|NCT03012061|467536451|FG001|Overall Study|Withdrawal by Subject|5|||
129884533|NCT03012061|467536452|FG002|Overall Study|Withdrawal by Subject|4|||
129884534|NCT03012061|467536450|FG000|Overall Study|Investigator Site Closed|1|||
129884535|NCT03012061|467536451|FG001|Overall Study|Investigator Site Closed|2|||
129884536|NCT03012061|467536452|FG002|Overall Study|Investigator Site Closed|0|||
129884537|NCT03012061|467536450|FG000|Overall Study|Lost to Follow-up|2|||
129884538|NCT03012061|467536451|FG001|Overall Study|Lost to Follow-up|1|||
129884539|NCT03012061|467536452|FG002|Overall Study|Lost to Follow-up|0|||
129884540|NCT03012061|467536450|FG000|Overall Study|Study closed/ Terminated|0|||
130025563|NCT01114529|468054173|FG002|Completed Study Medication at Month 24|Missing|0|||
129884541|NCT03012061|467536451|FG001|Overall Study|Study closed/ Terminated|0|||
129884542|NCT03012061|467536452|FG002|Overall Study|Study closed/ Terminated|1|||
129884543|NCT03012061|467536450|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
129884544|NCT03012061|467536451|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
129884545|NCT03012061|467536452|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
129884546|NCT03012061|467536450|FG000|Overall Study|Protocol Violation|0|||
129884547|NCT03012061|467536451|FG001|Overall Study|Protocol Violation|0|||
129884548|NCT03012061|467536452|FG002|Overall Study|Protocol Violation|2|||
129884549|NCT03012061|467536450|FG000|Overall Study|Lack of Efficacy|0|||
130233029|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130025564|NCT01114529|468054171|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
130025565|NCT01114529|468054172|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
130025566|NCT01114529|468054173|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
130025567|NCT01114529|468054171|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
130025568|NCT01114529|468054172|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
130025569|NCT01114529|468054173|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
130025570|NCT01114529|468054171|FG000|Completed Study Phase at Month 24|Death|8|||
130025571|NCT01114529|468054172|FG001|Completed Study Phase at Month 24|Death|5|||
130025572|NCT01114529|468054173|FG002|Completed Study Phase at Month 24|Death|4|||
130025573|NCT01114529|468054171|FG000|Completed Study Phase at Month 24|Other|2|||
130025574|NCT01114529|468054172|FG001|Completed Study Phase at Month 24|Other|0|||
130025575|NCT01114529|468054173|FG002|Completed Study Phase at Month 24|Other|0|||
130025576|NCT01114529|468054171|FG000|Completed Study Phase at Month 24|Missing|2|||
130025577|NCT01114529|468054172|FG001|Completed Study Phase at Month 24|Missing|0|||
130025578|NCT01114529|468054173|FG002|Completed Study Phase at Month 24|Missing|0|||
130025579|NCT02623335|468054176|FG000|Overall Study|Death|8|||
130025580|NCT02623335|468054177|FG001|Overall Study|Death|7|||
130025581|NCT02623335|468054176|FG000|Overall Study|Lost to Follow-up|15|||
130025582|NCT02623335|468054177|FG001|Overall Study|Lost to Follow-up|23|||
130025583|NCT02623335|468054176|FG000|Overall Study|Withdrawal by Subject|2|||
130025584|NCT02623335|468054177|FG001|Overall Study|Withdrawal by Subject|5|||
130025585|NCT02623335|468054176|FG000|Overall Study|Protocol Violation|2|||
130025586|NCT02623335|468054177|FG001|Overall Study|Protocol Violation|1|||
130025587|NCT03739528|468054178|FG000|Overall Study|Not treated|8|||
130025588|NCT03739528|468054179|FG001|Overall Study|Not treated|12|||
130025589|NCT03739528|468054178|FG000|Overall Study|Treatment and study discontinued|6|||
130025590|NCT03739528|468054179|FG001|Overall Study|Treatment and study discontinued|2|||
130025591|NCT03739528|468054178|FG000|Overall Study|Treatment discontinued + study completed|1|||
130025592|NCT03739528|468054179|FG001|Overall Study|Treatment discontinued + study completed|3|||
130025593|NCT01046695|468054180|FG000|Overall Study|Subject had a pacemaker|0|||
130025594|NCT01046695|468054181|FG001|Overall Study|Subject had a pacemaker|1|||
130025595|NCT01046695|468054180|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
130025596|NCT01046695|468054181|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
130025597|NCT03072160|468054182|FG000|Overall Study|Adverse Event|3|||
130025598|NCT03072160|468054183|FG001|Overall Study|Adverse Event|1|||
130025599|NCT03072160|468054182|FG000|Overall Study|Refused further treatment|6|||
130025600|NCT03072160|468054183|FG001|Overall Study|Refused further treatment|1|||
130025601|NCT03072160|468054182|FG000|Overall Study|Physician Decision|1|||
130233030|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130025602|NCT03072160|468054183|FG001|Overall Study|Physician Decision|0|||
130025603|NCT03072160|468054182|FG000|Overall Study|Disease progression on study|1|||
130025604|NCT03072160|468054183|FG001|Overall Study|Disease progression on study|1|||
130025605|NCT03072160|468054182|FG000|Overall Study|No contact|0|||
130025606|NCT03072160|468054183|FG001|Overall Study|No contact|1|||
130025607|NCT03261531|468054184|FG000|Overall Study|Withdrawal by Subject|4|||
130025608|NCT00666926|468054186|FG000|Overall Study|Adverse Event|0|||
130025609|NCT00666926|468054187|FG001|Overall Study|Adverse Event|0|||
130025610|NCT00666926|468054188|FG002|Overall Study|Adverse Event|0|||
130025611|NCT00666926|468054189|FG003|Overall Study|Adverse Event|0|||
130099996|NCT00320801|468324103|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
130099997|NCT00320801|468324104|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
130099998|NCT00320801|468324105|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
130099999|NCT00320801|468324106|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
130100000|NCT00320801|468324103|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
130100001|NCT00320801|468324104|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
130100002|NCT00320801|468324105|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
130100003|NCT00320801|468324106|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
130100004|NCT00320801|468324103|FG000|Open-label Run-in Period|Did not qualify|1|||
130100005|NCT00320801|468324104|FG001|Open-label Run-in Period|Did not qualify|0|||
130100006|NCT00320801|468324105|FG002|Open-label Run-in Period|Did not qualify|0|||
130100007|NCT00320801|468324106|FG003|Open-label Run-in Period|Did not qualify|0|||
130100008|NCT00320801|468324103|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130100009|NCT00320801|468324104|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130100010|NCT00320801|468324105|FG002|Double-blind Phase|Withdrawal by Subject|1|||
130100011|NCT00320801|468324106|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130100012|NCT00320801|468324103|FG000|Double-blind Phase|Adverse Event|0|||
130100013|NCT00320801|468324104|FG001|Double-blind Phase|Adverse Event|2|||
130100014|NCT00320801|468324105|FG002|Double-blind Phase|Adverse Event|8|||
130100015|NCT00320801|468324106|FG003|Double-blind Phase|Adverse Event|0|||
130100016|NCT00320801|468324103|FG000|Double-blind Phase|Administrative|0|||
130100017|NCT00320801|468324104|FG001|Double-blind Phase|Administrative|0|||
130100018|NCT00320801|468324105|FG002|Double-blind Phase|Administrative|4|||
130100019|NCT00320801|468324106|FG003|Double-blind Phase|Administrative|0|||
130100020|NCT00320801|468324103|FG000|Double-blind Phase|Lack of Efficacy|0|||
130100021|NCT00320801|468324104|FG001|Double-blind Phase|Lack of Efficacy|9|||
130100022|NCT00320801|468324105|FG002|Double-blind Phase|Lack of Efficacy|1|||
130100023|NCT00320801|468324106|FG003|Double-blind Phase|Lack of Efficacy|0|||
130100024|NCT00320801|468324103|FG000|Extension Phase|Withdrawal by Subject|0|||
130100025|NCT00320801|468324104|FG001|Extension Phase|Withdrawal by Subject|0|||
130100026|NCT00320801|468324105|FG002|Extension Phase|Withdrawal by Subject|0|||
130100027|NCT00320801|468324106|FG003|Extension Phase|Withdrawal by Subject|6|||
130233031|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233032|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
130233033|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
130233034|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
130233035|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233036|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233037|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233038|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233039|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233040|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233041|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233042|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
130233043|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
130233044|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
130233045|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233046|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233047|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233048|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233049|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233050|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233051|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233052|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
130233053|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
130233054|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
130233055|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233056|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233057|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233058|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233059|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233060|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130100028|NCT00320801|468324103|FG000|Extension Phase|Adverse Event|0|||
130100029|NCT00320801|468324104|FG001|Extension Phase|Adverse Event|0|||
130100030|NCT00320801|468324105|FG002|Extension Phase|Adverse Event|0|||
130100031|NCT00320801|468324106|FG003|Extension Phase|Adverse Event|8|||
130100032|NCT00320801|468324103|FG000|Extension Phase|Administrative|0|||
130100033|NCT00320801|468324104|FG001|Extension Phase|Administrative|0|||
130100034|NCT00320801|468324105|FG002|Extension Phase|Administrative|0|||
130100035|NCT00320801|468324106|FG003|Extension Phase|Administrative|29|||
130233061|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233062|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
130233063|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
130233064|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
130233065|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233066|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130025612|NCT00666926|468054190|FG004|Overall Study|Adverse Event|0|||
130025613|NCT00666926|468054191|FG005|Overall Study|Adverse Event|0|||
130025614|NCT00666926|468054192|FG006|Overall Study|Adverse Event|0|||
130025615|NCT00666926|468054193|FG007|Overall Study|Adverse Event|0|||
130025616|NCT00666926|468054194|FG008|Overall Study|Adverse Event|0|||
130025617|NCT00666926|468054195|FG009|Overall Study|Adverse Event|2|||
130025618|NCT00666926|468054196|FG010|Overall Study|Adverse Event|2|||
130025619|NCT00666926|468054197|FG011|Overall Study|Adverse Event|2|||
130233067|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233068|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233069|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233070|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233071|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233072|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233073|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
130233074|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
130233075|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233076|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233077|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233078|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233079|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233080|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233081|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233082|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233083|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
130233084|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
130233085|NCT01232283|468817894|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130025620|NCT00666926|468054198|FG012|Overall Study|Adverse Event|0|||
130025621|NCT00666926|468054199|FG013|Overall Study|Adverse Event|1|||
130025622|NCT00666926|468054200|FG014|Overall Study|Adverse Event|0|||
130025623|NCT00666926|468054201|FG015|Overall Study|Adverse Event|0|||
130025624|NCT00666926|468054186|FG000|Overall Study|Laboratory abnormality|0|||
130025625|NCT00666926|468054187|FG001|Overall Study|Laboratory abnormality|0|||
130025626|NCT00666926|468054188|FG002|Overall Study|Laboratory abnormality|0|||
130025627|NCT00666926|468054189|FG003|Overall Study|Laboratory abnormality|0|||
130025628|NCT00666926|468054190|FG004|Overall Study|Laboratory abnormality|0|||
130025629|NCT00666926|468054191|FG005|Overall Study|Laboratory abnormality|0|||
130025630|NCT00666926|468054192|FG006|Overall Study|Laboratory abnormality|0|||
130025631|NCT00666926|468054193|FG007|Overall Study|Laboratory abnormality|0|||
130025632|NCT00666926|468054194|FG008|Overall Study|Laboratory abnormality|0|||
130025633|NCT00666926|468054195|FG009|Overall Study|Laboratory abnormality|0|||
130025634|NCT00666926|468054196|FG010|Overall Study|Laboratory abnormality|1|||
130025635|NCT00666926|468054197|FG011|Overall Study|Laboratory abnormality|0|||
130025636|NCT00666926|468054198|FG012|Overall Study|Laboratory abnormality|0|||
130025637|NCT00666926|468054199|FG013|Overall Study|Laboratory abnormality|0|||
130025638|NCT00666926|468054200|FG014|Overall Study|Laboratory abnormality|0|||
130025639|NCT00666926|468054201|FG015|Overall Study|Laboratory abnormality|1|||
130233086|NCT01232283|468817895|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233087|NCT01232283|468817896|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233088|NCT01232283|468817897|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130025640|NCT00666926|468054186|FG000|Overall Study|Lack of Efficacy|0|||
130025641|NCT00666926|468054187|FG001|Overall Study|Lack of Efficacy|0|||
130025642|NCT00666926|468054188|FG002|Overall Study|Lack of Efficacy|0|||
130025643|NCT00666926|468054189|FG003|Overall Study|Lack of Efficacy|0|||
130025644|NCT00666926|468054190|FG004|Overall Study|Lack of Efficacy|0|||
130025645|NCT00666926|468054191|FG005|Overall Study|Lack of Efficacy|1|||
130025646|NCT00666926|468054192|FG006|Overall Study|Lack of Efficacy|0|||
130233089|NCT01232283|468817898|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233090|NCT01232283|468817899|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233091|NCT01232283|468817900|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233092|NCT01232283|468817901|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
130233093|NCT01232283|468817902|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
130233094|NCT01232283|468817903|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
130233095|NCT02792504|468817906|FG000|Overall Study|Lost to Follow-up|24|||
130233096|NCT02792504|468817906|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
130233097|NCT00848497|468817913|FG000|Overall Study|Screen failure|2|||
130233098|NCT00848497|468817914|FG001|Overall Study|Screen failure|0|||
130233099|NCT00848497|468817913|FG000|Overall Study|Withdrawal by Subject|0|||
130233100|NCT00848497|468817914|FG001|Overall Study|Withdrawal by Subject|1|||
130233101|NCT02966834|468817915|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233102|NCT02966834|468817916|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233103|NCT02966834|468817917|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233104|NCT02966834|468817918|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233105|NCT02966834|468817919|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
130233106|NCT02966834|468817920|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
130233107|NCT02966834|468817915|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
130233108|NCT02966834|468817916|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233109|NCT02966834|468817917|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233110|NCT02966834|468817918|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233111|NCT02966834|468817919|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233112|NCT02966834|468817920|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130233113|NCT02966834|468817915|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130233114|NCT02966834|468817916|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130025647|NCT00666926|468054193|FG007|Overall Study|Lack of Efficacy|0|||
130025648|NCT00666926|468054194|FG008|Overall Study|Lack of Efficacy|0|||
130025649|NCT00666926|468054195|FG009|Overall Study|Lack of Efficacy|0|||
130025650|NCT00666926|468054196|FG010|Overall Study|Lack of Efficacy|0|||
130025651|NCT00666926|468054197|FG011|Overall Study|Lack of Efficacy|1|||
130025652|NCT00666926|468054198|FG012|Overall Study|Lack of Efficacy|0|||
130025653|NCT00666926|468054199|FG013|Overall Study|Lack of Efficacy|0|||
130025654|NCT00666926|468054200|FG014|Overall Study|Lack of Efficacy|0|||
130025655|NCT00666926|468054201|FG015|Overall Study|Lack of Efficacy|0|||
130025656|NCT00666926|468054186|FG000|Overall Study|Lost to Follow-up|0|||
130025657|NCT00666926|468054187|FG001|Overall Study|Lost to Follow-up|0|||
130025658|NCT00666926|468054188|FG002|Overall Study|Lost to Follow-up|0|||
130025659|NCT00666926|468054189|FG003|Overall Study|Lost to Follow-up|1|||
130025660|NCT00666926|468054190|FG004|Overall Study|Lost to Follow-up|0|||
130025661|NCT00666926|468054191|FG005|Overall Study|Lost to Follow-up|0|||
130025662|NCT00666926|468054192|FG006|Overall Study|Lost to Follow-up|0|||
130025663|NCT00666926|468054193|FG007|Overall Study|Lost to Follow-up|0|||
130025664|NCT00666926|468054194|FG008|Overall Study|Lost to Follow-up|0|||
130025665|NCT00666926|468054195|FG009|Overall Study|Lost to Follow-up|0|||
130025666|NCT00666926|468054196|FG010|Overall Study|Lost to Follow-up|0|||
130025667|NCT00666926|468054197|FG011|Overall Study|Lost to Follow-up|0|||
130025668|NCT00666926|468054198|FG012|Overall Study|Lost to Follow-up|0|||
130025669|NCT00666926|468054199|FG013|Overall Study|Lost to Follow-up|0|||
130025670|NCT00666926|468054200|FG014|Overall Study|Lost to Follow-up|0|||
130025671|NCT00666926|468054201|FG015|Overall Study|Lost to Follow-up|0|||
130233115|NCT02966834|468817917|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
130316113|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316114|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
130316115|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316116|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316117|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316118|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316119|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
130316120|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316121|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316122|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316123|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316124|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316125|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316126|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316127|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
130316128|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316129|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316130|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316131|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130316132|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
130025672|NCT00666926|468054186|FG000|Overall Study|Other|2|||
130025673|NCT00666926|468054187|FG001|Overall Study|Other|4|||
130025674|NCT00666926|468054188|FG002|Overall Study|Other|3|||
130025675|NCT00666926|468054189|FG003|Overall Study|Other|3|||
130025676|NCT00666926|468054190|FG004|Overall Study|Other|3|||
130025677|NCT00666926|468054191|FG005|Overall Study|Other|3|||
130025678|NCT00666926|468054192|FG006|Overall Study|Other|4|||
130025679|NCT00666926|468054193|FG007|Overall Study|Other|0|||
130233116|NCT02966834|468817918|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
130233117|NCT02966834|468817919|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
130233118|NCT02966834|468817920|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
130233119|NCT02966834|468817915|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130233120|NCT02966834|468817916|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130233121|NCT02966834|468817917|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
130233122|NCT02966834|468817918|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
130025680|NCT00666926|468054194|FG008|Overall Study|Other|3|||
130025681|NCT00666926|468054195|FG009|Overall Study|Other|5|||
130025682|NCT00666926|468054196|FG010|Overall Study|Other|3|||
130025683|NCT00666926|468054197|FG011|Overall Study|Other|26|||
130100036|NCT00320801|468324103|FG000|Extension Phase|Lack of Efficacy|0|||
130100037|NCT00320801|468324104|FG001|Extension Phase|Lack of Efficacy|0|||
130100038|NCT00320801|468324105|FG002|Extension Phase|Lack of Efficacy|0|||
130100039|NCT00320801|468324106|FG003|Extension Phase|Lack of Efficacy|2|||
130100040|NCT00320801|468324103|FG000|Extension Phase|Lost to Follow-up|0|||
130100041|NCT00320801|468324104|FG001|Extension Phase|Lost to Follow-up|0|||
130100042|NCT00320801|468324105|FG002|Extension Phase|Lost to Follow-up|0|||
130100043|NCT00320801|468324106|FG003|Extension Phase|Lost to Follow-up|3|||
130100044|NCT06067191|468324107|FG000|Overall Study|Withdrawal by Subject|0|||
130100045|NCT06067191|468324108|FG001|Overall Study|Withdrawal by Subject|1|||
130100046|NCT00877799|468324110|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
130100047|NCT00877799|468324111|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
130233123|NCT02966834|468817919|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
130233124|NCT02966834|468817920|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
130233125|NCT02966834|468817915|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130025684|NCT00666926|468054198|FG012|Overall Study|Other|3|||
130025685|NCT00666926|468054199|FG013|Overall Study|Other|2|||
130233126|NCT02966834|468817916|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130233127|NCT02966834|468817917|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130233128|NCT02966834|468817918|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
130233129|NCT02966834|468817919|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130233130|NCT02966834|468817920|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
130025686|NCT00666926|468054200|FG014|Overall Study|Other|4|||
130233131|NCT02966834|468817915|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129800237|NCT04755283|467236268|FG000|Overall Study|Withdrawal by Subject|14|||
130025687|NCT00666926|468054201|FG015|Overall Study|Other|4|||
130025688|NCT00666926|468054186|FG000|Overall Study|Withdrawal by Subject|0|||
130025689|NCT00666926|468054187|FG001|Overall Study|Withdrawal by Subject|0|||
130025690|NCT00666926|468054188|FG002|Overall Study|Withdrawal by Subject|0|||
130025691|NCT00666926|468054189|FG003|Overall Study|Withdrawal by Subject|0|||
130025692|NCT00666926|468054190|FG004|Overall Study|Withdrawal by Subject|0|||
130025693|NCT00666926|468054191|FG005|Overall Study|Withdrawal by Subject|0|||
130025694|NCT00666926|468054192|FG006|Overall Study|Withdrawal by Subject|0|||
130025695|NCT00666926|468054193|FG007|Overall Study|Withdrawal by Subject|1|||
130025696|NCT00666926|468054194|FG008|Overall Study|Withdrawal by Subject|0|||
130233132|NCT02966834|468817916|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233133|NCT02966834|468817917|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233134|NCT02966834|468817918|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
130233135|NCT02966834|468817919|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233136|NCT02966834|468817920|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
130233137|NCT03729362|468819666|FG000|Overall Study|Withdrawal by Subject|2|||
130233138|NCT03729362|468819667|FG001|Overall Study|Withdrawal by Subject|0|||
130233139|NCT03729362|468819666|FG000|Overall Study|Physician Decision|1|||
130233140|NCT03729362|468819667|FG001|Overall Study|Physician Decision|0|||
130233141|NCT03729362|468819666|FG000|Overall Study|COVID-19 Pandemic|1|||
130233142|NCT03729362|468819667|FG001|Overall Study|COVID-19 Pandemic|0|||
130025697|NCT00666926|468054195|FG009|Overall Study|Withdrawal by Subject|3|||
130025698|NCT00666926|468054196|FG010|Overall Study|Withdrawal by Subject|0|||
130233143|NCT03729362|468819666|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
130233144|NCT03729362|468819667|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
130233145|NCT03729362|468819666|FG000|Overall Study|Adverse Event|0|||
130025699|NCT00666926|468054197|FG011|Overall Study|Withdrawal by Subject|3|||
130025700|NCT00666926|468054198|FG012|Overall Study|Withdrawal by Subject|0|||
130025701|NCT00666926|468054199|FG013|Overall Study|Withdrawal by Subject|1|||
130025702|NCT00666926|468054200|FG014|Overall Study|Withdrawal by Subject|3|||
130025703|NCT00666926|468054201|FG015|Overall Study|Withdrawal by Subject|3|||
130233146|NCT03729362|468819667|FG001|Overall Study|Adverse Event|1|||
130233147|NCT03729362|468819666|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
130025704|NCT00666926|468054186|FG000|Overall Study|Death|0|||
130100048|NCT00877799|468324112|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
130100049|NCT00877799|468324113|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
130100050|NCT00877799|468324114|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
130100051|NCT00877799|468324110|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
130100052|NCT00877799|468324111|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
130100053|NCT00877799|468324112|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
130100054|NCT00877799|468324113|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
130100055|NCT00877799|468324114|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
130100056|NCT00877799|468324110|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130100057|NCT00877799|468324111|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
130100058|NCT00877799|468324112|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130100059|NCT00877799|468324113|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130100060|NCT00877799|468324114|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
130100061|NCT00877799|468324110|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130100062|NCT00877799|468324111|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130100063|NCT00877799|468324112|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130100064|NCT00877799|468324113|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
130100065|NCT00877799|468324114|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
130100066|NCT00877799|468324110|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
130100067|NCT00877799|468324111|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
130100068|NCT00877799|468324112|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
130100069|NCT00877799|468324113|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
130100070|NCT00877799|468324114|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
130100071|NCT04054011|468324115|FG000|Overall Study|COVID|3|||
130100072|NCT00557830|468324116|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
130100073|NCT00557830|468324117|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
130100074|NCT00557830|468324118|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
130100075|NCT00557830|468324116|FG000|Screening Treatment Phase|Adverse Event|2|||
130100076|NCT00557830|468324117|FG001|Screening Treatment Phase|Adverse Event|0|||
130100077|NCT00557830|468324118|FG002|Screening Treatment Phase|Adverse Event|0|||
130100078|NCT00557830|468324116|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
130100079|NCT00557830|468324117|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
130100080|NCT00557830|468324118|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
130100081|NCT00538473|468324119|FG000|Overall Study|Adverse Event|1|||
130100082|NCT00538473|468324120|FG001|Overall Study|Adverse Event|0|||
130100083|NCT00669110|468324121|FG000|Overall Study|Adverse Event|4|||
130100084|NCT00669110|468324122|FG001|Overall Study|Adverse Event|3|||
130100085|NCT00669110|468324121|FG000|Overall Study|Caregiver request|3|||
130100086|NCT00669110|468324122|FG001|Overall Study|Caregiver request|2|||
130100087|NCT00669110|468324121|FG000|Overall Study|Physician Decision|0|||
130025705|NCT00666926|468054187|FG001|Overall Study|Death|0|||
130025706|NCT00666926|468054188|FG002|Overall Study|Death|0|||
130025707|NCT00666926|468054189|FG003|Overall Study|Death|0|||
130025708|NCT00666926|468054190|FG004|Overall Study|Death|0|||
130025709|NCT00666926|468054191|FG005|Overall Study|Death|0|||
130025710|NCT00666926|468054192|FG006|Overall Study|Death|0|||
130025711|NCT00666926|468054193|FG007|Overall Study|Death|0|||
130025712|NCT00666926|468054194|FG008|Overall Study|Death|0|||
130025713|NCT00666926|468054195|FG009|Overall Study|Death|0|||
130025714|NCT00666926|468054196|FG010|Overall Study|Death|0|||
130025715|NCT00666926|468054197|FG011|Overall Study|Death|1|||
130025716|NCT00666926|468054198|FG012|Overall Study|Death|0|||
130025717|NCT00666926|468054199|FG013|Overall Study|Death|0|||
130025718|NCT00666926|468054200|FG014|Overall Study|Death|0|||
130100088|NCT00669110|468324122|FG001|Overall Study|Physician Decision|1|||
130100089|NCT00669110|468324121|FG000|Overall Study|Lost to Follow-up|1|||
130100090|NCT00669110|468324122|FG001|Overall Study|Lost to Follow-up|0|||
130100091|NCT00669110|468324121|FG000|Overall Study|Protocol Violation|0|||
130100092|NCT00669110|468324122|FG001|Overall Study|Protocol Violation|5|||
130100093|NCT00669110|468324121|FG000|Overall Study|Withdrawal by Subject|0|||
130100094|NCT00669110|468324122|FG001|Overall Study|Withdrawal by Subject|2|||
130100095|NCT01870921|468324123|FG000|Overall Study|Subject decision|80|||
130100096|NCT01870921|468324123|FG000|Overall Study|Severe non-compliance to protocol|7|||
130100097|NCT01870921|468324123|FG000|Overall Study|Subject Lost to Follow up|2|||
130100098|NCT01870921|468324123|FG000|Overall Study|Other|1|||
130233148|NCT03729362|468819667|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
130025719|NCT00666926|468054201|FG015|Overall Study|Death|0|||
130025720|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
130025721|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
130025722|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
130025723|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Death|28|||
130025724|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Death|0|||
130233149|NCT02711137|468819668|FG000|Overall Study|Death|1|||
130233150|NCT02711137|468819669|FG001|Overall Study|Death|4|||
130233151|NCT02711137|468819670|FG002|Overall Study|Death|5|||
130233152|NCT02711137|468819671|FG003|Overall Study|Death|5|||
130233153|NCT02711137|468819672|FG004|Overall Study|Death|3|||
130233154|NCT02711137|468819673|FG005|Overall Study|Death|1|||
130233155|NCT02711137|468819674|FG006|Overall Study|Death|61|||
130233156|NCT02711137|468819675|FG007|Overall Study|Death|3|||
130233157|NCT02711137|468819676|FG008|Overall Study|Death|0|||
130233158|NCT02711137|468819677|FG009|Overall Study|Death|1|||
130233159|NCT02711137|468819678|FG010|Overall Study|Death|1|||
130233160|NCT02711137|468819679|FG011|Overall Study|Death|1|||
130233161|NCT02711137|468819680|FG012|Overall Study|Death|0|||
130233162|NCT02711137|468819681|FG013|Overall Study|Death|0|||
130233163|NCT02711137|468819682|FG014|Overall Study|Death|0|||
130233164|NCT02711137|468819668|FG000|Overall Study|Study Terminated by Sponsor|0|||
130233165|NCT02711137|468819669|FG001|Overall Study|Study Terminated by Sponsor|0|||
130233166|NCT02711137|468819670|FG002|Overall Study|Study Terminated by Sponsor|1|||
130233167|NCT02711137|468819671|FG003|Overall Study|Study Terminated by Sponsor|0|||
130233168|NCT02711137|468819672|FG004|Overall Study|Study Terminated by Sponsor|0|||
130233169|NCT02711137|468819673|FG005|Overall Study|Study Terminated by Sponsor|0|||
130233170|NCT02711137|468819674|FG006|Overall Study|Study Terminated by Sponsor|1|||
130100099|NCT04409509|468324126|FG000|Overall Study|Failure to meet randomization requirement|1|||
130100100|NCT04409509|468324127|FG001|Overall Study|Failure to meet randomization requirement|0|||
130233171|NCT02711137|468819675|FG007|Overall Study|Study Terminated by Sponsor|0|||
130233172|NCT02711137|468819676|FG008|Overall Study|Study Terminated by Sponsor|0|||
130233173|NCT02711137|468819677|FG009|Overall Study|Study Terminated by Sponsor|0|||
130100101|NCT04409509|468324126|FG000|Overall Study|Adverse Event|0|||
130233174|NCT02711137|468819678|FG010|Overall Study|Study Terminated by Sponsor|0|||
130233175|NCT02711137|468819679|FG011|Overall Study|Study Terminated by Sponsor|0|||
130233176|NCT02711137|468819680|FG012|Overall Study|Study Terminated by Sponsor|0|||
130233177|NCT02711137|468819681|FG013|Overall Study|Study Terminated by Sponsor|0|||
130233178|NCT02711137|468819682|FG014|Overall Study|Study Terminated by Sponsor|0|||
130233179|NCT02711137|468819668|FG000|Overall Study|Physician Decision|1|||
130233180|NCT02711137|468819669|FG001|Overall Study|Physician Decision|0|||
130233181|NCT02711137|468819670|FG002|Overall Study|Physician Decision|2|||
130025725|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Death|0|||
130025726|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
130233182|NCT02711137|468819671|FG003|Overall Study|Physician Decision|1|||
130233183|NCT02711137|468819672|FG004|Overall Study|Physician Decision|1|||
130233184|NCT02711137|468819673|FG005|Overall Study|Physician Decision|0|||
130233185|NCT02711137|468819674|FG006|Overall Study|Physician Decision|12|||
130233186|NCT02711137|468819675|FG007|Overall Study|Physician Decision|2|||
130233187|NCT02711137|468819676|FG008|Overall Study|Physician Decision|1|||
130233188|NCT02711137|468819677|FG009|Overall Study|Physician Decision|1|||
130233189|NCT02711137|468819678|FG010|Overall Study|Physician Decision|3|||
130233190|NCT02711137|468819679|FG011|Overall Study|Physician Decision|2|||
130233191|NCT02711137|468819680|FG012|Overall Study|Physician Decision|1|||
130233192|NCT02711137|468819681|FG013|Overall Study|Physician Decision|1|||
130233193|NCT02711137|468819682|FG014|Overall Study|Physician Decision|2|||
130025727|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
130025728|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
130025729|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
130025730|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
130025731|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
130025732|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
130025733|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
130025734|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
130025735|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
130025736|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
130025737|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
130025738|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
130025739|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
130025740|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
130025741|NCT00820755|468054202|FG000|Period 1: Combination Therapy Phase|Other|11|||
130025742|NCT00820755|468054203|FG001|Period 1: Combination Therapy Phase|Other|0|||
130025743|NCT00820755|468054204|FG002|Period 1: Combination Therapy Phase|Other|0|||
130025744|NCT00820755|468054202|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
130025745|NCT00820755|468054203|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
130025746|NCT00820755|468054204|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
130025747|NCT00091832|468054210|FG000|Overall Study|Physician Decision|1|||
130025748|NCT00091832|468054211|FG001|Overall Study|Physician Decision|0|||
130025749|NCT00091832|468054212|FG002|Overall Study|Physician Decision|0|||
130025750|NCT00091832|468054213|FG003|Overall Study|Physician Decision|0|||
130025751|NCT00091832|468054214|FG004|Overall Study|Physician Decision|0|||
130025752|NCT00091832|468054215|FG005|Overall Study|Physician Decision|0|||
130025753|NCT00091832|468054210|FG000|Overall Study|Adverse Event|0|||
130025754|NCT00091832|468054211|FG001|Overall Study|Adverse Event|0|||
130025755|NCT00091832|468054212|FG002|Overall Study|Adverse Event|0|||
130025756|NCT00091832|468054213|FG003|Overall Study|Adverse Event|1|||
130025757|NCT00091832|468054214|FG004|Overall Study|Adverse Event|3|||
130025758|NCT00091832|468054215|FG005|Overall Study|Adverse Event|0|||
130233194|NCT02711137|468819668|FG000|Overall Study|Other|0|||
130233195|NCT02711137|468819669|FG001|Overall Study|Other|1|||
130233196|NCT02711137|468819670|FG002|Overall Study|Other|0|||
130233197|NCT02711137|468819671|FG003|Overall Study|Other|0|||
130233198|NCT02711137|468819672|FG004|Overall Study|Other|0|||
130233199|NCT02711137|468819673|FG005|Overall Study|Other|0|||
130233200|NCT02711137|468819674|FG006|Overall Study|Other|3|||
130233201|NCT02711137|468819675|FG007|Overall Study|Other|0|||
130233202|NCT02711137|468819676|FG008|Overall Study|Other|0|||
130025759|NCT00091832|468054210|FG000|Overall Study|Withdrawal by Subject|4|||
130025760|NCT00091832|468054211|FG001|Overall Study|Withdrawal by Subject|5|||
130025761|NCT00091832|468054212|FG002|Overall Study|Withdrawal by Subject|0|||
130025762|NCT00091832|468054213|FG003|Overall Study|Withdrawal by Subject|1|||
130025763|NCT00091832|468054214|FG004|Overall Study|Withdrawal by Subject|3|||
130025764|NCT00091832|468054215|FG005|Overall Study|Withdrawal by Subject|1|||
130025765|NCT00091832|468054210|FG000|Overall Study|Death|6|||
130233203|NCT02711137|468819677|FG009|Overall Study|Other|0|||
130233204|NCT02711137|468819678|FG010|Overall Study|Other|0|||
130233205|NCT02711137|468819679|FG011|Overall Study|Other|0|||
130233206|NCT02711137|468819680|FG012|Overall Study|Other|0|||
130233207|NCT02711137|468819681|FG013|Overall Study|Other|0|||
130233208|NCT02711137|468819682|FG014|Overall Study|Other|1|||
130233209|NCT02711137|468819668|FG000|Overall Study|Withdrawal by Subject|1|||
130233210|NCT02711137|468819669|FG001|Overall Study|Withdrawal by Subject|0|||
130025766|NCT00091832|468054211|FG001|Overall Study|Death|4|||
130025767|NCT00091832|468054212|FG002|Overall Study|Death|5|||
130025768|NCT00091832|468054213|FG003|Overall Study|Death|8|||
130233211|NCT02711137|468819670|FG002|Overall Study|Withdrawal by Subject|0|||
130233212|NCT02711137|468819671|FG003|Overall Study|Withdrawal by Subject|1|||
130233213|NCT02711137|468819672|FG004|Overall Study|Withdrawal by Subject|1|||
130233214|NCT02711137|468819673|FG005|Overall Study|Withdrawal by Subject|0|||
130233215|NCT02711137|468819674|FG006|Overall Study|Withdrawal by Subject|7|||
130025769|NCT00091832|468054214|FG004|Overall Study|Death|5|||
130025770|NCT00091832|468054215|FG005|Overall Study|Death|6|||
130233216|NCT02711137|468819675|FG007|Overall Study|Withdrawal by Subject|0|||
130233217|NCT02711137|468819676|FG008|Overall Study|Withdrawal by Subject|0|||
130233218|NCT02711137|468819677|FG009|Overall Study|Withdrawal by Subject|0|||
130233219|NCT02711137|468819678|FG010|Overall Study|Withdrawal by Subject|0|||
130233220|NCT02711137|468819679|FG011|Overall Study|Withdrawal by Subject|0|||
130233221|NCT02711137|468819680|FG012|Overall Study|Withdrawal by Subject|0|||
130233222|NCT02711137|468819681|FG013|Overall Study|Withdrawal by Subject|1|||
130233223|NCT02711137|468819682|FG014|Overall Study|Withdrawal by Subject|0|||
130233224|NCT02711137|468819668|FG000|Overall Study|Lost to Follow-up|1|||
130233225|NCT02711137|468819669|FG001|Overall Study|Lost to Follow-up|0|||
130233226|NCT02711137|468819670|FG002|Overall Study|Lost to Follow-up|0|||
130233227|NCT02711137|468819671|FG003|Overall Study|Lost to Follow-up|0|||
130025771|NCT00091832|468054210|FG000|Overall Study|Disease Progression|2|||
130025772|NCT00091832|468054211|FG001|Overall Study|Disease Progression|0|||
130025773|NCT00091832|468054212|FG002|Overall Study|Disease Progression|0|||
130025774|NCT00091832|468054213|FG003|Overall Study|Disease Progression|1|||
130025775|NCT00091832|468054214|FG004|Overall Study|Disease Progression|1|||
130025776|NCT00091832|468054215|FG005|Overall Study|Disease Progression|2|||
130025777|NCT00091832|468054210|FG000|Overall Study|Ineligibility Determined|0|||
130025778|NCT00091832|468054211|FG001|Overall Study|Ineligibility Determined|0|||
130100102|NCT04409509|468324127|FG001|Overall Study|Adverse Event|1|||
130233228|NCT02711137|468819672|FG004|Overall Study|Lost to Follow-up|0|||
130233229|NCT02711137|468819673|FG005|Overall Study|Lost to Follow-up|0|||
130233230|NCT02711137|468819674|FG006|Overall Study|Lost to Follow-up|2|||
130233231|NCT02711137|468819675|FG007|Overall Study|Lost to Follow-up|0|||
130233232|NCT02711137|468819676|FG008|Overall Study|Lost to Follow-up|0|||
130233233|NCT02711137|468819677|FG009|Overall Study|Lost to Follow-up|0|||
130233234|NCT02711137|468819678|FG010|Overall Study|Lost to Follow-up|0|||
130233235|NCT02711137|468819679|FG011|Overall Study|Lost to Follow-up|0|||
130233236|NCT02711137|468819680|FG012|Overall Study|Lost to Follow-up|0|||
130233237|NCT02711137|468819681|FG013|Overall Study|Lost to Follow-up|0|||
130233238|NCT02711137|468819682|FG014|Overall Study|Lost to Follow-up|0|||
130233239|NCT01113749|468819683|FG000|Overall Study|Lost to Follow-up|1|||
130233240|NCT01113749|468819684|FG001|Overall Study|Lost to Follow-up|2|||
130233241|NCT03427892|468819685|FG000|Overall Study|Lost to Follow-up|2|||
130233242|NCT00548327|468819686|FG000|Overall Study|Adverse Event|0|||
130233243|NCT00548327|468819687|FG001|Overall Study|Adverse Event|1|||
130233244|NCT00274456|468819691|FG000|Overall Study|Still on treatment|2|||
130233245|NCT00274456|468819692|FG001|Overall Study|Still on treatment|3|||
130233246|NCT00274456|468819693|FG002|Overall Study|Still on treatment|5|||
130233247|NCT00274456|468819694|FG003|Overall Study|Still on treatment|1|||
130233248|NCT00274456|468819691|FG000|Overall Study|Unacceptable toxicity|10|||
130233249|NCT00274456|468819692|FG001|Overall Study|Unacceptable toxicity|5|||
130233250|NCT00274456|468819693|FG002|Overall Study|Unacceptable toxicity|12|||
130233251|NCT00274456|468819694|FG003|Overall Study|Unacceptable toxicity|16|||
130233252|NCT00274456|468819691|FG000|Overall Study|Adverse Event|0|||
130233253|NCT00274456|468819692|FG001|Overall Study|Adverse Event|1|||
130233254|NCT00274456|468819693|FG002|Overall Study|Adverse Event|2|||
130233255|NCT00274456|468819694|FG003|Overall Study|Adverse Event|2|||
130233256|NCT00274456|468819691|FG000|Overall Study|Physician Decision|7|||
130233257|NCT00274456|468819692|FG001|Overall Study|Physician Decision|5|||
130233258|NCT00274456|468819693|FG002|Overall Study|Physician Decision|6|||
130233259|NCT00274456|468819694|FG003|Overall Study|Physician Decision|13|||
130233260|NCT00274456|468819691|FG000|Overall Study|Lost to Follow-up|0|||
130233261|NCT00274456|468819692|FG001|Overall Study|Lost to Follow-up|0|||
130233262|NCT00274456|468819693|FG002|Overall Study|Lost to Follow-up|1|||
130233263|NCT00274456|468819694|FG003|Overall Study|Lost to Follow-up|0|||
130233264|NCT00274456|468819691|FG000|Overall Study|Withdrawal by Subject|18|||
130233265|NCT00274456|468819692|FG001|Overall Study|Withdrawal by Subject|13|||
130233266|NCT00274456|468819693|FG002|Overall Study|Withdrawal by Subject|9|||
130233267|NCT00274456|468819694|FG003|Overall Study|Withdrawal by Subject|13|||
130025779|NCT00091832|468054212|FG002|Overall Study|Ineligibility Determined|1|||
130025780|NCT00091832|468054213|FG003|Overall Study|Ineligibility Determined|0|||
130233268|NCT03255187|468819695|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
130233269|NCT03255187|468819696|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
130025781|NCT00091832|468054214|FG004|Overall Study|Ineligibility Determined|1|||
130100103|NCT04409509|468324126|FG000|Overall Study|Death|11|||
130233270|NCT03255187|468819695|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
130025782|NCT00091832|468054215|FG005|Overall Study|Ineligibility Determined|0|||
130025783|NCT00091832|468054210|FG000|Overall Study|Lost to Follow-up|1|||
130025784|NCT00091832|468054211|FG001|Overall Study|Lost to Follow-up|0|||
130025785|NCT00091832|468054212|FG002|Overall Study|Lost to Follow-up|3|||
130025786|NCT00091832|468054213|FG003|Overall Study|Lost to Follow-up|3|||
130025787|NCT00091832|468054214|FG004|Overall Study|Lost to Follow-up|2|||
130025788|NCT00091832|468054215|FG005|Overall Study|Lost to Follow-up|1|||
130025789|NCT00091832|468054210|FG000|Overall Study|Noncompliance|0|||
130025790|NCT00091832|468054211|FG001|Overall Study|Noncompliance|1|||
130025791|NCT00091832|468054212|FG002|Overall Study|Noncompliance|0|||
130025792|NCT00091832|468054213|FG003|Overall Study|Noncompliance|0|||
130025793|NCT00091832|468054214|FG004|Overall Study|Noncompliance|0|||
130025794|NCT00091832|468054215|FG005|Overall Study|Noncompliance|0|||
130025795|NCT00091832|468054210|FG000|Overall Study|Other|0|||
130025796|NCT00091832|468054211|FG001|Overall Study|Other|1|||
130025797|NCT00091832|468054212|FG002|Overall Study|Other|2|||
130025798|NCT00091832|468054213|FG003|Overall Study|Other|0|||
130025799|NCT00091832|468054214|FG004|Overall Study|Other|0|||
130025800|NCT00091832|468054215|FG005|Overall Study|Other|0|||
130025801|NCT00091832|468054210|FG000|Overall Study|Protocol Violation|0|||
130025802|NCT00091832|468054211|FG001|Overall Study|Protocol Violation|0|||
130025803|NCT00091832|468054212|FG002|Overall Study|Protocol Violation|1|||
130025804|NCT00091832|468054213|FG003|Overall Study|Protocol Violation|0|||
130025805|NCT00091832|468054214|FG004|Overall Study|Protocol Violation|0|||
130025806|NCT00091832|468054215|FG005|Overall Study|Protocol Violation|1|||
130025807|NCT00464178|468054216|FG000|Overall Study|Protocol Violation|1|||
130025808|NCT00464178|468054216|FG000|Overall Study|Withdrawal by Subject|1|||
130025809|NCT00946309|468054219|FG000|Overall Study|Protocol Violation|1|||
130025810|NCT00946309|468054220|FG001|Overall Study|Protocol Violation|0|||
130025811|NCT00946309|468054219|FG000|Overall Study|Lost to Follow-up|0|||
130025812|NCT00946309|468054220|FG001|Overall Study|Lost to Follow-up|1|||
130025813|NCT00946309|468054219|FG000|Overall Study|Procedure cancelled/discontinued|0|||
130025814|NCT00946309|468054220|FG001|Overall Study|Procedure cancelled/discontinued|3|||
130025815|NCT01725750|468054226|FG000|Overall Study|Adverse Event|1|||
130025816|NCT01725750|468054227|FG001|Overall Study|Adverse Event|0|||
130025817|NCT01725750|468054226|FG000|Overall Study|Lost to Follow-up|1|||
130025818|NCT01725750|468054227|FG001|Overall Study|Lost to Follow-up|1|||
130025819|NCT01725750|468054226|FG000|Overall Study|Withdrawal by Subject|0|||
130025820|NCT01725750|468054227|FG001|Overall Study|Withdrawal by Subject|9|||
130025821|NCT02542072|468054228|FG000|First Intervention (1 Month)|Adverse Event|1|||
130025822|NCT02542072|468054229|FG001|First Intervention (1 Month)|Adverse Event|1|||
130025823|NCT02542072|468054228|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
130025824|NCT02542072|468054229|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
130025825|NCT02542072|468054228|FG000|First Intervention (1 Month)|Lens discomfort|1|||
130025826|NCT02542072|468054229|FG001|First Intervention (1 Month)|Lens discomfort|2|||
130025827|NCT02542072|468054228|FG000|First Intervention (1 Month)|Protocol Violation|1|||
130025828|NCT02542072|468054229|FG001|First Intervention (1 Month)|Protocol Violation|0|||
130025829|NCT02542072|468054228|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
130025830|NCT02542072|468054229|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
130025831|NCT02542072|468054228|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
130025832|NCT02542072|468054229|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
130025833|NCT00654498|468054230|FG000|Overall Study|Not Treated|1|||
130025834|NCT00654498|468054231|FG001|Overall Study|Not Treated|0|||
130025835|NCT00654498|468054230|FG000|Overall Study|Adverse Event|6|||
130025836|NCT00654498|468054231|FG001|Overall Study|Adverse Event|1|||
130025837|NCT00654498|468054230|FG000|Overall Study|Protocol Violation|1|||
130025838|NCT00654498|468054231|FG001|Overall Study|Protocol Violation|1|||
130025839|NCT00654498|468054230|FG000|Overall Study|Lost to Follow-up|1|||
130025840|NCT00654498|468054231|FG001|Overall Study|Lost to Follow-up|5|||
130025841|NCT00654498|468054230|FG000|Overall Study|Withdrawal by Subject|1|||
130025842|NCT00654498|468054231|FG001|Overall Study|Withdrawal by Subject|0|||
130100104|NCT04409509|468324127|FG001|Overall Study|Death|10|||
130100105|NCT04409509|468324126|FG000|Overall Study|Non-compliance with study drug|0|||
130100106|NCT04409509|468324127|FG001|Overall Study|Non-compliance with study drug|1|||
130100107|NCT04409509|468324126|FG000|Overall Study|Lost to Follow-up|0|||
130100108|NCT04409509|468324127|FG001|Overall Study|Lost to Follow-up|3|||
130100109|NCT04409509|468324126|FG000|Overall Study|Withdrawal by Subject|0|||
130100110|NCT04409509|468324127|FG001|Overall Study|Withdrawal by Subject|3|||
130025843|NCT00654498|468054230|FG000|Overall Study|Other reason not defined above|4|||
130025844|NCT00654498|468054231|FG001|Overall Study|Other reason not defined above|5|||
130025845|NCT01738971|468054242|FG000|Overall Study|Lost to Follow-up|19|||
130025846|NCT01738971|468054243|FG001|Overall Study|Lost to Follow-up|30|||
130025847|NCT01738971|468054244|FG002|Overall Study|Lost to Follow-up|17|||
130025848|NCT01031446|468054245|FG000|Overall Study|Disease Progression|38|||
130025849|NCT01031446|468054245|FG000|Overall Study|Adverse Event|9|||
130025850|NCT01031446|468054245|FG000|Overall Study|Physician Decision|4|||
130025851|NCT01031446|468054245|FG000|Overall Study|Withdrawal by Subject|3|||
130025852|NCT01031446|468054245|FG000|Overall Study|Still on treatment|1|||
130025853|NCT03631706|468054250|FG000|Overall Study|Randomized, not treated|1|||
130100111|NCT04409509|468324126|FG000|Overall Study|Randomized by mistake|0|||
130100112|NCT04409509|468324127|FG001|Overall Study|Randomized by mistake|1|||
130100113|NCT04409509|468324126|FG000|Overall Study|Other|1|||
130100114|NCT04409509|468324127|FG001|Overall Study|Other|1|||
130100115|NCT03707145|468324128|FG000|Overall Study|Lost to Follow-up|0|||
130100116|NCT03707145|468324129|FG001|Overall Study|Lost to Follow-up|1|||
130100117|NCT03707145|468324130|FG002|Overall Study|Lost to Follow-up|1|||
130100118|NCT03707145|468324131|FG003|Overall Study|Lost to Follow-up|0|||
130233271|NCT03255187|468819696|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
130233272|NCT00375752|468819697|FG000|Overall Study|Lack of Efficacy|4|||
130233273|NCT00375752|468819698|FG001|Overall Study|Lack of Efficacy|4|||
130233274|NCT00375752|468819697|FG000|Overall Study|Adverse Event|1|||
130233275|NCT00375752|468819698|FG001|Overall Study|Adverse Event|6|||
130233276|NCT00375752|468819697|FG000|Overall Study|Withdrawal by Subject|6|||
130233277|NCT00375752|468819698|FG001|Overall Study|Withdrawal by Subject|1|||
130233278|NCT00375752|468819697|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
130233279|NCT00375752|468819698|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
130233280|NCT00375752|468819697|FG000|Overall Study|Protocol Violation|0|||
130233281|NCT00375752|468819698|FG001|Overall Study|Protocol Violation|2|||
130233282|NCT00375752|468819697|FG000|Overall Study|Administrative Problems|0|||
130100119|NCT02851069|468324136|FG000|Overall Study|Failure to Return|3|||
130100120|NCT02851069|468324136|FG000|Overall Study|Other|3|||
130100121|NCT03539952|468324145|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
130233283|NCT00375752|468819698|FG001|Overall Study|Administrative Problems|1|||
130233284|NCT02034006|468819699|FG000|Overall Study|Withdrawal by Subject|7|||
130233285|NCT02034006|468819699|FG000|Overall Study|Lost to Follow-up|5|||
130233286|NCT02034006|468819699|FG000|Overall Study|Death|1|||
130233287|NCT02034006|468819699|FG000|Overall Study|Pregnancy|1|||
130233288|NCT00109343|468819700|FG000|Overall Study|Adverse Event|1|||
130233289|NCT00109343|468819701|FG001|Overall Study|Adverse Event|0|||
130233290|NCT00109343|468819702|FG002|Overall Study|Adverse Event|2|||
130233291|NCT00109343|468819700|FG000|Overall Study|Lack of Efficacy|1|||
130233292|NCT00109343|468819701|FG001|Overall Study|Lack of Efficacy|0|||
130233293|NCT00109343|468819702|FG002|Overall Study|Lack of Efficacy|0|||
130025854|NCT03631706|468054251|FG001|Overall Study|Randomized, not treated|0|||
130025855|NCT05888103|468055767|FG000|Overall Study|Participant decision|3|||
130025856|NCT05888103|468055768|FG001|Overall Study|Participant decision|3|||
130025857|NCT00680836|468055769|FG000|Overall Study|Withdrawal by Subject|3|||
130233294|NCT00109343|468819700|FG000|Overall Study|Lost to Follow-up|35|||
130233295|NCT00109343|468819701|FG001|Overall Study|Lost to Follow-up|20|||
130233296|NCT00109343|468819702|FG002|Overall Study|Lost to Follow-up|14|||
130233297|NCT00109343|468819700|FG000|Overall Study|Protocol Violation|1|||
130025858|NCT00680836|468055770|FG001|Overall Study|Withdrawal by Subject|0|||
130025859|NCT00680836|468055769|FG000|Overall Study|Lost to Follow-up|3|||
130025860|NCT00680836|468055770|FG001|Overall Study|Lost to Follow-up|1|||
130025861|NCT00680836|468055769|FG000|Overall Study|Physician Decision|2|||
130233298|NCT00109343|468819701|FG001|Overall Study|Protocol Violation|2|||
130025862|NCT00680836|468055770|FG001|Overall Study|Physician Decision|1|||
130025863|NCT05512949|468055771|FG000|Overall Study|Lost to Follow-up|4|||
130100122|NCT03539952|468324146|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
130100123|NCT03539952|468324145|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
130233299|NCT00109343|468819702|FG002|Overall Study|Protocol Violation|2|||
130233300|NCT00109343|468819700|FG000|Overall Study|Withdrawal by Subject|15|||
130233301|NCT00109343|468819701|FG001|Overall Study|Withdrawal by Subject|11|||
130233302|NCT00109343|468819702|FG002|Overall Study|Withdrawal by Subject|10|||
130233303|NCT00109343|468819700|FG000|Overall Study|Subject Moved|6|||
130233304|NCT00109343|468819701|FG001|Overall Study|Subject Moved|2|||
130233305|NCT00109343|468819702|FG002|Overall Study|Subject Moved|1|||
130233306|NCT00109343|468819700|FG000|Overall Study|Other|5|||
130233307|NCT00109343|468819701|FG001|Overall Study|Other|2|||
130233308|NCT00109343|468819702|FG002|Overall Study|Other|1|||
130233309|NCT00750269|468819703|FG000|Overall Study|Protocol Violation|0|||
130233310|NCT00750269|468819704|FG001|Overall Study|Protocol Violation|1|||
130233311|NCT00750269|468819705|FG002|Overall Study|Protocol Violation|1|||
130233312|NCT00750269|468819706|FG003|Overall Study|Protocol Violation|2|||
130233313|NCT00750269|468819707|FG004|Overall Study|Protocol Violation|4|||
130233314|NCT00750269|468819703|FG000|Overall Study|Withdrawal by Subject|0|||
130233315|NCT00750269|468819704|FG001|Overall Study|Withdrawal by Subject|0|||
130233316|NCT00750269|468819705|FG002|Overall Study|Withdrawal by Subject|2|||
130233317|NCT00750269|468819706|FG003|Overall Study|Withdrawal by Subject|2|||
130233318|NCT00750269|468819707|FG004|Overall Study|Withdrawal by Subject|2|||
130233319|NCT00750269|468819703|FG000|Overall Study|Physician Decision|0|||
130233320|NCT00750269|468819704|FG001|Overall Study|Physician Decision|0|||
130233321|NCT00750269|468819705|FG002|Overall Study|Physician Decision|0|||
130233322|NCT00750269|468819706|FG003|Overall Study|Physician Decision|0|||
130233323|NCT00750269|468819707|FG004|Overall Study|Physician Decision|2|||
130233324|NCT00750269|468819703|FG000|Overall Study|Patient too large for positioning|0|||
130233325|NCT00750269|468819704|FG001|Overall Study|Patient too large for positioning|0|||
130233326|NCT00750269|468819705|FG002|Overall Study|Patient too large for positioning|1|||
130233327|NCT00750269|468819706|FG003|Overall Study|Patient too large for positioning|0|||
130233328|NCT00750269|468819707|FG004|Overall Study|Patient too large for positioning|0|||
130233329|NCT00750269|468819703|FG000|Overall Study|Site error|0|||
130233330|NCT00750269|468819704|FG001|Overall Study|Site error|0|||
130233331|NCT00750269|468819705|FG002|Overall Study|Site error|0|||
130233332|NCT00750269|468819706|FG003|Overall Study|Site error|1|||
130233333|NCT00750269|468819707|FG004|Overall Study|Site error|0|||
130233334|NCT00750269|468819703|FG000|Overall Study|SBRT plan could not be drawn|0|||
130233335|NCT00750269|468819704|FG001|Overall Study|SBRT plan could not be drawn|0|||
130233336|NCT00750269|468819705|FG002|Overall Study|SBRT plan could not be drawn|0|||
130233337|NCT00750269|468819706|FG003|Overall Study|SBRT plan could not be drawn|0|||
130233338|NCT00750269|468819707|FG004|Overall Study|SBRT plan could not be drawn|1|||
130233339|NCT00750269|468819703|FG000|Overall Study|Fiducials could not be placed|0|||
130233340|NCT00750269|468819704|FG001|Overall Study|Fiducials could not be placed|0|||
130233341|NCT00750269|468819705|FG002|Overall Study|Fiducials could not be placed|0|||
130233342|NCT00750269|468819706|FG003|Overall Study|Fiducials could not be placed|0|||
130233343|NCT00750269|468819707|FG004|Overall Study|Fiducials could not be placed|1|||
130233344|NCT02100631|468819709|FG000|Overall Study|Withdrawal by Subject|1|||
130233345|NCT02100631|468819710|FG001|Overall Study|Withdrawal by Subject|0|||
130233346|NCT02100631|468819711|FG002|Overall Study|Withdrawal by Subject|0|||
130233347|NCT02100631|468819709|FG000|Overall Study|Lost to Follow-up|3|||
130233348|NCT02100631|468819710|FG001|Overall Study|Lost to Follow-up|4|||
130233349|NCT02100631|468819711|FG002|Overall Study|Lost to Follow-up|0|||
130233350|NCT02100631|468819709|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
130233351|NCT02100631|468819710|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
130233352|NCT02100631|468819711|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
130233353|NCT03944616|468819713|FG000|Overall Study|Lost to Follow-up|0|||
130233354|NCT03944616|468819714|FG001|Overall Study|Lost to Follow-up|2|||
130233355|NCT01721798|468819715|FG000|Overall Study|Death|0|||
130025864|NCT05512949|468055772|FG001|Overall Study|Lost to Follow-up|6|||
130025865|NCT05512949|468055773|FG002|Overall Study|Lost to Follow-up|2|||
130025866|NCT05512949|468055771|FG000|Overall Study|Protocol Violation|0|||
130025867|NCT05512949|468055772|FG001|Overall Study|Protocol Violation|0|||
130025868|NCT05512949|468055773|FG002|Overall Study|Protocol Violation|1|||
130025869|NCT05512949|468055771|FG000|Overall Study|Withdrawal by Subject|1|||
130025870|NCT05512949|468055772|FG001|Overall Study|Withdrawal by Subject|1|||
130025871|NCT05512949|468055773|FG002|Overall Study|Withdrawal by Subject|2|||
130233356|NCT01721798|468819716|FG001|Overall Study|Death|0|||
130233357|NCT01721798|468819717|FG002|Overall Study|Death|1|||
130233358|NCT01721798|468819718|FG003|Overall Study|Death|1|||
130233359|NCT01721798|468819715|FG000|Overall Study|Lost to Follow-up|2|||
130233360|NCT01721798|468819716|FG001|Overall Study|Lost to Follow-up|2|||
130233361|NCT01721798|468819717|FG002|Overall Study|Lost to Follow-up|9|||
130233362|NCT01721798|468819718|FG003|Overall Study|Lost to Follow-up|9|||
130233363|NCT01721798|468819715|FG000|Overall Study|Pregnancy|0|||
130233364|NCT01721798|468819716|FG001|Overall Study|Pregnancy|0|||
130233365|NCT01721798|468819717|FG002|Overall Study|Pregnancy|1|||
130233366|NCT01721798|468819718|FG003|Overall Study|Pregnancy|1|||
130233367|NCT01721798|468819715|FG000|Overall Study|Withdrawal by Subject|1|||
130233368|NCT01721798|468819716|FG001|Overall Study|Withdrawal by Subject|0|||
130233369|NCT01721798|468819717|FG002|Overall Study|Withdrawal by Subject|2|||
130233370|NCT01721798|468819718|FG003|Overall Study|Withdrawal by Subject|1|||
130233371|NCT01721798|468819715|FG000|Overall Study|Not eligible for 24 month visit|1|||
130233372|NCT01721798|468819716|FG001|Overall Study|Not eligible for 24 month visit|0|||
130233373|NCT01721798|468819717|FG002|Overall Study|Not eligible for 24 month visit|8|||
130233374|NCT01721798|468819718|FG003|Overall Study|Not eligible for 24 month visit|7|||
130233375|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
130233376|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
130233377|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
130233378|NCT00961064|468819719|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
130233379|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
130233380|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
130233381|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
130233382|NCT00961064|468819719|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
130233383|NCT01294046|468819720|FG000|Overall Study|Infection and surgical explant|1|||
130233384|NCT01294046|468819720|FG000|Overall Study|Eligibility criteria expanded|1|||
130233385|NCT01294046|468819720|FG000|Overall Study|Stimulation response inadqequate|1|||
130233386|NCT00761319|468819721|FG000|Overall Study|Protocol Violation|21|||
130233387|NCT00761319|468819722|FG001|Overall Study|Protocol Violation|14|||
130233388|NCT00761319|468819721|FG000|Overall Study|Adverse Event|11|||
130233389|NCT00761319|468819722|FG001|Overall Study|Adverse Event|7|||
130233390|NCT00761319|468819721|FG000|Overall Study|Withdrawal by Subject|8|||
130233391|NCT00761319|468819722|FG001|Overall Study|Withdrawal by Subject|7|||
130233392|NCT00761319|468819721|FG000|Overall Study|Noncompliance|4|||
130233393|NCT00761319|468819722|FG001|Overall Study|Noncompliance|3|||
130233394|NCT00761319|468819721|FG000|Overall Study|Lost to Follow-up|1|||
130233395|NCT00761319|468819722|FG001|Overall Study|Lost to Follow-up|1|||
130233396|NCT00761319|468819721|FG000|Overall Study|Nonspecified|2|||
130233397|NCT00761319|468819722|FG001|Overall Study|Nonspecified|2|||
130233398|NCT00761319|468819721|FG000|Overall Study|Missing|1|||
130233399|NCT00761319|468819722|FG001|Overall Study|Missing|0|||
130233400|NCT03261401|468819723|FG000|Overall Study|Withdrawal by Subject|0|||
130233401|NCT03261401|468819724|FG001|Overall Study|Withdrawal by Subject|0|||
130233402|NCT03261401|468819725|FG002|Overall Study|Withdrawal by Subject|0|||
130233403|NCT03261401|468819726|FG003|Overall Study|Withdrawal by Subject|0|||
130233404|NCT03261401|468819727|FG004|Overall Study|Withdrawal by Subject|0|||
130233405|NCT03261401|468819728|FG005|Overall Study|Withdrawal by Subject|1|||
130233406|NCT03261401|468819729|FG006|Overall Study|Withdrawal by Subject|0|||
130233407|NCT03261401|468819730|FG007|Overall Study|Withdrawal by Subject|0|||
130233408|NCT03261401|468819731|FG008|Overall Study|Withdrawal by Subject|0|||
130233409|NCT03261401|468819732|FG009|Overall Study|Withdrawal by Subject|0|||
130233410|NCT03261401|468819733|FG010|Overall Study|Withdrawal by Subject|0|||
130233411|NCT03261401|468819734|FG011|Overall Study|Withdrawal by Subject|0|||
130233412|NCT03261401|468819735|FG012|Overall Study|Withdrawal by Subject|0|||
130233413|NCT03261401|468819723|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
130233414|NCT03261401|468819724|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
130233415|NCT03261401|468819725|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
130233416|NCT03261401|468819726|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
130233417|NCT03261401|468819727|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
130233418|NCT03261401|468819728|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
130233419|NCT03261401|468819729|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
130233420|NCT03261401|468819730|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
130233421|NCT03261401|468819731|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
130233422|NCT03261401|468819732|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
130233423|NCT03261401|468819733|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
130233424|NCT03261401|468819734|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
130233425|NCT03261401|468819735|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
130233426|NCT00915525|468819736|FG000|Overall Study|Protocol Violation|9|||
130233427|NCT00915525|468819737|FG001|Overall Study|Protocol Violation|4|||
130233428|NCT00915525|468819736|FG000|Overall Study|Withdrawal by Subject|59|||
130233429|NCT00915525|468819737|FG001|Overall Study|Withdrawal by Subject|21|||
130233430|NCT00915525|468819736|FG000|Overall Study|Lost to Follow-up|27|||
130233431|NCT00915525|468819737|FG001|Overall Study|Lost to Follow-up|16|||
130233432|NCT00915525|468819736|FG000|Overall Study|Pregnancy|2|||
130233433|NCT00915525|468819737|FG001|Overall Study|Pregnancy|0|||
130233434|NCT00915525|468819736|FG000|Overall Study|Lack of Efficacy|15|||
130233435|NCT00915525|468819737|FG001|Overall Study|Lack of Efficacy|32|||
130233436|NCT00915525|468819736|FG000|Overall Study|Adverse Event|29|||
130233437|NCT00915525|468819737|FG001|Overall Study|Adverse Event|13|||
130233438|NCT00915525|468819736|FG000|Overall Study|Missing|12|||
130233439|NCT00915525|468819737|FG001|Overall Study|Missing|1|||
130233440|NCT00915525|468819736|FG000|Overall Study|Other Reason|35|||
130233441|NCT00915525|468819737|FG001|Overall Study|Other Reason|12|||
130233442|NCT00915525|468819736|FG000|Overall Study|Site Closed|27|||
130233443|NCT00915525|468819737|FG001|Overall Study|Site Closed|9|||
130233444|NCT00915525|468819736|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
130233445|NCT00915525|468819737|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
130233446|NCT00915525|468819736|FG000|Overall Study|Study Burden|28|||
130233447|NCT00915525|468819737|FG001|Overall Study|Study Burden|12|||
130233448|NCT00915525|468819736|FG000|Overall Study|Non-Compliance|3|||
130233449|NCT00915525|468819737|FG001|Overall Study|Non-Compliance|1|||
130233450|NCT00915525|468819736|FG000|Overall Study|Patient Moved|15|||
130233451|NCT00915525|468819737|FG001|Overall Study|Patient Moved|9|||
130233452|NCT02765035|468819745|FG000|First Intervention (90 Days)|Adverse Event|1|||
130233453|NCT02765035|468819746|FG001|First Intervention (90 Days)|Adverse Event|1|||
130100124|NCT03539952|468324146|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
130233454|NCT02765035|468819745|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
130233455|NCT02765035|468819746|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
130233456|NCT01712178|468819748|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
130233457|NCT01712178|468819749|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
130233458|NCT01712178|468819748|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
130233459|NCT01712178|468819749|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
130233460|NCT01712178|468819748|FG000|Overall Study|Lost to Follow-up|0|||
130233461|NCT01712178|468819749|FG001|Overall Study|Lost to Follow-up|1|||
130233462|NCT00091819|468819750|FG000|Overall Study|Adverse Event|1|||
130233463|NCT00091819|468819751|FG001|Overall Study|Adverse Event|1|||
130233464|NCT00091819|468819750|FG000|Overall Study|Death|4|||
130233465|NCT00091819|468819751|FG001|Overall Study|Death|5|||
130233466|NCT00091819|468819750|FG000|Overall Study|Lost to Follow-up|26|||
130233467|NCT00091819|468819751|FG001|Overall Study|Lost to Follow-up|23|||
130233468|NCT00091819|468819750|FG000|Overall Study|Withdrawal by Subject|5|||
130233469|NCT00091819|468819751|FG001|Overall Study|Withdrawal by Subject|8|||
130233470|NCT00091819|468819750|FG000|Overall Study|Protocol Violation|1|||
130233471|NCT00091819|468819751|FG001|Overall Study|Protocol Violation|2|||
130233472|NCT00091819|468819750|FG000|Overall Study|Other|2|||
130233473|NCT00091819|468819751|FG001|Overall Study|Other|3|||
130233474|NCT00091819|468819750|FG000|Overall Study|Never received study treatment|3|||
130233475|NCT00091819|468819751|FG001|Overall Study|Never received study treatment|4|||
130233476|NCT00984867|468819752|FG000|Overall Study|Adverse Event|3|||
130233477|NCT00984867|468819753|FG001|Overall Study|Adverse Event|7|||
130233478|NCT00984867|468819752|FG000|Overall Study|Death|1|||
130233479|NCT00984867|468819753|FG001|Overall Study|Death|0|||
130233480|NCT00984867|468819752|FG000|Overall Study|Withdrawal by Subject|13|||
130233481|NCT00984867|468819753|FG001|Overall Study|Withdrawal by Subject|4|||
130233482|NCT00984867|468819752|FG000|Overall Study|Lost to Follow-up|3|||
130233483|NCT00984867|468819753|FG001|Overall Study|Lost to Follow-up|4|||
130233484|NCT00984867|468819752|FG000|Overall Study|Poor/non-compliance|0|||
130233485|NCT00984867|468819753|FG001|Overall Study|Poor/non-compliance|1|||
130233486|NCT00984867|468819752|FG000|Overall Study|Subject no longer meets study criteria|1|||
130233487|NCT00984867|468819753|FG001|Overall Study|Subject no longer meets study criteria|1|||
130233488|NCT00984867|468819752|FG000|Overall Study|site closing|1|||
130233489|NCT00984867|468819753|FG001|Overall Study|site closing|0|||
130233490|NCT00984867|468819752|FG000|Overall Study|lack of efficacy and subject compliance|1|||
130233491|NCT00984867|468819753|FG001|Overall Study|lack of efficacy and subject compliance|0|||
130233492|NCT00634504|468819758|FG000|Overall Study|Protocol Violation|1|||
130233493|NCT00634504|468819759|FG001|Overall Study|Protocol Violation|0|||
130233494|NCT05001620|468819762|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
130233495|NCT05001620|468819763|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
130233496|NCT00481676|468819764|FG000|Overall Study|Adverse Event|0|||
130233497|NCT00481676|468819765|FG001|Overall Study|Adverse Event|1|||
130233498|NCT00481676|468819764|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130233499|NCT00481676|468819765|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130233500|NCT00481676|468819764|FG000|Overall Study|Administrative problem|1|||
130233501|NCT00481676|468819765|FG001|Overall Study|Administrative problem|0|||
130233502|NCT03937778|468819766|FG000|Overall Study|Withdrawal by Subject|1|||
130233503|NCT03937778|468819766|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
130233504|NCT00819039|468819767|FG000|Overall Study|Physician Decision|1|||
130233505|NCT00819039|468819768|FG001|Overall Study|Physician Decision|0|||
130233506|NCT00819039|468819769|FG002|Overall Study|Physician Decision|1|||
130233507|NCT00819039|468819767|FG000|Overall Study|Protocol Violation|1|||
130233508|NCT00819039|468819768|FG001|Overall Study|Protocol Violation|0|||
130233509|NCT00819039|468819769|FG002|Overall Study|Protocol Violation|0|||
130233510|NCT01240694|468819770|FG000|Overall Study|Adverse Event|9|||
130233511|NCT01240694|468819770|FG000|Overall Study|Lack of Efficacy|6|||
130233512|NCT01240694|468819770|FG000|Overall Study|Withdrawal by Subject|6|||
130233513|NCT01240694|468819770|FG000|Overall Study|Protocol Violation|2|||
130233514|NCT01240694|468819770|FG000|Overall Study|Lost to Follow-up|2|||
130233515|NCT01240694|468819770|FG000|Overall Study|Other than specified|3|||
130233516|NCT01240694|468819770|FG000|Overall Study|Withdrawn due to early study termination|107|||
130233517|NCT01513590|468819771|FG000|Overall Study|Adverse Event|2|||
130233518|NCT01513590|468819772|FG001|Overall Study|Adverse Event|3|||
130233519|NCT01513590|468819771|FG000|Overall Study|Withdrawal Criteria|3|||
130233520|NCT01513590|468819772|FG001|Overall Study|Withdrawal Criteria|0|||
130233521|NCT01513590|468819771|FG000|Overall Study|Unclassified|5|||
130233522|NCT01513590|468819772|FG001|Overall Study|Unclassified|10|||
130233523|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
130233524|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
130233525|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
130233526|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
130233527|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
130233528|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
130233529|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
130233530|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
130233531|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
130233532|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
130233533|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Death|3|||
130233534|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Death|1|||
130233535|NCT01056276|468819773|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
130233536|NCT01056276|468819774|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
130233537|NCT01056276|468819773|FG000|Maintenance Therapy|Toxicity|0|||
130233538|NCT01056276|468819774|FG001|Maintenance Therapy|Toxicity|2|||
130233539|NCT01056276|468819773|FG000|Maintenance Therapy|Progressive Disease|0|||
130233540|NCT01056276|468819774|FG001|Maintenance Therapy|Progressive Disease|9|||
130233541|NCT01056276|468819773|FG000|Maintenance Therapy|Physician Decision|0|||
130233542|NCT01056276|468819774|FG001|Maintenance Therapy|Physician Decision|1|||
130233543|NCT01056276|468819773|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
130233544|NCT01056276|468819774|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
130233545|NCT01056276|468819773|FG000|Maintenance Therapy|Intercurrent Illness|0|||
130233546|NCT01056276|468819774|FG001|Maintenance Therapy|Intercurrent Illness|1|||
130233547|NCT01056276|468819773|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
130233548|NCT01056276|468819774|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
130233549|NCT01881425|468819775|FG000|Overall Study|Death|5|||
130233550|NCT01881425|468819776|FG001|Overall Study|Death|1|||
130233551|NCT01881425|468819775|FG000|Overall Study|Withdrawal by Subject|8|||
130233552|NCT01881425|468819776|FG001|Overall Study|Withdrawal by Subject|3|||
130233553|NCT01881425|468819775|FG000|Overall Study|Physician Decision|2|||
130233554|NCT01881425|468819776|FG001|Overall Study|Physician Decision|1|||
130233555|NCT01881425|468819775|FG000|Overall Study|Adverse Event|3|||
130233556|NCT01881425|468819776|FG001|Overall Study|Adverse Event|0|||
130233557|NCT01881425|468819775|FG000|Overall Study|General Anesthesia panic attack|0|||
130233558|NCT01881425|468819776|FG001|Overall Study|General Anesthesia panic attack|1|||
130233559|NCT01881425|468819775|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
130233560|NCT01881425|468819776|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
130233561|NCT01881425|468819775|FG000|Overall Study|Lost to Follow-up|7|||
130233562|NCT01881425|468819776|FG001|Overall Study|Lost to Follow-up|2|||
130233563|NCT01200355|468819777|FG000|Overall Study|Death|7|||
130233564|NCT01200355|468819778|FG001|Overall Study|Death|2|||
130233565|NCT04424901|468819779|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
130233566|NCT04424901|468819780|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
130233567|NCT01206764|468819781|FG000|Overall Study|Adverse Event|20|||
130233568|NCT01206764|468819781|FG000|Overall Study|Abnormal laboratory value|2|||
130233569|NCT01206764|468819781|FG000|Overall Study|Abnormal test procedure result|1|||
130233570|NCT01206764|468819781|FG000|Overall Study|Patient withdrew consent|5|||
130233571|NCT01206764|468819781|FG000|Overall Study|Lost to Follow-up|6|||
130233572|NCT01206764|468819781|FG000|Overall Study|Death|11|||
130233573|NCT01206764|468819781|FG000|Overall Study|New cancer therapy|2|||
130233574|NCT01206764|468819781|FG000|Overall Study|Disease progression|88|||
130233575|NCT01206764|468819781|FG000|Overall Study|Protocol deviation|3|||
130233576|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
130233577|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
130233578|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
130233579|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
130233580|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
130233581|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
130233582|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
130233583|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
130233584|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
130233585|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
130233586|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
130233587|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
130233588|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
130233589|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
130233590|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
130233591|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
130233592|NCT00410163|468819783|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
130233593|NCT00410163|468819784|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
130233594|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
130233595|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
130233596|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
130233597|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
130233598|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
130233599|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
130233600|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
130233601|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
130233602|NCT00410163|468819783|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
130233603|NCT00410163|468819784|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
130233604|NCT00797563|468819786|FG000|Overall Study|Adverse Event|1|||
130233605|NCT00688597|468819787|FG000|Overall Study|Adverse Event|2|||
130233606|NCT00688597|468819788|FG001|Overall Study|Adverse Event|0|||
130233607|NCT00688597|468819789|FG002|Overall Study|Adverse Event|0|||
130233608|NCT00688597|468819787|FG000|Overall Study|Physician Decision|1|||
130233609|NCT00688597|468819788|FG001|Overall Study|Physician Decision|0|||
130233610|NCT00688597|468819789|FG002|Overall Study|Physician Decision|0|||
130233611|NCT05853120|468819790|FG000|Overall Study|Lost to Follow-up|4|||
130100125|NCT03539952|468324145|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
130100126|NCT03539952|468324146|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
130233612|NCT05853120|468819791|FG001|Overall Study|Lost to Follow-up|4|||
130233613|NCT05853120|468819790|FG000|Overall Study|Physician Decision|3|||
130233614|NCT05853120|468819791|FG001|Overall Study|Physician Decision|0|||
130233615|NCT05853120|468819790|FG000|Overall Study|Withdrawal by Subject|5|||
130233616|NCT05853120|468819791|FG001|Overall Study|Withdrawal by Subject|2|||
130233617|NCT02855268|468819792|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
130233618|NCT02855268|468819793|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
130233619|NCT02855268|468819792|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
130233620|NCT02855268|468819793|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
130233621|NCT02855268|468819792|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
130233622|NCT02855268|468819793|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
130233623|NCT02855268|468819792|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
130233624|NCT02855268|468819793|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
130233625|NCT02855268|468819792|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
130233626|NCT02855268|468819793|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
130233627|NCT02855268|468819792|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
130233628|NCT02855268|468819793|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
130233629|NCT00465517|468819794|FG000|Overall Study|Adverse Event|7|||
130233630|NCT00465517|468819795|FG001|Overall Study|Adverse Event|3|||
130233631|NCT00465517|468819794|FG000|Overall Study|Lost to Follow-up|1|||
130233632|NCT00465517|468819795|FG001|Overall Study|Lost to Follow-up|0|||
130233633|NCT00465517|468819794|FG000|Overall Study|Withdrawal by Subject|4|||
130233634|NCT00465517|468819795|FG001|Overall Study|Withdrawal by Subject|1|||
130233635|NCT00834041|468819803|FG000|Overall Study|Withdrawal by Subject|1|||
130100127|NCT03539952|468324145|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
130025872|NCT05512949|468055771|FG000|Overall Study|Completion status unknown|1|||
130025873|NCT05512949|468055772|FG001|Overall Study|Completion status unknown|3|||
130025874|NCT05512949|468055773|FG002|Overall Study|Completion status unknown|0|||
130025875|NCT01583179|468055774|FG000|Overall Study|Screen failure|1|||
130025876|NCT01583179|468055775|FG001|Overall Study|Screen failure|2|||
130025877|NCT00568555|468055778|FG000|Overall Study|Withdrawal by Subject|1|||
130025878|NCT00568555|468055779|FG001|Overall Study|Withdrawal by Subject|1|||
130025879|NCT00860158|468055787|FG000|Overall Study|Study Terminated|1|||
130025880|NCT00669617|468055789|FG000|Period 1|Withdrawal by Subject|0|||
130025881|NCT00669617|468055790|FG001|Period 1|Withdrawal by Subject|0|||
130025882|NCT00669617|468055791|FG002|Period 1|Withdrawal by Subject|1|||
130025883|NCT00669617|468055792|FG003|Period 1|Withdrawal by Subject|0|||
130025884|NCT00669617|468055793|FG004|Period 1|Withdrawal by Subject|0|||
130025885|NCT00669617|468055789|FG000|Period 1|Protocol Deviation|0|||
130025886|NCT00669617|468055790|FG001|Period 1|Protocol Deviation|0|||
130025887|NCT00669617|468055791|FG002|Period 1|Protocol Deviation|0|||
130025888|NCT00669617|468055792|FG003|Period 1|Protocol Deviation|0|||
130025889|NCT00669617|468055793|FG004|Period 1|Protocol Deviation|1|||
130025890|NCT00669617|468055789|FG000|Period 3|Lost to Follow-up|1|||
130025891|NCT00669617|468055790|FG001|Period 3|Lost to Follow-up|0|||
130025892|NCT00669617|468055791|FG002|Period 3|Lost to Follow-up|0|||
130025893|NCT00669617|468055792|FG003|Period 3|Lost to Follow-up|0|||
130025894|NCT00669617|468055793|FG004|Period 3|Lost to Follow-up|0|||
130025895|NCT05499520|468055794|FG000|Overall Study|Lost to Follow-up|0|||
130025896|NCT05499520|468055795|FG001|Overall Study|Lost to Follow-up|0|||
130025897|NCT05499520|468055796|FG002|Overall Study|Lost to Follow-up|38|||
130025898|NCT05499520|468055797|FG003|Overall Study|Lost to Follow-up|41|||
130025899|NCT05499520|468055798|FG004|Overall Study|Lost to Follow-up|46|||
130025900|NCT05499520|468055799|FG005|Overall Study|Lost to Follow-up|0|||
130025901|NCT05499520|468055800|FG006|Overall Study|Lost to Follow-up|31|||
130025902|NCT05499520|468055801|FG007|Overall Study|Lost to Follow-up|45|||
130025903|NCT05499520|468055802|FG008|Overall Study|Lost to Follow-up|42|||
130025904|NCT05499520|468055803|FG009|Overall Study|Lost to Follow-up|0|||
130025905|NCT05499520|468055804|FG010|Overall Study|Lost to Follow-up|0|||
130025906|NCT05499520|468055805|FG011|Overall Study|Lost to Follow-up|37|||
130025907|NCT05499520|468055806|FG012|Overall Study|Lost to Follow-up|53|||
130025908|NCT05499520|468055807|FG013|Overall Study|Lost to Follow-up|49|||
130025909|NCT05499520|468055808|FG014|Overall Study|Lost to Follow-up|0|||
130025910|NCT05499520|468055809|FG015|Overall Study|Lost to Follow-up|36|||
130025911|NCT05499520|468055810|FG016|Overall Study|Lost to Follow-up|58|||
130025912|NCT05499520|468055811|FG017|Overall Study|Lost to Follow-up|53|||
130025913|NCT01613326|468055812|FG000|Overall Study|Adverse Event|7|||
130025914|NCT01613326|468055813|FG001|Overall Study|Adverse Event|5|||
130025915|NCT01613326|468055812|FG000|Overall Study|Withdrawal by Subject|3|||
130025916|NCT01613326|468055813|FG001|Overall Study|Withdrawal by Subject|4|||
130025917|NCT01613326|468055812|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130025918|NCT01613326|468055813|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130025919|NCT01613326|468055812|FG000|Overall Study|inability to use device|1|||
130025920|NCT01613326|468055813|FG001|Overall Study|inability to use device|0|||
130025921|NCT01613326|468055812|FG000|Overall Study|Lack of Efficacy|0|||
130025922|NCT01613326|468055813|FG001|Overall Study|Lack of Efficacy|1|||
130025923|NCT01613326|468055812|FG000|Overall Study|Lost to Follow-up|0|||
130025924|NCT01613326|468055813|FG001|Overall Study|Lost to Follow-up|1|||
130025925|NCT01613326|468055812|FG000|Overall Study|Administrative|0|||
130025926|NCT01613326|468055813|FG001|Overall Study|Administrative|2|||
130025927|NCT01613326|468055812|FG000|Overall Study|Protocol Violation|0|||
130025928|NCT01613326|468055813|FG001|Overall Study|Protocol Violation|1|||
130233636|NCT00834041|468819804|FG001|Overall Study|Withdrawal by Subject|0|||
130233637|NCT00834041|468819803|FG000|Overall Study|Lost to Follow-up|0|||
130233638|NCT00834041|468819804|FG001|Overall Study|Lost to Follow-up|1|||
130233639|NCT01799889|468821127|FG000|Overall Study|Adverse Event|4|||
130233640|NCT01799889|468821128|FG001|Overall Study|Adverse Event|4|||
130233641|NCT01799889|468821129|FG002|Overall Study|Adverse Event|5|||
130233642|NCT01799889|468821130|FG003|Overall Study|Adverse Event|1|||
130233643|NCT01799889|468821131|FG004|Overall Study|Adverse Event|11|||
130233644|NCT01799889|468821132|FG005|Overall Study|Adverse Event|1|||
130233645|NCT01799889|468821133|FG006|Overall Study|Adverse Event|5|||
130233646|NCT01799889|468821134|FG007|Overall Study|Adverse Event|2|||
130233647|NCT01799889|468821135|FG008|Overall Study|Adverse Event|3|||
130233648|NCT01799889|468821136|FG009|Overall Study|Adverse Event|1|||
130233649|NCT01799889|468821137|FG010|Overall Study|Adverse Event|1|||
130233650|NCT01799889|468821138|FG011|Overall Study|Adverse Event|0|||
130233651|NCT01799889|468821127|FG000|Overall Study|Death|1|||
130233652|NCT01799889|468821128|FG001|Overall Study|Death|0|||
130233653|NCT01799889|468821129|FG002|Overall Study|Death|5|||
130233654|NCT01799889|468821130|FG003|Overall Study|Death|3|||
130233655|NCT01799889|468821131|FG004|Overall Study|Death|1|||
130233656|NCT01799889|468821132|FG005|Overall Study|Death|0|||
130233657|NCT01799889|468821133|FG006|Overall Study|Death|0|||
130233658|NCT01799889|468821134|FG007|Overall Study|Death|0|||
130233659|NCT01799889|468821135|FG008|Overall Study|Death|1|||
130233660|NCT01799889|468821136|FG009|Overall Study|Death|0|||
130233661|NCT01799889|468821137|FG010|Overall Study|Death|1|||
130233662|NCT01799889|468821138|FG011|Overall Study|Death|0|||
130233663|NCT01799889|468821127|FG000|Overall Study|Lack of Efficacy|1|||
130233664|NCT01799889|468821128|FG001|Overall Study|Lack of Efficacy|1|||
130233665|NCT01799889|468821129|FG002|Overall Study|Lack of Efficacy|0|||
130233666|NCT01799889|468821130|FG003|Overall Study|Lack of Efficacy|1|||
130233667|NCT01799889|468821131|FG004|Overall Study|Lack of Efficacy|2|||
130233668|NCT01799889|468821132|FG005|Overall Study|Lack of Efficacy|2|||
130233669|NCT01799889|468821133|FG006|Overall Study|Lack of Efficacy|0|||
130233670|NCT01799889|468821134|FG007|Overall Study|Lack of Efficacy|0|||
130233671|NCT01799889|468821135|FG008|Overall Study|Lack of Efficacy|2|||
130233672|NCT01799889|468821136|FG009|Overall Study|Lack of Efficacy|0|||
130233673|NCT01799889|468821137|FG010|Overall Study|Lack of Efficacy|1|||
130233674|NCT01799889|468821138|FG011|Overall Study|Lack of Efficacy|0|||
130233675|NCT01799889|468821127|FG000|Overall Study|Lost to Follow-up|0|||
130233676|NCT01799889|468821128|FG001|Overall Study|Lost to Follow-up|1|||
130233677|NCT01799889|468821129|FG002|Overall Study|Lost to Follow-up|0|||
130233678|NCT01799889|468821130|FG003|Overall Study|Lost to Follow-up|0|||
130233679|NCT01799889|468821131|FG004|Overall Study|Lost to Follow-up|0|||
130233680|NCT01799889|468821132|FG005|Overall Study|Lost to Follow-up|0|||
130233681|NCT01799889|468821133|FG006|Overall Study|Lost to Follow-up|0|||
130233682|NCT01799889|468821134|FG007|Overall Study|Lost to Follow-up|0|||
130233683|NCT01799889|468821135|FG008|Overall Study|Lost to Follow-up|0|||
130233684|NCT01799889|468821136|FG009|Overall Study|Lost to Follow-up|0|||
130233685|NCT01799889|468821137|FG010|Overall Study|Lost to Follow-up|0|||
130233686|NCT01799889|468821138|FG011|Overall Study|Lost to Follow-up|0|||
130233687|NCT01799889|468821127|FG000|Overall Study|Physician Decision|3|||
130233688|NCT01799889|468821128|FG001|Overall Study|Physician Decision|2|||
130233689|NCT01799889|468821129|FG002|Overall Study|Physician Decision|4|||
130233690|NCT01799889|468821130|FG003|Overall Study|Physician Decision|4|||
130233691|NCT01799889|468821131|FG004|Overall Study|Physician Decision|5|||
130233692|NCT01799889|468821132|FG005|Overall Study|Physician Decision|5|||
130233693|NCT01799889|468821133|FG006|Overall Study|Physician Decision|5|||
130233694|NCT01799889|468821134|FG007|Overall Study|Physician Decision|2|||
130233695|NCT01799889|468821135|FG008|Overall Study|Physician Decision|6|||
130233696|NCT01799889|468821136|FG009|Overall Study|Physician Decision|0|||
130233697|NCT01799889|468821137|FG010|Overall Study|Physician Decision|0|||
130233698|NCT01799889|468821138|FG011|Overall Study|Physician Decision|1|||
130233699|NCT01799889|468821127|FG000|Overall Study|Progressive Disease|30|||
130233700|NCT01799889|468821128|FG001|Overall Study|Progressive Disease|26|||
130233701|NCT01799889|468821129|FG002|Overall Study|Progressive Disease|25|||
130233702|NCT01799889|468821130|FG003|Overall Study|Progressive Disease|30|||
130233703|NCT01799889|468821131|FG004|Overall Study|Progressive Disease|23|||
130233704|NCT01799889|468821132|FG005|Overall Study|Progressive Disease|9|||
130233705|NCT01799889|468821133|FG006|Overall Study|Progressive Disease|8|||
130233706|NCT01799889|468821134|FG007|Overall Study|Progressive Disease|13|||
130233707|NCT01799889|468821135|FG008|Overall Study|Progressive Disease|18|||
130233708|NCT01799889|468821136|FG009|Overall Study|Progressive Disease|5|||
130233709|NCT01799889|468821137|FG010|Overall Study|Progressive Disease|3|||
130233710|NCT01799889|468821138|FG011|Overall Study|Progressive Disease|1|||
130233711|NCT01799889|468821127|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
130233712|NCT01799889|468821128|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
130233713|NCT01799889|468821129|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
130233714|NCT01799889|468821130|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
130233715|NCT01799889|468821131|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
130233716|NCT01799889|468821132|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
130025929|NCT03980938|468055814|FG000|Treatment Period 1|Study Terminated|1|||
130025930|NCT03980938|468055815|FG001|Treatment Period 1|Study Terminated|1|||
130025931|NCT03980938|468055814|FG000|Treatment Period 2|Study Terminated|2|||
130025932|NCT03980938|468055815|FG001|Treatment Period 2|Study Terminated|2|||
130025933|NCT00840827|468055816|FG000|Overall Study|Adverse Event|1|||
130025934|NCT00840827|468055816|FG000|Overall Study|Lack of Efficacy|4|||
130025935|NCT00840827|468055816|FG000|Overall Study|Physician Decision|1|||
130025936|NCT01445535|468055817|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
130025937|NCT01445535|468055818|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
130025938|NCT01445535|468055819|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
130025939|NCT01445535|468055820|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
130025940|NCT01445535|468055817|FG000|Overall Study|Disease progression|1|||
130025941|NCT01445535|468055818|FG001|Overall Study|Disease progression|0|||
130233717|NCT01799889|468821133|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
130233718|NCT01799889|468821134|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
130233719|NCT01799889|468821135|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
130233720|NCT01799889|468821136|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
130233721|NCT01799889|468821137|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
130233722|NCT01799889|468821138|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
130233723|NCT01799889|468821127|FG000|Overall Study|Study Terminated By Sponsor|1|||
130233724|NCT01799889|468821128|FG001|Overall Study|Study Terminated By Sponsor|0|||
130233725|NCT01799889|468821129|FG002|Overall Study|Study Terminated By Sponsor|0|||
130233726|NCT01799889|468821130|FG003|Overall Study|Study Terminated By Sponsor|0|||
130233727|NCT01799889|468821131|FG004|Overall Study|Study Terminated By Sponsor|2|||
130233728|NCT01799889|468821132|FG005|Overall Study|Study Terminated By Sponsor|1|||
130233729|NCT01799889|468821133|FG006|Overall Study|Study Terminated By Sponsor|0|||
130233730|NCT01799889|468821134|FG007|Overall Study|Study Terminated By Sponsor|2|||
130233731|NCT01799889|468821135|FG008|Overall Study|Study Terminated By Sponsor|1|||
130233732|NCT01799889|468821136|FG009|Overall Study|Study Terminated By Sponsor|1|||
130233733|NCT01799889|468821137|FG010|Overall Study|Study Terminated By Sponsor|0|||
130233734|NCT01799889|468821138|FG011|Overall Study|Study Terminated By Sponsor|0|||
130233735|NCT01799889|468821127|FG000|Overall Study|Withdrawal by Subject|1|||
130233736|NCT01799889|468821128|FG001|Overall Study|Withdrawal by Subject|6|||
130233737|NCT01799889|468821129|FG002|Overall Study|Withdrawal by Subject|4|||
130233738|NCT01799889|468821130|FG003|Overall Study|Withdrawal by Subject|0|||
130233739|NCT01799889|468821131|FG004|Overall Study|Withdrawal by Subject|5|||
130233740|NCT01799889|468821132|FG005|Overall Study|Withdrawal by Subject|1|||
130233741|NCT01799889|468821133|FG006|Overall Study|Withdrawal by Subject|3|||
130233742|NCT01799889|468821134|FG007|Overall Study|Withdrawal by Subject|1|||
130025942|NCT01445535|468055819|FG002|Overall Study|Disease progression|1|||
130233743|NCT01799889|468821135|FG008|Overall Study|Withdrawal by Subject|2|||
130233744|NCT01799889|468821136|FG009|Overall Study|Withdrawal by Subject|1|||
130233745|NCT01799889|468821137|FG010|Overall Study|Withdrawal by Subject|1|||
130233746|NCT01799889|468821138|FG011|Overall Study|Withdrawal by Subject|1|||
130233747|NCT01799889|468821127|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130233748|NCT01799889|468821128|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130233749|NCT01799889|468821129|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130233750|NCT01799889|468821130|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130233751|NCT01799889|468821131|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130233752|NCT01799889|468821132|FG005|Overall Study|Non-Compliance With Study Drug|1|||
130233753|NCT01799889|468821133|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130233754|NCT01799889|468821134|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130233755|NCT01799889|468821135|FG008|Overall Study|Non-Compliance With Study Drug|0|||
130233756|NCT01799889|468821136|FG009|Overall Study|Non-Compliance With Study Drug|0|||
130233757|NCT01799889|468821137|FG010|Overall Study|Non-Compliance With Study Drug|0|||
130233758|NCT01799889|468821138|FG011|Overall Study|Non-Compliance With Study Drug|0|||
130233759|NCT02194465|468821143|FG000|Overall Study|Adverse Event|6|||
130233760|NCT02194465|468821144|FG001|Overall Study|Adverse Event|1|||
130233761|NCT02194465|468821145|FG002|Overall Study|Adverse Event|4|||
130233762|NCT02194465|468821146|FG003|Overall Study|Adverse Event|4|||
130233763|NCT02194465|468821147|FG004|Overall Study|Adverse Event|4|||
130233764|NCT02194465|468821148|FG005|Overall Study|Adverse Event|2|||
130233765|NCT02194465|468821149|FG006|Overall Study|Adverse Event|0|||
130233766|NCT02194465|468821143|FG000|Overall Study|Lost to Follow-up|0|||
130233767|NCT02194465|468821144|FG001|Overall Study|Lost to Follow-up|0|||
130233768|NCT02194465|468821145|FG002|Overall Study|Lost to Follow-up|0|||
130233769|NCT02194465|468821146|FG003|Overall Study|Lost to Follow-up|1|||
130233770|NCT02194465|468821147|FG004|Overall Study|Lost to Follow-up|0|||
130233771|NCT02194465|468821148|FG005|Overall Study|Lost to Follow-up|1|||
130233772|NCT02194465|468821149|FG006|Overall Study|Lost to Follow-up|0|||
130233773|NCT02194465|468821143|FG000|Overall Study|Physician Decision|1|||
130233774|NCT02194465|468821144|FG001|Overall Study|Physician Decision|0|||
130233775|NCT02194465|468821145|FG002|Overall Study|Physician Decision|0|||
130233776|NCT02194465|468821146|FG003|Overall Study|Physician Decision|0|||
130233777|NCT02194465|468821147|FG004|Overall Study|Physician Decision|0|||
130233778|NCT02194465|468821148|FG005|Overall Study|Physician Decision|0|||
130233779|NCT02194465|468821149|FG006|Overall Study|Physician Decision|0|||
130233780|NCT02194465|468821143|FG000|Overall Study|Protocol Violation|1|||
130233781|NCT02194465|468821144|FG001|Overall Study|Protocol Violation|1|||
130233782|NCT02194465|468821145|FG002|Overall Study|Protocol Violation|2|||
130233783|NCT02194465|468821146|FG003|Overall Study|Protocol Violation|1|||
130233784|NCT02194465|468821147|FG004|Overall Study|Protocol Violation|1|||
130233785|NCT02194465|468821148|FG005|Overall Study|Protocol Violation|0|||
130233786|NCT02194465|468821149|FG006|Overall Study|Protocol Violation|0|||
130233787|NCT02194465|468821143|FG000|Overall Study|Withdrawal by Subject|1|||
130233788|NCT02194465|468821144|FG001|Overall Study|Withdrawal by Subject|3|||
130233789|NCT02194465|468821145|FG002|Overall Study|Withdrawal by Subject|1|||
130233790|NCT02194465|468821146|FG003|Overall Study|Withdrawal by Subject|2|||
130233791|NCT02194465|468821147|FG004|Overall Study|Withdrawal by Subject|2|||
130233792|NCT02194465|468821148|FG005|Overall Study|Withdrawal by Subject|1|||
130233793|NCT02194465|468821149|FG006|Overall Study|Withdrawal by Subject|2|||
130233794|NCT02194465|468821143|FG000|Overall Study|Discontinued follow-up period|0|||
130233795|NCT02194465|468821144|FG001|Overall Study|Discontinued follow-up period|2|||
130233796|NCT02194465|468821145|FG002|Overall Study|Discontinued follow-up period|1|||
130233797|NCT02194465|468821146|FG003|Overall Study|Discontinued follow-up period|0|||
130233798|NCT02194465|468821147|FG004|Overall Study|Discontinued follow-up period|2|||
130233799|NCT02194465|468821148|FG005|Overall Study|Discontinued follow-up period|0|||
130233800|NCT02194465|468821149|FG006|Overall Study|Discontinued follow-up period|0|||
130233801|NCT01408641|468821150|FG000|Overall Study|Physician Decision|1|||
130233802|NCT01408641|468821151|FG001|Overall Study|Physician Decision|0|||
130233803|NCT00576758|468821152|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
130233804|NCT00576758|468821153|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
130233805|NCT00576758|468821152|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
130233806|NCT00576758|468821153|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
130233807|NCT00576758|468821152|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
130233808|NCT00576758|468821153|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
130233809|NCT00576758|468821152|FG000|Induction Treatment Period|Death|1|||
130233810|NCT00576758|468821153|FG001|Induction Treatment Period|Death|0|||
130233811|NCT00576758|468821152|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
130233812|NCT00576758|468821153|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
130233813|NCT00576758|468821152|FG000|Induction Treatment Period|Withdrew consent|1|||
130233814|NCT00576758|468821153|FG001|Induction Treatment Period|Withdrew consent|0|||
130233815|NCT00576758|468821152|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
130233816|NCT00576758|468821153|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
130233817|NCT00576758|468821152|FG000|Extension Treatment Period|Death|1|||
130233818|NCT00576758|468821153|FG001|Extension Treatment Period|Death|1|||
130233819|NCT00576758|468821152|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
130233820|NCT00576758|468821153|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
130233821|NCT00576758|468821152|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
130233822|NCT00576758|468821153|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
130233823|NCT00576758|468821152|FG000|Extension Treatment Period|Administrative/Other|3|||
130233824|NCT00576758|468821153|FG001|Extension Treatment Period|Administrative/Other|1|||
130233825|NCT00576758|468821152|FG000|Follow-up Period|Administrative/Other|6|||
130233826|NCT00576758|468821153|FG001|Follow-up Period|Administrative/Other|8|||
130233827|NCT00576758|468821152|FG000|Follow-up Period|Death|3|||
130233828|NCT00576758|468821153|FG001|Follow-up Period|Death|3|||
130233829|NCT00576758|468821152|FG000|Follow-up Period|Insufficient therapeutic response|16|||
130233830|NCT00576758|468821153|FG001|Follow-up Period|Insufficient therapeutic response|5|||
130233831|NCT00576758|468821152|FG000|Follow-up Period|Withdrew consent|2|||
130233832|NCT00576758|468821153|FG001|Follow-up Period|Withdrew consent|1|||
130233833|NCT00089648|468821154|FG000|Overall Study|Adverse Event|7|||
130233834|NCT00089648|468821154|FG000|Overall Study|Withdrawal by Subject|1|||
130233835|NCT00089648|468821154|FG000|Overall Study|Lack of Efficacy|33|||
130233836|NCT00423605|468821155|FG000|Overall Study|Adverse Event|129|||
130233837|NCT00423605|468821155|FG000|Overall Study|Withdrawal by Subject|36|||
130233838|NCT00423605|468821155|FG000|Overall Study|Lost to Follow-up|15|||
130233839|NCT00423605|468821155|FG000|Overall Study|Lack of Efficacy|38|||
130233840|NCT00423605|468821155|FG000|Overall Study|Sponsor Decision|3|||
130233841|NCT00423605|468821155|FG000|Overall Study|Physician Decision|8|||
130233842|NCT00423605|468821155|FG000|Overall Study|Protocol Violation|7|||
130233843|NCT00423605|468821155|FG000|Overall Study|Not one of the pre-specified options|5|||
130233844|NCT03183908|468821158|FG000|Overall Study|Missing Symptom Diary Data|0|||
130233845|NCT03183908|468821159|FG001|Overall Study|Missing Symptom Diary Data|2|||
130233846|NCT03738696|468821160|FG000|Overall Study|Withdrawal by Subject|0|||
130233847|NCT03738696|468821161|FG001|Overall Study|Withdrawal by Subject|1|||
130233848|NCT03738696|468821160|FG000|Overall Study|Lost to Follow-up|8|||
130233849|NCT03738696|468821161|FG001|Overall Study|Lost to Follow-up|14|||
130233850|NCT02566005|468821164|FG000|Overall Study|vaginal bleeding|0|||
130233851|NCT02566005|468821165|FG001|Overall Study|vaginal bleeding|1|||
130233852|NCT02566005|468821164|FG000|Overall Study|received foley|8|||
130233853|NCT02566005|468821165|FG001|Overall Study|received foley|0|||
130233854|NCT02566005|468821164|FG000|Overall Study|did not receive foley|0|||
130233855|NCT02566005|468821165|FG001|Overall Study|did not receive foley|1|||
130233856|NCT02566005|468821164|FG000|Overall Study|labor after randomization|0|||
130233857|NCT02566005|468821165|FG001|Overall Study|labor after randomization|4|||
130233858|NCT03617588|468821166|FG000|Overall Study|Withdrawal by Subject|1|||
130233859|NCT03617588|468821167|FG001|Overall Study|Withdrawal by Subject|0|||
130233860|NCT01294514|468821168|FG000|Overall Study|Excluded due to Arrhythmia|1|||
130233861|NCT01715298|468821169|FG000|Overall Study|Lost to Follow-up|0|||
130233862|NCT01715298|468821170|FG001|Overall Study|Lost to Follow-up|2|||
130233863|NCT01715298|468821169|FG000|Overall Study|Patient/guardian decision|7|||
130233864|NCT01715298|468821170|FG001|Overall Study|Patient/guardian decision|9|||
130233865|NCT01499511|468821175|FG000|Overall Study|Death|1|||
130233866|NCT01499511|468821176|FG001|Overall Study|Death|0|||
130233867|NCT00726453|468821178|FG000|Primary Enrollment Group|Death|18|||
130233868|NCT00726453|468821179|FG001|Primary Enrollment Group|Death|0|||
130233869|NCT00726453|468821178|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
130233870|NCT00726453|468821179|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
130233871|NCT00726453|468821178|FG000|38 mm Length Group|Death|0|||
130233872|NCT00726453|468821179|FG001|38 mm Length Group|Death|3|||
130233873|NCT00941928|468821181|FG000|Overall Study|Withdrawal by Subject|1|||
130233874|NCT00941928|468821181|FG000|Overall Study|Disease Progression|1|||
130233875|NCT03482024|468821188|FG000|Overall Study|Physician Decision|1|||
130233876|NCT03482024|468821189|FG001|Overall Study|Physician Decision|0|||
130233877|NCT03482024|468821190|FG002|Overall Study|Physician Decision|0|||
130233878|NCT03482024|468821191|FG003|Overall Study|Physician Decision|0|||
130233879|NCT03482024|468821192|FG004|Overall Study|Physician Decision|0|||
130233880|NCT04796415|468821193|FG000|Overall Study|not interested|12|||
130233881|NCT04796415|468821193|FG000|Overall Study|health issue|8|||
130233882|NCT04796415|468821193|FG000|Overall Study|Other|4|||
130233883|NCT04796415|468821193|FG000|Overall Study|discharged from home health service|3|||
130233884|NCT04796415|468821193|FG000|Overall Study|re-hospitalization|2|||
130233885|NCT04796415|468821193|FG000|Overall Study|moving to nursing home|1|||
130233886|NCT04796415|468821193|FG000|Overall Study|lost contact|1|||
130233887|NCT00147238|468821200|FG000|Overall Study|Inevaluable|8|||
130233888|NCT00297167|468821201|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
130233889|NCT00297167|468821202|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
130233890|NCT00297167|468821203|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
130233891|NCT00297167|468821201|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
130233892|NCT00297167|468821202|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
130233893|NCT00297167|468821203|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
130233894|NCT03185208|468821206|FG000|Overall Study|Did not start study medication|0|||
130233895|NCT03185208|468821207|FG001|Overall Study|Did not start study medication|3|||
130233896|NCT03834350|468821208|FG000|Overall Study|Withdrawal by Subject|1|||
130233897|NCT02410629|468821209|FG000|Overall Study|Family cannot commit to the study|2|||
130233898|NCT02410629|468821210|FG001|Overall Study|Family cannot commit to the study|1|||
130233899|NCT02410629|468821209|FG000|Overall Study|Subject returned to work|1|||
130233900|NCT02410629|468821210|FG001|Overall Study|Subject returned to work|0|||
130233901|NCT02410629|468821209|FG000|Overall Study|Subject moved back to home country|0|||
130233902|NCT02410629|468821210|FG001|Overall Study|Subject moved back to home country|1|||
130233903|NCT02410629|468821209|FG000|Overall Study|Subject underwent heart surgery|0|||
130233904|NCT02410629|468821210|FG001|Overall Study|Subject underwent heart surgery|1|||
130233905|NCT02765165|468821211|FG000|Treatment Period|Progressive disease|3|||
130233906|NCT02765165|468821212|FG001|Treatment Period|Progressive disease|2|||
130233907|NCT02765165|468821213|FG002|Treatment Period|Progressive disease|3|||
130233908|NCT02765165|468821214|FG003|Treatment Period|Progressive disease|3|||
130233909|NCT02765165|468821215|FG004|Treatment Period|Progressive disease|4|||
130233910|NCT02765165|468821216|FG005|Treatment Period|Progressive disease|2|||
130233911|NCT02765165|468821217|FG006|Treatment Period|Progressive disease|2|||
130233912|NCT02765165|468821211|FG000|Treatment Period|Physician Decision|0|||
130233913|NCT02765165|468821212|FG001|Treatment Period|Physician Decision|1|||
130233914|NCT02765165|468821213|FG002|Treatment Period|Physician Decision|0|||
130233915|NCT02765165|468821214|FG003|Treatment Period|Physician Decision|0|||
130233916|NCT02765165|468821215|FG004|Treatment Period|Physician Decision|0|||
130233917|NCT02765165|468821216|FG005|Treatment Period|Physician Decision|0|||
130233918|NCT02765165|468821217|FG006|Treatment Period|Physician Decision|0|||
130233919|NCT02765165|468821211|FG000|Treatment Period|Adverse Event|0|||
130233920|NCT02765165|468821212|FG001|Treatment Period|Adverse Event|1|||
130233921|NCT02765165|468821213|FG002|Treatment Period|Adverse Event|0|||
130233922|NCT02765165|468821214|FG003|Treatment Period|Adverse Event|0|||
130233923|NCT02765165|468821215|FG004|Treatment Period|Adverse Event|0|||
130233924|NCT02765165|468821216|FG005|Treatment Period|Adverse Event|0|||
130233925|NCT02765165|468821217|FG006|Treatment Period|Adverse Event|0|||
130233926|NCT02765165|468821211|FG000|Treatment Period|Withdrawal by Subject|0|||
130233927|NCT02765165|468821212|FG001|Treatment Period|Withdrawal by Subject|0|||
130233928|NCT02765165|468821213|FG002|Treatment Period|Withdrawal by Subject|0|||
130233929|NCT02765165|468821214|FG003|Treatment Period|Withdrawal by Subject|0|||
130233930|NCT02765165|468821215|FG004|Treatment Period|Withdrawal by Subject|2|||
130233931|NCT02765165|468821216|FG005|Treatment Period|Withdrawal by Subject|0|||
130233932|NCT02765165|468821217|FG006|Treatment Period|Withdrawal by Subject|0|||
130233933|NCT02765165|468821211|FG000|Treatment Period|Study terminated|0|||
130233934|NCT02765165|468821212|FG001|Treatment Period|Study terminated|0|||
130233935|NCT02765165|468821213|FG002|Treatment Period|Study terminated|0|||
130233936|NCT02765165|468821214|FG003|Treatment Period|Study terminated|0|||
130233937|NCT02765165|468821215|FG004|Treatment Period|Study terminated|0|||
130233938|NCT02765165|468821216|FG005|Treatment Period|Study terminated|1|||
130233939|NCT02765165|468821217|FG006|Treatment Period|Study terminated|2|||
130233940|NCT02765165|468821211|FG000|Post-treatment Follow-up|Death|1|||
130233941|NCT02765165|468821212|FG001|Post-treatment Follow-up|Death|2|||
130233942|NCT02765165|468821213|FG002|Post-treatment Follow-up|Death|1|||
130233943|NCT02765165|468821214|FG003|Post-treatment Follow-up|Death|1|||
130233944|NCT02765165|468821215|FG004|Post-treatment Follow-up|Death|1|||
130233945|NCT02765165|468821216|FG005|Post-treatment Follow-up|Death|1|||
130233946|NCT02765165|468821217|FG006|Post-treatment Follow-up|Death|0|||
130233947|NCT02765165|468821211|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
130233948|NCT02765165|468821212|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
130233949|NCT02765165|468821213|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
130233950|NCT02765165|468821214|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
130233951|NCT02765165|468821215|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
130233952|NCT02765165|468821216|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
130233953|NCT02765165|468821217|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
130233954|NCT02765165|468821211|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233955|NCT02765165|468821212|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233956|NCT02765165|468821213|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
130233957|NCT02765165|468821214|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233958|NCT02765165|468821215|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233959|NCT02765165|468821216|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233960|NCT02765165|468821217|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
130233961|NCT02765165|468821211|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233962|NCT02765165|468821212|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233963|NCT02765165|468821213|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
130233964|NCT02765165|468821214|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
130233965|NCT02765165|468821215|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233966|NCT02765165|468821216|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233967|NCT02765165|468821217|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
130233968|NCT02765165|468821211|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233969|NCT02765165|468821212|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
130233970|NCT02765165|468821213|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233971|NCT02765165|468821214|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233972|NCT02765165|468821215|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233973|NCT02765165|468821216|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233974|NCT02765165|468821217|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
130233975|NCT02765165|468821211|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233976|NCT02765165|468821212|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233977|NCT02765165|468821213|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233978|NCT02765165|468821214|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
130233979|NCT02765165|468821215|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
130233980|NCT02765165|468821216|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
130233981|NCT02765165|468821217|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
130233982|NCT01186770|468821218|FG000|Overall Study|Ineligibility|0|||
130233983|NCT01186770|468821219|FG001|Overall Study|Ineligibility|0|||
130233984|NCT01186770|468821220|FG002|Overall Study|Ineligibility|2|||
130233985|NCT01186770|468821221|FG003|Overall Study|Ineligibility|0|||
130233986|NCT01186770|468821218|FG000|Overall Study|Protocol Violation|7|||
130233987|NCT01186770|468821219|FG001|Overall Study|Protocol Violation|9|||
130233988|NCT01186770|468821220|FG002|Overall Study|Protocol Violation|12|||
130233989|NCT01186770|468821221|FG003|Overall Study|Protocol Violation|14|||
130233990|NCT01186770|468821218|FG000|Overall Study|Adverse Event|2|||
130233991|NCT01186770|468821219|FG001|Overall Study|Adverse Event|9|||
130233992|NCT01186770|468821220|FG002|Overall Study|Adverse Event|7|||
130233993|NCT01186770|468821221|FG003|Overall Study|Adverse Event|9|||
130233994|NCT01186770|468821218|FG000|Overall Study|Withdrawal by Subject|15|||
130233995|NCT01186770|468821219|FG001|Overall Study|Withdrawal by Subject|13|||
130233996|NCT01186770|468821220|FG002|Overall Study|Withdrawal by Subject|11|||
130233997|NCT01186770|468821221|FG003|Overall Study|Withdrawal by Subject|17|||
130233998|NCT01186770|468821218|FG000|Overall Study|Lost to Follow-up|10|||
130233999|NCT01186770|468821219|FG001|Overall Study|Lost to Follow-up|6|||
130234000|NCT01186770|468821220|FG002|Overall Study|Lost to Follow-up|14|||
130234001|NCT01186770|468821221|FG003|Overall Study|Lost to Follow-up|9|||
130234002|NCT01186770|468821218|FG000|Overall Study|Insufficient response to treatment|7|||
130234003|NCT01186770|468821219|FG001|Overall Study|Insufficient response to treatment|8|||
130234004|NCT01186770|468821220|FG002|Overall Study|Insufficient response to treatment|5|||
130234005|NCT01186770|468821221|FG003|Overall Study|Insufficient response to treatment|7|||
130234006|NCT01186770|468821218|FG000|Overall Study|Other than specified|0|||
130234007|NCT01186770|468821219|FG001|Overall Study|Other than specified|1|||
130234008|NCT01186770|468821220|FG002|Overall Study|Other than specified|1|||
130234009|NCT01186770|468821221|FG003|Overall Study|Other than specified|2|||
130234010|NCT02567188|468821222|FG000|Overall Study|Death|10|||
130234011|NCT02567188|468821222|FG000|Overall Study|Terminated Mircera Treatment|9|||
130234012|NCT02567188|468821222|FG000|Overall Study|Lost to Follow-up|5|||
130234013|NCT02567188|468821222|FG000|Overall Study|Adverse Event|1|||
130234014|NCT02567188|468821222|FG000|Overall Study|Withdrawal by Subject|1|||
130234015|NCT02567188|468821222|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
130234016|NCT02567188|468821222|FG000|Overall Study|Moved and Changed Clinic|1|||
130234017|NCT02567188|468821222|FG000|Overall Study|Started Hemodialysis|2|||
130234018|NCT02567188|468821222|FG000|Overall Study|Protocol Violation|5|||
130234019|NCT00321763|468821223|FG000|Overall Study|Adverse Event|1|||
130234020|NCT00321763|468821224|FG001|Overall Study|Adverse Event|1|||
130234021|NCT00321763|468821225|FG002|Overall Study|Adverse Event|0|||
130234022|NCT00321763|468821226|FG003|Overall Study|Adverse Event|1|||
130234023|NCT00321763|468821223|FG000|Overall Study|Withdrawal by Subject|2|||
130234024|NCT00321763|468821224|FG001|Overall Study|Withdrawal by Subject|0|||
130234025|NCT00321763|468821225|FG002|Overall Study|Withdrawal by Subject|1|||
130234026|NCT00321763|468821226|FG003|Overall Study|Withdrawal by Subject|0|||
130234027|NCT00321763|468821223|FG000|Overall Study|Lost to Follow-up|3|||
130234028|NCT00321763|468821224|FG001|Overall Study|Lost to Follow-up|1|||
130234029|NCT00321763|468821225|FG002|Overall Study|Lost to Follow-up|5|||
130234030|NCT00321763|468821226|FG003|Overall Study|Lost to Follow-up|4|||
130025943|NCT01445535|468055820|FG003|Overall Study|Disease progression|0|||
130025944|NCT01445535|468055817|FG000|Overall Study|PI discretion|0|||
130025945|NCT01445535|468055818|FG001|Overall Study|PI discretion|0|||
130025946|NCT01445535|468055819|FG002|Overall Study|PI discretion|0|||
130025947|NCT01445535|468055820|FG003|Overall Study|PI discretion|1|||
130025948|NCT00420511|468055823|FG000|Overall Study|Adverse Event|1|||
130025949|NCT00420511|468055824|FG001|Overall Study|Adverse Event|1|||
130025950|NCT00420511|468055823|FG000|Overall Study|Lost to Follow-up|1|||
130234031|NCT01572792|468821227|FG000|Lead-in Study|Lost to Follow-up|5|||
130234032|NCT01572792|468821228|FG001|Lead-in Study|Lost to Follow-up|9|||
130234033|NCT01572792|468821229|FG002|Lead-in Study|Lost to Follow-up|4|||
130234034|NCT01572792|468821230|FG003|Lead-in Study|Lost to Follow-up|2|||
130234035|NCT01572792|468821231|FG004|Lead-in Study|Lost to Follow-up|4|||
130234036|NCT01572792|468821227|FG000|Lead-in Study|Withdrawal by Subject|22|||
130234037|NCT01572792|468821228|FG001|Lead-in Study|Withdrawal by Subject|11|||
130234038|NCT01572792|468821229|FG002|Lead-in Study|Withdrawal by Subject|12|||
130234039|NCT01572792|468821230|FG003|Lead-in Study|Withdrawal by Subject|24|||
130234040|NCT01572792|468821231|FG004|Lead-in Study|Withdrawal by Subject|11|||
130234041|NCT01572792|468821227|FG000|Lead-in Study|Protocol Violation|19|||
130234042|NCT01572792|468821228|FG001|Lead-in Study|Protocol Violation|10|||
130234043|NCT01572792|468821229|FG002|Lead-in Study|Protocol Violation|12|||
130234044|NCT01572792|468821230|FG003|Lead-in Study|Protocol Violation|13|||
130234045|NCT01572792|468821231|FG004|Lead-in Study|Protocol Violation|21|||
130234046|NCT01572792|468821227|FG000|Lead-in Study|Lack of Efficacy|20|||
130234047|NCT01572792|468821228|FG001|Lead-in Study|Lack of Efficacy|5|||
130234048|NCT01572792|468821229|FG002|Lead-in Study|Lack of Efficacy|4|||
130234049|NCT01572792|468821230|FG003|Lead-in Study|Lack of Efficacy|8|||
130234050|NCT01572792|468821231|FG004|Lead-in Study|Lack of Efficacy|10|||
130234051|NCT01572792|468821227|FG000|Lead-in Study|Adverse Event|21|||
130234052|NCT01572792|468821228|FG001|Lead-in Study|Adverse Event|21|||
130234053|NCT01572792|468821229|FG002|Lead-in Study|Adverse Event|22|||
130234054|NCT01572792|468821230|FG003|Lead-in Study|Adverse Event|16|||
130234055|NCT01572792|468821231|FG004|Lead-in Study|Adverse Event|14|||
130234056|NCT01572792|468821227|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
130234057|NCT01572792|468821228|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
130234058|NCT01572792|468821229|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
130234059|NCT01572792|468821230|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
130234060|NCT01572792|468821231|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
130234061|NCT01572792|468821227|FG000|Extension Study|Lost to Follow-up|6|||
130234062|NCT01572792|468821228|FG001|Extension Study|Lost to Follow-up|2|||
130234063|NCT01572792|468821229|FG002|Extension Study|Lost to Follow-up|0|||
130234064|NCT01572792|468821230|FG003|Extension Study|Lost to Follow-up|3|||
130234065|NCT01572792|468821231|FG004|Extension Study|Lost to Follow-up|3|||
130234066|NCT01572792|468821227|FG000|Extension Study|Withdrawal by Subject|7|||
130234067|NCT01572792|468821228|FG001|Extension Study|Withdrawal by Subject|6|||
130234068|NCT01572792|468821229|FG002|Extension Study|Withdrawal by Subject|11|||
130234069|NCT01572792|468821230|FG003|Extension Study|Withdrawal by Subject|8|||
130234070|NCT01572792|468821231|FG004|Extension Study|Withdrawal by Subject|14|||
130234071|NCT01572792|468821227|FG000|Extension Study|Protocol Violation|0|||
130234072|NCT01572792|468821228|FG001|Extension Study|Protocol Violation|4|||
130234073|NCT01572792|468821229|FG002|Extension Study|Protocol Violation|3|||
130234074|NCT01572792|468821230|FG003|Extension Study|Protocol Violation|4|||
130234075|NCT01572792|468821231|FG004|Extension Study|Protocol Violation|3|||
130234076|NCT01572792|468821227|FG000|Extension Study|Lack of Efficacy|2|||
130234077|NCT01572792|468821228|FG001|Extension Study|Lack of Efficacy|3|||
130234078|NCT01572792|468821229|FG002|Extension Study|Lack of Efficacy|3|||
130234079|NCT01572792|468821230|FG003|Extension Study|Lack of Efficacy|2|||
130234080|NCT01572792|468821231|FG004|Extension Study|Lack of Efficacy|2|||
130234081|NCT01572792|468821227|FG000|Extension Study|Adverse Event|7|||
130234082|NCT01572792|468821228|FG001|Extension Study|Adverse Event|6|||
130234083|NCT01572792|468821229|FG002|Extension Study|Adverse Event|5|||
130234084|NCT01572792|468821230|FG003|Extension Study|Adverse Event|6|||
130234085|NCT01572792|468821231|FG004|Extension Study|Adverse Event|4|||
130234086|NCT01572792|468821227|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
130234087|NCT01572792|468821228|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
130234088|NCT01572792|468821229|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
130234089|NCT01572792|468821230|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
130234090|NCT01572792|468821231|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
130234091|NCT01129128|468821232|FG000|Overall Study|Lost to Follow-up|2|||
130234092|NCT01129128|468821233|FG001|Overall Study|Lost to Follow-up|2|||
130234093|NCT01129128|468821234|FG002|Overall Study|Lost to Follow-up|1|||
130234094|NCT01129128|468821232|FG000|Overall Study|Protocol Violation|0|||
130234095|NCT01129128|468821233|FG001|Overall Study|Protocol Violation|1|||
130234096|NCT01129128|468821234|FG002|Overall Study|Protocol Violation|0|||
130234097|NCT01129128|468821232|FG000|Overall Study|Withdrawal by Subject|0|||
130234098|NCT01129128|468821233|FG001|Overall Study|Withdrawal by Subject|1|||
130234099|NCT01129128|468821234|FG002|Overall Study|Withdrawal by Subject|3|||
130234100|NCT01129128|468821232|FG000|Overall Study|Physician Decision|1|||
130234101|NCT01129128|468821233|FG001|Overall Study|Physician Decision|0|||
130234102|NCT01129128|468821234|FG002|Overall Study|Physician Decision|0|||
130234103|NCT00961415|468821235|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
130234104|NCT00961415|468821236|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
130234105|NCT00961415|468821237|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
130234106|NCT00961415|468821235|FG000|Induction Treatment Phase|Death|77|||
130234107|NCT00961415|468821236|FG001|Induction Treatment Phase|Death|0|||
130234108|NCT00961415|468821237|FG002|Induction Treatment Phase|Death|0|||
130234109|NCT00961415|468821235|FG000|Induction Treatment Phase|Protocol Violation|1|||
130234110|NCT00961415|468821236|FG001|Induction Treatment Phase|Protocol Violation|0|||
130234111|NCT00961415|468821237|FG002|Induction Treatment Phase|Protocol Violation|0|||
130234112|NCT00961415|468821235|FG000|Induction Treatment Phase|Physician Decision|2|||
130234113|NCT00961415|468821236|FG001|Induction Treatment Phase|Physician Decision|0|||
130234114|NCT00961415|468821237|FG002|Induction Treatment Phase|Physician Decision|0|||
130234115|NCT00961415|468821235|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
130234116|NCT00961415|468821236|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
130234117|NCT00961415|468821237|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
130025951|NCT00420511|468055824|FG001|Overall Study|Lost to Follow-up|0|||
130234118|NCT00961415|468821235|FG000|Induction Treatment Phase|Other Reason|5|||
130234119|NCT00961415|468821236|FG001|Induction Treatment Phase|Other Reason|0|||
130234120|NCT00961415|468821237|FG002|Induction Treatment Phase|Other Reason|0|||
130234121|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Death|0|||
130234122|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Death|42|||
130234123|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Death|34|||
130234124|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Investigators decision|0|||
130234125|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Investigators decision|2|||
130234126|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Investigators decision|0|||
130234127|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
130234128|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
130234129|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
130234130|NCT00961415|468821235|FG000|Maintenance Treatment Phase|Other reason|0|||
130234131|NCT00961415|468821236|FG001|Maintenance Treatment Phase|Other reason|1|||
130234132|NCT00961415|468821237|FG002|Maintenance Treatment Phase|Other reason|3|||
130234133|NCT00639509|468821248|FG000|Overall Study|Death|1|||
130234134|NCT01933594|468821249|FG000|Overall Study|Lost to Follow-up|1|||
130234135|NCT01933594|468821250|FG001|Overall Study|Lost to Follow-up|0|||
130234136|NCT01933594|468821251|FG002|Overall Study|Lost to Follow-up|0|||
130234137|NCT01933594|468821252|FG003|Overall Study|Lost to Follow-up|0|||
130234138|NCT01933594|468821253|FG004|Overall Study|Lost to Follow-up|1|||
130234139|NCT01933594|468821254|FG005|Overall Study|Lost to Follow-up|0|||
130234140|NCT01933594|468821249|FG000|Overall Study|Ineligible for subsequent study step|0|||
130234141|NCT01933594|468821250|FG001|Overall Study|Ineligible for subsequent study step|0|||
130234142|NCT01933594|468821251|FG002|Overall Study|Ineligible for subsequent study step|0|||
130234143|NCT01933594|468821252|FG003|Overall Study|Ineligible for subsequent study step|0|||
130234144|NCT01933594|468821253|FG004|Overall Study|Ineligible for subsequent study step|1|||
130234145|NCT01933594|468821254|FG005|Overall Study|Ineligible for subsequent study step|0|||
130234146|NCT05049122|468821255|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
130234147|NCT05049122|468821255|FG000|Overall Study|Participant moved|1|||
130234148|NCT05049122|468821255|FG000|Overall Study|At the direction of the doctor|1|||
130234149|NCT05722015|468821256|FG000|Overall Study|Death|57|||
130234150|NCT05722015|468821257|FG001|Overall Study|Death|37|||
130234151|NCT05722015|468821256|FG000|Overall Study|Lost to Follow-up|1|||
130234152|NCT05722015|468821257|FG001|Overall Study|Lost to Follow-up|0|||
130234153|NCT05722015|468821256|FG000|Overall Study|Withdrawal by Subject|5|||
130234154|NCT05722015|468821257|FG001|Overall Study|Withdrawal by Subject|1|||
130234155|NCT05722015|468821256|FG000|Overall Study|Participants Ongoing|188|||
130234156|NCT05722015|468821257|FG001|Overall Study|Participants Ongoing|88|||
130234157|NCT04513366|468821258|FG000|Treatment Phase|Withdrawal by Subject|6|||
130234158|NCT04513366|468821259|FG001|Treatment Phase|Withdrawal by Subject|8|||
130234159|NCT04513366|468821260|FG002|Treatment Phase|Withdrawal by Subject|3|||
130234160|NCT04513366|468821258|FG000|Treatment Phase|Lost to Follow-up|1|||
130234161|NCT04513366|468821259|FG001|Treatment Phase|Lost to Follow-up|2|||
130234162|NCT04513366|468821260|FG002|Treatment Phase|Lost to Follow-up|5|||
130234163|NCT04513366|468821258|FG000|Treatment Phase|Other than Specified|1|||
130234164|NCT04513366|468821259|FG001|Treatment Phase|Other than Specified|0|||
130234165|NCT04513366|468821260|FG002|Treatment Phase|Other than Specified|2|||
130234166|NCT04513366|468821258|FG000|Treatment Phase|Physician Decision|2|||
130025952|NCT01337973|468055825|FG000|Overall Study|Lost to Follow-up|2|||
130025953|NCT01337973|468055826|FG001|Overall Study|Lost to Follow-up|4|||
130234167|NCT04513366|468821259|FG001|Treatment Phase|Physician Decision|0|||
130025954|NCT01337973|468055827|FG002|Overall Study|Lost to Follow-up|3|||
130234168|NCT04513366|468821260|FG002|Treatment Phase|Physician Decision|0|||
130234169|NCT04513366|468821258|FG000|Treatment Phase|Adverse Event|0|||
130234170|NCT04513366|468821259|FG001|Treatment Phase|Adverse Event|1|||
130234171|NCT04513366|468821260|FG002|Treatment Phase|Adverse Event|1|||
130234172|NCT04513366|468821258|FG000|Extension Phase|Withdrawal by Subject|3|||
130234173|NCT04513366|468821259|FG001|Extension Phase|Withdrawal by Subject|1|||
130234174|NCT04513366|468821260|FG002|Extension Phase|Withdrawal by Subject|1|||
130234175|NCT04513366|468821258|FG000|Extension Phase|Other than Specified|4|||
130234176|NCT04513366|468821259|FG001|Extension Phase|Other than Specified|0|||
130234177|NCT04513366|468821260|FG002|Extension Phase|Other than Specified|1|||
130234178|NCT04513366|468821258|FG000|Extension Phase|Lost to Follow-up|1|||
130234179|NCT04513366|468821259|FG001|Extension Phase|Lost to Follow-up|1|||
130234180|NCT04513366|468821260|FG002|Extension Phase|Lost to Follow-up|1|||
130234181|NCT04513366|468821258|FG000|Extension Phase|Sponsor Decision|0|||
130234182|NCT04513366|468821259|FG001|Extension Phase|Sponsor Decision|1|||
130234183|NCT04513366|468821260|FG002|Extension Phase|Sponsor Decision|0|||
130234184|NCT04513366|468821258|FG000|Extension Phase|Death|0|||
130234185|NCT04513366|468821259|FG001|Extension Phase|Death|1|||
130234186|NCT04513366|468821260|FG002|Extension Phase|Death|0|||
130234187|NCT04513366|468821258|FG000|Extension Phase|Adverse Event|0|||
130234188|NCT04513366|468821259|FG001|Extension Phase|Adverse Event|0|||
130234189|NCT04513366|468821260|FG002|Extension Phase|Adverse Event|1|||
130234190|NCT04478266|468821264|FG000|Overall Study|Adverse Event|20|||
130234191|NCT04478266|468821265|FG001|Overall Study|Adverse Event|21|||
130234192|NCT04478266|468821264|FG000|Overall Study|Progressive disease|146|||
130234193|NCT04478266|468821265|FG001|Overall Study|Progressive disease|168|||
130234194|NCT04478266|468821264|FG000|Overall Study|Poor compliance to protocol|1|||
130234195|NCT04478266|468821265|FG001|Overall Study|Poor compliance to protocol|0|||
130234196|NCT04478266|468821264|FG000|Overall Study|Withdrawal by Subject|19|||
130234197|NCT04478266|468821265|FG001|Overall Study|Withdrawal by Subject|16|||
130234198|NCT04478266|468821264|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
130234199|NCT04478266|468821265|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
130234200|NCT04478266|468821264|FG000|Overall Study|Study terminated by sponsor|33|||
130234201|NCT04478266|468821265|FG001|Overall Study|Study terminated by sponsor|35|||
130234202|NCT04478266|468821264|FG000|Overall Study|Other: unspecified|5|||
130234203|NCT04478266|468821265|FG001|Overall Study|Other: unspecified|7|||
130234204|NCT04478266|468821264|FG000|Overall Study|Randomized but not treated|1|||
130234205|NCT04478266|468821265|FG001|Overall Study|Randomized but not treated|1|||
130234206|NCT04058717|468821266|FG000|Randomization Period|Lost to Follow-up|2|||
130234207|NCT04058717|468821267|FG001|Randomization Period|Lost to Follow-up|3|||
130234208|NCT04058717|468821268|FG002|Randomization Period|Lost to Follow-up|4|||
130234209|NCT04058717|468821269|FG003|Randomization Period|Lost to Follow-up|4|||
130234210|NCT04058717|468821266|FG000|Randomization Period|Withdrawal by Subject|1|||
130234211|NCT04058717|468821267|FG001|Randomization Period|Withdrawal by Subject|3|||
130234212|NCT04058717|468821268|FG002|Randomization Period|Withdrawal by Subject|3|||
130234213|NCT04058717|468821269|FG003|Randomization Period|Withdrawal by Subject|3|||
130234214|NCT04058717|468821266|FG000|Randomization Period|PI decision|0|||
130234215|NCT04058717|468821267|FG001|Randomization Period|PI decision|1|||
130234216|NCT04058717|468821268|FG002|Randomization Period|PI decision|0|||
130234217|NCT04058717|468821269|FG003|Randomization Period|PI decision|0|||
130234218|NCT00671788|468821270|FG000|Overall Study|Adverse Event|8|||
130234219|NCT00671788|468821270|FG000|Overall Study|Refused further treatment|3|||
130234220|NCT00671788|468821270|FG000|Overall Study|Ineligible|1|||
130234221|NCT00671788|468821270|FG000|Overall Study|MD Decision|1|||
130234222|NCT00671788|468821270|FG000|Overall Study|Other|1|||
130234223|NCT01832766|468821271|FG000|Washout|Lost to Follow-up|0|||
130234224|NCT01832766|468821272|FG001|Washout|Lost to Follow-up|1|||
130234225|NCT03074500|468821277|FG000|Overall Study|Lost to Follow-up|1|||
130234226|NCT03074500|468821278|FG001|Overall Study|Lost to Follow-up|0|||
130234227|NCT03074500|468821279|FG002|Overall Study|Lost to Follow-up|0|||
130234228|NCT03074500|468821277|FG000|Overall Study|Lack of Efficacy|0|||
130234229|NCT03074500|468821278|FG001|Overall Study|Lack of Efficacy|1|||
130234230|NCT03074500|468821279|FG002|Overall Study|Lack of Efficacy|0|||
130234231|NCT03074500|468821277|FG000|Overall Study|Adverse Event|0|||
130234232|NCT03074500|468821278|FG001|Overall Study|Adverse Event|0|||
130234233|NCT03074500|468821279|FG002|Overall Study|Adverse Event|1|||
130234234|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
130234235|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
130234236|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Death|1|||
130234237|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Death|3|||
130234238|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
130234239|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
130234240|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
130234241|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
130234242|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
130234243|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
130234244|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
130234245|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
130234246|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
130234247|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
130234248|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
130234249|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
130234250|NCT00362232|468822379|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
130234251|NCT00362232|468822380|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
130234252|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
130234253|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
130234254|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
130234255|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
130234256|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
130234257|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
130234258|NCT00362232|468822379|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
130234259|NCT00362232|468822380|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
130234260|NCT02233413|468822383|FG000|Overall Study|Lost to Follow-up|7|||
130234261|NCT02233413|468822384|FG001|Overall Study|Lost to Follow-up|9|||
130234262|NCT02233413|468822383|FG000|Overall Study|Withdrawal by Subject|4|||
130234263|NCT02233413|468822384|FG001|Overall Study|Withdrawal by Subject|5|||
130234264|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
130234265|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
130234266|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
130234267|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
130234268|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
130234269|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
130234270|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
130234271|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
130234272|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
130234273|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
130234274|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
130234275|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
130234276|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
130234277|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
130234278|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
130234279|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
130234280|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
130234281|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
130234282|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
130234283|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
130234284|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
130234285|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
130234286|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
130234287|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
130234288|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
130234289|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
130234290|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
130234291|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
130234292|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
130234293|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
130234294|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
130234295|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
130234296|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
130234297|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
130025955|NCT01337973|468055825|FG000|Overall Study|Death|1|||
130025956|NCT01337973|468055826|FG001|Overall Study|Death|2|||
130025957|NCT01337973|468055827|FG002|Overall Study|Death|1|||
130025958|NCT01337973|468055825|FG000|Overall Study|Withdrawal by Subject|10|||
130025959|NCT01337973|468055826|FG001|Overall Study|Withdrawal by Subject|8|||
130234298|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
130234299|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
130234300|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
130234301|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
130234302|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
130234303|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
130234304|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
130234305|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
130234306|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
130234307|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
130234308|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
130234309|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
130234310|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
130234311|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
130234312|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
130234313|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
130234314|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
130234315|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
130234316|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
130234317|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
130234318|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
130234319|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
130234320|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
130234321|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
130234322|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
130234323|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
130234324|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
130234325|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
130234326|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
130234327|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
130234328|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
130234329|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
130234330|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
130234331|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
130234332|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
130234333|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
130234334|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
130234335|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
130234336|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
130234337|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
130234338|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
130234339|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
130234340|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
130234341|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
130234342|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
130234343|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
130234344|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
130234345|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
130234346|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
130234347|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
130234348|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
130234349|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
130234350|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
130234351|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
130234352|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
130234353|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
130234354|NCT00090103|468822385|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
130234355|NCT00090103|468822386|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
130234356|NCT00090103|468822387|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
130234357|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
130234358|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
130234359|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
130234360|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
130234361|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
130234362|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
130234363|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
130234364|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
130234365|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
130234366|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
130234367|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
130234368|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
130234369|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
130234370|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
130234371|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
130234372|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
130234373|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
130234374|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
130234375|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
130234376|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
130234377|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
130234378|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
130234379|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
130234380|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
130234381|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
130234382|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
130234383|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
130234384|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
130234385|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
130234386|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
130234387|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
130234388|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
130234389|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
130234390|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
130234391|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
130234392|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
130234393|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
130234394|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
130234395|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
130234396|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
130234397|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
130234398|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
130234399|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
130234400|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
130234401|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
130234402|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
130234403|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
130234404|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
130234405|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Death|1|||
130234406|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Death|0|||
130234407|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Death|1|||
130234408|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
130234409|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
130234410|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
130234411|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
130234412|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
130234413|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
130234414|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
130234415|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
130234416|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
130234417|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
130234418|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
130234419|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
130234420|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
130234421|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
130234422|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
130234423|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
130234424|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
130234425|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
130234426|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
130234427|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
130234428|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
130234429|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Depression|0|||
130234430|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Depression|1|||
130234431|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Depression|0|||
130234432|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
130234433|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
130234434|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
130234435|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Jailed|0|||
130234436|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Jailed|1|||
130234437|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Jailed|0|||
130234438|NCT00090103|468822385|FG000|16-Week Safety Follow-up Period|Other|0|||
130234439|NCT00090103|468822386|FG001|16-Week Safety Follow-up Period|Other|1|||
130234440|NCT00090103|468822387|FG002|16-Week Safety Follow-up Period|Other|0|||
130234441|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
130234442|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
130234443|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
130234444|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
130234445|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
130234446|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
130234447|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
130234448|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
130234449|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
130234450|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
130234451|NCT03979313|468822388|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
130234452|NCT03979313|468822389|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
130234453|NCT03979313|468822388|FG000|All Subjects|Any Other Reason|16|||
130234454|NCT03979313|468822389|FG001|All Subjects|Any Other Reason|23|||
130234455|NCT03979313|468822388|FG000|All Subjects|Covid-19|1|||
130234456|NCT03979313|468822389|FG001|All Subjects|Covid-19|3|||
130234457|NCT03979313|468822388|FG000|All Subjects|Withdrawal by Subject|35|||
130234458|NCT03979313|468822389|FG001|All Subjects|Withdrawal by Subject|44|||
130234459|NCT03979313|468822388|FG000|All Subjects|Death|0|||
130234460|NCT03979313|468822389|FG001|All Subjects|Death|5|||
130234461|NCT03979313|468822388|FG000|All Subjects|Lost to Follow-up|28|||
130234462|NCT03979313|468822389|FG001|All Subjects|Lost to Follow-up|61|||
130234463|NCT00300053|468822390|FG000|Overall Study|Patient/Caregiver Preference|2|||
130234464|NCT00300053|468822391|FG001|Overall Study|Patient/Caregiver Preference|2|||
130234465|NCT00300053|468822392|FG002|Overall Study|Patient/Caregiver Preference|3|||
130234466|NCT00300053|468822390|FG000|Overall Study|Death|0|||
130234467|NCT00300053|468822391|FG001|Overall Study|Death|0|||
130234468|NCT00300053|468822392|FG002|Overall Study|Death|3|||
130234469|NCT00300053|468822390|FG000|Overall Study|Lost to Follow-up|0|||
130234470|NCT00300053|468822391|FG001|Overall Study|Lost to Follow-up|1|||
130234471|NCT00300053|468822392|FG002|Overall Study|Lost to Follow-up|0|||
130234472|NCT02472405|468822396|FG000|Overall Study|Lost to Follow-up|9|||
130234473|NCT02472405|468822396|FG000|Overall Study|Adverse Event|1|||
130234474|NCT02736617|468822399|FG000|Treatment|Adverse Event|1|||
130234475|NCT02736617|468822399|FG000|Treatment|Lack of Efficacy|1|||
130234476|NCT02736617|468822399|FG000|Treatment|Withdrawal by Subject|1|||
130234477|NCT02736617|468822399|FG000|Maintenance|Lack of Efficacy|4|||
130234478|NCT02736617|468822399|FG000|Maintenance|Physician Decision|1|||
130234479|NCT02911116|468822404|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130234480|NCT02911116|468822405|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130234481|NCT02911116|468822404|FG000|Overall Study|Lost to Follow-up|0|||
130234482|NCT02911116|468822405|FG001|Overall Study|Lost to Follow-up|1|||
130234483|NCT02469857|468822406|FG000|Overall Study|Death|24|||
130234484|NCT02469857|468822407|FG001|Overall Study|Death|29|||
130234485|NCT02469857|468822406|FG000|Overall Study|Discontinuation|1|||
130234486|NCT02469857|468822407|FG001|Overall Study|Discontinuation|3|||
130234487|NCT02110693|468822408|FG000|Overall Study|Withdrawal by Subject|6|||
130234488|NCT02110693|468822409|FG001|Overall Study|Withdrawal by Subject|7|||
130234489|NCT02110693|468822408|FG000|Overall Study|skipped assessment|15|||
130234490|NCT02110693|468822409|FG001|Overall Study|skipped assessment|18|||
130234491|NCT02110693|468822408|FG000|Overall Study|technical difficulties|6|||
130234492|NCT02110693|468822409|FG001|Overall Study|technical difficulties|4|||
130234493|NCT02110693|468822408|FG000|Overall Study|Other|1|||
130234494|NCT02110693|468822409|FG001|Overall Study|Other|0|||
130234495|NCT04810962|468822410|FG000|Overall Study|Adverse Event|0|||
130234496|NCT04810962|468822411|FG001|Overall Study|Adverse Event|1|||
130234497|NCT04810962|468822410|FG000|Overall Study|Lost to Follow-up|2|||
130234498|NCT04810962|468822411|FG001|Overall Study|Lost to Follow-up|1|||
130234499|NCT04810962|468822410|FG000|Overall Study|Physician Decision|1|||
130234500|NCT04810962|468822411|FG001|Overall Study|Physician Decision|0|||
130234501|NCT04810962|468822410|FG000|Overall Study|Withdrawal by Subject|1|||
130234502|NCT04810962|468822411|FG001|Overall Study|Withdrawal by Subject|3|||
130234503|NCT04810962|468822410|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
130234504|NCT04810962|468822411|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
130234505|NCT00805532|468822412|FG000|Overall Study|invalid data|0|||
130234506|NCT00805532|468822413|FG001|Overall Study|invalid data|1|||
130234507|NCT02701634|468822415|FG000|Overall Study|Adverse Event|2|||
130234508|NCT02701634|468822416|FG001|Overall Study|Adverse Event|3|||
130234509|NCT02701634|468822415|FG000|Overall Study|Death|1|||
130234510|NCT02701634|468822416|FG001|Overall Study|Death|0|||
130234511|NCT02701634|468822415|FG000|Overall Study|Investigator's Discretion|7|||
130234512|NCT02701634|468822416|FG001|Overall Study|Investigator's Discretion|4|||
130234513|NCT02701634|468822415|FG000|Overall Study|Study terminated by Sponsor|15|||
130234514|NCT02701634|468822416|FG001|Overall Study|Study terminated by Sponsor|17|||
130234515|NCT02701634|468822415|FG000|Overall Study|Withdrew Consent|6|||
130234516|NCT02701634|468822416|FG001|Overall Study|Withdrew Consent|7|||
130234517|NCT02701634|468822415|FG000|Overall Study|Randomized but not treated|1|||
130234518|NCT02701634|468822416|FG001|Overall Study|Randomized but not treated|0|||
130234519|NCT01033136|468822419|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
130234520|NCT01033136|468822420|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
130234521|NCT00630292|468822421|FG000|Overall Study|Withdrawal by Subject|1|||
130234522|NCT00142415|468822422|FG000|Overall Study|Physician Decision|0|||
130234523|NCT00142415|468822423|FG001|Overall Study|Physician Decision|0|||
130234524|NCT00142415|468822424|FG002|Overall Study|Physician Decision|0|||
130025960|NCT01337973|468055827|FG002|Overall Study|Withdrawal by Subject|4|||
130234525|NCT00142415|468822425|FG003|Overall Study|Physician Decision|0|||
130234526|NCT00142415|468822426|FG004|Overall Study|Physician Decision|1|||
130234527|NCT00142415|468822427|FG005|Overall Study|Physician Decision|2|||
130234528|NCT01189266|468822432|FG000|Overall Study|Adverse Event|1|||
130234529|NCT01189266|468822433|FG001|Overall Study|Adverse Event|0|||
130234530|NCT01189266|468822434|FG002|Overall Study|Adverse Event|5|||
130234531|NCT01189266|468822432|FG000|Overall Study|Death|0|||
130234532|NCT01189266|468822433|FG001|Overall Study|Death|0|||
130234533|NCT01189266|468822434|FG002|Overall Study|Death|5|||
130234534|NCT01189266|468822432|FG000|Overall Study|Lack of Efficacy|4|||
130234535|NCT01189266|468822433|FG001|Overall Study|Lack of Efficacy|5|||
130234536|NCT01189266|468822434|FG002|Overall Study|Lack of Efficacy|44|||
130234537|NCT01189266|468822432|FG000|Overall Study|Physician Decision|0|||
130234538|NCT01189266|468822433|FG001|Overall Study|Physician Decision|0|||
130234539|NCT01189266|468822434|FG002|Overall Study|Physician Decision|1|||
130234540|NCT01189266|468822432|FG000|Overall Study|Protocol Violation|0|||
130234541|NCT01189266|468822433|FG001|Overall Study|Protocol Violation|1|||
130234542|NCT01189266|468822434|FG002|Overall Study|Protocol Violation|1|||
130234543|NCT01189266|468822432|FG000|Overall Study|Withdrawal by Subject|0|||
130234544|NCT01189266|468822433|FG001|Overall Study|Withdrawal by Subject|0|||
130234545|NCT01189266|468822434|FG002|Overall Study|Withdrawal by Subject|1|||
130234546|NCT01189266|468822432|FG000|Overall Study|Patient refuses further therapy|1|||
130234547|NCT01189266|468822433|FG001|Overall Study|Patient refuses further therapy|0|||
130234548|NCT01189266|468822434|FG002|Overall Study|Patient refuses further therapy|7|||
130234549|NCT01189266|468822432|FG000|Overall Study|No treatment|0|||
130234550|NCT01189266|468822433|FG001|Overall Study|No treatment|0|||
130234551|NCT01189266|468822434|FG002|Overall Study|No treatment|1|||
130234552|NCT04009837|468822435|FG000|Overall Study|Withdrawal by Subject|5|||
130234553|NCT04009837|468822436|FG001|Overall Study|Withdrawal by Subject|4|||
130234554|NCT04009837|468822435|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
130234555|NCT04009837|468822436|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
130234556|NCT03530696|468822439|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
130234557|NCT03530696|468822440|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
130234558|NCT02472353|468822441|FG000|Overall Study|Lost to Follow-up|1|||
130234559|NCT02472353|468822442|FG001|Overall Study|Lost to Follow-up|1|||
130234560|NCT02472353|468822441|FG000|Overall Study|Withdrawal by Subject|2|||
130234561|NCT02472353|468822442|FG001|Overall Study|Withdrawal by Subject|1|||
130234562|NCT02472353|468822441|FG000|Overall Study|Study Termination|1|||
130234563|NCT02472353|468822442|FG001|Overall Study|Study Termination|4|||
130234564|NCT03416179|468822443|FG000|Overall Study|Death|90|||
130025961|NCT01337973|468055825|FG000|Overall Study|missing data on primary outcome|3|||
130234565|NCT03416179|468822444|FG001|Overall Study|Death|87|||
130234566|NCT03416179|468822445|FG002|Overall Study|Death|117|||
130234567|NCT03416179|468822446|FG003|Overall Study|Death|113|||
130234568|NCT03416179|468822443|FG000|Overall Study|Withdrawal by Subject|15|||
130234569|NCT03416179|468822444|FG001|Overall Study|Withdrawal by Subject|20|||
130234570|NCT03416179|468822445|FG002|Overall Study|Withdrawal by Subject|6|||
130234571|NCT03416179|468822446|FG003|Overall Study|Withdrawal by Subject|9|||
130234572|NCT03416179|468822443|FG000|Overall Study|Lost to Follow-up|1|||
130234573|NCT03416179|468822444|FG001|Overall Study|Lost to Follow-up|1|||
130234574|NCT03416179|468822445|FG002|Overall Study|Lost to Follow-up|0|||
130234575|NCT03416179|468822446|FG003|Overall Study|Lost to Follow-up|3|||
130234576|NCT03416179|468822443|FG000|Overall Study|Study participation terminated by Sponsor|93|||
130234577|NCT03416179|468822444|FG001|Overall Study|Study participation terminated by Sponsor|91|||
130234578|NCT03416179|468822445|FG002|Overall Study|Study participation terminated by Sponsor|26|||
130234579|NCT03416179|468822446|FG003|Overall Study|Study participation terminated by Sponsor|31|||
130234580|NCT03416179|468822443|FG000|Overall Study|Other|2|||
130234581|NCT03416179|468822444|FG001|Overall Study|Other|3|||
130234582|NCT03416179|468822445|FG002|Overall Study|Other|1|||
130234583|NCT03416179|468822446|FG003|Overall Study|Other|0|||
130234584|NCT02657551|468822466|FG000|Overall Study|Adverse Event|2|||
130234585|NCT02657551|468822466|FG000|Overall Study|Withdrawal by Subject|1|||
130234586|NCT02657551|468822466|FG000|Overall Study|Non-Compliance|1|||
130234587|NCT02657551|468822466|FG000|Overall Study|Progression / Relapse|4|||
130234588|NCT01035138|468822467|FG000|Overall Study|Adverse Event|4|||
130234589|NCT01035138|468822468|FG001|Overall Study|Adverse Event|0|||
130234590|NCT01035138|468822469|FG002|Overall Study|Adverse Event|2|||
130234591|NCT01035138|468822467|FG000|Overall Study|Caregiver Decision|2|||
130234592|NCT01035138|468822468|FG001|Overall Study|Caregiver Decision|0|||
130234593|NCT01035138|468822469|FG002|Overall Study|Caregiver Decision|1|||
130234594|NCT01035138|468822467|FG000|Overall Study|Withdrawal by Subject|1|||
130234595|NCT01035138|468822468|FG001|Overall Study|Withdrawal by Subject|0|||
130234596|NCT01035138|468822469|FG002|Overall Study|Withdrawal by Subject|0|||
130234597|NCT01035138|468822467|FG000|Overall Study|Physician Decision|0|||
130234598|NCT01035138|468822468|FG001|Overall Study|Physician Decision|0|||
130234599|NCT01035138|468822469|FG002|Overall Study|Physician Decision|1|||
130234600|NCT01035138|468822467|FG000|Overall Study|Sponsor Decision|66|||
130234601|NCT01035138|468822468|FG001|Overall Study|Sponsor Decision|60|||
130234602|NCT01035138|468822469|FG002|Overall Study|Sponsor Decision|42|||
130234603|NCT01035138|468822467|FG000|Overall Study|Lost to Follow-up|0|||
130234604|NCT01035138|468822468|FG001|Overall Study|Lost to Follow-up|0|||
130234605|NCT01035138|468822469|FG002|Overall Study|Lost to Follow-up|1|||
130234606|NCT02916927|468822470|FG000|Overall Study|Discharged prior to study drug receipt|0|||
130234607|NCT02916927|468822471|FG001|Overall Study|Discharged prior to study drug receipt|2|||
130234608|NCT02916927|468822470|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
130234609|NCT02916927|468822471|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
130234610|NCT02916927|468822470|FG000|Overall Study|Withdrawal before first time point|1|||
130234611|NCT02916927|468822471|FG001|Overall Study|Withdrawal before first time point|0|||
130234612|NCT00655889|468822472|FG000|Overall Study|Inadequate cell growth|1|||
130234613|NCT00655889|468822472|FG000|Overall Study|Protocol Violation|1|||
130234614|NCT04585893|468822475|FG000|Overall Study|Death|1|||
130234615|NCT04585893|468822476|FG001|Overall Study|Death|0|||
130234616|NCT01366092|468822477|FG000|Overall Study|Progressive cGVHD|2|||
130234617|NCT01366092|468822477|FG000|Overall Study|Physician Decision|1|||
130234618|NCT01366092|468822477|FG000|Overall Study|Withdrawal by Subject|1|||
130234619|NCT03608163|468822478|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
130234620|NCT03608163|468822479|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
130234621|NCT05399680|468823867|FG000|Overall Study|Lost to Follow-up|1|||
130234622|NCT05399680|468823868|FG001|Overall Study|Lost to Follow-up|0|||
130234623|NCT05399680|468823867|FG000|Overall Study|Death|0|||
130234624|NCT05399680|468823868|FG001|Overall Study|Death|1|||
130234625|NCT02659865|468823869|FG000|Period 1|Withdrawal by Subject|1|||
130234626|NCT02659865|468823870|FG001|Period 1|Withdrawal by Subject|0|||
130234627|NCT02659865|468823871|FG002|Period 1|Withdrawal by Subject|0|||
130234628|NCT02659865|468823872|FG003|Period 1|Withdrawal by Subject|0|||
130234629|NCT02659865|468823873|FG004|Period 1|Withdrawal by Subject|0|||
130234630|NCT02659865|468823869|FG000|Period 1|Adverse Event|0|||
130234631|NCT02659865|468823870|FG001|Period 1|Adverse Event|0|||
130234632|NCT02659865|468823871|FG002|Period 1|Adverse Event|0|||
130234633|NCT02659865|468823872|FG003|Period 1|Adverse Event|0|||
130234634|NCT02659865|468823873|FG004|Period 1|Adverse Event|1|||
130234635|NCT01288430|468823875|FG000|Part 1|Progressive disease|2|||
130234636|NCT01288430|468823876|FG001|Part 1|Progressive disease|1|||
130234637|NCT01288430|468823877|FG002|Part 1|Progressive disease|1|||
130234638|NCT01288430|468823878|FG003|Part 1|Progressive disease|6|||
130234639|NCT01288430|468823879|FG004|Part 1|Progressive disease|2|||
130234640|NCT01288430|468823880|FG005|Part 1|Progressive disease|4|||
130234641|NCT01288430|468823881|FG006|Part 1|Progressive disease|2|||
130234642|NCT01288430|468823882|FG007|Part 1|Progressive disease|0|||
130234643|NCT01288430|468823883|FG008|Part 1|Progressive disease|0|||
130234644|NCT01288430|468823884|FG009|Part 1|Progressive disease|0|||
130234645|NCT01288430|468823875|FG000|Part 1|Clinical disease progression|0|||
130234646|NCT01288430|468823876|FG001|Part 1|Clinical disease progression|0|||
130234647|NCT01288430|468823877|FG002|Part 1|Clinical disease progression|1|||
130234648|NCT01288430|468823878|FG003|Part 1|Clinical disease progression|0|||
130234649|NCT01288430|468823879|FG004|Part 1|Clinical disease progression|0|||
130234650|NCT01288430|468823880|FG005|Part 1|Clinical disease progression|2|||
130234651|NCT01288430|468823881|FG006|Part 1|Clinical disease progression|2|||
130234652|NCT01288430|468823882|FG007|Part 1|Clinical disease progression|0|||
130234653|NCT01288430|468823883|FG008|Part 1|Clinical disease progression|0|||
130234654|NCT01288430|468823884|FG009|Part 1|Clinical disease progression|0|||
130234655|NCT01288430|468823875|FG000|Part 1|Death due to disease progression|0|||
130234656|NCT01288430|468823876|FG001|Part 1|Death due to disease progression|0|||
130234657|NCT01288430|468823877|FG002|Part 1|Death due to disease progression|0|||
130234658|NCT01288430|468823878|FG003|Part 1|Death due to disease progression|0|||
130234659|NCT01288430|468823879|FG004|Part 1|Death due to disease progression|1|||
130234660|NCT01288430|468823880|FG005|Part 1|Death due to disease progression|0|||
130234661|NCT01288430|468823881|FG006|Part 1|Death due to disease progression|0|||
130234662|NCT01288430|468823882|FG007|Part 1|Death due to disease progression|0|||
130234663|NCT01288430|468823883|FG008|Part 1|Death due to disease progression|0|||
130234664|NCT01288430|468823884|FG009|Part 1|Death due to disease progression|0|||
130234665|NCT01288430|468823875|FG000|Part 1|Adverse Event|0|||
130234666|NCT01288430|468823876|FG001|Part 1|Adverse Event|0|||
130234667|NCT01288430|468823877|FG002|Part 1|Adverse Event|3|||
130234668|NCT01288430|468823878|FG003|Part 1|Adverse Event|1|||
130234669|NCT01288430|468823879|FG004|Part 1|Adverse Event|0|||
130234670|NCT01288430|468823880|FG005|Part 1|Adverse Event|0|||
130234671|NCT01288430|468823881|FG006|Part 1|Adverse Event|2|||
130234672|NCT01288430|468823882|FG007|Part 1|Adverse Event|0|||
130234673|NCT01288430|468823883|FG008|Part 1|Adverse Event|0|||
130234674|NCT01288430|468823884|FG009|Part 1|Adverse Event|0|||
130234675|NCT01288430|468823875|FG000|Part 1|Other|0|||
130234676|NCT01288430|468823876|FG001|Part 1|Other|2|||
130234677|NCT01288430|468823877|FG002|Part 1|Other|0|||
130234678|NCT01288430|468823878|FG003|Part 1|Other|0|||
130234679|NCT01288430|468823879|FG004|Part 1|Other|0|||
130234680|NCT01288430|468823880|FG005|Part 1|Other|0|||
130234681|NCT01288430|468823881|FG006|Part 1|Other|1|||
130234682|NCT01288430|468823882|FG007|Part 1|Other|0|||
130234683|NCT01288430|468823883|FG008|Part 1|Other|0|||
130234684|NCT01288430|468823884|FG009|Part 1|Other|0|||
130234685|NCT01288430|468823875|FG000|Part 2|Progressive disease|0|||
130234686|NCT01288430|468823876|FG001|Part 2|Progressive disease|0|||
130234687|NCT01288430|468823877|FG002|Part 2|Progressive disease|0|||
130234688|NCT01288430|468823878|FG003|Part 2|Progressive disease|0|||
130234689|NCT01288430|468823879|FG004|Part 2|Progressive disease|0|||
130234690|NCT01288430|468823880|FG005|Part 2|Progressive disease|0|||
130234691|NCT01288430|468823881|FG006|Part 2|Progressive disease|0|||
130234692|NCT01288430|468823882|FG007|Part 2|Progressive disease|8|||
130234693|NCT01288430|468823883|FG008|Part 2|Progressive disease|7|||
130234694|NCT01288430|468823884|FG009|Part 2|Progressive disease|2|||
130234695|NCT01288430|468823875|FG000|Part 2|Clinical disease progression|0|||
130234696|NCT01288430|468823876|FG001|Part 2|Clinical disease progression|0|||
130234697|NCT01288430|468823877|FG002|Part 2|Clinical disease progression|0|||
130234698|NCT01288430|468823878|FG003|Part 2|Clinical disease progression|0|||
130234699|NCT01288430|468823879|FG004|Part 2|Clinical disease progression|0|||
130234700|NCT01288430|468823880|FG005|Part 2|Clinical disease progression|0|||
130234701|NCT01288430|468823881|FG006|Part 2|Clinical disease progression|0|||
130234702|NCT01288430|468823882|FG007|Part 2|Clinical disease progression|2|||
130234703|NCT01288430|468823883|FG008|Part 2|Clinical disease progression|0|||
130234704|NCT01288430|468823884|FG009|Part 2|Clinical disease progression|0|||
130234705|NCT01288430|468823875|FG000|Part 2|Withdrawal by Subject|0|||
130234706|NCT01288430|468823876|FG001|Part 2|Withdrawal by Subject|0|||
130234707|NCT01288430|468823877|FG002|Part 2|Withdrawal by Subject|0|||
130234708|NCT01288430|468823878|FG003|Part 2|Withdrawal by Subject|0|||
130234709|NCT01288430|468823879|FG004|Part 2|Withdrawal by Subject|0|||
130234710|NCT01288430|468823880|FG005|Part 2|Withdrawal by Subject|0|||
130234711|NCT01288430|468823881|FG006|Part 2|Withdrawal by Subject|0|||
130234712|NCT01288430|468823882|FG007|Part 2|Withdrawal by Subject|1|||
130234713|NCT01288430|468823883|FG008|Part 2|Withdrawal by Subject|4|||
130234714|NCT01288430|468823884|FG009|Part 2|Withdrawal by Subject|0|||
130234715|NCT01288430|468823875|FG000|Part 2|Adverse Event|0|||
130234716|NCT01288430|468823876|FG001|Part 2|Adverse Event|0|||
130234717|NCT01288430|468823877|FG002|Part 2|Adverse Event|0|||
130234718|NCT01288430|468823878|FG003|Part 2|Adverse Event|0|||
130234719|NCT01288430|468823879|FG004|Part 2|Adverse Event|0|||
130234720|NCT01288430|468823880|FG005|Part 2|Adverse Event|0|||
130234721|NCT01288430|468823881|FG006|Part 2|Adverse Event|0|||
130234722|NCT01288430|468823882|FG007|Part 2|Adverse Event|1|||
130234723|NCT01288430|468823883|FG008|Part 2|Adverse Event|1|||
130234724|NCT01288430|468823884|FG009|Part 2|Adverse Event|0|||
130234725|NCT01288430|468823875|FG000|Part 2|Other|0|||
130234726|NCT01288430|468823876|FG001|Part 2|Other|0|||
130234727|NCT01288430|468823877|FG002|Part 2|Other|0|||
130234728|NCT01288430|468823878|FG003|Part 2|Other|0|||
130234729|NCT01288430|468823879|FG004|Part 2|Other|0|||
130234730|NCT01288430|468823880|FG005|Part 2|Other|0|||
130234731|NCT01288430|468823881|FG006|Part 2|Other|0|||
130234732|NCT01288430|468823882|FG007|Part 2|Other|0|||
130234733|NCT01288430|468823883|FG008|Part 2|Other|0|||
130234734|NCT01288430|468823884|FG009|Part 2|Other|1|||
130234735|NCT03836053|468823890|FG000|Overall Study|Protocol-specified criteria|0|||
130234736|NCT03836053|468823891|FG001|Overall Study|Protocol-specified criteria|2|||
130234737|NCT03836053|468823892|FG002|Overall Study|Protocol-specified criteria|1|||
130234738|NCT03836053|468823890|FG000|Overall Study|Death|1|||
130234739|NCT03836053|468823891|FG001|Overall Study|Death|6|||
130234740|NCT03836053|468823892|FG002|Overall Study|Death|4|||
130234741|NCT03836053|468823890|FG000|Overall Study|Withdrawal of consent from study|0|||
130234742|NCT03836053|468823891|FG001|Overall Study|Withdrawal of consent from study|0|||
130234743|NCT03836053|468823892|FG002|Overall Study|Withdrawal of consent from study|1|||
130234744|NCT03836053|468823890|FG000|Overall Study|Decision by sponsor|0|||
130234745|NCT03836053|468823891|FG001|Overall Study|Decision by sponsor|2|||
130234746|NCT03836053|468823892|FG002|Overall Study|Decision by sponsor|4|||
130234747|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
130234748|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
130234749|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
130234750|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Death|1|||
130234751|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Death|1|||
130234752|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Death|0|||
130234753|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
130234754|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
130234755|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
130234756|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
130234757|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
130234758|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
130234759|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
130234760|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
130234761|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
130234762|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
130234763|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
130234764|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
130234765|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
130234766|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
130234767|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
130234768|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
130234769|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
130234770|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
130234771|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
130234772|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
130234773|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
130234774|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
130234775|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
130234776|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
130234777|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Other|10|||
130234778|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Other|4|||
130234779|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Other|0|||
130234780|NCT04006457|468823893|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
130234781|NCT04006457|468823894|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
130234782|NCT04006457|468823895|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
130234783|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
130234784|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
130234785|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
130234786|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
130234787|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
130234788|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
130234789|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
130234790|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
130234791|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
130234792|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
130234793|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
130234794|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
130234795|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
130234796|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
130234797|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
130234798|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Other|2|||
130234799|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Other|3|||
130234800|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Other|0|||
130234801|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
130234802|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
130234803|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
130234804|NCT04006457|468823893|FG000|Main Study: Treatment Period 2|Ongoing|86|||
130234805|NCT04006457|468823894|FG001|Main Study: Treatment Period 2|Ongoing|96|||
130234806|NCT04006457|468823895|FG002|Main Study: Treatment Period 2|Ongoing|0|||
130234807|NCT04006457|468823893|FG000|Main Study Observation Period|Adverse Event|1|||
130234808|NCT04006457|468823894|FG001|Main Study Observation Period|Adverse Event|1|||
130234809|NCT04006457|468823895|FG002|Main Study Observation Period|Adverse Event|0|||
130234810|NCT04006457|468823893|FG000|Main Study Observation Period|Lost to Follow-up|0|||
130234811|NCT04006457|468823894|FG001|Main Study Observation Period|Lost to Follow-up|1|||
130234812|NCT04006457|468823895|FG002|Main Study Observation Period|Lost to Follow-up|0|||
130234813|NCT04006457|468823893|FG000|Main Study Observation Period|Pregnancy|1|||
130234814|NCT04006457|468823894|FG001|Main Study Observation Period|Pregnancy|0|||
130234815|NCT04006457|468823895|FG002|Main Study Observation Period|Pregnancy|0|||
130234816|NCT04006457|468823893|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
130234817|NCT04006457|468823894|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
130234818|NCT04006457|468823895|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
130234819|NCT04006457|468823893|FG000|Main Study Observation Period|Other|8|||
130234820|NCT04006457|468823894|FG001|Main Study Observation Period|Other|16|||
130234821|NCT04006457|468823895|FG002|Main Study Observation Period|Other|0|||
130234822|NCT04006457|468823893|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
130234823|NCT04006457|468823894|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
130234824|NCT04006457|468823895|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
130234825|NCT04006457|468823893|FG000|Main Study Observation Period|Ongoing|2|||
130234826|NCT04006457|468823894|FG001|Main Study Observation Period|Ongoing|1|||
130234827|NCT04006457|468823895|FG002|Main Study Observation Period|Ongoing|0|||
130234828|NCT04006457|468823893|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
130234829|NCT04006457|468823894|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
130234830|NCT04006457|468823895|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
130234831|NCT04486716|468823896|FG000|Core Phase|Subject decision|6|||
130234832|NCT04486716|468823896|FG000|Core Phase|Adverse Event|5|||
130234833|NCT04486716|468823896|FG000|Core Phase|Lost to Follow-up|1|||
130234834|NCT04486716|468823896|FG000|Core Phase|Physician Decision|1|||
130234835|NCT04486716|468823896|FG000|Core Phase|Enrolled subjects not treated|9|||
130234836|NCT02332707|468823897|FG000|Overall Study|Adverse Event|0|||
130234837|NCT02332707|468823898|FG001|Overall Study|Adverse Event|0|||
130234838|NCT02332707|468823899|FG002|Overall Study|Adverse Event|0|||
130234839|NCT02332707|468823900|FG003|Overall Study|Adverse Event|0|||
130234840|NCT02332707|468823901|FG004|Overall Study|Adverse Event|0|||
130234841|NCT02332707|468823902|FG005|Overall Study|Adverse Event|0|||
130234842|NCT02332707|468823903|FG006|Overall Study|Adverse Event|0|||
130234843|NCT02332707|468823904|FG007|Overall Study|Adverse Event|0|||
130234844|NCT02332707|468823905|FG008|Overall Study|Adverse Event|0|||
130234845|NCT02332707|468823906|FG009|Overall Study|Adverse Event|0|||
130234846|NCT02332707|468823907|FG010|Overall Study|Adverse Event|0|||
130234847|NCT02332707|468823908|FG011|Overall Study|Adverse Event|0|||
130234848|NCT02332707|468823909|FG012|Overall Study|Adverse Event|1|||
130234849|NCT02332707|468823910|FG013|Overall Study|Adverse Event|0|||
130234850|NCT02332707|468823911|FG014|Overall Study|Adverse Event|0|||
130234851|NCT02332707|468823912|FG015|Overall Study|Adverse Event|0|||
130100128|NCT03539952|468324146|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
130234852|NCT02332707|468823913|FG016|Overall Study|Adverse Event|0|||
130234853|NCT02332707|468823914|FG017|Overall Study|Adverse Event|0|||
130234854|NCT02332707|468823897|FG000|Overall Study|Lost to Follow-up|0|||
130234855|NCT02332707|468823898|FG001|Overall Study|Lost to Follow-up|0|||
130025962|NCT01337973|468055826|FG001|Overall Study|missing data on primary outcome|1|||
130025963|NCT01337973|468055827|FG002|Overall Study|missing data on primary outcome|3|||
130025964|NCT02494596|468055828|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130025965|NCT02494596|468055829|FG001|Overall Study|Insufficient Therapeutic Response|3|||
130025966|NCT02494596|468055830|FG002|Overall Study|Insufficient Therapeutic Response|1|||
130025967|NCT02494596|468055828|FG000|Overall Study|Adverse Event|0|||
130025968|NCT02494596|468055829|FG001|Overall Study|Adverse Event|1|||
130025969|NCT02494596|468055830|FG002|Overall Study|Adverse Event|0|||
130025970|NCT02494596|468055828|FG000|Overall Study|Refused Treatment|0|||
130025971|NCT02494596|468055829|FG001|Overall Study|Refused Treatment|1|||
130025972|NCT02494596|468055830|FG002|Overall Study|Refused Treatment|0|||
130025973|NCT00584194|468055831|FG000|Overall Study|Other|135|||
130025974|NCT02624492|468055833|FG000|Overall Study|Adverse Event|2|||
130025975|NCT02624492|468055834|FG001|Overall Study|Adverse Event|2|||
130025976|NCT02624492|468055835|FG002|Overall Study|Adverse Event|2|||
130025977|NCT02624492|468055833|FG000|Overall Study|Progressive disease|0|||
130025978|NCT02624492|468055834|FG001|Overall Study|Progressive disease|2|||
130025979|NCT02624492|468055835|FG002|Overall Study|Progressive disease|3|||
130025980|NCT03555266|468055841|FG000|Overall Study|Protocol Violation|6|||
130025981|NCT03555266|468055842|FG001|Overall Study|Protocol Violation|4|||
130025982|NCT02167945|468055843|FG000|Overall Study|Adverse Event|16|||
130025983|NCT02167945|468055843|FG000|Overall Study|Withdrew Consent|42|||
130025984|NCT02167945|468055843|FG000|Overall Study|Lost to Follow-up|122|||
130025985|NCT02167945|468055843|FG000|Overall Study|COVID-19 logistical restrictions|6|||
130025986|NCT02167945|468055843|FG000|Overall Study|Other, not specified|63|||
130025987|NCT02239263|468055844|FG000|Overall Study|Protocol Violation|6|||
130025988|NCT01058096|468055846|FG000|Double-blind Treatment Phase|Adverse Event|11|||
130025989|NCT01058096|468055847|FG001|Double-blind Treatment Phase|Adverse Event|15|||
130025990|NCT01058096|468055846|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
130025991|NCT01058096|468055847|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
130025992|NCT01058096|468055846|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
130025993|NCT01058096|468055847|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
130025994|NCT01058096|468055846|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
130025995|NCT01058096|468055847|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
130025996|NCT01058096|468055846|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130025997|NCT01058096|468055847|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130025998|NCT01058096|468055846|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
130025999|NCT01058096|468055847|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
130026000|NCT04276207|468055848|FG000|Period 1|Withdrawal by Subject|0|||
130026001|NCT04276207|468055849|FG001|Period 1|Withdrawal by Subject|1|||
130026002|NCT04451330|468055850|FG000|Overall Study|Adverse Event|1|||
130026003|NCT04451330|468055851|FG001|Overall Study|Adverse Event|2|||
130026004|NCT04451330|468055850|FG000|Overall Study|Lost to Follow-up|5|||
130026005|NCT04451330|468055851|FG001|Overall Study|Lost to Follow-up|0|||
130026006|NCT04451330|468055850|FG000|Overall Study|Withdrawal by Subject|3|||
130026007|NCT04451330|468055851|FG001|Overall Study|Withdrawal by Subject|1|||
130026008|NCT04451330|468055850|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130026009|NCT04451330|468055851|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130026010|NCT04451330|468055850|FG000|Overall Study|Other than specified|0|||
130026011|NCT04451330|468055851|FG001|Overall Study|Other than specified|1|||
130026012|NCT02769624|468055852|FG000|Overall Study|Lost to Follow-up|0|||
130026013|NCT02769624|468055853|FG001|Overall Study|Lost to Follow-up|1|||
130026014|NCT05099640|468055854|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
130026015|NCT05099640|468055855|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
130026016|NCT05099640|468055856|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
130026017|NCT05099640|468055854|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
130026018|NCT05099640|468055855|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
130026019|NCT05099640|468055856|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
130026020|NCT05099640|468055854|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
130026021|NCT05099640|468055855|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
130026022|NCT05099640|468055856|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
130026023|NCT05099640|468055854|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
130026024|NCT05099640|468055855|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
130026025|NCT05099640|468055856|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
130026026|NCT05099640|468055854|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
130026027|NCT05099640|468055855|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
130026028|NCT05099640|468055856|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
130026029|NCT05099640|468055854|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
130026030|NCT05099640|468055855|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
130026031|NCT05099640|468055856|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
130026032|NCT00179959|468055857|FG000|Overall Study|Lost to Follow-up|3|||
130026033|NCT00179959|468055858|FG001|Overall Study|Lost to Follow-up|1|||
130026034|NCT00179959|468055857|FG000|Overall Study|Withdrawal by Subject|3|||
130026035|NCT00179959|468055858|FG001|Overall Study|Withdrawal by Subject|2|||
130026036|NCT00448708|468055859|FG000|Overall Study|Death|21|||
130026037|NCT00448708|468055860|FG001|Overall Study|Death|17|||
130026038|NCT00448708|468055859|FG000|Overall Study|Withdrawal by Subject|8|||
130026039|NCT00448708|468055860|FG001|Overall Study|Withdrawal by Subject|4|||
130026040|NCT00448708|468055859|FG000|Overall Study|Lost to Follow-up|6|||
130026041|NCT00448708|468055860|FG001|Overall Study|Lost to Follow-up|8|||
130026042|NCT00448708|468055859|FG000|Overall Study|not listed|0|||
130026043|NCT00448708|468055860|FG001|Overall Study|not listed|2|||
130026044|NCT01960855|468055861|FG000|Overall Study|Subject noncompliant|1|||
130026045|NCT01960855|468055862|FG001|Overall Study|Subject noncompliant|0|||
130026046|NCT01960855|468055863|FG002|Overall Study|Subject noncompliant|0|||
130026047|NCT01960855|468055864|FG003|Overall Study|Subject noncompliant|0|||
130026048|NCT01960855|468055865|FG004|Overall Study|Subject noncompliant|0|||
130026049|NCT01960855|468055861|FG000|Overall Study|Adverse Event|2|||
130234856|NCT02332707|468823899|FG002|Overall Study|Lost to Follow-up|0|||
130234857|NCT02332707|468823900|FG003|Overall Study|Lost to Follow-up|0|||
130234858|NCT02332707|468823901|FG004|Overall Study|Lost to Follow-up|0|||
130234859|NCT02332707|468823902|FG005|Overall Study|Lost to Follow-up|1|||
130234860|NCT02332707|468823903|FG006|Overall Study|Lost to Follow-up|0|||
130234861|NCT02332707|468823904|FG007|Overall Study|Lost to Follow-up|0|||
130234862|NCT02332707|468823905|FG008|Overall Study|Lost to Follow-up|0|||
130234863|NCT02332707|468823906|FG009|Overall Study|Lost to Follow-up|0|||
130234864|NCT02332707|468823907|FG010|Overall Study|Lost to Follow-up|2|||
130234865|NCT02332707|468823908|FG011|Overall Study|Lost to Follow-up|0|||
130234866|NCT02332707|468823909|FG012|Overall Study|Lost to Follow-up|3|||
130234867|NCT02332707|468823910|FG013|Overall Study|Lost to Follow-up|0|||
130234868|NCT02332707|468823911|FG014|Overall Study|Lost to Follow-up|0|||
130234869|NCT02332707|468823912|FG015|Overall Study|Lost to Follow-up|0|||
130234870|NCT02332707|468823913|FG016|Overall Study|Lost to Follow-up|0|||
130234871|NCT02332707|468823914|FG017|Overall Study|Lost to Follow-up|0|||
130234872|NCT02332707|468823897|FG000|Overall Study|Physician Decision|0|||
130234873|NCT02332707|468823898|FG001|Overall Study|Physician Decision|0|||
130234874|NCT02332707|468823899|FG002|Overall Study|Physician Decision|0|||
130234875|NCT02332707|468823900|FG003|Overall Study|Physician Decision|1|||
130234876|NCT02332707|468823901|FG004|Overall Study|Physician Decision|0|||
130234877|NCT02332707|468823902|FG005|Overall Study|Physician Decision|0|||
130234878|NCT02332707|468823903|FG006|Overall Study|Physician Decision|0|||
130234879|NCT02332707|468823904|FG007|Overall Study|Physician Decision|0|||
130234880|NCT02332707|468823905|FG008|Overall Study|Physician Decision|0|||
130234881|NCT02332707|468823906|FG009|Overall Study|Physician Decision|0|||
130234882|NCT02332707|468823907|FG010|Overall Study|Physician Decision|0|||
130234883|NCT02332707|468823908|FG011|Overall Study|Physician Decision|0|||
130234884|NCT02332707|468823909|FG012|Overall Study|Physician Decision|1|||
130234885|NCT02332707|468823910|FG013|Overall Study|Physician Decision|0|||
130234886|NCT02332707|468823911|FG014|Overall Study|Physician Decision|0|||
130234887|NCT02332707|468823912|FG015|Overall Study|Physician Decision|0|||
130234888|NCT02332707|468823913|FG016|Overall Study|Physician Decision|0|||
130234889|NCT02332707|468823914|FG017|Overall Study|Physician Decision|0|||
130234890|NCT02332707|468823897|FG000|Overall Study|Withdrawal by Subject|0|||
130234891|NCT02332707|468823898|FG001|Overall Study|Withdrawal by Subject|0|||
130234892|NCT02332707|468823899|FG002|Overall Study|Withdrawal by Subject|1|||
130234893|NCT02332707|468823900|FG003|Overall Study|Withdrawal by Subject|0|||
130234894|NCT02332707|468823901|FG004|Overall Study|Withdrawal by Subject|0|||
130234895|NCT02332707|468823902|FG005|Overall Study|Withdrawal by Subject|0|||
130234896|NCT02332707|468823903|FG006|Overall Study|Withdrawal by Subject|0|||
130234897|NCT02332707|468823904|FG007|Overall Study|Withdrawal by Subject|0|||
130234898|NCT02332707|468823905|FG008|Overall Study|Withdrawal by Subject|0|||
130234899|NCT02332707|468823906|FG009|Overall Study|Withdrawal by Subject|3|||
130234900|NCT02332707|468823907|FG010|Overall Study|Withdrawal by Subject|0|||
130234901|NCT02332707|468823908|FG011|Overall Study|Withdrawal by Subject|0|||
130234902|NCT02332707|468823909|FG012|Overall Study|Withdrawal by Subject|0|||
130234903|NCT02332707|468823910|FG013|Overall Study|Withdrawal by Subject|0|||
130234904|NCT02332707|468823911|FG014|Overall Study|Withdrawal by Subject|0|||
130234905|NCT02332707|468823912|FG015|Overall Study|Withdrawal by Subject|0|||
130234906|NCT02332707|468823913|FG016|Overall Study|Withdrawal by Subject|0|||
130234907|NCT02332707|468823914|FG017|Overall Study|Withdrawal by Subject|0|||
130234908|NCT04761822|468823915|FG000|Overall Study|Adverse Event|3|||
130234909|NCT04761822|468823916|FG001|Overall Study|Adverse Event|1|||
130234910|NCT04761822|468823917|FG002|Overall Study|Adverse Event|1|||
130234911|NCT04761822|468823918|FG003|Overall Study|Adverse Event|3|||
130234912|NCT04761822|468823915|FG000|Overall Study|Lost to Follow-up|1|||
130234913|NCT04761822|468823916|FG001|Overall Study|Lost to Follow-up|0|||
130234914|NCT04761822|468823917|FG002|Overall Study|Lost to Follow-up|2|||
130234915|NCT04761822|468823918|FG003|Overall Study|Lost to Follow-up|3|||
130234916|NCT04761822|468823915|FG000|Overall Study|Physician Decision|0|||
130234917|NCT04761822|468823916|FG001|Overall Study|Physician Decision|1|||
130234918|NCT04761822|468823917|FG002|Overall Study|Physician Decision|0|||
130234919|NCT04761822|468823918|FG003|Overall Study|Physician Decision|0|||
130234920|NCT04761822|468823915|FG000|Overall Study|Withdrawal by Subject|3|||
130234921|NCT04761822|468823916|FG001|Overall Study|Withdrawal by Subject|8|||
130234922|NCT04761822|468823917|FG002|Overall Study|Withdrawal by Subject|1|||
130234923|NCT04761822|468823918|FG003|Overall Study|Withdrawal by Subject|11|||
130234924|NCT04761822|468823915|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
130234925|NCT04761822|468823916|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130234926|NCT04761822|468823917|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130234927|NCT04761822|468823918|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
130234928|NCT04761822|468823915|FG000|Overall Study|Participant requested unblinding|0|||
130234929|NCT04761822|468823916|FG001|Overall Study|Participant requested unblinding|0|||
130234930|NCT04761822|468823917|FG002|Overall Study|Participant requested unblinding|0|||
130234931|NCT04761822|468823918|FG003|Overall Study|Participant requested unblinding|1|||
130234932|NCT00947544|468823923|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
130234933|NCT00947544|468823924|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
130234934|NCT01240746|468823925|FG000|Overall Study|Adverse Event|2|||
130234935|NCT01240746|468823926|FG001|Overall Study|Adverse Event|0|||
130234936|NCT01240746|468823927|FG002|Overall Study|Adverse Event|10|||
130234937|NCT01240746|468823925|FG000|Overall Study|Lost to Follow-up|23|||
130234938|NCT01240746|468823926|FG001|Overall Study|Lost to Follow-up|20|||
130234939|NCT01240746|468823927|FG002|Overall Study|Lost to Follow-up|102|||
130234940|NCT01240746|468823925|FG000|Overall Study|Protocol Violation|24|||
130234941|NCT01240746|468823926|FG001|Overall Study|Protocol Violation|15|||
130234942|NCT01240746|468823927|FG002|Overall Study|Protocol Violation|72|||
130234943|NCT01240746|468823925|FG000|Overall Study|Withdrawal by Subject|10|||
130234944|NCT01240746|468823926|FG001|Overall Study|Withdrawal by Subject|13|||
130234945|NCT01240746|468823927|FG002|Overall Study|Withdrawal by Subject|59|||
130234946|NCT02471183|468823931|FG000|Main Treatment Period|Adverse Event|1|||
130234947|NCT02471183|468823931|FG000|Main Treatment Period|Withdrawal by Subject|1|||
130234948|NCT02471183|468823931|FG000|Extended Treatment Period|Lack of Efficacy|1|||
130234949|NCT02690727|468823932|FG000|Overall Study|Adverse Event|2|||
130234950|NCT02690727|468823933|FG001|Overall Study|Adverse Event|2|||
130234951|NCT01461551|468823939|FG000|Overall Study|Physician Decision|2|||
130234952|NCT01461551|468823940|FG001|Overall Study|Physician Decision|1|||
130234953|NCT01461551|468823941|FG002|Overall Study|Physician Decision|2|||
130234954|NCT00827567|468823942|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
130234955|NCT01155141|468823943|FG000|Overall Study|Withdrawal by Subject|1|||
130234956|NCT01155141|468823943|FG000|Overall Study|Screen Failure|1|||
130234957|NCT03473197|468823944|FG000|Overall Study|Adverse Event|4|||
130234958|NCT03473197|468823944|FG000|Overall Study|Lost to Follow-up|1|||
130234959|NCT03473197|468823944|FG000|Overall Study|Withdrawal by Subject|5|||
130234960|NCT00785629|468823947|FG000|Overall Study|Adverse Event|2|||
130234961|NCT00785629|468823948|FG001|Overall Study|Adverse Event|1|||
130234962|NCT00785629|468823949|FG002|Overall Study|Adverse Event|1|||
130234963|NCT00785629|468823950|FG003|Overall Study|Adverse Event|5|||
130234964|NCT00785629|468823947|FG000|Overall Study|Protocol Violation|1|||
130234965|NCT00785629|468823948|FG001|Overall Study|Protocol Violation|2|||
130234966|NCT00785629|468823949|FG002|Overall Study|Protocol Violation|4|||
130234967|NCT00785629|468823950|FG003|Overall Study|Protocol Violation|5|||
130234968|NCT00785629|468823947|FG000|Overall Study|administrative decision|5|||
130234969|NCT00785629|468823948|FG001|Overall Study|administrative decision|1|||
130234970|NCT00785629|468823949|FG002|Overall Study|administrative decision|3|||
130234971|NCT00785629|468823950|FG003|Overall Study|administrative decision|4|||
130234972|NCT00785629|468823947|FG000|Overall Study|Withdrawal by Subject|0|||
130234973|NCT00785629|468823948|FG001|Overall Study|Withdrawal by Subject|1|||
130234974|NCT00785629|468823949|FG002|Overall Study|Withdrawal by Subject|2|||
130234975|NCT00785629|468823950|FG003|Overall Study|Withdrawal by Subject|2|||
130234976|NCT00851591|468823951|FG000|Overall Study|Withdrawal by Subject|2|||
130234977|NCT00851591|468823952|FG001|Overall Study|Withdrawal by Subject|0|||
130234978|NCT02326883|468823954|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
130234979|NCT02326883|468823955|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
130234980|NCT02326883|468823956|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
130234981|NCT04154956|468823957|FG000|Overall Study|Death|109|||
130234982|NCT04154956|468823958|FG001|Overall Study|Death|110|||
130234983|NCT04154956|468823957|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
130234984|NCT04154956|468823958|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
130234985|NCT04154956|468823957|FG000|Overall Study|Withdrawal by Subject|1|||
130234986|NCT04154956|468823958|FG001|Overall Study|Withdrawal by Subject|7|||
130234987|NCT04154956|468823957|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
130234988|NCT04154956|468823958|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
130234989|NCT01859741|468823959|FG000|Overall Study|Death|3|||
130234990|NCT01859741|468823960|FG001|Overall Study|Death|2|||
130234991|NCT01859741|468823961|FG002|Overall Study|Death|4|||
130234992|NCT01859741|468823962|FG003|Overall Study|Death|3|||
130234993|NCT01859741|468823963|FG004|Overall Study|Death|5|||
130234994|NCT01859741|468823964|FG005|Overall Study|Death|4|||
130234995|NCT01859741|468823965|FG006|Overall Study|Death|51|||
130234996|NCT01859741|468823966|FG007|Overall Study|Death|51|||
130234997|NCT01859741|468823959|FG000|Overall Study|Lost to Follow-up|0|||
130234998|NCT01859741|468823960|FG001|Overall Study|Lost to Follow-up|0|||
130234999|NCT01859741|468823961|FG002|Overall Study|Lost to Follow-up|0|||
130235000|NCT01859741|468823962|FG003|Overall Study|Lost to Follow-up|0|||
130235001|NCT01859741|468823963|FG004|Overall Study|Lost to Follow-up|0|||
130235002|NCT01859741|468823964|FG005|Overall Study|Lost to Follow-up|1|||
130235003|NCT01859741|468823965|FG006|Overall Study|Lost to Follow-up|0|||
130235004|NCT01859741|468823966|FG007|Overall Study|Lost to Follow-up|4|||
130235005|NCT01859741|468823959|FG000|Overall Study|Withdrawal by Subject|0|||
130235006|NCT01859741|468823960|FG001|Overall Study|Withdrawal by Subject|1|||
130235007|NCT01859741|468823961|FG002|Overall Study|Withdrawal by Subject|2|||
130235008|NCT01859741|468823962|FG003|Overall Study|Withdrawal by Subject|0|||
130235009|NCT01859741|468823963|FG004|Overall Study|Withdrawal by Subject|0|||
130235010|NCT01859741|468823964|FG005|Overall Study|Withdrawal by Subject|1|||
130235011|NCT01859741|468823965|FG006|Overall Study|Withdrawal by Subject|1|||
130235012|NCT01859741|468823966|FG007|Overall Study|Withdrawal by Subject|1|||
130235013|NCT01859741|468823959|FG000|Overall Study|Study Terminated by Sponsor|0|||
130235014|NCT01859741|468823960|FG001|Overall Study|Study Terminated by Sponsor|0|||
130235015|NCT01859741|468823961|FG002|Overall Study|Study Terminated by Sponsor|0|||
130235016|NCT01859741|468823962|FG003|Overall Study|Study Terminated by Sponsor|0|||
130235017|NCT01859741|468823963|FG004|Overall Study|Study Terminated by Sponsor|1|||
130235018|NCT01859741|468823964|FG005|Overall Study|Study Terminated by Sponsor|0|||
130235019|NCT01859741|468823965|FG006|Overall Study|Study Terminated by Sponsor|16|||
130235020|NCT01859741|468823966|FG007|Overall Study|Study Terminated by Sponsor|14|||
130235021|NCT01859741|468823959|FG000|Overall Study|Other|0|||
130235022|NCT01859741|468823960|FG001|Overall Study|Other|0|||
130235023|NCT01859741|468823961|FG002|Overall Study|Other|0|||
130235024|NCT01859741|468823962|FG003|Overall Study|Other|0|||
130235025|NCT01859741|468823963|FG004|Overall Study|Other|0|||
130235026|NCT01859741|468823964|FG005|Overall Study|Other|0|||
130235027|NCT01859741|468823965|FG006|Overall Study|Other|2|||
130235028|NCT01859741|468823966|FG007|Overall Study|Other|0|||
130235029|NCT02412657|468823970|FG000|Overall Study|Lost to Follow-up|1|||
130235030|NCT02412657|468823971|FG001|Overall Study|Lost to Follow-up|0|||
130235031|NCT02412657|468823972|FG002|Overall Study|Lost to Follow-up|0|||
130235032|NCT02412657|468823970|FG000|Overall Study|Protocol Violation|0|||
130235033|NCT02412657|468823971|FG001|Overall Study|Protocol Violation|2|||
130235034|NCT02412657|468823972|FG002|Overall Study|Protocol Violation|3|||
130235035|NCT03620162|468823976|FG000|Overall Study|Physician Decision|4|||
130235036|NCT03620162|468823977|FG001|Overall Study|Physician Decision|0|||
130235037|NCT03620162|468823978|FG002|Overall Study|Physician Decision|1|||
130235038|NCT03620162|468823979|FG003|Overall Study|Physician Decision|0|||
130235039|NCT03620162|468823980|FG004|Overall Study|Physician Decision|2|||
130235040|NCT03620162|468823976|FG000|Overall Study|Lost to Follow-up|2|||
130235041|NCT03620162|468823977|FG001|Overall Study|Lost to Follow-up|6|||
130235042|NCT03620162|468823978|FG002|Overall Study|Lost to Follow-up|7|||
130235043|NCT03620162|468823979|FG003|Overall Study|Lost to Follow-up|3|||
130235044|NCT03620162|468823980|FG004|Overall Study|Lost to Follow-up|2|||
130235045|NCT03620162|468823976|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
130235046|NCT03620162|468823977|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
130235047|NCT03620162|468823978|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
130235048|NCT03620162|468823979|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
130235049|NCT03620162|468823980|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
130235050|NCT01682031|468823983|FG000|Overall Study|Withdrawal by Subject|0|||
130235051|NCT01682031|468823984|FG001|Overall Study|Withdrawal by Subject|1|||
130235052|NCT01682031|468823983|FG000|Overall Study|Adverse Event|0|||
130235053|NCT01682031|468823984|FG001|Overall Study|Adverse Event|2|||
130235054|NCT01682031|468823983|FG000|Overall Study|MRI results indicate increased nodul|0|||
130235055|NCT01682031|468823984|FG001|Overall Study|MRI results indicate increased nodul|1|||
130235056|NCT01682031|468823983|FG000|Overall Study|Patient could not swallow tablets|1|||
130235057|NCT01682031|468823984|FG001|Overall Study|Patient could not swallow tablets|0|||
130235058|NCT01682031|468823983|FG000|Overall Study|Patient stopped selenium on his own|0|||
130235059|NCT01682031|468823984|FG001|Overall Study|Patient stopped selenium on his own|1|||
130235060|NCT01056536|468823986|FG000|Overall Study|Lost to Follow-up|202|||
130235061|NCT01056536|468823987|FG001|Overall Study|Lost to Follow-up|116|||
130235062|NCT01056536|468823988|FG002|Overall Study|Lost to Follow-up|248|||
130235063|NCT02763566|468823989|FG000|Overall Study|Lost to Follow-up|1|||
130235064|NCT02763566|468823990|FG001|Overall Study|Lost to Follow-up|4|||
130235065|NCT02763566|468823991|FG002|Overall Study|Lost to Follow-up|0|||
130235066|NCT02763566|468823992|FG003|Overall Study|Lost to Follow-up|1|||
130235067|NCT02763566|468823989|FG000|Overall Study|On study treatment at study conclusion|114|||
130235068|NCT02763566|468823990|FG001|Overall Study|On study treatment at study conclusion|34|||
130235069|NCT02763566|468823991|FG002|Overall Study|On study treatment at study conclusion|54|||
130235070|NCT02763566|468823992|FG003|Overall Study|On study treatment at study conclusion|13|||
130235071|NCT02763566|468823989|FG000|Overall Study|Withdrawal by Subject|3|||
130235072|NCT02763566|468823990|FG001|Overall Study|Withdrawal by Subject|1|||
130235073|NCT02763566|468823991|FG002|Overall Study|Withdrawal by Subject|0|||
130235074|NCT02763566|468823992|FG003|Overall Study|Withdrawal by Subject|0|||
130235075|NCT00315445|468823993|FG000|Overall Study|Adverse Event|7|||
130235076|NCT00315445|468823994|FG001|Overall Study|Adverse Event|12|||
130235077|NCT00315445|468823995|FG002|Overall Study|Adverse Event|15|||
130235078|NCT00315445|468823993|FG000|Overall Study|Lack of Efficacy|16|||
130235079|NCT00315445|468823994|FG001|Overall Study|Lack of Efficacy|1|||
130235080|NCT00315445|468823995|FG002|Overall Study|Lack of Efficacy|7|||
130235081|NCT00315445|468823993|FG000|Overall Study|Lost to Follow-up|1|||
130235082|NCT00315445|468823994|FG001|Overall Study|Lost to Follow-up|0|||
130235083|NCT00315445|468823995|FG002|Overall Study|Lost to Follow-up|1|||
130235084|NCT00315445|468823993|FG000|Overall Study|Protocol Violation|2|||
130235085|NCT00315445|468823994|FG001|Overall Study|Protocol Violation|0|||
130235086|NCT00315445|468823995|FG002|Overall Study|Protocol Violation|1|||
130235087|NCT00315445|468823993|FG000|Overall Study|Other|1|||
130235088|NCT00315445|468823994|FG001|Overall Study|Other|3|||
130235089|NCT00315445|468823995|FG002|Overall Study|Other|0|||
130235090|NCT01101178|468823998|FG000|Period 1|Withdrawal by Subject|1|||
130235091|NCT01101178|468823999|FG001|Period 1|Withdrawal by Subject|2|||
130235092|NCT01101178|468823998|FG000|Period 1|Positive drug screen|1|||
130235093|NCT01101178|468823999|FG001|Period 1|Positive drug screen|1|||
130235094|NCT01101178|468823998|FG000|Period 1|Adverse Event|2|||
130235095|NCT01101178|468823999|FG001|Period 1|Adverse Event|1|||
130235096|NCT01101178|468823998|FG000|Period 2|Withdrawal by Subject|0|||
130235097|NCT01101178|468823999|FG001|Period 2|Withdrawal by Subject|1|||
130235098|NCT01850641|468824000|FG000|Overall Study|Physician Decision|1|||
130235099|NCT01850641|468824000|FG000|Overall Study|Decrease in serum phosphorus|1|||
130235100|NCT01850641|468824000|FG000|Overall Study|Decrease in serum calcium|2|||
130235101|NCT01850641|468824000|FG000|Overall Study|Increase in serum ferritin|1|||
130235102|NCT00141817|468824001|FG000|Overall Study|Protocol Violation|0|||
130235103|NCT00141817|468824002|FG001|Overall Study|Protocol Violation|0|||
130235104|NCT00141817|468824003|FG002|Overall Study|Protocol Violation|1|||
130235105|NCT00141817|468824004|FG003|Overall Study|Protocol Violation|0|||
130235106|NCT00141817|468824001|FG000|Overall Study|Parent request|1|||
130235107|NCT00141817|468824002|FG001|Overall Study|Parent request|0|||
130235108|NCT00141817|468824003|FG002|Overall Study|Parent request|0|||
130235109|NCT00141817|468824004|FG003|Overall Study|Parent request|0|||
130235110|NCT00846365|468824011|FG000|Overall Study|Adverse Event|20|||
130235111|NCT00846365|468824012|FG001|Overall Study|Adverse Event|30|||
130235112|NCT00846365|468824013|FG002|Overall Study|Adverse Event|11|||
130235113|NCT00846365|468824011|FG000|Overall Study|Protocol Violation|5|||
130235114|NCT00846365|468824012|FG001|Overall Study|Protocol Violation|4|||
130235115|NCT00846365|468824013|FG002|Overall Study|Protocol Violation|0|||
130235116|NCT00846365|468824011|FG000|Overall Study|Lost to Follow-up|8|||
130235117|NCT00846365|468824012|FG001|Overall Study|Lost to Follow-up|2|||
130235118|NCT00846365|468824013|FG002|Overall Study|Lost to Follow-up|5|||
130235119|NCT00846365|468824011|FG000|Overall Study|Withdrawal by Subject|11|||
130235120|NCT00846365|468824012|FG001|Overall Study|Withdrawal by Subject|11|||
130235121|NCT00846365|468824013|FG002|Overall Study|Withdrawal by Subject|9|||
130235122|NCT00846365|468824011|FG000|Overall Study|Pregnancy|1|||
130026050|NCT01960855|468055862|FG001|Overall Study|Adverse Event|0|||
130026051|NCT01960855|468055863|FG002|Overall Study|Adverse Event|6|||
130026052|NCT01960855|468055864|FG003|Overall Study|Adverse Event|2|||
130026053|NCT01960855|468055865|FG004|Overall Study|Adverse Event|2|||
130026054|NCT01960855|468055861|FG000|Overall Study|Lack of Efficacy|1|||
130235123|NCT00846365|468824012|FG001|Overall Study|Pregnancy|0|||
130235124|NCT00846365|468824013|FG002|Overall Study|Pregnancy|0|||
130235125|NCT00846365|468824011|FG000|Overall Study|Lack of Efficacy|1|||
130235126|NCT00846365|468824012|FG001|Overall Study|Lack of Efficacy|1|||
130235127|NCT00846365|468824013|FG002|Overall Study|Lack of Efficacy|2|||
130235128|NCT00846365|468824011|FG000|Overall Study|Other|9|||
130235129|NCT00846365|468824012|FG001|Overall Study|Other|1|||
130235130|NCT00846365|468824013|FG002|Overall Study|Other|6|||
130235131|NCT03479905|468824014|FG000|Overall Study|Other airway method used|4|||
130235132|NCT03479905|468824015|FG001|Overall Study|Other airway method used|5|||
130235133|NCT03479905|468824016|FG002|Overall Study|Other airway method used|5|||
130235134|NCT00862992|468824017|FG000|Overall Study|Adverse Event|2|||
130235135|NCT00862992|468824018|FG001|Overall Study|Adverse Event|1|||
130026055|NCT01960855|468055862|FG001|Overall Study|Lack of Efficacy|1|||
130026056|NCT01960855|468055863|FG002|Overall Study|Lack of Efficacy|0|||
130026057|NCT01960855|468055864|FG003|Overall Study|Lack of Efficacy|0|||
130235136|NCT00862992|468824019|FG002|Overall Study|Adverse Event|1|||
130235137|NCT00862992|468824017|FG000|Overall Study|Physician Decision|1|||
130235138|NCT00862992|468824018|FG001|Overall Study|Physician Decision|0|||
130235139|NCT00862992|468824019|FG002|Overall Study|Physician Decision|0|||
130235140|NCT00862992|468824017|FG000|Overall Study|Withdrawal by Subject|0|||
130235141|NCT00862992|468824018|FG001|Overall Study|Withdrawal by Subject|0|||
130235142|NCT00862992|468824019|FG002|Overall Study|Withdrawal by Subject|2|||
130235143|NCT00720759|468824020|FG000|Overall Study|Lost to Follow-up|0|||
130235144|NCT00720759|468824021|FG001|Overall Study|Lost to Follow-up|1|||
130235145|NCT00720759|468824022|FG002|Overall Study|Lost to Follow-up|1|||
130235146|NCT00720759|468824023|FG003|Overall Study|Lost to Follow-up|0|||
130235147|NCT02318940|468824024|FG000|Overall Study|lost the record|1|||
130235148|NCT02318940|468824025|FG001|Overall Study|lost the record|0|||
130235149|NCT01047319|468824026|FG000|Overall Study|Teva requested participant withdrawal|3|||
130235150|NCT01047319|468824027|FG001|Overall Study|Teva requested participant withdrawal|0|||
130235151|NCT01047319|468824028|FG002|Overall Study|Teva requested participant withdrawal|1|||
130235152|NCT01047319|468824026|FG000|Overall Study|Protocol Violation|3|||
130235153|NCT01047319|468824027|FG001|Overall Study|Protocol Violation|2|||
130235154|NCT01047319|468824028|FG002|Overall Study|Protocol Violation|4|||
130235155|NCT01047319|468824026|FG000|Overall Study|Lack of Efficacy|4|||
130235156|NCT01047319|468824027|FG001|Overall Study|Lack of Efficacy|3|||
130235157|NCT01047319|468824028|FG002|Overall Study|Lack of Efficacy|3|||
130235158|NCT01047319|468824026|FG000|Overall Study|Death|5|||
130235159|NCT01047319|468824027|FG001|Overall Study|Death|1|||
130235160|NCT01047319|468824028|FG002|Overall Study|Death|5|||
130235161|NCT01047319|468824026|FG000|Overall Study|Pregnancy|13|||
130235162|NCT01047319|468824027|FG001|Overall Study|Pregnancy|8|||
130235163|NCT01047319|468824028|FG002|Overall Study|Pregnancy|8|||
130235164|NCT01047319|468824026|FG000|Overall Study|Physician Decision|12|||
130235165|NCT01047319|468824027|FG001|Overall Study|Physician Decision|9|||
130235166|NCT01047319|468824028|FG002|Overall Study|Physician Decision|10|||
130235167|NCT01047319|468824026|FG000|Overall Study|Lost to Follow-up|14|||
130235168|NCT01047319|468824027|FG001|Overall Study|Lost to Follow-up|10|||
130235169|NCT01047319|468824028|FG002|Overall Study|Lost to Follow-up|10|||
130235170|NCT01047319|468824026|FG000|Overall Study|Adverse Event|16|||
130235171|NCT01047319|468824027|FG001|Overall Study|Adverse Event|27|||
130235172|NCT01047319|468824028|FG002|Overall Study|Adverse Event|21|||
130235173|NCT01047319|468824026|FG000|Overall Study|Withdrawal by Subject|77|||
130235174|NCT01047319|468824027|FG001|Overall Study|Withdrawal by Subject|75|||
130100129|NCT03539952|468324145|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
130026058|NCT01960855|468055865|FG004|Overall Study|Lack of Efficacy|0|||
130026059|NCT01960855|468055861|FG000|Overall Study|Other|2|||
130026060|NCT01960855|468055862|FG001|Overall Study|Other|1|||
130026061|NCT01960855|468055863|FG002|Overall Study|Other|1|||
130026062|NCT01960855|468055864|FG003|Overall Study|Other|1|||
130026063|NCT01960855|468055865|FG004|Overall Study|Other|0|||
129884550|NCT03012061|467536451|FG001|Overall Study|Lack of Efficacy|1|||
130100130|NCT03539952|468324146|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
130235175|NCT01047319|468824028|FG002|Overall Study|Withdrawal by Subject|87|||
130235176|NCT01047319|468824026|FG000|Overall Study|Study terminated by Sponsor|198|||
130235177|NCT01047319|468824027|FG001|Overall Study|Study terminated by Sponsor|215|||
130235178|NCT01047319|468824028|FG002|Overall Study|Study terminated by Sponsor|203|||
130235179|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
130235180|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
129884551|NCT03012061|467536452|FG002|Overall Study|Lack of Efficacy|0|||
130026064|NCT01960855|468055861|FG000|Overall Study|Consent withdrawn by subject|3|||
130026065|NCT01960855|468055862|FG001|Overall Study|Consent withdrawn by subject|1|||
130235181|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
130235182|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Death|0|||
130235183|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Death|0|||
130235184|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Death|1|||
130235185|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
130235186|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
130235187|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
130235188|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
130235189|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
130235190|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
130235191|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
130235192|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
130235193|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
130235194|NCT02696798|468824031|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
130235195|NCT02696798|468824032|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
130235196|NCT02696798|468824033|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
130235197|NCT02696798|468824031|FG000|Extended Treatment Period|Adverse Event|1|||
130235198|NCT02696798|468824032|FG001|Extended Treatment Period|Adverse Event|4|||
130235199|NCT02696798|468824033|FG002|Extended Treatment Period|Adverse Event|5|||
130235200|NCT02696798|468824031|FG000|Extended Treatment Period|Lack of Efficacy|7|||
130235201|NCT02696798|468824032|FG001|Extended Treatment Period|Lack of Efficacy|2|||
130235202|NCT02696798|468824033|FG002|Extended Treatment Period|Lack of Efficacy|2|||
130235203|NCT02696798|468824031|FG000|Extended Treatment Period|Lost to Follow-up|1|||
130235204|NCT02696798|468824032|FG001|Extended Treatment Period|Lost to Follow-up|0|||
130235205|NCT02696798|468824033|FG002|Extended Treatment Period|Lost to Follow-up|0|||
130235206|NCT02696798|468824031|FG000|Extended Treatment Period|Physician Decision|0|||
130235207|NCT02696798|468824032|FG001|Extended Treatment Period|Physician Decision|1|||
130235208|NCT02696798|468824033|FG002|Extended Treatment Period|Physician Decision|0|||
130235209|NCT02696798|468824031|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
130235210|NCT02696798|468824032|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
130235211|NCT02696798|468824033|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
130235212|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
130235213|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
130235214|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
130235215|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
130235216|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
130235217|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
130235218|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
130235219|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
130235220|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
130235221|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
130235222|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
130235223|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
130235224|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
130235225|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
130235226|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
130235227|NCT02696798|468824031|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
130235228|NCT02696798|468824032|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
130235229|NCT02696798|468824033|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
130235230|NCT01277861|468824034|FG000|Overall Study|Physician Decision|2|||
130235231|NCT01277861|468824035|FG001|Overall Study|Physician Decision|2|||
130235232|NCT00857389|468824036|FG000|Overall Study|Did not proceed to transplant|2|||
130235233|NCT01157845|468824037|FG000|Overall Study|Lost to Follow-up|5|||
130235234|NCT01157845|468824037|FG000|Overall Study|Withdrawal by Subject|12|||
130235235|NCT01157845|468824037|FG000|Overall Study|Physician Decision|3|||
130235236|NCT01157845|468824037|FG000|Overall Study|Protocol Violation|13|||
130235237|NCT01157845|468824037|FG000|Overall Study|Study was ended|1|||
130235238|NCT01157845|468824037|FG000|Overall Study|Device malfunction|1|||
130235239|NCT03311555|468824038|FG000|Overall Study|Adverse Event|1|||
130235240|NCT04530630|468825679|FG000|Overall Study|Physician Decision|1|||
130235241|NCT03675308|468825682|FG000|Overall Study|Adverse Event|3|||
130235242|NCT03675308|468825683|FG001|Overall Study|Adverse Event|2|||
130235243|NCT03675308|468825682|FG000|Overall Study|Withdrawal by Subject|6|||
130235244|NCT03675308|468825683|FG001|Overall Study|Withdrawal by Subject|4|||
130235245|NCT03675308|468825682|FG000|Overall Study|Lost to Follow-up|3|||
130235246|NCT03675308|468825683|FG001|Overall Study|Lost to Follow-up|0|||
130235247|NCT03675308|468825682|FG000|Overall Study|Lack of Efficacy|1|||
130235248|NCT03675308|468825683|FG001|Overall Study|Lack of Efficacy|1|||
130235249|NCT03675308|468825682|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
130235250|NCT03675308|468825683|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
130235251|NCT03675308|468825682|FG000|Overall Study|Other|0|||
130235252|NCT03675308|468825683|FG001|Overall Study|Other|1|||
130235253|NCT00788671|468825687|FG000|Overall Study|Death|2|||
130235254|NCT00788671|468825687|FG000|Overall Study|Unable to biopsy|1|||
130235255|NCT00788671|468825687|FG000|Overall Study|Withdrawal by Subject|4|||
130235256|NCT00788671|468825687|FG000|Overall Study|IUD expulsed|1|||
130235257|NCT00788671|468825687|FG000|Overall Study|Lost to follow up|2|||
130235258|NCT05172609|468825688|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
130235259|NCT05172609|468825689|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
130235260|NCT05172609|468825688|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
130235261|NCT05172609|468825689|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
130235262|NCT05172609|468825688|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
130235263|NCT05172609|468825689|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
130235264|NCT04476043|468825692|FG000|Overall Study|Withdrawal by Subject|1|||
130235265|NCT04476043|468825693|FG001|Overall Study|Withdrawal by Subject|3|||
130235266|NCT04476043|468825694|FG002|Overall Study|Withdrawal by Subject|4|||
130235267|NCT04476043|468825695|FG003|Overall Study|Withdrawal by Subject|1|||
130235268|NCT04476043|468825692|FG000|Overall Study|Lost to Follow-up|1|||
130235269|NCT04476043|468825693|FG001|Overall Study|Lost to Follow-up|1|||
130235270|NCT04476043|468825694|FG002|Overall Study|Lost to Follow-up|2|||
130235271|NCT04476043|468825695|FG003|Overall Study|Lost to Follow-up|1|||
130235272|NCT04476043|468825692|FG000|Overall Study|Adverse Event|2|||
130235273|NCT04476043|468825693|FG001|Overall Study|Adverse Event|0|||
130235274|NCT04476043|468825694|FG002|Overall Study|Adverse Event|1|||
130235275|NCT04476043|468825695|FG003|Overall Study|Adverse Event|0|||
130235276|NCT04476043|468825692|FG000|Overall Study|Protocol Violation|0|||
130235277|NCT04476043|468825693|FG001|Overall Study|Protocol Violation|1|||
130235278|NCT04476043|468825694|FG002|Overall Study|Protocol Violation|0|||
130235279|NCT04476043|468825695|FG003|Overall Study|Protocol Violation|0|||
130235280|NCT06217380|468825696|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
130235281|NCT06217380|468825696|FG000|Overall Study|Physician Decision|1|||
130235282|NCT06217380|468825696|FG000|Overall Study|Withdrawal by Subject|2|||
130235283|NCT06633965|468825697|FG000|Overall Study|Withdrawal by Subject|0|||
130235284|NCT06633965|468825698|FG001|Overall Study|Withdrawal by Subject|1|||
130235285|NCT01963611|468825705|FG000|Overall Study|Adverse Event|1|||
130235286|NCT01963611|468825706|FG001|Overall Study|Adverse Event|1|||
130235287|NCT01963611|468825707|FG002|Overall Study|Adverse Event|3|||
130235288|NCT01963611|468825708|FG003|Overall Study|Adverse Event|4|||
130235289|NCT01963611|468825709|FG004|Overall Study|Adverse Event|3|||
130235290|NCT01963611|468825705|FG000|Overall Study|Protocol Violation|0|||
130235291|NCT01963611|468825706|FG001|Overall Study|Protocol Violation|0|||
130235292|NCT01963611|468825707|FG002|Overall Study|Protocol Violation|0|||
130235293|NCT01963611|468825708|FG003|Overall Study|Protocol Violation|1|||
130235294|NCT01963611|468825709|FG004|Overall Study|Protocol Violation|0|||
130235295|NCT01963611|468825705|FG000|Overall Study|Lack of Efficacy|0|||
130235296|NCT01963611|468825706|FG001|Overall Study|Lack of Efficacy|0|||
130235297|NCT01963611|468825707|FG002|Overall Study|Lack of Efficacy|0|||
130235298|NCT01963611|468825708|FG003|Overall Study|Lack of Efficacy|1|||
130235299|NCT01963611|468825709|FG004|Overall Study|Lack of Efficacy|0|||
130235300|NCT01963611|468825705|FG000|Overall Study|Withdrawal by Subject|3|||
130235301|NCT01963611|468825706|FG001|Overall Study|Withdrawal by Subject|2|||
130235302|NCT01963611|468825707|FG002|Overall Study|Withdrawal by Subject|1|||
130235303|NCT01963611|468825708|FG003|Overall Study|Withdrawal by Subject|1|||
130235304|NCT01963611|468825709|FG004|Overall Study|Withdrawal by Subject|3|||
130235305|NCT01963611|468825705|FG000|Overall Study|Other|47|||
130235306|NCT01963611|468825706|FG001|Overall Study|Other|46|||
130235307|NCT01963611|468825707|FG002|Overall Study|Other|48|||
130235308|NCT01963611|468825708|FG003|Overall Study|Other|45|||
130235309|NCT01963611|468825709|FG004|Overall Study|Other|45|||
130235310|NCT01126424|468825710|FG000|Overall Study|Adverse Event|0|||
130235311|NCT01126424|468825711|FG001|Overall Study|Adverse Event|0|||
130235312|NCT01126424|468825712|FG002|Overall Study|Adverse Event|0|||
130235313|NCT01126424|468825713|FG003|Overall Study|Adverse Event|0|||
130235314|NCT01126424|468825714|FG004|Overall Study|Adverse Event|1|||
130235315|NCT01126424|468825715|FG005|Overall Study|Adverse Event|0|||
130235316|NCT01126424|468825710|FG000|Overall Study|Withdrawal by Subject|0|||
130235317|NCT01126424|468825711|FG001|Overall Study|Withdrawal by Subject|0|||
130235318|NCT01126424|468825712|FG002|Overall Study|Withdrawal by Subject|1|||
130235319|NCT01126424|468825713|FG003|Overall Study|Withdrawal by Subject|3|||
130235320|NCT01126424|468825714|FG004|Overall Study|Withdrawal by Subject|1|||
130235321|NCT01126424|468825715|FG005|Overall Study|Withdrawal by Subject|0|||
130235322|NCT03801252|468825717|FG000|Overall Study|Protocol Violation|1|||
130235323|NCT03801252|468825718|FG001|Overall Study|Protocol Violation|2|||
130235324|NCT01134042|468825719|FG000|Overall Study|Adverse Event|3|||
130235325|NCT01134042|468825720|FG001|Overall Study|Adverse Event|7|||
130235326|NCT01134042|468825721|FG002|Overall Study|Adverse Event|2|||
130235327|NCT01134042|468825719|FG000|Overall Study|Lack of Efficacy|21|||
130235328|NCT01134042|468825720|FG001|Overall Study|Lack of Efficacy|6|||
130235329|NCT01134042|468825721|FG002|Overall Study|Lack of Efficacy|18|||
130235330|NCT01134042|468825719|FG000|Overall Study|Protocol Violation|5|||
130235331|NCT01134042|468825720|FG001|Overall Study|Protocol Violation|3|||
130235332|NCT01134042|468825721|FG002|Overall Study|Protocol Violation|5|||
130235333|NCT01134042|468825719|FG000|Overall Study|Lost to Follow-up|2|||
130235334|NCT01134042|468825720|FG001|Overall Study|Lost to Follow-up|0|||
130235335|NCT01134042|468825721|FG002|Overall Study|Lost to Follow-up|1|||
130235336|NCT01134042|468825719|FG000|Overall Study|Physician Decision|4|||
130235337|NCT01134042|468825720|FG001|Overall Study|Physician Decision|8|||
130235338|NCT01134042|468825721|FG002|Overall Study|Physician Decision|1|||
130235339|NCT01134042|468825719|FG000|Overall Study|Withdrawal by Subject|13|||
130235340|NCT01134042|468825720|FG001|Overall Study|Withdrawal by Subject|4|||
130235341|NCT01134042|468825721|FG002|Overall Study|Withdrawal by Subject|7|||
130235342|NCT02328105|468825722|FG000|Overall Study|Death|6|||
130235343|NCT02328105|468825722|FG000|Overall Study|Withdrawal by Subject|1|||
130235344|NCT02328105|468825722|FG000|Overall Study|Still On Study in Follow-Up|4|||
130235345|NCT01588509|468825726|FG000|Overall Study|Lost to Follow-up|1|||
130235346|NCT01588509|468825727|FG001|Overall Study|Lost to Follow-up|0|||
130235347|NCT01983930|468825728|FG000|Overall Study|Withdrawal by Subject|9|||
130235348|NCT01983930|468825729|FG001|Overall Study|Withdrawal by Subject|8|||
130235349|NCT01983930|468825728|FG000|Overall Study|Adverse Event|0|||
130235350|NCT01983930|468825729|FG001|Overall Study|Adverse Event|1|||
130235351|NCT00393367|468825730|FG000|Overall Study|Protocol Violation|2|||
130235352|NCT00393367|468825731|FG001|Overall Study|Protocol Violation|5|||
130235353|NCT00393367|468825730|FG000|Overall Study|Withdrawal by Subject|0|||
130235354|NCT00393367|468825731|FG001|Overall Study|Withdrawal by Subject|2|||
130235355|NCT03286504|468825732|FG000|Overall Study|Lost to Follow-up|19|||
130235356|NCT03286504|468825733|FG001|Overall Study|Lost to Follow-up|16|||
130235357|NCT01432327|468825734|FG000|Posttest 3 Months|depression|3|||
130235358|NCT01432327|468825735|FG001|Posttest 3 Months|depression|0|||
130235359|NCT01432327|468825736|FG002|Posttest 3 Months|depression|0|||
130235360|NCT01432327|468825737|FG003|Posttest 3 Months|depression|0|||
130235361|NCT01432327|468825734|FG000|Posttest 3 Months|Lost to Follow-up|1|||
130235362|NCT01432327|468825735|FG001|Posttest 3 Months|Lost to Follow-up|0|||
130235363|NCT01432327|468825736|FG002|Posttest 3 Months|Lost to Follow-up|2|||
130235364|NCT01432327|468825737|FG003|Posttest 3 Months|Lost to Follow-up|1|||
130235365|NCT01432327|468825734|FG000|Posttest 3 Months|Allergic reaction|0|||
130235366|NCT01432327|468825735|FG001|Posttest 3 Months|Allergic reaction|2|||
130235367|NCT01432327|468825736|FG002|Posttest 3 Months|Allergic reaction|0|||
130235368|NCT01432327|468825737|FG003|Posttest 3 Months|Allergic reaction|0|||
130235369|NCT01432327|468825734|FG000|Posttest 6 Months|Lost to Follow-up|0|||
130235370|NCT01432327|468825735|FG001|Posttest 6 Months|Lost to Follow-up|0|||
130235371|NCT01432327|468825736|FG002|Posttest 6 Months|Lost to Follow-up|3|||
130235372|NCT01432327|468825737|FG003|Posttest 6 Months|Lost to Follow-up|2|||
130235373|NCT01432327|468825734|FG000|Posttest 6 Months|Allergic reaction|0|||
130235374|NCT01432327|468825735|FG001|Posttest 6 Months|Allergic reaction|0|||
130235375|NCT01432327|468825736|FG002|Posttest 6 Months|Allergic reaction|1|||
130235376|NCT01432327|468825737|FG003|Posttest 6 Months|Allergic reaction|0|||
130235377|NCT01432327|468825734|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
130235378|NCT01432327|468825735|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
130235379|NCT01432327|468825736|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
130235380|NCT01432327|468825737|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
130235381|NCT01432327|468825734|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
130235382|NCT01432327|468825735|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
130235383|NCT01432327|468825736|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
130235384|NCT01432327|468825737|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
130235385|NCT01432327|468825734|FG000|Posttest 1 Year|Lost to Follow-up|0|||
130235386|NCT01432327|468825735|FG001|Posttest 1 Year|Lost to Follow-up|0|||
130235387|NCT01432327|468825736|FG002|Posttest 1 Year|Lost to Follow-up|4|||
130235388|NCT01432327|468825737|FG003|Posttest 1 Year|Lost to Follow-up|2|||
130235389|NCT01432327|468825734|FG000|Posttest 1 Year|Allergic reaction|0|||
130235390|NCT01432327|468825735|FG001|Posttest 1 Year|Allergic reaction|0|||
130235391|NCT01432327|468825736|FG002|Posttest 1 Year|Allergic reaction|1|||
130235392|NCT01432327|468825737|FG003|Posttest 1 Year|Allergic reaction|1|||
130235393|NCT00141921|468825740|FG000|Overall Study|Remain on Study|28|||
130235394|NCT00141921|468825740|FG000|Overall Study|Withdrawal by Subject|42|||
130235395|NCT00141921|468825740|FG000|Overall Study|Lost to Follow-up|19|||
130235396|NCT00141921|468825740|FG000|Overall Study|Noncompliance|17|||
130235397|NCT00141921|468825740|FG000|Overall Study|Disease Progression|7|||
130235398|NCT00141921|468825740|FG000|Overall Study|Protocol Deviation|7|||
130235399|NCT00141921|468825740|FG000|Overall Study|Adverse Event|5|||
130235400|NCT00141921|468825740|FG000|Overall Study|Administrative Decision|2|||
130235401|NCT00141921|468825740|FG000|Overall Study|Pregnancy|4|||
130235402|NCT00141921|468825740|FG000|Overall Study|Ineligibility Determined|2|||
130235403|NCT00141921|468825740|FG000|Overall Study|Other|8|||
130235404|NCT02030600|468825743|FG000|Treatment Period 1|Adverse Event|5|||
130235405|NCT02030600|468825744|FG001|Treatment Period 1|Adverse Event|7|||
130235406|NCT02030600|468825743|FG000|Treatment Period 1|Lack of Efficacy|0|||
130235407|NCT02030600|468825744|FG001|Treatment Period 1|Lack of Efficacy|1|||
130235408|NCT02030600|468825743|FG000|Treatment Period 1|Lost to Follow-up|11|||
130235409|NCT02030600|468825744|FG001|Treatment Period 1|Lost to Follow-up|3|||
130235410|NCT02030600|468825743|FG000|Treatment Period 1|Protocol Violation|22|||
130235411|NCT02030600|468825744|FG001|Treatment Period 1|Protocol Violation|17|||
130235412|NCT02030600|468825743|FG000|Treatment Period 1|Withdrawal by Subject|13|||
130235413|NCT02030600|468825744|FG001|Treatment Period 1|Withdrawal by Subject|17|||
130235414|NCT02030600|468825743|FG000|Treatment Period 1|Casebook Unsigned|1|||
130235415|NCT02030600|468825744|FG001|Treatment Period 1|Casebook Unsigned|0|||
130235416|NCT02030600|468825743|FG000|Treatment Period 1|Unclassified|1|||
130235417|NCT02030600|468825744|FG001|Treatment Period 1|Unclassified|0|||
130235418|NCT02030600|468825743|FG000|Treatment Period 2|Adverse Event|4|||
130235419|NCT02030600|468825744|FG001|Treatment Period 2|Adverse Event|4|||
130235420|NCT02030600|468825743|FG000|Treatment Period 2|Lack of Efficacy|2|||
130235421|NCT02030600|468825744|FG001|Treatment Period 2|Lack of Efficacy|1|||
130235422|NCT02030600|468825743|FG000|Treatment Period 2|Lost to Follow-up|4|||
130235423|NCT02030600|468825744|FG001|Treatment Period 2|Lost to Follow-up|2|||
130235424|NCT02030600|468825743|FG000|Treatment Period 2|Protocol Violation|1|||
130235425|NCT02030600|468825744|FG001|Treatment Period 2|Protocol Violation|2|||
130235426|NCT02030600|468825743|FG000|Treatment Period 2|Withdrawal by Subject|13|||
130235427|NCT02030600|468825744|FG001|Treatment Period 2|Withdrawal by Subject|9|||
130235428|NCT02030600|468825743|FG000|Treatment Period 2|Unclassified|1|||
130235429|NCT02030600|468825744|FG001|Treatment Period 2|Unclassified|0|||
130235430|NCT01155323|468825745|FG000|First Intervention|exclusion criteria|1|||
130235431|NCT01155323|468825746|FG001|First Intervention|exclusion criteria|1|||
130235432|NCT01155323|468825745|FG000|Second Intervention|Lost to Follow-up|1|||
130235433|NCT01155323|468825746|FG001|Second Intervention|Lost to Follow-up|1|||
130235434|NCT02471339|468825750|FG000|Overall Study|Did not provide follow-up data|2|||
130235435|NCT02471339|468825751|FG001|Overall Study|Did not provide follow-up data|0|||
130235436|NCT00626639|468825759|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
130235437|NCT00626639|468825760|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
130235438|NCT00303186|468825761|FG000|Overall Study|Other|52|||
130235439|NCT00937950|468825763|FG000|Overall Study|Withdrawal by Subject|23|||
130235440|NCT00937950|468825763|FG000|Overall Study|Migrated/moved from study area|27|||
130235441|NCT00937950|468825763|FG000|Overall Study|Lost to Follow-up|144|||
130235442|NCT00937950|468825763|FG000|Overall Study|Missing confirmed|4|||
130235443|NCT00937950|468825763|FG000|Overall Study|Other|18|||
130235444|NCT01137786|468825764|FG000|Overall Study|Lost to Follow-up|0|||
130235445|NCT01137786|468825765|FG001|Overall Study|Lost to Follow-up|2|||
130235446|NCT01137786|468825764|FG000|Overall Study|Withdrawal by Subject|1|||
130235447|NCT01137786|468825765|FG001|Overall Study|Withdrawal by Subject|1|||
130235448|NCT00460798|468825767|FG000|Overall Study|Death|59|||
130235449|NCT00460798|468825767|FG000|Overall Study|Adverse Event|27|||
130235450|NCT00460798|468825767|FG000|Overall Study|Lost to Follow-up|19|||
130235451|NCT00460798|468825767|FG000|Overall Study|Progressive Disease|99|||
130235452|NCT00460798|468825767|FG000|Overall Study|Other|27|||
130235453|NCT00460798|468825767|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
130235454|NCT00460798|468825767|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
130235455|NCT01898130|468825768|FG000|Treatment|Withdrawal by Subject|2|||
130235456|NCT01898130|468825768|FG000|Treatment|Progressive Disease|4|||
130235457|NCT01898130|468825768|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
130235458|NCT02320396|468825772|FG000|Overall Study|Adverse Event|2|||
130235459|NCT02320396|468825773|FG001|Overall Study|Adverse Event|2|||
130235460|NCT02320396|468825772|FG000|Overall Study|Pregnancy|0|||
130235461|NCT02320396|468825773|FG001|Overall Study|Pregnancy|1|||
130235462|NCT02320396|468825772|FG000|Overall Study|Protocol Violation|0|||
130235463|NCT02320396|468825773|FG001|Overall Study|Protocol Violation|1|||
130235464|NCT02320396|468825772|FG000|Overall Study|Withdrawal by Subject|2|||
130235465|NCT02320396|468825773|FG001|Overall Study|Withdrawal by Subject|0|||
130235466|NCT04666298|468825776|FG000|Overall Study|Subject decision|1|||
130235467|NCT04666298|468825777|FG001|Overall Study|Subject decision|0|||
130235468|NCT04666298|468825778|FG002|Overall Study|Subject decision|0|||
130235469|NCT04666298|468825779|FG003|Overall Study|Subject decision|2|||
130235470|NCT04666298|468825776|FG000|Overall Study|Death|1|||
130235471|NCT04666298|468825777|FG001|Overall Study|Death|0|||
130235472|NCT04666298|468825778|FG002|Overall Study|Death|0|||
130235473|NCT04666298|468825779|FG003|Overall Study|Death|0|||
130235474|NCT04666298|468825776|FG000|Overall Study|Lost to Follow-up|0|||
130235475|NCT04666298|468825777|FG001|Overall Study|Lost to Follow-up|0|||
130235476|NCT04666298|468825778|FG002|Overall Study|Lost to Follow-up|0|||
130235477|NCT04666298|468825779|FG003|Overall Study|Lost to Follow-up|1|||
130235478|NCT04666298|468825776|FG000|Overall Study|Physician Decision|0|||
130235479|NCT04666298|468825777|FG001|Overall Study|Physician Decision|0|||
130235480|NCT04666298|468825778|FG002|Overall Study|Physician Decision|0|||
130235481|NCT04666298|468825779|FG003|Overall Study|Physician Decision|1|||
130235482|NCT04666298|468825776|FG000|Overall Study|Protocol deviation|0|||
130235483|NCT04666298|468825777|FG001|Overall Study|Protocol deviation|0|||
130235484|NCT04666298|468825778|FG002|Overall Study|Protocol deviation|1|||
130235485|NCT04666298|468825779|FG003|Overall Study|Protocol deviation|0|||
130235486|NCT00844519|468825782|FG000|Overall Study|Withdrawal by Subject|1|||
130235487|NCT00844519|468825783|FG001|Overall Study|Withdrawal by Subject|1|||
130235488|NCT00844519|468825782|FG000|Overall Study|Adverse Event|1|||
130235489|NCT00844519|468825783|FG001|Overall Study|Adverse Event|0|||
130235490|NCT00226655|468825784|FG000|Overall Study|Death|13|||
130235491|NCT00226655|468825784|FG000|Overall Study|Withdrawal by Subject|15|||
130235492|NCT00226655|468825784|FG000|Overall Study|Adverse Event|35|||
130235493|NCT00226655|468825784|FG000|Overall Study|Physician Decision|6|||
130235494|NCT00226655|468825784|FG000|Overall Study|Clinical deterioration|10|||
130235495|NCT06438601|468825785|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
130235496|NCT06438601|468825786|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
130235497|NCT06438601|468825785|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
130235498|NCT06438601|468825786|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
130235499|NCT01311661|468825789|FG000|Overall Study|Adverse Event|2|||
130235500|NCT01311661|468825789|FG000|Overall Study|Protocol Violation|3|||
130235501|NCT01311661|468825789|FG000|Overall Study|Withdrawal by Subject|2|||
130235502|NCT03188822|468825790|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
130235503|NCT03188822|468825790|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
130026066|NCT01960855|468055863|FG002|Overall Study|Consent withdrawn by subject|2|||
130026067|NCT01960855|468055864|FG003|Overall Study|Consent withdrawn by subject|1|||
130026068|NCT01960855|468055865|FG004|Overall Study|Consent withdrawn by subject|1|||
130026069|NCT01960855|468055861|FG000|Overall Study|Lost to Follow-up|2|||
130235504|NCT01285518|468825791|FG000|Overall Study|Lost to Follow-up|0|||
130235505|NCT01285518|468825792|FG001|Overall Study|Lost to Follow-up|0|||
130235506|NCT01285518|468825793|FG002|Overall Study|Lost to Follow-up|0|||
130026070|NCT01960855|468055862|FG001|Overall Study|Lost to Follow-up|1|||
130026071|NCT01960855|468055863|FG002|Overall Study|Lost to Follow-up|0|||
130235507|NCT01285518|468825794|FG003|Overall Study|Lost to Follow-up|0|||
130235508|NCT01285518|468825795|FG004|Overall Study|Lost to Follow-up|0|||
130235509|NCT01285518|468825796|FG005|Overall Study|Lost to Follow-up|1|||
130235510|NCT01285518|468825797|FG006|Overall Study|Lost to Follow-up|0|||
130235511|NCT01285518|468825798|FG007|Overall Study|Lost to Follow-up|0|||
130235512|NCT03805841|468825799|FG000|Overall Study|Clinical Progression|2|||
130235513|NCT03805841|468825800|FG001|Overall Study|Clinical Progression|0|||
130026072|NCT01960855|468055864|FG003|Overall Study|Lost to Follow-up|0|||
130235514|NCT03805841|468825801|FG002|Overall Study|Clinical Progression|0|||
130235515|NCT03805841|468825799|FG000|Overall Study|Death|0|||
130235516|NCT03805841|468825800|FG001|Overall Study|Death|3|||
130235517|NCT03805841|468825801|FG002|Overall Study|Death|1|||
130235518|NCT03805841|468825799|FG000|Overall Study|Lost to Follow-up|0|||
130235519|NCT03805841|468825800|FG001|Overall Study|Lost to Follow-up|0|||
130235520|NCT03805841|468825801|FG002|Overall Study|Lost to Follow-up|1|||
130235521|NCT03805841|468825799|FG000|Overall Study|Withdrawal by Subject|2|||
130235522|NCT03805841|468825800|FG001|Overall Study|Withdrawal by Subject|3|||
130235523|NCT03805841|468825801|FG002|Overall Study|Withdrawal by Subject|0|||
130235524|NCT03805841|468825799|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
130235525|NCT03805841|468825800|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
130235526|NCT03805841|468825801|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
130235527|NCT02460289|468825809|FG000|Overall Study|Adverse Event|1|||
130235528|NCT02460289|468825809|FG000|Overall Study|Withdrawal by Subject|8|||
130235529|NCT02460289|468825809|FG000|Overall Study|Lost to Follow-up|1|||
130235530|NCT01977846|468825810|FG000|Total Study - Prospective|Death|0|||
130235531|NCT01977846|468825811|FG001|Total Study - Prospective|Death|1|||
130235532|NCT01977846|468825810|FG000|Total Study - Prospective|Lost to Follow-up|0|||
130235533|NCT01977846|468825811|FG001|Total Study - Prospective|Lost to Follow-up|8|||
130235534|NCT01977846|468825810|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
130235535|NCT01977846|468825811|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
130235536|NCT01977846|468825810|FG000|Total Study - Prospective|Not available at time of visit|0|||
130235537|NCT01977846|468825811|FG001|Total Study - Prospective|Not available at time of visit|5|||
130235538|NCT01977846|468825810|FG000|Total Study - Prospective|No show|0|||
130235539|NCT01977846|468825811|FG001|Total Study - Prospective|No show|1|||
130235540|NCT01977846|468825810|FG000|Total Study - Prospective|Protocol Violation|0|||
130235541|NCT01977846|468825811|FG001|Total Study - Prospective|Protocol Violation|1|||
130235542|NCT02164916|468825812|FG000|Overall Study|Adverse Event|3|||
130235543|NCT02164916|468825813|FG001|Overall Study|Adverse Event|8|||
130235544|NCT02164916|468825812|FG000|Overall Study|Death|1|||
130235545|NCT02164916|468825813|FG001|Overall Study|Death|1|||
130235546|NCT02164916|468825812|FG000|Overall Study|Refusal unrelated to adverse event|3|||
130235547|NCT02164916|468825813|FG001|Overall Study|Refusal unrelated to adverse event|7|||
130235548|NCT02164916|468825812|FG000|Overall Study|Progression|37|||
130235549|NCT02164916|468825813|FG001|Overall Study|Progression|26|||
130235550|NCT02164916|468825812|FG000|Overall Study|Not protocol specified|5|||
130235551|NCT02164916|468825813|FG001|Overall Study|Not protocol specified|1|||
130235552|NCT02164916|468825812|FG000|Overall Study|Reason under review|1|||
130235553|NCT02164916|468825813|FG001|Overall Study|Reason under review|6|||
130235554|NCT02164916|468825812|FG000|Overall Study|Not eligible|2|||
130235555|NCT02164916|468825813|FG001|Overall Study|Not eligible|5|||
130235556|NCT00596635|468825816|FG000|Overall Study|Lost to Follow-up|0|||
130235557|NCT00596635|468825817|FG001|Overall Study|Lost to Follow-up|2|||
130235558|NCT00596635|468825818|FG002|Overall Study|Lost to Follow-up|0|||
130235559|NCT00596635|468825816|FG000|Overall Study|Treatment for symptomatic UTI|4|||
130235560|NCT00596635|468825817|FG001|Overall Study|Treatment for symptomatic UTI|6|||
130235561|NCT00596635|468825818|FG002|Overall Study|Treatment for symptomatic UTI|3|||
130235562|NCT00596635|468825816|FG000|Overall Study|Hip fracture|2|||
130235563|NCT00596635|468825817|FG001|Overall Study|Hip fracture|3|||
130235564|NCT00596635|468825818|FG002|Overall Study|Hip fracture|3|||
130235565|NCT00596635|468825816|FG000|Overall Study|Could not provide urine specimen|1|||
130235566|NCT00596635|468825817|FG001|Overall Study|Could not provide urine specimen|2|||
130235567|NCT00596635|468825818|FG002|Overall Study|Could not provide urine specimen|2|||
130235568|NCT00127803|468825822|FG000|Overall Study|Adverse Event|2|||
130235569|NCT00127803|468825823|FG001|Overall Study|Adverse Event|0|||
130235570|NCT00127803|468825824|FG002|Overall Study|Adverse Event|0|||
130235571|NCT00127803|468825825|FG003|Overall Study|Adverse Event|0|||
130235572|NCT00127803|468825822|FG000|Overall Study|Withdrawal by Subject|1|||
130235573|NCT00127803|468825823|FG001|Overall Study|Withdrawal by Subject|0|||
130235574|NCT00127803|468825824|FG002|Overall Study|Withdrawal by Subject|0|||
130235575|NCT00127803|468825825|FG003|Overall Study|Withdrawal by Subject|0|||
130235576|NCT00127803|468825822|FG000|Overall Study|Lost to Follow-up|0|||
130235577|NCT00127803|468825823|FG001|Overall Study|Lost to Follow-up|0|||
130235578|NCT00127803|468825824|FG002|Overall Study|Lost to Follow-up|0|||
130235579|NCT00127803|468825825|FG003|Overall Study|Lost to Follow-up|1|||
130235580|NCT01925417|468825830|FG000|Overall Study|Withdrawal by Subject|2|||
130235581|NCT01925417|468825830|FG000|Overall Study|Death|1|||
130235582|NCT03454555|468827876|FG000|Overall Study|Death|6|||
130235583|NCT03454555|468827877|FG001|Overall Study|Death|6|||
130235584|NCT03454555|468827876|FG000|Overall Study|Lost to Follow-up|31|||
130235585|NCT03454555|468827877|FG001|Overall Study|Lost to Follow-up|12|||
130235586|NCT03454555|468827876|FG000|Overall Study|Physician Decision|2|||
130235587|NCT03454555|468827877|FG001|Overall Study|Physician Decision|6|||
130235588|NCT03454555|468827876|FG000|Overall Study|Withdrawal by Subject|34|||
130235589|NCT03454555|468827877|FG001|Overall Study|Withdrawal by Subject|5|||
130235590|NCT03454555|468827876|FG000|Overall Study|Ineligible|1|||
130235591|NCT03454555|468827877|FG001|Overall Study|Ineligible|5|||
130235592|NCT01386385|468827878|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
130235593|NCT01386385|468827879|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235594|NCT01386385|468827880|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235595|NCT01386385|468827881|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235596|NCT01386385|468827882|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235597|NCT01386385|468827883|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235598|NCT01386385|468827884|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235599|NCT01386385|468827885|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
130235600|NCT01386385|468827878|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
130235601|NCT01386385|468827879|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235602|NCT01386385|468827880|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235603|NCT01386385|468827881|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235604|NCT01386385|468827882|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235605|NCT01386385|468827883|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235606|NCT01386385|468827884|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235607|NCT01386385|468827885|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
130235608|NCT01386385|468827878|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235609|NCT01386385|468827879|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235610|NCT01386385|468827880|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
130235611|NCT01386385|468827881|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235612|NCT01386385|468827882|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235613|NCT01386385|468827883|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235614|NCT01386385|468827884|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235615|NCT01386385|468827885|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
130235616|NCT01386385|468827878|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235617|NCT01386385|468827879|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235618|NCT01386385|468827880|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235619|NCT01386385|468827881|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235620|NCT01386385|468827882|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
130235621|NCT01386385|468827883|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235622|NCT01386385|468827884|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235623|NCT01386385|468827885|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
130235624|NCT01386385|468827878|FG000|Phase II Concurrent CRT|Adverse Event|0|||
130235625|NCT01386385|468827879|FG001|Phase II Concurrent CRT|Adverse Event|0|||
130235626|NCT01386385|468827880|FG002|Phase II Concurrent CRT|Adverse Event|0|||
130235627|NCT01386385|468827881|FG003|Phase II Concurrent CRT|Adverse Event|0|||
130235628|NCT01386385|468827882|FG004|Phase II Concurrent CRT|Adverse Event|0|||
130235629|NCT01386385|468827883|FG005|Phase II Concurrent CRT|Adverse Event|0|||
130235630|NCT01386385|468827884|FG006|Phase II Concurrent CRT|Adverse Event|3|||
130235631|NCT01386385|468827885|FG007|Phase II Concurrent CRT|Adverse Event|3|||
130235632|NCT01386385|468827878|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235633|NCT01386385|468827879|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235634|NCT01386385|468827880|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235635|NCT01386385|468827881|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235636|NCT01386385|468827882|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235637|NCT01386385|468827883|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235638|NCT01386385|468827884|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
130235639|NCT01386385|468827885|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
130235640|NCT01386385|468827878|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
130235641|NCT01386385|468827879|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
130235642|NCT01386385|468827880|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
130235643|NCT01386385|468827881|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
130235644|NCT01386385|468827882|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
130235645|NCT01386385|468827883|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
130235646|NCT01386385|468827884|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
130235647|NCT01386385|468827885|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
130235648|NCT01386385|468827878|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235649|NCT01386385|468827879|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235650|NCT01386385|468827880|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235651|NCT01386385|468827881|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235652|NCT01386385|468827882|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235653|NCT01386385|468827883|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235654|NCT01386385|468827884|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
130235655|NCT01386385|468827885|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
130235656|NCT01386385|468827878|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235657|NCT01386385|468827879|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235658|NCT01386385|468827880|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235659|NCT01386385|468827881|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235660|NCT01386385|468827882|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235661|NCT01386385|468827883|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
130235662|NCT01386385|468827884|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
130235663|NCT01386385|468827885|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
130235664|NCT05399485|468827886|FG000|DBT Phase|Other|6|||
130235665|NCT05399485|468827887|FG001|DBT Phase|Other|5|||
130235666|NCT05399485|468827886|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
130235667|NCT05399485|468827887|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
130235668|NCT05399485|468827886|FG000|DBT Phase|Withdrawal by Subject|3|||
130235669|NCT05399485|468827887|FG001|DBT Phase|Withdrawal by Subject|2|||
130235670|NCT05399485|468827886|FG000|DBT Phase|Protocol Violation|2|||
130235671|NCT05399485|468827887|FG001|DBT Phase|Protocol Violation|1|||
130235672|NCT05399485|468827886|FG000|DBT Phase|Physician Decision|0|||
130235673|NCT05399485|468827887|FG001|DBT Phase|Physician Decision|1|||
130235674|NCT05399485|468827886|FG000|DBT Phase|Adverse Event|2|||
130235675|NCT05399485|468827887|FG001|DBT Phase|Adverse Event|1|||
130235676|NCT05399485|468827886|FG000|OLE Phase|Not reported|0|||
130235677|NCT05399485|468827887|FG001|OLE Phase|Not reported|1|||
130235678|NCT05399485|468827886|FG000|OLE Phase|Other|3|||
130235679|NCT05399485|468827887|FG001|OLE Phase|Other|3|||
130235680|NCT05399485|468827886|FG000|OLE Phase|Withdrawal by Subject|8|||
130235681|NCT05399485|468827887|FG001|OLE Phase|Withdrawal by Subject|5|||
130235682|NCT05399485|468827886|FG000|OLE Phase|Pregnancy|0|||
130235683|NCT05399485|468827887|FG001|OLE Phase|Pregnancy|1|||
130235684|NCT05399485|468827886|FG000|OLE Phase|Physician Decision|2|||
130235685|NCT05399485|468827887|FG001|OLE Phase|Physician Decision|0|||
130235686|NCT05399485|468827886|FG000|OLE Phase|Adverse Event|0|||
130235687|NCT05399485|468827887|FG001|OLE Phase|Adverse Event|1|||
130235688|NCT05399485|468827886|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
130235689|NCT05399485|468827887|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
130235690|NCT03405870|468827890|FG000|Overall Study|Withdrawal|1|||
130235691|NCT03405870|468827891|FG001|Overall Study|Withdrawal|0|||
130235692|NCT03405870|468827892|FG002|Overall Study|Withdrawal|1|||
130235693|NCT03405870|468827893|FG003|Overall Study|Withdrawal|0|||
130235694|NCT03405870|468827894|FG004|Overall Study|Withdrawal|0|||
130235695|NCT03405870|468827895|FG005|Overall Study|Withdrawal|0|||
130235696|NCT03405870|468827896|FG006|Overall Study|Withdrawal|1|||
130235697|NCT03405870|468827897|FG007|Overall Study|Withdrawal|0|||
130235698|NCT03737994|468827898|FG000|Overall Study|Withdrawal by Subject|0|||
130235699|NCT03737994|468827899|FG001|Overall Study|Withdrawal by Subject|0|||
130235700|NCT03737994|468827900|FG002|Overall Study|Withdrawal by Subject|0|||
130235701|NCT03737994|468827901|FG003|Overall Study|Withdrawal by Subject|0|||
130235702|NCT03737994|468827902|FG004|Overall Study|Withdrawal by Subject|0|||
130235703|NCT03737994|468827903|FG005|Overall Study|Withdrawal by Subject|0|||
130235704|NCT03737994|468827904|FG006|Overall Study|Withdrawal by Subject|1|||
130235705|NCT03846479|468827905|FG000|Overall Study|Death|8|||
130235706|NCT03846479|468827905|FG000|Overall Study|Lost to Follow-up|1|||
130235707|NCT01473134|468827906|FG000|Overall Study|Lost to Follow-up|21|||
130235708|NCT01473134|468827907|FG001|Overall Study|Lost to Follow-up|13|||
130235709|NCT01473134|468827906|FG000|Overall Study|Protocol Violation|32|||
130235710|NCT01473134|468827907|FG001|Overall Study|Protocol Violation|19|||
130235711|NCT01473134|468827906|FG000|Overall Study|Withdrawal by Subject|1|||
130026073|NCT01960855|468055865|FG004|Overall Study|Lost to Follow-up|2|||
130026074|NCT03604445|468055866|FG000|Overall Study|Death|0|||
130026075|NCT03604445|468055867|FG001|Overall Study|Death|0|||
130235712|NCT01473134|468827907|FG001|Overall Study|Withdrawal by Subject|2|||
130235713|NCT01473134|468827906|FG000|Overall Study|Death|0|||
130235714|NCT01473134|468827907|FG001|Overall Study|Death|1|||
130235715|NCT01473134|468827906|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
130235716|NCT01473134|468827907|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
130235717|NCT05020015|468827914|FG000|Overall Study|Ongoing on study|1|||
130235718|NCT05020015|468827915|FG001|Overall Study|Ongoing on study|3|||
130235719|NCT05020015|468827916|FG002|Overall Study|Ongoing on study|4|||
130235720|NCT05020015|468827917|FG003|Overall Study|Ongoing on study|7|||
130235721|NCT05020015|468827914|FG000|Overall Study|Death|2|||
130235722|NCT05020015|468827915|FG001|Overall Study|Death|3|||
130235723|NCT05020015|468827916|FG002|Overall Study|Death|4|||
130235724|NCT05020015|468827917|FG003|Overall Study|Death|0|||
130235725|NCT05020015|468827914|FG000|Overall Study|Withdrawal by Subject|0|||
130235726|NCT05020015|468827915|FG001|Overall Study|Withdrawal by Subject|0|||
130235727|NCT05020015|468827916|FG002|Overall Study|Withdrawal by Subject|1|||
130235728|NCT05020015|468827917|FG003|Overall Study|Withdrawal by Subject|0|||
130235729|NCT05020015|468827914|FG000|Overall Study|Reason Not Specified|0|||
130235730|NCT05020015|468827915|FG001|Overall Study|Reason Not Specified|0|||
130235731|NCT05020015|468827916|FG002|Overall Study|Reason Not Specified|2|||
130235732|NCT05020015|468827917|FG003|Overall Study|Reason Not Specified|0|||
130235733|NCT00614393|468827924|FG000|Overall Study|Adverse Event|20|||
130235734|NCT00614393|468827925|FG001|Overall Study|Adverse Event|2|||
130235735|NCT00614393|468827926|FG002|Overall Study|Adverse Event|3|||
130235736|NCT00614393|468827927|FG003|Overall Study|Adverse Event|13|||
130235737|NCT00614393|468827928|FG004|Overall Study|Adverse Event|21|||
130235738|NCT00614393|468827924|FG000|Overall Study|Lost to Follow-up|0|||
130235739|NCT00614393|468827925|FG001|Overall Study|Lost to Follow-up|0|||
130235740|NCT00614393|468827926|FG002|Overall Study|Lost to Follow-up|0|||
130235741|NCT00614393|468827927|FG003|Overall Study|Lost to Follow-up|1|||
130235742|NCT00614393|468827928|FG004|Overall Study|Lost to Follow-up|2|||
130235743|NCT00614393|468827924|FG000|Overall Study|Physician Decision|17|||
130235744|NCT00614393|468827925|FG001|Overall Study|Physician Decision|0|||
130235745|NCT00614393|468827926|FG002|Overall Study|Physician Decision|1|||
130235746|NCT00614393|468827927|FG003|Overall Study|Physician Decision|8|||
130235747|NCT00614393|468827928|FG004|Overall Study|Physician Decision|9|||
130235748|NCT00614393|468827924|FG000|Overall Study|Progressive Disease|118|||
130235749|NCT00614393|468827925|FG001|Overall Study|Progressive Disease|5|||
130235750|NCT00614393|468827926|FG002|Overall Study|Progressive Disease|5|||
130235751|NCT00614393|468827927|FG003|Overall Study|Progressive Disease|138|||
130235752|NCT00614393|468827928|FG004|Overall Study|Progressive Disease|130|||
130235753|NCT00614393|468827924|FG000|Overall Study|Protocol Violation|1|||
130235754|NCT00614393|468827925|FG001|Overall Study|Protocol Violation|0|||
130235755|NCT00614393|468827926|FG002|Overall Study|Protocol Violation|0|||
130235756|NCT00614393|468827927|FG003|Overall Study|Protocol Violation|0|||
130235757|NCT00614393|468827928|FG004|Overall Study|Protocol Violation|0|||
130235758|NCT00614393|468827924|FG000|Overall Study|Terminated by Sponsor|0|||
130235759|NCT00614393|468827925|FG001|Overall Study|Terminated by Sponsor|0|||
130026076|NCT03604445|468055868|FG002|Overall Study|Death|0|||
130026077|NCT03604445|468055869|FG003|Overall Study|Death|0|||
130235760|NCT00614393|468827926|FG002|Overall Study|Terminated by Sponsor|0|||
130235761|NCT00614393|468827927|FG003|Overall Study|Terminated by Sponsor|0|||
130235762|NCT00614393|468827928|FG004|Overall Study|Terminated by Sponsor|1|||
130235763|NCT00614393|468827924|FG000|Overall Study|Withdrawal by Subject|20|||
130026078|NCT03604445|468055870|FG004|Overall Study|Death|0|||
130235764|NCT00614393|468827925|FG001|Overall Study|Withdrawal by Subject|1|||
130235765|NCT00614393|468827926|FG002|Overall Study|Withdrawal by Subject|1|||
130235766|NCT00614393|468827927|FG003|Overall Study|Withdrawal by Subject|16|||
130235767|NCT00614393|468827928|FG004|Overall Study|Withdrawal by Subject|13|||
130235768|NCT00614393|468827924|FG000|Overall Study|Other|4|||
130235769|NCT00614393|468827925|FG001|Overall Study|Other|0|||
130235770|NCT00614393|468827926|FG002|Overall Study|Other|0|||
130235771|NCT00614393|468827927|FG003|Overall Study|Other|4|||
130235772|NCT00614393|468827928|FG004|Overall Study|Other|2|||
130235773|NCT00614393|468827924|FG000|Overall Study|Not Treated|0|||
130235774|NCT00614393|468827925|FG001|Overall Study|Not Treated|0|||
130235775|NCT00614393|468827926|FG002|Overall Study|Not Treated|0|||
130235776|NCT00614393|468827927|FG003|Overall Study|Not Treated|0|||
130235777|NCT00614393|468827928|FG004|Overall Study|Not Treated|2|||
130235778|NCT00855582|468827929|FG000|Overall Study|Adverse Event|2|||
130235779|NCT00855582|468827930|FG001|Overall Study|Adverse Event|6|||
130235780|NCT00855582|468827931|FG002|Overall Study|Adverse Event|3|||
130235781|NCT00855582|468827929|FG000|Overall Study|Death|1|||
130235782|NCT00855582|468827930|FG001|Overall Study|Death|0|||
130235783|NCT00855582|468827931|FG002|Overall Study|Death|0|||
130235784|NCT00855582|468827929|FG000|Overall Study|Lack of Efficacy|1|||
130235785|NCT00855582|468827930|FG001|Overall Study|Lack of Efficacy|3|||
130235786|NCT00855582|468827931|FG002|Overall Study|Lack of Efficacy|8|||
130235787|NCT00855582|468827929|FG000|Overall Study|Lost to Follow-up|1|||
130235788|NCT00855582|468827930|FG001|Overall Study|Lost to Follow-up|3|||
130235789|NCT00855582|468827931|FG002|Overall Study|Lost to Follow-up|1|||
130235790|NCT00855582|468827929|FG000|Overall Study|Physician Decision|0|||
130235791|NCT00855582|468827930|FG001|Overall Study|Physician Decision|0|||
130235792|NCT00855582|468827931|FG002|Overall Study|Physician Decision|1|||
130235793|NCT00855582|468827929|FG000|Overall Study|Protocol Violation|6|||
130235794|NCT00855582|468827930|FG001|Overall Study|Protocol Violation|2|||
130235795|NCT00855582|468827931|FG002|Overall Study|Protocol Violation|6|||
130235796|NCT00855582|468827929|FG000|Overall Study|Entry Criteria Not Met|8|||
130235797|NCT00855582|468827930|FG001|Overall Study|Entry Criteria Not Met|6|||
130235798|NCT00855582|468827931|FG002|Overall Study|Entry Criteria Not Met|3|||
130235799|NCT00855582|468827929|FG000|Overall Study|Withdrawal by Subject|7|||
130235800|NCT00855582|468827930|FG001|Overall Study|Withdrawal by Subject|4|||
130235801|NCT00855582|468827931|FG002|Overall Study|Withdrawal by Subject|8|||
130235802|NCT03345004|468827932|FG000|Overall Study|Physician Decision|1|||
130235803|NCT03345004|468827933|FG001|Overall Study|Physician Decision|0|||
130235804|NCT03345004|468827932|FG000|Overall Study|Withdrawal by Subject|0|||
130235805|NCT03345004|468827933|FG001|Overall Study|Withdrawal by Subject|1|||
130235806|NCT01013753|468827934|FG000|Overall Study|Adverse Event|8|||
130235807|NCT01013753|468827934|FG000|Overall Study|Protocol Violation|3|||
130235808|NCT01013753|468827934|FG000|Overall Study|Lost to Follow-up|1|||
130235809|NCT01013753|468827934|FG000|Overall Study|Withdrawal by Subject|2|||
130235810|NCT01013753|468827934|FG000|Overall Study|Other|2|||
130235811|NCT03320369|468827937|FG000|Overall Study|Adverse Event|1|||
130235812|NCT03320369|468827937|FG000|Overall Study|Withdrawal by Subject|2|||
130235813|NCT01732692|468827938|FG000|Overall Study|Adverse Event|0|||
130235814|NCT01732692|468827939|FG001|Overall Study|Adverse Event|1|||
130235815|NCT01281306|468827940|FG000|Overall Study|Lack of Efficacy|0|||
130235816|NCT01281306|468827941|FG001|Overall Study|Lack of Efficacy|1|||
130235817|NCT01281306|468827942|FG002|Overall Study|Lack of Efficacy|3|||
130235818|NCT01281306|468827943|FG003|Overall Study|Lack of Efficacy|0|||
130235819|NCT01281306|468827944|FG004|Overall Study|Lack of Efficacy|2|||
130235820|NCT01281306|468827945|FG005|Overall Study|Lack of Efficacy|0|||
130235821|NCT01281306|468827946|FG006|Overall Study|Lack of Efficacy|1|||
130235822|NCT01281306|468827940|FG000|Overall Study|Withdrawal by Subject|1|||
130235823|NCT01281306|468827941|FG001|Overall Study|Withdrawal by Subject|0|||
130235824|NCT01281306|468827942|FG002|Overall Study|Withdrawal by Subject|2|||
130235825|NCT01281306|468827943|FG003|Overall Study|Withdrawal by Subject|4|||
130235826|NCT01281306|468827944|FG004|Overall Study|Withdrawal by Subject|1|||
130235827|NCT01281306|468827945|FG005|Overall Study|Withdrawal by Subject|3|||
130235828|NCT01281306|468827946|FG006|Overall Study|Withdrawal by Subject|1|||
130235829|NCT01281306|468827940|FG000|Overall Study|Protocol deviation|0|||
130235830|NCT01281306|468827941|FG001|Overall Study|Protocol deviation|1|||
130235831|NCT01281306|468827942|FG002|Overall Study|Protocol deviation|1|||
130235832|NCT01281306|468827943|FG003|Overall Study|Protocol deviation|1|||
130235833|NCT01281306|468827944|FG004|Overall Study|Protocol deviation|1|||
130235834|NCT01281306|468827945|FG005|Overall Study|Protocol deviation|0|||
130235835|NCT01281306|468827946|FG006|Overall Study|Protocol deviation|0|||
130235836|NCT01281306|468827940|FG000|Overall Study|Condition no longer requires study drug|1|||
130235837|NCT01281306|468827941|FG001|Overall Study|Condition no longer requires study drug|0|||
130235838|NCT01281306|468827942|FG002|Overall Study|Condition no longer requires study drug|0|||
130235839|NCT01281306|468827943|FG003|Overall Study|Condition no longer requires study drug|0|||
130235840|NCT01281306|468827944|FG004|Overall Study|Condition no longer requires study drug|0|||
130235841|NCT01281306|468827945|FG005|Overall Study|Condition no longer requires study drug|1|||
130235842|NCT01281306|468827946|FG006|Overall Study|Condition no longer requires study drug|1|||
130235843|NCT01281306|468827940|FG000|Overall Study|Lost to Follow-up|1|||
130235844|NCT01281306|468827941|FG001|Overall Study|Lost to Follow-up|0|||
130235845|NCT01281306|468827942|FG002|Overall Study|Lost to Follow-up|0|||
130235846|NCT01281306|468827943|FG003|Overall Study|Lost to Follow-up|2|||
130235847|NCT01281306|468827944|FG004|Overall Study|Lost to Follow-up|0|||
130235848|NCT01281306|468827945|FG005|Overall Study|Lost to Follow-up|0|||
130235849|NCT01281306|468827946|FG006|Overall Study|Lost to Follow-up|1|||
130235850|NCT01281306|468827940|FG000|Overall Study|Death|1|||
130235851|NCT01281306|468827941|FG001|Overall Study|Death|0|||
130235852|NCT01281306|468827942|FG002|Overall Study|Death|0|||
130235853|NCT01281306|468827943|FG003|Overall Study|Death|0|||
130235854|NCT01281306|468827944|FG004|Overall Study|Death|0|||
130235855|NCT01281306|468827945|FG005|Overall Study|Death|0|||
130235856|NCT01281306|468827946|FG006|Overall Study|Death|0|||
130235857|NCT01281306|468827940|FG000|Overall Study|Adverse Event|3|||
130235858|NCT01281306|468827941|FG001|Overall Study|Adverse Event|2|||
130235859|NCT01281306|468827942|FG002|Overall Study|Adverse Event|2|||
130235860|NCT01281306|468827943|FG003|Overall Study|Adverse Event|3|||
130235861|NCT01281306|468827944|FG004|Overall Study|Adverse Event|5|||
130235862|NCT01281306|468827945|FG005|Overall Study|Adverse Event|3|||
130235863|NCT01281306|468827946|FG006|Overall Study|Adverse Event|3|||
130235864|NCT01281306|468827940|FG000|Overall Study|Randomized in error|1|||
130235865|NCT01281306|468827941|FG001|Overall Study|Randomized in error|0|||
130235866|NCT01281306|468827942|FG002|Overall Study|Randomized in error|0|||
130235867|NCT01281306|468827943|FG003|Overall Study|Randomized in error|1|||
130235868|NCT01281306|468827944|FG004|Overall Study|Randomized in error|0|||
130235869|NCT01281306|468827945|FG005|Overall Study|Randomized in error|0|||
130235870|NCT01281306|468827946|FG006|Overall Study|Randomized in error|0|||
130235871|NCT02606253|468827947|FG000|Overall Study|Adverse Event|2|||
130235872|NCT02606253|468827948|FG001|Overall Study|Adverse Event|0|||
130235873|NCT02606253|468827949|FG002|Overall Study|Adverse Event|0|||
130235874|NCT02606253|468827947|FG000|Overall Study|Protocol Violation|2|||
130235875|NCT02606253|468827948|FG001|Overall Study|Protocol Violation|1|||
130235876|NCT02606253|468827949|FG002|Overall Study|Protocol Violation|0|||
130235877|NCT02606253|468827947|FG000|Overall Study|Physician Decision|1|||
130235878|NCT02606253|468827948|FG001|Overall Study|Physician Decision|1|||
130235879|NCT02606253|468827949|FG002|Overall Study|Physician Decision|0|||
130235880|NCT03331562|468827952|FG000|Overall Study|Adverse Event|2|||
130235881|NCT03331562|468827953|FG001|Overall Study|Adverse Event|0|||
130235882|NCT03331562|468827952|FG000|Overall Study|Death|1|||
130235883|NCT03331562|468827953|FG001|Overall Study|Death|0|||
130235884|NCT03718000|468827954|FG000|Overall Study|Relocation|2|||
130235885|NCT03718000|468827955|FG001|Overall Study|Relocation|4|||
130235886|NCT03718000|468827954|FG000|Overall Study|Pregnancy|0|||
130235887|NCT03718000|468827955|FG001|Overall Study|Pregnancy|1|||
130235888|NCT05522751|468827958|FG000|Overall Study|Adverse Event|1|||
130235889|NCT02475213|468827959|FG000|Overall Study|Adverse Event|2|||
130235890|NCT02475213|468827960|FG001|Overall Study|Adverse Event|0|||
130235891|NCT02475213|468827961|FG002|Overall Study|Adverse Event|0|||
130235892|NCT02475213|468827962|FG003|Overall Study|Adverse Event|1|||
130235893|NCT02475213|468827963|FG004|Overall Study|Adverse Event|1|||
130235894|NCT02475213|468827964|FG005|Overall Study|Adverse Event|4|||
130235895|NCT02475213|468827965|FG006|Overall Study|Adverse Event|6|||
130235896|NCT02475213|468827966|FG007|Overall Study|Adverse Event|2|||
130235897|NCT02475213|468827959|FG000|Overall Study|Physician Decision|1|||
130235898|NCT02475213|468827960|FG001|Overall Study|Physician Decision|1|||
130235899|NCT02475213|468827961|FG002|Overall Study|Physician Decision|1|||
130235900|NCT02475213|468827962|FG003|Overall Study|Physician Decision|0|||
130235901|NCT02475213|468827963|FG004|Overall Study|Physician Decision|0|||
130235902|NCT02475213|468827964|FG005|Overall Study|Physician Decision|1|||
130235903|NCT02475213|468827965|FG006|Overall Study|Physician Decision|4|||
130235904|NCT02475213|468827966|FG007|Overall Study|Physician Decision|0|||
130235905|NCT02475213|468827959|FG000|Overall Study|Progressive Disease|3|||
130235906|NCT02475213|468827960|FG001|Overall Study|Progressive Disease|2|||
130235907|NCT02475213|468827961|FG002|Overall Study|Progressive Disease|2|||
130235908|NCT02475213|468827962|FG003|Overall Study|Progressive Disease|13|||
130235909|NCT02475213|468827963|FG004|Overall Study|Progressive Disease|15|||
130235910|NCT02475213|468827964|FG005|Overall Study|Progressive Disease|25|||
130235911|NCT02475213|468827965|FG006|Overall Study|Progressive Disease|30|||
130235912|NCT02475213|468827966|FG007|Overall Study|Progressive Disease|10|||
130235913|NCT02475213|468827959|FG000|Overall Study|Death|0|||
130235914|NCT02475213|468827960|FG001|Overall Study|Death|0|||
130235915|NCT02475213|468827961|FG002|Overall Study|Death|0|||
130235916|NCT02475213|468827962|FG003|Overall Study|Death|0|||
130235917|NCT02475213|468827963|FG004|Overall Study|Death|0|||
130235918|NCT02475213|468827964|FG005|Overall Study|Death|4|||
130235919|NCT02475213|468827965|FG006|Overall Study|Death|1|||
130235920|NCT02475213|468827966|FG007|Overall Study|Death|0|||
130235921|NCT02475213|468827959|FG000|Overall Study|Protocol Violation|0|||
130235922|NCT02475213|468827960|FG001|Overall Study|Protocol Violation|0|||
130235923|NCT02475213|468827961|FG002|Overall Study|Protocol Violation|0|||
130235924|NCT02475213|468827962|FG003|Overall Study|Protocol Violation|0|||
130235925|NCT02475213|468827963|FG004|Overall Study|Protocol Violation|1|||
130235926|NCT02475213|468827964|FG005|Overall Study|Protocol Violation|0|||
130235927|NCT02475213|468827965|FG006|Overall Study|Protocol Violation|0|||
130235928|NCT02475213|468827966|FG007|Overall Study|Protocol Violation|0|||
130235929|NCT02475213|468827959|FG000|Overall Study|Withdrawal by Subject|0|||
130235930|NCT02475213|468827960|FG001|Overall Study|Withdrawal by Subject|0|||
130235931|NCT02475213|468827961|FG002|Overall Study|Withdrawal by Subject|0|||
130235932|NCT02475213|468827962|FG003|Overall Study|Withdrawal by Subject|1|||
130235933|NCT02475213|468827963|FG004|Overall Study|Withdrawal by Subject|0|||
130235934|NCT02475213|468827964|FG005|Overall Study|Withdrawal by Subject|2|||
130235935|NCT02475213|468827965|FG006|Overall Study|Withdrawal by Subject|2|||
130235936|NCT02475213|468827966|FG007|Overall Study|Withdrawal by Subject|0|||
130235937|NCT02475213|468827959|FG000|Overall Study|Other|0|||
130235938|NCT02475213|468827960|FG001|Overall Study|Other|0|||
130235939|NCT02475213|468827961|FG002|Overall Study|Other|0|||
130235940|NCT02475213|468827962|FG003|Overall Study|Other|1|||
130235941|NCT02475213|468827963|FG004|Overall Study|Other|3|||
130235942|NCT02475213|468827964|FG005|Overall Study|Other|1|||
130235943|NCT02475213|468827965|FG006|Overall Study|Other|0|||
130235944|NCT02475213|468827966|FG007|Overall Study|Other|0|||
130235945|NCT00505921|468827967|FG000|Overall Study|Ineligible|1|||
130235946|NCT00505921|468827967|FG000|Overall Study|Failed to Mobilize|8|||
130235947|NCT02441283|468827968|FG000|Overall Study|Withdrew consent|15|||
130235948|NCT02441283|468827968|FG000|Overall Study|Lost to Follow-up|42|||
130235949|NCT02441283|468827968|FG000|Overall Study|Death|1|||
130235950|NCT02441283|468827968|FG000|Overall Study|Other, not specified|32|||
130235951|NCT02382939|468827974|FG000|Overall Study|Adverse Event|1|||
130235952|NCT02382939|468827975|FG001|Overall Study|Adverse Event|1|||
130235953|NCT02382939|468827974|FG000|Overall Study|Withdrawal by Subject|2|||
130235954|NCT02382939|468827975|FG001|Overall Study|Withdrawal by Subject|2|||
130235955|NCT00537277|468827978|FG000|Overall Study|Adverse Event|1|||
130235956|NCT00537277|468827978|FG000|Overall Study|Lack of Efficacy|2|||
130235957|NCT00537277|468827978|FG000|Overall Study|Lost to Follow-up|12|||
130235958|NCT00537277|468827978|FG000|Overall Study|Protocol Violation|11|||
130100131|NCT03539952|468324145|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
130100132|NCT03539952|468324146|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
130100133|NCT03539952|468324145|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
130100134|NCT03539952|468324146|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
130100135|NCT03075215|468324147|FG000|12-Month Primary Endpoint|Death|152|||
130100136|NCT03075215|468324147|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
130100137|NCT03075215|468324147|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
130100138|NCT03075215|468324147|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
130100139|NCT02756182|468324148|FG000|Overall Study|StudyTechnical Difficulties|4|||
130100140|NCT01319994|468325919|FG000|Overall Study|Protocol Violation|7|||
130100141|NCT01319994|468325920|FG001|Overall Study|Protocol Violation|6|||
130100142|NCT01340794|468325921|FG000|Overall Study|Withdrawal by Subject|0|||
130100143|NCT01340794|468325922|FG001|Overall Study|Withdrawal by Subject|1|||
130100144|NCT03255226|468325930|FG000|Overall Study|Adverse Event|2|||
130100145|NCT03255226|468325930|FG000|Overall Study|Physician Decision|3|||
130100146|NCT03255226|468325930|FG000|Overall Study|Withdrawal by Subject|1|||
130235959|NCT00537277|468827978|FG000|Overall Study|Unclassified|4|||
130235960|NCT00537277|468827978|FG000|Overall Study|Inability to tolerate trial medication|4|||
130235961|NCT00537277|468827978|FG000|Overall Study|Non-compliance with trial procedures|15|||
130235962|NCT05383209|468827979|FG000|Overall Study|Adverse Event: Non-ocular|0|||
130235963|NCT05383209|468827980|FG001|Overall Study|Adverse Event: Non-ocular|1|||
130235964|NCT05383209|468827981|FG002|Overall Study|Adverse Event: Non-ocular|0|||
130235965|NCT05383209|468827979|FG000|Overall Study|Lost to Follow-up|2|||
130235966|NCT05383209|468827980|FG001|Overall Study|Lost to Follow-up|1|||
130235967|NCT05383209|468827981|FG002|Overall Study|Lost to Follow-up|4|||
130235968|NCT05383209|468827979|FG000|Overall Study|Withdrawal by Subject|2|||
130235969|NCT05383209|468827980|FG001|Overall Study|Withdrawal by Subject|0|||
130235970|NCT05383209|468827981|FG002|Overall Study|Withdrawal by Subject|1|||
130235971|NCT05383209|468827979|FG000|Overall Study|Death|1|||
130235972|NCT05383209|468827980|FG001|Overall Study|Death|0|||
130235973|NCT05383209|468827981|FG002|Overall Study|Death|0|||
130235974|NCT05383209|468827979|FG000|Overall Study|Other|0|||
130235975|NCT05383209|468827980|FG001|Overall Study|Other|1|||
130235976|NCT05383209|468827981|FG002|Overall Study|Other|0|||
130235977|NCT00717886|468827982|FG000|Overall Study|Withdrawal by Subject|3|||
130235978|NCT00717886|468827982|FG000|Overall Study|Treatment Failure|1|||
130235979|NCT00716417|468827983|FG000|Overall Study|Adverse Event|0|||
130235980|NCT00716417|468827984|FG001|Overall Study|Adverse Event|0|||
130235981|NCT00716417|468827985|FG002|Overall Study|Adverse Event|2|||
130235982|NCT00716417|468827986|FG003|Overall Study|Adverse Event|1|||
130235983|NCT00716417|468827987|FG004|Overall Study|Adverse Event|0|||
130235984|NCT00716417|468827988|FG005|Overall Study|Adverse Event|0|||
130235985|NCT00716417|468827989|FG006|Overall Study|Adverse Event|3|||
130235986|NCT00716417|468827990|FG007|Overall Study|Adverse Event|1|||
130235987|NCT00716417|468827991|FG008|Overall Study|Adverse Event|0|||
130235988|NCT00716417|468827992|FG009|Overall Study|Adverse Event|3|||
130235989|NCT00716417|468827983|FG000|Overall Study|Withdrawal by Subject|0|||
130235990|NCT00716417|468827984|FG001|Overall Study|Withdrawal by Subject|1|||
130235991|NCT00716417|468827985|FG002|Overall Study|Withdrawal by Subject|0|||
130235992|NCT00716417|468827986|FG003|Overall Study|Withdrawal by Subject|2|||
130235993|NCT00716417|468827987|FG004|Overall Study|Withdrawal by Subject|0|||
130235994|NCT00716417|468827988|FG005|Overall Study|Withdrawal by Subject|0|||
130235995|NCT00716417|468827989|FG006|Overall Study|Withdrawal by Subject|1|||
130235996|NCT00716417|468827990|FG007|Overall Study|Withdrawal by Subject|0|||
130235997|NCT00716417|468827991|FG008|Overall Study|Withdrawal by Subject|0|||
130235998|NCT00716417|468827992|FG009|Overall Study|Withdrawal by Subject|0|||
130235999|NCT00716417|468827983|FG000|Overall Study|Progressive disease|3|||
130236000|NCT00716417|468827984|FG001|Overall Study|Progressive disease|5|||
130236001|NCT00716417|468827985|FG002|Overall Study|Progressive disease|3|||
130236002|NCT00716417|468827986|FG003|Overall Study|Progressive disease|8|||
130236003|NCT00716417|468827987|FG004|Overall Study|Progressive disease|0|||
130236004|NCT00716417|468827988|FG005|Overall Study|Progressive disease|3|||
130236005|NCT00716417|468827989|FG006|Overall Study|Progressive disease|3|||
130236006|NCT00716417|468827990|FG007|Overall Study|Progressive disease|1|||
130236007|NCT00716417|468827991|FG008|Overall Study|Progressive disease|5|||
130236008|NCT00716417|468827992|FG009|Overall Study|Progressive disease|0|||
130236009|NCT00716417|468827983|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
130236010|NCT00716417|468827984|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
130236011|NCT00716417|468827985|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
130236012|NCT00716417|468827986|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
130236013|NCT00716417|468827987|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
130236014|NCT00716417|468827988|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
130236015|NCT00716417|468827989|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
130236016|NCT00716417|468827990|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
130236017|NCT00716417|468827991|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
130236018|NCT00716417|468827992|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
130236019|NCT00716417|468827983|FG000|Overall Study|On patient request due to toxicities|0|||
130236020|NCT00716417|468827984|FG001|Overall Study|On patient request due to toxicities|0|||
130236021|NCT00716417|468827985|FG002|Overall Study|On patient request due to toxicities|0|||
130236022|NCT00716417|468827986|FG003|Overall Study|On patient request due to toxicities|0|||
130236023|NCT00716417|468827987|FG004|Overall Study|On patient request due to toxicities|0|||
130236024|NCT00716417|468827988|FG005|Overall Study|On patient request due to toxicities|0|||
130236025|NCT00716417|468827989|FG006|Overall Study|On patient request due to toxicities|0|||
130236026|NCT00716417|468827990|FG007|Overall Study|On patient request due to toxicities|1|||
130236027|NCT00716417|468827991|FG008|Overall Study|On patient request due to toxicities|0|||
130236028|NCT00716417|468827992|FG009|Overall Study|On patient request due to toxicities|0|||
130236029|NCT01369433|468827993|FG000|Overall Study|Adverse Event|31|||
130236030|NCT01369433|468827994|FG001|Overall Study|Adverse Event|1|||
130236031|NCT01369433|468827993|FG000|Overall Study|Required significant surgical procedure|1|||
130236032|NCT01369433|468827994|FG001|Overall Study|Required significant surgical procedure|0|||
130236033|NCT01369433|468827993|FG000|Overall Study|Non-compliance|1|||
130236034|NCT01369433|468827994|FG001|Overall Study|Non-compliance|0|||
130236035|NCT01369433|468827993|FG000|Overall Study|Withdrawal by Subject|5|||
130236036|NCT01369433|468827994|FG001|Overall Study|Withdrawal by Subject|2|||
130236037|NCT01369433|468827993|FG000|Overall Study|Study terminated by Sponsor|67|||
130236038|NCT01369433|468827994|FG001|Overall Study|Study terminated by Sponsor|0|||
130236039|NCT01369433|468827993|FG000|Overall Study|Lost to Follow-up|1|||
130236040|NCT01369433|468827994|FG001|Overall Study|Lost to Follow-up|0|||
130236041|NCT01369433|468827993|FG000|Overall Study|Death|5|||
130236042|NCT01369433|468827994|FG001|Overall Study|Death|0|||
130236043|NCT01369433|468827993|FG000|Overall Study|Investigator discretion|6|||
130236044|NCT01369433|468827994|FG001|Overall Study|Investigator discretion|1|||
130236045|NCT01369433|468827993|FG000|Overall Study|Progressive Disease|92|||
130236046|NCT01369433|468827994|FG001|Overall Study|Progressive Disease|12|||
130236047|NCT01553851|468827995|FG000|Overall Study|Adverse Event|2|||
130236048|NCT01553851|468827995|FG000|Overall Study|constipation|1|||
130236049|NCT01838876|468827997|FG000|Overall Study|Adverse Event|49|||
130236050|NCT01838876|468827997|FG000|Overall Study|Insufficient Therapeutic Response|10|||
130236051|NCT01838876|468827997|FG000|Overall Study|Protocol Violation|34|||
130236052|NCT01838876|468827997|FG000|Overall Study|Withdrawal of Consent|33|||
130236053|NCT01838876|468827997|FG000|Overall Study|Lost to Follow-up|21|||
130236054|NCT01838876|468827997|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
130236055|NCT01838876|468827997|FG000|Overall Study|Reason not Specified|7|||
130236056|NCT01838876|468827997|FG000|Overall Study|Did not meet eligibility criteria|78|||
130236057|NCT02101294|468827998|FG000|Overall Study|Withdrawal by Subject|5|||
130236058|NCT02101294|468827998|FG000|Overall Study|Lost to Follow-up|6|||
130236059|NCT02755090|468828004|FG000|Overall Study|equipment malfunction|1|||
130236060|NCT02755090|468828005|FG001|Overall Study|equipment malfunction|0|||
130236061|NCT00207740|468828009|FG000|Overall Study|Adverse Event|4|||
130236062|NCT00207740|468828010|FG001|Overall Study|Adverse Event|14|||
130236063|NCT00207740|468828011|FG002|Overall Study|Adverse Event|14|||
130236064|NCT00207740|468828012|FG003|Overall Study|Adverse Event|11|||
130236065|NCT00207740|468828009|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130236066|NCT00207740|468828010|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130236067|NCT00207740|468828011|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130236068|NCT00207740|468828012|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
130236069|NCT00207740|468828009|FG000|Overall Study|Lost to Follow-up|0|||
130236070|NCT00207740|468828010|FG001|Overall Study|Lost to Follow-up|2|||
130236071|NCT00207740|468828011|FG002|Overall Study|Lost to Follow-up|1|||
130236072|NCT00207740|468828012|FG003|Overall Study|Lost to Follow-up|1|||
130236073|NCT00207740|468828009|FG000|Overall Study|Death|0|||
130236074|NCT00207740|468828010|FG001|Overall Study|Death|0|||
130236075|NCT00207740|468828011|FG002|Overall Study|Death|0|||
130236076|NCT00207740|468828012|FG003|Overall Study|Death|1|||
130236077|NCT00207740|468828009|FG000|Overall Study|Sponsor Directive|22|||
130236078|NCT00207740|468828010|FG001|Overall Study|Sponsor Directive|15|||
130236079|NCT00207740|468828011|FG002|Overall Study|Sponsor Directive|16|||
130236080|NCT00207740|468828012|FG003|Overall Study|Sponsor Directive|21|||
130236081|NCT00207740|468828009|FG000|Overall Study|Other|2|||
130236082|NCT00207740|468828010|FG001|Overall Study|Other|10|||
130236083|NCT00207740|468828011|FG002|Overall Study|Other|7|||
130236084|NCT00207740|468828012|FG003|Overall Study|Other|5|||
130236085|NCT00390013|468828013|FG000|Phase 1|tired|0|||
130236086|NCT00390013|468828014|FG001|Phase 1|tired|0|||
130236087|NCT00390013|468828015|FG002|Phase 1|tired|0|||
130236088|NCT00390013|468828016|FG003|Phase 1|tired|1|||
130236089|NCT00390013|468828013|FG000|Phase 2 First Treatment|tired|1|||
130236090|NCT00390013|468828014|FG001|Phase 2 First Treatment|tired|0|||
130236091|NCT00390013|468828015|FG002|Phase 2 First Treatment|tired|0|||
130236092|NCT00390013|468828016|FG003|Phase 2 First Treatment|tired|0|||
130236093|NCT00390013|468828013|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
130236094|NCT00390013|468828014|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
130236095|NCT00390013|468828015|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
130236096|NCT00390013|468828016|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
130236097|NCT00924898|468828022|FG000|Overall Study|Withdrawal by Subject|2|||
130236098|NCT00294658|468828023|FG000|Overall Study|Death|0|||
130236099|NCT00294658|468828024|FG001|Overall Study|Death|1|||
130236100|NCT00294658|468828023|FG000|Overall Study|Lost to Follow-up|4|||
130236101|NCT00294658|468828024|FG001|Overall Study|Lost to Follow-up|0|||
130236102|NCT00294658|468828023|FG000|Overall Study|Physician Decision|1|||
130236103|NCT00294658|468828024|FG001|Overall Study|Physician Decision|2|||
130236104|NCT00294658|468828023|FG000|Overall Study|Pregnancy|0|||
130236105|NCT00294658|468828024|FG001|Overall Study|Pregnancy|1|||
130236106|NCT00294658|468828023|FG000|Overall Study|Withdrawal by Subject|0|||
130236107|NCT00294658|468828024|FG001|Overall Study|Withdrawal by Subject|4|||
130236108|NCT00294658|468828023|FG000|Overall Study|Found to have invasive thymoma|1|||
130236109|NCT00294658|468828024|FG001|Overall Study|Found to have invasive thymoma|0|||
130236110|NCT00294658|468828023|FG000|Overall Study|Patient and family were not satisfied|0|||
130236111|NCT00294658|468828024|FG001|Overall Study|Patient and family were not satisfied|1|||
130236112|NCT01910441|468828025|FG000|Overall Study|Sponsor decision|0|||
130236113|NCT01910441|468828026|FG001|Overall Study|Sponsor decision|2|||
130236114|NCT01910441|468828025|FG000|Overall Study|Lost to Follow-up|6|||
130236115|NCT01910441|468828026|FG001|Overall Study|Lost to Follow-up|5|||
130236116|NCT01910441|468828025|FG000|Overall Study|Withdrawal by Subject|0|||
130236117|NCT01910441|468828026|FG001|Overall Study|Withdrawal by Subject|1|||
130236118|NCT01910441|468828025|FG000|Overall Study|Non-compliance|0|||
130236119|NCT01910441|468828026|FG001|Overall Study|Non-compliance|1|||
130236120|NCT01910441|468828025|FG000|Overall Study|Adverse Event|1|||
130236121|NCT01910441|468828026|FG001|Overall Study|Adverse Event|0|||
130236122|NCT01910441|468828025|FG000|Overall Study|Physician Decision|0|||
130236123|NCT01910441|468828026|FG001|Overall Study|Physician Decision|1|||
130236124|NCT01811238|468828027|FG000|Overall Study|Withdrawal by Subject|42|||
130236125|NCT01811238|468828027|FG000|Overall Study|Adverse Event|25|||
130236126|NCT01811238|468828027|FG000|Overall Study|Protocol Violation|4|||
130236127|NCT01811238|468828027|FG000|Overall Study|Lack of Efficacy|4|||
130236128|NCT01811238|468828027|FG000|Overall Study|subject refused study medication|6|||
130236129|NCT02340949|468828028|FG000|Overall Study|Adverse Event|4|||
130236130|NCT02340949|468828029|FG001|Overall Study|Adverse Event|2|||
130236131|NCT02340949|468828028|FG000|Overall Study|Withdrawal by Subject|2|||
130236132|NCT02340949|468828029|FG001|Overall Study|Withdrawal by Subject|0|||
130236133|NCT02340949|468828028|FG000|Overall Study|Progression disease|6|||
130236134|NCT02340949|468828029|FG001|Overall Study|Progression disease|2|||
130236135|NCT02340949|468828028|FG000|Overall Study|Death|3|||
130236136|NCT02340949|468828029|FG001|Overall Study|Death|0|||
130236137|NCT02340949|468828028|FG000|Overall Study|Physician Decision|1|||
130236138|NCT02340949|468828029|FG001|Overall Study|Physician Decision|0|||
130236139|NCT01192178|468828030|FG000|Overall Study|Withdrawal by Subject|6|||
130236140|NCT01192178|468828031|FG001|Overall Study|Withdrawal by Subject|10|||
130236141|NCT01192178|468828030|FG000|Overall Study|Protocol Violation|10|||
130236142|NCT01192178|468828031|FG001|Overall Study|Protocol Violation|3|||
130236143|NCT01192178|468828030|FG000|Overall Study|Physician Decision|2|||
130236144|NCT01192178|468828031|FG001|Overall Study|Physician Decision|4|||
130236145|NCT01192178|468828030|FG000|Overall Study|Lost to Follow-up|3|||
130236146|NCT01192178|468828031|FG001|Overall Study|Lost to Follow-up|3|||
130236147|NCT01192178|468828030|FG000|Overall Study|Adverse Event|2|||
130236148|NCT01192178|468828031|FG001|Overall Study|Adverse Event|1|||
130236149|NCT01192178|468828030|FG000|Overall Study|Lack of Efficacy|1|||
130236150|NCT01192178|468828031|FG001|Overall Study|Lack of Efficacy|2|||
130236151|NCT01155570|468828032|FG000|Overall Study|Adverse Event|39|||
130236152|NCT01155570|468828032|FG000|Overall Study|Lack of Efficacy|46|||
130236153|NCT01155570|468828032|FG000|Overall Study|Participant's Economic Reasons|17|||
130236154|NCT01155570|468828032|FG000|Overall Study|No Hospital Visits|7|||
130236155|NCT01155570|468828032|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
130236156|NCT01155570|468828032|FG000|Overall Study|Adverse Event + Other Reasons|7|||
130236157|NCT01155570|468828032|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
130236158|NCT01155570|468828032|FG000|Overall Study|Other Reasons|23|||
130236159|NCT00296517|468828033|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
130236160|NCT00296517|468828034|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
130236161|NCT00296517|468828033|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
130236162|NCT00296517|468828034|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
130236163|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
130236164|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
130236165|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
130236166|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
130236167|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
130236168|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
130236169|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
130236170|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
130236171|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
130236172|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
130236173|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
130236174|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
130236175|NCT00296517|468828033|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
130236176|NCT00296517|468828034|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
130236177|NCT04584788|468828053|FG000|Overall Study|Physician Decision|8|||
130236178|NCT04584788|468828053|FG000|Overall Study|Withdrawal by Subject|1|||
130236179|NCT04584788|468828053|FG000|Overall Study|Adverse Event|3|||
130316133|NCT02079740|469124298|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316134|NCT02079740|469124299|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316135|NCT02079740|469124300|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316136|NCT02079740|469124301|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316137|NCT02079740|469124302|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316138|NCT02079740|469124303|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316139|NCT02079740|469124304|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316140|NCT02079740|469124305|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316141|NCT02079740|469124306|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316142|NCT02079740|469124307|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
130316143|NCT02079740|469124308|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
130316144|NCT02079740|469124309|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
130316145|NCT02079740|469124310|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
130316146|NCT03493945|469124311|FG000|Phase I Dose Escalation|Ineligible|0|||
130316147|NCT03493945|469124312|FG001|Phase I Dose Escalation|Ineligible|0|||
130316148|NCT03493945|469124313|FG002|Phase I Dose Escalation|Ineligible|1|||
130316149|NCT03493945|469124314|FG003|Phase I Dose Escalation|Ineligible|0|||
130316150|NCT03493945|469124315|FG004|Phase I Dose Escalation|Ineligible|0|||
130316151|NCT03493945|469124316|FG005|Phase I Dose Escalation|Ineligible|0|||
130316152|NCT03493945|469124317|FG006|Phase I Dose Escalation|Ineligible|0|||
130316153|NCT03493945|469124311|FG000|Phase I Dose Escalation|New therapy|0|||
130316154|NCT03493945|469124312|FG001|Phase I Dose Escalation|New therapy|1|||
130316155|NCT03493945|469124313|FG002|Phase I Dose Escalation|New therapy|0|||
130316156|NCT03493945|469124314|FG003|Phase I Dose Escalation|New therapy|0|||
130316157|NCT03493945|469124315|FG004|Phase I Dose Escalation|New therapy|0|||
130316158|NCT03493945|469124316|FG005|Phase I Dose Escalation|New therapy|0|||
130316159|NCT03493945|469124317|FG006|Phase I Dose Escalation|New therapy|0|||
130316160|NCT03493945|469124311|FG000|Phase II Dose Expansion|Refused further treatment|0|||
130316161|NCT03493945|469124312|FG001|Phase II Dose Expansion|Refused further treatment|0|||
130316162|NCT03493945|469124313|FG002|Phase II Dose Expansion|Refused further treatment|0|||
130316163|NCT03493945|469124314|FG003|Phase II Dose Expansion|Refused further treatment|0|||
130316164|NCT03493945|469124315|FG004|Phase II Dose Expansion|Refused further treatment|1|||
130316165|NCT03493945|469124316|FG005|Phase II Dose Expansion|Refused further treatment|1|||
130316166|NCT03493945|469124317|FG006|Phase II Dose Expansion|Refused further treatment|0|||
130316167|NCT03493945|469124311|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316168|NCT03493945|469124312|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316169|NCT03493945|469124313|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316170|NCT03493945|469124314|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
130316171|NCT03493945|469124315|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316172|NCT03493945|469124316|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316173|NCT03493945|469124317|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
130316174|NCT01690052|469124322|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
130316175|NCT01690052|469124323|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
130316176|NCT02421172|469124324|FG000|Period 1|Adverse Event|1|||
130316177|NCT02421172|469124325|FG001|Period 1|Adverse Event|0|||
130316178|NCT02421172|469124326|FG002|Period 1|Adverse Event|0|||
130316179|NCT02421172|469124327|FG003|Period 1|Adverse Event|0|||
130316180|NCT02421172|469124328|FG004|Period 1|Adverse Event|0|||
130316181|NCT02421172|469124324|FG000|Period 1|Lost to Follow-up|3|||
130316182|NCT02421172|469124325|FG001|Period 1|Lost to Follow-up|1|||
130316183|NCT02421172|469124326|FG002|Period 1|Lost to Follow-up|0|||
130316184|NCT02421172|469124327|FG003|Period 1|Lost to Follow-up|0|||
130316185|NCT02421172|469124328|FG004|Period 1|Lost to Follow-up|0|||
130316186|NCT02421172|469124324|FG000|Period 1|Patient/guardian decision|0|||
130316187|NCT02421172|469124325|FG001|Period 1|Patient/guardian decision|1|||
130316188|NCT02421172|469124326|FG002|Period 1|Patient/guardian decision|0|||
130316189|NCT02421172|469124327|FG003|Period 1|Patient/guardian decision|0|||
130316190|NCT02421172|469124328|FG004|Period 1|Patient/guardian decision|0|||
129884552|NCT03012061|467536450|FG000|Overall Study|Adverse Event|2|||
130316191|NCT02421172|469124324|FG000|Period 2|Adverse Event|0|||
130316192|NCT02421172|469124325|FG001|Period 2|Adverse Event|0|||
130316193|NCT02421172|469124326|FG002|Period 2|Adverse Event|4|||
130316194|NCT02421172|469124327|FG003|Period 2|Adverse Event|0|||
130316195|NCT02421172|469124328|FG004|Period 2|Adverse Event|0|||
130316196|NCT02421172|469124324|FG000|Period 2|Lost to Follow-up|0|||
130316197|NCT02421172|469124325|FG001|Period 2|Lost to Follow-up|0|||
130236180|NCT03095287|468829731|FG000|Overall Study|Treatment Failure|1|||
130236181|NCT03095287|468829731|FG000|Overall Study|Adverse Event|1|||
130236182|NCT02394275|468829734|FG000|Overall Study|Adverse Event|22|||
130236183|NCT02394275|468829734|FG000|Overall Study|Lost to Follow-up|7|||
130236184|NCT04757636|468829740|FG000|Overall Study|Adverse Event|25|||
130236185|NCT04757636|468829741|FG001|Overall Study|Adverse Event|8|||
130236186|NCT04757636|468829742|FG002|Overall Study|Adverse Event|11|||
130236187|NCT04757636|468829740|FG000|Overall Study|Death|9|||
130236188|NCT04757636|468829741|FG001|Overall Study|Death|12|||
130236189|NCT04757636|468829742|FG002|Overall Study|Death|6|||
130236190|NCT04757636|468829740|FG000|Overall Study|Lack of Efficacy|2|||
130236191|NCT04757636|468829741|FG001|Overall Study|Lack of Efficacy|0|||
130236192|NCT04757636|468829742|FG002|Overall Study|Lack of Efficacy|0|||
130236193|NCT04757636|468829740|FG000|Overall Study|Lost to Follow-up|1|||
130236194|NCT04757636|468829741|FG001|Overall Study|Lost to Follow-up|6|||
130236195|NCT04757636|468829742|FG002|Overall Study|Lost to Follow-up|7|||
130236196|NCT04757636|468829740|FG000|Overall Study|Physician Decision|1|||
130236197|NCT04757636|468829741|FG001|Overall Study|Physician Decision|3|||
130236198|NCT04757636|468829742|FG002|Overall Study|Physician Decision|4|||
130236199|NCT04757636|468829740|FG000|Overall Study|Withdrawal by Subject|20|||
130236200|NCT04757636|468829741|FG001|Overall Study|Withdrawal by Subject|23|||
130236201|NCT04757636|468829742|FG002|Overall Study|Withdrawal by Subject|18|||
130236202|NCT04757636|468829740|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
130236203|NCT04757636|468829741|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
130236204|NCT04757636|468829742|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
130236205|NCT04757636|468829740|FG000|Overall Study|Study Terminated by Sponsor|103|||
130236206|NCT04757636|468829741|FG001|Overall Study|Study Terminated by Sponsor|104|||
130236207|NCT04757636|468829742|FG002|Overall Study|Study Terminated by Sponsor|114|||
130236208|NCT04757636|468829740|FG000|Overall Study|Sponsor Decision|0|||
130236209|NCT04757636|468829741|FG001|Overall Study|Sponsor Decision|0|||
130236210|NCT04757636|468829742|FG002|Overall Study|Sponsor Decision|1|||
130236211|NCT04757636|468829740|FG000|Overall Study|Randomized in Error|0|||
130236212|NCT04757636|468829741|FG001|Overall Study|Randomized in Error|0|||
130236213|NCT04757636|468829742|FG002|Overall Study|Randomized in Error|2|||
130236214|NCT05350423|468829748|FG000|Overall Study|Lost to Follow-up|3|||
130026079|NCT03604445|468055871|FG005|Overall Study|Death|0|||
130026080|NCT03604445|468055872|FG006|Overall Study|Death|0|||
130026081|NCT03604445|468055873|FG007|Overall Study|Death|0|||
130026082|NCT03604445|468055874|FG008|Overall Study|Death|1|||
130026083|NCT03604445|468055866|FG000|Overall Study|Withdrawal by Subject|0|||
130236215|NCT05350423|468829749|FG001|Overall Study|Lost to Follow-up|3|||
130236216|NCT05350423|468829748|FG000|Overall Study|screen failure|5|||
130236217|NCT05350423|468829749|FG001|Overall Study|screen failure|6|||
130236218|NCT02097277|468829750|FG000|Overall Study|Subject no longer meets study criteria|0|||
130236219|NCT02097277|468829751|FG001|Overall Study|Subject no longer meets study criteria|1|||
130236220|NCT02097277|468829752|FG002|Overall Study|Subject no longer meets study criteria|0|||
130236221|NCT02097277|468829753|FG003|Overall Study|Subject no longer meets study criteria|1|||
130026084|NCT03604445|468055867|FG001|Overall Study|Withdrawal by Subject|0|||
130236222|NCT02097277|468829754|FG004|Overall Study|Subject no longer meets study criteria|0|||
130236223|NCT02097277|468829750|FG000|Overall Study|Subject request to discontinue treatment|0|||
130236224|NCT02097277|468829751|FG001|Overall Study|Subject request to discontinue treatment|0|||
130026085|NCT03604445|468055868|FG002|Overall Study|Withdrawal by Subject|0|||
130026086|NCT03604445|468055869|FG003|Overall Study|Withdrawal by Subject|0|||
130236225|NCT02097277|468829752|FG002|Overall Study|Subject request to discontinue treatment|0|||
130236226|NCT02097277|468829753|FG003|Overall Study|Subject request to discontinue treatment|0|||
130236227|NCT02097277|468829754|FG004|Overall Study|Subject request to discontinue treatment|1|||
130236228|NCT02097277|468829750|FG000|Overall Study|Lost to Follow-up|0|||
130236229|NCT02097277|468829751|FG001|Overall Study|Lost to Follow-up|1|||
130236230|NCT02097277|468829752|FG002|Overall Study|Lost to Follow-up|1|||
130236231|NCT02097277|468829753|FG003|Overall Study|Lost to Follow-up|0|||
130236232|NCT02097277|468829754|FG004|Overall Study|Lost to Follow-up|0|||
130236233|NCT02097277|468829750|FG000|Overall Study|Withdrawal by Subject|2|||
130236234|NCT02097277|468829751|FG001|Overall Study|Withdrawal by Subject|1|||
130236235|NCT02097277|468829752|FG002|Overall Study|Withdrawal by Subject|0|||
130236236|NCT02097277|468829753|FG003|Overall Study|Withdrawal by Subject|1|||
130236237|NCT02097277|468829754|FG004|Overall Study|Withdrawal by Subject|0|||
130236238|NCT02097277|468829750|FG000|Overall Study|Adverse Event|0|||
130236239|NCT02097277|468829751|FG001|Overall Study|Adverse Event|0|||
130236240|NCT02097277|468829752|FG002|Overall Study|Adverse Event|1|||
130236241|NCT02097277|468829753|FG003|Overall Study|Adverse Event|2|||
130236242|NCT02097277|468829754|FG004|Overall Study|Adverse Event|0|||
130236243|NCT01091259|468829757|FG000|Overall Study|Adverse Event|3|||
130236244|NCT01091259|468829757|FG000|Overall Study|Lack of Efficacy|2|||
130236245|NCT00671060|468829760|FG000|Overall Study|Protocol Violation|1|||
130236246|NCT00671060|468829761|FG001|Overall Study|Protocol Violation|0|||
130100147|NCT03255226|468325930|FG000|Overall Study|Serum or blood sodium increased|4|||
130236247|NCT00671060|468829760|FG000|Overall Study|Physician Decision|0|||
130236248|NCT00671060|468829761|FG001|Overall Study|Physician Decision|1|||
130236249|NCT06057064|468829762|FG000|Overall Study|Death|2|||
130236250|NCT06057064|468829763|FG001|Overall Study|Death|0|||
130236251|NCT06057064|468829762|FG000|Overall Study|Physician Decision|1|||
130236252|NCT06057064|468829763|FG001|Overall Study|Physician Decision|0|||
130236253|NCT06057064|468829762|FG000|Overall Study|Withdrawal by Subject|1|||
130236254|NCT06057064|468829763|FG001|Overall Study|Withdrawal by Subject|1|||
130236255|NCT01541748|468829764|FG000|Overall Study|Lost to Follow-up|17|||
130236256|NCT01541748|468829764|FG000|Overall Study|Moved out of state|1|||
130236257|NCT01541748|468829764|FG000|Overall Study|Withdrawal by Subject|7|||
130236258|NCT01541748|468829764|FG000|Overall Study|Screen failure|5|||
130236259|NCT01541748|468829764|FG000|Overall Study|Did not receive study device|1|||
130236260|NCT02832037|468829765|FG000|Overall Study|Administrative reasons|0|||
130236261|NCT02832037|468829766|FG001|Overall Study|Administrative reasons|0|||
130236262|NCT02832037|468829767|FG002|Overall Study|Administrative reasons|1|||
130236263|NCT02832037|468829768|FG003|Overall Study|Administrative reasons|0|||
130236264|NCT02832037|468829769|FG004|Overall Study|Administrative reasons|0|||
130236265|NCT02832037|468829765|FG000|Overall Study|Protocol Violation|3|||
130236266|NCT02832037|468829766|FG001|Overall Study|Protocol Violation|0|||
130100148|NCT03255226|468325930|FG000|Overall Study|Serum or blood potassium increased|4|||
130236267|NCT02832037|468829767|FG002|Overall Study|Protocol Violation|4|||
130236268|NCT02832037|468829768|FG003|Overall Study|Protocol Violation|1|||
130236269|NCT02832037|468829769|FG004|Overall Study|Protocol Violation|2|||
130236270|NCT02832037|468829765|FG000|Overall Study|Lost to Follow-up|2|||
130236271|NCT02832037|468829766|FG001|Overall Study|Lost to Follow-up|0|||
130236272|NCT02832037|468829767|FG002|Overall Study|Lost to Follow-up|3|||
130236273|NCT02832037|468829768|FG003|Overall Study|Lost to Follow-up|0|||
130236274|NCT02832037|468829769|FG004|Overall Study|Lost to Follow-up|5|||
130236275|NCT02832037|468829765|FG000|Overall Study|Withdrawal by Subject|9|||
130236276|NCT02832037|468829766|FG001|Overall Study|Withdrawal by Subject|8|||
130236277|NCT02832037|468829767|FG002|Overall Study|Withdrawal by Subject|0|||
130236278|NCT02832037|468829768|FG003|Overall Study|Withdrawal by Subject|4|||
130236279|NCT02832037|468829769|FG004|Overall Study|Withdrawal by Subject|8|||
130236280|NCT02832037|468829765|FG000|Overall Study|Adverse Event|5|||
130236281|NCT02832037|468829766|FG001|Overall Study|Adverse Event|4|||
130236282|NCT02832037|468829767|FG002|Overall Study|Adverse Event|0|||
130236283|NCT02832037|468829768|FG003|Overall Study|Adverse Event|2|||
130236284|NCT02832037|468829769|FG004|Overall Study|Adverse Event|4|||
130236285|NCT03329989|468829770|FG000|Overall Study|Withdrawal by Subject|9|||
130236286|NCT03329989|468829770|FG000|Overall Study|Lost to Follow-up|8|||
130236287|NCT03329989|468829770|FG000|Overall Study|Adverse Event|5|||
130236288|NCT03329989|468829770|FG000|Overall Study|Protocol Violation|1|||
130236289|NCT00435942|468829773|FG000|Overall Study|Death|17|||
130236290|NCT00435942|468829774|FG001|Overall Study|Death|10|||
130236291|NCT00435942|468829773|FG000|Overall Study|Withdrawal by Subject|2|||
130236292|NCT00435942|468829774|FG001|Overall Study|Withdrawal by Subject|0|||
130236293|NCT00435942|468829773|FG000|Overall Study|Lost to Follow-up|0|||
130236294|NCT00435942|468829774|FG001|Overall Study|Lost to Follow-up|16|||
130236295|NCT00435942|468829773|FG000|Overall Study|Conversion to Open Repair|1|||
130236296|NCT00435942|468829774|FG001|Overall Study|Conversion to Open Repair|0|||
130236297|NCT00435942|468829773|FG000|Overall Study|Technical Failure|3|||
130236298|NCT00435942|468829774|FG001|Overall Study|Technical Failure|0|||
130236299|NCT00435942|468829773|FG000|Overall Study|Other|0|||
130236300|NCT00435942|468829774|FG001|Overall Study|Other|1|||
130236301|NCT04491994|468829775|FG000|Overall Study|Withdrawal by Subject|10|||
130236302|NCT04491994|468829776|FG001|Overall Study|Withdrawal by Subject|5|||
130236303|NCT04491994|468829775|FG000|Overall Study|developed fever > 3 days|4|||
130236304|NCT04491994|468829776|FG001|Overall Study|developed fever > 3 days|1|||
130236305|NCT04491994|468829775|FG000|Overall Study|Protocol Violation|11|||
130236306|NCT04491994|468829776|FG001|Overall Study|Protocol Violation|2|||
130236307|NCT04491994|468829775|FG000|Overall Study|Lost to Follow-up|4|||
130236308|NCT04491994|468829776|FG001|Overall Study|Lost to Follow-up|3|||
130236309|NCT04167462|468829784|FG000|Overall Study|Other reasons|3|||
130236310|NCT04167462|468829785|FG001|Overall Study|Other reasons|2|||
130236311|NCT04167462|468829784|FG000|Overall Study|Withdrawal by Subject|6|||
130236312|NCT04167462|468829785|FG001|Overall Study|Withdrawal by Subject|7|||
130236313|NCT04167462|468829784|FG000|Overall Study|Adverse Event|4|||
130236314|NCT04167462|468829785|FG001|Overall Study|Adverse Event|0|||
130236315|NCT04167462|468829784|FG000|Overall Study|Pregnancy|1|||
130236316|NCT04167462|468829785|FG001|Overall Study|Pregnancy|0|||
130236317|NCT04167462|468829784|FG000|Overall Study|Lack of Efficacy|0|||
130236318|NCT04167462|468829785|FG001|Overall Study|Lack of Efficacy|1|||
130236319|NCT03881371|468829790|FG000|Overall Study|Adverse Event|8|||
130236320|NCT03881371|468829791|FG001|Overall Study|Adverse Event|9|||
130236321|NCT03881371|468829790|FG000|Overall Study|Death|1|||
130236322|NCT03881371|468829791|FG001|Overall Study|Death|0|||
130236323|NCT03881371|468829790|FG000|Overall Study|Lost to Follow-up|1|||
130236324|NCT03881371|468829791|FG001|Overall Study|Lost to Follow-up|0|||
130236325|NCT03881371|468829790|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130236326|NCT03881371|468829791|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130236327|NCT03881371|468829790|FG000|Overall Study|Physician Decision|3|||
130236328|NCT03881371|468829791|FG001|Overall Study|Physician Decision|3|||
130236329|NCT03881371|468829790|FG000|Overall Study|Withdrawal by Subject|2|||
130236330|NCT03881371|468829791|FG001|Overall Study|Withdrawal by Subject|10|||
130236331|NCT03881371|468829790|FG000|Overall Study|Discontinuation from Study|1|||
130236332|NCT03881371|468829791|FG001|Overall Study|Discontinuation from Study|0|||
130236333|NCT00933933|468829795|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
130236334|NCT00933933|468829796|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
130236335|NCT00933933|468829797|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
130236336|NCT00933933|468829795|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
130236337|NCT00933933|468829796|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
130236338|NCT00933933|468829797|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
130236339|NCT01138046|468829798|FG000|Overall Study|Withdrawal due to death|6|||
130236340|NCT02178956|468829799|FG000|Overall Study|Lost to Follow-up|4|||
130236341|NCT02178956|468829800|FG001|Overall Study|Lost to Follow-up|4|||
130236342|NCT02178956|468829799|FG000|Overall Study|Sponsor terminated study|49|||
130236343|NCT02178956|468829800|FG001|Overall Study|Sponsor terminated study|58|||
130236344|NCT02178956|468829799|FG000|Overall Study|Withdrawal by Subject|15|||
130236345|NCT02178956|468829800|FG001|Overall Study|Withdrawal by Subject|11|||
130236346|NCT02178956|468829799|FG000|Overall Study|Various Reasons|3|||
130236347|NCT02178956|468829800|FG001|Overall Study|Various Reasons|5|||
130236348|NCT01900314|468829801|FG000|Overall Study|Lost to Follow-up|1|||
130236349|NCT01900314|468829802|FG001|Overall Study|Lost to Follow-up|0|||
130236350|NCT01900314|468829801|FG000|Overall Study|Protocol Violation|0|||
130236351|NCT01900314|468829802|FG001|Overall Study|Protocol Violation|1|||
130236352|NCT01900314|468829801|FG000|Overall Study|Withdrawal by Subject|3|||
130236353|NCT01900314|468829802|FG001|Overall Study|Withdrawal by Subject|3|||
130236354|NCT04225832|468829803|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
130236355|NCT04225832|468829804|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
130236356|NCT04225832|468829803|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
130236357|NCT04225832|468829804|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
130236358|NCT03282097|468829805|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
130236359|NCT03282097|468829806|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
130236360|NCT03282097|468829805|FG000|Intervention Visit Complete|Patient Death|13|||
130236361|NCT03282097|468829806|FG001|Intervention Visit Complete|Patient Death|15|||
130236362|NCT03282097|468829805|FG000|Intervention Visit Complete|Caregiver Death|0|||
130236363|NCT03282097|468829806|FG001|Intervention Visit Complete|Caregiver Death|3|||
130236364|NCT03282097|468829805|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
130236365|NCT03282097|468829806|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
130236366|NCT03282097|468829805|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
130236367|NCT03282097|468829806|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
130236368|NCT03282097|468829805|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
130236369|NCT03282097|468829806|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
130236370|NCT03282097|468829805|FG000|Primary Outcome Data Collection Complete|Missing|2|||
130236371|NCT03282097|468829806|FG001|Primary Outcome Data Collection Complete|Missing|3|||
130236372|NCT03282097|468829805|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
130236373|NCT03282097|468829806|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
130236374|NCT03282097|468829805|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
130236375|NCT03282097|468829806|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
130236376|NCT03282097|468829805|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
130236377|NCT03282097|468829806|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
130236378|NCT06001021|468829810|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
130236379|NCT06001021|468829811|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130236380|NCT06001021|468829812|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130236381|NCT06001021|468829813|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
130236382|NCT06001021|468829814|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
130236383|NCT06001021|468829815|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
130236384|NCT06001021|468829816|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
130236385|NCT06001021|468829810|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
130236386|NCT06001021|468829811|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236387|NCT06001021|468829812|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236388|NCT06001021|468829813|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
130236389|NCT06001021|468829814|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
130236390|NCT06001021|468829815|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236391|NCT06001021|468829816|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
130236392|NCT04797169|468829817|FG000|Overall Study|Lost to Follow-up|84|||
130236393|NCT04797169|468829818|FG001|Overall Study|Lost to Follow-up|67|||
130236394|NCT04797169|468829817|FG000|Overall Study|Pregnancy|1|||
130236395|NCT04797169|468829818|FG001|Overall Study|Pregnancy|3|||
130236396|NCT04797169|468829817|FG000|Overall Study|Withdrawal by Subject|27|||
130236397|NCT04797169|468829818|FG001|Overall Study|Withdrawal by Subject|35|||
130236398|NCT03839641|468829827|FG000|Overall Study|Withdrawal by Subject|1|||
130236399|NCT03839641|468829828|FG001|Overall Study|Withdrawal by Subject|1|||
130236400|NCT02550795|468829835|FG000|Overall Study|Physician Decision|0|||
130236401|NCT02550795|468829836|FG001|Overall Study|Physician Decision|1|||
130236402|NCT02550795|468829837|FG002|Overall Study|Physician Decision|0|||
130236403|NCT00879658|468829838|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130236404|NCT00879658|468829839|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130236405|NCT00879658|468829840|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130236406|NCT00879658|468829841|FG003|Overall Study|Abnormal laboratory value(s)|1|||
130236407|NCT00879658|468829842|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130236408|NCT00879658|468829843|FG005|Overall Study|Abnormal laboratory value(s)|0|||
130236409|NCT00879658|468829844|FG006|Overall Study|Abnormal laboratory value(s)|0|||
130236410|NCT00879658|468829838|FG000|Overall Study|Administrative problems|2|||
130026087|NCT03604445|468055870|FG004|Overall Study|Withdrawal by Subject|0|||
130026088|NCT03604445|468055871|FG005|Overall Study|Withdrawal by Subject|0|||
130236411|NCT00879658|468829839|FG001|Overall Study|Administrative problems|1|||
130236412|NCT00879658|468829840|FG002|Overall Study|Administrative problems|0|||
130236413|NCT00879658|468829841|FG003|Overall Study|Administrative problems|1|||
130236414|NCT00879658|468829842|FG004|Overall Study|Administrative problems|0|||
130236415|NCT00879658|468829843|FG005|Overall Study|Administrative problems|0|||
130236416|NCT00879658|468829844|FG006|Overall Study|Administrative problems|0|||
130236417|NCT00879658|468829838|FG000|Overall Study|Adverse Event|6|||
130026089|NCT03604445|468055872|FG006|Overall Study|Withdrawal by Subject|1|||
130026090|NCT03604445|468055873|FG007|Overall Study|Withdrawal by Subject|0|||
130026091|NCT03604445|468055874|FG008|Overall Study|Withdrawal by Subject|0|||
130236418|NCT00879658|468829839|FG001|Overall Study|Adverse Event|4|||
130236419|NCT00879658|468829840|FG002|Overall Study|Adverse Event|3|||
130236420|NCT00879658|468829841|FG003|Overall Study|Adverse Event|1|||
130236421|NCT00879658|468829842|FG004|Overall Study|Adverse Event|2|||
130236422|NCT00879658|468829843|FG005|Overall Study|Adverse Event|0|||
130236423|NCT00879658|468829844|FG006|Overall Study|Adverse Event|0|||
130236424|NCT00879658|468829838|FG000|Overall Study|Protocol Violation|1|||
130236425|NCT00879658|468829839|FG001|Overall Study|Protocol Violation|0|||
130236426|NCT00879658|468829840|FG002|Overall Study|Protocol Violation|0|||
130236427|NCT00879658|468829841|FG003|Overall Study|Protocol Violation|0|||
130236428|NCT00879658|468829842|FG004|Overall Study|Protocol Violation|0|||
130236429|NCT00879658|468829843|FG005|Overall Study|Protocol Violation|0|||
130236430|NCT00879658|468829844|FG006|Overall Study|Protocol Violation|0|||
130236431|NCT00879658|468829838|FG000|Overall Study|Withdrawal by Subject|3|||
130236432|NCT00879658|468829839|FG001|Overall Study|Withdrawal by Subject|0|||
130236433|NCT00879658|468829840|FG002|Overall Study|Withdrawal by Subject|2|||
130236434|NCT00879658|468829841|FG003|Overall Study|Withdrawal by Subject|0|||
130236435|NCT00879658|468829842|FG004|Overall Study|Withdrawal by Subject|0|||
130236436|NCT00879658|468829843|FG005|Overall Study|Withdrawal by Subject|1|||
130236437|NCT00879658|468829844|FG006|Overall Study|Withdrawal by Subject|0|||
130236438|NCT00879658|468829838|FG000|Overall Study|Lack of Efficacy|0|||
130236439|NCT00879658|468829839|FG001|Overall Study|Lack of Efficacy|0|||
130236440|NCT00879658|468829840|FG002|Overall Study|Lack of Efficacy|2|||
130236441|NCT00879658|468829841|FG003|Overall Study|Lack of Efficacy|0|||
130236442|NCT00879658|468829842|FG004|Overall Study|Lack of Efficacy|0|||
130236443|NCT00879658|468829843|FG005|Overall Study|Lack of Efficacy|0|||
130236444|NCT00879658|468829844|FG006|Overall Study|Lack of Efficacy|0|||
130236445|NCT00879658|468829838|FG000|Overall Study|misrandomized (never received study med)|0|||
130236446|NCT00879658|468829839|FG001|Overall Study|misrandomized (never received study med)|0|||
130236447|NCT00879658|468829840|FG002|Overall Study|misrandomized (never received study med)|0|||
130236448|NCT00879658|468829841|FG003|Overall Study|misrandomized (never received study med)|1|||
130236449|NCT00879658|468829842|FG004|Overall Study|misrandomized (never received study med)|0|||
130236450|NCT00879658|468829843|FG005|Overall Study|misrandomized (never received study med)|0|||
130236451|NCT00879658|468829844|FG006|Overall Study|misrandomized (never received study med)|0|||
130236452|NCT00580840|468829845|FG000|Run-in|Adverse Event|17|||
130236453|NCT00580840|468829846|FG001|Run-in|Adverse Event|0|||
130236454|NCT00580840|468829847|FG002|Run-in|Adverse Event|0|||
130236455|NCT00580840|468829848|FG003|Run-in|Adverse Event|0|||
130236456|NCT00580840|468829845|FG000|Run-in|Lack of Efficacy|93|||
130236457|NCT00580840|468829846|FG001|Run-in|Lack of Efficacy|0|||
130236458|NCT00580840|468829847|FG002|Run-in|Lack of Efficacy|0|||
130236459|NCT00580840|468829848|FG003|Run-in|Lack of Efficacy|0|||
130236460|NCT00580840|468829845|FG000|Run-in|Loss of Efficacy|1|||
130236461|NCT00580840|468829846|FG001|Run-in|Loss of Efficacy|0|||
130236462|NCT00580840|468829847|FG002|Run-in|Loss of Efficacy|0|||
130236463|NCT00580840|468829848|FG003|Run-in|Loss of Efficacy|0|||
130236464|NCT00580840|468829845|FG000|Run-in|Lost to Follow-up|4|||
130236465|NCT00580840|468829846|FG001|Run-in|Lost to Follow-up|0|||
130236466|NCT00580840|468829847|FG002|Run-in|Lost to Follow-up|0|||
130236467|NCT00580840|468829848|FG003|Run-in|Lost to Follow-up|0|||
130236468|NCT00580840|468829845|FG000|Run-in|Withdrawal by Subject|5|||
130236469|NCT00580840|468829846|FG001|Run-in|Withdrawal by Subject|0|||
130236470|NCT00580840|468829847|FG002|Run-in|Withdrawal by Subject|0|||
130236471|NCT00580840|468829848|FG003|Run-in|Withdrawal by Subject|0|||
130236472|NCT00580840|468829845|FG000|Run-in|Other: Per Sponsor Request|2|||
130236473|NCT00580840|468829846|FG001|Run-in|Other: Per Sponsor Request|0|||
130236474|NCT00580840|468829847|FG002|Run-in|Other: Per Sponsor Request|0|||
130236475|NCT00580840|468829848|FG003|Run-in|Other: Per Sponsor Request|0|||
130236476|NCT00580840|468829845|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
130236477|NCT00580840|468829846|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130236478|NCT00580840|468829847|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130236479|NCT00580840|468829848|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
130236480|NCT00580840|468829845|FG000|Run-in|Other: Exclusionary Lab Value|1|||
130236481|NCT00580840|468829846|FG001|Run-in|Other: Exclusionary Lab Value|0|||
130236482|NCT00580840|468829847|FG002|Run-in|Other: Exclusionary Lab Value|0|||
130236483|NCT00580840|468829848|FG003|Run-in|Other: Exclusionary Lab Value|0|||
130236484|NCT00580840|468829845|FG000|Double-Blind|Adverse Event|0|||
130236485|NCT00580840|468829846|FG001|Double-Blind|Adverse Event|3|||
130236486|NCT00580840|468829847|FG002|Double-Blind|Adverse Event|4|||
130236487|NCT00580840|468829848|FG003|Double-Blind|Adverse Event|1|||
130236488|NCT00580840|468829845|FG000|Double-Blind|Loss of Efficacy|0|||
130236489|NCT00580840|468829846|FG001|Double-Blind|Loss of Efficacy|1|||
130236490|NCT00580840|468829847|FG002|Double-Blind|Loss of Efficacy|2|||
130236491|NCT00580840|468829848|FG003|Double-Blind|Loss of Efficacy|10|||
130236492|NCT00580840|468829845|FG000|Double-Blind|Lost to Follow-up|0|||
130236493|NCT00580840|468829846|FG001|Double-Blind|Lost to Follow-up|1|||
130236494|NCT00580840|468829847|FG002|Double-Blind|Lost to Follow-up|0|||
130236495|NCT00580840|468829848|FG003|Double-Blind|Lost to Follow-up|2|||
130236496|NCT00580840|468829845|FG000|Double-Blind|Withdrawal by Subject|0|||
130236497|NCT00580840|468829846|FG001|Double-Blind|Withdrawal by Subject|1|||
130236498|NCT00580840|468829847|FG002|Double-Blind|Withdrawal by Subject|2|||
130236499|NCT00580840|468829848|FG003|Double-Blind|Withdrawal by Subject|2|||
130236500|NCT00580840|468829845|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
130236501|NCT00580840|468829846|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
130236502|NCT00580840|468829847|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
130236503|NCT00580840|468829848|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
130236504|NCT00580840|468829845|FG000|Double-Blind|Other: Forbidden Medication|0|||
130236505|NCT00580840|468829846|FG001|Double-Blind|Other: Forbidden Medication|0|||
130236506|NCT00580840|468829847|FG002|Double-Blind|Other: Forbidden Medication|1|||
130236507|NCT00580840|468829848|FG003|Double-Blind|Other: Forbidden Medication|0|||
130236508|NCT01551173|468829849|FG000|Overall Study|Withdrawal by Subject|11|||
130236509|NCT01551173|468829850|FG001|Overall Study|Withdrawal by Subject|16|||
130236510|NCT01551173|468829849|FG000|Overall Study|Adverse Event|7|||
130236511|NCT01551173|468829850|FG001|Overall Study|Adverse Event|6|||
130236512|NCT01551173|468829849|FG000|Overall Study|Lost to Follow-up|5|||
130236513|NCT01551173|468829850|FG001|Overall Study|Lost to Follow-up|7|||
130236514|NCT01551173|468829849|FG000|Overall Study|Other|5|||
130236515|NCT01551173|468829850|FG001|Overall Study|Other|3|||
130236516|NCT04530344|468829851|FG000|Overall Study|Lost to Follow-up|3|||
130236517|NCT04530344|468829852|FG001|Overall Study|Lost to Follow-up|3|||
130236518|NCT04530344|468829853|FG002|Overall Study|Lost to Follow-up|3|||
130236519|NCT04530344|468829854|FG003|Overall Study|Lost to Follow-up|10|||
130236520|NCT04530344|468829851|FG000|Overall Study|Withdrawal by Subject|14|||
130236521|NCT04530344|468829852|FG001|Overall Study|Withdrawal by Subject|5|||
130236522|NCT04530344|468829853|FG002|Overall Study|Withdrawal by Subject|18|||
130236523|NCT04530344|468829854|FG003|Overall Study|Withdrawal by Subject|33|||
130236524|NCT04530344|468829851|FG000|Overall Study|Adverse Event|0|||
130236525|NCT04530344|468829852|FG001|Overall Study|Adverse Event|0|||
130236526|NCT04530344|468829853|FG002|Overall Study|Adverse Event|0|||
130236527|NCT04530344|468829854|FG003|Overall Study|Adverse Event|1|||
130236528|NCT04530344|468829851|FG000|Overall Study|Lack of Efficacy|0|||
130236529|NCT04530344|468829852|FG001|Overall Study|Lack of Efficacy|0|||
130236530|NCT04530344|468829853|FG002|Overall Study|Lack of Efficacy|0|||
130236531|NCT04530344|468829854|FG003|Overall Study|Lack of Efficacy|1|||
130236532|NCT04530344|468829851|FG000|Overall Study|Physician Decision|0|||
130236533|NCT04530344|468829852|FG001|Overall Study|Physician Decision|0|||
130236534|NCT04530344|468829853|FG002|Overall Study|Physician Decision|1|||
130236535|NCT04530344|468829854|FG003|Overall Study|Physician Decision|1|||
130236536|NCT04530344|468829851|FG000|Overall Study|Pregnancy|0|||
130236537|NCT04530344|468829852|FG001|Overall Study|Pregnancy|0|||
130236538|NCT04530344|468829853|FG002|Overall Study|Pregnancy|2|||
130236539|NCT04530344|468829854|FG003|Overall Study|Pregnancy|1|||
130236540|NCT04530344|468829851|FG000|Overall Study|Protocol Violation|0|||
130236541|NCT04530344|468829852|FG001|Overall Study|Protocol Violation|0|||
130236542|NCT04530344|468829853|FG002|Overall Study|Protocol Violation|0|||
130236543|NCT04530344|468829854|FG003|Overall Study|Protocol Violation|1|||
130236544|NCT04530344|468829851|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
130236545|NCT04530344|468829852|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
130236546|NCT04530344|468829853|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
130236547|NCT04530344|468829854|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
130236548|NCT04530344|468829851|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130236549|NCT04530344|468829852|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130236550|NCT04530344|468829853|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
130236551|NCT04530344|468829854|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
130236552|NCT04530344|468829851|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
130236553|NCT04530344|468829852|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
130236554|NCT04530344|468829853|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
130236555|NCT04530344|468829854|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
130236556|NCT04530344|468829851|FG000|Overall Study|Personal Reasons|0|||
130236557|NCT04530344|468829852|FG001|Overall Study|Personal Reasons|0|||
130236558|NCT04530344|468829853|FG002|Overall Study|Personal Reasons|0|||
130236559|NCT04530344|468829854|FG003|Overall Study|Personal Reasons|1|||
130316198|NCT02421172|469124326|FG002|Period 2|Lost to Follow-up|0|||
130236560|NCT04530344|468829851|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130236561|NCT04530344|468829852|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130236562|NCT04530344|468829853|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
130236563|NCT04530344|468829854|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
130236564|NCT01402700|468829855|FG000|Overall Study|Death|3|||
130236565|NCT01402700|468829855|FG000|Overall Study|Withdrawal by Subject|3|||
130236566|NCT01402700|468829855|FG000|Overall Study|Missed Visit|1|||
130236567|NCT02401230|468829859|FG000|Overall Study|Adverse Event|3|||
130236568|NCT02401230|468829860|FG001|Overall Study|Adverse Event|2|||
130236569|NCT02401230|468829861|FG002|Overall Study|Adverse Event|0|||
130236570|NCT02401230|468829859|FG000|Overall Study|Withdrawal by Subject|2|||
130236571|NCT02401230|468829860|FG001|Overall Study|Withdrawal by Subject|1|||
130236572|NCT02401230|468829861|FG002|Overall Study|Withdrawal by Subject|1|||
130236573|NCT02401230|468829859|FG000|Overall Study|Lost to Follow-up|1|||
130236574|NCT02401230|468829860|FG001|Overall Study|Lost to Follow-up|3|||
130236575|NCT02401230|468829861|FG002|Overall Study|Lost to Follow-up|3|||
130236576|NCT00830765|468829862|FG000|Overall Study|Protocol Violation|3|||
130236577|NCT00830765|468829863|FG001|Overall Study|Protocol Violation|2|||
130236578|NCT01299909|468829864|FG000|Overall Study|Lost to Follow-up|22|||
130236579|NCT01299909|468829865|FG001|Overall Study|Lost to Follow-up|18|||
130236580|NCT01299909|468829866|FG002|Overall Study|Lost to Follow-up|17|||
130236581|NCT00964782|468829867|FG000|Overall Study|Lost to Follow-up|1|||
130236582|NCT00964782|468829868|FG001|Overall Study|Lost to Follow-up|0|||
130236583|NCT01143324|468829874|FG000|Overall Study|Lost to Follow-up|11|||
130236584|NCT01143324|468829874|FG000|Overall Study|Withdrawal by Subject|4|||
130236585|NCT01143324|468829874|FG000|Overall Study|Explant of the device|4|||
130236586|NCT02774889|468829884|FG000|Overall Study|Lost to Follow-up|2|||
130236587|NCT02774889|468829885|FG001|Overall Study|Lost to Follow-up|1|||
130236588|NCT00858988|468829886|FG000|Analysis|Lactulose unable to be detected in urine|2|||
130236589|NCT00858988|468829887|FG001|Analysis|Lactulose unable to be detected in urine|1|||
130236590|NCT01349595|468829888|FG000|Overall Study|Lack of funding|2|||
130236591|NCT01349595|468829889|FG001|Overall Study|Lack of funding|2|||
130236592|NCT00549055|468831775|FG000|Overall Study|Adverse Event|4|||
130236593|NCT00549055|468831775|FG000|Overall Study|Lack of Efficacy|18|||
130236594|NCT00549055|468831775|FG000|Overall Study|Stabilization|5|||
130236595|NCT00549055|468831775|FG000|Overall Study|Progression to fibrosis|2|||
130236596|NCT00549055|468831775|FG000|Overall Study|Decrease of size|1|||
130236597|NCT00549055|468831775|FG000|Overall Study|Active choroidal neovascula increased|1|||
130236598|NCT00549055|468831775|FG000|Overall Study|Vitreous hemorrhage|1|||
130236599|NCT00549055|468831775|FG000|Overall Study|Growth choroidal neovascularisation|1|||
130236600|NCT00549055|468831775|FG000|Overall Study|Choroidal neovascularization|1|||
130236601|NCT00549055|468831775|FG000|Overall Study|Very low visual acuity (VA)|1|||
130236602|NCT00770809|468831780|FG000|Overall Study|Adverse Event|9|||
130236603|NCT00770809|468831781|FG001|Overall Study|Adverse Event|1|||
130236604|NCT00770809|468831782|FG002|Overall Study|Adverse Event|12|||
130236605|NCT00770809|468831780|FG000|Overall Study|Death|1|||
130236606|NCT00770809|468831781|FG001|Overall Study|Death|0|||
130236607|NCT00770809|468831782|FG002|Overall Study|Death|0|||
130236608|NCT00770809|468831780|FG000|Overall Study|Withdrawal by Subject|3|||
130236609|NCT00770809|468831781|FG001|Overall Study|Withdrawal by Subject|3|||
130236610|NCT00770809|468831782|FG002|Overall Study|Withdrawal by Subject|7|||
130236611|NCT00770809|468831780|FG000|Overall Study|Progression|2|||
130236612|NCT00770809|468831781|FG001|Overall Study|Progression|2|||
130236613|NCT00770809|468831782|FG002|Overall Study|Progression|0|||
130236614|NCT00770809|468831780|FG000|Overall Study|Complicating illness|0|||
130236615|NCT00770809|468831781|FG001|Overall Study|Complicating illness|0|||
130236616|NCT00770809|468831782|FG002|Overall Study|Complicating illness|1|||
130236617|NCT00770809|468831780|FG000|Overall Study|Other Medical Reasons|2|||
130236618|NCT00770809|468831781|FG001|Overall Study|Other Medical Reasons|4|||
130236619|NCT00770809|468831782|FG002|Overall Study|Other Medical Reasons|3|||
130236620|NCT02469233|468831783|FG000|Overall Study|Death|1|||
130236621|NCT02469233|468831784|FG001|Overall Study|Death|1|||
130236622|NCT02469233|468831783|FG000|Overall Study|Lost to post or 6 month follow up|7|||
130236623|NCT02469233|468831784|FG001|Overall Study|Lost to post or 6 month follow up|2|||
130236624|NCT03474107|468831785|FG000|Overall Study|Adverse Event|42|||
130236625|NCT03474107|468831786|FG001|Overall Study|Adverse Event|46|||
130236626|NCT03474107|468831785|FG000|Overall Study|Death|2|||
130236627|NCT03474107|468831786|FG001|Overall Study|Death|2|||
130236628|NCT03474107|468831785|FG000|Overall Study|Lost to Follow-up|0|||
130236629|NCT03474107|468831786|FG001|Overall Study|Lost to Follow-up|1|||
130236630|NCT03474107|468831785|FG000|Overall Study|Progressive Disease|177|||
130236631|NCT03474107|468831786|FG001|Overall Study|Progressive Disease|180|||
130236632|NCT03474107|468831785|FG000|Overall Study|Protocol Violation|1|||
130236633|NCT03474107|468831786|FG001|Overall Study|Protocol Violation|1|||
130236634|NCT03474107|468831785|FG000|Overall Study|Withdrawal by Subject|15|||
130236635|NCT03474107|468831786|FG001|Overall Study|Withdrawal by Subject|27|||
130236636|NCT03474107|468831785|FG000|Overall Study|Physician Decision|7|||
130236637|NCT03474107|468831786|FG001|Overall Study|Physician Decision|22|||
130236638|NCT03474107|468831785|FG000|Overall Study|Miscellaneous|1|||
130236639|NCT03474107|468831786|FG001|Overall Study|Miscellaneous|6|||
130236640|NCT02127671|468831787|FG000|Overall Study|Death|2|||
130236641|NCT02127671|468831788|FG001|Overall Study|Death|2|||
130236642|NCT02127671|468831787|FG000|Overall Study|Lost to Follow-up|4|||
130236643|NCT02127671|468831788|FG001|Overall Study|Lost to Follow-up|2|||
130236644|NCT02127671|468831787|FG000|Overall Study|Physician Decision|1|||
130236645|NCT02127671|468831788|FG001|Overall Study|Physician Decision|0|||
130236646|NCT02127671|468831787|FG000|Overall Study|incarceration|0|||
130236647|NCT02127671|468831788|FG001|Overall Study|incarceration|1|||
130236648|NCT02127671|468831787|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
130236649|NCT02127671|468831788|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
130236650|NCT00764517|468831789|FG000|Overall Study|Adverse Event|9|||
130236651|NCT00764517|468831790|FG001|Overall Study|Adverse Event|3|||
130236652|NCT00764517|468831789|FG000|Overall Study|Death|3|||
130236653|NCT00764517|468831790|FG001|Overall Study|Death|11|||
130236654|NCT00764517|468831789|FG000|Overall Study|Physician Decision|3|||
130236655|NCT00764517|468831790|FG001|Overall Study|Physician Decision|0|||
130236656|NCT03813654|468831795|FG000|Overall Study|Protocol Violation|0|||
130236657|NCT03813654|468831796|FG001|Overall Study|Protocol Violation|1|||
130236658|NCT03813654|468831797|FG002|Overall Study|Protocol Violation|2|||
130236659|NCT03813654|468831795|FG000|Overall Study|Withdrawal by Subject|1|||
130236660|NCT03813654|468831796|FG001|Overall Study|Withdrawal by Subject|0|||
130236661|NCT03813654|468831797|FG002|Overall Study|Withdrawal by Subject|0|||
130236662|NCT01208051|468831798|FG000|Total Enrollment|Withdrawal by Subject|0|||
130236663|NCT01208051|468831799|FG001|Total Enrollment|Withdrawal by Subject|1|||
130236664|NCT01208051|468831800|FG002|Total Enrollment|Withdrawal by Subject|0|||
130236665|NCT01208051|468831801|FG003|Total Enrollment|Withdrawal by Subject|0|||
130236666|NCT01208051|468831802|FG004|Total Enrollment|Withdrawal by Subject|2|||
130236667|NCT01208051|468831798|FG000|Total Enrollment|Brain metastases|0|||
130236668|NCT01208051|468831799|FG001|Total Enrollment|Brain metastases|0|||
130236669|NCT01208051|468831800|FG002|Total Enrollment|Brain metastases|1|||
130236670|NCT01208051|468831801|FG003|Total Enrollment|Brain metastases|0|||
130236671|NCT01208051|468831802|FG004|Total Enrollment|Brain metastases|0|||
130236672|NCT02107898|468831805|FG000|Overall Study|Adverse Event|4|||
130236673|NCT02107898|468831806|FG001|Overall Study|Adverse Event|7|||
130236674|NCT02107898|468831805|FG000|Overall Study|Poor compliance to protocol|0|||
130236675|NCT02107898|468831806|FG001|Overall Study|Poor compliance to protocol|1|||
130236676|NCT02107898|468831805|FG000|Overall Study|Participant moved|0|||
130236677|NCT02107898|468831806|FG001|Overall Study|Participant moved|2|||
130236678|NCT02107898|468831805|FG000|Overall Study|Consent withdrawn by participant|2|||
130236679|NCT02107898|468831806|FG001|Overall Study|Consent withdrawn by participant|1|||
130236680|NCT02107898|468831805|FG000|Overall Study|Randomized but not treated|0|||
130236681|NCT02107898|468831806|FG001|Overall Study|Randomized but not treated|1|||
130236682|NCT01283386|468831807|FG000|Overall Study|Death|2|||
130236683|NCT01283386|468831808|FG001|Overall Study|Death|0|||
130236684|NCT01283386|468831807|FG000|Overall Study|Withdrawal by Subject|2|||
130236685|NCT01283386|468831808|FG001|Overall Study|Withdrawal by Subject|1|||
130236686|NCT01283386|468831807|FG000|Overall Study|Relapse of underlying disease|1|||
130236687|NCT01283386|468831808|FG001|Overall Study|Relapse of underlying disease|3|||
130236688|NCT01283386|468831807|FG000|Overall Study|Progression of underlying disease|2|||
130236689|NCT01283386|468831808|FG001|Overall Study|Progression of underlying disease|7|||
130236690|NCT01283386|468831807|FG000|Overall Study|Reason not specified|1|||
130236691|NCT01283386|468831808|FG001|Overall Study|Reason not specified|0|||
130236692|NCT01283386|468831807|FG000|Overall Study|Protocol Violation|0|||
130236693|NCT01283386|468831808|FG001|Overall Study|Protocol Violation|1|||
130236694|NCT01531153|468831809|FG000|Overall Study|Withdrawal by Subject|10|||
130236695|NCT01531153|468831810|FG001|Overall Study|Withdrawal by Subject|9|||
130236696|NCT01531153|468831811|FG002|Overall Study|Withdrawal by Subject|15|||
130236697|NCT00770367|468831812|FG000|First Intervention|Withdrawal by Subject|0|||
130236698|NCT00770367|468831813|FG001|First Intervention|Withdrawal by Subject|2|||
130236699|NCT00770367|468831812|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
130236700|NCT00770367|468831813|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
130236701|NCT00770367|468831812|FG000|Second Intervention|Lost to Follow-up|2|||
130236702|NCT00770367|468831813|FG001|Second Intervention|Lost to Follow-up|0|||
130236703|NCT00920816|468831815|FG000|Overall Study|Death|116|||
130236704|NCT00920816|468831816|FG001|Overall Study|Death|63|||
130236705|NCT00920816|468831817|FG002|Overall Study|Death|8|||
130236706|NCT00920816|468831818|FG003|Overall Study|Death|3|||
130236707|NCT00920816|468831815|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
130236708|NCT00920816|468831816|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
130236709|NCT00920816|468831817|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
130236710|NCT00920816|468831818|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
130236711|NCT00920816|468831815|FG000|Overall Study|Global deterioration of health status|2|||
130236712|NCT00920816|468831816|FG001|Overall Study|Global deterioration of health status|0|||
130236713|NCT00920816|468831817|FG002|Overall Study|Global deterioration of health status|0|||
130236714|NCT00920816|468831818|FG003|Overall Study|Global deterioration of health status|0|||
130236715|NCT00920816|468831815|FG000|Overall Study|Objective progression or relapse|6|||
130236716|NCT00920816|468831816|FG001|Overall Study|Objective progression or relapse|2|||
130236717|NCT00920816|468831817|FG002|Overall Study|Objective progression or relapse|0|||
130236718|NCT00920816|468831818|FG003|Overall Study|Objective progression or relapse|0|||
130236719|NCT00920816|468831815|FG000|Overall Study|Other|26|||
130236720|NCT00920816|468831816|FG001|Overall Study|Other|15|||
130236721|NCT00920816|468831817|FG002|Overall Study|Other|1|||
130236722|NCT00920816|468831818|FG003|Overall Study|Other|2|||
130236723|NCT00920816|468831815|FG000|Overall Study|Lost to Follow-up|11|||
130236724|NCT00920816|468831816|FG001|Overall Study|Lost to Follow-up|2|||
130236725|NCT00920816|468831817|FG002|Overall Study|Lost to Follow-up|0|||
130236726|NCT00920816|468831818|FG003|Overall Study|Lost to Follow-up|0|||
130236727|NCT00920816|468831815|FG000|Overall Study|Adverse Event|1|||
130236728|NCT00920816|468831816|FG001|Overall Study|Adverse Event|1|||
130236729|NCT00920816|468831817|FG002|Overall Study|Adverse Event|1|||
130236730|NCT00920816|468831818|FG003|Overall Study|Adverse Event|0|||
130236731|NCT00920816|468831815|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
130236732|NCT00920816|468831816|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
130236733|NCT00920816|468831817|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
130236734|NCT00920816|468831818|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
130236735|NCT00920816|468831815|FG000|Overall Study|Randomized but not treated|3|||
130236736|NCT00920816|468831816|FG001|Overall Study|Randomized but not treated|0|||
130236737|NCT00920816|468831817|FG002|Overall Study|Randomized but not treated|0|||
130236738|NCT00920816|468831818|FG003|Overall Study|Randomized but not treated|0|||
130236739|NCT01180777|468831819|FG000|Overall Study|Protocol Violation|6|||
130236740|NCT01180777|468831819|FG000|Overall Study|Poor lens fit|4|||
130236741|NCT01180777|468831819|FG000|Overall Study|Lost to Follow-up|1|||
130236742|NCT01180777|468831819|FG000|Overall Study|Adverse Event|1|||
130236743|NCT03517137|468831822|FG000|Overall Study|Lack of Efficacy|1|||
130236744|NCT03517137|468831822|FG000|Overall Study|Adverse Event|2|||
130236745|NCT03517137|468831822|FG000|Overall Study|Withdrawal by Subject|2|||
130236746|NCT03517137|468831822|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
130236747|NCT01582451|468831823|FG000|Overall Study|Adverse Event|1|||
130236748|NCT01582451|468831824|FG001|Overall Study|Adverse Event|3|||
130236749|NCT01582451|468831823|FG000|Overall Study|Death|3|||
130236750|NCT01582451|468831824|FG001|Overall Study|Death|3|||
130236751|NCT01582451|468831823|FG000|Overall Study|Lost to Follow-up|0|||
130236752|NCT01582451|468831824|FG001|Overall Study|Lost to Follow-up|2|||
130236753|NCT01582451|468831823|FG000|Overall Study|Protocol Violation|11|||
130236754|NCT01582451|468831824|FG001|Overall Study|Protocol Violation|3|||
130236755|NCT01582451|468831823|FG000|Overall Study|Withdrawal by Subject|13|||
130236756|NCT01582451|468831824|FG001|Overall Study|Withdrawal by Subject|9|||
130236757|NCT01582451|468831823|FG000|Overall Study|Physician Decision|3|||
130236758|NCT01582451|468831824|FG001|Overall Study|Physician Decision|0|||
130236759|NCT01582451|468831823|FG000|Overall Study|Sponsor Decision|1|||
130026092|NCT03604445|468055866|FG000|Overall Study|Missing visit|0|||
130026093|NCT03604445|468055867|FG001|Overall Study|Missing visit|0|||
130026094|NCT03604445|468055868|FG002|Overall Study|Missing visit|0|||
130026095|NCT03604445|468055869|FG003|Overall Study|Missing visit|0|||
130026096|NCT03604445|468055870|FG004|Overall Study|Missing visit|0|||
130026097|NCT03604445|468055871|FG005|Overall Study|Missing visit|1|||
130026098|NCT03604445|468055872|FG006|Overall Study|Missing visit|0|||
130236760|NCT01582451|468831824|FG001|Overall Study|Sponsor Decision|0|||
130236761|NCT00487188|468831828|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
130236762|NCT00487188|468831829|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
130236763|NCT00487188|468831830|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
129884553|NCT03012061|467536451|FG001|Overall Study|Adverse Event|0|||
130026099|NCT03604445|468055873|FG007|Overall Study|Missing visit|1|||
130026100|NCT03604445|468055874|FG008|Overall Study|Missing visit|0|||
130236764|NCT00487188|468831828|FG000|Induction Phase|Adverse Event|5|||
130236765|NCT00487188|468831829|FG001|Induction Phase|Adverse Event|0|||
130236766|NCT00487188|468831830|FG002|Induction Phase|Adverse Event|0|||
130236767|NCT00487188|468831828|FG000|Induction Phase|Lack of Efficacy|0|||
130236768|NCT00487188|468831829|FG001|Induction Phase|Lack of Efficacy|1|||
130236769|NCT00487188|468831830|FG002|Induction Phase|Lack of Efficacy|0|||
130236770|NCT00487188|468831828|FG000|Induction Phase|Protocol Violation|1|||
130236771|NCT00487188|468831829|FG001|Induction Phase|Protocol Violation|0|||
130236772|NCT00487188|468831830|FG002|Induction Phase|Protocol Violation|0|||
130236773|NCT00487188|468831828|FG000|Induction Phase|Refused Treatment|1|||
130236774|NCT00487188|468831829|FG001|Induction Phase|Refused Treatment|2|||
130236775|NCT00487188|468831830|FG002|Induction Phase|Refused Treatment|0|||
130236776|NCT00487188|468831828|FG000|Induction Phase|Lost to Follow-up|2|||
130236777|NCT00487188|468831829|FG001|Induction Phase|Lost to Follow-up|2|||
130236778|NCT00487188|468831830|FG002|Induction Phase|Lost to Follow-up|0|||
130236779|NCT00487188|468831828|FG000|Induction Phase|Administrative|0|||
130236780|NCT00487188|468831829|FG001|Induction Phase|Administrative|1|||
130236781|NCT00487188|468831830|FG002|Induction Phase|Administrative|0|||
130236782|NCT00487188|468831828|FG000|Maintenance Phase|Adverse Event|1|||
130236783|NCT00487188|468831829|FG001|Maintenance Phase|Adverse Event|0|||
130236784|NCT00487188|468831830|FG002|Maintenance Phase|Adverse Event|0|||
130236785|NCT00487188|468831828|FG000|Maintenance Phase|Death|1|||
130236786|NCT00487188|468831829|FG001|Maintenance Phase|Death|0|||
130236787|NCT00487188|468831830|FG002|Maintenance Phase|Death|0|||
130236788|NCT00487188|468831828|FG000|Maintenance Phase|Lost to Follow-up|1|||
130236789|NCT00487188|468831829|FG001|Maintenance Phase|Lost to Follow-up|0|||
130236790|NCT00487188|468831830|FG002|Maintenance Phase|Lost to Follow-up|0|||
130236791|NCT00487188|468831828|FG000|Maintenance Phase|Administrative|0|||
130236792|NCT00487188|468831829|FG001|Maintenance Phase|Administrative|0|||
130236793|NCT00487188|468831830|FG002|Maintenance Phase|Administrative|1|||
130236794|NCT03822416|468831833|FG000|Overall Study|Lost to Follow-up|1|||
130236795|NCT03822416|468831834|FG001|Overall Study|Lost to Follow-up|0|||
130236796|NCT03822416|468831833|FG000|Overall Study|Withdrawal by Subject|0|||
130236797|NCT03822416|468831834|FG001|Overall Study|Withdrawal by Subject|1|||
130236798|NCT01995201|468831837|FG000|From Baseline Until Week 24|Adverse Event|4|||
130236799|NCT01995201|468831838|FG001|From Baseline Until Week 24|Adverse Event|15|||
130236800|NCT01995201|468831839|FG002|From Baseline Until Week 24|Adverse Event|0|||
130236801|NCT01995201|468831840|FG003|From Baseline Until Week 24|Adverse Event|0|||
130236802|NCT01995201|468831841|FG004|From Baseline Until Week 24|Adverse Event|0|||
130236803|NCT01995201|468831842|FG005|From Baseline Until Week 24|Adverse Event|0|||
130236804|NCT01995201|468831843|FG006|From Baseline Until Week 24|Adverse Event|0|||
130236805|NCT01995201|468831837|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236806|NCT01995201|468831838|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
130236807|NCT01995201|468831839|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236808|NCT01995201|468831840|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236809|NCT01995201|468831841|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236810|NCT01995201|468831842|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236811|NCT01995201|468831843|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
130236812|NCT01995201|468831837|FG000|From Baseline Until Week 24|Death|0|||
130236813|NCT01995201|468831838|FG001|From Baseline Until Week 24|Death|1|||
130236814|NCT01995201|468831839|FG002|From Baseline Until Week 24|Death|0|||
130236815|NCT01995201|468831840|FG003|From Baseline Until Week 24|Death|0|||
130236816|NCT01995201|468831841|FG004|From Baseline Until Week 24|Death|0|||
130236817|NCT01995201|468831842|FG005|From Baseline Until Week 24|Death|0|||
130236818|NCT01995201|468831843|FG006|From Baseline Until Week 24|Death|0|||
130236819|NCT01995201|468831837|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
130236820|NCT01995201|468831838|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
130236821|NCT01995201|468831839|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
130236822|NCT01995201|468831840|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
130236823|NCT01995201|468831841|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
130236824|NCT01995201|468831842|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
130236825|NCT01995201|468831843|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
130236826|NCT01995201|468831837|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
130236827|NCT01995201|468831838|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
130236828|NCT01995201|468831839|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
130236829|NCT01995201|468831840|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
130236830|NCT01995201|468831841|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
130236831|NCT01995201|468831842|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
130236832|NCT01995201|468831843|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
130236833|NCT01995201|468831837|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
130236834|NCT01995201|468831838|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
130236835|NCT01995201|468831839|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236836|NCT01995201|468831840|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236837|NCT01995201|468831841|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236838|NCT01995201|468831842|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236839|NCT01995201|468831843|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
130236840|NCT01995201|468831837|FG000|From Baseline Until Week 24|Physician Decision|0|||
130236841|NCT01995201|468831838|FG001|From Baseline Until Week 24|Physician Decision|2|||
130236842|NCT01995201|468831839|FG002|From Baseline Until Week 24|Physician Decision|0|||
130236843|NCT01995201|468831840|FG003|From Baseline Until Week 24|Physician Decision|0|||
130236844|NCT01995201|468831841|FG004|From Baseline Until Week 24|Physician Decision|0|||
130236845|NCT01995201|468831842|FG005|From Baseline Until Week 24|Physician Decision|0|||
130236846|NCT01995201|468831843|FG006|From Baseline Until Week 24|Physician Decision|0|||
130236847|NCT01995201|468831837|FG000|From Baseline Until Week 24|Protocol Violation|0|||
130236848|NCT01995201|468831838|FG001|From Baseline Until Week 24|Protocol Violation|9|||
130236849|NCT01995201|468831839|FG002|From Baseline Until Week 24|Protocol Violation|0|||
130236850|NCT01995201|468831840|FG003|From Baseline Until Week 24|Protocol Violation|0|||
130236851|NCT01995201|468831841|FG004|From Baseline Until Week 24|Protocol Violation|0|||
130236852|NCT01995201|468831842|FG005|From Baseline Until Week 24|Protocol Violation|0|||
130236853|NCT01995201|468831843|FG006|From Baseline Until Week 24|Protocol Violation|0|||
130236854|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Adverse Event|0|||
130236855|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Adverse Event|0|||
130236856|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Adverse Event|2|||
130236857|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Adverse Event|1|||
130236858|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Adverse Event|1|||
130236859|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Adverse Event|3|||
130236860|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Adverse Event|1|||
130236861|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Death|0|||
130236862|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Death|0|||
130236863|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Death|0|||
130236864|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Death|0|||
130236865|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Death|0|||
130236866|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Death|2|||
130236867|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Death|0|||
130236868|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236869|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236870|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
130236871|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236872|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
130236873|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
130236874|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
130236875|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236876|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236877|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236878|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236879|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
130236880|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
130236881|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
130236882|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236883|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236884|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
130236885|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236886|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
130236887|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236888|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
130236889|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Physician Decision|0|||
130236890|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Physician Decision|0|||
130236891|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Physician Decision|0|||
130236892|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Physician Decision|0|||
130236893|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Physician Decision|1|||
130236894|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Physician Decision|0|||
130236895|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Physician Decision|0|||
130236896|NCT01995201|468831837|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
130236897|NCT01995201|468831838|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
130236898|NCT01995201|468831839|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
130236899|NCT01995201|468831840|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
130236900|NCT01995201|468831841|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
130236901|NCT01995201|468831842|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
130236902|NCT01995201|468831843|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
130236903|NCT03329001|468831844|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130316199|NCT02421172|469124327|FG003|Period 2|Lost to Follow-up|1|||
130316200|NCT02421172|469124328|FG004|Period 2|Lost to Follow-up|0|||
130316201|NCT02421172|469124324|FG000|Period 2|Patient/guardian decision|0|||
130316202|NCT02421172|469124325|FG001|Period 2|Patient/guardian decision|0|||
130316203|NCT02421172|469124326|FG002|Period 2|Patient/guardian decision|3|||
130316204|NCT02421172|469124327|FG003|Period 2|Patient/guardian decision|2|||
130236904|NCT03329001|468831845|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236905|NCT03329001|468831846|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
130236906|NCT03329001|468831847|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
130236907|NCT03329001|468831848|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236908|NCT03329001|468831849|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236909|NCT03329001|468831850|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236910|NCT03329001|468831851|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
130236911|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236912|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236913|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236914|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
130236915|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236916|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236917|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236918|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
130236919|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236920|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236921|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236922|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
130236923|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236924|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236925|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236926|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
130236927|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236928|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236929|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236930|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
130236931|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236932|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236933|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236934|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
130236935|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236936|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236937|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
130236938|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236939|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236940|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236941|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236942|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
130236943|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236944|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236945|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
130236946|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236947|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236948|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236949|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236950|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
130236951|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236952|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236953|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
130236954|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236955|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129884554|NCT03012061|467536452|FG002|Overall Study|Adverse Event|0|||
130236956|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236957|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236958|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
130236959|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236960|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236961|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
130236962|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236963|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236964|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236965|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236966|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
130236967|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236968|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236969|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
130236970|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
130236971|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236972|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236973|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236974|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
130236975|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236976|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236977|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
130236978|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236979|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236980|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236981|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236982|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
130236983|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130026101|NCT03604445|468055866|FG000|Overall Study|Adverse Event|0|||
130026102|NCT03604445|468055867|FG001|Overall Study|Adverse Event|0|||
130026103|NCT03604445|468055868|FG002|Overall Study|Adverse Event|0|||
130026104|NCT03604445|468055869|FG003|Overall Study|Adverse Event|1|||
130026105|NCT03604445|468055870|FG004|Overall Study|Adverse Event|0|||
130026106|NCT03604445|468055871|FG005|Overall Study|Adverse Event|0|||
130236984|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236985|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
130236986|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
130236987|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236988|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236989|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236990|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
130236991|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236992|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236993|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
130236994|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
130236995|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236996|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236997|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236998|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
130236999|NCT03329001|468831844|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237000|NCT03329001|468831845|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237001|NCT03329001|468831846|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
130237002|NCT03329001|468831847|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
130237003|NCT03329001|468831848|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237004|NCT03329001|468831849|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237005|NCT03329001|468831850|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237006|NCT03329001|468831851|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
130237007|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237008|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237009|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237010|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
130237011|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237012|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237013|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237014|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
130237015|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237016|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237017|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237018|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
130237019|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237020|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237021|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237022|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
130237023|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237024|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237025|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
130237026|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237027|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237028|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237029|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237030|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
130237031|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237032|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237033|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
130237034|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
130237035|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237036|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237037|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237038|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
130237039|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237040|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237041|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
130237042|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237043|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237044|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237045|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237046|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
130237047|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237048|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237049|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
130237050|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237051|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237052|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237053|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237054|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
130237055|NCT03329001|468831844|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237056|NCT03329001|468831845|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237057|NCT03329001|468831846|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237058|NCT03329001|468831847|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
130237059|NCT03329001|468831848|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237060|NCT03329001|468831849|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237061|NCT03329001|468831850|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237062|NCT03329001|468831851|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
130237063|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237064|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237065|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237066|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237067|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237068|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
130237069|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237070|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
130237071|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237072|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237073|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237074|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237075|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
130237076|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237077|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237078|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
130237079|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237080|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237081|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237082|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237083|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
130237084|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
130237085|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237086|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
130237087|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237088|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237089|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237090|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237091|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
130237092|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237093|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237094|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
130237095|NCT03329001|468831844|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237096|NCT03329001|468831845|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237097|NCT03329001|468831846|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237098|NCT03329001|468831847|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237099|NCT03329001|468831848|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
130237100|NCT03329001|468831849|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
130026107|NCT03604445|468055872|FG006|Overall Study|Adverse Event|0|||
130026108|NCT03604445|468055873|FG007|Overall Study|Adverse Event|0|||
130026109|NCT03604445|468055874|FG008|Overall Study|Adverse Event|1|||
130026110|NCT04178772|468055879|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
130026111|NCT04178772|468055879|FG000|Overall Study|study terminated early due to COVID-19|7|||
130237101|NCT03329001|468831850|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237102|NCT03329001|468831851|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
130237103|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237104|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237105|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237106|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237107|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237108|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
130237109|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
130237110|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
130237111|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237112|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237113|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237114|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237115|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237116|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237117|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
130237118|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
130237119|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237120|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237121|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237122|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237123|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237124|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
130237125|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
130237126|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
130237127|NCT03329001|468831844|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237128|NCT03329001|468831845|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237129|NCT03329001|468831846|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237130|NCT03329001|468831847|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237131|NCT03329001|468831848|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237132|NCT03329001|468831849|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
130237133|NCT03329001|468831850|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
130237134|NCT03329001|468831851|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
130237135|NCT02709369|468831855|FG000|Overall Study|Lost to Follow-up|15|||
130237136|NCT02709369|468831855|FG000|Overall Study|Withdrawal by Subject|10|||
130237137|NCT02709369|468831855|FG000|Overall Study|Did not received intervention|2|||
130237138|NCT00963235|468831856|FG000|Overall Study|Withdrawal by Subject|22|||
130237139|NCT00963235|468831856|FG000|Overall Study|Lost to Follow-up|14|||
130237140|NCT00963235|468831856|FG000|Overall Study|Failed to return|9|||
130237141|NCT00963235|468831856|FG000|Overall Study|Protocol Violation|7|||
130237142|NCT00963235|468831856|FG000|Overall Study|Adverse Event|5|||
130237143|NCT00963235|468831856|FG000|Overall Study|Physician Decision|2|||
130237144|NCT00963235|468831856|FG000|Overall Study|Other|1|||
130237145|NCT01104766|468831858|FG000|Overall Study|Did not meet inc/exc criteria|1|||
130237146|NCT01104766|468831859|FG001|Overall Study|Did not meet inc/exc criteria|0|||
130237147|NCT01104766|468831860|FG002|Overall Study|Did not meet inc/exc criteria|0|||
130237148|NCT01104766|468831861|FG003|Overall Study|Did not meet inc/exc criteria|0|||
130237149|NCT01104766|468831858|FG000|Overall Study|Adverse Event|17|||
130237150|NCT01104766|468831859|FG001|Overall Study|Adverse Event|15|||
130237151|NCT01104766|468831860|FG002|Overall Study|Adverse Event|20|||
130237152|NCT01104766|468831861|FG003|Overall Study|Adverse Event|14|||
130237153|NCT01104766|468831858|FG000|Overall Study|Lack of Efficacy|20|||
130237154|NCT01104766|468831859|FG001|Overall Study|Lack of Efficacy|15|||
130026112|NCT00773279|468055885|FG000|Period 1|Adverse Event|2|||
130237155|NCT01104766|468831860|FG002|Overall Study|Lack of Efficacy|14|||
130237156|NCT01104766|468831861|FG003|Overall Study|Lack of Efficacy|8|||
130026113|NCT00773279|468055886|FG001|Period 1|Adverse Event|1|||
130026114|NCT00773279|468055885|FG000|Period 1|Lack of Efficacy|0|||
130237157|NCT01104766|468831858|FG000|Overall Study|Protocol Violation|2|||
130237158|NCT01104766|468831859|FG001|Overall Study|Protocol Violation|0|||
130237159|NCT01104766|468831860|FG002|Overall Study|Protocol Violation|0|||
130237160|NCT01104766|468831861|FG003|Overall Study|Protocol Violation|0|||
130237161|NCT01104766|468831858|FG000|Overall Study|Withdrawal by Subject|17|||
130237162|NCT01104766|468831859|FG001|Overall Study|Withdrawal by Subject|19|||
130237163|NCT01104766|468831860|FG002|Overall Study|Withdrawal by Subject|25|||
130237164|NCT01104766|468831861|FG003|Overall Study|Withdrawal by Subject|15|||
130237165|NCT01104766|468831858|FG000|Overall Study|Lost to Follow-up|1|||
130237166|NCT01104766|468831859|FG001|Overall Study|Lost to Follow-up|2|||
130237167|NCT01104766|468831860|FG002|Overall Study|Lost to Follow-up|1|||
130237168|NCT01104766|468831861|FG003|Overall Study|Lost to Follow-up|1|||
130237169|NCT01341470|468831863|FG000|Overall Study|Sponsor decision|0|||
130237170|NCT01341470|468831864|FG001|Overall Study|Sponsor decision|0|||
130237171|NCT01341470|468831865|FG002|Overall Study|Sponsor decision|1|||
130237172|NCT01341470|468831866|FG003|Overall Study|Sponsor decision|1|||
130237173|NCT01341470|468831867|FG004|Overall Study|Sponsor decision|0|||
130237174|NCT01341470|468831868|FG005|Overall Study|Sponsor decision|1|||
130237175|NCT01136915|468831870|FG000|Overall Study|Lost to Follow-up|2|||
130237176|NCT01136915|468831871|FG001|Overall Study|Lost to Follow-up|0|||
130237177|NCT01136915|468831870|FG000|Overall Study|Exclusion criterion met|0|||
130237178|NCT01136915|468831871|FG001|Overall Study|Exclusion criterion met|1|||
130100149|NCT01035229|468325931|FG000|Overall Study|Adverse Event|61|||
130237179|NCT01756235|468831872|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
130237180|NCT05376358|468831873|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
130100150|NCT01035229|468325932|FG001|Overall Study|Adverse Event|14|||
130237181|NCT05376358|468831874|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
130237182|NCT05376358|468831873|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
130237183|NCT05376358|468831874|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
130237184|NCT05376358|468831873|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
130026115|NCT00773279|468055886|FG001|Period 1|Lack of Efficacy|2|||
130026116|NCT00773279|468055885|FG000|Period 1|Unclassified|5|||
130026117|NCT00773279|468055886|FG001|Period 1|Unclassified|1|||
130026118|NCT00773279|468055885|FG000|Period 2|Adverse Event|0|||
130026119|NCT00773279|468055886|FG001|Period 2|Adverse Event|1|||
130026120|NCT00773279|468055885|FG000|Period 2|Lack of Efficacy|1|||
130026121|NCT00773279|468055886|FG001|Period 2|Lack of Efficacy|0|||
130026122|NCT00773279|468055885|FG000|Period 2|Protocol Violation|0|||
130026123|NCT00773279|468055886|FG001|Period 2|Protocol Violation|3|||
130026124|NCT00773279|468055885|FG000|Period 2|Unclassified|2|||
130026125|NCT00773279|468055886|FG001|Period 2|Unclassified|2|||
130026126|NCT00713219|468055887|FG000|Overall Study|Death|1|||
130026127|NCT00713219|468055887|FG000|Overall Study|Protocol Violation|1|||
130026128|NCT00802360|468055888|FG000|Overall Study|Stimulation failure|4|||
130026129|NCT00802360|468055889|FG001|Overall Study|Stimulation failure|0|||
130026130|NCT00802360|468055890|FG002|Overall Study|Stimulation failure|3|||
130026131|NCT00802360|468055891|FG003|Overall Study|Stimulation failure|3|||
130026132|NCT00802360|468055888|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
130026133|NCT00802360|468055889|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
130026134|NCT00802360|468055890|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
130026135|NCT00802360|468055891|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
130026136|NCT00802360|468055888|FG000|Overall Study|Cycle cancelled|0|||
130026137|NCT00802360|468055889|FG001|Overall Study|Cycle cancelled|1|||
130026138|NCT00802360|468055890|FG002|Overall Study|Cycle cancelled|1|||
130026139|NCT00802360|468055891|FG003|Overall Study|Cycle cancelled|1|||
130026140|NCT00802360|468055888|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
130026141|NCT00802360|468055889|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
130026142|NCT00802360|468055890|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
130026143|NCT00802360|468055891|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
130026144|NCT00802360|468055888|FG000|Overall Study|No positive serum pregnancy|17|||
130026145|NCT00802360|468055889|FG001|Overall Study|No positive serum pregnancy|20|||
130026146|NCT00802360|468055890|FG002|Overall Study|No positive serum pregnancy|14|||
130026147|NCT00802360|468055891|FG003|Overall Study|No positive serum pregnancy|10|||
130026148|NCT00802360|468055888|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
130026149|NCT00802360|468055889|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130026150|NCT00802360|468055890|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
130026151|NCT00802360|468055891|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
130026152|NCT00802360|468055888|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
130026153|NCT00802360|468055889|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
130026154|NCT00802360|468055890|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
130026155|NCT00802360|468055891|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
130026156|NCT00802360|468055888|FG000|Overall Study|Other|2|||
130026157|NCT00802360|468055889|FG001|Overall Study|Other|3|||
130026158|NCT00802360|468055890|FG002|Overall Study|Other|6|||
130026159|NCT00802360|468055891|FG003|Overall Study|Other|3|||
130026160|NCT02041962|468055892|FG000|Overall Study|Lost Aetna Coverage|43|||
130026161|NCT02041962|468055893|FG001|Overall Study|Lost Aetna Coverage|40|||
130026162|NCT02041962|468055892|FG000|Overall Study|Death|1|||
130026163|NCT02041962|468055893|FG001|Overall Study|Death|1|||
130026164|NCT02041962|468055892|FG000|Overall Study|Lost to Follow-up|37|||
130026165|NCT02041962|468055893|FG001|Overall Study|Lost to Follow-up|32|||
130026166|NCT02041962|468055892|FG000|Overall Study|Withdrawal by Subject|0|||
130026167|NCT02041962|468055893|FG001|Overall Study|Withdrawal by Subject|11|||
130026168|NCT01225562|468055894|FG000|Overall Study|Withdrawal by Subject|52|||
130026169|NCT01225562|468055895|FG001|Overall Study|Withdrawal by Subject|50|||
130026170|NCT01225562|468055896|FG002|Overall Study|Withdrawal by Subject|52|||
130026171|NCT01225562|468055894|FG000|Overall Study|Lost to Follow-up|3|||
130026172|NCT01225562|468055895|FG001|Overall Study|Lost to Follow-up|6|||
130026173|NCT01225562|468055896|FG002|Overall Study|Lost to Follow-up|1|||
130026174|NCT01481896|468055897|FG000|Overall Study|Lost to Follow-up|12|||
130026175|NCT01162421|468055900|FG000|Overall Study|Did not receive study drug|2|||
130026176|NCT01162421|468055901|FG001|Overall Study|Did not receive study drug|1|||
130026177|NCT01162421|468055900|FG000|Overall Study|Adverse Event|2|||
130026178|NCT01162421|468055901|FG001|Overall Study|Adverse Event|5|||
130026179|NCT01162421|468055900|FG000|Overall Study|Lost to Follow-up|0|||
130026180|NCT01162421|468055901|FG001|Overall Study|Lost to Follow-up|2|||
130026181|NCT01162421|468055900|FG000|Overall Study|Lack of Efficacy|2|||
130026182|NCT01162421|468055901|FG001|Overall Study|Lack of Efficacy|2|||
130026183|NCT01162421|468055900|FG000|Overall Study|Other|2|||
130026184|NCT01162421|468055901|FG001|Overall Study|Other|3|||
130026185|NCT01107444|468055902|FG000|Overall Study|Withdrawal by Subject|8|||
130026186|NCT01107444|468055903|FG001|Overall Study|Withdrawal by Subject|12|||
130026187|NCT01107444|468055902|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
130026188|NCT01107444|468055903|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
130026189|NCT01557166|468055904|FG000|Overall Study|Adverse Event|20|||
130237185|NCT05376358|468831874|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
130237186|NCT05376358|468831873|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
130237187|NCT05376358|468831874|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
130237188|NCT05376358|468831873|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
130026190|NCT01557166|468055905|FG001|Overall Study|Adverse Event|6|||
130026191|NCT01557166|468055904|FG000|Overall Study|Lack of Efficacy|2|||
130026192|NCT01557166|468055905|FG001|Overall Study|Lack of Efficacy|1|||
130026193|NCT01557166|468055904|FG000|Overall Study|Protocol Violation|8|||
130026194|NCT01557166|468055905|FG001|Overall Study|Protocol Violation|5|||
130026195|NCT01557166|468055904|FG000|Overall Study|Withdrawn consent|12|||
129884555|NCT02696902|467536453|FG000|Overall Study|Lost to Follow-up|0|||
129884556|NCT02696902|467536454|FG001|Overall Study|Lost to Follow-up|1|||
130026196|NCT01557166|468055905|FG001|Overall Study|Withdrawn consent|20|||
130026197|NCT01557166|468055904|FG000|Overall Study|Target dose not tolerated|1|||
130026198|NCT01557166|468055905|FG001|Overall Study|Target dose not tolerated|0|||
130026199|NCT01557166|468055904|FG000|Overall Study|Psychiatric disorder|1|||
130026200|NCT01557166|468055905|FG001|Overall Study|Psychiatric disorder|0|||
130026201|NCT01557166|468055904|FG000|Overall Study|Unclassified|2|||
130026202|NCT01557166|468055905|FG001|Overall Study|Unclassified|5|||
130026203|NCT01465659|468055906|FG000|Completed 1 Cycle of Treatment|Death|0|||
130026204|NCT01465659|468055907|FG001|Completed 1 Cycle of Treatment|Death|1|||
130026205|NCT01465659|468055908|FG002|Completed 1 Cycle of Treatment|Death|0|||
130026206|NCT01465659|468055909|FG003|Completed 1 Cycle of Treatment|Death|0|||
130026207|NCT01465659|468055906|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
130026208|NCT01465659|468055907|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
130026209|NCT01465659|468055908|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
130026210|NCT01465659|468055909|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
130026211|NCT01465659|468055906|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
130026212|NCT01465659|468055907|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
130026213|NCT01465659|468055908|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
130026214|NCT01465659|468055909|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
130026215|NCT01465659|468055906|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
130026216|NCT01465659|468055907|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
130026217|NCT01465659|468055908|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
130026218|NCT01465659|468055909|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
130026219|NCT01465659|468055906|FG000|Completed Follow for 1 Year|Death|6|||
130026220|NCT01465659|468055907|FG001|Completed Follow for 1 Year|Death|3|||
130026221|NCT01465659|468055908|FG002|Completed Follow for 1 Year|Death|2|||
130026222|NCT01465659|468055909|FG003|Completed Follow for 1 Year|Death|4|||
130026223|NCT02445586|468055910|FG000|Overall Study|Death|14|||
130026224|NCT02445586|468055910|FG000|Overall Study|Withdrawal by Subject|13|||
130026225|NCT02445586|468055910|FG000|Overall Study|Disease Progression|10|||
130026226|NCT02445586|468055910|FG000|Overall Study|Protocol Violation|1|||
130026227|NCT02445586|468055910|FG000|Overall Study|Medical Condition|1|||
130026228|NCT00428597|468055911|FG000|Overall Study|Randomized but not treated|3|||
130026229|NCT00428597|468055912|FG001|Overall Study|Randomized but not treated|3|||
130026230|NCT00428597|468055911|FG000|Overall Study|Objective Progression or Relapse|19|||
130026231|NCT00428597|468055912|FG001|Overall Study|Objective Progression or Relapse|47|||
130026232|NCT00428597|468055911|FG000|Overall Study|Study Terminated by Sponsor|41|||
130026233|NCT00428597|468055912|FG001|Overall Study|Study Terminated by Sponsor|16|||
130026234|NCT00428597|468055911|FG000|Overall Study|Adverse Event|15|||
130026235|NCT00428597|468055912|FG001|Overall Study|Adverse Event|7|||
130026236|NCT00428597|468055911|FG000|Overall Study|Global Deterioration of Health Status|1|||
130026237|NCT00428597|468055912|FG001|Overall Study|Global Deterioration of Health Status|5|||
130026238|NCT00428597|468055911|FG000|Overall Study|Protocol Violation|2|||
130026239|NCT00428597|468055912|FG001|Overall Study|Protocol Violation|1|||
130026240|NCT00428597|468055911|FG000|Overall Study|Withdrawal by Subject|2|||
130026241|NCT00428597|468055912|FG001|Overall Study|Withdrawal by Subject|1|||
130026242|NCT00428597|468055911|FG000|Overall Study|Other|1|||
130026243|NCT00428597|468055912|FG001|Overall Study|Other|1|||
130026244|NCT00428597|468055911|FG000|Overall Study|Lost to Follow-up|0|||
130026245|NCT00428597|468055912|FG001|Overall Study|Lost to Follow-up|1|||
130026246|NCT00428597|468055911|FG000|Overall Study|Pregnancy|1|||
130026247|NCT00428597|468055912|FG001|Overall Study|Pregnancy|0|||
130026248|NCT00428597|468055911|FG000|Overall Study|Death|1|||
130026249|NCT00428597|468055912|FG001|Overall Study|Death|3|||
130026250|NCT01469000|468055913|FG000|Overall Study|Withdrawal by Subject|16|||
130026251|NCT01469000|468055914|FG001|Overall Study|Withdrawal by Subject|3|||
130026252|NCT01469000|468055913|FG000|Overall Study|Sponsor Decision|4|||
130026253|NCT01469000|468055914|FG001|Overall Study|Sponsor Decision|1|||
130026254|NCT00686647|468055923|FG000|Overall Study|Lost to Follow-up|1|||
130026255|NCT00686647|468055923|FG000|Overall Study|Death|1|||
130026256|NCT05501119|468055932|FG000|Overall Study|Withdrawal by Subject|2|||
130026257|NCT05501119|468055932|FG000|Overall Study|Lost to Follow-up|5|||
130100151|NCT01035229|468325931|FG000|Overall Study|Withdrawal by Subject|20|||
130100152|NCT01035229|468325932|FG001|Overall Study|Withdrawal by Subject|7|||
130026258|NCT01356589|468055936|FG000|Overall Study|Enrolled, but not treated|3|||
130026259|NCT01356589|468055936|FG000|Overall Study|Dose data not recorded|2|||
130026260|NCT01462266|468055937|FG000|Overall Study|Adverse Event|7|||
130026261|NCT01462266|468055938|FG001|Overall Study|Adverse Event|6|||
130026262|NCT01462266|468055937|FG000|Overall Study|Death|2|||
130026263|NCT01462266|468055938|FG001|Overall Study|Death|1|||
130026264|NCT01462266|468055937|FG000|Overall Study|Lack of Efficacy|0|||
130026265|NCT01462266|468055938|FG001|Overall Study|Lack of Efficacy|2|||
130026266|NCT01462266|468055937|FG000|Overall Study|Lost to Follow-up|4|||
130026267|NCT01462266|468055938|FG001|Overall Study|Lost to Follow-up|3|||
130026268|NCT01462266|468055937|FG000|Overall Study|Non-compliance with study drug|3|||
130026269|NCT01462266|468055938|FG001|Overall Study|Non-compliance with study drug|0|||
130026270|NCT01462266|468055937|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
130026271|NCT01462266|468055938|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
130026272|NCT01462266|468055937|FG000|Overall Study|Physician Decision|2|||
130026273|NCT01462266|468055938|FG001|Overall Study|Physician Decision|5|||
130026274|NCT01462266|468055937|FG000|Overall Study|Protocol Violation|1|||
130026275|NCT01462266|468055938|FG001|Overall Study|Protocol Violation|3|||
130026276|NCT01462266|468055937|FG000|Overall Study|Withdrawal by Subject|7|||
130026277|NCT01462266|468055938|FG001|Overall Study|Withdrawal by Subject|2|||
130026278|NCT01462266|468055937|FG000|Overall Study|Screen failure|1|||
130026279|NCT01462266|468055938|FG001|Overall Study|Screen failure|1|||
130026280|NCT01106846|468055939|FG000|Overall Study|Change in surgical procedure|0|||
130026281|NCT01106846|468055940|FG001|Overall Study|Change in surgical procedure|1|||
130026282|NCT02447848|468055949|FG000|Overall Study|Patient discharged|3|||
130026283|NCT02447848|468055949|FG000|Overall Study|Lack of Efficacy|4|||
130026284|NCT02447848|468055949|FG000|Overall Study|Withdrawal by Subject|4|||
130026285|NCT04698629|468055951|FG000|Overall Study|Adverse Event|1|||
130026286|NCT03344003|468055952|FG000|Overall Study|Switched to alternative treatment|1|||
130026287|NCT03344003|468055953|FG001|Overall Study|Switched to alternative treatment|0|||
130026288|NCT03344003|468055952|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
130026289|NCT03344003|468055953|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
130026290|NCT05847686|468057828|FG000|Overall Study|Withdrawal by Subject|3|||
130026291|NCT06272370|468057829|FG000|Overall Study|Lost to Follow-up|0|||
130026292|NCT06272370|468057830|FG001|Overall Study|Lost to Follow-up|3|||
130026293|NCT06272370|468057831|FG002|Overall Study|Lost to Follow-up|1|||
130026294|NCT06272370|468057832|FG003|Overall Study|Lost to Follow-up|1|||
130026295|NCT00352534|468057834|FG000|Initial Staging|Ineligible|8|||
130026296|NCT00352534|468057835|FG001|Initial Staging|Ineligible|9|||
130026297|NCT00352534|468057836|FG002|Initial Staging|Ineligible|0|||
130026298|NCT00352534|468057837|FG003|Initial Staging|Ineligible|0|||
130026299|NCT00352534|468057838|FG004|Initial Staging|Ineligible|0|||
130026300|NCT00352534|468057839|FG005|Initial Staging|Ineligible|0|||
130026301|NCT00352534|468057840|FG006|Initial Staging|Ineligible|0|||
130026302|NCT00352534|468057834|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
130026303|NCT00352534|468057835|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
130026304|NCT00352534|468057836|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
130026305|NCT00352534|468057837|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
130026306|NCT00352534|468057838|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
130026307|NCT00352534|468057839|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
130026308|NCT00352534|468057840|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
130026309|NCT00352534|468057834|FG000|Final Risk Group Assignment|Physician Decision|0|||
130026310|NCT00352534|468057835|FG001|Final Risk Group Assignment|Physician Decision|0|||
130026311|NCT00352534|468057836|FG002|Final Risk Group Assignment|Physician Decision|0|||
130026312|NCT00352534|468057837|FG003|Final Risk Group Assignment|Physician Decision|0|||
130026313|NCT00352534|468057838|FG004|Final Risk Group Assignment|Physician Decision|0|||
130026314|NCT00352534|468057839|FG005|Final Risk Group Assignment|Physician Decision|8|||
130026315|NCT00352534|468057840|FG006|Final Risk Group Assignment|Physician Decision|0|||
130026316|NCT00352534|468057834|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
130026317|NCT00352534|468057835|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
130026318|NCT00352534|468057836|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
130026319|NCT00352534|468057837|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
130026320|NCT00352534|468057838|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
130026321|NCT00352534|468057839|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
130026322|NCT00352534|468057840|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
130026323|NCT00352534|468057834|FG000|Final Risk Group Assignment|Ineligible|0|||
130026324|NCT00352534|468057835|FG001|Final Risk Group Assignment|Ineligible|0|||
130026325|NCT00352534|468057836|FG002|Final Risk Group Assignment|Ineligible|3|||
130026326|NCT00352534|468057837|FG003|Final Risk Group Assignment|Ineligible|1|||
130026327|NCT00352534|468057838|FG004|Final Risk Group Assignment|Ineligible|0|||
130100153|NCT01035229|468325931|FG000|Overall Study|Lost to Follow-up|1|||
130237189|NCT05376358|468831874|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
130237190|NCT05376358|468831873|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
130237191|NCT05376358|468831874|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
130237192|NCT03965923|468831875|FG000|Overall Study|Withdrawal by Subject|1|||
130237193|NCT03965923|468831876|FG001|Overall Study|Withdrawal by Subject|2|||
130100154|NCT01035229|468325932|FG001|Overall Study|Lost to Follow-up|0|||
130100155|NCT01035229|468325931|FG000|Overall Study|Administrative problems|1|||
130026328|NCT00352534|468057839|FG005|Final Risk Group Assignment|Ineligible|13|||
130026329|NCT00352534|468057840|FG006|Final Risk Group Assignment|Ineligible|0|||
130026330|NCT00352534|468057834|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130237194|NCT03965923|468831877|FG002|Overall Study|Withdrawal by Subject|3|||
130026331|NCT00352534|468057835|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130026332|NCT00352534|468057836|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130237195|NCT03965923|468831878|FG003|Overall Study|Withdrawal by Subject|1|||
130237196|NCT03965923|468831879|FG004|Overall Study|Withdrawal by Subject|2|||
130237197|NCT03965923|468831880|FG005|Overall Study|Withdrawal by Subject|0|||
130237198|NCT03965923|468831881|FG006|Overall Study|Withdrawal by Subject|4|||
130237199|NCT03965923|468831882|FG007|Overall Study|Withdrawal by Subject|3|||
130237200|NCT03965923|468831883|FG008|Overall Study|Withdrawal by Subject|4|||
130237201|NCT03965923|468831884|FG009|Overall Study|Withdrawal by Subject|0|||
130237202|NCT03965923|468831885|FG010|Overall Study|Withdrawal by Subject|2|||
130237203|NCT03965923|468831886|FG011|Overall Study|Withdrawal by Subject|0|||
130237204|NCT03965923|468831875|FG000|Overall Study|Lost to Follow-up|2|||
130237205|NCT03965923|468831876|FG001|Overall Study|Lost to Follow-up|1|||
130237206|NCT03965923|468831877|FG002|Overall Study|Lost to Follow-up|1|||
130237207|NCT03965923|468831878|FG003|Overall Study|Lost to Follow-up|0|||
130237208|NCT03965923|468831879|FG004|Overall Study|Lost to Follow-up|2|||
130237209|NCT03965923|468831880|FG005|Overall Study|Lost to Follow-up|1|||
130237210|NCT03965923|468831881|FG006|Overall Study|Lost to Follow-up|2|||
130237211|NCT03965923|468831882|FG007|Overall Study|Lost to Follow-up|1|||
130237212|NCT03965923|468831883|FG008|Overall Study|Lost to Follow-up|0|||
130237213|NCT03965923|468831884|FG009|Overall Study|Lost to Follow-up|2|||
130100156|NCT01035229|468325932|FG001|Overall Study|Administrative problems|1|||
130237214|NCT03965923|468831885|FG010|Overall Study|Lost to Follow-up|0|||
130237215|NCT03965923|468831886|FG011|Overall Study|Lost to Follow-up|0|||
130237216|NCT03965923|468831875|FG000|Overall Study|Death|0|||
130237217|NCT03965923|468831876|FG001|Overall Study|Death|0|||
130237218|NCT03965923|468831877|FG002|Overall Study|Death|0|||
130026333|NCT00352534|468057837|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130026334|NCT00352534|468057838|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130026335|NCT00352534|468057839|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
130026336|NCT00352534|468057840|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
130026337|NCT00352534|468057834|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130026338|NCT00352534|468057835|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130026339|NCT00352534|468057836|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130026340|NCT00352534|468057837|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130026341|NCT00352534|468057838|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130026342|NCT00352534|468057839|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
130026343|NCT00352534|468057840|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
130026344|NCT00352534|468057834|FG000|Final Risk Group Assignment|Death|0|||
130026345|NCT00352534|468057835|FG001|Final Risk Group Assignment|Death|0|||
130026346|NCT00352534|468057836|FG002|Final Risk Group Assignment|Death|0|||
130026347|NCT00352534|468057837|FG003|Final Risk Group Assignment|Death|0|||
130026348|NCT00352534|468057838|FG004|Final Risk Group Assignment|Death|0|||
130026349|NCT00352534|468057839|FG005|Final Risk Group Assignment|Death|2|||
130026350|NCT00352534|468057840|FG006|Final Risk Group Assignment|Death|0|||
130026351|NCT01602341|468057841|FG000|Overall Study|Adverse Event|0|||
130237219|NCT03965923|468831878|FG003|Overall Study|Death|0|||
130237220|NCT03965923|468831879|FG004|Overall Study|Death|0|||
130237221|NCT03965923|468831880|FG005|Overall Study|Death|0|||
130237222|NCT03965923|468831881|FG006|Overall Study|Death|0|||
130237223|NCT03965923|468831882|FG007|Overall Study|Death|1|||
130026352|NCT01602341|468057842|FG001|Overall Study|Adverse Event|1|||
130026353|NCT04439279|468057843|FG000|Overall Study|Adverse Event|7|||
130026354|NCT04439279|468057843|FG000|Overall Study|Death|4|||
130026355|NCT04439279|468057843|FG000|Overall Study|Disease progression|17|||
130026356|NCT04439279|468057843|FG000|Overall Study|Complicating disease|3|||
130026357|NCT04439279|468057843|FG000|Overall Study|Withdrawal by Subject|2|||
130026358|NCT04439279|468057843|FG000|Overall Study|Ineligible|1|||
130026359|NCT04439279|468057843|FG000|Overall Study|Treatment still ongoing|1|||
130026360|NCT03521791|468057844|FG000|Overall Study|Protocol Violation|7|||
130026361|NCT03521791|468057845|FG001|Overall Study|Protocol Violation|17|||
130026362|NCT02090855|468057846|FG000|Overall Study|no evaluable Standard of Truth results|2|||
130026363|NCT03038308|468057848|FG000|Overall Study|Surgical resection|1|||
130026364|NCT03038308|468057848|FG000|Overall Study|Withdrawal by Subject|2|||
130026365|NCT03038308|468057848|FG000|Overall Study|Lost to Follow-up|1|||
130026366|NCT01777763|468057860|FG000|Overall Study|Adverse Event|2|||
130026367|NCT01777763|468057861|FG001|Overall Study|Adverse Event|32|||
130026368|NCT01777763|468057860|FG000|Overall Study|Protocol Violation|1|||
130026369|NCT01777763|468057861|FG001|Overall Study|Protocol Violation|7|||
130026370|NCT01777763|468057860|FG000|Overall Study|Withdrawal by Subject|0|||
130026371|NCT01777763|468057861|FG001|Overall Study|Withdrawal by Subject|2|||
130026372|NCT01777763|468057860|FG000|Overall Study|Treatment Failure|1|||
130026373|NCT01777763|468057861|FG001|Overall Study|Treatment Failure|6|||
130026374|NCT01246206|468057870|FG000|Overall Study|Patient did not receive study regiments.|1|||
130026375|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
130026376|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
130026377|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
130026378|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
130026379|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
130026380|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
130026381|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
130026382|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
130026383|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
130026384|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
130026385|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
130026386|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
130026387|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
130026388|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
130237224|NCT03965923|468831883|FG008|Overall Study|Death|4|||
130237225|NCT03965923|468831884|FG009|Overall Study|Death|0|||
130237226|NCT03965923|468831885|FG010|Overall Study|Death|4|||
130237227|NCT03965923|468831886|FG011|Overall Study|Death|0|||
130237228|NCT03965923|468831875|FG000|Overall Study|Other reason|0|||
130237229|NCT03965923|468831876|FG001|Overall Study|Other reason|0|||
130026389|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
130026390|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
130026391|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
130026392|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
130237230|NCT03965923|468831877|FG002|Overall Study|Other reason|0|||
130237231|NCT03965923|468831878|FG003|Overall Study|Other reason|1|||
130237232|NCT03965923|468831879|FG004|Overall Study|Other reason|0|||
130237233|NCT03965923|468831880|FG005|Overall Study|Other reason|0|||
130237234|NCT03965923|468831881|FG006|Overall Study|Other reason|0|||
130237235|NCT03965923|468831882|FG007|Overall Study|Other reason|0|||
130237236|NCT03965923|468831883|FG008|Overall Study|Other reason|0|||
130237237|NCT03965923|468831884|FG009|Overall Study|Other reason|0|||
130026393|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
130026394|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
130026395|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
130026396|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
130026397|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
130026398|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
130026399|NCT04660643|468057871|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
130026400|NCT04660643|468057872|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
130026401|NCT04660643|468057873|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
130026402|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
130026403|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
130026404|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
130026405|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
130026406|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
130026407|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
130026408|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
130026409|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
130026410|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
130026411|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
130026412|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
130026413|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
130026414|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
130026415|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
130026416|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
130026417|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
130026418|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
130026419|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
130026420|NCT04660643|468057871|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
130026421|NCT04660643|468057872|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
130026422|NCT04660643|468057873|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
130026423|NCT03988907|468057874|FG000|Overall Study|Unable to complete visit|0|||
130026424|NCT03988907|468057875|FG001|Overall Study|Unable to complete visit|1|||
130026425|NCT02810964|468057876|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
130026426|NCT02810964|468057877|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
130237238|NCT03965923|468831885|FG010|Overall Study|Other reason|2|||
130237239|NCT03965923|468831886|FG011|Overall Study|Other reason|0|||
130237240|NCT04221490|468831887|FG000|At 30 Days Follow-up|Death|7|||
130237241|NCT04221490|468831887|FG000|At 30 Days Follow-up|Missed Visit|4|||
130237242|NCT04221490|468831887|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
130237243|NCT04221490|468831887|FG000|At 6 Months Follow-up|Death|9|||
130237244|NCT04221490|468831887|FG000|At 6 Months Follow-up|Physician Decision|1|||
130237245|NCT04221490|468831887|FG000|At 6 Months Follow-up|Missed Visit|8|||
130237246|NCT04221490|468831887|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
130237247|NCT03034967|468831888|FG000|Overall Study|Withdrawal by Subject|9|||
130237248|NCT03034967|468831889|FG001|Overall Study|Withdrawal by Subject|2|||
130237249|NCT03034967|468831890|FG002|Overall Study|Withdrawal by Subject|6|||
130237250|NCT03034967|468831891|FG003|Overall Study|Withdrawal by Subject|6|||
130237251|NCT03034967|468831892|FG004|Overall Study|Withdrawal by Subject|9|||
130237252|NCT03034967|468831893|FG005|Overall Study|Withdrawal by Subject|2|||
130237253|NCT03034967|468831888|FG000|Overall Study|Physician Decision|1|||
130237254|NCT03034967|468831889|FG001|Overall Study|Physician Decision|0|||
130237255|NCT03034967|468831890|FG002|Overall Study|Physician Decision|1|||
130237256|NCT03034967|468831891|FG003|Overall Study|Physician Decision|1|||
130237257|NCT03034967|468831892|FG004|Overall Study|Physician Decision|1|||
130237258|NCT03034967|468831893|FG005|Overall Study|Physician Decision|0|||
130237259|NCT03034967|468831888|FG000|Overall Study|Lost to Follow-up|0|||
130237260|NCT03034967|468831889|FG001|Overall Study|Lost to Follow-up|0|||
130237261|NCT03034967|468831890|FG002|Overall Study|Lost to Follow-up|0|||
130237262|NCT03034967|468831891|FG003|Overall Study|Lost to Follow-up|1|||
130237263|NCT03034967|468831892|FG004|Overall Study|Lost to Follow-up|0|||
130237264|NCT03034967|468831893|FG005|Overall Study|Lost to Follow-up|2|||
130237265|NCT03034967|468831888|FG000|Overall Study|Liver function test abnormality|0|||
130026427|NCT02810964|468057876|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
130237266|NCT03034967|468831889|FG001|Overall Study|Liver function test abnormality|0|||
130237267|NCT03034967|468831890|FG002|Overall Study|Liver function test abnormality|1|||
130237268|NCT03034967|468831891|FG003|Overall Study|Liver function test abnormality|0|||
130026428|NCT02810964|468057877|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
130026429|NCT02810964|468057876|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
130026430|NCT02810964|468057877|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
130026431|NCT02810964|468057876|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
130026432|NCT02810964|468057877|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
130026433|NCT01171820|468057879|FG000|Overall Study|Death|3|||
130026434|NCT01171820|468057880|FG001|Overall Study|Death|3|||
130026435|NCT01171820|468057879|FG000|Overall Study|Lost to Follow-up|0|||
130026436|NCT01171820|468057880|FG001|Overall Study|Lost to Follow-up|1|||
130026437|NCT01171820|468057879|FG000|Overall Study|Withdrawal by Subject|2|||
130026438|NCT01171820|468057880|FG001|Overall Study|Withdrawal by Subject|0|||
130026439|NCT01171820|468057879|FG000|Overall Study|Physician Decision|0|||
130026440|NCT01171820|468057880|FG001|Overall Study|Physician Decision|1|||
130026441|NCT01171820|468057879|FG000|Overall Study|1-Year Missed Visit|1|||
130026442|NCT01171820|468057880|FG001|Overall Study|1-Year Missed Visit|1|||
130026443|NCT03969875|468057881|FG000|Overall Study|did not receive allocated intervention|3|||
130026444|NCT03969875|468057882|FG001|Overall Study|did not receive allocated intervention|3|||
130026445|NCT03969875|468057883|FG002|Overall Study|did not receive allocated intervention|4|||
130026446|NCT03969875|468057881|FG000|Overall Study|Protocol Violation|4|||
130026447|NCT03969875|468057882|FG001|Overall Study|Protocol Violation|2|||
130026448|NCT03969875|468057883|FG002|Overall Study|Protocol Violation|2|||
130026449|NCT01307033|468057884|FG000|8-week Double-blind Period|Adverse Event|2|||
130026450|NCT01307033|468057885|FG001|8-week Double-blind Period|Adverse Event|0|||
130026451|NCT01307033|468057886|FG002|8-week Double-blind Period|Adverse Event|0|||
130026452|NCT01307033|468057887|FG003|8-week Double-blind Period|Adverse Event|0|||
130026453|NCT01307033|468057884|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
130026454|NCT01307033|468057885|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
130026455|NCT01307033|468057886|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
130026456|NCT01307033|468057887|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
130026457|NCT01307033|468057884|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
130026458|NCT01307033|468057885|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
130026459|NCT01307033|468057886|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
130026460|NCT01307033|468057887|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
130026461|NCT01307033|468057884|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
130026462|NCT01307033|468057885|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
130026463|NCT01307033|468057886|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
130026464|NCT01307033|468057887|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
130026465|NCT01307033|468057884|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
130026466|NCT01307033|468057885|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
130026467|NCT01307033|468057886|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
130026468|NCT01307033|468057887|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
130026469|NCT01307033|468057884|FG000|44-week Open-label Extension|Adverse Event|0|||
130026470|NCT01307033|468057885|FG001|44-week Open-label Extension|Adverse Event|0|||
130026471|NCT01307033|468057886|FG002|44-week Open-label Extension|Adverse Event|2|||
130026472|NCT01307033|468057887|FG003|44-week Open-label Extension|Adverse Event|1|||
130026473|NCT01307033|468057884|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
130026474|NCT01307033|468057885|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
130026475|NCT01307033|468057886|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
130026476|NCT01307033|468057887|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
130026477|NCT01307033|468057884|FG000|44-week Open-label Extension|Physician Decision|0|||
130026478|NCT01307033|468057885|FG001|44-week Open-label Extension|Physician Decision|0|||
130026479|NCT01307033|468057886|FG002|44-week Open-label Extension|Physician Decision|1|||
130026480|NCT01307033|468057887|FG003|44-week Open-label Extension|Physician Decision|0|||
130026481|NCT01307033|468057884|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
130026482|NCT01307033|468057885|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
130026483|NCT01307033|468057886|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
130026484|NCT01307033|468057887|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
130026485|NCT01307033|468057884|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
130026486|NCT01307033|468057885|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
130026487|NCT01307033|468057886|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
130026488|NCT01307033|468057887|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
130026489|NCT01307033|468057884|FG000|44-week Open-label Extension|Death|0|||
130026490|NCT01307033|468057885|FG001|44-week Open-label Extension|Death|0|||
130026491|NCT01307033|468057886|FG002|44-week Open-label Extension|Death|0|||
130026492|NCT01307033|468057887|FG003|44-week Open-label Extension|Death|1|||
130026493|NCT01231555|468057888|FG000|Overall Study|Study terminated|8|||
130026494|NCT01231555|468057889|FG001|Overall Study|Study terminated|5|||
130026495|NCT01231555|468057890|FG002|Overall Study|Study terminated|8|||
130026496|NCT01231555|468057888|FG000|Overall Study|Withdrawal by Subject|0|||
130026497|NCT01231555|468057889|FG001|Overall Study|Withdrawal by Subject|2|||
130026498|NCT01231555|468057890|FG002|Overall Study|Withdrawal by Subject|0|||
130026499|NCT00927368|468057895|FG000|Overall Study|enrollment in another study|1|||
130026500|NCT00927368|468057896|FG001|Overall Study|enrollment in another study|1|||
130026501|NCT00927368|468057897|FG002|Overall Study|enrollment in another study|2|||
130026502|NCT00927368|468057895|FG000|Overall Study|Lost to Follow-up|4|||
130026503|NCT00927368|468057896|FG001|Overall Study|Lost to Follow-up|0|||
130026504|NCT00927368|468057897|FG002|Overall Study|Lost to Follow-up|0|||
130026505|NCT00927368|468057895|FG000|Overall Study|equipment failure|1|||
130026506|NCT00927368|468057896|FG001|Overall Study|equipment failure|0|||
130026507|NCT00927368|468057897|FG002|Overall Study|equipment failure|0|||
130026508|NCT00927368|468057895|FG000|Overall Study|ineligible post randomization|0|||
130026509|NCT00927368|468057896|FG001|Overall Study|ineligible post randomization|3|||
130026510|NCT00927368|468057897|FG002|Overall Study|ineligible post randomization|1|||
130026511|NCT00927368|468057895|FG000|Overall Study|cancellation of surgery|0|||
130026512|NCT00927368|468057896|FG001|Overall Study|cancellation of surgery|1|||
130026513|NCT00927368|468057897|FG002|Overall Study|cancellation of surgery|2|||
130026514|NCT00331409|468057898|FG000|Overall Study|Lack of Efficacy|4|||
130026515|NCT03370770|468057899|FG000|Overall Study|Patient was followed in another hospital center|1|||
130026516|NCT03370770|468057899|FG000|Overall Study|Progressive Disease|98|||
130026517|NCT03370770|468057899|FG000|Overall Study|Adverse Event|2|||
130026518|NCT03370770|468057899|FG000|Overall Study|Death|5|||
130026519|NCT00234039|468057900|FG000|Overall Study|Adverse Event|2|||
130026520|NCT00234039|468057900|FG000|Overall Study|Progression/relapse|34|||
130026521|NCT00234039|468057900|FG000|Overall Study|Other - Not Protocol Specified|3|||
130026522|NCT00234039|468057900|FG000|Overall Study|Ineligible|9|||
130026523|NCT00234039|468057900|FG000|Overall Study|No Protocol Treatment Received|2|||
130026524|NCT03683394|468057901|FG000|Overall Study|Withdrawal by Subject|4|||
130026525|NCT03683394|468057902|FG001|Overall Study|Withdrawal by Subject|8|||
130026526|NCT03683394|468057901|FG000|Overall Study|Lost to Follow-up|7|||
130026527|NCT03683394|468057902|FG001|Overall Study|Lost to Follow-up|0|||
130026528|NCT03683394|468057901|FG000|Overall Study|Death|3|||
130026529|NCT03683394|468057902|FG001|Overall Study|Death|1|||
130026530|NCT00559273|468057903|FG000|Correction Period (20 Weeks)|Death|3|||
130026531|NCT00559273|468057904|FG001|Correction Period (20 Weeks)|Death|4|||
130026532|NCT00559273|468057903|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
130026533|NCT00559273|468057904|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
130026534|NCT00559273|468057903|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
130026535|NCT00559273|468057904|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
130026536|NCT00559273|468057903|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
130026537|NCT00559273|468057904|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
130026538|NCT00559273|468057903|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
130026539|NCT00559273|468057904|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
130237269|NCT03034967|468831892|FG004|Overall Study|Liver function test abnormality|0|||
130237270|NCT03034967|468831893|FG005|Overall Study|Liver function test abnormality|0|||
130237271|NCT03034967|468831888|FG000|Overall Study|Protocol Violation|1|||
130237272|NCT03034967|468831889|FG001|Overall Study|Protocol Violation|0|||
130237273|NCT03034967|468831890|FG002|Overall Study|Protocol Violation|0|||
130026540|NCT00559273|468057903|FG000|Evaluation Period (8 Weeks)|Death|1|||
130026541|NCT00559273|468057904|FG001|Evaluation Period (8 Weeks)|Death|3|||
130026542|NCT00559273|468057903|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
130026543|NCT00559273|468057904|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
130026544|NCT00559273|468057903|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
130026545|NCT00559273|468057904|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
130026546|NCT00559273|468057903|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
130026547|NCT00559273|468057904|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
130026548|NCT00395967|468057905|FG000|Treatment Period|Failed Mobilization|1|||
130026549|NCT00395967|468057905|FG000|Follow-up Period|Death|1|||
130100157|NCT01035229|468325931|FG000|Overall Study|Death|13|||
130237274|NCT03034967|468831891|FG003|Overall Study|Protocol Violation|0|||
130026550|NCT00395967|468057905|FG000|Follow-up Period|Lost to Follow-up|1|||
130026551|NCT03653390|468057910|FG000|Overall Study|Lost to Follow-up|12|||
130026552|NCT03653390|468057911|FG001|Overall Study|Lost to Follow-up|8|||
130237275|NCT03034967|468831892|FG004|Overall Study|Protocol Violation|0|||
130237276|NCT03034967|468831893|FG005|Overall Study|Protocol Violation|2|||
130237277|NCT03034967|468831888|FG000|Overall Study|Lack of Efficacy|0|||
130237278|NCT03034967|468831889|FG001|Overall Study|Lack of Efficacy|1|||
130237279|NCT03034967|468831890|FG002|Overall Study|Lack of Efficacy|2|||
130237280|NCT03034967|468831891|FG003|Overall Study|Lack of Efficacy|1|||
130237281|NCT03034967|468831892|FG004|Overall Study|Lack of Efficacy|1|||
130237282|NCT03034967|468831893|FG005|Overall Study|Lack of Efficacy|0|||
130237283|NCT03034967|468831888|FG000|Overall Study|Adverse Event, non-fatal|3|||
130237284|NCT03034967|468831889|FG001|Overall Study|Adverse Event, non-fatal|1|||
130237285|NCT03034967|468831890|FG002|Overall Study|Adverse Event, non-fatal|2|||
130237286|NCT03034967|468831891|FG003|Overall Study|Adverse Event, non-fatal|0|||
130237287|NCT03034967|468831892|FG004|Overall Study|Adverse Event, non-fatal|2|||
130237288|NCT03034967|468831893|FG005|Overall Study|Adverse Event, non-fatal|8|||
130237289|NCT03034967|468831888|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
130237290|NCT03034967|468831889|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
130237291|NCT03034967|468831890|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
130237292|NCT03034967|468831891|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
130237293|NCT03034967|468831892|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
130237294|NCT03034967|468831893|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
130237295|NCT04225039|468831900|FG000|Overall Study|Withdrawal by Subject|1|||
130237296|NCT04225039|468831901|FG001|Overall Study|Withdrawal by Subject|0|||
130237297|NCT04225039|468831902|FG002|Overall Study|Withdrawal by Subject|0|||
130237298|NCT04225039|468831903|FG003|Overall Study|Withdrawal by Subject|1|||
130237299|NCT04225039|468831900|FG000|Overall Study|Currently active on study treatment|0|||
130237300|NCT04225039|468831901|FG001|Overall Study|Currently active on study treatment|1|||
130237301|NCT04225039|468831902|FG002|Overall Study|Currently active on study treatment|0|||
130237302|NCT04225039|468831903|FG003|Overall Study|Currently active on study treatment|0|||
130237303|NCT04225039|468831900|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
130237304|NCT04225039|468831901|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130237305|NCT04225039|468831902|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130237306|NCT04225039|468831903|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
130237307|NCT04225039|468831900|FG000|Overall Study|Ineligible for treatment|0|||
130237308|NCT04225039|468831901|FG001|Overall Study|Ineligible for treatment|0|||
130237309|NCT04225039|468831902|FG002|Overall Study|Ineligible for treatment|0|||
130237310|NCT04225039|468831903|FG003|Overall Study|Ineligible for treatment|4|||
130237311|NCT02802228|468831905|FG000|Overall Study|Withdrawal by Subject|2|||
130237312|NCT02802228|468831906|FG001|Overall Study|Withdrawal by Subject|0|||
130237313|NCT02802228|468831905|FG000|Overall Study|Lost to Follow-up|1|||
130237314|NCT02802228|468831906|FG001|Overall Study|Lost to Follow-up|0|||
130237315|NCT02802228|468831905|FG000|Overall Study|Adverse Event|1|||
130237316|NCT02802228|468831906|FG001|Overall Study|Adverse Event|0|||
130237317|NCT02802228|468831905|FG000|Overall Study|Physician Decision|1|||
130237318|NCT02802228|468831906|FG001|Overall Study|Physician Decision|0|||
130237319|NCT02225587|468831907|FG000|Overall Study|Adverse Event|5|||
130237320|NCT02225587|468831908|FG001|Overall Study|Adverse Event|5|||
130237321|NCT02225587|468831907|FG000|Overall Study|Lost to Follow-up|5|||
130237322|NCT02225587|468831908|FG001|Overall Study|Lost to Follow-up|5|||
130237323|NCT02225587|468831907|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130237324|NCT02225587|468831908|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130237325|NCT02225587|468831907|FG000|Overall Study|Physician Decision|2|||
130237326|NCT02225587|468831908|FG001|Overall Study|Physician Decision|0|||
130237327|NCT02225587|468831907|FG000|Overall Study|Protocol Violation|1|||
130237328|NCT02225587|468831908|FG001|Overall Study|Protocol Violation|0|||
130237329|NCT02225587|468831907|FG000|Overall Study|Participant Moved|1|||
130237330|NCT02225587|468831908|FG001|Overall Study|Participant Moved|0|||
130237331|NCT02225587|468831907|FG000|Overall Study|Withdrawal by Subject|13|||
130237332|NCT02225587|468831908|FG001|Overall Study|Withdrawal by Subject|28|||
130237333|NCT02879695|468831911|FG000|Overall Study|Did not start study treatment|2|||
130237334|NCT02879695|468831912|FG001|Overall Study|Did not start study treatment|0|||
130237335|NCT02879695|468831913|FG002|Overall Study|Did not start study treatment|3|||
130237336|NCT02879695|468831914|FG003|Overall Study|Did not start study treatment|0|||
130237337|NCT00157755|468831917|FG000|Overall Study|Death|2|||
130237338|NCT00157755|468831918|FG001|Overall Study|Death|3|||
130237339|NCT00157755|468831919|FG002|Overall Study|Death|3|||
130237340|NCT00157755|468831920|FG003|Overall Study|Death|2|||
130237341|NCT00157755|468831921|FG004|Overall Study|Death|0|||
130237342|NCT00157755|468831922|FG005|Overall Study|Death|0|||
130237343|NCT00157755|468831917|FG000|Overall Study|Lost to Follow-up|0|||
130237344|NCT00157755|468831918|FG001|Overall Study|Lost to Follow-up|0|||
130237345|NCT00157755|468831919|FG002|Overall Study|Lost to Follow-up|1|||
130237346|NCT00157755|468831920|FG003|Overall Study|Lost to Follow-up|0|||
130237347|NCT00157755|468831921|FG004|Overall Study|Lost to Follow-up|0|||
130237348|NCT00157755|468831922|FG005|Overall Study|Lost to Follow-up|0|||
130237349|NCT00157755|468831917|FG000|Overall Study|Withdrawal by Subject|0|||
130237350|NCT00157755|468831918|FG001|Overall Study|Withdrawal by Subject|0|||
130237351|NCT00157755|468831919|FG002|Overall Study|Withdrawal by Subject|1|||
130237352|NCT00157755|468831920|FG003|Overall Study|Withdrawal by Subject|1|||
130237353|NCT00157755|468831921|FG004|Overall Study|Withdrawal by Subject|1|||
130237354|NCT00157755|468831922|FG005|Overall Study|Withdrawal by Subject|2|||
130237355|NCT00157755|468831917|FG000|Overall Study|Explant due to infection|0|||
130237356|NCT00157755|468831918|FG001|Overall Study|Explant due to infection|0|||
130237357|NCT00157755|468831919|FG002|Overall Study|Explant due to infection|1|||
130237358|NCT00157755|468831920|FG003|Overall Study|Explant due to infection|0|||
130237359|NCT00157755|468831921|FG004|Overall Study|Explant due to infection|0|||
130237360|NCT00157755|468831922|FG005|Overall Study|Explant due to infection|0|||
130237361|NCT00157755|468831917|FG000|Overall Study|Medical reason|0|||
130237362|NCT00157755|468831918|FG001|Overall Study|Medical reason|0|||
130237363|NCT00157755|468831919|FG002|Overall Study|Medical reason|1|||
130237364|NCT00157755|468831920|FG003|Overall Study|Medical reason|1|||
130237365|NCT00157755|468831921|FG004|Overall Study|Medical reason|0|||
130237366|NCT00157755|468831922|FG005|Overall Study|Medical reason|0|||
130237367|NCT00157755|468831917|FG000|Overall Study|Study site closure|0|||
130237368|NCT00157755|468831918|FG001|Overall Study|Study site closure|1|||
130237369|NCT00157755|468831919|FG002|Overall Study|Study site closure|0|||
130237370|NCT00157755|468831920|FG003|Overall Study|Study site closure|0|||
130237371|NCT00157755|468831921|FG004|Overall Study|Study site closure|0|||
130237372|NCT00157755|468831922|FG005|Overall Study|Study site closure|0|||
130237373|NCT00157755|468831917|FG000|Overall Study|Subject non-compliance|0|||
130237374|NCT00157755|468831918|FG001|Overall Study|Subject non-compliance|0|||
130237375|NCT00157755|468831919|FG002|Overall Study|Subject non-compliance|0|||
130237376|NCT00157755|468831920|FG003|Overall Study|Subject non-compliance|0|||
130237377|NCT00157755|468831921|FG004|Overall Study|Subject non-compliance|0|||
130237378|NCT00157755|468831922|FG005|Overall Study|Subject non-compliance|1|||
130237379|NCT00157755|468831917|FG000|Overall Study|Study completion|0|||
130237380|NCT00157755|468831918|FG001|Overall Study|Study completion|0|||
130237381|NCT00157755|468831919|FG002|Overall Study|Study completion|0|||
130237382|NCT00157755|468831920|FG003|Overall Study|Study completion|0|||
130237383|NCT00157755|468831921|FG004|Overall Study|Study completion|1|||
130237384|NCT00157755|468831922|FG005|Overall Study|Study completion|2|||
130237385|NCT05523297|468831927|FG000|Overall Study|Death|7|||
130237386|NCT05523297|468831928|FG001|Overall Study|Death|8|||
130237387|NCT05523297|468831927|FG000|Overall Study|Lost to Follow-up|2|||
130237388|NCT05523297|468831928|FG001|Overall Study|Lost to Follow-up|1|||
130237389|NCT03462680|468831929|FG000|Overall Study|Withdrawal by Subject|3|||
130237390|NCT03462680|468831930|FG001|Overall Study|Withdrawal by Subject|5|||
130237391|NCT02246777|468831931|FG000|Overall Study|Adverse Event|2|||
130237392|NCT02246777|468831931|FG000|Overall Study|Change of residence|1|||
130237393|NCT04133909|468831932|FG000|Overall Study|Death|11|||
130237394|NCT04133909|468831933|FG001|Overall Study|Death|11|||
130237395|NCT04133909|468831932|FG000|Overall Study|Adverse Event|4|||
130237396|NCT04133909|468831933|FG001|Overall Study|Adverse Event|5|||
130237397|NCT04133909|468831932|FG000|Overall Study|Lost to Follow-up|3|||
130237398|NCT04133909|468831933|FG001|Overall Study|Lost to Follow-up|5|||
130237399|NCT04133909|468831932|FG000|Overall Study|Physician Decision|4|||
130237400|NCT04133909|468831933|FG001|Overall Study|Physician Decision|7|||
130237401|NCT04133909|468831932|FG000|Overall Study|Withdrawal by Subject|40|||
130237402|NCT04133909|468831933|FG001|Overall Study|Withdrawal by Subject|35|||
130237403|NCT04133909|468831932|FG000|Overall Study|Lack of Efficacy|2|||
130237404|NCT04133909|468831933|FG001|Overall Study|Lack of Efficacy|7|||
130237405|NCT04133909|468831932|FG000|Overall Study|Randomized in error|1|||
130237406|NCT04133909|468831933|FG001|Overall Study|Randomized in error|1|||
130237407|NCT04817410|468833957|FG000|Overall Study|Withdrawal by Subject|5|||
130237408|NCT04817410|468833957|FG000|Overall Study|Physician Decision|3|||
130237409|NCT03595748|468833958|FG000|Overall Study|Death|11|||
130237410|NCT03595748|468833959|FG001|Overall Study|Death|12|||
130237411|NCT03595748|468833958|FG000|Overall Study|Withdrawal by Subject|28|||
130237412|NCT03595748|468833959|FG001|Overall Study|Withdrawal by Subject|29|||
130100158|NCT01035229|468325932|FG001|Overall Study|Death|5|||
130237413|NCT03595748|468833958|FG000|Overall Study|Protocol Violation|0|||
130237414|NCT03595748|468833959|FG001|Overall Study|Protocol Violation|1|||
130237415|NCT04809974|468833961|FG000|Lead-in Phase|Withdrawal by Subject|3|||
130237416|NCT04809974|468833962|FG001|Lead-in Phase|Withdrawal by Subject|0|||
130237417|NCT04809974|468833963|FG002|Lead-in Phase|Withdrawal by Subject|0|||
130237418|NCT04809974|468833961|FG000|Lead-in Phase|No longer eligible|11|||
130237419|NCT04809974|468833962|FG001|Lead-in Phase|No longer eligible|0|||
130237420|NCT04809974|468833963|FG002|Lead-in Phase|No longer eligible|0|||
130237421|NCT04809974|468833961|FG000|Randomized Phase|Lost to Follow-up|0|||
130237422|NCT04809974|468833962|FG001|Randomized Phase|Lost to Follow-up|1|||
130100159|NCT01035229|468325931|FG000|Overall Study|New cancer therapy|2|||
130100160|NCT01035229|468325932|FG001|Overall Study|New cancer therapy|0|||
130100161|NCT01035229|468325931|FG000|Overall Study|Protocol Violation|0|||
130100162|NCT01035229|468325932|FG001|Overall Study|Protocol Violation|2|||
130100163|NCT01035229|468325931|FG000|Overall Study|Sponsor's decision to end study|3|||
130100164|NCT01035229|468325932|FG001|Overall Study|Sponsor's decision to end study|3|||
130100165|NCT01035229|468325931|FG000|Overall Study|Disease Progression|261|||
130100166|NCT01035229|468325932|FG001|Overall Study|Disease Progression|152|||
130237423|NCT04809974|468833963|FG002|Randomized Phase|Lost to Follow-up|5|||
130237424|NCT04809974|468833961|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
130237425|NCT04809974|468833962|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
130026553|NCT03653390|468057912|FG002|Overall Study|Lost to Follow-up|7|||
130026554|NCT03653390|468057910|FG000|Overall Study|Withdrawal by Subject|6|||
130026555|NCT03653390|468057911|FG001|Overall Study|Withdrawal by Subject|1|||
130026556|NCT03653390|468057912|FG002|Overall Study|Withdrawal by Subject|1|||
130026557|NCT03653390|468057910|FG000|Overall Study|Death|1|||
130026558|NCT03653390|468057911|FG001|Overall Study|Death|0|||
130026559|NCT03653390|468057912|FG002|Overall Study|Death|0|||
130026560|NCT03653390|468057910|FG000|Overall Study|Paper Survey Lost|1|||
130026561|NCT03653390|468057911|FG001|Overall Study|Paper Survey Lost|0|||
130026562|NCT03653390|468057912|FG002|Overall Study|Paper Survey Lost|0|||
130026563|NCT03118947|468057913|FG000|Overall Study|Adverse Event|7|||
130026564|NCT03118947|468057913|FG000|Overall Study|Death|3|||
130026565|NCT03118947|468057913|FG000|Overall Study|Lack of Efficacy|4|||
130026566|NCT03118947|468057913|FG000|Overall Study|Non-compliance with study drug|1|||
130026567|NCT03118947|468057913|FG000|Overall Study|Protocol Violation|2|||
130026568|NCT03118947|468057913|FG000|Overall Study|Withdrawal by Subject|3|||
130026569|NCT03118947|468057913|FG000|Overall Study|Withdrawal by caregiver|3|||
130026570|NCT03118947|468057913|FG000|Overall Study|Change in patient's living situation|4|||
130026571|NCT03118947|468057913|FG000|Overall Study|Lost to Follow-up|2|||
130026572|NCT01109940|468057914|FG000|Overall Study|Administrative problems|2|||
130026573|NCT01109940|468057915|FG001|Overall Study|Administrative problems|0|||
130026574|NCT01109940|468057916|FG002|Overall Study|Administrative problems|0|||
130026575|NCT01109940|468057917|FG003|Overall Study|Administrative problems|0|||
130026576|NCT01109940|468057914|FG000|Overall Study|Serious Adverse Event|2|||
130026577|NCT01109940|468057915|FG001|Overall Study|Serious Adverse Event|1|||
130026578|NCT01109940|468057916|FG002|Overall Study|Serious Adverse Event|0|||
130026579|NCT01109940|468057917|FG003|Overall Study|Serious Adverse Event|0|||
130026580|NCT01109940|468057914|FG000|Overall Study|Lost to Follow-up|1|||
130026581|NCT01109940|468057915|FG001|Overall Study|Lost to Follow-up|0|||
130026582|NCT01109940|468057916|FG002|Overall Study|Lost to Follow-up|0|||
130026583|NCT01109940|468057917|FG003|Overall Study|Lost to Follow-up|0|||
130026584|NCT01109940|468057914|FG000|Overall Study|Patient withdrew consent|1|||
130026585|NCT01109940|468057915|FG001|Overall Study|Patient withdrew consent|1|||
130026586|NCT01109940|468057916|FG002|Overall Study|Patient withdrew consent|0|||
130026587|NCT01109940|468057917|FG003|Overall Study|Patient withdrew consent|0|||
130026588|NCT01109940|468057914|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130026589|NCT01109940|468057915|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130026590|NCT01109940|468057916|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130237426|NCT04809974|468833963|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
130237427|NCT04809974|468833961|FG000|Randomized Phase|Adverse Event|0|||
130237428|NCT04809974|468833962|FG001|Randomized Phase|Adverse Event|1|||
130237429|NCT04809974|468833963|FG002|Randomized Phase|Adverse Event|4|||
130237430|NCT04809974|468833961|FG000|Randomized Phase|Withdrawal by Subject|0|||
130237431|NCT04809974|468833962|FG001|Randomized Phase|Withdrawal by Subject|0|||
130237432|NCT04809974|468833963|FG002|Randomized Phase|Withdrawal by Subject|5|||
130237433|NCT05493111|468833964|FG000|Overall Study|Adverse Event|3|||
130237434|NCT05493111|468833965|FG001|Overall Study|Adverse Event|4|||
130026591|NCT01109940|468057917|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130026592|NCT01262976|468057920|FG000|Up to Month 2|Serious Adverse Event|0|||
130026593|NCT01262976|468057921|FG001|Up to Month 2|Serious Adverse Event|0|||
130026594|NCT01262976|468057922|FG002|Up to Month 2|Serious Adverse Event|1|||
130026595|NCT01262976|468057923|FG003|Up to Month 2|Serious Adverse Event|0|||
130026596|NCT01262976|468057924|FG004|Up to Month 2|Serious Adverse Event|0|||
130026597|NCT01262976|468057925|FG005|Up to Month 2|Serious Adverse Event|0|||
130026598|NCT01262976|468057920|FG000|Up to Month 2|Withdrawal by Subject|1|||
130026599|NCT01262976|468057921|FG001|Up to Month 2|Withdrawal by Subject|0|||
130026600|NCT01262976|468057922|FG002|Up to Month 2|Withdrawal by Subject|0|||
130026601|NCT01262976|468057923|FG003|Up to Month 2|Withdrawal by Subject|0|||
130026602|NCT01262976|468057924|FG004|Up to Month 2|Withdrawal by Subject|0|||
130026603|NCT01262976|468057925|FG005|Up to Month 2|Withdrawal by Subject|0|||
130026604|NCT01262976|468057920|FG000|Up to Month 2|Migrated/moved from study area|0|||
130026605|NCT01262976|468057921|FG001|Up to Month 2|Migrated/moved from study area|1|||
130026606|NCT01262976|468057922|FG002|Up to Month 2|Migrated/moved from study area|0|||
130026607|NCT01262976|468057923|FG003|Up to Month 2|Migrated/moved from study area|0|||
130026608|NCT01262976|468057924|FG004|Up to Month 2|Migrated/moved from study area|1|||
130026609|NCT01262976|468057925|FG005|Up to Month 2|Migrated/moved from study area|1|||
130237435|NCT05493111|468833964|FG000|Overall Study|Withdrawal of Consent|19|||
130237436|NCT05493111|468833965|FG001|Overall Study|Withdrawal of Consent|10|||
130237437|NCT05493111|468833964|FG000|Overall Study|Non-compliance|1|||
130026610|NCT01262976|468057920|FG000|Up to Month 2|Lost to Follow-up|1|||
130026611|NCT01262976|468057921|FG001|Up to Month 2|Lost to Follow-up|0|||
130026612|NCT01262976|468057922|FG002|Up to Month 2|Lost to Follow-up|0|||
130026613|NCT01262976|468057923|FG003|Up to Month 2|Lost to Follow-up|1|||
130026614|NCT01262976|468057924|FG004|Up to Month 2|Lost to Follow-up|1|||
130026615|NCT01262976|468057925|FG005|Up to Month 2|Lost to Follow-up|1|||
130026616|NCT01262976|468057920|FG000|Up to Month 2|Other|1|||
130026617|NCT01262976|468057921|FG001|Up to Month 2|Other|0|||
130026618|NCT01262976|468057922|FG002|Up to Month 2|Other|0|||
130026619|NCT01262976|468057923|FG003|Up to Month 2|Other|1|||
130026620|NCT01262976|468057924|FG004|Up to Month 2|Other|0|||
130026621|NCT01262976|468057925|FG005|Up to Month 2|Other|2|||
130026622|NCT01262976|468057920|FG000|Up to Month 7|Serious Adverse Event|0|||
130026623|NCT01262976|468057921|FG001|Up to Month 7|Serious Adverse Event|0|||
130026624|NCT01262976|468057922|FG002|Up to Month 7|Serious Adverse Event|2|||
130026625|NCT01262976|468057923|FG003|Up to Month 7|Serious Adverse Event|0|||
130026626|NCT01262976|468057924|FG004|Up to Month 7|Serious Adverse Event|0|||
130026627|NCT01262976|468057925|FG005|Up to Month 7|Serious Adverse Event|0|||
130026628|NCT01262976|468057920|FG000|Up to Month 7|Withdrawal by Subject|1|||
130026629|NCT01262976|468057921|FG001|Up to Month 7|Withdrawal by Subject|0|||
130026630|NCT01262976|468057922|FG002|Up to Month 7|Withdrawal by Subject|0|||
130237438|NCT05493111|468833965|FG001|Overall Study|Non-compliance|1|||
130237439|NCT05493111|468833964|FG000|Overall Study|Lost to Follow-up|8|||
130237440|NCT05493111|468833965|FG001|Overall Study|Lost to Follow-up|1|||
130237441|NCT05493111|468833964|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
130237442|NCT05493111|468833965|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
130237443|NCT05493111|468833964|FG000|Overall Study|Withdrawal by Subject|1|||
130237444|NCT05493111|468833965|FG001|Overall Study|Withdrawal by Subject|1|||
130237445|NCT06125964|468833966|FG000|Overall Study|Lost to Follow-up|0|||
130237446|NCT06125964|468833967|FG001|Overall Study|Lost to Follow-up|1|||
130237447|NCT06125964|468833968|FG002|Overall Study|Lost to Follow-up|0|||
130237448|NCT06125964|468833969|FG003|Overall Study|Lost to Follow-up|0|||
130237449|NCT01787838|468833970|FG000|Overall Study|refused|1413|||
130237450|NCT01431976|468833971|FG000|Overall Study|Adverse Event|6|||
130237451|NCT01431976|468833971|FG000|Overall Study|Lack of Efficacy|2|||
130237452|NCT01431976|468833971|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130237453|NCT01431976|468833971|FG000|Overall Study|Physician Decision|1|||
130237454|NCT01431976|468833971|FG000|Overall Study|Withdrawal by Subject|1|||
130237455|NCT01136954|468833973|FG000|Overall Study|Adverse Event|3|||
130237456|NCT01136954|468833974|FG001|Overall Study|Adverse Event|2|||
130237457|NCT01136954|468833973|FG000|Overall Study|Withdrawal by Subject|6|||
130237458|NCT01136954|468833974|FG001|Overall Study|Withdrawal by Subject|2|||
130237459|NCT01136954|468833973|FG000|Overall Study|Lack of Efficacy|14|||
130237460|NCT01136954|468833974|FG001|Overall Study|Lack of Efficacy|13|||
130026631|NCT01262976|468057923|FG003|Up to Month 7|Withdrawal by Subject|0|||
130026632|NCT01262976|468057924|FG004|Up to Month 7|Withdrawal by Subject|0|||
130026633|NCT01262976|468057925|FG005|Up to Month 7|Withdrawal by Subject|0|||
130237461|NCT01136954|468833973|FG000|Overall Study|Physician Decision|0|||
130237462|NCT01136954|468833974|FG001|Overall Study|Physician Decision|1|||
130237463|NCT01136954|468833973|FG000|Overall Study|Other|1|||
130026634|NCT01262976|468057920|FG000|Up to Month 7|Migrated/moved from study area|0|||
130026635|NCT01262976|468057921|FG001|Up to Month 7|Migrated/moved from study area|0|||
130026636|NCT01262976|468057922|FG002|Up to Month 7|Migrated/moved from study area|1|||
130026637|NCT01262976|468057923|FG003|Up to Month 7|Migrated/moved from study area|3|||
130026638|NCT01262976|468057924|FG004|Up to Month 7|Migrated/moved from study area|1|||
130026639|NCT01262976|468057925|FG005|Up to Month 7|Migrated/moved from study area|1|||
130026640|NCT01262976|468057920|FG000|Up to Month 7|Lost to Follow-up|1|||
130026641|NCT01262976|468057921|FG001|Up to Month 7|Lost to Follow-up|0|||
130026642|NCT01262976|468057922|FG002|Up to Month 7|Lost to Follow-up|1|||
130026643|NCT01262976|468057923|FG003|Up to Month 7|Lost to Follow-up|3|||
130026644|NCT01262976|468057924|FG004|Up to Month 7|Lost to Follow-up|1|||
130026645|NCT01262976|468057925|FG005|Up to Month 7|Lost to Follow-up|3|||
130026646|NCT01262976|468057920|FG000|Up to Month 7|Other|3|||
130100167|NCT00798707|468325934|FG000|Overall Study|Adverse Event|6|||
130100168|NCT00798707|468325935|FG001|Overall Study|Adverse Event|8|||
130100169|NCT00798707|468325936|FG002|Overall Study|Adverse Event|8|||
130100170|NCT00798707|468325934|FG000|Overall Study|Failed to return|2|||
130100171|NCT00798707|468325935|FG001|Overall Study|Failed to return|2|||
130100172|NCT00798707|468325936|FG002|Overall Study|Failed to return|0|||
130100173|NCT00798707|468325934|FG000|Overall Study|Investigator|0|||
130100174|NCT00798707|468325935|FG001|Overall Study|Investigator|1|||
130100175|NCT00798707|468325936|FG002|Overall Study|Investigator|2|||
130100176|NCT00798707|468325934|FG000|Overall Study|Lack of Efficacy|2|||
130100177|NCT00798707|468325935|FG001|Overall Study|Lack of Efficacy|2|||
130100178|NCT00798707|468325936|FG002|Overall Study|Lack of Efficacy|1|||
130100179|NCT00798707|468325934|FG000|Overall Study|Lost to Follow-up|5|||
130100180|NCT00798707|468325935|FG001|Overall Study|Lost to Follow-up|6|||
130100181|NCT00798707|468325936|FG002|Overall Study|Lost to Follow-up|6|||
130100182|NCT00798707|468325934|FG000|Overall Study|Other|0|||
130100183|NCT00798707|468325935|FG001|Overall Study|Other|1|||
130100184|NCT00798707|468325936|FG002|Overall Study|Other|0|||
130100185|NCT00798707|468325934|FG000|Overall Study|Protocol Violation|4|||
130100186|NCT00798707|468325935|FG001|Overall Study|Protocol Violation|0|||
130100187|NCT00798707|468325936|FG002|Overall Study|Protocol Violation|2|||
130100188|NCT00798707|468325934|FG000|Overall Study|Withdrawal by Subject|3|||
130100189|NCT00798707|468325935|FG001|Overall Study|Withdrawal by Subject|8|||
130100190|NCT00798707|468325936|FG002|Overall Study|Withdrawal by Subject|2|||
130100191|NCT00798707|468325934|FG000|Overall Study|Randomized not treated|4|||
130100192|NCT00798707|468325935|FG001|Overall Study|Randomized not treated|5|||
130100193|NCT00798707|468325936|FG002|Overall Study|Randomized not treated|1|||
130100194|NCT03256526|468325939|FG000|Overall Study|Adverse Event|1|||
130026647|NCT01262976|468057921|FG001|Up to Month 7|Other|0|||
130100195|NCT03256526|468325940|FG001|Overall Study|Adverse Event|0|||
130100196|NCT03256526|468325941|FG002|Overall Study|Adverse Event|1|||
130100197|NCT03256526|468325939|FG000|Overall Study|Lost to Follow-up|1|||
130100198|NCT03256526|468325940|FG001|Overall Study|Lost to Follow-up|0|||
130100199|NCT03256526|468325941|FG002|Overall Study|Lost to Follow-up|2|||
130026648|NCT01262976|468057922|FG002|Up to Month 7|Other|2|||
130026649|NCT01262976|468057923|FG003|Up to Month 7|Other|0|||
130100200|NCT02875340|468325942|FG000|Overall Study|Death|2|||
130100201|NCT02875340|468325942|FG000|Overall Study|Withdrawal by Subject|2|||
130026650|NCT01262976|468057924|FG004|Up to Month 7|Other|0|||
130026651|NCT01262976|468057925|FG005|Up to Month 7|Other|0|||
130237464|NCT01136954|468833974|FG001|Overall Study|Other|3|||
130237465|NCT00782067|468833975|FG000|Overall Study|Adverse Event|35|||
130237466|NCT00782067|468833975|FG000|Overall Study|Subject withdrew consent|11|||
130237467|NCT00782067|468833975|FG000|Overall Study|Lost to Follow-up|2|||
130237468|NCT00782067|468833975|FG000|Overall Study|Administrative problems|14|||
130237469|NCT00782067|468833975|FG000|Overall Study|Death|9|||
130237470|NCT00782067|468833975|FG000|Overall Study|Disease progression|43|||
130237471|NCT00782067|468833975|FG000|Overall Study|Protocol deviation|2|||
130237472|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
130237473|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
130237474|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
130237475|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
130237476|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
130237477|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
130237478|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
130237479|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
130237480|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
130237481|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
130237482|NCT00973973|468833981|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
130237483|NCT00973973|468833982|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
130237484|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
130237485|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
130237486|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
130237487|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
130237488|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
130237489|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
130237490|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
130237491|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
130237492|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
130237493|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
130237494|NCT00973973|468833981|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
130237495|NCT00973973|468833982|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
130237496|NCT02020941|468833983|FG000|Overall Study|Adverse Event|1|||
130237497|NCT02020941|468833983|FG000|Overall Study|Physician Decision|2|||
130237498|NCT02020941|468833983|FG000|Overall Study|Withdrawal by Subject|1|||
130237499|NCT02020941|468833983|FG000|Overall Study|Disease Progression|4|||
130237500|NCT02239328|468833991|FG000|Overall Study|Benign disease noted at time of surgery|6|||
130237501|NCT02239328|468833991|FG000|Overall Study|Equipment or website malfunction|2|||
130237502|NCT03483103|468833992|FG000|Pre-Treatment Phase|Other reasons|1|||
130237503|NCT03483103|468833992|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
130237504|NCT03483103|468833992|FG000|Pre-Treatment Phase|Disease-related complications|1|||
130237505|NCT03483103|468833992|FG000|Pre-Treatment Phase|Death|5|||
130237506|NCT03483103|468833992|FG000|Treatment Phase|Withdrawal by Subject|7|||
130237507|NCT03483103|468833992|FG000|Treatment Phase|Other reasons|1|||
130237508|NCT03483103|468833992|FG000|Treatment Phase|Death|23|||
130237509|NCT03483103|468833992|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
130237510|NCT03483103|468833992|FG000|Treatment Phase|Received nonconforming product|1|||
130237511|NCT01481779|468833993|FG000|Overall Study|Adverse Event|23|||
130237512|NCT01481779|468833994|FG001|Overall Study|Adverse Event|5|||
130237513|NCT01481779|468833993|FG000|Overall Study|Lost to Follow-up|3|||
130237514|NCT01481779|468833994|FG001|Overall Study|Lost to Follow-up|2|||
129884557|NCT02696902|467536455|FG002|Overall Study|Lost to Follow-up|1|||
130026652|NCT01262976|468057920|FG000|Up to Year 1|Serious Adverse Event|0|||
130237515|NCT01481779|468833993|FG000|Overall Study|Protocol Violation|2|||
130237516|NCT01481779|468833994|FG001|Overall Study|Protocol Violation|3|||
130237517|NCT01481779|468833993|FG000|Overall Study|Withdrawal by Subject|26|||
130237518|NCT01481779|468833994|FG001|Overall Study|Withdrawal by Subject|13|||
130237519|NCT01481779|468833993|FG000|Overall Study|Physician Decision|13|||
130237520|NCT01481779|468833994|FG001|Overall Study|Physician Decision|4|||
130237521|NCT01481779|468833993|FG000|Overall Study|Sponsor Decision|3|||
130237522|NCT01481779|468833994|FG001|Overall Study|Sponsor Decision|1|||
130237523|NCT02378181|468833995|FG000|Overall Study|Lost to Follow-up|2|||
130237524|NCT02378181|468833996|FG001|Overall Study|Lost to Follow-up|5|||
130237525|NCT02378181|468833995|FG000|Overall Study|Withdrawal by Subject|1|||
130237526|NCT02378181|468833996|FG001|Overall Study|Withdrawal by Subject|1|||
130237527|NCT02378181|468833995|FG000|Overall Study|Incarcerated|0|||
130237528|NCT02378181|468833996|FG001|Overall Study|Incarcerated|1|||
130237529|NCT04115059|468833997|FG000|Overall Study|Withdrawal by Subject|1|||
130237530|NCT04115059|468833997|FG000|Overall Study|Lack of Efficacy|2|||
130026653|NCT01262976|468057921|FG001|Up to Year 1|Serious Adverse Event|0|||
130026654|NCT01262976|468057922|FG002|Up to Year 1|Serious Adverse Event|2|||
130237531|NCT06420232|468834006|FG000|Overall Study|Withdrawal by Subject|3|||
130237532|NCT00689936|468834007|FG000|Active Treatment Phase|Adverse Event|68|||
130237533|NCT00689936|468834008|FG001|Active Treatment Phase|Adverse Event|71|||
130237534|NCT00689936|468834009|FG002|Active Treatment Phase|Adverse Event|76|||
130237535|NCT00689936|468834007|FG000|Active Treatment Phase|Disease Progression|273|||
130237536|NCT00689936|468834008|FG001|Active Treatment Phase|Disease Progression|362|||
130237537|NCT00689936|468834009|FG002|Active Treatment Phase|Disease Progression|339|||
130237538|NCT00689936|468834007|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
130237539|NCT00689936|468834008|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
130237540|NCT00689936|468834009|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
130237541|NCT00689936|468834007|FG000|Active Treatment Phase|Death|60|||
130026655|NCT01262976|468057923|FG003|Up to Year 1|Serious Adverse Event|0|||
130026656|NCT01262976|468057924|FG004|Up to Year 1|Serious Adverse Event|0|||
130026657|NCT01262976|468057925|FG005|Up to Year 1|Serious Adverse Event|0|||
130237542|NCT00689936|468834008|FG001|Active Treatment Phase|Death|28|||
130237543|NCT00689936|468834009|FG002|Active Treatment Phase|Death|37|||
130237544|NCT00689936|468834007|FG000|Active Treatment Phase|Lost to Follow-up|0|||
130026658|NCT01262976|468057920|FG000|Up to Year 1|Withdrawal by Subject|1|||
130026659|NCT01262976|468057921|FG001|Up to Year 1|Withdrawal by Subject|0|||
130026660|NCT01262976|468057922|FG002|Up to Year 1|Withdrawal by Subject|0|||
130026661|NCT01262976|468057923|FG003|Up to Year 1|Withdrawal by Subject|0|||
130026662|NCT01262976|468057924|FG004|Up to Year 1|Withdrawal by Subject|0|||
130026663|NCT01262976|468057925|FG005|Up to Year 1|Withdrawal by Subject|0|||
130026664|NCT01262976|468057920|FG000|Up to Year 1|Migrated/moved from study area|1|||
130026665|NCT01262976|468057921|FG001|Up to Year 1|Migrated/moved from study area|0|||
130026666|NCT01262976|468057922|FG002|Up to Year 1|Migrated/moved from study area|0|||
130026667|NCT01262976|468057923|FG003|Up to Year 1|Migrated/moved from study area|3|||
130026668|NCT01262976|468057924|FG004|Up to Year 1|Migrated/moved from study area|3|||
130026669|NCT01262976|468057925|FG005|Up to Year 1|Migrated/moved from study area|2|||
130026670|NCT01262976|468057920|FG000|Up to Year 1|Lost to Follow-up|4|||
130026671|NCT01262976|468057921|FG001|Up to Year 1|Lost to Follow-up|0|||
130026672|NCT01262976|468057922|FG002|Up to Year 1|Lost to Follow-up|0|||
130026673|NCT01262976|468057923|FG003|Up to Year 1|Lost to Follow-up|1|||
130026674|NCT01262976|468057924|FG004|Up to Year 1|Lost to Follow-up|6|||
130026675|NCT01262976|468057925|FG005|Up to Year 1|Lost to Follow-up|5|||
130026676|NCT01262976|468057920|FG000|Up to Year 1|Other|3|||
130026677|NCT01262976|468057921|FG001|Up to Year 1|Other|1|||
130026678|NCT01262976|468057922|FG002|Up to Year 1|Other|0|||
130026679|NCT01262976|468057923|FG003|Up to Year 1|Other|0|||
130026680|NCT01262976|468057924|FG004|Up to Year 1|Other|2|||
130026681|NCT01262976|468057925|FG005|Up to Year 1|Other|1|||
130026682|NCT01262976|468057920|FG000|Up to Year 1|Subjects with unknown completion status|0|||
130026683|NCT01262976|468057921|FG001|Up to Year 1|Subjects with unknown completion status|0|||
130026684|NCT01262976|468057922|FG002|Up to Year 1|Subjects with unknown completion status|1|||
130026685|NCT01262976|468057923|FG003|Up to Year 1|Subjects with unknown completion status|0|||
130026686|NCT01262976|468057924|FG004|Up to Year 1|Subjects with unknown completion status|0|||
130026687|NCT01262976|468057925|FG005|Up to Year 1|Subjects with unknown completion status|1|||
130026688|NCT01262976|468057920|FG000|Up to Year 2|Serious Adverse Event|0|||
130026689|NCT01262976|468057921|FG001|Up to Year 2|Serious Adverse Event|0|||
130026690|NCT01262976|468057922|FG002|Up to Year 2|Serious Adverse Event|2|||
130026691|NCT01262976|468057923|FG003|Up to Year 2|Serious Adverse Event|0|||
130026692|NCT01262976|468057924|FG004|Up to Year 2|Serious Adverse Event|0|||
130026693|NCT01262976|468057925|FG005|Up to Year 2|Serious Adverse Event|0|||
130026694|NCT01262976|468057920|FG000|Up to Year 2|Withdrawal by Subject|1|||
130026695|NCT01262976|468057921|FG001|Up to Year 2|Withdrawal by Subject|0|||
130026696|NCT01262976|468057922|FG002|Up to Year 2|Withdrawal by Subject|0|||
130026697|NCT01262976|468057923|FG003|Up to Year 2|Withdrawal by Subject|0|||
130026698|NCT01262976|468057924|FG004|Up to Year 2|Withdrawal by Subject|0|||
130026699|NCT01262976|468057925|FG005|Up to Year 2|Withdrawal by Subject|0|||
130026700|NCT01262976|468057920|FG000|Up to Year 2|Migrated/moved from study area|0|||
130026701|NCT01262976|468057921|FG001|Up to Year 2|Migrated/moved from study area|0|||
130026702|NCT01262976|468057922|FG002|Up to Year 2|Migrated/moved from study area|0|||
130026703|NCT01262976|468057923|FG003|Up to Year 2|Migrated/moved from study area|2|||
130026704|NCT01262976|468057924|FG004|Up to Year 2|Migrated/moved from study area|1|||
130026705|NCT01262976|468057925|FG005|Up to Year 2|Migrated/moved from study area|2|||
130026706|NCT01262976|468057920|FG000|Up to Year 2|Lost to Follow-up|1|||
130026707|NCT01262976|468057921|FG001|Up to Year 2|Lost to Follow-up|1|||
130026708|NCT01262976|468057922|FG002|Up to Year 2|Lost to Follow-up|2|||
130026709|NCT01262976|468057923|FG003|Up to Year 2|Lost to Follow-up|2|||
130026710|NCT01262976|468057924|FG004|Up to Year 2|Lost to Follow-up|3|||
130026711|NCT01262976|468057925|FG005|Up to Year 2|Lost to Follow-up|3|||
130100202|NCT02875340|468325942|FG000|Overall Study|Physician Decision|3|||
130100203|NCT02875340|468325942|FG000|Overall Study|Adverse Event|1|||
130100204|NCT01160770|468325943|FG000|Overall Study|Adverse Event|10|||
130100205|NCT01160770|468325943|FG000|Overall Study|Protocol Violation|2|||
130100206|NCT01160770|468325943|FG000|Overall Study|Subject/parent/caregiver request|33|||
130100207|NCT01160770|468325943|FG000|Overall Study|Physician Decision|1|||
130237545|NCT00689936|468834008|FG001|Active Treatment Phase|Lost to Follow-up|2|||
130026712|NCT01262976|468057920|FG000|Up to Year 2|Subjects with unknown completion status|0|||
130026713|NCT01262976|468057921|FG001|Up to Year 2|Subjects with unknown completion status|0|||
130026714|NCT01262976|468057922|FG002|Up to Year 2|Subjects with unknown completion status|1|||
130026715|NCT01262976|468057923|FG003|Up to Year 2|Subjects with unknown completion status|0|||
130026716|NCT01262976|468057924|FG004|Up to Year 2|Subjects with unknown completion status|0|||
130026717|NCT01262976|468057925|FG005|Up to Year 2|Subjects with unknown completion status|0|||
130026718|NCT01262976|468057920|FG000|Up to Year 2|Other|3|||
130026719|NCT01262976|468057921|FG001|Up to Year 2|Other|0|||
130026720|NCT01262976|468057922|FG002|Up to Year 2|Other|0|||
130026721|NCT01262976|468057923|FG003|Up to Year 2|Other|0|||
130100208|NCT01160770|468325943|FG000|Overall Study|Lost to Follow-up|7|||
130100209|NCT01160770|468325943|FG000|Overall Study|Study termination or sponsor request|1|||
130100210|NCT01160770|468325943|FG000|Overall Study|Death|9|||
130237546|NCT00689936|468834009|FG002|Active Treatment Phase|Lost to Follow-up|2|||
130237547|NCT00689936|468834007|FG000|Active Treatment Phase|Protocol Violation|2|||
130237548|NCT00689936|468834008|FG001|Active Treatment Phase|Protocol Violation|2|||
130237549|NCT00689936|468834009|FG002|Active Treatment Phase|Protocol Violation|4|||
130237550|NCT00689936|468834007|FG000|Active Treatment Phase|Study Close Out|64|||
130237551|NCT00689936|468834008|FG001|Active Treatment Phase|Study Close Out|26|||
130237552|NCT00689936|468834009|FG002|Active Treatment Phase|Study Close Out|21|||
130237553|NCT00689936|468834007|FG000|Active Treatment Phase|Miscellaneous|52|||
130237554|NCT00689936|468834008|FG001|Active Treatment Phase|Miscellaneous|34|||
130237555|NCT00689936|468834009|FG002|Active Treatment Phase|Miscellaneous|47|||
130237556|NCT00689936|468834007|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
130237557|NCT00689936|468834008|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
130237558|NCT00689936|468834009|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
130237559|NCT01303419|468834010|FG000|Overall Study|Discontinuation of study|60|||
130237560|NCT01303419|468834010|FG000|Overall Study|Did not complete both imaging methods|5|||
130237561|NCT01303419|468834010|FG000|Overall Study|Did not meet all I/E after screening|31|||
130237562|NCT00311168|468834013|FG000|First Intervention|Withdrawal by Subject|2|||
130237563|NCT00311168|468834014|FG001|First Intervention|Withdrawal by Subject|2|||
130237564|NCT00311168|468834013|FG000|First Intervention|Lost to Follow-up|1|||
130026722|NCT01262976|468057924|FG004|Up to Year 2|Other|0|||
130026723|NCT01262976|468057925|FG005|Up to Year 2|Other|0|||
130026724|NCT01262976|468057920|FG000|Up to Year 3|Serious Adverse Event|0|||
130026725|NCT01262976|468057921|FG001|Up to Year 3|Serious Adverse Event|0|||
130026726|NCT01262976|468057922|FG002|Up to Year 3|Serious Adverse Event|2|||
130237565|NCT00311168|468834014|FG001|First Intervention|Lost to Follow-up|1|||
130237566|NCT00311168|468834013|FG000|First Intervention|Protocol Violation|1|||
130237567|NCT00311168|468834014|FG001|First Intervention|Protocol Violation|1|||
130237568|NCT00311168|468834013|FG000|First Intervention|Adverse Event|1|||
130237569|NCT00311168|468834014|FG001|First Intervention|Adverse Event|0|||
130237570|NCT00311168|468834013|FG000|First Intervention|Other|2|||
130237571|NCT00311168|468834014|FG001|First Intervention|Other|2|||
130237572|NCT00311168|468834013|FG000|Second Intervention|Lost to Follow-up|9|||
130237573|NCT00311168|468834014|FG001|Second Intervention|Lost to Follow-up|2|||
130237574|NCT00311168|468834013|FG000|Second Intervention|Withdrawal by Subject|0|||
130237575|NCT00311168|468834014|FG001|Second Intervention|Withdrawal by Subject|1|||
130237576|NCT00311168|468834013|FG000|Second Intervention|Other|1|||
130237577|NCT00311168|468834014|FG001|Second Intervention|Other|1|||
130237578|NCT05513950|468834021|FG000|Overall Study|Not treated due to technical reasons|0|||
130237579|NCT05513950|468834022|FG001|Overall Study|Not treated due to technical reasons|0|||
130237580|NCT05513950|468834023|FG002|Overall Study|Not treated due to technical reasons|1|||
130237581|NCT05513950|468834024|FG003|Overall Study|Not treated due to technical reasons|0|||
130237582|NCT06001866|468834025|FG000|Overall Study|Withdrawal by Subject|0|||
130237583|NCT06001866|468834026|FG001|Overall Study|Withdrawal by Subject|2|||
130237584|NCT06001866|468834025|FG000|Overall Study|Protocol Violation|0|||
130237585|NCT06001866|468834026|FG001|Overall Study|Protocol Violation|2|||
130237586|NCT02903914|468834027|FG000|Overall Study|Adverse Event|0|||
130237587|NCT02903914|468834028|FG001|Overall Study|Adverse Event|0|||
130237588|NCT02903914|468834029|FG002|Overall Study|Adverse Event|1|||
130237589|NCT02903914|468834030|FG003|Overall Study|Adverse Event|0|||
130237590|NCT02903914|468834031|FG004|Overall Study|Adverse Event|0|||
130237591|NCT02903914|468834032|FG005|Overall Study|Adverse Event|0|||
130237592|NCT02903914|468834033|FG006|Overall Study|Adverse Event|2|||
130237593|NCT02903914|468834034|FG007|Overall Study|Adverse Event|0|||
130237594|NCT02903914|468834027|FG000|Overall Study|Withdrawal by Subject|3|||
130237595|NCT02903914|468834028|FG001|Overall Study|Withdrawal by Subject|1|||
130237596|NCT02903914|468834029|FG002|Overall Study|Withdrawal by Subject|28|||
130237597|NCT02903914|468834030|FG003|Overall Study|Withdrawal by Subject|0|||
130237598|NCT02903914|468834031|FG004|Overall Study|Withdrawal by Subject|1|||
130237599|NCT02903914|468834032|FG005|Overall Study|Withdrawal by Subject|2|||
130237600|NCT02903914|468834033|FG006|Overall Study|Withdrawal by Subject|12|||
130237601|NCT02903914|468834034|FG007|Overall Study|Withdrawal by Subject|0|||
130237602|NCT02903914|468834027|FG000|Overall Study|Progressive Disease|1|||
130237603|NCT02903914|468834028|FG001|Overall Study|Progressive Disease|0|||
130237604|NCT02903914|468834029|FG002|Overall Study|Progressive Disease|4|||
130237605|NCT02903914|468834030|FG003|Overall Study|Progressive Disease|0|||
130237606|NCT02903914|468834031|FG004|Overall Study|Progressive Disease|0|||
130237607|NCT02903914|468834032|FG005|Overall Study|Progressive Disease|0|||
130237608|NCT02903914|468834033|FG006|Overall Study|Progressive Disease|2|||
130237609|NCT02903914|468834034|FG007|Overall Study|Progressive Disease|0|||
130237610|NCT02903914|468834027|FG000|Overall Study|Death|0|||
130237611|NCT02903914|468834028|FG001|Overall Study|Death|0|||
130237612|NCT02903914|468834029|FG002|Overall Study|Death|9|||
130237613|NCT02903914|468834030|FG003|Overall Study|Death|0|||
130237614|NCT02903914|468834031|FG004|Overall Study|Death|1|||
130237615|NCT02903914|468834032|FG005|Overall Study|Death|3|||
130237616|NCT02903914|468834033|FG006|Overall Study|Death|24|||
130237617|NCT02903914|468834034|FG007|Overall Study|Death|2|||
130237618|NCT02903914|468834027|FG000|Overall Study|Lost to Follow-up|0|||
130237619|NCT02903914|468834028|FG001|Overall Study|Lost to Follow-up|1|||
130237620|NCT02903914|468834029|FG002|Overall Study|Lost to Follow-up|0|||
130237621|NCT02903914|468834030|FG003|Overall Study|Lost to Follow-up|0|||
130237622|NCT02903914|468834031|FG004|Overall Study|Lost to Follow-up|2|||
130237623|NCT02903914|468834032|FG005|Overall Study|Lost to Follow-up|0|||
130237624|NCT02903914|468834033|FG006|Overall Study|Lost to Follow-up|1|||
130237625|NCT02903914|468834034|FG007|Overall Study|Lost to Follow-up|0|||
130237626|NCT02903914|468834027|FG000|Overall Study|Physician Decision|0|||
130237627|NCT02903914|468834028|FG001|Overall Study|Physician Decision|0|||
130237628|NCT02903914|468834029|FG002|Overall Study|Physician Decision|1|||
130237629|NCT02903914|468834030|FG003|Overall Study|Physician Decision|0|||
130237630|NCT02903914|468834031|FG004|Overall Study|Physician Decision|0|||
130237631|NCT02903914|468834032|FG005|Overall Study|Physician Decision|0|||
130237632|NCT02903914|468834033|FG006|Overall Study|Physician Decision|1|||
130237633|NCT02903914|468834034|FG007|Overall Study|Physician Decision|0|||
130237634|NCT02903914|468834027|FG000|Overall Study|Symptomatic Deterioration|0|||
130237635|NCT02903914|468834028|FG001|Overall Study|Symptomatic Deterioration|0|||
130237636|NCT02903914|468834029|FG002|Overall Study|Symptomatic Deterioration|1|||
130237637|NCT02903914|468834030|FG003|Overall Study|Symptomatic Deterioration|0|||
130237638|NCT02903914|468834031|FG004|Overall Study|Symptomatic Deterioration|0|||
130237639|NCT02903914|468834032|FG005|Overall Study|Symptomatic Deterioration|0|||
130237640|NCT02903914|468834033|FG006|Overall Study|Symptomatic Deterioration|0|||
130237641|NCT02903914|468834034|FG007|Overall Study|Symptomatic Deterioration|0|||
130237642|NCT02903914|468834027|FG000|Overall Study|New Cancer Therapy|2|||
130237643|NCT02903914|468834028|FG001|Overall Study|New Cancer Therapy|2|||
130026727|NCT01262976|468057923|FG003|Up to Year 3|Serious Adverse Event|0|||
130026728|NCT01262976|468057924|FG004|Up to Year 3|Serious Adverse Event|0|||
130026729|NCT01262976|468057925|FG005|Up to Year 3|Serious Adverse Event|0|||
130237644|NCT02903914|468834029|FG002|Overall Study|New Cancer Therapy|21|||
130237645|NCT02903914|468834030|FG003|Overall Study|New Cancer Therapy|4|||
130237646|NCT02903914|468834031|FG004|Overall Study|New Cancer Therapy|3|||
130237647|NCT02903914|468834032|FG005|Overall Study|New Cancer Therapy|6|||
130237648|NCT02903914|468834033|FG006|Overall Study|New Cancer Therapy|56|||
130237649|NCT02903914|468834034|FG007|Overall Study|New Cancer Therapy|3|||
130237650|NCT02903914|468834027|FG000|Overall Study|Didn't Return to Site|1|||
130237651|NCT02903914|468834028|FG001|Overall Study|Didn't Return to Site|0|||
130237652|NCT02903914|468834029|FG002|Overall Study|Didn't Return to Site|1|||
130237653|NCT02903914|468834030|FG003|Overall Study|Didn't Return to Site|1|||
130026730|NCT01262976|468057920|FG000|Up to Year 3|Withdrawal by Subject|1|||
130026731|NCT01262976|468057921|FG001|Up to Year 3|Withdrawal by Subject|0|||
130026732|NCT01262976|468057922|FG002|Up to Year 3|Withdrawal by Subject|0|||
130026733|NCT01262976|468057923|FG003|Up to Year 3|Withdrawal by Subject|0|||
130237654|NCT02903914|468834031|FG004|Overall Study|Didn't Return to Site|0|||
130237655|NCT02903914|468834032|FG005|Overall Study|Didn't Return to Site|0|||
130237656|NCT02903914|468834033|FG006|Overall Study|Didn't Return to Site|2|||
130237657|NCT02903914|468834034|FG007|Overall Study|Didn't Return to Site|0|||
130237658|NCT02903914|468834027|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
130237659|NCT02903914|468834028|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
130237660|NCT02903914|468834029|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
130237661|NCT02903914|468834030|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
130237662|NCT02903914|468834031|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
130237663|NCT02903914|468834032|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
130237664|NCT02903914|468834033|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
130237665|NCT02903914|468834034|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
130237666|NCT02903914|468834027|FG000|Overall Study|Follow-up Did Not Occur|0|||
130237667|NCT02903914|468834028|FG001|Overall Study|Follow-up Did Not Occur|1|||
130237668|NCT02903914|468834029|FG002|Overall Study|Follow-up Did Not Occur|1|||
130237669|NCT02903914|468834030|FG003|Overall Study|Follow-up Did Not Occur|0|||
130237670|NCT02903914|468834031|FG004|Overall Study|Follow-up Did Not Occur|2|||
130237671|NCT02903914|468834032|FG005|Overall Study|Follow-up Did Not Occur|0|||
130237672|NCT02903914|468834033|FG006|Overall Study|Follow-up Did Not Occur|8|||
130237673|NCT02903914|468834034|FG007|Overall Study|Follow-up Did Not Occur|0|||
130237674|NCT02903914|468834027|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
130237675|NCT02903914|468834028|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
130237676|NCT02903914|468834029|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
130237677|NCT02903914|468834030|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
130237678|NCT02903914|468834031|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
130237679|NCT02903914|468834032|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
130237680|NCT02903914|468834033|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
130237681|NCT02903914|468834034|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
130237682|NCT02903914|468834027|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237683|NCT02903914|468834028|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237684|NCT02903914|468834029|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
130237685|NCT02903914|468834030|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237686|NCT02903914|468834031|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237687|NCT02903914|468834032|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
130237688|NCT02903914|468834033|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237689|NCT02903914|468834034|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
130237690|NCT02903914|468834027|FG000|Overall Study|Clinical Disease Progression|0|||
130237691|NCT02903914|468834028|FG001|Overall Study|Clinical Disease Progression|0|||
130237692|NCT02903914|468834029|FG002|Overall Study|Clinical Disease Progression|2|||
130237693|NCT02903914|468834030|FG003|Overall Study|Clinical Disease Progression|0|||
130237694|NCT02903914|468834031|FG004|Overall Study|Clinical Disease Progression|0|||
130237695|NCT02903914|468834032|FG005|Overall Study|Clinical Disease Progression|0|||
130237696|NCT02903914|468834033|FG006|Overall Study|Clinical Disease Progression|0|||
130237697|NCT02903914|468834034|FG007|Overall Study|Clinical Disease Progression|0|||
130237698|NCT02903914|468834027|FG000|Overall Study|Completed Follow-up Period|0|||
130237699|NCT02903914|468834028|FG001|Overall Study|Completed Follow-up Period|0|||
130237700|NCT02903914|468834029|FG002|Overall Study|Completed Follow-up Period|6|||
130237701|NCT02903914|468834030|FG003|Overall Study|Completed Follow-up Period|2|||
130237702|NCT02903914|468834031|FG004|Overall Study|Completed Follow-up Period|1|||
130237703|NCT02903914|468834032|FG005|Overall Study|Completed Follow-up Period|0|||
130237704|NCT02903914|468834033|FG006|Overall Study|Completed Follow-up Period|9|||
130237705|NCT02903914|468834034|FG007|Overall Study|Completed Follow-up Period|1|||
130237706|NCT02903914|468834027|FG000|Overall Study|Taken off Treatment per Protocol|0|||
130237707|NCT02903914|468834028|FG001|Overall Study|Taken off Treatment per Protocol|0|||
130237708|NCT02903914|468834029|FG002|Overall Study|Taken off Treatment per Protocol|0|||
130237709|NCT02903914|468834030|FG003|Overall Study|Taken off Treatment per Protocol|0|||
130237710|NCT02903914|468834031|FG004|Overall Study|Taken off Treatment per Protocol|0|||
130237711|NCT02903914|468834032|FG005|Overall Study|Taken off Treatment per Protocol|1|||
130237712|NCT02903914|468834033|FG006|Overall Study|Taken off Treatment per Protocol|0|||
130237713|NCT02903914|468834034|FG007|Overall Study|Taken off Treatment per Protocol|0|||
130237714|NCT02903914|468834027|FG000|Overall Study|Refused Further Treatment/Contact|0|||
130237715|NCT02903914|468834028|FG001|Overall Study|Refused Further Treatment/Contact|0|||
130237716|NCT02903914|468834029|FG002|Overall Study|Refused Further Treatment/Contact|0|||
130026734|NCT01262976|468057924|FG004|Up to Year 3|Withdrawal by Subject|0|||
130026735|NCT01262976|468057925|FG005|Up to Year 3|Withdrawal by Subject|0|||
130026736|NCT01262976|468057920|FG000|Up to Year 3|Migrated/moved from study area|0|||
130237717|NCT02903914|468834030|FG003|Overall Study|Refused Further Treatment/Contact|0|||
130237718|NCT02903914|468834031|FG004|Overall Study|Refused Further Treatment/Contact|0|||
130237719|NCT02903914|468834032|FG005|Overall Study|Refused Further Treatment/Contact|0|||
130237720|NCT02903914|468834033|FG006|Overall Study|Refused Further Treatment/Contact|1|||
130237721|NCT02903914|468834034|FG007|Overall Study|Refused Further Treatment/Contact|0|||
130237722|NCT02903914|468834027|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237723|NCT02903914|468834028|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237724|NCT02903914|468834029|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237725|NCT02903914|468834030|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237726|NCT02903914|468834031|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130100211|NCT01160770|468325943|FG000|Overall Study|Lack of Efficacy|15|||
130237727|NCT02903914|468834032|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237728|NCT02903914|468834033|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
130237729|NCT02903914|468834034|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
130237730|NCT03112603|468834038|FG000|End of Randomization Period|Lost to Follow-up|3|||
130237731|NCT03112603|468834039|FG001|End of Randomization Period|Lost to Follow-up|0|||
130237732|NCT03112603|468834040|FG002|End of Randomization Period|Lost to Follow-up|0|||
130237733|NCT03112603|468834038|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
130237734|NCT03112603|468834039|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
130237735|NCT03112603|468834040|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
130237736|NCT03112603|468834038|FG000|End of Randomization Period|Physician Decision|43|||
130237737|NCT03112603|468834039|FG001|End of Randomization Period|Physician Decision|18|||
130237738|NCT03112603|468834040|FG002|End of Randomization Period|Physician Decision|0|||
130237739|NCT03112603|468834038|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
130237740|NCT03112603|468834039|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
130237741|NCT03112603|468834040|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
130237742|NCT03112603|468834038|FG000|End of Randomization Period|Death|10|||
130237743|NCT03112603|468834039|FG001|End of Randomization Period|Death|7|||
130237744|NCT03112603|468834040|FG002|End of Randomization Period|Death|0|||
130237745|NCT03112603|468834038|FG000|End of Randomization Period|Disease Relapse|12|||
130237746|NCT03112603|468834039|FG001|End of Randomization Period|Disease Relapse|7|||
130237747|NCT03112603|468834040|FG002|End of Randomization Period|Disease Relapse|0|||
130237748|NCT03112603|468834038|FG000|End of Randomization Period|Lack of Efficacy|25|||
130237749|NCT03112603|468834039|FG001|End of Randomization Period|Lack of Efficacy|77|||
130237750|NCT03112603|468834040|FG002|End of Randomization Period|Lack of Efficacy|0|||
130237751|NCT03112603|468834038|FG000|End of Randomization Period|Adverse Event|32|||
130237752|NCT03112603|468834039|FG001|End of Randomization Period|Adverse Event|12|||
130237753|NCT03112603|468834040|FG002|End of Randomization Period|Adverse Event|0|||
130237754|NCT03112603|468834038|FG000|End of Cross Over Period|Death|0|||
130237755|NCT03112603|468834039|FG001|End of Cross Over Period|Death|0|||
130237756|NCT03112603|468834040|FG002|End of Cross Over Period|Death|2|||
130237757|NCT03112603|468834038|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
130237758|NCT03112603|468834039|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
130237759|NCT03112603|468834040|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
130237760|NCT03112603|468834038|FG000|End of Cross Over Period|Physician Decision|0|||
130237761|NCT03112603|468834039|FG001|End of Cross Over Period|Physician Decision|0|||
130237762|NCT03112603|468834040|FG002|End of Cross Over Period|Physician Decision|29|||
130237763|NCT03112603|468834038|FG000|End of Cross Over Period|Lack of Efficacy|0|||
130237764|NCT03112603|468834039|FG001|End of Cross Over Period|Lack of Efficacy|0|||
130237765|NCT03112603|468834040|FG002|End of Cross Over Period|Lack of Efficacy|8|||
130237766|NCT03112603|468834038|FG000|End of Cross Over Period|Adverse Event|0|||
130237767|NCT03112603|468834039|FG001|End of Cross Over Period|Adverse Event|0|||
130237768|NCT03112603|468834040|FG002|End of Cross Over Period|Adverse Event|6|||
130237769|NCT03112603|468834038|FG000|End of Cross Over Period|Disease Relapse|0|||
130237770|NCT03112603|468834039|FG001|End of Cross Over Period|Disease Relapse|0|||
130237771|NCT03112603|468834040|FG002|End of Cross Over Period|Disease Relapse|2|||
130237772|NCT04725188|468834041|FG000|Overall Study|Death|72|||
130237773|NCT04725188|468834042|FG001|Overall Study|Death|69|||
130026737|NCT01262976|468057921|FG001|Up to Year 3|Migrated/moved from study area|0|||
130026738|NCT01262976|468057922|FG002|Up to Year 3|Migrated/moved from study area|0|||
130026739|NCT01262976|468057923|FG003|Up to Year 3|Migrated/moved from study area|2|||
130026740|NCT01262976|468057924|FG004|Up to Year 3|Migrated/moved from study area|1|||
130026741|NCT01262976|468057925|FG005|Up to Year 3|Migrated/moved from study area|1|||
130237774|NCT04725188|468834043|FG002|Overall Study|Death|76|||
130237775|NCT04725188|468834041|FG000|Overall Study|Lost to Follow-up|1|||
130237776|NCT04725188|468834042|FG001|Overall Study|Lost to Follow-up|0|||
130237777|NCT04725188|468834043|FG002|Overall Study|Lost to Follow-up|1|||
130237778|NCT04725188|468834041|FG000|Overall Study|Withdrawal by Subject|2|||
130237779|NCT04725188|468834042|FG001|Overall Study|Withdrawal by Subject|2|||
130237780|NCT04725188|468834043|FG002|Overall Study|Withdrawal by Subject|1|||
130237781|NCT04725188|468834041|FG000|Overall Study|Sponsor Decision|12|||
130237782|NCT04725188|468834042|FG001|Overall Study|Sponsor Decision|12|||
130237783|NCT04725188|468834043|FG002|Overall Study|Sponsor Decision|7|||
130026742|NCT01262976|468057920|FG000|Up to Year 3|Lost to Follow-up|2|||
130026743|NCT01262976|468057921|FG001|Up to Year 3|Lost to Follow-up|2|||
130026744|NCT01262976|468057922|FG002|Up to Year 3|Lost to Follow-up|4|||
130026745|NCT01262976|468057923|FG003|Up to Year 3|Lost to Follow-up|3|||
130026746|NCT01262976|468057924|FG004|Up to Year 3|Lost to Follow-up|1|||
130026747|NCT01262976|468057925|FG005|Up to Year 3|Lost to Follow-up|3|||
130026748|NCT01262976|468057920|FG000|Up to Year 3|Subjects with unknown completion status|0|||
130026749|NCT01262976|468057921|FG001|Up to Year 3|Subjects with unknown completion status|0|||
130026750|NCT01262976|468057922|FG002|Up to Year 3|Subjects with unknown completion status|1|||
130026751|NCT01262976|468057923|FG003|Up to Year 3|Subjects with unknown completion status|0|||
130026752|NCT01262976|468057924|FG004|Up to Year 3|Subjects with unknown completion status|0|||
130026753|NCT01262976|468057925|FG005|Up to Year 3|Subjects with unknown completion status|0|||
130026754|NCT01262976|468057920|FG000|Up to Year 3|Other|3|||
130026755|NCT01262976|468057921|FG001|Up to Year 3|Other|0|||
130026756|NCT01262976|468057922|FG002|Up to Year 3|Other|0|||
130026757|NCT01262976|468057923|FG003|Up to Year 3|Other|0|||
130026758|NCT01262976|468057924|FG004|Up to Year 3|Other|0|||
130026759|NCT01262976|468057925|FG005|Up to Year 3|Other|0|||
130026760|NCT02690194|468057928|FG000|Overall Study|Withdrawal by Subject|1|||
130026761|NCT02690194|468057929|FG001|Overall Study|Withdrawal by Subject|4|||
130026762|NCT02690194|468057930|FG002|Overall Study|Withdrawal by Subject|0|||
130026763|NCT00189462|468057932|FG000|Overall Study|Lack of Efficacy|5|||
130026764|NCT00189462|468057933|FG001|Overall Study|Lack of Efficacy|1|||
130026765|NCT00189462|468057932|FG000|Overall Study|Lost to Follow-up|18|||
130026766|NCT00189462|468057933|FG001|Overall Study|Lost to Follow-up|20|||
130026767|NCT02400255|468057935|FG000|Overall Study|Relapse|4|||
130026768|NCT02400255|468057936|FG001|Overall Study|Relapse|1|||
130026769|NCT02400255|468057937|FG002|Overall Study|Relapse|1|||
130026770|NCT02400255|468057938|FG003|Overall Study|Relapse|2|||
130026771|NCT02400255|468057935|FG000|Overall Study|Adverse Event|6|||
130026772|NCT02400255|468057936|FG001|Overall Study|Adverse Event|3|||
130026773|NCT02400255|468057937|FG002|Overall Study|Adverse Event|0|||
130026774|NCT02400255|468057938|FG003|Overall Study|Adverse Event|0|||
130026775|NCT02400255|468057935|FG000|Overall Study|Physician Decision|6|||
130026776|NCT02400255|468057936|FG001|Overall Study|Physician Decision|0|||
130237784|NCT02337829|468834044|FG000|Overall Study|Death|0|||
130237785|NCT02337829|468834045|FG001|Overall Study|Death|1|||
130026777|NCT02400255|468057937|FG002|Overall Study|Physician Decision|0|||
130026778|NCT02400255|468057938|FG003|Overall Study|Physician Decision|0|||
130026779|NCT02400255|468057935|FG000|Overall Study|Loss of insurance|1|||
130026780|NCT02400255|468057936|FG001|Overall Study|Loss of insurance|0|||
130026781|NCT02400255|468057937|FG002|Overall Study|Loss of insurance|0|||
130026782|NCT02400255|468057938|FG003|Overall Study|Loss of insurance|0|||
130026783|NCT01961544|468057939|FG000|Overall Study|Protocol Violation|1|||
130026784|NCT01961544|468057939|FG000|Overall Study|Withdrawal by Subject|7|||
130026785|NCT01961544|468057939|FG000|Overall Study|Adverse Event|1|||
130026786|NCT01961544|468057939|FG000|Overall Study|Physician Decision|2|||
130026787|NCT01961544|468057939|FG000|Overall Study|Poor Tolerance|1|||
130026788|NCT01961544|468057939|FG000|Overall Study|Aggravation of Steral Pain|1|||
130026789|NCT03665285|468057940|FG000|Overall Study|Started New Anticancer Treatment|1|||
130026790|NCT03665285|468057941|FG001|Overall Study|Started New Anticancer Treatment|1|||
130026791|NCT03665285|468057942|FG002|Overall Study|Started New Anticancer Treatment|2|||
130026792|NCT03665285|468057943|FG003|Overall Study|Started New Anticancer Treatment|4|||
130026793|NCT03665285|468057944|FG004|Overall Study|Started New Anticancer Treatment|1|||
130026794|NCT03665285|468057945|FG005|Overall Study|Started New Anticancer Treatment|1|||
130026795|NCT03665285|468057946|FG006|Overall Study|Started New Anticancer Treatment|2|||
130026796|NCT03665285|468057947|FG007|Overall Study|Started New Anticancer Treatment|15|||
130026797|NCT03665285|468057948|FG008|Overall Study|Started New Anticancer Treatment|1|||
130237786|NCT02337829|468834046|FG002|Overall Study|Death|0|||
130237787|NCT02337829|468834047|FG003|Overall Study|Death|0|||
130026798|NCT03665285|468057940|FG000|Overall Study|Disease Progression|0|||
130237788|NCT02337829|468834044|FG000|Overall Study|Study terminated by sponsor|12|||
130237789|NCT02337829|468834045|FG001|Overall Study|Study terminated by sponsor|10|||
130237790|NCT02337829|468834046|FG002|Overall Study|Study terminated by sponsor|5|||
130237791|NCT02337829|468834047|FG003|Overall Study|Study terminated by sponsor|6|||
130237792|NCT02337829|468834044|FG000|Overall Study|discontinued for other reasons|6|||
130237793|NCT02337829|468834045|FG001|Overall Study|discontinued for other reasons|3|||
130237794|NCT02337829|468834046|FG002|Overall Study|discontinued for other reasons|1|||
130237795|NCT02337829|468834047|FG003|Overall Study|discontinued for other reasons|4|||
130237796|NCT03330197|468834048|FG000|Overall Study|Adverse Event|0|||
130237797|NCT03330197|468834049|FG001|Overall Study|Adverse Event|1|||
130237798|NCT03330197|468834048|FG000|Overall Study|Withdrawal by Subject|0|||
130237799|NCT03330197|468834049|FG001|Overall Study|Withdrawal by Subject|1|||
130237800|NCT00695019|468834060|FG000|Overall Study|Withdrawal by Subject|8|||
130237801|NCT00695019|468834061|FG001|Overall Study|Withdrawal by Subject|6|||
130237802|NCT00695019|468834062|FG002|Overall Study|Withdrawal by Subject|4|||
130237803|NCT00695019|468834060|FG000|Overall Study|Protocol Violation|1|||
130237804|NCT00695019|468834061|FG001|Overall Study|Protocol Violation|3|||
130237805|NCT00695019|468834062|FG002|Overall Study|Protocol Violation|1|||
130237806|NCT00695019|468834060|FG000|Overall Study|Lack of Efficacy|0|||
130237807|NCT00695019|468834061|FG001|Overall Study|Lack of Efficacy|0|||
130237808|NCT00695019|468834062|FG002|Overall Study|Lack of Efficacy|1|||
130237809|NCT00695019|468834060|FG000|Overall Study|Various|4|||
130237810|NCT00695019|468834061|FG001|Overall Study|Various|5|||
130237811|NCT00695019|468834062|FG002|Overall Study|Various|4|||
130237812|NCT03197129|468834065|FG000|Overall Study|did not answer the VPT: shyness|4|||
130237813|NCT03197129|468834066|FG001|Overall Study|did not answer the VPT: shyness|5|||
130237814|NCT01564407|468834067|FG000|Overall Study|Lost to Follow-up|0|||
130237815|NCT01564407|468834068|FG001|Overall Study|Lost to Follow-up|1|||
130237816|NCT01564407|468834069|FG002|Overall Study|Lost to Follow-up|0|||
130237817|NCT01564407|468834070|FG003|Overall Study|Lost to Follow-up|0|||
130026799|NCT03665285|468057941|FG001|Overall Study|Disease Progression|0|||
130026800|NCT03665285|468057942|FG002|Overall Study|Disease Progression|3|||
130026801|NCT03665285|468057943|FG003|Overall Study|Disease Progression|1|||
130237818|NCT01564407|468834071|FG004|Overall Study|Lost to Follow-up|0|||
130237819|NCT01564407|468834067|FG000|Overall Study|Withdrawal by Subject|0|||
130237820|NCT01564407|468834068|FG001|Overall Study|Withdrawal by Subject|1|||
130237821|NCT01564407|468834069|FG002|Overall Study|Withdrawal by Subject|0|||
130026802|NCT03665285|468057944|FG004|Overall Study|Disease Progression|0|||
130026803|NCT03665285|468057945|FG005|Overall Study|Disease Progression|0|||
130237822|NCT01564407|468834070|FG003|Overall Study|Withdrawal by Subject|0|||
130237823|NCT01564407|468834071|FG004|Overall Study|Withdrawal by Subject|0|||
130237824|NCT01564407|468834067|FG000|Overall Study|funding lost, study ended|0|||
130026804|NCT03665285|468057946|FG006|Overall Study|Disease Progression|0|||
130026805|NCT03665285|468057947|FG007|Overall Study|Disease Progression|7|||
130026806|NCT03665285|468057948|FG008|Overall Study|Disease Progression|1|||
130237825|NCT01564407|468834068|FG001|Overall Study|funding lost, study ended|0|||
130237826|NCT01564407|468834069|FG002|Overall Study|funding lost, study ended|0|||
130237827|NCT01564407|468834070|FG003|Overall Study|funding lost, study ended|1|||
130237828|NCT01564407|468834071|FG004|Overall Study|funding lost, study ended|0|||
130237829|NCT02442349|468834072|FG000|Overall Study|Death|95|||
130237830|NCT02442349|468834072|FG000|Overall Study|Withdrawal by Subject|27|||
130237831|NCT02442349|468834072|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
130237832|NCT02442349|468834072|FG000|Overall Study|Lost to Follow-up|1|||
130237833|NCT00314145|468834073|FG000|Overall Study|Withdrawal by Subject|8|||
130237834|NCT00314145|468834074|FG001|Overall Study|Withdrawal by Subject|10|||
130237835|NCT00314145|468834073|FG000|Overall Study|Lost to Follow-up|5|||
130237836|NCT00314145|468834074|FG001|Overall Study|Lost to Follow-up|12|||
130237837|NCT00314145|468834073|FG000|Overall Study|Physician Decision|3|||
130237838|NCT00314145|468834074|FG001|Overall Study|Physician Decision|4|||
130237839|NCT00314145|468834073|FG000|Overall Study|Adverse Event|0|||
130237840|NCT00314145|468834074|FG001|Overall Study|Adverse Event|3|||
130237841|NCT00314145|468834073|FG000|Overall Study|Protocol Violation|3|||
130237842|NCT00314145|468834074|FG001|Overall Study|Protocol Violation|0|||
130237843|NCT00314145|468834073|FG000|Overall Study|Sponsor Decision|2|||
130237844|NCT00314145|468834074|FG001|Overall Study|Sponsor Decision|0|||
130237845|NCT03507790|468834077|FG000|Overall Study|Adverse Event|0|||
130237846|NCT03507790|468834078|FG001|Overall Study|Adverse Event|11|||
130237847|NCT03507790|468834079|FG002|Overall Study|Adverse Event|3|||
130237848|NCT03507790|468834077|FG000|Overall Study|Withdrawal by Subject|2|||
130237849|NCT03507790|468834078|FG001|Overall Study|Withdrawal by Subject|0|||
130237850|NCT03507790|468834079|FG002|Overall Study|Withdrawal by Subject|0|||
130237851|NCT03507790|468834077|FG000|Overall Study|Subject moved to another location|1|||
130237852|NCT03507790|468834078|FG001|Overall Study|Subject moved to another location|2|||
130237853|NCT03507790|468834079|FG002|Overall Study|Subject moved to another location|0|||
130237854|NCT03507790|468834077|FG000|Overall Study|Non-compliance with study drug|0|||
130237855|NCT03507790|468834078|FG001|Overall Study|Non-compliance with study drug|0|||
130237856|NCT03507790|468834079|FG002|Overall Study|Non-compliance with study drug|1|||
130237857|NCT03507790|468834077|FG000|Overall Study|COVID 19 Pandemic|0|||
130237858|NCT03507790|468834078|FG001|Overall Study|COVID 19 Pandemic|1|||
130237859|NCT03507790|468834079|FG002|Overall Study|COVID 19 Pandemic|0|||
130237860|NCT03507790|468834077|FG000|Overall Study|Lost to Follow-up|0|||
130237861|NCT03507790|468834078|FG001|Overall Study|Lost to Follow-up|1|||
130237862|NCT03507790|468834079|FG002|Overall Study|Lost to Follow-up|0|||
130237863|NCT03507790|468834077|FG000|Overall Study|Discontinuation of the trial at the site|1|||
130237864|NCT03507790|468834078|FG001|Overall Study|Discontinuation of the trial at the site|1|||
130237865|NCT03507790|468834079|FG002|Overall Study|Discontinuation of the trial at the site|0|||
130237866|NCT03507790|468834077|FG000|Overall Study|Randomized in error|0|||
130237867|NCT03507790|468834078|FG001|Overall Study|Randomized in error|0|||
130237868|NCT03507790|468834079|FG002|Overall Study|Randomized in error|1|||
130237869|NCT02296125|468834082|FG000|Overall Study|Withdrawal by Subject|18|||
130237870|NCT02296125|468834083|FG001|Overall Study|Withdrawal by Subject|8|||
130237871|NCT02296125|468834084|FG002|Overall Study|Withdrawal by Subject|6|||
130237872|NCT02296125|468834085|FG003|Overall Study|Withdrawal by Subject|2|||
130237873|NCT02296125|468834082|FG000|Overall Study|Adverse Event|41|||
130237874|NCT02296125|468834083|FG001|Overall Study|Adverse Event|52|||
130237875|NCT02296125|468834084|FG002|Overall Study|Adverse Event|9|||
130237876|NCT02296125|468834085|FG003|Overall Study|Adverse Event|4|||
130237877|NCT02296125|468834082|FG000|Overall Study|Severe non-compliance to protocol|0|||
130237878|NCT02296125|468834083|FG001|Overall Study|Severe non-compliance to protocol|1|||
130237879|NCT02296125|468834084|FG002|Overall Study|Severe non-compliance to protocol|0|||
130237880|NCT02296125|468834085|FG003|Overall Study|Severe non-compliance to protocol|0|||
130237881|NCT02296125|468834082|FG000|Overall Study|Condition under investigation worsened|153|||
130237882|NCT02296125|468834083|FG001|Overall Study|Condition under investigation worsened|199|||
130237883|NCT02296125|468834084|FG002|Overall Study|Condition under investigation worsened|39|||
130237884|NCT02296125|468834085|FG003|Overall Study|Condition under investigation worsened|56|||
130237885|NCT02296125|468834082|FG000|Overall Study|Any reason not specifically recorded|6|||
130237886|NCT02296125|468834083|FG001|Overall Study|Any reason not specifically recorded|4|||
130237887|NCT02296125|468834084|FG002|Overall Study|Any reason not specifically recorded|2|||
130237888|NCT02296125|468834085|FG003|Overall Study|Any reason not specifically recorded|0|||
130237889|NCT01160614|468834086|FG000|Overall Study|Withdrawal by Subject|0|||
130237890|NCT01160614|468834087|FG001|Overall Study|Withdrawal by Subject|2|||
130237891|NCT03314935|468834088|FG000|Phase 1|Death|4|||
130237892|NCT03314935|468834089|FG001|Phase 1|Death|2|||
130237893|NCT03314935|468834090|FG002|Phase 1|Death|5|||
130237894|NCT03314935|468834091|FG003|Phase 1|Death|4|||
130237895|NCT03314935|468834092|FG004|Phase 1|Death|3|||
130237896|NCT03314935|468834093|FG005|Phase 1|Death|4|||
130237897|NCT03314935|468834094|FG006|Phase 1|Death|5|||
130237898|NCT03314935|468834095|FG007|Phase 1|Death|4|||
130026807|NCT03665285|468057940|FG000|Overall Study|Hospice|0|||
130026808|NCT03665285|468057941|FG001|Overall Study|Hospice|0|||
130026809|NCT03665285|468057942|FG002|Overall Study|Hospice|0|||
130026810|NCT03665285|468057943|FG003|Overall Study|Hospice|0|||
130026811|NCT03665285|468057944|FG004|Overall Study|Hospice|0|||
130026812|NCT03665285|468057945|FG005|Overall Study|Hospice|0|||
130026813|NCT03665285|468057946|FG006|Overall Study|Hospice|0|||
130026814|NCT03665285|468057947|FG007|Overall Study|Hospice|2|||
130026815|NCT03665285|468057948|FG008|Overall Study|Hospice|0|||
130026816|NCT03665285|468057940|FG000|Overall Study|Withdrawal by Subject|0|||
130026817|NCT03665285|468057941|FG001|Overall Study|Withdrawal by Subject|0|||
130026818|NCT03665285|468057942|FG002|Overall Study|Withdrawal by Subject|0|||
130026819|NCT03665285|468057943|FG003|Overall Study|Withdrawal by Subject|0|||
130026820|NCT03665285|468057944|FG004|Overall Study|Withdrawal by Subject|1|||
130026821|NCT03665285|468057945|FG005|Overall Study|Withdrawal by Subject|0|||
130026822|NCT03665285|468057946|FG006|Overall Study|Withdrawal by Subject|0|||
130026823|NCT03665285|468057947|FG007|Overall Study|Withdrawal by Subject|2|||
130026824|NCT03665285|468057948|FG008|Overall Study|Withdrawal by Subject|0|||
130026825|NCT03665285|468057940|FG000|Overall Study|Physician Decision|0|||
130026826|NCT03665285|468057941|FG001|Overall Study|Physician Decision|0|||
130026827|NCT03665285|468057942|FG002|Overall Study|Physician Decision|0|||
130026828|NCT03665285|468057943|FG003|Overall Study|Physician Decision|0|||
130026829|NCT03665285|468057944|FG004|Overall Study|Physician Decision|0|||
130026830|NCT03665285|468057945|FG005|Overall Study|Physician Decision|0|||
130026831|NCT03665285|468057946|FG006|Overall Study|Physician Decision|0|||
130026832|NCT03665285|468057947|FG007|Overall Study|Physician Decision|2|||
130026833|NCT03665285|468057948|FG008|Overall Study|Physician Decision|0|||
130026834|NCT00354601|468057949|FG000|Overall Study|Protocol Violation|1|||
130026835|NCT00354601|468057949|FG000|Overall Study|progression|1|||
130026836|NCT03603652|468057950|FG000|Overall Study|Death|2|||
130026837|NCT03213366|468057955|FG000|Overall Study|Lost to Follow-up|9|||
130026838|NCT03213366|468057956|FG001|Overall Study|Lost to Follow-up|4|||
130026839|NCT02532855|468057957|FG000|Overall Study|Lost to Follow-up|4|||
130026840|NCT02532855|468057958|FG001|Overall Study|Lost to Follow-up|3|||
130026841|NCT02532855|468057957|FG000|Overall Study|Withdrawal by Subject|4|||
130026842|NCT02532855|468057958|FG001|Overall Study|Withdrawal by Subject|8|||
130026843|NCT01727258|468057959|FG000|Overall Study|Adverse Event|0|||
130026844|NCT01727258|468057960|FG001|Overall Study|Adverse Event|2|||
130026845|NCT01727258|468057961|FG002|Overall Study|Adverse Event|0|||
130026846|NCT01727258|468057959|FG000|Overall Study|Noncompliance with Study Drug|0|||
130026847|NCT01727258|468057960|FG001|Overall Study|Noncompliance with Study Drug|0|||
130026848|NCT01727258|468057961|FG002|Overall Study|Noncompliance with Study Drug|1|||
130026849|NCT01727258|468057959|FG000|Overall Study|Withdrawal by Subject|1|||
130026850|NCT01727258|468057960|FG001|Overall Study|Withdrawal by Subject|1|||
130026851|NCT01727258|468057961|FG002|Overall Study|Withdrawal by Subject|0|||
130026852|NCT01727258|468057959|FG000|Overall Study|Lost to Follow-up|1|||
130026853|NCT01727258|468057960|FG001|Overall Study|Lost to Follow-up|0|||
130026854|NCT01727258|468057961|FG002|Overall Study|Lost to Follow-up|0|||
130026855|NCT02058147|468057962|FG000|Overall Study|Randomized but not treated|0|||
130026856|NCT02058147|468057963|FG001|Overall Study|Randomized but not treated|0|||
130026857|NCT02058147|468057964|FG002|Overall Study|Randomized but not treated|1|||
130026858|NCT02058147|468057962|FG000|Overall Study|Adverse Event|12|||
130026859|NCT02058147|468057963|FG001|Overall Study|Adverse Event|9|||
130026860|NCT02058147|468057964|FG002|Overall Study|Adverse Event|21|||
130026861|NCT02058147|468057962|FG000|Overall Study|Lack of Efficacy|1|||
130026862|NCT02058147|468057963|FG001|Overall Study|Lack of Efficacy|0|||
130026863|NCT02058147|468057964|FG002|Overall Study|Lack of Efficacy|3|||
130026864|NCT02058147|468057962|FG000|Overall Study|Poor compliance to protocol|8|||
130026865|NCT02058147|468057963|FG001|Overall Study|Poor compliance to protocol|9|||
130026866|NCT02058147|468057964|FG002|Overall Study|Poor compliance to protocol|4|||
130026867|NCT02058147|468057962|FG000|Overall Study|Other than specified|8|||
130026868|NCT02058147|468057963|FG001|Overall Study|Other than specified|9|||
130026869|NCT02058147|468057964|FG002|Overall Study|Other than specified|0|||
130026870|NCT01360645|468057971|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
130026871|NCT01360645|468057972|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
130026872|NCT01360645|468057973|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
130026873|NCT01360645|468057974|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
130026874|NCT01360645|468057971|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
130026875|NCT01360645|468057972|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
130026876|NCT01360645|468057973|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
130026877|NCT01360645|468057974|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
130026878|NCT01360645|468057971|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
130026879|NCT01360645|468057972|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
130026880|NCT01360645|468057973|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
130026881|NCT01360645|468057974|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
130026882|NCT01360645|468057971|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
130026883|NCT01360645|468057972|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
130026884|NCT01360645|468057973|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
130026885|NCT01360645|468057974|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
130026886|NCT01360645|468057971|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
130026887|NCT01360645|468057972|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
130026888|NCT01360645|468057973|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
130026889|NCT01360645|468057974|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
130026890|NCT01360645|468057971|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
130026891|NCT01360645|468057972|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
130026892|NCT01360645|468057973|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
130026893|NCT01360645|468057974|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
130026894|NCT01360645|468057971|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
130237899|NCT03314935|468834096|FG008|Phase 1|Death|3|||
130237900|NCT03314935|468834097|FG009|Phase 1|Death|0|||
130237901|NCT03314935|468834098|FG010|Phase 1|Death|0|||
130237902|NCT03314935|468834099|FG011|Phase 1|Death|0|||
130237903|NCT03314935|468834100|FG012|Phase 1|Death|0|||
130237904|NCT03314935|468834101|FG013|Phase 1|Death|0|||
130237905|NCT03314935|468834102|FG014|Phase 1|Death|0|||
130237906|NCT03314935|468834088|FG000|Phase 1|Withdrawal by Subject|2|||
130237907|NCT03314935|468834089|FG001|Phase 1|Withdrawal by Subject|1|||
130237908|NCT03314935|468834090|FG002|Phase 1|Withdrawal by Subject|1|||
130237909|NCT03314935|468834091|FG003|Phase 1|Withdrawal by Subject|2|||
130237910|NCT03314935|468834092|FG004|Phase 1|Withdrawal by Subject|1|||
130237911|NCT03314935|468834093|FG005|Phase 1|Withdrawal by Subject|0|||
130237912|NCT03314935|468834094|FG006|Phase 1|Withdrawal by Subject|1|||
130237913|NCT03314935|468834095|FG007|Phase 1|Withdrawal by Subject|0|||
130237914|NCT03314935|468834096|FG008|Phase 1|Withdrawal by Subject|1|||
130026895|NCT01360645|468057972|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
130026896|NCT01360645|468057973|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
130026897|NCT01360645|468057974|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
130237915|NCT03314935|468834097|FG009|Phase 1|Withdrawal by Subject|0|||
130237916|NCT03314935|468834098|FG010|Phase 1|Withdrawal by Subject|0|||
130237917|NCT03314935|468834099|FG011|Phase 1|Withdrawal by Subject|0|||
130237918|NCT03314935|468834100|FG012|Phase 1|Withdrawal by Subject|0|||
130026898|NCT01360645|468057971|FG000|Phase B (6 Weeks)|Adverse Event|0|||
130026899|NCT01360645|468057972|FG001|Phase B (6 Weeks)|Adverse Event|6|||
130026900|NCT01360645|468057973|FG002|Phase B (6 Weeks)|Adverse Event|0|||
130026901|NCT01360645|468057974|FG003|Phase B (6 Weeks)|Adverse Event|0|||
130026902|NCT01360645|468057971|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130026903|NCT01360645|468057972|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
130026904|NCT01360645|468057973|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
130026905|NCT01360645|468057974|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130026906|NCT01360645|468057971|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130026907|NCT01360645|468057972|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
130026908|NCT01360645|468057973|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
130026909|NCT01360645|468057974|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130026910|NCT01360645|468057971|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
130026911|NCT01360645|468057972|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
130026912|NCT01360645|468057973|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
130026913|NCT01360645|468057974|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
130026914|NCT01360645|468057971|FG000|Phase A+|Lost to Follow-up|0|||
130026915|NCT01360645|468057972|FG001|Phase A+|Lost to Follow-up|0|||
130026916|NCT01360645|468057973|FG002|Phase A+|Lost to Follow-up|0|||
130026917|NCT01360645|468057974|FG003|Phase A+|Lost to Follow-up|7|||
130026918|NCT01360645|468057971|FG000|Phase A+|Adverse Event|0|||
130026919|NCT01360645|468057972|FG001|Phase A+|Adverse Event|0|||
130026920|NCT01360645|468057973|FG002|Phase A+|Adverse Event|0|||
130026921|NCT01360645|468057974|FG003|Phase A+|Adverse Event|2|||
130026922|NCT01360645|468057971|FG000|Phase A+|Met Withdrawal Criteria|0|||
130100212|NCT01160770|468325943|FG000|Overall Study|Other Reasons|1|||
130237919|NCT03314935|468834101|FG013|Phase 1|Withdrawal by Subject|0|||
130237920|NCT03314935|468834102|FG014|Phase 1|Withdrawal by Subject|0|||
130237921|NCT03314935|468834088|FG000|Phase 1|Progressive Disease|2|||
130237922|NCT03314935|468834089|FG001|Phase 1|Progressive Disease|0|||
130237923|NCT03314935|468834090|FG002|Phase 1|Progressive Disease|0|||
130237924|NCT03314935|468834091|FG003|Phase 1|Progressive Disease|1|||
130237925|NCT03314935|468834092|FG004|Phase 1|Progressive Disease|0|||
130237926|NCT03314935|468834093|FG005|Phase 1|Progressive Disease|0|||
130237927|NCT03314935|468834094|FG006|Phase 1|Progressive Disease|0|||
130237928|NCT03314935|468834095|FG007|Phase 1|Progressive Disease|0|||
130237929|NCT03314935|468834096|FG008|Phase 1|Progressive Disease|0|||
130237930|NCT03314935|468834097|FG009|Phase 1|Progressive Disease|0|||
130237931|NCT03314935|468834098|FG010|Phase 1|Progressive Disease|0|||
130026923|NCT01360645|468057972|FG001|Phase A+|Met Withdrawal Criteria|0|||
130026924|NCT01360645|468057973|FG002|Phase A+|Met Withdrawal Criteria|0|||
130237932|NCT03314935|468834099|FG011|Phase 1|Progressive Disease|0|||
130237933|NCT03314935|468834100|FG012|Phase 1|Progressive Disease|0|||
130100213|NCT03457727|468325944|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
130100214|NCT03457727|468325945|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
130237934|NCT03314935|468834101|FG013|Phase 1|Progressive Disease|0|||
130026925|NCT01360645|468057974|FG003|Phase A+|Met Withdrawal Criteria|4|||
130026926|NCT01360645|468057971|FG000|Phase A+|Physician Decision|0|||
130026927|NCT01360645|468057972|FG001|Phase A+|Physician Decision|0|||
130026928|NCT01360645|468057973|FG002|Phase A+|Physician Decision|0|||
130237935|NCT03314935|468834102|FG014|Phase 1|Progressive Disease|0|||
130237936|NCT03314935|468834088|FG000|Phase 1|Study Terminated by Sponsor|0|||
130237937|NCT03314935|468834089|FG001|Phase 1|Study Terminated by Sponsor|1|||
130237938|NCT03314935|468834090|FG002|Phase 1|Study Terminated by Sponsor|0|||
130237939|NCT03314935|468834091|FG003|Phase 1|Study Terminated by Sponsor|0|||
130237940|NCT03314935|468834092|FG004|Phase 1|Study Terminated by Sponsor|0|||
130237941|NCT03314935|468834093|FG005|Phase 1|Study Terminated by Sponsor|0|||
130237942|NCT03314935|468834094|FG006|Phase 1|Study Terminated by Sponsor|0|||
130237943|NCT03314935|468834095|FG007|Phase 1|Study Terminated by Sponsor|0|||
130237944|NCT03314935|468834096|FG008|Phase 1|Study Terminated by Sponsor|1|||
130237945|NCT03314935|468834097|FG009|Phase 1|Study Terminated by Sponsor|0|||
130237946|NCT03314935|468834098|FG010|Phase 1|Study Terminated by Sponsor|0|||
130237947|NCT03314935|468834099|FG011|Phase 1|Study Terminated by Sponsor|0|||
130237948|NCT03314935|468834100|FG012|Phase 1|Study Terminated by Sponsor|0|||
130237949|NCT03314935|468834101|FG013|Phase 1|Study Terminated by Sponsor|0|||
130237950|NCT03314935|468834102|FG014|Phase 1|Study Terminated by Sponsor|0|||
130237951|NCT03314935|468834088|FG000|Phase 1|"Captured as Other in Database"|0|||
130237952|NCT03314935|468834089|FG001|Phase 1|"Captured as Other in Database"|2|||
130237953|NCT03314935|468834090|FG002|Phase 1|"Captured as Other in Database"|0|||
130237954|NCT03314935|468834091|FG003|Phase 1|"Captured as Other in Database"|0|||
130237955|NCT03314935|468834092|FG004|Phase 1|"Captured as Other in Database"|0|||
130237956|NCT03314935|468834093|FG005|Phase 1|"Captured as Other in Database"|0|||
130237957|NCT03314935|468834094|FG006|Phase 1|"Captured as Other in Database"|1|||
130237958|NCT03314935|468834095|FG007|Phase 1|"Captured as Other in Database"|1|||
130237959|NCT03314935|468834096|FG008|Phase 1|"Captured as Other in Database"|1|||
130237960|NCT03314935|468834097|FG009|Phase 1|"Captured as Other in Database"|0|||
130237961|NCT03314935|468834098|FG010|Phase 1|"Captured as Other in Database"|0|||
130237962|NCT03314935|468834099|FG011|Phase 1|"Captured as Other in Database"|0|||
130237963|NCT03314935|468834100|FG012|Phase 1|"Captured as Other in Database"|0|||
130237964|NCT03314935|468834101|FG013|Phase 1|"Captured as Other in Database"|0|||
130237965|NCT03314935|468834102|FG014|Phase 1|"Captured as Other in Database"|0|||
130237966|NCT03314935|468834088|FG000|Phase 1|Lost to Follow-up|0|||
130237967|NCT03314935|468834089|FG001|Phase 1|Lost to Follow-up|0|||
130026929|NCT01360645|468057974|FG003|Phase A+|Physician Decision|2|||
130026930|NCT01360645|468057971|FG000|Phase A+|Withdrawal by Subject|0|||
130026931|NCT01360645|468057972|FG001|Phase A+|Withdrawal by Subject|0|||
130026932|NCT01360645|468057973|FG002|Phase A+|Withdrawal by Subject|0|||
130026933|NCT01360645|468057974|FG003|Phase A+|Withdrawal by Subject|5|||
130026934|NCT01360645|468057971|FG000|Phase A+|Protocol Deviation|0|||
130026935|NCT01360645|468057972|FG001|Phase A+|Protocol Deviation|0|||
130026936|NCT01360645|468057973|FG002|Phase A+|Protocol Deviation|0|||
130237968|NCT03314935|468834090|FG002|Phase 1|Lost to Follow-up|0|||
130237969|NCT03314935|468834091|FG003|Phase 1|Lost to Follow-up|0|||
130237970|NCT03314935|468834092|FG004|Phase 1|Lost to Follow-up|0|||
130237971|NCT03314935|468834093|FG005|Phase 1|Lost to Follow-up|0|||
130237972|NCT03314935|468834094|FG006|Phase 1|Lost to Follow-up|0|||
130237973|NCT03314935|468834095|FG007|Phase 1|Lost to Follow-up|0|||
130237974|NCT03314935|468834096|FG008|Phase 1|Lost to Follow-up|1|||
130237975|NCT03314935|468834097|FG009|Phase 1|Lost to Follow-up|0|||
130237976|NCT03314935|468834098|FG010|Phase 1|Lost to Follow-up|0|||
130237977|NCT03314935|468834099|FG011|Phase 1|Lost to Follow-up|0|||
130237978|NCT03314935|468834100|FG012|Phase 1|Lost to Follow-up|0|||
130237979|NCT03314935|468834101|FG013|Phase 1|Lost to Follow-up|0|||
130237980|NCT03314935|468834102|FG014|Phase 1|Lost to Follow-up|0|||
130237981|NCT03314935|468834088|FG000|Phase 2|Death|0|||
130237982|NCT03314935|468834089|FG001|Phase 2|Death|0|||
130237983|NCT03314935|468834090|FG002|Phase 2|Death|0|||
130237984|NCT03314935|468834091|FG003|Phase 2|Death|0|||
130237985|NCT03314935|468834092|FG004|Phase 2|Death|0|||
130237986|NCT03314935|468834093|FG005|Phase 2|Death|0|||
130237987|NCT03314935|468834094|FG006|Phase 2|Death|0|||
130237988|NCT03314935|468834095|FG007|Phase 2|Death|0|||
130237989|NCT03314935|468834096|FG008|Phase 2|Death|0|||
130237990|NCT03314935|468834097|FG009|Phase 2|Death|5|||
130237991|NCT03314935|468834098|FG010|Phase 2|Death|20|||
130237992|NCT03314935|468834099|FG011|Phase 2|Death|6|||
130237993|NCT03314935|468834100|FG012|Phase 2|Death|7|||
130237994|NCT03314935|468834101|FG013|Phase 2|Death|6|||
130237995|NCT03314935|468834102|FG014|Phase 2|Death|17|||
130237996|NCT03314935|468834088|FG000|Phase 2|Withdrawal by Subject|0|||
130237997|NCT03314935|468834089|FG001|Phase 2|Withdrawal by Subject|0|||
130237998|NCT03314935|468834090|FG002|Phase 2|Withdrawal by Subject|0|||
130237999|NCT03314935|468834091|FG003|Phase 2|Withdrawal by Subject|0|||
130238000|NCT03314935|468834092|FG004|Phase 2|Withdrawal by Subject|0|||
130238001|NCT03314935|468834093|FG005|Phase 2|Withdrawal by Subject|0|||
130238002|NCT03314935|468834094|FG006|Phase 2|Withdrawal by Subject|0|||
130238003|NCT03314935|468834095|FG007|Phase 2|Withdrawal by Subject|0|||
130238004|NCT03314935|468834096|FG008|Phase 2|Withdrawal by Subject|0|||
130238005|NCT03314935|468834097|FG009|Phase 2|Withdrawal by Subject|1|||
130238006|NCT03314935|468834098|FG010|Phase 2|Withdrawal by Subject|4|||
130238007|NCT03314935|468834099|FG011|Phase 2|Withdrawal by Subject|0|||
130238008|NCT03314935|468834100|FG012|Phase 2|Withdrawal by Subject|1|||
130238009|NCT03314935|468834101|FG013|Phase 2|Withdrawal by Subject|0|||
130238010|NCT03314935|468834102|FG014|Phase 2|Withdrawal by Subject|1|||
130238011|NCT03314935|468834088|FG000|Phase 2|Progressive Disease|0|||
130238012|NCT03314935|468834089|FG001|Phase 2|Progressive Disease|0|||
130238013|NCT03314935|468834090|FG002|Phase 2|Progressive Disease|0|||
130238014|NCT03314935|468834091|FG003|Phase 2|Progressive Disease|0|||
130238015|NCT03314935|468834092|FG004|Phase 2|Progressive Disease|0|||
130238016|NCT03314935|468834093|FG005|Phase 2|Progressive Disease|0|||
130238017|NCT03314935|468834094|FG006|Phase 2|Progressive Disease|0|||
130238018|NCT03314935|468834095|FG007|Phase 2|Progressive Disease|0|||
130026937|NCT01360645|468057974|FG003|Phase A+|Protocol Deviation|4|||
130238019|NCT03314935|468834096|FG008|Phase 2|Progressive Disease|0|||
130238020|NCT03314935|468834097|FG009|Phase 2|Progressive Disease|1|||
130238021|NCT03314935|468834098|FG010|Phase 2|Progressive Disease|1|||
130238022|NCT03314935|468834099|FG011|Phase 2|Progressive Disease|1|||
130238023|NCT03314935|468834100|FG012|Phase 2|Progressive Disease|2|||
130238024|NCT03314935|468834101|FG013|Phase 2|Progressive Disease|0|||
130238025|NCT03314935|468834102|FG014|Phase 2|Progressive Disease|1|||
130238026|NCT03314935|468834088|FG000|Phase 2|Study Terminated by Sponsor|0|||
130238027|NCT03314935|468834089|FG001|Phase 2|Study Terminated by Sponsor|0|||
130238028|NCT03314935|468834090|FG002|Phase 2|Study Terminated by Sponsor|0|||
130238029|NCT03314935|468834091|FG003|Phase 2|Study Terminated by Sponsor|0|||
130238030|NCT03314935|468834092|FG004|Phase 2|Study Terminated by Sponsor|0|||
130238031|NCT03314935|468834093|FG005|Phase 2|Study Terminated by Sponsor|0|||
130238032|NCT03314935|468834094|FG006|Phase 2|Study Terminated by Sponsor|0|||
130238033|NCT03314935|468834095|FG007|Phase 2|Study Terminated by Sponsor|0|||
130238034|NCT03314935|468834096|FG008|Phase 2|Study Terminated by Sponsor|0|||
130238035|NCT03314935|468834097|FG009|Phase 2|Study Terminated by Sponsor|0|||
130026938|NCT01014585|468057975|FG000|Overall Study|Adverse Event|0|||
130026939|NCT01014585|468057976|FG001|Overall Study|Adverse Event|2|||
130238036|NCT03314935|468834098|FG010|Phase 2|Study Terminated by Sponsor|7|||
130238037|NCT03314935|468834099|FG011|Phase 2|Study Terminated by Sponsor|2|||
130238038|NCT03314935|468834100|FG012|Phase 2|Study Terminated by Sponsor|1|||
130238039|NCT03314935|468834101|FG013|Phase 2|Study Terminated by Sponsor|4|||
130238040|NCT03314935|468834102|FG014|Phase 2|Study Terminated by Sponsor|4|||
130238041|NCT03314935|468834088|FG000|Phase 2|Lost to Follow-up|0|||
130238042|NCT03314935|468834089|FG001|Phase 2|Lost to Follow-up|0|||
130238043|NCT03314935|468834090|FG002|Phase 2|Lost to Follow-up|0|||
130238044|NCT03314935|468834091|FG003|Phase 2|Lost to Follow-up|0|||
130238045|NCT03314935|468834092|FG004|Phase 2|Lost to Follow-up|0|||
130238046|NCT03314935|468834093|FG005|Phase 2|Lost to Follow-up|0|||
130238047|NCT03314935|468834094|FG006|Phase 2|Lost to Follow-up|0|||
130238048|NCT03314935|468834095|FG007|Phase 2|Lost to Follow-up|0|||
130238049|NCT03314935|468834096|FG008|Phase 2|Lost to Follow-up|0|||
130238050|NCT03314935|468834097|FG009|Phase 2|Lost to Follow-up|1|||
130238051|NCT03314935|468834098|FG010|Phase 2|Lost to Follow-up|0|||
130238052|NCT03314935|468834099|FG011|Phase 2|Lost to Follow-up|0|||
130238053|NCT03314935|468834100|FG012|Phase 2|Lost to Follow-up|0|||
130238054|NCT03314935|468834101|FG013|Phase 2|Lost to Follow-up|0|||
130238055|NCT03314935|468834102|FG014|Phase 2|Lost to Follow-up|1|||
130238056|NCT03314935|468834088|FG000|Phase 2|Physician Decision|0|||
130238057|NCT03314935|468834089|FG001|Phase 2|Physician Decision|0|||
130238058|NCT03314935|468834090|FG002|Phase 2|Physician Decision|0|||
130238059|NCT03314935|468834091|FG003|Phase 2|Physician Decision|0|||
130238060|NCT03314935|468834092|FG004|Phase 2|Physician Decision|0|||
130238061|NCT03314935|468834093|FG005|Phase 2|Physician Decision|0|||
130238062|NCT03314935|468834094|FG006|Phase 2|Physician Decision|0|||
130238063|NCT03314935|468834095|FG007|Phase 2|Physician Decision|0|||
130238064|NCT03314935|468834096|FG008|Phase 2|Physician Decision|0|||
130238065|NCT03314935|468834097|FG009|Phase 2|Physician Decision|0|||
130238066|NCT03314935|468834098|FG010|Phase 2|Physician Decision|1|||
130238067|NCT03314935|468834099|FG011|Phase 2|Physician Decision|0|||
130238068|NCT03314935|468834100|FG012|Phase 2|Physician Decision|0|||
130238069|NCT03314935|468834101|FG013|Phase 2|Physician Decision|0|||
130238070|NCT03314935|468834102|FG014|Phase 2|Physician Decision|0|||
130238071|NCT05845619|468834103|FG000|Overall Study|duplicate enrollment|2|||
130238072|NCT05845619|468834104|FG001|Overall Study|duplicate enrollment|2|||
130238073|NCT05845619|468834105|FG002|Overall Study|duplicate enrollment|1|||
130238074|NCT03636477|468834109|FG000|Overall Study|Adverse Event|0|||
130238075|NCT03636477|468834110|FG001|Overall Study|Adverse Event|0|||
130238076|NCT03636477|468834111|FG002|Overall Study|Adverse Event|1|||
130238077|NCT03621592|468834112|FG000|Overall Study|Lost to Follow-up|1|||
130238078|NCT03621592|468834113|FG001|Overall Study|Lost to Follow-up|0|||
130238079|NCT03621592|468834112|FG000|Overall Study|Lack of Improvement|1|||
130238080|NCT03621592|468834113|FG001|Overall Study|Lack of Improvement|0|||
130238081|NCT03621592|468834112|FG000|Overall Study|Preference to receive wound care closer to home|1|||
130238082|NCT03621592|468834113|FG001|Overall Study|Preference to receive wound care closer to home|0|||
130238083|NCT03621592|468834112|FG000|Overall Study|Lack of healing|0|||
130238084|NCT03621592|468834113|FG001|Overall Study|Lack of healing|2|||
130238085|NCT02382380|468834115|FG000|Overall Study|Withdrawal by Subject|2|||
130238086|NCT02382380|468834116|FG001|Overall Study|Withdrawal by Subject|2|||
130238087|NCT02382380|468834115|FG000|Overall Study|Lost to Follow-up|0|||
130238088|NCT02382380|468834116|FG001|Overall Study|Lost to Follow-up|1|||
130238089|NCT05168800|468834117|FG000|Time 1 Survey|Did not start T1 survey|182|||
130238090|NCT05168800|468834118|FG001|Time 1 Survey|Did not start T1 survey|150|||
130238091|NCT05168800|468834119|FG002|Time 1 Survey|Did not start T1 survey|140|||
130238092|NCT05168800|468834117|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
130238093|NCT05168800|468834118|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
129884558|NCT02696902|467536453|FG000|Overall Study|Withdrawal by Subject|0|||
130100215|NCT03457727|468325946|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
130238094|NCT05168800|468834119|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
130238095|NCT05168800|468834117|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
130238096|NCT05168800|468834118|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
130238097|NCT05168800|468834119|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
130238098|NCT05168800|468834117|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
130238099|NCT05168800|468834118|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
130238100|NCT05168800|468834119|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
130238101|NCT05168800|468834117|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
130238102|NCT05168800|468834118|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
130238103|NCT05168800|468834119|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
130238104|NCT05168800|468834117|FG000|Time 1 Survey|Withdrawal by Subject|6|||
130238105|NCT05168800|468834118|FG001|Time 1 Survey|Withdrawal by Subject|3|||
130238106|NCT05168800|468834119|FG002|Time 1 Survey|Withdrawal by Subject|2|||
130238107|NCT05168800|468834117|FG000|Time 2 Survey|Already excluded at Time 1|228|||
130238108|NCT05168800|468834118|FG001|Time 2 Survey|Already excluded at Time 1|202|||
130238109|NCT05168800|468834119|FG002|Time 2 Survey|Already excluded at Time 1|173|||
130238110|NCT05168800|468834117|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
130238111|NCT05168800|468834118|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
130238112|NCT05168800|468834119|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
130238113|NCT05168800|468834117|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
130238114|NCT05168800|468834118|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
130238115|NCT05168800|468834119|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
130238116|NCT05168800|468834117|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
130026940|NCT01014585|468057977|FG002|Overall Study|Adverse Event|0|||
130026941|NCT01014585|468057978|FG003|Overall Study|Adverse Event|3|||
130026942|NCT01014585|468057975|FG000|Overall Study|Withdrawal by Subject|2|||
130026943|NCT01014585|468057976|FG001|Overall Study|Withdrawal by Subject|0|||
130026944|NCT01014585|468057977|FG002|Overall Study|Withdrawal by Subject|1|||
130026945|NCT01014585|468057978|FG003|Overall Study|Withdrawal by Subject|3|||
130026946|NCT01014585|468057975|FG000|Overall Study|Lost to Follow-up|0|||
130026947|NCT01014585|468057976|FG001|Overall Study|Lost to Follow-up|0|||
130026948|NCT01014585|468057977|FG002|Overall Study|Lost to Follow-up|0|||
130026949|NCT01014585|468057978|FG003|Overall Study|Lost to Follow-up|2|||
130026950|NCT01014585|468057975|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
130026951|NCT01014585|468057976|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
130026952|NCT01014585|468057977|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
130026953|NCT01014585|468057978|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
130026954|NCT02817087|468057979|FG000|Overall Study|Withdrawal by Subject|2|||
130026955|NCT02817087|468057980|FG001|Overall Study|Withdrawal by Subject|0|||
130026956|NCT00508391|468057981|FG000|First Treatment|Withdrawal by Subject|6|||
130026957|NCT00508391|468057982|FG001|First Treatment|Withdrawal by Subject|3|||
130026958|NCT00508391|468057981|FG000|Second Treatment|Withdrawal by Subject|2|||
130026959|NCT00508391|468057982|FG001|Second Treatment|Withdrawal by Subject|0|||
130238117|NCT05168800|468834118|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
130238118|NCT05168800|468834119|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
130238119|NCT05168800|468834117|FG000|Time 2 Survey|Withdrawal by Subject|1|||
130238120|NCT05168800|468834118|FG001|Time 2 Survey|Withdrawal by Subject|0|||
130238121|NCT05168800|468834119|FG002|Time 2 Survey|Withdrawal by Subject|1|||
130238122|NCT05168800|468834117|FG000|Time 3 Survey|Already excluded at Time 1|228|||
130238123|NCT05168800|468834118|FG001|Time 3 Survey|Already excluded at Time 1|200|||
130238124|NCT05168800|468834119|FG002|Time 3 Survey|Already excluded at Time 1|173|||
130238125|NCT05168800|468834117|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
130238126|NCT05168800|468834118|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
130238127|NCT05168800|468834119|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
130238128|NCT05168800|468834117|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
130238129|NCT05168800|468834118|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
130238130|NCT05168800|468834119|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
130238131|NCT05168800|468834117|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
130238132|NCT05168800|468834118|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
130238133|NCT05168800|468834119|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
130238134|NCT04556097|468834120|FG000|Overall Study|Death|0|||
130238135|NCT04556097|468834121|FG001|Overall Study|Death|5|||
130238136|NCT04556097|468834122|FG002|Overall Study|Death|0|||
130238137|NCT04556097|468834123|FG003|Overall Study|Death|0|||
130238138|NCT04556097|468834120|FG000|Overall Study|No caregiver|43|||
130238139|NCT04556097|468834121|FG001|Overall Study|No caregiver|53|||
130238140|NCT04556097|468834122|FG002|Overall Study|No caregiver|0|||
130238141|NCT04556097|468834123|FG003|Overall Study|No caregiver|0|||
130238142|NCT04556097|468834120|FG000|Overall Study|Ineligible, SNF|2|||
130238143|NCT04556097|468834121|FG001|Overall Study|Ineligible, SNF|2|||
130238144|NCT04556097|468834122|FG002|Overall Study|Ineligible, SNF|0|||
130238145|NCT04556097|468834123|FG003|Overall Study|Ineligible, SNF|0|||
130238146|NCT04556097|468834120|FG000|Overall Study|Ineligible, health|3|||
130238147|NCT04556097|468834121|FG001|Overall Study|Ineligible, health|4|||
130238148|NCT04556097|468834122|FG002|Overall Study|Ineligible, health|0|||
130238149|NCT04556097|468834123|FG003|Overall Study|Ineligible, health|0|||
130238150|NCT04556097|468834120|FG000|Overall Study|Ineligible, language|0|||
130238151|NCT04556097|468834121|FG001|Overall Study|Ineligible, language|1|||
130238152|NCT04556097|468834122|FG002|Overall Study|Ineligible, language|0|||
130238153|NCT04556097|468834123|FG003|Overall Study|Ineligible, language|0|||
130238154|NCT04556097|468834120|FG000|Overall Study|Ineligible, no longer in care management|0|||
130238155|NCT04556097|468834121|FG001|Overall Study|Ineligible, no longer in care management|2|||
130238156|NCT04556097|468834122|FG002|Overall Study|Ineligible, no longer in care management|1|||
130238157|NCT04556097|468834123|FG003|Overall Study|Ineligible, no longer in care management|0|||
130238158|NCT04556097|468834120|FG000|Overall Study|No dementia|13|||
130238159|NCT04556097|468834121|FG001|Overall Study|No dementia|3|||
130238160|NCT04556097|468834122|FG002|Overall Study|No dementia|0|||
130238161|NCT04556097|468834123|FG003|Overall Study|No dementia|0|||
130238162|NCT04556097|468834120|FG000|Overall Study|Missing identifier|2|||
130238163|NCT04556097|468834121|FG001|Overall Study|Missing identifier|4|||
130238164|NCT04556097|468834122|FG002|Overall Study|Missing identifier|0|||
130238165|NCT04556097|468834123|FG003|Overall Study|Missing identifier|0|||
130238166|NCT04556097|468834120|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
130238167|NCT04556097|468834121|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
130238168|NCT04556097|468834122|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
130238169|NCT04556097|468834123|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
130238170|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
130238171|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
130238172|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
130238173|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
130238174|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
130238175|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
130238176|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238177|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238178|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
130238179|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
130238180|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
130238181|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
130238182|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
130238183|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
130238184|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
130238185|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
130238186|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238187|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
130238188|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238189|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
130238190|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130238191|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
130238192|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130238193|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
130238194|NCT00620542|468836183|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
130238195|NCT00620542|468836184|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
130238196|NCT00620542|468836185|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
130238197|NCT00620542|468836186|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
130238198|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
130238199|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
130238200|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
130238201|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
130238202|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
130238203|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
130238204|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
130238205|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
130238206|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
130238207|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
130238208|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
130238209|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
130238210|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
130238211|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
130238212|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
130238213|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
130238214|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
130238215|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
130238216|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
130238217|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
130238218|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
130238219|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
130238220|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
130238221|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
130238222|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
130238223|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
130238224|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
130238225|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
130238226|NCT00620542|468836183|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
130238227|NCT00620542|468836184|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
130238228|NCT00620542|468836185|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
130238229|NCT00620542|468836186|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
130238230|NCT01970371|468836187|FG000|Overall Study|Death|8|||
130238231|NCT01970371|468836188|FG001|Overall Study|Death|13|||
130238232|NCT01970371|468836189|FG002|Overall Study|Death|12|||
130238233|NCT01970371|468836187|FG000|Overall Study|Lost to Follow-up|0|||
130238234|NCT01970371|468836188|FG001|Overall Study|Lost to Follow-up|0|||
130238235|NCT01970371|468836189|FG002|Overall Study|Lost to Follow-up|1|||
130238236|NCT01348269|468836190|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
130238237|NCT01348269|468836191|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
130238238|NCT01348269|468836190|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
130238239|NCT01348269|468836191|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
130238240|NCT01348269|468836190|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
130238241|NCT01348269|468836191|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
130238242|NCT04727749|468836192|FG000|Overall Study|Lost to Follow-up|10|||
130238243|NCT04727749|468836193|FG001|Overall Study|Lost to Follow-up|3|||
130238244|NCT03575364|468836197|FG000|Overall Study|Death|45|||
130238245|NCT03575364|468836197|FG000|Overall Study|Lost to Follow-up|114|||
130238246|NCT03575364|468836197|FG000|Overall Study|Withdrawal by Subject|21|||
130238247|NCT03575364|468836197|FG000|Overall Study|Physician Decision|11|||
130238248|NCT03575364|468836197|FG000|Overall Study|Subject Refused Follow-up|13|||
130238249|NCT03575364|468836197|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
130238250|NCT03575364|468836197|FG000|Overall Study|Patient moved out of the state|1|||
130238251|NCT03575364|468836197|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
130238252|NCT03575364|468836197|FG000|Overall Study|Patient is lost to follow up|1|||
130238253|NCT03575364|468836197|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
130238254|NCT02313155|468836198|FG000|Overall Study|Lost to Follow-up|0|||
130238255|NCT02313155|468836199|FG001|Overall Study|Lost to Follow-up|1|||
130238256|NCT02213926|468836200|FG000|Overall Study|Death|59|||
130238257|NCT02213926|468836200|FG000|Overall Study|Withdrawal by Subject|10|||
130238258|NCT02213926|468836200|FG000|Overall Study|study terminated by sponsor|51|||
130238259|NCT02213926|468836200|FG000|Overall Study|Lost to Follow-up|3|||
130238260|NCT02213926|468836200|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
130238261|NCT01697579|468836201|FG000|Base Study-Cycle 1|Adverse Event|1|||
130238262|NCT01697579|468836202|FG001|Base Study-Cycle 1|Adverse Event|0|||
130238263|NCT01697579|468836203|FG002|Base Study-Cycle 1|Adverse Event|0|||
130238264|NCT01697579|468836204|FG003|Base Study-Cycle 1|Adverse Event|0|||
130238265|NCT01697579|468836205|FG004|Base Study-Cycle 1|Adverse Event|0|||
130238266|NCT01697579|468836206|FG005|Base Study-Cycle 1|Adverse Event|0|||
130238267|NCT01697579|468836207|FG006|Base Study-Cycle 1|Adverse Event|0|||
130238268|NCT01697579|468836201|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
130238269|NCT01697579|468836202|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238270|NCT01697579|468836203|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238271|NCT01697579|468836204|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238272|NCT01697579|468836205|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238273|NCT01697579|468836206|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238274|NCT01697579|468836207|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
130238275|NCT01697579|468836201|FG000|Base Study-Cycle 1|Protocol Violation|0|||
130238276|NCT01697579|468836202|FG001|Base Study-Cycle 1|Protocol Violation|0|||
130238277|NCT01697579|468836203|FG002|Base Study-Cycle 1|Protocol Violation|0|||
130238278|NCT01697579|468836204|FG003|Base Study-Cycle 1|Protocol Violation|0|||
130238279|NCT01697579|468836205|FG004|Base Study-Cycle 1|Protocol Violation|3|||
130238280|NCT01697579|468836206|FG005|Base Study-Cycle 1|Protocol Violation|0|||
130238281|NCT01697579|468836207|FG006|Base Study-Cycle 1|Protocol Violation|0|||
130238282|NCT01697579|468836201|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238283|NCT01697579|468836202|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
130238284|NCT01697579|468836203|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238285|NCT01697579|468836204|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238286|NCT01697579|468836205|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238287|NCT01697579|468836206|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238288|NCT01697579|468836207|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
130238289|NCT01697579|468836201|FG000|Base Study-Cycle 1|Technical Problems|0|||
130238290|NCT01697579|468836202|FG001|Base Study-Cycle 1|Technical Problems|0|||
130238291|NCT01697579|468836203|FG002|Base Study-Cycle 1|Technical Problems|1|||
130238292|NCT01697579|468836204|FG003|Base Study-Cycle 1|Technical Problems|1|||
130238293|NCT01697579|468836205|FG004|Base Study-Cycle 1|Technical Problems|0|||
130238294|NCT01697579|468836206|FG005|Base Study-Cycle 1|Technical Problems|0|||
130238295|NCT01697579|468836207|FG006|Base Study-Cycle 1|Technical Problems|0|||
130238296|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Death|0|||
130238297|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Death|0|||
130238298|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Death|0|||
130238299|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Death|0|||
130238300|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Death|0|||
130238301|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Death|0|||
130238302|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Death|2|||
130238303|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238304|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238305|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238306|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238307|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130238308|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
130238309|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
130238310|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238311|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238312|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238313|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238314|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
130238315|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
130238316|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
130238317|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238318|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238319|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238320|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238321|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238322|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
130238323|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
130238324|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238325|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238326|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238327|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238328|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
130238329|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
130238330|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
130238331|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238332|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238333|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238334|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238335|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238336|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
130238337|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
130238338|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238339|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238340|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238341|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238342|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
130238343|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
130238344|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
130238345|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238346|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238347|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238348|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238349|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
130238350|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
130026960|NCT02251912|468057983|FG000|Overall Study|Withdrawal by Subject|2|||
130238351|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
130238352|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238353|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238354|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238355|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238356|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238357|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
130238358|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
130238359|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238360|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238361|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238362|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238363|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238364|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
130238365|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
130238366|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238367|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238368|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238369|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238370|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238371|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
130238372|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
130238373|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238374|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238375|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238376|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238377|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
130238378|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
130238379|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
130238380|NCT01697579|468836201|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238381|NCT01697579|468836202|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238382|NCT01697579|468836203|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238383|NCT01697579|468836204|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238384|NCT01697579|468836205|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238385|NCT01697579|468836206|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
130238386|NCT01697579|468836207|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
130238387|NCT02452190|468836208|FG000|Overall Study|Withdrawal by Sponsor|1|||
130238388|NCT02452190|468836209|FG001|Overall Study|Withdrawal by Sponsor|3|||
130238389|NCT02452190|468836208|FG000|Overall Study|Pregnancy|1|||
130238390|NCT02452190|468836209|FG001|Overall Study|Pregnancy|0|||
130238391|NCT02452190|468836208|FG000|Overall Study|Investigator's Decision|2|||
130238392|NCT02452190|468836209|FG001|Overall Study|Investigator's Decision|0|||
130238393|NCT02452190|468836208|FG000|Overall Study|Lack of Efficacy|3|||
130238394|NCT02452190|468836209|FG001|Overall Study|Lack of Efficacy|1|||
130238395|NCT02452190|468836208|FG000|Overall Study|Lost to Follow-up|4|||
130238396|NCT02452190|468836209|FG001|Overall Study|Lost to Follow-up|3|||
130238397|NCT02452190|468836208|FG000|Overall Study|Adverse Event|2|||
130238398|NCT02452190|468836209|FG001|Overall Study|Adverse Event|5|||
130238399|NCT02452190|468836208|FG000|Overall Study|Withdrawal by Subject|20|||
130238400|NCT02452190|468836209|FG001|Overall Study|Withdrawal by Subject|11|||
130238401|NCT02452190|468836208|FG000|Overall Study|Noncompliance with study drug|1|||
130238402|NCT02452190|468836209|FG001|Overall Study|Noncompliance with study drug|0|||
130238403|NCT02452190|468836208|FG000|Overall Study|Participant traveled abroad|1|||
130238404|NCT02452190|468836209|FG001|Overall Study|Participant traveled abroad|0|||
130238405|NCT02452190|468836208|FG000|Overall Study|Death|0|||
130238406|NCT02452190|468836209|FG001|Overall Study|Death|1|||
130238407|NCT01044498|468836210|FG000|Overall Study|Withdrew consent|1|||
130238408|NCT01044498|468836211|FG001|Overall Study|Withdrew consent|1|||
130238409|NCT01044498|468836210|FG000|Overall Study|Adverse Event|1|||
130238410|NCT01044498|468836211|FG001|Overall Study|Adverse Event|1|||
130238411|NCT01044498|468836210|FG000|Overall Study|Other|1|||
130238412|NCT01044498|468836211|FG001|Overall Study|Other|0|||
130238413|NCT02327078|468836216|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130238414|NCT02327078|468836217|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130238415|NCT02327078|468836218|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
130238416|NCT02327078|468836219|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130238417|NCT02327078|468836220|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
130238418|NCT02327078|468836221|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130238419|NCT02327078|468836222|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
130100216|NCT03457727|468325947|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
130238420|NCT02327078|468836223|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
130238421|NCT02327078|468836224|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
130238422|NCT02327078|468836216|FG000|Overall Study|Death|2|||
130238423|NCT02327078|468836217|FG001|Overall Study|Death|4|||
130238424|NCT02327078|468836218|FG002|Overall Study|Death|10|||
130238425|NCT02327078|468836219|FG003|Overall Study|Death|6|||
130238426|NCT02327078|468836220|FG004|Overall Study|Death|4|||
130238427|NCT02327078|468836221|FG005|Overall Study|Death|3|||
130238428|NCT02327078|468836222|FG006|Overall Study|Death|2|||
130238429|NCT02327078|468836223|FG007|Overall Study|Death|51|||
130238430|NCT02327078|468836224|FG008|Overall Study|Death|97|||
130238431|NCT02327078|468836216|FG000|Overall Study|Lost to Follow-up|0|||
130238432|NCT02327078|468836217|FG001|Overall Study|Lost to Follow-up|1|||
130238433|NCT02327078|468836218|FG002|Overall Study|Lost to Follow-up|1|||
130238434|NCT02327078|468836219|FG003|Overall Study|Lost to Follow-up|0|||
130238435|NCT02327078|468836220|FG004|Overall Study|Lost to Follow-up|0|||
130238436|NCT02327078|468836221|FG005|Overall Study|Lost to Follow-up|0|||
130238437|NCT02327078|468836222|FG006|Overall Study|Lost to Follow-up|0|||
130238438|NCT02327078|468836223|FG007|Overall Study|Lost to Follow-up|2|||
130238439|NCT02327078|468836224|FG008|Overall Study|Lost to Follow-up|5|||
130238440|NCT02327078|468836216|FG000|Overall Study|Site Terminated by Sponsor|1|||
130238441|NCT02327078|468836217|FG001|Overall Study|Site Terminated by Sponsor|0|||
130238442|NCT02327078|468836218|FG002|Overall Study|Site Terminated by Sponsor|1|||
130238443|NCT02327078|468836219|FG003|Overall Study|Site Terminated by Sponsor|4|||
130238444|NCT02327078|468836220|FG004|Overall Study|Site Terminated by Sponsor|0|||
130238445|NCT02327078|468836221|FG005|Overall Study|Site Terminated by Sponsor|0|||
130238446|NCT02327078|468836222|FG006|Overall Study|Site Terminated by Sponsor|0|||
130238447|NCT02327078|468836223|FG007|Overall Study|Site Terminated by Sponsor|11|||
130238448|NCT02327078|468836224|FG008|Overall Study|Site Terminated by Sponsor|25|||
130238449|NCT02327078|468836216|FG000|Overall Study|Physician Decision|0|||
130238450|NCT02327078|468836217|FG001|Overall Study|Physician Decision|0|||
130238451|NCT02327078|468836218|FG002|Overall Study|Physician Decision|0|||
130238452|NCT02327078|468836219|FG003|Overall Study|Physician Decision|1|||
130238453|NCT02327078|468836220|FG004|Overall Study|Physician Decision|0|||
130238454|NCT02327078|468836221|FG005|Overall Study|Physician Decision|0|||
130238455|NCT02327078|468836222|FG006|Overall Study|Physician Decision|0|||
130238456|NCT02327078|468836223|FG007|Overall Study|Physician Decision|0|||
130026961|NCT02251912|468057984|FG001|Overall Study|Withdrawal by Subject|3|||
130026962|NCT02251912|468057983|FG000|Overall Study|Adverse Event|0|||
130026963|NCT02251912|468057984|FG001|Overall Study|Adverse Event|2|||
130026964|NCT01818726|468057985|FG000|Overall Study|Administrative reasons|5|||
130026965|NCT01818726|468057986|FG001|Overall Study|Administrative reasons|1|||
130238457|NCT02327078|468836224|FG008|Overall Study|Physician Decision|1|||
130238458|NCT02327078|468836216|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238459|NCT02327078|468836217|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238460|NCT02327078|468836218|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238461|NCT02327078|468836219|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130238462|NCT02327078|468836220|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130238463|NCT02327078|468836221|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
130238464|NCT02327078|468836222|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
130238465|NCT02327078|468836223|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
130238466|NCT02327078|468836224|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
130238467|NCT02327078|468836216|FG000|Overall Study|Reason not Specified|0|||
130026966|NCT01818726|468057985|FG000|Overall Study|Withdrawal by Subject|0|||
130026967|NCT01818726|468057986|FG001|Overall Study|Withdrawal by Subject|1|||
130026968|NCT01818726|468057985|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
130026969|NCT01818726|468057986|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
130026970|NCT03336502|468057987|FG000|Overall Study|Physician Decision|0|||
130238468|NCT02327078|468836217|FG001|Overall Study|Reason not Specified|0|||
130026971|NCT03336502|468057988|FG001|Overall Study|Physician Decision|1|||
130238469|NCT02327078|468836218|FG002|Overall Study|Reason not Specified|0|||
130238470|NCT02327078|468836219|FG003|Overall Study|Reason not Specified|0|||
130238471|NCT02327078|468836220|FG004|Overall Study|Reason not Specified|0|||
130238472|NCT02327078|468836221|FG005|Overall Study|Reason not Specified|0|||
130238473|NCT02327078|468836222|FG006|Overall Study|Reason not Specified|0|||
130238474|NCT02327078|468836223|FG007|Overall Study|Reason not Specified|5|||
130238475|NCT02327078|468836224|FG008|Overall Study|Reason not Specified|12|||
130238476|NCT03916926|468836228|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
130238477|NCT03916926|468836229|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
130238478|NCT03916926|468836228|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
130026972|NCT03336502|468057987|FG000|Overall Study|Prohibited Drugs|1|||
130026973|NCT03336502|468057988|FG001|Overall Study|Prohibited Drugs|1|||
130026974|NCT03336502|468057987|FG000|Overall Study|Death|1|||
130026975|NCT03336502|468057988|FG001|Overall Study|Death|2|||
130026976|NCT03336502|468057987|FG000|Overall Study|Adverse Event|2|||
130026977|NCT03336502|468057988|FG001|Overall Study|Adverse Event|5|||
130026978|NCT00480857|468057989|FG000|Overall Study|Lack of Efficacy|2|||
130026979|NCT00611247|468057990|FG000|Overall Study|Death|1|||
130026980|NCT00611247|468057991|FG001|Overall Study|Death|5|||
130026981|NCT00611247|468057990|FG000|Overall Study|Lack of Efficacy|1|||
130026982|NCT00611247|468057991|FG001|Overall Study|Lack of Efficacy|16|||
130026983|NCT01948830|468057992|FG000|Overall Study|Physician Decision|1|||
130026984|NCT01948830|468057993|FG001|Overall Study|Physician Decision|3|||
130026985|NCT01948830|468057992|FG000|Overall Study|Protocol deviation|1|||
130026986|NCT01948830|468057993|FG001|Overall Study|Protocol deviation|2|||
130026987|NCT01948830|468057992|FG000|Overall Study|Lost to Follow-up|5|||
130026988|NCT01948830|468057993|FG001|Overall Study|Lost to Follow-up|4|||
130026989|NCT01948830|468057992|FG000|Overall Study|Withdrawal by Subject|14|||
130026990|NCT01948830|468057993|FG001|Overall Study|Withdrawal by Subject|17|||
130026991|NCT01948830|468057992|FG000|Overall Study|Adverse Event|9|||
130026992|NCT01948830|468057993|FG001|Overall Study|Adverse Event|2|||
130026993|NCT01948830|468057992|FG000|Overall Study|Death|3|||
130026994|NCT01948830|468057993|FG001|Overall Study|Death|4|||
130026995|NCT01890421|468057994|FG000|Overall Study|Adverse Event|1|||
130026996|NCT01890421|468057994|FG000|Overall Study|Other reason|10|||
130238479|NCT03916926|468836229|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
130238480|NCT03916926|468836228|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
130238481|NCT03916926|468836229|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
130238482|NCT03916926|468836228|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
130238483|NCT03916926|468836229|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
130238484|NCT01081951|468836230|FG000|Overall Study|Death|54|||
130238485|NCT01081951|468836231|FG001|Overall Study|Death|47|||
130238486|NCT01081951|468836230|FG000|Overall Study|Withdrawal by Subject|2|||
130238487|NCT01081951|468836231|FG001|Overall Study|Withdrawal by Subject|6|||
130238488|NCT01081951|468836230|FG000|Overall Study|Allocated treatment but did not take it|0|||
130238489|NCT01081951|468836231|FG001|Overall Study|Allocated treatment but did not take it|1|||
130238490|NCT01081951|468836230|FG000|Overall Study|Lost to Follow-up|0|||
130238491|NCT01081951|468836231|FG001|Overall Study|Lost to Follow-up|1|||
130238492|NCT03765073|468836233|FG000|Stage 1|Lost to Follow-up|1|||
130238493|NCT03765073|468836234|FG001|Stage 1|Lost to Follow-up|0|||
130238494|NCT03765073|468836235|FG002|Stage 1|Lost to Follow-up|0|||
130238495|NCT03765073|468836236|FG003|Stage 1|Lost to Follow-up|0|||
130238496|NCT03765073|468836237|FG004|Stage 1|Lost to Follow-up|0|||
130238497|NCT03765073|468836238|FG005|Stage 1|Lost to Follow-up|0|||
130238498|NCT03765073|468836239|FG006|Stage 1|Lost to Follow-up|0|||
130238499|NCT03765073|468836240|FG007|Stage 1|Lost to Follow-up|0|||
130026997|NCT04506294|468058003|FG000|Overall Study|Lost to Follow-up|70|||
130238500|NCT03765073|468836241|FG008|Stage 1|Lost to Follow-up|0|||
130238501|NCT03765073|468836242|FG009|Stage 1|Lost to Follow-up|0|||
130238502|NCT03765073|468836243|FG010|Stage 1|Lost to Follow-up|0|||
130238503|NCT03765073|468836244|FG011|Stage 1|Lost to Follow-up|0|||
130238504|NCT03765073|468836245|FG012|Stage 1|Lost to Follow-up|0|||
130238505|NCT03765073|468836246|FG013|Stage 1|Lost to Follow-up|0|||
130238506|NCT03765073|468836247|FG014|Stage 1|Lost to Follow-up|0|||
130238507|NCT03765073|468836248|FG015|Stage 1|Lost to Follow-up|0|||
130238508|NCT03765073|468836249|FG016|Stage 1|Lost to Follow-up|0|||
130238509|NCT03765073|468836250|FG017|Stage 1|Lost to Follow-up|0|||
130238510|NCT03765073|468836251|FG018|Stage 1|Lost to Follow-up|0|||
130026998|NCT04506294|468058004|FG001|Overall Study|Lost to Follow-up|20|||
130026999|NCT04506294|468058003|FG000|Overall Study|Withdrawal by Subject|16|||
130238511|NCT03765073|468836252|FG019|Stage 1|Lost to Follow-up|0|||
130027000|NCT04506294|468058004|FG001|Overall Study|Withdrawal by Subject|2|||
130027001|NCT01931059|468058005|FG000|Day 1|Pregnancy|0|||
130238512|NCT03765073|468836253|FG020|Stage 1|Lost to Follow-up|0|||
130027002|NCT01931059|468058006|FG001|Day 1|Pregnancy|1|||
130238513|NCT03765073|468836233|FG000|Stage 1|Withdrawal by participant|0|||
130238514|NCT03765073|468836234|FG001|Stage 1|Withdrawal by participant|1|||
130238515|NCT03765073|468836235|FG002|Stage 1|Withdrawal by participant|0|||
130238516|NCT03765073|468836236|FG003|Stage 1|Withdrawal by participant|0|||
130238517|NCT03765073|468836237|FG004|Stage 1|Withdrawal by participant|0|||
130027003|NCT01931059|468058005|FG000|Day3|Lost to Follow-up|1|||
130238518|NCT03765073|468836238|FG005|Stage 1|Withdrawal by participant|0|||
130238519|NCT03765073|468836239|FG006|Stage 1|Withdrawal by participant|0|||
130238520|NCT03765073|468836240|FG007|Stage 1|Withdrawal by participant|0|||
130238521|NCT03765073|468836241|FG008|Stage 1|Withdrawal by participant|0|||
130238522|NCT03765073|468836242|FG009|Stage 1|Withdrawal by participant|0|||
130238523|NCT03765073|468836243|FG010|Stage 1|Withdrawal by participant|0|||
130238524|NCT03765073|468836244|FG011|Stage 1|Withdrawal by participant|0|||
130238525|NCT03765073|468836245|FG012|Stage 1|Withdrawal by participant|0|||
130238526|NCT03765073|468836246|FG013|Stage 1|Withdrawal by participant|0|||
130238527|NCT03765073|468836247|FG014|Stage 1|Withdrawal by participant|0|||
130238528|NCT03765073|468836248|FG015|Stage 1|Withdrawal by participant|0|||
130238529|NCT03765073|468836249|FG016|Stage 1|Withdrawal by participant|0|||
130238530|NCT03765073|468836250|FG017|Stage 1|Withdrawal by participant|0|||
130238531|NCT03765073|468836251|FG018|Stage 1|Withdrawal by participant|0|||
130238532|NCT03765073|468836252|FG019|Stage 1|Withdrawal by participant|0|||
130238533|NCT03765073|468836253|FG020|Stage 1|Withdrawal by participant|0|||
130238534|NCT03765073|468836233|FG000|Stage 2|Death|0|||
130238535|NCT03765073|468836234|FG001|Stage 2|Death|0|||
130238536|NCT03765073|468836235|FG002|Stage 2|Death|0|||
130238537|NCT03765073|468836236|FG003|Stage 2|Death|0|||
130238538|NCT03765073|468836237|FG004|Stage 2|Death|0|||
130238539|NCT03765073|468836238|FG005|Stage 2|Death|0|||
130238540|NCT03765073|468836239|FG006|Stage 2|Death|0|||
130238541|NCT03765073|468836240|FG007|Stage 2|Death|0|||
130238542|NCT03765073|468836241|FG008|Stage 2|Death|0|||
130238543|NCT03765073|468836242|FG009|Stage 2|Death|1|||
130238544|NCT03765073|468836243|FG010|Stage 2|Death|0|||
130238545|NCT03765073|468836244|FG011|Stage 2|Death|1|||
130238546|NCT03765073|468836245|FG012|Stage 2|Death|0|||
130238547|NCT03765073|468836246|FG013|Stage 2|Death|0|||
130238548|NCT03765073|468836247|FG014|Stage 2|Death|0|||
130238549|NCT03765073|468836248|FG015|Stage 2|Death|0|||
130238550|NCT03765073|468836249|FG016|Stage 2|Death|2|||
130238551|NCT03765073|468836250|FG017|Stage 2|Death|0|||
130238552|NCT03765073|468836251|FG018|Stage 2|Death|0|||
130238553|NCT03765073|468836252|FG019|Stage 2|Death|0|||
130238554|NCT03765073|468836253|FG020|Stage 2|Death|0|||
130238555|NCT03765073|468836233|FG000|Stage 2|Lost to Follow-up|0|||
130238556|NCT03765073|468836234|FG001|Stage 2|Lost to Follow-up|0|||
130238557|NCT03765073|468836235|FG002|Stage 2|Lost to Follow-up|0|||
130238558|NCT03765073|468836236|FG003|Stage 2|Lost to Follow-up|5|||
130238559|NCT03765073|468836237|FG004|Stage 2|Lost to Follow-up|1|||
130238560|NCT03765073|468836238|FG005|Stage 2|Lost to Follow-up|0|||
130238561|NCT03765073|468836239|FG006|Stage 2|Lost to Follow-up|3|||
130238562|NCT03765073|468836240|FG007|Stage 2|Lost to Follow-up|3|||
130238563|NCT03765073|468836241|FG008|Stage 2|Lost to Follow-up|1|||
130238564|NCT03765073|468836242|FG009|Stage 2|Lost to Follow-up|6|||
130238565|NCT03765073|468836243|FG010|Stage 2|Lost to Follow-up|5|||
130238566|NCT03765073|468836244|FG011|Stage 2|Lost to Follow-up|1|||
130238567|NCT03765073|468836245|FG012|Stage 2|Lost to Follow-up|1|||
130238568|NCT03765073|468836246|FG013|Stage 2|Lost to Follow-up|3|||
130238569|NCT03765073|468836247|FG014|Stage 2|Lost to Follow-up|3|||
130238570|NCT03765073|468836248|FG015|Stage 2|Lost to Follow-up|1|||
130238571|NCT03765073|468836249|FG016|Stage 2|Lost to Follow-up|6|||
130238572|NCT03765073|468836250|FG017|Stage 2|Lost to Follow-up|0|||
130238573|NCT03765073|468836251|FG018|Stage 2|Lost to Follow-up|0|||
130238574|NCT03765073|468836252|FG019|Stage 2|Lost to Follow-up|0|||
130238575|NCT03765073|468836253|FG020|Stage 2|Lost to Follow-up|0|||
130027004|NCT01931059|468058006|FG001|Day3|Lost to Follow-up|0|||
130027005|NCT00769119|468058007|FG000|Overall Study|Voluntary discontinuation|0|||
130238576|NCT03765073|468836233|FG000|Stage 2|Other|0|||
130238577|NCT03765073|468836234|FG001|Stage 2|Other|0|||
130238578|NCT03765073|468836235|FG002|Stage 2|Other|0|||
130238579|NCT03765073|468836236|FG003|Stage 2|Other|0|||
130238580|NCT03765073|468836237|FG004|Stage 2|Other|0|||
130238581|NCT03765073|468836238|FG005|Stage 2|Other|0|||
130027006|NCT00769119|468058008|FG001|Overall Study|Voluntary discontinuation|2|||
130238582|NCT03765073|468836239|FG006|Stage 2|Other|0|||
130238583|NCT03765073|468836240|FG007|Stage 2|Other|1|||
130238584|NCT03765073|468836241|FG008|Stage 2|Other|1|||
130238585|NCT03765073|468836242|FG009|Stage 2|Other|3|||
130238586|NCT03765073|468836243|FG010|Stage 2|Other|0|||
130238587|NCT03765073|468836244|FG011|Stage 2|Other|0|||
130238588|NCT03765073|468836245|FG012|Stage 2|Other|0|||
130238589|NCT03765073|468836246|FG013|Stage 2|Other|0|||
130238590|NCT03765073|468836247|FG014|Stage 2|Other|0|||
130238591|NCT03765073|468836248|FG015|Stage 2|Other|1|||
130027007|NCT00769119|468058007|FG000|Overall Study|Adverse Event|1|||
130027008|NCT00769119|468058008|FG001|Overall Study|Adverse Event|1|||
130238592|NCT03765073|468836249|FG016|Stage 2|Other|2|||
130238593|NCT03765073|468836250|FG017|Stage 2|Other|0|||
130238594|NCT03765073|468836251|FG018|Stage 2|Other|0|||
130238595|NCT03765073|468836252|FG019|Stage 2|Other|0|||
130238596|NCT03765073|468836253|FG020|Stage 2|Other|0|||
130238597|NCT03765073|468836233|FG000|Stage 2|Withdrawal by parent/guardian|0|||
130238598|NCT03765073|468836234|FG001|Stage 2|Withdrawal by parent/guardian|0|||
130238599|NCT03765073|468836235|FG002|Stage 2|Withdrawal by parent/guardian|0|||
130238600|NCT03765073|468836236|FG003|Stage 2|Withdrawal by parent/guardian|0|||
130027009|NCT00769119|468058007|FG000|Overall Study|Disallowed medication|1|||
130027010|NCT00769119|468058008|FG001|Overall Study|Disallowed medication|0|||
130027011|NCT01961115|468058012|FG000|Overall Study|Disease Progression|1|||
130027012|NCT01961115|468058013|FG001|Overall Study|Disease Progression|0|||
130027013|NCT01961115|468058014|FG002|Overall Study|Disease Progression|3|||
130027014|NCT01961115|468058012|FG000|Overall Study|Adverse Event|1|||
130027015|NCT01961115|468058013|FG001|Overall Study|Adverse Event|0|||
130027016|NCT01961115|468058014|FG002|Overall Study|Adverse Event|1|||
130027017|NCT00578643|468058015|FG000|Overall Study|Death|1|||
130027018|NCT00578643|468058015|FG000|Overall Study|Lost to Follow-up|1|||
130027019|NCT03828487|468058016|FG000|Overall Study|Physician Decision|1|||
130027020|NCT01990261|468058018|FG000|Overall Study|Death Before Treatment Start|2|||
130027021|NCT01990261|468058018|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
130027022|NCT01990261|468058018|FG000|Overall Study|Death From other Causes|1|||
130238601|NCT03765073|468836237|FG004|Stage 2|Withdrawal by parent/guardian|0|||
130238602|NCT03765073|468836238|FG005|Stage 2|Withdrawal by parent/guardian|0|||
130027023|NCT01990261|468058018|FG000|Overall Study|Disease Progression (PD)|8|||
130027024|NCT01990261|468058018|FG000|Overall Study|PD Before Treatment Start|1|||
130027025|NCT01990261|468058018|FG000|Overall Study|Dossier not Approved|1|||
130027026|NCT01990261|468058018|FG000|Overall Study|Lost to Follow-up|2|||
130027027|NCT01445678|468058020|FG000|Overall Study|Adverse Event|12|||
130027028|NCT01445678|468058021|FG001|Overall Study|Adverse Event|8|||
130027029|NCT01445678|468058020|FG000|Overall Study|Lack of Efficacy|0|||
130027030|NCT01445678|468058021|FG001|Overall Study|Lack of Efficacy|2|||
130027031|NCT01445678|468058020|FG000|Overall Study|Lost to Follow-up|8|||
130238603|NCT03765073|468836239|FG006|Stage 2|Withdrawal by parent/guardian|0|||
130238604|NCT03765073|468836240|FG007|Stage 2|Withdrawal by parent/guardian|0|||
130238605|NCT03765073|468836241|FG008|Stage 2|Withdrawal by parent/guardian|0|||
130238606|NCT03765073|468836242|FG009|Stage 2|Withdrawal by parent/guardian|0|||
130238607|NCT03765073|468836243|FG010|Stage 2|Withdrawal by parent/guardian|3|||
130238608|NCT03765073|468836244|FG011|Stage 2|Withdrawal by parent/guardian|3|||
130238609|NCT03765073|468836245|FG012|Stage 2|Withdrawal by parent/guardian|3|||
130238610|NCT03765073|468836246|FG013|Stage 2|Withdrawal by parent/guardian|1|||
130238611|NCT03765073|468836247|FG014|Stage 2|Withdrawal by parent/guardian|1|||
130238612|NCT03765073|468836248|FG015|Stage 2|Withdrawal by parent/guardian|0|||
130238613|NCT03765073|468836249|FG016|Stage 2|Withdrawal by parent/guardian|3|||
130238614|NCT03765073|468836250|FG017|Stage 2|Withdrawal by parent/guardian|0|||
130238615|NCT03765073|468836251|FG018|Stage 2|Withdrawal by parent/guardian|0|||
130238616|NCT03765073|468836252|FG019|Stage 2|Withdrawal by parent/guardian|0|||
130238617|NCT03765073|468836253|FG020|Stage 2|Withdrawal by parent/guardian|0|||
130238618|NCT03765073|468836233|FG000|Stage 2|Withdrawal by Subject|0|||
130238619|NCT03765073|468836234|FG001|Stage 2|Withdrawal by Subject|0|||
130238620|NCT03765073|468836235|FG002|Stage 2|Withdrawal by Subject|0|||
130238621|NCT03765073|468836236|FG003|Stage 2|Withdrawal by Subject|3|||
130238622|NCT03765073|468836237|FG004|Stage 2|Withdrawal by Subject|3|||
130238623|NCT03765073|468836238|FG005|Stage 2|Withdrawal by Subject|3|||
130238624|NCT03765073|468836239|FG006|Stage 2|Withdrawal by Subject|0|||
130238625|NCT03765073|468836240|FG007|Stage 2|Withdrawal by Subject|1|||
130238626|NCT03765073|468836241|FG008|Stage 2|Withdrawal by Subject|0|||
130238627|NCT03765073|468836242|FG009|Stage 2|Withdrawal by Subject|5|||
130238628|NCT03765073|468836243|FG010|Stage 2|Withdrawal by Subject|0|||
130238629|NCT03765073|468836244|FG011|Stage 2|Withdrawal by Subject|0|||
130238630|NCT03765073|468836245|FG012|Stage 2|Withdrawal by Subject|0|||
130238631|NCT03765073|468836246|FG013|Stage 2|Withdrawal by Subject|0|||
130238632|NCT03765073|468836247|FG014|Stage 2|Withdrawal by Subject|0|||
130238633|NCT03765073|468836248|FG015|Stage 2|Withdrawal by Subject|0|||
130238634|NCT03765073|468836249|FG016|Stage 2|Withdrawal by Subject|0|||
130238635|NCT03765073|468836250|FG017|Stage 2|Withdrawal by Subject|0|||
130238636|NCT03765073|468836251|FG018|Stage 2|Withdrawal by Subject|0|||
130238637|NCT03765073|468836252|FG019|Stage 2|Withdrawal by Subject|0|||
130238638|NCT03765073|468836253|FG020|Stage 2|Withdrawal by Subject|0|||
130238639|NCT03765073|468836233|FG000|Stage 3|Adverse Event|0|||
130238640|NCT03765073|468836234|FG001|Stage 3|Adverse Event|0|||
130027032|NCT01445678|468058021|FG001|Overall Study|Lost to Follow-up|5|||
130027033|NCT01445678|468058020|FG000|Overall Study|Protocol Violation|1|||
130027034|NCT01445678|468058021|FG001|Overall Study|Protocol Violation|1|||
130100217|NCT00929201|468325948|FG000|Period 1|Withdrawal by Subject|0|||
130100218|NCT00929201|468325949|FG001|Period 1|Withdrawal by Subject|1|||
130238641|NCT03765073|468836235|FG002|Stage 3|Adverse Event|0|||
130238642|NCT03765073|468836236|FG003|Stage 3|Adverse Event|0|||
130238643|NCT03765073|468836237|FG004|Stage 3|Adverse Event|0|||
130238644|NCT03765073|468836238|FG005|Stage 3|Adverse Event|0|||
130027035|NCT01445678|468058020|FG000|Overall Study|Withdrawal by Subject|9|||
130027036|NCT01445678|468058021|FG001|Overall Study|Withdrawal by Subject|5|||
130238645|NCT03765073|468836239|FG006|Stage 3|Adverse Event|0|||
130238646|NCT03765073|468836240|FG007|Stage 3|Adverse Event|0|||
130238647|NCT03765073|468836241|FG008|Stage 3|Adverse Event|0|||
130238648|NCT03765073|468836242|FG009|Stage 3|Adverse Event|0|||
130238649|NCT03765073|468836243|FG010|Stage 3|Adverse Event|0|||
130238650|NCT03765073|468836244|FG011|Stage 3|Adverse Event|0|||
130238651|NCT03765073|468836245|FG012|Stage 3|Adverse Event|0|||
130238652|NCT03765073|468836246|FG013|Stage 3|Adverse Event|0|||
130238653|NCT03765073|468836247|FG014|Stage 3|Adverse Event|0|||
130238654|NCT03765073|468836248|FG015|Stage 3|Adverse Event|0|||
130238655|NCT03765073|468836249|FG016|Stage 3|Adverse Event|0|||
130238656|NCT03765073|468836250|FG017|Stage 3|Adverse Event|0|||
130238657|NCT03765073|468836251|FG018|Stage 3|Adverse Event|1|||
130238658|NCT03765073|468836252|FG019|Stage 3|Adverse Event|0|||
130238659|NCT03765073|468836253|FG020|Stage 3|Adverse Event|0|||
130238660|NCT03765073|468836233|FG000|Stage 3|Death|0|||
130238661|NCT03765073|468836234|FG001|Stage 3|Death|0|||
130238662|NCT03765073|468836235|FG002|Stage 3|Death|0|||
130238663|NCT03765073|468836236|FG003|Stage 3|Death|0|||
130238664|NCT03765073|468836237|FG004|Stage 3|Death|0|||
130238665|NCT03765073|468836238|FG005|Stage 3|Death|0|||
130238666|NCT03765073|468836239|FG006|Stage 3|Death|0|||
130238667|NCT03765073|468836240|FG007|Stage 3|Death|0|||
130238668|NCT03765073|468836241|FG008|Stage 3|Death|0|||
130238669|NCT03765073|468836242|FG009|Stage 3|Death|0|||
130238670|NCT03765073|468836243|FG010|Stage 3|Death|0|||
130238671|NCT03765073|468836244|FG011|Stage 3|Death|0|||
130238672|NCT03765073|468836245|FG012|Stage 3|Death|0|||
130238673|NCT03765073|468836246|FG013|Stage 3|Death|0|||
130238674|NCT03765073|468836247|FG014|Stage 3|Death|0|||
130238675|NCT03765073|468836248|FG015|Stage 3|Death|0|||
130238676|NCT03765073|468836249|FG016|Stage 3|Death|0|||
130238677|NCT03765073|468836250|FG017|Stage 3|Death|0|||
130238678|NCT03765073|468836251|FG018|Stage 3|Death|0|||
130238679|NCT03765073|468836252|FG019|Stage 3|Death|3|||
130238680|NCT03765073|468836253|FG020|Stage 3|Death|2|||
130238681|NCT03765073|468836233|FG000|Stage 3|Lost to Follow-up|0|||
130238682|NCT03765073|468836234|FG001|Stage 3|Lost to Follow-up|0|||
130238683|NCT03765073|468836235|FG002|Stage 3|Lost to Follow-up|0|||
130238684|NCT03765073|468836236|FG003|Stage 3|Lost to Follow-up|0|||
130238685|NCT03765073|468836237|FG004|Stage 3|Lost to Follow-up|0|||
130238686|NCT03765073|468836238|FG005|Stage 3|Lost to Follow-up|0|||
130238687|NCT03765073|468836239|FG006|Stage 3|Lost to Follow-up|0|||
130238688|NCT03765073|468836240|FG007|Stage 3|Lost to Follow-up|0|||
130238689|NCT03765073|468836241|FG008|Stage 3|Lost to Follow-up|0|||
130238690|NCT03765073|468836242|FG009|Stage 3|Lost to Follow-up|0|||
130238691|NCT03765073|468836243|FG010|Stage 3|Lost to Follow-up|0|||
130238692|NCT03765073|468836244|FG011|Stage 3|Lost to Follow-up|0|||
130238693|NCT03765073|468836245|FG012|Stage 3|Lost to Follow-up|0|||
130238694|NCT03765073|468836246|FG013|Stage 3|Lost to Follow-up|0|||
130238695|NCT03765073|468836247|FG014|Stage 3|Lost to Follow-up|0|||
130238696|NCT03765073|468836248|FG015|Stage 3|Lost to Follow-up|0|||
130238697|NCT03765073|468836249|FG016|Stage 3|Lost to Follow-up|0|||
130027037|NCT02307370|468058022|FG000|Overall Study|Death|5|||
130027038|NCT02307370|468058022|FG000|Overall Study|Lost to Follow-up|1|||
130027039|NCT02307370|468058022|FG000|Overall Study|Withdrawal by Subject|1|||
130027040|NCT02307370|468058022|FG000|Overall Study|Declined Addendum ICF|6|||
130027041|NCT02307370|468058022|FG000|Overall Study|No response during telephone contact|5|||
130027042|NCT02307370|468058022|FG000|Overall Study|Protocol Violation|1|||
130027043|NCT00865020|468058023|FG000|Overall Study|Withdrawal by Subject|22|||
130027044|NCT00865020|468058024|FG001|Overall Study|Withdrawal by Subject|16|||
130027045|NCT00865020|468058023|FG000|Overall Study|Adverse Event|9|||
130027046|NCT00865020|468058024|FG001|Overall Study|Adverse Event|14|||
130027047|NCT00865020|468058023|FG000|Overall Study|Abnormal test procedure result(s)|6|||
130100219|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
130100220|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130100221|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130238698|NCT03765073|468836250|FG017|Stage 3|Lost to Follow-up|8|||
130238699|NCT03765073|468836251|FG018|Stage 3|Lost to Follow-up|5|||
130238700|NCT03765073|468836252|FG019|Stage 3|Lost to Follow-up|7|||
130238701|NCT03765073|468836253|FG020|Stage 3|Lost to Follow-up|4|||
130238702|NCT03765073|468836233|FG000|Stage 3|No longer meets eligibility criteria|0|||
130238703|NCT03765073|468836234|FG001|Stage 3|No longer meets eligibility criteria|0|||
130238704|NCT03765073|468836235|FG002|Stage 3|No longer meets eligibility criteria|0|||
130238705|NCT03765073|468836236|FG003|Stage 3|No longer meets eligibility criteria|0|||
130238706|NCT03765073|468836237|FG004|Stage 3|No longer meets eligibility criteria|0|||
130238707|NCT03765073|468836238|FG005|Stage 3|No longer meets eligibility criteria|0|||
130238708|NCT03765073|468836239|FG006|Stage 3|No longer meets eligibility criteria|0|||
130238709|NCT03765073|468836240|FG007|Stage 3|No longer meets eligibility criteria|0|||
130238710|NCT03765073|468836241|FG008|Stage 3|No longer meets eligibility criteria|0|||
130238711|NCT03765073|468836242|FG009|Stage 3|No longer meets eligibility criteria|0|||
130027048|NCT00865020|468058024|FG001|Overall Study|Abnormal test procedure result(s)|8|||
130027049|NCT00865020|468058023|FG000|Overall Study|Lost to Follow-up|6|||
130027050|NCT00865020|468058024|FG001|Overall Study|Lost to Follow-up|4|||
130027051|NCT00865020|468058023|FG000|Overall Study|Protocol deviation|4|||
130027052|NCT00865020|468058024|FG001|Overall Study|Protocol deviation|1|||
130027053|NCT00865020|468058023|FG000|Overall Study|Administrative problems|0|||
130027054|NCT00865020|468058024|FG001|Overall Study|Administrative problems|2|||
130027055|NCT00865020|468058023|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130027056|NCT00865020|468058024|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130027057|NCT00865020|468058023|FG000|Overall Study|Death|0|||
130027058|NCT00865020|468058024|FG001|Overall Study|Death|1|||
130027059|NCT00865020|468058023|FG000|Overall Study|Randomized but discontinued|2|||
130027060|NCT00865020|468058024|FG001|Overall Study|Randomized but discontinued|4|||
130027061|NCT03641560|468058025|FG000|Overall Study|Withdrawal by Subject|6|||
130027062|NCT03641560|468058025|FG000|Overall Study|Progressive disease|40|||
130027063|NCT03641560|468058025|FG000|Overall Study|Death|6|||
130027064|NCT00388947|468060638|FG000|Overall Study|Protocol Violation|47|||
130027065|NCT00544869|468060639|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
130027066|NCT00544869|468060640|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
130027067|NCT00544869|468060641|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
130027068|NCT00544869|468060639|FG000|Overall Study|Adverse Event|6|||
130027069|NCT00544869|468060640|FG001|Overall Study|Adverse Event|1|||
130027070|NCT00544869|468060641|FG002|Overall Study|Adverse Event|0|||
130027071|NCT00544869|468060639|FG000|Overall Study|Lack of Efficacy|1|||
130027072|NCT00544869|468060640|FG001|Overall Study|Lack of Efficacy|1|||
130027073|NCT00544869|468060641|FG002|Overall Study|Lack of Efficacy|0|||
130027074|NCT00544869|468060639|FG000|Overall Study|Physician Decision|2|||
130027075|NCT00544869|468060640|FG001|Overall Study|Physician Decision|0|||
130027076|NCT00544869|468060641|FG002|Overall Study|Physician Decision|0|||
130027077|NCT00925600|468060642|FG000|Overall Study|Withdrawal by Subject|16|||
130027078|NCT00925600|468060643|FG001|Overall Study|Withdrawal by Subject|14|||
130027079|NCT00925600|468060642|FG000|Overall Study|Death|4|||
130027080|NCT00925600|468060643|FG001|Overall Study|Death|3|||
130027081|NCT00925600|468060642|FG000|Overall Study|Lost to Follow-up|2|||
130027082|NCT00925600|468060643|FG001|Overall Study|Lost to Follow-up|2|||
130027083|NCT00925600|468060642|FG000|Overall Study|Disease Progression|1|||
130027084|NCT00925600|468060643|FG001|Overall Study|Disease Progression|3|||
130027085|NCT00925600|468060642|FG000|Overall Study|Administrative Decision|1|||
130027086|NCT00925600|468060643|FG001|Overall Study|Administrative Decision|1|||
130027087|NCT00925600|468060642|FG000|Overall Study|Noncompliance|2|||
130027088|NCT00925600|468060643|FG001|Overall Study|Noncompliance|0|||
130027089|NCT00925600|468060642|FG000|Overall Study|Ineligibility Determined|2|||
130027090|NCT00925600|468060643|FG001|Overall Study|Ineligibility Determined|0|||
130027091|NCT00925600|468060642|FG000|Overall Study|Protocol Deviation|0|||
130027092|NCT00925600|468060643|FG001|Overall Study|Protocol Deviation|1|||
130027093|NCT00925600|468060642|FG000|Overall Study|Requirement for Alternative Therapy|0|||
130027094|NCT00925600|468060643|FG001|Overall Study|Requirement for Alternative Therapy|1|||
130027095|NCT00925600|468060642|FG000|Overall Study|Other|3|||
130027096|NCT00925600|468060643|FG001|Overall Study|Other|1|||
130027097|NCT00925600|468060642|FG000|Overall Study|Adverse Event|1|||
130027098|NCT00925600|468060643|FG001|Overall Study|Adverse Event|2|||
130027099|NCT01974817|468060646|FG000|Overall Study|Death|4|||
130027100|NCT01974817|468060646|FG000|Overall Study|Lost to Follow-up|2|||
130027101|NCT01974817|468060646|FG000|Overall Study|Protocol Violation|2|||
130027102|NCT01891643|468060647|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130027103|NCT01891643|468060648|FG001|Overall Study|Adverse event unrelated to study drug|5|||
130027104|NCT01891643|468060647|FG000|Overall Study|Disease Progression|4|||
130027105|NCT01891643|468060648|FG001|Overall Study|Disease Progression|3|||
130027106|NCT01891643|468060647|FG000|Overall Study|Study Drug Toxicity|3|||
130100222|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
130238712|NCT03765073|468836243|FG010|Stage 3|No longer meets eligibility criteria|0|||
130238713|NCT03765073|468836244|FG011|Stage 3|No longer meets eligibility criteria|0|||
130238714|NCT03765073|468836245|FG012|Stage 3|No longer meets eligibility criteria|0|||
130238715|NCT03765073|468836246|FG013|Stage 3|No longer meets eligibility criteria|0|||
130238716|NCT03765073|468836247|FG014|Stage 3|No longer meets eligibility criteria|0|||
130238717|NCT03765073|468836248|FG015|Stage 3|No longer meets eligibility criteria|0|||
129884559|NCT02696902|467536454|FG001|Overall Study|Withdrawal by Subject|0|||
130027107|NCT01891643|468060648|FG001|Overall Study|Study Drug Toxicity|0|||
130027108|NCT01891643|468060647|FG000|Overall Study|Maximum Clinical Benefit|0|||
130027109|NCT01891643|468060648|FG001|Overall Study|Maximum Clinical Benefit|1|||
130027110|NCT01891643|468060647|FG000|Overall Study|Poor/Non-compliance|0|||
130027111|NCT01891643|468060648|FG001|Overall Study|Poor/Non-compliance|1|||
130027112|NCT01891643|468060647|FG000|Overall Study|Participant request to discontinue|1|||
130027113|NCT01891643|468060648|FG001|Overall Study|Participant request to discontinue|0|||
130027114|NCT02965716|468060649|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130100223|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
130238718|NCT03765073|468836249|FG016|Stage 3|No longer meets eligibility criteria|0|||
130238719|NCT03765073|468836250|FG017|Stage 3|No longer meets eligibility criteria|0|||
130238720|NCT03765073|468836251|FG018|Stage 3|No longer meets eligibility criteria|1|||
130238721|NCT03765073|468836252|FG019|Stage 3|No longer meets eligibility criteria|0|||
130238722|NCT03765073|468836253|FG020|Stage 3|No longer meets eligibility criteria|1|||
130238723|NCT03765073|468836233|FG000|Stage 3|Other|0|||
130238724|NCT03765073|468836234|FG001|Stage 3|Other|0|||
130238725|NCT03765073|468836235|FG002|Stage 3|Other|0|||
130238726|NCT03765073|468836236|FG003|Stage 3|Other|0|||
130238727|NCT03765073|468836237|FG004|Stage 3|Other|0|||
130238728|NCT03765073|468836238|FG005|Stage 3|Other|0|||
130100224|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
130238729|NCT03765073|468836239|FG006|Stage 3|Other|0|||
130238730|NCT03765073|468836240|FG007|Stage 3|Other|0|||
130238731|NCT03765073|468836241|FG008|Stage 3|Other|0|||
130238732|NCT03765073|468836242|FG009|Stage 3|Other|0|||
130238733|NCT03765073|468836243|FG010|Stage 3|Other|0|||
130238734|NCT03765073|468836244|FG011|Stage 3|Other|0|||
130238735|NCT03765073|468836245|FG012|Stage 3|Other|0|||
130238736|NCT03765073|468836246|FG013|Stage 3|Other|0|||
130238737|NCT03765073|468836247|FG014|Stage 3|Other|0|||
130238738|NCT03765073|468836248|FG015|Stage 3|Other|0|||
130238739|NCT03765073|468836249|FG016|Stage 3|Other|0|||
130238740|NCT03765073|468836250|FG017|Stage 3|Other|1|||
130238741|NCT03765073|468836251|FG018|Stage 3|Other|2|||
130238742|NCT03765073|468836252|FG019|Stage 3|Other|2|||
130238743|NCT03765073|468836253|FG020|Stage 3|Other|2|||
130238744|NCT03765073|468836233|FG000|Stage 3|Withdrawal by parent/guardian|0|||
130238745|NCT03765073|468836234|FG001|Stage 3|Withdrawal by parent/guardian|0|||
130238746|NCT03765073|468836235|FG002|Stage 3|Withdrawal by parent/guardian|0|||
130238747|NCT03765073|468836236|FG003|Stage 3|Withdrawal by parent/guardian|0|||
130238748|NCT03765073|468836237|FG004|Stage 3|Withdrawal by parent/guardian|0|||
130238749|NCT03765073|468836238|FG005|Stage 3|Withdrawal by parent/guardian|0|||
130238750|NCT03765073|468836239|FG006|Stage 3|Withdrawal by parent/guardian|0|||
130238751|NCT03765073|468836240|FG007|Stage 3|Withdrawal by parent/guardian|0|||
130238752|NCT03765073|468836241|FG008|Stage 3|Withdrawal by parent/guardian|0|||
130238753|NCT03765073|468836242|FG009|Stage 3|Withdrawal by parent/guardian|0|||
130238754|NCT03765073|468836243|FG010|Stage 3|Withdrawal by parent/guardian|0|||
130238755|NCT03765073|468836244|FG011|Stage 3|Withdrawal by parent/guardian|0|||
130238756|NCT03765073|468836245|FG012|Stage 3|Withdrawal by parent/guardian|0|||
130238757|NCT03765073|468836246|FG013|Stage 3|Withdrawal by parent/guardian|0|||
130238758|NCT03765073|468836247|FG014|Stage 3|Withdrawal by parent/guardian|0|||
130238759|NCT03765073|468836248|FG015|Stage 3|Withdrawal by parent/guardian|0|||
130238760|NCT03765073|468836249|FG016|Stage 3|Withdrawal by parent/guardian|0|||
130238761|NCT03765073|468836250|FG017|Stage 3|Withdrawal by parent/guardian|0|||
130238762|NCT03765073|468836251|FG018|Stage 3|Withdrawal by parent/guardian|0|||
130238763|NCT03765073|468836252|FG019|Stage 3|Withdrawal by parent/guardian|6|||
130238764|NCT03765073|468836253|FG020|Stage 3|Withdrawal by parent/guardian|9|||
130238765|NCT03765073|468836233|FG000|Stage 3|Withdrawal by Subject|0|||
130238766|NCT03765073|468836234|FG001|Stage 3|Withdrawal by Subject|0|||
130238767|NCT03765073|468836235|FG002|Stage 3|Withdrawal by Subject|0|||
130238768|NCT03765073|468836236|FG003|Stage 3|Withdrawal by Subject|0|||
130238769|NCT03765073|468836237|FG004|Stage 3|Withdrawal by Subject|0|||
130238770|NCT03765073|468836238|FG005|Stage 3|Withdrawal by Subject|0|||
130238771|NCT03765073|468836239|FG006|Stage 3|Withdrawal by Subject|0|||
130238772|NCT03765073|468836240|FG007|Stage 3|Withdrawal by Subject|0|||
130238773|NCT03765073|468836241|FG008|Stage 3|Withdrawal by Subject|0|||
130238774|NCT03765073|468836242|FG009|Stage 3|Withdrawal by Subject|0|||
130238775|NCT03765073|468836243|FG010|Stage 3|Withdrawal by Subject|0|||
130238776|NCT03765073|468836244|FG011|Stage 3|Withdrawal by Subject|0|||
130100225|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
130238777|NCT03765073|468836245|FG012|Stage 3|Withdrawal by Subject|0|||
130238778|NCT03765073|468836246|FG013|Stage 3|Withdrawal by Subject|0|||
130238779|NCT03765073|468836247|FG014|Stage 3|Withdrawal by Subject|0|||
130238780|NCT03765073|468836248|FG015|Stage 3|Withdrawal by Subject|0|||
130238781|NCT03765073|468836249|FG016|Stage 3|Withdrawal by Subject|0|||
130238782|NCT03765073|468836250|FG017|Stage 3|Withdrawal by Subject|8|||
130238783|NCT03765073|468836251|FG018|Stage 3|Withdrawal by Subject|11|||
130238784|NCT03765073|468836252|FG019|Stage 3|Withdrawal by Subject|0|||
130238785|NCT03765073|468836253|FG020|Stage 3|Withdrawal by Subject|0|||
130238786|NCT04537299|468836254|FG000|Overall Study|Withdrawal by Subject|2|||
130238787|NCT04537299|468836255|FG001|Overall Study|Withdrawal by Subject|0|||
130238788|NCT04537299|468836254|FG000|Overall Study|Protocol Violation|1|||
130238789|NCT04537299|468836255|FG001|Overall Study|Protocol Violation|1|||
130238790|NCT03806296|468836258|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
130238791|NCT03806296|468836259|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
130238792|NCT03806296|468836260|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
130238793|NCT03806296|468836258|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
130238794|NCT03806296|468836259|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
130238795|NCT03806296|468836260|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
130238796|NCT03806296|468836258|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
130238797|NCT03806296|468836259|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
130238798|NCT03806296|468836260|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
130238799|NCT00876343|468836267|FG000|Overall Study|Adverse Event|7|||
130238800|NCT00876343|468836268|FG001|Overall Study|Adverse Event|8|||
130238801|NCT00876343|468836269|FG002|Overall Study|Adverse Event|2|||
130238802|NCT00876343|468836267|FG000|Overall Study|Withdrawal by Subject|4|||
130238803|NCT00876343|468836268|FG001|Overall Study|Withdrawal by Subject|4|||
130238804|NCT00876343|468836269|FG002|Overall Study|Withdrawal by Subject|3|||
130238805|NCT00876343|468836267|FG000|Overall Study|Lack of Efficacy|0|||
130238806|NCT00876343|468836268|FG001|Overall Study|Lack of Efficacy|0|||
130238807|NCT00876343|468836269|FG002|Overall Study|Lack of Efficacy|1|||
130238808|NCT00876343|468836267|FG000|Overall Study|Protocol Violation|4|||
130238809|NCT00876343|468836268|FG001|Overall Study|Protocol Violation|1|||
130238810|NCT00876343|468836269|FG002|Overall Study|Protocol Violation|1|||
130238811|NCT00876343|468836267|FG000|Overall Study|Physician Decision|0|||
130238812|NCT00876343|468836268|FG001|Overall Study|Physician Decision|1|||
130238813|NCT00876343|468836269|FG002|Overall Study|Physician Decision|1|||
130238814|NCT00876343|468836267|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
130238815|NCT00876343|468836268|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
130238816|NCT00876343|468836269|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
130238817|NCT00876343|468836267|FG000|Overall Study|Change of residence or other commitments|2|||
130238818|NCT00876343|468836268|FG001|Overall Study|Change of residence or other commitments|2|||
130238819|NCT00876343|468836269|FG002|Overall Study|Change of residence or other commitments|3|||
130238820|NCT01933932|468836272|FG000|Overall Study|Death|173|||
130238821|NCT01933932|468836273|FG001|Overall Study|Death|163|||
130238822|NCT01933932|468836272|FG000|Overall Study|Withdrawal by Subject|11|||
130238823|NCT01933932|468836273|FG001|Overall Study|Withdrawal by Subject|14|||
130238824|NCT01933932|468836272|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130238825|NCT01933932|468836273|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130238826|NCT01925794|468836281|FG000|180 Days|Death|2|||
130238827|NCT01925794|468836281|FG000|180 Days|Withdrawal by Subject|2|||
130238828|NCT01925794|468836281|FG000|270 Days|Death|2|||
130027115|NCT02965716|468060650|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
130027116|NCT02965716|468060649|FG000|Overall Study|Progression/Relapse|8|||
130027117|NCT02965716|468060650|FG001|Overall Study|Progression/Relapse|16|||
130238829|NCT01925794|468836281|FG000|270 Days|Protocol Violation|3|||
130238830|NCT00790036|468836282|FG000|Overall Study|Abnormal lab values|3|||
130238831|NCT00790036|468836283|FG001|Overall Study|Abnormal lab values|2|||
130238832|NCT00790036|468836282|FG000|Overall Study|Administrative problems|5|||
130238833|NCT00790036|468836283|FG001|Overall Study|Administrative problems|9|||
130238834|NCT00790036|468836282|FG000|Overall Study|Adverse Event|113|||
130238835|NCT00790036|468836283|FG001|Overall Study|Adverse Event|44|||
130238836|NCT00790036|468836282|FG000|Overall Study|Death|1|||
130238837|NCT00790036|468836283|FG001|Overall Study|Death|0|||
130238838|NCT00790036|468836282|FG000|Overall Study|Disease progression|24|||
130238839|NCT00790036|468836283|FG001|Overall Study|Disease progression|48|||
130238840|NCT00790036|468836282|FG000|Overall Study|Lost to Follow-up|1|||
130238841|NCT00790036|468836283|FG001|Overall Study|Lost to Follow-up|2|||
130027118|NCT02965716|468060649|FG000|Overall Study|Death|1|||
130027119|NCT02965716|468060650|FG001|Overall Study|Death|0|||
130027120|NCT02965716|468060649|FG000|Overall Study|Not Protocol Specified|1|||
130027121|NCT02965716|468060650|FG001|Overall Study|Not Protocol Specified|3|||
130027122|NCT04047797|468060651|FG000|Overall Study|Progressive Disease|1|||
130027123|NCT03523351|468060652|FG000|Overall Study|Death|13|||
130027124|NCT03523351|468060653|FG001|Overall Study|Death|11|||
130027125|NCT03523351|468060652|FG000|Overall Study|Lost to Follow-up|2|||
130027126|NCT03523351|468060653|FG001|Overall Study|Lost to Follow-up|3|||
130027127|NCT03523351|468060652|FG000|Overall Study|Withdrawal by Subject|4|||
130027128|NCT03523351|468060653|FG001|Overall Study|Withdrawal by Subject|0|||
130027129|NCT03523351|468060652|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
130027130|NCT03523351|468060653|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
130027131|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
130027132|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
130027133|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
130027134|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130027135|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130027136|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130027137|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130027138|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130027139|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
130027140|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
130027141|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
130027142|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130027143|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130027144|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130027145|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130238842|NCT00790036|468836282|FG000|Overall Study|Protocol Violation|10|||
130238843|NCT00790036|468836283|FG001|Overall Study|Protocol Violation|2|||
130238844|NCT00790036|468836282|FG000|Overall Study|Withdrawal by Subject|18|||
130238845|NCT00790036|468836283|FG001|Overall Study|Withdrawal by Subject|7|||
130238846|NCT00790036|468836282|FG000|Overall Study|Subject/guardian decision|20|||
130238847|NCT00790036|468836283|FG001|Overall Study|Subject/guardian decision|7|||
130238848|NCT03126110|468836292|FG000|Phase 1|Death|2|||
130238849|NCT03126110|468836293|FG001|Phase 1|Death|2|||
130238850|NCT03126110|468836294|FG002|Phase 1|Death|4|||
130027146|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130027147|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
130027148|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
130027149|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
130238851|NCT03126110|468836295|FG003|Phase 1|Death|3|||
130238852|NCT03126110|468836296|FG004|Phase 1|Death|4|||
130238853|NCT03126110|468836297|FG005|Phase 1|Death|4|||
130238854|NCT03126110|468836298|FG006|Phase 1|Death|3|||
130238855|NCT03126110|468836299|FG007|Phase 1|Death|4|||
130238856|NCT03126110|468836300|FG008|Phase 1|Death|5|||
130238857|NCT03126110|468836301|FG009|Phase 1|Death|2|||
130238858|NCT03126110|468836302|FG010|Phase 1|Death|6|||
130027150|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130027151|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130238859|NCT03126110|468836303|FG011|Phase 1|Death|0|||
130238860|NCT03126110|468836304|FG012|Phase 1|Death|0|||
130238861|NCT03126110|468836305|FG013|Phase 1|Death|0|||
130238862|NCT03126110|468836306|FG014|Phase 1|Death|0|||
130238863|NCT03126110|468836307|FG015|Phase 1|Death|0|||
130238864|NCT03126110|468836308|FG016|Phase 1|Death|0|||
130238865|NCT03126110|468836292|FG000|Phase 1|Lost to Follow-up|0|||
130238866|NCT03126110|468836293|FG001|Phase 1|Lost to Follow-up|1|||
130238867|NCT03126110|468836294|FG002|Phase 1|Lost to Follow-up|0|||
130238868|NCT03126110|468836295|FG003|Phase 1|Lost to Follow-up|0|||
130238869|NCT03126110|468836296|FG004|Phase 1|Lost to Follow-up|0|||
130238870|NCT03126110|468836297|FG005|Phase 1|Lost to Follow-up|0|||
130238871|NCT03126110|468836298|FG006|Phase 1|Lost to Follow-up|0|||
130238872|NCT03126110|468836299|FG007|Phase 1|Lost to Follow-up|0|||
130238873|NCT03126110|468836300|FG008|Phase 1|Lost to Follow-up|1|||
130238874|NCT03126110|468836301|FG009|Phase 1|Lost to Follow-up|0|||
130238875|NCT03126110|468836302|FG010|Phase 1|Lost to Follow-up|0|||
130238876|NCT03126110|468836303|FG011|Phase 1|Lost to Follow-up|0|||
130238877|NCT03126110|468836304|FG012|Phase 1|Lost to Follow-up|0|||
130238878|NCT03126110|468836305|FG013|Phase 1|Lost to Follow-up|0|||
130238879|NCT03126110|468836306|FG014|Phase 1|Lost to Follow-up|0|||
130238880|NCT03126110|468836307|FG015|Phase 1|Lost to Follow-up|0|||
130238881|NCT03126110|468836308|FG016|Phase 1|Lost to Follow-up|0|||
130238882|NCT03126110|468836292|FG000|Phase 1|Withdrawal by Subject|1|||
130238883|NCT03126110|468836293|FG001|Phase 1|Withdrawal by Subject|0|||
130238884|NCT03126110|468836294|FG002|Phase 1|Withdrawal by Subject|0|||
130238885|NCT03126110|468836295|FG003|Phase 1|Withdrawal by Subject|1|||
130238886|NCT03126110|468836296|FG004|Phase 1|Withdrawal by Subject|1|||
130238887|NCT03126110|468836297|FG005|Phase 1|Withdrawal by Subject|0|||
130238888|NCT03126110|468836298|FG006|Phase 1|Withdrawal by Subject|0|||
130238889|NCT03126110|468836299|FG007|Phase 1|Withdrawal by Subject|0|||
130238890|NCT03126110|468836300|FG008|Phase 1|Withdrawal by Subject|2|||
130238891|NCT03126110|468836301|FG009|Phase 1|Withdrawal by Subject|1|||
130238892|NCT03126110|468836302|FG010|Phase 1|Withdrawal by Subject|0|||
130238893|NCT03126110|468836303|FG011|Phase 1|Withdrawal by Subject|0|||
130238894|NCT03126110|468836304|FG012|Phase 1|Withdrawal by Subject|0|||
130238895|NCT03126110|468836305|FG013|Phase 1|Withdrawal by Subject|0|||
130238896|NCT03126110|468836306|FG014|Phase 1|Withdrawal by Subject|0|||
130238897|NCT03126110|468836307|FG015|Phase 1|Withdrawal by Subject|0|||
130238898|NCT03126110|468836308|FG016|Phase 1|Withdrawal by Subject|0|||
130238899|NCT03126110|468836292|FG000|Phase 1|Safety follow-up no longer necessary|1|||
130238900|NCT03126110|468836293|FG001|Phase 1|Safety follow-up no longer necessary|0|||
130238901|NCT03126110|468836294|FG002|Phase 1|Safety follow-up no longer necessary|0|||
130238902|NCT03126110|468836295|FG003|Phase 1|Safety follow-up no longer necessary|0|||
130238903|NCT03126110|468836296|FG004|Phase 1|Safety follow-up no longer necessary|0|||
130238904|NCT03126110|468836297|FG005|Phase 1|Safety follow-up no longer necessary|0|||
130238905|NCT03126110|468836298|FG006|Phase 1|Safety follow-up no longer necessary|0|||
130238906|NCT03126110|468836299|FG007|Phase 1|Safety follow-up no longer necessary|0|||
130238907|NCT03126110|468836300|FG008|Phase 1|Safety follow-up no longer necessary|0|||
130238908|NCT03126110|468836301|FG009|Phase 1|Safety follow-up no longer necessary|0|||
130238909|NCT03126110|468836302|FG010|Phase 1|Safety follow-up no longer necessary|0|||
130238910|NCT03126110|468836303|FG011|Phase 1|Safety follow-up no longer necessary|0|||
130238911|NCT03126110|468836304|FG012|Phase 1|Safety follow-up no longer necessary|0|||
130238912|NCT03126110|468836305|FG013|Phase 1|Safety follow-up no longer necessary|0|||
130238913|NCT03126110|468836306|FG014|Phase 1|Safety follow-up no longer necessary|0|||
130238914|NCT03126110|468836307|FG015|Phase 1|Safety follow-up no longer necessary|0|||
130238915|NCT03126110|468836308|FG016|Phase 1|Safety follow-up no longer necessary|0|||
130238916|NCT03126110|468836292|FG000|Phase 1|Survival follow-up no longer necessary|0|||
130238917|NCT03126110|468836293|FG001|Phase 1|Survival follow-up no longer necessary|0|||
130238918|NCT03126110|468836294|FG002|Phase 1|Survival follow-up no longer necessary|1|||
130238919|NCT03126110|468836295|FG003|Phase 1|Survival follow-up no longer necessary|0|||
130238920|NCT03126110|468836296|FG004|Phase 1|Survival follow-up no longer necessary|0|||
130238921|NCT03126110|468836297|FG005|Phase 1|Survival follow-up no longer necessary|0|||
130238922|NCT03126110|468836298|FG006|Phase 1|Survival follow-up no longer necessary|0|||
130238923|NCT03126110|468836299|FG007|Phase 1|Survival follow-up no longer necessary|0|||
130238924|NCT03126110|468836300|FG008|Phase 1|Survival follow-up no longer necessary|0|||
130238925|NCT03126110|468836301|FG009|Phase 1|Survival follow-up no longer necessary|0|||
130238926|NCT03126110|468836302|FG010|Phase 1|Survival follow-up no longer necessary|0|||
130238927|NCT03126110|468836303|FG011|Phase 1|Survival follow-up no longer necessary|0|||
130238928|NCT03126110|468836304|FG012|Phase 1|Survival follow-up no longer necessary|0|||
130238929|NCT03126110|468836305|FG013|Phase 1|Survival follow-up no longer necessary|0|||
130238930|NCT03126110|468836306|FG014|Phase 1|Survival follow-up no longer necessary|0|||
130238931|NCT03126110|468836307|FG015|Phase 1|Survival follow-up no longer necessary|0|||
130238932|NCT03126110|468836308|FG016|Phase 1|Survival follow-up no longer necessary|0|||
130238933|NCT03126110|468836292|FG000|Phase 2|Study terminated by the sponsor|0|||
130238934|NCT03126110|468836293|FG001|Phase 2|Study terminated by the sponsor|0|||
130238935|NCT03126110|468836294|FG002|Phase 2|Study terminated by the sponsor|0|||
130238936|NCT03126110|468836295|FG003|Phase 2|Study terminated by the sponsor|0|||
130238937|NCT03126110|468836296|FG004|Phase 2|Study terminated by the sponsor|0|||
130238938|NCT03126110|468836297|FG005|Phase 2|Study terminated by the sponsor|0|||
130238939|NCT03126110|468836298|FG006|Phase 2|Study terminated by the sponsor|0|||
130238940|NCT03126110|468836299|FG007|Phase 2|Study terminated by the sponsor|0|||
130238941|NCT03126110|468836300|FG008|Phase 2|Study terminated by the sponsor|0|||
130238942|NCT03126110|468836301|FG009|Phase 2|Study terminated by the sponsor|0|||
130238943|NCT03126110|468836302|FG010|Phase 2|Study terminated by the sponsor|0|||
130238944|NCT03126110|468836303|FG011|Phase 2|Study terminated by the sponsor|0|||
130238945|NCT03126110|468836304|FG012|Phase 2|Study terminated by the sponsor|0|||
130238946|NCT03126110|468836305|FG013|Phase 2|Study terminated by the sponsor|4|||
130238947|NCT03126110|468836306|FG014|Phase 2|Study terminated by the sponsor|0|||
130238948|NCT03126110|468836307|FG015|Phase 2|Study terminated by the sponsor|0|||
130238949|NCT03126110|468836308|FG016|Phase 2|Study terminated by the sponsor|0|||
130238950|NCT03126110|468836292|FG000|Phase 2|Withdrawal by Subject|0|||
130238951|NCT03126110|468836293|FG001|Phase 2|Withdrawal by Subject|0|||
130238952|NCT03126110|468836294|FG002|Phase 2|Withdrawal by Subject|0|||
130238953|NCT03126110|468836295|FG003|Phase 2|Withdrawal by Subject|0|||
130238954|NCT03126110|468836296|FG004|Phase 2|Withdrawal by Subject|0|||
130238955|NCT03126110|468836297|FG005|Phase 2|Withdrawal by Subject|0|||
130238956|NCT03126110|468836298|FG006|Phase 2|Withdrawal by Subject|0|||
130238957|NCT03126110|468836299|FG007|Phase 2|Withdrawal by Subject|0|||
130238958|NCT03126110|468836300|FG008|Phase 2|Withdrawal by Subject|0|||
130238959|NCT03126110|468836301|FG009|Phase 2|Withdrawal by Subject|0|||
130238960|NCT03126110|468836302|FG010|Phase 2|Withdrawal by Subject|0|||
130238961|NCT03126110|468836303|FG011|Phase 2|Withdrawal by Subject|1|||
130238962|NCT03126110|468836304|FG012|Phase 2|Withdrawal by Subject|3|||
130238963|NCT03126110|468836305|FG013|Phase 2|Withdrawal by Subject|3|||
130238964|NCT03126110|468836306|FG014|Phase 2|Withdrawal by Subject|2|||
130238965|NCT03126110|468836307|FG015|Phase 2|Withdrawal by Subject|1|||
130238966|NCT03126110|468836308|FG016|Phase 2|Withdrawal by Subject|0|||
130238967|NCT03126110|468836292|FG000|Phase 2|Lost to Follow-up|0|||
130238968|NCT03126110|468836293|FG001|Phase 2|Lost to Follow-up|0|||
130238969|NCT03126110|468836294|FG002|Phase 2|Lost to Follow-up|0|||
130238970|NCT03126110|468836295|FG003|Phase 2|Lost to Follow-up|0|||
130238971|NCT03126110|468836296|FG004|Phase 2|Lost to Follow-up|0|||
130238972|NCT03126110|468836297|FG005|Phase 2|Lost to Follow-up|0|||
130238973|NCT03126110|468836298|FG006|Phase 2|Lost to Follow-up|0|||
130238974|NCT03126110|468836299|FG007|Phase 2|Lost to Follow-up|0|||
130238975|NCT03126110|468836300|FG008|Phase 2|Lost to Follow-up|0|||
130238976|NCT03126110|468836301|FG009|Phase 2|Lost to Follow-up|0|||
130238977|NCT03126110|468836302|FG010|Phase 2|Lost to Follow-up|0|||
130238978|NCT03126110|468836303|FG011|Phase 2|Lost to Follow-up|1|||
130238979|NCT03126110|468836304|FG012|Phase 2|Lost to Follow-up|1|||
130238980|NCT03126110|468836305|FG013|Phase 2|Lost to Follow-up|1|||
130238981|NCT03126110|468836306|FG014|Phase 2|Lost to Follow-up|2|||
130238982|NCT03126110|468836307|FG015|Phase 2|Lost to Follow-up|0|||
130238983|NCT03126110|468836308|FG016|Phase 2|Lost to Follow-up|0|||
130238984|NCT03126110|468836292|FG000|Phase 2|Death|0|||
130238985|NCT03126110|468836293|FG001|Phase 2|Death|0|||
130238986|NCT03126110|468836294|FG002|Phase 2|Death|0|||
130238987|NCT03126110|468836295|FG003|Phase 2|Death|0|||
130238988|NCT03126110|468836296|FG004|Phase 2|Death|0|||
130238989|NCT03126110|468836297|FG005|Phase 2|Death|0|||
130238990|NCT03126110|468836298|FG006|Phase 2|Death|0|||
130238991|NCT03126110|468836299|FG007|Phase 2|Death|0|||
130238992|NCT03126110|468836300|FG008|Phase 2|Death|0|||
130238993|NCT03126110|468836301|FG009|Phase 2|Death|0|||
130238994|NCT03126110|468836302|FG010|Phase 2|Death|0|||
130238995|NCT03126110|468836303|FG011|Phase 2|Death|6|||
130238996|NCT03126110|468836304|FG012|Phase 2|Death|12|||
130238997|NCT03126110|468836305|FG013|Phase 2|Death|25|||
130238998|NCT03126110|468836306|FG014|Phase 2|Death|11|||
130238999|NCT03126110|468836307|FG015|Phase 2|Death|3|||
130239000|NCT03126110|468836308|FG016|Phase 2|Death|2|||
130239001|NCT03126110|468836292|FG000|Phase 2|Progressive Disease|0|||
130239002|NCT03126110|468836293|FG001|Phase 2|Progressive Disease|0|||
130239003|NCT03126110|468836294|FG002|Phase 2|Progressive Disease|0|||
130239004|NCT03126110|468836295|FG003|Phase 2|Progressive Disease|0|||
130239005|NCT03126110|468836296|FG004|Phase 2|Progressive Disease|0|||
130239006|NCT03126110|468836297|FG005|Phase 2|Progressive Disease|0|||
130239007|NCT03126110|468836298|FG006|Phase 2|Progressive Disease|0|||
130239008|NCT03126110|468836299|FG007|Phase 2|Progressive Disease|0|||
130239009|NCT03126110|468836300|FG008|Phase 2|Progressive Disease|0|||
130239010|NCT03126110|468836301|FG009|Phase 2|Progressive Disease|0|||
130239011|NCT03126110|468836302|FG010|Phase 2|Progressive Disease|0|||
130239012|NCT03126110|468836303|FG011|Phase 2|Progressive Disease|0|||
130239013|NCT03126110|468836304|FG012|Phase 2|Progressive Disease|0|||
130239014|NCT03126110|468836305|FG013|Phase 2|Progressive Disease|1|||
130239015|NCT03126110|468836306|FG014|Phase 2|Progressive Disease|0|||
130239016|NCT03126110|468836307|FG015|Phase 2|Progressive Disease|0|||
130239017|NCT03126110|468836308|FG016|Phase 2|Progressive Disease|0|||
130239018|NCT03126110|468836292|FG000|Phase 2|Started new treatment|0|||
130239019|NCT03126110|468836293|FG001|Phase 2|Started new treatment|0|||
130239020|NCT03126110|468836294|FG002|Phase 2|Started new treatment|0|||
130239021|NCT03126110|468836295|FG003|Phase 2|Started new treatment|0|||
130239022|NCT03126110|468836296|FG004|Phase 2|Started new treatment|0|||
130239023|NCT03126110|468836297|FG005|Phase 2|Started new treatment|0|||
130027152|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130027153|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130027154|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130027155|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
130239024|NCT03126110|468836298|FG006|Phase 2|Started new treatment|0|||
130239025|NCT03126110|468836299|FG007|Phase 2|Started new treatment|0|||
130239026|NCT03126110|468836300|FG008|Phase 2|Started new treatment|0|||
130239027|NCT03126110|468836301|FG009|Phase 2|Started new treatment|0|||
130239028|NCT03126110|468836302|FG010|Phase 2|Started new treatment|0|||
130239029|NCT03126110|468836303|FG011|Phase 2|Started new treatment|0|||
130239030|NCT03126110|468836304|FG012|Phase 2|Started new treatment|0|||
130239031|NCT03126110|468836305|FG013|Phase 2|Started new treatment|0|||
130239032|NCT03126110|468836306|FG014|Phase 2|Started new treatment|1|||
130239033|NCT03126110|468836307|FG015|Phase 2|Started new treatment|0|||
130239034|NCT03126110|468836308|FG016|Phase 2|Started new treatment|0|||
130239035|NCT04235374|468836309|FG000|Overall Study|Death|91|||
130239036|NCT04235374|468836310|FG001|Overall Study|Death|91|||
130239037|NCT04235374|468836309|FG000|Overall Study|Refused|2|||
130239038|NCT04235374|468836310|FG001|Overall Study|Refused|2|||
130239039|NCT04235374|468836309|FG000|Overall Study|Unavailable|12|||
130239040|NCT04235374|468836310|FG001|Overall Study|Unavailable|3|||
130239041|NCT04235374|468836309|FG000|Overall Study|Withdrawal by Subject|0|||
130239042|NCT04235374|468836310|FG001|Overall Study|Withdrawal by Subject|1|||
130239043|NCT04235374|468836309|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
130239044|NCT04235374|468836310|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
130239045|NCT04967222|468836318|FG000|Randomized|Lost to Follow-up|0|||
130239046|NCT04967222|468836319|FG001|Randomized|Lost to Follow-up|1|||
130239047|NCT04967222|468836320|FG002|Randomized|Lost to Follow-up|1|||
130027156|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
130027157|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
130027158|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130027159|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130027160|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130027161|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130027162|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130027163|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
130027164|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
130027165|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
130027166|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130027167|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130027168|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130027169|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130239048|NCT04967222|468836318|FG000|Randomized|Physician Decision|0|||
130239049|NCT04967222|468836319|FG001|Randomized|Physician Decision|0|||
130239050|NCT04967222|468836320|FG002|Randomized|Physician Decision|1|||
130239051|NCT04967222|468836318|FG000|Randomized|Withdrawal by Subject|0|||
130239052|NCT04967222|468836319|FG001|Randomized|Withdrawal by Subject|0|||
130239053|NCT04967222|468836320|FG002|Randomized|Withdrawal by Subject|2|||
130239054|NCT04967222|468836318|FG000|Randomized|abnormal finding in MRI|0|||
130239055|NCT04967222|468836319|FG001|Randomized|abnormal finding in MRI|2|||
130239056|NCT04967222|468836320|FG002|Randomized|abnormal finding in MRI|0|||
130239057|NCT01295944|468836321|FG000|Overall Study|Switched to alternative treatment|1|||
130239058|NCT01295944|468836321|FG000|Overall Study|Ineligible|9|||
130239059|NCT01295944|468836321|FG000|Overall Study|Withdrawal by Subject|1|||
130239060|NCT01295944|468836321|FG000|Overall Study|Participant chose to be treated in Peru|1|||
130239061|NCT01295944|468836321|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
130239062|NCT01295944|468836321|FG000|Overall Study|Physician Decision|1|||
130239063|NCT01295944|468836321|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
130239064|NCT01295944|468836321|FG000|Overall Study|Disease progression|4|||
130239065|NCT01295944|468836321|FG000|Overall Study|Transferred care before starting new treatment|1|||
130239066|NCT02783274|468836329|FG000|Overall Study|Withdrawal by Subject|16|||
130239067|NCT02783274|468836329|FG000|Overall Study|Physician Decision|6|||
130239068|NCT02783274|468836329|FG000|Overall Study|Death|9|||
130239069|NCT02783274|468836329|FG000|Overall Study|Lost to Follow-up|22|||
130239070|NCT02783274|468836329|FG000|Overall Study|Other|22|||
130239071|NCT04717557|468836330|FG000|Overall Study|Withdrawal by Subject|2|||
130239072|NCT04717557|468836331|FG001|Overall Study|Withdrawal by Subject|0|||
130027170|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130027171|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
130027172|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
130027173|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130027174|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130027175|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130027176|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130027177|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130027178|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130027179|NCT01097629|468060667|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
130027180|NCT01097629|468060668|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
130239073|NCT04717557|468836330|FG000|Overall Study|Death|1|||
130239074|NCT04717557|468836331|FG001|Overall Study|Death|0|||
130239075|NCT02516241|468836335|FG000|Overall Study|Death|255|||
130239076|NCT02516241|468836336|FG001|Overall Study|Death|262|||
130239077|NCT02516241|468836337|FG002|Overall Study|Death|270|||
130239078|NCT02516241|468836335|FG000|Overall Study|Lost to Follow-up|1|||
130027181|NCT01097629|468060669|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
130239079|NCT02516241|468836336|FG001|Overall Study|Lost to Follow-up|1|||
130239080|NCT02516241|468836337|FG002|Overall Study|Lost to Follow-up|3|||
130239081|NCT02516241|468836335|FG000|Overall Study|Withdrawal by Subject|2|||
130239082|NCT02516241|468836336|FG001|Overall Study|Withdrawal by Subject|7|||
130239083|NCT02516241|468836337|FG002|Overall Study|Withdrawal by Subject|12|||
130239084|NCT02516241|468836335|FG000|Overall Study|participants ongoing at data cut-off|84|||
130239085|NCT02516241|468836336|FG001|Overall Study|participants ongoing at data cut-off|76|||
130239086|NCT02516241|468836337|FG002|Overall Study|participants ongoing at data cut-off|59|||
130239087|NCT00724945|468836338|FG000|Period 1|non-compliance|1|||
130239088|NCT00724945|468836339|FG001|Period 1|non-compliance|0|||
130239089|NCT00724945|468836338|FG000|Period 1|Adverse Event|1|||
130239090|NCT00724945|468836339|FG001|Period 1|Adverse Event|1|||
130239091|NCT00724945|468836338|FG000|Period 1|Lost to Follow-up|1|||
130239092|NCT00724945|468836339|FG001|Period 1|Lost to Follow-up|0|||
130239093|NCT00724945|468836338|FG000|Period 2|lens comfort issue|3|||
130239094|NCT00724945|468836339|FG001|Period 2|lens comfort issue|0|||
130239095|NCT00724945|468836338|FG000|Period 2|lens physiology issue|1|||
130239096|NCT00724945|468836339|FG001|Period 2|lens physiology issue|0|||
130239097|NCT04835441|468836340|FG000|Overall Study|Physician Decision|4|||
130239098|NCT04835441|468836341|FG001|Overall Study|Physician Decision|4|||
130239099|NCT04835441|468836340|FG000|Overall Study|Other|1|||
130239100|NCT04835441|468836341|FG001|Overall Study|Other|1|||
130239101|NCT04835441|468836340|FG000|Overall Study|Lost to Follow-up|0|||
130239102|NCT04835441|468836341|FG001|Overall Study|Lost to Follow-up|1|||
130239103|NCT03069989|468836345|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
130239104|NCT03069989|468836346|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
130239105|NCT01901562|468837498|FG000|Overall Study|Protocol Violation|5|||
130239106|NCT01901562|468837498|FG000|Overall Study|Excluded intraoperatively|4|||
130239107|NCT00088153|468837499|FG000|Overall Study|Physician Decision|3|||
130239108|NCT00088153|468837500|FG001|Overall Study|Physician Decision|3|||
130239109|NCT00088153|468837499|FG000|Overall Study|Withdrawal by Subject|10|||
130239110|NCT00088153|468837500|FG001|Overall Study|Withdrawal by Subject|10|||
130239111|NCT00088153|468837499|FG000|Overall Study|Lost to Follow-up|11|||
130239112|NCT00088153|468837500|FG001|Overall Study|Lost to Follow-up|12|||
130239113|NCT00976027|468837502|FG000|Overall Study|Serious Adverse Event|36|||
130239114|NCT00976027|468837503|FG001|Overall Study|Serious Adverse Event|17|||
130239115|NCT00976027|468837502|FG000|Overall Study|Adverse Event|0|||
130239116|NCT00976027|468837503|FG001|Overall Study|Adverse Event|2|||
130239117|NCT00976027|468837502|FG000|Overall Study|Protocol Violation|60|||
130239118|NCT00976027|468837503|FG001|Overall Study|Protocol Violation|27|||
130239119|NCT00976027|468837502|FG000|Overall Study|Lost to Follow-up|208|||
130239120|NCT00976027|468837503|FG001|Overall Study|Lost to Follow-up|103|||
130239121|NCT00976027|468837502|FG000|Overall Study|Withdrawal by Subject|107|||
129884560|NCT02696902|467536455|FG002|Overall Study|Withdrawal by Subject|1|||
130239122|NCT00976027|468837503|FG001|Overall Study|Withdrawal by Subject|66|||
130239123|NCT04435626|468837508|FG000|Overall Study|Lost to Follow-up|1|||
130239124|NCT04435626|468837509|FG001|Overall Study|Lost to Follow-up|5|||
130239125|NCT04435626|468837508|FG000|Overall Study|Withdrawal by Subject|6|||
130239126|NCT04435626|468837509|FG001|Overall Study|Withdrawal by Subject|7|||
130239127|NCT04435626|468837508|FG000|Overall Study|major GCP violations|8|||
130239128|NCT04435626|468837509|FG001|Overall Study|major GCP violations|7|||
130239129|NCT01771107|468837517|FG000|Overall Study|Adverse Event|1|||
130239130|NCT01771107|468837518|FG001|Overall Study|Adverse Event|3|||
130239131|NCT01771107|468837517|FG000|Overall Study|Withdrawal by Subject|0|||
129884561|NCT02696902|467536453|FG000|Overall Study|Death|19|||
130027182|NCT01097629|468060670|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130027183|NCT01097629|468060671|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130027184|NCT01097629|468060672|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130027185|NCT01097629|468060673|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130027186|NCT01097629|468060674|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130027187|NCT01097629|468060667|FG000|DB RO Phase|Withdrawal by Subject|0|||
130027188|NCT01097629|468060668|FG001|DB RO Phase|Withdrawal by Subject|0|||
130027189|NCT01097629|468060669|FG002|DB RO Phase|Withdrawal by Subject|0|||
130027190|NCT01097629|468060670|FG003|DB RO Phase|Withdrawal by Subject|0|||
130027191|NCT01097629|468060671|FG004|DB RO Phase|Withdrawal by Subject|0|||
130027192|NCT01097629|468060672|FG005|DB RO Phase|Withdrawal by Subject|0|||
130027193|NCT01097629|468060673|FG006|DB RO Phase|Withdrawal by Subject|0|||
130027194|NCT01097629|468060674|FG007|DB RO Phase|Withdrawal by Subject|1|||
130027195|NCT01097629|468060667|FG000|DB RO Phase|Protocol Violation|0|||
130027196|NCT01097629|468060668|FG001|DB RO Phase|Protocol Violation|0|||
130027197|NCT01097629|468060669|FG002|DB RO Phase|Protocol Violation|0|||
130027198|NCT01097629|468060670|FG003|DB RO Phase|Protocol Violation|1|||
130027199|NCT01097629|468060671|FG004|DB RO Phase|Protocol Violation|0|||
130027200|NCT01097629|468060672|FG005|DB RO Phase|Protocol Violation|1|||
130027201|NCT01097629|468060673|FG006|DB RO Phase|Protocol Violation|1|||
130027202|NCT01097629|468060674|FG007|DB RO Phase|Protocol Violation|0|||
130027203|NCT01097629|468060667|FG000|DB RO Phase|Lost to Follow-up|0|||
130027204|NCT01097629|468060668|FG001|DB RO Phase|Lost to Follow-up|0|||
130027205|NCT01097629|468060669|FG002|DB RO Phase|Lost to Follow-up|0|||
130027206|NCT01097629|468060670|FG003|DB RO Phase|Lost to Follow-up|0|||
130027207|NCT01097629|468060671|FG004|DB RO Phase|Lost to Follow-up|0|||
130239132|NCT01771107|468837518|FG001|Overall Study|Withdrawal by Subject|2|||
130239133|NCT01771107|468837517|FG000|Overall Study|Lost to Follow-up|0|||
130239134|NCT01771107|468837518|FG001|Overall Study|Lost to Follow-up|1|||
130239135|NCT01771107|468837517|FG000|Overall Study|participant moved|0|||
130239136|NCT01771107|468837518|FG001|Overall Study|participant moved|1|||
130239137|NCT01771107|468837517|FG000|Overall Study|Other|0|||
130239138|NCT01771107|468837518|FG001|Overall Study|Other|1|||
130239139|NCT05248386|468837520|FG000|Overall Study|Technical problems|0|||
130239140|NCT05248386|468837521|FG001|Overall Study|Technical problems|1|||
130239141|NCT05248386|468837520|FG000|Overall Study|Withdrawal by Subject|15|||
130239142|NCT05248386|468837521|FG001|Overall Study|Withdrawal by Subject|10|||
130027208|NCT01097629|468060672|FG005|DB RO Phase|Lost to Follow-up|0|||
130027209|NCT01097629|468060673|FG006|DB RO Phase|Lost to Follow-up|2|||
130027210|NCT01097629|468060674|FG007|DB RO Phase|Lost to Follow-up|0|||
130027211|NCT00947531|468060676|FG000|Overall Study|Withdrawal by Subject|10|||
130027212|NCT00947531|468060677|FG001|Overall Study|Withdrawal by Subject|7|||
130027213|NCT00947531|468060676|FG000|Overall Study|Administrative Reason|0|||
130027214|NCT00947531|468060677|FG001|Overall Study|Administrative Reason|1|||
130027215|NCT00947531|468060676|FG000|Overall Study|Adverse Event|2|||
130027216|NCT00947531|468060677|FG001|Overall Study|Adverse Event|2|||
130239143|NCT05248386|468837520|FG000|Overall Study|Physician Decision|0|||
130239144|NCT05248386|468837521|FG001|Overall Study|Physician Decision|1|||
130239145|NCT05248386|468837520|FG000|Overall Study|Adverse Event|2|||
130027217|NCT00947531|468060676|FG000|Overall Study|Lack of Efficacy|1|||
130027218|NCT00947531|468060677|FG001|Overall Study|Lack of Efficacy|0|||
130027219|NCT00947531|468060676|FG000|Overall Study|Other|1|||
130027220|NCT00947531|468060677|FG001|Overall Study|Other|1|||
130027221|NCT01773421|468060679|FG000|Treatment Phase|Other|0|||
130027222|NCT01773421|468060680|FG001|Treatment Phase|Other|0|||
130027223|NCT01773421|468060681|FG002|Treatment Phase|Other|2|||
130027224|NCT01773421|468060682|FG003|Treatment Phase|Other|0|||
130027225|NCT01773421|468060683|FG004|Treatment Phase|Other|0|||
130027226|NCT01773421|468060684|FG005|Treatment Phase|Other|0|||
130027227|NCT01773421|468060685|FG006|Treatment Phase|Other|0|||
130027228|NCT01773421|468060679|FG000|Treatment Phase|Adverse Event|0|||
130027229|NCT01773421|468060680|FG001|Treatment Phase|Adverse Event|0|||
130027230|NCT01773421|468060681|FG002|Treatment Phase|Adverse Event|3|||
130027231|NCT01773421|468060682|FG003|Treatment Phase|Adverse Event|1|||
130027232|NCT01773421|468060683|FG004|Treatment Phase|Adverse Event|0|||
130027233|NCT01773421|468060684|FG005|Treatment Phase|Adverse Event|0|||
130027234|NCT01773421|468060685|FG006|Treatment Phase|Adverse Event|0|||
130027235|NCT01773421|468060679|FG000|Treatment Phase|Withdrawal by Subject|0|||
130027236|NCT01773421|468060680|FG001|Treatment Phase|Withdrawal by Subject|0|||
130027237|NCT01773421|468060681|FG002|Treatment Phase|Withdrawal by Subject|1|||
130027238|NCT01773421|468060682|FG003|Treatment Phase|Withdrawal by Subject|1|||
130027239|NCT01773421|468060683|FG004|Treatment Phase|Withdrawal by Subject|0|||
130027240|NCT01773421|468060684|FG005|Treatment Phase|Withdrawal by Subject|0|||
130027241|NCT01773421|468060685|FG006|Treatment Phase|Withdrawal by Subject|0|||
130027242|NCT01773421|468060679|FG000|Extension Phase|Other|0|||
130027243|NCT01773421|468060680|FG001|Extension Phase|Other|0|||
130027244|NCT01773421|468060681|FG002|Extension Phase|Other|0|||
130027245|NCT01773421|468060682|FG003|Extension Phase|Other|0|||
130027246|NCT01773421|468060683|FG004|Extension Phase|Other|1|||
130027247|NCT01773421|468060684|FG005|Extension Phase|Other|2|||
130027248|NCT01773421|468060685|FG006|Extension Phase|Other|0|||
130027249|NCT01773421|468060679|FG000|Extension Phase|Adverse Event|0|||
130027250|NCT01773421|468060680|FG001|Extension Phase|Adverse Event|0|||
130027251|NCT01773421|468060681|FG002|Extension Phase|Adverse Event|0|||
130027252|NCT01773421|468060682|FG003|Extension Phase|Adverse Event|0|||
130027253|NCT01773421|468060683|FG004|Extension Phase|Adverse Event|2|||
130027254|NCT01773421|468060684|FG005|Extension Phase|Adverse Event|0|||
130027255|NCT01773421|468060685|FG006|Extension Phase|Adverse Event|0|||
130027256|NCT03502330|468060686|FG000|Overall Study|Adverse Event|2|||
130027257|NCT03502330|468060687|FG001|Overall Study|Adverse Event|1|||
130027258|NCT03502330|468060688|FG002|Overall Study|Adverse Event|0|||
130027259|NCT03502330|468060689|FG003|Overall Study|Adverse Event|0|||
130027260|NCT03502330|468060690|FG004|Overall Study|Adverse Event|1|||
130027261|NCT03502330|468060691|FG005|Overall Study|Adverse Event|0|||
130027262|NCT03502330|468060692|FG006|Overall Study|Adverse Event|1|||
130027263|NCT03502330|468060693|FG007|Overall Study|Adverse Event|1|||
130027264|NCT03502330|468060694|FG008|Overall Study|Adverse Event|0|||
130027265|NCT03502330|468060686|FG000|Overall Study|Lack of Efficacy|1|||
130027266|NCT03502330|468060687|FG001|Overall Study|Lack of Efficacy|5|||
130027267|NCT03502330|468060688|FG002|Overall Study|Lack of Efficacy|3|||
130027268|NCT03502330|468060689|FG003|Overall Study|Lack of Efficacy|5|||
130027269|NCT03502330|468060690|FG004|Overall Study|Lack of Efficacy|1|||
130027270|NCT03502330|468060691|FG005|Overall Study|Lack of Efficacy|5|||
130027271|NCT03502330|468060692|FG006|Overall Study|Lack of Efficacy|5|||
130027272|NCT03502330|468060693|FG007|Overall Study|Lack of Efficacy|6|||
130100226|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
130100227|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
130100228|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
130100229|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
130027273|NCT03502330|468060694|FG008|Overall Study|Lack of Efficacy|0|||
130027274|NCT03502330|468060686|FG000|Overall Study|Physician Decision|0|||
130027275|NCT03502330|468060687|FG001|Overall Study|Physician Decision|0|||
130027276|NCT03502330|468060688|FG002|Overall Study|Physician Decision|0|||
130027277|NCT03502330|468060689|FG003|Overall Study|Physician Decision|0|||
130027278|NCT03502330|468060690|FG004|Overall Study|Physician Decision|1|||
130027279|NCT03502330|468060691|FG005|Overall Study|Physician Decision|0|||
130027280|NCT03502330|468060692|FG006|Overall Study|Physician Decision|0|||
130027281|NCT03502330|468060693|FG007|Overall Study|Physician Decision|0|||
130027282|NCT03502330|468060694|FG008|Overall Study|Physician Decision|0|||
130027283|NCT03502330|468060686|FG000|Overall Study|Withdrawal by Subject|0|||
130027284|NCT03502330|468060687|FG001|Overall Study|Withdrawal by Subject|0|||
130027285|NCT03502330|468060688|FG002|Overall Study|Withdrawal by Subject|0|||
130027286|NCT03502330|468060689|FG003|Overall Study|Withdrawal by Subject|0|||
130027287|NCT03502330|468060690|FG004|Overall Study|Withdrawal by Subject|0|||
130027288|NCT03502330|468060691|FG005|Overall Study|Withdrawal by Subject|1|||
130027289|NCT03502330|468060692|FG006|Overall Study|Withdrawal by Subject|0|||
130027290|NCT03502330|468060693|FG007|Overall Study|Withdrawal by Subject|1|||
130027291|NCT03502330|468060694|FG008|Overall Study|Withdrawal by Subject|0|||
130027292|NCT03502330|468060686|FG000|Overall Study|Death|0|||
130027293|NCT03502330|468060687|FG001|Overall Study|Death|0|||
130027294|NCT03502330|468060688|FG002|Overall Study|Death|0|||
130027295|NCT03502330|468060689|FG003|Overall Study|Death|0|||
130027296|NCT03502330|468060690|FG004|Overall Study|Death|0|||
130027297|NCT03502330|468060691|FG005|Overall Study|Death|0|||
130027298|NCT03502330|468060692|FG006|Overall Study|Death|2|||
130027299|NCT03502330|468060693|FG007|Overall Study|Death|0|||
130027300|NCT03502330|468060694|FG008|Overall Study|Death|0|||
130027301|NCT02804763|468060695|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
130027302|NCT02804763|468060696|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
130027303|NCT02804763|468060697|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
130027304|NCT02804763|468060698|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
130027305|NCT02804763|468060695|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
130027306|NCT02804763|468060696|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
130027307|NCT02804763|468060697|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
130027308|NCT02804763|468060698|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
130027309|NCT02804763|468060695|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
130027310|NCT02804763|468060696|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
130027311|NCT02804763|468060697|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
130027312|NCT02804763|468060698|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
130027313|NCT02804763|468060695|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
130027314|NCT02804763|468060696|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
130027315|NCT02804763|468060697|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
130027316|NCT02804763|468060698|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
130027317|NCT02804763|468060695|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
130027318|NCT02804763|468060696|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
130239146|NCT05248386|468837521|FG001|Overall Study|Adverse Event|4|||
130239147|NCT05248386|468837520|FG000|Overall Study|Other|1|||
130239148|NCT05248386|468837521|FG001|Overall Study|Other|0|||
130239149|NCT05248386|468837520|FG000|Overall Study|Lack of Efficacy|14|||
130239150|NCT05248386|468837521|FG001|Overall Study|Lack of Efficacy|12|||
130239151|NCT02864992|468837522|FG000|Overall Study|still on treatment|15|||
130239152|NCT02864992|468837523|FG001|Overall Study|still on treatment|1|||
130027319|NCT02804763|468060697|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
130027320|NCT02804763|468060698|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
130027321|NCT02804763|468060695|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
130027322|NCT02804763|468060696|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
130027323|NCT02804763|468060697|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
130027324|NCT02804763|468060698|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
130027325|NCT02472847|468060699|FG000|Overall Study|Withdrawal by Subject|1|||
130100230|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
130239153|NCT02864992|468837524|FG002|Overall Study|still on treatment|33|||
130027326|NCT02472847|468060700|FG001|Overall Study|Withdrawal by Subject|5|||
130027327|NCT04656990|468060701|FG000|Baseline|pandemic|20|||
130239154|NCT03785366|468837525|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
130239155|NCT03785366|468837526|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
130239156|NCT03785366|468837525|FG000|Overall Study|Lost to Follow-up|1|||
130239157|NCT03785366|468837526|FG001|Overall Study|Lost to Follow-up|0|||
130239158|NCT03785366|468837525|FG000|Overall Study|Partial IUD Expulsion|0|||
130239159|NCT03785366|468837526|FG001|Overall Study|Partial IUD Expulsion|2|||
130239160|NCT03785366|468837525|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
130239161|NCT03785366|468837526|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
130239162|NCT03240874|468837527|FG000|Overall Study|Lost to Follow-up|0|||
130239163|NCT03240874|468837528|FG001|Overall Study|Lost to Follow-up|2|||
130239164|NCT03240874|468837529|FG002|Overall Study|Lost to Follow-up|4|||
130239165|NCT03240874|468837530|FG003|Overall Study|Lost to Follow-up|1|||
130239166|NCT05252702|468837531|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
130239167|NCT05252702|468837531|FG000|Overall Study|Death|16|||
130239168|NCT05252702|468837531|FG000|Overall Study|System explant|5|||
130239169|NCT05252702|468837531|FG000|Overall Study|Lost to Follow-up|1|||
130239170|NCT05252702|468837531|FG000|Overall Study|Withdrawn by investigator|1|||
130239171|NCT05252702|468837531|FG000|Overall Study|Visit not due|306|||
130239172|NCT05252702|468837531|FG000|Overall Study|Visit within window but not completed|92|||
130239173|NCT05252702|468837531|FG000|Overall Study|Unsuccessful implant|1|||
130239174|NCT04153864|468837532|FG000|Overall Study|Withdrawal by Subject|21|||
130239175|NCT04153864|468837533|FG001|Overall Study|Withdrawal by Subject|7|||
130239176|NCT04153864|468837534|FG002|Overall Study|Withdrawal by Subject|23|||
130239177|NCT04153864|468837535|FG003|Overall Study|Withdrawal by Subject|2|||
130239178|NCT04153864|468837532|FG000|Overall Study|Lost to Follow-up|4|||
130239179|NCT04153864|468837533|FG001|Overall Study|Lost to Follow-up|0|||
130239180|NCT04153864|468837534|FG002|Overall Study|Lost to Follow-up|3|||
130239181|NCT04153864|468837535|FG003|Overall Study|Lost to Follow-up|0|||
130239182|NCT04153864|468837532|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
130239183|NCT04153864|468837533|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
130239184|NCT04153864|468837534|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
130239185|NCT04153864|468837535|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
130239186|NCT04958707|468837536|FG000|Post Intervention|Withdrawal by Subject|1|||
130239187|NCT04958707|468837537|FG001|Post Intervention|Withdrawal by Subject|0|||
130239188|NCT04958707|468837538|FG002|Post Intervention|Withdrawal by Subject|0|||
130239189|NCT04958707|468837536|FG000|3 Months Follow- up|Lost to Follow-up|0|||
130239190|NCT04958707|468837537|FG001|3 Months Follow- up|Lost to Follow-up|3|||
130239191|NCT04958707|468837538|FG002|3 Months Follow- up|Lost to Follow-up|0|||
130239192|NCT04958707|468837536|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
130239193|NCT04958707|468837537|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
130239194|NCT04958707|468837538|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
130239195|NCT04279522|468837539|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
130239196|NCT04279522|468837540|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
130239197|NCT04279522|468837539|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
130239198|NCT04279522|468837540|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
130239199|NCT04279522|468837539|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
130239200|NCT04279522|468837540|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
130239201|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
130027328|NCT04656990|468060702|FG001|Baseline|pandemic|24|||
130027329|NCT04656990|468060701|FG000|Follow Up Period|Lost to Follow-up|61|||
130027330|NCT04656990|468060702|FG001|Follow Up Period|Lost to Follow-up|73|||
130100231|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
130027331|NCT00623831|468060705|FG000|Overall Study|Withdrawal by Subject|1|||
130027332|NCT00623831|468060706|FG001|Overall Study|Withdrawal by Subject|0|||
130027333|NCT00623831|468060705|FG000|Overall Study|Progressive Disease|0|||
130027334|NCT00623831|468060706|FG001|Overall Study|Progressive Disease|1|||
130027335|NCT00282243|468060707|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
130027336|NCT00282243|468060707|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
130027337|NCT00282243|468060707|FG000|Extension Treatment Period|Adverse Event|15|||
130027338|NCT00282243|468060707|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
130027339|NCT00282243|468060707|FG000|Extension Treatment Period|Non-compliance|2|||
130027340|NCT00282243|468060707|FG000|Extension Treatment Period|Physician Decision|1|||
130027341|NCT01070329|468060708|FG000|Overall Study|Adverse Event|13|||
130027342|NCT01070329|468060709|FG001|Overall Study|Adverse Event|10|||
130027343|NCT01070329|468060708|FG000|Overall Study|Lost to Follow-up|22|||
130027344|NCT01070329|468060709|FG001|Overall Study|Lost to Follow-up|12|||
130027345|NCT01070329|468060708|FG000|Overall Study|Withdrawal by Subject|9|||
130027346|NCT01070329|468060709|FG001|Overall Study|Withdrawal by Subject|11|||
130027347|NCT01070329|468060708|FG000|Overall Study|Protocol Violation|3|||
130027348|NCT01070329|468060709|FG001|Overall Study|Protocol Violation|8|||
130027349|NCT01070329|468060708|FG000|Overall Study|Lack of Efficacy|2|||
130027350|NCT01070329|468060709|FG001|Overall Study|Lack of Efficacy|6|||
130027351|NCT01070329|468060708|FG000|Overall Study|Physician Decision|2|||
130027352|NCT01070329|468060709|FG001|Overall Study|Physician Decision|1|||
130027353|NCT01070329|468060708|FG000|Overall Study|Entry Criteria Not Met|1|||
130027354|NCT01070329|468060709|FG001|Overall Study|Entry Criteria Not Met|0|||
130027355|NCT01070329|468060708|FG000|Overall Study|Sponsor Decision|0|||
130027356|NCT01070329|468060709|FG001|Overall Study|Sponsor Decision|1|||
130027357|NCT02863848|468060712|FG000|Overall Study|Lost to Follow-up|1|||
130027358|NCT02863848|468060713|FG001|Overall Study|Lost to Follow-up|1|||
130027359|NCT02863848|468060712|FG000|Overall Study|Protocol Violation|1|||
130027360|NCT02863848|468060713|FG001|Overall Study|Protocol Violation|2|||
130027361|NCT03588741|468060714|FG000|Overall Study|Withdrawal by Subject|1|||
130027362|NCT02522767|468060715|FG000|Double-blind|Withdrawal by Subject|8|||
130027363|NCT02522767|468060716|FG001|Double-blind|Withdrawal by Subject|11|||
130027364|NCT02522767|468060715|FG000|Double-blind|Lost to Follow-up|1|||
130027365|NCT02522767|468060716|FG001|Double-blind|Lost to Follow-up|0|||
130027366|NCT02522767|468060715|FG000|Double-blind|Adverse Event|1|||
130239202|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
130239203|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
130027367|NCT02522767|468060716|FG001|Double-blind|Adverse Event|10|||
130027368|NCT02522767|468060715|FG000|Double-blind|Protocol Violation|0|||
130027369|NCT02522767|468060716|FG001|Double-blind|Protocol Violation|1|||
130027370|NCT02522767|468060715|FG000|Double-blind|Lack of Efficacy|0|||
130239204|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
130027371|NCT02522767|468060716|FG001|Double-blind|Lack of Efficacy|2|||
130027372|NCT02522767|468060715|FG000|Double-blind|Protocol Deviation|1|||
130239205|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Physician Decision|0|||
130027373|NCT02522767|468060716|FG001|Double-blind|Protocol Deviation|0|||
130027374|NCT02522767|468060715|FG000|Open-label|Withdrawal by Subject|2|||
130027375|NCT02522767|468060716|FG001|Open-label|Withdrawal by Subject|3|||
130239206|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Physician Decision|3|||
130027376|NCT02522767|468060715|FG000|Open-label|Lost to Follow-up|0|||
130027377|NCT02522767|468060716|FG001|Open-label|Lost to Follow-up|1|||
130027378|NCT02522767|468060715|FG000|Open-label|Adverse Event|2|||
130027379|NCT02522767|468060716|FG001|Open-label|Adverse Event|1|||
130027380|NCT02522767|468060715|FG000|Open-label|Lack of Efficacy|1|||
130027381|NCT02522767|468060716|FG001|Open-label|Lack of Efficacy|1|||
130027382|NCT02522767|468060715|FG000|Open-label|Protocol Violation|0|||
130027383|NCT02522767|468060716|FG001|Open-label|Protocol Violation|1|||
130027384|NCT00548548|468060717|FG000|Overall Study|Death|345|||
130027385|NCT00548548|468060718|FG001|Overall Study|Death|348|||
130027386|NCT00548548|468060717|FG000|Overall Study|Lost to Follow-up|17|||
130027387|NCT00548548|468060718|FG001|Overall Study|Lost to Follow-up|18|||
130027388|NCT01705691|468060719|FG000|Overall Study|Death|1|||
130027389|NCT01705691|468060720|FG001|Overall Study|Death|2|||
130027390|NCT01705691|468060719|FG000|Overall Study|Withdrawal by Subject|1|||
130027391|NCT01705691|468060720|FG001|Overall Study|Withdrawal by Subject|2|||
130027392|NCT01705691|468060719|FG000|Overall Study|Lost to Follow-up|1|||
130027393|NCT01705691|468060720|FG001|Overall Study|Lost to Follow-up|1|||
130027394|NCT01705691|468060719|FG000|Overall Study|Other|0|||
130027395|NCT01705691|468060720|FG001|Overall Study|Other|1|||
130027396|NCT02913313|468060721|FG000|Overall Study|DISEASE PROGRESSION|1|||
130027397|NCT02913313|468060722|FG001|Overall Study|DISEASE PROGRESSION|2|||
130027398|NCT02913313|468060723|FG002|Overall Study|DISEASE PROGRESSION|2|||
130027399|NCT02913313|468060724|FG003|Overall Study|DISEASE PROGRESSION|4|||
130027400|NCT02913313|468060725|FG004|Overall Study|DISEASE PROGRESSION|6|||
130027401|NCT02913313|468060726|FG005|Overall Study|DISEASE PROGRESSION|4|||
130027402|NCT02913313|468060727|FG006|Overall Study|DISEASE PROGRESSION|19|||
130027403|NCT02913313|468060728|FG007|Overall Study|DISEASE PROGRESSION|3|||
130027404|NCT02913313|468060729|FG008|Overall Study|DISEASE PROGRESSION|4|||
130027405|NCT02913313|468060730|FG009|Overall Study|DISEASE PROGRESSION|4|||
130027406|NCT02913313|468060731|FG010|Overall Study|DISEASE PROGRESSION|11|||
130027407|NCT02913313|468060732|FG011|Overall Study|DISEASE PROGRESSION|5|||
130027408|NCT02913313|468060733|FG012|Overall Study|DISEASE PROGRESSION|14|||
130027409|NCT02913313|468060734|FG013|Overall Study|DISEASE PROGRESSION|3|||
130027410|NCT02913313|468060721|FG000|Overall Study|Not Reported|0|||
130027411|NCT02913313|468060722|FG001|Overall Study|Not Reported|0|||
130027412|NCT02913313|468060723|FG002|Overall Study|Not Reported|0|||
130027413|NCT02913313|468060724|FG003|Overall Study|Not Reported|0|||
130027414|NCT02913313|468060725|FG004|Overall Study|Not Reported|1|||
130027415|NCT02913313|468060726|FG005|Overall Study|Not Reported|0|||
130027416|NCT02913313|468060727|FG006|Overall Study|Not Reported|0|||
130027417|NCT02913313|468060728|FG007|Overall Study|Not Reported|0|||
130027418|NCT02913313|468060729|FG008|Overall Study|Not Reported|0|||
130027419|NCT02913313|468060730|FG009|Overall Study|Not Reported|0|||
130027420|NCT02913313|468060731|FG010|Overall Study|Not Reported|4|||
130027421|NCT02913313|468060732|FG011|Overall Study|Not Reported|0|||
130027422|NCT02913313|468060733|FG012|Overall Study|Not Reported|0|||
130027423|NCT02913313|468060734|FG013|Overall Study|Not Reported|0|||
130027424|NCT02913313|468060721|FG000|Overall Study|Other reasons|0|||
130027425|NCT02913313|468060722|FG001|Overall Study|Other reasons|0|||
130027426|NCT02913313|468060723|FG002|Overall Study|Other reasons|0|||
130027427|NCT02913313|468060724|FG003|Overall Study|Other reasons|0|||
130027428|NCT02913313|468060725|FG004|Overall Study|Other reasons|1|||
130027429|NCT02913313|468060726|FG005|Overall Study|Other reasons|0|||
130027430|NCT02913313|468060727|FG006|Overall Study|Other reasons|0|||
130027431|NCT02913313|468060728|FG007|Overall Study|Other reasons|0|||
130027432|NCT02913313|468060729|FG008|Overall Study|Other reasons|0|||
130027433|NCT02913313|468060730|FG009|Overall Study|Other reasons|0|||
130027434|NCT02913313|468060731|FG010|Overall Study|Other reasons|1|||
130027435|NCT02913313|468060732|FG011|Overall Study|Other reasons|0|||
130027436|NCT02913313|468060733|FG012|Overall Study|Other reasons|0|||
130027437|NCT02913313|468060734|FG013|Overall Study|Other reasons|0|||
130027438|NCT02913313|468060721|FG000|Overall Study|Withdrawal by Subject|0|||
130027439|NCT02913313|468060722|FG001|Overall Study|Withdrawal by Subject|0|||
130027440|NCT02913313|468060723|FG002|Overall Study|Withdrawal by Subject|1|||
130027441|NCT02913313|468060724|FG003|Overall Study|Withdrawal by Subject|0|||
130027442|NCT02913313|468060725|FG004|Overall Study|Withdrawal by Subject|0|||
130027443|NCT02913313|468060726|FG005|Overall Study|Withdrawal by Subject|0|||
130027444|NCT02913313|468060727|FG006|Overall Study|Withdrawal by Subject|1|||
130027445|NCT02913313|468060728|FG007|Overall Study|Withdrawal by Subject|1|||
130027446|NCT02913313|468060729|FG008|Overall Study|Withdrawal by Subject|0|||
130027447|NCT02913313|468060730|FG009|Overall Study|Withdrawal by Subject|0|||
130027448|NCT02913313|468060731|FG010|Overall Study|Withdrawal by Subject|1|||
130027449|NCT02913313|468060732|FG011|Overall Study|Withdrawal by Subject|0|||
130027450|NCT02913313|468060733|FG012|Overall Study|Withdrawal by Subject|0|||
130027451|NCT02913313|468060734|FG013|Overall Study|Withdrawal by Subject|0|||
130027452|NCT02913313|468060721|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027453|NCT02913313|468060722|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027454|NCT02913313|468060723|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027455|NCT02913313|468060724|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027456|NCT02913313|468060725|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130239207|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Adverse Event|0|||
130239208|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Adverse Event|1|||
130239209|NCT04279522|468837539|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
130239210|NCT04279522|468837540|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
130239211|NCT02629159|468837543|FG000|Overall Study|Adverse Event|17|||
130239212|NCT02629159|468837544|FG001|Overall Study|Adverse Event|20|||
130239213|NCT02629159|468837545|FG002|Overall Study|Adverse Event|22|||
130239214|NCT02629159|468837543|FG000|Overall Study|Withdrawal by Subject|22|||
130239215|NCT02629159|468837544|FG001|Overall Study|Withdrawal by Subject|11|||
130239216|NCT02629159|468837545|FG002|Overall Study|Withdrawal by Subject|15|||
130239217|NCT02629159|468837543|FG000|Overall Study|Lost to Follow-up|7|||
130239218|NCT02629159|468837544|FG001|Overall Study|Lost to Follow-up|4|||
130239219|NCT02629159|468837545|FG002|Overall Study|Lost to Follow-up|5|||
130239220|NCT02629159|468837543|FG000|Overall Study|Lack of Efficacy|4|||
130239221|NCT02629159|468837544|FG001|Overall Study|Lack of Efficacy|0|||
130239222|NCT02629159|468837545|FG002|Overall Study|Lack of Efficacy|1|||
130239223|NCT02629159|468837543|FG000|Overall Study|Other|6|||
130239224|NCT02629159|468837544|FG001|Overall Study|Other|4|||
130239225|NCT02629159|468837545|FG002|Overall Study|Other|8|||
130239226|NCT05352399|468837558|FG000|Overall Study|Discontinued intervention|6|||
130239227|NCT01802281|468837559|FG000|Overall Study|Death|1|||
130239228|NCT01802281|468837560|FG001|Overall Study|Death|2|||
130239229|NCT01802281|468837559|FG000|Overall Study|Withdrawal by Subject|2|||
130239230|NCT01802281|468837560|FG001|Overall Study|Withdrawal by Subject|1|||
130239231|NCT01802281|468837559|FG000|Overall Study|Ineligible|5|||
130239232|NCT01802281|468837560|FG001|Overall Study|Ineligible|3|||
130239233|NCT02685735|468837561|FG000|Overall Study|Surgery Cancelled|4|||
130239234|NCT02685735|468837562|FG001|Overall Study|Surgery Cancelled|9|||
130239235|NCT02685735|468837561|FG000|Overall Study|Adverse Event|10|||
130239236|NCT02685735|468837562|FG001|Overall Study|Adverse Event|3|||
130239237|NCT02685735|468837561|FG000|Overall Study|Preop testing found to be incomplete|2|||
130239238|NCT02685735|468837562|FG001|Overall Study|Preop testing found to be incomplete|2|||
130239239|NCT02685735|468837561|FG000|Overall Study|Withdrawal by Subject|1|||
130239240|NCT02685735|468837562|FG001|Overall Study|Withdrawal by Subject|2|||
130239241|NCT02685735|468837561|FG000|Overall Study|Death|1|||
130239242|NCT02685735|468837562|FG001|Overall Study|Death|0|||
130239243|NCT00927472|468837572|FG000|Overall Study|Withdrawal by Subject|10|||
130239244|NCT00927472|468837573|FG001|Overall Study|Withdrawal by Subject|11|||
130239245|NCT00927472|468837572|FG000|Overall Study|Lost to Follow-up|1|||
130239246|NCT00927472|468837573|FG001|Overall Study|Lost to Follow-up|6|||
130239247|NCT00927472|468837572|FG000|Overall Study|Protocol Violation|0|||
130027457|NCT02913313|468060726|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027458|NCT02913313|468060727|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027459|NCT02913313|468060728|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130239248|NCT00927472|468837573|FG001|Overall Study|Protocol Violation|1|||
130239249|NCT00927472|468837572|FG000|Overall Study|Post treatment Assessment out of window|0|||
130239250|NCT00927472|468837573|FG001|Overall Study|Post treatment Assessment out of window|4|||
130239251|NCT05436613|468837581|FG000|Overall Study|Lost to Follow-up|9|||
130239252|NCT05436613|468837581|FG000|Overall Study|Withdrawal by Subject|3|||
130239253|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
130239254|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
130239255|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
130239256|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
130239257|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
130239258|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
130239259|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
130239260|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
130239261|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
130239262|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
130239263|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
130239264|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
130239265|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
130239266|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
130239267|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
130239268|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
130239269|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
130239270|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
130239271|NCT01069939|468837586|FG000|Randomised and Included in the Analyses|Removal|1|||
130027460|NCT02913313|468060729|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027461|NCT02913313|468060730|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027462|NCT02913313|468060731|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
130027463|NCT02913313|468060732|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
130027464|NCT02913313|468060733|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
130027465|NCT02913313|468060734|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
130027466|NCT02913313|468060721|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
130027467|NCT02913313|468060722|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
130027468|NCT02913313|468060723|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
130027469|NCT02913313|468060724|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
130027470|NCT02913313|468060725|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
130027471|NCT02913313|468060726|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
130027472|NCT02913313|468060727|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
130027473|NCT02913313|468060728|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
130027474|NCT02913313|468060729|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
130027475|NCT02913313|468060730|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
130027476|NCT02913313|468060731|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
130027477|NCT02913313|468060732|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
130027478|NCT02913313|468060733|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
130027479|NCT02913313|468060734|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
130027480|NCT04088409|468060735|FG000|Part A|Withdrawal by Subject|2|||
130027481|NCT04088409|468060736|FG001|Part A|Withdrawal by Subject|1|||
130027482|NCT04088409|468060735|FG000|Part A|Did Not Meet Randomization Criteria|2|||
130027483|NCT04088409|468060736|FG001|Part A|Did Not Meet Randomization Criteria|0|||
130027484|NCT04088409|468060735|FG000|Part A|Lack of Efficacy|9|||
130027485|NCT04088409|468060736|FG001|Part A|Lack of Efficacy|0|||
130027486|NCT04088409|468060735|FG000|Part A|Lost to Follow-up|1|||
130027487|NCT04088409|468060736|FG001|Part A|Lost to Follow-up|0|||
130027488|NCT04088409|468060735|FG000|Part A|Adverse Event|1|||
130027489|NCT04088409|468060736|FG001|Part A|Adverse Event|0|||
130027490|NCT04088409|468060735|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
130027491|NCT04088409|468060736|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
130027492|NCT04088409|468060735|FG000|Part B|Ongoing Treatment|10|||
130027493|NCT04088409|468060736|FG001|Part B|Ongoing Treatment|0|||
130027494|NCT04233229|468060737|FG000|Overall Study|Withdrawal by Subject|0|||
130027495|NCT04233229|468060738|FG001|Overall Study|Withdrawal by Subject|1|||
130027496|NCT04233229|468060737|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
130027497|NCT04233229|468060738|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
130027498|NCT04233229|468060737|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
130027499|NCT04233229|468060738|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
130027500|NCT00841763|468060739|FG000|Overall Study|Withdrawal by Subject|60|||
130027501|NCT00841763|468060740|FG001|Overall Study|Withdrawal by Subject|17|||
130027502|NCT00841763|468060741|FG002|Overall Study|Withdrawal by Subject|4|||
130027503|NCT00841763|468060742|FG003|Overall Study|Withdrawal by Subject|1|||
130027504|NCT00841763|468060739|FG000|Overall Study|Adverse Event|9|||
130027505|NCT00841763|468060740|FG001|Overall Study|Adverse Event|10|||
130027506|NCT00841763|468060741|FG002|Overall Study|Adverse Event|3|||
130027507|NCT00841763|468060742|FG003|Overall Study|Adverse Event|2|||
130027508|NCT00841763|468060739|FG000|Overall Study|Lost to Follow-up|63|||
130027509|NCT00841763|468060740|FG001|Overall Study|Lost to Follow-up|25|||
130027510|NCT00841763|468060741|FG002|Overall Study|Lost to Follow-up|0|||
130027511|NCT00841763|468060742|FG003|Overall Study|Lost to Follow-up|0|||
130027512|NCT00841763|468060739|FG000|Overall Study|Protocol Violation|20|||
130027513|NCT00841763|468060740|FG001|Overall Study|Protocol Violation|3|||
130027514|NCT00841763|468060741|FG002|Overall Study|Protocol Violation|1|||
130027515|NCT00841763|468060742|FG003|Overall Study|Protocol Violation|0|||
130027516|NCT00841763|468060739|FG000|Overall Study|Administrative Reasons|3|||
130027517|NCT00841763|468060740|FG001|Overall Study|Administrative Reasons|1|||
130027518|NCT00841763|468060741|FG002|Overall Study|Administrative Reasons|0|||
130027519|NCT00841763|468060742|FG003|Overall Study|Administrative Reasons|0|||
130239272|NCT01069939|468837587|FG001|Randomised and Included in the Analyses|Removal|0|||
130239273|NCT00191100|468837594|FG000|Overall Study|Adverse Event|18|||
130239274|NCT00191100|468837595|FG001|Overall Study|Adverse Event|1|||
130239275|NCT00191100|468837594|FG000|Overall Study|Lost to Follow-up|2|||
130239276|NCT00191100|468837595|FG001|Overall Study|Lost to Follow-up|0|||
130239277|NCT00191100|468837594|FG000|Overall Study|Patient Moved|0|||
130239278|NCT00191100|468837595|FG001|Overall Study|Patient Moved|1|||
130239279|NCT00191100|468837594|FG000|Overall Study|Withdrawal by Subject|9|||
130239280|NCT00191100|468837595|FG001|Overall Study|Withdrawal by Subject|3|||
130239281|NCT00191100|468837594|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
130239282|NCT00191100|468837595|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
130239283|NCT00191100|468837594|FG000|Overall Study|Clinical Relapse|2|||
130239284|NCT00191100|468837595|FG001|Overall Study|Clinical Relapse|1|||
130239285|NCT00191100|468837594|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
130239286|NCT00191100|468837595|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
130239287|NCT00191100|468837594|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
130239288|NCT00191100|468837595|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
130239289|NCT00191100|468837594|FG000|Overall Study|Physician Decision|3|||
130239290|NCT00191100|468837595|FG001|Overall Study|Physician Decision|1|||
130239291|NCT00191100|468837594|FG000|Overall Study|Death from Study Drug Toxicity|2|||
130239292|NCT00191100|468837595|FG001|Overall Study|Death from Study Drug Toxicity|0|||
130239293|NCT00191100|468837594|FG000|Overall Study|Protocol Violation|1|||
130239294|NCT00191100|468837595|FG001|Overall Study|Protocol Violation|1|||
130239295|NCT00191100|468837594|FG000|Overall Study|Death from Other Cause|1|||
130239296|NCT00191100|468837595|FG001|Overall Study|Death from Other Cause|0|||
130239297|NCT00191100|468837594|FG000|Overall Study|Reason Not Specified|0|||
130239298|NCT00191100|468837595|FG001|Overall Study|Reason Not Specified|1|||
130239299|NCT01525589|468837598|FG000|Overall Study|Non-treatment-related AE|1|||
130239300|NCT01525589|468837599|FG001|Overall Study|Non-treatment-related AE|0|||
130239301|NCT01525589|468837600|FG002|Overall Study|Non-treatment-related AE|0|||
130239302|NCT01525589|468837598|FG000|Overall Study|Progressive disease|48|||
130239303|NCT01525589|468837599|FG001|Overall Study|Progressive disease|15|||
130239304|NCT01525589|468837600|FG002|Overall Study|Progressive disease|29|||
130239305|NCT01525589|468837598|FG000|Overall Study|Never treated|2|||
130239306|NCT01525589|468837599|FG001|Overall Study|Never treated|0|||
130239307|NCT01525589|468837600|FG002|Overall Study|Never treated|0|||
130239308|NCT01525589|468837598|FG000|Overall Study|Physician Decision|4|||
130239309|NCT01525589|468837599|FG001|Overall Study|Physician Decision|2|||
130239310|NCT01525589|468837600|FG002|Overall Study|Physician Decision|2|||
130239311|NCT01525589|468837598|FG000|Overall Study|Death|0|||
130239312|NCT01525589|468837599|FG001|Overall Study|Death|0|||
130239313|NCT01525589|468837600|FG002|Overall Study|Death|2|||
130239314|NCT01525589|468837598|FG000|Overall Study|Treatment-related AE|1|||
130239315|NCT01525589|468837599|FG001|Overall Study|Treatment-related AE|1|||
130239316|NCT01525589|468837600|FG002|Overall Study|Treatment-related AE|2|||
130239317|NCT01525589|468837598|FG000|Overall Study|Other reasons|0|||
130239318|NCT01525589|468837599|FG001|Overall Study|Other reasons|1|||
130239319|NCT01525589|468837600|FG002|Overall Study|Other reasons|0|||
130239320|NCT01525589|468837598|FG000|Overall Study|Withdrawal by Subject|0|||
130239321|NCT01525589|468837599|FG001|Overall Study|Withdrawal by Subject|1|||
130239322|NCT01525589|468837600|FG002|Overall Study|Withdrawal by Subject|0|||
130239323|NCT02101853|468837602|FG000|Block 1 Induction|Adverse Event|11|||
130239324|NCT02101853|468837603|FG001|Block 1 Induction|Adverse Event|0|||
130239325|NCT02101853|468837604|FG002|Block 1 Induction|Adverse Event|0|||
130239326|NCT02101853|468837605|FG003|Block 1 Induction|Adverse Event|0|||
130239327|NCT02101853|468837606|FG004|Block 1 Induction|Adverse Event|0|||
130239328|NCT02101853|468837607|FG005|Block 1 Induction|Adverse Event|0|||
130239329|NCT02101853|468837602|FG000|Block 1 Induction|Death|20|||
130239330|NCT02101853|468837603|FG001|Block 1 Induction|Death|0|||
130239331|NCT02101853|468837604|FG002|Block 1 Induction|Death|0|||
130239332|NCT02101853|468837605|FG003|Block 1 Induction|Death|0|||
130239333|NCT02101853|468837606|FG004|Block 1 Induction|Death|0|||
130239334|NCT02101853|468837607|FG005|Block 1 Induction|Death|0|||
130239335|NCT02101853|468837602|FG000|Block 1 Induction|Lack of Efficacy|6|||
130239336|NCT02101853|468837603|FG001|Block 1 Induction|Lack of Efficacy|0|||
130239337|NCT02101853|468837604|FG002|Block 1 Induction|Lack of Efficacy|0|||
130239338|NCT02101853|468837605|FG003|Block 1 Induction|Lack of Efficacy|0|||
130239339|NCT02101853|468837606|FG004|Block 1 Induction|Lack of Efficacy|0|||
130239340|NCT02101853|468837607|FG005|Block 1 Induction|Lack of Efficacy|0|||
130239341|NCT02101853|468837602|FG000|Block 1 Induction|Physician Decision|61|||
130239342|NCT02101853|468837603|FG001|Block 1 Induction|Physician Decision|0|||
130239343|NCT02101853|468837604|FG002|Block 1 Induction|Physician Decision|0|||
130239344|NCT02101853|468837605|FG003|Block 1 Induction|Physician Decision|0|||
130239345|NCT02101853|468837606|FG004|Block 1 Induction|Physician Decision|0|||
130239346|NCT02101853|468837607|FG005|Block 1 Induction|Physician Decision|0|||
130239347|NCT02101853|468837602|FG000|Block 1 Induction|Protocol Violation|2|||
130239348|NCT02101853|468837603|FG001|Block 1 Induction|Protocol Violation|0|||
130239349|NCT02101853|468837604|FG002|Block 1 Induction|Protocol Violation|0|||
130239350|NCT02101853|468837605|FG003|Block 1 Induction|Protocol Violation|0|||
130239351|NCT02101853|468837606|FG004|Block 1 Induction|Protocol Violation|0|||
130239352|NCT02101853|468837607|FG005|Block 1 Induction|Protocol Violation|0|||
130239353|NCT02101853|468837602|FG000|Block 1 Induction|Withdrawal by Subject|65|||
130239354|NCT02101853|468837603|FG001|Block 1 Induction|Withdrawal by Subject|0|||
130239355|NCT02101853|468837604|FG002|Block 1 Induction|Withdrawal by Subject|0|||
130239356|NCT02101853|468837605|FG003|Block 1 Induction|Withdrawal by Subject|0|||
130239357|NCT02101853|468837606|FG004|Block 1 Induction|Withdrawal by Subject|0|||
130239358|NCT02101853|468837607|FG005|Block 1 Induction|Withdrawal by Subject|0|||
130239359|NCT02101853|468837602|FG000|Block 1 Induction|Ineligible|8|||
130239360|NCT02101853|468837603|FG001|Block 1 Induction|Ineligible|0|||
130239361|NCT02101853|468837604|FG002|Block 1 Induction|Ineligible|0|||
130239362|NCT02101853|468837605|FG003|Block 1 Induction|Ineligible|0|||
130239363|NCT02101853|468837606|FG004|Block 1 Induction|Ineligible|0|||
130239364|NCT02101853|468837607|FG005|Block 1 Induction|Ineligible|0|||
130239365|NCT02101853|468837602|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
130239366|NCT02101853|468837603|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130239367|NCT02101853|468837604|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130239368|NCT02101853|468837605|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130239369|NCT02101853|468837606|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130239370|NCT02101853|468837607|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
130239371|NCT02101853|468837602|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
130239372|NCT02101853|468837603|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239373|NCT02101853|468837604|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239374|NCT02101853|468837605|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239375|NCT02101853|468837606|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239376|NCT02101853|468837607|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239377|NCT02101853|468837602|FG000|Post Induction Randomization|Adverse Event|0|||
130239378|NCT02101853|468837603|FG001|Post Induction Randomization|Adverse Event|3|||
130239379|NCT02101853|468837604|FG002|Post Induction Randomization|Adverse Event|8|||
130239380|NCT02101853|468837605|FG003|Post Induction Randomization|Adverse Event|4|||
130239381|NCT02101853|468837606|FG004|Post Induction Randomization|Adverse Event|4|||
130239382|NCT02101853|468837607|FG005|Post Induction Randomization|Adverse Event|0|||
130239383|NCT02101853|468837602|FG000|Post Induction Randomization|Death|0|||
130239384|NCT02101853|468837603|FG001|Post Induction Randomization|Death|9|||
130239385|NCT02101853|468837604|FG002|Post Induction Randomization|Death|2|||
130239386|NCT02101853|468837605|FG003|Post Induction Randomization|Death|2|||
130239387|NCT02101853|468837606|FG004|Post Induction Randomization|Death|0|||
130239388|NCT02101853|468837607|FG005|Post Induction Randomization|Death|0|||
130239389|NCT02101853|468837602|FG000|Post Induction Randomization|Lack of Efficacy|0|||
130239390|NCT02101853|468837603|FG001|Post Induction Randomization|Lack of Efficacy|14|||
130239391|NCT02101853|468837604|FG002|Post Induction Randomization|Lack of Efficacy|23|||
130239392|NCT02101853|468837605|FG003|Post Induction Randomization|Lack of Efficacy|18|||
130027520|NCT00841763|468060739|FG000|Overall Study|Unable to Classify|7|||
130027521|NCT00841763|468060740|FG001|Overall Study|Unable to Classify|1|||
130027522|NCT00841763|468060741|FG002|Overall Study|Unable to Classify|0|||
130027523|NCT00841763|468060742|FG003|Overall Study|Unable to Classify|0|||
130027524|NCT00648167|468060743|FG000|Overall Study|Adverse Event|6|||
130027525|NCT00648167|468060743|FG000|Overall Study|unable to swallow tablets|1|||
130027526|NCT01482910|468060748|FG000|Overall Study|Adverse Event|6|||
130027527|NCT01482910|468060749|FG001|Overall Study|Adverse Event|5|||
130027528|NCT01482910|468060748|FG000|Overall Study|Lost to Follow-up|0|||
130027529|NCT01482910|468060749|FG001|Overall Study|Lost to Follow-up|1|||
130027530|NCT01482910|468060748|FG000|Overall Study|Protocol Violation|1|||
130027531|NCT01482910|468060749|FG001|Overall Study|Protocol Violation|1|||
130027532|NCT01482910|468060748|FG000|Overall Study|Withdrawal by Subject|7|||
130027533|NCT01482910|468060749|FG001|Overall Study|Withdrawal by Subject|2|||
130027534|NCT01482910|468060748|FG000|Overall Study|Death|1|||
130027535|NCT01482910|468060749|FG001|Overall Study|Death|0|||
130027536|NCT00440726|468060750|FG000|Phase 1|Dose-Limiting Toxicity|0|||
130027537|NCT00440726|468060751|FG001|Phase 1|Dose-Limiting Toxicity|1|||
130027538|NCT00440726|468060752|FG002|Phase 1|Dose-Limiting Toxicity|0|||
130239393|NCT02101853|468837606|FG004|Post Induction Randomization|Lack of Efficacy|21|||
130027539|NCT00440726|468060750|FG000|Phase 1|Physician Decision|1|||
130027540|NCT00440726|468060751|FG001|Phase 1|Physician Decision|0|||
130027541|NCT00440726|468060752|FG002|Phase 1|Physician Decision|0|||
130027542|NCT00440726|468060750|FG000|Phase 2|Death|0|||
130027543|NCT00440726|468060751|FG001|Phase 2|Death|0|||
130027544|NCT00440726|468060752|FG002|Phase 2|Death|1|||
130027545|NCT00440726|468060750|FG000|Phase 2|Adverse Event|0|||
130027546|NCT00440726|468060751|FG001|Phase 2|Adverse Event|0|||
130027547|NCT00440726|468060752|FG002|Phase 2|Adverse Event|1|||
130027548|NCT02614079|468060756|FG000|Overall Study|Withdrawal by Subject|1|||
130027549|NCT00110019|468060759|FG000|Overall Study|Lack of Efficacy|253|||
130027550|NCT00110019|468060760|FG001|Overall Study|Lack of Efficacy|285|||
130027551|NCT00110019|468060759|FG000|Overall Study|Adverse Event|61|||
130027552|NCT00110019|468060760|FG001|Overall Study|Adverse Event|40|||
130027553|NCT00110019|468060759|FG000|Overall Study|Death|13|||
130027554|NCT00110019|468060760|FG001|Overall Study|Death|15|||
130027555|NCT00110019|468060759|FG000|Overall Study|Withdrawal by Subject|21|||
130027556|NCT00110019|468060760|FG001|Overall Study|Withdrawal by Subject|9|||
130027557|NCT00110019|468060759|FG000|Overall Study|alternative therapy|5|||
130027558|NCT00110019|468060760|FG001|Overall Study|alternative therapy|1|||
130027559|NCT00110019|468060759|FG000|Overall Study|complicating disease|1|||
130027560|NCT00110019|468060760|FG001|Overall Study|complicating disease|1|||
130027561|NCT00110019|468060759|FG000|Overall Study|symptom deterioration|13|||
130027562|NCT00110019|468060760|FG001|Overall Study|symptom deterioration|16|||
130027563|NCT00110019|468060759|FG000|Overall Study|Not start protocol therapy|17|||
130239394|NCT02101853|468837607|FG005|Post Induction Randomization|Lack of Efficacy|0|||
130239395|NCT02101853|468837602|FG000|Post Induction Randomization|Physician Decision|0|||
130239396|NCT02101853|468837603|FG001|Post Induction Randomization|Physician Decision|43|||
130239397|NCT02101853|468837604|FG002|Post Induction Randomization|Physician Decision|23|||
130239398|NCT02101853|468837605|FG003|Post Induction Randomization|Physician Decision|14|||
130239399|NCT02101853|468837606|FG004|Post Induction Randomization|Physician Decision|14|||
130239400|NCT02101853|468837607|FG005|Post Induction Randomization|Physician Decision|0|||
130239401|NCT02101853|468837602|FG000|Post Induction Randomization|Protocol Violation|0|||
130239402|NCT02101853|468837603|FG001|Post Induction Randomization|Protocol Violation|3|||
130239403|NCT02101853|468837604|FG002|Post Induction Randomization|Protocol Violation|0|||
130239404|NCT02101853|468837605|FG003|Post Induction Randomization|Protocol Violation|0|||
130239405|NCT02101853|468837606|FG004|Post Induction Randomization|Protocol Violation|0|||
130239406|NCT02101853|468837607|FG005|Post Induction Randomization|Protocol Violation|0|||
130239407|NCT02101853|468837602|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
130239408|NCT02101853|468837603|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
130239409|NCT02101853|468837604|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
130239410|NCT02101853|468837605|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
130239411|NCT02101853|468837606|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
130239412|NCT02101853|468837607|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
130239413|NCT02101853|468837602|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130027564|NCT00110019|468060760|FG001|Overall Study|Not start protocol therapy|16|||
130027565|NCT00110019|468060759|FG000|Overall Study|other reasons|22|||
130027566|NCT00110019|468060760|FG001|Overall Study|other reasons|30|||
130316205|NCT02421172|469124328|FG004|Period 2|Patient/guardian decision|1|||
130027567|NCT04426695|468060763|FG000|Overall Study|Death|2|||
129884562|NCT02696902|467536454|FG001|Overall Study|Death|3|||
130027568|NCT04426695|468060764|FG001|Overall Study|Death|0|||
130027569|NCT04426695|468060765|FG002|Overall Study|Death|1|||
130027570|NCT04426695|468060766|FG003|Overall Study|Death|27|||
130027571|NCT04426695|468060767|FG004|Overall Study|Death|25|||
130027572|NCT04426695|468060768|FG005|Overall Study|Death|21|||
130027573|NCT04426695|468060769|FG006|Overall Study|Death|42|||
130239414|NCT02101853|468837603|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239415|NCT02101853|468837604|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239416|NCT02101853|468837605|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
130239417|NCT02101853|468837606|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239418|NCT02101853|468837607|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
130239419|NCT02101853|468837602|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130239420|NCT02101853|468837603|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
130239421|NCT02101853|468837604|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
130239422|NCT02101853|468837605|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130239423|NCT02101853|468837606|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130239424|NCT02101853|468837607|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
130239425|NCT02101853|468837602|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130239426|NCT02101853|468837603|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
130239427|NCT02101853|468837604|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130239428|NCT02101853|468837605|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130239429|NCT02101853|468837606|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130239430|NCT02101853|468837607|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
130239431|NCT02101853|468837602|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130239432|NCT02101853|468837603|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130239433|NCT02101853|468837604|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130239434|NCT02101853|468837605|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
130239435|NCT02101853|468837606|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
130239436|NCT02101853|468837607|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
130239437|NCT02101853|468837602|FG000|Blinatumomab Salvage Therapy|Death|0|||
130239438|NCT02101853|468837603|FG001|Blinatumomab Salvage Therapy|Death|0|||
130239439|NCT02101853|468837604|FG002|Blinatumomab Salvage Therapy|Death|0|||
130239440|NCT02101853|468837605|FG003|Blinatumomab Salvage Therapy|Death|0|||
130239441|NCT02101853|468837606|FG004|Blinatumomab Salvage Therapy|Death|0|||
130239442|NCT02101853|468837607|FG005|Blinatumomab Salvage Therapy|Death|2|||
130239443|NCT02101853|468837602|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130239444|NCT02101853|468837603|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130239445|NCT02101853|468837604|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130239446|NCT02101853|468837605|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130239447|NCT02101853|468837606|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
130239448|NCT02101853|468837607|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
130239449|NCT02101853|468837602|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
130239450|NCT02101853|468837603|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
130239451|NCT02101853|468837604|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
130239452|NCT02101853|468837605|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
130239453|NCT02101853|468837606|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
130239454|NCT02101853|468837607|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
130239455|NCT02101853|468837602|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130239456|NCT02101853|468837603|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130239457|NCT02101853|468837604|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130239458|NCT02101853|468837605|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130239459|NCT02101853|468837606|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
130239460|NCT02101853|468837607|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
130239461|NCT04409002|468837608|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
130239462|NCT06481579|468837609|FG000|Overall Study|Death|1|||
130239463|NCT06481579|468837610|FG001|Overall Study|Death|0|||
130239464|NCT06481579|468837609|FG000|Overall Study|Withdrawal by Subject|3|||
130239465|NCT06481579|468837610|FG001|Overall Study|Withdrawal by Subject|0|||
130239466|NCT06481579|468837609|FG000|Overall Study|Other|1|||
130239467|NCT06481579|468837610|FG001|Overall Study|Other|1|||
130239468|NCT05032196|468837611|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239469|NCT05032196|468837612|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
130239470|NCT05032196|468837613|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239471|NCT05032196|468837614|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239472|NCT05032196|468837615|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239473|NCT05032196|468837616|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
130239474|NCT05032196|468837611|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239475|NCT05032196|468837612|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239476|NCT05032196|468837613|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239477|NCT05032196|468837614|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
130239478|NCT05032196|468837615|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239479|NCT05032196|468837616|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
130239480|NCT05032196|468837611|FG000|Period 2 (Multidose)|Physician Decision|0|||
130239481|NCT05032196|468837612|FG001|Period 2 (Multidose)|Physician Decision|0|||
130239482|NCT05032196|468837613|FG002|Period 2 (Multidose)|Physician Decision|0|||
130239483|NCT05032196|468837614|FG003|Period 2 (Multidose)|Physician Decision|0|||
130239484|NCT05032196|468837615|FG004|Period 2 (Multidose)|Physician Decision|1|||
130239485|NCT05032196|468837616|FG005|Period 2 (Multidose)|Physician Decision|0|||
130239486|NCT05260008|468837617|FG000|Overall Study|Physician Decision|0|||
130239487|NCT05260008|468837618|FG001|Overall Study|Physician Decision|1|||
130239488|NCT05260008|468837619|FG002|Overall Study|Physician Decision|0|||
130239489|NCT05260008|468837620|FG003|Overall Study|Physician Decision|0|||
130239490|NCT05977868|468838676|FG000|Overall Study|Withdrawal by Subject|1|||
130239491|NCT05977868|468838677|FG001|Overall Study|Withdrawal by Subject|2|||
130239492|NCT05977868|468838676|FG000|Overall Study|Transitioned to comfort care|1|||
130239493|NCT05977868|468838677|FG001|Overall Study|Transitioned to comfort care|0|||
130239494|NCT05696847|468838686|FG000|Overall Study|Withdrawal by Subject|1|||
130239495|NCT05696847|468838687|FG001|Overall Study|Withdrawal by Subject|0|||
130239496|NCT05696847|468838688|FG002|Overall Study|Withdrawal by Subject|0|||
130239497|NCT05696847|468838689|FG003|Overall Study|Withdrawal by Subject|0|||
130239498|NCT05696847|468838690|FG004|Overall Study|Withdrawal by Subject|0|||
130239499|NCT05696847|468838691|FG005|Overall Study|Withdrawal by Subject|0|||
130239500|NCT05696847|468838686|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130239501|NCT05696847|468838687|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130239502|NCT05696847|468838688|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130239503|NCT05696847|468838689|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130239504|NCT05696847|468838690|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130239505|NCT05696847|468838691|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130239506|NCT05696847|468838686|FG000|Overall Study|Adverse Event|0|||
130239507|NCT05696847|468838687|FG001|Overall Study|Adverse Event|0|||
130239508|NCT05696847|468838688|FG002|Overall Study|Adverse Event|0|||
130239509|NCT05696847|468838689|FG003|Overall Study|Adverse Event|0|||
130239510|NCT05696847|468838690|FG004|Overall Study|Adverse Event|0|||
130239511|NCT05696847|468838691|FG005|Overall Study|Adverse Event|1|||
130239512|NCT05696847|468838686|FG000|Overall Study|Sponsor Decision|0|||
130239513|NCT05696847|468838687|FG001|Overall Study|Sponsor Decision|0|||
130239514|NCT05696847|468838688|FG002|Overall Study|Sponsor Decision|0|||
130239515|NCT05696847|468838689|FG003|Overall Study|Sponsor Decision|1|||
130239516|NCT05696847|468838690|FG004|Overall Study|Sponsor Decision|0|||
130239517|NCT05696847|468838691|FG005|Overall Study|Sponsor Decision|0|||
130239518|NCT03323502|468838692|FG000|Overall Study|Resident could not be linked to CMS data|594|||
130239519|NCT03323502|468838693|FG001|Overall Study|Resident could not be linked to CMS data|435|||
130239520|NCT03323502|468838692|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
130239521|NCT03323502|468838693|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
130239522|NCT03323502|468838692|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
130239523|NCT03323502|468838693|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
130239524|NCT03323502|468838692|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
130239525|NCT03323502|468838693|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
130239526|NCT03323502|468838692|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
130239527|NCT03323502|468838693|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
130239528|NCT04092777|468838694|FG000|Overall Study|Lost to Follow-up|28|||
130239529|NCT04092777|468838695|FG001|Overall Study|Lost to Follow-up|46|||
130239530|NCT04092777|468838694|FG000|Overall Study|Withdrawal by Subject|8|||
130239531|NCT04092777|468838695|FG001|Overall Study|Withdrawal by Subject|5|||
130239532|NCT00975923|468838700|FG000|Overall Study|Withdrawal by Subject|0|||
130239533|NCT00975923|468838701|FG001|Overall Study|Withdrawal by Subject|1|||
130239534|NCT04896385|468838702|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
130239535|NCT04896385|468838703|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
130239536|NCT04896385|468838704|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
130239537|NCT04896385|468838705|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
130239538|NCT04896385|468838702|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
130239539|NCT04896385|468838703|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
130239540|NCT04896385|468838704|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130239541|NCT04896385|468838705|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
130239542|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130316206|NCT00683878|469124329|FG000|Overall Study|Lack of Efficacy|3|||
130316207|NCT00683878|469124330|FG001|Overall Study|Lack of Efficacy|0|||
130316208|NCT00683878|469124331|FG002|Overall Study|Lack of Efficacy|1|||
130316209|NCT00683878|469124329|FG000|Overall Study|Adverse Event|4|||
130316210|NCT00683878|469124330|FG001|Overall Study|Adverse Event|3|||
130316211|NCT00683878|469124331|FG002|Overall Study|Adverse Event|3|||
130027574|NCT04426695|468060770|FG007|Overall Study|Death|23|||
130027575|NCT04426695|468060771|FG008|Overall Study|Death|37|||
130027576|NCT04426695|468060772|FG009|Overall Study|Death|14|||
130027577|NCT04426695|468060773|FG010|Overall Study|Death|8|||
130027578|NCT04426695|468060774|FG011|Overall Study|Death|7|||
130027579|NCT04426695|468060775|FG012|Overall Study|Death|13|||
130027580|NCT04426695|468060776|FG013|Overall Study|Death|25|||
130027581|NCT04426695|468060777|FG014|Overall Study|Death|19|||
130027582|NCT04426695|468060778|FG015|Overall Study|Death|7|||
130027583|NCT04426695|468060779|FG016|Overall Study|Death|8|||
130027584|NCT04426695|468060780|FG017|Overall Study|Death|4|||
130027585|NCT04426695|468060763|FG000|Overall Study|Lost to Follow-up|2|||
130027586|NCT04426695|468060764|FG001|Overall Study|Lost to Follow-up|4|||
130027587|NCT04426695|468060765|FG002|Overall Study|Lost to Follow-up|1|||
130027588|NCT04426695|468060766|FG003|Overall Study|Lost to Follow-up|19|||
130027589|NCT04426695|468060767|FG004|Overall Study|Lost to Follow-up|10|||
130027590|NCT04426695|468060768|FG005|Overall Study|Lost to Follow-up|14|||
130027591|NCT04426695|468060769|FG006|Overall Study|Lost to Follow-up|5|||
130027592|NCT04426695|468060770|FG007|Overall Study|Lost to Follow-up|14|||
130027593|NCT04426695|468060771|FG008|Overall Study|Lost to Follow-up|10|||
130239543|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
130239544|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
130239545|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
130239546|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130239547|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
130239548|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
130239549|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
130239550|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
130239551|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
130239552|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
130239553|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
130239554|NCT04896385|468838702|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
130239555|NCT04896385|468838703|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
130239556|NCT04896385|468838704|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
130239557|NCT04896385|468838705|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
130239558|NCT05291689|468838708|FG000|Overall Study|Adverse Event|3|||
130239559|NCT05291689|468838708|FG000|Overall Study|Lack of Efficacy|10|||
130239560|NCT05291689|468838708|FG000|Overall Study|Withdrawal by Subject|4|||
130239561|NCT01931098|468838709|FG000|Overall Study|Withdrawal by Subject|0|||
130239562|NCT01931098|468838710|FG001|Overall Study|Withdrawal by Subject|1|||
130239563|NCT01931098|468838709|FG000|Overall Study|Enrolled in different protocol|0|||
130239564|NCT01931098|468838710|FG001|Overall Study|Enrolled in different protocol|1|||
130239565|NCT01931098|468838709|FG000|Overall Study|Unable to begin trmt:active infection|0|||
130239566|NCT01931098|468838710|FG001|Overall Study|Unable to begin trmt:active infection|1|||
130239567|NCT01931098|468838709|FG000|Overall Study|Refused further treatment|0|||
130027594|NCT04426695|468060772|FG009|Overall Study|Lost to Follow-up|11|||
130027595|NCT04426695|468060773|FG010|Overall Study|Lost to Follow-up|12|||
130027596|NCT04426695|468060774|FG011|Overall Study|Lost to Follow-up|6|||
130027597|NCT04426695|468060775|FG012|Overall Study|Lost to Follow-up|2|||
130027598|NCT04426695|468060776|FG013|Overall Study|Lost to Follow-up|2|||
130100232|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
130100233|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
130100234|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
130100235|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
130239568|NCT01931098|468838710|FG001|Overall Study|Refused further treatment|1|||
130239569|NCT02278354|468838711|FG000|Overall Study|Lost to Follow-up|2|||
130239570|NCT02278354|468838712|FG001|Overall Study|Lost to Follow-up|2|||
130239571|NCT02278354|468838711|FG000|Overall Study|Withdrawal by Subject|0|||
130027599|NCT04426695|468060777|FG014|Overall Study|Lost to Follow-up|2|||
130027600|NCT04426695|468060778|FG015|Overall Study|Lost to Follow-up|0|||
130027601|NCT04426695|468060779|FG016|Overall Study|Lost to Follow-up|0|||
130239572|NCT02278354|468838712|FG001|Overall Study|Withdrawal by Subject|1|||
130239573|NCT02278354|468838711|FG000|Overall Study|<10 professional fights|2|||
130027602|NCT04426695|468060780|FG017|Overall Study|Lost to Follow-up|0|||
130027603|NCT04426695|468060763|FG000|Overall Study|Participant Decision|1|||
130027604|NCT04426695|468060764|FG001|Overall Study|Participant Decision|2|||
130027605|NCT04426695|468060765|FG002|Overall Study|Participant Decision|2|||
130239574|NCT02278354|468838712|FG001|Overall Study|<10 professional fights|0|||
130239575|NCT02612155|468838714|FG000|Overall Study|Death|1|||
130239576|NCT02612155|468838715|FG001|Overall Study|Death|1|||
130239577|NCT02612155|468838714|FG000|Overall Study|Lost to Follow-up|2|||
130239578|NCT02612155|468838715|FG001|Overall Study|Lost to Follow-up|2|||
130239579|NCT02572167|468838718|FG000|Overall Study|Withdrawal by Subject|0|||
130239580|NCT02572167|468838719|FG001|Overall Study|Withdrawal by Subject|3|||
130239581|NCT02572167|468838720|FG002|Overall Study|Withdrawal by Subject|0|||
130239582|NCT02572167|468838718|FG000|Overall Study|Lost to Follow-up|2|||
130239583|NCT02572167|468838719|FG001|Overall Study|Lost to Follow-up|5|||
130239584|NCT02572167|468838720|FG002|Overall Study|Lost to Follow-up|3|||
130239585|NCT02572167|468838718|FG000|Overall Study|Death|0|||
130239586|NCT02572167|468838719|FG001|Overall Study|Death|8|||
130239587|NCT02572167|468838720|FG002|Overall Study|Death|3|||
130239588|NCT02572167|468838718|FG000|Overall Study|Did not meet inclusion criteria|0|||
130239589|NCT02572167|468838719|FG001|Overall Study|Did not meet inclusion criteria|0|||
130239590|NCT02572167|468838720|FG002|Overall Study|Did not meet inclusion criteria|1|||
130239591|NCT02572167|468838718|FG000|Overall Study|Study closure by Sponsor|4|||
130239592|NCT02572167|468838719|FG001|Overall Study|Study closure by Sponsor|40|||
130239593|NCT02572167|468838720|FG002|Overall Study|Study closure by Sponsor|24|||
130239594|NCT00569127|468838721|FG000|Overall Study|Adverse Event|57|||
130239595|NCT00569127|468838722|FG001|Overall Study|Adverse Event|47|||
130239596|NCT00569127|468838721|FG000|Overall Study|Withdrawal by Subject|13|||
130239597|NCT00569127|468838722|FG001|Overall Study|Withdrawal by Subject|27|||
130239598|NCT00569127|468838721|FG000|Overall Study|Progression|99|||
130239599|NCT00569127|468838722|FG001|Overall Study|Progression|100|||
130239600|NCT00569127|468838721|FG000|Overall Study|Death|4|||
130239601|NCT00569127|468838722|FG001|Overall Study|Death|3|||
130239602|NCT00569127|468838721|FG000|Overall Study|Other|20|||
130239603|NCT00569127|468838722|FG001|Overall Study|Other|19|||
130239604|NCT00569127|468838721|FG000|Overall Study|Lost to Follow-up|0|||
130239605|NCT00569127|468838722|FG001|Overall Study|Lost to Follow-up|3|||
130239606|NCT00569127|468838721|FG000|Overall Study|Not Eligible|14|||
130239607|NCT00569127|468838722|FG001|Overall Study|Not Eligible|11|||
130239608|NCT00569127|468838721|FG000|Overall Study|Still on Treatment|7|||
130239609|NCT00569127|468838722|FG001|Overall Study|Still on Treatment|3|||
130239610|NCT03036254|468838725|FG000|Overall Study|Adverse Event|6|||
130239611|NCT03036254|468838726|FG001|Overall Study|Adverse Event|4|||
130239612|NCT03036254|468838725|FG000|Overall Study|Death|3|||
130239613|NCT03036254|468838726|FG001|Overall Study|Death|1|||
130239614|NCT03036254|468838725|FG000|Overall Study|Lack of Efficacy|5|||
130239615|NCT03036254|468838726|FG001|Overall Study|Lack of Efficacy|1|||
130239616|NCT03036254|468838725|FG000|Overall Study|Withdrawal by Subject|3|||
130239617|NCT03036254|468838726|FG001|Overall Study|Withdrawal by Subject|5|||
130239618|NCT06354257|468838727|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130239619|NCT06354257|468838727|FG000|Treatment Period 2|Adverse Event|1|||
130239620|NCT03168672|468838728|FG000|Overall Study|Withdrawal by Subject|13|||
130239621|NCT03168672|468838728|FG000|Overall Study|Death|3|||
130239622|NCT03168672|468838728|FG000|Overall Study|Investigator's Decision|137|||
130027606|NCT04426695|468060766|FG003|Overall Study|Participant Decision|12|||
130027607|NCT04426695|468060767|FG004|Overall Study|Participant Decision|18|||
130027608|NCT04426695|468060768|FG005|Overall Study|Participant Decision|22|||
130239623|NCT03168672|468838728|FG000|Overall Study|Adverse Event|1|||
130239624|NCT03168672|468838728|FG000|Overall Study|Other|2|||
130239625|NCT03168672|468838728|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
130239626|NCT01757847|468838729|FG000|Overall Study|Withdrawal by Subject|3|||
130239627|NCT01757847|468838730|FG001|Overall Study|Withdrawal by Subject|4|||
130239628|NCT00831844|468838731|FG000|Overall Study|Adverse Event|2|||
130239629|NCT00831844|468838732|FG001|Overall Study|Adverse Event|0|||
130239630|NCT00831844|468838733|FG002|Overall Study|Adverse Event|0|||
130239631|NCT00831844|468838734|FG003|Overall Study|Adverse Event|0|||
130239632|NCT00831844|468838735|FG004|Overall Study|Adverse Event|1|||
130239633|NCT00831844|468838736|FG005|Overall Study|Adverse Event|1|||
130239634|NCT00831844|468838737|FG006|Overall Study|Adverse Event|2|||
130239635|NCT00831844|468838738|FG007|Overall Study|Adverse Event|0|||
130239636|NCT00831844|468838739|FG008|Overall Study|Adverse Event|0|||
130239637|NCT00831844|468838740|FG009|Overall Study|Adverse Event|0|||
130239638|NCT00831844|468838731|FG000|Overall Study|Death|0|||
130239639|NCT00831844|468838732|FG001|Overall Study|Death|0|||
130239640|NCT00831844|468838733|FG002|Overall Study|Death|0|||
130239641|NCT00831844|468838734|FG003|Overall Study|Death|1|||
130239642|NCT00831844|468838735|FG004|Overall Study|Death|0|||
130239643|NCT00831844|468838736|FG005|Overall Study|Death|0|||
130239644|NCT00831844|468838737|FG006|Overall Study|Death|0|||
130239645|NCT00831844|468838738|FG007|Overall Study|Death|0|||
130239646|NCT00831844|468838739|FG008|Overall Study|Death|0|||
130239647|NCT00831844|468838740|FG009|Overall Study|Death|0|||
130239648|NCT00831844|468838731|FG000|Overall Study|Lack of Efficacy|8|||
130239649|NCT00831844|468838732|FG001|Overall Study|Lack of Efficacy|10|||
130239650|NCT00831844|468838733|FG002|Overall Study|Lack of Efficacy|15|||
130239651|NCT00831844|468838734|FG003|Overall Study|Lack of Efficacy|8|||
130239652|NCT00831844|468838735|FG004|Overall Study|Lack of Efficacy|11|||
130239653|NCT00831844|468838736|FG005|Overall Study|Lack of Efficacy|17|||
130239654|NCT00831844|468838737|FG006|Overall Study|Lack of Efficacy|8|||
130239655|NCT00831844|468838738|FG007|Overall Study|Lack of Efficacy|9|||
130239656|NCT00831844|468838739|FG008|Overall Study|Lack of Efficacy|7|||
130239657|NCT00831844|468838740|FG009|Overall Study|Lack of Efficacy|0|||
130239658|NCT00831844|468838731|FG000|Overall Study|Physician Decision|0|||
130239659|NCT00831844|468838732|FG001|Overall Study|Physician Decision|1|||
130239660|NCT00831844|468838733|FG002|Overall Study|Physician Decision|3|||
130239661|NCT00831844|468838734|FG003|Overall Study|Physician Decision|1|||
130239662|NCT00831844|468838735|FG004|Overall Study|Physician Decision|1|||
130239663|NCT00831844|468838736|FG005|Overall Study|Physician Decision|1|||
130239664|NCT00831844|468838737|FG006|Overall Study|Physician Decision|0|||
130239665|NCT00831844|468838738|FG007|Overall Study|Physician Decision|0|||
130239666|NCT00831844|468838739|FG008|Overall Study|Physician Decision|1|||
130239667|NCT00831844|468838740|FG009|Overall Study|Physician Decision|0|||
130239668|NCT00831844|468838731|FG000|Overall Study|Withdrawal by Subject|0|||
130239669|NCT00831844|468838732|FG001|Overall Study|Withdrawal by Subject|0|||
130027609|NCT04426695|468060769|FG006|Overall Study|Participant Decision|13|||
130027610|NCT04426695|468060770|FG007|Overall Study|Participant Decision|13|||
130027611|NCT04426695|468060771|FG008|Overall Study|Participant Decision|10|||
130239670|NCT00831844|468838733|FG002|Overall Study|Withdrawal by Subject|1|||
130239671|NCT00831844|468838734|FG003|Overall Study|Withdrawal by Subject|0|||
130239672|NCT00831844|468838735|FG004|Overall Study|Withdrawal by Subject|0|||
130239673|NCT00831844|468838736|FG005|Overall Study|Withdrawal by Subject|0|||
130239674|NCT00831844|468838737|FG006|Overall Study|Withdrawal by Subject|0|||
130239675|NCT00831844|468838738|FG007|Overall Study|Withdrawal by Subject|1|||
130239676|NCT00831844|468838739|FG008|Overall Study|Withdrawal by Subject|1|||
130239677|NCT00831844|468838740|FG009|Overall Study|Withdrawal by Subject|0|||
130239678|NCT00831844|468838731|FG000|Overall Study|Ineligible|0|||
130239679|NCT00831844|468838732|FG001|Overall Study|Ineligible|1|||
130027612|NCT04426695|468060772|FG009|Overall Study|Participant Decision|15|||
130027613|NCT04426695|468060773|FG010|Overall Study|Participant Decision|16|||
130027614|NCT04426695|468060774|FG011|Overall Study|Participant Decision|17|||
130027615|NCT04426695|468060775|FG012|Overall Study|Participant Decision|2|||
130027616|NCT04426695|468060776|FG013|Overall Study|Participant Decision|1|||
130027617|NCT04426695|468060777|FG014|Overall Study|Participant Decision|2|||
130027618|NCT04426695|468060778|FG015|Overall Study|Participant Decision|0|||
130027619|NCT04426695|468060779|FG016|Overall Study|Participant Decision|0|||
130027620|NCT04426695|468060780|FG017|Overall Study|Participant Decision|0|||
130027621|NCT04426695|468060763|FG000|Overall Study|Adverse Event|0|||
130027622|NCT04426695|468060764|FG001|Overall Study|Adverse Event|0|||
130027623|NCT04426695|468060765|FG002|Overall Study|Adverse Event|0|||
130027624|NCT04426695|468060766|FG003|Overall Study|Adverse Event|0|||
130027625|NCT04426695|468060767|FG004|Overall Study|Adverse Event|0|||
130027626|NCT04426695|468060768|FG005|Overall Study|Adverse Event|0|||
130027627|NCT04426695|468060769|FG006|Overall Study|Adverse Event|0|||
130027628|NCT04426695|468060770|FG007|Overall Study|Adverse Event|1|||
130027629|NCT04426695|468060771|FG008|Overall Study|Adverse Event|0|||
130027630|NCT04426695|468060772|FG009|Overall Study|Adverse Event|0|||
130027631|NCT04426695|468060773|FG010|Overall Study|Adverse Event|1|||
130239680|NCT00831844|468838733|FG002|Overall Study|Ineligible|1|||
130027632|NCT04426695|468060774|FG011|Overall Study|Adverse Event|1|||
130027633|NCT04426695|468060775|FG012|Overall Study|Adverse Event|0|||
130027634|NCT04426695|468060776|FG013|Overall Study|Adverse Event|0|||
130239681|NCT00831844|468838734|FG003|Overall Study|Ineligible|0|||
130239682|NCT00831844|468838735|FG004|Overall Study|Ineligible|1|||
130027635|NCT04426695|468060777|FG014|Overall Study|Adverse Event|0|||
130027636|NCT04426695|468060778|FG015|Overall Study|Adverse Event|0|||
130027637|NCT04426695|468060779|FG016|Overall Study|Adverse Event|0|||
130027638|NCT04426695|468060780|FG017|Overall Study|Adverse Event|0|||
130027639|NCT04426695|468060763|FG000|Overall Study|Sponsor Request|0|||
130027640|NCT04426695|468060764|FG001|Overall Study|Sponsor Request|0|||
130027641|NCT04426695|468060765|FG002|Overall Study|Sponsor Request|0|||
130027642|NCT04426695|468060766|FG003|Overall Study|Sponsor Request|0|||
130027643|NCT04426695|468060767|FG004|Overall Study|Sponsor Request|0|||
130027644|NCT04426695|468060768|FG005|Overall Study|Sponsor Request|0|||
130027645|NCT04426695|468060769|FG006|Overall Study|Sponsor Request|1|||
130027646|NCT04426695|468060770|FG007|Overall Study|Sponsor Request|0|||
130027647|NCT04426695|468060771|FG008|Overall Study|Sponsor Request|0|||
130027648|NCT04426695|468060772|FG009|Overall Study|Sponsor Request|0|||
130027649|NCT04426695|468060773|FG010|Overall Study|Sponsor Request|0|||
130027650|NCT04426695|468060774|FG011|Overall Study|Sponsor Request|0|||
130027651|NCT04426695|468060775|FG012|Overall Study|Sponsor Request|0|||
130027652|NCT04426695|468060776|FG013|Overall Study|Sponsor Request|0|||
130027653|NCT04426695|468060777|FG014|Overall Study|Sponsor Request|0|||
130027654|NCT04426695|468060778|FG015|Overall Study|Sponsor Request|0|||
130027655|NCT04426695|468060779|FG016|Overall Study|Sponsor Request|0|||
130027656|NCT04426695|468060780|FG017|Overall Study|Sponsor Request|0|||
130027657|NCT04426695|468060763|FG000|Overall Study|Physician Decision|0|||
130027658|NCT04426695|468060764|FG001|Overall Study|Physician Decision|0|||
130027659|NCT04426695|468060765|FG002|Overall Study|Physician Decision|0|||
130027660|NCT04426695|468060766|FG003|Overall Study|Physician Decision|0|||
130027661|NCT04426695|468060767|FG004|Overall Study|Physician Decision|0|||
130027662|NCT04426695|468060768|FG005|Overall Study|Physician Decision|0|||
130027663|NCT04426695|468060769|FG006|Overall Study|Physician Decision|0|||
130027664|NCT04426695|468060770|FG007|Overall Study|Physician Decision|0|||
130027665|NCT04426695|468060771|FG008|Overall Study|Physician Decision|0|||
130027666|NCT04426695|468060772|FG009|Overall Study|Physician Decision|1|||
130027667|NCT04426695|468060773|FG010|Overall Study|Physician Decision|0|||
130027668|NCT04426695|468060774|FG011|Overall Study|Physician Decision|0|||
130027669|NCT04426695|468060775|FG012|Overall Study|Physician Decision|1|||
130027670|NCT04426695|468060776|FG013|Overall Study|Physician Decision|0|||
130027671|NCT04426695|468060777|FG014|Overall Study|Physician Decision|0|||
130027672|NCT04426695|468060778|FG015|Overall Study|Physician Decision|0|||
130027673|NCT04426695|468060779|FG016|Overall Study|Physician Decision|0|||
130027674|NCT04426695|468060780|FG017|Overall Study|Physician Decision|0|||
130027675|NCT04426695|468060763|FG000|Overall Study|Randomized but Never Treated|3|||
130027676|NCT04426695|468060764|FG001|Overall Study|Randomized but Never Treated|1|||
130027677|NCT04426695|468060765|FG002|Overall Study|Randomized but Never Treated|0|||
130027678|NCT04426695|468060766|FG003|Overall Study|Randomized but Never Treated|4|||
130027679|NCT04426695|468060767|FG004|Overall Study|Randomized but Never Treated|5|||
130027680|NCT04426695|468060768|FG005|Overall Study|Randomized but Never Treated|5|||
130027681|NCT04426695|468060769|FG006|Overall Study|Randomized but Never Treated|4|||
130027682|NCT04426695|468060770|FG007|Overall Study|Randomized but Never Treated|6|||
130027683|NCT04426695|468060771|FG008|Overall Study|Randomized but Never Treated|6|||
130027684|NCT04426695|468060772|FG009|Overall Study|Randomized but Never Treated|3|||
130239683|NCT00831844|468838736|FG005|Overall Study|Ineligible|0|||
130239684|NCT00831844|468838737|FG006|Overall Study|Ineligible|0|||
130239685|NCT00831844|468838738|FG007|Overall Study|Ineligible|0|||
130239686|NCT00831844|468838739|FG008|Overall Study|Ineligible|0|||
130239687|NCT00831844|468838740|FG009|Overall Study|Ineligible|0|||
130239688|NCT04738487|468838743|FG000|Overall Study|Participant Ongoing in Study|298|||
130239689|NCT04738487|468838744|FG001|Overall Study|Participant Ongoing in Study|297|||
130239690|NCT04738487|468838743|FG000|Overall Study|Withdrawal by Subject|7|||
130239691|NCT04738487|468838744|FG001|Overall Study|Withdrawal by Subject|9|||
130239692|NCT04738487|468838743|FG000|Overall Study|Lost to Follow-up|2|||
130239693|NCT04738487|468838744|FG001|Overall Study|Lost to Follow-up|0|||
130027685|NCT04426695|468060773|FG010|Overall Study|Randomized but Never Treated|3|||
130027686|NCT04426695|468060774|FG011|Overall Study|Randomized but Never Treated|6|||
130027687|NCT04426695|468060775|FG012|Overall Study|Randomized but Never Treated|1|||
130239694|NCT04738487|468838743|FG000|Overall Study|Death|287|||
130239695|NCT04738487|468838744|FG001|Overall Study|Death|306|||
130239696|NCT05350202|468838745|FG000|Visit 1 - Baseline|Not-treated|18|||
130239697|NCT05350202|468838746|FG001|Visit 1 - Baseline|Not-treated|0|||
130027688|NCT04426695|468060776|FG013|Overall Study|Randomized but Never Treated|2|||
130239698|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
130239699|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
130239700|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
130239701|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
130239702|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
130239703|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
130239704|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
130239705|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
130239706|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
130239707|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
130239708|NCT05350202|468838745|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
130239709|NCT05350202|468838746|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
130239710|NCT04635423|468838747|FG000|Overall Study|Ongoing|493|||
130239711|NCT04635423|468838748|FG001|Overall Study|Ongoing|501|||
130239712|NCT04635423|468838747|FG000|Overall Study|Withdrawal by Subject|36|||
130239713|NCT04635423|468838748|FG001|Overall Study|Withdrawal by Subject|29|||
130239714|NCT05119569|468838763|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
130239715|NCT05119569|468838764|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
130239716|NCT05119569|468838765|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130239717|NCT05119569|468838766|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130239718|NCT05119569|468838763|FG000|Double Blind Treatment Phase|Adverse Event|6|||
130239719|NCT05119569|468838764|FG001|Double Blind Treatment Phase|Adverse Event|0|||
130239720|NCT05119569|468838765|FG002|Double Blind Treatment Phase|Adverse Event|0|||
130239721|NCT05119569|468838766|FG003|Double Blind Treatment Phase|Adverse Event|0|||
130239722|NCT05119569|468838763|FG000|Open Label Extension Phase|Ongoing in the study|0|||
130239723|NCT05119569|468838764|FG001|Open Label Extension Phase|Ongoing in the study|0|||
130239724|NCT05119569|468838765|FG002|Open Label Extension Phase|Ongoing in the study|65|||
130239725|NCT05119569|468838766|FG003|Open Label Extension Phase|Ongoing in the study|34|||
130239726|NCT03683030|468838767|FG000|Overall Study|Enrolled but screen failures|12|||
130239727|NCT03683030|468838768|FG001|Overall Study|Enrolled but screen failures|7|||
130239728|NCT03683030|468838767|FG000|Overall Study|Enrolled but no catheter inserted|11|||
130239729|NCT03683030|468838768|FG001|Overall Study|Enrolled but no catheter inserted|13|||
130239730|NCT03683030|468838767|FG000|Overall Study|Withdrawal by Subject|0|||
130239731|NCT03683030|468838768|FG001|Overall Study|Withdrawal by Subject|2|||
130239732|NCT03683030|468838767|FG000|Overall Study|Early termination by subject|1|||
130239733|NCT03683030|468838768|FG001|Overall Study|Early termination by subject|0|||
130239734|NCT03683030|468838767|FG000|Overall Study|Lost to Follow-up|0|||
130239735|NCT03683030|468838768|FG001|Overall Study|Lost to Follow-up|6|||
130239736|NCT03683030|468838767|FG000|Overall Study|Death|0|||
130239737|NCT03683030|468838768|FG001|Overall Study|Death|2|||
130239738|NCT03683030|468838767|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
130239739|NCT03683030|468838768|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
130239740|NCT03488524|468838769|FG000|Overall Study|Withdrawal by Subject|51|||
130239741|NCT03488524|468838769|FG000|Overall Study|Death|19|||
130239742|NCT03488524|468838769|FG000|Overall Study|Study Sponsor|11|||
130239743|NCT03488524|468838769|FG000|Overall Study|Physician Decision|4|||
130239744|NCT03488524|468838769|FG000|Overall Study|Lost to Follow-up|3|||
130239745|NCT02390284|468838770|FG000|Overall Study|Physician Decision|0|||
130239746|NCT02390284|468838771|FG001|Overall Study|Physician Decision|0|||
130239747|NCT02390284|468838772|FG002|Overall Study|Physician Decision|9|||
130239748|NCT03980223|468838773|FG000|Overall Study|Lost to Follow-up|3|||
130239749|NCT03980223|468838774|FG001|Overall Study|Lost to Follow-up|7|||
130239750|NCT03980223|468838775|FG002|Overall Study|Lost to Follow-up|10|||
130239751|NCT03980223|468838776|FG003|Overall Study|Lost to Follow-up|8|||
130239752|NCT03980223|468838773|FG000|Overall Study|Withdrawal by Subject|0|||
130239753|NCT03980223|468838774|FG001|Overall Study|Withdrawal by Subject|0|||
130239754|NCT03980223|468838775|FG002|Overall Study|Withdrawal by Subject|1|||
130239755|NCT03980223|468838776|FG003|Overall Study|Withdrawal by Subject|2|||
130239756|NCT03980223|468838773|FG000|Overall Study|Physician Decision|0|||
130239757|NCT03980223|468838774|FG001|Overall Study|Physician Decision|0|||
130239758|NCT03980223|468838775|FG002|Overall Study|Physician Decision|1|||
130239759|NCT03980223|468838776|FG003|Overall Study|Physician Decision|0|||
130239760|NCT03980223|468838773|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
130239761|NCT03980223|468838774|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
130239762|NCT03980223|468838775|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
130239763|NCT03980223|468838776|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
130239764|NCT06239610|468838777|FG000|Overall Study|no usable migration data for minimum of one day|11|||
130239765|NCT01922934|468838781|FG000|Eligible Patients|Death|0|||
130239766|NCT01922934|468838782|FG001|Eligible Patients|Death|7|||
130239767|NCT01922934|468838781|FG000|Eligible Patients|Physician Decision|17|||
130239768|NCT01922934|468838782|FG001|Eligible Patients|Physician Decision|0|||
130239769|NCT01922934|468838781|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
130239770|NCT01922934|468838782|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
130239771|NCT01922934|468838781|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
130239772|NCT01922934|468838782|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
130239773|NCT01922934|468838781|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
130239774|NCT01922934|468838782|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
130239775|NCT01922934|468838781|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
130239776|NCT01922934|468838782|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
130239777|NCT05166876|468838785|FG000|Overall Study|Withdrawal by Subject|1|||
130239778|NCT05166876|468838786|FG001|Overall Study|Withdrawal by Subject|0|||
130239779|NCT05166876|468838787|FG002|Overall Study|Withdrawal by Subject|0|||
130239780|NCT00658528|468838788|FG000|Overall Study|Adverse Event|5|||
130239781|NCT00658528|468838789|FG001|Overall Study|Adverse Event|7|||
130239782|NCT00658528|468838788|FG000|Overall Study|Lost to Follow-up|14|||
130239783|NCT00658528|468838789|FG001|Overall Study|Lost to Follow-up|22|||
130239784|NCT00658528|468838788|FG000|Overall Study|Withdrawal by Subject|8|||
130239785|NCT00658528|468838789|FG001|Overall Study|Withdrawal by Subject|6|||
130239786|NCT00658528|468838788|FG000|Overall Study|Withdrawal of consent|5|||
130239787|NCT00658528|468838789|FG001|Overall Study|Withdrawal of consent|6|||
130239788|NCT00658528|468838788|FG000|Overall Study|Other|8|||
130239789|NCT00658528|468838789|FG001|Overall Study|Other|4|||
130239790|NCT01937299|468838790|FG000|Overall Study|Adverse Event|13|||
130239791|NCT01937299|468838791|FG001|Overall Study|Adverse Event|0|||
130239792|NCT01937299|468838790|FG000|Overall Study|Lack of Efficacy|0|||
130239793|NCT01937299|468838791|FG001|Overall Study|Lack of Efficacy|4|||
130239794|NCT01937299|468838790|FG000|Overall Study|Withdrawal by Subject|1|||
130027689|NCT04426695|468060777|FG014|Overall Study|Randomized but Never Treated|0|||
130239795|NCT01937299|468838791|FG001|Overall Study|Withdrawal by Subject|0|||
130239796|NCT00385840|468838792|FG000|Overall Study|Adverse Event|1|||
130239797|NCT00385840|468838793|FG001|Overall Study|Adverse Event|1|||
130239798|NCT00385840|468838792|FG000|Overall Study|Lost to Follow-up|3|||
130239799|NCT00385840|468838793|FG001|Overall Study|Lost to Follow-up|13|||
130239800|NCT01706328|468838801|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
130239801|NCT01706328|468838802|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130239802|NCT01706328|468838803|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130239803|NCT01706328|468838801|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
130239804|NCT01706328|468838802|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130239805|NCT01706328|468838803|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130239806|NCT01706328|468838801|FG000|2-week Run-in Period|Physician Decision|4|||
130239807|NCT01706328|468838802|FG001|2-week Run-in Period|Physician Decision|0|||
130027690|NCT04426695|468060778|FG015|Overall Study|Randomized but Never Treated|0|||
130027691|NCT04426695|468060779|FG016|Overall Study|Randomized but Never Treated|0|||
130027692|NCT04426695|468060780|FG017|Overall Study|Randomized but Never Treated|0|||
130027693|NCT04303000|468060781|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
130027694|NCT04303000|468060782|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
130239808|NCT01706328|468838803|FG002|2-week Run-in Period|Physician Decision|0|||
130027695|NCT04303000|468060783|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
130239809|NCT01706328|468838801|FG000|2-week Run-in Period|Adverse Event|4|||
130239810|NCT01706328|468838802|FG001|2-week Run-in Period|Adverse Event|0|||
130239811|NCT01706328|468838803|FG002|2-week Run-in Period|Adverse Event|0|||
130239812|NCT01706328|468838801|FG000|2-week Run-in Period|Lost to Follow-up|2|||
130239813|NCT01706328|468838802|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130239814|NCT01706328|468838803|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130239815|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
130239816|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
130239817|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
130239818|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
130239819|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
130239820|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
130239821|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
130239822|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
130239823|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
130239824|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
130239825|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
130239826|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
130239827|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
130239828|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
130239829|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
130239830|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
130239831|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
130239832|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
130239833|NCT01706328|468838801|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130239834|NCT01706328|468838802|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
130239835|NCT01706328|468838803|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
130239836|NCT03018938|468838806|FG000|Overall Study|Death|0|||
130239837|NCT03018938|468838807|FG001|Overall Study|Death|1|||
130239838|NCT03018938|468838806|FG000|Overall Study|Lost to Follow-up|21|||
130239839|NCT03018938|468838807|FG001|Overall Study|Lost to Follow-up|32|||
130239840|NCT03018938|468838806|FG000|Overall Study|Withdrawal by Subject|38|||
130239841|NCT03018938|468838807|FG001|Overall Study|Withdrawal by Subject|45|||
130239842|NCT03018938|468838806|FG000|Overall Study|Physician Decision|3|||
130239843|NCT03018938|468838807|FG001|Overall Study|Physician Decision|2|||
130239844|NCT03018938|468838806|FG000|Overall Study|Sponsor Decision|0|||
130239845|NCT03018938|468838807|FG001|Overall Study|Sponsor Decision|1|||
130239846|NCT03018938|468838806|FG000|Overall Study|Screen failure-After randomization|4|||
130239847|NCT03018938|468838807|FG001|Overall Study|Screen failure-After randomization|2|||
130239848|NCT03018938|468838806|FG000|Overall Study|Not recorded|0|||
130239849|NCT03018938|468838807|FG001|Overall Study|Not recorded|2|||
130239850|NCT02916771|468838814|FG000|Overall Study|Withdrawal by Subject|9|||
130239851|NCT02916771|468838814|FG000|Overall Study|Physician Decision|1|||
130239852|NCT02916771|468838814|FG000|Overall Study|Began treatment for another active malignancy|1|||
130239853|NCT05759338|468838815|FG000|Overall Study|Withdrawal by Subject|3|||
130239854|NCT02924376|468838816|FG000|Overall Study|Progressive Disease|4|||
130239855|NCT02924376|468838817|FG001|Overall Study|Progressive Disease|0|||
130239856|NCT02924376|468838818|FG002|Overall Study|Progressive Disease|1|||
130239857|NCT02924376|468838819|FG003|Overall Study|Progressive Disease|0|||
130239858|NCT02924376|468838816|FG000|Overall Study|Death|73|||
130239859|NCT02924376|468838817|FG001|Overall Study|Death|18|||
130239860|NCT02924376|468838818|FG002|Overall Study|Death|15|||
130239861|NCT02924376|468838819|FG003|Overall Study|Death|2|||
130239862|NCT02924376|468838816|FG000|Overall Study|Lost to Follow-up|3|||
130239863|NCT02924376|468838817|FG001|Overall Study|Lost to Follow-up|0|||
130239864|NCT02924376|468838818|FG002|Overall Study|Lost to Follow-up|0|||
130239865|NCT02924376|468838819|FG003|Overall Study|Lost to Follow-up|0|||
130239866|NCT02924376|468838816|FG000|Overall Study|Study Terminated by Sponsor|19|||
130239867|NCT02924376|468838817|FG001|Overall Study|Study Terminated by Sponsor|0|||
130239868|NCT02924376|468838818|FG002|Overall Study|Study Terminated by Sponsor|0|||
130239869|NCT02924376|468838819|FG003|Overall Study|Study Terminated by Sponsor|0|||
130239870|NCT02924376|468838816|FG000|Overall Study|Physician Decision|1|||
130239871|NCT02924376|468838817|FG001|Overall Study|Physician Decision|0|||
130239872|NCT02924376|468838818|FG002|Overall Study|Physician Decision|0|||
130239873|NCT02924376|468838819|FG003|Overall Study|Physician Decision|0|||
130239874|NCT02924376|468838816|FG000|Overall Study|Withdrawal by Subject|7|||
130239875|NCT02924376|468838817|FG001|Overall Study|Withdrawal by Subject|2|||
129884563|NCT02696902|467536455|FG002|Overall Study|Death|24|||
130027696|NCT01552681|468060784|FG000|Overall Study|Withdrawal by Subject|4|||
130027697|NCT01552681|468060785|FG001|Overall Study|Withdrawal by Subject|0|||
130027698|NCT01552681|468060784|FG000|Overall Study|Physician Decision|1|||
130027699|NCT01552681|468060785|FG001|Overall Study|Physician Decision|0|||
130239876|NCT02924376|468838818|FG002|Overall Study|Withdrawal by Subject|1|||
130239877|NCT02924376|468838819|FG003|Overall Study|Withdrawal by Subject|0|||
130239878|NCT02924376|468838816|FG000|Overall Study|Rolled Over to Another Study|1|||
130239879|NCT02924376|468838817|FG001|Overall Study|Rolled Over to Another Study|0|||
130239880|NCT02924376|468838818|FG002|Overall Study|Rolled Over to Another Study|0|||
130239881|NCT02924376|468838819|FG003|Overall Study|Rolled Over to Another Study|0|||
130239882|NCT06455111|468838821|FG000|Overall Study|Withdrawal by Subject|11|||
130239883|NCT06455111|468838822|FG001|Overall Study|Withdrawal by Subject|4|||
130239884|NCT00005047|468840110|FG000|Overall Study|Withdrawal by Subject|12|||
130239885|NCT00005047|468840111|FG001|Overall Study|Withdrawal by Subject|0|||
130239886|NCT00005047|468840112|FG002|Overall Study|Withdrawal by Subject|0|||
130239887|NCT00005047|468840113|FG003|Overall Study|Withdrawal by Subject|0|||
130239888|NCT00005047|468840110|FG000|Overall Study|Adverse Event|5|||
130239889|NCT00005047|468840111|FG001|Overall Study|Adverse Event|0|||
130239890|NCT00005047|468840112|FG002|Overall Study|Adverse Event|0|||
130239891|NCT00005047|468840113|FG003|Overall Study|Adverse Event|0|||
130239892|NCT00005047|468840110|FG000|Overall Study|Lost to Follow-up|1|||
130239893|NCT00005047|468840111|FG001|Overall Study|Lost to Follow-up|0|||
130239894|NCT00005047|468840112|FG002|Overall Study|Lost to Follow-up|0|||
130239895|NCT00005047|468840113|FG003|Overall Study|Lost to Follow-up|0|||
130239896|NCT00005047|468840110|FG000|Overall Study|Lack of Efficacy|1|||
130239897|NCT00005047|468840111|FG001|Overall Study|Lack of Efficacy|0|||
130239898|NCT00005047|468840112|FG002|Overall Study|Lack of Efficacy|0|||
130239899|NCT00005047|468840113|FG003|Overall Study|Lack of Efficacy|0|||
130239900|NCT00098475|468840121|FG000|Step 1|Progressive disease|33|||
130239901|NCT00098475|468840122|FG001|Step 1|Progressive disease|35|||
130239902|NCT00098475|468840123|FG002|Step 1|Progressive disease|2|||
130027700|NCT01552681|468060784|FG000|Overall Study|Subject moved away|0|||
130239903|NCT00098475|468840124|FG003|Step 1|Progressive disease|1|||
130239904|NCT00098475|468840121|FG000|Step 1|Adverse Event|56|||
130239905|NCT00098475|468840122|FG001|Step 1|Adverse Event|37|||
130239906|NCT00098475|468840123|FG002|Step 1|Adverse Event|0|||
130239907|NCT00098475|468840124|FG003|Step 1|Adverse Event|1|||
130239908|NCT00098475|468840121|FG000|Step 1|Death|8|||
130239909|NCT00098475|468840122|FG001|Step 1|Death|5|||
130239910|NCT00098475|468840123|FG002|Step 1|Death|0|||
130239911|NCT00098475|468840124|FG003|Step 1|Death|1|||
130239912|NCT00098475|468840121|FG000|Step 1|Withdrawal by Subject|14|||
130239913|NCT00098475|468840122|FG001|Step 1|Withdrawal by Subject|11|||
130239914|NCT00098475|468840123|FG002|Step 1|Withdrawal by Subject|0|||
130239915|NCT00098475|468840124|FG003|Step 1|Withdrawal by Subject|0|||
130239916|NCT00098475|468840121|FG000|Step 1|Physician Decision|5|||
130239917|NCT00098475|468840122|FG001|Step 1|Physician Decision|2|||
130239918|NCT00098475|468840123|FG002|Step 1|Physician Decision|0|||
130239919|NCT00098475|468840124|FG003|Step 1|Physician Decision|0|||
130239920|NCT00098475|468840121|FG000|Step 1|Alternative therapy|31|||
130239921|NCT00098475|468840122|FG001|Step 1|Alternative therapy|43|||
130239922|NCT00098475|468840123|FG002|Step 1|Alternative therapy|1|||
130239923|NCT00098475|468840124|FG003|Step 1|Alternative therapy|0|||
130239924|NCT00098475|468840121|FG000|Step 1|Other disease|2|||
130239925|NCT00098475|468840122|FG001|Step 1|Other disease|1|||
130239926|NCT00098475|468840123|FG002|Step 1|Other disease|1|||
130239927|NCT00098475|468840124|FG003|Step 1|Other disease|0|||
130239928|NCT00098475|468840121|FG000|Step 1|Never started treatment|0|||
130239929|NCT00098475|468840122|FG001|Step 1|Never started treatment|2|||
130239930|NCT00098475|468840123|FG002|Step 1|Never started treatment|0|||
130239931|NCT00098475|468840124|FG003|Step 1|Never started treatment|0|||
130239932|NCT00098475|468840121|FG000|Step 1|Still on treatment as of this analysis|14|||
130239933|NCT00098475|468840122|FG001|Step 1|Still on treatment as of this analysis|27|||
130239934|NCT00098475|468840123|FG002|Step 1|Still on treatment as of this analysis|0|||
130239935|NCT00098475|468840124|FG003|Step 1|Still on treatment as of this analysis|0|||
130239936|NCT00098475|468840121|FG000|Step 1|Knee surgery|1|||
130239937|NCT00098475|468840122|FG001|Step 1|Knee surgery|0|||
130239938|NCT00098475|468840123|FG002|Step 1|Knee surgery|0|||
130239939|NCT00098475|468840124|FG003|Step 1|Knee surgery|0|||
130239940|NCT00098475|468840121|FG000|Step 1|Complications|1|||
130239941|NCT00098475|468840122|FG001|Step 1|Complications|0|||
130239942|NCT00098475|468840123|FG002|Step 1|Complications|0|||
130239943|NCT00098475|468840124|FG003|Step 1|Complications|0|||
130239944|NCT00098475|468840121|FG000|Step 1|Cannot comply due to other tx|0|||
130239945|NCT00098475|468840122|FG001|Step 1|Cannot comply due to other tx|1|||
130239946|NCT00098475|468840123|FG002|Step 1|Cannot comply due to other tx|0|||
130239947|NCT00098475|468840124|FG003|Step 1|Cannot comply due to other tx|0|||
130239948|NCT00098475|468840121|FG000|Step 1|Both patient and physician's decision|2|||
130239949|NCT00098475|468840122|FG001|Step 1|Both patient and physician's decision|1|||
130239950|NCT00098475|468840123|FG002|Step 1|Both patient and physician's decision|0|||
130239951|NCT00098475|468840124|FG003|Step 1|Both patient and physician's decision|0|||
130239952|NCT00098475|468840121|FG000|Step 1|Incorrect disease assessment|2|||
130239953|NCT00098475|468840122|FG001|Step 1|Incorrect disease assessment|0|||
130239954|NCT00098475|468840123|FG002|Step 1|Incorrect disease assessment|0|||
130239955|NCT00098475|468840124|FG003|Step 1|Incorrect disease assessment|0|||
130239956|NCT00098475|468840121|FG000|Step 1|Off treatment for > specified timeframe|1|||
130239957|NCT00098475|468840122|FG001|Step 1|Off treatment for > specified timeframe|1|||
130239958|NCT00098475|468840123|FG002|Step 1|Off treatment for > specified timeframe|0|||
130239959|NCT00098475|468840124|FG003|Step 1|Off treatment for > specified timeframe|0|||
130239960|NCT00098475|468840121|FG000|Step 1|Declining performance status|0|||
130239961|NCT00098475|468840122|FG001|Step 1|Declining performance status|1|||
130239962|NCT00098475|468840123|FG002|Step 1|Declining performance status|0|||
130239963|NCT00098475|468840124|FG003|Step 1|Declining performance status|0|||
130239964|NCT00098475|468840121|FG000|Step 1|Insurance issue|0|||
130239965|NCT00098475|468840122|FG001|Step 1|Insurance issue|1|||
130239966|NCT00098475|468840123|FG002|Step 1|Insurance issue|0|||
130239967|NCT00098475|468840124|FG003|Step 1|Insurance issue|0|||
130239968|NCT00098475|468840121|FG000|Step 1|Rising paraprotein|0|||
130239969|NCT00098475|468840122|FG001|Step 1|Rising paraprotein|1|||
130239970|NCT00098475|468840123|FG002|Step 1|Rising paraprotein|0|||
130239971|NCT00098475|468840124|FG003|Step 1|Rising paraprotein|0|||
130239972|NCT00098475|468840121|FG000|Step 1|Referred to other physicians|0|||
130239973|NCT00098475|468840122|FG001|Step 1|Referred to other physicians|1|||
130239974|NCT00098475|468840123|FG002|Step 1|Referred to other physicians|0|||
130239975|NCT00098475|468840124|FG003|Step 1|Referred to other physicians|0|||
130239976|NCT00098475|468840121|FG000|Step 1|Criteria to continue treatment not met|0|||
130239977|NCT00098475|468840122|FG001|Step 1|Criteria to continue treatment not met|1|||
130239978|NCT00098475|468840123|FG002|Step 1|Criteria to continue treatment not met|0|||
130239979|NCT00098475|468840124|FG003|Step 1|Criteria to continue treatment not met|0|||
130239980|NCT00098475|468840121|FG000|Step 1|Misinterpretation of lab data|0|||
130239981|NCT00098475|468840122|FG001|Step 1|Misinterpretation of lab data|1|||
130239982|NCT00098475|468840123|FG002|Step 1|Misinterpretation of lab data|0|||
130239983|NCT00098475|468840124|FG003|Step 1|Misinterpretation of lab data|0|||
130239984|NCT00098475|468840121|FG000|Step 1|Patient fell with fracture|1|||
130239985|NCT00098475|468840122|FG001|Step 1|Patient fell with fracture|0|||
130239986|NCT00098475|468840123|FG002|Step 1|Patient fell with fracture|0|||
130239987|NCT00098475|468840124|FG003|Step 1|Patient fell with fracture|0|||
130239988|NCT00098475|468840121|FG000|Step 1|Not documented|0|||
130239989|NCT00098475|468840122|FG001|Step 1|Not documented|1|||
130239990|NCT00098475|468840123|FG002|Step 1|Not documented|0|||
130239991|NCT00098475|468840124|FG003|Step 1|Not documented|0|||
130239992|NCT00098475|468840121|FG000|Step 2|Disease progression|1|||
130239993|NCT00098475|468840122|FG001|Step 2|Disease progression|4|||
130239994|NCT00098475|468840123|FG002|Step 2|Disease progression|0|||
130239995|NCT00098475|468840124|FG003|Step 2|Disease progression|0|||
130239996|NCT00098475|468840121|FG000|Step 2|Adverse Event|2|||
130239997|NCT00098475|468840122|FG001|Step 2|Adverse Event|0|||
130239998|NCT00098475|468840123|FG002|Step 2|Adverse Event|0|||
130239999|NCT00098475|468840124|FG003|Step 2|Adverse Event|0|||
130240000|NCT00098475|468840121|FG000|Step 2|Withdrawal by Subject|0|||
130240001|NCT00098475|468840122|FG001|Step 2|Withdrawal by Subject|2|||
130240002|NCT00098475|468840123|FG002|Step 2|Withdrawal by Subject|0|||
130240003|NCT00098475|468840124|FG003|Step 2|Withdrawal by Subject|0|||
130240004|NCT00098475|468840121|FG000|Step 2|Physician Decision|0|||
130240005|NCT00098475|468840122|FG001|Step 2|Physician Decision|1|||
130240006|NCT00098475|468840123|FG002|Step 2|Physician Decision|0|||
130240007|NCT00098475|468840124|FG003|Step 2|Physician Decision|0|||
130240008|NCT00098475|468840121|FG000|Step 2|Alternative therapy|1|||
130240009|NCT00098475|468840122|FG001|Step 2|Alternative therapy|2|||
130240010|NCT00098475|468840123|FG002|Step 2|Alternative therapy|0|||
130240011|NCT00098475|468840124|FG003|Step 2|Alternative therapy|0|||
130240012|NCT00098475|468840121|FG000|Step 2|Never started treatment|1|||
130240013|NCT00098475|468840122|FG001|Step 2|Never started treatment|1|||
130240014|NCT00098475|468840123|FG002|Step 2|Never started treatment|0|||
130240015|NCT00098475|468840124|FG003|Step 2|Never started treatment|0|||
130240016|NCT04132050|468840125|FG000|Period I (Double-blind Period)|Adverse Event|3|||
130240017|NCT04132050|468840126|FG001|Period I (Double-blind Period)|Adverse Event|0|||
130240018|NCT04132050|468840125|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
130240019|NCT04132050|468840126|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
130240020|NCT04132050|468840125|FG000|R788 Treatment Period|Adverse Event|5|||
130240021|NCT04132050|468840126|FG001|R788 Treatment Period|Adverse Event|0|||
130240022|NCT04132050|468840125|FG000|R788 Treatment Period|Lack of Efficacy|5|||
130240023|NCT04132050|468840126|FG001|R788 Treatment Period|Lack of Efficacy|0|||
130240024|NCT04132050|468840125|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
130240025|NCT04132050|468840126|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
130240026|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
130240027|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
130240028|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
130240029|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
130240030|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
130240031|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
130240032|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
130240033|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
130240034|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
130240035|NCT00433537|468840127|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
130240036|NCT00433537|468840128|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
130240037|NCT00433537|468840129|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
130240038|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
130240039|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
130240040|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
130240041|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
130240042|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
130240043|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
130240044|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
130240045|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
130240046|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
130240047|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
130240048|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
130240049|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
130027701|NCT01552681|468060785|FG001|Overall Study|Subject moved away|1|||
130240050|NCT00433537|468840127|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
130240051|NCT00433537|468840128|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
130240052|NCT00433537|468840129|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
130240053|NCT00843882|468840130|FG000|Step 1|Lack of Efficacy|14|||
130240054|NCT00843882|468840131|FG001|Step 1|Lack of Efficacy|10|||
130240055|NCT00843882|468840132|FG002|Step 1|Lack of Efficacy|21|||
130240056|NCT00843882|468840130|FG000|Step 1|Adverse Event|8|||
130240057|NCT00843882|468840131|FG001|Step 1|Adverse Event|17|||
130240058|NCT00843882|468840132|FG002|Step 1|Adverse Event|20|||
130240059|NCT00843882|468840130|FG000|Step 1|Death|1|||
130240060|NCT00843882|468840131|FG001|Step 1|Death|2|||
130240061|NCT00843882|468840132|FG002|Step 1|Death|4|||
130240062|NCT00843882|468840130|FG000|Step 1|Withdrawal by Subject|6|||
130240063|NCT00843882|468840131|FG001|Step 1|Withdrawal by Subject|12|||
130240064|NCT00843882|468840132|FG002|Step 1|Withdrawal by Subject|9|||
130240065|NCT00843882|468840130|FG000|Step 1|Physician Decision|0|||
130240066|NCT00843882|468840131|FG001|Step 1|Physician Decision|5|||
130240067|NCT00843882|468840132|FG002|Step 1|Physician Decision|1|||
130027702|NCT01987908|468060786|FG000|Placebo Lead-in Period|Adverse Event|2|||
130027703|NCT01987908|468060787|FG001|Placebo Lead-in Period|Adverse Event|0|||
130240068|NCT00843882|468840130|FG000|Step 1|Patient and physician's decision|0|||
130240069|NCT00843882|468840131|FG001|Step 1|Patient and physician's decision|0|||
130240070|NCT00843882|468840132|FG002|Step 1|Patient and physician's decision|1|||
130240071|NCT00843882|468840130|FG000|Step 1|Other complicating disease|1|||
130240072|NCT00843882|468840131|FG001|Step 1|Other complicating disease|3|||
130240073|NCT00843882|468840132|FG002|Step 1|Other complicating disease|4|||
130240074|NCT00843882|468840130|FG000|Step 1|Alternative therapy|0|||
130240075|NCT00843882|468840131|FG001|Step 1|Alternative therapy|1|||
130240076|NCT00843882|468840132|FG002|Step 1|Alternative therapy|1|||
130240077|NCT00843882|468840130|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
130240078|NCT00843882|468840131|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
130240079|NCT00843882|468840132|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
130240080|NCT00843882|468840130|FG000|Step 1|Off treatment reason unknown|0|||
130240081|NCT00843882|468840131|FG001|Step 1|Off treatment reason unknown|1|||
130240082|NCT00843882|468840132|FG002|Step 1|Off treatment reason unknown|4|||
130240083|NCT00843882|468840130|FG000|Step 1|Never started treatment|2|||
130240084|NCT00843882|468840131|FG001|Step 1|Never started treatment|0|||
130240085|NCT00843882|468840132|FG002|Step 1|Never started treatment|0|||
130240086|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
130240087|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
130240088|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
130240089|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
130240090|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
130240091|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
130240092|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
130240093|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
130240094|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
130240095|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
130240096|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
130240097|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
130240098|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
130240099|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
130240100|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
130240101|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
130240102|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
130240103|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
130240104|NCT00843882|468840130|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
130240105|NCT00843882|468840131|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
130240106|NCT00843882|468840132|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
130240107|NCT05317546|468840133|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
130240108|NCT05317546|468840134|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
130240109|NCT03331250|468840135|FG000|Overall Study|Withdrawal by Subject|1|||
130240110|NCT04590963|468840136|FG000|Overall Study|Death|118|||
130240111|NCT04590963|468840137|FG001|Overall Study|Death|59|||
130240112|NCT04590963|468840136|FG000|Overall Study|Lost to Follow-up|1|||
130240113|NCT04590963|468840137|FG001|Overall Study|Lost to Follow-up|1|||
130240114|NCT04590963|468840136|FG000|Overall Study|Progressive disease|0|||
130240115|NCT04590963|468840137|FG001|Overall Study|Progressive disease|1|||
130240116|NCT04590963|468840136|FG000|Overall Study|Study terminated by sponsor|103|||
130240117|NCT04590963|468840137|FG001|Overall Study|Study terminated by sponsor|50|||
130240118|NCT04590963|468840136|FG000|Overall Study|Withdrawal by Subject|15|||
130240119|NCT04590963|468840137|FG001|Overall Study|Withdrawal by Subject|8|||
130240120|NCT04590963|468840136|FG000|Overall Study|Ongoing at data cut-off|9|||
130240121|NCT04590963|468840137|FG001|Overall Study|Ongoing at data cut-off|4|||
130240122|NCT04590963|468840136|FG000|Overall Study|Screen failure|1|||
130240123|NCT04590963|468840137|FG001|Overall Study|Screen failure|0|||
130240124|NCT04057365|468840138|FG000|Overall Study|Withdrawal by Subject|2|||
130240125|NCT04057365|468840139|FG001|Overall Study|Withdrawal by Subject|0|||
130240126|NCT03976375|468840140|FG000|Overall Study|Death|158|||
130240127|NCT03976375|468840141|FG001|Overall Study|Death|160|||
130240128|NCT03976375|468840142|FG002|Overall Study|Death|42|||
130027704|NCT01987908|468060788|FG002|Placebo Lead-in Period|Adverse Event|0|||
130240129|NCT03976375|468840140|FG000|Overall Study|Lost to Follow-up|2|||
130240130|NCT03976375|468840141|FG001|Overall Study|Lost to Follow-up|1|||
130240131|NCT03976375|468840142|FG002|Overall Study|Lost to Follow-up|1|||
130240132|NCT03976375|468840140|FG000|Overall Study|Withdrawal by Subject|5|||
130240133|NCT03976375|468840141|FG001|Overall Study|Withdrawal by Subject|9|||
130240134|NCT03976375|468840142|FG002|Overall Study|Withdrawal by Subject|4|||
130240135|NCT03976375|468840140|FG000|Overall Study|Sponsor decision|20|||
130240136|NCT03976375|468840141|FG001|Overall Study|Sponsor decision|19|||
130240137|NCT03976375|468840142|FG002|Overall Study|Sponsor decision|1|||
130240138|NCT01063114|468840143|FG000|Overall Study|Lost to Follow-up|1|||
130240139|NCT05556057|468840156|FG000|Overall Study|Lost to Follow-up|5|||
130240140|NCT05556057|468840157|FG001|Overall Study|Lost to Follow-up|4|||
130240141|NCT05556057|468840156|FG000|Overall Study|Withdrawal by Subject|0|||
130240142|NCT05556057|468840157|FG001|Overall Study|Withdrawal by Subject|2|||
130240143|NCT02466971|468840161|FG000|Overall Study|eligible and never treated|14|||
130240144|NCT02466971|468840162|FG001|Overall Study|eligible and never treated|20|||
130240145|NCT02466971|468840161|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
130240146|NCT02466971|468840162|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
130240147|NCT02466971|468840161|FG000|Overall Study|ineligible and treated|1|||
130240148|NCT02466971|468840162|FG001|Overall Study|ineligible and treated|0|||
130240149|NCT02466971|468840161|FG000|Overall Study|ineligible and never treated|0|||
130240150|NCT02466971|468840162|FG001|Overall Study|ineligible and never treated|1|||
130240151|NCT04818112|468840167|FG000|Overall Study|Withdrawal by Subject|54|||
130240152|NCT04818112|468840168|FG001|Overall Study|Withdrawal by Subject|12|||
130240153|NCT04818112|468840167|FG000|Overall Study|Lost to Follow-up|38|||
130240154|NCT04818112|468840168|FG001|Overall Study|Lost to Follow-up|10|||
130240155|NCT06187909|468840169|FG000|Overall Study|Withdrawal by Subject|2|||
130240156|NCT06187909|468840170|FG001|Overall Study|Withdrawal by Subject|2|||
130240157|NCT05020743|468840171|FG000|Overall Study|Enrollment in Interventional Study|2|||
130240158|NCT05020743|468840172|FG001|Overall Study|Enrollment in Interventional Study|9|||
130240159|NCT05020743|468840173|FG002|Overall Study|Enrollment in Interventional Study|0|||
130240160|NCT05020743|468840171|FG000|Overall Study|Withdrawal by Subject|0|||
130027705|NCT01987908|468060786|FG000|Placebo Lead-in Period|Physician Decision|2|||
130240161|NCT05020743|468840172|FG001|Overall Study|Withdrawal by Subject|3|||
130240162|NCT05020743|468840173|FG002|Overall Study|Withdrawal by Subject|1|||
130240163|NCT05020743|468840171|FG000|Overall Study|Lost to Follow-up|1|||
130240164|NCT05020743|468840172|FG001|Overall Study|Lost to Follow-up|0|||
130240165|NCT05020743|468840173|FG002|Overall Study|Lost to Follow-up|0|||
130240166|NCT05020743|468840171|FG000|Overall Study|Study Termination by Sponsor|10|||
130240167|NCT05020743|468840172|FG001|Overall Study|Study Termination by Sponsor|11|||
130240168|NCT05020743|468840173|FG002|Overall Study|Study Termination by Sponsor|10|||
130240169|NCT01913353|468840176|FG000|Overall Study|Adverse Event|2|||
130240170|NCT01913353|468840177|FG001|Overall Study|Adverse Event|0|||
130240171|NCT01913353|468840176|FG000|Overall Study|Physician Decision|0|||
130240172|NCT01913353|468840177|FG001|Overall Study|Physician Decision|2|||
130240173|NCT01913353|468840176|FG000|Overall Study|Withdrawal by Subject|20|||
130240174|NCT01913353|468840177|FG001|Overall Study|Withdrawal by Subject|6|||
130240175|NCT01913353|468840176|FG000|Overall Study|multiple reasons|10|||
130240176|NCT01913353|468840177|FG001|Overall Study|multiple reasons|7|||
130240177|NCT04017962|468840178|FG000|Overall Study|Death|2|||
130240178|NCT04017962|468840179|FG001|Overall Study|Death|0|||
130240179|NCT04017962|468840178|FG000|Overall Study|Lost to Follow-up|2|||
130240180|NCT04017962|468840179|FG001|Overall Study|Lost to Follow-up|0|||
130240181|NCT04017962|468840178|FG000|Overall Study|Physician Decision|1|||
130240182|NCT04017962|468840179|FG001|Overall Study|Physician Decision|0|||
130240183|NCT04017962|468840178|FG000|Overall Study|Discontinued LTV|5|||
130240184|NCT04017962|468840179|FG001|Overall Study|Discontinued LTV|0|||
130240185|NCT01260948|468840181|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
130240186|NCT01260948|468840182|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
130240187|NCT01260948|468840181|FG000|Second Intervention|Emesis|0|||
130240188|NCT01260948|468840182|FG001|Second Intervention|Emesis|1|||
130240189|NCT00462462|468840183|FG000|Overall Study|Physician Decision|0|||
130240190|NCT00462462|468840184|FG001|Overall Study|Physician Decision|1|||
130240191|NCT01163617|468840185|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240192|NCT01163617|468840186|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
130240193|NCT01163617|468840187|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240194|NCT01163617|468840188|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240195|NCT01163617|468840189|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240196|NCT01163617|468840190|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130027706|NCT01987908|468060787|FG001|Placebo Lead-in Period|Physician Decision|0|||
130027707|NCT01987908|468060788|FG002|Placebo Lead-in Period|Physician Decision|0|||
130027708|NCT01987908|468060786|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
130027709|NCT01987908|468060787|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
130027710|NCT01987908|468060788|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
130240197|NCT01163617|468840191|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240198|NCT01163617|468840192|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
130240199|NCT01163617|468840185|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240200|NCT01163617|468840186|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
130027711|NCT01987908|468060786|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
130027712|NCT01987908|468060787|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
130027713|NCT01987908|468060788|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
130027714|NCT01987908|468060786|FG000|Treatment Period|Adverse Event|0|||
130027715|NCT01987908|468060787|FG001|Treatment Period|Adverse Event|1|||
130027716|NCT01987908|468060788|FG002|Treatment Period|Adverse Event|1|||
130027717|NCT01987908|468060786|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
130027718|NCT01987908|468060787|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
130027719|NCT01987908|468060788|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
130027720|NCT01987908|468060786|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
130027721|NCT01987908|468060787|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
130027722|NCT01987908|468060788|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
130027723|NCT01262625|468060789|FG000|Overall Study|Administrative Error|1|||
130240201|NCT01163617|468840187|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240202|NCT01163617|468840188|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130027724|NCT01262625|468060790|FG001|Overall Study|Administrative Error|1|||
130027725|NCT01262625|468060789|FG000|Overall Study|Site Closed|1|||
130027726|NCT01262625|468060790|FG001|Overall Study|Site Closed|0|||
130027727|NCT02789657|468060791|FG000|Overall Study|Withdrawal by Subject|2|||
130027728|NCT02789657|468060792|FG001|Overall Study|Withdrawal by Subject|0|||
130027729|NCT02789657|468060793|FG002|Overall Study|Withdrawal by Subject|0|||
130240203|NCT01163617|468840189|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130027730|NCT02789657|468060794|FG003|Overall Study|Withdrawal by Subject|0|||
130027731|NCT00236080|468060795|FG000|Overall Study|Adverse Event|0|||
130027732|NCT00236080|468060796|FG001|Overall Study|Adverse Event|0|||
130240204|NCT01163617|468840190|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130027733|NCT00236080|468060797|FG002|Overall Study|Adverse Event|3|||
130027734|NCT00236080|468060798|FG003|Overall Study|Adverse Event|1|||
130027735|NCT00236080|468060799|FG004|Overall Study|Adverse Event|0|||
130027736|NCT00236080|468060795|FG000|Overall Study|Lost to Follow-up|0|||
130027737|NCT00236080|468060796|FG001|Overall Study|Lost to Follow-up|1|||
130027738|NCT00236080|468060797|FG002|Overall Study|Lost to Follow-up|0|||
130027739|NCT00236080|468060798|FG003|Overall Study|Lost to Follow-up|0|||
130027740|NCT00236080|468060799|FG004|Overall Study|Lost to Follow-up|0|||
130027741|NCT00236080|468060795|FG000|Overall Study|Physician Decision|1|||
130027742|NCT00236080|468060796|FG001|Overall Study|Physician Decision|0|||
130027743|NCT00236080|468060797|FG002|Overall Study|Physician Decision|1|||
130027744|NCT00236080|468060798|FG003|Overall Study|Physician Decision|1|||
130027745|NCT00236080|468060799|FG004|Overall Study|Physician Decision|1|||
130027746|NCT00236080|468060795|FG000|Overall Study|Withdrawal by Subject|1|||
130027747|NCT00236080|468060796|FG001|Overall Study|Withdrawal by Subject|0|||
130027748|NCT00236080|468060797|FG002|Overall Study|Withdrawal by Subject|0|||
130027749|NCT00236080|468060798|FG003|Overall Study|Withdrawal by Subject|0|||
130027750|NCT00236080|468060799|FG004|Overall Study|Withdrawal by Subject|0|||
130027751|NCT00236080|468060795|FG000|Overall Study|Miscellaneous|0|||
130027752|NCT00236080|468060796|FG001|Overall Study|Miscellaneous|0|||
130027753|NCT00236080|468060797|FG002|Overall Study|Miscellaneous|1|||
130027754|NCT00236080|468060798|FG003|Overall Study|Miscellaneous|0|||
130027755|NCT00236080|468060799|FG004|Overall Study|Miscellaneous|0|||
130027756|NCT03882424|468060800|FG000|Overall Study|Lost to Follow-up|3|||
130027757|NCT03882424|468060801|FG001|Overall Study|Lost to Follow-up|0|||
130240205|NCT01163617|468840191|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240206|NCT01163617|468840192|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
130240207|NCT01163617|468840185|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240208|NCT01163617|468840186|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240209|NCT01163617|468840187|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
130240210|NCT01163617|468840188|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240211|NCT01163617|468840189|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240212|NCT01163617|468840190|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240213|NCT01163617|468840191|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240214|NCT01163617|468840192|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
130240215|NCT02394756|468840193|FG000|Period 1|Lens Discomfort|0|||
130240216|NCT02394756|468840194|FG001|Period 1|Lens Discomfort|0|||
130027758|NCT03882424|468060802|FG002|Overall Study|Lost to Follow-up|0|||
130240217|NCT02394756|468840195|FG002|Period 1|Lens Discomfort|0|||
130240218|NCT02394756|468840196|FG003|Period 1|Lens Discomfort|0|||
130240219|NCT02394756|468840197|FG004|Period 1|Lens Discomfort|0|||
130240220|NCT02394756|468840198|FG005|Period 1|Lens Discomfort|1|||
130240221|NCT02394756|468840193|FG000|Period 1|Withdrawal by Subject|0|||
130240222|NCT02394756|468840194|FG001|Period 1|Withdrawal by Subject|1|||
130240223|NCT02394756|468840195|FG002|Period 1|Withdrawal by Subject|1|||
130240224|NCT02394756|468840196|FG003|Period 1|Withdrawal by Subject|1|||
130240225|NCT02394756|468840197|FG004|Period 1|Withdrawal by Subject|0|||
130240226|NCT02394756|468840198|FG005|Period 1|Withdrawal by Subject|0|||
130027759|NCT03882424|468060800|FG000|Overall Study|schedule conflict|1|||
130240227|NCT02394756|468840193|FG000|Period 2|Unsatisfactory Visual Response|0|||
130027760|NCT03882424|468060801|FG001|Overall Study|schedule conflict|0|||
130240228|NCT02394756|468840194|FG001|Period 2|Unsatisfactory Visual Response|0|||
130240229|NCT02394756|468840195|FG002|Period 2|Unsatisfactory Visual Response|0|||
130240230|NCT02394756|468840196|FG003|Period 2|Unsatisfactory Visual Response|0|||
130027761|NCT03882424|468060802|FG002|Overall Study|schedule conflict|0|||
130027762|NCT01214044|468060803|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
130027763|NCT01214044|468060803|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
130027764|NCT01214044|468060803|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
130027765|NCT01214044|468060803|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
130027766|NCT01214044|468060803|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
130027767|NCT01214044|468060803|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
130027768|NCT02772757|468060807|FG000|Overall Study|Withdrawal by Subject|1|||
130027769|NCT02772757|468060808|FG001|Overall Study|Withdrawal by Subject|0|||
130027770|NCT02772757|468060809|FG002|Overall Study|Withdrawal by Subject|1|||
130027771|NCT02772757|468060807|FG000|Overall Study|Protocol Violation|0|||
130027772|NCT02772757|468060808|FG001|Overall Study|Protocol Violation|0|||
130027773|NCT02772757|468060809|FG002|Overall Study|Protocol Violation|1|||
130027774|NCT02772757|468060807|FG000|Overall Study|Physician Decision|0|||
130027775|NCT02772757|468060808|FG001|Overall Study|Physician Decision|3|||
130027776|NCT02772757|468060809|FG002|Overall Study|Physician Decision|3|||
130027777|NCT04698525|468060810|FG000|Overall Study|Lost to Follow-up|1|||
130027778|NCT04698525|468060811|FG001|Overall Study|Lost to Follow-up|2|||
130027779|NCT04698525|468060810|FG000|Overall Study|Three suffered of Covid-19|2|||
130027780|NCT04698525|468060811|FG001|Overall Study|Three suffered of Covid-19|1|||
130027781|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Adverse Event|21|||
130027782|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Adverse Event|6|||
130027783|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
130027784|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
130027785|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
130027786|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
130027787|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
130027788|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
130027789|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Physician Decision|0|||
130027790|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Physician Decision|3|||
130027791|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
130027792|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
130027793|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
130240231|NCT02394756|468840197|FG004|Period 2|Unsatisfactory Visual Response|1|||
130027794|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
130027795|NCT00510276|468060815|FG000|Acute Double-Blind Phase|Subject Decision|26|||
130027796|NCT00510276|468060816|FG001|Acute Double-Blind Phase|Subject Decision|28|||
130027797|NCT00510276|468060815|FG000|Extension Open-Label Phase|Adverse Event|9|||
130027798|NCT00510276|468060816|FG001|Extension Open-Label Phase|Adverse Event|18|||
130027799|NCT00510276|468060815|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
130027800|NCT00510276|468060816|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
130240232|NCT02394756|468840198|FG005|Period 2|Unsatisfactory Visual Response|0|||
130240233|NCT02335944|468840199|FG000|Treatment Phase|Progressive Disease|2|||
130240234|NCT02335944|468840200|FG001|Treatment Phase|Progressive Disease|5|||
130240235|NCT02335944|468840201|FG002|Treatment Phase|Progressive Disease|2|||
130240236|NCT02335944|468840202|FG003|Treatment Phase|Progressive Disease|11|||
129884564|NCT02696902|467536453|FG000|Overall Study|Participant not fit post-randomization|0|||
130027801|NCT00510276|468060815|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
130027802|NCT00510276|468060816|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
129884565|NCT02696902|467536454|FG001|Overall Study|Participant not fit post-randomization|0|||
129884566|NCT02696902|467536455|FG002|Overall Study|Participant not fit post-randomization|1|||
130027803|NCT00510276|468060815|FG000|Extension Open-Label Phase|Physician Decision|2|||
130027804|NCT00510276|468060816|FG001|Extension Open-Label Phase|Physician Decision|3|||
130027805|NCT00510276|468060815|FG000|Extension Open-Label Phase|Protocol Violation|0|||
130027806|NCT00510276|468060816|FG001|Extension Open-Label Phase|Protocol Violation|1|||
130027807|NCT00510276|468060815|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
130027808|NCT00510276|468060816|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
130027809|NCT00510276|468060815|FG000|Extension Open-Label Phase|Subject Decision|7|||
130027810|NCT00510276|468060816|FG001|Extension Open-Label Phase|Subject Decision|9|||
130027811|NCT00441792|468060819|FG000|Overall Study|Lost to Follow-up|0|||
130027812|NCT00441792|468060820|FG001|Overall Study|Lost to Follow-up|2|||
130027813|NCT00130286|468060827|FG000|Overall Study|Withdrawal by Subject|0|||
130027814|NCT00130286|468060828|FG001|Overall Study|Withdrawal by Subject|1|||
130027815|NCT00130286|468060829|FG002|Overall Study|Withdrawal by Subject|2|||
130027816|NCT00130286|468060830|FG003|Overall Study|Withdrawal by Subject|2|||
130027817|NCT00130286|468060827|FG000|Overall Study|Adverse Event|0|||
130027818|NCT00130286|468060828|FG001|Overall Study|Adverse Event|0|||
130027819|NCT00130286|468060829|FG002|Overall Study|Adverse Event|2|||
130027820|NCT00130286|468060830|FG003|Overall Study|Adverse Event|0|||
130027821|NCT00130286|468060827|FG000|Overall Study|Missing lab specimens|0|||
130027822|NCT00130286|468060828|FG001|Overall Study|Missing lab specimens|2|||
130027823|NCT00130286|468060829|FG002|Overall Study|Missing lab specimens|0|||
130027824|NCT00130286|468060830|FG003|Overall Study|Missing lab specimens|0|||
130027825|NCT02154425|468060831|FG000|Screening Period|Adverse Event|1|||
130027826|NCT02908516|468060838|FG000|Overall Study|Study Terminated|3|||
130027827|NCT02908516|468060839|FG001|Overall Study|Study Terminated|3|||
130027828|NCT00565617|468060840|FG000|Overall Study|Withdrawal by Subject|1|||
130027829|NCT01133171|468060841|FG000|Overall Study|Withdrawal by Subject|1|||
130027830|NCT01133171|468060842|FG001|Overall Study|Withdrawal by Subject|2|||
130027831|NCT01133171|468060843|FG002|Overall Study|Withdrawal by Subject|0|||
130027832|NCT02526550|468060844|FG000|Overall Study|Lost to Follow-up|1|||
130027833|NCT03969888|468060845|FG000|Overall Study|Never Received Study Drug|0|||
130027834|NCT03969888|468060846|FG001|Overall Study|Never Received Study Drug|0|||
130027835|NCT03969888|468060847|FG002|Overall Study|Never Received Study Drug|1|||
130027836|NCT03969888|468060848|FG003|Overall Study|Never Received Study Drug|0|||
130027837|NCT03969888|468060849|FG004|Overall Study|Never Received Study Drug|0|||
130027838|NCT03969888|468060850|FG005|Overall Study|Never Received Study Drug|0|||
130027839|NCT03969888|468060851|FG006|Overall Study|Never Received Study Drug|1|||
130027840|NCT03969888|468060852|FG007|Overall Study|Never Received Study Drug|0|||
130027841|NCT03969888|468060845|FG000|Overall Study|Reason Not Specified|0|||
130027842|NCT03969888|468060846|FG001|Overall Study|Reason Not Specified|0|||
130027843|NCT03969888|468060847|FG002|Overall Study|Reason Not Specified|0|||
130027844|NCT03969888|468060848|FG003|Overall Study|Reason Not Specified|0|||
130027845|NCT03969888|468060849|FG004|Overall Study|Reason Not Specified|0|||
130027846|NCT03969888|468060850|FG005|Overall Study|Reason Not Specified|0|||
130027847|NCT03969888|468060851|FG006|Overall Study|Reason Not Specified|0|||
130027848|NCT03969888|468060852|FG007|Overall Study|Reason Not Specified|1|||
130027849|NCT01446419|468060858|FG000|Overall Study|Death|1|||
130027850|NCT01446419|468060859|FG001|Overall Study|Death|0|||
130027851|NCT01446419|468060858|FG000|Overall Study|Withdrawal by Subject|1|||
130027852|NCT01446419|468060859|FG001|Overall Study|Withdrawal by Subject|1|||
130027853|NCT01446419|468060858|FG000|Overall Study|Terminated per protocol|3|||
130027854|NCT01446419|468060859|FG001|Overall Study|Terminated per protocol|0|||
130027855|NCT02867761|468060860|FG000|Overall Study|Participant withdrawn by investigator|0|||
130027856|NCT02867761|468060861|FG001|Overall Study|Participant withdrawn by investigator|1|||
130027857|NCT02867761|468060860|FG000|Overall Study|Lost to Follow-up|25|||
130027858|NCT02867761|468060861|FG001|Overall Study|Lost to Follow-up|18|||
130027859|NCT02867761|468060860|FG000|Overall Study|Unable to complete protocol|3|||
130027860|NCT02867761|468060861|FG001|Overall Study|Unable to complete protocol|7|||
130027861|NCT01078805|468060863|FG000|Overall Study|Clinically significant abnormal lab|5|||
130027862|NCT01078805|468060863|FG000|Overall Study|Death|134|||
130027863|NCT01078805|468060863|FG000|Overall Study|Lost to Follow-up|676|||
130027864|NCT01078805|468060863|FG000|Overall Study|Physician Decision|169|||
130027865|NCT01078805|468060863|FG000|Overall Study|Serious adverse event|26|||
130027866|NCT01078805|468060863|FG000|Overall Study|Sponsor decision|46|||
130027867|NCT01078805|468060863|FG000|Overall Study|Withdrawal by Subject|739|||
130027868|NCT01078805|468060863|FG000|Overall Study|Other|173|||
129884567|NCT02696902|467536453|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
129884568|NCT02696902|467536454|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
129884569|NCT02696902|467536455|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
129884570|NCT02696902|467536453|FG000|Overall Study|Principal investigator's decision|1|||
129884571|NCT02696902|467536454|FG001|Overall Study|Principal investigator's decision|0|||
129884572|NCT02696902|467536455|FG002|Overall Study|Principal investigator's decision|0|||
129884573|NCT02696902|467536453|FG000|Overall Study|Sponsor's decision|1|||
129884574|NCT02696902|467536454|FG001|Overall Study|Sponsor's decision|0|||
129884575|NCT02696902|467536455|FG002|Overall Study|Sponsor's decision|0|||
129884576|NCT02696902|467536453|FG000|Overall Study|Transferred to other hospital|1|||
129884577|NCT02696902|467536454|FG001|Overall Study|Transferred to other hospital|0|||
129884578|NCT02696902|467536455|FG002|Overall Study|Transferred to other hospital|0|||
129884579|NCT03918239|467538559|FG000|Overall Study|Lost to Follow-up|3|||
129884580|NCT03918239|467538560|FG001|Overall Study|Lost to Follow-up|1|||
129884581|NCT03918239|467538559|FG000|Overall Study|Pregnancy|0|||
129884582|NCT03918239|467538560|FG001|Overall Study|Pregnancy|2|||
129884583|NCT03918239|467538559|FG000|Overall Study|Withdrawal by Subject|3|||
129884584|NCT03918239|467538560|FG001|Overall Study|Withdrawal by Subject|3|||
129884585|NCT03918239|467538559|FG000|Overall Study|positive urine drug screening results|4|||
129884586|NCT03918239|467538560|FG001|Overall Study|positive urine drug screening results|1|||
129884587|NCT00593554|467538563|FG000|Overall Study|Death|1|||
129884588|NCT00593554|467538564|FG001|Overall Study|Death|2|||
129884589|NCT00593554|467538563|FG000|Overall Study|Physician Decision|0|||
129884590|NCT00593554|467538564|FG001|Overall Study|Physician Decision|1|||
129884591|NCT00593554|467538563|FG000|Overall Study|Withdrawal by Subject|1|||
129884592|NCT00593554|467538564|FG001|Overall Study|Withdrawal by Subject|0|||
129884593|NCT00593554|467538563|FG000|Overall Study|Disease Progression|1|||
129884594|NCT00593554|467538564|FG001|Overall Study|Disease Progression|2|||
129884595|NCT02086552|467538566|FG000|Overall Study|Withdrawal by Subject|1|||
129884596|NCT02080520|467538572|FG000|Overall Study|Self-reported symptoms|5|||
129884597|NCT02080520|467538573|FG001|Overall Study|Self-reported symptoms|6|||
129884598|NCT02080520|467538572|FG000|Overall Study|Unable to contact|2|||
129884599|NCT02080520|467538573|FG001|Overall Study|Unable to contact|1|||
129884600|NCT02080520|467538572|FG000|Overall Study|Initiated aspirin|2|||
129884601|NCT02080520|467538573|FG001|Overall Study|Initiated aspirin|0|||
129884602|NCT02080520|467538572|FG000|Overall Study|Atrial fibrillation|1|||
129884603|NCT02080520|467538573|FG001|Overall Study|Atrial fibrillation|1|||
130240237|NCT02335944|468840203|FG004|Treatment Phase|Progressive Disease|4|||
130240238|NCT02335944|468840204|FG005|Treatment Phase|Progressive Disease|25|||
130100236|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130240239|NCT02335944|468840205|FG006|Treatment Phase|Progressive Disease|2|||
130240240|NCT02335944|468840206|FG007|Treatment Phase|Progressive Disease|30|||
130240241|NCT02335944|468840207|FG008|Treatment Phase|Progressive Disease|27|||
130240242|NCT02335944|468840208|FG009|Treatment Phase|Progressive Disease|0|||
130240243|NCT02335944|468840199|FG000|Treatment Phase|Adverse Event|2|||
130240244|NCT02335944|468840200|FG001|Treatment Phase|Adverse Event|0|||
130240245|NCT02335944|468840201|FG002|Treatment Phase|Adverse Event|0|||
130240246|NCT02335944|468840202|FG003|Treatment Phase|Adverse Event|2|||
130240247|NCT02335944|468840203|FG004|Treatment Phase|Adverse Event|1|||
130240248|NCT02335944|468840204|FG005|Treatment Phase|Adverse Event|15|||
130240249|NCT02335944|468840205|FG006|Treatment Phase|Adverse Event|0|||
130240250|NCT02335944|468840206|FG007|Treatment Phase|Adverse Event|5|||
130240251|NCT02335944|468840207|FG008|Treatment Phase|Adverse Event|7|||
130240252|NCT02335944|468840208|FG009|Treatment Phase|Adverse Event|0|||
130240253|NCT02335944|468840199|FG000|Treatment Phase|Physician Decision|0|||
130240254|NCT02335944|468840200|FG001|Treatment Phase|Physician Decision|0|||
130240255|NCT02335944|468840201|FG002|Treatment Phase|Physician Decision|0|||
130240256|NCT02335944|468840202|FG003|Treatment Phase|Physician Decision|1|||
130240257|NCT02335944|468840203|FG004|Treatment Phase|Physician Decision|0|||
130240258|NCT02335944|468840204|FG005|Treatment Phase|Physician Decision|6|||
130240259|NCT02335944|468840205|FG006|Treatment Phase|Physician Decision|1|||
130240260|NCT02335944|468840206|FG007|Treatment Phase|Physician Decision|2|||
130240261|NCT02335944|468840207|FG008|Treatment Phase|Physician Decision|1|||
130240262|NCT02335944|468840208|FG009|Treatment Phase|Physician Decision|0|||
130240263|NCT02335944|468840199|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
130240264|NCT02335944|468840200|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
130240265|NCT02335944|468840201|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
130240266|NCT02335944|468840202|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
130240267|NCT02335944|468840203|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
130240268|NCT02335944|468840204|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
130240269|NCT02335944|468840205|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
130240270|NCT02335944|468840206|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
130240271|NCT02335944|468840207|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
130240272|NCT02335944|468840208|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
130240273|NCT02335944|468840199|FG000|Treatment Phase|Subject/Guardian Decision|0|||
130240274|NCT02335944|468840200|FG001|Treatment Phase|Subject/Guardian Decision|0|||
130240275|NCT02335944|468840201|FG002|Treatment Phase|Subject/Guardian Decision|1|||
130240276|NCT02335944|468840202|FG003|Treatment Phase|Subject/Guardian Decision|0|||
130240277|NCT02335944|468840203|FG004|Treatment Phase|Subject/Guardian Decision|0|||
130240278|NCT02335944|468840204|FG005|Treatment Phase|Subject/Guardian Decision|1|||
130240279|NCT02335944|468840205|FG006|Treatment Phase|Subject/Guardian Decision|0|||
130240280|NCT02335944|468840206|FG007|Treatment Phase|Subject/Guardian Decision|4|||
130240281|NCT02335944|468840207|FG008|Treatment Phase|Subject/Guardian Decision|0|||
130240282|NCT02335944|468840208|FG009|Treatment Phase|Subject/Guardian Decision|0|||
130240283|NCT02335944|468840199|FG000|Post-treatment Follow-up|Progressive Disease|0|||
130240284|NCT02335944|468840200|FG001|Post-treatment Follow-up|Progressive Disease|0|||
130240285|NCT02335944|468840201|FG002|Post-treatment Follow-up|Progressive Disease|0|||
130240286|NCT02335944|468840202|FG003|Post-treatment Follow-up|Progressive Disease|1|||
130240287|NCT02335944|468840203|FG004|Post-treatment Follow-up|Progressive Disease|0|||
130240288|NCT02335944|468840204|FG005|Post-treatment Follow-up|Progressive Disease|9|||
130240289|NCT02335944|468840205|FG006|Post-treatment Follow-up|Progressive Disease|0|||
130240290|NCT02335944|468840206|FG007|Post-treatment Follow-up|Progressive Disease|2|||
130240291|NCT02335944|468840207|FG008|Post-treatment Follow-up|Progressive Disease|3|||
130100237|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130100238|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
130240292|NCT02335944|468840208|FG009|Post-treatment Follow-up|Progressive Disease|0|||
130100239|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
130100240|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
130100241|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
130100242|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
130240293|NCT02335944|468840199|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130100243|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
130240294|NCT02335944|468840200|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240295|NCT02335944|468840201|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240296|NCT02335944|468840202|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240297|NCT02335944|468840203|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240298|NCT02335944|468840204|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
130240299|NCT02335944|468840205|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240300|NCT02335944|468840206|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240301|NCT02335944|468840207|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240302|NCT02335944|468840208|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
130240303|NCT02335944|468840199|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240304|NCT02335944|468840200|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240305|NCT02335944|468840201|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240306|NCT02335944|468840202|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240307|NCT02335944|468840203|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240308|NCT02335944|468840204|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240309|NCT02335944|468840205|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240310|NCT02335944|468840206|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
130240311|NCT02335944|468840207|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240312|NCT02335944|468840208|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
130240313|NCT02335944|468840199|FG000|Post-treatment Follow-up|Adverse Event|0|||
130240314|NCT02335944|468840200|FG001|Post-treatment Follow-up|Adverse Event|0|||
130240315|NCT02335944|468840201|FG002|Post-treatment Follow-up|Adverse Event|0|||
130240316|NCT02335944|468840202|FG003|Post-treatment Follow-up|Adverse Event|0|||
130240317|NCT02335944|468840203|FG004|Post-treatment Follow-up|Adverse Event|0|||
130240318|NCT02335944|468840204|FG005|Post-treatment Follow-up|Adverse Event|1|||
130240319|NCT02335944|468840205|FG006|Post-treatment Follow-up|Adverse Event|0|||
130240320|NCT02335944|468840206|FG007|Post-treatment Follow-up|Adverse Event|0|||
130240321|NCT02335944|468840207|FG008|Post-treatment Follow-up|Adverse Event|0|||
130240322|NCT02335944|468840208|FG009|Post-treatment Follow-up|Adverse Event|0|||
130240323|NCT02335944|468840199|FG000|Post-treatment Follow-up|Death|0|||
130240324|NCT02335944|468840200|FG001|Post-treatment Follow-up|Death|0|||
130240325|NCT02335944|468840201|FG002|Post-treatment Follow-up|Death|0|||
130240326|NCT02335944|468840202|FG003|Post-treatment Follow-up|Death|1|||
130240327|NCT02335944|468840203|FG004|Post-treatment Follow-up|Death|0|||
130240328|NCT02335944|468840204|FG005|Post-treatment Follow-up|Death|1|||
130240329|NCT02335944|468840205|FG006|Post-treatment Follow-up|Death|0|||
130240330|NCT02335944|468840206|FG007|Post-treatment Follow-up|Death|0|||
130240331|NCT02335944|468840207|FG008|Post-treatment Follow-up|Death|0|||
130240332|NCT02335944|468840208|FG009|Post-treatment Follow-up|Death|0|||
130027869|NCT01078805|468060863|FG000|Overall Study|Didn't take study drug|82|||
130027870|NCT05900115|468062613|FG000|Overall Study|Lost to Follow-up|129|||
130027871|NCT05900115|468062614|FG001|Overall Study|Lost to Follow-up|98|||
130027872|NCT04187092|468062617|FG000|Overall Study|Lost to Follow-up|1|||
130240333|NCT02335944|468840199|FG000|Post-treatment Follow-up|Physician Decision|1|||
130240334|NCT02335944|468840200|FG001|Post-treatment Follow-up|Physician Decision|0|||
130240335|NCT02335944|468840201|FG002|Post-treatment Follow-up|Physician Decision|0|||
130240336|NCT02335944|468840202|FG003|Post-treatment Follow-up|Physician Decision|0|||
130027873|NCT04187092|468062618|FG001|Overall Study|Lost to Follow-up|1|||
130027874|NCT04187092|468062617|FG000|Overall Study|Withdrawal by Subject|1|||
130027875|NCT04187092|468062618|FG001|Overall Study|Withdrawal by Subject|1|||
130027876|NCT04187092|468062617|FG000|Overall Study|Adverse Event|0|||
130027877|NCT04187092|468062618|FG001|Overall Study|Adverse Event|1|||
130027878|NCT00619502|468062622|FG000|Overall Study|Lost to Follow-up|8|||
130027879|NCT00619502|468062623|FG001|Overall Study|Lost to Follow-up|10|||
130027880|NCT01475734|468062624|FG000|Overall Study|Withdrawal by Subject|1|||
130027881|NCT01475734|468062625|FG001|Overall Study|Withdrawal by Subject|0|||
130027882|NCT01475734|468062624|FG000|Overall Study|Protocol Violation|1|||
130027883|NCT01475734|468062625|FG001|Overall Study|Protocol Violation|0|||
130027884|NCT01475734|468062624|FG000|Overall Study|Physician Decision|0|||
130027885|NCT01475734|468062625|FG001|Overall Study|Physician Decision|1|||
130027886|NCT00771472|468062626|FG000|Overall Study|Physician Decision|2|||
130027887|NCT00771472|468062627|FG001|Overall Study|Physician Decision|3|||
130027888|NCT00771472|468062626|FG000|Overall Study|Progressive Disease|3|||
130027889|NCT00771472|468062627|FG001|Overall Study|Progressive Disease|1|||
130027890|NCT00771472|468062626|FG000|Overall Study|Protocol Violation|1|||
130240337|NCT02335944|468840203|FG004|Post-treatment Follow-up|Physician Decision|0|||
130240338|NCT02335944|468840204|FG005|Post-treatment Follow-up|Physician Decision|0|||
130240339|NCT02335944|468840205|FG006|Post-treatment Follow-up|Physician Decision|0|||
130027891|NCT00771472|468062627|FG001|Overall Study|Protocol Violation|0|||
130027892|NCT00880750|468062630|FG000|First Intervention|Adverse Event|1|||
130027893|NCT00880750|468062631|FG001|First Intervention|Adverse Event|0|||
130027894|NCT00880750|468062630|FG000|First Intervention|Unable to collect urine|4|||
130027895|NCT00880750|468062631|FG001|First Intervention|Unable to collect urine|0|||
130027896|NCT00880750|468062630|FG000|First Intervention|Non-compliance with meals|0|||
130027897|NCT00880750|468062631|FG001|First Intervention|Non-compliance with meals|1|||
130027898|NCT00880750|468062630|FG000|First Intervention|Withdrawal by Subject|2|||
130027899|NCT00880750|468062631|FG001|First Intervention|Withdrawal by Subject|0|||
130027900|NCT00880750|468062630|FG000|First Intervention|Lost to Follow-up|2|||
130027901|NCT00880750|468062631|FG001|First Intervention|Lost to Follow-up|0|||
130027902|NCT00880750|468062630|FG000|Second Intervention|Withdrawal by Subject|2|||
130027903|NCT00880750|468062631|FG001|Second Intervention|Withdrawal by Subject|2|||
130027904|NCT00880750|468062630|FG000|Second Intervention|Protocol Violation|1|||
130240340|NCT02335944|468840206|FG007|Post-treatment Follow-up|Physician Decision|1|||
130027905|NCT00880750|468062631|FG001|Second Intervention|Protocol Violation|0|||
130027906|NCT00880750|468062630|FG000|Second Intervention|Unable to collect urine|1|||
130027907|NCT00880750|468062631|FG001|Second Intervention|Unable to collect urine|0|||
130027908|NCT00483327|468062635|FG000|Overall Study|Adverse Event|1|||
130027909|NCT00483327|468062635|FG000|Overall Study|Withdrawal by Subject|3|||
130027910|NCT00483327|468062635|FG000|Overall Study|Lost to Follow-up|4|||
130027911|NCT00483327|468062635|FG000|Overall Study|Patient Non Compliance|2|||
130027912|NCT00670007|468062636|FG000|Overall Study|Drug abuse|1|||
130027913|NCT00670007|468062636|FG000|Overall Study|Lung transplant|1|||
130240341|NCT02335944|468840207|FG008|Post-treatment Follow-up|Physician Decision|0|||
130240342|NCT02335944|468840208|FG009|Post-treatment Follow-up|Physician Decision|0|||
130240343|NCT00832975|468840209|FG000|Overall Study|Lost to Follow-up|7|||
130240344|NCT00832975|468840209|FG000|Overall Study|Protocol Violation|6|||
130240345|NCT00832975|468840209|FG000|Overall Study|Death|5|||
130240346|NCT00832975|468840209|FG000|Overall Study|Physician Decision|4|||
130240347|NCT00832975|468840209|FG000|Overall Study|Withdrawal by Subject|3|||
130240348|NCT00832975|468840209|FG000|Overall Study|Other reasons|14|||
130240349|NCT02811159|468840210|FG000|Treatment Course 1|Lost to Follow-up|1|||
130240350|NCT04603066|468840211|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
130240351|NCT04603066|468840212|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
130240352|NCT02406612|468840213|FG000|Overall Study|Screening Failure|3|||
130240353|NCT02406612|468840214|FG001|Overall Study|Screening Failure|0|||
130240354|NCT02406612|468840213|FG000|Overall Study|Intra-procedural Exclusion|1|||
130240355|NCT02406612|468840214|FG001|Overall Study|Intra-procedural Exclusion|3|||
130240356|NCT02406612|468840213|FG000|Overall Study|Guidewire Failure|0|||
130240357|NCT02406612|468840214|FG001|Overall Study|Guidewire Failure|1|||
130240358|NCT01371981|468840215|FG000|Overall Study|Adverse Event|12|||
130027914|NCT00670007|468062636|FG000|Overall Study|Travel/Vacation|1|||
130240359|NCT01371981|468840216|FG001|Overall Study|Adverse Event|17|||
130240360|NCT01371981|468840217|FG002|Overall Study|Adverse Event|0|||
130240361|NCT01371981|468840218|FG003|Overall Study|Adverse Event|4|||
130240362|NCT01371981|468840219|FG004|Overall Study|Adverse Event|1|||
130240363|NCT01371981|468840220|FG005|Overall Study|Adverse Event|0|||
130027915|NCT00670007|468062636|FG000|Overall Study|Adverse event, serious fatal|1|||
130027916|NCT00670007|468062636|FG000|Overall Study|Adverse Event|1|||
130027917|NCT00670007|468062636|FG000|Overall Study|Withdrawal by Subject|4|||
130027918|NCT00618722|468062637|FG000|Overall Study|Refusal of Treatment|0|||
130027919|NCT00618722|468062638|FG001|Overall Study|Refusal of Treatment|0|||
130027920|NCT00618722|468062639|FG002|Overall Study|Refusal of Treatment|1|||
130027921|NCT00618722|468062640|FG003|Overall Study|Refusal of Treatment|0|||
130027922|NCT00618722|468062637|FG000|Overall Study|Patient Request|1|||
130027923|NCT00618722|468062638|FG001|Overall Study|Patient Request|1|||
130027924|NCT00618722|468062639|FG002|Overall Study|Patient Request|1|||
130027925|NCT00618722|468062640|FG003|Overall Study|Patient Request|1|||
130027926|NCT00618722|468062637|FG000|Overall Study|Inability to Complete Study Procedure|0|||
130027927|NCT00618722|468062638|FG001|Overall Study|Inability to Complete Study Procedure|1|||
130027928|NCT00618722|468062639|FG002|Overall Study|Inability to Complete Study Procedure|0|||
130027929|NCT00618722|468062640|FG003|Overall Study|Inability to Complete Study Procedure|0|||
130027930|NCT00618722|468062637|FG000|Overall Study|Lost to Follow-up|2|||
130027931|NCT00618722|468062638|FG001|Overall Study|Lost to Follow-up|0|||
130027932|NCT00618722|468062639|FG002|Overall Study|Lost to Follow-up|0|||
130027933|NCT00618722|468062640|FG003|Overall Study|Lost to Follow-up|2|||
130027934|NCT00618722|468062637|FG000|Overall Study|Miscellaneous Reasons|0|||
130027935|NCT00618722|468062638|FG001|Overall Study|Miscellaneous Reasons|0|||
130027936|NCT00618722|468062639|FG002|Overall Study|Miscellaneous Reasons|1|||
130027937|NCT00618722|468062640|FG003|Overall Study|Miscellaneous Reasons|1|||
130027938|NCT00200057|468062643|FG000|Overall Study|Lack of Efficacy|3|||
130027939|NCT00200057|468062643|FG000|Overall Study|Exited due to terminal illness of PI|2|||
130027940|NCT00200057|468062643|FG000|Overall Study|Withdrawal by Subject|1|||
130027941|NCT00200057|468062643|FG000|Overall Study|Change in medical condition|1|||
130027942|NCT00200057|468062643|FG000|Overall Study|Infection|1|||
130027943|NCT00200057|468062643|FG000|Overall Study|Death|1|||
130027944|NCT00778830|468062644|FG000|Overall Study|Ongoing at data cut-off|0|||
130027945|NCT00778830|468062645|FG001|Overall Study|Ongoing at data cut-off|1|||
130027946|NCT00132041|468062649|FG000|Baseline|Ineligible|6|||
130027947|NCT00132041|468062649|FG000|3 Months Post Ablation|Transplant|1|||
130027948|NCT00132041|468062649|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
130027949|NCT00132041|468062649|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
130027950|NCT00132041|468062649|FG000|6 Months Post Ablation|Death|2|||
130027951|NCT00132041|468062649|FG000|6 Months Post Ablation|Transplant|6|||
130027952|NCT00132041|468062649|FG000|9 Months Post Ablation|Death|1|||
130027953|NCT00132041|468062649|FG000|9 Months Post Ablation|Transplant|1|||
130027954|NCT00132041|468062649|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
130027955|NCT00132041|468062649|FG000|12 Months Post Ablation|Death|1|||
130027956|NCT00132041|468062649|FG000|12 Months Post Ablation|Transplant|1|||
130027957|NCT00132041|468062649|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
130027958|NCT00132041|468062649|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
130027959|NCT00132041|468062649|FG000|15 Months Post Ablation|Death|1|||
130027960|NCT00132041|468062649|FG000|15 Months Post Ablation|Transplant|5|||
130027961|NCT00132041|468062649|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
130027962|NCT00132041|468062649|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
130027963|NCT00132041|468062649|FG000|18 Months Post Ablation|Transplant|1|||
130027964|NCT00132041|468062649|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
130027965|NCT00132041|468062649|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
130027966|NCT03609619|468062650|FG000|Overall Study|Adverse Event|1|||
130027967|NCT03609619|468062651|FG001|Overall Study|Adverse Event|0|||
130027968|NCT03609619|468062650|FG000|Overall Study|Lack of Efficacy|1|||
130027969|NCT03609619|468062651|FG001|Overall Study|Lack of Efficacy|2|||
130027970|NCT03609619|468062650|FG000|Overall Study|Protocol Violation|5|||
130027971|NCT03609619|468062651|FG001|Overall Study|Protocol Violation|0|||
130027972|NCT03609619|468062650|FG000|Overall Study|Withdrawal by Subject|2|||
130027973|NCT03609619|468062651|FG001|Overall Study|Withdrawal by Subject|3|||
130027974|NCT03609619|468062650|FG000|Overall Study|Lost to Follow-up|1|||
130027975|NCT03609619|468062651|FG001|Overall Study|Lost to Follow-up|1|||
130027976|NCT00956943|468062652|FG000|Overall Study|Lost to Follow-up|9|||
130027977|NCT00956943|468062653|FG001|Overall Study|Lost to Follow-up|10|||
130027978|NCT02613208|468062654|FG000|Overall Study|Withdrawal by Subject|1|||
130027979|NCT02613208|468062654|FG000|Overall Study|Change of address|2|||
130027980|NCT02613208|468062654|FG000|Overall Study|Physician Decision|2|||
130027981|NCT02613208|468062654|FG000|Overall Study|Lost to Follow-up|5|||
130027982|NCT02613208|468062654|FG000|Overall Study|Death|37|||
130027983|NCT02663895|468062655|FG000|Overall Study|Adverse Event|3|||
130027984|NCT02663895|468062655|FG000|Overall Study|Physician Decision|2|||
130027985|NCT02663895|468062655|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
130027986|NCT02663895|468062655|FG000|Overall Study|Withdrawal by Subject|1|||
130027987|NCT02327260|468062659|FG000|Overall Study|Lost to Follow-up|2|||
130027988|NCT02327260|468062660|FG001|Overall Study|Lost to Follow-up|3|||
130027989|NCT02327260|468062661|FG002|Overall Study|Lost to Follow-up|2|||
130027990|NCT02327260|468062659|FG000|Overall Study|invalid phone number|1|||
130027991|NCT02327260|468062660|FG001|Overall Study|invalid phone number|1|||
130027992|NCT02327260|468062661|FG002|Overall Study|invalid phone number|0|||
130027993|NCT02327260|468062659|FG000|Overall Study|non-adherence to protocol|2|||
130027994|NCT02327260|468062660|FG001|Overall Study|non-adherence to protocol|0|||
130027995|NCT02327260|468062661|FG002|Overall Study|non-adherence to protocol|0|||
130027996|NCT02327260|468062659|FG000|Overall Study|cognitive concerns|1|||
130027997|NCT02327260|468062660|FG001|Overall Study|cognitive concerns|0|||
130027998|NCT02327260|468062661|FG002|Overall Study|cognitive concerns|0|||
130027999|NCT01400932|468062663|FG000|Overall Study|Adverse Event|10|||
130028000|NCT01400932|468062664|FG001|Overall Study|Adverse Event|5|||
130028001|NCT01400932|468062663|FG000|Overall Study|Lack of Efficacy|0|||
130028002|NCT01400932|468062664|FG001|Overall Study|Lack of Efficacy|3|||
130028003|NCT01400932|468062663|FG000|Overall Study|Withdrawal by Subject|2|||
130028004|NCT01400932|468062664|FG001|Overall Study|Withdrawal by Subject|6|||
130028005|NCT01400932|468062663|FG000|Overall Study|Lost to Follow-up|1|||
130028006|NCT01400932|468062664|FG001|Overall Study|Lost to Follow-up|0|||
130028007|NCT01400932|468062663|FG000|Overall Study|Protocol Deviation|0|||
130028008|NCT01400932|468062664|FG001|Overall Study|Protocol Deviation|1|||
130028009|NCT01400932|468062663|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130028010|NCT01400932|468062664|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130028011|NCT03244059|468062666|FG000|Specific Aim 1|Physician Decision|1|||
130028012|NCT03244059|468062667|FG001|Specific Aim 1|Physician Decision|0|||
130028013|NCT03244059|468062666|FG000|Specific Aim 2|Physician Decision|1|||
130028014|NCT03244059|468062667|FG001|Specific Aim 2|Physician Decision|0|||
130028015|NCT01276821|468062668|FG000|Overall Study|Protocol Violation|0|||
130028016|NCT01276821|468062669|FG001|Overall Study|Protocol Violation|1|||
130028017|NCT00270894|468062670|FG000|Overall Study|Adverse Event|1|||
130028018|NCT00270894|468062670|FG000|Overall Study|Withdrawal by Subject|1|||
130028019|NCT01748071|468062671|FG000|Overall Study|Adverse Event|2|||
130028020|NCT01748071|468062672|FG001|Overall Study|Adverse Event|2|||
130028021|NCT01748071|468062673|FG002|Overall Study|Adverse Event|0|||
130028022|NCT00605267|468062674|FG000|Overall Study|Adverse Event|0|||
130028023|NCT00605267|468062675|FG001|Overall Study|Adverse Event|1|||
130028024|NCT00605267|468062674|FG000|Overall Study|Lack of Efficacy|1|||
130028025|NCT00605267|468062675|FG001|Overall Study|Lack of Efficacy|5|||
130028026|NCT00605267|468062674|FG000|Overall Study|Withdrawal by Subject|2|||
130028027|NCT00605267|468062675|FG001|Overall Study|Withdrawal by Subject|3|||
130028028|NCT02939131|468062676|FG000|Overall Study|Unable to get to clinic|6|||
130028029|NCT02939131|468062677|FG001|Overall Study|Unable to get to clinic|4|||
130028030|NCT02939131|468062676|FG000|Overall Study|Lost to Follow-up|2|||
130028031|NCT02939131|468062677|FG001|Overall Study|Lost to Follow-up|4|||
130028032|NCT02939131|468062676|FG000|Overall Study|severe debilitation|1|||
130028033|NCT02939131|468062677|FG001|Overall Study|severe debilitation|0|||
130028034|NCT02939131|468062676|FG000|Overall Study|Other|0|||
130028035|NCT02939131|468062677|FG001|Overall Study|Other|1|||
130028036|NCT02939131|468062676|FG000|Overall Study|not willing to adhere to protocol|2|||
130028037|NCT02939131|468062677|FG001|Overall Study|not willing to adhere to protocol|0|||
130028038|NCT00793793|468062678|FG000|Overall Study|Adverse Event|0|||
130028039|NCT00793793|468062679|FG001|Overall Study|Adverse Event|0|||
130028040|NCT00793793|468062680|FG002|Overall Study|Adverse Event|1|||
130028041|NCT00793793|468062681|FG003|Overall Study|Adverse Event|1|||
130028042|NCT00793793|468062682|FG004|Overall Study|Adverse Event|0|||
130028043|NCT00793793|468062683|FG005|Overall Study|Adverse Event|1|||
130240364|NCT01371981|468840215|FG000|Overall Study|Death|22|||
130240365|NCT01371981|468840216|FG001|Overall Study|Death|16|||
130240366|NCT01371981|468840217|FG002|Overall Study|Death|0|||
130240367|NCT01371981|468840218|FG003|Overall Study|Death|0|||
130240368|NCT01371981|468840219|FG004|Overall Study|Death|2|||
130240369|NCT01371981|468840220|FG005|Overall Study|Death|2|||
130240370|NCT01371981|468840215|FG000|Overall Study|Lack of Efficacy|69|||
130240371|NCT01371981|468840216|FG001|Overall Study|Lack of Efficacy|61|||
130240372|NCT01371981|468840217|FG002|Overall Study|Lack of Efficacy|4|||
130240373|NCT01371981|468840218|FG003|Overall Study|Lack of Efficacy|8|||
130240374|NCT01371981|468840219|FG004|Overall Study|Lack of Efficacy|5|||
130240375|NCT01371981|468840220|FG005|Overall Study|Lack of Efficacy|0|||
130240376|NCT01371981|468840215|FG000|Overall Study|Physician Decision|48|||
130240377|NCT01371981|468840216|FG001|Overall Study|Physician Decision|63|||
130240378|NCT01371981|468840217|FG002|Overall Study|Physician Decision|1|||
130240379|NCT01371981|468840218|FG003|Overall Study|Physician Decision|7|||
130240380|NCT01371981|468840219|FG004|Overall Study|Physician Decision|14|||
130240381|NCT01371981|468840220|FG005|Overall Study|Physician Decision|3|||
130240382|NCT01371981|468840215|FG000|Overall Study|Withdrawal by Subject|12|||
130240383|NCT01371981|468840216|FG001|Overall Study|Withdrawal by Subject|19|||
130240384|NCT01371981|468840217|FG002|Overall Study|Withdrawal by Subject|1|||
130240385|NCT01371981|468840218|FG003|Overall Study|Withdrawal by Subject|2|||
130240386|NCT01371981|468840219|FG004|Overall Study|Withdrawal by Subject|10|||
130240387|NCT01371981|468840220|FG005|Overall Study|Withdrawal by Subject|3|||
130240388|NCT01371981|468840215|FG000|Overall Study|Ineligible|19|||
130240389|NCT01371981|468840216|FG001|Overall Study|Ineligible|13|||
130240390|NCT01371981|468840217|FG002|Overall Study|Ineligible|0|||
130240391|NCT01371981|468840218|FG003|Overall Study|Ineligible|0|||
130240392|NCT01371981|468840219|FG004|Overall Study|Ineligible|0|||
130240393|NCT01371981|468840220|FG005|Overall Study|Ineligible|4|||
130240394|NCT01371981|468840215|FG000|Overall Study|Did not start treatment|2|||
130240395|NCT01371981|468840216|FG001|Overall Study|Did not start treatment|3|||
130240396|NCT01371981|468840217|FG002|Overall Study|Did not start treatment|0|||
130240397|NCT01371981|468840218|FG003|Overall Study|Did not start treatment|0|||
130240398|NCT01371981|468840219|FG004|Overall Study|Did not start treatment|0|||
130240399|NCT01371981|468840220|FG005|Overall Study|Did not start treatment|2|||
130240400|NCT05253807|468840221|FG000|Overall Study|Death|1|||
130240401|NCT05253807|468840222|FG001|Overall Study|Death|4|||
130240402|NCT05253807|468840221|FG000|Overall Study|Withdrawal by Subject|1|||
129884604|NCT02080520|467538572|FG000|Overall Study|Cancer|1|||
129884605|NCT02080520|467538573|FG001|Overall Study|Cancer|2|||
129884606|NCT02080520|467538572|FG000|Overall Study|Not interested in study|1|||
129884607|NCT02080520|467538573|FG001|Overall Study|Not interested in study|3|||
129884608|NCT02080520|467538572|FG000|Overall Study|Too busy|1|||
129884609|NCT02080520|467538573|FG001|Overall Study|Too busy|1|||
129884610|NCT02080520|467538572|FG000|Overall Study|Work-related injury|1|||
129884611|NCT02080520|467538573|FG001|Overall Study|Work-related injury|0|||
129884612|NCT02080520|467538572|FG000|Overall Study|Personal reasons|0|||
129884613|NCT02080520|467538573|FG001|Overall Study|Personal reasons|3|||
129884614|NCT04397523|467538574|FG000|Overall Study|Lost to Follow-up|3|||
130028044|NCT00793793|468062684|FG006|Overall Study|Adverse Event|2|||
130240403|NCT05253807|468840222|FG001|Overall Study|Withdrawal by Subject|0|||
130240404|NCT05253807|468840221|FG000|Overall Study|Study Terminated by Sponsor|1|||
130240405|NCT05253807|468840222|FG001|Overall Study|Study Terminated by Sponsor|1|||
129884615|NCT04397523|467538574|FG000|Overall Study|Transfer from/to other hospital|8|||
130240406|NCT04611126|468840223|FG000|Overall Study|TIL expansion unsuccessful|1|||
130240407|NCT04611126|468840224|FG001|Overall Study|TIL expansion unsuccessful|0|||
130028045|NCT00793793|468062685|FG007|Overall Study|Adverse Event|0|||
130240408|NCT03459846|468840229|FG000|Overall Study|Death|52|||
130240409|NCT03459846|468840230|FG001|Overall Study|Death|46|||
130240410|NCT03459846|468840229|FG000|Overall Study|Study terminated by sponsor|24|||
130240411|NCT03459846|468840230|FG001|Overall Study|Study terminated by sponsor|28|||
130240412|NCT03459846|468840229|FG000|Overall Study|Withdrawal by Subject|2|||
130240413|NCT03459846|468840230|FG001|Overall Study|Withdrawal by Subject|2|||
130240414|NCT05578872|468840238|FG000|Overall Study|Withdrawal by Subject|2|||
130240415|NCT05578872|468840239|FG001|Overall Study|Withdrawal by Subject|1|||
130240416|NCT05578872|468840238|FG000|Overall Study|Adverse Event|1|||
130240417|NCT05578872|468840239|FG001|Overall Study|Adverse Event|1|||
130240418|NCT05578872|468840238|FG000|Overall Study|Physician Decision|1|||
130240419|NCT05578872|468840239|FG001|Overall Study|Physician Decision|2|||
130240420|NCT05578872|468840238|FG000|Overall Study|Progressive disease|10|||
130240421|NCT05578872|468840239|FG001|Overall Study|Progressive disease|9|||
130240422|NCT05578872|468840238|FG000|Overall Study|Sponsor decision|0|||
130240423|NCT05578872|468840239|FG001|Overall Study|Sponsor decision|1|||
130240424|NCT05578872|468840238|FG000|Overall Study|Toxicity and Patient's decision|0|||
130240425|NCT05578872|468840239|FG001|Overall Study|Toxicity and Patient's decision|1|||
130240426|NCT03506477|468840527|FG000|Overall Study|Withdrawal by Subject|1|||
130240427|NCT03506477|468840528|FG001|Overall Study|Withdrawal by Subject|0|||
130240428|NCT00632359|468840533|FG000|Overall Study|Withdrawal by Subject|2|||
130240429|NCT06717399|468840534|FG000|Overall Study|Death|1|||
130240430|NCT05763875|468840539|FG000|Overall Study|Subject decision|5|||
130240431|NCT05763875|468840540|FG001|Overall Study|Subject decision|2|||
130240432|NCT05763875|468840541|FG002|Overall Study|Subject decision|1|||
130240433|NCT05763875|468840539|FG000|Overall Study|Lost to Follow-up|4|||
130240434|NCT05763875|468840540|FG001|Overall Study|Lost to Follow-up|1|||
130240435|NCT05763875|468840541|FG002|Overall Study|Lost to Follow-up|2|||
130240436|NCT05763875|468840539|FG000|Overall Study|Adverse Event|1|||
130240437|NCT05763875|468840540|FG001|Overall Study|Adverse Event|0|||
130240438|NCT05763875|468840541|FG002|Overall Study|Adverse Event|0|||
130240439|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130240440|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130240441|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
130240442|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
130240443|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130240444|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130240445|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
130240446|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
130240447|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130240448|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130240449|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
130240450|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
130240451|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130240452|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130240453|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
130240454|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
130240455|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130240456|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130240457|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
130240458|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
130240459|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130240460|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130240461|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
130240462|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
130240463|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130240464|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130240465|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
130240466|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
130240467|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130240468|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130240469|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
130240470|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
130240471|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130240472|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130240473|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
130240474|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
130240475|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130240476|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130240477|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
130240478|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
130240479|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130240480|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130240481|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
130240482|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
130240483|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
130240484|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
130240485|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
130240486|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
130240487|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130240488|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130028046|NCT00793793|468062686|FG008|Overall Study|Adverse Event|0|||
130028047|NCT00793793|468062687|FG009|Overall Study|Adverse Event|0|||
130240489|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
130240490|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
130240491|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130240492|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130240493|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
130240494|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
130240495|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130240496|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130240497|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
130240498|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
130240499|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
130240500|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
130240501|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
130240502|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
130240503|NCT00217737|468840542|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
130240504|NCT00217737|468840543|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
130240505|NCT00217737|468840544|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
130240506|NCT00217737|468840545|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
130240507|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
130240508|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
130240509|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
130240510|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
130240511|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
130240512|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
130240513|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
130240514|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
130240515|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Study suspension|0|||
130240516|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Study suspension|45|||
130240517|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Study suspension|0|||
130240518|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Study suspension|0|||
130240519|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
130240520|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
130240521|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
130240522|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
130240523|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Death|2|||
130240524|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Death|3|||
130240525|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Death|0|||
130240526|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Death|0|||
130240527|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
130028048|NCT00793793|468062688|FG010|Overall Study|Adverse Event|0|||
130240528|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
130240529|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
130240530|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
130240531|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
130240532|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
130240533|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
130240534|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
130240535|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
130240536|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
130240537|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
130240538|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
130240539|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130240540|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
130240541|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130240542|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
130240543|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130240544|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
130240545|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130240546|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
130240547|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
130240548|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130240549|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130240550|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
130240551|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
130240552|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
130240553|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
130240554|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
130240555|NCT00217737|468840542|FG000|Step 2 Randomization/Registration|Other|1|||
130240556|NCT00217737|468840543|FG001|Step 2 Randomization/Registration|Other|2|||
130240557|NCT00217737|468840544|FG002|Step 2 Randomization/Registration|Other|0|||
130240558|NCT00217737|468840545|FG003|Step 2 Randomization/Registration|Other|0|||
130240559|NCT02145390|468840546|FG000|Overall Study|Withdrawal by Subject|1|||
130240560|NCT01732783|468841438|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
130240561|NCT01732783|468841439|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
130240562|NCT01732783|468841440|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
130240563|NCT01732783|468841438|FG000|Overall Study|Death|13|||
130240564|NCT01732783|468841439|FG001|Overall Study|Death|4|||
130240565|NCT01732783|468841440|FG002|Overall Study|Death|1|||
130240566|NCT01732783|468841438|FG000|Overall Study|Lost to Follow-up|7|||
130240567|NCT01732783|468841439|FG001|Overall Study|Lost to Follow-up|1|||
130240568|NCT01732783|468841440|FG002|Overall Study|Lost to Follow-up|1|||
130240569|NCT01732783|468841438|FG000|Overall Study|Administrative Decision|8|||
130240570|NCT01732783|468841439|FG001|Overall Study|Administrative Decision|2|||
130240571|NCT01732783|468841440|FG002|Overall Study|Administrative Decision|1|||
130240572|NCT01732783|468841438|FG000|Overall Study|Withdrawal by Subject|1|||
130240573|NCT01732783|468841439|FG001|Overall Study|Withdrawal by Subject|0|||
130240574|NCT01732783|468841440|FG002|Overall Study|Withdrawal by Subject|0|||
130240575|NCT02717611|468841441|FG000|Overall Study|Death|13|||
130240576|NCT02717611|468841441|FG000|Overall Study|Withdrawal by Subject|6|||
130100244|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
130100245|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
130100246|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
130100247|NCT01299272|468325955|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
130100248|NCT01299272|468325956|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
130100249|NCT01299272|468325957|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
130100250|NCT01299272|468325958|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
130240577|NCT02717611|468841441|FG000|Overall Study|Active, not recruiting|40|||
130240578|NCT02717611|468841441|FG000|Overall Study|Complicating disease|1|||
130240579|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
130240580|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
130240581|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
130240582|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
130240583|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
130240584|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
130028049|NCT00793793|468062689|FG011|Overall Study|Adverse Event|2|||
130028050|NCT00793793|468062678|FG000|Overall Study|Protocol Violation|0|||
130028051|NCT00793793|468062679|FG001|Overall Study|Protocol Violation|0|||
130028052|NCT00793793|468062680|FG002|Overall Study|Protocol Violation|0|||
130240585|NCT00325416|468841442|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
130240586|NCT00325416|468841443|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
130028053|NCT00793793|468062681|FG003|Overall Study|Protocol Violation|1|||
130240587|NCT00325416|468841442|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
130240588|NCT00325416|468841443|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
130240589|NCT00325416|468841442|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
130240590|NCT00325416|468841443|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
130240591|NCT04589650|468841444|FG000|Overall Study|Subject decision|6|||
130240592|NCT04589650|468841445|FG001|Overall Study|Subject decision|2|||
130240593|NCT04589650|468841446|FG002|Overall Study|Subject decision|2|||
130240594|NCT04589650|468841447|FG003|Overall Study|Subject decision|0|||
130240595|NCT04589650|468841448|FG004|Overall Study|Subject decision|0|||
130240596|NCT04589650|468841449|FG005|Overall Study|Subject decision|0|||
130240597|NCT04589650|468841444|FG000|Overall Study|Adverse Event|3|||
130240598|NCT04589650|468841445|FG001|Overall Study|Adverse Event|1|||
130240599|NCT04589650|468841446|FG002|Overall Study|Adverse Event|1|||
130240600|NCT04589650|468841447|FG003|Overall Study|Adverse Event|1|||
130240601|NCT04589650|468841448|FG004|Overall Study|Adverse Event|0|||
130240602|NCT04589650|468841449|FG005|Overall Study|Adverse Event|1|||
130240603|NCT04589650|468841444|FG000|Overall Study|Physician Decision|1|||
130240604|NCT04589650|468841445|FG001|Overall Study|Physician Decision|1|||
130240605|NCT04589650|468841446|FG002|Overall Study|Physician Decision|0|||
130240606|NCT04589650|468841447|FG003|Overall Study|Physician Decision|0|||
130240607|NCT04589650|468841448|FG004|Overall Study|Physician Decision|0|||
130240608|NCT04589650|468841449|FG005|Overall Study|Physician Decision|0|||
130240609|NCT04589650|468841444|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130240610|NCT04589650|468841445|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130240611|NCT04589650|468841446|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130240612|NCT04589650|468841447|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130240613|NCT04589650|468841448|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130240614|NCT04589650|468841449|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130240615|NCT04589650|468841444|FG000|Overall Study|Death|0|||
130240616|NCT04589650|468841445|FG001|Overall Study|Death|0|||
130240617|NCT04589650|468841446|FG002|Overall Study|Death|0|||
130240618|NCT04589650|468841447|FG003|Overall Study|Death|1|||
130240619|NCT04589650|468841448|FG004|Overall Study|Death|0|||
130240620|NCT04589650|468841449|FG005|Overall Study|Death|0|||
130240621|NCT04589650|468841444|FG000|Overall Study|Guardian Decision|0|||
130240622|NCT04589650|468841445|FG001|Overall Study|Guardian Decision|0|||
130240623|NCT04589650|468841446|FG002|Overall Study|Guardian Decision|0|||
130240624|NCT04589650|468841447|FG003|Overall Study|Guardian Decision|1|||
130240625|NCT04589650|468841448|FG004|Overall Study|Guardian Decision|0|||
130240626|NCT04589650|468841449|FG005|Overall Study|Guardian Decision|0|||
130240627|NCT02324153|468841450|FG000|Overall Study|Withdrawal by Subject|4|||
130240628|NCT02324153|468841451|FG001|Overall Study|Withdrawal by Subject|1|||
130240629|NCT02324153|468841450|FG000|Overall Study|Surgery postponed after randomization|3|||
130240630|NCT02324153|468841451|FG001|Overall Study|Surgery postponed after randomization|0|||
130240631|NCT02324153|468841450|FG000|Overall Study|Developed delirium preoperatively|1|||
130240632|NCT02324153|468841451|FG001|Overall Study|Developed delirium preoperatively|0|||
130240633|NCT03122106|468841454|FG000|Overall Study|Not enough tissue|1|||
130240634|NCT03122106|468841454|FG000|Overall Study|Disease progression during screening|2|||
130240635|NCT03122106|468841454|FG000|Overall Study|Poor RNA quality for vaccine|1|||
130028054|NCT00793793|468062682|FG004|Overall Study|Protocol Violation|0|||
130028055|NCT00793793|468062683|FG005|Overall Study|Protocol Violation|0|||
130028056|NCT00793793|468062684|FG006|Overall Study|Protocol Violation|0|||
130028057|NCT00793793|468062685|FG007|Overall Study|Protocol Violation|0|||
130240636|NCT01147458|468841456|FG000|First Intervention|Study terminated by sponsor|8|||
130240637|NCT01147458|468841457|FG001|First Intervention|Study terminated by sponsor|8|||
130240638|NCT01147458|468841458|FG002|First Intervention|Study terminated by sponsor|7|||
130240639|NCT01147458|468841459|FG003|First Intervention|Study terminated by sponsor|8|||
130240640|NCT01147458|468841456|FG000|First Intervention|Protocol Violation|2|||
130240641|NCT01147458|468841457|FG001|First Intervention|Protocol Violation|3|||
130240642|NCT01147458|468841458|FG002|First Intervention|Protocol Violation|2|||
130240643|NCT01147458|468841459|FG003|First Intervention|Protocol Violation|3|||
130028058|NCT00793793|468062686|FG008|Overall Study|Protocol Violation|0|||
130028059|NCT00793793|468062687|FG009|Overall Study|Protocol Violation|0|||
130240644|NCT01147458|468841456|FG000|First Intervention|Withdrawal by Subject|3|||
130240645|NCT01147458|468841457|FG001|First Intervention|Withdrawal by Subject|0|||
130240646|NCT01147458|468841458|FG002|First Intervention|Withdrawal by Subject|1|||
130240647|NCT01147458|468841459|FG003|First Intervention|Withdrawal by Subject|0|||
130240648|NCT01147458|468841456|FG000|First Intervention|Adverse Event|0|||
130240649|NCT01147458|468841457|FG001|First Intervention|Adverse Event|3|||
130240650|NCT01147458|468841458|FG002|First Intervention|Adverse Event|2|||
130240651|NCT01147458|468841459|FG003|First Intervention|Adverse Event|3|||
130240652|NCT01147458|468841456|FG000|First Intervention|Other|1|||
130240653|NCT01147458|468841457|FG001|First Intervention|Other|2|||
130240654|NCT01147458|468841458|FG002|First Intervention|Other|0|||
130240655|NCT01147458|468841459|FG003|First Intervention|Other|0|||
130240656|NCT01147458|468841456|FG000|Second Intervention|Study terminated by sponsor|7|||
130240657|NCT01147458|468841457|FG001|Second Intervention|Study terminated by sponsor|5|||
130240658|NCT01147458|468841458|FG002|Second Intervention|Study terminated by sponsor|5|||
130028060|NCT00793793|468062688|FG010|Overall Study|Protocol Violation|0|||
130240659|NCT01147458|468841459|FG003|Second Intervention|Study terminated by sponsor|3|||
130240660|NCT01147458|468841456|FG000|Second Intervention|Protocol Violation|0|||
130240661|NCT01147458|468841457|FG001|Second Intervention|Protocol Violation|1|||
130240662|NCT01147458|468841458|FG002|Second Intervention|Protocol Violation|1|||
130240663|NCT01147458|468841459|FG003|Second Intervention|Protocol Violation|0|||
130240664|NCT01147458|468841456|FG000|Second Intervention|Withdrawal by Subject|0|||
130240665|NCT01147458|468841457|FG001|Second Intervention|Withdrawal by Subject|1|||
130240666|NCT01147458|468841458|FG002|Second Intervention|Withdrawal by Subject|0|||
130240667|NCT01147458|468841459|FG003|Second Intervention|Withdrawal by Subject|0|||
130240668|NCT01147458|468841456|FG000|Second Intervention|Adverse Event|2|||
130240669|NCT01147458|468841457|FG001|Second Intervention|Adverse Event|0|||
130240670|NCT01147458|468841458|FG002|Second Intervention|Adverse Event|1|||
130240671|NCT01147458|468841459|FG003|Second Intervention|Adverse Event|1|||
130240672|NCT01147458|468841456|FG000|Second Intervention|Other|0|||
130240673|NCT01147458|468841457|FG001|Second Intervention|Other|0|||
130240674|NCT01147458|468841458|FG002|Second Intervention|Other|1|||
130240675|NCT01147458|468841459|FG003|Second Intervention|Other|0|||
130240676|NCT03550209|468841460|FG000|Overall Study|Lost to Follow-up|1|||
130240677|NCT03550209|468841461|FG001|Overall Study|Lost to Follow-up|0|||
130028061|NCT00793793|468062689|FG011|Overall Study|Protocol Violation|0|||
130240678|NCT03550209|468841462|FG002|Overall Study|Lost to Follow-up|1|||
130240679|NCT03550209|468841463|FG003|Overall Study|Lost to Follow-up|0|||
130240680|NCT03550209|468841460|FG000|Overall Study|Withdrawal by Subject|0|||
130240681|NCT03550209|468841461|FG001|Overall Study|Withdrawal by Subject|3|||
130240682|NCT03550209|468841462|FG002|Overall Study|Withdrawal by Subject|1|||
130240683|NCT03550209|468841463|FG003|Overall Study|Withdrawal by Subject|2|||
130240684|NCT03550209|468841460|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
130240685|NCT03550209|468841461|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
130240686|NCT03550209|468841462|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
130240687|NCT03550209|468841463|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
130240688|NCT02555878|468841464|FG000|Overall Study|Lost to Follow-up|2|||
130240689|NCT02555878|468841465|FG001|Overall Study|Lost to Follow-up|3|||
130240690|NCT02555878|468841464|FG000|Overall Study|Withdrawal by Subject|48|||
130240691|NCT02555878|468841465|FG001|Overall Study|Withdrawal by Subject|48|||
130240692|NCT02555878|468841464|FG000|Overall Study|Adverse Event|12|||
130240693|NCT02555878|468841465|FG001|Overall Study|Adverse Event|8|||
130240694|NCT02555878|468841464|FG000|Overall Study|Death|74|||
130240695|NCT02555878|468841465|FG001|Overall Study|Death|59|||
130240696|NCT02555878|468841464|FG000|Overall Study|Protocol Violation|1|||
130240697|NCT02555878|468841465|FG001|Overall Study|Protocol Violation|2|||
130240698|NCT02555878|468841464|FG000|Overall Study|Physician Decision|12|||
130240699|NCT02555878|468841465|FG001|Overall Study|Physician Decision|13|||
130240700|NCT02555878|468841464|FG000|Overall Study|Other|17|||
130240701|NCT02555878|468841465|FG001|Overall Study|Other|17|||
130240702|NCT00765076|468841466|FG000|Overall Study|Adverse Event|1|||
130240703|NCT00765076|468841467|FG001|Overall Study|Adverse Event|0|||
130240704|NCT00765076|468841468|FG002|Overall Study|Adverse Event|0|||
130240705|NCT00765076|468841466|FG000|Overall Study|Withdrawal by Subject|0|||
130240706|NCT00765076|468841467|FG001|Overall Study|Withdrawal by Subject|0|||
130240707|NCT00765076|468841468|FG002|Overall Study|Withdrawal by Subject|1|||
130240708|NCT02875080|468841469|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
130240709|NCT02875080|468841470|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
130240710|NCT02875080|468841471|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
130240711|NCT00768053|468841472|FG000|Overall Study|Adverse Event|10|||
130240712|NCT00768053|468841472|FG000|Overall Study|Lost to Follow-up|1|||
130240713|NCT01164475|468841473|FG000|Overall Study|Lack of Efficacy|1|||
130240714|NCT01164475|468841474|FG001|Overall Study|Lack of Efficacy|0|||
130240715|NCT01164475|468841473|FG000|Overall Study|Other|0|||
130240716|NCT01164475|468841474|FG001|Overall Study|Other|1|||
130240717|NCT01164475|468841473|FG000|Overall Study|Progressive disease|0|||
130240718|NCT01164475|468841474|FG001|Overall Study|Progressive disease|1|||
130240719|NCT01164475|468841473|FG000|Overall Study|Protocol Violation|1|||
130240720|NCT01164475|468841474|FG001|Overall Study|Protocol Violation|0|||
130240721|NCT03244189|468841476|FG000|Overall Study|Death|0|||
130240722|NCT03244189|468841477|FG001|Overall Study|Death|2|||
130240723|NCT03244189|468841476|FG000|Overall Study|Lost to Follow-up|92|||
130240724|NCT03244189|468841477|FG001|Overall Study|Lost to Follow-up|107|||
130240725|NCT03244189|468841476|FG000|Overall Study|Physician Decision|4|||
130240726|NCT03244189|468841477|FG001|Overall Study|Physician Decision|2|||
130240727|NCT03244189|468841476|FG000|Overall Study|Pregnancy|7|||
130240728|NCT03244189|468841477|FG001|Overall Study|Pregnancy|5|||
130240729|NCT03244189|468841476|FG000|Overall Study|Protocol Violation|0|||
130240730|NCT03244189|468841477|FG001|Overall Study|Protocol Violation|2|||
130240731|NCT03244189|468841476|FG000|Overall Study|Withdrawal by Subject|45|||
130240732|NCT03244189|468841477|FG001|Overall Study|Withdrawal by Subject|23|||
130100251|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
130240733|NCT03244189|468841476|FG000|Overall Study|Technical Problems|2|||
130110721|NCT03705169|468365848|FG003|Overall Study|Did not receive study treatment|1|||
130240734|NCT03244189|468841477|FG001|Overall Study|Technical Problems|0|||
130240735|NCT06170827|468841478|FG000|Overall Study|Withdrawal by Subject|1|||
130240736|NCT06170827|468841479|FG001|Overall Study|Withdrawal by Subject|1|||
130240737|NCT03421808|468841484|FG000|Overall Study|COVID related problems|2|||
130240738|NCT03421808|468841485|FG001|Overall Study|COVID related problems|0|||
130240739|NCT03421808|468841484|FG000|Overall Study|Withdrawal by Subject|1|||
130240740|NCT03421808|468841485|FG001|Overall Study|Withdrawal by Subject|0|||
130240741|NCT03421808|468841484|FG000|Overall Study|Protocol Violation|0|||
130240742|NCT03421808|468841485|FG001|Overall Study|Protocol Violation|1|||
130240743|NCT02180867|468841488|FG000|Overall Study|Adverse Event|3|||
130240744|NCT02180867|468841489|FG001|Overall Study|Adverse Event|4|||
130240745|NCT02180867|468841490|FG002|Overall Study|Adverse Event|1|||
130240746|NCT02180867|468841491|FG003|Overall Study|Adverse Event|5|||
130240747|NCT02180867|468841492|FG004|Overall Study|Adverse Event|0|||
130240748|NCT02180867|468841493|FG005|Overall Study|Adverse Event|0|||
130240749|NCT02180867|468841494|FG006|Overall Study|Adverse Event|0|||
130240750|NCT02180867|468841488|FG000|Overall Study|Death|0|||
130240751|NCT02180867|468841489|FG001|Overall Study|Death|0|||
130240752|NCT02180867|468841490|FG002|Overall Study|Death|0|||
130240753|NCT02180867|468841491|FG003|Overall Study|Death|0|||
130240754|NCT02180867|468841492|FG004|Overall Study|Death|1|||
130240755|NCT02180867|468841493|FG005|Overall Study|Death|0|||
130240756|NCT02180867|468841494|FG006|Overall Study|Death|0|||
130240757|NCT02180867|468841488|FG000|Overall Study|Lack of Efficacy|0|||
130240758|NCT02180867|468841489|FG001|Overall Study|Lack of Efficacy|2|||
130240759|NCT02180867|468841490|FG002|Overall Study|Lack of Efficacy|0|||
130240760|NCT02180867|468841491|FG003|Overall Study|Lack of Efficacy|1|||
130240761|NCT02180867|468841492|FG004|Overall Study|Lack of Efficacy|6|||
130240762|NCT02180867|468841493|FG005|Overall Study|Lack of Efficacy|0|||
130240763|NCT02180867|468841494|FG006|Overall Study|Lack of Efficacy|1|||
130240764|NCT02180867|468841488|FG000|Overall Study|Physician Decision|1|||
130240765|NCT02180867|468841489|FG001|Overall Study|Physician Decision|3|||
130240766|NCT02180867|468841490|FG002|Overall Study|Physician Decision|1|||
130240767|NCT02180867|468841491|FG003|Overall Study|Physician Decision|10|||
130240768|NCT02180867|468841492|FG004|Overall Study|Physician Decision|9|||
130240769|NCT02180867|468841493|FG005|Overall Study|Physician Decision|3|||
130240770|NCT02180867|468841494|FG006|Overall Study|Physician Decision|4|||
130240771|NCT02180867|468841488|FG000|Overall Study|Withdrawal by Subject|0|||
130240772|NCT02180867|468841489|FG001|Overall Study|Withdrawal by Subject|0|||
130240773|NCT02180867|468841490|FG002|Overall Study|Withdrawal by Subject|0|||
130240774|NCT02180867|468841491|FG003|Overall Study|Withdrawal by Subject|1|||
130240775|NCT02180867|468841492|FG004|Overall Study|Withdrawal by Subject|1|||
130240776|NCT02180867|468841493|FG005|Overall Study|Withdrawal by Subject|0|||
130240777|NCT02180867|468841494|FG006|Overall Study|Withdrawal by Subject|0|||
130240778|NCT02180867|468841488|FG000|Overall Study|Ineligible|1|||
130240779|NCT02180867|468841489|FG001|Overall Study|Ineligible|2|||
130240780|NCT02180867|468841490|FG002|Overall Study|Ineligible|0|||
130240781|NCT02180867|468841491|FG003|Overall Study|Ineligible|3|||
130240782|NCT02180867|468841492|FG004|Overall Study|Ineligible|5|||
130240783|NCT02180867|468841493|FG005|Overall Study|Ineligible|0|||
130240784|NCT02180867|468841494|FG006|Overall Study|Ineligible|0|||
130240785|NCT02180867|468841488|FG000|Overall Study|Repeat Eligibility Studies|0|||
130240786|NCT02180867|468841489|FG001|Overall Study|Repeat Eligibility Studies|0|||
130240787|NCT02180867|468841490|FG002|Overall Study|Repeat Eligibility Studies|0|||
130240788|NCT02180867|468841491|FG003|Overall Study|Repeat Eligibility Studies|0|||
130240789|NCT02180867|468841492|FG004|Overall Study|Repeat Eligibility Studies|1|||
130240790|NCT02180867|468841493|FG005|Overall Study|Repeat Eligibility Studies|0|||
130240791|NCT02180867|468841494|FG006|Overall Study|Repeat Eligibility Studies|0|||
130240792|NCT02180867|468841488|FG000|Overall Study|Refusal of further protocol therapy|1|||
130240793|NCT02180867|468841489|FG001|Overall Study|Refusal of further protocol therapy|0|||
130240794|NCT02180867|468841490|FG002|Overall Study|Refusal of further protocol therapy|2|||
130240795|NCT02180867|468841491|FG003|Overall Study|Refusal of further protocol therapy|6|||
130240796|NCT02180867|468841492|FG004|Overall Study|Refusal of further protocol therapy|4|||
130240797|NCT02180867|468841493|FG005|Overall Study|Refusal of further protocol therapy|0|||
130240798|NCT02180867|468841494|FG006|Overall Study|Refusal of further protocol therapy|0|||
130240799|NCT02337686|468841495|FG000|Overall Study|Adverse Event|1|||
130240800|NCT00177671|468842460|FG000|Overall Study|Withdrawal by Subject|5|||
130240801|NCT00177671|468842461|FG001|Overall Study|Withdrawal by Subject|6|||
130240802|NCT00177671|468842460|FG000|Overall Study|medical complications|2|||
130240803|NCT00177671|468842461|FG001|Overall Study|medical complications|0|||
130240804|NCT00177671|468842460|FG000|Overall Study|Adverse Event|6|||
130240805|NCT00177671|468842461|FG001|Overall Study|Adverse Event|0|||
130240806|NCT00177671|468842460|FG000|Overall Study|Physician Decision|12|||
130240807|NCT00177671|468842461|FG001|Overall Study|Physician Decision|8|||
130240808|NCT02293499|468842462|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
130240809|NCT02293499|468842463|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
130316212|NCT00683878|469124329|FG000|Overall Study|Withdrawal by Subject|9|||
130100252|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
130100253|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
130100254|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
130100255|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
130100256|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
130100257|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
130100258|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
130100259|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
130100260|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
130100261|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
130100262|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
130100263|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
130100264|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
130100265|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
130100266|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
130100267|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
130100268|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
130100269|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
130100270|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
130100271|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
130100272|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
130100273|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
130100274|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
130100275|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
130100276|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
130100277|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
130100278|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
130100279|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
130100280|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
130100281|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
130100282|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
130100283|NCT01299272|468325955|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
130100284|NCT01299272|468325956|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
130100285|NCT01299272|468325957|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
130100286|NCT01299272|468325958|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
130100287|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
130100288|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
130100289|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
130100290|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
130100291|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
130100292|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
130100293|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
130100294|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
130100295|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
130100296|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
130100297|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
130100298|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
130100299|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
130100300|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
130100301|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
129884616|NCT00684762|467538600|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
129884617|NCT00684762|467538601|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130240810|NCT02293499|468842464|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
130240811|NCT02293499|468842462|FG000|Intervention - Camp|Withdrawal by Subject|3|||
130240812|NCT02293499|468842463|FG001|Intervention - Camp|Withdrawal by Subject|6|||
130240813|NCT02293499|468842464|FG002|Intervention - Camp|Withdrawal by Subject|2|||
130240814|NCT02293499|468842462|FG000|Intervention - Camp|these are those not showing up at camp|24|||
130240815|NCT02293499|468842463|FG001|Intervention - Camp|these are those not showing up at camp|28|||
130240816|NCT02293499|468842464|FG002|Intervention - Camp|these are those not showing up at camp|4|||
130240817|NCT02293499|468842462|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
130240818|NCT02293499|468842463|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
130240819|NCT02293499|468842464|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
130240820|NCT02293499|468842462|FG000|3 Month Follow Up|Lost to Follow-up|14|||
130240821|NCT02293499|468842463|FG001|3 Month Follow Up|Lost to Follow-up|15|||
130240822|NCT02293499|468842464|FG002|3 Month Follow Up|Lost to Follow-up|6|||
130240823|NCT02293499|468842462|FG000|6 Month Follow Up|Lost to Follow-up|17|||
130240824|NCT02293499|468842463|FG001|6 Month Follow Up|Lost to Follow-up|27|||
130240825|NCT02293499|468842464|FG002|6 Month Follow Up|Lost to Follow-up|6|||
130240826|NCT02293499|468842462|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
130240827|NCT02293499|468842463|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
130240828|NCT02293499|468842464|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
130240829|NCT02293499|468842462|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
130240830|NCT02293499|468842463|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
130240831|NCT02293499|468842464|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
130240832|NCT02293499|468842462|FG000|9 Month Follow Up|Lost to Follow-up|24|||
130240833|NCT02293499|468842463|FG001|9 Month Follow Up|Lost to Follow-up|28|||
130240834|NCT02293499|468842464|FG002|9 Month Follow Up|Lost to Follow-up|4|||
130240835|NCT02293499|468842462|FG000|12 Month Follow Up|Lost to Follow-up|26|||
130240836|NCT02293499|468842463|FG001|12 Month Follow Up|Lost to Follow-up|25|||
130240837|NCT02293499|468842464|FG002|12 Month Follow Up|Lost to Follow-up|6|||
130240838|NCT02293499|468842462|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
130240839|NCT02293499|468842463|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
130240840|NCT02293499|468842464|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
130240841|NCT02293499|468842462|FG000|15 Month Follow Up|Lost to Follow-up|22|||
130240842|NCT02293499|468842463|FG001|15 Month Follow Up|Lost to Follow-up|22|||
130240843|NCT02293499|468842464|FG002|15 Month Follow Up|Lost to Follow-up|7|||
130240844|NCT00690898|468842465|FG000|SCREENING|Screen failure|18|||
130240845|NCT00690898|468842465|FG000|TREATMENT|Adverse Event|3|||
130240846|NCT00690898|468842465|FG000|TREATMENT|Lack of Efficacy|18|||
130240847|NCT00690898|468842465|FG000|TREATMENT|Withdrawal by Subject|4|||
130240848|NCT00690898|468842465|FG000|TREATMENT|Other (not otherwise specified)|1|||
130240849|NCT01847209|468842468|FG000|Overall Study|Withdrawal by Subject|1|||
130240850|NCT01847209|468842468|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
130240851|NCT02008370|468842489|FG000|Overall Study|Lost to Follow-up|7|||
130240852|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
130240853|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
130240854|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
130240855|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
130240856|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
130240857|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240858|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
130240859|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240860|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240861|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
130240862|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Death|0|||
130240863|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Death|0|||
130240864|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Death|1|||
130240865|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Death|0|||
130240866|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Death|0|||
130240867|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
130240868|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
130240869|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
130240870|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
130240871|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
130240872|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Other|2|||
130240873|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Other|1|||
130240874|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Other|0|||
130240875|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Other|0|||
130240876|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Other|0|||
130240877|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240878|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240879|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
130240880|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240881|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
130240882|NCT03317496|468842493|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130240883|NCT03317496|468842494|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
130240884|NCT03317496|468842495|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130240885|NCT03317496|468842496|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
130240886|NCT03317496|468842497|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
130240887|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
130240888|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
130240889|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
130240890|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
130240891|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
130240892|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
130240893|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130240894|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130028062|NCT00793793|468062678|FG000|Overall Study|Lost to Follow-up|0|||
130240895|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130240896|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
130240897|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240898|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240899|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
130240900|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240901|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
130240902|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
130028063|NCT00793793|468062679|FG001|Overall Study|Lost to Follow-up|0|||
130240903|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
130240904|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
130240905|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
130240906|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
130240907|NCT03317496|468842493|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
130240908|NCT03317496|468842494|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
130240909|NCT03317496|468842495|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
130240910|NCT03317496|468842496|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
130240911|NCT03317496|468842497|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
130240912|NCT03317496|468842493|FG000|Phase 2: Treatment|Adverse Event|0|||
130240913|NCT03317496|468842494|FG001|Phase 2: Treatment|Adverse Event|0|||
130240914|NCT03317496|468842495|FG002|Phase 2: Treatment|Adverse Event|0|||
130240915|NCT03317496|468842496|FG003|Phase 2: Treatment|Adverse Event|0|||
130240916|NCT03317496|468842497|FG004|Phase 2: Treatment|Adverse Event|6|||
130240917|NCT03317496|468842493|FG000|Phase 2: Treatment|Progressive disease|0|||
130240918|NCT03317496|468842494|FG001|Phase 2: Treatment|Progressive disease|0|||
130240919|NCT03317496|468842495|FG002|Phase 2: Treatment|Progressive disease|0|||
130240920|NCT03317496|468842496|FG003|Phase 2: Treatment|Progressive disease|0|||
130240921|NCT03317496|468842497|FG004|Phase 2: Treatment|Progressive disease|22|||
130240922|NCT03317496|468842493|FG000|Phase 2: Treatment|Other|0|||
130240923|NCT03317496|468842494|FG001|Phase 2: Treatment|Other|0|||
130240924|NCT03317496|468842495|FG002|Phase 2: Treatment|Other|0|||
130240925|NCT03317496|468842496|FG003|Phase 2: Treatment|Other|0|||
130240926|NCT03317496|468842497|FG004|Phase 2: Treatment|Other|4|||
130240927|NCT03317496|468842493|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
130240928|NCT03317496|468842494|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
130240929|NCT03317496|468842495|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
130240930|NCT03317496|468842496|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
130240931|NCT03317496|468842497|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
130240932|NCT03317496|468842493|FG000|Phase 2: Treatment|Physician Decision|0|||
130240933|NCT03317496|468842494|FG001|Phase 2: Treatment|Physician Decision|0|||
130240934|NCT03317496|468842495|FG002|Phase 2: Treatment|Physician Decision|0|||
130240935|NCT03317496|468842496|FG003|Phase 2: Treatment|Physician Decision|0|||
130240936|NCT03317496|468842497|FG004|Phase 2: Treatment|Physician Decision|1|||
130240937|NCT03317496|468842493|FG000|Phase 2: Treatment|Death|0|||
130240938|NCT03317496|468842494|FG001|Phase 2: Treatment|Death|0|||
130240939|NCT03317496|468842495|FG002|Phase 2: Treatment|Death|0|||
130240940|NCT03317496|468842496|FG003|Phase 2: Treatment|Death|0|||
130240941|NCT03317496|468842497|FG004|Phase 2: Treatment|Death|1|||
130240942|NCT03317496|468842493|FG000|Phase 2: Follow-up|Death|0|||
130240943|NCT03317496|468842494|FG001|Phase 2: Follow-up|Death|0|||
130240944|NCT03317496|468842495|FG002|Phase 2: Follow-up|Death|0|||
130240945|NCT03317496|468842496|FG003|Phase 2: Follow-up|Death|0|||
130240946|NCT03317496|468842497|FG004|Phase 2: Follow-up|Death|24|||
130240947|NCT03317496|468842493|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
130240948|NCT03317496|468842494|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
130240949|NCT03317496|468842495|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
130240950|NCT03317496|468842496|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
130240951|NCT03317496|468842497|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
130240952|NCT03317496|468842493|FG000|Phase 2: Follow-up|Other|0|||
130028064|NCT00793793|468062680|FG002|Overall Study|Lost to Follow-up|1|||
130028065|NCT00793793|468062681|FG003|Overall Study|Lost to Follow-up|0|||
130240953|NCT03317496|468842494|FG001|Phase 2: Follow-up|Other|0|||
130240954|NCT03317496|468842495|FG002|Phase 2: Follow-up|Other|0|||
130240955|NCT03317496|468842496|FG003|Phase 2: Follow-up|Other|0|||
130240956|NCT03317496|468842497|FG004|Phase 2: Follow-up|Other|1|||
130240957|NCT03317496|468842493|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240958|NCT03317496|468842494|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240959|NCT03317496|468842495|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240960|NCT03317496|468842496|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
130240961|NCT03317496|468842497|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
130240962|NCT02737618|468842498|FG000|Overall Study|Withdrawal by Subject|9|||
130240963|NCT01879852|468842502|FG000|Overall Study|Withdrawal by Subject|2|||
130240964|NCT01879852|468842503|FG001|Overall Study|Withdrawal by Subject|0|||
130240965|NCT02696616|468842504|FG000|Overall Study|Adverse Event|0|||
130240966|NCT02696616|468842505|FG001|Overall Study|Adverse Event|1|||
130240967|NCT02696616|468842506|FG002|Overall Study|Adverse Event|0|||
130240968|NCT02696616|468842507|FG003|Overall Study|Adverse Event|0|||
130240969|NCT02696616|468842508|FG004|Overall Study|Adverse Event|0|||
130028066|NCT00793793|468062682|FG004|Overall Study|Lost to Follow-up|0|||
130240970|NCT02696616|468842509|FG005|Overall Study|Adverse Event|0|||
130240971|NCT02696616|468842510|FG006|Overall Study|Adverse Event|0|||
130240972|NCT01500083|468842513|FG000|Overall Study|Adverse Event|4|||
130240973|NCT01500083|468842514|FG001|Overall Study|Adverse Event|17|||
130240974|NCT01500083|468842513|FG000|Overall Study|Death|0|||
130240975|NCT01500083|468842514|FG001|Overall Study|Death|2|||
130240976|NCT01500083|468842513|FG000|Overall Study|Lost to Follow-up|1|||
130240977|NCT01500083|468842514|FG001|Overall Study|Lost to Follow-up|0|||
130240978|NCT01500083|468842513|FG000|Overall Study|Withdrawal of Consent|0|||
130240979|NCT01500083|468842514|FG001|Overall Study|Withdrawal of Consent|1|||
130240980|NCT01500083|468842513|FG000|Overall Study|Disease Progression|2|||
130240981|NCT01500083|468842514|FG001|Overall Study|Disease Progression|10|||
130240982|NCT01500083|468842513|FG000|Overall Study|Investigator Discretion|3|||
130240983|NCT01500083|468842514|FG001|Overall Study|Investigator Discretion|8|||
130240984|NCT01500083|468842513|FG000|Overall Study|Other Reasons|2|||
130240985|NCT01500083|468842514|FG001|Overall Study|Other Reasons|5|||
130240986|NCT01555931|468842515|FG000|Overall Study|Lost to Follow-up|2|||
130240987|NCT01555931|468842516|FG001|Overall Study|Lost to Follow-up|5|||
130240988|NCT02299167|468842519|FG000|Overall Study|patients were excluded from the study|11|||
130240989|NCT04615507|468842520|FG000|Period 1|Covid-19 exposure|2|||
130240990|NCT04615507|468842521|FG001|Period 1|Covid-19 exposure|1|||
130240991|NCT04615507|468842520|FG000|Period 2|Covid-19 exposure|0|||
130240992|NCT04615507|468842521|FG001|Period 2|Covid-19 exposure|1|||
130240993|NCT04615507|468842520|FG000|Period 2|Protocol Violation|1|||
130240994|NCT04615507|468842521|FG001|Period 2|Protocol Violation|0|||
130240995|NCT04615507|468842520|FG000|Period 2|Withdrawal by Subject|1|||
130240996|NCT04615507|468842521|FG001|Period 2|Withdrawal by Subject|0|||
130028067|NCT00793793|468062683|FG005|Overall Study|Lost to Follow-up|0|||
130240997|NCT04615507|468842520|FG000|Period 2|Adverse Event|0|||
130240998|NCT04615507|468842521|FG001|Period 2|Adverse Event|1|||
130028068|NCT00793793|468062684|FG006|Overall Study|Lost to Follow-up|0|||
130240999|NCT04615507|468842520|FG000|Period 3|Covid-19 exposure|0|||
130241000|NCT04615507|468842521|FG001|Period 3|Covid-19 exposure|1|||
130241001|NCT04598828|468842522|FG000|Overall Study|Physician Decision|1|||
130241002|NCT04598828|468842523|FG001|Overall Study|Physician Decision|0|||
130241003|NCT04598828|468842522|FG000|Overall Study|Withdrawal by Subject|0|||
130241004|NCT04598828|468842523|FG001|Overall Study|Withdrawal by Subject|1|||
130241005|NCT04598828|468842522|FG000|Overall Study|Withdrawal by Subject|0|||
130241006|NCT04598828|468842523|FG001|Overall Study|Withdrawal by Subject|1|||
130241007|NCT02676973|468842524|FG000|Overall Study|Withdrawal by Subject|9|||
130241008|NCT02676973|468842525|FG001|Overall Study|Withdrawal by Subject|8|||
130241009|NCT02676973|468842526|FG002|Overall Study|Withdrawal by Subject|11|||
130241010|NCT02676973|468842524|FG000|Overall Study|Lost to Follow-up|8|||
130241011|NCT02676973|468842525|FG001|Overall Study|Lost to Follow-up|12|||
130241012|NCT02676973|468842526|FG002|Overall Study|Lost to Follow-up|8|||
130241013|NCT02676973|468842524|FG000|Overall Study|Death|2|||
130241014|NCT02676973|468842525|FG001|Overall Study|Death|1|||
130241015|NCT02676973|468842526|FG002|Overall Study|Death|5|||
130241016|NCT01078662|468842528|FG000|Overall Study|Death|41|||
130241017|NCT01078662|468842529|FG001|Overall Study|Death|103|||
130241018|NCT01078662|468842530|FG002|Overall Study|Death|18|||
130241019|NCT01078662|468842531|FG003|Overall Study|Death|5|||
130241020|NCT01078662|468842532|FG004|Overall Study|Death|8|||
130241021|NCT01078662|468842528|FG000|Overall Study|Patients reached data cut-off|12|||
130241022|NCT01078662|468842529|FG001|Overall Study|Patients reached data cut-off|53|||
130241023|NCT01078662|468842530|FG002|Overall Study|Patients reached data cut-off|2|||
130241024|NCT01078662|468842531|FG003|Overall Study|Patients reached data cut-off|2|||
130241025|NCT01078662|468842532|FG004|Overall Study|Patients reached data cut-off|3|||
130241026|NCT01078662|468842528|FG000|Overall Study|Withdrawal by Subject|4|||
130241027|NCT01078662|468842529|FG001|Overall Study|Withdrawal by Subject|11|||
130241028|NCT01078662|468842530|FG002|Overall Study|Withdrawal by Subject|1|||
130241029|NCT01078662|468842531|FG003|Overall Study|Withdrawal by Subject|0|||
130241030|NCT01078662|468842532|FG004|Overall Study|Withdrawal by Subject|0|||
130241031|NCT01078662|468842528|FG000|Overall Study|Protocol Violation|0|||
130241032|NCT01078662|468842529|FG001|Overall Study|Protocol Violation|1|||
130241033|NCT01078662|468842530|FG002|Overall Study|Protocol Violation|0|||
130241034|NCT01078662|468842531|FG003|Overall Study|Protocol Violation|0|||
130241035|NCT01078662|468842532|FG004|Overall Study|Protocol Violation|0|||
130241036|NCT01078662|468842528|FG000|Overall Study|Lost to Follow-up|1|||
130241037|NCT01078662|468842529|FG001|Overall Study|Lost to Follow-up|0|||
130241038|NCT01078662|468842530|FG002|Overall Study|Lost to Follow-up|0|||
130241039|NCT01078662|468842531|FG003|Overall Study|Lost to Follow-up|0|||
130241040|NCT01078662|468842532|FG004|Overall Study|Lost to Follow-up|0|||
130241041|NCT00700635|468842534|FG000|Overall Study|Adverse Event|1|||
130241042|NCT00700635|468842535|FG001|Overall Study|Adverse Event|0|||
130241043|NCT00700635|468842536|FG002|Overall Study|Adverse Event|0|||
130241044|NCT00700635|468842534|FG000|Overall Study|Lost to Follow-up|1|||
130241045|NCT00700635|468842535|FG001|Overall Study|Lost to Follow-up|3|||
130241046|NCT00700635|468842536|FG002|Overall Study|Lost to Follow-up|0|||
130241047|NCT00700635|468842534|FG000|Overall Study|Protocol Violation|2|||
130241048|NCT00700635|468842535|FG001|Overall Study|Protocol Violation|2|||
130241049|NCT00700635|468842536|FG002|Overall Study|Protocol Violation|0|||
130028069|NCT00793793|468062685|FG007|Overall Study|Lost to Follow-up|0|||
130241050|NCT00700635|468842534|FG000|Overall Study|Withdrawal by Subject|7|||
130241051|NCT00700635|468842535|FG001|Overall Study|Withdrawal by Subject|3|||
130241052|NCT00700635|468842536|FG002|Overall Study|Withdrawal by Subject|1|||
130241053|NCT05172570|468842537|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
130241054|NCT05172570|468842538|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
130241055|NCT05172570|468842539|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
130241056|NCT05172570|468842537|FG000|Overall Study|PI Decision due to equipment shortages|0|||
130241057|NCT05172570|468842538|FG001|Overall Study|PI Decision due to equipment shortages|0|||
130028070|NCT00793793|468062686|FG008|Overall Study|Lost to Follow-up|1|||
130028071|NCT00793793|468062687|FG009|Overall Study|Lost to Follow-up|3|||
130241058|NCT05172570|468842539|FG002|Overall Study|PI Decision due to equipment shortages|1|||
130241059|NCT04937387|468842542|FG000|Overall Study|Adverse Event|1|||
130241060|NCT04937387|468842543|FG001|Overall Study|Adverse Event|0|||
130241061|NCT04937387|468842544|FG002|Overall Study|Adverse Event|2|||
130241062|NCT04937387|468842545|FG003|Overall Study|Adverse Event|0|||
130241063|NCT04937387|468842542|FG000|Overall Study|Lack of Efficacy|1|||
130241064|NCT04937387|468842543|FG001|Overall Study|Lack of Efficacy|0|||
130241065|NCT04937387|468842544|FG002|Overall Study|Lack of Efficacy|0|||
130241066|NCT04937387|468842545|FG003|Overall Study|Lack of Efficacy|1|||
130241067|NCT04937387|468842542|FG000|Overall Study|Withdrawal by Subject|1|||
130241068|NCT04937387|468842543|FG001|Overall Study|Withdrawal by Subject|0|||
130241069|NCT04937387|468842544|FG002|Overall Study|Withdrawal by Subject|1|||
130241070|NCT04937387|468842545|FG003|Overall Study|Withdrawal by Subject|1|||
130241071|NCT04937387|468842542|FG000|Overall Study|Randomized in error|0|||
130241072|NCT04937387|468842543|FG001|Overall Study|Randomized in error|0|||
130241073|NCT04937387|468842544|FG002|Overall Study|Randomized in error|0|||
130241074|NCT04937387|468842545|FG003|Overall Study|Randomized in error|1|||
130241075|NCT02872714|468842554|FG000|Overall Study|Progressive Disease|1|||
130241076|NCT02872714|468842555|FG001|Overall Study|Progressive Disease|2|||
130241077|NCT02872714|468842556|FG002|Overall Study|Progressive Disease|0|||
130241078|NCT02872714|468842557|FG003|Overall Study|Progressive Disease|0|||
130241079|NCT02872714|468842558|FG004|Overall Study|Progressive Disease|0|||
130241080|NCT02872714|468842554|FG000|Overall Study|Death|87|||
130241081|NCT02872714|468842555|FG001|Overall Study|Death|36|||
130241082|NCT02872714|468842556|FG002|Overall Study|Death|8|||
130241083|NCT02872714|468842557|FG003|Overall Study|Death|81|||
130241084|NCT02872714|468842558|FG004|Overall Study|Death|2|||
130028072|NCT00793793|468062688|FG010|Overall Study|Lost to Follow-up|1|||
130028073|NCT00793793|468062689|FG011|Overall Study|Lost to Follow-up|0|||
130028074|NCT00793793|468062678|FG000|Overall Study|Withdrawal by Subject|0|||
130241085|NCT02872714|468842554|FG000|Overall Study|Lost to Follow-up|2|||
130241086|NCT02872714|468842555|FG001|Overall Study|Lost to Follow-up|1|||
130241087|NCT02872714|468842556|FG002|Overall Study|Lost to Follow-up|0|||
130241088|NCT02872714|468842557|FG003|Overall Study|Lost to Follow-up|3|||
130028075|NCT00793793|468062679|FG001|Overall Study|Withdrawal by Subject|0|||
130241089|NCT02872714|468842558|FG004|Overall Study|Lost to Follow-up|0|||
130241090|NCT02872714|468842554|FG000|Overall Study|Physician Decision|0|||
130241091|NCT02872714|468842555|FG001|Overall Study|Physician Decision|0|||
130241092|NCT02872714|468842556|FG002|Overall Study|Physician Decision|0|||
130241093|NCT02872714|468842557|FG003|Overall Study|Physician Decision|1|||
130241094|NCT02872714|468842558|FG004|Overall Study|Physician Decision|0|||
130241095|NCT02872714|468842554|FG000|Overall Study|Withdrawal by Subject|1|||
130241096|NCT02872714|468842555|FG001|Overall Study|Withdrawal by Subject|3|||
130241097|NCT02872714|468842556|FG002|Overall Study|Withdrawal by Subject|0|||
130241098|NCT02872714|468842557|FG003|Overall Study|Withdrawal by Subject|2|||
130241099|NCT02872714|468842558|FG004|Overall Study|Withdrawal by Subject|0|||
130241100|NCT02872714|468842554|FG000|Overall Study|Captured as Other|2|||
130241101|NCT02872714|468842555|FG001|Overall Study|Captured as Other|0|||
130241102|NCT02872714|468842556|FG002|Overall Study|Captured as Other|0|||
130241103|NCT02872714|468842557|FG003|Overall Study|Captured as Other|1|||
130241104|NCT02872714|468842558|FG004|Overall Study|Captured as Other|0|||
130241105|NCT01001104|468843448|FG000|Overall Study|Adverse Event|2|||
130241106|NCT01001104|468843449|FG001|Overall Study|Adverse Event|1|||
130241107|NCT01001104|468843450|FG002|Overall Study|Adverse Event|0|||
130241108|NCT01001104|468843451|FG003|Overall Study|Adverse Event|0|||
130241109|NCT01001104|468843448|FG000|Overall Study|Lost to Follow-up|0|||
130241110|NCT01001104|468843449|FG001|Overall Study|Lost to Follow-up|0|||
130241111|NCT01001104|468843450|FG002|Overall Study|Lost to Follow-up|1|||
130241112|NCT01001104|468843451|FG003|Overall Study|Lost to Follow-up|0|||
130241113|NCT01001104|468843448|FG000|Overall Study|Entry Criteria Not Met|0|||
130241114|NCT01001104|468843449|FG001|Overall Study|Entry Criteria Not Met|0|||
130241115|NCT01001104|468843450|FG002|Overall Study|Entry Criteria Not Met|0|||
130241116|NCT01001104|468843451|FG003|Overall Study|Entry Criteria Not Met|1|||
130241117|NCT01001104|468843448|FG000|Overall Study|Withdrawal by Subject|0|||
130241118|NCT01001104|468843449|FG001|Overall Study|Withdrawal by Subject|0|||
130241119|NCT01001104|468843450|FG002|Overall Study|Withdrawal by Subject|0|||
130241120|NCT01001104|468843451|FG003|Overall Study|Withdrawal by Subject|2|||
130241121|NCT02397837|468843452|FG000|Overall Study|Withdrawal by Subject|6|||
130241122|NCT02397837|468843453|FG001|Overall Study|Withdrawal by Subject|5|||
130241123|NCT02397837|468843452|FG000|Overall Study|Physician Decision|1|||
130241124|NCT02397837|468843453|FG001|Overall Study|Physician Decision|1|||
130241125|NCT00599313|468843455|FG000|Overall Study|Adverse Event|19|||
130241126|NCT00599313|468843455|FG000|Overall Study|Disease Progression|12|||
130241127|NCT00599313|468843455|FG000|Overall Study|Patient Request|4|||
130241128|NCT00599313|468843455|FG000|Overall Study|Ineligible|1|||
130241129|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Adverse Event|2|||
130241130|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
130241131|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
130241132|NCT02536794|468843456|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
130241133|NCT02536794|468843456|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
130241134|NCT02536794|468843456|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
130241135|NCT00898807|468843469|FG000|Overall Study|Withdrawal by Subject|5|||
130241136|NCT00898807|468843470|FG001|Overall Study|Withdrawal by Subject|3|||
130241137|NCT00898807|468843469|FG000|Overall Study|Family pressure to discontinue|2|||
130028076|NCT00793793|468062680|FG002|Overall Study|Withdrawal by Subject|0|||
130028077|NCT00793793|468062681|FG003|Overall Study|Withdrawal by Subject|0|||
130028078|NCT00793793|468062682|FG004|Overall Study|Withdrawal by Subject|1|||
130028079|NCT00793793|468062683|FG005|Overall Study|Withdrawal by Subject|0|||
130028080|NCT00793793|468062684|FG006|Overall Study|Withdrawal by Subject|0|||
130028081|NCT00793793|468062685|FG007|Overall Study|Withdrawal by Subject|0|||
130028082|NCT00793793|468062686|FG008|Overall Study|Withdrawal by Subject|1|||
130241138|NCT00898807|468843470|FG001|Overall Study|Family pressure to discontinue|2|||
130241139|NCT00898807|468843469|FG000|Overall Study|Lost to Follow-up|1|||
130241140|NCT00898807|468843470|FG001|Overall Study|Lost to Follow-up|3|||
130241141|NCT00898807|468843469|FG000|Overall Study|Death|0|||
130241142|NCT00898807|468843470|FG001|Overall Study|Death|1|||
130241143|NCT00817063|468843471|FG000|Overall Study|Adverse Event|32|||
130241144|NCT00817063|468843472|FG001|Overall Study|Adverse Event|13|||
130241145|NCT00817063|468843471|FG000|Overall Study|Death|1|||
130241146|NCT00817063|468843472|FG001|Overall Study|Death|1|||
130241147|NCT00817063|468843471|FG000|Overall Study|Lack of Efficacy|33|||
130241148|NCT00817063|468843472|FG001|Overall Study|Lack of Efficacy|86|||
130241149|NCT00817063|468843471|FG000|Overall Study|Failure to Return|13|||
130241150|NCT00817063|468843472|FG001|Overall Study|Failure to Return|12|||
130241151|NCT00817063|468843471|FG000|Overall Study|Violation of Selection at Entry|7|||
130241152|NCT00817063|468843472|FG001|Overall Study|Violation of Selection at Entry|4|||
130241153|NCT00817063|468843471|FG000|Overall Study|Protocol Violation|3|||
130241154|NCT00817063|468843472|FG001|Overall Study|Protocol Violation|8|||
130241155|NCT00817063|468843471|FG000|Overall Study|Withdrawal by Subject|17|||
130241156|NCT00817063|468843472|FG001|Overall Study|Withdrawal by Subject|37|||
130241157|NCT00817063|468843471|FG000|Overall Study|Early Improvement|19|||
130241158|NCT00817063|468843472|FG001|Overall Study|Early Improvement|4|||
130241159|NCT00817063|468843471|FG000|Overall Study|Administrative|10|||
130241160|NCT00817063|468843472|FG001|Overall Study|Administrative|4|||
130241161|NCT00817063|468843471|FG000|Overall Study|Abnormality of Laboratory Test|2|||
130241162|NCT00817063|468843472|FG001|Overall Study|Abnormality of Laboratory Test|1|||
130241163|NCT01496456|468843473|FG000|Overall Study|Protocol Violation|1|||
130241164|NCT01496456|468843473|FG000|Overall Study|Lost to Follow-up|7|||
130241165|NCT04919161|468843474|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
130241166|NCT04919161|468843475|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
130241167|NCT04919161|468843474|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
130241168|NCT04919161|468843475|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
130241169|NCT04919161|468843474|FG000|Overall Study|Acute ankle sprain after session 1|0|||
130241170|NCT04919161|468843475|FG001|Overall Study|Acute ankle sprain after session 1|1|||
130241171|NCT02489773|468843476|FG000|Overall Study|Lost to Follow-up|4|||
130241172|NCT02489773|468843477|FG001|Overall Study|Lost to Follow-up|1|||
130241173|NCT02489773|468843476|FG000|Overall Study|Physician Decision|1|||
130241174|NCT02489773|468843477|FG001|Overall Study|Physician Decision|0|||
130241175|NCT02489773|468843476|FG000|Overall Study|Withdrawal by Subject|1|||
130241176|NCT02489773|468843477|FG001|Overall Study|Withdrawal by Subject|0|||
130241177|NCT02489773|468843476|FG000|Overall Study|Leave the country or the state|1|||
130241178|NCT02489773|468843477|FG001|Overall Study|Leave the country or the state|1|||
130241179|NCT00712920|468843478|FG000|Overall Study|Adverse Event|3|||
130241180|NCT00712920|468843479|FG001|Overall Study|Adverse Event|4|||
130241181|NCT00712920|468843480|FG002|Overall Study|Adverse Event|7|||
130241182|NCT00712920|468843478|FG000|Overall Study|Withdrawal by Subject|4|||
130241183|NCT00712920|468843479|FG001|Overall Study|Withdrawal by Subject|2|||
130241184|NCT00712920|468843480|FG002|Overall Study|Withdrawal by Subject|1|||
130241185|NCT00712920|468843478|FG000|Overall Study|Lost to Follow-up|1|||
130241186|NCT00712920|468843479|FG001|Overall Study|Lost to Follow-up|4|||
130241187|NCT00712920|468843480|FG002|Overall Study|Lost to Follow-up|0|||
130241188|NCT00712920|468843478|FG000|Overall Study|Lack of Efficacy|1|||
130241189|NCT00712920|468843479|FG001|Overall Study|Lack of Efficacy|0|||
130241190|NCT00712920|468843480|FG002|Overall Study|Lack of Efficacy|1|||
130241191|NCT00712920|468843478|FG000|Overall Study|Other|5|||
130241192|NCT00712920|468843479|FG001|Overall Study|Other|7|||
130241193|NCT00712920|468843480|FG002|Overall Study|Other|3|||
130241194|NCT00712920|468843478|FG000|Overall Study|Non-compliance|3|||
130241195|NCT00712920|468843479|FG001|Overall Study|Non-compliance|0|||
130241196|NCT00712920|468843480|FG002|Overall Study|Non-compliance|0|||
130241197|NCT02362451|468843483|FG000|Overall Study|Withdrawal by Subject|0|||
130241198|NCT02362451|468843484|FG001|Overall Study|Withdrawal by Subject|1|||
130241199|NCT02362451|468843483|FG000|Overall Study|Lack of Efficacy|2|||
130241200|NCT02362451|468843484|FG001|Overall Study|Lack of Efficacy|0|||
130241201|NCT02362451|468843483|FG000|Overall Study|Progression|1|||
130241202|NCT02362451|468843484|FG001|Overall Study|Progression|0|||
130241203|NCT02362451|468843483|FG000|Overall Study|Participant chose other therapy.|1|||
130241204|NCT02362451|468843484|FG001|Overall Study|Participant chose other therapy.|0|||
130241205|NCT02115386|468843485|FG000|Overall Study|Protocol Violation|1|||
130028083|NCT00793793|468062687|FG009|Overall Study|Withdrawal by Subject|0|||
130028084|NCT00793793|468062688|FG010|Overall Study|Withdrawal by Subject|0|||
130241206|NCT02115386|468843485|FG000|Overall Study|Administrative - trial was terminated|6|||
130241207|NCT02493855|468843486|FG000|Overall Study|Non-compliance|1|||
130241208|NCT02493855|468843487|FG001|Overall Study|Non-compliance|0|||
130241209|NCT02493855|468843488|FG002|Overall Study|Non-compliance|0|||
130241210|NCT02493855|468843486|FG000|Overall Study|Adverse Event|0|||
130241211|NCT02493855|468843487|FG001|Overall Study|Adverse Event|1|||
130241212|NCT02493855|468843488|FG002|Overall Study|Adverse Event|0|||
130241213|NCT02493855|468843486|FG000|Overall Study|Withdrawal by Subject|1|||
130241214|NCT02493855|468843487|FG001|Overall Study|Withdrawal by Subject|0|||
130028085|NCT00793793|468062689|FG011|Overall Study|Withdrawal by Subject|0|||
130028086|NCT00793793|468062678|FG000|Overall Study|reason not specified|0|||
130028087|NCT00793793|468062679|FG001|Overall Study|reason not specified|1|||
130028088|NCT00793793|468062680|FG002|Overall Study|reason not specified|0|||
130028089|NCT00793793|468062681|FG003|Overall Study|reason not specified|1|||
130028090|NCT00793793|468062682|FG004|Overall Study|reason not specified|1|||
130028091|NCT00793793|468062683|FG005|Overall Study|reason not specified|1|||
130028092|NCT00793793|468062684|FG006|Overall Study|reason not specified|2|||
130028093|NCT00793793|468062685|FG007|Overall Study|reason not specified|0|||
130028094|NCT00793793|468062686|FG008|Overall Study|reason not specified|7|||
130028095|NCT00793793|468062687|FG009|Overall Study|reason not specified|6|||
130028096|NCT00793793|468062688|FG010|Overall Study|reason not specified|2|||
130028097|NCT00793793|468062689|FG011|Overall Study|reason not specified|4|||
130028098|NCT00950170|468062690|FG000|Overall Study|Parent/Legal Guardian Request|1|||
130028099|NCT00950170|468062690|FG000|Overall Study|Adverse Event|2|||
130028100|NCT00950170|468062690|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130028101|NCT01254669|468062691|FG000|Overall Study|Withdrawal by Subject|0|||
130028102|NCT01254669|468062692|FG001|Overall Study|Withdrawal by Subject|1|||
130028103|NCT01254669|468062691|FG000|Overall Study|time constraint|2|||
130028104|NCT01254669|468062692|FG001|Overall Study|time constraint|2|||
130028105|NCT01254669|468062691|FG000|Overall Study|called to clinic during intervention|1|||
130028106|NCT01254669|468062692|FG001|Overall Study|called to clinic during intervention|1|||
130028107|NCT04173741|468062693|FG000|Overall Study|IVC measurement cannot be done|1|||
130028108|NCT04173741|468062694|FG001|Overall Study|IVC measurement cannot be done|1|||
130028109|NCT02631538|468062695|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
130028110|NCT02631538|468062696|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
130028111|NCT02631538|468062697|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
130028112|NCT02631538|468062698|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
130028113|NCT02631538|468062695|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
130028114|NCT02631538|468062696|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
130028115|NCT02631538|468062697|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
130028116|NCT02631538|468062698|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
130028117|NCT02631538|468062695|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
130028118|NCT02631538|468062696|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
130028119|NCT02631538|468062697|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
130028120|NCT02631538|468062698|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
130028121|NCT02631538|468062695|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
130028122|NCT02631538|468062696|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
130028123|NCT02631538|468062697|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
130028124|NCT02631538|468062698|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
130028125|NCT02631538|468062695|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
130028126|NCT02631538|468062696|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
130028127|NCT02631538|468062697|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
130028128|NCT02631538|468062698|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
130028129|NCT02631538|468062695|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
130028130|NCT02631538|468062696|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
130028131|NCT02631538|468062697|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
130028132|NCT02631538|468062698|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
130028133|NCT00849667|468062699|FG000|Overall Study|Withdrawal by Subject|16|||
130028134|NCT00849667|468062700|FG001|Overall Study|Withdrawal by Subject|33|||
130028135|NCT00849667|468062701|FG002|Overall Study|Withdrawal by Subject|35|||
130028136|NCT00849667|468062699|FG000|Overall Study|Lost to Follow-up|8|||
130028137|NCT00849667|468062700|FG001|Overall Study|Lost to Follow-up|8|||
130028138|NCT00849667|468062701|FG002|Overall Study|Lost to Follow-up|8|||
130028139|NCT00849667|468062699|FG000|Overall Study|Adverse Event|1|||
130028140|NCT00849667|468062700|FG001|Overall Study|Adverse Event|2|||
130028141|NCT00849667|468062701|FG002|Overall Study|Adverse Event|0|||
130028142|NCT00849667|468062699|FG000|Overall Study|Other|18|||
130028143|NCT00849667|468062700|FG001|Overall Study|Other|19|||
130028144|NCT00849667|468062701|FG002|Overall Study|Other|18|||
130028145|NCT00849667|468062699|FG000|Overall Study|Progressive disease|119|||
130028146|NCT00849667|468062700|FG001|Overall Study|Progressive disease|100|||
130241215|NCT02493855|468843488|FG002|Overall Study|Withdrawal by Subject|0|||
130241216|NCT02453048|468843489|FG000|Overall Study|Only part of initial 6 mo. study|0|||
130241217|NCT02453048|468843490|FG001|Overall Study|Only part of initial 6 mo. study|0|||
130241218|NCT02453048|468843491|FG002|Overall Study|Only part of initial 6 mo. study|0|||
130241219|NCT02453048|468843492|FG003|Overall Study|Only part of initial 6 mo. study|0|||
130241220|NCT02453048|468843493|FG004|Overall Study|Only part of initial 6 mo. study|6|||
130241221|NCT02453048|468843489|FG000|Overall Study|Lost to Follow-up|0|||
130241222|NCT02453048|468843490|FG001|Overall Study|Lost to Follow-up|1|||
130241223|NCT02453048|468843491|FG002|Overall Study|Lost to Follow-up|2|||
130241224|NCT02453048|468843492|FG003|Overall Study|Lost to Follow-up|0|||
130241225|NCT02453048|468843493|FG004|Overall Study|Lost to Follow-up|0|||
130241226|NCT03600428|468843495|FG000|Overall Study|Not eligible|0|||
130241227|NCT03600428|468843496|FG001|Overall Study|Not eligible|1|||
130241228|NCT03600428|468843495|FG000|Overall Study|Lost to Follow-up|5|||
130241229|NCT03600428|468843496|FG001|Overall Study|Lost to Follow-up|4|||
130241230|NCT01695746|468843500|FG000|Overall Study|Adverse Event|1|||
130241231|NCT01695746|468843500|FG000|Overall Study|Non-compliance by the participant|3|||
130241232|NCT01695746|468843500|FG000|Overall Study|Protocol Violation|5|||
130241233|NCT01695746|468843500|FG000|Overall Study|Participant not willing to participate|3|||
130241234|NCT01202591|468843501|FG000|Overall Study|Adverse Event|2|||
130241235|NCT01202591|468843502|FG001|Overall Study|Adverse Event|1|||
130241236|NCT01202591|468843503|FG002|Overall Study|Adverse Event|4|||
130241237|NCT01202591|468843504|FG003|Overall Study|Adverse Event|4|||
130241238|NCT01202591|468843505|FG004|Overall Study|Adverse Event|0|||
130241239|NCT01202591|468843506|FG005|Overall Study|Adverse Event|0|||
130241240|NCT01202591|468843501|FG000|Overall Study|Other reason as per investigator|3|||
130241241|NCT01202591|468843502|FG001|Overall Study|Other reason as per investigator|4|||
130241242|NCT01202591|468843503|FG002|Overall Study|Other reason as per investigator|7|||
130241243|NCT01202591|468843504|FG003|Overall Study|Other reason as per investigator|3|||
130241244|NCT01202591|468843505|FG004|Overall Study|Other reason as per investigator|1|||
130241245|NCT01202591|468843506|FG005|Overall Study|Other reason as per investigator|3|||
130241246|NCT01202591|468843501|FG000|Overall Study|Withdrawal by Subject|0|||
130241247|NCT01202591|468843502|FG001|Overall Study|Withdrawal by Subject|0|||
130241248|NCT01202591|468843503|FG002|Overall Study|Withdrawal by Subject|0|||
130241249|NCT01202591|468843504|FG003|Overall Study|Withdrawal by Subject|0|||
130028147|NCT00849667|468062701|FG002|Overall Study|Progressive disease|112|||
130028148|NCT00849667|468062699|FG000|Overall Study|Sponsor decision|208|||
130028149|NCT00849667|468062700|FG001|Overall Study|Sponsor decision|204|||
130241250|NCT01202591|468843505|FG004|Overall Study|Withdrawal by Subject|2|||
130241251|NCT01202591|468843506|FG005|Overall Study|Withdrawal by Subject|1|||
130241252|NCT01202591|468843501|FG000|Overall Study|Objective Disease Progression|0|||
130241253|NCT01202591|468843502|FG001|Overall Study|Objective Disease Progression|0|||
130241254|NCT01202591|468843503|FG002|Overall Study|Objective Disease Progression|0|||
130241255|NCT01202591|468843504|FG003|Overall Study|Objective Disease Progression|0|||
130241256|NCT01202591|468843505|FG004|Overall Study|Objective Disease Progression|2|||
130028150|NCT00849667|468062701|FG002|Overall Study|Sponsor decision|190|||
130028151|NCT00849667|468062699|FG000|Overall Study|Investigator discretion|0|||
130028152|NCT00849667|468062700|FG001|Overall Study|Investigator discretion|0|||
130028153|NCT00849667|468062701|FG002|Overall Study|Investigator discretion|1|||
130028154|NCT03486392|468062707|FG000|Overall Study|Lost to Follow-up|0|||
130028155|NCT03486392|468062708|FG001|Overall Study|Lost to Follow-up|0|||
130028156|NCT03486392|468062709|FG002|Overall Study|Lost to Follow-up|8|||
130028157|NCT03486392|468062710|FG003|Overall Study|Lost to Follow-up|5|||
130028158|NCT03486392|468062711|FG004|Overall Study|Lost to Follow-up|2|||
130028159|NCT03486392|468062707|FG000|Overall Study|Withdrawal by Subject|3|||
130028160|NCT03486392|468062708|FG001|Overall Study|Withdrawal by Subject|0|||
130028161|NCT03486392|468062709|FG002|Overall Study|Withdrawal by Subject|6|||
130241257|NCT01202591|468843506|FG005|Overall Study|Objective Disease Progression|0|||
130241258|NCT02830087|468843509|FG000|Overall Study|No study staff to follow-up patients|4|||
130241259|NCT02830087|468843510|FG001|Overall Study|No study staff to follow-up patients|4|||
130241260|NCT02830087|468843511|FG002|Overall Study|No study staff to follow-up patients|4|||
130241261|NCT02830087|468843512|FG003|Overall Study|No study staff to follow-up patients|3|||
130241262|NCT02830087|468843513|FG004|Overall Study|No study staff to follow-up patients|3|||
130241263|NCT02830087|468843514|FG005|Overall Study|No study staff to follow-up patients|3|||
130241264|NCT02583269|468843515|FG000|Overall Study|Patient hospitalized prior to start|1|||
130241265|NCT02583269|468843516|FG001|Overall Study|Patient hospitalized prior to start|0|||
130241266|NCT02583269|468843517|FG002|Overall Study|Patient hospitalized prior to start|0|||
130241267|NCT02583269|468843518|FG003|Overall Study|Patient hospitalized prior to start|0|||
130241268|NCT02583269|468843519|FG004|Overall Study|Patient hospitalized prior to start|0|||
130241269|NCT03611946|468843520|FG000|Overall Study|Withdrawal by Subject|0|||
130241270|NCT03611946|468843521|FG001|Overall Study|Withdrawal by Subject|0|||
130241271|NCT03611946|468843522|FG002|Overall Study|Withdrawal by Subject|1|||
130241272|NCT03611946|468843523|FG003|Overall Study|Withdrawal by Subject|0|||
130241273|NCT02207608|468843524|FG000|Overall Study|Adverse Event|1|||
130241274|NCT02207608|468843525|FG001|Overall Study|Adverse Event|0|||
130241275|NCT00980460|468843526|FG000|Overall Study|Death|0|||
130028162|NCT03486392|468062710|FG003|Overall Study|Withdrawal by Subject|4|||
130028163|NCT03486392|468062711|FG004|Overall Study|Withdrawal by Subject|1|||
130028164|NCT03486392|468062707|FG000|Overall Study|Death|0|||
130028165|NCT03486392|468062708|FG001|Overall Study|Death|0|||
130028166|NCT03486392|468062709|FG002|Overall Study|Death|0|||
130028167|NCT03486392|468062710|FG003|Overall Study|Death|0|||
130028168|NCT03486392|468062711|FG004|Overall Study|Death|1|||
130241276|NCT00980460|468843527|FG001|Overall Study|Death|0|||
130241277|NCT00980460|468843528|FG002|Overall Study|Death|1|||
130028169|NCT00888355|468062718|FG000|Overall Study|Adverse Event|10|||
130028170|NCT00888355|468062719|FG001|Overall Study|Adverse Event|0|||
130241278|NCT00980460|468843529|FG003|Overall Study|Death|2|||
130028171|NCT00888355|468062720|FG002|Overall Study|Adverse Event|3|||
130028172|NCT00888355|468062721|FG003|Overall Study|Adverse Event|3|||
130028173|NCT00888355|468062718|FG000|Overall Study|Lack of Efficacy|9|||
130028174|NCT00888355|468062719|FG001|Overall Study|Lack of Efficacy|2|||
130028175|NCT00888355|468062720|FG002|Overall Study|Lack of Efficacy|5|||
130028176|NCT00888355|468062721|FG003|Overall Study|Lack of Efficacy|2|||
130028177|NCT00888355|468062718|FG000|Overall Study|Lost to Follow-up|0|||
130241279|NCT00980460|468843530|FG004|Overall Study|Death|1|||
130241280|NCT00980460|468843526|FG000|Overall Study|Lack of Efficacy|0|||
130028178|NCT00888355|468062719|FG001|Overall Study|Lost to Follow-up|2|||
130028179|NCT00888355|468062720|FG002|Overall Study|Lost to Follow-up|2|||
130028180|NCT00888355|468062721|FG003|Overall Study|Lost to Follow-up|0|||
130028181|NCT00888355|468062718|FG000|Overall Study|Protocol Violation|3|||
130028182|NCT00888355|468062719|FG001|Overall Study|Protocol Violation|2|||
130028183|NCT00888355|468062720|FG002|Overall Study|Protocol Violation|1|||
130028184|NCT00888355|468062721|FG003|Overall Study|Protocol Violation|2|||
130028185|NCT00888355|468062718|FG000|Overall Study|Withdrawal by Subject|0|||
130028186|NCT00888355|468062719|FG001|Overall Study|Withdrawal by Subject|3|||
130028187|NCT00888355|468062720|FG002|Overall Study|Withdrawal by Subject|1|||
130028188|NCT00888355|468062721|FG003|Overall Study|Withdrawal by Subject|3|||
130028189|NCT01551693|468062723|FG000|Overall Study|Disease Progression|1|||
130028190|NCT01551693|468062724|FG001|Overall Study|Disease Progression|0|||
130028191|NCT01551693|468062723|FG000|Overall Study|Adverse Event|0|||
130028192|NCT01551693|468062724|FG001|Overall Study|Adverse Event|1|||
130028193|NCT01551693|468062723|FG000|Overall Study|Withdrawal by Subject|0|||
130028194|NCT01551693|468062724|FG001|Overall Study|Withdrawal by Subject|1|||
130028195|NCT02211261|468062726|FG000|Overall Study|Withdrawal by Subject|0|||
130028196|NCT02211261|468062727|FG001|Overall Study|Withdrawal by Subject|0|||
130028197|NCT02211261|468062728|FG002|Overall Study|Withdrawal by Subject|1|||
130028198|NCT02211261|468062729|FG003|Overall Study|Withdrawal by Subject|0|||
130028199|NCT02211261|468062730|FG004|Overall Study|Withdrawal by Subject|2|||
130028200|NCT02211261|468062731|FG005|Overall Study|Withdrawal by Subject|0|||
130028201|NCT02211261|468062732|FG006|Overall Study|Withdrawal by Subject|0|||
130028202|NCT02211261|468062733|FG007|Overall Study|Withdrawal by Subject|0|||
130028203|NCT02211261|468062734|FG008|Overall Study|Withdrawal by Subject|0|||
130028204|NCT02211261|468062735|FG009|Overall Study|Withdrawal by Subject|0|||
130028205|NCT02211261|468062736|FG010|Overall Study|Withdrawal by Subject|0|||
130028206|NCT02211261|468062726|FG000|Overall Study|Other|0|||
130028207|NCT02211261|468062727|FG001|Overall Study|Other|0|||
130241281|NCT00980460|468843527|FG001|Overall Study|Lack of Efficacy|0|||
130241282|NCT00980460|468843528|FG002|Overall Study|Lack of Efficacy|10|||
130241283|NCT00980460|468843529|FG003|Overall Study|Lack of Efficacy|6|||
130241284|NCT00980460|468843530|FG004|Overall Study|Lack of Efficacy|8|||
130241285|NCT00980460|468843526|FG000|Overall Study|Lost to Follow-up|0|||
130241286|NCT00980460|468843527|FG001|Overall Study|Lost to Follow-up|0|||
130241287|NCT00980460|468843528|FG002|Overall Study|Lost to Follow-up|0|||
130241288|NCT00980460|468843529|FG003|Overall Study|Lost to Follow-up|1|||
130241289|NCT00980460|468843530|FG004|Overall Study|Lost to Follow-up|0|||
130241290|NCT00980460|468843526|FG000|Overall Study|Physician Decision|0|||
130241291|NCT00980460|468843527|FG001|Overall Study|Physician Decision|0|||
130241292|NCT00980460|468843528|FG002|Overall Study|Physician Decision|11|||
130241293|NCT00980460|468843529|FG003|Overall Study|Physician Decision|5|||
130241294|NCT00980460|468843530|FG004|Overall Study|Physician Decision|3|||
130241295|NCT00980460|468843526|FG000|Overall Study|Withdrawal by Subject|0|||
130241296|NCT00980460|468843527|FG001|Overall Study|Withdrawal by Subject|0|||
130241297|NCT00980460|468843528|FG002|Overall Study|Withdrawal by Subject|1|||
130241298|NCT00980460|468843529|FG003|Overall Study|Withdrawal by Subject|0|||
130241299|NCT00980460|468843530|FG004|Overall Study|Withdrawal by Subject|0|||
130241300|NCT00980460|468843526|FG000|Overall Study|Ineligible|0|||
130241301|NCT00980460|468843527|FG001|Overall Study|Ineligible|2|||
130241302|NCT00980460|468843528|FG002|Overall Study|Ineligible|3|||
130241303|NCT00980460|468843529|FG003|Overall Study|Ineligible|1|||
130241304|NCT00980460|468843530|FG004|Overall Study|Ineligible|4|||
130241305|NCT00980460|468843526|FG000|Overall Study|Refusal of further therapy|0|||
130241306|NCT00980460|468843527|FG001|Overall Study|Refusal of further therapy|2|||
130241307|NCT00980460|468843528|FG002|Overall Study|Refusal of further therapy|3|||
130241308|NCT00980460|468843529|FG003|Overall Study|Refusal of further therapy|2|||
130241309|NCT00980460|468843530|FG004|Overall Study|Refusal of further therapy|0|||
130241310|NCT00980460|468843526|FG000|Overall Study|No therapy within 42 days of resection|0|||
130241311|NCT00980460|468843527|FG001|Overall Study|No therapy within 42 days of resection|0|||
130241312|NCT00980460|468843528|FG002|Overall Study|No therapy within 42 days of resection|3|||
130241313|NCT00980460|468843529|FG003|Overall Study|No therapy within 42 days of resection|1|||
130241314|NCT00980460|468843530|FG004|Overall Study|No therapy within 42 days of resection|0|||
130241315|NCT00980460|468843526|FG000|Overall Study|No transplant by protocol timepoints|0|||
130241316|NCT00980460|468843527|FG001|Overall Study|No transplant by protocol timepoints|0|||
130241317|NCT00980460|468843528|FG002|Overall Study|No transplant by protocol timepoints|3|||
130241318|NCT00980460|468843529|FG003|Overall Study|No transplant by protocol timepoints|0|||
130241319|NCT00980460|468843530|FG004|Overall Study|No transplant by protocol timepoints|0|||
130241320|NCT03599713|468843534|FG000|Overall Study|Death|38|||
130241321|NCT03599713|468843535|FG001|Overall Study|Death|3|||
130241322|NCT03599713|468843534|FG000|Overall Study|Withdrawal by Subject|17|||
130241323|NCT03599713|468843535|FG001|Overall Study|Withdrawal by Subject|0|||
130241324|NCT03599713|468843534|FG000|Overall Study|Lost to Follow-up|4|||
130028208|NCT02211261|468062728|FG002|Overall Study|Other|0|||
130028209|NCT02211261|468062729|FG003|Overall Study|Other|0|||
130028210|NCT02211261|468062730|FG004|Overall Study|Other|0|||
130028211|NCT02211261|468062731|FG005|Overall Study|Other|1|||
130028212|NCT02211261|468062732|FG006|Overall Study|Other|0|||
130241325|NCT03599713|468843535|FG001|Overall Study|Lost to Follow-up|0|||
130028213|NCT02211261|468062733|FG007|Overall Study|Other|0|||
130028214|NCT02211261|468062734|FG008|Overall Study|Other|0|||
130028215|NCT02211261|468062735|FG009|Overall Study|Other|2|||
130028216|NCT02211261|468062736|FG010|Overall Study|Other|0|||
130241326|NCT03599713|468843534|FG000|Overall Study|Discontinued Due to End of Study|42|||
130241327|NCT03599713|468843535|FG001|Overall Study|Discontinued Due to End of Study|3|||
130241328|NCT05800145|468843536|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
130241329|NCT05800145|468843537|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241330|NCT05800145|468843538|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241331|NCT05800145|468843539|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
130241332|NCT05800145|468843540|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241333|NCT05800145|468843541|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130241334|NCT05800145|468843536|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
130241335|NCT05800145|468843537|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241336|NCT05800145|468843538|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241337|NCT05800145|468843539|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
130241338|NCT05800145|468843540|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241339|NCT05800145|468843541|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
130241340|NCT05800145|468843536|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130241341|NCT05800145|468843537|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
130241342|NCT05800145|468843538|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
130241343|NCT05800145|468843539|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
130241344|NCT05800145|468843540|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
130241345|NCT05800145|468843541|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130241346|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241347|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241348|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241349|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
130241350|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241351|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241352|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241353|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
130241354|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241355|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241356|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
130241357|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
130241358|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241359|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241360|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241361|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
130241362|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241363|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241364|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
130241365|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241366|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241367|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241368|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241369|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
130241370|NCT02850406|468843542|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
130241371|NCT02850406|468843543|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
130241372|NCT02850406|468843544|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
130241373|NCT02850406|468843545|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
130241374|NCT02850406|468843546|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
130241375|NCT02850406|468843547|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
130241376|NCT02850406|468843548|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
130241377|NCT02850406|468843549|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
130241378|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241379|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241380|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241381|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241382|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
130241383|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
130241384|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241385|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
130241386|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241387|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241388|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241389|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241390|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
130241391|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
130241392|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241393|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241394|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241395|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241396|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241397|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241398|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
130241399|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241400|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241401|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
130241402|NCT02850406|468843542|FG000|Part C (Up to 52 Weeks)|Other|0|||
130241403|NCT02850406|468843543|FG001|Part C (Up to 52 Weeks)|Other|0|||
130241404|NCT02850406|468843544|FG002|Part C (Up to 52 Weeks)|Other|0|||
130241405|NCT02850406|468843545|FG003|Part C (Up to 52 Weeks)|Other|0|||
130241406|NCT02850406|468843546|FG004|Part C (Up to 52 Weeks)|Other|1|||
130241407|NCT02850406|468843547|FG005|Part C (Up to 52 Weeks)|Other|3|||
130241408|NCT02850406|468843548|FG006|Part C (Up to 52 Weeks)|Other|0|||
130241409|NCT02850406|468843549|FG007|Part C (Up to 52 Weeks)|Other|0|||
130241410|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241411|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241412|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241413|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241414|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241415|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241416|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
130241417|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
130241418|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241419|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241420|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241421|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241422|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241423|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241424|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
130241425|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
130241426|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241427|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241428|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241429|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241430|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
130241431|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
130100302|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
130241432|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
130241433|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
130241434|NCT02850406|468843542|FG000|Part D (Up to 52 Weeks)|Other|0|||
130241435|NCT02850406|468843543|FG001|Part D (Up to 52 Weeks)|Other|0|||
130241436|NCT02850406|468843544|FG002|Part D (Up to 52 Weeks)|Other|0|||
130241437|NCT02850406|468843545|FG003|Part D (Up to 52 Weeks)|Other|0|||
130241438|NCT02850406|468843546|FG004|Part D (Up to 52 Weeks)|Other|0|||
130241439|NCT02850406|468843547|FG005|Part D (Up to 52 Weeks)|Other|0|||
130241440|NCT02850406|468843548|FG006|Part D (Up to 52 Weeks)|Other|0|||
130241441|NCT02850406|468843549|FG007|Part D (Up to 52 Weeks)|Other|1|||
130241442|NCT00876395|468844870|FG000|Overall Study|Untreated|8|||
130241443|NCT00876395|468844871|FG001|Overall Study|Untreated|1|||
130241444|NCT00876395|468844870|FG000|Overall Study|Adverse Event|63|||
130241445|NCT00876395|468844871|FG001|Overall Study|Adverse Event|11|||
130241446|NCT00876395|468844870|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130241447|NCT00876395|468844871|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130241448|NCT00876395|468844870|FG000|Overall Study|Disease progression|259|||
130241449|NCT00876395|468844871|FG001|Overall Study|Disease progression|162|||
130241450|NCT00876395|468844870|FG000|Overall Study|New cancer therapy|25|||
130241451|NCT00876395|468844871|FG001|Overall Study|New cancer therapy|7|||
130241452|NCT00876395|468844870|FG000|Overall Study|Protocol Violation|5|||
130241453|NCT00876395|468844871|FG001|Overall Study|Protocol Violation|2|||
130241454|NCT00876395|468844870|FG000|Overall Study|Withdrawal by Subject|66|||
130241455|NCT00876395|468844871|FG001|Overall Study|Withdrawal by Subject|33|||
130241456|NCT00876395|468844870|FG000|Overall Study|Lost to Follow-up|2|||
130241457|NCT00876395|468844871|FG001|Overall Study|Lost to Follow-up|0|||
130241458|NCT00876395|468844870|FG000|Overall Study|Administrative problems|39|||
130241459|NCT00876395|468844871|FG001|Overall Study|Administrative problems|23|||
130100303|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
130100304|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
130241460|NCT00876395|468844870|FG000|Overall Study|Death|12|||
130241461|NCT00876395|468844871|FG001|Overall Study|Death|0|||
130241462|NCT03807843|468844872|FG000|Overall Study|Lost to Follow-up|1|||
130241463|NCT03807843|468844873|FG001|Overall Study|Lost to Follow-up|0|||
130241464|NCT01312129|468844874|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
130241465|NCT01312129|468844875|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
130241466|NCT00924651|468844878|FG000|Overall Study|Chemo started too soon|2|||
130241467|NCT00924651|468844879|FG001|Overall Study|Chemo started too soon|3|||
130241468|NCT00924651|468844878|FG000|Overall Study|No Reason|3|||
130241469|NCT00924651|468844879|FG001|Overall Study|No Reason|7|||
130241470|NCT00924651|468844878|FG000|Overall Study|Overwhelmed|6|||
130241471|NCT00924651|468844879|FG001|Overall Study|Overwhelmed|6|||
130241472|NCT00924651|468844878|FG000|Overall Study|Noncompliant|1|||
130241473|NCT00924651|468844879|FG001|Overall Study|Noncompliant|4|||
130241474|NCT00924651|468844878|FG000|Overall Study|Medical|1|||
130241475|NCT00924651|468844879|FG001|Overall Study|Medical|3|||
130241476|NCT00924651|468844878|FG000|Overall Study|Changed Mind|10|||
130100305|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
130241477|NCT00924651|468844879|FG001|Overall Study|Changed Mind|1|||
130241478|NCT00924651|468844878|FG000|Overall Study|Incomplete Form|2|||
130241479|NCT00924651|468844879|FG001|Overall Study|Incomplete Form|1|||
130241480|NCT01991314|468844880|FG000|Overall Study|Adverse Event|5|||
130241481|NCT01991314|468844881|FG001|Overall Study|Adverse Event|1|||
130241482|NCT01991314|468844880|FG000|Overall Study|Lost to Follow-up|6|||
130241483|NCT01991314|468844881|FG001|Overall Study|Lost to Follow-up|10|||
130241484|NCT00970944|468844882|FG000|Overall Study|Death|1|||
130241485|NCT00970944|468844883|FG001|Overall Study|Death|0|||
130241486|NCT00970944|468844882|FG000|Overall Study|Physician Decision|0|||
130241487|NCT00970944|468844883|FG001|Overall Study|Physician Decision|2|||
130241488|NCT00662259|468844884|FG000|Overall Study|Adverse Event|2|||
130241489|NCT00662259|468844885|FG001|Overall Study|Adverse Event|0|||
130241490|NCT01033942|468844886|FG000|Overall Study|Withdrawal by Subject|1|||
130241491|NCT01033942|468844887|FG001|Overall Study|Withdrawal by Subject|1|||
130241492|NCT01033942|468844888|FG002|Overall Study|Withdrawal by Subject|1|||
130241493|NCT01033942|468844886|FG000|Overall Study|Lost to Follow-up|1|||
130241494|NCT01033942|468844887|FG001|Overall Study|Lost to Follow-up|0|||
130241495|NCT01033942|468844888|FG002|Overall Study|Lost to Follow-up|0|||
130241496|NCT01033942|468844886|FG000|Overall Study|Enrolled in Extension Study|0|||
130028217|NCT02211261|468062726|FG000|Overall Study|Lost to Follow-up|0|||
130028218|NCT02211261|468062727|FG001|Overall Study|Lost to Follow-up|0|||
130028219|NCT02211261|468062728|FG002|Overall Study|Lost to Follow-up|0|||
130028220|NCT02211261|468062729|FG003|Overall Study|Lost to Follow-up|0|||
130028221|NCT02211261|468062730|FG004|Overall Study|Lost to Follow-up|0|||
130028222|NCT02211261|468062731|FG005|Overall Study|Lost to Follow-up|0|||
130028223|NCT02211261|468062732|FG006|Overall Study|Lost to Follow-up|0|||
130028224|NCT02211261|468062733|FG007|Overall Study|Lost to Follow-up|1|||
130028225|NCT02211261|468062734|FG008|Overall Study|Lost to Follow-up|0|||
130028226|NCT02211261|468062735|FG009|Overall Study|Lost to Follow-up|0|||
130028227|NCT02211261|468062736|FG010|Overall Study|Lost to Follow-up|0|||
130028228|NCT04897867|468062737|FG000|Overall Study|Withdrawal of Consent|1|||
130028229|NCT04897867|468062737|FG000|Overall Study|Pregnancy|1|||
130028230|NCT04897867|468062737|FG000|Overall Study|Lost to Follow-up|7|||
130028231|NCT04897867|468062737|FG000|Overall Study|Reason not Specified|2|||
130028232|NCT01171612|468062742|FG000|Overall Study|Lost to Follow-up|51|||
130028233|NCT00243659|468062743|FG000|Overall Study|Withdrawal by Subject|1|||
130028234|NCT00243659|468062744|FG001|Overall Study|Withdrawal by Subject|1|||
130028235|NCT00243659|468062743|FG000|Overall Study|Protocol Violation|1|||
130028236|NCT00243659|468062744|FG001|Overall Study|Protocol Violation|2|||
130028237|NCT03310970|468062745|FG000|Overall Study|Withdrawal by Subject|0|||
130028238|NCT03310970|468062746|FG001|Overall Study|Withdrawal by Subject|1|||
130028239|NCT03430986|468062747|FG000|24-week Control Period|Adverse Event|1|||
130028240|NCT03430986|468062748|FG001|24-week Control Period|Adverse Event|0|||
130028241|NCT03430986|468062747|FG000|24-week Control Period|Lost to Follow-up|2|||
130028242|NCT03430986|468062748|FG001|24-week Control Period|Lost to Follow-up|2|||
130028243|NCT03430986|468062747|FG000|24-week Control Period|Withdrawal by Participant|5|||
130028244|NCT03430986|468062748|FG001|24-week Control Period|Withdrawal by Participant|0|||
130028245|NCT03430986|468062747|FG000|24-week Control Period|Protocol Deviation|0|||
130028246|NCT03430986|468062748|FG001|24-week Control Period|Protocol Deviation|2|||
130028247|NCT03430986|468062747|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
130028248|NCT03430986|468062748|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
130028249|NCT03430986|468062747|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
130028250|NCT03430986|468062748|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
130028251|NCT01609842|468062750|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
130028252|NCT01609842|468062751|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
130028253|NCT02474329|468062752|FG000|Overall Study|Withdraw or did not contribute data.|13|||
130028254|NCT02911688|468064308|FG000|Washout|Lost to Follow-up|1|||
130028255|NCT02911688|468064309|FG001|Washout|Lost to Follow-up|1|||
130028256|NCT02911688|468064308|FG000|Washout|Withdrawal by Subject|0|||
130028257|NCT02911688|468064309|FG001|Washout|Withdrawal by Subject|1|||
130028258|NCT02720757|468064310|FG000|Overall Study|Other reason|5|||
130028259|NCT02720757|468064310|FG000|Overall Study|Loss of contact|4|||
130241497|NCT01033942|468844887|FG001|Overall Study|Enrolled in Extension Study|3|||
130241498|NCT01033942|468844888|FG002|Overall Study|Enrolled in Extension Study|0|||
130241499|NCT02693418|468844889|FG000|Overall Study|Lost to Follow-up|1|||
130241500|NCT02693418|468844890|FG001|Overall Study|Lost to Follow-up|2|||
130241501|NCT02693418|468844891|FG002|Overall Study|Lost to Follow-up|0|||
130241502|NCT02693418|468844892|FG003|Overall Study|Lost to Follow-up|0|||
130241503|NCT02693418|468844893|FG004|Overall Study|Lost to Follow-up|0|||
130241504|NCT02693418|468844889|FG000|Overall Study|Menses during study period|0|||
130241505|NCT02693418|468844890|FG001|Overall Study|Menses during study period|0|||
130028260|NCT02720757|468064310|FG000|Overall Study|Informed consent withdrawal|1|||
130028261|NCT02720757|468064310|FG000|Overall Study|Patients wish to withdraw|2|||
130028262|NCT02720757|468064310|FG000|Overall Study|Missing|3|||
130028263|NCT02720757|468064310|FG000|Overall Study|General exclusion|3|||
130028264|NCT00883493|468064311|FG000|Overall Study|Adverse Event|11|||
130028265|NCT00883493|468064312|FG001|Overall Study|Adverse Event|12|||
130028266|NCT00883493|468064311|FG000|Overall Study|Lack of Efficacy|4|||
130028267|NCT00883493|468064312|FG001|Overall Study|Lack of Efficacy|3|||
130028268|NCT00883493|468064311|FG000|Overall Study|Lost to Follow-up|7|||
130028269|NCT00883493|468064312|FG001|Overall Study|Lost to Follow-up|6|||
130241506|NCT02693418|468844891|FG002|Overall Study|Menses during study period|2|||
130241507|NCT02693418|468844892|FG003|Overall Study|Menses during study period|0|||
130241508|NCT02693418|468844893|FG004|Overall Study|Menses during study period|0|||
130241509|NCT01750346|468844895|FG000|Overall Study|Adverse Event|1|||
130241510|NCT01750346|468844896|FG001|Overall Study|Adverse Event|0|||
130241511|NCT01750346|468844897|FG002|Overall Study|Adverse Event|0|||
130241512|NCT02260986|468844898|FG000|Overall Study|Adverse Event|24|||
130241513|NCT02260986|468844899|FG001|Overall Study|Adverse Event|0|||
130241514|NCT02260986|468844900|FG002|Overall Study|Adverse Event|11|||
130241515|NCT02260986|468844898|FG000|Overall Study|Lack of Efficacy|27|||
130241516|NCT02260986|468844899|FG001|Overall Study|Lack of Efficacy|3|||
130241517|NCT02260986|468844900|FG002|Overall Study|Lack of Efficacy|0|||
130241518|NCT02260986|468844898|FG000|Overall Study|Protocol Violation|14|||
130241519|NCT02260986|468844899|FG001|Overall Study|Protocol Violation|5|||
130241520|NCT02260986|468844900|FG002|Overall Study|Protocol Violation|16|||
130241521|NCT02260986|468844898|FG000|Overall Study|Car accident|0|||
130241522|NCT02260986|468844899|FG001|Overall Study|Car accident|0|||
130241523|NCT02260986|468844900|FG002|Overall Study|Car accident|1|||
130241524|NCT02260986|468844898|FG000|Overall Study|Withdrawal by Subject|17|||
130241525|NCT02260986|468844899|FG001|Overall Study|Withdrawal by Subject|4|||
130241526|NCT02260986|468844900|FG002|Overall Study|Withdrawal by Subject|9|||
130241527|NCT02260986|468844898|FG000|Overall Study|Incorrect randomization|0|||
130241528|NCT02260986|468844899|FG001|Overall Study|Incorrect randomization|1|||
130241529|NCT02260986|468844900|FG002|Overall Study|Incorrect randomization|0|||
130241530|NCT02260986|468844898|FG000|Overall Study|Lack of investigation product supply|2|||
130241531|NCT02260986|468844899|FG001|Overall Study|Lack of investigation product supply|0|||
130241532|NCT02260986|468844900|FG002|Overall Study|Lack of investigation product supply|1|||
130241533|NCT02260986|468844898|FG000|Overall Study|Lost to Follow-up|4|||
130241534|NCT02260986|468844899|FG001|Overall Study|Lost to Follow-up|0|||
130241535|NCT02260986|468844900|FG002|Overall Study|Lost to Follow-up|3|||
130241536|NCT02260986|468844898|FG000|Overall Study|Pregnancy|2|||
130241537|NCT02260986|468844899|FG001|Overall Study|Pregnancy|0|||
130241538|NCT02260986|468844900|FG002|Overall Study|Pregnancy|0|||
130241539|NCT02782468|468844903|FG000|Overall Study|Progressive Disease|2|||
130241540|NCT02782468|468844904|FG001|Overall Study|Progressive Disease|5|||
130241541|NCT02782468|468844905|FG002|Overall Study|Progressive Disease|0|||
130241542|NCT02782468|468844906|FG003|Overall Study|Progressive Disease|4|||
130241543|NCT02782468|468844903|FG000|Overall Study|Adverse Event|0|||
130241544|NCT02782468|468844904|FG001|Overall Study|Adverse Event|2|||
130241545|NCT02782468|468844905|FG002|Overall Study|Adverse Event|2|||
130241546|NCT02782468|468844906|FG003|Overall Study|Adverse Event|3|||
130241547|NCT02782468|468844903|FG000|Overall Study|Other|0|||
130241548|NCT02782468|468844904|FG001|Overall Study|Other|0|||
130241549|NCT02782468|468844905|FG002|Overall Study|Other|1|||
130241550|NCT02782468|468844906|FG003|Overall Study|Other|1|||
130241551|NCT02782468|468844903|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130241552|NCT02782468|468844904|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130241553|NCT02782468|468844905|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
130241554|NCT02782468|468844906|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
130241555|NCT02782468|468844903|FG000|Overall Study|Symptomatic Deterioration|0|||
130241556|NCT02782468|468844904|FG001|Overall Study|Symptomatic Deterioration|0|||
130241557|NCT02782468|468844905|FG002|Overall Study|Symptomatic Deterioration|0|||
130241558|NCT02782468|468844906|FG003|Overall Study|Symptomatic Deterioration|1|||
130241559|NCT02782468|468844903|FG000|Overall Study|Withdrawal by Subject|1|||
130241560|NCT02782468|468844904|FG001|Overall Study|Withdrawal by Subject|0|||
130241561|NCT02782468|468844905|FG002|Overall Study|Withdrawal by Subject|0|||
130241562|NCT02782468|468844906|FG003|Overall Study|Withdrawal by Subject|0|||
130241563|NCT00356590|468844907|FG000|Overall Study|Adverse Event|54|||
130241564|NCT00356590|468844907|FG000|Overall Study|Death|10|||
130241565|NCT00356590|468844907|FG000|Overall Study|Lost to Follow-up|35|||
130241566|NCT00356590|468844907|FG000|Overall Study|Physician Decision|46|||
130241567|NCT00356590|468844907|FG000|Overall Study|Withdrawal by Subject|41|||
130241568|NCT00356590|468844907|FG000|Overall Study|Completed month 12 only|2|||
130241569|NCT00356590|468844907|FG000|Overall Study|Protocol issues|6|||
130241570|NCT00356590|468844907|FG000|Overall Study|Response status|28|||
130241571|NCT00356590|468844907|FG000|Overall Study|Other|52|||
130241572|NCT01482221|468844912|FG000|Overall Study|Lack of Efficacy|1|||
130241573|NCT01482221|468844913|FG001|Overall Study|Lack of Efficacy|0|||
130241574|NCT01482221|468844914|FG002|Overall Study|Lack of Efficacy|1|||
130241575|NCT01482221|468844912|FG000|Overall Study|Lost to Follow-up|3|||
130241576|NCT01482221|468844913|FG001|Overall Study|Lost to Follow-up|2|||
130241577|NCT01482221|468844914|FG002|Overall Study|Lost to Follow-up|1|||
130241578|NCT01482221|468844912|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
130241579|NCT01482221|468844913|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
130241580|NCT01482221|468844914|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
130241581|NCT01482221|468844912|FG000|Overall Study|Condition under Investigation Worsened|3|||
130241582|NCT01482221|468844913|FG001|Overall Study|Condition under Investigation Worsened|2|||
130241583|NCT01482221|468844914|FG002|Overall Study|Condition under Investigation Worsened|4|||
130241584|NCT01482221|468844912|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130241585|NCT01482221|468844913|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
130241586|NCT01482221|468844914|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130241587|NCT01482221|468844912|FG000|Overall Study|Adverse Event|1|||
130241588|NCT01482221|468844913|FG001|Overall Study|Adverse Event|7|||
130241589|NCT01482221|468844914|FG002|Overall Study|Adverse Event|3|||
130241590|NCT01482221|468844912|FG000|Overall Study|Withdrawal by Subject|10|||
130241591|NCT01482221|468844913|FG001|Overall Study|Withdrawal by Subject|7|||
130241592|NCT01482221|468844914|FG002|Overall Study|Withdrawal by Subject|12|||
130241593|NCT01482221|468844912|FG000|Overall Study|Incorrect randomization|0|||
130241594|NCT01482221|468844913|FG001|Overall Study|Incorrect randomization|1|||
130241595|NCT01482221|468844914|FG002|Overall Study|Incorrect randomization|0|||
130241596|NCT01482221|468844912|FG000|Overall Study|Physician Decision|0|||
130241597|NCT01482221|468844913|FG001|Overall Study|Physician Decision|1|||
130241598|NCT01482221|468844914|FG002|Overall Study|Physician Decision|0|||
130241599|NCT03086343|468844915|FG000|Period 1|Adverse Event|7|||
130241600|NCT03086343|468844916|FG001|Period 1|Adverse Event|7|||
130241601|NCT03086343|468844917|FG002|Period 1|Adverse Event|0|||
130241602|NCT03086343|468844918|FG003|Period 1|Adverse Event|1|||
130241603|NCT03086343|468844915|FG000|Period 1|Withdrawal by Subject|6|||
130241604|NCT03086343|468844916|FG001|Period 1|Withdrawal by Subject|10|||
130241605|NCT03086343|468844917|FG002|Period 1|Withdrawal by Subject|0|||
130241606|NCT03086343|468844918|FG003|Period 1|Withdrawal by Subject|0|||
130241607|NCT03086343|468844915|FG000|Period 1|Lost to Follow-up|1|||
130241608|NCT03086343|468844916|FG001|Period 1|Lost to Follow-up|3|||
130241609|NCT03086343|468844917|FG002|Period 1|Lost to Follow-up|1|||
130241610|NCT03086343|468844918|FG003|Period 1|Lost to Follow-up|0|||
130241611|NCT03086343|468844915|FG000|Period 1|Other, Not Specified|10|||
130241612|NCT03086343|468844916|FG001|Period 1|Other, Not Specified|12|||
130241613|NCT03086343|468844917|FG002|Period 1|Other, Not Specified|2|||
130241614|NCT03086343|468844918|FG003|Period 1|Other, Not Specified|1|||
130241615|NCT03086343|468844915|FG000|Period 1|Missing|1|||
130241616|NCT03086343|468844916|FG001|Period 1|Missing|0|||
130241617|NCT03086343|468844917|FG002|Period 1|Missing|0|||
130241618|NCT03086343|468844918|FG003|Period 1|Missing|0|||
130241619|NCT03086343|468844915|FG000|Period 2|Adverse Event|20|||
130241620|NCT03086343|468844916|FG001|Period 2|Adverse Event|11|||
130241621|NCT03086343|468844917|FG002|Period 2|Adverse Event|1|||
130241622|NCT03086343|468844918|FG003|Period 2|Adverse Event|2|||
130241623|NCT03086343|468844915|FG000|Period 2|Withdrawal by Subject|15|||
130241624|NCT03086343|468844916|FG001|Period 2|Withdrawal by Subject|25|||
130241625|NCT03086343|468844917|FG002|Period 2|Withdrawal by Subject|2|||
130241626|NCT03086343|468844918|FG003|Period 2|Withdrawal by Subject|2|||
130241627|NCT03086343|468844915|FG000|Period 2|Lost to Follow-up|6|||
130241628|NCT03086343|468844916|FG001|Period 2|Lost to Follow-up|11|||
130241629|NCT03086343|468844917|FG002|Period 2|Lost to Follow-up|1|||
130241630|NCT03086343|468844918|FG003|Period 2|Lost to Follow-up|0|||
130241631|NCT03086343|468844915|FG000|Period 2|COVID-19 Infection|5|||
130241632|NCT03086343|468844916|FG001|Period 2|COVID-19 Infection|0|||
130241633|NCT03086343|468844917|FG002|Period 2|COVID-19 Infection|0|||
130241634|NCT03086343|468844918|FG003|Period 2|COVID-19 Infection|0|||
130241635|NCT03086343|468844915|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
130241636|NCT03086343|468844916|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
130241637|NCT03086343|468844917|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
130241638|NCT03086343|468844918|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
130241639|NCT03086343|468844915|FG000|Period 2|Other, Not Specified|23|||
130241640|NCT03086343|468844916|FG001|Period 2|Other, Not Specified|22|||
130241641|NCT03086343|468844917|FG002|Period 2|Other, Not Specified|2|||
130241642|NCT03086343|468844918|FG003|Period 2|Other, Not Specified|4|||
130241643|NCT05607043|468844920|FG000|Overall Study|Lost to Follow-up|2|||
130241644|NCT00741611|468844921|FG000|Overall Study|Death|0|||
130241645|NCT00741611|468844922|FG001|Overall Study|Death|0|||
130241646|NCT00741611|468844923|FG002|Overall Study|Death|1|||
130241647|NCT00741611|468844921|FG000|Overall Study|Withdrawal by Subject|0|||
130241648|NCT00741611|468844922|FG001|Overall Study|Withdrawal by Subject|2|||
130241649|NCT00741611|468844923|FG002|Overall Study|Withdrawal by Subject|2|||
130241650|NCT00800540|468844931|FG000|Period One: 6 Weeks|Noncompliance|1|||
130241651|NCT00800540|468844932|FG001|Period One: 6 Weeks|Noncompliance|0|||
130241652|NCT00800540|468844931|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
130241653|NCT00800540|468844932|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
130241654|NCT00800540|468844931|FG000|Period 2: 6 Weeks|Adverse Event|0|||
130241655|NCT00800540|468844932|FG001|Period 2: 6 Weeks|Adverse Event|1|||
130241656|NCT01922011|468844933|FG000|Overall Study|Protocol Violation|0|||
130241657|NCT01922011|468844934|FG001|Overall Study|Protocol Violation|1|||
130241658|NCT01922011|468844933|FG000|Overall Study|Physician Decision|0|||
130241659|NCT01922011|468844934|FG001|Overall Study|Physician Decision|1|||
130241660|NCT01922011|468844933|FG000|Overall Study|Parent/Guardian Decision|3|||
130241661|NCT01922011|468844934|FG001|Overall Study|Parent/Guardian Decision|0|||
130241662|NCT01922011|468844933|FG000|Overall Study|Lost to Follow-up|0|||
130241663|NCT01922011|468844934|FG001|Overall Study|Lost to Follow-up|1|||
130241664|NCT01922011|468844933|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
130241665|NCT01922011|468844934|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
130241666|NCT01922011|468844933|FG000|Overall Study|Not Treated|1|||
130241667|NCT01922011|468844934|FG001|Overall Study|Not Treated|0|||
130241668|NCT01922011|468844933|FG000|Overall Study|Lack of willing home health agency|1|||
130241669|NCT01922011|468844934|FG001|Overall Study|Lack of willing home health agency|0|||
130241670|NCT01922011|468844933|FG000|Overall Study|Randomized in error|1|||
130241671|NCT01922011|468844934|FG001|Overall Study|Randomized in error|0|||
130241672|NCT04398134|468844935|FG000|Overall Study|Adverse Event|0|||
130241673|NCT04398134|468844936|FG001|Overall Study|Adverse Event|0|||
130241674|NCT04398134|468844937|FG002|Overall Study|Adverse Event|1|||
130241675|NCT04398134|468844938|FG003|Overall Study|Adverse Event|0|||
130241676|NCT04398134|468844935|FG000|Overall Study|Withdrawal by Subject|2|||
130241677|NCT04398134|468844936|FG001|Overall Study|Withdrawal by Subject|0|||
130241678|NCT04398134|468844937|FG002|Overall Study|Withdrawal by Subject|0|||
130241679|NCT04398134|468844938|FG003|Overall Study|Withdrawal by Subject|1|||
130241680|NCT04398134|468844935|FG000|Overall Study|Study Terminated by Sponsor|30|||
130241681|NCT04398134|468844936|FG001|Overall Study|Study Terminated by Sponsor|11|||
130241682|NCT04398134|468844937|FG002|Overall Study|Study Terminated by Sponsor|32|||
130241683|NCT04398134|468844938|FG003|Overall Study|Study Terminated by Sponsor|11|||
130241684|NCT00153920|468844940|FG000|Overall Study|Adverse Event|9|||
130241685|NCT00153920|468844940|FG000|Overall Study|Progressive Disease|9|||
130241686|NCT00153920|468844940|FG000|Overall Study|Physician Decision|3|||
130241687|NCT00153920|468844940|FG000|Overall Study|Lack of Response|3|||
130241688|NCT00153920|468844940|FG000|Overall Study|Death|2|||
130241689|NCT00153920|468844940|FG000|Overall Study|Withdrawal by Subject|1|||
130241690|NCT00153920|468844940|FG000|Overall Study|Non-Protocol Therapy|1|||
130241691|NCT00153920|468844940|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
130241692|NCT00153920|468844940|FG000|Overall Study|Progressive Disease before Trt|1|||
130241693|NCT02202616|468844941|FG000|Overall Study|Screen failed|24|||
130241694|NCT02202616|468844941|FG000|Overall Study|Adverse Event|32|||
130241695|NCT02202616|468844941|FG000|Overall Study|Protocol deviation|18|||
130241696|NCT02202616|468844941|FG000|Overall Study|Patient withdrew consent|12|||
130241697|NCT02202616|468844941|FG000|Overall Study|Lost to Follow-up|6|||
130241698|NCT02202616|468844941|FG000|Overall Study|Administrative problems|6|||
130241699|NCT02202616|468844941|FG000|Overall Study|Abnormal test procedure result|1|||
130241700|NCT02202616|468844941|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130241701|NCT01334515|468844944|FG000|Overall Study|Adverse Event|1|||
130241702|NCT01334515|468844945|FG001|Overall Study|Adverse Event|6|||
130241703|NCT01334515|468844944|FG000|Overall Study|Death|1|||
130241704|NCT01334515|468844945|FG001|Overall Study|Death|0|||
130241705|NCT01334515|468844944|FG000|Overall Study|Lack of Efficacy|8|||
130241706|NCT01334515|468844945|FG001|Overall Study|Lack of Efficacy|21|||
130241707|NCT01334515|468844944|FG000|Overall Study|Physician Decision|1|||
130241708|NCT01334515|468844945|FG001|Overall Study|Physician Decision|1|||
130241709|NCT01334515|468844944|FG000|Overall Study|Withdrawal by Subject|1|||
130241710|NCT01334515|468844945|FG001|Overall Study|Withdrawal by Subject|1|||
130241711|NCT04327271|468844946|FG000|Overall Study|Death|1|||
130241712|NCT04327271|468844947|FG001|Overall Study|Death|0|||
130241713|NCT04327271|468844946|FG000|Overall Study|Withdrawal by Subject|1|||
130241714|NCT04327271|468844947|FG001|Overall Study|Withdrawal by Subject|0|||
130241715|NCT04327271|468844946|FG000|Overall Study|randomization error (data capture)|4|||
130241716|NCT04327271|468844947|FG001|Overall Study|randomization error (data capture)|3|||
130241717|NCT01479530|468844949|FG000|Overall Study|Adverse Event|5|||
130241718|NCT01479530|468844950|FG001|Overall Study|Adverse Event|6|||
130241719|NCT01479530|468844949|FG000|Overall Study|Lack of Efficacy|0|||
130241720|NCT01479530|468844950|FG001|Overall Study|Lack of Efficacy|1|||
130241721|NCT01479530|468844949|FG000|Overall Study|Protocol Violation|2|||
130241722|NCT01479530|468844950|FG001|Overall Study|Protocol Violation|3|||
130241723|NCT01479530|468844949|FG000|Overall Study|Withdrawal of Consent|3|||
130241724|NCT01479530|468844950|FG001|Overall Study|Withdrawal of Consent|2|||
130241725|NCT00303628|468844951|FG000|Overall Study|Disease progression|0|||
130241726|NCT00303628|468844952|FG001|Overall Study|Disease progression|1|||
130241727|NCT00303628|468844951|FG000|Overall Study|Adverse Event|26|||
130241728|NCT00303628|468844952|FG001|Overall Study|Adverse Event|36|||
130241729|NCT00303628|468844951|FG000|Overall Study|Death|0|||
130241730|NCT00303628|468844952|FG001|Overall Study|Death|1|||
130241731|NCT00303628|468844951|FG000|Overall Study|Withdrawal by Subject|11|||
130241732|NCT00303628|468844952|FG001|Overall Study|Withdrawal by Subject|20|||
130241733|NCT00303628|468844951|FG000|Overall Study|Alternative therapy|2|||
130241734|NCT00303628|468844952|FG001|Overall Study|Alternative therapy|0|||
130241735|NCT00303628|468844951|FG000|Overall Study|Other complicating disease|0|||
130241736|NCT00303628|468844952|FG001|Overall Study|Other complicating disease|1|||
130241737|NCT00303628|468844951|FG000|Overall Study|Not start protocol therapy|3|||
130241738|NCT00303628|468844952|FG001|Overall Study|Not start protocol therapy|5|||
130241739|NCT00303628|468844951|FG000|Overall Study|Other|8|||
130241740|NCT00303628|468844952|FG001|Overall Study|Other|9|||
130241741|NCT01666652|468844953|FG000|Overall Study|Serious Adverse Event|0|||
130241742|NCT01666652|468844954|FG001|Overall Study|Serious Adverse Event|0|||
130241743|NCT01666652|468844955|FG002|Overall Study|Serious Adverse Event|0|||
130241744|NCT01666652|468844956|FG003|Overall Study|Serious Adverse Event|1|||
130241745|NCT01666652|468844957|FG004|Overall Study|Serious Adverse Event|0|||
130241746|NCT01666652|468844953|FG000|Overall Study|Withdrawal by Subject|0|||
130241747|NCT01666652|468844954|FG001|Overall Study|Withdrawal by Subject|0|||
130241748|NCT01666652|468844955|FG002|Overall Study|Withdrawal by Subject|0|||
130241749|NCT01666652|468844956|FG003|Overall Study|Withdrawal by Subject|0|||
130241750|NCT01666652|468844957|FG004|Overall Study|Withdrawal by Subject|1|||
130241751|NCT01666652|468844953|FG000|Overall Study|Moved from study area|1|||
130241752|NCT01666652|468844954|FG001|Overall Study|Moved from study area|0|||
130241753|NCT01666652|468844955|FG002|Overall Study|Moved from study area|0|||
130241754|NCT01666652|468844956|FG003|Overall Study|Moved from study area|2|||
130241755|NCT01666652|468844957|FG004|Overall Study|Moved from study area|0|||
130241756|NCT01666652|468844953|FG000|Overall Study|Lost to Follow-up|1|||
130241757|NCT01666652|468844954|FG001|Overall Study|Lost to Follow-up|1|||
130241758|NCT01666652|468844955|FG002|Overall Study|Lost to Follow-up|1|||
130241759|NCT01666652|468844956|FG003|Overall Study|Lost to Follow-up|1|||
130241760|NCT01666652|468844957|FG004|Overall Study|Lost to Follow-up|0|||
130241761|NCT01018979|468844958|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
130241762|NCT01018979|468844959|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
130241763|NCT01018979|468844958|FG000|Overall Study|Not received at least one dose|0|||
130241764|NCT01018979|468844959|FG001|Overall Study|Not received at least one dose|1|||
130241765|NCT03010501|468844962|FG000|Study Week 1|Withdrawal by Subject|2|||
130241766|NCT03010501|468844963|FG001|Study Week 1|Withdrawal by Subject|1|||
130241767|NCT03010501|468844964|FG002|Study Week 1|Withdrawal by Subject|0|||
130241768|NCT03010501|468844965|FG003|Study Week 1|Withdrawal by Subject|2|||
130241769|NCT03010501|468844966|FG004|Study Week 1|Withdrawal by Subject|0|||
130241770|NCT03010501|468844967|FG005|Study Week 1|Withdrawal by Subject|0|||
130241771|NCT03010501|468844962|FG000|Study Week 3|Withdrawal by Subject|0|||
130241772|NCT03010501|468844963|FG001|Study Week 3|Withdrawal by Subject|0|||
130241773|NCT03010501|468844964|FG002|Study Week 3|Withdrawal by Subject|0|||
130241774|NCT03010501|468844965|FG003|Study Week 3|Withdrawal by Subject|1|||
130241775|NCT03010501|468844966|FG004|Study Week 3|Withdrawal by Subject|0|||
130241776|NCT03010501|468844967|FG005|Study Week 3|Withdrawal by Subject|0|||
130241777|NCT00640289|468844968|FG000|Overall Study|Death|3|||
130241778|NCT00640289|468844968|FG000|Overall Study|Withdrawal by Subject|1|||
130241779|NCT00640289|468844968|FG000|Overall Study|Lost to Follow-up|1|||
130241780|NCT00640289|468844968|FG000|Overall Study|Data collected under different amendment|2|||
130241781|NCT00640289|468844968|FG000|Overall Study|Transferred to another center|1|||
130241782|NCT00640289|468844968|FG000|Overall Study|Missing status|5|||
130241783|NCT00544882|468844971|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
130241784|NCT00544882|468844972|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
130241785|NCT00544882|468844973|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
130241786|NCT00544882|468844971|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
130241787|NCT00544882|468844972|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
130241788|NCT00544882|468844973|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
130241789|NCT00544882|468844971|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
130241790|NCT00544882|468844972|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
130241791|NCT00544882|468844973|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
130241792|NCT00544882|468844971|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
130241793|NCT00544882|468844972|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
130241794|NCT00544882|468844973|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
130241795|NCT00544882|468844971|FG000|Cycle 3: Follow-up|Noncompliance|0|||
130241796|NCT00544882|468844972|FG001|Cycle 3: Follow-up|Noncompliance|1|||
130241797|NCT00544882|468844973|FG002|Cycle 3: Follow-up|Noncompliance|0|||
130241798|NCT00544882|468844971|FG000|Cycle 3: Follow-up|Pregnancy|0|||
130241799|NCT00544882|468844972|FG001|Cycle 3: Follow-up|Pregnancy|1|||
130241800|NCT00544882|468844973|FG002|Cycle 3: Follow-up|Pregnancy|0|||
130241801|NCT03043573|468844974|FG000|Overall Study|Lost to Follow-up|3|||
130241802|NCT03043573|468844975|FG001|Overall Study|Lost to Follow-up|3|||
130241803|NCT03043573|468844974|FG000|Overall Study|Physician Decision|0|||
130241804|NCT03043573|468844975|FG001|Overall Study|Physician Decision|5|||
130241805|NCT03043573|468844974|FG000|Overall Study|Withdrawal by Subject|0|||
130241806|NCT03043573|468844975|FG001|Overall Study|Withdrawal by Subject|4|||
130241807|NCT01373229|468846030|FG000|Overall Study|Death|3|||
130241808|NCT01373229|468846030|FG000|Overall Study|Physician Decision|3|||
130241809|NCT00143507|468846031|FG000|Overall Study|Death|572|||
130241810|NCT00143507|468846032|FG001|Overall Study|Death|547|||
130241811|NCT00143507|468846031|FG000|Overall Study|Withdrawal by Subject|114|||
130241812|NCT00143507|468846032|FG001|Overall Study|Withdrawal by Subject|102|||
130241813|NCT00143507|468846031|FG000|Overall Study|Lost to Follow-up|1|||
130241814|NCT00143507|468846032|FG001|Overall Study|Lost to Follow-up|0|||
130241815|NCT00143507|468846031|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
130241816|NCT00143507|468846032|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
130241817|NCT00587457|468846033|FG000|Overall Study|Adverse Event|1|||
130241818|NCT00587457|468846034|FG001|Overall Study|Adverse Event|2|||
130241819|NCT00587457|468846035|FG002|Overall Study|Adverse Event|1|||
130241820|NCT00587457|468846033|FG000|Overall Study|Disease progression|2|||
130241821|NCT00587457|468846034|FG001|Overall Study|Disease progression|0|||
130241822|NCT00587457|468846035|FG002|Overall Study|Disease progression|2|||
130241823|NCT00587457|468846033|FG000|Overall Study|Initiation of alternative therapy|0|||
130241824|NCT00587457|468846034|FG001|Overall Study|Initiation of alternative therapy|1|||
130241825|NCT00587457|468846035|FG002|Overall Study|Initiation of alternative therapy|0|||
130241826|NCT00587457|468846033|FG000|Overall Study|Undefined|0|||
130241827|NCT00587457|468846034|FG001|Overall Study|Undefined|0|||
130241828|NCT00587457|468846035|FG002|Overall Study|Undefined|1|||
130241829|NCT00587457|468846033|FG000|Overall Study|Development of neutralizing Abs|0|||
130241830|NCT00587457|468846034|FG001|Overall Study|Development of neutralizing Abs|0|||
130241831|NCT00587457|468846035|FG002|Overall Study|Development of neutralizing Abs|1|||
130241832|NCT03234881|468846036|FG000|Overall Study|Lost to Follow-up|9|||
130241833|NCT03234881|468846037|FG001|Overall Study|Lost to Follow-up|3|||
130241834|NCT00729586|468846038|FG000|Overall Study|Ineligible|0|||
130241835|NCT00729586|468846039|FG001|Overall Study|Ineligible|1|||
130241836|NCT00729586|468846038|FG000|Overall Study|never treated|1|||
130241837|NCT00729586|468846039|FG001|Overall Study|never treated|0|||
130241838|NCT00972738|468846041|FG000|Overall Study|Adverse Event|7|||
130241839|NCT00972738|468846042|FG001|Overall Study|Adverse Event|1|||
130241840|NCT00972738|468846043|FG002|Overall Study|Adverse Event|8|||
130241841|NCT00972738|468846041|FG000|Overall Study|Protocol Violation|2|||
130241842|NCT00972738|468846042|FG001|Overall Study|Protocol Violation|1|||
130241843|NCT00972738|468846043|FG002|Overall Study|Protocol Violation|3|||
130241844|NCT00972738|468846041|FG000|Overall Study|Lost to Follow-up|1|||
130241845|NCT00972738|468846042|FG001|Overall Study|Lost to Follow-up|0|||
130241846|NCT00972738|468846043|FG002|Overall Study|Lost to Follow-up|1|||
130241847|NCT00972738|468846041|FG000|Overall Study|Lack of Efficacy|5|||
130241848|NCT00972738|468846042|FG001|Overall Study|Lack of Efficacy|1|||
130241849|NCT00972738|468846043|FG002|Overall Study|Lack of Efficacy|11|||
130241850|NCT00972738|468846041|FG000|Overall Study|Withdrawal by Subject|5|||
130241851|NCT00972738|468846042|FG001|Overall Study|Withdrawal by Subject|1|||
130241852|NCT00972738|468846043|FG002|Overall Study|Withdrawal by Subject|4|||
130241853|NCT00972738|468846041|FG000|Overall Study|Moved|0|||
130241854|NCT00972738|468846042|FG001|Overall Study|Moved|0|||
130241855|NCT00972738|468846043|FG002|Overall Study|Moved|1|||
130241856|NCT00972738|468846041|FG000|Overall Study|Other|1|||
130241857|NCT00972738|468846042|FG001|Overall Study|Other|2|||
130241858|NCT00972738|468846043|FG002|Overall Study|Other|1|||
130241859|NCT03915067|468846044|FG000|Overall Study|Adverse Event|0|||
130241860|NCT03915067|468846045|FG001|Overall Study|Adverse Event|0|||
130241861|NCT03915067|468846046|FG002|Overall Study|Adverse Event|1|||
130241862|NCT03915067|468846044|FG000|Overall Study|Withdrawal by Subject|4|||
130241863|NCT03915067|468846045|FG001|Overall Study|Withdrawal by Subject|3|||
130241864|NCT03915067|468846046|FG002|Overall Study|Withdrawal by Subject|0|||
130241865|NCT03915067|468846044|FG000|Overall Study|Lost to Follow-up|3|||
130241866|NCT03915067|468846045|FG001|Overall Study|Lost to Follow-up|2|||
130241867|NCT03915067|468846046|FG002|Overall Study|Lost to Follow-up|0|||
130241868|NCT03915067|468846044|FG000|Overall Study|Protocol Deviation|0|||
130241869|NCT03915067|468846045|FG001|Overall Study|Protocol Deviation|0|||
130241870|NCT03915067|468846046|FG002|Overall Study|Protocol Deviation|1|||
130241871|NCT03915067|468846044|FG000|Overall Study|Covid-19 Related Issues|2|||
130241872|NCT03915067|468846045|FG001|Overall Study|Covid-19 Related Issues|4|||
130241873|NCT03915067|468846046|FG002|Overall Study|Covid-19 Related Issues|4|||
130241874|NCT03915067|468846044|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
130241875|NCT03915067|468846045|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
130241876|NCT03915067|468846046|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
130241877|NCT02034591|468846054|FG000|Overall Study|Withdrawal by Subject|0|||
130241878|NCT02034591|468846055|FG001|Overall Study|Withdrawal by Subject|0|||
130241879|NCT02034591|468846056|FG002|Overall Study|Withdrawal by Subject|0|||
130241880|NCT02034591|468846057|FG003|Overall Study|Withdrawal by Subject|0|||
130241881|NCT02034591|468846058|FG004|Overall Study|Withdrawal by Subject|1|||
130241882|NCT02034591|468846059|FG005|Overall Study|Withdrawal by Subject|0|||
130241883|NCT01793935|468846062|FG000|Overall Study|Pregnancy|1|||
130241884|NCT01793935|468846063|FG001|Overall Study|Pregnancy|0|||
130241885|NCT01793935|468846062|FG000|Overall Study|Protocol Violation|2|||
130241886|NCT01793935|468846063|FG001|Overall Study|Protocol Violation|1|||
130241887|NCT01793935|468846062|FG000|Overall Study|Adverse Event|2|||
130241888|NCT01793935|468846063|FG001|Overall Study|Adverse Event|0|||
130241889|NCT01793935|468846062|FG000|Overall Study|Patient did not take study medication|1|||
130241890|NCT01793935|468846063|FG001|Overall Study|Patient did not take study medication|1|||
130241891|NCT01793935|468846062|FG000|Overall Study|Lost to Follow-up|0|||
130241892|NCT01793935|468846063|FG001|Overall Study|Lost to Follow-up|1|||
130241893|NCT01121926|468846064|FG000|First Intervention Period|Adverse Event|1|||
130241894|NCT01121926|468846065|FG001|First Intervention Period|Adverse Event|0|||
130241895|NCT01121926|468846064|FG000|Washout Period|Adverse Event|0|||
130241896|NCT01121926|468846065|FG001|Washout Period|Adverse Event|1|||
130241897|NCT01121926|468846064|FG000|Washout Period|Positive pregnancy test|0|||
130241898|NCT01121926|468846065|FG001|Washout Period|Positive pregnancy test|1|||
130241899|NCT00416949|468846067|FG000|Overall Study|Patients refused to participate|5|||
130241900|NCT00313170|468846068|FG000|Overall Study|Death|2|||
130241901|NCT00313170|468846069|FG001|Overall Study|Death|4|||
130241902|NCT00313170|468846070|FG002|Overall Study|Death|2|||
130241903|NCT00313170|468846068|FG000|Overall Study|Adverse Event|1|||
130241904|NCT00313170|468846069|FG001|Overall Study|Adverse Event|2|||
130241905|NCT00313170|468846070|FG002|Overall Study|Adverse Event|0|||
130241906|NCT00313170|468846068|FG000|Overall Study|Disease progression|31|||
130241907|NCT00313170|468846069|FG001|Overall Study|Disease progression|26|||
130241908|NCT00313170|468846070|FG002|Overall Study|Disease progression|27|||
130241909|NCT00313170|468846068|FG000|Overall Study|Withdrawal by Subject|1|||
130241910|NCT00313170|468846069|FG001|Overall Study|Withdrawal by Subject|0|||
130241911|NCT00313170|468846070|FG002|Overall Study|Withdrawal by Subject|1|||
130241912|NCT00313170|468846068|FG000|Overall Study|Incorrect enrollment|0|||
130241913|NCT00313170|468846069|FG001|Overall Study|Incorrect enrollment|2|||
130241914|NCT00313170|468846070|FG002|Overall Study|Incorrect enrollment|1|||
130241915|NCT00313170|468846068|FG000|Overall Study|Lost to Follow-up|0|||
130241916|NCT00313170|468846069|FG001|Overall Study|Lost to Follow-up|0|||
130241917|NCT00313170|468846070|FG002|Overall Study|Lost to Follow-up|1|||
130241918|NCT00313170|468846068|FG000|Overall Study|Progression (investigators opinion)|1|||
130241919|NCT00313170|468846069|FG001|Overall Study|Progression (investigators opinion)|0|||
130241920|NCT00313170|468846070|FG002|Overall Study|Progression (investigators opinion)|0|||
130241921|NCT01410604|468846072|FG000|Overall Study|Adverse Event|2|||
130241922|NCT01410604|468846073|FG001|Overall Study|Adverse Event|1|||
130241923|NCT01410604|468846072|FG000|Overall Study|Lost to Follow-up|1|||
130241924|NCT01410604|468846073|FG001|Overall Study|Lost to Follow-up|0|||
130241925|NCT01410604|468846072|FG000|Overall Study|Physician Decision|0|||
130241926|NCT01410604|468846073|FG001|Overall Study|Physician Decision|1|||
130241927|NCT00529035|468846075|FG000|Overall Study|Withdrawal by Subject|1|||
130241928|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Other|4|||
130241929|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Other|1|||
130241930|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
130241931|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130241932|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
130241933|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
130241934|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
130241935|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130241936|NCT03439514|468846076|FG000|Double-Blind Treatment Period|Death|1|||
130241937|NCT03439514|468846077|FG001|Double-Blind Treatment Period|Death|2|||
130241938|NCT02175758|468846078|FG000|Treatment Phase|Lost to Follow-up|0|||
130241939|NCT02175758|468846079|FG001|Treatment Phase|Lost to Follow-up|1|||
130241940|NCT02175758|468846080|FG002|Treatment Phase|Lost to Follow-up|0|||
130241941|NCT02175758|468846081|FG003|Treatment Phase|Lost to Follow-up|0|||
130241942|NCT02175758|468846082|FG004|Treatment Phase|Lost to Follow-up|0|||
130241943|NCT02175758|468846083|FG005|Treatment Phase|Lost to Follow-up|0|||
130241944|NCT02175758|468846078|FG000|Treatment Phase|Adverse Event|0|||
130241945|NCT02175758|468846079|FG001|Treatment Phase|Adverse Event|0|||
130241946|NCT02175758|468846080|FG002|Treatment Phase|Adverse Event|0|||
130241947|NCT02175758|468846081|FG003|Treatment Phase|Adverse Event|0|||
130241948|NCT02175758|468846082|FG004|Treatment Phase|Adverse Event|1|||
130241949|NCT02175758|468846083|FG005|Treatment Phase|Adverse Event|0|||
130241950|NCT01047501|468846084|FG000|Overall Study|Adverse Event|7|||
130241951|NCT01047501|468846085|FG001|Overall Study|Adverse Event|8|||
130241952|NCT01047501|468846086|FG002|Overall Study|Adverse Event|5|||
130241953|NCT01047501|468846084|FG000|Overall Study|Withdrew Consent|6|||
130241954|NCT01047501|468846085|FG001|Overall Study|Withdrew Consent|2|||
130241955|NCT01047501|468846086|FG002|Overall Study|Withdrew Consent|4|||
130241956|NCT01047501|468846084|FG000|Overall Study|Lost to Follow-up|0|||
130241957|NCT01047501|468846085|FG001|Overall Study|Lost to Follow-up|1|||
130241958|NCT01047501|468846086|FG002|Overall Study|Lost to Follow-up|1|||
130241959|NCT01047501|468846084|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
130241960|NCT01047501|468846085|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
130241961|NCT01047501|468846086|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
130241962|NCT01047501|468846084|FG000|Overall Study|Death|1|||
130241963|NCT01047501|468846085|FG001|Overall Study|Death|0|||
130241964|NCT01047501|468846086|FG002|Overall Study|Death|0|||
130241965|NCT01047501|468846084|FG000|Overall Study|Other discontinuation|1|||
130241966|NCT01047501|468846085|FG001|Overall Study|Other discontinuation|0|||
130241967|NCT01047501|468846086|FG002|Overall Study|Other discontinuation|1|||
130241968|NCT01047501|468846084|FG000|Overall Study|Investigator judgement|0|||
130241969|NCT01047501|468846085|FG001|Overall Study|Investigator judgement|0|||
130241970|NCT01047501|468846086|FG002|Overall Study|Investigator judgement|1|||
130241971|NCT00429299|468846089|FG000|Overall Study|Disease Progression|1|||
130241972|NCT00429299|468846090|FG001|Overall Study|Disease Progression|1|||
130241973|NCT00429299|468846091|FG002|Overall Study|Disease Progression|0|||
130241974|NCT00429299|468846089|FG000|Overall Study|Adverse Event|2|||
130241975|NCT00429299|468846090|FG001|Overall Study|Adverse Event|5|||
130241976|NCT00429299|468846091|FG002|Overall Study|Adverse Event|1|||
130241977|NCT00429299|468846089|FG000|Overall Study|Protocol Violation|1|||
130241978|NCT00429299|468846090|FG001|Overall Study|Protocol Violation|0|||
130241979|NCT00429299|468846091|FG002|Overall Study|Protocol Violation|0|||
130241980|NCT00429299|468846089|FG000|Overall Study|Withdrawal by Subject|0|||
130241981|NCT00429299|468846090|FG001|Overall Study|Withdrawal by Subject|1|||
130241982|NCT00429299|468846091|FG002|Overall Study|Withdrawal by Subject|3|||
130241983|NCT01510756|468846092|FG000|Overall Study|Death|1|||
130241984|NCT01510756|468846092|FG000|Overall Study|Lack of Efficacy|2|||
130241985|NCT01510756|468846092|FG000|Overall Study|Physician Decision|1|||
130241986|NCT03927157|468846093|FG000|Overall Study|Adverse Event|1|||
130241987|NCT03927157|468846094|FG001|Overall Study|Adverse Event|3|||
130241988|NCT03927157|468846093|FG000|Overall Study|Protocol Violation|1|||
130241989|NCT03927157|468846094|FG001|Overall Study|Protocol Violation|2|||
130241990|NCT03927157|468846093|FG000|Overall Study|Withdrawal by Subject|8|||
130241991|NCT03927157|468846094|FG001|Overall Study|Withdrawal by Subject|21|||
130241992|NCT03927157|468846093|FG000|Overall Study|Due to COVID-19 pandemic|5|||
130241993|NCT03927157|468846094|FG001|Overall Study|Due to COVID-19 pandemic|2|||
130241994|NCT03927157|468846093|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
130241995|NCT03927157|468846094|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
130241996|NCT03927157|468846093|FG000|Overall Study|Other than above|0|||
130241997|NCT03927157|468846094|FG001|Overall Study|Other than above|1|||
130241998|NCT04871113|468846095|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130241999|NCT04871113|468846096|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242000|NCT04871113|468846097|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242001|NCT04871113|468846098|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242002|NCT04871113|468846099|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242003|NCT04871113|468846100|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
130242004|NCT04871113|468846101|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242005|NCT04871113|468846102|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242006|NCT04871113|468846103|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242007|NCT04871113|468846104|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
130242008|NCT04871113|468846095|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242009|NCT04871113|468846096|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242010|NCT04871113|468846097|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242011|NCT04871113|468846098|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242012|NCT04871113|468846099|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242013|NCT04871113|468846100|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242014|NCT04871113|468846101|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
130242015|NCT04871113|468846102|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
130242016|NCT04871113|468846103|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242017|NCT04871113|468846104|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
130242018|NCT02447029|468846105|FG000|Overall Study|Withdrawal by Subject|3|||
130242019|NCT02447029|468846106|FG001|Overall Study|Withdrawal by Subject|2|||
130242020|NCT01239745|468846107|FG000|Overall Study|Study terminated by sponsor|45|||
130242021|NCT01239745|468846107|FG000|Overall Study|Adverse Event|1|||
130028270|NCT00883493|468064311|FG000|Overall Study|Withdrawal by Subject|11|||
130028271|NCT00883493|468064312|FG001|Overall Study|Withdrawal by Subject|20|||
130242022|NCT00726557|468846108|FG000|Overall Study|Screening failure|4|||
130242023|NCT00726557|468846108|FG000|Overall Study|No end of treatment documentation|37|||
130242024|NCT00726557|468846108|FG000|Overall Study|No follow-up documentation available|55|||
130242025|NCT00726557|468846108|FG000|Overall Study|Treatment less than 3 months|17|||
130242026|NCT00726557|468846108|FG000|Overall Study|Inclusion criteria not met|15|||
130242027|NCT01257542|468846111|FG000|Overall Study|Protocol Violation|3|||
130242028|NCT01257542|468846112|FG001|Overall Study|Protocol Violation|5|||
130242029|NCT01257542|468846111|FG000|Overall Study|Withdrawal by Subject|0|||
130242030|NCT01257542|468846112|FG001|Overall Study|Withdrawal by Subject|2|||
130242047|NCT00776997|468846122|FG000|Overall Study|Adverse Event|2|||
130242048|NCT03487445|468846123|FG000|Randomization|Not treated for administrative reasons|1|||
130242049|NCT03487445|468846124|FG001|Randomization|Not treated for administrative reasons|0|||
130242050|NCT03301714|468846125|FG000|Overall Study|Lost to Follow-up|10|||
130242051|NCT03301714|468846126|FG001|Overall Study|Lost to Follow-up|4|||
130242052|NCT03301714|468846127|FG002|Overall Study|Lost to Follow-up|4|||
130242053|NCT03301714|468846125|FG000|Overall Study|Did not receive allocated intervention|0|||
130242054|NCT03301714|468846126|FG001|Overall Study|Did not receive allocated intervention|2|||
130242055|NCT03301714|468846127|FG002|Overall Study|Did not receive allocated intervention|3|||
130242056|NCT01251861|468846130|FG000|Overall Study|Disease progression|6|||
130242057|NCT01251861|468846131|FG001|Overall Study|Disease progression|6|||
130242058|NCT01251861|468846130|FG000|Overall Study|Adverse Event|2|||
130242059|NCT01251861|468846131|FG001|Overall Study|Adverse Event|17|||
130242060|NCT01251861|468846130|FG000|Overall Study|Withdrawal by Subject|2|||
130242061|NCT01251861|468846131|FG001|Overall Study|Withdrawal by Subject|2|||
130242062|NCT01251861|468846130|FG000|Overall Study|Alternative therapy|1|||
130242063|NCT01251861|468846131|FG001|Overall Study|Alternative therapy|0|||
130242064|NCT01251861|468846130|FG000|Overall Study|Other complicating disease|0|||
130242065|NCT01251861|468846131|FG001|Overall Study|Other complicating disease|1|||
130242066|NCT01251861|468846130|FG000|Overall Study|Physician Decision|1|||
130242067|NCT01251861|468846131|FG001|Overall Study|Physician Decision|0|||
130242068|NCT01251861|468846130|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
130242069|NCT01251861|468846131|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
130242070|NCT01251861|468846130|FG000|Overall Study|Other|1|||
130242071|NCT01251861|468846131|FG001|Overall Study|Other|0|||
130242072|NCT01251861|468846130|FG000|Overall Study|Never started therapy|4|||
130242073|NCT01251861|468846131|FG001|Overall Study|Never started therapy|1|||
130242074|NCT01251861|468846130|FG000|Overall Study|Potential interaction of drugs|0|||
130242075|NCT01251861|468846131|FG001|Overall Study|Potential interaction of drugs|1|||
130242076|NCT03580928|468846134|FG000|Overall Study|Death|0|||
130242077|NCT03580928|468846135|FG001|Overall Study|Death|3|||
130242078|NCT03580928|468846134|FG000|Overall Study|Withdrawal by Subject|2|||
130242079|NCT03580928|468846135|FG001|Overall Study|Withdrawal by Subject|1|||
130242080|NCT03580928|468846134|FG000|Overall Study|Lost to Follow-up|2|||
130242081|NCT03580928|468846135|FG001|Overall Study|Lost to Follow-up|0|||
130242082|NCT03580928|468846134|FG000|Overall Study|Progressive Disease|0|||
130242083|NCT03580928|468846135|FG001|Overall Study|Progressive Disease|1|||
130242084|NCT05643794|468847225|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130242085|NCT05643794|468847226|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130242086|NCT05643794|468847227|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
130242087|NCT05643794|468847225|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130242088|NCT05643794|468847226|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130242089|NCT05643794|468847227|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130242090|NCT05643794|468847225|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242091|NCT05643794|468847226|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
130242092|NCT05643794|468847227|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242093|NCT05643794|468847225|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130242094|NCT05643794|468847226|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130242095|NCT05643794|468847227|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130242096|NCT05643794|468847225|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
130242097|NCT05643794|468847226|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242098|NCT05643794|468847227|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
130242099|NCT05643794|468847225|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
130242100|NCT05643794|468847226|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
130242101|NCT05643794|468847227|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
130242102|NCT04167670|468847230|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
130242103|NCT04167670|468847231|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
130242104|NCT04167670|468847232|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
130242105|NCT04167670|468847230|FG000|Overall Study|Significant protocol deviation|3|||
130242106|NCT04167670|468847231|FG001|Overall Study|Significant protocol deviation|1|||
130242107|NCT04167670|468847232|FG002|Overall Study|Significant protocol deviation|0|||
130242108|NCT04167670|468847230|FG000|Overall Study|Lost to Follow-up|0|||
130242109|NCT04167670|468847231|FG001|Overall Study|Lost to Follow-up|3|||
130242110|NCT04167670|468847232|FG002|Overall Study|Lost to Follow-up|3|||
130242111|NCT04167670|468847230|FG000|Overall Study|Voluntary Withdrawal|0|||
130242112|NCT04167670|468847231|FG001|Overall Study|Voluntary Withdrawal|1|||
130242113|NCT04167670|468847232|FG002|Overall Study|Voluntary Withdrawal|1|||
130028272|NCT00883493|468064311|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
130028273|NCT00883493|468064312|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
130028274|NCT00883493|468064311|FG000|Overall Study|Study specific disc. criteria|2|||
130028275|NCT00883493|468064312|FG001|Overall Study|Study specific disc. criteria|0|||
130028276|NCT00883493|468064311|FG000|Overall Study|Other|5|||
130028277|NCT00883493|468064312|FG001|Overall Study|Other|3|||
130028278|NCT00988247|468064313|FG000|Overall Study|Adverse Event|17|||
130028279|NCT00988247|468064314|FG001|Overall Study|Adverse Event|3|||
130028280|NCT00988247|468064313|FG000|Overall Study|Withdrawal by Subject|44|||
130028281|NCT00988247|468064314|FG001|Overall Study|Withdrawal by Subject|13|||
130028282|NCT00988247|468064313|FG000|Overall Study|Pregnancy|1|||
130028283|NCT00988247|468064314|FG001|Overall Study|Pregnancy|2|||
130028284|NCT00988247|468064313|FG000|Overall Study|Lost to Follow-up|11|||
130028285|NCT00988247|468064314|FG001|Overall Study|Lost to Follow-up|2|||
130028286|NCT00988247|468064313|FG000|Overall Study|Protocol Violation|4|||
130242114|NCT04167670|468847230|FG000|Overall Study|Withdrawal of Consent|4|||
130242115|NCT04167670|468847231|FG001|Overall Study|Withdrawal of Consent|1|||
130242116|NCT04167670|468847232|FG002|Overall Study|Withdrawal of Consent|3|||
130242117|NCT04167670|468847230|FG000|Overall Study|Miscellaneous|7|||
130242118|NCT04167670|468847231|FG001|Overall Study|Miscellaneous|5|||
130242119|NCT04167670|468847232|FG002|Overall Study|Miscellaneous|3|||
130242120|NCT01127061|468847233|FG000|Overall Study|Lost to Follow-up|7|||
130242121|NCT01127061|468847234|FG001|Overall Study|Lost to Follow-up|10|||
130242122|NCT01127061|468847233|FG000|Overall Study|Physician Decision|3|||
130242123|NCT01127061|468847234|FG001|Overall Study|Physician Decision|3|||
130242124|NCT04827446|468847237|FG000|Overall Study|Lost to Follow-up|1|||
130100306|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
130100307|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
130100308|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
130100309|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
130100310|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
130100311|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
130100312|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
130100313|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
130242125|NCT04827446|468847238|FG001|Overall Study|Lost to Follow-up|1|||
130028287|NCT00988247|468064314|FG001|Overall Study|Protocol Violation|5|||
130100314|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
130100315|NCT01299272|468325955|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
130100316|NCT01299272|468325956|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
130100317|NCT01299272|468325957|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
130100318|NCT01299272|468325958|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
130100319|NCT03606109|468325959|FG000|Overall Study|Lost to Follow-up|2|||
130100320|NCT03606109|468325960|FG001|Overall Study|Lost to Follow-up|1|||
130100321|NCT03669640|468325961|FG000|Overall Study|Study Terminated by Sponsor|0|||
130100322|NCT03669640|468325962|FG001|Overall Study|Study Terminated by Sponsor|0|||
130100323|NCT03669640|468325963|FG002|Overall Study|Study Terminated by Sponsor|0|||
130100324|NCT03669640|468325964|FG003|Overall Study|Study Terminated by Sponsor|0|||
130100325|NCT03669640|468325965|FG004|Overall Study|Study Terminated by Sponsor|1|||
130100326|NCT03669640|468325966|FG005|Overall Study|Study Terminated by Sponsor|0|||
130100327|NCT03669640|468325961|FG000|Overall Study|Lost to Follow-up|0|||
130100328|NCT03669640|468325962|FG001|Overall Study|Lost to Follow-up|0|||
130100329|NCT03669640|468325963|FG002|Overall Study|Lost to Follow-up|2|||
130100330|NCT03669640|468325964|FG003|Overall Study|Lost to Follow-up|0|||
130100331|NCT03669640|468325965|FG004|Overall Study|Lost to Follow-up|0|||
130100332|NCT03669640|468325966|FG005|Overall Study|Lost to Follow-up|0|||
130100333|NCT03669640|468325961|FG000|Overall Study|Death|0|||
130100334|NCT03669640|468325962|FG001|Overall Study|Death|0|||
130100335|NCT03669640|468325963|FG002|Overall Study|Death|1|||
130242126|NCT04827446|468847237|FG000|Overall Study|Death|2|||
130028288|NCT00988247|468064313|FG000|Overall Study|Sponsor requested withdrawal|3|||
130028289|NCT00988247|468064314|FG001|Overall Study|Sponsor requested withdrawal|1|||
130028290|NCT00988247|468064313|FG000|Overall Study|Other|3|||
130028291|NCT00988247|468064314|FG001|Overall Study|Other|0|||
130028292|NCT02661594|468064315|FG000|Overall Study|Protocol Violation|1|||
130028293|NCT02661594|468064316|FG001|Overall Study|Protocol Violation|0|||
130028294|NCT02661594|468064317|FG002|Overall Study|Protocol Violation|1|||
130028295|NCT02661594|468064318|FG003|Overall Study|Protocol Violation|0|||
130028296|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028297|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
130028298|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028299|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028300|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028301|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
130028302|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
130028303|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
130100336|NCT03669640|468325964|FG003|Overall Study|Death|0|||
130100337|NCT03669640|468325965|FG004|Overall Study|Death|0|||
130100338|NCT03669640|468325966|FG005|Overall Study|Death|0|||
130100339|NCT03669640|468325961|FG000|Overall Study|Withdrawal by Subject|1|||
130242127|NCT04827446|468847238|FG001|Overall Study|Death|0|||
130242128|NCT04827446|468847237|FG000|Overall Study|Withdrawal by Subject|2|||
130242129|NCT04827446|468847238|FG001|Overall Study|Withdrawal by Subject|2|||
130242130|NCT00003456|468847241|FG000|Overall Study|Not evaluable|8|||
130242131|NCT00479232|468847242|FG000|Overall Study|Adverse Event|0|||
130242132|NCT00479232|468847243|FG001|Overall Study|Adverse Event|0|||
130242133|NCT00479232|468847244|FG002|Overall Study|Adverse Event|5|||
130242134|NCT00479232|468847245|FG003|Overall Study|Adverse Event|0|||
130242135|NCT00479232|468847246|FG004|Overall Study|Adverse Event|0|||
130242136|NCT00479232|468847247|FG005|Overall Study|Adverse Event|10|||
130242137|NCT00479232|468847242|FG000|Overall Study|Deviation from Protocol|0|||
130242138|NCT00479232|468847243|FG001|Overall Study|Deviation from Protocol|0|||
130242139|NCT00479232|468847244|FG002|Overall Study|Deviation from Protocol|1|||
130242140|NCT00479232|468847245|FG003|Overall Study|Deviation from Protocol|0|||
130242141|NCT00479232|468847246|FG004|Overall Study|Deviation from Protocol|0|||
130242142|NCT00479232|468847247|FG005|Overall Study|Deviation from Protocol|0|||
130242143|NCT00479232|468847242|FG000|Overall Study|Lack of Efficacy|0|||
130028304|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
130242144|NCT00479232|468847243|FG001|Overall Study|Lack of Efficacy|0|||
130242145|NCT00479232|468847244|FG002|Overall Study|Lack of Efficacy|2|||
130242146|NCT00479232|468847245|FG003|Overall Study|Lack of Efficacy|0|||
130242147|NCT00479232|468847246|FG004|Overall Study|Lack of Efficacy|0|||
130242148|NCT00479232|468847247|FG005|Overall Study|Lack of Efficacy|4|||
130242149|NCT00479232|468847242|FG000|Overall Study|Physician Decision|0|||
130242150|NCT00479232|468847243|FG001|Overall Study|Physician Decision|0|||
130242151|NCT00479232|468847244|FG002|Overall Study|Physician Decision|2|||
130242152|NCT00479232|468847245|FG003|Overall Study|Physician Decision|0|||
130242153|NCT00479232|468847246|FG004|Overall Study|Physician Decision|0|||
130242154|NCT00479232|468847247|FG005|Overall Study|Physician Decision|1|||
130242155|NCT00479232|468847242|FG000|Overall Study|Progressive Disease|3|||
130242156|NCT00479232|468847243|FG001|Overall Study|Progressive Disease|1|||
130242157|NCT00479232|468847244|FG002|Overall Study|Progressive Disease|12|||
130242158|NCT00479232|468847245|FG003|Overall Study|Progressive Disease|3|||
130242159|NCT00479232|468847246|FG004|Overall Study|Progressive Disease|3|||
130242160|NCT00479232|468847247|FG005|Overall Study|Progressive Disease|12|||
130242161|NCT00479232|468847242|FG000|Overall Study|Withdrew Consent|0|||
130242162|NCT00479232|468847243|FG001|Overall Study|Withdrew Consent|2|||
130242163|NCT00479232|468847244|FG002|Overall Study|Withdrew Consent|6|||
130242164|NCT00479232|468847245|FG003|Overall Study|Withdrew Consent|0|||
130242165|NCT00479232|468847246|FG004|Overall Study|Withdrew Consent|1|||
130242166|NCT00479232|468847247|FG005|Overall Study|Withdrew Consent|3|||
130242167|NCT05399771|468847248|FG000|Overall Study|Physician Decision|3|||
130242168|NCT05399771|468847248|FG000|Overall Study|Adverse Event|1|||
130242169|NCT00484159|468847249|FG000|Overall Study|Lost to Follow-up|1|||
130242170|NCT00484159|468847250|FG001|Overall Study|Lost to Follow-up|1|||
130242171|NCT00484159|468847251|FG002|Overall Study|Lost to Follow-up|0|||
130242172|NCT03720847|468847252|FG000|Washout|Physician Decision|1|||
130242173|NCT03720847|468847253|FG001|Washout|Physician Decision|2|||
130242174|NCT01239680|468847254|FG000|Overall Study|Withdrawal by Subject|2|||
130242175|NCT01239680|468847255|FG001|Overall Study|Withdrawal by Subject|0|||
130242176|NCT03033901|468847256|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
130242177|NCT03033901|468847256|FG000|Overall Study|Refused PSG|23|||
130242178|NCT03033901|468847256|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
130242179|NCT03033901|468847256|FG000|Overall Study|Missing Oximetry Data|3|||
130242180|NCT02513199|468847259|FG000|Treatment|Death|1|||
130242181|NCT02513199|468847259|FG000|Treatment|Lost to Follow-up|1|||
130242182|NCT02513199|468847259|FG000|Follow-Up|Death|11|||
130242183|NCT04307394|468847265|FG000|Overall Study|Lost to Follow-up|3|||
130242184|NCT04307394|468847265|FG000|Overall Study|Withdrawal by Subject|2|||
130242185|NCT01521364|468847273|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
130242186|NCT01521364|468847273|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
130242187|NCT04900272|468847274|FG000|Overall Study|Lost to Follow-up|2|||
130242188|NCT04900272|468847274|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
130028305|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
130028306|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130242189|NCT04900272|468847274|FG000|Overall Study|Withdrawal by Subject|1|||
130242190|NCT05059080|468847275|FG000|Overall Study|Withdrawal by Subject|3|||
130242191|NCT05059080|468847275|FG000|Overall Study|Study Terminated by Sponsor|64|||
130242192|NCT00081458|468847277|FG000|Overall Study|Adverse Event|1|||
130242193|NCT00081458|468847278|FG001|Overall Study|Adverse Event|5|||
130242194|NCT00081458|468847279|FG002|Overall Study|Adverse Event|2|||
130242195|NCT00081458|468847277|FG000|Overall Study|Withdrawal by Subject|0|||
130242196|NCT00081458|468847278|FG001|Overall Study|Withdrawal by Subject|3|||
130242197|NCT00081458|468847279|FG002|Overall Study|Withdrawal by Subject|1|||
130242198|NCT00081458|468847277|FG000|Overall Study|Randomized but not dosed|0|||
130242199|NCT00081458|468847278|FG001|Overall Study|Randomized but not dosed|0|||
130242200|NCT00081458|468847279|FG002|Overall Study|Randomized but not dosed|1|||
130242201|NCT00549328|468847280|FG000|Overall Study|Adverse Event|2|||
130242202|NCT00549328|468847280|FG000|Overall Study|Disease Progression|10|||
130242203|NCT00549328|468847280|FG000|Overall Study|Death|1|||
130242204|NCT00549328|468847280|FG000|Overall Study|Use of Prohibited Medication|1|||
130242205|NCT00770484|468847281|FG000|Overall Study|Withdrawal by Subject|1|||
130242206|NCT00770484|468847282|FG001|Overall Study|Withdrawal by Subject|0|||
130242207|NCT01946802|468847287|FG000|Overall Study|Death|1|||
130242208|NCT01946802|468847287|FG000|Overall Study|Withdrawal by Subject|2|||
130028307|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130028308|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130242209|NCT01946802|468847287|FG000|Overall Study|Combined septic shock|1|||
130242210|NCT01946802|468847287|FG000|Overall Study|Protocol Violation|1|||
130242211|NCT03097315|468847288|FG000|Overall Study|Withdrawal by Subject|1|||
130242212|NCT03384966|468847289|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
130242213|NCT03384966|468847290|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
130242214|NCT03384966|468847291|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
130242215|NCT03384966|468847289|FG000|Follow-up Period|Adverse Event|1|||
130242216|NCT03384966|468847290|FG001|Follow-up Period|Adverse Event|0|||
130242217|NCT03384966|468847291|FG002|Follow-up Period|Adverse Event|0|||
130242218|NCT03637374|468847292|FG000|Overall Study|Death|2|||
130242219|NCT03637374|468847293|FG001|Overall Study|Death|0|||
130242220|NCT02836769|468847295|FG000|Overall Study|Lost to Follow-up|10|||
130242221|NCT02836769|468847295|FG000|Overall Study|Medical withdrawal|2|||
130242222|NCT02836769|468847295|FG000|Overall Study|Withdrawal by Subject|3|||
130242223|NCT00376506|468847304|FG000|Overall Study|Death|0|||
130242224|NCT00376506|468847305|FG001|Overall Study|Death|2|||
130242225|NCT02948400|468847308|FG000|Overall Study|Withdrawal by Subject|17|||
130242226|NCT02948400|468847309|FG001|Overall Study|Withdrawal by Subject|10|||
130242227|NCT02948400|468847308|FG000|Overall Study|failed to attend appointments|47|||
130242228|NCT02948400|468847309|FG001|Overall Study|failed to attend appointments|34|||
130242229|NCT02948400|468847308|FG000|Overall Study|COVID-related closure|6|||
130242230|NCT02948400|468847309|FG001|Overall Study|COVID-related closure|2|||
130242231|NCT02948400|468847308|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
130242232|NCT02948400|468847309|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
130242233|NCT02948400|468847308|FG000|Overall Study|motion sickness in virtual reality|2|||
130242234|NCT02948400|468847309|FG001|Overall Study|motion sickness in virtual reality|0|||
130242235|NCT02403271|468847310|FG000|Period 1|Other varied reasons|1|||
130242236|NCT02403271|468847311|FG001|Period 1|Other varied reasons|0|||
130242237|NCT02403271|468847310|FG000|Period 2|Withdrawal by Subject|0|||
130242238|NCT02403271|468847311|FG001|Period 2|Withdrawal by Subject|14|||
130242239|NCT02403271|468847310|FG000|Period 2|Death|0|||
130242240|NCT02403271|468847311|FG001|Period 2|Death|84|||
130242241|NCT02403271|468847310|FG000|Period 2|Lost to Follow-up|0|||
130242242|NCT02403271|468847311|FG001|Period 2|Lost to Follow-up|2|||
130242243|NCT02403271|468847310|FG000|Period 2|Study Terminated by Sponsor|0|||
130242244|NCT02403271|468847311|FG001|Period 2|Study Terminated by Sponsor|14|||
130242245|NCT02403271|468847310|FG000|Period 2|Other varied reasons|0|||
130242246|NCT02403271|468847311|FG001|Period 2|Other varied reasons|10|||
130242247|NCT00221104|468847316|FG000|Overall Study|Adverse Event|1|||
130242248|NCT00221104|468847317|FG001|Overall Study|Adverse Event|0|||
130242249|NCT00221104|468847316|FG000|Overall Study|Physician Decision|1|||
130242250|NCT00221104|468847317|FG001|Overall Study|Physician Decision|0|||
130242251|NCT00221104|468847316|FG000|Overall Study|Protocol Violation|2|||
130242252|NCT00221104|468847317|FG001|Overall Study|Protocol Violation|0|||
130242253|NCT00221104|468847316|FG000|Overall Study|Withdrawal by Subject|42|||
130242254|NCT00221104|468847317|FG001|Overall Study|Withdrawal by Subject|29|||
130242255|NCT00221104|468847316|FG000|Overall Study|Others|37|||
130242256|NCT00221104|468847317|FG001|Overall Study|Others|47|||
130242257|NCT02989389|468847318|FG000|Period 1|Lost to Follow-up|0|||
130242258|NCT02989389|468847319|FG001|Period 1|Lost to Follow-up|1|||
130242259|NCT02989389|468847320|FG002|Period 1|Lost to Follow-up|0|||
130242260|NCT02989389|468847321|FG003|Period 1|Lost to Follow-up|0|||
130242261|NCT02989389|468847322|FG004|Period 1|Lost to Follow-up|0|||
130242262|NCT02989389|468847323|FG005|Period 1|Lost to Follow-up|0|||
130242263|NCT02989389|468847324|FG006|Period 1|Lost to Follow-up|0|||
130242264|NCT02989389|468847325|FG007|Period 1|Lost to Follow-up|0|||
130242265|NCT02989389|468847326|FG008|Period 1|Lost to Follow-up|0|||
130242266|NCT02989389|468847327|FG009|Period 1|Lost to Follow-up|0|||
130242267|NCT02989389|468847318|FG000|Period 1|Physician Decision|0|||
130242268|NCT02989389|468847319|FG001|Period 1|Physician Decision|0|||
130242269|NCT02989389|468847320|FG002|Period 1|Physician Decision|0|||
130242270|NCT02989389|468847321|FG003|Period 1|Physician Decision|0|||
130242271|NCT02989389|468847322|FG004|Period 1|Physician Decision|0|||
130242272|NCT02989389|468847323|FG005|Period 1|Physician Decision|0|||
130242273|NCT02989389|468847324|FG006|Period 1|Physician Decision|0|||
130242274|NCT02989389|468847325|FG007|Period 1|Physician Decision|0|||
130242275|NCT02989389|468847326|FG008|Period 1|Physician Decision|1|||
130242276|NCT02989389|468847327|FG009|Period 1|Physician Decision|0|||
130242277|NCT04470427|468847328|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
130242278|NCT04470427|468847329|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
130242279|NCT04470427|468847330|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
130242280|NCT04470427|468847331|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
130242281|NCT04470427|468847332|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
130242282|NCT04470427|468847333|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
130242283|NCT04470427|468847328|FG000|Part B :Open-label|Other than specified|0|||
130242284|NCT04470427|468847329|FG001|Part B :Open-label|Other than specified|0|||
130242285|NCT04470427|468847330|FG002|Part B :Open-label|Other than specified|788|||
130242286|NCT04470427|468847331|FG003|Part B :Open-label|Other than specified|0|||
130242287|NCT04470427|468847332|FG004|Part B :Open-label|Other than specified|523|||
130242288|NCT04470427|468847333|FG005|Part B :Open-label|Other than specified|0|||
130242289|NCT04470427|468847328|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
130242290|NCT04470427|468847329|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
130242291|NCT04470427|468847330|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
130242292|NCT04470427|468847331|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
130242293|NCT04470427|468847332|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
130242294|NCT04470427|468847333|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
130242295|NCT04470427|468847328|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
130242296|NCT04470427|468847329|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
130242297|NCT04470427|468847330|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
130242298|NCT04470427|468847331|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
130242299|NCT04470427|468847332|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
130242300|NCT04470427|468847333|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
130242301|NCT03412890|468847340|FG000|Overall Study|Adverse Event|5|||
130242302|NCT03412890|468847341|FG001|Overall Study|Adverse Event|5|||
130242303|NCT03412890|468847342|FG002|Overall Study|Adverse Event|9|||
130242304|NCT03412890|468847340|FG000|Overall Study|Protocol deviation|2|||
130242305|NCT03412890|468847341|FG001|Overall Study|Protocol deviation|1|||
130242306|NCT03412890|468847342|FG002|Overall Study|Protocol deviation|2|||
130242307|NCT03412890|468847340|FG000|Overall Study|Lost to Follow-up|7|||
130242308|NCT03412890|468847341|FG001|Overall Study|Lost to Follow-up|10|||
130242309|NCT03412890|468847342|FG002|Overall Study|Lost to Follow-up|10|||
130242310|NCT03412890|468847340|FG000|Overall Study|Withdrawal by Subject|9|||
130242311|NCT03412890|468847341|FG001|Overall Study|Withdrawal by Subject|12|||
130242312|NCT03412890|468847342|FG002|Overall Study|Withdrawal by Subject|11|||
130242313|NCT03412890|468847340|FG000|Overall Study|Lack of Efficacy|2|||
130242314|NCT03412890|468847341|FG001|Overall Study|Lack of Efficacy|7|||
130242315|NCT03412890|468847342|FG002|Overall Study|Lack of Efficacy|5|||
130242316|NCT03412890|468847340|FG000|Overall Study|Other|5|||
130242317|NCT03412890|468847341|FG001|Overall Study|Other|6|||
130242318|NCT03412890|468847342|FG002|Overall Study|Other|5|||
130242319|NCT03412890|468847340|FG000|Overall Study|Participants who did not receive any study drug|0|||
130242320|NCT03412890|468847341|FG001|Overall Study|Participants who did not receive any study drug|1|||
130242321|NCT03412890|468847342|FG002|Overall Study|Participants who did not receive any study drug|0|||
130242322|NCT00021255|468847343|FG000|Overall Study|Death|1|||
130242323|NCT00021255|468847344|FG001|Overall Study|Death|0|||
130242324|NCT00021255|468847345|FG002|Overall Study|Death|2|||
130242325|NCT00021255|468847343|FG000|Overall Study|Breast cancer relapse|5|||
130242326|NCT00021255|468847344|FG001|Overall Study|Breast cancer relapse|18|||
130242327|NCT00021255|468847345|FG002|Overall Study|Breast cancer relapse|11|||
130242328|NCT00021255|468847343|FG000|Overall Study|Second primary malignancy|0|||
130242329|NCT00021255|468847344|FG001|Overall Study|Second primary malignancy|4|||
130242330|NCT00021255|468847345|FG002|Overall Study|Second primary malignancy|1|||
130242331|NCT00021255|468847343|FG000|Overall Study|Withdrawal by Subject|41|||
130242332|NCT00021255|468847344|FG001|Overall Study|Withdrawal by Subject|64|||
130242333|NCT00021255|468847345|FG002|Overall Study|Withdrawal by Subject|26|||
130242334|NCT00021255|468847343|FG000|Overall Study|Lost to Follow-up|0|||
130242335|NCT00021255|468847344|FG001|Overall Study|Lost to Follow-up|2|||
130242336|NCT00021255|468847345|FG002|Overall Study|Lost to Follow-up|3|||
130242337|NCT00021255|468847343|FG000|Overall Study|Cardiac toxicity|0|||
130242338|NCT00021255|468847344|FG001|Overall Study|Cardiac toxicity|61|||
130242339|NCT00021255|468847345|FG002|Overall Study|Cardiac toxicity|32|||
130242340|NCT00021255|468847343|FG000|Overall Study|Herceptin toxicity|0|||
130242341|NCT00021255|468847344|FG001|Overall Study|Herceptin toxicity|22|||
130242342|NCT00021255|468847345|FG002|Overall Study|Herceptin toxicity|6|||
130242343|NCT00021255|468847343|FG000|Overall Study|Adverse Event|46|||
130242344|NCT00021255|468847344|FG001|Overall Study|Adverse Event|30|||
130242345|NCT00021255|468847345|FG002|Overall Study|Adverse Event|18|||
130242346|NCT00021255|468847343|FG000|Overall Study|Protocol Violation|0|||
130242347|NCT00021255|468847344|FG001|Overall Study|Protocol Violation|2|||
130242348|NCT00021255|468847345|FG002|Overall Study|Protocol Violation|0|||
130242349|NCT00021255|468847343|FG000|Overall Study|Other than specified above|0|||
130242350|NCT00021255|468847344|FG001|Overall Study|Other than specified above|38|||
130242351|NCT00021255|468847345|FG002|Overall Study|Other than specified above|19|||
130242352|NCT00021255|468847343|FG000|Overall Study|Missing|0|||
130242353|NCT00021255|468847344|FG001|Overall Study|Missing|27|||
130242354|NCT00021255|468847345|FG002|Overall Study|Missing|13|||
130242355|NCT00021255|468847343|FG000|Overall Study|Randomized but not treated|28|||
130242356|NCT00021255|468847344|FG001|Overall Study|Randomized but not treated|2|||
130242357|NCT00021255|468847345|FG002|Overall Study|Randomized but not treated|18|||
130242358|NCT01132755|468847348|FG000|Overall Study|Procedure not done due to medical reason|23|||
130242359|NCT01132755|468847348|FG000|Overall Study|Protocol Violation|15|||
130242360|NCT01132755|468847348|FG000|Overall Study|Withdrawal by Subject|4|||
130242361|NCT02232698|468847349|FG000|Overall Study|Pregnancy|1|||
130242362|NCT02232698|468847350|FG001|Overall Study|Pregnancy|1|||
130242363|NCT02232698|468847349|FG000|Overall Study|Met exclusion criteria|1|||
130242364|NCT02232698|468847350|FG001|Overall Study|Met exclusion criteria|1|||
130242365|NCT02232698|468847349|FG000|Overall Study|Had device-associated symptoms|7|||
130242366|NCT02232698|468847350|FG001|Overall Study|Had device-associated symptoms|0|||
130242367|NCT02232698|468847349|FG000|Overall Study|Non-compliance with study device|1|||
130242368|NCT02232698|468847350|FG001|Overall Study|Non-compliance with study device|4|||
130242369|NCT02232698|468847349|FG000|Overall Study|Allocated to control group|0|||
130242370|NCT02232698|468847350|FG001|Overall Study|Allocated to control group|3|||
130242371|NCT02232698|468847349|FG000|Overall Study|Withdrawal by Subject|0|||
130242372|NCT02232698|468847350|FG001|Overall Study|Withdrawal by Subject|11|||
130242373|NCT02393755|468847351|FG000|Overall Study|Withdrawal by Subject|0|||
130242374|NCT02393755|468847352|FG001|Overall Study|Withdrawal by Subject|3|||
130242375|NCT02393755|468847351|FG000|Overall Study|Adverse Event|0|||
130242376|NCT02393755|468847352|FG001|Overall Study|Adverse Event|2|||
130242377|NCT02393755|468847351|FG000|Overall Study|Physician Decision|0|||
130242378|NCT02393755|468847352|FG001|Overall Study|Physician Decision|2|||
130242379|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
130242380|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
130242381|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
130242382|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
130242383|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
130242384|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
130242385|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
130242386|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
130242387|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
130242388|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
130242389|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
130242390|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
130242391|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
130242392|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
130242393|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
130242394|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
130242395|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
130242396|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
130242397|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
130242398|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
130242399|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
130242400|NCT02337946|468847353|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
130242401|NCT02337946|468847354|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
130242402|NCT02337946|468847355|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
130242403|NCT02337946|468847353|FG000|In-between Period|Without Informed Consent|1|||
130242404|NCT02337946|468847354|FG001|In-between Period|Without Informed Consent|0|||
130242405|NCT02337946|468847355|FG002|In-between Period|Without Informed Consent|0|||
130242406|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
130242407|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
130242408|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
130242409|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
130242410|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
130242411|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
130242412|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
130242413|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
130242414|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
130242415|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
130242416|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
130242417|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
130242418|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
130242419|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
130242420|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
130242421|NCT02337946|468847353|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
130242422|NCT02337946|468847354|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
130242423|NCT02337946|468847355|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
130242424|NCT05324371|468847357|FG000|Overall Study|Withdrawal by Subject|1|||
130242425|NCT05324371|468847357|FG000|Overall Study|Death|1|||
130242426|NCT02949934|468847359|FG000|Natural Drinking Period|Adverse Event|1|||
130242427|NCT02949934|468847360|FG001|Natural Drinking Period|Adverse Event|0|||
130242428|NCT02949934|468847361|FG002|Natural Drinking Period|Adverse Event|0|||
130242429|NCT02949934|468847362|FG003|Natural Drinking Period|Adverse Event|1|||
130242430|NCT02949934|468847363|FG004|Natural Drinking Period|Adverse Event|0|||
130242431|NCT02949934|468847364|FG005|Natural Drinking Period|Adverse Event|0|||
130242432|NCT02949934|468847359|FG000|Natural Drinking Period|Lost to Follow-up|0|||
130242433|NCT02949934|468847360|FG001|Natural Drinking Period|Lost to Follow-up|0|||
130242434|NCT02949934|468847361|FG002|Natural Drinking Period|Lost to Follow-up|0|||
130242435|NCT02949934|468847362|FG003|Natural Drinking Period|Lost to Follow-up|0|||
130242436|NCT02949934|468847363|FG004|Natural Drinking Period|Lost to Follow-up|1|||
130242437|NCT02949934|468847364|FG005|Natural Drinking Period|Lost to Follow-up|0|||
130242438|NCT02949934|468847359|FG000|Neuroimaging|Protocol Violation|2|||
130242439|NCT02949934|468847360|FG001|Neuroimaging|Protocol Violation|0|||
130242440|NCT02949934|468847361|FG002|Neuroimaging|Protocol Violation|0|||
130242441|NCT02949934|468847362|FG003|Neuroimaging|Protocol Violation|0|||
130242442|NCT02949934|468847363|FG004|Neuroimaging|Protocol Violation|1|||
130242443|NCT02949934|468847364|FG005|Neuroimaging|Protocol Violation|0|||
130242444|NCT02949934|468847359|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
130242445|NCT02949934|468847360|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
130242446|NCT02949934|468847361|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
130242447|NCT02949934|468847362|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
130242448|NCT02949934|468847363|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
130242449|NCT02949934|468847364|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
130242450|NCT02949934|468847359|FG000|Neuroimaging|Not scanned|0|||
130242451|NCT02949934|468847360|FG001|Neuroimaging|Not scanned|0|||
130242452|NCT02949934|468847361|FG002|Neuroimaging|Not scanned|1|||
130242453|NCT02949934|468847362|FG003|Neuroimaging|Not scanned|0|||
130242454|NCT02949934|468847363|FG004|Neuroimaging|Not scanned|0|||
130242455|NCT02949934|468847364|FG005|Neuroimaging|Not scanned|2|||
130242456|NCT02949934|468847359|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
130242457|NCT02949934|468847360|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130242458|NCT02949934|468847361|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130242459|NCT02949934|468847362|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
130242460|NCT02949934|468847363|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
130242461|NCT02949934|468847364|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
130242462|NCT02949934|468847359|FG000|Bar Laboratory|Adverse Event|1|||
130242463|NCT02949934|468847360|FG001|Bar Laboratory|Adverse Event|0|||
130242464|NCT02949934|468847361|FG002|Bar Laboratory|Adverse Event|2|||
130242465|NCT02949934|468847362|FG003|Bar Laboratory|Adverse Event|0|||
130242466|NCT02949934|468847363|FG004|Bar Laboratory|Adverse Event|1|||
130242467|NCT02949934|468847364|FG005|Bar Laboratory|Adverse Event|0|||
130242468|NCT02949934|468847359|FG000|Bar Laboratory|Protocol Violation|0|||
130242469|NCT02949934|468847360|FG001|Bar Laboratory|Protocol Violation|0|||
130242470|NCT02949934|468847361|FG002|Bar Laboratory|Protocol Violation|0|||
130242471|NCT02949934|468847362|FG003|Bar Laboratory|Protocol Violation|1|||
130242472|NCT02949934|468847363|FG004|Bar Laboratory|Protocol Violation|0|||
130242473|NCT02949934|468847364|FG005|Bar Laboratory|Protocol Violation|0|||
130242474|NCT01363076|468848007|FG000|Overall Study|Withdrawal by Subject|0|||
130242475|NCT01363076|468848008|FG001|Overall Study|Withdrawal by Subject|1|||
130242476|NCT04706403|468848009|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
130242477|NCT04706403|468848010|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
130242478|NCT04706403|468848011|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
130242479|NCT04706403|468848012|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
130242480|NCT04706403|468848013|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
130242481|NCT00182637|468848014|FG000|Overall Study|Adverse Event|2|||
130242482|NCT00182637|468848014|FG000|Overall Study|Disease Progression|1|||
130242483|NCT04766333|468848017|FG000|Overall Study|Lost to Follow-up|40|||
130242484|NCT04766333|468848018|FG001|Overall Study|Lost to Follow-up|826|||
130242485|NCT00639379|468848019|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
130242486|NCT00639379|468848020|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
130242487|NCT00639379|468848019|FG000|Period 1 - 2 Weeks|lens issue|3|||
130242488|NCT00639379|468848020|FG001|Period 1 - 2 Weeks|lens issue|0|||
130242489|NCT01771913|468848028|FG000|Overall Study|Withdrawal by Subject|1|||
130242490|NCT01771913|468848029|FG001|Overall Study|Withdrawal by Subject|0|||
130242491|NCT00407511|468848030|FG000|Overall Study|Adverse Event|9|||
130242492|NCT00407511|468848030|FG000|Overall Study|Lost to Follow-up|4|||
130242493|NCT00407511|468848030|FG000|Overall Study|Other|5|||
130242494|NCT00407511|468848030|FG000|Overall Study|Withdrawal by Subject|4|||
130242495|NCT02636283|468848031|FG000|Overall Study|Adverse Event|2|||
130242496|NCT02636283|468848032|FG001|Overall Study|Adverse Event|0|||
130242497|NCT02636283|468848031|FG000|Overall Study|Trial Terminated Prematurely|0|||
130242498|NCT02636283|468848032|FG001|Overall Study|Trial Terminated Prematurely|3|||
130242499|NCT00195429|468848035|FG000|Overall Study|Adverse Event|2|||
130242500|NCT00195429|468848036|FG001|Overall Study|Adverse Event|4|||
130242501|NCT00195429|468848035|FG000|Overall Study|Lack of Efficacy|2|||
130242502|NCT00195429|468848036|FG001|Overall Study|Lack of Efficacy|1|||
130242503|NCT00195429|468848035|FG000|Overall Study|Lost to Follow-up|1|||
130242504|NCT00195429|468848036|FG001|Overall Study|Lost to Follow-up|0|||
130242505|NCT02541903|468848037|FG000|Overall Study|Death|1|||
130242506|NCT04795323|468848040|FG000|Overall Study|Did not interact with TARA|1|||
130242507|NCT04795323|468848041|FG001|Overall Study|Did not interact with TARA|0|||
130242508|NCT03142750|468848043|FG000|Overall Study|Lost to Follow-up|4|||
130242509|NCT03142750|468848044|FG001|Overall Study|Lost to Follow-up|1|||
130242510|NCT04925934|468848045|FG000|Overall Study|Adverse Event|1|||
130242511|NCT04925934|468848046|FG001|Overall Study|Adverse Event|0|||
130242512|NCT04925934|468848047|FG002|Overall Study|Adverse Event|0|||
130242513|NCT04925934|468848045|FG000|Overall Study|Lost to Follow-up|2|||
130242514|NCT04925934|468848046|FG001|Overall Study|Lost to Follow-up|0|||
130242515|NCT04925934|468848047|FG002|Overall Study|Lost to Follow-up|1|||
130242516|NCT04925934|468848045|FG000|Overall Study|Death|0|||
130242517|NCT04925934|468848046|FG001|Overall Study|Death|1|||
130242518|NCT04925934|468848047|FG002|Overall Study|Death|0|||
130242519|NCT04925934|468848045|FG000|Overall Study|Withdrawal by Subject|8|||
130242520|NCT04925934|468848046|FG001|Overall Study|Withdrawal by Subject|5|||
130242521|NCT04925934|468848047|FG002|Overall Study|Withdrawal by Subject|9|||
130242522|NCT04925934|468848045|FG000|Overall Study|Other|2|||
130242523|NCT04925934|468848046|FG001|Overall Study|Other|2|||
130242524|NCT04925934|468848047|FG002|Overall Study|Other|2|||
130242525|NCT04925934|468848045|FG000|Overall Study|Eastern European Conflict|7|||
130242526|NCT04925934|468848046|FG001|Overall Study|Eastern European Conflict|3|||
130242527|NCT04925934|468848047|FG002|Overall Study|Eastern European Conflict|2|||
130242528|NCT03158688|468848048|FG000|Overall Study|Withdrawal by Subject|14|||
130242529|NCT03158688|468848049|FG001|Overall Study|Withdrawal by Subject|28|||
130242530|NCT03158688|468848048|FG000|Overall Study|Decision by sponsor|13|||
130242531|NCT03158688|468848049|FG001|Overall Study|Decision by sponsor|37|||
130242532|NCT03158688|468848048|FG000|Overall Study|Lost to Follow-up|4|||
130242533|NCT03158688|468848049|FG001|Overall Study|Lost to Follow-up|3|||
130242534|NCT03158688|468848048|FG000|Overall Study|Death|74|||
130242535|NCT03158688|468848049|FG001|Overall Study|Death|142|||
130242536|NCT00374868|468848053|FG000|Overall Study|Adverse Event|12|||
130242537|NCT00374868|468848053|FG000|Overall Study|Progressive Disease|7|||
130242538|NCT00374868|468848053|FG000|Overall Study|Physician Decision|13|||
130242539|NCT00374868|468848053|FG000|Overall Study|Lost to Follow-up|1|||
130242540|NCT00374868|468848053|FG000|Overall Study|Death|2|||
130242541|NCT00374868|468848053|FG000|Overall Study|Other - Not Specified|1|||
130242542|NCT03188185|468848054|FG000|Stage 1|Adverse Event|4|||
130242543|NCT03188185|468848055|FG001|Stage 1|Adverse Event|12|||
130242544|NCT03188185|468848056|FG002|Stage 1|Adverse Event|0|||
130242545|NCT03188185|468848057|FG003|Stage 1|Adverse Event|0|||
130242546|NCT03188185|468848054|FG000|Stage 1|Lack of Efficacy|0|||
130242547|NCT03188185|468848055|FG001|Stage 1|Lack of Efficacy|2|||
130242548|NCT03188185|468848056|FG002|Stage 1|Lack of Efficacy|0|||
130242549|NCT03188185|468848057|FG003|Stage 1|Lack of Efficacy|0|||
130242550|NCT03188185|468848054|FG000|Stage 1|Lost to Follow-up|6|||
130242551|NCT03188185|468848055|FG001|Stage 1|Lost to Follow-up|1|||
130028309|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130242552|NCT03188185|468848056|FG002|Stage 1|Lost to Follow-up|0|||
130242553|NCT03188185|468848057|FG003|Stage 1|Lost to Follow-up|0|||
130028310|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130242554|NCT03188185|468848054|FG000|Stage 1|Withdrawal by Subject|9|||
130242555|NCT03188185|468848055|FG001|Stage 1|Withdrawal by Subject|0|||
130242556|NCT03188185|468848056|FG002|Stage 1|Withdrawal by Subject|0|||
130242557|NCT03188185|468848057|FG003|Stage 1|Withdrawal by Subject|0|||
130028311|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130242558|NCT03188185|468848054|FG000|Stage 1|Identified as a professional patient|0|||
130242559|NCT03188185|468848055|FG001|Stage 1|Identified as a professional patient|1|||
130242560|NCT03188185|468848056|FG002|Stage 1|Identified as a professional patient|0|||
130242561|NCT03188185|468848057|FG003|Stage 1|Identified as a professional patient|0|||
130242562|NCT03188185|468848054|FG000|Stage 2|Adverse Event|0|||
130242563|NCT03188185|468848055|FG001|Stage 2|Adverse Event|0|||
130242564|NCT03188185|468848056|FG002|Stage 2|Adverse Event|2|||
130242565|NCT03188185|468848057|FG003|Stage 2|Adverse Event|4|||
130242566|NCT03188185|468848054|FG000|Stage 2|Lack of Efficacy|0|||
130242567|NCT03188185|468848055|FG001|Stage 2|Lack of Efficacy|0|||
130242568|NCT03188185|468848056|FG002|Stage 2|Lack of Efficacy|3|||
130242569|NCT03188185|468848057|FG003|Stage 2|Lack of Efficacy|0|||
130242570|NCT03188185|468848054|FG000|Stage 2|Lost to Follow-up|0|||
130242571|NCT03188185|468848055|FG001|Stage 2|Lost to Follow-up|0|||
130242572|NCT03188185|468848056|FG002|Stage 2|Lost to Follow-up|1|||
130242573|NCT03188185|468848057|FG003|Stage 2|Lost to Follow-up|0|||
130242574|NCT03188185|468848054|FG000|Stage 2|Physician Decision|0|||
130242575|NCT03188185|468848055|FG001|Stage 2|Physician Decision|0|||
130242576|NCT03188185|468848056|FG002|Stage 2|Physician Decision|0|||
130242577|NCT03188185|468848057|FG003|Stage 2|Physician Decision|1|||
130242578|NCT03188185|468848054|FG000|Stage 2|Withdrawal by Subject|0|||
130242579|NCT03188185|468848055|FG001|Stage 2|Withdrawal by Subject|0|||
130242580|NCT03188185|468848056|FG002|Stage 2|Withdrawal by Subject|3|||
130242581|NCT03188185|468848057|FG003|Stage 2|Withdrawal by Subject|1|||
130242582|NCT02315625|468848061|FG000|First Intervention|Disease Progression|1|||
130242583|NCT02315625|468848062|FG001|First Intervention|Disease Progression|0|||
130242584|NCT02315625|468848061|FG000|Second Intervention|Physician Decision|2|||
130242585|NCT02315625|468848062|FG001|Second Intervention|Physician Decision|1|||
130242586|NCT02315625|468848061|FG000|Second Intervention|Study closure|1|||
130242587|NCT02315625|468848062|FG001|Second Intervention|Study closure|0|||
130242588|NCT02315625|468848061|FG000|Second Intervention|Disease Progression|1|||
130242589|NCT02315625|468848062|FG001|Second Intervention|Disease Progression|0|||
130242590|NCT04822194|468848065|FG000|Overall Study|Withdrawal by Subject|5|||
130242591|NCT04822194|468848066|FG001|Overall Study|Withdrawal by Subject|4|||
130242592|NCT04822194|468848065|FG000|Overall Study|Technical issues with MR scanner|1|||
130242593|NCT04822194|468848066|FG001|Overall Study|Technical issues with MR scanner|0|||
130242594|NCT04822194|468848065|FG000|Overall Study|Lost to Follow-up|5|||
130242595|NCT04822194|468848066|FG001|Overall Study|Lost to Follow-up|7|||
130242596|NCT01947933|468848068|FG000|Overall Study|Withdrawal by Subject|0|||
130242597|NCT01947933|468848069|FG001|Overall Study|Withdrawal by Subject|0|||
130242598|NCT01947933|468848070|FG002|Overall Study|Withdrawal by Subject|1|||
130242599|NCT01947933|468848071|FG003|Overall Study|Withdrawal by Subject|0|||
130242600|NCT01947933|468848072|FG004|Overall Study|Withdrawal by Subject|0|||
130242601|NCT01947933|468848073|FG005|Overall Study|Withdrawal by Subject|0|||
130242602|NCT01947933|468848074|FG006|Overall Study|Withdrawal by Subject|0|||
130242603|NCT01947933|468848075|FG007|Overall Study|Withdrawal by Subject|0|||
130242604|NCT01947933|468848076|FG008|Overall Study|Withdrawal by Subject|0|||
130242605|NCT01947933|468848068|FG000|Overall Study|Lost to Follow-up|0|||
130242606|NCT01947933|468848069|FG001|Overall Study|Lost to Follow-up|0|||
130242607|NCT01947933|468848070|FG002|Overall Study|Lost to Follow-up|0|||
130242608|NCT01947933|468848071|FG003|Overall Study|Lost to Follow-up|0|||
130242609|NCT01947933|468848072|FG004|Overall Study|Lost to Follow-up|0|||
130242610|NCT01947933|468848073|FG005|Overall Study|Lost to Follow-up|0|||
130242611|NCT01947933|468848074|FG006|Overall Study|Lost to Follow-up|0|||
130242612|NCT01947933|468848075|FG007|Overall Study|Lost to Follow-up|0|||
130242613|NCT01947933|468848076|FG008|Overall Study|Lost to Follow-up|1|||
130242614|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
130242615|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
130242616|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130242617|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
130242618|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
130242619|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
130242620|NCT02965833|468848079|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
130242621|NCT02965833|468848080|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
130242622|NCT02965833|468848079|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
130242623|NCT02965833|468848080|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
130242624|NCT03442569|468848081|FG000|Overall Study|Subject was ineligible after enrollment|1|||
130242625|NCT03770455|468848082|FG000|Overall Study|Screen failures|3|||
130242626|NCT02582632|468849465|FG000|Overall Study|Other|1|||
130242627|NCT03298061|468849466|FG000|Overall Study|Adverse Event|3|||
130242628|NCT03298061|468849466|FG000|Overall Study|Lack of Efficacy|6|||
130242629|NCT03298061|468849466|FG000|Overall Study|Protocol Violation|1|||
130242630|NCT03298061|468849466|FG000|Overall Study|Physician Decision|7|||
130242631|NCT03298061|468849466|FG000|Overall Study|Withdrawal by Subject|10|||
130242632|NCT01617967|468849467|FG000|Overall Study|Protocol Violation|0|||
130242633|NCT01617967|468849468|FG001|Overall Study|Protocol Violation|0|||
130242634|NCT01617967|468849469|FG002|Overall Study|Protocol Violation|0|||
130242635|NCT01617967|468849470|FG003|Overall Study|Protocol Violation|1|||
130242636|NCT01617967|468849471|FG004|Overall Study|Protocol Violation|0|||
130242637|NCT01617967|468849472|FG005|Overall Study|Protocol Violation|0|||
130242638|NCT01617967|468849467|FG000|Overall Study|Withdrawal by Subject|0|||
130242639|NCT01617967|468849468|FG001|Overall Study|Withdrawal by Subject|0|||
130242640|NCT01617967|468849469|FG002|Overall Study|Withdrawal by Subject|0|||
130242641|NCT01617967|468849470|FG003|Overall Study|Withdrawal by Subject|0|||
130242642|NCT01617967|468849471|FG004|Overall Study|Withdrawal by Subject|0|||
130242643|NCT01617967|468849472|FG005|Overall Study|Withdrawal by Subject|1|||
130242644|NCT01617967|468849467|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
130242645|NCT01617967|468849468|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
130242646|NCT01617967|468849469|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
130242647|NCT01617967|468849470|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
130242648|NCT01617967|468849471|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
130242649|NCT01617967|468849472|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
130242650|NCT05276804|468849479|FG000|Overall Study|screen failure|23|||
130242651|NCT05276804|468849480|FG001|Overall Study|screen failure|0|||
130242652|NCT02827708|468849481|FG000|Overall Study|Lost to Follow-up|3|||
130242653|NCT02827708|468849482|FG001|Overall Study|Lost to Follow-up|1|||
130242654|NCT02827708|468849481|FG000|Overall Study|Withdrawal by Subject|1|||
130242655|NCT02827708|468849482|FG001|Overall Study|Withdrawal by Subject|2|||
130242656|NCT02827708|468849481|FG000|Overall Study|Death|1|||
130242657|NCT02827708|468849482|FG001|Overall Study|Death|2|||
130242658|NCT02383173|468849486|FG000|Overall Study|Palliative Care Team withdrew|0|||
130242659|NCT02383173|468849487|FG001|Overall Study|Palliative Care Team withdrew|2|||
130242660|NCT01297244|468849488|FG000|Overall Study|Progressive disease|22|||
130242661|NCT01297244|468849489|FG001|Overall Study|Progressive disease|3|||
130242662|NCT01297244|468849488|FG000|Overall Study|Adverse Event|9|||
130242663|NCT01297244|468849489|FG001|Overall Study|Adverse Event|1|||
130242664|NCT01297244|468849488|FG000|Overall Study|Death|1|||
130242665|NCT01297244|468849489|FG001|Overall Study|Death|1|||
130242666|NCT01297244|468849488|FG000|Overall Study|Clinical progression|1|||
130242667|NCT01297244|468849489|FG001|Overall Study|Clinical progression|1|||
130242668|NCT01297244|468849488|FG000|Overall Study|Withdrawal by Subject|2|||
130242669|NCT01297244|468849489|FG001|Overall Study|Withdrawal by Subject|0|||
130242670|NCT03677401|468849490|FG000|Overall Study|Adverse Event|4|||
130242671|NCT03677401|468849491|FG001|Overall Study|Adverse Event|14|||
130242672|NCT03677401|468849490|FG000|Overall Study|Lack of Efficacy|3|||
130242673|NCT03677401|468849491|FG001|Overall Study|Lack of Efficacy|1|||
130242674|NCT03677401|468849490|FG000|Overall Study|Withdrawal by Subject|2|||
130242675|NCT03677401|468849491|FG001|Overall Study|Withdrawal by Subject|2|||
130242676|NCT03677401|468849490|FG000|Overall Study|Sponsor decision|0|||
130242677|NCT03677401|468849491|FG001|Overall Study|Sponsor decision|1|||
130242678|NCT03677401|468849490|FG000|Overall Study|Reason Unspecified|1|||
130242679|NCT03677401|468849491|FG001|Overall Study|Reason Unspecified|0|||
130242680|NCT01177410|468849492|FG000|Overall Study|Adverse Event|0|||
130242681|NCT01177410|468849493|FG001|Overall Study|Adverse Event|2|||
130242682|NCT01177410|468849494|FG002|Overall Study|Adverse Event|2|||
130242683|NCT01177410|468849492|FG000|Overall Study|Withdrawal by Subject|1|||
130242684|NCT01177410|468849493|FG001|Overall Study|Withdrawal by Subject|4|||
130242685|NCT01177410|468849494|FG002|Overall Study|Withdrawal by Subject|3|||
130242686|NCT01177410|468849492|FG000|Overall Study|Lost to Follow-up|0|||
130242687|NCT01177410|468849493|FG001|Overall Study|Lost to Follow-up|1|||
130242688|NCT01177410|468849494|FG002|Overall Study|Lost to Follow-up|0|||
130242689|NCT00875667|468849498|FG000|Overall Study|Adverse Event|29|||
130242690|NCT00875667|468849499|FG001|Overall Study|Adverse Event|10|||
130242691|NCT00875667|468849498|FG000|Overall Study|Withdrawal by Subject|17|||
130242692|NCT00875667|468849499|FG001|Overall Study|Withdrawal by Subject|5|||
130242693|NCT00875667|468849498|FG000|Overall Study|Death|7|||
130242694|NCT00875667|468849499|FG001|Overall Study|Death|2|||
130242695|NCT00875667|468849498|FG000|Overall Study|Protocol Violation|2|||
130242696|NCT00875667|468849499|FG001|Overall Study|Protocol Violation|0|||
130028312|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130028313|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130028314|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
130028315|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
130028316|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028317|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028318|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028319|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130242697|NCT00875667|468849498|FG000|Overall Study|Disease Progression|100|||
130242698|NCT00875667|468849499|FG001|Overall Study|Disease Progression|49|||
130242699|NCT00875667|468849498|FG000|Overall Study|Miscellaneous|12|||
130100340|NCT03669640|468325962|FG001|Overall Study|Withdrawal by Subject|2|||
130242700|NCT00875667|468849499|FG001|Overall Study|Miscellaneous|6|||
130242701|NCT00875667|468849498|FG000|Overall Study|Randomized but no Study Drug Given|3|||
130242702|NCT00875667|468849499|FG001|Overall Study|Randomized but no Study Drug Given|1|||
130242703|NCT00894647|468849500|FG000|Overall Study|Adverse Event|5|||
130242704|NCT00894647|468849501|FG001|Overall Study|Adverse Event|4|||
130242705|NCT00894647|468849500|FG000|Overall Study|Withdrawal by Subject|4|||
130242706|NCT00894647|468849501|FG001|Overall Study|Withdrawal by Subject|4|||
130242707|NCT00894647|468849500|FG000|Overall Study|Lost to Follow-up|0|||
130242708|NCT00894647|468849501|FG001|Overall Study|Lost to Follow-up|2|||
130242709|NCT00894647|468849500|FG000|Overall Study|Non-compliance with study procedures|0|||
130242710|NCT00894647|468849501|FG001|Overall Study|Non-compliance with study procedures|2|||
130242711|NCT00894647|468849500|FG000|Overall Study|Other, not due to AE|1|||
130242712|NCT00894647|468849501|FG001|Overall Study|Other, not due to AE|2|||
130242713|NCT01913470|468849502|FG000|Overall Study|Lost to Follow-up|0|||
130242714|NCT01913470|468849503|FG001|Overall Study|Lost to Follow-up|1|||
130242715|NCT01913470|468849502|FG000|Overall Study|Physician Decision|0|||
130242716|NCT01913470|468849503|FG001|Overall Study|Physician Decision|1|||
130242717|NCT01913470|468849502|FG000|Overall Study|Withdrawal by Subject|0|||
130242718|NCT01913470|468849503|FG001|Overall Study|Withdrawal by Subject|1|||
130242719|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130242720|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130242721|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
130242722|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
130242723|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
130242724|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
130242725|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
130242726|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
130242727|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
130242728|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
130242729|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
130242730|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
130242731|NCT02573467|468849509|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
130242732|NCT02573467|468849510|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
130242733|NCT02573467|468849511|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
130242734|NCT02573467|468849512|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
130242735|NCT02573467|468849509|FG000|Post-treatment Follow up Epoch|Death|1|||
130242736|NCT02573467|468849510|FG001|Post-treatment Follow up Epoch|Death|1|||
130242737|NCT02573467|468849511|FG002|Post-treatment Follow up Epoch|Death|0|||
130242738|NCT02573467|468849512|FG003|Post-treatment Follow up Epoch|Death|1|||
130242739|NCT02573467|468849509|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
130242740|NCT02573467|468849510|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
130242741|NCT02573467|468849511|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
130242742|NCT02573467|468849512|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
130242743|NCT02573467|468849509|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
130242744|NCT02573467|468849510|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
130242745|NCT02573467|468849511|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
130242746|NCT02573467|468849512|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
130242747|NCT00923702|468849513|FG000|Overall Study|Ongoing enrollment|0|||
130242748|NCT00923702|468849514|FG001|Overall Study|Ongoing enrollment|0|||
130242749|NCT00923702|468849515|FG002|Overall Study|Ongoing enrollment|0|||
130242750|NCT00923702|468849516|FG003|Overall Study|Ongoing enrollment|0|||
130242751|NCT00923702|468849517|FG004|Overall Study|Ongoing enrollment|354|||
130242752|NCT00367458|468849518|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
130242753|NCT00367458|468849519|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
130242754|NCT04339972|468849525|FG000|Overall Study|Scheduling Issues|3|||
130242755|NCT04339972|468849526|FG001|Overall Study|Scheduling Issues|3|||
130242756|NCT04339972|468849525|FG000|Overall Study|dropout|1|||
130242757|NCT04339972|468849526|FG001|Overall Study|dropout|1|||
130242758|NCT04339972|468849525|FG000|Overall Study|Technical issues|1|||
130242759|NCT04339972|468849526|FG001|Overall Study|Technical issues|0|||
130242760|NCT04339972|468849525|FG000|Overall Study|Claustraphobia|0|||
130242761|NCT04339972|468849526|FG001|Overall Study|Claustraphobia|1|||
130242762|NCT02691663|468849527|FG000|Overall Study|Screen failure after baseline|2|||
130242763|NCT02691663|468849528|FG001|Overall Study|Screen failure after baseline|2|||
130242764|NCT02691663|468849527|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
130242765|NCT02691663|468849528|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
130242766|NCT02691663|468849527|FG000|Overall Study|Withdrawn after Follow up 2|1|||
130242767|NCT02691663|468849528|FG001|Overall Study|Withdrawn after Follow up 2|1|||
130242768|NCT02691663|468849527|FG000|Overall Study|Lost to Follow-up|3|||
130242769|NCT02691663|468849528|FG001|Overall Study|Lost to Follow-up|2|||
130242770|NCT02942407|468849532|FG000|Overall Study|Lost to Follow-up|3|||
130242771|NCT02942407|468849533|FG001|Overall Study|Lost to Follow-up|2|||
130242772|NCT02942407|468849532|FG000|Overall Study|Withdrawal by Subject|7|||
130242773|NCT02942407|468849533|FG001|Overall Study|Withdrawal by Subject|9|||
130242774|NCT02942407|468849532|FG000|Overall Study|Death|16|||
130242775|NCT02942407|468849533|FG001|Overall Study|Death|13|||
130242776|NCT01716156|468849535|FG000|Overall Study|Protocol Violation|1|||
130242777|NCT01716156|468849536|FG001|Overall Study|Protocol Violation|0|||
130242778|NCT01716156|468849537|FG002|Overall Study|Protocol Violation|0|||
130242779|NCT01716156|468849535|FG000|Overall Study|Withdrawal by Subject|0|||
130242780|NCT01716156|468849536|FG001|Overall Study|Withdrawal by Subject|1|||
130242781|NCT01716156|468849537|FG002|Overall Study|Withdrawal by Subject|2|||
130242782|NCT01716156|468849535|FG000|Overall Study|Lost to Follow-up|1|||
130242783|NCT01716156|468849536|FG001|Overall Study|Lost to Follow-up|0|||
130242784|NCT01716156|468849537|FG002|Overall Study|Lost to Follow-up|0|||
130242785|NCT03925220|468849538|FG000|Overall Study|Withdrawal by Subject|4|||
130242786|NCT03925220|468849539|FG001|Overall Study|Withdrawal by Subject|4|||
130242787|NCT03925220|468849540|FG002|Overall Study|Withdrawal by Subject|4|||
130242788|NCT03925220|468849541|FG003|Overall Study|Withdrawal by Subject|4|||
130242789|NCT03925220|468849538|FG000|Overall Study|Lost to Follow-up|40|||
130242790|NCT03925220|468849539|FG001|Overall Study|Lost to Follow-up|46|||
130242791|NCT03925220|468849540|FG002|Overall Study|Lost to Follow-up|37|||
130242792|NCT03925220|468849541|FG003|Overall Study|Lost to Follow-up|38|||
130242793|NCT05221866|468849542|FG000|Overall Study|Withdrawal by Subject|5|||
130242794|NCT05221866|468849543|FG001|Overall Study|Withdrawal by Subject|7|||
130242795|NCT05221866|468849544|FG002|Overall Study|Withdrawal by Subject|6|||
130242796|NCT05221866|468849545|FG003|Overall Study|Withdrawal by Subject|4|||
130242797|NCT05221866|468849542|FG000|Overall Study|Physician Decision|3|||
130242798|NCT05221866|468849543|FG001|Overall Study|Physician Decision|2|||
130242799|NCT05221866|468849544|FG002|Overall Study|Physician Decision|1|||
130242800|NCT05221866|468849545|FG003|Overall Study|Physician Decision|4|||
130242801|NCT05221866|468849542|FG000|Overall Study|Lost to Follow-up|12|||
130242802|NCT05221866|468849543|FG001|Overall Study|Lost to Follow-up|17|||
130242803|NCT05221866|468849544|FG002|Overall Study|Lost to Follow-up|14|||
130242804|NCT05221866|468849545|FG003|Overall Study|Lost to Follow-up|14|||
130242805|NCT05221866|468849542|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
130242806|NCT05221866|468849543|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
130242807|NCT05221866|468849544|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
130242808|NCT05221866|468849545|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
130242809|NCT05561140|468849546|FG000|Randomized Treatment Period|Adverse Event|1|||
129884618|NCT01394250|467538602|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
130242810|NCT05561140|468849547|FG001|Randomized Treatment Period|Adverse Event|0|||
130242811|NCT05561140|468849546|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129884619|NCT01394250|467538603|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
130242812|NCT05561140|468849547|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130242813|NCT05561140|468849546|FG000|Open Label Treatment Period|Adverse Event|6|||
130242814|NCT05561140|468849547|FG001|Open Label Treatment Period|Adverse Event|4|||
130242815|NCT05561140|468849546|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
130242816|NCT05561140|468849547|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
130242817|NCT05561140|468849546|FG000|Open Label Treatment Period|Physician Decision|0|||
130242818|NCT05561140|468849547|FG001|Open Label Treatment Period|Physician Decision|1|||
130242819|NCT05561140|468849546|FG000|Open Label Treatment Period|Pregnancy|1|||
130242820|NCT05561140|468849547|FG001|Open Label Treatment Period|Pregnancy|0|||
130242821|NCT05561140|468849546|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
130242822|NCT05561140|468849547|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
130242823|NCT05561140|468849546|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
130242824|NCT05561140|468849547|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
130242825|NCT05561140|468849546|FG000|Open Label Treatment Period|Other|1|||
130242826|NCT05561140|468849547|FG001|Open Label Treatment Period|Other|0|||
130242827|NCT01944774|468849548|FG000|Overall Study|Withdrawal by Subject|2|||
130242828|NCT01944774|468849549|FG001|Overall Study|Withdrawal by Subject|3|||
130242829|NCT01944774|468849550|FG002|Overall Study|Withdrawal by Subject|3|||
130242830|NCT01944774|468849548|FG000|Overall Study|Adverse Event|3|||
130242831|NCT01944774|468849549|FG001|Overall Study|Adverse Event|2|||
130242832|NCT01944774|468849550|FG002|Overall Study|Adverse Event|3|||
130242833|NCT01944774|468849548|FG000|Overall Study|Lack of Efficacy|1|||
130242834|NCT01944774|468849549|FG001|Overall Study|Lack of Efficacy|2|||
130242835|NCT01944774|468849550|FG002|Overall Study|Lack of Efficacy|2|||
130242836|NCT01944774|468849548|FG000|Overall Study|Lost to Follow-up|0|||
130242837|NCT01944774|468849549|FG001|Overall Study|Lost to Follow-up|1|||
130242838|NCT01944774|468849550|FG002|Overall Study|Lost to Follow-up|0|||
130242839|NCT03325439|468849556|FG000|Overall Study|Ineligibility|3|||
130242840|NCT00774748|468849557|FG000|Overall Study|Lost to Follow-up|3|||
130242841|NCT00866320|468849558|FG000|Overall Study|Withdrawal by Subject|4|||
130242842|NCT00866320|468849558|FG000|Overall Study|Death|2|||
130242843|NCT03349515|468849559|FG000|Overall Study|Lack of Efficacy|2|||
130242844|NCT03349515|468849560|FG001|Overall Study|Lack of Efficacy|0|||
130242845|NCT03349515|468849559|FG000|Overall Study|Physician Decision|3|||
130242846|NCT03349515|468849560|FG001|Overall Study|Physician Decision|1|||
130242847|NCT02503865|468849561|FG000|Overall Study|Moved out of area|1|||
130242848|NCT02503865|468849562|FG001|Overall Study|Moved out of area|8|||
130242849|NCT02503865|468849563|FG002|Overall Study|Moved out of area|0|||
130242850|NCT02503865|468849561|FG000|Overall Study|Refused treatment|4|||
130242851|NCT02503865|468849562|FG001|Overall Study|Refused treatment|39|||
130028320|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130242852|NCT02503865|468849563|FG002|Overall Study|Refused treatment|2|||
130242853|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
130242854|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
130242855|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
130242856|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Death|1|||
130242857|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Death|0|||
130242858|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Death|0|||
130242859|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
130242860|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
130242861|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
130242862|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
130242863|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
130242864|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
130242865|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
130242866|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
130242867|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
130242868|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
130242869|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
130028321|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
130028322|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
130242870|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
130242871|NCT05073315|468849564|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
130242872|NCT05073315|468849565|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
130242873|NCT05073315|468849566|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
130242874|NCT05073315|468849564|FG000|Period 2|Adverse Event|0|||
130242875|NCT05073315|468849565|FG001|Period 2|Adverse Event|3|||
130242876|NCT05073315|468849566|FG002|Period 2|Adverse Event|6|||
130242877|NCT05073315|468849564|FG000|Period 2|Lost to Follow-up|0|||
130242878|NCT05073315|468849565|FG001|Period 2|Lost to Follow-up|5|||
130242879|NCT05073315|468849566|FG002|Period 2|Lost to Follow-up|5|||
130242880|NCT05073315|468849564|FG000|Period 2|Withdrawal by Subject|0|||
130242881|NCT05073315|468849565|FG001|Period 2|Withdrawal by Subject|4|||
130242882|NCT05073315|468849566|FG002|Period 2|Withdrawal by Subject|9|||
130242883|NCT05073315|468849564|FG000|Period 2|Protocol Violation|0|||
130242884|NCT05073315|468849565|FG001|Period 2|Protocol Violation|0|||
130242885|NCT05073315|468849566|FG002|Period 2|Protocol Violation|1|||
130242886|NCT01529268|468849567|FG000|Overall Study|Lost to Follow-up|9|||
130242887|NCT01529268|468849568|FG001|Overall Study|Lost to Follow-up|3|||
130242888|NCT01529268|468849567|FG000|Overall Study|Moved|3|||
130242889|NCT01529268|468849568|FG001|Overall Study|Moved|0|||
130242890|NCT04069520|468849574|FG000|Overall Study|Lost to Follow-up|0|||
130242891|NCT04069520|468849575|FG001|Overall Study|Lost to Follow-up|2|||
130242892|NCT04069520|468849574|FG000|Overall Study|Withdrawal by Subject|0|||
130242893|NCT04069520|468849575|FG001|Overall Study|Withdrawal by Subject|1|||
130242894|NCT04069520|468849574|FG000|Overall Study|Prior Injury|1|||
130242895|NCT04069520|468849575|FG001|Overall Study|Prior Injury|0|||
130242896|NCT04069520|468849574|FG000|Overall Study|Orthodontia|1|||
130242897|NCT04069520|468849575|FG001|Overall Study|Orthodontia|0|||
130242898|NCT04069520|468849574|FG000|Overall Study|Cut from team|0|||
130242899|NCT04069520|468849575|FG001|Overall Study|Cut from team|2|||
130242900|NCT01068912|468849576|FG000|Overall Study|Adverse Event|2|||
130242901|NCT01068912|468849577|FG001|Overall Study|Adverse Event|3|||
130242902|NCT01068912|468849578|FG002|Overall Study|Adverse Event|2|||
130242903|NCT01068912|468849576|FG000|Overall Study|Withdrawal by Subject|5|||
130028323|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130242904|NCT01068912|468849577|FG001|Overall Study|Withdrawal by Subject|6|||
130242905|NCT01068912|468849578|FG002|Overall Study|Withdrawal by Subject|6|||
130242906|NCT01068912|468849576|FG000|Overall Study|Lost to Follow-up|3|||
130242907|NCT01068912|468849577|FG001|Overall Study|Lost to Follow-up|7|||
130242908|NCT01068912|468849578|FG002|Overall Study|Lost to Follow-up|3|||
130242909|NCT01068912|468849576|FG000|Overall Study|Protocol Violation|0|||
130242910|NCT01068912|468849577|FG001|Overall Study|Protocol Violation|2|||
130242911|NCT01068912|468849578|FG002|Overall Study|Protocol Violation|0|||
130242912|NCT01068912|468849576|FG000|Overall Study|aggravation influenza|1|||
130242913|NCT01068912|468849577|FG001|Overall Study|aggravation influenza|1|||
130242914|NCT01068912|468849578|FG002|Overall Study|aggravation influenza|1|||
130242915|NCT01068912|468849576|FG000|Overall Study|other underlying illness|0|||
130242916|NCT01068912|468849577|FG001|Overall Study|other underlying illness|3|||
130242917|NCT01068912|468849578|FG002|Overall Study|other underlying illness|3|||
130242918|NCT00294398|468849579|FG000|Overall Study|Lost to Follow-up|21|||
130242919|NCT00294398|468849580|FG001|Overall Study|Lost to Follow-up|26|||
130242920|NCT00118287|468849584|FG000|Overall Study|Intracranial haemorrhage|1|||
130242921|NCT00118287|468849584|FG000|Overall Study|Muscle pain|1|||
130242922|NCT03407482|468849585|FG000|Overall Study|Adverse Event|12|||
130242923|NCT03407482|468849585|FG000|Overall Study|Disease Relapse|1|||
130242924|NCT03407482|468849585|FG000|Overall Study|Lost to Follow-up|1|||
130242925|NCT03407482|468849585|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130242926|NCT03407482|468849585|FG000|Overall Study|Pregnancy|2|||
130242927|NCT03407482|468849585|FG000|Overall Study|Protocol Violation|1|||
130242928|NCT03407482|468849585|FG000|Overall Study|Study Terminated By Sponsor|106|||
130242929|NCT03407482|468849585|FG000|Overall Study|Withdrawal by Subject|6|||
130242930|NCT03407482|468849585|FG000|Overall Study|Data Entry Error|1|||
130242931|NCT05089357|468849588|FG000|Overall Study|Withdrawal by Subject|23|||
130242932|NCT05089357|468849588|FG000|Overall Study|Lost to Follow-up|6|||
130242933|NCT05089357|468849588|FG000|Overall Study|Medical reason|1|||
130242934|NCT05089357|468849588|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
130242935|NCT05089357|468849588|FG000|Overall Study|Pregnancy|2|||
130242936|NCT05537571|468849589|FG000|Overall Study|Withdrawal by Subject|1|||
130242937|NCT05537571|468849590|FG001|Overall Study|Withdrawal by Subject|1|||
130242938|NCT05537571|468849591|FG002|Overall Study|Withdrawal by Subject|0|||
130242939|NCT05537571|468849592|FG003|Overall Study|Withdrawal by Subject|0|||
130242940|NCT05537571|468849593|FG004|Overall Study|Withdrawal by Subject|0|||
130242941|NCT05537571|468849589|FG000|Overall Study|Adverse Event|2|||
130242942|NCT05537571|468849590|FG001|Overall Study|Adverse Event|0|||
130242943|NCT05537571|468849591|FG002|Overall Study|Adverse Event|0|||
130242944|NCT05537571|468849592|FG003|Overall Study|Adverse Event|0|||
130242945|NCT05537571|468849593|FG004|Overall Study|Adverse Event|0|||
130242946|NCT05537571|468849589|FG000|Overall Study|Hepatitis A screening result|2|||
130242947|NCT05537571|468849590|FG001|Overall Study|Hepatitis A screening result|0|||
130242948|NCT05537571|468849591|FG002|Overall Study|Hepatitis A screening result|0|||
130242949|NCT05537571|468849592|FG003|Overall Study|Hepatitis A screening result|0|||
130242950|NCT05537571|468849593|FG004|Overall Study|Hepatitis A screening result|0|||
130242951|NCT05537571|468849589|FG000|Overall Study|Lost to Follow-up|0|||
130242952|NCT05537571|468849590|FG001|Overall Study|Lost to Follow-up|0|||
130242953|NCT05537571|468849591|FG002|Overall Study|Lost to Follow-up|1|||
130242954|NCT05537571|468849592|FG003|Overall Study|Lost to Follow-up|0|||
130242955|NCT05537571|468849593|FG004|Overall Study|Lost to Follow-up|1|||
130242956|NCT05752487|468849598|FG000|Overall Study|Enrolled, not treated|9|||
130242957|NCT05752487|468849598|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
130242958|NCT05752487|468849598|FG000|Overall Study|Withdrawal by Subject|2|||
130242959|NCT03091439|468849599|FG000|Overall Study|Study Terminated by the Sponsor|1|||
130242960|NCT03091439|468849600|FG001|Overall Study|Study Terminated by the Sponsor|0|||
130242961|NCT01860989|468849601|FG000|Overall Study|Unsatisfactory therapeutic|5|||
130242962|NCT01685437|468849604|FG000|Overall Study|Withdrawal by Subject|22|||
130242963|NCT01685437|468849604|FG000|Overall Study|Lost to Follow-up|3|||
130242964|NCT01685437|468849604|FG000|Overall Study|Adverse Event|1|||
130242965|NCT01685437|468849604|FG000|Overall Study|Protocol Violation|4|||
130242966|NCT01685437|468849604|FG000|Overall Study|Unable to make visits due to work|1|||
130242967|NCT01214720|468849607|FG000|Overall Study|Alive and still on treatment|34|||
130242968|NCT01214720|468849608|FG001|Overall Study|Alive and still on treatment|18|||
130242969|NCT01214720|468849607|FG000|Overall Study|Alive and in follow-up|45|||
130242970|NCT01214720|468849608|FG001|Overall Study|Alive and in follow-up|48|||
130242971|NCT01214720|468849607|FG000|Overall Study|Lost to Follow-up|6|||
130242972|NCT01214720|468849608|FG001|Overall Study|Lost to Follow-up|2|||
130242973|NCT02347787|468849609|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
130242974|NCT02347787|468849610|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
130242975|NCT02347787|468849609|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
130242976|NCT02347787|468849610|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
130242977|NCT02347787|468849609|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
130242978|NCT02347787|468849610|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
130242979|NCT02347787|468849609|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
130242980|NCT02347787|468849610|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
130242981|NCT01039675|468849619|FG000|Overall Study|Adverse Event|0|||
130242982|NCT01039675|468849620|FG001|Overall Study|Adverse Event|2|||
130242983|NCT01039675|468849619|FG000|Overall Study|Lack of Efficacy|0|||
130242984|NCT01039675|468849620|FG001|Overall Study|Lack of Efficacy|2|||
130242985|NCT01039675|468849619|FG000|Overall Study|Withdrawal by Subject|0|||
130242986|NCT01039675|468849620|FG001|Overall Study|Withdrawal by Subject|1|||
130242987|NCT01039675|468849619|FG000|Overall Study|Lost to Follow-up|0|||
130242988|NCT01039675|468849620|FG001|Overall Study|Lost to Follow-up|1|||
130242989|NCT01039675|468849619|FG000|Overall Study|Physician Decision|0|||
130242990|NCT01039675|468849620|FG001|Overall Study|Physician Decision|1|||
130242991|NCT00992836|468851404|FG000|Overall Study|Lost to Follow-up|1|||
130242992|NCT00992836|468851404|FG000|Overall Study|Withdrawal by Subject|2|||
130242993|NCT00992836|468851404|FG000|Overall Study|Protocol Violation|2|||
130242994|NCT01137812|468851405|FG000|Overall Study|Adverse Event|21|||
130242995|NCT01137812|468851406|FG001|Overall Study|Adverse Event|14|||
130242996|NCT01137812|468851405|FG000|Overall Study|Lost to Follow-up|6|||
130242997|NCT01137812|468851406|FG001|Overall Study|Lost to Follow-up|8|||
130242998|NCT01137812|468851405|FG000|Overall Study|Physician Decision|25|||
130242999|NCT01137812|468851406|FG001|Overall Study|Physician Decision|17|||
130243000|NCT01137812|468851405|FG000|Overall Study|Protocol Violation|5|||
130243001|NCT01137812|468851406|FG001|Overall Study|Protocol Violation|4|||
130243002|NCT01137812|468851405|FG000|Overall Study|Withdrawal by Subject|5|||
130243003|NCT01137812|468851406|FG001|Overall Study|Withdrawal by Subject|13|||
130243004|NCT01137812|468851405|FG000|Overall Study|Death|2|||
130243005|NCT01137812|468851406|FG001|Overall Study|Death|0|||
130243006|NCT01137812|468851405|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
130243007|NCT01137812|468851406|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
130243008|NCT01137812|468851405|FG000|Overall Study|Other|19|||
130243009|NCT01137812|468851406|FG001|Overall Study|Other|27|||
130243010|NCT04621760|468851407|FG000|Overall Study|Lost to Follow-up|2|||
130243011|NCT04621760|468851408|FG001|Overall Study|Lost to Follow-up|4|||
130243012|NCT04621760|468851407|FG000|Overall Study|Withdrawal by Subject|1|||
130243013|NCT04621760|468851408|FG001|Overall Study|Withdrawal by Subject|0|||
130243014|NCT04602000|468851411|FG000|Overall Study|Withdrawal by Subject|3|||
130243015|NCT04602000|468851412|FG001|Overall Study|Withdrawal by Subject|6|||
130243016|NCT04602000|468851413|FG002|Overall Study|Withdrawal by Subject|3|||
130243017|NCT04602000|468851414|FG003|Overall Study|Withdrawal by Subject|27|||
130243018|NCT04602000|468851415|FG004|Overall Study|Withdrawal by Subject|39|||
130243019|NCT04602000|468851411|FG000|Overall Study|Physician Decision|1|||
130243020|NCT04602000|468851412|FG001|Overall Study|Physician Decision|0|||
130243021|NCT04602000|468851413|FG002|Overall Study|Physician Decision|0|||
130243022|NCT04602000|468851414|FG003|Overall Study|Physician Decision|2|||
130243023|NCT04602000|468851415|FG004|Overall Study|Physician Decision|2|||
130243024|NCT04602000|468851411|FG000|Overall Study|Death|0|||
130243025|NCT04602000|468851412|FG001|Overall Study|Death|1|||
130243026|NCT04602000|468851413|FG002|Overall Study|Death|0|||
130243027|NCT04602000|468851414|FG003|Overall Study|Death|1|||
130243028|NCT04602000|468851415|FG004|Overall Study|Death|2|||
130243029|NCT04602000|468851411|FG000|Overall Study|Lost to Follow-up|0|||
130243030|NCT04602000|468851412|FG001|Overall Study|Lost to Follow-up|0|||
130243031|NCT04602000|468851413|FG002|Overall Study|Lost to Follow-up|0|||
130243032|NCT04602000|468851414|FG003|Overall Study|Lost to Follow-up|3|||
130243033|NCT04602000|468851415|FG004|Overall Study|Lost to Follow-up|4|||
130243034|NCT04602000|468851411|FG000|Overall Study|Other|4|||
130243035|NCT04602000|468851412|FG001|Overall Study|Other|1|||
130243036|NCT04602000|468851413|FG002|Overall Study|Other|2|||
130243037|NCT04602000|468851414|FG003|Overall Study|Other|5|||
130243038|NCT04602000|468851415|FG004|Overall Study|Other|4|||
130243039|NCT04602000|468851411|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243040|NCT04602000|468851412|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243041|NCT04602000|468851413|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
130243042|NCT04602000|468851414|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243043|NCT04602000|468851415|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
130243044|NCT00471354|468851416|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
130243045|NCT00471354|468851416|FG000|Overall Study|Adverse Event|13|||
130243046|NCT00471354|468851416|FG000|Overall Study|Protocol Violation|12|||
130243047|NCT00471354|468851416|FG000|Overall Study|Withdrawal by Subject|1|||
130243048|NCT00471354|468851416|FG000|Overall Study|Physician Decision|4|||
130243049|NCT00471354|468851416|FG000|Overall Study|Sponsor Decision|1|||
130243050|NCT00471354|468851416|FG000|Overall Study|Lost to Follow-up|3|||
130243051|NCT00471354|468851416|FG000|Overall Study|Lack of Efficacy|5|||
130243052|NCT00471354|468851416|FG000|Overall Study|Patient/Caregiver Decision|12|||
130243053|NCT02153827|468851420|FG000|Overall Study|Lost to Follow-up|3|||
130243054|NCT02153827|468851421|FG001|Overall Study|Lost to Follow-up|9|||
130243055|NCT01158404|468851422|FG000|Overall Study|Withdrawal by Subject|0|||
130243056|NCT01158404|468851423|FG001|Overall Study|Withdrawal by Subject|1|||
130243057|NCT01158404|468851424|FG002|Overall Study|Withdrawal by Subject|0|||
130243058|NCT01158404|468851425|FG003|Overall Study|Withdrawal by Subject|0|||
130243059|NCT01158404|468851426|FG004|Overall Study|Withdrawal by Subject|3|||
130243060|NCT01158404|468851427|FG005|Overall Study|Withdrawal by Subject|1|||
130243061|NCT01158404|468851428|FG006|Overall Study|Withdrawal by Subject|0|||
130243062|NCT01158404|468851429|FG007|Overall Study|Withdrawal by Subject|1|||
130243063|NCT01158404|468851422|FG000|Overall Study|Physician Decision|0|||
130243064|NCT01158404|468851423|FG001|Overall Study|Physician Decision|0|||
130243065|NCT01158404|468851424|FG002|Overall Study|Physician Decision|0|||
130243066|NCT01158404|468851425|FG003|Overall Study|Physician Decision|0|||
130243067|NCT01158404|468851426|FG004|Overall Study|Physician Decision|0|||
130243068|NCT01158404|468851427|FG005|Overall Study|Physician Decision|0|||
130243069|NCT01158404|468851428|FG006|Overall Study|Physician Decision|0|||
130243070|NCT01158404|468851429|FG007|Overall Study|Physician Decision|1|||
130243071|NCT01158404|468851422|FG000|Overall Study|Progressive Disease|0|||
130243072|NCT01158404|468851423|FG001|Overall Study|Progressive Disease|0|||
130243073|NCT01158404|468851424|FG002|Overall Study|Progressive Disease|0|||
130243074|NCT01158404|468851425|FG003|Overall Study|Progressive Disease|0|||
130243075|NCT01158404|468851426|FG004|Overall Study|Progressive Disease|0|||
130243076|NCT01158404|468851427|FG005|Overall Study|Progressive Disease|0|||
130243077|NCT01158404|468851428|FG006|Overall Study|Progressive Disease|1|||
130243078|NCT01158404|468851429|FG007|Overall Study|Progressive Disease|0|||
130243079|NCT02143778|468851431|FG000|Overall Study|Withdrawal by Subject|2|||
130243080|NCT02143778|468851431|FG000|Overall Study|Device malfunction|1|||
130243081|NCT00625378|468851433|FG000|Overall Study|Adverse Event|22|||
130243082|NCT00625378|468851434|FG001|Overall Study|Adverse Event|0|||
130243083|NCT00625378|468851433|FG000|Overall Study|Withdrawal by Subject|16|||
130243084|NCT00625378|468851434|FG001|Overall Study|Withdrawal by Subject|0|||
130243085|NCT00625378|468851433|FG000|Overall Study|Death|38|||
130243086|NCT00625378|468851434|FG001|Overall Study|Death|0|||
130243087|NCT00625378|468851433|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
130243088|NCT00625378|468851434|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
130243089|NCT00625378|468851433|FG000|Overall Study|Lost to Follow-up|17|||
130243090|NCT00625378|468851434|FG001|Overall Study|Lost to Follow-up|0|||
130243091|NCT00625378|468851433|FG000|Overall Study|Non-compliant with study medication|3|||
130243092|NCT00625378|468851434|FG001|Overall Study|Non-compliant with study medication|0|||
130243093|NCT00625378|468851433|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
130243094|NCT00625378|468851434|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
130243095|NCT00625378|468851433|FG000|Overall Study|Medical decision|1|||
130243096|NCT00625378|468851434|FG001|Overall Study|Medical decision|0|||
130243097|NCT00625378|468851433|FG000|Overall Study|Multiple toxicities|1|||
130243098|NCT00625378|468851434|FG001|Overall Study|Multiple toxicities|0|||
130243099|NCT00625378|468851433|FG000|Overall Study|New cancer|1|||
130243100|NCT00625378|468851434|FG001|Overall Study|New cancer|0|||
130243101|NCT00625378|468851433|FG000|Overall Study|PTA program|2|||
130243102|NCT00625378|468851434|FG001|Overall Study|PTA program|0|||
130243103|NCT00625378|468851433|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
130243104|NCT00625378|468851434|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
130243105|NCT00625378|468851433|FG000|Overall Study|Sponsor decision|1|||
130243106|NCT00625378|468851434|FG001|Overall Study|Sponsor decision|0|||
130243107|NCT00625378|468851433|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
130243108|NCT00625378|468851434|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
130243109|NCT00625378|468851433|FG000|Overall Study|Switch to commercial drug|6|||
130243110|NCT00625378|468851434|FG001|Overall Study|Switch to commercial drug|1|||
130243111|NCT00625378|468851433|FG000|Overall Study|Missing|2|||
130243112|NCT00625378|468851434|FG001|Overall Study|Missing|0|||
130243113|NCT00625378|468851433|FG000|Overall Study|End of treatment not available|2|||
130243114|NCT00625378|468851434|FG001|Overall Study|End of treatment not available|0|||
130243115|NCT00625378|468851433|FG000|Overall Study|Never treated|2|||
130243116|NCT00625378|468851434|FG001|Overall Study|Never treated|0|||
130243117|NCT02639559|468851436|FG000|Overall Study|Mobilization failure|0|||
130243118|NCT02639559|468851437|FG001|Overall Study|Mobilization failure|3|||
130243119|NCT02639559|468851436|FG000|Overall Study|Issues with vascular acess|1|||
130243120|NCT02639559|468851437|FG001|Overall Study|Issues with vascular acess|0|||
130243121|NCT03880565|468851438|FG000|Overall Study|Withdrawal by Subject|1|||
130243122|NCT03880565|468851439|FG001|Overall Study|Withdrawal by Subject|0|||
130028324|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130028325|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130028326|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
130028327|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
130028328|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
130028329|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
130028330|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
130028331|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130028332|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
130028333|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
130100341|NCT03669640|468325963|FG002|Overall Study|Withdrawal by Subject|1|||
130243123|NCT02969018|468851444|FG000|Overall Study|Adverse Event|2|||
130243124|NCT02969018|468851445|FG001|Overall Study|Adverse Event|4|||
130243125|NCT02969018|468851446|FG002|Overall Study|Adverse Event|1|||
130243126|NCT02969018|468851447|FG003|Overall Study|Adverse Event|2|||
130243127|NCT02969018|468851448|FG004|Overall Study|Adverse Event|0|||
130243128|NCT02969018|468851449|FG005|Overall Study|Adverse Event|1|||
130243129|NCT02969018|468851450|FG006|Overall Study|Adverse Event|2|||
130243130|NCT02969018|468851451|FG007|Overall Study|Adverse Event|0|||
130243131|NCT02969018|468851444|FG000|Overall Study|Lack of Efficacy|0|||
130243132|NCT02969018|468851445|FG001|Overall Study|Lack of Efficacy|1|||
130243133|NCT02969018|468851446|FG002|Overall Study|Lack of Efficacy|0|||
130243134|NCT02969018|468851447|FG003|Overall Study|Lack of Efficacy|0|||
130243135|NCT02969018|468851448|FG004|Overall Study|Lack of Efficacy|1|||
130243136|NCT02969018|468851449|FG005|Overall Study|Lack of Efficacy|1|||
130243137|NCT02969018|468851450|FG006|Overall Study|Lack of Efficacy|1|||
130243138|NCT02969018|468851451|FG007|Overall Study|Lack of Efficacy|1|||
130243139|NCT02969018|468851444|FG000|Overall Study|Lost to Follow-up|1|||
130243140|NCT02969018|468851445|FG001|Overall Study|Lost to Follow-up|2|||
130243141|NCT02969018|468851446|FG002|Overall Study|Lost to Follow-up|2|||
130243142|NCT02969018|468851447|FG003|Overall Study|Lost to Follow-up|0|||
130243143|NCT02969018|468851448|FG004|Overall Study|Lost to Follow-up|1|||
130243144|NCT02969018|468851449|FG005|Overall Study|Lost to Follow-up|1|||
130243145|NCT02969018|468851450|FG006|Overall Study|Lost to Follow-up|0|||
130243146|NCT02969018|468851451|FG007|Overall Study|Lost to Follow-up|1|||
130243147|NCT02969018|468851444|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243148|NCT02969018|468851445|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243149|NCT02969018|468851446|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243150|NCT02969018|468851447|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243151|NCT02969018|468851448|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243152|NCT02969018|468851449|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243153|NCT02969018|468851450|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
130243154|NCT02969018|468851451|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130243155|NCT02969018|468851444|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130243156|NCT02969018|468851445|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130243157|NCT02969018|468851446|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130243158|NCT02969018|468851447|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130243159|NCT02969018|468851448|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130243160|NCT02969018|468851449|FG005|Overall Study|Non-Compliance With Study Drug|0|||
130243161|NCT02969018|468851450|FG006|Overall Study|Non-Compliance With Study Drug|0|||
130243162|NCT02969018|468851451|FG007|Overall Study|Non-Compliance With Study Drug|0|||
130243163|NCT02969018|468851444|FG000|Overall Study|Other|0|||
130243164|NCT02969018|468851445|FG001|Overall Study|Other|0|||
130243165|NCT02969018|468851446|FG002|Overall Study|Other|0|||
130243166|NCT02969018|468851447|FG003|Overall Study|Other|1|||
130243167|NCT02969018|468851448|FG004|Overall Study|Other|0|||
130243168|NCT02969018|468851449|FG005|Overall Study|Other|0|||
130243169|NCT02969018|468851450|FG006|Overall Study|Other|0|||
130243170|NCT02969018|468851451|FG007|Overall Study|Other|2|||
130243171|NCT02969018|468851444|FG000|Overall Study|Pregnancy|0|||
130243172|NCT02969018|468851445|FG001|Overall Study|Pregnancy|0|||
130243173|NCT02969018|468851446|FG002|Overall Study|Pregnancy|0|||
130243174|NCT02969018|468851447|FG003|Overall Study|Pregnancy|0|||
130243175|NCT02969018|468851448|FG004|Overall Study|Pregnancy|0|||
130243176|NCT02969018|468851449|FG005|Overall Study|Pregnancy|1|||
130243177|NCT02969018|468851450|FG006|Overall Study|Pregnancy|0|||
130243178|NCT02969018|468851451|FG007|Overall Study|Pregnancy|0|||
130243179|NCT02969018|468851444|FG000|Overall Study|Protocol Violation|0|||
130243180|NCT02969018|468851445|FG001|Overall Study|Protocol Violation|0|||
130243181|NCT02969018|468851446|FG002|Overall Study|Protocol Violation|1|||
130243182|NCT02969018|468851447|FG003|Overall Study|Protocol Violation|1|||
130243183|NCT02969018|468851448|FG004|Overall Study|Protocol Violation|0|||
130243184|NCT02969018|468851449|FG005|Overall Study|Protocol Violation|0|||
130243185|NCT02969018|468851450|FG006|Overall Study|Protocol Violation|0|||
130243186|NCT02969018|468851451|FG007|Overall Study|Protocol Violation|0|||
130243187|NCT02969018|468851444|FG000|Overall Study|Withdrawal by Subject|0|||
130243188|NCT02969018|468851445|FG001|Overall Study|Withdrawal by Subject|1|||
130243189|NCT02969018|468851446|FG002|Overall Study|Withdrawal by Subject|2|||
130243190|NCT02969018|468851447|FG003|Overall Study|Withdrawal by Subject|1|||
130243191|NCT02969018|468851448|FG004|Overall Study|Withdrawal by Subject|0|||
130243192|NCT02969018|468851449|FG005|Overall Study|Withdrawal by Subject|4|||
130243193|NCT02969018|468851450|FG006|Overall Study|Withdrawal by Subject|4|||
130243194|NCT02969018|468851451|FG007|Overall Study|Withdrawal by Subject|3|||
130243195|NCT04790201|468851455|FG000|Overall Study|Lost to Follow-up|0|||
130243196|NCT04790201|468851456|FG001|Overall Study|Lost to Follow-up|0|||
130243197|NCT04790201|468851457|FG002|Overall Study|Lost to Follow-up|2|||
130243198|NCT04790201|468851455|FG000|Overall Study|Death|0|||
130243199|NCT04790201|468851456|FG001|Overall Study|Death|1|||
130243200|NCT04790201|468851457|FG002|Overall Study|Death|0|||
130243201|NCT04790201|468851455|FG000|Overall Study|Protocol Violation|1|||
130243202|NCT04790201|468851456|FG001|Overall Study|Protocol Violation|0|||
130243203|NCT04790201|468851457|FG002|Overall Study|Protocol Violation|1|||
130243204|NCT05762679|468851460|FG000|Overall Study|Withdrawal by Subject|1|||
130243205|NCT05762679|468851460|FG000|Overall Study|No analyzable imaging data|1|||
130243206|NCT03670628|468851461|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
130243207|NCT03670628|468851462|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
130243208|NCT03670628|468851461|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
130243209|NCT03670628|468851462|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
130243210|NCT06377488|468851463|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
130243211|NCT06377488|468851463|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
130243212|NCT06377488|468851463|FG000|Overall Study|Protocol Violation|1|||
130243213|NCT06377488|468851463|FG000|Overall Study|Lost to Follow-up|1|||
130243214|NCT06377488|468851463|FG000|Overall Study|Incorrect Lens Dispensed|2|||
130243215|NCT01179516|468851464|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
130243216|NCT01179516|468851465|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
130243217|NCT01179516|468851466|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
130243218|NCT01179516|468851464|FG000|Overall Study|Lack of Efficacy|4|||
130243219|NCT01179516|468851465|FG001|Overall Study|Lack of Efficacy|2|||
130243220|NCT01179516|468851466|FG002|Overall Study|Lack of Efficacy|0|||
130243221|NCT01179516|468851464|FG000|Overall Study|Noncompliance with Study Drug|2|||
130243222|NCT01179516|468851465|FG001|Overall Study|Noncompliance with Study Drug|0|||
130243223|NCT01179516|468851466|FG002|Overall Study|Noncompliance with Study Drug|1|||
130243224|NCT01179516|468851464|FG000|Overall Study|Protocol Deviations|4|||
130243225|NCT01179516|468851465|FG001|Overall Study|Protocol Deviations|3|||
130243226|NCT01179516|468851466|FG002|Overall Study|Protocol Deviations|3|||
130243227|NCT01179516|468851464|FG000|Overall Study|Withdrawal of Consent|2|||
130243228|NCT01179516|468851465|FG001|Overall Study|Withdrawal of Consent|6|||
130243229|NCT01179516|468851466|FG002|Overall Study|Withdrawal of Consent|10|||
130243230|NCT01179516|468851464|FG000|Overall Study|Lost to Follow-up|7|||
130100342|NCT03669640|468325964|FG003|Overall Study|Withdrawal by Subject|0|||
130243231|NCT01179516|468851465|FG001|Overall Study|Lost to Follow-up|7|||
130243232|NCT01179516|468851466|FG002|Overall Study|Lost to Follow-up|3|||
130243233|NCT01179516|468851464|FG000|Overall Study|Other|2|||
130243234|NCT01179516|468851465|FG001|Overall Study|Other|0|||
130243235|NCT01179516|468851466|FG002|Overall Study|Other|2|||
130243236|NCT02112552|468851469|FG000|Overall Study|Withdrawal by Subject|1|||
130243237|NCT02112552|468851469|FG000|Overall Study|Adverse Event|1|||
130243238|NCT02965456|468851470|FG000|Overall Study|Lost to Follow-up|40|||
130243239|NCT02965456|468851471|FG001|Overall Study|Lost to Follow-up|18|||
130243240|NCT02965456|468851470|FG000|Overall Study|Subject Request|22|||
130243241|NCT02965456|468851471|FG001|Overall Study|Subject Request|13|||
130243242|NCT02965456|468851470|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
130243243|NCT02965456|468851471|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
130243244|NCT02965456|468851470|FG000|Overall Study|Adverse Event|3|||
130243245|NCT02965456|468851471|FG001|Overall Study|Adverse Event|0|||
130243246|NCT02965456|468851470|FG000|Overall Study|Noncompliance with Study Drug|1|||
130243247|NCT02965456|468851471|FG001|Overall Study|Noncompliance with Study Drug|1|||
130243248|NCT02965456|468851470|FG000|Overall Study|Worsening Condition|0|||
130243249|NCT02965456|468851471|FG001|Overall Study|Worsening Condition|2|||
130243250|NCT02965456|468851470|FG000|Overall Study|Lack of Efficacy|1|||
130243251|NCT02965456|468851471|FG001|Overall Study|Lack of Efficacy|0|||
130243252|NCT02965456|468851470|FG000|Overall Study|Physician Decision|0|||
130243253|NCT02965456|468851471|FG001|Overall Study|Physician Decision|1|||
130243254|NCT02965456|468851470|FG000|Overall Study|Pregnancy|1|||
130243255|NCT02965456|468851471|FG001|Overall Study|Pregnancy|0|||
130243256|NCT02965456|468851470|FG000|Overall Study|Protocol Violation|0|||
130243257|NCT02965456|468851471|FG001|Overall Study|Protocol Violation|1|||
130243258|NCT02965456|468851470|FG000|Overall Study|Participant ran out of study drug|0|||
130243259|NCT02965456|468851471|FG001|Overall Study|Participant ran out of study drug|1|||
130243260|NCT00303953|468851472|FG000|Overall Study|Ineligible|1|||
130243261|NCT00303953|468851472|FG000|Overall Study|Death|1|||
130243262|NCT00303953|468851472|FG000|Overall Study|Adverse Event|4|||
130243263|NCT00303953|468851472|FG000|Overall Study|Lack of Efficacy|12|||
130243264|NCT00303953|468851472|FG000|Overall Study|Physician Decision|1|||
130243265|NCT04465955|468851473|FG000|Overall Study|Withdrew consent|6|||
130243266|NCT04465955|468851474|FG001|Overall Study|Withdrew consent|10|||
130243267|NCT04465955|468851475|FG002|Overall Study|Withdrew consent|7|||
130243268|NCT04465955|468851473|FG000|Overall Study|Adverse Event|6|||
130243269|NCT04465955|468851474|FG001|Overall Study|Adverse Event|5|||
130243270|NCT04465955|468851475|FG002|Overall Study|Adverse Event|1|||
130243271|NCT04465955|468851473|FG000|Overall Study|Lost to Follow-up|2|||
130243272|NCT04465955|468851474|FG001|Overall Study|Lost to Follow-up|0|||
130243273|NCT04465955|468851475|FG002|Overall Study|Lost to Follow-up|3|||
130243274|NCT04465955|468851473|FG000|Overall Study|Other|1|||
130243275|NCT04465955|468851474|FG001|Overall Study|Other|1|||
130243276|NCT04465955|468851475|FG002|Overall Study|Other|3|||
130243277|NCT00387127|468851478|FG000|Overall Study|Lost to Follow-up|0|||
130243278|NCT00387127|468851479|FG001|Overall Study|Lost to Follow-up|4|||
130243279|NCT00387127|468851478|FG000|Overall Study|Death|16|||
130243280|NCT00387127|468851479|FG001|Overall Study|Death|16|||
130243281|NCT00387127|468851478|FG000|Overall Study|Physician Decision|0|||
130243282|NCT00387127|468851479|FG001|Overall Study|Physician Decision|1|||
130243283|NCT00387127|468851478|FG000|Overall Study|Withdrawal by Subject|3|||
130243284|NCT00387127|468851479|FG001|Overall Study|Withdrawal by Subject|2|||
130243285|NCT00387127|468851478|FG000|Overall Study|Required by Protocol Amendment #4|12|||
130243286|NCT00387127|468851479|FG001|Overall Study|Required by Protocol Amendment #4|10|||
130243287|NCT00387127|468851478|FG000|Overall Study|Serious Adverse Event|1|||
130243288|NCT00387127|468851479|FG001|Overall Study|Serious Adverse Event|1|||
130243289|NCT00387127|468851478|FG000|Overall Study|Sponsor Unblinded|1|||
130243290|NCT00387127|468851479|FG001|Overall Study|Sponsor Unblinded|0|||
130243291|NCT00812097|468851480|FG000|Overall Study|Death|3|||
130243292|NCT00812097|468851481|FG001|Overall Study|Death|10|||
130243293|NCT00812097|468851482|FG002|Overall Study|Death|3|||
130243294|NCT00812097|468851483|FG003|Overall Study|Death|3|||
130243295|NCT00812097|468851480|FG000|Overall Study|Withdrawal by Subject|14|||
130243296|NCT00812097|468851481|FG001|Overall Study|Withdrawal by Subject|12|||
130243297|NCT00812097|468851482|FG002|Overall Study|Withdrawal by Subject|8|||
130243298|NCT00812097|468851483|FG003|Overall Study|Withdrawal by Subject|2|||
130243299|NCT00812097|468851480|FG000|Overall Study|Lost to Follow-up|90|||
130243300|NCT00812097|468851481|FG001|Overall Study|Lost to Follow-up|14|||
130243301|NCT00812097|468851482|FG002|Overall Study|Lost to Follow-up|17|||
130243302|NCT00812097|468851483|FG003|Overall Study|Lost to Follow-up|5|||
130243303|NCT00812097|468851480|FG000|Overall Study|Explantation of study device(s)|27|||
130243304|NCT00812097|468851481|FG001|Overall Study|Explantation of study device(s)|29|||
130243305|NCT00812097|468851482|FG002|Overall Study|Explantation of study device(s)|14|||
130243306|NCT00812097|468851483|FG003|Overall Study|Explantation of study device(s)|20|||
130243307|NCT00812097|468851480|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
130243308|NCT00812097|468851481|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
130243309|NCT00812097|468851482|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
130243310|NCT00812097|468851483|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
130243311|NCT01786109|468851484|FG000|Overall Study|fail manometry barostat tube placement|1|||
130243312|NCT01786109|468851485|FG001|Overall Study|fail manometry barostat tube placement|0|||
130243313|NCT01786109|468851486|FG002|Overall Study|fail manometry barostat tube placement|0|||
130243314|NCT01786109|468851484|FG000|Overall Study|unrelated illness|0|||
130243315|NCT01786109|468851485|FG001|Overall Study|unrelated illness|0|||
130243316|NCT01786109|468851486|FG002|Overall Study|unrelated illness|1|||
130243317|NCT01786109|468851484|FG000|Overall Study|adverse effects colon preparation|0|||
130243318|NCT01786109|468851485|FG001|Overall Study|adverse effects colon preparation|0|||
130243319|NCT01786109|468851486|FG002|Overall Study|adverse effects colon preparation|1|||
130243320|NCT00317369|468851487|FG000|Overall Study|Adverse Event|2|||
130243321|NCT00317369|468851488|FG001|Overall Study|Adverse Event|1|||
130243322|NCT00317369|468851489|FG002|Overall Study|Adverse Event|0|||
130243323|NCT00317369|468851487|FG000|Overall Study|Lack of Efficacy|0|||
130243324|NCT00317369|468851488|FG001|Overall Study|Lack of Efficacy|1|||
130243325|NCT00317369|468851489|FG002|Overall Study|Lack of Efficacy|1|||
130243326|NCT00317369|468851487|FG000|Overall Study|Withdrawal by Subject|0|||
130243327|NCT00317369|468851488|FG001|Overall Study|Withdrawal by Subject|0|||
130243328|NCT00317369|468851489|FG002|Overall Study|Withdrawal by Subject|1|||
130243329|NCT00825175|468851492|FG000|Overall Study|Withdrawal by Subject|0|||
130243330|NCT00825175|468851493|FG001|Overall Study|Withdrawal by Subject|5|||
130243331|NCT02762604|468851494|FG000|Overall Study|Lost to Follow-up|2|||
130100343|NCT03669640|468325965|FG004|Overall Study|Withdrawal by Subject|1|||
130100344|NCT03669640|468325966|FG005|Overall Study|Withdrawal by Subject|3|||
130100345|NCT03669640|468325961|FG000|Overall Study|Protocol Violation|1|||
130100346|NCT03669640|468325962|FG001|Overall Study|Protocol Violation|0|||
130100347|NCT03669640|468325963|FG002|Overall Study|Protocol Violation|0|||
130243332|NCT02762604|468851495|FG001|Overall Study|Lost to Follow-up|7|||
130100348|NCT03669640|468325964|FG003|Overall Study|Protocol Violation|0|||
130243333|NCT02762604|468851494|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
130243334|NCT02762604|468851495|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
130243335|NCT02691572|468851501|FG000|Overall Study|Withdrawal by Subject|1|||
130243336|NCT02691572|468851502|FG001|Overall Study|Withdrawal by Subject|0|||
130243337|NCT02691572|468851501|FG000|Overall Study|Protocol Violation|0|||
130243338|NCT02691572|468851502|FG001|Overall Study|Protocol Violation|1|||
130243339|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
130243340|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
130243341|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Death|28|||
130243342|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Death|29|||
130243343|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
130243344|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
130243345|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Other|30|||
130243346|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Other|20|||
130243347|NCT00699751|468851503|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
130243348|NCT00699751|468851504|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
130243349|NCT00699751|468851503|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
130243350|NCT00699751|468851504|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
130243351|NCT00699751|468851503|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
130243352|NCT00699751|468851504|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
130243353|NCT00699751|468851503|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
130243354|NCT00699751|468851504|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
130243355|NCT03370302|468851507|FG000|Dose Escalation Phase|Other|0|||
130243356|NCT03370302|468851508|FG001|Dose Escalation Phase|Other|1|||
130243357|NCT03370302|468851509|FG002|Dose Escalation Phase|Other|1|||
130243358|NCT03370302|468851510|FG003|Dose Escalation Phase|Other|0|||
130243359|NCT03370302|468851511|FG004|Dose Escalation Phase|Other|0|||
130243360|NCT03370302|468851512|FG005|Dose Escalation Phase|Other|0|||
130243361|NCT03370302|468851507|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130243362|NCT03370302|468851508|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
130243363|NCT03370302|468851509|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
130243364|NCT03370302|468851510|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130243365|NCT03370302|468851511|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130243366|NCT03370302|468851512|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
130243367|NCT03370302|468851507|FG000|Dose Escalation Phase|Adverse Event|1|||
130243368|NCT03370302|468851508|FG001|Dose Escalation Phase|Adverse Event|0|||
130243369|NCT03370302|468851509|FG002|Dose Escalation Phase|Adverse Event|2|||
130243370|NCT03370302|468851510|FG003|Dose Escalation Phase|Adverse Event|0|||
130243371|NCT03370302|468851511|FG004|Dose Escalation Phase|Adverse Event|0|||
130243372|NCT03370302|468851512|FG005|Dose Escalation Phase|Adverse Event|0|||
130243373|NCT03370302|468851507|FG000|Dose Escalation Phase|Progressive Disease|2|||
130243374|NCT03370302|468851508|FG001|Dose Escalation Phase|Progressive Disease|4|||
130243375|NCT03370302|468851509|FG002|Dose Escalation Phase|Progressive Disease|2|||
130243376|NCT03370302|468851510|FG003|Dose Escalation Phase|Progressive Disease|0|||
130243377|NCT03370302|468851511|FG004|Dose Escalation Phase|Progressive Disease|3|||
130243378|NCT03370302|468851512|FG005|Dose Escalation Phase|Progressive Disease|1|||
130243379|NCT03370302|468851507|FG000|Dose Expansion Phase|Progressive Disease|0|||
130243380|NCT03370302|468851508|FG001|Dose Expansion Phase|Progressive Disease|0|||
130243381|NCT03370302|468851509|FG002|Dose Expansion Phase|Progressive Disease|0|||
130243382|NCT03370302|468851510|FG003|Dose Expansion Phase|Progressive Disease|6|||
130243383|NCT03370302|468851511|FG004|Dose Expansion Phase|Progressive Disease|0|||
130243384|NCT03370302|468851512|FG005|Dose Expansion Phase|Progressive Disease|0|||
130243385|NCT01428128|468851513|FG000|Overall Study|Withdrawal by Subject|4|||
130243386|NCT01428128|468851513|FG000|Overall Study|Screen failure by p53|10|||
130243387|NCT01428128|468851513|FG000|Overall Study|Received Neulasta in one cycle|2|||
130243388|NCT01428128|468851513|FG000|Overall Study|Adverse Event|1|||
130243389|NCT00985790|468851516|FG000|Overall Study|Withdrawal by Subject|1|||
130243390|NCT00985790|468851517|FG001|Overall Study|Withdrawal by Subject|1|||
130243391|NCT00985790|468851516|FG000|Overall Study|Lost to Follow-up|6|||
130243392|NCT00985790|468851517|FG001|Overall Study|Lost to Follow-up|7|||
130243393|NCT04124965|468851521|FG000|Overall Study|Adverse event, non-fatal|3|||
130243394|NCT04124965|468851522|FG001|Overall Study|Adverse event, non-fatal|1|||
130243395|NCT04124965|468851521|FG000|Overall Study|Withdrawal by Subject|1|||
130028334|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
130028335|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130028336|NCT00289913|468064319|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
130028337|NCT00289913|468064320|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130028338|NCT00289913|468064321|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
130028339|NCT00289913|468064322|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130243396|NCT04124965|468851522|FG001|Overall Study|Withdrawal by Subject|1|||
130243397|NCT04124965|468851521|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
130243398|NCT04124965|468851522|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
130243399|NCT04124965|468851521|FG000|Overall Study|Pregnancy|1|||
130243400|NCT04124965|468851522|FG001|Overall Study|Pregnancy|0|||
130243401|NCT04124965|468851521|FG000|Overall Study|Sponsor and participant decision|0|||
130243402|NCT04124965|468851522|FG001|Overall Study|Sponsor and participant decision|1|||
130243403|NCT04124965|468851521|FG000|Overall Study|Personal surgery|0|||
130243404|NCT04124965|468851522|FG001|Overall Study|Personal surgery|1|||
130243405|NCT04124965|468851521|FG000|Overall Study|Physician Decision|0|||
130243406|NCT04124965|468851522|FG001|Overall Study|Physician Decision|1|||
130243407|NCT02184156|468851523|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
130028340|NCT00289913|468064323|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130028341|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028342|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028343|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
130028344|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028345|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028346|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
130028347|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
130028348|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
130028349|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
130028350|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
130028351|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130028352|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
130028353|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130028354|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130243408|NCT02184156|468851524|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
130243409|NCT02184156|468851523|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
130243410|NCT02184156|468851524|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
130243411|NCT00002874|468851525|FG000|Overall Study|Withdrawal by Subject|1|||
130243412|NCT00002874|468851526|FG001|Overall Study|Withdrawal by Subject|1|||
130243413|NCT00002874|468851525|FG000|Overall Study|Protocol Violation|44|||
130243414|NCT00002874|468851526|FG001|Overall Study|Protocol Violation|34|||
130243415|NCT01397747|468851529|FG000|Overall Study|Multitarget DNA test excluded|689|||
130243416|NCT01397747|468851529|FG000|Overall Study|Colonoscopy excluded|304|||
130243417|NCT01397747|468851529|FG000|Overall Study|FIT excluded|34|||
130243418|NCT03828383|468851530|FG000|Overall Study|Lost to Follow-up|3|||
130243419|NCT03828383|468851531|FG001|Overall Study|Lost to Follow-up|2|||
130243420|NCT03828383|468851530|FG000|Overall Study|Withdrawal by Subject|4|||
130243421|NCT03828383|468851531|FG001|Overall Study|Withdrawal by Subject|5|||
130243422|NCT00308685|468851533|FG000|Overall Study|Lost to Follow-up|1|||
130243423|NCT00308685|468851534|FG001|Overall Study|Lost to Follow-up|0|||
130243424|NCT00308685|468851533|FG000|Overall Study|Need to administer prohibited medication|1|||
130243425|NCT00308685|468851534|FG001|Overall Study|Need to administer prohibited medication|2|||
130243426|NCT00308685|468851533|FG000|Overall Study|Other than specified|1|||
130243427|NCT00308685|468851534|FG001|Overall Study|Other than specified|3|||
130243428|NCT03158311|468851537|FG000|Overall Study|Subject/Guardian Decision|10|||
130028355|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
130028356|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
130028357|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
130028358|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
130028359|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130028360|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130243429|NCT03158311|468851538|FG001|Overall Study|Subject/Guardian Decision|6|||
130243430|NCT03158311|468851539|FG002|Overall Study|Subject/Guardian Decision|11|||
130243431|NCT03158311|468851537|FG000|Overall Study|Adverse Event|5|||
130243432|NCT03158311|468851538|FG001|Overall Study|Adverse Event|3|||
130243433|NCT03158311|468851539|FG002|Overall Study|Adverse Event|3|||
130243434|NCT03158311|468851537|FG000|Overall Study|Techinical Problems|3|||
130243435|NCT03158311|468851538|FG001|Overall Study|Techinical Problems|1|||
130243436|NCT03158311|468851539|FG002|Overall Study|Techinical Problems|5|||
130243437|NCT03158311|468851537|FG000|Overall Study|Physician Decision|2|||
130243438|NCT03158311|468851538|FG001|Overall Study|Physician Decision|3|||
130243439|NCT03158311|468851539|FG002|Overall Study|Physician Decision|7|||
130243440|NCT03158311|468851537|FG000|Overall Study|Lost to Follow-up|1|||
130243441|NCT03158311|468851538|FG001|Overall Study|Lost to Follow-up|1|||
130243442|NCT03158311|468851539|FG002|Overall Study|Lost to Follow-up|1|||
130243443|NCT03158311|468851537|FG000|Overall Study|Sponsor decision|1|||
130243444|NCT03158311|468851538|FG001|Overall Study|Sponsor decision|0|||
130243445|NCT03158311|468851539|FG002|Overall Study|Sponsor decision|0|||
130243446|NCT03158311|468851537|FG000|Overall Study|Pregnancy|0|||
130243447|NCT03158311|468851538|FG001|Overall Study|Pregnancy|2|||
130243448|NCT03158311|468851539|FG002|Overall Study|Pregnancy|0|||
130243449|NCT03158311|468851537|FG000|Overall Study|Randomized in error|0|||
130243450|NCT03158311|468851538|FG001|Overall Study|Randomized in error|0|||
130243451|NCT03158311|468851539|FG002|Overall Study|Randomized in error|1|||
130243452|NCT01018953|468851540|FG000|Overall Study|Adverse Event|2|||
130243453|NCT01018953|468851540|FG000|Overall Study|Withdrawal by Subject|1|||
130243454|NCT01018953|468851540|FG000|Overall Study|Study termination by sponsor|5|||
130243455|NCT02665455|468851541|FG000|Overall Study|Withdrawal by Subject|6|||
130243456|NCT02665455|468851541|FG000|Overall Study|Lost to Follow-up|1|||
130243457|NCT02665455|468851541|FG000|Overall Study|Adverse Event|1|||
130243458|NCT02665455|468851541|FG000|Overall Study|Protocol Violation|1|||
130243459|NCT01928771|468851543|FG000|Overall Study|Adverse Event|6|||
130243460|NCT01928771|468851544|FG001|Overall Study|Adverse Event|5|||
130243461|NCT01928771|468851545|FG002|Overall Study|Adverse Event|1|||
130243462|NCT01928771|468851543|FG000|Overall Study|Death|2|||
130243463|NCT01928771|468851544|FG001|Overall Study|Death|2|||
130243464|NCT01928771|468851545|FG002|Overall Study|Death|2|||
130243465|NCT01928771|468851543|FG000|Overall Study|Lost to Follow-up|5|||
130243466|NCT01928771|468851544|FG001|Overall Study|Lost to Follow-up|6|||
130243467|NCT01928771|468851545|FG002|Overall Study|Lost to Follow-up|3|||
130243468|NCT01928771|468851543|FG000|Overall Study|Withdrawal by Subject|20|||
130243469|NCT01928771|468851544|FG001|Overall Study|Withdrawal by Subject|15|||
130243470|NCT01928771|468851545|FG002|Overall Study|Withdrawal by Subject|17|||
130243471|NCT01928771|468851543|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
130243472|NCT01928771|468851544|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130243473|NCT01928771|468851545|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
130243474|NCT01928771|468851543|FG000|Overall Study|Other Reasons|9|||
130243475|NCT01928771|468851544|FG001|Overall Study|Other Reasons|9|||
130243476|NCT01928771|468851545|FG002|Overall Study|Other Reasons|14|||
130243477|NCT01928771|468851543|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130243478|NCT01928771|468851544|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130243479|NCT01928771|468851545|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
130243480|NCT03921541|468853290|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
130100349|NCT03669640|468325965|FG004|Overall Study|Protocol Violation|0|||
130100350|NCT03669640|468325966|FG005|Overall Study|Protocol Violation|0|||
130100351|NCT03669640|468325961|FG000|Overall Study|Physician Decision|0|||
130100352|NCT03669640|468325962|FG001|Overall Study|Physician Decision|2|||
130100353|NCT03669640|468325963|FG002|Overall Study|Physician Decision|0|||
130100354|NCT03669640|468325964|FG003|Overall Study|Physician Decision|0|||
130100355|NCT03669640|468325965|FG004|Overall Study|Physician Decision|0|||
130100356|NCT03669640|468325966|FG005|Overall Study|Physician Decision|0|||
130100357|NCT03669640|468325961|FG000|Overall Study|Disease Relapse|1|||
130100358|NCT03669640|468325962|FG001|Overall Study|Disease Relapse|0|||
130100359|NCT03669640|468325963|FG002|Overall Study|Disease Relapse|0|||
130243481|NCT03921541|468853291|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130243482|NCT02642679|468853292|FG000|Overall Study|Withdrawal by Subject|1|||
130100360|NCT03669640|468325964|FG003|Overall Study|Disease Relapse|0|||
130100361|NCT03669640|468325965|FG004|Overall Study|Disease Relapse|0|||
130100362|NCT03669640|468325966|FG005|Overall Study|Disease Relapse|0|||
130100363|NCT03669640|468325961|FG000|Overall Study|Adverse Event|2|||
130100364|NCT03669640|468325962|FG001|Overall Study|Adverse Event|1|||
130100365|NCT03669640|468325963|FG002|Overall Study|Adverse Event|0|||
130100366|NCT03669640|468325964|FG003|Overall Study|Adverse Event|0|||
130100367|NCT03669640|468325965|FG004|Overall Study|Adverse Event|1|||
130100368|NCT03669640|468325966|FG005|Overall Study|Adverse Event|0|||
130100369|NCT03533608|468325967|FG000|Overall Study|Withdrawal by Subject|3|||
130100370|NCT03533608|468325967|FG000|Overall Study|Physician Decision|2|||
130100371|NCT03514121|468325968|FG000|Overall Study|Withdrawal by Subject|0|||
130100372|NCT03514121|468325969|FG001|Overall Study|Withdrawal by Subject|0|||
130100373|NCT03514121|468325970|FG002|Overall Study|Withdrawal by Subject|0|||
130100374|NCT03514121|468325971|FG003|Overall Study|Withdrawal by Subject|0|||
130100375|NCT03514121|468325972|FG004|Overall Study|Withdrawal by Subject|1|||
130243483|NCT02642679|468853292|FG000|Overall Study|Physician Decision|1|||
130243484|NCT02642679|468853292|FG000|Overall Study|Physician Decision|1|||
130243485|NCT01653262|468853293|FG000|Overall Study|Lack of Efficacy|1|||
130100376|NCT03514121|468325973|FG005|Overall Study|Withdrawal by Subject|2|||
130100377|NCT03514121|468325974|FG006|Overall Study|Withdrawal by Subject|1|||
130100378|NCT03514121|468325975|FG007|Overall Study|Withdrawal by Subject|1|||
130100379|NCT03514121|468325976|FG008|Overall Study|Withdrawal by Subject|7|||
130100380|NCT03514121|468325977|FG009|Overall Study|Withdrawal by Subject|2|||
130100381|NCT03514121|468325968|FG000|Overall Study|Death|0|||
130100382|NCT03514121|468325969|FG001|Overall Study|Death|0|||
130100383|NCT03514121|468325970|FG002|Overall Study|Death|0|||
130100384|NCT03514121|468325971|FG003|Overall Study|Death|0|||
130100385|NCT03514121|468325972|FG004|Overall Study|Death|0|||
130100386|NCT03514121|468325973|FG005|Overall Study|Death|3|||
130100387|NCT03514121|468325974|FG006|Overall Study|Death|2|||
130100388|NCT03514121|468325975|FG007|Overall Study|Death|1|||
130100389|NCT03514121|468325976|FG008|Overall Study|Death|26|||
130100390|NCT03514121|468325977|FG009|Overall Study|Death|3|||
130100391|NCT03514121|468325968|FG000|Overall Study|Lost to Follow-up|0|||
130100392|NCT03514121|468325969|FG001|Overall Study|Lost to Follow-up|0|||
130100393|NCT03514121|468325970|FG002|Overall Study|Lost to Follow-up|1|||
130100394|NCT03514121|468325971|FG003|Overall Study|Lost to Follow-up|0|||
130100395|NCT03514121|468325972|FG004|Overall Study|Lost to Follow-up|0|||
130100396|NCT03514121|468325973|FG005|Overall Study|Lost to Follow-up|0|||
130100397|NCT03514121|468325974|FG006|Overall Study|Lost to Follow-up|0|||
130100398|NCT03514121|468325975|FG007|Overall Study|Lost to Follow-up|0|||
130100399|NCT03514121|468325976|FG008|Overall Study|Lost to Follow-up|1|||
130100400|NCT03514121|468325977|FG009|Overall Study|Lost to Follow-up|0|||
130100401|NCT03514121|468325968|FG000|Overall Study|Adverse Event|0|||
130100402|NCT03514121|468325969|FG001|Overall Study|Adverse Event|0|||
130100403|NCT03514121|468325970|FG002|Overall Study|Adverse Event|0|||
130100404|NCT03514121|468325971|FG003|Overall Study|Adverse Event|0|||
130100405|NCT03514121|468325972|FG004|Overall Study|Adverse Event|0|||
130100406|NCT03514121|468325973|FG005|Overall Study|Adverse Event|0|||
130100407|NCT03514121|468325974|FG006|Overall Study|Adverse Event|1|||
130100408|NCT03514121|468325975|FG007|Overall Study|Adverse Event|0|||
130100409|NCT03514121|468325976|FG008|Overall Study|Adverse Event|0|||
130100410|NCT03514121|468325977|FG009|Overall Study|Adverse Event|0|||
130100411|NCT03514121|468325968|FG000|Overall Study|Other|0|||
130100412|NCT03514121|468325969|FG001|Overall Study|Other|1|||
130100413|NCT03514121|468325970|FG002|Overall Study|Other|1|||
130100414|NCT03514121|468325971|FG003|Overall Study|Other|0|||
130243486|NCT01653262|468853293|FG000|Overall Study|SAE, non-fatal|1|||
130100415|NCT03514121|468325972|FG004|Overall Study|Other|1|||
130100416|NCT03514121|468325973|FG005|Overall Study|Other|2|||
130100417|NCT03514121|468325974|FG006|Overall Study|Other|3|||
130100418|NCT03514121|468325975|FG007|Overall Study|Other|2|||
130100419|NCT03514121|468325976|FG008|Overall Study|Other|7|||
130028361|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130028362|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028363|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130028364|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028365|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028366|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130028367|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
130028368|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
130028369|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
130028370|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
130028371|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
130028372|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
130028373|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
130028374|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
130028375|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
130028376|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
130028377|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
130028378|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
130028379|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
130028380|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
130028381|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
130028382|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130028383|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130028384|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130028385|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
130028386|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130028387|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130028388|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130028389|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
130028390|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
130028391|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130028392|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130028393|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130028394|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
130028395|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
130028396|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130028397|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130028398|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130028399|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
130028400|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
130028401|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130028402|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130028403|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130100420|NCT03514121|468325977|FG009|Overall Study|Other|3|||
129884620|NCT01394250|467538602|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
130028404|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
130028405|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
130028406|NCT00289913|468064319|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130028407|NCT00289913|468064320|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130028408|NCT00289913|468064321|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
130028409|NCT00289913|468064322|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
129884621|NCT01394250|467538603|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
130028410|NCT00289913|468064323|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
130028411|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028412|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
130028413|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028414|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028415|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
130028416|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
130028417|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
129800238|NCT04755283|467236269|FG001|Overall Study|Withdrawal by Subject|3|||
130243487|NCT01653262|468853293|FG000|Overall Study|AE, non-serious non-fatal|1|||
130243488|NCT01112267|468853295|FG000|Overall Study|Adverse Event|24|||
130243489|NCT01112267|468853296|FG001|Overall Study|Adverse Event|6|||
130100421|NCT03514121|468325968|FG000|Overall Study|Study termination by Sponsor|0|||
130243490|NCT01112267|468853295|FG000|Overall Study|Withdrawal by Subject|3|||
130243491|NCT01112267|468853296|FG001|Overall Study|Withdrawal by Subject|5|||
129884622|NCT02310126|467538604|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
130243492|NCT01112267|468853295|FG000|Overall Study|Protocol Violation|5|||
130243493|NCT01112267|468853296|FG001|Overall Study|Protocol Violation|3|||
130028418|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
130028419|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
130028420|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
130028421|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130028422|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130028423|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130028424|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
130028425|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
130028426|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028427|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028428|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028429|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
130028430|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
130028431|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
129884623|NCT02310126|467538605|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
130243494|NCT01112267|468853295|FG000|Overall Study|Participants not compliant|1|||
130243495|NCT01112267|468853296|FG001|Overall Study|Participants not compliant|2|||
130243496|NCT01112267|468853295|FG000|Overall Study|Participants not receive any study drug|1|||
130243497|NCT01112267|468853296|FG001|Overall Study|Participants not receive any study drug|2|||
130243498|NCT00420407|468853298|FG000|Overall Study|Lost to Follow-up|0|||
130243499|NCT00420407|468853299|FG001|Overall Study|Lost to Follow-up|3|||
130243500|NCT00420407|468853298|FG000|Overall Study|Physician Decision|2|||
130243501|NCT00420407|468853299|FG001|Overall Study|Physician Decision|1|||
130243502|NCT00420407|468853298|FG000|Overall Study|subject identified as detainee|1|||
130243503|NCT00420407|468853299|FG001|Overall Study|subject identified as detainee|0|||
130243504|NCT00420407|468853298|FG000|Overall Study|subject identified as Jehovah's witness|1|||
130243505|NCT00420407|468853299|FG001|Overall Study|subject identified as Jehovah's witness|0|||
130243506|NCT00420407|468853298|FG000|Overall Study|Withdrawal by Subject|0|||
130243507|NCT00420407|468853299|FG001|Overall Study|Withdrawal by Subject|2|||
130243508|NCT05638737|468853302|FG000|Overall Study|Withdrawal by Subject|4|||
130243509|NCT05638737|468853303|FG001|Overall Study|Withdrawal by Subject|7|||
130243510|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
130243511|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
130243512|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
130243513|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
130243514|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
130243515|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
130243516|NCT04633447|468853306|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
130243517|NCT04633447|468853307|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
130243518|NCT04633447|468853306|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
130243519|NCT04633447|468853307|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
130243520|NCT04633447|468853306|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
130243521|NCT04633447|468853307|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
130243522|NCT03641924|468853308|FG000|Overall Study|Withdrawal by Subject|26|||
130243523|NCT03641924|468853308|FG000|Overall Study|Lost to Follow-up|16|||
130243524|NCT03641924|468853308|FG000|Overall Study|Protocol Violation|10|||
130243525|NCT04333498|468853309|FG000|Overall Study|Lost to Follow-up|1|||
130243526|NCT04333498|468853310|FG001|Overall Study|Lost to Follow-up|0|||
130243527|NCT04333498|468853309|FG000|Overall Study|Lost to Follow-up|0|||
130243528|NCT04333498|468853310|FG001|Overall Study|Lost to Follow-up|1|||
130243529|NCT01565694|468853311|FG000|Dose-Titration Period|Adverse Event|4|||
130243530|NCT01565694|468853311|FG000|Dose-Titration Period|Protocol Violation|10|||
130243531|NCT01565694|468853311|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
130243532|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
130243533|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
130243534|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
130243535|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
130243536|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
130243537|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
130243538|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243539|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243540|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243541|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130100422|NCT03514121|468325969|FG001|Overall Study|Study termination by Sponsor|0|||
130243542|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
130243543|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
130243544|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243545|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243546|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243547|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243548|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
130243549|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
130243550|NCT00541229|468853318|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130243551|NCT00541229|468853319|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
130243552|NCT00541229|468853320|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
130243553|NCT00541229|468853321|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
130243554|NCT00541229|468853322|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130243555|NCT00541229|468853323|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
130243556|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
130243557|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
130243558|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
130243559|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
130243560|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
130243561|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
130243562|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
130243563|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
130243564|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
130243565|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
130243566|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
130243567|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
130243568|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243569|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243570|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243571|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243572|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
130243573|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
130243574|NCT00541229|468853318|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130243575|NCT00541229|468853319|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
130243576|NCT00541229|468853320|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130243577|NCT00541229|468853321|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
130243578|NCT00541229|468853322|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
130243579|NCT00541229|468853323|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
130243580|NCT00541229|468853318|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
130243581|NCT00541229|468853319|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
130243582|NCT00541229|468853320|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
130243583|NCT00541229|468853321|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
130243584|NCT00541229|468853322|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
130243585|NCT00541229|468853323|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
130243586|NCT00541229|468853318|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
130100423|NCT03514121|468325970|FG002|Overall Study|Study termination by Sponsor|0|||
130100424|NCT03514121|468325971|FG003|Overall Study|Study termination by Sponsor|0|||
130243587|NCT00541229|468853319|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243588|NCT00541229|468853320|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243589|NCT00541229|468853321|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243590|NCT00541229|468853322|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
130243591|NCT00541229|468853323|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
130243592|NCT00541229|468853318|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
130243593|NCT00541229|468853319|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243594|NCT00541229|468853320|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243595|NCT00541229|468853321|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243596|NCT00541229|468853322|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243597|NCT00541229|468853323|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
130243598|NCT00541229|468853318|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243599|NCT00541229|468853319|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243600|NCT00541229|468853320|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243601|NCT00541229|468853321|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243602|NCT00541229|468853322|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
130243603|NCT00541229|468853323|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
130243604|NCT00541229|468853318|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130243605|NCT00541229|468853319|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
130243606|NCT00541229|468853320|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
130243607|NCT00541229|468853321|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
130243608|NCT00541229|468853322|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130243609|NCT00541229|468853323|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
130243610|NCT00541229|468853318|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
130243611|NCT00541229|468853319|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
130243612|NCT00541229|468853320|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
130243613|NCT00541229|468853321|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
130243614|NCT00541229|468853322|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
130243615|NCT00541229|468853323|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
130243616|NCT00541229|468853318|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130028432|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
130243617|NCT00541229|468853319|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243618|NCT00541229|468853320|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243619|NCT00541229|468853321|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243620|NCT00541229|468853322|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
130243621|NCT00541229|468853323|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
130243622|NCT00541229|468853318|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243623|NCT00541229|468853319|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243624|NCT00541229|468853320|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
130243625|NCT00541229|468853321|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243626|NCT00541229|468853322|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243627|NCT00541229|468853323|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
130243628|NCT00134719|468853324|FG000|Primary Vaccination Phase|Adverse Event|4|||
130243629|NCT00134719|468853325|FG001|Primary Vaccination Phase|Adverse Event|0|||
130243630|NCT00134719|468853326|FG002|Primary Vaccination Phase|Adverse Event|0|||
130243631|NCT00134719|468853324|FG000|Primary Vaccination Phase|Protocol Violation|1|||
130243632|NCT00134719|468853325|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130243633|NCT00134719|468853326|FG002|Primary Vaccination Phase|Protocol Violation|0|||
130243634|NCT00134719|468853324|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
130243635|NCT00134719|468853325|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
130243636|NCT00134719|468853326|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
130243637|NCT00134719|468853324|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
130243638|NCT00134719|468853325|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
130243639|NCT00134719|468853326|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
130243640|NCT00134719|468853324|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
130243641|NCT00134719|468853325|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
130243642|NCT00134719|468853326|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
130243643|NCT00134719|468853324|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
130243644|NCT00134719|468853325|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
130243645|NCT00134719|468853326|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
130243646|NCT03439839|468853327|FG000|Overall Study|Death|3|||
130243647|NCT03439839|468853328|FG001|Overall Study|Death|0|||
130243648|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243649|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
130243650|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
130243651|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243652|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243653|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243654|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
130243655|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
130243656|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243657|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
130243658|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243659|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243660|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243661|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
130243662|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243663|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243664|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
130243665|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243666|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130028433|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
130028434|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
130243667|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243668|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
130243669|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
130243670|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243671|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243672|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243673|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243674|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243675|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
130243676|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243677|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243678|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
130243679|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243680|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130028435|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
130028436|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130028437|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
130028438|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
130028439|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130028440|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
130243681|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243682|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
130243683|NCT01807520|468853329|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
130243684|NCT01807520|468853330|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243685|NCT01807520|468853331|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243686|NCT01807520|468853332|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243687|NCT01807520|468853333|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243688|NCT01807520|468853334|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243689|NCT01807520|468853335|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
130243690|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
130243691|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
130243692|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243693|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243694|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
130243695|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243696|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
130243697|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243698|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243699|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243700|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
130243701|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243702|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243703|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
130243704|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
130243705|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243706|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243707|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243708|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243709|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243710|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
130243711|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243712|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
130243713|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243714|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243715|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243716|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243717|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
130243718|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
130243719|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243720|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243721|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
130243722|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243723|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243724|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
130243725|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
130243726|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
130243727|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243728|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243729|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
130243730|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243731|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
130243732|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130243733|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130243734|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243735|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
130243736|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243737|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243738|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
130243739|NCT01807520|468853329|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
130243740|NCT01807520|468853330|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
130243741|NCT01807520|468853331|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130243742|NCT01807520|468853332|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
130243743|NCT01807520|468853333|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
130243744|NCT01807520|468853334|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130243745|NCT01807520|468853335|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
130243746|NCT01807520|468853329|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243747|NCT01807520|468853330|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243748|NCT01807520|468853331|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243749|NCT01807520|468853332|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243750|NCT01807520|468853333|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243751|NCT01807520|468853334|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
130243752|NCT01807520|468853335|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
130243753|NCT01807520|468853329|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243754|NCT01807520|468853330|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243755|NCT01807520|468853331|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243756|NCT01807520|468853332|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243757|NCT01807520|468853333|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243758|NCT01807520|468853334|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
130243759|NCT01807520|468853335|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
130243760|NCT01807520|468853329|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243761|NCT01807520|468853330|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243762|NCT01807520|468853331|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243763|NCT01807520|468853332|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243764|NCT01807520|468853333|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
130243765|NCT01807520|468853334|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
130243766|NCT01807520|468853335|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
130243767|NCT01797185|468853341|FG000|Overall Study|Adverse Event|5|||
130243768|NCT01797185|468853342|FG001|Overall Study|Adverse Event|15|||
130243769|NCT01797185|468853343|FG002|Overall Study|Adverse Event|6|||
130243770|NCT01797185|468853341|FG000|Overall Study|Withdrawal by Subject|6|||
130243771|NCT01797185|468853342|FG001|Overall Study|Withdrawal by Subject|9|||
130243772|NCT01797185|468853343|FG002|Overall Study|Withdrawal by Subject|5|||
130243773|NCT01797185|468853341|FG000|Overall Study|Site terminated|8|||
130243774|NCT01797185|468853342|FG001|Overall Study|Site terminated|4|||
130243775|NCT01797185|468853343|FG002|Overall Study|Site terminated|0|||
130243776|NCT01797185|468853341|FG000|Overall Study|Lost to Follow-up|2|||
130243777|NCT01797185|468853342|FG001|Overall Study|Lost to Follow-up|6|||
130243778|NCT01797185|468853343|FG002|Overall Study|Lost to Follow-up|1|||
130243779|NCT01797185|468853341|FG000|Overall Study|Withdrawn per sponsor|5|||
130243780|NCT01797185|468853342|FG001|Overall Study|Withdrawn per sponsor|0|||
130243781|NCT01797185|468853343|FG002|Overall Study|Withdrawn per sponsor|0|||
130243782|NCT01797185|468853341|FG000|Overall Study|Physician Decision|1|||
130243783|NCT01797185|468853342|FG001|Overall Study|Physician Decision|3|||
130243784|NCT01797185|468853343|FG002|Overall Study|Physician Decision|0|||
130243785|NCT01797185|468853341|FG000|Overall Study|Protocol Violation|1|||
130243786|NCT01797185|468853342|FG001|Overall Study|Protocol Violation|1|||
130243787|NCT01797185|468853343|FG002|Overall Study|Protocol Violation|0|||
130243788|NCT00723944|468853344|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
130243789|NCT00723944|468853345|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
130243790|NCT00723944|468853344|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
130243791|NCT00723944|468853345|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
130243792|NCT00723944|468853344|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
130243793|NCT00723944|468853345|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
130243794|NCT05177094|468853346|FG000|Overall Study|Adverse Event|5|||
130243795|NCT05177094|468853347|FG001|Overall Study|Adverse Event|5|||
130243796|NCT05177094|468853346|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
130243797|NCT05177094|468853347|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
130243798|NCT05177094|468853346|FG000|Overall Study|Protocol Deviation|3|||
130243799|NCT05177094|468853347|FG001|Overall Study|Protocol Deviation|0|||
130243800|NCT05177094|468853346|FG000|Overall Study|Withdrawal by Subject|6|||
130243801|NCT05177094|468853347|FG001|Overall Study|Withdrawal by Subject|3|||
130243802|NCT05177094|468853346|FG000|Overall Study|Participant could not tolerate long study visits|1|||
130243803|NCT05177094|468853347|FG001|Overall Study|Participant could not tolerate long study visits|0|||
130243804|NCT02400736|468853348|FG000|Overall Study|Lost to Follow-up|6|||
130243805|NCT02400736|468853349|FG001|Overall Study|Lost to Follow-up|6|||
130243806|NCT02400736|468853348|FG000|Overall Study|Withdrawal by Subject|2|||
130243807|NCT02400736|468853349|FG001|Overall Study|Withdrawal by Subject|1|||
130243808|NCT02400736|468853348|FG000|Overall Study|Moved from the area|3|||
130243809|NCT02400736|468853349|FG001|Overall Study|Moved from the area|1|||
130243810|NCT03520569|468853350|FG000|Overall Study|Withdrawal by Subject|1|||
130243811|NCT03418675|468853351|FG000|Overall Study|Lost to Follow-up|13|||
130243812|NCT03418675|468853352|FG001|Overall Study|Lost to Follow-up|10|||
130243813|NCT03418675|468853351|FG000|Overall Study|Adverse Event|2|||
130243814|NCT03418675|468853352|FG001|Overall Study|Adverse Event|0|||
130243815|NCT01178411|468853353|FG000|Overall Study|Adverse Event|5|||
130243816|NCT01178411|468853353|FG000|Overall Study|Withdrawal by Subject|4|||
130243817|NCT01178411|468853353|FG000|Overall Study|Protocol Violation|1|||
130243818|NCT01178411|468853353|FG000|Overall Study|Progressive disease per RECIST|32|||
130243819|NCT01178411|468853353|FG000|Overall Study|Progressive disease per clinician|9|||
130243820|NCT01178411|468853353|FG000|Overall Study|Physician Decision|6|||
130243821|NCT01178411|468853353|FG000|Overall Study|Death|1|||
130243822|NCT01178411|468853353|FG000|Overall Study|No reason provided|1|||
130243823|NCT01178411|468853353|FG000|Overall Study|Drug manufacturing ended|1|||
130243824|NCT01875237|468853354|FG000|Overall Study|GVDH before DLI|1|||
130243825|NCT01875237|468853355|FG001|Overall Study|GVDH before DLI|0|||
130243826|NCT01875237|468853354|FG000|Overall Study|DLI cells could not be produced|1|||
130243827|NCT01875237|468853355|FG001|Overall Study|DLI cells could not be produced|0|||
130243828|NCT03558672|468853356|FG000|Overall Study|Study Early Termination|10|||
130243829|NCT00421733|468853358|FG000|Overall Study|Adverse Event|4|||
130243830|NCT00421733|468853359|FG001|Overall Study|Adverse Event|9|||
130243831|NCT00421733|468853360|FG002|Overall Study|Adverse Event|2|||
130243832|NCT00421733|468853358|FG000|Overall Study|Lost to Follow-up|1|||
130243833|NCT00421733|468853359|FG001|Overall Study|Lost to Follow-up|2|||
130243834|NCT00421733|468853360|FG002|Overall Study|Lost to Follow-up|4|||
130243835|NCT00421733|468853358|FG000|Overall Study|Withdrawal by Subject|1|||
130243836|NCT00421733|468853359|FG001|Overall Study|Withdrawal by Subject|2|||
130243837|NCT00421733|468853360|FG002|Overall Study|Withdrawal by Subject|7|||
130243838|NCT00421733|468853358|FG000|Overall Study|Death|0|||
130243839|NCT00421733|468853359|FG001|Overall Study|Death|3|||
130243840|NCT00421733|468853360|FG002|Overall Study|Death|0|||
130243841|NCT00421733|468853358|FG000|Overall Study|Required dialysis|1|||
130243842|NCT00421733|468853359|FG001|Overall Study|Required dialysis|0|||
130243843|NCT00421733|468853360|FG002|Overall Study|Required dialysis|0|||
130243844|NCT00421733|468853358|FG000|Overall Study|Administrative|2|||
130243845|NCT00421733|468853359|FG001|Overall Study|Administrative|0|||
130243846|NCT00421733|468853360|FG002|Overall Study|Administrative|0|||
130243847|NCT00421733|468853358|FG000|Overall Study|Did not satisfy entry criteria|1|||
130243848|NCT00421733|468853359|FG001|Overall Study|Did not satisfy entry criteria|3|||
130243849|NCT00421733|468853360|FG002|Overall Study|Did not satisfy entry criteria|2|||
130243850|NCT00421733|468853358|FG000|Overall Study|Sponsor request|1|||
130243851|NCT00421733|468853359|FG001|Overall Study|Sponsor request|0|||
130243852|NCT00421733|468853360|FG002|Overall Study|Sponsor request|3|||
130243853|NCT00421733|468853358|FG000|Overall Study|Protocol deviation|4|||
130243854|NCT00421733|468853359|FG001|Overall Study|Protocol deviation|7|||
130243855|NCT00421733|468853360|FG002|Overall Study|Protocol deviation|2|||
130243856|NCT02265744|468853365|FG000|Overall Study|Poor/Non-compliance|1|||
130243857|NCT02265744|468853366|FG001|Overall Study|Poor/Non-compliance|1|||
130243858|NCT02265744|468853367|FG002|Overall Study|Poor/Non-compliance|0|||
130243859|NCT02265744|468853368|FG003|Overall Study|Poor/Non-compliance|0|||
130243860|NCT02265744|468853369|FG004|Overall Study|Poor/Non-compliance|2|||
130243861|NCT02265744|468853365|FG000|Overall Study|Lost to Follow-up|0|||
130243862|NCT02265744|468853366|FG001|Overall Study|Lost to Follow-up|0|||
130243863|NCT02265744|468853367|FG002|Overall Study|Lost to Follow-up|0|||
130243864|NCT02265744|468853368|FG003|Overall Study|Lost to Follow-up|1|||
130243865|NCT02265744|468853369|FG004|Overall Study|Lost to Follow-up|0|||
130243866|NCT02265744|468853365|FG000|Overall Study|Death|0|||
130243867|NCT02265744|468853366|FG001|Overall Study|Death|0|||
130243868|NCT02265744|468853367|FG002|Overall Study|Death|0|||
130243869|NCT02265744|468853368|FG003|Overall Study|Death|2|||
130243870|NCT02265744|468853369|FG004|Overall Study|Death|0|||
130243871|NCT02265744|468853365|FG000|Overall Study|Withdrawal by Subject|2|||
130243872|NCT02265744|468853366|FG001|Overall Study|Withdrawal by Subject|0|||
130243873|NCT02265744|468853367|FG002|Overall Study|Withdrawal by Subject|0|||
130243874|NCT02265744|468853368|FG003|Overall Study|Withdrawal by Subject|2|||
130243875|NCT02265744|468853369|FG004|Overall Study|Withdrawal by Subject|0|||
130243876|NCT02265744|468853365|FG000|Overall Study|Participant request to discontinue|2|||
130243877|NCT02265744|468853366|FG001|Overall Study|Participant request to discontinue|2|||
130243878|NCT02265744|468853367|FG002|Overall Study|Participant request to discontinue|2|||
130243879|NCT02265744|468853368|FG003|Overall Study|Participant request to discontinue|0|||
130243880|NCT02265744|468853369|FG004|Overall Study|Participant request to discontinue|0|||
130243881|NCT02265744|468853365|FG000|Overall Study|Adverse Event|8|||
130243882|NCT02265744|468853366|FG001|Overall Study|Adverse Event|4|||
130243883|NCT02265744|468853367|FG002|Overall Study|Adverse Event|9|||
130243884|NCT02265744|468853368|FG003|Overall Study|Adverse Event|8|||
130243885|NCT02265744|468853369|FG004|Overall Study|Adverse Event|2|||
130243886|NCT02265744|468853365|FG000|Overall Study|Lack of Efficacy|2|||
130243887|NCT02265744|468853366|FG001|Overall Study|Lack of Efficacy|4|||
130243888|NCT02265744|468853367|FG002|Overall Study|Lack of Efficacy|3|||
130243889|NCT02265744|468853368|FG003|Overall Study|Lack of Efficacy|4|||
130243890|NCT02265744|468853369|FG004|Overall Study|Lack of Efficacy|5|||
130243891|NCT02265744|468853365|FG000|Overall Study|Reason not provided by Investigator|1|||
130243892|NCT02265744|468853366|FG001|Overall Study|Reason not provided by Investigator|0|||
130243893|NCT02265744|468853367|FG002|Overall Study|Reason not provided by Investigator|0|||
130243894|NCT02265744|468853368|FG003|Overall Study|Reason not provided by Investigator|2|||
130243895|NCT02265744|468853369|FG004|Overall Study|Reason not provided by Investigator|0|||
130243896|NCT02265744|468853365|FG000|Overall Study|Administrative reason by sponsor|3|||
130243897|NCT02265744|468853366|FG001|Overall Study|Administrative reason by sponsor|2|||
130243898|NCT02265744|468853367|FG002|Overall Study|Administrative reason by sponsor|2|||
130243899|NCT02265744|468853368|FG003|Overall Study|Administrative reason by sponsor|3|||
130243900|NCT02265744|468853369|FG004|Overall Study|Administrative reason by sponsor|3|||
130028441|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130028442|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130028443|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130028444|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
130028445|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
130028446|NCT00289913|468064319|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130028447|NCT00289913|468064320|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
130028448|NCT00289913|468064321|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130028449|NCT00289913|468064322|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130028450|NCT00289913|468064323|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
130028451|NCT00214461|468064326|FG000|Overall Study|Adverse Event|0|||
130028452|NCT00214461|468064327|FG001|Overall Study|Adverse Event|0|||
130028453|NCT00214461|468064328|FG002|Overall Study|Adverse Event|1|||
130028454|NCT00214461|468064329|FG003|Overall Study|Adverse Event|1|||
130028455|NCT00214461|468064326|FG000|Overall Study|Withdrawal by Subject|0|||
130028456|NCT00214461|468064327|FG001|Overall Study|Withdrawal by Subject|0|||
130028457|NCT00214461|468064328|FG002|Overall Study|Withdrawal by Subject|1|||
130028458|NCT00214461|468064329|FG003|Overall Study|Withdrawal by Subject|0|||
130028459|NCT03502187|468064330|FG000|Overall Study|Withdrawal by Subject|4|||
130028460|NCT03502187|468064331|FG001|Overall Study|Withdrawal by Subject|3|||
130028461|NCT03502187|468064332|FG002|Overall Study|Withdrawal by Subject|3|||
130028462|NCT03502187|468064330|FG000|Overall Study|Lost to Follow-up|5|||
130028463|NCT03502187|468064331|FG001|Overall Study|Lost to Follow-up|4|||
130028464|NCT03502187|468064332|FG002|Overall Study|Lost to Follow-up|5|||
130028465|NCT02908100|468064334|FG000|Overall Study|Adverse Event|7|||
130243901|NCT02265744|468853365|FG000|Overall Study|Subject no longer meets study criteria|0|||
130243902|NCT02265744|468853366|FG001|Overall Study|Subject no longer meets study criteria|0|||
130243903|NCT02265744|468853367|FG002|Overall Study|Subject no longer meets study criteria|0|||
130243904|NCT02265744|468853368|FG003|Overall Study|Subject no longer meets study criteria|0|||
130028466|NCT02908100|468064335|FG001|Overall Study|Adverse Event|6|||
130028467|NCT02908100|468064336|FG002|Overall Study|Adverse Event|9|||
130028468|NCT02908100|468064334|FG000|Overall Study|Death|2|||
130028469|NCT02908100|468064335|FG001|Overall Study|Death|0|||
130028470|NCT02908100|468064336|FG002|Overall Study|Death|0|||
130028471|NCT02908100|468064334|FG000|Overall Study|Lack of Efficacy|2|||
130028472|NCT02908100|468064335|FG001|Overall Study|Lack of Efficacy|3|||
130028473|NCT02908100|468064336|FG002|Overall Study|Lack of Efficacy|3|||
130028474|NCT02908100|468064334|FG000|Overall Study|Lost to Follow-up|0|||
130028475|NCT02908100|468064335|FG001|Overall Study|Lost to Follow-up|1|||
130028476|NCT02908100|468064336|FG002|Overall Study|Lost to Follow-up|2|||
130028477|NCT02908100|468064334|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130028478|NCT02908100|468064335|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130028479|NCT02908100|468064336|FG002|Overall Study|Non-Compliance With Study Drug|2|||
130028480|NCT02908100|468064334|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
130028481|NCT02908100|468064335|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
130028482|NCT02908100|468064336|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
130028483|NCT02908100|468064334|FG000|Overall Study|Physician Decision|0|||
130028484|NCT02908100|468064335|FG001|Overall Study|Physician Decision|1|||
130028485|NCT02908100|468064336|FG002|Overall Study|Physician Decision|0|||
130028486|NCT02908100|468064334|FG000|Overall Study|Pregnancy|1|||
130028487|NCT02908100|468064335|FG001|Overall Study|Pregnancy|2|||
130028488|NCT02908100|468064336|FG002|Overall Study|Pregnancy|0|||
130028489|NCT02908100|468064334|FG000|Overall Study|Withdrawal by Subject|8|||
130028490|NCT02908100|468064335|FG001|Overall Study|Withdrawal by Subject|7|||
129884624|NCT02310126|467538604|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
130028491|NCT02908100|468064336|FG002|Overall Study|Withdrawal by Subject|5|||
130028492|NCT02908100|468064334|FG000|Overall Study|Randomised in Error|1|||
130028493|NCT02908100|468064335|FG001|Overall Study|Randomised in Error|0|||
130028494|NCT02908100|468064336|FG002|Overall Study|Randomised in Error|0|||
130028495|NCT00400400|468064337|FG000|Overall Study|Adverse Event|9|||
130028496|NCT00400400|468064338|FG001|Overall Study|Adverse Event|8|||
130028497|NCT00400400|468064337|FG000|Overall Study|Protocol Violation|2|||
130028498|NCT00400400|468064338|FG001|Overall Study|Protocol Violation|0|||
130028499|NCT00400400|468064337|FG000|Overall Study|Withdrawal by Subject|1|||
130028500|NCT00400400|468064338|FG001|Overall Study|Withdrawal by Subject|3|||
130028501|NCT00400400|468064337|FG000|Overall Study|Administrative Problem|1|||
130028502|NCT00400400|468064338|FG001|Overall Study|Administrative Problem|0|||
130028503|NCT00400400|468064337|FG000|Overall Study|Lost to Follow-up|0|||
130028504|NCT00400400|468064338|FG001|Overall Study|Lost to Follow-up|1|||
130028505|NCT00400400|468064337|FG000|Overall Study|Did not receive study drug|1|||
130243905|NCT02265744|468853369|FG004|Overall Study|Subject no longer meets study criteria|1|||
130028506|NCT00400400|468064338|FG001|Overall Study|Did not receive study drug|3|||
130028507|NCT01688050|468064339|FG000|Overall Study|Death|7|||
130028508|NCT01688050|468064339|FG000|Overall Study|Conversion to open repair|1|||
130028509|NCT01688050|468064339|FG000|Overall Study|Lost to Follow-up|13|||
130028510|NCT01688050|468064339|FG000|Overall Study|Withdrawal by Subject|10|||
130028511|NCT01731678|468064356|FG000|Overall Study|Withdrawal by Subject|3|||
130028512|NCT01731678|468064356|FG000|Overall Study|Did not meet inclusion criteria|1|||
130028513|NCT01731678|468064356|FG000|Overall Study|RMT too high, making TMS difficult|3|||
130028514|NCT02649634|468064358|FG000|Overall Study|Withdrawal by Subject|3|||
130028515|NCT02649634|468064359|FG001|Overall Study|Withdrawal by Subject|5|||
130028516|NCT02649634|468064358|FG000|Overall Study|Lost to Follow-up|0|||
130028517|NCT02649634|468064359|FG001|Overall Study|Lost to Follow-up|1|||
130028518|NCT01318122|468064360|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130028519|NCT01318122|468064361|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130028520|NCT01318122|468064362|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
130028521|NCT01318122|468064363|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
130028522|NCT01318122|468064360|FG000|Enrolled - Long-Term Extension Study|Other|1|||
130028523|NCT01318122|468064361|FG001|Enrolled - Long-Term Extension Study|Other|0|||
130028524|NCT01318122|468064362|FG002|Enrolled - Long-Term Extension Study|Other|0|||
130028525|NCT01318122|468064363|FG003|Enrolled - Long-Term Extension Study|Other|0|||
130028526|NCT01318122|468064360|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
130028527|NCT01318122|468064361|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
130028528|NCT01318122|468064362|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
130028529|NCT01318122|468064363|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
130028530|NCT01318122|468064360|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
130028531|NCT01318122|468064361|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130028532|NCT01318122|468064362|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130028533|NCT01318122|468064363|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
130028534|NCT01318122|468064360|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130028535|NCT01318122|468064361|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
130028536|NCT01318122|468064362|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130028537|NCT01318122|468064363|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130028538|NCT01318122|468064360|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130028539|NCT01318122|468064361|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130028540|NCT01318122|468064362|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
130028541|NCT01318122|468064363|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
130028542|NCT01486199|468064364|FG000|Two Year Period Between Study Days|Physician Decision|1|||
130028543|NCT01486199|468064365|FG001|Two Year Period Between Study Days|Physician Decision|0|||
130028544|NCT02471716|468064367|FG000|Overall Study|Withdrawal by Subject|0|||
130028545|NCT02471716|468064368|FG001|Overall Study|Withdrawal by Subject|1|||
130028546|NCT02471716|468064369|FG002|Overall Study|Withdrawal by Subject|0|||
130028547|NCT02471716|468064370|FG003|Overall Study|Withdrawal by Subject|2|||
130028548|NCT02471716|468064371|FG004|Overall Study|Withdrawal by Subject|5|||
130028549|NCT02471716|468064367|FG000|Overall Study|Study Terminiated by sponsor|0|||
130028550|NCT02471716|468064368|FG001|Overall Study|Study Terminiated by sponsor|0|||
130243906|NCT02265744|468853365|FG000|Overall Study|Pregnancy|1|||
130243907|NCT02265744|468853366|FG001|Overall Study|Pregnancy|2|||
130243908|NCT02265744|468853367|FG002|Overall Study|Pregnancy|1|||
130243909|NCT02265744|468853368|FG003|Overall Study|Pregnancy|1|||
130243910|NCT02265744|468853369|FG004|Overall Study|Pregnancy|0|||
130243911|NCT05161936|468853372|FG000|Overall Study|Study terminated by Sponsor|1|||
130243912|NCT05161936|468853373|FG001|Overall Study|Study terminated by Sponsor|0|||
130243913|NCT05161936|468853374|FG002|Overall Study|Study terminated by Sponsor|0|||
130243914|NCT05161936|468853372|FG000|Overall Study|Withdrawal by Subject|0|||
130243915|NCT05161936|468853373|FG001|Overall Study|Withdrawal by Subject|0|||
130243916|NCT05161936|468853374|FG002|Overall Study|Withdrawal by Subject|1|||
130243917|NCT02384460|468853379|FG000|Overall Study|Protocol Violation|0|||
130028551|NCT02471716|468064369|FG002|Overall Study|Study Terminiated by sponsor|0|||
130028552|NCT02471716|468064370|FG003|Overall Study|Study Terminiated by sponsor|1|||
130028553|NCT02471716|468064371|FG004|Overall Study|Study Terminiated by sponsor|0|||
130028554|NCT02471716|468064367|FG000|Overall Study|Lost to Follow-up|0|||
130028555|NCT02471716|468064368|FG001|Overall Study|Lost to Follow-up|0|||
130028556|NCT02471716|468064369|FG002|Overall Study|Lost to Follow-up|0|||
130028557|NCT02471716|468064370|FG003|Overall Study|Lost to Follow-up|3|||
130028558|NCT02471716|468064371|FG004|Overall Study|Lost to Follow-up|2|||
130028559|NCT02471716|468064367|FG000|Overall Study|Death|0|||
130028560|NCT02471716|468064368|FG001|Overall Study|Death|0|||
130028561|NCT02471716|468064369|FG002|Overall Study|Death|0|||
130028562|NCT02471716|468064370|FG003|Overall Study|Death|1|||
130028563|NCT02471716|468064371|FG004|Overall Study|Death|0|||
130243918|NCT02384460|468853380|FG001|Overall Study|Protocol Violation|1|||
130243919|NCT02384460|468853379|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
130243920|NCT02384460|468853380|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
130243921|NCT02384460|468853379|FG000|Overall Study|Adverse Event|5|||
130243922|NCT02384460|468853380|FG001|Overall Study|Adverse Event|2|||
130243923|NCT02384460|468853379|FG000|Overall Study|Withdrawal by Subject|0|||
130243924|NCT02384460|468853380|FG001|Overall Study|Withdrawal by Subject|3|||
130243925|NCT02384460|468853379|FG000|Overall Study|Elective medical treatment|1|||
130243926|NCT02384460|468853380|FG001|Overall Study|Elective medical treatment|0|||
130243927|NCT02384460|468853379|FG000|Overall Study|Non-compliance|1|||
130243928|NCT02384460|468853380|FG001|Overall Study|Non-compliance|0|||
130243929|NCT01060111|468853381|FG000|Overall Study|Adverse Event|9|||
130243930|NCT01060111|468853382|FG001|Overall Study|Adverse Event|5|||
130243931|NCT01060111|468853383|FG002|Overall Study|Adverse Event|18|||
130243932|NCT01060111|468853381|FG000|Overall Study|Lack of Efficacy|2|||
130243933|NCT01060111|468853382|FG001|Overall Study|Lack of Efficacy|1|||
130243934|NCT01060111|468853383|FG002|Overall Study|Lack of Efficacy|0|||
130243935|NCT01060111|468853381|FG000|Overall Study|Inappropriate participant|5|||
130243936|NCT01060111|468853382|FG001|Overall Study|Inappropriate participant|4|||
130243937|NCT01060111|468853383|FG002|Overall Study|Inappropriate participant|5|||
130243938|NCT01060111|468853381|FG000|Overall Study|Participants' evasion for hospital visit|0|||
130243939|NCT01060111|468853382|FG001|Overall Study|Participants' evasion for hospital visit|3|||
130243940|NCT01060111|468853383|FG002|Overall Study|Participants' evasion for hospital visit|2|||
130243941|NCT01060111|468853381|FG000|Overall Study|Participants' non-cooperation|8|||
130243942|NCT01060111|468853382|FG001|Overall Study|Participants' non-cooperation|6|||
130243943|NCT01060111|468853383|FG002|Overall Study|Participants' non-cooperation|6|||
130243944|NCT01060111|468853381|FG000|Overall Study|Adverse event and insufficient effect|0|||
130243945|NCT01060111|468853382|FG001|Overall Study|Adverse event and insufficient effect|1|||
130243946|NCT01060111|468853383|FG002|Overall Study|Adverse event and insufficient effect|0|||
130243947|NCT01060111|468853381|FG000|Overall Study|Participants' non-cooperation|1|||
130243948|NCT01060111|468853382|FG001|Overall Study|Participants' non-cooperation|0|||
130243949|NCT01060111|468853383|FG002|Overall Study|Participants' non-cooperation|0|||
130243950|NCT01060111|468853381|FG000|Overall Study|Other|2|||
130028564|NCT02471716|468064367|FG000|Overall Study|Other|0|||
130028565|NCT02471716|468064368|FG001|Overall Study|Other|0|||
130028566|NCT02471716|468064369|FG002|Overall Study|Other|0|||
130028567|NCT02471716|468064370|FG003|Overall Study|Other|8|||
130028568|NCT02471716|468064371|FG004|Overall Study|Other|9|||
130028569|NCT01737931|468064376|FG000|Overall Study|Withdrawal by Subject|0|||
130028570|NCT01737931|468064377|FG001|Overall Study|Withdrawal by Subject|1|||
130028571|NCT01737931|468064378|FG002|Overall Study|Withdrawal by Subject|1|||
130028572|NCT01737931|468064376|FG000|Overall Study|Physician Decision|0|||
130028573|NCT01737931|468064377|FG001|Overall Study|Physician Decision|1|||
130028574|NCT01737931|468064378|FG002|Overall Study|Physician Decision|0|||
130028575|NCT03183128|468064379|FG000|Overall Study|Adverse Event|1|||
130028576|NCT03183128|468064380|FG001|Overall Study|Adverse Event|2|||
130028577|NCT03183128|468064379|FG000|Overall Study|Withdrawal by Subject|1|||
130028578|NCT03183128|468064380|FG001|Overall Study|Withdrawal by Subject|8|||
130243951|NCT01060111|468853382|FG001|Overall Study|Other|3|||
130243952|NCT01060111|468853383|FG002|Overall Study|Other|4|||
130243953|NCT04999020|468853386|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
130243954|NCT04999020|468853387|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
130243955|NCT04999020|468853388|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
130243956|NCT04999020|468853389|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
130028579|NCT03183128|468064379|FG000|Overall Study|Protocol Violation|2|||
130028580|NCT03183128|468064380|FG001|Overall Study|Protocol Violation|0|||
130028581|NCT03183128|468064379|FG000|Overall Study|Lack of Efficacy|4|||
130028582|NCT03183128|468064380|FG001|Overall Study|Lack of Efficacy|27|||
130028583|NCT03183128|468064379|FG000|Overall Study|Lost to Follow-up|1|||
130028584|NCT03183128|468064380|FG001|Overall Study|Lost to Follow-up|0|||
130028585|NCT03183128|468064379|FG000|Overall Study|Death|2|||
130028586|NCT03183128|468064380|FG001|Overall Study|Death|0|||
130028587|NCT03183128|468064379|FG000|Overall Study|Physician Decision|1|||
130028588|NCT03183128|468064380|FG001|Overall Study|Physician Decision|0|||
130028589|NCT00364182|468064381|FG000|First Intervention|Secondary prophylaxis|1|||
130028590|NCT00364182|468064382|FG001|First Intervention|Secondary prophylaxis|0|||
130100425|NCT03514121|468325972|FG004|Overall Study|Study termination by Sponsor|0|||
130028591|NCT00364182|468064383|FG002|First Intervention|Secondary prophylaxis|0|||
130028592|NCT00364182|468064381|FG000|First Intervention|Withdrawal by Subject|2|||
130028593|NCT00364182|468064382|FG001|First Intervention|Withdrawal by Subject|0|||
130028594|NCT00364182|468064383|FG002|First Intervention|Withdrawal by Subject|0|||
130028595|NCT00364182|468064381|FG000|Second Intervention|non-compliance|0|||
130028596|NCT00364182|468064382|FG001|Second Intervention|non-compliance|1|||
130028597|NCT00364182|468064383|FG002|Second Intervention|non-compliance|1|||
130028598|NCT00364182|468064381|FG000|Second Intervention|Protocol Violation|0|||
130028599|NCT00364182|468064382|FG001|Second Intervention|Protocol Violation|1|||
130028600|NCT00364182|468064383|FG002|Second Intervention|Protocol Violation|0|||
130028601|NCT00364182|468064381|FG000|Second Intervention|Adverse Event|0|||
130028602|NCT00364182|468064382|FG001|Second Intervention|Adverse Event|0|||
130100426|NCT03514121|468325973|FG005|Overall Study|Study termination by Sponsor|0|||
130100427|NCT03514121|468325974|FG006|Overall Study|Study termination by Sponsor|0|||
130028603|NCT00364182|468064383|FG002|Second Intervention|Adverse Event|1|||
130028604|NCT00364182|468064381|FG000|Third Intervention|non-compliance|0|||
130028605|NCT00364182|468064382|FG001|Third Intervention|non-compliance|1|||
130028606|NCT00364182|468064383|FG002|Third Intervention|non-compliance|0|||
130028607|NCT00364182|468064381|FG000|Third Intervention|Lost to Follow-up|0|||
130028608|NCT00364182|468064382|FG001|Third Intervention|Lost to Follow-up|0|||
130028609|NCT00364182|468064383|FG002|Third Intervention|Lost to Follow-up|1|||
130028610|NCT02921425|468064387|FG000|Overall Study|Protocol Violation|9|||
130028611|NCT01227967|468064388|FG000|Overall Study|Protocol Violation|3|||
130028612|NCT01227967|468064389|FG001|Overall Study|Protocol Violation|1|||
130028613|NCT01227967|468064388|FG000|Overall Study|Death|0|||
130028614|NCT01227967|468064389|FG001|Overall Study|Death|1|||
130028615|NCT01227967|468064388|FG000|Overall Study|Lost to Follow-up|8|||
130028616|NCT01227967|468064389|FG001|Overall Study|Lost to Follow-up|3|||
130028617|NCT01227967|468064388|FG000|Overall Study|Withdrawal by Subject|4|||
130028618|NCT01227967|468064389|FG001|Overall Study|Withdrawal by Subject|3|||
130028619|NCT01227967|468064388|FG000|Overall Study|Physician Decision|0|||
130028620|NCT01227967|468064389|FG001|Overall Study|Physician Decision|1|||
130028621|NCT01227967|468064388|FG000|Overall Study|Never Started Treatment|0|||
130028622|NCT01227967|468064389|FG001|Overall Study|Never Started Treatment|4|||
130028623|NCT01227967|468064388|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
130028624|NCT01227967|468064389|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
130100428|NCT03514121|468325975|FG007|Overall Study|Study termination by Sponsor|0|||
130100429|NCT03514121|468325976|FG008|Overall Study|Study termination by Sponsor|11|||
130100430|NCT03514121|468325977|FG009|Overall Study|Study termination by Sponsor|3|||
130100431|NCT03514121|468325968|FG000|Overall Study|Investigator decision|0|||
130100432|NCT03514121|468325969|FG001|Overall Study|Investigator decision|0|||
130100433|NCT03514121|468325970|FG002|Overall Study|Investigator decision|0|||
130100434|NCT03514121|468325971|FG003|Overall Study|Investigator decision|0|||
130100435|NCT03514121|468325972|FG004|Overall Study|Investigator decision|0|||
130100436|NCT03514121|468325973|FG005|Overall Study|Investigator decision|0|||
130100437|NCT03514121|468325974|FG006|Overall Study|Investigator decision|0|||
130100438|NCT03514121|468325975|FG007|Overall Study|Investigator decision|0|||
130028625|NCT03403400|468064390|FG000|Overall Study|Lost to Follow-up|1|||
130028626|NCT03403400|468064391|FG001|Overall Study|Lost to Follow-up|0|||
130028627|NCT03403400|468064392|FG002|Overall Study|Lost to Follow-up|1|||
130028628|NCT03403400|468064390|FG000|Overall Study|Hospitalization|1|||
130028629|NCT03403400|468064391|FG001|Overall Study|Hospitalization|0|||
130028630|NCT03403400|468064392|FG002|Overall Study|Hospitalization|0|||
130028631|NCT03403400|468064390|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
130028632|NCT03403400|468064391|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
130028633|NCT03403400|468064392|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
130100439|NCT03514121|468325976|FG008|Overall Study|Investigator decision|1|||
130028634|NCT01384292|468064396|FG000|Part B|Severe non-compliance to protocol|1|||
130028635|NCT01384292|468064397|FG001|Part B|Severe non-compliance to protocol|0|||
130028636|NCT01384292|468064398|FG002|Part B|Severe non-compliance to protocol|0|||
130028637|NCT04062214|468064399|FG000|Week 12|Death|1|||
130028638|NCT04062214|468064400|FG001|Week 12|Death|1|||
130028639|NCT04062214|468064399|FG000|Week 12|Withdrawal by Subject|14|||
130028640|NCT04062214|468064400|FG001|Week 12|Withdrawal by Subject|13|||
130028641|NCT04062214|468064399|FG000|Week 12|Lost to Follow-up|55|||
130028642|NCT04062214|468064400|FG001|Week 12|Lost to Follow-up|68|||
130028643|NCT04062214|468064399|FG000|Week 12|Intermittent missing|31|||
130028644|NCT04062214|468064400|FG001|Week 12|Intermittent missing|29|||
130243957|NCT04999020|468853386|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
130243958|NCT04999020|468853387|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
130028645|NCT04062214|468064399|FG000|Week 36|Withdrawal by Subject|4|||
130243959|NCT04999020|468853388|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
130028646|NCT04062214|468064400|FG001|Week 36|Withdrawal by Subject|5|||
130028647|NCT04062214|468064399|FG000|Week 36|Lost to Follow-up|50|||
130028648|NCT04062214|468064400|FG001|Week 36|Lost to Follow-up|46|||
130028649|NCT04062214|468064399|FG000|Week 36|Death|0|||
130028650|NCT04062214|468064400|FG001|Week 36|Death|1|||
130028651|NCT04666038|468064401|FG000|Overall Study|Progressive Disease|2|||
130028652|NCT04666038|468064402|FG001|Overall Study|Progressive Disease|0|||
130028653|NCT04666038|468064401|FG000|Overall Study|Death|38|||
130028654|NCT04666038|468064402|FG001|Overall Study|Death|32|||
130028655|NCT04666038|468064401|FG000|Overall Study|Withdrawal by Subject|10|||
130028656|NCT04666038|468064402|FG001|Overall Study|Withdrawal by Subject|19|||
130028657|NCT04666038|468064401|FG000|Overall Study|Lost to Follow-up|0|||
130028658|NCT04666038|468064402|FG001|Overall Study|Lost to Follow-up|2|||
130028659|NCT04666038|468064401|FG000|Overall Study|On Study Treatment|46|||
130028660|NCT04666038|468064402|FG001|Overall Study|On Study Treatment|5|||
130028661|NCT04666038|468064401|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
130028662|NCT04666038|468064402|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
130028663|NCT01282229|468064413|FG000|Overall Study|Protocol Violation|2|||
130028664|NCT01988090|468064421|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
130028665|NCT01988090|468064422|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
130028666|NCT01988090|468064421|FG000|Start Treament After Randomization|Protocol Violation|0|||
130028667|NCT01988090|468064422|FG001|Start Treament After Randomization|Protocol Violation|1|||
130028668|NCT01988090|468064421|FG000|Complete Study After Start|Withdrawal by Subject|2|||
130028669|NCT01988090|468064422|FG001|Complete Study After Start|Withdrawal by Subject|0|||
130028670|NCT01988090|468064421|FG000|Complete Study After Start|Protocol Violation|1|||
130028671|NCT01988090|468064422|FG001|Complete Study After Start|Protocol Violation|1|||
130028672|NCT03094195|468064423|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
130028673|NCT03094195|468064424|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
130028674|NCT03094195|468064425|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
130028675|NCT03094195|468064426|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130028676|NCT03094195|468064427|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130028677|NCT03094195|468064428|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130028678|NCT03094195|468064429|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130028679|NCT03094195|468064430|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130028680|NCT03094195|468064423|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
130028681|NCT03094195|468064424|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
130028682|NCT03094195|468064425|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
130028683|NCT03094195|468064426|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130028684|NCT03094195|468064427|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130028685|NCT03094195|468064428|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130028686|NCT03094195|468064429|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130028687|NCT03094195|468064430|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130028688|NCT03094195|468064423|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130028689|NCT03094195|468064424|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130243960|NCT04999020|468853389|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
130028690|NCT03094195|468064425|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130028691|NCT03094195|468064426|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130028692|NCT03094195|468064427|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130028693|NCT03094195|468064428|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130243961|NCT04999020|468853386|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
130028694|NCT03094195|468064429|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130028695|NCT03094195|468064430|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130028696|NCT03094195|468064423|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130028697|NCT03094195|468064424|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
130028698|NCT03094195|468064425|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
130028699|NCT03094195|468064426|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130028700|NCT03094195|468064427|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130243962|NCT04999020|468853387|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
130028701|NCT03094195|468064428|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130028702|NCT03094195|468064429|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130028703|NCT03094195|468064430|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130028704|NCT03887130|468064440|FG000|Overall Study|Progressive disease|23|||
130028705|NCT03887130|468064441|FG001|Overall Study|Progressive disease|14|||
130028706|NCT03887130|468064442|FG002|Overall Study|Progressive disease|7|||
130028707|NCT03887130|468064440|FG000|Overall Study|Protocol Violation|3|||
130028708|NCT03887130|468064441|FG001|Overall Study|Protocol Violation|1|||
130028709|NCT03887130|468064442|FG002|Overall Study|Protocol Violation|2|||
130028710|NCT03887130|468064440|FG000|Overall Study|Drug related toxicity|7|||
130028711|NCT03887130|468064441|FG001|Overall Study|Drug related toxicity|7|||
130028712|NCT03887130|468064442|FG002|Overall Study|Drug related toxicity|13|||
130028713|NCT03887130|468064440|FG000|Overall Study|Non drug related toxicity|3|||
130028714|NCT03887130|468064441|FG001|Overall Study|Non drug related toxicity|0|||
130028715|NCT03887130|468064442|FG002|Overall Study|Non drug related toxicity|0|||
130028716|NCT03887130|468064440|FG000|Overall Study|Death|2|||
130028717|NCT03887130|468064441|FG001|Overall Study|Death|2|||
130028718|NCT03887130|468064442|FG002|Overall Study|Death|1|||
130028719|NCT03887130|468064440|FG000|Overall Study|Withdrawal by Subject|7|||
130028720|NCT03887130|468064441|FG001|Overall Study|Withdrawal by Subject|6|||
130028721|NCT03887130|468064442|FG002|Overall Study|Withdrawal by Subject|11|||
130028722|NCT03887130|468064440|FG000|Overall Study|other reason|6|||
130100440|NCT03514121|468325977|FG009|Overall Study|Investigator decision|0|||
130243963|NCT04999020|468853388|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
130243964|NCT04999020|468853389|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
130243965|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130243966|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130243967|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
130243968|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
130243969|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
130243970|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
130243971|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
130243972|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
130243973|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130243974|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130243975|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
130243976|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
130243977|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130243978|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130243979|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
130243980|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
130243981|NCT04999020|468853386|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
130243982|NCT04999020|468853387|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
130243983|NCT04999020|468853388|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
130243984|NCT04999020|468853389|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
130243985|NCT02448043|468853390|FG000|Overall Study|Withdrawal by Subject|2|||
130243986|NCT02448043|468853391|FG001|Overall Study|Withdrawal by Subject|2|||
130243987|NCT02448043|468853390|FG000|Overall Study|Protocol Violation|1|||
130243988|NCT02448043|468853391|FG001|Overall Study|Protocol Violation|2|||
130243989|NCT00997126|468853392|FG000|Overall Study|Physician Decision|7|||
130243990|NCT00997126|468853393|FG001|Overall Study|Physician Decision|11|||
130243991|NCT02583477|468853398|FG000|Overall Study|Adverse Event|0|||
130243992|NCT02583477|468853399|FG001|Overall Study|Adverse Event|2|||
130243993|NCT02583477|468853398|FG000|Overall Study|Death|1|||
130243994|NCT02583477|468853399|FG001|Overall Study|Death|16|||
130243995|NCT02583477|468853398|FG000|Overall Study|Study terminated|2|||
130243996|NCT02583477|468853399|FG001|Overall Study|Study terminated|2|||
130243997|NCT01327703|468853402|FG000|Second Treatment Period|Adverse Event|1|||
130243998|NCT01327703|468853403|FG001|Second Treatment Period|Adverse Event|1|||
130243999|NCT01327703|468853402|FG000|Second Treatment Period|Protocol Violation|0|||
130244000|NCT01327703|468853403|FG001|Second Treatment Period|Protocol Violation|1|||
130244001|NCT01131585|468853404|FG000|Overall Study|Adverse Event|0|||
130244002|NCT01131585|468853405|FG001|Overall Study|Adverse Event|2|||
130244003|NCT01131585|468853404|FG000|Overall Study|Abnormal laboratory value|1|||
130244004|NCT01131585|468853405|FG001|Overall Study|Abnormal laboratory value|0|||
130244005|NCT01131585|468853404|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130244006|NCT01131585|468853405|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130244007|NCT01131585|468853404|FG000|Overall Study|Protocol Violation|2|||
130244008|NCT01131585|468853405|FG001|Overall Study|Protocol Violation|1|||
130244009|NCT01131585|468853404|FG000|Overall Study|Withdrawal by Subject|3|||
130244010|NCT01131585|468853405|FG001|Overall Study|Withdrawal by Subject|3|||
130244011|NCT01131585|468853404|FG000|Overall Study|Lost to Follow-up|0|||
130244012|NCT01131585|468853405|FG001|Overall Study|Lost to Follow-up|1|||
130244013|NCT01131585|468853404|FG000|Overall Study|Administrative problems|1|||
130028723|NCT03887130|468064441|FG001|Overall Study|other reason|20|||
130028724|NCT03887130|468064442|FG002|Overall Study|other reason|17|||
130028725|NCT01439945|468064443|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
130028726|NCT01439945|468064444|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
130028727|NCT01439945|468064445|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
130028728|NCT01439945|468064446|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130028729|NCT01439945|468064443|FG000|Double-Blind Treatment Phase|Ineligible|1|||
130028730|NCT01439945|468064444|FG001|Double-Blind Treatment Phase|Ineligible|2|||
130028731|NCT01439945|468064445|FG002|Double-Blind Treatment Phase|Ineligible|0|||
130028732|NCT01439945|468064446|FG003|Double-Blind Treatment Phase|Ineligible|1|||
130028733|NCT04082663|468064447|FG000|Overall Study|Adverse Event|6|||
130028734|NCT04082663|468064447|FG000|Overall Study|Lost to Follow-up|1|||
130028735|NCT00705263|468064448|FG000|Overall Study|Withdrawal by Subject|2|||
130028736|NCT01752023|468064449|FG000|Overall Study|Physician Decision|2|||
130028737|NCT01752023|468064450|FG001|Overall Study|Physician Decision|1|||
130028738|NCT02440581|468064451|FG000|Overall Study|Death|0|||
130028739|NCT02440581|468064452|FG001|Overall Study|Death|0|||
130028740|NCT02440581|468064453|FG002|Overall Study|Death|7|||
130028741|NCT02440581|468064454|FG003|Overall Study|Death|5|||
130244014|NCT01131585|468853405|FG001|Overall Study|Administrative problems|1|||
130028742|NCT02440581|468064451|FG000|Overall Study|Transplanted|1|||
130028743|NCT02440581|468064452|FG001|Overall Study|Transplanted|0|||
130028744|NCT02440581|468064453|FG002|Overall Study|Transplanted|3|||
130028745|NCT02440581|468064454|FG003|Overall Study|Transplanted|2|||
130028746|NCT02440581|468064451|FG000|Overall Study|Withdrawal by Subject|4|||
130028747|NCT02440581|468064452|FG001|Overall Study|Withdrawal by Subject|11|||
130028748|NCT02440581|468064453|FG002|Overall Study|Withdrawal by Subject|3|||
130028749|NCT02440581|468064454|FG003|Overall Study|Withdrawal by Subject|7|||
130028750|NCT03186989|468064455|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130244015|NCT01131585|468853404|FG000|Overall Study|Study termination|78|||
130028751|NCT03186989|468064456|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130028752|NCT03186989|468064457|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
130028753|NCT03186989|468064458|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
130028754|NCT03186989|468064459|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
130028755|NCT03186989|468064460|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130028756|NCT03186989|468064461|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130028757|NCT03186989|468064462|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130028758|NCT03186989|468064463|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130244016|NCT01131585|468853405|FG001|Overall Study|Study termination|32|||
130244017|NCT00927082|468853406|FG000|Overall Study|Lost to Follow-up|9|||
130244018|NCT00927082|468853407|FG001|Overall Study|Lost to Follow-up|8|||
130244019|NCT00927082|468853408|FG002|Overall Study|Lost to Follow-up|12|||
130244020|NCT00927082|468853409|FG003|Overall Study|Lost to Follow-up|16|||
130244021|NCT00927082|468853406|FG000|Overall Study|Withdrawal by Subject|3|||
130244022|NCT00927082|468853407|FG001|Overall Study|Withdrawal by Subject|2|||
130244023|NCT00927082|468853408|FG002|Overall Study|Withdrawal by Subject|7|||
130028759|NCT03186989|468064464|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130028760|NCT03186989|468064465|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
130028761|NCT03186989|468064455|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028762|NCT03186989|468064456|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028763|NCT03186989|468064457|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028764|NCT03186989|468064458|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028765|NCT03186989|468064459|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028766|NCT03186989|468064460|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
130028767|NCT03186989|468064461|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028768|NCT03186989|468064462|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028769|NCT03186989|468064463|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028770|NCT03186989|468064464|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028771|NCT03186989|468064465|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
130028772|NCT03186989|468064455|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028773|NCT03186989|468064456|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028774|NCT03186989|468064457|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130244024|NCT00927082|468853409|FG003|Overall Study|Withdrawal by Subject|2|||
130244025|NCT00927082|468853406|FG000|Overall Study|Death|0|||
130244026|NCT00927082|468853407|FG001|Overall Study|Death|0|||
130244027|NCT00927082|468853408|FG002|Overall Study|Death|1|||
130244028|NCT00927082|468853409|FG003|Overall Study|Death|0|||
130244029|NCT00927082|468853406|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
130244030|NCT00927082|468853407|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
130244031|NCT00927082|468853408|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
130244032|NCT00927082|468853409|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
130244033|NCT01860404|468853411|FG000|Overall Study|Lost to Follow-up|3|||
130244034|NCT01860404|468853412|FG001|Overall Study|Lost to Follow-up|4|||
130244035|NCT01860404|468853413|FG002|Overall Study|Lost to Follow-up|1|||
130244036|NCT01860404|468853414|FG003|Overall Study|Lost to Follow-up|6|||
130244037|NCT01860404|468853415|FG004|Overall Study|Lost to Follow-up|4|||
130244038|NCT01860404|468853411|FG000|Overall Study|Withdrawal by Subject|0|||
130244039|NCT01860404|468853412|FG001|Overall Study|Withdrawal by Subject|0|||
130244040|NCT01860404|468853413|FG002|Overall Study|Withdrawal by Subject|4|||
130244041|NCT01860404|468853414|FG003|Overall Study|Withdrawal by Subject|0|||
130244042|NCT01860404|468853415|FG004|Overall Study|Withdrawal by Subject|0|||
130244043|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
130244044|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
130244045|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
130028775|NCT03186989|468064458|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028776|NCT03186989|468064459|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028777|NCT03186989|468064460|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130244046|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
130244047|NCT00849472|468853416|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
130244048|NCT00849472|468853416|FG000|Weekly Paclitaxel|Disease Progression|1|||
130028778|NCT03186989|468064461|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
130028779|NCT03186989|468064462|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028780|NCT03186989|468064463|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028781|NCT03186989|468064464|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028782|NCT03186989|468064465|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
130028783|NCT03186989|468064455|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130028784|NCT03186989|468064456|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130028785|NCT03186989|468064457|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130028786|NCT03186989|468064458|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130028787|NCT03186989|468064459|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130244049|NCT00849472|468853416|FG000|Weekly Paclitaxel|Adverse Event|11|||
130244050|NCT00849472|468853416|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
130244051|NCT00849472|468853416|FG000|Weekly Paclitaxel|Physician Decision|3|||
130244052|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
130244053|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
130244054|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
130244055|NCT00849472|468853416|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
130244056|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
130244057|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
130244058|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
130028788|NCT03186989|468064460|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
130028789|NCT03186989|468064461|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
130028790|NCT03186989|468064462|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130028791|NCT03186989|468064463|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
130028792|NCT03186989|468064464|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130028793|NCT03186989|468064465|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
130100441|NCT04242264|468325978|FG000|Overall Study|Lost to Follow-up|2|||
130100442|NCT04242264|468325979|FG001|Overall Study|Lost to Follow-up|2|||
130100443|NCT04242264|468325980|FG002|Overall Study|Lost to Follow-up|1|||
130100444|NCT04242264|468325981|FG003|Overall Study|Lost to Follow-up|1|||
130100445|NCT04242264|468325978|FG000|Overall Study|Withdrawal by Subject|1|||
130100446|NCT04242264|468325979|FG001|Overall Study|Withdrawal by Subject|0|||
130100447|NCT04242264|468325980|FG002|Overall Study|Withdrawal by Subject|0|||
130100448|NCT04242264|468325981|FG003|Overall Study|Withdrawal by Subject|0|||
130100449|NCT00471237|468325985|FG000|Overall Study|Adverse Event|6|||
130100450|NCT00471237|468325986|FG001|Overall Study|Adverse Event|5|||
130100451|NCT00471237|468325987|FG002|Overall Study|Adverse Event|4|||
130100452|NCT00471237|468325988|FG003|Overall Study|Adverse Event|8|||
130100453|NCT00471237|468325989|FG004|Overall Study|Adverse Event|7|||
130100454|NCT00471237|468325990|FG005|Overall Study|Adverse Event|5|||
130100455|NCT00471237|468325991|FG006|Overall Study|Adverse Event|0|||
130244059|NCT00849472|468853416|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
130244060|NCT05259033|468853421|FG000|Overall Study|Withdrawal by Subject|10|||
130244061|NCT05259033|468853422|FG001|Overall Study|Withdrawal by Subject|5|||
130028794|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
130028795|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
130028796|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
130100456|NCT00471237|468325985|FG000|Overall Study|Lost to Follow-up|1|||
130100457|NCT00471237|468325986|FG001|Overall Study|Lost to Follow-up|1|||
130244062|NCT05259033|468853421|FG000|Overall Study|Lost to Follow-up|1|||
130244063|NCT05259033|468853422|FG001|Overall Study|Lost to Follow-up|0|||
130244064|NCT05259033|468853421|FG000|Overall Study|Death|2|||
130244065|NCT05259033|468853422|FG001|Overall Study|Death|0|||
130244066|NCT04180696|468853423|FG000|Overall Study|Death|5|||
130244067|NCT04180696|468853424|FG001|Overall Study|Death|6|||
130244068|NCT04180696|468853423|FG000|Overall Study|Lost to Follow-up|1|||
130244069|NCT04180696|468853424|FG001|Overall Study|Lost to Follow-up|0|||
130244070|NCT04180696|468853423|FG000|Overall Study|Withdrawal by Subject|0|||
130244071|NCT04180696|468853424|FG001|Overall Study|Withdrawal by Subject|1|||
130244072|NCT04210375|468853425|FG000|Overall Study|Death|0|||
130100458|NCT00471237|468325987|FG002|Overall Study|Lost to Follow-up|0|||
130100459|NCT00471237|468325988|FG003|Overall Study|Lost to Follow-up|2|||
130244073|NCT04210375|468853426|FG001|Overall Study|Death|1|||
130244074|NCT04210375|468853427|FG002|Overall Study|Death|0|||
130244075|NCT04210375|468853428|FG003|Overall Study|Death|0|||
130100460|NCT00471237|468325989|FG004|Overall Study|Lost to Follow-up|3|||
130100461|NCT00471237|468325990|FG005|Overall Study|Lost to Follow-up|0|||
130100462|NCT00471237|468325991|FG006|Overall Study|Lost to Follow-up|0|||
130028797|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130028798|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130028799|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130028800|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130028801|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130028802|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
130028803|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
130028804|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
130028805|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
130028806|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130028807|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130028808|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130028809|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130028810|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130028811|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
130028812|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
130028813|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
130028814|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130028815|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130028816|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130100463|NCT00471237|468325985|FG000|Overall Study|Protocol Violation|3|||
130244076|NCT00424008|468853429|FG000|Overall Study|Adverse Event|8|||
130244077|NCT00424008|468853430|FG001|Overall Study|Adverse Event|6|||
130244078|NCT00424008|468853429|FG000|Overall Study|Lack of Efficacy|40|||
130244079|NCT00424008|468853430|FG001|Overall Study|Lack of Efficacy|34|||
130028817|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130028818|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130028819|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130028820|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
130028821|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
130028822|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
130028823|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
130028824|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130028825|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130028826|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130028827|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130028828|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130028829|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
130028830|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
130028831|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
130028832|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028833|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028834|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028835|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028836|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028837|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028838|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
130028839|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130028840|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130028841|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
130028842|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130028843|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130028844|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130028845|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130244080|NCT00424008|468853429|FG000|Overall Study|Lost to Follow-up|1|||
130028846|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130100464|NCT00471237|468325986|FG001|Overall Study|Protocol Violation|6|||
130100465|NCT00471237|468325987|FG002|Overall Study|Protocol Violation|3|||
130100466|NCT00471237|468325988|FG003|Overall Study|Protocol Violation|2|||
130100467|NCT00471237|468325989|FG004|Overall Study|Protocol Violation|2|||
130100468|NCT00471237|468325990|FG005|Overall Study|Protocol Violation|4|||
130100469|NCT00471237|468325991|FG006|Overall Study|Protocol Violation|1|||
130100470|NCT00471237|468325985|FG000|Overall Study|Withdrawal by Subject|8|||
130100471|NCT00471237|468325986|FG001|Overall Study|Withdrawal by Subject|6|||
130100472|NCT00471237|468325987|FG002|Overall Study|Withdrawal by Subject|5|||
130100473|NCT00471237|468325988|FG003|Overall Study|Withdrawal by Subject|8|||
130100474|NCT00471237|468325989|FG004|Overall Study|Withdrawal by Subject|7|||
130100475|NCT00471237|468325990|FG005|Overall Study|Withdrawal by Subject|4|||
130100476|NCT00471237|468325991|FG006|Overall Study|Withdrawal by Subject|2|||
130100477|NCT00471237|468325985|FG000|Overall Study|Sponsor terminated study|20|||
130100478|NCT00471237|468325986|FG001|Overall Study|Sponsor terminated study|23|||
130244081|NCT00424008|468853430|FG001|Overall Study|Lost to Follow-up|2|||
130028847|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
130028848|NCT01583374|468064471|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028849|NCT01583374|468064472|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
130028850|NCT01583374|468064473|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028851|NCT01583374|468064474|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028852|NCT01583374|468064475|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028853|NCT01583374|468064476|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028854|NCT01583374|468064477|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028855|NCT01583374|468064478|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028856|NCT01583374|468064479|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
130028857|NCT01583374|468064471|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028858|NCT01583374|468064472|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028859|NCT01583374|468064473|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028860|NCT01583374|468064474|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028861|NCT01583374|468064475|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028862|NCT01583374|468064476|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028863|NCT01583374|468064477|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028864|NCT01583374|468064478|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
130028865|NCT01583374|468064479|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
130028866|NCT01583374|468064471|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130028867|NCT01583374|468064472|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130028868|NCT01583374|468064473|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
130028869|NCT01583374|468064474|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130028870|NCT01583374|468064475|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130028871|NCT01583374|468064476|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130028872|NCT01583374|468064477|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130028873|NCT01583374|468064478|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
130028874|NCT01583374|468064479|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
130028875|NCT01583374|468064471|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
130028876|NCT01583374|468064472|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
130028877|NCT01583374|468064473|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
130028878|NCT01583374|468064474|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
130028879|NCT01583374|468064475|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
130028880|NCT01583374|468064476|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
130028881|NCT01583374|468064477|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
130028882|NCT01583374|468064478|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
130028883|NCT01583374|468064479|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
130028884|NCT01583374|468064471|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130028885|NCT01583374|468064472|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
130028886|NCT01583374|468064473|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
130028887|NCT01583374|468064474|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130028888|NCT01583374|468064475|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
130028889|NCT01583374|468064476|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130028890|NCT01583374|468064477|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130028891|NCT01583374|468064478|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130028892|NCT01583374|468064479|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
130028893|NCT01583374|468064471|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130028894|NCT01583374|468064472|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130028895|NCT01583374|468064473|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
130028896|NCT01583374|468064474|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130028897|NCT01583374|468064475|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
130028898|NCT01583374|468064476|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
130028899|NCT01583374|468064477|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130028900|NCT01583374|468064478|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130028901|NCT01583374|468064479|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
130028902|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
130028903|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
130028904|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130028905|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130028906|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
130244082|NCT00424008|468853429|FG000|Overall Study|Withdrawal by Subject|5|||
130244083|NCT00424008|468853430|FG001|Overall Study|Withdrawal by Subject|8|||
130244084|NCT00424008|468853429|FG000|Overall Study|Noncompliance with protocol|13|||
130244085|NCT00424008|468853430|FG001|Overall Study|Noncompliance with protocol|7|||
130028907|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130028908|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
130244086|NCT00424008|468853429|FG000|Overall Study|Did not meet protocol eligibility|16|||
130028909|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
130028910|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
130028911|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
130028912|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
130028913|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
130028914|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
130028915|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
130028916|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
130028917|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
130028918|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
130028919|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
130028920|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130028921|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130028922|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130028923|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130028924|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
130028925|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130028926|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
130028927|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
130028928|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
130028929|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
130028930|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
130028931|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
130100479|NCT00471237|468325987|FG002|Overall Study|Sponsor terminated study|19|||
130100480|NCT00471237|468325988|FG003|Overall Study|Sponsor terminated study|22|||
130244087|NCT00424008|468853430|FG001|Overall Study|Did not meet protocol eligibility|21|||
130244088|NCT00424008|468853429|FG000|Overall Study|Administrative|266|||
130244089|NCT00424008|468853430|FG001|Overall Study|Administrative|257|||
130244090|NCT02593864|468853433|FG000|Overall Study|Withdrawal by Subject|3|||
130244091|NCT02593864|468853433|FG000|Overall Study|Lost to Follow-up|3|||
130244092|NCT01405911|468853434|FG000|Overall Study|Pre-treatment lab AE|0|||
130244093|NCT01405911|468853435|FG001|Overall Study|Pre-treatment lab AE|1|||
130244094|NCT01405911|468853436|FG002|Overall Study|Pre-treatment lab AE|0|||
130244095|NCT01405911|468853434|FG000|Overall Study|Lost to Follow-up|0|||
130244096|NCT01405911|468853435|FG001|Overall Study|Lost to Follow-up|1|||
130244097|NCT01405911|468853436|FG002|Overall Study|Lost to Follow-up|0|||
130244098|NCT01405911|468853434|FG000|Overall Study|Protocol Violation|1|||
130244099|NCT01405911|468853435|FG001|Overall Study|Protocol Violation|0|||
130244100|NCT01405911|468853436|FG002|Overall Study|Protocol Violation|0|||
130244101|NCT01405911|468853434|FG000|Overall Study|Withdrawal by Subject|3|||
130244102|NCT01405911|468853435|FG001|Overall Study|Withdrawal by Subject|1|||
130244103|NCT01405911|468853436|FG002|Overall Study|Withdrawal by Subject|1|||
130244104|NCT03932331|468853441|FG000|Overall Study|Death|0|||
130244105|NCT03932331|468853442|FG001|Overall Study|Death|7|||
130244106|NCT03932331|468853443|FG002|Overall Study|Death|2|||
130244107|NCT03932331|468853441|FG000|Overall Study|Withdrawal by Subject|0|||
130244108|NCT03932331|468853442|FG001|Overall Study|Withdrawal by Subject|3|||
130244109|NCT03932331|468853443|FG002|Overall Study|Withdrawal by Subject|0|||
130244110|NCT03932331|468853441|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
130244111|NCT03932331|468853442|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
130244112|NCT03932331|468853443|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
130244113|NCT03932331|468853441|FG000|Overall Study|Progressive disease|3|||
130244114|NCT03932331|468853442|FG001|Overall Study|Progressive disease|0|||
130244115|NCT03932331|468853443|FG002|Overall Study|Progressive disease|0|||
130244116|NCT03932331|468853441|FG000|Overall Study|Lung infection|1|||
130244117|NCT03932331|468853442|FG001|Overall Study|Lung infection|0|||
130244118|NCT03932331|468853443|FG002|Overall Study|Lung infection|0|||
130244119|NCT03932331|468853441|FG000|Overall Study|Other|0|||
130244120|NCT03932331|468853442|FG001|Overall Study|Other|0|||
130244121|NCT03932331|468853443|FG002|Overall Study|Other|58|||
130244122|NCT01937117|468853444|FG000|Overall Study|Disease Progression|7|||
130244123|NCT01937117|468853444|FG000|Overall Study|Physician Decision|4|||
130244124|NCT01937117|468853444|FG000|Overall Study|Adverse Event|2|||
130244125|NCT01407367|468853447|FG000|Overall Study|Death|24|||
130244126|NCT01407367|468853448|FG001|Overall Study|Death|32|||
130244127|NCT01407367|468853447|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
130244128|NCT01407367|468853448|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
130244129|NCT01407367|468853447|FG000|Overall Study|Withdrawal by Subject|4|||
130244130|NCT01407367|468853448|FG001|Overall Study|Withdrawal by Subject|15|||
130244131|NCT01407367|468853447|FG000|Overall Study|Lost to Follow-up|0|||
130244132|NCT01407367|468853448|FG001|Overall Study|Lost to Follow-up|2|||
130244133|NCT01452347|468853451|FG000|Overall Study|Adverse Event|2|||
130244134|NCT01452347|468853452|FG001|Overall Study|Adverse Event|1|||
130244135|NCT01452347|468853451|FG000|Overall Study|Non compliance protocol|2|||
130244136|NCT01452347|468853452|FG001|Overall Study|Non compliance protocol|0|||
130244137|NCT01452347|468853451|FG000|Overall Study|Lost to Follow-up|2|||
130244138|NCT01452347|468853452|FG001|Overall Study|Lost to Follow-up|0|||
130244139|NCT01452347|468853451|FG000|Overall Study|Withdrawal by Subject|3|||
130244140|NCT01452347|468853452|FG001|Overall Study|Withdrawal by Subject|3|||
130244141|NCT01452347|468853451|FG000|Overall Study|Not treated|6|||
130244142|NCT01452347|468853452|FG001|Overall Study|Not treated|3|||
130244143|NCT01452347|468853451|FG000|Overall Study|Other reason not defined above|2|||
130244144|NCT01452347|468853452|FG001|Overall Study|Other reason not defined above|0|||
130244145|NCT05417113|468855103|FG000|Overall Study|Lost to Follow-up|2|||
130244146|NCT05417113|468855104|FG001|Overall Study|Lost to Follow-up|2|||
130244147|NCT01022580|468855105|FG000|Overall Study|Death|18|||
130244148|NCT01022580|468855106|FG001|Overall Study|Death|22|||
130244149|NCT01500096|468855109|FG000|Overall Study|Lost to Follow-up|1|||
130244150|NCT01500096|468855110|FG001|Overall Study|Lost to Follow-up|0|||
130244151|NCT01500096|468855111|FG002|Overall Study|Lost to Follow-up|0|||
130244152|NCT01500096|468855112|FG003|Overall Study|Lost to Follow-up|2|||
130244153|NCT01734928|468855113|FG000|Randomization|Physician Decision|0|||
130244154|NCT01734928|468855114|FG001|Randomization|Physician Decision|1|||
130244155|NCT01734928|468855113|FG000|Randomization|clinical progression|0|||
130244156|NCT01734928|468855114|FG001|Randomization|clinical progression|1|||
130244157|NCT01734928|468855113|FG000|Randomization|progressive disease|0|||
130244158|NCT01734928|468855114|FG001|Randomization|progressive disease|2|||
130244159|NCT01734928|468855113|FG000|Randomization|Withdrew informed consent|0|||
130244160|NCT01734928|468855114|FG001|Randomization|Withdrew informed consent|4|||
130244161|NCT01734928|468855113|FG000|Randomization|Death|1|||
130244162|NCT01734928|468855114|FG001|Randomization|Death|0|||
130244163|NCT01734928|468855113|FG000|Randomization|Randomization error|1|||
130244164|NCT01734928|468855114|FG001|Randomization|Randomization error|0|||
130244165|NCT01734928|468855113|FG000|Randomization|Lost to Follow-up|1|||
130244166|NCT01734928|468855114|FG001|Randomization|Lost to Follow-up|0|||
130244167|NCT01734928|468855113|FG000|Treatment Period|Lost to Follow-up|0|||
130244168|NCT01734928|468855114|FG001|Treatment Period|Lost to Follow-up|2|||
130244169|NCT01734928|468855113|FG000|Treatment Period|Progressive Disease|167|||
130244170|NCT01734928|468855114|FG001|Treatment Period|Progressive Disease|165|||
130244171|NCT01734928|468855113|FG000|Treatment Period|Adverse Event|39|||
130244172|NCT01734928|468855114|FG001|Treatment Period|Adverse Event|52|||
130244173|NCT01734928|468855113|FG000|Treatment Period|Withdrawal of Consent|25|||
130244174|NCT01734928|468855114|FG001|Treatment Period|Withdrawal of Consent|22|||
130244175|NCT01734928|468855113|FG000|Treatment Period|Death|20|||
130244176|NCT01734928|468855114|FG001|Treatment Period|Death|9|||
130244177|NCT01734928|468855113|FG000|Treatment Period|Other Reasons|27|||
130244178|NCT01734928|468855114|FG001|Treatment Period|Other Reasons|19|||
130244179|NCT01734928|468855113|FG000|Treatment Period|Pregnancy|0|||
130244180|NCT01734928|468855114|FG001|Treatment Period|Pregnancy|1|||
130244181|NCT01778985|468855115|FG000|Overall Study|Lost to Follow-up|1|||
130244182|NCT01778985|468855116|FG001|Overall Study|Lost to Follow-up|0|||
130244183|NCT01778985|468855115|FG000|Overall Study|Physician Decision|2|||
130244184|NCT01778985|468855116|FG001|Overall Study|Physician Decision|2|||
130244185|NCT01778985|468855115|FG000|Overall Study|Protocol Violation|4|||
130244186|NCT01778985|468855116|FG001|Overall Study|Protocol Violation|1|||
130244187|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
130244188|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Adverse Event|1|||
130244189|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
130244190|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Physician Decision|1|||
130244191|NCT00088881|468855117|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
130244192|NCT00088881|468855117|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
130244193|NCT00088881|468855117|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
130244194|NCT01631188|468855123|FG000|Overall Study|Physician Decision|75|||
130244195|NCT03600350|468855124|FG000|Overall Study|Death|1|||
130244196|NCT03600350|468855124|FG000|Overall Study|On Follow Up|18|||
130244197|NCT00835978|468855125|FG000|Overall Study|Death|33|||
130244198|NCT00835978|468855126|FG001|Overall Study|Death|40|||
130244199|NCT00835978|468855127|FG002|Overall Study|Death|49|||
130028932|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
130244200|NCT00835978|468855128|FG003|Overall Study|Death|4|||
130244201|NCT00835978|468855125|FG000|Overall Study|Lost to Follow-up|3|||
130244202|NCT00835978|468855126|FG001|Overall Study|Lost to Follow-up|4|||
130244203|NCT00835978|468855127|FG002|Overall Study|Lost to Follow-up|2|||
130244204|NCT00835978|468855128|FG003|Overall Study|Lost to Follow-up|1|||
130244205|NCT00835978|468855125|FG000|Overall Study|Other|5|||
130244206|NCT00835978|468855126|FG001|Overall Study|Other|1|||
130244207|NCT00835978|468855127|FG002|Overall Study|Other|8|||
130244208|NCT00835978|468855128|FG003|Overall Study|Other|0|||
130244209|NCT00835978|468855125|FG000|Overall Study|Objective progression or relapse|2|||
130244210|NCT00835978|468855126|FG001|Overall Study|Objective progression or relapse|0|||
130244211|NCT00835978|468855127|FG002|Overall Study|Objective progression or relapse|1|||
130244212|NCT00835978|468855128|FG003|Overall Study|Objective progression or relapse|0|||
130244213|NCT00835978|468855125|FG000|Overall Study|Adverse Event|1|||
130244214|NCT00835978|468855126|FG001|Overall Study|Adverse Event|0|||
130244215|NCT00835978|468855127|FG002|Overall Study|Adverse Event|1|||
130244216|NCT00835978|468855128|FG003|Overall Study|Adverse Event|0|||
130244217|NCT00835978|468855125|FG000|Overall Study|Withdrawal by Subject|0|||
130244218|NCT00835978|468855126|FG001|Overall Study|Withdrawal by Subject|3|||
130244219|NCT00835978|468855127|FG002|Overall Study|Withdrawal by Subject|0|||
130244220|NCT00835978|468855128|FG003|Overall Study|Withdrawal by Subject|5|||
130244221|NCT00835978|468855125|FG000|Overall Study|Study terminated by sponsor|12|||
130028933|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
130028934|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
130028935|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
130028936|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
130028937|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
130028938|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028939|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028940|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028941|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028942|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
130028943|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028944|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
130028945|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028946|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
130028947|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130028948|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130244222|NCT00835978|468855126|FG001|Overall Study|Study terminated by sponsor|8|||
130244223|NCT00835978|468855127|FG002|Overall Study|Study terminated by sponsor|30|||
130244224|NCT00835978|468855128|FG003|Overall Study|Study terminated by sponsor|0|||
130244225|NCT03684057|468855129|FG000|Overall Study|Withdrawal by Subject|4|||
130244226|NCT03684057|468855130|FG001|Overall Study|Withdrawal by Subject|5|||
130244227|NCT01105130|468855131|FG000|Overall Study|Withdrawal by Subject|4|||
130028949|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130028950|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130028951|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130028952|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130028953|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
130028954|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130028955|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
130028956|NCT01583374|468064471|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
130028957|NCT01583374|468064472|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
130028958|NCT01583374|468064473|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
130028959|NCT01583374|468064474|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
130028960|NCT01583374|468064475|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
130028961|NCT01583374|468064476|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
130028962|NCT01583374|468064477|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
130028963|NCT01583374|468064478|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
130028964|NCT01583374|468064479|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
130028965|NCT01292057|468064482|FG000|Overall Study|Protocol Violation|1|||
130028966|NCT01292057|468064483|FG001|Overall Study|Protocol Violation|1|||
130028967|NCT01292057|468064482|FG000|Overall Study|Lost to Follow-up|1|||
130028968|NCT01292057|468064483|FG001|Overall Study|Lost to Follow-up|1|||
130028969|NCT01506882|468064486|FG000|Overall Study|Lack of Efficacy|4|||
130028970|NCT01506882|468064487|FG001|Overall Study|Lack of Efficacy|3|||
130028971|NCT01506882|468064486|FG000|Overall Study|Lost to Follow-up|1|||
130028972|NCT01506882|468064487|FG001|Overall Study|Lost to Follow-up|0|||
130028973|NCT01506882|468064486|FG000|Overall Study|Withdrawal by Subject|9|||
130244228|NCT01105130|468855132|FG001|Overall Study|Withdrawal by Subject|6|||
130244229|NCT01105130|468855133|FG002|Overall Study|Withdrawal by Subject|2|||
130028974|NCT01506882|468064487|FG001|Overall Study|Withdrawal by Subject|3|||
130028975|NCT01506882|468064486|FG000|Overall Study|SAE, non-fatal|2|||
130028976|NCT01506882|468064487|FG001|Overall Study|SAE, non-fatal|0|||
130244230|NCT01105130|468855131|FG000|Overall Study|Never Started|2|||
130244231|NCT01105130|468855132|FG001|Overall Study|Never Started|2|||
130244232|NCT01105130|468855133|FG002|Overall Study|Never Started|4|||
130028977|NCT01506882|468064486|FG000|Overall Study|AE, non-serious non-fatal|3|||
130028978|NCT01506882|468064487|FG001|Overall Study|AE, non-serious non-fatal|1|||
130028979|NCT01506882|468064486|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
130028980|NCT01506882|468064487|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
130028981|NCT01506882|468064486|FG000|Overall Study|Other Reason|2|||
130028982|NCT01506882|468064487|FG001|Overall Study|Other Reason|0|||
130028983|NCT00821678|468064492|FG000|Overall Study|Withdrawal by Subject|8|||
130028984|NCT00821678|468064493|FG001|Overall Study|Withdrawal by Subject|0|||
130028985|NCT00821678|468064492|FG000|Overall Study|Lost to Follow-up|13|||
130028986|NCT00821678|468064493|FG001|Overall Study|Lost to Follow-up|12|||
130028987|NCT00821678|468064492|FG000|Overall Study|Death|0|||
130028988|NCT00821678|468064493|FG001|Overall Study|Death|2|||
130028989|NCT00376961|468066486|FG000|Initial Registration|Adverse Event|1|||
130028990|NCT00376961|468066487|FG001|Initial Registration|Adverse Event|0|||
130244233|NCT01105130|468855131|FG000|Overall Study|Toxicity|1|||
130244234|NCT01105130|468855132|FG001|Overall Study|Toxicity|3|||
130244235|NCT01105130|468855133|FG002|Overall Study|Toxicity|2|||
130028991|NCT00376961|468066486|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
130028992|NCT00376961|468066487|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
130028993|NCT00376961|468066486|FG000|Initial Registration|Progression/relapse|1|||
130028994|NCT00376961|468066487|FG001|Initial Registration|Progression/relapse|0|||
130028995|NCT00376961|468066486|FG000|Initial Registration|Ineligible|3|||
130028996|NCT00376961|468066487|FG001|Initial Registration|Ineligible|0|||
130028997|NCT00376961|468066486|FG000|Maintenance|Adverse Event|0|||
130028998|NCT00376961|468066487|FG001|Maintenance|Adverse Event|1|||
130028999|NCT00376961|468066486|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
130029000|NCT00376961|468066487|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
130029001|NCT00376961|468066486|FG000|Maintenance|Progression/relapse|0|||
130029002|NCT00376961|468066487|FG001|Maintenance|Progression/relapse|18|||
130029003|NCT00376961|468066486|FG000|Maintenance|Ineligible|0|||
130029004|NCT00376961|468066487|FG001|Maintenance|Ineligible|3|||
130029005|NCT01059448|468066489|FG000|Overall Study|Adverse Event|1|||
130029006|NCT01059448|468066490|FG001|Overall Study|Adverse Event|3|||
130029007|NCT01059448|468066491|FG002|Overall Study|Adverse Event|0|||
130029008|NCT01059448|468066492|FG003|Overall Study|Adverse Event|1|||
130029009|NCT01059448|468066489|FG000|Overall Study|Withdrawal by Subject|2|||
130029010|NCT01059448|468066490|FG001|Overall Study|Withdrawal by Subject|0|||
130029011|NCT01059448|468066491|FG002|Overall Study|Withdrawal by Subject|2|||
130029012|NCT01059448|468066492|FG003|Overall Study|Withdrawal by Subject|4|||
130029013|NCT01059448|468066489|FG000|Overall Study|Disease Progression|2|||
130029014|NCT01059448|468066490|FG001|Overall Study|Disease Progression|1|||
130029015|NCT01059448|468066491|FG002|Overall Study|Disease Progression|4|||
130029016|NCT01059448|468066492|FG003|Overall Study|Disease Progression|2|||
130029017|NCT01059448|468066489|FG000|Overall Study|Administrative Decision|43|||
130244236|NCT01105130|468855131|FG000|Overall Study|Multiple Reasons|3|||
130029018|NCT01059448|468066490|FG001|Overall Study|Administrative Decision|49|||
130244237|NCT01105130|468855132|FG001|Overall Study|Multiple Reasons|0|||
130029019|NCT01059448|468066491|FG002|Overall Study|Administrative Decision|45|||
130029020|NCT01059448|468066492|FG003|Overall Study|Administrative Decision|46|||
130029021|NCT01059448|468066489|FG000|Overall Study|Lost to Follow-up|0|||
130029022|NCT01059448|468066490|FG001|Overall Study|Lost to Follow-up|0|||
130029023|NCT01059448|468066491|FG002|Overall Study|Lost to Follow-up|2|||
130029024|NCT01059448|468066492|FG003|Overall Study|Lost to Follow-up|0|||
130029025|NCT01059448|468066489|FG000|Overall Study|Death|0|||
130029026|NCT01059448|468066490|FG001|Overall Study|Death|1|||
130244238|NCT01105130|468855133|FG002|Overall Study|Multiple Reasons|2|||
130029027|NCT01059448|468066491|FG002|Overall Study|Death|0|||
130029028|NCT01059448|468066492|FG003|Overall Study|Death|0|||
130029029|NCT01059448|468066489|FG000|Overall Study|Other|1|||
130029030|NCT01059448|468066490|FG001|Overall Study|Other|1|||
130029031|NCT01059448|468066491|FG002|Overall Study|Other|0|||
130029032|NCT01059448|468066492|FG003|Overall Study|Other|1|||
130029033|NCT02591615|468066493|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
130029034|NCT02591615|468066494|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
130029035|NCT02591615|468066495|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
130029036|NCT02591615|468066496|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
130029037|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
130029038|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
130029039|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
130029040|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
130029041|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
130029042|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
130029043|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
130029044|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
130029045|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
130029046|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
130029047|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
130029048|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
130029049|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
130029050|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
130029051|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
130029052|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
130029053|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
130029054|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
130029055|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
130029056|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
130029057|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
130029058|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
130029059|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
130029060|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
130029061|NCT02591615|468066493|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
130029062|NCT02591615|468066494|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
130029063|NCT02591615|468066495|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
130029064|NCT02591615|468066496|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
130029065|NCT02591615|468066493|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
130029066|NCT02591615|468066494|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
130029067|NCT02591615|468066495|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
130029068|NCT02591615|468066496|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
130029069|NCT02591615|468066493|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
130029070|NCT02591615|468066494|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
130029071|NCT02591615|468066495|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
130029072|NCT02591615|468066496|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
130029073|NCT02591615|468066493|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
130029074|NCT02591615|468066494|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
130029075|NCT02591615|468066495|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
130029076|NCT02591615|468066496|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
130029077|NCT02591615|468066493|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
130029078|NCT02591615|468066494|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
130029079|NCT02591615|468066495|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
130029080|NCT02591615|468066496|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
130029081|NCT02591615|468066493|FG000|Maintenance MK-3475|Adverse Event|0|||
130029082|NCT02591615|468066494|FG001|Maintenance MK-3475|Adverse Event|3|||
130029083|NCT02591615|468066495|FG002|Maintenance MK-3475|Adverse Event|1|||
130029084|NCT02591615|468066496|FG003|Maintenance MK-3475|Adverse Event|2|||
130029085|NCT02591615|468066493|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
130029086|NCT02591615|468066494|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
130029087|NCT02591615|468066495|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
130029088|NCT02591615|468066496|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
130029089|NCT02591615|468066493|FG000|Maintenance MK-3475|Death|0|||
130029090|NCT02591615|468066494|FG001|Maintenance MK-3475|Death|1|||
130029091|NCT02591615|468066495|FG002|Maintenance MK-3475|Death|1|||
130029092|NCT02591615|468066496|FG003|Maintenance MK-3475|Death|0|||
130029093|NCT02591615|468066493|FG000|Maintenance MK-3475|Physician discretion|0|||
130029094|NCT02591615|468066494|FG001|Maintenance MK-3475|Physician discretion|0|||
130029095|NCT02591615|468066495|FG002|Maintenance MK-3475|Physician discretion|1|||
130029096|NCT02591615|468066496|FG003|Maintenance MK-3475|Physician discretion|0|||
130029097|NCT02591615|468066493|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
130029098|NCT02591615|468066494|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
130029099|NCT02591615|468066495|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
130029100|NCT02591615|468066496|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
130029101|NCT02591615|468066493|FG000|Maintenance MK-3475|In active treatment|2|||
130029102|NCT02591615|468066494|FG001|Maintenance MK-3475|In active treatment|0|||
130029103|NCT02591615|468066495|FG002|Maintenance MK-3475|In active treatment|0|||
130029104|NCT02591615|468066496|FG003|Maintenance MK-3475|In active treatment|1|||
130029105|NCT04188197|468066497|FG000|Overall Study|Lost to Follow-up|4|||
130029106|NCT04188197|468066498|FG001|Overall Study|Lost to Follow-up|1|||
130029107|NCT04188197|468066497|FG000|Overall Study|Withdrawal by Subject|1|||
130029108|NCT04188197|468066498|FG001|Overall Study|Withdrawal by Subject|1|||
130029109|NCT04188197|468066497|FG000|Overall Study|Pregnancy|0|||
130029110|NCT04188197|468066498|FG001|Overall Study|Pregnancy|1|||
130029111|NCT02107703|468066501|FG000|Overall Study|Withdrawal by Subject|46|||
130029112|NCT02107703|468066502|FG001|Overall Study|Withdrawal by Subject|21|||
130029113|NCT02107703|468066501|FG000|Overall Study|Lost to Follow-up|20|||
130029114|NCT02107703|468066502|FG001|Overall Study|Lost to Follow-up|9|||
130029115|NCT02107703|468066501|FG000|Overall Study|On study treatment/follow up|48|||
130029116|NCT02107703|468066502|FG001|Overall Study|On study treatment/follow up|5|||
130029117|NCT00809328|468066505|FG000|Overall Study|Lack of Efficacy|18|||
130029118|NCT00809328|468066505|FG000|Overall Study|Adverse Event|6|||
130029119|NCT00809328|468066505|FG000|Overall Study|Protocol Violation|3|||
130029120|NCT00809328|468066505|FG000|Overall Study|Withdrawal by Subject|2|||
130029121|NCT06441877|468066508|FG000|Overall Study|Withdrawal by Subject|0|||
130029122|NCT06441877|468066509|FG001|Overall Study|Withdrawal by Subject|2|||
130029123|NCT06441877|468066510|FG002|Overall Study|Withdrawal by Subject|0|||
130029124|NCT06441877|468066511|FG003|Overall Study|Withdrawal by Subject|0|||
130029125|NCT00066690|468066512|FG000|Overall Study|Adverse Event|145|||
130029126|NCT00066690|468066513|FG001|Overall Study|Adverse Event|58|||
130029127|NCT00066690|468066514|FG002|Overall Study|Adverse Event|126|||
130029128|NCT00066690|468066512|FG000|Overall Study|Death|3|||
130029129|NCT00066690|468066513|FG001|Overall Study|Death|0|||
130029130|NCT00066690|468066514|FG002|Overall Study|Death|2|||
130029131|NCT00066690|468066512|FG000|Overall Study|Lack of Efficacy|114|||
130029132|NCT00066690|468066513|FG001|Overall Study|Lack of Efficacy|110|||
130029133|NCT00066690|468066514|FG002|Overall Study|Lack of Efficacy|76|||
130029134|NCT00066690|468066512|FG000|Overall Study|Lost to Follow-up|40|||
130029135|NCT00066690|468066513|FG001|Overall Study|Lost to Follow-up|21|||
130029136|NCT00066690|468066514|FG002|Overall Study|Lost to Follow-up|29|||
130029137|NCT00066690|468066512|FG000|Overall Study|Withdrawal by Subject|50|||
130029138|NCT00066690|468066513|FG001|Overall Study|Withdrawal by Subject|55|||
130029139|NCT00066690|468066514|FG002|Overall Study|Withdrawal by Subject|49|||
130029140|NCT00066690|468066512|FG000|Overall Study|Treatment Ongoing|246|||
130029141|NCT00066690|468066513|FG001|Overall Study|Treatment Ongoing|278|||
130029142|NCT00066690|468066514|FG002|Overall Study|Treatment Ongoing|282|||
130029143|NCT03706365|468066518|FG000|Overall Study|Lost to Follow-up|7|||
130029144|NCT03706365|468066519|FG001|Overall Study|Lost to Follow-up|0|||
130029145|NCT03706365|468066518|FG000|Overall Study|Withdrawal by Subject|17|||
130029146|NCT03706365|468066519|FG001|Overall Study|Withdrawal by Subject|15|||
130029147|NCT03706365|468066518|FG000|Overall Study|On Study Treatment|51|||
130029148|NCT03706365|468066519|FG001|Overall Study|On Study Treatment|51|||
130029149|NCT03116113|468066520|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029150|NCT03116113|468066521|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029151|NCT03116113|468066522|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029152|NCT03116113|468066523|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029153|NCT03116113|468066524|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029154|NCT03116113|468066525|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029155|NCT03116113|468066526|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
130029156|NCT03116113|468066527|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
130029157|NCT03116113|468066528|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
130029158|NCT02159807|468066529|FG000|Overall Study|Adverse Event|0|||
130029159|NCT02159807|468066530|FG001|Overall Study|Adverse Event|0|||
130029160|NCT02159807|468066531|FG002|Overall Study|Adverse Event|1|||
130029161|NCT02159807|468066529|FG000|Overall Study|No CSF|1|||
130029162|NCT02159807|468066530|FG001|Overall Study|No CSF|1|||
130029163|NCT02159807|468066531|FG002|Overall Study|No CSF|1|||
130029164|NCT02159807|468066529|FG000|Overall Study|elevated blood pressure|0|||
130029165|NCT02159807|468066530|FG001|Overall Study|elevated blood pressure|0|||
130244239|NCT02927145|468855135|FG000|Initial Recruitment|Withdrawal by Subject|0|||
130244240|NCT02927145|468855136|FG001|Initial Recruitment|Withdrawal by Subject|1|||
130244241|NCT02927145|468855137|FG002|Initial Recruitment|Withdrawal by Subject|1|||
130244242|NCT02927145|468855138|FG003|Initial Recruitment|Withdrawal by Subject|4|||
130244243|NCT02927145|468855139|FG004|Initial Recruitment|Withdrawal by Subject|1|||
130244244|NCT02927145|468855140|FG005|Initial Recruitment|Withdrawal by Subject|1|||
130244245|NCT02927145|468855141|FG006|Initial Recruitment|Withdrawal by Subject|0|||
130244246|NCT02927145|468855142|FG007|Initial Recruitment|Withdrawal by Subject|0|||
130244247|NCT02927145|468855143|FG008|Initial Recruitment|Withdrawal by Subject|2|||
130244248|NCT02927145|468855135|FG000|Initial Recruitment|Adverse Event|0|||
130029166|NCT02159807|468066531|FG002|Overall Study|elevated blood pressure|1|||
130029167|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
130029168|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
130029169|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
130029170|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
130029171|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
130244249|NCT02927145|468855136|FG001|Initial Recruitment|Adverse Event|0|||
130029172|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
130029173|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
130029174|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
130244250|NCT02927145|468855137|FG002|Initial Recruitment|Adverse Event|0|||
130244251|NCT02927145|468855138|FG003|Initial Recruitment|Adverse Event|0|||
130244252|NCT02927145|468855139|FG004|Initial Recruitment|Adverse Event|2|||
130029175|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130029176|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
130029177|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130029178|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
130029179|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
130029180|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130029181|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130029182|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
130029183|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
130029184|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
130029185|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130029186|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130029187|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
130029188|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130029189|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130029190|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130029191|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
130029192|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
130029193|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
130029194|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
130029195|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
130029196|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
130029197|NCT05195528|468066533|FG000|Placebo-controlled Treatment Period|Other|0|||
130029198|NCT05195528|468066534|FG001|Placebo-controlled Treatment Period|Other|0|||
130029199|NCT05195528|468066535|FG002|Placebo-controlled Treatment Period|Other|1|||
130029200|NCT05195528|468066536|FG003|Placebo-controlled Treatment Period|Other|0|||
130029201|NCT05195528|468066537|FG004|Placebo-controlled Treatment Period|Other|0|||
130029202|NCT05195528|468066533|FG000|Extension Period|PTE or AE or SAE|0|||
130029203|NCT05195528|468066534|FG001|Extension Period|PTE or AE or SAE|4|||
130029204|NCT05195528|468066535|FG002|Extension Period|PTE or AE or SAE|5|||
130029205|NCT05195528|468066536|FG003|Extension Period|PTE or AE or SAE|4|||
130029206|NCT05195528|468066537|FG004|Extension Period|PTE or AE or SAE|4|||
130029207|NCT05195528|468066533|FG000|Extension Period|Protocol Violation|0|||
130244253|NCT02927145|468855140|FG005|Initial Recruitment|Adverse Event|0|||
130244254|NCT02927145|468855141|FG006|Initial Recruitment|Adverse Event|0|||
130244255|NCT02927145|468855142|FG007|Initial Recruitment|Adverse Event|0|||
130029208|NCT05195528|468066534|FG001|Extension Period|Protocol Violation|2|||
130029209|NCT05195528|468066535|FG002|Extension Period|Protocol Violation|1|||
130029210|NCT05195528|468066536|FG003|Extension Period|Protocol Violation|0|||
130029211|NCT05195528|468066537|FG004|Extension Period|Protocol Violation|1|||
130029212|NCT05195528|468066533|FG000|Extension Period|Lost to Follow-up|0|||
130029213|NCT05195528|468066534|FG001|Extension Period|Lost to Follow-up|6|||
130029214|NCT05195528|468066535|FG002|Extension Period|Lost to Follow-up|13|||
130029215|NCT05195528|468066536|FG003|Extension Period|Lost to Follow-up|3|||
130029216|NCT05195528|468066537|FG004|Extension Period|Lost to Follow-up|7|||
130029217|NCT05195528|468066533|FG000|Extension Period|Withdrawal by Subject|0|||
130029218|NCT05195528|468066534|FG001|Extension Period|Withdrawal by Subject|12|||
130029219|NCT05195528|468066535|FG002|Extension Period|Withdrawal by Subject|9|||
130029220|NCT05195528|468066536|FG003|Extension Period|Withdrawal by Subject|6|||
130029221|NCT05195528|468066537|FG004|Extension Period|Withdrawal by Subject|5|||
130100481|NCT00471237|468325989|FG004|Overall Study|Sponsor terminated study|18|||
130029222|NCT05195528|468066533|FG000|Extension Period|Lack of Efficacy|0|||
130029223|NCT05195528|468066534|FG001|Extension Period|Lack of Efficacy|3|||
130029224|NCT05195528|468066535|FG002|Extension Period|Lack of Efficacy|0|||
130100482|NCT00471237|468325990|FG005|Overall Study|Sponsor terminated study|24|||
130100483|NCT00471237|468325991|FG006|Overall Study|Sponsor terminated study|0|||
130029225|NCT05195528|468066536|FG003|Extension Period|Lack of Efficacy|0|||
130029226|NCT05195528|468066537|FG004|Extension Period|Lack of Efficacy|2|||
130029227|NCT05195528|468066533|FG000|Extension Period|Not Treated|0|||
130029228|NCT05195528|468066534|FG001|Extension Period|Not Treated|0|||
130029229|NCT05195528|468066535|FG002|Extension Period|Not Treated|2|||
130244256|NCT02927145|468855143|FG008|Initial Recruitment|Adverse Event|0|||
130244257|NCT02927145|468855135|FG000|Invitation for Additional Challenge|Pregnancy|0|||
130244258|NCT02927145|468855136|FG001|Invitation for Additional Challenge|Pregnancy|0|||
130244259|NCT02927145|468855137|FG002|Invitation for Additional Challenge|Pregnancy|0|||
130244260|NCT02927145|468855138|FG003|Invitation for Additional Challenge|Pregnancy|0|||
130244261|NCT02927145|468855139|FG004|Invitation for Additional Challenge|Pregnancy|0|||
130244262|NCT02927145|468855140|FG005|Invitation for Additional Challenge|Pregnancy|0|||
130244263|NCT02927145|468855141|FG006|Invitation for Additional Challenge|Pregnancy|1|||
130244264|NCT02927145|468855142|FG007|Invitation for Additional Challenge|Pregnancy|0|||
130244265|NCT02927145|468855143|FG008|Invitation for Additional Challenge|Pregnancy|0|||
130244266|NCT01363440|468855144|FG000|Overall Study|Adverse Event|5|||
130244267|NCT01363440|468855145|FG001|Overall Study|Adverse Event|4|||
130244268|NCT01363440|468855146|FG002|Overall Study|Adverse Event|4|||
130244269|NCT01363440|468855144|FG000|Overall Study|Death|3|||
130244270|NCT01363440|468855145|FG001|Overall Study|Death|7|||
130244271|NCT01363440|468855146|FG002|Overall Study|Death|5|||
130244272|NCT01363440|468855144|FG000|Overall Study|Withdrawal by Subject|9|||
130244273|NCT01363440|468855145|FG001|Overall Study|Withdrawal by Subject|11|||
130244274|NCT01363440|468855146|FG002|Overall Study|Withdrawal by Subject|11|||
130244275|NCT01363440|468855144|FG000|Overall Study|Lost to Follow-up|2|||
130244276|NCT01363440|468855145|FG001|Overall Study|Lost to Follow-up|4|||
130244277|NCT01363440|468855146|FG002|Overall Study|Lost to Follow-up|5|||
130244278|NCT01363440|468855144|FG000|Overall Study|Other|4|||
130244279|NCT01363440|468855145|FG001|Overall Study|Other|5|||
130029230|NCT05195528|468066536|FG003|Extension Period|Not Treated|3|||
130029231|NCT05195528|468066537|FG004|Extension Period|Not Treated|0|||
130029232|NCT05195528|468066533|FG000|Extension Period|Other|0|||
130029233|NCT05195528|468066534|FG001|Extension Period|Other|1|||
130029234|NCT05195528|468066535|FG002|Extension Period|Other|1|||
130029235|NCT05195528|468066536|FG003|Extension Period|Other|0|||
130029236|NCT05195528|468066537|FG004|Extension Period|Other|0|||
130029237|NCT01552902|468066538|FG000|Overall Study|Adverse Event|1|||
130029238|NCT01552902|468066539|FG001|Overall Study|Adverse Event|15|||
130029239|NCT01552902|468066540|FG002|Overall Study|Adverse Event|14|||
130029240|NCT01552902|468066538|FG000|Overall Study|Protocol Violation|3|||
130029241|NCT01552902|468066539|FG001|Overall Study|Protocol Violation|3|||
130029242|NCT01552902|468066540|FG002|Overall Study|Protocol Violation|3|||
130029243|NCT01552902|468066538|FG000|Overall Study|Lack of Efficacy|4|||
130029244|NCT01552902|468066539|FG001|Overall Study|Lack of Efficacy|3|||
130029245|NCT01552902|468066540|FG002|Overall Study|Lack of Efficacy|1|||
130029246|NCT01552902|468066538|FG000|Overall Study|Withdrawal by Subject|1|||
130029247|NCT01552902|468066539|FG001|Overall Study|Withdrawal by Subject|9|||
130244280|NCT01363440|468855146|FG002|Overall Study|Other|2|||
130244281|NCT02323334|468855149|FG000|Period 3|Lost to Follow-up|0|||
130244282|NCT02323334|468855150|FG001|Period 3|Lost to Follow-up|0|||
130244283|NCT02323334|468855151|FG002|Period 3|Lost to Follow-up|1|||
130244284|NCT02323334|468855152|FG003|Period 3|Lost to Follow-up|0|||
130244285|NCT02323334|468855153|FG004|Period 3|Lost to Follow-up|0|||
130244286|NCT02323334|468855154|FG005|Period 3|Lost to Follow-up|0|||
130244287|NCT02323334|468855155|FG006|Period 3|Lost to Follow-up|0|||
130244288|NCT02323334|468855156|FG007|Period 3|Lost to Follow-up|0|||
130244289|NCT02323334|468855157|FG008|Period 3|Lost to Follow-up|0|||
130244290|NCT02323334|468855158|FG009|Period 3|Lost to Follow-up|0|||
130244291|NCT02323334|468855159|FG010|Period 3|Lost to Follow-up|0|||
130244292|NCT02323334|468855160|FG011|Period 3|Lost to Follow-up|0|||
130244293|NCT02323334|468855161|FG012|Period 3|Lost to Follow-up|0|||
130244294|NCT02323334|468855162|FG013|Period 3|Lost to Follow-up|0|||
130244295|NCT02323334|468855163|FG014|Period 3|Lost to Follow-up|0|||
130244296|NCT02323334|468855164|FG015|Period 3|Lost to Follow-up|0|||
130244297|NCT02323334|468855165|FG016|Period 3|Lost to Follow-up|0|||
130244298|NCT02323334|468855149|FG000|Period 3|Withdrawal by Subject|1|||
130029248|NCT01552902|468066540|FG002|Overall Study|Withdrawal by Subject|6|||
130244299|NCT02323334|468855150|FG001|Period 3|Withdrawal by Subject|0|||
130244300|NCT02323334|468855151|FG002|Period 3|Withdrawal by Subject|0|||
130244301|NCT02323334|468855152|FG003|Period 3|Withdrawal by Subject|0|||
130244302|NCT02323334|468855153|FG004|Period 3|Withdrawal by Subject|0|||
130029249|NCT01552902|468066538|FG000|Overall Study|Lost to Follow-up|1|||
130029250|NCT01552902|468066539|FG001|Overall Study|Lost to Follow-up|3|||
130029251|NCT01552902|468066540|FG002|Overall Study|Lost to Follow-up|6|||
130029252|NCT01552902|468066538|FG000|Overall Study|Other|3|||
130029253|NCT01552902|468066539|FG001|Overall Study|Other|4|||
130029254|NCT01552902|468066540|FG002|Overall Study|Other|3|||
130029255|NCT02487108|468066546|FG000|Overall Study|Adverse Event|1|||
130244303|NCT02323334|468855154|FG005|Period 3|Withdrawal by Subject|0|||
130100484|NCT00471237|468325985|FG000|Overall Study|Non-compliance|0|||
130100485|NCT00471237|468325986|FG001|Overall Study|Non-compliance|1|||
130100486|NCT00471237|468325987|FG002|Overall Study|Non-compliance|0|||
130100487|NCT00471237|468325988|FG003|Overall Study|Non-compliance|1|||
130100488|NCT00471237|468325989|FG004|Overall Study|Non-compliance|0|||
130100489|NCT00471237|468325990|FG005|Overall Study|Non-compliance|0|||
130100490|NCT00471237|468325991|FG006|Overall Study|Non-compliance|0|||
130100491|NCT00471237|468325985|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
130100492|NCT00471237|468325986|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
130100493|NCT00471237|468325987|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
130100494|NCT00471237|468325988|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
130100495|NCT00471237|468325989|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
130100496|NCT00471237|468325990|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
130100497|NCT00471237|468325991|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
130100498|NCT00471237|468325985|FG000|Overall Study|Early stopping due to non-efficacy|1|||
130100499|NCT00471237|468325986|FG001|Overall Study|Early stopping due to non-efficacy|0|||
130100500|NCT00471237|468325987|FG002|Overall Study|Early stopping due to non-efficacy|0|||
130100501|NCT00471237|468325988|FG003|Overall Study|Early stopping due to non-efficacy|0|||
130100502|NCT00471237|468325989|FG004|Overall Study|Early stopping due to non-efficacy|1|||
130100503|NCT00471237|468325990|FG005|Overall Study|Early stopping due to non-efficacy|0|||
130100504|NCT00471237|468325991|FG006|Overall Study|Early stopping due to non-efficacy|0|||
130100505|NCT00471237|468325985|FG000|Overall Study|Participant planned to travel to abraod|1|||
130100506|NCT00471237|468325986|FG001|Overall Study|Participant planned to travel to abraod|0|||
130100507|NCT00471237|468325987|FG002|Overall Study|Participant planned to travel to abraod|0|||
130100508|NCT00471237|468325988|FG003|Overall Study|Participant planned to travel to abraod|0|||
130100509|NCT00471237|468325989|FG004|Overall Study|Participant planned to travel to abraod|0|||
130100510|NCT00471237|468325990|FG005|Overall Study|Participant planned to travel to abraod|1|||
130100511|NCT00471237|468325991|FG006|Overall Study|Participant planned to travel to abraod|0|||
130100512|NCT00471237|468325985|FG000|Overall Study|High parathyroid hormone|0|||
130100513|NCT00471237|468325986|FG001|Overall Study|High parathyroid hormone|0|||
130100514|NCT00471237|468325987|FG002|Overall Study|High parathyroid hormone|1|||
130100515|NCT00471237|468325988|FG003|Overall Study|High parathyroid hormone|0|||
130100516|NCT00471237|468325989|FG004|Overall Study|High parathyroid hormone|0|||
130100517|NCT00471237|468325990|FG005|Overall Study|High parathyroid hormone|0|||
130100518|NCT00471237|468325991|FG006|Overall Study|High parathyroid hormone|0|||
130100519|NCT00471237|468325985|FG000|Overall Study|Participant lost medication|0|||
130100520|NCT00471237|468325986|FG001|Overall Study|Participant lost medication|0|||
130100521|NCT00471237|468325987|FG002|Overall Study|Participant lost medication|0|||
130100522|NCT00471237|468325988|FG003|Overall Study|Participant lost medication|0|||
130100523|NCT00471237|468325989|FG004|Overall Study|Participant lost medication|1|||
130100524|NCT00471237|468325990|FG005|Overall Study|Participant lost medication|0|||
130100525|NCT00471237|468325991|FG006|Overall Study|Participant lost medication|0|||
130100526|NCT00471237|468325985|FG000|Overall Study|Administration of prohibited medicine|0|||
130100527|NCT00471237|468325986|FG001|Overall Study|Administration of prohibited medicine|0|||
130100528|NCT00471237|468325987|FG002|Overall Study|Administration of prohibited medicine|0|||
130100529|NCT00471237|468325988|FG003|Overall Study|Administration of prohibited medicine|0|||
130100530|NCT00471237|468325989|FG004|Overall Study|Administration of prohibited medicine|1|||
130100531|NCT00471237|468325990|FG005|Overall Study|Administration of prohibited medicine|0|||
130100532|NCT00471237|468325991|FG006|Overall Study|Administration of prohibited medicine|0|||
130100533|NCT00471237|468325985|FG000|Overall Study|Participant shifted residence|0|||
130100534|NCT00471237|468325986|FG001|Overall Study|Participant shifted residence|0|||
130100535|NCT00471237|468325987|FG002|Overall Study|Participant shifted residence|0|||
130100536|NCT00471237|468325988|FG003|Overall Study|Participant shifted residence|0|||
130100537|NCT00471237|468325989|FG004|Overall Study|Participant shifted residence|1|||
130100538|NCT00471237|468325990|FG005|Overall Study|Participant shifted residence|0|||
130100539|NCT00471237|468325991|FG006|Overall Study|Participant shifted residence|0|||
130100540|NCT00471237|468325985|FG000|Overall Study|Participant's decision|0|||
130100541|NCT00471237|468325986|FG001|Overall Study|Participant's decision|0|||
130100542|NCT00471237|468325987|FG002|Overall Study|Participant's decision|0|||
130100543|NCT00471237|468325988|FG003|Overall Study|Participant's decision|0|||
130100544|NCT00471237|468325989|FG004|Overall Study|Participant's decision|0|||
130244304|NCT02323334|468855155|FG006|Period 3|Withdrawal by Subject|0|||
130244305|NCT02323334|468855156|FG007|Period 3|Withdrawal by Subject|0|||
130244306|NCT02323334|468855157|FG008|Period 3|Withdrawal by Subject|0|||
130244307|NCT02323334|468855158|FG009|Period 3|Withdrawal by Subject|0|||
130244308|NCT02323334|468855159|FG010|Period 3|Withdrawal by Subject|0|||
130244309|NCT02323334|468855160|FG011|Period 3|Withdrawal by Subject|0|||
130029256|NCT02487108|468066547|FG001|Overall Study|Adverse Event|6|||
130029257|NCT02487108|468066548|FG002|Overall Study|Adverse Event|12|||
130029258|NCT02487108|468066549|FG003|Overall Study|Adverse Event|6|||
130029259|NCT02487108|468066546|FG000|Overall Study|Withdrawal by Subject|8|||
130029260|NCT02487108|468066547|FG001|Overall Study|Withdrawal by Subject|5|||
130029261|NCT02487108|468066548|FG002|Overall Study|Withdrawal by Subject|5|||
130029262|NCT02487108|468066549|FG003|Overall Study|Withdrawal by Subject|0|||
130029263|NCT02487108|468066546|FG000|Overall Study|Non-compliance to study medication|3|||
130029264|NCT02487108|468066547|FG001|Overall Study|Non-compliance to study medication|2|||
130029265|NCT02487108|468066548|FG002|Overall Study|Non-compliance to study medication|5|||
130029266|NCT02487108|468066549|FG003|Overall Study|Non-compliance to study medication|4|||
130029267|NCT02487108|468066546|FG000|Overall Study|Protocol Violation|1|||
130029268|NCT02487108|468066547|FG001|Overall Study|Protocol Violation|1|||
130029269|NCT02487108|468066548|FG002|Overall Study|Protocol Violation|2|||
130029270|NCT02487108|468066549|FG003|Overall Study|Protocol Violation|0|||
130029271|NCT02487108|468066546|FG000|Overall Study|Non-compliance to study procedures|0|||
130029272|NCT02487108|468066547|FG001|Overall Study|Non-compliance to study procedures|0|||
130029273|NCT02487108|468066548|FG002|Overall Study|Non-compliance to study procedures|0|||
130029274|NCT02487108|468066549|FG003|Overall Study|Non-compliance to study procedures|1|||
130029275|NCT02487108|468066546|FG000|Overall Study|Other than specified|3|||
130029276|NCT02487108|468066547|FG001|Overall Study|Other than specified|2|||
130029277|NCT02487108|468066548|FG002|Overall Study|Other than specified|2|||
130029278|NCT02487108|468066549|FG003|Overall Study|Other than specified|0|||
130244310|NCT02323334|468855161|FG012|Period 3|Withdrawal by Subject|0|||
130029279|NCT02367521|468066550|FG000|Overall Study|severe headache after intervention|2|||
130029280|NCT02367521|468066551|FG001|Overall Study|severe headache after intervention|0|||
130029281|NCT02367521|468066550|FG000|Overall Study|unable to find transportation|2|||
130029282|NCT02367521|468066551|FG001|Overall Study|unable to find transportation|0|||
130029283|NCT00600171|468066552|FG000|Overall Study|Adverse Event|0|||
130029284|NCT00600171|468066553|FG001|Overall Study|Adverse Event|1|||
130244311|NCT02323334|468855162|FG013|Period 3|Withdrawal by Subject|0|||
130029285|NCT00600171|468066554|FG002|Overall Study|Adverse Event|0|||
130029286|NCT00600171|468066555|FG003|Overall Study|Adverse Event|0|||
130029287|NCT00600171|468066556|FG004|Overall Study|Adverse Event|1|||
130029288|NCT00600171|468066557|FG005|Overall Study|Adverse Event|0|||
130029289|NCT00600171|468066552|FG000|Overall Study|Lack of Efficacy|9|||
130029290|NCT00600171|468066553|FG001|Overall Study|Lack of Efficacy|12|||
130029291|NCT00600171|468066554|FG002|Overall Study|Lack of Efficacy|3|||
130029292|NCT00600171|468066555|FG003|Overall Study|Lack of Efficacy|5|||
130029293|NCT00600171|468066556|FG004|Overall Study|Lack of Efficacy|4|||
130029294|NCT00600171|468066557|FG005|Overall Study|Lack of Efficacy|0|||
130029295|NCT00600171|468066552|FG000|Overall Study|Protocol Violation|1|||
130029296|NCT00600171|468066553|FG001|Overall Study|Protocol Violation|2|||
130029297|NCT00600171|468066554|FG002|Overall Study|Protocol Violation|0|||
130029298|NCT00600171|468066555|FG003|Overall Study|Protocol Violation|1|||
130244312|NCT02323334|468855163|FG014|Period 3|Withdrawal by Subject|0|||
130029299|NCT00600171|468066556|FG004|Overall Study|Protocol Violation|0|||
130244313|NCT02323334|468855164|FG015|Period 3|Withdrawal by Subject|0|||
130029300|NCT00600171|468066557|FG005|Overall Study|Protocol Violation|0|||
130029301|NCT00600171|468066552|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
130029302|NCT00600171|468066553|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130029303|NCT00600171|468066554|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
130029304|NCT00600171|468066555|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
130029305|NCT00600171|468066556|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130244314|NCT02323334|468855165|FG016|Period 3|Withdrawal by Subject|0|||
130244315|NCT02506036|468855166|FG000|First Intervention (4-6 Weeks)|Death|1|||
130244316|NCT02506036|468855167|FG001|First Intervention (4-6 Weeks)|Death|0|||
130029306|NCT00600171|468066557|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130100545|NCT00471237|468325990|FG005|Overall Study|Participant's decision|1|||
130244317|NCT02506036|468855166|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
130029307|NCT00600171|468066552|FG000|Overall Study|Withdrawal by Subject|3|||
130244318|NCT02506036|468855167|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
130244319|NCT02506036|468855166|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
130244320|NCT02506036|468855167|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
130244321|NCT00552058|468855168|FG000|Overall Study|Adverse Event|8|||
130244322|NCT00552058|468855169|FG001|Overall Study|Adverse Event|7|||
130244323|NCT00552058|468855168|FG000|Overall Study|Lack of Efficacy|1|||
130244324|NCT00552058|468855169|FG001|Overall Study|Lack of Efficacy|5|||
130244325|NCT00552058|468855168|FG000|Overall Study|Lost to Follow-up|1|||
130244326|NCT00552058|468855169|FG001|Overall Study|Lost to Follow-up|0|||
130244327|NCT00552058|468855168|FG000|Overall Study|Withdrawal by Subject|4|||
130244328|NCT00552058|468855169|FG001|Overall Study|Withdrawal by Subject|4|||
130244329|NCT00552058|468855168|FG000|Overall Study|Other: Protocol Violation|0|||
130029308|NCT00600171|468066553|FG001|Overall Study|Withdrawal by Subject|0|||
130029309|NCT00600171|468066554|FG002|Overall Study|Withdrawal by Subject|0|||
130029310|NCT00600171|468066555|FG003|Overall Study|Withdrawal by Subject|1|||
130029311|NCT00600171|468066556|FG004|Overall Study|Withdrawal by Subject|1|||
130029312|NCT00600171|468066557|FG005|Overall Study|Withdrawal by Subject|1|||
130029313|NCT00600171|468066552|FG000|Overall Study|Physician Decision|0|||
130029314|NCT00600171|468066553|FG001|Overall Study|Physician Decision|1|||
130029315|NCT00600171|468066554|FG002|Overall Study|Physician Decision|0|||
130029316|NCT00600171|468066555|FG003|Overall Study|Physician Decision|1|||
130029317|NCT00600171|468066556|FG004|Overall Study|Physician Decision|0|||
130029318|NCT00600171|468066557|FG005|Overall Study|Physician Decision|2|||
130029319|NCT00600171|468066552|FG000|Overall Study|Lost to Follow-up|0|||
130029320|NCT00600171|468066553|FG001|Overall Study|Lost to Follow-up|0|||
130029321|NCT00600171|468066554|FG002|Overall Study|Lost to Follow-up|0|||
130029322|NCT00600171|468066555|FG003|Overall Study|Lost to Follow-up|1|||
130029323|NCT00600171|468066556|FG004|Overall Study|Lost to Follow-up|0|||
130029324|NCT00600171|468066557|FG005|Overall Study|Lost to Follow-up|0|||
130029325|NCT00542191|468066561|FG000|Overall Study|Death|3|||
130029326|NCT00469612|468066562|FG000|Overall Study|Study terminated before data collected|2|||
130029327|NCT00469612|468066563|FG001|Overall Study|Study terminated before data collected|0|||
130029328|NCT01084551|468066564|FG000|Overall Study|Adverse Event|2|||
130029329|NCT01084551|468066565|FG001|Overall Study|Adverse Event|9|||
130029330|NCT01084551|468066566|FG002|Overall Study|Adverse Event|4|||
130029331|NCT01084551|468066564|FG000|Overall Study|Lack of Efficacy|2|||
130244330|NCT00552058|468855169|FG001|Overall Study|Other: Protocol Violation|1|||
130244331|NCT00552058|468855168|FG000|Overall Study|Other: Non Compliance|1|||
130029332|NCT01084551|468066565|FG001|Overall Study|Lack of Efficacy|0|||
130029333|NCT01084551|468066566|FG002|Overall Study|Lack of Efficacy|1|||
130029334|NCT01084551|468066564|FG000|Overall Study|Withdrawal by Subject|2|||
130029335|NCT01084551|468066565|FG001|Overall Study|Withdrawal by Subject|1|||
130029336|NCT01084551|468066566|FG002|Overall Study|Withdrawal by Subject|0|||
130029337|NCT01084551|468066564|FG000|Overall Study|Protocol Violation|2|||
130029338|NCT01084551|468066565|FG001|Overall Study|Protocol Violation|4|||
130029339|NCT01084551|468066566|FG002|Overall Study|Protocol Violation|0|||
130029340|NCT01084551|468066564|FG000|Overall Study|Lost to Follow-up|0|||
130029341|NCT01084551|468066565|FG001|Overall Study|Lost to Follow-up|0|||
130029342|NCT01084551|468066566|FG002|Overall Study|Lost to Follow-up|3|||
130029343|NCT01084551|468066564|FG000|Overall Study|Physician Decision|1|||
130029344|NCT01084551|468066565|FG001|Overall Study|Physician Decision|0|||
130029345|NCT01084551|468066566|FG002|Overall Study|Physician Decision|0|||
130029346|NCT00463476|468066569|FG000|Overall Study|Withdrawal by Subject|1|||
130029347|NCT00463476|468066570|FG001|Overall Study|Withdrawal by Subject|2|||
130029348|NCT00463476|468066569|FG000|Overall Study|Lost to Follow-up|1|||
130029349|NCT00463476|468066570|FG001|Overall Study|Lost to Follow-up|1|||
130029350|NCT01169779|468066575|FG000|Overall Study|Adverse Event|3|||
130029351|NCT01169779|468066576|FG001|Overall Study|Adverse Event|11|||
130029352|NCT01169779|468066575|FG000|Overall Study|Lack of Efficacy|1|||
130029353|NCT01169779|468066576|FG001|Overall Study|Lack of Efficacy|0|||
130029354|NCT01169779|468066575|FG000|Overall Study|Protocol Violation|1|||
130029355|NCT01169779|468066576|FG001|Overall Study|Protocol Violation|1|||
130029356|NCT01169779|468066575|FG000|Overall Study|Withdrawal by Subject|3|||
130029357|NCT01169779|468066576|FG001|Overall Study|Withdrawal by Subject|2|||
130029358|NCT01169779|468066575|FG000|Overall Study|Familial and personal reasons|3|||
130029359|NCT01169779|468066576|FG001|Overall Study|Familial and personal reasons|3|||
130029360|NCT01279057|468066578|FG000|Overall Study|Adverse Event|1|||
130029361|NCT01279057|468066579|FG001|Overall Study|Adverse Event|0|||
130029362|NCT01279057|468066580|FG002|Overall Study|Adverse Event|1|||
130029363|NCT01279057|468066578|FG000|Overall Study|Insufficient therapeutic response|0|||
130029364|NCT01279057|468066579|FG001|Overall Study|Insufficient therapeutic response|0|||
130244332|NCT00552058|468855169|FG001|Overall Study|Other: Non Compliance|2|||
130029365|NCT01279057|468066580|FG002|Overall Study|Insufficient therapeutic response|1|||
130029366|NCT01279057|468066578|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
130029367|NCT01279057|468066579|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
130029368|NCT01279057|468066580|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
130029369|NCT01279057|468066578|FG000|Overall Study|Withdrew consent|2|||
130029370|NCT01279057|468066579|FG001|Overall Study|Withdrew consent|0|||
130029371|NCT01279057|468066580|FG002|Overall Study|Withdrew consent|1|||
130029372|NCT01279057|468066578|FG000|Overall Study|Pregnancy|0|||
130029373|NCT01279057|468066579|FG001|Overall Study|Pregnancy|1|||
130029374|NCT01279057|468066580|FG002|Overall Study|Pregnancy|0|||
130029375|NCT01279057|468066578|FG000|Overall Study|Other|3|||
130029376|NCT01279057|468066579|FG001|Overall Study|Other|3|||
130029377|NCT01279057|468066580|FG002|Overall Study|Other|0|||
130029378|NCT01427309|468066582|FG000|Overall Study|Lost to Follow-up|130|||
130029379|NCT01427309|468066583|FG001|Overall Study|Lost to Follow-up|145|||
130029380|NCT01427309|468066584|FG002|Overall Study|Lost to Follow-up|122|||
130029381|NCT01427309|468066585|FG003|Overall Study|Lost to Follow-up|135|||
130029382|NCT01427309|468066582|FG000|Overall Study|Protocol Violation|42|||
130029383|NCT01427309|468066583|FG001|Overall Study|Protocol Violation|69|||
130029384|NCT01427309|468066584|FG002|Overall Study|Protocol Violation|125|||
130029385|NCT01427309|468066585|FG003|Overall Study|Protocol Violation|124|||
130029386|NCT01427309|468066582|FG000|Overall Study|Adverse Event|0|||
130029387|NCT01427309|468066583|FG001|Overall Study|Adverse Event|0|||
130029388|NCT01427309|468066584|FG002|Overall Study|Adverse Event|3|||
130029389|NCT01427309|468066585|FG003|Overall Study|Adverse Event|1|||
130029390|NCT01427309|468066582|FG000|Overall Study|Serious adverse event|52|||
130029391|NCT01427309|468066583|FG001|Overall Study|Serious adverse event|45|||
130029392|NCT01427309|468066584|FG002|Overall Study|Serious adverse event|50|||
130029393|NCT01427309|468066585|FG003|Overall Study|Serious adverse event|61|||
130029394|NCT01427309|468066582|FG000|Overall Study|Withdrawal by Subject|148|||
130029395|NCT01427309|468066583|FG001|Overall Study|Withdrawal by Subject|148|||
130029396|NCT01427309|468066584|FG002|Overall Study|Withdrawal by Subject|61|||
130029397|NCT01427309|468066585|FG003|Overall Study|Withdrawal by Subject|55|||
130029398|NCT03617705|468066588|FG000|Overall Study|Withdrawal by Subject|2|||
130029399|NCT03617705|468066588|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
130029400|NCT03617705|468066588|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
130029401|NCT01061008|468066589|FG000|Overall Study|Badiocephalic fistula failed|3|||
130029402|NCT01061008|468066590|FG001|Overall Study|Badiocephalic fistula failed|2|||
130029403|NCT01061008|468066589|FG000|Overall Study|Death|1|||
130029404|NCT01061008|468066590|FG001|Overall Study|Death|0|||
130029405|NCT01061008|468066589|FG000|Overall Study|Withdrawal by Subject|1|||
130029406|NCT01061008|468066590|FG001|Overall Study|Withdrawal by Subject|3|||
130029407|NCT01061008|468066589|FG000|Overall Study|Unable to exercise following surgery|1|||
130029408|NCT01061008|468066590|FG001|Overall Study|Unable to exercise following surgery|0|||
130029409|NCT01061008|468066589|FG000|Overall Study|Adverse Event|0|||
130029410|NCT01061008|468066590|FG001|Overall Study|Adverse Event|1|||
130029411|NCT02024971|468066591|FG000|Overall Study|Data Not Available|30|||
130029412|NCT02024971|468066591|FG000|Overall Study|Lost to Follow-up|6|||
130029413|NCT01299727|468066595|FG000|Overall Study|Withdrawal by Subject|1|||
130029414|NCT01299727|468066596|FG001|Overall Study|Withdrawal by Subject|0|||
130029415|NCT01299727|468066597|FG002|Overall Study|Withdrawal by Subject|0|||
130029416|NCT01299727|468066595|FG000|Overall Study|Adverse Event|0|||
130029417|NCT01299727|468066596|FG001|Overall Study|Adverse Event|0|||
130029418|NCT01299727|468066597|FG002|Overall Study|Adverse Event|1|||
130029419|NCT01299727|468066595|FG000|Overall Study|Completed the Treatment Period|3|||
130029420|NCT01299727|468066596|FG001|Overall Study|Completed the Treatment Period|4|||
130029421|NCT01299727|468066597|FG002|Overall Study|Completed the Treatment Period|3|||
130029422|NCT00944034|468066602|FG000|Overall Study|Inappropriate enrollment|0|||
130029423|NCT00944034|468066603|FG001|Overall Study|Inappropriate enrollment|1|||
130029424|NCT00944034|468066604|FG002|Overall Study|Inappropriate enrollment|0|||
130029425|NCT00944034|468066605|FG003|Overall Study|Inappropriate enrollment|1|||
130029426|NCT00944034|468066606|FG004|Overall Study|Inappropriate enrollment|2|||
130029427|NCT00944034|468066607|FG005|Overall Study|Inappropriate enrollment|1|||
130029428|NCT00944034|468066608|FG006|Overall Study|Inappropriate enrollment|0|||
130029429|NCT00944034|468066609|FG007|Overall Study|Inappropriate enrollment|0|||
130029430|NCT00944034|468066610|FG008|Overall Study|Inappropriate enrollment|1|||
130029431|NCT00944034|468066611|FG009|Overall Study|Inappropriate enrollment|1|||
130029432|NCT00944034|468066612|FG010|Overall Study|Inappropriate enrollment|0|||
130029433|NCT00944034|468066613|FG011|Overall Study|Inappropriate enrollment|0|||
130029434|NCT00944034|468066602|FG000|Overall Study|Withdrawal by Subject|3|||
130029435|NCT00944034|468066603|FG001|Overall Study|Withdrawal by Subject|2|||
130029436|NCT00944034|468066604|FG002|Overall Study|Withdrawal by Subject|6|||
130029437|NCT00944034|468066605|FG003|Overall Study|Withdrawal by Subject|2|||
130029438|NCT00944034|468066606|FG004|Overall Study|Withdrawal by Subject|5|||
130029439|NCT00944034|468066607|FG005|Overall Study|Withdrawal by Subject|8|||
130029440|NCT00944034|468066608|FG006|Overall Study|Withdrawal by Subject|2|||
130029441|NCT00944034|468066609|FG007|Overall Study|Withdrawal by Subject|2|||
130029442|NCT00944034|468066610|FG008|Overall Study|Withdrawal by Subject|3|||
130029443|NCT00944034|468066611|FG009|Overall Study|Withdrawal by Subject|4|||
130029444|NCT00944034|468066612|FG010|Overall Study|Withdrawal by Subject|0|||
130029445|NCT00944034|468066613|FG011|Overall Study|Withdrawal by Subject|4|||
130029446|NCT00944034|468066602|FG000|Overall Study|Lost to Follow-up|0|||
130029447|NCT00944034|468066603|FG001|Overall Study|Lost to Follow-up|4|||
130029448|NCT00944034|468066604|FG002|Overall Study|Lost to Follow-up|2|||
130029449|NCT00944034|468066605|FG003|Overall Study|Lost to Follow-up|0|||
130029450|NCT00944034|468066606|FG004|Overall Study|Lost to Follow-up|5|||
130029451|NCT00944034|468066607|FG005|Overall Study|Lost to Follow-up|7|||
130029452|NCT00944034|468066608|FG006|Overall Study|Lost to Follow-up|0|||
130029453|NCT00944034|468066609|FG007|Overall Study|Lost to Follow-up|1|||
130029454|NCT00944034|468066610|FG008|Overall Study|Lost to Follow-up|5|||
130029455|NCT00944034|468066611|FG009|Overall Study|Lost to Follow-up|1|||
130029456|NCT00944034|468066612|FG010|Overall Study|Lost to Follow-up|1|||
130029457|NCT00944034|468066613|FG011|Overall Study|Lost to Follow-up|0|||
130029458|NCT00944034|468066602|FG000|Overall Study|Death|0|||
130029459|NCT00944034|468066603|FG001|Overall Study|Death|0|||
130029460|NCT00944034|468066604|FG002|Overall Study|Death|1|||
130029461|NCT00944034|468066605|FG003|Overall Study|Death|0|||
130029462|NCT00944034|468066606|FG004|Overall Study|Death|0|||
130029463|NCT00944034|468066607|FG005|Overall Study|Death|0|||
130029464|NCT00944034|468066608|FG006|Overall Study|Death|0|||
130029465|NCT00944034|468066609|FG007|Overall Study|Death|0|||
130029466|NCT00944034|468066610|FG008|Overall Study|Death|0|||
130029467|NCT00944034|468066611|FG009|Overall Study|Death|0|||
130029468|NCT00944034|468066612|FG010|Overall Study|Death|0|||
130029469|NCT00944034|468066613|FG011|Overall Study|Death|0|||
130029470|NCT00944034|468066602|FG000|Overall Study|Protocol Violation|2|||
130029471|NCT00944034|468066603|FG001|Overall Study|Protocol Violation|0|||
130029472|NCT00944034|468066604|FG002|Overall Study|Protocol Violation|0|||
130029473|NCT00944034|468066605|FG003|Overall Study|Protocol Violation|1|||
130029474|NCT00944034|468066606|FG004|Overall Study|Protocol Violation|2|||
130029475|NCT00944034|468066607|FG005|Overall Study|Protocol Violation|3|||
130029476|NCT00944034|468066608|FG006|Overall Study|Protocol Violation|0|||
130029477|NCT00944034|468066609|FG007|Overall Study|Protocol Violation|1|||
130029478|NCT00944034|468066610|FG008|Overall Study|Protocol Violation|1|||
130029479|NCT00944034|468066611|FG009|Overall Study|Protocol Violation|4|||
130029480|NCT00944034|468066612|FG010|Overall Study|Protocol Violation|0|||
130029481|NCT00944034|468066613|FG011|Overall Study|Protocol Violation|0|||
130029482|NCT00944034|468066602|FG000|Overall Study|Unable to classify|0|||
130029483|NCT00944034|468066603|FG001|Overall Study|Unable to classify|0|||
130029484|NCT00944034|468066604|FG002|Overall Study|Unable to classify|0|||
130029485|NCT00944034|468066605|FG003|Overall Study|Unable to classify|0|||
130029486|NCT00944034|468066606|FG004|Overall Study|Unable to classify|0|||
130029487|NCT00944034|468066607|FG005|Overall Study|Unable to classify|1|||
130029488|NCT00944034|468066608|FG006|Overall Study|Unable to classify|1|||
130029489|NCT00944034|468066609|FG007|Overall Study|Unable to classify|1|||
130029490|NCT00944034|468066610|FG008|Overall Study|Unable to classify|0|||
130029491|NCT00944034|468066611|FG009|Overall Study|Unable to classify|0|||
130029492|NCT00944034|468066612|FG010|Overall Study|Unable to classify|0|||
130029493|NCT00944034|468066613|FG011|Overall Study|Unable to classify|0|||
130029494|NCT00944034|468066602|FG000|Overall Study|Administrative reason|0|||
130029495|NCT00944034|468066603|FG001|Overall Study|Administrative reason|0|||
130029496|NCT00944034|468066604|FG002|Overall Study|Administrative reason|0|||
130029497|NCT00944034|468066605|FG003|Overall Study|Administrative reason|0|||
130029498|NCT00944034|468066606|FG004|Overall Study|Administrative reason|0|||
130029499|NCT00944034|468066607|FG005|Overall Study|Administrative reason|0|||
130029500|NCT00944034|468066608|FG006|Overall Study|Administrative reason|1|||
130029501|NCT00944034|468066609|FG007|Overall Study|Administrative reason|0|||
130029502|NCT00944034|468066610|FG008|Overall Study|Administrative reason|0|||
130029503|NCT00944034|468066611|FG009|Overall Study|Administrative reason|0|||
130029504|NCT00944034|468066612|FG010|Overall Study|Administrative reason|0|||
130029505|NCT00944034|468066613|FG011|Overall Study|Administrative reason|0|||
130029506|NCT00531960|468066616|FG000|Overall Study|Adverse Event|5|||
130029507|NCT00531960|468066617|FG001|Overall Study|Adverse Event|4|||
130029508|NCT00531960|468066616|FG000|Overall Study|Death|3|||
130029509|NCT00531960|468066617|FG001|Overall Study|Death|2|||
130029510|NCT00531960|468066616|FG000|Overall Study|Lack of Efficacy|42|||
130029511|NCT00531960|468066617|FG001|Overall Study|Lack of Efficacy|41|||
130029512|NCT00531960|468066616|FG000|Overall Study|Violation of Selection Criteria|2|||
130029513|NCT00531960|468066617|FG001|Overall Study|Violation of Selection Criteria|0|||
130029514|NCT00531960|468066616|FG000|Overall Study|Refused Treatment|5|||
130029515|NCT00531960|468066617|FG001|Overall Study|Refused Treatment|6|||
130029516|NCT00531960|468066616|FG000|Overall Study|Other|4|||
130029517|NCT00531960|468066617|FG001|Overall Study|Other|10|||
130029518|NCT01500057|468066618|FG000|Overall Study|Lost to Follow-up|6|||
130029519|NCT01500057|468066619|FG001|Overall Study|Lost to Follow-up|4|||
130029520|NCT00330187|468066626|FG000|Overall Study|Lost to Follow-up|12|||
130029521|NCT00330187|468066627|FG001|Overall Study|Lost to Follow-up|13|||
130029522|NCT00330187|468066628|FG002|Overall Study|Lost to Follow-up|14|||
130029523|NCT00330187|468066629|FG003|Overall Study|Lost to Follow-up|10|||
130029524|NCT00330187|468066626|FG000|Overall Study|Withdrawal by Subject|8|||
130029525|NCT00330187|468066627|FG001|Overall Study|Withdrawal by Subject|5|||
130029526|NCT00330187|468066628|FG002|Overall Study|Withdrawal by Subject|4|||
130029527|NCT00330187|468066629|FG003|Overall Study|Withdrawal by Subject|4|||
130029528|NCT03258814|468066630|FG000|Overall Study|Early Termination|4|||
130029529|NCT03258814|468066631|FG001|Overall Study|Early Termination|3|||
130029530|NCT03258814|468066632|FG002|Overall Study|Early Termination|10|||
130029531|NCT01413958|468066633|FG000|Overall Study|Lost to Follow-up|0|||
130029532|NCT01413958|468066634|FG001|Overall Study|Lost to Follow-up|1|||
130029533|NCT01900002|468066635|FG000|Overall Study|Withdrawal by Subject|2|||
130029534|NCT01900002|468066635|FG000|Overall Study|ineligible for Y-90|4|||
130029535|NCT01573910|468066642|FG000|Overall Study|Adverse Event|4|||
130029536|NCT01573910|468066643|FG001|Overall Study|Adverse Event|4|||
130029537|NCT01573910|468066642|FG000|Overall Study|Lost to Follow-up|2|||
130029538|NCT01573910|468066643|FG001|Overall Study|Lost to Follow-up|1|||
130029539|NCT01573910|468066642|FG000|Overall Study|Withdrawal by Subject|0|||
130029540|NCT01573910|468066643|FG001|Overall Study|Withdrawal by Subject|1|||
130029541|NCT01573910|468066642|FG000|Overall Study|Protocol Violation|3|||
130029542|NCT01573910|468066643|FG001|Overall Study|Protocol Violation|0|||
130029543|NCT01573910|468066642|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
130029544|NCT01573910|468066643|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
130029545|NCT02601573|468066650|FG000|Overall Study|Lost to Follow-up|0|||
130029546|NCT02601573|468066651|FG001|Overall Study|Lost to Follow-up|3|||
130029547|NCT02601573|468066652|FG002|Overall Study|Lost to Follow-up|1|||
130029548|NCT02601573|468066653|FG003|Overall Study|Lost to Follow-up|0|||
130029549|NCT02601573|468066654|FG004|Overall Study|Lost to Follow-up|2|||
130029550|NCT02601573|468066650|FG000|Overall Study|Withdrawal by Subject|0|||
130029551|NCT02601573|468066651|FG001|Overall Study|Withdrawal by Subject|1|||
130029552|NCT02601573|468066652|FG002|Overall Study|Withdrawal by Subject|0|||
130029553|NCT02601573|468066653|FG003|Overall Study|Withdrawal by Subject|1|||
130029554|NCT02601573|468066654|FG004|Overall Study|Withdrawal by Subject|0|||
130029555|NCT00974220|468066655|FG000|Treatment Period 1|Adverse Event|2|||
130029556|NCT00974220|468066656|FG001|Treatment Period 1|Adverse Event|1|||
130029557|NCT00974220|468066655|FG000|Treatment Period 1|noncompliant subjects|0|||
130029558|NCT00974220|468066656|FG001|Treatment Period 1|noncompliant subjects|1|||
130029559|NCT01763164|468066657|FG000|Treatment Phase|Participant/Guardian decision|26|||
130029560|NCT01763164|468066658|FG001|Treatment Phase|Participant/Guardian decision|14|||
130029561|NCT01763164|468066657|FG000|Treatment Phase|Protocol Violation|1|||
130029562|NCT01763164|468066658|FG001|Treatment Phase|Protocol Violation|1|||
130029563|NCT01763164|468066657|FG000|Treatment Phase|Progressive Disease|142|||
130029564|NCT01763164|468066658|FG001|Treatment Phase|Progressive Disease|76|||
130029565|NCT01763164|468066657|FG000|Treatment Phase|Physician Decision|24|||
130029566|NCT01763164|468066658|FG001|Treatment Phase|Physician Decision|13|||
130029567|NCT01763164|468066657|FG000|Treatment Phase|Death|10|||
130029568|NCT01763164|468066658|FG001|Treatment Phase|Death|1|||
130029569|NCT01763164|468066657|FG000|Treatment Phase|Adverse Event|66|||
130029570|NCT01763164|468066658|FG001|Treatment Phase|Adverse Event|8|||
130029571|NCT01763164|468066657|FG000|Treatment Phase|Randomized but not Treated|0|||
130029572|NCT01763164|468066658|FG001|Treatment Phase|Randomized but not Treated|19|||
130029573|NCT01763164|468066657|FG000|Treatment Phase|Other|0|||
130029574|NCT01763164|468066658|FG001|Treatment Phase|Other|1|||
130029575|NCT01763164|468066657|FG000|Follow up Phase|New therapy for study indication|12|||
130029576|NCT01763164|468066658|FG001|Follow up Phase|New therapy for study indication|3|||
130029577|NCT01763164|468066657|FG000|Follow up Phase|Death|21|||
130029578|NCT01763164|468066658|FG001|Follow up Phase|Death|4|||
130029579|NCT01763164|468066657|FG000|Follow up Phase|Subject/guardian decision|9|||
130029580|NCT01763164|468066658|FG001|Follow up Phase|Subject/guardian decision|2|||
130029581|NCT01763164|468066657|FG000|Follow up Phase|Progressive disease|127|||
130029582|NCT01763164|468066658|FG001|Follow up Phase|Progressive disease|62|||
130029583|NCT01763164|468066657|FG000|Follow up Phase|Physician Decision|10|||
130029584|NCT01763164|468066658|FG001|Follow up Phase|Physician Decision|3|||
130029585|NCT01763164|468066657|FG000|Follow up Phase|Lost to Follow-up|1|||
130029586|NCT01763164|468066658|FG001|Follow up Phase|Lost to Follow-up|0|||
130029587|NCT01763164|468066657|FG000|Follow up Phase|Adverse Event|17|||
130029588|NCT01763164|468066658|FG001|Follow up Phase|Adverse Event|1|||
130029589|NCT01273064|468066661|FG000|Overall Study|Adverse Event|5|||
130029590|NCT01273064|468066662|FG001|Overall Study|Adverse Event|1|||
130029591|NCT01273064|468066663|FG002|Overall Study|Adverse Event|3|||
130029592|NCT01273064|468066664|FG003|Overall Study|Adverse Event|2|||
130029593|NCT01273064|468066665|FG004|Overall Study|Adverse Event|1|||
130029594|NCT01273064|468066661|FG000|Overall Study|Withdrawal by Subject|4|||
130029595|NCT01273064|468066662|FG001|Overall Study|Withdrawal by Subject|2|||
130029596|NCT01273064|468066663|FG002|Overall Study|Withdrawal by Subject|2|||
130029597|NCT01273064|468066664|FG003|Overall Study|Withdrawal by Subject|2|||
130029598|NCT01273064|468066665|FG004|Overall Study|Withdrawal by Subject|0|||
130029599|NCT01273064|468066661|FG000|Overall Study|Study Termination|13|||
130029600|NCT01273064|468066662|FG001|Overall Study|Study Termination|27|||
130029601|NCT01273064|468066663|FG002|Overall Study|Study Termination|26|||
130100546|NCT00471237|468325991|FG006|Overall Study|Participant's decision|0|||
130100547|NCT00578448|468325992|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
130100548|NCT00578448|468325992|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
130100549|NCT00578448|468325992|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
130100550|NCT00578448|468325992|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
130100551|NCT01976104|468325993|FG000|Overall Study|Adverse Event|0|||
130100552|NCT01976104|468325994|FG001|Overall Study|Adverse Event|0|||
130100553|NCT01976104|468325995|FG002|Overall Study|Adverse Event|1|||
130100554|NCT01976104|468325996|FG003|Overall Study|Adverse Event|0|||
130100555|NCT01976104|468325993|FG000|Overall Study|Lost to Follow-up|3|||
130100556|NCT01976104|468325994|FG001|Overall Study|Lost to Follow-up|0|||
130100557|NCT01976104|468325995|FG002|Overall Study|Lost to Follow-up|1|||
130100558|NCT01976104|468325996|FG003|Overall Study|Lost to Follow-up|1|||
130100559|NCT01976104|468325993|FG000|Overall Study|Subject Choice|0|||
130100560|NCT01976104|468325994|FG001|Overall Study|Subject Choice|1|||
130100561|NCT01976104|468325995|FG002|Overall Study|Subject Choice|0|||
130100562|NCT01976104|468325996|FG003|Overall Study|Subject Choice|1|||
130100563|NCT01976104|468325993|FG000|Overall Study|Withdrawal by Subject|3|||
130100564|NCT01976104|468325994|FG001|Overall Study|Withdrawal by Subject|0|||
130100565|NCT01976104|468325995|FG002|Overall Study|Withdrawal by Subject|0|||
130100566|NCT01976104|468325996|FG003|Overall Study|Withdrawal by Subject|1|||
130100567|NCT01976104|468325993|FG000|Overall Study|Other|0|||
130100568|NCT01976104|468325994|FG001|Overall Study|Other|1|||
130100569|NCT01976104|468325995|FG002|Overall Study|Other|0|||
130029602|NCT01273064|468066664|FG003|Overall Study|Study Termination|16|||
130029603|NCT01273064|468066665|FG004|Overall Study|Study Termination|8|||
130029604|NCT01273064|468066661|FG000|Overall Study|Lost to Follow-up|1|||
130029605|NCT01273064|468066662|FG001|Overall Study|Lost to Follow-up|0|||
130029606|NCT01273064|468066663|FG002|Overall Study|Lost to Follow-up|0|||
130029607|NCT01273064|468066664|FG003|Overall Study|Lost to Follow-up|0|||
130029608|NCT01273064|468066665|FG004|Overall Study|Lost to Follow-up|0|||
130029609|NCT01273064|468066661|FG000|Overall Study|Physician Decision|0|||
130029610|NCT01273064|468066662|FG001|Overall Study|Physician Decision|0|||
130029611|NCT01273064|468066663|FG002|Overall Study|Physician Decision|0|||
130029612|NCT01273064|468066664|FG003|Overall Study|Physician Decision|0|||
130029613|NCT01273064|468066665|FG004|Overall Study|Physician Decision|1|||
130029614|NCT00291551|468066666|FG000|Overall Study|Death|7|||
130029615|NCT00291551|468066666|FG000|Overall Study|Withdrawal by Subject|6|||
130029616|NCT02658812|468066667|FG000|Overall Study|Disease Progression|7|||
130029617|NCT02658812|468066667|FG000|Overall Study|Unrelated to study treatment|1|||
130029618|NCT02658812|468066667|FG000|Overall Study|Adverse Event|1|||
130029619|NCT01512264|468066668|FG000|Overall Study|Lost to Follow-up|0|||
130029620|NCT01512264|468066669|FG001|Overall Study|Lost to Follow-up|0|||
130029621|NCT01512264|468066670|FG002|Overall Study|Lost to Follow-up|0|||
130029622|NCT01512264|468066671|FG003|Overall Study|Lost to Follow-up|1|||
130029623|NCT02411747|468066672|FG000|Overall Study|Withdrawal by Subject|1|||
130029624|NCT02411747|468066673|FG001|Overall Study|Withdrawal by Subject|0|||
130029625|NCT02411747|468066672|FG000|Overall Study|Protocol Violation|2|||
130029626|NCT02411747|468066673|FG001|Overall Study|Protocol Violation|4|||
130029627|NCT00996203|468066674|FG000|Overall Study|Adverse Event|3|||
130029628|NCT00996203|468066674|FG000|Overall Study|Lost to Follow-up|1|||
130029629|NCT00996203|468066674|FG000|Overall Study|Lack of Efficacy|1|||
130029630|NCT00996203|468066674|FG000|Overall Study|Protocol Violation|2|||
130029631|NCT03686969|468066676|FG000|Overall Study|Study terminated|1|||
130029632|NCT03686969|468066677|FG001|Overall Study|Study terminated|0|||
130029633|NCT00848120|468066678|FG000|Overall Study|Adverse Event|1|||
130029634|NCT00560755|468066679|FG000|Overall Study|Protocol Violation|15|||
130029635|NCT00560755|468066679|FG000|Overall Study|Withdrawal by Subject|26|||
130029636|NCT00560755|468066679|FG000|Overall Study|Lost to Follow-up|9|||
130029637|NCT00560755|468066679|FG000|Overall Study|Adverse Event|8|||
130029638|NCT00560755|468066679|FG000|Overall Study|Physician Decision|2|||
130029639|NCT04574999|468068437|FG000|Overall Study|Adverse Event|1|||
130029640|NCT04574999|468068438|FG001|Overall Study|Adverse Event|0|||
130029641|NCT04574999|468068437|FG000|Overall Study|Lack of Efficacy|2|||
130029642|NCT04574999|468068438|FG001|Overall Study|Lack of Efficacy|3|||
130029643|NCT04574999|468068437|FG000|Overall Study|Protocol Violation|1|||
130029644|NCT04574999|468068438|FG001|Overall Study|Protocol Violation|0|||
130029645|NCT04574999|468068437|FG000|Overall Study|Withdrawal by Subject|2|||
130029646|NCT04574999|468068438|FG001|Overall Study|Withdrawal by Subject|2|||
130029647|NCT04574999|468068437|FG000|Overall Study|Lost to Follow-up|1|||
130029648|NCT04574999|468068438|FG001|Overall Study|Lost to Follow-up|0|||
130029649|NCT04574999|468068437|FG000|Overall Study|Personal problems|1|||
130029650|NCT04574999|468068438|FG001|Overall Study|Personal problems|0|||
130029651|NCT04574999|468068437|FG000|Overall Study|Previous planned surgery|1|||
130029652|NCT04574999|468068438|FG001|Overall Study|Previous planned surgery|0|||
130029653|NCT00008385|468068441|FG000|Overall Study|Off treatment reasons not reported|79|||
130029654|NCT00008385|468068442|FG001|Overall Study|Off treatment reasons not reported|70|||
130029655|NCT00008385|468068441|FG000|Overall Study|Progressive disease|52|||
130029656|NCT00008385|468068442|FG001|Overall Study|Progressive disease|117|||
130029657|NCT00008385|468068441|FG000|Overall Study|Adverse Event|8|||
130029658|NCT00008385|468068442|FG001|Overall Study|Adverse Event|20|||
130029659|NCT00008385|468068441|FG000|Overall Study|Death|12|||
130029660|NCT00008385|468068442|FG001|Overall Study|Death|18|||
130029661|NCT00008385|468068441|FG000|Overall Study|Withdrawal by Subject|67|||
130029662|NCT00008385|468068442|FG001|Overall Study|Withdrawal by Subject|157|||
130029663|NCT00008385|468068441|FG000|Overall Study|Start non-protocol therapy|3|||
130029664|NCT00008385|468068442|FG001|Overall Study|Start non-protocol therapy|1|||
130029665|NCT00008385|468068441|FG000|Overall Study|Other complicating disease|17|||
130029666|NCT00008385|468068442|FG001|Overall Study|Other complicating disease|30|||
130029667|NCT00008385|468068441|FG000|Overall Study|Maximum dose reached|0|||
130029668|NCT00008385|468068442|FG001|Overall Study|Maximum dose reached|2|||
130029669|NCT00008385|468068441|FG000|Overall Study|Other|105|||
130029670|NCT00008385|468068442|FG001|Overall Study|Other|212|||
130029671|NCT00008385|468068441|FG000|Overall Study|Not start protocol therapy|44|||
130029672|NCT00008385|468068442|FG001|Overall Study|Not start protocol therapy|175|||
130029673|NCT00582556|468068443|FG000|Overall Study|Withdrawal by Subject|0|||
130029674|NCT00582556|468068444|FG001|Overall Study|Withdrawal by Subject|1|||
130029675|NCT00582556|468068445|FG002|Overall Study|Withdrawal by Subject|1|||
130100570|NCT01976104|468325996|FG003|Overall Study|Other|0|||
130029676|NCT00582556|468068443|FG000|Overall Study|Physician Decision|0|||
130100571|NCT01317199|468325997|FG000|Dose-escalation Phase 1|Physician Decision|5|||
130029677|NCT00582556|468068444|FG001|Overall Study|Physician Decision|0|||
130029678|NCT00582556|468068445|FG002|Overall Study|Physician Decision|1|||
130029679|NCT01993888|468068448|FG000|Overall Study|Death|1|||
130029680|NCT01993888|468068449|FG001|Overall Study|Death|1|||
130029681|NCT01993888|468068448|FG000|Overall Study|Lost to Follow-up|1|||
130029682|NCT01993888|468068449|FG001|Overall Study|Lost to Follow-up|1|||
130029683|NCT01993888|468068448|FG000|Overall Study|Withdrawal by Subject|0|||
130029684|NCT01993888|468068449|FG001|Overall Study|Withdrawal by Subject|1|||
130029685|NCT00832819|468068450|FG000|Overall Study|Adverse Event|0|||
130029686|NCT00832819|468068451|FG001|Overall Study|Adverse Event|1|||
130029687|NCT00832819|468068452|FG002|Overall Study|Adverse Event|0|||
130029688|NCT00832819|468068450|FG000|Overall Study|Protocol Violation|0|||
130029689|NCT00832819|468068451|FG001|Overall Study|Protocol Violation|0|||
130029690|NCT00832819|468068452|FG002|Overall Study|Protocol Violation|1|||
130029691|NCT00317044|468068453|FG000|Overall Study|Protocol Violation|28|||
130029692|NCT00317044|468068454|FG001|Overall Study|Protocol Violation|22|||
130029693|NCT00317044|468068455|FG002|Overall Study|Protocol Violation|20|||
130029694|NCT00317044|468068453|FG000|Overall Study|Adverse Event|4|||
130029695|NCT00317044|468068454|FG001|Overall Study|Adverse Event|7|||
130029696|NCT00317044|468068455|FG002|Overall Study|Adverse Event|4|||
130029697|NCT00317044|468068453|FG000|Overall Study|Withdrawal by Subject|10|||
130029698|NCT00317044|468068454|FG001|Overall Study|Withdrawal by Subject|7|||
130029699|NCT00317044|468068455|FG002|Overall Study|Withdrawal by Subject|12|||
130029700|NCT00317044|468068453|FG000|Overall Study|Lost to Follow-up|0|||
130029701|NCT00317044|468068454|FG001|Overall Study|Lost to Follow-up|2|||
130029702|NCT00317044|468068455|FG002|Overall Study|Lost to Follow-up|3|||
130029703|NCT00317044|468068453|FG000|Overall Study|Multiple Reasons|6|||
130029704|NCT00317044|468068454|FG001|Overall Study|Multiple Reasons|2|||
130029705|NCT00317044|468068455|FG002|Overall Study|Multiple Reasons|6|||
130029706|NCT05742984|468068456|FG000|Overall Study|Adverse Event|0|||
130029707|NCT05742984|468068457|FG001|Overall Study|Adverse Event|0|||
130029708|NCT05742984|468068458|FG002|Overall Study|Adverse Event|1|||
130029709|NCT05742984|468068459|FG003|Overall Study|Adverse Event|0|||
130029710|NCT05742984|468068460|FG004|Overall Study|Adverse Event|1|||
130029711|NCT05742984|468068461|FG005|Overall Study|Adverse Event|1|||
130029712|NCT05742984|468068456|FG000|Overall Study|Withdrawal by Subject|0|||
130029713|NCT05742984|468068457|FG001|Overall Study|Withdrawal by Subject|1|||
130029714|NCT05742984|468068458|FG002|Overall Study|Withdrawal by Subject|0|||
130029715|NCT05742984|468068459|FG003|Overall Study|Withdrawal by Subject|0|||
130029716|NCT05742984|468068460|FG004|Overall Study|Withdrawal by Subject|0|||
130029717|NCT05742984|468068461|FG005|Overall Study|Withdrawal by Subject|2|||
130029718|NCT00379340|468068462|FG000|Overall Study|Death|0|||
130029719|NCT00379340|468068463|FG001|Overall Study|Death|0|||
130029720|NCT00379340|468068464|FG002|Overall Study|Death|0|||
130029721|NCT00379340|468068465|FG003|Overall Study|Death|2|||
130029722|NCT00379340|468068466|FG004|Overall Study|Death|0|||
130029723|NCT00379340|468068462|FG000|Overall Study|Lack of Efficacy|6|||
130029724|NCT00379340|468068463|FG001|Overall Study|Lack of Efficacy|1|||
130029725|NCT00379340|468068464|FG002|Overall Study|Lack of Efficacy|0|||
130029726|NCT00379340|468068465|FG003|Overall Study|Lack of Efficacy|4|||
130029727|NCT00379340|468068466|FG004|Overall Study|Lack of Efficacy|3|||
130029728|NCT00379340|468068462|FG000|Overall Study|Physician Decision|6|||
130029729|NCT00379340|468068463|FG001|Overall Study|Physician Decision|2|||
130029730|NCT00379340|468068464|FG002|Overall Study|Physician Decision|1|||
130029731|NCT00379340|468068465|FG003|Overall Study|Physician Decision|2|||
130029732|NCT00379340|468068466|FG004|Overall Study|Physician Decision|3|||
130029733|NCT00379340|468068462|FG000|Overall Study|Withdrawal by Subject|0|||
130029734|NCT00379340|468068463|FG001|Overall Study|Withdrawal by Subject|0|||
130029735|NCT00379340|468068464|FG002|Overall Study|Withdrawal by Subject|0|||
130029736|NCT00379340|468068465|FG003|Overall Study|Withdrawal by Subject|1|||
130029737|NCT00379340|468068466|FG004|Overall Study|Withdrawal by Subject|0|||
130029738|NCT00379340|468068462|FG000|Overall Study|Refusal of further protocol therapy|1|||
130029739|NCT00379340|468068463|FG001|Overall Study|Refusal of further protocol therapy|0|||
130029740|NCT00379340|468068464|FG002|Overall Study|Refusal of further protocol therapy|1|||
130029741|NCT00379340|468068465|FG003|Overall Study|Refusal of further protocol therapy|1|||
130029742|NCT00379340|468068466|FG004|Overall Study|Refusal of further protocol therapy|7|||
130029743|NCT00379340|468068462|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
130029744|NCT00379340|468068463|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
130029745|NCT00379340|468068464|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
130029746|NCT00379340|468068465|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
130029747|NCT00379340|468068466|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
130029748|NCT00379340|468068462|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
130029749|NCT00379340|468068463|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
130029750|NCT00379340|468068464|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
130029751|NCT00379340|468068465|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
130029752|NCT00379340|468068466|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
130029753|NCT02162862|468068470|FG000|Overall Study|Lost to Follow-up|0|||
130029754|NCT02162862|468068471|FG001|Overall Study|Lost to Follow-up|11|||
130029755|NCT02162862|468068472|FG002|Overall Study|Lost to Follow-up|0|||
130029756|NCT02162862|468068470|FG000|Overall Study|Subject did not feel the med was needed|0|||
130029757|NCT02162862|468068471|FG001|Overall Study|Subject did not feel the med was needed|0|||
130029758|NCT02162862|468068472|FG002|Overall Study|Subject did not feel the med was needed|4|||
130029759|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
130029760|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
130029761|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
130029762|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
130029763|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
130029764|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
130244333|NCT00552058|468855168|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
130244334|NCT00552058|468855169|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
130244335|NCT00552058|468855168|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
130244336|NCT00552058|468855169|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
130244337|NCT00552058|468855168|FG000|Overall Study|Other: Positive Stool Result|0|||
130244338|NCT00552058|468855169|FG001|Overall Study|Other: Positive Stool Result|1|||
130244339|NCT00552058|468855168|FG000|Overall Study|Other: Randomized in error|0|||
130244340|NCT00552058|468855169|FG001|Overall Study|Other: Randomized in error|1|||
130244341|NCT00552058|468855168|FG000|Overall Study|Other: Sponsors Decision|0|||
130244342|NCT00552058|468855169|FG001|Overall Study|Other: Sponsors Decision|1|||
130244343|NCT00552058|468855168|FG000|Overall Study|Other: Early Roll Over|1|||
130244344|NCT00552058|468855169|FG001|Overall Study|Other: Early Roll Over|0|||
130029765|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
130029766|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
130029767|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
130029768|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
130029769|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
130029770|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
130029771|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
130029772|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
130029773|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
130029774|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
130029775|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
130029776|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
130029777|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
130029778|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
130029779|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
130029780|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
130029781|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
130029782|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
130029783|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
130029784|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
130029785|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
130244345|NCT03422718|468855172|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
130244346|NCT03422718|468855173|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
130244347|NCT03422718|468855174|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
130244348|NCT03422718|468855175|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
130244349|NCT03422718|468855176|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
130244350|NCT03422718|468855177|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
130244351|NCT03422718|468855178|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
130244352|NCT03422718|468855179|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
130244353|NCT03422718|468855172|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
130244354|NCT03422718|468855173|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
130244355|NCT03422718|468855174|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
130244356|NCT03422718|468855175|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
130029786|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
130029787|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130029788|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
130029789|NCT00849017|468068475|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
130029790|NCT00849017|468068476|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
130029791|NCT00849017|468068477|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
130029792|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
130029793|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130029794|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
130029795|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130029796|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
130029797|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
130029798|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
130029799|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
130029800|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
130029801|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
130029802|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
130029803|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
130029804|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
130029805|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130029806|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130029807|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
130029808|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
130029809|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
130029810|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
130029811|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
130029812|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
130029813|NCT00849017|468068475|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
130029814|NCT00849017|468068476|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
130029815|NCT00849017|468068477|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
130029816|NCT00553462|468068483|FG000|Overall Study|Adverse Event|4|||
130029817|NCT00553462|468068483|FG000|Overall Study|Progression|4|||
130029818|NCT00553462|468068483|FG000|Overall Study|Withdrawal by Subject|5|||
130029819|NCT00553462|468068483|FG000|Overall Study|Physician Decision|1|||
130029820|NCT01869348|468068485|FG000|Overall Study|Withdrawal by Subject|1|||
130029821|NCT01869348|468068486|FG001|Overall Study|Withdrawal by Subject|1|||
130029822|NCT03075163|468068487|FG000|Overall Study|not eligible for treatment limb|138|||
130029823|NCT03075163|468068488|FG001|Overall Study|not eligible for treatment limb|138|||
130029824|NCT00110994|468068489|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
130029825|NCT00110994|468068490|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
130029826|NCT00110994|468068489|FG000|Double-blind (DB) Treatment|Death|1|||
130029827|NCT00110994|468068490|FG001|Double-blind (DB) Treatment|Death|0|||
130029828|NCT00110994|468068489|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
130029829|NCT00110994|468068490|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
130029830|NCT00110994|468068489|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
130029831|NCT00110994|468068490|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
130029832|NCT00110994|468068489|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
130029833|NCT00110994|468068490|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
130029834|NCT00110994|468068489|FG000|Double-blind (DB) Treatment|other reasons|2|||
130029835|NCT00110994|468068490|FG001|Double-blind (DB) Treatment|other reasons|3|||
130029836|NCT00110994|468068489|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
130029837|NCT00110994|468068490|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
130029838|NCT00110994|468068489|FG000|Active Follow-up|Other reasons|0|||
130029839|NCT00110994|468068490|FG001|Active Follow-up|Other reasons|2|||
130029840|NCT00110994|468068489|FG000|Long Term Follow-up|Death|19|||
130100572|NCT01317199|468325998|FG001|Dose-escalation Phase 1|Physician Decision|0|||
130244357|NCT03422718|468855176|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
130029841|NCT00110994|468068490|FG001|Long Term Follow-up|Death|17|||
130029842|NCT01570244|468068493|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
130029843|NCT04134494|468068498|FG000|Overall Study|Lost to Follow-up|2|||
130029844|NCT00781365|468068499|FG000|Overall Study|Withdrawal by Subject|13|||
130029845|NCT00781365|468068500|FG001|Overall Study|Withdrawal by Subject|8|||
130029846|NCT00781365|468068499|FG000|Overall Study|Did Not Attend Visit|20|||
130029847|NCT00781365|468068500|FG001|Overall Study|Did Not Attend Visit|28|||
130029848|NCT00781365|468068499|FG000|Overall Study|Language barrier|1|||
130029849|NCT00781365|468068500|FG001|Overall Study|Language barrier|0|||
130029850|NCT01879410|468068501|FG000|Overall Study|Adverse Event|9|||
130029851|NCT01879410|468068502|FG001|Overall Study|Adverse Event|14|||
130029852|NCT01879410|468068501|FG000|Overall Study|Lack of Efficacy|4|||
130029853|NCT01879410|468068502|FG001|Overall Study|Lack of Efficacy|6|||
130029854|NCT01879410|468068501|FG000|Overall Study|Protocol Violation|1|||
130029855|NCT01879410|468068502|FG001|Overall Study|Protocol Violation|7|||
130029856|NCT01879410|468068501|FG000|Overall Study|Lost to Follow-up|2|||
130029857|NCT01879410|468068502|FG001|Overall Study|Lost to Follow-up|1|||
130029858|NCT01879410|468068501|FG000|Overall Study|Withdrawal by Subject|7|||
130029859|NCT01879410|468068502|FG001|Overall Study|Withdrawal by Subject|8|||
130029860|NCT01879410|468068501|FG000|Overall Study|Randomised in Error|1|||
130029861|NCT01879410|468068502|FG001|Overall Study|Randomised in Error|2|||
130029862|NCT01756456|468068510|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
130029863|NCT01756456|468068511|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
130029864|NCT01756456|468068512|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
130029865|NCT01756456|468068513|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
130029866|NCT01756456|468068514|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
130029867|NCT01756456|468068515|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
130029868|NCT01756456|468068510|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130029869|NCT01756456|468068511|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130029870|NCT01756456|468068512|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130029871|NCT01756456|468068513|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
130029872|NCT01756456|468068514|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
130029873|NCT01756456|468068515|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
130029874|NCT01756456|468068510|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130029875|NCT01756456|468068511|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
130029876|NCT01756456|468068512|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130029877|NCT01756456|468068513|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130029878|NCT01756456|468068514|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130029879|NCT01756456|468068515|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
130029880|NCT01756456|468068510|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
130029881|NCT01756456|468068511|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
130029882|NCT01756456|468068512|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
130029883|NCT01756456|468068513|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
130029884|NCT01756456|468068514|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
130029885|NCT01756456|468068515|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
130029886|NCT01756456|468068510|FG000|Treatment Period: Phase I/II|Other causes|0|||
130029887|NCT01756456|468068511|FG001|Treatment Period: Phase I/II|Other causes|0|||
130029888|NCT01756456|468068512|FG002|Treatment Period: Phase I/II|Other causes|0|||
130029889|NCT01756456|468068513|FG003|Treatment Period: Phase I/II|Other causes|1|||
130029890|NCT01756456|468068514|FG004|Treatment Period: Phase I/II|Other causes|2|||
130029891|NCT01756456|468068515|FG005|Treatment Period: Phase I/II|Other causes|2|||
130029892|NCT01756456|468068510|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
130029893|NCT01756456|468068511|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
130029894|NCT01756456|468068512|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
130029895|NCT01756456|468068513|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
130029896|NCT01756456|468068514|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
130029897|NCT01756456|468068515|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
130029898|NCT01756456|468068510|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130029899|NCT01756456|468068511|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
130029900|NCT01756456|468068512|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130029901|NCT01756456|468068513|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130029902|NCT01756456|468068514|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130029903|NCT01756456|468068515|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
130029904|NCT01756456|468068510|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130029905|NCT01756456|468068511|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130029906|NCT01756456|468068512|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130029907|NCT01756456|468068513|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130029908|NCT01756456|468068514|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
130029909|NCT01756456|468068515|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
130029910|NCT01756456|468068510|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
130029911|NCT01756456|468068511|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
130029912|NCT01756456|468068512|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
130029913|NCT01756456|468068513|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
130029914|NCT01756456|468068514|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
130029915|NCT01756456|468068515|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
130029916|NCT01756456|468068510|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
130029917|NCT01756456|468068511|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
130029918|NCT01756456|468068512|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
130029919|NCT01756456|468068513|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
130029920|NCT01756456|468068514|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
130029921|NCT01756456|468068515|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
130029922|NCT01756456|468068510|FG000|Follow Up Period Phase I/II|Other causes|0|||
130029923|NCT01756456|468068511|FG001|Follow Up Period Phase I/II|Other causes|0|||
130029924|NCT01756456|468068512|FG002|Follow Up Period Phase I/II|Other causes|0|||
130029925|NCT01756456|468068513|FG003|Follow Up Period Phase I/II|Other causes|1|||
130029926|NCT01756456|468068514|FG004|Follow Up Period Phase I/II|Other causes|3|||
130029927|NCT01756456|468068515|FG005|Follow Up Period Phase I/II|Other causes|5|||
130029928|NCT04525703|468068518|FG000|Overall Study|Lost to Follow-up|6|||
130029929|NCT04525703|468068519|FG001|Overall Study|Lost to Follow-up|15|||
130029930|NCT04525703|468068520|FG002|Overall Study|Lost to Follow-up|8|||
130029931|NCT01375764|468068522|FG000|Overall Study|Lost to Follow-up|0|||
130029932|NCT01375764|468068523|FG001|Overall Study|Lost to Follow-up|1|||
130029933|NCT01375764|468068524|FG002|Overall Study|Lost to Follow-up|0|||
130029934|NCT01375764|468068525|FG003|Overall Study|Lost to Follow-up|0|||
130029935|NCT01375764|468068526|FG004|Overall Study|Lost to Follow-up|0|||
130029936|NCT01375764|468068522|FG000|Overall Study|Withdrawal by Subject|2|||
130029937|NCT01375764|468068523|FG001|Overall Study|Withdrawal by Subject|0|||
130029938|NCT01375764|468068524|FG002|Overall Study|Withdrawal by Subject|0|||
130029939|NCT01375764|468068525|FG003|Overall Study|Withdrawal by Subject|0|||
130029940|NCT01375764|468068526|FG004|Overall Study|Withdrawal by Subject|1|||
130029941|NCT01375764|468068522|FG000|Overall Study|Other|0|||
130029942|NCT01375764|468068523|FG001|Overall Study|Other|0|||
130029943|NCT01375764|468068524|FG002|Overall Study|Other|0|||
130029944|NCT01375764|468068525|FG003|Overall Study|Other|1|||
130029945|NCT01375764|468068526|FG004|Overall Study|Other|0|||
130029946|NCT03595280|468068527|FG000|Overall Study|Lost to Follow-up|6|||
130029947|NCT03595280|468068528|FG001|Overall Study|Lost to Follow-up|9|||
130029948|NCT03595280|468068529|FG002|Overall Study|Lost to Follow-up|15|||
130029949|NCT00854828|468068530|FG000|Overall Study|Death|1|||
130029950|NCT00854828|468068531|FG001|Overall Study|Death|0|||
130029951|NCT00854828|468068532|FG002|Overall Study|Death|0|||
130029952|NCT00854828|468068533|FG003|Overall Study|Death|0|||
130029953|NCT00854828|468068530|FG000|Overall Study|Withdrawal by Subject|1|||
130029954|NCT00854828|468068531|FG001|Overall Study|Withdrawal by Subject|1|||
130029955|NCT00854828|468068532|FG002|Overall Study|Withdrawal by Subject|0|||
130029956|NCT00854828|468068533|FG003|Overall Study|Withdrawal by Subject|9|||
130029957|NCT00854828|468068530|FG000|Overall Study|Missed 24mo visit|1|||
130029958|NCT00854828|468068531|FG001|Overall Study|Missed 24mo visit|1|||
130029959|NCT00854828|468068532|FG002|Overall Study|Missed 24mo visit|8|||
130029960|NCT00854828|468068533|FG003|Overall Study|Missed 24mo visit|8|||
130029961|NCT04957290|468068535|FG000|Overall Study|Progressive disease|3|||
130029962|NCT04957290|468068536|FG001|Overall Study|Progressive disease|3|||
130029963|NCT04957290|468068537|FG002|Overall Study|Progressive disease|2|||
130029964|NCT04957290|468068538|FG003|Overall Study|Progressive disease|0|||
130029965|NCT04957290|468068539|FG004|Overall Study|Progressive disease|0|||
130029966|NCT04957290|468068540|FG005|Overall Study|Progressive disease|0|||
130029967|NCT04957290|468068535|FG000|Overall Study|Withdrawal by Subject|1|||
130100573|NCT01317199|468325999|FG002|Dose-escalation Phase 1|Physician Decision|0|||
130029968|NCT04957290|468068536|FG001|Overall Study|Withdrawal by Subject|0|||
130029969|NCT04957290|468068537|FG002|Overall Study|Withdrawal by Subject|1|||
130029970|NCT04957290|468068538|FG003|Overall Study|Withdrawal by Subject|0|||
130029971|NCT04957290|468068539|FG004|Overall Study|Withdrawal by Subject|0|||
130029972|NCT04957290|468068540|FG005|Overall Study|Withdrawal by Subject|0|||
130029973|NCT04957290|468068535|FG000|Overall Study|Death|0|||
130029974|NCT04957290|468068536|FG001|Overall Study|Death|2|||
130029975|NCT04957290|468068537|FG002|Overall Study|Death|1|||
130029976|NCT04957290|468068538|FG003|Overall Study|Death|0|||
130029977|NCT04957290|468068539|FG004|Overall Study|Death|0|||
130029978|NCT04957290|468068540|FG005|Overall Study|Death|0|||
130029979|NCT04957290|468068535|FG000|Overall Study|non compliance with study drug|0|||
130029980|NCT04957290|468068536|FG001|Overall Study|non compliance with study drug|1|||
130029981|NCT04957290|468068537|FG002|Overall Study|non compliance with study drug|0|||
130029982|NCT04957290|468068538|FG003|Overall Study|non compliance with study drug|0|||
130029983|NCT04957290|468068539|FG004|Overall Study|non compliance with study drug|0|||
130029984|NCT04957290|468068540|FG005|Overall Study|non compliance with study drug|0|||
130029985|NCT04957290|468068535|FG000|Overall Study|none specified.|0|||
130029986|NCT04957290|468068536|FG001|Overall Study|none specified.|1|||
130029987|NCT04957290|468068537|FG002|Overall Study|none specified.|2|||
130029988|NCT04957290|468068538|FG003|Overall Study|none specified.|0|||
130029989|NCT04957290|468068539|FG004|Overall Study|none specified.|0|||
130029990|NCT04957290|468068540|FG005|Overall Study|none specified.|0|||
130029991|NCT04957290|468068535|FG000|Overall Study|unacceptable toxicity|0|||
130029992|NCT04957290|468068536|FG001|Overall Study|unacceptable toxicity|0|||
130029993|NCT04957290|468068537|FG002|Overall Study|unacceptable toxicity|1|||
130029994|NCT04957290|468068538|FG003|Overall Study|unacceptable toxicity|0|||
130029995|NCT04957290|468068539|FG004|Overall Study|unacceptable toxicity|0|||
130029996|NCT04957290|468068540|FG005|Overall Study|unacceptable toxicity|0|||
130029997|NCT04957290|468068535|FG000|Overall Study|Adverse Event|0|||
130029998|NCT04957290|468068536|FG001|Overall Study|Adverse Event|0|||
130029999|NCT04957290|468068537|FG002|Overall Study|Adverse Event|1|||
130030000|NCT04957290|468068538|FG003|Overall Study|Adverse Event|0|||
130030001|NCT04957290|468068539|FG004|Overall Study|Adverse Event|0|||
130030002|NCT04957290|468068540|FG005|Overall Study|Adverse Event|0|||
130030003|NCT04957290|468068535|FG000|Overall Study|study terminated by sponsor|0|||
130030004|NCT04957290|468068536|FG001|Overall Study|study terminated by sponsor|0|||
130030005|NCT04957290|468068537|FG002|Overall Study|study terminated by sponsor|2|||
130030006|NCT04957290|468068538|FG003|Overall Study|study terminated by sponsor|0|||
130030007|NCT04957290|468068539|FG004|Overall Study|study terminated by sponsor|0|||
130030008|NCT04957290|468068540|FG005|Overall Study|study terminated by sponsor|0|||
130030009|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030010|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030011|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030012|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
130030013|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030014|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
130030015|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030016|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030017|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030018|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030019|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030020|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030021|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030022|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030023|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030024|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030025|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030026|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030027|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030028|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030029|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030030|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030031|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
130030032|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130030033|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
130030034|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130030035|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
130030036|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130030037|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130030038|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
130030039|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030040|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030041|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030042|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030043|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030044|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030045|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030046|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030047|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030048|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030049|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030050|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030051|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030052|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030053|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030054|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
130030055|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130030056|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
130030057|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130030058|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
130030059|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
130030060|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
130030061|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130030062|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
130030063|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030064|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030065|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030066|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030067|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030068|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030069|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030070|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030071|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030072|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030073|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030074|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030075|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030076|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030077|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
130030078|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030079|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030080|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
130030081|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030082|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
130030083|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030084|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030085|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030086|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030087|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030088|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030089|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030090|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030091|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030092|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030093|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030094|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030095|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030096|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030097|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130100574|NCT01317199|468326000|FG003|Dose-escalation Phase 1|Physician Decision|0|||
130030098|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030099|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030100|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
130030101|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
130030102|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030103|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030104|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
130030105|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030106|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030107|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030108|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030109|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030110|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030111|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030112|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030113|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030114|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030115|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030116|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030117|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030118|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030119|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030120|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030121|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030122|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030123|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
130030124|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030125|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030126|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
130030127|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030128|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030129|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030130|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030131|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030132|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030133|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030134|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030135|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030136|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130100575|NCT01317199|468325997|FG000|Dose-escalation Phase 1|Disease progression|1|||
130100576|NCT01317199|468325998|FG001|Dose-escalation Phase 1|Disease progression|0|||
130100577|NCT01317199|468325999|FG002|Dose-escalation Phase 1|Disease progression|0|||
130100578|NCT01317199|468326000|FG003|Dose-escalation Phase 1|Disease progression|0|||
130100579|NCT01317199|468325997|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
130100580|NCT01317199|468325998|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
130100581|NCT01317199|468325999|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
130100582|NCT01317199|468326000|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
130100583|NCT01317199|468325997|FG000|Randomized Phase 2|Disease progression|0|||
130100584|NCT01317199|468325998|FG001|Randomized Phase 2|Disease progression|3|||
130100585|NCT01317199|468325999|FG002|Randomized Phase 2|Disease progression|7|||
130100586|NCT01317199|468326000|FG003|Randomized Phase 2|Disease progression|5|||
130100587|NCT01317199|468325997|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
130100588|NCT01317199|468325998|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
130244358|NCT03422718|468855177|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
130244359|NCT03422718|468855178|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
130100589|NCT01317199|468325999|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
130030137|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030138|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030139|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030140|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030141|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030142|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030143|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030144|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030145|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030146|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
130030147|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030148|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030149|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
130030150|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030151|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030152|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030153|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030154|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030155|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030156|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030157|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030158|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030159|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030160|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030161|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030162|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030163|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030164|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030165|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030166|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030167|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030168|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030169|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
130030170|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030171|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030172|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030173|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
130030174|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130244360|NCT03422718|468855179|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
130030175|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030176|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030177|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030178|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030179|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030180|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030181|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030182|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030183|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030184|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030185|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030186|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030187|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030188|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030189|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030190|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030191|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030192|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
130030193|NCT00896532|468068541|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030194|NCT00896532|468068542|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
130030195|NCT00896532|468068543|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030196|NCT00896532|468068544|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
130030197|NCT00896532|468068545|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
130030198|NCT00896532|468068546|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030199|NCT00896532|468068547|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030200|NCT00896532|468068548|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030201|NCT00896532|468068549|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030202|NCT00896532|468068550|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030203|NCT00896532|468068551|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030204|NCT00896532|468068552|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030205|NCT00896532|468068553|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030206|NCT00896532|468068554|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030207|NCT00896532|468068555|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030208|NCT00896532|468068556|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030209|NCT00896532|468068557|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030210|NCT00896532|468068558|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030211|NCT00896532|468068559|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030212|NCT00896532|468068560|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030213|NCT00896532|468068561|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030214|NCT00896532|468068562|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130030215|NCT00896532|468068563|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
130100590|NCT01317199|468326000|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
130100591|NCT01317199|468325997|FG000|Randomized Phase 2|Adverse Event|0|||
130030216|NCT00896532|468068541|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030217|NCT00896532|468068542|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030218|NCT00896532|468068543|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030219|NCT00896532|468068544|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030220|NCT00896532|468068545|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030221|NCT00896532|468068546|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030222|NCT00896532|468068547|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030223|NCT00896532|468068548|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030224|NCT00896532|468068549|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
130030225|NCT00896532|468068550|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030226|NCT00896532|468068551|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030227|NCT00896532|468068552|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030228|NCT00896532|468068553|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030229|NCT00896532|468068554|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030230|NCT00896532|468068555|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030231|NCT00896532|468068556|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030232|NCT00896532|468068557|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030233|NCT00896532|468068558|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030234|NCT00896532|468068559|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030235|NCT00896532|468068560|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030236|NCT00896532|468068561|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030237|NCT00896532|468068562|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030238|NCT00896532|468068563|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
130030239|NCT00896532|468068541|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030240|NCT00896532|468068542|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030241|NCT00896532|468068543|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030242|NCT00896532|468068544|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030243|NCT00896532|468068545|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030244|NCT00896532|468068546|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030245|NCT00896532|468068547|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030246|NCT00896532|468068548|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030247|NCT00896532|468068549|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030248|NCT00896532|468068550|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030249|NCT00896532|468068551|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030250|NCT00896532|468068552|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030251|NCT00896532|468068553|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
130100592|NCT01317199|468325998|FG001|Randomized Phase 2|Adverse Event|0|||
130030252|NCT00896532|468068554|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030253|NCT00896532|468068555|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030254|NCT00896532|468068556|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030255|NCT00896532|468068557|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030256|NCT00896532|468068558|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030257|NCT00896532|468068559|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030258|NCT00896532|468068560|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030259|NCT00896532|468068561|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030260|NCT00896532|468068562|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030261|NCT00896532|468068563|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
130030262|NCT00896532|468068541|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030263|NCT00896532|468068542|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030264|NCT00896532|468068543|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030265|NCT00896532|468068544|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030266|NCT00896532|468068545|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030267|NCT00896532|468068546|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030268|NCT00896532|468068547|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030269|NCT00896532|468068548|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030270|NCT00896532|468068549|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030271|NCT00896532|468068550|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030272|NCT00896532|468068551|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
130030273|NCT00896532|468068552|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030274|NCT00896532|468068553|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
130030275|NCT00896532|468068554|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030276|NCT00896532|468068555|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030277|NCT00896532|468068556|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030278|NCT00896532|468068557|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030279|NCT00896532|468068558|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030280|NCT00896532|468068559|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030281|NCT00896532|468068560|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030282|NCT00896532|468068561|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030283|NCT00896532|468068562|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030284|NCT00896532|468068563|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
130030285|NCT00896532|468068541|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030286|NCT00896532|468068542|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030287|NCT00896532|468068543|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030288|NCT00896532|468068544|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030289|NCT00896532|468068545|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030290|NCT00896532|468068546|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030291|NCT00896532|468068547|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030292|NCT00896532|468068548|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030293|NCT00896532|468068549|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030294|NCT00896532|468068550|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030295|NCT00896532|468068551|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030296|NCT00896532|468068552|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030297|NCT00896532|468068553|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
130030298|NCT00896532|468068554|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
130030299|NCT00896532|468068555|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030300|NCT00896532|468068556|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030301|NCT00896532|468068557|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030302|NCT00896532|468068558|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030303|NCT00896532|468068559|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030304|NCT00896532|468068560|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030305|NCT00896532|468068561|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030306|NCT00896532|468068562|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030307|NCT00896532|468068563|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
130030308|NCT00896532|468068541|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
130030309|NCT00896532|468068542|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
130030310|NCT00896532|468068543|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
130030311|NCT00896532|468068544|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
130030312|NCT00896532|468068545|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
130100593|NCT01317199|468325999|FG002|Randomized Phase 2|Adverse Event|0|||
130030313|NCT00896532|468068546|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
130030314|NCT00896532|468068547|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
130030315|NCT00896532|468068548|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
130030316|NCT00896532|468068549|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
130030317|NCT00896532|468068550|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
130030318|NCT00896532|468068551|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
130030319|NCT00896532|468068552|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
130030320|NCT00896532|468068553|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
130030321|NCT00896532|468068554|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
130030322|NCT00896532|468068555|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
130030323|NCT00896532|468068556|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
130030324|NCT00896532|468068557|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
130030325|NCT00896532|468068558|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
130030326|NCT00896532|468068559|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
130030327|NCT00896532|468068560|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
130030328|NCT00896532|468068561|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
130030329|NCT00896532|468068562|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
130030330|NCT00896532|468068563|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
130030331|NCT00896532|468068541|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030332|NCT00896532|468068542|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030333|NCT00896532|468068543|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030334|NCT00896532|468068544|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030335|NCT00896532|468068545|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030336|NCT00896532|468068546|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030337|NCT00896532|468068547|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030338|NCT00896532|468068548|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030339|NCT00896532|468068549|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030340|NCT00896532|468068550|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030341|NCT00896532|468068551|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130100594|NCT01317199|468326000|FG003|Randomized Phase 2|Adverse Event|1|||
130100595|NCT01317199|468325997|FG000|Randomized Phase 2|Comorbidities|0|||
130100596|NCT01317199|468325998|FG001|Randomized Phase 2|Comorbidities|2|||
130100597|NCT01317199|468325999|FG002|Randomized Phase 2|Comorbidities|2|||
130100598|NCT01317199|468326000|FG003|Randomized Phase 2|Comorbidities|2|||
130100599|NCT01317199|468325997|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
130100600|NCT01317199|468325998|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
130100601|NCT01317199|468325999|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
130100602|NCT01317199|468326000|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
130100603|NCT01317199|468325997|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
130100604|NCT01317199|468325998|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
130100605|NCT01317199|468325999|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
130100606|NCT01317199|468326000|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
130100607|NCT01317199|468325997|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
130100608|NCT01317199|468325998|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
130100609|NCT01317199|468325999|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
130100610|NCT01317199|468326000|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
130100611|NCT01317199|468325997|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
130100612|NCT01317199|468325998|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
130100613|NCT01317199|468325999|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
130100614|NCT01317199|468326000|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
130100615|NCT01353209|468326001|FG000|Overall Study|Adverse Event|1|||
130100616|NCT01353209|468326002|FG001|Overall Study|Adverse Event|1|||
130100617|NCT01301625|468326008|FG000|Overall Study|Death|5|||
130100618|NCT01301625|468326008|FG000|Overall Study|Not Due|21|||
130100619|NCT01301625|468326008|FG000|Overall Study|Expected|8|||
130100620|NCT01301625|468326008|FG000|Overall Study|Lost to Follow-up|1|||
130100621|NCT03237325|468326012|FG000|Overall Study|Lost to Follow-up|3|||
130030342|NCT00896532|468068552|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030343|NCT00896532|468068553|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030344|NCT00896532|468068554|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030345|NCT00896532|468068555|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030346|NCT00896532|468068556|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
130030347|NCT00896532|468068557|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
130030348|NCT00896532|468068558|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030349|NCT00896532|468068559|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030350|NCT00896532|468068560|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030351|NCT00896532|468068561|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130100622|NCT03237325|468326013|FG001|Overall Study|Lost to Follow-up|5|||
130100623|NCT03237325|468326012|FG000|Overall Study|Physician Decision|2|||
130100624|NCT03237325|468326013|FG001|Overall Study|Physician Decision|4|||
130030352|NCT00896532|468068562|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030353|NCT00896532|468068563|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
130030354|NCT00896532|468068541|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030355|NCT00896532|468068542|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030356|NCT00896532|468068543|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030357|NCT00896532|468068544|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030358|NCT00896532|468068545|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030359|NCT00896532|468068546|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030360|NCT00896532|468068547|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030361|NCT00896532|468068548|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030362|NCT00896532|468068549|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030363|NCT00896532|468068550|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030364|NCT00896532|468068551|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030365|NCT00896532|468068552|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030366|NCT00896532|468068553|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130244361|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
130244362|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
130244363|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
130244364|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130030367|NCT00896532|468068554|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030368|NCT00896532|468068555|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030369|NCT00896532|468068556|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
130030370|NCT00896532|468068557|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
130030371|NCT00896532|468068558|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
130030372|NCT00896532|468068559|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030373|NCT00896532|468068560|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030374|NCT00896532|468068561|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130244365|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
130244366|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130244367|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
130244368|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
130244369|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244370|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
130244371|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244372|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130100625|NCT03237325|468326012|FG000|Overall Study|Withdrawal by Subject|9|||
130100626|NCT03237325|468326013|FG001|Overall Study|Withdrawal by Subject|12|||
130100627|NCT03237325|468326012|FG000|Overall Study|Noncompliance with Study Procedures|1|||
130100628|NCT03237325|468326013|FG001|Overall Study|Noncompliance with Study Procedures|1|||
130100629|NCT03237325|468326012|FG000|Overall Study|Termination by Sponsor|0|||
130100630|NCT03237325|468326013|FG001|Overall Study|Termination by Sponsor|1|||
130100631|NCT03237325|468326012|FG000|Overall Study|Reason other than described|0|||
130100632|NCT03237325|468326013|FG001|Overall Study|Reason other than described|2|||
130100633|NCT02684370|468326014|FG000|Part A|Adverse Event|2|||
130100634|NCT02684370|468326015|FG001|Part A|Adverse Event|0|||
130100635|NCT02684370|468326016|FG002|Part A|Adverse Event|1|||
130100636|NCT02684370|468326017|FG003|Part A|Adverse Event|0|||
130100637|NCT02684370|468326018|FG004|Part A|Adverse Event|0|||
130100638|NCT02684370|468326019|FG005|Part A|Adverse Event|0|||
130100639|NCT02684370|468326014|FG000|Part A|Lost to Follow-up|1|||
130100640|NCT02684370|468326015|FG001|Part A|Lost to Follow-up|1|||
130100641|NCT02684370|468326016|FG002|Part A|Lost to Follow-up|0|||
130100642|NCT02684370|468326017|FG003|Part A|Lost to Follow-up|0|||
130100643|NCT02684370|468326018|FG004|Part A|Lost to Follow-up|0|||
130100644|NCT02684370|468326019|FG005|Part A|Lost to Follow-up|0|||
130100645|NCT02684370|468326014|FG000|Part A|Subject Withdrawal|1|||
130100646|NCT02684370|468326015|FG001|Part A|Subject Withdrawal|0|||
130100647|NCT02684370|468326016|FG002|Part A|Subject Withdrawal|3|||
130100648|NCT02684370|468326017|FG003|Part A|Subject Withdrawal|0|||
130100649|NCT02684370|468326018|FG004|Part A|Subject Withdrawal|0|||
130100650|NCT02684370|468326019|FG005|Part A|Subject Withdrawal|0|||
130100651|NCT02684370|468326014|FG000|Part A|Other|0|||
130100652|NCT02684370|468326015|FG001|Part A|Other|0|||
130100653|NCT02684370|468326016|FG002|Part A|Other|1|||
130100654|NCT02684370|468326017|FG003|Part A|Other|0|||
130100655|NCT02684370|468326018|FG004|Part A|Other|0|||
130100656|NCT02684370|468326019|FG005|Part A|Other|0|||
130100657|NCT02684370|468326014|FG000|Part B|Adverse Event|0|||
130100658|NCT02684370|468326015|FG001|Part B|Adverse Event|0|||
130100659|NCT02684370|468326016|FG002|Part B|Adverse Event|0|||
130100660|NCT02684370|468326017|FG003|Part B|Adverse Event|0|||
130100661|NCT02684370|468326018|FG004|Part B|Adverse Event|2|||
130100662|NCT02684370|468326019|FG005|Part B|Adverse Event|1|||
130100663|NCT02684370|468326014|FG000|Part B|Lost to Follow-up|0|||
130100664|NCT02684370|468326015|FG001|Part B|Lost to Follow-up|0|||
130100665|NCT02684370|468326016|FG002|Part B|Lost to Follow-up|0|||
130100666|NCT02684370|468326017|FG003|Part B|Lost to Follow-up|1|||
130100667|NCT02684370|468326018|FG004|Part B|Lost to Follow-up|2|||
130100668|NCT02684370|468326019|FG005|Part B|Lost to Follow-up|5|||
130100669|NCT02684370|468326014|FG000|Part B|Subject Withdrawal|0|||
130100670|NCT02684370|468326015|FG001|Part B|Subject Withdrawal|0|||
130100671|NCT02684370|468326016|FG002|Part B|Subject Withdrawal|0|||
130100672|NCT02684370|468326017|FG003|Part B|Subject Withdrawal|1|||
130100673|NCT02684370|468326018|FG004|Part B|Subject Withdrawal|1|||
130100674|NCT02684370|468326019|FG005|Part B|Subject Withdrawal|2|||
130100675|NCT04221373|468326020|FG000|Overall Study|Physician Decision|4|||
130100676|NCT04221373|468326021|FG001|Overall Study|Physician Decision|0|||
130100677|NCT00138658|468326023|FG000|Overall Study|Adverse Event|23|||
130100678|NCT00138658|468326023|FG000|Overall Study|Death|1|||
130100679|NCT00138658|468326023|FG000|Overall Study|Disease Progression|21|||
130100680|NCT00138658|468326023|FG000|Overall Study|Physician Decision|11|||
130100681|NCT00138658|468326023|FG000|Overall Study|Withdrawal by Subject|5|||
130100682|NCT00337727|468326028|FG000|Overall Study|Adverse Event|5|||
130100683|NCT00337727|468326029|FG001|Overall Study|Adverse Event|3|||
130100684|NCT00337727|468326028|FG000|Overall Study|Lost to Follow-up|5|||
130100685|NCT00337727|468326029|FG001|Overall Study|Lost to Follow-up|4|||
130100686|NCT00337727|468326028|FG000|Overall Study|Physician Decision|1|||
130100687|NCT00337727|468326029|FG001|Overall Study|Physician Decision|0|||
130100688|NCT00337727|468326028|FG000|Overall Study|Protocol Violation|4|||
130100689|NCT00337727|468326029|FG001|Overall Study|Protocol Violation|0|||
130100690|NCT00337727|468326028|FG000|Overall Study|Withdrawal by Subject|3|||
130100691|NCT00337727|468326029|FG001|Overall Study|Withdrawal by Subject|5|||
130244373|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
130244374|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
130244375|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244376|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
130244377|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
130244378|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
130244379|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
130244380|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
130244381|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
130244382|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
130244383|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
130244384|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
130244385|NCT03422718|468855172|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
130244386|NCT03422718|468855173|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
130244387|NCT03422718|468855174|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
130244388|NCT03422718|468855175|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
130244389|NCT03422718|468855176|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
130244390|NCT03422718|468855177|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
130244391|NCT03422718|468855178|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
130244392|NCT03422718|468855179|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
130244393|NCT01129284|468855180|FG000|Overall Study|Adverse Event|2|||
130244394|NCT01129284|468855181|FG001|Overall Study|Adverse Event|0|||
130244395|NCT01129284|468855182|FG002|Overall Study|Adverse Event|1|||
130244396|NCT00845182|468855190|FG000|Overall Study|Lost to Follow-up|3|||
130244397|NCT00845182|468855191|FG001|Overall Study|Lost to Follow-up|3|||
130244398|NCT00845182|468855192|FG002|Overall Study|Lost to Follow-up|4|||
130244399|NCT00845182|468855190|FG000|Overall Study|Adverse Event|0|||
130244400|NCT00845182|468855191|FG001|Overall Study|Adverse Event|1|||
130244401|NCT00845182|468855192|FG002|Overall Study|Adverse Event|1|||
130244402|NCT00845182|468855190|FG000|Overall Study|Physician Decision|0|||
130244403|NCT00845182|468855191|FG001|Overall Study|Physician Decision|0|||
130244404|NCT00845182|468855192|FG002|Overall Study|Physician Decision|1|||
130244405|NCT01625182|468855195|FG000|Overall Study|Administrative problems|1|||
130244406|NCT01625182|468855196|FG001|Overall Study|Administrative problems|0|||
130244407|NCT01625182|468855195|FG000|Overall Study|Protocol deviation|0|||
130244408|NCT01625182|468855196|FG001|Overall Study|Protocol deviation|2|||
130244409|NCT01625182|468855195|FG000|Overall Study|Adverse Event|2|||
130244410|NCT01625182|468855196|FG001|Overall Study|Adverse Event|0|||
130244411|NCT01625182|468855195|FG000|Overall Study|Withdrawal by Subject|5|||
130244412|NCT01625182|468855196|FG001|Overall Study|Withdrawal by Subject|1|||
130244413|NCT01625182|468855195|FG000|Overall Study|Lack of Efficacy|12|||
130244414|NCT01625182|468855196|FG001|Overall Study|Lack of Efficacy|8|||
130244415|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
130244416|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
130244417|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
130244418|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
130244419|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
130244420|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
130244421|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
130244422|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
130244423|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
130244424|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
130244425|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
130244426|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
130244427|NCT00447278|468855197|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
130244428|NCT00447278|468855198|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
130244429|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
130244430|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
130244431|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
130244432|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
130244433|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
130244434|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
130244435|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
130244436|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
130244437|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
130244438|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
130244439|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
130244440|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
130244441|NCT00447278|468855197|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
130244442|NCT00447278|468855198|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
130244443|NCT01348698|468855199|FG000|Overall Study|Does not meet lesion size criteria|1|||
130244444|NCT01348698|468855199|FG000|Overall Study|Death|3|||
130244445|NCT01348698|468855199|FG000|Overall Study|PI decision to close study|68|||
130244446|NCT02595749|468855200|FG000|Overall Study|Withdrawal by Subject|12|||
130244447|NCT02595749|468855201|FG001|Overall Study|Withdrawal by Subject|7|||
130244448|NCT00263562|468855202|FG000|Overall Study|Protocol Violation|3|||
130244449|NCT00263562|468855203|FG001|Overall Study|Protocol Violation|0|||
130244450|NCT05427916|468855209|FG000|Overall Study|Adverse Event|3|||
130244451|NCT05427916|468855210|FG001|Overall Study|Adverse Event|0|||
130244452|NCT05427916|468855209|FG000|Overall Study|Lack of Efficacy|6|||
130244453|NCT05427916|468855210|FG001|Overall Study|Lack of Efficacy|0|||
130244454|NCT05427916|468855209|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
130244455|NCT05427916|468855210|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
130244456|NCT05558410|468855211|FG000|Overall Study|Adverse Event|1|||
130244457|NCT05558410|468855212|FG001|Overall Study|Adverse Event|2|||
130244458|NCT05558410|468855213|FG002|Overall Study|Adverse Event|0|||
130244459|NCT05558410|468855211|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
130244460|NCT05558410|468855212|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
130244461|NCT05558410|468855213|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
130244462|NCT05558410|468855211|FG000|Overall Study|Lost to Follow-up|10|||
130244463|NCT05558410|468855212|FG001|Overall Study|Lost to Follow-up|17|||
130244464|NCT05558410|468855213|FG002|Overall Study|Lost to Follow-up|19|||
130244465|NCT05558410|468855211|FG000|Overall Study|Death|1|||
130244466|NCT05558410|468855212|FG001|Overall Study|Death|0|||
130244467|NCT05558410|468855213|FG002|Overall Study|Death|0|||
130244468|NCT05558410|468855211|FG000|Overall Study|Other non-compliance|0|||
130244469|NCT05558410|468855212|FG001|Overall Study|Other non-compliance|1|||
130244470|NCT05558410|468855213|FG002|Overall Study|Other non-compliance|2|||
130244471|NCT05558410|468855211|FG000|Overall Study|Sponsor Decision|1|||
130244472|NCT05558410|468855212|FG001|Overall Study|Sponsor Decision|0|||
130244473|NCT05558410|468855213|FG002|Overall Study|Sponsor Decision|0|||
130244474|NCT05558410|468855211|FG000|Overall Study|Other|1|||
130244475|NCT05558410|468855212|FG001|Overall Study|Other|0|||
130244476|NCT05558410|468855213|FG002|Overall Study|Other|1|||
130244477|NCT00933166|468855218|FG000|Overall Study|Lost to Follow-up|4|||
130244478|NCT00933166|468855218|FG000|Overall Study|Lack of Efficacy|9|||
130244479|NCT00933166|468855218|FG000|Overall Study|Unavailable|4|||
130244480|NCT00933166|468855218|FG000|Overall Study|Withdrawal by Subject|1|||
130244481|NCT03501277|468855222|FG000|Intervention Period 1 (4 Days)|Other|0|||
130244482|NCT03501277|468855223|FG001|Intervention Period 1 (4 Days)|Other|0|||
130244483|NCT03501277|468855224|FG002|Intervention Period 1 (4 Days)|Other|1|||
130244484|NCT03501277|468855225|FG003|Intervention Period 1 (4 Days)|Other|0|||
130244485|NCT03501277|468855222|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
130244486|NCT03501277|468855223|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
130244487|NCT03501277|468855224|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
130244488|NCT03501277|468855225|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
130244489|NCT03501277|468855222|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
130244490|NCT03501277|468855223|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
130030375|NCT00896532|468068562|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030376|NCT00896532|468068563|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
130030377|NCT00896532|468068541|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030378|NCT00896532|468068542|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030379|NCT00896532|468068543|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030380|NCT00896532|468068544|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030381|NCT00896532|468068545|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030382|NCT00896532|468068546|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030383|NCT00896532|468068547|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030384|NCT00896532|468068548|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030385|NCT00896532|468068549|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030386|NCT00896532|468068550|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030387|NCT00896532|468068551|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030388|NCT00896532|468068552|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030389|NCT00896532|468068553|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030390|NCT00896532|468068554|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030391|NCT00896532|468068555|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030392|NCT00896532|468068556|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030393|NCT00896532|468068557|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
130030394|NCT00896532|468068558|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030395|NCT00896532|468068559|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030396|NCT00896532|468068560|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030397|NCT00896532|468068561|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030398|NCT00896532|468068562|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030399|NCT00896532|468068563|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
130030400|NCT00896532|468068541|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
130030401|NCT00896532|468068542|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
130030402|NCT00896532|468068543|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
130030403|NCT00896532|468068544|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
130030404|NCT00896532|468068545|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
130030405|NCT00896532|468068546|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
130030406|NCT00896532|468068547|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
130030407|NCT00896532|468068548|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
130030408|NCT00896532|468068549|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
130030409|NCT00896532|468068550|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
130030410|NCT00896532|468068551|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
130030411|NCT00896532|468068552|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
130030412|NCT00896532|468068553|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
130030413|NCT00896532|468068554|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
130030414|NCT00896532|468068555|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
130030415|NCT00896532|468068556|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
130030416|NCT00896532|468068557|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
130030417|NCT00896532|468068558|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
130030418|NCT00896532|468068559|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
130030419|NCT00896532|468068560|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
130030420|NCT00896532|468068561|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
130030421|NCT00896532|468068562|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
130030422|NCT00896532|468068563|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
130030423|NCT00896532|468068541|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030424|NCT00896532|468068542|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030425|NCT00896532|468068543|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030426|NCT00896532|468068544|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030427|NCT00896532|468068545|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030428|NCT00896532|468068546|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030429|NCT00896532|468068547|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030430|NCT00896532|468068548|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030431|NCT00896532|468068549|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030432|NCT00896532|468068550|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030433|NCT00896532|468068551|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030434|NCT00896532|468068552|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130244491|NCT03501277|468855224|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
130244492|NCT03501277|468855225|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
130244493|NCT03501277|468855222|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
130244494|NCT03501277|468855223|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
130244495|NCT03501277|468855224|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
130244496|NCT03501277|468855225|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
130244497|NCT06038643|468855229|FG000|Overall Study|Withdrawal by Subject|9|||
130244498|NCT06038643|468855230|FG001|Overall Study|Withdrawal by Subject|4|||
130244499|NCT06038643|468855229|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
130244500|NCT06038643|468855230|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
130244501|NCT04739709|468855238|FG000|Overall Study|Physician Decision|1|||
130244502|NCT04739709|468855239|FG001|Overall Study|Physician Decision|0|||
130244503|NCT02530242|468855248|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
130244504|NCT02530242|468855249|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
130244505|NCT00283959|468855250|FG000|Extension Period|Low Compliance|1|||
130244506|NCT05591755|468855251|FG000|Overall Study|Screen Failure|1|||
130244507|NCT05591755|468855252|FG001|Overall Study|Screen Failure|0|||
130244508|NCT05591755|468855253|FG002|Overall Study|Screen Failure|0|||
130244509|NCT05591755|468855254|FG003|Overall Study|Screen Failure|0|||
130244510|NCT05591755|468855251|FG000|Overall Study|Protocol Violation|0|||
130244511|NCT05591755|468855252|FG001|Overall Study|Protocol Violation|0|||
130244512|NCT05591755|468855253|FG002|Overall Study|Protocol Violation|2|||
130244513|NCT05591755|468855254|FG003|Overall Study|Protocol Violation|0|||
130244514|NCT05591755|468855251|FG000|Overall Study|Withdrawal by Subject|0|||
130244515|NCT05591755|468855252|FG001|Overall Study|Withdrawal by Subject|1|||
130244516|NCT05591755|468855253|FG002|Overall Study|Withdrawal by Subject|0|||
130244517|NCT05591755|468855254|FG003|Overall Study|Withdrawal by Subject|0|||
130244518|NCT00433290|468855255|FG000|Overall Study|Adverse Event|24|||
130244519|NCT00433290|468855256|FG001|Overall Study|Adverse Event|7|||
130244520|NCT00433290|468855255|FG000|Overall Study|Lack of Efficacy|1|||
130244521|NCT00433290|468855256|FG001|Overall Study|Lack of Efficacy|5|||
130244522|NCT00433290|468855255|FG000|Overall Study|Withdrawal by Subject|4|||
130244523|NCT00433290|468855256|FG001|Overall Study|Withdrawal by Subject|2|||
130244524|NCT00433290|468855255|FG000|Overall Study|Protocol Violation|3|||
130244525|NCT00433290|468855256|FG001|Overall Study|Protocol Violation|2|||
130244526|NCT00433290|468855255|FG000|Overall Study|Physician Decision|2|||
130244527|NCT00433290|468855256|FG001|Overall Study|Physician Decision|0|||
130244528|NCT00433290|468855255|FG000|Overall Study|Entry Criteria Not Met|0|||
130244529|NCT00433290|468855256|FG001|Overall Study|Entry Criteria Not Met|1|||
130244530|NCT00433290|468855255|FG000|Overall Study|Lost to Follow-up|1|||
130244531|NCT00433290|468855256|FG001|Overall Study|Lost to Follow-up|0|||
130244532|NCT01483651|468855257|FG000|Overall Study|Withdrawal by Subject|0|||
130244533|NCT01483651|468855258|FG001|Overall Study|Withdrawal by Subject|1|||
130244534|NCT01483651|468855259|FG002|Overall Study|Withdrawal by Subject|1|||
130244535|NCT01483651|468855260|FG003|Overall Study|Withdrawal by Subject|0|||
130244536|NCT01483651|468855261|FG004|Overall Study|Withdrawal by Subject|0|||
130244537|NCT01483651|468855262|FG005|Overall Study|Withdrawal by Subject|1|||
130244538|NCT00504309|468855272|FG000|Overall Study|Death|0|||
130244539|NCT00504309|468855273|FG001|Overall Study|Death|0|||
130244540|NCT00504309|468855274|FG002|Overall Study|Death|0|||
130244541|NCT00504309|468855275|FG003|Overall Study|Death|0|||
130244542|NCT00504309|468855276|FG004|Overall Study|Death|1|||
130244543|NCT00504309|468855277|FG005|Overall Study|Death|0|||
130244544|NCT00504309|468855272|FG000|Overall Study|Withdrawal by Subject|0|||
130244545|NCT00504309|468855273|FG001|Overall Study|Withdrawal by Subject|0|||
130244546|NCT00504309|468855274|FG002|Overall Study|Withdrawal by Subject|1|||
130244547|NCT00504309|468855275|FG003|Overall Study|Withdrawal by Subject|0|||
130244548|NCT00504309|468855276|FG004|Overall Study|Withdrawal by Subject|0|||
130244549|NCT00504309|468855277|FG005|Overall Study|Withdrawal by Subject|0|||
130244550|NCT03345095|468855278|FG000|Overall Study|Lack of Efficacy|184|||
130244551|NCT03345095|468855279|FG001|Overall Study|Lack of Efficacy|156|||
130244552|NCT03345095|468855278|FG000|Overall Study|Adverse Event|36|||
130244553|NCT03345095|468855279|FG001|Overall Study|Adverse Event|118|||
130244554|NCT03345095|468855278|FG000|Overall Study|Withdrawal by Subject|22|||
130244555|NCT03345095|468855279|FG001|Overall Study|Withdrawal by Subject|59|||
130244556|NCT03345095|468855278|FG000|Overall Study|Physician Decision|3|||
130244557|NCT03345095|468855279|FG001|Overall Study|Physician Decision|18|||
130244558|NCT03345095|468855278|FG000|Overall Study|Death|2|||
130244559|NCT03345095|468855279|FG001|Overall Study|Death|4|||
130244560|NCT03345095|468855278|FG000|Overall Study|Other reasons|2|||
130244561|NCT03345095|468855279|FG001|Overall Study|Other reasons|11|||
130244562|NCT03345095|468855278|FG000|Overall Study|Protocol Violation|0|||
130244563|NCT03345095|468855279|FG001|Overall Study|Protocol Violation|1|||
130244564|NCT01121575|468855280|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
130244565|NCT01121575|468855281|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
130244566|NCT01121575|468855282|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
130244567|NCT01121575|468855283|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
130244568|NCT01121575|468855284|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
130244569|NCT01121575|468855285|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
130244570|NCT01121575|468855280|FG000|Overall Study|Unspecified Reasons|8|||
130244571|NCT01121575|468855281|FG001|Overall Study|Unspecified Reasons|6|||
130244572|NCT01121575|468855282|FG002|Overall Study|Unspecified Reasons|7|||
130244573|NCT01121575|468855283|FG003|Overall Study|Unspecified Reasons|5|||
130244574|NCT01121575|468855284|FG004|Overall Study|Unspecified Reasons|13|||
130244575|NCT01121575|468855285|FG005|Overall Study|Unspecified Reasons|10|||
130244576|NCT01121575|468855280|FG000|Overall Study|Death|6|||
130244577|NCT01121575|468855281|FG001|Overall Study|Death|0|||
130244578|NCT01121575|468855282|FG002|Overall Study|Death|0|||
130244579|NCT01121575|468855283|FG003|Overall Study|Death|1|||
130244580|NCT01121575|468855284|FG004|Overall Study|Death|7|||
130244581|NCT01121575|468855285|FG005|Overall Study|Death|1|||
130244582|NCT00724503|468855287|FG000|Overall Study|Lost to Follow-up|4|||
130244583|NCT00724503|468855288|FG001|Overall Study|Lost to Follow-up|8|||
130244584|NCT00724503|468855287|FG000|Overall Study|Withdrawal by Subject|11|||
130244585|NCT00724503|468855288|FG001|Overall Study|Withdrawal by Subject|23|||
130244586|NCT00724503|468855287|FG000|Overall Study|Death|190|||
130244587|NCT00724503|468855288|FG001|Overall Study|Death|182|||
130244588|NCT00724503|468855287|FG000|Overall Study|Adverse Event|1|||
130244589|NCT00724503|468855288|FG001|Overall Study|Adverse Event|0|||
130244590|NCT00724503|468855287|FG000|Overall Study|Not otherwise specified|4|||
130244591|NCT00724503|468855288|FG001|Overall Study|Not otherwise specified|7|||
130244592|NCT01186419|468855291|FG000|Overall Study|Withdrawal by Subject|5|||
130244593|NCT01186419|468855292|FG001|Overall Study|Withdrawal by Subject|3|||
130244594|NCT01186419|468855291|FG000|Overall Study|Adverse Event|1|||
130244595|NCT01186419|468855292|FG001|Overall Study|Adverse Event|2|||
130244596|NCT01186419|468855291|FG000|Overall Study|Physician Decision|0|||
130244597|NCT01186419|468855292|FG001|Overall Study|Physician Decision|3|||
130244598|NCT01186419|468855291|FG000|Overall Study|Other|1|||
130244599|NCT01186419|468855292|FG001|Overall Study|Other|1|||
130244600|NCT01560416|468855296|FG000|Randomized Phase|Crossover Participants|7|||
130244601|NCT01560416|468855297|FG001|Randomized Phase|Crossover Participants|0|||
130244602|NCT00853047|468855298|FG000|Core Phase|Participant Request|0|||
130244603|NCT00853047|468855299|FG001|Core Phase|Participant Request|0|||
130244604|NCT00853047|468855300|FG002|Core Phase|Participant Request|0|||
130244605|NCT00853047|468855301|FG003|Core Phase|Participant Request|1|||
130244606|NCT00853047|468855302|FG004|Core Phase|Participant Request|0|||
130244607|NCT00853047|468855303|FG005|Core Phase|Participant Request|0|||
130244608|NCT00853047|468855298|FG000|Open-Label Extension Phase|Participant Request|0|||
130244609|NCT00853047|468855299|FG001|Open-Label Extension Phase|Participant Request|0|||
130244610|NCT00853047|468855300|FG002|Open-Label Extension Phase|Participant Request|0|||
130244611|NCT00853047|468855301|FG003|Open-Label Extension Phase|Participant Request|0|||
130244612|NCT00853047|468855302|FG004|Open-Label Extension Phase|Participant Request|0|||
130244613|NCT00853047|468855303|FG005|Open-Label Extension Phase|Participant Request|7|||
130244614|NCT00853047|468855298|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130244615|NCT00853047|468855299|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130244616|NCT00853047|468855300|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130244617|NCT00853047|468855301|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
130244618|NCT00853047|468855302|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
130244619|NCT00853047|468855303|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
130244620|NCT00853047|468855298|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244621|NCT00853047|468855299|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244622|NCT00853047|468855300|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244623|NCT00853047|468855301|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130052123|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130244624|NCT00853047|468855302|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
130244625|NCT00853047|468855303|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
130244626|NCT00853047|468855298|FG000|Open-Label Extension Phase|Investigator Decision|0|||
130244627|NCT00853047|468855299|FG001|Open-Label Extension Phase|Investigator Decision|0|||
130244628|NCT00853047|468855300|FG002|Open-Label Extension Phase|Investigator Decision|0|||
130244629|NCT00853047|468855301|FG003|Open-Label Extension Phase|Investigator Decision|0|||
130052124|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130244630|NCT00853047|468855302|FG004|Open-Label Extension Phase|Investigator Decision|0|||
130244631|NCT00853047|468855303|FG005|Open-Label Extension Phase|Investigator Decision|1|||
130244632|NCT00853047|468855298|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
130244633|NCT00853047|468855299|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
130244634|NCT00853047|468855300|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
130244635|NCT00853047|468855301|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
130244636|NCT00853047|468855302|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
130244637|NCT00853047|468855303|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
130244638|NCT00004859|468855304|FG000|Overall Study|Lack of Efficacy|43|||
130244639|NCT00004859|468855305|FG001|Overall Study|Lack of Efficacy|113|||
130100692|NCT00577031|468326030|FG000|Overall Study|Adverse Event|52|||
130244640|NCT00004859|468855304|FG000|Overall Study|Adverse Event|31|||
130244641|NCT00004859|468855305|FG001|Overall Study|Adverse Event|93|||
130244642|NCT00004859|468855304|FG000|Overall Study|Death|5|||
130244643|NCT00004859|468855305|FG001|Overall Study|Death|5|||
130244644|NCT00004859|468855304|FG000|Overall Study|Withdrawal by Subject|7|||
130244645|NCT00004859|468855305|FG001|Overall Study|Withdrawal by Subject|33|||
130244646|NCT00004859|468855304|FG000|Overall Study|Protocol Violation|2|||
130244647|NCT00004859|468855305|FG001|Overall Study|Protocol Violation|2|||
130244648|NCT00004859|468855304|FG000|Overall Study|other disease|0|||
130244649|NCT00004859|468855305|FG001|Overall Study|other disease|3|||
130244650|NCT00004859|468855304|FG000|Overall Study|error|3|||
130244651|NCT00004859|468855305|FG001|Overall Study|error|1|||
130244652|NCT00004859|468855304|FG000|Overall Study|missing data|14|||
130244653|NCT00004859|468855305|FG001|Overall Study|missing data|11|||
130244654|NCT00004859|468855304|FG000|Overall Study|Other|13|||
130244655|NCT00004859|468855305|FG001|Overall Study|Other|21|||
130244656|NCT00504231|468856961|FG000|Overall Study|Discrepant chart documentation re route|0|||
130244657|NCT00504231|468856962|FG001|Overall Study|Discrepant chart documentation re route|0|||
130244658|NCT00504231|468856963|FG002|Overall Study|Discrepant chart documentation re route|1|||
130244659|NCT00504231|468856964|FG003|Overall Study|Discrepant chart documentation re route|0|||
130244660|NCT00456612|468856967|FG000|Overall Study|Withdrawal by Subject|3|||
130244661|NCT00266812|468856968|FG000|Overall Study|Disease Progression|9|||
130244662|NCT00266812|468856969|FG001|Overall Study|Disease Progression|3|||
130244663|NCT00266812|468856968|FG000|Overall Study|Death|5|||
130244664|NCT00266812|468856969|FG001|Overall Study|Death|4|||
130244665|NCT00266812|468856968|FG000|Overall Study|Adverse Event|3|||
130244666|NCT00266812|468856969|FG001|Overall Study|Adverse Event|1|||
130244667|NCT00266812|468856968|FG000|Overall Study|Protocol Violation|0|||
130244668|NCT00266812|468856969|FG001|Overall Study|Protocol Violation|1|||
130244669|NCT00266812|468856968|FG000|Overall Study|Withdrawal by Subject|0|||
130244670|NCT00266812|468856969|FG001|Overall Study|Withdrawal by Subject|2|||
130244671|NCT00266812|468856968|FG000|Overall Study|Discontinued before starting study drug|4|||
130244672|NCT00266812|468856969|FG001|Overall Study|Discontinued before starting study drug|0|||
130244673|NCT03695094|468856970|FG000|Overall Study|Adverse Event|1|||
130244674|NCT03695094|468856971|FG001|Overall Study|Adverse Event|1|||
130244675|NCT03695094|468856970|FG000|Overall Study|Withdrawal by Subject|1|||
130244676|NCT03695094|468856971|FG001|Overall Study|Withdrawal by Subject|0|||
130244677|NCT00530075|468856974|FG000|Overall Study|Adverse Event|1|||
130244678|NCT00530075|468856974|FG000|Overall Study|Death|1|||
130244679|NCT00530075|468856974|FG000|Overall Study|Lack of Efficacy|3|||
130244680|NCT00530075|468856974|FG000|Overall Study|Protocol Violation|1|||
130244681|NCT00530075|468856974|FG000|Overall Study|Withdrawal by Subject|1|||
130244682|NCT02316613|468856975|FG000|Overall Study|Death|63|||
130244683|NCT02316613|468856975|FG000|Overall Study|Lost to Follow-up|9|||
130244684|NCT02316613|468856975|FG000|Overall Study|Lymphoma transformation|2|||
130244685|NCT02316613|468856975|FG000|Overall Study|Participant moved/changed medical team|11|||
130244686|NCT02316613|468856975|FG000|Overall Study|No data and duplicate cases|5|||
130244687|NCT02316613|468856975|FG000|Overall Study|Did not met selection criteria|14|||
130244688|NCT00758043|468856979|FG000|Overall Study|Adverse Event|1|||
130244689|NCT00758043|468856980|FG001|Overall Study|Adverse Event|20|||
130244690|NCT00758043|468856981|FG002|Overall Study|Adverse Event|12|||
130244691|NCT00758043|468856982|FG003|Overall Study|Adverse Event|62|||
130244692|NCT00758043|468856979|FG000|Overall Study|Lack of Efficacy|0|||
130244693|NCT00758043|468856980|FG001|Overall Study|Lack of Efficacy|6|||
130244694|NCT00758043|468856981|FG002|Overall Study|Lack of Efficacy|18|||
130244695|NCT00758043|468856982|FG003|Overall Study|Lack of Efficacy|12|||
130244696|NCT00758043|468856979|FG000|Overall Study|Refused Further Treatment|0|||
130100693|NCT00577031|468326030|FG000|Overall Study|Progression of disease|93|||
130244697|NCT00758043|468856980|FG001|Overall Study|Refused Further Treatment|11|||
130244698|NCT00758043|468856981|FG002|Overall Study|Refused Further Treatment|5|||
130244699|NCT00758043|468856982|FG003|Overall Study|Refused Further Treatment|8|||
130244700|NCT00758043|468856979|FG000|Overall Study|Lost to Follow-up|0|||
130244701|NCT00758043|468856980|FG001|Overall Study|Lost to Follow-up|2|||
130244702|NCT00758043|468856981|FG002|Overall Study|Lost to Follow-up|2|||
130244703|NCT00758043|468856982|FG003|Overall Study|Lost to Follow-up|5|||
130244704|NCT00758043|468856979|FG000|Overall Study|Withdrawal by Subject|0|||
130244705|NCT00758043|468856980|FG001|Overall Study|Withdrawal by Subject|1|||
130244706|NCT00758043|468856981|FG002|Overall Study|Withdrawal by Subject|1|||
130244707|NCT00758043|468856982|FG003|Overall Study|Withdrawal by Subject|4|||
130244708|NCT00758043|468856979|FG000|Overall Study|Required Prohibited Medication|0|||
130244709|NCT00758043|468856980|FG001|Overall Study|Required Prohibited Medication|0|||
130244710|NCT00758043|468856981|FG002|Overall Study|Required Prohibited Medication|1|||
130244711|NCT00758043|468856982|FG003|Overall Study|Required Prohibited Medication|3|||
130244712|NCT00758043|468856979|FG000|Overall Study|Non-Compliant With study Drug|0|||
130244713|NCT00758043|468856980|FG001|Overall Study|Non-Compliant With study Drug|0|||
130244714|NCT00758043|468856981|FG002|Overall Study|Non-Compliant With study Drug|0|||
130244715|NCT00758043|468856982|FG003|Overall Study|Non-Compliant With study Drug|1|||
130244716|NCT00758043|468856979|FG000|Overall Study|Other Reasons|0|||
130244717|NCT00758043|468856980|FG001|Overall Study|Other Reasons|1|||
130244718|NCT00758043|468856981|FG002|Overall Study|Other Reasons|0|||
130244719|NCT00758043|468856982|FG003|Overall Study|Other Reasons|5|||
130244720|NCT02400580|468856987|FG000|Overall Study|Withdrawal by Subject|1|||
130244721|NCT02400580|468856988|FG001|Overall Study|Withdrawal by Subject|1|||
130244722|NCT02400580|468856987|FG000|Overall Study|Adverse Event|1|||
130244723|NCT02400580|468856988|FG001|Overall Study|Adverse Event|0|||
130244724|NCT00965094|468856989|FG000|Overall Study|Adverse Event|5|||
130244725|NCT00965094|468856990|FG001|Overall Study|Adverse Event|0|||
130244726|NCT00965094|468856989|FG000|Overall Study|Lost to Follow-up|0|||
130244727|NCT00965094|468856990|FG001|Overall Study|Lost to Follow-up|1|||
130244728|NCT01336972|468856994|FG000|Overall Study|Adverse Event|1|||
130244729|NCT01336972|468856995|FG001|Overall Study|Adverse Event|1|||
130244730|NCT01336972|468856996|FG002|Overall Study|Adverse Event|0|||
130244731|NCT02441114|468856997|FG000|Washout2|Withdrawal by Subject|4|||
130244732|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
130244733|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
130244734|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
130244735|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
130244736|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
130244737|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
130244738|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
130244739|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
130244740|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
130030435|NCT00896532|468068553|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030436|NCT00896532|468068554|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130244741|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
130244742|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
130244743|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
130244744|NCT03446573|468856999|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
130244745|NCT03446573|468857000|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
130244746|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
130244747|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
130244748|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
130030437|NCT00896532|468068555|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130244749|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
130244750|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
130244751|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
130244752|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
130244753|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
130244754|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
130244755|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
130244756|NCT03446573|468856999|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
130244757|NCT03446573|468857000|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
130244758|NCT01371565|468857003|FG000|Overall Study|Withdrawal by Subject|1|||
130244759|NCT01371565|468857003|FG000|Overall Study|Death|1|||
130244760|NCT01371565|468857003|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
130244761|NCT04270760|468857004|FG000|Overall Study|Withdrawal by Subject|0|||
130244762|NCT04270760|468857005|FG001|Overall Study|Withdrawal by Subject|1|||
130244763|NCT04270760|468857006|FG002|Overall Study|Withdrawal by Subject|3|||
130244764|NCT04270760|468857007|FG003|Overall Study|Withdrawal by Subject|0|||
130244765|NCT04270760|468857008|FG004|Overall Study|Withdrawal by Subject|0|||
130244766|NCT04270760|468857004|FG000|Overall Study|Lost to Follow-up|1|||
130244767|NCT04270760|468857005|FG001|Overall Study|Lost to Follow-up|2|||
130244768|NCT04270760|468857006|FG002|Overall Study|Lost to Follow-up|1|||
130244769|NCT04270760|468857007|FG003|Overall Study|Lost to Follow-up|0|||
130244770|NCT04270760|468857008|FG004|Overall Study|Lost to Follow-up|0|||
130244771|NCT04270760|468857004|FG000|Overall Study|Death|0|||
130244772|NCT04270760|468857005|FG001|Overall Study|Death|0|||
130244773|NCT04270760|468857006|FG002|Overall Study|Death|0|||
130244774|NCT04270760|468857007|FG003|Overall Study|Death|0|||
130244775|NCT04270760|468857008|FG004|Overall Study|Death|1|||
130244776|NCT02070991|468857009|FG000|Overall Study|Death|2|||
130244777|NCT02070991|468857010|FG001|Overall Study|Death|0|||
130244778|NCT02070991|468857009|FG000|Overall Study|Withdrawal by Subject|1|||
130244779|NCT02070991|468857010|FG001|Overall Study|Withdrawal by Subject|0|||
130244780|NCT00827242|468857011|FG000|Overall Study|Withdrawal by Subject|2|||
130244781|NCT00827242|468857012|FG001|Overall Study|Withdrawal by Subject|4|||
130244782|NCT00827242|468857011|FG000|Overall Study|Protocol Violation|1|||
130244783|NCT00827242|468857012|FG001|Overall Study|Protocol Violation|3|||
130244784|NCT00827242|468857011|FG000|Overall Study|Lost to Follow-up|0|||
130244785|NCT00827242|468857012|FG001|Overall Study|Lost to Follow-up|3|||
130244786|NCT00827242|468857011|FG000|Overall Study|Adverse Event Excluding Death|2|||
130244787|NCT00827242|468857012|FG001|Overall Study|Adverse Event Excluding Death|1|||
130244788|NCT00827242|468857011|FG000|Overall Study|Entry Criteria Not Met|4|||
130244789|NCT00827242|468857012|FG001|Overall Study|Entry Criteria Not Met|1|||
130244790|NCT00827242|468857011|FG000|Overall Study|Physician Decision|2|||
130244791|NCT00827242|468857012|FG001|Overall Study|Physician Decision|0|||
130244792|NCT00827242|468857011|FG000|Overall Study|Death|1|||
130244793|NCT00827242|468857012|FG001|Overall Study|Death|0|||
130244794|NCT00827242|468857011|FG000|Overall Study|Lack of Efficacy|1|||
130244795|NCT00827242|468857012|FG001|Overall Study|Lack of Efficacy|0|||
130244796|NCT02609633|468857017|FG000|Overall Study|Consent Withdrawn|0|||
130244797|NCT02609633|468857018|FG001|Overall Study|Consent Withdrawn|1|||
130244798|NCT02609633|468857017|FG000|Overall Study|Protocol Deviation|1|||
130244799|NCT02609633|468857018|FG001|Overall Study|Protocol Deviation|0|||
130244800|NCT02609633|468857017|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
130244801|NCT02609633|468857018|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
130244802|NCT02609633|468857017|FG000|Overall Study|Reason not Specified|2|||
130244803|NCT02609633|468857018|FG001|Overall Study|Reason not Specified|1|||
130100694|NCT00577031|468326030|FG000|Overall Study|Protocol Violation|5|||
130244804|NCT05987540|468857019|FG000|Overall Study|Withdrawal by Subject|2|||
130244805|NCT05987540|468857019|FG000|Overall Study|Death|1|||
130244806|NCT05987540|468857019|FG000|Overall Study|Study Termination|1|||
130244807|NCT05987540|468857019|FG000|Overall Study|Adverse Event|2|||
130244808|NCT00471107|468857020|FG000|Overall Study|Technical problems/data loss|3|||
130244809|NCT00471107|468857021|FG001|Overall Study|Technical problems/data loss|1|||
130244810|NCT00471107|468857022|FG002|Overall Study|Technical problems/data loss|3|||
130244811|NCT01769443|468857023|FG000|Overall Study|Study closure|1|||
130244812|NCT01769443|468857024|FG001|Overall Study|Study closure|0|||
130244813|NCT04996264|468857025|FG000|Overall Study|Lost to Follow-up|0|||
130244814|NCT04996264|468857026|FG001|Overall Study|Lost to Follow-up|1|||
130244815|NCT04996264|468857025|FG000|Overall Study|Withdrawal by Subject|4|||
130244816|NCT04996264|468857026|FG001|Overall Study|Withdrawal by Subject|3|||
130244817|NCT04996264|468857025|FG000|Overall Study|1 left AMA|0|||
130244818|NCT04996264|468857026|FG001|Overall Study|1 left AMA|1|||
130244819|NCT04996264|468857025|FG000|Overall Study|Subject changed hospitals|0|||
130030438|NCT00896532|468068556|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030439|NCT00896532|468068557|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
130030440|NCT00896532|468068558|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030441|NCT00896532|468068559|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130244820|NCT04996264|468857026|FG001|Overall Study|Subject changed hospitals|1|||
130244821|NCT04996264|468857025|FG000|Overall Study|unable to complete due to work|0|||
130244822|NCT04996264|468857026|FG001|Overall Study|unable to complete due to work|1|||
130244823|NCT04433975|468857027|FG000|1-month Follow Up|Withdrawal by Subject|1|||
130244824|NCT04433975|468857028|FG001|1-month Follow Up|Withdrawal by Subject|1|||
130244825|NCT04433975|468857027|FG000|1-month Follow Up|Lost to Follow-up|21|||
130244826|NCT04433975|468857028|FG001|1-month Follow Up|Lost to Follow-up|25|||
130244827|NCT04433975|468857027|FG000|3-month Follow Up|Lost to Follow-up|20|||
130244828|NCT04433975|468857028|FG001|3-month Follow Up|Lost to Follow-up|24|||
130244829|NCT04433975|468857027|FG000|3-month Follow Up|Death|1|||
130244830|NCT04433975|468857028|FG001|3-month Follow Up|Death|0|||
130244831|NCT04433975|468857027|FG000|3-month Follow Up|Withdrawal by Subject|2|||
130244832|NCT04433975|468857028|FG001|3-month Follow Up|Withdrawal by Subject|0|||
130244833|NCT04433975|468857027|FG000|6-month Follow Up|Lost to Follow-up|23|||
130244834|NCT04433975|468857028|FG001|6-month Follow Up|Lost to Follow-up|28|||
130244835|NCT04433975|468857027|FG000|6-month Follow Up|Withdrawal by Subject|1|||
130244836|NCT04433975|468857028|FG001|6-month Follow Up|Withdrawal by Subject|1|||
130244837|NCT04433975|468857027|FG000|9-month Follow Up|Lost to Follow-up|27|||
130244838|NCT04433975|468857028|FG001|9-month Follow Up|Lost to Follow-up|36|||
130244839|NCT04433975|468857027|FG000|9-month Follow Up|Death|0|||
130244840|NCT04433975|468857028|FG001|9-month Follow Up|Death|1|||
130244841|NCT04433975|468857027|FG000|12-month Follow Up|Lost to Follow-up|27|||
130244842|NCT04433975|468857028|FG001|12-month Follow Up|Lost to Follow-up|31|||
130244843|NCT04606771|468857029|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
130244844|NCT04606771|468857030|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
130244845|NCT04606771|468857029|FG000|Overall Study|Death|5|||
130244846|NCT04606771|468857030|FG001|Overall Study|Death|6|||
130244847|NCT04606771|468857029|FG000|Overall Study|Wrong randomisation|0|||
130244848|NCT04606771|468857030|FG001|Overall Study|Wrong randomisation|1|||
130244849|NCT04392635|468857031|FG000|Overall Study|Lost to Follow-up|0|||
130244850|NCT04392635|468857032|FG001|Overall Study|Lost to Follow-up|1|||
130244851|NCT02030418|468857033|FG000|Overall Study|Death|78|||
130244852|NCT02030418|468857033|FG000|Overall Study|Missed 12-Month Visit|9|||
130244853|NCT02030418|468857033|FG000|Overall Study|Withdrawn|57|||
130244854|NCT01149538|468857036|FG000|Overall Study|Lost to Follow-up|0|||
130244855|NCT01149538|468857037|FG001|Overall Study|Lost to Follow-up|1|||
130244856|NCT01149538|468857036|FG000|Overall Study|Withdrawal by Subject|5|||
130244857|NCT01149538|468857037|FG001|Overall Study|Withdrawal by Subject|3|||
130244858|NCT00250718|468857038|FG000|Overall Study|Death|1|||
130244859|NCT00250718|468857038|FG000|Overall Study|Adverse Event|1|||
130244860|NCT00250718|468857038|FG000|Overall Study|Withdrawal by Subject|1|||
130244861|NCT06100250|468857039|FG000|Overall Study|Lost to Follow-up|5|||
130244862|NCT02021318|468857040|FG000|Overall Study|Adverse Event|2|||
130244863|NCT02021318|468857041|FG001|Overall Study|Adverse Event|1|||
130244864|NCT02021318|468857040|FG000|Overall Study|Death|33|||
130244865|NCT02021318|468857041|FG001|Overall Study|Death|34|||
130244866|NCT02021318|468857040|FG000|Overall Study|Lost to Follow-up|3|||
130244867|NCT02021318|468857041|FG001|Overall Study|Lost to Follow-up|3|||
130244868|NCT02021318|468857040|FG000|Overall Study|Progressive Disease|0|||
130244869|NCT02021318|468857041|FG001|Overall Study|Progressive Disease|1|||
130244870|NCT02021318|468857040|FG000|Overall Study|Withdrawal by Subject|30|||
130244871|NCT02021318|468857041|FG001|Overall Study|Withdrawal by Subject|18|||
130244872|NCT02021318|468857040|FG000|Overall Study|Physician Decision|3|||
130244873|NCT02021318|468857041|FG001|Overall Study|Physician Decision|3|||
130244874|NCT02021318|468857040|FG000|Overall Study|Miscellaneous|2|||
130244875|NCT02021318|468857041|FG001|Overall Study|Miscellaneous|3|||
130244876|NCT00421993|468857045|FG000|Overall Study|Withdrawal by Subject|22|||
130244877|NCT00421993|468857046|FG001|Overall Study|Withdrawal by Subject|23|||
130244878|NCT00421993|468857047|FG002|Overall Study|Withdrawal by Subject|23|||
130244879|NCT00421993|468857048|FG003|Overall Study|Withdrawal by Subject|24|||
130244880|NCT00421993|468857045|FG000|Overall Study|Lost to Follow-up|18|||
130244881|NCT00421993|468857046|FG001|Overall Study|Lost to Follow-up|19|||
130244882|NCT00421993|468857047|FG002|Overall Study|Lost to Follow-up|22|||
130244883|NCT00421993|468857048|FG003|Overall Study|Lost to Follow-up|20|||
130244884|NCT00421993|468857045|FG000|Overall Study|Adverse Event|11|||
130244885|NCT00421993|468857046|FG001|Overall Study|Adverse Event|1|||
130244886|NCT00421993|468857047|FG002|Overall Study|Adverse Event|6|||
130244887|NCT00421993|468857048|FG003|Overall Study|Adverse Event|4|||
130244888|NCT00421993|468857045|FG000|Overall Study|Protocol Violation|2|||
130244889|NCT00421993|468857046|FG001|Overall Study|Protocol Violation|2|||
130244890|NCT00421993|468857047|FG002|Overall Study|Protocol Violation|0|||
130244891|NCT00421993|468857048|FG003|Overall Study|Protocol Violation|1|||
130244892|NCT00421993|468857045|FG000|Overall Study|Lack of Efficacy|0|||
130244893|NCT00421993|468857046|FG001|Overall Study|Lack of Efficacy|3|||
130244894|NCT00421993|468857047|FG002|Overall Study|Lack of Efficacy|0|||
130244895|NCT00421993|468857048|FG003|Overall Study|Lack of Efficacy|5|||
130244896|NCT00421993|468857045|FG000|Overall Study|Pregnancy|0|||
130244897|NCT00421993|468857046|FG001|Overall Study|Pregnancy|1|||
130244898|NCT00421993|468857047|FG002|Overall Study|Pregnancy|1|||
130244899|NCT00421993|468857048|FG003|Overall Study|Pregnancy|2|||
130244900|NCT00421993|468857045|FG000|Overall Study|Subject transportation issues|0|||
130244901|NCT00421993|468857046|FG001|Overall Study|Subject transportation issues|0|||
130244902|NCT00421993|468857047|FG002|Overall Study|Subject transportation issues|0|||
130244903|NCT00421993|468857048|FG003|Overall Study|Subject transportation issues|1|||
130244904|NCT01980888|468857049|FG000|Overall Study|Study Terminated by Sponsor|116|||
130244905|NCT01980888|468857050|FG001|Overall Study|Study Terminated by Sponsor|122|||
130244906|NCT01980888|468857049|FG000|Overall Study|Withdrew Consent|17|||
130100695|NCT00577031|468326030|FG000|Overall Study|Participant withdrew consent|13|||
130244907|NCT01980888|468857050|FG001|Overall Study|Withdrew Consent|6|||
130244908|NCT01980888|468857049|FG000|Overall Study|Investigator's Discretion|8|||
130244909|NCT01980888|468857050|FG001|Overall Study|Investigator's Discretion|3|||
130244910|NCT01980888|468857049|FG000|Overall Study|Non-Compliance with Study Drug|3|||
130100696|NCT00577031|468326030|FG000|Overall Study|Participant non-compliance|5|||
130244911|NCT01980888|468857050|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130244912|NCT05762744|468857056|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
130244913|NCT05762744|468857057|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
130244914|NCT05762744|468857056|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
130100697|NCT00577031|468326030|FG000|Overall Study|Need for surgery|17|||
130100698|NCT00577031|468326030|FG000|Overall Study|Medical decision|14|||
130100699|NCT00577031|468326030|FG000|Overall Study|Death|6|||
130100700|NCT04764669|468326032|FG000|Overall Study|Adverse Event|1|||
130100701|NCT04764669|468326033|FG001|Overall Study|Adverse Event|0|||
130100702|NCT04764669|468326034|FG002|Overall Study|Adverse Event|1|||
130100703|NCT04764669|468326035|FG003|Overall Study|Adverse Event|0|||
130100704|NCT04764669|468326032|FG000|Overall Study|Subject Choice|0|||
130100705|NCT04764669|468326033|FG001|Overall Study|Subject Choice|0|||
130100706|NCT04764669|468326034|FG002|Overall Study|Subject Choice|1|||
130100707|NCT04764669|468326035|FG003|Overall Study|Subject Choice|0|||
130100708|NCT04764669|468326032|FG000|Overall Study|Withdrawal by Subject|2|||
130100709|NCT04764669|468326033|FG001|Overall Study|Withdrawal by Subject|0|||
130100710|NCT04764669|468326034|FG002|Overall Study|Withdrawal by Subject|0|||
130100711|NCT04764669|468326035|FG003|Overall Study|Withdrawal by Subject|0|||
130100712|NCT00807040|468326036|FG000|Overall Study|Death|24|||
130100713|NCT00807040|468326037|FG001|Overall Study|Death|29|||
130100714|NCT00807040|468326036|FG000|Overall Study|Withdrawal by Subject|8|||
130100715|NCT00807040|468326037|FG001|Overall Study|Withdrawal by Subject|6|||
130100716|NCT00807040|468326036|FG000|Overall Study|Lost to Follow-up|4|||
130100717|NCT00807040|468326037|FG001|Overall Study|Lost to Follow-up|6|||
130100718|NCT00625846|468326038|FG000|Overall Study|Withdrawal by Subject|2|||
130100719|NCT00625846|468326039|FG001|Overall Study|Withdrawal by Subject|0|||
130244915|NCT05762744|468857057|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
130244916|NCT01671059|468857058|FG000|Overall Study|Adverse Event|4|||
130244917|NCT01671059|468857058|FG000|Overall Study|Lack of Efficacy|1|||
130244918|NCT01030900|468857065|FG000|Overall Study|Not treated due to congestive heart failure|1|||
130244919|NCT01030900|468857065|FG000|Overall Study|Not treated due to rapid disease|1|||
130244920|NCT01179399|468857066|FG000|Overall Study|Adverse Event|1|||
130244921|NCT01179399|468857066|FG000|Overall Study|Lack of Efficacy|30|||
130244922|NCT01179399|468857066|FG000|Overall Study|Withdrawal by Subject|1|||
130100720|NCT00625846|468326040|FG002|Overall Study|Withdrawal by Subject|1|||
130100721|NCT00625846|468326041|FG003|Overall Study|Withdrawal by Subject|2|||
130100722|NCT01067339|468326048|FG000|Overall Study|Withdrawal by Subject|6|||
130100723|NCT01067339|468326049|FG001|Overall Study|Withdrawal by Subject|5|||
130100724|NCT00890409|468326050|FG000|Overall Study|Lost to Follow-up|20|||
130100725|NCT00890409|468326051|FG001|Overall Study|Lost to Follow-up|21|||
130100726|NCT00769132|468326053|FG000|Period 1|Adverse Event|1|||
130100727|NCT00769132|468326054|FG001|Period 1|Adverse Event|0|||
130100728|NCT00769132|468326055|FG002|Period 1|Adverse Event|0|||
130244923|NCT00441896|468857067|FG000|Overall Study|Withdrawal by Subject|0|||
130244924|NCT00441896|468857068|FG001|Overall Study|Withdrawal by Subject|0|||
130244925|NCT00441896|468857069|FG002|Overall Study|Withdrawal by Subject|0|||
130244926|NCT00441896|468857070|FG003|Overall Study|Withdrawal by Subject|1|||
130244927|NCT00441896|468857071|FG004|Overall Study|Withdrawal by Subject|0|||
130244928|NCT00441896|468857072|FG005|Overall Study|Withdrawal by Subject|0|||
130244929|NCT00441896|468857073|FG006|Overall Study|Withdrawal by Subject|0|||
130244930|NCT00441896|468857074|FG007|Overall Study|Withdrawal by Subject|0|||
130244931|NCT00441896|468857075|FG008|Overall Study|Withdrawal by Subject|0|||
130244932|NCT00441896|468857076|FG009|Overall Study|Withdrawal by Subject|0|||
130244933|NCT00441896|468857067|FG000|Overall Study|Other|0|||
130244934|NCT00441896|468857068|FG001|Overall Study|Other|0|||
130244935|NCT00441896|468857069|FG002|Overall Study|Other|0|||
130244936|NCT00441896|468857070|FG003|Overall Study|Other|0|||
130244937|NCT00441896|468857071|FG004|Overall Study|Other|1|||
130244938|NCT00441896|468857072|FG005|Overall Study|Other|0|||
130244939|NCT00441896|468857073|FG006|Overall Study|Other|0|||
130244940|NCT00441896|468857074|FG007|Overall Study|Other|0|||
130244941|NCT00441896|468857075|FG008|Overall Study|Other|0|||
130244942|NCT00441896|468857076|FG009|Overall Study|Other|0|||
130244943|NCT01301092|468857077|FG000|Overall Study|Lost to Follow-up|0|||
130244944|NCT01301092|468857078|FG001|Overall Study|Lost to Follow-up|0|||
130244945|NCT01301092|468857079|FG002|Overall Study|Lost to Follow-up|1|||
130244946|NCT03334175|468857080|FG000|Overall Study|Lost to Follow-up|0|||
130244947|NCT03334175|468857081|FG001|Overall Study|Lost to Follow-up|1|||
130244948|NCT01350973|468857082|FG000|Overall Study|Adverse Event|4|||
130244949|NCT01350973|468857083|FG001|Overall Study|Adverse Event|7|||
130244950|NCT01350973|468857084|FG002|Overall Study|Adverse Event|7|||
130244951|NCT01350973|468857082|FG000|Overall Study|Voluntary Withdrawal|2|||
130244952|NCT01350973|468857083|FG001|Overall Study|Voluntary Withdrawal|1|||
130244953|NCT01350973|468857084|FG002|Overall Study|Voluntary Withdrawal|1|||
130244954|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130244955|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
130244956|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130244957|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
130244958|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
130244959|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130244960|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
130244961|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
130244962|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
130244963|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
130244964|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
130244965|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
130244966|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
130244967|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130244968|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130244969|NCT03738215|468857088|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130244970|NCT03738215|468857089|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
130244971|NCT03738215|468857090|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
130244972|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
130244973|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
130244974|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
130244975|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
130244976|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
130244977|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
130244978|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
130244979|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
130244980|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
130244981|NCT03738215|468857088|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
130244982|NCT03738215|468857089|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
130244983|NCT03738215|468857090|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
130244984|NCT02638493|468857091|FG000|Overall Study|Inability to provide semen samples|2|||
130244985|NCT02638493|468857092|FG001|Overall Study|Inability to provide semen samples|0|||
130244986|NCT02638493|468857093|FG002|Overall Study|Inability to provide semen samples|0|||
130244987|NCT01033071|468857094|FG000|Overall Study|Adverse Event|28|||
130244988|NCT01033071|468857095|FG001|Overall Study|Adverse Event|51|||
130244989|NCT01033071|468857096|FG002|Overall Study|Adverse Event|26|||
130244990|NCT01033071|468857094|FG000|Overall Study|Protocol Violation|0|||
130244991|NCT01033071|468857095|FG001|Overall Study|Protocol Violation|2|||
130244992|NCT01033071|468857096|FG002|Overall Study|Protocol Violation|1|||
130244993|NCT01033071|468857094|FG000|Overall Study|Lost to Follow-up|4|||
130244994|NCT01033071|468857095|FG001|Overall Study|Lost to Follow-up|5|||
130244995|NCT01033071|468857096|FG002|Overall Study|Lost to Follow-up|5|||
130244996|NCT01033071|468857094|FG000|Overall Study|Withdrawal by Subject|17|||
130244997|NCT01033071|468857095|FG001|Overall Study|Withdrawal by Subject|14|||
130244998|NCT01033071|468857096|FG002|Overall Study|Withdrawal by Subject|11|||
130244999|NCT01033071|468857094|FG000|Overall Study|Lack of Efficacy|0|||
130245000|NCT01033071|468857095|FG001|Overall Study|Lack of Efficacy|1|||
130245001|NCT01033071|468857096|FG002|Overall Study|Lack of Efficacy|1|||
130245002|NCT01033071|468857094|FG000|Overall Study|Other|6|||
130245003|NCT01033071|468857095|FG001|Overall Study|Other|4|||
130245004|NCT01033071|468857096|FG002|Overall Study|Other|3|||
130245005|NCT01695772|468857100|FG000|Overall Study|Withdrawal by Subject|18|||
130245006|NCT01695772|468857100|FG000|Overall Study|Progressive Disease|8|||
130245007|NCT01695772|468857100|FG000|Overall Study|Investigator Decision|5|||
130245008|NCT01695772|468857100|FG000|Overall Study|Lost to Follow-up|4|||
130245009|NCT01695772|468857100|FG000|Overall Study|Protocol Violation|2|||
130245010|NCT01695772|468857100|FG000|Overall Study|Unspecified Reason|1|||
130245011|NCT04073407|468857104|FG000|Part 1|Withdrawal by Subject|1|||
130245012|NCT04073407|468857105|FG001|Part 1|Withdrawal by Subject|0|||
130245013|NCT04073407|468857104|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
130245014|NCT04073407|468857105|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
130245015|NCT04073407|468857104|FG000|Part 2|Withdrawal by Subject|0|||
130245016|NCT04073407|468857105|FG001|Part 2|Withdrawal by Subject|1|||
130030442|NCT00896532|468068560|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030443|NCT00896532|468068561|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030444|NCT00896532|468068562|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030445|NCT00896532|468068563|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
130030446|NCT00896532|468068541|FG000|Months 48-72: Follow-on Phase|Death|0|||
130030447|NCT00896532|468068542|FG001|Months 48-72: Follow-on Phase|Death|0|||
130245017|NCT04941898|468859507|FG000|Overall Study|Protocol Violation|1|||
130245018|NCT02724644|468859508|FG000|Overall Study|Adverse Event|7|||
130245019|NCT02724644|468859509|FG001|Overall Study|Adverse Event|1|||
130245020|NCT02724644|468859508|FG000|Overall Study|Lost to Follow-up|6|||
130245021|NCT02724644|468859509|FG001|Overall Study|Lost to Follow-up|2|||
130245022|NCT02724644|468859508|FG000|Overall Study|Withdrawal by Subject|7|||
130030448|NCT00896532|468068543|FG002|Months 48-72: Follow-on Phase|Death|0|||
130245023|NCT02724644|468859509|FG001|Overall Study|Withdrawal by Subject|1|||
130245024|NCT02724644|468859508|FG000|Overall Study|Administrative|1|||
130245025|NCT02724644|468859509|FG001|Overall Study|Administrative|0|||
130245026|NCT00884949|468859510|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
130245027|NCT00884949|468859510|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
130245028|NCT03022630|468859511|FG000|Overall Study|Death|9|||
130245029|NCT03022630|468859512|FG001|Overall Study|Death|7|||
130245030|NCT03022630|468859511|FG000|Overall Study|Withdrawal by Subject|0|||
130245031|NCT03022630|468859512|FG001|Overall Study|Withdrawal by Subject|5|||
130245032|NCT01567085|468859515|FG000|Overall Study|Death|6|||
130245033|NCT01567085|468859515|FG000|Overall Study|Adverse Event|6|||
130245034|NCT01567085|468859515|FG000|Overall Study|Lost to Follow-up|3|||
130245035|NCT01567085|468859515|FG000|Overall Study|Graft loss|2|||
130245036|NCT01567085|468859515|FG000|Overall Study|Renal transplantectomy|1|||
130245037|NCT01567085|468859515|FG000|Overall Study|Returned to chronic dialysis|1|||
130245038|NCT01567085|468859515|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
130245039|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245040|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
130245041|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130100729|NCT00769132|468326056|FG003|Period 1|Adverse Event|1|||
130100730|NCT00769132|468326053|FG000|Period 2|Withdrawal by Subject|0|||
130245042|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245043|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245044|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
130245045|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
130245046|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245047|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130100731|NCT00769132|468326054|FG001|Period 2|Withdrawal by Subject|0|||
130030449|NCT00896532|468068544|FG003|Months 48-72: Follow-on Phase|Death|0|||
130030450|NCT00896532|468068545|FG004|Months 48-72: Follow-on Phase|Death|0|||
130245048|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245049|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245050|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
130245051|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
130245052|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245053|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245054|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245055|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245056|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
130245057|NCT03928704|468859519|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
130245058|NCT03928704|468859520|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
130030451|NCT00896532|468068546|FG005|Months 48-72: Follow-on Phase|Death|0|||
130245059|NCT03928704|468859521|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245060|NCT03928704|468859522|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245061|NCT03928704|468859523|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245062|NCT03928704|468859524|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
130245063|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245064|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245065|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
130245066|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245067|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245068|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
130245069|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245070|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245071|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
130245072|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130030452|NCT00896532|468068547|FG006|Months 48-72: Follow-on Phase|Death|0|||
130030453|NCT00896532|468068548|FG007|Months 48-72: Follow-on Phase|Death|0|||
130245073|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245074|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
130245075|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
130245076|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
130245077|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
130245078|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
130245079|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
130245080|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
130245081|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245082|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245083|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
130245084|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245085|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245086|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
130245087|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245088|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245089|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245090|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245091|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
130245092|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
130245093|NCT03928704|468859519|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
130245094|NCT03928704|468859520|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
130030454|NCT00896532|468068549|FG008|Months 48-72: Follow-on Phase|Death|0|||
130245095|NCT03928704|468859521|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
130245096|NCT03928704|468859522|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
130245097|NCT03928704|468859523|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
130030455|NCT00896532|468068550|FG009|Months 48-72: Follow-on Phase|Death|0|||
130245098|NCT03928704|468859524|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
130245099|NCT04575324|468859527|FG000|Overall Study|Lost to Follow-up|29|||
130245100|NCT04575324|468859528|FG001|Overall Study|Lost to Follow-up|25|||
130245101|NCT04575324|468859527|FG000|Overall Study|Death|1|||
130245102|NCT04575324|468859528|FG001|Overall Study|Death|2|||
130245103|NCT04575324|468859527|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
130245104|NCT04575324|468859528|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
130245105|NCT01002105|468859532|FG000|Overall Study|Lost to Follow-up|10|||
130245106|NCT01002105|468859533|FG001|Overall Study|Lost to Follow-up|16|||
130245107|NCT01002105|468859532|FG000|Overall Study|non compliance|5|||
130245108|NCT01002105|468859533|FG001|Overall Study|non compliance|3|||
130245109|NCT01002105|468859532|FG000|Overall Study|condition worsened|4|||
130245110|NCT01002105|468859533|FG001|Overall Study|condition worsened|2|||
130245111|NCT00327171|468859536|FG000|Overall Study|Did not receive study medication|3|||
130245112|NCT00327171|468859537|FG001|Overall Study|Did not receive study medication|0|||
130245113|NCT00327171|468859536|FG000|Overall Study|Adverse Event|23|||
130245114|NCT00327171|468859537|FG001|Overall Study|Adverse Event|23|||
130245115|NCT00327171|468859536|FG000|Overall Study|Disease progression/lack of efficacy|68|||
130245116|NCT00327171|468859537|FG001|Overall Study|Disease progression/lack of efficacy|69|||
130245117|NCT00327171|468859536|FG000|Overall Study|Investigator/participant request|1|||
130245118|NCT00327171|468859537|FG001|Overall Study|Investigator/participant request|8|||
130245119|NCT00327171|468859536|FG000|Overall Study|Clinical progression|12|||
130245120|NCT00327171|468859537|FG001|Overall Study|Clinical progression|8|||
130245121|NCT00327171|468859536|FG000|Overall Study|Undisclosed history of ischemia|0|||
130245122|NCT00327171|468859537|FG001|Overall Study|Undisclosed history of ischemia|1|||
130245123|NCT00327171|468859536|FG000|Overall Study|Other|1|||
130245124|NCT00327171|468859537|FG001|Overall Study|Other|0|||
130245125|NCT01166945|468859538|FG000|Randomized|diagnosed with Group A strep|4|||
130245126|NCT01166945|468859539|FG001|Randomized|diagnosed with Group A strep|4|||
130245127|NCT01166945|468859538|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
130245128|NCT01166945|468859539|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
130245129|NCT01166945|468859538|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
130245130|NCT01166945|468859539|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
130245131|NCT01166945|468859538|FG000|Day 30|Lost to Follow-up|4|||
130245132|NCT01166945|468859539|FG001|Day 30|Lost to Follow-up|3|||
130245133|NCT00784927|468859543|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
130030456|NCT00896532|468068551|FG010|Months 48-72: Follow-on Phase|Death|0|||
130030457|NCT00896532|468068552|FG011|Months 48-72: Follow-on Phase|Death|0|||
130245134|NCT00784927|468859543|FG000|Overall Study|Protocol Violation|1|||
130245135|NCT00784927|468859543|FG000|Overall Study|Ineligible|1|||
130245136|NCT00422461|468859550|FG000|Overall Study|Adverse Event|1|||
130245137|NCT00422461|468859551|FG001|Overall Study|Adverse Event|2|||
130245138|NCT00422461|468859552|FG002|Overall Study|Adverse Event|1|||
130245139|NCT00422461|468859553|FG003|Overall Study|Adverse Event|1|||
130245140|NCT00422461|468859550|FG000|Overall Study|Other|0|||
130245141|NCT00422461|468859551|FG001|Overall Study|Other|0|||
130245142|NCT00422461|468859552|FG002|Overall Study|Other|0|||
130245143|NCT00422461|468859553|FG003|Overall Study|Other|2|||
130245144|NCT00422461|468859550|FG000|Overall Study|Participants no longer willing to participate in study|1|||
130245145|NCT00422461|468859551|FG001|Overall Study|Participants no longer willing to participate in study|0|||
130245146|NCT00422461|468859552|FG002|Overall Study|Participants no longer willing to participate in study|0|||
130245147|NCT00422461|468859553|FG003|Overall Study|Participants no longer willing to participate in study|0|||
130245148|NCT00422461|468859550|FG000|Overall Study|Randomized but not treated|1|||
130245149|NCT00422461|468859551|FG001|Overall Study|Randomized but not treated|1|||
130245150|NCT00422461|468859552|FG002|Overall Study|Randomized but not treated|0|||
130245151|NCT00422461|468859553|FG003|Overall Study|Randomized but not treated|0|||
130245152|NCT01471574|468859554|FG000|Treatment Period|Lack of Efficacy|12|||
130245153|NCT01471574|468859555|FG001|Treatment Period|Lack of Efficacy|4|||
130245154|NCT01471574|468859556|FG002|Treatment Period|Lack of Efficacy|14|||
130245155|NCT01471574|468859557|FG003|Treatment Period|Lack of Efficacy|1|||
130245156|NCT01471574|468859554|FG000|Treatment Period|Adverse Event|7|||
130245157|NCT01471574|468859555|FG001|Treatment Period|Adverse Event|3|||
130245158|NCT01471574|468859556|FG002|Treatment Period|Adverse Event|6|||
130245159|NCT01471574|468859557|FG003|Treatment Period|Adverse Event|1|||
130245160|NCT01471574|468859554|FG000|Treatment Period|Withdrawal by Subject|5|||
130245161|NCT01471574|468859555|FG001|Treatment Period|Withdrawal by Subject|1|||
130245162|NCT01471574|468859556|FG002|Treatment Period|Withdrawal by Subject|1|||
130245163|NCT01471574|468859557|FG003|Treatment Period|Withdrawal by Subject|0|||
130245164|NCT01471574|468859554|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
130245165|NCT01471574|468859555|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
130245166|NCT01471574|468859556|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
130245167|NCT01471574|468859557|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
130245168|NCT01471574|468859554|FG000|Treatment Period|Lost to Follow-up|1|||
130030458|NCT00896532|468068553|FG012|Months 48-72: Follow-on Phase|Death|0|||
130030459|NCT00896532|468068554|FG013|Months 48-72: Follow-on Phase|Death|0|||
130030460|NCT00896532|468068555|FG014|Months 48-72: Follow-on Phase|Death|0|||
130030461|NCT00896532|468068556|FG015|Months 48-72: Follow-on Phase|Death|0|||
130030462|NCT00896532|468068557|FG016|Months 48-72: Follow-on Phase|Death|0|||
130030463|NCT00896532|468068558|FG017|Months 48-72: Follow-on Phase|Death|0|||
130030464|NCT00896532|468068559|FG018|Months 48-72: Follow-on Phase|Death|1|||
130030465|NCT00896532|468068560|FG019|Months 48-72: Follow-on Phase|Death|0|||
130030466|NCT00896532|468068561|FG020|Months 48-72: Follow-on Phase|Death|0|||
130100732|NCT00769132|468326055|FG002|Period 2|Withdrawal by Subject|0|||
130245169|NCT01471574|468859555|FG001|Treatment Period|Lost to Follow-up|2|||
130245170|NCT01471574|468859556|FG002|Treatment Period|Lost to Follow-up|2|||
130245171|NCT01471574|468859557|FG003|Treatment Period|Lost to Follow-up|0|||
130245172|NCT01471574|468859554|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
130245173|NCT01471574|468859555|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130245174|NCT01471574|468859556|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130245175|NCT01471574|468859557|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
130245176|NCT01471574|468859554|FG000|Treatment Period|Other|1|||
130245177|NCT01471574|468859555|FG001|Treatment Period|Other|0|||
130245178|NCT01471574|468859556|FG002|Treatment Period|Other|0|||
130245179|NCT01471574|468859557|FG003|Treatment Period|Other|0|||
130245180|NCT01471574|468859554|FG000|Follow-up Period|Withdrawal by Subject|3|||
130245181|NCT01471574|468859555|FG001|Follow-up Period|Withdrawal by Subject|0|||
130245182|NCT01471574|468859556|FG002|Follow-up Period|Withdrawal by Subject|3|||
130245183|NCT01471574|468859557|FG003|Follow-up Period|Withdrawal by Subject|1|||
130245184|NCT01471574|468859554|FG000|Follow-up Period|Lost to Follow-up|4|||
130245185|NCT01471574|468859555|FG001|Follow-up Period|Lost to Follow-up|1|||
130245186|NCT01471574|468859556|FG002|Follow-up Period|Lost to Follow-up|3|||
130245187|NCT01471574|468859557|FG003|Follow-up Period|Lost to Follow-up|2|||
130245188|NCT01471574|468859554|FG000|Follow-up Period|Death|0|||
130245189|NCT01471574|468859555|FG001|Follow-up Period|Death|0|||
130245190|NCT01471574|468859556|FG002|Follow-up Period|Death|1|||
130245191|NCT01471574|468859557|FG003|Follow-up Period|Death|0|||
130245192|NCT01471574|468859554|FG000|Follow-up Period|Follow-up no longer required|0|||
130245193|NCT01471574|468859555|FG001|Follow-up Period|Follow-up no longer required|1|||
130100733|NCT00769132|468326056|FG003|Period 2|Withdrawal by Subject|1|||
130245194|NCT01471574|468859556|FG002|Follow-up Period|Follow-up no longer required|0|||
130245195|NCT01471574|468859557|FG003|Follow-up Period|Follow-up no longer required|0|||
130245196|NCT01795937|468859558|FG000|Overall Study|Withdrawal by Subject|1|||
130245197|NCT01795937|468859559|FG001|Overall Study|Withdrawal by Subject|0|||
130245198|NCT01795937|468859560|FG002|Overall Study|Withdrawal by Subject|0|||
130245199|NCT01795937|468859558|FG000|Overall Study|Physician Decision|0|||
130245200|NCT01795937|468859559|FG001|Overall Study|Physician Decision|1|||
130245201|NCT01795937|468859560|FG002|Overall Study|Physician Decision|0|||
130245202|NCT04027946|468859561|FG000|Overall Study|Screen failures|3|||
130245203|NCT01028053|468859566|FG000|Overall Study|Screen Failure|113|||
130245204|NCT01028053|468859566|FG000|Overall Study|Patient Request|11|||
130245205|NCT01028053|468859566|FG000|Overall Study|Protocol Violation|1|||
130245206|NCT01028053|468859566|FG000|Overall Study|Physician Decision|2|||
130245207|NCT01028053|468859566|FG000|Overall Study|Technical Problem|1|||
130245208|NCT01028053|468859566|FG000|Overall Study|Terminated by Sponsor|1|||
130245209|NCT01028053|468859566|FG000|Overall Study|Various reasons|4|||
130245210|NCT00983957|468859570|FG000|Overall Study|Adverse Event|1|||
130245211|NCT00983957|468859570|FG000|Overall Study|Personal Reasons|1|||
130245212|NCT00986232|468859571|FG000|Overall Study|Adverse Event|1|||
130245213|NCT00986232|468859572|FG001|Overall Study|Adverse Event|2|||
130245214|NCT00986232|468859573|FG002|Overall Study|Adverse Event|3|||
130245215|NCT00986232|468859574|FG003|Overall Study|Adverse Event|0|||
130245216|NCT00986232|468859571|FG000|Overall Study|Lost to Follow-up|19|||
130245217|NCT00986232|468859572|FG001|Overall Study|Lost to Follow-up|12|||
130245218|NCT00986232|468859573|FG002|Overall Study|Lost to Follow-up|12|||
130245219|NCT00986232|468859574|FG003|Overall Study|Lost to Follow-up|7|||
130245220|NCT00986232|468859571|FG000|Overall Study|Protocol Violation|2|||
130245221|NCT00986232|468859572|FG001|Overall Study|Protocol Violation|3|||
130245222|NCT00986232|468859573|FG002|Overall Study|Protocol Violation|0|||
130245223|NCT00986232|468859574|FG003|Overall Study|Protocol Violation|1|||
130245224|NCT00986232|468859571|FG000|Overall Study|Withdrawal by Subject|13|||
130245225|NCT00986232|468859572|FG001|Overall Study|Withdrawal by Subject|16|||
130245226|NCT00986232|468859573|FG002|Overall Study|Withdrawal by Subject|12|||
130245227|NCT00986232|468859574|FG003|Overall Study|Withdrawal by Subject|3|||
130245228|NCT00986232|468859571|FG000|Overall Study|Missed one or more bleeds|13|||
130245229|NCT00986232|468859572|FG001|Overall Study|Missed one or more bleeds|10|||
130245230|NCT00986232|468859573|FG002|Overall Study|Missed one or more bleeds|6|||
130245231|NCT00986232|468859574|FG003|Overall Study|Missed one or more bleeds|7|||
130245232|NCT00986232|468859571|FG000|Overall Study|Incomplete safety follow-up|3|||
130245233|NCT00986232|468859572|FG001|Overall Study|Incomplete safety follow-up|7|||
130245234|NCT00986232|468859573|FG002|Overall Study|Incomplete safety follow-up|2|||
130245235|NCT00986232|468859574|FG003|Overall Study|Incomplete safety follow-up|2|||
130245236|NCT00790933|468859575|FG000|Overall Study|Adverse Event|94|||
130245237|NCT00790933|468859576|FG001|Overall Study|Adverse Event|119|||
130245238|NCT00790933|468859577|FG002|Overall Study|Adverse Event|65|||
130245239|NCT00790933|468859578|FG003|Overall Study|Adverse Event|5|||
130245240|NCT00790933|468859579|FG004|Overall Study|Adverse Event|69|||
130245241|NCT00790933|468859575|FG000|Overall Study|Protocol Violation(s)|8|||
130245242|NCT00790933|468859576|FG001|Overall Study|Protocol Violation(s)|18|||
130245243|NCT00790933|468859577|FG002|Overall Study|Protocol Violation(s)|7|||
130245244|NCT00790933|468859578|FG003|Overall Study|Protocol Violation(s)|0|||
130245245|NCT00790933|468859579|FG004|Overall Study|Protocol Violation(s)|12|||
130245246|NCT00790933|468859575|FG000|Overall Study|Lack of Efficacy|192|||
130245247|NCT00790933|468859576|FG001|Overall Study|Lack of Efficacy|176|||
130245248|NCT00790933|468859577|FG002|Overall Study|Lack of Efficacy|130|||
130245249|NCT00790933|468859578|FG003|Overall Study|Lack of Efficacy|1|||
130245250|NCT00790933|468859579|FG004|Overall Study|Lack of Efficacy|121|||
130245251|NCT00790933|468859575|FG000|Overall Study|Study Terminated by Sponsor|0|||
130245252|NCT00790933|468859576|FG001|Overall Study|Study Terminated by Sponsor|0|||
130245253|NCT00790933|468859577|FG002|Overall Study|Study Terminated by Sponsor|1|||
130245254|NCT00790933|468859578|FG003|Overall Study|Study Terminated by Sponsor|0|||
130245255|NCT00790933|468859579|FG004|Overall Study|Study Terminated by Sponsor|0|||
130245256|NCT00790933|468859575|FG000|Overall Study|Withdrawal by Subject|123|||
130245257|NCT00790933|468859576|FG001|Overall Study|Withdrawal by Subject|120|||
130245258|NCT00790933|468859577|FG002|Overall Study|Withdrawal by Subject|52|||
130245259|NCT00790933|468859578|FG003|Overall Study|Withdrawal by Subject|6|||
130245260|NCT00790933|468859579|FG004|Overall Study|Withdrawal by Subject|50|||
130245261|NCT00790933|468859575|FG000|Overall Study|Lost to Follow-up|13|||
130245262|NCT00790933|468859576|FG001|Overall Study|Lost to Follow-up|31|||
130245263|NCT00790933|468859577|FG002|Overall Study|Lost to Follow-up|10|||
130245264|NCT00790933|468859578|FG003|Overall Study|Lost to Follow-up|1|||
130245265|NCT00790933|468859579|FG004|Overall Study|Lost to Follow-up|15|||
130245266|NCT00790933|468859575|FG000|Overall Study|Reason Not Specified|8|||
130245267|NCT00790933|468859576|FG001|Overall Study|Reason Not Specified|16|||
130245268|NCT00790933|468859577|FG002|Overall Study|Reason Not Specified|4|||
130245269|NCT00790933|468859578|FG003|Overall Study|Reason Not Specified|1|||
130245270|NCT00790933|468859579|FG004|Overall Study|Reason Not Specified|9|||
130245271|NCT00245570|468859582|FG000|Washout Between Periods III and IV|Adverse Event|0|||
130030467|NCT00896532|468068562|FG021|Months 48-72: Follow-on Phase|Death|0|||
130030468|NCT00896532|468068563|FG022|Months 48-72: Follow-on Phase|Death|0|||
130030469|NCT00896532|468068541|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030470|NCT00896532|468068542|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030471|NCT00896532|468068543|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030472|NCT00896532|468068544|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030473|NCT00896532|468068545|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030474|NCT00896532|468068546|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030475|NCT00896532|468068547|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030476|NCT00896532|468068548|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030477|NCT00896532|468068549|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030478|NCT00896532|468068550|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030479|NCT00896532|468068551|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030480|NCT00896532|468068552|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030481|NCT00896532|468068553|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030482|NCT00896532|468068554|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130245272|NCT00245570|468859583|FG001|Washout Between Periods III and IV|Adverse Event|1|||
130245273|NCT00245570|468859584|FG002|Washout Between Periods III and IV|Adverse Event|0|||
130245274|NCT00245570|468859585|FG003|Washout Between Periods III and IV|Adverse Event|0|||
130245275|NCT00245570|468859586|FG004|Washout Between Periods III and IV|Adverse Event|0|||
130245276|NCT00245570|468859587|FG005|Washout Between Periods III and IV|Adverse Event|0|||
130245277|NCT01829165|468859588|FG000|Overall Study|Did not complete intervention|2|||
130245278|NCT01829165|468859589|FG001|Overall Study|Did not complete intervention|0|||
130245279|NCT04233580|468859610|FG000|Overall Study|Adverse Event|3|||
130245280|NCT04233580|468859611|FG001|Overall Study|Adverse Event|3|||
130245281|NCT04233580|468859610|FG000|Overall Study|Withdrawal by Subject|2|||
130245282|NCT04233580|468859611|FG001|Overall Study|Withdrawal by Subject|1|||
130245283|NCT03954938|468859612|FG000|Overall Study|Withdrawal by Subject|2|||
130245284|NCT03954938|468859612|FG000|Overall Study|Adverse Event|1|||
130245285|NCT02421510|468859613|FG000|Overall Study|Other|4|||
130245286|NCT02421510|468859614|FG001|Overall Study|Other|2|||
130245287|NCT02421510|468859615|FG002|Overall Study|Other|3|||
130245288|NCT02421510|468859613|FG000|Overall Study|Protocol Violation|1|||
130245289|NCT02421510|468859614|FG001|Overall Study|Protocol Violation|2|||
130245290|NCT02421510|468859615|FG002|Overall Study|Protocol Violation|0|||
130245291|NCT02421510|468859613|FG000|Overall Study|Death|1|||
130245292|NCT02421510|468859614|FG001|Overall Study|Death|0|||
130245293|NCT02421510|468859615|FG002|Overall Study|Death|0|||
130245294|NCT02421510|468859613|FG000|Overall Study|Noncompliance with study drug|1|||
130245295|NCT02421510|468859614|FG001|Overall Study|Noncompliance with study drug|0|||
130245296|NCT02421510|468859615|FG002|Overall Study|Noncompliance with study drug|0|||
130245297|NCT02421510|468859613|FG000|Overall Study|Physician Decision|1|||
130245298|NCT02421510|468859614|FG001|Overall Study|Physician Decision|1|||
130245299|NCT02421510|468859615|FG002|Overall Study|Physician Decision|3|||
130245300|NCT02421510|468859613|FG000|Overall Study|Adverse Event|9|||
130245301|NCT02421510|468859614|FG001|Overall Study|Adverse Event|10|||
130245302|NCT02421510|468859615|FG002|Overall Study|Adverse Event|18|||
130245303|NCT02421510|468859613|FG000|Overall Study|Pregnancy|1|||
130245304|NCT02421510|468859614|FG001|Overall Study|Pregnancy|1|||
130245305|NCT02421510|468859615|FG002|Overall Study|Pregnancy|0|||
130245306|NCT02421510|468859613|FG000|Overall Study|Withdrawal by Subject|14|||
130245307|NCT02421510|468859614|FG001|Overall Study|Withdrawal by Subject|18|||
130245308|NCT02421510|468859615|FG002|Overall Study|Withdrawal by Subject|12|||
130245309|NCT02421510|468859613|FG000|Overall Study|Lost to Follow-up|1|||
130245310|NCT02421510|468859614|FG001|Overall Study|Lost to Follow-up|1|||
130245311|NCT02421510|468859615|FG002|Overall Study|Lost to Follow-up|0|||
130245312|NCT00899847|468859616|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
130245313|NCT00724893|468859619|FG000|Overall Study|Adverse Event|76|||
130245314|NCT00724893|468859620|FG001|Overall Study|Adverse Event|142|||
130245315|NCT00724893|468859619|FG000|Overall Study|Withdrawal by Subject|0|||
130245316|NCT00724893|468859620|FG001|Overall Study|Withdrawal by Subject|1|||
130245317|NCT00724893|468859619|FG000|Overall Study|Lack of virologic response|94|||
130245318|NCT00724893|468859620|FG001|Overall Study|Lack of virologic response|202|||
130245319|NCT00724893|468859619|FG000|Overall Study|Reason not specified|193|||
130245320|NCT00724893|468859620|FG001|Overall Study|Reason not specified|7|||
130030483|NCT00896532|468068555|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130245321|NCT00724893|468859619|FG000|Overall Study|Patient choice|0|||
130245322|NCT00724893|468859620|FG001|Overall Study|Patient choice|26|||
130030484|NCT00896532|468068556|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030485|NCT00896532|468068557|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130245323|NCT00724893|468859619|FG000|Overall Study|Geographic reasons|0|||
130245324|NCT00724893|468859620|FG001|Overall Study|Geographic reasons|11|||
130245325|NCT00724893|468859619|FG000|Overall Study|Incarceration|0|||
130245326|NCT00724893|468859620|FG001|Overall Study|Incarceration|9|||
130245327|NCT00724893|468859619|FG000|Overall Study|Substance abuse|0|||
130245328|NCT00724893|468859620|FG001|Overall Study|Substance abuse|3|||
130245329|NCT00724893|468859619|FG000|Overall Study|Financial reasons|0|||
130245330|NCT00724893|468859620|FG001|Overall Study|Financial reasons|2|||
130245331|NCT00724893|468859619|FG000|Overall Study|Assigned shorter treatment|0|||
130245332|NCT00724893|468859620|FG001|Overall Study|Assigned shorter treatment|2|||
130245333|NCT00724893|468859619|FG000|Overall Study|Lost to Follow-up|0|||
130245334|NCT00724893|468859620|FG001|Overall Study|Lost to Follow-up|52|||
130245335|NCT00724893|468859619|FG000|Overall Study|Unknown, missing data|1|||
130245336|NCT00724893|468859620|FG001|Overall Study|Unknown, missing data|1|||
130245337|NCT01279200|468859623|FG000|Overall Study|Withdrawal by Subject|1|||
130245338|NCT01279200|468859624|FG001|Overall Study|Withdrawal by Subject|3|||
130245339|NCT01279200|468859623|FG000|Overall Study|Patient withdrawal due to high cost|0|||
130245340|NCT01279200|468859624|FG001|Overall Study|Patient withdrawal due to high cost|1|||
130245341|NCT01279200|468859623|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
130245342|NCT01279200|468859624|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
130245343|NCT01279200|468859623|FG000|Overall Study|ultrasound screening failure|0|||
130245344|NCT01279200|468859624|FG001|Overall Study|ultrasound screening failure|1|||
130245345|NCT01279200|468859623|FG000|Overall Study|Lost to Follow-up|0|||
130245346|NCT01279200|468859624|FG001|Overall Study|Lost to Follow-up|1|||
130245347|NCT01279200|468859623|FG000|Overall Study|Adverse Event|1|||
130245348|NCT01279200|468859624|FG001|Overall Study|Adverse Event|0|||
130245349|NCT00888849|468859627|FG000|Overall Study|Death|4|||
130245350|NCT00888849|468859628|FG001|Overall Study|Death|7|||
130245351|NCT00888849|468859627|FG000|Overall Study|Lost to Follow-up|1|||
130245352|NCT00888849|468859628|FG001|Overall Study|Lost to Follow-up|2|||
130245353|NCT00896233|468859633|FG000|Overall Study|Claustrophobia during MRI|1|||
130245354|NCT04280562|468859634|FG000|Study|Adverse Event|2|||
130245355|NCT04280562|468859635|FG001|Study|Adverse Event|0|||
130245356|NCT04280562|468859634|FG000|Study|Lost to Follow-up|3|||
130245357|NCT04280562|468859635|FG001|Study|Lost to Follow-up|3|||
130245358|NCT05507450|468859639|FG000|Overall Study|Death|0|||
130245359|NCT05507450|468859640|FG001|Overall Study|Death|0|||
130245360|NCT05507450|468859641|FG002|Overall Study|Death|1|||
130245361|NCT05507450|468859642|FG003|Overall Study|Death|0|||
130245362|NCT05507450|468859639|FG000|Overall Study|Lost to Follow-up|22|||
130245363|NCT05507450|468859640|FG001|Overall Study|Lost to Follow-up|20|||
130245364|NCT05507450|468859641|FG002|Overall Study|Lost to Follow-up|20|||
130245365|NCT05507450|468859642|FG003|Overall Study|Lost to Follow-up|7|||
130245366|NCT05507450|468859639|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130245367|NCT05507450|468859640|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130245368|NCT05507450|468859641|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130245369|NCT05507450|468859642|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130245370|NCT05507450|468859639|FG000|Overall Study|Withdrawal by Subject|4|||
130245371|NCT05507450|468859640|FG001|Overall Study|Withdrawal by Subject|11|||
130245372|NCT05507450|468859641|FG002|Overall Study|Withdrawal by Subject|7|||
130245373|NCT05507450|468859642|FG003|Overall Study|Withdrawal by Subject|3|||
130245374|NCT05507450|468859639|FG000|Overall Study|Participant left the country|0|||
130245375|NCT05507450|468859640|FG001|Overall Study|Participant left the country|0|||
130245376|NCT05507450|468859641|FG002|Overall Study|Participant left the country|1|||
130245377|NCT05507450|468859642|FG003|Overall Study|Participant left the country|0|||
130245378|NCT00514917|468859646|FG000|Overall Study|Death|4|||
130245379|NCT00514917|468859647|FG001|Overall Study|Death|10|||
130245380|NCT00514917|468859646|FG000|Overall Study|Protocol Violation|1|||
130245381|NCT00514917|468859647|FG001|Overall Study|Protocol Violation|0|||
130245382|NCT00514917|468859646|FG000|Overall Study|Lost to Follow-up|4|||
130245383|NCT00514917|468859647|FG001|Overall Study|Lost to Follow-up|3|||
130245384|NCT00514917|468859646|FG000|Overall Study|Withdrawal by Subject|18|||
130245385|NCT00514917|468859647|FG001|Overall Study|Withdrawal by Subject|16|||
130245386|NCT00514917|468859646|FG000|Overall Study|Discontinued due to study closure|88|||
130245387|NCT00514917|468859647|FG001|Overall Study|Discontinued due to study closure|81|||
130030486|NCT00896532|468068558|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030487|NCT00896532|468068559|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030488|NCT00896532|468068560|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130245388|NCT00514917|468859646|FG000|Overall Study|Undefined|11|||
130245389|NCT00514917|468859647|FG001|Overall Study|Undefined|5|||
130245390|NCT02697422|468859648|FG000|Overall Study|Declined exit survey|9|||
130245391|NCT02697422|468859649|FG001|Overall Study|Declined exit survey|2|||
130245392|NCT02697422|468859648|FG000|Overall Study|Lost to Follow-up|13|||
130245393|NCT02697422|468859649|FG001|Overall Study|Lost to Follow-up|8|||
130245394|NCT02697422|468859648|FG000|Overall Study|Death|2|||
130245395|NCT02697422|468859649|FG001|Overall Study|Death|1|||
130245396|NCT02697422|468859648|FG000|Overall Study|Withdrawal by Subject|0|||
130245397|NCT02697422|468859649|FG001|Overall Study|Withdrawal by Subject|1|||
130245398|NCT02697422|468859648|FG000|Overall Study|Physician Decision|1|||
130245399|NCT02697422|468859649|FG001|Overall Study|Physician Decision|1|||
130245400|NCT02697422|468859648|FG000|Overall Study|Exit survey data lost|1|||
130245401|NCT02697422|468859649|FG001|Overall Study|Exit survey data lost|0|||
130245402|NCT03983109|468859652|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
130245403|NCT03983109|468859653|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
130245404|NCT04149353|468859656|FG000|Overall Study|Study terminated|1|||
130245405|NCT00309244|468859659|FG000|Overall Study|Adverse Event|29|||
130245406|NCT00309244|468859660|FG001|Overall Study|Adverse Event|12|||
130245407|NCT00309244|468859659|FG000|Overall Study|Lost to Follow-up|6|||
130245408|NCT00309244|468859660|FG001|Overall Study|Lost to Follow-up|22|||
130245409|NCT00309244|468859659|FG000|Overall Study|Physician Decision|5|||
130245410|NCT00309244|468859660|FG001|Overall Study|Physician Decision|8|||
130245411|NCT00309244|468859659|FG000|Overall Study|Protocol Violation|6|||
130245412|NCT00309244|468859660|FG001|Overall Study|Protocol Violation|3|||
130245413|NCT00309244|468859659|FG000|Overall Study|Withdrawal by Subject|50|||
130245414|NCT00309244|468859660|FG001|Overall Study|Withdrawal by Subject|32|||
130245415|NCT00309244|468859659|FG000|Overall Study|Various|7|||
130245416|NCT00309244|468859660|FG001|Overall Study|Various|7|||
130245417|NCT00309244|468859659|FG000|Overall Study|Randomized but not dosed|11|||
130245418|NCT00309244|468859660|FG001|Overall Study|Randomized but not dosed|12|||
130245419|NCT00309244|468859659|FG000|Overall Study|Death|4|||
130245420|NCT00309244|468859660|FG001|Overall Study|Death|1|||
130245421|NCT01263028|468859661|FG000|Overall Study|Withdrawal by Subject|1|||
130245422|NCT01263028|468859661|FG000|Overall Study|Adverse Event|1|||
130245423|NCT01263028|468859661|FG000|Overall Study|Study terminated due to low enrollment.|4|||
130245424|NCT03019588|468859662|FG000|Overall Study|Death|44|||
130245425|NCT03019588|468859663|FG001|Overall Study|Death|46|||
130245426|NCT03019588|468859662|FG000|Overall Study|Study terminated by Sponsor|3|||
130245427|NCT03019588|468859663|FG001|Overall Study|Study terminated by Sponsor|1|||
130245428|NCT00887588|468859664|FG000|Core Period|Death|1|||
130245429|NCT00887588|468859665|FG001|Core Period|Death|1|||
130245430|NCT00887588|468859664|FG000|Core Period|Lost to Follow-up|3|||
130245431|NCT00887588|468859665|FG001|Core Period|Lost to Follow-up|1|||
130245432|NCT00887588|468859664|FG000|Core Period|Withdrawal by Subject|6|||
130245433|NCT00887588|468859665|FG001|Core Period|Withdrawal by Subject|8|||
130245434|NCT00887588|468859664|FG000|Core Period|Adverse Event|9|||
130245435|NCT00887588|468859665|FG001|Core Period|Adverse Event|11|||
130245436|NCT00887588|468859664|FG000|Extension Period|Adverse Event|4|||
130245437|NCT00887588|468859665|FG001|Extension Period|Adverse Event|4|||
130245438|NCT00887588|468859664|FG000|Extension Period|Death|0|||
130245439|NCT00887588|468859665|FG001|Extension Period|Death|1|||
130245440|NCT00887588|468859664|FG000|Extension Period|Protocol deviation|1|||
130245441|NCT00887588|468859665|FG001|Extension Period|Protocol deviation|0|||
130245442|NCT00887588|468859664|FG000|Extension Period|Lost to Follow-up|1|||
130245443|NCT00887588|468859665|FG001|Extension Period|Lost to Follow-up|0|||
130245444|NCT00366535|468859666|FG000|First Phase: 12 Weeks|Adverse Event|1|||
130245445|NCT00366535|468859667|FG001|First Phase: 12 Weeks|Adverse Event|3|||
130245446|NCT00366535|468859666|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
130245447|NCT00366535|468859667|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
130245448|NCT00366535|468859666|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
130245449|NCT00366535|468859667|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
130245450|NCT00366535|468859666|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
130245451|NCT00366535|468859667|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
130245452|NCT03753542|468859672|FG000|Overall Study|Lost to Follow-up|9|||
130245453|NCT03753542|468859673|FG001|Overall Study|Lost to Follow-up|14|||
130245454|NCT03554473|468861551|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
130245455|NCT03554473|468861552|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
130245456|NCT03554473|468861553|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
130245457|NCT03554473|468861551|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
130245458|NCT03554473|468861552|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
130245459|NCT03554473|468861553|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
130245460|NCT03554473|468861551|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
130245461|NCT03554473|468861552|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
130245462|NCT03554473|468861553|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
130245463|NCT04971837|468861557|FG000|Overall Study|Long Term Illness|1|||
130245464|NCT04971837|468861557|FG000|Overall Study|BMI too low|9|||
130245465|NCT04971837|468861557|FG000|Overall Study|geographic location|1|||
130245466|NCT04971837|468861557|FG000|Overall Study|Discontinued scheduling conflict|1|||
130245467|NCT00160615|468861558|FG000|Overall Study|Adverse Event|5|||
130245468|NCT00160615|468861559|FG001|Overall Study|Adverse Event|12|||
130245469|NCT00160615|468861558|FG000|Overall Study|Withdrawal by Subject|0|||
130245470|NCT00160615|468861559|FG001|Overall Study|Withdrawal by Subject|2|||
130245471|NCT00160615|468861558|FG000|Overall Study|Lack of Efficacy|11|||
130245472|NCT00160615|468861559|FG001|Overall Study|Lack of Efficacy|23|||
130245473|NCT00160615|468861558|FG000|Overall Study|Patient decision|1|||
130245474|NCT00160615|468861559|FG001|Overall Study|Patient decision|2|||
130245475|NCT00160615|468861558|FG000|Overall Study|Investigator decision|1|||
130245476|NCT00160615|468861559|FG001|Overall Study|Investigator decision|1|||
130245477|NCT00160615|468861558|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
130245478|NCT00160615|468861559|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
130245479|NCT00160615|468861558|FG000|Overall Study|Switch to surgical treatment|0|||
130245480|NCT00160615|468861559|FG001|Overall Study|Switch to surgical treatment|2|||
130245481|NCT00160615|468861558|FG000|Overall Study|Non-compliance was suspected|0|||
130245482|NCT00160615|468861559|FG001|Overall Study|Non-compliance was suspected|1|||
130245483|NCT00160615|468861558|FG000|Overall Study|Poor compliance|0|||
130245484|NCT00160615|468861559|FG001|Overall Study|Poor compliance|1|||
130245485|NCT03166631|468861560|FG000|Overall Study|Progressive disease|2|||
130245486|NCT03166631|468861561|FG001|Overall Study|Progressive disease|1|||
130245487|NCT03166631|468861562|FG002|Overall Study|Progressive disease|3|||
130245488|NCT03166631|468861563|FG003|Overall Study|Progressive disease|4|||
130245489|NCT03166631|468861564|FG004|Overall Study|Progressive disease|2|||
130245490|NCT03166631|468861565|FG005|Overall Study|Progressive disease|2|||
130245491|NCT03166631|468861566|FG006|Overall Study|Progressive disease|5|||
130245492|NCT03166631|468861567|FG007|Overall Study|Progressive disease|6|||
130245493|NCT03166631|468861568|FG008|Overall Study|Progressive disease|11|||
130245494|NCT03166631|468861569|FG009|Overall Study|Progressive disease|5|||
130245495|NCT03166631|468861570|FG010|Overall Study|Progressive disease|7|||
130245496|NCT03166631|468861560|FG000|Overall Study|Physician Decision|0|||
130245497|NCT03166631|468861561|FG001|Overall Study|Physician Decision|0|||
130245498|NCT03166631|468861562|FG002|Overall Study|Physician Decision|0|||
130245499|NCT03166631|468861563|FG003|Overall Study|Physician Decision|0|||
130245500|NCT03166631|468861564|FG004|Overall Study|Physician Decision|0|||
130245501|NCT03166631|468861565|FG005|Overall Study|Physician Decision|0|||
130245502|NCT03166631|468861566|FG006|Overall Study|Physician Decision|1|||
130245503|NCT03166631|468861567|FG007|Overall Study|Physician Decision|0|||
130245504|NCT03166631|468861568|FG008|Overall Study|Physician Decision|1|||
130245505|NCT03166631|468861569|FG009|Overall Study|Physician Decision|0|||
130245506|NCT03166631|468861570|FG010|Overall Study|Physician Decision|1|||
130245507|NCT03166631|468861560|FG000|Overall Study|Death|0|||
130245508|NCT03166631|468861561|FG001|Overall Study|Death|0|||
130245509|NCT03166631|468861562|FG002|Overall Study|Death|0|||
130245510|NCT03166631|468861563|FG003|Overall Study|Death|0|||
130245511|NCT03166631|468861564|FG004|Overall Study|Death|1|||
130245512|NCT03166631|468861565|FG005|Overall Study|Death|0|||
130245513|NCT03166631|468861566|FG006|Overall Study|Death|1|||
130245514|NCT03166631|468861567|FG007|Overall Study|Death|0|||
130245515|NCT03166631|468861568|FG008|Overall Study|Death|0|||
130245516|NCT03166631|468861569|FG009|Overall Study|Death|0|||
130245517|NCT03166631|468861570|FG010|Overall Study|Death|0|||
130245518|NCT03166631|468861560|FG000|Overall Study|Adverse Event|1|||
130245519|NCT03166631|468861561|FG001|Overall Study|Adverse Event|0|||
130245520|NCT03166631|468861562|FG002|Overall Study|Adverse Event|0|||
130245521|NCT03166631|468861563|FG003|Overall Study|Adverse Event|0|||
130245522|NCT03166631|468861564|FG004|Overall Study|Adverse Event|0|||
130245523|NCT03166631|468861565|FG005|Overall Study|Adverse Event|1|||
130245524|NCT03166631|468861566|FG006|Overall Study|Adverse Event|1|||
130245525|NCT03166631|468861567|FG007|Overall Study|Adverse Event|0|||
130245526|NCT03166631|468861568|FG008|Overall Study|Adverse Event|1|||
130245527|NCT03166631|468861569|FG009|Overall Study|Adverse Event|2|||
130245528|NCT03166631|468861570|FG010|Overall Study|Adverse Event|1|||
130245529|NCT03166631|468861560|FG000|Overall Study|Withdrawal by Subject|0|||
130245530|NCT03166631|468861561|FG001|Overall Study|Withdrawal by Subject|0|||
130245531|NCT03166631|468861562|FG002|Overall Study|Withdrawal by Subject|0|||
130245532|NCT03166631|468861563|FG003|Overall Study|Withdrawal by Subject|0|||
130245533|NCT03166631|468861564|FG004|Overall Study|Withdrawal by Subject|0|||
130245534|NCT03166631|468861565|FG005|Overall Study|Withdrawal by Subject|0|||
130245535|NCT03166631|468861566|FG006|Overall Study|Withdrawal by Subject|0|||
130245536|NCT03166631|468861567|FG007|Overall Study|Withdrawal by Subject|0|||
130245537|NCT03166631|468861568|FG008|Overall Study|Withdrawal by Subject|1|||
130245538|NCT03166631|468861569|FG009|Overall Study|Withdrawal by Subject|1|||
130245539|NCT03166631|468861570|FG010|Overall Study|Withdrawal by Subject|0|||
130245540|NCT00567580|468861573|FG000|Overall Study|Protocol Violation|28|||
130245541|NCT00567580|468861574|FG001|Overall Study|Protocol Violation|24|||
130245542|NCT00567580|468861575|FG002|Overall Study|Protocol Violation|24|||
130245543|NCT00382070|468861576|FG000|Overall Study|No follow up data mapped to Other|17|||
130245544|NCT00382070|468861577|FG001|Overall Study|No follow up data mapped to Other|19|||
130245545|NCT00382070|468861576|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
130245546|NCT00382070|468861577|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
130245547|NCT00382070|468861576|FG000|Overall Study|No clinical assessment|9|||
130030489|NCT00896532|468068561|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130030490|NCT00896532|468068562|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
130030491|NCT00896532|468068563|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
130245548|NCT00382070|468861577|FG001|Overall Study|No clinical assessment|11|||
130245549|NCT00284934|468861578|FG000|Overall Study|Adverse Event|1|||
130245550|NCT00284934|468861579|FG001|Overall Study|Adverse Event|2|||
130245551|NCT00284934|468861578|FG000|Overall Study|Other reasons|3|||
130245552|NCT00284934|468861579|FG001|Overall Study|Other reasons|1|||
130245553|NCT03309605|468861582|FG000|Overall Study|Adverse Event|0|||
130245554|NCT03309605|468861583|FG001|Overall Study|Adverse Event|0|||
130245555|NCT03309605|468861584|FG002|Overall Study|Adverse Event|0|||
130245556|NCT03309605|468861585|FG003|Overall Study|Adverse Event|1|||
130245557|NCT03309605|468861586|FG004|Overall Study|Adverse Event|0|||
130245558|NCT03309605|468861587|FG005|Overall Study|Adverse Event|0|||
130245559|NCT03309605|468861588|FG006|Overall Study|Adverse Event|2|||
130245560|NCT03309605|468861589|FG007|Overall Study|Adverse Event|1|||
130245561|NCT03309605|468861582|FG000|Overall Study|Withdrawal by Subject|0|||
130245562|NCT03309605|468861583|FG001|Overall Study|Withdrawal by Subject|0|||
130245563|NCT03309605|468861584|FG002|Overall Study|Withdrawal by Subject|0|||
130245564|NCT03309605|468861585|FG003|Overall Study|Withdrawal by Subject|0|||
130245565|NCT03309605|468861586|FG004|Overall Study|Withdrawal by Subject|1|||
130245566|NCT03309605|468861587|FG005|Overall Study|Withdrawal by Subject|0|||
130245567|NCT03309605|468861588|FG006|Overall Study|Withdrawal by Subject|1|||
130245568|NCT03309605|468861589|FG007|Overall Study|Withdrawal by Subject|1|||
130245569|NCT03197935|468861590|FG000|Overall Study|Death due to any cause|26|||
130245570|NCT03197935|468861591|FG001|Overall Study|Death due to any cause|15|||
130245571|NCT03197935|468861590|FG000|Overall Study|Lost to Follow-up|3|||
130245572|NCT03197935|468861591|FG001|Overall Study|Lost to Follow-up|5|||
130245573|NCT03197935|468861590|FG000|Overall Study|Physician Decision|2|||
130245574|NCT03197935|468861591|FG001|Overall Study|Physician Decision|1|||
130245575|NCT03197935|468861590|FG000|Overall Study|Withdrawal by Subject|16|||
130245576|NCT03197935|468861591|FG001|Overall Study|Withdrawal by Subject|8|||
130245577|NCT02082483|468861592|FG000|Overall Study|Lost to Follow-up|1|||
130245578|NCT02082483|468861593|FG001|Overall Study|Lost to Follow-up|1|||
130245579|NCT02082483|468861592|FG000|Overall Study|Withdrawal by Subject|2|||
130245580|NCT02082483|468861593|FG001|Overall Study|Withdrawal by Subject|1|||
130245581|NCT02082483|468861592|FG000|Overall Study|Physician Decision|1|||
130030492|NCT00896532|468068541|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030493|NCT00896532|468068542|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030494|NCT00896532|468068543|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030495|NCT00896532|468068544|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030496|NCT00896532|468068545|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030497|NCT00896532|468068546|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030498|NCT00896532|468068547|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030499|NCT00896532|468068548|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130245582|NCT02082483|468861593|FG001|Overall Study|Physician Decision|1|||
130245583|NCT02082483|468861592|FG000|Overall Study|Death|2|||
130245584|NCT02082483|468861593|FG001|Overall Study|Death|3|||
130245585|NCT00864513|468861595|FG000|Overall Study|Withdrawal by Subject|3|||
130245586|NCT05938010|468861596|FG000|Overall Study|Lost to Follow-up|2|||
130245587|NCT03073109|468861597|FG000|Overall Study|Adverse Event|0|||
130245588|NCT03073109|468861598|FG001|Overall Study|Adverse Event|1|||
130245589|NCT03073109|468861597|FG000|Overall Study|Other|2|||
130245590|NCT03073109|468861598|FG001|Overall Study|Other|0|||
130245591|NCT03073109|468861597|FG000|Overall Study|Lost to Follow-up|8|||
130245592|NCT03073109|468861598|FG001|Overall Study|Lost to Follow-up|1|||
130245593|NCT01562444|468861601|FG000|Overall Study|Did not meet entry criteria|2|||
130245594|NCT01562444|468861602|FG001|Overall Study|Did not meet entry criteria|0|||
130245595|NCT01562444|468861603|FG002|Overall Study|Did not meet entry criteria|3|||
130245596|NCT01562444|468861601|FG000|Overall Study|Did not comply with blood draw schedule|1|||
130245597|NCT01562444|468861602|FG001|Overall Study|Did not comply with blood draw schedule|0|||
130245598|NCT01562444|468861603|FG002|Overall Study|Did not comply with blood draw schedule|1|||
130245599|NCT01562444|468861601|FG000|Overall Study|Unavailable serological results|0|||
130245600|NCT01562444|468861602|FG001|Overall Study|Unavailable serological results|2|||
130245601|NCT01562444|468861603|FG002|Overall Study|Unavailable serological results|2|||
130245602|NCT01562444|468861601|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
130245603|NCT01562444|468861602|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
130245604|NCT01562444|468861603|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
130245605|NCT01562444|468861601|FG000|Overall Study|Protocol forbidden medication|1|||
130245606|NCT01562444|468861602|FG001|Overall Study|Protocol forbidden medication|0|||
130245607|NCT01562444|468861603|FG002|Overall Study|Protocol forbidden medication|0|||
130245608|NCT00574951|468861611|FG000|Overall Study|Ineligible - improper prior treatment|1|||
130245609|NCT01160744|468861616|FG000|Overall Study|Withdrawal by Subject|11|||
130245610|NCT01160744|468861617|FG001|Overall Study|Withdrawal by Subject|5|||
130245611|NCT01160744|468861618|FG002|Overall Study|Withdrawal by Subject|6|||
130245612|NCT01160744|468861619|FG003|Overall Study|Withdrawal by Subject|4|||
130245613|NCT01160744|468861616|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
130245614|NCT01160744|468861617|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
130245615|NCT01160744|468861618|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
130245616|NCT01160744|468861619|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
130245617|NCT02301429|468861620|FG000|Overall Study|not acceptable vascular anatomy|3|||
130245618|NCT02217982|468861621|FG000|Overall Study|Trial discontinued|1|||
130245619|NCT02217982|468861622|FG001|Overall Study|Trial discontinued|0|||
130245620|NCT02217982|468861621|FG000|Overall Study|Adverse Event|0|||
130245621|NCT02217982|468861622|FG001|Overall Study|Adverse Event|1|||
130245622|NCT01755637|468861627|FG000|Period 1|Adverse Event|0|||
130245623|NCT01755637|468861628|FG001|Period 1|Adverse Event|1|||
130245624|NCT01814332|468861630|FG000|Overall Study|Adverse Event|8|||
130245625|NCT01814332|468861631|FG001|Overall Study|Adverse Event|3|||
130245626|NCT01814332|468861630|FG000|Overall Study|Withdrawal by Subject|3|||
130245627|NCT01814332|468861631|FG001|Overall Study|Withdrawal by Subject|8|||
130245628|NCT01814332|468861630|FG000|Overall Study|Protocol Violation|0|||
130245629|NCT01814332|468861631|FG001|Overall Study|Protocol Violation|4|||
130245630|NCT01814332|468861630|FG000|Overall Study|Lost to Follow-up|5|||
130245631|NCT01814332|468861631|FG001|Overall Study|Lost to Follow-up|1|||
130245632|NCT01096186|468861632|FG000|Overall Study|Adverse Event|16|||
130245633|NCT01096186|468861632|FG000|Overall Study|Death|4|||
130245634|NCT01096186|468861632|FG000|Overall Study|Lack of Efficacy|4|||
130245635|NCT01096186|468861632|FG000|Overall Study|Lost to Follow-up|2|||
130245636|NCT01096186|468861632|FG000|Overall Study|Withdrawal by Subject|22|||
130245637|NCT01096186|468861632|FG000|Overall Study|Physician Decision|1|||
130245638|NCT01096186|468861632|FG000|Overall Study|Noncompliance with study drug|1|||
130100734|NCT00769132|468326053|FG000|Period 3|Withdrawal by Subject|1|||
130100735|NCT00769132|468326054|FG001|Period 3|Withdrawal by Subject|0|||
130100736|NCT00769132|468326055|FG002|Period 3|Withdrawal by Subject|0|||
130100737|NCT00769132|468326056|FG003|Period 3|Withdrawal by Subject|0|||
130100738|NCT00769132|468326053|FG000|Period 4|Withdrawal by Subject|0|||
130100739|NCT00769132|468326054|FG001|Period 4|Withdrawal by Subject|1|||
130245639|NCT00122187|468861637|FG000|Overall Study|Withdrew because of resource limitations|2|||
130245640|NCT00122187|468861638|FG001|Overall Study|Withdrew because of resource limitations|2|||
130245641|NCT02061592|468861639|FG000|Period 1|Withdrawal by Subject|1|||
130245642|NCT02061592|468861640|FG001|Period 1|Withdrawal by Subject|0|||
130245643|NCT02061592|468861639|FG000|Period 1|Protocol Violation|1|||
130245644|NCT02061592|468861640|FG001|Period 1|Protocol Violation|0|||
130245645|NCT02061592|468861639|FG000|Period 2|Lost to Follow-up|0|||
130245646|NCT02061592|468861640|FG001|Period 2|Lost to Follow-up|1|||
130245647|NCT03338023|468861641|FG000|Overall Study|Withdrawal by Subject|3|||
130245648|NCT03338023|468861642|FG001|Overall Study|Withdrawal by Subject|4|||
130245649|NCT03338023|468861641|FG000|Overall Study|Protocol Violation|3|||
130245650|NCT03338023|468861642|FG001|Overall Study|Protocol Violation|3|||
130245651|NCT03338023|468861641|FG000|Overall Study|Lost to Follow-up|2|||
130245652|NCT03338023|468861642|FG001|Overall Study|Lost to Follow-up|1|||
130245653|NCT03338023|468861641|FG000|Overall Study|Physician Decision|1|||
130245654|NCT03338023|468861642|FG001|Overall Study|Physician Decision|2|||
130245655|NCT00685698|468861643|FG000|Overall Study|Withdrawal by Subject|1|||
130245656|NCT00685698|468861643|FG000|Overall Study|Protocol Violation|6|||
130245657|NCT00685698|468861643|FG000|Overall Study|Adverse Event|3|||
130245658|NCT00685698|468861643|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
130245659|NCT00685698|468861643|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
130245660|NCT00685698|468861643|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
130245661|NCT05061706|468861645|FG000|Overall Study|Adverse Event|29|||
130245662|NCT05061706|468861646|FG001|Overall Study|Adverse Event|1|||
130245663|NCT05061706|468861645|FG000|Overall Study|Lack of Efficacy|0|||
130245664|NCT05061706|468861646|FG001|Overall Study|Lack of Efficacy|1|||
130245665|NCT05061706|468861645|FG000|Overall Study|Lost to Follow-up|2|||
130245666|NCT05061706|468861646|FG001|Overall Study|Lost to Follow-up|2|||
130245667|NCT05061706|468861645|FG000|Overall Study|Protocol Violation|3|||
130245668|NCT05061706|468861646|FG001|Overall Study|Protocol Violation|1|||
130245669|NCT05061706|468861645|FG000|Overall Study|Withdrawal by Subject|3|||
130245670|NCT05061706|468861646|FG001|Overall Study|Withdrawal by Subject|9|||
130245671|NCT01873833|468861648|FG000|Overall Study|Withdrawal by Subject|1|||
130245672|NCT02068599|468861654|FG000|Overall Study|Adverse Event|4|||
130245673|NCT02068599|468861655|FG001|Overall Study|Adverse Event|1|||
130245674|NCT02068599|468861656|FG002|Overall Study|Adverse Event|1|||
130245675|NCT02068599|468861654|FG000|Overall Study|Withdrawal by Subject|2|||
130245676|NCT02068599|468861655|FG001|Overall Study|Withdrawal by Subject|7|||
130245677|NCT02068599|468861656|FG002|Overall Study|Withdrawal by Subject|5|||
130245678|NCT02068599|468861654|FG000|Overall Study|Protocol Violation|4|||
130245679|NCT02068599|468861655|FG001|Overall Study|Protocol Violation|2|||
130245680|NCT02068599|468861656|FG002|Overall Study|Protocol Violation|3|||
130245681|NCT02068599|468861654|FG000|Overall Study|Lost to Follow-up|1|||
130245682|NCT02068599|468861655|FG001|Overall Study|Lost to Follow-up|0|||
130245683|NCT02068599|468861656|FG002|Overall Study|Lost to Follow-up|0|||
130245684|NCT02068599|468861654|FG000|Overall Study|Lack of Efficacy|0|||
130245685|NCT02068599|468861655|FG001|Overall Study|Lack of Efficacy|0|||
130245686|NCT02068599|468861656|FG002|Overall Study|Lack of Efficacy|3|||
130245687|NCT02068599|468861654|FG000|Overall Study|Noncompliance|0|||
130245688|NCT02068599|468861655|FG001|Overall Study|Noncompliance|0|||
130245689|NCT02068599|468861656|FG002|Overall Study|Noncompliance|1|||
130245690|NCT01871727|468861657|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
130245691|NCT01871727|468861658|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
130245692|NCT01871727|468861659|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
130245693|NCT01871727|468861660|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
130245694|NCT01871727|468861661|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
130245695|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
130245696|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
130245697|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
130245698|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
130245699|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
130245700|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245701|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245702|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245703|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
130245704|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
130245705|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245706|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245707|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245708|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
130245709|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
130245710|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245711|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245712|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245713|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
130245714|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
130245715|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245716|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245717|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245718|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
130245719|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
130245720|NCT01871727|468861657|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245721|NCT01871727|468861658|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245722|NCT01871727|468861659|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245723|NCT01871727|468861660|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
130245724|NCT01871727|468861661|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
130245725|NCT00356421|468861663|FG000|Overall Study|Lack of Efficacy|3|||
130245726|NCT00356421|468861664|FG001|Overall Study|Lack of Efficacy|0|||
130245727|NCT00356421|468861663|FG000|Overall Study|Withdrawal by Subject|9|||
130245728|NCT00356421|468861664|FG001|Overall Study|Withdrawal by Subject|2|||
130245729|NCT00356421|468861663|FG000|Overall Study|Related to study drug|15|||
130245730|NCT00356421|468861664|FG001|Overall Study|Related to study drug|12|||
130245731|NCT00356421|468861663|FG000|Overall Study|Not related to study drug|5|||
130245732|NCT00356421|468861664|FG001|Overall Study|Not related to study drug|3|||
130245733|NCT00501085|468861665|FG000|Overall Study|Lost to Follow-up|195|||
130245734|NCT00501085|468861665|FG000|Overall Study|Withdrawal by Subject|34|||
130245735|NCT00501085|468861665|FG000|Overall Study|Subject Decision|1|||
130245736|NCT00501085|468861665|FG000|Overall Study|Revision Surgery|7|||
130245737|NCT00501085|468861665|FG000|Overall Study|Explantation Surgery|26|||
130245738|NCT00501085|468861665|FG000|Overall Study|Adverse Event|4|||
130245739|NCT00501085|468861665|FG000|Overall Study|Non-Compliance|24|||
130245740|NCT00501085|468861665|FG000|Overall Study|Study closed by sponsor|109|||
130245741|NCT00501085|468861665|FG000|Overall Study|Other loss to follow-up|32|||
130245742|NCT02958527|468861666|FG000|Overall Study|Not collected CRFs|12|||
130245743|NCT02945046|468861667|FG000|Overall Study|Adverse Event|1|||
130245744|NCT02945046|468861668|FG001|Overall Study|Adverse Event|0|||
130245745|NCT02945046|468861669|FG002|Overall Study|Adverse Event|2|||
130245746|NCT02945046|468861667|FG000|Overall Study|Withdrawal by Subject|3|||
130245747|NCT02945046|468861668|FG001|Overall Study|Withdrawal by Subject|3|||
130245748|NCT02945046|468861669|FG002|Overall Study|Withdrawal by Subject|3|||
130245749|NCT02945046|468861667|FG000|Overall Study|Protocol Violation|2|||
130245750|NCT02945046|468861668|FG001|Overall Study|Protocol Violation|3|||
130245751|NCT02945046|468861669|FG002|Overall Study|Protocol Violation|2|||
130245752|NCT02945046|468861667|FG000|Overall Study|Lost to Follow-up|1|||
130245753|NCT02945046|468861668|FG001|Overall Study|Lost to Follow-up|1|||
130245754|NCT02945046|468861669|FG002|Overall Study|Lost to Follow-up|0|||
130245755|NCT02945046|468861667|FG000|Overall Study|Lack of Efficacy|1|||
130245756|NCT02945046|468861668|FG001|Overall Study|Lack of Efficacy|2|||
130245757|NCT02945046|468861669|FG002|Overall Study|Lack of Efficacy|1|||
130245758|NCT02945046|468861667|FG000|Overall Study|Other than specified|5|||
130245759|NCT02945046|468861668|FG001|Overall Study|Other than specified|4|||
130245760|NCT02945046|468861669|FG002|Overall Study|Other than specified|7|||
130245761|NCT03113136|468861670|FG000|Overall Study|Lost to Follow-up|22|||
130245762|NCT03113136|468861671|FG001|Overall Study|Lost to Follow-up|47|||
130245763|NCT03113136|468861672|FG002|Overall Study|Lost to Follow-up|54|||
130245764|NCT03113136|468861670|FG000|Overall Study|Withdrawal by Subject|4|||
130245765|NCT03113136|468861671|FG001|Overall Study|Withdrawal by Subject|13|||
130245766|NCT03113136|468861672|FG002|Overall Study|Withdrawal by Subject|14|||
130245767|NCT03113136|468861670|FG000|Overall Study|Ineligible|0|||
130245768|NCT03113136|468861671|FG001|Overall Study|Ineligible|2|||
130245769|NCT03113136|468861672|FG002|Overall Study|Ineligible|1|||
130245770|NCT03113136|468861670|FG000|Overall Study|Study Team Decision|1|||
130245771|NCT03113136|468861671|FG001|Overall Study|Study Team Decision|4|||
130245772|NCT03113136|468861672|FG002|Overall Study|Study Team Decision|0|||
130245773|NCT01666314|468861676|FG000|Overall Study|Adverse Event|3|||
130245774|NCT01666314|468861677|FG001|Overall Study|Adverse Event|13|||
130245775|NCT01666314|468861678|FG002|Overall Study|Adverse Event|7|||
130245776|NCT01666314|468861679|FG003|Overall Study|Adverse Event|7|||
130245777|NCT01666314|468861676|FG000|Overall Study|Progressive Disease|11|||
130245778|NCT01666314|468861677|FG001|Overall Study|Progressive Disease|9|||
130245779|NCT01666314|468861678|FG002|Overall Study|Progressive Disease|19|||
130245780|NCT01666314|468861679|FG003|Overall Study|Progressive Disease|20|||
130245781|NCT01666314|468861676|FG000|Overall Study|Symptomatic Deterioration|1|||
130245782|NCT01666314|468861677|FG001|Overall Study|Symptomatic Deterioration|0|||
130245783|NCT01666314|468861678|FG002|Overall Study|Symptomatic Deterioration|2|||
130245784|NCT01666314|468861679|FG003|Overall Study|Symptomatic Deterioration|0|||
130245785|NCT01666314|468861676|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
130245786|NCT01666314|468861677|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
130245787|NCT01666314|468861678|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
130245788|NCT01666314|468861679|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
130245789|NCT01666314|468861676|FG000|Overall Study|Withdrawal by Subject|1|||
130245790|NCT01666314|468861677|FG001|Overall Study|Withdrawal by Subject|1|||
130245791|NCT01666314|468861678|FG002|Overall Study|Withdrawal by Subject|2|||
130245792|NCT01666314|468861679|FG003|Overall Study|Withdrawal by Subject|3|||
130245793|NCT01666314|468861676|FG000|Overall Study|Reason not Specified|10|||
130245794|NCT01666314|468861677|FG001|Overall Study|Reason not Specified|7|||
130245795|NCT01666314|468861678|FG002|Overall Study|Reason not Specified|5|||
130245796|NCT01666314|468861679|FG003|Overall Study|Reason not Specified|5|||
130245797|NCT02114684|468861682|FG000|Overall Study|Death|6|||
130245798|NCT02114684|468861683|FG001|Overall Study|Death|4|||
130245799|NCT02114684|468861682|FG000|Overall Study|Lost to Follow-up|1|||
130245800|NCT02114684|468861683|FG001|Overall Study|Lost to Follow-up|2|||
130245801|NCT02114684|468861682|FG000|Overall Study|Withdrawal by Subject|1|||
130245802|NCT02114684|468861683|FG001|Overall Study|Withdrawal by Subject|2|||
130245803|NCT02114684|468861682|FG000|Overall Study|Relocation|3|||
130245804|NCT02114684|468861683|FG001|Overall Study|Relocation|1|||
130245805|NCT02114684|468861682|FG000|Overall Study|Rifampicin resistant on culture|0|||
130245806|NCT02114684|468861683|FG001|Overall Study|Rifampicin resistant on culture|1|||
130245807|NCT02114684|468861682|FG000|Overall Study|Patient Incarcerated|1|||
130245808|NCT02114684|468861683|FG001|Overall Study|Patient Incarcerated|0|||
130245809|NCT04625972|468861686|FG000|Overall Study|Death|3|||
130245810|NCT04625972|468861687|FG001|Overall Study|Death|2|||
130245811|NCT04625972|468861686|FG000|Overall Study|Lost to Follow-up|82|||
130245812|NCT04625972|468861687|FG001|Overall Study|Lost to Follow-up|38|||
130245813|NCT04625972|468861686|FG000|Overall Study|Physician Decision|2|||
130245814|NCT04625972|468861687|FG001|Overall Study|Physician Decision|0|||
130245815|NCT04625972|468861686|FG000|Overall Study|Protocol Violation|0|||
130245816|NCT04625972|468861687|FG001|Overall Study|Protocol Violation|1|||
130245817|NCT04625972|468861686|FG000|Overall Study|Withdrawal by Subject|37|||
130245818|NCT04625972|468861687|FG001|Overall Study|Withdrawal by Subject|24|||
130245819|NCT04625972|468861686|FG000|Overall Study|Not specified elsewhere|8|||
130245820|NCT04625972|468861687|FG001|Overall Study|Not specified elsewhere|6|||
130245821|NCT00694122|468861688|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
130245822|NCT00694122|468861689|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
130245823|NCT00694122|468861688|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
130245824|NCT00694122|468861689|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
130245825|NCT00694122|468861688|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
130245826|NCT00694122|468861689|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
130245827|NCT03020888|468861694|FG000|Overall Study|Physician Decision|4|||
130245828|NCT03020888|468861694|FG000|Overall Study|Withdrawal by Subject|6|||
130245829|NCT03020888|468861694|FG000|Overall Study|Insurance coverage|2|||
130245830|NCT03020888|468861694|FG000|Overall Study|Lost to Follow-up|1|||
130245831|NCT01198548|468861701|FG000|Overall Study|Disease Progression|9|||
129800239|NCT04755283|467236270|FG002|Overall Study|Withdrawal by Subject|6|||
130245832|NCT01198548|468861701|FG000|Overall Study|Administrative Decision|1|||
130245833|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
130245834|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
130245835|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
130245836|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Physician Decision|2|||
130245837|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Physician Decision|4|||
130245838|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Physician Decision|0|||
130245839|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
130245840|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
130245841|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
130245842|NCT01245062|468861703|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
130245843|NCT01245062|468861704|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
130245844|NCT01245062|468861705|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
130245845|NCT01245062|468861703|FG000|Cross-over Phase|Lost to Follow-up|0|||
130245846|NCT01245062|468861704|FG001|Cross-over Phase|Lost to Follow-up|0|||
130245847|NCT01245062|468861705|FG002|Cross-over Phase|Lost to Follow-up|1|||
130245848|NCT01245062|468861703|FG000|Cross-over Phase|Physician Decision|0|||
130245849|NCT01245062|468861704|FG001|Cross-over Phase|Physician Decision|0|||
130245850|NCT01245062|468861705|FG002|Cross-over Phase|Physician Decision|1|||
130245851|NCT01245062|468861703|FG000|Cross-over Phase|Withdrew Consent|0|||
130245852|NCT01245062|468861704|FG001|Cross-over Phase|Withdrew Consent|0|||
130245853|NCT01245062|468861705|FG002|Cross-over Phase|Withdrew Consent|4|||
130245854|NCT01245062|468861703|FG000|Cross-over Phase|Study closed/ terminated|0|||
130245855|NCT01245062|468861704|FG001|Cross-over Phase|Study closed/ terminated|0|||
130245856|NCT01245062|468861705|FG002|Cross-over Phase|Study closed/ terminated|11|||
130245857|NCT02015104|468861706|FG000|Overall Study|Withdrew consent after first dose drug|1|||
130245858|NCT02015104|468861707|FG001|Overall Study|Withdrew consent after first dose drug|0|||
130245859|NCT02015104|468861706|FG000|Overall Study|Withdrew consent prior to treatment|0|||
130245860|NCT02015104|468861707|FG001|Overall Study|Withdrew consent prior to treatment|1|||
130245861|NCT05788328|468863545|FG000|Treatment Period 4 (5 Days)|Other|1|||
130245862|NCT05788328|468863545|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
130245863|NCT00145327|468863546|FG000|Overall Study|Withdrawal by Subject|77|||
130245864|NCT00145327|468863547|FG001|Overall Study|Withdrawal by Subject|72|||
130245865|NCT00145327|468863548|FG002|Overall Study|Withdrawal by Subject|164|||
130245866|NCT00145327|468863546|FG000|Overall Study|Death|26|||
130245867|NCT00145327|468863547|FG001|Overall Study|Death|18|||
130245868|NCT00145327|468863548|FG002|Overall Study|Death|30|||
130245869|NCT00145327|468863546|FG000|Overall Study|Adverse Event|14|||
130245870|NCT00145327|468863547|FG001|Overall Study|Adverse Event|11|||
130245871|NCT00145327|468863548|FG002|Overall Study|Adverse Event|22|||
130245872|NCT00145327|468863546|FG000|Overall Study|Lost to Follow-up|9|||
130245873|NCT00145327|468863547|FG001|Overall Study|Lost to Follow-up|14|||
130245874|NCT00145327|468863548|FG002|Overall Study|Lost to Follow-up|14|||
130245875|NCT00145327|468863546|FG000|Overall Study|Administrative problems|12|||
130245876|NCT00145327|468863547|FG001|Overall Study|Administrative problems|9|||
130245877|NCT00145327|468863548|FG002|Overall Study|Administrative problems|13|||
130245878|NCT00145327|468863546|FG000|Overall Study|Protocol Violation|2|||
130245879|NCT00145327|468863547|FG001|Overall Study|Protocol Violation|0|||
130245880|NCT00145327|468863548|FG002|Overall Study|Protocol Violation|2|||
130245881|NCT00145327|468863546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130245882|NCT00145327|468863547|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130245883|NCT00145327|468863548|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130245884|NCT00145327|468863546|FG000|Overall Study|Missing - not stated|1|||
130245885|NCT00145327|468863547|FG001|Overall Study|Missing - not stated|0|||
130245886|NCT00145327|468863548|FG002|Overall Study|Missing - not stated|1|||
130245887|NCT03315689|468863549|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
130245888|NCT03315689|468863550|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
130030500|NCT00896532|468068549|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030501|NCT00896532|468068550|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030502|NCT00896532|468068551|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030503|NCT00896532|468068552|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030504|NCT00896532|468068553|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030505|NCT00896532|468068554|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030506|NCT00896532|468068555|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030507|NCT00896532|468068556|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030508|NCT00896532|468068557|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030509|NCT00896532|468068558|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030510|NCT00896532|468068559|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030511|NCT00896532|468068560|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030512|NCT00896532|468068561|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030513|NCT00896532|468068562|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
130245889|NCT03315689|468863549|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
130245890|NCT03315689|468863550|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
130245891|NCT03315689|468863549|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
130245892|NCT03315689|468863550|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
130245893|NCT00762788|468863551|FG000|Overall Study|Lost to Follow-up|26|||
130245894|NCT00762788|468863552|FG001|Overall Study|Lost to Follow-up|37|||
130245895|NCT00762788|468863553|FG002|Overall Study|Lost to Follow-up|21|||
130245896|NCT00762788|468863554|FG003|Overall Study|Lost to Follow-up|26|||
130245897|NCT00762788|468863555|FG004|Overall Study|Lost to Follow-up|13|||
130245898|NCT00762788|468863556|FG005|Overall Study|Lost to Follow-up|21|||
130245899|NCT00669331|468863558|FG000|Randomisation to First Dose|Adverse Event|1|||
130245900|NCT00669331|468863559|FG001|Randomisation to First Dose|Adverse Event|0|||
130245901|NCT00669331|468863558|FG000|Randomisation to First Dose|Protocol Violation|1|||
130245902|NCT00669331|468863559|FG001|Randomisation to First Dose|Protocol Violation|0|||
130245903|NCT00669331|468863558|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
130245904|NCT00669331|468863559|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
130245905|NCT00669331|468863558|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
130245906|NCT00669331|468863559|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
130100740|NCT00769132|468326055|FG002|Period 4|Withdrawal by Subject|0|||
130100741|NCT00769132|468326056|FG003|Period 4|Withdrawal by Subject|0|||
130100742|NCT01833897|468326060|FG000|Overall Study|Lack of Efficacy|1|||
130100743|NCT00127192|468326061|FG000|Overall Study|Adverse Event|0|||
130100744|NCT00127192|468326062|FG001|Overall Study|Adverse Event|1|||
130100745|NCT00127192|468326063|FG002|Overall Study|Adverse Event|1|||
130245907|NCT00669331|468863558|FG000|Randomisation to First Dose|Death|1|||
130245908|NCT00669331|468863559|FG001|Randomisation to First Dose|Death|0|||
130245909|NCT00669331|468863558|FG000|Randomisation to First Dose|Sponsor decision|0|||
130030514|NCT00896532|468068563|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
130030515|NCT02149810|468068564|FG000|Overall Study|Physician Decision|1|||
130030516|NCT02149810|468068565|FG001|Overall Study|Physician Decision|2|||
130030517|NCT02149810|468068564|FG000|Overall Study|Lost to Follow-up|2|||
130030518|NCT02149810|468068565|FG001|Overall Study|Lost to Follow-up|1|||
130030519|NCT02149810|468068564|FG000|Overall Study|Withdrawal by Subject|5|||
130030520|NCT02149810|468068565|FG001|Overall Study|Withdrawal by Subject|1|||
130030521|NCT01176916|468068566|FG000|Overall Study|Adverse Event|61|||
130030522|NCT01176916|468068566|FG000|Overall Study|Death|1|||
130030523|NCT01176916|468068566|FG000|Overall Study|Lost to Follow-up|15|||
130030524|NCT01176916|468068566|FG000|Overall Study|Objective progression or relapse|17|||
130030525|NCT01176916|468068566|FG000|Overall Study|Protocol Violation|24|||
130030526|NCT01176916|468068566|FG000|Overall Study|Withdrawal by Subject|37|||
130030527|NCT01176916|468068566|FG000|Overall Study|Other|6|||
130030528|NCT01176916|468068566|FG000|Overall Study|Withdrawal prior to Treatment|6|||
130030529|NCT03158220|468068567|FG000|Overall Study|Screen Failure|0|||
130030530|NCT03158220|468068568|FG001|Overall Study|Screen Failure|1|||
130030531|NCT03158220|468068567|FG000|Overall Study|Withdrawal by Subject|8|||
130030532|NCT03158220|468068568|FG001|Overall Study|Withdrawal by Subject|9|||
130030533|NCT03158220|468068567|FG000|Overall Study|Status unknown|0|||
130030534|NCT03158220|468068568|FG001|Overall Study|Status unknown|1|||
130030535|NCT03158220|468068567|FG000|Overall Study|Lost to Follow-up|8|||
130030536|NCT03158220|468068568|FG001|Overall Study|Lost to Follow-up|5|||
130030537|NCT03158220|468068567|FG000|Overall Study|Physician Decision|1|||
130030538|NCT03158220|468068568|FG001|Overall Study|Physician Decision|0|||
130030539|NCT01015833|468068569|FG000|Overall Study|Death|1|||
130030540|NCT01015833|468068570|FG001|Overall Study|Death|0|||
130030541|NCT01015833|468068569|FG000|Overall Study|Withdrawal by Subject|3|||
130030542|NCT01015833|468068570|FG001|Overall Study|Withdrawal by Subject|2|||
130030543|NCT01015833|468068569|FG000|Overall Study|Adverse Event|0|||
130030544|NCT01015833|468068570|FG001|Overall Study|Adverse Event|1|||
130030545|NCT01015833|468068569|FG000|Overall Study|Physician Decision|2|||
130030546|NCT01015833|468068570|FG001|Overall Study|Physician Decision|0|||
130030547|NCT01015833|468068569|FG000|Overall Study|Symptomatic deterioration|0|||
130030548|NCT01015833|468068570|FG001|Overall Study|Symptomatic deterioration|1|||
130030549|NCT01015833|468068569|FG000|Overall Study|Other|5|||
130030550|NCT01015833|468068570|FG001|Overall Study|Other|1|||
130030551|NCT01015833|468068569|FG000|Overall Study|Motor Vehicle Accidents|1|||
130030552|NCT01015833|468068570|FG001|Overall Study|Motor Vehicle Accidents|0|||
130030553|NCT01015833|468068569|FG000|Overall Study|Did not start treatment|1|||
130030554|NCT01015833|468068570|FG001|Overall Study|Did not start treatment|0|||
130030555|NCT01671280|468068571|FG000|Overall Study|Withdrawal by Subject|2|||
130030556|NCT01959165|468068572|FG000|Overall Study|Adverse Event|0|||
130030557|NCT01959165|468068573|FG001|Overall Study|Adverse Event|0|||
130030558|NCT01959165|468068574|FG002|Overall Study|Adverse Event|0|||
130030559|NCT01959165|468068575|FG003|Overall Study|Adverse Event|1|||
130030560|NCT01959165|468068572|FG000|Overall Study|Lack of Efficacy|1|||
130030561|NCT01959165|468068573|FG001|Overall Study|Lack of Efficacy|0|||
130245910|NCT00669331|468863559|FG001|Randomisation to First Dose|Sponsor decision|1|||
130245911|NCT00669331|468863558|FG000|Randomisation to First Dose|Randomised in error|3|||
130030562|NCT01959165|468068574|FG002|Overall Study|Lack of Efficacy|0|||
130030563|NCT01959165|468068575|FG003|Overall Study|Lack of Efficacy|0|||
130030564|NCT01959165|468068572|FG000|Overall Study|overdose|0|||
130030565|NCT01959165|468068573|FG001|Overall Study|overdose|0|||
130030566|NCT01959165|468068574|FG002|Overall Study|overdose|0|||
130100746|NCT00127192|468326064|FG003|Overall Study|Adverse Event|1|||
130245912|NCT00669331|468863559|FG001|Randomisation to First Dose|Randomised in error|10|||
130030567|NCT01959165|468068575|FG003|Overall Study|overdose|1|||
130030568|NCT01959165|468068572|FG000|Overall Study|Welfare recipient|0|||
130030569|NCT01959165|468068573|FG001|Overall Study|Welfare recipient|1|||
130100747|NCT00127192|468326065|FG004|Overall Study|Adverse Event|0|||
130245913|NCT00669331|468863558|FG000|Blinded Treatment Period|Adverse Event|16|||
130245914|NCT00669331|468863559|FG001|Blinded Treatment Period|Adverse Event|10|||
130245915|NCT00669331|468863558|FG000|Blinded Treatment Period|Protocol Violation|1|||
130245916|NCT00669331|468863559|FG001|Blinded Treatment Period|Protocol Violation|1|||
130245917|NCT00669331|468863558|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
130245918|NCT00669331|468863559|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
130245919|NCT00669331|468863558|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
130245920|NCT00669331|468863559|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
130245921|NCT00669331|468863558|FG000|Blinded Treatment Period|Death|0|||
130245922|NCT00669331|468863559|FG001|Blinded Treatment Period|Death|2|||
130245923|NCT00669331|468863558|FG000|Blinded Treatment Period|Physician Decision|3|||
130245924|NCT00669331|468863559|FG001|Blinded Treatment Period|Physician Decision|3|||
130245925|NCT00669331|468863558|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
130245926|NCT00669331|468863559|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
130245927|NCT01454063|468863560|FG000|Randomized|Adverse Event|1|||
130245928|NCT01454063|468863561|FG001|Randomized|Adverse Event|1|||
130245929|NCT01454063|468863560|FG000|Randomized|Protocol Violation|0|||
130245930|NCT01454063|468863561|FG001|Randomized|Protocol Violation|1|||
130245931|NCT03055195|468863562|FG000|Overall Study|Lack of Efficacy|1|||
130245932|NCT03055195|468863563|FG001|Overall Study|Lack of Efficacy|0|||
130245933|NCT03055195|468863562|FG000|Overall Study|Withdrawal by Subject|6|||
130245934|NCT03055195|468863563|FG001|Overall Study|Withdrawal by Subject|7|||
130245935|NCT03055195|468863562|FG000|Overall Study|Study Terminated by Sponsor|2|||
130245936|NCT03055195|468863563|FG001|Overall Study|Study Terminated by Sponsor|6|||
130245937|NCT03055195|468863562|FG000|Overall Study|Protocol Violation|2|||
130245938|NCT03055195|468863563|FG001|Overall Study|Protocol Violation|1|||
130245939|NCT03055195|468863562|FG000|Overall Study|Physician Decision|1|||
130245940|NCT03055195|468863563|FG001|Overall Study|Physician Decision|0|||
130245941|NCT02568423|468863566|FG000|Overall Study|Lost to Follow-up|0|||
130245942|NCT02568423|468863567|FG001|Overall Study|Lost to Follow-up|2|||
130245943|NCT02568423|468863568|FG002|Overall Study|Lost to Follow-up|0|||
130245944|NCT02568423|468863569|FG003|Overall Study|Lost to Follow-up|0|||
130245945|NCT02568423|468863570|FG004|Overall Study|Lost to Follow-up|0|||
130245946|NCT02568423|468863571|FG005|Overall Study|Lost to Follow-up|0|||
130245947|NCT02568423|468863572|FG006|Overall Study|Lost to Follow-up|0|||
130245948|NCT02568423|468863573|FG007|Overall Study|Lost to Follow-up|0|||
130245949|NCT02568423|468863566|FG000|Overall Study|Physician Decision|0|||
130245950|NCT02568423|468863567|FG001|Overall Study|Physician Decision|0|||
130245951|NCT02568423|468863568|FG002|Overall Study|Physician Decision|0|||
130245952|NCT02568423|468863569|FG003|Overall Study|Physician Decision|0|||
130245953|NCT02568423|468863570|FG004|Overall Study|Physician Decision|0|||
130245954|NCT02568423|468863571|FG005|Overall Study|Physician Decision|1|||
130245955|NCT02568423|468863572|FG006|Overall Study|Physician Decision|0|||
130245956|NCT02568423|468863573|FG007|Overall Study|Physician Decision|0|||
130245957|NCT01027416|468863576|FG000|Overall Study|Withdrawal by Subject|0|||
130245958|NCT01027416|468863577|FG001|Overall Study|Withdrawal by Subject|1|||
130245959|NCT01027416|468863576|FG000|Overall Study|Physician Decision|1|||
130245960|NCT01027416|468863577|FG001|Overall Study|Physician Decision|4|||
130245961|NCT01960842|468863584|FG000|Overall Study|Adverse Event|1|||
130245962|NCT01960842|468863584|FG000|Overall Study|Withdrawal by Subject|2|||
130245963|NCT00397930|468863585|FG000|Overall Study|Personal reasons|14|||
130245964|NCT00397930|468863586|FG001|Overall Study|Personal reasons|8|||
130245965|NCT00397930|468863585|FG000|Overall Study|Other medical|9|||
130030570|NCT01959165|468068574|FG002|Overall Study|Welfare recipient|0|||
130030571|NCT01959165|468068575|FG003|Overall Study|Welfare recipient|0|||
130245966|NCT00397930|468863586|FG001|Overall Study|Other medical|4|||
130245967|NCT00397930|468863585|FG000|Overall Study|Unknown reasons|9|||
130245968|NCT00397930|468863586|FG001|Overall Study|Unknown reasons|14|||
130245969|NCT00397930|468863585|FG000|Overall Study|Noncompliant|3|||
130245970|NCT00397930|468863586|FG001|Overall Study|Noncompliant|2|||
130245971|NCT00397930|468863585|FG000|Overall Study|Too time-consuming|2|||
130245972|NCT00397930|468863586|FG001|Overall Study|Too time-consuming|9|||
130245973|NCT00397930|468863585|FG000|Overall Study|Started own yoga program|1|||
130245974|NCT00397930|468863586|FG001|Overall Study|Started own yoga program|1|||
130245975|NCT00397930|468863585|FG000|Overall Study|Did not want to be in control group|0|||
130030572|NCT02899156|468068591|FG000|Overall Study|Death|1|||
130030573|NCT02899156|468068592|FG001|Overall Study|Death|0|||
130030574|NCT02899156|468068591|FG000|Overall Study|Physician Decision|0|||
130245976|NCT00397930|468863586|FG001|Overall Study|Did not want to be in control group|1|||
130245977|NCT00397930|468863585|FG000|Overall Study|Withdrawal by Subject|0|||
130245978|NCT00397930|468863586|FG001|Overall Study|Withdrawal by Subject|8|||
130245979|NCT00397930|468863585|FG000|Overall Study|Missing data|0|||
130245980|NCT00397930|468863586|FG001|Overall Study|Missing data|4|||
130245981|NCT02391584|468863587|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
130245982|NCT02391584|468863588|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
130245983|NCT02391584|468863587|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
130030575|NCT02899156|468068592|FG001|Overall Study|Physician Decision|1|||
130030576|NCT00787787|468068595|FG000|Overall Study|Lack of Efficacy|4|||
130030577|NCT00787787|468068595|FG000|Overall Study|Adverse Event|3|||
130030578|NCT05032950|468068597|FG000|Overall Study|Adverse Event|0|||
130030579|NCT05032950|468068598|FG001|Overall Study|Adverse Event|0|||
130030580|NCT05032950|468068599|FG002|Overall Study|Adverse Event|1|||
130245984|NCT02391584|468863588|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
130245985|NCT02391584|468863587|FG000|3 Month|Lost to Follow-up|1|||
130245986|NCT02391584|468863588|FG001|3 Month|Lost to Follow-up|0|||
130245987|NCT02391584|468863587|FG000|6 Month|Withdrawal by Subject|1|||
130245988|NCT02391584|468863588|FG001|6 Month|Withdrawal by Subject|0|||
130245989|NCT02391584|468863587|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
130245990|NCT02391584|468863588|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
130245991|NCT02056288|468863591|FG000|In-Hospital Data|Surgery cancelled|1|||
130245992|NCT02056288|468863592|FG001|In-Hospital Data|Surgery cancelled|0|||
130245993|NCT02056288|468863591|FG000|In-Hospital Data|Protocol Violation|3|||
130245994|NCT02056288|468863592|FG001|In-Hospital Data|Protocol Violation|0|||
130245995|NCT02056288|468863591|FG000|In-Hospital Data|Physician Decision|1|||
130245996|NCT02056288|468863592|FG001|In-Hospital Data|Physician Decision|0|||
130245997|NCT02056288|468863591|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
130245998|NCT02056288|468863592|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
130245999|NCT00500110|468863599|FG000|Overall Study|Withdrawal by Subject|3|||
130246000|NCT01502072|468863600|FG000|Overall Study|Withdrawal by Subject|1|||
130246001|NCT01502072|468863601|FG001|Overall Study|Withdrawal by Subject|0|||
130246002|NCT01502072|468863602|FG002|Overall Study|Withdrawal by Subject|0|||
130246003|NCT01502072|468863600|FG000|Overall Study|Death|0|||
130246004|NCT01502072|468863601|FG001|Overall Study|Death|1|||
130246005|NCT01502072|468863602|FG002|Overall Study|Death|0|||
130246006|NCT00617903|468863608|FG000|Overall Study|Withdrawal by Subject|2|||
130246007|NCT00617903|468863609|FG001|Overall Study|Withdrawal by Subject|3|||
130246008|NCT00617903|468863608|FG000|Overall Study|Lost to Follow-up|1|||
130030581|NCT05032950|468068600|FG003|Overall Study|Adverse Event|1|||
130030582|NCT05032950|468068601|FG004|Overall Study|Adverse Event|0|||
130030583|NCT05032950|468068602|FG005|Overall Study|Adverse Event|0|||
130100748|NCT00127192|468326061|FG000|Overall Study|Lack of Efficacy|2|||
130246009|NCT00617903|468863609|FG001|Overall Study|Lost to Follow-up|1|||
130246010|NCT00617903|468863608|FG000|Overall Study|Lack of Efficacy|0|||
130246011|NCT00617903|468863609|FG001|Overall Study|Lack of Efficacy|1|||
130246012|NCT00617903|468863608|FG000|Overall Study|Adverse Event|0|||
130246013|NCT00617903|468863609|FG001|Overall Study|Adverse Event|1|||
130246014|NCT00617903|468863608|FG000|Overall Study|noncompliance|0|||
130246015|NCT00617903|468863609|FG001|Overall Study|noncompliance|1|||
130100749|NCT00127192|468326062|FG001|Overall Study|Lack of Efficacy|0|||
130246016|NCT04676646|468863610|FG000|Open-label Run-in Phase|Adverse Event|3|||
130246017|NCT04676646|468863611|FG001|Open-label Run-in Phase|Adverse Event|0|||
130246018|NCT04676646|468863612|FG002|Open-label Run-in Phase|Adverse Event|0|||
130246019|NCT04676646|468863610|FG000|Open-label Run-in Phase|Death|3|||
130246020|NCT04676646|468863611|FG001|Open-label Run-in Phase|Death|0|||
130246021|NCT04676646|468863612|FG002|Open-label Run-in Phase|Death|0|||
130246022|NCT04676646|468863610|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
130246023|NCT04676646|468863611|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
130246024|NCT04676646|468863612|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
130246025|NCT04676646|468863610|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
130246026|NCT04676646|468863611|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
130246027|NCT04676646|468863612|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
130246028|NCT04676646|468863610|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
130246029|NCT04676646|468863611|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
130246030|NCT04676646|468863612|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
130246031|NCT04676646|468863610|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
130246032|NCT04676646|468863611|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
130246033|NCT04676646|468863612|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
130246034|NCT04676646|468863610|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
130030584|NCT02959814|468068604|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
130030585|NCT02959814|468068604|FG000|Overall Study|Excluded based on anatomical criteria|2|||
130100750|NCT00127192|468326063|FG002|Overall Study|Lack of Efficacy|0|||
130246035|NCT04676646|468863611|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
130246036|NCT04676646|468863612|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
130030586|NCT02959814|468068604|FG000|Overall Study|Protocol Violation|7|||
130246037|NCT04676646|468863610|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
130246038|NCT04676646|468863611|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
130246039|NCT04676646|468863612|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
130246040|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
130246041|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
130246042|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
130246043|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Death|0|||
130246044|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Death|1|||
130246045|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Death|2|||
130246046|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
130246047|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
130246048|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
130246049|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
130030587|NCT02959814|468068604|FG000|Overall Study|FFR not measured|2|||
130030588|NCT02959814|468068604|FG000|Overall Study|In-procedure QFR not computed|6|||
130030589|NCT02959814|468068604|FG000|Overall Study|Excluded by FFR core-lab|24|||
130030590|NCT02116621|468068605|FG000|Baseline|Withdrawal by Subject|0|||
130030591|NCT02116621|468068606|FG001|Baseline|Withdrawal by Subject|4|||
130246050|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
130246051|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
130246052|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
130246053|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
130246054|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
130246055|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
130246056|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
130246057|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
130246058|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
130246059|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
130246060|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
130246061|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
130246062|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
130246063|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
130030592|NCT02116621|468068605|FG000|Three Month Follow-up|Death|1|||
130030593|NCT02116621|468068606|FG001|Three Month Follow-up|Death|1|||
130030594|NCT02116621|468068605|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
130030595|NCT02116621|468068606|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
130030596|NCT02116621|468068605|FG000|Three Month Follow-up|Lost to Follow-up|0|||
130030597|NCT02116621|468068606|FG001|Three Month Follow-up|Lost to Follow-up|1|||
130246064|NCT04676646|468863610|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
130246065|NCT04676646|468863611|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
130246066|NCT04676646|468863612|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
130246067|NCT03123588|468863620|FG000|Overall Study|Study Terminated by Sponsor|2|||
130246068|NCT03123588|468863621|FG001|Overall Study|Study Terminated by Sponsor|5|||
130246069|NCT03123588|468863620|FG000|Overall Study|Withdrawal by Subject|1|||
130246070|NCT03123588|468863621|FG001|Overall Study|Withdrawal by Subject|0|||
130246071|NCT03123588|468863620|FG000|Overall Study|Adverse Event|1|||
130246072|NCT03123588|468863621|FG001|Overall Study|Adverse Event|0|||
130246073|NCT03123588|468863620|FG000|Overall Study|Physician Decision|2|||
130246074|NCT03123588|468863621|FG001|Overall Study|Physician Decision|1|||
130246075|NCT01058005|468863622|FG000|Overall Study|Adverse Event|0|||
130246076|NCT01058005|468863623|FG001|Overall Study|Adverse Event|2|||
130246077|NCT01058005|468863624|FG002|Overall Study|Adverse Event|1|||
130246078|NCT01058005|468863622|FG000|Overall Study|Physician Decision|2|||
130246079|NCT01058005|468863623|FG001|Overall Study|Physician Decision|2|||
130246080|NCT01058005|468863624|FG002|Overall Study|Physician Decision|0|||
130246081|NCT01058005|468863622|FG000|Overall Study|Withdrawal by Subject|4|||
130246082|NCT01058005|468863623|FG001|Overall Study|Withdrawal by Subject|5|||
130246083|NCT01058005|468863624|FG002|Overall Study|Withdrawal by Subject|11|||
130246084|NCT01058005|468863622|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
130246085|NCT01058005|468863623|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
130246086|NCT01058005|468863624|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
130246087|NCT01058005|468863622|FG000|Overall Study|Reason Missing|5|||
130246088|NCT01058005|468863623|FG001|Overall Study|Reason Missing|3|||
130246089|NCT01058005|468863624|FG002|Overall Study|Reason Missing|1|||
130246090|NCT02287025|468863625|FG000|Overall Study|Not treated|2|||
130246091|NCT02287025|468863626|FG001|Overall Study|Not treated|0|||
130030598|NCT02116621|468068605|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
130030599|NCT02116621|468068606|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
130030600|NCT02116621|468068605|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
130030601|NCT02116621|468068606|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
130246092|NCT02287025|468863625|FG000|Overall Study|Progression of disease|3|||
130246093|NCT02287025|468863626|FG001|Overall Study|Progression of disease|2|||
130246094|NCT02287025|468863625|FG000|Overall Study|Adverse Event|2|||
130246095|NCT02287025|468863626|FG001|Overall Study|Adverse Event|4|||
130246096|NCT02287025|468863625|FG000|Overall Study|Withdrawal by Subject|2|||
130246097|NCT02287025|468863626|FG001|Overall Study|Withdrawal by Subject|2|||
130246098|NCT02287025|468863625|FG000|Overall Study|Screening failed|1|||
130246099|NCT02287025|468863626|FG001|Overall Study|Screening failed|1|||
130246100|NCT04053452|468863627|FG000|Overall Study|Withdrawal by Subject|1|||
130246101|NCT04053452|468863628|FG001|Overall Study|Withdrawal by Subject|0|||
130246102|NCT04053452|468863627|FG000|Overall Study|Time restraint due to inpatient needs|1|||
130246103|NCT04053452|468863628|FG001|Overall Study|Time restraint due to inpatient needs|2|||
130246104|NCT01421134|468863629|FG000|Overall Study|Adverse Event|3|||
130246105|NCT01421134|468863630|FG001|Overall Study|Adverse Event|5|||
130246106|NCT01421134|468863629|FG000|Overall Study|Lack of Efficacy|2|||
130246107|NCT01421134|468863630|FG001|Overall Study|Lack of Efficacy|4|||
130246108|NCT01421134|468863629|FG000|Overall Study|Protocol Violation|0|||
130246109|NCT01421134|468863630|FG001|Overall Study|Protocol Violation|3|||
130246110|NCT01421134|468863629|FG000|Overall Study|Withdrawal by Subject|1|||
130246111|NCT01421134|468863630|FG001|Overall Study|Withdrawal by Subject|1|||
130246112|NCT01421134|468863629|FG000|Overall Study|Administrative|0|||
130246113|NCT01421134|468863630|FG001|Overall Study|Administrative|1|||
130246114|NCT01421134|468863629|FG000|Overall Study|Lost to Follow-up|1|||
130246115|NCT01421134|468863630|FG001|Overall Study|Lost to Follow-up|1|||
130246116|NCT02346370|468863633|FG000|Overall Study|Not treated|1|||
130246117|NCT02346370|468863634|FG001|Overall Study|Not treated|0|||
130246118|NCT02346370|468863635|FG002|Overall Study|Not treated|0|||
130246119|NCT02346370|468863633|FG000|Overall Study|Withdrawal of consent|1|||
130246120|NCT02346370|468863634|FG001|Overall Study|Withdrawal of consent|0|||
130246121|NCT02346370|468863635|FG002|Overall Study|Withdrawal of consent|0|||
130246122|NCT02346370|468863633|FG000|Overall Study|Death|1|||
130246123|NCT02346370|468863634|FG001|Overall Study|Death|3|||
130030602|NCT02116621|468068605|FG000|Six Month Follow-up|Lost to Follow-up|2|||
130030603|NCT02116621|468068606|FG001|Six Month Follow-up|Lost to Follow-up|1|||
130030604|NCT02116621|468068605|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
130030605|NCT02116621|468068606|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
130030606|NCT02116621|468068605|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
130030607|NCT02116621|468068606|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
130030608|NCT02116621|468068605|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
130030609|NCT02116621|468068606|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
130030610|NCT02116621|468068605|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
130030611|NCT02116621|468068606|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
130030612|NCT02116621|468068605|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
130030613|NCT02116621|468068606|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
130030614|NCT00961961|468068607|FG000|Phase I|Withdrawal by Subject|7|||
130030615|NCT00961961|468068608|FG001|Phase I|Withdrawal by Subject|0|||
130030616|NCT00961961|468068609|FG002|Phase I|Withdrawal by Subject|0|||
130030617|NCT00961961|468068610|FG003|Phase I|Withdrawal by Subject|0|||
130030618|NCT00961961|468068607|FG000|Phase I|Lost to Follow-up|10|||
130030619|NCT00961961|468068608|FG001|Phase I|Lost to Follow-up|0|||
130030620|NCT00961961|468068609|FG002|Phase I|Lost to Follow-up|0|||
130030621|NCT00961961|468068610|FG003|Phase I|Lost to Follow-up|0|||
130030622|NCT00961961|468068607|FG000|Phase I|Lack of Efficacy|94|||
130030623|NCT00961961|468068608|FG001|Phase I|Lack of Efficacy|0|||
130030624|NCT00961961|468068609|FG002|Phase I|Lack of Efficacy|0|||
130030625|NCT00961961|468068610|FG003|Phase I|Lack of Efficacy|0|||
130030626|NCT00961961|468068607|FG000|Phase I|Adverse Event|7|||
130030627|NCT00961961|468068608|FG001|Phase I|Adverse Event|0|||
130030628|NCT00961961|468068609|FG002|Phase I|Adverse Event|0|||
130030629|NCT00961961|468068610|FG003|Phase I|Adverse Event|0|||
130030630|NCT00961961|468068607|FG000|Phase I|Physician Decision|8|||
130030631|NCT00961961|468068608|FG001|Phase I|Physician Decision|0|||
130030632|NCT00961961|468068609|FG002|Phase I|Physician Decision|0|||
130030633|NCT00961961|468068610|FG003|Phase I|Physician Decision|0|||
130030634|NCT00961961|468068607|FG000|Phase II|Lost to Follow-up|0|||
130030635|NCT00961961|468068608|FG001|Phase II|Lost to Follow-up|0|||
130030636|NCT00961961|468068609|FG002|Phase II|Lost to Follow-up|10|||
130030637|NCT00961961|468068610|FG003|Phase II|Lost to Follow-up|7|||
130030638|NCT00961961|468068607|FG000|Phase II|Adverse Event|0|||
130030639|NCT00961961|468068608|FG001|Phase II|Adverse Event|0|||
130030640|NCT00961961|468068609|FG002|Phase II|Adverse Event|0|||
130030641|NCT00961961|468068610|FG003|Phase II|Adverse Event|1|||
130030642|NCT00961961|468068607|FG000|Phase II|Physician Decision|0|||
130030643|NCT00961961|468068608|FG001|Phase II|Physician Decision|0|||
130030644|NCT00961961|468068609|FG002|Phase II|Physician Decision|1|||
130030645|NCT00961961|468068610|FG003|Phase II|Physician Decision|0|||
130030646|NCT00961961|468068607|FG000|Phase II|Withdrawal by Subject|0|||
130246124|NCT02346370|468863635|FG002|Overall Study|Death|1|||
130246125|NCT02346370|468863633|FG000|Overall Study|Sponsor discontinued study|5|||
130246126|NCT02346370|468863634|FG001|Overall Study|Sponsor discontinued study|0|||
130246127|NCT02346370|468863635|FG002|Overall Study|Sponsor discontinued study|2|||
130246128|NCT02346370|468863633|FG000|Overall Study|Radiologic progression|0|||
130246129|NCT02346370|468863634|FG001|Overall Study|Radiologic progression|0|||
130246130|NCT02346370|468863635|FG002|Overall Study|Radiologic progression|1|||
130246131|NCT02346370|468863633|FG000|Overall Study|Physician Decision|0|||
130246132|NCT02346370|468863634|FG001|Overall Study|Physician Decision|1|||
130246133|NCT02346370|468863635|FG002|Overall Study|Physician Decision|0|||
130246134|NCT03528577|468863636|FG000|Sequence 1|Failed Spirometry|1|||
130246135|NCT03528577|468863636|FG000|Sequence 1|Restricted medication|1|||
130246136|NCT03528577|468863636|FG000|Sequence 2|Adverse Event|1|||
130246137|NCT03528577|468863636|FG000|Sequence 2|Withdrawal by Subject|1|||
130246138|NCT03528577|468863636|FG000|Sequence 2|Failed Spirometry|1|||
130246139|NCT03528577|468863636|FG000|Sequence 3|Failed Spirometry|1|||
130246140|NCT03528577|468863636|FG000|Sequence 4|Failed Spirometry|2|||
130246141|NCT03528577|468863636|FG000|Sequence 4|Adverse Event|1|||
130246142|NCT04882215|468863637|FG000|Overall Study|Withdrawal by Subject|5|||
130246143|NCT04882215|468863638|FG001|Overall Study|Withdrawal by Subject|0|||
130246144|NCT04263532|468863639|FG000|Overall Study|Withdrawal by Subject|2|||
130246145|NCT04263532|468863640|FG001|Overall Study|Withdrawal by Subject|0|||
130246146|NCT04098302|468863643|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
130246147|NCT04098302|468863644|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
130246148|NCT04098302|468863645|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
130246149|NCT04098302|468863646|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
130246150|NCT04098302|468863643|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
130246151|NCT04098302|468863644|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130246152|NCT04098302|468863645|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130246153|NCT04098302|468863646|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
130246154|NCT04098302|468863643|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
130246155|NCT04098302|468863644|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
130246156|NCT04098302|468863645|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
130246157|NCT04098302|468863646|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
130246158|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
130246159|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
130246160|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
130246161|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
130246162|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
130246163|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
130246164|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
130246165|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
130246166|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130246167|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130246168|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
130246169|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
130246170|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130246171|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130246172|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
130246173|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
130246174|NCT04098302|468863643|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130246175|NCT04098302|468863644|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130246176|NCT04098302|468863645|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
130246177|NCT04098302|468863646|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
130246178|NCT01290731|468863649|FG000|Overall Study|Withdrawal by Subject|1|||
130246179|NCT01399099|468863650|FG000|Overall Study|Lost to Follow-up|14|||
130246180|NCT01399099|468863650|FG000|Overall Study|Physician Decision|1|||
130246181|NCT01399099|468863650|FG000|Overall Study|Protocol Violation|1|||
130246182|NCT01399099|468863650|FG000|Overall Study|Skin Irritation|13|||
130246183|NCT01399099|468863650|FG000|Overall Study|Infection|1|||
130246184|NCT01399099|468863650|FG000|Overall Study|Miscellaneous|4|||
130246185|NCT01668537|468863651|FG000|Overall Study|Request to Discontinue Prematurely|1|||
130246186|NCT01668537|468863652|FG001|Overall Study|Request to Discontinue Prematurely|1|||
130246187|NCT01668537|468863651|FG000|Overall Study|Subject unwilling/unable to comply|5|||
130246188|NCT01668537|468863652|FG001|Overall Study|Subject unwilling/unable to comply|0|||
130246189|NCT01668537|468863651|FG000|Overall Study|Reason Precludes Participation|1|||
130246190|NCT01668537|468863652|FG001|Overall Study|Reason Precludes Participation|0|||
130246191|NCT01668537|468863651|FG000|Overall Study|Lost to Follow-up|13|||
130246192|NCT01668537|468863652|FG001|Overall Study|Lost to Follow-up|6|||
130246193|NCT01668537|468863651|FG000|Overall Study|Other|2|||
130246194|NCT01668537|468863652|FG001|Overall Study|Other|3|||
130246195|NCT05064800|468863653|FG000|Period 3|Withdrawal by Subject|0|||
130246196|NCT05064800|468863654|FG001|Period 3|Withdrawal by Subject|0|||
129800240|NCT04755283|467236268|FG000|Overall Study|Lost to Follow-up|0|||
130246197|NCT05064800|468863655|FG002|Period 3|Withdrawal by Subject|0|||
130246198|NCT05064800|468863656|FG003|Period 3|Withdrawal by Subject|0|||
130246199|NCT05064800|468863657|FG004|Period 3|Withdrawal by Subject|1|||
130246200|NCT05064800|468863658|FG005|Period 3|Withdrawal by Subject|0|||
130246201|NCT04477486|468863659|FG000|Overall Study|Death|2|||
130246202|NCT04477486|468863659|FG000|Overall Study|Ongoing at Time of Analysis|11|||
130246203|NCT01078545|468863662|FG000|Overall Study|Lost to Follow-up|13|||
130246204|NCT01078545|468863662|FG000|Overall Study|Physician Decision|6|||
130246205|NCT01078545|468863662|FG000|Overall Study|Withdrawal by Subject|3|||
130246206|NCT01078545|468863662|FG000|Overall Study|Death|3|||
130246207|NCT01078545|468863662|FG000|Overall Study|Participant moved to another physician|1|||
130246208|NCT02497755|468863663|FG000|Overall Study|Protocol Violation|1|||
130246209|NCT02497755|468863664|FG001|Overall Study|Protocol Violation|0|||
130246210|NCT01774370|468863667|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
130246211|NCT01774370|468863667|FG000|Overall Study|Administered prior to the contract date|4|||
130246212|NCT01774370|468863667|FG000|Overall Study|Subjects of contraindications|34|||
130246213|NCT01774370|468863667|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
130246214|NCT01774370|468863667|FG000|Overall Study|Follow-up failure|34|||
130246215|NCT05436288|468863668|FG000|Overall Study|Lost to Follow-up|1|||
130246216|NCT05436288|468863668|FG000|Overall Study|Adverse Event|1|||
130246217|NCT01436500|468863672|FG000|Overall Study|Death|1|||
130246218|NCT01436500|468863673|FG001|Overall Study|Death|0|||
130246219|NCT01436500|468863674|FG002|Overall Study|Death|0|||
130246220|NCT01436500|468863675|FG003|Overall Study|Death|0|||
130246221|NCT01436500|468863676|FG004|Overall Study|Death|0|||
130246222|NCT01436500|468863672|FG000|Overall Study|Adverse Event|0|||
130246223|NCT01436500|468863673|FG001|Overall Study|Adverse Event|2|||
130246224|NCT01436500|468863674|FG002|Overall Study|Adverse Event|2|||
130246225|NCT01436500|468863675|FG003|Overall Study|Adverse Event|0|||
130246226|NCT01436500|468863676|FG004|Overall Study|Adverse Event|1|||
130246227|NCT01436500|468863672|FG000|Overall Study|Withdrawal by Subject|0|||
130246228|NCT01436500|468863673|FG001|Overall Study|Withdrawal by Subject|0|||
130246229|NCT01436500|468863674|FG002|Overall Study|Withdrawal by Subject|2|||
130246230|NCT01436500|468863675|FG003|Overall Study|Withdrawal by Subject|0|||
130246231|NCT01436500|468863676|FG004|Overall Study|Withdrawal by Subject|2|||
130246232|NCT01436500|468863672|FG000|Overall Study|Physician Decision|0|||
130246233|NCT01436500|468863673|FG001|Overall Study|Physician Decision|0|||
130246234|NCT01436500|468863674|FG002|Overall Study|Physician Decision|1|||
130246235|NCT01436500|468863675|FG003|Overall Study|Physician Decision|0|||
130246236|NCT01436500|468863676|FG004|Overall Study|Physician Decision|0|||
130246237|NCT01436500|468863672|FG000|Overall Study|liver transplant|1|||
130246238|NCT01436500|468863673|FG001|Overall Study|liver transplant|0|||
130246239|NCT01436500|468863674|FG002|Overall Study|liver transplant|0|||
130246240|NCT01436500|468863675|FG003|Overall Study|liver transplant|0|||
130246241|NCT01436500|468863676|FG004|Overall Study|liver transplant|0|||
130246242|NCT01436500|468863672|FG000|Overall Study|initiation of dialysis|0|||
130246243|NCT01436500|468863673|FG001|Overall Study|initiation of dialysis|0|||
130246244|NCT01436500|468863674|FG002|Overall Study|initiation of dialysis|0|||
130246245|NCT01436500|468863675|FG003|Overall Study|initiation of dialysis|0|||
130246246|NCT01436500|468863676|FG004|Overall Study|initiation of dialysis|1|||
130246247|NCT01436500|468863672|FG000|Overall Study|discontinued study drug|1|||
130246248|NCT01436500|468863673|FG001|Overall Study|discontinued study drug|0|||
130246249|NCT01436500|468863674|FG002|Overall Study|discontinued study drug|0|||
130246250|NCT01436500|468863675|FG003|Overall Study|discontinued study drug|0|||
130246251|NCT01436500|468863676|FG004|Overall Study|discontinued study drug|0|||
130246252|NCT01436500|468863672|FG000|Overall Study|Other|0|||
130246253|NCT01436500|468863673|FG001|Overall Study|Other|1|||
130246254|NCT01436500|468863674|FG002|Overall Study|Other|0|||
130246255|NCT01436500|468863675|FG003|Overall Study|Other|1|||
130246256|NCT01436500|468863676|FG004|Overall Study|Other|0|||
130246257|NCT01487161|468863678|FG000|Overall Study|Adverse Event|1|||
130246258|NCT01487161|468863679|FG001|Overall Study|Adverse Event|0|||
130246259|NCT01487161|468863680|FG002|Overall Study|Adverse Event|0|||
130246260|NCT01487161|468863681|FG003|Overall Study|Adverse Event|0|||
130246261|NCT01487161|468863678|FG000|Overall Study|Withdrawal by Subject|1|||
130246262|NCT01487161|468863679|FG001|Overall Study|Withdrawal by Subject|1|||
130246263|NCT01487161|468863680|FG002|Overall Study|Withdrawal by Subject|1|||
130246264|NCT01487161|468863681|FG003|Overall Study|Withdrawal by Subject|2|||
130246265|NCT01487161|468863678|FG000|Overall Study|missing data|0|||
130246266|NCT01487161|468863679|FG001|Overall Study|missing data|1|||
130246267|NCT01487161|468863680|FG002|Overall Study|missing data|0|||
130246268|NCT01487161|468863681|FG003|Overall Study|missing data|0|||
130246269|NCT02675452|468863685|FG000|Overall Study|Sponsor decision|0|||
130246270|NCT02675452|468863686|FG001|Overall Study|Sponsor decision|0|||
130246271|NCT02675452|468863687|FG002|Overall Study|Sponsor decision|0|||
130246272|NCT02675452|468863688|FG003|Overall Study|Sponsor decision|0|||
130246273|NCT02675452|468863689|FG004|Overall Study|Sponsor decision|0|||
130246274|NCT02675452|468863690|FG005|Overall Study|Sponsor decision|0|||
130246275|NCT02675452|468863691|FG006|Overall Study|Sponsor decision|0|||
130246276|NCT02675452|468863692|FG007|Overall Study|Sponsor decision|0|||
130246277|NCT02675452|468863693|FG008|Overall Study|Sponsor decision|0|||
130246278|NCT02675452|468863694|FG009|Overall Study|Sponsor decision|1|||
130246279|NCT02675452|468863695|FG010|Overall Study|Sponsor decision|0|||
130246280|NCT02675452|468863696|FG011|Overall Study|Sponsor decision|0|||
130246281|NCT02675452|468863697|FG012|Overall Study|Sponsor decision|0|||
130246282|NCT02675452|468863698|FG013|Overall Study|Sponsor decision|2|||
130246283|NCT02675452|468863699|FG014|Overall Study|Sponsor decision|1|||
130246284|NCT02675452|468863700|FG015|Overall Study|Sponsor decision|0|||
130246285|NCT02675452|468863701|FG016|Overall Study|Sponsor decision|1|||
130246286|NCT02675452|468863702|FG017|Overall Study|Sponsor decision|0|||
130246287|NCT02675452|468863703|FG018|Overall Study|Sponsor decision|0|||
130246288|NCT02675452|468863704|FG019|Overall Study|Sponsor decision|0|||
130246289|NCT02675452|468863705|FG020|Overall Study|Sponsor decision|0|||
130246290|NCT02675452|468863706|FG021|Overall Study|Sponsor decision|0|||
130246291|NCT02675452|468863707|FG022|Overall Study|Sponsor decision|0|||
130246292|NCT02675452|468863708|FG023|Overall Study|Sponsor decision|0|||
130246293|NCT02675452|468863709|FG024|Overall Study|Sponsor decision|0|||
130246294|NCT02675452|468863710|FG025|Overall Study|Sponsor decision|0|||
130246295|NCT02675452|468863711|FG026|Overall Study|Sponsor decision|2|||
130246296|NCT02675452|468863712|FG027|Overall Study|Sponsor decision|0|||
130246297|NCT02675452|468863713|FG028|Overall Study|Sponsor decision|0|||
130246298|NCT02675452|468863685|FG000|Overall Study|Withdrawal by Subject|0|||
130246299|NCT02675452|468863686|FG001|Overall Study|Withdrawal by Subject|0|||
130246300|NCT02675452|468863687|FG002|Overall Study|Withdrawal by Subject|0|||
130246301|NCT02675452|468863688|FG003|Overall Study|Withdrawal by Subject|0|||
130246302|NCT02675452|468863689|FG004|Overall Study|Withdrawal by Subject|0|||
130246303|NCT02675452|468863690|FG005|Overall Study|Withdrawal by Subject|0|||
130246304|NCT02675452|468863691|FG006|Overall Study|Withdrawal by Subject|0|||
130246305|NCT02675452|468863692|FG007|Overall Study|Withdrawal by Subject|0|||
130246306|NCT02675452|468863693|FG008|Overall Study|Withdrawal by Subject|0|||
130246307|NCT02675452|468863694|FG009|Overall Study|Withdrawal by Subject|1|||
130246308|NCT02675452|468863695|FG010|Overall Study|Withdrawal by Subject|0|||
130246309|NCT02675452|468863696|FG011|Overall Study|Withdrawal by Subject|1|||
130246310|NCT02675452|468863697|FG012|Overall Study|Withdrawal by Subject|0|||
130246311|NCT02675452|468863698|FG013|Overall Study|Withdrawal by Subject|1|||
130246312|NCT02675452|468863699|FG014|Overall Study|Withdrawal by Subject|1|||
130246313|NCT02675452|468863700|FG015|Overall Study|Withdrawal by Subject|0|||
130246314|NCT02675452|468863701|FG016|Overall Study|Withdrawal by Subject|2|||
130246315|NCT02675452|468863702|FG017|Overall Study|Withdrawal by Subject|0|||
130246316|NCT02675452|468863703|FG018|Overall Study|Withdrawal by Subject|0|||
130246317|NCT02675452|468863704|FG019|Overall Study|Withdrawal by Subject|0|||
130246318|NCT02675452|468863705|FG020|Overall Study|Withdrawal by Subject|0|||
130246319|NCT02675452|468863706|FG021|Overall Study|Withdrawal by Subject|0|||
130246320|NCT02675452|468863707|FG022|Overall Study|Withdrawal by Subject|3|||
130246321|NCT02675452|468863708|FG023|Overall Study|Withdrawal by Subject|0|||
130246322|NCT02675452|468863709|FG024|Overall Study|Withdrawal by Subject|1|||
130246323|NCT02675452|468863710|FG025|Overall Study|Withdrawal by Subject|0|||
130246324|NCT02675452|468863711|FG026|Overall Study|Withdrawal by Subject|1|||
130246325|NCT02675452|468863712|FG027|Overall Study|Withdrawal by Subject|3|||
130246326|NCT02675452|468863713|FG028|Overall Study|Withdrawal by Subject|4|||
130246327|NCT02675452|468863685|FG000|Overall Study|Death|0|||
130246328|NCT02675452|468863686|FG001|Overall Study|Death|0|||
130246329|NCT02675452|468863687|FG002|Overall Study|Death|1|||
130246330|NCT02675452|468863688|FG003|Overall Study|Death|0|||
130246331|NCT02675452|468863689|FG004|Overall Study|Death|0|||
130246332|NCT02675452|468863690|FG005|Overall Study|Death|1|||
130246333|NCT02675452|468863691|FG006|Overall Study|Death|0|||
130246334|NCT02675452|468863692|FG007|Overall Study|Death|0|||
130246335|NCT02675452|468863693|FG008|Overall Study|Death|1|||
130246336|NCT02675452|468863694|FG009|Overall Study|Death|0|||
130246337|NCT02675452|468863695|FG010|Overall Study|Death|0|||
130246338|NCT02675452|468863696|FG011|Overall Study|Death|0|||
130246339|NCT02675452|468863697|FG012|Overall Study|Death|1|||
130246340|NCT02675452|468863698|FG013|Overall Study|Death|0|||
130246341|NCT02675452|468863699|FG014|Overall Study|Death|0|||
130246342|NCT02675452|468863700|FG015|Overall Study|Death|2|||
130246343|NCT02675452|468863701|FG016|Overall Study|Death|0|||
130246344|NCT02675452|468863702|FG017|Overall Study|Death|0|||
130246345|NCT02675452|468863703|FG018|Overall Study|Death|4|||
130246346|NCT02675452|468863704|FG019|Overall Study|Death|3|||
130246347|NCT02675452|468863705|FG020|Overall Study|Death|3|||
130246348|NCT02675452|468863706|FG021|Overall Study|Death|3|||
130246349|NCT02675452|468863707|FG022|Overall Study|Death|7|||
130246350|NCT02675452|468863708|FG023|Overall Study|Death|5|||
130246351|NCT02675452|468863709|FG024|Overall Study|Death|3|||
130246352|NCT02675452|468863710|FG025|Overall Study|Death|4|||
130246353|NCT02675452|468863711|FG026|Overall Study|Death|7|||
130246354|NCT02675452|468863712|FG027|Overall Study|Death|6|||
130246355|NCT02675452|468863713|FG028|Overall Study|Death|9|||
130030647|NCT00961961|468068608|FG001|Phase II|Withdrawal by Subject|0|||
130030648|NCT00961961|468068609|FG002|Phase II|Withdrawal by Subject|1|||
130030649|NCT00961961|468068610|FG003|Phase II|Withdrawal by Subject|0|||
130030650|NCT01412957|468068611|FG000|Overall Study|Withdrawal by Subject|6|||
130030651|NCT01412957|468068612|FG001|Overall Study|Withdrawal by Subject|22|||
130030652|NCT01412957|468068611|FG000|Overall Study|Lost to Follow-up|7|||
130030653|NCT01412957|468068612|FG001|Overall Study|Lost to Follow-up|2|||
130030654|NCT01412957|468068611|FG000|Overall Study|Death|136|||
130030655|NCT01412957|468068612|FG001|Overall Study|Death|133|||
130030656|NCT04722991|468068618|FG000|Overall Study|Adverse Event|12|||
130030657|NCT04722991|468068619|FG001|Overall Study|Adverse Event|4|||
130030658|NCT04722991|468068618|FG000|Overall Study|Death|2|||
130030659|NCT04722991|468068619|FG001|Overall Study|Death|0|||
130030660|NCT04722991|468068618|FG000|Overall Study|Lost to Follow-up|1|||
130030661|NCT04722991|468068619|FG001|Overall Study|Lost to Follow-up|1|||
130030662|NCT04722991|468068618|FG000|Overall Study|Withdrawal cirterion met|2|||
130030663|NCT04722991|468068619|FG001|Overall Study|Withdrawal cirterion met|2|||
130030664|NCT04722991|468068618|FG000|Overall Study|Other|1|||
130030665|NCT04722991|468068619|FG001|Overall Study|Other|0|||
130030666|NCT04722991|468068618|FG000|Overall Study|Non-compliance|0|||
130030667|NCT04722991|468068619|FG001|Overall Study|Non-compliance|1|||
130030668|NCT04722991|468068618|FG000|Overall Study|Withdrawal by Subject|0|||
130030669|NCT04722991|468068619|FG001|Overall Study|Withdrawal by Subject|1|||
130246356|NCT02675452|468863685|FG000|Overall Study|Lost to Follow-up|0|||
130246357|NCT02675452|468863686|FG001|Overall Study|Lost to Follow-up|1|||
130246358|NCT02675452|468863687|FG002|Overall Study|Lost to Follow-up|0|||
130246359|NCT02675452|468863688|FG003|Overall Study|Lost to Follow-up|0|||
130246360|NCT02675452|468863689|FG004|Overall Study|Lost to Follow-up|0|||
130246361|NCT02675452|468863690|FG005|Overall Study|Lost to Follow-up|0|||
130246362|NCT02675452|468863691|FG006|Overall Study|Lost to Follow-up|0|||
130246363|NCT02675452|468863692|FG007|Overall Study|Lost to Follow-up|0|||
130246364|NCT02675452|468863693|FG008|Overall Study|Lost to Follow-up|0|||
130246365|NCT02675452|468863694|FG009|Overall Study|Lost to Follow-up|0|||
130246366|NCT02675452|468863695|FG010|Overall Study|Lost to Follow-up|0|||
130246367|NCT02675452|468863696|FG011|Overall Study|Lost to Follow-up|0|||
130246368|NCT02675452|468863697|FG012|Overall Study|Lost to Follow-up|1|||
130246369|NCT02675452|468863698|FG013|Overall Study|Lost to Follow-up|0|||
130246370|NCT02675452|468863699|FG014|Overall Study|Lost to Follow-up|0|||
130246371|NCT02675452|468863700|FG015|Overall Study|Lost to Follow-up|0|||
130246372|NCT02675452|468863701|FG016|Overall Study|Lost to Follow-up|0|||
130246373|NCT02675452|468863702|FG017|Overall Study|Lost to Follow-up|0|||
130246374|NCT02675452|468863703|FG018|Overall Study|Lost to Follow-up|0|||
130246375|NCT02675452|468863704|FG019|Overall Study|Lost to Follow-up|0|||
130246376|NCT02675452|468863705|FG020|Overall Study|Lost to Follow-up|0|||
130246377|NCT02675452|468863706|FG021|Overall Study|Lost to Follow-up|0|||
130246378|NCT02675452|468863707|FG022|Overall Study|Lost to Follow-up|0|||
130246379|NCT02675452|468863708|FG023|Overall Study|Lost to Follow-up|0|||
130246380|NCT02675452|468863709|FG024|Overall Study|Lost to Follow-up|0|||
130246381|NCT02675452|468863710|FG025|Overall Study|Lost to Follow-up|0|||
130246382|NCT02675452|468863711|FG026|Overall Study|Lost to Follow-up|1|||
130246383|NCT02675452|468863712|FG027|Overall Study|Lost to Follow-up|0|||
130246384|NCT02675452|468863713|FG028|Overall Study|Lost to Follow-up|0|||
130246385|NCT02675452|468863685|FG000|Overall Study|Other|0|||
130246386|NCT02675452|468863686|FG001|Overall Study|Other|0|||
130246387|NCT02675452|468863687|FG002|Overall Study|Other|0|||
130246388|NCT02675452|468863688|FG003|Overall Study|Other|0|||
130246389|NCT02675452|468863689|FG004|Overall Study|Other|0|||
130246390|NCT02675452|468863690|FG005|Overall Study|Other|0|||
130246391|NCT02675452|468863691|FG006|Overall Study|Other|0|||
130246392|NCT02675452|468863692|FG007|Overall Study|Other|0|||
130246393|NCT02675452|468863693|FG008|Overall Study|Other|0|||
130246394|NCT02675452|468863694|FG009|Overall Study|Other|0|||
130246395|NCT02675452|468863695|FG010|Overall Study|Other|0|||
130246396|NCT02675452|468863696|FG011|Overall Study|Other|0|||
130246397|NCT02675452|468863697|FG012|Overall Study|Other|0|||
130246398|NCT02675452|468863698|FG013|Overall Study|Other|0|||
130246399|NCT02675452|468863699|FG014|Overall Study|Other|0|||
130246400|NCT02675452|468863700|FG015|Overall Study|Other|0|||
130246401|NCT02675452|468863701|FG016|Overall Study|Other|0|||
130246402|NCT02675452|468863702|FG017|Overall Study|Other|0|||
130246403|NCT02675452|468863703|FG018|Overall Study|Other|0|||
130246404|NCT02675452|468863704|FG019|Overall Study|Other|0|||
130246405|NCT02675452|468863705|FG020|Overall Study|Other|0|||
130246406|NCT02675452|468863706|FG021|Overall Study|Other|0|||
130246407|NCT02675452|468863707|FG022|Overall Study|Other|0|||
130246408|NCT02675452|468863708|FG023|Overall Study|Other|0|||
130246409|NCT02675452|468863709|FG024|Overall Study|Other|0|||
130246410|NCT02675452|468863710|FG025|Overall Study|Other|0|||
130246411|NCT02675452|468863711|FG026|Overall Study|Other|1|||
130246412|NCT02675452|468863712|FG027|Overall Study|Other|0|||
130246413|NCT02675452|468863713|FG028|Overall Study|Other|0|||
130246414|NCT02939781|468863714|FG000|Overall Study|Protocol Violation|8|||
130246415|NCT02939781|468863714|FG000|Overall Study|Withdrawal by Subject|1|||
130246416|NCT00541775|468863715|FG000|Overall Study|Adverse Event|3|||
130246417|NCT00541775|468863716|FG001|Overall Study|Adverse Event|2|||
130246418|NCT00541775|468863717|FG002|Overall Study|Adverse Event|1|||
130246419|NCT00541775|468863715|FG000|Overall Study|Lack of Efficacy|0|||
130246420|NCT00541775|468863716|FG001|Overall Study|Lack of Efficacy|0|||
130246421|NCT00541775|468863717|FG002|Overall Study|Lack of Efficacy|3|||
130246422|NCT00541775|468863715|FG000|Overall Study|Lost to Follow-up|0|||
130246423|NCT00541775|468863716|FG001|Overall Study|Lost to Follow-up|0|||
130246424|NCT00541775|468863717|FG002|Overall Study|Lost to Follow-up|2|||
130246425|NCT00541775|468863715|FG000|Overall Study|Protocol Violation|1|||
130246426|NCT00541775|468863716|FG001|Overall Study|Protocol Violation|0|||
130246427|NCT00541775|468863717|FG002|Overall Study|Protocol Violation|0|||
130246428|NCT00541775|468863715|FG000|Overall Study|Withdrawal by Subject and Other|5|||
130246429|NCT00541775|468863716|FG001|Overall Study|Withdrawal by Subject and Other|0|||
130246430|NCT00541775|468863717|FG002|Overall Study|Withdrawal by Subject and Other|2|||
130246431|NCT00032487|468863718|FG000|Overall Study|Withdrawal by Subject|67|||
130246432|NCT00032487|468863719|FG001|Overall Study|Withdrawal by Subject|43|||
130246433|NCT00032487|468863718|FG000|Overall Study|Adverse Event|3|||
130246434|NCT00032487|468863719|FG001|Overall Study|Adverse Event|7|||
130246435|NCT00032487|468863718|FG000|Overall Study|Lost to Follow-up|57|||
130246436|NCT00032487|468863719|FG001|Overall Study|Lost to Follow-up|58|||
130246437|NCT00032487|468863718|FG000|Overall Study|Had other reason|12|||
130246438|NCT00032487|468863719|FG001|Overall Study|Had other reason|12|||
130246439|NCT02569242|468863721|FG000|Overall Study|Death|1|||
130246440|NCT02569242|468863722|FG001|Overall Study|Death|0|||
130246441|NCT02569242|468863721|FG000|Overall Study|Withdrawal by Subject|0|||
130246442|NCT02569242|468863722|FG001|Overall Study|Withdrawal by Subject|1|||
130246443|NCT00689052|468863723|FG000|Overall Study|Adverse Event|4|||
130246444|NCT00689052|468863724|FG001|Overall Study|Adverse Event|6|||
130246445|NCT00689052|468863723|FG000|Overall Study|Protocol Violation|1|||
130246446|NCT00689052|468863724|FG001|Overall Study|Protocol Violation|0|||
130246447|NCT00689052|468863723|FG000|Overall Study|Lost to Follow-up|2|||
130246448|NCT00689052|468863724|FG001|Overall Study|Lost to Follow-up|0|||
130246449|NCT00689052|468863723|FG000|Overall Study|Withdrawal by Subject|2|||
130246450|NCT00689052|468863724|FG001|Overall Study|Withdrawal by Subject|0|||
130246451|NCT00689052|468863723|FG000|Overall Study|Early termination of the trial|22|||
130246452|NCT00689052|468863724|FG001|Overall Study|Early termination of the trial|24|||
130246453|NCT03003468|468863725|FG000|Overall Study|Withdrawal by Subject|0|||
130246454|NCT03003468|468863726|FG001|Overall Study|Withdrawal by Subject|0|||
130246455|NCT03003468|468863727|FG002|Overall Study|Withdrawal by Subject|1|||
130246456|NCT03003468|468863725|FG000|Overall Study|No measurable lesions|0|||
130246457|NCT03003468|468863726|FG001|Overall Study|No measurable lesions|0|||
130246458|NCT03003468|468863727|FG002|Overall Study|No measurable lesions|1|||
130246459|NCT03259308|468863735|FG000|Overall Study|Adverse Event|5|||
130246460|NCT03259308|468863736|FG001|Overall Study|Adverse Event|4|||
130246461|NCT03259308|468863737|FG002|Overall Study|Adverse Event|1|||
130246462|NCT03259308|468863735|FG000|Overall Study|Withdrawal by Subject|2|||
130246463|NCT03259308|468863736|FG001|Overall Study|Withdrawal by Subject|1|||
130246464|NCT03259308|468863737|FG002|Overall Study|Withdrawal by Subject|3|||
130246465|NCT03259308|468863735|FG000|Overall Study|Lost to Follow-up|0|||
130246466|NCT03259308|468863736|FG001|Overall Study|Lost to Follow-up|0|||
130246467|NCT03259308|468863737|FG002|Overall Study|Lost to Follow-up|1|||
130246468|NCT03259308|468863735|FG000|Overall Study|Pregnancy|0|||
130246469|NCT03259308|468863736|FG001|Overall Study|Pregnancy|0|||
130246470|NCT03259308|468863737|FG002|Overall Study|Pregnancy|1|||
130246471|NCT03259308|468863735|FG000|Overall Study|Protocol Deviation|0|||
130246472|NCT03259308|468863736|FG001|Overall Study|Protocol Deviation|3|||
130246473|NCT03259308|468863737|FG002|Overall Study|Protocol Deviation|0|||
130246474|NCT03259308|468863735|FG000|Overall Study|Lack of Efficacy|0|||
130246475|NCT03259308|468863736|FG001|Overall Study|Lack of Efficacy|0|||
130246476|NCT03259308|468863737|FG002|Overall Study|Lack of Efficacy|1|||
130246477|NCT01727154|468863738|FG000|Overall Study|Death|17|||
130246478|NCT01727154|468863738|FG000|Overall Study|Withdrawal by Subject|14|||
130246479|NCT01727154|468863738|FG000|Overall Study|Subject Withdrew Consent|18|||
130246480|NCT01727154|468863738|FG000|Overall Study|Study Terminated|6|||
130246481|NCT01727154|468863738|FG000|Overall Study|No Discontinuation Documentation|4|||
130246482|NCT00003474|468863739|FG000|Overall Study|Not Evaluable|14|||
130246483|NCT06025695|468863740|FG000|Overall Study|Adverse Event|5|||
130246484|NCT06025695|468863741|FG001|Overall Study|Adverse Event|6|||
130246485|NCT06025695|468863740|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
130246486|NCT06025695|468863741|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
130246487|NCT06025695|468863740|FG000|Overall Study|Other|23|||
130246488|NCT06025695|468863741|FG001|Overall Study|Other|19|||
130246489|NCT06025695|468863740|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
130246490|NCT06025695|468863741|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
130246491|NCT03834883|468863742|FG000|Second Treatment|Withdrawal by Subject|1|||
130246492|NCT03834883|468863743|FG001|Second Treatment|Withdrawal by Subject|0|||
130246493|NCT03834883|468863744|FG002|Second Treatment|Withdrawal by Subject|0|||
130246494|NCT03834883|468863745|FG003|Second Treatment|Withdrawal by Subject|0|||
130246495|NCT03834883|468863742|FG000|Second Treatment|COVID-19 pandemic|1|||
130246496|NCT03834883|468863743|FG001|Second Treatment|COVID-19 pandemic|0|||
130246497|NCT03834883|468863744|FG002|Second Treatment|COVID-19 pandemic|1|||
130246498|NCT03834883|468863745|FG003|Second Treatment|COVID-19 pandemic|1|||
130246499|NCT01629563|468865330|FG000|Overall Study|Adverse Event|16|||
130246500|NCT01629563|468865331|FG001|Overall Study|Adverse Event|16|||
130246501|NCT01629563|468865330|FG000|Overall Study|Death|2|||
130246502|NCT01629563|468865331|FG001|Overall Study|Death|0|||
130246503|NCT01629563|468865330|FG000|Overall Study|Lack of Efficacy|2|||
130246504|NCT01629563|468865331|FG001|Overall Study|Lack of Efficacy|3|||
130246505|NCT01629563|468865330|FG000|Overall Study|Lost to Follow-up|1|||
130246506|NCT01629563|468865331|FG001|Overall Study|Lost to Follow-up|0|||
130246507|NCT01629563|468865330|FG000|Overall Study|Pregnancy|1|||
130246508|NCT01629563|468865331|FG001|Overall Study|Pregnancy|2|||
130246509|NCT01629563|468865330|FG000|Overall Study|Protocol Violation|0|||
130246510|NCT01629563|468865331|FG001|Overall Study|Protocol Violation|1|||
130246511|NCT01629563|468865330|FG000|Overall Study|Withdrawal by Subject|27|||
130246512|NCT01629563|468865331|FG001|Overall Study|Withdrawal by Subject|20|||
130246513|NCT01629563|468865330|FG000|Overall Study|surgery|0|||
130246514|NCT01629563|468865331|FG001|Overall Study|surgery|3|||
130246515|NCT01629563|468865330|FG000|Overall Study|Lack of return of menses|12|||
130246516|NCT01629563|468865331|FG001|Overall Study|Lack of return of menses|7|||
130246517|NCT01629563|468865330|FG000|Overall Study|Protocol Violation|0|||
130246518|NCT01629563|468865331|FG001|Overall Study|Protocol Violation|1|||
130246519|NCT00454142|468865332|FG000|Overall Study|Withdrawal by Subject|1|||
130246520|NCT02545127|468865335|FG000|Overall Study|Lost to Follow-up|1|||
130246521|NCT02545127|468865336|FG001|Overall Study|Lost to Follow-up|0|||
130246522|NCT02802865|468865337|FG000|Overall Study|Pregnancy|1|||
130246523|NCT02802865|468865338|FG001|Overall Study|Pregnancy|1|||
130246524|NCT02802865|468865337|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
130246525|NCT02802865|468865338|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
130246526|NCT01783015|468865339|FG000|Blinded Treatment|Adverse Event|0|||
130246527|NCT01783015|468865340|FG001|Blinded Treatment|Adverse Event|1|||
130246528|NCT01783015|468865341|FG002|Blinded Treatment|Adverse Event|0|||
130246529|NCT01783015|468865339|FG000|Blinded Treatment|Protocol Violation|0|||
130246530|NCT01783015|468865340|FG001|Blinded Treatment|Protocol Violation|1|||
130246531|NCT01783015|468865341|FG002|Blinded Treatment|Protocol Violation|0|||
130246532|NCT01783015|468865339|FG000|Blinded Treatment|Withdrawal by Subject|0|||
130246533|NCT01783015|468865340|FG001|Blinded Treatment|Withdrawal by Subject|1|||
130246534|NCT01783015|468865341|FG002|Blinded Treatment|Withdrawal by Subject|0|||
130246535|NCT01783015|468865339|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
130246536|NCT01783015|468865340|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
130246537|NCT01783015|468865341|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
130246538|NCT01783015|468865339|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
130246539|NCT01783015|468865340|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
130246540|NCT01783015|468865341|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
130246541|NCT00509600|468865342|FG000|Overall Study|Adverse Event|1|||
130246542|NCT02930941|468865344|FG000|Overall Study|Lost to Follow-up|1|||
130246543|NCT02930941|468865345|FG001|Overall Study|Lost to Follow-up|2|||
130246544|NCT00289978|468865346|FG000|Overall Study|Withdrawal by Subject|31|||
130246545|NCT00289978|468865347|FG001|Overall Study|Withdrawal by Subject|17|||
130246546|NCT00289978|468865348|FG002|Overall Study|Withdrawal by Subject|28|||
130246547|NCT00289978|468865346|FG000|Overall Study|Adverse Event|22|||
130246548|NCT00289978|468865347|FG001|Overall Study|Adverse Event|13|||
130246549|NCT00289978|468865348|FG002|Overall Study|Adverse Event|18|||
130246550|NCT00289978|468865346|FG000|Overall Study|Lack of Efficacy|13|||
130246551|NCT00289978|468865347|FG001|Overall Study|Lack of Efficacy|6|||
130246552|NCT00289978|468865348|FG002|Overall Study|Lack of Efficacy|25|||
130246553|NCT00289978|468865346|FG000|Overall Study|Abnormal laboratory value(s)|20|||
130246554|NCT00289978|468865347|FG001|Overall Study|Abnormal laboratory value(s)|9|||
130246555|NCT00289978|468865348|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130246556|NCT00289978|468865346|FG000|Overall Study|Lost to Follow-up|3|||
130246557|NCT00289978|468865347|FG001|Overall Study|Lost to Follow-up|5|||
130246558|NCT00289978|468865348|FG002|Overall Study|Lost to Follow-up|7|||
130246559|NCT00289978|468865346|FG000|Overall Study|Protocol Violation|5|||
130246560|NCT00289978|468865347|FG001|Overall Study|Protocol Violation|5|||
130246561|NCT00289978|468865348|FG002|Overall Study|Protocol Violation|4|||
130246562|NCT00289978|468865346|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130246563|NCT00289978|468865347|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130246564|NCT00289978|468865348|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130246565|NCT00289978|468865346|FG000|Overall Study|Death|1|||
130246566|NCT00289978|468865347|FG001|Overall Study|Death|0|||
130246567|NCT00289978|468865348|FG002|Overall Study|Death|2|||
130246568|NCT00720083|468865351|FG000|Overall Study|Ineligible|1|||
130246569|NCT00720083|468865352|FG001|Overall Study|Ineligible|2|||
130246570|NCT01967277|468865354|FG000|Overall Study|Lost to Follow-up|1|||
130246571|NCT01967277|468865355|FG001|Overall Study|Lost to Follow-up|2|||
130246572|NCT01967277|468865354|FG000|Overall Study|Unrelated illness|0|||
130246573|NCT01967277|468865355|FG001|Overall Study|Unrelated illness|1|||
130246574|NCT00585585|468865358|FG000|Overall Study|Adverse Event|1|||
130246575|NCT00103506|468865359|FG000|Overall Study|Study closed by sponsor|34|||
130246576|NCT00103506|468865360|FG001|Overall Study|Study closed by sponsor|37|||
130246577|NCT00103506|468865359|FG000|Overall Study|Death|257|||
130246578|NCT00103506|468865360|FG001|Overall Study|Death|253|||
130246579|NCT00103506|468865359|FG000|Overall Study|Lost to Follow-up|13|||
130246580|NCT00103506|468865360|FG001|Overall Study|Lost to Follow-up|13|||
130246581|NCT00103506|468865359|FG000|Overall Study|Withdrawal by Subject|18|||
130246582|NCT00103506|468865360|FG001|Overall Study|Withdrawal by Subject|21|||
130246583|NCT00585169|468865361|FG000|Overall Study|Withdrawal by Subject|1|||
130246584|NCT00710970|468865362|FG000|Overall Study|Never took drug|3|||
130246585|NCT01028560|468865363|FG000|Overall Study|Lack of Efficacy|3|||
130246586|NCT01028560|468865364|FG001|Overall Study|Lack of Efficacy|6|||
130246587|NCT01028560|468865363|FG000|Overall Study|Withdrawal by Subject|7|||
130246588|NCT01028560|468865364|FG001|Overall Study|Withdrawal by Subject|12|||
130246589|NCT03055221|468865365|FG000|Overall Study|Adverse Event|2|||
130246590|NCT03055221|468865365|FG000|Overall Study|Withdrawal by Subject|4|||
130100751|NCT00127192|468326064|FG003|Overall Study|Lack of Efficacy|0|||
130246591|NCT03055221|468865365|FG000|Overall Study|Death|6|||
130246592|NCT03055221|468865365|FG000|Overall Study|Physician Decision|1|||
130246593|NCT03055221|468865365|FG000|Overall Study|Study terminated by Sponsor|3|||
129800241|NCT04755283|467236269|FG001|Overall Study|Lost to Follow-up|0|||
130246594|NCT03055221|468865365|FG000|Overall Study|Lost to Follow-up|4|||
130246595|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
130246596|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
130246597|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
130246598|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
130246599|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
130246600|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
130246601|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
130246602|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
130246603|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
130246604|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
130246605|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
130246606|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
130246607|NCT01243424|468865366|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
130246608|NCT01243424|468865367|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
130246609|NCT01243424|468865366|FG000|Discontinuation From Treatment|Not treated|5|||
130246610|NCT01243424|468865367|FG001|Discontinuation From Treatment|Not treated|4|||
130246611|NCT01243424|468865366|FG000|Discontinuation From Treatment|Adverse Event|457|||
130246612|NCT01243424|468865367|FG001|Discontinuation From Treatment|Adverse Event|523|||
130246613|NCT01243424|468865366|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
130246614|NCT01243424|468865367|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
130246615|NCT01243424|468865366|FG000|Discontinuation From Treatment|Protocol Violation|46|||
130246616|NCT01243424|468865367|FG001|Discontinuation From Treatment|Protocol Violation|47|||
130246617|NCT01243424|468865366|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
130246618|NCT01243424|468865367|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
130246619|NCT01243424|468865366|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
130246620|NCT01243424|468865367|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
130246621|NCT01243424|468865366|FG000|Discontinuation From Treatment|Other than listed above|230|||
130246622|NCT01243424|468865367|FG001|Discontinuation From Treatment|Other than listed above|211|||
130246623|NCT00710554|468865377|FG000|Overall Study|Adverse Event|24|||
130246624|NCT00710554|468865378|FG001|Overall Study|Adverse Event|7|||
130246625|NCT00710554|468865377|FG000|Overall Study|Withdrawal by Subject|7|||
130246626|NCT00710554|468865378|FG001|Overall Study|Withdrawal by Subject|3|||
130246627|NCT00710554|468865377|FG000|Overall Study|Lost to Follow-up|7|||
130246628|NCT00710554|468865378|FG001|Overall Study|Lost to Follow-up|1|||
130246629|NCT00710554|468865377|FG000|Overall Study|Lack of Efficacy|11|||
130246630|NCT00710554|468865378|FG001|Overall Study|Lack of Efficacy|12|||
130246631|NCT00710554|468865377|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
130246632|NCT00710554|468865378|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
130246633|NCT01301001|468865383|FG000|First Intervention|Lost to Follow-up|4|||
130246634|NCT01301001|468865384|FG001|First Intervention|Lost to Follow-up|4|||
130246635|NCT01301001|468865383|FG000|First Intervention|Withdrawal by Subject|1|||
130246636|NCT01301001|468865384|FG001|First Intervention|Withdrawal by Subject|4|||
130246637|NCT01301001|468865383|FG000|First Intervention|Adverse Event|5|||
130246638|NCT01301001|468865384|FG001|First Intervention|Adverse Event|0|||
130246639|NCT01301001|468865383|FG000|First Intervention|Protocol Violation|0|||
130246640|NCT01301001|468865384|FG001|First Intervention|Protocol Violation|1|||
130246641|NCT01301001|468865383|FG000|Second Intervention|Adverse Event|2|||
130246642|NCT01301001|468865384|FG001|Second Intervention|Adverse Event|0|||
130246643|NCT01301001|468865383|FG000|Second Intervention|Withdrawal by Subject|2|||
130246644|NCT01301001|468865384|FG001|Second Intervention|Withdrawal by Subject|0|||
130246645|NCT01441414|468865387|FG000|Overall Study|Participant died|9|||
130246646|NCT01441414|468865387|FG000|Overall Study|Other reasons|3|||
130246647|NCT01441414|468865387|FG000|Overall Study|Study terminated by sponsor|2|||
130246648|NCT01441414|468865387|FG000|Overall Study|Subject refused further follow-up|1|||
130246649|NCT01433978|468865388|FG000|Core Study|Adverse Event, Non-Fatal|0|||
130246650|NCT01433978|468865389|FG001|Core Study|Adverse Event, Non-Fatal|1|||
130246651|NCT01433978|468865390|FG002|Core Study|Adverse Event, Non-Fatal|0|||
130246652|NCT01433978|468865388|FG000|Core Study|Lack of Efficacy|5|||
130246653|NCT01433978|468865389|FG001|Core Study|Lack of Efficacy|1|||
130246654|NCT01433978|468865390|FG002|Core Study|Lack of Efficacy|0|||
130246655|NCT01433978|468865388|FG000|Core Study|Study Terminated by Sponsor|6|||
130246656|NCT01433978|468865389|FG001|Core Study|Study Terminated by Sponsor|9|||
130246657|NCT01433978|468865390|FG002|Core Study|Study Terminated by Sponsor|0|||
130246658|NCT01433978|468865388|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
130246659|NCT01433978|468865389|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
130246660|NCT01433978|468865390|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
130246661|NCT01433978|468865388|FG000|Extension Phase|Lack of Efficacy|0|||
130246662|NCT01433978|468865389|FG001|Extension Phase|Lack of Efficacy|0|||
130246663|NCT01433978|468865390|FG002|Extension Phase|Lack of Efficacy|1|||
130246664|NCT01433978|468865388|FG000|Extension Phase|Study Terminated by Sponsor|0|||
130246665|NCT01433978|468865389|FG001|Extension Phase|Study Terminated by Sponsor|0|||
130246666|NCT01433978|468865390|FG002|Extension Phase|Study Terminated by Sponsor|4|||
130246667|NCT01773889|468865391|FG000|Overall Study|lack of funding|2|||
130246668|NCT02565186|468865392|FG000|Overall Study|Adverse Event|113|||
130246669|NCT02565186|468865393|FG001|Overall Study|Adverse Event|148|||
130246670|NCT02565186|468865392|FG000|Overall Study|Lost to Follow-up|102|||
130246671|NCT02565186|468865393|FG001|Overall Study|Lost to Follow-up|93|||
130100752|NCT00127192|468326065|FG004|Overall Study|Lack of Efficacy|2|||
130100753|NCT00127192|468326061|FG000|Overall Study|Withdrawal by Subject|0|||
130100754|NCT00127192|468326062|FG001|Overall Study|Withdrawal by Subject|0|||
130100755|NCT00127192|468326063|FG002|Overall Study|Withdrawal by Subject|1|||
130100756|NCT00127192|468326064|FG003|Overall Study|Withdrawal by Subject|0|||
130100757|NCT00127192|468326065|FG004|Overall Study|Withdrawal by Subject|3|||
130100758|NCT00127192|468326061|FG000|Overall Study|Adverse event in pre-treatment period|1|||
130100759|NCT00127192|468326062|FG001|Overall Study|Adverse event in pre-treatment period|0|||
130100760|NCT00127192|468326063|FG002|Overall Study|Adverse event in pre-treatment period|0|||
130100761|NCT00127192|468326064|FG003|Overall Study|Adverse event in pre-treatment period|0|||
130100762|NCT00127192|468326065|FG004|Overall Study|Adverse event in pre-treatment period|0|||
130100763|NCT00077766|468326066|FG000|Overall Study|Adverse Event|1|||
130100764|NCT00077766|468326067|FG001|Overall Study|Adverse Event|1|||
130100765|NCT00077766|468326066|FG000|Overall Study|Withdrawal by Subject|4|||
130100766|NCT00077766|468326067|FG001|Overall Study|Withdrawal by Subject|3|||
130100767|NCT00077766|468326066|FG000|Overall Study|Death|12|||
130100768|NCT00077766|468326067|FG001|Overall Study|Death|10|||
130100769|NCT00077766|468326066|FG000|Overall Study|Lost to Follow-up|2|||
130100770|NCT00077766|468326067|FG001|Overall Study|Lost to Follow-up|0|||
130100771|NCT00077766|468326066|FG000|Overall Study|Protocol Violation|1|||
130246672|NCT02565186|468865392|FG000|Overall Study|Non-Compliance|57|||
130246673|NCT02565186|468865393|FG001|Overall Study|Non-Compliance|55|||
130246674|NCT02565186|468865392|FG000|Overall Study|Withdrawal by Subject|229|||
130246675|NCT02565186|468865393|FG001|Overall Study|Withdrawal by Subject|214|||
130246676|NCT02565186|468865392|FG000|Overall Study|Physician Decision|18|||
130246677|NCT02565186|468865393|FG001|Overall Study|Physician Decision|16|||
130246678|NCT02565186|468865392|FG000|Overall Study|Sponsor Request|5|||
130246679|NCT02565186|468865393|FG001|Overall Study|Sponsor Request|9|||
130246680|NCT02565186|468865392|FG000|Overall Study|Missing|1|||
130246681|NCT02565186|468865393|FG001|Overall Study|Missing|0|||
130246682|NCT02565186|468865392|FG000|Overall Study|Did Not Receive Study Drug|55|||
130246683|NCT02565186|468865393|FG001|Overall Study|Did Not Receive Study Drug|86|||
130246684|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
130246685|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
130246686|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
130246687|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
130246688|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
130246689|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
130246690|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
130246691|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
130246692|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
130246693|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
130246694|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
130246695|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
130246696|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
130246697|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
130246698|NCT00976391|468865394|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
130246699|NCT00976391|468865395|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
130246700|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
130246701|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
130246702|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130246703|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
130246704|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
130246705|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
130246706|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
130246707|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
130246708|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
130246709|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
130246710|NCT00976391|468865394|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
130246711|NCT00976391|468865395|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130246712|NCT05156125|468865396|FG000|Overall Study|Lack of Efficacy|1|||
130246713|NCT05156125|468865397|FG001|Overall Study|Lack of Efficacy|1|||
130246714|NCT05156125|468865398|FG002|Overall Study|Lack of Efficacy|1|||
130246715|NCT05156125|468865396|FG000|Overall Study|Physician Decision|0|||
129800242|NCT04755283|467236270|FG002|Overall Study|Lost to Follow-up|1|||
130100772|NCT00077766|468326067|FG001|Overall Study|Protocol Violation|0|||
130100773|NCT00077766|468326066|FG000|Overall Study|Kidney Transplantation|9|||
130100774|NCT00077766|468326067|FG001|Overall Study|Kidney Transplantation|5|||
130100775|NCT00077766|468326066|FG000|Overall Study|Transplantation|5|||
130246716|NCT05156125|468865397|FG001|Overall Study|Physician Decision|0|||
130246717|NCT05156125|468865398|FG002|Overall Study|Physician Decision|1|||
130246718|NCT05156125|468865396|FG000|Overall Study|Non-compliance|0|||
130246719|NCT05156125|468865397|FG001|Overall Study|Non-compliance|1|||
130246720|NCT05156125|468865398|FG002|Overall Study|Non-compliance|1|||
130246721|NCT05156125|468865396|FG000|Overall Study|Withdrawal by Subject|0|||
130246722|NCT05156125|468865397|FG001|Overall Study|Withdrawal by Subject|0|||
130246723|NCT05156125|468865398|FG002|Overall Study|Withdrawal by Subject|1|||
130246724|NCT05156125|468865396|FG000|Overall Study|Adverse Event|2|||
130246725|NCT05156125|468865397|FG001|Overall Study|Adverse Event|1|||
130246726|NCT05156125|468865398|FG002|Overall Study|Adverse Event|0|||
130246727|NCT02852434|468865399|FG000|Overall Study|Withdrawal by Subject|0|||
130246728|NCT02852434|468865400|FG001|Overall Study|Withdrawal by Subject|1|||
130246729|NCT02852434|468865399|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
130246730|NCT02852434|468865400|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
130246731|NCT02018887|468865403|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
130246732|NCT02018887|468865404|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246733|NCT02018887|468865405|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246734|NCT02018887|468865406|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246735|NCT02018887|468865407|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246736|NCT02018887|468865408|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246737|NCT02018887|468865409|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246738|NCT02018887|468865410|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246739|NCT02018887|468865411|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246740|NCT02018887|468865412|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246741|NCT02018887|468865413|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
130246742|NCT02018887|468865403|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246743|NCT02018887|468865404|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246744|NCT02018887|468865405|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246745|NCT02018887|468865406|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246746|NCT02018887|468865407|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
130246747|NCT02018887|468865408|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246748|NCT02018887|468865409|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
130246749|NCT02018887|468865410|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
130246750|NCT02018887|468865411|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246751|NCT02018887|468865412|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246752|NCT02018887|468865413|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
130246753|NCT02018887|468865403|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
130246754|NCT02018887|468865404|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
130246755|NCT02018887|468865405|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
130246756|NCT02018887|468865406|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
130246757|NCT02018887|468865407|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
130246758|NCT02018887|468865408|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
130246759|NCT02018887|468865409|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
130246760|NCT02018887|468865410|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
130246761|NCT02018887|468865411|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
130246762|NCT02018887|468865412|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
130246763|NCT02018887|468865413|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
130246764|NCT02018887|468865403|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
130246765|NCT02018887|468865404|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
130246766|NCT02018887|468865405|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
130246767|NCT02018887|468865406|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
130246768|NCT02018887|468865407|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
130246769|NCT02018887|468865408|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
130246770|NCT02018887|468865409|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
130246771|NCT02018887|468865410|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
130246772|NCT02018887|468865411|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
130246773|NCT02018887|468865412|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
130246774|NCT02018887|468865413|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
130246775|NCT01145222|468865414|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
130246776|NCT01145222|468865415|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
130246777|NCT01145222|468865416|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
130246778|NCT01145222|468865417|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
130246779|NCT01145222|468865414|FG000|Overall Study|Poor bowel preparation|0|||
130246780|NCT01145222|468865415|FG001|Overall Study|Poor bowel preparation|0|||
130246781|NCT01145222|468865416|FG002|Overall Study|Poor bowel preparation|0|||
130246782|NCT01145222|468865417|FG003|Overall Study|Poor bowel preparation|1|||
130246783|NCT00927186|468865418|FG000|12 Months Primary Study|Adverse Event|5|||
130246784|NCT00927186|468865419|FG001|12 Months Primary Study|Adverse Event|2|||
130246785|NCT00927186|468865418|FG000|12 Months Primary Study|Lost to Follow-up|1|||
130246786|NCT00927186|468865419|FG001|12 Months Primary Study|Lost to Follow-up|0|||
130246787|NCT00927186|468865418|FG000|12 Months Primary Study|Protocol Violation|0|||
130030670|NCT00413959|468068620|FG000|Overall Study|Pt had only one cycle.|1|||
130030671|NCT04343651|468068624|FG000|Overall Study|Physician Decision|2|||
130246788|NCT00927186|468865419|FG001|12 Months Primary Study|Protocol Violation|1|||
130246789|NCT00927186|468865418|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
130246790|NCT00927186|468865419|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
130246791|NCT01698008|468865420|FG000|Overall Study|Withdrawal by Subject|1|||
130246792|NCT01698008|468865421|FG001|Overall Study|Withdrawal by Subject|2|||
130246793|NCT01011283|468865423|FG000|Overall Study|Adverse Event|4|||
130246794|NCT01011283|468865424|FG001|Overall Study|Adverse Event|2|||
130246795|NCT01011283|468865423|FG000|Overall Study|Progressive Disease|0|||
130246796|NCT01011283|468865424|FG001|Overall Study|Progressive Disease|2|||
130246797|NCT01011283|468865423|FG000|Overall Study|Terminated by Sponsor|5|||
130246798|NCT01011283|468865424|FG001|Overall Study|Terminated by Sponsor|5|||
130246799|NCT01011283|468865423|FG000|Overall Study|Other|2|||
130246800|NCT01011283|468865424|FG001|Overall Study|Other|2|||
130246801|NCT02959892|468865428|FG000|Overall Study|PET tracer synthesis failure|1|||
130246802|NCT02959892|468865429|FG001|Overall Study|PET tracer synthesis failure|0|||
130246803|NCT02959892|468865428|FG000|Overall Study|Study termination|0|||
130246804|NCT02959892|468865429|FG001|Overall Study|Study termination|1|||
130246805|NCT00799864|468865433|FG000|Overall Study|Participant reached a virologic endpoint|9|||
130246806|NCT00799864|468865434|FG001|Overall Study|Participant reached a virologic endpoint|2|||
130246807|NCT00799864|468865435|FG002|Overall Study|Participant reached a virologic endpoint|2|||
130246808|NCT00799864|468865436|FG003|Overall Study|Participant reached a virologic endpoint|0|||
130246809|NCT00799864|468865437|FG004|Overall Study|Participant reached a virologic endpoint|0|||
130246810|NCT00799864|468865433|FG000|Overall Study|Other|2|||
130246811|NCT00799864|468865434|FG001|Overall Study|Other|1|||
130246812|NCT00799864|468865435|FG002|Overall Study|Other|0|||
130246813|NCT00799864|468865436|FG003|Overall Study|Other|0|||
130246814|NCT00799864|468865437|FG004|Overall Study|Other|0|||
130246815|NCT03364686|468865438|FG000|Overall Study|Physician Decision|2|||
130246816|NCT01210443|468865441|FG000|Overall Study|Study terminated by sponsor|2|||
130246817|NCT01936974|468865442|FG000|Overall Study|Physician Decision|2|||
130246818|NCT01936974|468865443|FG001|Overall Study|Physician Decision|5|||
130246819|NCT04584554|468865446|FG000|Overall Study|Withdrawal by Subject|2|||
130246820|NCT04584554|468865447|FG001|Overall Study|Withdrawal by Subject|2|||
130246821|NCT02807181|468865448|FG000|Overall Study|Death|28|||
130246822|NCT02807181|468865449|FG001|Overall Study|Death|24|||
130246823|NCT02807181|468865448|FG000|Overall Study|Withdrawal by Subject|1|||
130246824|NCT02807181|468865449|FG001|Overall Study|Withdrawal by Subject|1|||
130246825|NCT02807181|468865448|FG000|Overall Study|Lost to Follow-up|0|||
130246826|NCT02807181|468865449|FG001|Overall Study|Lost to Follow-up|2|||
130246827|NCT02807181|468865448|FG000|Overall Study|Subject decision|1|||
130246828|NCT02807181|468865449|FG001|Overall Study|Subject decision|0|||
130246829|NCT02807181|468865448|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
130246830|NCT02807181|468865449|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
130246831|NCT02807181|468865448|FG000|Overall Study|In Study|3|||
130246832|NCT02807181|468865449|FG001|Overall Study|In Study|3|||
130246833|NCT02807181|468865448|FG000|Overall Study|Post Progression|3|||
130246834|NCT02807181|468865449|FG001|Overall Study|Post Progression|2|||
130030672|NCT04343651|468068625|FG001|Overall Study|Physician Decision|1|||
130030673|NCT04343651|468068624|FG000|Overall Study|Lost to Follow-up|2|||
130030674|NCT04343651|468068625|FG001|Overall Study|Lost to Follow-up|1|||
130030675|NCT04343651|468068624|FG000|Overall Study|Protocol Violation|4|||
130030676|NCT04343651|468068625|FG001|Overall Study|Protocol Violation|6|||
130246835|NCT00063999|468865450|FG000|Overall Study|Withdrawal by Subject|1|||
130030677|NCT04343651|468068624|FG000|Overall Study|Missing|3|||
130030678|NCT04343651|468068625|FG001|Overall Study|Missing|9|||
130030679|NCT04343651|468068624|FG000|Overall Study|Withdrawal by Subject|0|||
130030680|NCT04343651|468068625|FG001|Overall Study|Withdrawal by Subject|4|||
130246836|NCT00063999|468865451|FG001|Overall Study|Withdrawal by Subject|0|||
130246837|NCT00063999|468865450|FG000|Overall Study|Ineligible|44|||
130246838|NCT00063999|468865451|FG001|Overall Study|Ineligible|24|||
130246839|NCT03767894|468865452|FG000|Overall Study|Withdrawal by Subject|1|||
130246840|NCT04243837|468865456|FG000|Overall Study|Adverse Event|2|||
130246841|NCT04243837|468865457|FG001|Overall Study|Adverse Event|1|||
130246842|NCT04243837|468865456|FG000|Overall Study|Withdrawal by Subject|4|||
130246843|NCT04243837|468865457|FG001|Overall Study|Withdrawal by Subject|2|||
130246844|NCT04243837|468865456|FG000|Overall Study|Covid-19 lock down|1|||
130246845|NCT04243837|468865457|FG001|Overall Study|Covid-19 lock down|0|||
130246846|NCT04243837|468865456|FG000|Overall Study|Study Terminated by Sponsor|11|||
130246847|NCT04243837|468865457|FG001|Overall Study|Study Terminated by Sponsor|12|||
130246848|NCT02280499|468865461|FG000|Overall Study|Death|14|||
130246849|NCT02280499|468865461|FG000|Overall Study|Lost to Follow-up|42|||
130246850|NCT02280499|468865461|FG000|Overall Study|Adverse Event|5|||
130246851|NCT00977561|468865465|FG000|Overall Study|Death|3|||
130246852|NCT00977561|468865466|FG001|Overall Study|Death|2|||
130246853|NCT00977561|468865465|FG000|Overall Study|Study terminated|0|||
130246854|NCT00977561|468865466|FG001|Overall Study|Study terminated|2|||
130246855|NCT00977561|468865465|FG000|Overall Study|Other|2|||
130246856|NCT00977561|468865466|FG001|Overall Study|Other|0|||
130246857|NCT04689009|468865473|FG000|Overall Study|Adverse Event|1|||
130246858|NCT04689009|468865474|FG001|Overall Study|Adverse Event|0|||
130246859|NCT04689009|468865473|FG000|Overall Study|Lost to Follow-up|1|||
130246860|NCT04689009|468865474|FG001|Overall Study|Lost to Follow-up|2|||
130246861|NCT04689009|468865473|FG000|Overall Study|Withdrawal by Subject|4|||
130246862|NCT04689009|468865474|FG001|Overall Study|Withdrawal by Subject|3|||
130246863|NCT04689009|468865473|FG000|Overall Study|Protocol Violation|1|||
130246864|NCT04689009|468865474|FG001|Overall Study|Protocol Violation|0|||
130246865|NCT02187055|468865475|FG000|Overall Study|Lack of Efficacy|10|||
130246866|NCT02187055|468865476|FG001|Overall Study|Lack of Efficacy|3|||
130246867|NCT02187055|468865477|FG002|Overall Study|Lack of Efficacy|7|||
130246868|NCT02187055|468865475|FG000|Overall Study|Lost to Follow-up|2|||
130246869|NCT02187055|468865476|FG001|Overall Study|Lost to Follow-up|7|||
130246870|NCT02187055|468865477|FG002|Overall Study|Lost to Follow-up|3|||
130246871|NCT02187055|468865475|FG000|Overall Study|No longer meets eligibility criteria|0|||
130246872|NCT02187055|468865476|FG001|Overall Study|No longer meets eligibility criteria|2|||
130246873|NCT02187055|468865477|FG002|Overall Study|No longer meets eligibility criteria|0|||
130246874|NCT02187055|468865475|FG000|Overall Study|No longer willing to participate|6|||
130246875|NCT02187055|468865476|FG001|Overall Study|No longer willing to participate|8|||
130246876|NCT02187055|468865477|FG002|Overall Study|No longer willing to participate|10|||
130246877|NCT02187055|468865475|FG000|Overall Study|Other|5|||
130246878|NCT02187055|468865476|FG001|Overall Study|Other|6|||
130246879|NCT02187055|468865477|FG002|Overall Study|Other|3|||
130246880|NCT02187055|468865475|FG000|Overall Study|Protocol Violation|9|||
130246881|NCT02187055|468865476|FG001|Overall Study|Protocol Violation|9|||
130246882|NCT02187055|468865477|FG002|Overall Study|Protocol Violation|4|||
130246883|NCT02187055|468865475|FG000|Overall Study|Pregnancy|3|||
130246884|NCT02187055|468865476|FG001|Overall Study|Pregnancy|1|||
130246885|NCT02187055|468865477|FG002|Overall Study|Pregnancy|0|||
130246886|NCT02187055|468865475|FG000|Overall Study|Withdrawal by Subject|11|||
130246887|NCT02187055|468865476|FG001|Overall Study|Withdrawal by Subject|11|||
130246888|NCT02187055|468865477|FG002|Overall Study|Withdrawal by Subject|11|||
130246889|NCT02187055|468865475|FG000|Overall Study|Adverse Event|21|||
130246890|NCT02187055|468865476|FG001|Overall Study|Adverse Event|26|||
130246891|NCT02187055|468865477|FG002|Overall Study|Adverse Event|36|||
130246892|NCT02187055|468865475|FG000|Overall Study|Death|2|||
130246893|NCT02187055|468865476|FG001|Overall Study|Death|0|||
130246894|NCT02187055|468865477|FG002|Overall Study|Death|0|||
130246895|NCT05737745|468865478|FG000|Overall Study|Withdrawal by Subject|0|||
130246896|NCT05737745|468865479|FG001|Overall Study|Withdrawal by Subject|6|||
130246897|NCT05737745|468865480|FG002|Overall Study|Withdrawal by Subject|1|||
130246898|NCT00165698|468865481|FG000|Overall Study|Adverse Event|2|||
130246899|NCT00165698|468865482|FG001|Overall Study|Adverse Event|10|||
130246900|NCT00165698|468865481|FG000|Overall Study|Lost to Follow-up|2|||
130246901|NCT00165698|468865482|FG001|Overall Study|Lost to Follow-up|2|||
130246902|NCT00165698|468865481|FG000|Overall Study|Withdrawal by Subject|2|||
130246903|NCT00165698|468865482|FG001|Overall Study|Withdrawal by Subject|1|||
130246904|NCT00165698|468865481|FG000|Overall Study|Protocol Violation|1|||
130246905|NCT00165698|468865482|FG001|Overall Study|Protocol Violation|0|||
130246906|NCT00165698|468865481|FG000|Overall Study|Not Taken/Lost the medicine|1|||
130246907|NCT00165698|468865482|FG001|Overall Study|Not Taken/Lost the medicine|2|||
130246908|NCT02547935|468865483|FG000|Overall Study|Other|0|||
130246909|NCT02547935|468865484|FG001|Overall Study|Other|1|||
130246910|NCT02547935|468865485|FG002|Overall Study|Other|0|||
130246911|NCT02547935|468865483|FG000|Overall Study|Withdrawal by Subject|2|||
130246912|NCT02547935|468865484|FG001|Overall Study|Withdrawal by Subject|3|||
130246913|NCT02547935|468865485|FG002|Overall Study|Withdrawal by Subject|4|||
130246914|NCT02547935|468865483|FG000|Overall Study|Screen Failure|2|||
130246915|NCT02547935|468865484|FG001|Overall Study|Screen Failure|0|||
130246916|NCT02547935|468865485|FG002|Overall Study|Screen Failure|0|||
130246917|NCT02547935|468865483|FG000|Overall Study|Physician Decision|0|||
130246918|NCT02547935|468865484|FG001|Overall Study|Physician Decision|1|||
130246919|NCT02547935|468865485|FG002|Overall Study|Physician Decision|0|||
130246920|NCT02547935|468865483|FG000|Overall Study|Lost to Follow-up|0|||
130246921|NCT02547935|468865484|FG001|Overall Study|Lost to Follow-up|2|||
130246922|NCT02547935|468865485|FG002|Overall Study|Lost to Follow-up|1|||
130246923|NCT02547935|468865483|FG000|Overall Study|Death|1|||
130246924|NCT02547935|468865484|FG001|Overall Study|Death|1|||
130246925|NCT02547935|468865485|FG002|Overall Study|Death|0|||
130030681|NCT04343651|468068624|FG000|Overall Study|Death|0|||
130030682|NCT04343651|468068625|FG001|Overall Study|Death|1|||
130030683|NCT04343651|468068624|FG000|Overall Study|Did not start treatment|1|||
130030684|NCT04343651|468068625|FG001|Overall Study|Did not start treatment|1|||
130030685|NCT04343651|468068624|FG000|Overall Study|Patient did not complete visits 3-6|0|||
130246926|NCT02487199|468865488|FG000|Overall Study|Withdrew Consent|0|||
130030686|NCT04343651|468068625|FG001|Overall Study|Patient did not complete visits 3-6|1|||
130246927|NCT02487199|468865489|FG001|Overall Study|Withdrew Consent|1|||
130246928|NCT05206604|468867707|FG000|Overall Study|Non-compliance with study drug|0|||
130246929|NCT05206604|468867708|FG001|Overall Study|Non-compliance with study drug|0|||
130246930|NCT05206604|468867709|FG002|Overall Study|Non-compliance with study drug|0|||
130246931|NCT05206604|468867710|FG003|Overall Study|Non-compliance with study drug|0|||
130246932|NCT05206604|468867711|FG004|Overall Study|Non-compliance with study drug|0|||
130246933|NCT05206604|468867712|FG005|Overall Study|Non-compliance with study drug|1|||
130246934|NCT05206604|468867713|FG006|Overall Study|Non-compliance with study drug|0|||
130246935|NCT05206604|468867714|FG007|Overall Study|Non-compliance with study drug|0|||
130246936|NCT03735498|468867715|FG000|Overall Study|Withdrawal by Subject|3|||
130246937|NCT03735498|468867715|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
130246938|NCT02014103|468867716|FG000|Overall Study|Protocol Violation|7|||
130246939|NCT02014103|468867717|FG001|Overall Study|Protocol Violation|7|||
130246940|NCT02014103|468867716|FG000|Overall Study|Adverse Event|1|||
130246941|NCT02014103|468867717|FG001|Overall Study|Adverse Event|0|||
130246942|NCT02014103|468867716|FG000|Overall Study|Lost venous access|1|||
130246943|NCT02014103|468867717|FG001|Overall Study|Lost venous access|0|||
130246944|NCT02014103|468867716|FG000|Overall Study|Withdrawal by Subject|0|||
130246945|NCT02014103|468867717|FG001|Overall Study|Withdrawal by Subject|2|||
130246946|NCT04289298|468867719|FG000|Overall Study|Lost to Follow-up|5|||
130246947|NCT04289298|468867720|FG001|Overall Study|Lost to Follow-up|0|||
130246948|NCT04289298|468867719|FG000|Overall Study|Withdrawal by Subject|2|||
130246949|NCT04289298|468867720|FG001|Overall Study|Withdrawal by Subject|0|||
130246950|NCT00620035|468867721|FG000|Overall Study|Adverse Event|106|||
130246951|NCT00620035|468867721|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130246952|NCT00620035|468867721|FG000|Overall Study|Other Reason|38|||
130246953|NCT01108796|468867724|FG000|Overall Study|Adverse Event|0|||
130246954|NCT01108796|468867725|FG001|Overall Study|Adverse Event|1|||
130246955|NCT01108796|468867724|FG000|Overall Study|Lost to Follow-up|7|||
130246956|NCT01108796|468867725|FG001|Overall Study|Lost to Follow-up|6|||
130246957|NCT01245751|468867727|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
130246958|NCT01245751|468867728|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
130246959|NCT01245751|468867729|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
130246960|NCT01245751|468867730|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
130246961|NCT01245751|468867727|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130246962|NCT01245751|468867728|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130246963|NCT01245751|468867729|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
130246964|NCT01245751|468867730|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
130246965|NCT01245751|468867727|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130246966|NCT01245751|468867728|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
130246967|NCT01245751|468867729|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130246968|NCT01245751|468867730|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
130246969|NCT00985192|468867731|FG000|Overall Study|Withdrawal by Subject|1|||
130246970|NCT00985192|468867731|FG000|Overall Study|Disease Progression|1|||
130246971|NCT00985192|468867731|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
130246972|NCT03387046|468867734|FG000|Overall Study|Adverse Event|1|||
130246973|NCT03387046|468867735|FG001|Overall Study|Adverse Event|1|||
130246974|NCT03794544|468867736|FG000|Overall Study|Withdrawal by Subject|1|||
130246975|NCT03794544|468867737|FG001|Overall Study|Withdrawal by Subject|1|||
130246976|NCT03794544|468867738|FG002|Overall Study|Withdrawal by Subject|0|||
130246977|NCT03794544|468867739|FG003|Overall Study|Withdrawal by Subject|0|||
130246978|NCT03794544|468867736|FG000|Overall Study|Death|0|||
130246979|NCT03794544|468867737|FG001|Overall Study|Death|0|||
130246980|NCT03794544|468867738|FG002|Overall Study|Death|0|||
130246981|NCT03794544|468867739|FG003|Overall Study|Death|1|||
130246982|NCT03794544|468867736|FG000|Overall Study|Lost to Follow-up|0|||
130246983|NCT03794544|468867737|FG001|Overall Study|Lost to Follow-up|1|||
130246984|NCT03794544|468867738|FG002|Overall Study|Lost to Follow-up|1|||
130246985|NCT03794544|468867739|FG003|Overall Study|Lost to Follow-up|0|||
130246986|NCT03794544|468867736|FG000|Overall Study|Other|0|||
130246987|NCT03794544|468867737|FG001|Overall Study|Other|1|||
130246988|NCT03794544|468867738|FG002|Overall Study|Other|0|||
130246989|NCT03794544|468867739|FG003|Overall Study|Other|0|||
130246990|NCT00676052|468867742|FG000|Overall Study|Adverse Event|0|||
130246991|NCT00676052|468867743|FG001|Overall Study|Adverse Event|1|||
130246992|NCT00676052|468867744|FG002|Overall Study|Adverse Event|1|||
130246993|NCT00676052|468867745|FG003|Overall Study|Adverse Event|2|||
130246994|NCT00676052|468867746|FG004|Overall Study|Adverse Event|2|||
130246995|NCT00676052|468867747|FG005|Overall Study|Adverse Event|2|||
130246996|NCT00676052|468867742|FG000|Overall Study|Lack of Efficacy|2|||
130246997|NCT00676052|468867743|FG001|Overall Study|Lack of Efficacy|2|||
130246998|NCT00676052|468867744|FG002|Overall Study|Lack of Efficacy|1|||
130246999|NCT00676052|468867745|FG003|Overall Study|Lack of Efficacy|1|||
130247000|NCT00676052|468867746|FG004|Overall Study|Lack of Efficacy|2|||
130247001|NCT00676052|468867747|FG005|Overall Study|Lack of Efficacy|1|||
130247002|NCT00676052|468867742|FG000|Overall Study|Protocol Violation|5|||
130247003|NCT00676052|468867743|FG001|Overall Study|Protocol Violation|3|||
130247004|NCT00676052|468867744|FG002|Overall Study|Protocol Violation|2|||
130247005|NCT00676052|468867745|FG003|Overall Study|Protocol Violation|2|||
130247006|NCT00676052|468867746|FG004|Overall Study|Protocol Violation|1|||
130247007|NCT00676052|468867747|FG005|Overall Study|Protocol Violation|2|||
130247008|NCT00676052|468867742|FG000|Overall Study|Lost to Follow-up|0|||
130247009|NCT00676052|468867743|FG001|Overall Study|Lost to Follow-up|0|||
130247010|NCT00676052|468867744|FG002|Overall Study|Lost to Follow-up|0|||
130247011|NCT00676052|468867745|FG003|Overall Study|Lost to Follow-up|0|||
130247012|NCT00676052|468867746|FG004|Overall Study|Lost to Follow-up|1|||
130247013|NCT00676052|468867747|FG005|Overall Study|Lost to Follow-up|0|||
130247014|NCT00676052|468867742|FG000|Overall Study|Physician Decision|1|||
130247015|NCT00676052|468867743|FG001|Overall Study|Physician Decision|1|||
130247016|NCT00676052|468867744|FG002|Overall Study|Physician Decision|1|||
130247017|NCT00676052|468867745|FG003|Overall Study|Physician Decision|0|||
130247018|NCT00676052|468867746|FG004|Overall Study|Physician Decision|0|||
130247019|NCT00676052|468867747|FG005|Overall Study|Physician Decision|1|||
130247020|NCT00676052|468867742|FG000|Overall Study|Withdrawal by Subject|1|||
130247021|NCT00676052|468867743|FG001|Overall Study|Withdrawal by Subject|0|||
130247022|NCT00676052|468867744|FG002|Overall Study|Withdrawal by Subject|1|||
130247023|NCT00676052|468867745|FG003|Overall Study|Withdrawal by Subject|0|||
130247024|NCT00676052|468867746|FG004|Overall Study|Withdrawal by Subject|0|||
130247025|NCT00676052|468867747|FG005|Overall Study|Withdrawal by Subject|0|||
130247026|NCT00120250|468867748|FG000|Overall Study|Lost to Follow-up|1|||
130247027|NCT00120250|468867749|FG001|Overall Study|Lost to Follow-up|1|||
130247028|NCT00120250|468867748|FG000|Overall Study|Protocol Violation|0|||
130247029|NCT00120250|468867749|FG001|Overall Study|Protocol Violation|1|||
130247030|NCT01964560|468867765|FG000|Overall Study|Adverse Event|23|||
130247031|NCT01964560|468867765|FG000|Overall Study|Lack of Efficacy|46|||
130247032|NCT01964560|468867765|FG000|Overall Study|Protocol deviation|2|||
130247033|NCT01964560|468867765|FG000|Overall Study|Lost to Follow-up|4|||
130247034|NCT01964560|468867765|FG000|Overall Study|Withdrawal by Subject|64|||
130247035|NCT01964560|468867765|FG000|Overall Study|Surgery-hemispherotomy|1|||
130247036|NCT01964560|468867765|FG000|Overall Study|Surgery|1|||
130247037|NCT01964560|468867765|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
130247038|NCT01964560|468867765|FG000|Overall Study|Patient and Investigator choice|1|||
130247039|NCT01964560|468867765|FG000|Overall Study|Patient was prescribed CBD|1|||
130247040|NCT01964560|468867765|FG000|Overall Study|Participant moved to another country|1|||
130247041|NCT00378560|468867766|FG000|Overall Study|Adverse Event|1|||
130247042|NCT00378560|468867767|FG001|Overall Study|Adverse Event|0|||
130247043|NCT00378560|468867766|FG000|Overall Study|Lost to Follow-up|24|||
130247044|NCT00378560|468867767|FG001|Overall Study|Lost to Follow-up|29|||
130247045|NCT00378560|468867766|FG000|Overall Study|Protocol Violation|2|||
130247046|NCT00378560|468867767|FG001|Overall Study|Protocol Violation|0|||
130030687|NCT02246621|468068626|FG000|Overall Study|Withdrawal by Subject|28|||
130030688|NCT02246621|468068627|FG001|Overall Study|Withdrawal by Subject|16|||
130030689|NCT02246621|468068626|FG000|Overall Study|Lost to Follow-up|1|||
130030690|NCT02246621|468068627|FG001|Overall Study|Lost to Follow-up|0|||
130030691|NCT02246621|468068626|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
130030692|NCT02246621|468068627|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
130030693|NCT01459614|468068628|FG000|Overall Study|Adverse Event|1|||
130030694|NCT01459614|468068629|FG001|Overall Study|Adverse Event|0|||
130030695|NCT03136107|468068639|FG000|Overall Study|Other (Not specified)|1|||
130247047|NCT00378560|468867766|FG000|Overall Study|Withdrawal by Subject|17|||
130247048|NCT00378560|468867767|FG001|Overall Study|Withdrawal by Subject|21|||
130247049|NCT00378560|468867766|FG000|Overall Study|Moved|4|||
130247050|NCT00378560|468867767|FG001|Overall Study|Moved|3|||
130247051|NCT00378560|468867766|FG000|Overall Study|Pregnancy|7|||
130247052|NCT00378560|468867767|FG001|Overall Study|Pregnancy|5|||
130247053|NCT00378560|468867766|FG000|Overall Study|Laboratory test values abnormal|1|||
130247054|NCT00378560|468867767|FG001|Overall Study|Laboratory test values abnormal|0|||
130247055|NCT04389671|468867768|FG000|Overall Study|Death|7|||
130247056|NCT04865978|468867770|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
130247057|NCT04865978|468867771|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
130247058|NCT03835117|468867772|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
130247059|NCT03835117|468867773|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
130247060|NCT01543503|468867777|FG000|Overall Study|Lost to Follow-up|32|||
130247061|NCT01543503|468867778|FG001|Overall Study|Lost to Follow-up|36|||
130247062|NCT01543503|468867777|FG000|Overall Study|Adverse Event|9|||
130247063|NCT01543503|468867778|FG001|Overall Study|Adverse Event|13|||
130247064|NCT01543503|468867777|FG000|Overall Study|Lack of Efficacy|4|||
130247065|NCT01543503|468867778|FG001|Overall Study|Lack of Efficacy|16|||
130247066|NCT01543503|468867777|FG000|Overall Study|Participant withdrew informed consent|8|||
130247067|NCT01543503|468867778|FG001|Overall Study|Participant withdrew informed consent|10|||
130247068|NCT01543503|468867777|FG000|Overall Study|Change of jobs|0|||
130247069|NCT01543503|468867778|FG001|Overall Study|Change of jobs|1|||
130247070|NCT01543503|468867777|FG000|Overall Study|Intolerance to the biologic treatment|0|||
130247071|NCT01543503|468867778|FG001|Overall Study|Intolerance to the biologic treatment|1|||
130247072|NCT01543503|468867777|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
130247073|NCT01543503|468867778|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
130247074|NCT01543503|468867777|FG000|Overall Study|Participant did not complete last visit|0|||
130247075|NCT01543503|468867778|FG001|Overall Study|Participant did not complete last visit|2|||
130030696|NCT03283085|468068640|FG000|Overall Study|Adverse Event|18|||
130247076|NCT01543503|468867777|FG000|Overall Study|Refused to continue treatment|7|||
130247077|NCT01543503|468867778|FG001|Overall Study|Refused to continue treatment|0|||
130247078|NCT01543503|468867777|FG000|Overall Study|Incorrect medication received|1|||
130247079|NCT01543503|468867778|FG001|Overall Study|Incorrect medication received|0|||
130247080|NCT01543503|468867777|FG000|Overall Study|Participant moved to another city|2|||
130247081|NCT01543503|468867778|FG001|Overall Study|Participant moved to another city|0|||
130247082|NCT01543503|468867777|FG000|Overall Study|Participant will not return for visits|0|||
130247083|NCT01543503|468867778|FG001|Overall Study|Participant will not return for visits|2|||
130030697|NCT03283085|468068641|FG001|Overall Study|Adverse Event|3|||
130030698|NCT03283085|468068642|FG002|Overall Study|Adverse Event|13|||
130030699|NCT03283085|468068643|FG003|Overall Study|Adverse Event|0|||
130030700|NCT03283085|468068644|FG004|Overall Study|Adverse Event|0|||
130030701|NCT03283085|468068645|FG005|Overall Study|Adverse Event|5|||
130030702|NCT03283085|468068640|FG000|Overall Study|Death|0|||
130247084|NCT01543503|468867777|FG000|Overall Study|Participant transferred to another city|1|||
130247085|NCT01543503|468867778|FG001|Overall Study|Participant transferred to another city|0|||
130247086|NCT01543503|468867777|FG000|Overall Study|Participant moved to Scotland|1|||
130247087|NCT01543503|468867778|FG001|Overall Study|Participant moved to Scotland|0|||
130247088|NCT01543503|468867777|FG000|Overall Study|Participant decision to stop treatment|1|||
130247089|NCT01543503|468867778|FG001|Overall Study|Participant decision to stop treatment|0|||
130247090|NCT01543503|468867777|FG000|Overall Study|Investigator did not wish to participate|1|||
130247091|NCT01543503|468867778|FG001|Overall Study|Investigator did not wish to participate|1|||
130247092|NCT01543503|468867777|FG000|Overall Study|Participant recruited after closing date|0|||
130247093|NCT01543503|468867778|FG001|Overall Study|Participant recruited after closing date|1|||
130247094|NCT01543503|468867777|FG000|Overall Study|Site stopped participation|5|||
130247095|NCT01543503|468867778|FG001|Overall Study|Site stopped participation|1|||
130247096|NCT01543503|468867777|FG000|Overall Study|Participant did not attend a visit|1|||
130247097|NCT01543503|468867778|FG001|Overall Study|Participant did not attend a visit|0|||
130247098|NCT01543503|468867777|FG000|Overall Study|Moved to other rheumatologic site|0|||
130247099|NCT01543503|468867778|FG001|Overall Study|Moved to other rheumatologic site|1|||
130247100|NCT01543503|468867777|FG000|Overall Study|Participant consented to another study|0|||
130247101|NCT01543503|468867778|FG001|Overall Study|Participant consented to another study|2|||
130247102|NCT01543503|468867777|FG000|Overall Study|Participant went to United States|1|||
130247103|NCT01543503|468867778|FG001|Overall Study|Participant went to United States|0|||
130247104|NCT01543503|468867777|FG000|Overall Study|Screen failure|1|||
130247105|NCT01543503|468867778|FG001|Overall Study|Screen failure|0|||
130247106|NCT01309100|468867781|FG000|Overall Study|Protocol Violation|1|||
130247107|NCT01309100|468867781|FG000|Overall Study|Positive Slit lamp finding|1|||
130247108|NCT01968785|468867784|FG000|Overall Study|Withdrawal by Subject|1|||
130247109|NCT01968785|468867785|FG001|Overall Study|Withdrawal by Subject|0|||
130247110|NCT04560309|468867789|FG000|Overall Study|Meet drop out criteria|1|||
130247111|NCT04560309|468867790|FG001|Overall Study|Meet drop out criteria|1|||
130247112|NCT04146909|468867791|FG000|Overall Study|Withdrawal by Subject|3|||
130247113|NCT04146909|468867791|FG000|Overall Study|Did not qualify after consented|1|||
130247114|NCT05085405|468867792|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247115|NCT05085405|468867793|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247116|NCT05085405|468867794|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
130247117|NCT05085405|468867795|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
130247118|NCT05085405|468867796|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247119|NCT05085405|468867797|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
130247120|NCT05085405|468867792|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247121|NCT05085405|468867793|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247122|NCT05085405|468867794|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247123|NCT05085405|468867795|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
130247124|NCT05085405|468867796|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247125|NCT05085405|468867797|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
130247126|NCT04000724|468867805|FG000|Overall Study|Withdrawal by Subject|5|||
130247127|NCT04000724|468867806|FG001|Overall Study|Withdrawal by Subject|3|||
130247128|NCT04000724|468867807|FG002|Overall Study|Withdrawal by Subject|4|||
130247129|NCT04000724|468867805|FG000|Overall Study|Lost to Follow-up|11|||
130247130|NCT04000724|468867806|FG001|Overall Study|Lost to Follow-up|7|||
130247131|NCT04000724|468867807|FG002|Overall Study|Lost to Follow-up|13|||
130247132|NCT00455455|468867808|FG000|Washout|Withdrawal by Subject|0|||
130030703|NCT03283085|468068641|FG001|Overall Study|Death|0|||
130030704|NCT03283085|468068642|FG002|Overall Study|Death|3|||
130030705|NCT03283085|468068643|FG003|Overall Study|Death|1|||
130030706|NCT03283085|468068644|FG004|Overall Study|Death|0|||
130247133|NCT00455455|468867809|FG001|Washout|Withdrawal by Subject|1|||
130247134|NCT00455455|468867808|FG000|Washout|Withdrawal by Subject|1|||
130247135|NCT00455455|468867809|FG001|Washout|Withdrawal by Subject|0|||
130247136|NCT03808909|468867810|FG000|Overall Study|Lost to Follow-up|3|||
130247137|NCT03808909|468867811|FG001|Overall Study|Lost to Follow-up|0|||
130247138|NCT01827943|468867812|FG000|Overall Study|Protocol Violation|8|||
130247139|NCT01827943|468867812|FG000|Overall Study|Never treated because of an rapid progression|1|||
130247140|NCT03335566|468867813|FG000|Overall Study|Adverse Event|0|||
130247141|NCT03335566|468867814|FG001|Overall Study|Adverse Event|1|||
130247142|NCT03335566|468867813|FG000|Overall Study|Lost to Follow-up|1|||
130247143|NCT03335566|468867814|FG001|Overall Study|Lost to Follow-up|0|||
130247144|NCT03335566|468867813|FG000|Overall Study|Technical Problems|1|||
130247145|NCT03335566|468867814|FG001|Overall Study|Technical Problems|0|||
130247146|NCT03335566|468867813|FG000|Overall Study|Protocol Violation|1|||
130247147|NCT03335566|468867814|FG001|Overall Study|Protocol Violation|0|||
130247148|NCT03335566|468867813|FG000|Overall Study|Other than specified above|1|||
130247149|NCT03335566|468867814|FG001|Overall Study|Other than specified above|2|||
130247150|NCT01084135|468867815|FG000|20 Week|Physician Decision|0|||
130247151|NCT01084135|468867816|FG001|20 Week|Physician Decision|1|||
130247152|NCT00663351|468867817|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
130247153|NCT00663351|468867818|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
130247154|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
130247155|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
130247156|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
130247157|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
130247158|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
130247159|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
130247160|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
130247161|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
130247162|NCT00663351|468867817|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
130247163|NCT00663351|468867818|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
130247164|NCT00567112|468867819|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
130247165|NCT00567112|468867820|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
130247166|NCT00567112|468867821|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
130247167|NCT00567112|468867819|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
130247168|NCT00567112|468867820|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
130247169|NCT00567112|468867821|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
130247170|NCT00567112|468867819|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
130247171|NCT00567112|468867820|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
130247172|NCT00567112|468867821|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
130247173|NCT00545948|468867824|FG000|Overall Study|Not Treated|1|||
130247174|NCT00545948|468867825|FG001|Overall Study|Not Treated|1|||
130247175|NCT00545948|468867826|FG002|Overall Study|Not Treated|7|||
130247176|NCT03467945|468867827|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130247177|NCT03467945|468867828|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130247178|NCT03467945|468867829|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130247179|NCT03467945|468867830|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130247180|NCT03467945|468867827|FG000|Treatment Period 3|Withdrawal by Subject|1|||
130247181|NCT03467945|468867828|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130247182|NCT03467945|468867829|FG002|Treatment Period 3|Withdrawal by Subject|2|||
130247183|NCT03467945|468867830|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130247184|NCT03520387|468867845|FG000|Pre-Randomization|Withdrawal by Subject|1|||
130247185|NCT03520387|468867846|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130247186|NCT03520387|468867847|FG002|Pre-Randomization|Withdrawal by Subject|0|||
130247187|NCT03520387|468867848|FG003|Pre-Randomization|Withdrawal by Subject|0|||
130247188|NCT03520387|468867849|FG004|Pre-Randomization|Withdrawal by Subject|0|||
130247189|NCT03520387|468867845|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
130247190|NCT03520387|468867846|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247191|NCT03520387|468867847|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247192|NCT03520387|468867848|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247193|NCT03520387|468867849|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
130247194|NCT03336866|468867850|FG000|Overall Study|Lost to Follow-up|2|||
130247195|NCT03336866|468867851|FG001|Overall Study|Lost to Follow-up|0|||
130247196|NCT03336866|468867852|FG002|Overall Study|Lost to Follow-up|3|||
130247197|NCT03336866|468867850|FG000|Overall Study|Withdrawal by Subject|1|||
130247198|NCT03336866|468867851|FG001|Overall Study|Withdrawal by Subject|1|||
130247199|NCT03336866|468867852|FG002|Overall Study|Withdrawal by Subject|0|||
130247200|NCT03336866|468867850|FG000|Overall Study|Noncompliance with clinic house rules|0|||
130247201|NCT03336866|468867851|FG001|Overall Study|Noncompliance with clinic house rules|0|||
130247202|NCT03336866|468867852|FG002|Overall Study|Noncompliance with clinic house rules|1|||
130247203|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Death|0|||
130247204|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Death|2|||
130247205|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Death|2|||
130247206|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Death|0|||
130247207|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
130247208|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
130247209|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
130247210|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
130247211|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
130247212|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
130247213|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
130247214|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
130247215|NCT04913675|468867853|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
130247216|NCT04913675|468867854|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
130247217|NCT04913675|468867855|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
130247218|NCT04913675|468867856|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
130247219|NCT04913675|468867853|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130247220|NCT04913675|468867854|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130247221|NCT04913675|468867855|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
130247222|NCT04913675|468867856|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
130247223|NCT02975700|468867857|FG000|Overall Study|Adverse Event|1|||
130247224|NCT02975700|468867857|FG000|Overall Study|Progressive disease|3|||
130247225|NCT02975700|468867857|FG000|Overall Study|Failed screening criteria|2|||
130247226|NCT05660538|468867859|FG000|Overall Study|Adverse Event|0|||
130247227|NCT05660538|468867860|FG001|Overall Study|Adverse Event|0|||
130247228|NCT05660538|468867861|FG002|Overall Study|Adverse Event|1|||
130247229|NCT05660538|468867862|FG003|Overall Study|Adverse Event|0|||
130247230|NCT05660538|468867859|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130247231|NCT05660538|468867860|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
130247232|NCT05660538|468867861|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
130247233|NCT05660538|468867862|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
130247234|NCT05660538|468867859|FG000|Overall Study|Lost to Follow-up|0|||
130247235|NCT05660538|468867860|FG001|Overall Study|Lost to Follow-up|0|||
130247236|NCT05660538|468867861|FG002|Overall Study|Lost to Follow-up|1|||
130247237|NCT05660538|468867862|FG003|Overall Study|Lost to Follow-up|1|||
130247238|NCT05660538|468867859|FG000|Overall Study|Death|0|||
130247239|NCT05660538|468867860|FG001|Overall Study|Death|0|||
130247240|NCT05660538|468867861|FG002|Overall Study|Death|1|||
130247241|NCT05660538|468867862|FG003|Overall Study|Death|0|||
130247242|NCT05660538|468867859|FG000|Overall Study|Physician Decision|0|||
130247243|NCT05660538|468867860|FG001|Overall Study|Physician Decision|0|||
130247244|NCT05660538|468867861|FG002|Overall Study|Physician Decision|0|||
130247245|NCT05660538|468867862|FG003|Overall Study|Physician Decision|1|||
130247246|NCT05660538|468867859|FG000|Overall Study|Sponsor Decision|1|||
130247247|NCT05660538|468867860|FG001|Overall Study|Sponsor Decision|0|||
130247248|NCT05660538|468867861|FG002|Overall Study|Sponsor Decision|0|||
130247249|NCT05660538|468867862|FG003|Overall Study|Sponsor Decision|0|||
130247250|NCT05660538|468867859|FG000|Overall Study|Other|1|||
130247251|NCT05660538|468867860|FG001|Overall Study|Other|0|||
130247252|NCT05660538|468867861|FG002|Overall Study|Other|0|||
130247253|NCT05660538|468867862|FG003|Overall Study|Other|1|||
130247254|NCT05660538|468867859|FG000|Overall Study|Randomized but did not receive study drug|1|||
130247255|NCT05660538|468867860|FG001|Overall Study|Randomized but did not receive study drug|0|||
130247256|NCT05660538|468867861|FG002|Overall Study|Randomized but did not receive study drug|0|||
130247257|NCT05660538|468867862|FG003|Overall Study|Randomized but did not receive study drug|1|||
130247258|NCT05660538|468867859|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130247259|NCT05660538|468867860|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
130247260|NCT05660538|468867861|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130247261|NCT05660538|468867862|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
130247262|NCT04518410|468867864|FG000|Overall Study|Lost to Follow-up|1|||
130247263|NCT04518410|468867865|FG001|Overall Study|Lost to Follow-up|1|||
130247264|NCT04518410|468867866|FG002|Overall Study|Lost to Follow-up|8|||
130247265|NCT04518410|468867867|FG003|Overall Study|Lost to Follow-up|5|||
130247266|NCT04518410|468867868|FG004|Overall Study|Lost to Follow-up|92|||
130247267|NCT04518410|468867869|FG005|Overall Study|Lost to Follow-up|25|||
130247268|NCT04518410|468867870|FG006|Overall Study|Lost to Follow-up|25|||
130247269|NCT04518410|468867871|FG007|Overall Study|Lost to Follow-up|3|||
130247270|NCT04518410|468867872|FG008|Overall Study|Lost to Follow-up|2|||
130247271|NCT04518410|468867873|FG009|Overall Study|Lost to Follow-up|13|||
130247272|NCT04518410|468867874|FG010|Overall Study|Lost to Follow-up|9|||
130247273|NCT04518410|468867875|FG011|Overall Study|Lost to Follow-up|13|||
130247274|NCT04518410|468867876|FG012|Overall Study|Lost to Follow-up|9|||
130247275|NCT04518410|468867877|FG013|Overall Study|Lost to Follow-up|13|||
130247276|NCT04518410|468867878|FG014|Overall Study|Lost to Follow-up|8|||
130247277|NCT04518410|468867879|FG015|Overall Study|Lost to Follow-up|10|||
130247278|NCT04518410|468867880|FG016|Overall Study|Lost to Follow-up|6|||
130247279|NCT04518410|468867881|FG017|Overall Study|Lost to Follow-up|13|||
130247280|NCT04518410|468867882|FG018|Overall Study|Lost to Follow-up|21|||
130247281|NCT04518410|468867883|FG019|Overall Study|Lost to Follow-up|6|||
130247282|NCT04518410|468867884|FG020|Overall Study|Lost to Follow-up|7|||
130247283|NCT04518410|468867885|FG021|Overall Study|Lost to Follow-up|21|||
130247284|NCT04518410|468867886|FG022|Overall Study|Lost to Follow-up|1|||
130247285|NCT04518410|468867887|FG023|Overall Study|Lost to Follow-up|7|||
130100776|NCT00077766|468326067|FG001|Overall Study|Transplantation|1|||
130100777|NCT00077766|468326066|FG000|Overall Study|Investigators Discretion|1|||
130100778|NCT00077766|468326067|FG001|Overall Study|Investigators Discretion|0|||
130100779|NCT00077766|468326066|FG000|Overall Study|Participant's decision|1|||
130100780|NCT00077766|468326067|FG001|Overall Study|Participant's decision|0|||
130100781|NCT00077766|468326066|FG000|Overall Study|Dialysis Discontinued|1|||
130100782|NCT00077766|468326067|FG001|Overall Study|Dialysis Discontinued|0|||
130100783|NCT00077766|468326066|FG000|Overall Study|Dialysis|0|||
130100784|NCT00077766|468326067|FG001|Overall Study|Dialysis|1|||
130100785|NCT00077766|468326066|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
130100786|NCT00077766|468326067|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
130100787|NCT00077766|468326066|FG000|Overall Study|Started Nocturnal Dialysis|0|||
130100788|NCT00077766|468326067|FG001|Overall Study|Started Nocturnal Dialysis|1|||
130100789|NCT00077766|468326066|FG000|Overall Study|Stop Dialysis|0|||
130100790|NCT00077766|468326067|FG001|Overall Study|Stop Dialysis|1|||
130100791|NCT00077766|468326066|FG000|Overall Study|Participants Vacation|2|||
130100792|NCT00077766|468326067|FG001|Overall Study|Participants Vacation|1|||
130100793|NCT01886105|468326068|FG000|Overall Study|Lack of Efficacy|3|||
130100794|NCT03843775|468326069|FG000|Overall Study|Adverse Event|1|||
130100795|NCT03843775|468326070|FG001|Overall Study|Adverse Event|1|||
130100796|NCT03843775|468326069|FG000|Overall Study|Lack of Efficacy|2|||
130100797|NCT03843775|468326070|FG001|Overall Study|Lack of Efficacy|6|||
130100798|NCT03843775|468326069|FG000|Overall Study|Withdrawal by Subject|0|||
130100799|NCT03843775|468326070|FG001|Overall Study|Withdrawal by Subject|1|||
130100800|NCT04150107|468326073|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
130100801|NCT04150107|468326074|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
130100802|NCT04150107|468326073|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
130100803|NCT04150107|468326074|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
130100804|NCT02184988|468326079|FG000|Overall Study|Pregnancy|2|||
130100805|NCT02184988|468326079|FG000|Overall Study|Adverse Event|2|||
130100806|NCT02184988|468326079|FG000|Overall Study|moving away/travelling/unable to complet|6|||
130100807|NCT02184988|468326079|FG000|Overall Study|work scheduling issues|4|||
130247286|NCT04518410|468867888|FG024|Overall Study|Lost to Follow-up|6|||
130247287|NCT04518410|468867864|FG000|Overall Study|Withdrawal by Subject|1|||
130247288|NCT04518410|468867865|FG001|Overall Study|Withdrawal by Subject|2|||
130030707|NCT03283085|468068645|FG005|Overall Study|Death|0|||
130030708|NCT03283085|468068640|FG000|Overall Study|Withdrawal by Subject|42|||
130030709|NCT03283085|468068641|FG001|Overall Study|Withdrawal by Subject|21|||
130030710|NCT03283085|468068642|FG002|Overall Study|Withdrawal by Subject|66|||
130030711|NCT03283085|468068643|FG003|Overall Study|Withdrawal by Subject|3|||
130030712|NCT03283085|468068644|FG004|Overall Study|Withdrawal by Subject|3|||
130030713|NCT03283085|468068645|FG005|Overall Study|Withdrawal by Subject|5|||
130030714|NCT03283085|468068640|FG000|Overall Study|Physician Decision|14|||
130030715|NCT03283085|468068641|FG001|Overall Study|Physician Decision|8|||
130030716|NCT03283085|468068642|FG002|Overall Study|Physician Decision|19|||
130030717|NCT03283085|468068643|FG003|Overall Study|Physician Decision|0|||
130030718|NCT03283085|468068644|FG004|Overall Study|Physician Decision|0|||
130030719|NCT03283085|468068645|FG005|Overall Study|Physician Decision|2|||
130030720|NCT03283085|468068640|FG000|Overall Study|Site Terminated by Sponsor|1|||
130030721|NCT03283085|468068641|FG001|Overall Study|Site Terminated by Sponsor|0|||
130030722|NCT03283085|468068642|FG002|Overall Study|Site Terminated by Sponsor|3|||
130030723|NCT03283085|468068643|FG003|Overall Study|Site Terminated by Sponsor|0|||
130030724|NCT03283085|468068644|FG004|Overall Study|Site Terminated by Sponsor|0|||
130030725|NCT03283085|468068645|FG005|Overall Study|Site Terminated by Sponsor|0|||
130030726|NCT03283085|468068640|FG000|Overall Study|Lost to Follow-up|2|||
130030727|NCT03283085|468068641|FG001|Overall Study|Lost to Follow-up|0|||
130030728|NCT03283085|468068642|FG002|Overall Study|Lost to Follow-up|2|||
130030729|NCT03283085|468068643|FG003|Overall Study|Lost to Follow-up|0|||
130030730|NCT03283085|468068644|FG004|Overall Study|Lost to Follow-up|0|||
130030731|NCT03283085|468068645|FG005|Overall Study|Lost to Follow-up|1|||
130030732|NCT03283085|468068640|FG000|Overall Study|Pregnancy|0|||
130100808|NCT02184988|468326079|FG000|Overall Study|various other reasons|9|||
130100809|NCT02184988|468326079|FG000|Overall Study|Lost to Follow-up|32|||
130100810|NCT03188991|468326080|FG000|Overall Study|Withdrawal by Subject|0|||
130100811|NCT03188991|468326081|FG001|Overall Study|Withdrawal by Subject|0|||
130247289|NCT04518410|468867866|FG002|Overall Study|Withdrawal by Subject|2|||
130247290|NCT04518410|468867867|FG003|Overall Study|Withdrawal by Subject|3|||
130247291|NCT04518410|468867868|FG004|Overall Study|Withdrawal by Subject|20|||
130030733|NCT03283085|468068641|FG001|Overall Study|Pregnancy|0|||
130030734|NCT03283085|468068642|FG002|Overall Study|Pregnancy|1|||
130030735|NCT03283085|468068643|FG003|Overall Study|Pregnancy|0|||
130030736|NCT03283085|468068644|FG004|Overall Study|Pregnancy|0|||
130030737|NCT03283085|468068645|FG005|Overall Study|Pregnancy|0|||
130030738|NCT03283085|468068640|FG000|Overall Study|Lack of Efficacy|12|||
130030739|NCT03283085|468068641|FG001|Overall Study|Lack of Efficacy|6|||
130247292|NCT04518410|468867869|FG005|Overall Study|Withdrawal by Subject|20|||
130247293|NCT04518410|468867870|FG006|Overall Study|Withdrawal by Subject|25|||
130247294|NCT04518410|468867871|FG007|Overall Study|Withdrawal by Subject|6|||
130247295|NCT04518410|468867872|FG008|Overall Study|Withdrawal by Subject|1|||
130247296|NCT04518410|468867873|FG009|Overall Study|Withdrawal by Subject|12|||
130247297|NCT04518410|468867874|FG010|Overall Study|Withdrawal by Subject|5|||
130247298|NCT04518410|468867875|FG011|Overall Study|Withdrawal by Subject|7|||
130247299|NCT04518410|468867876|FG012|Overall Study|Withdrawal by Subject|2|||
130247300|NCT04518410|468867877|FG013|Overall Study|Withdrawal by Subject|13|||
130247301|NCT04518410|468867878|FG014|Overall Study|Withdrawal by Subject|4|||
130247302|NCT04518410|468867879|FG015|Overall Study|Withdrawal by Subject|9|||
130247303|NCT04518410|468867880|FG016|Overall Study|Withdrawal by Subject|0|||
130247304|NCT04518410|468867881|FG017|Overall Study|Withdrawal by Subject|15|||
130247305|NCT04518410|468867882|FG018|Overall Study|Withdrawal by Subject|12|||
130247306|NCT04518410|468867883|FG019|Overall Study|Withdrawal by Subject|9|||
130247307|NCT04518410|468867884|FG020|Overall Study|Withdrawal by Subject|14|||
130247308|NCT04518410|468867885|FG021|Overall Study|Withdrawal by Subject|3|||
130247309|NCT04518410|468867886|FG022|Overall Study|Withdrawal by Subject|2|||
130247310|NCT04518410|468867887|FG023|Overall Study|Withdrawal by Subject|9|||
130247311|NCT04518410|468867888|FG024|Overall Study|Withdrawal by Subject|8|||
130247312|NCT04518410|468867864|FG000|Overall Study|Other|1|||
130247313|NCT04518410|468867865|FG001|Overall Study|Other|0|||
130247314|NCT04518410|468867866|FG002|Overall Study|Other|0|||
130247315|NCT04518410|468867867|FG003|Overall Study|Other|1|||
130247316|NCT04518410|468867868|FG004|Overall Study|Other|6|||
130247317|NCT04518410|468867869|FG005|Overall Study|Other|6|||
130247318|NCT04518410|468867870|FG006|Overall Study|Other|5|||
130247319|NCT04518410|468867871|FG007|Overall Study|Other|2|||
130247320|NCT04518410|468867872|FG008|Overall Study|Other|0|||
130247321|NCT04518410|468867873|FG009|Overall Study|Other|1|||
130247322|NCT04518410|468867874|FG010|Overall Study|Other|0|||
130247323|NCT04518410|468867875|FG011|Overall Study|Other|2|||
130247324|NCT04518410|468867876|FG012|Overall Study|Other|0|||
130247325|NCT04518410|468867877|FG013|Overall Study|Other|0|||
130247326|NCT04518410|468867878|FG014|Overall Study|Other|0|||
130247327|NCT04518410|468867879|FG015|Overall Study|Other|3|||
130247328|NCT04518410|468867880|FG016|Overall Study|Other|1|||
130247329|NCT04518410|468867881|FG017|Overall Study|Other|1|||
130247330|NCT04518410|468867882|FG018|Overall Study|Other|1|||
130247331|NCT04518410|468867883|FG019|Overall Study|Other|0|||
130247332|NCT04518410|468867884|FG020|Overall Study|Other|1|||
130247333|NCT04518410|468867885|FG021|Overall Study|Other|0|||
130247334|NCT04518410|468867886|FG022|Overall Study|Other|1|||
130247335|NCT04518410|468867887|FG023|Overall Study|Other|2|||
130247336|NCT04518410|468867888|FG024|Overall Study|Other|2|||
130247337|NCT04518410|468867864|FG000|Overall Study|Protocol Violation|0|||
130247338|NCT04518410|468867865|FG001|Overall Study|Protocol Violation|0|||
130247339|NCT04518410|468867866|FG002|Overall Study|Protocol Violation|0|||
130247340|NCT04518410|468867867|FG003|Overall Study|Protocol Violation|2|||
130247341|NCT04518410|468867868|FG004|Overall Study|Protocol Violation|17|||
130247342|NCT04518410|468867869|FG005|Overall Study|Protocol Violation|1|||
130247343|NCT04518410|468867870|FG006|Overall Study|Protocol Violation|2|||
130247344|NCT04518410|468867871|FG007|Overall Study|Protocol Violation|1|||
130247345|NCT04518410|468867872|FG008|Overall Study|Protocol Violation|0|||
130247346|NCT04518410|468867873|FG009|Overall Study|Protocol Violation|0|||
130247347|NCT04518410|468867874|FG010|Overall Study|Protocol Violation|0|||
130247348|NCT04518410|468867875|FG011|Overall Study|Protocol Violation|0|||
130247349|NCT04518410|468867876|FG012|Overall Study|Protocol Violation|0|||
130247350|NCT04518410|468867877|FG013|Overall Study|Protocol Violation|0|||
130247351|NCT04518410|468867878|FG014|Overall Study|Protocol Violation|0|||
130247352|NCT04518410|468867879|FG015|Overall Study|Protocol Violation|0|||
130247353|NCT04518410|468867880|FG016|Overall Study|Protocol Violation|1|||
130247354|NCT04518410|468867881|FG017|Overall Study|Protocol Violation|1|||
130247355|NCT04518410|468867882|FG018|Overall Study|Protocol Violation|0|||
130247356|NCT04518410|468867883|FG019|Overall Study|Protocol Violation|0|||
130247357|NCT04518410|468867884|FG020|Overall Study|Protocol Violation|1|||
130247358|NCT04518410|468867885|FG021|Overall Study|Protocol Violation|2|||
130247359|NCT04518410|468867886|FG022|Overall Study|Protocol Violation|0|||
130247360|NCT04518410|468867887|FG023|Overall Study|Protocol Violation|3|||
130247361|NCT04518410|468867888|FG024|Overall Study|Protocol Violation|0|||
130247362|NCT04518410|468867864|FG000|Overall Study|Death|0|||
130247363|NCT04518410|468867865|FG001|Overall Study|Death|0|||
130247364|NCT04518410|468867866|FG002|Overall Study|Death|0|||
130247365|NCT04518410|468867867|FG003|Overall Study|Death|0|||
130247366|NCT04518410|468867868|FG004|Overall Study|Death|12|||
130247367|NCT04518410|468867869|FG005|Overall Study|Death|2|||
130247368|NCT04518410|468867870|FG006|Overall Study|Death|11|||
130247369|NCT04518410|468867871|FG007|Overall Study|Death|0|||
130247370|NCT04518410|468867872|FG008|Overall Study|Death|1|||
130247371|NCT04518410|468867873|FG009|Overall Study|Death|0|||
130247372|NCT04518410|468867874|FG010|Overall Study|Death|0|||
130247373|NCT04518410|468867875|FG011|Overall Study|Death|0|||
130247374|NCT04518410|468867876|FG012|Overall Study|Death|0|||
130247375|NCT04518410|468867877|FG013|Overall Study|Death|1|||
130247376|NCT04518410|468867878|FG014|Overall Study|Death|1|||
130247377|NCT04518410|468867879|FG015|Overall Study|Death|0|||
130247378|NCT04518410|468867880|FG016|Overall Study|Death|0|||
130247379|NCT04518410|468867881|FG017|Overall Study|Death|1|||
130247380|NCT04518410|468867882|FG018|Overall Study|Death|4|||
130247381|NCT04518410|468867883|FG019|Overall Study|Death|4|||
130247382|NCT04518410|468867884|FG020|Overall Study|Death|1|||
130247383|NCT04518410|468867885|FG021|Overall Study|Death|0|||
130247384|NCT04518410|468867886|FG022|Overall Study|Death|0|||
130247385|NCT04518410|468867887|FG023|Overall Study|Death|0|||
130247386|NCT04518410|468867888|FG024|Overall Study|Death|0|||
130247387|NCT04518410|468867864|FG000|Overall Study|Requirement to start alternative therapy|0|||
130247388|NCT04518410|468867865|FG001|Overall Study|Requirement to start alternative therapy|0|||
130247389|NCT04518410|468867866|FG002|Overall Study|Requirement to start alternative therapy|1|||
130247390|NCT04518410|468867867|FG003|Overall Study|Requirement to start alternative therapy|0|||
130247391|NCT04518410|468867868|FG004|Overall Study|Requirement to start alternative therapy|0|||
130247392|NCT04518410|468867869|FG005|Overall Study|Requirement to start alternative therapy|0|||
130247393|NCT04518410|468867870|FG006|Overall Study|Requirement to start alternative therapy|0|||
130247394|NCT04518410|468867871|FG007|Overall Study|Requirement to start alternative therapy|0|||
130247395|NCT04518410|468867872|FG008|Overall Study|Requirement to start alternative therapy|0|||
130247396|NCT04518410|468867873|FG009|Overall Study|Requirement to start alternative therapy|0|||
130247397|NCT04518410|468867874|FG010|Overall Study|Requirement to start alternative therapy|0|||
130247398|NCT04518410|468867875|FG011|Overall Study|Requirement to start alternative therapy|0|||
130247399|NCT04518410|468867876|FG012|Overall Study|Requirement to start alternative therapy|0|||
130247400|NCT04518410|468867877|FG013|Overall Study|Requirement to start alternative therapy|0|||
130247401|NCT04518410|468867878|FG014|Overall Study|Requirement to start alternative therapy|0|||
130247402|NCT04518410|468867879|FG015|Overall Study|Requirement to start alternative therapy|0|||
130247403|NCT04518410|468867880|FG016|Overall Study|Requirement to start alternative therapy|0|||
130247404|NCT04518410|468867881|FG017|Overall Study|Requirement to start alternative therapy|0|||
130247405|NCT04518410|468867882|FG018|Overall Study|Requirement to start alternative therapy|0|||
130247406|NCT04518410|468867883|FG019|Overall Study|Requirement to start alternative therapy|0|||
130247407|NCT04518410|468867884|FG020|Overall Study|Requirement to start alternative therapy|0|||
130247408|NCT04518410|468867885|FG021|Overall Study|Requirement to start alternative therapy|0|||
130247409|NCT04518410|468867886|FG022|Overall Study|Requirement to start alternative therapy|0|||
130247410|NCT04518410|468867887|FG023|Overall Study|Requirement to start alternative therapy|0|||
130247411|NCT04518410|468867888|FG024|Overall Study|Requirement to start alternative therapy|0|||
130247412|NCT04518410|468867864|FG000|Overall Study|Randomized but not treated|0|||
130247413|NCT04518410|468867865|FG001|Overall Study|Randomized but not treated|0|||
130247414|NCT04518410|468867866|FG002|Overall Study|Randomized but not treated|0|||
130247415|NCT04518410|468867867|FG003|Overall Study|Randomized but not treated|2|||
130247416|NCT04518410|468867868|FG004|Overall Study|Randomized but not treated|6|||
130247417|NCT04518410|468867869|FG005|Overall Study|Randomized but not treated|4|||
130247418|NCT04518410|468867870|FG006|Overall Study|Randomized but not treated|3|||
130247419|NCT04518410|468867871|FG007|Overall Study|Randomized but not treated|3|||
130247420|NCT04518410|468867872|FG008|Overall Study|Randomized but not treated|0|||
130247421|NCT04518410|468867873|FG009|Overall Study|Randomized but not treated|4|||
130247422|NCT04518410|468867874|FG010|Overall Study|Randomized but not treated|0|||
130247423|NCT04518410|468867875|FG011|Overall Study|Randomized but not treated|0|||
130247424|NCT04518410|468867876|FG012|Overall Study|Randomized but not treated|1|||
130030740|NCT03283085|468068642|FG002|Overall Study|Lack of Efficacy|24|||
130247425|NCT04518410|468867877|FG013|Overall Study|Randomized but not treated|3|||
130247426|NCT04518410|468867878|FG014|Overall Study|Randomized but not treated|3|||
130247427|NCT04518410|468867879|FG015|Overall Study|Randomized but not treated|3|||
130247428|NCT04518410|468867880|FG016|Overall Study|Randomized but not treated|4|||
130247429|NCT04518410|468867881|FG017|Overall Study|Randomized but not treated|5|||
130247430|NCT04518410|468867882|FG018|Overall Study|Randomized but not treated|4|||
130247431|NCT04518410|468867883|FG019|Overall Study|Randomized but not treated|0|||
130247432|NCT04518410|468867884|FG020|Overall Study|Randomized but not treated|0|||
130247433|NCT04518410|468867885|FG021|Overall Study|Randomized but not treated|5|||
130247434|NCT04518410|468867886|FG022|Overall Study|Randomized but not treated|0|||
130247435|NCT04518410|468867887|FG023|Overall Study|Randomized but not treated|3|||
130247436|NCT04518410|468867888|FG024|Overall Study|Randomized but not treated|1|||
130247437|NCT04518410|468867864|FG000|Overall Study|Screen Fail but Randomized|0|||
130247438|NCT04518410|468867865|FG001|Overall Study|Screen Fail but Randomized|0|||
130247439|NCT04518410|468867866|FG002|Overall Study|Screen Fail but Randomized|0|||
130247440|NCT04518410|468867867|FG003|Overall Study|Screen Fail but Randomized|0|||
130247441|NCT04518410|468867868|FG004|Overall Study|Screen Fail but Randomized|2|||
130247442|NCT04518410|468867869|FG005|Overall Study|Screen Fail but Randomized|0|||
130030741|NCT03283085|468068643|FG003|Overall Study|Lack of Efficacy|1|||
130030742|NCT03283085|468068644|FG004|Overall Study|Lack of Efficacy|1|||
130030743|NCT03283085|468068645|FG005|Overall Study|Lack of Efficacy|0|||
130030744|NCT03283085|468068640|FG000|Overall Study|Reason not Specified|0|||
130030745|NCT03283085|468068641|FG001|Overall Study|Reason not Specified|4|||
130030746|NCT03283085|468068642|FG002|Overall Study|Reason not Specified|8|||
130030747|NCT03283085|468068643|FG003|Overall Study|Reason not Specified|0|||
130030748|NCT03283085|468068644|FG004|Overall Study|Reason not Specified|0|||
130030749|NCT03283085|468068645|FG005|Overall Study|Reason not Specified|1|||
130030750|NCT02292771|468068649|FG000|Overall Study|Withdrawal by Subject|2|||
130030751|NCT02292771|468068650|FG001|Overall Study|Withdrawal by Subject|1|||
130030752|NCT02292771|468068649|FG000|Overall Study|Lost to Follow-up|2|||
130030753|NCT02292771|468068650|FG001|Overall Study|Lost to Follow-up|1|||
130030754|NCT00430755|468070503|FG000|Overall Study|Withdrawal by Subject|53|||
130030755|NCT00103012|468070506|FG000|Overall Study|Withdrawal by Subject|2|||
130030756|NCT00103012|468070507|FG001|Overall Study|Withdrawal by Subject|1|||
130100812|NCT03188991|468326082|FG002|Overall Study|Withdrawal by Subject|0|||
130247443|NCT04518410|468867870|FG006|Overall Study|Screen Fail but Randomized|0|||
130247444|NCT04518410|468867871|FG007|Overall Study|Screen Fail but Randomized|0|||
130100813|NCT03188991|468326083|FG003|Overall Study|Withdrawal by Subject|1|||
130100814|NCT00464308|468327238|FG000|Overall Study|Adverse Event|22|||
130100815|NCT00464308|468327239|FG001|Overall Study|Adverse Event|27|||
130100816|NCT00464308|468327240|FG002|Overall Study|Adverse Event|16|||
130100817|NCT00464308|468327238|FG000|Overall Study|Lost to Follow-up|29|||
130100818|NCT00464308|468327239|FG001|Overall Study|Lost to Follow-up|19|||
130100819|NCT00464308|468327240|FG002|Overall Study|Lost to Follow-up|20|||
130100820|NCT00464308|468327238|FG000|Overall Study|Patient discontinued and other reasons|17|||
130100821|NCT00464308|468327239|FG001|Overall Study|Patient discontinued and other reasons|17|||
130100822|NCT00464308|468327240|FG002|Overall Study|Patient discontinued and other reasons|23|||
130100823|NCT00464308|468327238|FG000|Overall Study|Physician Decision|1|||
130100824|NCT00464308|468327239|FG001|Overall Study|Physician Decision|0|||
130100825|NCT00464308|468327240|FG002|Overall Study|Physician Decision|0|||
130100826|NCT01513759|468327241|FG000|Overall Study|Protocol Violation|4|||
130100827|NCT01513759|468327241|FG000|Overall Study|Death during catheter placement|1|||
130100828|NCT00630994|468327242|FG000|Overall Study|Adverse Event|1|||
130100829|NCT00630994|468327242|FG000|Overall Study|Disease Progression|1|||
130100830|NCT00630994|468327242|FG000|Overall Study|Lack of Efficacy|1|||
130100831|NCT00630994|468327242|FG000|Overall Study|Other|1|||
130100832|NCT03286426|468327243|FG000|Overall Study|Physician Decision|3|||
130100833|NCT05553600|468327244|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
130100834|NCT05553600|468327245|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
130100835|NCT05553600|468327246|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
130100836|NCT05553600|468327247|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
130247445|NCT04518410|468867872|FG008|Overall Study|Screen Fail but Randomized|0|||
130030757|NCT00103012|468070508|FG002|Overall Study|Withdrawal by Subject|2|||
130100837|NCT05553600|468327244|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
130100838|NCT05553600|468327245|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
130247446|NCT04518410|468867873|FG009|Overall Study|Screen Fail but Randomized|0|||
130247447|NCT04518410|468867874|FG010|Overall Study|Screen Fail but Randomized|0|||
130247448|NCT04518410|468867875|FG011|Overall Study|Screen Fail but Randomized|0|||
130030758|NCT00103012|468070506|FG000|Overall Study|Pregnancy|1|||
130030759|NCT00103012|468070507|FG001|Overall Study|Pregnancy|0|||
130030760|NCT00103012|468070508|FG002|Overall Study|Pregnancy|0|||
130030761|NCT00103012|468070506|FG000|Overall Study|Adverse Event|0|||
130030762|NCT00103012|468070507|FG001|Overall Study|Adverse Event|0|||
130247449|NCT04518410|468867876|FG012|Overall Study|Screen Fail but Randomized|0|||
130247450|NCT04518410|468867877|FG013|Overall Study|Screen Fail but Randomized|0|||
130247451|NCT04518410|468867878|FG014|Overall Study|Screen Fail but Randomized|0|||
130247452|NCT04518410|468867879|FG015|Overall Study|Screen Fail but Randomized|0|||
130247453|NCT04518410|468867880|FG016|Overall Study|Screen Fail but Randomized|0|||
130247454|NCT04518410|468867881|FG017|Overall Study|Screen Fail but Randomized|0|||
130247455|NCT04518410|468867882|FG018|Overall Study|Screen Fail but Randomized|0|||
130247456|NCT04518410|468867883|FG019|Overall Study|Screen Fail but Randomized|0|||
130247457|NCT04518410|468867884|FG020|Overall Study|Screen Fail but Randomized|0|||
130247458|NCT04518410|468867885|FG021|Overall Study|Screen Fail but Randomized|0|||
130247459|NCT04518410|468867886|FG022|Overall Study|Screen Fail but Randomized|0|||
130247460|NCT04518410|468867887|FG023|Overall Study|Screen Fail but Randomized|0|||
130247461|NCT04518410|468867888|FG024|Overall Study|Screen Fail but Randomized|0|||
130247462|NCT04518410|468867864|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247463|NCT04518410|468867865|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247464|NCT04518410|468867866|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247465|NCT04518410|468867867|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247466|NCT04518410|468867868|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
130247467|NCT04518410|468867869|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
130247468|NCT04518410|468867870|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
130247469|NCT04518410|468867871|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247470|NCT04518410|468867872|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
130247471|NCT04518410|468867873|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
130247472|NCT04518410|468867874|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247473|NCT04518410|468867875|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247474|NCT04518410|468867876|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247475|NCT04518410|468867877|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247476|NCT04518410|468867878|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
130247477|NCT04518410|468867879|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
130030763|NCT00103012|468070508|FG002|Overall Study|Adverse Event|1|||
130030764|NCT00103012|468070506|FG000|Overall Study|Subject non-compliant with medications|0|||
130030765|NCT00103012|468070507|FG001|Overall Study|Subject non-compliant with medications|0|||
130030766|NCT00103012|468070508|FG002|Overall Study|Subject non-compliant with medications|1|||
130030767|NCT05019131|468070516|FG000|Overall Study|Lost to Follow-up|0|||
130247478|NCT04518410|468867880|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
130247479|NCT04518410|468867881|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
130247480|NCT04518410|468867882|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
130247481|NCT04518410|468867883|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
130247482|NCT04518410|468867884|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
130247483|NCT04518410|468867885|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
130247484|NCT04518410|468867886|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
130247485|NCT04518410|468867887|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
130247486|NCT04518410|468867888|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
130247487|NCT04518410|468867864|FG000|Overall Study|Dual Enrolled Subject|0|||
130247488|NCT04518410|468867865|FG001|Overall Study|Dual Enrolled Subject|0|||
130247489|NCT04518410|468867866|FG002|Overall Study|Dual Enrolled Subject|0|||
130247490|NCT04518410|468867867|FG003|Overall Study|Dual Enrolled Subject|0|||
130247491|NCT04518410|468867868|FG004|Overall Study|Dual Enrolled Subject|0|||
130247492|NCT04518410|468867869|FG005|Overall Study|Dual Enrolled Subject|0|||
130247493|NCT04518410|468867870|FG006|Overall Study|Dual Enrolled Subject|0|||
130247494|NCT04518410|468867871|FG007|Overall Study|Dual Enrolled Subject|0|||
130247495|NCT04518410|468867872|FG008|Overall Study|Dual Enrolled Subject|0|||
130247496|NCT04518410|468867873|FG009|Overall Study|Dual Enrolled Subject|0|||
130247497|NCT04518410|468867874|FG010|Overall Study|Dual Enrolled Subject|0|||
130247498|NCT04518410|468867875|FG011|Overall Study|Dual Enrolled Subject|0|||
130247499|NCT04518410|468867876|FG012|Overall Study|Dual Enrolled Subject|0|||
130247500|NCT04518410|468867877|FG013|Overall Study|Dual Enrolled Subject|0|||
130247501|NCT04518410|468867878|FG014|Overall Study|Dual Enrolled Subject|0|||
130247502|NCT04518410|468867879|FG015|Overall Study|Dual Enrolled Subject|0|||
130247503|NCT04518410|468867880|FG016|Overall Study|Dual Enrolled Subject|0|||
130100839|NCT05553600|468327246|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
130100840|NCT05553600|468327247|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
130100841|NCT05553600|468327244|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
130100842|NCT05553600|468327245|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
130100843|NCT05553600|468327246|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
130100844|NCT05553600|468327247|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
130100845|NCT05553600|468327244|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
130100846|NCT05553600|468327245|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
130100847|NCT05553600|468327246|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
130100848|NCT05553600|468327247|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
130100849|NCT05553600|468327244|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
130100850|NCT05553600|468327245|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
130100851|NCT05553600|468327246|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
130100852|NCT05553600|468327247|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
130100853|NCT05553600|468327244|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
130100854|NCT05553600|468327245|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
130100855|NCT05553600|468327246|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
130100856|NCT05553600|468327247|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
130100857|NCT05553600|468327244|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
130247504|NCT04518410|468867881|FG017|Overall Study|Dual Enrolled Subject|1|||
130247505|NCT04518410|468867882|FG018|Overall Study|Dual Enrolled Subject|0|||
130247506|NCT04518410|468867883|FG019|Overall Study|Dual Enrolled Subject|0|||
130247507|NCT04518410|468867884|FG020|Overall Study|Dual Enrolled Subject|0|||
130247508|NCT04518410|468867885|FG021|Overall Study|Dual Enrolled Subject|0|||
130247509|NCT04518410|468867886|FG022|Overall Study|Dual Enrolled Subject|0|||
130247510|NCT04518410|468867887|FG023|Overall Study|Dual Enrolled Subject|0|||
130247511|NCT04518410|468867888|FG024|Overall Study|Dual Enrolled Subject|0|||
130247512|NCT03462563|468867889|FG000|Overall Study|Death|1|||
130247513|NCT03462563|468867890|FG001|Overall Study|Death|1|||
130247514|NCT03462563|468867889|FG000|Overall Study|Termination of study|2|||
130247515|NCT03462563|468867890|FG001|Overall Study|Termination of study|1|||
130247516|NCT03462563|468867889|FG000|Overall Study|Adverse Event|1|||
130247517|NCT03462563|468867890|FG001|Overall Study|Adverse Event|3|||
130247518|NCT03462563|468867889|FG000|Overall Study|Unspecified reason|10|||
130247519|NCT03462563|468867890|FG001|Overall Study|Unspecified reason|12|||
130247520|NCT03462563|468867889|FG000|Overall Study|Physician Decision|1|||
130247521|NCT03462563|468867890|FG001|Overall Study|Physician Decision|0|||
130247522|NCT01740427|468867891|FG000|Overall Study|Objective Progression or Relapse|286|||
130247523|NCT01740427|468867892|FG001|Overall Study|Objective Progression or Relapse|172|||
130247524|NCT01740427|468867891|FG000|Overall Study|Adverse Event|32|||
130247525|NCT01740427|468867892|FG001|Overall Study|Adverse Event|9|||
130247526|NCT01740427|468867891|FG000|Overall Study|Global Deterioration of Health Status|28|||
130247527|NCT01740427|468867892|FG001|Overall Study|Global Deterioration of Health Status|12|||
130247528|NCT01740427|468867891|FG000|Overall Study|Participant Refused Continued Treatment|27|||
130247529|NCT01740427|468867892|FG001|Overall Study|Participant Refused Continued Treatment|15|||
130247530|NCT01740427|468867891|FG000|Overall Study|Unspecified reasons|52|||
130247531|NCT01740427|468867892|FG001|Overall Study|Unspecified reasons|8|||
130247532|NCT01740427|468867891|FG000|Overall Study|Death|10|||
130247533|NCT01740427|468867892|FG001|Overall Study|Death|3|||
130247534|NCT01740427|468867891|FG000|Overall Study|Protocol Violation|5|||
130247535|NCT01740427|468867892|FG001|Overall Study|Protocol Violation|3|||
130247536|NCT01740427|468867891|FG000|Overall Study|Lost to Follow-up|3|||
130247537|NCT01740427|468867892|FG001|Overall Study|Lost to Follow-up|0|||
130247538|NCT01740427|468867891|FG000|Overall Study|Site Terminated by Sponsor|1|||
130247539|NCT01740427|468867892|FG001|Overall Study|Site Terminated by Sponsor|0|||
130247540|NCT04796207|468867893|FG000|Overall Study|Lost to Follow-up|7|||
130247541|NCT04796207|468867894|FG001|Overall Study|Lost to Follow-up|2|||
130247542|NCT02405962|468867897|FG000|Overall Study|Lost to Follow-up|1|||
130247543|NCT02405962|468867898|FG001|Overall Study|Lost to Follow-up|4|||
130247544|NCT02405962|468867897|FG000|Overall Study|A participant has moved to another place|0|||
130247545|NCT02405962|468867898|FG001|Overall Study|A participant has moved to another place|1|||
130247546|NCT03679884|468867899|FG000|Overall Study|Other|12|||
130247547|NCT03679884|468867900|FG001|Overall Study|Other|12|||
130247548|NCT03679884|468867901|FG002|Overall Study|Other|12|||
130247549|NCT03679884|468867902|FG003|Overall Study|Other|7|||
130247550|NCT03679884|468867903|FG004|Overall Study|Other|8|||
130247551|NCT03679884|468867899|FG000|Overall Study|Lack of Efficacy|15|||
130247552|NCT03679884|468867900|FG001|Overall Study|Lack of Efficacy|29|||
130247553|NCT03679884|468867901|FG002|Overall Study|Lack of Efficacy|13|||
130247554|NCT03679884|468867902|FG003|Overall Study|Lack of Efficacy|29|||
130247555|NCT03679884|468867903|FG004|Overall Study|Lack of Efficacy|10|||
130247556|NCT03679884|468867899|FG000|Overall Study|Death|1|||
130247557|NCT03679884|468867900|FG001|Overall Study|Death|0|||
130247558|NCT03679884|468867901|FG002|Overall Study|Death|0|||
130247559|NCT03679884|468867902|FG003|Overall Study|Death|0|||
130247560|NCT03679884|468867903|FG004|Overall Study|Death|0|||
130247561|NCT03679884|468867899|FG000|Overall Study|Adverse Event|2|||
130247562|NCT03679884|468867900|FG001|Overall Study|Adverse Event|10|||
130247563|NCT03679884|468867901|FG002|Overall Study|Adverse Event|9|||
130247564|NCT03679884|468867902|FG003|Overall Study|Adverse Event|6|||
130247565|NCT03679884|468867903|FG004|Overall Study|Adverse Event|6|||
130247566|NCT03679884|468867899|FG000|Overall Study|Withdrawal by Subject|12|||
130247567|NCT03679884|468867900|FG001|Overall Study|Withdrawal by Subject|23|||
130247568|NCT03679884|468867901|FG002|Overall Study|Withdrawal by Subject|8|||
130247569|NCT03679884|468867902|FG003|Overall Study|Withdrawal by Subject|8|||
130247570|NCT03679884|468867903|FG004|Overall Study|Withdrawal by Subject|9|||
130247571|NCT03679884|468867899|FG000|Overall Study|Lost to Follow-up|1|||
130247572|NCT03679884|468867900|FG001|Overall Study|Lost to Follow-up|4|||
130247573|NCT03679884|468867901|FG002|Overall Study|Lost to Follow-up|2|||
130247574|NCT03679884|468867902|FG003|Overall Study|Lost to Follow-up|0|||
130247575|NCT03679884|468867903|FG004|Overall Study|Lost to Follow-up|3|||
130247576|NCT01107457|468867904|FG000|Part A|Adverse Event|1|||
130247577|NCT01107457|468867905|FG001|Part A|Adverse Event|2|||
130247578|NCT01107457|468867906|FG002|Part A|Adverse Event|1|||
130247579|NCT01107457|468867907|FG003|Part A|Adverse Event|0|||
130247580|NCT01107457|468867908|FG004|Part A|Adverse Event|0|||
130247581|NCT01107457|468867909|FG005|Part A|Adverse Event|0|||
130247582|NCT01107457|468867904|FG000|Part A|Withdrawal by Subject|3|||
130247583|NCT01107457|468867905|FG001|Part A|Withdrawal by Subject|3|||
130247584|NCT01107457|468867906|FG002|Part A|Withdrawal by Subject|0|||
130247585|NCT01107457|468867907|FG003|Part A|Withdrawal by Subject|3|||
130247586|NCT01107457|468867908|FG004|Part A|Withdrawal by Subject|1|||
130247587|NCT01107457|468867909|FG005|Part A|Withdrawal by Subject|0|||
130247588|NCT01107457|468867904|FG000|Part A|Lost to Follow-up|0|||
130247589|NCT01107457|468867905|FG001|Part A|Lost to Follow-up|1|||
130247590|NCT01107457|468867906|FG002|Part A|Lost to Follow-up|0|||
130247591|NCT01107457|468867907|FG003|Part A|Lost to Follow-up|0|||
130247592|NCT01107457|468867908|FG004|Part A|Lost to Follow-up|0|||
130247593|NCT01107457|468867909|FG005|Part A|Lost to Follow-up|0|||
130247594|NCT01107457|468867904|FG000|Part A|Lack of Efficacy|1|||
130247595|NCT01107457|468867905|FG001|Part A|Lack of Efficacy|0|||
130247596|NCT01107457|468867906|FG002|Part A|Lack of Efficacy|0|||
130247597|NCT01107457|468867907|FG003|Part A|Lack of Efficacy|0|||
130247598|NCT01107457|468867908|FG004|Part A|Lack of Efficacy|0|||
130247599|NCT01107457|468867909|FG005|Part A|Lack of Efficacy|0|||
130247600|NCT01107457|468867904|FG000|Part A|Protocol Violation|0|||
130247601|NCT01107457|468867905|FG001|Part A|Protocol Violation|1|||
130247602|NCT01107457|468867906|FG002|Part A|Protocol Violation|0|||
130247603|NCT01107457|468867907|FG003|Part A|Protocol Violation|0|||
130247604|NCT01107457|468867908|FG004|Part A|Protocol Violation|0|||
130247605|NCT01107457|468867909|FG005|Part A|Protocol Violation|0|||
130247606|NCT01107457|468867904|FG000|Part B and C|Adverse Event|0|||
130247607|NCT01107457|468867905|FG001|Part B and C|Adverse Event|0|||
130247608|NCT01107457|468867906|FG002|Part B and C|Adverse Event|0|||
130247609|NCT01107457|468867907|FG003|Part B and C|Adverse Event|0|||
130247610|NCT01107457|468867908|FG004|Part B and C|Adverse Event|0|||
130247611|NCT01107457|468867909|FG005|Part B and C|Adverse Event|12|||
130247612|NCT01107457|468867904|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247613|NCT01107457|468867905|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247614|NCT01107457|468867906|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247615|NCT01107457|468867907|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247616|NCT01107457|468867908|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
130247617|NCT01107457|468867909|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
130247618|NCT01107457|468867904|FG000|Part B and C|Physician Decision|0|||
130247619|NCT01107457|468867905|FG001|Part B and C|Physician Decision|0|||
130247620|NCT01107457|468867906|FG002|Part B and C|Physician Decision|0|||
130247621|NCT01107457|468867907|FG003|Part B and C|Physician Decision|0|||
130247622|NCT01107457|468867908|FG004|Part B and C|Physician Decision|0|||
130247623|NCT01107457|468867909|FG005|Part B and C|Physician Decision|3|||
130247624|NCT01107457|468867904|FG000|Part B and C|Lack of Efficacy|0|||
130247625|NCT01107457|468867905|FG001|Part B and C|Lack of Efficacy|0|||
130247626|NCT01107457|468867906|FG002|Part B and C|Lack of Efficacy|0|||
130247627|NCT01107457|468867907|FG003|Part B and C|Lack of Efficacy|0|||
130247628|NCT01107457|468867908|FG004|Part B and C|Lack of Efficacy|0|||
130247629|NCT01107457|468867909|FG005|Part B and C|Lack of Efficacy|7|||
130247630|NCT01107457|468867904|FG000|Part B and C|Lost to Follow-up|0|||
130247631|NCT01107457|468867905|FG001|Part B and C|Lost to Follow-up|0|||
130247632|NCT01107457|468867906|FG002|Part B and C|Lost to Follow-up|0|||
130247633|NCT01107457|468867907|FG003|Part B and C|Lost to Follow-up|0|||
130247634|NCT01107457|468867908|FG004|Part B and C|Lost to Follow-up|0|||
130247635|NCT01107457|468867909|FG005|Part B and C|Lost to Follow-up|10|||
130247636|NCT01107457|468867904|FG000|Part B and C|Protocol Violation|0|||
130247637|NCT01107457|468867905|FG001|Part B and C|Protocol Violation|0|||
130247638|NCT01107457|468867906|FG002|Part B and C|Protocol Violation|0|||
130247639|NCT01107457|468867907|FG003|Part B and C|Protocol Violation|0|||
130247640|NCT01107457|468867908|FG004|Part B and C|Protocol Violation|0|||
130247641|NCT01107457|468867909|FG005|Part B and C|Protocol Violation|1|||
130247642|NCT01107457|468867904|FG000|Part B and C|Sponsor Decision|0|||
130247643|NCT01107457|468867905|FG001|Part B and C|Sponsor Decision|0|||
130247644|NCT01107457|468867906|FG002|Part B and C|Sponsor Decision|0|||
130247645|NCT01107457|468867907|FG003|Part B and C|Sponsor Decision|0|||
130247646|NCT01107457|468867908|FG004|Part B and C|Sponsor Decision|0|||
130247647|NCT01107457|468867909|FG005|Part B and C|Sponsor Decision|66|||
130247648|NCT01107457|468867904|FG000|Part B and C|Withdrawal by Subject|0|||
130247649|NCT01107457|468867905|FG001|Part B and C|Withdrawal by Subject|0|||
130247650|NCT01107457|468867906|FG002|Part B and C|Withdrawal by Subject|0|||
130247651|NCT01107457|468867907|FG003|Part B and C|Withdrawal by Subject|0|||
130247652|NCT01107457|468867908|FG004|Part B and C|Withdrawal by Subject|0|||
130247653|NCT01107457|468867909|FG005|Part B and C|Withdrawal by Subject|16|||
130247654|NCT01107457|468867904|FG000|Part B and C|Clinical Relapse|0|||
130247655|NCT01107457|468867905|FG001|Part B and C|Clinical Relapse|0|||
130247656|NCT01107457|468867906|FG002|Part B and C|Clinical Relapse|0|||
130247657|NCT01107457|468867907|FG003|Part B and C|Clinical Relapse|0|||
130247658|NCT01107457|468867908|FG004|Part B and C|Clinical Relapse|0|||
130247659|NCT01107457|468867909|FG005|Part B and C|Clinical Relapse|4|||
130247660|NCT00105508|468867910|FG000|Overall Study|Prephase Dropout|1|||
130247661|NCT00105508|468867911|FG001|Overall Study|Prephase Dropout|0|||
130247662|NCT00105508|468867910|FG000|Overall Study|Adverse Event|16|||
130247663|NCT00105508|468867911|FG001|Overall Study|Adverse Event|19|||
130247664|NCT00105508|468867910|FG000|Overall Study|Insufficient Efficacy|1|||
130247665|NCT00105508|468867911|FG001|Overall Study|Insufficient Efficacy|0|||
130247666|NCT00105508|468867910|FG000|Overall Study|Withdrawal by Subject|10|||
130247667|NCT00105508|468867911|FG001|Overall Study|Withdrawal by Subject|6|||
130247668|NCT00105508|468867910|FG000|Overall Study|Lost to Follow-up|3|||
130247669|NCT00105508|468867911|FG001|Overall Study|Lost to Follow-up|0|||
130247670|NCT00105508|468867910|FG000|Overall Study|Protocol Violation|1|||
130247671|NCT00105508|468867911|FG001|Overall Study|Protocol Violation|2|||
130247672|NCT00105508|468867910|FG000|Overall Study|Other|8|||
130247673|NCT00105508|468867911|FG001|Overall Study|Other|9|||
130030768|NCT05019131|468070517|FG001|Overall Study|Lost to Follow-up|3|||
130030769|NCT04684420|468070518|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130030770|NCT04684420|468070519|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130030771|NCT04684420|468070520|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
130030772|NCT04684420|468070521|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
130030773|NCT04684420|468070518|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
130030774|NCT04684420|468070519|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
130030775|NCT04684420|468070520|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
130030776|NCT04684420|468070521|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
130030777|NCT03480802|468070523|FG000|Overall Study|Lost to Follow-up|5|||
130030778|NCT03480802|468070524|FG001|Overall Study|Lost to Follow-up|1|||
130030779|NCT03480802|468070523|FG000|Overall Study|Withdrawal by Subject|2|||
130030780|NCT03480802|468070524|FG001|Overall Study|Withdrawal by Subject|1|||
130030781|NCT03480802|468070523|FG000|Overall Study|Relocated|0|||
130030782|NCT03480802|468070524|FG001|Overall Study|Relocated|1|||
130030783|NCT01703000|468070525|FG000|Overall Study|Death|1|||
130030784|NCT03822884|468070526|FG000|Overall Study|Withdrawal by Subject|0|||
130030785|NCT03822884|468070527|FG001|Overall Study|Withdrawal by Subject|0|||
130030786|NCT03822884|468070528|FG002|Overall Study|Withdrawal by Subject|0|||
130030787|NCT03822884|468070529|FG003|Overall Study|Withdrawal by Subject|0|||
130030788|NCT03822884|468070530|FG004|Overall Study|Withdrawal by Subject|1|||
130030789|NCT03822884|468070531|FG005|Overall Study|Withdrawal by Subject|0|||
130030790|NCT00432237|468070537|FG000|Overall Study|Adverse Event|0|||
130030791|NCT00432237|468070538|FG001|Overall Study|Adverse Event|0|||
130030792|NCT00432237|468070539|FG002|Overall Study|Adverse Event|0|||
130030793|NCT00432237|468070540|FG003|Overall Study|Adverse Event|1|||
130030794|NCT00432237|468070537|FG000|Overall Study|Lack of Efficacy|0|||
130030795|NCT00432237|468070538|FG001|Overall Study|Lack of Efficacy|0|||
130030796|NCT00432237|468070539|FG002|Overall Study|Lack of Efficacy|0|||
130030797|NCT00432237|468070540|FG003|Overall Study|Lack of Efficacy|1|||
130030798|NCT00432237|468070537|FG000|Overall Study|Lost to Follow-up|10|||
130030799|NCT00432237|468070538|FG001|Overall Study|Lost to Follow-up|10|||
130030800|NCT00432237|468070539|FG002|Overall Study|Lost to Follow-up|18|||
130030801|NCT00432237|468070540|FG003|Overall Study|Lost to Follow-up|18|||
130030802|NCT00432237|468070537|FG000|Overall Study|Physician Decision|1|||
130030803|NCT00432237|468070538|FG001|Overall Study|Physician Decision|3|||
130030804|NCT00432237|468070539|FG002|Overall Study|Physician Decision|2|||
130030805|NCT00432237|468070540|FG003|Overall Study|Physician Decision|1|||
130030806|NCT00432237|468070537|FG000|Overall Study|Pregnancy|0|||
130030807|NCT00432237|468070538|FG001|Overall Study|Pregnancy|1|||
130030808|NCT00432237|468070539|FG002|Overall Study|Pregnancy|0|||
130030809|NCT00432237|468070540|FG003|Overall Study|Pregnancy|0|||
130030810|NCT00432237|468070537|FG000|Overall Study|Protocol Violation|13|||
130030811|NCT00432237|468070538|FG001|Overall Study|Protocol Violation|10|||
130030812|NCT00432237|468070539|FG002|Overall Study|Protocol Violation|11|||
130100858|NCT05553600|468327245|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
130030813|NCT00432237|468070540|FG003|Overall Study|Protocol Violation|8|||
130030814|NCT00432237|468070537|FG000|Overall Study|Withdrawal by Subject|5|||
130030815|NCT00432237|468070538|FG001|Overall Study|Withdrawal by Subject|6|||
130030816|NCT00432237|468070539|FG002|Overall Study|Withdrawal by Subject|9|||
130030817|NCT00432237|468070540|FG003|Overall Study|Withdrawal by Subject|11|||
130030818|NCT00432237|468070537|FG000|Overall Study|Lack of Qualifying Event|38|||
130030819|NCT00432237|468070538|FG001|Overall Study|Lack of Qualifying Event|71|||
130030820|NCT00432237|468070539|FG002|Overall Study|Lack of Qualifying Event|69|||
130030821|NCT00432237|468070540|FG003|Overall Study|Lack of Qualifying Event|84|||
130030822|NCT01354132|468070541|FG000|Randomization|Physician Decision|1|||
130030823|NCT01354132|468070542|FG001|Randomization|Physician Decision|0|||
130030824|NCT01354132|468070541|FG000|Randomization|Withdrawal by Subject|0|||
130247674|NCT00086307|468867912|FG000|Overall Study|Lack of Efficacy|1|||
130247675|NCT00086307|468867913|FG001|Overall Study|Lack of Efficacy|1|||
130247676|NCT00086307|468867914|FG002|Overall Study|Lack of Efficacy|2|||
130247677|NCT00086307|468867912|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
130247678|NCT00086307|468867913|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
130247679|NCT00086307|468867914|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
130247680|NCT00086307|468867912|FG000|Overall Study|Nausea and headaches|0|||
130247681|NCT00086307|468867913|FG001|Overall Study|Nausea and headaches|0|||
130247682|NCT00086307|468867914|FG002|Overall Study|Nausea and headaches|1|||
130247683|NCT00086307|468867912|FG000|Overall Study|Constipation and sleepiness|0|||
130247684|NCT00086307|468867913|FG001|Overall Study|Constipation and sleepiness|0|||
130247685|NCT00086307|468867914|FG002|Overall Study|Constipation and sleepiness|1|||
130247686|NCT00086307|468867912|FG000|Overall Study|Suicidal ideation|0|||
130247687|NCT00086307|468867913|FG001|Overall Study|Suicidal ideation|0|||
130247688|NCT00086307|468867914|FG002|Overall Study|Suicidal ideation|1|||
130247689|NCT00086307|468867912|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
130247690|NCT00086307|468867913|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
130247691|NCT00086307|468867914|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
130247692|NCT00086307|468867912|FG000|Overall Study|Withdrawal by Subject|0|||
130247693|NCT00086307|468867913|FG001|Overall Study|Withdrawal by Subject|0|||
130247694|NCT00086307|468867914|FG002|Overall Study|Withdrawal by Subject|2|||
130247695|NCT00362609|468867915|FG000|Overall Study|Withdrawal by Subject|0|||
130247696|NCT00362609|468867916|FG001|Overall Study|Withdrawal by Subject|1|||
130247697|NCT00362609|468867915|FG000|Overall Study|Protocol Violation|0|||
130247698|NCT00362609|468867916|FG001|Overall Study|Protocol Violation|1|||
130247699|NCT01800058|468867918|FG000|Overall Study|Lost to Follow-up|1|||
130247700|NCT03787212|468869666|FG000|Period 1|Study Termination|2|||
130247701|NCT03787212|468869667|FG001|Period 1|Study Termination|2|||
130247702|NCT04193176|468869668|FG000|Overall Study|Withdrawal by Subject|6|||
130247703|NCT04193176|468869669|FG001|Overall Study|Withdrawal by Subject|10|||
130247704|NCT02370394|468869670|FG000|Overall Study|Lost to Follow-up|2|||
130247705|NCT02370394|468869671|FG001|Overall Study|Lost to Follow-up|1|||
130247706|NCT02370394|468869670|FG000|Overall Study|Withdrawal by Subject|0|||
130247707|NCT02370394|468869671|FG001|Overall Study|Withdrawal by Subject|1|||
130247708|NCT00520572|468869673|FG000|Overall Study|Adverse Event|9|||
130247709|NCT00520572|468869674|FG001|Overall Study|Adverse Event|3|||
130247710|NCT00520572|468869675|FG002|Overall Study|Adverse Event|6|||
130247711|NCT00520572|468869676|FG003|Overall Study|Adverse Event|9|||
130247712|NCT00520572|468869677|FG004|Overall Study|Adverse Event|7|||
130247713|NCT00520572|468869678|FG005|Overall Study|Adverse Event|2|||
130247714|NCT00520572|468869673|FG000|Overall Study|Withdrawal by Subject|0|||
130247715|NCT00520572|468869674|FG001|Overall Study|Withdrawal by Subject|9|||
130247716|NCT00520572|468869675|FG002|Overall Study|Withdrawal by Subject|5|||
130247717|NCT00520572|468869676|FG003|Overall Study|Withdrawal by Subject|2|||
130247718|NCT00520572|468869677|FG004|Overall Study|Withdrawal by Subject|2|||
130247719|NCT00520572|468869678|FG005|Overall Study|Withdrawal by Subject|0|||
130247720|NCT00520572|468869673|FG000|Overall Study|Protocol Violation|0|||
130247721|NCT00520572|468869674|FG001|Overall Study|Protocol Violation|0|||
130247722|NCT00520572|468869675|FG002|Overall Study|Protocol Violation|1|||
130247723|NCT00520572|468869676|FG003|Overall Study|Protocol Violation|0|||
130247724|NCT00520572|468869677|FG004|Overall Study|Protocol Violation|0|||
130247725|NCT00520572|468869678|FG005|Overall Study|Protocol Violation|0|||
130247726|NCT00520572|468869673|FG000|Overall Study|Lack of Efficacy|1|||
130030825|NCT01354132|468070542|FG001|Randomization|Withdrawal by Subject|1|||
130030826|NCT01354132|468070541|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
130247727|NCT00520572|468869674|FG001|Overall Study|Lack of Efficacy|1|||
130247728|NCT00520572|468869675|FG002|Overall Study|Lack of Efficacy|1|||
130247729|NCT00520572|468869676|FG003|Overall Study|Lack of Efficacy|2|||
130247730|NCT00520572|468869677|FG004|Overall Study|Lack of Efficacy|1|||
130247731|NCT00520572|468869678|FG005|Overall Study|Lack of Efficacy|0|||
130247732|NCT00520572|468869673|FG000|Overall Study|Lost to Follow-up|0|||
130247733|NCT00520572|468869674|FG001|Overall Study|Lost to Follow-up|0|||
130247734|NCT00520572|468869675|FG002|Overall Study|Lost to Follow-up|0|||
130247735|NCT00520572|468869676|FG003|Overall Study|Lost to Follow-up|0|||
130247736|NCT00520572|468869677|FG004|Overall Study|Lost to Follow-up|1|||
130247737|NCT00520572|468869678|FG005|Overall Study|Lost to Follow-up|0|||
130247738|NCT00520572|468869673|FG000|Overall Study|Incorrect enrollment|1|||
130247739|NCT00520572|468869674|FG001|Overall Study|Incorrect enrollment|0|||
130247740|NCT00520572|468869675|FG002|Overall Study|Incorrect enrollment|1|||
130247741|NCT00520572|468869676|FG003|Overall Study|Incorrect enrollment|0|||
130247742|NCT00520572|468869677|FG004|Overall Study|Incorrect enrollment|1|||
130247743|NCT00520572|468869678|FG005|Overall Study|Incorrect enrollment|0|||
130247744|NCT00520572|468869673|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247745|NCT00520572|468869674|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
130247746|NCT00520572|468869675|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247747|NCT00520572|468869676|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247748|NCT00520572|468869677|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247749|NCT00520572|468869678|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
130247750|NCT00520572|468869673|FG000|Overall Study|Long break in taking Medication|0|||
130247751|NCT00520572|468869674|FG001|Overall Study|Long break in taking Medication|0|||
130247752|NCT00520572|468869675|FG002|Overall Study|Long break in taking Medication|0|||
130247753|NCT00520572|468869676|FG003|Overall Study|Long break in taking Medication|1|||
130247754|NCT00520572|468869677|FG004|Overall Study|Long break in taking Medication|0|||
130247755|NCT00520572|468869678|FG005|Overall Study|Long break in taking Medication|0|||
130247756|NCT00520572|468869673|FG000|Overall Study|Did not receive Treatment|1|||
130247757|NCT00520572|468869674|FG001|Overall Study|Did not receive Treatment|0|||
130247758|NCT00520572|468869675|FG002|Overall Study|Did not receive Treatment|1|||
130247759|NCT00520572|468869676|FG003|Overall Study|Did not receive Treatment|0|||
130247760|NCT00520572|468869677|FG004|Overall Study|Did not receive Treatment|0|||
130247761|NCT00520572|468869678|FG005|Overall Study|Did not receive Treatment|0|||
130247762|NCT02181621|468869679|FG000|Overall Study|Adverse Event|1|||
130247763|NCT02181621|468869680|FG001|Overall Study|Adverse Event|0|||
130247764|NCT02181621|468869679|FG000|Overall Study|Previously Enrolled|0|||
130247765|NCT02181621|468869680|FG001|Overall Study|Previously Enrolled|1|||
130247766|NCT02181621|468869679|FG000|Overall Study|Enrollment Hold|1|||
130247767|NCT02181621|468869680|FG001|Overall Study|Enrollment Hold|1|||
130247768|NCT00960856|468869681|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130247769|NCT00960856|468869682|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130247770|NCT00960856|468869683|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
130247771|NCT00960856|468869684|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
130247772|NCT00960856|468869681|FG000|Washout Period of 7 Days|Adverse Event|0|||
130247773|NCT00960856|468869682|FG001|Washout Period of 7 Days|Adverse Event|0|||
130247774|NCT00960856|468869683|FG002|Washout Period of 7 Days|Adverse Event|1|||
130247775|NCT00960856|468869684|FG003|Washout Period of 7 Days|Adverse Event|0|||
130247776|NCT00337194|468869687|FG000|Overall Study|Adverse Event|5|||
130247777|NCT00337194|468869688|FG001|Overall Study|Adverse Event|1|||
130247778|NCT00337194|468869687|FG000|Overall Study|Death|2|||
130247779|NCT00337194|468869688|FG001|Overall Study|Death|0|||
130247780|NCT00337194|468869687|FG000|Overall Study|Withdrawal by Subject|1|||
130247781|NCT00337194|468869688|FG001|Overall Study|Withdrawal by Subject|0|||
130247782|NCT00337194|468869687|FG000|Overall Study|Disease progression|1|||
130247783|NCT00337194|468869688|FG001|Overall Study|Disease progression|2|||
130247784|NCT00337194|468869687|FG000|Overall Study|Subsequent non-protocol therapy|3|||
130247785|NCT00337194|468869688|FG001|Overall Study|Subsequent non-protocol therapy|1|||
130247786|NCT03188705|468869689|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
130030827|NCT01354132|468070542|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
130030828|NCT01354132|468070541|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
130030829|NCT01354132|468070542|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
130030830|NCT01354132|468070541|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
130030831|NCT01354132|468070542|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
130030832|NCT00603239|468070543|FG000|Overall Study|Adverse Event|4|||
130247787|NCT03188705|468869689|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
130247788|NCT01174459|468869690|FG000|Overall Study|case report form (CRF) not collected|5|||
130247789|NCT01717859|468869692|FG000|Overall Study|Adverse Event|5|||
130247790|NCT01717859|468869692|FG000|Overall Study|Moved out of state|1|||
130247791|NCT01717859|468869692|FG000|Overall Study|Patient concerned about mental health|1|||
130247792|NCT01717859|468869692|FG000|Overall Study|Lost to Follow-up|1|||
130247793|NCT01717859|468869692|FG000|Overall Study|Withdrawal by Subject|2|||
130247794|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|No Data|249|||
130247795|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|No Data|66|||
130247796|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|No Data|2|||
130247797|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|Other|33|||
130247798|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|Other|20|||
130247799|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|Other|0|||
130247800|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
130247801|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
130247802|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
130030833|NCT00603239|468070544|FG001|Overall Study|Adverse Event|1|||
130030834|NCT00603239|468070543|FG000|Overall Study|Entry criteria not met|0|||
130247803|NCT01623752|468869693|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
130247804|NCT01623752|468869694|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
129800243|NCT04755283|467236268|FG000|Overall Study|Death|31|||
130247805|NCT01623752|468869695|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
130247806|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
130247807|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
130247808|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
130247809|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|Other|5|||
130247810|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|Other|1|||
130247811|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|Other|0|||
130247812|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|No Data|43|||
130247813|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|No Data|11|||
130247814|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|No Data|0|||
130247815|NCT01623752|468869693|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
130247816|NCT01623752|468869694|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
130247817|NCT01623752|468869695|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
130247818|NCT03994120|468869696|FG000|Overall Study|Lost to Follow-up|3|||
130247819|NCT03994120|468869697|FG001|Overall Study|Lost to Follow-up|1|||
130247820|NCT01111292|468869698|FG000|Treatment|Physician Decision|1|||
130247821|NCT01111292|468869699|FG001|Treatment|Physician Decision|1|||
130247822|NCT00564070|468869702|FG000|Overall Study|Lost to Follow-up|9|||
130247823|NCT00564070|468869703|FG001|Overall Study|Lost to Follow-up|7|||
130247824|NCT00564070|468869702|FG000|Overall Study|Worsening depression, referred to care|3|||
130247825|NCT00564070|468869703|FG001|Overall Study|Worsening depression, referred to care|0|||
130247826|NCT03142334|468869707|FG000|Overall Study|Death|18|||
130247827|NCT03142334|468869708|FG001|Overall Study|Death|33|||
130247828|NCT03142334|468869707|FG000|Overall Study|Withdrawal by Subject|15|||
130247829|NCT03142334|468869708|FG001|Overall Study|Withdrawal by Subject|11|||
130247830|NCT03142334|468869707|FG000|Overall Study|Ongoing on trial follow up|463|||
130247831|NCT03142334|468869708|FG001|Overall Study|Ongoing on trial follow up|454|||
130247832|NCT01217047|468869709|FG000|Overall Study|Lost to Follow-up|0|||
130247833|NCT01217047|468869710|FG001|Overall Study|Lost to Follow-up|1|||
130247834|NCT01217047|468869711|FG002|Overall Study|Lost to Follow-up|0|||
130247835|NCT05529173|468869712|FG000|Overall Study|Physician Decision|3|||
130247836|NCT05529173|468869713|FG001|Overall Study|Physician Decision|6|||
130247837|NCT05529173|468869712|FG000|Overall Study|Sample shipment delay more than one day|4|||
130247838|NCT05529173|468869713|FG001|Overall Study|Sample shipment delay more than one day|0|||
130247839|NCT00609973|468869722|FG000|Overall Study|Adverse Event|2|||
130247840|NCT00609973|468869723|FG001|Overall Study|Adverse Event|1|||
130247841|NCT00609973|468869722|FG000|Overall Study|Protocol Violation|4|||
130247842|NCT00609973|468869723|FG001|Overall Study|Protocol Violation|3|||
130247843|NCT00609973|468869722|FG000|Overall Study|Lost to Follow-up|2|||
130247844|NCT00609973|468869723|FG001|Overall Study|Lost to Follow-up|1|||
130247845|NCT00609973|468869722|FG000|Overall Study|Withdrawal by Subject|0|||
130247846|NCT00609973|468869723|FG001|Overall Study|Withdrawal by Subject|1|||
130247847|NCT00191152|468869724|FG000|Initial Treatment|Adverse Event|43|||
130247848|NCT00191152|468869725|FG001|Initial Treatment|Adverse Event|67|||
130247849|NCT00191152|468869724|FG000|Initial Treatment|Physician Decision|40|||
130247850|NCT00191152|468869725|FG001|Initial Treatment|Physician Decision|31|||
130247851|NCT00191152|468869724|FG000|Initial Treatment|Withdrawal by Subject|40|||
130247852|NCT00191152|468869725|FG001|Initial Treatment|Withdrawal by Subject|28|||
130247853|NCT00191152|468869724|FG000|Initial Treatment|Lost to Follow-up|0|||
130247854|NCT00191152|468869725|FG001|Initial Treatment|Lost to Follow-up|6|||
130247855|NCT00191152|468869724|FG000|Initial Treatment|Other|18|||
130247856|NCT00191152|468869725|FG001|Initial Treatment|Other|21|||
130247857|NCT00191152|468869724|FG000|Crossover Treatment|Adverse Event|8|||
130247858|NCT00191152|468869725|FG001|Crossover Treatment|Adverse Event|8|||
130247859|NCT00191152|468869724|FG000|Crossover Treatment|Physician Decision|7|||
130247860|NCT00191152|468869725|FG001|Crossover Treatment|Physician Decision|7|||
130247861|NCT00191152|468869724|FG000|Crossover Treatment|Withdrawal by Subject|6|||
130247862|NCT00191152|468869725|FG001|Crossover Treatment|Withdrawal by Subject|9|||
130247863|NCT00191152|468869724|FG000|Crossover Treatment|Lost to Follow-up|2|||
130247864|NCT00191152|468869725|FG001|Crossover Treatment|Lost to Follow-up|1|||
130247865|NCT00191152|468869724|FG000|Crossover Treatment|Other|4|||
130247866|NCT00191152|468869725|FG001|Crossover Treatment|Other|3|||
130247867|NCT00114777|468869726|FG000|Randomization to Month 36|Death|10|||
130247868|NCT00114777|468869727|FG001|Randomization to Month 36|Death|4|||
130247869|NCT00114777|468869728|FG002|Randomization to Month 36|Death|3|||
130247870|NCT00114777|468869726|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
130247871|NCT00114777|468869727|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
130247872|NCT00114777|468869728|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
130247873|NCT00114777|468869726|FG000|Randomization to Month 36|Lack of Efficacy|19|||
130247874|NCT00114777|468869727|FG001|Randomization to Month 36|Lack of Efficacy|15|||
130247875|NCT00114777|468869728|FG002|Randomization to Month 36|Lack of Efficacy|17|||
130247876|NCT00114777|468869726|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
130247877|NCT00114777|468869727|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
130247878|NCT00114777|468869728|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
130247879|NCT00114777|468869726|FG000|Randomization to Month 36|Adverse Event|34|||
130247880|NCT00114777|468869727|FG001|Randomization to Month 36|Adverse Event|35|||
130247881|NCT00114777|468869728|FG002|Randomization to Month 36|Adverse Event|44|||
130247882|NCT00114777|468869726|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
130247883|NCT00114777|468869727|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
130247884|NCT00114777|468869728|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
130247885|NCT00114777|468869726|FG000|Randomization to Month 36|Other|9|||
130247886|NCT00114777|468869727|FG001|Randomization to Month 36|Other|3|||
130247887|NCT00114777|468869728|FG002|Randomization to Month 36|Other|12|||
130247888|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Death|8|||
130247889|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Death|13|||
130247890|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Death|7|||
130247891|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
130247892|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
130247893|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
130247894|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
130247895|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
130247896|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
130247897|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
130247898|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
130247899|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
130247900|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
130247901|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
130247902|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
130247903|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
130247904|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
130247905|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
130247906|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
130247907|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
130247908|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
130247909|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
130247910|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
130247911|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
130247912|NCT00114777|468869726|FG000|Long-Term Extension to Month 84|Other|2|||
130247913|NCT00114777|468869727|FG001|Long-Term Extension to Month 84|Other|0|||
130247914|NCT00114777|468869728|FG002|Long-Term Extension to Month 84|Other|2|||
130247915|NCT00629239|468869733|FG000|Overall Study|Adverse Event|7|||
130247916|NCT00629239|468869734|FG001|Overall Study|Adverse Event|4|||
130247917|NCT00629239|468869733|FG000|Overall Study|Physician Decision|1|||
130247918|NCT00629239|468869734|FG001|Overall Study|Physician Decision|0|||
130247919|NCT01851369|468869735|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247920|NCT01851369|468869736|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247921|NCT01851369|468869737|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247922|NCT01851369|468869738|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247923|NCT01851369|468869739|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247924|NCT01851369|468869740|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
130247925|NCT01851369|468869741|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247926|NCT01851369|468869742|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247927|NCT01851369|468869743|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247928|NCT01851369|468869744|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247929|NCT01851369|468869745|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247930|NCT01851369|468869746|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247931|NCT01851369|468869747|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
130247932|NCT02453191|468869750|FG000|Overall Study|Withdrawal by Subject|1|||
130247933|NCT01520714|468869751|FG000|Overall Study|Protocol Violation|0|||
130247934|NCT01520714|468869752|FG001|Overall Study|Protocol Violation|3|||
130247935|NCT01520714|468869751|FG000|Overall Study|Adverse Event|0|||
130247936|NCT01520714|468869752|FG001|Overall Study|Adverse Event|2|||
130247937|NCT01520714|468869751|FG000|Overall Study|Lack of Efficacy|0|||
130247938|NCT01520714|468869752|FG001|Overall Study|Lack of Efficacy|1|||
130247939|NCT00183391|468869753|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
130247940|NCT00183391|468869754|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
130247941|NCT00183391|468869753|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
130247942|NCT00183391|468869754|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
130247943|NCT02336503|468869756|FG000|Overall Study|Lost to Follow-up|0|||
130247944|NCT02336503|468869757|FG001|Overall Study|Lost to Follow-up|3|||
130247945|NCT02336503|468869758|FG002|Overall Study|Lost to Follow-up|0|||
130247946|NCT02336503|468869759|FG003|Overall Study|Lost to Follow-up|2|||
130247947|NCT02336503|468869756|FG000|Overall Study|Withdrawal by Subject|2|||
130247948|NCT02336503|468869757|FG001|Overall Study|Withdrawal by Subject|0|||
130247949|NCT02336503|468869758|FG002|Overall Study|Withdrawal by Subject|0|||
130247950|NCT02336503|468869759|FG003|Overall Study|Withdrawal by Subject|4|||
130247951|NCT02336503|468869756|FG000|Overall Study|Adverse Event|0|||
130247952|NCT02336503|468869757|FG001|Overall Study|Adverse Event|0|||
130247953|NCT02336503|468869758|FG002|Overall Study|Adverse Event|1|||
130247954|NCT02336503|468869759|FG003|Overall Study|Adverse Event|0|||
130247955|NCT02460380|468869760|FG000|Overall Study|Withdrawal by Subject|10|||
130247956|NCT02460380|468869761|FG001|Overall Study|Withdrawal by Subject|5|||
130247957|NCT00395512|468869762|FG000|Overall Study|Adverse Event|3|||
130247958|NCT00395512|468869763|FG001|Overall Study|Adverse Event|8|||
130247959|NCT00395512|468869764|FG002|Overall Study|Adverse Event|6|||
130247960|NCT00395512|468869765|FG003|Overall Study|Adverse Event|6|||
130247961|NCT00395512|468869762|FG000|Overall Study|Protocol Violation|2|||
130247962|NCT00395512|468869763|FG001|Overall Study|Protocol Violation|3|||
130247963|NCT00395512|468869764|FG002|Overall Study|Protocol Violation|6|||
130247964|NCT00395512|468869765|FG003|Overall Study|Protocol Violation|7|||
130247965|NCT00395512|468869762|FG000|Overall Study|Lost to Follow-up|2|||
130247966|NCT00395512|468869763|FG001|Overall Study|Lost to Follow-up|6|||
130247967|NCT00395512|468869764|FG002|Overall Study|Lost to Follow-up|5|||
130247968|NCT00395512|468869765|FG003|Overall Study|Lost to Follow-up|5|||
130247969|NCT00395512|468869762|FG000|Overall Study|Withdrawal by Subject|6|||
130247970|NCT00395512|468869763|FG001|Overall Study|Withdrawal by Subject|5|||
130247971|NCT00395512|468869764|FG002|Overall Study|Withdrawal by Subject|5|||
130247972|NCT00395512|468869765|FG003|Overall Study|Withdrawal by Subject|12|||
130247973|NCT00395512|468869762|FG000|Overall Study|Physician Decision|6|||
130247974|NCT00395512|468869763|FG001|Overall Study|Physician Decision|4|||
130247975|NCT00395512|468869764|FG002|Overall Study|Physician Decision|2|||
130030835|NCT00603239|468070544|FG001|Overall Study|Entry criteria not met|1|||
130030836|NCT00603239|468070543|FG000|Overall Study|Loss of glucose control|3|||
130030837|NCT00603239|468070544|FG001|Overall Study|Loss of glucose control|0|||
130030838|NCT00603239|468070543|FG000|Overall Study|Lost to Follow-up|2|||
130030839|NCT00603239|468070544|FG001|Overall Study|Lost to Follow-up|1|||
130030840|NCT00603239|468070543|FG000|Overall Study|Physician Decision|2|||
130030841|NCT00603239|468070544|FG001|Overall Study|Physician Decision|0|||
130030842|NCT00603239|468070543|FG000|Overall Study|Protocol Violation|2|||
130030843|NCT00603239|468070544|FG001|Overall Study|Protocol Violation|0|||
130030844|NCT00603239|468070543|FG000|Overall Study|Subject decision|2|||
130247976|NCT00395512|468869765|FG003|Overall Study|Physician Decision|2|||
130247977|NCT00395512|468869762|FG000|Overall Study|Other|1|||
130247978|NCT00395512|468869763|FG001|Overall Study|Other|1|||
130030845|NCT00603239|468070544|FG001|Overall Study|Subject decision|1|||
130030846|NCT02357420|468070545|FG000|Overall Study|Adverse Event|3|||
130247979|NCT00395512|468869764|FG002|Overall Study|Other|0|||
130030847|NCT02357420|468070546|FG001|Overall Study|Adverse Event|3|||
130030848|NCT02357420|468070547|FG002|Overall Study|Adverse Event|8|||
130030849|NCT02357420|468070548|FG003|Overall Study|Adverse Event|9|||
130247980|NCT00395512|468869765|FG003|Overall Study|Other|0|||
130247981|NCT00395512|468869762|FG000|Overall Study|Hyperglycemic Rescue|18|||
130247982|NCT00395512|468869763|FG001|Overall Study|Hyperglycemic Rescue|10|||
130247983|NCT00395512|468869764|FG002|Overall Study|Hyperglycemic Rescue|4|||
130247984|NCT00395512|468869765|FG003|Overall Study|Hyperglycemic Rescue|6|||
130247985|NCT01986751|468869770|FG000|Overall Study|improperly consented|10|||
130247986|NCT01986751|468869771|FG001|Overall Study|improperly consented|2|||
130247987|NCT01478087|468869772|FG000|Overall Study|due to sponsor closing study|1|||
130247988|NCT03566550|468869773|FG000|Overall Study|Withdrawal by Subject|0|||
130247989|NCT03566550|468869774|FG001|Overall Study|Withdrawal by Subject|1|||
130247990|NCT04576949|468869780|FG000|Overall Study|Adverse Event|1|||
130030850|NCT02357420|468070545|FG000|Overall Study|Investigator Decision|1|||
130030851|NCT02357420|468070546|FG001|Overall Study|Investigator Decision|0|||
130030852|NCT02357420|468070547|FG002|Overall Study|Investigator Decision|0|||
130030853|NCT02357420|468070548|FG003|Overall Study|Investigator Decision|0|||
130030854|NCT02357420|468070545|FG000|Overall Study|Prohibited Medication|1|||
130030855|NCT02357420|468070546|FG001|Overall Study|Prohibited Medication|1|||
130030856|NCT02357420|468070547|FG002|Overall Study|Prohibited Medication|0|||
130030857|NCT02357420|468070548|FG003|Overall Study|Prohibited Medication|0|||
130030858|NCT02357420|468070545|FG000|Overall Study|Protocol Non-compliance|0|||
130030859|NCT02357420|468070546|FG001|Overall Study|Protocol Non-compliance|0|||
130030860|NCT02357420|468070547|FG002|Overall Study|Protocol Non-compliance|0|||
130030861|NCT02357420|468070548|FG003|Overall Study|Protocol Non-compliance|1|||
130030862|NCT02357420|468070545|FG000|Overall Study|Withdrawn Consent|4|||
130030863|NCT02357420|468070546|FG001|Overall Study|Withdrawn Consent|8|||
130030864|NCT02357420|468070547|FG002|Overall Study|Withdrawn Consent|6|||
130030865|NCT02357420|468070548|FG003|Overall Study|Withdrawn Consent|6|||
130030866|NCT02357420|468070545|FG000|Overall Study|Lost to Follow-up|3|||
130030867|NCT02357420|468070546|FG001|Overall Study|Lost to Follow-up|0|||
130030868|NCT02357420|468070547|FG002|Overall Study|Lost to Follow-up|2|||
130030869|NCT02357420|468070548|FG003|Overall Study|Lost to Follow-up|3|||
130247991|NCT04576949|468869781|FG001|Overall Study|Adverse Event|3|||
130247992|NCT04576949|468869782|FG002|Overall Study|Adverse Event|2|||
130247993|NCT04576949|468869780|FG000|Overall Study|Withdrawal by Subject|41|||
130247994|NCT04576949|468869781|FG001|Overall Study|Withdrawal by Subject|26|||
130247995|NCT04576949|468869782|FG002|Overall Study|Withdrawal by Subject|18|||
130247996|NCT04576949|468869780|FG000|Overall Study|Physician Decision|3|||
130247997|NCT04576949|468869781|FG001|Overall Study|Physician Decision|0|||
130247998|NCT04576949|468869782|FG002|Overall Study|Physician Decision|0|||
130247999|NCT04576949|468869780|FG000|Overall Study|Death|0|||
130248000|NCT04576949|468869781|FG001|Overall Study|Death|1|||
130248001|NCT04576949|468869782|FG002|Overall Study|Death|0|||
130248002|NCT04576949|468869780|FG000|Overall Study|Lost to Follow-up|29|||
130248003|NCT04576949|468869781|FG001|Overall Study|Lost to Follow-up|37|||
130248004|NCT04576949|468869782|FG002|Overall Study|Lost to Follow-up|24|||
130248005|NCT04576949|468869780|FG000|Overall Study|Other, Not Specified|2|||
130248006|NCT04576949|468869781|FG001|Overall Study|Other, Not Specified|3|||
130248007|NCT04576949|468869782|FG002|Overall Study|Other, Not Specified|1|||
130248008|NCT04576949|468869780|FG000|Overall Study|Other|1|||
130248009|NCT04576949|468869781|FG001|Overall Study|Other|0|||
130248010|NCT04576949|468869782|FG002|Overall Study|Other|0|||
130248011|NCT00052715|468869783|FG000|Overall Study|wrong histology|1|||
130248012|NCT01063881|468869784|FG000|Overall Study|Adverse Event|12|||
130248013|NCT01063881|468869785|FG001|Overall Study|Adverse Event|2|||
130248014|NCT01063881|468869786|FG002|Overall Study|Adverse Event|0|||
130030870|NCT00928070|468070551|FG000|Overall Study|Lost to Follow-up|1|||
130030871|NCT00928070|468070552|FG001|Overall Study|Lost to Follow-up|2|||
130030872|NCT00928070|468070551|FG000|Overall Study|Withdrawal by Subject|10|||
130030873|NCT00928070|468070552|FG001|Overall Study|Withdrawal by Subject|3|||
130030874|NCT00928070|468070551|FG000|Overall Study|Adverse Event|14|||
130030875|NCT00928070|468070552|FG001|Overall Study|Adverse Event|26|||
130248015|NCT01063881|468869784|FG000|Overall Study|Lost to Follow-up|13|||
130248016|NCT01063881|468869785|FG001|Overall Study|Lost to Follow-up|7|||
130248017|NCT01063881|468869786|FG002|Overall Study|Lost to Follow-up|1|||
130248018|NCT01063881|468869784|FG000|Overall Study|Withdrawal by Subject|25|||
130030876|NCT00928070|468070551|FG000|Overall Study|Lack of Efficacy|9|||
130030877|NCT00928070|468070552|FG001|Overall Study|Lack of Efficacy|5|||
130248019|NCT01063881|468869785|FG001|Overall Study|Withdrawal by Subject|1|||
129884625|NCT02310126|467538605|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
129884626|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
129884627|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
129884628|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
129884629|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
129884630|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
129884631|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
129884632|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129884633|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
129884634|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129884635|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
129884636|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
129884637|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
129884638|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
129884639|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
129884640|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
129884641|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
129884642|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
129884643|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
129884644|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
129884645|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
129884646|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
129884647|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
129884648|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
129884649|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
129884650|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
129884651|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
129884652|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
129884653|NCT02441946|467538615|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
129884654|NCT02441946|467538616|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
129884655|NCT02441946|467538617|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
129884656|NCT02441946|467538615|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
129884657|NCT02441946|467538616|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129884658|NCT02441946|467538617|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129884659|NCT03537261|467538619|FG000|Overall Study|Lost to Follow-up|4|||
129884660|NCT03537261|467538620|FG001|Overall Study|Lost to Follow-up|5|||
129884661|NCT03537261|467538619|FG000|Overall Study|Withdrawal by Subject|4|||
129884662|NCT03537261|467538620|FG001|Overall Study|Withdrawal by Subject|6|||
129884663|NCT03537261|467538619|FG000|Overall Study|Did not return study questionnaires|0|||
129884664|NCT03537261|467538620|FG001|Overall Study|Did not return study questionnaires|1|||
129884665|NCT03237013|467538621|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
129884666|NCT03237013|467538622|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
129884667|NCT03237013|467538623|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
129884668|NCT00502996|467538626|FG000|Overall Study|Lost to Follow-up|9|||
129884669|NCT00502996|467538626|FG000|Overall Study|Protocol Violation|2|||
129884670|NCT00502996|467538626|FG000|Overall Study|Treatment failure|25|||
129884671|NCT00502996|467538626|FG000|Overall Study|Withdrawal Informed Consent|6|||
129884672|NCT00502996|467538626|FG000|Overall Study|Adverse Event|2|||
129884673|NCT01729728|467538627|FG000|Overall Study|Adverse Event|0|||
129884674|NCT01729728|467538628|FG001|Overall Study|Adverse Event|6|||
130030878|NCT00928070|468070551|FG000|Overall Study|Did not meet entrance criteria|16|||
130030879|NCT00928070|468070552|FG001|Overall Study|Did not meet entrance criteria|9|||
130030880|NCT00928070|468070551|FG000|Overall Study|Protocol Violation|6|||
130030881|NCT00928070|468070552|FG001|Overall Study|Protocol Violation|5|||
130248020|NCT01063881|468869786|FG002|Overall Study|Withdrawal by Subject|0|||
130248021|NCT01063881|468869784|FG000|Overall Study|Reason for not completed not specified|5|||
130248022|NCT01063881|468869785|FG001|Overall Study|Reason for not completed not specified|1|||
130248023|NCT01063881|468869786|FG002|Overall Study|Reason for not completed not specified|0|||
130248024|NCT01489358|468869787|FG000|Overall Study|Lost to Follow-up|0|||
130248025|NCT01489358|468869788|FG001|Overall Study|Lost to Follow-up|0|||
130248026|NCT01489358|468869789|FG002|Overall Study|Lost to Follow-up|2|||
129884675|NCT01729728|467538629|FG002|Overall Study|Adverse Event|0|||
129884676|NCT01729728|467538627|FG000|Overall Study|Protocol Violation|1|||
129884677|NCT01729728|467538628|FG001|Overall Study|Protocol Violation|0|||
129884678|NCT01729728|467538629|FG002|Overall Study|Protocol Violation|1|||
129884679|NCT04267614|467538630|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
129884680|NCT04267614|467538630|FG000|Overall Study|Lost to Follow-up|115|||
129884681|NCT00988351|467538631|FG000|Overall Study|Withdrawal by Subject|8|||
130248027|NCT00736476|468869790|FG000|Overall Study|Adverse Event|1|||
130248028|NCT00736476|468869791|FG001|Overall Study|Adverse Event|0|||
130248029|NCT03518203|468869796|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
130248030|NCT03518203|468869796|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
130248031|NCT03511066|468869799|FG000|Overall Study|Withdrawal by Subject|1|||
130248032|NCT03511066|468869800|FG001|Overall Study|Withdrawal by Subject|2|||
130248033|NCT03511066|468869801|FG002|Overall Study|Withdrawal by Subject|3|||
130248034|NCT03511066|468869799|FG000|Overall Study|Lost to Follow-up|2|||
130248035|NCT03511066|468869800|FG001|Overall Study|Lost to Follow-up|3|||
130248036|NCT03511066|468869801|FG002|Overall Study|Lost to Follow-up|0|||
130248037|NCT02362412|468869802|FG000|Treatment Period III|Lost to Follow-up|0|||
130248038|NCT02362412|468869803|FG001|Treatment Period III|Lost to Follow-up|1|||
130248039|NCT01541254|468869804|FG000|Overall Study|Withdrawal by Subject|1|||
130248040|NCT01541254|468869804|FG000|Overall Study|excluded - metal allergy|1|||
130248041|NCT01541254|468869804|FG000|Overall Study|enrolled after study closed|1|||
130248042|NCT01541254|468869804|FG000|Overall Study|GI bleed prior to procedure|1|||
130248043|NCT01541254|468869804|FG000|Overall Study|stent not required|1|||
130248044|NCT01541254|468869804|FG000|Overall Study|alternate stent used|1|||
130248045|NCT05103332|468869807|FG000|Overall Study|Lost to Follow-up|0|||
130248046|NCT05103332|468869808|FG001|Overall Study|Lost to Follow-up|2|||
130248047|NCT05103332|468869809|FG002|Overall Study|Lost to Follow-up|1|||
130248048|NCT05103332|468869810|FG003|Overall Study|Lost to Follow-up|0|||
130248049|NCT05103332|468869811|FG004|Overall Study|Lost to Follow-up|0|||
130248050|NCT05103332|468869812|FG005|Overall Study|Lost to Follow-up|2|||
130248051|NCT05103332|468869807|FG000|Overall Study|Physician Decision|0|||
130248052|NCT05103332|468869808|FG001|Overall Study|Physician Decision|1|||
130248053|NCT05103332|468869809|FG002|Overall Study|Physician Decision|0|||
130248054|NCT05103332|468869810|FG003|Overall Study|Physician Decision|1|||
130248055|NCT05103332|468869811|FG004|Overall Study|Physician Decision|0|||
130248056|NCT05103332|468869812|FG005|Overall Study|Physician Decision|0|||
130248057|NCT05103332|468869807|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
130248058|NCT05103332|468869808|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
130248059|NCT05103332|468869809|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
130248060|NCT05103332|468869810|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
130248061|NCT05103332|468869811|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
130248062|NCT05103332|468869812|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
130248063|NCT05103332|468869807|FG000|Overall Study|Unspeccified|0|||
130248064|NCT05103332|468869808|FG001|Overall Study|Unspeccified|0|||
130248065|NCT05103332|468869809|FG002|Overall Study|Unspeccified|0|||
130248066|NCT05103332|468869810|FG003|Overall Study|Unspeccified|1|||
130248067|NCT05103332|468869811|FG004|Overall Study|Unspeccified|0|||
130248068|NCT05103332|468869812|FG005|Overall Study|Unspeccified|0|||
130248069|NCT02218268|468869813|FG000|24 Hour Washout|Physician Decision|11|||
130248070|NCT02218268|468869814|FG001|24 Hour Washout|Physician Decision|9|||
130248071|NCT03651336|468869815|FG000|Overall Study|Withdrawal by Subject|4|||
130248072|NCT01125748|468869818|FG000|Overall Study|Adverse Event|0|||
130248073|NCT01125748|468869819|FG001|Overall Study|Adverse Event|2|||
130248074|NCT01125748|468869818|FG000|Overall Study|Lost to Follow-up|0|||
130248075|NCT01125748|468869819|FG001|Overall Study|Lost to Follow-up|1|||
130248076|NCT01125748|468869818|FG000|Overall Study|Physician Decision|8|||
130248077|NCT01125748|468869819|FG001|Overall Study|Physician Decision|7|||
130248078|NCT01125748|468869818|FG000|Overall Study|Patient Decision to Withdraw|2|||
130248079|NCT01125748|468869819|FG001|Overall Study|Patient Decision to Withdraw|4|||
130248080|NCT01028391|468869820|FG000|Overall Study|Adverse Event|4|||
130248081|NCT01028391|468869821|FG001|Overall Study|Adverse Event|0|||
130248082|NCT01028391|468869820|FG000|Overall Study|Lack of Efficacy|0|||
130248083|NCT01028391|468869821|FG001|Overall Study|Lack of Efficacy|2|||
130248084|NCT01028391|468869820|FG000|Overall Study|Lost to Follow-up|3|||
130248085|NCT01028391|468869821|FG001|Overall Study|Lost to Follow-up|4|||
130248086|NCT01028391|468869820|FG000|Overall Study|Physician Decision|0|||
130248087|NCT01028391|468869821|FG001|Overall Study|Physician Decision|1|||
130248088|NCT01028391|468869820|FG000|Overall Study|Withdrawal by Subject|6|||
130248089|NCT01028391|468869821|FG001|Overall Study|Withdrawal by Subject|3|||
130248090|NCT01028391|468869820|FG000|Overall Study|Needed excluded medication|1|||
130248091|NCT01028391|468869821|FG001|Overall Study|Needed excluded medication|1|||
130030882|NCT00928070|468070551|FG000|Overall Study|Randomized but not treated|2|||
130248092|NCT01227395|468869822|FG000|Overall Study|Protocol Violation|0|||
130248093|NCT01227395|468869823|FG001|Overall Study|Protocol Violation|1|||
130248094|NCT00683384|468869828|FG000|Overall Study|Death|1|||
130248095|NCT00683384|468869828|FG000|Overall Study|Adverse Event|1|||
130248096|NCT00120874|468869830|FG000|Overall Study|Death|0|||
130030883|NCT00928070|468070552|FG001|Overall Study|Randomized but not treated|2|||
130248097|NCT00120874|468869831|FG001|Overall Study|Death|1|||
130248098|NCT03882801|468871389|FG000|Period 1|Adverse Event|0|||
130248099|NCT03882801|468871390|FG001|Period 1|Adverse Event|1|||
130248100|NCT03882801|468871389|FG000|Period 1|Non-compliance with study drug|1|||
130248101|NCT03882801|468871390|FG001|Period 1|Non-compliance with study drug|1|||
130248102|NCT03882801|468871389|FG000|Period 1|Never treated with study drug|1|||
130248103|NCT03882801|468871390|FG001|Period 1|Never treated with study drug|0|||
130248104|NCT03882801|468871389|FG000|Washout Period|Physician Decision|0|||
130248105|NCT03882801|468871390|FG001|Washout Period|Physician Decision|1|||
130248106|NCT03882801|468871389|FG000|Period 2|Non-compliance with study drug|0|||
130248107|NCT03882801|468871390|FG001|Period 2|Non-compliance with study drug|1|||
130248108|NCT03548415|468871397|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130248109|NCT03548415|468871398|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130248110|NCT03548415|468871399|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
130248111|NCT03548415|468871400|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
130248112|NCT03548415|468871401|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
130248113|NCT01803737|468871402|FG000|Overall Study|Lack of Time|1|||
130248114|NCT01803737|468871403|FG001|Overall Study|Lack of Time|0|||
130248115|NCT01803737|468871402|FG000|Overall Study|Medical Reason|0|||
130248116|NCT01803737|468871403|FG001|Overall Study|Medical Reason|1|||
130248117|NCT01803737|468871402|FG000|Overall Study|Lost to Follow-up|0|||
130248118|NCT01803737|468871403|FG001|Overall Study|Lost to Follow-up|2|||
130248119|NCT01529112|468871404|FG000|Overall Study|Adverse Event|2|||
130248120|NCT01529112|468871405|FG001|Overall Study|Adverse Event|0|||
130248121|NCT01529112|468871404|FG000|Overall Study|Death|59|||
130248122|NCT01529112|468871405|FG001|Overall Study|Death|38|||
130248123|NCT01529112|468871404|FG000|Overall Study|Protocol Violation|1|||
130248124|NCT01529112|468871405|FG001|Overall Study|Protocol Violation|0|||
130248125|NCT01529112|468871404|FG000|Overall Study|Withdrawal by Subject|7|||
130248126|NCT01529112|468871405|FG001|Overall Study|Withdrawal by Subject|3|||
130248127|NCT03607695|468871406|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
130248128|NCT03607695|468871406|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
130248129|NCT02741193|468871407|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
130248130|NCT02741193|468871407|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
130248131|NCT02502383|468871408|FG000|Overall Study|Lost to Follow-up|130|||
130248132|NCT02502383|468871409|FG001|Overall Study|Lost to Follow-up|131|||
130248133|NCT02502383|468871408|FG000|Overall Study|Withdrawal by Subject|31|||
130248134|NCT02502383|468871409|FG001|Overall Study|Withdrawal by Subject|24|||
130248135|NCT00458705|468871412|FG000|Overall Study|Adverse Event|4|||
130248136|NCT00458705|468871412|FG000|Overall Study|Not Treated|1|||
130248137|NCT00604383|468871413|FG000|Overall Study|Withdrawal by Subject|33|||
130248138|NCT00604383|468871414|FG001|Overall Study|Withdrawal by Subject|31|||
130248139|NCT00604383|468871413|FG000|Overall Study|Lost to Follow-up|24|||
130248140|NCT00604383|468871414|FG001|Overall Study|Lost to Follow-up|19|||
130248141|NCT00604383|468871413|FG000|Overall Study|Death|14|||
130248142|NCT00604383|468871414|FG001|Overall Study|Death|22|||
130248143|NCT00604383|468871413|FG000|Overall Study|Adverse Event|16|||
130248144|NCT00604383|468871414|FG001|Overall Study|Adverse Event|9|||
130248145|NCT00604383|468871413|FG000|Overall Study|Physician Decision|0|||
130248146|NCT00604383|468871414|FG001|Overall Study|Physician Decision|3|||
130248147|NCT01122680|468871417|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
130248148|NCT01122680|468871418|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
130248149|NCT01122680|468871419|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
130248150|NCT01122680|468871420|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
130248151|NCT01122680|468871417|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
130248152|NCT01122680|468871418|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
130248153|NCT01122680|468871419|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
130248154|NCT01122680|468871420|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
130248155|NCT01122680|468871417|FG000|Period 1 (4 Weeks)|Other|1|||
130248156|NCT01122680|468871418|FG001|Period 1 (4 Weeks)|Other|1|||
130248157|NCT01122680|468871419|FG002|Period 1 (4 Weeks)|Other|0|||
130248158|NCT01122680|468871420|FG003|Period 1 (4 Weeks)|Other|0|||
130248159|NCT01122680|468871417|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
130248160|NCT01122680|468871418|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
130248161|NCT01122680|468871419|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
130248162|NCT01122680|468871420|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
130248163|NCT01122680|468871417|FG000|Period 2 (4 Weeks)|Other|1|||
130248164|NCT01122680|468871418|FG001|Period 2 (4 Weeks)|Other|0|||
130248165|NCT01122680|468871419|FG002|Period 2 (4 Weeks)|Other|0|||
130248166|NCT01122680|468871420|FG003|Period 2 (4 Weeks)|Other|0|||
130248167|NCT01122680|468871417|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
130248168|NCT01122680|468871418|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
130248169|NCT01122680|468871419|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
130248170|NCT01122680|468871420|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
130248171|NCT01122680|468871417|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130248172|NCT01122680|468871418|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
130248173|NCT01122680|468871419|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130248174|NCT01122680|468871420|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
130248175|NCT00225758|468871421|FG000|Overall Study|Adverse Event|4|||
130248176|NCT01530997|468871425|FG000|Overall Study|Physician Decision|1|||
130248177|NCT01530997|468871425|FG000|Overall Study|Withdrawal by Subject|1|||
130248178|NCT03892915|468871426|FG000|Overall Study|Lost to Follow-up|6|||
130248179|NCT03892915|468871427|FG001|Overall Study|Lost to Follow-up|12|||
130248180|NCT03892915|468871426|FG000|Overall Study|Death|0|||
130248181|NCT03892915|468871427|FG001|Overall Study|Death|2|||
130248182|NCT03892915|468871426|FG000|Overall Study|Withdrawal by Subject|1|||
130248183|NCT03892915|468871427|FG001|Overall Study|Withdrawal by Subject|1|||
130248184|NCT03892915|468871426|FG000|Overall Study|unsuccessful delivery|13|||
130248185|NCT03892915|468871427|FG001|Overall Study|unsuccessful delivery|18|||
130248186|NCT02181738|468871430|FG000|Overall Study|Participant Withdrew Consent|2|||
130248187|NCT02181738|468871431|FG001|Overall Study|Participant Withdrew Consent|1|||
130248188|NCT02181738|468871432|FG002|Overall Study|Participant Withdrew Consent|1|||
130248189|NCT02181738|468871433|FG003|Overall Study|Participant Withdrew Consent|1|||
130248190|NCT02181738|468871430|FG000|Overall Study|Lost to Follow-up|1|||
130248191|NCT02181738|468871431|FG001|Overall Study|Lost to Follow-up|2|||
129884682|NCT00988351|467538632|FG001|Overall Study|Withdrawal by Subject|0|||
129884683|NCT00988351|467538631|FG000|Overall Study|Lost to Follow-up|6|||
129884684|NCT00988351|467538632|FG001|Overall Study|Lost to Follow-up|9|||
129884685|NCT00988351|467538631|FG000|Overall Study|not using CPAP|5|||
129884686|NCT00988351|467538632|FG001|Overall Study|not using CPAP|3|||
129884687|NCT00363896|467538640|FG000|Overall Study|Withdrawal by Subject|29|||
129884688|NCT00363896|467538641|FG001|Overall Study|Withdrawal by Subject|16|||
129884689|NCT00363896|467538640|FG000|Overall Study|Adverse Event|24|||
129884690|NCT00363896|467538641|FG001|Overall Study|Adverse Event|13|||
129884691|NCT00363896|467538640|FG000|Overall Study|COPD exacerbation|13|||
129884692|NCT00363896|467538641|FG001|Overall Study|COPD exacerbation|7|||
129884693|NCT00363896|467538640|FG000|Overall Study|Lack of Efficacy|12|||
129884694|NCT00363896|467538641|FG001|Overall Study|Lack of Efficacy|8|||
129884695|NCT00363896|467538640|FG000|Overall Study|Protocol Violation|6|||
129884696|NCT00363896|467538641|FG001|Overall Study|Protocol Violation|1|||
129884697|NCT00363896|467538640|FG000|Overall Study|Lost to Follow-up|3|||
129884698|NCT00363896|467538641|FG001|Overall Study|Lost to Follow-up|0|||
129884699|NCT00363896|467538640|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
129884700|NCT00363896|467538641|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
129884701|NCT00363896|467538640|FG000|Overall Study|Other|1|||
129884702|NCT00363896|467538641|FG001|Overall Study|Other|2|||
129884703|NCT00924469|467538646|FG000|Overall Study|Adverse Event|2|||
129884704|NCT00924469|467538647|FG001|Overall Study|Adverse Event|0|||
129884705|NCT00924469|467538646|FG000|Overall Study|Withdrawal by Subject|0|||
129884706|NCT00924469|467538647|FG001|Overall Study|Withdrawal by Subject|1|||
129884707|NCT00924469|467538646|FG000|Overall Study|Lost to Follow-up|0|||
129884708|NCT00924469|467538647|FG001|Overall Study|Lost to Follow-up|1|||
129884709|NCT00630058|467538648|FG000|Overall Study|Adverse Event|1|||
129884710|NCT00630058|467538649|FG001|Overall Study|Adverse Event|1|||
129884711|NCT00630058|467538648|FG000|Overall Study|Withdrawal by Subject|0|||
129884712|NCT00630058|467538649|FG001|Overall Study|Withdrawal by Subject|1|||
129884713|NCT00630058|467538648|FG000|Overall Study|stopping criteria|3|||
129884714|NCT00630058|467538649|FG001|Overall Study|stopping criteria|2|||
129884715|NCT01651936|467538650|FG000|Base Study|Adverse Event|3|||
130030884|NCT00928070|468070551|FG000|Overall Study|Other|5|||
130030885|NCT00928070|468070552|FG001|Overall Study|Other|5|||
130248192|NCT02181738|468871432|FG002|Overall Study|Lost to Follow-up|1|||
130248193|NCT02181738|468871433|FG003|Overall Study|Lost to Follow-up|1|||
130248194|NCT02181738|468871430|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
130248195|NCT02181738|468871431|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
130248196|NCT02181738|468871432|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
130248197|NCT02181738|468871433|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
130248198|NCT02181738|468871430|FG000|Overall Study|Poor/Non-Compliance|1|||
130248199|NCT02181738|468871431|FG001|Overall Study|Poor/Non-Compliance|0|||
130248200|NCT02181738|468871432|FG002|Overall Study|Poor/Non-Compliance|2|||
130248201|NCT02181738|468871433|FG003|Overall Study|Poor/Non-Compliance|1|||
130248202|NCT02181738|468871430|FG000|Overall Study|Disease Progression|28|||
130248203|NCT02181738|468871431|FG001|Overall Study|Disease Progression|35|||
130248204|NCT02181738|468871432|FG002|Overall Study|Disease Progression|40|||
130248205|NCT02181738|468871433|FG003|Overall Study|Disease Progression|0|||
130248206|NCT02181738|468871430|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
130248207|NCT02181738|468871431|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
130248208|NCT02181738|468871432|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
130248209|NCT02181738|468871433|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
130248210|NCT02181738|468871430|FG000|Overall Study|Study Drug Toxicity|6|||
130248211|NCT02181738|468871431|FG001|Overall Study|Study Drug Toxicity|11|||
130248212|NCT02181738|468871432|FG002|Overall Study|Study Drug Toxicity|8|||
130248213|NCT02181738|468871433|FG003|Overall Study|Study Drug Toxicity|1|||
130248214|NCT02181738|468871430|FG000|Overall Study|Other Reasons|14|||
130248215|NCT02181738|468871431|FG001|Overall Study|Other Reasons|16|||
130248216|NCT02181738|468871432|FG002|Overall Study|Other Reasons|28|||
130248217|NCT02181738|468871433|FG003|Overall Study|Other Reasons|0|||
130248218|NCT02181738|468871430|FG000|Overall Study|Maximum Clinical Benefit|3|||
130248219|NCT02181738|468871431|FG001|Overall Study|Maximum Clinical Benefit|0|||
130248220|NCT02181738|468871432|FG002|Overall Study|Maximum Clinical Benefit|1|||
129884716|NCT01651936|467538651|FG001|Base Study|Adverse Event|0|||
129884717|NCT01651936|467538652|FG002|Base Study|Adverse Event|0|||
129884718|NCT01651936|467538650|FG000|Base Study|Withdrawal by Subject|1|||
129884719|NCT01651936|467538651|FG001|Base Study|Withdrawal by Subject|1|||
129884720|NCT01651936|467538652|FG002|Base Study|Withdrawal by Subject|0|||
129884721|NCT01651936|467538650|FG000|Base Study|Early Escape|2|||
129884722|NCT01651936|467538651|FG001|Base Study|Early Escape|8|||
129884723|NCT01651936|467538652|FG002|Base Study|Early Escape|0|||
129884724|NCT01651936|467538650|FG000|Base Study|Study terminated by sponsor|21|||
129884725|NCT01651936|467538651|FG001|Base Study|Study terminated by sponsor|16|||
130030886|NCT00191854|468070553|FG000|Overall Study|Death|26|||
130030887|NCT00191854|468070554|FG001|Overall Study|Death|23|||
130030888|NCT00191854|468070555|FG002|Overall Study|Death|29|||
130030889|NCT00191854|468070553|FG000|Overall Study|Lost to Follow-up|7|||
130030890|NCT00191854|468070554|FG001|Overall Study|Lost to Follow-up|5|||
130030891|NCT00191854|468070555|FG002|Overall Study|Lost to Follow-up|5|||
130248221|NCT02181738|468871433|FG003|Overall Study|Maximum Clinical Benefit|0|||
130248222|NCT02181738|468871430|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130248223|NCT02181738|468871431|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130248224|NCT02181738|468871432|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130248225|NCT02181738|468871433|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
130248226|NCT02318277|468871436|FG000|Overall Study|Physician Decision|0|||
130248227|NCT02318277|468871437|FG001|Overall Study|Physician Decision|0|||
130248228|NCT02318277|468871438|FG002|Overall Study|Physician Decision|0|||
130248229|NCT02318277|468871439|FG003|Overall Study|Physician Decision|0|||
130248230|NCT02318277|468871440|FG004|Overall Study|Physician Decision|0|||
130248231|NCT02318277|468871441|FG005|Overall Study|Physician Decision|0|||
130248232|NCT02318277|468871442|FG006|Overall Study|Physician Decision|0|||
130248233|NCT02318277|468871443|FG007|Overall Study|Physician Decision|1|||
130248234|NCT02318277|468871436|FG000|Overall Study|Other|0|||
130248235|NCT02318277|468871437|FG001|Overall Study|Other|0|||
130248236|NCT02318277|468871438|FG002|Overall Study|Other|0|||
130248237|NCT02318277|468871439|FG003|Overall Study|Other|0|||
130248238|NCT02318277|468871440|FG004|Overall Study|Other|0|||
130248239|NCT02318277|468871441|FG005|Overall Study|Other|0|||
130248240|NCT02318277|468871442|FG006|Overall Study|Other|1|||
130248241|NCT02318277|468871443|FG007|Overall Study|Other|0|||
130248242|NCT02318277|468871436|FG000|Overall Study|Withdrawal by Subject|0|||
130248243|NCT02318277|468871437|FG001|Overall Study|Withdrawal by Subject|0|||
130248244|NCT02318277|468871438|FG002|Overall Study|Withdrawal by Subject|1|||
130248245|NCT02318277|468871439|FG003|Overall Study|Withdrawal by Subject|0|||
130248246|NCT02318277|468871440|FG004|Overall Study|Withdrawal by Subject|1|||
130248247|NCT02318277|468871441|FG005|Overall Study|Withdrawal by Subject|1|||
130248248|NCT02318277|468871442|FG006|Overall Study|Withdrawal by Subject|6|||
130248249|NCT02318277|468871443|FG007|Overall Study|Withdrawal by Subject|14|||
130248250|NCT02318277|468871436|FG000|Overall Study|Participant trial terminated by sponsor|0|||
130248251|NCT02318277|468871437|FG001|Overall Study|Participant trial terminated by sponsor|0|||
130248252|NCT02318277|468871438|FG002|Overall Study|Participant trial terminated by sponsor|1|||
130248253|NCT02318277|468871439|FG003|Overall Study|Participant trial terminated by sponsor|0|||
130248254|NCT02318277|468871440|FG004|Overall Study|Participant trial terminated by sponsor|1|||
130248255|NCT02318277|468871441|FG005|Overall Study|Participant trial terminated by sponsor|2|||
130248256|NCT02318277|468871442|FG006|Overall Study|Participant trial terminated by sponsor|5|||
130248257|NCT02318277|468871443|FG007|Overall Study|Participant trial terminated by sponsor|16|||
130248258|NCT02318277|468871436|FG000|Overall Study|Lost to Follow-up|1|||
130248259|NCT02318277|468871437|FG001|Overall Study|Lost to Follow-up|0|||
130248260|NCT02318277|468871438|FG002|Overall Study|Lost to Follow-up|1|||
130248261|NCT02318277|468871439|FG003|Overall Study|Lost to Follow-up|0|||
130248262|NCT02318277|468871440|FG004|Overall Study|Lost to Follow-up|0|||
130248263|NCT02318277|468871441|FG005|Overall Study|Lost to Follow-up|0|||
130248264|NCT02318277|468871442|FG006|Overall Study|Lost to Follow-up|3|||
130248265|NCT02318277|468871443|FG007|Overall Study|Lost to Follow-up|4|||
130248266|NCT02318277|468871436|FG000|Overall Study|Death|5|||
130248267|NCT02318277|468871437|FG001|Overall Study|Death|3|||
130248268|NCT02318277|468871438|FG002|Overall Study|Death|1|||
130248269|NCT02318277|468871439|FG003|Overall Study|Death|4|||
130248270|NCT02318277|468871440|FG004|Overall Study|Death|6|||
130248271|NCT02318277|468871441|FG005|Overall Study|Death|5|||
130248272|NCT02318277|468871442|FG006|Overall Study|Death|34|||
130248273|NCT02318277|468871443|FG007|Overall Study|Death|58|||
130248274|NCT02318277|468871436|FG000|Overall Study|Transitioned to Hospice|0|||
130248275|NCT02318277|468871437|FG001|Overall Study|Transitioned to Hospice|0|||
130030892|NCT00191854|468070553|FG000|Overall Study|Withdrawal by Subject|4|||
130030893|NCT00191854|468070554|FG001|Overall Study|Withdrawal by Subject|2|||
130100859|NCT05553600|468327246|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
130248276|NCT02318277|468871438|FG002|Overall Study|Transitioned to Hospice|0|||
130248277|NCT02318277|468871439|FG003|Overall Study|Transitioned to Hospice|0|||
130248278|NCT02318277|468871440|FG004|Overall Study|Transitioned to Hospice|0|||
130248279|NCT02318277|468871441|FG005|Overall Study|Transitioned to Hospice|1|||
130030894|NCT00191854|468070555|FG002|Overall Study|Withdrawal by Subject|3|||
130030895|NCT00191854|468070553|FG000|Overall Study|Sponsor Decision|0|||
130030896|NCT00191854|468070554|FG001|Overall Study|Sponsor Decision|0|||
130248280|NCT02318277|468871442|FG006|Overall Study|Transitioned to Hospice|0|||
130248281|NCT02318277|468871443|FG007|Overall Study|Transitioned to Hospice|0|||
130248282|NCT01691482|468871444|FG000|Treatment Period 2|Adverse Event|0|||
130248283|NCT01691482|468871445|FG001|Treatment Period 2|Adverse Event|1|||
130248284|NCT01691482|468871444|FG000|Treatment Period 2|Protocol Violation|1|||
130248285|NCT01691482|468871445|FG001|Treatment Period 2|Protocol Violation|1|||
130248286|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
130248287|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
130248288|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
130248289|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
130248290|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
130248291|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
130248292|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130248293|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130248294|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
130248295|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130248296|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130248297|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
130030897|NCT00191854|468070555|FG002|Overall Study|Sponsor Decision|1|||
130248298|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130248299|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130248300|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
130248301|NCT00407030|468871446|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
130248302|NCT00407030|468871447|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
130248303|NCT00407030|468871448|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
130248304|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
130248305|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
130248306|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
130248307|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
130248308|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
130248309|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
130248310|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
130248311|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
130248312|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
130248313|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
130248314|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
130248315|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
130248316|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
130248317|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
130248318|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
130248319|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
130248320|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
130248321|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
130248322|NCT00407030|468871446|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
130248323|NCT00407030|468871447|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
130248324|NCT00407030|468871448|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
130248325|NCT02829957|468871450|FG000|Overall Study|Lost to Follow-up|2|||
130248326|NCT02829957|468871451|FG001|Overall Study|Lost to Follow-up|1|||
130248327|NCT00754559|468871452|FG000|Overall Study|Adverse Event|15|||
130248328|NCT00754559|468871452|FG000|Overall Study|Protocol Violation|11|||
130248329|NCT00754559|468871452|FG000|Overall Study|Lack of Efficacy|10|||
130248330|NCT00754559|468871452|FG000|Overall Study|Lost to Follow-up|2|||
130248331|NCT00754559|468871452|FG000|Overall Study|Administrative reason|1|||
130248332|NCT00754559|468871452|FG000|Overall Study|Other|5|||
130248333|NCT00754559|468871452|FG000|Overall Study|Withdrawal by Subject|3|||
130248334|NCT01663987|468871453|FG000|Overall Study|Adverse Event|7|||
130248335|NCT01663987|468871454|FG001|Overall Study|Adverse Event|2|||
130248336|NCT01663987|468871453|FG000|Overall Study|Lost to Follow-up|1|||
130248337|NCT01663987|468871454|FG001|Overall Study|Lost to Follow-up|1|||
130248338|NCT01663987|468871453|FG000|Overall Study|Withdrawal by Subject|2|||
130248339|NCT01663987|468871454|FG001|Overall Study|Withdrawal by Subject|3|||
130248340|NCT01663987|468871453|FG000|Overall Study|Other reason not defined above|3|||
130248341|NCT01663987|468871454|FG001|Overall Study|Other reason not defined above|0|||
130248342|NCT01370538|468871456|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
130248343|NCT01370538|468871457|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
130248344|NCT01370538|468871456|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130248345|NCT01370538|468871457|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130248346|NCT01370538|468871456|FG000|Overall Study|Adverse Event|1|||
130248347|NCT01370538|468871457|FG001|Overall Study|Adverse Event|0|||
130248348|NCT01370538|468871456|FG000|Overall Study|Protocol Violation|8|||
130248349|NCT01370538|468871457|FG001|Overall Study|Protocol Violation|5|||
130248350|NCT01370538|468871456|FG000|Overall Study|Development of study specific withdrawal|1|||
130248351|NCT01370538|468871457|FG001|Overall Study|Development of study specific withdrawal|1|||
130248352|NCT01370538|468871456|FG000|Overall Study|Lost to follow up|6|||
130248353|NCT01370538|468871457|FG001|Overall Study|Lost to follow up|10|||
130248354|NCT04193527|468871458|FG000|Overall Study|Other|1|||
130248355|NCT04193527|468871459|FG001|Overall Study|Other|1|||
130248356|NCT04193527|468871460|FG002|Overall Study|Other|0|||
130248357|NCT00676689|468871461|FG000|Overall Study|Screen Failure|2|||
130248358|NCT00676689|468871461|FG000|Overall Study|Death|2|||
130248359|NCT00676689|468871461|FG000|Overall Study|Lost to Follow-up|4|||
130248360|NCT00676689|468871461|FG000|Overall Study|Physician Decision|1|||
130248361|NCT00676689|468871461|FG000|Overall Study|Withdrawal by Subject|3|||
130248362|NCT00676689|468871461|FG000|Overall Study|Continuing FU|49|||
130030898|NCT00191854|468070553|FG000|Overall Study|Screen Failure|0|||
130030899|NCT00191854|468070554|FG001|Overall Study|Screen Failure|0|||
130030900|NCT00191854|468070555|FG002|Overall Study|Screen Failure|1|||
130248363|NCT02366130|468871462|FG000|Overall Study|Withdrawal by Subject|3|||
130248364|NCT02366130|468871462|FG000|Overall Study|Ineligible|6|||
130248365|NCT01945242|468871463|FG000|Overall Study|Physician Decision|3|||
130248366|NCT01945242|468871464|FG001|Overall Study|Physician Decision|3|||
130248367|NCT05661734|468871465|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
130248368|NCT05661734|468871465|FG000|Overall Study|Lost to Follow-up|13|||
130248369|NCT05661734|468871465|FG000|Overall Study|Enrolled but not dosed|2|||
130248370|NCT01026038|468871466|FG000|Overall Study|Lost to Follow-up|1|||
130248371|NCT01026038|468871467|FG001|Overall Study|Lost to Follow-up|1|||
130248372|NCT01026038|468871468|FG002|Overall Study|Lost to Follow-up|0|||
130248373|NCT03601052|468871469|FG000|Overall Study|Lost to Follow-up|2|||
130248374|NCT01348490|468871470|FG000|Overall Study|Death|1|||
130248375|NCT01348490|468871470|FG000|Overall Study|Adverse Event|3|||
130248376|NCT01348490|468871470|FG000|Overall Study|Consent withdrawn|7|||
130248377|NCT01348490|468871470|FG000|Overall Study|Disease progression|3|||
130248378|NCT01348490|468871470|FG000|Overall Study|Lost to Follow-up|1|||
130248379|NCT01348490|468871470|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
130248380|NCT01348490|468871470|FG000|Overall Study|Other Unspecified|8|||
130248381|NCT00300495|468871471|FG000|Overall Study|Protocol Violation|4|||
130248382|NCT00300495|468871472|FG001|Overall Study|Protocol Violation|1|||
130248383|NCT01184118|468871473|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
130248384|NCT01184118|468871473|FG000|Overall Study|No physiologic confirmation of asthma|8|||
130248385|NCT01184118|468871473|FG000|Overall Study|FEV1 <60% predicted|2|||
130248386|NCT01184118|468871473|FG000|Overall Study|Exclusionary medical condition|2|||
130248387|NCT01184118|468871473|FG000|Overall Study|Withdrawal by Subject|5|||
130248388|NCT03632720|468871474|FG000|Overall Study|Adverse Event|2|||
130248389|NCT03632720|468871475|FG001|Overall Study|Adverse Event|0|||
130248390|NCT03632720|468871476|FG002|Overall Study|Adverse Event|0|||
130248391|NCT03632720|468871474|FG000|Overall Study|Lost to Follow-up|0|||
130248392|NCT03632720|468871475|FG001|Overall Study|Lost to Follow-up|1|||
130248393|NCT03632720|468871476|FG002|Overall Study|Lost to Follow-up|0|||
130248394|NCT03632720|468871474|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
130248395|NCT03632720|468871475|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
130248396|NCT03632720|468871476|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
130248397|NCT03632720|468871474|FG000|Overall Study|Screen failure|0|||
130248398|NCT03632720|468871475|FG001|Overall Study|Screen failure|1|||
130248399|NCT03632720|468871476|FG002|Overall Study|Screen failure|0|||
130248400|NCT00682435|468871477|FG000|Overall Study|Insufficient data|5|||
130248401|NCT00682435|468871477|FG000|Overall Study|Erroneously enrolled twice|2|||
130248402|NCT01049828|468871479|FG000|Overall Study|Claustrophibia and Frustration|2|||
130248403|NCT00290238|468871480|FG000|Overall Study|Study terminated|27|||
130248404|NCT00290238|468871481|FG001|Overall Study|Study terminated|27|||
130248405|NCT00290238|468871480|FG000|Overall Study|Lost to Follow-up|0|||
130248406|NCT00290238|468871481|FG001|Overall Study|Lost to Follow-up|1|||
130248407|NCT00290238|468871480|FG000|Overall Study|Withdrawal by Subject|15|||
130248408|NCT00290238|468871481|FG001|Overall Study|Withdrawal by Subject|13|||
130248409|NCT02186171|468871482|FG000|Overall Study|Withdrawal by Subject|1|||
130248410|NCT02186171|468871483|FG001|Overall Study|Withdrawal by Subject|9|||
130248411|NCT02186171|468871482|FG000|Overall Study|Lost to Follow-up|2|||
130248412|NCT02186171|468871483|FG001|Overall Study|Lost to Follow-up|2|||
130248413|NCT02186171|468871482|FG000|Overall Study|Death|1|||
130248414|NCT02186171|468871483|FG001|Overall Study|Death|2|||
130248415|NCT02186171|468871482|FG000|Overall Study|Protocol-specified Criteria|0|||
130248416|NCT02186171|468871483|FG001|Overall Study|Protocol-specified Criteria|2|||
130030901|NCT05254418|468070559|FG000|Overall Study|Adverse Event|2|||
130030902|NCT06118385|468070560|FG000|Overall Study|Protocol Violation|0|||
130030903|NCT06118385|468070561|FG001|Overall Study|Protocol Violation|0|||
130030904|NCT06118385|468070562|FG002|Overall Study|Protocol Violation|0|||
130030905|NCT06118385|468070563|FG003|Overall Study|Protocol Violation|0|||
130100860|NCT05553600|468327247|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
130248417|NCT02946996|468871484|FG000|Overall Study|non-evaluable|3|||
130248418|NCT02946996|468871485|FG001|Overall Study|non-evaluable|6|||
130248419|NCT02946996|468871486|FG002|Overall Study|non-evaluable|5|||
130248420|NCT06868667|468871490|FG000|Overall Study|Death|0|||
130248421|NCT06868667|468871491|FG001|Overall Study|Death|4|||
130248422|NCT06868667|468871490|FG000|Overall Study|Lost to Follow-up|0|||
130248423|NCT06868667|468871491|FG001|Overall Study|Lost to Follow-up|1|||
130248424|NCT06868667|468871490|FG000|Overall Study|Withdrawal by Subject|1|||
130248425|NCT06868667|468871491|FG001|Overall Study|Withdrawal by Subject|0|||
130248426|NCT06868667|468871490|FG000|Overall Study|Ongoing|9|||
130248427|NCT06868667|468871491|FG001|Overall Study|Ongoing|9|||
130248428|NCT05330429|468871494|FG000|Overall Study|Study Terminated by Sponsor|4|||
130248429|NCT05330429|468871495|FG001|Overall Study|Study Terminated by Sponsor|33|||
130248430|NCT05330429|468871496|FG002|Overall Study|Study Terminated by Sponsor|12|||
130248431|NCT05330429|468871494|FG000|Overall Study|Death|5|||
130248432|NCT05330429|468871495|FG001|Overall Study|Death|2|||
130248433|NCT05330429|468871496|FG002|Overall Study|Death|4|||
130248434|NCT05330429|468871494|FG000|Overall Study|Withdrew Consent|0|||
130248435|NCT05330429|468871495|FG001|Overall Study|Withdrew Consent|5|||
130248436|NCT05330429|468871496|FG002|Overall Study|Withdrew Consent|4|||
130248437|NCT05330429|468871494|FG000|Overall Study|Investigator's Discretion|0|||
130248438|NCT05330429|468871495|FG001|Overall Study|Investigator's Discretion|1|||
130248439|NCT05330429|468871496|FG002|Overall Study|Investigator's Discretion|3|||
130248440|NCT05330429|468871494|FG000|Overall Study|Subject Decision|1|||
130248441|NCT05330429|468871495|FG001|Overall Study|Subject Decision|2|||
130248442|NCT05330429|468871496|FG002|Overall Study|Subject Decision|0|||
130248443|NCT05330429|468871494|FG000|Overall Study|Lost to Follow-up|0|||
130248444|NCT05330429|468871495|FG001|Overall Study|Lost to Follow-up|1|||
130248445|NCT05330429|468871496|FG002|Overall Study|Lost to Follow-up|0|||
130248446|NCT03572218|468871497|FG000|Overall Study|Lost to Follow-up|3|||
130248447|NCT03572218|468871498|FG001|Overall Study|Lost to Follow-up|2|||
130248448|NCT03572218|468871497|FG000|Overall Study|No longer available for study visits|2|||
130248449|NCT03572218|468871498|FG001|Overall Study|No longer available for study visits|1|||
130248450|NCT03572218|468871497|FG000|Overall Study|No longer interested|1|||
130248451|NCT03572218|468871498|FG001|Overall Study|No longer interested|2|||
130248452|NCT00286455|468871499|FG000|Overall Study|Hyperglycemia rescue|19|||
130248453|NCT00286455|468871500|FG001|Overall Study|Hyperglycemia rescue|13|||
130248454|NCT00286455|468871501|FG002|Overall Study|Hyperglycemia rescue|10|||
130248455|NCT00286455|468871499|FG000|Overall Study|Adverse Event|1|||
130248456|NCT00286455|468871500|FG001|Overall Study|Adverse Event|3|||
130248457|NCT00286455|468871501|FG002|Overall Study|Adverse Event|2|||
130248458|NCT00286455|468871499|FG000|Overall Study|Lost to Follow-up|0|||
130248459|NCT00286455|468871500|FG001|Overall Study|Lost to Follow-up|3|||
130248460|NCT00286455|468871501|FG002|Overall Study|Lost to Follow-up|3|||
130248461|NCT00286455|468871499|FG000|Overall Study|Physician Decision|3|||
130248462|NCT00286455|468871500|FG001|Overall Study|Physician Decision|0|||
130248463|NCT00286455|468871501|FG002|Overall Study|Physician Decision|2|||
130248464|NCT00286455|468871499|FG000|Overall Study|Protocol Violation|1|||
130248465|NCT00286455|468871500|FG001|Overall Study|Protocol Violation|1|||
130248466|NCT00286455|468871501|FG002|Overall Study|Protocol Violation|0|||
130248467|NCT00286455|468871499|FG000|Overall Study|Participant Non-compliance|1|||
130248468|NCT00286455|468871500|FG001|Overall Study|Participant Non-compliance|0|||
130248469|NCT00286455|468871501|FG002|Overall Study|Participant Non-compliance|0|||
130248470|NCT00286455|468871499|FG000|Overall Study|Withdrawal by Subject|0|||
130248471|NCT00286455|468871500|FG001|Overall Study|Withdrawal by Subject|8|||
130248472|NCT00286455|468871501|FG002|Overall Study|Withdrawal by Subject|7|||
130248473|NCT06097273|468871502|FG000|Overall Study|Death|2|||
130248474|NCT06097273|468871503|FG001|Overall Study|Death|1|||
130248475|NCT06097273|468871504|FG002|Overall Study|Death|2|||
130248476|NCT06097273|468871505|FG003|Overall Study|Death|2|||
130248477|NCT06097273|468871502|FG000|Overall Study|Lost to Follow-up|27|||
129800244|NCT04755283|467236269|FG001|Overall Study|Death|36|||
130248478|NCT06097273|468871503|FG001|Overall Study|Lost to Follow-up|18|||
130248479|NCT06097273|468871504|FG002|Overall Study|Lost to Follow-up|36|||
130248480|NCT06097273|468871505|FG003|Overall Study|Lost to Follow-up|31|||
130248481|NCT06097273|468871502|FG000|Overall Study|Physician Decision|0|||
130248482|NCT06097273|468871503|FG001|Overall Study|Physician Decision|1|||
130248483|NCT06097273|468871504|FG002|Overall Study|Physician Decision|0|||
130248484|NCT06097273|468871505|FG003|Overall Study|Physician Decision|3|||
130248485|NCT06097273|468871502|FG000|Overall Study|Protocol Violation|1|||
130248486|NCT06097273|468871503|FG001|Overall Study|Protocol Violation|1|||
130248487|NCT06097273|468871504|FG002|Overall Study|Protocol Violation|2|||
130248488|NCT06097273|468871505|FG003|Overall Study|Protocol Violation|1|||
130248489|NCT06097273|468871502|FG000|Overall Study|Withdrawal by Subject|14|||
130248490|NCT06097273|468871503|FG001|Overall Study|Withdrawal by Subject|11|||
130248491|NCT06097273|468871504|FG002|Overall Study|Withdrawal by Subject|14|||
130248492|NCT06097273|468871505|FG003|Overall Study|Withdrawal by Subject|15|||
130248493|NCT06097273|468871502|FG000|Overall Study|Other Than Specified|7|||
130248494|NCT06097273|468871503|FG001|Overall Study|Other Than Specified|3|||
130248495|NCT06097273|468871504|FG002|Overall Study|Other Than Specified|11|||
130248496|NCT06097273|468871505|FG003|Overall Study|Other Than Specified|6|||
130248497|NCT00394472|468872924|FG000|Overall Study|Protocol Violation|1|||
130248498|NCT00394472|468872925|FG001|Overall Study|Protocol Violation|3|||
130248499|NCT00394472|468872924|FG000|Overall Study|incorrect enrolment|4|||
130248500|NCT00394472|468872925|FG001|Overall Study|incorrect enrolment|2|||
130248501|NCT00394472|468872924|FG000|Overall Study|Adverse Event|4|||
130248502|NCT00394472|468872925|FG001|Overall Study|Adverse Event|2|||
130248503|NCT00394472|468872924|FG000|Overall Study|Withdrawal by Subject|0|||
130248504|NCT00394472|468872925|FG001|Overall Study|Withdrawal by Subject|2|||
130248505|NCT00394472|468872924|FG000|Overall Study|Physician Decision|0|||
130248506|NCT00394472|468872925|FG001|Overall Study|Physician Decision|1|||
130248507|NCT00394472|468872924|FG000|Overall Study|Lost to Follow-up|0|||
130248508|NCT00394472|468872925|FG001|Overall Study|Lost to Follow-up|1|||
130248509|NCT03931785|468872926|FG000|Overall Study|Lost to Follow-up|4|||
130248510|NCT03931785|468872927|FG001|Overall Study|Lost to Follow-up|1|||
130248511|NCT03931785|468872928|FG002|Overall Study|Lost to Follow-up|4|||
130248512|NCT03931785|468872929|FG003|Overall Study|Lost to Follow-up|3|||
130248513|NCT03931785|468872926|FG000|Overall Study|Adverse Event|1|||
130248514|NCT03931785|468872927|FG001|Overall Study|Adverse Event|0|||
130248515|NCT03931785|468872928|FG002|Overall Study|Adverse Event|3|||
130248516|NCT03931785|468872929|FG003|Overall Study|Adverse Event|4|||
130248517|NCT03931785|468872926|FG000|Overall Study|Protocol Violation|0|||
130248518|NCT03931785|468872927|FG001|Overall Study|Protocol Violation|1|||
130248519|NCT03931785|468872928|FG002|Overall Study|Protocol Violation|0|||
130248520|NCT03931785|468872929|FG003|Overall Study|Protocol Violation|0|||
130248521|NCT03931785|468872926|FG000|Overall Study|Noncompliance With Study drug|0|||
130248522|NCT03931785|468872927|FG001|Overall Study|Noncompliance With Study drug|1|||
130248523|NCT03931785|468872928|FG002|Overall Study|Noncompliance With Study drug|0|||
130248524|NCT03931785|468872929|FG003|Overall Study|Noncompliance With Study drug|0|||
130248525|NCT03931785|468872926|FG000|Overall Study|Other Not specified|0|||
130248526|NCT03931785|468872927|FG001|Overall Study|Other Not specified|2|||
130248527|NCT03931785|468872928|FG002|Overall Study|Other Not specified|2|||
130248528|NCT03931785|468872929|FG003|Overall Study|Other Not specified|2|||
130248529|NCT03931785|468872926|FG000|Overall Study|Withdrawal by Subject|0|||
130248530|NCT03931785|468872927|FG001|Overall Study|Withdrawal by Subject|2|||
130248531|NCT03931785|468872928|FG002|Overall Study|Withdrawal by Subject|4|||
130248532|NCT03931785|468872929|FG003|Overall Study|Withdrawal by Subject|1|||
130248533|NCT03931785|468872926|FG000|Overall Study|Pregnancy|0|||
130248534|NCT03931785|468872927|FG001|Overall Study|Pregnancy|0|||
130248535|NCT03931785|468872928|FG002|Overall Study|Pregnancy|0|||
130248536|NCT03931785|468872929|FG003|Overall Study|Pregnancy|1|||
130248537|NCT04605588|468872933|FG000|Overall Study|Withdrawal by Subject|1|||
130248538|NCT04605588|468872934|FG001|Overall Study|Withdrawal by Subject|0|||
130248539|NCT01230814|468872935|FG000|Overall Study|Lost to Follow-up|11|||
130248540|NCT01230814|468872936|FG001|Overall Study|Lost to Follow-up|3|||
130248541|NCT01230814|468872935|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
130248542|NCT01230814|468872936|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
130248543|NCT01748552|468872939|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
130248544|NCT01748552|468872940|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
130248545|NCT01748552|468872941|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
130248546|NCT01748552|468872942|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
130248547|NCT01748552|468872943|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
130248548|NCT01748552|468872944|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
130248549|NCT01748552|468872945|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
130248550|NCT01748552|468872946|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
130248551|NCT01748552|468872947|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
130248552|NCT01748552|468872948|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
130248553|NCT01748552|468872949|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
130248554|NCT01748552|468872950|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
130248555|NCT01748552|468872939|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248556|NCT01748552|468872940|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248557|NCT01748552|468872941|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248558|NCT01748552|468872942|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248559|NCT01748552|468872943|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248560|NCT01748552|468872944|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248561|NCT01748552|468872945|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130248562|NCT01748552|468872946|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130248563|NCT01748552|468872947|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
130248564|NCT01748552|468872948|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248565|NCT01748552|468872949|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248566|NCT01748552|468872950|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
130248567|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
130248568|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
130248569|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
130248570|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
130248571|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
130248572|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
130248573|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
130248574|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
130248575|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130248576|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130248577|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
130248578|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
130248579|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
130248580|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
130248581|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
130248582|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
130248583|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
130248584|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
130248585|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
130248586|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
130248587|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
130248588|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
130248589|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
130248590|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
130248591|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
130248592|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130248593|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130248594|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
130248595|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
130248596|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
130248597|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
130248598|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
130248599|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
130248600|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
130248601|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
130248602|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
130248603|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130248604|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130248605|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
130248606|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
130248607|NCT02596893|468872955|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
130248608|NCT02596893|468872956|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
130248609|NCT02596893|468872957|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
130248610|NCT02596893|468872958|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
130248611|NCT00004228|468872961|FG000|Overall Study|Adverse Event|0|||
130248612|NCT00004228|468872962|FG001|Overall Study|Adverse Event|1|||
130248613|NCT00004228|468872963|FG002|Overall Study|Adverse Event|0|||
130248614|NCT00004228|468872964|FG003|Overall Study|Adverse Event|0|||
130248615|NCT00004228|468872965|FG004|Overall Study|Adverse Event|1|||
130248616|NCT00004228|468872966|FG005|Overall Study|Adverse Event|0|||
130248617|NCT00004228|468872967|FG006|Overall Study|Adverse Event|0|||
130248618|NCT00004228|468872961|FG000|Overall Study|Death|0|||
130248619|NCT00004228|468872962|FG001|Overall Study|Death|1|||
130248620|NCT00004228|468872963|FG002|Overall Study|Death|2|||
130248621|NCT00004228|468872964|FG003|Overall Study|Death|0|||
130248622|NCT00004228|468872965|FG004|Overall Study|Death|1|||
130248623|NCT00004228|468872966|FG005|Overall Study|Death|0|||
130248624|NCT00004228|468872967|FG006|Overall Study|Death|0|||
130248625|NCT00004228|468872961|FG000|Overall Study|Lack of Efficacy|1|||
130248626|NCT00004228|468872962|FG001|Overall Study|Lack of Efficacy|6|||
130248627|NCT00004228|468872963|FG002|Overall Study|Lack of Efficacy|5|||
130248628|NCT00004228|468872964|FG003|Overall Study|Lack of Efficacy|3|||
130248629|NCT00004228|468872965|FG004|Overall Study|Lack of Efficacy|9|||
130248630|NCT00004228|468872966|FG005|Overall Study|Lack of Efficacy|8|||
130248631|NCT00004228|468872967|FG006|Overall Study|Lack of Efficacy|4|||
130248632|NCT00004228|468872961|FG000|Overall Study|Lost to Follow-up|0|||
130248633|NCT00004228|468872962|FG001|Overall Study|Lost to Follow-up|0|||
130248634|NCT00004228|468872963|FG002|Overall Study|Lost to Follow-up|1|||
130248635|NCT00004228|468872964|FG003|Overall Study|Lost to Follow-up|0|||
130248636|NCT00004228|468872965|FG004|Overall Study|Lost to Follow-up|0|||
130248637|NCT00004228|468872966|FG005|Overall Study|Lost to Follow-up|0|||
130248638|NCT00004228|468872967|FG006|Overall Study|Lost to Follow-up|0|||
130248639|NCT00004228|468872961|FG000|Overall Study|Physician Decision|1|||
130248640|NCT00004228|468872962|FG001|Overall Study|Physician Decision|0|||
130248641|NCT00004228|468872963|FG002|Overall Study|Physician Decision|3|||
130248642|NCT00004228|468872964|FG003|Overall Study|Physician Decision|2|||
130248643|NCT00004228|468872965|FG004|Overall Study|Physician Decision|1|||
130248644|NCT00004228|468872966|FG005|Overall Study|Physician Decision|1|||
130248645|NCT00004228|468872967|FG006|Overall Study|Physician Decision|1|||
130248646|NCT00004228|468872961|FG000|Overall Study|Protocol Violation|0|||
130248647|NCT00004228|468872962|FG001|Overall Study|Protocol Violation|5|||
130248648|NCT00004228|468872963|FG002|Overall Study|Protocol Violation|2|||
130248649|NCT00004228|468872964|FG003|Overall Study|Protocol Violation|1|||
130248650|NCT00004228|468872965|FG004|Overall Study|Protocol Violation|1|||
130248651|NCT00004228|468872966|FG005|Overall Study|Protocol Violation|2|||
130248652|NCT00004228|468872967|FG006|Overall Study|Protocol Violation|0|||
130248653|NCT00004228|468872961|FG000|Overall Study|Withdrawal by Subject|3|||
130248654|NCT00004228|468872962|FG001|Overall Study|Withdrawal by Subject|0|||
130248655|NCT00004228|468872963|FG002|Overall Study|Withdrawal by Subject|1|||
130248656|NCT00004228|468872964|FG003|Overall Study|Withdrawal by Subject|0|||
130248657|NCT00004228|468872965|FG004|Overall Study|Withdrawal by Subject|2|||
130248658|NCT00004228|468872966|FG005|Overall Study|Withdrawal by Subject|1|||
130248659|NCT00004228|468872967|FG006|Overall Study|Withdrawal by Subject|2|||
130248660|NCT00004228|468872961|FG000|Overall Study|Other|0|||
130248661|NCT00004228|468872962|FG001|Overall Study|Other|0|||
130248662|NCT00004228|468872963|FG002|Overall Study|Other|1|||
130248663|NCT00004228|468872964|FG003|Overall Study|Other|0|||
130248664|NCT00004228|468872965|FG004|Overall Study|Other|0|||
130248665|NCT00004228|468872966|FG005|Overall Study|Other|0|||
130248666|NCT00004228|468872967|FG006|Overall Study|Other|0|||
130248667|NCT00004228|468872961|FG000|Overall Study|ineligible|4|||
130248668|NCT00004228|468872962|FG001|Overall Study|ineligible|2|||
130248669|NCT00004228|468872963|FG002|Overall Study|ineligible|4|||
130248670|NCT00004228|468872964|FG003|Overall Study|ineligible|1|||
130248671|NCT00004228|468872965|FG004|Overall Study|ineligible|1|||
130248672|NCT00004228|468872966|FG005|Overall Study|ineligible|2|||
130248673|NCT00004228|468872967|FG006|Overall Study|ineligible|5|||
130248674|NCT02255279|468872968|FG000|Overall Study|Lost to Follow-up|2|||
130248675|NCT02255279|468872969|FG001|Overall Study|Lost to Follow-up|2|||
130248676|NCT02255279|468872968|FG000|Overall Study|Protocol Violation|0|||
130248677|NCT02255279|468872969|FG001|Overall Study|Protocol Violation|1|||
130248678|NCT02255279|468872968|FG000|Overall Study|Withdrawal by Subject|3|||
130248679|NCT02255279|468872969|FG001|Overall Study|Withdrawal by Subject|6|||
130248680|NCT00363467|468872970|FG000|Overall Study|Physician Decision|1|||
130248681|NCT00903344|468872971|FG000|Overall Study|Pregnancy|2|||
130248682|NCT00903344|468872972|FG001|Overall Study|Pregnancy|3|||
130248683|NCT00903344|468872971|FG000|Overall Study|Lost to Follow-up|3|||
130248684|NCT00903344|468872972|FG001|Overall Study|Lost to Follow-up|0|||
130248685|NCT01524705|468872973|FG000|Overall Study|Adverse Event|2|||
130248686|NCT01524705|468872974|FG001|Overall Study|Adverse Event|0|||
130248687|NCT01524705|468872973|FG000|Overall Study|Death|1|||
130248688|NCT01524705|468872974|FG001|Overall Study|Death|0|||
130248689|NCT01524705|468872973|FG000|Overall Study|Lost to Follow-up|0|||
130248690|NCT01524705|468872974|FG001|Overall Study|Lost to Follow-up|1|||
130248691|NCT01524705|468872973|FG000|Overall Study|Withdrawal by Subject|0|||
130248692|NCT01524705|468872974|FG001|Overall Study|Withdrawal by Subject|1|||
130248693|NCT01524705|468872973|FG000|Overall Study|Pancreatic Cancer|0|||
130100861|NCT05553600|468327244|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
130248694|NCT01524705|468872974|FG001|Overall Study|Pancreatic Cancer|1|||
130248695|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
130248696|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
130248697|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
130248698|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
130248699|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
130248700|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
130248701|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
130248702|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
130248703|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
130248704|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
130248705|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
130248706|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
130248707|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
130248708|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
130248709|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
130248710|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
130248711|NCT01755156|468872975|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
130248712|NCT01755156|468872976|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
130248713|NCT01755156|468872975|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
130248714|NCT01755156|468872976|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
130248715|NCT01755156|468872975|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
130248716|NCT01755156|468872976|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
130248717|NCT00527748|468872979|FG000|Overall Study|Other|3|||
130248718|NCT01093885|468872981|FG000|Overall Study|Adverse Event|4|||
130248719|NCT01093885|468872981|FG000|Overall Study|Lost to Follow-up|1|||
130248720|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
130248721|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
130248722|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
130248723|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
130248724|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
130248725|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
130248726|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
130248727|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
130248728|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
130248729|NCT00292370|468872982|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
130248730|NCT00292370|468872983|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
130248731|NCT00292370|468872984|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
130248732|NCT00292370|468872982|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
130248733|NCT00292370|468872983|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
130248734|NCT00292370|468872984|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
130248735|NCT00292370|468872982|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
130248736|NCT00292370|468872983|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
130248737|NCT00292370|468872984|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
130248738|NCT02533674|468872985|FG000|Dose Level I|Progressive disease|1|||
130248739|NCT02533674|468872986|FG001|Dose Level I|Progressive disease|0|||
130248740|NCT02533674|468872987|FG002|Dose Level I|Progressive disease|0|||
130248741|NCT02533674|468872988|FG003|Dose Level I|Progressive disease|0|||
130248742|NCT02533674|468872989|FG004|Dose Level I|Progressive disease|0|||
130248743|NCT02533674|468872990|FG005|Dose Level I|Progressive disease|0|||
130248744|NCT02533674|468872991|FG006|Dose Level I|Progressive disease|0|||
130248745|NCT02533674|468872992|FG007|Dose Level I|Progressive disease|0|||
130248746|NCT02533674|468872985|FG000|Dose Level I|Withdrawal by Subject|1|||
130248747|NCT02533674|468872986|FG001|Dose Level I|Withdrawal by Subject|0|||
130248748|NCT02533674|468872987|FG002|Dose Level I|Withdrawal by Subject|0|||
130248749|NCT02533674|468872988|FG003|Dose Level I|Withdrawal by Subject|0|||
130248750|NCT02533674|468872989|FG004|Dose Level I|Withdrawal by Subject|0|||
130248751|NCT02533674|468872990|FG005|Dose Level I|Withdrawal by Subject|0|||
130248752|NCT02533674|468872991|FG006|Dose Level I|Withdrawal by Subject|0|||
130248753|NCT02533674|468872992|FG007|Dose Level I|Withdrawal by Subject|0|||
130248754|NCT02533674|468872985|FG000|Dose Level I|Physician Decision|1|||
130248755|NCT02533674|468872986|FG001|Dose Level I|Physician Decision|0|||
130248756|NCT02533674|468872987|FG002|Dose Level I|Physician Decision|0|||
130248757|NCT02533674|468872988|FG003|Dose Level I|Physician Decision|0|||
130248758|NCT02533674|468872989|FG004|Dose Level I|Physician Decision|0|||
130248759|NCT02533674|468872990|FG005|Dose Level I|Physician Decision|0|||
130248760|NCT02533674|468872991|FG006|Dose Level I|Physician Decision|0|||
130248761|NCT02533674|468872992|FG007|Dose Level I|Physician Decision|0|||
130248762|NCT02533674|468872985|FG000|Dose Level I|Death|1|||
130248763|NCT02533674|468872986|FG001|Dose Level I|Death|0|||
130248764|NCT02533674|468872987|FG002|Dose Level I|Death|0|||
130248765|NCT02533674|468872988|FG003|Dose Level I|Death|0|||
130248766|NCT02533674|468872989|FG004|Dose Level I|Death|0|||
130248767|NCT02533674|468872990|FG005|Dose Level I|Death|0|||
130248768|NCT02533674|468872991|FG006|Dose Level I|Death|0|||
130248769|NCT02533674|468872992|FG007|Dose Level I|Death|0|||
130248770|NCT02533674|468872985|FG000|Dose Level I|Never Treated|1|||
130248771|NCT02533674|468872986|FG001|Dose Level I|Never Treated|0|||
130030906|NCT06118385|468070564|FG004|Overall Study|Protocol Violation|0|||
130030907|NCT06118385|468070565|FG005|Overall Study|Protocol Violation|0|||
130248772|NCT02533674|468872987|FG002|Dose Level I|Never Treated|0|||
130248773|NCT02533674|468872988|FG003|Dose Level I|Never Treated|0|||
130248774|NCT02533674|468872989|FG004|Dose Level I|Never Treated|0|||
130248775|NCT02533674|468872990|FG005|Dose Level I|Never Treated|0|||
130248776|NCT02533674|468872991|FG006|Dose Level I|Never Treated|0|||
130248777|NCT02533674|468872992|FG007|Dose Level I|Never Treated|0|||
130248778|NCT02533674|468872985|FG000|Dose Level II|Progressive disease|0|||
130248779|NCT02533674|468872986|FG001|Dose Level II|Progressive disease|3|||
130248780|NCT02533674|468872987|FG002|Dose Level II|Progressive disease|0|||
130248781|NCT02533674|468872988|FG003|Dose Level II|Progressive disease|0|||
130248782|NCT02533674|468872989|FG004|Dose Level II|Progressive disease|0|||
130248783|NCT02533674|468872990|FG005|Dose Level II|Progressive disease|0|||
130248784|NCT02533674|468872991|FG006|Dose Level II|Progressive disease|0|||
130248785|NCT02533674|468872992|FG007|Dose Level II|Progressive disease|0|||
130248786|NCT02533674|468872985|FG000|Dose Level II|Withdrawal by Subject|0|||
130248787|NCT02533674|468872986|FG001|Dose Level II|Withdrawal by Subject|1|||
130248788|NCT02533674|468872987|FG002|Dose Level II|Withdrawal by Subject|0|||
130248789|NCT02533674|468872988|FG003|Dose Level II|Withdrawal by Subject|0|||
130248790|NCT02533674|468872989|FG004|Dose Level II|Withdrawal by Subject|0|||
130248791|NCT02533674|468872990|FG005|Dose Level II|Withdrawal by Subject|0|||
130248792|NCT02533674|468872991|FG006|Dose Level II|Withdrawal by Subject|0|||
130030908|NCT06118385|468070566|FG006|Overall Study|Protocol Violation|0|||
130030909|NCT06118385|468070567|FG007|Overall Study|Protocol Violation|0|||
130248793|NCT02533674|468872992|FG007|Dose Level II|Withdrawal by Subject|0|||
130248794|NCT02533674|468872985|FG000|Dose Level II|Treatment-related AE|0|||
130248795|NCT02533674|468872986|FG001|Dose Level II|Treatment-related AE|1|||
130248796|NCT02533674|468872987|FG002|Dose Level II|Treatment-related AE|0|||
130248797|NCT02533674|468872988|FG003|Dose Level II|Treatment-related AE|0|||
130248798|NCT02533674|468872989|FG004|Dose Level II|Treatment-related AE|0|||
130248799|NCT02533674|468872990|FG005|Dose Level II|Treatment-related AE|0|||
130248800|NCT02533674|468872991|FG006|Dose Level II|Treatment-related AE|0|||
130248801|NCT02533674|468872992|FG007|Dose Level II|Treatment-related AE|0|||
130248802|NCT02533674|468872985|FG000|Dose Level II|Physician Decision|0|||
130248803|NCT02533674|468872986|FG001|Dose Level II|Physician Decision|1|||
130030910|NCT06118385|468070568|FG008|Overall Study|Protocol Violation|1|||
130030911|NCT06118385|468070569|FG009|Overall Study|Protocol Violation|0|||
130248804|NCT02533674|468872987|FG002|Dose Level II|Physician Decision|0|||
130248805|NCT02533674|468872988|FG003|Dose Level II|Physician Decision|0|||
130248806|NCT02533674|468872989|FG004|Dose Level II|Physician Decision|0|||
130248807|NCT02533674|468872990|FG005|Dose Level II|Physician Decision|0|||
130248808|NCT02533674|468872991|FG006|Dose Level II|Physician Decision|0|||
130248809|NCT02533674|468872992|FG007|Dose Level II|Physician Decision|0|||
130248810|NCT02533674|468872985|FG000|Dose Level II|Non-treatment-related AE|0|||
130248811|NCT02533674|468872986|FG001|Dose Level II|Non-treatment-related AE|1|||
130248812|NCT02533674|468872987|FG002|Dose Level II|Non-treatment-related AE|0|||
130248813|NCT02533674|468872988|FG003|Dose Level II|Non-treatment-related AE|0|||
130248814|NCT02533674|468872989|FG004|Dose Level II|Non-treatment-related AE|0|||
130248815|NCT02533674|468872990|FG005|Dose Level II|Non-treatment-related AE|0|||
130248816|NCT02533674|468872991|FG006|Dose Level II|Non-treatment-related AE|0|||
130248817|NCT02533674|468872992|FG007|Dose Level II|Non-treatment-related AE|0|||
130248818|NCT02533674|468872985|FG000|Dose Level III|Progressive disease|0|||
130248819|NCT02533674|468872986|FG001|Dose Level III|Progressive disease|0|||
130248820|NCT02533674|468872987|FG002|Dose Level III|Progressive disease|2|||
130248821|NCT02533674|468872988|FG003|Dose Level III|Progressive disease|0|||
130248822|NCT02533674|468872989|FG004|Dose Level III|Progressive disease|0|||
130248823|NCT02533674|468872990|FG005|Dose Level III|Progressive disease|0|||
130248824|NCT02533674|468872991|FG006|Dose Level III|Progressive disease|0|||
130248825|NCT02533674|468872992|FG007|Dose Level III|Progressive disease|0|||
130248826|NCT02533674|468872985|FG000|Dose Level III|Withdrawal by Subject|0|||
130248827|NCT02533674|468872986|FG001|Dose Level III|Withdrawal by Subject|0|||
130030912|NCT06118385|468070570|FG010|Overall Study|Protocol Violation|0|||
130030913|NCT06118385|468070571|FG011|Overall Study|Protocol Violation|0|||
130248828|NCT02533674|468872987|FG002|Dose Level III|Withdrawal by Subject|1|||
130248829|NCT02533674|468872988|FG003|Dose Level III|Withdrawal by Subject|0|||
130248830|NCT02533674|468872989|FG004|Dose Level III|Withdrawal by Subject|0|||
130248831|NCT02533674|468872990|FG005|Dose Level III|Withdrawal by Subject|0|||
130248832|NCT02533674|468872991|FG006|Dose Level III|Withdrawal by Subject|0|||
130248833|NCT02533674|468872992|FG007|Dose Level III|Withdrawal by Subject|0|||
130248834|NCT02533674|468872985|FG000|Dose Level III|Treatment-related AE|0|||
130248835|NCT02533674|468872986|FG001|Dose Level III|Treatment-related AE|0|||
130030914|NCT06118385|468070560|FG000|Overall Study|Out-of-range blood tests|0|||
130030915|NCT06118385|468070561|FG001|Overall Study|Out-of-range blood tests|0|||
130248836|NCT02533674|468872987|FG002|Dose Level III|Treatment-related AE|1|||
130248837|NCT02533674|468872988|FG003|Dose Level III|Treatment-related AE|0|||
130248838|NCT02533674|468872989|FG004|Dose Level III|Treatment-related AE|0|||
130248839|NCT02533674|468872990|FG005|Dose Level III|Treatment-related AE|0|||
130248840|NCT02533674|468872991|FG006|Dose Level III|Treatment-related AE|0|||
130248841|NCT02533674|468872992|FG007|Dose Level III|Treatment-related AE|0|||
130248842|NCT02533674|468872985|FG000|Dose Level IV|Progressive disease|0|||
130248843|NCT02533674|468872986|FG001|Dose Level IV|Progressive disease|0|||
130248844|NCT02533674|468872987|FG002|Dose Level IV|Progressive disease|0|||
130248845|NCT02533674|468872988|FG003|Dose Level IV|Progressive disease|3|||
130248846|NCT02533674|468872989|FG004|Dose Level IV|Progressive disease|0|||
130248847|NCT02533674|468872990|FG005|Dose Level IV|Progressive disease|0|||
130248848|NCT02533674|468872991|FG006|Dose Level IV|Progressive disease|0|||
130248849|NCT02533674|468872992|FG007|Dose Level IV|Progressive disease|0|||
130248850|NCT02533674|468872985|FG000|Dose Level IV|Withdrawal by Subject|0|||
130030916|NCT06118385|468070562|FG002|Overall Study|Out-of-range blood tests|0|||
130030917|NCT06118385|468070563|FG003|Overall Study|Out-of-range blood tests|0|||
130030918|NCT06118385|468070564|FG004|Overall Study|Out-of-range blood tests|0|||
130030919|NCT06118385|468070565|FG005|Overall Study|Out-of-range blood tests|0|||
130030920|NCT06118385|468070566|FG006|Overall Study|Out-of-range blood tests|0|||
130030921|NCT06118385|468070567|FG007|Overall Study|Out-of-range blood tests|0|||
130030922|NCT06118385|468070568|FG008|Overall Study|Out-of-range blood tests|1|||
130030923|NCT06118385|468070569|FG009|Overall Study|Out-of-range blood tests|0|||
130030924|NCT06118385|468070570|FG010|Overall Study|Out-of-range blood tests|0|||
130030925|NCT06118385|468070571|FG011|Overall Study|Out-of-range blood tests|0|||
130030926|NCT01323478|468070572|FG000|Overall Study|Adverse Event|7|||
130030927|NCT01323478|468070572|FG000|Overall Study|Lack of Efficacy|4|||
130030928|NCT01323478|468070572|FG000|Overall Study|Non-compliance With Study Product|3|||
130030929|NCT01323478|468070572|FG000|Overall Study|Protocol Violation|1|||
130030930|NCT01323478|468070572|FG000|Overall Study|Withdrawal of Consent|1|||
130030931|NCT01323478|468070572|FG000|Overall Study|Administrative or Other Reasons|8|||
130030932|NCT02411448|468070573|FG000|Overall Study|Withdrawal by Subject|1|||
130030933|NCT02411448|468070574|FG001|Overall Study|Withdrawal by Subject|14|||
130030934|NCT02411448|468070575|FG002|Overall Study|Withdrawal by Subject|9|||
130030935|NCT02411448|468070573|FG000|Overall Study|Other|0|||
130030936|NCT02411448|468070574|FG001|Overall Study|Other|2|||
130030937|NCT02411448|468070575|FG002|Overall Study|Other|0|||
130030938|NCT02411448|468070573|FG000|Overall Study|Did not receive study treatment|0|||
130030939|NCT02411448|468070574|FG001|Overall Study|Did not receive study treatment|3|||
130030940|NCT02411448|468070575|FG002|Overall Study|Did not receive study treatment|0|||
130030941|NCT02411448|468070573|FG000|Overall Study|Alive on study treatment|3|||
130030942|NCT02411448|468070574|FG001|Overall Study|Alive on study treatment|64|||
130030943|NCT02411448|468070575|FG002|Overall Study|Alive on study treatment|43|||
130030944|NCT02771522|468070578|FG000|Overall Study|Lost to Follow-up|3|||
130030945|NCT02771522|468070578|FG000|Overall Study|Withdrawal by Subject|2|||
130030946|NCT02771522|468070578|FG000|Overall Study|No white spot lesions|3|||
130030947|NCT05655377|468070579|FG000|Overall Study|Withdrawal by Subject|2|||
130030948|NCT01256177|468070580|FG000|Overall Study|Withdrawal by Subject|23|||
130030949|NCT01256177|468070581|FG001|Overall Study|Withdrawal by Subject|22|||
130030950|NCT01256177|468070580|FG000|Overall Study|Lost to Follow-up|2|||
130030951|NCT01256177|468070581|FG001|Overall Study|Lost to Follow-up|2|||
130030952|NCT01256177|468070580|FG000|Overall Study|Adverse Event|8|||
130030953|NCT01256177|468070581|FG001|Overall Study|Adverse Event|9|||
130030954|NCT01256177|468070580|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130030955|NCT01256177|468070581|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130030956|NCT01256177|468070580|FG000|Overall Study|Condition under Investigation Worsened|1|||
130030957|NCT01256177|468070581|FG001|Overall Study|Condition under Investigation Worsened|0|||
130030958|NCT01256177|468070580|FG000|Overall Study|Lack of Efficacy|11|||
130030959|NCT01256177|468070581|FG001|Overall Study|Lack of Efficacy|2|||
130030960|NCT01256177|468070580|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
130030961|NCT01256177|468070581|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
130030962|NCT03624946|468070585|FG000|Overall Study|Lost to Follow-up|0|||
130030963|NCT03624946|468070586|FG001|Overall Study|Lost to Follow-up|1|||
130248851|NCT02533674|468872986|FG001|Dose Level IV|Withdrawal by Subject|0|||
130030964|NCT01728779|468070587|FG000|Overall Study|Withdrawal by Subject|1|||
130030965|NCT00624520|468070588|FG000|Overall Study|Withdrawal by Subject|12|||
130030966|NCT00624520|468070589|FG001|Overall Study|Withdrawal by Subject|7|||
130030967|NCT00624520|468070588|FG000|Overall Study|Death|0|||
130030968|NCT00624520|468070589|FG001|Overall Study|Death|1|||
130100862|NCT05553600|468327245|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
130248852|NCT02533674|468872987|FG002|Dose Level IV|Withdrawal by Subject|0|||
130248853|NCT02533674|468872988|FG003|Dose Level IV|Withdrawal by Subject|1|||
130248854|NCT02533674|468872989|FG004|Dose Level IV|Withdrawal by Subject|0|||
130030969|NCT01925209|468070590|FG000|Treatment Epoch|Physician Decision|1|||
130030970|NCT01925209|468070591|FG001|Treatment Epoch|Physician Decision|0|||
130030971|NCT01925209|468070592|FG002|Treatment Epoch|Physician Decision|0|||
130030972|NCT01925209|468070593|FG003|Treatment Epoch|Physician Decision|0|||
130248855|NCT02533674|468872990|FG005|Dose Level IV|Withdrawal by Subject|0|||
130248856|NCT02533674|468872991|FG006|Dose Level IV|Withdrawal by Subject|0|||
130248857|NCT02533674|468872992|FG007|Dose Level IV|Withdrawal by Subject|0|||
130248858|NCT02533674|468872985|FG000|Dose Level IV|Physician Decision|0|||
130248859|NCT02533674|468872986|FG001|Dose Level IV|Physician Decision|0|||
130248860|NCT02533674|468872987|FG002|Dose Level IV|Physician Decision|0|||
130248861|NCT02533674|468872988|FG003|Dose Level IV|Physician Decision|1|||
130248862|NCT02533674|468872989|FG004|Dose Level IV|Physician Decision|0|||
130248863|NCT02533674|468872990|FG005|Dose Level IV|Physician Decision|0|||
130248864|NCT02533674|468872991|FG006|Dose Level IV|Physician Decision|0|||
130248865|NCT02533674|468872992|FG007|Dose Level IV|Physician Decision|0|||
130248866|NCT02533674|468872985|FG000|Dose Level V|Progressive disease|0|||
130248867|NCT02533674|468872986|FG001|Dose Level V|Progressive disease|0|||
130248868|NCT02533674|468872987|FG002|Dose Level V|Progressive disease|0|||
130248869|NCT02533674|468872988|FG003|Dose Level V|Progressive disease|0|||
130248870|NCT02533674|468872989|FG004|Dose Level V|Progressive disease|3|||
130248871|NCT02533674|468872990|FG005|Dose Level V|Progressive disease|0|||
130248872|NCT02533674|468872991|FG006|Dose Level V|Progressive disease|0|||
130248873|NCT02533674|468872992|FG007|Dose Level V|Progressive disease|0|||
130248874|NCT02533674|468872985|FG000|Dose Level V|Withdrawal by Subject|0|||
130248875|NCT02533674|468872986|FG001|Dose Level V|Withdrawal by Subject|0|||
130248876|NCT02533674|468872987|FG002|Dose Level V|Withdrawal by Subject|0|||
130248877|NCT02533674|468872988|FG003|Dose Level V|Withdrawal by Subject|0|||
130248878|NCT02533674|468872989|FG004|Dose Level V|Withdrawal by Subject|1|||
130248879|NCT02533674|468872990|FG005|Dose Level V|Withdrawal by Subject|0|||
130248880|NCT02533674|468872991|FG006|Dose Level V|Withdrawal by Subject|0|||
130248881|NCT02533674|468872992|FG007|Dose Level V|Withdrawal by Subject|0|||
130248882|NCT02533674|468872985|FG000|Dose Level V|Physician Decision|0|||
130248883|NCT02533674|468872986|FG001|Dose Level V|Physician Decision|0|||
130248884|NCT02533674|468872987|FG002|Dose Level V|Physician Decision|0|||
130248885|NCT02533674|468872988|FG003|Dose Level V|Physician Decision|0|||
130248886|NCT02533674|468872989|FG004|Dose Level V|Physician Decision|1|||
130248887|NCT02533674|468872990|FG005|Dose Level V|Physician Decision|0|||
130248888|NCT02533674|468872991|FG006|Dose Level V|Physician Decision|0|||
130248889|NCT02533674|468872992|FG007|Dose Level V|Physician Decision|0|||
130248890|NCT02533674|468872985|FG000|Dose Level VI|Progressive disease|0|||
130248891|NCT02533674|468872986|FG001|Dose Level VI|Progressive disease|0|||
130248892|NCT02533674|468872987|FG002|Dose Level VI|Progressive disease|0|||
130248893|NCT02533674|468872988|FG003|Dose Level VI|Progressive disease|0|||
130248894|NCT02533674|468872989|FG004|Dose Level VI|Progressive disease|0|||
130248895|NCT02533674|468872990|FG005|Dose Level VI|Progressive disease|7|||
130248896|NCT02533674|468872991|FG006|Dose Level VI|Progressive disease|0|||
130248897|NCT02533674|468872992|FG007|Dose Level VI|Progressive disease|0|||
130248898|NCT02533674|468872985|FG000|Dose Level VI|Withdrawal by Subject|0|||
130248899|NCT02533674|468872986|FG001|Dose Level VI|Withdrawal by Subject|0|||
130248900|NCT02533674|468872987|FG002|Dose Level VI|Withdrawal by Subject|0|||
130248901|NCT02533674|468872988|FG003|Dose Level VI|Withdrawal by Subject|0|||
130248902|NCT02533674|468872989|FG004|Dose Level VI|Withdrawal by Subject|0|||
130248903|NCT02533674|468872990|FG005|Dose Level VI|Withdrawal by Subject|1|||
130100863|NCT05553600|468327246|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
130248904|NCT02533674|468872991|FG006|Dose Level VI|Withdrawal by Subject|0|||
130248905|NCT02533674|468872992|FG007|Dose Level VI|Withdrawal by Subject|0|||
130248906|NCT02533674|468872985|FG000|Dose Level VI|Treatment-related AE|0|||
130248907|NCT02533674|468872986|FG001|Dose Level VI|Treatment-related AE|0|||
130248908|NCT02533674|468872987|FG002|Dose Level VI|Treatment-related AE|0|||
130248909|NCT02533674|468872988|FG003|Dose Level VI|Treatment-related AE|0|||
130248910|NCT02533674|468872989|FG004|Dose Level VI|Treatment-related AE|0|||
130248911|NCT02533674|468872990|FG005|Dose Level VI|Treatment-related AE|1|||
130248912|NCT02533674|468872991|FG006|Dose Level VI|Treatment-related AE|0|||
130248913|NCT02533674|468872992|FG007|Dose Level VI|Treatment-related AE|0|||
130248914|NCT02533674|468872985|FG000|Dose Level VII|Progressive disease|0|||
130248915|NCT02533674|468872986|FG001|Dose Level VII|Progressive disease|0|||
130248916|NCT02533674|468872987|FG002|Dose Level VII|Progressive disease|0|||
130248917|NCT02533674|468872988|FG003|Dose Level VII|Progressive disease|0|||
130248918|NCT02533674|468872989|FG004|Dose Level VII|Progressive disease|0|||
130248919|NCT02533674|468872990|FG005|Dose Level VII|Progressive disease|0|||
130248920|NCT02533674|468872991|FG006|Dose Level VII|Progressive disease|10|||
130248921|NCT02533674|468872992|FG007|Dose Level VII|Progressive disease|0|||
130248922|NCT02533674|468872985|FG000|Dose Level VII|Withdrawal by Subject|0|||
130248923|NCT02533674|468872986|FG001|Dose Level VII|Withdrawal by Subject|0|||
130248924|NCT02533674|468872987|FG002|Dose Level VII|Withdrawal by Subject|0|||
130248925|NCT02533674|468872988|FG003|Dose Level VII|Withdrawal by Subject|0|||
130248926|NCT02533674|468872989|FG004|Dose Level VII|Withdrawal by Subject|0|||
130248927|NCT02533674|468872990|FG005|Dose Level VII|Withdrawal by Subject|0|||
130248928|NCT02533674|468872991|FG006|Dose Level VII|Withdrawal by Subject|3|||
130248929|NCT02533674|468872992|FG007|Dose Level VII|Withdrawal by Subject|0|||
130248930|NCT02533674|468872985|FG000|Dose Level VII|Treatment-related AE|0|||
130248931|NCT02533674|468872986|FG001|Dose Level VII|Treatment-related AE|0|||
130248932|NCT02533674|468872987|FG002|Dose Level VII|Treatment-related AE|0|||
130248933|NCT02533674|468872988|FG003|Dose Level VII|Treatment-related AE|0|||
130248934|NCT02533674|468872989|FG004|Dose Level VII|Treatment-related AE|0|||
130248935|NCT02533674|468872990|FG005|Dose Level VII|Treatment-related AE|0|||
130248936|NCT02533674|468872991|FG006|Dose Level VII|Treatment-related AE|1|||
130248937|NCT02533674|468872992|FG007|Dose Level VII|Treatment-related AE|0|||
130248938|NCT02533674|468872985|FG000|Dose Level VII|Death|0|||
130248939|NCT02533674|468872986|FG001|Dose Level VII|Death|0|||
130248940|NCT02533674|468872987|FG002|Dose Level VII|Death|0|||
130248941|NCT02533674|468872988|FG003|Dose Level VII|Death|0|||
130248942|NCT02533674|468872989|FG004|Dose Level VII|Death|0|||
130248943|NCT02533674|468872990|FG005|Dose Level VII|Death|0|||
130248944|NCT02533674|468872991|FG006|Dose Level VII|Death|2|||
130248945|NCT02533674|468872992|FG007|Dose Level VII|Death|0|||
130248946|NCT02533674|468872985|FG000|Dose Level VIII|Progressive disease|0|||
130248947|NCT02533674|468872986|FG001|Dose Level VIII|Progressive disease|0|||
130248948|NCT02533674|468872987|FG002|Dose Level VIII|Progressive disease|0|||
130248949|NCT02533674|468872988|FG003|Dose Level VIII|Progressive disease|0|||
130248950|NCT02533674|468872989|FG004|Dose Level VIII|Progressive disease|0|||
130248951|NCT02533674|468872990|FG005|Dose Level VIII|Progressive disease|0|||
130248952|NCT02533674|468872991|FG006|Dose Level VIII|Progressive disease|0|||
130248953|NCT02533674|468872992|FG007|Dose Level VIII|Progressive disease|3|||
130248954|NCT02533674|468872985|FG000|Dose Level VIII|Withdrawal by Subject|0|||
130248955|NCT02533674|468872986|FG001|Dose Level VIII|Withdrawal by Subject|0|||
130248956|NCT02533674|468872987|FG002|Dose Level VIII|Withdrawal by Subject|0|||
130248957|NCT02533674|468872988|FG003|Dose Level VIII|Withdrawal by Subject|0|||
130248958|NCT02533674|468872989|FG004|Dose Level VIII|Withdrawal by Subject|0|||
130248959|NCT02533674|468872990|FG005|Dose Level VIII|Withdrawal by Subject|0|||
130248960|NCT02533674|468872991|FG006|Dose Level VIII|Withdrawal by Subject|0|||
130248961|NCT02533674|468872992|FG007|Dose Level VIII|Withdrawal by Subject|1|||
130248962|NCT02533674|468872985|FG000|Dose Level VIII|Treatment-related AE|0|||
130248963|NCT02533674|468872986|FG001|Dose Level VIII|Treatment-related AE|0|||
130248964|NCT02533674|468872987|FG002|Dose Level VIII|Treatment-related AE|0|||
130248965|NCT02533674|468872988|FG003|Dose Level VIII|Treatment-related AE|0|||
130248966|NCT02533674|468872989|FG004|Dose Level VIII|Treatment-related AE|0|||
130248967|NCT02533674|468872990|FG005|Dose Level VIII|Treatment-related AE|0|||
130248968|NCT02533674|468872991|FG006|Dose Level VIII|Treatment-related AE|0|||
130248969|NCT02533674|468872992|FG007|Dose Level VIII|Treatment-related AE|1|||
130248970|NCT02533674|468872985|FG000|Dose Level VIII|Never treated|0|||
130248971|NCT02533674|468872986|FG001|Dose Level VIII|Never treated|0|||
130248972|NCT02533674|468872987|FG002|Dose Level VIII|Never treated|0|||
130248973|NCT02533674|468872988|FG003|Dose Level VIII|Never treated|0|||
130248974|NCT02533674|468872989|FG004|Dose Level VIII|Never treated|0|||
130248975|NCT02533674|468872990|FG005|Dose Level VIII|Never treated|0|||
130248976|NCT02533674|468872991|FG006|Dose Level VIII|Never treated|0|||
130248977|NCT02533674|468872992|FG007|Dose Level VIII|Never treated|1|||
130248978|NCT01560988|468872993|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
130248979|NCT01560988|468872994|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
130248980|NCT01560988|468872993|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
130248981|NCT01560988|468872994|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
130248982|NCT01560988|468872993|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
130248983|NCT01560988|468872994|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
130248984|NCT01346709|468872995|FG000|Overall Study|Protocol Violation|35|||
130248985|NCT01346709|468872995|FG000|Overall Study|Lost to Follow-up|31|||
130030973|NCT01925209|468070590|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
130030974|NCT01925209|468070591|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
130030975|NCT01925209|468070592|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
130030976|NCT01925209|468070593|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
130030977|NCT01925209|468070590|FG000|Treatment Epoch|Death|1|||
130030978|NCT01925209|468070591|FG001|Treatment Epoch|Death|0|||
130030979|NCT01925209|468070592|FG002|Treatment Epoch|Death|0|||
130248986|NCT01346709|468872995|FG000|Overall Study|Missing data in candidate risk factor|285|||
130248987|NCT01292473|468872999|FG000|Overall Study|Adverse Event|1|||
130248988|NCT01292473|468873000|FG001|Overall Study|Adverse Event|0|||
130248989|NCT01292473|468873001|FG002|Overall Study|Adverse Event|1|||
130248990|NCT01292473|468873002|FG003|Overall Study|Adverse Event|1|||
130248991|NCT01292473|468872999|FG000|Overall Study|Lost to Follow-up|1|||
130248992|NCT01292473|468873000|FG001|Overall Study|Lost to Follow-up|1|||
130248993|NCT01292473|468873001|FG002|Overall Study|Lost to Follow-up|2|||
130248994|NCT01292473|468873002|FG003|Overall Study|Lost to Follow-up|2|||
130248995|NCT01292473|468872999|FG000|Overall Study|Withdrawal by Subject|3|||
130248996|NCT01292473|468873000|FG001|Overall Study|Withdrawal by Subject|4|||
130248997|NCT01292473|468873001|FG002|Overall Study|Withdrawal by Subject|3|||
130248998|NCT01292473|468873002|FG003|Overall Study|Withdrawal by Subject|3|||
130248999|NCT01292473|468872999|FG000|Overall Study|Physician Decision|0|||
130249000|NCT01292473|468873000|FG001|Overall Study|Physician Decision|1|||
130249001|NCT01292473|468873001|FG002|Overall Study|Physician Decision|0|||
130249002|NCT01292473|468873002|FG003|Overall Study|Physician Decision|0|||
130249003|NCT01292473|468872999|FG000|Overall Study|Disease Progression|0|||
130249004|NCT01292473|468873000|FG001|Overall Study|Disease Progression|1|||
130249005|NCT01292473|468873001|FG002|Overall Study|Disease Progression|3|||
130249006|NCT01292473|468873002|FG003|Overall Study|Disease Progression|6|||
130249007|NCT02123511|468873007|FG000|Overall Study|Cancelled treatment|1|||
130249008|NCT02123511|468873008|FG001|Overall Study|Cancelled treatment|0|||
130249009|NCT02123511|468873007|FG000|Overall Study|Incomplete data|1|||
130249010|NCT02123511|468873008|FG001|Overall Study|Incomplete data|3|||
130249011|NCT02123511|468873007|FG000|Overall Study|Ineligible|0|||
130249012|NCT02123511|468873008|FG001|Overall Study|Ineligible|1|||
130249013|NCT04821245|468873009|FG000|Overall Study|Withdrawal by Subject|3|||
130249014|NCT04821245|468873009|FG000|Overall Study|Physician Decision|1|||
130249015|NCT04821245|468873009|FG000|Overall Study|Protocol Violation|5|||
130249016|NCT01975285|468873019|FG000|Overall Study|Failed Block and follow up|2|||
130249017|NCT01975285|468873020|FG001|Overall Study|Failed Block and follow up|2|||
130030980|NCT01925209|468070593|FG003|Treatment Epoch|Death|0|||
130100864|NCT05553600|468327247|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
130249018|NCT00576407|468873025|FG000|Overall Study|Death|7|||
130100865|NCT05553600|468327244|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
130249019|NCT00576407|468873025|FG000|Overall Study|Physician Decision|1|||
130249020|NCT00756444|468873026|FG000|Overall Study|Adverse Event|1|||
130249021|NCT00756444|468873027|FG001|Overall Study|Adverse Event|1|||
130249022|NCT00756444|468873026|FG000|Overall Study|Withdrawal by Subject|6|||
130249023|NCT00756444|468873027|FG001|Overall Study|Withdrawal by Subject|8|||
130249024|NCT00756444|468873026|FG000|Overall Study|Lost to Follow-up|0|||
130030981|NCT01925209|468070590|FG000|Treatment Epoch|Protocol deviation|0|||
130030982|NCT01925209|468070591|FG001|Treatment Epoch|Protocol deviation|0|||
129884726|NCT01651936|467538652|FG002|Base Study|Study terminated by sponsor|0|||
130100866|NCT05553600|468327245|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
130100867|NCT05553600|468327246|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
130100868|NCT05553600|468327247|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
130100869|NCT05553600|468327244|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
130100870|NCT05553600|468327245|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
130100871|NCT05553600|468327246|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
130100872|NCT05553600|468327247|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
130100873|NCT05553600|468327244|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
130100874|NCT05553600|468327245|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
130100875|NCT05553600|468327246|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
130100876|NCT05553600|468327247|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
130100877|NCT05553600|468327244|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
130100878|NCT05553600|468327245|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
130100879|NCT05553600|468327246|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
130100880|NCT05553600|468327247|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
130249025|NCT00756444|468873027|FG001|Overall Study|Lost to Follow-up|1|||
130249026|NCT00756444|468873026|FG000|Overall Study|Death|5|||
130249027|NCT00756444|468873027|FG001|Overall Study|Death|4|||
130249028|NCT00756444|468873026|FG000|Overall Study|Disease Progression|2|||
130249029|NCT00756444|468873027|FG001|Overall Study|Disease Progression|7|||
129884727|NCT01651936|467538650|FG000|Extension Study|Lack of Efficacy|0|||
129884728|NCT01651936|467538651|FG001|Extension Study|Lack of Efficacy|0|||
129884729|NCT01651936|467538652|FG002|Extension Study|Lack of Efficacy|1|||
129884730|NCT01651936|467538650|FG000|Extension Study|Study terminated by sponsor|0|||
129884731|NCT01651936|467538651|FG001|Extension Study|Study terminated by sponsor|0|||
129884732|NCT01651936|467538652|FG002|Extension Study|Study terminated by sponsor|13|||
129884733|NCT03044353|467538653|FG000|Overall Study|Adverse Event|0|||
129884734|NCT03044353|467538654|FG001|Overall Study|Adverse Event|1|||
129884735|NCT03044353|467538655|FG002|Overall Study|Adverse Event|0|||
129884736|NCT02141659|467538662|FG000|Overall Study|Major Protocol Deviation|0|||
129884737|NCT02141659|467538663|FG001|Overall Study|Major Protocol Deviation|1|||
129884738|NCT02141659|467538664|FG002|Overall Study|Major Protocol Deviation|0|||
129884739|NCT02141659|467538665|FG003|Overall Study|Major Protocol Deviation|0|||
129884740|NCT02141659|467538666|FG004|Overall Study|Major Protocol Deviation|0|||
129884741|NCT02141659|467538667|FG005|Overall Study|Major Protocol Deviation|0|||
129884742|NCT02141659|467538662|FG000|Overall Study|Lack of Efficacy|0|||
129884743|NCT02141659|467538663|FG001|Overall Study|Lack of Efficacy|0|||
129884744|NCT02141659|467538664|FG002|Overall Study|Lack of Efficacy|0|||
130249030|NCT00756444|468873026|FG000|Overall Study|Ineligibility Determined|1|||
130249031|NCT00756444|468873027|FG001|Overall Study|Ineligibility Determined|0|||
130249032|NCT03071965|468873028|FG000|Overall Study|Adverse Event|0|||
130249033|NCT03071965|468873029|FG001|Overall Study|Adverse Event|0|||
130249034|NCT03071965|468873030|FG002|Overall Study|Adverse Event|1|||
130249035|NCT03071965|468873031|FG003|Overall Study|Adverse Event|0|||
130249036|NCT03071965|468873028|FG000|Overall Study|Death|0|||
130249037|NCT03071965|468873029|FG001|Overall Study|Death|0|||
130249038|NCT03071965|468873030|FG002|Overall Study|Death|1|||
130249039|NCT03071965|468873031|FG003|Overall Study|Death|1|||
130249040|NCT03071965|468873028|FG000|Overall Study|COVID-19|0|||
130249041|NCT03071965|468873029|FG001|Overall Study|COVID-19|1|||
129884745|NCT02141659|467538665|FG003|Overall Study|Lack of Efficacy|0|||
129884746|NCT02141659|467538666|FG004|Overall Study|Lack of Efficacy|0|||
130100881|NCT04930536|468327248|FG000|Overall Study|Adverse Event|1|||
130100882|NCT04930536|468327249|FG001|Overall Study|Adverse Event|0|||
130100883|NCT04930536|468327248|FG000|Overall Study|Disease Progression|2|||
130100884|NCT04930536|468327249|FG001|Overall Study|Disease Progression|0|||
130100885|NCT04930536|468327248|FG000|Overall Study|Patient Decision|4|||
130100886|NCT04930536|468327249|FG001|Overall Study|Patient Decision|2|||
130249042|NCT03071965|468873030|FG002|Overall Study|COVID-19|0|||
130249043|NCT03071965|468873031|FG003|Overall Study|COVID-19|1|||
130249044|NCT03071965|468873028|FG000|Overall Study|Other Health Reason|0|||
130249045|NCT03071965|468873029|FG001|Overall Study|Other Health Reason|0|||
130249046|NCT03071965|468873030|FG002|Overall Study|Other Health Reason|0|||
130249047|NCT03071965|468873031|FG003|Overall Study|Other Health Reason|1|||
130249048|NCT05587998|468873032|FG000|Overall Study|Withdrawal by Subject|1|||
129884747|NCT02141659|467538667|FG005|Overall Study|Lack of Efficacy|1|||
129884748|NCT02141659|467538662|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
129884749|NCT02141659|467538663|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
129884750|NCT02141659|467538664|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
129884751|NCT02141659|467538665|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
130249049|NCT05587998|468873033|FG001|Overall Study|Withdrawal by Subject|1|||
130249050|NCT05587998|468873032|FG000|Overall Study|Not treated|3|||
130249051|NCT05587998|468873033|FG001|Overall Study|Not treated|1|||
130249052|NCT05587998|468873032|FG000|Overall Study|Non-compliance with study procedures|0|||
130249053|NCT05587998|468873033|FG001|Overall Study|Non-compliance with study procedures|1|||
130030983|NCT01925209|468070592|FG002|Treatment Epoch|Protocol deviation|1|||
130030984|NCT01925209|468070593|FG003|Treatment Epoch|Protocol deviation|1|||
130030985|NCT01925209|468070590|FG000|Treatment Epoch|Withdrawal by Subject|4|||
130030986|NCT01925209|468070591|FG001|Treatment Epoch|Withdrawal by Subject|3|||
130030987|NCT01925209|468070592|FG002|Treatment Epoch|Withdrawal by Subject|3|||
130030988|NCT01925209|468070593|FG003|Treatment Epoch|Withdrawal by Subject|2|||
130030989|NCT01925209|468070590|FG000|Treatment Epoch|Adverse Event|3|||
130249054|NCT03225989|468873034|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
130249055|NCT03225989|468873035|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
130249056|NCT03225989|468873036|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
130249057|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
130249058|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
130249059|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
130249060|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130249061|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
130249062|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
130249063|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
130249064|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
130249065|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
130249066|NCT03225989|468873034|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
130249067|NCT03225989|468873035|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
130249068|NCT03225989|468873036|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
130249069|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
130249070|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
130249071|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
130249072|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
130249073|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
130249074|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
129884752|NCT02141659|467538666|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
130100887|NCT04930536|468327248|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
130030990|NCT01925209|468070591|FG001|Treatment Epoch|Adverse Event|5|||
130030991|NCT01925209|468070592|FG002|Treatment Epoch|Adverse Event|3|||
130030992|NCT01925209|468070593|FG003|Treatment Epoch|Adverse Event|1|||
130030993|NCT01925209|468070590|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
130030994|NCT01925209|468070591|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
130030995|NCT01925209|468070592|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
130030996|NCT01925209|468070593|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
130030997|NCT01925209|468070590|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
130100888|NCT04930536|468327249|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
130249075|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
130249076|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
130249077|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
130249078|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
130249079|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
130249080|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
130249081|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
130249082|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
130249083|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
130249084|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
130249085|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
130249086|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
130249087|NCT03225989|468873034|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
130249088|NCT03225989|468873035|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
130249089|NCT03225989|468873036|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
130249090|NCT00601107|468873037|FG000|Overall Study|Adverse Event|0|||
130249091|NCT00601107|468873038|FG001|Overall Study|Adverse Event|1|||
130249092|NCT00601107|468873039|FG002|Overall Study|Adverse Event|3|||
130249093|NCT00601107|468873040|FG003|Overall Study|Adverse Event|0|||
130249094|NCT00601107|468873037|FG000|Overall Study|Withdrawal by Subject|5|||
130249095|NCT00601107|468873038|FG001|Overall Study|Withdrawal by Subject|4|||
130249096|NCT00601107|468873039|FG002|Overall Study|Withdrawal by Subject|7|||
130249097|NCT00601107|468873040|FG003|Overall Study|Withdrawal by Subject|4|||
130249098|NCT00601107|468873037|FG000|Overall Study|Lost to Follow-up|3|||
130249099|NCT00601107|468873038|FG001|Overall Study|Lost to Follow-up|3|||
130249100|NCT00601107|468873039|FG002|Overall Study|Lost to Follow-up|0|||
130249101|NCT00601107|468873040|FG003|Overall Study|Lost to Follow-up|3|||
130249102|NCT00601107|468873037|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130249103|NCT00601107|468873038|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130249104|NCT00601107|468873039|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
130249105|NCT00601107|468873040|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
130249106|NCT00601107|468873037|FG000|Overall Study|Worsening of Psoriasis|4|||
130249107|NCT00601107|468873038|FG001|Overall Study|Worsening of Psoriasis|1|||
130249108|NCT00601107|468873039|FG002|Overall Study|Worsening of Psoriasis|1|||
130249109|NCT00601107|468873040|FG003|Overall Study|Worsening of Psoriasis|4|||
130249110|NCT00601107|468873037|FG000|Overall Study|Undefined|1|||
130249111|NCT00601107|468873038|FG001|Overall Study|Undefined|0|||
130249112|NCT00601107|468873039|FG002|Overall Study|Undefined|1|||
130249113|NCT00601107|468873040|FG003|Overall Study|Undefined|0|||
130249114|NCT01181128|468873041|FG000|Overall Study|Withdrawal by Subject|2|||
130249115|NCT01181128|468873042|FG001|Overall Study|Withdrawal by Subject|2|||
130249116|NCT01181128|468873043|FG002|Overall Study|Withdrawal by Subject|0|||
129800245|NCT04755283|467236270|FG002|Overall Study|Death|34|||
130030998|NCT01925209|468070591|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
130249117|NCT01181128|468873041|FG000|Overall Study|Death|1|||
130249118|NCT01181128|468873042|FG001|Overall Study|Death|0|||
130030999|NCT01925209|468070592|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
130031000|NCT01925209|468070593|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
130249119|NCT01181128|468873043|FG002|Overall Study|Death|0|||
130249120|NCT01181128|468873041|FG000|Overall Study|Physician Decision|2|||
130249121|NCT01181128|468873042|FG001|Overall Study|Physician Decision|0|||
130249122|NCT01181128|468873043|FG002|Overall Study|Physician Decision|0|||
130249123|NCT01181128|468873041|FG000|Overall Study|Adverse Event|0|||
130249124|NCT01181128|468873042|FG001|Overall Study|Adverse Event|2|||
130249125|NCT01181128|468873043|FG002|Overall Study|Adverse Event|0|||
130249126|NCT01181128|468873041|FG000|Overall Study|Other|1|||
130249127|NCT01181128|468873042|FG001|Overall Study|Other|1|||
130249128|NCT01181128|468873043|FG002|Overall Study|Other|1|||
130249129|NCT01362270|468873044|FG000|Overall Study|Withdrawal by Subject|1|||
130249130|NCT01362270|468873045|FG001|Overall Study|Withdrawal by Subject|0|||
130249131|NCT01362270|468873044|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
130249132|NCT01362270|468873045|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
130249133|NCT01362270|468873044|FG000|Overall Study|Met excl. criteria before 1st session|1|||
130249134|NCT01362270|468873045|FG001|Overall Study|Met excl. criteria before 1st session|1|||
130249135|NCT04595370|468873048|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
130249136|NCT04595370|468873049|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249137|NCT04595370|468873050|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249138|NCT04595370|468873051|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249139|NCT04595370|468873052|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130249140|NCT04595370|468873053|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
130031001|NCT01925209|468070590|FG000|Follow-up|Adverse Event|1|||
130249141|NCT04595370|468873048|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130031002|NCT01925209|468070591|FG001|Follow-up|Adverse Event|4|||
130031003|NCT01925209|468070592|FG002|Follow-up|Adverse Event|0|||
130249142|NCT04595370|468873049|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249143|NCT04595370|468873050|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
130249144|NCT04595370|468873051|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249145|NCT04595370|468873052|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249146|NCT04595370|468873053|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
130249147|NCT04595370|468873048|FG000|Overall Study|Adverse Event|0|||
130249148|NCT04595370|468873049|FG001|Overall Study|Adverse Event|4|||
130249149|NCT04595370|468873050|FG002|Overall Study|Adverse Event|3|||
130249150|NCT04595370|468873051|FG003|Overall Study|Adverse Event|1|||
130249151|NCT04595370|468873052|FG004|Overall Study|Adverse Event|1|||
130249152|NCT04595370|468873053|FG005|Overall Study|Adverse Event|1|||
130249153|NCT04595370|468873048|FG000|Overall Study|Withdrawal of Consent|1|||
130249154|NCT04595370|468873049|FG001|Overall Study|Withdrawal of Consent|1|||
130249155|NCT04595370|468873050|FG002|Overall Study|Withdrawal of Consent|1|||
130249156|NCT04595370|468873051|FG003|Overall Study|Withdrawal of Consent|0|||
130249157|NCT04595370|468873052|FG004|Overall Study|Withdrawal of Consent|0|||
130249158|NCT04595370|468873053|FG005|Overall Study|Withdrawal of Consent|0|||
130249159|NCT04595370|468873048|FG000|Overall Study|Death|0|||
130249160|NCT04595370|468873049|FG001|Overall Study|Death|1|||
130249161|NCT04595370|468873050|FG002|Overall Study|Death|0|||
130249162|NCT04595370|468873051|FG003|Overall Study|Death|0|||
130249163|NCT04595370|468873052|FG004|Overall Study|Death|1|||
130249164|NCT04595370|468873053|FG005|Overall Study|Death|0|||
130249165|NCT04595370|468873048|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249166|NCT04595370|468873049|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249167|NCT04595370|468873050|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130249168|NCT04595370|468873051|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249169|NCT04595370|468873052|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249170|NCT04595370|468873053|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130249171|NCT04595370|468873048|FG000|Overall Study|Withdrawal by Subject|0|||
130249172|NCT04595370|468873049|FG001|Overall Study|Withdrawal by Subject|0|||
130249173|NCT04595370|468873050|FG002|Overall Study|Withdrawal by Subject|1|||
130249174|NCT04595370|468873051|FG003|Overall Study|Withdrawal by Subject|0|||
130249175|NCT04595370|468873052|FG004|Overall Study|Withdrawal by Subject|2|||
130249176|NCT04595370|468873053|FG005|Overall Study|Withdrawal by Subject|0|||
130249177|NCT04595370|468873048|FG000|Overall Study|Lost to Follow-up|0|||
130249178|NCT04595370|468873049|FG001|Overall Study|Lost to Follow-up|0|||
130249179|NCT04595370|468873050|FG002|Overall Study|Lost to Follow-up|0|||
130249180|NCT04595370|468873051|FG003|Overall Study|Lost to Follow-up|0|||
130249181|NCT04595370|468873052|FG004|Overall Study|Lost to Follow-up|1|||
130249182|NCT04595370|468873053|FG005|Overall Study|Lost to Follow-up|0|||
130031004|NCT01925209|468070593|FG003|Follow-up|Adverse Event|1|||
130249183|NCT04595370|468873048|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130249184|NCT04595370|468873049|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
130249185|NCT04595370|468873050|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
130249186|NCT04595370|468873051|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130249187|NCT04595370|468873052|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
130249188|NCT04595370|468873053|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
130249189|NCT01341990|468873054|FG000|Overall Study|Adverse Event|0|||
130249190|NCT01341990|468873055|FG001|Overall Study|Adverse Event|1|||
130249191|NCT01341990|468873054|FG000|Overall Study|Torn Study Lens|1|||
130249192|NCT01341990|468873055|FG001|Overall Study|Torn Study Lens|0|||
130249193|NCT01341990|468873054|FG000|Overall Study|Withdrawal by Subject|2|||
130249194|NCT01341990|468873055|FG001|Overall Study|Withdrawal by Subject|0|||
130249195|NCT01751685|468873057|FG000|6-mo Followup|Missed study visit|1|||
130249196|NCT01751685|468873058|FG001|6-mo Followup|Missed study visit|0|||
130249197|NCT01751685|468873057|FG000|6-mo Followup|Withdrawal by Subject|2|||
130249198|NCT01751685|468873058|FG001|6-mo Followup|Withdrawal by Subject|2|||
130249199|NCT01751685|468873057|FG000|6-mo Followup|Lost to Follow-up|0|||
130249200|NCT01751685|468873058|FG001|6-mo Followup|Lost to Follow-up|1|||
130249201|NCT01751685|468873057|FG000|12-mo Followup|Lost to Follow-up|5|||
130249202|NCT01751685|468873058|FG001|12-mo Followup|Lost to Follow-up|0|||
130249203|NCT04401293|468873059|FG000|Overall Study|Withdrawal by Subject|1|||
130249204|NCT04401293|468873060|FG001|Overall Study|Withdrawal by Subject|3|||
130249205|NCT00694161|468873061|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
130249206|NCT00694161|468873061|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
130249207|NCT00694161|468873061|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
130249208|NCT00837330|468873062|FG000|Overall Study|Lost to Follow-up|1|||
130249209|NCT00837330|468873063|FG001|Overall Study|Lost to Follow-up|3|||
130249210|NCT01117350|468873071|FG000|Comparative Period|Not Treated|5|||
130249211|NCT01117350|468873072|FG001|Comparative Period|Not Treated|8|||
130249212|NCT01117350|468873071|FG000|Comparative Period|Adverse Event|6|||
130249213|NCT01117350|468873072|FG001|Comparative Period|Adverse Event|33|||
130249214|NCT01117350|468873071|FG000|Comparative Period|Lost to Follow-up|11|||
130249215|NCT01117350|468873072|FG001|Comparative Period|Lost to Follow-up|7|||
130249216|NCT01117350|468873071|FG000|Comparative Period|Withdrawal by Subject|9|||
130249217|NCT01117350|468873072|FG001|Comparative Period|Withdrawal by Subject|13|||
130249218|NCT01117350|468873071|FG000|Comparative Period|Protocol Violation|8|||
130249219|NCT01117350|468873072|FG001|Comparative Period|Protocol Violation|12|||
130249220|NCT01117350|468873071|FG000|Comparative Period|Lack of Efficacy|1|||
130249221|NCT01117350|468873072|FG001|Comparative Period|Lack of Efficacy|0|||
130249222|NCT01117350|468873071|FG000|Comparative Period|Physician Decision|0|||
130249223|NCT01117350|468873072|FG001|Comparative Period|Physician Decision|1|||
130249224|NCT01117350|468873071|FG000|Comparative Period|Move to another city/country|2|||
130249225|NCT01117350|468873072|FG001|Comparative Period|Move to another city/country|1|||
130249226|NCT01117350|468873071|FG000|Extension Period|Not included in extension, not treated|0|||
130249227|NCT01117350|468873072|FG001|Extension Period|Not included in extension, not treated|50|||
130249228|NCT01117350|468873071|FG000|Extension Period|Adverse Event|0|||
130249229|NCT01117350|468873072|FG001|Extension Period|Adverse Event|2|||
130249230|NCT01117350|468873071|FG000|Extension Period|Protocol Violation|0|||
130249231|NCT01117350|468873072|FG001|Extension Period|Protocol Violation|2|||
130031005|NCT01925209|468070590|FG000|Follow-up|Physician Decision|0|||
130249232|NCT01117350|468873071|FG000|Extension Period|Lost to Follow-up|0|||
130249233|NCT01117350|468873072|FG001|Extension Period|Lost to Follow-up|2|||
130249234|NCT01117350|468873071|FG000|Extension Period|Withdrawal by Subject|0|||
129884753|NCT02141659|467538667|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
129884754|NCT01927731|467538668|FG000|Overall Study|Graft Failure|1|||
129884755|NCT01927731|467538669|FG001|Overall Study|Graft Failure|2|||
129884756|NCT01927731|467538668|FG000|Overall Study|Physician Decision|2|||
129884757|NCT01927731|467538669|FG001|Overall Study|Physician Decision|3|||
129884758|NCT01927731|467538668|FG000|Overall Study|Withdrawal by Subject|0|||
129884759|NCT01927731|467538669|FG001|Overall Study|Withdrawal by Subject|2|||
129884760|NCT01927731|467538668|FG000|Overall Study|Death|0|||
129884761|NCT01927731|467538669|FG001|Overall Study|Death|3|||
129884762|NCT01388530|467538672|FG000|Overall Study|Lost to Follow-up|5|||
129884763|NCT00305864|467538673|FG000|Overall Study|Ineligible / No protocol treatment|0|||
129884764|NCT00305864|467538674|FG001|Overall Study|Ineligible / No protocol treatment|1|||
129884765|NCT00305864|467538675|FG002|Overall Study|Ineligible / No protocol treatment|1|||
129884766|NCT00305864|467538676|FG003|Overall Study|Ineligible / No protocol treatment|13|||
129884767|NCT02836613|467538677|FG000|Overall Study|Accidental drowning|1|||
129884768|NCT02836613|467538678|FG001|Overall Study|Accidental drowning|0|||
129884769|NCT02836613|467538677|FG000|Overall Study|Lost to Follow-up|0|||
129884770|NCT02836613|467538678|FG001|Overall Study|Lost to Follow-up|1|||
129884771|NCT02836613|467538677|FG000|Overall Study|Withdrawal by Subject|0|||
129884772|NCT02836613|467538678|FG001|Overall Study|Withdrawal by Subject|2|||
129884773|NCT03881059|467538679|FG000|Treatment Period - Part A|Adverse Event|1|||
129884774|NCT03881059|467538680|FG001|Treatment Period - Part A|Adverse Event|3|||
129884775|NCT03881059|467538681|FG002|Treatment Period - Part A|Adverse Event|4|||
129884776|NCT03881059|467538679|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
129884777|NCT03881059|467538680|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
129884778|NCT03881059|467538681|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
129884779|NCT03881059|467538679|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
129884780|NCT03881059|467538680|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
129884781|NCT03881059|467538681|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
129884782|NCT03881059|467538679|FG000|Treatment Period - Part A|Other reasons|2|||
129884783|NCT03881059|467538680|FG001|Treatment Period - Part A|Other reasons|1|||
129884784|NCT03881059|467538681|FG002|Treatment Period - Part A|Other reasons|0|||
129884785|NCT03881059|467538679|FG000|Treatment Period - Part B|Adverse Event|0|||
129884786|NCT03881059|467538680|FG001|Treatment Period - Part B|Adverse Event|0|||
129884787|NCT03881059|467538681|FG002|Treatment Period - Part B|Adverse Event|3|||
129884788|NCT03881059|467538679|FG000|Treatment Period - Part B|Death|0|||
129884789|NCT03881059|467538680|FG001|Treatment Period - Part B|Death|1|||
129884790|NCT03881059|467538681|FG002|Treatment Period - Part B|Death|1|||
129884791|NCT03881059|467538679|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
129884792|NCT03881059|467538680|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
129884793|NCT03881059|467538681|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
129884794|NCT03881059|467538679|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
129884795|NCT03881059|467538680|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
129884796|NCT03881059|467538681|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
129884797|NCT03881059|467538679|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
129884798|NCT03881059|467538680|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
129884799|NCT03881059|467538681|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
129884800|NCT03881059|467538679|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
129884801|NCT03881059|467538680|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
129884802|NCT03881059|467538681|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
129884803|NCT03881059|467538679|FG000|Treatment Period - Part B|Other reasons|4|||
129884804|NCT03881059|467538680|FG001|Treatment Period - Part B|Other reasons|3|||
129884805|NCT03881059|467538681|FG002|Treatment Period - Part B|Other reasons|3|||
129884806|NCT05284019|467538682|FG000|Overall Study|Study terminated|2|||
129884807|NCT05284019|467538683|FG001|Overall Study|Study terminated|2|||
129884808|NCT05284019|467538684|FG002|Overall Study|Study terminated|2|||
129884809|NCT05284019|467538685|FG003|Overall Study|Study terminated|5|||
129884810|NCT05284019|467538686|FG004|Overall Study|Study terminated|15|||
129884811|NCT05284019|467538682|FG000|Overall Study|Withdrawal by Subject|0|||
129884812|NCT05284019|467538683|FG001|Overall Study|Withdrawal by Subject|0|||
129884813|NCT05284019|467538684|FG002|Overall Study|Withdrawal by Subject|0|||
129884814|NCT05284019|467538685|FG003|Overall Study|Withdrawal by Subject|1|||
129884815|NCT05284019|467538686|FG004|Overall Study|Withdrawal by Subject|1|||
129884816|NCT05284019|467538682|FG000|Overall Study|Lost to Follow-up|1|||
129884817|NCT05284019|467538683|FG001|Overall Study|Lost to Follow-up|0|||
129884818|NCT05284019|467538684|FG002|Overall Study|Lost to Follow-up|0|||
129884819|NCT05284019|467538685|FG003|Overall Study|Lost to Follow-up|2|||
129884820|NCT05284019|467538686|FG004|Overall Study|Lost to Follow-up|1|||
129884821|NCT02065570|467538687|FG000|Induction Study|Adverse Event|5|||
129884822|NCT02065570|467538688|FG001|Induction Study|Adverse Event|12|||
129884823|NCT02065570|467538689|FG002|Induction Study|Adverse Event|0|||
129884824|NCT02065570|467538690|FG003|Induction Study|Adverse Event|0|||
129884825|NCT02065570|467538687|FG000|Induction Study|Withdrawal by Subject|2|||
129884826|NCT02065570|467538688|FG001|Induction Study|Withdrawal by Subject|3|||
129884827|NCT02065570|467538689|FG002|Induction Study|Withdrawal by Subject|0|||
129884828|NCT02065570|467538690|FG003|Induction Study|Withdrawal by Subject|0|||
129884829|NCT02065570|467538687|FG000|Induction Study|Lost to Follow-up|1|||
129884830|NCT02065570|467538688|FG001|Induction Study|Lost to Follow-up|1|||
129884831|NCT02065570|467538689|FG002|Induction Study|Lost to Follow-up|0|||
129884832|NCT02065570|467538690|FG003|Induction Study|Lost to Follow-up|0|||
129884833|NCT02065570|467538687|FG000|Induction Study|Other, Not Specified|6|||
129884834|NCT02065570|467538688|FG001|Induction Study|Other, Not Specified|5|||
129884835|NCT02065570|467538689|FG002|Induction Study|Other, Not Specified|0|||
129884836|NCT02065570|467538690|FG003|Induction Study|Other, Not Specified|0|||
129884837|NCT02065570|467538687|FG000|Maintenance Study|Adverse Event|0|||
129884838|NCT02065570|467538688|FG001|Maintenance Study|Adverse Event|0|||
129884839|NCT02065570|467538689|FG002|Maintenance Study|Adverse Event|8|||
129884840|NCT02065570|467538690|FG003|Maintenance Study|Adverse Event|8|||
129884841|NCT02065570|467538687|FG000|Maintenance Study|Withdrawal by Subject|0|||
129884842|NCT02065570|467538688|FG001|Maintenance Study|Withdrawal by Subject|0|||
129884843|NCT02065570|467538689|FG002|Maintenance Study|Withdrawal by Subject|1|||
129884844|NCT02065570|467538690|FG003|Maintenance Study|Withdrawal by Subject|4|||
129884845|NCT02065570|467538687|FG000|Maintenance Study|Lost to Follow-up|0|||
129884846|NCT02065570|467538688|FG001|Maintenance Study|Lost to Follow-up|0|||
129884847|NCT02065570|467538689|FG002|Maintenance Study|Lost to Follow-up|2|||
129884848|NCT02065570|467538690|FG003|Maintenance Study|Lost to Follow-up|2|||
129884849|NCT02065570|467538687|FG000|Maintenance Study|Other, Not Specified|0|||
129884850|NCT02065570|467538688|FG001|Maintenance Study|Other, Not Specified|0|||
129884851|NCT02065570|467538689|FG002|Maintenance Study|Other, Not Specified|11|||
129884852|NCT02065570|467538690|FG003|Maintenance Study|Other, Not Specified|5|||
129884853|NCT03382600|467538694|FG000|Overall Study|Adverse Event|3|||
129884854|NCT03382600|467538695|FG001|Overall Study|Adverse Event|3|||
130249235|NCT01117350|468873072|FG001|Extension Period|Withdrawal by Subject|3|||
130249236|NCT01117350|468873071|FG000|Extension Period|Lack of Efficacy|0|||
130249237|NCT01117350|468873072|FG001|Extension Period|Lack of Efficacy|2|||
130249238|NCT01117350|468873071|FG000|Extension Period|Inclusion criteria not respected|0|||
130249239|NCT01117350|468873072|FG001|Extension Period|Inclusion criteria not respected|1|||
130249240|NCT01117350|468873071|FG000|Extension Period|Prohibited medication|0|||
130249241|NCT01117350|468873072|FG001|Extension Period|Prohibited medication|1|||
130249242|NCT00450749|468873083|FG000|Overall Study|Withdrawal by Subject|0|||
130249243|NCT00450749|468873084|FG001|Overall Study|Withdrawal by Subject|0|||
130249244|NCT00450749|468873085|FG002|Overall Study|Withdrawal by Subject|2|||
130249245|NCT00450749|468873083|FG000|Overall Study|Noncompliant|0|||
130249246|NCT00450749|468873084|FG001|Overall Study|Noncompliant|1|||
130249247|NCT00450749|468873085|FG002|Overall Study|Noncompliant|0|||
130249248|NCT01245049|468873086|FG000|Overall Study|Migrated/moved from study area|0|||
130249249|NCT01245049|468873087|FG001|Overall Study|Migrated/moved from study area|1|||
130249250|NCT01245049|468873086|FG000|Overall Study|Withdrawal by Subject|0|||
130249251|NCT01245049|468873087|FG001|Overall Study|Withdrawal by Subject|1|||
130249252|NCT01245049|468873086|FG000|Overall Study|Lost to Follow-up|1|||
130249253|NCT01245049|468873087|FG001|Overall Study|Lost to Follow-up|2|||
130249254|NCT01027754|468874902|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
130249255|NCT01027754|468874903|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
129884855|NCT03382600|467538694|FG000|Overall Study|Clinical Disease Progression|2|||
129884856|NCT03382600|467538695|FG001|Overall Study|Clinical Disease Progression|4|||
129884857|NCT03382600|467538694|FG000|Overall Study|Radiological Progression|40|||
129884858|NCT03382600|467538695|FG001|Overall Study|Radiological Progression|31|||
130249256|NCT01027754|468874902|FG000|Overall Study|Withdrawal by Subject|0|||
129884859|NCT03382600|467538694|FG000|Overall Study|Withdrawal by Subject|0|||
129884860|NCT03382600|467538695|FG001|Overall Study|Withdrawal by Subject|1|||
130031006|NCT01925209|468070591|FG001|Follow-up|Physician Decision|0|||
130249257|NCT01027754|468874903|FG001|Overall Study|Withdrawal by Subject|5|||
130249258|NCT01213251|468874904|FG000|Overall Study|Death|2|||
130249259|NCT01213251|468874905|FG001|Overall Study|Death|1|||
130249260|NCT01213251|468874906|FG002|Overall Study|Death|2|||
129884861|NCT03382600|467538694|FG000|Overall Study|Other|9|||
129884862|NCT03382600|467538695|FG001|Overall Study|Other|7|||
129884863|NCT01000376|467538696|FG000|Cycle 1 Day 1|Adverse Event|1|||
129884864|NCT01000376|467538697|FG001|Cycle 1 Day 1|Adverse Event|0|||
129884865|NCT01000376|467538696|FG000|Cycle 1 Day 1|Progressive Disease|1|||
130249261|NCT01213251|468874904|FG000|Overall Study|Exit|3|||
130031007|NCT01925209|468070592|FG002|Follow-up|Physician Decision|1|||
130031008|NCT01925209|468070593|FG003|Follow-up|Physician Decision|0|||
130031009|NCT01925209|468070590|FG000|Follow-up|Non-compliance with study treatment|0|||
130249262|NCT01213251|468874905|FG001|Overall Study|Exit|2|||
130249263|NCT01213251|468874906|FG002|Overall Study|Exit|8|||
130249264|NCT01213251|468874904|FG000|Overall Study|Protocol Violation|1|||
130249265|NCT01213251|468874905|FG001|Overall Study|Protocol Violation|1|||
130249266|NCT01213251|468874906|FG002|Overall Study|Protocol Violation|0|||
130249267|NCT01213251|468874904|FG000|Overall Study|Missed 18-Month Follow-up|0|||
130249268|NCT01213251|468874905|FG001|Overall Study|Missed 18-Month Follow-up|0|||
130249269|NCT01213251|468874906|FG002|Overall Study|Missed 18-Month Follow-up|1|||
130249270|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
130249271|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249272|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249273|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249274|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249275|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
130249276|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
130249277|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
130031010|NCT01925209|468070591|FG001|Follow-up|Non-compliance with study treatment|0|||
130249278|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249279|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
130249280|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249281|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249282|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249283|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
130249284|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
130249285|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249286|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249287|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249288|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249289|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249290|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
130249291|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
130249292|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249293|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249294|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249295|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130249296|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
130249297|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
130031011|NCT01925209|468070592|FG002|Follow-up|Non-compliance with study treatment|0|||
130249298|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249299|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
130249300|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249301|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249302|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249303|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249304|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
130249305|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249306|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249307|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249308|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249309|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
130249310|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
130249311|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
130249312|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249313|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130249314|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130249315|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249316|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249317|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
130249318|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
130249319|NCT01557244|468874907|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
130249320|NCT01557244|468874908|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249321|NCT01557244|468874909|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
130249322|NCT01557244|468874910|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249323|NCT01557244|468874911|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130031012|NCT01925209|468070593|FG003|Follow-up|Non-compliance with study treatment|1|||
130249324|NCT01557244|468874912|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249325|NCT01557244|468874913|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
130249326|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130249327|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130249328|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249329|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249330|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249331|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
130249332|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
130249333|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
130249334|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
130249335|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249336|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249337|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249338|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249339|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
130249340|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249341|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249342|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249343|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
130249344|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249345|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249346|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
130249347|NCT01557244|468874907|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
130249348|NCT01557244|468874908|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
130249349|NCT01557244|468874909|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249350|NCT01557244|468874910|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249351|NCT01557244|468874911|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249352|NCT01557244|468874912|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249353|NCT01557244|468874913|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
130249354|NCT03312114|468874914|FG000|Overall Study|All the five enrolled dropped out of the|5|||
130249355|NCT01313676|468874915|FG000|Overall Study|Adverse Event|395|||
130249356|NCT01313676|468874916|FG001|Overall Study|Adverse Event|365|||
130249357|NCT01313676|468874917|FG002|Overall Study|Adverse Event|372|||
130249358|NCT01313676|468874918|FG003|Overall Study|Adverse Event|333|||
130249359|NCT01313676|468874915|FG000|Overall Study|Lack of Efficacy|98|||
130249360|NCT01313676|468874916|FG001|Overall Study|Lack of Efficacy|90|||
130249361|NCT01313676|468874917|FG002|Overall Study|Lack of Efficacy|65|||
130249362|NCT01313676|468874918|FG003|Overall Study|Lack of Efficacy|46|||
130249363|NCT01313676|468874915|FG000|Overall Study|Protocol Violation|37|||
130249364|NCT01313676|468874916|FG001|Overall Study|Protocol Violation|44|||
130249365|NCT01313676|468874917|FG002|Overall Study|Protocol Violation|46|||
130249366|NCT01313676|468874918|FG003|Overall Study|Protocol Violation|44|||
130249367|NCT01313676|468874915|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
130249368|NCT01313676|468874916|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
130249369|NCT01313676|468874917|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
130249370|NCT01313676|468874918|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
130031013|NCT01925209|468070590|FG000|Follow-up|Withdrawal by Subject|0|||
130031014|NCT01925209|468070591|FG001|Follow-up|Withdrawal by Subject|2|||
130031015|NCT01925209|468070592|FG002|Follow-up|Withdrawal by Subject|0|||
130249371|NCT01313676|468874915|FG000|Overall Study|Study Closed/terminated|7|||
130031016|NCT01925209|468070593|FG003|Follow-up|Withdrawal by Subject|2|||
130031017|NCT02796755|468070594|FG000|Overall Study|Adverse Event|2|||
130249372|NCT01313676|468874916|FG001|Overall Study|Study Closed/terminated|6|||
130249373|NCT01313676|468874917|FG002|Overall Study|Study Closed/terminated|9|||
130249374|NCT01313676|468874918|FG003|Overall Study|Study Closed/terminated|9|||
130249375|NCT01313676|468874915|FG000|Overall Study|Lost to Follow-up|0|||
130249376|NCT01313676|468874916|FG001|Overall Study|Lost to Follow-up|0|||
130249377|NCT01313676|468874917|FG002|Overall Study|Lost to Follow-up|1|||
130249378|NCT01313676|468874918|FG003|Overall Study|Lost to Follow-up|0|||
130249379|NCT01313676|468874915|FG000|Overall Study|Physician Decision|53|||
130249380|NCT01313676|468874916|FG001|Overall Study|Physician Decision|64|||
130031018|NCT02796755|468070595|FG001|Overall Study|Adverse Event|0|||
130031019|NCT04398732|468070599|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
130031020|NCT00556426|468070600|FG000|Overall Study|Withdrawal by Subject|3|||
130249381|NCT01313676|468874917|FG002|Overall Study|Physician Decision|62|||
130249382|NCT01313676|468874918|FG003|Overall Study|Physician Decision|48|||
130249383|NCT01313676|468874915|FG000|Overall Study|Decision by Participant or Proxy|643|||
130249384|NCT01313676|468874916|FG001|Overall Study|Decision by Participant or Proxy|527|||
130249385|NCT01313676|468874917|FG002|Overall Study|Decision by Participant or Proxy|515|||
130249386|NCT01313676|468874918|FG003|Overall Study|Decision by Participant or Proxy|492|||
130249387|NCT01313676|468874915|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
130249388|NCT01313676|468874916|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
130031021|NCT00556426|468070600|FG000|Overall Study|Death|6|||
130031022|NCT01596257|468070602|FG000|Overall Study|Inadequate Collection|23|||
130031023|NCT01596257|468070603|FG001|Overall Study|Inadequate Collection|19|||
130249389|NCT01313676|468874917|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
130249390|NCT01313676|468874918|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
130249391|NCT01313676|468874915|FG000|Overall Study|Investigator Site Closed|12|||
130249392|NCT01313676|468874916|FG001|Overall Study|Investigator Site Closed|11|||
130031024|NCT02347631|468070607|FG000|First Intervention (2 Months)|Adverse Event|1|||
130031025|NCT02347631|468070608|FG001|First Intervention (2 Months)|Adverse Event|1|||
130249393|NCT01313676|468874917|FG002|Overall Study|Investigator Site Closed|15|||
130249394|NCT01313676|468874918|FG003|Overall Study|Investigator Site Closed|10|||
130249395|NCT01313676|468874915|FG000|Overall Study|Missing|1|||
130249396|NCT01313676|468874916|FG001|Overall Study|Missing|1|||
130249397|NCT01313676|468874917|FG002|Overall Study|Missing|1|||
130249398|NCT01313676|468874918|FG003|Overall Study|Missing|0|||
130249399|NCT00944645|468874919|FG000|Period 2|Adverse Event|1|||
130249400|NCT00944645|468874920|FG001|Period 2|Adverse Event|0|||
130249401|NCT00944645|468874919|FG000|Period 2|Lost to Follow-up|0|||
130249402|NCT00944645|468874920|FG001|Period 2|Lost to Follow-up|3|||
130249403|NCT00944645|468874919|FG000|Period 2|Withdrawal by Subject|7|||
130249404|NCT00944645|468874920|FG001|Period 2|Withdrawal by Subject|6|||
130249405|NCT03537729|468874921|FG000|Overall Study|Death|2|||
130249406|NCT03537729|468874922|FG001|Overall Study|Death|2|||
130249407|NCT03537729|468874923|FG002|Overall Study|Death|7|||
130249408|NCT03537729|468874921|FG000|Overall Study|Withdrawal by Subject|3|||
130249409|NCT03537729|468874922|FG001|Overall Study|Withdrawal by Subject|3|||
130249410|NCT03537729|468874923|FG002|Overall Study|Withdrawal by Subject|0|||
130249411|NCT03537729|468874921|FG000|Overall Study|Subject Moved|8|||
130249412|NCT03537729|468874922|FG001|Overall Study|Subject Moved|5|||
130249413|NCT03537729|468874923|FG002|Overall Study|Subject Moved|4|||
130249414|NCT03537729|468874921|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
130249415|NCT03537729|468874922|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
130249416|NCT03537729|468874923|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
130249417|NCT03537729|468874921|FG000|Overall Study|COVID-19 Site Restrictions|11|||
130249418|NCT03537729|468874922|FG001|Overall Study|COVID-19 Site Restrictions|15|||
130249419|NCT03537729|468874923|FG002|Overall Study|COVID-19 Site Restrictions|18|||
130249420|NCT03537729|468874921|FG000|Overall Study|Decline in Health|5|||
130249421|NCT03537729|468874922|FG001|Overall Study|Decline in Health|9|||
130249422|NCT03537729|468874923|FG002|Overall Study|Decline in Health|4|||
130249423|NCT03537729|468874921|FG000|Overall Study|Determined Ineligible|0|||
130249424|NCT03537729|468874922|FG001|Overall Study|Determined Ineligible|0|||
130249425|NCT03537729|468874923|FG002|Overall Study|Determined Ineligible|1|||
130249426|NCT02562040|468874925|FG000|Overall Study|Lost to Follow-up|20|||
130249427|NCT02562040|468874926|FG001|Overall Study|Lost to Follow-up|28|||
130249428|NCT02562040|468874925|FG000|Overall Study|Withdrawal by Subject|8|||
130249429|NCT02562040|468874926|FG001|Overall Study|Withdrawal by Subject|7|||
130249430|NCT02562040|468874925|FG000|Overall Study|Adverse Event|1|||
130249431|NCT02562040|468874926|FG001|Overall Study|Adverse Event|0|||
130249432|NCT01902303|468874927|FG000|Overall Study|Adverse Event|0|||
130249433|NCT01902303|468874928|FG001|Overall Study|Adverse Event|1|||
130031026|NCT02347631|468070607|FG000|First Intervention (2 Months)|Pregnancy|1|||
130249434|NCT01902303|468874927|FG000|Overall Study|Lost to Follow-up|0|||
130249435|NCT01902303|468874928|FG001|Overall Study|Lost to Follow-up|1|||
130249436|NCT01902303|468874927|FG000|Overall Study|Protocol Violation|2|||
130031027|NCT02347631|468070608|FG001|First Intervention (2 Months)|Pregnancy|0|||
130249437|NCT01902303|468874928|FG001|Overall Study|Protocol Violation|2|||
130249438|NCT01902303|468874927|FG000|Overall Study|subject lost investigational product|0|||
130249439|NCT01902303|468874928|FG001|Overall Study|subject lost investigational product|1|||
130249440|NCT01902303|468874927|FG000|Overall Study|Did not develop a cold sore|21|||
130249441|NCT01902303|468874928|FG001|Overall Study|Did not develop a cold sore|19|||
130249442|NCT02821000|468874929|FG000|Overall Study|Death|89|||
130249443|NCT02821000|468874929|FG000|Overall Study|Sponsor Decision|12|||
130249444|NCT02821000|468874929|FG000|Overall Study|Withdrawal by Subject|2|||
130249445|NCT00326495|468874930|FG000|Overall Study|Switched to alternative treatment|1|||
130249446|NCT00326495|468874930|FG000|Overall Study|Disease progression before treatment|1|||
130249447|NCT00326495|468874930|FG000|Overall Study|Refused further treatment|2|||
130249448|NCT00326495|468874930|FG000|Overall Study|Subject off study before assessment|1|||
130249449|NCT04359680|468874931|FG000|Overall Study|Withdrawal by Subject|29|||
130249450|NCT04359680|468874932|FG001|Overall Study|Withdrawal by Subject|24|||
130249451|NCT04359680|468874931|FG000|Overall Study|Adverse Event|6|||
130249452|NCT04359680|468874932|FG001|Overall Study|Adverse Event|2|||
130249453|NCT04359680|468874931|FG000|Overall Study|Lost to Follow-up|56|||
130249454|NCT04359680|468874932|FG001|Overall Study|Lost to Follow-up|59|||
130249455|NCT04359680|468874931|FG000|Overall Study|Protocol Violation|3|||
130249456|NCT04359680|468874932|FG001|Overall Study|Protocol Violation|5|||
130249457|NCT04359680|468874931|FG000|Overall Study|Physician Decision|1|||
130249458|NCT04359680|468874932|FG001|Overall Study|Physician Decision|1|||
130249459|NCT04359680|468874931|FG000|Overall Study|Sponsor Decision|0|||
130249460|NCT04359680|468874932|FG001|Overall Study|Sponsor Decision|1|||
130249461|NCT01654250|468874933|FG000|Overall Study|Lost to Follow-up|1|||
130249462|NCT01654250|468874934|FG001|Overall Study|Lost to Follow-up|0|||
130249463|NCT01862029|468874935|FG000|Overall Study|Physician Decision|1|||
130249464|NCT01530256|468874937|FG000|Overall Study|Death|2|||
130249465|NCT02004275|468874938|FG000|Phase 1|Ineligible|0|||
130249466|NCT02004275|468874939|FG001|Phase 1|Ineligible|0|||
130249467|NCT02004275|468874940|FG002|Phase 1|Ineligible|0|||
130249468|NCT02004275|468874941|FG003|Phase 1|Ineligible|1|||
130249469|NCT02004275|468874942|FG004|Phase 1|Ineligible|1|||
130249470|NCT02004275|468874943|FG005|Phase 1|Ineligible|0|||
130249471|NCT02004275|468874938|FG000|Phase 1|Protocol Violation|0|||
130249472|NCT02004275|468874939|FG001|Phase 1|Protocol Violation|0|||
130249473|NCT02004275|468874940|FG002|Phase 1|Protocol Violation|0|||
130249474|NCT02004275|468874941|FG003|Phase 1|Protocol Violation|1|||
130249475|NCT02004275|468874942|FG004|Phase 1|Protocol Violation|0|||
130249476|NCT02004275|468874943|FG005|Phase 1|Protocol Violation|5|||
130249477|NCT02004275|468874938|FG000|Phase 2 Part 1|Ineligible|6|||
130249478|NCT02004275|468874939|FG001|Phase 2 Part 1|Ineligible|9|||
130249479|NCT02004275|468874940|FG002|Phase 2 Part 1|Ineligible|0|||
130249480|NCT02004275|468874941|FG003|Phase 2 Part 1|Ineligible|0|||
130249481|NCT02004275|468874942|FG004|Phase 2 Part 1|Ineligible|0|||
130249482|NCT02004275|468874943|FG005|Phase 2 Part 1|Ineligible|0|||
130249483|NCT02004275|468874938|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
130249484|NCT02004275|468874939|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
130249485|NCT02004275|468874940|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
130249486|NCT02004275|468874941|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
130249487|NCT02004275|468874942|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
130249488|NCT02004275|468874943|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
130249489|NCT02595437|468874945|FG000|Triferic Via IV|Withdrawal by Subject|1|||
130249490|NCT04914000|468874952|FG000|Overall Study|Lost to Follow-up|8|||
130249491|NCT04914000|468874952|FG000|Overall Study|Withdrawal by Subject|1|||
130249492|NCT01429623|468874953|FG000|Overall Study|Death|1|||
130249493|NCT01429623|468874954|FG001|Overall Study|Death|0|||
130249494|NCT01429623|468874953|FG000|Overall Study|Adverse Event|7|||
130249495|NCT01429623|468874954|FG001|Overall Study|Adverse Event|14|||
130249496|NCT01429623|468874953|FG000|Overall Study|Withdrawal by Subject|19|||
130249497|NCT01429623|468874954|FG001|Overall Study|Withdrawal by Subject|13|||
130249498|NCT01429623|468874953|FG000|Overall Study|Physician Decision|2|||
130249499|NCT01429623|468874954|FG001|Overall Study|Physician Decision|3|||
130249500|NCT01429623|468874953|FG000|Overall Study|Protocol Violation|3|||
130249501|NCT01429623|468874954|FG001|Overall Study|Protocol Violation|2|||
130249502|NCT01429623|468874953|FG000|Overall Study|Assorted|1|||
130249503|NCT01429623|468874954|FG001|Overall Study|Assorted|2|||
130249504|NCT01429623|468874953|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
130249505|NCT01429623|468874954|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
130249506|NCT01429623|468874953|FG000|Overall Study|No post baseline data|4|||
130249507|NCT01429623|468874954|FG001|Overall Study|No post baseline data|4|||
130249508|NCT01896986|468874955|FG000|Overall Study|samples lost|14|||
130249509|NCT01896986|468874956|FG001|Overall Study|samples lost|23|||
130249510|NCT01750281|468874957|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
130249511|NCT01750281|468874958|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
130249512|NCT01750281|468874959|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
130249513|NCT01750281|468874957|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
130249514|NCT01750281|468874958|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
130249515|NCT01750281|468874959|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
130249516|NCT01750281|468874957|FG000|Overall Study|Did not receive treatment|0|||
130249517|NCT01750281|468874958|FG001|Overall Study|Did not receive treatment|1|||
130249518|NCT01750281|468874959|FG002|Overall Study|Did not receive treatment|0|||
130249519|NCT01061710|468874965|FG000|Overall Study|Protocol Violation|14|||
130249520|NCT03757715|468874967|FG000|Overall Study|Lost to Follow-up|4|||
130249521|NCT03757715|468874968|FG001|Overall Study|Lost to Follow-up|9|||
130249522|NCT03757715|468874967|FG000|Overall Study|Withdrawal by Subject|1|||
130249523|NCT03757715|468874968|FG001|Overall Study|Withdrawal by Subject|1|||
130249524|NCT00281580|468874969|FG000|Overall Study|Adverse Event|2|||
130249525|NCT00281580|468874970|FG001|Overall Study|Adverse Event|0|||
130249526|NCT00281580|468874971|FG002|Overall Study|Adverse Event|2|||
130249527|NCT00281580|468874972|FG003|Overall Study|Adverse Event|4|||
130249528|NCT00281580|468874973|FG004|Overall Study|Adverse Event|1|||
130249529|NCT00281580|468874974|FG005|Overall Study|Adverse Event|0|||
130249530|NCT00281580|468874975|FG006|Overall Study|Adverse Event|1|||
130249531|NCT00281580|468874976|FG007|Overall Study|Adverse Event|0|||
130249532|NCT00281580|468874977|FG008|Overall Study|Adverse Event|1|||
130249533|NCT00281580|468874978|FG009|Overall Study|Adverse Event|6|||
130249534|NCT00281580|468874979|FG010|Overall Study|Adverse Event|0|||
130249535|NCT00281580|468874980|FG011|Overall Study|Adverse Event|5|||
130249536|NCT00281580|468874981|FG012|Overall Study|Adverse Event|8|||
130249537|NCT00281580|468874982|FG013|Overall Study|Adverse Event|2|||
130249538|NCT00281580|468874983|FG014|Overall Study|Adverse Event|3|||
130249539|NCT00281580|468874984|FG015|Overall Study|Adverse Event|3|||
130249540|NCT00281580|468874969|FG000|Overall Study|Protocol Violation|0|||
130249541|NCT00281580|468874970|FG001|Overall Study|Protocol Violation|0|||
130249542|NCT00281580|468874971|FG002|Overall Study|Protocol Violation|1|||
130249543|NCT00281580|468874972|FG003|Overall Study|Protocol Violation|1|||
130249544|NCT00281580|468874973|FG004|Overall Study|Protocol Violation|0|||
130249545|NCT00281580|468874974|FG005|Overall Study|Protocol Violation|0|||
130249546|NCT00281580|468874975|FG006|Overall Study|Protocol Violation|1|||
130249547|NCT00281580|468874976|FG007|Overall Study|Protocol Violation|0|||
130249548|NCT00281580|468874977|FG008|Overall Study|Protocol Violation|2|||
130249549|NCT00281580|468874978|FG009|Overall Study|Protocol Violation|0|||
130249550|NCT00281580|468874979|FG010|Overall Study|Protocol Violation|1|||
130249551|NCT00281580|468874980|FG011|Overall Study|Protocol Violation|2|||
130249552|NCT00281580|468874981|FG012|Overall Study|Protocol Violation|0|||
130249553|NCT00281580|468874982|FG013|Overall Study|Protocol Violation|1|||
130249554|NCT00281580|468874983|FG014|Overall Study|Protocol Violation|1|||
130249555|NCT00281580|468874984|FG015|Overall Study|Protocol Violation|3|||
130249556|NCT00281580|468874969|FG000|Overall Study|Withdrawal by Subject|3|||
130249557|NCT00281580|468874970|FG001|Overall Study|Withdrawal by Subject|0|||
130249558|NCT00281580|468874971|FG002|Overall Study|Withdrawal by Subject|1|||
130249559|NCT00281580|468874972|FG003|Overall Study|Withdrawal by Subject|1|||
130249560|NCT00281580|468874973|FG004|Overall Study|Withdrawal by Subject|1|||
130249561|NCT00281580|468874974|FG005|Overall Study|Withdrawal by Subject|2|||
130249562|NCT00281580|468874975|FG006|Overall Study|Withdrawal by Subject|2|||
130249563|NCT00281580|468874976|FG007|Overall Study|Withdrawal by Subject|0|||
130249564|NCT00281580|468874977|FG008|Overall Study|Withdrawal by Subject|1|||
130249565|NCT00281580|468874978|FG009|Overall Study|Withdrawal by Subject|4|||
130249566|NCT00281580|468874979|FG010|Overall Study|Withdrawal by Subject|1|||
130249567|NCT00281580|468874980|FG011|Overall Study|Withdrawal by Subject|1|||
130249568|NCT00281580|468874981|FG012|Overall Study|Withdrawal by Subject|2|||
130249569|NCT00281580|468874982|FG013|Overall Study|Withdrawal by Subject|2|||
130249570|NCT00281580|468874983|FG014|Overall Study|Withdrawal by Subject|1|||
130249571|NCT00281580|468874984|FG015|Overall Study|Withdrawal by Subject|5|||
130249572|NCT00281580|468874969|FG000|Overall Study|Lack of Efficacy|2|||
130249573|NCT00281580|468874970|FG001|Overall Study|Lack of Efficacy|1|||
130249574|NCT00281580|468874971|FG002|Overall Study|Lack of Efficacy|1|||
130249575|NCT00281580|468874972|FG003|Overall Study|Lack of Efficacy|6|||
130249576|NCT00281580|468874973|FG004|Overall Study|Lack of Efficacy|2|||
130249577|NCT00281580|468874974|FG005|Overall Study|Lack of Efficacy|0|||
130249578|NCT00281580|468874975|FG006|Overall Study|Lack of Efficacy|0|||
130249579|NCT00281580|468874976|FG007|Overall Study|Lack of Efficacy|0|||
130249580|NCT00281580|468874977|FG008|Overall Study|Lack of Efficacy|0|||
130249581|NCT00281580|468874978|FG009|Overall Study|Lack of Efficacy|0|||
130249582|NCT00281580|468874979|FG010|Overall Study|Lack of Efficacy|0|||
130249583|NCT00281580|468874980|FG011|Overall Study|Lack of Efficacy|1|||
130249584|NCT00281580|468874981|FG012|Overall Study|Lack of Efficacy|0|||
130249585|NCT00281580|468874982|FG013|Overall Study|Lack of Efficacy|2|||
130249586|NCT00281580|468874983|FG014|Overall Study|Lack of Efficacy|1|||
130249587|NCT00281580|468874984|FG015|Overall Study|Lack of Efficacy|0|||
130249588|NCT00281580|468874969|FG000|Overall Study|Lost to Follow-up|0|||
130249589|NCT00281580|468874970|FG001|Overall Study|Lost to Follow-up|0|||
130249590|NCT00281580|468874971|FG002|Overall Study|Lost to Follow-up|0|||
130249591|NCT00281580|468874972|FG003|Overall Study|Lost to Follow-up|3|||
130249592|NCT00281580|468874973|FG004|Overall Study|Lost to Follow-up|0|||
130249593|NCT00281580|468874974|FG005|Overall Study|Lost to Follow-up|1|||
130249594|NCT00281580|468874975|FG006|Overall Study|Lost to Follow-up|0|||
130249595|NCT00281580|468874976|FG007|Overall Study|Lost to Follow-up|1|||
130249596|NCT00281580|468874977|FG008|Overall Study|Lost to Follow-up|2|||
130249597|NCT00281580|468874978|FG009|Overall Study|Lost to Follow-up|1|||
130249598|NCT00281580|468874979|FG010|Overall Study|Lost to Follow-up|1|||
130249599|NCT00281580|468874980|FG011|Overall Study|Lost to Follow-up|0|||
130249600|NCT00281580|468874981|FG012|Overall Study|Lost to Follow-up|1|||
130249601|NCT00281580|468874982|FG013|Overall Study|Lost to Follow-up|0|||
130249602|NCT00281580|468874983|FG014|Overall Study|Lost to Follow-up|0|||
130249603|NCT00281580|468874984|FG015|Overall Study|Lost to Follow-up|0|||
130249604|NCT00281580|468874969|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
130249605|NCT00281580|468874970|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
130100889|NCT01432600|468327250|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
130100890|NCT01432600|468327251|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
130100891|NCT01432600|468327252|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
130100892|NCT03286400|468327256|FG000|Overall Study|Death|10|||
130249606|NCT00281580|468874971|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
130100893|NCT03286400|468327256|FG000|Overall Study|Lost to Follow-up|10|||
130100894|NCT03286400|468327256|FG000|Overall Study|Physician Decision|1|||
130100895|NCT03286400|468327256|FG000|Overall Study|Scheduling difficulty|4|||
130100896|NCT00826176|468327259|FG000|Overall Study|Lost to Follow-up|1|||
130100897|NCT00826176|468327260|FG001|Overall Study|Lost to Follow-up|0|||
130100898|NCT00826176|468327259|FG000|Overall Study|Subject Withdrew Consent|3|||
130100899|NCT00826176|468327260|FG001|Overall Study|Subject Withdrew Consent|0|||
130249607|NCT00281580|468874972|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
130249608|NCT00281580|468874973|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
130249609|NCT00281580|468874974|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
130249610|NCT00281580|468874975|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
130249611|NCT00281580|468874976|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
130249612|NCT00281580|468874977|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
130249613|NCT00281580|468874978|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
130249614|NCT00281580|468874979|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
130249615|NCT00281580|468874980|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
130249616|NCT00281580|468874981|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
130249617|NCT00281580|468874982|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
130249618|NCT00281580|468874983|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
130249619|NCT00281580|468874984|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
130249620|NCT03302936|468874985|FG000|Overall Study|Protocol Violation|3|||
130249621|NCT03302936|468874986|FG001|Overall Study|Protocol Violation|4|||
130249622|NCT01550965|468874987|FG000|Overall Study|Adverse Event|26|||
129884866|NCT01000376|467538697|FG001|Cycle 1 Day 1|Progressive Disease|0|||
129884867|NCT00896454|467538698|FG000|Overall Study|Death|10|||
129884868|NCT00896454|467538698|FG000|Overall Study|Adverse Event|8|||
129884869|NCT00896454|467538698|FG000|Overall Study|Disease Progression|5|||
129884870|NCT00896454|467538698|FG000|Overall Study|Other|4|||
130249623|NCT01550965|468874987|FG000|Overall Study|Withdrawal by Subject|10|||
130249624|NCT01550965|468874987|FG000|Overall Study|Lost to Follow-up|2|||
130249625|NCT01550965|468874987|FG000|Overall Study|Lack of Efficacy|59|||
130249626|NCT01550965|468874987|FG000|Overall Study|Other|13|||
130249627|NCT03016403|468874990|FG000|Baseline|Death|5|||
130249628|NCT03016403|468874991|FG001|Baseline|Death|8|||
130249629|NCT03016403|468874992|FG002|Baseline|Death|1|||
130249630|NCT03016403|468874993|FG003|Baseline|Death|0|||
130249631|NCT03016403|468874990|FG000|Baseline|Withdrawal by Subject|2|||
130249632|NCT03016403|468874991|FG001|Baseline|Withdrawal by Subject|8|||
130249633|NCT03016403|468874992|FG002|Baseline|Withdrawal by Subject|4|||
130249634|NCT03016403|468874993|FG003|Baseline|Withdrawal by Subject|10|||
130249635|NCT03016403|468874990|FG000|Baseline|Lost to Follow-up|9|||
130249636|NCT03016403|468874991|FG001|Baseline|Lost to Follow-up|11|||
130249637|NCT03016403|468874992|FG002|Baseline|Lost to Follow-up|6|||
130249638|NCT03016403|468874993|FG003|Baseline|Lost to Follow-up|24|||
130249639|NCT03016403|468874990|FG000|6-week Follow-up|Death|1|||
130249640|NCT03016403|468874991|FG001|6-week Follow-up|Death|4|||
130249641|NCT03016403|468874992|FG002|6-week Follow-up|Death|0|||
130249642|NCT03016403|468874993|FG003|6-week Follow-up|Death|0|||
130249643|NCT03016403|468874990|FG000|6-week Follow-up|Lost to Follow-up|2|||
130249644|NCT03016403|468874991|FG001|6-week Follow-up|Lost to Follow-up|7|||
130249645|NCT03016403|468874992|FG002|6-week Follow-up|Lost to Follow-up|4|||
130249646|NCT03016403|468874993|FG003|6-week Follow-up|Lost to Follow-up|8|||
130249647|NCT03016403|468874990|FG000|6-week Follow-up|Withdrawal by Subject|0|||
130249648|NCT03016403|468874991|FG001|6-week Follow-up|Withdrawal by Subject|2|||
130249649|NCT03016403|468874992|FG002|6-week Follow-up|Withdrawal by Subject|0|||
130249650|NCT03016403|468874993|FG003|6-week Follow-up|Withdrawal by Subject|1|||
130249651|NCT03016403|468874990|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
130249652|NCT03016403|468874991|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
130249653|NCT03016403|468874992|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
130249654|NCT03016403|468874993|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
130249655|NCT03016403|468874990|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
130249656|NCT03016403|468874991|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
130249657|NCT03016403|468874992|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
130249658|NCT03016403|468874993|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
130249659|NCT03016403|468874990|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130249660|NCT03016403|468874991|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130249661|NCT03016403|468874992|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
130249662|NCT03016403|468874993|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
130249663|NCT05463705|468874994|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
130249664|NCT05463705|468874995|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
130249665|NCT05463705|468874996|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
130249666|NCT05463705|468874997|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
130249667|NCT05463705|468874998|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
130249668|NCT05463705|468874999|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
130249669|NCT00621322|468875000|FG000|Overall Study|Lost to Follow-up|0|||
130249670|NCT00621322|468875001|FG001|Overall Study|Lost to Follow-up|0|||
130249671|NCT00621322|468875002|FG002|Overall Study|Lost to Follow-up|0|||
130249672|NCT00621322|468875003|FG003|Overall Study|Lost to Follow-up|0|||
130249673|NCT00621322|468875004|FG004|Overall Study|Lost to Follow-up|1|||
130249674|NCT00621322|468875005|FG005|Overall Study|Lost to Follow-up|0|||
130249675|NCT00621322|468875000|FG000|Overall Study|Physician Decision|0|||
130249676|NCT00621322|468875001|FG001|Overall Study|Physician Decision|0|||
130249677|NCT00621322|468875002|FG002|Overall Study|Physician Decision|1|||
130249678|NCT00621322|468875003|FG003|Overall Study|Physician Decision|1|||
130249679|NCT00621322|468875004|FG004|Overall Study|Physician Decision|0|||
130249680|NCT00621322|468875005|FG005|Overall Study|Physician Decision|0|||
130249681|NCT00621322|468875000|FG000|Overall Study|Withdrawal by Subject|0|||
130249682|NCT00621322|468875001|FG001|Overall Study|Withdrawal by Subject|0|||
130249683|NCT00621322|468875002|FG002|Overall Study|Withdrawal by Subject|0|||
130249684|NCT00621322|468875003|FG003|Overall Study|Withdrawal by Subject|1|||
130249685|NCT00621322|468875004|FG004|Overall Study|Withdrawal by Subject|0|||
130249686|NCT00621322|468875005|FG005|Overall Study|Withdrawal by Subject|2|||
130249687|NCT00621322|468875000|FG000|Overall Study|Migrated/moved from study area|1|||
130249688|NCT00621322|468875001|FG001|Overall Study|Migrated/moved from study area|0|||
130249689|NCT00621322|468875002|FG002|Overall Study|Migrated/moved from study area|1|||
130249690|NCT00621322|468875003|FG003|Overall Study|Migrated/moved from study area|1|||
130249691|NCT00621322|468875004|FG004|Overall Study|Migrated/moved from study area|0|||
130249692|NCT00621322|468875005|FG005|Overall Study|Migrated/moved from study area|2|||
130249693|NCT01655069|468875011|FG000|Overall Study|Physician Decision|0|||
130249694|NCT01655069|468875012|FG001|Overall Study|Physician Decision|0|||
130249695|NCT01655069|468875013|FG002|Overall Study|Physician Decision|0|||
130249696|NCT01655069|468875014|FG003|Overall Study|Physician Decision|1|||
129884871|NCT00896454|467538698|FG000|Overall Study|Requirement for alternative therapy|3|||
129884872|NCT00896454|467538698|FG000|Overall Study|Ongoing in study|2|||
129884873|NCT00896454|467538698|FG000|Overall Study|Withdrawal by Subject|1|||
129884874|NCT03688711|467538699|FG000|Overall Study|Withdrawal by Subject|0|||
130249697|NCT01655069|468875011|FG000|Overall Study|Adverse Event|6|||
130249698|NCT01655069|468875012|FG001|Overall Study|Adverse Event|7|||
130249699|NCT01655069|468875013|FG002|Overall Study|Adverse Event|2|||
130249700|NCT01655069|468875014|FG003|Overall Study|Adverse Event|3|||
130249701|NCT01655069|468875011|FG000|Overall Study|Lack of Efficacy|0|||
130249702|NCT01655069|468875012|FG001|Overall Study|Lack of Efficacy|1|||
129884875|NCT03688711|467538700|FG001|Overall Study|Withdrawal by Subject|1|||
129884876|NCT05033080|467538702|FG000|Overall Study|Adverse Event|4|||
129884877|NCT05033080|467538703|FG001|Overall Study|Adverse Event|4|||
129884878|NCT05033080|467538702|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
129884879|NCT05033080|467538703|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
129884880|NCT05033080|467538702|FG000|Overall Study|Lost to Follow-up|1|||
129884881|NCT05033080|467538703|FG001|Overall Study|Lost to Follow-up|0|||
129884882|NCT05033080|467538702|FG000|Overall Study|Other non-compliance|0|||
129884883|NCT05033080|467538703|FG001|Overall Study|Other non-compliance|1|||
129884884|NCT05033080|467538702|FG000|Overall Study|Physician Decision|0|||
129884885|NCT05033080|467538703|FG001|Overall Study|Physician Decision|1|||
129884886|NCT05033080|467538702|FG000|Overall Study|Other|1|||
129884887|NCT05033080|467538703|FG001|Overall Study|Other|1|||
129884888|NCT01263106|467538704|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
129884889|NCT01263106|467538705|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
129884890|NCT02058290|467538710|FG000|Overall Study|Protocol Violation|2|||
129884891|NCT02058290|467538711|FG001|Overall Study|Protocol Violation|1|||
129884892|NCT02058290|467538710|FG000|Overall Study|Physician Decision|1|||
129884893|NCT02058290|467538711|FG001|Overall Study|Physician Decision|0|||
129884894|NCT02058290|467538710|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
129884895|NCT02058290|467538711|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
129884896|NCT02058290|467538710|FG000|Overall Study|Withdrawal by Subject|0|||
129884897|NCT02058290|467538711|FG001|Overall Study|Withdrawal by Subject|1|||
129884898|NCT05822921|467538714|FG000|Overall Study|Lost to Follow-up|1|||
129884899|NCT05822921|467538715|FG001|Overall Study|Lost to Follow-up|1|||
129884900|NCT00544544|467538716|FG000|Overall Study|Withdrawal by Subject|1|||
129884901|NCT00544544|467538716|FG000|Overall Study|Adverse Event|1|||
129884902|NCT00544544|467538716|FG000|Overall Study|Lost to Follow-up|1|||
129884903|NCT03406702|467538717|FG000|Overall Study|Missed Day 27 Dosing|1|||
129884904|NCT01857622|467538722|FG000|Overall Study|Adverse Event|5|||
129884905|NCT01857622|467538723|FG001|Overall Study|Adverse Event|0|||
129884906|NCT01857622|467538724|FG002|Overall Study|Adverse Event|2|||
129884907|NCT01857622|467538722|FG000|Overall Study|Physician Decision|1|||
129884908|NCT01857622|467538723|FG001|Overall Study|Physician Decision|0|||
129884909|NCT01857622|467538724|FG002|Overall Study|Physician Decision|0|||
129884910|NCT01857622|467538722|FG000|Overall Study|Protocol Violation|4|||
129884911|NCT01857622|467538723|FG001|Overall Study|Protocol Violation|1|||
129884912|NCT01857622|467538724|FG002|Overall Study|Protocol Violation|0|||
129884913|NCT01857622|467538722|FG000|Overall Study|Withdrawal by Subject|1|||
129884914|NCT01857622|467538723|FG001|Overall Study|Withdrawal by Subject|0|||
130249703|NCT01655069|468875013|FG002|Overall Study|Lack of Efficacy|0|||
130249704|NCT01655069|468875014|FG003|Overall Study|Lack of Efficacy|0|||
130249705|NCT01655069|468875011|FG000|Overall Study|No Treatment Needed|0|||
130249706|NCT01655069|468875012|FG001|Overall Study|No Treatment Needed|1|||
130249707|NCT01655069|468875013|FG002|Overall Study|No Treatment Needed|0|||
130249708|NCT01655069|468875014|FG003|Overall Study|No Treatment Needed|0|||
129884915|NCT01857622|467538724|FG002|Overall Study|Withdrawal by Subject|0|||
129884916|NCT01291225|467538726|FG000|Overall Study|Lost to Follow-up|85|||
129884917|NCT01291225|467538727|FG001|Overall Study|Lost to Follow-up|39|||
129884918|NCT01267253|467538728|FG000|Overall Study|Ineligible - required test not done|1|||
130249709|NCT01655069|468875011|FG000|Overall Study|Withdrawal by Subject|2|||
130249710|NCT01655069|468875012|FG001|Overall Study|Withdrawal by Subject|3|||
130249711|NCT01655069|468875013|FG002|Overall Study|Withdrawal by Subject|0|||
129884919|NCT01267253|467538728|FG000|Overall Study|Inevaluable-never received study treatme|2|||
130100900|NCT00826176|468327259|FG000|Overall Study|Administrative|9|||
129884920|NCT04318093|467538729|FG000|Overall Study|Adverse Event|2|||
129884921|NCT04318093|467538730|FG001|Overall Study|Adverse Event|2|||
129884922|NCT04318093|467538729|FG000|Overall Study|Participant withdrew consent|1|||
129884923|NCT04318093|467538730|FG001|Overall Study|Participant withdrew consent|0|||
129884924|NCT04318093|467538729|FG000|Overall Study|Other reasons|0|||
129884925|NCT04318093|467538730|FG001|Overall Study|Other reasons|1|||
129884926|NCT00876460|467538733|FG000|Combination Therapy Phase|Progressive disease|2|||
129884927|NCT00876460|467538734|FG001|Combination Therapy Phase|Progressive disease|3|||
129884928|NCT00876460|467538735|FG002|Combination Therapy Phase|Progressive disease|3|||
130100901|NCT00826176|468327260|FG001|Overall Study|Administrative|0|||
130249712|NCT01655069|468875014|FG003|Overall Study|Withdrawal by Subject|0|||
130249713|NCT06399471|468875015|FG000|Overall Study|Withdrawal by Subject|1|||
130249714|NCT00986102|468875016|FG000|Overall Study|Lost to Follow-up|0|||
130249715|NCT00986102|468875017|FG001|Overall Study|Lost to Follow-up|1|||
130249716|NCT00986102|468875018|FG002|Overall Study|Lost to Follow-up|0|||
130249717|NCT00986102|468875019|FG003|Overall Study|Lost to Follow-up|1|||
130249718|NCT00986102|468875016|FG000|Overall Study|Withdrawal by Subject|1|||
130249719|NCT00986102|468875017|FG001|Overall Study|Withdrawal by Subject|1|||
130249720|NCT00986102|468875018|FG002|Overall Study|Withdrawal by Subject|0|||
130249721|NCT00986102|468875019|FG003|Overall Study|Withdrawal by Subject|0|||
130249722|NCT06083493|468875020|FG000|Overall Study|Technical issues with the interventional device|2|||
130249723|NCT06083493|468875021|FG001|Overall Study|Technical issues with the interventional device|2|||
130249724|NCT06083493|468875020|FG000|Overall Study|Performed incorrect visual task|1|||
130249725|NCT06083493|468875021|FG001|Overall Study|Performed incorrect visual task|0|||
130249726|NCT06083493|468875020|FG000|Overall Study|Insufficient baseline performance|0|||
130249727|NCT06083493|468875021|FG001|Overall Study|Insufficient baseline performance|1|||
130249728|NCT00147537|468875022|FG000|Phase 1b|Death|0|||
130249729|NCT00147537|468875023|FG001|Phase 1b|Death|1|||
130249730|NCT00147537|468875024|FG002|Phase 1b|Death|2|||
130249731|NCT00147537|468875025|FG003|Phase 1b|Death|1|||
130249732|NCT00147537|468875026|FG004|Phase 1b|Death|2|||
130249733|NCT00147537|468875027|FG005|Phase 1b|Death|2|||
130249734|NCT00147537|468875028|FG006|Phase 1b|Death|1|||
130249735|NCT00147537|468875029|FG007|Phase 1b|Death|3|||
130249736|NCT00147537|468875030|FG008|Phase 1b|Death|9|||
130249737|NCT00147537|468875031|FG009|Phase 1b|Death|0|||
130249738|NCT00147537|468875032|FG010|Phase 1b|Death|0|||
130249739|NCT00147537|468875022|FG000|Phase 1b|Lost to Follow-up|2|||
130249740|NCT00147537|468875023|FG001|Phase 1b|Lost to Follow-up|1|||
130249741|NCT00147537|468875024|FG002|Phase 1b|Lost to Follow-up|0|||
130249742|NCT00147537|468875025|FG003|Phase 1b|Lost to Follow-up|0|||
130249743|NCT00147537|468875026|FG004|Phase 1b|Lost to Follow-up|0|||
130249744|NCT00147537|468875027|FG005|Phase 1b|Lost to Follow-up|0|||
130249745|NCT00147537|468875028|FG006|Phase 1b|Lost to Follow-up|2|||
130249746|NCT00147537|468875029|FG007|Phase 1b|Lost to Follow-up|0|||
130249747|NCT00147537|468875030|FG008|Phase 1b|Lost to Follow-up|1|||
130249748|NCT00147537|468875031|FG009|Phase 1b|Lost to Follow-up|0|||
130249749|NCT00147537|468875032|FG010|Phase 1b|Lost to Follow-up|0|||
130249750|NCT00147537|468875022|FG000|Phase 1b|Other|0|||
130249751|NCT00147537|468875023|FG001|Phase 1b|Other|0|||
130249752|NCT00147537|468875024|FG002|Phase 1b|Other|2|||
130249753|NCT00147537|468875025|FG003|Phase 1b|Other|1|||
130249754|NCT00147537|468875026|FG004|Phase 1b|Other|1|||
130249755|NCT00147537|468875027|FG005|Phase 1b|Other|1|||
130249756|NCT00147537|468875028|FG006|Phase 1b|Other|14|||
130249757|NCT00147537|468875029|FG007|Phase 1b|Other|4|||
130249758|NCT00147537|468875030|FG008|Phase 1b|Other|4|||
130249759|NCT00147537|468875031|FG009|Phase 1b|Other|0|||
130249760|NCT00147537|468875032|FG010|Phase 1b|Other|0|||
130249761|NCT00147537|468875022|FG000|Phase 1b|Withdrawal by Subject|0|||
130249762|NCT00147537|468875023|FG001|Phase 1b|Withdrawal by Subject|0|||
130249763|NCT00147537|468875024|FG002|Phase 1b|Withdrawal by Subject|0|||
130249764|NCT00147537|468875025|FG003|Phase 1b|Withdrawal by Subject|0|||
130249765|NCT00147537|468875026|FG004|Phase 1b|Withdrawal by Subject|0|||
130249766|NCT00147537|468875027|FG005|Phase 1b|Withdrawal by Subject|0|||
130249767|NCT00147537|468875028|FG006|Phase 1b|Withdrawal by Subject|0|||
130249768|NCT00147537|468875029|FG007|Phase 1b|Withdrawal by Subject|0|||
130249769|NCT00147537|468875030|FG008|Phase 1b|Withdrawal by Subject|2|||
130249770|NCT00147537|468875031|FG009|Phase 1b|Withdrawal by Subject|0|||
130249771|NCT00147537|468875032|FG010|Phase 1b|Withdrawal by Subject|0|||
130249772|NCT00147537|468875022|FG000|Phase 1b|Randomized but not treated|0|||
130249773|NCT00147537|468875023|FG001|Phase 1b|Randomized but not treated|0|||
130249774|NCT00147537|468875024|FG002|Phase 1b|Randomized but not treated|0|||
130249775|NCT00147537|468875025|FG003|Phase 1b|Randomized but not treated|0|||
130249776|NCT00147537|468875026|FG004|Phase 1b|Randomized but not treated|0|||
130249777|NCT00147537|468875027|FG005|Phase 1b|Randomized but not treated|0|||
130249778|NCT00147537|468875028|FG006|Phase 1b|Randomized but not treated|1|||
130249779|NCT00147537|468875029|FG007|Phase 1b|Randomized but not treated|0|||
130249780|NCT00147537|468875030|FG008|Phase 1b|Randomized but not treated|1|||
130249781|NCT00147537|468875031|FG009|Phase 1b|Randomized but not treated|0|||
130249782|NCT00147537|468875032|FG010|Phase 1b|Randomized but not treated|0|||
130249783|NCT00147537|468875022|FG000|Phase 2|Death|0|||
130249784|NCT00147537|468875023|FG001|Phase 2|Death|0|||
130249785|NCT00147537|468875024|FG002|Phase 2|Death|0|||
130249786|NCT00147537|468875025|FG003|Phase 2|Death|0|||
130249787|NCT00147537|468875026|FG004|Phase 2|Death|0|||
130249788|NCT00147537|468875027|FG005|Phase 2|Death|0|||
130249789|NCT00147537|468875028|FG006|Phase 2|Death|0|||
130249790|NCT00147537|468875029|FG007|Phase 2|Death|0|||
130249791|NCT00147537|468875030|FG008|Phase 2|Death|0|||
130249792|NCT00147537|468875031|FG009|Phase 2|Death|85|||
130249793|NCT00147537|468875032|FG010|Phase 2|Death|31|||
130249794|NCT00147537|468875022|FG000|Phase 2|Lost to Follow-up|0|||
130249795|NCT00147537|468875023|FG001|Phase 2|Lost to Follow-up|0|||
130249796|NCT00147537|468875024|FG002|Phase 2|Lost to Follow-up|0|||
130249797|NCT00147537|468875025|FG003|Phase 2|Lost to Follow-up|0|||
130249798|NCT00147537|468875026|FG004|Phase 2|Lost to Follow-up|0|||
130249799|NCT00147537|468875027|FG005|Phase 2|Lost to Follow-up|0|||
130249800|NCT00147537|468875028|FG006|Phase 2|Lost to Follow-up|0|||
130249801|NCT00147537|468875029|FG007|Phase 2|Lost to Follow-up|0|||
130249802|NCT00147537|468875030|FG008|Phase 2|Lost to Follow-up|0|||
130249803|NCT00147537|468875031|FG009|Phase 2|Lost to Follow-up|12|||
130249804|NCT00147537|468875032|FG010|Phase 2|Lost to Follow-up|4|||
130249805|NCT00147537|468875022|FG000|Phase 2|Other|0|||
130249806|NCT00147537|468875023|FG001|Phase 2|Other|0|||
130249807|NCT00147537|468875024|FG002|Phase 2|Other|0|||
130249808|NCT00147537|468875025|FG003|Phase 2|Other|0|||
130249809|NCT00147537|468875026|FG004|Phase 2|Other|0|||
130249810|NCT00147537|468875027|FG005|Phase 2|Other|0|||
130249811|NCT00147537|468875028|FG006|Phase 2|Other|0|||
130249812|NCT00147537|468875029|FG007|Phase 2|Other|0|||
130249813|NCT00147537|468875030|FG008|Phase 2|Other|0|||
130249814|NCT00147537|468875031|FG009|Phase 2|Other|47|||
130249815|NCT00147537|468875032|FG010|Phase 2|Other|12|||
130249816|NCT00147537|468875022|FG000|Phase 2|Withdrawal by Subject|0|||
130249817|NCT00147537|468875023|FG001|Phase 2|Withdrawal by Subject|0|||
130249818|NCT00147537|468875024|FG002|Phase 2|Withdrawal by Subject|0|||
130249819|NCT00147537|468875025|FG003|Phase 2|Withdrawal by Subject|0|||
130249820|NCT00147537|468875026|FG004|Phase 2|Withdrawal by Subject|0|||
130249821|NCT00147537|468875027|FG005|Phase 2|Withdrawal by Subject|0|||
130249822|NCT00147537|468875028|FG006|Phase 2|Withdrawal by Subject|0|||
130249823|NCT00147537|468875029|FG007|Phase 2|Withdrawal by Subject|0|||
130249824|NCT00147537|468875030|FG008|Phase 2|Withdrawal by Subject|0|||
130249825|NCT00147537|468875031|FG009|Phase 2|Withdrawal by Subject|16|||
130249826|NCT00147537|468875032|FG010|Phase 2|Withdrawal by Subject|4|||
130249827|NCT00147537|468875022|FG000|Phase 2|Randomized but not treated|0|||
130249828|NCT00147537|468875023|FG001|Phase 2|Randomized but not treated|0|||
130249829|NCT00147537|468875024|FG002|Phase 2|Randomized but not treated|0|||
130249830|NCT00147537|468875025|FG003|Phase 2|Randomized but not treated|0|||
130249831|NCT00147537|468875026|FG004|Phase 2|Randomized but not treated|0|||
130249832|NCT00147537|468875027|FG005|Phase 2|Randomized but not treated|0|||
130249833|NCT00147537|468875028|FG006|Phase 2|Randomized but not treated|0|||
130249834|NCT00147537|468875029|FG007|Phase 2|Randomized but not treated|0|||
130249835|NCT00147537|468875030|FG008|Phase 2|Randomized but not treated|0|||
130249836|NCT00147537|468875031|FG009|Phase 2|Randomized but not treated|1|||
130249837|NCT00147537|468875032|FG010|Phase 2|Randomized but not treated|1|||
130249838|NCT00345592|468875033|FG000|Overall Study|Death|14|||
130249839|NCT00345592|468875034|FG001|Overall Study|Death|16|||
130249840|NCT00345592|468875033|FG000|Overall Study|Withdrawal by Subject|11|||
130249841|NCT00345592|468875034|FG001|Overall Study|Withdrawal by Subject|8|||
130249842|NCT02006654|468875036|FG000|Overall Study|Withdrawal before treatment|4|||
130249843|NCT02006654|468875037|FG001|Overall Study|Withdrawal before treatment|2|||
130249844|NCT02006654|468875036|FG000|Overall Study|Adverse Event|16|||
130249845|NCT02006654|468875037|FG001|Overall Study|Adverse Event|17|||
130249846|NCT02006654|468875036|FG000|Overall Study|Death|1|||
130249847|NCT02006654|468875037|FG001|Overall Study|Death|0|||
130249848|NCT02006654|468875036|FG000|Overall Study|Withdrawal by Subject|14|||
130249849|NCT02006654|468875037|FG001|Overall Study|Withdrawal by Subject|12|||
130249850|NCT02006654|468875036|FG000|Overall Study|Protocol Violation|5|||
130249851|NCT02006654|468875037|FG001|Overall Study|Protocol Violation|8|||
130249852|NCT02006654|468875036|FG000|Overall Study|Lost to Follow-up|1|||
130249853|NCT02006654|468875037|FG001|Overall Study|Lost to Follow-up|0|||
130249854|NCT02006654|468875036|FG000|Overall Study|patient's will|2|||
130249855|NCT02006654|468875037|FG001|Overall Study|patient's will|1|||
130249856|NCT02006654|468875036|FG000|Overall Study|insufficient compliance|1|||
130249857|NCT02006654|468875037|FG001|Overall Study|insufficient compliance|0|||
130249858|NCT02006654|468875036|FG000|Overall Study|worsening cognitive condition|0|||
130249859|NCT02006654|468875037|FG001|Overall Study|worsening cognitive condition|1|||
130249860|NCT02006654|468875036|FG000|Overall Study|faecal incontinence|0|||
130249861|NCT02006654|468875037|FG001|Overall Study|faecal incontinence|1|||
130249862|NCT02006654|468875036|FG000|Overall Study|mood disorder|0|||
130249863|NCT02006654|468875037|FG001|Overall Study|mood disorder|1|||
130249864|NCT02006654|468875036|FG000|Overall Study|disallowed medication|1|||
130249865|NCT02006654|468875037|FG001|Overall Study|disallowed medication|0|||
130249866|NCT02006654|468875036|FG000|Overall Study|moving out of state|0|||
130249867|NCT02006654|468875037|FG001|Overall Study|moving out of state|1|||
130249868|NCT03438656|468875038|FG000|Overall Study|Lost to Follow-up|2|||
130249869|NCT03721965|468875039|FG000|Overall Study|Death|1|||
130249870|NCT03721965|468875039|FG000|Overall Study|Study Terminated by Sponsor|1|||
130249871|NCT00563316|468875040|FG000|Overall Study|Adverse Event|2|||
130249872|NCT00563316|468875040|FG000|Overall Study|Physician Decision|1|||
130249873|NCT00563316|468875040|FG000|Overall Study|Lost to Follow-up|2|||
130249874|NCT00563316|468875040|FG000|Overall Study|Death|1|||
130249875|NCT00563316|468875040|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
130249876|NCT00563316|468875040|FG000|Overall Study|Other|1|||
130249877|NCT01108055|468875047|FG000|Overall Study|Ineligible|11|||
130249878|NCT01108055|468875047|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
130249879|NCT03339453|468875049|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
130249880|NCT03339453|468875050|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
130249881|NCT00800384|468875053|FG000|Overall Study|Withdrawal by Subject|24|||
130249882|NCT00800384|468875054|FG001|Overall Study|Withdrawal by Subject|17|||
130249883|NCT00800384|468875053|FG000|Overall Study|Lost to Follow-up|17|||
130249884|NCT00800384|468875054|FG001|Overall Study|Lost to Follow-up|26|||
130249885|NCT00504556|468876772|FG000|Overall Study|Adverse Event|11|||
130249886|NCT00504556|468876773|FG001|Overall Study|Adverse Event|11|||
130249887|NCT00504556|468876774|FG002|Overall Study|Adverse Event|14|||
130249888|NCT00504556|468876775|FG003|Overall Study|Adverse Event|13|||
130249889|NCT00504556|468876776|FG004|Overall Study|Adverse Event|5|||
130249890|NCT00504556|468876772|FG000|Overall Study|Death|3|||
130249891|NCT00504556|468876773|FG001|Overall Study|Death|3|||
130249892|NCT00504556|468876774|FG002|Overall Study|Death|1|||
130249893|NCT00504556|468876775|FG003|Overall Study|Death|0|||
130249894|NCT00504556|468876776|FG004|Overall Study|Death|2|||
130249895|NCT00504556|468876772|FG000|Overall Study|Protocol Violation|1|||
130249896|NCT00504556|468876773|FG001|Overall Study|Protocol Violation|3|||
130249897|NCT00504556|468876774|FG002|Overall Study|Protocol Violation|2|||
130249898|NCT00504556|468876775|FG003|Overall Study|Protocol Violation|1|||
130249899|NCT00504556|468876776|FG004|Overall Study|Protocol Violation|2|||
130249900|NCT00504556|468876772|FG000|Overall Study|Lost to Follow-up|0|||
130249901|NCT00504556|468876773|FG001|Overall Study|Lost to Follow-up|0|||
130249902|NCT00504556|468876774|FG002|Overall Study|Lost to Follow-up|1|||
130249903|NCT00504556|468876775|FG003|Overall Study|Lost to Follow-up|1|||
130249904|NCT00504556|468876776|FG004|Overall Study|Lost to Follow-up|1|||
130249905|NCT00504556|468876772|FG000|Overall Study|Withdrawal by Subject|16|||
130249906|NCT00504556|468876773|FG001|Overall Study|Withdrawal by Subject|16|||
130249907|NCT00504556|468876774|FG002|Overall Study|Withdrawal by Subject|7|||
130249908|NCT00504556|468876775|FG003|Overall Study|Withdrawal by Subject|8|||
130249909|NCT00504556|468876776|FG004|Overall Study|Withdrawal by Subject|12|||
130031028|NCT02347631|468070607|FG000|First Intervention (2 Months)|Moved out of area|0|||
130031029|NCT02347631|468070608|FG001|First Intervention (2 Months)|Moved out of area|2|||
130031030|NCT02347631|468070607|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
130249910|NCT00504556|468876772|FG000|Overall Study|administrative reasons|0|||
130249911|NCT00504556|468876773|FG001|Overall Study|administrative reasons|2|||
130249912|NCT00504556|468876774|FG002|Overall Study|administrative reasons|2|||
130249913|NCT00504556|468876775|FG003|Overall Study|administrative reasons|1|||
130249914|NCT00504556|468876776|FG004|Overall Study|administrative reasons|2|||
130249915|NCT00504556|468876772|FG000|Overall Study|did not meet entry criteria|2|||
130249916|NCT00504556|468876773|FG001|Overall Study|did not meet entry criteria|0|||
130249917|NCT00504556|468876774|FG002|Overall Study|did not meet entry criteria|1|||
130249918|NCT00504556|468876775|FG003|Overall Study|did not meet entry criteria|1|||
130249919|NCT00504556|468876776|FG004|Overall Study|did not meet entry criteria|0|||
130249920|NCT00504556|468876772|FG000|Overall Study|data monitor committee decision|0|||
130249921|NCT00504556|468876773|FG001|Overall Study|data monitor committee decision|0|||
130249922|NCT00504556|468876774|FG002|Overall Study|data monitor committee decision|0|||
130249923|NCT00504556|468876775|FG003|Overall Study|data monitor committee decision|100|||
130249924|NCT00504556|468876776|FG004|Overall Study|data monitor committee decision|0|||
130249925|NCT00504556|468876772|FG000|Overall Study|Other|2|||
130249926|NCT00504556|468876773|FG001|Overall Study|Other|2|||
130249927|NCT00504556|468876774|FG002|Overall Study|Other|2|||
130249928|NCT00504556|468876775|FG003|Overall Study|Other|3|||
130249929|NCT00504556|468876776|FG004|Overall Study|Other|0|||
130249930|NCT00504556|468876772|FG000|Overall Study|not in safety analysis set|0|||
130249931|NCT00504556|468876773|FG001|Overall Study|not in safety analysis set|1|||
130249932|NCT00504556|468876774|FG002|Overall Study|not in safety analysis set|1|||
130249933|NCT00504556|468876775|FG003|Overall Study|not in safety analysis set|0|||
130249934|NCT00504556|468876776|FG004|Overall Study|not in safety analysis set|1|||
130249935|NCT03280615|468876777|FG000|Overall Study|Lost to Follow-up|1|||
130249936|NCT03280615|468876778|FG001|Overall Study|Lost to Follow-up|2|||
130249937|NCT03280615|468876777|FG000|Overall Study|Adverse Event|1|||
130249938|NCT03280615|468876778|FG001|Overall Study|Adverse Event|1|||
130249939|NCT03280615|468876777|FG000|Overall Study|Withdrawal by Subject|2|||
130249940|NCT03280615|468876778|FG001|Overall Study|Withdrawal by Subject|2|||
130249941|NCT01013870|468876781|FG000|Overall Study|Lost to Follow-up|1|||
130249942|NCT01013870|468876782|FG001|Overall Study|Lost to Follow-up|3|||
130249943|NCT01386645|468876783|FG000|Overall Study|Physician Decision|0|||
130249944|NCT01386645|468876784|FG001|Overall Study|Physician Decision|0|||
130249945|NCT01386645|468876785|FG002|Overall Study|Physician Decision|1|||
130249946|NCT01386645|468876783|FG000|Overall Study|Withdrawal by Subject|0|||
130249947|NCT01386645|468876784|FG001|Overall Study|Withdrawal by Subject|1|||
130249948|NCT01386645|468876785|FG002|Overall Study|Withdrawal by Subject|1|||
130249949|NCT00432991|468876786|FG000|Overall Study|Protocol Violation|7|||
130249950|NCT00432991|468876787|FG001|Overall Study|Protocol Violation|12|||
130249951|NCT03142451|468876797|FG000|Overall Study|Adverse Event|5|||
130249952|NCT03142451|468876798|FG001|Overall Study|Adverse Event|2|||
130249953|NCT03142451|468876797|FG000|Overall Study|Lost to Follow-up|25|||
130249954|NCT03142451|468876798|FG001|Overall Study|Lost to Follow-up|8|||
130249955|NCT03142451|468876797|FG000|Overall Study|Participant request|24|||
130249956|NCT03142451|468876798|FG001|Overall Study|Participant request|12|||
130031031|NCT02347631|468070608|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
130249957|NCT03142451|468876797|FG000|Overall Study|Protocol Violation|3|||
130249958|NCT03142451|468876798|FG001|Overall Study|Protocol Violation|1|||
130249959|NCT03142451|468876797|FG000|Overall Study|Other|1|||
130249960|NCT03142451|468876798|FG001|Overall Study|Other|1|||
130249961|NCT00090402|468876799|FG000|Overall Study|Death|1|||
130249962|NCT00090402|468876800|FG001|Overall Study|Death|1|||
130249963|NCT00090402|468876801|FG002|Overall Study|Death|0|||
130249964|NCT00090402|468876799|FG000|Overall Study|subject moved|0|||
130249965|NCT00090402|468876800|FG001|Overall Study|subject moved|1|||
130249966|NCT00090402|468876801|FG002|Overall Study|subject moved|0|||
130249967|NCT00090402|468876799|FG000|Overall Study|stopped taking study medication|1|||
130249968|NCT00090402|468876800|FG001|Overall Study|stopped taking study medication|0|||
130249969|NCT00090402|468876801|FG002|Overall Study|stopped taking study medication|1|||
130249970|NCT04621786|468876812|FG000|Overall Study|Lost to Follow-up|9|||
130249971|NCT04621786|468876812|FG000|Overall Study|Protocol Violation|3|||
130031032|NCT02347631|468070607|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
130249972|NCT02365064|468876815|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
130249973|NCT02365064|468876816|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
130249974|NCT02365064|468876815|FG000|Overall Study|Withdrawal by Subject|6|||
130249975|NCT02365064|468876816|FG001|Overall Study|Withdrawal by Subject|9|||
130249976|NCT02365064|468876815|FG000|Overall Study|Treatment intolerance|2|||
130249977|NCT02365064|468876816|FG001|Overall Study|Treatment intolerance|4|||
130249978|NCT01716559|468876817|FG000|Overall Study|Adverse Event|11|||
130249979|NCT01716559|468876817|FG000|Overall Study|Death|21|||
130249980|NCT01716559|468876817|FG000|Overall Study|Withdrawal by Subject|4|||
130249981|NCT01716559|468876817|FG000|Overall Study|Other withdrawal reason|75|||
130249982|NCT01133977|468876820|FG000|Overall Study|Adverse Event|0|||
130249983|NCT01133977|468876821|FG001|Overall Study|Adverse Event|0|||
130249984|NCT01133977|468876822|FG002|Overall Study|Adverse Event|1|||
130249985|NCT01133977|468876823|FG003|Overall Study|Adverse Event|0|||
130249986|NCT01133977|468876824|FG004|Overall Study|Adverse Event|0|||
130249987|NCT01133977|468876820|FG000|Overall Study|Death|1|||
130249988|NCT01133977|468876821|FG001|Overall Study|Death|1|||
130249989|NCT01133977|468876822|FG002|Overall Study|Death|1|||
130249990|NCT01133977|468876823|FG003|Overall Study|Death|7|||
130249991|NCT01133977|468876824|FG004|Overall Study|Death|3|||
130249992|NCT01133977|468876820|FG000|Overall Study|Started a New Line of Therapy|2|||
130249993|NCT01133977|468876821|FG001|Overall Study|Started a New Line of Therapy|6|||
130249994|NCT01133977|468876822|FG002|Overall Study|Started a New Line of Therapy|4|||
130249995|NCT01133977|468876823|FG003|Overall Study|Started a New Line of Therapy|25|||
130249996|NCT01133977|468876824|FG004|Overall Study|Started a New Line of Therapy|33|||
130249997|NCT01133977|468876820|FG000|Overall Study|Lost to Follow-up|0|||
130249998|NCT01133977|468876821|FG001|Overall Study|Lost to Follow-up|0|||
130249999|NCT01133977|468876822|FG002|Overall Study|Lost to Follow-up|0|||
130250000|NCT01133977|468876823|FG003|Overall Study|Lost to Follow-up|2|||
130250001|NCT01133977|468876824|FG004|Overall Study|Lost to Follow-up|1|||
130250002|NCT01133977|468876820|FG000|Overall Study|Withdrawal by Subject|0|||
130250003|NCT01133977|468876821|FG001|Overall Study|Withdrawal by Subject|0|||
130250004|NCT01133977|468876822|FG002|Overall Study|Withdrawal by Subject|0|||
130250005|NCT01133977|468876823|FG003|Overall Study|Withdrawal by Subject|5|||
130250006|NCT01133977|468876824|FG004|Overall Study|Withdrawal by Subject|1|||
130250007|NCT02773537|468876825|FG000|Overall Study|Lost to Follow-up|0|||
130250008|NCT02773537|468876826|FG001|Overall Study|Lost to Follow-up|1|||
130250009|NCT02773537|468876827|FG002|Overall Study|Lost to Follow-up|4|||
130250010|NCT00662038|468876828|FG000|Overall Study|Reason not specified|3|||
130250011|NCT00662038|468876828|FG000|Overall Study|Withdrawn consent|22|||
130250012|NCT00662038|468876828|FG000|Overall Study|Withdrawal by Subject|83|||
130250013|NCT00662038|468876828|FG000|Overall Study|Sponsor decision|1|||
130250014|NCT00662038|468876828|FG000|Overall Study|Physician Decision|19|||
130250015|NCT00662038|468876828|FG000|Overall Study|Lung transplantation|44|||
130250016|NCT00662038|468876828|FG000|Overall Study|Lost to Follow-up|1|||
130250017|NCT00662038|468876828|FG000|Overall Study|Death|95|||
130250018|NCT00662038|468876828|FG000|Overall Study|Adverse Event|358|||
130250019|NCT00662038|468876828|FG000|Overall Study|Continued treatment|5|||
130250020|NCT01840163|468876829|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
130250021|NCT01840163|468876830|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
130250022|NCT01840163|468876829|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
130250023|NCT01840163|468876830|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
130250024|NCT01840163|468876829|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
130250025|NCT01840163|468876830|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
130250026|NCT00397046|468876831|FG000|Overall Study|Disease Progression|3|||
130250027|NCT00397046|468876832|FG001|Overall Study|Disease Progression|3|||
130250028|NCT00397046|468876833|FG002|Overall Study|Disease Progression|10|||
130250029|NCT00397046|468876834|FG003|Overall Study|Disease Progression|5|||
130250030|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
130250031|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
130250032|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130250033|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
130250034|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130250035|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
130250036|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
130250037|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250038|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250039|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
130250040|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
130250041|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
130250042|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Other|6|||
130250043|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Other|3|||
130250044|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Other|0|||
130250045|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
130250046|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130250047|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130250048|NCT03636269|468876837|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
130250049|NCT03636269|468876838|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
130250050|NCT03636269|468876839|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
130250051|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Adverse Event|0|||
130250052|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Adverse Event|0|||
130250053|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Adverse Event|21|||
130250054|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
130250055|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
130250056|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
130250057|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250058|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
130250059|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
130250060|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
130250061|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
129884929|NCT00876460|467538736|FG003|Combination Therapy Phase|Progressive disease|3|||
130250062|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
130250063|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Administrative|0|||
130031033|NCT02347631|468070608|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
130031034|NCT02347631|468070607|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
130031035|NCT02347631|468070608|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
130031036|NCT02347631|468070607|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
130031037|NCT02347631|468070608|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
130250064|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Administrative|0|||
130250065|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Administrative|36|||
130250066|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Other|0|||
130250067|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Other|0|||
130250068|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Other|9|||
130250069|NCT03636269|468876837|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
130250070|NCT03636269|468876838|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
130250071|NCT03636269|468876839|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
130250072|NCT00493285|468876848|FG000|Overall Study|Lost to Follow-up|0|||
130250073|NCT00493285|468876849|FG001|Overall Study|Lost to Follow-up|0|||
130250074|NCT00493285|468876850|FG002|Overall Study|Lost to Follow-up|0|||
130250075|NCT00493285|468876851|FG003|Overall Study|Lost to Follow-up|0|||
130250076|NCT00493285|468876852|FG004|Overall Study|Lost to Follow-up|1|||
130250077|NCT00493285|468876853|FG005|Overall Study|Lost to Follow-up|0|||
130250078|NCT04535362|468876854|FG000|Overall Study|Lost to Follow-up|3|||
130250079|NCT04535362|468876855|FG001|Overall Study|Lost to Follow-up|1|||
130250080|NCT03791060|468876856|FG000|Overall Study|Withdrawal by Subject|1|||
130250081|NCT03774810|468876857|FG000|Phase 1|Lack of Efficacy|21|||
130250082|NCT03774810|468876858|FG001|Phase 1|Lack of Efficacy|0|||
130250083|NCT03774810|468876859|FG002|Phase 1|Lack of Efficacy|0|||
130250084|NCT03774810|468876860|FG003|Phase 1|Lack of Efficacy|0|||
130250085|NCT03774810|468876861|FG004|Phase 1|Lack of Efficacy|0|||
130250086|NCT03774810|468876857|FG000|Phase 1|Withdrawal by Subject|9|||
130250087|NCT03774810|468876858|FG001|Phase 1|Withdrawal by Subject|0|||
130250088|NCT03774810|468876859|FG002|Phase 1|Withdrawal by Subject|0|||
130250089|NCT03774810|468876860|FG003|Phase 1|Withdrawal by Subject|0|||
130250090|NCT03774810|468876861|FG004|Phase 1|Withdrawal by Subject|0|||
130250091|NCT03774810|468876857|FG000|Phase 1|Lost to Follow-up|2|||
130250092|NCT03774810|468876858|FG001|Phase 1|Lost to Follow-up|0|||
130250093|NCT03774810|468876859|FG002|Phase 1|Lost to Follow-up|0|||
130250094|NCT03774810|468876860|FG003|Phase 1|Lost to Follow-up|0|||
130250095|NCT03774810|468876861|FG004|Phase 1|Lost to Follow-up|0|||
130250096|NCT03774810|468876857|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
130250097|NCT03774810|468876858|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
130250098|NCT03774810|468876859|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
130250099|NCT03774810|468876860|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
130250100|NCT03774810|468876861|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
130250101|NCT03774810|468876857|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
130250102|NCT03774810|468876858|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
130250103|NCT03774810|468876859|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
130250104|NCT03774810|468876860|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
130250105|NCT03774810|468876861|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
130250106|NCT03774810|468876857|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250107|NCT03774810|468876858|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
130250108|NCT03774810|468876859|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250109|NCT03774810|468876860|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250110|NCT03774810|468876861|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
130250111|NCT03774810|468876857|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
130250112|NCT03774810|468876858|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
130250113|NCT03774810|468876859|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
130250114|NCT03774810|468876860|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
130250115|NCT03774810|468876861|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
130250116|NCT03774810|468876857|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
130250117|NCT03774810|468876858|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
130250118|NCT03774810|468876859|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
130250119|NCT03774810|468876860|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
130250120|NCT03774810|468876861|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
130250121|NCT03774810|468876857|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130250122|NCT03774810|468876858|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130250123|NCT03774810|468876859|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
130250124|NCT03774810|468876860|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
130250125|NCT03774810|468876861|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
130250126|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
130250127|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
130250128|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
130250129|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
130250130|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
130031038|NCT02347631|468070607|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
130031039|NCT02347631|468070608|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
130031040|NCT00934102|468070610|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
130031041|NCT00934102|468070611|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
130031042|NCT00934102|468070612|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
130031043|NCT02318784|468070613|FG000|Overall Study|Adverse Event|13|||
130031044|NCT02318784|468070613|FG000|Overall Study|Death|2|||
130031045|NCT02318784|468070613|FG000|Overall Study|Progressive Disease|37|||
130031046|NCT02318784|468070613|FG000|Overall Study|Withdrawal by Subject|10|||
130031047|NCT02304926|468070614|FG000|Overall Study|Lost to Follow-up|2|||
130031048|NCT02304926|468070615|FG001|Overall Study|Lost to Follow-up|1|||
130031049|NCT00792298|468070617|FG000|Treatment Period 1|Adverse Event|0|||
130031050|NCT00792298|468070618|FG001|Treatment Period 1|Adverse Event|1|||
130031051|NCT00792298|468070619|FG002|Treatment Period 1|Adverse Event|0|||
130031052|NCT00792298|468070620|FG003|Treatment Period 1|Adverse Event|1|||
130100902|NCT00297882|468327266|FG000|Day 14|Lack of Efficacy|12|||
130031053|NCT00792298|468070621|FG004|Treatment Period 1|Adverse Event|0|||
130031054|NCT00792298|468070622|FG005|Treatment Period 1|Adverse Event|1|||
130031055|NCT00792298|468070623|FG006|Treatment Period 1|Adverse Event|1|||
130250131|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
130250132|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
130250133|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
130250134|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
130250135|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
130250136|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
130250137|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
130250138|NCT00290758|468876871|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
130031056|NCT00792298|468070624|FG007|Treatment Period 1|Adverse Event|0|||
130031057|NCT00792298|468070617|FG000|Treatment Period 1|Lack of Efficacy|0|||
130031058|NCT00792298|468070618|FG001|Treatment Period 1|Lack of Efficacy|0|||
130250139|NCT00290758|468876872|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
130250140|NCT00290758|468876871|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
130250141|NCT00290758|468876872|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
130250142|NCT00474968|468876873|FG000|Overall Study|Withdrawal by Subject|8|||
130250143|NCT00474968|468876874|FG001|Overall Study|Withdrawal by Subject|7|||
130250144|NCT00474968|468876873|FG000|Overall Study|Protocol Violation|9|||
130250145|NCT00474968|468876874|FG001|Overall Study|Protocol Violation|8|||
130250146|NCT00474968|468876873|FG000|Overall Study|Sample not collected|1|||
130250147|NCT00474968|468876874|FG001|Overall Study|Sample not collected|1|||
130250148|NCT00981175|468876875|FG000|Primary Dose Vaccination|Adverse Event|1|||
130250149|NCT00981175|468876876|FG001|Primary Dose Vaccination|Adverse Event|0|||
130250150|NCT00981175|468876875|FG000|Primary Dose Vaccination|Protocol Violation|0|||
130250151|NCT00981175|468876876|FG001|Primary Dose Vaccination|Protocol Violation|1|||
130250152|NCT00981175|468876875|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
130250153|NCT00981175|468876876|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
130250154|NCT00981175|468876875|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
130031059|NCT00792298|468070619|FG002|Treatment Period 1|Lack of Efficacy|1|||
130250155|NCT00981175|468876876|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
130250156|NCT02619812|468876877|FG000|Overall Study|Withdrawal by Subject|0|||
130031060|NCT00792298|468070620|FG003|Treatment Period 1|Lack of Efficacy|0|||
130031061|NCT00792298|468070621|FG004|Treatment Period 1|Lack of Efficacy|0|||
130031062|NCT00792298|468070622|FG005|Treatment Period 1|Lack of Efficacy|0|||
130031063|NCT00792298|468070623|FG006|Treatment Period 1|Lack of Efficacy|0|||
130031064|NCT00792298|468070624|FG007|Treatment Period 1|Lack of Efficacy|0|||
130031065|NCT00792298|468070617|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130031066|NCT00792298|468070618|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130100903|NCT00297882|468327267|FG001|Day 14|Lack of Efficacy|49|||
130100904|NCT00297882|468327266|FG000|Day 28|Lost to Follow-up|13|||
130250157|NCT02619812|468876878|FG001|Overall Study|Withdrawal by Subject|0|||
130250158|NCT02619812|468876879|FG002|Overall Study|Withdrawal by Subject|1|||
130250159|NCT02619812|468876880|FG003|Overall Study|Withdrawal by Subject|2|||
130250160|NCT04189588|468876882|FG000|Overall Study|Death|0|||
130250161|NCT04189588|468876883|FG001|Overall Study|Death|1|||
130250162|NCT04189588|468876882|FG000|Overall Study|Lost to Follow-up|0|||
130250163|NCT04189588|468876883|FG001|Overall Study|Lost to Follow-up|1|||
130250164|NCT01658735|468876884|FG000|Overall Study|Lack of Efficacy|1|||
130250165|NCT01658735|468876885|FG001|Overall Study|Lack of Efficacy|0|||
130250166|NCT01658735|468876886|FG002|Overall Study|Lack of Efficacy|1|||
130250167|NCT01658735|468876884|FG000|Overall Study|Lost to Follow-up|1|||
130250168|NCT01658735|468876885|FG001|Overall Study|Lost to Follow-up|1|||
130250169|NCT01658735|468876886|FG002|Overall Study|Lost to Follow-up|0|||
130250170|NCT01658735|468876884|FG000|Overall Study|Protocol Violation|0|||
130250171|NCT01658735|468876885|FG001|Overall Study|Protocol Violation|1|||
130250172|NCT01658735|468876886|FG002|Overall Study|Protocol Violation|0|||
130250173|NCT01658735|468876884|FG000|Overall Study|Withdrawal by Subject|3|||
130250174|NCT01658735|468876885|FG001|Overall Study|Withdrawal by Subject|5|||
130250175|NCT01658735|468876886|FG002|Overall Study|Withdrawal by Subject|3|||
130250176|NCT03156621|468876887|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
130031067|NCT00792298|468070619|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130031068|NCT00792298|468070620|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130031069|NCT00792298|468070621|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130031070|NCT00792298|468070622|FG005|Treatment Period 1|Withdrawal by Subject|2|||
130031071|NCT00792298|468070623|FG006|Treatment Period 1|Withdrawal by Subject|1|||
130250177|NCT03156621|468876888|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
130250178|NCT03156621|468876887|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
130250179|NCT03156621|468876888|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
130250180|NCT01379937|468876889|FG000|Overall Study|Protocol Violation|0|||
130250181|NCT01379937|468876890|FG001|Overall Study|Protocol Violation|0|||
130250182|NCT01379937|468876891|FG002|Overall Study|Protocol Violation|0|||
130250183|NCT01379937|468876892|FG003|Overall Study|Protocol Violation|1|||
130250184|NCT01379937|468876889|FG000|Overall Study|Consent withdrawal|0|||
130250185|NCT01379937|468876890|FG001|Overall Study|Consent withdrawal|1|||
130250186|NCT01379937|468876891|FG002|Overall Study|Consent withdrawal|0|||
130250187|NCT01379937|468876892|FG003|Overall Study|Consent withdrawal|0|||
130250188|NCT01379937|468876889|FG000|Overall Study|Lost to Follow-up|1|||
130250189|NCT01379937|468876890|FG001|Overall Study|Lost to Follow-up|2|||
130250190|NCT01379937|468876891|FG002|Overall Study|Lost to Follow-up|2|||
130250191|NCT01379937|468876892|FG003|Overall Study|Lost to Follow-up|0|||
130250192|NCT04034056|468876898|FG000|Overall Study|Withdrawal by Subject|2|||
130250193|NCT04034056|468876898|FG000|Overall Study|Reason Not Specified|13|||
130250194|NCT04034056|468876898|FG000|Overall Study|Adverse Event|56|||
130250195|NCT01260311|468876902|FG000|Overall Study|Adverse Event|11|||
130250196|NCT01260311|468876902|FG000|Overall Study|Lack of Efficacy|4|||
130250197|NCT01260311|468876902|FG000|Overall Study|Lost to Follow-up|25|||
130250198|NCT01260311|468876902|FG000|Overall Study|Withdrawal by Subject|6|||
130250199|NCT01260311|468876902|FG000|Overall Study|Financial Constraints|77|||
130250200|NCT01260311|468876902|FG000|Overall Study|Gone to Province|2|||
130250201|NCT01260311|468876902|FG000|Overall Study|Medication Stopped|1|||
130250202|NCT01260311|468876902|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
130250203|NCT01089543|468876909|FG000|Overall Study|Withdrawal by Subject|2|||
130250204|NCT01089543|468876910|FG001|Overall Study|Withdrawal by Subject|3|||
130250205|NCT01089543|468876911|FG002|Overall Study|Withdrawal by Subject|3|||
130250206|NCT01089543|468876912|FG003|Overall Study|Withdrawal by Subject|1|||
130250207|NCT01089543|468876909|FG000|Overall Study|Physician Decision|1|||
130250208|NCT01089543|468876910|FG001|Overall Study|Physician Decision|0|||
130250209|NCT01089543|468876911|FG002|Overall Study|Physician Decision|0|||
130250210|NCT01089543|468876912|FG003|Overall Study|Physician Decision|1|||
130250211|NCT01089543|468876909|FG000|Overall Study|Adverse Event|0|||
130250212|NCT01089543|468876910|FG001|Overall Study|Adverse Event|1|||
130250213|NCT01089543|468876911|FG002|Overall Study|Adverse Event|0|||
130250214|NCT01089543|468876912|FG003|Overall Study|Adverse Event|0|||
130250215|NCT01248468|468876914|FG000|Overall Study|Administrative problem|1|||
130250216|NCT01248468|468876915|FG001|Overall Study|Administrative problem|0|||
130250217|NCT01248468|468876916|FG002|Overall Study|Administrative problem|0|||
130250218|NCT01248468|468876914|FG000|Overall Study|Lost to Follow-up|9|||
130250219|NCT01248468|468876915|FG001|Overall Study|Lost to Follow-up|12|||
130250220|NCT01248468|468876916|FG002|Overall Study|Lost to Follow-up|4|||
130250221|NCT01248468|468876914|FG000|Overall Study|Pregnancy|1|||
130250222|NCT01248468|468876915|FG001|Overall Study|Pregnancy|0|||
130250223|NCT01248468|468876916|FG002|Overall Study|Pregnancy|0|||
130250224|NCT01248468|468876914|FG000|Overall Study|Withdrawal by Subject|4|||
130250225|NCT01248468|468876915|FG001|Overall Study|Withdrawal by Subject|2|||
130250226|NCT01248468|468876916|FG002|Overall Study|Withdrawal by Subject|0|||
130250227|NCT00468546|468876918|FG000|Week 24 Analysis|Lack of Efficacy|83|||
130250228|NCT00468546|468876919|FG001|Week 24 Analysis|Lack of Efficacy|37|||
130250229|NCT00468546|468876918|FG000|Week 24 Analysis|Refused treatment|5|||
130250230|NCT00468546|468876919|FG001|Week 24 Analysis|Refused treatment|5|||
130250231|NCT00468546|468876918|FG000|Week 24 Analysis|Adverse Event|1|||
130250232|NCT00468546|468876919|FG001|Week 24 Analysis|Adverse Event|8|||
130250233|NCT00468546|468876918|FG000|Week 24 Analysis|Failure to return|3|||
130100905|NCT00297882|468327267|FG001|Day 28|Lost to Follow-up|23|||
130250234|NCT00468546|468876919|FG001|Week 24 Analysis|Failure to return|4|||
130250235|NCT00468546|468876918|FG000|Week 24 Analysis|Rescue therapy|2|||
130250236|NCT00468546|468876919|FG001|Week 24 Analysis|Rescue therapy|0|||
130250237|NCT00468546|468876918|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
130250238|NCT00468546|468876919|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
130250239|NCT00468546|468876918|FG000|Week 24 Analysis|Due to clinical hold|1|||
130250240|NCT00468546|468876919|FG001|Week 24 Analysis|Due to clinical hold|0|||
130250241|NCT00468546|468876918|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
130250242|NCT00468546|468876919|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
130250243|NCT00468546|468876918|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
130250244|NCT00468546|468876919|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
130250245|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
130250246|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
130250247|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Death|1|||
130250248|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Death|0|||
130250249|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
130031072|NCT00792298|468070624|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130031073|NCT00792298|468070617|FG000|Treatment Period 1|Lost to Follow-up|0|||
130031074|NCT00792298|468070618|FG001|Treatment Period 1|Lost to Follow-up|0|||
130031075|NCT00792298|468070619|FG002|Treatment Period 1|Lost to Follow-up|0|||
130031076|NCT00792298|468070620|FG003|Treatment Period 1|Lost to Follow-up|0|||
130031077|NCT00792298|468070621|FG004|Treatment Period 1|Lost to Follow-up|0|||
130031078|NCT00792298|468070622|FG005|Treatment Period 1|Lost to Follow-up|0|||
130031079|NCT00792298|468070623|FG006|Treatment Period 1|Lost to Follow-up|1|||
130031080|NCT00792298|468070624|FG007|Treatment Period 1|Lost to Follow-up|0|||
130031081|NCT00792298|468070617|FG000|Treatment Period 1|Physician Decision|0|||
130031082|NCT00792298|468070618|FG001|Treatment Period 1|Physician Decision|0|||
130031083|NCT00792298|468070619|FG002|Treatment Period 1|Physician Decision|0|||
130250250|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
130250251|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
130250252|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
130250253|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
130250254|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
130250255|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
130250256|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
130250257|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
130250258|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
130250259|NCT00468546|468876918|FG000|Week 24 to Week 104 Analysis|Other|17|||
130250260|NCT00468546|468876919|FG001|Week 24 to Week 104 Analysis|Other|14|||
130250261|NCT00472641|468876920|FG000|Overall Study|Lack of Efficacy|3|||
130250262|NCT00472641|468876920|FG000|Overall Study|Adverse Event|3|||
130250263|NCT00472641|468876920|FG000|Overall Study|Lost to Follow-up|1|||
130250264|NCT00478140|468876921|FG000|Overall Study|Clinical Disease Progression|1|||
130250265|NCT01189227|468876924|FG000|Overall Study|Study terminated due to low accrual|6|||
130250266|NCT01189227|468876925|FG001|Overall Study|Study terminated due to low accrual|3|||
130250267|NCT03211832|468876926|FG000|Overall Study|No longer with agency|32|||
130250268|NCT03211832|468876927|FG001|Overall Study|No longer with agency|49|||
130250269|NCT03211832|468876928|FG002|Overall Study|No longer with agency|30|||
130250270|NCT03211832|468876926|FG000|Overall Study|Declined survey|3|||
130250271|NCT03211832|468876927|FG001|Overall Study|Declined survey|3|||
130250272|NCT03211832|468876928|FG002|Overall Study|Declined survey|2|||
130250273|NCT03211832|468876926|FG000|Overall Study|Not available during data collection|1|||
130250274|NCT03211832|468876927|FG001|Overall Study|Not available during data collection|0|||
130250275|NCT03211832|468876928|FG002|Overall Study|Not available during data collection|2|||
130250276|NCT02489045|468876934|FG000|Overall Study|unable to collect usable data|53|||
130250277|NCT02489045|468876934|FG000|Follow-up|Lost to Follow-up|10|||
130250278|NCT03111732|468876939|FG000|Overall Study|Enrolled in different study|1|||
130250279|NCT03111732|468876939|FG000|Overall Study|Progressive disease|3|||
130250280|NCT03111732|468876939|FG000|Overall Study|Withdrawal by Subject|1|||
130250281|NCT02151604|468876941|FG000|Overall Study|Lost to Follow-up|3|||
130250282|NCT02151604|468876941|FG000|Overall Study|Withdrawal by Subject|2|||
130250283|NCT02151604|468876941|FG000|Overall Study|Physician Decision|3|||
130250284|NCT02151604|468876941|FG000|Overall Study|Death|1|||
130250285|NCT04495478|468876942|FG000|Overall Study|Withdrawal by Subject|0|||
130250286|NCT04495478|468876943|FG001|Overall Study|Withdrawal by Subject|0|||
130250287|NCT04495478|468876944|FG002|Overall Study|Withdrawal by Subject|0|||
130250288|NCT04495478|468876945|FG003|Overall Study|Withdrawal by Subject|1|||
130250289|NCT04495478|468876946|FG004|Overall Study|Withdrawal by Subject|0|||
130250290|NCT04495478|468876947|FG005|Overall Study|Withdrawal by Subject|0|||
130031084|NCT00792298|468070620|FG003|Treatment Period 1|Physician Decision|1|||
130031085|NCT00792298|468070621|FG004|Treatment Period 1|Physician Decision|0|||
130031086|NCT00792298|468070622|FG005|Treatment Period 1|Physician Decision|0|||
130031087|NCT00792298|468070623|FG006|Treatment Period 1|Physician Decision|1|||
130031088|NCT00792298|468070624|FG007|Treatment Period 1|Physician Decision|0|||
130250291|NCT04495478|468876948|FG006|Overall Study|Withdrawal by Subject|0|||
130250292|NCT04495478|468876942|FG000|Overall Study|Physician Decision|0|||
130250293|NCT04495478|468876943|FG001|Overall Study|Physician Decision|1|||
130250294|NCT04495478|468876944|FG002|Overall Study|Physician Decision|0|||
130250295|NCT04495478|468876945|FG003|Overall Study|Physician Decision|0|||
130250296|NCT04495478|468876946|FG004|Overall Study|Physician Decision|1|||
130250297|NCT04495478|468876947|FG005|Overall Study|Physician Decision|0|||
130250298|NCT04495478|468876948|FG006|Overall Study|Physician Decision|0|||
130250299|NCT03004183|468878815|FG000|Overall Study|Adverse Event|7|||
130250300|NCT03004183|468878815|FG000|Overall Study|Lost to Follow-up|1|||
130250301|NCT03004183|468878815|FG000|Overall Study|Physician Decision|40|||
130250302|NCT03004183|468878815|FG000|Overall Study|Withdrawal by Subject|1|||
130250303|NCT03004183|468878815|FG000|Overall Study|COVID-19|1|||
130250304|NCT02529488|468878816|FG000|Overall Study|Adverse Event|1|||
130250305|NCT02529488|468878816|FG000|Overall Study|Death|3|||
130250306|NCT02698787|468878817|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
130250307|NCT02698787|468878818|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
130031089|NCT00792298|468070617|FG000|Treatment Period 1|Protocol Violation|0|||
130031090|NCT00792298|468070618|FG001|Treatment Period 1|Protocol Violation|0|||
130031091|NCT00792298|468070619|FG002|Treatment Period 1|Protocol Violation|0|||
130031092|NCT00792298|468070620|FG003|Treatment Period 1|Protocol Violation|0|||
130031093|NCT00792298|468070621|FG004|Treatment Period 1|Protocol Violation|0|||
130031094|NCT00792298|468070622|FG005|Treatment Period 1|Protocol Violation|0|||
130031095|NCT00792298|468070623|FG006|Treatment Period 1|Protocol Violation|0|||
130031096|NCT00792298|468070624|FG007|Treatment Period 1|Protocol Violation|1|||
130031097|NCT00792298|468070617|FG000|Washout|Adverse Event|0|||
130031098|NCT00792298|468070618|FG001|Washout|Adverse Event|0|||
130031099|NCT00792298|468070619|FG002|Washout|Adverse Event|0|||
130031100|NCT00792298|468070620|FG003|Washout|Adverse Event|0|||
130031101|NCT00792298|468070621|FG004|Washout|Adverse Event|0|||
130031102|NCT00792298|468070622|FG005|Washout|Adverse Event|1|||
130031103|NCT00792298|468070623|FG006|Washout|Adverse Event|0|||
130031104|NCT00792298|468070624|FG007|Washout|Adverse Event|0|||
130031105|NCT00792298|468070617|FG000|Washout|Withdrawal by Subject|0|||
130031106|NCT00792298|468070618|FG001|Washout|Withdrawal by Subject|0|||
130031107|NCT00792298|468070619|FG002|Washout|Withdrawal by Subject|1|||
130031108|NCT00792298|468070620|FG003|Washout|Withdrawal by Subject|0|||
130031109|NCT00792298|468070621|FG004|Washout|Withdrawal by Subject|0|||
130031110|NCT00792298|468070622|FG005|Washout|Withdrawal by Subject|1|||
130031111|NCT00792298|468070623|FG006|Washout|Withdrawal by Subject|0|||
130100906|NCT00297882|468327266|FG000|Day 28|Lack of Efficacy|3|||
130250308|NCT02933151|468878827|FG000|Overall Study|Lost to Follow-up|19|||
130250309|NCT02933151|468878828|FG001|Overall Study|Lost to Follow-up|18|||
130250310|NCT02933151|468878827|FG000|Overall Study|Death|1732|||
130250311|NCT02933151|468878828|FG001|Overall Study|Death|1827|||
130250312|NCT02933151|468878827|FG000|Overall Study|Transplant|210|||
130031112|NCT00792298|468070624|FG007|Washout|Withdrawal by Subject|0|||
130031113|NCT00792298|468070617|FG000|Treatment Period 2|Lack of Efficacy|0|||
130031114|NCT00792298|468070618|FG001|Treatment Period 2|Lack of Efficacy|0|||
130031115|NCT00792298|468070619|FG002|Treatment Period 2|Lack of Efficacy|0|||
130031116|NCT00792298|468070620|FG003|Treatment Period 2|Lack of Efficacy|0|||
130031117|NCT00792298|468070621|FG004|Treatment Period 2|Lack of Efficacy|1|||
130031118|NCT00792298|468070622|FG005|Treatment Period 2|Lack of Efficacy|0|||
130250313|NCT02933151|468878828|FG001|Overall Study|Transplant|278|||
130250314|NCT02933151|468878827|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
130250315|NCT02933151|468878828|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
130250316|NCT02933151|468878827|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
130250317|NCT02933151|468878828|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
130250318|NCT02933151|468878827|FG000|Overall Study|Recovered Kidney Function|47|||
130250319|NCT02933151|468878828|FG001|Overall Study|Recovered Kidney Function|29|||
130250320|NCT03048019|468878829|FG000|Overall Study|Adverse Event|1|||
130250321|NCT03048019|468878830|FG001|Overall Study|Adverse Event|0|||
130250322|NCT03400787|468878831|FG000|Overall Study|Lost to Follow-up|1|||
130250323|NCT03400787|468878832|FG001|Overall Study|Lost to Follow-up|0|||
130250324|NCT03400787|468878831|FG000|Overall Study|Death|1|||
130250325|NCT03400787|468878832|FG001|Overall Study|Death|0|||
130250326|NCT03400787|468878831|FG000|Overall Study|Protocol Violation|0|||
130250327|NCT03400787|468878832|FG001|Overall Study|Protocol Violation|2|||
130250328|NCT03400787|468878831|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
130250329|NCT03400787|468878832|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
130250330|NCT04432298|468878836|FG000|Overall Study|Other than specified|1|||
130250331|NCT04432298|468878837|FG001|Overall Study|Other than specified|0|||
130250332|NCT04432298|468878836|FG000|Overall Study|Lost to Follow-up|0|||
130250333|NCT04432298|468878837|FG001|Overall Study|Lost to Follow-up|1|||
130250334|NCT04432298|468878836|FG000|Overall Study|Death|3|||
130250335|NCT04432298|468878837|FG001|Overall Study|Death|2|||
130250336|NCT04432298|468878836|FG000|Overall Study|Withdrawal by Subject|2|||
130250337|NCT04432298|468878837|FG001|Overall Study|Withdrawal by Subject|0|||
130250338|NCT02451007|468878842|FG000|Overall Study|Withdrawal by Subject|4|||
130250339|NCT02451007|468878842|FG000|Overall Study|Adverse Event|1|||
130250340|NCT02451007|468878842|FG000|Overall Study|Disease Progression|2|||
130250341|NCT00348374|468878843|FG000|Overall Study|Adverse Event|1|||
130250342|NCT00348374|468878844|FG001|Overall Study|Adverse Event|4|||
130250343|NCT00348374|468878843|FG000|Overall Study|Lost to Follow-up|1|||
130250344|NCT00348374|468878844|FG001|Overall Study|Lost to Follow-up|3|||
130250345|NCT00348374|468878843|FG000|Overall Study|Withdrawal by Subject|5|||
130250346|NCT00348374|468878844|FG001|Overall Study|Withdrawal by Subject|5|||
130250347|NCT00348374|468878843|FG000|Overall Study|Other|11|||
130250348|NCT00348374|468878844|FG001|Overall Study|Other|12|||
130250349|NCT00348374|468878843|FG000|Overall Study|ongoing at date of cutoff|1|||
130250350|NCT00348374|468878844|FG001|Overall Study|ongoing at date of cutoff|1|||
130250351|NCT00348374|468878843|FG000|Overall Study|randomized but did not receive treatment|0|||
130250352|NCT00348374|468878844|FG001|Overall Study|randomized but did not receive treatment|7|||
130250353|NCT02070380|468878853|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
130250354|NCT02070380|468878854|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
130250355|NCT02070380|468878855|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
130250356|NCT02070380|468878856|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
130250357|NCT02070380|468878853|FG000|Second Injection|Image sets missing or technically inadeq|0|||
130250358|NCT02070380|468878854|FG001|Second Injection|Image sets missing or technically inadeq|1|||
130250359|NCT02070380|468878855|FG002|Second Injection|Image sets missing or technically inadeq|0|||
130250360|NCT02070380|468878856|FG003|Second Injection|Image sets missing or technically inadeq|0|||
130250361|NCT02070380|468878853|FG000|Second Injection|Protocol Violation|0|||
130250362|NCT02070380|468878854|FG001|Second Injection|Protocol Violation|1|||
130250363|NCT02070380|468878855|FG002|Second Injection|Protocol Violation|1|||
130250364|NCT02070380|468878856|FG003|Second Injection|Protocol Violation|5|||
130250365|NCT02105012|468878869|FG000|Overall Study|Withdrawal by Subject|11|||
130250366|NCT02105012|468878869|FG000|Overall Study|Protocol Specified Criteria|9|||
130250367|NCT02105012|468878869|FG000|Overall Study|Lost to Follow-up|4|||
130250368|NCT02105012|468878869|FG000|Overall Study|Protocol Violation|4|||
129884930|NCT00876460|467538737|FG004|Combination Therapy Phase|Progressive disease|3|||
129884931|NCT00876460|467538738|FG005|Combination Therapy Phase|Progressive disease|1|||
129884932|NCT00876460|467538739|FG006|Combination Therapy Phase|Progressive disease|1|||
129884933|NCT00876460|467538740|FG007|Combination Therapy Phase|Progressive disease|1|||
129884934|NCT00876460|467538733|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
129884935|NCT00876460|467538734|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
130031119|NCT00792298|468070623|FG006|Treatment Period 2|Lack of Efficacy|0|||
130031120|NCT00792298|468070624|FG007|Treatment Period 2|Lack of Efficacy|0|||
130250369|NCT02105012|468878869|FG000|Overall Study|Physician Decision|3|||
130250370|NCT02105012|468878869|FG000|Overall Study|Adverse Event|1|||
130250371|NCT02105012|468878869|FG000|Overall Study|Lack of Efficacy|1|||
130250372|NCT03436420|468878870|FG000|Overall Study|Lack of Efficacy|3|||
130250373|NCT01104870|468878873|FG000|Overall Study|Adverse Event|1|||
130250374|NCT01104870|468878874|FG001|Overall Study|Adverse Event|1|||
130250375|NCT01104870|468878875|FG002|Overall Study|Adverse Event|0|||
130250376|NCT01104870|468878873|FG000|Overall Study|Death|0|||
130250377|NCT01104870|468878874|FG001|Overall Study|Death|0|||
130250378|NCT01104870|468878875|FG002|Overall Study|Death|1|||
130250379|NCT01104870|468878873|FG000|Overall Study|Withdrawal by Subject|0|||
129884936|NCT00876460|467538735|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
130100907|NCT00297882|468327267|FG001|Day 28|Lack of Efficacy|0|||
130250380|NCT01104870|468878874|FG001|Overall Study|Withdrawal by Subject|0|||
130250381|NCT01104870|468878875|FG002|Overall Study|Withdrawal by Subject|1|||
130250382|NCT04985682|468878876|FG000|Overall Study|Withdrawal by Subject|1|||
130250383|NCT00079781|468878888|FG000|Pre-implant Period|Withdrawal by Subject|2|||
130250384|NCT00079781|468878889|FG001|Pre-implant Period|Withdrawal by Subject|0|||
130250385|NCT00079781|468878890|FG002|Pre-implant Period|Withdrawal by Subject|0|||
130250386|NCT00079781|468878888|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
130250387|NCT00079781|468878889|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
130250388|NCT00079781|468878890|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
130250389|NCT00079781|468878888|FG000|Follow-up Period|Withdrawal by Subject|3|||
130250390|NCT00079781|468878889|FG001|Follow-up Period|Withdrawal by Subject|0|||
130250391|NCT00079781|468878890|FG002|Follow-up Period|Withdrawal by Subject|1|||
130250392|NCT00079781|468878888|FG000|Follow-up Period|Lost to Follow-up|1|||
130250393|NCT00079781|468878889|FG001|Follow-up Period|Lost to Follow-up|0|||
130250394|NCT00079781|468878890|FG002|Follow-up Period|Lost to Follow-up|0|||
130250395|NCT00079781|468878888|FG000|Follow-up Period|Death|0|||
130250396|NCT00079781|468878889|FG001|Follow-up Period|Death|0|||
130250397|NCT00079781|468878890|FG002|Follow-up Period|Death|1|||
130250398|NCT04641975|468878891|FG000|Overall Study|Protocol Violation|1|||
130250399|NCT04641975|468878892|FG001|Overall Study|Protocol Violation|2|||
130250400|NCT04641975|468878893|FG002|Overall Study|Protocol Violation|0|||
130250401|NCT04641975|468878894|FG003|Overall Study|Protocol Violation|0|||
130250402|NCT04641975|468878891|FG000|Overall Study|Adverse Event|0|||
130250403|NCT04641975|468878892|FG001|Overall Study|Adverse Event|0|||
130250404|NCT04641975|468878893|FG002|Overall Study|Adverse Event|1|||
130250405|NCT04641975|468878894|FG003|Overall Study|Adverse Event|1|||
130250406|NCT04641975|468878891|FG000|Overall Study|Withdrawal by Subject|1|||
130250407|NCT04641975|468878892|FG001|Overall Study|Withdrawal by Subject|0|||
130250408|NCT04641975|468878893|FG002|Overall Study|Withdrawal by Subject|0|||
130250409|NCT04641975|468878894|FG003|Overall Study|Withdrawal by Subject|0|||
130250410|NCT01259024|468878896|FG000|Overall Study|Physician Decision|1|||
130250411|NCT01657500|468878897|FG000|Overall Study|set impropperly matched|3|||
130250412|NCT01657500|468878898|FG001|Overall Study|set impropperly matched|3|||
130250413|NCT01657500|468878897|FG000|Overall Study|Lost to Follow-up|2|||
130250414|NCT01657500|468878898|FG001|Overall Study|Lost to Follow-up|2|||
130250415|NCT02067156|468878899|FG000|Overall Study|Lost to Follow-up|4|||
130250416|NCT03596983|468878900|FG000|Overall Study|Withdrawal by Subject|3|||
130250417|NCT04008069|468878901|FG000|Open-Label Period|Adverse Event|1|||
130250418|NCT04008069|468878902|FG001|Open-Label Period|Adverse Event|0|||
130250419|NCT04008069|468878903|FG002|Open-Label Period|Adverse Event|0|||
130250420|NCT04008069|468878901|FG000|Open-Label Period|Lack of Efficacy|4|||
130250421|NCT04008069|468878902|FG001|Open-Label Period|Lack of Efficacy|0|||
130250422|NCT04008069|468878903|FG002|Open-Label Period|Lack of Efficacy|0|||
130250423|NCT04008069|468878901|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
130250424|NCT04008069|468878902|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
130250425|NCT04008069|468878903|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
130250426|NCT04008069|468878901|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
130250427|NCT04008069|468878902|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
130250428|NCT04008069|468878903|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
130250429|NCT02134028|468878905|FG000|Overall Study|Lack of Efficacy|1|||
130250430|NCT02134028|468878906|FG001|Overall Study|Lack of Efficacy|0|||
130250431|NCT02134028|468878907|FG002|Overall Study|Lack of Efficacy|3|||
130250432|NCT02134028|468878908|FG003|Overall Study|Lack of Efficacy|2|||
130250433|NCT02134028|468878909|FG004|Overall Study|Lack of Efficacy|1|||
130250434|NCT02134028|468878910|FG005|Overall Study|Lack of Efficacy|2|||
130250435|NCT02134028|468878911|FG006|Overall Study|Lack of Efficacy|1|||
130250436|NCT02134028|468878912|FG007|Overall Study|Lack of Efficacy|0|||
130250437|NCT02134028|468878905|FG000|Overall Study|Poor compliance to protocol|1|||
130250438|NCT02134028|468878906|FG001|Overall Study|Poor compliance to protocol|1|||
130250439|NCT02134028|468878907|FG002|Overall Study|Poor compliance to protocol|3|||
130250440|NCT02134028|468878908|FG003|Overall Study|Poor compliance to protocol|7|||
130250441|NCT02134028|468878909|FG004|Overall Study|Poor compliance to protocol|1|||
130031121|NCT00792298|468070617|FG000|Treatment Period 2|Physician Decision|0|||
130031122|NCT00792298|468070618|FG001|Treatment Period 2|Physician Decision|0|||
130250442|NCT02134028|468878910|FG005|Overall Study|Poor compliance to protocol|1|||
130250443|NCT02134028|468878911|FG006|Overall Study|Poor compliance to protocol|0|||
130250444|NCT02134028|468878912|FG007|Overall Study|Poor compliance to protocol|0|||
130250445|NCT02134028|468878905|FG000|Overall Study|Other unspecified|4|||
130250446|NCT02134028|468878906|FG001|Overall Study|Other unspecified|22|||
130250447|NCT02134028|468878907|FG002|Overall Study|Other unspecified|33|||
130250448|NCT02134028|468878908|FG003|Overall Study|Other unspecified|64|||
130250449|NCT02134028|468878909|FG004|Overall Study|Other unspecified|8|||
130250450|NCT02134028|468878910|FG005|Overall Study|Other unspecified|6|||
130250451|NCT02134028|468878911|FG006|Overall Study|Other unspecified|2|||
130250452|NCT02134028|468878912|FG007|Overall Study|Other unspecified|1|||
130250453|NCT02134028|468878905|FG000|Overall Study|Adverse Event|3|||
130250454|NCT02134028|468878906|FG001|Overall Study|Adverse Event|19|||
130250455|NCT02134028|468878907|FG002|Overall Study|Adverse Event|13|||
130250456|NCT02134028|468878908|FG003|Overall Study|Adverse Event|32|||
130250457|NCT02134028|468878909|FG004|Overall Study|Adverse Event|4|||
130250458|NCT02134028|468878910|FG005|Overall Study|Adverse Event|5|||
130250459|NCT02134028|468878911|FG006|Overall Study|Adverse Event|1|||
130250460|NCT02134028|468878912|FG007|Overall Study|Adverse Event|2|||
130250461|NCT00819832|468878915|FG000|Overall Study|Sponsor Termination of Study|3|||
130250462|NCT00819832|468878916|FG001|Overall Study|Sponsor Termination of Study|0|||
130250463|NCT00819832|468878917|FG002|Overall Study|Sponsor Termination of Study|0|||
130250464|NCT00819832|468878918|FG003|Overall Study|Sponsor Termination of Study|0|||
130250465|NCT00819832|468878919|FG004|Overall Study|Sponsor Termination of Study|0|||
130250466|NCT00819832|468878920|FG005|Overall Study|Sponsor Termination of Study|0|||
130250467|NCT01452789|468878929|FG000|Overall Study|Withdrawal by Subject|3|||
130250468|NCT01452789|468878930|FG001|Overall Study|Withdrawal by Subject|2|||
130250469|NCT01340170|468878931|FG000|Overall Study|Lost to Follow-up|2|||
130250470|NCT01340170|468878932|FG001|Overall Study|Lost to Follow-up|4|||
130250471|NCT01340170|468878933|FG002|Overall Study|Lost to Follow-up|0|||
130250472|NCT01340170|468878931|FG000|Overall Study|Implant failure|1|||
130250473|NCT01340170|468878932|FG001|Overall Study|Implant failure|3|||
130250474|NCT01340170|468878933|FG002|Overall Study|Implant failure|0|||
130250475|NCT03878602|468878934|FG000|Overall Study|cord blood donation|7|||
130250476|NCT03878602|468878935|FG001|Overall Study|cord blood donation|1|||
130250477|NCT03878602|468878934|FG000|Overall Study|incomplete data collection|2|||
130250478|NCT03878602|468878935|FG001|Overall Study|incomplete data collection|0|||
130250479|NCT00066170|468878936|FG000|Overall Study|Adverse Event|2|||
130250480|NCT00066170|468878937|FG001|Overall Study|Adverse Event|4|||
130250481|NCT00066170|468878938|FG002|Overall Study|Adverse Event|1|||
130250482|NCT00066170|468878939|FG003|Overall Study|Adverse Event|7|||
130250483|NCT00066170|468878936|FG000|Overall Study|Serious Adverse Event|0|||
130250484|NCT00066170|468878937|FG001|Overall Study|Serious Adverse Event|0|||
130250485|NCT00066170|468878938|FG002|Overall Study|Serious Adverse Event|1|||
130250486|NCT00066170|468878939|FG003|Overall Study|Serious Adverse Event|1|||
130250487|NCT00066170|468878936|FG000|Overall Study|Lost to Follow-up|0|||
130250488|NCT00066170|468878937|FG001|Overall Study|Lost to Follow-up|1|||
130250489|NCT00066170|468878938|FG002|Overall Study|Lost to Follow-up|0|||
130250490|NCT00066170|468878939|FG003|Overall Study|Lost to Follow-up|0|||
130250491|NCT00066170|468878936|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
130250492|NCT00066170|468878937|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
130250493|NCT00066170|468878938|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
130250494|NCT00066170|468878939|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
130250495|NCT00066170|468878936|FG000|Overall Study|Protocol Violation|3|||
130250496|NCT00066170|468878937|FG001|Overall Study|Protocol Violation|0|||
130250497|NCT00066170|468878938|FG002|Overall Study|Protocol Violation|0|||
130250498|NCT00066170|468878939|FG003|Overall Study|Protocol Violation|0|||
130250499|NCT00066170|468878936|FG000|Overall Study|Other|1|||
130250500|NCT00066170|468878937|FG001|Overall Study|Other|5|||
130250501|NCT00066170|468878938|FG002|Overall Study|Other|2|||
130250502|NCT00066170|468878939|FG003|Overall Study|Other|0|||
130250503|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Adverse Event|14|||
130250504|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Adverse Event|27|||
130250505|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Adverse Event|60|||
130250506|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Adverse Event|0|||
130250507|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Adverse Event|0|||
130250508|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Pregnancy|0|||
130250509|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Pregnancy|7|||
130250510|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Pregnancy|9|||
130250511|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Pregnancy|0|||
130250512|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Pregnancy|0|||
130250513|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
130250514|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
130250515|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
130250516|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
130250517|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
130250518|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
130250519|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
130250520|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
130250521|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
130250522|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
130250523|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Death|1|||
130250524|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Death|2|||
130250525|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Death|2|||
130250526|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Death|0|||
130100908|NCT04484805|468327268|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
130100909|NCT04484805|468327269|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
130100910|NCT04484805|468327268|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
130100911|NCT04484805|468327269|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
130100912|NCT02116309|468327271|FG000|Overall Study|Lost to Follow-up|0|||
130100913|NCT02116309|468327272|FG001|Overall Study|Lost to Follow-up|1|||
130100914|NCT00848965|468327273|FG000|Overall Study|Adverse Event|1|||
130100915|NCT00848965|468327273|FG000|Overall Study|Withdrawal by Subject|1|||
130250527|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Death|0|||
130250528|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
130250529|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
130250530|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
130250531|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
130250532|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
130250533|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
130250534|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
130250535|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
130250536|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
130250537|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
130250538|NCT00098293|468878940|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
130250539|NCT00098293|468878941|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
130100916|NCT03710824|468327274|FG000|Overall Study|Withdrawal by Subject|1|||
130100917|NCT03710824|468327274|FG000|Overall Study|Lost to Follow-up|3|||
130250540|NCT00098293|468878942|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250541|NCT00098293|468878943|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250542|NCT00098293|468878944|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
130250543|NCT00098293|468878940|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250544|NCT00098293|468878941|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250545|NCT00098293|468878942|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
130100918|NCT03710824|468327274|FG000|Overall Study|Adverse Event|25|||
130100919|NCT03710824|468327274|FG000|Overall Study|Treatment discontinuation|2|||
130100920|NCT02329834|468327275|FG000|Overall Study|Physician Decision|1|||
130250546|NCT00098293|468878943|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130100921|NCT02329834|468327276|FG001|Overall Study|Physician Decision|0|||
130100922|NCT05102162|468327281|FG000|Overall Study|Withdrawal by Subject|3|||
130100923|NCT05102162|468327282|FG001|Overall Study|Withdrawal by Subject|0|||
130100924|NCT05102162|468327281|FG000|Overall Study|Baseline cultures negative|4|||
130250547|NCT00098293|468878944|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
130250548|NCT00098293|468878940|FG000|Open-label (OL) Phase|Adverse Event|0|||
130250549|NCT00098293|468878941|FG001|Open-label (OL) Phase|Adverse Event|3|||
130250550|NCT00098293|468878942|FG002|Open-label (OL) Phase|Adverse Event|7|||
130250551|NCT00098293|468878943|FG003|Open-label (OL) Phase|Adverse Event|6|||
130250552|NCT00098293|468878944|FG004|Open-label (OL) Phase|Adverse Event|0|||
130250553|NCT00098293|468878940|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
130100925|NCT05102162|468327282|FG001|Overall Study|Baseline cultures negative|2|||
130100926|NCT05102162|468327281|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
130100927|NCT05102162|468327282|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
130100928|NCT05102162|468327281|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
130100929|NCT05102162|468327282|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
130100930|NCT01165424|468327283|FG000|Overall Study|Clinical adverse experiences|1|||
130100931|NCT01165424|468327283|FG000|Overall Study|Laboratory adverse experiences|1|||
130100932|NCT01165424|468327283|FG000|Overall Study|Did not meet entry criteria|1|||
130100933|NCT01165424|468327283|FG000|Overall Study|Participant moved (relocated)|1|||
130100934|NCT02181673|468327284|FG000|Up to Week 24|Adverse Event|2|||
130100935|NCT02181673|468327285|FG001|Up to Week 24|Adverse Event|0|||
130100936|NCT02181673|468327286|FG002|Up to Week 24|Adverse Event|3|||
130100937|NCT02181673|468327284|FG000|Up to Week 24|Death|1|||
130100938|NCT02181673|468327285|FG001|Up to Week 24|Death|0|||
130100939|NCT02181673|468327286|FG002|Up to Week 24|Death|0|||
130100940|NCT02181673|468327284|FG000|Up to Week 24|Lack of Efficacy|1|||
130100941|NCT02181673|468327285|FG001|Up to Week 24|Lack of Efficacy|0|||
130250554|NCT00098293|468878941|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
130250555|NCT00098293|468878942|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
130250556|NCT00098293|468878943|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
130250557|NCT00098293|468878944|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
130250558|NCT00098293|468878940|FG000|Open-label (OL) Phase|Pregnancy|0|||
130250559|NCT00098293|468878941|FG001|Open-label (OL) Phase|Pregnancy|1|||
130250560|NCT00098293|468878942|FG002|Open-label (OL) Phase|Pregnancy|0|||
130250561|NCT00098293|468878943|FG003|Open-label (OL) Phase|Pregnancy|3|||
130250562|NCT00098293|468878944|FG004|Open-label (OL) Phase|Pregnancy|0|||
130250563|NCT00098293|468878940|FG000|Open-label (OL) Phase|Protocol Violation|0|||
130250564|NCT00098293|468878941|FG001|Open-label (OL) Phase|Protocol Violation|6|||
130031123|NCT00792298|468070619|FG002|Treatment Period 2|Physician Decision|0|||
130250565|NCT00098293|468878942|FG002|Open-label (OL) Phase|Protocol Violation|13|||
130250566|NCT00098293|468878943|FG003|Open-label (OL) Phase|Protocol Violation|16|||
130250567|NCT00098293|468878944|FG004|Open-label (OL) Phase|Protocol Violation|0|||
130250568|NCT00098293|468878940|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
130250569|NCT00098293|468878941|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
130250570|NCT00098293|468878942|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
130250571|NCT00098293|468878943|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
130250572|NCT00098293|468878944|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
130250573|NCT00098293|468878940|FG000|Open-label (OL) Phase|Death|0|||
130250574|NCT00098293|468878941|FG001|Open-label (OL) Phase|Death|2|||
130250575|NCT00098293|468878942|FG002|Open-label (OL) Phase|Death|3|||
130250576|NCT00098293|468878943|FG003|Open-label (OL) Phase|Death|0|||
130250577|NCT00098293|468878944|FG004|Open-label (OL) Phase|Death|0|||
130250578|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Death|0|||
130250579|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Death|0|||
130250580|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Death|0|||
130250581|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Death|0|||
130250582|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Death|1|||
130250583|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250584|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250585|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250586|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
130250587|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
130250588|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250589|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250590|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250591|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
130250592|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
130250593|NCT00098293|468878940|FG000|Supplemental Phase (SP)|Other|0|||
130250594|NCT00098293|468878941|FG001|Supplemental Phase (SP)|Other|0|||
130250595|NCT00098293|468878942|FG002|Supplemental Phase (SP)|Other|0|||
130250596|NCT00098293|468878943|FG003|Supplemental Phase (SP)|Other|0|||
130250597|NCT00098293|468878944|FG004|Supplemental Phase (SP)|Other|22|||
130100942|NCT02181673|468327286|FG002|Up to Week 24|Lack of Efficacy|0|||
130250598|NCT01370642|468878945|FG000|Overall Study|Adverse Event|2|||
130250599|NCT01370642|468878946|FG001|Overall Study|Adverse Event|1|||
130250600|NCT01370642|468878947|FG002|Overall Study|Adverse Event|1|||
130250601|NCT01370642|468878945|FG000|Overall Study|Detectable HCV RNA|0|||
130250602|NCT01370642|468878946|FG001|Overall Study|Detectable HCV RNA|0|||
130250603|NCT01370642|468878947|FG002|Overall Study|Detectable HCV RNA|22|||
130250604|NCT01370642|468878945|FG000|Overall Study|Lost to Follow-up|0|||
130250605|NCT01370642|468878946|FG001|Overall Study|Lost to Follow-up|0|||
130250606|NCT01370642|468878947|FG002|Overall Study|Lost to Follow-up|1|||
130250607|NCT01370642|468878945|FG000|Overall Study|Physician Decision|4|||
130250608|NCT01370642|468878946|FG001|Overall Study|Physician Decision|1|||
130250609|NCT01370642|468878947|FG002|Overall Study|Physician Decision|2|||
130250610|NCT01370642|468878945|FG000|Overall Study|Withdrawal by Subject|2|||
130250611|NCT01370642|468878946|FG001|Overall Study|Withdrawal by Subject|4|||
130250612|NCT01370642|468878947|FG002|Overall Study|Withdrawal by Subject|3|||
130250613|NCT01796470|468878948|FG000|Overall Study|Adverse Event|4|||
130250614|NCT01796470|468878949|FG001|Overall Study|Adverse Event|2|||
130250615|NCT01796470|468878950|FG002|Overall Study|Adverse Event|2|||
130250616|NCT01796470|468878951|FG003|Overall Study|Adverse Event|1|||
130250617|NCT01796470|468878952|FG004|Overall Study|Adverse Event|3|||
130250618|NCT01796470|468878948|FG000|Overall Study|Death|2|||
130250619|NCT01796470|468878949|FG001|Overall Study|Death|0|||
130250620|NCT01796470|468878950|FG002|Overall Study|Death|0|||
130250621|NCT01796470|468878951|FG003|Overall Study|Death|0|||
130250622|NCT01796470|468878952|FG004|Overall Study|Death|1|||
130250623|NCT01796470|468878948|FG000|Overall Study|Initiated New Therapy|9|||
130250624|NCT01796470|468878949|FG001|Overall Study|Initiated New Therapy|0|||
130250625|NCT01796470|468878950|FG002|Overall Study|Initiated New Therapy|0|||
130250626|NCT01796470|468878951|FG003|Overall Study|Initiated New Therapy|0|||
130250627|NCT01796470|468878952|FG004|Overall Study|Initiated New Therapy|2|||
130250628|NCT01796470|468878948|FG000|Overall Study|Lost to Follow-up|0|||
130250629|NCT01796470|468878949|FG001|Overall Study|Lost to Follow-up|1|||
130250630|NCT01796470|468878950|FG002|Overall Study|Lost to Follow-up|0|||
130250631|NCT01796470|468878951|FG003|Overall Study|Lost to Follow-up|0|||
130250632|NCT01796470|468878952|FG004|Overall Study|Lost to Follow-up|0|||
130250633|NCT01796470|468878948|FG000|Overall Study|Physician Decision|5|||
130250634|NCT01796470|468878949|FG001|Overall Study|Physician Decision|4|||
130250635|NCT01796470|468878950|FG002|Overall Study|Physician Decision|1|||
130250636|NCT01796470|468878951|FG003|Overall Study|Physician Decision|0|||
130250637|NCT01796470|468878952|FG004|Overall Study|Physician Decision|1|||
130250638|NCT01796470|468878948|FG000|Overall Study|Progressive Disease|7|||
130250639|NCT01796470|468878949|FG001|Overall Study|Progressive Disease|7|||
130250640|NCT01796470|468878950|FG002|Overall Study|Progressive Disease|3|||
130250641|NCT01796470|468878951|FG003|Overall Study|Progressive Disease|2|||
130250642|NCT01796470|468878952|FG004|Overall Study|Progressive Disease|0|||
130250643|NCT01796470|468878948|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
130250644|NCT01796470|468878949|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
130250645|NCT01796470|468878950|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
130250646|NCT01796470|468878951|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
130250647|NCT01796470|468878952|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
130250648|NCT01796470|468878948|FG000|Overall Study|Withdrawal by Subject|7|||
130250649|NCT01796470|468878949|FG001|Overall Study|Withdrawal by Subject|0|||
130250650|NCT01796470|468878950|FG002|Overall Study|Withdrawal by Subject|0|||
130250651|NCT01796470|468878951|FG003|Overall Study|Withdrawal by Subject|0|||
130250652|NCT01796470|468878952|FG004|Overall Study|Withdrawal by Subject|1|||
130250653|NCT01927861|468878953|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
130250654|NCT01927861|468878954|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
130250655|NCT01927861|468878953|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
130250656|NCT01927861|468878954|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
130250657|NCT00987935|468878955|FG000|Overall Study|Progressive disease|3|||
130250658|NCT00987935|468878956|FG001|Overall Study|Progressive disease|2|||
130250659|NCT00987935|468878957|FG002|Overall Study|Progressive disease|3|||
130250660|NCT00987935|468878958|FG003|Overall Study|Progressive disease|2|||
130250661|NCT00987935|468878959|FG004|Overall Study|Progressive disease|5|||
130250662|NCT00987935|468878960|FG005|Overall Study|Progressive disease|3|||
130250663|NCT00987935|468878961|FG006|Overall Study|Progressive disease|9|||
130250664|NCT00987935|468878962|FG007|Overall Study|Progressive disease|48|||
130250665|NCT00987935|468878963|FG008|Overall Study|Progressive disease|23|||
130250666|NCT00987935|468878955|FG000|Overall Study|Adverse Event|0|||
130250667|NCT00987935|468878956|FG001|Overall Study|Adverse Event|1|||
130250668|NCT00987935|468878957|FG002|Overall Study|Adverse Event|0|||
130250669|NCT00987935|468878958|FG003|Overall Study|Adverse Event|1|||
130250670|NCT00987935|468878959|FG004|Overall Study|Adverse Event|1|||
130250671|NCT00987935|468878960|FG005|Overall Study|Adverse Event|0|||
130250672|NCT00987935|468878961|FG006|Overall Study|Adverse Event|2|||
130250673|NCT00987935|468878962|FG007|Overall Study|Adverse Event|10|||
130250674|NCT00987935|468878963|FG008|Overall Study|Adverse Event|6|||
130250675|NCT00987935|468878955|FG000|Overall Study|Refused to continue taking trial med.|1|||
130250676|NCT00987935|468878956|FG001|Overall Study|Refused to continue taking trial med.|0|||
130250677|NCT00987935|468878957|FG002|Overall Study|Refused to continue taking trial med.|0|||
130250678|NCT00987935|468878958|FG003|Overall Study|Refused to continue taking trial med.|0|||
130250679|NCT00987935|468878959|FG004|Overall Study|Refused to continue taking trial med.|1|||
130250680|NCT00987935|468878960|FG005|Overall Study|Refused to continue taking trial med.|0|||
130250681|NCT00987935|468878961|FG006|Overall Study|Refused to continue taking trial med.|4|||
130250682|NCT00987935|468878962|FG007|Overall Study|Refused to continue taking trial med.|4|||
130250683|NCT00987935|468878963|FG008|Overall Study|Refused to continue taking trial med.|2|||
130250684|NCT00987935|468878955|FG000|Overall Study|Reason other than those specified above|0|||
130250685|NCT00987935|468878956|FG001|Overall Study|Reason other than those specified above|0|||
130250686|NCT00987935|468878957|FG002|Overall Study|Reason other than those specified above|0|||
130250687|NCT00987935|468878958|FG003|Overall Study|Reason other than those specified above|0|||
130250688|NCT00987935|468878959|FG004|Overall Study|Reason other than those specified above|0|||
130250689|NCT00987935|468878960|FG005|Overall Study|Reason other than those specified above|0|||
130250690|NCT00987935|468878961|FG006|Overall Study|Reason other than those specified above|0|||
130250691|NCT00987935|468878962|FG007|Overall Study|Reason other than those specified above|0|||
130250692|NCT00987935|468878963|FG008|Overall Study|Reason other than those specified above|1|||
130250693|NCT02176525|468878964|FG000|Overall Study|Adverse Event|0|||
130250694|NCT02176525|468878965|FG001|Overall Study|Adverse Event|0|||
130250695|NCT02176525|468878966|FG002|Overall Study|Adverse Event|0|||
130250696|NCT02176525|468878967|FG003|Overall Study|Adverse Event|1|||
130250697|NCT02176525|468878968|FG004|Overall Study|Adverse Event|1|||
130250698|NCT02176525|468878969|FG005|Overall Study|Adverse Event|0|||
130250699|NCT02176525|468878970|FG006|Overall Study|Adverse Event|1|||
130250700|NCT02176525|468878971|FG007|Overall Study|Adverse Event|0|||
130250701|NCT02176525|468878964|FG000|Overall Study|not treated|1|||
130250702|NCT02176525|468878965|FG001|Overall Study|not treated|0|||
130250703|NCT02176525|468878966|FG002|Overall Study|not treated|0|||
130250704|NCT02176525|468878967|FG003|Overall Study|not treated|0|||
130250705|NCT02176525|468878968|FG004|Overall Study|not treated|0|||
130250706|NCT02176525|468878969|FG005|Overall Study|not treated|1|||
130250707|NCT02176525|468878970|FG006|Overall Study|not treated|0|||
130250708|NCT02176525|468878971|FG007|Overall Study|not treated|0|||
130250709|NCT01905267|468878972|FG000|Overall Study|Physician Decision|2|||
130250710|NCT01905267|468878973|FG001|Overall Study|Physician Decision|2|||
130250711|NCT01608308|468878974|FG000|Overall Study|pretreatment medical and billing reasons|0|||
130250712|NCT01608308|468878975|FG001|Overall Study|pretreatment medical and billing reasons|2|||
130031124|NCT00792298|468070620|FG003|Treatment Period 2|Physician Decision|0|||
130031125|NCT00792298|468070621|FG004|Treatment Period 2|Physician Decision|0|||
130250713|NCT05652140|468878976|FG000|Overall Study|Lost to Follow-up|7|||
130250714|NCT05652140|468878977|FG001|Overall Study|Lost to Follow-up|16|||
130250715|NCT05652140|468878978|FG002|Overall Study|Lost to Follow-up|22|||
130250716|NCT05652140|468878979|FG003|Overall Study|Lost to Follow-up|31|||
130250717|NCT06048705|468878982|FG000|Overall Study|Physician Decision|1|||
130250718|NCT06048705|468878983|FG001|Overall Study|Physician Decision|0|||
130250719|NCT06048705|468878984|FG002|Overall Study|Physician Decision|0|||
130250720|NCT06048705|468878982|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
130250721|NCT06048705|468878983|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
130250722|NCT06048705|468878984|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
130250723|NCT06048705|468878982|FG000|Overall Study|Death prior to lymphodepletion|0|||
130250724|NCT06048705|468878983|FG001|Overall Study|Death prior to lymphodepletion|0|||
130250725|NCT06048705|468878984|FG002|Overall Study|Death prior to lymphodepletion|1|||
130250726|NCT01016015|468878985|FG000|Overall Study|Not Treated|3|||
130250727|NCT01016015|468878985|FG000|Overall Study|Withdrawal by Subject|1|||
130250728|NCT01016015|468878985|FG000|Overall Study|Adverse Event|15|||
130250729|NCT04648241|468878986|FG000|Overall Study|Lost to Follow-up|1|||
130250730|NCT04648241|468878987|FG001|Overall Study|Lost to Follow-up|0|||
130250731|NCT02057666|468878988|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
130250732|NCT02057666|468878989|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
130250733|NCT02057666|468878988|FG000|Double Blind Treatment Period|Poor tolerability|7|||
130250734|NCT02057666|468878989|FG001|Double Blind Treatment Period|Poor tolerability|2|||
130250735|NCT02057666|468878988|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
130250736|NCT02057666|468878989|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
130250737|NCT02057666|468878988|FG000|Double Blind Treatment Period|Physician Decision|1|||
130250738|NCT02057666|468878989|FG001|Double Blind Treatment Period|Physician Decision|0|||
130250739|NCT02057666|468878988|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
130250740|NCT02057666|468878989|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
130250741|NCT02057666|468878988|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
130250742|NCT02057666|468878989|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
130250743|NCT02057666|468878988|FG000|Double Blind Treatment Period|Sponsor's request|70|||
130250744|NCT02057666|468878989|FG001|Double Blind Treatment Period|Sponsor's request|34|||
130250745|NCT02057666|468878988|FG000|Open-Label Treatment Period|Poor tolerability|0|||
130250746|NCT02057666|468878989|FG001|Open-Label Treatment Period|Poor tolerability|1|||
130250747|NCT02057666|468878988|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
130250748|NCT02057666|468878989|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
130250749|NCT02057666|468878988|FG000|Open-Label Treatment Period|Sponsor's request|0|||
130250750|NCT02057666|468878989|FG001|Open-Label Treatment Period|Sponsor's request|4|||
130250751|NCT00236197|468878994|FG000|Overall Study|Withdrawal by Subject|3|||
130250752|NCT00236197|468878995|FG001|Overall Study|Withdrawal by Subject|2|||
130250753|NCT00236197|468878994|FG000|Overall Study|Lost to Follow-up|1|||
130250754|NCT00236197|468878995|FG001|Overall Study|Lost to Follow-up|5|||
130250755|NCT00236197|468878994|FG000|Overall Study|Protocol Violation|0|||
130250756|NCT00236197|468878995|FG001|Overall Study|Protocol Violation|3|||
130250757|NCT00236197|468878994|FG000|Overall Study|Medication non-compliance|1|||
130250758|NCT00236197|468878995|FG001|Overall Study|Medication non-compliance|2|||
130250759|NCT00236197|468878994|FG000|Overall Study|Other|0|||
130250760|NCT00236197|468878995|FG001|Overall Study|Other|2|||
130250761|NCT01793129|468881076|FG000|Overall Study|Lost to Follow-up|3|||
130250762|NCT01793129|468881077|FG001|Overall Study|Lost to Follow-up|7|||
130250763|NCT01793129|468881076|FG000|Overall Study|Withdrawal by Subject|0|||
130250764|NCT01793129|468881077|FG001|Overall Study|Withdrawal by Subject|2|||
130250765|NCT01428713|468881080|FG000|Overall Study|Non-compliance|2|||
130250766|NCT01428713|468881081|FG001|Overall Study|Non-compliance|2|||
130250767|NCT01428713|468881080|FG000|Overall Study|Withdrawal by Subject|1|||
130250768|NCT01428713|468881081|FG001|Overall Study|Withdrawal by Subject|1|||
130250769|NCT01428713|468881080|FG000|Overall Study|Adverse Event|0|||
130250770|NCT01428713|468881081|FG001|Overall Study|Adverse Event|2|||
130100943|NCT02181673|468327284|FG000|Up to Week 24|Lost to Follow-up|1|||
130250771|NCT00862277|468881082|FG000|Overall Study|Protocol Violation|1|||
130250772|NCT00862277|468881083|FG001|Overall Study|Protocol Violation|2|||
130250773|NCT00862277|468881084|FG002|Overall Study|Protocol Violation|5|||
130250774|NCT01052428|468881085|FG000|Overall Study|Death|1|||
130250775|NCT01052428|468881086|FG001|Overall Study|Death|0|||
130250776|NCT01052428|468881085|FG000|Overall Study|Withdrawal by Subject|0|||
130250777|NCT01052428|468881086|FG001|Overall Study|Withdrawal by Subject|1|||
130250778|NCT00871000|468881087|FG000|Overall Study|Withdrawal by Subject|1|||
130031126|NCT00792298|468070622|FG005|Treatment Period 2|Physician Decision|0|||
130031127|NCT00792298|468070623|FG006|Treatment Period 2|Physician Decision|1|||
130031128|NCT00792298|468070624|FG007|Treatment Period 2|Physician Decision|0|||
130031129|NCT00792298|468070617|FG000|Treatment Period 2|Pregnancy|0|||
130031130|NCT00792298|468070618|FG001|Treatment Period 2|Pregnancy|0|||
130250779|NCT00871000|468881088|FG001|Overall Study|Withdrawal by Subject|0|||
130250780|NCT00605657|468881090|FG000|Overall Study|Adverse Event|1|||
130250781|NCT00605657|468881090|FG000|Overall Study|Protocol Violation|1|||
130250782|NCT01034657|468881092|FG000|Core Phase|Withdrawal by Subject|1|||
130250783|NCT01034657|468881093|FG001|Core Phase|Withdrawal by Subject|0|||
130250784|NCT01034657|468881094|FG002|Core Phase|Withdrawal by Subject|0|||
130250785|NCT01034657|468881092|FG000|Core Phase|Lack of Efficacy|2|||
130250786|NCT01034657|468881093|FG001|Core Phase|Lack of Efficacy|0|||
130250787|NCT01034657|468881094|FG002|Core Phase|Lack of Efficacy|0|||
130250788|NCT01034657|468881092|FG000|Core Phase|Abnormal laboratory value|1|||
130250789|NCT01034657|468881093|FG001|Core Phase|Abnormal laboratory value|0|||
130250790|NCT01034657|468881094|FG002|Core Phase|Abnormal laboratory value|0|||
130250791|NCT01034657|468881092|FG000|Core Phase|Adverse Event|8|||
130250792|NCT01034657|468881093|FG001|Core Phase|Adverse Event|0|||
130250793|NCT01034657|468881094|FG002|Core Phase|Adverse Event|0|||
130250794|NCT01034657|468881092|FG000|Core Phase|Protocol Violation|2|||
130250795|NCT01034657|468881093|FG001|Core Phase|Protocol Violation|0|||
130250796|NCT01034657|468881094|FG002|Core Phase|Protocol Violation|0|||
130250797|NCT01034657|468881092|FG000|Randomized Phase|Withdrawal by Subject|0|||
130250798|NCT01034657|468881093|FG001|Randomized Phase|Withdrawal by Subject|2|||
130250799|NCT01034657|468881094|FG002|Randomized Phase|Withdrawal by Subject|0|||
130250800|NCT01034657|468881092|FG000|Randomized Phase|Lack of Efficacy|5|||
130250801|NCT01034657|468881093|FG001|Randomized Phase|Lack of Efficacy|1|||
130250802|NCT01034657|468881094|FG002|Randomized Phase|Lack of Efficacy|0|||
130250803|NCT01034657|468881092|FG000|Randomized Phase|Abnormal laboratory value|0|||
130031131|NCT00792298|468070619|FG002|Treatment Period 2|Pregnancy|1|||
130250804|NCT01034657|468881093|FG001|Randomized Phase|Abnormal laboratory value|1|||
130250805|NCT01034657|468881094|FG002|Randomized Phase|Abnormal laboratory value|0|||
130250806|NCT01034657|468881092|FG000|Randomized Phase|Adverse Event|0|||
130250807|NCT01034657|468881093|FG001|Randomized Phase|Adverse Event|2|||
130250808|NCT01034657|468881094|FG002|Randomized Phase|Adverse Event|1|||
130250809|NCT01791205|468881095|FG000|Phase II|Lack of Efficacy|6|||
130250810|NCT01791205|468881096|FG001|Phase II|Lack of Efficacy|0|||
130031132|NCT00792298|468070620|FG003|Treatment Period 2|Pregnancy|0|||
130031133|NCT00792298|468070621|FG004|Treatment Period 2|Pregnancy|0|||
130250811|NCT01791205|468881095|FG000|Phase II|Adverse Event|2|||
130250812|NCT01791205|468881096|FG001|Phase II|Adverse Event|0|||
130250813|NCT01791205|468881095|FG000|Phase II|Safety|1|||
130250814|NCT01791205|468881096|FG001|Phase II|Safety|0|||
130250815|NCT01791205|468881095|FG000|Phase II|Lost to Follow-up|1|||
130250816|NCT01791205|468881096|FG001|Phase II|Lost to Follow-up|0|||
130250817|NCT01791205|468881095|FG000|Phase II|Remission of disease|1|||
130250818|NCT01791205|468881096|FG001|Phase II|Remission of disease|0|||
130250819|NCT01791205|468881095|FG000|Phase II|Physician's decision|1|||
129884937|NCT00876460|467538736|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
130031134|NCT00792298|468070622|FG005|Treatment Period 2|Pregnancy|0|||
130031135|NCT00792298|468070623|FG006|Treatment Period 2|Pregnancy|0|||
130031136|NCT00792298|468070624|FG007|Treatment Period 2|Pregnancy|0|||
130031137|NCT00792298|468070617|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130031138|NCT00792298|468070618|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130031139|NCT00792298|468070619|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130031140|NCT00792298|468070620|FG003|Treatment Period 2|Withdrawal by Subject|2|||
130031141|NCT00792298|468070621|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130031142|NCT00792298|468070622|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130031143|NCT00792298|468070623|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130031144|NCT00792298|468070624|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130031145|NCT04007159|468070630|FG000|Induction Phase|(missed study visits)|16|||
130031146|NCT04007159|468070630|FG000|Induction Phase|Withdrawal by Subject|4|||
130031147|NCT04007159|468070630|FG000|Induction Phase|Adverse Event|2|||
130031148|NCT04007159|468070630|FG000|Challenge Phase|missed study visits|3|||
130031149|NCT04258579|468070632|FG000|Overall Study|Withdrawal by Subject|7|||
130031150|NCT04258579|468070632|FG000|Overall Study|Lost to Follow-up|3|||
130031151|NCT04258579|468070632|FG000|Overall Study|Protocol Violation|2|||
130031152|NCT04258579|468070632|FG000|Overall Study|Adverse Event|1|||
130031153|NCT02388295|468070633|FG000|Dose Escalation Week 1|Adverse Event|1|||
130031154|NCT02388295|468070634|FG001|Dose Escalation Week 1|Adverse Event|2|||
130031155|NCT02388295|468070635|FG002|Dose Escalation Week 1|Adverse Event|1|||
130031156|NCT02388295|468070633|FG000|Dose Escalation Week 1|Determined not eligible|1|||
130031157|NCT02388295|468070634|FG001|Dose Escalation Week 1|Determined not eligible|1|||
130031158|NCT02388295|468070635|FG002|Dose Escalation Week 1|Determined not eligible|1|||
130031159|NCT02388295|468070633|FG000|Dose Escalation Week 2|Protocol Violation|0|||
130031160|NCT02388295|468070634|FG001|Dose Escalation Week 2|Protocol Violation|1|||
130031161|NCT02388295|468070635|FG002|Dose Escalation Week 2|Protocol Violation|0|||
130031162|NCT02388295|468070633|FG000|Dose Escalation Week 2|Determined not eligible|1|||
130031163|NCT02388295|468070634|FG001|Dose Escalation Week 2|Determined not eligible|1|||
130031164|NCT02388295|468070635|FG002|Dose Escalation Week 2|Determined not eligible|1|||
130031165|NCT02388295|468070633|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
130031166|NCT02388295|468070634|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
130031167|NCT02388295|468070635|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
130031168|NCT02076165|468070637|FG000|Overall Study|Lost to Follow-up|7|||
130031169|NCT02076165|468070638|FG001|Overall Study|Lost to Follow-up|5|||
130031170|NCT02076165|468070637|FG000|Overall Study|Refused follow-up assessment|1|||
130031171|NCT02076165|468070638|FG001|Overall Study|Refused follow-up assessment|1|||
130031172|NCT03157531|468070642|FG000|Overall Study|Death|2|||
130031173|NCT03157531|468070642|FG000|Overall Study|Lost to Follow-up|4|||
130031174|NCT00331006|468070643|FG000|Screening Phase|Withdrawal by Subject|1|||
130031175|NCT00331006|468070643|FG000|Screening Phase|enrollment halted|1|||
130031176|NCT00331006|468070643|FG000|Screening Phase|Lost to Follow-up|1|||
130031177|NCT00331006|468070643|FG000|Screening Phase|Ineligible for treatment phase|4|||
130031178|NCT00331006|468070643|FG000|Treatment Phase|Withdrawal by Subject|1|||
130031179|NCT00331006|468070643|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
130031180|NCT00331006|468070643|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
130031181|NCT01950819|468070644|FG000|Overall Study|Graft Loss|35|||
130031182|NCT01950819|468070645|FG001|Overall Study|Graft Loss|30|||
130031183|NCT01950819|468070644|FG000|Overall Study|Death|29|||
130031184|NCT01950819|468070645|FG001|Overall Study|Death|34|||
130031185|NCT01950819|468070644|FG000|Overall Study|Subject / Gardian decision|54|||
130031186|NCT01950819|468070645|FG001|Overall Study|Subject / Gardian decision|51|||
130031187|NCT01950819|468070644|FG000|Overall Study|technical problems|2|||
130031188|NCT01950819|468070645|FG001|Overall Study|technical problems|0|||
130031189|NCT01950819|468070644|FG000|Overall Study|Pregnancy|0|||
130031190|NCT01950819|468070645|FG001|Overall Study|Pregnancy|2|||
130031191|NCT01950819|468070644|FG000|Overall Study|Lost to Follow-up|9|||
130031192|NCT01950819|468070645|FG001|Overall Study|Lost to Follow-up|17|||
130031193|NCT02928952|468070649|FG000|Overall Study|Lost to Follow-up|5|||
130031194|NCT02928952|468070650|FG001|Overall Study|Lost to Follow-up|5|||
130031195|NCT02928952|468070649|FG000|Overall Study|Withdrawal by Subject|5|||
130031196|NCT02928952|468070650|FG001|Overall Study|Withdrawal by Subject|1|||
130031197|NCT02928952|468070649|FG000|Overall Study|Physician Decision|0|||
130031198|NCT02928952|468070650|FG001|Overall Study|Physician Decision|1|||
130250820|NCT01791205|468881096|FG001|Phase II|Physician's decision|0|||
130031199|NCT00723957|468070651|FG000|Overall Study|Adverse event unrelated to study drug|1|||
130250821|NCT02242903|468881107|FG000|Overall Study|Withdrawal by Subject|1|||
130250822|NCT02242903|468881108|FG001|Overall Study|Withdrawal by Subject|0|||
130250823|NCT02242903|468881109|FG002|Overall Study|Withdrawal by Subject|0|||
130250824|NCT02242903|468881110|FG003|Overall Study|Withdrawal by Subject|0|||
130250825|NCT02242903|468881111|FG004|Overall Study|Withdrawal by Subject|0|||
130250826|NCT02242903|468881112|FG005|Overall Study|Withdrawal by Subject|0|||
130250827|NCT02242903|468881113|FG006|Overall Study|Withdrawal by Subject|0|||
130250828|NCT01546987|468881118|FG000|Overall Study|Protocol Violation|3|||
130250829|NCT01546987|468881119|FG001|Overall Study|Protocol Violation|4|||
130250830|NCT03473301|468881122|FG000|Overall Study|Protocol Violation|4|||
130250831|NCT03473301|468881123|FG001|Overall Study|Protocol Violation|0|||
130250832|NCT03473301|468881124|FG002|Overall Study|Protocol Violation|0|||
130250833|NCT03473301|468881122|FG000|Overall Study|Withdrawal by Subject|0|||
130250834|NCT03473301|468881123|FG001|Overall Study|Withdrawal by Subject|1|||
130250835|NCT03473301|468881124|FG002|Overall Study|Withdrawal by Subject|0|||
130250836|NCT03473301|468881122|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
130250837|NCT03473301|468881123|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
130250838|NCT03473301|468881124|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
130250839|NCT05287685|468881125|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
130250840|NCT05287685|468881126|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
130250841|NCT05287685|468881125|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
130250842|NCT05287685|468881126|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
130250843|NCT04135352|468881127|FG000|Overall Study|Not treated-randomization error|0|||
130250844|NCT04135352|468881128|FG001|Overall Study|Not treated-randomization error|0|||
130250845|NCT04135352|468881129|FG002|Overall Study|Not treated-randomization error|1|||
130250846|NCT04135352|468881130|FG003|Overall Study|Not treated-randomization error|0|||
130250847|NCT04135352|468881131|FG004|Overall Study|Not treated-randomization error|0|||
130250848|NCT04135352|468881132|FG005|Overall Study|Not treated-randomization error|0|||
130250849|NCT04135352|468881133|FG006|Overall Study|Not treated-randomization error|0|||
130250850|NCT04135352|468881134|FG007|Overall Study|Not treated-randomization error|0|||
130250851|NCT04135352|468881127|FG000|Overall Study|Withdrawal by Subject|0|||
130250852|NCT04135352|468881128|FG001|Overall Study|Withdrawal by Subject|0|||
130250853|NCT04135352|468881129|FG002|Overall Study|Withdrawal by Subject|2|||
130250854|NCT04135352|468881130|FG003|Overall Study|Withdrawal by Subject|0|||
130250855|NCT04135352|468881131|FG004|Overall Study|Withdrawal by Subject|0|||
130250856|NCT04135352|468881132|FG005|Overall Study|Withdrawal by Subject|0|||
130250857|NCT04135352|468881133|FG006|Overall Study|Withdrawal by Subject|0|||
130250858|NCT04135352|468881134|FG007|Overall Study|Withdrawal by Subject|0|||
130250859|NCT04135352|468881127|FG000|Overall Study|Sponsor Decision|0|||
130250860|NCT04135352|468881128|FG001|Overall Study|Sponsor Decision|0|||
130250861|NCT04135352|468881129|FG002|Overall Study|Sponsor Decision|2|||
130250862|NCT04135352|468881130|FG003|Overall Study|Sponsor Decision|5|||
130250863|NCT04135352|468881131|FG004|Overall Study|Sponsor Decision|1|||
130250864|NCT04135352|468881132|FG005|Overall Study|Sponsor Decision|4|||
130250865|NCT04135352|468881133|FG006|Overall Study|Sponsor Decision|0|||
130250866|NCT04135352|468881134|FG007|Overall Study|Sponsor Decision|0|||
130250867|NCT04135352|468881127|FG000|Overall Study|Physician Decision|0|||
130250868|NCT04135352|468881128|FG001|Overall Study|Physician Decision|0|||
130250869|NCT04135352|468881129|FG002|Overall Study|Physician Decision|1|||
130250870|NCT04135352|468881130|FG003|Overall Study|Physician Decision|0|||
130250871|NCT04135352|468881131|FG004|Overall Study|Physician Decision|1|||
130250872|NCT04135352|468881132|FG005|Overall Study|Physician Decision|0|||
130250873|NCT04135352|468881133|FG006|Overall Study|Physician Decision|0|||
130250874|NCT04135352|468881134|FG007|Overall Study|Physician Decision|0|||
130250875|NCT04135352|468881127|FG000|Overall Study|Death|3|||
130250876|NCT04135352|468881128|FG001|Overall Study|Death|4|||
130250877|NCT04135352|468881129|FG002|Overall Study|Death|7|||
130250878|NCT04135352|468881130|FG003|Overall Study|Death|0|||
130250879|NCT04135352|468881131|FG004|Overall Study|Death|3|||
130250880|NCT04135352|468881132|FG005|Overall Study|Death|1|||
130250881|NCT04135352|468881133|FG006|Overall Study|Death|0|||
130250882|NCT04135352|468881134|FG007|Overall Study|Death|0|||
130250883|NCT03093870|468881135|FG000|Overall Study|Withdrawal by Subject|2|||
130250884|NCT03093870|468881136|FG001|Overall Study|Withdrawal by Subject|6|||
130031200|NCT00723957|468070652|FG001|Overall Study|Adverse event unrelated to study drug|4|||
130031201|NCT00723957|468070651|FG000|Overall Study|Death|3|||
130031202|NCT00723957|468070652|FG001|Overall Study|Death|4|||
130031203|NCT00723957|468070651|FG000|Overall Study|Disease progression|27|||
130031204|NCT00723957|468070652|FG001|Overall Study|Disease progression|25|||
130250885|NCT03093870|468881137|FG002|Overall Study|Withdrawal by Subject|5|||
130250886|NCT03093870|468881135|FG000|Overall Study|Death|1|||
130250887|NCT03093870|468881136|FG001|Overall Study|Death|35|||
130250888|NCT03093870|468881137|FG002|Overall Study|Death|35|||
130250889|NCT03093870|468881135|FG000|Overall Study|Radiographic disease progression|10|||
130250890|NCT03093870|468881136|FG001|Overall Study|Radiographic disease progression|0|||
130250891|NCT03093870|468881137|FG002|Overall Study|Radiographic disease progression|0|||
130250892|NCT03093870|468881135|FG000|Overall Study|Clinical disease progression|1|||
130250893|NCT03093870|468881136|FG001|Overall Study|Clinical disease progression|0|||
130250894|NCT03093870|468881137|FG002|Overall Study|Clinical disease progression|0|||
130250895|NCT03093870|468881135|FG000|Overall Study|Physician Decision|2|||
130250896|NCT03093870|468881136|FG001|Overall Study|Physician Decision|0|||
130250897|NCT03093870|468881137|FG002|Overall Study|Physician Decision|0|||
130250898|NCT03093870|468881135|FG000|Overall Study|Adverse Event|7|||
130250899|NCT03093870|468881136|FG001|Overall Study|Adverse Event|0|||
130250900|NCT03093870|468881137|FG002|Overall Study|Adverse Event|0|||
130250901|NCT03093870|468881135|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
130250902|NCT03093870|468881136|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
130250903|NCT03093870|468881137|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
130250904|NCT03093870|468881135|FG000|Overall Study|Lost to Follow-up|0|||
130250905|NCT03093870|468881136|FG001|Overall Study|Lost to Follow-up|0|||
130250906|NCT03093870|468881137|FG002|Overall Study|Lost to Follow-up|1|||
130250907|NCT03722030|468881143|FG000|Overall Study|Withdrawal by Subject|1|||
130250908|NCT03722030|468881144|FG001|Overall Study|Withdrawal by Subject|0|||
130250909|NCT02191397|468881146|FG000|Overall Study|Adverse Event|28|||
130250910|NCT02191397|468881147|FG001|Overall Study|Adverse Event|17|||
130250911|NCT02191397|468881146|FG000|Overall Study|Lack of Efficacy|10|||
130250912|NCT02191397|468881147|FG001|Overall Study|Lack of Efficacy|5|||
130250913|NCT02191397|468881146|FG000|Overall Study|Protocol Violation|0|||
130250914|NCT02191397|468881147|FG001|Overall Study|Protocol Violation|3|||
130250915|NCT02191397|468881146|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
130250916|NCT02191397|468881147|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
130250917|NCT02191397|468881146|FG000|Overall Study|Lost to Follow-up|10|||
130250918|NCT02191397|468881147|FG001|Overall Study|Lost to Follow-up|11|||
130250919|NCT02191397|468881146|FG000|Overall Study|Physician Decision|8|||
130250920|NCT02191397|468881147|FG001|Overall Study|Physician Decision|3|||
130250921|NCT02191397|468881146|FG000|Overall Study|Withdrawal by Subject|22|||
130250922|NCT02191397|468881147|FG001|Overall Study|Withdrawal by Subject|27|||
130250923|NCT03721107|468881148|FG000|Overall Study|Adverse Event|1|||
130250924|NCT03721107|468881149|FG001|Overall Study|Adverse Event|1|||
130250925|NCT03721107|468881150|FG002|Overall Study|Adverse Event|6|||
130250926|NCT03721107|468881151|FG003|Overall Study|Adverse Event|5|||
130250927|NCT03721107|468881148|FG000|Overall Study|Lost to Follow-up|2|||
130250928|NCT03721107|468881149|FG001|Overall Study|Lost to Follow-up|0|||
130250929|NCT03721107|468881150|FG002|Overall Study|Lost to Follow-up|3|||
130250930|NCT03721107|468881151|FG003|Overall Study|Lost to Follow-up|0|||
130250931|NCT03721107|468881148|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130250932|NCT03721107|468881149|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130250933|NCT03721107|468881150|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
130250934|NCT03721107|468881151|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
130250935|NCT03721107|468881148|FG000|Overall Study|Physician Decision|0|||
130250936|NCT03721107|468881149|FG001|Overall Study|Physician Decision|1|||
130250937|NCT03721107|468881150|FG002|Overall Study|Physician Decision|0|||
130250938|NCT03721107|468881151|FG003|Overall Study|Physician Decision|0|||
130250939|NCT03721107|468881148|FG000|Overall Study|Pregnancy|0|||
130250940|NCT03721107|468881149|FG001|Overall Study|Pregnancy|0|||
130250941|NCT03721107|468881150|FG002|Overall Study|Pregnancy|1|||
130250942|NCT03721107|468881151|FG003|Overall Study|Pregnancy|0|||
130250943|NCT03721107|468881148|FG000|Overall Study|Withdrawal by Subject|1|||
130250944|NCT03721107|468881149|FG001|Overall Study|Withdrawal by Subject|1|||
130250945|NCT03721107|468881150|FG002|Overall Study|Withdrawal by Subject|5|||
130250946|NCT03721107|468881151|FG003|Overall Study|Withdrawal by Subject|5|||
130250947|NCT03721107|468881148|FG000|Overall Study|Other|1|||
130250948|NCT03721107|468881149|FG001|Overall Study|Other|0|||
130250949|NCT03721107|468881150|FG002|Overall Study|Other|0|||
130250950|NCT03721107|468881151|FG003|Overall Study|Other|1|||
130250951|NCT03888482|468881152|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
130250952|NCT03888482|468881153|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
130250953|NCT03888482|468881152|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
130250954|NCT03888482|468881153|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
130250955|NCT02554474|468881154|FG000|Overall Study|Protocol Violation|1|||
130250956|NCT02554474|468881155|FG001|Overall Study|Protocol Violation|1|||
130250957|NCT02554474|468881154|FG000|Overall Study|Health issue not related to the study|1|||
130250958|NCT02554474|468881155|FG001|Overall Study|Health issue not related to the study|0|||
130031205|NCT00723957|468070651|FG000|Overall Study|Maximum clinical benefit|4|||
130031206|NCT00723957|468070652|FG001|Overall Study|Maximum clinical benefit|5|||
130031207|NCT00723957|468070651|FG000|Overall Study|Investigator decision|1|||
130031208|NCT00723957|468070652|FG001|Overall Study|Investigator decision|1|||
130031209|NCT00723957|468070651|FG000|Overall Study|Study drug toxicity|4|||
130031210|NCT00723957|468070652|FG001|Overall Study|Study drug toxicity|6|||
130031211|NCT00723957|468070651|FG000|Overall Study|Withdrawal by Subject|7|||
130031212|NCT00723957|468070652|FG001|Overall Study|Withdrawal by Subject|5|||
130031213|NCT00723957|468070651|FG000|Overall Study|Reason not analyzed|1|||
130031214|NCT00723957|468070652|FG001|Overall Study|Reason not analyzed|0|||
130031215|NCT00723957|468070651|FG000|Overall Study|Never received treatment|3|||
130031216|NCT00723957|468070652|FG001|Overall Study|Never received treatment|3|||
130031217|NCT01850615|468070654|FG000|Overall Study|Protocol Violation|4|||
130031218|NCT01850615|468070655|FG001|Overall Study|Protocol Violation|1|||
130250959|NCT02554474|468881154|FG000|Overall Study|Withdrawal by Subject|1|||
130250960|NCT02554474|468881155|FG001|Overall Study|Withdrawal by Subject|1|||
130250961|NCT02991859|468881156|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250962|NCT02991859|468881157|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
130250963|NCT02991859|468881158|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130031219|NCT01850615|468070654|FG000|Overall Study|Adverse Event|2|||
130250964|NCT02991859|468881159|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250965|NCT02991859|468881160|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
130250966|NCT02991859|468881161|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250967|NCT02991859|468881162|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250968|NCT02991859|468881163|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250969|NCT02991859|468881164|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250970|NCT02991859|468881165|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250971|NCT02991859|468881166|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250972|NCT02991859|468881167|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250973|NCT02991859|468881168|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250974|NCT02991859|468881169|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250975|NCT02991859|468881170|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250976|NCT02991859|468881171|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250977|NCT02991859|468881172|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
130250978|NCT02991859|468881156|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250979|NCT02991859|468881157|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250980|NCT02991859|468881158|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250981|NCT02991859|468881159|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250982|NCT02991859|468881160|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250983|NCT02991859|468881161|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250984|NCT02991859|468881162|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250985|NCT02991859|468881163|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250986|NCT02991859|468881164|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250987|NCT02991859|468881165|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250988|NCT02991859|468881166|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250989|NCT02991859|468881167|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250990|NCT02991859|468881168|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
130250991|NCT02991859|468881169|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
130250992|NCT02991859|468881170|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250993|NCT02991859|468881171|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250994|NCT02991859|468881172|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
130250995|NCT02991859|468881156|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250996|NCT02991859|468881157|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250997|NCT02991859|468881158|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250998|NCT02991859|468881159|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130250999|NCT02991859|468881160|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130031220|NCT01850615|468070655|FG001|Overall Study|Adverse Event|1|||
130031221|NCT01850615|468070654|FG000|Overall Study|Withdrawal by Subject|3|||
130031222|NCT01850615|468070655|FG001|Overall Study|Withdrawal by Subject|1|||
130031223|NCT01850615|468070654|FG000|Overall Study|Lost to Follow-up|0|||
130031224|NCT01850615|468070655|FG001|Overall Study|Lost to Follow-up|1|||
130031225|NCT01850615|468070654|FG000|Overall Study|Unclassified|0|||
130031226|NCT01850615|468070655|FG001|Overall Study|Unclassified|1|||
130031227|NCT00706628|468070656|FG000|Overall Study|Other Adverse Event|16|||
130031228|NCT00706628|468070657|FG001|Overall Study|Other Adverse Event|5|||
130031229|NCT00706628|468070658|FG002|Overall Study|Other Adverse Event|5|||
130031230|NCT00706628|468070659|FG003|Overall Study|Other Adverse Event|2|||
130031231|NCT00706628|468070656|FG000|Overall Study|Non compliant with protocol|0|||
130031232|NCT00706628|468070657|FG001|Overall Study|Non compliant with protocol|1|||
130031233|NCT00706628|468070658|FG002|Overall Study|Non compliant with protocol|0|||
130031234|NCT00706628|468070659|FG003|Overall Study|Non compliant with protocol|0|||
130031235|NCT00706628|468070656|FG000|Overall Study|Consent withdrawn|6|||
130031236|NCT00706628|468070657|FG001|Overall Study|Consent withdrawn|1|||
130031237|NCT00706628|468070658|FG002|Overall Study|Consent withdrawn|3|||
130031238|NCT00706628|468070659|FG003|Overall Study|Consent withdrawn|0|||
130031239|NCT00706628|468070656|FG000|Overall Study|Progressive disease|20|||
130031240|NCT00706628|468070657|FG001|Overall Study|Progressive disease|13|||
130100944|NCT02181673|468327285|FG001|Up to Week 24|Lost to Follow-up|0|||
130100945|NCT02181673|468327286|FG002|Up to Week 24|Lost to Follow-up|0|||
130100946|NCT02181673|468327284|FG000|Up to Week 24|Physician Decision|0|||
130100947|NCT02181673|468327285|FG001|Up to Week 24|Physician Decision|0|||
130100948|NCT02181673|468327286|FG002|Up to Week 24|Physician Decision|3|||
130100949|NCT02181673|468327284|FG000|Up to Week 24|Withdrawal by Subject|10|||
130100950|NCT02181673|468327285|FG001|Up to Week 24|Withdrawal by Subject|0|||
130100951|NCT02181673|468327286|FG002|Up to Week 24|Withdrawal by Subject|1|||
130100952|NCT02181673|468327284|FG000|Up to Week 24|Other|2|||
130100953|NCT02181673|468327285|FG001|Up to Week 24|Other|0|||
130100954|NCT02181673|468327286|FG002|Up to Week 24|Other|3|||
130100955|NCT02181673|468327284|FG000|Up to Week 24|Randomized not Treated|0|||
130100956|NCT02181673|468327285|FG001|Up to Week 24|Randomized not Treated|0|||
130100957|NCT02181673|468327286|FG002|Up to Week 24|Randomized not Treated|1|||
130100958|NCT02181673|468327284|FG000|Week 24-Week 60|Adverse Event|0|||
130100959|NCT02181673|468327285|FG001|Week 24-Week 60|Adverse Event|4|||
130100960|NCT02181673|468327286|FG002|Week 24-Week 60|Adverse Event|10|||
130100961|NCT02181673|468327284|FG000|Week 24-Week 60|Other|0|||
130100962|NCT02181673|468327285|FG001|Week 24-Week 60|Other|2|||
130100963|NCT02181673|468327286|FG002|Week 24-Week 60|Other|1|||
130100964|NCT02181673|468327284|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
130100965|NCT02181673|468327285|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
130031241|NCT00706628|468070658|FG002|Overall Study|Progressive disease|8|||
130031242|NCT00706628|468070659|FG003|Overall Study|Progressive disease|1|||
130031243|NCT00706628|468070656|FG000|Overall Study|Other than those stated above|4|||
130031244|NCT00706628|468070657|FG001|Overall Study|Other than those stated above|0|||
130031245|NCT00706628|468070658|FG002|Overall Study|Other than those stated above|0|||
130031246|NCT00706628|468070659|FG003|Overall Study|Other than those stated above|0|||
130031247|NCT00706628|468070656|FG000|Overall Study|Not treated|1|||
130031248|NCT00706628|468070657|FG001|Overall Study|Not treated|1|||
130031249|NCT00706628|468070658|FG002|Overall Study|Not treated|0|||
130031250|NCT00706628|468070659|FG003|Overall Study|Not treated|0|||
130031251|NCT02266433|468070664|FG000|Overall Study|Lost to Follow-up|54|||
130100966|NCT02181673|468327286|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
130100967|NCT02181673|468327284|FG000|Week 24-Week 60|Pregnancy|0|||
130100968|NCT02181673|468327285|FG001|Week 24-Week 60|Pregnancy|0|||
130100969|NCT02181673|468327286|FG002|Week 24-Week 60|Pregnancy|1|||
130100970|NCT02181673|468327284|FG000|Week 24-Week 60|Lack of Efficacy|0|||
130100971|NCT02181673|468327285|FG001|Week 24-Week 60|Lack of Efficacy|0|||
130100972|NCT02181673|468327286|FG002|Week 24-Week 60|Lack of Efficacy|1|||
130100973|NCT02181673|468327284|FG000|Week 24-Week 60|Lost to Follow-up|0|||
130100974|NCT02181673|468327285|FG001|Week 24-Week 60|Lost to Follow-up|0|||
130100975|NCT02181673|468327286|FG002|Week 24-Week 60|Lost to Follow-up|1|||
130100976|NCT02181673|468327284|FG000|Week 24-Week 60|Physician Decision|0|||
130100977|NCT02181673|468327285|FG001|Week 24-Week 60|Physician Decision|0|||
130100978|NCT02181673|468327286|FG002|Week 24-Week 60|Physician Decision|1|||
130100979|NCT00433771|468327287|FG000|Overall Study|screen fail|14|||
130100980|NCT00433771|468327287|FG000|Overall Study|Treated and later found to be ineligible|2|||
130100981|NCT00433771|468327287|FG000|Overall Study|Death|2|||
130100982|NCT00433771|468327287|FG000|Overall Study|Failure to deploy stent|1|||
130100983|NCT02230332|468327290|FG000|Overall Study|Adverse Event|2|||
130100984|NCT02230332|468327291|FG001|Overall Study|Adverse Event|1|||
130100985|NCT02230332|468327290|FG000|Overall Study|Lost to Follow-up|1|||
130100986|NCT02230332|468327291|FG001|Overall Study|Lost to Follow-up|0|||
130100987|NCT02230332|468327290|FG000|Overall Study|Protocol Violation|1|||
130100988|NCT02230332|468327291|FG001|Overall Study|Protocol Violation|0|||
130100989|NCT01036594|468327293|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
130100990|NCT01036594|468327294|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
130100991|NCT01036594|468327293|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
130100992|NCT01036594|468327294|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
129884938|NCT00876460|467538737|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
130031252|NCT02266433|468070665|FG001|Overall Study|Lost to Follow-up|46|||
130100993|NCT01036594|468327293|FG000|Week 12 Evaluation|Adverse Event|5|||
130100994|NCT01036594|468327294|FG001|Week 12 Evaluation|Adverse Event|0|||
130100995|NCT01036594|468327293|FG000|Week 12 Evaluation|Physician Decision|1|||
130100996|NCT01036594|468327294|FG001|Week 12 Evaluation|Physician Decision|0|||
130100997|NCT01036594|468327293|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
130100998|NCT01036594|468327294|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
130100999|NCT01036594|468327293|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
130101000|NCT01036594|468327294|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
130031253|NCT02266433|468070664|FG000|Overall Study|Withdrawal by Subject|5|||
130031254|NCT02266433|468070665|FG001|Overall Study|Withdrawal by Subject|7|||
130101001|NCT01036594|468327293|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
130101002|NCT01036594|468327294|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
130101003|NCT01036594|468327293|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
130101004|NCT01036594|468327294|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
130031255|NCT01285349|468070669|FG000|Overall Study|Lost to Follow-up|27|||
130031256|NCT01285349|468070670|FG001|Overall Study|Lost to Follow-up|20|||
130031257|NCT01285349|468070671|FG002|Overall Study|Lost to Follow-up|27|||
130031258|NCT00712348|468070672|FG000|Overall Study|Withdrawal by Subject|1|||
130031259|NCT01194440|468070673|FG000|Baseline (First Dose)|Reason not specified|4|||
130031260|NCT01194440|468070673|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
130031261|NCT01194440|468070673|FG000|Baseline (First Dose)|Change in therapy|1|||
130031262|NCT01194440|468070673|FG000|Baseline (First Dose)|Adverse Event|1|||
130031263|NCT01194440|468070673|FG000|6-months (2nd Dose)|Change in therapy|4|||
130031264|NCT00927563|468070674|FG000|Overall Study|Lost to Follow-up|1|||
130031265|NCT00927563|468070674|FG000|Overall Study|Withdrawal by Subject|1|||
130031266|NCT01468987|468070675|FG000|Overall Study|Adverse Event|12|||
130031267|NCT01468987|468070676|FG001|Overall Study|Adverse Event|9|||
130031268|NCT01468987|468070675|FG000|Overall Study|Death|4|||
130031269|NCT01468987|468070676|FG001|Overall Study|Death|1|||
130031270|NCT01468987|468070675|FG000|Overall Study|Lost to Follow-up|10|||
130031271|NCT01468987|468070676|FG001|Overall Study|Lost to Follow-up|5|||
130031272|NCT01468987|468070675|FG000|Overall Study|Protocol Violation|8|||
130031273|NCT01468987|468070676|FG001|Overall Study|Protocol Violation|2|||
130031274|NCT01468987|468070675|FG000|Overall Study|Withdrawal by Subject|28|||
130031275|NCT01468987|468070676|FG001|Overall Study|Withdrawal by Subject|28|||
130031276|NCT01468987|468070675|FG000|Overall Study|Physician Decision|8|||
130031277|NCT01468987|468070676|FG001|Overall Study|Physician Decision|15|||
130031278|NCT01468987|468070675|FG000|Overall Study|Sponsor Decision|1|||
130031279|NCT01468987|468070676|FG001|Overall Study|Sponsor Decision|0|||
130031280|NCT01245673|468070679|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
130031281|NCT01929135|468070681|FG000|Overall Study|Lost to Follow-up|1|||
130031282|NCT01929135|468070682|FG001|Overall Study|Lost to Follow-up|1|||
130031283|NCT02425098|468070683|FG000|Overall Study|Lost to Follow-up|7|||
130031284|NCT02425098|468070684|FG001|Overall Study|Lost to Follow-up|7|||
130031285|NCT02425098|468070683|FG000|Overall Study|Withdrawal by Subject|4|||
130031286|NCT02425098|468070684|FG001|Overall Study|Withdrawal by Subject|8|||
130031287|NCT02425098|468070683|FG000|Overall Study|Pregnancy|2|||
130031288|NCT02425098|468070684|FG001|Overall Study|Pregnancy|0|||
130031289|NCT02425098|468070683|FG000|Overall Study|Reason not Specified|0|||
130031290|NCT02425098|468070684|FG001|Overall Study|Reason not Specified|1|||
130251000|NCT02991859|468881161|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
130251001|NCT02991859|468881162|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251002|NCT02991859|468881163|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251003|NCT02991859|468881164|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251004|NCT02991859|468881165|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251005|NCT02991859|468881166|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251006|NCT02991859|468881167|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251007|NCT02991859|468881168|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251008|NCT02991859|468881169|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251009|NCT02991859|468881170|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251010|NCT02991859|468881171|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251011|NCT02991859|468881172|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
130251012|NCT02991859|468881156|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251013|NCT02991859|468881157|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251014|NCT02991859|468881158|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251015|NCT02991859|468881159|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251016|NCT02991859|468881160|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251017|NCT02991859|468881161|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251018|NCT02991859|468881162|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251019|NCT02991859|468881163|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251020|NCT02991859|468881164|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251021|NCT02991859|468881165|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
130251022|NCT02991859|468881166|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251023|NCT02991859|468881167|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251024|NCT02991859|468881168|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251025|NCT02991859|468881169|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251026|NCT02991859|468881170|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130031291|NCT02078219|468070685|FG000|Overall Study|Other|2|||
130031292|NCT02078219|468070686|FG001|Overall Study|Other|2|||
130031293|NCT02078219|468070687|FG002|Overall Study|Other|3|||
130031294|NCT02078219|468070688|FG003|Overall Study|Other|0|||
130031295|NCT02078219|468070689|FG004|Overall Study|Other|1|||
130031296|NCT02078219|468070685|FG000|Overall Study|Withdrawal by Subject|0|||
130031297|NCT02078219|468070686|FG001|Overall Study|Withdrawal by Subject|1|||
130031298|NCT02078219|468070687|FG002|Overall Study|Withdrawal by Subject|0|||
130251027|NCT02991859|468881171|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251028|NCT02991859|468881172|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
130251029|NCT02991859|468881156|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251030|NCT02991859|468881157|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251031|NCT02991859|468881158|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251032|NCT02991859|468881159|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130031299|NCT02078219|468070688|FG003|Overall Study|Withdrawal by Subject|1|||
130031300|NCT02078219|468070689|FG004|Overall Study|Withdrawal by Subject|1|||
130031301|NCT02078219|468070685|FG000|Overall Study|Protocol Violation|0|||
130031302|NCT02078219|468070686|FG001|Overall Study|Protocol Violation|0|||
130031303|NCT02078219|468070687|FG002|Overall Study|Protocol Violation|0|||
130251033|NCT02991859|468881160|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251034|NCT02991859|468881161|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251035|NCT02991859|468881162|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251036|NCT02991859|468881163|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251037|NCT02991859|468881164|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
130251038|NCT02991859|468881165|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251039|NCT02991859|468881166|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251040|NCT02991859|468881167|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251041|NCT02991859|468881168|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251042|NCT02991859|468881169|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251043|NCT02991859|468881170|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251044|NCT02991859|468881171|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251045|NCT02991859|468881172|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
130251046|NCT04223687|468881178|FG000|Overall Study|Missing primary outcome|1|||
130251047|NCT04223687|468881179|FG001|Overall Study|Missing primary outcome|0|||
130251048|NCT00425854|468881180|FG000|Overall Study|Progressive Disease|19|||
130251049|NCT00425854|468881181|FG001|Overall Study|Progressive Disease|12|||
130251050|NCT00425854|468881180|FG000|Overall Study|Dose reduction toxicity AE|8|||
130251051|NCT00425854|468881181|FG001|Overall Study|Dose reduction toxicity AE|7|||
130251052|NCT00425854|468881180|FG000|Overall Study|Other Adverse Event|2|||
130251053|NCT00425854|468881181|FG001|Overall Study|Other Adverse Event|2|||
130251054|NCT03163264|468881187|FG000|Overall Study|Withdrawal by Subject|13|||
130251055|NCT03163264|468881188|FG001|Overall Study|Withdrawal by Subject|3|||
130251056|NCT03163264|468881189|FG002|Overall Study|Withdrawal by Subject|4|||
130251057|NCT03163264|468881190|FG003|Overall Study|Withdrawal by Subject|2|||
130251058|NCT03163264|468881187|FG000|Overall Study|Lost to Follow-up|17|||
130251059|NCT03163264|468881188|FG001|Overall Study|Lost to Follow-up|20|||
130251060|NCT03163264|468881189|FG002|Overall Study|Lost to Follow-up|0|||
130251061|NCT03163264|468881190|FG003|Overall Study|Lost to Follow-up|0|||
130251062|NCT03163264|468881187|FG000|Overall Study|Death|0|||
130251063|NCT03163264|468881188|FG001|Overall Study|Death|2|||
130251064|NCT03163264|468881189|FG002|Overall Study|Death|0|||
130251065|NCT03163264|468881190|FG003|Overall Study|Death|0|||
130251066|NCT02614066|468881191|FG000|Overall Study|Death|6|||
130251067|NCT02614066|468881192|FG001|Overall Study|Death|14|||
130251068|NCT02614066|468881193|FG002|Overall Study|Death|11|||
130251069|NCT02614066|468881194|FG003|Overall Study|Death|29|||
130251070|NCT02614066|468881191|FG000|Overall Study|Full consent withdrawn|0|||
130251071|NCT02614066|468881192|FG001|Overall Study|Full consent withdrawn|1|||
130251072|NCT02614066|468881193|FG002|Overall Study|Full consent withdrawn|0|||
130251073|NCT02614066|468881194|FG003|Overall Study|Full consent withdrawn|8|||
130251074|NCT02614066|468881191|FG000|Overall Study|Lost to Follow-up|0|||
130251075|NCT02614066|468881192|FG001|Overall Study|Lost to Follow-up|2|||
130251076|NCT02614066|468881193|FG002|Overall Study|Lost to Follow-up|2|||
130251077|NCT02614066|468881194|FG003|Overall Study|Lost to Follow-up|2|||
130251078|NCT02614066|468881191|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
130251079|NCT02614066|468881192|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
130251080|NCT02614066|468881193|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
130251081|NCT02614066|468881194|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
130251082|NCT02614066|468881191|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
130031304|NCT02078219|468070688|FG003|Overall Study|Protocol Violation|1|||
130031305|NCT02078219|468070689|FG004|Overall Study|Protocol Violation|0|||
130031306|NCT02078219|468070685|FG000|Overall Study|Death|0|||
130031307|NCT02078219|468070686|FG001|Overall Study|Death|0|||
130031308|NCT02078219|468070687|FG002|Overall Study|Death|0|||
130031309|NCT02078219|468070688|FG003|Overall Study|Death|1|||
130031310|NCT02078219|468070689|FG004|Overall Study|Death|0|||
130031311|NCT02078219|468070685|FG000|Overall Study|Adverse Event|1|||
130031312|NCT02078219|468070686|FG001|Overall Study|Adverse Event|1|||
130251083|NCT02614066|468881192|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
130251084|NCT02614066|468881193|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
130251085|NCT02614066|468881194|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
130251086|NCT02614066|468881191|FG000|Overall Study|Reason not specified|0|||
130251087|NCT02614066|468881192|FG001|Overall Study|Reason not specified|2|||
130031313|NCT02078219|468070687|FG002|Overall Study|Adverse Event|3|||
130031314|NCT02078219|468070688|FG003|Overall Study|Adverse Event|1|||
130031315|NCT02078219|468070689|FG004|Overall Study|Adverse Event|0|||
130031316|NCT04025632|468072544|FG000|Overall Study|Adverse Event|1|||
130251088|NCT02614066|468881193|FG002|Overall Study|Reason not specified|1|||
130251089|NCT02614066|468881194|FG003|Overall Study|Reason not specified|1|||
130251090|NCT05259722|468881201|FG000|Overall Study|Adverse Event|2|||
130251091|NCT05259722|468881202|FG001|Overall Study|Adverse Event|24|||
130251092|NCT05259722|468881201|FG000|Overall Study|Lost to Follow-up|5|||
130251093|NCT05259722|468881202|FG001|Overall Study|Lost to Follow-up|1|||
130251094|NCT05259722|468881201|FG000|Overall Study|Lack of Efficacy|8|||
130251095|NCT05259722|468881202|FG001|Overall Study|Lack of Efficacy|26|||
130251096|NCT05259722|468881201|FG000|Overall Study|Withdrawal by Subject|15|||
130251097|NCT05259722|468881202|FG001|Overall Study|Withdrawal by Subject|33|||
130251098|NCT05259722|468881201|FG000|Overall Study|Various reasons|3|||
130251099|NCT05259722|468881202|FG001|Overall Study|Various reasons|9|||
130251100|NCT05259722|468881201|FG000|Overall Study|Not exposed to IMP|1|||
130251101|NCT05259722|468881202|FG001|Overall Study|Not exposed to IMP|12|||
130251102|NCT05259722|468881201|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
130251103|NCT05259722|468881202|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
130251104|NCT03069937|468881203|FG000|Overall Study|Second primary malignancy noted|1|||
130251105|NCT00962650|468881204|FG000|Overall Study|Transgastric DP was not completed|2|||
130251106|NCT00231465|468881206|FG000|Overall Study|Completed only one cycle|1|||
130251107|NCT00231465|468881206|FG000|Overall Study|Did not have follow up CT scans|1|||
130251108|NCT01185366|468881207|FG000|First Line Therapy|Insurance Coverage Denied|1|||
130251109|NCT01185366|468881208|FG001|First Line Therapy|Insurance Coverage Denied|1|||
130251110|NCT01185366|468881207|FG000|First Line Therapy|Withdrawal by Subject|1|||
130251111|NCT01185366|468881208|FG001|First Line Therapy|Withdrawal by Subject|0|||
130251112|NCT01185366|468881207|FG000|First Line Therapy|Lack of Metastatic Site|1|||
130251113|NCT01185366|468881208|FG001|First Line Therapy|Lack of Metastatic Site|0|||
130251114|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
130251115|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
130251116|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
130251117|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
130251118|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
130251119|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
130251120|NCT01185366|468881207|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
130251121|NCT01185366|468881208|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
130251122|NCT02774278|468881213|FG000|Overall Study|Lack of Efficacy|199|||
130251123|NCT02774278|468881213|FG000|Overall Study|Death|29|||
130251124|NCT02774278|468881213|FG000|Overall Study|Adverse event/intercurrent illness|16|||
130251125|NCT02774278|468881213|FG000|Overall Study|Refused treatment/did not cooperate|9|||
130251126|NCT02774278|468881213|FG000|Overall Study|Administrative reasons|6|||
130251127|NCT02774278|468881213|FG000|Overall Study|Withdrawal by Subject|3|||
130251128|NCT02774278|468881213|FG000|Overall Study|Protocol Violation|2|||
130251129|NCT00127933|468881216|FG000|Overall Study|Randomized but not dosed|1|||
130251130|NCT00127933|468881217|FG001|Overall Study|Randomized but not dosed|0|||
130251131|NCT01783938|468881219|FG000|Overall Study|Disease Progression|18|||
130251132|NCT01783938|468881220|FG001|Overall Study|Disease Progression|41|||
130251133|NCT01783938|468881219|FG000|Overall Study|Study Drug Toxicity|27|||
130251134|NCT01783938|468881220|FG001|Overall Study|Study Drug Toxicity|14|||
130251135|NCT01783938|468881219|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
130251136|NCT01783938|468881220|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
130251137|NCT01783938|468881219|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
130251138|NCT01783938|468881220|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
130251139|NCT01783938|468881219|FG000|Overall Study|Participant Withdrew Consent|2|||
130251140|NCT01783938|468881220|FG001|Overall Study|Participant Withdrew Consent|0|||
130251141|NCT01783938|468881219|FG000|Overall Study|Maximum Clinical Benefit|1|||
130251142|NCT01783938|468881220|FG001|Overall Study|Maximum Clinical Benefit|0|||
130251143|NCT01783938|468881219|FG000|Overall Study|Other Reasons|3|||
130251144|NCT01783938|468881220|FG001|Overall Study|Other Reasons|1|||
130031317|NCT04025632|468072545|FG001|Overall Study|Adverse Event|1|||
130031318|NCT04025632|468072544|FG000|Overall Study|Withdrawal by Subject|1|||
130031319|NCT04025632|468072545|FG001|Overall Study|Withdrawal by Subject|1|||
130031320|NCT04025632|468072544|FG000|Overall Study|Study Terminated by Sponsor|10|||
130031321|NCT04025632|468072545|FG001|Overall Study|Study Terminated by Sponsor|9|||
130031322|NCT04025632|468072544|FG000|Overall Study|Physician Decision|3|||
130031323|NCT04025632|468072545|FG001|Overall Study|Physician Decision|1|||
130031324|NCT00127127|468072546|FG000|Overall Study|Adverse Event|0|||
130031325|NCT00127127|468072547|FG001|Overall Study|Adverse Event|2|||
130251145|NCT00498485|468881221|FG000|Overall Study|Adverse Event|1|||
130251146|NCT00498485|468881222|FG001|Overall Study|Adverse Event|5|||
130251147|NCT03072875|468881223|FG000|Overall Study|Lost to Follow-up|1|||
130031326|NCT00127127|468072548|FG002|Overall Study|Adverse Event|0|||
130251148|NCT03478787|468881224|FG000|Overall Study|Adverse Event|5|||
130251149|NCT03478787|468881225|FG001|Overall Study|Adverse Event|1|||
130251150|NCT03478787|468881224|FG000|Overall Study|Protocol Violation|3|||
130251151|NCT03478787|468881225|FG001|Overall Study|Protocol Violation|0|||
130031327|NCT00127127|468072549|FG003|Overall Study|Adverse Event|1|||
130251152|NCT03478787|468881224|FG000|Overall Study|Lack of Efficacy|7|||
130251153|NCT03478787|468881225|FG001|Overall Study|Lack of Efficacy|1|||
130251154|NCT03478787|468881224|FG000|Overall Study|Lost to Follow-up|9|||
130251155|NCT03478787|468881225|FG001|Overall Study|Lost to Follow-up|5|||
130251156|NCT03478787|468881224|FG000|Overall Study|Withdrawal by Subject|2|||
130251157|NCT03478787|468881225|FG001|Overall Study|Withdrawal by Subject|6|||
130251158|NCT03478787|468881224|FG000|Overall Study|Other, Not Specified|3|||
130251159|NCT03478787|468881225|FG001|Overall Study|Other, Not Specified|0|||
130251160|NCT01539525|468881226|FG000|Overall Study|Lost to Follow-up|19|||
130251161|NCT01539525|468881227|FG001|Overall Study|Lost to Follow-up|12|||
130251162|NCT01539525|468881228|FG002|Overall Study|Lost to Follow-up|11|||
130251163|NCT01539525|468881226|FG000|Overall Study|Withdrawal by Subject|0|||
130251164|NCT01539525|468881227|FG001|Overall Study|Withdrawal by Subject|3|||
130251165|NCT01539525|468881228|FG002|Overall Study|Withdrawal by Subject|2|||
130251166|NCT01539525|468881226|FG000|Overall Study|Protocol Violation|1|||
130251167|NCT01539525|468881227|FG001|Overall Study|Protocol Violation|1|||
130251168|NCT01539525|468881228|FG002|Overall Study|Protocol Violation|4|||
130251169|NCT01712074|468881229|FG000|Placebo Run-in Period|Adverse Event|2|||
130251170|NCT01712074|468881230|FG001|Placebo Run-in Period|Adverse Event|0|||
130251171|NCT01712074|468881231|FG002|Placebo Run-in Period|Adverse Event|0|||
130251172|NCT01712074|468881229|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
130251173|NCT01712074|468881230|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
130251174|NCT01712074|468881231|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
130251175|NCT01712074|468881229|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
130251176|NCT01712074|468881230|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
130251177|NCT01712074|468881231|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
130251178|NCT01712074|468881229|FG000|Placebo Run-in Period|Other|1|||
130251179|NCT01712074|468881230|FG001|Placebo Run-in Period|Other|0|||
130251180|NCT01712074|468881231|FG002|Placebo Run-in Period|Other|0|||
130251181|NCT01712074|468881229|FG000|Placebo Run-in Period|No longer willing to participate|1|||
130251182|NCT01712074|468881230|FG001|Placebo Run-in Period|No longer willing to participate|0|||
130251183|NCT01712074|468881231|FG002|Placebo Run-in Period|No longer willing to participate|0|||
130251184|NCT01712074|468881229|FG000|Double Blind Period|Adverse Event|0|||
130251185|NCT01712074|468881230|FG001|Double Blind Period|Adverse Event|2|||
130251186|NCT01712074|468881231|FG002|Double Blind Period|Adverse Event|1|||
130251187|NCT01712074|468881229|FG000|Double Blind Period|No longer willing to participate|0|||
130251188|NCT01712074|468881230|FG001|Double Blind Period|No longer willing to participate|2|||
130251189|NCT01712074|468881231|FG002|Double Blind Period|No longer willing to participate|4|||
130251190|NCT01712074|468881229|FG000|Double Blind Period|Death|0|||
130251191|NCT01712074|468881230|FG001|Double Blind Period|Death|1|||
130251192|NCT01712074|468881231|FG002|Double Blind Period|Death|0|||
130251193|NCT01712074|468881229|FG000|Double Blind Period|Lost to Follow-up|0|||
130251194|NCT01712074|468881230|FG001|Double Blind Period|Lost to Follow-up|2|||
130251195|NCT01712074|468881231|FG002|Double Blind Period|Lost to Follow-up|1|||
130251196|NCT01712074|468881229|FG000|Double Blind Period|Other|0|||
130251197|NCT01712074|468881230|FG001|Double Blind Period|Other|4|||
130251198|NCT01712074|468881231|FG002|Double Blind Period|Other|1|||
130251199|NCT01712074|468881229|FG000|Double Blind Period|Protocol Violation|0|||
130251200|NCT01712074|468881230|FG001|Double Blind Period|Protocol Violation|0|||
130251201|NCT01712074|468881231|FG002|Double Blind Period|Protocol Violation|1|||
130251202|NCT01712074|468881229|FG000|Double Blind Period|No longer met eligibility criteria|0|||
130251203|NCT01712074|468881230|FG001|Double Blind Period|No longer met eligibility criteria|3|||
130251204|NCT01712074|468881231|FG002|Double Blind Period|No longer met eligibility criteria|0|||
130251205|NCT02268851|468881232|FG000|Overall Study|Death|0|||
130251206|NCT02268851|468881233|FG001|Overall Study|Death|0|||
130251207|NCT02268851|468881234|FG002|Overall Study|Death|0|||
130251208|NCT02268851|468881235|FG003|Overall Study|Death|1|||
130251209|NCT02268851|468881236|FG004|Overall Study|Death|2|||
130251210|NCT02268851|468881237|FG005|Overall Study|Death|1|||
130251211|NCT02268851|468881232|FG000|Overall Study|Adverse Event|0|||
130251212|NCT02268851|468881233|FG001|Overall Study|Adverse Event|0|||
130251213|NCT02268851|468881234|FG002|Overall Study|Adverse Event|0|||
130251214|NCT02268851|468881235|FG003|Overall Study|Adverse Event|0|||
130251215|NCT02268851|468881236|FG004|Overall Study|Adverse Event|2|||
130251216|NCT02268851|468881237|FG005|Overall Study|Adverse Event|2|||
130251217|NCT02268851|468881232|FG000|Overall Study|Withdrawal by Subject|0|||
130251218|NCT02268851|468881233|FG001|Overall Study|Withdrawal by Subject|0|||
130101005|NCT01036594|468327293|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
130251219|NCT02268851|468881234|FG002|Overall Study|Withdrawal by Subject|0|||
130251220|NCT02268851|468881235|FG003|Overall Study|Withdrawal by Subject|2|||
130251221|NCT02268851|468881236|FG004|Overall Study|Withdrawal by Subject|0|||
130251222|NCT02268851|468881237|FG005|Overall Study|Withdrawal by Subject|1|||
130251223|NCT02268851|468881232|FG000|Overall Study|Progressive Disease|1|||
130251224|NCT02268851|468881233|FG001|Overall Study|Progressive Disease|3|||
130251225|NCT02268851|468881234|FG002|Overall Study|Progressive Disease|0|||
130251226|NCT02268851|468881235|FG003|Overall Study|Progressive Disease|0|||
130251227|NCT02268851|468881236|FG004|Overall Study|Progressive Disease|1|||
130251228|NCT02268851|468881237|FG005|Overall Study|Progressive Disease|4|||
130251229|NCT02268851|468881232|FG000|Overall Study|Physician Decision|0|||
130251230|NCT02268851|468881233|FG001|Overall Study|Physician Decision|0|||
130251231|NCT02268851|468881234|FG002|Overall Study|Physician Decision|1|||
130251232|NCT02268851|468881235|FG003|Overall Study|Physician Decision|0|||
130251233|NCT02268851|468881236|FG004|Overall Study|Physician Decision|0|||
130251234|NCT02268851|468881237|FG005|Overall Study|Physician Decision|1|||
130251235|NCT02268851|468881232|FG000|Overall Study|Patient Compliance|0|||
130251236|NCT02268851|468881233|FG001|Overall Study|Patient Compliance|0|||
130251237|NCT02268851|468881234|FG002|Overall Study|Patient Compliance|0|||
130251238|NCT02268851|468881235|FG003|Overall Study|Patient Compliance|0|||
130251239|NCT02268851|468881236|FG004|Overall Study|Patient Compliance|1|||
130251240|NCT02268851|468881237|FG005|Overall Study|Patient Compliance|1|||
130251241|NCT02268851|468881232|FG000|Overall Study|Co-Morbid Condition|0|||
130251242|NCT02268851|468881233|FG001|Overall Study|Co-Morbid Condition|0|||
130251243|NCT02268851|468881234|FG002|Overall Study|Co-Morbid Condition|0|||
130251244|NCT02268851|468881235|FG003|Overall Study|Co-Morbid Condition|0|||
130251245|NCT02268851|468881236|FG004|Overall Study|Co-Morbid Condition|1|||
130251246|NCT02268851|468881237|FG005|Overall Study|Co-Morbid Condition|1|||
130251247|NCT02539394|468881240|FG000|Overall Study|Protocol Violation|1|||
130251248|NCT02539394|468881241|FG001|Overall Study|Protocol Violation|3|||
130251249|NCT02539394|468881240|FG000|Overall Study|Lost to Follow-up|1|||
130251250|NCT02539394|468881241|FG001|Overall Study|Lost to Follow-up|2|||
130251251|NCT02539394|468881240|FG000|Overall Study|Incomplete dataset|6|||
130251252|NCT02539394|468881241|FG001|Overall Study|Incomplete dataset|6|||
130251253|NCT01472835|468881242|FG000|Overall Study|Lost to Follow-up|2|||
130251254|NCT01472835|468881243|FG001|Overall Study|Lost to Follow-up|0|||
130251255|NCT02205359|468881260|FG000|Overall Study|Death|293|||
130251256|NCT02205359|468881261|FG001|Overall Study|Death|327|||
130251257|NCT02205359|468881260|FG000|Overall Study|Lost to Follow-up|182|||
130251258|NCT02205359|468881261|FG001|Overall Study|Lost to Follow-up|162|||
130251259|NCT02205359|468881260|FG000|Overall Study|Physician Decision|51|||
130251260|NCT02205359|468881261|FG001|Overall Study|Physician Decision|53|||
130251261|NCT02205359|468881260|FG000|Overall Study|Withdrawal by Subject|167|||
130251262|NCT02205359|468881261|FG001|Overall Study|Withdrawal by Subject|169|||
130251263|NCT02792257|468881268|FG000|Overall Study|Lost to Follow-up|3|||
130251264|NCT02792257|468881269|FG001|Overall Study|Lost to Follow-up|4|||
130251265|NCT02792257|468881268|FG000|Overall Study|Allergy|0|||
130251266|NCT02792257|468881269|FG001|Overall Study|Allergy|1|||
130251267|NCT02792257|468881268|FG000|Overall Study|Protocol Violation|2|||
130251268|NCT02792257|468881269|FG001|Overall Study|Protocol Violation|0|||
130251269|NCT02792257|468881268|FG000|Overall Study|Excessive Agitation|0|||
130251270|NCT02792257|468881269|FG001|Overall Study|Excessive Agitation|1|||
130251271|NCT02792257|468881268|FG000|Overall Study|Not Feeling Well|0|||
130251272|NCT02792257|468881269|FG001|Overall Study|Not Feeling Well|1|||
130251273|NCT00553475|468881270|FG000|Overall Study|Adverse Event|7|||
130251274|NCT00553475|468881271|FG001|Overall Study|Adverse Event|17|||
130251275|NCT00553475|468881272|FG002|Overall Study|Adverse Event|13|||
130251276|NCT00553475|468881270|FG000|Overall Study|Lack of Efficacy|7|||
130251277|NCT00553475|468881271|FG001|Overall Study|Lack of Efficacy|1|||
130251278|NCT00553475|468881272|FG002|Overall Study|Lack of Efficacy|0|||
130251279|NCT00553475|468881270|FG000|Overall Study|Withdrawal by Subject|1|||
130251280|NCT00553475|468881271|FG001|Overall Study|Withdrawal by Subject|1|||
130251281|NCT00553475|468881272|FG002|Overall Study|Withdrawal by Subject|0|||
130251282|NCT00553475|468881270|FG000|Overall Study|Physician Decision|1|||
130251283|NCT00553475|468881271|FG001|Overall Study|Physician Decision|0|||
130251284|NCT00553475|468881272|FG002|Overall Study|Physician Decision|0|||
130251285|NCT00553475|468881270|FG000|Overall Study|Due to moving|0|||
130251286|NCT00553475|468881271|FG001|Overall Study|Due to moving|1|||
130251287|NCT00553475|468881272|FG002|Overall Study|Due to moving|0|||
130251288|NCT01905683|468881275|FG000|Overall Study|Protocol Violation|1|||
130251289|NCT01905683|468881275|FG000|Overall Study|Re-injection criteria not met; others|13|||
130251290|NCT01905683|468881275|FG000|Overall Study|Physician Decision|1|||
130251291|NCT01905683|468881275|FG000|Overall Study|Lack of Efficacy|8|||
130251292|NCT01905683|468881275|FG000|Overall Study|Withdrawal by Subject|20|||
130251293|NCT01905683|468881275|FG000|Overall Study|Adverse Event|4|||
130251294|NCT01905683|468881275|FG000|Overall Study|Lost to Follow-up|4|||
130251295|NCT00537082|468881277|FG000|Overall Study|Adverse Event|6|||
130251296|NCT00537082|468881278|FG001|Overall Study|Adverse Event|6|||
130251297|NCT00537082|468881279|FG002|Overall Study|Adverse Event|3|||
130251298|NCT00537082|468881277|FG000|Overall Study|Protocol Violation|0|||
130251299|NCT00537082|468881278|FG001|Overall Study|Protocol Violation|2|||
130251300|NCT00537082|468881279|FG002|Overall Study|Protocol Violation|1|||
130251301|NCT00537082|468881277|FG000|Overall Study|Lack of Efficacy|0|||
130251302|NCT00537082|468881278|FG001|Overall Study|Lack of Efficacy|0|||
130251303|NCT00537082|468881279|FG002|Overall Study|Lack of Efficacy|2|||
130251304|NCT00537082|468881277|FG000|Overall Study|Withdrawal by Subject|0|||
130251305|NCT00537082|468881278|FG001|Overall Study|Withdrawal by Subject|1|||
130251306|NCT00537082|468881279|FG002|Overall Study|Withdrawal by Subject|0|||
130251307|NCT00537082|468881277|FG000|Overall Study|Discontinued before initiating treatment|3|||
130251308|NCT00537082|468881278|FG001|Overall Study|Discontinued before initiating treatment|0|||
130251309|NCT00537082|468881279|FG002|Overall Study|Discontinued before initiating treatment|0|||
130251310|NCT02568254|468881280|FG000|Period 2|Adverse Event|0|||
130251311|NCT02568254|468881281|FG001|Period 2|Adverse Event|0|||
130251312|NCT02568254|468881282|FG002|Period 2|Adverse Event|1|||
130251313|NCT02568254|468881283|FG003|Period 2|Adverse Event|0|||
130251314|NCT02568254|468881284|FG004|Period 2|Adverse Event|0|||
130251315|NCT02568254|468881285|FG005|Period 2|Adverse Event|0|||
130251316|NCT02568254|468881280|FG000|Period 3|Unstatisfactory Lens fitting|0|||
130251317|NCT02568254|468881281|FG001|Period 3|Unstatisfactory Lens fitting|0|||
130251318|NCT02568254|468881282|FG002|Period 3|Unstatisfactory Lens fitting|0|||
130251319|NCT02568254|468881283|FG003|Period 3|Unstatisfactory Lens fitting|0|||
130251320|NCT02568254|468881284|FG004|Period 3|Unstatisfactory Lens fitting|1|||
130251321|NCT02568254|468881285|FG005|Period 3|Unstatisfactory Lens fitting|0|||
130251322|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
130251323|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
130251324|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
130251325|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Adverse Event|5|||
130251326|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Adverse Event|1|||
130251327|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Adverse Event|0|||
130251328|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
130251329|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
130251330|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
130251331|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Death|8|||
130251332|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Death|24|||
130251333|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Death|0|||
130251334|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
130251335|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
130251336|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
130251337|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
130251338|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
130251339|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
130251340|NCT02931539|468881286|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
130251341|NCT02931539|468881287|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
130251342|NCT02931539|468881288|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
130251343|NCT02931539|468881286|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
130251344|NCT02931539|468881287|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
130251345|NCT02931539|468881288|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
130251346|NCT03178942|468881291|FG000|Overall Study|Withdrawal by Subject|2|||
130251347|NCT03178942|468881292|FG001|Overall Study|Withdrawal by Subject|0|||
130251348|NCT03178942|468881291|FG000|Overall Study|Lost to Follow-up|1|||
130251349|NCT03178942|468881292|FG001|Overall Study|Lost to Follow-up|2|||
130251350|NCT01926509|468883076|FG000|Overall Study|vital sign met discontinuation criteria|1|||
130251351|NCT01926509|468883077|FG001|Overall Study|vital sign met discontinuation criteria|0|||
130251352|NCT01926509|468883078|FG002|Overall Study|vital sign met discontinuation criteria|0|||
130251353|NCT01926509|468883079|FG003|Overall Study|vital sign met discontinuation criteria|0|||
130251354|NCT03681093|468883080|FG000|Overall Study|Subject decision|0|||
130251355|NCT03681093|468883081|FG001|Overall Study|Subject decision|2|||
130251356|NCT03681093|468883082|FG002|Overall Study|Subject decision|1|||
130251357|NCT01882829|468883086|FG000|Overall Study|Adverse Event|4|||
130251358|NCT01882829|468883086|FG000|Overall Study|Protocol Violation|1|||
130251359|NCT01882829|468883086|FG000|Overall Study|Withdrawal by Subject|1|||
130251360|NCT02469961|468883088|FG000|Overall Study|Physician Decision|4|||
130251361|NCT02469961|468883089|FG001|Overall Study|Physician Decision|1|||
130251362|NCT05130281|468883093|FG000|Overall Study|Withdrawal by Subject|0|||
130251363|NCT05130281|468883094|FG001|Overall Study|Withdrawal by Subject|0|||
130251364|NCT05130281|468883095|FG002|Overall Study|Withdrawal by Subject|1|||
130251365|NCT06844812|468883096|FG000|Overall Study|Lost to Follow-up|5|||
130251366|NCT06844812|468883096|FG000|Overall Study|stigmatization concerns|2|||
130251367|NCT06844812|468883096|FG000|Overall Study|medication refusal|2|||
130251368|NCT06844812|468883096|FG000|Overall Study|concerns about possible side effects|2|||
130251369|NCT06844812|468883096|FG000|Overall Study|wanting to seek another specialist opinion|2|||
130251370|NCT06844812|468883096|FG000|Overall Study|side effects (dizziness)|1|||
130251371|NCT00368849|468883099|FG000|Overall Study|Withdrawal by Subject|0|||
130251372|NCT00368849|468883100|FG001|Overall Study|Withdrawal by Subject|1|||
130251373|NCT00368849|468883099|FG000|Overall Study|Physician Decision|0|||
130251374|NCT00368849|468883100|FG001|Overall Study|Physician Decision|1|||
130251375|NCT01699685|468883104|FG000|Period 1|Adverse Event|1|||
130251376|NCT01699685|468883105|FG001|Period 1|Adverse Event|1|||
130251377|NCT01699685|468883104|FG000|Period 1|Medical or ethical, noncompliance|2|||
130251378|NCT01699685|468883105|FG001|Period 1|Medical or ethical, noncompliance|0|||
130251379|NCT01699685|468883104|FG000|Period 1|Other|0|||
130251380|NCT01699685|468883105|FG001|Period 1|Other|1|||
130251381|NCT01699685|468883104|FG000|Period 1|Patient request|0|||
130251382|NCT01699685|468883105|FG001|Period 1|Patient request|1|||
130251383|NCT01699685|468883104|FG000|Period 2|Lost to Follow-up|1|||
130251384|NCT01699685|468883105|FG001|Period 2|Lost to Follow-up|0|||
130251385|NCT03635996|468883106|FG000|Overall Study|Study terminated by Sponsor|94|||
130251386|NCT03635996|468883106|FG000|Overall Study|Withdrawal by Subject|20|||
130251387|NCT03635996|468883106|FG000|Overall Study|Ablation|26|||
130251388|NCT03635996|468883106|FG000|Overall Study|Adverse Event|7|||
130251389|NCT03635996|468883106|FG000|Overall Study|Physician Decision|3|||
130251390|NCT03635996|468883106|FG000|Overall Study|Prohibited medication|5|||
130251391|NCT03635996|468883106|FG000|Overall Study|Did not meet eligibility criteria|5|||
130251392|NCT03635996|468883106|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
130251393|NCT03635996|468883106|FG000|Overall Study|Protocol Violation|1|||
130251394|NCT03635996|468883106|FG000|Overall Study|Lost to Follow-up|1|||
130251395|NCT05058456|468883107|FG000|Overall Study|Death|1|||
130251396|NCT05058456|468883107|FG000|Overall Study|End of Study data not yet due for release|34|||
130251397|NCT01832038|468883108|FG000|Overall Study|Death|5|||
130251398|NCT01832038|468883108|FG000|Overall Study|Adverse Event|50|||
130251399|NCT01832038|468883108|FG000|Overall Study|Lack of Efficacy|81|||
130251400|NCT01832038|468883108|FG000|Overall Study|Protocol Violation|7|||
130251401|NCT01832038|468883108|FG000|Overall Study|Lost to Follow-up|10|||
130251402|NCT01832038|468883108|FG000|Overall Study|Withdrawal by Subject|49|||
130251403|NCT01832038|468883108|FG000|Overall Study|Visit non-compliance|2|||
130251404|NCT01832038|468883108|FG000|Overall Study|Subject refused to return visit|2|||
130251405|NCT01832038|468883108|FG000|Overall Study|Not convenient to come back to site|2|||
130251406|NCT01832038|468883108|FG000|Overall Study|Participant was asked to quit|5|||
130251407|NCT01832038|468883108|FG000|Overall Study|Back home|1|||
130251408|NCT01832038|468883108|FG000|Overall Study|Pregnancy|1|||
130251409|NCT01832038|468883108|FG000|Overall Study|Low compliance|3|||
130251410|NCT01832038|468883108|FG000|Overall Study|Prohibit procedure|2|||
130251411|NCT01832038|468883108|FG000|Overall Study|Not possible to visit the hospital|1|||
130251412|NCT01832038|468883108|FG000|Overall Study|Changes of implementation system|3|||
130251413|NCT01832038|468883108|FG000|Overall Study|Plan to pregnancy|7|||
130251414|NCT01832038|468883108|FG000|Overall Study|Bad mood and has suicidal thought|1|||
130251415|NCT01832038|468883108|FG000|Overall Study|Prohibited concomitant medication|1|||
130251416|NCT01832038|468883108|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
130251417|NCT01832038|468883108|FG000|Overall Study|Subject considered the efficacy was poor|1|||
130251418|NCT00107614|468883114|FG000|Overall Study|Physician Decision|10|||
130251419|NCT00107614|468883114|FG000|Overall Study|Death|2|||
130251420|NCT00101400|468883121|FG000|Survival Follow-Up|Alive|7|||
130251421|NCT05333965|468883142|FG000|First Intervention|Adverse Event|0|||
130251422|NCT05333965|468883143|FG001|First Intervention|Adverse Event|1|||
130251423|NCT05333965|468883142|FG000|First Intervention|Withdrawal by Subject|0|||
130251424|NCT05333965|468883143|FG001|First Intervention|Withdrawal by Subject|1|||
130251425|NCT00382863|468883144|FG000|Overall Study|Death|9|||
130251426|NCT00382863|468883145|FG001|Overall Study|Death|9|||
130251427|NCT00382863|468883144|FG000|Overall Study|Lost to Follow-up|1|||
130251428|NCT00382863|468883145|FG001|Overall Study|Lost to Follow-up|2|||
130251429|NCT00382863|468883144|FG000|Overall Study|Withdrawal by Subject|5|||
130251430|NCT00382863|468883145|FG001|Overall Study|Withdrawal by Subject|25|||
130251431|NCT02168439|468883146|FG000|Overall Study|Protocol Violation|0|||
130251432|NCT02168439|468883147|FG001|Overall Study|Protocol Violation|2|||
130031328|NCT00127127|468072546|FG000|Overall Study|Lack of Efficacy|1|||
130031329|NCT00127127|468072547|FG001|Overall Study|Lack of Efficacy|3|||
130031330|NCT00127127|468072548|FG002|Overall Study|Lack of Efficacy|0|||
130251433|NCT02180672|468883150|FG000|Overall Study|Lost to Follow-up|5|||
130251434|NCT02180672|468883151|FG001|Overall Study|Lost to Follow-up|7|||
130251435|NCT02837952|468883152|FG000|Overall Study|Adverse Event|0|||
130251436|NCT02837952|468883153|FG001|Overall Study|Adverse Event|1|||
130251437|NCT02837952|468883152|FG000|Overall Study|Withdrawal by Subject|4|||
130251438|NCT02837952|468883153|FG001|Overall Study|Withdrawal by Subject|5|||
130251439|NCT02837952|468883152|FG000|Overall Study|Medication Error|1|||
130251440|NCT02837952|468883153|FG001|Overall Study|Medication Error|0|||
130251441|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Adverse Event|2|||
130251442|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Adverse Event|0|||
130251443|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Physician Decision|0|||
130251444|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Physician Decision|1|||
130251445|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
130251446|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
130251447|NCT01362530|468883154|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
130251448|NCT01362530|468883155|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
130251449|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
130251450|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
130251451|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
130251452|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
130251453|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
130251454|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
130251455|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
130251456|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
130251457|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
130251458|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
130251459|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
130251460|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
130251461|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
130251462|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
130251463|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
130251464|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
130251465|NCT01362530|468883154|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
130251466|NCT01362530|468883155|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
130251467|NCT03021005|468883157|FG000|Overall Study|Lost to Follow-up|39|||
130251468|NCT03021005|468883158|FG001|Overall Study|Lost to Follow-up|26|||
130251469|NCT00215553|468883165|FG000|Overall Study|Adverse Event|0|||
130251470|NCT00215553|468883166|FG001|Overall Study|Adverse Event|1|||
130251471|NCT00215553|468883167|FG002|Overall Study|Adverse Event|2|||
130251472|NCT00215553|468883168|FG003|Overall Study|Adverse Event|1|||
130251473|NCT00215553|468883169|FG004|Overall Study|Adverse Event|2|||
130251474|NCT00215553|468883170|FG005|Overall Study|Adverse Event|6|||
130251475|NCT00215553|468883171|FG006|Overall Study|Adverse Event|0|||
130251476|NCT00276380|468883175|FG000|Overall Study|Adverse Event|5|||
130251477|NCT00276380|468883176|FG001|Overall Study|Adverse Event|3|||
130251478|NCT00276380|468883175|FG000|Overall Study|Lost to Follow-up|1|||
130251479|NCT00276380|468883176|FG001|Overall Study|Lost to Follow-up|1|||
130251480|NCT00276380|468883175|FG000|Overall Study|Withdrawal by Subject|3|||
130251481|NCT00276380|468883176|FG001|Overall Study|Withdrawal by Subject|6|||
130251482|NCT00276380|468883175|FG000|Overall Study|Death|5|||
130251483|NCT00276380|468883176|FG001|Overall Study|Death|3|||
130251484|NCT00276380|468883175|FG000|Overall Study|Abnormal aPPT Levels|0|||
130251485|NCT00276380|468883176|FG001|Overall Study|Abnormal aPPT Levels|1|||
130251486|NCT00552279|468883177|FG000|Overall Study|Adverse Event|0|||
130251487|NCT00552279|468883178|FG001|Overall Study|Adverse Event|1|||
130251488|NCT00552279|468883177|FG000|Overall Study|Withdrawal by Subject|12|||
130251489|NCT00552279|468883178|FG001|Overall Study|Withdrawal by Subject|1|||
130251490|NCT00552279|468883177|FG000|Overall Study|Lost to Follow-up|1|||
130251491|NCT00552279|468883178|FG001|Overall Study|Lost to Follow-up|0|||
130251492|NCT00552279|468883177|FG000|Overall Study|Other|1|||
130251493|NCT00552279|468883178|FG001|Overall Study|Other|1|||
130251494|NCT04829214|468883179|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
130251495|NCT04829214|468883180|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
130251496|NCT04829214|468883179|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
130251497|NCT04829214|468883180|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
130251498|NCT02739828|468883181|FG000|Overall Study|Adverse Event|1|||
130251499|NCT02739828|468883181|FG000|Overall Study|Lost to Follow-up|4|||
130251500|NCT01392495|468883182|FG000|Overall Study|Death|3|||
130251501|NCT01392495|468883182|FG000|Overall Study|Administrative problems|8|||
130251502|NCT01392495|468883182|FG000|Overall Study|Withdrawal by Subject|2|||
130251503|NCT01392495|468883182|FG000|Overall Study|Adverse Event|3|||
130251504|NCT02571244|468883183|FG000|Overall Study|Lost to Follow-up|0|||
130251505|NCT02571244|468883184|FG001|Overall Study|Lost to Follow-up|1|||
130251506|NCT02571244|468883183|FG000|Overall Study|Unable to reach out post discharge|3|||
130251507|NCT02571244|468883184|FG001|Overall Study|Unable to reach out post discharge|0|||
130251508|NCT04629521|468883185|FG000|Overall Study|Death|1|||
130031331|NCT00127127|468072549|FG003|Overall Study|Lack of Efficacy|2|||
130031332|NCT01524991|468072550|FG000|Overall Study|Adverse Event|12|||
130031333|NCT01524991|468072550|FG000|Overall Study|Death|1|||
130031334|NCT01524991|468072550|FG000|Overall Study|Disease ProgressionDu|17|||
130031335|NCT01524991|468072550|FG000|Overall Study|Other complicating disease|1|||
130031336|NCT01524991|468072550|FG000|Overall Study|Withdrawal by Subject|2|||
130031337|NCT01524991|468072550|FG000|Overall Study|Symptomatic Deterioration|1|||
130031338|NCT01805180|468072551|FG000|Lead-in Donor Phase|screen failure|1|||
130031339|NCT01805180|468072552|FG001|Lead-in Donor Phase|screen failure|0|||
130031340|NCT01805180|468072553|FG002|Lead-in Donor Phase|screen failure|0|||
130031341|NCT00398112|468072574|FG000|Overall Study|Adverse Event|4|||
130031342|NCT00398112|468072574|FG000|Overall Study|Disease progression|9|||
130031343|NCT00398112|468072574|FG000|Overall Study|Alternative treatment|1|||
130031344|NCT00398112|468072574|FG000|Overall Study|Withdrawal by Subject|3|||
130031345|NCT00398112|468072574|FG000|Overall Study|Death|1|||
130251509|NCT04629521|468883185|FG000|Overall Study|Lost to Follow-up|3|||
130251510|NCT04629521|468883185|FG000|Overall Study|Subject withdrew consent|3|||
130251511|NCT04629521|468883185|FG000|Overall Study|Enrolled in error|1|||
130251512|NCT01065766|468883194|FG000|Overall Study|Assessed before the contracted date|1|||
130251513|NCT01065766|468883194|FG000|Overall Study|Contraindication to administration|6|||
130251514|NCT01065766|468883194|FG000|Overall Study|Violated dosage/administration|25|||
130251515|NCT04818086|468883197|FG000|Overall Study|Physician Decision|1|||
130251516|NCT04818086|468883198|FG001|Overall Study|Physician Decision|0|||
130251517|NCT04818086|468883197|FG000|Overall Study|Withdrawal by Subject|0|||
130251518|NCT04818086|468883198|FG001|Overall Study|Withdrawal by Subject|1|||
130251519|NCT04128228|468883200|FG000|Overall Study|Withdrawal by Subject|3|||
130251520|NCT04128228|468883201|FG001|Overall Study|Withdrawal by Subject|3|||
130251521|NCT04128228|468883202|FG002|Overall Study|Withdrawal by Subject|0|||
130251522|NCT04128228|468883203|FG003|Overall Study|Withdrawal by Subject|0|||
130251523|NCT04128228|468883200|FG000|Overall Study|noncompliance|2|||
130251524|NCT04128228|468883201|FG001|Overall Study|noncompliance|2|||
130251525|NCT04128228|468883202|FG002|Overall Study|noncompliance|0|||
130251526|NCT04128228|468883203|FG003|Overall Study|noncompliance|0|||
130251527|NCT01602666|468883204|FG000|Induction Chemotherapy|Death|2|||
130251528|NCT01602666|468883205|FG001|Induction Chemotherapy|Death|1|||
130251529|NCT01602666|468883204|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
130251530|NCT01602666|468883205|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
130251531|NCT01602666|468883204|FG000|Induction Chemotherapy|Physician Decision|12|||
130251532|NCT01602666|468883205|FG001|Induction Chemotherapy|Physician Decision|5|||
130251533|NCT01602666|468883204|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
130251534|NCT01602666|468883205|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
130251535|NCT01602666|468883204|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
129884939|NCT00876460|467538738|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
130031346|NCT05148884|468072575|FG000|Overall Study|Withdrawal by Subject|3|||
130031347|NCT05148884|468072576|FG001|Overall Study|Withdrawal by Subject|0|||
130031348|NCT05148884|468072575|FG000|Overall Study|Deep brain stimulation operation|0|||
130251536|NCT01602666|468883205|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
129884940|NCT00876460|467538739|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
130251537|NCT01602666|468883204|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
130251538|NCT01602666|468883205|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
130251539|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
130251540|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
130251541|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
130251542|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
130251543|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
130031349|NCT05148884|468072576|FG001|Overall Study|Deep brain stimulation operation|1|||
130031350|NCT00365989|468072577|FG000|Overall Study|Withdrawal by Subject|1|||
130251544|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
130251545|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
130251546|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
130251547|NCT01602666|468883204|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
130251548|NCT01602666|468883205|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
130251549|NCT00215657|468883210|FG000|Overall Study|Adverse Event|5|||
130251550|NCT00215657|468883211|FG001|Overall Study|Adverse Event|1|||
130251551|NCT00215657|468883212|FG002|Overall Study|Adverse Event|3|||
130251552|NCT00215657|468883213|FG003|Overall Study|Adverse Event|0|||
130251553|NCT00215657|468883214|FG004|Overall Study|Adverse Event|3|||
130251554|NCT00215657|468883215|FG005|Overall Study|Adverse Event|1|||
130251555|NCT00215657|468883216|FG006|Overall Study|Adverse Event|0|||
130251556|NCT00215657|468883217|FG007|Overall Study|Adverse Event|3|||
130251557|NCT00215657|468883210|FG000|Overall Study|Withdrawal by Subject|6|||
130251558|NCT00215657|468883211|FG001|Overall Study|Withdrawal by Subject|3|||
130251559|NCT00215657|468883212|FG002|Overall Study|Withdrawal by Subject|3|||
130251560|NCT00215657|468883213|FG003|Overall Study|Withdrawal by Subject|1|||
130251561|NCT00215657|468883214|FG004|Overall Study|Withdrawal by Subject|6|||
130251562|NCT00215657|468883215|FG005|Overall Study|Withdrawal by Subject|1|||
130251563|NCT00215657|468883216|FG006|Overall Study|Withdrawal by Subject|10|||
130251564|NCT00215657|468883217|FG007|Overall Study|Withdrawal by Subject|3|||
130251565|NCT00215657|468883210|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
130251566|NCT00215657|468883211|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
130251567|NCT00215657|468883212|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
130251568|NCT00215657|468883213|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
130251569|NCT00215657|468883214|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
130251570|NCT00215657|468883215|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
130251571|NCT00215657|468883216|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
130251572|NCT00215657|468883217|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
130251573|NCT00215657|468883210|FG000|Overall Study|Insufficient testosterone response|5|||
130251574|NCT00215657|468883211|FG001|Overall Study|Insufficient testosterone response|4|||
130251575|NCT00215657|468883212|FG002|Overall Study|Insufficient testosterone response|1|||
130251576|NCT00215657|468883213|FG003|Overall Study|Insufficient testosterone response|12|||
130251577|NCT00215657|468883214|FG004|Overall Study|Insufficient testosterone response|8|||
130251578|NCT00215657|468883215|FG005|Overall Study|Insufficient testosterone response|12|||
130251579|NCT00215657|468883216|FG006|Overall Study|Insufficient testosterone response|4|||
130251580|NCT00215657|468883217|FG007|Overall Study|Insufficient testosterone response|7|||
130251581|NCT00215657|468883210|FG000|Overall Study|Other|3|||
130251582|NCT00215657|468883211|FG001|Overall Study|Other|1|||
130251583|NCT00215657|468883212|FG002|Overall Study|Other|2|||
130251584|NCT00215657|468883213|FG003|Overall Study|Other|3|||
130251585|NCT00215657|468883214|FG004|Overall Study|Other|5|||
130251586|NCT00215657|468883215|FG005|Overall Study|Other|4|||
130251587|NCT00215657|468883216|FG006|Overall Study|Other|6|||
130251588|NCT00215657|468883217|FG007|Overall Study|Other|1|||
130251589|NCT03769467|468883218|FG000|Overall Study|Adverse Event|1|||
130251590|NCT03769467|468883219|FG001|Overall Study|Adverse Event|1|||
130251591|NCT03769467|468883220|FG002|Overall Study|Adverse Event|0|||
130251592|NCT03769467|468883218|FG000|Overall Study|Death|3|||
130251593|NCT03769467|468883219|FG001|Overall Study|Death|3|||
130251594|NCT03769467|468883220|FG002|Overall Study|Death|0|||
130251595|NCT03769467|468883218|FG000|Overall Study|Study Terminated By Sponsor|2|||
130251596|NCT03769467|468883219|FG001|Overall Study|Study Terminated By Sponsor|1|||
130251597|NCT03769467|468883220|FG002|Overall Study|Study Terminated By Sponsor|0|||
130251598|NCT03769467|468883218|FG000|Overall Study|Withdrawal by Subject|0|||
130251599|NCT03769467|468883219|FG001|Overall Study|Withdrawal by Subject|1|||
130031351|NCT00365989|468072577|FG000|Overall Study|Non-compliance|1|||
130031352|NCT00851903|468072579|FG000|Overall Study|Withdrawal by Subject|2|||
130031353|NCT02318095|468072580|FG000|Overall Study|Adverse Event|1|||
130031354|NCT00686127|468072581|FG000|Overall Study|Withdrawal by Subject|14|||
130251600|NCT03769467|468883220|FG002|Overall Study|Withdrawal by Subject|0|||
130251601|NCT04754399|468883221|FG000|Overall Study|Adverse Event|5|||
130251602|NCT04754399|468883221|FG000|Overall Study|Withdrawal by Subject|6|||
130251603|NCT04565756|468883222|FG000|Overall Study|Withdrawal by Subject|0|||
130251604|NCT04565756|468883223|FG001|Overall Study|Withdrawal by Subject|0|||
130251605|NCT04565756|468883224|FG002|Overall Study|Withdrawal by Subject|0|||
130251606|NCT04565756|468883225|FG003|Overall Study|Withdrawal by Subject|0|||
130251607|NCT04565756|468883226|FG004|Overall Study|Withdrawal by Subject|1|||
130031355|NCT00686127|468072582|FG001|Overall Study|Withdrawal by Subject|6|||
130031356|NCT02300129|468072583|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
130031357|NCT02300129|468072584|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
130251608|NCT04565756|468883227|FG005|Overall Study|Withdrawal by Subject|0|||
130251609|NCT04565756|468883222|FG000|Overall Study|Protocol Violation|0|||
130251610|NCT04565756|468883223|FG001|Overall Study|Protocol Violation|0|||
130251611|NCT04565756|468883224|FG002|Overall Study|Protocol Violation|0|||
130251612|NCT04565756|468883225|FG003|Overall Study|Protocol Violation|0|||
130251613|NCT04565756|468883226|FG004|Overall Study|Protocol Violation|0|||
130251614|NCT04565756|468883227|FG005|Overall Study|Protocol Violation|1|||
130251615|NCT00968968|468883230|FG000|Overall Study|Study closed/terminated|10|||
130251616|NCT00968968|468883231|FG001|Overall Study|Study closed/terminated|10|||
130251617|NCT00968968|468883230|FG000|Overall Study|Protocol defined stopping criteria|3|||
130251618|NCT00968968|468883231|FG001|Overall Study|Protocol defined stopping criteria|1|||
130251619|NCT00968968|468883230|FG000|Overall Study|Withdrawal by Subject|2|||
130251620|NCT00968968|468883231|FG001|Overall Study|Withdrawal by Subject|0|||
130251621|NCT00968968|468883230|FG000|Overall Study|Physician Decision|1|||
130251622|NCT00968968|468883231|FG001|Overall Study|Physician Decision|2|||
130251623|NCT00968968|468883230|FG000|Overall Study|Lost to Follow-up|0|||
130251624|NCT00968968|468883231|FG001|Overall Study|Lost to Follow-up|1|||
130251625|NCT03624036|468883232|FG000|Overall Study|Death|2|||
130251626|NCT03624036|468883233|FG001|Overall Study|Death|3|||
130251627|NCT03624036|468883234|FG002|Overall Study|Death|0|||
130251628|NCT03624036|468883235|FG003|Overall Study|Death|1|||
130251629|NCT03624036|468883232|FG000|Overall Study|Withdrawal by Subject|1|||
130251630|NCT03624036|468883233|FG001|Overall Study|Withdrawal by Subject|0|||
130251631|NCT03624036|468883234|FG002|Overall Study|Withdrawal by Subject|1|||
130251632|NCT03624036|468883235|FG003|Overall Study|Withdrawal by Subject|0|||
130251633|NCT03624036|468883232|FG000|Overall Study|Enrolled but Never Treated|1|||
130251634|NCT03624036|468883233|FG001|Overall Study|Enrolled but Never Treated|0|||
130251635|NCT03624036|468883234|FG002|Overall Study|Enrolled but Never Treated|0|||
130251636|NCT03624036|468883235|FG003|Overall Study|Enrolled but Never Treated|0|||
130251637|NCT03624036|468883232|FG000|Overall Study|Reason not Specified|3|||
130251638|NCT03624036|468883233|FG001|Overall Study|Reason not Specified|0|||
130251639|NCT03624036|468883234|FG002|Overall Study|Reason not Specified|2|||
130251640|NCT03624036|468883235|FG003|Overall Study|Reason not Specified|2|||
130251641|NCT00930176|468883241|FG000|Overall Study|Death|1|||
130251642|NCT02413346|468883243|FG000|Overall Study|Adverse Event|6|||
130251643|NCT02413346|468883244|FG001|Overall Study|Adverse Event|6|||
130251644|NCT02413346|468883243|FG000|Overall Study|Withdrawal by Subject|30|||
130251645|NCT02413346|468883244|FG001|Overall Study|Withdrawal by Subject|40|||
130251646|NCT02413346|468883243|FG000|Overall Study|Lost to Follow-up|17|||
130251647|NCT02413346|468883244|FG001|Overall Study|Lost to Follow-up|21|||
130251648|NCT02413346|468883243|FG000|Overall Study|Protocol Violation|2|||
130251649|NCT02413346|468883244|FG001|Overall Study|Protocol Violation|0|||
130251650|NCT02413346|468883243|FG000|Overall Study|Other Miscellaneous Reasons|4|||
130251651|NCT02413346|468883244|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130251652|NCT00954538|468883248|FG000|Part III|Withdrawal by Subject|0|||
130251653|NCT00954538|468883249|FG001|Part III|Withdrawal by Subject|0|||
130251654|NCT00954538|468883250|FG002|Part III|Withdrawal by Subject|0|||
130251655|NCT00954538|468883251|FG003|Part III|Withdrawal by Subject|0|||
130251656|NCT00954538|468883252|FG004|Part III|Withdrawal by Subject|1|||
130251657|NCT00954538|468883253|FG005|Part III|Withdrawal by Subject|0|||
130251658|NCT00992394|468883254|FG000|Overall Study|Lack of Efficacy|6|||
130251659|NCT00992394|468883255|FG001|Overall Study|Lack of Efficacy|3|||
130251660|NCT00992394|468883254|FG000|Overall Study|Adverse Event|4|||
130251661|NCT00992394|468883255|FG001|Overall Study|Adverse Event|5|||
130251662|NCT00992394|468883254|FG000|Overall Study|Withdrawal by Subject|8|||
130251663|NCT00992394|468883255|FG001|Overall Study|Withdrawal by Subject|2|||
130251664|NCT00992394|468883254|FG000|Overall Study|Physician Decision|1|||
130251665|NCT00992394|468883255|FG001|Overall Study|Physician Decision|0|||
130251666|NCT00992394|468883254|FG000|Overall Study|Protocol Violation|2|||
130251667|NCT00992394|468883255|FG001|Overall Study|Protocol Violation|4|||
130251668|NCT00992394|468883254|FG000|Overall Study|Lost to Follow-up|2|||
130251669|NCT00992394|468883255|FG001|Overall Study|Lost to Follow-up|0|||
130251670|NCT00992394|468883254|FG000|Overall Study|Other event|1|||
130251671|NCT00992394|468883255|FG001|Overall Study|Other event|0|||
130251672|NCT00655746|468883258|FG000|Overall Study|Withdrawal by Subject|1|||
130251673|NCT03061214|468883262|FG000|Overall Study|Withdrawal by Subject|21|||
130251674|NCT03061214|468883263|FG001|Overall Study|Withdrawal by Subject|26|||
130251675|NCT03061214|468883264|FG002|Overall Study|Withdrawal by Subject|9|||
130251676|NCT03061214|468883262|FG000|Overall Study|Lost to Follow-up|3|||
130251677|NCT03061214|468883263|FG001|Overall Study|Lost to Follow-up|1|||
130251678|NCT03061214|468883264|FG002|Overall Study|Lost to Follow-up|1|||
130251679|NCT03061214|468883262|FG000|Overall Study|Death|1|||
130251680|NCT03061214|468883263|FG001|Overall Study|Death|1|||
130251681|NCT03061214|468883264|FG002|Overall Study|Death|0|||
130251682|NCT01569763|468885382|FG000|Overall Study|Lack of Efficacy|2|||
130251683|NCT01569763|468885383|FG001|Overall Study|Lack of Efficacy|7|||
130251684|NCT01569763|468885382|FG000|Overall Study|Adverse Event|1|||
130251685|NCT01569763|468885383|FG001|Overall Study|Adverse Event|0|||
130251686|NCT02730169|468885384|FG000|Overall Study|Protocol Violation|1|||
130251687|NCT02730169|468885385|FG001|Overall Study|Protocol Violation|0|||
130251688|NCT02730169|468885386|FG002|Overall Study|Protocol Violation|0|||
130251689|NCT02730169|468885387|FG003|Overall Study|Protocol Violation|1|||
130251690|NCT02730169|468885384|FG000|Overall Study|Adverse Event|2|||
130251691|NCT02730169|468885385|FG001|Overall Study|Adverse Event|3|||
130251692|NCT02730169|468885386|FG002|Overall Study|Adverse Event|3|||
130251693|NCT02730169|468885387|FG003|Overall Study|Adverse Event|0|||
130251694|NCT02730169|468885384|FG000|Overall Study|Adverse Event of Special Interest|0|||
130251695|NCT02730169|468885385|FG001|Overall Study|Adverse Event of Special Interest|1|||
130251696|NCT02730169|468885386|FG002|Overall Study|Adverse Event of Special Interest|2|||
130251697|NCT02730169|468885387|FG003|Overall Study|Adverse Event of Special Interest|0|||
130251698|NCT02730169|468885384|FG000|Overall Study|Withdrawal by Subject|6|||
130251699|NCT02730169|468885385|FG001|Overall Study|Withdrawal by Subject|11|||
130251700|NCT02730169|468885386|FG002|Overall Study|Withdrawal by Subject|6|||
130251701|NCT02730169|468885387|FG003|Overall Study|Withdrawal by Subject|8|||
130251702|NCT02730169|468885384|FG000|Overall Study|Lost to Follow-up|5|||
130251703|NCT02730169|468885385|FG001|Overall Study|Lost to Follow-up|6|||
130251704|NCT02730169|468885386|FG002|Overall Study|Lost to Follow-up|5|||
130251705|NCT02730169|468885387|FG003|Overall Study|Lost to Follow-up|6|||
130251706|NCT02730169|468885384|FG000|Overall Study|Other|0|||
130251707|NCT02730169|468885385|FG001|Overall Study|Other|0|||
130251708|NCT02730169|468885386|FG002|Overall Study|Other|1|||
130251709|NCT02730169|468885387|FG003|Overall Study|Other|1|||
130251710|NCT03211858|468885395|FG000|Overall Study|Adverse Event|8|||
130251711|NCT03211858|468885396|FG001|Overall Study|Adverse Event|6|||
130251712|NCT03211858|468885395|FG000|Overall Study|Lack of Efficacy|0|||
130251713|NCT03211858|468885396|FG001|Overall Study|Lack of Efficacy|4|||
130251714|NCT03211858|468885395|FG000|Overall Study|Poor compliance to protocol|6|||
130251715|NCT03211858|468885396|FG001|Overall Study|Poor compliance to protocol|2|||
130251716|NCT03211858|468885395|FG000|Overall Study|Non-serious Hypoglycemia|1|||
130251717|NCT03211858|468885396|FG001|Overall Study|Non-serious Hypoglycemia|0|||
130251718|NCT03211858|468885395|FG000|Overall Study|Other than specified above|22|||
130251719|NCT03211858|468885396|FG001|Overall Study|Other than specified above|21|||
130251720|NCT03810365|468885397|FG000|Overall Study|Lost to Follow-up|2|||
130251721|NCT03810365|468885398|FG001|Overall Study|Lost to Follow-up|2|||
130251722|NCT03810365|468885397|FG000|Overall Study|Withdrawal by Subject|4|||
130251723|NCT03810365|468885398|FG001|Overall Study|Withdrawal by Subject|5|||
130251724|NCT02402907|468885407|FG000|Overall Study|Delivered vaginally|9|||
130251725|NCT02402907|468885408|FG001|Overall Study|Delivered vaginally|3|||
130251726|NCT02402907|468885407|FG000|Overall Study|Delivered outside of Sinai|1|||
130031358|NCT02300129|468072585|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
130031359|NCT02300129|468072586|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
130031360|NCT02300129|468072583|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
130031361|NCT02300129|468072584|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
130031362|NCT02300129|468072585|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
130031363|NCT02300129|468072586|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
130031364|NCT02300129|468072583|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
130031365|NCT02300129|468072584|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
130031366|NCT02300129|468072585|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
130031367|NCT02300129|468072586|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
130101006|NCT01036594|468327294|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
130251727|NCT02402907|468885408|FG001|Overall Study|Delivered outside of Sinai|1|||
130251728|NCT02402907|468885407|FG000|Overall Study|Lost to follow up after C-Section|10|||
130251729|NCT02402907|468885408|FG001|Overall Study|Lost to follow up after C-Section|23|||
130251730|NCT00449787|468885409|FG000|Overall Study|Lost to Follow-up|10|||
130251731|NCT00449787|468885410|FG001|Overall Study|Lost to Follow-up|8|||
130251732|NCT00449787|468885409|FG000|Overall Study|Did not require medication|95|||
130251733|NCT00449787|468885410|FG001|Overall Study|Did not require medication|92|||
130251734|NCT03701074|468885411|FG000|Overall Study|Physician Decision|1|||
130251735|NCT03701074|468885412|FG001|Overall Study|Physician Decision|0|||
130251736|NCT01423084|468885413|FG000|Overall Study|Adverse Event|0|||
130251737|NCT01423084|468885414|FG001|Overall Study|Adverse Event|1|||
130251738|NCT01423084|468885413|FG000|Overall Study|Withdrawal by Subject|2|||
130251739|NCT01423084|468885414|FG001|Overall Study|Withdrawal by Subject|3|||
130251740|NCT00661687|468885418|FG000|Overall Study|Study related symptoms and complaints|5|||
130251741|NCT00661687|468885418|FG000|Overall Study|Positive slit lamp findings|4|||
130031368|NCT00522392|468072589|FG000|Overall Study|Disease progression|0|||
130031369|NCT00522392|468072590|FG001|Overall Study|Disease progression|3|||
130251742|NCT00661687|468885418|FG000|Overall Study|Inability to maintain wearing schedule|3|||
130251743|NCT00661687|468885418|FG000|Overall Study|Physician Decision|1|||
130251744|NCT00661687|468885418|FG000|Overall Study|Adverse Event|2|||
130251745|NCT03574389|468885419|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
130251746|NCT03574389|468885420|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
130251747|NCT03574389|468885421|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
130251748|NCT03574389|468885422|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
130251749|NCT03574389|468885423|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
130251750|NCT03574389|468885424|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
130251751|NCT03574389|468885425|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
130251752|NCT03574389|468885419|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
130251753|NCT03574389|468885420|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
130251754|NCT03574389|468885421|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
130251755|NCT03574389|468885422|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
130251756|NCT03574389|468885423|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
130251757|NCT03574389|468885424|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
130251758|NCT03574389|468885425|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
130251759|NCT03574389|468885419|FG000|Vaccination Period|Other|6|||
130251760|NCT03574389|468885420|FG001|Vaccination Period|Other|0|||
130251761|NCT03574389|468885421|FG002|Vaccination Period|Other|0|||
130251762|NCT03574389|468885422|FG003|Vaccination Period|Other|0|||
130251763|NCT03574389|468885423|FG004|Vaccination Period|Other|0|||
130251764|NCT03574389|468885424|FG005|Vaccination Period|Other|0|||
130251765|NCT03574389|468885425|FG006|Vaccination Period|Other|0|||
130251766|NCT03574389|468885419|FG000|Vaccination Period|Adverse Event|0|||
130251767|NCT03574389|468885420|FG001|Vaccination Period|Adverse Event|1|||
130251768|NCT03574389|468885421|FG002|Vaccination Period|Adverse Event|0|||
130251769|NCT03574389|468885422|FG003|Vaccination Period|Adverse Event|0|||
130251770|NCT03574389|468885423|FG004|Vaccination Period|Adverse Event|0|||
130251771|NCT03574389|468885424|FG005|Vaccination Period|Adverse Event|0|||
130251772|NCT03574389|468885425|FG006|Vaccination Period|Adverse Event|0|||
130251773|NCT03574389|468885419|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
130251774|NCT03574389|468885420|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
130251775|NCT03574389|468885421|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
130251776|NCT03574389|468885422|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
130251777|NCT03574389|468885423|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
130251778|NCT03574389|468885424|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
130251779|NCT03574389|468885425|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
130251780|NCT02094885|468885428|FG000|Overall Study|Death|1|||
130251781|NCT02094885|468885429|FG001|Overall Study|Death|5|||
130251782|NCT02094885|468885428|FG000|Overall Study|Withdrawn due to age|1|||
130251783|NCT02094885|468885429|FG001|Overall Study|Withdrawn due to age|0|||
130251784|NCT03707821|468885432|FG000|Overall Study|Protocol Violation|0|||
130251785|NCT03707821|468885433|FG001|Overall Study|Protocol Violation|1|||
130251786|NCT03707821|468885432|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130251787|NCT03707821|468885433|FG001|Overall Study|Unsatisfactory Visual Response|0|||
130251788|NCT03707821|468885432|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
130251789|NCT03707821|468885433|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
130251790|NCT00756314|468885434|FG000|Overall Study|Lost to Follow-up|2|||
130251791|NCT00756314|468885435|FG001|Overall Study|Lost to Follow-up|59|||
130251792|NCT02605967|468885436|FG000|Overall Study|subject / guardian decision|1|||
130251793|NCT02605967|468885437|FG001|Overall Study|subject / guardian decision|2|||
130251794|NCT02605967|468885436|FG000|Overall Study|Physician Decision|10|||
130251795|NCT02605967|468885437|FG001|Overall Study|Physician Decision|1|||
130251796|NCT02605967|468885436|FG000|Overall Study|Death|4|||
129800246|NCT05597020|467236278|FG000|Washout|Forbidden medication|2|||
130031370|NCT00522392|468072589|FG000|Overall Study|Adverse Event|7|||
130031371|NCT00522392|468072590|FG001|Overall Study|Adverse Event|7|||
130031372|NCT00522392|468072589|FG000|Overall Study|Withdrawal by Subject|1|||
130031373|NCT00522392|468072590|FG001|Overall Study|Withdrawal by Subject|1|||
130251797|NCT02605967|468885437|FG001|Overall Study|Death|2|||
130251798|NCT02605967|468885436|FG000|Overall Study|Adverse Event|1|||
130251799|NCT02605967|468885437|FG001|Overall Study|Adverse Event|0|||
130251800|NCT02605967|468885436|FG000|Overall Study|progressive disease|66|||
130251801|NCT02605967|468885437|FG001|Overall Study|progressive disease|35|||
130251802|NCT00159874|468885442|FG000|Overall Study|Adverse Event|2|||
130251803|NCT00159874|468885443|FG001|Overall Study|Adverse Event|2|||
130251804|NCT00159874|468885444|FG002|Overall Study|Adverse Event|5|||
130251805|NCT00159874|468885445|FG003|Overall Study|Adverse Event|1|||
130251806|NCT00159874|468885446|FG004|Overall Study|Adverse Event|1|||
130251807|NCT00159874|468885447|FG005|Overall Study|Adverse Event|2|||
130251808|NCT00159874|468885448|FG006|Overall Study|Adverse Event|0|||
130251809|NCT00159874|468885442|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
130251810|NCT00159874|468885443|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
130251811|NCT00159874|468885444|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
130251812|NCT00159874|468885445|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
130251813|NCT00159874|468885446|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
130251814|NCT00159874|468885447|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
130251815|NCT00159874|468885448|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
130251816|NCT00159874|468885442|FG000|Overall Study|Lack of Efficacy|2|||
130251817|NCT00159874|468885443|FG001|Overall Study|Lack of Efficacy|0|||
130251818|NCT00159874|468885444|FG002|Overall Study|Lack of Efficacy|1|||
130251819|NCT00159874|468885445|FG003|Overall Study|Lack of Efficacy|1|||
130251820|NCT00159874|468885446|FG004|Overall Study|Lack of Efficacy|0|||
130251821|NCT00159874|468885447|FG005|Overall Study|Lack of Efficacy|3|||
130251822|NCT00159874|468885448|FG006|Overall Study|Lack of Efficacy|0|||
130251823|NCT00159874|468885442|FG000|Overall Study|Lost to Follow-up|1|||
130251824|NCT00159874|468885443|FG001|Overall Study|Lost to Follow-up|0|||
130251825|NCT00159874|468885444|FG002|Overall Study|Lost to Follow-up|3|||
130251826|NCT00159874|468885445|FG003|Overall Study|Lost to Follow-up|0|||
130251827|NCT00159874|468885446|FG004|Overall Study|Lost to Follow-up|1|||
130251828|NCT00159874|468885447|FG005|Overall Study|Lost to Follow-up|2|||
130251829|NCT00159874|468885448|FG006|Overall Study|Lost to Follow-up|1|||
130251830|NCT00159874|468885442|FG000|Overall Study|Other|8|||
130251831|NCT00159874|468885443|FG001|Overall Study|Other|8|||
130251832|NCT00159874|468885444|FG002|Overall Study|Other|8|||
130251833|NCT00159874|468885445|FG003|Overall Study|Other|0|||
130251834|NCT00159874|468885446|FG004|Overall Study|Other|2|||
130251835|NCT00159874|468885447|FG005|Overall Study|Other|1|||
130251836|NCT00159874|468885448|FG006|Overall Study|Other|3|||
130251837|NCT00159874|468885442|FG000|Overall Study|Protocol Violation|0|||
130251838|NCT00159874|468885443|FG001|Overall Study|Protocol Violation|5|||
130251839|NCT00159874|468885444|FG002|Overall Study|Protocol Violation|2|||
130251840|NCT00159874|468885445|FG003|Overall Study|Protocol Violation|0|||
130251841|NCT00159874|468885446|FG004|Overall Study|Protocol Violation|0|||
130251842|NCT00159874|468885447|FG005|Overall Study|Protocol Violation|0|||
130251843|NCT00159874|468885448|FG006|Overall Study|Protocol Violation|0|||
130251844|NCT00159874|468885442|FG000|Overall Study|Death|3|||
130251845|NCT00159874|468885443|FG001|Overall Study|Death|8|||
130251846|NCT00159874|468885444|FG002|Overall Study|Death|15|||
130251847|NCT00159874|468885445|FG003|Overall Study|Death|0|||
130251848|NCT00159874|468885446|FG004|Overall Study|Death|1|||
130251849|NCT00159874|468885447|FG005|Overall Study|Death|2|||
130251850|NCT00159874|468885448|FG006|Overall Study|Death|0|||
130251851|NCT00159874|468885442|FG000|Overall Study|Withdrawal by Subject|2|||
130251852|NCT00159874|468885443|FG001|Overall Study|Withdrawal by Subject|6|||
130251853|NCT00159874|468885444|FG002|Overall Study|Withdrawal by Subject|8|||
130251854|NCT00159874|468885445|FG003|Overall Study|Withdrawal by Subject|4|||
130251855|NCT00159874|468885446|FG004|Overall Study|Withdrawal by Subject|3|||
130251856|NCT00159874|468885447|FG005|Overall Study|Withdrawal by Subject|2|||
130251857|NCT00159874|468885448|FG006|Overall Study|Withdrawal by Subject|1|||
130251858|NCT00159874|468885442|FG000|Overall Study|Pregnancy|1|||
130251859|NCT00159874|468885443|FG001|Overall Study|Pregnancy|1|||
130251860|NCT00159874|468885444|FG002|Overall Study|Pregnancy|0|||
130251861|NCT00159874|468885445|FG003|Overall Study|Pregnancy|0|||
129884941|NCT00876460|467538740|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
130251862|NCT00159874|468885446|FG004|Overall Study|Pregnancy|0|||
130251863|NCT00159874|468885447|FG005|Overall Study|Pregnancy|0|||
130251864|NCT00159874|468885448|FG006|Overall Study|Pregnancy|0|||
130251865|NCT05122143|468885451|FG000|Overall Study|Adverse Event|1|||
130251866|NCT05122143|468885452|FG001|Overall Study|Adverse Event|0|||
130251867|NCT05122143|468885453|FG002|Overall Study|Adverse Event|0|||
130251868|NCT05122143|468885454|FG003|Overall Study|Adverse Event|0|||
130251869|NCT05122143|468885455|FG004|Overall Study|Adverse Event|1|||
130251870|NCT05122143|468885456|FG005|Overall Study|Adverse Event|0|||
130251871|NCT05122143|468885451|FG000|Overall Study|Protocol non-compliance|0|||
130251872|NCT05122143|468885452|FG001|Overall Study|Protocol non-compliance|0|||
130251873|NCT05122143|468885453|FG002|Overall Study|Protocol non-compliance|1|||
130251874|NCT05122143|468885454|FG003|Overall Study|Protocol non-compliance|0|||
130251875|NCT05122143|468885455|FG004|Overall Study|Protocol non-compliance|0|||
130251876|NCT05122143|468885456|FG005|Overall Study|Protocol non-compliance|0|||
130251877|NCT05122143|468885451|FG000|Overall Study|Covid contact|0|||
130251878|NCT05122143|468885452|FG001|Overall Study|Covid contact|0|||
130251879|NCT05122143|468885453|FG002|Overall Study|Covid contact|0|||
130251880|NCT05122143|468885454|FG003|Overall Study|Covid contact|0|||
130251881|NCT05122143|468885455|FG004|Overall Study|Covid contact|1|||
130251882|NCT05122143|468885456|FG005|Overall Study|Covid contact|0|||
130251883|NCT01475825|468885457|FG000|Overall Study|Adverse Event|41|||
130251884|NCT01475825|468885458|FG001|Overall Study|Adverse Event|15|||
130251885|NCT01475825|468885459|FG002|Overall Study|Adverse Event|27|||
130251886|NCT01475825|468885460|FG003|Overall Study|Adverse Event|11|||
130251887|NCT01475825|468885457|FG000|Overall Study|Death|1|||
130251888|NCT01475825|468885458|FG001|Overall Study|Death|0|||
130251889|NCT01475825|468885459|FG002|Overall Study|Death|1|||
130251890|NCT01475825|468885460|FG003|Overall Study|Death|0|||
130251891|NCT01475825|468885457|FG000|Overall Study|Lack of Efficacy|0|||
130251892|NCT01475825|468885458|FG001|Overall Study|Lack of Efficacy|0|||
130251893|NCT01475825|468885459|FG002|Overall Study|Lack of Efficacy|1|||
130251894|NCT01475825|468885460|FG003|Overall Study|Lack of Efficacy|0|||
130251895|NCT01475825|468885457|FG000|Overall Study|Lost to Follow-up|0|||
130251896|NCT01475825|468885458|FG001|Overall Study|Lost to Follow-up|0|||
130251897|NCT01475825|468885459|FG002|Overall Study|Lost to Follow-up|3|||
130251898|NCT01475825|468885460|FG003|Overall Study|Lost to Follow-up|1|||
130251899|NCT01475825|468885457|FG000|Overall Study|Non-compliance with Study Drug|1|||
130251900|NCT01475825|468885458|FG001|Overall Study|Non-compliance with Study Drug|2|||
130251901|NCT01475825|468885459|FG002|Overall Study|Non-compliance with Study Drug|4|||
130251902|NCT01475825|468885460|FG003|Overall Study|Non-compliance with Study Drug|0|||
130251903|NCT01475825|468885457|FG000|Overall Study|Other: Not available|0|||
130251904|NCT01475825|468885458|FG001|Overall Study|Other: Not available|0|||
130251905|NCT01475825|468885459|FG002|Overall Study|Other: Not available|2|||
130251906|NCT01475825|468885460|FG003|Overall Study|Other: Not available|0|||
130251907|NCT01475825|468885457|FG000|Overall Study|Protocol Violation|1|||
130251908|NCT01475825|468885458|FG001|Overall Study|Protocol Violation|0|||
130251909|NCT01475825|468885459|FG002|Overall Study|Protocol Violation|0|||
130251910|NCT01475825|468885460|FG003|Overall Study|Protocol Violation|0|||
130031374|NCT00522392|468072589|FG000|Overall Study|Physician Decision|0|||
130031375|NCT00522392|468072590|FG001|Overall Study|Physician Decision|1|||
130031376|NCT00522392|468072589|FG000|Overall Study|Non-compliance|0|||
130031377|NCT00522392|468072590|FG001|Overall Study|Non-compliance|1|||
130031378|NCT05211336|468072595|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
130031379|NCT05211336|468072596|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
130031380|NCT05211336|468072595|FG000|Overall Study|Progressive disease|0|||
130031381|NCT05211336|468072596|FG001|Overall Study|Progressive disease|4|||
130031382|NCT05211336|468072595|FG000|Overall Study|Death due to myocardial infarction|0|||
130031383|NCT05211336|468072596|FG001|Overall Study|Death due to myocardial infarction|1|||
130031384|NCT05211336|468072595|FG000|Overall Study|Death due to unknown cause|0|||
130031385|NCT05211336|468072596|FG001|Overall Study|Death due to unknown cause|1|||
130031386|NCT05211336|468072595|FG000|Overall Study|Worsening kidney function and quality of response|0|||
130031387|NCT05211336|468072596|FG001|Overall Study|Worsening kidney function and quality of response|1|||
130031388|NCT00332709|468072598|FG000|Overall Study|Adverse Event|11|||
130031389|NCT00332709|468072599|FG001|Overall Study|Adverse Event|14|||
130031390|NCT00332709|468072598|FG000|Overall Study|Withdrawal by Subject|2|||
130251911|NCT01475825|468885457|FG000|Overall Study|Physician Decision|0|||
130251912|NCT01475825|468885458|FG001|Overall Study|Physician Decision|1|||
130251913|NCT01475825|468885459|FG002|Overall Study|Physician Decision|0|||
130251914|NCT01475825|468885460|FG003|Overall Study|Physician Decision|0|||
130251915|NCT01475825|468885457|FG000|Overall Study|Withdrawal by Subject|8|||
130251916|NCT01475825|468885458|FG001|Overall Study|Withdrawal by Subject|3|||
130251917|NCT01475825|468885459|FG002|Overall Study|Withdrawal by Subject|11|||
130251918|NCT01475825|468885460|FG003|Overall Study|Withdrawal by Subject|7|||
130251919|NCT01475825|468885457|FG000|Overall Study|Did not enter OLC|15|||
130251920|NCT01475825|468885458|FG001|Overall Study|Did not enter OLC|11|||
130251921|NCT01475825|468885459|FG002|Overall Study|Did not enter OLC|15|||
130251922|NCT01475825|468885460|FG003|Overall Study|Did not enter OLC|11|||
130251923|NCT00309946|468885463|FG000|Overall Study|Withdrawal by Subject|1|||
130251924|NCT02624687|468885467|FG000|Overall Study|Withdrawal by Subject|1|||
130251925|NCT02624687|468885468|FG001|Overall Study|Withdrawal by Subject|1|||
130251926|NCT02624687|468885467|FG000|Overall Study|medical leave from work|0|||
130251927|NCT02624687|468885468|FG001|Overall Study|medical leave from work|1|||
130251928|NCT03111108|468885469|FG000|Overall Study|Death|0|||
130251929|NCT03111108|468885470|FG001|Overall Study|Death|1|||
130251930|NCT03111108|468885469|FG000|Overall Study|Withdrawal by Subject|1|||
130251931|NCT03111108|468885470|FG001|Overall Study|Withdrawal by Subject|0|||
130251932|NCT02771145|468885471|FG000|Overall Study|Adverse Event|3|||
130251933|NCT02771145|468885471|FG000|Overall Study|Lost to Follow-up|1|||
130251934|NCT02264821|468885472|FG000|Overall Study|Protocol Violation|1|||
130251935|NCT02264821|468885473|FG001|Overall Study|Protocol Violation|3|||
130251936|NCT02264821|468885474|FG002|Overall Study|Protocol Violation|6|||
130251937|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
130251938|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
130251939|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
130251940|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
130251941|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
130251942|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
130251943|NCT02662582|468885476|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130251944|NCT02662582|468885477|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130251945|NCT00511199|468885479|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
130251946|NCT00511199|468885480|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
130251947|NCT00511199|468885479|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
130251948|NCT00511199|468885480|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
130251949|NCT00511199|468885479|FG000|Overall Study|Withdrawal of Informed Consent|19|||
130251950|NCT00511199|468885480|FG001|Overall Study|Withdrawal of Informed Consent|4|||
130251951|NCT00511199|468885479|FG000|Overall Study|Pregnancy|6|||
130251952|NCT00511199|468885480|FG001|Overall Study|Pregnancy|3|||
130251953|NCT00511199|468885479|FG000|Overall Study|Pregnancy Wish|16|||
130251954|NCT00511199|468885480|FG001|Overall Study|Pregnancy Wish|8|||
130251955|NCT00511199|468885479|FG000|Overall Study|Lost to Follow-up|40|||
130251956|NCT00511199|468885480|FG001|Overall Study|Lost to Follow-up|17|||
130031391|NCT00332709|468072599|FG001|Overall Study|Withdrawal by Subject|3|||
130031392|NCT00332709|468072598|FG000|Overall Study|Lost to Follow-up|2|||
130031393|NCT00332709|468072599|FG001|Overall Study|Lost to Follow-up|0|||
130031394|NCT00332709|468072598|FG000|Overall Study|Administrative Problems|0|||
130031395|NCT00332709|468072599|FG001|Overall Study|Administrative Problems|3|||
130031396|NCT00332709|468072598|FG000|Overall Study|Abnormal test procedure result|1|||
130031397|NCT00332709|468072599|FG001|Overall Study|Abnormal test procedure result|0|||
130031398|NCT03575104|468072600|FG000|Overall Study|Adverse Event|4|||
130031399|NCT03575104|468072601|FG001|Overall Study|Adverse Event|3|||
130031400|NCT03575104|468072602|FG002|Overall Study|Adverse Event|4|||
130031401|NCT03575104|468072600|FG000|Overall Study|Withdrawal by Subject|13|||
130031402|NCT03575104|468072601|FG001|Overall Study|Withdrawal by Subject|16|||
130031403|NCT03575104|468072602|FG002|Overall Study|Withdrawal by Subject|11|||
130031404|NCT03575104|468072600|FG000|Overall Study|Other reasons|6|||
130031405|NCT03575104|468072601|FG001|Overall Study|Other reasons|8|||
130031406|NCT03575104|468072602|FG002|Overall Study|Other reasons|6|||
130031407|NCT03575104|468072600|FG000|Overall Study|Lost to Follow-up|1|||
130251957|NCT00511199|468885479|FG000|Overall Study|Other Reason|78|||
130251958|NCT00511199|468885480|FG001|Overall Study|Other Reason|37|||
130251959|NCT01953354|468885486|FG000|Overall Study|Withdrawal by Subject|0|||
130251960|NCT01953354|468885487|FG001|Overall Study|Withdrawal by Subject|1|||
130251961|NCT01953354|468885486|FG000|Overall Study|Decision of Sponsor|0|||
130031408|NCT03575104|468072601|FG001|Overall Study|Lost to Follow-up|2|||
130251962|NCT01953354|468885487|FG001|Overall Study|Decision of Sponsor|1|||
130251963|NCT01953354|468885486|FG000|Overall Study|Disease Exacerbation|1|||
130251964|NCT01953354|468885487|FG001|Overall Study|Disease Exacerbation|0|||
130251965|NCT01570192|468885488|FG000|Overall Study|no qualifying organism|6|||
130251966|NCT01570192|468885489|FG001|Overall Study|no qualifying organism|12|||
130251967|NCT01570192|468885488|FG000|Overall Study|changed to palliative care|1|||
130251968|NCT01570192|468885489|FG001|Overall Study|changed to palliative care|0|||
130251969|NCT01570192|468885488|FG000|Overall Study|Physician Decision|0|||
130251970|NCT01570192|468885489|FG001|Overall Study|Physician Decision|1|||
130251971|NCT01696214|468885490|FG000|Overall Study|Lost to Follow-up|1|||
130251972|NCT01696214|468885491|FG001|Overall Study|Lost to Follow-up|0|||
130251973|NCT01696214|468885492|FG002|Overall Study|Lost to Follow-up|0|||
130251974|NCT01696214|468885493|FG003|Overall Study|Lost to Follow-up|0|||
130251975|NCT00806026|468885494|FG000|Overall Study|Death|0|||
130251976|NCT00806026|468885495|FG001|Overall Study|Death|0|||
130251977|NCT00806026|468885496|FG002|Overall Study|Death|0|||
130251978|NCT00806026|468885497|FG003|Overall Study|Death|1|||
130251979|NCT00806026|468885498|FG004|Overall Study|Death|0|||
130251980|NCT00806026|468885499|FG005|Overall Study|Death|0|||
130251981|NCT00806026|468885494|FG000|Overall Study|Did not meet entrance criteria|4|||
130251982|NCT00806026|468885495|FG001|Overall Study|Did not meet entrance criteria|1|||
130251983|NCT00806026|468885496|FG002|Overall Study|Did not meet entrance criteria|2|||
130251984|NCT00806026|468885497|FG003|Overall Study|Did not meet entrance criteria|1|||
130251985|NCT00806026|468885498|FG004|Overall Study|Did not meet entrance criteria|0|||
130251986|NCT00806026|468885499|FG005|Overall Study|Did not meet entrance criteria|0|||
130251987|NCT00806026|468885494|FG000|Overall Study|Lack of Efficacy|5|||
130251988|NCT00806026|468885495|FG001|Overall Study|Lack of Efficacy|18|||
130251989|NCT00806026|468885496|FG002|Overall Study|Lack of Efficacy|13|||
130251990|NCT00806026|468885497|FG003|Overall Study|Lack of Efficacy|4|||
130251991|NCT00806026|468885498|FG004|Overall Study|Lack of Efficacy|8|||
130251992|NCT00806026|468885499|FG005|Overall Study|Lack of Efficacy|7|||
130251993|NCT00806026|468885494|FG000|Overall Study|Lost to Follow-up|8|||
130251994|NCT00806026|468885495|FG001|Overall Study|Lost to Follow-up|15|||
130251995|NCT00806026|468885496|FG002|Overall Study|Lost to Follow-up|8|||
130251996|NCT00806026|468885497|FG003|Overall Study|Lost to Follow-up|2|||
130251997|NCT00806026|468885498|FG004|Overall Study|Lost to Follow-up|6|||
130251998|NCT00806026|468885499|FG005|Overall Study|Lost to Follow-up|6|||
130251999|NCT00806026|468885494|FG000|Overall Study|Withdrawal by Subject|14|||
130252000|NCT00806026|468885495|FG001|Overall Study|Withdrawal by Subject|17|||
130252001|NCT00806026|468885496|FG002|Overall Study|Withdrawal by Subject|9|||
130252002|NCT00806026|468885497|FG003|Overall Study|Withdrawal by Subject|2|||
130252003|NCT00806026|468885498|FG004|Overall Study|Withdrawal by Subject|5|||
130252004|NCT00806026|468885499|FG005|Overall Study|Withdrawal by Subject|3|||
130252005|NCT00806026|468885494|FG000|Overall Study|Other|3|||
130252006|NCT00806026|468885495|FG001|Overall Study|Other|6|||
130252007|NCT00806026|468885496|FG002|Overall Study|Other|8|||
130252008|NCT00806026|468885497|FG003|Overall Study|Other|2|||
130252009|NCT00806026|468885498|FG004|Overall Study|Other|0|||
130252010|NCT00806026|468885499|FG005|Overall Study|Other|4|||
130252011|NCT00806026|468885494|FG000|Overall Study|Protocol Violation|6|||
130252012|NCT00806026|468885495|FG001|Overall Study|Protocol Violation|9|||
130252013|NCT00806026|468885496|FG002|Overall Study|Protocol Violation|9|||
130252014|NCT00806026|468885497|FG003|Overall Study|Protocol Violation|0|||
130252015|NCT00806026|468885498|FG004|Overall Study|Protocol Violation|2|||
130252016|NCT00806026|468885499|FG005|Overall Study|Protocol Violation|3|||
130252017|NCT00806026|468885494|FG000|Overall Study|Adverse Event|52|||
130252018|NCT00806026|468885495|FG001|Overall Study|Adverse Event|35|||
130252019|NCT00806026|468885496|FG002|Overall Study|Adverse Event|44|||
130252020|NCT00806026|468885497|FG003|Overall Study|Adverse Event|17|||
130252021|NCT00806026|468885498|FG004|Overall Study|Adverse Event|9|||
130252022|NCT00806026|468885499|FG005|Overall Study|Adverse Event|9|||
130252023|NCT03180138|468885500|FG000|Overall Study|Mobile-phone could not be verified|2|||
130252024|NCT03180138|468885501|FG001|Overall Study|Mobile-phone could not be verified|13|||
130252025|NCT03180138|468885502|FG002|Overall Study|Mobile-phone could not be verified|15|||
130252026|NCT03180138|468885500|FG000|Overall Study|No prior immunization records|17|||
130252027|NCT03180138|468885501|FG001|Overall Study|No prior immunization records|0|||
129884942|NCT00876460|467538733|FG000|Combination Therapy Phase|Adverse Event|0|||
130101007|NCT03664024|468327299|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
130101008|NCT03664024|468327299|FG000|Overall Study|Lost to Follow-up|2|||
130101009|NCT03664024|468327299|FG000|Overall Study|Withdrawal by Subject|2|||
130101010|NCT03664024|468327299|FG000|Overall Study|Death|80|||
130101011|NCT00227591|468327300|FG000|Overall Study|Withdrawal by Subject|1|||
130101012|NCT02057549|468327302|FG000|Overall Study|Lost to Follow-up|1|||
130101013|NCT02057549|468327303|FG001|Overall Study|Lost to Follow-up|0|||
130101014|NCT02057549|468327302|FG000|Overall Study|Physician Decision|1|||
130101015|NCT02057549|468327303|FG001|Overall Study|Physician Decision|0|||
130252028|NCT03180138|468885502|FG002|Overall Study|No prior immunization records|6|||
130252029|NCT03180138|468885500|FG000|Overall Study|Found to be >24 mon after randomization|3|||
130101016|NCT02057549|468327302|FG000|Overall Study|Withdrawal by Subject|1|||
130252030|NCT03180138|468885501|FG001|Overall Study|Found to be >24 mon after randomization|0|||
130252031|NCT03180138|468885502|FG002|Overall Study|Found to be >24 mon after randomization|3|||
130252032|NCT00452530|468885504|FG000|Overall Study|Death|1|||
130252033|NCT00452530|468885505|FG001|Overall Study|Death|0|||
130252034|NCT00452530|468885504|FG000|Overall Study|Adverse Event|40|||
130252035|NCT00452530|468885505|FG001|Overall Study|Adverse Event|44|||
130252036|NCT00452530|468885504|FG000|Overall Study|Withdrawal by Subject|68|||
130252037|NCT00452530|468885505|FG001|Overall Study|Withdrawal by Subject|57|||
130252038|NCT00452530|468885504|FG000|Overall Study|Lost to Follow-up|1|||
130252039|NCT00452530|468885505|FG001|Overall Study|Lost to Follow-up|0|||
130252040|NCT00452530|468885504|FG000|Overall Study|Poor compliance/noncompliance|1|||
130101017|NCT02057549|468327303|FG001|Overall Study|Withdrawal by Subject|0|||
130252041|NCT00452530|468885505|FG001|Overall Study|Poor compliance/noncompliance|2|||
130252042|NCT00452530|468885504|FG000|Overall Study|No longer met study criteria|18|||
130252043|NCT00452530|468885505|FG001|Overall Study|No longer met study criteria|22|||
130252044|NCT00452530|468885504|FG000|Overall Study|Other|7|||
130252045|NCT00452530|468885505|FG001|Overall Study|Other|11|||
130252046|NCT02100644|468885506|FG000|LTG Escalation Phase|Adverse Event|9|||
130252047|NCT02100644|468885507|FG001|LTG Escalation Phase|Adverse Event|0|||
130252048|NCT02100644|468885508|FG002|LTG Escalation Phase|Adverse Event|0|||
130252049|NCT02100644|468885506|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
130101018|NCT01418365|468327306|FG000|First Intervention|Withdrawal by Subject|0|||
130101019|NCT01418365|468327307|FG001|First Intervention|Withdrawal by Subject|1|||
130101020|NCT01418365|468327306|FG000|First Intervention|Non-compliance|1|||
130101021|NCT01418365|468327307|FG001|First Intervention|Non-compliance|0|||
130101022|NCT01418365|468327306|FG000|Second Intervention|Withdrawal by Subject|0|||
130101023|NCT01418365|468327307|FG001|Second Intervention|Withdrawal by Subject|1|||
130101024|NCT03917654|468327313|FG000|Year 1|Withdrawal by Subject|1|||
130101025|NCT03917654|468327314|FG001|Year 1|Withdrawal by Subject|0|||
130101026|NCT03917654|468327315|FG002|Year 1|Withdrawal by Subject|0|||
130101027|NCT03917654|468327316|FG003|Year 1|Withdrawal by Subject|0|||
130101028|NCT03917654|468327317|FG004|Year 1|Withdrawal by Subject|0|||
130101029|NCT03917654|468327318|FG005|Year 1|Withdrawal by Subject|1|||
130101030|NCT03917654|468327319|FG006|Year 1|Withdrawal by Subject|6|||
130101031|NCT03917654|468327320|FG007|Year 1|Withdrawal by Subject|2|||
130101032|NCT03917654|468327321|FG008|Year 1|Withdrawal by Subject|5|||
130101033|NCT03917654|468327322|FG009|Year 1|Withdrawal by Subject|3|||
130101034|NCT03917654|468327323|FG010|Year 1|Withdrawal by Subject|1|||
130101035|NCT03917654|468327324|FG011|Year 1|Withdrawal by Subject|0|||
130101036|NCT03917654|468327313|FG000|Year 1|Travel|0|||
130101037|NCT03917654|468327314|FG001|Year 1|Travel|1|||
130101038|NCT03917654|468327315|FG002|Year 1|Travel|1|||
130101039|NCT03917654|468327316|FG003|Year 1|Travel|0|||
130101040|NCT03917654|468327317|FG004|Year 1|Travel|4|||
130101041|NCT03917654|468327318|FG005|Year 1|Travel|4|||
130101042|NCT03917654|468327319|FG006|Year 1|Travel|10|||
130101043|NCT03917654|468327320|FG007|Year 1|Travel|8|||
130101044|NCT03917654|468327321|FG008|Year 1|Travel|2|||
130101045|NCT03917654|468327322|FG009|Year 1|Travel|5|||
130101046|NCT03917654|468327323|FG010|Year 1|Travel|3|||
130101047|NCT03917654|468327324|FG011|Year 1|Travel|3|||
130101048|NCT03917654|468327313|FG000|Year 1|Subject moved away from site|0|||
130101049|NCT03917654|468327314|FG001|Year 1|Subject moved away from site|1|||
130101050|NCT03917654|468327315|FG002|Year 1|Subject moved away from site|0|||
130101051|NCT03917654|468327316|FG003|Year 1|Subject moved away from site|0|||
130101052|NCT03917654|468327317|FG004|Year 1|Subject moved away from site|0|||
130101053|NCT03917654|468327318|FG005|Year 1|Subject moved away from site|0|||
130101054|NCT03917654|468327319|FG006|Year 1|Subject moved away from site|1|||
130101055|NCT03917654|468327320|FG007|Year 1|Subject moved away from site|2|||
130101056|NCT03917654|468327321|FG008|Year 1|Subject moved away from site|1|||
130101057|NCT03917654|468327322|FG009|Year 1|Subject moved away from site|0|||
130101058|NCT03917654|468327323|FG010|Year 1|Subject moved away from site|0|||
130101059|NCT03917654|468327324|FG011|Year 1|Subject moved away from site|3|||
130101060|NCT03917654|468327313|FG000|Year 1|Spouse/Family member request|0|||
130101061|NCT03917654|468327314|FG001|Year 1|Spouse/Family member request|0|||
130101062|NCT03917654|468327315|FG002|Year 1|Spouse/Family member request|1|||
130101063|NCT03917654|468327316|FG003|Year 1|Spouse/Family member request|0|||
130101064|NCT03917654|468327317|FG004|Year 1|Spouse/Family member request|1|||
130101065|NCT03917654|468327318|FG005|Year 1|Spouse/Family member request|0|||
130101066|NCT03917654|468327319|FG006|Year 1|Spouse/Family member request|0|||
130101067|NCT03917654|468327320|FG007|Year 1|Spouse/Family member request|2|||
130101068|NCT03917654|468327321|FG008|Year 1|Spouse/Family member request|0|||
130101069|NCT03917654|468327322|FG009|Year 1|Spouse/Family member request|0|||
130101070|NCT03917654|468327323|FG010|Year 1|Spouse/Family member request|0|||
130101071|NCT03917654|468327324|FG011|Year 1|Spouse/Family member request|1|||
130101072|NCT03917654|468327313|FG000|Year 1|Death|0|||
130101073|NCT03917654|468327314|FG001|Year 1|Death|0|||
130101074|NCT03917654|468327315|FG002|Year 1|Death|0|||
130101075|NCT03917654|468327316|FG003|Year 1|Death|0|||
130101076|NCT03917654|468327317|FG004|Year 1|Death|0|||
130101077|NCT03917654|468327318|FG005|Year 1|Death|0|||
130101078|NCT03917654|468327319|FG006|Year 1|Death|0|||
130101079|NCT03917654|468327320|FG007|Year 1|Death|0|||
130101080|NCT03917654|468327321|FG008|Year 1|Death|1|||
130101081|NCT03917654|468327322|FG009|Year 1|Death|1|||
130252050|NCT02100644|468885507|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
130031409|NCT03575104|468072602|FG002|Overall Study|Lost to Follow-up|1|||
130031410|NCT01409928|468072604|FG000|Overall Study|Physician Decision|12|||
130031411|NCT00408005|468072607|FG000|Induction|Adverse Event|19|||
130031412|NCT00408005|468072608|FG001|Induction|Adverse Event|3|||
130031413|NCT00408005|468072609|FG002|Induction|Adverse Event|0|||
130031414|NCT00408005|468072610|FG003|Induction|Adverse Event|0|||
130031415|NCT00408005|468072611|FG004|Induction|Adverse Event|0|||
130031416|NCT00408005|468072612|FG005|Induction|Adverse Event|0|||
130031417|NCT00408005|468072613|FG006|Induction|Adverse Event|0|||
130031418|NCT00408005|468072614|FG007|Induction|Adverse Event|0|||
130031419|NCT00408005|468072607|FG000|Induction|Death|6|||
130031420|NCT00408005|468072608|FG001|Induction|Death|0|||
130031421|NCT00408005|468072609|FG002|Induction|Death|0|||
130031422|NCT00408005|468072610|FG003|Induction|Death|0|||
130031423|NCT00408005|468072611|FG004|Induction|Death|0|||
130031424|NCT00408005|468072612|FG005|Induction|Death|0|||
130031425|NCT00408005|468072613|FG006|Induction|Death|0|||
130031426|NCT00408005|468072614|FG007|Induction|Death|0|||
130031427|NCT00408005|468072607|FG000|Induction|Physician Decision|83|||
130031428|NCT00408005|468072608|FG001|Induction|Physician Decision|9|||
130031429|NCT00408005|468072609|FG002|Induction|Physician Decision|0|||
130031430|NCT00408005|468072610|FG003|Induction|Physician Decision|0|||
130031431|NCT00408005|468072611|FG004|Induction|Physician Decision|0|||
130031432|NCT00408005|468072612|FG005|Induction|Physician Decision|0|||
130031433|NCT00408005|468072613|FG006|Induction|Physician Decision|0|||
130031434|NCT00408005|468072614|FG007|Induction|Physician Decision|0|||
130031435|NCT00408005|468072607|FG000|Induction|Withdrawal by Subject|2|||
130031436|NCT00408005|468072608|FG001|Induction|Withdrawal by Subject|4|||
130031437|NCT00408005|468072609|FG002|Induction|Withdrawal by Subject|0|||
130031438|NCT00408005|468072610|FG003|Induction|Withdrawal by Subject|0|||
130031439|NCT00408005|468072611|FG004|Induction|Withdrawal by Subject|0|||
130031440|NCT00408005|468072612|FG005|Induction|Withdrawal by Subject|0|||
130031441|NCT00408005|468072613|FG006|Induction|Withdrawal by Subject|0|||
130031442|NCT00408005|468072614|FG007|Induction|Withdrawal by Subject|0|||
130031443|NCT00408005|468072607|FG000|Induction|Ineligible|33|||
130031444|NCT00408005|468072608|FG001|Induction|Ineligible|14|||
130031445|NCT00408005|468072609|FG002|Induction|Ineligible|0|||
130031446|NCT00408005|468072610|FG003|Induction|Ineligible|0|||
130031447|NCT00408005|468072611|FG004|Induction|Ineligible|0|||
130031448|NCT00408005|468072612|FG005|Induction|Ineligible|0|||
130031449|NCT00408005|468072613|FG006|Induction|Ineligible|0|||
130031450|NCT00408005|468072614|FG007|Induction|Ineligible|0|||
130031451|NCT00408005|468072607|FG000|Induction|Refusal of Further Protocol Therapy|225|||
130031452|NCT00408005|468072608|FG001|Induction|Refusal of Further Protocol Therapy|44|||
130031453|NCT00408005|468072609|FG002|Induction|Refusal of Further Protocol Therapy|0|||
130031454|NCT00408005|468072610|FG003|Induction|Refusal of Further Protocol Therapy|0|||
130031455|NCT00408005|468072611|FG004|Induction|Refusal of Further Protocol Therapy|0|||
130031456|NCT00408005|468072612|FG005|Induction|Refusal of Further Protocol Therapy|0|||
130031457|NCT00408005|468072613|FG006|Induction|Refusal of Further Protocol Therapy|0|||
130031458|NCT00408005|468072614|FG007|Induction|Refusal of Further Protocol Therapy|0|||
130031459|NCT00408005|468072607|FG000|Induction|Entered another COG therapeutic protocol|4|||
130031460|NCT00408005|468072608|FG001|Induction|Entered another COG therapeutic protocol|0|||
130031461|NCT00408005|468072609|FG002|Induction|Entered another COG therapeutic protocol|0|||
130031462|NCT00408005|468072610|FG003|Induction|Entered another COG therapeutic protocol|0|||
130031463|NCT00408005|468072611|FG004|Induction|Entered another COG therapeutic protocol|0|||
130031464|NCT00408005|468072612|FG005|Induction|Entered another COG therapeutic protocol|0|||
130031465|NCT00408005|468072613|FG006|Induction|Entered another COG therapeutic protocol|0|||
130031466|NCT00408005|468072614|FG007|Induction|Entered another COG therapeutic protocol|0|||
130031467|NCT00408005|468072607|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
130031468|NCT00408005|468072608|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
130031469|NCT00408005|468072609|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
130031470|NCT00408005|468072610|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
130031471|NCT00408005|468072611|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
130031472|NCT00408005|468072612|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
130031473|NCT00408005|468072613|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
130031474|NCT00408005|468072614|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
130031475|NCT00408005|468072607|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
130031476|NCT00408005|468072608|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
130031477|NCT00408005|468072609|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
130101082|NCT03917654|468327323|FG010|Year 1|Death|0|||
130252051|NCT02100644|468885508|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
130031478|NCT00408005|468072610|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
130031479|NCT00408005|468072611|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
130031480|NCT00408005|468072612|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
130031481|NCT00408005|468072613|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
130031482|NCT00408005|468072614|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
130031483|NCT00408005|468072607|FG000|Induction|Progressive Disease|0|||
130101083|NCT03917654|468327324|FG011|Year 1|Death|0|||
130101084|NCT03917654|468327313|FG000|Year 1|Lost to Follow-up|0|||
130101085|NCT03917654|468327314|FG001|Year 1|Lost to Follow-up|0|||
130101086|NCT03917654|468327315|FG002|Year 1|Lost to Follow-up|0|||
130101087|NCT03917654|468327316|FG003|Year 1|Lost to Follow-up|0|||
130101088|NCT03917654|468327317|FG004|Year 1|Lost to Follow-up|0|||
130101089|NCT03917654|468327318|FG005|Year 1|Lost to Follow-up|0|||
130101090|NCT03917654|468327319|FG006|Year 1|Lost to Follow-up|2|||
130101091|NCT03917654|468327320|FG007|Year 1|Lost to Follow-up|0|||
130101092|NCT03917654|468327321|FG008|Year 1|Lost to Follow-up|0|||
130101093|NCT03917654|468327322|FG009|Year 1|Lost to Follow-up|0|||
130101094|NCT03917654|468327323|FG010|Year 1|Lost to Follow-up|0|||
130101095|NCT03917654|468327324|FG011|Year 1|Lost to Follow-up|0|||
130101096|NCT03917654|468327313|FG000|Year 1|Missed visits|0|||
130101097|NCT03917654|468327314|FG001|Year 1|Missed visits|0|||
130101098|NCT03917654|468327315|FG002|Year 1|Missed visits|0|||
130101099|NCT03917654|468327316|FG003|Year 1|Missed visits|0|||
130101100|NCT03917654|468327317|FG004|Year 1|Missed visits|0|||
130101101|NCT03917654|468327318|FG005|Year 1|Missed visits|0|||
130101102|NCT03917654|468327319|FG006|Year 1|Missed visits|0|||
130101103|NCT03917654|468327320|FG007|Year 1|Missed visits|0|||
130101104|NCT03917654|468327321|FG008|Year 1|Missed visits|0|||
130101105|NCT03917654|468327322|FG009|Year 1|Missed visits|0|||
130101106|NCT03917654|468327323|FG010|Year 1|Missed visits|1|||
130101107|NCT03917654|468327324|FG011|Year 1|Missed visits|1|||
130101108|NCT03917654|468327313|FG000|Year 1|Pregnancy|0|||
130101109|NCT03917654|468327314|FG001|Year 1|Pregnancy|0|||
130101110|NCT03917654|468327315|FG002|Year 1|Pregnancy|0|||
130101111|NCT03917654|468327316|FG003|Year 1|Pregnancy|0|||
130101112|NCT03917654|468327317|FG004|Year 1|Pregnancy|0|||
130101113|NCT03917654|468327318|FG005|Year 1|Pregnancy|0|||
130101114|NCT03917654|468327319|FG006|Year 1|Pregnancy|0|||
130101115|NCT03917654|468327320|FG007|Year 1|Pregnancy|1|||
130101116|NCT03917654|468327321|FG008|Year 1|Pregnancy|0|||
130101117|NCT03917654|468327322|FG009|Year 1|Pregnancy|1|||
130101118|NCT03917654|468327323|FG010|Year 1|Pregnancy|0|||
130101119|NCT03917654|468327324|FG011|Year 1|Pregnancy|0|||
130101120|NCT03917654|468327313|FG000|Year 2|Travel|1|||
130101121|NCT03917654|468327314|FG001|Year 2|Travel|0|||
130252052|NCT02100644|468885506|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
130252053|NCT02100644|468885507|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
130252054|NCT02100644|468885508|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
130252055|NCT00728182|468885509|FG000|Overall Study|Adverse Event|1|||
130252056|NCT00728182|468885510|FG001|Overall Study|Adverse Event|0|||
130252057|NCT00728182|468885509|FG000|Overall Study|Lost to Follow-up|2|||
130252058|NCT00728182|468885510|FG001|Overall Study|Lost to Follow-up|0|||
130252059|NCT00728182|468885509|FG000|Overall Study|Death|0|||
130252060|NCT00728182|468885510|FG001|Overall Study|Death|2|||
130252061|NCT00728182|468885509|FG000|Overall Study|Protocol Noncompliance|0|||
130252062|NCT00728182|468885510|FG001|Overall Study|Protocol Noncompliance|1|||
130252063|NCT01898091|468885512|FG000|Overall Study|Lost to Follow-up|1|||
130252064|NCT01898091|468885513|FG001|Overall Study|Lost to Follow-up|1|||
130252065|NCT01898091|468885512|FG000|Overall Study|Withdrawal by Subject|1|||
130252066|NCT01898091|468885513|FG001|Overall Study|Withdrawal by Subject|5|||
130252067|NCT01618708|468885514|FG000|Overall Study|Adverse Event|10|||
130252068|NCT01618708|468885515|FG001|Overall Study|Adverse Event|10|||
130252069|NCT01618708|468885514|FG000|Overall Study|Lost to Follow-up|3|||
130252070|NCT01618708|468885515|FG001|Overall Study|Lost to Follow-up|3|||
130101122|NCT03917654|468327315|FG002|Year 2|Travel|0|||
130101123|NCT03917654|468327316|FG003|Year 2|Travel|0|||
130101124|NCT03917654|468327317|FG004|Year 2|Travel|1|||
130101125|NCT03917654|468327318|FG005|Year 2|Travel|1|||
130101126|NCT03917654|468327319|FG006|Year 2|Travel|2|||
130101127|NCT03917654|468327320|FG007|Year 2|Travel|1|||
130101128|NCT03917654|468327321|FG008|Year 2|Travel|0|||
130101129|NCT03917654|468327322|FG009|Year 2|Travel|1|||
130252071|NCT01618708|468885514|FG000|Overall Study|Withdrawal by Subject|17|||
130252072|NCT01618708|468885515|FG001|Overall Study|Withdrawal by Subject|22|||
130252073|NCT01618708|468885514|FG000|Overall Study|Lack of Efficacy|8|||
130101130|NCT03917654|468327323|FG010|Year 2|Travel|0|||
130101131|NCT03917654|468327324|FG011|Year 2|Travel|1|||
130101132|NCT03917654|468327313|FG000|Year 2|Married|1|||
130101133|NCT03917654|468327314|FG001|Year 2|Married|0|||
130101134|NCT03917654|468327315|FG002|Year 2|Married|0|||
130101135|NCT03917654|468327316|FG003|Year 2|Married|0|||
130101136|NCT03917654|468327317|FG004|Year 2|Married|0|||
130101137|NCT03917654|468327318|FG005|Year 2|Married|0|||
130101138|NCT03917654|468327319|FG006|Year 2|Married|1|||
130101139|NCT03917654|468327320|FG007|Year 2|Married|1|||
130101140|NCT03917654|468327321|FG008|Year 2|Married|0|||
130101141|NCT03917654|468327322|FG009|Year 2|Married|0|||
130101142|NCT03917654|468327323|FG010|Year 2|Married|0|||
130101143|NCT03917654|468327324|FG011|Year 2|Married|0|||
130252074|NCT01618708|468885515|FG001|Overall Study|Lack of Efficacy|8|||
130252075|NCT01618708|468885514|FG000|Overall Study|Technical problems|2|||
130252076|NCT01618708|468885515|FG001|Overall Study|Technical problems|0|||
130252077|NCT01618708|468885514|FG000|Overall Study|Other than specified above|1|||
130031484|NCT00408005|468072608|FG001|Induction|Progressive Disease|1|||
130252078|NCT01618708|468885515|FG001|Overall Study|Other than specified above|1|||
130252079|NCT01618708|468885514|FG000|Overall Study|Randomized but not treated|3|||
130252080|NCT01618708|468885515|FG001|Overall Study|Randomized but not treated|2|||
130252081|NCT01630811|468885518|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130252082|NCT01630811|468885519|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130252083|NCT01725308|468885520|FG000|Treatment Period I|Did Not Receive Drug|1|||
130252084|NCT01725308|468885521|FG001|Treatment Period I|Did Not Receive Drug|0|||
130252085|NCT01725308|468885522|FG002|Treatment Period I|Did Not Receive Drug|0|||
130252086|NCT01725308|468885520|FG000|Treatment Period I|Adverse Event|5|||
130252087|NCT01725308|468885521|FG001|Treatment Period I|Adverse Event|4|||
130252088|NCT01725308|468885522|FG002|Treatment Period I|Adverse Event|21|||
130252089|NCT01725308|468885520|FG000|Treatment Period I|Insufficient Response|7|||
130252090|NCT01725308|468885521|FG001|Treatment Period I|Insufficient Response|0|||
130252091|NCT01725308|468885522|FG002|Treatment Period I|Insufficient Response|5|||
130252092|NCT01725308|468885520|FG000|Treatment Period I|Worsening of the Target Disease|8|||
130252093|NCT01725308|468885521|FG001|Treatment Period I|Worsening of the Target Disease|0|||
130252094|NCT01725308|468885522|FG002|Treatment Period I|Worsening of the Target Disease|2|||
130252095|NCT01725308|468885520|FG000|Treatment Period I|Changes in the Episodes|3|||
130252096|NCT01725308|468885521|FG001|Treatment Period I|Changes in the Episodes|0|||
130252097|NCT01725308|468885522|FG002|Treatment Period I|Changes in the Episodes|2|||
130252098|NCT01725308|468885520|FG000|Treatment Period I|Withdrawal of Consent|12|||
130252099|NCT01725308|468885521|FG001|Treatment Period I|Withdrawal of Consent|7|||
130252100|NCT01725308|468885522|FG002|Treatment Period I|Withdrawal of Consent|5|||
130252101|NCT01725308|468885520|FG000|Treatment Period I|Lost to Follow-up|3|||
130252102|NCT01725308|468885521|FG001|Treatment Period I|Lost to Follow-up|2|||
130252103|NCT01725308|468885522|FG002|Treatment Period I|Lost to Follow-up|2|||
130252104|NCT01725308|468885520|FG000|Treatment Period I|Protocol Deviations|3|||
130252105|NCT01725308|468885521|FG001|Treatment Period I|Protocol Deviations|1|||
130252106|NCT01725308|468885522|FG002|Treatment Period I|Protocol Deviations|1|||
130252107|NCT01725308|468885520|FG000|Treatment Period I|Miscellaneous|2|||
130252108|NCT01725308|468885521|FG001|Treatment Period I|Miscellaneous|0|||
130252109|NCT01725308|468885522|FG002|Treatment Period I|Miscellaneous|3|||
130252110|NCT01725308|468885520|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
130252111|NCT01725308|468885521|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
130252112|NCT01725308|468885522|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
130252113|NCT01725308|468885520|FG000|Treatment Period II|Did Not Receive Drug|4|||
130252114|NCT01725308|468885521|FG001|Treatment Period II|Did Not Receive Drug|0|||
130252115|NCT01725308|468885522|FG002|Treatment Period II|Did Not Receive Drug|0|||
130252116|NCT01725308|468885520|FG000|Treatment Period II|Adverse Event|13|||
130252117|NCT01725308|468885521|FG001|Treatment Period II|Adverse Event|8|||
130252118|NCT01725308|468885522|FG002|Treatment Period II|Adverse Event|20|||
130252119|NCT01725308|468885520|FG000|Treatment Period II|Insufficient Response|2|||
130252120|NCT01725308|468885521|FG001|Treatment Period II|Insufficient Response|4|||
130252121|NCT01725308|468885522|FG002|Treatment Period II|Insufficient Response|6|||
130252122|NCT01725308|468885520|FG000|Treatment Period II|Worsening of the Target Disease|1|||
130252123|NCT01725308|468885521|FG001|Treatment Period II|Worsening of the Target Disease|4|||
130252124|NCT01725308|468885522|FG002|Treatment Period II|Worsening of the Target Disease|2|||
130252125|NCT01725308|468885520|FG000|Treatment Period II|Changes in the Episodes|1|||
130252126|NCT01725308|468885521|FG001|Treatment Period II|Changes in the Episodes|0|||
130252127|NCT01725308|468885522|FG002|Treatment Period II|Changes in the Episodes|5|||
130252128|NCT01725308|468885520|FG000|Treatment Period II|Withdrawal of Consent|28|||
130252129|NCT01725308|468885521|FG001|Treatment Period II|Withdrawal of Consent|2|||
130252130|NCT01725308|468885522|FG002|Treatment Period II|Withdrawal of Consent|16|||
130252131|NCT01725308|468885520|FG000|Treatment Period II|Lost to Follow-up|1|||
130252132|NCT01725308|468885521|FG001|Treatment Period II|Lost to Follow-up|5|||
130252133|NCT01725308|468885522|FG002|Treatment Period II|Lost to Follow-up|3|||
130252134|NCT01725308|468885520|FG000|Treatment Period II|Protocol Deviations|0|||
130252135|NCT01725308|468885521|FG001|Treatment Period II|Protocol Deviations|0|||
130252136|NCT01725308|468885522|FG002|Treatment Period II|Protocol Deviations|1|||
130252137|NCT01725308|468885520|FG000|Treatment Period II|Miscellaneous|5|||
130252138|NCT01725308|468885521|FG001|Treatment Period II|Miscellaneous|3|||
130031485|NCT00408005|468072609|FG002|Induction|Progressive Disease|0|||
130031486|NCT00408005|468072610|FG003|Induction|Progressive Disease|0|||
130252139|NCT01725308|468885522|FG002|Treatment Period II|Miscellaneous|7|||
130252140|NCT03511209|468885526|FG000|Overall Study|Withdrawal by Subject|2|||
130252141|NCT03511209|468885527|FG001|Overall Study|Withdrawal by Subject|4|||
130252142|NCT03511209|468885526|FG000|Overall Study|Death|1|||
130252143|NCT03511209|468885527|FG001|Overall Study|Death|0|||
130252144|NCT03511209|468885526|FG000|Overall Study|Lost to Follow-up|0|||
130031487|NCT00408005|468072611|FG004|Induction|Progressive Disease|0|||
130252145|NCT03511209|468885527|FG001|Overall Study|Lost to Follow-up|2|||
130031488|NCT00408005|468072612|FG005|Induction|Progressive Disease|0|||
130031489|NCT00408005|468072613|FG006|Induction|Progressive Disease|0|||
130252146|NCT00401830|468885531|FG000|Overall Study|Adverse Event|10|||
130252147|NCT00401830|468885532|FG001|Overall Study|Adverse Event|18|||
130252148|NCT00401830|468885531|FG000|Overall Study|Lack of Efficacy|11|||
130252149|NCT00401830|468885532|FG001|Overall Study|Lack of Efficacy|5|||
130252150|NCT00401830|468885531|FG000|Overall Study|Withdrawal by Subject|4|||
130252151|NCT00401830|468885532|FG001|Overall Study|Withdrawal by Subject|3|||
130252152|NCT00401830|468885531|FG000|Overall Study|Protocol Violation|3|||
130252153|NCT00401830|468885532|FG001|Overall Study|Protocol Violation|3|||
130252154|NCT00401830|468885531|FG000|Overall Study|Non-compliance with drug study|1|||
130252155|NCT00401830|468885532|FG001|Overall Study|Non-compliance with drug study|0|||
130252156|NCT00401830|468885531|FG000|Overall Study|Lost to Follow-up|1|||
130252157|NCT00401830|468885532|FG001|Overall Study|Lost to Follow-up|3|||
130252158|NCT00401830|468885531|FG000|Overall Study|Other: Personal / Family problems|1|||
130252159|NCT00401830|468885532|FG001|Overall Study|Other: Personal / Family problems|0|||
130252160|NCT03378635|468885535|FG000|Overall Study|Adverse Event|1|||
130252161|NCT03378635|468885536|FG001|Overall Study|Adverse Event|0|||
130252162|NCT03378635|468885537|FG002|Overall Study|Adverse Event|0|||
130252163|NCT03378635|468885535|FG000|Overall Study|Withdrawal by Subject|1|||
130252164|NCT03378635|468885536|FG001|Overall Study|Withdrawal by Subject|0|||
130252165|NCT03378635|468885537|FG002|Overall Study|Withdrawal by Subject|0|||
130252166|NCT01316900|468885541|FG000|Overall Study|Adverse Event|10|||
130252167|NCT01316900|468885542|FG001|Overall Study|Adverse Event|10|||
130252168|NCT01316900|468885543|FG002|Overall Study|Adverse Event|15|||
130252169|NCT01316900|468885544|FG003|Overall Study|Adverse Event|9|||
130252170|NCT01316900|468885541|FG000|Overall Study|Lack of Efficacy|17|||
130252171|NCT01316900|468885542|FG001|Overall Study|Lack of Efficacy|9|||
130252172|NCT01316900|468885543|FG002|Overall Study|Lack of Efficacy|5|||
130252173|NCT01316900|468885544|FG003|Overall Study|Lack of Efficacy|7|||
130252174|NCT01316900|468885541|FG000|Overall Study|Protocol Violation|7|||
130252175|NCT01316900|468885542|FG001|Overall Study|Protocol Violation|1|||
130252176|NCT01316900|468885543|FG002|Overall Study|Protocol Violation|4|||
130252177|NCT01316900|468885544|FG003|Overall Study|Protocol Violation|0|||
130252178|NCT01316900|468885541|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
130252179|NCT01316900|468885542|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
130252180|NCT01316900|468885543|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
130252181|NCT01316900|468885544|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
130252182|NCT01316900|468885541|FG000|Overall Study|Lost to Follow-up|1|||
130252183|NCT01316900|468885542|FG001|Overall Study|Lost to Follow-up|0|||
130252184|NCT01316900|468885543|FG002|Overall Study|Lost to Follow-up|1|||
130252185|NCT01316900|468885544|FG003|Overall Study|Lost to Follow-up|1|||
130252186|NCT01316900|468885541|FG000|Overall Study|Withdrawal by Subject|7|||
130252187|NCT01316900|468885542|FG001|Overall Study|Withdrawal by Subject|8|||
130252188|NCT01316900|468885543|FG002|Overall Study|Withdrawal by Subject|6|||
130252189|NCT01316900|468885544|FG003|Overall Study|Withdrawal by Subject|9|||
130252190|NCT01684033|468885545|FG000|Period 1, First 30 Days|Adverse Event|1|||
130252191|NCT01684033|468885546|FG001|Period 1, First 30 Days|Adverse Event|1|||
130252192|NCT01684033|468885545|FG000|Period 1, First 30 Days|Noncompliance|1|||
130252193|NCT01684033|468885546|FG001|Period 1, First 30 Days|Noncompliance|0|||
130252194|NCT01684033|468885545|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
130252195|NCT01684033|468885546|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
130252196|NCT01684033|468885545|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
130252197|NCT01684033|468885546|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
130252198|NCT01684033|468885545|FG000|Period 2, Second 30 Days|Adverse Event|1|||
130252199|NCT01684033|468885546|FG001|Period 2, Second 30 Days|Adverse Event|0|||
130252200|NCT02496156|468885547|FG000|Overall Study|Lost to Follow-up|5|||
130252201|NCT02496156|468885548|FG001|Overall Study|Lost to Follow-up|0|||
130252202|NCT02496156|468885547|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
130252203|NCT02496156|468885548|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
130252204|NCT00089583|468885549|FG000|Overall Study|Adverse Event|0|||
130252205|NCT00089583|468885550|FG001|Overall Study|Adverse Event|3|||
130252206|NCT00089583|468885549|FG000|Overall Study|Insufficient Viral Load Response|5|||
130252207|NCT00089583|468885550|FG001|Overall Study|Insufficient Viral Load Response|5|||
130252208|NCT00089583|468885549|FG000|Overall Study|Withdrawal by Subject|0|||
130252209|NCT00089583|468885550|FG001|Overall Study|Withdrawal by Subject|4|||
130252210|NCT00089583|468885549|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
130252211|NCT00089583|468885550|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
130252212|NCT00089583|468885549|FG000|Overall Study|Participant Refused Study Medication|0|||
130252213|NCT00089583|468885550|FG001|Overall Study|Participant Refused Study Medication|2|||
130252214|NCT00089583|468885549|FG000|Overall Study|Non-Compliance|0|||
130252215|NCT00089583|468885550|FG001|Overall Study|Non-Compliance|4|||
130252216|NCT00089583|468885549|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
130252217|NCT00089583|468885550|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
130252218|NCT00089583|468885549|FG000|Overall Study|Participant Management Criteria Met|0|||
130252219|NCT00089583|468885550|FG001|Overall Study|Participant Management Criteria Met|1|||
130252220|NCT00089583|468885549|FG000|Overall Study|Reason Not Provided|0|||
130252221|NCT00089583|468885550|FG001|Overall Study|Reason Not Provided|1|||
130252222|NCT00089583|468885549|FG000|Overall Study|Protocol Violation|0|||
130252223|NCT00089583|468885550|FG001|Overall Study|Protocol Violation|3|||
130252224|NCT00089583|468885549|FG000|Overall Study|Principal Investigator Decision|0|||
130252225|NCT00089583|468885550|FG001|Overall Study|Principal Investigator Decision|10|||
130252226|NCT00089583|468885549|FG000|Overall Study|Start of Disallowed Medication|0|||
130252227|NCT00089583|468885550|FG001|Overall Study|Start of Disallowed Medication|1|||
130252228|NCT00089583|468885549|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
130252229|NCT00089583|468885550|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
130252230|NCT00089583|468885549|FG000|Overall Study|Participant Incarcerated|0|||
130252231|NCT00089583|468885550|FG001|Overall Study|Participant Incarcerated|1|||
130252232|NCT00507507|468885551|FG000|Treatment Period|Lost to Follow-up|0|||
130252233|NCT00507507|468885552|FG001|Treatment Period|Lost to Follow-up|2|||
130252234|NCT00507507|468885551|FG000|Treatment Period|Physician Decision|4|||
130252235|NCT00507507|468885552|FG001|Treatment Period|Physician Decision|1|||
130252236|NCT00507507|468885551|FG000|Treatment Period|Protocol Violation|1|||
130252237|NCT00507507|468885552|FG001|Treatment Period|Protocol Violation|2|||
130252238|NCT00507507|468885551|FG000|Treatment Period|Adverse Event|1|||
130252239|NCT00507507|468885552|FG001|Treatment Period|Adverse Event|1|||
130252240|NCT00507507|468885551|FG000|Treatment Period|Withdrawal by Subject|46|||
130252241|NCT00507507|468885552|FG001|Treatment Period|Withdrawal by Subject|47|||
130252242|NCT00507507|468885551|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
130252243|NCT00507507|468885552|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
130252244|NCT00507507|468885551|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
130252245|NCT00507507|468885552|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
130252246|NCT00507507|468885551|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
130252247|NCT00507507|468885552|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
130252248|NCT02916433|468885553|FG000|Overall Study|Withdrawal by Subject|1|||
130252249|NCT02916433|468885554|FG001|Overall Study|Withdrawal by Subject|0|||
130252250|NCT02916433|468885553|FG000|Overall Study|Physician Decision|1|||
130252251|NCT02916433|468885554|FG001|Overall Study|Physician Decision|0|||
130252252|NCT03760666|468885555|FG000|Overall Study|Adverse Event|2|||
130252253|NCT03760666|468885556|FG001|Overall Study|Adverse Event|4|||
130252254|NCT03760666|468885557|FG002|Overall Study|Adverse Event|1|||
130252255|NCT03760666|468885555|FG000|Overall Study|AML Disease Progression|3|||
130252256|NCT03760666|468885556|FG001|Overall Study|AML Disease Progression|3|||
130252257|NCT03760666|468885557|FG002|Overall Study|AML Disease Progression|0|||
130252258|NCT03760666|468885555|FG000|Overall Study|Physician Decision|0|||
130252259|NCT03760666|468885556|FG001|Overall Study|Physician Decision|3|||
130252260|NCT03760666|468885557|FG002|Overall Study|Physician Decision|0|||
130252261|NCT03760666|468885555|FG000|Overall Study|Withdrawal by Subject|0|||
130252262|NCT03760666|468885556|FG001|Overall Study|Withdrawal by Subject|1|||
130252263|NCT03760666|468885557|FG002|Overall Study|Withdrawal by Subject|0|||
130252264|NCT01623154|468885558|FG000|Overall Study|Did not drink Pranactin Citric|4|||
130252265|NCT00890097|468885559|FG000|Overall Study|Adverse Event|21|||
130252266|NCT00890097|468885560|FG001|Overall Study|Adverse Event|32|||
130252267|NCT00890097|468885561|FG002|Overall Study|Adverse Event|28|||
130252268|NCT00890097|468885559|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
130252269|NCT00890097|468885560|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
130252270|NCT00890097|468885561|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
130252271|NCT00890097|468885559|FG000|Overall Study|Withdrew Consent|9|||
130252272|NCT00890097|468885560|FG001|Overall Study|Withdrew Consent|6|||
129884943|NCT00876460|467538734|FG001|Combination Therapy Phase|Adverse Event|2|||
129884944|NCT00876460|467538735|FG002|Combination Therapy Phase|Adverse Event|0|||
129884945|NCT00876460|467538736|FG003|Combination Therapy Phase|Adverse Event|2|||
129884946|NCT00876460|467538737|FG004|Combination Therapy Phase|Adverse Event|2|||
130031490|NCT00408005|468072614|FG007|Induction|Progressive Disease|0|||
130031491|NCT00408005|468072607|FG000|Induction|Inevaluable|18|||
130031492|NCT00408005|468072608|FG001|Induction|Inevaluable|14|||
130252273|NCT00890097|468885561|FG002|Overall Study|Withdrew Consent|9|||
130252274|NCT00890097|468885559|FG000|Overall Study|Lost to Follow-up|5|||
130252275|NCT00890097|468885560|FG001|Overall Study|Lost to Follow-up|5|||
130252276|NCT00890097|468885561|FG002|Overall Study|Lost to Follow-up|5|||
130252277|NCT00890097|468885559|FG000|Overall Study|Noncompliance|0|||
130252278|NCT00890097|468885560|FG001|Overall Study|Noncompliance|4|||
130252279|NCT00890097|468885561|FG002|Overall Study|Noncompliance|4|||
130252280|NCT00890097|468885559|FG000|Overall Study|Sponsor Decision|7|||
130252281|NCT00890097|468885560|FG001|Overall Study|Sponsor Decision|11|||
130252282|NCT00890097|468885561|FG002|Overall Study|Sponsor Decision|7|||
130252283|NCT00890097|468885559|FG000|Overall Study|Did not attend final visit|2|||
130252284|NCT00890097|468885560|FG001|Overall Study|Did not attend final visit|3|||
130252285|NCT00890097|468885561|FG002|Overall Study|Did not attend final visit|0|||
130252286|NCT00890097|468885559|FG000|Overall Study|Subject Decision|3|||
130252287|NCT00890097|468885560|FG001|Overall Study|Subject Decision|2|||
130252288|NCT00890097|468885561|FG002|Overall Study|Subject Decision|6|||
130252289|NCT00890097|468885559|FG000|Overall Study|Randomization Error|2|||
130252290|NCT00890097|468885560|FG001|Overall Study|Randomization Error|0|||
130252291|NCT00890097|468885561|FG002|Overall Study|Randomization Error|0|||
130252292|NCT00890097|468885559|FG000|Overall Study|Failed inclusion criteria|3|||
130252293|NCT00890097|468885560|FG001|Overall Study|Failed inclusion criteria|4|||
130252294|NCT00890097|468885561|FG002|Overall Study|Failed inclusion criteria|0|||
130252295|NCT00890097|468885559|FG000|Overall Study|Transportation|0|||
130252296|NCT00890097|468885560|FG001|Overall Study|Transportation|2|||
130252297|NCT00890097|468885561|FG002|Overall Study|Transportation|0|||
130252298|NCT00890097|468885559|FG000|Overall Study|Subject Moved|0|||
130252299|NCT00890097|468885560|FG001|Overall Study|Subject Moved|4|||
130252300|NCT00890097|468885561|FG002|Overall Study|Subject Moved|0|||
130252301|NCT00890097|468885559|FG000|Overall Study|Protocol Deviation|1|||
130252302|NCT00890097|468885560|FG001|Overall Study|Protocol Deviation|1|||
130252303|NCT00890097|468885561|FG002|Overall Study|Protocol Deviation|1|||
130252304|NCT02656173|468885565|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
130252305|NCT02656173|468885566|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
130252306|NCT02656173|468885565|FG000|Overall Study|Adverse Event|7|||
130252307|NCT02656173|468885566|FG001|Overall Study|Adverse Event|5|||
130252308|NCT02656173|468885565|FG000|Overall Study|Withdrawal by Subject|1|||
130252309|NCT02656173|468885566|FG001|Overall Study|Withdrawal by Subject|3|||
130252310|NCT02656173|468885565|FG000|Overall Study|Protocol Violation|0|||
130252311|NCT02656173|468885566|FG001|Overall Study|Protocol Violation|1|||
130252312|NCT02656173|468885565|FG000|Overall Study|Miscellaneous|2|||
130252313|NCT02656173|468885566|FG001|Overall Study|Miscellaneous|0|||
130252314|NCT01064622|468885567|FG000|Randomized Phase II|Withdrawal by Subject|2|||
130252315|NCT01064622|468885568|FG001|Randomized Phase II|Withdrawal by Subject|2|||
130252316|NCT01064622|468885567|FG000|Randomized Phase II|Protocol Violation|0|||
130252317|NCT01064622|468885568|FG001|Randomized Phase II|Protocol Violation|1|||
130252318|NCT03449147|468885569|FG000|52-week Treatment Period|Death|0|||
130252319|NCT03449147|468885570|FG001|52-week Treatment Period|Death|1|||
130252320|NCT03449147|468885571|FG002|52-week Treatment Period|Death|0|||
130252321|NCT03449147|468885569|FG000|52-week Treatment Period|Lost to Follow-up|6|||
130252322|NCT03449147|468885570|FG001|52-week Treatment Period|Lost to Follow-up|2|||
130252323|NCT03449147|468885571|FG002|52-week Treatment Period|Lost to Follow-up|5|||
130252324|NCT03449147|468885569|FG000|52-week Treatment Period|Other|0|||
130252325|NCT03449147|468885570|FG001|52-week Treatment Period|Other|1|||
130252326|NCT03449147|468885571|FG002|52-week Treatment Period|Other|2|||
130252327|NCT03449147|468885569|FG000|52-week Treatment Period|Physician Decision|1|||
130252328|NCT03449147|468885570|FG001|52-week Treatment Period|Physician Decision|0|||
130252329|NCT03449147|468885571|FG002|52-week Treatment Period|Physician Decision|3|||
130252330|NCT03449147|468885569|FG000|52-week Treatment Period|Screen Failure|1|||
129800247|NCT05597020|467236279|FG001|Washout|Forbidden medication|0|||
130031493|NCT00408005|468072609|FG002|Induction|Inevaluable|0|||
130252331|NCT03449147|468885570|FG001|52-week Treatment Period|Screen Failure|2|||
130252332|NCT03449147|468885571|FG002|52-week Treatment Period|Screen Failure|0|||
130252333|NCT03449147|468885569|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
130252334|NCT03449147|468885570|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
130252335|NCT03449147|468885571|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
130252336|NCT03449147|468885569|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
130031494|NCT00408005|468072610|FG003|Induction|Inevaluable|0|||
130031495|NCT00408005|468072611|FG004|Induction|Inevaluable|0|||
130252337|NCT03449147|468885570|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
130252338|NCT03449147|468885571|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
130031496|NCT00408005|468072612|FG005|Induction|Inevaluable|0|||
130031497|NCT00408005|468072613|FG006|Induction|Inevaluable|0|||
130031498|NCT00408005|468072614|FG007|Induction|Inevaluable|0|||
130252339|NCT03449147|468885569|FG000|12-Week Off-Treatment Durability Period|Other|0|||
130252340|NCT03449147|468885570|FG001|12-Week Off-Treatment Durability Period|Other|1|||
130252341|NCT03449147|468885571|FG002|12-Week Off-Treatment Durability Period|Other|0|||
130252342|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Death|2|||
130252343|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
130252344|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
130252345|NCT00974233|468885575|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
130252346|NCT00974233|468885575|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
130252347|NCT00974233|468885575|FG000|Maintenance Lenalidomide|Adverse Event|8|||
130252348|NCT01691092|468885576|FG000|Overall Study|Lost to Follow-up|10|||
130252349|NCT01691092|468885576|FG000|Overall Study|Physician Decision|4|||
130252350|NCT01691092|468885576|FG000|Overall Study|Withdrawal by Subject|3|||
130252351|NCT01691092|468885576|FG000|Overall Study|non-compliance|3|||
130252352|NCT01691092|468885576|FG000|Overall Study|used for different study|2|||
130252353|NCT01691092|468885576|FG000|Overall Study|screen fail|19|||
130252354|NCT01657942|468885577|FG000|Overall Study|Alternative Treatment|7|||
130252355|NCT01657942|468885577|FG000|Overall Study|Lost to Follow-up|1|||
130252356|NCT00185614|468887313|FG000|Inter-treatment Period|Physician Decision|1|||
130252357|NCT00185614|468887313|FG000|Inter-treatment Period|Relapse|2|||
130252358|NCT00185614|468887313|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
130252359|NCT03160573|468887314|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
130252360|NCT03160573|468887315|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
130252361|NCT03160573|468887316|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
130252362|NCT03160573|468887317|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
130252363|NCT02144337|468887318|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
130252364|NCT02144337|468887319|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
130252365|NCT02144337|468887318|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
130252366|NCT02144337|468887319|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
130252367|NCT02144337|468887318|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
130252368|NCT02144337|468887319|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
130252369|NCT02144337|468887318|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
130252370|NCT02144337|468887319|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
130252371|NCT02144337|468887318|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
130252372|NCT02144337|468887319|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
130252373|NCT01730729|468887322|FG000|Overall Study|Adverse Event|1|||
130252374|NCT01730729|468887322|FG000|Overall Study|Death|1|||
130252375|NCT01730729|468887322|FG000|Overall Study|Progressive Disease|12|||
130252376|NCT01661595|468887323|FG000|Phase 1: Week 0-4|Adverse Event|1|||
130252377|NCT01661595|468887324|FG001|Phase 1: Week 0-4|Adverse Event|0|||
130252378|NCT01661595|468887325|FG002|Phase 1: Week 0-4|Adverse Event|0|||
130252379|NCT01661595|468887326|FG003|Phase 1: Week 0-4|Adverse Event|0|||
130252380|NCT01661595|468887323|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
130252381|NCT01661595|468887324|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
130252382|NCT01661595|468887325|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
130252383|NCT01661595|468887326|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
130252384|NCT00912509|468887327|FG000|Overall Study|Lost to Follow-up|1|||
130252385|NCT00912509|468887328|FG001|Overall Study|Lost to Follow-up|0|||
130252386|NCT00912509|468887327|FG000|Overall Study|Lack of Efficacy|4|||
130252387|NCT00912509|468887328|FG001|Overall Study|Lack of Efficacy|3|||
130252388|NCT02715856|468887329|FG000|Overall Study|Software Issues|12|||
130252389|NCT02715856|468887330|FG001|Overall Study|Software Issues|7|||
130252390|NCT02715856|468887329|FG000|Overall Study|Death|6|||
130252391|NCT02715856|468887330|FG001|Overall Study|Death|5|||
130252392|NCT02715856|468887329|FG000|Overall Study|Non- Compliant|0|||
130252393|NCT02715856|468887330|FG001|Overall Study|Non- Compliant|40|||
130252394|NCT02462057|468887331|FG000|Overall Study|Left Vitality|32|||
130252395|NCT02462057|468887332|FG001|Overall Study|Left Vitality|27|||
130252396|NCT02462057|468887333|FG002|Overall Study|Left Vitality|23|||
130252397|NCT02462057|468887334|FG003|Overall Study|Left Vitality|35|||
130252398|NCT02462057|468887335|FG004|Overall Study|Left Vitality|33|||
130252399|NCT02462057|468887331|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
130252400|NCT02462057|468887332|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
130252401|NCT02462057|468887333|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
130252402|NCT02462057|468887334|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
130252403|NCT02462057|468887335|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
130252404|NCT01682603|468887336|FG000|Overall Study|Lost to Follow-up|3|||
130252405|NCT02336555|468887337|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
130252406|NCT02336555|468887338|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
130252407|NCT02336555|468887337|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
130252408|NCT02336555|468887338|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
130252409|NCT02336555|468887337|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
130252410|NCT02336555|468887338|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
130252411|NCT00993473|468887339|FG000|Overall Study|Adverse Event|0|||
130252412|NCT00993473|468887340|FG001|Overall Study|Adverse Event|2|||
130252413|NCT00993473|468887339|FG000|Overall Study|Protocol Violation|1|||
130252414|NCT00993473|468887340|FG001|Overall Study|Protocol Violation|2|||
130252415|NCT00993473|468887339|FG000|Overall Study|Lost to Follow-up|1|||
130252416|NCT00993473|468887340|FG001|Overall Study|Lost to Follow-up|0|||
130252417|NCT00993473|468887339|FG000|Overall Study|Withdrawal by Subject|1|||
130252418|NCT00993473|468887340|FG001|Overall Study|Withdrawal by Subject|5|||
130252419|NCT00993473|468887339|FG000|Overall Study|Technical problem with CGM device|0|||
130252420|NCT00993473|468887340|FG001|Overall Study|Technical problem with CGM device|1|||
130252421|NCT00993473|468887339|FG000|Overall Study|Family event|1|||
130252422|NCT00993473|468887340|FG001|Overall Study|Family event|0|||
130252423|NCT01772693|468887341|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
130252424|NCT01772693|468887342|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
130252425|NCT01772693|468887341|FG000|Overall Study|Withdrawal by Subject|2|||
130252426|NCT01772693|468887342|FG001|Overall Study|Withdrawal by Subject|0|||
130252427|NCT01772693|468887341|FG000|Overall Study|Alternative Treatment|2|||
130252428|NCT01772693|468887342|FG001|Overall Study|Alternative Treatment|0|||
130252429|NCT01959919|468887343|FG000|Overall Study|Did not meet the eligibility criteria|2|||
130252430|NCT01697501|468887344|FG000|Overall Study|Protocol Violation|2|||
130252431|NCT00128492|468887345|FG000|Overall Study|AE unrelated to study|2|||
130252432|NCT00128492|468887346|FG001|Overall Study|AE unrelated to study|9|||
130252433|NCT00128492|468887345|FG000|Overall Study|Study drug intolerance (AE)|2|||
130252434|NCT00128492|468887346|FG001|Overall Study|Study drug intolerance (AE)|8|||
130252435|NCT00128492|468887345|FG000|Overall Study|AE related to study|1|||
130252436|NCT00128492|468887346|FG001|Overall Study|AE related to study|4|||
130252437|NCT00128492|468887345|FG000|Overall Study|Death|1|||
130252438|NCT00128492|468887346|FG001|Overall Study|Death|0|||
130252439|NCT00128492|468887345|FG000|Overall Study|Lost to Follow-up|1|||
130252440|NCT00128492|468887346|FG001|Overall Study|Lost to Follow-up|5|||
130252441|NCT00128492|468887345|FG000|Overall Study|Noncompliance|0|||
130252442|NCT00128492|468887346|FG001|Overall Study|Noncompliance|5|||
130252443|NCT00128492|468887345|FG000|Overall Study|Personal or administrative|10|||
130252444|NCT00128492|468887346|FG001|Overall Study|Personal or administrative|22|||
130252445|NCT00128492|468887345|FG000|Overall Study|Withdrawal by Subject|3|||
130252446|NCT00128492|468887346|FG001|Overall Study|Withdrawal by Subject|5|||
130252447|NCT00128492|468887345|FG000|Overall Study|Pregnancy|0|||
130252448|NCT00128492|468887346|FG001|Overall Study|Pregnancy|1|||
130252449|NCT00692237|468887348|FG000|Overall Study|Withdrawal by Subject|1|||
130252450|NCT00692237|468887349|FG001|Overall Study|Withdrawal by Subject|3|||
130252451|NCT00692237|468887348|FG000|Overall Study|Adverse Event|0|||
130252452|NCT00692237|468887349|FG001|Overall Study|Adverse Event|1|||
130252453|NCT01347086|468887350|FG000|Overall Study|failed screening visit|0|||
130252454|NCT01347086|468887351|FG001|Overall Study|failed screening visit|0|||
130252455|NCT01347086|468887352|FG002|Overall Study|failed screening visit|1|||
130252456|NCT01347086|468887353|FG003|Overall Study|failed screening visit|0|||
130031499|NCT00408005|468072607|FG000|Induction|Failed to Complete Randomization|3|||
130031500|NCT00408005|468072608|FG001|Induction|Failed to Complete Randomization|2|||
130031501|NCT00408005|468072609|FG002|Induction|Failed to Complete Randomization|0|||
130031502|NCT00408005|468072610|FG003|Induction|Failed to Complete Randomization|0|||
130031503|NCT00408005|468072611|FG004|Induction|Failed to Complete Randomization|0|||
130031504|NCT00408005|468072612|FG005|Induction|Failed to Complete Randomization|0|||
130031505|NCT00408005|468072613|FG006|Induction|Failed to Complete Randomization|0|||
130031506|NCT00408005|468072614|FG007|Induction|Failed to Complete Randomization|0|||
130031507|NCT00408005|468072607|FG000|Induction|Protocol Deviation|3|||
130031508|NCT00408005|468072608|FG001|Induction|Protocol Deviation|1|||
130031509|NCT00408005|468072609|FG002|Induction|Protocol Deviation|0|||
130031510|NCT00408005|468072610|FG003|Induction|Protocol Deviation|0|||
130031511|NCT00408005|468072611|FG004|Induction|Protocol Deviation|0|||
130031512|NCT00408005|468072612|FG005|Induction|Protocol Deviation|0|||
130031513|NCT00408005|468072613|FG006|Induction|Protocol Deviation|0|||
130031514|NCT00408005|468072614|FG007|Induction|Protocol Deviation|0|||
130031515|NCT00408005|468072607|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
130031516|NCT00408005|468072608|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031517|NCT00408005|468072609|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031518|NCT00408005|468072610|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031519|NCT00408005|468072611|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031520|NCT00408005|468072612|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031521|NCT00408005|468072613|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031522|NCT00408005|468072614|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
130031523|NCT00408005|468072607|FG000|Induction|Recurrent leukemia|1|||
130252457|NCT01347086|468887354|FG004|Overall Study|failed screening visit|0|||
130031524|NCT00408005|468072608|FG001|Induction|Recurrent leukemia|0|||
130031525|NCT00408005|468072609|FG002|Induction|Recurrent leukemia|0|||
130031526|NCT00408005|468072610|FG003|Induction|Recurrent leukemia|0|||
130031527|NCT00408005|468072611|FG004|Induction|Recurrent leukemia|0|||
130252458|NCT01347086|468887355|FG005|Overall Study|failed screening visit|0|||
130252459|NCT01347086|468887356|FG006|Overall Study|failed screening visit|1|||
130031528|NCT00408005|468072612|FG005|Induction|Recurrent leukemia|0|||
130031529|NCT00408005|468072613|FG006|Induction|Recurrent leukemia|0|||
130031530|NCT00408005|468072614|FG007|Induction|Recurrent leukemia|0|||
130252460|NCT01347086|468887357|FG007|Overall Study|failed screening visit|1|||
130252461|NCT01347086|468887358|FG008|Overall Study|failed screening visit|0|||
130252462|NCT01347086|468887359|FG009|Overall Study|failed screening visit|1|||
130252463|NCT00395447|468887360|FG000|Overall Study|Death|37|||
130252464|NCT00395447|468887361|FG001|Overall Study|Death|32|||
130252465|NCT00395447|468887360|FG000|Overall Study|Lost to Follow-up|52|||
130252466|NCT00395447|468887361|FG001|Overall Study|Lost to Follow-up|43|||
130252467|NCT00395447|468887360|FG000|Overall Study|Withdrawal by Subject|24|||
130252468|NCT00395447|468887361|FG001|Overall Study|Withdrawal by Subject|19|||
130252469|NCT00395447|468887360|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
130252470|NCT00395447|468887361|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
130252471|NCT02150863|468887363|FG000|Overall Study|Lost to Follow-up|0|||
130252472|NCT02150863|468887364|FG001|Overall Study|Lost to Follow-up|1|||
130252473|NCT02150863|468887365|FG002|Overall Study|Lost to Follow-up|0|||
130252474|NCT01651208|468887366|FG000|Overall Study|Lost to Follow-up|14|||
130252475|NCT01651208|468887367|FG001|Overall Study|Lost to Follow-up|16|||
130252476|NCT00104884|468887372|FG000|Overall Study|Disease progression|4|||
130252477|NCT05071027|468887376|FG000|Overall Study|Lost to Follow-up|1|||
130252478|NCT05071027|468887377|FG001|Overall Study|Lost to Follow-up|4|||
130252479|NCT02314247|468887382|FG000|Overall Study|Adverse Event|2|||
130252480|NCT02314247|468887383|FG001|Overall Study|Adverse Event|1|||
130252481|NCT02314247|468887384|FG002|Overall Study|Adverse Event|0|||
130252482|NCT02314247|468887382|FG000|Overall Study|Withdrawal by Subject|1|||
130252483|NCT02314247|468887383|FG001|Overall Study|Withdrawal by Subject|3|||
130252484|NCT02314247|468887384|FG002|Overall Study|Withdrawal by Subject|1|||
130252485|NCT02314247|468887382|FG000|Overall Study|Progression of Disease|6|||
130252486|NCT02314247|468887383|FG001|Overall Study|Progression of Disease|2|||
130252487|NCT02314247|468887384|FG002|Overall Study|Progression of Disease|0|||
130252488|NCT02965976|468887385|FG000|Overall Study|Withdrawal by Subject|2|||
130252489|NCT02965976|468887386|FG001|Overall Study|Withdrawal by Subject|0|||
130252490|NCT01687595|468887387|FG000|Overall Study|Withdrawal by Subject|8|||
130252491|NCT01687595|468887388|FG001|Overall Study|Withdrawal by Subject|0|||
130252492|NCT01687595|468887387|FG000|Overall Study|Lost to Follow-up|3|||
130252493|NCT01687595|468887388|FG001|Overall Study|Lost to Follow-up|1|||
130252494|NCT01687595|468887387|FG000|Overall Study|Investigator's decision|1|||
130252495|NCT01687595|468887388|FG001|Overall Study|Investigator's decision|0|||
130252496|NCT01687595|468887387|FG000|Overall Study|Sponsor's decision|1|||
130252497|NCT01687595|468887388|FG001|Overall Study|Sponsor's decision|0|||
130252498|NCT01687595|468887387|FG000|Overall Study|Noncompliance|1|||
130252499|NCT01687595|468887388|FG001|Overall Study|Noncompliance|2|||
130252500|NCT01687595|468887387|FG000|Overall Study|Other than specified|56|||
130252501|NCT01687595|468887388|FG001|Overall Study|Other than specified|7|||
130252502|NCT00489359|468887391|FG000|Overall Study|Death|0|||
130252503|NCT00489359|468887392|FG001|Overall Study|Death|2|||
130252504|NCT00489359|468887391|FG000|Overall Study|Progressive Disease|5|||
130252505|NCT00489359|468887392|FG001|Overall Study|Progressive Disease|6|||
130252506|NCT00489359|468887391|FG000|Overall Study|Lost to Follow-up|1|||
130252507|NCT00489359|468887392|FG001|Overall Study|Lost to Follow-up|0|||
130252508|NCT00489359|468887391|FG000|Overall Study|Withdrawal by Subject|1|||
130252509|NCT00489359|468887392|FG001|Overall Study|Withdrawal by Subject|5|||
130252510|NCT00489359|468887391|FG000|Overall Study|Adverse Event|0|||
130252511|NCT00489359|468887392|FG001|Overall Study|Adverse Event|16|||
130252512|NCT04191733|468887394|FG000|Overall Study|Withdrawn due to study closure|13|||
130252513|NCT04191733|468887395|FG001|Overall Study|Withdrawn due to study closure|14|||
130252514|NCT04191733|468887394|FG000|Overall Study|Withdrawal by Subject|2|||
130252515|NCT04191733|468887395|FG001|Overall Study|Withdrawal by Subject|4|||
130252516|NCT04191733|468887394|FG000|Overall Study|Physician Decision|1|||
130252517|NCT04191733|468887395|FG001|Overall Study|Physician Decision|1|||
130252518|NCT04191733|468887394|FG000|Overall Study|Lost to Follow-up|5|||
130252519|NCT04191733|468887395|FG001|Overall Study|Lost to Follow-up|6|||
130252520|NCT04191733|468887394|FG000|Overall Study|Death|0|||
130252521|NCT04191733|468887395|FG001|Overall Study|Death|1|||
130252522|NCT01903733|468887398|FG000|Overall Study|Death|23|||
130252523|NCT01903733|468887399|FG001|Overall Study|Death|54|||
130252524|NCT01903733|468887400|FG002|Overall Study|Death|30|||
130252525|NCT01903733|468887401|FG003|Overall Study|Death|98|||
130252526|NCT01903733|468887398|FG000|Overall Study|Participant refused further follow-up|35|||
130252527|NCT01903733|468887399|FG001|Overall Study|Participant refused further follow-up|38|||
130252528|NCT01903733|468887400|FG002|Overall Study|Participant refused further follow-up|13|||
130252529|NCT01903733|468887401|FG003|Overall Study|Participant refused further follow-up|9|||
130252530|NCT01903733|468887398|FG000|Overall Study|Lost to Follow-up|18|||
130252531|NCT01903733|468887399|FG001|Overall Study|Lost to Follow-up|19|||
130252532|NCT01903733|468887400|FG002|Overall Study|Lost to Follow-up|6|||
130031531|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130031532|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130252533|NCT01903733|468887401|FG003|Overall Study|Lost to Follow-up|9|||
130252534|NCT01903733|468887398|FG000|Overall Study|Other|10|||
130252535|NCT01903733|468887399|FG001|Overall Study|Other|15|||
130252536|NCT01903733|468887400|FG002|Overall Study|Other|12|||
130252537|NCT01903733|468887401|FG003|Overall Study|Other|3|||
130252538|NCT01903733|468887398|FG000|Overall Study|Missing|2|||
130252539|NCT01903733|468887399|FG001|Overall Study|Missing|0|||
130252540|NCT01903733|468887400|FG002|Overall Study|Missing|0|||
130031533|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
130031534|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
130031535|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
130031536|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
130031537|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
130031538|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130031539|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
130031540|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
130031541|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
130031542|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
130031543|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
130031544|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
130031545|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
130031546|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
130252541|NCT01903733|468887401|FG003|Overall Study|Missing|0|||
130252542|NCT01903733|468887398|FG000|Overall Study|Investigator request|18|||
130252543|NCT01903733|468887399|FG001|Overall Study|Investigator request|0|||
130252544|NCT01903733|468887400|FG002|Overall Study|Investigator request|0|||
130252545|NCT01903733|468887401|FG003|Overall Study|Investigator request|0|||
130252546|NCT01714063|468887402|FG000|Overall Study|Equipment malfunction|2|||
130031547|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130252547|NCT02294019|468887404|FG000|Overall Study|Adverse Event|2|||
130252548|NCT02294019|468887404|FG000|Overall Study|Protocol Violation|68|||
130252549|NCT02294019|468887404|FG000|Overall Study|Lost to Follow-up|31|||
130252550|NCT02294019|468887404|FG000|Overall Study|Other|1|||
130252551|NCT02294019|468887404|FG000|Overall Study|Withdrawal by Subject|1|||
130252552|NCT02369159|468887405|FG000|Overall Study|Adverse Event|0|||
130252553|NCT02369159|468887406|FG001|Overall Study|Adverse Event|1|||
130252554|NCT02369159|468887405|FG000|Overall Study|Lost to Follow-up|1|||
130252555|NCT02369159|468887406|FG001|Overall Study|Lost to Follow-up|1|||
130252556|NCT02369159|468887405|FG000|Overall Study|Withdrawal by Subject|7|||
130252557|NCT02369159|468887406|FG001|Overall Study|Withdrawal by Subject|0|||
130252558|NCT03769116|468887407|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
130252559|NCT03769116|468887408|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
130252560|NCT03769116|468887407|FG000|Part 3 - Open Label|Physician Decision|1|||
130101144|NCT03917654|468327313|FG000|Year 2|Subject moved away from site|1|||
130252561|NCT03769116|468887408|FG001|Part 3 - Open Label|Physician Decision|0|||
130252562|NCT03769116|468887407|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
130252563|NCT03769116|468887408|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
130252564|NCT01887600|468887410|FG000|Overall Study|Death|39|||
130252565|NCT01887600|468887411|FG001|Overall Study|Death|16|||
130252566|NCT01887600|468887410|FG000|Overall Study|Lack of Efficacy|3|||
130252567|NCT01887600|468887411|FG001|Overall Study|Lack of Efficacy|26|||
130252568|NCT01887600|468887410|FG000|Overall Study|Lost to Follow-up|5|||
130252569|NCT01887600|468887411|FG001|Overall Study|Lost to Follow-up|1|||
130252570|NCT01887600|468887410|FG000|Overall Study|Physician Decision|7|||
130252571|NCT01887600|468887411|FG001|Overall Study|Physician Decision|8|||
130252572|NCT01887600|468887410|FG000|Overall Study|Protocol Deviation|3|||
130252573|NCT01887600|468887411|FG001|Overall Study|Protocol Deviation|0|||
130252574|NCT01887600|468887410|FG000|Overall Study|Withdrawal by Subject|58|||
130252575|NCT01887600|468887411|FG001|Overall Study|Withdrawal by Subject|52|||
130252576|NCT01887600|468887410|FG000|Overall Study|Adverse Event|21|||
130252577|NCT01887600|468887411|FG001|Overall Study|Adverse Event|9|||
130252578|NCT01887600|468887410|FG000|Overall Study|Non-compliance with study drug|3|||
130252579|NCT01887600|468887411|FG001|Overall Study|Non-compliance with study drug|0|||
130252580|NCT01887600|468887410|FG000|Overall Study|Miscellaneous|6|||
130252581|NCT01887600|468887411|FG001|Overall Study|Miscellaneous|2|||
130252582|NCT01887600|468887410|FG000|Overall Study|Progressive Disease|1|||
130252583|NCT01887600|468887411|FG001|Overall Study|Progressive Disease|0|||
130252584|NCT03688139|468887412|FG000|Overall Study|Lost to Follow-up|2|||
130252585|NCT03688139|468887413|FG001|Overall Study|Lost to Follow-up|0|||
130252586|NCT03688139|468887412|FG000|Overall Study|Physician Decision|0|||
130252587|NCT03688139|468887413|FG001|Overall Study|Physician Decision|1|||
130252588|NCT03688139|468887412|FG000|Overall Study|Withdrawal by Subject|2|||
130252589|NCT03688139|468887413|FG001|Overall Study|Withdrawal by Subject|3|||
130252590|NCT00420056|468887414|FG000|Overall Study|Objective progression or relapse|17|||
130252591|NCT00025233|468887418|FG000|Overall Study|Ineligible: wrong cell type|1|||
130252592|NCT00025233|468887418|FG000|Overall Study|Ineligible: wrong primary|1|||
130252593|NCT00025233|468887418|FG000|Overall Study|Ineligible: improper prior treatment|1|||
130252594|NCT00025233|468887418|FG000|Overall Study|Never treated|1|||
130252595|NCT03425188|468887419|FG000|Overall Study|Withdrawal by Subject|1|||
130252596|NCT00655356|468887420|FG000|Overall Study|Withdrawal by Subject|3|||
130252597|NCT00655356|468887421|FG001|Overall Study|Withdrawal by Subject|4|||
130252598|NCT00655356|468887420|FG000|Overall Study|Sponsor Request|10|||
130252599|NCT00655356|468887421|FG001|Overall Study|Sponsor Request|4|||
130252600|NCT00655356|468887420|FG000|Overall Study|Adverse Event|1|||
130252601|NCT00655356|468887421|FG001|Overall Study|Adverse Event|1|||
130252602|NCT00655356|468887420|FG000|Overall Study|Protocol Violation|2|||
130252603|NCT00655356|468887421|FG001|Overall Study|Protocol Violation|1|||
130101145|NCT03917654|468327314|FG001|Year 2|Subject moved away from site|0|||
130252604|NCT00655356|468887420|FG000|Overall Study|Other Reason|1|||
130252605|NCT00655356|468887421|FG001|Overall Study|Other Reason|0|||
130252606|NCT01412983|468887422|FG000|1st Period|Ineligible|0|||
130252607|NCT01412983|468887423|FG001|1st Period|Ineligible|1|||
130252608|NCT01412983|468887422|FG000|1st Period|Positive slit lamp finding|0|||
130252609|NCT01412983|468887423|FG001|1st Period|Positive slit lamp finding|1|||
130252610|NCT01412983|468887422|FG000|1st Period|Unacceptable lens movement|0|||
130252611|NCT01412983|468887423|FG001|1st Period|Unacceptable lens movement|1|||
130252612|NCT01412983|468887422|FG000|1st Period|Inability to maintain wear|0|||
130252613|NCT01412983|468887423|FG001|1st Period|Inability to maintain wear|1|||
130252614|NCT01694771|468887424|FG000|Overall Study|Adverse Event|18|||
130252615|NCT01694771|468887425|FG001|Overall Study|Adverse Event|16|||
130252616|NCT01694771|468887424|FG000|Overall Study|Lack of Efficacy|1|||
130252617|NCT01694771|468887425|FG001|Overall Study|Lack of Efficacy|0|||
130252618|NCT01694771|468887424|FG000|Overall Study|Non compliance protocol|7|||
130252619|NCT01694771|468887425|FG001|Overall Study|Non compliance protocol|6|||
130252620|NCT01694771|468887424|FG000|Overall Study|Lost to Follow-up|2|||
130252621|NCT01694771|468887425|FG001|Overall Study|Lost to Follow-up|3|||
130252622|NCT01694771|468887424|FG000|Overall Study|Consent withdrawn|7|||
130252623|NCT01694771|468887425|FG001|Overall Study|Consent withdrawn|9|||
130252624|NCT01694771|468887424|FG000|Overall Study|Other reasons|5|||
130252625|NCT01694771|468887425|FG001|Overall Study|Other reasons|6|||
130252626|NCT00289900|468887426|FG000|Overall Study|Adverse Event|28|||
130252627|NCT00289900|468887427|FG001|Overall Study|Adverse Event|40|||
130252628|NCT00289900|468887428|FG002|Overall Study|Adverse Event|13|||
130252629|NCT00289900|468887429|FG003|Overall Study|Adverse Event|19|||
130252630|NCT00289900|468887430|FG004|Overall Study|Adverse Event|20|||
130252631|NCT00289900|468887431|FG005|Overall Study|Adverse Event|33|||
130252632|NCT00289900|468887426|FG000|Overall Study|Lost to Follow-up|7|||
130252633|NCT00289900|468887427|FG001|Overall Study|Lost to Follow-up|7|||
130252634|NCT00289900|468887428|FG002|Overall Study|Lost to Follow-up|8|||
130252635|NCT00289900|468887429|FG003|Overall Study|Lost to Follow-up|8|||
130252636|NCT00289900|468887430|FG004|Overall Study|Lost to Follow-up|4|||
130252637|NCT00289900|468887431|FG005|Overall Study|Lost to Follow-up|8|||
130252638|NCT00289900|468887426|FG000|Overall Study|Participant had flushing|18|||
130252639|NCT00289900|468887427|FG001|Overall Study|Participant had flushing|42|||
130252640|NCT00289900|468887428|FG002|Overall Study|Participant had flushing|1|||
130252641|NCT00289900|468887429|FG003|Overall Study|Participant had flushing|2|||
130252642|NCT00289900|468887430|FG004|Overall Study|Participant had flushing|0|||
130252643|NCT00289900|468887431|FG005|Overall Study|Participant had flushing|4|||
130252644|NCT00289900|468887426|FG000|Overall Study|Other|0|||
130252645|NCT00289900|468887427|FG001|Overall Study|Other|0|||
130252646|NCT00289900|468887428|FG002|Overall Study|Other|0|||
130252647|NCT00289900|468887429|FG003|Overall Study|Other|5|||
130252648|NCT00289900|468887430|FG004|Overall Study|Other|1|||
130252649|NCT00289900|468887431|FG005|Overall Study|Other|0|||
130252650|NCT00289900|468887426|FG000|Overall Study|Participant moved|1|||
130252651|NCT00289900|468887427|FG001|Overall Study|Participant moved|0|||
130252652|NCT00289900|468887428|FG002|Overall Study|Participant moved|0|||
130252653|NCT00289900|468887429|FG003|Overall Study|Participant moved|1|||
130252654|NCT00289900|468887430|FG004|Overall Study|Participant moved|1|||
130252655|NCT00289900|468887431|FG005|Overall Study|Participant moved|1|||
130252656|NCT00289900|468887426|FG000|Overall Study|Withdrawal by Subject|10|||
130252657|NCT00289900|468887427|FG001|Overall Study|Withdrawal by Subject|21|||
130252658|NCT00289900|468887428|FG002|Overall Study|Withdrawal by Subject|8|||
130252659|NCT00289900|468887429|FG003|Overall Study|Withdrawal by Subject|18|||
130252660|NCT00289900|468887430|FG004|Overall Study|Withdrawal by Subject|12|||
130252661|NCT00289900|468887431|FG005|Overall Study|Withdrawal by Subject|11|||
130252662|NCT00289900|468887426|FG000|Overall Study|Protocol Violation|3|||
130252663|NCT00289900|468887427|FG001|Overall Study|Protocol Violation|9|||
130252664|NCT00289900|468887428|FG002|Overall Study|Protocol Violation|2|||
130252665|NCT00289900|468887429|FG003|Overall Study|Protocol Violation|6|||
130252666|NCT00289900|468887430|FG004|Overall Study|Protocol Violation|7|||
130252667|NCT00289900|468887431|FG005|Overall Study|Protocol Violation|4|||
130252668|NCT00289900|468887426|FG000|Overall Study|site terminated|1|||
130252669|NCT00289900|468887427|FG001|Overall Study|site terminated|0|||
130252670|NCT00289900|468887428|FG002|Overall Study|site terminated|1|||
130252671|NCT00289900|468887429|FG003|Overall Study|site terminated|0|||
130252672|NCT00289900|468887430|FG004|Overall Study|site terminated|0|||
130252673|NCT00289900|468887431|FG005|Overall Study|site terminated|0|||
130252674|NCT00289900|468887426|FG000|Overall Study|Not treated|0|||
130252675|NCT00289900|468887427|FG001|Overall Study|Not treated|1|||
130252676|NCT00289900|468887428|FG002|Overall Study|Not treated|0|||
130252677|NCT00289900|468887429|FG003|Overall Study|Not treated|0|||
130252678|NCT00289900|468887430|FG004|Overall Study|Not treated|0|||
130252679|NCT00289900|468887431|FG005|Overall Study|Not treated|0|||
130252680|NCT01152385|468887432|FG000|Overall Study|Withdrawal by Subject|3|||
130252681|NCT01152385|468887433|FG001|Overall Study|Withdrawal by Subject|1|||
130252682|NCT01152385|468887434|FG002|Overall Study|Withdrawal by Subject|1|||
130252683|NCT01152385|468887435|FG003|Overall Study|Withdrawal by Subject|1|||
130252684|NCT01152385|468887432|FG000|Overall Study|Protocol Violation|0|||
130101146|NCT03917654|468327315|FG002|Year 2|Subject moved away from site|0|||
130252685|NCT01152385|468887433|FG001|Overall Study|Protocol Violation|0|||
130252686|NCT01152385|468887434|FG002|Overall Study|Protocol Violation|0|||
130252687|NCT01152385|468887435|FG003|Overall Study|Protocol Violation|1|||
130252688|NCT01152385|468887432|FG000|Overall Study|Adverse Event|1|||
130252689|NCT01152385|468887433|FG001|Overall Study|Adverse Event|1|||
130252690|NCT01152385|468887434|FG002|Overall Study|Adverse Event|0|||
130252691|NCT01152385|468887435|FG003|Overall Study|Adverse Event|0|||
130252692|NCT01152385|468887432|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130252693|NCT01152385|468887433|FG001|Overall Study|Study-specific withdrawal criteria|1|||
130252694|NCT01152385|468887434|FG002|Overall Study|Study-specific withdrawal criteria|2|||
130252695|NCT01152385|468887435|FG003|Overall Study|Study-specific withdrawal criteria|0|||
130252696|NCT01152385|468887432|FG000|Overall Study|Other|4|||
130252697|NCT01152385|468887433|FG001|Overall Study|Other|3|||
130252698|NCT01152385|468887434|FG002|Overall Study|Other|2|||
130252699|NCT01152385|468887435|FG003|Overall Study|Other|3|||
130252700|NCT05486065|468887436|FG000|Overall Study|Withdrawal by Subject|1|||
130031548|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130031549|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
130031550|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130031551|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
130031552|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130031553|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130031554|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
130031555|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130031556|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130031557|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
130031558|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
130031559|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
130031560|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
130031561|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
130031562|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
130031563|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130252701|NCT05486065|468887437|FG001|Overall Study|Withdrawal by Subject|5|||
130252702|NCT05486065|468887438|FG002|Overall Study|Withdrawal by Subject|4|||
130252703|NCT05486065|468887439|FG003|Overall Study|Withdrawal by Subject|3|||
130252704|NCT05486065|468887436|FG000|Overall Study|Lost to Follow-up|4|||
130252705|NCT05486065|468887437|FG001|Overall Study|Lost to Follow-up|2|||
130252706|NCT05486065|468887438|FG002|Overall Study|Lost to Follow-up|2|||
130252707|NCT05486065|468887439|FG003|Overall Study|Lost to Follow-up|2|||
130252708|NCT05486065|468887436|FG000|Overall Study|Physician Decision|0|||
130031564|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130031565|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
130031566|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
130031567|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130031568|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
130031569|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130031570|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
130031571|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
130031572|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
130031573|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
130031574|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
130031575|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
130031576|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
130031577|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
130031578|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
130031579|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031580|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031581|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031582|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031583|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
130031584|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031585|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031586|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
130031587|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130031588|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130031589|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
130031590|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
130031591|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
130052125|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130252709|NCT05486065|468887437|FG001|Overall Study|Physician Decision|1|||
130252710|NCT05486065|468887438|FG002|Overall Study|Physician Decision|1|||
130252711|NCT05486065|468887439|FG003|Overall Study|Physician Decision|0|||
130252712|NCT05486065|468887436|FG000|Overall Study|Failure to meet randomization criteria|0|||
130252713|NCT05486065|468887437|FG001|Overall Study|Failure to meet randomization criteria|0|||
130252714|NCT05486065|468887438|FG002|Overall Study|Failure to meet randomization criteria|0|||
130252715|NCT05486065|468887439|FG003|Overall Study|Failure to meet randomization criteria|1|||
130252716|NCT03810495|468887444|FG000|Overall Study|Lost to Follow-up|2|||
130252717|NCT03810495|468887444|FG000|Overall Study|Withdrawal by Subject|1|||
130252718|NCT03289741|468887445|FG000|Overall Study|Adverse Event|1|||
130252719|NCT03289741|468887446|FG001|Overall Study|Adverse Event|1|||
130252720|NCT03289741|468887445|FG000|Overall Study|Physician Decision|2|||
130252721|NCT03289741|468887446|FG001|Overall Study|Physician Decision|2|||
130252722|NCT03289741|468887445|FG000|Overall Study|Withdrawal by Subject|1|||
130252723|NCT03289741|468887446|FG001|Overall Study|Withdrawal by Subject|0|||
130252724|NCT02536339|468887448|FG000|Overall Study|Death|20|||
130252725|NCT02536339|468887448|FG000|Overall Study|Withdrawal by Subject|3|||
130252726|NCT02536339|468887448|FG000|Overall Study|Lost to Follow-up|2|||
130252727|NCT02536339|468887448|FG000|Overall Study|Treatment discontinued|2|||
130252728|NCT02536339|468887448|FG000|Overall Study|Physician Decision|1|||
130252729|NCT02037984|468887449|FG000|Overall Study|Lack of Efficacy|0|||
130252730|NCT02037984|468887450|FG001|Overall Study|Lack of Efficacy|0|||
130252731|NCT02037984|468887451|FG002|Overall Study|Lack of Efficacy|3|||
130252732|NCT02037984|468887452|FG003|Overall Study|Lack of Efficacy|10|||
130252733|NCT02037984|468887453|FG004|Overall Study|Lack of Efficacy|2|||
130252734|NCT02037984|468887454|FG005|Overall Study|Lack of Efficacy|2|||
130252735|NCT02037984|468887455|FG006|Overall Study|Lack of Efficacy|4|||
130252736|NCT02037984|468887456|FG007|Overall Study|Lack of Efficacy|3|||
130252737|NCT02037984|468887449|FG000|Overall Study|Lost to Follow-up|1|||
130252738|NCT02037984|468887450|FG001|Overall Study|Lost to Follow-up|0|||
130252739|NCT02037984|468887451|FG002|Overall Study|Lost to Follow-up|3|||
130252740|NCT02037984|468887452|FG003|Overall Study|Lost to Follow-up|5|||
130252741|NCT02037984|468887453|FG004|Overall Study|Lost to Follow-up|2|||
130252742|NCT02037984|468887454|FG005|Overall Study|Lost to Follow-up|2|||
130252743|NCT02037984|468887455|FG006|Overall Study|Lost to Follow-up|2|||
130252744|NCT02037984|468887456|FG007|Overall Study|Lost to Follow-up|4|||
130252745|NCT02037984|468887449|FG000|Overall Study|Physician Decision|0|||
130252746|NCT02037984|468887450|FG001|Overall Study|Physician Decision|0|||
130252747|NCT02037984|468887451|FG002|Overall Study|Physician Decision|0|||
130252748|NCT02037984|468887452|FG003|Overall Study|Physician Decision|0|||
130252749|NCT02037984|468887453|FG004|Overall Study|Physician Decision|0|||
130252750|NCT02037984|468887454|FG005|Overall Study|Physician Decision|0|||
130252751|NCT02037984|468887455|FG006|Overall Study|Physician Decision|1|||
130252752|NCT02037984|468887456|FG007|Overall Study|Physician Decision|0|||
130252753|NCT02037984|468887449|FG000|Overall Study|Protocol Violation|0|||
130252754|NCT02037984|468887450|FG001|Overall Study|Protocol Violation|0|||
130252755|NCT02037984|468887451|FG002|Overall Study|Protocol Violation|0|||
130252756|NCT02037984|468887452|FG003|Overall Study|Protocol Violation|0|||
130252757|NCT02037984|468887453|FG004|Overall Study|Protocol Violation|0|||
130252758|NCT02037984|468887454|FG005|Overall Study|Protocol Violation|1|||
130252759|NCT02037984|468887455|FG006|Overall Study|Protocol Violation|2|||
130252760|NCT02037984|468887456|FG007|Overall Study|Protocol Violation|0|||
130252761|NCT02037984|468887449|FG000|Overall Study|Technical Problems|0|||
130252762|NCT02037984|468887450|FG001|Overall Study|Technical Problems|0|||
130252763|NCT02037984|468887451|FG002|Overall Study|Technical Problems|3|||
130252764|NCT02037984|468887452|FG003|Overall Study|Technical Problems|3|||
130252765|NCT02037984|468887453|FG004|Overall Study|Technical Problems|2|||
130252766|NCT02037984|468887454|FG005|Overall Study|Technical Problems|3|||
130252767|NCT02037984|468887455|FG006|Overall Study|Technical Problems|4|||
130252768|NCT02037984|468887456|FG007|Overall Study|Technical Problems|2|||
130252769|NCT02037984|468887449|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130252770|NCT02037984|468887450|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130252771|NCT02037984|468887451|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
130252772|NCT02037984|468887452|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
130252773|NCT02037984|468887453|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
130252774|NCT02037984|468887454|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
130252775|NCT02037984|468887455|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
130252776|NCT02037984|468887456|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
130252777|NCT02037984|468887449|FG000|Overall Study|Withdrawal by Subject|0|||
130252778|NCT02037984|468887450|FG001|Overall Study|Withdrawal by Subject|0|||
130252779|NCT02037984|468887451|FG002|Overall Study|Withdrawal by Subject|0|||
130252780|NCT02037984|468887452|FG003|Overall Study|Withdrawal by Subject|1|||
130252781|NCT02037984|468887453|FG004|Overall Study|Withdrawal by Subject|1|||
130252782|NCT02037984|468887454|FG005|Overall Study|Withdrawal by Subject|3|||
130252783|NCT02037984|468887455|FG006|Overall Study|Withdrawal by Subject|0|||
129884947|NCT00876460|467538738|FG005|Combination Therapy Phase|Adverse Event|0|||
129884948|NCT00876460|467538739|FG006|Combination Therapy Phase|Adverse Event|3|||
129884949|NCT00876460|467538740|FG007|Combination Therapy Phase|Adverse Event|2|||
129884950|NCT00876460|467538733|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
129884951|NCT00876460|467538734|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
129884952|NCT00876460|467538735|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
129884953|NCT00876460|467538736|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
129884954|NCT00876460|467538737|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
129884955|NCT00876460|467538738|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
129884956|NCT00876460|467538739|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
129884957|NCT00876460|467538740|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
129884958|NCT00876460|467538733|FG000|Combination Therapy Phase|Other reason not defined above|0|||
129884959|NCT00876460|467538734|FG001|Combination Therapy Phase|Other reason not defined above|0|||
129884960|NCT00876460|467538735|FG002|Combination Therapy Phase|Other reason not defined above|0|||
129884961|NCT00876460|467538736|FG003|Combination Therapy Phase|Other reason not defined above|0|||
129884962|NCT00876460|467538737|FG004|Combination Therapy Phase|Other reason not defined above|0|||
129884963|NCT00876460|467538738|FG005|Combination Therapy Phase|Other reason not defined above|0|||
129884964|NCT00876460|467538739|FG006|Combination Therapy Phase|Other reason not defined above|1|||
129884965|NCT00876460|467538740|FG007|Combination Therapy Phase|Other reason not defined above|2|||
129884966|NCT00876460|467538733|FG000|Combination Therapy Phase|Not treated|0|||
129884967|NCT00876460|467538734|FG001|Combination Therapy Phase|Not treated|0|||
129884968|NCT00876460|467538735|FG002|Combination Therapy Phase|Not treated|0|||
129884969|NCT00876460|467538736|FG003|Combination Therapy Phase|Not treated|0|||
129884970|NCT00876460|467538737|FG004|Combination Therapy Phase|Not treated|0|||
129884971|NCT00876460|467538738|FG005|Combination Therapy Phase|Not treated|0|||
129884972|NCT00876460|467538739|FG006|Combination Therapy Phase|Not treated|1|||
129884973|NCT00876460|467538740|FG007|Combination Therapy Phase|Not treated|0|||
129884974|NCT00876460|467538733|FG000|Mono Therapy Phase|Progressive disease|0|||
129884975|NCT00876460|467538734|FG001|Mono Therapy Phase|Progressive disease|0|||
129884976|NCT00876460|467538735|FG002|Mono Therapy Phase|Progressive disease|0|||
129884977|NCT00876460|467538736|FG003|Mono Therapy Phase|Progressive disease|0|||
129884978|NCT00876460|467538737|FG004|Mono Therapy Phase|Progressive disease|2|||
129884979|NCT00876460|467538738|FG005|Mono Therapy Phase|Progressive disease|0|||
129884980|NCT00876460|467538739|FG006|Mono Therapy Phase|Progressive disease|1|||
129884981|NCT00876460|467538740|FG007|Mono Therapy Phase|Progressive disease|3|||
129884982|NCT00876460|467538733|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
129884983|NCT00876460|467538734|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
129884984|NCT00876460|467538735|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
129884985|NCT00876460|467538736|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
129884986|NCT00876460|467538737|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
129884987|NCT00876460|467538738|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
129884988|NCT00876460|467538739|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
129884989|NCT00876460|467538740|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
129884990|NCT00876460|467538733|FG000|Mono Therapy Phase|Adverse Event|0|||
129884991|NCT00876460|467538734|FG001|Mono Therapy Phase|Adverse Event|0|||
129884992|NCT00876460|467538735|FG002|Mono Therapy Phase|Adverse Event|0|||
129884993|NCT00876460|467538736|FG003|Mono Therapy Phase|Adverse Event|1|||
129884994|NCT00876460|467538737|FG004|Mono Therapy Phase|Adverse Event|0|||
129884995|NCT00876460|467538738|FG005|Mono Therapy Phase|Adverse Event|0|||
129884996|NCT00876460|467538739|FG006|Mono Therapy Phase|Adverse Event|0|||
129884997|NCT00876460|467538740|FG007|Mono Therapy Phase|Adverse Event|0|||
129884998|NCT00127413|467538742|FG000|Overall Study|Lost to Follow-up|6|||
129884999|NCT00127413|467538743|FG001|Overall Study|Lost to Follow-up|4|||
129885000|NCT00127413|467538744|FG002|Overall Study|Lost to Follow-up|8|||
129885001|NCT00127413|467538745|FG003|Overall Study|Lost to Follow-up|2|||
129885002|NCT00547911|467538748|FG000|Overall Study|Adverse Event|0|||
129885003|NCT00547911|467538749|FG001|Overall Study|Adverse Event|0|||
129885004|NCT00547911|467538750|FG002|Overall Study|Adverse Event|0|||
129885005|NCT00547911|467538751|FG003|Overall Study|Adverse Event|1|||
129885006|NCT00547911|467538752|FG004|Overall Study|Adverse Event|0|||
130252784|NCT02037984|468887456|FG007|Overall Study|Withdrawal by Subject|1|||
130252785|NCT05520333|468888976|FG000|Overall Study|Lost to Follow-up|3|||
129885007|NCT00547911|467538753|FG005|Overall Study|Adverse Event|0|||
129885008|NCT01644474|467538754|FG000|Overall Study|Poor compliance to protocol|1|||
129885009|NCT01644474|467538755|FG001|Overall Study|Poor compliance to protocol|0|||
130252786|NCT05520333|468888977|FG001|Overall Study|Lost to Follow-up|6|||
130252787|NCT02457546|468888978|FG000|Overall Study|Other reasons|4|||
129885010|NCT01644474|467538754|FG000|Overall Study|Consent withdrawn by participant|0|||
129885011|NCT01644474|467538755|FG001|Overall Study|Consent withdrawn by participant|1|||
129885012|NCT01644474|467538754|FG000|Overall Study|Participant moved|0|||
129885013|NCT01644474|467538755|FG001|Overall Study|Participant moved|1|||
129885014|NCT01644474|467538754|FG000|Overall Study|Adverse Event|4|||
129885015|NCT01644474|467538755|FG001|Overall Study|Adverse Event|5|||
129885016|NCT01644474|467538754|FG000|Overall Study|Site scheduling error|1|||
129885017|NCT01644474|467538755|FG001|Overall Study|Site scheduling error|1|||
130031592|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130031593|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
130252788|NCT02457546|468888979|FG001|Overall Study|Other reasons|1|||
130252789|NCT02457546|468888978|FG000|Overall Study|Refused to complete study/procedures|1|||
130252790|NCT02457546|468888979|FG001|Overall Study|Refused to complete study/procedures|1|||
130252791|NCT02457546|468888978|FG000|Overall Study|Lost to Follow-up|4|||
130252792|NCT02457546|468888979|FG001|Overall Study|Lost to Follow-up|1|||
130252793|NCT02457546|468888978|FG000|Overall Study|Adverse Event|0|||
129885018|NCT01644474|467538754|FG000|Overall Study|Protocol Violation|1|||
129885019|NCT01644474|467538755|FG001|Overall Study|Protocol Violation|0|||
129885020|NCT02044458|467538759|FG000|Overall Study|Protocol Violation|3|||
129885021|NCT02044458|467538760|FG001|Overall Study|Protocol Violation|8|||
129885022|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885023|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885024|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885025|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885026|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885027|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
129885028|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885029|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885030|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885031|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885032|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885033|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
129885034|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885035|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885036|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885037|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885038|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885039|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
129885040|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885041|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885042|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885043|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885044|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885045|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885046|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
129885047|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885048|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885049|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885050|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885051|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885052|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885053|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885054|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885055|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
129885056|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885057|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
129885058|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885059|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885060|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
129885061|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885062|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
130031594|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
130031595|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130031596|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130031597|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130031598|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130031599|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
130031600|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
130252794|NCT02457546|468888979|FG001|Overall Study|Adverse Event|1|||
130252795|NCT01633112|468888980|FG000|Overall Study|Lack of Efficacy|1|||
130252796|NCT01633112|468888981|FG001|Overall Study|Lack of Efficacy|6|||
130252797|NCT01633112|468888982|FG002|Overall Study|Lack of Efficacy|13|||
130252798|NCT01633112|468888980|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130252799|NCT01633112|468888981|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130252800|NCT01633112|468888982|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130252801|NCT01633112|468888980|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130252802|NCT01633112|468888981|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130252803|NCT01633112|468888982|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130252804|NCT01633112|468888980|FG000|Overall Study|Administrative problems|1|||
130252805|NCT01633112|468888981|FG001|Overall Study|Administrative problems|2|||
130252806|NCT01633112|468888982|FG002|Overall Study|Administrative problems|5|||
130252807|NCT01633112|468888980|FG000|Overall Study|Adverse Event|16|||
130252808|NCT01633112|468888981|FG001|Overall Study|Adverse Event|18|||
130252809|NCT01633112|468888982|FG002|Overall Study|Adverse Event|20|||
130252810|NCT01633112|468888980|FG000|Overall Study|Lost to Follow-up|7|||
130252811|NCT01633112|468888981|FG001|Overall Study|Lost to Follow-up|19|||
130252812|NCT01633112|468888982|FG002|Overall Study|Lost to Follow-up|6|||
130252813|NCT01633112|468888980|FG000|Overall Study|Protocol Violation|4|||
130252814|NCT01633112|468888981|FG001|Overall Study|Protocol Violation|0|||
130252815|NCT01633112|468888982|FG002|Overall Study|Protocol Violation|2|||
130252816|NCT01633112|468888980|FG000|Overall Study|Subject no longer requires study drug|0|||
130252817|NCT01633112|468888981|FG001|Overall Study|Subject no longer requires study drug|0|||
130252818|NCT01633112|468888982|FG002|Overall Study|Subject no longer requires study drug|1|||
130252819|NCT01633112|468888980|FG000|Overall Study|Withdrawal by Subject|20|||
130252820|NCT01633112|468888981|FG001|Overall Study|Withdrawal by Subject|12|||
130252821|NCT01633112|468888982|FG002|Overall Study|Withdrawal by Subject|41|||
130252822|NCT01633112|468888980|FG000|Overall Study|missing Study Completion CRF|1|||
130031601|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
130031602|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
130031603|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130031604|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130031605|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130031606|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130031607|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130252823|NCT01633112|468888981|FG001|Overall Study|missing Study Completion CRF|1|||
130252824|NCT01633112|468888982|FG002|Overall Study|missing Study Completion CRF|4|||
130252825|NCT01908699|468888983|FG000|Overall Study|Adverse Event|8|||
130252826|NCT01908699|468888984|FG001|Overall Study|Adverse Event|12|||
130252827|NCT01908699|468888983|FG000|Overall Study|Lack of Efficacy|2|||
130252828|NCT01908699|468888984|FG001|Overall Study|Lack of Efficacy|2|||
130252829|NCT01908699|468888983|FG000|Overall Study|Lost to Follow-up|2|||
130252830|NCT01908699|468888984|FG001|Overall Study|Lost to Follow-up|4|||
130252831|NCT01908699|468888983|FG000|Overall Study|Physician Decision|8|||
130252832|NCT01908699|468888984|FG001|Overall Study|Physician Decision|8|||
130252833|NCT01908699|468888983|FG000|Overall Study|Withdrawal by Subject|15|||
130252834|NCT01908699|468888984|FG001|Overall Study|Withdrawal by Subject|10|||
130252835|NCT01908699|468888983|FG000|Overall Study|Pregnancy|0|||
130252836|NCT01908699|468888984|FG001|Overall Study|Pregnancy|1|||
130252837|NCT01908699|468888983|FG000|Overall Study|Randomized in Error|1|||
130252838|NCT01908699|468888984|FG001|Overall Study|Randomized in Error|0|||
130252839|NCT01908699|468888983|FG000|Overall Study|Death|9|||
130252840|NCT01908699|468888984|FG001|Overall Study|Death|12|||
130252841|NCT01908699|468888983|FG000|Overall Study|Progressive Disease|30|||
130252842|NCT01908699|468888984|FG001|Overall Study|Progressive Disease|29|||
130252843|NCT03439072|468888985|FG000|Overall Study|Withdrawal by Subject|2|||
130252844|NCT03439072|468888986|FG001|Overall Study|Withdrawal by Subject|3|||
130252845|NCT03439072|468888985|FG000|Overall Study|Physician Decision|0|||
130252846|NCT03439072|468888986|FG001|Overall Study|Physician Decision|1|||
130252847|NCT01537432|468888990|FG000|Overall Study|Lost to Follow-up|3|||
130252848|NCT01537432|468888991|FG001|Overall Study|Lost to Follow-up|1|||
130252849|NCT01537432|468888990|FG000|Overall Study|Withdrawal by Subject|0|||
130252850|NCT01537432|468888991|FG001|Overall Study|Withdrawal by Subject|1|||
130031608|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
130031609|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130252851|NCT01537432|468888990|FG000|Overall Study|Administrative problems|1|||
130252852|NCT01537432|468888991|FG001|Overall Study|Administrative problems|0|||
130252853|NCT01537432|468888990|FG000|Overall Study|Adverse Event|1|||
130252854|NCT01537432|468888991|FG001|Overall Study|Adverse Event|0|||
130252855|NCT01537432|468888990|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130252856|NCT01537432|468888991|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130252857|NCT00889005|468888992|FG000|Overall Study|Lost to Follow-up|4|||
130252858|NCT00889005|468888993|FG001|Overall Study|Lost to Follow-up|2|||
130252859|NCT00889005|468888992|FG000|Overall Study|Withdrawal by Subject|4|||
130031610|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
130252860|NCT00889005|468888993|FG001|Overall Study|Withdrawal by Subject|0|||
130252861|NCT05166902|468888994|FG000|First Intervention|Lost to Follow-up|0|||
130252862|NCT05166902|468888995|FG001|First Intervention|Lost to Follow-up|1|||
130252863|NCT01998477|468888996|FG000|Overall Study|Lost to Follow-up|4|||
130252864|NCT01998477|468888997|FG001|Overall Study|Lost to Follow-up|5|||
130252865|NCT01998477|468888996|FG000|Overall Study|Withdrawal by Subject|6|||
130252866|NCT01998477|468888997|FG001|Overall Study|Withdrawal by Subject|0|||
130252867|NCT00779909|468888998|FG000|Overall Study|Lost to Follow-up|1|||
130252868|NCT00779909|468888999|FG001|Overall Study|Lost to Follow-up|0|||
130252869|NCT00779909|468889000|FG002|Overall Study|Lost to Follow-up|0|||
130252870|NCT00779909|468889001|FG003|Overall Study|Lost to Follow-up|1|||
130252871|NCT00779909|468888998|FG000|Overall Study|Withdrawal by Subject|0|||
130252872|NCT00779909|468888999|FG001|Overall Study|Withdrawal by Subject|1|||
130252873|NCT00779909|468889000|FG002|Overall Study|Withdrawal by Subject|0|||
130252874|NCT00779909|468889001|FG003|Overall Study|Withdrawal by Subject|0|||
130252875|NCT03523585|468889002|FG000|Overall Study|Progressive Disease|174|||
130252876|NCT03523585|468889003|FG001|Overall Study|Progressive Disease|64|||
130252877|NCT03523585|468889004|FG002|Overall Study|Progressive Disease|77|||
130252878|NCT03523585|468889002|FG000|Overall Study|Adverse Event|74|||
130252879|NCT03523585|468889003|FG001|Overall Study|Adverse Event|5|||
130252880|NCT03523585|468889004|FG002|Overall Study|Adverse Event|9|||
130252881|NCT03523585|468889002|FG000|Overall Study|Withdrawal by Subject|30|||
130252882|NCT03523585|468889003|FG001|Overall Study|Withdrawal by Subject|11|||
130252883|NCT03523585|468889004|FG002|Overall Study|Withdrawal by Subject|6|||
130252884|NCT03523585|468889002|FG000|Overall Study|Clinical Progression|23|||
130252885|NCT03523585|468889003|FG001|Overall Study|Clinical Progression|5|||
130252886|NCT03523585|468889004|FG002|Overall Study|Clinical Progression|10|||
130252887|NCT03523585|468889002|FG000|Overall Study|Death|4|||
130252888|NCT03523585|468889003|FG001|Overall Study|Death|0|||
130252889|NCT03523585|468889004|FG002|Overall Study|Death|1|||
130252890|NCT03523585|468889002|FG000|Overall Study|Physician Decision|2|||
130252891|NCT03523585|468889003|FG001|Overall Study|Physician Decision|1|||
130252892|NCT03523585|468889004|FG002|Overall Study|Physician Decision|0|||
130252893|NCT03523585|468889002|FG000|Overall Study|Lost to Follow-up|1|||
130252894|NCT03523585|468889003|FG001|Overall Study|Lost to Follow-up|0|||
130252895|NCT03523585|468889004|FG002|Overall Study|Lost to Follow-up|0|||
130252896|NCT03523585|468889002|FG000|Overall Study|Miscellaneous|1|||
130252897|NCT03523585|468889003|FG001|Overall Study|Miscellaneous|0|||
130252898|NCT03523585|468889004|FG002|Overall Study|Miscellaneous|0|||
130252899|NCT03523585|468889002|FG000|Overall Study|Protocol Deviation|1|||
130252900|NCT03523585|468889003|FG001|Overall Study|Protocol Deviation|0|||
130252901|NCT03523585|468889004|FG002|Overall Study|Protocol Deviation|1|||
130252902|NCT03523585|468889002|FG000|Overall Study|Randomized But Not Treated|2|||
130252903|NCT03523585|468889003|FG001|Overall Study|Randomized But Not Treated|4|||
130252904|NCT03523585|468889004|FG002|Overall Study|Randomized But Not Treated|3|||
130252905|NCT02872142|468889010|FG000|Overall Study|Adverse Event|2|||
130252906|NCT02872142|468889010|FG000|Overall Study|Death|1|||
130252907|NCT02872142|468889010|FG000|Overall Study|Participant Decision|3|||
130252908|NCT01903720|468889011|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
130252909|NCT01903720|468889011|FG000|Overall Study|Adverse Event|1|||
130252910|NCT01903720|468889011|FG000|Overall Study|Rescinding of informed consent|2|||
130252911|NCT01903720|468889011|FG000|Overall Study|Lost to Follow-up|2|||
130252912|NCT01903720|468889011|FG000|Overall Study|Treatment with alternative drug|1|||
130252913|NCT02244957|468889012|FG000|Overall Study|Lack of Efficacy|1|||
130252914|NCT02244957|468889013|FG001|Overall Study|Lack of Efficacy|0|||
130252915|NCT00836901|468889014|FG000|First Intervention|Withdrawal by Subject|1|||
130252916|NCT00836901|468889015|FG001|First Intervention|Withdrawal by Subject|0|||
130252917|NCT00830336|468889016|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130252918|NCT00830336|468889017|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
130252919|NCT03760081|468889018|FG000|Overall Study|Miscellaneous|0|||
130252920|NCT03760081|468889019|FG001|Overall Study|Miscellaneous|1|||
130252921|NCT03760081|468889018|FG000|Overall Study|Progressive Disease|5|||
130252922|NCT03760081|468889019|FG001|Overall Study|Progressive Disease|10|||
130252923|NCT03760081|468889018|FG000|Overall Study|Death|1|||
130252924|NCT03760081|468889019|FG001|Overall Study|Death|1|||
130252925|NCT05261490|468889020|FG000|Overall Study|Other|1|||
130252926|NCT05261490|468889021|FG001|Overall Study|Other|0|||
130252927|NCT05261490|468889022|FG002|Overall Study|Other|0|||
130252928|NCT05261490|468889020|FG000|Overall Study|Study Terminated by Sponsor|1|||
130252929|NCT05261490|468889021|FG001|Overall Study|Study Terminated by Sponsor|1|||
130252930|NCT05261490|468889022|FG002|Overall Study|Study Terminated by Sponsor|4|||
130252931|NCT05261490|468889020|FG000|Overall Study|Death|1|||
130252932|NCT05261490|468889021|FG001|Overall Study|Death|2|||
130252933|NCT05261490|468889022|FG002|Overall Study|Death|0|||
130252934|NCT01646216|468889034|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
130252935|NCT01646216|468889035|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
130252936|NCT01646216|468889034|FG000|Overall Study|Did not complete training|0|||
130252937|NCT01646216|468889035|FG001|Overall Study|Did not complete training|2|||
130252938|NCT01646216|468889034|FG000|Overall Study|Investigator decision|1|||
130252939|NCT01646216|468889035|FG001|Overall Study|Investigator decision|1|||
130252940|NCT02395627|468889036|FG000|Overall Study|Withdrawal by Subject|0|||
130252941|NCT02395627|468889037|FG001|Overall Study|Withdrawal by Subject|2|||
130252942|NCT02395627|468889038|FG002|Overall Study|Withdrawal by Subject|0|||
129885063|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
129885064|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
129885065|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
129885066|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885067|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885068|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885069|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885070|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885071|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885072|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885073|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885074|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885075|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
129885076|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885077|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885078|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885079|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885080|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885081|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885082|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885083|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885084|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
129885085|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
130252943|NCT02395627|468889036|FG000|Overall Study|Did not receive pembrolizumab|3|||
130252944|NCT02395627|468889037|FG001|Overall Study|Did not receive pembrolizumab|1|||
130252945|NCT02395627|468889038|FG002|Overall Study|Did not receive pembrolizumab|0|||
130252946|NCT02633527|468889039|FG000|Overall Study|Failed to meet eligibility|0|||
130252947|NCT02633527|468889040|FG001|Overall Study|Failed to meet eligibility|1|||
130252948|NCT02633527|468889041|FG002|Overall Study|Failed to meet eligibility|1|||
130252949|NCT02633527|468889042|FG003|Overall Study|Failed to meet eligibility|0|||
130252950|NCT02633527|468889043|FG004|Overall Study|Failed to meet eligibility|1|||
130252951|NCT02633527|468889039|FG000|Overall Study|Adverse Event|0|||
130252952|NCT02633527|468889040|FG001|Overall Study|Adverse Event|4|||
130252953|NCT02633527|468889041|FG002|Overall Study|Adverse Event|3|||
130252954|NCT02633527|468889042|FG003|Overall Study|Adverse Event|1|||
130252955|NCT02633527|468889043|FG004|Overall Study|Adverse Event|5|||
130252956|NCT02633527|468889039|FG000|Overall Study|Lost to Follow-up|1|||
130252957|NCT02633527|468889040|FG001|Overall Study|Lost to Follow-up|2|||
130252958|NCT02633527|468889041|FG002|Overall Study|Lost to Follow-up|5|||
130252959|NCT02633527|468889042|FG003|Overall Study|Lost to Follow-up|5|||
130252960|NCT02633527|468889043|FG004|Overall Study|Lost to Follow-up|4|||
130252961|NCT02633527|468889039|FG000|Overall Study|Withdrawal by Subject|0|||
130252962|NCT02633527|468889040|FG001|Overall Study|Withdrawal by Subject|3|||
130252963|NCT02633527|468889041|FG002|Overall Study|Withdrawal by Subject|5|||
130252964|NCT02633527|468889042|FG003|Overall Study|Withdrawal by Subject|4|||
130252965|NCT02633527|468889043|FG004|Overall Study|Withdrawal by Subject|4|||
130252966|NCT02633527|468889039|FG000|Overall Study|Protocol Violation|0|||
130252967|NCT02633527|468889040|FG001|Overall Study|Protocol Violation|1|||
130252968|NCT02633527|468889041|FG002|Overall Study|Protocol Violation|1|||
130252969|NCT02633527|468889042|FG003|Overall Study|Protocol Violation|1|||
130252970|NCT02633527|468889043|FG004|Overall Study|Protocol Violation|1|||
130252971|NCT02633527|468889039|FG000|Overall Study|Physician Decision|0|||
130252972|NCT02633527|468889040|FG001|Overall Study|Physician Decision|0|||
130252973|NCT02633527|468889041|FG002|Overall Study|Physician Decision|0|||
130252974|NCT02633527|468889042|FG003|Overall Study|Physician Decision|0|||
130252975|NCT02633527|468889043|FG004|Overall Study|Physician Decision|1|||
130252976|NCT02633527|468889039|FG000|Overall Study|Administrative reason|1|||
130252977|NCT02633527|468889040|FG001|Overall Study|Administrative reason|0|||
130252978|NCT02633527|468889041|FG002|Overall Study|Administrative reason|0|||
130252979|NCT02633527|468889042|FG003|Overall Study|Administrative reason|1|||
130252980|NCT02633527|468889043|FG004|Overall Study|Administrative reason|0|||
130252981|NCT02633527|468889039|FG000|Overall Study|Multiple reasons|1|||
130252982|NCT02633527|468889040|FG001|Overall Study|Multiple reasons|0|||
130252983|NCT02633527|468889041|FG002|Overall Study|Multiple reasons|2|||
130252984|NCT02633527|468889042|FG003|Overall Study|Multiple reasons|2|||
130252985|NCT02633527|468889043|FG004|Overall Study|Multiple reasons|1|||
130252986|NCT01681849|468889044|FG000|Overall Study|Protocol Violation|2|||
130252987|NCT01681849|468889045|FG001|Overall Study|Protocol Violation|0|||
130252988|NCT01681849|468889046|FG002|Overall Study|Protocol Violation|0|||
130252989|NCT01681849|468889044|FG000|Overall Study|Withdrawal by Subject|3|||
130252990|NCT01681849|468889045|FG001|Overall Study|Withdrawal by Subject|5|||
130252991|NCT01681849|468889046|FG002|Overall Study|Withdrawal by Subject|33|||
130252992|NCT01681849|468889044|FG000|Overall Study|Lost to Follow-up|3|||
130252993|NCT01681849|468889045|FG001|Overall Study|Lost to Follow-up|2|||
130252994|NCT01681849|468889046|FG002|Overall Study|Lost to Follow-up|6|||
130252995|NCT02852005|468889049|FG000|Overall Study|Lost to Follow-up|0|||
130252996|NCT02852005|468889050|FG001|Overall Study|Lost to Follow-up|0|||
130252997|NCT02852005|468889051|FG002|Overall Study|Lost to Follow-up|0|||
130252998|NCT02852005|468889052|FG003|Overall Study|Lost to Follow-up|0|||
130252999|NCT02852005|468889053|FG004|Overall Study|Lost to Follow-up|1|||
130253000|NCT02852005|468889049|FG000|Overall Study|Withdrawal by Subject|1|||
130253001|NCT02852005|468889050|FG001|Overall Study|Withdrawal by Subject|0|||
130253002|NCT02852005|468889051|FG002|Overall Study|Withdrawal by Subject|0|||
130253003|NCT02852005|468889052|FG003|Overall Study|Withdrawal by Subject|0|||
130253004|NCT02852005|468889053|FG004|Overall Study|Withdrawal by Subject|0|||
130253005|NCT02420314|468889056|FG000|Overall Study|Withdrawal by Subject|1|||
130253006|NCT02420314|468889056|FG000|Overall Study|Protocol Violation|1|||
130253007|NCT03760068|468889058|FG000|Overall Study|Withdrawal by Subject|7|||
130253008|NCT03760068|468889059|FG001|Overall Study|Withdrawal by Subject|8|||
130253009|NCT03760068|468889058|FG000|Overall Study|Adverse Event|1|||
130253010|NCT03760068|468889059|FG001|Overall Study|Adverse Event|2|||
130253011|NCT03760068|468889058|FG000|Overall Study|Administrative Decision by Sponsor|0|||
130101147|NCT03917654|468327316|FG003|Year 2|Subject moved away from site|0|||
130101148|NCT03917654|468327317|FG004|Year 2|Subject moved away from site|1|||
130101149|NCT03917654|468327318|FG005|Year 2|Subject moved away from site|0|||
130101150|NCT03917654|468327319|FG006|Year 2|Subject moved away from site|2|||
130101151|NCT03917654|468327320|FG007|Year 2|Subject moved away from site|3|||
130101152|NCT03917654|468327321|FG008|Year 2|Subject moved away from site|0|||
130101153|NCT03917654|468327322|FG009|Year 2|Subject moved away from site|2|||
130101154|NCT03917654|468327323|FG010|Year 2|Subject moved away from site|0|||
130101155|NCT03917654|468327324|FG011|Year 2|Subject moved away from site|1|||
130101156|NCT03917654|468327313|FG000|Year 2|Year 2 Screening failure|0|||
130101157|NCT03917654|468327314|FG001|Year 2|Year 2 Screening failure|1|||
130101158|NCT03917654|468327315|FG002|Year 2|Year 2 Screening failure|0|||
130101159|NCT03917654|468327316|FG003|Year 2|Year 2 Screening failure|0|||
130101160|NCT03917654|468327317|FG004|Year 2|Year 2 Screening failure|2|||
130101161|NCT03917654|468327318|FG005|Year 2|Year 2 Screening failure|0|||
130101162|NCT03917654|468327319|FG006|Year 2|Year 2 Screening failure|4|||
130101163|NCT03917654|468327320|FG007|Year 2|Year 2 Screening failure|3|||
130101164|NCT03917654|468327321|FG008|Year 2|Year 2 Screening failure|10|||
130101165|NCT03917654|468327322|FG009|Year 2|Year 2 Screening failure|2|||
130101166|NCT03917654|468327323|FG010|Year 2|Year 2 Screening failure|1|||
130101167|NCT03917654|468327324|FG011|Year 2|Year 2 Screening failure|1|||
130101168|NCT03917654|468327313|FG000|Year 2|Death|0|||
130101169|NCT03917654|468327314|FG001|Year 2|Death|0|||
130101170|NCT03917654|468327315|FG002|Year 2|Death|0|||
130101171|NCT03917654|468327316|FG003|Year 2|Death|0|||
130101172|NCT03917654|468327317|FG004|Year 2|Death|0|||
130101173|NCT03917654|468327318|FG005|Year 2|Death|1|||
130101174|NCT03917654|468327319|FG006|Year 2|Death|0|||
130101175|NCT03917654|468327320|FG007|Year 2|Death|0|||
130101176|NCT03917654|468327321|FG008|Year 2|Death|1|||
130101177|NCT03917654|468327322|FG009|Year 2|Death|1|||
130101178|NCT03917654|468327323|FG010|Year 2|Death|0|||
130101179|NCT03917654|468327324|FG011|Year 2|Death|0|||
130101180|NCT03917654|468327313|FG000|Year 2|Withdrawal by Subject|0|||
130101181|NCT03917654|468327314|FG001|Year 2|Withdrawal by Subject|0|||
130101182|NCT03917654|468327315|FG002|Year 2|Withdrawal by Subject|0|||
130101183|NCT03917654|468327316|FG003|Year 2|Withdrawal by Subject|0|||
130101184|NCT03917654|468327317|FG004|Year 2|Withdrawal by Subject|0|||
130101185|NCT03917654|468327318|FG005|Year 2|Withdrawal by Subject|0|||
130253012|NCT03760068|468889059|FG001|Overall Study|Administrative Decision by Sponsor|2|||
130253013|NCT03760068|468889058|FG000|Overall Study|Physician Decision|1|||
130253014|NCT03760068|468889059|FG001|Overall Study|Physician Decision|2|||
130253015|NCT03760068|468889058|FG000|Overall Study|Lost to Follow-up|4|||
130253016|NCT03760068|468889059|FG001|Overall Study|Lost to Follow-up|9|||
130253017|NCT03760068|468889058|FG000|Overall Study|Subject Moved Out of State|1|||
130253018|NCT03760068|468889059|FG001|Overall Study|Subject Moved Out of State|0|||
130253019|NCT03460704|468889063|FG000|Overall Study|Withdrawal by Subject|11|||
130253020|NCT03460704|468889064|FG001|Overall Study|Withdrawal by Subject|14|||
130253021|NCT03460704|468889063|FG000|Overall Study|Study terminated by the Sponsor|29|||
130253022|NCT03460704|468889064|FG001|Overall Study|Study terminated by the Sponsor|19|||
130253023|NCT03460704|468889063|FG000|Overall Study|Adverse Event|10|||
130253024|NCT03460704|468889064|FG001|Overall Study|Adverse Event|5|||
130253025|NCT03460704|468889063|FG000|Overall Study|Death|3|||
130253026|NCT03460704|468889064|FG001|Overall Study|Death|2|||
130101186|NCT03917654|468327319|FG006|Year 2|Withdrawal by Subject|3|||
130101187|NCT03917654|468327320|FG007|Year 2|Withdrawal by Subject|0|||
130101188|NCT03917654|468327321|FG008|Year 2|Withdrawal by Subject|2|||
130101189|NCT03917654|468327322|FG009|Year 2|Withdrawal by Subject|5|||
130101190|NCT03917654|468327323|FG010|Year 2|Withdrawal by Subject|0|||
130101191|NCT03917654|468327324|FG011|Year 2|Withdrawal by Subject|0|||
130101192|NCT03917654|468327313|FG000|Year 2|Spouse/family member request|0|||
130253027|NCT03460704|468889063|FG000|Overall Study|Non-Compliance with Study Drug|3|||
130253028|NCT03460704|468889064|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130253029|NCT03460704|468889063|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130253030|NCT03460704|468889064|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
130253031|NCT03460704|468889063|FG000|Overall Study|Other|2|||
130253032|NCT03460704|468889064|FG001|Overall Study|Other|1|||
130253033|NCT02913326|468889069|FG000|Overall Study|Reason not listed|0|||
130253034|NCT02913326|468889070|FG001|Overall Study|Reason not listed|1|||
130253035|NCT02913326|468889069|FG000|Overall Study|Lost to Follow-up|0|||
130253036|NCT02913326|468889070|FG001|Overall Study|Lost to Follow-up|1|||
130253037|NCT02913326|468889069|FG000|Overall Study|Adverse Event|1|||
130253038|NCT02913326|468889070|FG001|Overall Study|Adverse Event|0|||
130253039|NCT01767857|468889071|FG000|Overall Study|Adverse Event|27|||
130253040|NCT01767857|468889072|FG001|Overall Study|Adverse Event|7|||
130253041|NCT01767857|468889071|FG000|Overall Study|Death|28|||
130253042|NCT01767857|468889072|FG001|Overall Study|Death|13|||
130253043|NCT01767857|468889071|FG000|Overall Study|Lack of Efficacy|299|||
130253044|NCT01767857|468889072|FG001|Overall Study|Lack of Efficacy|151|||
130253045|NCT01767857|468889071|FG000|Overall Study|Lost to Follow-up|1|||
130253046|NCT01767857|468889072|FG001|Overall Study|Lost to Follow-up|1|||
130253047|NCT01767857|468889071|FG000|Overall Study|Withdrawal by Subject|38|||
130253048|NCT01767857|468889072|FG001|Overall Study|Withdrawal by Subject|18|||
130253049|NCT01767857|468889071|FG000|Overall Study|Physician Decision|17|||
130253050|NCT01767857|468889072|FG001|Overall Study|Physician Decision|10|||
130253051|NCT01767857|468889071|FG000|Overall Study|Protocol Terminated|1|||
130253052|NCT01767857|468889072|FG001|Overall Study|Protocol Terminated|0|||
130253053|NCT01767857|468889071|FG000|Overall Study|Randomized But Never Treated|19|||
130253054|NCT01767857|468889072|FG001|Overall Study|Randomized But Never Treated|13|||
130253055|NCT01390584|468889096|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
130253056|NCT01390584|468889097|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
130253057|NCT01390584|468889098|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
130253058|NCT01720602|468889099|FG000|Overall Study|Adverse Event|3|||
130253059|NCT01720602|468889099|FG000|Overall Study|Progressive disease on therapy|2|||
130253060|NCT00452400|468889100|FG000|Overall Study|Adverse Event|1|||
130253061|NCT00452400|468889101|FG001|Overall Study|Adverse Event|1|||
130253062|NCT00452400|468889102|FG002|Overall Study|Adverse Event|5|||
130253063|NCT00452400|468889103|FG003|Overall Study|Adverse Event|0|||
130253064|NCT00452400|468889104|FG004|Overall Study|Adverse Event|2|||
130253065|NCT00452400|468889100|FG000|Overall Study|Protocol Violation|0|||
130253066|NCT00452400|468889101|FG001|Overall Study|Protocol Violation|0|||
130253067|NCT00452400|468889102|FG002|Overall Study|Protocol Violation|1|||
130253068|NCT00452400|468889103|FG003|Overall Study|Protocol Violation|0|||
130253069|NCT00452400|468889104|FG004|Overall Study|Protocol Violation|0|||
130253070|NCT00452400|468889100|FG000|Overall Study|Lost to Follow-up|1|||
130253071|NCT00452400|468889101|FG001|Overall Study|Lost to Follow-up|0|||
130253072|NCT00452400|468889102|FG002|Overall Study|Lost to Follow-up|0|||
130253073|NCT00452400|468889103|FG003|Overall Study|Lost to Follow-up|0|||
130253074|NCT00452400|468889104|FG004|Overall Study|Lost to Follow-up|0|||
130253075|NCT00452400|468889100|FG000|Overall Study|Withdrawal by Subject|1|||
130253076|NCT00452400|468889101|FG001|Overall Study|Withdrawal by Subject|0|||
130253077|NCT00452400|468889102|FG002|Overall Study|Withdrawal by Subject|1|||
130253078|NCT00452400|468889103|FG003|Overall Study|Withdrawal by Subject|0|||
130253079|NCT00452400|468889104|FG004|Overall Study|Withdrawal by Subject|0|||
130253080|NCT00452400|468889100|FG000|Overall Study|Lack of Efficacy|2|||
130253081|NCT00452400|468889101|FG001|Overall Study|Lack of Efficacy|0|||
130253082|NCT00452400|468889102|FG002|Overall Study|Lack of Efficacy|0|||
130253083|NCT00452400|468889103|FG003|Overall Study|Lack of Efficacy|0|||
130253084|NCT00452400|468889104|FG004|Overall Study|Lack of Efficacy|0|||
130253085|NCT00452400|468889100|FG000|Overall Study|Other reasons not listed above|0|||
130253086|NCT00452400|468889101|FG001|Overall Study|Other reasons not listed above|0|||
130253087|NCT00452400|468889102|FG002|Overall Study|Other reasons not listed above|0|||
130253088|NCT00452400|468889103|FG003|Overall Study|Other reasons not listed above|1|||
130253089|NCT00452400|468889104|FG004|Overall Study|Other reasons not listed above|1|||
130253090|NCT01943825|468889105|FG000|Overall Study|Lost to Follow-up|9|||
130253091|NCT01943825|468889106|FG001|Overall Study|Lost to Follow-up|3|||
130253092|NCT01943825|468889107|FG002|Overall Study|Lost to Follow-up|12|||
130253093|NCT01943825|468889108|FG003|Overall Study|Lost to Follow-up|8|||
130253094|NCT01943825|468889105|FG000|Overall Study|Withdrawal by Subject|1|||
130253095|NCT01943825|468889106|FG001|Overall Study|Withdrawal by Subject|0|||
130253096|NCT01943825|468889107|FG002|Overall Study|Withdrawal by Subject|3|||
130253097|NCT01943825|468889108|FG003|Overall Study|Withdrawal by Subject|2|||
130253098|NCT01943825|468889105|FG000|Overall Study|Other than specified above|0|||
130253099|NCT01943825|468889106|FG001|Overall Study|Other than specified above|1|||
130253100|NCT01943825|468889107|FG002|Overall Study|Other than specified above|0|||
130253101|NCT01943825|468889108|FG003|Overall Study|Other than specified above|1|||
130253102|NCT01835431|468889109|FG000|Overall Study|Adverse Event|1|||
130253103|NCT01835431|468889110|FG001|Overall Study|Adverse Event|0|||
130253104|NCT01835431|468889109|FG000|Overall Study|other|0|||
130253105|NCT01835431|468889110|FG001|Overall Study|other|2|||
130253106|NCT01835431|468889109|FG000|Overall Study|Withdrawal by Subject|6|||
130253107|NCT01835431|468889110|FG001|Overall Study|Withdrawal by Subject|10|||
130253108|NCT01835431|468889109|FG000|Overall Study|Protocol Violation|1|||
130253109|NCT01835431|468889110|FG001|Overall Study|Protocol Violation|0|||
130253110|NCT00562861|468889113|FG000|Overall Study|Adverse Event|1|||
130253111|NCT00562861|468889114|FG001|Overall Study|Adverse Event|1|||
130253112|NCT00562861|468889113|FG000|Overall Study|Lack of Efficacy|5|||
130253113|NCT00562861|468889114|FG001|Overall Study|Lack of Efficacy|5|||
130253114|NCT00562861|468889113|FG000|Overall Study|noncompliance, moved|7|||
130253115|NCT00562861|468889114|FG001|Overall Study|noncompliance, moved|2|||
130253116|NCT00562861|468889113|FG000|Overall Study|Lost to Follow-up|7|||
130253117|NCT00562861|468889114|FG001|Overall Study|Lost to Follow-up|3|||
130253118|NCT04349098|468889115|FG000|Overall Study|Death|16|||
130253119|NCT04349098|468889116|FG001|Overall Study|Death|8|||
130253120|NCT04349098|468889115|FG000|Overall Study|Lost to Follow-up|11|||
130253121|NCT04349098|468889116|FG001|Overall Study|Lost to Follow-up|8|||
130253122|NCT04349098|468889115|FG000|Overall Study|Withdrawal by Subject|8|||
130253123|NCT04349098|468889116|FG001|Overall Study|Withdrawal by Subject|5|||
130253124|NCT04349098|468889115|FG000|Overall Study|Other|3|||
130253125|NCT04349098|468889116|FG001|Overall Study|Other|5|||
130253126|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
130253127|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
130253128|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
130253129|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
130253130|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
130253131|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
130253132|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
130253133|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130253134|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
130253135|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
130253136|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
130253137|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
130253138|NCT01703221|468889117|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130253139|NCT01703221|468889118|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
130253140|NCT01703221|468889119|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
130253141|NCT01703221|468889117|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
130253142|NCT01703221|468889118|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
130253143|NCT01703221|468889119|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
130253144|NCT01703221|468889117|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
130253145|NCT01703221|468889118|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
130253146|NCT01703221|468889119|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
130253147|NCT01703221|468889117|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
130253148|NCT01703221|468889118|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
130253149|NCT01703221|468889119|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
130253150|NCT03927846|468889121|FG000|Overall Study|Lost to Follow-up|10|||
130253151|NCT03927846|468889122|FG001|Overall Study|Lost to Follow-up|11|||
130253152|NCT03878069|468889123|FG000|Overall Study|Death|0|||
130253153|NCT03878069|468889124|FG001|Overall Study|Death|1|||
130253154|NCT03878069|468889125|FG002|Overall Study|Death|0|||
130253155|NCT00834587|468889126|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130253156|NCT00834587|468889127|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130253157|NCT02113878|468890639|FG000|Overall Study|Adverse Event|1|||
130253158|NCT02113878|468890640|FG001|Overall Study|Adverse Event|0|||
130253159|NCT02113878|468890639|FG000|Overall Study|Withdrawal by Subject|1|||
130253160|NCT02113878|468890640|FG001|Overall Study|Withdrawal by Subject|0|||
130253161|NCT02113878|468890639|FG000|Overall Study|patient non-compliance|1|||
130253162|NCT02113878|468890640|FG001|Overall Study|patient non-compliance|0|||
130253163|NCT04744831|468890641|FG000|Overall Study|Progressive Disease|31|||
130253164|NCT04744831|468890642|FG001|Overall Study|Progressive Disease|27|||
130253165|NCT04744831|468890643|FG002|Overall Study|Progressive Disease|25|||
130253166|NCT04744831|468890641|FG000|Overall Study|Adverse Event|3|||
130031611|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130031612|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130031613|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
130031614|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
130031615|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
130031616|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
130031617|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130031618|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
130031619|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130031620|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130031621|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130031622|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130031623|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
130031624|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
130031625|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130031626|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
130031627|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
130031628|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
130031629|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
130031630|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
130031631|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
130031632|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
130031633|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
130031634|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
130031635|NCT00408005|468072607|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130031636|NCT00408005|468072608|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130031637|NCT00408005|468072609|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
130031638|NCT00408005|468072610|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
130031639|NCT00408005|468072611|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
130031640|NCT00408005|468072612|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
130031641|NCT00408005|468072613|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130031642|NCT00408005|468072614|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
130031643|NCT04067518|468072615|FG000|Overall Study|Adverse Event|1|||
130031644|NCT04067518|468072616|FG001|Overall Study|Adverse Event|3|||
130031645|NCT04067518|468072615|FG000|Overall Study|Screen failures|0|||
130031646|NCT04067518|468072616|FG001|Overall Study|Screen failures|1|||
130031647|NCT04067518|468072615|FG000|Overall Study|Enrolled but not treated|0|||
130031648|NCT04067518|468072616|FG001|Overall Study|Enrolled but not treated|1|||
130031649|NCT00862251|468072617|FG000|Overall Study|Adverse Event|8|||
130031650|NCT00862251|468072618|FG001|Overall Study|Adverse Event|3|||
130031651|NCT00862251|468072619|FG002|Overall Study|Adverse Event|1|||
130101193|NCT03917654|468327314|FG001|Year 2|Spouse/family member request|0|||
130101194|NCT03917654|468327315|FG002|Year 2|Spouse/family member request|0|||
130253167|NCT04744831|468890642|FG001|Overall Study|Adverse Event|3|||
130253168|NCT04744831|468890643|FG002|Overall Study|Adverse Event|3|||
130253169|NCT04744831|468890641|FG000|Overall Study|Clinical Progression|3|||
130253170|NCT04744831|468890642|FG001|Overall Study|Clinical Progression|2|||
130253171|NCT04744831|468890643|FG002|Overall Study|Clinical Progression|5|||
130253172|NCT04744831|468890641|FG000|Overall Study|Other|0|||
130253173|NCT04744831|468890642|FG001|Overall Study|Other|2|||
130253174|NCT04744831|468890643|FG002|Overall Study|Other|1|||
130253175|NCT04744831|468890641|FG000|Overall Study|Death|0|||
130253176|NCT04744831|468890642|FG001|Overall Study|Death|2|||
130253177|NCT04744831|468890643|FG002|Overall Study|Death|1|||
130253178|NCT00530257|468890649|FG000|Overall Study|Lost to Follow-up|1|||
130253179|NCT01897896|468890653|FG000|Overall Study|Death|1|||
130253180|NCT01897896|468890654|FG001|Overall Study|Death|0|||
130253181|NCT01897896|468890653|FG000|Overall Study|Adverse Event|11|||
130253182|NCT01897896|468890654|FG001|Overall Study|Adverse Event|1|||
130253183|NCT01897896|468890653|FG000|Overall Study|Lost to Follow-up|1|||
130253184|NCT01897896|468890654|FG001|Overall Study|Lost to Follow-up|0|||
130253185|NCT01897896|468890653|FG000|Overall Study|Non-compliance with study drug dosing|1|||
130253186|NCT01897896|468890654|FG001|Overall Study|Non-compliance with study drug dosing|1|||
130253187|NCT01897896|468890653|FG000|Overall Study|Withdrawal by Subject|7|||
130253188|NCT01897896|468890654|FG001|Overall Study|Withdrawal by Subject|1|||
130253189|NCT01897896|468890653|FG000|Overall Study|Require drug that interfere with study|1|||
130253190|NCT01897896|468890654|FG001|Overall Study|Require drug that interfere with study|4|||
130253191|NCT01897896|468890653|FG000|Overall Study|Protocol Violation|1|||
130253192|NCT01897896|468890654|FG001|Overall Study|Protocol Violation|1|||
130253193|NCT01897896|468890653|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
130253194|NCT01897896|468890654|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
130253195|NCT01897896|468890653|FG000|Overall Study|Caregiver can no longer participate|0|||
130253196|NCT01897896|468890654|FG001|Overall Study|Caregiver can no longer participate|2|||
130253197|NCT01897896|468890653|FG000|Overall Study|Other than specified|2|||
130253198|NCT01897896|468890654|FG001|Overall Study|Other than specified|1|||
130253199|NCT05069415|468890655|FG000|Overall Study|Withdrawal by Subject|2|||
130253200|NCT05069415|468890656|FG001|Overall Study|Withdrawal by Subject|0|||
130253201|NCT05069415|468890655|FG000|Overall Study|Adverse Event|2|||
130253202|NCT05069415|468890656|FG001|Overall Study|Adverse Event|0|||
130253203|NCT00203242|468890657|FG000|Overall Study|Lost to Follow-up|1|||
130253204|NCT00866775|468890658|FG000|Overall Study|Adverse Event|5|||
130253205|NCT00866775|468890659|FG001|Overall Study|Adverse Event|19|||
130253206|NCT00866775|468890658|FG000|Overall Study|Death|1|||
130253207|NCT00866775|468890659|FG001|Overall Study|Death|0|||
130253208|NCT00866775|468890658|FG000|Overall Study|Lost to Follow-up|0|||
130253209|NCT00866775|468890659|FG001|Overall Study|Lost to Follow-up|4|||
130253210|NCT00866775|468890658|FG000|Overall Study|Physician Decision|0|||
130253211|NCT00866775|468890659|FG001|Overall Study|Physician Decision|3|||
130253212|NCT00866775|468890658|FG000|Overall Study|Protocol Violation|3|||
130253213|NCT00866775|468890659|FG001|Overall Study|Protocol Violation|4|||
130253214|NCT00866775|468890658|FG000|Overall Study|Withdrawal by Subject|4|||
130253215|NCT00866775|468890659|FG001|Overall Study|Withdrawal by Subject|4|||
130253216|NCT00866775|468890658|FG000|Overall Study|met exit criteria|23|||
130253217|NCT00866775|468890659|FG001|Overall Study|met exit criteria|17|||
130253218|NCT00866775|468890658|FG000|Overall Study|discontinued due to communication error|0|||
130253219|NCT00866775|468890659|FG001|Overall Study|discontinued due to communication error|1|||
130253220|NCT01500135|468890660|FG000|Overall Study|Withdrawal of Consent|4|||
130253221|NCT01500135|468890661|FG001|Overall Study|Withdrawal of Consent|0|||
130253222|NCT01500135|468890660|FG000|Overall Study|Lost to Follow-up|6|||
130253223|NCT01500135|468890661|FG001|Overall Study|Lost to Follow-up|4|||
130253224|NCT01500135|468890660|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
130253225|NCT01500135|468890661|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
130253226|NCT01500135|468890660|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
130253227|NCT01500135|468890661|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
130253228|NCT01500135|468890660|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
130253229|NCT01500135|468890661|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
130253230|NCT01500135|468890660|FG000|Overall Study|Participant was a Safety Concern|1|||
130253231|NCT01500135|468890661|FG001|Overall Study|Participant was a Safety Concern|0|||
130253232|NCT01500135|468890660|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
130253233|NCT01500135|468890661|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
130253234|NCT02003898|468890666|FG000|Overall Study|Death|3|||
130253235|NCT02003898|468890666|FG000|Overall Study|Lost to Follow-up|12|||
130253236|NCT02003898|468890666|FG000|Overall Study|Withdrawal by Subject|52|||
130253237|NCT05345405|468890669|FG000|Overall Study|Withdrawal by Subject|2|||
130253238|NCT05345405|468890670|FG001|Overall Study|Withdrawal by Subject|0|||
130253239|NCT05345405|468890671|FG002|Overall Study|Withdrawal by Subject|0|||
130253240|NCT05345405|468890669|FG000|Overall Study|Did not meet eligibility criteria|0|||
130253241|NCT05345405|468890670|FG001|Overall Study|Did not meet eligibility criteria|2|||
130253242|NCT05345405|468890671|FG002|Overall Study|Did not meet eligibility criteria|0|||
130253243|NCT05345405|468890669|FG000|Overall Study|Lost to Follow-up|0|||
130253244|NCT05345405|468890670|FG001|Overall Study|Lost to Follow-up|0|||
130253245|NCT05345405|468890671|FG002|Overall Study|Lost to Follow-up|1|||
130253246|NCT03766906|468890673|FG000|Overall Study|Withdrawal by Subject|6|||
130253247|NCT03268499|468890678|FG000|Overall Study|Withdrawal by Subject|2|||
130253248|NCT03268499|468890679|FG001|Overall Study|Withdrawal by Subject|1|||
130253249|NCT03533491|468890680|FG000|Overall Study|Lost to Follow-up|2|||
130253250|NCT01725282|468890683|FG000|Overall Study|Adverse Event|1|||
130253251|NCT01725282|468890684|FG001|Overall Study|Adverse Event|3|||
130253252|NCT01725282|468890685|FG002|Overall Study|Adverse Event|6|||
130253253|NCT01725282|468890686|FG003|Overall Study|Adverse Event|4|||
130253254|NCT01725282|468890683|FG000|Overall Study|Exacerbation of Target Disease|1|||
130253255|NCT01725282|468890684|FG001|Overall Study|Exacerbation of Target Disease|0|||
130253256|NCT01725282|468890685|FG002|Overall Study|Exacerbation of Target Disease|0|||
130253257|NCT01725282|468890686|FG003|Overall Study|Exacerbation of Target Disease|1|||
130253258|NCT01725282|468890683|FG000|Overall Study|Met Exclusion Criteria|0|||
130253259|NCT01725282|468890684|FG001|Overall Study|Met Exclusion Criteria|0|||
130253260|NCT01725282|468890685|FG002|Overall Study|Met Exclusion Criteria|1|||
130253261|NCT01725282|468890686|FG003|Overall Study|Met Exclusion Criteria|0|||
130253262|NCT01725282|468890683|FG000|Overall Study|Study Site Withdrawal|0|||
130253263|NCT01725282|468890684|FG001|Overall Study|Study Site Withdrawal|1|||
130253264|NCT01725282|468890685|FG002|Overall Study|Study Site Withdrawal|0|||
130253265|NCT01725282|468890686|FG003|Overall Study|Study Site Withdrawal|0|||
130253266|NCT01725282|468890683|FG000|Overall Study|Withdrawal by Subject|0|||
130253267|NCT01725282|468890684|FG001|Overall Study|Withdrawal by Subject|0|||
130253268|NCT01725282|468890685|FG002|Overall Study|Withdrawal by Subject|1|||
130253269|NCT01725282|468890686|FG003|Overall Study|Withdrawal by Subject|1|||
130253270|NCT01725282|468890683|FG000|Overall Study|Lack of Efficacy|0|||
130253271|NCT01725282|468890684|FG001|Overall Study|Lack of Efficacy|1|||
130253272|NCT01725282|468890685|FG002|Overall Study|Lack of Efficacy|0|||
130253273|NCT01725282|468890686|FG003|Overall Study|Lack of Efficacy|1|||
130253274|NCT04064567|468890687|FG000|Overall Study|Lost to Follow-up|23|||
130253275|NCT04064567|468890688|FG001|Overall Study|Lost to Follow-up|22|||
130253276|NCT04064567|468890687|FG000|Overall Study|Withdrawal by Subject|0|||
130253277|NCT04064567|468890688|FG001|Overall Study|Withdrawal by Subject|1|||
130253278|NCT04064567|468890687|FG000|Overall Study|Reincarcerated|7|||
130253279|NCT04064567|468890688|FG001|Overall Study|Reincarcerated|10|||
130253280|NCT04064567|468890687|FG000|Overall Study|Moved out of U.S.|0|||
130253281|NCT04064567|468890688|FG001|Overall Study|Moved out of U.S.|1|||
130253282|NCT04576481|468890690|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
130253283|NCT04576481|468890691|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
130253284|NCT04576481|468890692|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
130253285|NCT04576481|468890693|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
130253286|NCT01682720|468890694|FG000|Overall Study|Randomized but Not Treated|0|||
130253287|NCT01682720|468890695|FG001|Overall Study|Randomized but Not Treated|1|||
130253288|NCT01682720|468890696|FG002|Overall Study|Randomized but Not Treated|1|||
130253289|NCT01682720|468890697|FG003|Overall Study|Randomized but Not Treated|0|||
130253290|NCT01682720|468890694|FG000|Overall Study|Terminated by Sponsor|83|||
130253291|NCT01682720|468890695|FG001|Overall Study|Terminated by Sponsor|0|||
130253292|NCT01682720|468890696|FG002|Overall Study|Terminated by Sponsor|0|||
130253293|NCT01682720|468890697|FG003|Overall Study|Terminated by Sponsor|0|||
130253294|NCT01682720|468890694|FG000|Overall Study|Efficacy Failure|0|||
130253295|NCT01682720|468890695|FG001|Overall Study|Efficacy Failure|3|||
130253296|NCT01682720|468890696|FG002|Overall Study|Efficacy Failure|3|||
130253297|NCT01682720|468890697|FG003|Overall Study|Efficacy Failure|30|||
130253298|NCT01682720|468890694|FG000|Overall Study|Lost to Follow-up|1|||
130253299|NCT01682720|468890695|FG001|Overall Study|Lost to Follow-up|1|||
130253300|NCT01682720|468890696|FG002|Overall Study|Lost to Follow-up|0|||
130253301|NCT01682720|468890697|FG003|Overall Study|Lost to Follow-up|6|||
130253302|NCT01682720|468890694|FG000|Overall Study|Subject Withdrew Consent|0|||
130253303|NCT01682720|468890695|FG001|Overall Study|Subject Withdrew Consent|0|||
130253304|NCT01682720|468890696|FG002|Overall Study|Subject Withdrew Consent|2|||
130253305|NCT01682720|468890697|FG003|Overall Study|Subject Withdrew Consent|2|||
130253306|NCT01682720|468890694|FG000|Overall Study|Adverse Event|1|||
130253307|NCT01682720|468890695|FG001|Overall Study|Adverse Event|0|||
130253308|NCT01682720|468890696|FG002|Overall Study|Adverse Event|1|||
130253309|NCT01682720|468890697|FG003|Overall Study|Adverse Event|1|||
130253310|NCT00069953|468890698|FG000|Overall Study|Protocol Violation|2|||
130253311|NCT02034565|468890699|FG000|Overall Study|Adverse Event|1|||
130253312|NCT02034565|468890700|FG001|Overall Study|Adverse Event|0|||
130253313|NCT00113373|468890701|FG000|Overall Study|Ineligible: wrong primary|1|||
130253314|NCT00113373|468890701|FG000|Overall Study|Ineligible: second primary|1|||
130253315|NCT00113373|468890701|FG000|Overall Study|Never Treated|1|||
130253316|NCT04525183|468890705|FG000|Overall Study|Withdrawal by Subject|0|||
130253317|NCT04525183|468890706|FG001|Overall Study|Withdrawal by Subject|0|||
130253318|NCT04525183|468890707|FG002|Overall Study|Withdrawal by Subject|3|||
130253319|NCT04525183|468890705|FG000|Overall Study|Study non-compliance|0|||
130253320|NCT04525183|468890706|FG001|Overall Study|Study non-compliance|0|||
130253321|NCT04525183|468890707|FG002|Overall Study|Study non-compliance|1|||
130253322|NCT04525183|468890705|FG000|Overall Study|Recurrent disease before starting on study|0|||
130253323|NCT04525183|468890706|FG001|Overall Study|Recurrent disease before starting on study|0|||
130253324|NCT04525183|468890707|FG002|Overall Study|Recurrent disease before starting on study|1|||
130253325|NCT00979407|468890708|FG000|Overall Study|Withdrawal by Subject|3|||
130253326|NCT00979407|468890709|FG001|Overall Study|Withdrawal by Subject|4|||
130253327|NCT00979407|468890708|FG000|Overall Study|Lost to Follow-up|3|||
130253328|NCT00979407|468890709|FG001|Overall Study|Lost to Follow-up|3|||
130253329|NCT01166646|468890710|FG000|Overall Study|Protocol Violation|0|||
130253330|NCT01166646|468890711|FG001|Overall Study|Protocol Violation|1|||
130253331|NCT01166646|468890710|FG000|Overall Study|Adverse Event|1|||
130253332|NCT01166646|468890711|FG001|Overall Study|Adverse Event|0|||
130253333|NCT01335685|468890715|FG000|Overall Study|Study Terminated by Sponsor|2|||
130253334|NCT01335685|468890716|FG001|Overall Study|Study Terminated by Sponsor|1|||
130253335|NCT01335685|468890717|FG002|Overall Study|Study Terminated by Sponsor|1|||
130253336|NCT01335685|468890718|FG003|Overall Study|Study Terminated by Sponsor|10|||
130253337|NCT01335685|468890719|FG004|Overall Study|Study Terminated by Sponsor|0|||
130253338|NCT01335685|468890720|FG005|Overall Study|Study Terminated by Sponsor|4|||
130253339|NCT01335685|468890721|FG006|Overall Study|Study Terminated by Sponsor|2|||
130253340|NCT01335685|468890722|FG007|Overall Study|Study Terminated by Sponsor|3|||
130253341|NCT01335685|468890715|FG000|Overall Study|Withdrawal by Subject|1|||
130253342|NCT01335685|468890716|FG001|Overall Study|Withdrawal by Subject|0|||
130253343|NCT01335685|468890717|FG002|Overall Study|Withdrawal by Subject|0|||
130253344|NCT01335685|468890718|FG003|Overall Study|Withdrawal by Subject|1|||
130253345|NCT01335685|468890719|FG004|Overall Study|Withdrawal by Subject|0|||
130253346|NCT01335685|468890720|FG005|Overall Study|Withdrawal by Subject|0|||
130253347|NCT01335685|468890721|FG006|Overall Study|Withdrawal by Subject|0|||
130253348|NCT01335685|468890722|FG007|Overall Study|Withdrawal by Subject|0|||
130253349|NCT01335685|468890715|FG000|Overall Study|Reason not Specified|0|||
130253350|NCT01335685|468890716|FG001|Overall Study|Reason not Specified|0|||
130253351|NCT01335685|468890717|FG002|Overall Study|Reason not Specified|1|||
130253352|NCT01335685|468890718|FG003|Overall Study|Reason not Specified|0|||
130253353|NCT01335685|468890719|FG004|Overall Study|Reason not Specified|0|||
130253354|NCT01335685|468890720|FG005|Overall Study|Reason not Specified|1|||
130253355|NCT01335685|468890721|FG006|Overall Study|Reason not Specified|0|||
130253356|NCT01335685|468890722|FG007|Overall Study|Reason not Specified|0|||
130253357|NCT03777020|468890727|FG000|Overall Study|Withdrawal by Subject|4|||
130253358|NCT03777020|468890728|FG001|Overall Study|Withdrawal by Subject|4|||
130253359|NCT03777020|468890727|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
130253360|NCT03777020|468890728|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
130253361|NCT00489476|468890729|FG000|Overall Study|Lost to Follow-up|0|||
130253362|NCT00489476|468890730|FG001|Overall Study|Lost to Follow-up|1|||
130253363|NCT00489476|468890731|FG002|Overall Study|Lost to Follow-up|0|||
130253364|NCT00489476|468890732|FG003|Overall Study|Lost to Follow-up|0|||
130253365|NCT00803049|468890733|FG000|Overall Study|Adverse Event|21|||
130253366|NCT00803049|468890734|FG001|Overall Study|Adverse Event|33|||
130253367|NCT00803049|468890735|FG002|Overall Study|Adverse Event|13|||
130253368|NCT00803049|468890736|FG003|Overall Study|Adverse Event|27|||
130253369|NCT00803049|468890733|FG000|Overall Study|Lack of Efficacy|10|||
130253370|NCT00803049|468890734|FG001|Overall Study|Lack of Efficacy|19|||
130253371|NCT00803049|468890735|FG002|Overall Study|Lack of Efficacy|6|||
130253372|NCT00803049|468890736|FG003|Overall Study|Lack of Efficacy|13|||
130253373|NCT00803049|468890733|FG000|Overall Study|Lost to Follow-up|0|||
130253374|NCT00803049|468890734|FG001|Overall Study|Lost to Follow-up|2|||
130253375|NCT00803049|468890735|FG002|Overall Study|Lost to Follow-up|0|||
130253376|NCT00803049|468890736|FG003|Overall Study|Lost to Follow-up|3|||
130253377|NCT00803049|468890733|FG000|Overall Study|Death|2|||
130253378|NCT00803049|468890734|FG001|Overall Study|Death|1|||
130253379|NCT00803049|468890735|FG002|Overall Study|Death|0|||
130253380|NCT00803049|468890736|FG003|Overall Study|Death|2|||
130253381|NCT00803049|468890733|FG000|Overall Study|Progressive Disease|6|||
130253382|NCT00803049|468890734|FG001|Overall Study|Progressive Disease|10|||
130253383|NCT00803049|468890735|FG002|Overall Study|Progressive Disease|6|||
130253384|NCT00803049|468890736|FG003|Overall Study|Progressive Disease|6|||
130253385|NCT00803049|468890733|FG000|Overall Study|Withdrawal by Subject|19|||
130253386|NCT00803049|468890734|FG001|Overall Study|Withdrawal by Subject|43|||
130253387|NCT00803049|468890735|FG002|Overall Study|Withdrawal by Subject|16|||
130253388|NCT00803049|468890736|FG003|Overall Study|Withdrawal by Subject|44|||
130253389|NCT00803049|468890733|FG000|Overall Study|Protocol Violation|0|||
130253390|NCT00803049|468890734|FG001|Overall Study|Protocol Violation|1|||
130253391|NCT00803049|468890735|FG002|Overall Study|Protocol Violation|1|||
130253392|NCT00803049|468890736|FG003|Overall Study|Protocol Violation|0|||
130253393|NCT00803049|468890733|FG000|Overall Study|Randomized and Not Treated|0|||
130253394|NCT00803049|468890734|FG001|Overall Study|Randomized and Not Treated|0|||
130253395|NCT00803049|468890735|FG002|Overall Study|Randomized and Not Treated|0|||
130253396|NCT00803049|468890736|FG003|Overall Study|Randomized and Not Treated|2|||
130253397|NCT00803049|468890733|FG000|Overall Study|Other than Specified Above|3|||
130253398|NCT00803049|468890734|FG001|Overall Study|Other than Specified Above|9|||
130253399|NCT00803049|468890735|FG002|Overall Study|Other than Specified Above|2|||
130253400|NCT00803049|468890736|FG003|Overall Study|Other than Specified Above|5|||
130031652|NCT00862251|468072617|FG000|Overall Study|Lost to Follow-up|0|||
130031653|NCT00862251|468072618|FG001|Overall Study|Lost to Follow-up|0|||
130031654|NCT00862251|468072619|FG002|Overall Study|Lost to Follow-up|1|||
130031655|NCT00862251|468072617|FG000|Overall Study|Protocol Violation|2|||
130031656|NCT00862251|468072618|FG001|Overall Study|Protocol Violation|0|||
130031657|NCT00862251|468072619|FG002|Overall Study|Protocol Violation|1|||
130031658|NCT00862251|468072617|FG000|Overall Study|Withdrawal by Subject|9|||
130031659|NCT00862251|468072618|FG001|Overall Study|Withdrawal by Subject|2|||
130031660|NCT00862251|468072619|FG002|Overall Study|Withdrawal by Subject|6|||
130031661|NCT00675025|468072620|FG000|Overall Study|Study Terminated by Sponsor|38|||
130031662|NCT00675025|468072621|FG001|Overall Study|Study Terminated by Sponsor|42|||
130031663|NCT00675025|468072620|FG000|Overall Study|Adverse Event|6|||
130031664|NCT00675025|468072621|FG001|Overall Study|Adverse Event|11|||
130031665|NCT00675025|468072620|FG000|Overall Study|Lost to Follow-up|6|||
130031666|NCT00675025|468072621|FG001|Overall Study|Lost to Follow-up|4|||
130031667|NCT00675025|468072620|FG000|Overall Study|Withdrawal by Subject|4|||
130031668|NCT00675025|468072621|FG001|Overall Study|Withdrawal by Subject|6|||
130031669|NCT02054702|468072625|FG000|Overall Study|Lost to Follow-up|3|||
130031670|NCT02054702|468072626|FG001|Overall Study|Lost to Follow-up|5|||
130031671|NCT02054702|468072625|FG000|Overall Study|Adverse Event|3|||
130031672|NCT02054702|468072626|FG001|Overall Study|Adverse Event|1|||
130031673|NCT02054702|468072625|FG000|Overall Study|Met Withdrawal Criteria|4|||
130031674|NCT02054702|468072626|FG001|Overall Study|Met Withdrawal Criteria|1|||
130031675|NCT02054702|468072625|FG000|Overall Study|Physician Decision|0|||
130031676|NCT02054702|468072626|FG001|Overall Study|Physician Decision|1|||
130031677|NCT02054702|468072625|FG000|Overall Study|Withdrawal by Subject|14|||
130031678|NCT02054702|468072626|FG001|Overall Study|Withdrawal by Subject|4|||
130031679|NCT03417440|468072638|FG000|Overall Study|Lost to Follow-up|0|||
130031680|NCT03417440|468072639|FG001|Overall Study|Lost to Follow-up|1|||
130031681|NCT03417440|468072640|FG002|Overall Study|Lost to Follow-up|0|||
130031682|NCT03417440|468072641|FG003|Overall Study|Lost to Follow-up|0|||
130031683|NCT03417440|468072642|FG004|Overall Study|Lost to Follow-up|1|||
130031684|NCT03417440|468072643|FG005|Overall Study|Lost to Follow-up|0|||
130031685|NCT03417440|468072644|FG006|Overall Study|Lost to Follow-up|0|||
130031686|NCT03417440|468072645|FG007|Overall Study|Lost to Follow-up|0|||
130031687|NCT03417440|468072638|FG000|Overall Study|Withdrawal by Subject|2|||
130031688|NCT03417440|468072639|FG001|Overall Study|Withdrawal by Subject|0|||
130031689|NCT03417440|468072640|FG002|Overall Study|Withdrawal by Subject|2|||
130031690|NCT03417440|468072641|FG003|Overall Study|Withdrawal by Subject|1|||
130031691|NCT03417440|468072642|FG004|Overall Study|Withdrawal by Subject|1|||
130031692|NCT03417440|468072643|FG005|Overall Study|Withdrawal by Subject|0|||
130031693|NCT03417440|468072644|FG006|Overall Study|Withdrawal by Subject|0|||
130031694|NCT03417440|468072645|FG007|Overall Study|Withdrawal by Subject|1|||
130031695|NCT03304522|468072646|FG000|Overall Study|Adverse Event|0|||
130031696|NCT03304522|468072647|FG001|Overall Study|Adverse Event|4|||
130031697|NCT03304522|468072646|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
130031698|NCT03304522|468072647|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
130031699|NCT03304522|468072646|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
130031700|NCT03304522|468072647|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
130031701|NCT03304522|468072646|FG000|Overall Study|Other|0|||
130031702|NCT03304522|468072647|FG001|Overall Study|Other|1|||
130031703|NCT00238264|468072650|FG000|Overall Study|Death|7|||
130031704|NCT00238264|468072650|FG000|Overall Study|Lost to Follow-up|18|||
130031705|NCT00238264|468072650|FG000|Overall Study|Withdrawal by Subject|4|||
130031706|NCT00238264|468072650|FG000|Overall Study|Ineligible|7|||
130031707|NCT02706938|468072651|FG000|First Period, 6 Weeks|Adverse Event|8|||
130031708|NCT02706938|468072652|FG001|First Period, 6 Weeks|Adverse Event|0|||
130031709|NCT02706938|468072651|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
130031710|NCT02706938|468072652|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
130031711|NCT02706938|468072651|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
130031712|NCT02706938|468072652|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
130031713|NCT02706938|468072651|FG000|Second Period, 6 Weeks|Adverse Event|0|||
130031714|NCT02706938|468072652|FG001|Second Period, 6 Weeks|Adverse Event|7|||
130253401|NCT04126174|468890737|FG000|Overall Study|Lost to Follow-up|3|||
130253402|NCT04126174|468890738|FG001|Overall Study|Lost to Follow-up|3|||
130031715|NCT02706938|468072651|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
130031716|NCT02706938|468072652|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
130031717|NCT01838044|468072653|FG000|Overall Study|Adverse Event|4|||
130031718|NCT01838044|468072654|FG001|Overall Study|Adverse Event|6|||
130031719|NCT01838044|468072653|FG000|Overall Study|Protocol Violation|3|||
130031720|NCT01838044|468072654|FG001|Overall Study|Protocol Violation|3|||
130031721|NCT01838044|468072653|FG000|Overall Study|Withdrawal by Subject|0|||
130031722|NCT01838044|468072654|FG001|Overall Study|Withdrawal by Subject|2|||
130031723|NCT01838044|468072653|FG000|Overall Study|Insufficient clinical response|1|||
130031724|NCT01838044|468072654|FG001|Overall Study|Insufficient clinical response|2|||
130031725|NCT01838044|468072653|FG000|Overall Study|Medication error without associated AE|0|||
130031726|NCT01838044|468072654|FG001|Overall Study|Medication error without associated AE|1|||
130253403|NCT01514422|468890739|FG000|Overall Study|Lost to Follow-up|1|||
130253404|NCT04439903|468890752|FG000|Overall Study|Withdrawal by Subject|2|||
130253405|NCT04439903|468890752|FG000|Overall Study|Screen Failure|1|||
130253406|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
130253407|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
130253408|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
130253409|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
130253410|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
130253411|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130253412|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
130253413|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130253414|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
130253415|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
130253416|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
130253417|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
130253418|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130253419|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130253420|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
130253421|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
130253422|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
130253423|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
130253424|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
130253425|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
130253426|NCT04003142|468890753|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
130253427|NCT04003142|468890754|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
130253428|NCT04003142|468890755|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
130253429|NCT04003142|468890756|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
130253430|NCT04003142|468890757|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
130253431|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
130253432|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
130253433|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
130253434|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
130253435|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
130253436|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Death|0|||
130253437|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Death|0|||
130253438|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Death|0|||
130253439|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Death|0|||
130253440|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Death|1|||
130253441|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
130253442|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
130253443|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
130253444|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
130253445|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
130253446|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253447|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253448|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
130253449|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253450|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
130253451|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
130253452|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
130253453|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
130253454|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
130253455|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
130253456|NCT04003142|468890753|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
130253457|NCT04003142|468890754|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
130253458|NCT04003142|468890755|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
130253459|NCT04003142|468890756|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
130253460|NCT04003142|468890757|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
130253461|NCT04042311|468890758|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
130253462|NCT04042311|468890758|FG000|Overall Study|Unable to tolerate|4|||
130253463|NCT04042311|468890758|FG000|Overall Study|Concurrent illness|2|||
130253464|NCT04042311|468890758|FG000|Overall Study|Adverse Event|2|||
130253465|NCT04042311|468890758|FG000|Overall Study|No longer meeting inclusion criteria|2|||
130253466|NCT04042311|468890758|FG000|Overall Study|No reason given|1|||
130253467|NCT04042311|468890758|FG000|Overall Study|Withdrawal by Subject|4|||
130253468|NCT03382873|468890759|FG000|Overall Study|Lost to Follow-up|9|||
130253469|NCT03382873|468890760|FG001|Overall Study|Lost to Follow-up|10|||
130253470|NCT03382873|468890759|FG000|Overall Study|Withdrawal by Subject|6|||
130253471|NCT03382873|468890760|FG001|Overall Study|Withdrawal by Subject|11|||
130253472|NCT03382873|468890759|FG000|Overall Study|Visit not completed due to pandemic|16|||
130253473|NCT03382873|468890760|FG001|Overall Study|Visit not completed due to pandemic|41|||
130253474|NCT01044459|468890771|FG000|Overall Study|Withdrawal by Subject|21|||
130031727|NCT01838044|468072653|FG000|Overall Study|Lost to Follow-up|0|||
130031728|NCT01838044|468072654|FG001|Overall Study|Lost to Follow-up|2|||
130031729|NCT00860470|468072655|FG000|Overall Study|Death|6|||
130031730|NCT00860470|468072656|FG001|Overall Study|Death|10|||
130031731|NCT00860470|468072655|FG000|Overall Study|Moved away|8|||
130031732|NCT00860470|468072656|FG001|Overall Study|Moved away|10|||
130253475|NCT01044459|468890772|FG001|Overall Study|Withdrawal by Subject|28|||
130253476|NCT01044459|468890771|FG000|Overall Study|Terminated by Sponsor|22|||
130253477|NCT01044459|468890772|FG001|Overall Study|Terminated by Sponsor|21|||
130253478|NCT01044459|468890771|FG000|Overall Study|Adverse Event|22|||
130031733|NCT00860470|468072655|FG000|Overall Study|Lost to Follow-up|34|||
130253479|NCT01044459|468890772|FG001|Overall Study|Adverse Event|20|||
130253480|NCT01044459|468890771|FG000|Overall Study|Lack of Efficacy|23|||
130253481|NCT01044459|468890772|FG001|Overall Study|Lack of Efficacy|12|||
130253482|NCT01044459|468890771|FG000|Overall Study|Protocol Violation|11|||
130253483|NCT01044459|468890772|FG001|Overall Study|Protocol Violation|16|||
130253484|NCT01044459|468890771|FG000|Overall Study|Other Reason|7|||
130253485|NCT01044459|468890772|FG001|Overall Study|Other Reason|14|||
130253486|NCT01044459|468890771|FG000|Overall Study|COPD exacerbation|9|||
130253487|NCT01044459|468890772|FG001|Overall Study|COPD exacerbation|8|||
130253488|NCT01044459|468890771|FG000|Overall Study|Lost to Follow-up|18|||
130031734|NCT00860470|468072656|FG001|Overall Study|Lost to Follow-up|39|||
130031735|NCT02292212|468072662|FG000|ViE Phase|Withdrawal by Subject|1|||
130031736|NCT02292212|468072662|FG000|ViE Phase|Protocol Violation|2|||
130031737|NCT01791855|468072665|FG000|Overall Study|Adverse Event|0|||
130031738|NCT01791855|468072666|FG001|Overall Study|Adverse Event|0|||
130031739|NCT01791855|468072667|FG002|Overall Study|Adverse Event|0|||
130031740|NCT01791855|468072668|FG003|Overall Study|Adverse Event|1|||
130031741|NCT01791855|468072665|FG000|Overall Study|Randomized, not treated|0|||
130031742|NCT01791855|468072666|FG001|Overall Study|Randomized, not treated|1|||
130031743|NCT01791855|468072667|FG002|Overall Study|Randomized, not treated|0|||
130031744|NCT01791855|468072668|FG003|Overall Study|Randomized, not treated|0|||
130031745|NCT00772447|468072669|FG000|Overall Study|Withdrawal by Subject|9|||
130031746|NCT00772447|468072670|FG001|Overall Study|Withdrawal by Subject|5|||
130031747|NCT00772447|468072669|FG000|Overall Study|Physician Decision|4|||
130031748|NCT00772447|468072670|FG001|Overall Study|Physician Decision|8|||
130031749|NCT00772447|468072669|FG000|Overall Study|Lost to Follow-up|2|||
130031750|NCT00772447|468072670|FG001|Overall Study|Lost to Follow-up|4|||
130031751|NCT00772447|468072669|FG000|Overall Study|incorrect enrolment|3|||
130031752|NCT00772447|468072670|FG001|Overall Study|incorrect enrolment|4|||
130031753|NCT00772447|468072669|FG000|Overall Study|Protocol Violation|0|||
130031754|NCT00772447|468072670|FG001|Overall Study|Protocol Violation|1|||
130031755|NCT00772447|468072669|FG000|Overall Study|all others|2|||
130031756|NCT00772447|468072670|FG001|Overall Study|all others|2|||
130031757|NCT01957137|468072674|FG000|Randomized Portion|Adverse Event|1|||
130031758|NCT01957137|468072674|FG000|Randomized Portion|Withdrawal by Subject|1|||
130031759|NCT03529409|468072675|FG000|Randomized|Lost to Follow-up|0|||
130031760|NCT03529409|468072676|FG001|Randomized|Lost to Follow-up|0|||
130031761|NCT03529409|468072677|FG002|Randomized|Lost to Follow-up|4|||
130031762|NCT03529409|468072675|FG000|Randomized|Excluded|0|||
130031763|NCT03529409|468072676|FG001|Randomized|Excluded|0|||
130031764|NCT03529409|468072677|FG002|Randomized|Excluded|1|||
130031765|NCT03529409|468072675|FG000|Post-treatment Assessment|Death|1|||
130031766|NCT03529409|468072676|FG001|Post-treatment Assessment|Death|0|||
130031767|NCT03529409|468072677|FG002|Post-treatment Assessment|Death|0|||
130031768|NCT03529409|468072675|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
130031769|NCT03529409|468072676|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
130031770|NCT03529409|468072677|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
130031771|NCT03529409|468072675|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
130031772|NCT03529409|468072676|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
130031773|NCT03529409|468072677|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
130031774|NCT03529409|468072675|FG000|Follow-up Assessment|Death|1|||
130031775|NCT03529409|468072676|FG001|Follow-up Assessment|Death|0|||
130031776|NCT03529409|468072677|FG002|Follow-up Assessment|Death|0|||
130031777|NCT03529409|468072675|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
130031778|NCT03529409|468072676|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
130031779|NCT03529409|468072677|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
130031780|NCT01497262|468072680|FG000|Overall Study|Abnormal Lab Values|4|||
130031781|NCT01497262|468072680|FG000|Overall Study|Abnormal Test Procedure Result|1|||
130031782|NCT01497262|468072680|FG000|Overall Study|Physician Decision|1|||
130031783|NCT01497262|468072680|FG000|Overall Study|Withdrawal by Subject|2|||
130253489|NCT01044459|468890772|FG001|Overall Study|Lost to Follow-up|12|||
130253490|NCT04105725|468890773|FG000|Primary Intervention|Lost to Follow-up|0|||
130253491|NCT04105725|468890774|FG001|Primary Intervention|Lost to Follow-up|2|||
130031784|NCT01497262|468072680|FG000|Overall Study|Adverse Event|2|||
130031785|NCT01497262|468072680|FG000|Overall Study|Protocol Violation|1|||
130031786|NCT02497001|468072681|FG000|Overall Study|Lost to Follow-up|10|||
130253492|NCT04105725|468890773|FG000|Primary Intervention|Withdrawal by Subject|0|||
130253493|NCT04105725|468890774|FG001|Primary Intervention|Withdrawal by Subject|1|||
130253494|NCT05346640|468890775|FG000|Overall Study|Lack of Efficacy|2|||
130253495|NCT05346640|468890775|FG000|Overall Study|Lost to Follow-up|14|||
130253496|NCT05346640|468890775|FG000|Overall Study|Protocol Violation|4|||
130253497|NCT05346640|468890775|FG000|Overall Study|Withdrawal by Subject|2|||
130253498|NCT05346640|468890775|FG000|Overall Study|Physiological Complications|3|||
130253499|NCT05346640|468890775|FG000|Overall Study|Other Reason|3|||
130253500|NCT00480025|468890776|FG000|Overall Study|Protocol Violation|12|||
130253501|NCT00480025|468890777|FG001|Overall Study|Protocol Violation|7|||
130253502|NCT00480025|468890776|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
130253503|NCT00480025|468890777|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
130253504|NCT00480025|468890776|FG000|Overall Study|Disease Progression / Recurrence|449|||
130253505|NCT00480025|468890777|FG001|Overall Study|Disease Progression / Recurrence|224|||
130253506|NCT00480025|468890776|FG000|Overall Study|Adverse Event|44|||
130253507|NCT00480025|468890777|FG001|Overall Study|Adverse Event|12|||
130253508|NCT00480025|468890776|FG000|Overall Study|Other|70|||
130253509|NCT00480025|468890777|FG001|Overall Study|Other|29|||
130253510|NCT00480025|468890776|FG000|Overall Study|SAE including intercurrent illness|76|||
130253511|NCT00480025|468890777|FG001|Overall Study|SAE including intercurrent illness|42|||
130253512|NCT04634331|468890782|FG000|Overall Study|Withdrawal by Subject|2|||
130253513|NCT04634331|468890783|FG001|Overall Study|Withdrawal by Subject|2|||
130253514|NCT03726879|468890784|FG000|Overall Study|Death|11|||
130253515|NCT03726879|468890785|FG001|Overall Study|Death|13|||
130253516|NCT03726879|468890784|FG000|Overall Study|Physician Decision|0|||
130253517|NCT03726879|468890785|FG001|Overall Study|Physician Decision|2|||
130253518|NCT03726879|468890784|FG000|Overall Study|Protocol Violation|0|||
130253519|NCT03726879|468890785|FG001|Overall Study|Protocol Violation|1|||
130253520|NCT03726879|468890784|FG000|Overall Study|Withdrawal by Subject|5|||
130253521|NCT03726879|468890785|FG001|Overall Study|Withdrawal by Subject|6|||
130253522|NCT03726879|468890784|FG000|Overall Study|TSH result is unstable|0|||
130253523|NCT03726879|468890785|FG001|Overall Study|TSH result is unstable|1|||
130253524|NCT03726879|468890784|FG000|Overall Study|Disease relapse|1|||
130253525|NCT03726879|468890785|FG001|Overall Study|Disease relapse|0|||
130253526|NCT03726879|468890784|FG000|Overall Study|Lost to Follow-up|3|||
130253527|NCT03726879|468890785|FG001|Overall Study|Lost to Follow-up|0|||
130253528|NCT02766478|468890786|FG000|Overall Study|Withdrawal by Subject|1|||
130253529|NCT02766478|468890787|FG001|Overall Study|Withdrawal by Subject|1|||
130253530|NCT05626686|468890788|FG000|Overall Study|Protocol Violation|3|||
130253531|NCT05626686|468890788|FG000|Overall Study|Withdrawal by Subject|3|||
130253532|NCT01093573|468890789|FG000|Overall Study|Physician Decision|0|||
130101195|NCT03917654|468327316|FG003|Year 2|Spouse/family member request|0|||
130101196|NCT03917654|468327317|FG004|Year 2|Spouse/family member request|0|||
130101197|NCT03917654|468327318|FG005|Year 2|Spouse/family member request|0|||
130101198|NCT03917654|468327319|FG006|Year 2|Spouse/family member request|1|||
130101199|NCT03917654|468327320|FG007|Year 2|Spouse/family member request|0|||
130101200|NCT03917654|468327321|FG008|Year 2|Spouse/family member request|0|||
130101201|NCT03917654|468327322|FG009|Year 2|Spouse/family member request|0|||
130101202|NCT03917654|468327323|FG010|Year 2|Spouse/family member request|0|||
130101203|NCT03917654|468327324|FG011|Year 2|Spouse/family member request|0|||
130101204|NCT03917654|468327313|FG000|Year 2|Lost to Follow-up|0|||
130101205|NCT03917654|468327314|FG001|Year 2|Lost to Follow-up|0|||
130101206|NCT03917654|468327315|FG002|Year 2|Lost to Follow-up|0|||
130101207|NCT03917654|468327316|FG003|Year 2|Lost to Follow-up|0|||
130253533|NCT01093573|468890790|FG001|Overall Study|Physician Decision|0|||
130253534|NCT01093573|468890791|FG002|Overall Study|Physician Decision|1|||
130253535|NCT01093573|468890789|FG000|Overall Study|Insurance Denied|0|||
130253536|NCT01093573|468890790|FG001|Overall Study|Insurance Denied|0|||
130253537|NCT01093573|468890791|FG002|Overall Study|Insurance Denied|1|||
130253538|NCT01197300|468892164|FG000|Overall Study|Lost to Follow-up|0|||
130253539|NCT01197300|468892165|FG001|Overall Study|Lost to Follow-up|1|||
130253540|NCT01197300|468892164|FG000|Overall Study|Protocol Violation|0|||
130253541|NCT01197300|468892165|FG001|Overall Study|Protocol Violation|1|||
130253542|NCT00581100|468892166|FG000|Overall Study|Death|1|||
130253543|NCT00581100|468892167|FG001|Overall Study|Death|0|||
130253544|NCT00581100|468892166|FG000|Overall Study|Adverse Event|2|||
130253545|NCT00581100|468892167|FG001|Overall Study|Adverse Event|1|||
130253546|NCT00581100|468892166|FG000|Overall Study|Withdrawal by Subject|1|||
130253547|NCT00581100|468892167|FG001|Overall Study|Withdrawal by Subject|4|||
130253548|NCT00581100|468892166|FG000|Overall Study|Other|3|||
130253549|NCT00581100|468892167|FG001|Overall Study|Other|0|||
130253550|NCT03058952|468892170|FG000|Overall Study|Adverse Event|1|||
130253551|NCT03058952|468892171|FG001|Overall Study|Adverse Event|0|||
130253552|NCT03058952|468892170|FG000|Overall Study|Lost to Follow-up|15|||
130253553|NCT03058952|468892171|FG001|Overall Study|Lost to Follow-up|15|||
130253554|NCT03058952|468892170|FG000|Overall Study|Withdrawal by Subject|7|||
130253555|NCT03058952|468892171|FG001|Overall Study|Withdrawal by Subject|11|||
130253556|NCT00590317|468892172|FG000|Overall Study|Lack of Efficacy|1|||
130253557|NCT00590317|468892173|FG001|Overall Study|Lack of Efficacy|5|||
130253558|NCT03837509|468892174|FG000|Phase 1|Death|5|||
130253559|NCT03837509|468892175|FG001|Phase 1|Death|2|||
130253560|NCT03837509|468892176|FG002|Phase 1|Death|0|||
130253561|NCT03837509|468892177|FG003|Phase 1|Death|0|||
130253562|NCT03837509|468892178|FG004|Phase 1|Death|0|||
130253563|NCT03837509|468892174|FG000|Phase 2|Death|0|||
130253564|NCT03837509|468892175|FG001|Phase 2|Death|0|||
130253565|NCT03837509|468892176|FG002|Phase 2|Death|0|||
130253566|NCT03837509|468892177|FG003|Phase 2|Death|1|||
130253567|NCT03837509|468892178|FG004|Phase 2|Death|1|||
130253568|NCT03682367|468892188|FG000|Overall Study|Protocol Violation|2|||
130253569|NCT03682367|468892189|FG001|Overall Study|Protocol Violation|1|||
130253570|NCT03682367|468892188|FG000|Overall Study|Closed Study Early|0|||
130253571|NCT03682367|468892189|FG001|Overall Study|Closed Study Early|3|||
130253572|NCT00129974|468892190|FG000|Overall Study|Other|1|||
130253573|NCT00414609|468892191|FG000|Core Study|Adverse Event|9|||
130253574|NCT00414609|468892192|FG001|Core Study|Adverse Event|11|||
130253575|NCT00414609|468892193|FG002|Core Study|Adverse Event|0|||
130253576|NCT00414609|468892191|FG000|Core Study|Abnormal laboratory values|0|||
130253577|NCT00414609|468892192|FG001|Core Study|Abnormal laboratory values|1|||
130253578|NCT00414609|468892193|FG002|Core Study|Abnormal laboratory values|0|||
130253579|NCT00414609|468892191|FG000|Core Study|Abnormal test procedure results|1|||
130253580|NCT00414609|468892192|FG001|Core Study|Abnormal test procedure results|1|||
130253581|NCT00414609|468892193|FG002|Core Study|Abnormal test procedure results|0|||
130253582|NCT00414609|468892191|FG000|Core Study|Protocol deviation|0|||
130253583|NCT00414609|468892192|FG001|Core Study|Protocol deviation|1|||
130253584|NCT00414609|468892193|FG002|Core Study|Protocol deviation|0|||
130253585|NCT00414609|468892191|FG000|Core Study|Patient withdrew consent|10|||
130253586|NCT00414609|468892192|FG001|Core Study|Patient withdrew consent|11|||
130253587|NCT00414609|468892193|FG002|Core Study|Patient withdrew consent|0|||
130253588|NCT00414609|468892191|FG000|Core Study|Lost to Follow-up|7|||
130253589|NCT00414609|468892192|FG001|Core Study|Lost to Follow-up|4|||
130253590|NCT00414609|468892193|FG002|Core Study|Lost to Follow-up|0|||
130253591|NCT00414609|468892191|FG000|Core Study|Administrative problems|0|||
130253592|NCT00414609|468892192|FG001|Core Study|Administrative problems|2|||
130253593|NCT00414609|468892193|FG002|Core Study|Administrative problems|0|||
130253594|NCT00414609|468892191|FG000|Core Study|Death|7|||
130253595|NCT00414609|468892192|FG001|Core Study|Death|14|||
130253596|NCT00414609|468892193|FG002|Core Study|Death|0|||
130253597|NCT00414609|468892191|FG000|Extension Study|Adverse Event|0|||
130253598|NCT00414609|468892192|FG001|Extension Study|Adverse Event|0|||
130253599|NCT00414609|468892193|FG002|Extension Study|Adverse Event|14|||
130253600|NCT00414609|468892191|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
130253601|NCT00414609|468892192|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
130253602|NCT00414609|468892193|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
130253603|NCT00414609|468892191|FG000|Extension Study|Withdrawal by Subject|0|||
130253604|NCT00414609|468892192|FG001|Extension Study|Withdrawal by Subject|0|||
130253605|NCT00414609|468892193|FG002|Extension Study|Withdrawal by Subject|13|||
130253606|NCT00414609|468892191|FG000|Extension Study|Lost to Follow-up|0|||
130253607|NCT00414609|468892192|FG001|Extension Study|Lost to Follow-up|0|||
130253608|NCT00414609|468892193|FG002|Extension Study|Lost to Follow-up|10|||
130253609|NCT00414609|468892191|FG000|Extension Study|Administrative problems|0|||
130253610|NCT00414609|468892192|FG001|Extension Study|Administrative problems|0|||
130253611|NCT00414609|468892193|FG002|Extension Study|Administrative problems|1|||
130253612|NCT00414609|468892191|FG000|Extension Study|Death|0|||
130253613|NCT00414609|468892192|FG001|Extension Study|Death|0|||
130253614|NCT00414609|468892193|FG002|Extension Study|Death|17|||
130253615|NCT01853280|468892198|FG000|Overall Study|Lack of Efficacy|2|||
130253616|NCT01853280|468892199|FG001|Overall Study|Lack of Efficacy|2|||
130253617|NCT01853280|468892198|FG000|Overall Study|Lost to Follow-up|0|||
130253618|NCT01853280|468892199|FG001|Overall Study|Lost to Follow-up|1|||
130253619|NCT01853280|468892198|FG000|Overall Study|Physician Decision|0|||
130253620|NCT01853280|468892199|FG001|Overall Study|Physician Decision|1|||
130253621|NCT01853280|468892198|FG000|Overall Study|Withdrawal by Subject|0|||
130253622|NCT01853280|468892199|FG001|Overall Study|Withdrawal by Subject|1|||
130253623|NCT01853280|468892198|FG000|Overall Study|Ineligible|0|||
130253624|NCT01853280|468892199|FG001|Overall Study|Ineligible|1|||
130253625|NCT03032484|468892200|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
130253626|NCT03032484|468892201|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
130253627|NCT03032484|468892200|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
130253628|NCT03032484|468892201|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
130253629|NCT01229111|468892202|FG000|Overall Study|Death|1|||
130253630|NCT04893811|468892203|FG000|Vaccination Phase|Death|1|||
130253631|NCT04893811|468892204|FG001|Vaccination Phase|Death|0|||
130253632|NCT04893811|468892203|FG000|Vaccination Phase|Lost to Follow-up|1|||
130253633|NCT04893811|468892204|FG001|Vaccination Phase|Lost to Follow-up|1|||
130253634|NCT04893811|468892203|FG000|Vaccination Phase|Protocol Violation|2|||
130253635|NCT04893811|468892204|FG001|Vaccination Phase|Protocol Violation|0|||
130253636|NCT04893811|468892203|FG000|Vaccination Phase|Withdrawal by Subject|2|||
130253637|NCT04893811|468892204|FG001|Vaccination Phase|Withdrawal by Subject|1|||
130253638|NCT04893811|468892203|FG000|Vaccination Phase|Other|0|||
130253639|NCT04893811|468892204|FG001|Vaccination Phase|Other|1|||
130253640|NCT04893811|468892203|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
130253641|NCT04893811|468892204|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
130253642|NCT04893811|468892203|FG000|Follow-up Phase|Lost to Follow-up|0|||
130253643|NCT04893811|468892204|FG001|Follow-up Phase|Lost to Follow-up|1|||
130253644|NCT05463952|468892216|FG000|Treatment|Progressive disease|4|||
130253645|NCT05463952|468892216|FG000|Treatment|Ongoing|2|||
130253646|NCT01946880|468892217|FG000|Overall Study|Lost to Follow-up|1|||
130253647|NCT01946880|468892218|FG001|Overall Study|Lost to Follow-up|0|||
130253648|NCT01946880|468892217|FG000|Overall Study|Physician Decision|1|||
130253649|NCT01946880|468892218|FG001|Overall Study|Physician Decision|1|||
130253650|NCT01946880|468892217|FG000|Overall Study|Withdrawal by Subject|3|||
130253651|NCT01946880|468892218|FG001|Overall Study|Withdrawal by Subject|2|||
130253652|NCT01946880|468892217|FG000|Overall Study|Met Primary Endpoint|1|||
130253653|NCT01946880|468892218|FG001|Overall Study|Met Primary Endpoint|0|||
130253654|NCT01946880|468892217|FG000|Overall Study|Personal and Family Issues|1|||
130253655|NCT01946880|468892218|FG001|Overall Study|Personal and Family Issues|0|||
130253656|NCT02758626|468892221|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
130253657|NCT02758626|468892222|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
130253658|NCT02758626|468892221|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
130253659|NCT02758626|468892222|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
130253660|NCT02758626|468892221|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
130253661|NCT02758626|468892222|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
130253662|NCT02758626|468892221|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
130253663|NCT02758626|468892222|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
130253664|NCT04204902|468892224|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
130253665|NCT04204902|468892225|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
130253666|NCT00456365|468892228|FG000|Overall Study|Lost to Follow-up|1|||
130253667|NCT00456365|468892229|FG001|Overall Study|Lost to Follow-up|3|||
130253668|NCT00456365|468892228|FG000|Overall Study|Withdrawal by Subject|4|||
130253669|NCT00456365|468892229|FG001|Overall Study|Withdrawal by Subject|7|||
130253670|NCT00456365|468892228|FG000|Overall Study|Pregnancy|1|||
130253671|NCT00456365|468892229|FG001|Overall Study|Pregnancy|1|||
130253672|NCT00456365|468892228|FG000|Overall Study|oncologic diagnosis|1|||
130253673|NCT00456365|468892229|FG001|Overall Study|oncologic diagnosis|1|||
130253674|NCT05451329|468892230|FG000|Overall Study|Adverse Event|1|||
130253675|NCT05451329|468892231|FG001|Overall Study|Adverse Event|1|||
130253676|NCT05451329|468892232|FG002|Overall Study|Adverse Event|0|||
130253677|NCT05451329|468892230|FG000|Overall Study|Withdrawal by Subject|1|||
130253678|NCT05451329|468892231|FG001|Overall Study|Withdrawal by Subject|0|||
130253679|NCT05451329|468892232|FG002|Overall Study|Withdrawal by Subject|0|||
130253680|NCT05451329|468892230|FG000|Overall Study|Investigational Product Lot exchange|1|||
130253681|NCT05451329|468892231|FG001|Overall Study|Investigational Product Lot exchange|1|||
130253682|NCT05451329|468892232|FG002|Overall Study|Investigational Product Lot exchange|0|||
130253683|NCT02202577|468892233|FG000|Overall Study|Lost to Follow-up|6|||
130253684|NCT02202577|468892234|FG001|Overall Study|Lost to Follow-up|16|||
130253685|NCT02202577|468892233|FG000|Overall Study|Protocol Violation|7|||
130253686|NCT02202577|468892234|FG001|Overall Study|Protocol Violation|3|||
130253687|NCT00829868|468892235|FG000|Washout|Physician Decision|1|||
130253688|NCT00829868|468892236|FG001|Washout|Physician Decision|0|||
130253689|NCT02799043|468892237|FG000|Overall Study|Adverse Event|0|||
130253690|NCT02799043|468892238|FG001|Overall Study|Adverse Event|1|||
130253691|NCT02799043|468892237|FG000|Overall Study|Death|1|||
130253692|NCT02799043|468892238|FG001|Overall Study|Death|1|||
130253693|NCT02799043|468892237|FG000|Overall Study|Lost to Follow-up|3|||
130031787|NCT02497001|468072682|FG001|Overall Study|Lost to Follow-up|2|||
130031788|NCT02497001|468072683|FG002|Overall Study|Lost to Follow-up|0|||
130253694|NCT02799043|468892238|FG001|Overall Study|Lost to Follow-up|6|||
130253695|NCT02799043|468892237|FG000|Overall Study|Withdrawal by Subject|4|||
130253696|NCT02799043|468892238|FG001|Overall Study|Withdrawal by Subject|4|||
130253697|NCT02799043|468892237|FG000|Overall Study|Moved to different country|0|||
130253698|NCT02799043|468892238|FG001|Overall Study|Moved to different country|1|||
130253699|NCT02799043|468892237|FG000|Overall Study|Trial Screen Failure|1|||
130253700|NCT02799043|468892238|FG001|Overall Study|Trial Screen Failure|0|||
130031789|NCT02497001|468072684|FG003|Overall Study|Lost to Follow-up|2|||
130253701|NCT02799043|468892237|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
130253702|NCT02799043|468892238|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
130253703|NCT06091956|468892239|FG000|Overall Study|Withdrawal by Subject|1|||
130253704|NCT06091956|468892239|FG000|Overall Study|Complicating Disease|1|||
130031790|NCT02497001|468072681|FG000|Overall Study|Adverse Event|28|||
130031791|NCT02497001|468072682|FG001|Overall Study|Adverse Event|30|||
130253705|NCT01421459|468892248|FG000|Overall Study|Adverse Event|6|||
130253706|NCT01421459|468892249|FG001|Overall Study|Adverse Event|10|||
130253707|NCT01421459|468892248|FG000|Overall Study|Death|1|||
130253708|NCT01421459|468892249|FG001|Overall Study|Death|1|||
130253709|NCT01421459|468892248|FG000|Overall Study|Lack of Efficacy|1|||
130253710|NCT01421459|468892249|FG001|Overall Study|Lack of Efficacy|2|||
130253711|NCT01421459|468892248|FG000|Overall Study|Lost to Follow-up|8|||
130253712|NCT01421459|468892249|FG001|Overall Study|Lost to Follow-up|9|||
130253713|NCT01421459|468892248|FG000|Overall Study|Physician Decision|9|||
130253714|NCT01421459|468892249|FG001|Overall Study|Physician Decision|9|||
130253715|NCT01421459|468892248|FG000|Overall Study|Protocol Violation|8|||
130253716|NCT01421459|468892249|FG001|Overall Study|Protocol Violation|5|||
130253717|NCT01421459|468892248|FG000|Overall Study|Withdrawal by Subject|12|||
130253718|NCT01421459|468892249|FG001|Overall Study|Withdrawal by Subject|16|||
130253719|NCT02899754|468892250|FG000|Overall Study|Lost to Follow-up|7|||
130253720|NCT02899754|468892251|FG001|Overall Study|Lost to Follow-up|9|||
130253721|NCT03996395|468892258|FG000|Overall Study|Lost to Follow-up|4|||
130253722|NCT03996395|468892258|FG000|Overall Study|Withdrawal by Subject|1|||
130253723|NCT03996395|468892258|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
130253724|NCT00392288|468892259|FG000|Overall Study|Adverse Event|17|||
129885086|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885087|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885088|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885089|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885090|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885091|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885092|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885093|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885094|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885095|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885096|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885097|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
129885098|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
129885099|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885100|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885101|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885102|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885103|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885104|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
130031792|NCT02497001|468072683|FG002|Overall Study|Adverse Event|11|||
130031793|NCT02497001|468072684|FG003|Overall Study|Adverse Event|11|||
130031794|NCT02497001|468072681|FG000|Overall Study|Withdrawal by Subject|14|||
130031795|NCT02497001|468072682|FG001|Overall Study|Withdrawal by Subject|37|||
130031796|NCT02497001|468072683|FG002|Overall Study|Withdrawal by Subject|19|||
130031797|NCT02497001|468072684|FG003|Overall Study|Withdrawal by Subject|15|||
130031798|NCT02497001|468072681|FG000|Overall Study|Physician Decision|5|||
130031799|NCT02497001|468072682|FG001|Overall Study|Physician Decision|11|||
130031800|NCT02497001|468072683|FG002|Overall Study|Physician Decision|5|||
130031801|NCT02497001|468072684|FG003|Overall Study|Physician Decision|1|||
130031802|NCT02497001|468072681|FG000|Overall Study|subjects that were not treated|1|||
130031803|NCT02497001|468072682|FG001|Overall Study|subjects that were not treated|2|||
130031804|NCT02497001|468072683|FG002|Overall Study|subjects that were not treated|2|||
130031805|NCT02497001|468072684|FG003|Overall Study|subjects that were not treated|1|||
130031806|NCT02497001|468072681|FG000|Overall Study|Major Protocol Deviation|3|||
130031807|NCT02497001|468072682|FG001|Overall Study|Major Protocol Deviation|4|||
130031808|NCT02497001|468072683|FG002|Overall Study|Major Protocol Deviation|4|||
130031809|NCT02497001|468072684|FG003|Overall Study|Major Protocol Deviation|4|||
130031810|NCT02497001|468072681|FG000|Overall Study|Lack of Efficacy|10|||
130031811|NCT02497001|468072682|FG001|Overall Study|Lack of Efficacy|16|||
130031812|NCT02497001|468072683|FG002|Overall Study|Lack of Efficacy|6|||
130031813|NCT02497001|468072684|FG003|Overall Study|Lack of Efficacy|6|||
130031814|NCT02497001|468072681|FG000|Overall Study|Protocol Violation|3|||
130031815|NCT02497001|468072682|FG001|Overall Study|Protocol Violation|1|||
130031816|NCT02497001|468072683|FG002|Overall Study|Protocol Violation|3|||
130031817|NCT02497001|468072684|FG003|Overall Study|Protocol Violation|1|||
130031818|NCT03898063|468072685|FG000|Overall Study|Withdrawal by Subject|10|||
130031819|NCT03898063|468072686|FG001|Overall Study|Withdrawal by Subject|8|||
130253725|NCT00392288|468892260|FG001|Overall Study|Adverse Event|7|||
130253726|NCT00392288|468892261|FG002|Overall Study|Adverse Event|8|||
130253727|NCT00392288|468892259|FG000|Overall Study|Lack of Efficacy|8|||
130253728|NCT00392288|468892260|FG001|Overall Study|Lack of Efficacy|5|||
130253729|NCT00392288|468892261|FG002|Overall Study|Lack of Efficacy|3|||
130253730|NCT00392288|468892259|FG000|Overall Study|Protocol Violation|1|||
130253731|NCT00392288|468892260|FG001|Overall Study|Protocol Violation|3|||
130253732|NCT00392288|468892261|FG002|Overall Study|Protocol Violation|1|||
130253733|NCT00392288|468892259|FG000|Overall Study|Lost to Follow-up|1|||
130253734|NCT00392288|468892260|FG001|Overall Study|Lost to Follow-up|1|||
130253735|NCT00392288|468892261|FG002|Overall Study|Lost to Follow-up|1|||
130031820|NCT00054132|468072687|FG000|Overall Study|Not Treated|1|||
130031821|NCT02949830|468072688|FG000|Overall Study|Adverse Event|1|||
130031822|NCT02949830|468072688|FG000|Overall Study|Withdrawal by Subject|1|||
130031823|NCT01290887|468072689|FG000|Overall Study|Adverse Event|6|||
130031824|NCT01290887|468072690|FG001|Overall Study|Adverse Event|11|||
130031825|NCT01290887|468072689|FG000|Overall Study|Lack of Efficacy|4|||
130253736|NCT00392288|468892259|FG000|Overall Study|Withdrawal by Subject|1|||
130253737|NCT00392288|468892260|FG001|Overall Study|Withdrawal by Subject|0|||
130031826|NCT01290887|468072690|FG001|Overall Study|Lack of Efficacy|5|||
130031827|NCT01290887|468072689|FG000|Overall Study|Withdrawal by Subject|26|||
130031828|NCT01290887|468072690|FG001|Overall Study|Withdrawal by Subject|32|||
130031829|NCT01290887|468072689|FG000|Overall Study|Protocol Violation|2|||
130031830|NCT01290887|468072690|FG001|Overall Study|Protocol Violation|1|||
130031831|NCT01290887|468072689|FG000|Overall Study|Lost to Follow-up|4|||
130253738|NCT00392288|468892261|FG002|Overall Study|Withdrawal by Subject|2|||
130253739|NCT00392288|468892259|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
130253740|NCT00392288|468892260|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
130253741|NCT00392288|468892261|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
130253742|NCT00392288|468892259|FG000|Overall Study|Other|3|||
130253743|NCT00392288|468892260|FG001|Overall Study|Other|4|||
130253744|NCT00392288|468892261|FG002|Overall Study|Other|1|||
130253745|NCT02544763|468892262|FG000|Overall Study|Adverse Event|8|||
130253746|NCT02544763|468892263|FG001|Overall Study|Adverse Event|8|||
130253747|NCT02544763|468892264|FG002|Overall Study|Adverse Event|0|||
130253748|NCT02544763|468892262|FG000|Overall Study|Withdrawn by parent/guardian|1|||
130253749|NCT02544763|468892263|FG001|Overall Study|Withdrawn by parent/guardian|1|||
130253750|NCT02544763|468892264|FG002|Overall Study|Withdrawn by parent/guardian|1|||
130253751|NCT02544763|468892262|FG000|Overall Study|Met withdrawal criteria|0|||
130253752|NCT02544763|468892263|FG001|Overall Study|Met withdrawal criteria|2|||
130253753|NCT02544763|468892264|FG002|Overall Study|Met withdrawal criteria|0|||
130253754|NCT02544763|468892262|FG000|Overall Study|Physician Decision|0|||
130253755|NCT02544763|468892263|FG001|Overall Study|Physician Decision|1|||
130253756|NCT02544763|468892264|FG002|Overall Study|Physician Decision|0|||
130253757|NCT02544763|468892262|FG000|Overall Study|Difficulties taking IMP|1|||
130253758|NCT02544763|468892263|FG001|Overall Study|Difficulties taking IMP|0|||
130253759|NCT02544763|468892264|FG002|Overall Study|Difficulties taking IMP|0|||
130253760|NCT02097225|468892265|FG000|Dose Level 4|Adverse Event|0|||
130253761|NCT02097225|468892266|FG001|Dose Level 4|Adverse Event|0|||
130253762|NCT02097225|468892267|FG002|Dose Level 4|Adverse Event|0|||
130253763|NCT02097225|468892268|FG003|Dose Level 4|Adverse Event|0|||
130253764|NCT02097225|468892269|FG004|Dose Level 4|Adverse Event|1|||
130253765|NCT01027351|468892271|FG000|Overall Study|Withdrawal by Subject|1|||
130253766|NCT01027351|468892272|FG001|Overall Study|Withdrawal by Subject|0|||
130253767|NCT01027351|468892273|FG002|Overall Study|Withdrawal by Subject|1|||
130253768|NCT01027351|468892274|FG003|Overall Study|Withdrawal by Subject|0|||
130253769|NCT01027351|468892275|FG004|Overall Study|Withdrawal by Subject|3|||
130253770|NCT01027351|468892276|FG005|Overall Study|Withdrawal by Subject|5|||
130253771|NCT01027351|468892271|FG000|Overall Study|Lost to Follow-up|1|||
130253772|NCT01027351|468892272|FG001|Overall Study|Lost to Follow-up|1|||
130253773|NCT01027351|468892273|FG002|Overall Study|Lost to Follow-up|0|||
130253774|NCT01027351|468892274|FG003|Overall Study|Lost to Follow-up|1|||
130253775|NCT01027351|468892275|FG004|Overall Study|Lost to Follow-up|6|||
130253776|NCT01027351|468892276|FG005|Overall Study|Lost to Follow-up|0|||
130253777|NCT01027351|468892271|FG000|Overall Study|Inappropriate enrollment|0|||
130253778|NCT01027351|468892272|FG001|Overall Study|Inappropriate enrollment|0|||
130253779|NCT01027351|468892273|FG002|Overall Study|Inappropriate enrollment|0|||
130253780|NCT01027351|468892274|FG003|Overall Study|Inappropriate enrollment|0|||
130253781|NCT01027351|468892275|FG004|Overall Study|Inappropriate enrollment|1|||
130253782|NCT01027351|468892276|FG005|Overall Study|Inappropriate enrollment|0|||
130253783|NCT01027351|468892271|FG000|Overall Study|Protocol Violation|1|||
130253784|NCT01027351|468892272|FG001|Overall Study|Protocol Violation|0|||
130253785|NCT01027351|468892273|FG002|Overall Study|Protocol Violation|0|||
130253786|NCT01027351|468892274|FG003|Overall Study|Protocol Violation|1|||
130253787|NCT01027351|468892275|FG004|Overall Study|Protocol Violation|1|||
129885105|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885106|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
130031832|NCT01290887|468072690|FG001|Overall Study|Lost to Follow-up|4|||
130101208|NCT03917654|468327317|FG004|Year 2|Lost to Follow-up|0|||
130253788|NCT01027351|468892276|FG005|Overall Study|Protocol Violation|0|||
130253789|NCT02757963|468892277|FG000|Overall Study|Adverse Event|3|||
130253790|NCT02757963|468892277|FG000|Overall Study|Reached Stopping Criteria|1054|||
130253791|NCT02757963|468892277|FG000|Overall Study|Lost to Follow-up|5|||
130253792|NCT02757963|468892277|FG000|Overall Study|Physician Decision|1|||
130253793|NCT02757963|468892277|FG000|Overall Study|Withdrawal by Subject|34|||
130031833|NCT01290887|468072689|FG000|Overall Study|Non-compliance to study procedures|0|||
130101209|NCT03917654|468327318|FG005|Year 2|Lost to Follow-up|0|||
130253794|NCT02971137|468892278|FG000|Overall Study|Lost to Follow-up|44|||
130253795|NCT02971137|468892279|FG001|Overall Study|Lost to Follow-up|56|||
130253796|NCT00911157|468892280|FG000|Overall Study|Adverse Event|4|||
130253797|NCT00911157|468892281|FG001|Overall Study|Adverse Event|1|||
130253798|NCT00911157|468892280|FG000|Overall Study|Withdrawal by Subject|1|||
130253799|NCT00911157|468892281|FG001|Overall Study|Withdrawal by Subject|1|||
130253800|NCT00911157|468892280|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
130253801|NCT00911157|468892281|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
130253802|NCT00911157|468892280|FG000|Overall Study|Need to treat for lung cancer|1|||
130253803|NCT00911157|468892281|FG001|Overall Study|Need to treat for lung cancer|0|||
130253804|NCT04755231|468892282|FG000|Overall Study|Lost to Follow-up|5|||
130253805|NCT04755231|468892282|FG000|Overall Study|Withdrawal by Subject|5|||
130253806|NCT04650893|468892283|FG000|Overall Study|Lost to Follow-up|11|||
130253807|NCT04650893|468892284|FG001|Overall Study|Lost to Follow-up|10|||
130253808|NCT04650893|468892285|FG002|Overall Study|Lost to Follow-up|11|||
130253809|NCT00176254|468892298|FG000|Overall Study|Lost to Follow-up|1|||
130253810|NCT01251965|468893914|FG000|Overall Study|Participant/physician decision|1|||
130253811|NCT01251965|468893915|FG001|Overall Study|Participant/physician decision|2|||
130253812|NCT01251965|468893916|FG002|Overall Study|Participant/physician decision|0|||
130253813|NCT01251965|468893914|FG000|Overall Study|Death|0|||
130253814|NCT01251965|468893915|FG001|Overall Study|Death|0|||
130253815|NCT01251965|468893916|FG002|Overall Study|Death|11|||
130253816|NCT04616196|468893917|FG000|Overall Study|Progressive Disease|3|||
130253817|NCT04616196|468893918|FG001|Overall Study|Progressive Disease|0|||
130253818|NCT04616196|468893919|FG002|Overall Study|Progressive Disease|4|||
130253819|NCT04616196|468893920|FG003|Overall Study|Progressive Disease|1|||
130031834|NCT01290887|468072690|FG001|Overall Study|Non-compliance to study procedures|1|||
130031835|NCT01290887|468072689|FG000|Overall Study|Non-compliance to study medications|1|||
130031836|NCT01290887|468072690|FG001|Overall Study|Non-compliance to study medications|0|||
130031837|NCT01290887|468072689|FG000|Overall Study|Sponsor closure of study|420|||
130031838|NCT01290887|468072690|FG001|Overall Study|Sponsor closure of study|476|||
130031839|NCT01290887|468072689|FG000|Overall Study|Other|3|||
130031840|NCT01290887|468072690|FG001|Overall Study|Other|6|||
130031841|NCT01795547|468072691|FG000|Overall Study|Adverse Event|16|||
130031842|NCT01795547|468072692|FG001|Overall Study|Adverse Event|27|||
130031843|NCT01795547|468072691|FG000|Overall Study|Lack of Efficacy|8|||
130031844|NCT01795547|468072692|FG001|Overall Study|Lack of Efficacy|3|||
130031845|NCT01795547|468072691|FG000|Overall Study|Protocol Violation|6|||
130253820|NCT04616196|468893917|FG000|Overall Study|Death|2|||
130253821|NCT04616196|468893918|FG001|Overall Study|Death|4|||
130253822|NCT04616196|468893919|FG002|Overall Study|Death|1|||
130253823|NCT04616196|468893920|FG003|Overall Study|Death|0|||
130253824|NCT04616196|468893917|FG000|Overall Study|Withdrawal by Subject|0|||
130253825|NCT04616196|468893918|FG001|Overall Study|Withdrawal by Subject|2|||
130253826|NCT04616196|468893919|FG002|Overall Study|Withdrawal by Subject|0|||
130253827|NCT04616196|468893920|FG003|Overall Study|Withdrawal by Subject|0|||
130253828|NCT04616196|468893917|FG000|Overall Study|Lost to Follow-up|1|||
130253829|NCT04616196|468893918|FG001|Overall Study|Lost to Follow-up|0|||
130253830|NCT04616196|468893919|FG002|Overall Study|Lost to Follow-up|0|||
130253831|NCT04616196|468893920|FG003|Overall Study|Lost to Follow-up|0|||
130253832|NCT04616196|468893917|FG000|Overall Study|Sponsor request|2|||
130031846|NCT01795547|468072692|FG001|Overall Study|Protocol Violation|4|||
130031847|NCT01795547|468072691|FG000|Overall Study|Lost to Follow-up|2|||
130031848|NCT01795547|468072692|FG001|Overall Study|Lost to Follow-up|5|||
130031849|NCT01795547|468072691|FG000|Overall Study|Withdrawal of consent|7|||
130031850|NCT01795547|468072692|FG001|Overall Study|Withdrawal of consent|12|||
130031851|NCT01795547|468072691|FG000|Overall Study|Not Treated|4|||
130031852|NCT01795547|468072692|FG001|Overall Study|Not Treated|10|||
130031853|NCT01795547|468072691|FG000|Overall Study|Non-compliance with IMP|1|||
130031854|NCT01795547|468072692|FG001|Overall Study|Non-compliance with IMP|1|||
130031855|NCT01795547|468072691|FG000|Overall Study|Others|4|||
130031856|NCT01795547|468072692|FG001|Overall Study|Others|1|||
130031857|NCT01795547|468072691|FG000|Overall Study|Not stated|0|||
130031858|NCT01795547|468072692|FG001|Overall Study|Not stated|1|||
130031859|NCT03437447|468072694|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130253833|NCT04616196|468893918|FG001|Overall Study|Sponsor request|1|||
130253834|NCT04616196|468893919|FG002|Overall Study|Sponsor request|1|||
130253835|NCT04616196|468893920|FG003|Overall Study|Sponsor request|2|||
130253836|NCT05401409|468893921|FG000|Overall Study|Lost to Follow-up|1|||
130253837|NCT05401409|468893922|FG001|Overall Study|Lost to Follow-up|0|||
130253838|NCT02371889|468893923|FG000|Overall Study|Adverse medication effect|11|||
130253839|NCT02371889|468893924|FG001|Overall Study|Adverse medication effect|2|||
130253840|NCT02371889|468893923|FG000|Overall Study|Lost to Follow-up|6|||
130253841|NCT02371889|468893924|FG001|Overall Study|Lost to Follow-up|5|||
130253842|NCT02371889|468893923|FG000|Overall Study|Personal time constraints|2|||
130253843|NCT02371889|468893924|FG001|Overall Study|Personal time constraints|4|||
130253844|NCT02371889|468893923|FG000|Overall Study|Lack of Efficacy|0|||
130253845|NCT02371889|468893924|FG001|Overall Study|Lack of Efficacy|2|||
130253846|NCT02371889|468893923|FG000|Overall Study|Relapse|0|||
130253847|NCT02371889|468893924|FG001|Overall Study|Relapse|1|||
130031860|NCT03437447|468072695|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130253848|NCT02579759|468893925|FG000|Overall Study|Protocol Violation|2|||
130253849|NCT02579759|468893926|FG001|Overall Study|Protocol Violation|0|||
130253850|NCT02579759|468893927|FG002|Overall Study|Protocol Violation|0|||
130253851|NCT02579759|468893925|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
130253852|NCT02579759|468893926|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
130253853|NCT02579759|468893927|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
130253854|NCT02579759|468893925|FG000|Overall Study|BfArM hold|13|||
130253855|NCT02579759|468893926|FG001|Overall Study|BfArM hold|12|||
130253856|NCT02579759|468893927|FG002|Overall Study|BfArM hold|12|||
130253857|NCT02579759|468893925|FG000|Overall Study|Sponsor stopped Dose 2|0|||
130253858|NCT02579759|468893926|FG001|Overall Study|Sponsor stopped Dose 2|41|||
130253859|NCT02579759|468893927|FG002|Overall Study|Sponsor stopped Dose 2|0|||
130253860|NCT02579759|468893925|FG000|Overall Study|Non compliance|0|||
130253861|NCT02579759|468893926|FG001|Overall Study|Non compliance|1|||
130031861|NCT03437447|468072696|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130253862|NCT02579759|468893927|FG002|Overall Study|Non compliance|0|||
130253863|NCT02579759|468893925|FG000|Overall Study|Pregnancy|0|||
130253864|NCT02579759|468893926|FG001|Overall Study|Pregnancy|1|||
130253865|NCT02579759|468893927|FG002|Overall Study|Pregnancy|0|||
130031862|NCT00484315|468072697|FG000|12-Month Clinical Follow-up|Death|6|||
130031863|NCT00484315|468072698|FG001|12-Month Clinical Follow-up|Death|2|||
130031864|NCT00484315|468072697|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
130031865|NCT00484315|468072698|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
130031866|NCT00484315|468072697|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
130031867|NCT00484315|468072698|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
130031868|NCT00484315|468072697|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
130031869|NCT00484315|468072698|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
130031870|NCT00484315|468072697|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
130031871|NCT00484315|468072698|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
130031872|NCT00484315|468072697|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
130031873|NCT00484315|468072698|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
130031874|NCT00484315|468072697|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
130031875|NCT00484315|468072698|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
130031876|NCT00943683|468072699|FG000|Overall Study|Adverse Event|3|||
130031877|NCT00943683|468072700|FG001|Overall Study|Adverse Event|3|||
130031878|NCT00943683|468072699|FG000|Overall Study|Lost to Follow-up|1|||
130031879|NCT00943683|468072700|FG001|Overall Study|Lost to Follow-up|1|||
130031880|NCT00943683|468072699|FG000|Overall Study|Protocol Violation|1|||
130031881|NCT00943683|468072700|FG001|Overall Study|Protocol Violation|2|||
130031882|NCT00943683|468072699|FG000|Overall Study|Withdrawal by Subject|1|||
130031883|NCT00943683|468072700|FG001|Overall Study|Withdrawal by Subject|0|||
130031884|NCT00943683|468072699|FG000|Overall Study|Patient Moved|1|||
130031885|NCT00943683|468072700|FG001|Overall Study|Patient Moved|0|||
130031886|NCT01551745|468072701|FG000|Overall Study|Withdrawal by Subject|1|||
130031887|NCT01551745|468072701|FG000|Overall Study|Disease Progression|2|||
130031888|NCT02764541|468072702|FG000|Overall Study|Withdrawal by Subject|0|||
130031889|NCT02764541|468072703|FG001|Overall Study|Withdrawal by Subject|0|||
130031890|NCT02764541|468072704|FG002|Overall Study|Withdrawal by Subject|0|||
130031891|NCT02764541|468072705|FG003|Overall Study|Withdrawal by Subject|0|||
130031892|NCT02764541|468072706|FG004|Overall Study|Withdrawal by Subject|1|||
130031893|NCT02764541|468072707|FG005|Overall Study|Withdrawal by Subject|1|||
130031894|NCT02764541|468072708|FG006|Overall Study|Withdrawal by Subject|0|||
130031895|NCT02764541|468072709|FG007|Overall Study|Withdrawal by Subject|1|||
130031896|NCT02764541|468072702|FG000|Overall Study|Adverse Event|1|||
130031897|NCT02764541|468072703|FG001|Overall Study|Adverse Event|0|||
130031898|NCT02764541|468072704|FG002|Overall Study|Adverse Event|0|||
130031899|NCT02764541|468072705|FG003|Overall Study|Adverse Event|0|||
130031900|NCT02764541|468072706|FG004|Overall Study|Adverse Event|0|||
130031901|NCT02764541|468072707|FG005|Overall Study|Adverse Event|0|||
130031902|NCT02764541|468072708|FG006|Overall Study|Adverse Event|1|||
130031903|NCT02764541|468072709|FG007|Overall Study|Adverse Event|0|||
130031904|NCT02764541|468072702|FG000|Overall Study|Metastasis|1|||
130253866|NCT02579759|468893925|FG000|Overall Study|Inclusion/exclusion criteria|0|||
130253867|NCT02579759|468893926|FG001|Overall Study|Inclusion/exclusion criteria|0|||
130031905|NCT02764541|468072703|FG001|Overall Study|Metastasis|0|||
130031906|NCT02764541|468072704|FG002|Overall Study|Metastasis|0|||
130031907|NCT02764541|468072705|FG003|Overall Study|Metastasis|0|||
130031908|NCT02764541|468072706|FG004|Overall Study|Metastasis|0|||
130031909|NCT02764541|468072707|FG005|Overall Study|Metastasis|0|||
130031910|NCT02764541|468072708|FG006|Overall Study|Metastasis|0|||
130031911|NCT02764541|468072709|FG007|Overall Study|Metastasis|0|||
130031912|NCT02764541|468072702|FG000|Overall Study|Disease progression|1|||
130031913|NCT02764541|468072703|FG001|Overall Study|Disease progression|1|||
130253868|NCT02579759|468893927|FG002|Overall Study|Inclusion/exclusion criteria|1|||
130253869|NCT02579759|468893925|FG000|Overall Study|Adverse Event|4|||
130253870|NCT02579759|468893926|FG001|Overall Study|Adverse Event|3|||
130253871|NCT02579759|468893927|FG002|Overall Study|Adverse Event|1|||
130253872|NCT02579759|468893925|FG000|Overall Study|Withdrawal by Subject|3|||
130253873|NCT02579759|468893926|FG001|Overall Study|Withdrawal by Subject|3|||
130253874|NCT02579759|468893927|FG002|Overall Study|Withdrawal by Subject|5|||
130253875|NCT02579759|468893925|FG000|Overall Study|Lost to Follow-up|2|||
130253876|NCT02579759|468893926|FG001|Overall Study|Lost to Follow-up|2|||
130253877|NCT02579759|468893927|FG002|Overall Study|Lost to Follow-up|2|||
130253878|NCT02410200|468893930|FG000|Overall Study|Adverse Event|2|||
130253879|NCT01050218|468893935|FG000|Overall Study|Adverse Event|37|||
130253880|NCT01050218|468893935|FG000|Overall Study|Lack of Efficacy|8|||
130253881|NCT01050218|468893935|FG000|Overall Study|Protocol Violation|3|||
130253882|NCT01050218|468893935|FG000|Overall Study|Withdrawal by Subject|18|||
130253883|NCT01050218|468893935|FG000|Overall Study|Discontinued by sponsor|18|||
130253884|NCT01050218|468893935|FG000|Overall Study|Compliance|2|||
130253885|NCT01050218|468893935|FG000|Overall Study|Failed to return|7|||
130253886|NCT01050218|468893935|FG000|Overall Study|Serious Adverse Event|1|||
130253887|NCT01050218|468893935|FG000|Overall Study|Family emergency|1|||
130253888|NCT01149460|468893936|FG000|Overall Study|Withdrawal by Subject|0|||
130253889|NCT01149460|468893937|FG001|Overall Study|Withdrawal by Subject|2|||
130253890|NCT02801578|468893944|FG000|Overall Study|Adverse Event|2|||
130253891|NCT00668642|468893945|FG000|First Off-cycle|Cancer progression|1|||
130253892|NCT00668642|468893946|FG001|First Off-cycle|Cancer progression|0|||
130253893|NCT00668642|468893945|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
130253894|NCT00668642|468893946|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
130253895|NCT03412591|468893947|FG000|Overall Study|Withdrawal by Subject|1|||
130253896|NCT03412591|468893948|FG001|Overall Study|Withdrawal by Subject|8|||
130253897|NCT03412591|468893947|FG000|Overall Study|Adverse Event|0|||
130253898|NCT03412591|468893948|FG001|Overall Study|Adverse Event|1|||
130253899|NCT02272985|468893949|FG000|Overall Study|Withdrawal by Subject|1|||
130253900|NCT02272985|468893949|FG000|Overall Study|hip fracture|1|||
130253901|NCT02272985|468893949|FG000|Overall Study|kidney transplantation|1|||
130253902|NCT00770679|468893950|FG000|Overall Study|Lost to Follow-up|3|||
130253903|NCT00770679|468893950|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
130253904|NCT00266032|468893956|FG000|Treatment|Adverse Event|42|||
130253905|NCT00266032|468893957|FG001|Treatment|Adverse Event|26|||
130253906|NCT00266032|468893958|FG002|Treatment|Adverse Event|10|||
130253907|NCT00266032|468893956|FG000|Treatment|Lost to Follow-up|19|||
130253908|NCT00266032|468893957|FG001|Treatment|Lost to Follow-up|4|||
130253909|NCT00266032|468893958|FG002|Treatment|Lost to Follow-up|2|||
130253910|NCT00266032|468893956|FG000|Treatment|Pregnancy|3|||
130253911|NCT00266032|468893957|FG001|Treatment|Pregnancy|2|||
130253912|NCT00266032|468893958|FG002|Treatment|Pregnancy|2|||
130253913|NCT00266032|468893956|FG000|Treatment|Protocol Violation|6|||
130253914|NCT00266032|468893957|FG001|Treatment|Protocol Violation|14|||
130253915|NCT00266032|468893958|FG002|Treatment|Protocol Violation|13|||
130253916|NCT00266032|468893956|FG000|Treatment|Withdrawal by Subject|28|||
130253917|NCT00266032|468893957|FG001|Treatment|Withdrawal by Subject|13|||
130253918|NCT00266032|468893958|FG002|Treatment|Withdrawal by Subject|12|||
130253919|NCT00266032|468893956|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
130253920|NCT00266032|468893957|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
130253921|NCT00266032|468893958|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
130253922|NCT00266032|468893956|FG000|Open-label Safety Extension|Adverse Event|5|||
130253923|NCT00266032|468893957|FG001|Open-label Safety Extension|Adverse Event|0|||
130253924|NCT00266032|468893958|FG002|Open-label Safety Extension|Adverse Event|4|||
130253925|NCT00266032|468893956|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
130253926|NCT00266032|468893957|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
130253927|NCT00266032|468893958|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
130253928|NCT00266032|468893956|FG000|Open-label Safety Extension|Pregnancy|4|||
130253929|NCT00266032|468893957|FG001|Open-label Safety Extension|Pregnancy|1|||
130253930|NCT00266032|468893958|FG002|Open-label Safety Extension|Pregnancy|2|||
130253931|NCT00266032|468893956|FG000|Open-label Safety Extension|Protocol Violation|1|||
130253932|NCT00266032|468893957|FG001|Open-label Safety Extension|Protocol Violation|3|||
130253933|NCT00266032|468893958|FG002|Open-label Safety Extension|Protocol Violation|2|||
130253934|NCT00266032|468893956|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
130253935|NCT00266032|468893957|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
130253936|NCT00266032|468893958|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
130253937|NCT00266032|468893956|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
130253938|NCT00266032|468893957|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
130253939|NCT00266032|468893958|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
130253940|NCT00814983|468893961|FG000|Overall Study|Screen failure|1|||
130253941|NCT00814983|468893962|FG001|Overall Study|Screen failure|0|||
130253942|NCT00814983|468893961|FG000|Overall Study|Withdrawal by Subject|1|||
130253943|NCT00814983|468893962|FG001|Overall Study|Withdrawal by Subject|0|||
130253944|NCT00814983|468893961|FG000|Overall Study|Graft failure|1|||
130253945|NCT00814983|468893962|FG001|Overall Study|Graft failure|0|||
130253946|NCT03627468|468893963|FG000|Overall Study|Adverse Event|5|||
130253947|NCT03627468|468893964|FG001|Overall Study|Adverse Event|33|||
130253948|NCT03627468|468893963|FG000|Overall Study|Withdrawal by Subject|13|||
130253949|NCT03627468|468893964|FG001|Overall Study|Withdrawal by Subject|23|||
130253950|NCT03627468|468893963|FG000|Overall Study|Physician Decision|1|||
130253951|NCT03627468|468893964|FG001|Overall Study|Physician Decision|0|||
130253952|NCT03627468|468893963|FG000|Overall Study|Protocol Violation|0|||
130253953|NCT03627468|468893964|FG001|Overall Study|Protocol Violation|2|||
130253954|NCT03627468|468893963|FG000|Overall Study|Lost to Follow-up|10|||
130253955|NCT03627468|468893964|FG001|Overall Study|Lost to Follow-up|16|||
130253956|NCT03627468|468893963|FG000|Overall Study|Death|1|||
130253957|NCT03627468|468893964|FG001|Overall Study|Death|0|||
130253958|NCT03627468|468893963|FG000|Overall Study|Pregnancy|1|||
130253959|NCT03627468|468893964|FG001|Overall Study|Pregnancy|1|||
130253960|NCT03627468|468893963|FG000|Overall Study|Lack of Efficacy|0|||
130253961|NCT03627468|468893964|FG001|Overall Study|Lack of Efficacy|2|||
130253962|NCT03627468|468893963|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
130253963|NCT03627468|468893964|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
130253964|NCT04157738|468893965|FG000|Overall Study|Moved out of state|0|||
130253965|NCT04157738|468893966|FG001|Overall Study|Moved out of state|2|||
130253966|NCT04157738|468893965|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
130253967|NCT04157738|468893966|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
130253968|NCT00160563|468893967|FG000|Overall Study|Adverse Event|1|||
130253969|NCT00160563|468893968|FG001|Overall Study|Adverse Event|1|||
130253970|NCT00160563|468893969|FG002|Overall Study|Adverse Event|1|||
130253971|NCT00160563|468893967|FG000|Overall Study|Lost to Follow-up|1|||
130253972|NCT00160563|468893968|FG001|Overall Study|Lost to Follow-up|1|||
130253973|NCT00160563|468893969|FG002|Overall Study|Lost to Follow-up|2|||
130253974|NCT00160563|468893967|FG000|Overall Study|Protocol Violation|0|||
130253975|NCT00160563|468893968|FG001|Overall Study|Protocol Violation|0|||
130253976|NCT00160563|468893969|FG002|Overall Study|Protocol Violation|3|||
130253977|NCT00160563|468893967|FG000|Overall Study|Withdrawal by Subject|1|||
130253978|NCT00160563|468893968|FG001|Overall Study|Withdrawal by Subject|2|||
130253979|NCT00160563|468893969|FG002|Overall Study|Withdrawal by Subject|3|||
130253980|NCT00160563|468893967|FG000|Overall Study|Other (listed in the study report)|48|||
130253981|NCT00160563|468893968|FG001|Overall Study|Other (listed in the study report)|40|||
130253982|NCT00160563|468893969|FG002|Overall Study|Other (listed in the study report)|81|||
130253983|NCT00160563|468893967|FG000|Overall Study|Missing reason|0|||
130253984|NCT00160563|468893968|FG001|Overall Study|Missing reason|1|||
130253985|NCT00160563|468893969|FG002|Overall Study|Missing reason|0|||
130253986|NCT01514357|468893973|FG000|Overall Study|Screen failure|2|||
130253987|NCT01514357|468893974|FG001|Overall Study|Screen failure|0|||
130253988|NCT01514357|468893973|FG000|Overall Study|Withdrawal by Subject|2|||
130253989|NCT01514357|468893974|FG001|Overall Study|Withdrawal by Subject|0|||
130253990|NCT00752219|468893975|FG000|Overall Study|Clinical failure|0|||
130253991|NCT00752219|468893976|FG001|Overall Study|Clinical failure|1|||
130253992|NCT00752219|468893975|FG000|Overall Study|Adverse Event|5|||
130253993|NCT00752219|468893976|FG001|Overall Study|Adverse Event|3|||
130253994|NCT00752219|468893975|FG000|Overall Study|Protocol deviation|1|||
130253995|NCT00752219|468893976|FG001|Overall Study|Protocol deviation|0|||
130253996|NCT00752219|468893975|FG000|Overall Study|Lost to Follow-up|1|||
130253997|NCT00752219|468893976|FG001|Overall Study|Lost to Follow-up|2|||
130253998|NCT00752219|468893975|FG000|Overall Study|Randomized but not treated|1|||
130253999|NCT00752219|468893976|FG001|Overall Study|Randomized but not treated|0|||
130254000|NCT00752219|468893975|FG000|Overall Study|Other|3|||
130254001|NCT00752219|468893976|FG001|Overall Study|Other|0|||
130031914|NCT02764541|468072704|FG002|Overall Study|Disease progression|0|||
130031915|NCT02764541|468072705|FG003|Overall Study|Disease progression|0|||
130031916|NCT02764541|468072706|FG004|Overall Study|Disease progression|0|||
130031917|NCT02764541|468072707|FG005|Overall Study|Disease progression|0|||
130031918|NCT02764541|468072708|FG006|Overall Study|Disease progression|0|||
130031919|NCT02764541|468072709|FG007|Overall Study|Disease progression|1|||
130031920|NCT02764541|468072702|FG000|Overall Study|Protocol Violation|0|||
130254002|NCT01047540|468893982|FG000|Overall Study|Protocol Violation|1|||
130254003|NCT01047540|468893983|FG001|Overall Study|Protocol Violation|0|||
130254004|NCT01047540|468893984|FG002|Overall Study|Protocol Violation|0|||
130254005|NCT01047540|468893985|FG003|Overall Study|Protocol Violation|0|||
130254006|NCT01047540|468893986|FG004|Overall Study|Protocol Violation|0|||
130254007|NCT01047540|468893982|FG000|Overall Study|Lost to Follow-up|1|||
130254008|NCT01047540|468893983|FG001|Overall Study|Lost to Follow-up|0|||
130254009|NCT01047540|468893984|FG002|Overall Study|Lost to Follow-up|0|||
130031921|NCT02764541|468072703|FG001|Overall Study|Protocol Violation|0|||
130254010|NCT01047540|468893985|FG003|Overall Study|Lost to Follow-up|0|||
130254011|NCT01047540|468893986|FG004|Overall Study|Lost to Follow-up|0|||
130031922|NCT02764541|468072704|FG002|Overall Study|Protocol Violation|0|||
130254012|NCT01047540|468893982|FG000|Overall Study|Withdrawal by Subject|1|||
130254013|NCT01047540|468893983|FG001|Overall Study|Withdrawal by Subject|0|||
130254014|NCT01047540|468893984|FG002|Overall Study|Withdrawal by Subject|3|||
130254015|NCT01047540|468893985|FG003|Overall Study|Withdrawal by Subject|0|||
130254016|NCT01047540|468893986|FG004|Overall Study|Withdrawal by Subject|1|||
130254017|NCT01047540|468893982|FG000|Overall Study|Pregnancy|1|||
130254018|NCT01047540|468893983|FG001|Overall Study|Pregnancy|0|||
130254019|NCT01047540|468893984|FG002|Overall Study|Pregnancy|0|||
130254020|NCT01047540|468893985|FG003|Overall Study|Pregnancy|0|||
130254021|NCT01047540|468893986|FG004|Overall Study|Pregnancy|0|||
130254022|NCT01047540|468893982|FG000|Overall Study|Adverse Event|1|||
130254023|NCT01047540|468893983|FG001|Overall Study|Adverse Event|0|||
130254024|NCT01047540|468893984|FG002|Overall Study|Adverse Event|0|||
130254025|NCT01047540|468893985|FG003|Overall Study|Adverse Event|0|||
130254026|NCT01047540|468893986|FG004|Overall Study|Adverse Event|0|||
130254027|NCT01437189|468893990|FG000|Overall Study|Adverse Event|3|||
130254028|NCT01437189|468893990|FG000|Overall Study|Lack of Efficacy|4|||
130254029|NCT01437189|468893990|FG000|Overall Study|Withdrawal by Subject|8|||
130254030|NCT00347269|468893991|FG000|Overall Study|Lost to Follow-up|74|||
130254031|NCT00347269|468893992|FG001|Overall Study|Lost to Follow-up|65|||
130254032|NCT00347269|468893991|FG000|Overall Study|Withdrawal by Subject|18|||
130254033|NCT00347269|468893992|FG001|Overall Study|Withdrawal by Subject|38|||
130254034|NCT00347269|468893991|FG000|Overall Study|Death|2|||
130254035|NCT00347269|468893992|FG001|Overall Study|Death|3|||
130254036|NCT03654326|468893993|FG000|Overall Study|Withdrawal by Subject|5|||
130254037|NCT03654326|468893994|FG001|Overall Study|Withdrawal by Subject|3|||
130254038|NCT03654326|468893993|FG000|Overall Study|Physician Decision|0|||
130254039|NCT03654326|468893994|FG001|Overall Study|Physician Decision|1|||
130254040|NCT03654326|468893993|FG000|Overall Study|Unable to adhere to study schedule|0|||
130254041|NCT03654326|468893994|FG001|Overall Study|Unable to adhere to study schedule|1|||
130254042|NCT03654326|468893993|FG000|Overall Study|Lost to Follow-up|1|||
130254043|NCT03654326|468893994|FG001|Overall Study|Lost to Follow-up|1|||
130254044|NCT04102514|468893995|FG000|Overall Study|Death|3|||
130254045|NCT04102514|468893996|FG001|Overall Study|Death|0|||
130254046|NCT04102514|468893997|FG002|Overall Study|Death|0|||
130254047|NCT04102514|468893998|FG003|Overall Study|Death|0|||
130254048|NCT04102514|468893995|FG000|Overall Study|Lost to Follow-up|0|||
130254049|NCT04102514|468893996|FG001|Overall Study|Lost to Follow-up|0|||
130254050|NCT04102514|468893997|FG002|Overall Study|Lost to Follow-up|3|||
130254051|NCT04102514|468893998|FG003|Overall Study|Lost to Follow-up|0|||
130254052|NCT04102514|468893995|FG000|Overall Study|Physician Decision|0|||
130254053|NCT04102514|468893996|FG001|Overall Study|Physician Decision|0|||
130254054|NCT04102514|468893997|FG002|Overall Study|Physician Decision|1|||
130254055|NCT04102514|468893998|FG003|Overall Study|Physician Decision|0|||
130254056|NCT04102514|468893995|FG000|Overall Study|Withdrawal by Subject|7|||
130254057|NCT04102514|468893996|FG001|Overall Study|Withdrawal by Subject|13|||
130254058|NCT04102514|468893997|FG002|Overall Study|Withdrawal by Subject|7|||
130254059|NCT04102514|468893998|FG003|Overall Study|Withdrawal by Subject|14|||
130254060|NCT04102514|468893995|FG000|Overall Study|Moved to longterm care facility|6|||
130254061|NCT04102514|468893996|FG001|Overall Study|Moved to longterm care facility|0|||
130254062|NCT04102514|468893997|FG002|Overall Study|Moved to longterm care facility|4|||
130254063|NCT04102514|468893998|FG003|Overall Study|Moved to longterm care facility|0|||
130254064|NCT01689649|468893999|FG000|Overall Study|Lack of Efficacy|3|||
130254065|NCT01689649|468893999|FG000|Overall Study|Non-compliance|11|||
130254066|NCT01689649|468893999|FG000|Overall Study|Protocol Violation|3|||
130254067|NCT01689649|468893999|FG000|Overall Study|Lost to Follow-up|5|||
130254068|NCT00835549|468894000|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
130254069|NCT00835549|468894001|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130254070|NCT00835042|468894002|FG000|First Intervention|Withdrawal by Subject|3|||
130254071|NCT00835042|468894003|FG001|First Intervention|Withdrawal by Subject|0|||
129885107|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
130101210|NCT03917654|468327319|FG006|Year 2|Lost to Follow-up|1|||
130101211|NCT03917654|468327320|FG007|Year 2|Lost to Follow-up|0|||
130101212|NCT03917654|468327321|FG008|Year 2|Lost to Follow-up|1|||
130101213|NCT03917654|468327322|FG009|Year 2|Lost to Follow-up|0|||
130101214|NCT03917654|468327323|FG010|Year 2|Lost to Follow-up|0|||
130254072|NCT00835042|468894002|FG000|First Intervention|Adverse Event|1|||
130254073|NCT00835042|468894003|FG001|First Intervention|Adverse Event|2|||
130254074|NCT00835042|468894002|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
130254075|NCT00835042|468894003|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
130254076|NCT00619918|468894004|FG000|Overall Study|Withdrawal by Subject|4|||
130254077|NCT00619918|468894005|FG001|Overall Study|Withdrawal by Subject|3|||
130254078|NCT00619918|468894004|FG000|Overall Study|Physician Decision|2|||
130254079|NCT00619918|468894005|FG001|Overall Study|Physician Decision|4|||
130254080|NCT00619918|468894004|FG000|Overall Study|Transfer to outside facility|3|||
130254081|NCT00619918|468894005|FG001|Overall Study|Transfer to outside facility|3|||
130254082|NCT00619918|468894004|FG000|Overall Study|Left before receiving first dose|7|||
130254083|NCT00619918|468894005|FG001|Overall Study|Left before receiving first dose|6|||
130254084|NCT00619918|468894004|FG000|Overall Study|ICU admission|4|||
130254085|NCT00619918|468894005|FG001|Overall Study|ICU admission|6|||
130254086|NCT05524948|468894030|FG000|Overall Study|Withdrawal by Subject|1|||
130254087|NCT05524948|468894031|FG001|Overall Study|Withdrawal by Subject|0|||
130254088|NCT05524948|468894030|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
130254089|NCT05524948|468894031|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
130254090|NCT00595075|468894034|FG000|Overall Study|Withdrawal by Subject|1|||
130254091|NCT00595075|468894035|FG001|Overall Study|Withdrawal by Subject|0|||
130254092|NCT02096354|468894038|FG000|Overall Study|Physician Decision|4|||
130254093|NCT02096354|468894039|FG001|Overall Study|Physician Decision|5|||
130254094|NCT02096354|468894040|FG002|Overall Study|Physician Decision|0|||
130254095|NCT02096354|468894038|FG000|Overall Study|Withdrawal by Subject|3|||
130254096|NCT02096354|468894039|FG001|Overall Study|Withdrawal by Subject|1|||
130254097|NCT02096354|468894040|FG002|Overall Study|Withdrawal by Subject|0|||
130254098|NCT02096354|468894038|FG000|Overall Study|Adverse Event|7|||
130254099|NCT02096354|468894039|FG001|Overall Study|Adverse Event|4|||
130254100|NCT02096354|468894040|FG002|Overall Study|Adverse Event|0|||
130254101|NCT02096354|468894038|FG000|Overall Study|Ineligible|0|||
130254102|NCT02096354|468894039|FG001|Overall Study|Ineligible|0|||
130254103|NCT02096354|468894040|FG002|Overall Study|Ineligible|11|||
130254104|NCT03715829|468894041|FG000|Dose Ranging Period|Adverse Event|2|||
130254105|NCT03715829|468894042|FG001|Dose Ranging Period|Adverse Event|4|||
130254106|NCT03715829|468894043|FG002|Dose Ranging Period|Adverse Event|5|||
130254107|NCT03715829|468894044|FG003|Dose Ranging Period|Adverse Event|2|||
130254108|NCT03715829|468894045|FG004|Dose Ranging Period|Adverse Event|3|||
130254109|NCT03715829|468894046|FG005|Dose Ranging Period|Adverse Event|3|||
130254110|NCT03715829|468894047|FG006|Dose Ranging Period|Adverse Event|0|||
130254111|NCT03715829|468894048|FG007|Dose Ranging Period|Adverse Event|0|||
130254112|NCT03715829|468894049|FG008|Dose Ranging Period|Adverse Event|0|||
130254113|NCT03715829|468894050|FG009|Dose Ranging Period|Adverse Event|0|||
130254114|NCT03715829|468894051|FG010|Dose Ranging Period|Adverse Event|0|||
130254115|NCT03715829|468894041|FG000|Dose Ranging Period|Lack of Efficacy|0|||
130254116|NCT03715829|468894042|FG001|Dose Ranging Period|Lack of Efficacy|1|||
130254117|NCT03715829|468894043|FG002|Dose Ranging Period|Lack of Efficacy|0|||
130254118|NCT03715829|468894044|FG003|Dose Ranging Period|Lack of Efficacy|1|||
130254119|NCT03715829|468894045|FG004|Dose Ranging Period|Lack of Efficacy|0|||
130254120|NCT03715829|468894046|FG005|Dose Ranging Period|Lack of Efficacy|0|||
130254121|NCT03715829|468894047|FG006|Dose Ranging Period|Lack of Efficacy|0|||
130254122|NCT03715829|468894048|FG007|Dose Ranging Period|Lack of Efficacy|0|||
130254123|NCT03715829|468894049|FG008|Dose Ranging Period|Lack of Efficacy|0|||
130254124|NCT03715829|468894050|FG009|Dose Ranging Period|Lack of Efficacy|0|||
130254125|NCT03715829|468894051|FG010|Dose Ranging Period|Lack of Efficacy|0|||
130254126|NCT03715829|468894041|FG000|Dose Ranging Period|Lost to Follow-up|2|||
130254127|NCT03715829|468894042|FG001|Dose Ranging Period|Lost to Follow-up|0|||
130254128|NCT03715829|468894043|FG002|Dose Ranging Period|Lost to Follow-up|1|||
130254129|NCT03715829|468894044|FG003|Dose Ranging Period|Lost to Follow-up|1|||
130254130|NCT03715829|468894045|FG004|Dose Ranging Period|Lost to Follow-up|1|||
130254131|NCT03715829|468894046|FG005|Dose Ranging Period|Lost to Follow-up|2|||
130254132|NCT03715829|468894047|FG006|Dose Ranging Period|Lost to Follow-up|0|||
130254133|NCT03715829|468894048|FG007|Dose Ranging Period|Lost to Follow-up|0|||
130254134|NCT03715829|468894049|FG008|Dose Ranging Period|Lost to Follow-up|0|||
130254135|NCT03715829|468894050|FG009|Dose Ranging Period|Lost to Follow-up|0|||
130254136|NCT03715829|468894051|FG010|Dose Ranging Period|Lost to Follow-up|0|||
130031923|NCT02764541|468072705|FG003|Overall Study|Protocol Violation|1|||
130031924|NCT02764541|468072706|FG004|Overall Study|Protocol Violation|0|||
130031925|NCT02764541|468072707|FG005|Overall Study|Protocol Violation|1|||
130031926|NCT02764541|468072708|FG006|Overall Study|Protocol Violation|0|||
130031927|NCT02764541|468072709|FG007|Overall Study|Protocol Violation|0|||
130031928|NCT02764541|468072702|FG000|Overall Study|Physician Decision|0|||
130031929|NCT02764541|468072703|FG001|Overall Study|Physician Decision|0|||
130031930|NCT02764541|468072704|FG002|Overall Study|Physician Decision|0|||
130031931|NCT02764541|468072705|FG003|Overall Study|Physician Decision|1|||
130031932|NCT02764541|468072706|FG004|Overall Study|Physician Decision|0|||
130031933|NCT02764541|468072707|FG005|Overall Study|Physician Decision|0|||
130031934|NCT02764541|468072708|FG006|Overall Study|Physician Decision|0|||
130031935|NCT02764541|468072709|FG007|Overall Study|Physician Decision|1|||
130031936|NCT02764541|468072702|FG000|Overall Study|Three Cycles completed before surgery|0|||
130031937|NCT02764541|468072703|FG001|Overall Study|Three Cycles completed before surgery|0|||
130031938|NCT02764541|468072704|FG002|Overall Study|Three Cycles completed before surgery|0|||
130254137|NCT03715829|468894041|FG000|Dose Ranging Period|Protocol Violation|0|||
130254138|NCT03715829|468894042|FG001|Dose Ranging Period|Protocol Violation|0|||
130254139|NCT03715829|468894043|FG002|Dose Ranging Period|Protocol Violation|0|||
130254140|NCT03715829|468894044|FG003|Dose Ranging Period|Protocol Violation|1|||
130254141|NCT03715829|468894045|FG004|Dose Ranging Period|Protocol Violation|0|||
130254142|NCT03715829|468894046|FG005|Dose Ranging Period|Protocol Violation|0|||
130254143|NCT03715829|468894047|FG006|Dose Ranging Period|Protocol Violation|0|||
130254144|NCT03715829|468894048|FG007|Dose Ranging Period|Protocol Violation|0|||
130254145|NCT03715829|468894049|FG008|Dose Ranging Period|Protocol Violation|0|||
130254146|NCT03715829|468894050|FG009|Dose Ranging Period|Protocol Violation|0|||
130254147|NCT03715829|468894051|FG010|Dose Ranging Period|Protocol Violation|0|||
130254148|NCT03715829|468894041|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
130254149|NCT03715829|468894042|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
130254150|NCT03715829|468894043|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
130254151|NCT03715829|468894044|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
130254152|NCT03715829|468894045|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
130254153|NCT03715829|468894046|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
130254154|NCT03715829|468894047|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
130254155|NCT03715829|468894048|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
130254156|NCT03715829|468894049|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
130254157|NCT03715829|468894050|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
130254158|NCT03715829|468894051|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
130254159|NCT03715829|468894041|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254160|NCT03715829|468894042|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254161|NCT03715829|468894043|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
130254162|NCT03715829|468894044|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254163|NCT03715829|468894045|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254164|NCT03715829|468894046|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254165|NCT03715829|468894047|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254166|NCT03715829|468894048|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254167|NCT03715829|468894049|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254168|NCT03715829|468894050|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254169|NCT03715829|468894051|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
130254170|NCT03715829|468894041|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254171|NCT03715829|468894042|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254172|NCT03715829|468894043|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
130254173|NCT03715829|468894044|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254174|NCT03715829|468894045|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
130254175|NCT03715829|468894046|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254176|NCT03715829|468894047|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254177|NCT03715829|468894048|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254178|NCT03715829|468894049|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254179|NCT03715829|468894050|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130031939|NCT02764541|468072705|FG003|Overall Study|Three Cycles completed before surgery|1|||
130031940|NCT02764541|468072706|FG004|Overall Study|Three Cycles completed before surgery|0|||
130031941|NCT02764541|468072707|FG005|Overall Study|Three Cycles completed before surgery|0|||
130031942|NCT02764541|468072708|FG006|Overall Study|Three Cycles completed before surgery|0|||
130031943|NCT02764541|468072709|FG007|Overall Study|Three Cycles completed before surgery|0|||
130031944|NCT02764541|468072702|FG000|Overall Study|Patient Compliance|0|||
130031945|NCT02764541|468072703|FG001|Overall Study|Patient Compliance|0|||
130031946|NCT02764541|468072704|FG002|Overall Study|Patient Compliance|1|||
130031947|NCT02764541|468072705|FG003|Overall Study|Patient Compliance|0|||
130031948|NCT02764541|468072706|FG004|Overall Study|Patient Compliance|0|||
130031949|NCT02764541|468072707|FG005|Overall Study|Patient Compliance|0|||
130031950|NCT02764541|468072708|FG006|Overall Study|Patient Compliance|0|||
130254180|NCT03715829|468894051|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
130254181|NCT03715829|468894041|FG000|Dose Ranging Period|Other|0|||
130254182|NCT03715829|468894042|FG001|Dose Ranging Period|Other|0|||
130254183|NCT03715829|468894043|FG002|Dose Ranging Period|Other|2|||
130254184|NCT03715829|468894044|FG003|Dose Ranging Period|Other|0|||
130254185|NCT03715829|468894045|FG004|Dose Ranging Period|Other|0|||
130254186|NCT03715829|468894046|FG005|Dose Ranging Period|Other|3|||
130254187|NCT03715829|468894047|FG006|Dose Ranging Period|Other|0|||
130254188|NCT03715829|468894048|FG007|Dose Ranging Period|Other|0|||
130254189|NCT03715829|468894049|FG008|Dose Ranging Period|Other|0|||
130254190|NCT03715829|468894050|FG009|Dose Ranging Period|Other|0|||
130254191|NCT03715829|468894051|FG010|Dose Ranging Period|Other|0|||
130254192|NCT03715829|468894041|FG000|Extension Period|Adverse Event|0|||
130254193|NCT03715829|468894042|FG001|Extension Period|Adverse Event|0|||
130254194|NCT03715829|468894043|FG002|Extension Period|Adverse Event|0|||
130254195|NCT03715829|468894044|FG003|Extension Period|Adverse Event|0|||
130254196|NCT03715829|468894045|FG004|Extension Period|Adverse Event|0|||
130254197|NCT03715829|468894046|FG005|Extension Period|Adverse Event|0|||
130254198|NCT03715829|468894047|FG006|Extension Period|Adverse Event|3|||
130254199|NCT03715829|468894048|FG007|Extension Period|Adverse Event|1|||
130254200|NCT03715829|468894049|FG008|Extension Period|Adverse Event|6|||
130254201|NCT03715829|468894050|FG009|Extension Period|Adverse Event|0|||
130254202|NCT03715829|468894051|FG010|Extension Period|Adverse Event|0|||
130254203|NCT03715829|468894041|FG000|Extension Period|Lack of Efficacy|0|||
130254204|NCT03715829|468894042|FG001|Extension Period|Lack of Efficacy|0|||
130254205|NCT03715829|468894043|FG002|Extension Period|Lack of Efficacy|0|||
130254206|NCT03715829|468894044|FG003|Extension Period|Lack of Efficacy|0|||
130254207|NCT03715829|468894045|FG004|Extension Period|Lack of Efficacy|0|||
130254208|NCT03715829|468894046|FG005|Extension Period|Lack of Efficacy|0|||
130254209|NCT03715829|468894047|FG006|Extension Period|Lack of Efficacy|1|||
130254210|NCT03715829|468894048|FG007|Extension Period|Lack of Efficacy|9|||
130254211|NCT03715829|468894049|FG008|Extension Period|Lack of Efficacy|2|||
130254212|NCT03715829|468894050|FG009|Extension Period|Lack of Efficacy|0|||
130254213|NCT03715829|468894051|FG010|Extension Period|Lack of Efficacy|0|||
130254214|NCT03715829|468894041|FG000|Extension Period|Lost to Follow-up|0|||
130254215|NCT03715829|468894042|FG001|Extension Period|Lost to Follow-up|0|||
130254216|NCT03715829|468894043|FG002|Extension Period|Lost to Follow-up|0|||
130254217|NCT03715829|468894044|FG003|Extension Period|Lost to Follow-up|0|||
130254218|NCT03715829|468894045|FG004|Extension Period|Lost to Follow-up|0|||
130254219|NCT03715829|468894046|FG005|Extension Period|Lost to Follow-up|0|||
130254220|NCT03715829|468894047|FG006|Extension Period|Lost to Follow-up|0|||
130254221|NCT03715829|468894048|FG007|Extension Period|Lost to Follow-up|0|||
130254222|NCT03715829|468894049|FG008|Extension Period|Lost to Follow-up|2|||
130254223|NCT03715829|468894050|FG009|Extension Period|Lost to Follow-up|0|||
130254224|NCT03715829|468894051|FG010|Extension Period|Lost to Follow-up|0|||
130254225|NCT03715829|468894041|FG000|Extension Period|Protocol Violation|0|||
130254226|NCT03715829|468894042|FG001|Extension Period|Protocol Violation|0|||
130254227|NCT03715829|468894043|FG002|Extension Period|Protocol Violation|0|||
130254228|NCT03715829|468894044|FG003|Extension Period|Protocol Violation|0|||
130254229|NCT03715829|468894045|FG004|Extension Period|Protocol Violation|0|||
130254230|NCT03715829|468894046|FG005|Extension Period|Protocol Violation|0|||
130254231|NCT03715829|468894047|FG006|Extension Period|Protocol Violation|0|||
130254232|NCT03715829|468894048|FG007|Extension Period|Protocol Violation|0|||
130254233|NCT03715829|468894049|FG008|Extension Period|Protocol Violation|1|||
130254234|NCT03715829|468894050|FG009|Extension Period|Protocol Violation|0|||
130254235|NCT03715829|468894051|FG010|Extension Period|Protocol Violation|0|||
130254236|NCT03715829|468894041|FG000|Extension Period|Withdrawal by Subject|0|||
130254237|NCT03715829|468894042|FG001|Extension Period|Withdrawal by Subject|0|||
130254238|NCT03715829|468894043|FG002|Extension Period|Withdrawal by Subject|0|||
130254239|NCT03715829|468894044|FG003|Extension Period|Withdrawal by Subject|0|||
130254240|NCT03715829|468894045|FG004|Extension Period|Withdrawal by Subject|0|||
130254241|NCT03715829|468894046|FG005|Extension Period|Withdrawal by Subject|0|||
130254242|NCT03715829|468894047|FG006|Extension Period|Withdrawal by Subject|3|||
130254243|NCT03715829|468894048|FG007|Extension Period|Withdrawal by Subject|3|||
130254244|NCT03715829|468894049|FG008|Extension Period|Withdrawal by Subject|12|||
130254245|NCT03715829|468894050|FG009|Extension Period|Withdrawal by Subject|3|||
130254246|NCT03715829|468894051|FG010|Extension Period|Withdrawal by Subject|0|||
130254247|NCT03715829|468894041|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254248|NCT03715829|468894042|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254249|NCT03715829|468894043|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254250|NCT03715829|468894044|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254251|NCT03715829|468894045|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254252|NCT03715829|468894046|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254253|NCT03715829|468894047|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254254|NCT03715829|468894048|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
130254255|NCT03715829|468894049|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
130254256|NCT03715829|468894050|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254257|NCT03715829|468894051|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
130254258|NCT03715829|468894041|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254259|NCT03715829|468894042|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254260|NCT03715829|468894043|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254261|NCT03715829|468894044|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254262|NCT03715829|468894045|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254263|NCT03715829|468894046|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254264|NCT03715829|468894047|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254265|NCT03715829|468894048|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254266|NCT03715829|468894049|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
130254267|NCT03715829|468894050|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254268|NCT03715829|468894051|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
130254269|NCT03715829|468894041|FG000|Extension Period|Other|0|||
130254270|NCT03715829|468894042|FG001|Extension Period|Other|0|||
130254271|NCT03715829|468894043|FG002|Extension Period|Other|0|||
130254272|NCT03715829|468894044|FG003|Extension Period|Other|0|||
130254273|NCT03715829|468894045|FG004|Extension Period|Other|0|||
130254274|NCT03715829|468894046|FG005|Extension Period|Other|0|||
130254275|NCT03715829|468894047|FG006|Extension Period|Other|1|||
130254276|NCT03715829|468894048|FG007|Extension Period|Other|2|||
130254277|NCT03715829|468894049|FG008|Extension Period|Other|4|||
130254278|NCT03715829|468894050|FG009|Extension Period|Other|0|||
130254279|NCT03715829|468894051|FG010|Extension Period|Other|0|||
130254280|NCT03579719|468894052|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
130254281|NCT00855166|468894053|FG000|Overall Study|Adverse Event|0|||
130254282|NCT00855166|468894054|FG001|Overall Study|Adverse Event|2|||
130254283|NCT00855166|468894053|FG000|Overall Study|Death|0|||
130254284|NCT00855166|468894054|FG001|Overall Study|Death|1|||
130254285|NCT00855166|468894053|FG000|Overall Study|Withdrawal by Subject|1|||
130254286|NCT00855166|468894054|FG001|Overall Study|Withdrawal by Subject|4|||
130254287|NCT00855166|468894053|FG000|Overall Study|Poor/non-compliance|2|||
130254288|NCT00855166|468894054|FG001|Overall Study|Poor/non-compliance|0|||
130254289|NCT00855166|468894053|FG000|Overall Study|Administrative reasons by sponsor|1|||
130254290|NCT00855166|468894054|FG001|Overall Study|Administrative reasons by sponsor|0|||
130254291|NCT00855166|468894053|FG000|Overall Study|Subject no longer meets study criteria|1|||
130254292|NCT00855166|468894054|FG001|Overall Study|Subject no longer meets study criteria|1|||
130254293|NCT01422382|468894055|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
130254294|NCT04818229|468894058|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
130254295|NCT04818229|468894059|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
130254296|NCT04818229|468894060|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
130254297|NCT04818229|468894058|FG000|Overall Study|Adverse Event|3|||
130254298|NCT04818229|468894059|FG001|Overall Study|Adverse Event|1|||
130254299|NCT04818229|468894060|FG002|Overall Study|Adverse Event|1|||
130254300|NCT04818229|468894058|FG000|Overall Study|Withdrawal by Subject|0|||
130254301|NCT04818229|468894059|FG001|Overall Study|Withdrawal by Subject|0|||
130254302|NCT04818229|468894060|FG002|Overall Study|Withdrawal by Subject|2|||
130254303|NCT04818229|468894058|FG000|Overall Study|Lost to Follow-up|0|||
130254304|NCT04818229|468894059|FG001|Overall Study|Lost to Follow-up|0|||
130254305|NCT04818229|468894060|FG002|Overall Study|Lost to Follow-up|1|||
130254306|NCT04082364|468894061|FG000|Overall Study|Death|23|||
130254307|NCT04082364|468894062|FG001|Overall Study|Death|1|||
130254308|NCT04082364|468894063|FG002|Overall Study|Death|1|||
130254309|NCT04082364|468894064|FG003|Overall Study|Death|2|||
130254310|NCT04082364|468894065|FG004|Overall Study|Death|1|||
130254311|NCT04082364|468894061|FG000|Overall Study|Lost to Follow-up|1|||
130254312|NCT04082364|468894062|FG001|Overall Study|Lost to Follow-up|0|||
130254313|NCT04082364|468894063|FG002|Overall Study|Lost to Follow-up|0|||
130254314|NCT04082364|468894064|FG003|Overall Study|Lost to Follow-up|0|||
130254315|NCT04082364|468894065|FG004|Overall Study|Lost to Follow-up|1|||
130254316|NCT04082364|468894061|FG000|Overall Study|Physician Decision|1|||
130254317|NCT04082364|468894062|FG001|Overall Study|Physician Decision|1|||
130254318|NCT04082364|468894063|FG002|Overall Study|Physician Decision|0|||
130254319|NCT04082364|468894064|FG003|Overall Study|Physician Decision|2|||
130254320|NCT04082364|468894065|FG004|Overall Study|Physician Decision|1|||
130254321|NCT04082364|468894061|FG000|Overall Study|Withdrawal by Subject|1|||
130254322|NCT04082364|468894062|FG001|Overall Study|Withdrawal by Subject|1|||
130254323|NCT04082364|468894063|FG002|Overall Study|Withdrawal by Subject|0|||
130254324|NCT04082364|468894064|FG003|Overall Study|Withdrawal by Subject|0|||
130254325|NCT04082364|468894065|FG004|Overall Study|Withdrawal by Subject|1|||
130254326|NCT04082364|468894061|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
130254327|NCT04082364|468894062|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
130031951|NCT02764541|468072709|FG007|Overall Study|Patient Compliance|0|||
130254328|NCT04082364|468894063|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
130254329|NCT04082364|468894064|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
130254330|NCT04082364|468894065|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
130254331|NCT04082364|468894061|FG000|Overall Study|Disease progression|0|||
130254332|NCT04082364|468894062|FG001|Overall Study|Disease progression|0|||
130254333|NCT04082364|468894063|FG002|Overall Study|Disease progression|0|||
130254334|NCT04082364|468894064|FG003|Overall Study|Disease progression|1|||
130254335|NCT04082364|468894065|FG004|Overall Study|Disease progression|0|||
130254336|NCT03186378|468894066|FG000|Overall Study|Lost to Follow-up|1|||
130254337|NCT03186378|468894067|FG001|Overall Study|Lost to Follow-up|0|||
130254338|NCT02181413|468894068|FG000|Overall Study|Withdrawal by Subject|45|||
130254339|NCT02181413|468894069|FG001|Overall Study|Withdrawal by Subject|61|||
130254340|NCT02181413|468894068|FG000|Overall Study|Reason Not Specified|2|||
130254341|NCT02181413|468894069|FG001|Overall Study|Reason Not Specified|5|||
130254342|NCT02181413|468894068|FG000|Overall Study|Lost to Follow-up|8|||
130254343|NCT02181413|468894069|FG001|Overall Study|Lost to Follow-up|7|||
130254344|NCT02514746|468894070|FG000|Overall Study|Chronically Ill|1|||
130254345|NCT02514746|468894071|FG001|Overall Study|Chronically Ill|2|||
130254346|NCT02514746|468894070|FG000|Overall Study|Physician Decision|4|||
130254347|NCT02514746|468894071|FG001|Overall Study|Physician Decision|2|||
130254348|NCT02514746|468894070|FG000|Overall Study|Withdrawal by Subject|12|||
130254349|NCT02514746|468894071|FG001|Overall Study|Withdrawal by Subject|10|||
130254350|NCT02514746|468894070|FG000|Overall Study|Other|5|||
130254351|NCT02514746|468894071|FG001|Overall Study|Other|1|||
130254352|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
130254353|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254354|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254355|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254356|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
130254357|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254358|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254359|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
130254360|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254361|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254362|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254363|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
130254364|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
130254365|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254366|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254367|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
130254368|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254369|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254370|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254371|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254372|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
130254373|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254374|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
130254375|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
130254376|NCT03973489|468894080|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
130254377|NCT03973489|468894081|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254378|NCT03973489|468894082|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254379|NCT03973489|468894083|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
130254380|NCT03973489|468894084|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254381|NCT03973489|468894085|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254382|NCT03973489|468894086|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254383|NCT03973489|468894087|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
130254384|NCT03973489|468894080|FG000|Second Intervention (1 Day)|Adverse Event|0|||
130254385|NCT03973489|468894081|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130254386|NCT03973489|468894082|FG002|Second Intervention (1 Day)|Adverse Event|0|||
130254387|NCT03973489|468894083|FG003|Second Intervention (1 Day)|Adverse Event|1|||
130254388|NCT03973489|468894084|FG004|Second Intervention (1 Day)|Adverse Event|0|||
130254389|NCT03973489|468894085|FG005|Second Intervention (1 Day)|Adverse Event|0|||
130254390|NCT03973489|468894086|FG006|Second Intervention (1 Day)|Adverse Event|0|||
130254391|NCT03973489|468894087|FG007|Second Intervention (1 Day)|Adverse Event|0|||
130031952|NCT02764541|468072702|FG000|Overall Study|Death|0|||
130031953|NCT02764541|468072703|FG001|Overall Study|Death|0|||
129885108|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
129885109|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
130031954|NCT02764541|468072704|FG002|Overall Study|Death|0|||
130031955|NCT02764541|468072705|FG003|Overall Study|Death|0|||
129885110|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Other|0|||
129885111|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Other|0|||
130101215|NCT03917654|468327324|FG011|Year 2|Lost to Follow-up|1|||
130254392|NCT03301415|468894088|FG000|Overall Study|Lost to Follow-up|2|||
130254393|NCT03301415|468894088|FG000|Overall Study|Unable to comply with visit schedule|2|||
130254394|NCT03247673|468894089|FG000|Overall Study|Withdrawal by Subject|1|||
130254395|NCT03247673|468894090|FG001|Overall Study|Withdrawal by Subject|0|||
130254396|NCT03247673|468894091|FG002|Overall Study|Withdrawal by Subject|3|||
130254397|NCT03247673|468894089|FG000|Overall Study|Lost to Follow-up|0|||
130254398|NCT03247673|468894090|FG001|Overall Study|Lost to Follow-up|0|||
130254399|NCT03247673|468894091|FG002|Overall Study|Lost to Follow-up|1|||
130254400|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
130254401|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254402|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254403|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254404|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130254405|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
130254406|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254407|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254408|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254409|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130254410|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
130254411|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254412|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254413|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254414|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130254415|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
130254416|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254417|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254418|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254419|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
130254420|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
130254421|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254422|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254423|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254424|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
130254425|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
130254426|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254427|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254428|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254429|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
130254430|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
130254431|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254432|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254433|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254434|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130254435|NCT01111552|468894092|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
130254436|NCT01111552|468894093|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254437|NCT01111552|468894094|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254438|NCT01111552|468894095|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254439|NCT01111552|468894096|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
130254440|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254441|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254442|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254443|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
130254444|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130254445|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130254446|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130254447|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
130254448|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
130254449|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130254450|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254451|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
130101216|NCT03917654|468327313|FG000|Year 2|Adverse Event|0|||
130101217|NCT03917654|468327314|FG001|Year 2|Adverse Event|0|||
130101218|NCT03917654|468327315|FG002|Year 2|Adverse Event|0|||
129885112|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Other|0|||
130254452|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254453|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254454|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
130254455|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254456|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
130254457|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254458|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254459|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
130254460|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254461|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
130254462|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254463|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254464|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
130254465|NCT01111552|468894092|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254466|NCT01111552|468894093|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254467|NCT01111552|468894094|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
130254468|NCT01111552|468894095|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254469|NCT01111552|468894096|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130254470|NCT04129398|468895746|FG000|Overall Study|Physician Decision|2|||
130254471|NCT02363283|468895751|FG000|Overall Study|Withdrawal by Subject|1|||
130254472|NCT02363283|468895751|FG000|Overall Study|Not eligible due to transaminitis|1|||
130254473|NCT00003907|468895761|FG000|Overall Study|Adverse Event|2|||
130254474|NCT00003907|468895762|FG001|Overall Study|Adverse Event|11|||
130254475|NCT00003907|468895761|FG000|Overall Study|Death|2|||
130254476|NCT00003907|468895762|FG001|Overall Study|Death|0|||
130254477|NCT00003907|468895761|FG000|Overall Study|Withdrawal by Subject|1|||
130254478|NCT00003907|468895762|FG001|Overall Study|Withdrawal by Subject|3|||
130254479|NCT00003907|468895761|FG000|Overall Study|Progressive disease|4|||
130254480|NCT00003907|468895762|FG001|Overall Study|Progressive disease|4|||
130254481|NCT00003907|468895761|FG000|Overall Study|Complicating disease|1|||
130254482|NCT00003907|468895762|FG001|Overall Study|Complicating disease|0|||
130254483|NCT00003907|468895761|FG000|Overall Study|Other|1|||
130254484|NCT00003907|468895762|FG001|Overall Study|Other|3|||
130254485|NCT00003907|468895761|FG000|Overall Study|ineligible or not treated|2|||
130254486|NCT00003907|468895762|FG001|Overall Study|ineligible or not treated|2|||
130254487|NCT01517178|468895763|FG000|Period 1|Adverse Event|1|||
130254488|NCT01517178|468895764|FG001|Period 1|Adverse Event|2|||
130254489|NCT01517178|468895763|FG000|Period 1|Lack of Efficacy|0|||
130254490|NCT01517178|468895764|FG001|Period 1|Lack of Efficacy|1|||
130254491|NCT01517178|468895763|FG000|Period 1|E.g. study termination|3|||
130254492|NCT01517178|468895764|FG001|Period 1|E.g. study termination|1|||
130254493|NCT01517178|468895763|FG000|Period 1|Withdrawal by Subject|0|||
130254494|NCT01517178|468895764|FG001|Period 1|Withdrawal by Subject|1|||
130254495|NCT01517178|468895763|FG000|Period 2|Adverse Event|1|||
130254496|NCT01517178|468895764|FG001|Period 2|Adverse Event|0|||
130254497|NCT01517178|468895763|FG000|Period 2|Withdrawal by Subject|3|||
130254498|NCT01517178|468895764|FG001|Period 2|Withdrawal by Subject|0|||
130254499|NCT01517178|468895763|FG000|Period 2|E.g. study termination|2|||
130254500|NCT01517178|468895764|FG001|Period 2|E.g. study termination|2|||
130254501|NCT01557569|468895767|FG000|Overall Study|Adverse Event|2|||
130254502|NCT01557569|468895768|FG001|Overall Study|Adverse Event|0|||
130031956|NCT02764541|468072706|FG004|Overall Study|Death|0|||
130031957|NCT02764541|468072707|FG005|Overall Study|Death|0|||
130031958|NCT02764541|468072708|FG006|Overall Study|Death|1|||
130254503|NCT01557569|468895767|FG000|Overall Study|high blood pressure|0|||
130254504|NCT01557569|468895768|FG001|Overall Study|high blood pressure|1|||
130254505|NCT01557569|468895767|FG000|Overall Study|Withdrawal by Subject|3|||
130254506|NCT01557569|468895768|FG001|Overall Study|Withdrawal by Subject|5|||
130254507|NCT01557569|468895767|FG000|Overall Study|noncompliance with rules of residential|0|||
130254508|NCT01557569|468895768|FG001|Overall Study|noncompliance with rules of residential|1|||
130254509|NCT04691115|468895774|FG000|Overall Study|Withdrawal by Subject|0|||
130254510|NCT04691115|468895775|FG001|Overall Study|Withdrawal by Subject|0|||
130254511|NCT04691115|468895776|FG002|Overall Study|Withdrawal by Subject|0|||
130254512|NCT04691115|468895777|FG003|Overall Study|Withdrawal by Subject|0|||
130254513|NCT04691115|468895778|FG004|Overall Study|Withdrawal by Subject|0|||
130254514|NCT04691115|468895779|FG005|Overall Study|Withdrawal by Subject|1|||
130254515|NCT04691115|468895780|FG006|Overall Study|Withdrawal by Subject|0|||
130254516|NCT04691115|468895781|FG007|Overall Study|Withdrawal by Subject|0|||
130254517|NCT04691115|468895782|FG008|Overall Study|Withdrawal by Subject|0|||
130254518|NCT04691115|468895783|FG009|Overall Study|Withdrawal by Subject|0|||
130254519|NCT04691115|468895784|FG010|Overall Study|Withdrawal by Subject|0|||
130254520|NCT04691115|468895785|FG011|Overall Study|Withdrawal by Subject|0|||
130254521|NCT04691115|468895786|FG012|Overall Study|Withdrawal by Subject|0|||
130031959|NCT02764541|468072709|FG007|Overall Study|Death|0|||
130254522|NCT04691115|468895787|FG013|Overall Study|Withdrawal by Subject|0|||
130254523|NCT04661839|468895792|FG000|Overall Study|Not Treated|0|||
130254524|NCT04661839|468895793|FG001|Overall Study|Not Treated|0|||
130254525|NCT04661839|468895794|FG002|Overall Study|Not Treated|1|||
130254526|NCT04661839|468895795|FG003|Overall Study|Not Treated|0|||
130254527|NCT04661839|468895792|FG000|Overall Study|Lost to Follow-up|1|||
130254528|NCT04661839|468895793|FG001|Overall Study|Lost to Follow-up|0|||
130254529|NCT04661839|468895794|FG002|Overall Study|Lost to Follow-up|0|||
130254530|NCT04661839|468895795|FG003|Overall Study|Lost to Follow-up|1|||
130254531|NCT03647137|468895796|FG000|Overall Study|Scan Limitation|2|||
130254532|NCT03647137|468895797|FG001|Overall Study|Scan Limitation|1|||
130254533|NCT03647137|468895798|FG002|Overall Study|Scan Limitation|1|||
130254534|NCT03647137|468895799|FG003|Overall Study|Scan Limitation|2|||
130254535|NCT03253627|468895802|FG000|Overall Study|Lost to Follow-up|1|||
130254536|NCT03253627|468895803|FG001|Overall Study|Lost to Follow-up|2|||
130254537|NCT03253627|468895802|FG000|Overall Study|Withdrawal by Subject|0|||
130254538|NCT03253627|468895803|FG001|Overall Study|Withdrawal by Subject|2|||
130254539|NCT03253627|468895802|FG000|Overall Study|Inability to complete MRI|1|||
130254540|NCT03253627|468895803|FG001|Overall Study|Inability to complete MRI|0|||
130254541|NCT03829683|468895806|FG000|Overall Study|Lost to Follow-up|1|||
130254542|NCT03829683|468895807|FG001|Overall Study|Lost to Follow-up|0|||
130254543|NCT03829683|468895806|FG000|Overall Study|Physician Decision|3|||
130254544|NCT03829683|468895807|FG001|Overall Study|Physician Decision|1|||
130254545|NCT03829683|468895806|FG000|Overall Study|Withdrawal by Subject|0|||
130254546|NCT03829683|468895807|FG001|Overall Study|Withdrawal by Subject|1|||
130254547|NCT03829683|468895806|FG000|Overall Study|Discharge from hospital|1|||
130254548|NCT03829683|468895807|FG001|Overall Study|Discharge from hospital|0|||
130254549|NCT01922895|468895811|FG000|Overall Study|Death|0|||
130254550|NCT01922895|468895812|FG001|Overall Study|Death|1|||
130254551|NCT01922895|468895811|FG000|Overall Study|Withdrawal by Subject|1|||
130254552|NCT01922895|468895812|FG001|Overall Study|Withdrawal by Subject|2|||
130254553|NCT01922895|468895811|FG000|Overall Study|Lost to Follow-up|5|||
130254554|NCT01922895|468895812|FG001|Overall Study|Lost to Follow-up|11|||
130254555|NCT01916226|468895813|FG000|Overall Study|Adverse Event|1|||
130254556|NCT01916226|468895814|FG001|Overall Study|Adverse Event|0|||
130254557|NCT01916226|468895815|FG002|Overall Study|Adverse Event|1|||
130254558|NCT01916226|468895816|FG003|Overall Study|Adverse Event|1|||
130254559|NCT01916226|468895813|FG000|Overall Study|Lack of Efficacy|0|||
130254560|NCT01916226|468895814|FG001|Overall Study|Lack of Efficacy|0|||
130254561|NCT01916226|468895815|FG002|Overall Study|Lack of Efficacy|2|||
130254562|NCT01916226|468895816|FG003|Overall Study|Lack of Efficacy|1|||
130254563|NCT01916226|468895813|FG000|Overall Study|Protocol Violation|0|||
130254564|NCT01916226|468895814|FG001|Overall Study|Protocol Violation|1|||
130254565|NCT01916226|468895815|FG002|Overall Study|Protocol Violation|0|||
130254566|NCT01916226|468895816|FG003|Overall Study|Protocol Violation|1|||
130254567|NCT01916226|468895813|FG000|Overall Study|Physician Decision|0|||
130254568|NCT01916226|468895814|FG001|Overall Study|Physician Decision|0|||
130254569|NCT01916226|468895815|FG002|Overall Study|Physician Decision|0|||
130254570|NCT01916226|468895816|FG003|Overall Study|Physician Decision|1|||
130254571|NCT03163667|468895817|FG000|Overall Study|Death|15|||
130254572|NCT03163667|468895818|FG001|Overall Study|Death|27|||
130254573|NCT03163667|468895817|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
130254574|NCT03163667|468895818|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
130254575|NCT05430919|468895819|FG000|Overall Study|Protocol Violation|0|||
130254576|NCT05430919|468895820|FG001|Overall Study|Protocol Violation|0|||
130254577|NCT05430919|468895821|FG002|Overall Study|Protocol Violation|1|||
130254578|NCT05430919|468895822|FG003|Overall Study|Protocol Violation|0|||
130254579|NCT05430919|468895819|FG000|Overall Study|Lost to Follow-up|0|||
130254580|NCT05430919|468895820|FG001|Overall Study|Lost to Follow-up|1|||
130254581|NCT05430919|468895821|FG002|Overall Study|Lost to Follow-up|0|||
130031960|NCT02764541|468072702|FG000|Overall Study|Insurance reasons|0|||
130254582|NCT05430919|468895822|FG003|Overall Study|Lost to Follow-up|0|||
130254583|NCT05430919|468895819|FG000|Overall Study|Withdrawal by Subject|3|||
130254584|NCT05430919|468895820|FG001|Overall Study|Withdrawal by Subject|0|||
130031961|NCT02764541|468072703|FG001|Overall Study|Insurance reasons|0|||
130254585|NCT05430919|468895821|FG002|Overall Study|Withdrawal by Subject|0|||
130254586|NCT05430919|468895822|FG003|Overall Study|Withdrawal by Subject|1|||
130254587|NCT01848457|468895825|FG000|Overall Study|Death|1|||
130031962|NCT02764541|468072704|FG002|Overall Study|Insurance reasons|0|||
130254588|NCT01848457|468895826|FG001|Overall Study|Death|0|||
130254589|NCT01848457|468895827|FG002|Overall Study|Death|0|||
130254590|NCT01848457|468895828|FG003|Overall Study|Death|0|||
130254591|NCT02940223|468895831|FG000|Overall Study|Failed Requirement|2|||
130254592|NCT02940223|468895832|FG001|Overall Study|Failed Requirement|0|||
130254593|NCT01813357|468895835|FG000|Overall Study|Lost to Follow-up|5|||
130254594|NCT01813357|468895836|FG001|Overall Study|Lost to Follow-up|6|||
130254595|NCT03773562|468895837|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
130254596|NCT03773562|468895837|FG000|Overall Study|Lost to Follow-up|10|||
130254597|NCT03773562|468895837|FG000|Overall Study|Withdrawal by Subject|1|||
130254598|NCT03131479|468895838|FG000|Overall Study|Adverse Event|0|||
130254599|NCT03131479|468895839|FG001|Overall Study|Adverse Event|0|||
130254600|NCT03131479|468895840|FG002|Overall Study|Adverse Event|1|||
130254601|NCT03131479|468895841|FG003|Overall Study|Adverse Event|1|||
130254602|NCT03131479|468895842|FG004|Overall Study|Adverse Event|0|||
130254603|NCT03131479|468895838|FG000|Overall Study|Subject/Guardian Decision|0|||
130254604|NCT03131479|468895839|FG001|Overall Study|Subject/Guardian Decision|0|||
130254605|NCT03131479|468895840|FG002|Overall Study|Subject/Guardian Decision|0|||
130254606|NCT03131479|468895841|FG003|Overall Study|Subject/Guardian Decision|1|||
130254607|NCT03131479|468895842|FG004|Overall Study|Subject/Guardian Decision|0|||
130254608|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
130254609|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
130254610|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
130254611|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
130254612|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
130254613|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
130254614|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
130254615|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
130254616|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
130254617|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
130254618|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
130254619|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
130254620|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
130254621|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
130254622|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
130254623|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
130254624|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
130254625|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
130254626|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
130254627|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
130254628|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
130254629|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
130254630|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
130254631|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
130254632|NCT01272219|468895843|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
130254633|NCT01272219|468895844|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
130254634|NCT01272219|468895845|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
130254635|NCT01272219|468895846|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
130254636|NCT01272219|468895847|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
130254637|NCT01272219|468895848|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
130254638|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130254639|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
130254640|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
130254641|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
130254642|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130254643|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
130254644|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254645|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254646|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254647|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
130254648|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254649|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
130254650|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254651|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
130254652|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254653|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
130254654|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254655|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
130254656|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130254657|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
130254658|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
130254659|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
130254660|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130254661|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
130254662|NCT01272219|468895843|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130254663|NCT01272219|468895844|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
130254664|NCT01272219|468895845|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
130254665|NCT01272219|468895846|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
130254666|NCT01272219|468895847|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130254667|NCT01272219|468895848|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
130254668|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254669|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254670|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254671|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
130254672|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
130254673|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
130254674|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254675|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254676|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254677|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
130254678|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
130254679|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
130254680|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254681|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254682|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254683|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
130254684|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
130254685|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
130254686|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254687|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254688|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254689|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
130254690|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
130254691|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
130254692|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
130254693|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
130254694|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
130254695|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
130254696|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
130254697|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
130254698|NCT01272219|468895843|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
130254699|NCT01272219|468895844|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
130254700|NCT01272219|468895845|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
130254701|NCT01272219|468895846|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
130254702|NCT01272219|468895847|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
130254703|NCT01272219|468895848|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
130254704|NCT00050011|468895850|FG000|Overall Study|Adverse Event|41|||
130254705|NCT00050011|468895851|FG001|Overall Study|Adverse Event|46|||
130254706|NCT00050011|468895850|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130254707|NCT00050011|468895851|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130254708|NCT00050011|468895850|FG000|Overall Study|Abnormal test procedure results|0|||
130254709|NCT00050011|468895851|FG001|Overall Study|Abnormal test procedure results|1|||
130254710|NCT00050011|468895850|FG000|Overall Study|Lack of Efficacy|16|||
130254711|NCT00050011|468895851|FG001|Overall Study|Lack of Efficacy|21|||
130254712|NCT00050011|468895850|FG000|Overall Study|Participant condition no longer required|1|||
130254713|NCT00050011|468895851|FG001|Overall Study|Participant condition no longer required|0|||
130254714|NCT00050011|468895850|FG000|Overall Study|Protocol Violation|4|||
130254715|NCT00050011|468895851|FG001|Overall Study|Protocol Violation|10|||
130254716|NCT00050011|468895850|FG000|Overall Study|Withdrawal by Subject|34|||
130254717|NCT00050011|468895851|FG001|Overall Study|Withdrawal by Subject|26|||
130254718|NCT00050011|468895850|FG000|Overall Study|Lost to Follow-up|7|||
130254719|NCT00050011|468895851|FG001|Overall Study|Lost to Follow-up|9|||
130254720|NCT00050011|468895850|FG000|Overall Study|Administrative problems|10|||
130254721|NCT00050011|468895851|FG001|Overall Study|Administrative problems|6|||
130254722|NCT00050011|468895850|FG000|Overall Study|Death|7|||
130254723|NCT00050011|468895851|FG001|Overall Study|Death|4|||
130254724|NCT00050011|468895850|FG000|Overall Study|Unknown - Reason is missing|0|||
130254725|NCT00050011|468895851|FG001|Overall Study|Unknown - Reason is missing|2|||
130254726|NCT04806373|468895852|FG000|Overall Study|Withdrawal by Subject|1|||
130254727|NCT04806373|468895853|FG001|Overall Study|Withdrawal by Subject|1|||
130254728|NCT05810597|468895854|FG000|Period 1|Adverse Event|2|||
130254729|NCT05810597|468895855|FG001|Period 1|Adverse Event|0|||
130254730|NCT05810597|468895854|FG000|Period 1|Physician Decision|1|||
130254731|NCT05810597|468895855|FG001|Period 1|Physician Decision|0|||
130254732|NCT05021224|468895860|FG000|Overall Study|Did not complete all survey items|4|||
130254733|NCT05021224|468895861|FG001|Overall Study|Did not complete all survey items|1|||
130254734|NCT05021224|468895862|FG002|Overall Study|Did not complete all survey items|0|||
130254735|NCT05021224|468895863|FG003|Overall Study|Did not complete all survey items|2|||
130254736|NCT02061085|468895864|FG000|Overall Study|Adverse Event|8|||
130254737|NCT04903093|468895869|FG000|Overall Study|Withdrawal by Subject|0|||
130031963|NCT02764541|468072705|FG003|Overall Study|Insurance reasons|0|||
130031964|NCT02764541|468072706|FG004|Overall Study|Insurance reasons|0|||
130031965|NCT02764541|468072707|FG005|Overall Study|Insurance reasons|0|||
130031966|NCT02764541|468072708|FG006|Overall Study|Insurance reasons|1|||
130031967|NCT02764541|468072709|FG007|Overall Study|Insurance reasons|0|||
130031968|NCT00749190|468072714|FG000|Overall Study|Adverse Event|0|||
130031969|NCT00749190|468072715|FG001|Overall Study|Adverse Event|2|||
130031970|NCT00749190|468072716|FG002|Overall Study|Adverse Event|0|||
130031971|NCT00749190|468072717|FG003|Overall Study|Adverse Event|4|||
130031972|NCT00749190|468072718|FG004|Overall Study|Adverse Event|0|||
130031973|NCT00749190|468072719|FG005|Overall Study|Adverse Event|3|||
130031974|NCT00749190|468072720|FG006|Overall Study|Adverse Event|0|||
130031975|NCT00749190|468072714|FG000|Overall Study|Lack of Efficacy|3|||
130031976|NCT00749190|468072715|FG001|Overall Study|Lack of Efficacy|1|||
130031977|NCT00749190|468072716|FG002|Overall Study|Lack of Efficacy|1|||
130031978|NCT00749190|468072717|FG003|Overall Study|Lack of Efficacy|0|||
130031979|NCT00749190|468072718|FG004|Overall Study|Lack of Efficacy|0|||
130031980|NCT00749190|468072719|FG005|Overall Study|Lack of Efficacy|1|||
130031981|NCT00749190|468072720|FG006|Overall Study|Lack of Efficacy|0|||
130031982|NCT00749190|468072714|FG000|Overall Study|Withdrawal by Subject|2|||
130031983|NCT00749190|468072715|FG001|Overall Study|Withdrawal by Subject|1|||
130031984|NCT00749190|468072716|FG002|Overall Study|Withdrawal by Subject|0|||
130031985|NCT00749190|468072717|FG003|Overall Study|Withdrawal by Subject|0|||
130031986|NCT00749190|468072718|FG004|Overall Study|Withdrawal by Subject|0|||
130031987|NCT00749190|468072719|FG005|Overall Study|Withdrawal by Subject|1|||
130031988|NCT00749190|468072720|FG006|Overall Study|Withdrawal by Subject|0|||
130031989|NCT00749190|468072714|FG000|Overall Study|Protocol Violation|0|||
130031990|NCT00749190|468072715|FG001|Overall Study|Protocol Violation|1|||
130031991|NCT00749190|468072716|FG002|Overall Study|Protocol Violation|0|||
130031992|NCT00749190|468072717|FG003|Overall Study|Protocol Violation|0|||
130031993|NCT00749190|468072718|FG004|Overall Study|Protocol Violation|0|||
130031994|NCT00749190|468072719|FG005|Overall Study|Protocol Violation|0|||
130031995|NCT00749190|468072720|FG006|Overall Study|Protocol Violation|1|||
130031996|NCT00749190|468072714|FG000|Overall Study|Other reason not defined above|0|||
130031997|NCT00749190|468072715|FG001|Overall Study|Other reason not defined above|0|||
130031998|NCT00749190|468072716|FG002|Overall Study|Other reason not defined above|0|||
130031999|NCT00749190|468072717|FG003|Overall Study|Other reason not defined above|1|||
130032000|NCT00749190|468072718|FG004|Overall Study|Other reason not defined above|0|||
130032001|NCT00749190|468072719|FG005|Overall Study|Other reason not defined above|0|||
130032002|NCT00749190|468072720|FG006|Overall Study|Other reason not defined above|0|||
130032003|NCT00355121|468072721|FG000|Overall Study|Did not receive study vaccine|1|||
130032004|NCT00355121|468072722|FG001|Overall Study|Did not receive study vaccine|0|||
130032005|NCT00355121|468072723|FG002|Overall Study|Did not receive study vaccine|1|||
130032006|NCT00355121|468072721|FG000|Overall Study|Adverse Event|0|||
130032007|NCT00355121|468072722|FG001|Overall Study|Adverse Event|1|||
130032008|NCT00355121|468072723|FG002|Overall Study|Adverse Event|0|||
130032009|NCT00355121|468072721|FG000|Overall Study|Protocol Violation|7|||
130032010|NCT00355121|468072722|FG001|Overall Study|Protocol Violation|9|||
130032011|NCT00355121|468072723|FG002|Overall Study|Protocol Violation|1|||
130032012|NCT00355121|468072721|FG000|Overall Study|Lost to Follow-up|4|||
130032013|NCT00355121|468072722|FG001|Overall Study|Lost to Follow-up|7|||
130032014|NCT00355121|468072723|FG002|Overall Study|Lost to Follow-up|1|||
130032015|NCT00355121|468072721|FG000|Overall Study|Withdrawal by Subject|9|||
130032016|NCT00355121|468072722|FG001|Overall Study|Withdrawal by Subject|10|||
130032017|NCT00355121|468072723|FG002|Overall Study|Withdrawal by Subject|2|||
130032018|NCT00355121|468072721|FG000|Overall Study|Serious adverse events|0|||
130032019|NCT00355121|468072722|FG001|Overall Study|Serious adverse events|2|||
130032020|NCT00355121|468072723|FG002|Overall Study|Serious adverse events|0|||
130032021|NCT02040142|468072732|FG000|Overall Study|Lost to Follow-up|5|||
130032022|NCT02040142|468072732|FG000|Overall Study|Death|17|||
130254738|NCT04903093|468895870|FG001|Overall Study|Withdrawal by Subject|0|||
130254739|NCT04903093|468895871|FG002|Overall Study|Withdrawal by Subject|0|||
130254740|NCT04903093|468895872|FG003|Overall Study|Withdrawal by Subject|1|||
130254741|NCT04903093|468895873|FG004|Overall Study|Withdrawal by Subject|0|||
130032023|NCT02040142|468072732|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
130032024|NCT01565980|468072734|FG000|Overall Study|Death|1|||
130032025|NCT01565980|468072735|FG001|Overall Study|Death|0|||
130254742|NCT04903093|468895874|FG005|Overall Study|Withdrawal by Subject|0|||
130254743|NCT02412436|468895875|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
130032026|NCT01565980|468072734|FG000|Overall Study|Lost to Follow-up|1|||
130032027|NCT01565980|468072735|FG001|Overall Study|Lost to Follow-up|0|||
130032028|NCT01565980|468072734|FG000|Overall Study|health complications|1|||
130032029|NCT01565980|468072735|FG001|Overall Study|health complications|1|||
130032030|NCT01565980|468072734|FG000|Overall Study|stopped medical treatment|1|||
130032031|NCT01565980|468072735|FG001|Overall Study|stopped medical treatment|0|||
130032032|NCT01565980|468072734|FG000|Overall Study|Withdrawal by Subject|0|||
130101219|NCT03917654|468327316|FG003|Year 2|Adverse Event|0|||
130254744|NCT02412436|468895875|FG000|Overall Study|Lost to Follow-up|6|||
130254745|NCT02412436|468895875|FG000|Overall Study|Unable to get to clinic|3|||
130254746|NCT02412436|468895875|FG000|Overall Study|Death|1|||
130254747|NCT02412436|468895875|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
130254748|NCT04090749|468895881|FG000|Open Label Pilot|Lost to Follow-up|1|||
130254749|NCT04090749|468895882|FG001|Open Label Pilot|Lost to Follow-up|0|||
130254750|NCT04090749|468895883|FG002|Open Label Pilot|Lost to Follow-up|0|||
130254751|NCT04090749|468895881|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
130032033|NCT01565980|468072735|FG001|Overall Study|Withdrawal by Subject|3|||
130254752|NCT04090749|468895882|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
130254753|NCT04090749|468895883|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
130254754|NCT04090749|468895881|FG000|Pilot Trial|Lost to Follow-up|0|||
130254755|NCT04090749|468895882|FG001|Pilot Trial|Lost to Follow-up|1|||
130254756|NCT04090749|468895883|FG002|Pilot Trial|Lost to Follow-up|1|||
130254757|NCT02184442|468895884|FG000|Overall Study|Death|61|||
130254758|NCT02184442|468895885|FG001|Overall Study|Death|65|||
130254759|NCT02184442|468895884|FG000|Overall Study|Withdrawal by Subject|3|||
130254760|NCT02184442|468895885|FG001|Overall Study|Withdrawal by Subject|11|||
130254761|NCT01852214|468895886|FG000|Period 1|Adverse Event|1|||
130254762|NCT01852214|468895887|FG001|Period 1|Adverse Event|2|||
130254763|NCT01852214|468895886|FG000|Period 1|Withdrawal by Subject|0|||
130254764|NCT01852214|468895887|FG001|Period 1|Withdrawal by Subject|1|||
130254765|NCT01852214|468895886|FG000|Washout Period|Withdrawal by Subject|0|||
130254766|NCT01852214|468895887|FG001|Washout Period|Withdrawal by Subject|1|||
130254767|NCT04091438|468895888|FG000|Treatment Period 1 (1 Day)|Other|1|||
130254768|NCT04091438|468895889|FG001|Treatment Period 1 (1 Day)|Other|0|||
130254769|NCT04091438|468895888|FG000|Washout Period (1 Day)|Protocol deviation|0|||
130254770|NCT04091438|468895889|FG001|Washout Period (1 Day)|Protocol deviation|1|||
130254771|NCT04091438|468895888|FG000|Washout Period (1 Day)|Other|0|||
130254772|NCT04091438|468895889|FG001|Washout Period (1 Day)|Other|1|||
130254773|NCT00421408|468895890|FG000|Overall Study|Lost to Follow-up|30|||
130254774|NCT00421408|468895891|FG001|Overall Study|Lost to Follow-up|20|||
130254775|NCT00421408|468895890|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
130254776|NCT00421408|468895891|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
130254777|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130254778|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130254779|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
130254780|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130254781|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130254782|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130254783|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Other|2|||
130254784|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Other|1|||
130254785|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Other|1|||
130254786|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
130254787|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
130254788|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
130254789|NCT02691494|468895894|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130254790|NCT02691494|468895895|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130254791|NCT02691494|468895896|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
130254792|NCT03249558|468895903|FG000|Overall Study|Lost to Follow-up|2|||
130254793|NCT03249558|468895904|FG001|Overall Study|Lost to Follow-up|1|||
130254794|NCT03249558|468895905|FG002|Overall Study|Lost to Follow-up|4|||
130254795|NCT03249558|468895903|FG000|Overall Study|Physician Decision|1|||
130254796|NCT03249558|468895904|FG001|Overall Study|Physician Decision|0|||
130254797|NCT03249558|468895905|FG002|Overall Study|Physician Decision|0|||
130254798|NCT03249558|468895903|FG000|Overall Study|Withdrawal by Subject|6|||
130254799|NCT03249558|468895904|FG001|Overall Study|Withdrawal by Subject|5|||
130254800|NCT03249558|468895905|FG002|Overall Study|Withdrawal by Subject|7|||
130254801|NCT03249558|468895903|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
130254802|NCT03249558|468895904|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
130254803|NCT03249558|468895905|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
130254804|NCT03249558|468895903|FG000|Overall Study|Protocol Violation|1|||
130254805|NCT03249558|468895904|FG001|Overall Study|Protocol Violation|1|||
130254806|NCT03249558|468895905|FG002|Overall Study|Protocol Violation|2|||
130254807|NCT02613507|468895907|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
130032034|NCT01955707|468072744|FG000|Overall Study|Adverse Event|1|||
130254808|NCT02613507|468895908|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
130254809|NCT02613507|468895907|FG000|Pre-Treamtent|Participant withdrew consent|0|||
130254810|NCT02613507|468895908|FG001|Pre-Treamtent|Participant withdrew consent|4|||
130032035|NCT01955707|468072745|FG001|Overall Study|Adverse Event|2|||
130032036|NCT01955707|468072744|FG000|Overall Study|Lost to Follow-up|2|||
130254811|NCT02613507|468895907|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
130254812|NCT02613507|468895908|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
130101220|NCT03917654|468327317|FG004|Year 2|Adverse Event|0|||
130101221|NCT03917654|468327318|FG005|Year 2|Adverse Event|0|||
130101222|NCT03917654|468327319|FG006|Year 2|Adverse Event|0|||
130101223|NCT03917654|468327320|FG007|Year 2|Adverse Event|0|||
130101224|NCT03917654|468327321|FG008|Year 2|Adverse Event|0|||
130101225|NCT03917654|468327322|FG009|Year 2|Adverse Event|1|||
130101226|NCT03917654|468327323|FG010|Year 2|Adverse Event|0|||
130101227|NCT03917654|468327324|FG011|Year 2|Adverse Event|0|||
130101228|NCT00905437|468327327|FG000|Overall Study|Adverse Event|3|||
130101229|NCT00905437|468327328|FG001|Overall Study|Adverse Event|2|||
130101230|NCT00905437|468327327|FG000|Overall Study|Lost to Follow-up|0|||
130101231|NCT00905437|468327328|FG001|Overall Study|Lost to Follow-up|1|||
130101232|NCT00905437|468327327|FG000|Overall Study|Withdrawal by Subject|0|||
130101233|NCT00905437|468327328|FG001|Overall Study|Withdrawal by Subject|1|||
130101234|NCT00905437|468327327|FG000|Overall Study|Other|5|||
130101235|NCT00905437|468327328|FG001|Overall Study|Other|6|||
130101236|NCT01306968|468327331|FG000|Overall Study|Lost to Follow-up|1|||
130101237|NCT01306968|468327332|FG001|Overall Study|Lost to Follow-up|1|||
130101238|NCT01306968|468327333|FG002|Overall Study|Lost to Follow-up|0|||
130101239|NCT01306968|468327334|FG003|Overall Study|Lost to Follow-up|0|||
130101240|NCT01306968|468327331|FG000|Overall Study|Physician Decision|0|||
130101241|NCT01306968|468327332|FG001|Overall Study|Physician Decision|1|||
130101242|NCT01306968|468327333|FG002|Overall Study|Physician Decision|0|||
130101243|NCT01306968|468327334|FG003|Overall Study|Physician Decision|0|||
130101244|NCT01306968|468327331|FG000|Overall Study|Relocated and left active duty|0|||
130101245|NCT01306968|468327332|FG001|Overall Study|Relocated and left active duty|1|||
130101246|NCT01306968|468327333|FG002|Overall Study|Relocated and left active duty|1|||
130101247|NCT01306968|468327334|FG003|Overall Study|Relocated and left active duty|1|||
130101248|NCT01306968|468327331|FG000|Overall Study|Withdrew - time commitment|0|||
130101249|NCT01306968|468327332|FG001|Overall Study|Withdrew - time commitment|0|||
130101250|NCT01306968|468327333|FG002|Overall Study|Withdrew - time commitment|0|||
130101251|NCT01306968|468327334|FG003|Overall Study|Withdrew - time commitment|2|||
130254813|NCT02613507|468895907|FG000|Treatment|Not reported|3|||
130254814|NCT02613507|468895908|FG001|Treatment|Not reported|0|||
130254815|NCT02613507|468895907|FG000|Treatment|Other reasons|8|||
130254816|NCT02613507|468895908|FG001|Treatment|Other reasons|0|||
130254817|NCT02613507|468895907|FG000|Treatment|Participant no longer meets criteria|3|||
130254818|NCT02613507|468895908|FG001|Treatment|Participant no longer meets criteria|0|||
130254819|NCT02613507|468895907|FG000|Treatment|Maximum clinical benefit|5|||
130254820|NCT02613507|468895908|FG001|Treatment|Maximum clinical benefit|10|||
130254821|NCT02613507|468895907|FG000|Treatment|Lost to Follow-up|1|||
130254822|NCT02613507|468895908|FG001|Treatment|Lost to Follow-up|0|||
130254823|NCT02613507|468895907|FG000|Treatment|Participant withdrew consent|0|||
130254824|NCT02613507|468895908|FG001|Treatment|Participant withdrew consent|2|||
130254825|NCT02613507|468895907|FG000|Treatment|Participant request to discontinue study treatment|13|||
130254826|NCT02613507|468895908|FG001|Treatment|Participant request to discontinue study treatment|17|||
130254827|NCT02613507|468895907|FG000|Treatment|Adverse event unrelated to study drug|20|||
130254828|NCT02613507|468895908|FG001|Treatment|Adverse event unrelated to study drug|3|||
130254829|NCT02613507|468895907|FG000|Treatment|Death|2|||
130254830|NCT02613507|468895908|FG001|Treatment|Death|0|||
130254831|NCT02613507|468895907|FG000|Treatment|Study drug toxicity|19|||
130254832|NCT02613507|468895908|FG001|Treatment|Study drug toxicity|14|||
130254833|NCT02613507|468895907|FG000|Treatment|Disease progression|263|||
130254834|NCT02613507|468895908|FG001|Treatment|Disease progression|110|||
130254835|NCT03941093|468895909|FG000|Overall Study|Protocol Violation|0|||
130254836|NCT03941093|468895910|FG001|Overall Study|Protocol Violation|1|||
130254837|NCT03941093|468895909|FG000|Overall Study|Withdrawal by Subject|9|||
130254838|NCT03941093|468895910|FG001|Overall Study|Withdrawal by Subject|6|||
130254839|NCT00561821|468895914|FG000|Overall Study|Not treated|0|||
130254840|NCT00561821|468895915|FG001|Overall Study|Not treated|0|||
130254841|NCT00561821|468895916|FG002|Overall Study|Not treated|1|||
130254842|NCT00561821|468895917|FG003|Overall Study|Not treated|0|||
130254843|NCT00561821|468895914|FG000|Overall Study|Withdrawal by Subject|0|||
130254844|NCT00561821|468895915|FG001|Overall Study|Withdrawal by Subject|1|||
130101252|NCT01306968|468327331|FG000|Overall Study|Withdrew over privacy concerns|0|||
130101253|NCT01306968|468327332|FG001|Overall Study|Withdrew over privacy concerns|0|||
130101254|NCT01306968|468327333|FG002|Overall Study|Withdrew over privacy concerns|0|||
130101255|NCT01306968|468327334|FG003|Overall Study|Withdrew over privacy concerns|1|||
130254845|NCT00561821|468895916|FG002|Overall Study|Withdrawal by Subject|0|||
130254846|NCT00561821|468895917|FG003|Overall Study|Withdrawal by Subject|2|||
130254847|NCT00561821|468895914|FG000|Overall Study|Reasons not related to trial|2|||
130254848|NCT00561821|468895915|FG001|Overall Study|Reasons not related to trial|1|||
130254849|NCT00561821|468895916|FG002|Overall Study|Reasons not related to trial|0|||
130254850|NCT00561821|468895917|FG003|Overall Study|Reasons not related to trial|0|||
130254851|NCT00561821|468895914|FG000|Overall Study|Other (reason not specified)|1|||
130101256|NCT00690573|468327346|FG000|Overall Study|Lack of Efficacy|8|||
130101257|NCT00690573|468327346|FG000|Overall Study|Withdrawal by Subject|1|||
130254852|NCT00561821|468895915|FG001|Overall Study|Other (reason not specified)|1|||
130032037|NCT01955707|468072745|FG001|Overall Study|Lost to Follow-up|1|||
130032038|NCT01955707|468072744|FG000|Overall Study|Withdrawal by Subject|0|||
130032039|NCT01955707|468072745|FG001|Overall Study|Withdrawal by Subject|3|||
130032040|NCT01955707|468072744|FG000|Overall Study|Death|13|||
130032041|NCT01955707|468072745|FG001|Overall Study|Death|14|||
130032042|NCT01955707|468072744|FG000|Overall Study|Other|4|||
130032043|NCT01955707|468072745|FG001|Overall Study|Other|2|||
130032044|NCT01468311|468072746|FG000|Overall Study|mobilization failure|1|||
130032045|NCT01468311|468072746|FG000|Overall Study|Withdrawal by Subject|1|||
130032046|NCT03219164|468074945|FG000|Overall Study|Study Terminated by Sponsor|16|||
130032047|NCT03219164|468074946|FG001|Overall Study|Study Terminated by Sponsor|12|||
130032048|NCT03219164|468074945|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
130032049|NCT03219164|468074946|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
130032050|NCT03219164|468074945|FG000|Overall Study|Lost to Follow-up|1|||
130032051|NCT03219164|468074946|FG001|Overall Study|Lost to Follow-up|1|||
130032052|NCT03219164|468074945|FG000|Overall Study|Adverse Event|1|||
130032053|NCT03219164|468074946|FG001|Overall Study|Adverse Event|0|||
130032054|NCT03219164|468074945|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130032055|NCT03219164|468074946|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130032056|NCT03219164|468074945|FG000|Overall Study|Protocol Violation|0|||
130032057|NCT03219164|468074946|FG001|Overall Study|Protocol Violation|1|||
130032058|NCT03219164|468074945|FG000|Overall Study|Withdrew Assent|1|||
130032059|NCT03219164|468074946|FG001|Overall Study|Withdrew Assent|0|||
130032060|NCT02689492|468074947|FG000|Overall Study|Lost to Follow-up|61|||
130032061|NCT02689492|468074947|FG000|Overall Study|Withdrawal by Subject|11|||
130032062|NCT02689492|468074947|FG000|Overall Study|Death|9|||
130032063|NCT02689492|468074947|FG000|Overall Study|Physician Decision|2|||
130032064|NCT02689492|468074947|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
130032065|NCT02689492|468074947|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
130032066|NCT02689492|468074947|FG000|Overall Study|Other than listed|1|||
130032067|NCT02029976|468074948|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
130032068|NCT02029976|468074949|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
130032069|NCT02029976|468074948|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
130032070|NCT02029976|468074949|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
130032071|NCT02029976|468074948|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
130032072|NCT02029976|468074949|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
130032073|NCT02029976|468074948|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
130032074|NCT02029976|468074949|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
130032075|NCT01717638|468074950|FG000|Overall Study|Lost to Follow-up|0|||
130032076|NCT01717638|468074951|FG001|Overall Study|Lost to Follow-up|0|||
130032077|NCT01717638|468074952|FG002|Overall Study|Lost to Follow-up|0|||
130032078|NCT01717638|468074953|FG003|Overall Study|Lost to Follow-up|0|||
130032079|NCT01717638|468074954|FG004|Overall Study|Lost to Follow-up|0|||
130032080|NCT01717638|468074955|FG005|Overall Study|Lost to Follow-up|1|||
130101258|NCT03505606|468328617|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
130254853|NCT00561821|468895916|FG002|Overall Study|Other (reason not specified)|0|||
130254854|NCT00561821|468895917|FG003|Overall Study|Other (reason not specified)|0|||
130254855|NCT00561821|468895914|FG000|Overall Study|Adverse Event|2|||
130254856|NCT00561821|468895915|FG001|Overall Study|Adverse Event|3|||
130254857|NCT00561821|468895916|FG002|Overall Study|Adverse Event|1|||
130032081|NCT01717638|468074956|FG006|Overall Study|Lost to Follow-up|0|||
130032082|NCT01717638|468074957|FG007|Overall Study|Lost to Follow-up|0|||
130032083|NCT01717638|468074958|FG008|Overall Study|Lost to Follow-up|0|||
130032084|NCT01717638|468074959|FG009|Overall Study|Lost to Follow-up|0|||
130032085|NCT01717638|468074960|FG010|Overall Study|Lost to Follow-up|0|||
130032086|NCT01717638|468074961|FG011|Overall Study|Lost to Follow-up|0|||
130032087|NCT01717638|468074962|FG012|Overall Study|Lost to Follow-up|0|||
130032088|NCT01717638|468074950|FG000|Overall Study|Father in hospital|0|||
130032089|NCT01717638|468074951|FG001|Overall Study|Father in hospital|0|||
130032090|NCT01717638|468074952|FG002|Overall Study|Father in hospital|0|||
130032091|NCT01717638|468074953|FG003|Overall Study|Father in hospital|0|||
130032092|NCT01717638|468074954|FG004|Overall Study|Father in hospital|0|||
130032093|NCT01717638|468074955|FG005|Overall Study|Father in hospital|0|||
130032094|NCT01717638|468074956|FG006|Overall Study|Father in hospital|0|||
130032095|NCT01717638|468074957|FG007|Overall Study|Father in hospital|0|||
130032096|NCT01717638|468074958|FG008|Overall Study|Father in hospital|0|||
130032097|NCT01717638|468074959|FG009|Overall Study|Father in hospital|0|||
130032098|NCT01717638|468074960|FG010|Overall Study|Father in hospital|0|||
130032099|NCT01717638|468074961|FG011|Overall Study|Father in hospital|0|||
130032100|NCT01717638|468074962|FG012|Overall Study|Father in hospital|1|||
130032101|NCT01717638|468074950|FG000|Overall Study|Withdrawal by Subject|0|||
130032102|NCT01717638|468074951|FG001|Overall Study|Withdrawal by Subject|1|||
130032103|NCT01717638|468074952|FG002|Overall Study|Withdrawal by Subject|1|||
130032104|NCT01717638|468074953|FG003|Overall Study|Withdrawal by Subject|0|||
130032105|NCT01717638|468074954|FG004|Overall Study|Withdrawal by Subject|1|||
130032106|NCT01717638|468074955|FG005|Overall Study|Withdrawal by Subject|0|||
130032107|NCT01717638|468074956|FG006|Overall Study|Withdrawal by Subject|2|||
130254858|NCT00561821|468895917|FG003|Overall Study|Adverse Event|1|||
130254859|NCT03379870|468896995|FG000|Overall Study|Lost to Follow-up|1|||
130254860|NCT03379870|468896996|FG001|Overall Study|Lost to Follow-up|0|||
130254861|NCT03379870|468896995|FG000|Overall Study|Protocol Violation|1|||
130254862|NCT03379870|468896996|FG001|Overall Study|Protocol Violation|1|||
130254863|NCT01394185|468896997|FG000|Overall Study|Withdrawal by Subject|2|||
130254864|NCT01394185|468896998|FG001|Overall Study|Withdrawal by Subject|0|||
130254865|NCT01394185|468896999|FG002|Overall Study|Withdrawal by Subject|0|||
130254866|NCT01394185|468897000|FG003|Overall Study|Withdrawal by Subject|0|||
130254867|NCT01394185|468897001|FG004|Overall Study|Withdrawal by Subject|1|||
130254868|NCT01394185|468897002|FG005|Overall Study|Withdrawal by Subject|0|||
130254869|NCT01394185|468896997|FG000|Overall Study|Change in protocol|3|||
130254870|NCT01394185|468896998|FG001|Overall Study|Change in protocol|0|||
130254871|NCT01394185|468896999|FG002|Overall Study|Change in protocol|0|||
130254872|NCT01394185|468897000|FG003|Overall Study|Change in protocol|0|||
130254873|NCT01394185|468897001|FG004|Overall Study|Change in protocol|3|||
130254874|NCT01394185|468897002|FG005|Overall Study|Change in protocol|0|||
130254875|NCT01394185|468896997|FG000|Overall Study|Protocol Violation|1|||
130254876|NCT01394185|468896998|FG001|Overall Study|Protocol Violation|0|||
130254877|NCT01394185|468896999|FG002|Overall Study|Protocol Violation|0|||
130254878|NCT01394185|468897000|FG003|Overall Study|Protocol Violation|1|||
130254879|NCT01394185|468897001|FG004|Overall Study|Protocol Violation|0|||
130254880|NCT01394185|468897002|FG005|Overall Study|Protocol Violation|1|||
130254881|NCT00267488|468897006|FG000|Overall Study|Sponsor Terminated Study|9|||
130254882|NCT00267488|468897006|FG000|Overall Study|Protocol Violation|1|||
130254883|NCT00267488|468897006|FG000|Overall Study|Other (Disease Progression)|1|||
130254884|NCT00831389|468897007|FG000|Overall Study|Withdrawal by Subject|0|||
130254885|NCT00831389|468897008|FG001|Overall Study|Withdrawal by Subject|1|||
130254886|NCT00278161|468897010|FG000|Overall Study|Death|11|||
130254887|NCT01592747|468897011|FG000|Overall Study|Loss of Therapeutic Response|107|||
130254888|NCT01592747|468897012|FG001|Overall Study|Loss of Therapeutic Response|108|||
130254889|NCT01592747|468897013|FG002|Overall Study|Loss of Therapeutic Response|100|||
130254890|NCT01592747|468897011|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130254891|NCT01592747|468897012|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130254892|NCT01592747|468897013|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
130254893|NCT01592747|468897011|FG000|Overall Study|Adverse Event|1|||
130254894|NCT01592747|468897012|FG001|Overall Study|Adverse Event|0|||
130254895|NCT01592747|468897013|FG002|Overall Study|Adverse Event|0|||
130254896|NCT01592747|468897011|FG000|Overall Study|Protocol Violation|4|||
130254897|NCT01592747|468897012|FG001|Overall Study|Protocol Violation|0|||
130254898|NCT01592747|468897013|FG002|Overall Study|Protocol Violation|4|||
130254899|NCT01592747|468897011|FG000|Overall Study|Lack of Efficacy|0|||
130254900|NCT01592747|468897012|FG001|Overall Study|Lack of Efficacy|1|||
130254901|NCT01592747|468897013|FG002|Overall Study|Lack of Efficacy|0|||
130254902|NCT01592747|468897011|FG000|Overall Study|Withdrawal by Subject|2|||
130254903|NCT01592747|468897012|FG001|Overall Study|Withdrawal by Subject|0|||
130254904|NCT01592747|468897013|FG002|Overall Study|Withdrawal by Subject|2|||
130254905|NCT01592747|468897011|FG000|Overall Study|Lost to Follow-up|1|||
130254906|NCT01592747|468897012|FG001|Overall Study|Lost to Follow-up|0|||
130254907|NCT01592747|468897013|FG002|Overall Study|Lost to Follow-up|1|||
130254908|NCT01592747|468897011|FG000|Overall Study|Other Reasons|1|||
130254909|NCT01592747|468897012|FG001|Overall Study|Other Reasons|1|||
130254910|NCT01592747|468897013|FG002|Overall Study|Other Reasons|0|||
130254911|NCT00124657|468897014|FG000|Overall Study|Toxicity|0|||
130254912|NCT00124657|468897015|FG001|Overall Study|Toxicity|0|||
130254913|NCT00124657|468897016|FG002|Overall Study|Toxicity|1|||
130254914|NCT00124657|468897014|FG000|Overall Study|Non-compliance|1|||
130254915|NCT00124657|468897015|FG001|Overall Study|Non-compliance|0|||
130254916|NCT00124657|468897016|FG002|Overall Study|Non-compliance|4|||
130254917|NCT00124657|468897014|FG000|Overall Study|Progressive disease|14|||
130254918|NCT00124657|468897015|FG001|Overall Study|Progressive disease|5|||
130032108|NCT01717638|468074957|FG007|Overall Study|Withdrawal by Subject|1|||
130032109|NCT01717638|468074958|FG008|Overall Study|Withdrawal by Subject|2|||
130254919|NCT00124657|468897016|FG002|Overall Study|Progressive disease|27|||
130254920|NCT00124657|468897014|FG000|Overall Study|Intercurrent illness|1|||
130254921|NCT00124657|468897015|FG001|Overall Study|Intercurrent illness|0|||
130254922|NCT00124657|468897016|FG002|Overall Study|Intercurrent illness|0|||
130254923|NCT01935947|468897017|FG000|Overall Study|Adverse Event|0|||
130254924|NCT01935947|468897018|FG001|Overall Study|Adverse Event|2|||
130254925|NCT01935947|468897019|FG002|Overall Study|Adverse Event|0|||
130254926|NCT01935947|468897017|FG000|Overall Study|Diease Progression|2|||
130254927|NCT01935947|468897018|FG001|Overall Study|Diease Progression|2|||
130254928|NCT01935947|468897019|FG002|Overall Study|Diease Progression|2|||
130254929|NCT01935947|468897017|FG000|Overall Study|Death|1|||
130254930|NCT01935947|468897018|FG001|Overall Study|Death|0|||
130254931|NCT01935947|468897019|FG002|Overall Study|Death|0|||
130254932|NCT01148771|468897020|FG000|Washout Period|Withdrawal by Subject|0|||
130254933|NCT01148771|468897021|FG001|Washout Period|Withdrawal by Subject|1|||
130254934|NCT02951819|468897026|FG000|Overall Study|Death|9|||
130101259|NCT03505606|468328618|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
130254935|NCT02951819|468897027|FG001|Overall Study|Death|7|||
130254936|NCT02951819|468897026|FG000|Overall Study|Withdrawal by Subject|3|||
130254937|NCT02951819|468897027|FG001|Overall Study|Withdrawal by Subject|0|||
130101260|NCT03505606|468328619|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
130101261|NCT03505606|468328617|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
130254938|NCT02951819|468897026|FG000|Overall Study|Adverse Event|1|||
130254939|NCT02951819|468897027|FG001|Overall Study|Adverse Event|0|||
130254940|NCT02951819|468897026|FG000|Overall Study|Lack of Efficacy|4|||
130254941|NCT02951819|468897027|FG001|Overall Study|Lack of Efficacy|0|||
130254942|NCT02951819|468897026|FG000|Overall Study|Lost to Follow-up|1|||
130254943|NCT02951819|468897027|FG001|Overall Study|Lost to Follow-up|0|||
130254944|NCT02951819|468897026|FG000|Overall Study|Progressive Disease|1|||
130254945|NCT02951819|468897027|FG001|Overall Study|Progressive Disease|0|||
130254946|NCT02951819|468897026|FG000|Overall Study|Other|9|||
130254947|NCT02951819|468897027|FG001|Overall Study|Other|0|||
130254948|NCT01443026|468897030|FG000|Overall Study|Physician Decision|1|||
130254949|NCT01443026|468897031|FG001|Overall Study|Physician Decision|0|||
130254950|NCT01443026|468897030|FG000|Overall Study|Death|0|||
130254951|NCT01443026|468897031|FG001|Overall Study|Death|1|||
130254952|NCT01443026|468897030|FG000|Overall Study|Withdrawal by Subject|0|||
130254953|NCT01443026|468897031|FG001|Overall Study|Withdrawal by Subject|3|||
130254954|NCT01443026|468897030|FG000|Overall Study|Lost to Follow-up|2|||
130254955|NCT01443026|468897031|FG001|Overall Study|Lost to Follow-up|1|||
130254956|NCT00581919|468897032|FG000|Overall Study|Adverse Event|8|||
130254957|NCT00581919|468897032|FG000|Overall Study|Death|1|||
130254958|NCT00581919|468897032|FG000|Overall Study|Disease Progression|10|||
130032110|NCT01717638|468074959|FG009|Overall Study|Withdrawal by Subject|1|||
130032111|NCT01717638|468074960|FG010|Overall Study|Withdrawal by Subject|0|||
130032112|NCT01717638|468074961|FG011|Overall Study|Withdrawal by Subject|0|||
130032113|NCT01717638|468074962|FG012|Overall Study|Withdrawal by Subject|18|||
130032114|NCT00434967|468074965|FG000|Overall Study|Adverse Event|2|||
130032115|NCT00434967|468074966|FG001|Overall Study|Adverse Event|4|||
130032116|NCT00434967|468074967|FG002|Overall Study|Adverse Event|3|||
130032117|NCT00434967|468074968|FG003|Overall Study|Adverse Event|3|||
130032118|NCT00434967|468074965|FG000|Overall Study|Lost to Follow-up|0|||
130032119|NCT00434967|468074966|FG001|Overall Study|Lost to Follow-up|0|||
130032120|NCT00434967|468074967|FG002|Overall Study|Lost to Follow-up|1|||
130032121|NCT00434967|468074968|FG003|Overall Study|Lost to Follow-up|0|||
130032122|NCT00434967|468074965|FG000|Overall Study|Withdrawal by Subject|2|||
130032123|NCT00434967|468074966|FG001|Overall Study|Withdrawal by Subject|2|||
130032124|NCT00434967|468074967|FG002|Overall Study|Withdrawal by Subject|4|||
130032125|NCT00434967|468074968|FG003|Overall Study|Withdrawal by Subject|6|||
130032126|NCT00434967|468074965|FG000|Overall Study|Randomized in error|0|||
130032127|NCT00434967|468074966|FG001|Overall Study|Randomized in error|0|||
130032128|NCT00434967|468074967|FG002|Overall Study|Randomized in error|0|||
130032129|NCT00434967|468074968|FG003|Overall Study|Randomized in error|1|||
130032130|NCT00434967|468074965|FG000|Overall Study|Protocol Violation|0|||
130032131|NCT00434967|468074966|FG001|Overall Study|Protocol Violation|1|||
130032132|NCT00434967|468074967|FG002|Overall Study|Protocol Violation|0|||
130032133|NCT00434967|468074968|FG003|Overall Study|Protocol Violation|1|||
130032134|NCT00434967|468074965|FG000|Overall Study|Physician Decision|1|||
130032135|NCT00434967|468074966|FG001|Overall Study|Physician Decision|1|||
130032136|NCT00434967|468074967|FG002|Overall Study|Physician Decision|1|||
130032137|NCT00434967|468074968|FG003|Overall Study|Physician Decision|0|||
130032138|NCT00434967|468074965|FG000|Overall Study|Patient Disposition Challenges|2|||
130032139|NCT00434967|468074966|FG001|Overall Study|Patient Disposition Challenges|0|||
130032140|NCT00434967|468074967|FG002|Overall Study|Patient Disposition Challenges|0|||
130032141|NCT00434967|468074968|FG003|Overall Study|Patient Disposition Challenges|3|||
130032142|NCT03155997|468074970|FG000|Overall Study|Withdrawal by Subject|119|||
130032143|NCT03155997|468074971|FG001|Overall Study|Withdrawal by Subject|134|||
130032144|NCT03155997|468074970|FG000|Overall Study|Lost to Follow-up|12|||
130032145|NCT03155997|468074971|FG001|Overall Study|Lost to Follow-up|13|||
130032146|NCT03155997|468074970|FG000|Overall Study|Missing disposition data|0|||
130032147|NCT03155997|468074971|FG001|Overall Study|Missing disposition data|1|||
130032148|NCT03155997|468074970|FG000|Overall Study|On study treatment|2027|||
130032149|NCT03155997|468074971|FG001|Overall Study|On study treatment|2074|||
130032150|NCT01848145|468074972|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
130032151|NCT01848145|468074972|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
130032152|NCT01848145|468074972|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
130254959|NCT00581919|468897032|FG000|Overall Study|Physician Decision|1|||
130254960|NCT00581919|468897032|FG000|Overall Study|Other Complicating Disease|1|||
130254961|NCT00581919|468897032|FG000|Overall Study|Started Non-Protocol Therapy|2|||
130254962|NCT00581919|468897032|FG000|Overall Study|Withdrawal by Subject|1|||
130254963|NCT02655601|468897033|FG000|Overall Study|Adverse Event|0|||
130254964|NCT02655601|468897034|FG001|Overall Study|Adverse Event|0|||
130254965|NCT02655601|468897035|FG002|Overall Study|Adverse Event|0|||
130254966|NCT02655601|468897036|FG003|Overall Study|Adverse Event|1|||
130101262|NCT03505606|468328618|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
130101263|NCT03505606|468328619|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
130101264|NCT03505606|468328617|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
130101265|NCT03505606|468328618|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
130101266|NCT03505606|468328619|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
130101267|NCT03505606|468328617|FG000|Overall Study|Poor compliance with refractive correction|0|||
130101268|NCT03505606|468328618|FG001|Overall Study|Poor compliance with refractive correction|0|||
130101269|NCT03505606|468328619|FG002|Overall Study|Poor compliance with refractive correction|1|||
130101270|NCT03505606|468328617|FG000|Overall Study|Insufficient anisometropia|0|||
130101271|NCT03505606|468328618|FG001|Overall Study|Insufficient anisometropia|0|||
130101272|NCT03505606|468328619|FG002|Overall Study|Insufficient anisometropia|2|||
130101273|NCT03505606|468328617|FG000|Overall Study|Ectopia Lentis|0|||
130101274|NCT03505606|468328618|FG001|Overall Study|Ectopia Lentis|0|||
130101275|NCT03505606|468328619|FG002|Overall Study|Ectopia Lentis|1|||
130101276|NCT03505606|468328617|FG000|Overall Study|alternation of amblyopic eye|0|||
130101277|NCT03505606|468328618|FG001|Overall Study|alternation of amblyopic eye|1|||
130254967|NCT02655601|468897037|FG004|Overall Study|Adverse Event|1|||
130254968|NCT02655601|468897038|FG005|Overall Study|Adverse Event|0|||
130254969|NCT02655601|468897033|FG000|Overall Study|Physician Decision|0|||
130254970|NCT02655601|468897034|FG001|Overall Study|Physician Decision|0|||
130254971|NCT02655601|468897035|FG002|Overall Study|Physician Decision|0|||
130254972|NCT02655601|468897036|FG003|Overall Study|Physician Decision|0|||
130254973|NCT02655601|468897037|FG004|Overall Study|Physician Decision|1|||
130254974|NCT02655601|468897038|FG005|Overall Study|Physician Decision|1|||
130254975|NCT02655601|468897033|FG000|Overall Study|Withdrawal by Subject|0|||
130254976|NCT02655601|468897034|FG001|Overall Study|Withdrawal by Subject|0|||
130254977|NCT02655601|468897035|FG002|Overall Study|Withdrawal by Subject|0|||
130254978|NCT02655601|468897036|FG003|Overall Study|Withdrawal by Subject|0|||
130254979|NCT02655601|468897037|FG004|Overall Study|Withdrawal by Subject|4|||
130254980|NCT02655601|468897038|FG005|Overall Study|Withdrawal by Subject|8|||
130254981|NCT02655601|468897033|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
130254982|NCT02655601|468897034|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254983|NCT02655601|468897035|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254984|NCT02655601|468897036|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254985|NCT02655601|468897037|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254986|NCT02655601|468897038|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
130254987|NCT02528305|468897042|FG000|Overall Study|Withdrawal by Subject|1|||
130254988|NCT02528305|468897042|FG000|Overall Study|Adverse Event|1|||
130254989|NCT02528305|468897042|FG000|Overall Study|Physician Decision|1|||
130254990|NCT00787800|468897043|FG000|Overall Study|Withdrawal by Subject|3|||
130254991|NCT00787800|468897044|FG001|Overall Study|Withdrawal by Subject|5|||
130254992|NCT00787800|468897043|FG000|Overall Study|Death|0|||
130254993|NCT00787800|468897044|FG001|Overall Study|Death|2|||
130254994|NCT04309500|468897046|FG000|Overall Study|Lost to Follow-up|1|||
130254995|NCT04309500|468897047|FG001|Overall Study|Lost to Follow-up|0|||
130254996|NCT04309500|468897048|FG002|Overall Study|Lost to Follow-up|0|||
130254997|NCT04309500|468897049|FG003|Overall Study|Lost to Follow-up|0|||
130254998|NCT00773461|468897050|FG000|Overall Study|Adverse Event|1|||
130254999|NCT00773461|468897051|FG001|Overall Study|Adverse Event|3|||
130255000|NCT00773461|468897050|FG000|Overall Study|Withdrawal by Subject|4|||
130255001|NCT00773461|468897051|FG001|Overall Study|Withdrawal by Subject|1|||
130255002|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
130255003|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
130101278|NCT03505606|468328619|FG002|Overall Study|alternation of amblyopic eye|0|||
130101279|NCT02087865|468328621|FG000|Overall Study|Withdrawal by Subject|6|||
130101280|NCT02087865|468328622|FG001|Overall Study|Withdrawal by Subject|0|||
130101281|NCT02087865|468328623|FG002|Overall Study|Withdrawal by Subject|1|||
130101282|NCT02087865|468328621|FG000|Overall Study|Lost to Follow-up|0|||
130101283|NCT02087865|468328622|FG001|Overall Study|Lost to Follow-up|0|||
130101284|NCT02087865|468328623|FG002|Overall Study|Lost to Follow-up|1|||
130101285|NCT02087865|468328621|FG000|Overall Study|Drug Non-compliance|0|||
130101286|NCT02087865|468328622|FG001|Overall Study|Drug Non-compliance|2|||
130101287|NCT02087865|468328623|FG002|Overall Study|Drug Non-compliance|0|||
130101288|NCT02087865|468328621|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
130101289|NCT02087865|468328622|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
130101290|NCT02087865|468328623|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
130255004|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
130255005|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
130101291|NCT01392469|468328626|FG000|Overall Study|Adverse Event|2|||
130255006|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
130255007|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
130255008|NCT00913835|468897052|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
130255009|NCT00913835|468897053|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
130255010|NCT00913835|468897052|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
130255011|NCT00913835|468897053|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
130255012|NCT00637156|468897054|FG000|Overall Study|Withdrawal by Subject|0|||
130255013|NCT00637156|468897055|FG001|Overall Study|Withdrawal by Subject|7|||
130255014|NCT00637156|468897054|FG000|Overall Study|Death|0|||
130255015|NCT00637156|468897055|FG001|Overall Study|Death|1|||
130255016|NCT00637156|468897054|FG000|Overall Study|Lost to Follow-up|10|||
130255017|NCT00637156|468897055|FG001|Overall Study|Lost to Follow-up|16|||
130255018|NCT00461812|468897056|FG000|Overall Study|study terminated|10|||
130255019|NCT01308788|468897057|FG000|2-year Treatment|medication change by treating physician|4|||
130255020|NCT01308788|468897058|FG001|2-year Treatment|medication change by treating physician|11|||
130255021|NCT03193437|468897059|FG000|Overall Study|Adverse Event|4|||
130255022|NCT03193437|468897059|FG000|Overall Study|Withdrawal by Subject|2|||
130255023|NCT03193437|468897059|FG000|Overall Study|Disease Progression|2|||
130255024|NCT05487378|468897060|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
130255025|NCT05487378|468897061|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
130255026|NCT05487378|468897060|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
130255027|NCT05487378|468897061|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
130255028|NCT02414841|468897062|FG000|Overall Study|Withdrawal by Subject|7|||
130255029|NCT02414841|468897063|FG001|Overall Study|Withdrawal by Subject|5|||
130255030|NCT02414841|468897062|FG000|Overall Study|Lost to Follow-up|13|||
130255031|NCT02414841|468897063|FG001|Overall Study|Lost to Follow-up|6|||
130255032|NCT02414841|468897062|FG000|Overall Study|Death|17|||
130255033|NCT02414841|468897063|FG001|Overall Study|Death|14|||
130255034|NCT02414841|468897062|FG000|Overall Study|Received a Kidney Transplant|13|||
130255035|NCT02414841|468897063|FG001|Overall Study|Received a Kidney Transplant|4|||
130255036|NCT02414841|468897062|FG000|Overall Study|Randomized But Not Treated|6|||
130255037|NCT02414841|468897063|FG001|Overall Study|Randomized But Not Treated|4|||
130255038|NCT00964678|468897079|FG000|Overall Study|Physician Decision|4|||
130255039|NCT03359395|468897082|FG000|First Intervention A / B|Withdrawal by Subject|1|||
130255040|NCT03359395|468897083|FG001|First Intervention A / B|Withdrawal by Subject|0|||
130255041|NCT03359395|468897082|FG000|First Intervention A / B|Lost to Follow-up|2|||
130255042|NCT03359395|468897083|FG001|First Intervention A / B|Lost to Follow-up|3|||
130255043|NCT03359395|468897082|FG000|Second Intervention B/A|Exclusion criteria|0|||
130255044|NCT03359395|468897083|FG001|Second Intervention B/A|Exclusion criteria|1|||
130255045|NCT03359395|468897082|FG000|Second Intervention B/A|Lost to Follow-up|3|||
130255046|NCT03359395|468897083|FG001|Second Intervention B/A|Lost to Follow-up|2|||
130255047|NCT03164356|468897086|FG000|Overall Study|Lost to Follow-up|1|||
130255048|NCT03164356|468897087|FG001|Overall Study|Lost to Follow-up|1|||
130255049|NCT03164356|468897088|FG002|Overall Study|Lost to Follow-up|2|||
130255050|NCT03164356|468897089|FG003|Overall Study|Lost to Follow-up|1|||
130255051|NCT03164356|468897086|FG000|Overall Study|Physician Decision|0|||
130255052|NCT03164356|468897087|FG001|Overall Study|Physician Decision|0|||
130255053|NCT03164356|468897088|FG002|Overall Study|Physician Decision|3|||
130255054|NCT03164356|468897089|FG003|Overall Study|Physician Decision|0|||
130255055|NCT03164356|468897086|FG000|Overall Study|Protocol Violation|2|||
130255056|NCT03164356|468897087|FG001|Overall Study|Protocol Violation|1|||
130255057|NCT03164356|468897088|FG002|Overall Study|Protocol Violation|0|||
130101292|NCT01392469|468328626|FG000|Overall Study|Withdrawal by Subject|1|||
130101293|NCT01392469|468328626|FG000|Overall Study|Protocol Violation|1|||
130101294|NCT00648739|468328629|FG000|Overall Study|Adverse Event|1|||
130101295|NCT00648739|468328630|FG001|Overall Study|Adverse Event|0|||
130101296|NCT00648739|468328631|FG002|Overall Study|Adverse Event|1|||
130101297|NCT00648739|468328632|FG003|Overall Study|Adverse Event|2|||
130101298|NCT00648739|468328633|FG004|Overall Study|Adverse Event|1|||
130101299|NCT00648739|468328634|FG005|Overall Study|Adverse Event|0|||
130101300|NCT00648739|468328635|FG006|Overall Study|Adverse Event|0|||
130101301|NCT00648739|468328629|FG000|Overall Study|Withdrawal by Subject|1|||
130101302|NCT00648739|468328630|FG001|Overall Study|Withdrawal by Subject|0|||
130101303|NCT00648739|468328631|FG002|Overall Study|Withdrawal by Subject|1|||
130255058|NCT03164356|468897089|FG003|Overall Study|Protocol Violation|0|||
130255059|NCT03164356|468897086|FG000|Overall Study|Withdrawal by Subject|1|||
130101304|NCT00648739|468328632|FG003|Overall Study|Withdrawal by Subject|0|||
130101305|NCT00648739|468328633|FG004|Overall Study|Withdrawal by Subject|0|||
130101306|NCT00648739|468328634|FG005|Overall Study|Withdrawal by Subject|2|||
130255060|NCT03164356|468897087|FG001|Overall Study|Withdrawal by Subject|0|||
130255061|NCT03164356|468897088|FG002|Overall Study|Withdrawal by Subject|0|||
130255062|NCT03164356|468897089|FG003|Overall Study|Withdrawal by Subject|0|||
130255063|NCT03164356|468897086|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
130255064|NCT03164356|468897087|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
130101307|NCT00648739|468328635|FG006|Overall Study|Withdrawal by Subject|0|||
130101308|NCT00648739|468328629|FG000|Overall Study|Lack of Efficacy|0|||
130101309|NCT00648739|468328630|FG001|Overall Study|Lack of Efficacy|0|||
130255065|NCT03164356|468897088|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
130255066|NCT03164356|468897089|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
130255067|NCT03164356|468897086|FG000|Overall Study|Subject Incarcerated|0|||
130255068|NCT03164356|468897087|FG001|Overall Study|Subject Incarcerated|1|||
130255069|NCT03164356|468897088|FG002|Overall Study|Subject Incarcerated|0|||
130255070|NCT03164356|468897089|FG003|Overall Study|Subject Incarcerated|0|||
130255071|NCT03164356|468897086|FG000|Overall Study|Prosthetist unable to participate|0|||
130255072|NCT03164356|468897087|FG001|Overall Study|Prosthetist unable to participate|2|||
130255073|NCT03164356|468897088|FG002|Overall Study|Prosthetist unable to participate|1|||
130255074|NCT03164356|468897089|FG003|Overall Study|Prosthetist unable to participate|0|||
130255075|NCT05943990|468897091|FG000|Overall Study|Study Terminated by Sponsor|0|||
130255076|NCT05943990|468897092|FG001|Overall Study|Study Terminated by Sponsor|0|||
130255077|NCT05943990|468897093|FG002|Overall Study|Study Terminated by Sponsor|1|||
130255078|NCT02657356|468897934|FG000|Overall Study|Death|1|||
130255079|NCT02657356|468897935|FG001|Overall Study|Death|0|||
130255080|NCT02657356|468897934|FG000|Overall Study|Withdrawal by Subject|5|||
130255081|NCT02657356|468897935|FG001|Overall Study|Withdrawal by Subject|6|||
130255082|NCT02657356|468897934|FG000|Overall Study|Terminated by Sponsor|8|||
130255083|NCT02657356|468897935|FG001|Overall Study|Terminated by Sponsor|5|||
130255084|NCT02657356|468897934|FG000|Overall Study|Rolled over to EAP study|6|||
130255085|NCT02657356|468897935|FG001|Overall Study|Rolled over to EAP study|4|||
130255086|NCT03443401|468897942|FG000|Overall Study|Lost to Follow-up|13|||
130255087|NCT03443401|468897942|FG000|Overall Study|Influential outlier|1|||
130255088|NCT00980044|468897943|FG000|Overall Study|Withdrawal by Subject|5|||
130255089|NCT00980044|468897944|FG001|Overall Study|Withdrawal by Subject|7|||
130255090|NCT00980044|468897945|FG002|Overall Study|Withdrawal by Subject|3|||
130255091|NCT00980044|468897943|FG000|Overall Study|Protocol Violation|0|||
130255092|NCT00980044|468897944|FG001|Overall Study|Protocol Violation|0|||
130255093|NCT00980044|468897945|FG002|Overall Study|Protocol Violation|2|||
130255094|NCT02904265|468897946|FG000|Overall Study|Physician Decision|1|||
130255095|NCT02904265|468897947|FG001|Overall Study|Physician Decision|2|||
130255096|NCT00833703|468897949|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
130255097|NCT00833703|468897950|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
130255098|NCT05538728|468897951|FG000|Overall Study|Withdrawal by Subject|1|||
130255099|NCT05538728|468897952|FG001|Overall Study|Withdrawal by Subject|1|||
130255100|NCT02254460|468897953|FG000|Overall Study|Adverse Event|1|||
130255101|NCT02254460|468897954|FG001|Overall Study|Adverse Event|0|||
130255102|NCT01904279|468897957|FG000|Overall Study|Lack of Efficacy|2|||
130255103|NCT01904279|468897958|FG001|Overall Study|Lack of Efficacy|3|||
130255104|NCT01904279|468897957|FG000|Overall Study|Withdrawal by Subject|1|||
130255105|NCT01904279|468897958|FG001|Overall Study|Withdrawal by Subject|0|||
130255106|NCT01356940|468897961|FG000|First Intervention (28 Days)|Adverse Event|1|||
130032153|NCT01848145|468074972|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
130032154|NCT01848145|468074972|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
130032155|NCT01848145|468074972|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
130032156|NCT01848145|468074972|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
130032157|NCT00501228|468074973|FG000|Overall Study|Withdrawal by Subject|1|||
130032158|NCT03804684|468074974|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
130255107|NCT01356940|468897962|FG001|First Intervention (28 Days)|Adverse Event|0|||
130255108|NCT01356940|468897961|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
130255109|NCT01356940|468897962|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
130255110|NCT01344356|468897965|FG000|Overall Study|Physician Decision|0|||
130255111|NCT01344356|468897966|FG001|Overall Study|Physician Decision|3|||
130255112|NCT01344356|468897965|FG000|Overall Study|Lost to Follow-up|0|||
130255113|NCT01344356|468897966|FG001|Overall Study|Lost to Follow-up|6|||
130255114|NCT00095576|468897967|FG000|Overall Study|Adverse Event|5|||
130255115|NCT00095576|468897968|FG001|Overall Study|Adverse Event|3|||
130255116|NCT00095576|468897967|FG000|Overall Study|Lost to Follow-up|233|||
130255117|NCT00095576|468897968|FG001|Overall Study|Lost to Follow-up|229|||
130255118|NCT00095576|468897967|FG000|Overall Study|Protocol Violation|1|||
130255119|NCT00095576|468897968|FG001|Overall Study|Protocol Violation|0|||
130255120|NCT00095576|468897967|FG000|Overall Study|Withdrawal by Subject|34|||
130032159|NCT03804684|468074975|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
130032160|NCT01147926|468074976|FG000|Overall Study|Subject Withdrew Consent|9|||
130101310|NCT00648739|468328631|FG002|Overall Study|Lack of Efficacy|0|||
130101311|NCT00648739|468328632|FG003|Overall Study|Lack of Efficacy|0|||
130255121|NCT00095576|468897968|FG001|Overall Study|Withdrawal by Subject|47|||
130255122|NCT00095576|468897967|FG000|Overall Study|Option to switch to a rollover study|1097|||
130255123|NCT00095576|468897968|FG001|Overall Study|Option to switch to a rollover study|1099|||
130255124|NCT00095576|468897967|FG000|Overall Study|Site terminated|75|||
130255125|NCT00095576|468897968|FG001|Overall Study|Site terminated|67|||
130255126|NCT00095576|468897967|FG000|Overall Study|Subject moved|30|||
130255127|NCT00095576|468897968|FG001|Overall Study|Subject moved|36|||
130255128|NCT00505687|468897969|FG000|Overall Study|Important protocol violation|2|||
130255129|NCT00505687|468897969|FG000|Overall Study|Lack of Efficacy|15|||
130255130|NCT00505687|468897969|FG000|Overall Study|Adverse Event|48|||
130255131|NCT00505687|468897969|FG000|Overall Study|Subject withdrew consent|15|||
130255132|NCT00505687|468897969|FG000|Overall Study|Lost to Follow-up|1|||
130255133|NCT00505687|468897969|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
130255134|NCT00505687|468897969|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
130255135|NCT00505687|468897969|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
130255136|NCT00505687|468897969|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
130255137|NCT00505687|468897969|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
130255138|NCT00505687|468897969|FG000|Overall Study|Other: Disease Progression|1|||
130255139|NCT00505687|468897969|FG000|Overall Study|Other: As Per Sponsor|8|||
130255140|NCT00480532|468897970|FG000|Overall Study|Withdrawal by Subject|2|||
130255141|NCT00480532|468897971|FG001|Overall Study|Withdrawal by Subject|4|||
130255142|NCT00480532|468897972|FG002|Overall Study|Withdrawal by Subject|3|||
130255143|NCT00480532|468897973|FG003|Overall Study|Withdrawal by Subject|1|||
130255144|NCT00480532|468897970|FG000|Overall Study|Protocol Violation|0|||
130255145|NCT00480532|468897971|FG001|Overall Study|Protocol Violation|0|||
130255146|NCT00480532|468897972|FG002|Overall Study|Protocol Violation|1|||
130255147|NCT00480532|468897973|FG003|Overall Study|Protocol Violation|0|||
130255148|NCT01817777|468897974|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
130255149|NCT01817777|468897975|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
130255150|NCT01817777|468897976|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
130255151|NCT01817777|468897974|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
130255152|NCT01817777|468897975|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
130255153|NCT01817777|468897976|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
129885113|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Other|0|||
129885114|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Other|0|||
130032161|NCT01147926|468074977|FG001|Overall Study|Subject Withdrew Consent|10|||
130032162|NCT01147926|468074976|FG000|Overall Study|Adverse Event|7|||
130032163|NCT01147926|468074977|FG001|Overall Study|Adverse Event|6|||
130032164|NCT01147926|468074976|FG000|Overall Study|Subject Non-Compliant|5|||
130032165|NCT01147926|468074977|FG001|Overall Study|Subject Non-Compliant|4|||
130032166|NCT01147926|468074976|FG000|Overall Study|Principal investigator left hospital|1|||
130032167|NCT01147926|468074977|FG001|Overall Study|Principal investigator left hospital|3|||
130032168|NCT01147926|468074976|FG000|Overall Study|Selection criteria not met|3|||
130032169|NCT01147926|468074977|FG001|Overall Study|Selection criteria not met|1|||
130032170|NCT01147926|468074976|FG000|Overall Study|Lost to Follow-up|0|||
130032171|NCT01147926|468074977|FG001|Overall Study|Lost to Follow-up|2|||
130032172|NCT01147926|468074976|FG000|Overall Study|Sponsor's Decision|0|||
130032173|NCT01147926|468074977|FG001|Overall Study|Sponsor's Decision|1|||
130032174|NCT01147926|468074976|FG000|Overall Study|Lack of Efficacy|1|||
130032175|NCT01147926|468074977|FG001|Overall Study|Lack of Efficacy|0|||
130032176|NCT01147926|468074976|FG000|Overall Study|Too busy, no time for study|1|||
130032177|NCT01147926|468074977|FG001|Overall Study|Too busy, no time for study|0|||
130032178|NCT01147926|468074976|FG000|Overall Study|Went on holiday|0|||
130032179|NCT01147926|468074977|FG001|Overall Study|Went on holiday|1|||
130032180|NCT01147926|468074976|FG000|Overall Study|Colonoscopy result|0|||
130032181|NCT01147926|468074977|FG001|Overall Study|Colonoscopy result|1|||
130032182|NCT01670994|468074982|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
130032183|NCT01670994|468074983|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
130032184|NCT01670994|468074982|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
130032185|NCT01670994|468074983|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
130032186|NCT01670994|468074982|FG000|Overall Study|Patient experienced DLT|0|||
130032187|NCT01670994|468074983|FG001|Overall Study|Patient experienced DLT|1|||
130032188|NCT02013544|468074984|FG000|Overall Study|Adverse Event|5|||
130032189|NCT02013544|468074985|FG001|Overall Study|Adverse Event|5|||
130032190|NCT02013544|468074984|FG000|Overall Study|Lost to Follow-up|2|||
130032191|NCT02013544|468074985|FG001|Overall Study|Lost to Follow-up|3|||
130032192|NCT02013544|468074984|FG000|Overall Study|Withdrawal by Subject|2|||
130032193|NCT02013544|468074985|FG001|Overall Study|Withdrawal by Subject|8|||
130255154|NCT01817777|468897974|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
130255155|NCT01817777|468897975|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
130255156|NCT01817777|468897976|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
130255157|NCT01817777|468897974|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
130032194|NCT02013544|468074984|FG000|Overall Study|Physician Decision|0|||
130032195|NCT02013544|468074985|FG001|Overall Study|Physician Decision|1|||
130032196|NCT02013544|468074984|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
130032197|NCT02013544|468074985|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
130032198|NCT01295125|468074986|FG000|Overall Study|Study stopped prematurely|9|||
130032199|NCT00885365|468074989|FG000|4 Weeks ON Treatment|Adverse Event|2|||
130255158|NCT01817777|468897975|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
130255159|NCT01817777|468897976|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
130255160|NCT01817777|468897974|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
130255161|NCT01817777|468897975|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
130255162|NCT01817777|468897976|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
130255163|NCT00443456|468897977|FG000|Overall Study|Adverse Event|16|||
130255164|NCT00443456|468897977|FG000|Overall Study|Move|1|||
130255165|NCT00443456|468897977|FG000|Overall Study|Withdrawal by Subject|1|||
130255166|NCT00557440|468897978|FG000|Treatment Period 1|Adverse Event|0|||
130255167|NCT00557440|468897979|FG001|Treatment Period 1|Adverse Event|0|||
130255168|NCT00557440|468897980|FG002|Treatment Period 1|Adverse Event|1|||
130255169|NCT03524157|468897981|FG000|Overall Study|cytology not readable|0|||
130255170|NCT03524157|468897982|FG001|Overall Study|cytology not readable|0|||
130255171|NCT03524157|468897983|FG002|Overall Study|cytology not readable|1|||
130255172|NCT02157610|468897984|FG000|Overall Study|Death|4|||
130255173|NCT02157610|468897985|FG001|Overall Study|Death|4|||
130255174|NCT01378195|468897986|FG000|Overall Study|Lost to Follow-up|29|||
130255175|NCT01378195|468897987|FG001|Overall Study|Lost to Follow-up|18|||
130255176|NCT00425555|468897988|FG000|Overall Study|Withdrawal by Subject|11|||
130255177|NCT00425555|468897989|FG001|Overall Study|Withdrawal by Subject|8|||
130255178|NCT00425555|468897988|FG000|Overall Study|Lost to Follow-up|0|||
130255179|NCT00425555|468897989|FG001|Overall Study|Lost to Follow-up|1|||
130255180|NCT00425555|468897988|FG000|Overall Study|Administrative problems|3|||
130255181|NCT00425555|468897989|FG001|Overall Study|Administrative problems|0|||
130255182|NCT00425555|468897988|FG000|Overall Study|Death|1|||
130255183|NCT00425555|468897989|FG001|Overall Study|Death|2|||
130032200|NCT00885365|468074990|FG001|4 Weeks ON Treatment|Adverse Event|4|||
130255184|NCT00425555|468897988|FG000|Overall Study|New cancer therapy|2|||
130255185|NCT00425555|468897989|FG001|Overall Study|New cancer therapy|1|||
130255186|NCT00425555|468897988|FG000|Overall Study|Disease progression|36|||
130255187|NCT00425555|468897989|FG001|Overall Study|Disease progression|33|||
130255188|NCT00425555|468897988|FG000|Overall Study|Adverse Event|25|||
130255189|NCT00425555|468897989|FG001|Overall Study|Adverse Event|15|||
130255190|NCT00425555|468897988|FG000|Overall Study|Protocol Violation|1|||
130255191|NCT00425555|468897989|FG001|Overall Study|Protocol Violation|0|||
130255192|NCT05418426|468897990|FG000|Overall Study|Adverse Event|0|||
130255193|NCT05418426|468897991|FG001|Overall Study|Adverse Event|1|||
130255194|NCT05418426|468897992|FG002|Overall Study|Adverse Event|0|||
130032201|NCT00885365|468074989|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
130032202|NCT00885365|468074990|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
130032203|NCT00885365|468074989|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
130032204|NCT00885365|468074990|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
130032205|NCT01824979|468074991|FG000|Overall Study|Withdrawal by Subject|5|||
130255195|NCT05418426|468897990|FG000|Overall Study|Withdrawal by Subject|0|||
130255196|NCT05418426|468897991|FG001|Overall Study|Withdrawal by Subject|1|||
130255197|NCT05418426|468897992|FG002|Overall Study|Withdrawal by Subject|0|||
130255198|NCT05418426|468897990|FG000|Overall Study|Protocol Violation|0|||
130255199|NCT05418426|468897991|FG001|Overall Study|Protocol Violation|0|||
130255200|NCT05418426|468897992|FG002|Overall Study|Protocol Violation|1|||
130255201|NCT01674062|468897993|FG000|Overall Study|Insufficient Therapeutic Response|56|||
130255202|NCT01674062|468897994|FG001|Overall Study|Insufficient Therapeutic Response|26|||
130032206|NCT01824979|468074992|FG001|Overall Study|Withdrawal by Subject|0|||
130032207|NCT01824979|468074991|FG000|Overall Study|Physician Decision|2|||
130032208|NCT01824979|468074992|FG001|Overall Study|Physician Decision|0|||
130032209|NCT01824979|468074991|FG000|Overall Study|Protocol Violation|6|||
130032210|NCT01824979|468074992|FG001|Overall Study|Protocol Violation|13|||
130032211|NCT01686568|468074994|FG000|Main Study|Withdrawal by Subject|1|||
130032212|NCT01686568|468074995|FG001|Main Study|Withdrawal by Subject|3|||
130032213|NCT01686568|468074994|FG000|Main Study|Noncompliance with protocol|0|||
130032214|NCT01686568|468074995|FG001|Main Study|Noncompliance with protocol|1|||
130032215|NCT01686568|468074994|FG000|Main Study|Liver enzymes above range of exclusion|1|||
130032216|NCT01686568|468074995|FG001|Main Study|Liver enzymes above range of exclusion|0|||
130032217|NCT01686568|468074994|FG000|Sub-Study|Not consented for sub-study|2|||
130032218|NCT01686568|468074995|FG001|Sub-Study|Not consented for sub-study|2|||
130032219|NCT03838484|468074998|FG000|Overall Study|Lost to Follow-up|0|||
130032220|NCT03838484|468074999|FG001|Overall Study|Lost to Follow-up|1|||
130032221|NCT03838484|468075000|FG002|Overall Study|Lost to Follow-up|0|||
130032222|NCT03838484|468075001|FG003|Overall Study|Lost to Follow-up|0|||
130032223|NCT00813995|468075002|FG000|Overall Study|Clinical adverse event|9|||
130032224|NCT00813995|468075003|FG001|Overall Study|Clinical adverse event|3|||
130032225|NCT00813995|468075002|FG000|Overall Study|Laboratory adverse event|0|||
130032226|NCT00813995|468075003|FG001|Overall Study|Laboratory adverse event|2|||
130101312|NCT00648739|468328633|FG004|Overall Study|Lack of Efficacy|1|||
130101313|NCT00648739|468328634|FG005|Overall Study|Lack of Efficacy|2|||
130032227|NCT00813995|468075002|FG000|Overall Study|Lack of Efficacy|1|||
130101314|NCT00648739|468328635|FG006|Overall Study|Lack of Efficacy|0|||
130255203|NCT01674062|468897993|FG000|Overall Study|Other|8|||
130255204|NCT01674062|468897994|FG001|Overall Study|Other|1|||
130255205|NCT01674062|468897993|FG000|Overall Study|Adverse Event|1|||
130255206|NCT01674062|468897994|FG001|Overall Study|Adverse Event|1|||
130255207|NCT01674062|468897993|FG000|Overall Study|Death|0|||
130255208|NCT01674062|468897994|FG001|Overall Study|Death|1|||
129885115|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Other|0|||
129885116|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Other|0|||
129885117|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Other|0|||
129885118|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Other|2|||
129885119|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Other|2|||
129885120|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Other|0|||
129885121|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Death|0|||
129885122|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Death|0|||
129885123|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Death|0|||
129885124|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Death|0|||
129885125|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Death|0|||
129885126|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Death|0|||
129885127|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Death|0|||
129885128|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Death|0|||
129885129|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Death|1|||
129885130|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Death|0|||
129885131|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Death|0|||
129885132|NCT01040780|467540580|FG000|Overall Study|Protocol Violation|1|||
129885133|NCT01040780|467540581|FG001|Overall Study|Protocol Violation|3|||
129885134|NCT00802737|467540582|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
129885135|NCT00802737|467540583|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
129885136|NCT00802737|467540584|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
129885137|NCT00802737|467540582|FG000|Overall Study|Death|6|||
129885138|NCT00802737|467540583|FG001|Overall Study|Death|5|||
129885139|NCT00802737|467540584|FG002|Overall Study|Death|1|||
129885140|NCT00802737|467540582|FG000|Overall Study|Adverse Event|1|||
129885141|NCT00802737|467540583|FG001|Overall Study|Adverse Event|0|||
129885142|NCT00802737|467540584|FG002|Overall Study|Adverse Event|0|||
129885143|NCT00802737|467540582|FG000|Overall Study|Received Prohibited Therapy|1|||
129885144|NCT00802737|467540583|FG001|Overall Study|Received Prohibited Therapy|0|||
129885145|NCT00802737|467540584|FG002|Overall Study|Received Prohibited Therapy|0|||
129885146|NCT00802737|467540582|FG000|Overall Study|Ongoing CLL-Treatment|0|||
129885147|NCT00802737|467540583|FG001|Overall Study|Ongoing CLL-Treatment|1|||
129885148|NCT00802737|467540584|FG002|Overall Study|Ongoing CLL-Treatment|0|||
129885149|NCT00802737|467540582|FG000|Overall Study|Participant too Unwell|0|||
129885150|NCT00802737|467540583|FG001|Overall Study|Participant too Unwell|2|||
129885151|NCT00802737|467540584|FG002|Overall Study|Participant too Unwell|0|||
129885152|NCT03864926|467540592|FG000|Overall Study|Death|0|||
129885153|NCT03864926|467540593|FG001|Overall Study|Death|2|||
129885154|NCT00445601|467540594|FG000|Overall Study|Withdrawal by Subject|11|||
129885155|NCT00445601|467540595|FG001|Overall Study|Withdrawal by Subject|11|||
129885156|NCT00445601|467540594|FG000|Overall Study|TURBT Complication|12|||
129885157|NCT00445601|467540595|FG001|Overall Study|TURBT Complication|8|||
129885158|NCT00445601|467540594|FG000|Overall Study|Incorrect Disease Status|6|||
129885159|NCT00445601|467540595|FG001|Overall Study|Incorrect Disease Status|6|||
129885160|NCT00445601|467540594|FG000|Overall Study|Drug Delivery Issue|2|||
129885161|NCT00445601|467540595|FG001|Overall Study|Drug Delivery Issue|2|||
129885162|NCT00445601|467540594|FG000|Overall Study|Adverse Event|2|||
129885163|NCT00445601|467540595|FG001|Overall Study|Adverse Event|0|||
129885164|NCT00445601|467540594|FG000|Overall Study|Death prior to TURBT|0|||
129885165|NCT00445601|467540595|FG001|Overall Study|Death prior to TURBT|1|||
129885166|NCT02391038|467540602|FG000|Overall Study|Progressive disease|3|||
129885167|NCT02391038|467540603|FG001|Overall Study|Progressive disease|3|||
129885168|NCT02391038|467540604|FG002|Overall Study|Progressive disease|6|||
129885169|NCT04213989|467540605|FG000|Overall Study|Withdrawal by Subject|3|||
129885170|NCT04213989|467540606|FG001|Overall Study|Withdrawal by Subject|2|||
129885171|NCT04213989|467540605|FG000|Overall Study|Physician Decision|1|||
130255209|NCT01674062|468897993|FG000|Overall Study|Programming Error|1|||
130255210|NCT01674062|468897994|FG001|Overall Study|Programming Error|0|||
130255211|NCT04620668|468897995|FG000|Overall Study|Withdrawal by Subject|2|||
130255212|NCT04620668|468897996|FG001|Overall Study|Withdrawal by Subject|0|||
129885172|NCT04213989|467540606|FG001|Overall Study|Physician Decision|0|||
130032228|NCT00813995|468075003|FG001|Overall Study|Lack of Efficacy|0|||
130255213|NCT04620668|468897995|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
130255214|NCT04620668|468897996|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
129885173|NCT04213989|467540605|FG000|Overall Study|Lost to Follow-up|0|||
129885174|NCT04213989|467540606|FG001|Overall Study|Lost to Follow-up|4|||
129885175|NCT02930122|467540608|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
129885176|NCT02930122|467540609|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
129885177|NCT01681368|467540610|FG000|Overall Study|Refused further treatment|1|||
129885178|NCT01681368|467540610|FG000|Overall Study|Refused further follow up|1|||
129885179|NCT01189890|467540611|FG000|Overall Study|Adverse Event|3|||
129885180|NCT01189890|467540612|FG001|Overall Study|Adverse Event|4|||
129885181|NCT01189890|467540611|FG000|Overall Study|Lack of Efficacy|7|||
129885182|NCT01189890|467540612|FG001|Overall Study|Lack of Efficacy|2|||
130255215|NCT04620668|468897995|FG000|Overall Study|Removed before analysis: missing data|2|||
130255216|NCT04620668|468897996|FG001|Overall Study|Removed before analysis: missing data|0|||
130255217|NCT04620668|468897995|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
130255218|NCT04620668|468897996|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
130255219|NCT04620668|468897995|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
130255220|NCT04620668|468897996|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
130255221|NCT02796651|468898004|FG000|Overall Study|Adverse Event|6|||
130255222|NCT02796651|468898004|FG000|Overall Study|Lost to Follow-up|1|||
130255223|NCT02796651|468898004|FG000|Overall Study|Withdrawal by Subject|4|||
130255224|NCT02796651|468898004|FG000|Overall Study|Protocol Violation|4|||
130255225|NCT02796651|468898004|FG000|Overall Study|Lack of Efficacy|1|||
130255226|NCT02796651|468898004|FG000|Overall Study|Other|10|||
130255227|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
130255228|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
130255229|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
130255230|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
130255231|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
130255232|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
130255233|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
130255234|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
130255235|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
130255236|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
130255237|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130255238|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130255239|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
130255240|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
130255241|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
130255242|NCT05014919|468898005|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
130255243|NCT05014919|468898006|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
130255244|NCT05014919|468898007|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
130255245|NCT05014919|468898005|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
130255246|NCT05014919|468898006|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
130255247|NCT05014919|468898007|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
130255248|NCT05014919|468898005|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
130255249|NCT05014919|468898006|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
130255250|NCT05014919|468898007|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
130255251|NCT00680914|468898008|FG000|Overall Study|Consent withdrawal|6|||
130255252|NCT00680914|468898009|FG001|Overall Study|Consent withdrawal|3|||
130255253|NCT00680914|468898008|FG000|Overall Study|Lost to Follow-up|4|||
130255254|NCT00680914|468898009|FG001|Overall Study|Lost to Follow-up|0|||
130255255|NCT00680914|468898008|FG000|Overall Study|serious adverse event (SAE)|0|||
130255256|NCT00680914|468898009|FG001|Overall Study|serious adverse event (SAE)|1|||
130255257|NCT02971163|468898010|FG000|Overall Study|Lost to Follow-up|4|||
130255258|NCT02971163|468898011|FG001|Overall Study|Lost to Follow-up|2|||
130255259|NCT00539500|468898012|FG000|Overall Study|Disease Progression|1|||
130255260|NCT00539500|468898012|FG000|Overall Study|Lost to Follow-up|2|||
130255261|NCT01491919|468898017|FG000|Overall Study|Insufficient PK sampling|1|||
130255262|NCT01491919|468898018|FG001|Overall Study|Insufficient PK sampling|2|||
130255263|NCT01491919|468898019|FG002|Overall Study|Insufficient PK sampling|1|||
130255264|NCT04003389|468898020|FG000|Overall Study|Adverse Event|27|||
130255265|NCT04003389|468898021|FG001|Overall Study|Adverse Event|34|||
130101315|NCT00648739|468328629|FG000|Overall Study|Investigator Considered it Advisable|0|||
130101316|NCT00648739|468328630|FG001|Overall Study|Investigator Considered it Advisable|0|||
130255266|NCT04003389|468898022|FG002|Overall Study|Adverse Event|28|||
130255267|NCT04003389|468898020|FG000|Overall Study|Lost to Follow-up|39|||
130255268|NCT04003389|468898021|FG001|Overall Study|Lost to Follow-up|30|||
130255269|NCT04003389|468898022|FG002|Overall Study|Lost to Follow-up|33|||
130255270|NCT04003389|468898020|FG000|Overall Study|Protocol Violation|1|||
130255271|NCT04003389|468898021|FG001|Overall Study|Protocol Violation|6|||
130255272|NCT04003389|468898022|FG002|Overall Study|Protocol Violation|5|||
130255273|NCT04003389|468898020|FG000|Overall Study|Withdrawal by Subject|119|||
130255274|NCT04003389|468898021|FG001|Overall Study|Withdrawal by Subject|79|||
130101317|NCT00648739|468328631|FG002|Overall Study|Investigator Considered it Advisable|0|||
130101318|NCT00648739|468328632|FG003|Overall Study|Investigator Considered it Advisable|0|||
130255275|NCT04003389|468898022|FG002|Overall Study|Withdrawal by Subject|85|||
130255276|NCT04003389|468898020|FG000|Overall Study|Miscellaneous|14|||
130255277|NCT04003389|468898021|FG001|Overall Study|Miscellaneous|11|||
130101319|NCT00648739|468328633|FG004|Overall Study|Investigator Considered it Advisable|0|||
130255278|NCT04003389|468898022|FG002|Overall Study|Miscellaneous|14|||
130255279|NCT04003389|468898020|FG000|Overall Study|Participant did not receive study drug|1|||
129885183|NCT01189890|467540611|FG000|Overall Study|Lost to Follow-up|1|||
130255280|NCT04003389|468898021|FG001|Overall Study|Participant did not receive study drug|0|||
130255281|NCT04003389|468898022|FG002|Overall Study|Participant did not receive study drug|0|||
130255282|NCT02871219|468898023|FG000|Overall Study|Adverse Event|15|||
130255283|NCT02871219|468898023|FG000|Overall Study|Death|3|||
130255284|NCT02871219|468898023|FG000|Overall Study|Progression|3|||
130255285|NCT02871219|468898023|FG000|Overall Study|Infections|7|||
130255286|NCT02871219|468898023|FG000|Overall Study|Infusion Related|4|||
130255287|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
130255288|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130255289|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130255290|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
130255291|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130255292|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
130255293|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130255294|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
130255295|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
130255296|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
130255297|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
130255298|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
130255299|NCT05375929|468898031|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130255300|NCT05375929|468898032|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
130255301|NCT05375929|468898033|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130255302|NCT05375929|468898034|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
130255303|NCT05375929|468898031|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
130255304|NCT05375929|468898032|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130255305|NCT05375929|468898033|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130255306|NCT05375929|468898034|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
130255307|NCT05375929|468898031|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130255308|NCT05375929|468898032|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
130255309|NCT05375929|468898033|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130255310|NCT05375929|468898034|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
130255311|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130255312|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130255313|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
130255314|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
130255315|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130255316|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130255317|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
130255318|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
130255319|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130255320|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130255321|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
130255322|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
130255323|NCT05375929|468898031|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130255324|NCT05375929|468898032|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130255325|NCT05375929|468898033|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
130255326|NCT05375929|468898034|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
130255327|NCT00322218|468898041|FG000|Overall Study|Death|3|||
130255328|NCT00322218|468898042|FG001|Overall Study|Death|6|||
130255329|NCT00908141|468898043|FG000|Overall Study|Withdrawal by Subject|0|||
130255330|NCT00908141|468898044|FG001|Overall Study|Withdrawal by Subject|1|||
130255331|NCT02520154|468898045|FG000|Overall Study|Death|1|||
130255332|NCT02520154|468898045|FG000|Overall Study|Withdrawal by Subject|2|||
130255333|NCT02520154|468898045|FG000|Overall Study|Physician Decision|2|||
130255334|NCT04280783|468899639|FG000|Overall Study|Family issues unrelated to the study.|1|||
130255335|NCT04280783|468899640|FG001|Overall Study|Family issues unrelated to the study.|0|||
130255336|NCT04280783|468899639|FG000|Overall Study|Withdrawal by Subject|0|||
130255337|NCT04280783|468899640|FG001|Overall Study|Withdrawal by Subject|1|||
130255338|NCT02254291|468899642|FG000|Overall Study|Withdrawal by Subject|0|||
130255339|NCT02254291|468899643|FG001|Overall Study|Withdrawal by Subject|3|||
130255340|NCT02254291|468899644|FG002|Overall Study|Withdrawal by Subject|1|||
130032229|NCT00813995|468075002|FG000|Overall Study|Lost to Follow-up|4|||
130255341|NCT02254291|468899642|FG000|Overall Study|Missing follow-up information|0|||
130255342|NCT02254291|468899643|FG001|Overall Study|Missing follow-up information|0|||
130255343|NCT02254291|468899644|FG002|Overall Study|Missing follow-up information|1|||
130255344|NCT00488293|468899649|FG000|Overall Study|Lost to Follow-up|28|||
130255345|NCT00488293|468899650|FG001|Overall Study|Lost to Follow-up|25|||
130255346|NCT00488293|468899649|FG000|Overall Study|Withdrawal by Subject|5|||
130255347|NCT00488293|468899650|FG001|Overall Study|Withdrawal by Subject|3|||
129885184|NCT01189890|467540612|FG001|Overall Study|Lost to Follow-up|7|||
129885185|NCT01189890|467540611|FG000|Overall Study|Protocol Violation|1|||
129885186|NCT01189890|467540612|FG001|Overall Study|Protocol Violation|5|||
129885187|NCT01189890|467540611|FG000|Overall Study|Withdrawal by Subject|15|||
130255348|NCT00488293|468899649|FG000|Overall Study|Death|2|||
129885188|NCT01189890|467540612|FG001|Overall Study|Withdrawal by Subject|11|||
130255349|NCT00488293|468899650|FG001|Overall Study|Death|1|||
130255350|NCT00488293|468899649|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
130255351|NCT00488293|468899650|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
130255352|NCT00500331|468899651|FG000|Overall Study|Adverse Event|0|||
130255353|NCT00500331|468899652|FG001|Overall Study|Adverse Event|2|||
130255354|NCT00500331|468899653|FG002|Overall Study|Adverse Event|0|||
130255355|NCT00500331|468899654|FG003|Overall Study|Adverse Event|1|||
130255356|NCT00500331|468899655|FG004|Overall Study|Adverse Event|2|||
130255357|NCT00500331|468899656|FG005|Overall Study|Adverse Event|2|||
130255358|NCT00500331|468899657|FG006|Overall Study|Adverse Event|0|||
129885189|NCT01189890|467540611|FG000|Overall Study|Non Compliance|0|||
129885190|NCT01189890|467540612|FG001|Overall Study|Non Compliance|1|||
129885191|NCT01189890|467540611|FG000|Overall Study|Physician Decision|5|||
129885192|NCT01189890|467540612|FG001|Overall Study|Physician Decision|4|||
129885193|NCT01189890|467540611|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
129885194|NCT01189890|467540612|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
129885195|NCT01807221|467540613|FG000|Overall Study|Progressive disease|1|||
129885196|NCT01807221|467540614|FG001|Overall Study|Progressive disease|0|||
129885197|NCT01807221|467540615|FG002|Overall Study|Progressive disease|1|||
129885198|NCT01807221|467540616|FG003|Overall Study|Progressive disease|0|||
129885199|NCT01807221|467540617|FG004|Overall Study|Progressive disease|0|||
129885200|NCT01807221|467540618|FG005|Overall Study|Progressive disease|0|||
129885201|NCT01807221|467540613|FG000|Overall Study|Death|7|||
129885202|NCT01807221|467540614|FG001|Overall Study|Death|9|||
129885203|NCT01807221|467540615|FG002|Overall Study|Death|4|||
129885204|NCT01807221|467540616|FG003|Overall Study|Death|2|||
129885205|NCT01807221|467540617|FG004|Overall Study|Death|1|||
129885206|NCT01807221|467540618|FG005|Overall Study|Death|6|||
129885207|NCT01807221|467540613|FG000|Overall Study|Physician Decision|2|||
129885208|NCT01807221|467540614|FG001|Overall Study|Physician Decision|1|||
129885209|NCT01807221|467540615|FG002|Overall Study|Physician Decision|0|||
129885210|NCT01807221|467540616|FG003|Overall Study|Physician Decision|0|||
129885211|NCT01807221|467540617|FG004|Overall Study|Physician Decision|0|||
130032230|NCT00813995|468075003|FG001|Overall Study|Lost to Follow-up|2|||
130255359|NCT00500331|468899651|FG000|Overall Study|Lost to Follow-up|1|||
130255360|NCT00500331|468899652|FG001|Overall Study|Lost to Follow-up|1|||
130255361|NCT00500331|468899653|FG002|Overall Study|Lost to Follow-up|1|||
130255362|NCT00500331|468899654|FG003|Overall Study|Lost to Follow-up|2|||
130255363|NCT00500331|468899655|FG004|Overall Study|Lost to Follow-up|1|||
130255364|NCT00500331|468899656|FG005|Overall Study|Lost to Follow-up|0|||
130255365|NCT00500331|468899657|FG006|Overall Study|Lost to Follow-up|0|||
130255366|NCT00500331|468899651|FG000|Overall Study|Protocol Violation|3|||
130255367|NCT00500331|468899652|FG001|Overall Study|Protocol Violation|1|||
129885212|NCT01807221|467540618|FG005|Overall Study|Physician Decision|0|||
129885213|NCT01807221|467540613|FG000|Overall Study|Adverse Event|33|||
130032231|NCT00813995|468075002|FG000|Overall Study|Other reason|2|||
130032232|NCT00813995|468075003|FG001|Overall Study|Other reason|2|||
130032233|NCT00813995|468075002|FG000|Overall Study|Protocol Violation|3|||
130032234|NCT00813995|468075003|FG001|Overall Study|Protocol Violation|2|||
130032235|NCT00813995|468075002|FG000|Overall Study|Subject moved|4|||
130255368|NCT00500331|468899653|FG002|Overall Study|Protocol Violation|1|||
130255369|NCT00500331|468899654|FG003|Overall Study|Protocol Violation|0|||
129885214|NCT01807221|467540614|FG001|Overall Study|Adverse Event|22|||
129885215|NCT01807221|467540615|FG002|Overall Study|Adverse Event|26|||
129885216|NCT01807221|467540616|FG003|Overall Study|Adverse Event|25|||
129885217|NCT01807221|467540617|FG004|Overall Study|Adverse Event|18|||
129885218|NCT01807221|467540618|FG005|Overall Study|Adverse Event|21|||
130032236|NCT00813995|468075003|FG001|Overall Study|Subject moved|0|||
129885219|NCT01807221|467540613|FG000|Overall Study|Protocol Violation|0|||
129885220|NCT01807221|467540614|FG001|Overall Study|Protocol Violation|2|||
129885221|NCT01807221|467540615|FG002|Overall Study|Protocol Violation|1|||
129885222|NCT01807221|467540616|FG003|Overall Study|Protocol Violation|2|||
129885223|NCT01807221|467540617|FG004|Overall Study|Protocol Violation|0|||
129885224|NCT01807221|467540618|FG005|Overall Study|Protocol Violation|1|||
130032237|NCT00813995|468075002|FG000|Overall Study|Withdrawal by Subject|0|||
130032238|NCT00813995|468075003|FG001|Overall Study|Withdrawal by Subject|5|||
129885225|NCT01807221|467540613|FG000|Overall Study|Non-compliance|1|||
130255370|NCT00500331|468899655|FG004|Overall Study|Protocol Violation|1|||
129885226|NCT01807221|467540614|FG001|Overall Study|Non-compliance|2|||
130255371|NCT00500331|468899656|FG005|Overall Study|Protocol Violation|1|||
129885227|NCT01807221|467540615|FG002|Overall Study|Non-compliance|0|||
130255372|NCT00500331|468899657|FG006|Overall Study|Protocol Violation|1|||
130255373|NCT00500331|468899651|FG000|Overall Study|Withdrawal by Subject|4|||
130255374|NCT00500331|468899652|FG001|Overall Study|Withdrawal by Subject|0|||
130255375|NCT00500331|468899653|FG002|Overall Study|Withdrawal by Subject|1|||
130255376|NCT00500331|468899654|FG003|Overall Study|Withdrawal by Subject|5|||
130255377|NCT00500331|468899655|FG004|Overall Study|Withdrawal by Subject|0|||
130255378|NCT00500331|468899656|FG005|Overall Study|Withdrawal by Subject|1|||
130255379|NCT00500331|468899657|FG006|Overall Study|Withdrawal by Subject|1|||
130255380|NCT00500331|468899651|FG000|Overall Study|Lack of Efficacy|3|||
130255381|NCT00500331|468899652|FG001|Overall Study|Lack of Efficacy|1|||
130255382|NCT00500331|468899653|FG002|Overall Study|Lack of Efficacy|0|||
130255383|NCT00500331|468899654|FG003|Overall Study|Lack of Efficacy|0|||
130255384|NCT00500331|468899655|FG004|Overall Study|Lack of Efficacy|0|||
130255385|NCT00500331|468899656|FG005|Overall Study|Lack of Efficacy|0|||
130255386|NCT00500331|468899657|FG006|Overall Study|Lack of Efficacy|0|||
130255387|NCT00500331|468899651|FG000|Overall Study|Liver function test abnormality|0|||
130255388|NCT00500331|468899652|FG001|Overall Study|Liver function test abnormality|0|||
130255389|NCT00500331|468899653|FG002|Overall Study|Liver function test abnormality|1|||
130255390|NCT00500331|468899654|FG003|Overall Study|Liver function test abnormality|0|||
130255391|NCT00500331|468899655|FG004|Overall Study|Liver function test abnormality|0|||
130255392|NCT00500331|468899656|FG005|Overall Study|Liver function test abnormality|0|||
130255393|NCT00500331|468899657|FG006|Overall Study|Liver function test abnormality|0|||
130255394|NCT00500331|468899651|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
130255395|NCT00500331|468899652|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
130255396|NCT00500331|468899653|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
130255397|NCT00500331|468899654|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
130255398|NCT00500331|468899655|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
130255399|NCT00500331|468899656|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
130255400|NCT00500331|468899657|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
130255401|NCT00500331|468899651|FG000|Overall Study|Didn't return for continuation of study|1|||
130255402|NCT00500331|468899652|FG001|Overall Study|Didn't return for continuation of study|0|||
130255403|NCT00500331|468899653|FG002|Overall Study|Didn't return for continuation of study|0|||
130255404|NCT00500331|468899654|FG003|Overall Study|Didn't return for continuation of study|0|||
130255405|NCT00500331|468899655|FG004|Overall Study|Didn't return for continuation of study|0|||
130255406|NCT00500331|468899656|FG005|Overall Study|Didn't return for continuation of study|0|||
130255407|NCT00500331|468899657|FG006|Overall Study|Didn't return for continuation of study|0|||
130255408|NCT00500331|468899651|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
130255409|NCT00500331|468899652|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255410|NCT00500331|468899653|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255411|NCT00500331|468899654|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255412|NCT00500331|468899655|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255413|NCT00500331|468899656|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255414|NCT00500331|468899657|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
130255415|NCT00500331|468899651|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
130255416|NCT00500331|468899652|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
130255417|NCT00500331|468899653|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
130255418|NCT00500331|468899654|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
130255419|NCT00500331|468899655|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
130255420|NCT00500331|468899656|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
130255421|NCT00500331|468899657|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
130255422|NCT00500331|468899651|FG000|Overall Study|Participant was randomized by mistake|1|||
130255423|NCT00500331|468899652|FG001|Overall Study|Participant was randomized by mistake|0|||
130255424|NCT00500331|468899653|FG002|Overall Study|Participant was randomized by mistake|0|||
130255425|NCT00500331|468899654|FG003|Overall Study|Participant was randomized by mistake|0|||
130255426|NCT00500331|468899655|FG004|Overall Study|Participant was randomized by mistake|0|||
130255427|NCT00500331|468899656|FG005|Overall Study|Participant was randomized by mistake|0|||
130255428|NCT00500331|468899657|FG006|Overall Study|Participant was randomized by mistake|0|||
130255429|NCT00500331|468899651|FG000|Overall Study|Diabetologist nurse in the study|0|||
130255430|NCT00500331|468899652|FG001|Overall Study|Diabetologist nurse in the study|0|||
130255431|NCT00500331|468899653|FG002|Overall Study|Diabetologist nurse in the study|1|||
130255432|NCT00500331|468899654|FG003|Overall Study|Diabetologist nurse in the study|0|||
130255433|NCT00500331|468899655|FG004|Overall Study|Diabetologist nurse in the study|0|||
130255434|NCT00500331|468899656|FG005|Overall Study|Diabetologist nurse in the study|0|||
130255435|NCT00500331|468899657|FG006|Overall Study|Diabetologist nurse in the study|0|||
130255436|NCT00500331|468899651|FG000|Overall Study|State ban of biological samples export|0|||
130255437|NCT00500331|468899652|FG001|Overall Study|State ban of biological samples export|0|||
130255438|NCT00500331|468899653|FG002|Overall Study|State ban of biological samples export|0|||
130255439|NCT00500331|468899654|FG003|Overall Study|State ban of biological samples export|1|||
130255440|NCT00500331|468899655|FG004|Overall Study|State ban of biological samples export|0|||
130255441|NCT00500331|468899656|FG005|Overall Study|State ban of biological samples export|0|||
130255442|NCT00500331|468899657|FG006|Overall Study|State ban of biological samples export|0|||
130255443|NCT00500331|468899651|FG000|Overall Study|Protocol violated|0|||
130255444|NCT00500331|468899652|FG001|Overall Study|Protocol violated|0|||
130255445|NCT00500331|468899653|FG002|Overall Study|Protocol violated|0|||
130255446|NCT00500331|468899654|FG003|Overall Study|Protocol violated|1|||
130255447|NCT00500331|468899655|FG004|Overall Study|Protocol violated|0|||
130255448|NCT00500331|468899656|FG005|Overall Study|Protocol violated|0|||
130255449|NCT00500331|468899657|FG006|Overall Study|Protocol violated|0|||
130255450|NCT03436732|468899658|FG000|Overall Study|Not treated-enrolled in different study|1|||
130255451|NCT03436732|468899659|FG001|Overall Study|Not treated-enrolled in different study|0|||
130255452|NCT03436732|468899658|FG000|Overall Study|Off study after cycle 1|1|||
130255453|NCT03436732|468899659|FG001|Overall Study|Off study after cycle 1|0|||
130255454|NCT03436732|468899658|FG000|Overall Study|Adverse Event|2|||
130255455|NCT03436732|468899659|FG001|Overall Study|Adverse Event|0|||
130255456|NCT03436732|468899658|FG000|Overall Study|Death|0|||
130255457|NCT03436732|468899659|FG001|Overall Study|Death|1|||
130255458|NCT03345550|468899660|FG000|Overall Study|Withdrawal by Subject|1|||
130255459|NCT03345550|468899661|FG001|Overall Study|Withdrawal by Subject|0|||
130255460|NCT03345550|468899660|FG000|Overall Study|Lost to Follow-up|4|||
130255461|NCT03345550|468899661|FG001|Overall Study|Lost to Follow-up|5|||
130255462|NCT00959049|468899662|FG000|Overall Study|Adverse Event|1|||
130255463|NCT00959049|468899663|FG001|Overall Study|Adverse Event|0|||
130255464|NCT00959049|468899664|FG002|Overall Study|Adverse Event|0|||
130255465|NCT00959049|468899665|FG003|Overall Study|Adverse Event|0|||
130255466|NCT00959049|468899666|FG004|Overall Study|Adverse Event|0|||
130255467|NCT00959049|468899667|FG005|Overall Study|Adverse Event|0|||
130255468|NCT00959049|468899662|FG000|Overall Study|Lost to Follow-up|17|||
130255469|NCT00959049|468899663|FG001|Overall Study|Lost to Follow-up|5|||
130255470|NCT00959049|468899664|FG002|Overall Study|Lost to Follow-up|1|||
130255471|NCT00959049|468899665|FG003|Overall Study|Lost to Follow-up|10|||
130255472|NCT00959049|468899666|FG004|Overall Study|Lost to Follow-up|9|||
130255473|NCT00959049|468899667|FG005|Overall Study|Lost to Follow-up|1|||
130255474|NCT00959049|468899662|FG000|Overall Study|Contraindicated medication|0|||
130255475|NCT00959049|468899663|FG001|Overall Study|Contraindicated medication|0|||
130255476|NCT00959049|468899664|FG002|Overall Study|Contraindicated medication|0|||
130255477|NCT00959049|468899665|FG003|Overall Study|Contraindicated medication|1|||
130255478|NCT00959049|468899666|FG004|Overall Study|Contraindicated medication|0|||
130255479|NCT00959049|468899667|FG005|Overall Study|Contraindicated medication|0|||
130255480|NCT00959049|468899662|FG000|Overall Study|Withdrawal by Subject|0|||
130255481|NCT00959049|468899663|FG001|Overall Study|Withdrawal by Subject|2|||
130255482|NCT00959049|468899664|FG002|Overall Study|Withdrawal by Subject|0|||
130255483|NCT00959049|468899665|FG003|Overall Study|Withdrawal by Subject|0|||
130255484|NCT00959049|468899666|FG004|Overall Study|Withdrawal by Subject|0|||
130255485|NCT00959049|468899667|FG005|Overall Study|Withdrawal by Subject|0|||
130255486|NCT00137449|468899668|FG000|Overall Study|Disease Progression|8|||
130255487|NCT00137449|468899669|FG001|Overall Study|Disease Progression|13|||
130255488|NCT00137449|468899668|FG000|Overall Study|Death|4|||
130255489|NCT00137449|468899669|FG001|Overall Study|Death|3|||
130255490|NCT00137449|468899668|FG000|Overall Study|Adverse Event|3|||
130255491|NCT00137449|468899669|FG001|Overall Study|Adverse Event|1|||
130255492|NCT00137449|468899668|FG000|Overall Study|Withdrawal by Subject|1|||
130255493|NCT00137449|468899669|FG001|Overall Study|Withdrawal by Subject|1|||
130255494|NCT02489279|468899670|FG000|Overall Study|Lost to Follow-up|12|||
130255495|NCT02489279|468899671|FG001|Overall Study|Lost to Follow-up|10|||
130255496|NCT02263547|468899672|FG000|Overall Study|Adverse Event|1|||
130255497|NCT02263547|468899672|FG000|Overall Study|Lost to Follow-up|2|||
130255498|NCT00586157|468899673|FG000|First Intervention|Worsening behavior|1|||
130255499|NCT00586157|468899674|FG001|First Intervention|Worsening behavior|0|||
130255500|NCT00586157|468899673|FG000|Second Intervention|Withdrawal by Subject|1|||
130255501|NCT00586157|468899674|FG001|Second Intervention|Withdrawal by Subject|0|||
130255502|NCT00586157|468899673|FG000|Second Intervention|Worsening behavior|1|||
130255503|NCT00586157|468899674|FG001|Second Intervention|Worsening behavior|0|||
130255504|NCT00586157|468899673|FG000|Second Intervention|Adverse Event|0|||
130255505|NCT00586157|468899674|FG001|Second Intervention|Adverse Event|1|||
130255506|NCT02378480|468899676|FG000|Overall Study|Physician Decision|1|||
130255507|NCT02378480|468899677|FG001|Overall Study|Physician Decision|1|||
130255508|NCT02378480|468899676|FG000|Overall Study|Death|1|||
130255509|NCT02378480|468899677|FG001|Overall Study|Death|2|||
130255510|NCT02378480|468899676|FG000|Overall Study|Randomized, but Not Treated|6|||
130255511|NCT02378480|468899677|FG001|Overall Study|Randomized, but Not Treated|4|||
130255512|NCT02378480|468899676|FG000|Overall Study|Adverse Event|0|||
130255513|NCT02378480|468899677|FG001|Overall Study|Adverse Event|1|||
130255514|NCT02378480|468899676|FG000|Overall Study|Missed EOT/PTE Visit|1|||
130255515|NCT02378480|468899677|FG001|Overall Study|Missed EOT/PTE Visit|2|||
130255516|NCT02378480|468899676|FG000|Overall Study|Withdrawal by Subject|9|||
130255517|NCT02378480|468899677|FG001|Overall Study|Withdrawal by Subject|4|||
130255518|NCT02378480|468899676|FG000|Overall Study|Lost to Follow-up|10|||
130255519|NCT02378480|468899677|FG001|Overall Study|Lost to Follow-up|18|||
130255520|NCT02014467|468899683|FG000|Overall Study|Adverse Event|4|||
130255521|NCT02014467|468899684|FG001|Overall Study|Adverse Event|0|||
130255522|NCT02014467|468899683|FG000|Overall Study|Protocol Violation|3|||
130255523|NCT02014467|468899684|FG001|Overall Study|Protocol Violation|0|||
130255524|NCT02014467|468899683|FG000|Overall Study|Physician Decision|2|||
130255525|NCT02014467|468899684|FG001|Overall Study|Physician Decision|3|||
130255526|NCT02014467|468899683|FG000|Overall Study|Withdrawal by Subject|16|||
130255527|NCT02014467|468899684|FG001|Overall Study|Withdrawal by Subject|4|||
130255528|NCT01230060|468899685|FG000|Overall Study|Withdrawal by Subject|1|||
130255529|NCT01217892|468899687|FG000|Overall Study|Adverse Event|1|||
130255530|NCT01217892|468899688|FG001|Overall Study|Adverse Event|1|||
130255531|NCT01217892|468899689|FG002|Overall Study|Adverse Event|1|||
130255532|NCT01217892|468899690|FG003|Overall Study|Adverse Event|0|||
130255533|NCT01217892|468899687|FG000|Overall Study|Withdrawal by Subject|0|||
130255534|NCT01217892|468899688|FG001|Overall Study|Withdrawal by Subject|2|||
130255535|NCT01217892|468899689|FG002|Overall Study|Withdrawal by Subject|1|||
130255536|NCT01217892|468899690|FG003|Overall Study|Withdrawal by Subject|0|||
130255537|NCT01217892|468899687|FG000|Overall Study|Lab value|1|||
130255538|NCT01217892|468899688|FG001|Overall Study|Lab value|0|||
130255539|NCT01217892|468899689|FG002|Overall Study|Lab value|1|||
130255540|NCT01217892|468899690|FG003|Overall Study|Lab value|0|||
130255541|NCT01217892|468899687|FG000|Overall Study|Subject no longer meets study criteria|5|||
130255542|NCT01217892|468899688|FG001|Overall Study|Subject no longer meets study criteria|2|||
130255543|NCT01217892|468899689|FG002|Overall Study|Subject no longer meets study criteria|4|||
130255544|NCT01217892|468899690|FG003|Overall Study|Subject no longer meets study criteria|8|||
130255545|NCT01217892|468899687|FG000|Overall Study|Incorrect enrollment|0|||
130255546|NCT01217892|468899688|FG001|Overall Study|Incorrect enrollment|1|||
130255547|NCT01217892|468899689|FG002|Overall Study|Incorrect enrollment|1|||
130255548|NCT01217892|468899690|FG003|Overall Study|Incorrect enrollment|0|||
130255549|NCT01217892|468899687|FG000|Overall Study|Poor/Non-Compliance|0|||
130255550|NCT01217892|468899688|FG001|Overall Study|Poor/Non-Compliance|0|||
130255551|NCT01217892|468899689|FG002|Overall Study|Poor/Non-Compliance|1|||
130255552|NCT01217892|468899690|FG003|Overall Study|Poor/Non-Compliance|0|||
130255553|NCT01052779|468899691|FG000|Overall Study|Adverse Event|1|||
130255554|NCT01052779|468899692|FG001|Overall Study|Adverse Event|4|||
130255555|NCT01052779|468899691|FG000|Overall Study|Withdrawal by Subject|1|||
130255556|NCT01052779|468899692|FG001|Overall Study|Withdrawal by Subject|2|||
130255557|NCT01052779|468899691|FG000|Overall Study|Other-Protocol Violation|1|||
130255558|NCT01052779|468899692|FG001|Overall Study|Other-Protocol Violation|1|||
130255559|NCT01052779|468899691|FG000|Overall Study|Other-Surgery|0|||
130255560|NCT01052779|468899692|FG001|Overall Study|Other-Surgery|2|||
130255561|NCT01052779|468899691|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
130255562|NCT01052779|468899692|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
130255563|NCT03802916|468899693|FG000|Overall Study|Adverse Event|0|||
130255564|NCT03802916|468899694|FG001|Overall Study|Adverse Event|1|||
130255565|NCT03802916|468899693|FG000|Overall Study|Withdrawal by Subject|0|||
130255566|NCT03802916|468899694|FG001|Overall Study|Withdrawal by Subject|1|||
130255567|NCT03663582|468899695|FG000|Overall Study|Physician Decision|1|||
130255568|NCT03242434|468899698|FG000|Overall Study|Death|0|||
130255569|NCT03242434|468899699|FG001|Overall Study|Death|2|||
130255570|NCT04507763|468899700|FG000|Overall Study|Participants did not meet entrance criteria|201|||
130255571|NCT03427619|468899701|FG000|Overall Study|Physician Decision|3|||
130255572|NCT03427619|468899701|FG000|Overall Study|Withdrawal by Subject|4|||
130101320|NCT00648739|468328634|FG005|Overall Study|Investigator Considered it Advisable|1|||
130101321|NCT00648739|468328635|FG006|Overall Study|Investigator Considered it Advisable|1|||
130101322|NCT00648739|468328629|FG000|Overall Study|Death|0|||
130101323|NCT00648739|468328630|FG001|Overall Study|Death|1|||
130101324|NCT00648739|468328631|FG002|Overall Study|Death|0|||
130101325|NCT00648739|468328632|FG003|Overall Study|Death|0|||
130101326|NCT00648739|468328633|FG004|Overall Study|Death|0|||
130101327|NCT00648739|468328634|FG005|Overall Study|Death|0|||
130101328|NCT00648739|468328635|FG006|Overall Study|Death|0|||
130101329|NCT00648739|468328629|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
130101330|NCT00648739|468328630|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
130101331|NCT00648739|468328631|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
130101332|NCT00648739|468328632|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
130101333|NCT00648739|468328633|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
130101334|NCT00648739|468328634|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
130101335|NCT00648739|468328635|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
130101336|NCT00648739|468328629|FG000|Overall Study|Follow-up Visits Not Completed|0|||
130101337|NCT00648739|468328630|FG001|Overall Study|Follow-up Visits Not Completed|1|||
130255573|NCT03427619|468899701|FG000|Overall Study|Lost to Follow-up|5|||
130255574|NCT03427619|468899701|FG000|Overall Study|Administrative|4|||
130255575|NCT03427619|468899701|FG000|Overall Study|Other|2|||
130255576|NCT03427619|468899701|FG000|Overall Study|Unknown or Missing Completion Status|48|||
130255577|NCT05763381|468899702|FG000|Overall Study|Lost to Follow-up|2|||
130255578|NCT05763381|468899703|FG001|Overall Study|Lost to Follow-up|3|||
129885228|NCT01807221|467540616|FG003|Overall Study|Non-compliance|1|||
130101338|NCT00648739|468328631|FG002|Overall Study|Follow-up Visits Not Completed|0|||
130255579|NCT05763381|468899702|FG000|Overall Study|Withdrawal by Subject|1|||
130255580|NCT05763381|468899703|FG001|Overall Study|Withdrawal by Subject|2|||
130255581|NCT02853136|468899704|FG000|Wash-out|Adverse Event|0|||
130255582|NCT02853136|468899705|FG001|Wash-out|Adverse Event|0|||
130255583|NCT02853136|468899706|FG002|Wash-out|Adverse Event|0|||
130255584|NCT02853136|468899707|FG003|Wash-out|Adverse Event|1|||
130255585|NCT00841815|468899708|FG000|Washout|Withdrawal by Subject|0|||
130255586|NCT00841815|468899709|FG001|Washout|Withdrawal by Subject|1|||
130255587|NCT00867334|468899711|FG000|Overall Study|Withdrawal by Subject|0|||
130255588|NCT00867334|468899712|FG001|Overall Study|Withdrawal by Subject|1|||
130255589|NCT00867334|468899711|FG000|Overall Study|Withdrawal by Subject|1|||
130255590|NCT00867334|468899712|FG001|Overall Study|Withdrawal by Subject|0|||
130255591|NCT00867334|468899711|FG000|Overall Study|Withdrawal by Subject|1|||
130255592|NCT00867334|468899712|FG001|Overall Study|Withdrawal by Subject|0|||
130255593|NCT03787615|468899713|FG000|Overall Study|Withdrawal by Subject|2|||
130255594|NCT03787615|468899713|FG000|Overall Study|Lost to Follow-up|2|||
130255595|NCT02697448|468899714|FG000|Overall Study|Protocol Violation|2|||
130255596|NCT02697448|468899715|FG001|Overall Study|Protocol Violation|4|||
130255597|NCT02697448|468899714|FG000|Overall Study|Clinical concerns during ablation|1|||
130255598|NCT02697448|468899715|FG001|Overall Study|Clinical concerns during ablation|1|||
130255599|NCT02697448|468899714|FG000|Overall Study|No data collected|2|||
130255600|NCT02697448|468899715|FG001|Overall Study|No data collected|0|||
130255601|NCT03464461|468899716|FG000|Overall Study|exclusionary medication given ,|1|||
130255602|NCT03464461|468899717|FG001|Overall Study|exclusionary medication given ,|2|||
130255603|NCT03464461|468899718|FG002|Overall Study|exclusionary medication given ,|0|||
130255604|NCT03464461|468899716|FG000|Overall Study|Physician Decision|0|||
130255605|NCT03464461|468899717|FG001|Overall Study|Physician Decision|1|||
130255606|NCT03464461|468899718|FG002|Overall Study|Physician Decision|0|||
130255607|NCT03685149|468899720|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
130255608|NCT03685149|468899721|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
130255609|NCT03685149|468899720|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130255610|NCT03685149|468899721|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130101339|NCT00648739|468328632|FG003|Overall Study|Follow-up Visits Not Completed|0|||
130101340|NCT00648739|468328633|FG004|Overall Study|Follow-up Visits Not Completed|0|||
130101341|NCT00648739|468328634|FG005|Overall Study|Follow-up Visits Not Completed|0|||
130101342|NCT00648739|468328635|FG006|Overall Study|Follow-up Visits Not Completed|0|||
130101343|NCT00564486|468328640|FG000|Overall Study|Adverse Event|0|||
130101344|NCT00564486|468328641|FG001|Overall Study|Adverse Event|1|||
130101345|NCT00564486|468328642|FG002|Overall Study|Adverse Event|0|||
130101346|NCT00564486|468328643|FG003|Overall Study|Adverse Event|0|||
130101347|NCT00564486|468328640|FG000|Overall Study|Withdrawal by Subject|4|||
130101348|NCT00564486|468328641|FG001|Overall Study|Withdrawal by Subject|0|||
130101349|NCT00564486|468328642|FG002|Overall Study|Withdrawal by Subject|0|||
130101350|NCT00564486|468328643|FG003|Overall Study|Withdrawal by Subject|5|||
130101351|NCT00564486|468328640|FG000|Overall Study|Subject refused to have blood drawn|0|||
130101352|NCT00564486|468328641|FG001|Overall Study|Subject refused to have blood drawn|0|||
130101353|NCT00564486|468328642|FG002|Overall Study|Subject refused to have blood drawn|1|||
130101354|NCT00564486|468328643|FG003|Overall Study|Subject refused to have blood drawn|0|||
130101355|NCT00564486|468328640|FG000|Overall Study|Lost to Follow-up|3|||
130101356|NCT00564486|468328641|FG001|Overall Study|Lost to Follow-up|0|||
130101357|NCT00564486|468328642|FG002|Overall Study|Lost to Follow-up|2|||
130101358|NCT00564486|468328643|FG003|Overall Study|Lost to Follow-up|2|||
130101359|NCT03862807|468328648|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
130101360|NCT04362761|468328649|FG000|Part A (48 Weeks)|Adverse Event|2|||
130101361|NCT04362761|468328649|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
130101362|NCT04362761|468328649|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
130255611|NCT03685149|468899720|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
130255612|NCT03685149|468899721|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
130255613|NCT04876391|468899722|FG000|Overall Study|Withdrawal by Subject|1|||
130255614|NCT04876391|468899723|FG001|Overall Study|Withdrawal by Subject|10|||
130101363|NCT04362761|468328649|FG000|Part A (48 Weeks)|Other|5|||
130101364|NCT04362761|468328649|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
130101365|NCT04362761|468328649|FG000|Part B (86 Weeks)|Other|4|||
130101366|NCT00684645|468328650|FG000|Overall Study|Death|2|||
130101367|NCT00684645|468328650|FG000|Overall Study|Progressive disease|67|||
130101368|NCT00684645|468328650|FG000|Overall Study|Adverse Event|27|||
130255615|NCT04876391|468899722|FG000|Overall Study|Lost to Follow-up|2|||
130255616|NCT04876391|468899723|FG001|Overall Study|Lost to Follow-up|4|||
130255617|NCT04876391|468899722|FG000|Overall Study|Lack of Efficacy|0|||
130255618|NCT04876391|468899723|FG001|Overall Study|Lack of Efficacy|2|||
130255619|NCT04876391|468899722|FG000|Overall Study|Adverse Event|3|||
130255620|NCT04876391|468899723|FG001|Overall Study|Adverse Event|1|||
130255621|NCT04876391|468899722|FG000|Overall Study|Patient non-compliance|0|||
130255622|NCT04876391|468899723|FG001|Overall Study|Patient non-compliance|1|||
130255623|NCT04876391|468899722|FG000|Overall Study|Personal reasons|0|||
130255624|NCT04876391|468899723|FG001|Overall Study|Personal reasons|1|||
130255625|NCT04876391|468899722|FG000|Overall Study|Withdrawn as per protocol|2|||
130255626|NCT04876391|468899723|FG001|Overall Study|Withdrawn as per protocol|2|||
130255627|NCT00209131|468899728|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
130255628|NCT00209131|468899729|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
130255629|NCT05360784|468899730|FG000|Overall Study|Discontinued|25|||
130255630|NCT05360784|468899731|FG001|Overall Study|Discontinued|11|||
130255631|NCT05142306|468899735|FG000|Overall Study|Withdrawal by Subject|0|||
130255632|NCT05142306|468899736|FG001|Overall Study|Withdrawal by Subject|0|||
130255633|NCT05142306|468899737|FG002|Overall Study|Withdrawal by Subject|1|||
130255634|NCT02251041|468899738|FG000|Overall Study|Did not receive intervention|15|||
130255635|NCT02251041|468899739|FG001|Overall Study|Did not receive intervention|4|||
130255636|NCT04079920|468899740|FG000|Overall Study|Adverse event, not related to study drug|2|||
130255637|NCT04079920|468899740|FG000|Overall Study|Adverse event related to study drug|10|||
130255638|NCT04079920|468899740|FG000|Overall Study|Death|2|||
130255639|NCT04079920|468899740|FG000|Overall Study|Lost to Follow-up|22|||
130255640|NCT04079920|468899740|FG000|Overall Study|Physician Decision|1|||
130255641|NCT04079920|468899740|FG000|Overall Study|Withdrawal by Subject|11|||
130255642|NCT04918771|468899741|FG000|Overall Study|Withdrawal by Subject|4|||
130255643|NCT04918771|468899742|FG001|Overall Study|Withdrawal by Subject|5|||
130255644|NCT04918771|468899741|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
130255645|NCT04918771|468899742|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
130255646|NCT01299961|468899749|FG000|Overall Study|Adverse Event|3|||
130255647|NCT01299961|468899749|FG000|Overall Study|Lack of Efficacy|2|||
130255648|NCT01299961|468899749|FG000|Overall Study|Lost to Follow-up|1|||
130255649|NCT02904096|468899750|FG000|Overall Study|Adverse Event|1|||
130255650|NCT02904096|468899751|FG001|Overall Study|Adverse Event|0|||
130255651|NCT02904096|468899750|FG000|Overall Study|Withdrawal by Subject|4|||
130255652|NCT02904096|468899751|FG001|Overall Study|Withdrawal by Subject|3|||
130255653|NCT02904096|468899750|FG000|Overall Study|Lost to Follow-up|10|||
130255654|NCT02904096|468899751|FG001|Overall Study|Lost to Follow-up|17|||
130255655|NCT02904096|468899750|FG000|Overall Study|Non-compliant|3|||
130255656|NCT02904096|468899751|FG001|Overall Study|Non-compliant|1|||
130255657|NCT02904096|468899750|FG000|Overall Study|Sponsor instructed|1|||
130255658|NCT02904096|468899751|FG001|Overall Study|Sponsor instructed|0|||
130255659|NCT05305651|468899752|FG000|Overall Study|Death|1|||
130255660|NCT05305651|468899752|FG000|Overall Study|Withdrawal by Subject|4|||
130255661|NCT05305651|468899752|FG000|Overall Study|Lost to Follow-up|4|||
130255662|NCT00526799|468899753|FG000|Overall Study|Withdrawal by Subject|1|||
130255663|NCT00526799|468899754|FG001|Overall Study|Withdrawal by Subject|0|||
130255664|NCT00526799|468899753|FG000|Overall Study|Intercurrent Complicating Disease|0|||
130255665|NCT00526799|468899754|FG001|Overall Study|Intercurrent Complicating Disease|1|||
130255666|NCT02298946|468899755|FG000|Overall Study|Did not receive treatment|2|||
130255667|NCT02298946|468899756|FG001|Overall Study|Did not receive treatment|0|||
130255668|NCT02298946|468899755|FG000|Overall Study|Unevaluable|2|||
130255669|NCT02298946|468899756|FG001|Overall Study|Unevaluable|1|||
130255670|NCT03648372|468899763|FG000|Overall Study|Withdrawal by Subject|2|||
130255671|NCT03648372|468899764|FG001|Overall Study|Withdrawal by Subject|0|||
130255672|NCT03648372|468899765|FG002|Overall Study|Withdrawal by Subject|0|||
130255673|NCT03648372|468899766|FG003|Overall Study|Withdrawal by Subject|0|||
130255674|NCT03648372|468899767|FG004|Overall Study|Withdrawal by Subject|0|||
130255675|NCT03648372|468899768|FG005|Overall Study|Withdrawal by Subject|1|||
130255676|NCT03648372|468899769|FG006|Overall Study|Withdrawal by Subject|2|||
130255677|NCT03648372|468899770|FG007|Overall Study|Withdrawal by Subject|0|||
130255678|NCT03648372|468899771|FG008|Overall Study|Withdrawal by Subject|0|||
130255679|NCT03648372|468899772|FG009|Overall Study|Withdrawal by Subject|0|||
130255680|NCT03648372|468899773|FG010|Overall Study|Withdrawal by Subject|2|||
130255681|NCT03648372|468899774|FG011|Overall Study|Withdrawal by Subject|0|||
130255682|NCT03648372|468899775|FG012|Overall Study|Withdrawal by Subject|2|||
130255683|NCT03648372|468899776|FG013|Overall Study|Withdrawal by Subject|0|||
130255684|NCT03648372|468899777|FG014|Overall Study|Withdrawal by Subject|0|||
130255685|NCT03648372|468899778|FG015|Overall Study|Withdrawal by Subject|0|||
130255686|NCT03648372|468899779|FG016|Overall Study|Withdrawal by Subject|1|||
130255687|NCT03648372|468899780|FG017|Overall Study|Withdrawal by Subject|0|||
130255688|NCT03648372|468899781|FG018|Overall Study|Withdrawal by Subject|0|||
130255689|NCT03648372|468899782|FG019|Overall Study|Withdrawal by Subject|0|||
130255690|NCT03648372|468899783|FG020|Overall Study|Withdrawal by Subject|0|||
130255691|NCT03648372|468899763|FG000|Overall Study|Progressive Disease|2|||
130255692|NCT03648372|468899764|FG001|Overall Study|Progressive Disease|3|||
130255693|NCT03648372|468899765|FG002|Overall Study|Progressive Disease|4|||
130255694|NCT03648372|468899766|FG003|Overall Study|Progressive Disease|3|||
130255695|NCT03648372|468899767|FG004|Overall Study|Progressive Disease|2|||
130255696|NCT03648372|468899768|FG005|Overall Study|Progressive Disease|2|||
130255697|NCT03648372|468899769|FG006|Overall Study|Progressive Disease|3|||
130255698|NCT03648372|468899770|FG007|Overall Study|Progressive Disease|3|||
130255699|NCT03648372|468899771|FG008|Overall Study|Progressive Disease|5|||
130255700|NCT03648372|468899772|FG009|Overall Study|Progressive Disease|5|||
130255701|NCT03648372|468899773|FG010|Overall Study|Progressive Disease|2|||
130255702|NCT03648372|468899774|FG011|Overall Study|Progressive Disease|3|||
130255703|NCT03648372|468899775|FG012|Overall Study|Progressive Disease|3|||
130255704|NCT03648372|468899776|FG013|Overall Study|Progressive Disease|3|||
130255705|NCT03648372|468899777|FG014|Overall Study|Progressive Disease|6|||
130255706|NCT03648372|468899778|FG015|Overall Study|Progressive Disease|0|||
130255707|NCT03648372|468899779|FG016|Overall Study|Progressive Disease|0|||
130255708|NCT03648372|468899780|FG017|Overall Study|Progressive Disease|0|||
130255709|NCT03648372|468899781|FG018|Overall Study|Progressive Disease|0|||
130255710|NCT03648372|468899782|FG019|Overall Study|Progressive Disease|0|||
130255711|NCT03648372|468899783|FG020|Overall Study|Progressive Disease|0|||
130255712|NCT03648372|468899763|FG000|Overall Study|Other|0|||
130255713|NCT03648372|468899764|FG001|Overall Study|Other|0|||
130255714|NCT03648372|468899765|FG002|Overall Study|Other|0|||
130255715|NCT03648372|468899766|FG003|Overall Study|Other|0|||
130255716|NCT03648372|468899767|FG004|Overall Study|Other|1|||
130255717|NCT03648372|468899768|FG005|Overall Study|Other|0|||
130255718|NCT03648372|468899769|FG006|Overall Study|Other|0|||
130255719|NCT03648372|468899770|FG007|Overall Study|Other|0|||
130255720|NCT03648372|468899771|FG008|Overall Study|Other|0|||
130255721|NCT03648372|468899772|FG009|Overall Study|Other|0|||
130255722|NCT03648372|468899773|FG010|Overall Study|Other|1|||
130255723|NCT03648372|468899774|FG011|Overall Study|Other|2|||
130255724|NCT03648372|468899775|FG012|Overall Study|Other|1|||
130255725|NCT03648372|468899776|FG013|Overall Study|Other|3|||
130255726|NCT03648372|468899777|FG014|Overall Study|Other|0|||
130255727|NCT03648372|468899778|FG015|Overall Study|Other|5|||
130255728|NCT03648372|468899779|FG016|Overall Study|Other|1|||
130255729|NCT03648372|468899780|FG017|Overall Study|Other|5|||
130255730|NCT03648372|468899781|FG018|Overall Study|Other|0|||
130255731|NCT03648372|468899782|FG019|Overall Study|Other|1|||
130255732|NCT03648372|468899783|FG020|Overall Study|Other|0|||
130255733|NCT03648372|468899763|FG000|Overall Study|Lost to Follow-up|0|||
130255734|NCT03648372|468899764|FG001|Overall Study|Lost to Follow-up|0|||
130255735|NCT03648372|468899765|FG002|Overall Study|Lost to Follow-up|0|||
130255736|NCT03648372|468899766|FG003|Overall Study|Lost to Follow-up|0|||
130255737|NCT03648372|468899767|FG004|Overall Study|Lost to Follow-up|0|||
130255738|NCT03648372|468899768|FG005|Overall Study|Lost to Follow-up|0|||
130255739|NCT03648372|468899769|FG006|Overall Study|Lost to Follow-up|0|||
130255740|NCT03648372|468899770|FG007|Overall Study|Lost to Follow-up|0|||
130255741|NCT03648372|468899771|FG008|Overall Study|Lost to Follow-up|0|||
130255742|NCT03648372|468899772|FG009|Overall Study|Lost to Follow-up|0|||
130255743|NCT03648372|468899773|FG010|Overall Study|Lost to Follow-up|0|||
130255744|NCT03648372|468899774|FG011|Overall Study|Lost to Follow-up|0|||
130255745|NCT03648372|468899775|FG012|Overall Study|Lost to Follow-up|0|||
130255746|NCT03648372|468899776|FG013|Overall Study|Lost to Follow-up|1|||
130255747|NCT03648372|468899777|FG014|Overall Study|Lost to Follow-up|0|||
130255748|NCT03648372|468899778|FG015|Overall Study|Lost to Follow-up|1|||
130255749|NCT03648372|468899779|FG016|Overall Study|Lost to Follow-up|0|||
130255750|NCT03648372|468899780|FG017|Overall Study|Lost to Follow-up|1|||
130255751|NCT03648372|468899781|FG018|Overall Study|Lost to Follow-up|0|||
130255752|NCT03648372|468899782|FG019|Overall Study|Lost to Follow-up|0|||
130255753|NCT03648372|468899783|FG020|Overall Study|Lost to Follow-up|0|||
130255754|NCT03648372|468899763|FG000|Overall Study|Start of a New Systemic Treatment|0|||
130255755|NCT03648372|468899764|FG001|Overall Study|Start of a New Systemic Treatment|0|||
130255756|NCT03648372|468899765|FG002|Overall Study|Start of a New Systemic Treatment|0|||
130255757|NCT03648372|468899766|FG003|Overall Study|Start of a New Systemic Treatment|0|||
130255758|NCT03648372|468899767|FG004|Overall Study|Start of a New Systemic Treatment|0|||
130255759|NCT03648372|468899768|FG005|Overall Study|Start of a New Systemic Treatment|0|||
130255760|NCT03648372|468899769|FG006|Overall Study|Start of a New Systemic Treatment|0|||
130255761|NCT03648372|468899770|FG007|Overall Study|Start of a New Systemic Treatment|2|||
130255762|NCT03648372|468899771|FG008|Overall Study|Start of a New Systemic Treatment|0|||
130255763|NCT03648372|468899772|FG009|Overall Study|Start of a New Systemic Treatment|0|||
130255764|NCT03648372|468899773|FG010|Overall Study|Start of a New Systemic Treatment|1|||
130255765|NCT03648372|468899774|FG011|Overall Study|Start of a New Systemic Treatment|0|||
130255766|NCT03648372|468899775|FG012|Overall Study|Start of a New Systemic Treatment|0|||
130255767|NCT03648372|468899776|FG013|Overall Study|Start of a New Systemic Treatment|0|||
130255768|NCT03648372|468899777|FG014|Overall Study|Start of a New Systemic Treatment|0|||
130255769|NCT03648372|468899778|FG015|Overall Study|Start of a New Systemic Treatment|0|||
130255770|NCT03648372|468899779|FG016|Overall Study|Start of a New Systemic Treatment|0|||
130255771|NCT03648372|468899780|FG017|Overall Study|Start of a New Systemic Treatment|0|||
130255772|NCT03648372|468899781|FG018|Overall Study|Start of a New Systemic Treatment|0|||
130255773|NCT03648372|468899782|FG019|Overall Study|Start of a New Systemic Treatment|0|||
130255774|NCT03648372|468899783|FG020|Overall Study|Start of a New Systemic Treatment|0|||
130255775|NCT05654181|468901117|FG000|Overall Study|Adverse Event|1|||
130255776|NCT05654181|468901118|FG001|Overall Study|Adverse Event|0|||
130255777|NCT05654181|468901119|FG002|Overall Study|Adverse Event|0|||
130255778|NCT05654181|468901120|FG003|Overall Study|Adverse Event|0|||
130255779|NCT05654181|468901121|FG004|Overall Study|Adverse Event|0|||
130255780|NCT05654181|468901122|FG005|Overall Study|Adverse Event|0|||
130255781|NCT05654181|468901123|FG006|Overall Study|Adverse Event|0|||
130255782|NCT05654181|468901124|FG007|Overall Study|Adverse Event|1|||
130255783|NCT05654181|468901125|FG008|Overall Study|Adverse Event|0|||
130255784|NCT05654181|468901126|FG009|Overall Study|Adverse Event|0|||
130255785|NCT05654181|468901117|FG000|Overall Study|Withdrawal by Subject|0|||
130255786|NCT05654181|468901118|FG001|Overall Study|Withdrawal by Subject|0|||
130255787|NCT05654181|468901119|FG002|Overall Study|Withdrawal by Subject|0|||
130255788|NCT05654181|468901120|FG003|Overall Study|Withdrawal by Subject|0|||
130255789|NCT05654181|468901121|FG004|Overall Study|Withdrawal by Subject|0|||
130255790|NCT05654181|468901122|FG005|Overall Study|Withdrawal by Subject|0|||
130255791|NCT05654181|468901123|FG006|Overall Study|Withdrawal by Subject|0|||
130255792|NCT05654181|468901124|FG007|Overall Study|Withdrawal by Subject|1|||
130255793|NCT05654181|468901125|FG008|Overall Study|Withdrawal by Subject|0|||
130255794|NCT05654181|468901126|FG009|Overall Study|Withdrawal by Subject|0|||
130255795|NCT05654181|468901117|FG000|Overall Study|Other|0|||
130255796|NCT05654181|468901118|FG001|Overall Study|Other|0|||
130255797|NCT05654181|468901119|FG002|Overall Study|Other|0|||
130255798|NCT05654181|468901120|FG003|Overall Study|Other|0|||
130255799|NCT05654181|468901121|FG004|Overall Study|Other|1|||
130255800|NCT05654181|468901122|FG005|Overall Study|Other|1|||
130255801|NCT05654181|468901123|FG006|Overall Study|Other|0|||
130255802|NCT05654181|468901124|FG007|Overall Study|Other|0|||
130255803|NCT05654181|468901125|FG008|Overall Study|Other|0|||
130255804|NCT05654181|468901126|FG009|Overall Study|Other|0|||
130255805|NCT04101331|468901127|FG000|Overall Study|Adverse Event|9|||
130255806|NCT04101331|468901127|FG000|Overall Study|Disease progression|82|||
130255807|NCT04101331|468901127|FG000|Overall Study|Withdrawal by Subject|1|||
130255808|NCT04101331|468901127|FG000|Overall Study|Investigator decision|6|||
130255809|NCT04101331|468901127|FG000|Overall Study|Death|6|||
130255810|NCT04101331|468901127|FG000|Overall Study|Allogenic transplant|1|||
130255811|NCT04110145|468901128|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255812|NCT04110145|468901129|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255813|NCT04110145|468901130|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255814|NCT04110145|468901131|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
130255815|NCT04110145|468901132|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
130255816|NCT00567502|468901140|FG000|Overall Study|Lost to Follow-up|91|||
130255817|NCT00567502|468901141|FG001|Overall Study|Lost to Follow-up|14|||
130255818|NCT00567502|468901142|FG002|Overall Study|Lost to Follow-up|351|||
130255819|NCT00567502|468901143|FG003|Overall Study|Lost to Follow-up|2|||
130255820|NCT00567502|468901140|FG000|Overall Study|Death|65|||
130255821|NCT00567502|468901141|FG001|Overall Study|Death|16|||
130255822|NCT00567502|468901142|FG002|Overall Study|Death|360|||
130255823|NCT00567502|468901143|FG003|Overall Study|Death|5|||
130255824|NCT00567502|468901140|FG000|Overall Study|Other|64|||
130255825|NCT00567502|468901141|FG001|Overall Study|Other|2|||
130255826|NCT00567502|468901142|FG002|Overall Study|Other|134|||
130255827|NCT00567502|468901143|FG003|Overall Study|Other|6|||
130255828|NCT00567502|468901140|FG000|Overall Study|Participant request|12|||
130255829|NCT00567502|468901141|FG001|Overall Study|Participant request|1|||
130255830|NCT00567502|468901142|FG002|Overall Study|Participant request|33|||
130255831|NCT00567502|468901143|FG003|Overall Study|Participant request|1|||
130255832|NCT00567502|468901140|FG000|Overall Study|Sponsor request|9|||
130255833|NCT00567502|468901141|FG001|Overall Study|Sponsor request|0|||
130255834|NCT00567502|468901142|FG002|Overall Study|Sponsor request|30|||
130255835|NCT00567502|468901143|FG003|Overall Study|Sponsor request|1|||
130255836|NCT00567502|468901140|FG000|Overall Study|Never Initiated Treatment|0|||
130255837|NCT00567502|468901141|FG001|Overall Study|Never Initiated Treatment|0|||
130101369|NCT00684645|468328650|FG000|Overall Study|Lost to Follow-up|3|||
130255838|NCT00567502|468901142|FG002|Overall Study|Never Initiated Treatment|0|||
130101370|NCT00684645|468328650|FG000|Overall Study|Other|15|||
130255839|NCT00567502|468901143|FG003|Overall Study|Never Initiated Treatment|72|||
130255840|NCT00337168|468901144|FG000|Overall Study|Death|5|||
130255841|NCT00337168|468901144|FG000|Overall Study|Not protocol specified|2|||
130255842|NCT00337168|468901144|FG000|Overall Study|Did not start therapy|1|||
130255843|NCT03283241|468901145|FG000|Overall Study|Adverse Event|4|||
130255844|NCT03283241|468901146|FG001|Overall Study|Adverse Event|1|||
130255845|NCT03283241|468901145|FG000|Overall Study|Withdrawal by Subject|0|||
130255846|NCT03283241|468901146|FG001|Overall Study|Withdrawal by Subject|1|||
130255847|NCT03283241|468901145|FG000|Overall Study|Subject relocated to Finland|0|||
130255848|NCT03283241|468901146|FG001|Overall Study|Subject relocated to Finland|1|||
130255849|NCT00666263|468901149|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
130255850|NCT00666263|468901150|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
130255851|NCT00666263|468901149|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
130255852|NCT00666263|468901150|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
130255853|NCT00666263|468901149|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
130255854|NCT00666263|468901150|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
130255855|NCT01225952|468901151|FG000|Overall Study|Lost to Follow-up|1|||
130255856|NCT01225952|468901152|FG001|Overall Study|Lost to Follow-up|0|||
130255857|NCT01225952|468901153|FG002|Overall Study|Lost to Follow-up|0|||
130255858|NCT01225952|468901151|FG000|Overall Study|Study Eye Explanted|0|||
130255859|NCT01225952|468901152|FG001|Overall Study|Study Eye Explanted|0|||
130255860|NCT01225952|468901153|FG002|Overall Study|Study Eye Explanted|1|||
130255861|NCT01225952|468901151|FG000|Overall Study|Withdrawal by Subject|4|||
130255862|NCT01225952|468901152|FG001|Overall Study|Withdrawal by Subject|4|||
130255863|NCT01225952|468901153|FG002|Overall Study|Withdrawal by Subject|5|||
130255864|NCT01225952|468901151|FG000|Overall Study|Surgical complications|1|||
130255865|NCT01225952|468901152|FG001|Overall Study|Surgical complications|0|||
130255866|NCT01225952|468901153|FG002|Overall Study|Surgical complications|0|||
130255867|NCT01285102|468901155|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
130255868|NCT03729609|468901171|FG000|Overall Study|Protocol Violation|1|||
130255869|NCT00605189|468901177|FG000|Overall Study|Adverse Event|1|||
130255870|NCT00605189|468901178|FG001|Overall Study|Adverse Event|0|||
130255871|NCT00605189|468901179|FG002|Overall Study|Adverse Event|0|||
130255872|NCT00605189|468901177|FG000|Overall Study|Other|2|||
130255873|NCT00605189|468901178|FG001|Overall Study|Other|2|||
130255874|NCT00605189|468901179|FG002|Overall Study|Other|0|||
130255875|NCT02919618|468901180|FG000|Overall Study|Death|1|||
130255876|NCT02592863|468901181|FG000|Overall Study|Withdrawal by Subject|2|||
130255877|NCT02592863|468901182|FG001|Overall Study|Withdrawal by Subject|2|||
130255878|NCT02592863|468901181|FG000|Overall Study|Lost to Follow-up|1|||
130255879|NCT02592863|468901182|FG001|Overall Study|Lost to Follow-up|1|||
130255880|NCT02743221|468901183|FG000|Overall Study|Progressive disease|29|||
130255881|NCT02743221|468901184|FG001|Overall Study|Progressive disease|38|||
130255882|NCT02743221|468901183|FG000|Overall Study|Adverse Event|17|||
130255883|NCT02743221|468901184|FG001|Overall Study|Adverse Event|14|||
130255884|NCT02743221|468901183|FG000|Overall Study|non medical reason|8|||
130255885|NCT02743221|468901184|FG001|Overall Study|non medical reason|2|||
130255886|NCT02743221|468901183|FG000|Overall Study|Physician Decision|2|||
130255887|NCT02743221|468901184|FG001|Overall Study|Physician Decision|5|||
130255888|NCT02743221|468901183|FG000|Overall Study|Patient not eligible, not treated|0|||
130255889|NCT02743221|468901184|FG001|Overall Study|Patient not eligible, not treated|1|||
130255890|NCT03411044|468901186|FG000|Overall Study|Death|30|||
130255891|NCT03411044|468901186|FG000|Overall Study|Withdrawal by Subject|48|||
130255892|NCT03411044|468901186|FG000|Overall Study|Lost to Follow-up|78|||
130255893|NCT03411044|468901186|FG000|Overall Study|Adverse Event|30|||
130255894|NCT03411044|468901186|FG000|Overall Study|Missing status|4|||
130255895|NCT02609503|468901187|FG000|Overall Study|Adverse Event|1|||
130255896|NCT02609503|468901187|FG000|Overall Study|Death|1|||
130255897|NCT02609503|468901187|FG000|Overall Study|Withdrawal by Subject|1|||
130255898|NCT02609503|468901187|FG000|Overall Study|Disease progression|1|||
130255899|NCT01969409|468901190|FG000|Overall Study|Death|2|||
130255900|NCT01969409|468901191|FG001|Overall Study|Death|2|||
130255901|NCT01969409|468901190|FG000|Overall Study|Transplant|1|||
130255902|NCT01969409|468901191|FG001|Overall Study|Transplant|1|||
130255903|NCT01969409|468901190|FG000|Overall Study|Withdrawal by Subject|0|||
130255904|NCT01969409|468901191|FG001|Overall Study|Withdrawal by Subject|1|||
130255905|NCT02226653|468901195|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
130255906|NCT02226653|468901196|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
130255907|NCT02226653|468901195|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
130255908|NCT02226653|468901196|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
130255909|NCT03078868|468901198|FG000|Overall Study|Physician Decision|3|||
129885229|NCT01807221|467540617|FG004|Overall Study|Non-compliance|0|||
130255910|NCT00967499|468901201|FG000|Overall Study|Adverse Event|0|||
130255911|NCT00967499|468901202|FG001|Overall Study|Adverse Event|1|||
130255912|NCT00967499|468901201|FG000|Overall Study|Protocol Violation|1|||
130255913|NCT00967499|468901202|FG001|Overall Study|Protocol Violation|0|||
130255914|NCT00967499|468901201|FG000|Overall Study|Sponsor Decision|1|||
130255915|NCT00967499|468901202|FG001|Overall Study|Sponsor Decision|0|||
130255916|NCT00967499|468901201|FG000|Overall Study|Randomized but not treated|63|||
130255917|NCT00967499|468901202|FG001|Overall Study|Randomized but not treated|59|||
130255918|NCT05535972|468901204|FG000|Overall Study|Withdrawal by Subject|31|||
130255919|NCT05535972|468901204|FG000|Overall Study|Lost to Follow-up|5|||
130255920|NCT05535972|468901204|FG000|Overall Study|Adverse Event|6|||
130255921|NCT05535972|468901204|FG000|Overall Study|Protocol Deviation|2|||
130255922|NCT04629196|468901208|FG000|Overall Study|Subject discontinued study drug|1|||
130255923|NCT04629196|468901209|FG001|Overall Study|Subject discontinued study drug|0|||
130255924|NCT04629196|468901208|FG000|Overall Study|Subject study drug dosing increased|1|||
130255925|NCT04629196|468901209|FG001|Overall Study|Subject study drug dosing increased|1|||
130255926|NCT04629196|468901208|FG000|Overall Study|Withdrawal by Subject|1|||
130255927|NCT04629196|468901209|FG001|Overall Study|Withdrawal by Subject|2|||
130255928|NCT01450631|468901213|FG000|Overall Study|Lost to Follow-up|2|||
130255929|NCT01450631|468901214|FG001|Overall Study|Lost to Follow-up|4|||
130255930|NCT01450631|468901213|FG000|Overall Study|Withdrawal by Subject|1|||
130255931|NCT01450631|468901214|FG001|Overall Study|Withdrawal by Subject|0|||
130255932|NCT00835354|468901215|FG000|First Intervention|Adverse Event|0|||
130255933|NCT00835354|468901216|FG001|First Intervention|Adverse Event|1|||
130255934|NCT03204812|468901217|FG000|Overall Study|Adverse Event|3|||
130255935|NCT01385995|468901218|FG000|Period 1, 2 Months|Physician Decision|1|||
130255936|NCT01385995|468901219|FG001|Period 1, 2 Months|Physician Decision|0|||
130255937|NCT00112385|468901220|FG000|Overall Study|Lost to Follow-up|1|||
130255938|NCT00112385|468901221|FG001|Overall Study|Lost to Follow-up|0|||
130255939|NCT00112385|468901220|FG000|Overall Study|Withdrawal by Subject|0|||
130255940|NCT00112385|468901221|FG001|Overall Study|Withdrawal by Subject|1|||
130255941|NCT04191135|468901244|FG000|Induction Treatment|Not Treated|2|||
130255942|NCT04191135|468901245|FG001|Induction Treatment|Not Treated|0|||
130255943|NCT04191135|468901246|FG002|Induction Treatment|Not Treated|0|||
130255944|NCT04191135|468901244|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
130255945|NCT04191135|468901245|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
130255946|NCT04191135|468901246|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
130255947|NCT04191135|468901244|FG000|Induction Treatment|Adverse Event|25|||
130255948|NCT04191135|468901245|FG001|Induction Treatment|Adverse Event|0|||
130255949|NCT04191135|468901246|FG002|Induction Treatment|Adverse Event|0|||
130255950|NCT04191135|468901244|FG000|Induction Treatment|Clinical Progression|8|||
130255951|NCT04191135|468901245|FG001|Induction Treatment|Clinical Progression|0|||
130255952|NCT04191135|468901246|FG002|Induction Treatment|Clinical Progression|0|||
130255953|NCT04191135|468901244|FG000|Induction Treatment|Excluded Medication|1|||
130255954|NCT04191135|468901245|FG001|Induction Treatment|Excluded Medication|0|||
130255955|NCT04191135|468901246|FG002|Induction Treatment|Excluded Medication|0|||
130255956|NCT04191135|468901244|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
130255957|NCT04191135|468901245|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
130255958|NCT04191135|468901246|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
130255959|NCT04191135|468901244|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
130255960|NCT04191135|468901245|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
130255961|NCT04191135|468901246|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
130255962|NCT04191135|468901244|FG000|Induction Treatment|Physician Decision|2|||
130255963|NCT04191135|468901245|FG001|Induction Treatment|Physician Decision|0|||
130255964|NCT04191135|468901246|FG002|Induction Treatment|Physician Decision|0|||
130255965|NCT04191135|468901244|FG000|Induction Treatment|Progressive Disease|135|||
130255966|NCT04191135|468901245|FG001|Induction Treatment|Progressive Disease|0|||
130255967|NCT04191135|468901246|FG002|Induction Treatment|Progressive Disease|0|||
130255968|NCT04191135|468901244|FG000|Induction Treatment|Protocol Violation|10|||
130255969|NCT04191135|468901245|FG001|Induction Treatment|Protocol Violation|0|||
130255970|NCT04191135|468901246|FG002|Induction Treatment|Protocol Violation|0|||
130255971|NCT04191135|468901244|FG000|Induction Treatment|Withdrawal by Subject|4|||
130255972|NCT04191135|468901245|FG001|Induction Treatment|Withdrawal by Subject|0|||
130255973|NCT04191135|468901246|FG002|Induction Treatment|Withdrawal by Subject|0|||
130255974|NCT04191135|468901244|FG000|Randomized Treatment|Death|0|||
130255975|NCT04191135|468901245|FG001|Randomized Treatment|Death|50|||
130255976|NCT04191135|468901246|FG002|Randomized Treatment|Death|54|||
130255977|NCT04191135|468901244|FG000|Randomized Treatment|Lost to Follow-up|0|||
130255978|NCT04191135|468901245|FG001|Randomized Treatment|Lost to Follow-up|0|||
130255979|NCT04191135|468901246|FG002|Randomized Treatment|Lost to Follow-up|1|||
130255980|NCT04191135|468901244|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130255981|NCT04191135|468901245|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130032239|NCT02507349|468075004|FG000|Overall Study|Death|12|||
130032240|NCT02507349|468075005|FG001|Overall Study|Death|16|||
130032241|NCT02507349|468075004|FG000|Overall Study|Withdrawal by Subject|1|||
130032242|NCT02507349|468075005|FG001|Overall Study|Withdrawal by Subject|1|||
130032243|NCT02507349|468075004|FG000|Overall Study|Lost to Follow-up|174|||
130032244|NCT02507349|468075005|FG001|Overall Study|Lost to Follow-up|144|||
130032245|NCT01614964|468075006|FG000|Overall Study|Withdrawal by Subject|2|||
130032246|NCT01614964|468075007|FG001|Overall Study|Withdrawal by Subject|0|||
130255982|NCT04191135|468901246|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130255983|NCT04191135|468901244|FG000|Randomized Treatment|Ongoing in Trial|0|||
130255984|NCT04191135|468901245|FG001|Randomized Treatment|Ongoing in Trial|83|||
130255985|NCT04191135|468901246|FG002|Randomized Treatment|Ongoing in Trial|81|||
130255986|NCT03514134|468903087|FG000|Overall Study|Lost to Follow-up|0|||
130255987|NCT03514134|468903088|FG001|Overall Study|Lost to Follow-up|1|||
130255988|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
130255989|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
130255990|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
130255991|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
130255992|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
130255993|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
130255994|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
130255995|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
130255996|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
130255997|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
130255998|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
130255999|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256000|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256001|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256002|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
130256003|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256004|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256005|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256006|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256007|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256008|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256009|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
130256010|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256011|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256012|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
130256013|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256014|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256015|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256016|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256017|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256018|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256019|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256020|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
130256021|NCT02471144|468903089|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
130256022|NCT02471144|468903090|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
130256023|NCT02471144|468903091|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256024|NCT02471144|468903092|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256025|NCT02471144|468903093|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256026|NCT02471144|468903094|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256027|NCT02471144|468903095|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256028|NCT02471144|468903096|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256029|NCT02471144|468903097|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256030|NCT02471144|468903098|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256031|NCT02471144|468903099|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
130256032|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256033|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256034|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256035|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256036|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130256037|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256038|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130256039|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256040|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
130256041|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256042|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
130256043|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256044|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256045|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256046|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256047|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256048|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
130256049|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256050|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256051|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
130256052|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256053|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
130256054|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256055|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256056|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256057|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256058|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256059|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256060|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256061|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256062|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
130256063|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256064|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
130256065|NCT02471144|468903089|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256066|NCT02471144|468903090|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256067|NCT02471144|468903091|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256068|NCT02471144|468903092|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129885230|NCT01807221|467540618|FG005|Overall Study|Non-compliance|0|||
129885231|NCT01807221|467540613|FG000|Overall Study|Logistical difficulties|0|||
129885232|NCT01807221|467540614|FG001|Overall Study|Logistical difficulties|1|||
129885233|NCT01807221|467540615|FG002|Overall Study|Logistical difficulties|0|||
130256069|NCT02471144|468903093|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256070|NCT02471144|468903094|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256071|NCT02471144|468903095|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256072|NCT02471144|468903096|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
130256073|NCT02471144|468903097|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
130256074|NCT02471144|468903098|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256075|NCT02471144|468903099|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
130256076|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256077|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256078|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256079|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256080|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256081|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256082|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256083|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256084|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
130256085|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
130256086|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
130256087|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256088|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256089|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256090|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256091|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256092|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256093|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256094|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256095|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256096|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
130256097|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
130256098|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256099|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256100|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256101|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256102|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256103|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256104|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256105|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256106|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256107|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
130256108|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
130256109|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256110|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129885234|NCT01807221|467540616|FG003|Overall Study|Logistical difficulties|0|||
129885235|NCT01807221|467540617|FG004|Overall Study|Logistical difficulties|1|||
129885236|NCT01807221|467540618|FG005|Overall Study|Logistical difficulties|0|||
129885237|NCT01807221|467540613|FG000|Overall Study|Withdrawal by Subject|33|||
129885238|NCT01807221|467540614|FG001|Overall Study|Withdrawal by Subject|15|||
129885239|NCT01807221|467540615|FG002|Overall Study|Withdrawal by Subject|8|||
129885240|NCT01807221|467540616|FG003|Overall Study|Withdrawal by Subject|14|||
130256111|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256112|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256113|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256114|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256115|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256116|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256117|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
130256118|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
130256119|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
130256120|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256121|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256122|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256123|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256124|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256125|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256126|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256127|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256128|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256129|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
130032247|NCT01614964|468075006|FG000|Overall Study|Lost to Follow-up|3|||
130032248|NCT01614964|468075007|FG001|Overall Study|Lost to Follow-up|0|||
130032249|NCT00888238|468075016|FG000|Washout Period After Period 2|Adverse Event|0|||
130032250|NCT00888238|468075017|FG001|Washout Period After Period 2|Adverse Event|0|||
130032251|NCT00888238|468075018|FG002|Washout Period After Period 2|Adverse Event|1|||
130256130|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
130256131|NCT02471144|468903089|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256132|NCT02471144|468903090|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130032252|NCT02700984|468075019|FG000|Overall Study|Death|2|||
130032253|NCT02700984|468075020|FG001|Overall Study|Death|1|||
130032254|NCT02700984|468075019|FG000|Overall Study|Lost to Follow-up|2|||
130032255|NCT02700984|468075020|FG001|Overall Study|Lost to Follow-up|1|||
130032256|NCT02700984|468075019|FG000|Overall Study|Physician Decision|0|||
130032257|NCT02700984|468075020|FG001|Overall Study|Physician Decision|1|||
130032258|NCT02700984|468075019|FG000|Overall Study|Withdrawal by Subject|8|||
130032259|NCT02700984|468075020|FG001|Overall Study|Withdrawal by Subject|9|||
130032260|NCT02700984|468075019|FG000|Overall Study|Reason not specified|3|||
130032261|NCT02700984|468075020|FG001|Overall Study|Reason not specified|2|||
130032262|NCT00473876|468075029|FG000|Overall Study|Lost to Follow-up|3|||
130032263|NCT00473876|468075030|FG001|Overall Study|Lost to Follow-up|1|||
130032264|NCT01032629|468075032|FG000|Overall Study|Closed Site|21|||
130032265|NCT01032629|468075033|FG001|Overall Study|Closed Site|18|||
130032266|NCT01032629|468075034|FG002|Overall Study|Closed Site|16|||
130032267|NCT01032629|468075032|FG000|Overall Study|Withdrawal by Subject|50|||
130032268|NCT01032629|468075033|FG001|Overall Study|Withdrawal by Subject|36|||
130032269|NCT01032629|468075034|FG002|Overall Study|Withdrawal by Subject|35|||
130032270|NCT01032629|468075032|FG000|Overall Study|Lost to Follow-up|74|||
130032271|NCT01032629|468075033|FG001|Overall Study|Lost to Follow-up|47|||
130032272|NCT01032629|468075034|FG002|Overall Study|Lost to Follow-up|37|||
130032273|NCT00348140|468075035|FG000|Overall Study|Adverse Event|46|||
130032274|NCT00348140|468075036|FG001|Overall Study|Adverse Event|49|||
130032275|NCT00348140|468075037|FG002|Overall Study|Adverse Event|78|||
130032276|NCT00348140|468075035|FG000|Overall Study|Lost to Follow-up|4|||
130032277|NCT00348140|468075036|FG001|Overall Study|Lost to Follow-up|4|||
130032278|NCT00348140|468075037|FG002|Overall Study|Lost to Follow-up|4|||
130032279|NCT00348140|468075035|FG000|Overall Study|Protocol Violation|12|||
130032280|NCT00348140|468075036|FG001|Overall Study|Protocol Violation|13|||
130032281|NCT00348140|468075037|FG002|Overall Study|Protocol Violation|14|||
130032282|NCT00348140|468075035|FG000|Overall Study|Withdrawal by Subject|32|||
130032283|NCT00348140|468075036|FG001|Overall Study|Withdrawal by Subject|40|||
130032284|NCT00348140|468075037|FG002|Overall Study|Withdrawal by Subject|40|||
130032285|NCT00348140|468075035|FG000|Overall Study|Non-compliance|8|||
130032286|NCT00348140|468075036|FG001|Overall Study|Non-compliance|13|||
130032287|NCT00348140|468075037|FG002|Overall Study|Non-compliance|5|||
130032288|NCT00348140|468075035|FG000|Overall Study|Participant at risk due to study drug|2|||
130032289|NCT00348140|468075036|FG001|Overall Study|Participant at risk due to study drug|0|||
130256133|NCT02471144|468903091|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130032290|NCT00348140|468075037|FG002|Overall Study|Participant at risk due to study drug|0|||
130032291|NCT00348140|468075035|FG000|Overall Study|Conditional medication increased dose|1|||
130032292|NCT00348140|468075036|FG001|Overall Study|Conditional medication increased dose|0|||
130032293|NCT00348140|468075037|FG002|Overall Study|Conditional medication increased dose|0|||
130032294|NCT00348140|468075035|FG000|Overall Study|Caregiver related|4|||
130032295|NCT00348140|468075036|FG001|Overall Study|Caregiver related|7|||
130032296|NCT00348140|468075037|FG002|Overall Study|Caregiver related|3|||
129885241|NCT01807221|467540617|FG004|Overall Study|Withdrawal by Subject|16|||
129885242|NCT01807221|467540618|FG005|Overall Study|Withdrawal by Subject|13|||
129885243|NCT01807221|467540613|FG000|Overall Study|Sponsor decision|2|||
129885244|NCT01807221|467540614|FG001|Overall Study|Sponsor decision|0|||
129885245|NCT01807221|467540615|FG002|Overall Study|Sponsor decision|1|||
129885246|NCT01807221|467540616|FG003|Overall Study|Sponsor decision|1|||
129885247|NCT01807221|467540617|FG004|Overall Study|Sponsor decision|0|||
129885248|NCT01807221|467540618|FG005|Overall Study|Sponsor decision|0|||
129885249|NCT01807221|467540613|FG000|Overall Study|Lost to Follow-up|1|||
129885250|NCT01807221|467540614|FG001|Overall Study|Lost to Follow-up|0|||
129885251|NCT01807221|467540615|FG002|Overall Study|Lost to Follow-up|2|||
129885252|NCT01807221|467540616|FG003|Overall Study|Lost to Follow-up|1|||
129885253|NCT01807221|467540617|FG004|Overall Study|Lost to Follow-up|0|||
129885254|NCT01807221|467540618|FG005|Overall Study|Lost to Follow-up|0|||
130101371|NCT02525627|468328664|FG000|Overall Study|Revision|1|||
130101372|NCT02525627|468328665|FG001|Overall Study|Revision|1|||
130101373|NCT02525627|468328664|FG000|Overall Study|Withdrawal by Subject|1|||
130101374|NCT02525627|468328665|FG001|Overall Study|Withdrawal by Subject|2|||
130256134|NCT02471144|468903092|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256135|NCT02471144|468903093|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256136|NCT02471144|468903094|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256137|NCT02471144|468903095|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256138|NCT02471144|468903096|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256139|NCT02471144|468903097|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
130256140|NCT02471144|468903098|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
130256141|NCT02471144|468903099|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
130256142|NCT00003645|468903100|FG000|Overall Study|Death|4|||
130256143|NCT00003645|468903101|FG001|Overall Study|Death|1|||
130256144|NCT00003645|468903100|FG000|Overall Study|Lost to Follow-up|7|||
130256145|NCT00003645|468903101|FG001|Overall Study|Lost to Follow-up|8|||
130256146|NCT00003645|468903100|FG000|Overall Study|Withdrawal by Subject|1|||
130256147|NCT00003645|468903101|FG001|Overall Study|Withdrawal by Subject|3|||
130256148|NCT03768336|468903104|FG000|Overall Study|Lost to Follow-up|3|||
130256149|NCT03768336|468903105|FG001|Overall Study|Lost to Follow-up|2|||
130256150|NCT03768336|468903104|FG000|Overall Study|Became Ineligible|2|||
130256151|NCT03768336|468903105|FG001|Overall Study|Became Ineligible|0|||
130256152|NCT03768336|468903104|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
130256153|NCT03768336|468903105|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
130256154|NCT03768336|468903104|FG000|Overall Study|Missed final survey (post-treatment|0|||
130256155|NCT03768336|468903105|FG001|Overall Study|Missed final survey (post-treatment|1|||
130256156|NCT03977155|468903106|FG000|Overall Study|Adverse Event|3|||
130256157|NCT03977155|468903107|FG001|Overall Study|Adverse Event|0|||
130256158|NCT03977155|468903108|FG002|Overall Study|Adverse Event|0|||
130256159|NCT03977155|468903106|FG000|Overall Study|Lost to Follow-up|0|||
130256160|NCT03977155|468903107|FG001|Overall Study|Lost to Follow-up|1|||
130256161|NCT03977155|468903108|FG002|Overall Study|Lost to Follow-up|0|||
130256162|NCT03977155|468903106|FG000|Overall Study|Withdrawal by Subject|1|||
130256163|NCT03977155|468903107|FG001|Overall Study|Withdrawal by Subject|1|||
130256164|NCT03977155|468903108|FG002|Overall Study|Withdrawal by Subject|2|||
130256165|NCT03977155|468903106|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
130256166|NCT03977155|468903107|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
130256167|NCT03977155|468903108|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
130256168|NCT03502681|468903111|FG000|Overall Study|Adverse Event|1|||
130256169|NCT03502681|468903112|FG001|Overall Study|Adverse Event|1|||
130256170|NCT03502681|468903111|FG000|Overall Study|Disease Progression|2|||
130256171|NCT03502681|468903112|FG001|Overall Study|Disease Progression|1|||
130256172|NCT01444781|468903113|FG000|Overall Study|Lost to Follow-up|0|||
130256173|NCT01444781|468903114|FG001|Overall Study|Lost to Follow-up|3|||
130256174|NCT01444781|468903115|FG002|Overall Study|Lost to Follow-up|1|||
130256175|NCT01444781|468903113|FG000|Overall Study|Withdrawal by Subject|3|||
130256176|NCT01444781|468903114|FG001|Overall Study|Withdrawal by Subject|1|||
130256177|NCT01444781|468903115|FG002|Overall Study|Withdrawal by Subject|2|||
130256178|NCT06790303|468903116|FG000|Overall Study|Study Terminated by sponsor|4|||
130256179|NCT06790303|468903116|FG000|Overall Study|Death|4|||
130256180|NCT00321932|468903122|FG000|Overall Study|Death|3|||
130256181|NCT00321932|468903123|FG001|Overall Study|Death|6|||
130256182|NCT00321932|468903122|FG000|Overall Study|Withdrawal by Subject|3|||
130256183|NCT00321932|468903123|FG001|Overall Study|Withdrawal by Subject|6|||
130256184|NCT00321932|468903122|FG000|Overall Study|Early relapse|2|||
130256185|NCT00321932|468903123|FG001|Overall Study|Early relapse|8|||
130256186|NCT00321932|468903122|FG000|Overall Study|Missing data|2|||
130256187|NCT00321932|468903123|FG001|Overall Study|Missing data|1|||
130256188|NCT03360344|468903126|FG000|Overall Study|Withdrawal by Subject|0|||
130256189|NCT03360344|468903127|FG001|Overall Study|Withdrawal by Subject|1|||
129885255|NCT02609659|467540619|FG000|Overall Study|Adverse Event|1|||
129885256|NCT02609659|467540619|FG000|Overall Study|Lost to Follow-up|6|||
130256190|NCT03360344|468903128|FG002|Overall Study|Withdrawal by Subject|1|||
130256191|NCT03257657|468903133|FG000|Overall Study|Lost to Follow-up|0|||
130256192|NCT03257657|468903134|FG001|Overall Study|Lost to Follow-up|3|||
130256193|NCT03257657|468903133|FG000|Overall Study|Withdrawn|0|||
130256194|NCT03257657|468903134|FG001|Overall Study|Withdrawn|1|||
130256195|NCT03257657|468903133|FG000|Overall Study|Noted not eligible right after enrolled|0|||
130256196|NCT03257657|468903134|FG001|Overall Study|Noted not eligible right after enrolled|1|||
130101375|NCT02525627|468328664|FG000|Overall Study|Death|1|||
130101376|NCT02525627|468328665|FG001|Overall Study|Death|0|||
130101377|NCT02525627|468328664|FG000|Overall Study|Site terminated|11|||
130101378|NCT02525627|468328665|FG001|Overall Study|Site terminated|10|||
130101379|NCT03746080|468328666|FG000|Overall Study|In follow up|2|||
130101380|NCT03746080|468328666|FG000|Overall Study|Death|15|||
130101381|NCT01473589|468328667|FG000|Overall Study|Adverse Event|1|||
130101382|NCT01473589|468328668|FG001|Overall Study|Adverse Event|1|||
130101383|NCT01473589|468328667|FG000|Overall Study|Death|2|||
130256197|NCT01905540|468903149|FG000|Period 3|Other|1|||
130256198|NCT01905540|468903150|FG001|Period 3|Other|0|||
130256199|NCT01905540|468903151|FG002|Period 3|Other|1|||
130256200|NCT01905540|468903152|FG003|Period 3|Other|1|||
130256201|NCT02367885|468903153|FG000|Overall Study|Lost to Follow-up|1|||
130256202|NCT02367885|468903154|FG001|Overall Study|Lost to Follow-up|0|||
130256203|NCT02367885|468903155|FG002|Overall Study|Lost to Follow-up|0|||
130256204|NCT02367885|468903153|FG000|Overall Study|Withdrawal by Subject|1|||
130256205|NCT02367885|468903154|FG001|Overall Study|Withdrawal by Subject|0|||
130256206|NCT02367885|468903155|FG002|Overall Study|Withdrawal by Subject|0|||
130256207|NCT01602484|468903156|FG000|Overall Study|Airway issues unrelated to study|0|||
130256208|NCT01602484|468903157|FG001|Overall Study|Airway issues unrelated to study|1|||
130256209|NCT02743962|468903160|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
130256210|NCT02743962|468903161|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
130256211|NCT02327169|468903163|FG000|Overall Study|Progressive Disease|1|||
130256212|NCT02327169|468903164|FG001|Overall Study|Progressive Disease|3|||
130256213|NCT02327169|468903165|FG002|Overall Study|Progressive Disease|4|||
130256214|NCT02327169|468903166|FG003|Overall Study|Progressive Disease|3|||
130256215|NCT02327169|468903167|FG004|Overall Study|Progressive Disease|4|||
130256216|NCT02327169|468903168|FG005|Overall Study|Progressive Disease|3|||
130256217|NCT02327169|468903169|FG006|Overall Study|Progressive Disease|3|||
130256218|NCT02327169|468903170|FG007|Overall Study|Progressive Disease|3|||
130256219|NCT02327169|468903171|FG008|Overall Study|Progressive Disease|4|||
130256220|NCT02327169|468903172|FG009|Overall Study|Progressive Disease|4|||
130256221|NCT02327169|468903173|FG010|Overall Study|Progressive Disease|4|||
130256222|NCT02327169|468903174|FG011|Overall Study|Progressive Disease|3|||
130256223|NCT02327169|468903175|FG012|Overall Study|Progressive Disease|1|||
130256224|NCT02327169|468903176|FG013|Overall Study|Progressive Disease|3|||
130256225|NCT02327169|468903177|FG014|Overall Study|Progressive Disease|3|||
130256226|NCT02327169|468903163|FG000|Overall Study|Adverse Event|2|||
130256227|NCT02327169|468903164|FG001|Overall Study|Adverse Event|0|||
130256228|NCT02327169|468903165|FG002|Overall Study|Adverse Event|1|||
130256229|NCT02327169|468903166|FG003|Overall Study|Adverse Event|0|||
130256230|NCT02327169|468903167|FG004|Overall Study|Adverse Event|1|||
130256231|NCT02327169|468903168|FG005|Overall Study|Adverse Event|0|||
130256232|NCT02327169|468903169|FG006|Overall Study|Adverse Event|0|||
130256233|NCT02327169|468903170|FG007|Overall Study|Adverse Event|0|||
130256234|NCT02327169|468903171|FG008|Overall Study|Adverse Event|0|||
130256235|NCT02327169|468903172|FG009|Overall Study|Adverse Event|2|||
130256236|NCT02327169|468903173|FG010|Overall Study|Adverse Event|0|||
130256237|NCT02327169|468903174|FG011|Overall Study|Adverse Event|3|||
130256238|NCT02327169|468903175|FG012|Overall Study|Adverse Event|0|||
130256239|NCT02327169|468903176|FG013|Overall Study|Adverse Event|2|||
130256240|NCT02327169|468903177|FG014|Overall Study|Adverse Event|1|||
130256241|NCT02327169|468903163|FG000|Overall Study|Symptomatic Deterioration|0|||
130256242|NCT02327169|468903164|FG001|Overall Study|Symptomatic Deterioration|0|||
130256243|NCT02327169|468903165|FG002|Overall Study|Symptomatic Deterioration|1|||
130256244|NCT02327169|468903166|FG003|Overall Study|Symptomatic Deterioration|0|||
130256245|NCT02327169|468903167|FG004|Overall Study|Symptomatic Deterioration|1|||
130256246|NCT02327169|468903168|FG005|Overall Study|Symptomatic Deterioration|1|||
130256247|NCT02327169|468903169|FG006|Overall Study|Symptomatic Deterioration|0|||
130101384|NCT01473589|468328668|FG001|Overall Study|Death|0|||
130101385|NCT01473589|468328667|FG000|Overall Study|Lost to Follow-up|2|||
130101386|NCT01473589|468328668|FG001|Overall Study|Lost to Follow-up|2|||
130256248|NCT02327169|468903170|FG007|Overall Study|Symptomatic Deterioration|0|||
130256249|NCT02327169|468903171|FG008|Overall Study|Symptomatic Deterioration|2|||
130256250|NCT02327169|468903172|FG009|Overall Study|Symptomatic Deterioration|1|||
130256251|NCT02327169|468903173|FG010|Overall Study|Symptomatic Deterioration|0|||
130101387|NCT01473589|468328667|FG000|Overall Study|Protocol Violation|1|||
130256252|NCT02327169|468903174|FG011|Overall Study|Symptomatic Deterioration|0|||
130256253|NCT02327169|468903175|FG012|Overall Study|Symptomatic Deterioration|0|||
130256254|NCT02327169|468903176|FG013|Overall Study|Symptomatic Deterioration|2|||
130256255|NCT02327169|468903177|FG014|Overall Study|Symptomatic Deterioration|1|||
130256256|NCT02327169|468903163|FG000|Overall Study|Reason Not Specified|0|||
130256257|NCT02327169|468903164|FG001|Overall Study|Reason Not Specified|0|||
130256258|NCT02327169|468903165|FG002|Overall Study|Reason Not Specified|1|||
130256259|NCT02327169|468903166|FG003|Overall Study|Reason Not Specified|0|||
130256260|NCT02327169|468903167|FG004|Overall Study|Reason Not Specified|0|||
130256261|NCT02327169|468903168|FG005|Overall Study|Reason Not Specified|0|||
130256262|NCT02327169|468903169|FG006|Overall Study|Reason Not Specified|0|||
130256263|NCT02327169|468903170|FG007|Overall Study|Reason Not Specified|0|||
130256264|NCT02327169|468903171|FG008|Overall Study|Reason Not Specified|0|||
130256265|NCT02327169|468903172|FG009|Overall Study|Reason Not Specified|1|||
130256266|NCT02327169|468903173|FG010|Overall Study|Reason Not Specified|2|||
130256267|NCT02327169|468903174|FG011|Overall Study|Reason Not Specified|1|||
130256268|NCT02327169|468903175|FG012|Overall Study|Reason Not Specified|0|||
130256269|NCT02327169|468903176|FG013|Overall Study|Reason Not Specified|0|||
130256270|NCT02327169|468903177|FG014|Overall Study|Reason Not Specified|2|||
130256271|NCT02327169|468903163|FG000|Overall Study|Withdrawal by Subject|1|||
130256272|NCT02327169|468903164|FG001|Overall Study|Withdrawal by Subject|0|||
130256273|NCT02327169|468903165|FG002|Overall Study|Withdrawal by Subject|0|||
130256274|NCT02327169|468903166|FG003|Overall Study|Withdrawal by Subject|0|||
130256275|NCT02327169|468903167|FG004|Overall Study|Withdrawal by Subject|1|||
130256276|NCT02327169|468903168|FG005|Overall Study|Withdrawal by Subject|0|||
130256277|NCT02327169|468903169|FG006|Overall Study|Withdrawal by Subject|0|||
130256278|NCT02327169|468903170|FG007|Overall Study|Withdrawal by Subject|1|||
130256279|NCT02327169|468903171|FG008|Overall Study|Withdrawal by Subject|0|||
129885257|NCT02609659|467540619|FG000|Overall Study|Other|1|||
129885258|NCT01004250|467540620|FG000|Induction Therapy Period|Adverse Event|10|||
129885259|NCT01004250|467540620|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
129885260|NCT01004250|467540620|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
129885261|NCT01004250|467540620|FG000|Induction Therapy Period|Physician Decision|2|||
129885262|NCT01004250|467540620|FG000|Maintenance Therapy Period|Adverse Event|15|||
129885263|NCT01004250|467540620|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
129885264|NCT01004250|467540620|FG000|Maintenance Therapy Period|Protocol Violation|1|||
129885265|NCT01004250|467540620|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
129885266|NCT01004250|467540620|FG000|Maintenance Therapy Period|Physician Decision|4|||
129885267|NCT01004250|467540620|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
129885268|NCT03943589|467540621|FG000|Overall Study|Death|1|||
129885269|NCT03943589|467540621|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
129885270|NCT00900627|467540622|FG000|Overall Study|Condition under investigation worsened|4|||
129885271|NCT00900627|467540623|FG001|Overall Study|Condition under investigation worsened|0|||
129885272|NCT00900627|467540624|FG002|Overall Study|Condition under investigation worsened|5|||
129885273|NCT00900627|467540625|FG003|Overall Study|Condition under investigation worsened|3|||
129885274|NCT00900627|467540626|FG004|Overall Study|Condition under investigation worsened|0|||
129885275|NCT00900627|467540627|FG005|Overall Study|Condition under investigation worsened|0|||
129885276|NCT00900627|467540622|FG000|Overall Study|Withdrawal by Subject|1|||
129885277|NCT00900627|467540623|FG001|Overall Study|Withdrawal by Subject|0|||
130032297|NCT00348140|468075035|FG000|Overall Study|Participant hospitalised|3|||
130032298|NCT00348140|468075036|FG001|Overall Study|Participant hospitalised|0|||
130032299|NCT00348140|468075037|FG002|Overall Study|Participant hospitalised|0|||
130032300|NCT00348140|468075035|FG000|Overall Study|Efficacy related|1|||
130032301|NCT00348140|468075036|FG001|Overall Study|Efficacy related|1|||
130032302|NCT00348140|468075037|FG002|Overall Study|Efficacy related|0|||
130032303|NCT00348140|468075035|FG000|Overall Study|Administration related|3|||
130032304|NCT00348140|468075036|FG001|Overall Study|Administration related|1|||
130032305|NCT00348140|468075037|FG002|Overall Study|Administration related|1|||
130032306|NCT00348140|468075035|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
130032307|NCT00348140|468075036|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
130032308|NCT00348140|468075037|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
130032309|NCT00348140|468075035|FG000|Overall Study|Participant unwell|1|||
130032310|NCT00348140|468075036|FG001|Overall Study|Participant unwell|0|||
130032311|NCT00348140|468075037|FG002|Overall Study|Participant unwell|0|||
130032312|NCT00348140|468075035|FG000|Overall Study|Screen failure|1|||
130032313|NCT00348140|468075036|FG001|Overall Study|Screen failure|0|||
130032314|NCT00348140|468075037|FG002|Overall Study|Screen failure|0|||
130032315|NCT00348140|468075035|FG000|Overall Study|Investigator decided to discontinue|4|||
130032316|NCT00348140|468075036|FG001|Overall Study|Investigator decided to discontinue|1|||
130032317|NCT00348140|468075037|FG002|Overall Study|Investigator decided to discontinue|4|||
130032318|NCT00348140|468075035|FG000|Overall Study|Decided to discontinue on their own|1|||
130032319|NCT00348140|468075036|FG001|Overall Study|Decided to discontinue on their own|4|||
130256280|NCT02327169|468903172|FG009|Overall Study|Withdrawal by Subject|0|||
130256281|NCT02327169|468903173|FG010|Overall Study|Withdrawal by Subject|0|||
130256282|NCT02327169|468903174|FG011|Overall Study|Withdrawal by Subject|0|||
129885278|NCT00900627|467540624|FG002|Overall Study|Withdrawal by Subject|1|||
129885279|NCT00900627|467540625|FG003|Overall Study|Withdrawal by Subject|0|||
129885280|NCT00900627|467540626|FG004|Overall Study|Withdrawal by Subject|1|||
130032320|NCT00348140|468075037|FG002|Overall Study|Decided to discontinue on their own|1|||
130032321|NCT00348140|468075035|FG000|Overall Study|Use of prohibited drug|1|||
130032322|NCT00348140|468075036|FG001|Overall Study|Use of prohibited drug|0|||
130032323|NCT00348140|468075037|FG002|Overall Study|Use of prohibited drug|2|||
130032324|NCT00348140|468075035|FG000|Overall Study|Disease progression|1|||
130032325|NCT00348140|468075036|FG001|Overall Study|Disease progression|2|||
130032326|NCT00348140|468075037|FG002|Overall Study|Disease progression|5|||
130032327|NCT00348140|468075035|FG000|Overall Study|Increased risk of cardiac infarction|0|||
130032328|NCT00348140|468075036|FG001|Overall Study|Increased risk of cardiac infarction|1|||
130032329|NCT00348140|468075037|FG002|Overall Study|Increased risk of cardiac infarction|0|||
130032330|NCT00348140|468075035|FG000|Overall Study|Serious adverse event|0|||
130032331|NCT00348140|468075036|FG001|Overall Study|Serious adverse event|1|||
130032332|NCT00348140|468075037|FG002|Overall Study|Serious adverse event|0|||
130032333|NCT00348140|468075035|FG000|Overall Study|Abnormal ECG|0|||
130032334|NCT00348140|468075036|FG001|Overall Study|Abnormal ECG|1|||
130032335|NCT00348140|468075037|FG002|Overall Study|Abnormal ECG|3|||
130032336|NCT00348140|468075035|FG000|Overall Study|Participant died|0|||
130032337|NCT00348140|468075036|FG001|Overall Study|Participant died|1|||
130032338|NCT00348140|468075037|FG002|Overall Study|Participant died|0|||
130032339|NCT00348140|468075035|FG000|Overall Study|Exclusion criteria met|0|||
130032340|NCT00348140|468075036|FG001|Overall Study|Exclusion criteria met|0|||
130032341|NCT00348140|468075037|FG002|Overall Study|Exclusion criteria met|1|||
130032342|NCT00348140|468075035|FG000|Overall Study|Memory declined|0|||
130032343|NCT00348140|468075036|FG001|Overall Study|Memory declined|0|||
130032344|NCT00348140|468075037|FG002|Overall Study|Memory declined|1|||
130032345|NCT03371355|468075040|FG000|Overall Study|Investigator judgment|0|||
130032346|NCT03371355|468075041|FG001|Overall Study|Investigator judgment|0|||
130032347|NCT03371355|468075042|FG002|Overall Study|Investigator judgment|1|||
130032348|NCT03371355|468075043|FG003|Overall Study|Investigator judgment|1|||
130032349|NCT03371355|468075040|FG000|Overall Study|Voluntary withdrawal|1|||
130032350|NCT03371355|468075041|FG001|Overall Study|Voluntary withdrawal|0|||
130032351|NCT03371355|468075042|FG002|Overall Study|Voluntary withdrawal|1|||
130032352|NCT03371355|468075043|FG003|Overall Study|Voluntary withdrawal|2|||
130032353|NCT03371355|468075040|FG000|Overall Study|Adverse Event|0|||
130032354|NCT03371355|468075041|FG001|Overall Study|Adverse Event|1|||
130032355|NCT03371355|468075042|FG002|Overall Study|Adverse Event|2|||
130032356|NCT03371355|468075043|FG003|Overall Study|Adverse Event|3|||
130032357|NCT03371355|468075040|FG000|Overall Study|Reason not Specified|0|||
130032358|NCT03371355|468075041|FG001|Overall Study|Reason not Specified|1|||
130032359|NCT03371355|468075042|FG002|Overall Study|Reason not Specified|0|||
130032360|NCT03371355|468075043|FG003|Overall Study|Reason not Specified|1|||
130032361|NCT02868892|468075044|FG000|Overall Study|Investigator left site and no follow-up|6|||
130032362|NCT01662648|468075045|FG000|Overall Study|Death|1|||
130032363|NCT01662648|468075046|FG001|Overall Study|Death|3|||
130032364|NCT01662648|468075045|FG000|Overall Study|Adverse Event|40|||
130032365|NCT01662648|468075046|FG001|Overall Study|Adverse Event|37|||
130032366|NCT01662648|468075045|FG000|Overall Study|Lack of Efficacy|17|||
130032367|NCT01662648|468075046|FG001|Overall Study|Lack of Efficacy|16|||
130032368|NCT01662648|468075045|FG000|Overall Study|Participant ineligible to continue trial|1|||
130032369|NCT01662648|468075046|FG001|Overall Study|Participant ineligible to continue trial|1|||
130032370|NCT01662648|468075045|FG000|Overall Study|Lost to Follow-up|24|||
130032371|NCT01662648|468075046|FG001|Overall Study|Lost to Follow-up|36|||
130032372|NCT01662648|468075045|FG000|Overall Study|Withdrawal by Subject|36|||
130032373|NCT01662648|468075046|FG001|Overall Study|Withdrawal by Subject|53|||
130032374|NCT01662648|468075045|FG000|Overall Study|Participant non-compliant|16|||
130032375|NCT01662648|468075046|FG001|Overall Study|Participant non-compliant|20|||
130032376|NCT01662648|468075045|FG000|Overall Study|Other|8|||
130256283|NCT02327169|468903175|FG012|Overall Study|Withdrawal by Subject|0|||
130256284|NCT02327169|468903176|FG013|Overall Study|Withdrawal by Subject|0|||
130256285|NCT02327169|468903177|FG014|Overall Study|Withdrawal by Subject|3|||
130256286|NCT02327169|468903163|FG000|Overall Study|Lost to Follow-up|0|||
130256287|NCT02327169|468903164|FG001|Overall Study|Lost to Follow-up|0|||
130256288|NCT02327169|468903165|FG002|Overall Study|Lost to Follow-up|0|||
130256289|NCT02327169|468903166|FG003|Overall Study|Lost to Follow-up|0|||
130256290|NCT02327169|468903167|FG004|Overall Study|Lost to Follow-up|1|||
130256291|NCT02327169|468903168|FG005|Overall Study|Lost to Follow-up|0|||
130256292|NCT02327169|468903169|FG006|Overall Study|Lost to Follow-up|0|||
130032377|NCT01662648|468075046|FG001|Overall Study|Other|11|||
130032378|NCT01662648|468075045|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
130032379|NCT01662648|468075046|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
130032380|NCT01662648|468075045|FG000|Overall Study|LOE and other reason unspecified|1|||
130032381|NCT01662648|468075046|FG001|Overall Study|LOE and other reason unspecified|0|||
130032382|NCT01662648|468075045|FG000|Overall Study|LOE and Participant non-compliant|0|||
130032383|NCT01662648|468075046|FG001|Overall Study|LOE and Participant non-compliant|1|||
130032384|NCT00619957|468075051|FG000|Month 24 Double-Blind|Adverse Event|9|||
130032385|NCT00619957|468075052|FG001|Month 24 Double-Blind|Adverse Event|7|||
130032386|NCT00619957|468075051|FG000|Month 24 Double-Blind|Protocol Violation|1|||
130032387|NCT00619957|468075052|FG001|Month 24 Double-Blind|Protocol Violation|0|||
130032388|NCT00619957|468075051|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
130032389|NCT00619957|468075052|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
130032390|NCT00619957|468075051|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
130032391|NCT00619957|468075052|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
130032392|NCT00619957|468075051|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
130032393|NCT00619957|468075052|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
129885281|NCT00900627|467540627|FG005|Overall Study|Withdrawal by Subject|2|||
129885282|NCT00900627|467540622|FG000|Overall Study|Adverse Event|1|||
129885283|NCT00900627|467540623|FG001|Overall Study|Adverse Event|2|||
130032394|NCT00619957|468075051|FG000|Month 48 Open-Label|Adverse Event|4|||
130032395|NCT00619957|468075052|FG001|Month 48 Open-Label|Adverse Event|4|||
130032396|NCT00619957|468075051|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
130032397|NCT00619957|468075052|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
130032398|NCT00619957|468075051|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
130032399|NCT00619957|468075052|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
130032400|NCT03751111|468075053|FG000|Overall Study|Lack of Efficacy|9|||
130032401|NCT03751111|468075054|FG001|Overall Study|Lack of Efficacy|30|||
130032402|NCT03751111|468075053|FG000|Overall Study|Adverse Event|3|||
130032403|NCT03751111|468075054|FG001|Overall Study|Adverse Event|2|||
130032404|NCT01264939|468075056|FG000|Overall Study|Adverse Event|1|||
130032405|NCT01264939|468075057|FG001|Overall Study|Adverse Event|3|||
130032406|NCT01264939|468075056|FG000|Overall Study|Lost to Follow-up|0|||
130032407|NCT01264939|468075057|FG001|Overall Study|Lost to Follow-up|3|||
130032408|NCT01264939|468075056|FG000|Overall Study|Physician Decision|1|||
130032409|NCT01264939|468075057|FG001|Overall Study|Physician Decision|1|||
130032410|NCT01264939|468075056|FG000|Overall Study|Patient/Guardian Decision|8|||
130032411|NCT01264939|468075057|FG001|Overall Study|Patient/Guardian Decision|10|||
130032412|NCT01264939|468075056|FG000|Overall Study|Disease Progression|8|||
130032413|NCT01264939|468075057|FG001|Overall Study|Disease Progression|11|||
130032414|NCT01145560|468075062|FG000|Overall Study|Withdrawal by Subject|2|||
130032415|NCT01145560|468075063|FG001|Overall Study|Withdrawal by Subject|1|||
130032416|NCT01145560|468075064|FG002|Overall Study|Withdrawal by Subject|0|||
130032417|NCT01145560|468075062|FG000|Overall Study|Lost to Follow-up|1|||
130032418|NCT01145560|468075063|FG001|Overall Study|Lost to Follow-up|1|||
130032419|NCT01145560|468075064|FG002|Overall Study|Lost to Follow-up|1|||
130032420|NCT01145560|468075062|FG000|Overall Study|No study drug by 24h after organ failure|1|||
130032421|NCT01145560|468075063|FG001|Overall Study|No study drug by 24h after organ failure|0|||
130032422|NCT01145560|468075064|FG002|Overall Study|No study drug by 24h after organ failure|0|||
130032423|NCT01145560|468075062|FG000|Overall Study|Accidental unblinding of study treatment|0|||
130256293|NCT02327169|468903170|FG007|Overall Study|Lost to Follow-up|0|||
130032424|NCT01145560|468075063|FG001|Overall Study|Accidental unblinding of study treatment|1|||
130032425|NCT01145560|468075064|FG002|Overall Study|Accidental unblinding of study treatment|0|||
130032426|NCT01145560|468075062|FG000|Overall Study|False insurance information|0|||
130256294|NCT02327169|468903171|FG008|Overall Study|Lost to Follow-up|0|||
130256295|NCT02327169|468903172|FG009|Overall Study|Lost to Follow-up|0|||
130256296|NCT02327169|468903173|FG010|Overall Study|Lost to Follow-up|0|||
130256297|NCT02327169|468903174|FG011|Overall Study|Lost to Follow-up|0|||
129885284|NCT00900627|467540624|FG002|Overall Study|Adverse Event|0|||
130032427|NCT01145560|468075063|FG001|Overall Study|False insurance information|1|||
130032428|NCT01145560|468075064|FG002|Overall Study|False insurance information|0|||
130032429|NCT01145560|468075062|FG000|Overall Study|Withdrawal of therapy|0|||
130032430|NCT01145560|468075063|FG001|Overall Study|Withdrawal of therapy|0|||
130032431|NCT01145560|468075064|FG002|Overall Study|Withdrawal of therapy|1|||
130032432|NCT02452762|468075066|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
130032433|NCT02452762|468075067|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
130032434|NCT02452762|468075066|FG000|Overall Study|Withdrawal by Subject|1|||
130032435|NCT02452762|468075067|FG001|Overall Study|Withdrawal by Subject|0|||
130032436|NCT00584870|468075068|FG000|Overall Study|Adverse Event|4|||
130032437|NCT00584870|468075069|FG001|Overall Study|Adverse Event|3|||
130032438|NCT00584870|468075070|FG002|Overall Study|Adverse Event|2|||
130032439|NCT00584870|468075068|FG000|Overall Study|Lost to Follow-up|4|||
130032440|NCT00584870|468075069|FG001|Overall Study|Lost to Follow-up|1|||
130032441|NCT00584870|468075070|FG002|Overall Study|Lost to Follow-up|1|||
130032442|NCT00584870|468075068|FG000|Overall Study|Lack of Efficacy|7|||
130032443|NCT00584870|468075069|FG001|Overall Study|Lack of Efficacy|14|||
130032444|NCT00584870|468075070|FG002|Overall Study|Lack of Efficacy|8|||
130032445|NCT00584870|468075068|FG000|Overall Study|Withdrawal by Subject|10|||
130101388|NCT01473589|468328668|FG001|Overall Study|Protocol Violation|0|||
130101389|NCT01473589|468328667|FG000|Overall Study|Withdrawal by Subject|5|||
130101390|NCT01473589|468328668|FG001|Overall Study|Withdrawal by Subject|11|||
130101391|NCT01473589|468328667|FG000|Overall Study|Physician Decision|0|||
130101392|NCT01473589|468328668|FG001|Overall Study|Physician Decision|1|||
130101393|NCT01473589|468328667|FG000|Overall Study|Entry criteria not met|0|||
130101394|NCT01473589|468328668|FG001|Overall Study|Entry criteria not met|1|||
130101395|NCT01819467|468328669|FG000|Overall Study|Physician Decision|20|||
130101396|NCT01819467|468328670|FG001|Overall Study|Physician Decision|9|||
130101397|NCT01607398|468328674|FG000|Overall Study|Adverse Event|0|||
130101398|NCT01607398|468328675|FG001|Overall Study|Adverse Event|2|||
130101399|NCT01607398|468328674|FG000|Overall Study|Severe COPD|2|||
130101400|NCT01607398|468328675|FG001|Overall Study|Severe COPD|0|||
130101401|NCT03079869|468328688|FG000|Overall Study|Adverse Event|6|||
130101402|NCT03079869|468328689|FG001|Overall Study|Adverse Event|8|||
130101403|NCT03079869|468328688|FG000|Overall Study|Withdrawal by Subject|4|||
130101404|NCT03079869|468328689|FG001|Overall Study|Withdrawal by Subject|1|||
130101405|NCT03079869|468328688|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
130101406|NCT03079869|468328689|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
130101407|NCT04139642|468328693|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
130101408|NCT04139642|468328694|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
130101409|NCT02871921|468328706|FG000|Overall Study|Withdrawal by Subject|34|||
130101410|NCT02871921|468328707|FG001|Overall Study|Withdrawal by Subject|27|||
130101411|NCT02871921|468328708|FG002|Overall Study|Withdrawal by Subject|27|||
130101412|NCT02871921|468328709|FG003|Overall Study|Withdrawal by Subject|30|||
130101413|NCT00539006|468328710|FG000|Pre-treatment|Other|0|||
130101414|NCT00539006|468328711|FG001|Pre-treatment|Other|1|||
130101415|NCT00539006|468328712|FG002|Pre-treatment|Other|0|||
130101416|NCT00539006|468328713|FG003|Pre-treatment|Other|0|||
130101417|NCT00539006|468328710|FG000|Treatment Period 1|Lost to Follow-up|0|||
130101418|NCT00539006|468328711|FG001|Treatment Period 1|Lost to Follow-up|0|||
130101419|NCT00539006|468328712|FG002|Treatment Period 1|Lost to Follow-up|1|||
130101420|NCT00539006|468328713|FG003|Treatment Period 1|Lost to Follow-up|0|||
130101421|NCT00539006|468328710|FG000|Treatment Period 1|Protocol Violation|0|||
130101422|NCT00539006|468328711|FG001|Treatment Period 1|Protocol Violation|0|||
130101423|NCT00539006|468328712|FG002|Treatment Period 1|Protocol Violation|1|||
130101424|NCT00539006|468328713|FG003|Treatment Period 1|Protocol Violation|0|||
130101425|NCT00539006|468328710|FG000|Treatment Period 1|Lack of Efficacy|0|||
130101426|NCT00539006|468328711|FG001|Treatment Period 1|Lack of Efficacy|0|||
130101427|NCT00539006|468328712|FG002|Treatment Period 1|Lack of Efficacy|0|||
130101428|NCT00539006|468328713|FG003|Treatment Period 1|Lack of Efficacy|1|||
130101429|NCT00539006|468328710|FG000|Washout|Adverse Event|2|||
130101430|NCT00539006|468328711|FG001|Washout|Adverse Event|1|||
130101431|NCT00539006|468328712|FG002|Washout|Adverse Event|0|||
130101432|NCT00539006|468328713|FG003|Washout|Adverse Event|0|||
130101433|NCT00539006|468328710|FG000|Washout|Protocol Violation|1|||
130101434|NCT00539006|468328711|FG001|Washout|Protocol Violation|1|||
130101435|NCT00539006|468328712|FG002|Washout|Protocol Violation|0|||
130101436|NCT00539006|468328713|FG003|Washout|Protocol Violation|0|||
130101437|NCT00539006|468328710|FG000|Washout|Withdrawal by Subject|0|||
130101438|NCT00539006|468328711|FG001|Washout|Withdrawal by Subject|2|||
130032446|NCT00584870|468075069|FG001|Overall Study|Withdrawal by Subject|5|||
130101439|NCT00539006|468328712|FG002|Washout|Withdrawal by Subject|0|||
130101440|NCT00539006|468328713|FG003|Washout|Withdrawal by Subject|0|||
130101441|NCT00539006|468328710|FG000|Washout|Failed to meet continuation criteria|16|||
130101442|NCT00539006|468328711|FG001|Washout|Failed to meet continuation criteria|5|||
130101443|NCT00539006|468328712|FG002|Washout|Failed to meet continuation criteria|14|||
130101444|NCT00539006|468328713|FG003|Washout|Failed to meet continuation criteria|6|||
130101445|NCT00539006|468328710|FG000|Washout|Other|1|||
130101446|NCT00539006|468328711|FG001|Washout|Other|1|||
130101447|NCT00539006|468328712|FG002|Washout|Other|2|||
130101448|NCT00539006|468328713|FG003|Washout|Other|3|||
130101449|NCT00539006|468328710|FG000|Treatment Period 2|Protocol Violation|1|||
130032447|NCT00584870|468075070|FG002|Overall Study|Withdrawal by Subject|3|||
130256298|NCT02327169|468903175|FG012|Overall Study|Lost to Follow-up|0|||
130256299|NCT02327169|468903176|FG013|Overall Study|Lost to Follow-up|0|||
130256300|NCT02327169|468903177|FG014|Overall Study|Lost to Follow-up|0|||
130256301|NCT01381679|468903182|FG000|Overall Study|Adverse Event|3|||
130256302|NCT01381679|468903182|FG000|Overall Study|Lost to Follow-up|885|||
130256303|NCT05473715|468903183|FG000|Overall Study|Trial terminate|2|||
130256304|NCT05473715|468903184|FG001|Overall Study|Trial terminate|1|||
130256305|NCT00427700|468903188|FG000|Overall Study|Lost to Follow-up|2|||
130256306|NCT00427700|468903189|FG001|Overall Study|Lost to Follow-up|5|||
130256307|NCT00427700|468903188|FG000|Overall Study|no induction of menses|1|||
130101450|NCT00539006|468328711|FG001|Treatment Period 2|Protocol Violation|0|||
130101451|NCT00539006|468328712|FG002|Treatment Period 2|Protocol Violation|0|||
130101452|NCT00539006|468328713|FG003|Treatment Period 2|Protocol Violation|0|||
130101453|NCT00539006|468328710|FG000|Treatment Period 2|Other|0|||
130101454|NCT00539006|468328711|FG001|Treatment Period 2|Other|1|||
130101455|NCT00539006|468328712|FG002|Treatment Period 2|Other|0|||
130101456|NCT00539006|468328713|FG003|Treatment Period 2|Other|0|||
130101457|NCT02353572|468328714|FG000|Overall Study|Withdrawal by Subject|1|||
130101458|NCT02353572|468328714|FG000|Overall Study|Study terminated|2|||
130101459|NCT00244881|468328722|FG000|Overall Study|Withdrawal by Subject|3|||
130101460|NCT03159611|468328723|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
130101461|NCT03159611|468328724|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
130101462|NCT03159611|468328723|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
130101463|NCT03159611|468328724|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
130101464|NCT03159611|468328723|FG000|Overall Study|Protocol Violation|7|||
130101465|NCT03159611|468328724|FG001|Overall Study|Protocol Violation|4|||
130101466|NCT03159611|468328723|FG000|Overall Study|Adverse Event|1|||
130101467|NCT03159611|468328724|FG001|Overall Study|Adverse Event|0|||
130101468|NCT03159611|468328723|FG000|Overall Study|Withdrawal by Subject|1|||
130101469|NCT03159611|468328724|FG001|Overall Study|Withdrawal by Subject|1|||
130101470|NCT03159611|468328723|FG000|Overall Study|Non-compliance with protocol requirement|3|||
130101471|NCT03159611|468328724|FG001|Overall Study|Non-compliance with protocol requirement|2|||
130101472|NCT03159611|468328723|FG000|Overall Study|Inability to perform procedures|1|||
130101473|NCT03159611|468328724|FG001|Overall Study|Inability to perform procedures|0|||
130101474|NCT00530621|468328725|FG000|Overall Study|Adverse Event|11|||
130101475|NCT00530621|468328726|FG001|Overall Study|Adverse Event|8|||
130101476|NCT00530621|468328725|FG000|Overall Study|Physician Decision|2|||
130101477|NCT00530621|468328726|FG001|Overall Study|Physician Decision|4|||
130101478|NCT00530621|468328725|FG000|Overall Study|Progressive Disease (PD)|47|||
130101479|NCT00530621|468328726|FG001|Overall Study|Progressive Disease (PD)|40|||
130101480|NCT00530621|468328725|FG000|Overall Study|Sponsor Decision|12|||
130101481|NCT00530621|468328726|FG001|Overall Study|Sponsor Decision|15|||
130101482|NCT00530621|468328725|FG000|Overall Study|Subject Decision|4|||
130101483|NCT00530621|468328726|FG001|Overall Study|Subject Decision|7|||
130101484|NCT00530621|468328725|FG000|Overall Study|Death|3|||
130101485|NCT00530621|468328726|FG001|Overall Study|Death|6|||
130101486|NCT00530621|468328725|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
130101487|NCT00530621|468328726|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
130101488|NCT00518011|468328727|FG000|Overall Study|Death|1|||
130101489|NCT00518011|468328728|FG001|Overall Study|Death|1|||
130101490|NCT00518011|468328727|FG000|Overall Study|Adverse Event|2|||
130101491|NCT00518011|468328728|FG001|Overall Study|Adverse Event|3|||
130101492|NCT00518011|468328727|FG000|Overall Study|Disease Progression|2|||
130101493|NCT00518011|468328728|FG001|Overall Study|Disease Progression|2|||
130101494|NCT00518011|468328727|FG000|Overall Study|Other Reasons|3|||
130101495|NCT00518011|468328728|FG001|Overall Study|Other Reasons|2|||
130101496|NCT00518011|468328727|FG000|Overall Study|Withdrawal by Subject|1|||
130101497|NCT00518011|468328728|FG001|Overall Study|Withdrawal by Subject|0|||
130101498|NCT03409328|468328729|FG000|Overall Study|Lost to Follow-up|6|||
130101499|NCT03409328|468328730|FG001|Overall Study|Lost to Follow-up|3|||
130101500|NCT02596009|468328731|FG000|Overall Study|Administrative problems|0|||
130101501|NCT02596009|468328732|FG001|Overall Study|Administrative problems|1|||
130101502|NCT02596009|468328733|FG002|Overall Study|Administrative problems|0|||
130101503|NCT02596009|468328734|FG003|Overall Study|Administrative problems|0|||
130101504|NCT02596009|468328735|FG004|Overall Study|Administrative problems|0|||
130256308|NCT00427700|468903189|FG001|Overall Study|no induction of menses|4|||
130256309|NCT00427700|468903188|FG000|Overall Study|Pregnancy|0|||
130256310|NCT00427700|468903189|FG001|Overall Study|Pregnancy|2|||
130256311|NCT02014376|468903190|FG000|Overall Study|Adverse Event|1|||
130256312|NCT02014376|468903191|FG001|Overall Study|Adverse Event|1|||
130256313|NCT02014376|468903192|FG002|Overall Study|Adverse Event|0|||
130256314|NCT02014376|468903190|FG000|Overall Study|Lost to Follow-up|2|||
130256315|NCT02014376|468903191|FG001|Overall Study|Lost to Follow-up|0|||
130101505|NCT02596009|468328736|FG005|Overall Study|Administrative problems|0|||
130101506|NCT02998645|468328737|FG000|Treatment Period 1|Adverse Event|6|||
130101507|NCT02998645|468328737|FG000|Treatment Period 1|Death|5|||
130256316|NCT02014376|468903192|FG002|Overall Study|Lost to Follow-up|0|||
130101508|NCT02998645|468328737|FG000|Treatment Period 1|Technical Problems|4|||
130256317|NCT01051661|468903195|FG000|Overall Study|Adverse Event|1|||
130101509|NCT02998645|468328737|FG000|Treatment Period 1|Lack of Efficacy|2|||
130256318|NCT01051661|468903196|FG001|Overall Study|Adverse Event|1|||
129885285|NCT00900627|467540625|FG003|Overall Study|Adverse Event|3|||
130101510|NCT02998645|468328737|FG000|Treatment Period 1|Progressive disease|1|||
130101511|NCT02998645|468328737|FG000|Treatment Period 1|Subject/guardian decision|1|||
130101512|NCT02998645|468328737|FG000|Treatment Period 2|Lack of Efficacy|5|||
130101513|NCT02998645|468328737|FG000|Treatment Period 2|Adverse Event|2|||
130101514|NCT02998645|468328737|FG000|Treatment Period 2|Progressive disease|2|||
130101515|NCT02998645|468328737|FG000|Treatment Period 2|Physician Decision|1|||
130256319|NCT01051661|468903197|FG002|Overall Study|Adverse Event|1|||
130256320|NCT01051661|468903198|FG003|Overall Study|Adverse Event|1|||
130256321|NCT01051661|468903199|FG004|Overall Study|Adverse Event|0|||
130256322|NCT01051661|468903200|FG005|Overall Study|Adverse Event|0|||
130256323|NCT01051661|468903195|FG000|Overall Study|Lost to Follow-up|13|||
130256324|NCT01051661|468903196|FG001|Overall Study|Lost to Follow-up|22|||
130256325|NCT01051661|468903197|FG002|Overall Study|Lost to Follow-up|15|||
130256326|NCT01051661|468903198|FG003|Overall Study|Lost to Follow-up|17|||
130256327|NCT01051661|468903199|FG004|Overall Study|Lost to Follow-up|10|||
130256328|NCT01051661|468903200|FG005|Overall Study|Lost to Follow-up|24|||
130256329|NCT01051661|468903195|FG000|Overall Study|Migrated/moved from study area|1|||
130256330|NCT01051661|468903196|FG001|Overall Study|Migrated/moved from study area|6|||
130256331|NCT01051661|468903197|FG002|Overall Study|Migrated/moved from study area|6|||
130256332|NCT01051661|468903198|FG003|Overall Study|Migrated/moved from study area|8|||
130256333|NCT01051661|468903199|FG004|Overall Study|Migrated/moved from study area|7|||
130256334|NCT01051661|468903200|FG005|Overall Study|Migrated/moved from study area|3|||
130256335|NCT01051661|468903195|FG000|Overall Study|Refused blood sampling|0|||
130256336|NCT01051661|468903196|FG001|Overall Study|Refused blood sampling|0|||
130256337|NCT01051661|468903197|FG002|Overall Study|Refused blood sampling|0|||
130256338|NCT01051661|468903198|FG003|Overall Study|Refused blood sampling|0|||
130256339|NCT01051661|468903199|FG004|Overall Study|Refused blood sampling|0|||
130256340|NCT01051661|468903200|FG005|Overall Study|Refused blood sampling|1|||
130256341|NCT01051661|468903195|FG000|Overall Study|Data not reliable|1|||
130256342|NCT01051661|468903196|FG001|Overall Study|Data not reliable|0|||
130256343|NCT01051661|468903197|FG002|Overall Study|Data not reliable|0|||
130256344|NCT01051661|468903198|FG003|Overall Study|Data not reliable|0|||
130256345|NCT01051661|468903199|FG004|Overall Study|Data not reliable|0|||
130256346|NCT01051661|468903200|FG005|Overall Study|Data not reliable|1|||
130256347|NCT01051661|468903195|FG000|Overall Study|Unable to attend visit(s)|2|||
130256348|NCT01051661|468903196|FG001|Overall Study|Unable to attend visit(s)|4|||
130256349|NCT01051661|468903197|FG002|Overall Study|Unable to attend visit(s)|2|||
130256350|NCT01051661|468903198|FG003|Overall Study|Unable to attend visit(s)|1|||
130256351|NCT01051661|468903199|FG004|Overall Study|Unable to attend visit(s)|3|||
130256352|NCT01051661|468903200|FG005|Overall Study|Unable to attend visit(s)|2|||
130256353|NCT01051661|468903195|FG000|Overall Study|Consent not received from both parents|0|||
130256354|NCT01051661|468903196|FG001|Overall Study|Consent not received from both parents|0|||
130256355|NCT01051661|468903197|FG002|Overall Study|Consent not received from both parents|0|||
130256356|NCT01051661|468903198|FG003|Overall Study|Consent not received from both parents|0|||
130256357|NCT01051661|468903199|FG004|Overall Study|Consent not received from both parents|0|||
130256358|NCT01051661|468903200|FG005|Overall Study|Consent not received from both parents|1|||
130256359|NCT01051661|468903195|FG000|Overall Study|Failure to comply with protocol|0|||
130032448|NCT00584870|468075068|FG000|Overall Study|Protocol Violation|1|||
130032449|NCT00584870|468075069|FG001|Overall Study|Protocol Violation|1|||
130256360|NCT01051661|468903196|FG001|Overall Study|Failure to comply with protocol|0|||
130256361|NCT01051661|468903197|FG002|Overall Study|Failure to comply with protocol|2|||
130256362|NCT01051661|468903198|FG003|Overall Study|Failure to comply with protocol|0|||
130256363|NCT01051661|468903199|FG004|Overall Study|Failure to comply with protocol|0|||
130256364|NCT01051661|468903200|FG005|Overall Study|Failure to comply with protocol|0|||
130256365|NCT01051661|468903195|FG000|Overall Study|Subject lost legal representation|0|||
130256366|NCT01051661|468903196|FG001|Overall Study|Subject lost legal representation|0|||
130256367|NCT01051661|468903197|FG002|Overall Study|Subject lost legal representation|0|||
130256368|NCT01051661|468903198|FG003|Overall Study|Subject lost legal representation|0|||
130256369|NCT01051661|468903199|FG004|Overall Study|Subject lost legal representation|1|||
130256370|NCT01051661|468903200|FG005|Overall Study|Subject lost legal representation|0|||
130256371|NCT01051661|468903195|FG000|Overall Study|Protocol Violation|0|||
130256372|NCT01051661|468903196|FG001|Overall Study|Protocol Violation|0|||
130256373|NCT01051661|468903197|FG002|Overall Study|Protocol Violation|0|||
130256374|NCT01051661|468903198|FG003|Overall Study|Protocol Violation|1|||
130256375|NCT01051661|468903199|FG004|Overall Study|Protocol Violation|2|||
130256376|NCT01051661|468903200|FG005|Overall Study|Protocol Violation|1|||
130256377|NCT01051661|468903195|FG000|Overall Study|Withdrawal by Subject|16|||
130256378|NCT01051661|468903196|FG001|Overall Study|Withdrawal by Subject|30|||
130256379|NCT01051661|468903197|FG002|Overall Study|Withdrawal by Subject|13|||
130256380|NCT01051661|468903198|FG003|Overall Study|Withdrawal by Subject|28|||
130256381|NCT01051661|468903199|FG004|Overall Study|Withdrawal by Subject|12|||
130032450|NCT00584870|468075070|FG002|Overall Study|Protocol Violation|2|||
130256382|NCT01051661|468903200|FG005|Overall Study|Withdrawal by Subject|34|||
130256383|NCT04642079|468903201|FG000|Overall Study|Lost to Follow-up|2|||
130256384|NCT04642079|468903202|FG001|Overall Study|Lost to Follow-up|5|||
130256385|NCT04642079|468903203|FG002|Overall Study|Lost to Follow-up|2|||
130256386|NCT04642079|468903204|FG003|Overall Study|Lost to Follow-up|0|||
130256387|NCT04642079|468903201|FG000|Overall Study|Withdrawal by Subject|0|||
130256388|NCT04642079|468903202|FG001|Overall Study|Withdrawal by Subject|4|||
130101516|NCT03930615|468328740|FG000|Overall Study|Death|9|||
130256389|NCT04642079|468903203|FG002|Overall Study|Withdrawal by Subject|1|||
130256390|NCT04642079|468903204|FG003|Overall Study|Withdrawal by Subject|2|||
130256391|NCT04642079|468903201|FG000|Overall Study|Other|0|||
130256392|NCT04642079|468903202|FG001|Overall Study|Other|0|||
130256393|NCT04642079|468903203|FG002|Overall Study|Other|0|||
130256394|NCT04642079|468903204|FG003|Overall Study|Other|1|||
130256395|NCT04642079|468903201|FG000|Overall Study|No longer met eligibility criteria|1|||
130256396|NCT04642079|468903202|FG001|Overall Study|No longer met eligibility criteria|0|||
130256397|NCT04642079|468903203|FG002|Overall Study|No longer met eligibility criteria|1|||
130256398|NCT04642079|468903204|FG003|Overall Study|No longer met eligibility criteria|1|||
130032451|NCT00584870|468075068|FG000|Overall Study|Did not met entrance criteria|1|||
130032452|NCT00584870|468075069|FG001|Overall Study|Did not met entrance criteria|0|||
130032453|NCT00584870|468075070|FG002|Overall Study|Did not met entrance criteria|0|||
130032454|NCT00584870|468075068|FG000|Overall Study|Other|2|||
130032455|NCT00584870|468075069|FG001|Overall Study|Other|0|||
130032456|NCT00584870|468075070|FG002|Overall Study|Other|0|||
130032457|NCT00584870|468075068|FG000|Overall Study|Randomized but not treated|0|||
130032458|NCT00584870|468075069|FG001|Overall Study|Randomized but not treated|1|||
130032459|NCT00584870|468075070|FG002|Overall Study|Randomized but not treated|2|||
130032460|NCT02675075|468075071|FG000|Overall Study|Lost to Follow-up|3|||
130032461|NCT02675075|468075072|FG001|Overall Study|Lost to Follow-up|0|||
130032462|NCT00675597|468075073|FG000|Overall Study|Withdrawal by Subject|3|||
130032463|NCT00631137|468075074|FG000|Overall Study|Withdrawal by Subject|1|||
130032464|NCT00631137|468075075|FG001|Overall Study|Withdrawal by Subject|0|||
130032465|NCT03682120|468075076|FG000|Overall Study|Lost to Follow-up|11|||
130032466|NCT03682120|468075077|FG001|Overall Study|Lost to Follow-up|4|||
130032467|NCT03682120|468075078|FG002|Overall Study|Lost to Follow-up|5|||
130032468|NCT03682120|468075079|FG003|Overall Study|Lost to Follow-up|2|||
130032469|NCT03682120|468075076|FG000|Overall Study|Physician Decision|1|||
130032470|NCT03682120|468075077|FG001|Overall Study|Physician Decision|0|||
130032471|NCT03682120|468075078|FG002|Overall Study|Physician Decision|0|||
130032472|NCT03682120|468075079|FG003|Overall Study|Physician Decision|0|||
130032473|NCT03682120|468075076|FG000|Overall Study|Withdrawal by Subject|1|||
130032474|NCT03682120|468075077|FG001|Overall Study|Withdrawal by Subject|2|||
130032475|NCT03682120|468075078|FG002|Overall Study|Withdrawal by Subject|3|||
130032476|NCT03682120|468075079|FG003|Overall Study|Withdrawal by Subject|0|||
130032477|NCT03682120|468075076|FG000|Overall Study|Death|0|||
130032478|NCT03682120|468075077|FG001|Overall Study|Death|1|||
130032479|NCT03682120|468075078|FG002|Overall Study|Death|0|||
130032480|NCT03682120|468075079|FG003|Overall Study|Death|0|||
130032481|NCT03682120|468075076|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
130032482|NCT03682120|468075077|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
130032483|NCT03682120|468075078|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
130032484|NCT03682120|468075079|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
130032485|NCT03308188|468075080|FG000|Overall Study|Withdrawal by Subject|0|||
130032486|NCT03308188|468075081|FG001|Overall Study|Withdrawal by Subject|3|||
130032487|NCT03308188|468075080|FG000|Overall Study|Death|0|||
130032488|NCT03308188|468075081|FG001|Overall Study|Death|1|||
130032489|NCT04752384|468075082|FG000|Overall Study|Withdrawal by Subject|1|||
130032490|NCT04752384|468075082|FG000|Overall Study|Death|1|||
130032491|NCT02330419|468075084|FG000|Overall Study|Lost to Follow-up|3|||
130032492|NCT02330419|468075085|FG001|Overall Study|Lost to Follow-up|7|||
130032493|NCT01813890|468075088|FG000|Overall Study|Adverse Event|0|||
130032494|NCT01813890|468075089|FG001|Overall Study|Adverse Event|3|||
130032495|NCT01813890|468075090|FG002|Overall Study|Adverse Event|4|||
130032496|NCT01813890|468075088|FG000|Overall Study|Lack of Efficacy|9|||
130032497|NCT01813890|468075089|FG001|Overall Study|Lack of Efficacy|1|||
130032498|NCT01813890|468075090|FG002|Overall Study|Lack of Efficacy|2|||
130032499|NCT04439123|468075091|FG000|Overall Study|Adverse Event|11|||
130032500|NCT04439123|468075091|FG000|Overall Study|Death|1|||
130032501|NCT04439123|468075091|FG000|Overall Study|Disease progression|19|||
130032502|NCT04439123|468075091|FG000|Overall Study|Withdrawal by Subject|2|||
130032503|NCT04439123|468075091|FG000|Overall Study|Still on treatment|2|||
130032504|NCT03952559|468075092|FG000|Double Blind Treatment Period|Adverse Event|0|||
130256399|NCT00635050|468903209|FG000|Overall Study|Withdrawal by Subject|1|||
130032505|NCT03952559|468075093|FG001|Double Blind Treatment Period|Adverse Event|2|||
130032506|NCT03952559|468075094|FG002|Double Blind Treatment Period|Adverse Event|1|||
130032507|NCT03952559|468075095|FG003|Double Blind Treatment Period|Adverse Event|0|||
130032508|NCT03952559|468075096|FG004|Double Blind Treatment Period|Adverse Event|1|||
130032509|NCT03952559|468075092|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
130032510|NCT03952559|468075093|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
130032511|NCT03952559|468075094|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
130032512|NCT03952559|468075095|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
130256400|NCT03038620|468903210|FG000|Overall Study|Lost to Follow-up|18|||
130256401|NCT03038620|468903211|FG001|Overall Study|Lost to Follow-up|23|||
130032513|NCT03952559|468075096|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130101517|NCT03930615|468328741|FG001|Overall Study|Death|3|||
130032514|NCT03952559|468075092|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130032515|NCT03952559|468075093|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
130032516|NCT03952559|468075094|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
130032517|NCT03952559|468075095|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
130032518|NCT03952559|468075096|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130032519|NCT03952559|468075092|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
130032520|NCT03952559|468075093|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
130032521|NCT03952559|468075094|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
130032522|NCT03952559|468075095|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
130032523|NCT03952559|468075096|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
130032524|NCT01870739|468075099|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
130032525|NCT01870739|468075100|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
130032526|NCT01870739|468075099|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
130032527|NCT01870739|468075100|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
130032528|NCT01870739|468075099|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
130032529|NCT01870739|468075100|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
130032530|NCT01870739|468075099|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
130032531|NCT01870739|468075100|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
130032532|NCT01870739|468075099|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
130032533|NCT01870739|468075100|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
130032534|NCT01870739|468075099|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
130032535|NCT01870739|468075100|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
130032536|NCT01870739|468075099|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
130032537|NCT01870739|468075100|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
130032538|NCT01986062|468075101|FG000|Overall Study|Lost to Follow-up|1|||
130032539|NCT01986062|468075102|FG001|Overall Study|Lost to Follow-up|0|||
130032540|NCT01986062|468075101|FG000|Overall Study|Withdrawal by Subject|0|||
130032541|NCT01986062|468075102|FG001|Overall Study|Withdrawal by Subject|1|||
130032542|NCT03538743|468075103|FG000|Overall Study|Adverse Event|0|||
130032543|NCT03538743|468075104|FG001|Overall Study|Adverse Event|0|||
130032544|NCT03538743|468075105|FG002|Overall Study|Adverse Event|1|||
130032545|NCT03538743|468075106|FG003|Overall Study|Adverse Event|1|||
130032546|NCT03538743|468075107|FG004|Overall Study|Adverse Event|0|||
130032547|NCT03538743|468075108|FG005|Overall Study|Adverse Event|0|||
130032548|NCT03538743|468075109|FG006|Overall Study|Adverse Event|0|||
130032549|NCT03538743|468075110|FG007|Overall Study|Adverse Event|0|||
130032550|NCT03538743|468075111|FG008|Overall Study|Adverse Event|0|||
130032551|NCT03538743|468075103|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
130032552|NCT03538743|468075104|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
130032553|NCT03538743|468075105|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
130032554|NCT03538743|468075106|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
130032555|NCT03538743|468075107|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
130032556|NCT03538743|468075108|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
130032557|NCT03538743|468075109|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
130032558|NCT03538743|468075110|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
130032559|NCT03538743|468075111|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
130032560|NCT03538743|468075103|FG000|Overall Study|Withdrawal by Subject|0|||
130032561|NCT03538743|468075104|FG001|Overall Study|Withdrawal by Subject|0|||
130032562|NCT03538743|468075105|FG002|Overall Study|Withdrawal by Subject|0|||
130032563|NCT03538743|468075106|FG003|Overall Study|Withdrawal by Subject|1|||
130032564|NCT03538743|468075107|FG004|Overall Study|Withdrawal by Subject|0|||
130032565|NCT03538743|468075108|FG005|Overall Study|Withdrawal by Subject|0|||
130032566|NCT03538743|468075109|FG006|Overall Study|Withdrawal by Subject|0|||
130032567|NCT03538743|468075110|FG007|Overall Study|Withdrawal by Subject|0|||
130032568|NCT03538743|468075111|FG008|Overall Study|Withdrawal by Subject|0|||
130032569|NCT04640766|468075112|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
130032570|NCT00630331|468075113|FG000|Overall Study|Death|2|||
130032571|NCT00630331|468075114|FG001|Overall Study|Death|1|||
130256402|NCT03038620|468903210|FG000|Overall Study|Withdrawal by Subject|0|||
130256403|NCT03038620|468903211|FG001|Overall Study|Withdrawal by Subject|15|||
130256404|NCT03038620|468903210|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
130256405|NCT03038620|468903211|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
130256406|NCT00759395|468903217|FG000|Overall Study|Adverse Event|1|||
130256407|NCT00759395|468903218|FG001|Overall Study|Adverse Event|0|||
130256408|NCT00759395|468903217|FG000|Overall Study|Withdrawal by Subject|1|||
130256409|NCT00759395|468903218|FG001|Overall Study|Withdrawal by Subject|0|||
130256410|NCT00759395|468903217|FG000|Overall Study|Lack of Efficacy|0|||
130256411|NCT00759395|468903218|FG001|Overall Study|Lack of Efficacy|2|||
130256412|NCT01435356|468903219|FG000|Overall Study|Adverse Event|2|||
130256413|NCT01435356|468903220|FG001|Overall Study|Adverse Event|0|||
130256414|NCT01435356|468903219|FG000|Overall Study|Disease progression/recurrence|17|||
130256415|NCT01435356|468903220|FG001|Overall Study|Disease progression/recurrence|10|||
130256416|NCT01435356|468903219|FG000|Overall Study|Protocol Violation|0|||
130256417|NCT01435356|468903220|FG001|Overall Study|Protocol Violation|1|||
130256418|NCT01435356|468903219|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
130256419|NCT01435356|468903220|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
130256420|NCT01435356|468903219|FG000|Overall Study|Withdrawal by Subject|1|||
130256421|NCT01435356|468903220|FG001|Overall Study|Withdrawal by Subject|1|||
130256422|NCT01435356|468903219|FG000|Overall Study|Facial palsy|1|||
130256423|NCT01435356|468903220|FG001|Overall Study|Facial palsy|0|||
130256424|NCT01435356|468903219|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
130256425|NCT01435356|468903220|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
130256426|NCT01435356|468903219|FG000|Overall Study|Physician Decision|1|||
130256427|NCT01435356|468903220|FG001|Overall Study|Physician Decision|0|||
130256428|NCT01435356|468903219|FG000|Overall Study|Patient decision|3|||
130256429|NCT01435356|468903220|FG001|Overall Study|Patient decision|0|||
130256430|NCT01435356|468903219|FG000|Overall Study|Patient moved to another city|1|||
130256431|NCT01435356|468903220|FG001|Overall Study|Patient moved to another city|1|||
130256432|NCT00437073|468903221|FG000|Overall Study|Sponsor Terminated Study|1|||
130256433|NCT00437073|468903222|FG001|Overall Study|Sponsor Terminated Study|0|||
130256434|NCT00437073|468903221|FG000|Overall Study|Physician Decision|0|||
130256435|NCT00437073|468903222|FG001|Overall Study|Physician Decision|1|||
130256436|NCT04875533|468903223|FG000|Overall Study|Adverse Event|6|||
130256437|NCT04875533|468903224|FG001|Overall Study|Adverse Event|4|||
130256438|NCT04875533|468903223|FG000|Overall Study|Protocol Violation|4|||
130256439|NCT04875533|468903224|FG001|Overall Study|Protocol Violation|0|||
130256440|NCT04875533|468903223|FG000|Overall Study|Withdrawal by Subject|8|||
130256441|NCT04875533|468903224|FG001|Overall Study|Withdrawal by Subject|5|||
130256442|NCT04875533|468903223|FG000|Overall Study|No longer meets eligibility criteria|1|||
130256443|NCT04875533|468903224|FG001|Overall Study|No longer meets eligibility criteria|0|||
130256444|NCT04875533|468903223|FG000|Overall Study|Other|0|||
130256445|NCT04875533|468903224|FG001|Overall Study|Other|2|||
130256446|NCT02657343|468903227|FG000|Overall Study|Death|0|||
130256447|NCT02657343|468903228|FG001|Overall Study|Death|2|||
130256448|NCT02657343|468903229|FG002|Overall Study|Death|0|||
130256449|NCT02657343|468903230|FG003|Overall Study|Death|0|||
130256450|NCT02657343|468903231|FG004|Overall Study|Death|0|||
130256451|NCT02657343|468903232|FG005|Overall Study|Death|0|||
130256452|NCT02657343|468903227|FG000|Overall Study|Patient went to hospice|1|||
130256453|NCT02657343|468903228|FG001|Overall Study|Patient went to hospice|0|||
130256454|NCT02657343|468903229|FG002|Overall Study|Patient went to hospice|0|||
130256455|NCT02657343|468903230|FG003|Overall Study|Patient went to hospice|0|||
130256456|NCT02657343|468903231|FG004|Overall Study|Patient went to hospice|0|||
130256457|NCT02657343|468903232|FG005|Overall Study|Patient went to hospice|0|||
130256458|NCT02657343|468903227|FG000|Overall Study|Withdrawal by Subject|0|||
130256459|NCT02657343|468903228|FG001|Overall Study|Withdrawal by Subject|0|||
130256460|NCT02657343|468903229|FG002|Overall Study|Withdrawal by Subject|0|||
130256461|NCT02657343|468903230|FG003|Overall Study|Withdrawal by Subject|0|||
130256462|NCT02657343|468903231|FG004|Overall Study|Withdrawal by Subject|1|||
130256463|NCT02657343|468903232|FG005|Overall Study|Withdrawal by Subject|0|||
130256464|NCT02011542|468903234|FG000|Overall Study|Physician Decision|1|||
130256465|NCT00982280|468903238|FG000|Observation Period|Not eligible to be dosed|19|||
130256466|NCT00982280|468903238|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
130256467|NCT00982280|468903238|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
130256468|NCT00982280|468903238|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
130256469|NCT00982280|468903238|FG000|Maintenance Period|Adverse Event|1|||
130256470|NCT01979185|468903239|FG000|Period 2|Other|0|||
130256471|NCT01979185|468903240|FG001|Period 2|Other|1|||
130256472|NCT00980798|468903241|FG000|Overall Study|Adverse Event|7|||
130256473|NCT00980798|468903242|FG001|Overall Study|Adverse Event|36|||
130256474|NCT00980798|468903241|FG000|Overall Study|Lack of Efficacy|16|||
130256475|NCT00980798|468903242|FG001|Overall Study|Lack of Efficacy|5|||
130256476|NCT00980798|468903241|FG000|Overall Study|Lost to Follow-up|0|||
130256477|NCT00980798|468903242|FG001|Overall Study|Lost to Follow-up|1|||
130256478|NCT00980798|468903241|FG000|Overall Study|Physician Decision|2|||
130032572|NCT00630331|468075115|FG002|Overall Study|Death|1|||
130032573|NCT00630331|468075113|FG000|Overall Study|Adverse Event|1|||
130032574|NCT00630331|468075114|FG001|Overall Study|Adverse Event|0|||
130032575|NCT00630331|468075115|FG002|Overall Study|Adverse Event|0|||
130032576|NCT00630331|468075113|FG000|Overall Study|Withdrawal by Subject|12|||
130032577|NCT00630331|468075114|FG001|Overall Study|Withdrawal by Subject|7|||
130032578|NCT00630331|468075115|FG002|Overall Study|Withdrawal by Subject|5|||
130032579|NCT00630331|468075113|FG000|Overall Study|Lost to Follow-up|175|||
130032580|NCT00630331|468075114|FG001|Overall Study|Lost to Follow-up|143|||
130032581|NCT00630331|468075115|FG002|Overall Study|Lost to Follow-up|170|||
130032582|NCT00630331|468075113|FG000|Overall Study|Inappropriate enrollment|3|||
130032583|NCT00630331|468075114|FG001|Overall Study|Inappropriate enrollment|6|||
130032584|NCT00630331|468075115|FG002|Overall Study|Inappropriate enrollment|3|||
130032585|NCT00630331|468075113|FG000|Overall Study|Unable to classify|9|||
130032586|NCT00630331|468075114|FG001|Overall Study|Unable to classify|4|||
130032587|NCT00630331|468075115|FG002|Overall Study|Unable to classify|3|||
130032588|NCT00630331|468075113|FG000|Overall Study|Protocol Violation|4|||
130032589|NCT00630331|468075114|FG001|Overall Study|Protocol Violation|5|||
130256479|NCT00980798|468903242|FG001|Overall Study|Physician Decision|1|||
130256480|NCT00980798|468903241|FG000|Overall Study|Withdrawal by Subject|8|||
130256481|NCT00980798|468903242|FG001|Overall Study|Withdrawal by Subject|11|||
130256482|NCT00980798|468903241|FG000|Overall Study|Other|0|||
130256483|NCT00980798|468903242|FG001|Overall Study|Other|1|||
130256484|NCT04221438|468903243|FG000|Overall Study|Adverse Event|1|||
130256485|NCT04221438|468903243|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
130256486|NCT04724837|468903246|FG000|Overall Study|Other|4|||
130256487|NCT04724837|468903247|FG001|Overall Study|Other|16|||
130256488|NCT04724837|468903248|FG002|Overall Study|Other|0|||
130256489|NCT04724837|468903246|FG000|Overall Study|Withdrawal by Subject|2|||
130256490|NCT04724837|468903247|FG001|Overall Study|Withdrawal by Subject|9|||
130256491|NCT04724837|468903248|FG002|Overall Study|Withdrawal by Subject|9|||
130256492|NCT04724837|468903246|FG000|Overall Study|Adverse Event|2|||
130256493|NCT04724837|468903247|FG001|Overall Study|Adverse Event|7|||
130256494|NCT04724837|468903248|FG002|Overall Study|Adverse Event|4|||
130256495|NCT04724837|468903246|FG000|Overall Study|Lost to Follow-up|0|||
130256496|NCT04724837|468903247|FG001|Overall Study|Lost to Follow-up|1|||
130256497|NCT04724837|468903248|FG002|Overall Study|Lost to Follow-up|3|||
130256498|NCT04724837|468903246|FG000|Overall Study|Physician Decision|1|||
130256499|NCT04724837|468903247|FG001|Overall Study|Physician Decision|2|||
130256500|NCT04724837|468903248|FG002|Overall Study|Physician Decision|0|||
130256501|NCT04724837|468903246|FG000|Overall Study|Death|0|||
130256502|NCT04724837|468903247|FG001|Overall Study|Death|0|||
130256503|NCT04724837|468903248|FG002|Overall Study|Death|1|||
130256504|NCT04724837|468903246|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130256505|NCT04724837|468903247|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
130256506|NCT04724837|468903248|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
130256507|NCT04724837|468903246|FG000|Overall Study|Study Terminated by Sponsor|0|||
130256508|NCT04724837|468903247|FG001|Overall Study|Study Terminated by Sponsor|1|||
130256509|NCT04724837|468903248|FG002|Overall Study|Study Terminated by Sponsor|0|||
130256510|NCT00522379|468903249|FG000|Overall Study|Adverse Event|12|||
130256511|NCT00522379|468903250|FG001|Overall Study|Adverse Event|15|||
130256512|NCT00522379|468903251|FG002|Overall Study|Adverse Event|12|||
130256513|NCT00522379|468903252|FG003|Overall Study|Adverse Event|5|||
130256514|NCT00522379|468903253|FG004|Overall Study|Adverse Event|17|||
130256515|NCT00522379|468903249|FG000|Overall Study|Lack of Efficacy|3|||
130032590|NCT00630331|468075115|FG002|Overall Study|Protocol Violation|6|||
130032591|NCT01827384|468075117|FG000|Overall Study|Switched to alternative treatment|0|||
130032592|NCT01827384|468075118|FG001|Overall Study|Switched to alternative treatment|0|||
130032593|NCT01827384|468075119|FG002|Overall Study|Switched to alternative treatment|0|||
130032594|NCT01827384|468075120|FG003|Overall Study|Switched to alternative treatment|0|||
130032595|NCT01827384|468075121|FG004|Overall Study|Switched to alternative treatment|0|||
130032596|NCT01827384|468075122|FG005|Overall Study|Switched to alternative treatment|0|||
130032597|NCT01827384|468075123|FG006|Overall Study|Switched to alternative treatment|0|||
130032598|NCT01827384|468075124|FG007|Overall Study|Switched to alternative treatment|0|||
130032599|NCT01827384|468075125|FG008|Overall Study|Switched to alternative treatment|0|||
130032600|NCT01827384|468075126|FG009|Overall Study|Switched to alternative treatment|0|||
130032601|NCT01827384|468075127|FG010|Overall Study|Switched to alternative treatment|0|||
130256516|NCT00522379|468903250|FG001|Overall Study|Lack of Efficacy|0|||
130256517|NCT00522379|468903251|FG002|Overall Study|Lack of Efficacy|2|||
130256518|NCT00522379|468903252|FG003|Overall Study|Lack of Efficacy|2|||
130256519|NCT00522379|468903253|FG004|Overall Study|Lack of Efficacy|7|||
130256520|NCT00522379|468903249|FG000|Overall Study|Withdrawal by Subject|2|||
130256521|NCT00522379|468903250|FG001|Overall Study|Withdrawal by Subject|3|||
130256522|NCT00522379|468903251|FG002|Overall Study|Withdrawal by Subject|1|||
130032602|NCT01827384|468075128|FG011|Overall Study|Switched to alternative treatment|0|||
130032603|NCT01827384|468075129|FG012|Overall Study|Switched to alternative treatment|0|||
130032604|NCT01827384|468075130|FG013|Overall Study|Switched to alternative treatment|2|||
129885286|NCT00900627|467540626|FG004|Overall Study|Adverse Event|0|||
129885287|NCT00900627|467540627|FG005|Overall Study|Adverse Event|0|||
129885288|NCT00900627|467540622|FG000|Overall Study|Death|0|||
129885289|NCT00900627|467540623|FG001|Overall Study|Death|0|||
129885290|NCT00900627|467540624|FG002|Overall Study|Death|0|||
129885291|NCT00900627|467540625|FG003|Overall Study|Death|0|||
129885292|NCT00900627|467540626|FG004|Overall Study|Death|28|||
129885293|NCT00900627|467540627|FG005|Overall Study|Death|24|||
129885294|NCT00373295|467540628|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129885295|NCT00373295|467540629|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
129885296|NCT00373295|467540630|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129885297|NCT00373295|467540631|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129885298|NCT00373295|467540632|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
129885299|NCT00373295|467540633|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130032605|NCT01827384|468075117|FG000|Overall Study|Disease progression before treatment|0|||
130032606|NCT01827384|468075118|FG001|Overall Study|Disease progression before treatment|0|||
130032607|NCT01827384|468075119|FG002|Overall Study|Disease progression before treatment|0|||
130032608|NCT01827384|468075120|FG003|Overall Study|Disease progression before treatment|0|||
130032609|NCT01827384|468075121|FG004|Overall Study|Disease progression before treatment|0|||
130032610|NCT01827384|468075122|FG005|Overall Study|Disease progression before treatment|0|||
130032611|NCT01827384|468075123|FG006|Overall Study|Disease progression before treatment|0|||
130032612|NCT01827384|468075124|FG007|Overall Study|Disease progression before treatment|0|||
130032613|NCT01827384|468075125|FG008|Overall Study|Disease progression before treatment|0|||
130032614|NCT01827384|468075126|FG009|Overall Study|Disease progression before treatment|0|||
130032615|NCT01827384|468075127|FG010|Overall Study|Disease progression before treatment|0|||
130032616|NCT01827384|468075128|FG011|Overall Study|Disease progression before treatment|0|||
130032617|NCT01827384|468075129|FG012|Overall Study|Disease progression before treatment|0|||
130032618|NCT01827384|468075130|FG013|Overall Study|Disease progression before treatment|4|||
130032619|NCT01827384|468075117|FG000|Overall Study|Ineligible|0|||
130032620|NCT01827384|468075118|FG001|Overall Study|Ineligible|0|||
130032621|NCT01827384|468075119|FG002|Overall Study|Ineligible|0|||
130032622|NCT01827384|468075120|FG003|Overall Study|Ineligible|0|||
130032623|NCT01827384|468075121|FG004|Overall Study|Ineligible|0|||
130032624|NCT01827384|468075122|FG005|Overall Study|Ineligible|0|||
130032625|NCT01827384|468075123|FG006|Overall Study|Ineligible|0|||
130032626|NCT01827384|468075124|FG007|Overall Study|Ineligible|0|||
130032627|NCT01827384|468075125|FG008|Overall Study|Ineligible|0|||
130032628|NCT01827384|468075126|FG009|Overall Study|Ineligible|0|||
130032629|NCT01827384|468075127|FG010|Overall Study|Ineligible|0|||
130032630|NCT01827384|468075128|FG011|Overall Study|Ineligible|0|||
130032631|NCT01827384|468075129|FG012|Overall Study|Ineligible|0|||
130032632|NCT01827384|468075130|FG013|Overall Study|Ineligible|19|||
130032633|NCT01827384|468075117|FG000|Overall Study|Participant died before treatment|0|||
130032634|NCT01827384|468075118|FG001|Overall Study|Participant died before treatment|0|||
130032635|NCT01827384|468075119|FG002|Overall Study|Participant died before treatment|0|||
130032636|NCT01827384|468075120|FG003|Overall Study|Participant died before treatment|0|||
130032637|NCT01827384|468075121|FG004|Overall Study|Participant died before treatment|0|||
130032638|NCT01827384|468075122|FG005|Overall Study|Participant died before treatment|0|||
130032639|NCT01827384|468075123|FG006|Overall Study|Participant died before treatment|0|||
130032640|NCT01827384|468075124|FG007|Overall Study|Participant died before treatment|0|||
130101518|NCT03930615|468328740|FG000|Overall Study|Lost to Follow-up|1|||
130256523|NCT00522379|468903252|FG003|Overall Study|Withdrawal by Subject|2|||
130256524|NCT00522379|468903253|FG004|Overall Study|Withdrawal by Subject|0|||
130256525|NCT00522379|468903249|FG000|Overall Study|Protocol Violation|1|||
130256526|NCT00522379|468903250|FG001|Overall Study|Protocol Violation|1|||
130256527|NCT00522379|468903251|FG002|Overall Study|Protocol Violation|2|||
130256528|NCT00522379|468903252|FG003|Overall Study|Protocol Violation|0|||
130256529|NCT00522379|468903253|FG004|Overall Study|Protocol Violation|0|||
130256530|NCT00522379|468903249|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
130256531|NCT00522379|468903250|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
130256532|NCT00522379|468903251|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
130256533|NCT00522379|468903252|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
130256534|NCT00522379|468903253|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
130256535|NCT00522379|468903249|FG000|Overall Study|Lost to Follow-up|1|||
130256536|NCT00522379|468903250|FG001|Overall Study|Lost to Follow-up|0|||
130256537|NCT00522379|468903251|FG002|Overall Study|Lost to Follow-up|4|||
130256538|NCT00522379|468903252|FG003|Overall Study|Lost to Follow-up|2|||
130256539|NCT00522379|468903253|FG004|Overall Study|Lost to Follow-up|2|||
130256540|NCT00522379|468903249|FG000|Overall Study|Randomization error|0|||
130256541|NCT00522379|468903250|FG001|Overall Study|Randomization error|0|||
129885300|NCT00830947|467540634|FG000|Overall Study|Lost to Follow-up|4|||
129885301|NCT00830947|467540635|FG001|Overall Study|Lost to Follow-up|4|||
130032641|NCT01827384|468075125|FG008|Overall Study|Participant died before treatment|0|||
129885302|NCT00594906|467540636|FG000|Overall Study|Physician Decision|1|||
129885303|NCT00594906|467540637|FG001|Overall Study|Physician Decision|0|||
129885304|NCT00594906|467540636|FG000|Overall Study|Physician Decision|0|||
130032642|NCT01827384|468075126|FG009|Overall Study|Participant died before treatment|0|||
130032643|NCT01827384|468075127|FG010|Overall Study|Participant died before treatment|0|||
130032644|NCT01827384|468075128|FG011|Overall Study|Participant died before treatment|0|||
130032645|NCT01827384|468075129|FG012|Overall Study|Participant died before treatment|0|||
130032646|NCT01827384|468075130|FG013|Overall Study|Participant died before treatment|5|||
130032647|NCT01827384|468075117|FG000|Overall Study|Insufficient tumor cells|0|||
130032648|NCT01827384|468075118|FG001|Overall Study|Insufficient tumor cells|0|||
130032649|NCT01827384|468075119|FG002|Overall Study|Insufficient tumor cells|0|||
130032650|NCT01827384|468075120|FG003|Overall Study|Insufficient tumor cells|0|||
130256542|NCT00522379|468903251|FG002|Overall Study|Randomization error|0|||
130032651|NCT01827384|468075121|FG004|Overall Study|Insufficient tumor cells|0|||
130032652|NCT01827384|468075122|FG005|Overall Study|Insufficient tumor cells|0|||
130032653|NCT01827384|468075123|FG006|Overall Study|Insufficient tumor cells|0|||
130032654|NCT01827384|468075124|FG007|Overall Study|Insufficient tumor cells|0|||
130032655|NCT01827384|468075125|FG008|Overall Study|Insufficient tumor cells|0|||
130032656|NCT01827384|468075126|FG009|Overall Study|Insufficient tumor cells|0|||
130032657|NCT01827384|468075127|FG010|Overall Study|Insufficient tumor cells|0|||
130032658|NCT01827384|468075128|FG011|Overall Study|Insufficient tumor cells|0|||
130032659|NCT01827384|468075129|FG012|Overall Study|Insufficient tumor cells|0|||
130032660|NCT01827384|468075130|FG013|Overall Study|Insufficient tumor cells|13|||
130032661|NCT01827384|468075117|FG000|Overall Study|No actionable mutation|0|||
130032662|NCT01827384|468075118|FG001|Overall Study|No actionable mutation|0|||
130032663|NCT01827384|468075119|FG002|Overall Study|No actionable mutation|0|||
130032664|NCT01827384|468075120|FG003|Overall Study|No actionable mutation|0|||
130032665|NCT01827384|468075121|FG004|Overall Study|No actionable mutation|0|||
130032666|NCT01827384|468075122|FG005|Overall Study|No actionable mutation|0|||
130032667|NCT01827384|468075123|FG006|Overall Study|No actionable mutation|0|||
130032668|NCT01827384|468075124|FG007|Overall Study|No actionable mutation|0|||
130032669|NCT01827384|468075125|FG008|Overall Study|No actionable mutation|0|||
130032670|NCT01827384|468075126|FG009|Overall Study|No actionable mutation|0|||
130032671|NCT01827384|468075127|FG010|Overall Study|No actionable mutation|0|||
130032672|NCT01827384|468075128|FG011|Overall Study|No actionable mutation|0|||
130032673|NCT01827384|468075129|FG012|Overall Study|No actionable mutation|0|||
130032674|NCT01827384|468075130|FG013|Overall Study|No actionable mutation|73|||
130032675|NCT01827384|468075117|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130032676|NCT01827384|468075118|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
130032677|NCT01827384|468075119|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
130032678|NCT01827384|468075120|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
130032679|NCT01827384|468075121|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
130032680|NCT01827384|468075122|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
130032681|NCT01827384|468075123|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
130032682|NCT01827384|468075124|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
130032683|NCT01827384|468075125|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
130032684|NCT01827384|468075126|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
130032685|NCT01827384|468075127|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
130032686|NCT01827384|468075128|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
130256543|NCT00522379|468903252|FG003|Overall Study|Randomization error|0|||
130256544|NCT00522379|468903253|FG004|Overall Study|Randomization error|1|||
130256545|NCT00522379|468903249|FG000|Overall Study|Dispensing error|1|||
130256546|NCT00522379|468903250|FG001|Overall Study|Dispensing error|0|||
130256547|NCT00522379|468903251|FG002|Overall Study|Dispensing error|0|||
130256548|NCT00522379|468903252|FG003|Overall Study|Dispensing error|1|||
130256549|NCT00522379|468903253|FG004|Overall Study|Dispensing error|0|||
130256550|NCT00522379|468903249|FG000|Overall Study|Subject Moved|1|||
130256551|NCT00522379|468903250|FG001|Overall Study|Subject Moved|1|||
130256552|NCT00522379|468903251|FG002|Overall Study|Subject Moved|0|||
130032687|NCT01827384|468075129|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
130032688|NCT01827384|468075130|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
130032689|NCT01817790|468075135|FG000|Overall Study|Adverse Event|0|||
130032690|NCT01817790|468075136|FG001|Overall Study|Adverse Event|2|||
130032691|NCT01817790|468075135|FG000|Overall Study|Lost to Follow-up|0|||
130032692|NCT01817790|468075136|FG001|Overall Study|Lost to Follow-up|1|||
130032693|NCT01817790|468075135|FG000|Overall Study|Protocol Violation|2|||
130032694|NCT01817790|468075136|FG001|Overall Study|Protocol Violation|1|||
130032695|NCT01817790|468075135|FG000|Overall Study|Withdrawal by Subject|1|||
130032696|NCT01817790|468075136|FG001|Overall Study|Withdrawal by Subject|3|||
130256553|NCT00522379|468903252|FG003|Overall Study|Subject Moved|0|||
130256554|NCT00522379|468903253|FG004|Overall Study|Subject Moved|0|||
130256555|NCT00522379|468903249|FG000|Overall Study|Sponsor Request|0|||
130256556|NCT00522379|468903250|FG001|Overall Study|Sponsor Request|1|||
130256557|NCT00522379|468903251|FG002|Overall Study|Sponsor Request|0|||
130032697|NCT01817790|468075135|FG000|Overall Study|Other: Could not attend appointment|1|||
130032698|NCT01817790|468075136|FG001|Overall Study|Other: Could not attend appointment|1|||
130032699|NCT01671345|468075137|FG000|Overall Study|Lost to Follow-up|10|||
130032700|NCT01671345|468075138|FG001|Overall Study|Lost to Follow-up|6|||
130032701|NCT01671345|468075137|FG000|Overall Study|visit with non-participating physician|3|||
130032702|NCT01671345|468075138|FG001|Overall Study|visit with non-participating physician|3|||
130032703|NCT03636906|468075139|FG000|Overall Study|Adverse Event|0|||
130032704|NCT03636906|468075140|FG001|Overall Study|Adverse Event|0|||
130032705|NCT03636906|468075141|FG002|Overall Study|Adverse Event|1|||
130032706|NCT03636906|468075139|FG000|Overall Study|Lost to Follow-up|1|||
130032707|NCT03636906|468075140|FG001|Overall Study|Lost to Follow-up|0|||
130032708|NCT03636906|468075141|FG002|Overall Study|Lost to Follow-up|0|||
130032709|NCT03636906|468075139|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
130032710|NCT03636906|468075140|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
130032711|NCT03636906|468075141|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
130032712|NCT03636906|468075139|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
130032713|NCT03636906|468075140|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
130032714|NCT03636906|468075141|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
130032715|NCT03636906|468075139|FG000|Overall Study|Other|0|||
130032716|NCT03636906|468075140|FG001|Overall Study|Other|0|||
130032717|NCT03636906|468075141|FG002|Overall Study|Other|1|||
130032718|NCT04280081|468075144|FG000|Overall Study|Adverse Event|4|||
130032719|NCT04280081|468075144|FG000|Overall Study|Death|2|||
130032720|NCT04280081|468075144|FG000|Overall Study|Progressive Disease|6|||
130032721|NCT01750918|468076911|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
130032722|NCT01750918|468076912|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
130032723|NCT01750918|468076913|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
130032724|NCT01750918|468076914|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
130032725|NCT01750918|468076915|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
130101519|NCT03930615|468328741|FG001|Overall Study|Lost to Follow-up|2|||
130256558|NCT00522379|468903252|FG003|Overall Study|Sponsor Request|0|||
130256559|NCT00522379|468903253|FG004|Overall Study|Sponsor Request|0|||
130256560|NCT00522379|468903249|FG000|Overall Study|Family Problem|0|||
130256561|NCT00522379|468903250|FG001|Overall Study|Family Problem|0|||
130256562|NCT00522379|468903251|FG002|Overall Study|Family Problem|1|||
130256563|NCT00522379|468903252|FG003|Overall Study|Family Problem|0|||
130256564|NCT00522379|468903253|FG004|Overall Study|Family Problem|0|||
130256565|NCT00522379|468903249|FG000|Overall Study|Site Closed|0|||
130256566|NCT00522379|468903250|FG001|Overall Study|Site Closed|0|||
130256567|NCT00522379|468903251|FG002|Overall Study|Site Closed|0|||
130256568|NCT00522379|468903252|FG003|Overall Study|Site Closed|1|||
130256569|NCT00522379|468903253|FG004|Overall Study|Site Closed|0|||
130256570|NCT00522379|468903249|FG000|Overall Study|Subject Withdrawal|0|||
130256571|NCT00522379|468903250|FG001|Overall Study|Subject Withdrawal|0|||
130256572|NCT00522379|468903251|FG002|Overall Study|Subject Withdrawal|0|||
130256573|NCT00522379|468903252|FG003|Overall Study|Subject Withdrawal|1|||
130256574|NCT00522379|468903253|FG004|Overall Study|Subject Withdrawal|0|||
130256575|NCT03034044|468903258|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
130032726|NCT01750918|468076916|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
130032727|NCT01750918|468076917|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
130032728|NCT01750918|468076918|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
130032729|NCT01750918|468076911|FG000|Overall Study|Lost to Follow-up|0|||
130032730|NCT01750918|468076912|FG001|Overall Study|Lost to Follow-up|0|||
130032731|NCT01750918|468076913|FG002|Overall Study|Lost to Follow-up|2|||
130032732|NCT01750918|468076914|FG003|Overall Study|Lost to Follow-up|2|||
130032733|NCT01750918|468076915|FG004|Overall Study|Lost to Follow-up|0|||
130032734|NCT01750918|468076916|FG005|Overall Study|Lost to Follow-up|0|||
130032735|NCT01750918|468076917|FG006|Overall Study|Lost to Follow-up|0|||
130032736|NCT01750918|468076918|FG007|Overall Study|Lost to Follow-up|1|||
130032737|NCT01750918|468076911|FG000|Overall Study|Withdrawal by Subject|0|||
130032738|NCT01750918|468076912|FG001|Overall Study|Withdrawal by Subject|0|||
130032739|NCT01750918|468076913|FG002|Overall Study|Withdrawal by Subject|1|||
130032740|NCT01750918|468076914|FG003|Overall Study|Withdrawal by Subject|2|||
130032741|NCT01750918|468076915|FG004|Overall Study|Withdrawal by Subject|1|||
130032742|NCT01750918|468076916|FG005|Overall Study|Withdrawal by Subject|1|||
130256576|NCT02402647|468903261|FG000|Overall Study|Lost to Follow-up|13|||
130256577|NCT02402647|468903262|FG001|Overall Study|Lost to Follow-up|7|||
130256578|NCT02402647|468903261|FG000|Overall Study|Protocol Violation|1|||
130256579|NCT02402647|468903262|FG001|Overall Study|Protocol Violation|1|||
130256580|NCT02402647|468903261|FG000|Overall Study|scheduled and timed out|2|||
130032743|NCT01750918|468076917|FG006|Overall Study|Withdrawal by Subject|2|||
130032744|NCT01750918|468076918|FG007|Overall Study|Withdrawal by Subject|2|||
130032745|NCT04840667|468076923|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
130256581|NCT02402647|468903262|FG001|Overall Study|scheduled and timed out|1|||
130256582|NCT02402647|468903261|FG000|Overall Study|medical illness|2|||
130256583|NCT02402647|468903262|FG001|Overall Study|medical illness|4|||
130256584|NCT02402647|468903261|FG000|Overall Study|Moved|2|||
130256585|NCT02402647|468903262|FG001|Overall Study|Moved|0|||
130256586|NCT02402647|468903261|FG000|Overall Study|loved one illness|1|||
130256587|NCT02402647|468903262|FG001|Overall Study|loved one illness|0|||
130256588|NCT02402647|468903261|FG000|Overall Study|deceased preexisting condition|2|||
130256589|NCT02402647|468903262|FG001|Overall Study|deceased preexisting condition|0|||
130256590|NCT02402647|468903261|FG000|Overall Study|Other|2|||
130256591|NCT02402647|468903262|FG001|Overall Study|Other|1|||
130256592|NCT04197583|468903263|FG000|Overall Study|Study Stent Replacement|34|||
130256593|NCT04197583|468903264|FG001|Overall Study|Study Stent Replacement|8|||
130256594|NCT04197583|468903263|FG000|Overall Study|Lost to Follow-up|14|||
130256595|NCT04197583|468903264|FG001|Overall Study|Lost to Follow-up|3|||
130256596|NCT04197583|468903263|FG000|Overall Study|Death|3|||
130256597|NCT04197583|468903264|FG001|Overall Study|Death|0|||
130256598|NCT04197583|468903263|FG000|Overall Study|Physician Decision|1|||
130256599|NCT04197583|468903264|FG001|Overall Study|Physician Decision|0|||
130256600|NCT04197583|468903263|FG000|Overall Study|Withdrawal by Subject|1|||
130256601|NCT04197583|468903264|FG001|Overall Study|Withdrawal by Subject|1|||
130256602|NCT04197583|468903263|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
130256603|NCT04197583|468903264|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
130256604|NCT04197583|468903263|FG000|Overall Study|Screen Failure|0|||
130256605|NCT04197583|468903264|FG001|Overall Study|Screen Failure|20|||
130256606|NCT00323622|468903266|FG000|Overall Study|Other|30|||
130256607|NCT00323622|468903267|FG001|Overall Study|Other|91|||
130256608|NCT00323622|468903268|FG002|Overall Study|Other|4|||
130256609|NCT00323622|468903269|FG003|Overall Study|Other|12|||
130256610|NCT00323622|468903270|FG004|Overall Study|Other|32|||
130256611|NCT00323622|468903271|FG005|Overall Study|Other|74|||
130256612|NCT00323622|468903272|FG006|Overall Study|Other|5|||
130256613|NCT00323622|468903273|FG007|Overall Study|Other|13|||
130256614|NCT00323622|468903266|FG000|Overall Study|Death|1|||
130256615|NCT00323622|468903267|FG001|Overall Study|Death|1|||
130256616|NCT00323622|468903268|FG002|Overall Study|Death|0|||
130256617|NCT00323622|468903269|FG003|Overall Study|Death|0|||
130256618|NCT00323622|468903270|FG004|Overall Study|Death|7|||
130256619|NCT00323622|468903271|FG005|Overall Study|Death|0|||
130256620|NCT00323622|468903272|FG006|Overall Study|Death|0|||
130256621|NCT00323622|468903273|FG007|Overall Study|Death|2|||
130256622|NCT03033784|468904875|FG000|Overall Study|Anxiety related to MRI scanner|0|||
130256623|NCT03033784|468904876|FG001|Overall Study|Anxiety related to MRI scanner|1|||
130256624|NCT03033784|468904877|FG002|Overall Study|Anxiety related to MRI scanner|0|||
130256625|NCT03033784|468904878|FG003|Overall Study|Anxiety related to MRI scanner|0|||
130256626|NCT03033784|468904879|FG004|Overall Study|Anxiety related to MRI scanner|0|||
130256627|NCT03033784|468904880|FG005|Overall Study|Anxiety related to MRI scanner|0|||
130256628|NCT03033784|468904881|FG006|Overall Study|Anxiety related to MRI scanner|0|||
130256629|NCT03033784|468904882|FG007|Overall Study|Anxiety related to MRI scanner|0|||
130256630|NCT03033784|468904883|FG008|Overall Study|Anxiety related to MRI scanner|0|||
130256631|NCT03033784|468904884|FG009|Overall Study|Anxiety related to MRI scanner|0|||
130256632|NCT03033784|468904885|FG010|Overall Study|Anxiety related to MRI scanner|0|||
130256633|NCT03033784|468904886|FG011|Overall Study|Anxiety related to MRI scanner|0|||
130256634|NCT03033784|468904887|FG012|Overall Study|Anxiety related to MRI scanner|0|||
130256635|NCT03033784|468904875|FG000|Overall Study|Withdrawal by Subject|0|||
130256636|NCT03033784|468904876|FG001|Overall Study|Withdrawal by Subject|0|||
130256637|NCT03033784|468904877|FG002|Overall Study|Withdrawal by Subject|0|||
130256638|NCT03033784|468904878|FG003|Overall Study|Withdrawal by Subject|0|||
130256639|NCT03033784|468904879|FG004|Overall Study|Withdrawal by Subject|0|||
130256640|NCT03033784|468904880|FG005|Overall Study|Withdrawal by Subject|0|||
130256641|NCT03033784|468904881|FG006|Overall Study|Withdrawal by Subject|0|||
130256642|NCT03033784|468904882|FG007|Overall Study|Withdrawal by Subject|0|||
130256643|NCT03033784|468904883|FG008|Overall Study|Withdrawal by Subject|0|||
130256644|NCT03033784|468904884|FG009|Overall Study|Withdrawal by Subject|0|||
130256645|NCT03033784|468904885|FG010|Overall Study|Withdrawal by Subject|0|||
130256646|NCT03033784|468904886|FG011|Overall Study|Withdrawal by Subject|0|||
130256647|NCT03033784|468904887|FG012|Overall Study|Withdrawal by Subject|2|||
130256648|NCT03332056|468904889|FG000|Overall Study|Incomplete questionnaires|8|||
130256649|NCT03332056|468904890|FG001|Overall Study|Incomplete questionnaires|9|||
130256650|NCT03332056|468904889|FG000|Overall Study|Passed stone prior to surgery date|1|||
130256651|NCT03332056|468904890|FG001|Overall Study|Passed stone prior to surgery date|0|||
130256652|NCT03332056|468904889|FG000|Overall Study|Did not require a ureteral stent|0|||
130256653|NCT03332056|468904890|FG001|Overall Study|Did not require a ureteral stent|1|||
130256654|NCT02374255|468904891|FG000|Overall Study|Withdrawal by Subject|2|||
130032746|NCT02338843|468076925|FG000|Overall Study|Adverse Event|2|||
130256655|NCT02374255|468904892|FG001|Overall Study|Withdrawal by Subject|0|||
130256656|NCT02374255|468904893|FG002|Overall Study|Withdrawal by Subject|0|||
130256657|NCT02374255|468904894|FG003|Overall Study|Withdrawal by Subject|0|||
130256658|NCT02093520|468904895|FG000|Overall Study|Not treated|6|||
130032747|NCT02338843|468076926|FG001|Overall Study|Adverse Event|1|||
130032748|NCT02338843|468076925|FG000|Overall Study|Death|40|||
130032749|NCT02338843|468076926|FG001|Overall Study|Death|53|||
130032750|NCT02338843|468076925|FG000|Overall Study|Physician Decision|1|||
130032751|NCT02338843|468076926|FG001|Overall Study|Physician Decision|0|||
130032752|NCT02338843|468076925|FG000|Overall Study|Withdrawal by Subject|0|||
130032753|NCT02338843|468076926|FG001|Overall Study|Withdrawal by Subject|2|||
130032754|NCT02338843|468076925|FG000|Overall Study|Subject Recovered|0|||
130032755|NCT02338843|468076926|FG001|Overall Study|Subject Recovered|2|||
130032756|NCT02338843|468076925|FG000|Overall Study|Discontinued prior to randomizat|1|||
130032757|NCT02338843|468076926|FG001|Overall Study|Discontinued prior to randomizat|0|||
130032758|NCT00023322|468076927|FG000|Overall Study|Lost to Follow-up|1|||
130032759|NCT01793792|468076938|FG000|Overall Study|Death|5|||
130032760|NCT01793792|468076938|FG000|Overall Study|Lost to Follow-up|5|||
130032761|NCT01793792|468076938|FG000|Overall Study|Withdrawal by Subject|1|||
130032762|NCT01793792|468076938|FG000|Overall Study|Device Not Implanted|1|||
130032763|NCT02185521|468076941|FG000|Overall Study|Withdrawal by Subject|1|||
130032764|NCT02185521|468076941|FG000|Overall Study|Protocol Violation|1|||
130032765|NCT01341457|468076942|FG000|Overall Study|Adverse Event|2|||
130256659|NCT02093520|468904896|FG001|Overall Study|Not treated|22|||
130256660|NCT03014089|468904897|FG000|Overall Study|Withdrawal by Subject|0|||
130256661|NCT03014089|468904898|FG001|Overall Study|Withdrawal by Subject|1|||
130256662|NCT03014089|468904899|FG002|Overall Study|Withdrawal by Subject|1|||
130256663|NCT03014089|468904900|FG003|Overall Study|Withdrawal by Subject|1|||
130256664|NCT03014089|468904897|FG000|Overall Study|Lost to Follow-up|1|||
130256665|NCT03014089|468904898|FG001|Overall Study|Lost to Follow-up|0|||
130256666|NCT03014089|468904899|FG002|Overall Study|Lost to Follow-up|0|||
130256667|NCT03014089|468904900|FG003|Overall Study|Lost to Follow-up|0|||
130256668|NCT03014089|468904897|FG000|Overall Study|Adverse Event|1|||
130256669|NCT03014089|468904898|FG001|Overall Study|Adverse Event|0|||
130256670|NCT03014089|468904899|FG002|Overall Study|Adverse Event|1|||
130256671|NCT03014089|468904900|FG003|Overall Study|Adverse Event|0|||
130256672|NCT01992757|468904909|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
130256673|NCT00688740|468904910|FG000|Overall Study|Adverse Event|45|||
130256674|NCT00688740|468904911|FG001|Overall Study|Adverse Event|8|||
130256675|NCT00688740|468904910|FG000|Overall Study|Death|2|||
130256676|NCT00688740|468904911|FG001|Overall Study|Death|2|||
130256677|NCT00688740|468904910|FG000|Overall Study|Lost to Follow-up|0|||
130256678|NCT00688740|468904911|FG001|Overall Study|Lost to Follow-up|1|||
130256679|NCT00688740|468904910|FG000|Overall Study|Consent Withdrawn|17|||
130256680|NCT00688740|468904911|FG001|Overall Study|Consent Withdrawn|17|||
130256681|NCT00688740|468904910|FG000|Overall Study|Breast Cancer Relapse|1|||
130256682|NCT00688740|468904911|FG001|Overall Study|Breast Cancer Relapse|4|||
130256683|NCT00688740|468904910|FG000|Overall Study|Violation of Inclusion Criteria|1|||
130256684|NCT00688740|468904911|FG001|Overall Study|Violation of Inclusion Criteria|3|||
130256685|NCT00856557|468904912|FG000|Overall Study|No patients with contextual flags|12|||
130256686|NCT00856557|468904913|FG001|Overall Study|No patients with contextual flags|16|||
130256687|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
130256688|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
130256689|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
130256690|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
130256691|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
130256692|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
130256693|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
130256694|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
130256695|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
130256696|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
130256697|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
130256698|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
130256699|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
130256700|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
129885305|NCT00594906|467540637|FG001|Overall Study|Physician Decision|1|||
130032766|NCT01341457|468076943|FG001|Overall Study|Adverse Event|0|||
130032767|NCT03124459|468076948|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130032768|NCT03124459|468076949|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130032769|NCT03124459|468076950|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130032770|NCT03124459|468076951|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130032771|NCT03124459|468076952|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
130032772|NCT03124459|468076953|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
130256701|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
130256702|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
130256703|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
129885306|NCT00594906|467540636|FG000|Overall Study|Death|0|||
130101520|NCT03930615|468328740|FG000|Overall Study|Physician Decision|3|||
129885307|NCT00594906|467540637|FG001|Overall Study|Death|1|||
129885308|NCT00839917|467540639|FG000|Overall Study|Lost to Follow-up|1|||
129885309|NCT00839917|467540640|FG001|Overall Study|Lost to Follow-up|0|||
129885310|NCT00839917|467540639|FG000|Overall Study|Did not receive vaccine|0|||
129885311|NCT00839917|467540640|FG001|Overall Study|Did not receive vaccine|1|||
129885312|NCT00867490|467540641|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
129885313|NCT00867490|467540641|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
129885314|NCT00867490|467540641|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
129885315|NCT00867490|467540641|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
129885316|NCT00867490|467540641|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
129885317|NCT01254565|467540642|FG000|Overall Study|Non-compliance to Study Procedures|0|||
129885318|NCT01254565|467540643|FG001|Overall Study|Non-compliance to Study Procedures|0|||
129885319|NCT01254565|467540644|FG002|Overall Study|Non-compliance to Study Procedures|0|||
129885320|NCT01254565|467540645|FG003|Overall Study|Non-compliance to Study Procedures|0|||
129885321|NCT01254565|467540646|FG004|Overall Study|Non-compliance to Study Procedures|1|||
129885322|NCT01254565|467540647|FG005|Overall Study|Non-compliance to Study Procedures|0|||
129885323|NCT01254565|467540642|FG000|Overall Study|Did not Receive Treatment|1|||
129885324|NCT01254565|467540643|FG001|Overall Study|Did not Receive Treatment|1|||
129885325|NCT01254565|467540644|FG002|Overall Study|Did not Receive Treatment|0|||
129885326|NCT01254565|467540645|FG003|Overall Study|Did not Receive Treatment|0|||
129885327|NCT01254565|467540646|FG004|Overall Study|Did not Receive Treatment|3|||
129885328|NCT01254565|467540647|FG005|Overall Study|Did not Receive Treatment|4|||
129885329|NCT01254565|467540642|FG000|Overall Study|Other|0|||
129885330|NCT01254565|467540643|FG001|Overall Study|Other|0|||
129885331|NCT01254565|467540644|FG002|Overall Study|Other|0|||
129885332|NCT01254565|467540645|FG003|Overall Study|Other|1|||
129885333|NCT01254565|467540646|FG004|Overall Study|Other|0|||
129885334|NCT01254565|467540647|FG005|Overall Study|Other|0|||
129885335|NCT00472186|467540648|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
129885336|NCT00472186|467540649|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
129885337|NCT04747275|467540650|FG000|Overall Study|Study terminated|0|||
129885338|NCT04747275|467540651|FG001|Overall Study|Study terminated|1|||
129885339|NCT03268590|467540655|FG000|Overall Study|Previously unknown exclusion criteria|1|||
129885340|NCT02139982|467540658|FG000|Overall Study|Lack of Efficacy|0|||
129885341|NCT02139982|467540659|FG001|Overall Study|Lack of Efficacy|1|||
129885342|NCT02139982|467540660|FG002|Overall Study|Lack of Efficacy|0|||
129885343|NCT02139982|467540661|FG003|Overall Study|Lack of Efficacy|1|||
129885344|NCT02139982|467540662|FG004|Overall Study|Lack of Efficacy|0|||
129885345|NCT02139982|467540663|FG005|Overall Study|Lack of Efficacy|0|||
129885346|NCT02139982|467540664|FG006|Overall Study|Lack of Efficacy|0|||
129885347|NCT02139982|467540665|FG007|Overall Study|Lack of Efficacy|0|||
129885348|NCT02139982|467540666|FG008|Overall Study|Lack of Efficacy|0|||
129885349|NCT02139982|467540667|FG009|Overall Study|Lack of Efficacy|0|||
129885350|NCT04254679|467540678|FG000|Overall Study|Protocol Violation|1|||
129885351|NCT04254679|467540679|FG001|Overall Study|Protocol Violation|1|||
129885352|NCT04254679|467540678|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
129885353|NCT04254679|467540679|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
129885354|NCT02823964|467540680|FG000|Overall Study|Adverse Event|2|||
129885355|NCT02823964|467540680|FG000|Overall Study|Physician Decision|1|||
129885356|NCT02823964|467540680|FG000|Overall Study|Lack of Efficacy|1|||
129885357|NCT02823964|467540680|FG000|Overall Study|Withdrawal by Subject|1|||
129885358|NCT00390455|467540685|FG000|Overall Study|Adverse Event|17|||
129885359|NCT00390455|467540686|FG001|Overall Study|Adverse Event|3|||
129885360|NCT00390455|467540685|FG000|Overall Study|Withdrawal by Subject|8|||
129885361|NCT00390455|467540686|FG001|Overall Study|Withdrawal by Subject|8|||
129885362|NCT00390455|467540685|FG000|Overall Study|Alternate Treatment|0|||
129885363|NCT00390455|467540686|FG001|Overall Study|Alternate Treatment|1|||
129885364|NCT00390455|467540685|FG000|Overall Study|Other Medical Reasons|7|||
129885365|NCT00390455|467540686|FG001|Overall Study|Other Medical Reasons|11|||
129885366|NCT00794820|467540692|FG000|Overall Study|Adverse Event|11|||
129885367|NCT00794820|467540692|FG000|Overall Study|Secondary Malignancies|2|||
129885368|NCT00794820|467540692|FG000|Overall Study|Resistant Disease|2|||
130032773|NCT03124459|468076948|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130032774|NCT03124459|468076949|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130032775|NCT03124459|468076950|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130032776|NCT03124459|468076951|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130032777|NCT03124459|468076952|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
129885369|NCT00794820|467540692|FG000|Overall Study|Ineligible/Screen Failure|1|||
129885370|NCT04076020|467540694|FG000|Overall Study|Death|4|||
129885371|NCT04076020|467540695|FG001|Overall Study|Death|6|||
129885372|NCT04076020|467540694|FG000|Overall Study|Withdrawal by Subject|12|||
129885373|NCT04076020|467540695|FG001|Overall Study|Withdrawal by Subject|8|||
129885374|NCT02500979|467540696|FG000|Period 1|Hyperglycemia|1|||
129885375|NCT02500979|467540697|FG001|Period 1|Hyperglycemia|0|||
129885376|NCT02500979|467540696|FG000|Period 1|Severe non-compliance to protocol|0|||
130032778|NCT03124459|468076953|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
130032779|NCT03124459|468076948|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130032780|NCT03124459|468076949|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130032781|NCT03124459|468076950|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130032782|NCT03124459|468076951|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
130032783|NCT03124459|468076952|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
130032784|NCT03124459|468076953|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
130032785|NCT03124459|468076948|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130032786|NCT03124459|468076949|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130032787|NCT03124459|468076950|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130032788|NCT03124459|468076951|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
130032789|NCT03124459|468076952|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
130032790|NCT03124459|468076953|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
130256704|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
130256705|NCT01432444|468904914|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
130256706|NCT01432444|468904915|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
130256707|NCT01432444|468904916|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
130256708|NCT01432444|468904914|FG000|Treatment Phase|Lost to Follow-up|0|||
130256709|NCT01432444|468904915|FG001|Treatment Phase|Lost to Follow-up|33|||
130256710|NCT01432444|468904916|FG002|Treatment Phase|Lost to Follow-up|0|||
130256711|NCT01432444|468904914|FG000|Treatment Phase|Adverse Event|0|||
130256712|NCT01432444|468904915|FG001|Treatment Phase|Adverse Event|37|||
130256713|NCT01432444|468904916|FG002|Treatment Phase|Adverse Event|0|||
130256714|NCT01432444|468904914|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
130256715|NCT01432444|468904915|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
130256716|NCT01432444|468904916|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
130256717|NCT01432444|468904914|FG000|Treatment Phase|Physician Decision|0|||
130256718|NCT01432444|468904915|FG001|Treatment Phase|Physician Decision|5|||
130256719|NCT01432444|468904916|FG002|Treatment Phase|Physician Decision|0|||
130256720|NCT01432444|468904914|FG000|Treatment Phase|Withdrawal by Subject|0|||
130256721|NCT01432444|468904915|FG001|Treatment Phase|Withdrawal by Subject|41|||
130256722|NCT01432444|468904916|FG002|Treatment Phase|Withdrawal by Subject|0|||
130256723|NCT01432444|468904914|FG000|Treatment Phase|Protocol Deviation|0|||
130256724|NCT01432444|468904915|FG001|Treatment Phase|Protocol Deviation|3|||
129885377|NCT02500979|467540697|FG001|Period 1|Severe non-compliance to protocol|1|||
129885378|NCT02500979|467540696|FG000|Period 1|Adverse Event|1|||
129885379|NCT02500979|467540697|FG001|Period 1|Adverse Event|0|||
129885380|NCT02500979|467540696|FG000|Period 1|Subject decision|2|||
129885381|NCT02500979|467540697|FG001|Period 1|Subject decision|0|||
129885382|NCT02500979|467540696|FG000|Period 2|Change in risk|1|||
129885383|NCT02500979|467540697|FG001|Period 2|Change in risk|0|||
129885384|NCT00672958|467540700|FG000|Overall Study|Adverse Event|11|||
130256725|NCT01432444|468904916|FG002|Treatment Phase|Protocol Deviation|0|||
130256726|NCT01432444|468904914|FG000|Treatment Phase|Lack of Efficacy|0|||
130256727|NCT01432444|468904915|FG001|Treatment Phase|Lack of Efficacy|10|||
130256728|NCT01432444|468904916|FG002|Treatment Phase|Lack of Efficacy|0|||
130256729|NCT01432444|468904914|FG000|Extension Phase|Lost to Follow-up|0|||
130256730|NCT01432444|468904915|FG001|Extension Phase|Lost to Follow-up|0|||
130256731|NCT01432444|468904916|FG002|Extension Phase|Lost to Follow-up|17|||
130256732|NCT01432444|468904914|FG000|Extension Phase|Adverse Event|0|||
130256733|NCT01432444|468904915|FG001|Extension Phase|Adverse Event|0|||
130256734|NCT01432444|468904916|FG002|Extension Phase|Adverse Event|10|||
130256735|NCT01432444|468904914|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
130256736|NCT01432444|468904915|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
130256737|NCT01432444|468904916|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
130256738|NCT01432444|468904914|FG000|Extension Phase|Met Withdrawal Criteria|0|||
130256739|NCT01432444|468904915|FG001|Extension Phase|Met Withdrawal Criteria|0|||
130256740|NCT01432444|468904916|FG002|Extension Phase|Met Withdrawal Criteria|144|||
130256741|NCT01432444|468904914|FG000|Extension Phase|Physician Decision|0|||
130256742|NCT01432444|468904915|FG001|Extension Phase|Physician Decision|0|||
130256743|NCT01432444|468904916|FG002|Extension Phase|Physician Decision|1|||
130256744|NCT01432444|468904914|FG000|Extension Phase|Withdrawal by Subject|0|||
130256745|NCT01432444|468904915|FG001|Extension Phase|Withdrawal by Subject|0|||
130256746|NCT01432444|468904916|FG002|Extension Phase|Withdrawal by Subject|13|||
129885385|NCT00672958|467540701|FG001|Overall Study|Adverse Event|9|||
130256747|NCT03673176|468904917|FG000|Overall Study|Death prior to intervention|1|||
130032791|NCT03124459|468076948|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130256748|NCT03673176|468904917|FG000|Overall Study|Death following intervention|3|||
130256749|NCT03673176|468904917|FG000|Overall Study|Withdrawal by Subject|1|||
130032792|NCT03124459|468076949|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130256750|NCT02301897|468904918|FG000|Treatment Course 1|Non-Compliance|0|||
130256751|NCT02301897|468904919|FG001|Treatment Course 1|Non-Compliance|0|||
129885386|NCT00672958|467540700|FG000|Overall Study|Lack of Efficacy|6|||
129885387|NCT00672958|467540701|FG001|Overall Study|Lack of Efficacy|11|||
130256752|NCT02301897|468904920|FG002|Treatment Course 1|Non-Compliance|1|||
130256753|NCT02301897|468904918|FG000|Treatment Course 1|Adverse Event|1|||
130256754|NCT02301897|468904919|FG001|Treatment Course 1|Adverse Event|1|||
130256755|NCT02301897|468904920|FG002|Treatment Course 1|Adverse Event|0|||
130256756|NCT02301897|468904918|FG000|Treatment Course 1|Lost to Follow-up|1|||
130256757|NCT02301897|468904919|FG001|Treatment Course 1|Lost to Follow-up|2|||
130256758|NCT02301897|468904920|FG002|Treatment Course 1|Lost to Follow-up|1|||
130101521|NCT03930615|468328741|FG001|Overall Study|Physician Decision|4|||
130101522|NCT03930615|468328740|FG000|Overall Study|Withdrawal by Subject|13|||
130101523|NCT03930615|468328741|FG001|Overall Study|Withdrawal by Subject|2|||
130101524|NCT03930615|468328740|FG000|Overall Study|Not treated|1|||
130101525|NCT03930615|468328741|FG001|Overall Study|Not treated|1|||
130101526|NCT04611152|468328744|FG000|Overall Study|Adverse Event|9|||
130101527|NCT04611152|468328745|FG001|Overall Study|Adverse Event|8|||
130101528|NCT04611152|468328744|FG000|Overall Study|Non-compliance with study schedule|1|||
130101529|NCT04611152|468328745|FG001|Overall Study|Non-compliance with study schedule|3|||
130101530|NCT04611152|468328744|FG000|Overall Study|Withdrawal by Subject|5|||
130101531|NCT04611152|468328745|FG001|Overall Study|Withdrawal by Subject|6|||
130101532|NCT04611152|468328744|FG000|Overall Study|Lost to Follow-up|11|||
130101533|NCT04611152|468328745|FG001|Overall Study|Lost to Follow-up|2|||
130101534|NCT03644927|468328748|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
130101535|NCT03644927|468328749|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
130101536|NCT00956813|468328753|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
130101537|NCT00956813|468328754|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
130101538|NCT00956813|468328753|FG000|Flaxseed and Placebo|Ineligible|3|||
130101539|NCT00956813|468328754|FG001|Flaxseed and Placebo|Ineligible|1|||
130101540|NCT04797637|468328755|FG000|Overall Study|Lost to Follow-up|23|||
130101541|NCT04797637|468328756|FG001|Overall Study|Lost to Follow-up|32|||
130101542|NCT04797637|468328755|FG000|Overall Study|Withdrawal by Subject|0|||
130101543|NCT04797637|468328756|FG001|Overall Study|Withdrawal by Subject|1|||
130101544|NCT00605839|468328761|FG000|Overall Study|Protocol Violation|1|||
130101545|NCT00605839|468328762|FG001|Overall Study|Protocol Violation|0|||
130101546|NCT00605839|468328763|FG002|Overall Study|Protocol Violation|0|||
130101547|NCT01023022|468328764|FG000|Overall Study|Death|5|||
130101548|NCT01023022|468328764|FG000|Overall Study|Lost to Follow-up|7|||
130101549|NCT01023022|468328764|FG000|Overall Study|due to technical issues|2|||
130101550|NCT03728257|468328765|FG000|Overall Study|Death|3|||
130101551|NCT03728257|468328766|FG001|Overall Study|Death|0|||
130101552|NCT03252015|468328769|FG000|Overall Study|Withdrawal by Subject|0|||
130101553|NCT03252015|468328770|FG001|Overall Study|Withdrawal by Subject|1|||
130101554|NCT03252015|468328771|FG002|Overall Study|Withdrawal by Subject|1|||
130101555|NCT03252015|468328772|FG003|Overall Study|Withdrawal by Subject|0|||
130101556|NCT03252015|468328769|FG000|Overall Study|Adverse Event|1|||
130101557|NCT03252015|468328770|FG001|Overall Study|Adverse Event|0|||
130101558|NCT03252015|468328771|FG002|Overall Study|Adverse Event|0|||
130101559|NCT03252015|468328772|FG003|Overall Study|Adverse Event|1|||
130101560|NCT03128931|468328773|FG000|Overall Study|Physician Decision|1|||
130101561|NCT03128931|468328773|FG000|Overall Study|Equipment Issues|3|||
130101562|NCT01329562|468328774|FG000|Overall Study|Protocol Violation|5|||
130101563|NCT01329562|468328775|FG001|Overall Study|Protocol Violation|3|||
130101564|NCT01329562|468328774|FG000|Overall Study|Lost to Follow-up|1|||
130101565|NCT01329562|468328775|FG001|Overall Study|Lost to Follow-up|1|||
130101566|NCT01329562|468328774|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
130101567|NCT01329562|468328775|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
130101568|NCT01329562|468328774|FG000|Overall Study|Physician Decision|0|||
130101569|NCT01329562|468328775|FG001|Overall Study|Physician Decision|1|||
130101570|NCT04993339|468328776|FG000|Overall Study|Lost to Follow-up|0|||
130256759|NCT02301897|468904918|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
130256760|NCT02301897|468904919|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
130101571|NCT04993339|468328777|FG001|Overall Study|Lost to Follow-up|1|||
130101572|NCT04993339|468328776|FG000|Overall Study|no MRI scan|3|||
130101573|NCT04993339|468328777|FG001|Overall Study|no MRI scan|1|||
130101574|NCT01525407|468328780|FG000|Overall Study|Change in recipient treatment plan|2|||
130101575|NCT01525407|468328781|FG001|Overall Study|Change in recipient treatment plan|2|||
130101576|NCT01525407|468328780|FG000|Overall Study|Withdrawal by Subject|0|||
130101577|NCT01525407|468328781|FG001|Overall Study|Withdrawal by Subject|1|||
130101578|NCT01525407|468328780|FG000|Overall Study|Transplant was delayed|0|||
130101579|NCT01525407|468328781|FG001|Overall Study|Transplant was delayed|1|||
130101580|NCT01525407|468328780|FG000|Overall Study|Delay in Transplant|1|||
130101581|NCT01525407|468328781|FG001|Overall Study|Delay in Transplant|0|||
130101582|NCT04502862|468328782|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
130101583|NCT04502862|468328783|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
130256761|NCT02301897|468904920|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
130101584|NCT04502862|468328782|FG000|Overall Study|Withdrawal by Subject|1|||
130101585|NCT04502862|468328783|FG001|Overall Study|Withdrawal by Subject|0|||
130032793|NCT03124459|468076950|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130032794|NCT03124459|468076951|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130032795|NCT03124459|468076952|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
130032796|NCT03124459|468076953|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
130032797|NCT03124459|468076948|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130032798|NCT03124459|468076949|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130032799|NCT03124459|468076950|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130032800|NCT03124459|468076951|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130032801|NCT03124459|468076952|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
130032802|NCT03124459|468076953|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
130032803|NCT00496366|468076954|FG000|Overall Study|Death|1|||
130032804|NCT01756274|468076959|FG000|Overall Study|Protocol Violation|2|||
130032805|NCT01756274|468076959|FG000|Overall Study|Laboratory error|1|||
130032806|NCT00486603|468076960|FG000|Overall Study|Withdrawal by Subject|1|||
130032807|NCT00486603|468076961|FG001|Overall Study|Withdrawal by Subject|0|||
130032808|NCT00486603|468076962|FG002|Overall Study|Withdrawal by Subject|0|||
130032809|NCT00486603|468076963|FG003|Overall Study|Withdrawal by Subject|0|||
130032810|NCT00486603|468076964|FG004|Overall Study|Withdrawal by Subject|0|||
130032811|NCT00486603|468076960|FG000|Overall Study|Physician Decision|0|||
130032812|NCT00486603|468076961|FG001|Overall Study|Physician Decision|1|||
130032813|NCT00486603|468076962|FG002|Overall Study|Physician Decision|0|||
130032814|NCT00486603|468076963|FG003|Overall Study|Physician Decision|0|||
130032815|NCT00486603|468076964|FG004|Overall Study|Physician Decision|0|||
130032816|NCT03514914|468076966|FG000|Overall Study|Death|3|||
130032817|NCT03514914|468076967|FG001|Overall Study|Death|3|||
130032818|NCT03514914|468076966|FG000|Overall Study|Lost to Follow-up|117|||
130032819|NCT03514914|468076967|FG001|Overall Study|Lost to Follow-up|89|||
130032820|NCT04336163|468076973|FG000|Overall Study|Lost to Follow-up|55|||
130032821|NCT04336163|468076974|FG001|Overall Study|Lost to Follow-up|0|||
130032822|NCT02978222|468076977|FG000|Overall Study|Withdrawal by Subject|2|||
130256762|NCT02301897|468904918|FG000|Treatment Course 1|Withdrawal by Subject|0|||
130256763|NCT02301897|468904919|FG001|Treatment Course 1|Withdrawal by Subject|0|||
130256764|NCT02301897|468904920|FG002|Treatment Course 1|Withdrawal by Subject|2|||
130256765|NCT02301897|468904918|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
130256766|NCT02301897|468904919|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
130256767|NCT02301897|468904920|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
130256768|NCT02301897|468904918|FG000|Treatment Course 2|Lost to Follow-up|0|||
130256769|NCT02301897|468904919|FG001|Treatment Course 2|Lost to Follow-up|2|||
130256770|NCT02301897|468904920|FG002|Treatment Course 2|Lost to Follow-up|0|||
130256771|NCT02301897|468904918|FG000|Treatment Course 2|Pregnancy|0|||
130256772|NCT02301897|468904919|FG001|Treatment Course 2|Pregnancy|1|||
130256773|NCT02301897|468904920|FG002|Treatment Course 2|Pregnancy|1|||
130256774|NCT02301897|468904918|FG000|Treatment Course 2|Withdrawal by Subject|0|||
130256775|NCT02301897|468904919|FG001|Treatment Course 2|Withdrawal by Subject|2|||
130256776|NCT02301897|468904920|FG002|Treatment Course 2|Withdrawal by Subject|0|||
130256777|NCT02301897|468904918|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
130032823|NCT02978222|468076978|FG001|Overall Study|Withdrawal by Subject|2|||
130032824|NCT02978222|468076977|FG000|Overall Study|Physician Decision|2|||
130032825|NCT02978222|468076978|FG001|Overall Study|Physician Decision|0|||
130256778|NCT02301897|468904919|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
130256779|NCT02301897|468904920|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
130256780|NCT02439957|468904921|FG000|Overall Study|Study Terminated|3|||
130256781|NCT02439957|468904922|FG001|Overall Study|Study Terminated|3|||
130032826|NCT02978222|468076977|FG000|Overall Study|Adverse Event|0|||
130032827|NCT02978222|468076978|FG001|Overall Study|Adverse Event|1|||
130032828|NCT02978222|468076977|FG000|Overall Study|Death|1|||
130032829|NCT02978222|468076978|FG001|Overall Study|Death|0|||
130032830|NCT02978222|468076977|FG000|Overall Study|Disease Progression|32|||
130032831|NCT02978222|468076978|FG001|Overall Study|Disease Progression|32|||
130032832|NCT02978222|468076977|FG000|Overall Study|Early Study Termination|24|||
130032833|NCT02978222|468076978|FG001|Overall Study|Early Study Termination|21|||
130256782|NCT00478257|468904927|FG000|Overall Study|Withdrawal by Subject|8|||
130256783|NCT00478257|468904928|FG001|Overall Study|Withdrawal by Subject|3|||
130256784|NCT03931330|468904929|FG000|Overall Study|Physician Decision|1|||
130256785|NCT03412929|468904930|FG000|Overall Study|Protocol Violation|3|||
130032834|NCT00868790|468076979|FG000|Period 1|Adverse Event|1|||
130032835|NCT00868790|468076980|FG001|Period 1|Adverse Event|0|||
130032836|NCT00868790|468076981|FG002|Period 1|Adverse Event|0|||
130032837|NCT00868790|468076982|FG003|Period 1|Adverse Event|0|||
130032838|NCT00868790|468076983|FG004|Period 1|Adverse Event|0|||
130032839|NCT00868790|468076984|FG005|Period 1|Adverse Event|0|||
130032840|NCT00868790|468076985|FG006|Period 1|Adverse Event|0|||
130032841|NCT00868790|468076986|FG007|Period 1|Adverse Event|3|||
130101586|NCT04502862|468328782|FG000|Overall Study|Adverse Event|1|||
130032842|NCT00868790|468076987|FG008|Period 1|Adverse Event|1|||
130032843|NCT00868790|468076988|FG009|Period 1|Adverse Event|0|||
130032844|NCT00868790|468076989|FG010|Period 1|Adverse Event|0|||
130256786|NCT04023487|468904933|FG000|Overall Study|Lost to Follow-up|5|||
130256787|NCT04023487|468904934|FG001|Overall Study|Lost to Follow-up|4|||
130256788|NCT04023487|468904933|FG000|Overall Study|Pregnancy|1|||
130256789|NCT04023487|468904934|FG001|Overall Study|Pregnancy|2|||
130256790|NCT04023487|468904933|FG000|Overall Study|Withdrawal by Subject|4|||
130256791|NCT04023487|468904934|FG001|Overall Study|Withdrawal by Subject|5|||
130256792|NCT04023487|468904933|FG000|Overall Study|Partially completed testing|8|||
130256793|NCT04023487|468904934|FG001|Overall Study|Partially completed testing|4|||
130256794|NCT04770285|468904937|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
130256795|NCT04770285|468904938|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
130256796|NCT04770285|468904937|FG000|Overall Study|Lack of Efficacy|0|||
130256797|NCT04770285|468904938|FG001|Overall Study|Lack of Efficacy|1|||
130256798|NCT04770285|468904937|FG000|Overall Study|Lost to Follow-up|11|||
130256799|NCT04770285|468904938|FG001|Overall Study|Lost to Follow-up|8|||
130256800|NCT04770285|468904937|FG000|Overall Study|Protocol Deviation|6|||
130256801|NCT04770285|468904938|FG001|Overall Study|Protocol Deviation|6|||
130256802|NCT04770285|468904937|FG000|Overall Study|Technical Problem|0|||
130256803|NCT04770285|468904938|FG001|Overall Study|Technical Problem|1|||
130256804|NCT04770285|468904937|FG000|Overall Study|Withdrawal by Subject|9|||
130256805|NCT04770285|468904938|FG001|Overall Study|Withdrawal by Subject|8|||
130256806|NCT04770285|468904937|FG000|Overall Study|Reason Not Specified|0|||
130256807|NCT04770285|468904938|FG001|Overall Study|Reason Not Specified|1|||
130256808|NCT03766399|468904939|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256809|NCT03766399|468904940|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256810|NCT03766399|468904941|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130032845|NCT00868790|468076990|FG011|Period 1|Adverse Event|0|||
130032846|NCT00868790|468076991|FG012|Period 1|Adverse Event|0|||
130032847|NCT00868790|468076992|FG013|Period 1|Adverse Event|1|||
130032848|NCT00868790|468076979|FG000|Period 1|Protocol Violation|1|||
130032849|NCT00868790|468076980|FG001|Period 1|Protocol Violation|0|||
130032850|NCT00868790|468076981|FG002|Period 1|Protocol Violation|0|||
130032851|NCT00868790|468076982|FG003|Period 1|Protocol Violation|0|||
130032852|NCT00868790|468076983|FG004|Period 1|Protocol Violation|0|||
130032853|NCT00868790|468076984|FG005|Period 1|Protocol Violation|0|||
130032854|NCT00868790|468076985|FG006|Period 1|Protocol Violation|0|||
130032855|NCT00868790|468076986|FG007|Period 1|Protocol Violation|0|||
130032856|NCT00868790|468076987|FG008|Period 1|Protocol Violation|0|||
130032857|NCT00868790|468076988|FG009|Period 1|Protocol Violation|0|||
130032858|NCT00868790|468076989|FG010|Period 1|Protocol Violation|0|||
130032859|NCT00868790|468076990|FG011|Period 1|Protocol Violation|0|||
130032860|NCT00868790|468076991|FG012|Period 1|Protocol Violation|0|||
130032861|NCT00868790|468076992|FG013|Period 1|Protocol Violation|0|||
130032862|NCT00868790|468076979|FG000|Period 1|Withdrawal by Subject|0|||
130032863|NCT00868790|468076980|FG001|Period 1|Withdrawal by Subject|1|||
130032864|NCT00868790|468076981|FG002|Period 1|Withdrawal by Subject|0|||
130032865|NCT00868790|468076982|FG003|Period 1|Withdrawal by Subject|0|||
130032866|NCT00868790|468076983|FG004|Period 1|Withdrawal by Subject|0|||
130032867|NCT00868790|468076984|FG005|Period 1|Withdrawal by Subject|0|||
130032868|NCT00868790|468076985|FG006|Period 1|Withdrawal by Subject|0|||
130032869|NCT00868790|468076986|FG007|Period 1|Withdrawal by Subject|0|||
130032870|NCT00868790|468076987|FG008|Period 1|Withdrawal by Subject|0|||
130032871|NCT00868790|468076988|FG009|Period 1|Withdrawal by Subject|0|||
130032872|NCT00868790|468076989|FG010|Period 1|Withdrawal by Subject|0|||
130032873|NCT00868790|468076990|FG011|Period 1|Withdrawal by Subject|0|||
130032874|NCT00868790|468076991|FG012|Period 1|Withdrawal by Subject|0|||
130032875|NCT00868790|468076992|FG013|Period 1|Withdrawal by Subject|1|||
130032876|NCT00868790|468076979|FG000|Period 1|Abnormal Triglycerides|0|||
130032877|NCT00868790|468076980|FG001|Period 1|Abnormal Triglycerides|0|||
130256811|NCT03766399|468904942|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256812|NCT03766399|468904943|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130032878|NCT00868790|468076981|FG002|Period 1|Abnormal Triglycerides|0|||
130032879|NCT00868790|468076982|FG003|Period 1|Abnormal Triglycerides|0|||
130032880|NCT00868790|468076983|FG004|Period 1|Abnormal Triglycerides|1|||
130256813|NCT03766399|468904944|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256814|NCT03766399|468904945|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256815|NCT03766399|468904946|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256816|NCT03766399|468904947|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130032881|NCT00868790|468076984|FG005|Period 1|Abnormal Triglycerides|0|||
130032882|NCT00868790|468076985|FG006|Period 1|Abnormal Triglycerides|0|||
130256817|NCT03766399|468904948|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256818|NCT03766399|468904949|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256819|NCT03766399|468904950|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256820|NCT03766399|468904951|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256821|NCT03766399|468904952|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
130256822|NCT03766399|468904953|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256823|NCT03766399|468904954|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256824|NCT03766399|468904955|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256825|NCT03766399|468904956|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
130256826|NCT00645658|468904957|FG000|Overall Study|Withdrawal by Subject|1|||
130256827|NCT00645658|468904958|FG001|Overall Study|Withdrawal by Subject|0|||
130256828|NCT00645658|468904957|FG000|Overall Study|Did not complete all assesments|0|||
130256829|NCT00645658|468904958|FG001|Overall Study|Did not complete all assesments|2|||
130256830|NCT03895372|468904961|FG000|Investigational Treatment Period|Adverse Event|1|||
130256831|NCT03895372|468904962|FG001|Investigational Treatment Period|Adverse Event|0|||
130256832|NCT03895372|468904963|FG002|Investigational Treatment Period|Adverse Event|0|||
130256833|NCT03895372|468904964|FG003|Investigational Treatment Period|Adverse Event|0|||
130256834|NCT03895372|468904965|FG004|Investigational Treatment Period|Adverse Event|0|||
130256835|NCT03895372|468904966|FG005|Investigational Treatment Period|Adverse Event|0|||
130256836|NCT03895372|468904967|FG006|Investigational Treatment Period|Adverse Event|4|||
130256837|NCT03895372|468904968|FG007|Investigational Treatment Period|Adverse Event|3|||
130256838|NCT03895372|468904961|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
130256839|NCT03895372|468904962|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
130256840|NCT03895372|468904963|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
130256841|NCT03895372|468904964|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
130256842|NCT03895372|468904965|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
130256843|NCT03895372|468904966|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
130256844|NCT03895372|468904967|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
130256845|NCT03895372|468904968|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
130256846|NCT03895372|468904961|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
130256847|NCT03895372|468904962|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
130256848|NCT03895372|468904963|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
130256849|NCT03895372|468904964|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
130256850|NCT03895372|468904965|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
130256851|NCT03895372|468904966|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
130256852|NCT03895372|468904967|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
130256853|NCT03895372|468904968|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
130256854|NCT03895372|468904961|FG000|Investigational Treatment Period|Other|0|||
130256855|NCT03895372|468904962|FG001|Investigational Treatment Period|Other|0|||
130256856|NCT03895372|468904963|FG002|Investigational Treatment Period|Other|0|||
130256857|NCT03895372|468904964|FG003|Investigational Treatment Period|Other|0|||
130256858|NCT03895372|468904965|FG004|Investigational Treatment Period|Other|0|||
130256859|NCT03895372|468904966|FG005|Investigational Treatment Period|Other|1|||
130256860|NCT03895372|468904967|FG006|Investigational Treatment Period|Other|0|||
130256861|NCT03895372|468904968|FG007|Investigational Treatment Period|Other|2|||
130256862|NCT03895372|468904961|FG000|Investigational Treatment Period|Protocol Violation|0|||
130256863|NCT03895372|468904962|FG001|Investigational Treatment Period|Protocol Violation|0|||
130256864|NCT03895372|468904963|FG002|Investigational Treatment Period|Protocol Violation|0|||
130256865|NCT03895372|468904964|FG003|Investigational Treatment Period|Protocol Violation|1|||
130256866|NCT03895372|468904965|FG004|Investigational Treatment Period|Protocol Violation|0|||
130256867|NCT03895372|468904966|FG005|Investigational Treatment Period|Protocol Violation|0|||
130256868|NCT03895372|468904967|FG006|Investigational Treatment Period|Protocol Violation|0|||
130256869|NCT03895372|468904968|FG007|Investigational Treatment Period|Protocol Violation|0|||
130256870|NCT03895372|468904961|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
130256871|NCT03895372|468904962|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
130256872|NCT03895372|468904963|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
130256873|NCT03895372|468904964|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
130256874|NCT03895372|468904965|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
130256875|NCT03895372|468904966|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
130256876|NCT03895372|468904967|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
130256877|NCT03895372|468904968|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
130256878|NCT03895372|468904961|FG000|Extension Treatment Period|Adverse Event|0|||
130256879|NCT03895372|468904962|FG001|Extension Treatment Period|Adverse Event|1|||
130256880|NCT03895372|468904963|FG002|Extension Treatment Period|Adverse Event|0|||
130256881|NCT03895372|468904964|FG003|Extension Treatment Period|Adverse Event|1|||
130256882|NCT03895372|468904965|FG004|Extension Treatment Period|Adverse Event|0|||
130256883|NCT03895372|468904966|FG005|Extension Treatment Period|Adverse Event|0|||
130256884|NCT03895372|468904967|FG006|Extension Treatment Period|Adverse Event|3|||
130256885|NCT03895372|468904968|FG007|Extension Treatment Period|Adverse Event|3|||
130256886|NCT03895372|468904961|FG000|Extension Treatment Period|Other|1|||
130256887|NCT03895372|468904962|FG001|Extension Treatment Period|Other|3|||
130256888|NCT03895372|468904963|FG002|Extension Treatment Period|Other|0|||
130256889|NCT03895372|468904964|FG003|Extension Treatment Period|Other|0|||
130256890|NCT03895372|468904965|FG004|Extension Treatment Period|Other|1|||
130256891|NCT03895372|468904966|FG005|Extension Treatment Period|Other|0|||
130256892|NCT03895372|468904967|FG006|Extension Treatment Period|Other|0|||
130256893|NCT03895372|468904968|FG007|Extension Treatment Period|Other|2|||
130256894|NCT03895372|468904961|FG000|Extension Treatment Period|Pregnancy|0|||
130256895|NCT03895372|468904962|FG001|Extension Treatment Period|Pregnancy|0|||
130256896|NCT03895372|468904963|FG002|Extension Treatment Period|Pregnancy|0|||
130256897|NCT03895372|468904964|FG003|Extension Treatment Period|Pregnancy|0|||
130256898|NCT03895372|468904965|FG004|Extension Treatment Period|Pregnancy|1|||
130256899|NCT03895372|468904966|FG005|Extension Treatment Period|Pregnancy|0|||
130256900|NCT03895372|468904967|FG006|Extension Treatment Period|Pregnancy|0|||
130256901|NCT03895372|468904968|FG007|Extension Treatment Period|Pregnancy|0|||
130256902|NCT03895372|468904961|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
130256903|NCT03895372|468904962|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
130256904|NCT03895372|468904963|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130256905|NCT03895372|468904964|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
130256906|NCT03895372|468904965|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
130256907|NCT03895372|468904966|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
130256908|NCT03895372|468904967|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
130256909|NCT03895372|468904968|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
130256910|NCT01472185|468904973|FG000|Overall Study|Randomized but Not Treated|0|||
130256911|NCT01472185|468904974|FG001|Overall Study|Randomized but Not Treated|1|||
130256912|NCT01472185|468904973|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
130256913|NCT01472185|468904974|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
130256914|NCT01472185|468904973|FG000|Overall Study|Hyperglycemia|5|||
130256915|NCT01472185|468904974|FG001|Overall Study|Hyperglycemia|2|||
130256916|NCT01472185|468904973|FG000|Overall Study|Investigator's Discretion|3|||
130256917|NCT01472185|468904974|FG001|Overall Study|Investigator's Discretion|1|||
130256918|NCT01472185|468904973|FG000|Overall Study|Lost to Follow-up|4|||
130256919|NCT01472185|468904974|FG001|Overall Study|Lost to Follow-up|1|||
130256920|NCT01472185|468904973|FG000|Overall Study|Protocol Violation|5|||
130256921|NCT01472185|468904974|FG001|Overall Study|Protocol Violation|1|||
130256922|NCT01472185|468904973|FG000|Overall Study|Subject Noncompliance|8|||
130256923|NCT01472185|468904974|FG001|Overall Study|Subject Noncompliance|15|||
130256924|NCT01472185|468904973|FG000|Overall Study|Subject Withdrew Consent|6|||
130256925|NCT01472185|468904974|FG001|Overall Study|Subject Withdrew Consent|3|||
130256926|NCT05889468|468904975|FG000|Overall Study|Lost to Follow-up|9|||
130256927|NCT05889468|468904976|FG001|Overall Study|Lost to Follow-up|2|||
130256928|NCT05889468|468904975|FG000|Overall Study|Withdrawal by Subject|2|||
130256929|NCT05889468|468904976|FG001|Overall Study|Withdrawal by Subject|2|||
130256930|NCT01309230|468904977|FG000|Overall Study|Withdrawal by Subject|0|||
130256931|NCT01309230|468904978|FG001|Overall Study|Withdrawal by Subject|2|||
130256932|NCT01309230|468904977|FG000|Overall Study|Observation arm closed|0|||
130256933|NCT01309230|468904978|FG001|Overall Study|Observation arm closed|2|||
130256934|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
130256935|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
130256936|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
130256937|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
130256938|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
130256939|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
130256940|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
130256941|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
130256942|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
130256943|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
130032883|NCT00868790|468076986|FG007|Period 1|Abnormal Triglycerides|0|||
130256944|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256945|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256946|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256947|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256948|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256949|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256950|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256951|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
130256952|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256953|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
130256954|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256955|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256956|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256957|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256958|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256959|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
130256960|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256961|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256962|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130256963|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
130032884|NCT00868790|468076987|FG008|Period 1|Abnormal Triglycerides|0|||
130032885|NCT00868790|468076988|FG009|Period 1|Abnormal Triglycerides|0|||
130032886|NCT00868790|468076989|FG010|Period 1|Abnormal Triglycerides|0|||
130032887|NCT00868790|468076990|FG011|Period 1|Abnormal Triglycerides|0|||
130032888|NCT00868790|468076991|FG012|Period 1|Abnormal Triglycerides|0|||
130032889|NCT00868790|468076992|FG013|Period 1|Abnormal Triglycerides|0|||
130032890|NCT00868790|468076979|FG000|Period 1|Lost to Follow-up|0|||
130032891|NCT00868790|468076980|FG001|Period 1|Lost to Follow-up|0|||
130032892|NCT00868790|468076981|FG002|Period 1|Lost to Follow-up|0|||
130032893|NCT00868790|468076982|FG003|Period 1|Lost to Follow-up|0|||
130032894|NCT00868790|468076983|FG004|Period 1|Lost to Follow-up|0|||
130032895|NCT00868790|468076984|FG005|Period 1|Lost to Follow-up|1|||
130032896|NCT00868790|468076985|FG006|Period 1|Lost to Follow-up|0|||
130032897|NCT00868790|468076986|FG007|Period 1|Lost to Follow-up|0|||
130032898|NCT00868790|468076987|FG008|Period 1|Lost to Follow-up|0|||
130032899|NCT00868790|468076988|FG009|Period 1|Lost to Follow-up|0|||
130032900|NCT00868790|468076989|FG010|Period 1|Lost to Follow-up|0|||
130032901|NCT00868790|468076990|FG011|Period 1|Lost to Follow-up|0|||
130032902|NCT00868790|468076991|FG012|Period 1|Lost to Follow-up|0|||
130032903|NCT00868790|468076992|FG013|Period 1|Lost to Follow-up|0|||
130032904|NCT00868790|468076979|FG000|Period 2|Adverse Event|0|||
130032905|NCT00868790|468076980|FG001|Period 2|Adverse Event|0|||
130032906|NCT00868790|468076981|FG002|Period 2|Adverse Event|0|||
130032907|NCT00868790|468076982|FG003|Period 2|Adverse Event|0|||
130032908|NCT00868790|468076983|FG004|Period 2|Adverse Event|0|||
130032909|NCT00868790|468076984|FG005|Period 2|Adverse Event|0|||
130032910|NCT00868790|468076985|FG006|Period 2|Adverse Event|0|||
130032911|NCT00868790|468076986|FG007|Period 2|Adverse Event|0|||
130032912|NCT00868790|468076987|FG008|Period 2|Adverse Event|1|||
130032913|NCT00868790|468076988|FG009|Period 2|Adverse Event|0|||
130032914|NCT00868790|468076989|FG010|Period 2|Adverse Event|0|||
130032915|NCT00868790|468076990|FG011|Period 2|Adverse Event|0|||
130032916|NCT00868790|468076991|FG012|Period 2|Adverse Event|0|||
130032917|NCT00868790|468076992|FG013|Period 2|Adverse Event|0|||
130032918|NCT00868790|468076979|FG000|Period 2|Lost to Follow-up|0|||
130256964|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256965|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256966|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256967|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130101587|NCT04502862|468328783|FG001|Overall Study|Adverse Event|1|||
130101588|NCT01808508|468330685|FG000|Overall Study|Lost to Follow-up|1|||
130101589|NCT01808508|468330686|FG001|Overall Study|Lost to Follow-up|0|||
130101590|NCT01808508|468330687|FG002|Overall Study|Lost to Follow-up|0|||
130101591|NCT01017731|468330688|FG000|Overall Study|Lost to Follow-up|2|||
130101592|NCT01017731|468330688|FG000|Overall Study|Withdrawal by Subject|3|||
130101593|NCT01017731|468330688|FG000|Overall Study|Physician Decision|2|||
130101594|NCT01017731|468330688|FG000|Overall Study|Adverse Event|1|||
130101595|NCT05378269|468330689|FG000|Overall Study|Protocol Violation|1|||
130101596|NCT05378269|468330690|FG001|Overall Study|Protocol Violation|0|||
130101597|NCT05378269|468330691|FG002|Overall Study|Protocol Violation|2|||
130101598|NCT05378269|468330692|FG003|Overall Study|Protocol Violation|0|||
130256968|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130256969|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130256970|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
130101599|NCT05378269|468330693|FG004|Overall Study|Protocol Violation|0|||
130101600|NCT00242567|468330696|FG000|Overall Study|Adverse Event|70|||
130101601|NCT00242567|468330697|FG001|Overall Study|Adverse Event|43|||
130101602|NCT00242567|468330696|FG000|Overall Study|Disease Progression|17|||
130101603|NCT00242567|468330697|FG001|Overall Study|Disease Progression|22|||
130101604|NCT00242567|468330696|FG000|Overall Study|Symptomatic deterioration|9|||
130256971|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
130256972|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
130256973|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
130256974|NCT02082977|468904987|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130032919|NCT00868790|468076980|FG001|Period 2|Lost to Follow-up|1|||
130032920|NCT00868790|468076981|FG002|Period 2|Lost to Follow-up|0|||
130032921|NCT00868790|468076982|FG003|Period 2|Lost to Follow-up|0|||
130032922|NCT00868790|468076983|FG004|Period 2|Lost to Follow-up|0|||
130032923|NCT00868790|468076984|FG005|Period 2|Lost to Follow-up|1|||
130032924|NCT00868790|468076985|FG006|Period 2|Lost to Follow-up|0|||
130032925|NCT00868790|468076986|FG007|Period 2|Lost to Follow-up|0|||
130032926|NCT00868790|468076987|FG008|Period 2|Lost to Follow-up|0|||
130032927|NCT00868790|468076988|FG009|Period 2|Lost to Follow-up|0|||
130032928|NCT00868790|468076989|FG010|Period 2|Lost to Follow-up|0|||
130032929|NCT00868790|468076990|FG011|Period 2|Lost to Follow-up|0|||
130101605|NCT00242567|468330697|FG001|Overall Study|Symptomatic deterioration|3|||
130101606|NCT00242567|468330696|FG000|Overall Study|Lack of Efficacy|2|||
130101607|NCT00242567|468330697|FG001|Overall Study|Lack of Efficacy|2|||
130101608|NCT00242567|468330696|FG000|Overall Study|Lost to Follow-up|9|||
130101609|NCT00242567|468330697|FG001|Overall Study|Lost to Follow-up|19|||
130101610|NCT00242567|468330696|FG000|Overall Study|Withdrawal by Subject|33|||
130101611|NCT00242567|468330697|FG001|Overall Study|Withdrawal by Subject|28|||
130101612|NCT00242567|468330696|FG000|Overall Study|Protocol Violation|12|||
130101613|NCT00242567|468330697|FG001|Overall Study|Protocol Violation|12|||
130101614|NCT00242567|468330696|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
130101615|NCT00242567|468330697|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
130101616|NCT00242567|468330696|FG000|Overall Study|Other|14|||
130101617|NCT00242567|468330697|FG001|Overall Study|Other|9|||
130101618|NCT01721200|468330698|FG000|Overall Study|Lost to Follow-up|3|||
130101619|NCT01721200|468330699|FG001|Overall Study|Lost to Follow-up|5|||
130101620|NCT03926728|468330700|FG000|Overall Study|Withdrawal by Subject|0|||
130101621|NCT03926728|468330701|FG001|Overall Study|Withdrawal by Subject|1|||
130101622|NCT03926728|468330702|FG002|Overall Study|Withdrawal by Subject|1|||
130101623|NCT03926728|468330703|FG003|Overall Study|Withdrawal by Subject|0|||
130256975|NCT02082977|468904988|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256976|NCT02082977|468904989|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130101624|NCT03926728|468330704|FG004|Overall Study|Withdrawal by Subject|0|||
130101625|NCT03926728|468330705|FG005|Overall Study|Withdrawal by Subject|1|||
130101626|NCT03926728|468330706|FG006|Overall Study|Withdrawal by Subject|1|||
130256977|NCT02082977|468904990|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256978|NCT02082977|468904991|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256979|NCT02082977|468904992|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256980|NCT02082977|468904993|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256981|NCT02082977|468904994|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
130256982|NCT02082977|468904995|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256983|NCT02082977|468904996|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
130256984|NCT00049543|468904997|FG000|Overall Study|still on treatment|2|||
130256985|NCT00049543|468904998|FG001|Overall Study|still on treatment|9|||
130256986|NCT03485157|468904999|FG000|Double Blind Phase|Lost to Follow-up|4|||
130256987|NCT03485157|468905000|FG001|Double Blind Phase|Lost to Follow-up|4|||
130256988|NCT03485157|468904999|FG000|Double Blind Phase|Adverse Event|2|||
130256989|NCT03485157|468905000|FG001|Double Blind Phase|Adverse Event|1|||
130256990|NCT03485157|468904999|FG000|Double Blind Phase|Withdrawal by Subject|6|||
130256991|NCT03485157|468905000|FG001|Double Blind Phase|Withdrawal by Subject|9|||
130256992|NCT03485157|468904999|FG000|Double Blind Phase|Removal by PI|3|||
130256993|NCT03485157|468905000|FG001|Double Blind Phase|Removal by PI|7|||
130256994|NCT03485157|468904999|FG000|Open Label Phase|Lost to Follow-up|1|||
130256995|NCT03485157|468905000|FG001|Open Label Phase|Lost to Follow-up|2|||
130256996|NCT03485157|468904999|FG000|Open Label Phase|Adverse Event|0|||
130256997|NCT03485157|468905000|FG001|Open Label Phase|Adverse Event|1|||
130256998|NCT03485157|468904999|FG000|Open Label Phase|Withdrawal by Subject|1|||
130256999|NCT03485157|468905000|FG001|Open Label Phase|Withdrawal by Subject|2|||
130257000|NCT03485157|468904999|FG000|Open Label Phase|Removal by PI|2|||
130257001|NCT03485157|468905000|FG001|Open Label Phase|Removal by PI|0|||
130257002|NCT04562090|468905001|FG000|Overall Study|Withdrawal by Subject|3|||
130257003|NCT04562090|468905002|FG001|Overall Study|Withdrawal by Subject|4|||
130257004|NCT04562090|468905001|FG000|Overall Study|Protocol Violation|2|||
130257005|NCT04562090|468905002|FG001|Overall Study|Protocol Violation|0|||
130257006|NCT04562090|468905001|FG000|Overall Study|Lack of Efficacy|0|||
130257007|NCT04562090|468905002|FG001|Overall Study|Lack of Efficacy|1|||
130257008|NCT04562090|468905001|FG000|Overall Study|Adverse Event|1|||
130257009|NCT04562090|468905002|FG001|Overall Study|Adverse Event|4|||
130257010|NCT04562090|468905001|FG000|Overall Study|Miscellaneous|0|||
130257011|NCT04562090|468905002|FG001|Overall Study|Miscellaneous|3|||
130257012|NCT03633058|468905003|FG000|Overall Study|Adverse Event|0|||
130257013|NCT03633058|468905004|FG001|Overall Study|Adverse Event|0|||
130257014|NCT03633058|468905005|FG002|Overall Study|Adverse Event|1|||
130257015|NCT03633058|468905006|FG003|Overall Study|Adverse Event|0|||
130257016|NCT03312543|468905007|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
130101627|NCT03926728|468330707|FG007|Overall Study|Withdrawal by Subject|0|||
130101628|NCT03926728|468330708|FG008|Overall Study|Withdrawal by Subject|0|||
130257017|NCT03312543|468905008|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
130257018|NCT03312543|468905007|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
130257019|NCT03312543|468905008|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
130257020|NCT03312543|468905007|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
130257021|NCT03312543|468905008|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
130257022|NCT03312543|468905007|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
130257023|NCT03312543|468905008|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
130257024|NCT03312543|468905007|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
130257025|NCT03312543|468905008|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
130101629|NCT03926728|468330709|FG009|Overall Study|Withdrawal by Subject|1|||
130101630|NCT03926728|468330710|FG010|Overall Study|Withdrawal by Subject|0|||
130101631|NCT03926728|468330711|FG011|Overall Study|Withdrawal by Subject|0|||
130101632|NCT02729545|468330712|FG000|Overall Study|Pregnancy|1|||
130101633|NCT02729545|468330713|FG001|Overall Study|Pregnancy|1|||
130101634|NCT02729545|468330712|FG000|Overall Study|Lost to Follow-up|0|||
130101635|NCT02729545|468330713|FG001|Overall Study|Lost to Follow-up|1|||
130101636|NCT02729545|468330712|FG000|Overall Study|Withdrawal by Subject|2|||
130101637|NCT02729545|468330713|FG001|Overall Study|Withdrawal by Subject|3|||
130101638|NCT00398632|468330714|FG000|Overall Study|Withdrawal by Subject|1|||
130101639|NCT00398632|468330714|FG000|Overall Study|Lack of Efficacy|1|||
130101640|NCT02411110|468330715|FG000|Treatment Period 1|Adverse Event|4|||
130101641|NCT02411110|468330716|FG001|Treatment Period 1|Adverse Event|2|||
130101642|NCT02411110|468330715|FG000|Treatment Period 1|Lost to Follow-up|1|||
130101643|NCT02411110|468330716|FG001|Treatment Period 1|Lost to Follow-up|0|||
130101644|NCT02411110|468330715|FG000|Treatment Period 1|Personal Reasons|2|||
130101645|NCT02411110|468330716|FG001|Treatment Period 1|Personal Reasons|5|||
130101646|NCT02411110|468330715|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
130101647|NCT02411110|468330716|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
130101648|NCT02411110|468330715|FG000|Treatment Period 2|Adverse Event|1|||
130101649|NCT02411110|468330716|FG001|Treatment Period 2|Adverse Event|0|||
130101650|NCT02411110|468330715|FG000|Treatment Period 2|Lost to Follow-up|0|||
130257026|NCT03312543|468905007|FG000|Regression (Week 12 to Week 24)|Death|0|||
130257027|NCT03312543|468905008|FG001|Regression (Week 12 to Week 24)|Death|1|||
130257028|NCT04134936|468905009|FG000|Overall Study|Adverse Event|3|||
130257029|NCT04134936|468905010|FG001|Overall Study|Adverse Event|2|||
130257030|NCT04134936|468905009|FG000|Overall Study|Withdrawal by Subject|2|||
130257031|NCT04134936|468905010|FG001|Overall Study|Withdrawal by Subject|3|||
130257032|NCT04134936|468905009|FG000|Overall Study|Physician Decision|0|||
130257033|NCT04134936|468905010|FG001|Overall Study|Physician Decision|1|||
130257034|NCT04134936|468905009|FG000|Overall Study|Progressive disease, joined another trial|1|||
130257035|NCT04134936|468905010|FG001|Overall Study|Progressive disease, joined another trial|0|||
130257036|NCT04134936|468905009|FG000|Overall Study|Progressive disease|1|||
130257037|NCT04134936|468905010|FG001|Overall Study|Progressive disease|0|||
130257038|NCT02420717|468905013|FG000|Overall Study|Did not receive all study medication|2|||
130257039|NCT02420717|468905014|FG001|Overall Study|Did not receive all study medication|0|||
130257040|NCT02420717|468905015|FG002|Overall Study|Did not receive all study medication|0|||
130257041|NCT04144517|468905018|FG000|Overall Study|Physician Decision|0|||
130257042|NCT04144517|468905019|FG001|Overall Study|Physician Decision|1|||
130257043|NCT04144517|468905018|FG000|Overall Study|Other|2|||
130257044|NCT04144517|468905019|FG001|Overall Study|Other|2|||
130257045|NCT04144517|468905018|FG000|Overall Study|Death|6|||
130257046|NCT04144517|468905019|FG001|Overall Study|Death|3|||
130257047|NCT00835367|468905025|FG000|Washout|Adverse Event|2|||
130257048|NCT00835367|468905026|FG001|Washout|Adverse Event|0|||
130257049|NCT00835367|468905025|FG000|Washout|Withdrawal by Subject|1|||
130257050|NCT00835367|468905026|FG001|Washout|Withdrawal by Subject|0|||
130257051|NCT00835367|468905025|FG000|Second Intervention|Adverse Event|1|||
130257052|NCT00835367|468905026|FG001|Second Intervention|Adverse Event|1|||
130257053|NCT00936936|468906552|FG000|Overall Study|Adverse Event|7|||
130257054|NCT00936936|468906553|FG001|Overall Study|Adverse Event|1|||
130257055|NCT00936936|468906552|FG000|Overall Study|Disease Progression|2|||
130257056|NCT00936936|468906553|FG001|Overall Study|Disease Progression|2|||
130257057|NCT00936936|468906552|FG000|Overall Study|Unrelated|3|||
130257058|NCT00936936|468906553|FG001|Overall Study|Unrelated|1|||
130257059|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
130257060|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
130257061|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
130257062|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
130257063|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
130257064|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
130101651|NCT02411110|468330716|FG001|Treatment Period 2|Lost to Follow-up|2|||
130101652|NCT02411110|468330715|FG000|Treatment Period 2|Personal Reasons|0|||
130101653|NCT02411110|468330716|FG001|Treatment Period 2|Personal Reasons|2|||
130101654|NCT01102972|468330719|FG000|Overall Study|Adverse Event|8|||
130101655|NCT01102972|468330720|FG001|Overall Study|Adverse Event|2|||
130101656|NCT01102972|468330719|FG000|Overall Study|Lack of Efficacy|2|||
130257065|NCT01373281|468906554|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
130257066|NCT01373281|468906555|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
130257067|NCT01373281|468906554|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
130257068|NCT01373281|468906555|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
130257069|NCT01373281|468906554|FG000|Surveillance Expansion Period|Protocol Violation|9|||
130257070|NCT01373281|468906555|FG001|Surveillance Expansion Period|Protocol Violation|1|||
130257071|NCT01373281|468906554|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
130257072|NCT01373281|468906555|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
130257073|NCT01373281|468906554|FG000|Surveillance Expansion Period|Serious adverse event|3|||
130257074|NCT01373281|468906555|FG001|Surveillance Expansion Period|Serious adverse event|4|||
130257075|NCT00851084|468906556|FG000|Overall Study|Randomized but not treated|1|||
130257076|NCT00851084|468906557|FG001|Overall Study|Randomized but not treated|0|||
130257077|NCT00851084|468906556|FG000|Overall Study|Adverse Event|26|||
130257078|NCT00851084|468906557|FG001|Overall Study|Adverse Event|36|||
130257079|NCT00851084|468906556|FG000|Overall Study|Disease progression|52|||
130257080|NCT00851084|468906557|FG001|Overall Study|Disease progression|47|||
130032930|NCT00868790|468076991|FG012|Period 2|Lost to Follow-up|0|||
130032931|NCT00868790|468076992|FG013|Period 2|Lost to Follow-up|0|||
130032932|NCT00868790|468076979|FG000|Period 2|Withdrawal by Subject|0|||
130032933|NCT00868790|468076980|FG001|Period 2|Withdrawal by Subject|0|||
130032934|NCT00868790|468076981|FG002|Period 2|Withdrawal by Subject|0|||
130032935|NCT00868790|468076982|FG003|Period 2|Withdrawal by Subject|0|||
130032936|NCT00868790|468076983|FG004|Period 2|Withdrawal by Subject|0|||
130032937|NCT00868790|468076984|FG005|Period 2|Withdrawal by Subject|0|||
130032938|NCT00868790|468076985|FG006|Period 2|Withdrawal by Subject|0|||
130032939|NCT00868790|468076986|FG007|Period 2|Withdrawal by Subject|0|||
130032940|NCT00868790|468076987|FG008|Period 2|Withdrawal by Subject|1|||
130032941|NCT00868790|468076988|FG009|Period 2|Withdrawal by Subject|0|||
130032942|NCT00868790|468076989|FG010|Period 2|Withdrawal by Subject|0|||
130032943|NCT00868790|468076990|FG011|Period 2|Withdrawal by Subject|0|||
130032944|NCT00868790|468076991|FG012|Period 2|Withdrawal by Subject|0|||
130032945|NCT00868790|468076992|FG013|Period 2|Withdrawal by Subject|1|||
130032946|NCT00868790|468076979|FG000|Period 3|Adverse Event|0|||
130032947|NCT00868790|468076980|FG001|Period 3|Adverse Event|0|||
130032948|NCT00868790|468076981|FG002|Period 3|Adverse Event|0|||
130032949|NCT00868790|468076982|FG003|Period 3|Adverse Event|0|||
130032950|NCT00868790|468076983|FG004|Period 3|Adverse Event|0|||
130032951|NCT00868790|468076984|FG005|Period 3|Adverse Event|0|||
130032952|NCT00868790|468076985|FG006|Period 3|Adverse Event|0|||
130032953|NCT00868790|468076986|FG007|Period 3|Adverse Event|0|||
130032954|NCT00868790|468076987|FG008|Period 3|Adverse Event|0|||
130032955|NCT00868790|468076988|FG009|Period 3|Adverse Event|1|||
130032956|NCT00868790|468076989|FG010|Period 3|Adverse Event|0|||
130032957|NCT00868790|468076990|FG011|Period 3|Adverse Event|0|||
130032958|NCT00868790|468076991|FG012|Period 3|Adverse Event|0|||
130032959|NCT00868790|468076992|FG013|Period 3|Adverse Event|0|||
130032960|NCT00868790|468076979|FG000|Period 3|Protocol Violation|0|||
130032961|NCT00868790|468076980|FG001|Period 3|Protocol Violation|0|||
130032962|NCT00868790|468076981|FG002|Period 3|Protocol Violation|0|||
130032963|NCT00868790|468076982|FG003|Period 3|Protocol Violation|0|||
130257081|NCT00851084|468906556|FG000|Overall Study|Poor compliance to protocol|1|||
130257082|NCT00851084|468906557|FG001|Overall Study|Poor compliance to protocol|1|||
130257083|NCT00851084|468906556|FG000|Overall Study|Physician Decision|13|||
130257084|NCT00851084|468906557|FG001|Overall Study|Physician Decision|14|||
130257085|NCT00851084|468906556|FG000|Overall Study|Consent withdrawn|0|||
130257086|NCT00851084|468906557|FG001|Overall Study|Consent withdrawn|2|||
130257087|NCT00851084|468906556|FG000|Overall Study|Withdrawal by Subject|11|||
130257088|NCT00851084|468906557|FG001|Overall Study|Withdrawal by Subject|12|||
130257089|NCT00851084|468906556|FG000|Overall Study|Metastatic surgery|6|||
130257090|NCT00851084|468906557|FG001|Overall Study|Metastatic surgery|6|||
130257091|NCT00851084|468906556|FG000|Overall Study|Other|7|||
130257092|NCT00851084|468906557|FG001|Overall Study|Other|1|||
130257093|NCT00734032|468906558|FG000|Overall Study|Adverse Event|0|||
130257094|NCT00734032|468906559|FG001|Overall Study|Adverse Event|1|||
130257095|NCT00734032|468906560|FG002|Overall Study|Adverse Event|0|||
130257096|NCT00734032|468906561|FG003|Overall Study|Adverse Event|0|||
130257097|NCT00133705|468906564|FG000|Overall Study|Withdrawal by Subject|2|||
130257098|NCT00133705|468906565|FG001|Overall Study|Withdrawal by Subject|3|||
130257099|NCT04992273|468906567|FG000|Overall Study|Lost to Follow-up|0|||
130257100|NCT04992273|468906568|FG001|Overall Study|Lost to Follow-up|1|||
130257101|NCT03440411|468906569|FG000|Overall Study|Adverse Event|0|||
130257102|NCT03440411|468906570|FG001|Overall Study|Adverse Event|0|||
130257103|NCT03440411|468906571|FG002|Overall Study|Adverse Event|1|||
130257104|NCT03440411|468906572|FG003|Overall Study|Adverse Event|0|||
130257105|NCT03440411|468906569|FG000|Overall Study|PD|2|||
130257106|NCT03440411|468906570|FG001|Overall Study|PD|1|||
130257107|NCT03440411|468906571|FG002|Overall Study|PD|1|||
130257108|NCT03440411|468906572|FG003|Overall Study|PD|1|||
130032964|NCT00868790|468076983|FG004|Period 3|Protocol Violation|0|||
130032965|NCT00868790|468076984|FG005|Period 3|Protocol Violation|0|||
130032966|NCT00868790|468076985|FG006|Period 3|Protocol Violation|0|||
130032967|NCT00868790|468076986|FG007|Period 3|Protocol Violation|0|||
130032968|NCT00868790|468076987|FG008|Period 3|Protocol Violation|0|||
130032969|NCT00868790|468076988|FG009|Period 3|Protocol Violation|0|||
130032970|NCT00868790|468076989|FG010|Period 3|Protocol Violation|1|||
130032971|NCT00868790|468076990|FG011|Period 3|Protocol Violation|0|||
130032972|NCT00868790|468076991|FG012|Period 3|Protocol Violation|0|||
130032973|NCT00868790|468076992|FG013|Period 3|Protocol Violation|0|||
130032974|NCT00868790|468076979|FG000|Period 3|Study Terminated by Sponsor|0|||
130257109|NCT03440411|468906569|FG000|Overall Study|Withdrawal by Subject|1|||
130257110|NCT03440411|468906570|FG001|Overall Study|Withdrawal by Subject|0|||
130257111|NCT03440411|468906571|FG002|Overall Study|Withdrawal by Subject|0|||
130257112|NCT03440411|468906572|FG003|Overall Study|Withdrawal by Subject|0|||
130257113|NCT03440411|468906569|FG000|Overall Study|Closed study by sponsor|0|||
130257114|NCT03440411|468906570|FG001|Overall Study|Closed study by sponsor|0|||
130257115|NCT03440411|468906571|FG002|Overall Study|Closed study by sponsor|0|||
130257116|NCT03440411|468906572|FG003|Overall Study|Closed study by sponsor|1|||
130257117|NCT00863304|468906575|FG000|Overall Study|Adverse Event|10|||
130257118|NCT00863304|468906576|FG001|Overall Study|Adverse Event|4|||
130257119|NCT00863304|468906577|FG002|Overall Study|Adverse Event|14|||
130257120|NCT00863304|468906578|FG003|Overall Study|Adverse Event|16|||
130257121|NCT00863304|468906575|FG000|Overall Study|Lost to Follow-up|1|||
130257122|NCT00863304|468906576|FG001|Overall Study|Lost to Follow-up|5|||
130257123|NCT00863304|468906577|FG002|Overall Study|Lost to Follow-up|4|||
130032975|NCT00868790|468076980|FG001|Period 3|Study Terminated by Sponsor|0|||
130032976|NCT00868790|468076981|FG002|Period 3|Study Terminated by Sponsor|0|||
130032977|NCT00868790|468076982|FG003|Period 3|Study Terminated by Sponsor|1|||
130032978|NCT00868790|468076983|FG004|Period 3|Study Terminated by Sponsor|0|||
130032979|NCT00868790|468076984|FG005|Period 3|Study Terminated by Sponsor|0|||
130032980|NCT00868790|468076985|FG006|Period 3|Study Terminated by Sponsor|0|||
130032981|NCT00868790|468076986|FG007|Period 3|Study Terminated by Sponsor|0|||
130032982|NCT00868790|468076987|FG008|Period 3|Study Terminated by Sponsor|0|||
130032983|NCT00868790|468076988|FG009|Period 3|Study Terminated by Sponsor|0|||
130032984|NCT00868790|468076989|FG010|Period 3|Study Terminated by Sponsor|0|||
130032985|NCT00868790|468076990|FG011|Period 3|Study Terminated by Sponsor|0|||
130032986|NCT00868790|468076991|FG012|Period 3|Study Terminated by Sponsor|0|||
130032987|NCT00868790|468076992|FG013|Period 3|Study Terminated by Sponsor|0|||
130032988|NCT00868790|468076979|FG000|Period 4|Adverse Event|0|||
130032989|NCT00868790|468076980|FG001|Period 4|Adverse Event|0|||
130032990|NCT00868790|468076981|FG002|Period 4|Adverse Event|0|||
130032991|NCT00868790|468076982|FG003|Period 4|Adverse Event|0|||
130032992|NCT00868790|468076983|FG004|Period 4|Adverse Event|0|||
130032993|NCT00868790|468076984|FG005|Period 4|Adverse Event|0|||
130032994|NCT00868790|468076985|FG006|Period 4|Adverse Event|0|||
130032995|NCT00868790|468076986|FG007|Period 4|Adverse Event|1|||
130032996|NCT00868790|468076987|FG008|Period 4|Adverse Event|0|||
130032997|NCT00868790|468076988|FG009|Period 4|Adverse Event|0|||
130032998|NCT00868790|468076989|FG010|Period 4|Adverse Event|1|||
130032999|NCT00868790|468076990|FG011|Period 4|Adverse Event|0|||
130033000|NCT00868790|468076991|FG012|Period 4|Adverse Event|1|||
130033001|NCT00868790|468076992|FG013|Period 4|Adverse Event|0|||
130033002|NCT00868790|468076979|FG000|Period 4|Lost to Follow-up|0|||
130033003|NCT00868790|468076980|FG001|Period 4|Lost to Follow-up|0|||
130033004|NCT00868790|468076981|FG002|Period 4|Lost to Follow-up|0|||
130033005|NCT00868790|468076982|FG003|Period 4|Lost to Follow-up|0|||
130033006|NCT00868790|468076983|FG004|Period 4|Lost to Follow-up|0|||
130033007|NCT00868790|468076984|FG005|Period 4|Lost to Follow-up|0|||
130033008|NCT00868790|468076985|FG006|Period 4|Lost to Follow-up|0|||
130033009|NCT00868790|468076986|FG007|Period 4|Lost to Follow-up|1|||
130033010|NCT00868790|468076987|FG008|Period 4|Lost to Follow-up|0|||
130033011|NCT00868790|468076988|FG009|Period 4|Lost to Follow-up|0|||
130033012|NCT00868790|468076989|FG010|Period 4|Lost to Follow-up|0|||
130033013|NCT00868790|468076990|FG011|Period 4|Lost to Follow-up|0|||
130033014|NCT00868790|468076991|FG012|Period 4|Lost to Follow-up|0|||
130033015|NCT00868790|468076992|FG013|Period 4|Lost to Follow-up|0|||
130033016|NCT00868790|468076979|FG000|Period 4|Study Terminated by Sponsor|2|||
130033017|NCT00868790|468076980|FG001|Period 4|Study Terminated by Sponsor|0|||
130033018|NCT00868790|468076981|FG002|Period 4|Study Terminated by Sponsor|0|||
130033019|NCT00868790|468076982|FG003|Period 4|Study Terminated by Sponsor|0|||
130033020|NCT00868790|468076983|FG004|Period 4|Study Terminated by Sponsor|0|||
130033021|NCT00868790|468076984|FG005|Period 4|Study Terminated by Sponsor|0|||
130033022|NCT00868790|468076985|FG006|Period 4|Study Terminated by Sponsor|0|||
130033023|NCT00868790|468076986|FG007|Period 4|Study Terminated by Sponsor|1|||
130033024|NCT00868790|468076987|FG008|Period 4|Study Terminated by Sponsor|2|||
130033025|NCT00868790|468076988|FG009|Period 4|Study Terminated by Sponsor|0|||
130033026|NCT00868790|468076989|FG010|Period 4|Study Terminated by Sponsor|2|||
130033027|NCT00868790|468076990|FG011|Period 4|Study Terminated by Sponsor|1|||
130033028|NCT00868790|468076991|FG012|Period 4|Study Terminated by Sponsor|0|||
130033029|NCT00868790|468076992|FG013|Period 4|Study Terminated by Sponsor|1|||
130033030|NCT00868790|468076979|FG000|Period 4|Abnormal ALT/AST|0|||
130033031|NCT00868790|468076980|FG001|Period 4|Abnormal ALT/AST|0|||
130033032|NCT00868790|468076981|FG002|Period 4|Abnormal ALT/AST|1|||
130033033|NCT00868790|468076982|FG003|Period 4|Abnormal ALT/AST|0|||
130033034|NCT00868790|468076983|FG004|Period 4|Abnormal ALT/AST|0|||
130033035|NCT00868790|468076984|FG005|Period 4|Abnormal ALT/AST|0|||
130033036|NCT00868790|468076985|FG006|Period 4|Abnormal ALT/AST|0|||
130033037|NCT00868790|468076986|FG007|Period 4|Abnormal ALT/AST|0|||
130033038|NCT00868790|468076987|FG008|Period 4|Abnormal ALT/AST|0|||
130033039|NCT00868790|468076988|FG009|Period 4|Abnormal ALT/AST|0|||
130033040|NCT00868790|468076989|FG010|Period 4|Abnormal ALT/AST|0|||
130033041|NCT00868790|468076990|FG011|Period 4|Abnormal ALT/AST|0|||
130033042|NCT00868790|468076991|FG012|Period 4|Abnormal ALT/AST|0|||
130101657|NCT01102972|468330720|FG001|Overall Study|Lack of Efficacy|1|||
130101658|NCT01102972|468330719|FG000|Overall Study|Protocol Violation|1|||
130101659|NCT01102972|468330720|FG001|Overall Study|Protocol Violation|0|||
130101660|NCT01102972|468330719|FG000|Overall Study|Lost to Follow-up|10|||
130101661|NCT01102972|468330720|FG001|Overall Study|Lost to Follow-up|5|||
130101662|NCT01102972|468330719|FG000|Overall Study|Investigator Discretion|2|||
130101663|NCT01102972|468330720|FG001|Overall Study|Investigator Discretion|0|||
130101664|NCT01102972|468330719|FG000|Overall Study|Withdrawal by Subject|6|||
130101665|NCT01102972|468330720|FG001|Overall Study|Withdrawal by Subject|6|||
130257124|NCT00863304|468906578|FG003|Overall Study|Lost to Follow-up|2|||
130257125|NCT00863304|468906575|FG000|Overall Study|Lack of Efficacy|57|||
130257126|NCT00863304|468906576|FG001|Overall Study|Lack of Efficacy|26|||
130257127|NCT00863304|468906577|FG002|Overall Study|Lack of Efficacy|30|||
130257128|NCT00863304|468906578|FG003|Overall Study|Lack of Efficacy|28|||
130257129|NCT00863304|468906575|FG000|Overall Study|Withdrawal by Subject|19|||
130257130|NCT00863304|468906576|FG001|Overall Study|Withdrawal by Subject|14|||
130257131|NCT00863304|468906577|FG002|Overall Study|Withdrawal by Subject|20|||
130257132|NCT00863304|468906578|FG003|Overall Study|Withdrawal by Subject|18|||
130257133|NCT00863304|468906575|FG000|Overall Study|Other|1|||
130257134|NCT00863304|468906576|FG001|Overall Study|Other|0|||
130257135|NCT00863304|468906577|FG002|Overall Study|Other|0|||
130257136|NCT00863304|468906578|FG003|Overall Study|Other|1|||
130257137|NCT00863304|468906575|FG000|Overall Study|Protocol Violation|2|||
130257138|NCT00863304|468906576|FG001|Overall Study|Protocol Violation|6|||
130257139|NCT00863304|468906577|FG002|Overall Study|Protocol Violation|2|||
130257140|NCT00863304|468906578|FG003|Overall Study|Protocol Violation|0|||
130257141|NCT00863304|468906575|FG000|Overall Study|Randomized, but not Treated|3|||
130257142|NCT00863304|468906576|FG001|Overall Study|Randomized, but not Treated|1|||
130257143|NCT00863304|468906577|FG002|Overall Study|Randomized, but not Treated|4|||
129885388|NCT00672958|467540700|FG000|Overall Study|Non-compliance with study drug|2|||
129885389|NCT00672958|467540701|FG001|Overall Study|Non-compliance with study drug|3|||
129885390|NCT00672958|467540700|FG000|Overall Study|Protocol deviations|11|||
129885391|NCT00672958|467540701|FG001|Overall Study|Protocol deviations|5|||
129885392|NCT00672958|467540700|FG000|Overall Study|Voluntary withdrawal|12|||
129885393|NCT00672958|467540701|FG001|Overall Study|Voluntary withdrawal|8|||
129885394|NCT00672958|467540700|FG000|Overall Study|Lost to Follow-up|22|||
129885395|NCT00672958|467540701|FG001|Overall Study|Lost to Follow-up|17|||
129885396|NCT00672958|467540700|FG000|Overall Study|Reason not specified|0|||
129885397|NCT00672958|467540701|FG001|Overall Study|Reason not specified|3|||
129885398|NCT01380990|467540702|FG000|Overall Study|Treatment Failure|1|||
129885399|NCT01380990|467540703|FG001|Overall Study|Treatment Failure|0|||
129885400|NCT01380990|467540702|FG000|Overall Study|Death|0|||
129885401|NCT01380990|467540703|FG001|Overall Study|Death|1|||
129885402|NCT01313923|467540710|FG000|Overall Study|Physician Decision|3|||
129885403|NCT02471404|467540711|FG000|Overall Study|Adverse Event|7|||
129885404|NCT02471404|467540712|FG001|Overall Study|Adverse Event|1|||
130101666|NCT01856257|468330724|FG000|Overall Study|Death|2|||
130101667|NCT01856257|468330725|FG001|Overall Study|Death|0|||
130101668|NCT01856257|468330726|FG002|Overall Study|Death|0|||
130101669|NCT01856257|468330727|FG003|Overall Study|Death|0|||
130101670|NCT01856257|468330724|FG000|Overall Study|Physician Decision|0|||
130101671|NCT01856257|468330725|FG001|Overall Study|Physician Decision|0|||
130101672|NCT01856257|468330726|FG002|Overall Study|Physician Decision|0|||
130101673|NCT01856257|468330727|FG003|Overall Study|Physician Decision|1|||
130101674|NCT01856257|468330724|FG000|Overall Study|Withdrawal by Subject|1|||
130101675|NCT01856257|468330725|FG001|Overall Study|Withdrawal by Subject|1|||
130257144|NCT00863304|468906578|FG003|Overall Study|Randomized, but not Treated|1|||
130257145|NCT00863304|468906575|FG000|Overall Study|Entered extension study|101|||
130257146|NCT00863304|468906576|FG001|Overall Study|Entered extension study|129|||
130257147|NCT00863304|468906577|FG002|Overall Study|Entered extension study|113|||
129885405|NCT02471404|467540713|FG002|Overall Study|Adverse Event|2|||
129885406|NCT02471404|467540711|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
129885407|NCT02471404|467540712|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
129885408|NCT02471404|467540713|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
129885409|NCT02471404|467540711|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
130101676|NCT01856257|468330726|FG002|Overall Study|Withdrawal by Subject|0|||
129885410|NCT02471404|467540712|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129885411|NCT02471404|467540713|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
130101677|NCT01856257|468330727|FG003|Overall Study|Withdrawal by Subject|0|||
130101678|NCT01856257|468330724|FG000|Overall Study|Donor complication|0|||
130101679|NCT01856257|468330725|FG001|Overall Study|Donor complication|0|||
130101680|NCT01856257|468330726|FG002|Overall Study|Donor complication|0|||
130101681|NCT01856257|468330727|FG003|Overall Study|Donor complication|1|||
130257148|NCT00863304|468906578|FG003|Overall Study|Entered extension study|125|||
130257149|NCT03528902|468906581|FG000|Overall Study|Adverse Event|1|||
130257150|NCT03528902|468906582|FG001|Overall Study|Adverse Event|0|||
130257151|NCT05030766|468906583|FG000|Phase 1 Participants|Lost to Follow-up|12|||
130257152|NCT05030766|468906584|FG001|Phase 1 Participants|Lost to Follow-up|22|||
130257153|NCT05030766|468906585|FG002|Phase 1 Participants|Lost to Follow-up|0|||
130257154|NCT05030766|468906586|FG003|Phase 1 Participants|Lost to Follow-up|0|||
130257155|NCT05030766|468906583|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
130257156|NCT05030766|468906584|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
130257157|NCT05030766|468906585|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
130257158|NCT05030766|468906586|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
130257159|NCT05030766|468906583|FG000|Phase 2 Participants|Lost to Follow-up|0|||
130257160|NCT05030766|468906584|FG001|Phase 2 Participants|Lost to Follow-up|0|||
130257161|NCT05030766|468906585|FG002|Phase 2 Participants|Lost to Follow-up|6|||
130257162|NCT05030766|468906586|FG003|Phase 2 Participants|Lost to Follow-up|2|||
130257163|NCT00023595|468906587|FG000|5 Year Follow up|Lost to Follow-up|2|||
130257164|NCT00023595|468906588|FG001|5 Year Follow up|Lost to Follow-up|2|||
130257165|NCT00023595|468906589|FG002|5 Year Follow up|Lost to Follow-up|1|||
130257166|NCT00023595|468906590|FG003|5 Year Follow up|Lost to Follow-up|7|||
130257167|NCT00023595|468906591|FG004|5 Year Follow up|Lost to Follow-up|3|||
130257168|NCT00023595|468906587|FG000|10 Year Follow up|Lost to Follow-up|12|||
130257169|NCT00023595|468906588|FG001|10 Year Follow up|Lost to Follow-up|10|||
130257170|NCT00023595|468906589|FG002|10 Year Follow up|Lost to Follow-up|3|||
130257171|NCT00023595|468906590|FG003|10 Year Follow up|Lost to Follow-up|0|||
130257172|NCT00023595|468906591|FG004|10 Year Follow up|Lost to Follow-up|0|||
130257173|NCT03900650|468906592|FG000|Overall Study|Withdrawal by Subject|1|||
130257174|NCT03900650|468906593|FG001|Overall Study|Withdrawal by Subject|1|||
130257175|NCT03900650|468906594|FG002|Overall Study|Withdrawal by Subject|0|||
130257176|NCT03900650|468906595|FG003|Overall Study|Withdrawal by Subject|0|||
130257177|NCT03900650|468906592|FG000|Overall Study|Withdrawn by staff|1|||
130257178|NCT03900650|468906593|FG001|Overall Study|Withdrawn by staff|0|||
130257179|NCT03900650|468906594|FG002|Overall Study|Withdrawn by staff|0|||
130257180|NCT03900650|468906595|FG003|Overall Study|Withdrawn by staff|0|||
130257181|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
130257182|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
130257183|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
130257184|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
130257185|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
130257186|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
130257187|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
130257188|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
130257189|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
130257190|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
130257191|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
130257192|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
130257193|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
130033043|NCT00868790|468076992|FG013|Period 4|Abnormal ALT/AST|0|||
130033044|NCT00868790|468076979|FG000|Post-study|Withdrawal by Subject|0|||
130033045|NCT00868790|468076980|FG001|Post-study|Withdrawal by Subject|0|||
130033046|NCT00868790|468076981|FG002|Post-study|Withdrawal by Subject|0|||
130033047|NCT00868790|468076982|FG003|Post-study|Withdrawal by Subject|0|||
130033048|NCT00868790|468076983|FG004|Post-study|Withdrawal by Subject|1|||
130033049|NCT00868790|468076984|FG005|Post-study|Withdrawal by Subject|0|||
130033050|NCT00868790|468076985|FG006|Post-study|Withdrawal by Subject|0|||
130033051|NCT00868790|468076986|FG007|Post-study|Withdrawal by Subject|0|||
130033052|NCT00868790|468076987|FG008|Post-study|Withdrawal by Subject|0|||
130257194|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
130257195|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
130257196|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
130257197|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
130257198|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
130257199|NCT00086515|468906596|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
130257200|NCT00086515|468906597|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
130257201|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
130257202|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
130257203|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
130257204|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
129885412|NCT02471404|467540711|FG000|Overall Study|Lost to Follow-up|1|||
130101682|NCT01157065|468330731|FG000|Overall Study|Death|0|||
130257205|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
130257206|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
130257207|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
130033053|NCT00868790|468076988|FG009|Post-study|Withdrawal by Subject|0|||
130033054|NCT00868790|468076989|FG010|Post-study|Withdrawal by Subject|0|||
130101683|NCT01157065|468330732|FG001|Overall Study|Death|1|||
130257208|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
130257209|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
130257210|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
130101684|NCT01060007|468330733|FG000|Overall Study|Withdrawal by Subject|1|||
130033055|NCT00868790|468076990|FG011|Post-study|Withdrawal by Subject|0|||
130033056|NCT00868790|468076991|FG012|Post-study|Withdrawal by Subject|0|||
130033057|NCT00868790|468076992|FG013|Post-study|Withdrawal by Subject|0|||
130033058|NCT00868790|468076979|FG000|Post-study|Excluded Medication|0|||
130033059|NCT00868790|468076980|FG001|Post-study|Excluded Medication|0|||
130257211|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
130257212|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
130257213|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
130257214|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
130257215|NCT00086515|468906596|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
130257216|NCT00086515|468906597|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
130257217|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
130257218|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
130257219|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
130257220|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
130257221|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
130033060|NCT00868790|468076981|FG002|Post-study|Excluded Medication|0|||
130033061|NCT00868790|468076982|FG003|Post-study|Excluded Medication|0|||
130033062|NCT00868790|468076983|FG004|Post-study|Excluded Medication|0|||
130033063|NCT00868790|468076984|FG005|Post-study|Excluded Medication|0|||
130257222|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
130257223|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
130257224|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
130257225|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
130257226|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
130257227|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
130257228|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
130033064|NCT00868790|468076985|FG006|Post-study|Excluded Medication|0|||
130257229|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
130257230|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
130257231|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
130257232|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
130257233|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
130257234|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
130257235|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
130257236|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
130257237|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
130257238|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
130257239|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
130257240|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
130257241|NCT00086515|468906596|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
130257242|NCT00086515|468906597|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
130257243|NCT02106832|468906598|FG000|Overall Study|Adverse Event|1|||
130257244|NCT02106832|468906599|FG001|Overall Study|Adverse Event|2|||
130257245|NCT02106832|468906600|FG002|Overall Study|Adverse Event|3|||
130257246|NCT02106832|468906601|FG003|Overall Study|Adverse Event|0|||
130257247|NCT02106832|468906598|FG000|Overall Study|Death|4|||
130257248|NCT02106832|468906599|FG001|Overall Study|Death|4|||
130257249|NCT02106832|468906600|FG002|Overall Study|Death|1|||
130257250|NCT02106832|468906601|FG003|Overall Study|Death|4|||
130257251|NCT02106832|468906598|FG000|Overall Study|Deterioration of general conditions|0|||
130033065|NCT00868790|468076986|FG007|Post-study|Excluded Medication|2|||
130033066|NCT00868790|468076987|FG008|Post-study|Excluded Medication|0|||
130033067|NCT00868790|468076988|FG009|Post-study|Excluded Medication|1|||
130033068|NCT00868790|468076989|FG010|Post-study|Excluded Medication|0|||
130033069|NCT00868790|468076990|FG011|Post-study|Excluded Medication|0|||
130033070|NCT00868790|468076991|FG012|Post-study|Excluded Medication|0|||
130101685|NCT01060007|468330733|FG000|Overall Study|Inevaluable for response at surgery|3|||
130101686|NCT05168657|468330734|FG000|Overall Study|Adverse Event|0|||
130257252|NCT02106832|468906599|FG001|Overall Study|Deterioration of general conditions|0|||
130033071|NCT00868790|468076992|FG013|Post-study|Excluded Medication|0|||
130033072|NCT03377634|468076996|FG000|Study Period|Adverse Event|1|||
130101687|NCT05168657|468330735|FG001|Overall Study|Adverse Event|0|||
130257253|NCT02106832|468906600|FG002|Overall Study|Deterioration of general conditions|1|||
130257254|NCT02106832|468906601|FG003|Overall Study|Deterioration of general conditions|0|||
130257255|NCT02106832|468906598|FG000|Overall Study|Lost to Follow-up|0|||
130257256|NCT02106832|468906599|FG001|Overall Study|Lost to Follow-up|1|||
130033073|NCT03377634|468076997|FG001|Study Period|Adverse Event|0|||
130033074|NCT03377634|468076996|FG000|Study Period|Withdrawal by Subject|1|||
130033075|NCT03377634|468076997|FG001|Study Period|Withdrawal by Subject|0|||
130257257|NCT02106832|468906600|FG002|Overall Study|Lost to Follow-up|1|||
130257258|NCT02106832|468906601|FG003|Overall Study|Lost to Follow-up|3|||
130257259|NCT02106832|468906598|FG000|Overall Study|Physician Decision|1|||
130257260|NCT02106832|468906599|FG001|Overall Study|Physician Decision|0|||
130257261|NCT02106832|468906600|FG002|Overall Study|Physician Decision|0|||
130257262|NCT02106832|468906601|FG003|Overall Study|Physician Decision|0|||
130257263|NCT02106832|468906598|FG000|Overall Study|Protocol Violation|0|||
130257264|NCT02106832|468906599|FG001|Overall Study|Protocol Violation|0|||
130257265|NCT02106832|468906600|FG002|Overall Study|Protocol Violation|0|||
130257266|NCT02106832|468906601|FG003|Overall Study|Protocol Violation|1|||
130257267|NCT02106832|468906598|FG000|Overall Study|Withdrawal by Subject|17|||
130257268|NCT02106832|468906599|FG001|Overall Study|Withdrawal by Subject|17|||
130257269|NCT02106832|468906600|FG002|Overall Study|Withdrawal by Subject|10|||
130257270|NCT02106832|468906601|FG003|Overall Study|Withdrawal by Subject|7|||
130257271|NCT02106832|468906598|FG000|Overall Study|Technical problems|0|||
130257272|NCT02106832|468906599|FG001|Overall Study|Technical problems|1|||
130257273|NCT02106832|468906600|FG002|Overall Study|Technical problems|0|||
130257274|NCT02106832|468906601|FG003|Overall Study|Technical problems|0|||
130257275|NCT00265122|468906602|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130257276|NCT00265122|468906603|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130257277|NCT00265122|468906604|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
130257278|NCT00265122|468906605|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
130257279|NCT00265122|468906606|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
130257280|NCT00265122|468906607|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
130257281|NCT00265122|468906602|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
130257282|NCT00265122|468906603|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257283|NCT00265122|468906604|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257284|NCT00265122|468906605|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
130033076|NCT00977470|468076998|FG000|Overall Study|Lack of Efficacy|32|||
130033077|NCT00977470|468076999|FG001|Overall Study|Lack of Efficacy|30|||
130257285|NCT00265122|468906606|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257286|NCT00265122|468906607|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
130257287|NCT00265122|468906602|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130257288|NCT00265122|468906603|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
130257289|NCT00265122|468906604|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
130257290|NCT00265122|468906605|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
130257291|NCT00265122|468906606|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130257292|NCT00265122|468906607|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
130257293|NCT00265122|468906602|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
130257294|NCT00265122|468906603|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
130257295|NCT00265122|468906604|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
130257296|NCT00265122|468906605|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
130257297|NCT00265122|468906606|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
130257298|NCT00265122|468906607|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
130257299|NCT00265122|468906602|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
130257300|NCT00265122|468906603|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
130257301|NCT00265122|468906604|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
130257302|NCT00265122|468906605|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
130257303|NCT00265122|468906606|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
130257304|NCT00265122|468906607|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
130257305|NCT00265122|468906602|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
130257306|NCT00265122|468906603|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130257307|NCT00265122|468906604|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
130257308|NCT00265122|468906605|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
130257309|NCT00265122|468906606|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130257310|NCT00265122|468906607|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
130257311|NCT05205616|468906614|FG000|Overall Study|Lost to Follow-up|4|||
130257312|NCT05205616|468906615|FG001|Overall Study|Lost to Follow-up|4|||
130257313|NCT00663260|468906624|FG000|Overall Study|Lack of Efficacy|2|||
130257314|NCT00663260|468906625|FG001|Overall Study|Lack of Efficacy|0|||
130257315|NCT00663260|468906626|FG002|Overall Study|Lack of Efficacy|0|||
130257316|NCT00663260|468906624|FG000|Overall Study|Adverse Event|12|||
130257317|NCT00663260|468906625|FG001|Overall Study|Adverse Event|7|||
130033078|NCT00977470|468076998|FG000|Overall Study|Physician Decision|2|||
130257318|NCT00663260|468906626|FG002|Overall Study|Adverse Event|6|||
130257319|NCT00663260|468906624|FG000|Overall Study|Withdrawal by Subject|3|||
130257320|NCT00663260|468906625|FG001|Overall Study|Withdrawal by Subject|1|||
130257321|NCT00663260|468906626|FG002|Overall Study|Withdrawal by Subject|6|||
130257322|NCT00663260|468906624|FG000|Overall Study|Death|1|||
130257323|NCT00663260|468906625|FG001|Overall Study|Death|0|||
130257324|NCT00663260|468906626|FG002|Overall Study|Death|1|||
130257325|NCT00663260|468906624|FG000|Overall Study|Lost to Follow-up|0|||
130257326|NCT00663260|468906625|FG001|Overall Study|Lost to Follow-up|1|||
130257327|NCT00663260|468906626|FG002|Overall Study|Lost to Follow-up|0|||
130257328|NCT00663260|468906624|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
130257329|NCT00663260|468906625|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
130257330|NCT00663260|468906626|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
130257331|NCT02231580|468906635|FG000|Overall Study|Adverse Event|5|||
130257332|NCT02231580|468906636|FG001|Overall Study|Adverse Event|0|||
130257333|NCT03620981|468906637|FG000|Overall Study|Adverse Event|14|||
130257334|NCT03620981|468906638|FG001|Overall Study|Adverse Event|38|||
130257335|NCT03620981|468906639|FG002|Overall Study|Adverse Event|25|||
130257336|NCT03620981|468906637|FG000|Overall Study|Lack of Efficacy|2|||
130257337|NCT03620981|468906638|FG001|Overall Study|Lack of Efficacy|1|||
130257338|NCT03620981|468906639|FG002|Overall Study|Lack of Efficacy|1|||
130257339|NCT03620981|468906637|FG000|Overall Study|Physician Decision|7|||
130257340|NCT03620981|468906638|FG001|Overall Study|Physician Decision|4|||
130257341|NCT03620981|468906639|FG002|Overall Study|Physician Decision|4|||
130257342|NCT03620981|468906637|FG000|Overall Study|Protocol Violation|1|||
130257343|NCT03620981|468906638|FG001|Overall Study|Protocol Violation|2|||
130257344|NCT03620981|468906639|FG002|Overall Study|Protocol Violation|1|||
130257345|NCT03620981|468906637|FG000|Overall Study|Withdrawal by Legal Representative|2|||
130257346|NCT03620981|468906638|FG001|Overall Study|Withdrawal by Legal Representative|1|||
130257347|NCT03620981|468906639|FG002|Overall Study|Withdrawal by Legal Representative|1|||
130257348|NCT03620981|468906637|FG000|Overall Study|Withdrawal by Care Giver|2|||
130257349|NCT03620981|468906638|FG001|Overall Study|Withdrawal by Care Giver|0|||
130257350|NCT03620981|468906639|FG002|Overall Study|Withdrawal by Care Giver|1|||
130257351|NCT03620981|468906637|FG000|Overall Study|Non-compliance with Study Drug|1|||
130257352|NCT03620981|468906638|FG001|Overall Study|Non-compliance with Study Drug|1|||
130257353|NCT03620981|468906639|FG002|Overall Study|Non-compliance with Study Drug|0|||
130257354|NCT02607722|468906642|FG000|Overall Study|No data reliability|1|||
130257355|NCT02607722|468906642|FG000|Overall Study|no patient visit|18|||
130257356|NCT02607722|468906642|FG000|Overall Study|missing info in CRF|13|||
130257357|NCT02607722|468906642|FG000|Overall Study|Withdrawal by Subject|616|||
130257358|NCT02607722|468906642|FG000|Overall Study|Lost to Follow-up|312|||
130257359|NCT02607722|468906642|FG000|Overall Study|Improved|22|||
130257360|NCT02607722|468906642|FG000|Overall Study|Lack of Efficacy|316|||
130257361|NCT02607722|468906642|FG000|Overall Study|Adverse Event|2553|||
130257362|NCT02607722|468906642|FG000|Overall Study|Not treated|1|||
130257363|NCT02607722|468906642|FG000|Overall Study|No CRF collected|138|||
130257364|NCT02607722|468906642|FG000|Overall Study|without CRF|4225|||
130257365|NCT02607722|468906642|FG000|Overall Study|Physician Decision|367|||
130257366|NCT04347538|468906643|FG000|Overall Study|Lost to Follow-up|4|||
130257367|NCT04347538|468906644|FG001|Overall Study|Lost to Follow-up|5|||
130257368|NCT04347538|468906645|FG002|Overall Study|Lost to Follow-up|7|||
130033079|NCT00977470|468076999|FG001|Overall Study|Physician Decision|0|||
130033080|NCT00977470|468076998|FG000|Overall Study|Adverse Event|1|||
130033081|NCT00977470|468076999|FG001|Overall Study|Adverse Event|2|||
130033082|NCT00977470|468076998|FG000|Overall Study|Protocol Violation|1|||
130033083|NCT00977470|468076999|FG001|Overall Study|Protocol Violation|0|||
130033084|NCT00977470|468076998|FG000|Overall Study|Withdrawal by Subject|0|||
130033085|NCT00977470|468076999|FG001|Overall Study|Withdrawal by Subject|2|||
130033086|NCT00977470|468076998|FG000|Overall Study|Death|0|||
130033087|NCT00977470|468076999|FG001|Overall Study|Death|2|||
130033088|NCT00977470|468076998|FG000|Overall Study|clinical decline|0|||
130033089|NCT00977470|468076999|FG001|Overall Study|clinical decline|1|||
130257369|NCT02135133|468906646|FG000|Overall Study|Adverse Event|10|||
130257370|NCT02135133|468906646|FG000|Overall Study|regulatory mandate|5|||
130257371|NCT03238196|468906647|FG000|Overall Study|Adverse Event|3|||
130257372|NCT03238196|468906648|FG001|Overall Study|Adverse Event|0|||
130257373|NCT03238196|468906649|FG002|Overall Study|Adverse Event|2|||
130257374|NCT03238196|468906650|FG003|Overall Study|Adverse Event|2|||
130257375|NCT03238196|468906647|FG000|Overall Study|Withdrawal by Subject|4|||
130257376|NCT03238196|468906648|FG001|Overall Study|Withdrawal by Subject|1|||
130257377|NCT03238196|468906649|FG002|Overall Study|Withdrawal by Subject|1|||
130257378|NCT03238196|468906650|FG003|Overall Study|Withdrawal by Subject|0|||
130033090|NCT00977470|468076998|FG000|Overall Study|prolonged recovery post-surgery|0|||
130257379|NCT03238196|468906647|FG000|Overall Study|Disease progression|14|||
130257380|NCT03238196|468906648|FG001|Overall Study|Disease progression|2|||
130257381|NCT03238196|468906649|FG002|Overall Study|Disease progression|3|||
130257382|NCT03238196|468906650|FG003|Overall Study|Disease progression|2|||
130257383|NCT03238196|468906647|FG000|Overall Study|Still on treatment|1|||
130257384|NCT03238196|468906648|FG001|Overall Study|Still on treatment|0|||
130257385|NCT03238196|468906649|FG002|Overall Study|Still on treatment|0|||
130257386|NCT03238196|468906650|FG003|Overall Study|Still on treatment|0|||
130257387|NCT05081843|468906651|FG000|Overall Study|Lost to Follow-up|135|||
130257388|NCT05081843|468906652|FG001|Overall Study|Lost to Follow-up|145|||
130257389|NCT02303821|468906653|FG000|Overall Study|Withdrawal by Subject|0|||
129885413|NCT02471404|467540712|FG001|Overall Study|Lost to Follow-up|1|||
129885414|NCT02471404|467540713|FG002|Overall Study|Lost to Follow-up|3|||
129885415|NCT02471404|467540711|FG000|Overall Study|Protocol Violation|1|||
129885416|NCT02471404|467540712|FG001|Overall Study|Protocol Violation|0|||
130257390|NCT02303821|468906654|FG001|Overall Study|Withdrawal by Subject|0|||
130257391|NCT02303821|468906655|FG002|Overall Study|Withdrawal by Subject|0|||
130257392|NCT02303821|468906656|FG003|Overall Study|Withdrawal by Subject|0|||
129885417|NCT02471404|467540713|FG002|Overall Study|Protocol Violation|0|||
129885418|NCT02471404|467540711|FG000|Overall Study|Withdrawal by Subject|8|||
129885419|NCT02471404|467540712|FG001|Overall Study|Withdrawal by Subject|4|||
129885420|NCT02471404|467540713|FG002|Overall Study|Withdrawal by Subject|5|||
129885421|NCT02471404|467540711|FG000|Overall Study|Other reasons not specified|10|||
129885422|NCT02471404|467540712|FG001|Overall Study|Other reasons not specified|7|||
129885423|NCT02471404|467540713|FG002|Overall Study|Other reasons not specified|12|||
129885424|NCT00065468|467540716|FG000|Overall Study|Death|172|||
129885425|NCT00065468|467540717|FG001|Overall Study|Death|169|||
129885426|NCT00065468|467540718|FG002|Overall Study|Death|171|||
129885427|NCT00065468|467540716|FG000|Overall Study|Withdrawal by Subject|3|||
129885428|NCT00065468|467540717|FG001|Overall Study|Withdrawal by Subject|4|||
129885429|NCT00065468|467540718|FG002|Overall Study|Withdrawal by Subject|5|||
129885430|NCT00065468|467540716|FG000|Overall Study|Lost to Follow-up|5|||
129885431|NCT00065468|467540717|FG001|Overall Study|Lost to Follow-up|3|||
129885432|NCT00065468|467540718|FG002|Overall Study|Lost to Follow-up|2|||
129885433|NCT00065468|467540716|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
130033091|NCT00977470|468076999|FG001|Overall Study|prolonged recovery post-surgery|1|||
130033092|NCT00977470|468076998|FG000|Overall Study|Still on-study|2|||
130033093|NCT00977470|468076999|FG001|Overall Study|Still on-study|0|||
130033094|NCT00737529|468077003|FG000|Overall Study|Disease Progression|95|||
130033095|NCT00737529|468077003|FG000|Overall Study|Adverse Event|24|||
130033096|NCT00737529|468077003|FG000|Overall Study|Withdrawal by Subject|5|||
130033097|NCT00737529|468077003|FG000|Overall Study|Death|4|||
130033098|NCT00737529|468077003|FG000|Overall Study|Protocol Violation|1|||
130033099|NCT00737529|468077003|FG000|Overall Study|Other|4|||
130033100|NCT03040024|468077004|FG000|Overall Study|Adverse Event|0|||
130033101|NCT03040024|468077005|FG001|Overall Study|Adverse Event|1|||
130033102|NCT03040024|468077006|FG002|Overall Study|Adverse Event|0|||
130033103|NCT03040024|468077004|FG000|Overall Study|Death|0|||
130033104|NCT03040024|468077005|FG001|Overall Study|Death|1|||
130033105|NCT03040024|468077006|FG002|Overall Study|Death|0|||
130033106|NCT03040024|468077004|FG000|Overall Study|Physician Decision|0|||
130033107|NCT03040024|468077005|FG001|Overall Study|Physician Decision|0|||
130033108|NCT03040024|468077006|FG002|Overall Study|Physician Decision|1|||
130033109|NCT01526148|468077014|FG000|Overall Study|Adverse Event|6|||
130033110|NCT01526148|468077015|FG001|Overall Study|Adverse Event|5|||
130033111|NCT01526148|468077014|FG000|Overall Study|Lost to Follow-up|3|||
130033112|NCT01526148|468077015|FG001|Overall Study|Lost to Follow-up|6|||
130033113|NCT01526148|468077014|FG000|Overall Study|Withdrawal by Subject|2|||
130033114|NCT01526148|468077015|FG001|Overall Study|Withdrawal by Subject|0|||
130033115|NCT01526148|468077014|FG000|Overall Study|Unstable Medical Condition|1|||
130033116|NCT01526148|468077015|FG001|Overall Study|Unstable Medical Condition|0|||
130033117|NCT01526148|468077014|FG000|Overall Study|Unable to discontinue concomitant med|1|||
130033118|NCT01526148|468077015|FG001|Overall Study|Unable to discontinue concomitant med|0|||
130033119|NCT01526148|468077014|FG000|Overall Study|Moved out of state|1|||
130033120|NCT01526148|468077015|FG001|Overall Study|Moved out of state|0|||
130033121|NCT01526148|468077014|FG000|Overall Study|Incarcerated|0|||
130033122|NCT01526148|468077015|FG001|Overall Study|Incarcerated|2|||
130033123|NCT01173653|468077016|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
130033124|NCT01173653|468077017|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
130033125|NCT01818297|468077018|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
130101688|NCT05168657|468330736|FG002|Overall Study|Adverse Event|1|||
130257393|NCT02303821|468906657|FG004|Overall Study|Withdrawal by Subject|0|||
130257394|NCT02303821|468906658|FG005|Overall Study|Withdrawal by Subject|0|||
129885434|NCT00065468|467540717|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
129885435|NCT00065468|467540718|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
130033126|NCT01818297|468077019|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
130033127|NCT01818297|468077018|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
130033128|NCT01818297|468077019|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
130033129|NCT01818297|468077018|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
130033130|NCT01818297|468077019|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
130101689|NCT05168657|468330737|FG003|Overall Study|Adverse Event|0|||
130257395|NCT02303821|468906659|FG006|Overall Study|Withdrawal by Subject|0|||
129885436|NCT00065468|467540716|FG000|Overall Study|Disease progression|0|||
129885437|NCT00065468|467540717|FG001|Overall Study|Disease progression|0|||
129885438|NCT00065468|467540718|FG002|Overall Study|Disease progression|1|||
129885439|NCT00065468|467540716|FG000|Overall Study|Other|14|||
130033131|NCT01651780|468077027|FG000|Overall Study|Physician decision: No 30-day visit|2|||
130033132|NCT01651780|468077028|FG001|Overall Study|Physician decision: No 30-day visit|1|||
130257396|NCT02303821|468906660|FG007|Overall Study|Withdrawal by Subject|2|||
130257397|NCT02303821|468906653|FG000|Overall Study|Death|0|||
130257398|NCT02303821|468906654|FG001|Overall Study|Death|2|||
130257399|NCT02303821|468906655|FG002|Overall Study|Death|0|||
130257400|NCT02303821|468906656|FG003|Overall Study|Death|0|||
130257401|NCT02303821|468906657|FG004|Overall Study|Death|0|||
130257402|NCT02303821|468906658|FG005|Overall Study|Death|3|||
130257403|NCT02303821|468906659|FG006|Overall Study|Death|41|||
129885440|NCT00065468|467540717|FG001|Overall Study|Other|24|||
129885441|NCT00065468|467540718|FG002|Overall Study|Other|18|||
129885442|NCT01225835|467540719|FG000|Overall Study|Completed protocol|2|||
129885443|NCT01225835|467540720|FG001|Overall Study|Completed protocol|1|||
130033133|NCT01651780|468077027|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
130033134|NCT01651780|468077028|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
130033135|NCT01651780|468077027|FG000|Overall Study|Withdrawal by Subject|2|||
130033136|NCT01651780|468077028|FG001|Overall Study|Withdrawal by Subject|0|||
130033137|NCT01651780|468077027|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
130033138|NCT01651780|468077028|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130033139|NCT01651780|468077027|FG000|Overall Study|Lost to Follow-up|1|||
130033140|NCT01651780|468077028|FG001|Overall Study|Lost to Follow-up|2|||
130033141|NCT01651780|468077027|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
130033142|NCT01651780|468077028|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
130033143|NCT01628926|468077029|FG000|Overall Study|Adverse Event|13|||
130033144|NCT01628926|468077030|FG001|Overall Study|Adverse Event|11|||
130033145|NCT01628926|468077031|FG002|Overall Study|Adverse Event|9|||
130033146|NCT01628926|468077029|FG000|Overall Study|Lack of Efficacy|2|||
130033147|NCT01628926|468077030|FG001|Overall Study|Lack of Efficacy|1|||
130033148|NCT01628926|468077031|FG002|Overall Study|Lack of Efficacy|5|||
130033149|NCT01628926|468077029|FG000|Overall Study|Withdrawal by Subject|6|||
130033150|NCT01628926|468077030|FG001|Overall Study|Withdrawal by Subject|4|||
130033151|NCT01628926|468077031|FG002|Overall Study|Withdrawal by Subject|2|||
130033152|NCT01628926|468077029|FG000|Overall Study|Protocol Violation|0|||
130033153|NCT01628926|468077030|FG001|Overall Study|Protocol Violation|1|||
130033154|NCT01628926|468077031|FG002|Overall Study|Protocol Violation|0|||
130033155|NCT01628926|468077029|FG000|Overall Study|Discontinuation criteria|3|||
130033156|NCT01628926|468077030|FG001|Overall Study|Discontinuation criteria|4|||
130033157|NCT01628926|468077031|FG002|Overall Study|Discontinuation criteria|0|||
130033158|NCT01628926|468077029|FG000|Overall Study|Physician Decision|2|||
130033159|NCT01628926|468077030|FG001|Overall Study|Physician Decision|2|||
130033160|NCT01628926|468077031|FG002|Overall Study|Physician Decision|1|||
130033161|NCT03029832|468077032|FG000|Overall Study|Safety Follow-Up Completed|2|||
130033162|NCT03029832|468077033|FG001|Overall Study|Safety Follow-Up Completed|0|||
130033163|NCT03029832|468077032|FG000|Overall Study|Death due to Disease Progression|1|||
130033164|NCT03029832|468077033|FG001|Overall Study|Death due to Disease Progression|0|||
130033165|NCT03029832|468077032|FG000|Overall Study|Study Terminated By Sponsor|1|||
130033166|NCT03029832|468077033|FG001|Overall Study|Study Terminated By Sponsor|1|||
130033167|NCT01412229|468077034|FG000|Overall Study|Physician Decision|1|||
130033168|NCT00151892|468077041|FG000|Overall Study|Lack of Efficacy|50|||
130033169|NCT00151892|468077042|FG001|Overall Study|Lack of Efficacy|57|||
130033170|NCT00151892|468077041|FG000|Overall Study|Patient request|10|||
130033171|NCT00151892|468077042|FG001|Overall Study|Patient request|7|||
130033172|NCT00151892|468077041|FG000|Overall Study|Lost to Follow-up|5|||
130033173|NCT00151892|468077042|FG001|Overall Study|Lost to Follow-up|10|||
130033174|NCT00151892|468077041|FG000|Overall Study|Adverse Event|6|||
130033175|NCT00151892|468077042|FG001|Overall Study|Adverse Event|3|||
130033176|NCT00151892|468077041|FG000|Overall Study|Protocol Violation|3|||
130033177|NCT00151892|468077042|FG001|Overall Study|Protocol Violation|3|||
130033178|NCT00151892|468077041|FG000|Overall Study|Non-compliance|0|||
130033179|NCT00151892|468077042|FG001|Overall Study|Non-compliance|1|||
130033180|NCT00151892|468077041|FG000|Overall Study|Pregnancy|0|||
130033181|NCT00151892|468077042|FG001|Overall Study|Pregnancy|1|||
130033182|NCT00151892|468077041|FG000|Overall Study|Did not return for a visit|1|||
130033183|NCT00151892|468077042|FG001|Overall Study|Did not return for a visit|0|||
130033184|NCT00151892|468077041|FG000|Overall Study|Used prohibited corticosteroids|1|||
130033185|NCT00151892|468077042|FG001|Overall Study|Used prohibited corticosteroids|0|||
130033186|NCT00151892|468077041|FG000|Overall Study|Lack of study medication at center|0|||
130033187|NCT00151892|468077042|FG001|Overall Study|Lack of study medication at center|1|||
130033188|NCT02901431|468077043|FG000|PK Part|Adverse Event|0|||
130033189|NCT02901431|468077044|FG001|PK Part|Adverse Event|1|||
130033190|NCT02901431|468077045|FG002|PK Part|Adverse Event|0|||
130033191|NCT02901431|468077046|FG003|PK Part|Adverse Event|0|||
130033192|NCT02901431|468077047|FG004|PK Part|Adverse Event|0|||
130033193|NCT02901431|468077048|FG005|PK Part|Adverse Event|0|||
130033194|NCT02901431|468077049|FG006|PK Part|Adverse Event|0|||
130033195|NCT02901431|468077050|FG007|PK Part|Adverse Event|0|||
130033196|NCT02901431|468077051|FG008|PK Part|Adverse Event|0|||
130033197|NCT02901431|468077052|FG009|PK Part|Adverse Event|0|||
130257404|NCT02303821|468906660|FG007|Overall Study|Death|29|||
130257405|NCT02303821|468906653|FG000|Overall Study|Lost to Follow-up|0|||
130257406|NCT02303821|468906654|FG001|Overall Study|Lost to Follow-up|0|||
130257407|NCT02303821|468906655|FG002|Overall Study|Lost to Follow-up|0|||
130257408|NCT02303821|468906656|FG003|Overall Study|Lost to Follow-up|0|||
130257409|NCT02303821|468906657|FG004|Overall Study|Lost to Follow-up|0|||
130257410|NCT02303821|468906658|FG005|Overall Study|Lost to Follow-up|0|||
130257411|NCT02303821|468906659|FG006|Overall Study|Lost to Follow-up|1|||
130257412|NCT02303821|468906660|FG007|Overall Study|Lost to Follow-up|0|||
130257413|NCT02303821|468906653|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129885444|NCT01225835|467540719|FG000|Overall Study|Did not meet hCG criterion|2|||
129885445|NCT01225835|467540720|FG001|Overall Study|Did not meet hCG criterion|0|||
129885446|NCT01225835|467540719|FG000|Overall Study|Adverse Event|2|||
129885447|NCT01225835|467540720|FG001|Overall Study|Adverse Event|1|||
130257414|NCT02303821|468906654|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257415|NCT02303821|468906655|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257416|NCT02303821|468906656|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257417|NCT02303821|468906657|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257418|NCT02303821|468906658|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257419|NCT02303821|468906659|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
130257420|NCT02303821|468906660|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
130257421|NCT02303821|468906653|FG000|Overall Study|Decision by sponsor|0|||
129885448|NCT01225835|467540719|FG000|Overall Study|Other|1|||
129885449|NCT01225835|467540720|FG001|Overall Study|Other|1|||
129885450|NCT03285113|467540721|FG000|Overall Study|Unable to implant leads|2|||
129885451|NCT00849680|467540724|FG000|Overall Study|Adverse Event|0|||
130257422|NCT02303821|468906654|FG001|Overall Study|Decision by sponsor|0|||
130257423|NCT02303821|468906655|FG002|Overall Study|Decision by sponsor|0|||
130257424|NCT02303821|468906656|FG003|Overall Study|Decision by sponsor|0|||
130257425|NCT02303821|468906657|FG004|Overall Study|Decision by sponsor|0|||
130257426|NCT02303821|468906658|FG005|Overall Study|Decision by sponsor|1|||
130257427|NCT02303821|468906659|FG006|Overall Study|Decision by sponsor|0|||
130257428|NCT02303821|468906660|FG007|Overall Study|Decision by sponsor|0|||
130257429|NCT02303821|468906653|FG000|Overall Study|Protocol-specified criteria|0|||
130257430|NCT02303821|468906654|FG001|Overall Study|Protocol-specified criteria|1|||
130257431|NCT02303821|468906655|FG002|Overall Study|Protocol-specified criteria|0|||
130257432|NCT02303821|468906656|FG003|Overall Study|Protocol-specified criteria|0|||
130257433|NCT02303821|468906657|FG004|Overall Study|Protocol-specified criteria|0|||
130257434|NCT02303821|468906658|FG005|Overall Study|Protocol-specified criteria|1|||
130257435|NCT02303821|468906659|FG006|Overall Study|Protocol-specified criteria|0|||
130257436|NCT02303821|468906660|FG007|Overall Study|Protocol-specified criteria|0|||
130033198|NCT02901431|468077053|FG010|PK Part|Adverse Event|0|||
130033199|NCT02901431|468077054|FG011|PK Part|Adverse Event|0|||
130033200|NCT02901431|468077055|FG012|PK Part|Adverse Event|0|||
130033201|NCT02901431|468077043|FG000|PK Part|Lost to Follow-up|0|||
130033202|NCT02901431|468077044|FG001|PK Part|Lost to Follow-up|0|||
130257437|NCT04938427|468906663|FG000|Overall Study|Adverse Event|5|||
130257438|NCT04938427|468906664|FG001|Overall Study|Adverse Event|19|||
130257439|NCT04938427|468906663|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130257440|NCT04938427|468906664|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130257441|NCT04938427|468906663|FG000|Overall Study|Withdrawal by Subject|1|||
130257442|NCT04938427|468906664|FG001|Overall Study|Withdrawal by Subject|0|||
130257443|NCT04938427|468906663|FG000|Overall Study|Reason Not Specified|2|||
130257444|NCT04938427|468906664|FG001|Overall Study|Reason Not Specified|1|||
130257445|NCT05852340|468906673|FG000|Period 5|Not completing the meal|0|||
130257446|NCT05852340|468906674|FG001|Period 5|Not completing the meal|1|||
130033203|NCT02901431|468077045|FG002|PK Part|Lost to Follow-up|1|||
130033204|NCT02901431|468077046|FG003|PK Part|Lost to Follow-up|0|||
130033205|NCT02901431|468077047|FG004|PK Part|Lost to Follow-up|0|||
130033206|NCT02901431|468077048|FG005|PK Part|Lost to Follow-up|0|||
130033207|NCT02901431|468077049|FG006|PK Part|Lost to Follow-up|0|||
130033208|NCT02901431|468077050|FG007|PK Part|Lost to Follow-up|0|||
130257447|NCT05852340|468906675|FG002|Period 5|Not completing the meal|0|||
130257448|NCT05852340|468906676|FG003|Period 5|Not completing the meal|0|||
130033209|NCT02901431|468077051|FG008|PK Part|Lost to Follow-up|0|||
130257449|NCT05852340|468906673|FG000|Period 5|Adverse Event|0|||
129885452|NCT00849680|467540725|FG001|Overall Study|Adverse Event|0|||
129885453|NCT00849680|467540726|FG002|Overall Study|Adverse Event|0|||
130033210|NCT02901431|468077052|FG009|PK Part|Lost to Follow-up|0|||
130033211|NCT02901431|468077053|FG010|PK Part|Lost to Follow-up|0|||
130033212|NCT02901431|468077054|FG011|PK Part|Lost to Follow-up|0|||
130257450|NCT05852340|468906674|FG001|Period 5|Adverse Event|0|||
130257451|NCT05852340|468906675|FG002|Period 5|Adverse Event|0|||
130257452|NCT05852340|468906676|FG003|Period 5|Adverse Event|1|||
129885454|NCT00849680|467540727|FG003|Overall Study|Adverse Event|0|||
130033213|NCT02901431|468077055|FG012|PK Part|Lost to Follow-up|0|||
130033214|NCT02901431|468077043|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
130257453|NCT05852470|468906677|FG000|Overall Study|Withdrawal by Subject|0|||
130257454|NCT05852470|468906678|FG001|Overall Study|Withdrawal by Subject|1|||
130257455|NCT01346592|468906684|FG000|Overall Study|Lost to Follow-up|62|||
130257456|NCT01346592|468906685|FG001|Overall Study|Lost to Follow-up|29|||
130257457|NCT01346592|468906686|FG002|Overall Study|Lost to Follow-up|29|||
130257458|NCT01346592|468906684|FG000|Overall Study|Protocol Violation|2|||
130257459|NCT01346592|468906685|FG001|Overall Study|Protocol Violation|1|||
130033215|NCT02901431|468077044|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033216|NCT02901431|468077045|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033217|NCT02901431|468077046|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033218|NCT02901431|468077047|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033219|NCT02901431|468077048|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033220|NCT02901431|468077049|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033221|NCT02901431|468077050|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033222|NCT02901431|468077051|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033223|NCT02901431|468077052|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033224|NCT02901431|468077053|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033225|NCT02901431|468077054|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033226|NCT02901431|468077055|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
130033227|NCT02901431|468077043|FG000|PK Part|Pending dose confirmation|0|||
130033228|NCT02901431|468077044|FG001|PK Part|Pending dose confirmation|1|||
130033229|NCT02901431|468077045|FG002|PK Part|Pending dose confirmation|0|||
130033230|NCT02901431|468077046|FG003|PK Part|Pending dose confirmation|0|||
130033231|NCT02901431|468077047|FG004|PK Part|Pending dose confirmation|0|||
130033232|NCT02901431|468077048|FG005|PK Part|Pending dose confirmation|0|||
130033233|NCT02901431|468077049|FG006|PK Part|Pending dose confirmation|0|||
130033234|NCT02901431|468077050|FG007|PK Part|Pending dose confirmation|0|||
130033235|NCT02901431|468077051|FG008|PK Part|Pending dose confirmation|0|||
130033236|NCT02901431|468077052|FG009|PK Part|Pending dose confirmation|0|||
130033237|NCT02901431|468077053|FG010|PK Part|Pending dose confirmation|0|||
130033238|NCT02901431|468077054|FG011|PK Part|Pending dose confirmation|0|||
130033239|NCT02901431|468077055|FG012|PK Part|Pending dose confirmation|0|||
130033240|NCT02901431|468077043|FG000|PK Part|8 weeks of treatment ran out|2|||
130033241|NCT02901431|468077044|FG001|PK Part|8 weeks of treatment ran out|0|||
130033242|NCT02901431|468077045|FG002|PK Part|8 weeks of treatment ran out|0|||
130033243|NCT02901431|468077046|FG003|PK Part|8 weeks of treatment ran out|0|||
130033244|NCT02901431|468077047|FG004|PK Part|8 weeks of treatment ran out|0|||
130033245|NCT02901431|468077048|FG005|PK Part|8 weeks of treatment ran out|0|||
130033246|NCT02901431|468077049|FG006|PK Part|8 weeks of treatment ran out|0|||
130033247|NCT02901431|468077050|FG007|PK Part|8 weeks of treatment ran out|0|||
130033248|NCT02901431|468077051|FG008|PK Part|8 weeks of treatment ran out|0|||
130033249|NCT02901431|468077052|FG009|PK Part|8 weeks of treatment ran out|0|||
130033250|NCT02901431|468077053|FG010|PK Part|8 weeks of treatment ran out|0|||
130033251|NCT02901431|468077054|FG011|PK Part|8 weeks of treatment ran out|0|||
130033252|NCT02901431|468077055|FG012|PK Part|8 weeks of treatment ran out|0|||
130033253|NCT02901431|468077043|FG000|PK Part|Stopped treatment after 8 weeks|1|||
130033254|NCT02901431|468077044|FG001|PK Part|Stopped treatment after 8 weeks|0|||
130033255|NCT02901431|468077045|FG002|PK Part|Stopped treatment after 8 weeks|1|||
130033256|NCT02901431|468077046|FG003|PK Part|Stopped treatment after 8 weeks|0|||
130033257|NCT02901431|468077047|FG004|PK Part|Stopped treatment after 8 weeks|0|||
130033258|NCT02901431|468077048|FG005|PK Part|Stopped treatment after 8 weeks|0|||
130033259|NCT02901431|468077049|FG006|PK Part|Stopped treatment after 8 weeks|0|||
130033260|NCT02901431|468077050|FG007|PK Part|Stopped treatment after 8 weeks|0|||
130033261|NCT02901431|468077051|FG008|PK Part|Stopped treatment after 8 weeks|0|||
130033262|NCT02901431|468077052|FG009|PK Part|Stopped treatment after 8 weeks|0|||
130033263|NCT02901431|468077053|FG010|PK Part|Stopped treatment after 8 weeks|0|||
130033264|NCT02901431|468077054|FG011|PK Part|Stopped treatment after 8 weeks|0|||
130033265|NCT02901431|468077055|FG012|PK Part|Stopped treatment after 8 weeks|0|||
130033266|NCT02901431|468077043|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
130033267|NCT02901431|468077044|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033268|NCT02901431|468077045|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
130033269|NCT02901431|468077046|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033270|NCT02901431|468077047|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033271|NCT02901431|468077048|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130257460|NCT01346592|468906686|FG002|Overall Study|Protocol Violation|0|||
130257461|NCT01346592|468906684|FG000|Overall Study|Death|1|||
130033272|NCT02901431|468077049|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033273|NCT02901431|468077050|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033274|NCT02901431|468077051|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033275|NCT02901431|468077052|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033276|NCT02901431|468077053|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033277|NCT02901431|468077054|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033278|NCT02901431|468077055|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
130033279|NCT02901431|468077043|FG000|PK Part|Discontinued per Sponsor|0|||
130033280|NCT02901431|468077044|FG001|PK Part|Discontinued per Sponsor|3|||
130257462|NCT01346592|468906685|FG001|Overall Study|Death|3|||
130257463|NCT01346592|468906686|FG002|Overall Study|Death|4|||
130101690|NCT05168657|468330738|FG004|Overall Study|Adverse Event|0|||
130101691|NCT05168657|468330739|FG005|Overall Study|Adverse Event|0|||
130101692|NCT05168657|468330740|FG006|Overall Study|Adverse Event|0|||
130101693|NCT05168657|468330741|FG007|Overall Study|Adverse Event|0|||
130101694|NCT04527549|468330742|FG000|Overall Study|Withdrawal by Subject|1|||
130101695|NCT04527549|468330743|FG001|Overall Study|Withdrawal by Subject|1|||
130101696|NCT02325739|468330748|FG000|Phase I Part|Adverse Event|1|||
130101697|NCT02325739|468330749|FG001|Phase I Part|Adverse Event|0|||
130101698|NCT02325739|468330750|FG002|Phase I Part|Adverse Event|1|||
130101699|NCT02325739|468330751|FG003|Phase I Part|Adverse Event|2|||
130101700|NCT02325739|468330752|FG004|Phase I Part|Adverse Event|3|||
130101701|NCT02325739|468330753|FG005|Phase I Part|Adverse Event|1|||
130101702|NCT02325739|468330754|FG006|Phase I Part|Adverse Event|0|||
130101703|NCT02325739|468330755|FG007|Phase I Part|Adverse Event|2|||
130101704|NCT02325739|468330756|FG008|Phase I Part|Adverse Event|0|||
130257464|NCT01346592|468906684|FG000|Overall Study|Adverse Event|0|||
130257465|NCT01346592|468906685|FG001|Overall Study|Adverse Event|1|||
130257466|NCT01346592|468906686|FG002|Overall Study|Adverse Event|0|||
130257467|NCT01346592|468906684|FG000|Overall Study|Withdrawal by Subject|77|||
130257468|NCT01346592|468906685|FG001|Overall Study|Withdrawal by Subject|51|||
130257469|NCT01346592|468906686|FG002|Overall Study|Withdrawal by Subject|38|||
130257470|NCT01346592|468906684|FG000|Overall Study|Inappropriate enrollment|3|||
130257471|NCT01346592|468906685|FG001|Overall Study|Inappropriate enrollment|1|||
130257472|NCT01346592|468906686|FG002|Overall Study|Inappropriate enrollment|1|||
130257473|NCT01346592|468906684|FG000|Overall Study|Administrative reason|1|||
130257474|NCT01346592|468906685|FG001|Overall Study|Administrative reason|0|||
130257475|NCT01346592|468906686|FG002|Overall Study|Administrative reason|0|||
130257476|NCT01346592|468906684|FG000|Overall Study|Unable to Classify|7|||
130257477|NCT01346592|468906685|FG001|Overall Study|Unable to Classify|3|||
130257478|NCT01346592|468906686|FG002|Overall Study|Unable to Classify|6|||
130257479|NCT02679274|468906687|FG000|Overall Study|Withdrawal by Subject|1|||
130257480|NCT02679274|468906688|FG001|Overall Study|Withdrawal by Subject|0|||
130257481|NCT02038036|468906691|FG000|Core Study|Adverse Event|7|||
130101705|NCT02325739|468330757|FG009|Phase I Part|Adverse Event|0|||
130101706|NCT02325739|468330758|FG010|Phase I Part|Adverse Event|0|||
130101707|NCT02325739|468330748|FG000|Phase I Part|Progressive disease|9|||
130101708|NCT02325739|468330749|FG001|Phase I Part|Progressive disease|6|||
130101709|NCT02325739|468330750|FG002|Phase I Part|Progressive disease|3|||
130101710|NCT02325739|468330751|FG003|Phase I Part|Progressive disease|23|||
130101711|NCT02325739|468330752|FG004|Phase I Part|Progressive disease|14|||
130101712|NCT02325739|468330753|FG005|Phase I Part|Progressive disease|6|||
130101713|NCT02325739|468330754|FG006|Phase I Part|Progressive disease|6|||
130101714|NCT02325739|468330755|FG007|Phase I Part|Progressive disease|3|||
130101715|NCT02325739|468330756|FG008|Phase I Part|Progressive disease|0|||
130101716|NCT02325739|468330757|FG009|Phase I Part|Progressive disease|0|||
130101717|NCT02325739|468330758|FG010|Phase I Part|Progressive disease|0|||
130101718|NCT02325739|468330748|FG000|Phase I Part|Subject/guardian decision|1|||
130257482|NCT02038036|468906692|FG001|Core Study|Adverse Event|7|||
130257483|NCT02038036|468906691|FG000|Core Study|Death|1|||
130257484|NCT02038036|468906692|FG001|Core Study|Death|1|||
130101719|NCT02325739|468330749|FG001|Phase I Part|Subject/guardian decision|0|||
130257485|NCT02038036|468906691|FG000|Core Study|Disease progression|2|||
130257486|NCT02038036|468906692|FG001|Core Study|Disease progression|2|||
130257487|NCT02038036|468906691|FG000|Core Study|Lost to Follow-up|0|||
130257488|NCT02038036|468906692|FG001|Core Study|Lost to Follow-up|1|||
130257489|NCT02038036|468906691|FG000|Core Study|Physician Decision|2|||
130257490|NCT02038036|468906692|FG001|Core Study|Physician Decision|1|||
130257491|NCT02038036|468906691|FG000|Core Study|Subject/guardian decision|0|||
130257492|NCT02038036|468906692|FG001|Core Study|Subject/guardian decision|1|||
130257493|NCT02038036|468906691|FG000|Core Study|Withdrawal by Subject|3|||
130257494|NCT02038036|468906692|FG001|Core Study|Withdrawal by Subject|1|||
130257495|NCT02038036|468906691|FG000|Crossover Period|Withdrawal by Subject|0|||
130257496|NCT02038036|468906692|FG001|Crossover Period|Withdrawal by Subject|3|||
130257497|NCT02038036|468906691|FG000|Crossover Period|Adverse Event|0|||
130257498|NCT02038036|468906692|FG001|Crossover Period|Adverse Event|9|||
130257499|NCT02038036|468906691|FG000|Crossover Period|Death|0|||
130257500|NCT02038036|468906692|FG001|Crossover Period|Death|2|||
130257501|NCT02038036|468906691|FG000|Crossover Period|Disease progression|0|||
130257502|NCT02038036|468906692|FG001|Crossover Period|Disease progression|3|||
130257503|NCT02038036|468906691|FG000|Crossover Period|Lost to Follow-up|0|||
130257504|NCT02038036|468906692|FG001|Crossover Period|Lost to Follow-up|1|||
130257505|NCT02038036|468906691|FG000|Crossover Period|Physician Decision|0|||
130257506|NCT02038036|468906692|FG001|Crossover Period|Physician Decision|2|||
130257507|NCT01972659|468906700|FG000|Overall Study|Protocol Violation|2|||
130257508|NCT01972659|468906701|FG001|Overall Study|Protocol Violation|2|||
130257509|NCT01972659|468906700|FG000|Overall Study|problems realted to acceleromyograph|2|||
130257510|NCT01972659|468906701|FG001|Overall Study|problems realted to acceleromyograph|1|||
130257511|NCT01397253|468908504|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
130257512|NCT01397253|468908505|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
130257513|NCT01892189|468908506|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130257514|NCT01892189|468908507|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
130257515|NCT01892189|468908508|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130257516|NCT01892189|468908509|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
130257517|NCT01892189|468908510|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
130257518|NCT01892189|468908511|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
130257519|NCT01892189|468908512|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
130257520|NCT01892189|468908513|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
130257521|NCT01892189|468908514|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
130257522|NCT01892189|468908506|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257523|NCT01892189|468908507|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257524|NCT01892189|468908508|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
130257525|NCT01892189|468908509|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130257526|NCT01892189|468908510|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257527|NCT01892189|468908511|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257528|NCT01892189|468908512|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130257529|NCT01892189|468908513|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130257530|NCT01892189|468908514|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130257531|NCT01892189|468908506|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257532|NCT01892189|468908507|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257533|NCT01892189|468908508|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257534|NCT01892189|468908509|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257535|NCT01892189|468908510|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130101720|NCT02325739|468330750|FG002|Phase I Part|Subject/guardian decision|1|||
130101721|NCT02325739|468330751|FG003|Phase I Part|Subject/guardian decision|1|||
130101722|NCT02325739|468330752|FG004|Phase I Part|Subject/guardian decision|0|||
130101723|NCT02325739|468330753|FG005|Phase I Part|Subject/guardian decision|0|||
130101724|NCT02325739|468330754|FG006|Phase I Part|Subject/guardian decision|0|||
130101725|NCT02325739|468330755|FG007|Phase I Part|Subject/guardian decision|1|||
130101726|NCT02325739|468330756|FG008|Phase I Part|Subject/guardian decision|0|||
130101727|NCT02325739|468330757|FG009|Phase I Part|Subject/guardian decision|0|||
130101728|NCT02325739|468330758|FG010|Phase I Part|Subject/guardian decision|0|||
130101729|NCT02325739|468330748|FG000|Phase I Part|Death|0|||
130101730|NCT02325739|468330749|FG001|Phase I Part|Death|0|||
130101731|NCT02325739|468330750|FG002|Phase I Part|Death|0|||
130101732|NCT02325739|468330751|FG003|Phase I Part|Death|0|||
130101733|NCT02325739|468330752|FG004|Phase I Part|Death|2|||
130101734|NCT02325739|468330753|FG005|Phase I Part|Death|0|||
130101735|NCT02325739|468330754|FG006|Phase I Part|Death|0|||
130101736|NCT02325739|468330755|FG007|Phase I Part|Death|0|||
130101737|NCT02325739|468330756|FG008|Phase I Part|Death|0|||
130101738|NCT02325739|468330757|FG009|Phase I Part|Death|0|||
130257536|NCT01892189|468908511|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
130101739|NCT02325739|468330758|FG010|Phase I Part|Death|0|||
130257537|NCT01892189|468908512|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130101740|NCT02325739|468330748|FG000|Phase II Part|Adverse Event|0|||
130101741|NCT02325739|468330749|FG001|Phase II Part|Adverse Event|0|||
130101742|NCT02325739|468330750|FG002|Phase II Part|Adverse Event|0|||
130257538|NCT01892189|468908513|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257539|NCT01892189|468908514|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
130257540|NCT03322566|468908522|FG000|Overall Study|Death|34|||
130257541|NCT03322566|468908523|FG001|Overall Study|Death|35|||
130033281|NCT02901431|468077045|FG002|PK Part|Discontinued per Sponsor|0|||
130033282|NCT02901431|468077046|FG003|PK Part|Discontinued per Sponsor|0|||
130033283|NCT02901431|468077047|FG004|PK Part|Discontinued per Sponsor|0|||
130033284|NCT02901431|468077048|FG005|PK Part|Discontinued per Sponsor|0|||
130033285|NCT02901431|468077049|FG006|PK Part|Discontinued per Sponsor|0|||
130033286|NCT02901431|468077050|FG007|PK Part|Discontinued per Sponsor|0|||
130033287|NCT02901431|468077051|FG008|PK Part|Discontinued per Sponsor|0|||
130033288|NCT02901431|468077052|FG009|PK Part|Discontinued per Sponsor|0|||
130033289|NCT02901431|468077053|FG010|PK Part|Discontinued per Sponsor|0|||
130033290|NCT02901431|468077054|FG011|PK Part|Discontinued per Sponsor|0|||
130033291|NCT02901431|468077055|FG012|PK Part|Discontinued per Sponsor|0|||
130033292|NCT02901431|468077043|FG000|PK Part|Withdrawal by Subject|1|||
130033293|NCT02901431|468077044|FG001|PK Part|Withdrawal by Subject|1|||
130033294|NCT02901431|468077045|FG002|PK Part|Withdrawal by Subject|3|||
130033295|NCT02901431|468077046|FG003|PK Part|Withdrawal by Subject|0|||
130033296|NCT02901431|468077047|FG004|PK Part|Withdrawal by Subject|0|||
130033297|NCT02901431|468077048|FG005|PK Part|Withdrawal by Subject|0|||
130033298|NCT02901431|468077049|FG006|PK Part|Withdrawal by Subject|0|||
130033299|NCT02901431|468077050|FG007|PK Part|Withdrawal by Subject|0|||
130033300|NCT02901431|468077051|FG008|PK Part|Withdrawal by Subject|0|||
130033301|NCT02901431|468077052|FG009|PK Part|Withdrawal by Subject|0|||
130033302|NCT02901431|468077053|FG010|PK Part|Withdrawal by Subject|0|||
130033303|NCT02901431|468077054|FG011|PK Part|Withdrawal by Subject|0|||
130033304|NCT02901431|468077055|FG012|PK Part|Withdrawal by Subject|0|||
130033305|NCT02901431|468077043|FG000|Main Treatment Part|Adverse Event|0|||
130033306|NCT02901431|468077044|FG001|Main Treatment Part|Adverse Event|0|||
130033307|NCT02901431|468077045|FG002|Main Treatment Part|Adverse Event|0|||
130033308|NCT02901431|468077046|FG003|Main Treatment Part|Adverse Event|3|||
130033309|NCT02901431|468077047|FG004|Main Treatment Part|Adverse Event|3|||
130033310|NCT02901431|468077048|FG005|Main Treatment Part|Adverse Event|4|||
130033311|NCT02901431|468077049|FG006|Main Treatment Part|Adverse Event|1|||
130033312|NCT02901431|468077050|FG007|Main Treatment Part|Adverse Event|0|||
130033313|NCT02901431|468077051|FG008|Main Treatment Part|Adverse Event|0|||
130033314|NCT02901431|468077052|FG009|Main Treatment Part|Adverse Event|0|||
130033315|NCT02901431|468077053|FG010|Main Treatment Part|Adverse Event|0|||
130033316|NCT02901431|468077054|FG011|Main Treatment Part|Adverse Event|0|||
130033317|NCT02901431|468077055|FG012|Main Treatment Part|Adverse Event|0|||
130033318|NCT02901431|468077043|FG000|Main Treatment Part|Lack of Efficacy|0|||
130033319|NCT02901431|468077044|FG001|Main Treatment Part|Lack of Efficacy|0|||
130033320|NCT02901431|468077045|FG002|Main Treatment Part|Lack of Efficacy|0|||
130033321|NCT02901431|468077046|FG003|Main Treatment Part|Lack of Efficacy|1|||
130033322|NCT02901431|468077047|FG004|Main Treatment Part|Lack of Efficacy|0|||
130033323|NCT02901431|468077048|FG005|Main Treatment Part|Lack of Efficacy|0|||
130033324|NCT02901431|468077049|FG006|Main Treatment Part|Lack of Efficacy|0|||
130033325|NCT02901431|468077050|FG007|Main Treatment Part|Lack of Efficacy|0|||
130033326|NCT02901431|468077051|FG008|Main Treatment Part|Lack of Efficacy|0|||
130033327|NCT02901431|468077052|FG009|Main Treatment Part|Lack of Efficacy|0|||
130033328|NCT02901431|468077053|FG010|Main Treatment Part|Lack of Efficacy|0|||
130033329|NCT02901431|468077054|FG011|Main Treatment Part|Lack of Efficacy|0|||
130033330|NCT02901431|468077055|FG012|Main Treatment Part|Lack of Efficacy|0|||
130033331|NCT02901431|468077043|FG000|Main Treatment Part|Lost to Follow-up|0|||
130033332|NCT02901431|468077044|FG001|Main Treatment Part|Lost to Follow-up|0|||
130033333|NCT02901431|468077045|FG002|Main Treatment Part|Lost to Follow-up|0|||
130033334|NCT02901431|468077046|FG003|Main Treatment Part|Lost to Follow-up|3|||
130033335|NCT02901431|468077047|FG004|Main Treatment Part|Lost to Follow-up|1|||
130033336|NCT02901431|468077048|FG005|Main Treatment Part|Lost to Follow-up|2|||
130033337|NCT02901431|468077049|FG006|Main Treatment Part|Lost to Follow-up|3|||
130033338|NCT02901431|468077050|FG007|Main Treatment Part|Lost to Follow-up|0|||
130033339|NCT02901431|468077051|FG008|Main Treatment Part|Lost to Follow-up|0|||
130033340|NCT02901431|468077052|FG009|Main Treatment Part|Lost to Follow-up|0|||
130033341|NCT02901431|468077053|FG010|Main Treatment Part|Lost to Follow-up|0|||
130033342|NCT02901431|468077054|FG011|Main Treatment Part|Lost to Follow-up|0|||
130033343|NCT02901431|468077055|FG012|Main Treatment Part|Lost to Follow-up|0|||
130033344|NCT02901431|468077043|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
130033345|NCT02901431|468077044|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
130033346|NCT02901431|468077045|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
130033347|NCT02901431|468077046|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
130033348|NCT02901431|468077047|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
130033349|NCT02901431|468077048|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
130101743|NCT02325739|468330751|FG003|Phase II Part|Adverse Event|0|||
130257542|NCT03322566|468908524|FG002|Overall Study|Death|23|||
130257543|NCT03322566|468908522|FG000|Overall Study|Physician Decision|6|||
130257544|NCT03322566|468908523|FG001|Overall Study|Physician Decision|7|||
130257545|NCT03322566|468908524|FG002|Overall Study|Physician Decision|2|||
130257546|NCT03322566|468908522|FG000|Overall Study|Withdrawal by Subject|4|||
130257547|NCT03322566|468908523|FG001|Overall Study|Withdrawal by Subject|3|||
130033350|NCT02901431|468077049|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
130033351|NCT02901431|468077050|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
130033352|NCT02901431|468077051|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
130033353|NCT02901431|468077052|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
130033354|NCT02901431|468077053|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
130033355|NCT02901431|468077054|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
130033356|NCT02901431|468077055|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
130033357|NCT02901431|468077043|FG000|Main Treatment Part|Physician Decision|0|||
130033358|NCT02901431|468077044|FG001|Main Treatment Part|Physician Decision|0|||
130033359|NCT02901431|468077045|FG002|Main Treatment Part|Physician Decision|0|||
130033360|NCT02901431|468077046|FG003|Main Treatment Part|Physician Decision|1|||
130033361|NCT02901431|468077047|FG004|Main Treatment Part|Physician Decision|0|||
130033362|NCT02901431|468077048|FG005|Main Treatment Part|Physician Decision|0|||
130033363|NCT02901431|468077049|FG006|Main Treatment Part|Physician Decision|1|||
130033364|NCT02901431|468077050|FG007|Main Treatment Part|Physician Decision|0|||
130033365|NCT02901431|468077051|FG008|Main Treatment Part|Physician Decision|0|||
130033366|NCT02901431|468077052|FG009|Main Treatment Part|Physician Decision|0|||
130033367|NCT02901431|468077053|FG010|Main Treatment Part|Physician Decision|0|||
130033368|NCT02901431|468077054|FG011|Main Treatment Part|Physician Decision|0|||
130033369|NCT02901431|468077055|FG012|Main Treatment Part|Physician Decision|0|||
130033370|NCT02901431|468077043|FG000|Main Treatment Part|Withdrawal by Subject|0|||
130033371|NCT02901431|468077044|FG001|Main Treatment Part|Withdrawal by Subject|0|||
130033372|NCT02901431|468077045|FG002|Main Treatment Part|Withdrawal by Subject|0|||
130033373|NCT02901431|468077046|FG003|Main Treatment Part|Withdrawal by Subject|18|||
130033374|NCT02901431|468077047|FG004|Main Treatment Part|Withdrawal by Subject|3|||
130033375|NCT02901431|468077048|FG005|Main Treatment Part|Withdrawal by Subject|5|||
130033376|NCT02901431|468077049|FG006|Main Treatment Part|Withdrawal by Subject|6|||
130033377|NCT02901431|468077050|FG007|Main Treatment Part|Withdrawal by Subject|0|||
130033378|NCT02901431|468077051|FG008|Main Treatment Part|Withdrawal by Subject|0|||
130033379|NCT02901431|468077052|FG009|Main Treatment Part|Withdrawal by Subject|0|||
130033380|NCT02901431|468077053|FG010|Main Treatment Part|Withdrawal by Subject|0|||
130033381|NCT02901431|468077054|FG011|Main Treatment Part|Withdrawal by Subject|0|||
130033382|NCT02901431|468077055|FG012|Main Treatment Part|Withdrawal by Subject|0|||
130033383|NCT02901431|468077043|FG000|Open Label Part|Adverse Event|0|||
130033384|NCT02901431|468077044|FG001|Open Label Part|Adverse Event|0|||
130033385|NCT02901431|468077045|FG002|Open Label Part|Adverse Event|0|||
130033386|NCT02901431|468077046|FG003|Open Label Part|Adverse Event|0|||
130033387|NCT02901431|468077047|FG004|Open Label Part|Adverse Event|0|||
130033388|NCT02901431|468077048|FG005|Open Label Part|Adverse Event|0|||
130033389|NCT02901431|468077049|FG006|Open Label Part|Adverse Event|0|||
130033390|NCT02901431|468077050|FG007|Open Label Part|Adverse Event|0|||
130033391|NCT02901431|468077051|FG008|Open Label Part|Adverse Event|4|||
130033392|NCT02901431|468077052|FG009|Open Label Part|Adverse Event|4|||
130033393|NCT02901431|468077053|FG010|Open Label Part|Adverse Event|0|||
130033394|NCT02901431|468077054|FG011|Open Label Part|Adverse Event|4|||
130033395|NCT02901431|468077055|FG012|Open Label Part|Adverse Event|1|||
130257548|NCT03322566|468908524|FG002|Overall Study|Withdrawal by Subject|6|||
130257549|NCT03322566|468908522|FG000|Overall Study|Lost to Follow-up|0|||
130257550|NCT03322566|468908523|FG001|Overall Study|Lost to Follow-up|0|||
130257551|NCT03322566|468908524|FG002|Overall Study|Lost to Follow-up|1|||
130257552|NCT03322566|468908522|FG000|Overall Study|Study terminated by sponsor|1|||
130033396|NCT02901431|468077043|FG000|Open Label Part|Lost to Follow-up|0|||
130033397|NCT02901431|468077044|FG001|Open Label Part|Lost to Follow-up|0|||
130033398|NCT02901431|468077045|FG002|Open Label Part|Lost to Follow-up|0|||
130033399|NCT02901431|468077046|FG003|Open Label Part|Lost to Follow-up|0|||
130033400|NCT02901431|468077047|FG004|Open Label Part|Lost to Follow-up|0|||
130033401|NCT02901431|468077048|FG005|Open Label Part|Lost to Follow-up|0|||
130033402|NCT02901431|468077049|FG006|Open Label Part|Lost to Follow-up|0|||
130257553|NCT03322566|468908523|FG001|Overall Study|Study terminated by sponsor|0|||
130033403|NCT02901431|468077050|FG007|Open Label Part|Lost to Follow-up|0|||
130033404|NCT02901431|468077051|FG008|Open Label Part|Lost to Follow-up|2|||
130033405|NCT02901431|468077052|FG009|Open Label Part|Lost to Follow-up|2|||
130033406|NCT02901431|468077053|FG010|Open Label Part|Lost to Follow-up|1|||
130033407|NCT02901431|468077054|FG011|Open Label Part|Lost to Follow-up|1|||
130033408|NCT02901431|468077055|FG012|Open Label Part|Lost to Follow-up|1|||
130033409|NCT02901431|468077043|FG000|Open Label Part|Physician Decision|0|||
130033410|NCT02901431|468077044|FG001|Open Label Part|Physician Decision|0|||
130257554|NCT03322566|468908524|FG002|Overall Study|Study terminated by sponsor|1|||
130257555|NCT03847519|468908525|FG000|Overall Study|Death|5|||
130033411|NCT02901431|468077045|FG002|Open Label Part|Physician Decision|0|||
130033412|NCT02901431|468077046|FG003|Open Label Part|Physician Decision|0|||
130257556|NCT03847519|468908526|FG001|Overall Study|Death|8|||
130257557|NCT03847519|468908527|FG002|Overall Study|Death|1|||
130257558|NCT03847519|468908525|FG000|Overall Study|Lost to Follow-up|1|||
130257559|NCT03847519|468908526|FG001|Overall Study|Lost to Follow-up|2|||
130257560|NCT03847519|468908527|FG002|Overall Study|Lost to Follow-up|0|||
130257561|NCT03847519|468908525|FG000|Overall Study|Study Terminated by Sponsor|0|||
130257562|NCT03847519|468908526|FG001|Overall Study|Study Terminated by Sponsor|3|||
130257563|NCT03847519|468908527|FG002|Overall Study|Study Terminated by Sponsor|2|||
130257564|NCT02314923|468908530|FG000|Overall Study|Death|0|||
130257565|NCT02314923|468908531|FG001|Overall Study|Death|0|||
130257566|NCT02314923|468908532|FG002|Overall Study|Death|0|||
130033413|NCT02901431|468077047|FG004|Open Label Part|Physician Decision|0|||
130033414|NCT02901431|468077048|FG005|Open Label Part|Physician Decision|0|||
130033415|NCT02901431|468077049|FG006|Open Label Part|Physician Decision|0|||
130033416|NCT02901431|468077050|FG007|Open Label Part|Physician Decision|0|||
130033417|NCT02901431|468077051|FG008|Open Label Part|Physician Decision|1|||
130033418|NCT02901431|468077052|FG009|Open Label Part|Physician Decision|1|||
130033419|NCT02901431|468077053|FG010|Open Label Part|Physician Decision|0|||
130033420|NCT02901431|468077054|FG011|Open Label Part|Physician Decision|0|||
130033421|NCT02901431|468077055|FG012|Open Label Part|Physician Decision|0|||
130033422|NCT02901431|468077043|FG000|Open Label Part|Study Terminated By Sponsor|0|||
130033423|NCT02901431|468077044|FG001|Open Label Part|Study Terminated By Sponsor|0|||
130033424|NCT02901431|468077045|FG002|Open Label Part|Study Terminated By Sponsor|0|||
130033425|NCT02901431|468077046|FG003|Open Label Part|Study Terminated By Sponsor|0|||
130033426|NCT02901431|468077047|FG004|Open Label Part|Study Terminated By Sponsor|0|||
130033427|NCT02901431|468077048|FG005|Open Label Part|Study Terminated By Sponsor|0|||
130033428|NCT02901431|468077049|FG006|Open Label Part|Study Terminated By Sponsor|0|||
130033429|NCT02901431|468077050|FG007|Open Label Part|Study Terminated By Sponsor|0|||
130033430|NCT02901431|468077051|FG008|Open Label Part|Study Terminated By Sponsor|35|||
130257567|NCT02314923|468908533|FG003|Overall Study|Death|1|||
130257568|NCT02314923|468908534|FG004|Overall Study|Death|0|||
130257569|NCT02314923|468908535|FG005|Overall Study|Death|0|||
130257570|NCT02314923|468908536|FG006|Overall Study|Death|0|||
130257571|NCT02314923|468908537|FG007|Overall Study|Death|0|||
130257572|NCT02314923|468908538|FG008|Overall Study|Death|0|||
130257573|NCT02314923|468908539|FG009|Overall Study|Death|0|||
130257574|NCT02314923|468908530|FG000|Overall Study|Lost to Follow-up|2|||
130257575|NCT02314923|468908531|FG001|Overall Study|Lost to Follow-up|3|||
130257576|NCT02314923|468908532|FG002|Overall Study|Lost to Follow-up|1|||
130257577|NCT02314923|468908533|FG003|Overall Study|Lost to Follow-up|0|||
130257578|NCT02314923|468908534|FG004|Overall Study|Lost to Follow-up|0|||
130257579|NCT02314923|468908535|FG005|Overall Study|Lost to Follow-up|0|||
130257580|NCT02314923|468908536|FG006|Overall Study|Lost to Follow-up|3|||
130257581|NCT02314923|468908537|FG007|Overall Study|Lost to Follow-up|4|||
130257582|NCT02314923|468908538|FG008|Overall Study|Lost to Follow-up|2|||
130257583|NCT02314923|468908539|FG009|Overall Study|Lost to Follow-up|0|||
130257584|NCT02314923|468908530|FG000|Overall Study|Withdrawal by Subject|0|||
130257585|NCT02314923|468908531|FG001|Overall Study|Withdrawal by Subject|0|||
130257586|NCT02314923|468908532|FG002|Overall Study|Withdrawal by Subject|1|||
130257587|NCT02314923|468908533|FG003|Overall Study|Withdrawal by Subject|0|||
130257588|NCT02314923|468908534|FG004|Overall Study|Withdrawal by Subject|1|||
130257589|NCT02314923|468908535|FG005|Overall Study|Withdrawal by Subject|0|||
130257590|NCT02314923|468908536|FG006|Overall Study|Withdrawal by Subject|1|||
130257591|NCT02314923|468908537|FG007|Overall Study|Withdrawal by Subject|0|||
130257592|NCT02314923|468908538|FG008|Overall Study|Withdrawal by Subject|0|||
130257593|NCT02314923|468908539|FG009|Overall Study|Withdrawal by Subject|0|||
130257594|NCT02314923|468908530|FG000|Overall Study|Physician Decision|0|||
130257595|NCT02314923|468908531|FG001|Overall Study|Physician Decision|1|||
130257596|NCT02314923|468908532|FG002|Overall Study|Physician Decision|0|||
130257597|NCT02314923|468908533|FG003|Overall Study|Physician Decision|0|||
130257598|NCT02314923|468908534|FG004|Overall Study|Physician Decision|0|||
130257599|NCT02314923|468908535|FG005|Overall Study|Physician Decision|0|||
130257600|NCT02314923|468908536|FG006|Overall Study|Physician Decision|0|||
130257601|NCT02314923|468908537|FG007|Overall Study|Physician Decision|0|||
130257602|NCT02314923|468908538|FG008|Overall Study|Physician Decision|0|||
130257603|NCT02314923|468908539|FG009|Overall Study|Physician Decision|0|||
130257604|NCT02314923|468908530|FG000|Overall Study|Participant unavailable|0|||
130257605|NCT02314923|468908531|FG001|Overall Study|Participant unavailable|0|||
130257606|NCT02314923|468908532|FG002|Overall Study|Participant unavailable|0|||
130257607|NCT02314923|468908533|FG003|Overall Study|Participant unavailable|0|||
130257608|NCT02314923|468908534|FG004|Overall Study|Participant unavailable|0|||
130257609|NCT02314923|468908535|FG005|Overall Study|Participant unavailable|1|||
130257610|NCT02314923|468908536|FG006|Overall Study|Participant unavailable|0|||
130257611|NCT02314923|468908537|FG007|Overall Study|Participant unavailable|0|||
130257612|NCT02314923|468908538|FG008|Overall Study|Participant unavailable|0|||
130257613|NCT02314923|468908539|FG009|Overall Study|Participant unavailable|0|||
130101744|NCT02325739|468330752|FG004|Phase II Part|Adverse Event|0|||
130257614|NCT02314923|468908530|FG000|Overall Study|Screen failure|0|||
130257615|NCT02314923|468908531|FG001|Overall Study|Screen failure|0|||
130257616|NCT02314923|468908532|FG002|Overall Study|Screen failure|0|||
130257617|NCT02314923|468908533|FG003|Overall Study|Screen failure|0|||
130257618|NCT02314923|468908534|FG004|Overall Study|Screen failure|0|||
130257619|NCT02314923|468908535|FG005|Overall Study|Screen failure|0|||
130257620|NCT02314923|468908536|FG006|Overall Study|Screen failure|1|||
130257621|NCT02314923|468908537|FG007|Overall Study|Screen failure|0|||
130257622|NCT02314923|468908538|FG008|Overall Study|Screen failure|0|||
130257623|NCT02314923|468908539|FG009|Overall Study|Screen failure|0|||
130257624|NCT02314923|468908530|FG000|Overall Study|Participant relocation|1|||
130257625|NCT02314923|468908531|FG001|Overall Study|Participant relocation|0|||
130257626|NCT02314923|468908532|FG002|Overall Study|Participant relocation|0|||
130257627|NCT02314923|468908533|FG003|Overall Study|Participant relocation|0|||
130257628|NCT02314923|468908534|FG004|Overall Study|Participant relocation|0|||
130257629|NCT02314923|468908535|FG005|Overall Study|Participant relocation|0|||
130257630|NCT02314923|468908536|FG006|Overall Study|Participant relocation|0|||
130257631|NCT02314923|468908537|FG007|Overall Study|Participant relocation|1|||
130257632|NCT02314923|468908538|FG008|Overall Study|Participant relocation|0|||
130257633|NCT02314923|468908539|FG009|Overall Study|Participant relocation|0|||
130257634|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Adverse Event|20|||
130257635|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Adverse Event|10|||
130257636|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Adverse Event|5|||
130257637|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Adverse Event|0|||
130257638|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Adverse Event|0|||
130257639|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Adverse Event|0|||
130257640|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Adverse Event|0|||
130257641|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Adverse Event|0|||
130257642|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Adverse Event|0|||
130257643|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Adverse Event|0|||
130257644|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Adverse Event|0|||
130257645|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Adverse Event|0|||
130257646|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257647|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257648|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
130257649|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257650|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257651|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257652|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257653|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257654|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257655|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257656|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257657|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
130257658|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
130257659|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
130257660|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
130257661|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
130257662|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
130257663|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
130257664|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
130257665|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
130257666|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
130257667|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
130257668|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
130257669|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
130257670|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
130257671|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
130257672|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
130257673|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
130257674|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
130257675|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
130257676|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
130257677|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
130257678|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
130257679|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
130257680|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
130257681|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
130257682|NCT00725985|468908540|FG000|ITP- Treatment Disposition|Other|50|||
130257683|NCT00725985|468908541|FG001|ITP- Treatment Disposition|Other|38|||
130257684|NCT00725985|468908542|FG002|ITP- Treatment Disposition|Other|24|||
130257685|NCT00725985|468908543|FG003|ITP- Treatment Disposition|Other|0|||
130257686|NCT00725985|468908544|FG004|ITP- Treatment Disposition|Other|0|||
130257687|NCT00725985|468908545|FG005|ITP- Treatment Disposition|Other|0|||
130033431|NCT02901431|468077052|FG009|Open Label Part|Study Terminated By Sponsor|12|||
130033432|NCT02901431|468077053|FG010|Open Label Part|Study Terminated By Sponsor|21|||
130033433|NCT02901431|468077054|FG011|Open Label Part|Study Terminated By Sponsor|31|||
130033434|NCT02901431|468077055|FG012|Open Label Part|Study Terminated By Sponsor|0|||
130033435|NCT02901431|468077043|FG000|Open Label Part|Withdrawal by Subject|0|||
130033436|NCT02901431|468077044|FG001|Open Label Part|Withdrawal by Subject|0|||
130033437|NCT02901431|468077045|FG002|Open Label Part|Withdrawal by Subject|0|||
130033438|NCT02901431|468077046|FG003|Open Label Part|Withdrawal by Subject|0|||
130033439|NCT02901431|468077047|FG004|Open Label Part|Withdrawal by Subject|0|||
130033440|NCT02901431|468077048|FG005|Open Label Part|Withdrawal by Subject|0|||
130033441|NCT02901431|468077049|FG006|Open Label Part|Withdrawal by Subject|0|||
130033442|NCT02901431|468077050|FG007|Open Label Part|Withdrawal by Subject|0|||
130033443|NCT02901431|468077051|FG008|Open Label Part|Withdrawal by Subject|6|||
130033444|NCT02901431|468077052|FG009|Open Label Part|Withdrawal by Subject|5|||
130033445|NCT02901431|468077053|FG010|Open Label Part|Withdrawal by Subject|7|||
130033446|NCT02901431|468077054|FG011|Open Label Part|Withdrawal by Subject|3|||
130033447|NCT02901431|468077055|FG012|Open Label Part|Withdrawal by Subject|1|||
130033448|NCT01889602|468077056|FG000|First Intervention|Adverse Event|1|||
130033449|NCT01889602|468077057|FG001|First Intervention|Adverse Event|1|||
130033450|NCT01889602|468077058|FG002|First Intervention|Adverse Event|1|||
130033451|NCT01889602|468077056|FG000|First Intervention|Protocol Violation|0|||
130033452|NCT01889602|468077057|FG001|First Intervention|Protocol Violation|1|||
130033453|NCT01889602|468077058|FG002|First Intervention|Protocol Violation|1|||
130033454|NCT01889602|468077056|FG000|First Intervention|Study ending|0|||
130033455|NCT01889602|468077057|FG001|First Intervention|Study ending|1|||
129885455|NCT00849680|467540728|FG004|Overall Study|Adverse Event|0|||
129885456|NCT00849680|467540729|FG005|Overall Study|Adverse Event|0|||
129885457|NCT00849680|467540730|FG006|Overall Study|Adverse Event|2|||
129885458|NCT00849680|467540731|FG007|Overall Study|Adverse Event|0|||
129885459|NCT00849680|467540724|FG000|Overall Study|Lost to Follow-up|7|||
130033456|NCT01889602|468077058|FG002|First Intervention|Study ending|0|||
130101745|NCT02325739|468330753|FG005|Phase II Part|Adverse Event|0|||
130101746|NCT02325739|468330754|FG006|Phase II Part|Adverse Event|0|||
130101747|NCT02325739|468330755|FG007|Phase II Part|Adverse Event|0|||
130101748|NCT02325739|468330756|FG008|Phase II Part|Adverse Event|4|||
130257688|NCT00725985|468908546|FG006|ITP- Treatment Disposition|Other|0|||
130257689|NCT00725985|468908547|FG007|ITP- Treatment Disposition|Other|0|||
130257690|NCT00725985|468908548|FG008|ITP- Treatment Disposition|Other|0|||
130257691|NCT00725985|468908549|FG009|ITP- Treatment Disposition|Other|0|||
130257692|NCT00725985|468908550|FG010|ITP- Treatment Disposition|Other|0|||
130257693|NCT00725985|468908551|FG011|ITP- Treatment Disposition|Other|0|||
130257694|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257695|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257696|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257697|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
130257698|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
130257699|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
130257700|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257701|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257702|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257703|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257704|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257705|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
130257706|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Death|0|||
130257707|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Death|0|||
130257708|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Death|0|||
130257709|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Death|0|||
129885460|NCT00849680|467540725|FG001|Overall Study|Lost to Follow-up|3|||
130257710|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Death|1|||
130257711|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Death|0|||
130257712|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Death|0|||
129885461|NCT00849680|467540726|FG002|Overall Study|Lost to Follow-up|12|||
129885462|NCT00849680|467540727|FG003|Overall Study|Lost to Follow-up|11|||
130033457|NCT01889602|468077056|FG000|Second Intervention|Adverse Event|0|||
130257713|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Death|0|||
130257714|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Death|0|||
130257715|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Death|0|||
130033458|NCT01889602|468077057|FG001|Second Intervention|Adverse Event|0|||
130033459|NCT01889602|468077058|FG002|Second Intervention|Adverse Event|1|||
130033460|NCT01889602|468077056|FG000|Second Intervention|Study ending|1|||
130257716|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Death|0|||
130257717|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Death|0|||
130257718|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129885463|NCT00849680|467540728|FG004|Overall Study|Lost to Follow-up|8|||
129885464|NCT00849680|467540729|FG005|Overall Study|Lost to Follow-up|11|||
130101749|NCT02325739|468330757|FG009|Phase II Part|Adverse Event|5|||
130101750|NCT02325739|468330758|FG010|Phase II Part|Adverse Event|1|||
129885465|NCT00849680|467540730|FG006|Overall Study|Lost to Follow-up|12|||
130033461|NCT01889602|468077057|FG001|Second Intervention|Study ending|0|||
130033462|NCT01889602|468077058|FG002|Second Intervention|Study ending|0|||
130033463|NCT01889602|468077056|FG000|Second Intervention|Withdrawal by Subject|0|||
130257719|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257720|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257721|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
130257722|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257723|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257724|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257725|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257726|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257727|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257728|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257729|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
130257730|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257731|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257732|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257733|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257734|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257735|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
130257736|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257737|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257738|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257739|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257740|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257741|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
130257742|NCT00725985|468908540|FG000|OLMP (Up to 96 Weeks)|Other|0|||
130257743|NCT00725985|468908541|FG001|OLMP (Up to 96 Weeks)|Other|0|||
130257744|NCT00725985|468908542|FG002|OLMP (Up to 96 Weeks)|Other|0|||
130257745|NCT00725985|468908543|FG003|OLMP (Up to 96 Weeks)|Other|15|||
130257746|NCT00725985|468908544|FG004|OLMP (Up to 96 Weeks)|Other|20|||
130257747|NCT00725985|468908545|FG005|OLMP (Up to 96 Weeks)|Other|44|||
130257748|NCT00725985|468908546|FG006|OLMP (Up to 96 Weeks)|Other|0|||
130257749|NCT00725985|468908547|FG007|OLMP (Up to 96 Weeks)|Other|0|||
130257750|NCT00725985|468908548|FG008|OLMP (Up to 96 Weeks)|Other|0|||
130257751|NCT00725985|468908549|FG009|OLMP (Up to 96 Weeks)|Other|0|||
130257752|NCT00725985|468908550|FG010|OLMP (Up to 96 Weeks)|Other|0|||
130257753|NCT00725985|468908551|FG011|OLMP (Up to 96 Weeks)|Other|0|||
130257754|NCT00725985|468908540|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257755|NCT00725985|468908541|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257756|NCT00725985|468908542|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130033464|NCT01889602|468077057|FG001|Second Intervention|Withdrawal by Subject|0|||
130033465|NCT01889602|468077058|FG002|Second Intervention|Withdrawal by Subject|1|||
130033466|NCT01889602|468077056|FG000|Third Intervention|Protocol Violation|1|||
130033467|NCT01889602|468077057|FG001|Third Intervention|Protocol Violation|0|||
130033468|NCT01889602|468077058|FG002|Third Intervention|Protocol Violation|0|||
130033469|NCT01889602|468077056|FG000|Third Intervention|Withdrawal by Subject|2|||
130033470|NCT01889602|468077057|FG001|Third Intervention|Withdrawal by Subject|2|||
130033471|NCT01889602|468077058|FG002|Third Intervention|Withdrawal by Subject|0|||
130033472|NCT00404092|468077059|FG000|Overall Study|Death|1|||
130033473|NCT00404092|468077060|FG001|Overall Study|Death|0|||
130033474|NCT00404092|468077061|FG002|Overall Study|Death|0|||
130033475|NCT00404092|468077062|FG003|Overall Study|Death|0|||
130033476|NCT00404092|468077059|FG000|Overall Study|Adverse Event|0|||
130033477|NCT00404092|468077060|FG001|Overall Study|Adverse Event|0|||
130033478|NCT00404092|468077061|FG002|Overall Study|Adverse Event|1|||
130033479|NCT00404092|468077062|FG003|Overall Study|Adverse Event|0|||
130033480|NCT04223609|468077067|FG000|Overall Study|Adverse Event|0|||
130033481|NCT04223609|468077068|FG001|Overall Study|Adverse Event|1|||
130033482|NCT04223609|468077067|FG000|Overall Study|Missed last visit|0|||
130033483|NCT04223609|468077068|FG001|Overall Study|Missed last visit|1|||
130033484|NCT01275222|468077071|FG000|Phase l by Treatment|Adverse Event|1|||
130257757|NCT00725985|468908543|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257758|NCT00725985|468908544|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257759|NCT00725985|468908545|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257760|NCT00725985|468908546|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257761|NCT00725985|468908547|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
130257762|NCT00725985|468908548|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257763|NCT00725985|468908549|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257764|NCT00725985|468908550|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130257765|NCT00725985|468908551|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
130033485|NCT01275222|468077072|FG001|Phase l by Treatment|Adverse Event|4|||
130033486|NCT01275222|468077073|FG002|Phase l by Treatment|Adverse Event|2|||
130033487|NCT01275222|468077074|FG003|Phase l by Treatment|Adverse Event|3|||
130033488|NCT01275222|468077075|FG004|Phase l by Treatment|Adverse Event|0|||
130033489|NCT01275222|468077076|FG005|Phase l by Treatment|Adverse Event|0|||
130033490|NCT01275222|468077071|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130033491|NCT01275222|468077072|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130033492|NCT01275222|468077073|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
130033493|NCT01275222|468077074|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130033494|NCT01275222|468077075|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130033495|NCT01275222|468077076|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
130033496|NCT01275222|468077071|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130257766|NCT00725985|468908540|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257767|NCT00725985|468908541|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257768|NCT00725985|468908542|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257769|NCT00725985|468908543|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257770|NCT00725985|468908544|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257771|NCT00725985|468908545|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257772|NCT00725985|468908546|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257773|NCT00725985|468908547|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257774|NCT00725985|468908548|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
130257775|NCT00725985|468908549|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257776|NCT00725985|468908550|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257777|NCT00725985|468908551|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
130257778|NCT00725985|468908540|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257779|NCT00725985|468908541|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257780|NCT00725985|468908542|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257781|NCT00725985|468908543|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257782|NCT00725985|468908544|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257783|NCT00725985|468908545|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257784|NCT00725985|468908546|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
130257785|NCT00725985|468908547|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
130257786|NCT00725985|468908548|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
130257787|NCT00725985|468908549|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257788|NCT00725985|468908550|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257789|NCT00725985|468908551|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
130257790|NCT00725985|468908540|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257791|NCT00725985|468908541|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257792|NCT00725985|468908542|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257793|NCT00725985|468908543|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257794|NCT00725985|468908544|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257795|NCT00725985|468908545|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257796|NCT00725985|468908546|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257797|NCT00725985|468908547|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257798|NCT00725985|468908548|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
130257799|NCT00725985|468908549|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
130257800|NCT00725985|468908550|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
130033497|NCT01275222|468077072|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130033498|NCT01275222|468077073|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130033499|NCT01275222|468077074|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
130033500|NCT01275222|468077075|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130033501|NCT01275222|468077076|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
130257801|NCT00725985|468908551|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
130257802|NCT02546323|468908552|FG000|Overall Study|Withdrawal by Subject|36|||
130257803|NCT02546323|468908553|FG001|Overall Study|Withdrawal by Subject|33|||
130257804|NCT02546323|468908552|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
130257805|NCT02546323|468908553|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
130033502|NCT01275222|468077071|FG000|Phase l by Treatment|Disease progression|12|||
130101751|NCT02325739|468330748|FG000|Phase II Part|Physician Decision|0|||
130257806|NCT02546323|468908552|FG000|Overall Study|Adverse Event|17|||
130257807|NCT02546323|468908553|FG001|Overall Study|Adverse Event|11|||
130257808|NCT02546323|468908552|FG000|Overall Study|Patient Specific Reasons|1|||
130257809|NCT02546323|468908553|FG001|Overall Study|Patient Specific Reasons|2|||
130257810|NCT02546323|468908552|FG000|Overall Study|Lost to Follow-up|2|||
130257811|NCT02546323|468908553|FG001|Overall Study|Lost to Follow-up|3|||
130257812|NCT02546323|468908552|FG000|Overall Study|Non-compliance with Study Drug|2|||
130257813|NCT02546323|468908553|FG001|Overall Study|Non-compliance with Study Drug|2|||
130257814|NCT02546323|468908552|FG000|Overall Study|Met Withdrawal Criteria|2|||
130101752|NCT02325739|468330749|FG001|Phase II Part|Physician Decision|0|||
130257815|NCT02546323|468908553|FG001|Overall Study|Met Withdrawal Criteria|14|||
130257816|NCT04476784|468908554|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
130257817|NCT04476784|468908555|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
130257818|NCT03605693|468908562|FG000|Overall Study|Lost to Follow-up|4|||
130033503|NCT01275222|468077072|FG001|Phase l by Treatment|Disease progression|8|||
130033504|NCT01275222|468077073|FG002|Phase l by Treatment|Disease progression|2|||
130257819|NCT03605693|468908563|FG001|Overall Study|Lost to Follow-up|0|||
130257820|NCT03605693|468908562|FG000|Overall Study|Physician Decision|1|||
130257821|NCT03605693|468908563|FG001|Overall Study|Physician Decision|0|||
130257822|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
130257823|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
130257824|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
130257825|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
130257826|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
130257827|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
130257828|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
130257829|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
130257830|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
130257831|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
130257832|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
130257833|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
130257834|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
130257835|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
130257836|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
130257837|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
130257838|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
130257839|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
130257840|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
130257841|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
130257842|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
130257843|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
130257844|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
130257845|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
130257846|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
130257847|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
130257848|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
130257849|NCT03093415|468908564|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
130257850|NCT03093415|468908565|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
130257851|NCT03093415|468908566|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
130257852|NCT03093415|468908564|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
130257853|NCT03093415|468908565|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
130257854|NCT03093415|468908566|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
130257855|NCT04581395|468908571|FG000|Overall Study|Protocol Violation|4|||
130257856|NCT04581395|468908572|FG001|Overall Study|Protocol Violation|3|||
130257857|NCT04581395|468908573|FG002|Overall Study|Protocol Violation|2|||
130257858|NCT04581395|468908571|FG000|Overall Study|Physician Decision|0|||
130257859|NCT04581395|468908572|FG001|Overall Study|Physician Decision|1|||
130257860|NCT04581395|468908573|FG002|Overall Study|Physician Decision|0|||
130257861|NCT00815633|468908574|FG000|Overall Study|study terminated|1|||
130257862|NCT00721110|468908575|FG000|Overall Study|Ultram use|1|||
130257863|NCT00721110|468908576|FG001|Overall Study|Ultram use|0|||
130257864|NCT00721110|468908577|FG002|Overall Study|Ultram use|0|||
130257865|NCT00721110|468908578|FG003|Overall Study|Ultram use|0|||
130257866|NCT00721110|468908575|FG000|Overall Study|vertical incision|0|||
130257867|NCT00721110|468908576|FG001|Overall Study|vertical incision|0|||
130257868|NCT00721110|468908577|FG002|Overall Study|vertical incision|1|||
130257869|NCT00721110|468908578|FG003|Overall Study|vertical incision|0|||
130257870|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
130257871|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130033505|NCT01275222|468077074|FG003|Phase l by Treatment|Disease progression|5|||
130033506|NCT01275222|468077075|FG004|Phase l by Treatment|Disease progression|0|||
130033507|NCT01275222|468077076|FG005|Phase l by Treatment|Disease progression|0|||
130033508|NCT01275222|468077071|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
130033509|NCT01275222|468077072|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
130257872|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130033510|NCT01275222|468077073|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
130257873|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130033511|NCT01275222|468077074|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
130033512|NCT01275222|468077075|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
130033513|NCT01275222|468077076|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
130033514|NCT01275222|468077071|FG000|Phase l by Treatment|Death|0|||
130033515|NCT01275222|468077072|FG001|Phase l by Treatment|Death|1|||
130033516|NCT01275222|468077073|FG002|Phase l by Treatment|Death|0|||
130033517|NCT01275222|468077074|FG003|Phase l by Treatment|Death|1|||
130033518|NCT01275222|468077075|FG004|Phase l by Treatment|Death|0|||
130033519|NCT01275222|468077076|FG005|Phase l by Treatment|Death|0|||
130033520|NCT01275222|468077071|FG000|Phase ll by Stratum|Adverse Event|0|||
130033521|NCT01275222|468077072|FG001|Phase ll by Stratum|Adverse Event|0|||
130033522|NCT01275222|468077073|FG002|Phase ll by Stratum|Adverse Event|0|||
130033523|NCT01275222|468077074|FG003|Phase ll by Stratum|Adverse Event|0|||
130033524|NCT01275222|468077075|FG004|Phase ll by Stratum|Adverse Event|2|||
130033525|NCT01275222|468077076|FG005|Phase ll by Stratum|Adverse Event|10|||
130033526|NCT01275222|468077071|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
130033527|NCT01275222|468077072|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
130033528|NCT01275222|468077073|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
130033529|NCT01275222|468077074|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
130033530|NCT01275222|468077075|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
130033531|NCT01275222|468077076|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
130033532|NCT01275222|468077071|FG000|Phase ll by Stratum|Disease progression|0|||
130257874|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130257875|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130257876|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
130257877|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
130257878|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
130257879|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
130257880|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
130257881|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
130257882|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
130257883|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
130257884|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
130257885|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
130257886|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
130257887|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
130257888|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
130257889|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
130257890|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
130257891|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
130257892|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
130257893|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
130257894|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
130257895|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
130257896|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
130257897|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
130257898|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
130257899|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
130257900|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
130257901|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
130257902|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
130257903|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
130257904|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
130257905|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
130033533|NCT01275222|468077072|FG001|Phase ll by Stratum|Disease progression|0|||
130033534|NCT01275222|468077073|FG002|Phase ll by Stratum|Disease progression|0|||
130033535|NCT01275222|468077074|FG003|Phase ll by Stratum|Disease progression|0|||
130033536|NCT01275222|468077075|FG004|Phase ll by Stratum|Disease progression|23|||
130257906|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
130257907|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
130257908|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
130257909|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
130257910|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
130257911|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
130033537|NCT01275222|468077076|FG005|Phase ll by Stratum|Disease progression|31|||
130033538|NCT01275222|468077071|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
130033539|NCT01275222|468077072|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
130257912|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
130257913|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130033540|NCT01275222|468077073|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
130033541|NCT01275222|468077074|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
130033542|NCT01275222|468077075|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
130033543|NCT01275222|468077076|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
130257914|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257915|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130033544|NCT01275222|468077071|FG000|Phase ll by Stratum|Death|0|||
130033545|NCT01275222|468077072|FG001|Phase ll by Stratum|Death|0|||
130257916|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257917|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257918|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
130257919|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257920|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
130257921|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257922|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257923|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257924|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257925|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
130257926|NCT01362790|468908579|FG000|Pilot Phase & Phase 2|Death on study|0|||
130257927|NCT01362790|468908580|FG001|Pilot Phase & Phase 2|Death on study|0|||
130257928|NCT01362790|468908581|FG002|Pilot Phase & Phase 2|Death on study|0|||
130257929|NCT01362790|468908582|FG003|Pilot Phase & Phase 2|Death on study|1|||
130257930|NCT01362790|468908583|FG004|Pilot Phase & Phase 2|Death on study|0|||
130257931|NCT01362790|468908584|FG005|Pilot Phase & Phase 2|Death on study|0|||
130257932|NCT01362790|468908585|FG006|Pilot Phase & Phase 2|Death on study|0|||
130257933|NCT01362790|468908579|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
130257934|NCT01362790|468908580|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
130257935|NCT01362790|468908581|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
130257936|NCT01362790|468908582|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
130257937|NCT01362790|468908583|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
130257938|NCT01362790|468908584|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
130257939|NCT01362790|468908585|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
130257940|NCT01362790|468908579|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257941|NCT01362790|468908580|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257942|NCT01362790|468908581|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257943|NCT01362790|468908582|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257944|NCT01362790|468908583|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
130257945|NCT01362790|468908584|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257946|NCT01362790|468908585|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
130257947|NCT01362790|468908579|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
130257948|NCT01362790|468908580|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
130257949|NCT01362790|468908581|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
130257950|NCT01362790|468908582|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
130257951|NCT01362790|468908583|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
130257952|NCT01362790|468908584|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
130257953|NCT01362790|468908585|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
130257954|NCT02457065|468908586|FG000|Overall Study|Lost to Follow-up|9|||
130257955|NCT02457065|468908587|FG001|Overall Study|Lost to Follow-up|11|||
130257956|NCT01554904|468908588|FG000|Overall Study|Withdrawal by Subject|3|||
130257957|NCT01554904|468908588|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
130257958|NCT01605097|468908590|FG000|Overall Study|Protocol Violation|1|||
130257959|NCT02038647|468908591|FG000|Overall Study|Progressive Disease|50|||
130257960|NCT02038647|468908592|FG001|Overall Study|Progressive Disease|59|||
130257961|NCT02038647|468908591|FG000|Overall Study|Adverse Event|18|||
130257962|NCT02038647|468908592|FG001|Overall Study|Adverse Event|10|||
130257963|NCT02038647|468908591|FG000|Overall Study|Symptomatic Deterioration|7|||
130257964|NCT02038647|468908592|FG001|Overall Study|Symptomatic Deterioration|7|||
130257965|NCT02038647|468908591|FG000|Overall Study|Withdrawal by Subject|5|||
130257966|NCT02038647|468908592|FG001|Overall Study|Withdrawal by Subject|2|||
130257967|NCT02038647|468908591|FG000|Overall Study|Not Reported|0|||
130257968|NCT02038647|468908592|FG001|Overall Study|Not Reported|1|||
130257969|NCT02038647|468908591|FG000|Overall Study|Ongoing at Datacut|9|||
130257970|NCT02038647|468908592|FG001|Overall Study|Ongoing at Datacut|10|||
130257971|NCT02757430|468908593|FG000|Overall Study|Physician Decision|6|||
130257972|NCT02757430|468908593|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
130257973|NCT02757430|468908593|FG000|Overall Study|No informed consent|1|||
130257974|NCT02757430|468908593|FG000|Overall Study|No procedure performed|2|||
130257975|NCT04716894|468908615|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
130257976|NCT04716894|468908615|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
130257977|NCT04507269|468908619|FG000|Overall Study|Withdrawal by Subject|1|||
130257978|NCT04507269|468908620|FG001|Overall Study|Withdrawal by Subject|1|||
130257979|NCT04507269|468908621|FG002|Overall Study|Withdrawal by Subject|0|||
130257980|NCT04507269|468908622|FG003|Overall Study|Withdrawal by Subject|0|||
130257981|NCT04507269|468908623|FG004|Overall Study|Withdrawal by Subject|0|||
130257982|NCT04507269|468908624|FG005|Overall Study|Withdrawal by Subject|0|||
130257983|NCT04507269|468908619|FG000|Overall Study|Lost to Follow-up|0|||
130257984|NCT04507269|468908620|FG001|Overall Study|Lost to Follow-up|0|||
130257985|NCT04507269|468908621|FG002|Overall Study|Lost to Follow-up|0|||
130257986|NCT04507269|468908622|FG003|Overall Study|Lost to Follow-up|0|||
130257987|NCT04507269|468908623|FG004|Overall Study|Lost to Follow-up|1|||
130257988|NCT04507269|468908624|FG005|Overall Study|Lost to Follow-up|0|||
130257989|NCT00071032|468908627|FG000|Overall Study|Lost to Follow-up|1|||
130257990|NCT00071032|468908628|FG001|Overall Study|Lost to Follow-up|1|||
130257991|NCT00071032|468908627|FG000|Overall Study|Withdrawal by Subject|8|||
130257992|NCT00071032|468908628|FG001|Overall Study|Withdrawal by Subject|6|||
130257993|NCT00071032|468908627|FG000|Overall Study|Missing Primary Outcome|0|||
130257994|NCT00071032|468908628|FG001|Overall Study|Missing Primary Outcome|1|||
130257995|NCT06071104|468908630|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
130257996|NCT03518060|468908631|FG000|Overall Study|Death|1|||
130257997|NCT03518060|468908631|FG000|Overall Study|Poor adherence|1|||
130257998|NCT03518060|468908631|FG000|Overall Study|Withdrawal of informed consent|2|||
129885466|NCT00849680|467540731|FG007|Overall Study|Lost to Follow-up|5|||
130033546|NCT01275222|468077073|FG002|Phase ll by Stratum|Death|0|||
130257999|NCT03518060|468908631|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
130258000|NCT03518060|468908631|FG000|Overall Study|Physician Decision|7|||
130258001|NCT03518060|468908631|FG000|Overall Study|Adverse drug reactions|23|||
130258002|NCT03518060|468908631|FG000|Overall Study|Withdrawal by Subject|25|||
130258003|NCT03518060|468908631|FG000|Overall Study|Lost to Follow-up|13|||
130258004|NCT01903863|468908633|FG000|Overall Study|Physician Decision|2|||
130258005|NCT01903863|468908634|FG001|Overall Study|Physician Decision|0|||
130258006|NCT04727151|468908639|FG000|Overall Study|Death|0|||
130258007|NCT04727151|468908640|FG001|Overall Study|Death|0|||
130258008|NCT04727151|468908641|FG002|Overall Study|Death|0|||
130258009|NCT04727151|468908642|FG003|Overall Study|Death|0|||
130258010|NCT04727151|468908643|FG004|Overall Study|Death|3|||
130258011|NCT04727151|468908639|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258012|NCT04727151|468908640|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258013|NCT04727151|468908641|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258014|NCT04727151|468908642|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
130258015|NCT04727151|468908643|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
130258016|NCT01969058|468908644|FG000|Overall Study|Withdrawal by Subject|2|||
130258017|NCT01969058|468908645|FG001|Overall Study|Withdrawal by Subject|0|||
130258018|NCT01969058|468908644|FG000|Overall Study|Adverse Event|1|||
130258019|NCT01969058|468908645|FG001|Overall Study|Adverse Event|0|||
130258020|NCT04976855|468908648|FG000|Part I|Withdrawal by Subject|0|||
130258021|NCT04976855|468908649|FG001|Part I|Withdrawal by Subject|1|||
130258022|NCT04976855|468908650|FG002|Part I|Withdrawal by Subject|0|||
130258023|NCT04976855|468908651|FG003|Part I|Withdrawal by Subject|0|||
130258024|NCT04976855|468908652|FG004|Part I|Withdrawal by Subject|0|||
130258025|NCT04976855|468908653|FG005|Part I|Withdrawal by Subject|0|||
130258026|NCT04976855|468908654|FG006|Part I|Withdrawal by Subject|0|||
130258027|NCT04976855|468908648|FG000|Part II|Adverse Event|0|||
130258028|NCT04976855|468908649|FG001|Part II|Adverse Event|0|||
130258029|NCT04976855|468908650|FG002|Part II|Adverse Event|0|||
130258030|NCT04976855|468908651|FG003|Part II|Adverse Event|1|||
130258031|NCT04976855|468908652|FG004|Part II|Adverse Event|0|||
130258032|NCT04976855|468908653|FG005|Part II|Adverse Event|0|||
130258033|NCT04976855|468908654|FG006|Part II|Adverse Event|0|||
130258034|NCT04976855|468908648|FG000|Part II|Withdrawal by Subject|0|||
130258035|NCT04976855|468908649|FG001|Part II|Withdrawal by Subject|0|||
130258036|NCT04976855|468908650|FG002|Part II|Withdrawal by Subject|0|||
130258037|NCT04976855|468908651|FG003|Part II|Withdrawal by Subject|0|||
130258038|NCT04976855|468908652|FG004|Part II|Withdrawal by Subject|1|||
130258039|NCT04976855|468908653|FG005|Part II|Withdrawal by Subject|0|||
130258040|NCT04976855|468908654|FG006|Part II|Withdrawal by Subject|0|||
130258041|NCT04976855|468908648|FG000|Part II|Lost to Follow-up|0|||
130258042|NCT04976855|468908649|FG001|Part II|Lost to Follow-up|0|||
130258043|NCT04976855|468908650|FG002|Part II|Lost to Follow-up|0|||
130258044|NCT04976855|468908651|FG003|Part II|Lost to Follow-up|0|||
130258045|NCT04976855|468908652|FG004|Part II|Lost to Follow-up|0|||
130258046|NCT04976855|468908653|FG005|Part II|Lost to Follow-up|1|||
130258047|NCT04976855|468908654|FG006|Part II|Lost to Follow-up|0|||
130258048|NCT05318287|468908655|FG000|Overall Study|Lost to Follow-up|8|||
130258049|NCT03537508|468908656|FG000|Overall Study|Adverse Event|2|||
130258050|NCT03537508|468908657|FG001|Overall Study|Adverse Event|1|||
130258051|NCT03537508|468908656|FG000|Overall Study|Protocol Violation|65|||
130258052|NCT03537508|468908657|FG001|Overall Study|Protocol Violation|48|||
130258053|NCT03537508|468908656|FG000|Overall Study|Lost to Follow-up|86|||
130258054|NCT03537508|468908657|FG001|Overall Study|Lost to Follow-up|60|||
130258055|NCT03537508|468908656|FG000|Overall Study|Withdrawal by parent/guardian|263|||
130258056|NCT03537508|468908657|FG001|Overall Study|Withdrawal by parent/guardian|149|||
130258057|NCT00835172|468908692|FG000|Washout|Protocol Violation|0|||
130258058|NCT00835172|468908693|FG001|Washout|Protocol Violation|1|||
130258059|NCT02495883|468908696|FG000|Overall Study|Excessive head motion|1|||
130033547|NCT01275222|468077074|FG003|Phase ll by Stratum|Death|0|||
130033548|NCT01275222|468077075|FG004|Phase ll by Stratum|Death|1|||
130033549|NCT01275222|468077076|FG005|Phase ll by Stratum|Death|1|||
130033550|NCT03440944|468077077|FG000|Overall Study|Physician Decision|1|||
130033551|NCT03440944|468077078|FG001|Overall Study|Physician Decision|0|||
130258060|NCT02495883|468908697|FG001|Overall Study|Excessive head motion|0|||
130258061|NCT02776735|468908698|FG000|Overall Study|Adverse Event|0|||
130258062|NCT02776735|468908699|FG001|Overall Study|Adverse Event|0|||
130258063|NCT02776735|468908700|FG002|Overall Study|Adverse Event|0|||
130258064|NCT02776735|468908701|FG003|Overall Study|Adverse Event|1|||
130258065|NCT02776735|468908702|FG004|Overall Study|Adverse Event|0|||
130258066|NCT02776735|468908703|FG005|Overall Study|Adverse Event|1|||
130033552|NCT03440944|468077077|FG000|Overall Study|No Acceptable Vasculature|0|||
130033553|NCT03440944|468077078|FG001|Overall Study|No Acceptable Vasculature|1|||
130258067|NCT02776735|468908698|FG000|Overall Study|Lost to Follow-up|0|||
130258068|NCT02776735|468908699|FG001|Overall Study|Lost to Follow-up|0|||
130258069|NCT02776735|468908700|FG002|Overall Study|Lost to Follow-up|0|||
130258070|NCT02776735|468908701|FG003|Overall Study|Lost to Follow-up|1|||
130258071|NCT02776735|468908702|FG004|Overall Study|Lost to Follow-up|0|||
130033554|NCT00591734|468077079|FG000|Overall Study|Lack of Efficacy|35|||
130033555|NCT00591734|468077079|FG000|Overall Study|Adverse Event|5|||
130033556|NCT00591734|468077079|FG000|Overall Study|Physician Decision|5|||
130033557|NCT00591734|468077079|FG000|Overall Study|Intercurrent Illness|8|||
130033558|NCT04672083|468077080|FG000|Overall Study|Lost to Follow-up|1|||
130033559|NCT04672083|468077081|FG001|Overall Study|Lost to Follow-up|0|||
130033560|NCT04672083|468077082|FG002|Overall Study|Lost to Follow-up|0|||
130033561|NCT04672083|468077083|FG003|Overall Study|Lost to Follow-up|0|||
130033562|NCT04672083|468077084|FG004|Overall Study|Lost to Follow-up|0|||
130033563|NCT02048904|468077085|FG000|Overall Study|Withdrawal by Subject|7|||
130033564|NCT02048904|468077085|FG000|Overall Study|Physician Decision|70|||
130033565|NCT00784758|468077086|FG000|Overall Study|Withdrawal by Subject|3|||
130033566|NCT00784758|468077087|FG001|Overall Study|Withdrawal by Subject|0|||
130033567|NCT00784758|468077086|FG000|Overall Study|Adverse Event|1|||
130033568|NCT00784758|468077087|FG001|Overall Study|Adverse Event|0|||
130033569|NCT02732951|468078501|FG000|Overall Study|Other than listed|1|||
130033570|NCT02732951|468078502|FG001|Overall Study|Other than listed|0|||
130033571|NCT02732951|468078501|FG000|Overall Study|Lost to Follow-up|0|||
130033572|NCT02732951|468078502|FG001|Overall Study|Lost to Follow-up|1|||
130033573|NCT02732951|468078501|FG000|Overall Study|Adverse Event|4|||
130033574|NCT02732951|468078502|FG001|Overall Study|Adverse Event|4|||
130033575|NCT02732951|468078501|FG000|Overall Study|Protocol Violation|0|||
130033576|NCT02732951|468078502|FG001|Overall Study|Protocol Violation|1|||
130033577|NCT05047523|468078512|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130033578|NCT05047523|468078513|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130033579|NCT05047523|468078514|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
130033580|NCT05047523|468078515|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130033581|NCT05047523|468078516|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130033582|NCT05047523|468078517|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
130033583|NCT05047523|468078512|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130258072|NCT02776735|468908703|FG005|Overall Study|Lost to Follow-up|0|||
130258073|NCT02776735|468908698|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130258074|NCT02776735|468908699|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130258075|NCT02776735|468908700|FG002|Overall Study|Withdrawal by parent/guardian|2|||
130258076|NCT02776735|468908701|FG003|Overall Study|Withdrawal by parent/guardian|2|||
130258077|NCT02776735|468908702|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130258078|NCT02776735|468908703|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130258079|NCT02776735|468908698|FG000|Overall Study|Withdrawal by Subject|1|||
130258080|NCT02776735|468908699|FG001|Overall Study|Withdrawal by Subject|0|||
130258081|NCT02776735|468908700|FG002|Overall Study|Withdrawal by Subject|0|||
130258082|NCT02776735|468908701|FG003|Overall Study|Withdrawal by Subject|0|||
130258083|NCT02776735|468908702|FG004|Overall Study|Withdrawal by Subject|0|||
130258084|NCT02776735|468908703|FG005|Overall Study|Withdrawal by Subject|1|||
130258085|NCT02776735|468908698|FG000|Overall Study|Other|0|||
130258086|NCT02776735|468908699|FG001|Overall Study|Other|0|||
130258087|NCT02776735|468908700|FG002|Overall Study|Other|3|||
130258088|NCT02776735|468908701|FG003|Overall Study|Other|0|||
130258089|NCT02776735|468908702|FG004|Overall Study|Other|0|||
130258090|NCT02776735|468908703|FG005|Overall Study|Other|0|||
130258091|NCT00791648|468910306|FG000|Overall Study|Physician Decision|0|||
130258092|NCT00791648|468910307|FG001|Overall Study|Physician Decision|1|||
130258093|NCT00791648|468910306|FG000|Overall Study|Withdrawal by Subject|0|||
130258094|NCT00791648|468910307|FG001|Overall Study|Withdrawal by Subject|1|||
130258095|NCT04976777|468910308|FG000|Overall Study|COVID-19 Infection|1|||
130258096|NCT04976777|468910309|FG001|Overall Study|COVID-19 Infection|0|||
130258097|NCT00462826|468910310|FG000|Overall Study|Ineligible - second primary|1|||
130258098|NCT00462826|468910310|FG000|Overall Study|Ineligible - wrong cell type|1|||
130258099|NCT00462826|468910310|FG000|Overall Study|Ineligible - wrong primary|2|||
130258100|NCT00462826|468910310|FG000|Overall Study|Never treated|1|||
130258101|NCT02332928|468910313|FG000|Overall Study|Withdrawal by Subject|0|||
130258102|NCT02332928|468910314|FG001|Overall Study|Withdrawal by Subject|2|||
130258103|NCT02332928|468910313|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
130258104|NCT02332928|468910314|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
130258105|NCT04484857|468910315|FG000|Overall Study|Adverse Event|2|||
130258106|NCT04484857|468910315|FG000|Overall Study|Death|10|||
130258107|NCT04484857|468910315|FG000|Overall Study|Withdrawal by Subject|3|||
130258108|NCT04484857|468910315|FG000|Overall Study|Transferred/Relocation|5|||
130033584|NCT05047523|468078513|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
130033585|NCT05047523|468078514|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130033586|NCT05047523|468078515|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130033587|NCT05047523|468078516|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130033588|NCT05047523|468078517|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
130033589|NCT05047523|468078512|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
130101753|NCT02325739|468330750|FG002|Phase II Part|Physician Decision|0|||
130258109|NCT04484857|468910315|FG000|Overall Study|Kidney Transplant|7|||
129885467|NCT00849680|467540724|FG000|Overall Study|Subject moved|1|||
129885468|NCT00849680|467540725|FG001|Overall Study|Subject moved|0|||
129885469|NCT00849680|467540726|FG002|Overall Study|Subject moved|3|||
129885470|NCT00849680|467540727|FG003|Overall Study|Subject moved|1|||
129885471|NCT00849680|467540728|FG004|Overall Study|Subject moved|0|||
129885472|NCT00849680|467540729|FG005|Overall Study|Subject moved|2|||
129885473|NCT00849680|467540730|FG006|Overall Study|Subject moved|2|||
129885474|NCT00849680|467540731|FG007|Overall Study|Subject moved|2|||
129885475|NCT00849680|467540724|FG000|Overall Study|Withdrawal by Subject|2|||
129885476|NCT00849680|467540725|FG001|Overall Study|Withdrawal by Subject|0|||
129885477|NCT00849680|467540726|FG002|Overall Study|Withdrawal by Subject|0|||
129885478|NCT00849680|467540727|FG003|Overall Study|Withdrawal by Subject|2|||
129885479|NCT00849680|467540728|FG004|Overall Study|Withdrawal by Subject|2|||
129885480|NCT00849680|467540729|FG005|Overall Study|Withdrawal by Subject|2|||
129885481|NCT00849680|467540730|FG006|Overall Study|Withdrawal by Subject|1|||
129885482|NCT00849680|467540731|FG007|Overall Study|Withdrawal by Subject|1|||
129885483|NCT00849680|467540724|FG000|Overall Study|Subject unable to comply with protocol|1|||
129885484|NCT00849680|467540725|FG001|Overall Study|Subject unable to comply with protocol|0|||
129885485|NCT00849680|467540726|FG002|Overall Study|Subject unable to comply with protocol|0|||
129885486|NCT00849680|467540727|FG003|Overall Study|Subject unable to comply with protocol|0|||
129885487|NCT00849680|467540728|FG004|Overall Study|Subject unable to comply with protocol|0|||
129885488|NCT00849680|467540729|FG005|Overall Study|Subject unable to comply with protocol|0|||
129885489|NCT00849680|467540730|FG006|Overall Study|Subject unable to comply with protocol|0|||
129885490|NCT00849680|467540731|FG007|Overall Study|Subject unable to comply with protocol|0|||
129885500|NCT02207374|467540737|FG000|Overall Study|Withdrawal by Subject|5|||
129885501|NCT02207374|467540738|FG001|Overall Study|Withdrawal by Subject|9|||
129885502|NCT02207374|467540739|FG002|Overall Study|Withdrawal by Subject|4|||
129885503|NCT02207374|467540737|FG000|Overall Study|Death|1|||
129885504|NCT02207374|467540738|FG001|Overall Study|Death|0|||
129885505|NCT02207374|467540739|FG002|Overall Study|Death|1|||
129885506|NCT02207374|467540737|FG000|Overall Study|Missing follow-up information|0|||
129885507|NCT02207374|467540738|FG001|Overall Study|Missing follow-up information|1|||
129885508|NCT02207374|467540739|FG002|Overall Study|Missing follow-up information|1|||
129885509|NCT02087150|467540740|FG000|Overall Study|Death|0|||
129885510|NCT02087150|467540741|FG001|Overall Study|Death|1|||
129885511|NCT02087150|467540742|FG002|Overall Study|Death|0|||
129885512|NCT02087150|467540740|FG000|Overall Study|Lost to Follow-up|6|||
129885513|NCT02087150|467540741|FG001|Overall Study|Lost to Follow-up|13|||
129885514|NCT02087150|467540742|FG002|Overall Study|Lost to Follow-up|7|||
129885515|NCT02087150|467540740|FG000|Overall Study|Withdrawal by Subject|2|||
129885516|NCT02087150|467540741|FG001|Overall Study|Withdrawal by Subject|5|||
129885517|NCT02087150|467540742|FG002|Overall Study|Withdrawal by Subject|3|||
129885518|NCT02087150|467540740|FG000|Overall Study|Physician Decision|0|||
129885519|NCT02087150|467540741|FG001|Overall Study|Physician Decision|1|||
129885520|NCT02087150|467540742|FG002|Overall Study|Physician Decision|0|||
129885521|NCT02087150|467540740|FG000|Overall Study|Procedure not done|1|||
129885522|NCT02087150|467540741|FG001|Overall Study|Procedure not done|13|||
129885523|NCT02087150|467540742|FG002|Overall Study|Procedure not done|0|||
129885524|NCT02087150|467540740|FG000|Overall Study|F/U not completed w/in study window|0|||
129885525|NCT02087150|467540741|FG001|Overall Study|F/U not completed w/in study window|0|||
129885526|NCT02087150|467540742|FG002|Overall Study|F/U not completed w/in study window|1|||
129885527|NCT02087150|467540740|FG000|Overall Study|Other|1|||
130033590|NCT05047523|468078513|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
130033591|NCT05047523|468078514|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
129885528|NCT02087150|467540741|FG001|Overall Study|Other|0|||
129885529|NCT02087150|467540742|FG002|Overall Study|Other|0|||
129885530|NCT02087150|467540740|FG000|Overall Study|Pt moved out of town|0|||
130033592|NCT05047523|468078515|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
129885531|NCT02087150|467540741|FG001|Overall Study|Pt moved out of town|1|||
129885532|NCT02087150|467540742|FG002|Overall Study|Pt moved out of town|0|||
129885533|NCT01448044|467540743|FG000|Treatment Period|Adverse Event|4|||
129885534|NCT01448044|467540744|FG001|Treatment Period|Adverse Event|3|||
129885535|NCT01448044|467540743|FG000|Treatment Period|Lack of Efficacy|5|||
129885536|NCT01448044|467540744|FG001|Treatment Period|Lack of Efficacy|12|||
129885537|NCT01448044|467540743|FG000|Treatment Period|Subject requested discontinue study drug|1|||
129885538|NCT01448044|467540744|FG001|Treatment Period|Subject requested discontinue study drug|0|||
130258110|NCT04484857|468910315|FG000|Overall Study|Other than specified|4|||
130258111|NCT04484857|468910315|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
130258112|NCT01822925|468910316|FG000|Overall Study|Adverse Event|1|||
130258113|NCT01822925|468910317|FG001|Overall Study|Adverse Event|1|||
130258114|NCT01822925|468910318|FG002|Overall Study|Adverse Event|1|||
130258115|NCT01822925|468910319|FG003|Overall Study|Adverse Event|1|||
130258116|NCT01822925|468910316|FG000|Overall Study|Lost to Follow-up|0|||
130258117|NCT01822925|468910317|FG001|Overall Study|Lost to Follow-up|1|||
130258118|NCT01822925|468910318|FG002|Overall Study|Lost to Follow-up|0|||
130258119|NCT01822925|468910319|FG003|Overall Study|Lost to Follow-up|0|||
130258120|NCT01822925|468910316|FG000|Overall Study|Protocol Violation|1|||
130258121|NCT01822925|468910317|FG001|Overall Study|Protocol Violation|0|||
130258122|NCT01822925|468910318|FG002|Overall Study|Protocol Violation|0|||
130258123|NCT01822925|468910319|FG003|Overall Study|Protocol Violation|1|||
130258124|NCT01822925|468910316|FG000|Overall Study|Withdrawal by Subject|2|||
130258125|NCT01822925|468910317|FG001|Overall Study|Withdrawal by Subject|0|||
130258126|NCT01822925|468910318|FG002|Overall Study|Withdrawal by Subject|2|||
130258127|NCT01822925|468910319|FG003|Overall Study|Withdrawal by Subject|2|||
130258128|NCT01822925|468910316|FG000|Overall Study|Taking prohibited medication|2|||
130258129|NCT01822925|468910317|FG001|Overall Study|Taking prohibited medication|0|||
130258130|NCT01822925|468910318|FG002|Overall Study|Taking prohibited medication|0|||
130258131|NCT01822925|468910319|FG003|Overall Study|Taking prohibited medication|1|||
130258132|NCT04617860|468910324|FG000|Overall Study|Adverse Event|0|||
130258133|NCT04617860|468910325|FG001|Overall Study|Adverse Event|2|||
130258134|NCT04617860|468910326|FG002|Overall Study|Adverse Event|2|||
130258135|NCT04617860|468910324|FG000|Overall Study|Withdrawal by Subject|0|||
130258136|NCT04617860|468910325|FG001|Overall Study|Withdrawal by Subject|0|||
130258137|NCT04617860|468910326|FG002|Overall Study|Withdrawal by Subject|2|||
130258138|NCT04617860|468910324|FG000|Overall Study|Physician Decision|0|||
130258139|NCT04617860|468910325|FG001|Overall Study|Physician Decision|1|||
130258140|NCT04617860|468910326|FG002|Overall Study|Physician Decision|0|||
130258141|NCT04617860|468910324|FG000|Overall Study|Sponsor Decision|0|||
130258142|NCT04617860|468910325|FG001|Overall Study|Sponsor Decision|3|||
130258143|NCT04617860|468910326|FG002|Overall Study|Sponsor Decision|1|||
130258144|NCT04617860|468910324|FG000|Overall Study|Termination of Study by Sponsor|8|||
130258145|NCT04617860|468910325|FG001|Overall Study|Termination of Study by Sponsor|4|||
130258146|NCT04617860|468910326|FG002|Overall Study|Termination of Study by Sponsor|13|||
130258147|NCT01055028|468910327|FG000|Screening|Screen Failure|1|||
130258148|NCT01055028|468910328|FG001|Screening|Screen Failure|1|||
130258149|NCT01055028|468910327|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
130258150|NCT01055028|468910328|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
130258151|NCT01055028|468910327|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
130258152|NCT01055028|468910328|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
130258153|NCT01055028|468910327|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
130258154|NCT01055028|468910328|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
130258155|NCT06582732|468910329|FG000|Initial Study Period|Adverse Event|0|||
130258156|NCT06582732|468910330|FG001|Initial Study Period|Adverse Event|0|||
130258157|NCT06582732|468910331|FG002|Initial Study Period|Adverse Event|0|||
130258158|NCT06582732|468910332|FG003|Initial Study Period|Adverse Event|2|||
130258159|NCT06582732|468910333|FG004|Initial Study Period|Adverse Event|0|||
130258160|NCT06582732|468910334|FG005|Initial Study Period|Adverse Event|0|||
130258161|NCT06582732|468910335|FG006|Initial Study Period|Adverse Event|0|||
130258162|NCT06582732|468910329|FG000|Initial Study Period|Death|1|||
130258163|NCT06582732|468910330|FG001|Initial Study Period|Death|0|||
130258164|NCT06582732|468910331|FG002|Initial Study Period|Death|0|||
130258165|NCT06582732|468910332|FG003|Initial Study Period|Death|0|||
130258166|NCT06582732|468910333|FG004|Initial Study Period|Death|1|||
130258167|NCT06582732|468910334|FG005|Initial Study Period|Death|0|||
130258168|NCT06582732|468910335|FG006|Initial Study Period|Death|0|||
130258169|NCT06582732|468910329|FG000|Initial Study Period|Lost to Follow-up|0|||
130258170|NCT06582732|468910330|FG001|Initial Study Period|Lost to Follow-up|0|||
130033593|NCT05047523|468078516|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
130258171|NCT06582732|468910331|FG002|Initial Study Period|Lost to Follow-up|2|||
130258172|NCT06582732|468910332|FG003|Initial Study Period|Lost to Follow-up|0|||
130258173|NCT06582732|468910333|FG004|Initial Study Period|Lost to Follow-up|0|||
130258174|NCT06582732|468910334|FG005|Initial Study Period|Lost to Follow-up|0|||
130258175|NCT06582732|468910335|FG006|Initial Study Period|Lost to Follow-up|0|||
130258176|NCT06582732|468910329|FG000|Initial Study Period|Withdrawal by Subject|0|||
130033594|NCT05047523|468078517|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
130033595|NCT05047523|468078512|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
130258177|NCT06582732|468910330|FG001|Initial Study Period|Withdrawal by Subject|1|||
130258178|NCT06582732|468910331|FG002|Initial Study Period|Withdrawal by Subject|0|||
130258179|NCT06582732|468910332|FG003|Initial Study Period|Withdrawal by Subject|1|||
130033596|NCT05047523|468078513|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130258180|NCT06582732|468910333|FG004|Initial Study Period|Withdrawal by Subject|3|||
130033597|NCT05047523|468078514|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130033598|NCT05047523|468078515|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130033599|NCT05047523|468078516|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130033600|NCT05047523|468078517|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
130033601|NCT05047523|468078512|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130033602|NCT05047523|468078513|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130033603|NCT05047523|468078514|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130033604|NCT05047523|468078515|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
130033605|NCT05047523|468078516|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
130033606|NCT05047523|468078517|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
130258181|NCT06582732|468910334|FG005|Initial Study Period|Withdrawal by Subject|1|||
130258182|NCT06582732|468910335|FG006|Initial Study Period|Withdrawal by Subject|2|||
130033607|NCT05047523|468078512|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
130033608|NCT05047523|468078513|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
130033609|NCT05047523|468078514|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
130258183|NCT06582732|468910329|FG000|Initial Study Period|Moved Away|0|||
130258184|NCT06582732|468910330|FG001|Initial Study Period|Moved Away|0|||
130258185|NCT06582732|468910331|FG002|Initial Study Period|Moved Away|0|||
130258186|NCT06582732|468910332|FG003|Initial Study Period|Moved Away|0|||
130258187|NCT06582732|468910333|FG004|Initial Study Period|Moved Away|1|||
130258188|NCT06582732|468910334|FG005|Initial Study Period|Moved Away|0|||
130258189|NCT06582732|468910335|FG006|Initial Study Period|Moved Away|0|||
130258190|NCT01182350|468910336|FG000|Overall Study|Adverse Event|5|||
130258191|NCT01182350|468910337|FG001|Overall Study|Adverse Event|0|||
129885539|NCT01448044|467540743|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
129885540|NCT01448044|467540744|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
129885541|NCT01448044|467540743|FG000|Treatment Period|Participant does not meet study criteria|1|||
129885542|NCT01448044|467540744|FG001|Treatment Period|Participant does not meet study criteria|0|||
129885543|NCT01448044|467540743|FG000|Treatment Period|Lost to Follow-up|2|||
129885544|NCT01448044|467540744|FG001|Treatment Period|Lost to Follow-up|1|||
129885545|NCT01448044|467540743|FG000|Treatment Period|Other reason|2|||
129885546|NCT01448044|467540744|FG001|Treatment Period|Other reason|0|||
129885547|NCT01448044|467540743|FG000|Follow Up Period|Withdrawal by Subject|1|||
129885548|NCT01448044|467540744|FG001|Follow Up Period|Withdrawal by Subject|1|||
129885549|NCT01448044|467540743|FG000|Follow Up Period|Lost to Follow-up|6|||
129885550|NCT01448044|467540744|FG001|Follow Up Period|Lost to Follow-up|2|||
129885551|NCT01448044|467540743|FG000|Follow Up Period|Other|5|||
129885552|NCT01448044|467540744|FG001|Follow Up Period|Other|11|||
129885553|NCT02500316|467540754|FG000|Overall Study|Adverse Event|3|||
129885554|NCT02500316|467540754|FG000|Overall Study|Lost to Follow-up|2|||
129885555|NCT02500316|467540754|FG000|Overall Study|Protocol Violation|1|||
129885556|NCT02500316|467540754|FG000|Overall Study|Withdrawal by Subject|15|||
129885557|NCT02500316|467540754|FG000|Overall Study|Final height achieved|5|||
129885558|NCT02500316|467540754|FG000|Overall Study|Due to war activity|1|||
129885559|NCT03560245|467540755|FG000|Overall Study|Withdrawal by Subject|3|||
129885560|NCT03560245|467540756|FG001|Overall Study|Withdrawal by Subject|2|||
129885561|NCT03560245|467540755|FG000|Overall Study|Adverse Event|1|||
129885562|NCT03560245|467540756|FG001|Overall Study|Adverse Event|1|||
129885563|NCT03560245|467540755|FG000|Overall Study|Protocol Violation|1|||
129885564|NCT03560245|467540756|FG001|Overall Study|Protocol Violation|0|||
129885565|NCT03560245|467540755|FG000|Overall Study|Death|0|||
129885566|NCT03560245|467540756|FG001|Overall Study|Death|1|||
129885567|NCT03560245|467540755|FG000|Overall Study|Lost to Follow-up|0|||
129885568|NCT03560245|467540756|FG001|Overall Study|Lost to Follow-up|1|||
129885569|NCT03560245|467540755|FG000|Overall Study|Physician Decision|0|||
130033610|NCT05047523|468078515|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
130033611|NCT05047523|468078516|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
130033612|NCT05047523|468078517|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
130033613|NCT03658889|468078518|FG000|Overall Study|Protocol Violation|2|||
130258192|NCT01182350|468910338|FG002|Overall Study|Adverse Event|0|||
129885570|NCT03560245|467540756|FG001|Overall Study|Physician Decision|1|||
130258193|NCT01182350|468910339|FG003|Overall Study|Adverse Event|0|||
130258194|NCT01182350|468910340|FG004|Overall Study|Adverse Event|0|||
130258195|NCT01182350|468910336|FG000|Overall Study|Disease Progression|15|||
129885571|NCT03560245|467540755|FG000|Overall Study|Other|0|||
129885572|NCT03560245|467540756|FG001|Overall Study|Other|1|||
129885573|NCT02611830|467540767|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
129885574|NCT02611830|467540768|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130033614|NCT03658889|468078519|FG001|Overall Study|Protocol Violation|0|||
130033615|NCT00224016|468078526|FG000|Titration Period|Withdrawal by Subject|0|||
130258196|NCT01182350|468910337|FG001|Overall Study|Disease Progression|12|||
130258197|NCT01182350|468910338|FG002|Overall Study|Disease Progression|0|||
130258198|NCT01182350|468910339|FG003|Overall Study|Disease Progression|1|||
130258199|NCT01182350|468910340|FG004|Overall Study|Disease Progression|0|||
130258200|NCT01182350|468910336|FG000|Overall Study|Death|0|||
129885575|NCT02611830|467540769|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
130258201|NCT01182350|468910337|FG001|Overall Study|Death|1|||
130258202|NCT01182350|468910338|FG002|Overall Study|Death|1|||
130258203|NCT01182350|468910339|FG003|Overall Study|Death|0|||
130258204|NCT01182350|468910340|FG004|Overall Study|Death|0|||
130258205|NCT01182350|468910336|FG000|Overall Study|Withdrawal by Subject|3|||
130258206|NCT01182350|468910337|FG001|Overall Study|Withdrawal by Subject|1|||
130258207|NCT01182350|468910338|FG002|Overall Study|Withdrawal by Subject|0|||
130258208|NCT01182350|468910339|FG003|Overall Study|Withdrawal by Subject|1|||
130258209|NCT01182350|468910340|FG004|Overall Study|Withdrawal by Subject|0|||
130258210|NCT01182350|468910336|FG000|Overall Study|Alternative Therapy|2|||
130258211|NCT01182350|468910337|FG001|Overall Study|Alternative Therapy|0|||
130258212|NCT01182350|468910338|FG002|Overall Study|Alternative Therapy|1|||
130258213|NCT01182350|468910339|FG003|Overall Study|Alternative Therapy|0|||
130258214|NCT01182350|468910340|FG004|Overall Study|Alternative Therapy|0|||
130258215|NCT01182350|468910336|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
130258216|NCT01182350|468910337|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
130258217|NCT01182350|468910338|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
130258218|NCT01182350|468910339|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
130258219|NCT01182350|468910340|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
130258220|NCT01182350|468910336|FG000|Overall Study|Unevaluable for Biopsy|0|||
130258221|NCT01182350|468910337|FG001|Overall Study|Unevaluable for Biopsy|0|||
130258222|NCT01182350|468910338|FG002|Overall Study|Unevaluable for Biopsy|0|||
130258223|NCT01182350|468910339|FG003|Overall Study|Unevaluable for Biopsy|0|||
130258224|NCT01182350|468910340|FG004|Overall Study|Unevaluable for Biopsy|3|||
130258225|NCT03898180|468910341|FG000|Overall Study|Death|178|||
130258226|NCT03898180|468910342|FG001|Overall Study|Death|173|||
130258227|NCT03898180|468910341|FG000|Overall Study|Physician Decision|1|||
130258228|NCT03898180|468910342|FG001|Overall Study|Physician Decision|0|||
130258229|NCT03898180|468910341|FG000|Overall Study|Sponsor Decision|3|||
130258230|NCT03898180|468910342|FG001|Overall Study|Sponsor Decision|0|||
130258231|NCT03898180|468910341|FG000|Overall Study|Lost to Follow-up|1|||
130258232|NCT03898180|468910342|FG001|Overall Study|Lost to Follow-up|0|||
130258233|NCT03898180|468910341|FG000|Overall Study|Withdrawal by Subject|5|||
130258234|NCT03898180|468910342|FG001|Overall Study|Withdrawal by Subject|4|||
130258235|NCT02507934|468910343|FG000|Overall Study|Lost to Follow-up|2|||
130258236|NCT02507934|468910344|FG001|Overall Study|Lost to Follow-up|0|||
130258237|NCT02507934|468910343|FG000|Overall Study|Withdrawal by Subject|2|||
130258238|NCT02507934|468910344|FG001|Overall Study|Withdrawal by Subject|0|||
130258239|NCT03559530|468910345|FG000|Overall Study|non-location of medical records|44|||
130258240|NCT03559530|468910346|FG001|Overall Study|non-location of medical records|0|||
130258241|NCT03559530|468910345|FG000|Overall Study|culture results not considered for treat|29|||
130258242|NCT03559530|468910346|FG001|Overall Study|culture results not considered for treat|0|||
130258243|NCT03559530|468910345|FG000|Overall Study|duplicate cases|8|||
130258244|NCT03559530|468910346|FG001|Overall Study|duplicate cases|0|||
130258245|NCT03559530|468910345|FG000|Overall Study|other species of Acinetobacte|7|||
130258246|NCT03559530|468910346|FG001|Overall Study|other species of Acinetobacte|0|||
130258247|NCT03559530|468910345|FG000|Overall Study|contamination / colonization|3|||
130258248|NCT03559530|468910346|FG001|Overall Study|contamination / colonization|0|||
130258249|NCT03331354|468910347|FG000|Overall Study|Withdrawal by Subject|1|||
130258250|NCT03331354|468910348|FG001|Overall Study|Withdrawal by Subject|3|||
130258251|NCT03331354|468910347|FG000|Overall Study|Lost to Follow-up|3|||
130258252|NCT03331354|468910348|FG001|Overall Study|Lost to Follow-up|3|||
130258253|NCT03331354|468910347|FG000|Overall Study|Found employment before initiated active intervention|0|||
130258254|NCT03331354|468910348|FG001|Overall Study|Found employment before initiated active intervention|4|||
130258255|NCT01646827|468910349|FG000|Overall Study|Lost to Follow-up|0|||
130258256|NCT01646827|468910350|FG001|Overall Study|Lost to Follow-up|3|||
130258257|NCT01646827|468910349|FG000|Overall Study|Physician Decision|1|||
130258258|NCT01646827|468910350|FG001|Overall Study|Physician Decision|2|||
130258259|NCT01646827|468910349|FG000|Overall Study|Withdrawal by Subject|1|||
130258260|NCT01646827|468910350|FG001|Overall Study|Withdrawal by Subject|0|||
130258261|NCT00928668|468910353|FG000|Overall Study|Adverse Event|1|||
130258262|NCT00928668|468910354|FG001|Overall Study|Adverse Event|0|||
130258263|NCT00928668|468910355|FG002|Overall Study|Adverse Event|0|||
130258264|NCT00928668|468910356|FG003|Overall Study|Adverse Event|0|||
130258265|NCT00928668|468910357|FG004|Overall Study|Adverse Event|0|||
130258266|NCT00928668|468910353|FG000|Overall Study|Protocol Violation|0|||
130258267|NCT00928668|468910354|FG001|Overall Study|Protocol Violation|0|||
130258268|NCT00928668|468910355|FG002|Overall Study|Protocol Violation|0|||
130258269|NCT00928668|468910356|FG003|Overall Study|Protocol Violation|0|||
130258270|NCT00928668|468910357|FG004|Overall Study|Protocol Violation|1|||
130258271|NCT00928668|468910353|FG000|Overall Study|Withdrawal by Subject|0|||
130258272|NCT00928668|468910354|FG001|Overall Study|Withdrawal by Subject|1|||
130258273|NCT00928668|468910355|FG002|Overall Study|Withdrawal by Subject|1|||
130258274|NCT00928668|468910356|FG003|Overall Study|Withdrawal by Subject|0|||
130258275|NCT00928668|468910357|FG004|Overall Study|Withdrawal by Subject|0|||
130258276|NCT00928668|468910353|FG000|Overall Study|Other reasons not listed above|0|||
130033616|NCT00224016|468078527|FG001|Titration Period|Withdrawal by Subject|1|||
130033617|NCT00224016|468078526|FG000|Titration Period|Lost to Follow-up|1|||
130033618|NCT00224016|468078527|FG001|Titration Period|Lost to Follow-up|0|||
130033619|NCT00224016|468078526|FG000|Maintenance Period|Withdrawal by Subject|2|||
130258277|NCT00928668|468910354|FG001|Overall Study|Other reasons not listed above|0|||
130258278|NCT00928668|468910355|FG002|Overall Study|Other reasons not listed above|0|||
130258279|NCT00928668|468910356|FG003|Overall Study|Other reasons not listed above|1|||
130258280|NCT00928668|468910357|FG004|Overall Study|Other reasons not listed above|0|||
130258281|NCT01767987|468910361|FG000|Overall Study|Physician Decision|4|||
130258282|NCT01767987|468910362|FG001|Overall Study|Physician Decision|1|||
130258283|NCT03232567|468910363|FG000|Overall Study|Withdrawal by Subject|0|||
130258284|NCT03232567|468910364|FG001|Overall Study|Withdrawal by Subject|1|||
130258285|NCT03232567|468910365|FG002|Overall Study|Withdrawal by Subject|0|||
130258286|NCT03232567|468910366|FG003|Overall Study|Withdrawal by Subject|0|||
130258287|NCT05837481|468910368|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
130258288|NCT05837481|468910369|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
130258289|NCT03038087|468910382|FG000|Overall Study|lost data|1|||
130258290|NCT00654355|468910383|FG000|Overall Study|Lost to Follow-up|2|||
130258291|NCT00654355|468910384|FG001|Overall Study|Lost to Follow-up|2|||
130258292|NCT05805150|468910391|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
130258293|NCT05805150|468910392|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
130258294|NCT02284893|468910393|FG000|26 Week (Short Term)|Adverse Event|1|||
130258295|NCT02284893|468910394|FG001|26 Week (Short Term)|Adverse Event|9|||
130258296|NCT02284893|468910393|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
130258297|NCT02284893|468910394|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
130258298|NCT02284893|468910393|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
130258299|NCT02284893|468910394|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
130258300|NCT02284893|468910393|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
130258301|NCT02284893|468910394|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
130258302|NCT02284893|468910393|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
130258303|NCT02284893|468910394|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
130258304|NCT02284893|468910393|FG000|26 Week (Short Term)|Other|1|||
130258305|NCT02284893|468910394|FG001|26 Week (Short Term)|Other|1|||
130258306|NCT02284893|468910393|FG000|52 Week (Long Term)|Adverse Event|3|||
130258307|NCT02284893|468910394|FG001|52 Week (Long Term)|Adverse Event|1|||
130258308|NCT02284893|468910393|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
130258309|NCT02284893|468910394|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
130258310|NCT02284893|468910393|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
130258311|NCT02284893|468910394|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
130258312|NCT02284893|468910393|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
130258313|NCT02284893|468910394|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
130258314|NCT02284893|468910393|FG000|52 Week (Long Term)|Non-Compliance|2|||
130258315|NCT02284893|468910394|FG001|52 Week (Long Term)|Non-Compliance|3|||
130258316|NCT00105066|468910401|FG000|Overall Study|Adverse Event|2|||
130258317|NCT00105066|468910402|FG001|Overall Study|Adverse Event|5|||
130258318|NCT01506726|468910415|FG000|Overall Study|Adverse Event|1|||
130258319|NCT01506726|468910416|FG001|Overall Study|Adverse Event|2|||
130258320|NCT02259231|468910423|FG000|Overall Study|Adverse Event|1|||
130258321|NCT02259231|468910424|FG001|Overall Study|Adverse Event|1|||
130258322|NCT02259231|468910425|FG002|Overall Study|Adverse Event|2|||
130258323|NCT02259231|468910426|FG003|Overall Study|Adverse Event|0|||
130258324|NCT02259231|468910427|FG004|Overall Study|Adverse Event|0|||
130258325|NCT02259231|468910428|FG005|Overall Study|Adverse Event|0|||
130258326|NCT02259231|468910429|FG006|Overall Study|Adverse Event|0|||
130258327|NCT02259231|468910423|FG000|Overall Study|Progressive Disease|4|||
130258328|NCT02259231|468910424|FG001|Overall Study|Progressive Disease|5|||
130258329|NCT02259231|468910425|FG002|Overall Study|Progressive Disease|4|||
130258330|NCT02259231|468910426|FG003|Overall Study|Progressive Disease|5|||
130258331|NCT02259231|468910427|FG004|Overall Study|Progressive Disease|4|||
130258332|NCT02259231|468910428|FG005|Overall Study|Progressive Disease|5|||
130258333|NCT02259231|468910429|FG006|Overall Study|Progressive Disease|4|||
130258334|NCT02259231|468910423|FG000|Overall Study|Sponsor termination of study|1|||
130258335|NCT02259231|468910424|FG001|Overall Study|Sponsor termination of study|0|||
130258336|NCT02259231|468910425|FG002|Overall Study|Sponsor termination of study|0|||
130258337|NCT02259231|468910426|FG003|Overall Study|Sponsor termination of study|1|||
130258338|NCT02259231|468910427|FG004|Overall Study|Sponsor termination of study|2|||
130258339|NCT02259231|468910428|FG005|Overall Study|Sponsor termination of study|1|||
130258340|NCT02259231|468910429|FG006|Overall Study|Sponsor termination of study|1|||
130258341|NCT00847730|468910433|FG000|Overall Study|Multiple interruptions in therapy|8|||
130258342|NCT04116489|468910437|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
130258343|NCT04116489|468910437|FG000|Overall Study|Withdrawal by Subject|1|||
130033620|NCT00224016|468078527|FG001|Maintenance Period|Withdrawal by Subject|0|||
130033621|NCT00224016|468078526|FG000|Maintenance Period|Lost to Follow-up|0|||
130033622|NCT00224016|468078527|FG001|Maintenance Period|Lost to Follow-up|1|||
130033623|NCT01609933|468078528|FG000|Overall Study|Adverse Event|1|||
130033624|NCT01609933|468078528|FG000|Overall Study|Withdrawal by Subject|3|||
130033625|NCT01252966|468078529|FG000|Overall Study|Lost to Follow-up|16|||
130033626|NCT01252966|468078530|FG001|Overall Study|Lost to Follow-up|10|||
130033627|NCT01252966|468078529|FG000|Overall Study|Withdrawal by Subject|7|||
130033628|NCT01252966|468078530|FG001|Overall Study|Withdrawal by Subject|3|||
130033629|NCT00206726|468078535|FG000|Overall Study|Delayed recovery of blood counts|1|||
130033630|NCT00206726|468078535|FG000|Overall Study|Progressive disease or relapsed disease|18|||
130033631|NCT00206726|468078535|FG000|Overall Study|Placed on new protocol|1|||
130033632|NCT00206726|468078535|FG000|Overall Study|Bone marrow transplant|1|||
130033633|NCT00206726|468078535|FG000|Overall Study|Adverse Event|17|||
130033634|NCT00206726|468078535|FG000|Overall Study|Death|4|||
130033635|NCT00206726|468078535|FG000|Overall Study|Protocol Violation|1|||
130033636|NCT00206726|468078535|FG000|Overall Study|Withdrawal by Subject|8|||
130033637|NCT01903876|468078536|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
130033638|NCT01903876|468078537|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
130258344|NCT02255656|468910442|FG000|Overall Study|Adverse Event|11|||
130258345|NCT02255656|468910442|FG000|Overall Study|Poor compliance to protocol|3|||
130258346|NCT02255656|468910442|FG000|Overall Study|Lost to Follow-up|30|||
130258347|NCT02255656|468910442|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
130258348|NCT02255656|468910442|FG000|Overall Study|Other|126|||
130258349|NCT03734536|468910443|FG000|Overall Study|Withdrew Consent|1|||
130258350|NCT03734536|468910444|FG001|Overall Study|Withdrew Consent|5|||
130258351|NCT03734536|468910443|FG000|Overall Study|Lost to Follow-up|10|||
130258352|NCT03734536|468910444|FG001|Overall Study|Lost to Follow-up|7|||
130258353|NCT01877278|468910445|FG000|Overall Study|Lost to Follow-up|3|||
130258354|NCT01877278|468910446|FG001|Overall Study|Lost to Follow-up|3|||
130258355|NCT05185453|468910453|FG000|Overall Study|Lost to Follow-up|13|||
130258356|NCT05185453|468910454|FG001|Overall Study|Lost to Follow-up|3|||
130258357|NCT02457793|468910455|FG000|Overall Study|Reason not specified|0|||
130258358|NCT02457793|468910456|FG001|Overall Study|Reason not specified|0|||
130258359|NCT02457793|468910457|FG002|Overall Study|Reason not specified|0|||
130258360|NCT02457793|468910458|FG003|Overall Study|Reason not specified|1|||
130258361|NCT02457793|468910459|FG004|Overall Study|Reason not specified|1|||
130258362|NCT02457793|468910460|FG005|Overall Study|Reason not specified|1|||
130258363|NCT02457793|468910455|FG000|Overall Study|Withdrawal by Subject|0|||
130258364|NCT02457793|468910456|FG001|Overall Study|Withdrawal by Subject|4|||
130258365|NCT02457793|468910457|FG002|Overall Study|Withdrawal by Subject|2|||
130258366|NCT02457793|468910458|FG003|Overall Study|Withdrawal by Subject|2|||
130258367|NCT02457793|468910459|FG004|Overall Study|Withdrawal by Subject|2|||
130258368|NCT02457793|468910460|FG005|Overall Study|Withdrawal by Subject|2|||
130258369|NCT02457793|468910455|FG000|Overall Study|Adverse Event|0|||
130258370|NCT02457793|468910456|FG001|Overall Study|Adverse Event|0|||
130258371|NCT02457793|468910457|FG002|Overall Study|Adverse Event|0|||
130258372|NCT02457793|468910458|FG003|Overall Study|Adverse Event|1|||
130258373|NCT02457793|468910459|FG004|Overall Study|Adverse Event|0|||
130258374|NCT02457793|468910460|FG005|Overall Study|Adverse Event|0|||
130258375|NCT02457793|468910455|FG000|Overall Study|Physician Decision|1|||
130258376|NCT02457793|468910456|FG001|Overall Study|Physician Decision|0|||
130258377|NCT02457793|468910457|FG002|Overall Study|Physician Decision|1|||
130258378|NCT02457793|468910458|FG003|Overall Study|Physician Decision|1|||
130258379|NCT02457793|468910459|FG004|Overall Study|Physician Decision|1|||
130258380|NCT02457793|468910460|FG005|Overall Study|Physician Decision|3|||
130258381|NCT02757768|468910465|FG000|Overall Study|Randomized Never Received Study Drug|3|||
130258382|NCT02757768|468910466|FG001|Overall Study|Randomized Never Received Study Drug|4|||
130258383|NCT02757768|468910465|FG000|Overall Study|Adverse Event|5|||
130258384|NCT02757768|468910466|FG001|Overall Study|Adverse Event|3|||
130258385|NCT02757768|468910465|FG000|Overall Study|Lack of Efficacy|2|||
130258386|NCT02757768|468910466|FG001|Overall Study|Lack of Efficacy|1|||
130258387|NCT02757768|468910465|FG000|Overall Study|Lost to Follow-up|1|||
130258388|NCT02757768|468910466|FG001|Overall Study|Lost to Follow-up|0|||
130258389|NCT02757768|468910465|FG000|Overall Study|Protocol Deviation|2|||
130258390|NCT02757768|468910466|FG001|Overall Study|Protocol Deviation|9|||
130258391|NCT02757768|468910465|FG000|Overall Study|Withdrawal by Subject|16|||
130258392|NCT02757768|468910466|FG001|Overall Study|Withdrawal by Subject|9|||
130258393|NCT02757768|468910465|FG000|Overall Study|Miscellaneous|4|||
130258394|NCT02757768|468910466|FG001|Overall Study|Miscellaneous|2|||
130258395|NCT05929326|468910467|FG000|Overall Study|unqualified sample|2|||
130258396|NCT05929326|468910468|FG001|Overall Study|unqualified sample|3|||
130258397|NCT05929326|468910469|FG002|Overall Study|unqualified sample|7|||
130258398|NCT04890509|468910470|FG000|Overall Study|Death|4|||
130258399|NCT04890509|468910471|FG001|Overall Study|Death|4|||
130258400|NCT02278003|468911768|FG000|Overall Study|Withdrawal by Subject|11|||
130258401|NCT02278003|468911769|FG001|Overall Study|Withdrawal by Subject|0|||
130258402|NCT02278003|468911768|FG000|Overall Study|Not Treated|1|||
130258403|NCT02278003|468911769|FG001|Overall Study|Not Treated|0|||
130258404|NCT02278003|468911768|FG000|Overall Study|Recognition task improperly completed|7|||
130258405|NCT02278003|468911769|FG001|Overall Study|Recognition task improperly completed|0|||
130033639|NCT01903876|468078536|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
130033640|NCT01903876|468078537|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
130033641|NCT04317690|468078540|FG000|Overall Study|did not have complete information for primary outcome|0|||
130033642|NCT04317690|468078541|FG001|Overall Study|did not have complete information for primary outcome|4|||
130033643|NCT04317690|468078542|FG002|Overall Study|did not have complete information for primary outcome|0|||
130033644|NCT04317690|468078543|FG003|Overall Study|did not have complete information for primary outcome|2|||
130033645|NCT04317690|468078544|FG004|Overall Study|did not have complete information for primary outcome|0|||
130258406|NCT04123704|468911772|FG000|Overall Study|Disease progression|2|||
130258407|NCT00939185|468911773|FG000|Overall Study|Adverse Event|3|||
130258408|NCT00939185|468911773|FG000|Overall Study|Lack of Efficacy|1|||
130258409|NCT00939185|468911773|FG000|Overall Study|Lost to Follow-up|6|||
130258410|NCT00939185|468911773|FG000|Overall Study|Other|3|||
130258411|NCT00939185|468911773|FG000|Overall Study|Withdrawal by Subject|2|||
130258412|NCT00939185|468911773|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
130258413|NCT00363298|468911774|FG000|First Study Week|Lack of Efficacy|6|||
130258414|NCT00363298|468911775|FG001|First Study Week|Lack of Efficacy|5|||
130258415|NCT00363298|468911774|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
130258416|NCT00363298|468911775|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
130258417|NCT03552029|468911776|FG000|Overall Study|Death|3|||
130258418|NCT03552029|468911777|FG001|Overall Study|Death|0|||
130258419|NCT03552029|468911776|FG000|Overall Study|Adverse Event|1|||
130258420|NCT03552029|468911777|FG001|Overall Study|Adverse Event|0|||
130258421|NCT03552029|468911776|FG000|Overall Study|Lack of Efficacy|0|||
130258422|NCT03552029|468911777|FG001|Overall Study|Lack of Efficacy|2|||
130258423|NCT03552029|468911776|FG000|Overall Study|Physician Decision|0|||
130258424|NCT03552029|468911777|FG001|Overall Study|Physician Decision|1|||
130258425|NCT03552029|468911776|FG000|Overall Study|Study terminated by Sponsor|0|||
130258426|NCT03552029|468911777|FG001|Overall Study|Study terminated by Sponsor|1|||
130258427|NCT03552029|468911776|FG000|Overall Study|Other|0|||
130258428|NCT03552029|468911777|FG001|Overall Study|Other|2|||
130258429|NCT03468998|468911783|FG000|Overall Study|Withdrawal by Subject|1|||
130258430|NCT03468998|468911784|FG001|Overall Study|Withdrawal by Subject|1|||
130258431|NCT03468998|468911785|FG002|Overall Study|Withdrawal by Subject|0|||
130258432|NCT03468998|468911786|FG003|Overall Study|Withdrawal by Subject|4|||
130258433|NCT03468998|468911787|FG004|Overall Study|Withdrawal by Subject|1|||
130258434|NCT03468998|468911788|FG005|Overall Study|Withdrawal by Subject|0|||
130258435|NCT00836706|468911791|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
130258436|NCT00836706|468911792|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130258437|NCT02989857|468911793|FG000|Randomization Phase|Not Treated|3|||
130258438|NCT02989857|468911794|FG001|Randomization Phase|Not Treated|2|||
130258439|NCT02989857|468911795|FG002|Randomization Phase|Not Treated|0|||
130258440|NCT00633126|468911800|FG000|Overall Study|Did not receive full dose|1|||
130258441|NCT02538614|468911813|FG000|Overall Study|Progressive Disease|2|||
130033646|NCT02612909|468078545|FG000|Phase 2|Withdrawal by Subject|2|||
130258442|NCT01425814|468911818|FG000|Period 1|Stability criteria not fulfilled|0|||
130033647|NCT02612909|468078546|FG001|Phase 2|Withdrawal by Subject|5|||
130033648|NCT02612909|468078547|FG002|Phase 2|Withdrawal by Subject|0|||
130258443|NCT01425814|468911819|FG001|Period 1|Stability criteria not fulfilled|1|||
130258444|NCT01425814|468911820|FG002|Period 1|Stability criteria not fulfilled|0|||
130258445|NCT01425814|468911821|FG003|Period 1|Stability criteria not fulfilled|0|||
130258446|NCT01425814|468911822|FG004|Period 1|Stability criteria not fulfilled|0|||
130258447|NCT01425814|468911823|FG005|Period 1|Stability criteria not fulfilled|0|||
130258448|NCT01425814|468911818|FG000|Period 2|Stability criteria not fulfilled|0|||
130258449|NCT01425814|468911819|FG001|Period 2|Stability criteria not fulfilled|1|||
130258450|NCT01425814|468911820|FG002|Period 2|Stability criteria not fulfilled|0|||
130258451|NCT01425814|468911821|FG003|Period 2|Stability criteria not fulfilled|0|||
130258452|NCT01425814|468911822|FG004|Period 2|Stability criteria not fulfilled|0|||
130258453|NCT01425814|468911823|FG005|Period 2|Stability criteria not fulfilled|0|||
130258454|NCT01425814|468911818|FG000|Period 3|Adverse Event|0|||
130258455|NCT01425814|468911819|FG001|Period 3|Adverse Event|0|||
130033649|NCT02612909|468078548|FG003|Phase 2|Withdrawal by Subject|0|||
130033650|NCT02612909|468078549|FG004|Phase 2|Withdrawal by Subject|0|||
130033651|NCT02612909|468078545|FG000|Phase 2|Pregnancy|0|||
130033652|NCT02612909|468078546|FG001|Phase 2|Pregnancy|0|||
130033653|NCT02612909|468078547|FG002|Phase 2|Pregnancy|1|||
130033654|NCT02612909|468078548|FG003|Phase 2|Pregnancy|0|||
130033655|NCT02612909|468078549|FG004|Phase 2|Pregnancy|0|||
130033656|NCT02612909|468078545|FG000|Phase 3|Withdrawal by Subject|0|||
130033657|NCT02612909|468078546|FG001|Phase 3|Withdrawal by Subject|0|||
130033658|NCT02612909|468078547|FG002|Phase 3|Withdrawal by Subject|0|||
130033659|NCT02612909|468078548|FG003|Phase 3|Withdrawal by Subject|1|||
130033660|NCT02612909|468078549|FG004|Phase 3|Withdrawal by Subject|0|||
130033661|NCT01719757|468078551|FG000|Overall Study|Adverse Event|38|||
130033662|NCT01719757|468078551|FG000|Overall Study|Withdrawal by Subject|15|||
130033663|NCT01719757|468078551|FG000|Overall Study|Lost to Follow-up|20|||
130033664|NCT01719757|468078551|FG000|Overall Study|Protocol Violation|1|||
130033665|NCT01719757|468078551|FG000|Overall Study|well controlled pain|27|||
130033666|NCT02626338|468078552|FG000|Overall Study|Lack of Efficacy|3|||
130033667|NCT02626338|468078553|FG001|Overall Study|Lack of Efficacy|2|||
130033668|NCT02626338|468078554|FG002|Overall Study|Lack of Efficacy|0|||
130033669|NCT01901224|468078560|FG000|Overall Study|study was not funded and terminated|2|||
130033670|NCT00450580|468078561|FG000|Overall Study|Adverse Event|5|||
130033671|NCT00450580|468078562|FG001|Overall Study|Adverse Event|7|||
130033672|NCT00450580|468078561|FG000|Overall Study|Lost to Follow-up|4|||
130033673|NCT00450580|468078562|FG001|Overall Study|Lost to Follow-up|5|||
130033674|NCT00450580|468078561|FG000|Overall Study|Withdrawal by Subject|2|||
130033675|NCT00450580|468078562|FG001|Overall Study|Withdrawal by Subject|2|||
130033676|NCT00450580|468078561|FG000|Overall Study|Protocol Violation|1|||
130033677|NCT00450580|468078562|FG001|Overall Study|Protocol Violation|1|||
130033678|NCT00450580|468078561|FG000|Overall Study|Protocol-defined virologic failure|1|||
130258456|NCT01425814|468911820|FG002|Period 3|Adverse Event|0|||
130258457|NCT01425814|468911821|FG003|Period 3|Adverse Event|0|||
130258458|NCT01425814|468911822|FG004|Period 3|Adverse Event|0|||
130258459|NCT01425814|468911823|FG005|Period 3|Adverse Event|1|||
130258460|NCT01425814|468911818|FG000|Period 4|Adverse Event|1|||
130258461|NCT01425814|468911819|FG001|Period 4|Adverse Event|0|||
130258462|NCT01425814|468911820|FG002|Period 4|Adverse Event|1|||
130258463|NCT01425814|468911821|FG003|Period 4|Adverse Event|0|||
130258464|NCT01425814|468911822|FG004|Period 4|Adverse Event|0|||
130258465|NCT01425814|468911823|FG005|Period 4|Adverse Event|0|||
130258466|NCT01425814|468911818|FG000|Period 5|Stability criteria not fulfilled|0|||
130258467|NCT01425814|468911819|FG001|Period 5|Stability criteria not fulfilled|0|||
130258468|NCT01425814|468911820|FG002|Period 5|Stability criteria not fulfilled|1|||
130258469|NCT01425814|468911821|FG003|Period 5|Stability criteria not fulfilled|0|||
130258470|NCT01425814|468911822|FG004|Period 5|Stability criteria not fulfilled|0|||
130258471|NCT01425814|468911823|FG005|Period 5|Stability criteria not fulfilled|1|||
130258472|NCT00565747|468911825|FG000|Overall Study|No embryo transfer|67|||
130258473|NCT00565747|468911826|FG001|Overall Study|No embryo transfer|73|||
130258474|NCT02684461|468911829|FG000|Overall Study|Adverse Event|1|||
130258475|NCT02684461|468911830|FG001|Overall Study|Adverse Event|0|||
130258476|NCT02684461|468911831|FG002|Overall Study|Adverse Event|0|||
130258477|NCT02684461|468911829|FG000|Overall Study|Lack of Efficacy|1|||
130033679|NCT00450580|468078562|FG001|Overall Study|Protocol-defined virologic failure|0|||
130033680|NCT00450580|468078561|FG000|Overall Study|Could not comply with scheduled visits|1|||
130258478|NCT02684461|468911830|FG001|Overall Study|Lack of Efficacy|2|||
130258479|NCT02684461|468911831|FG002|Overall Study|Lack of Efficacy|0|||
130258480|NCT02390076|468911832|FG000|Overall Study|Lost to Follow-up|2|||
130258481|NCT02390076|468911833|FG001|Overall Study|Lost to Follow-up|1|||
130258482|NCT02390076|468911834|FG002|Overall Study|Lost to Follow-up|4|||
130258483|NCT01358734|468911840|FG000|Overall Study|Adverse Event|4|||
130258484|NCT01358734|468911841|FG001|Overall Study|Adverse Event|7|||
130033681|NCT00450580|468078562|FG001|Overall Study|Could not comply with scheduled visits|0|||
130033682|NCT00450580|468078561|FG000|Overall Study|Patient went to Brazil|1|||
130033683|NCT00450580|468078562|FG001|Overall Study|Patient went to Brazil|0|||
130033684|NCT00450580|468078561|FG000|Overall Study|Patient could not swallow Norvir|1|||
130258485|NCT01358734|468911842|FG002|Overall Study|Adverse Event|3|||
130033685|NCT00450580|468078562|FG001|Overall Study|Patient could not swallow Norvir|0|||
130033686|NCT00450580|468078561|FG000|Overall Study|Withdrawal due to pregnancy|0|||
130258486|NCT01358734|468911840|FG000|Overall Study|Lack of Efficacy|0|||
130258487|NCT01358734|468911841|FG001|Overall Study|Lack of Efficacy|1|||
130258488|NCT01358734|468911842|FG002|Overall Study|Lack of Efficacy|3|||
130258489|NCT01358734|468911840|FG000|Overall Study|Withdrawal by Subject|1|||
130258490|NCT01358734|468911841|FG001|Overall Study|Withdrawal by Subject|6|||
130033687|NCT00450580|468078562|FG001|Overall Study|Withdrawal due to pregnancy|1|||
130033688|NCT00393718|468078564|FG000|Overall Study|Adverse Event|20|||
130033689|NCT00393718|468078565|FG001|Overall Study|Adverse Event|8|||
130033690|NCT00393718|468078564|FG000|Overall Study|Protocol Violation|1|||
130033691|NCT00393718|468078565|FG001|Overall Study|Protocol Violation|2|||
130258491|NCT01358734|468911842|FG002|Overall Study|Withdrawal by Subject|3|||
130258492|NCT01358734|468911840|FG000|Overall Study|Death|3|||
130258493|NCT01358734|468911841|FG001|Overall Study|Death|7|||
130258494|NCT01358734|468911842|FG002|Overall Study|Death|2|||
130258495|NCT01358734|468911840|FG000|Overall Study|Progressive Disease|5|||
130258496|NCT01358734|468911841|FG001|Overall Study|Progressive Disease|13|||
130258497|NCT01358734|468911842|FG002|Overall Study|Progressive Disease|16|||
130258498|NCT01358734|468911840|FG000|Overall Study|Non-compliance with study drug|0|||
130258499|NCT01358734|468911841|FG001|Overall Study|Non-compliance with study drug|0|||
130258500|NCT01358734|468911842|FG002|Overall Study|Non-compliance with study drug|1|||
130258501|NCT01358734|468911840|FG000|Overall Study|Other|2|||
130258502|NCT01358734|468911841|FG001|Overall Study|Other|5|||
130258503|NCT01358734|468911842|FG002|Overall Study|Other|4|||
130258504|NCT01358734|468911840|FG000|Overall Study|Protocol Violation|0|||
130258505|NCT01358734|468911841|FG001|Overall Study|Protocol Violation|0|||
130258506|NCT01358734|468911842|FG002|Overall Study|Protocol Violation|2|||
130258507|NCT03243084|468911846|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
129885576|NCT02611830|467540770|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
129885577|NCT02611830|467540767|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
129885578|NCT02611830|467540768|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
130033692|NCT00393718|468078564|FG000|Overall Study|Lack of Efficacy|10|||
130258508|NCT03243084|468911847|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
130258509|NCT02095106|468911848|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130258510|NCT02095106|468911849|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130258511|NCT00553254|468911852|FG000|Overall Study|Death|3|||
130258512|NCT00553254|468911853|FG001|Overall Study|Death|6|||
130258513|NCT00553254|468911854|FG002|Overall Study|Death|25|||
130258514|NCT00553254|468911852|FG000|Overall Study|Lost to Follow-up|0|||
130258515|NCT00553254|468911853|FG001|Overall Study|Lost to Follow-up|0|||
130258516|NCT00553254|468911854|FG002|Overall Study|Lost to Follow-up|2|||
130258517|NCT00553254|468911852|FG000|Overall Study|Withdrawal by Subject|2|||
130258518|NCT00553254|468911853|FG001|Overall Study|Withdrawal by Subject|0|||
130258519|NCT00553254|468911854|FG002|Overall Study|Withdrawal by Subject|2|||
130258520|NCT00553254|468911852|FG000|Overall Study|Study terminated by Sponsor|0|||
130258521|NCT00553254|468911853|FG001|Overall Study|Study terminated by Sponsor|0|||
130258522|NCT00553254|468911854|FG002|Overall Study|Study terminated by Sponsor|1|||
130258523|NCT00553254|468911852|FG000|Overall Study|Other|1|||
130258524|NCT00553254|468911853|FG001|Overall Study|Other|0|||
130258525|NCT00553254|468911854|FG002|Overall Study|Other|13|||
130258526|NCT02300233|468911862|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
130258527|NCT02300233|468911863|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130258528|NCT02300233|468911864|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
130258529|NCT02300233|468911862|FG000|Overall Study|Withdrawal by Subject|1|||
130258530|NCT02300233|468911863|FG001|Overall Study|Withdrawal by Subject|0|||
130258531|NCT02300233|468911864|FG002|Overall Study|Withdrawal by Subject|3|||
130258532|NCT02300233|468911862|FG000|Overall Study|Investigator Judgement|0|||
130258533|NCT02300233|468911863|FG001|Overall Study|Investigator Judgement|0|||
130258534|NCT02300233|468911864|FG002|Overall Study|Investigator Judgement|1|||
130258535|NCT02300233|468911862|FG000|Overall Study|Reason Not Specified|0|||
130258536|NCT02300233|468911863|FG001|Overall Study|Reason Not Specified|0|||
130258537|NCT02300233|468911864|FG002|Overall Study|Reason Not Specified|5|||
130258538|NCT00833690|468911865|FG000|Overall Study|Withdrawal by Subject|1|||
130258539|NCT00833690|468911866|FG001|Overall Study|Withdrawal by Subject|0|||
130258540|NCT00833690|468911867|FG002|Overall Study|Withdrawal by Subject|0|||
130258541|NCT00833690|468911865|FG000|Overall Study|Discontinued study drug|3|||
130258542|NCT00833690|468911866|FG001|Overall Study|Discontinued study drug|2|||
130258543|NCT00833690|468911867|FG002|Overall Study|Discontinued study drug|0|||
130258544|NCT05448950|468911868|FG000|Overall Study|Death|2|||
129885579|NCT02611830|467540769|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
130033693|NCT00393718|468078565|FG001|Overall Study|Lack of Efficacy|9|||
130033694|NCT00393718|468078564|FG000|Overall Study|Hypoglycaemia|3|||
130258545|NCT05448950|468911868|FG000|Overall Study|Withdrawal by Subject|1|||
130258546|NCT05448950|468911868|FG000|Overall Study|AVG abandoned|4|||
130258547|NCT04752566|468911869|FG000|Overall Study|Protocol Violation|0|||
130258548|NCT04752566|468911870|FG001|Overall Study|Protocol Violation|1|||
130258549|NCT04752566|468911869|FG000|Overall Study|Death|1|||
130258550|NCT04752566|468911870|FG001|Overall Study|Death|0|||
130258551|NCT04752566|468911869|FG000|Overall Study|Adverse Event|1|||
130258552|NCT04752566|468911870|FG001|Overall Study|Adverse Event|0|||
130258553|NCT04752566|468911869|FG000|Overall Study|Withdrawal by Subject|2|||
130258554|NCT04752566|468911870|FG001|Overall Study|Withdrawal by Subject|0|||
130258555|NCT04752566|468911869|FG000|Overall Study|Physician Decision|1|||
130258556|NCT04752566|468911870|FG001|Overall Study|Physician Decision|1|||
130258557|NCT01153516|468911871|FG000|Overall Study|Both subjects refused surgery|2|||
130258558|NCT01153516|468911872|FG001|Overall Study|Both subjects refused surgery|0|||
130258559|NCT03773484|468911873|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
130258560|NCT01889251|468911874|FG000|Overall Study|Adverse Event|1|||
130258561|NCT01889251|468911875|FG001|Overall Study|Adverse Event|0|||
130258562|NCT01344226|468911880|FG000|Overall Study|Protocol Violation|2|||
130258563|NCT01344226|468911880|FG000|Overall Study|Withdrawal by Subject|3|||
130258564|NCT01344226|468911880|FG000|Overall Study|Lack of Efficacy|3|||
130258565|NCT02302222|468911883|FG000|Overall Study|Physician Decision|0|||
130258566|NCT02302222|468911884|FG001|Overall Study|Physician Decision|4|||
130258567|NCT02302222|468911883|FG000|Overall Study|Lost to Follow-up|1|||
130258568|NCT02302222|468911884|FG001|Overall Study|Lost to Follow-up|0|||
130258569|NCT02302222|468911883|FG000|Overall Study|Treatment discontinued before day 5|0|||
130258570|NCT02302222|468911884|FG001|Overall Study|Treatment discontinued before day 5|1|||
130258571|NCT02302222|468911883|FG000|Overall Study|Withdrawn prior to any treatment|0|||
130258572|NCT02302222|468911884|FG001|Overall Study|Withdrawn prior to any treatment|1|||
130258573|NCT03781570|468911890|FG000|Overall Study|Technical Issues (equipment failure)|31|||
130258574|NCT03781570|468911890|FG000|Overall Study|Withdrawal by Subject|7|||
130258575|NCT03781570|468911890|FG000|Overall Study|Physical Constraints|11|||
130258576|NCT01107496|468911891|FG000|Overall Study|Adverse Event|1|||
130258577|NCT01107496|468911892|FG001|Overall Study|Adverse Event|0|||
130258578|NCT01107496|468911891|FG000|Overall Study|Lack of Efficacy|1|||
130258579|NCT01107496|468911892|FG001|Overall Study|Lack of Efficacy|0|||
130258580|NCT01107496|468911891|FG000|Overall Study|Protocol Violation|0|||
130258581|NCT01107496|468911892|FG001|Overall Study|Protocol Violation|1|||
130258582|NCT01107496|468911891|FG000|Overall Study|Lost to Follow-up|0|||
130258583|NCT01107496|468911892|FG001|Overall Study|Lost to Follow-up|1|||
130258584|NCT03709472|468911893|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
130258585|NCT03709472|468911894|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
130033695|NCT00393718|468078565|FG001|Overall Study|Hypoglycaemia|2|||
130033696|NCT00393718|468078564|FG000|Overall Study|Subject decision|5|||
130033697|NCT00393718|468078565|FG001|Overall Study|Subject decision|0|||
130033698|NCT00393718|468078564|FG000|Overall Study|Withdrawal of consent|2|||
130033699|NCT00393718|468078565|FG001|Overall Study|Withdrawal of consent|1|||
130033700|NCT00393718|468078564|FG000|Overall Study|Missed measurement|1|||
130033701|NCT00393718|468078565|FG001|Overall Study|Missed measurement|0|||
130033702|NCT00393718|468078564|FG000|Overall Study|Move|1|||
130033703|NCT00393718|468078565|FG001|Overall Study|Move|0|||
130033704|NCT03902080|468078566|FG000|Overall Study|Adverse Event|17|||
130033705|NCT03902080|468078567|FG001|Overall Study|Adverse Event|15|||
130033706|NCT03902080|468078566|FG000|Overall Study|Withdrawal by Subject|28|||
130033707|NCT03902080|468078567|FG001|Overall Study|Withdrawal by Subject|35|||
130033708|NCT03902080|468078566|FG000|Overall Study|Lost to Follow-up|6|||
130033709|NCT03902080|468078567|FG001|Overall Study|Lost to Follow-up|7|||
130033710|NCT03902080|468078566|FG000|Overall Study|Other|3|||
130033711|NCT03902080|468078567|FG001|Overall Study|Other|5|||
130033712|NCT03902080|468078566|FG000|Overall Study|Non compliance|4|||
130033713|NCT03902080|468078567|FG001|Overall Study|Non compliance|3|||
130033714|NCT03902080|468078566|FG000|Overall Study|Physician Decision|5|||
130033715|NCT03902080|468078567|FG001|Overall Study|Physician Decision|1|||
130033716|NCT03902080|468078566|FG000|Overall Study|Protocol Violation|3|||
130033717|NCT03902080|468078567|FG001|Overall Study|Protocol Violation|3|||
130033718|NCT03902080|468078566|FG000|Overall Study|Lack of Efficacy|1|||
130033719|NCT03902080|468078567|FG001|Overall Study|Lack of Efficacy|3|||
130258586|NCT03709472|468911893|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
130258587|NCT03709472|468911894|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
130258588|NCT03559556|468911895|FG000|Overall Study|Withdrawal by Subject|1|||
130258589|NCT02496000|468911897|FG000|Overall Study|Withdrawal by Subject|1|||
130033720|NCT03902080|468078566|FG000|Overall Study|Withdrawn prior to dosing|0|||
130033721|NCT03902080|468078567|FG001|Overall Study|Withdrawn prior to dosing|1|||
130033722|NCT00391976|468078572|FG000|Overall Study|Adverse Event|0|||
130033723|NCT00391976|468078573|FG001|Overall Study|Adverse Event|0|||
130033724|NCT00391976|468078574|FG002|Overall Study|Adverse Event|1|||
130258590|NCT02496000|468911898|FG001|Overall Study|Withdrawal by Subject|2|||
130258591|NCT02496000|468911899|FG002|Overall Study|Withdrawal by Subject|0|||
130258592|NCT02496000|468911897|FG000|Overall Study|Lost to Follow-up|1|||
130258593|NCT02496000|468911898|FG001|Overall Study|Lost to Follow-up|0|||
130258594|NCT02496000|468911899|FG002|Overall Study|Lost to Follow-up|1|||
130258595|NCT02496000|468911897|FG000|Overall Study|Protocol Violation|0|||
130258596|NCT02496000|468911898|FG001|Overall Study|Protocol Violation|0|||
130258597|NCT02496000|468911899|FG002|Overall Study|Protocol Violation|1|||
130258598|NCT02496000|468911897|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
130258599|NCT02496000|468911898|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
130258600|NCT02496000|468911899|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
130258601|NCT02496000|468911897|FG000|Overall Study|undetermined|0|||
130258602|NCT02496000|468911898|FG001|Overall Study|undetermined|1|||
130258603|NCT02496000|468911899|FG002|Overall Study|undetermined|0|||
130258604|NCT03274466|468911900|FG000|Overall Study|Withdrawal by Subject|7|||
130258605|NCT03274466|468911901|FG001|Overall Study|Withdrawal by Subject|3|||
130258606|NCT03274466|468911900|FG000|Overall Study|Protocol Specified Withdrawal|5|||
130258607|NCT03274466|468911901|FG001|Overall Study|Protocol Specified Withdrawal|11|||
130258608|NCT03274466|468911900|FG000|Overall Study|Lost to Follow-up|5|||
130258609|NCT03274466|468911901|FG001|Overall Study|Lost to Follow-up|7|||
130258610|NCT03274466|468911900|FG000|Overall Study|Subject Non-compliance|0|||
130258611|NCT03274466|468911901|FG001|Overall Study|Subject Non-compliance|1|||
130258612|NCT03274466|468911900|FG000|Overall Study|Adverse Event|3|||
130258613|NCT03274466|468911901|FG001|Overall Study|Adverse Event|3|||
130258614|NCT03274466|468911900|FG000|Overall Study|Physician Decision|0|||
130258615|NCT03274466|468911901|FG001|Overall Study|Physician Decision|1|||
130258616|NCT03274466|468911900|FG000|Overall Study|Protocol Violation|3|||
130258617|NCT03274466|468911901|FG001|Overall Study|Protocol Violation|3|||
130258618|NCT00618787|468911902|FG000|Overall Study|Adverse Event|0|||
130258619|NCT00618787|468911903|FG001|Overall Study|Adverse Event|1|||
130258620|NCT00618787|468911902|FG000|Overall Study|Withdrawal by Subject|2|||
130258621|NCT00618787|468911903|FG001|Overall Study|Withdrawal by Subject|1|||
130258622|NCT00618787|468911902|FG000|Overall Study|Lost to Follow-up|1|||
130258623|NCT00618787|468911903|FG001|Overall Study|Lost to Follow-up|0|||
130258624|NCT01107886|468911904|FG000|Overall Study|Lost to Follow-up|15|||
130258625|NCT01107886|468911905|FG001|Overall Study|Lost to Follow-up|13|||
130258626|NCT01107886|468911904|FG000|Overall Study|Withdrawal by Subject|180|||
130258627|NCT01107886|468911905|FG001|Overall Study|Withdrawal by Subject|196|||
130258628|NCT01107886|468911904|FG000|Overall Study|Administrative withdrawal of consent|7|||
130258629|NCT01107886|468911905|FG001|Overall Study|Administrative withdrawal of consent|5|||
130258630|NCT01649869|468911910|FG000|Overall Study|Family member illness|1|||
130258631|NCT01649869|468911911|FG001|Overall Study|Family member illness|0|||
130258632|NCT01649869|468911910|FG000|Overall Study|Required treatment outside protocol|1|||
130258633|NCT01649869|468911911|FG001|Overall Study|Required treatment outside protocol|0|||
130258634|NCT01649869|468911910|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
130258635|NCT01649869|468911911|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
130258636|NCT02333799|468914660|FG000|Treatment Period|Withdrawal by Subject|1|||
130258637|NCT02333799|468914660|FG000|Treatment Period|Death|6|||
130258638|NCT02333799|468914660|FG000|6 Month Follow Up Period|Physician Decision|1|||
130258639|NCT02333799|468914660|FG000|6 Month Follow Up Period|Death|1|||
130258640|NCT02333799|468914660|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
130258641|NCT02333799|468914660|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
130258642|NCT01657370|468914664|FG000|Overall Study|Withdrawal by Subject|0|||
130258643|NCT01657370|468914665|FG001|Overall Study|Withdrawal by Subject|0|||
130258644|NCT01657370|468914666|FG002|Overall Study|Withdrawal by Subject|1|||
130258645|NCT01657370|468914667|FG003|Overall Study|Withdrawal by Subject|0|||
130258646|NCT01657370|468914668|FG004|Overall Study|Withdrawal by Subject|0|||
130258647|NCT01657370|468914669|FG005|Overall Study|Withdrawal by Subject|1|||
130258648|NCT01657370|468914664|FG000|Overall Study|Physician Decision|2|||
130258649|NCT01657370|468914665|FG001|Overall Study|Physician Decision|3|||
130258650|NCT01657370|468914666|FG002|Overall Study|Physician Decision|1|||
130258651|NCT01657370|468914667|FG003|Overall Study|Physician Decision|2|||
130258652|NCT01657370|468914668|FG004|Overall Study|Physician Decision|5|||
130258653|NCT01657370|468914669|FG005|Overall Study|Physician Decision|0|||
130258654|NCT01657370|468914664|FG000|Overall Study|Lack of Qualifying Event|1|||
130258655|NCT01657370|468914665|FG001|Overall Study|Lack of Qualifying Event|0|||
130258656|NCT01657370|468914666|FG002|Overall Study|Lack of Qualifying Event|3|||
130258657|NCT01657370|468914667|FG003|Overall Study|Lack of Qualifying Event|2|||
130258658|NCT01657370|468914668|FG004|Overall Study|Lack of Qualifying Event|1|||
130258659|NCT01657370|468914669|FG005|Overall Study|Lack of Qualifying Event|2|||
130258660|NCT01657370|468914664|FG000|Overall Study|Adverse Event|0|||
130258661|NCT01657370|468914665|FG001|Overall Study|Adverse Event|0|||
130258662|NCT01657370|468914666|FG002|Overall Study|Adverse Event|0|||
130258663|NCT01657370|468914667|FG003|Overall Study|Adverse Event|0|||
130258664|NCT01657370|468914668|FG004|Overall Study|Adverse Event|1|||
130258665|NCT01657370|468914669|FG005|Overall Study|Adverse Event|0|||
130258666|NCT01657370|468914664|FG000|Overall Study|Protocol Violation|1|||
130258667|NCT01657370|468914665|FG001|Overall Study|Protocol Violation|1|||
130258668|NCT01657370|468914666|FG002|Overall Study|Protocol Violation|1|||
130258669|NCT01657370|468914667|FG003|Overall Study|Protocol Violation|1|||
130258670|NCT01657370|468914668|FG004|Overall Study|Protocol Violation|0|||
130258671|NCT01657370|468914669|FG005|Overall Study|Protocol Violation|0|||
130258672|NCT01657370|468914664|FG000|Overall Study|Lost to Follow-up|2|||
130258673|NCT01657370|468914665|FG001|Overall Study|Lost to Follow-up|0|||
129885580|NCT02611830|467540770|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
130033725|NCT00391976|468078572|FG000|Overall Study|Withdrawal of consent|0|||
130033726|NCT00391976|468078573|FG001|Overall Study|Withdrawal of consent|1|||
130033727|NCT00391976|468078574|FG002|Overall Study|Withdrawal of consent|1|||
130033728|NCT00391976|468078572|FG000|Overall Study|Lost to Follow-up|1|||
130033729|NCT00391976|468078573|FG001|Overall Study|Lost to Follow-up|2|||
130033730|NCT00391976|468078574|FG002|Overall Study|Lost to Follow-up|0|||
130033731|NCT00391976|468078572|FG000|Overall Study|Inappropriate enrollment|1|||
130033732|NCT00391976|468078573|FG001|Overall Study|Inappropriate enrollment|1|||
130033733|NCT00391976|468078574|FG002|Overall Study|Inappropriate enrollment|0|||
130033734|NCT00391976|468078572|FG000|Overall Study|Protocol deviation/violation|4|||
130033735|NCT00391976|468078573|FG001|Overall Study|Protocol deviation/violation|2|||
130033736|NCT00391976|468078574|FG002|Overall Study|Protocol deviation/violation|1|||
130033737|NCT00391976|468078572|FG000|Overall Study|Recurrence/no eradication of infection|21|||
130033738|NCT00391976|468078573|FG001|Overall Study|Recurrence/no eradication of infection|19|||
130033739|NCT00391976|468078574|FG002|Overall Study|Recurrence/no eradication of infection|0|||
130033740|NCT00391976|468078572|FG000|Overall Study|Unable to classify|0|||
130033741|NCT00391976|468078573|FG001|Overall Study|Unable to classify|0|||
130033742|NCT00391976|468078574|FG002|Overall Study|Unable to classify|1|||
130033743|NCT00391976|468078572|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
130033744|NCT00391976|468078573|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
130033745|NCT00391976|468078574|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
130033746|NCT01919307|468078575|FG000|Overall Study|Withdrawal by Subject|9|||
130033747|NCT01701258|468078581|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
130033748|NCT01701258|468078582|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
130033749|NCT01701258|468078583|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
130033750|NCT01701258|468078584|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
130033751|NCT01701258|468078585|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
130033752|NCT01701258|468078586|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
130033753|NCT01701258|468078587|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
130033754|NCT01701258|468078588|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
130033755|NCT01701258|468078589|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
130033756|NCT01701258|468078590|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
130033757|NCT01701258|468078591|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
130033758|NCT01701258|468078592|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
130033759|NCT01701258|468078593|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
130033760|NCT01701258|468078581|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
130033761|NCT01701258|468078582|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
130033762|NCT01701258|468078583|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
130033763|NCT01701258|468078584|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
130033764|NCT01701258|468078585|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
130033765|NCT01701258|468078586|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
130033766|NCT01701258|468078587|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
130033767|NCT01701258|468078588|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
130033768|NCT01701258|468078589|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
130033769|NCT01701258|468078590|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
130033770|NCT01701258|468078591|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
130033771|NCT01701258|468078592|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
130033772|NCT01701258|468078593|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
130033773|NCT01701258|468078581|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
130033774|NCT01701258|468078582|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
130033775|NCT01701258|468078583|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
130033776|NCT01701258|468078584|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
130033777|NCT01701258|468078585|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
130033778|NCT01701258|468078586|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
130033779|NCT01701258|468078587|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
130033780|NCT01701258|468078588|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
130033781|NCT01701258|468078589|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
130033782|NCT01701258|468078590|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
129885581|NCT02611830|467540767|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
130258674|NCT01657370|468914666|FG002|Overall Study|Lost to Follow-up|1|||
130258675|NCT01657370|468914667|FG003|Overall Study|Lost to Follow-up|0|||
130258676|NCT01657370|468914668|FG004|Overall Study|Lost to Follow-up|0|||
130033783|NCT01701258|468078591|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
130033784|NCT01701258|468078592|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
130033785|NCT01701258|468078593|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
130033786|NCT01701258|468078581|FG000|Assessment and Scheduling|Investigator Terminated|2|||
130033787|NCT01701258|468078582|FG001|Assessment and Scheduling|Investigator Terminated|0|||
130258677|NCT01657370|468914669|FG005|Overall Study|Lost to Follow-up|1|||
130258678|NCT03440385|468914680|FG000|Overall Study|Other Reason|4|||
130258679|NCT03440385|468914681|FG001|Overall Study|Other Reason|1|||
130258680|NCT03440385|468914680|FG000|Overall Study|Site Closed|1|||
130258681|NCT03440385|468914681|FG001|Overall Study|Site Closed|0|||
130258682|NCT03440385|468914680|FG000|Overall Study|Lost to Follow-up|2|||
130258683|NCT03440385|468914681|FG001|Overall Study|Lost to Follow-up|0|||
130258684|NCT03440385|468914680|FG000|Overall Study|Withdrawal by Subject|12|||
130258685|NCT03440385|468914681|FG001|Overall Study|Withdrawal by Subject|6|||
130258686|NCT03440385|468914680|FG000|Overall Study|Lack of Efficacy|9|||
130258687|NCT03440385|468914681|FG001|Overall Study|Lack of Efficacy|2|||
130258688|NCT03440385|468914680|FG000|Overall Study|Adverse Event|15|||
130101754|NCT02325739|468330751|FG003|Phase II Part|Physician Decision|0|||
130258689|NCT03440385|468914681|FG001|Overall Study|Adverse Event|11|||
130258690|NCT01168596|468914687|FG000|Overall Study|Withdrawal by Subject|3|||
130258691|NCT01168596|468914688|FG001|Overall Study|Withdrawal by Subject|1|||
130258692|NCT00876447|468914691|FG000|Overall Study|Other miscellaneous reasons|3|||
130258693|NCT00876447|468914692|FG001|Overall Study|Other miscellaneous reasons|8|||
130258694|NCT00876447|468914691|FG000|Overall Study|Site closure|19|||
130258695|NCT00876447|468914692|FG001|Overall Study|Site closure|14|||
130258696|NCT00876447|468914691|FG000|Overall Study|Protocol Violation|9|||
130258697|NCT00876447|468914692|FG001|Overall Study|Protocol Violation|3|||
130258698|NCT00876447|468914691|FG000|Overall Study|Personal reasons|30|||
130258699|NCT00876447|468914692|FG001|Overall Study|Personal reasons|28|||
130258700|NCT00876447|468914691|FG000|Overall Study|Lost to Follow-up|6|||
130258701|NCT00876447|468914692|FG001|Overall Study|Lost to Follow-up|15|||
130258702|NCT00876447|468914691|FG000|Overall Study|Pregnancy|4|||
130258703|NCT00876447|468914692|FG001|Overall Study|Pregnancy|2|||
130258704|NCT00876447|468914691|FG000|Overall Study|Lack of Efficacy|5|||
130258705|NCT00876447|468914692|FG001|Overall Study|Lack of Efficacy|3|||
130258706|NCT00876447|468914691|FG000|Overall Study|Adverse Event|4|||
130258707|NCT00876447|468914692|FG001|Overall Study|Adverse Event|8|||
130258708|NCT00189423|468914699|FG000|Overall Study|Death|746|||
130258709|NCT00189423|468914700|FG001|Overall Study|Death|747|||
130258710|NCT00189423|468914699|FG000|Overall Study|Withdrawal by Subject|9|||
130258711|NCT00189423|468914700|FG001|Overall Study|Withdrawal by Subject|9|||
130258712|NCT00189423|468914699|FG000|Overall Study|Lost to Follow-up|10|||
130258713|NCT00189423|468914700|FG001|Overall Study|Lost to Follow-up|10|||
130258714|NCT04622592|468914702|FG000|Overall Study|Death|0|||
130258715|NCT04622592|468914703|FG001|Overall Study|Death|0|||
130258716|NCT04622592|468914704|FG002|Overall Study|Death|1|||
130258717|NCT04622592|468914705|FG003|Overall Study|Death|0|||
130258718|NCT04622592|468914706|FG004|Overall Study|Death|0|||
130258719|NCT04622592|468914707|FG005|Overall Study|Death|0|||
130258720|NCT04622592|468914708|FG006|Overall Study|Death|0|||
130258721|NCT04622592|468914709|FG007|Overall Study|Death|1|||
130258722|NCT04622592|468914702|FG000|Overall Study|Lost to Follow-up|0|||
130033788|NCT01701258|468078583|FG002|Assessment and Scheduling|Investigator Terminated|0|||
130033789|NCT01701258|468078584|FG003|Assessment and Scheduling|Investigator Terminated|0|||
130033790|NCT01701258|468078585|FG004|Assessment and Scheduling|Investigator Terminated|0|||
130033791|NCT01701258|468078586|FG005|Assessment and Scheduling|Investigator Terminated|0|||
130033792|NCT01701258|468078587|FG006|Assessment and Scheduling|Investigator Terminated|0|||
130033793|NCT01701258|468078588|FG007|Assessment and Scheduling|Investigator Terminated|0|||
130033794|NCT01701258|468078589|FG008|Assessment and Scheduling|Investigator Terminated|0|||
130033795|NCT01701258|468078590|FG009|Assessment and Scheduling|Investigator Terminated|0|||
130101755|NCT02325739|468330752|FG004|Phase II Part|Physician Decision|0|||
130258723|NCT04622592|468914703|FG001|Overall Study|Lost to Follow-up|0|||
130258724|NCT04622592|468914704|FG002|Overall Study|Lost to Follow-up|0|||
130258725|NCT04622592|468914705|FG003|Overall Study|Lost to Follow-up|3|||
130258726|NCT04622592|468914706|FG004|Overall Study|Lost to Follow-up|1|||
130258727|NCT04622592|468914707|FG005|Overall Study|Lost to Follow-up|0|||
130033796|NCT01701258|468078591|FG010|Assessment and Scheduling|Investigator Terminated|0|||
130033797|NCT01701258|468078592|FG011|Assessment and Scheduling|Investigator Terminated|0|||
130258728|NCT04622592|468914708|FG006|Overall Study|Lost to Follow-up|2|||
130258729|NCT04622592|468914709|FG007|Overall Study|Lost to Follow-up|2|||
130258730|NCT04622592|468914702|FG000|Overall Study|Physician Decision|0|||
130258731|NCT04622592|468914703|FG001|Overall Study|Physician Decision|0|||
130258732|NCT04622592|468914704|FG002|Overall Study|Physician Decision|0|||
130258733|NCT04622592|468914705|FG003|Overall Study|Physician Decision|0|||
130258734|NCT04622592|468914706|FG004|Overall Study|Physician Decision|1|||
130033798|NCT01701258|468078593|FG012|Assessment and Scheduling|Investigator Terminated|0|||
130033799|NCT03093402|468078594|FG000|Overall Study|Lost to Follow-up|1|||
130033800|NCT03093402|468078595|FG001|Overall Study|Lost to Follow-up|0|||
130033801|NCT03093402|468078596|FG002|Overall Study|Lost to Follow-up|0|||
130033802|NCT03093402|468078597|FG003|Overall Study|Lost to Follow-up|0|||
130033803|NCT03093402|468078594|FG000|Overall Study|Withdrawal by Subject|3|||
130033804|NCT03093402|468078595|FG001|Overall Study|Withdrawal by Subject|3|||
130033805|NCT03093402|468078596|FG002|Overall Study|Withdrawal by Subject|0|||
130033806|NCT03093402|468078597|FG003|Overall Study|Withdrawal by Subject|1|||
130033807|NCT03093402|468078594|FG000|Overall Study|Withdrew prior to dosing|2|||
130033808|NCT03093402|468078595|FG001|Overall Study|Withdrew prior to dosing|1|||
130033809|NCT03093402|468078596|FG002|Overall Study|Withdrew prior to dosing|2|||
130033810|NCT03093402|468078597|FG003|Overall Study|Withdrew prior to dosing|3|||
130033811|NCT03093402|468078594|FG000|Overall Study|Ineligible for study|1|||
130033812|NCT03093402|468078595|FG001|Overall Study|Ineligible for study|0|||
130033813|NCT03093402|468078596|FG002|Overall Study|Ineligible for study|0|||
130101756|NCT02325739|468330753|FG005|Phase II Part|Physician Decision|0|||
130101757|NCT02325739|468330754|FG006|Phase II Part|Physician Decision|0|||
130101758|NCT02325739|468330755|FG007|Phase II Part|Physician Decision|0|||
130258735|NCT04622592|468914707|FG005|Overall Study|Physician Decision|0|||
130258736|NCT04622592|468914708|FG006|Overall Study|Physician Decision|0|||
130258737|NCT04622592|468914709|FG007|Overall Study|Physician Decision|0|||
130258738|NCT04622592|468914702|FG000|Overall Study|Withdrawal by Subject|1|||
130258739|NCT04622592|468914703|FG001|Overall Study|Withdrawal by Subject|0|||
130258740|NCT04622592|468914704|FG002|Overall Study|Withdrawal by Subject|2|||
130258741|NCT04622592|468914705|FG003|Overall Study|Withdrawal by Subject|0|||
130258742|NCT04622592|468914706|FG004|Overall Study|Withdrawal by Subject|0|||
130258743|NCT04622592|468914707|FG005|Overall Study|Withdrawal by Subject|0|||
130258744|NCT04622592|468914708|FG006|Overall Study|Withdrawal by Subject|1|||
130258745|NCT04622592|468914709|FG007|Overall Study|Withdrawal by Subject|4|||
130258746|NCT04622592|468914702|FG000|Overall Study|Other than specified above|0|||
130258747|NCT04622592|468914703|FG001|Overall Study|Other than specified above|0|||
130258748|NCT04622592|468914704|FG002|Overall Study|Other than specified above|1|||
130258749|NCT04622592|468914705|FG003|Overall Study|Other than specified above|0|||
130258750|NCT04622592|468914706|FG004|Overall Study|Other than specified above|0|||
130258751|NCT04622592|468914707|FG005|Overall Study|Other than specified above|0|||
130258752|NCT04622592|468914708|FG006|Overall Study|Other than specified above|0|||
130258753|NCT04622592|468914709|FG007|Overall Study|Other than specified above|0|||
130258754|NCT00183248|468914714|FG000|Overall Study|Lost to Follow-up|0|||
130258755|NCT00183248|468914715|FG001|Overall Study|Lost to Follow-up|1|||
130258756|NCT00183248|468914714|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
130258757|NCT00183248|468914715|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
130258758|NCT03309202|468914716|FG000|Overall Study|Lost to Follow-up|1|||
130258759|NCT03309202|468914717|FG001|Overall Study|Lost to Follow-up|0|||
130258760|NCT03309202|468914718|FG002|Overall Study|Lost to Follow-up|0|||
130258761|NCT03309202|468914719|FG003|Overall Study|Lost to Follow-up|0|||
130258762|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
130258763|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
130101759|NCT02325739|468330756|FG008|Phase II Part|Physician Decision|0|||
130101760|NCT02325739|468330757|FG009|Phase II Part|Physician Decision|1|||
130033814|NCT03093402|468078597|FG003|Overall Study|Ineligible for study|0|||
130033815|NCT03093402|468078594|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
130101761|NCT02325739|468330758|FG010|Phase II Part|Physician Decision|0|||
130101762|NCT02325739|468330748|FG000|Phase II Part|Progressive disease|0|||
130258764|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
130258765|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
130258766|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
130258767|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
130258768|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
130258769|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
130258770|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
130258771|NCT04734210|468914720|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
130033816|NCT03093402|468078595|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
130033817|NCT03093402|468078596|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
130033818|NCT03093402|468078597|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
130033819|NCT02429856|468078600|FG000|Overall Study|Death|12|||
130258772|NCT04734210|468914721|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
130258773|NCT04734210|468914722|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
130258774|NCT02138825|468914723|FG000|Main Study Treatment|Adverse Event|11|||
130258775|NCT02138825|468914724|FG001|Main Study Treatment|Adverse Event|3|||
130258776|NCT02138825|468914723|FG000|Main Study Treatment|Death|1|||
130258777|NCT02138825|468914724|FG001|Main Study Treatment|Death|2|||
130258778|NCT02138825|468914723|FG000|Main Study Treatment|Protocol Violation|2|||
130258779|NCT02138825|468914724|FG001|Main Study Treatment|Protocol Violation|2|||
130258780|NCT02138825|468914723|FG000|Main Study Treatment|Sponsor decision|12|||
130258781|NCT02138825|468914724|FG001|Main Study Treatment|Sponsor decision|18|||
130258782|NCT02138825|468914723|FG000|Main Study Treatment|Study terminated by sponsor|10|||
130258783|NCT02138825|468914724|FG001|Main Study Treatment|Study terminated by sponsor|9|||
130258784|NCT02138825|468914723|FG000|Main Study Treatment|Withdrawal by Subject|3|||
130258785|NCT02138825|468914724|FG001|Main Study Treatment|Withdrawal by Subject|1|||
130258786|NCT02138825|468914723|FG000|Main Study Treatment|Medical decision|1|||
130258787|NCT02138825|468914724|FG001|Main Study Treatment|Medical decision|0|||
130258788|NCT02138825|468914723|FG000|Long-term Extension|Study termination by sponsor|32|||
130033820|NCT02429856|468078601|FG001|Overall Study|Death|13|||
130033821|NCT02429856|468078600|FG000|Overall Study|Lost to Follow-up|6|||
130033822|NCT02429856|468078601|FG001|Overall Study|Lost to Follow-up|5|||
130258789|NCT02138825|468914724|FG001|Long-term Extension|Study termination by sponsor|38|||
130258790|NCT02138825|468914723|FG000|Safety Follow-up|Adverse Event|4|||
130258791|NCT02138825|468914724|FG001|Safety Follow-up|Adverse Event|3|||
130258792|NCT02138825|468914723|FG000|Safety Follow-up|Death|11|||
130258793|NCT02138825|468914724|FG001|Safety Follow-up|Death|5|||
130258794|NCT02138825|468914723|FG000|Safety Follow-up|Withdrawal by Subject|5|||
130258795|NCT02138825|468914724|FG001|Safety Follow-up|Withdrawal by Subject|3|||
130258796|NCT02138825|468914723|FG000|Safety Follow-up|clinic worsening|1|||
130258797|NCT02138825|468914724|FG001|Safety Follow-up|clinic worsening|0|||
130258798|NCT02138825|468914723|FG000|Safety Follow-up|withdrawal by PI|1|||
130258799|NCT02138825|468914724|FG001|Safety Follow-up|withdrawal by PI|0|||
130258800|NCT02138825|468914723|FG000|Safety Follow-up|logistical difficulties|0|||
130258801|NCT02138825|468914724|FG001|Safety Follow-up|logistical difficulties|1|||
130258802|NCT02138825|468914723|FG000|Safety Follow-up|progressive disease|0|||
130258803|NCT02138825|468914724|FG001|Safety Follow-up|progressive disease|2|||
130258804|NCT02138825|468914723|FG000|Safety Follow-up|too unwell to attend the visit|0|||
130258805|NCT02138825|468914724|FG001|Safety Follow-up|too unwell to attend the visit|1|||
130258806|NCT02138825|468914723|FG000|Safety Follow-up|treatment unblinded|0|||
130258807|NCT02138825|468914724|FG001|Safety Follow-up|treatment unblinded|1|||
130258808|NCT02138825|468914723|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
130258809|NCT02138825|468914724|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
130258810|NCT03493958|468914725|FG000|Overall Study|Withdrawal by Subject|6|||
130258811|NCT03493958|468914725|FG000|Overall Study|Lost to Follow-up|7|||
130258812|NCT03493958|468914725|FG000|Overall Study|Did not complete all required study procedures|2|||
130258813|NCT00904371|468914728|FG000|Overall Study|Adverse Event|2|||
130258814|NCT00904371|468914728|FG000|Overall Study|Lost to Follow-up|4|||
130258815|NCT00904371|468914728|FG000|Overall Study|Discontinued at target blood pressure|2|||
130258816|NCT00904371|468914728|FG000|Overall Study|Continued with Tritace|1|||
130258817|NCT00583219|468914733|FG000|Phase 2|Withdrawal by Subject|1|||
130258818|NCT02090764|468914734|FG000|Overall Study|Adverse Event|1|||
130258819|NCT02090764|468914735|FG001|Overall Study|Adverse Event|3|||
130258820|NCT02090764|468914734|FG000|Overall Study|Lack of Efficacy|0|||
130258821|NCT02090764|468914735|FG001|Overall Study|Lack of Efficacy|13|||
130258822|NCT02090764|468914734|FG000|Overall Study|Withdrawal by Subject|2|||
130258823|NCT02090764|468914735|FG001|Overall Study|Withdrawal by Subject|1|||
130258824|NCT02090764|468914734|FG000|Overall Study|Intercurrent illness and other|1|||
130033823|NCT02429856|468078600|FG000|Overall Study|Withdrawal by Subject|1|||
130258825|NCT02090764|468914735|FG001|Overall Study|Intercurrent illness and other|1|||
130258826|NCT02090764|468914734|FG000|Overall Study|Lost to Follow-up|2|||
130033824|NCT02429856|468078601|FG001|Overall Study|Withdrawal by Subject|1|||
130101763|NCT02325739|468330749|FG001|Phase II Part|Progressive disease|0|||
130258827|NCT02090764|468914735|FG001|Overall Study|Lost to Follow-up|2|||
130258828|NCT00754572|468914736|FG000|Overall Study|Adverse Event|19|||
130258829|NCT00754572|468914736|FG000|Overall Study|Other|39|||
130258830|NCT00754572|468914736|FG000|Overall Study|Protocol Violation|3|||
130258831|NCT00754572|468914736|FG000|Overall Study|Withdrawal by Subject|3|||
130258832|NCT00754572|468914736|FG000|Overall Study|Lack of Efficacy|2|||
130258833|NCT00754572|468914736|FG000|Overall Study|Death|1|||
130258834|NCT00754572|468914736|FG000|Overall Study|Administrative Reason|3|||
130258835|NCT00754572|468914736|FG000|Overall Study|Lost to Follow-up|1|||
130033825|NCT00763009|468078608|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
130258836|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130258837|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
130258838|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130258839|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130258840|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
130258841|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130258842|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130258843|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
130258844|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
130258845|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
130258846|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130258847|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130033826|NCT00891735|468078610|FG000|Overall Study|Adverse Event|2|||
130033827|NCT00891735|468078611|FG001|Overall Study|Adverse Event|0|||
130101764|NCT02325739|468330750|FG002|Phase II Part|Progressive disease|0|||
130101765|NCT02325739|468330751|FG003|Phase II Part|Progressive disease|0|||
130101766|NCT02325739|468330752|FG004|Phase II Part|Progressive disease|0|||
130101767|NCT02325739|468330753|FG005|Phase II Part|Progressive disease|0|||
130101768|NCT02325739|468330754|FG006|Phase II Part|Progressive disease|0|||
130101769|NCT02325739|468330755|FG007|Phase II Part|Progressive disease|0|||
130101770|NCT02325739|468330756|FG008|Phase II Part|Progressive disease|22|||
130101771|NCT02325739|468330757|FG009|Phase II Part|Progressive disease|29|||
130101772|NCT02325739|468330758|FG010|Phase II Part|Progressive disease|18|||
130101773|NCT02325739|468330748|FG000|Phase II Part|Subject/guardian decision|0|||
130101774|NCT02325739|468330749|FG001|Phase II Part|Subject/guardian decision|0|||
130101775|NCT02325739|468330750|FG002|Phase II Part|Subject/guardian decision|0|||
130101776|NCT02325739|468330751|FG003|Phase II Part|Subject/guardian decision|0|||
130101777|NCT02325739|468330752|FG004|Phase II Part|Subject/guardian decision|0|||
130101778|NCT02325739|468330753|FG005|Phase II Part|Subject/guardian decision|0|||
130101779|NCT02325739|468330754|FG006|Phase II Part|Subject/guardian decision|0|||
130258848|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130258849|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130258850|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130033828|NCT00891735|468078612|FG002|Overall Study|Adverse Event|2|||
130033829|NCT00891735|468078613|FG003|Overall Study|Adverse Event|0|||
130033830|NCT00891735|468078610|FG000|Overall Study|Death|8|||
130033831|NCT00891735|468078611|FG001|Overall Study|Death|5|||
130033832|NCT00891735|468078612|FG002|Overall Study|Death|4|||
130033833|NCT00891735|468078613|FG003|Overall Study|Death|5|||
130033834|NCT00891735|468078610|FG000|Overall Study|Lost to Follow-up|2|||
130033835|NCT00891735|468078611|FG001|Overall Study|Lost to Follow-up|2|||
130033836|NCT00891735|468078612|FG002|Overall Study|Lost to Follow-up|2|||
130033837|NCT00891735|468078613|FG003|Overall Study|Lost to Follow-up|2|||
130033838|NCT00891735|468078610|FG000|Overall Study|Physician's decision to withdraw patient|1|||
130033839|NCT00891735|468078611|FG001|Overall Study|Physician's decision to withdraw patient|0|||
130033840|NCT00891735|468078612|FG002|Overall Study|Physician's decision to withdraw patient|0|||
130033841|NCT00891735|468078613|FG003|Overall Study|Physician's decision to withdraw patient|0|||
130033842|NCT00891735|468078610|FG000|Overall Study|Patient's decision to withdraw|4|||
130033843|NCT00891735|468078611|FG001|Overall Study|Patient's decision to withdraw|9|||
130033844|NCT00891735|468078612|FG002|Overall Study|Patient's decision to withdraw|4|||
130033845|NCT00891735|468078613|FG003|Overall Study|Patient's decision to withdraw|8|||
130033846|NCT01355289|468078614|FG000|Core Study|Adverse Event, Non-Fatal|1|||
130033847|NCT01355289|468078615|FG001|Core Study|Adverse Event, Non-Fatal|0|||
130033848|NCT01355289|468078616|FG002|Core Study|Adverse Event, Non-Fatal|0|||
130033849|NCT01355289|468078617|FG003|Core Study|Adverse Event, Non-Fatal|0|||
130033850|NCT01355289|468078618|FG004|Core Study|Adverse Event, Non-Fatal|0|||
130033851|NCT01355289|468078614|FG000|Core Study|Inadequate Therapeutic Effect|0|||
130033852|NCT01355289|468078615|FG001|Core Study|Inadequate Therapeutic Effect|0|||
130033853|NCT01355289|468078616|FG002|Core Study|Inadequate Therapeutic Effect|0|||
130033854|NCT01355289|468078617|FG003|Core Study|Inadequate Therapeutic Effect|1|||
130033855|NCT01355289|468078618|FG004|Core Study|Inadequate Therapeutic Effect|0|||
130033856|NCT01355289|468078614|FG000|Core Study|Other|0|||
130033857|NCT01355289|468078615|FG001|Core Study|Other|0|||
130101780|NCT02325739|468330755|FG007|Phase II Part|Subject/guardian decision|0|||
130101781|NCT02325739|468330756|FG008|Phase II Part|Subject/guardian decision|4|||
130101782|NCT02325739|468330757|FG009|Phase II Part|Subject/guardian decision|1|||
130101783|NCT02325739|468330758|FG010|Phase II Part|Subject/guardian decision|1|||
130101784|NCT03319368|468330763|FG000|Overall Study|Discharge swabs not collected from resident|57|||
130101785|NCT03319368|468330764|FG001|Overall Study|Discharge swabs not collected from resident|46|||
130101786|NCT03000075|468330765|FG000|Part A|Adverse Event|4|||
130101787|NCT03000075|468330766|FG001|Part A|Adverse Event|0|||
130101788|NCT03000075|468330767|FG002|Part A|Adverse Event|0|||
130101789|NCT03000075|468330768|FG003|Part A|Adverse Event|0|||
130101790|NCT03000075|468330769|FG004|Part A|Adverse Event|0|||
130101791|NCT03000075|468330770|FG005|Part A|Adverse Event|0|||
130101792|NCT03000075|468330771|FG006|Part A|Adverse Event|0|||
130101793|NCT03000075|468330765|FG000|Part B|Not dosed due to AE|0|||
130101794|NCT03000075|468330766|FG001|Part B|Not dosed due to AE|0|||
130101795|NCT03000075|468330767|FG002|Part B|Not dosed due to AE|0|||
130101796|NCT03000075|468330768|FG003|Part B|Not dosed due to AE|0|||
130101797|NCT03000075|468330769|FG004|Part B|Not dosed due to AE|0|||
130101798|NCT03000075|468330770|FG005|Part B|Not dosed due to AE|2|||
130101799|NCT03000075|468330771|FG006|Part B|Not dosed due to AE|1|||
130101800|NCT03000075|468330765|FG000|Part B|Adverse Event|0|||
130101801|NCT03000075|468330766|FG001|Part B|Adverse Event|0|||
130101802|NCT03000075|468330767|FG002|Part B|Adverse Event|0|||
130101803|NCT03000075|468330768|FG003|Part B|Adverse Event|0|||
130101804|NCT03000075|468330769|FG004|Part B|Adverse Event|1|||
130101805|NCT03000075|468330770|FG005|Part B|Adverse Event|0|||
130101806|NCT03000075|468330771|FG006|Part B|Adverse Event|0|||
130101807|NCT00440193|468330776|FG000|Treatment Period|Adverse Event|74|||
130101808|NCT00440193|468330777|FG001|Treatment Period|Adverse Event|67|||
130101809|NCT00440193|468330776|FG000|Treatment Period|Death|19|||
130101810|NCT00440193|468330777|FG001|Treatment Period|Death|22|||
130101811|NCT00440193|468330776|FG000|Treatment Period|Lack of Efficacy|0|||
130101812|NCT00440193|468330777|FG001|Treatment Period|Lack of Efficacy|1|||
130101813|NCT00440193|468330776|FG000|Treatment Period|Lost to Follow-up|12|||
130101814|NCT00440193|468330777|FG001|Treatment Period|Lost to Follow-up|18|||
130101815|NCT00440193|468330776|FG000|Treatment Period|Physician Decision|3|||
130101816|NCT00440193|468330777|FG001|Treatment Period|Physician Decision|6|||
130101817|NCT00440193|468330776|FG000|Treatment Period|Protocol Violation|16|||
130101818|NCT00440193|468330777|FG001|Treatment Period|Protocol Violation|19|||
130101819|NCT00440193|468330776|FG000|Treatment Period|Withdrawal by Subject|36|||
130101820|NCT00440193|468330777|FG001|Treatment Period|Withdrawal by Subject|77|||
130101821|NCT00440193|468330776|FG000|Treatment Period|Clinical endpoint reached|28|||
130101822|NCT00440193|468330777|FG001|Treatment Period|Clinical endpoint reached|25|||
130101823|NCT00440193|468330776|FG000|Treatment Period|Study terminated by sponsor|102|||
130101824|NCT00440193|468330777|FG001|Treatment Period|Study terminated by sponsor|94|||
130101825|NCT00440193|468330776|FG000|Treatment Period|Protocol driven decision point|2|||
130101826|NCT00440193|468330777|FG001|Treatment Period|Protocol driven decision point|2|||
130101827|NCT00440193|468330776|FG000|Treatment Period|Switch to commercial drug|0|||
130101828|NCT00440193|468330777|FG001|Treatment Period|Switch to commercial drug|2|||
130101829|NCT00440193|468330776|FG000|Treatment Period|Technical problems|1|||
130101830|NCT00440193|468330777|FG001|Treatment Period|Technical problems|1|||
130101831|NCT00440193|468330776|FG000|Treatment Period|Participant convenience|5|||
130101832|NCT00440193|468330777|FG001|Treatment Period|Participant convenience|2|||
130101833|NCT00440193|468330776|FG000|Treatment Period|Participant did not receive treatment|7|||
130101834|NCT00440193|468330777|FG001|Treatment Period|Participant did not receive treatment|13|||
130101835|NCT00440193|468330776|FG000|Treatment Period|Site closed by investigator|0|||
130101836|NCT00440193|468330777|FG001|Treatment Period|Site closed by investigator|2|||
130101837|NCT00440193|468330776|FG000|Observational Period|Adverse Event|2|||
130101838|NCT00440193|468330777|FG001|Observational Period|Adverse Event|2|||
130101839|NCT00440193|468330776|FG000|Observational Period|Death|15|||
130101840|NCT00440193|468330777|FG001|Observational Period|Death|20|||
130101841|NCT00440193|468330776|FG000|Observational Period|Lost to Follow-up|12|||
130101842|NCT00440193|468330777|FG001|Observational Period|Lost to Follow-up|8|||
130101843|NCT00440193|468330776|FG000|Observational Period|Protocol Violation|1|||
130101844|NCT00440193|468330777|FG001|Observational Period|Protocol Violation|0|||
130101845|NCT00440193|468330776|FG000|Observational Period|Withdrawal by Subject|11|||
130101846|NCT00440193|468330777|FG001|Observational Period|Withdrawal by Subject|8|||
130101847|NCT00440193|468330776|FG000|Observational Period|Physician Decision|1|||
130101848|NCT00440193|468330777|FG001|Observational Period|Physician Decision|0|||
130101849|NCT00440193|468330776|FG000|Observational Period|Clinical endpoint reached|1|||
130101850|NCT00440193|468330777|FG001|Observational Period|Clinical endpoint reached|0|||
130101851|NCT00440193|468330776|FG000|Observational Period|Participant convenience|2|||
130101852|NCT00440193|468330777|FG001|Observational Period|Participant convenience|0|||
130101853|NCT00824993|468330778|FG000|Overall Study|Withdrawal by Subject|1|||
130101854|NCT00824993|468330779|FG001|Overall Study|Withdrawal by Subject|1|||
130101855|NCT00824993|468330778|FG000|Overall Study|Malignancy Relapse|9|||
130101856|NCT00824993|468330779|FG001|Overall Study|Malignancy Relapse|10|||
130101857|NCT00824993|468330778|FG000|Overall Study|Rapid Bone Loss|0|||
130101858|NCT00824993|468330779|FG001|Overall Study|Rapid Bone Loss|1|||
130101859|NCT00824993|468330778|FG000|Overall Study|Non-Compliant|2|||
130101860|NCT00824993|468330779|FG001|Overall Study|Non-Compliant|1|||
130101861|NCT00824993|468330778|FG000|Overall Study|Insurance Issue|2|||
130101862|NCT00824993|468330779|FG001|Overall Study|Insurance Issue|1|||
130101863|NCT00824993|468330778|FG000|Overall Study|Death|0|||
130101864|NCT00824993|468330779|FG001|Overall Study|Death|3|||
130101865|NCT02864953|468330783|FG000|Overall Study|Adverse Event|22|||
130101866|NCT02864953|468330784|FG001|Overall Study|Adverse Event|19|||
130101867|NCT02864953|468330783|FG000|Overall Study|Withdrawal by Subject|1|||
130101868|NCT02864953|468330784|FG001|Overall Study|Withdrawal by Subject|0|||
130101869|NCT02864953|468330783|FG000|Overall Study|Physician Decision|4|||
130101870|NCT02864953|468330784|FG001|Overall Study|Physician Decision|2|||
130101871|NCT02864953|468330783|FG000|Overall Study|Death|3|||
130101872|NCT02864953|468330784|FG001|Overall Study|Death|13|||
130101873|NCT02864953|468330783|FG000|Overall Study|Reason not specified|14|||
130101874|NCT02864953|468330784|FG001|Overall Study|Reason not specified|12|||
130101875|NCT02864953|468330783|FG000|Overall Study|Withdrew Prior to Dosing|9|||
130101876|NCT02864953|468330784|FG001|Overall Study|Withdrew Prior to Dosing|8|||
130101877|NCT00061568|468330785|FG000|Overall Study|Lost to Follow-up|12|||
130101878|NCT00061568|468330786|FG001|Overall Study|Lost to Follow-up|0|||
130101879|NCT00061568|468330785|FG000|Overall Study|Death|6|||
130101880|NCT00061568|468330786|FG001|Overall Study|Death|0|||
130101881|NCT00061568|468330785|FG000|Overall Study|Withdrawal by Subject|1|||
130101882|NCT00061568|468330786|FG001|Overall Study|Withdrawal by Subject|0|||
130101883|NCT01381068|468330787|FG000|Overall Study|Death|1|||
130101884|NCT01381068|468330788|FG001|Overall Study|Death|0|||
130101885|NCT01071278|468330792|FG000|Overall Study|Premature Discontinuation|254|||
130101886|NCT01071278|468330792|FG000|Overall Study|Completion Status Unknown|459|||
130101887|NCT00903409|468330793|FG000|Overall Study|Adverse Event|11|||
130101888|NCT00903409|468330794|FG001|Overall Study|Adverse Event|9|||
130101889|NCT00903409|468330793|FG000|Overall Study|Non-compliance with Protocol|1|||
130101890|NCT00903409|468330794|FG001|Overall Study|Non-compliance with Protocol|1|||
130101891|NCT00903409|468330793|FG000|Overall Study|Laboratory Abnormality|2|||
130101892|NCT00903409|468330794|FG001|Overall Study|Laboratory Abnormality|0|||
130101893|NCT00903409|468330793|FG000|Overall Study|Withdrawal by Subject|8|||
130101894|NCT00903409|468330794|FG001|Overall Study|Withdrawal by Subject|8|||
130101895|NCT00903409|468330793|FG000|Overall Study|Other|2|||
130101896|NCT00903409|468330794|FG001|Overall Study|Other|3|||
130101897|NCT00903409|468330793|FG000|Overall Study|Lost to Follow-up|2|||
130101898|NCT00903409|468330794|FG001|Overall Study|Lost to Follow-up|6|||
130101899|NCT00797316|468330795|FG000|Overall Study|Administrative problems|1|||
130101900|NCT00797316|468330796|FG001|Overall Study|Administrative problems|0|||
130101901|NCT00797316|468330795|FG000|Overall Study|Adverse Event|5|||
130101902|NCT00797316|468330796|FG001|Overall Study|Adverse Event|3|||
130101903|NCT00797316|468330795|FG000|Overall Study|Lost to Follow-up|4|||
130101904|NCT00797316|468330796|FG001|Overall Study|Lost to Follow-up|8|||
130101905|NCT00797316|468330795|FG000|Overall Study|Protocol Deviation|1|||
130101906|NCT00797316|468330796|FG001|Overall Study|Protocol Deviation|2|||
130101907|NCT00797316|468330795|FG000|Overall Study|Patient withdrew consent|12|||
130101908|NCT00797316|468330796|FG001|Overall Study|Patient withdrew consent|6|||
130101909|NCT00797316|468330795|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130101910|NCT00797316|468330796|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130101911|NCT03239340|468330803|FG000|Overall Study|Other|26|||
130101912|NCT03239340|468330803|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
130101913|NCT03239340|468330803|FG000|Overall Study|Death|40|||
130101914|NCT03239340|468330803|FG000|Overall Study|Lost to Follow-up|2|||
130101915|NCT03239340|468330803|FG000|Overall Study|Physician Decision|16|||
130101916|NCT03239340|468330803|FG000|Overall Study|Withdrawal by Subject|27|||
130101917|NCT03868059|468330807|FG000|Overall Study|Adverse Event|3|||
130101918|NCT03868059|468330807|FG000|Overall Study|Lost to Follow-up|3|||
130101919|NCT03868059|468330807|FG000|Overall Study|Withdrawal by Subject|6|||
130101920|NCT02061293|468330808|FG000|Overall Study|Elevated Blood Pressure|1|||
130101921|NCT02061293|468330809|FG001|Overall Study|Elevated Blood Pressure|1|||
130101922|NCT04066894|468330810|FG000|Overall Study|Lack of Efficacy|1|||
130101923|NCT04066894|468330810|FG000|Overall Study|Screen Failure|1|||
130101924|NCT03494816|468330812|FG000|Overall Study|Protocol Violation|2|||
130101925|NCT03494816|468330812|FG000|Overall Study|Physician Decision|2|||
130101926|NCT03494816|468330812|FG000|Overall Study|Did not start trial treatment|1|||
130101927|NCT03494816|468330812|FG000|Overall Study|Adverse Event|1|||
130101928|NCT01283282|468330817|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
130101929|NCT01283282|468330818|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
130101930|NCT01283282|468330817|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
130101931|NCT01283282|468330818|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
130101932|NCT01283282|468330817|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
130101933|NCT01283282|468330818|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
130033858|NCT01355289|468078616|FG002|Core Study|Other|0|||
130033859|NCT01355289|468078617|FG003|Core Study|Other|1|||
130033860|NCT01355289|468078618|FG004|Core Study|Other|0|||
130033861|NCT01355289|468078614|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
130033862|NCT01355289|468078615|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
130033863|NCT01355289|468078616|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
130033864|NCT01355289|468078617|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
130033865|NCT01355289|468078618|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
130033866|NCT01355289|468078614|FG000|Open Label Extension|Lost to Follow-up|0|||
130033867|NCT01355289|468078615|FG001|Open Label Extension|Lost to Follow-up|0|||
130033868|NCT01355289|468078616|FG002|Open Label Extension|Lost to Follow-up|0|||
130033869|NCT01355289|468078617|FG003|Open Label Extension|Lost to Follow-up|0|||
130033870|NCT01355289|468078618|FG004|Open Label Extension|Lost to Follow-up|1|||
130033871|NCT01355289|468078614|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
130033872|NCT01355289|468078615|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
130033873|NCT01355289|468078616|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
130033874|NCT01355289|468078617|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
130033875|NCT01355289|468078618|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
130033876|NCT01355289|468078614|FG000|Open Label Extension|Other|0|||
130033877|NCT01355289|468078615|FG001|Open Label Extension|Other|0|||
130033878|NCT01355289|468078616|FG002|Open Label Extension|Other|0|||
130033879|NCT01355289|468078617|FG003|Open Label Extension|Other|0|||
130033880|NCT01355289|468078618|FG004|Open Label Extension|Other|3|||
130033881|NCT01085682|468078619|FG000|Overall Study|Withdrawal by Subject|25|||
130033882|NCT01085682|468078620|FG001|Overall Study|Withdrawal by Subject|25|||
130033883|NCT01451645|468078621|FG000|Overall Study|Protocol Violation|1|||
130033884|NCT01451645|468078622|FG001|Overall Study|Protocol Violation|0|||
130033885|NCT01451645|468078621|FG000|Overall Study|Adverse Event|0|||
130033886|NCT01451645|468078622|FG001|Overall Study|Adverse Event|3|||
130033887|NCT01451645|468078621|FG000|Overall Study|Withdrawal by Subject|4|||
130033888|NCT01451645|468078622|FG001|Overall Study|Withdrawal by Subject|2|||
130033889|NCT01451645|468078621|FG000|Overall Study|Lost to Follow-up|4|||
130033890|NCT01451645|468078622|FG001|Overall Study|Lost to Follow-up|3|||
130033891|NCT01661790|468078627|FG000|Overall Study|Lost to Follow-up|0|||
130033892|NCT01661790|468078628|FG001|Overall Study|Lost to Follow-up|2|||
130033893|NCT00891202|468078629|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
130033894|NCT00891202|468078630|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
130033895|NCT00891202|468078631|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
130033896|NCT00891202|468078632|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
130033897|NCT00891202|468078629|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
130033898|NCT00891202|468078630|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
130033899|NCT00891202|468078631|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
130033900|NCT00891202|468078632|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
130033901|NCT00891202|468078629|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
130033902|NCT00891202|468078630|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
130033903|NCT00891202|468078631|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
130033904|NCT00891202|468078632|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
130033905|NCT00891202|468078629|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
130033906|NCT00891202|468078630|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
130033907|NCT00891202|468078631|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
130033908|NCT00891202|468078632|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
130033909|NCT01291017|468078635|FG000|Overall Study|Lost to Follow-up|2|||
130033910|NCT01291017|468078635|FG000|Overall Study|Withdrawal by Subject|3|||
130033911|NCT04980391|468078636|FG000|Overall Study|Death|0|||
130033912|NCT04980391|468078637|FG001|Overall Study|Death|0|||
130033913|NCT04980391|468078638|FG002|Overall Study|Death|1|||
130033914|NCT04980391|468078639|FG003|Overall Study|Death|1|||
130033915|NCT04980391|468078636|FG000|Overall Study|Lost to Follow-up|3|||
130033916|NCT04980391|468078637|FG001|Overall Study|Lost to Follow-up|3|||
130033917|NCT04980391|468078638|FG002|Overall Study|Lost to Follow-up|2|||
130033918|NCT04980391|468078639|FG003|Overall Study|Lost to Follow-up|3|||
130033919|NCT04980391|468078636|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
130033920|NCT04980391|468078637|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
130033921|NCT04980391|468078638|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
130033922|NCT04980391|468078639|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
130033923|NCT04980391|468078636|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130033924|NCT04980391|468078637|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130033925|NCT04980391|468078638|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130033926|NCT04980391|468078639|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130033927|NCT04980391|468078636|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
130033928|NCT04980391|468078637|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
130033929|NCT04980391|468078638|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
130033930|NCT04980391|468078639|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
130258851|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130258852|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
130258853|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
130258854|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
130258855|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
130258856|NCT02836249|468914739|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
130258857|NCT02836249|468914740|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130258858|NCT02836249|468914741|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130258859|NCT02836249|468914742|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
130258860|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130258861|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130258862|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
130258863|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
130258864|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130258865|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130258866|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
130258867|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
130258868|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Death|0|||
130258869|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Death|0|||
130258870|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Death|1|||
130258871|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Death|0|||
130258872|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130258873|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130258874|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
130258875|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
130258876|NCT02836249|468914739|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
130258877|NCT02836249|468914740|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
130258878|NCT02836249|468914741|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
130258879|NCT02836249|468914742|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
130258880|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258881|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
130258882|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258883|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
130258884|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
130258885|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
130258886|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
130258887|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258888|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258889|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258890|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130033931|NCT03690869|468078640|FG000|Overall Study|Adverse Event|0|||
130033932|NCT03690869|468078641|FG001|Overall Study|Adverse Event|0|||
130033933|NCT03690869|468078642|FG002|Overall Study|Adverse Event|0|||
130033934|NCT03690869|468078643|FG003|Overall Study|Adverse Event|1|||
130033935|NCT03690869|468078644|FG004|Overall Study|Adverse Event|0|||
130033936|NCT03690869|468078645|FG005|Overall Study|Adverse Event|0|||
130033937|NCT03690869|468078646|FG006|Overall Study|Adverse Event|0|||
130033938|NCT03690869|468078647|FG007|Overall Study|Adverse Event|1|||
130033939|NCT03690869|468078648|FG008|Overall Study|Adverse Event|0|||
130033940|NCT03690869|468078649|FG009|Overall Study|Adverse Event|1|||
130033941|NCT03690869|468078640|FG000|Overall Study|Death|1|||
130033942|NCT03690869|468078641|FG001|Overall Study|Death|1|||
130033943|NCT03690869|468078642|FG002|Overall Study|Death|1|||
130033944|NCT03690869|468078643|FG003|Overall Study|Death|4|||
130033945|NCT03690869|468078644|FG004|Overall Study|Death|2|||
130033946|NCT03690869|468078645|FG005|Overall Study|Death|5|||
130033947|NCT03690869|468078646|FG006|Overall Study|Death|3|||
130033948|NCT03690869|468078647|FG007|Overall Study|Death|2|||
130033949|NCT03690869|468078648|FG008|Overall Study|Death|0|||
130033950|NCT03690869|468078649|FG009|Overall Study|Death|3|||
130258891|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258892|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258893|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258894|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130258895|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
130033951|NCT03690869|468078640|FG000|Overall Study|Lost to Follow-up|0|||
130033952|NCT03690869|468078641|FG001|Overall Study|Lost to Follow-up|0|||
130033953|NCT03690869|468078642|FG002|Overall Study|Lost to Follow-up|1|||
130033954|NCT03690869|468078643|FG003|Overall Study|Lost to Follow-up|0|||
130033955|NCT03690869|468078644|FG004|Overall Study|Lost to Follow-up|0|||
130033956|NCT03690869|468078645|FG005|Overall Study|Lost to Follow-up|0|||
130033957|NCT03690869|468078646|FG006|Overall Study|Lost to Follow-up|0|||
130033958|NCT03690869|468078647|FG007|Overall Study|Lost to Follow-up|0|||
130033959|NCT03690869|468078648|FG008|Overall Study|Lost to Follow-up|0|||
130033960|NCT03690869|468078649|FG009|Overall Study|Lost to Follow-up|0|||
130033961|NCT03690869|468078640|FG000|Overall Study|Other Treatment|1|||
130033962|NCT03690869|468078641|FG001|Overall Study|Other Treatment|1|||
130033963|NCT03690869|468078642|FG002|Overall Study|Other Treatment|1|||
130033964|NCT03690869|468078643|FG003|Overall Study|Other Treatment|2|||
130033965|NCT03690869|468078644|FG004|Overall Study|Other Treatment|3|||
130033966|NCT03690869|468078645|FG005|Overall Study|Other Treatment|1|||
130033967|NCT03690869|468078646|FG006|Overall Study|Other Treatment|2|||
130033968|NCT03690869|468078647|FG007|Overall Study|Other Treatment|7|||
130033969|NCT03690869|468078648|FG008|Overall Study|Other Treatment|0|||
130033970|NCT03690869|468078649|FG009|Overall Study|Other Treatment|3|||
130033971|NCT03690869|468078640|FG000|Overall Study|Physician Decision|0|||
130033972|NCT03690869|468078641|FG001|Overall Study|Physician Decision|1|||
130033973|NCT03690869|468078642|FG002|Overall Study|Physician Decision|0|||
130033974|NCT03690869|468078643|FG003|Overall Study|Physician Decision|0|||
130033975|NCT03690869|468078644|FG004|Overall Study|Physician Decision|0|||
130033976|NCT03690869|468078645|FG005|Overall Study|Physician Decision|0|||
130033977|NCT03690869|468078646|FG006|Overall Study|Physician Decision|0|||
130033978|NCT03690869|468078647|FG007|Overall Study|Physician Decision|0|||
130033979|NCT03690869|468078648|FG008|Overall Study|Physician Decision|0|||
130033980|NCT03690869|468078649|FG009|Overall Study|Physician Decision|0|||
130033981|NCT03690869|468078640|FG000|Overall Study|Progressive Disease|1|||
130033982|NCT03690869|468078641|FG001|Overall Study|Progressive Disease|2|||
130033983|NCT03690869|468078642|FG002|Overall Study|Progressive Disease|0|||
130033984|NCT03690869|468078643|FG003|Overall Study|Progressive Disease|1|||
130033985|NCT03690869|468078644|FG004|Overall Study|Progressive Disease|0|||
130033986|NCT03690869|468078645|FG005|Overall Study|Progressive Disease|0|||
130033987|NCT03690869|468078646|FG006|Overall Study|Progressive Disease|0|||
130033988|NCT03690869|468078647|FG007|Overall Study|Progressive Disease|0|||
130033989|NCT03690869|468078648|FG008|Overall Study|Progressive Disease|1|||
130033990|NCT03690869|468078649|FG009|Overall Study|Progressive Disease|1|||
130258896|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
130258897|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
130258898|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
130258899|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
130258900|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
130258901|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
130258902|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
130258903|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
130258904|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
130258905|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
130258906|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
130258907|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
130258908|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
130258909|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
130258910|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
130258911|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
130033991|NCT03690869|468078640|FG000|Overall Study|Subject Decision|0|||
130033992|NCT03690869|468078641|FG001|Overall Study|Subject Decision|0|||
130033993|NCT03690869|468078642|FG002|Overall Study|Subject Decision|0|||
130033994|NCT03690869|468078643|FG003|Overall Study|Subject Decision|1|||
130033995|NCT03690869|468078644|FG004|Overall Study|Subject Decision|0|||
130033996|NCT03690869|468078645|FG005|Overall Study|Subject Decision|0|||
130033997|NCT03690869|468078646|FG006|Overall Study|Subject Decision|0|||
130033998|NCT03690869|468078647|FG007|Overall Study|Subject Decision|1|||
130033999|NCT03690869|468078648|FG008|Overall Study|Subject Decision|0|||
130034000|NCT03690869|468078649|FG009|Overall Study|Subject Decision|0|||
130034001|NCT01431287|468081044|FG000|Overall Study|not treated|0|||
130034002|NCT01431287|468081045|FG001|Overall Study|not treated|0|||
130034003|NCT01431287|468081046|FG002|Overall Study|not treated|1|||
130034004|NCT01431287|468081047|FG003|Overall Study|not treated|0|||
130034005|NCT01431287|468081048|FG004|Overall Study|not treated|0|||
130034006|NCT01431287|468081044|FG000|Overall Study|Adverse Event|59|||
130034007|NCT01431287|468081045|FG001|Overall Study|Adverse Event|57|||
130034008|NCT01431287|468081046|FG002|Overall Study|Adverse Event|53|||
130101934|NCT00777920|468330819|FG000|Overall Study|Adverse Event|39|||
130101935|NCT00777920|468330819|FG000|Overall Study|Withdrawal of Consent|4|||
130034009|NCT01431287|468081047|FG003|Overall Study|Adverse Event|33|||
130034010|NCT01431287|468081048|FG004|Overall Study|Adverse Event|41|||
130034011|NCT01431287|468081044|FG000|Overall Study|Non compliant with protocol|6|||
130034012|NCT01431287|468081045|FG001|Overall Study|Non compliant with protocol|6|||
130034013|NCT01431287|468081046|FG002|Overall Study|Non compliant with protocol|5|||
130034014|NCT01431287|468081047|FG003|Overall Study|Non compliant with protocol|6|||
130034015|NCT01431287|468081048|FG004|Overall Study|Non compliant with protocol|5|||
130101936|NCT00777920|468330819|FG000|Overall Study|Lost to Follow-up|1|||
130258912|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
130034016|NCT01431287|468081044|FG000|Overall Study|Lost to Follow-up|0|||
130258913|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
130258914|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258915|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258916|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258917|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258918|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258919|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258920|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258921|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258922|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258923|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258924|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258925|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258926|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258927|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
130258928|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
130258929|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258930|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
130258931|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258932|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258933|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258934|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
130258935|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258936|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258937|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258938|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258939|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258940|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258941|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258942|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258943|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130258944|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258945|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258946|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258947|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
130258948|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258949|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258950|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
130258951|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258952|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258953|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258954|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258955|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258956|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258957|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258958|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258959|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
130258960|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258961|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258962|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
130258963|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258964|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258965|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258966|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258967|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258968|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258969|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258970|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258971|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258972|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258973|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258974|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258975|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
130258976|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130258977|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130258978|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130258979|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258980|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258981|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258982|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258983|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258984|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258985|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258986|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258987|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258988|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258989|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258990|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258991|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130258992|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
130258993|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
130258994|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
130258995|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
130258996|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
130258997|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
130258998|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
130258999|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
130259000|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
130259001|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
130259002|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
130259003|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
130259004|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
130259005|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
130259006|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
130259007|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
130259008|NCT02958865|468914743|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259009|NCT02958865|468914744|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259010|NCT02958865|468914745|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259011|NCT02958865|468914746|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259012|NCT02958865|468914747|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
130259013|NCT02958865|468914748|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259014|NCT02958865|468914749|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259015|NCT02958865|468914750|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259016|NCT02958865|468914751|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259017|NCT02958865|468914752|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259018|NCT02958865|468914753|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130034017|NCT01431287|468081045|FG001|Overall Study|Lost to Follow-up|3|||
130034018|NCT01431287|468081046|FG002|Overall Study|Lost to Follow-up|2|||
130034019|NCT01431287|468081047|FG003|Overall Study|Lost to Follow-up|3|||
130034020|NCT01431287|468081048|FG004|Overall Study|Lost to Follow-up|1|||
130034021|NCT01431287|468081044|FG000|Overall Study|Consent withdrawn not due to AE|29|||
130034022|NCT01431287|468081045|FG001|Overall Study|Consent withdrawn not due to AE|30|||
130034023|NCT01431287|468081046|FG002|Overall Study|Consent withdrawn not due to AE|34|||
130034024|NCT01431287|468081047|FG003|Overall Study|Consent withdrawn not due to AE|19|||
130034025|NCT01431287|468081048|FG004|Overall Study|Consent withdrawn not due to AE|29|||
130034026|NCT01431287|468081044|FG000|Overall Study|not stated above|4|||
130034027|NCT01431287|468081045|FG001|Overall Study|not stated above|2|||
130034028|NCT01431287|468081046|FG002|Overall Study|not stated above|2|||
130034029|NCT01431287|468081047|FG003|Overall Study|not stated above|2|||
130034030|NCT01431287|468081048|FG004|Overall Study|not stated above|1|||
130034031|NCT02224664|468081050|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
130034032|NCT02224664|468081051|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130034033|NCT02224664|468081052|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130034034|NCT02224664|468081053|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130034035|NCT02224664|468081054|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
130034036|NCT02224664|468081050|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
130034037|NCT02224664|468081051|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
130034038|NCT02224664|468081052|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
130034039|NCT02224664|468081053|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
130034040|NCT02224664|468081054|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
130034041|NCT02224664|468081050|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
130034042|NCT02224664|468081051|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
130034043|NCT02224664|468081052|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
130034044|NCT02224664|468081053|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
130034045|NCT02224664|468081054|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
130034046|NCT01154101|468081059|FG000|Overall Study|Adverse Event|0|||
130034047|NCT01154101|468081060|FG001|Overall Study|Adverse Event|2|||
130034048|NCT01154101|468081061|FG002|Overall Study|Adverse Event|1|||
130034049|NCT01154101|468081062|FG003|Overall Study|Adverse Event|1|||
130034050|NCT01154101|468081063|FG004|Overall Study|Adverse Event|0|||
130034051|NCT01154101|468081059|FG000|Overall Study|Lost to Follow-up|0|||
130034052|NCT01154101|468081060|FG001|Overall Study|Lost to Follow-up|1|||
130034053|NCT01154101|468081061|FG002|Overall Study|Lost to Follow-up|0|||
130034054|NCT01154101|468081062|FG003|Overall Study|Lost to Follow-up|1|||
130034055|NCT01154101|468081063|FG004|Overall Study|Lost to Follow-up|0|||
130034056|NCT01154101|468081059|FG000|Overall Study|Withdrawal by Subject|0|||
130034057|NCT01154101|468081060|FG001|Overall Study|Withdrawal by Subject|1|||
130034058|NCT01154101|468081061|FG002|Overall Study|Withdrawal by Subject|2|||
130034059|NCT01154101|468081062|FG003|Overall Study|Withdrawal by Subject|0|||
129885582|NCT02611830|467540768|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
129885583|NCT02611830|467540769|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
130034060|NCT01154101|468081063|FG004|Overall Study|Withdrawal by Subject|1|||
130034061|NCT04125680|468081065|FG000|Overall Study|Lost to Follow-up|15|||
130034062|NCT01562028|468081066|FG000|Overall Study|Withdrawal by Subject|1|||
130034063|NCT01562028|468081067|FG001|Overall Study|Withdrawal by Subject|1|||
130034064|NCT01562028|468081066|FG000|Overall Study|Lost to Follow-up|2|||
130034065|NCT01562028|468081067|FG001|Overall Study|Lost to Follow-up|1|||
130034066|NCT02360098|468081068|FG000|Overall Study|Physician Decision|7|||
130034067|NCT04938648|468081069|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
130034068|NCT04938648|468081070|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
130034069|NCT04938648|468081069|FG000|Overall Study|Patient too ill|0|||
130034070|NCT04938648|468081070|FG001|Overall Study|Patient too ill|1|||
130034071|NCT04938648|468081069|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
130034072|NCT04938648|468081070|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
130034073|NCT04938648|468081069|FG000|Overall Study|Patient did not have memory problems|1|||
130034074|NCT04938648|468081070|FG001|Overall Study|Patient did not have memory problems|1|||
130034075|NCT04938648|468081069|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
130034076|NCT04938648|468081070|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
130034077|NCT04938648|468081069|FG000|Overall Study|Care partner could not be reached|0|||
130034078|NCT04938648|468081070|FG001|Overall Study|Care partner could not be reached|1|||
130034079|NCT04938648|468081069|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
130034080|NCT04938648|468081070|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
130034081|NCT04938648|468081069|FG000|Overall Study|Withdrawal by Subject|2|||
130034082|NCT04938648|468081070|FG001|Overall Study|Withdrawal by Subject|1|||
130034083|NCT03293654|468081071|FG000|Overall Study|Lost to Follow-up|0|||
130034084|NCT03293654|468081072|FG001|Overall Study|Lost to Follow-up|1|||
130034085|NCT03293654|468081073|FG002|Overall Study|Lost to Follow-up|0|||
130034086|NCT02542267|468081074|FG000|Overall Study|Withdrawal by Subject|10|||
130034087|NCT02542267|468081074|FG000|Overall Study|Physician Decision|6|||
130034088|NCT02542267|468081074|FG000|Overall Study|Lost to Follow-up|4|||
130034089|NCT02542267|468081074|FG000|Overall Study|Death|13|||
130259019|NCT02958865|468914754|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259020|NCT02958865|468914755|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259021|NCT02958865|468914756|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259022|NCT02958865|468914757|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259023|NCT02958865|468914758|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130259024|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259025|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259026|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259027|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259028|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259029|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259030|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259031|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259032|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259033|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
130259034|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
130259035|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259036|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
130259037|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259038|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
130259039|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
130259040|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259041|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259042|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259043|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259044|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259045|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259046|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259047|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259048|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
130259049|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
130259050|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259051|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
130259052|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259053|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
130259054|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
130259055|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
130259056|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259057|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259058|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259059|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259060|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259061|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259062|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259063|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259064|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130034090|NCT02542267|468081074|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
130034091|NCT02542267|468081074|FG000|Overall Study|Other|9|||
130034092|NCT02886702|468081075|FG000|Overall Study|Other|4|||
130034093|NCT02886702|468081076|FG001|Overall Study|Other|3|||
130034094|NCT02886702|468081077|FG002|Overall Study|Other|9|||
130034095|NCT02886702|468081075|FG000|Overall Study|Withdrawal by Subject|24|||
130034096|NCT02886702|468081076|FG001|Overall Study|Withdrawal by Subject|18|||
130034097|NCT02886702|468081077|FG002|Overall Study|Withdrawal by Subject|22|||
130034098|NCT02886702|468081075|FG000|Overall Study|Significant Worsening of Condition|0|||
130034099|NCT02886702|468081076|FG001|Overall Study|Significant Worsening of Condition|1|||
130034100|NCT02886702|468081077|FG002|Overall Study|Significant Worsening of Condition|0|||
130034101|NCT02886702|468081075|FG000|Overall Study|Protocol Violation|2|||
130034102|NCT02886702|468081076|FG001|Overall Study|Protocol Violation|2|||
130034103|NCT02886702|468081077|FG002|Overall Study|Protocol Violation|1|||
130101937|NCT00777920|468330819|FG000|Overall Study|Investigator's discretion|1|||
130101938|NCT00777920|468330819|FG000|Overall Study|Clinical status did not improve|1|||
130101939|NCT00777920|468330819|FG000|Overall Study|Other, not specified|4|||
130259065|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
130259066|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259067|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259068|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259069|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259070|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
130259071|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
130259072|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259073|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259074|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259075|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259076|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259077|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259078|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259079|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259080|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259081|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259082|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
130259083|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
130259084|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
130259085|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
130259086|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
130259087|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
130259088|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
130259089|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
130259090|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
130259091|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
130259092|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
130259093|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
130259094|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
130259095|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
130259096|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
130259097|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
130259098|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
130259099|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
130259100|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
130259101|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
130259102|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
130259103|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
130259104|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259105|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259106|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259107|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259108|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259109|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259110|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259111|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259112|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259113|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259114|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259115|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259116|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259117|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
130034104|NCT02886702|468081075|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130259118|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259119|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
130259120|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259121|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259122|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259123|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259124|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259125|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259126|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259127|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259128|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259129|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259130|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259131|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259132|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130034105|NCT02886702|468081076|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129885584|NCT02611830|467540770|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
130259133|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
130259134|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259135|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
130259136|NCT02958865|468914743|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259137|NCT02958865|468914744|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259138|NCT02958865|468914745|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259139|NCT02958865|468914746|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259140|NCT02958865|468914747|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259141|NCT02958865|468914748|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259142|NCT02958865|468914749|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259143|NCT02958865|468914750|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259144|NCT02958865|468914751|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259145|NCT02958865|468914752|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
130259146|NCT02958865|468914753|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259147|NCT02958865|468914754|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259148|NCT02958865|468914755|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259149|NCT02958865|468914756|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259150|NCT02958865|468914757|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259151|NCT02958865|468914758|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
130259152|NCT02661815|468914759|FG000|Overall Study|Withdrawal by Subject|1|||
130259153|NCT02661815|468914760|FG001|Overall Study|Withdrawal by Subject|0|||
130259154|NCT02661815|468914761|FG002|Overall Study|Withdrawal by Subject|0|||
130259155|NCT02661815|468914762|FG003|Overall Study|Withdrawal by Subject|0|||
130259156|NCT01728246|468914765|FG000|Overall Study|Participant needed rescue medication|1|||
130259157|NCT01728246|468914766|FG001|Overall Study|Participant needed rescue medication|5|||
130259158|NCT01728246|468914765|FG000|Overall Study|Protocol Violation|1|||
130259159|NCT01728246|468914766|FG001|Overall Study|Protocol Violation|0|||
130259160|NCT01728246|468914765|FG000|Overall Study|Withdrawal by Subject|2|||
130259161|NCT01728246|468914766|FG001|Overall Study|Withdrawal by Subject|3|||
130259162|NCT01728246|468914765|FG000|Overall Study|Lost to Follow-up|23|||
130259163|NCT01728246|468914766|FG001|Overall Study|Lost to Follow-up|22|||
130259164|NCT01728246|468914765|FG000|Overall Study|Lack of Efficacy|1|||
130259165|NCT01728246|468914766|FG001|Overall Study|Lack of Efficacy|1|||
130259166|NCT01728246|468914765|FG000|Overall Study|Adverse Event|8|||
130259167|NCT01728246|468914766|FG001|Overall Study|Adverse Event|5|||
130259168|NCT01983111|468914767|FG000|Overall Study|Withdrawal by Subject|8|||
130259169|NCT01983111|468914768|FG001|Overall Study|Withdrawal by Subject|6|||
130259170|NCT01983111|468914767|FG000|Overall Study|Adverse Event|4|||
130259171|NCT01983111|468914768|FG001|Overall Study|Adverse Event|0|||
130259172|NCT01983111|468914767|FG000|Overall Study|Protocol Violation|0|||
130259173|NCT01983111|468914768|FG001|Overall Study|Protocol Violation|1|||
130259174|NCT00855335|468914769|FG000|Overall Study|Lost to Follow-up|0|||
130259175|NCT00855335|468914770|FG001|Overall Study|Lost to Follow-up|0|||
130259176|NCT00855335|468914771|FG002|Overall Study|Lost to Follow-up|3|||
130259177|NCT00855335|468914772|FG003|Overall Study|Lost to Follow-up|1|||
130259178|NCT00855335|468914773|FG004|Overall Study|Lost to Follow-up|0|||
130259179|NCT00855335|468914769|FG000|Overall Study|Withdrawal by Subject|0|||
130259180|NCT00855335|468914770|FG001|Overall Study|Withdrawal by Subject|0|||
130259181|NCT00855335|468914771|FG002|Overall Study|Withdrawal by Subject|0|||
130259182|NCT00855335|468914772|FG003|Overall Study|Withdrawal by Subject|1|||
130259183|NCT00855335|468914773|FG004|Overall Study|Withdrawal by Subject|0|||
130259184|NCT00855335|468914769|FG000|Overall Study|Adverse Event|2|||
130259185|NCT00855335|468914770|FG001|Overall Study|Adverse Event|0|||
130259186|NCT00855335|468914771|FG002|Overall Study|Adverse Event|0|||
130259187|NCT00855335|468914772|FG003|Overall Study|Adverse Event|0|||
130259188|NCT00855335|468914773|FG004|Overall Study|Adverse Event|0|||
130259189|NCT00855335|468914769|FG000|Overall Study|Physician Decision|1|||
130259190|NCT00855335|468914770|FG001|Overall Study|Physician Decision|1|||
130259191|NCT00855335|468914771|FG002|Overall Study|Physician Decision|0|||
130259192|NCT00855335|468914772|FG003|Overall Study|Physician Decision|0|||
130259193|NCT00855335|468914773|FG004|Overall Study|Physician Decision|0|||
130034106|NCT02886702|468081077|FG002|Overall Study|Non-Compliance With Study Drug|4|||
130034107|NCT02886702|468081075|FG000|Overall Study|Lost to Follow-up|11|||
130034108|NCT02886702|468081076|FG001|Overall Study|Lost to Follow-up|13|||
130259194|NCT00855335|468914769|FG000|Overall Study|Other|2|||
130259195|NCT00855335|468914770|FG001|Overall Study|Other|1|||
130259196|NCT00855335|468914771|FG002|Overall Study|Other|2|||
130259197|NCT00855335|468914772|FG003|Overall Study|Other|5|||
130034109|NCT02886702|468081077|FG002|Overall Study|Lost to Follow-up|8|||
130034110|NCT02886702|468081075|FG000|Overall Study|Lack of Efficacy|3|||
130034111|NCT02886702|468081076|FG001|Overall Study|Lack of Efficacy|4|||
130034112|NCT02886702|468081077|FG002|Overall Study|Lack of Efficacy|5|||
130259198|NCT00855335|468914773|FG004|Overall Study|Other|1|||
130259199|NCT03502200|468914774|FG000|Overall Study|Adverse Event|1|||
130259200|NCT03502200|468914775|FG001|Overall Study|Adverse Event|0|||
130259201|NCT03502200|468914774|FG000|Overall Study|Lost to Follow-up|36|||
130259202|NCT03502200|468914775|FG001|Overall Study|Lost to Follow-up|38|||
130259203|NCT03502200|468914774|FG000|Overall Study|Study Team Decision|1|||
130259204|NCT03502200|468914775|FG001|Overall Study|Study Team Decision|1|||
130259205|NCT03502200|468914774|FG000|Overall Study|Withdrawal by Subject|5|||
130259206|NCT03502200|468914775|FG001|Overall Study|Withdrawal by Subject|7|||
130259207|NCT03502200|468914774|FG000|Overall Study|Death|0|||
130259208|NCT03502200|468914775|FG001|Overall Study|Death|2|||
130259209|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Adverse Event|3|||
130259210|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Adverse Event|0|||
130259211|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Adverse Event|0|||
130259212|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
130259213|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
130259214|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
130259215|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
130259216|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
130259217|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
130259218|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
130259219|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
130259220|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
130259221|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
130259222|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
130259223|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
130259224|NCT04380142|468914779|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
130259225|NCT04380142|468914780|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
130259226|NCT04380142|468914781|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
130259227|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130259228|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130259229|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Adverse Event|14|||
130259230|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
130259231|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
130259232|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
130259233|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130259234|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
130259235|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
130259236|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
130259237|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
130259238|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
130259239|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
130259240|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
130259241|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
130259242|NCT04380142|468914779|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
130259243|NCT04380142|468914780|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
130259244|NCT04380142|468914781|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
130259245|NCT00787150|468914782|FG000|Overall Study|Adverse Event|4|||
130259246|NCT00787150|468914783|FG001|Overall Study|Adverse Event|4|||
130259247|NCT00787150|468914784|FG002|Overall Study|Adverse Event|4|||
130259248|NCT00787150|468914782|FG000|Overall Study|Physician Decision|1|||
130259249|NCT00787150|468914783|FG001|Overall Study|Physician Decision|2|||
130259250|NCT00787150|468914784|FG002|Overall Study|Physician Decision|1|||
130259251|NCT00787150|468914782|FG000|Overall Study|Withdrawal by Subject|2|||
130259252|NCT00787150|468914783|FG001|Overall Study|Withdrawal by Subject|1|||
130259253|NCT00787150|468914784|FG002|Overall Study|Withdrawal by Subject|0|||
130259254|NCT00787150|468914782|FG000|Overall Study|Dosing incorrect study durg|2|||
130259255|NCT00787150|468914783|FG001|Overall Study|Dosing incorrect study durg|0|||
130259256|NCT00787150|468914784|FG002|Overall Study|Dosing incorrect study durg|0|||
130259257|NCT01849276|468914791|FG000|Followed for Survival for 5 Years|Death|1|||
130259258|NCT01849276|468914791|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
130259259|NCT00879398|468914794|FG000|Overall Study|Visit Stop|399|||
130259260|NCT00879398|468914794|FG000|Overall Study|Lack of Efficacy|64|||
130259261|NCT00879398|468914794|FG000|Overall Study|Adverse Event|41|||
130259262|NCT00879398|468914794|FG000|Overall Study|Other Reasons|171|||
130259263|NCT01380080|468914796|FG000|Overall Study|Death|36|||
130259264|NCT01380080|468914797|FG001|Overall Study|Death|44|||
130259265|NCT01380080|468914796|FG000|Overall Study|Site is closing|28|||
130259266|NCT01380080|468914797|FG001|Overall Study|Site is closing|31|||
130101940|NCT00483717|468330820|FG000|Overall Study|Protocol Violation|5|||
130101941|NCT00483717|468330821|FG001|Overall Study|Protocol Violation|7|||
130101942|NCT00483717|468330820|FG000|Overall Study|Time of dosing missing|1|||
130259267|NCT01380080|468914796|FG000|Overall Study|Not able to get to clinic|7|||
130034113|NCT02886702|468081075|FG000|Overall Study|Adverse Event|4|||
130034114|NCT02886702|468081076|FG001|Overall Study|Adverse Event|9|||
130034115|NCT02886702|468081077|FG002|Overall Study|Adverse Event|3|||
130034116|NCT02886702|468081075|FG000|Overall Study|Administrative Reasons|0|||
130259268|NCT01380080|468914797|FG001|Overall Study|Not able to get to clinic|1|||
130259269|NCT01380080|468914796|FG000|Overall Study|Not willing to adhere to requirements|6|||
130259270|NCT01380080|468914797|FG001|Overall Study|Not willing to adhere to requirements|2|||
130259271|NCT01380080|468914796|FG000|Overall Study|Withdrawal by Subject|5|||
130259272|NCT01380080|468914797|FG001|Overall Study|Withdrawal by Subject|2|||
130259273|NCT01380080|468914796|FG000|Overall Study|Lost to Follow-up|3|||
130259274|NCT01380080|468914797|FG001|Overall Study|Lost to Follow-up|3|||
130259275|NCT04251533|468914798|FG000|Overall Study|Progressive disease|33|||
130259276|NCT04251533|468914799|FG001|Overall Study|Progressive disease|29|||
130034117|NCT02886702|468081076|FG001|Overall Study|Administrative Reasons|0|||
130034118|NCT02886702|468081077|FG002|Overall Study|Administrative Reasons|1|||
130259277|NCT04251533|468914800|FG002|Overall Study|Progressive disease|22|||
130259278|NCT04251533|468914798|FG000|Overall Study|Death|5|||
130259279|NCT04251533|468914799|FG001|Overall Study|Death|1|||
130259280|NCT04251533|468914800|FG002|Overall Study|Death|3|||
130259281|NCT04251533|468914798|FG000|Overall Study|Physician Decision|3|||
130259282|NCT04251533|468914799|FG001|Overall Study|Physician Decision|2|||
130259283|NCT04251533|468914800|FG002|Overall Study|Physician Decision|4|||
130259284|NCT04251533|468914798|FG000|Overall Study|Participant decision|1|||
130259285|NCT04251533|468914799|FG001|Overall Study|Participant decision|3|||
130259286|NCT04251533|468914800|FG002|Overall Study|Participant decision|1|||
130259287|NCT04251533|468914798|FG000|Overall Study|Adverse Event|2|||
130259288|NCT04251533|468914799|FG001|Overall Study|Adverse Event|1|||
130259289|NCT04251533|468914800|FG002|Overall Study|Adverse Event|1|||
130259290|NCT00210132|468914805|FG000|Overall Study|Protocol Violation|1|||
130259291|NCT00210132|468914806|FG001|Overall Study|Protocol Violation|4|||
130259292|NCT01722669|468914811|FG000|Overall Study|Withdrawal by Subject|0|||
130259293|NCT01722669|468914812|FG001|Overall Study|Withdrawal by Subject|0|||
130259294|NCT01722669|468914813|FG002|Overall Study|Withdrawal by Subject|0|||
130259295|NCT01722669|468914814|FG003|Overall Study|Withdrawal by Subject|0|||
130259296|NCT01722669|468914815|FG004|Overall Study|Withdrawal by Subject|0|||
130259297|NCT01722669|468914816|FG005|Overall Study|Withdrawal by Subject|2|||
130259298|NCT03211416|468914817|FG000|Overall Study|Adverse Event|7|||
130259299|NCT03211416|468914817|FG000|Overall Study|Lack of Efficacy|2|||
130259300|NCT03211416|468914817|FG000|Overall Study|Physician Decision|1|||
130259301|NCT03448393|468914821|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259302|NCT03448393|468914822|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259303|NCT03448393|468914823|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
130259304|NCT03448393|468914824|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259305|NCT03448393|468914825|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259306|NCT03448393|468914826|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259307|NCT03448393|468914827|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259308|NCT03448393|468914828|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
130259309|NCT03448393|468914829|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
130259310|NCT03448393|468914821|FG000|Dose Expansion|Not treated - screen failure|0|||
130259311|NCT03448393|468914822|FG001|Dose Expansion|Not treated - screen failure|0|||
130259312|NCT03448393|468914823|FG002|Dose Expansion|Not treated - screen failure|0|||
130259313|NCT03448393|468914824|FG003|Dose Expansion|Not treated - screen failure|0|||
130259314|NCT03448393|468914825|FG004|Dose Expansion|Not treated - screen failure|0|||
130259315|NCT03448393|468914826|FG005|Dose Expansion|Not treated - screen failure|0|||
130259316|NCT03448393|468914827|FG006|Dose Expansion|Not treated - screen failure|0|||
130259317|NCT03448393|468914828|FG007|Dose Expansion|Not treated - screen failure|0|||
130259318|NCT03448393|468914829|FG008|Dose Expansion|Not treated - screen failure|7|||
130259319|NCT01587196|468914830|FG000|Overall Study|Lost to Follow-up|50|||
130259320|NCT01587196|468914830|FG000|Overall Study|Withdrawal by Subject|4|||
130259321|NCT00643279|468914836|FG000|Overall Study|Death|13|||
130259322|NCT00643279|468914837|FG001|Overall Study|Death|11|||
130259323|NCT00643279|468914836|FG000|Overall Study|Withdrawal by Subject|3|||
130259324|NCT00643279|468914837|FG001|Overall Study|Withdrawal by Subject|0|||
130259325|NCT00643279|468914836|FG000|Overall Study|Lost to Follow-up|0|||
130259326|NCT00643279|468914837|FG001|Overall Study|Lost to Follow-up|1|||
130259327|NCT00643279|468914836|FG000|Overall Study|Physician Decision|0|||
130259328|NCT00643279|468914837|FG001|Overall Study|Physician Decision|1|||
130034119|NCT01974323|468081078|FG000|Overall Study|Other Reasons|25|||
130034120|NCT01974323|468081079|FG001|Overall Study|Other Reasons|28|||
130034121|NCT01974323|468081078|FG000|Overall Study|Protocol Violation|2|||
130034122|NCT01974323|468081079|FG001|Overall Study|Protocol Violation|2|||
130034123|NCT01974323|468081078|FG000|Overall Study|Personal Reasons|15|||
130034124|NCT01974323|468081079|FG001|Overall Study|Personal Reasons|19|||
130034125|NCT01974323|468081078|FG000|Overall Study|Lost to Follow-up|45|||
130034126|NCT01974323|468081079|FG001|Overall Study|Lost to Follow-up|40|||
130034127|NCT01974323|468081078|FG000|Overall Study|Pregnancy|2|||
130034128|NCT01974323|468081079|FG001|Overall Study|Pregnancy|1|||
130259329|NCT05715827|468914838|FG000|Overall Study|Physician Decision|0|||
130259330|NCT05715827|468914839|FG001|Overall Study|Physician Decision|1|||
130259331|NCT05715827|468914838|FG000|Overall Study|console communication error|0|||
130259332|NCT05715827|468914839|FG001|Overall Study|console communication error|1|||
130259333|NCT03814044|468914840|FG000|Overall Study|Protocol deviation|1|||
130259334|NCT03557502|468914841|FG000|Protocol 2|Withdrawal by Subject|1|||
130259335|NCT03557502|468914842|FG001|Protocol 2|Withdrawal by Subject|1|||
130259336|NCT03557502|468914841|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
130259337|NCT03557502|468914842|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
130259338|NCT03021486|468916145|FG000|Overall Study|Withdrawal by Subject|1|||
130259339|NCT03021486|468916146|FG001|Overall Study|Withdrawal by Subject|1|||
130259340|NCT03021486|468916147|FG002|Overall Study|Withdrawal by Subject|3|||
130259341|NCT03021486|468916145|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
130259342|NCT03021486|468916146|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
130259343|NCT03021486|468916147|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
130259344|NCT04887831|468916148|FG000|Overall Study|Death|26|||
130259345|NCT04887831|468916149|FG001|Overall Study|Death|26|||
130259346|NCT04887831|468916148|FG000|Overall Study|Lost to Follow-up|0|||
130259347|NCT04887831|468916149|FG001|Overall Study|Lost to Follow-up|1|||
130259348|NCT04887831|468916148|FG000|Overall Study|Withdrawal by Subject|2|||
130259349|NCT04887831|468916149|FG001|Overall Study|Withdrawal by Subject|1|||
130259350|NCT04887831|468916148|FG000|Overall Study|Study Terminated by Sponsor|18|||
130259351|NCT04887831|468916149|FG001|Overall Study|Study Terminated by Sponsor|17|||
130259352|NCT04887831|468916148|FG000|Overall Study|Other|1|||
130259353|NCT04887831|468916149|FG001|Overall Study|Other|0|||
130259354|NCT00730327|468916150|FG000|Overall Study|Lost to Follow-up|14|||
130259355|NCT00730327|468916151|FG001|Overall Study|Lost to Follow-up|16|||
130259356|NCT00730327|468916150|FG000|Overall Study|Adverse Event|8|||
130259357|NCT00730327|468916151|FG001|Overall Study|Adverse Event|1|||
130259358|NCT00730327|468916150|FG000|Overall Study|Withdrawal by Subject|3|||
130259359|NCT00730327|468916151|FG001|Overall Study|Withdrawal by Subject|13|||
130259360|NCT00730327|468916150|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
130259361|NCT00730327|468916151|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
130259362|NCT02552225|468916152|FG000|Overall Study|Withdrawal by Subject|1|||
130259363|NCT02552225|468916153|FG001|Overall Study|Withdrawal by Subject|0|||
130259364|NCT02297516|468916154|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
130259365|NCT02297516|468916155|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
130034129|NCT01974323|468081078|FG000|Overall Study|Lack of Efficacy|1|||
130259366|NCT02297516|468916154|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
130259367|NCT02297516|468916155|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
130259368|NCT02297516|468916154|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
130259369|NCT02297516|468916155|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
130034130|NCT01974323|468081079|FG001|Overall Study|Lack of Efficacy|1|||
130034131|NCT01974323|468081078|FG000|Overall Study|Adverse Event|2|||
130259370|NCT03674281|468916156|FG000|Overall Study|screen failure|2|||
130259371|NCT03674281|468916157|FG001|Overall Study|screen failure|0|||
130259372|NCT03674281|468916158|FG002|Overall Study|screen failure|0|||
130259373|NCT03674281|468916156|FG000|Overall Study|Withdrawal by Subject|1|||
130259374|NCT03674281|468916157|FG001|Overall Study|Withdrawal by Subject|3|||
130259375|NCT03674281|468916158|FG002|Overall Study|Withdrawal by Subject|3|||
130259376|NCT00366457|468916161|FG000|Overall Study|never began study therapy|2|||
130259377|NCT01497197|468916162|FG000|Overall Study|Lost to Follow-up|1|||
130259378|NCT01497197|468916163|FG001|Overall Study|Lost to Follow-up|0|||
130259379|NCT01497197|468916162|FG000|Overall Study|Protocol Violation|0|||
130259380|NCT01497197|468916163|FG001|Overall Study|Protocol Violation|2|||
130259381|NCT01497197|468916162|FG000|Overall Study|Withdrawal by Subject|2|||
130259382|NCT01497197|468916163|FG001|Overall Study|Withdrawal by Subject|1|||
130259383|NCT01497197|468916162|FG000|Overall Study|Excessive/lack of response to treatment|1|||
130259384|NCT01497197|468916163|FG001|Overall Study|Excessive/lack of response to treatment|0|||
130259385|NCT01497197|468916162|FG000|Overall Study|Risk of OHSS|1|||
130259386|NCT01497197|468916163|FG001|Overall Study|Risk of OHSS|0|||
130034132|NCT01974323|468081079|FG001|Overall Study|Adverse Event|2|||
130259387|NCT01497197|468916162|FG000|Overall Study|No oocytes retrieved|3|||
130259388|NCT01497197|468916163|FG001|Overall Study|No oocytes retrieved|2|||
130259389|NCT01497197|468916162|FG000|Overall Study|No fertilisation|6|||
130259390|NCT01497197|468916163|FG001|Overall Study|No fertilisation|5|||
130259391|NCT01497197|468916162|FG000|Overall Study|Intention to freeze all embryos|0|||
130259392|NCT01497197|468916163|FG001|Overall Study|Intention to freeze all embryos|1|||
130259393|NCT01497197|468916162|FG000|Overall Study|All embryos discarded|0|||
130259394|NCT01497197|468916163|FG001|Overall Study|All embryos discarded|3|||
130034133|NCT00331760|468081080|FG000|Overall Study|Ineligible / no protocol treatment|15|||
130034134|NCT00331760|468081081|FG001|Overall Study|Ineligible / no protocol treatment|8|||
130259395|NCT01497197|468916162|FG000|Overall Study|Other|3|||
130259396|NCT01497197|468916163|FG001|Overall Study|Other|1|||
130259397|NCT00415636|468916166|FG000|Overall Study|Symptomatic deterioration|1|||
130259398|NCT00415636|468916167|FG001|Overall Study|Symptomatic deterioration|0|||
130259399|NCT00415636|468916168|FG002|Overall Study|Symptomatic deterioration|1|||
130259400|NCT00415636|468916169|FG003|Overall Study|Symptomatic deterioration|2|||
130259401|NCT00415636|468916170|FG004|Overall Study|Symptomatic deterioration|0|||
130259402|NCT00415636|468916171|FG005|Overall Study|Symptomatic deterioration|1|||
130259403|NCT00415636|468916166|FG000|Overall Study|Adverse Event|0|||
130259404|NCT00415636|468916167|FG001|Overall Study|Adverse Event|0|||
130259405|NCT00415636|468916168|FG002|Overall Study|Adverse Event|0|||
130259406|NCT00415636|468916169|FG003|Overall Study|Adverse Event|1|||
130259407|NCT00415636|468916170|FG004|Overall Study|Adverse Event|1|||
130259408|NCT00415636|468916171|FG005|Overall Study|Adverse Event|0|||
130259409|NCT00415636|468916166|FG000|Overall Study|Withdrawal by Subject|0|||
130259410|NCT00415636|468916167|FG001|Overall Study|Withdrawal by Subject|0|||
130259411|NCT00415636|468916168|FG002|Overall Study|Withdrawal by Subject|0|||
130259412|NCT00415636|468916169|FG003|Overall Study|Withdrawal by Subject|0|||
130259413|NCT00415636|468916170|FG004|Overall Study|Withdrawal by Subject|1|||
130259414|NCT00415636|468916171|FG005|Overall Study|Withdrawal by Subject|0|||
130259415|NCT00415636|468916166|FG000|Overall Study|Disease progression|0|||
130259416|NCT00415636|468916167|FG001|Overall Study|Disease progression|0|||
130259417|NCT00415636|468916168|FG002|Overall Study|Disease progression|0|||
130259418|NCT00415636|468916169|FG003|Overall Study|Disease progression|3|||
130259419|NCT00415636|468916170|FG004|Overall Study|Disease progression|0|||
130259420|NCT00415636|468916171|FG005|Overall Study|Disease progression|1|||
130259421|NCT05201807|468916177|FG000|Overall Study|Adverse Event|1|||
130259422|NCT05201807|468916177|FG000|Overall Study|COVID-19 Related|1|||
130259423|NCT01209767|468916178|FG000|Overall Study|Withdrawal by Subject|1|||
130259424|NCT01209767|468916178|FG000|Overall Study|Lost to Follow-up|3|||
130259425|NCT01702298|468916179|FG000|Overall Study|Withdrawal by Subject|1|||
130259426|NCT04507204|468916180|FG000|Overall Study|Adverse Event|8|||
130259427|NCT04507204|468916181|FG001|Overall Study|Adverse Event|13|||
130259428|NCT04507204|468916180|FG000|Overall Study|Death|0|||
130259429|NCT04507204|468916181|FG001|Overall Study|Death|1|||
130259430|NCT04507204|468916180|FG000|Overall Study|Lost to Follow-up|15|||
130259431|NCT04507204|468916181|FG001|Overall Study|Lost to Follow-up|14|||
130259432|NCT04507204|468916180|FG000|Overall Study|Poor Compliance with Protocol|2|||
130259433|NCT04507204|468916181|FG001|Overall Study|Poor Compliance with Protocol|4|||
130259434|NCT04507204|468916180|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
130259435|NCT04507204|468916181|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
130259436|NCT04507204|468916180|FG000|Overall Study|Withdrawal of Patient Consent|21|||
130259437|NCT04507204|468916181|FG001|Overall Study|Withdrawal of Patient Consent|13|||
130259438|NCT03580044|468916185|FG000|Overall Study|Death|2|||
130259439|NCT03580044|468916186|FG001|Overall Study|Death|1|||
130259440|NCT03580044|468916185|FG000|Overall Study|Withdrawal by Subject|1|||
130259441|NCT03580044|468916186|FG001|Overall Study|Withdrawal by Subject|1|||
130259442|NCT01664624|468916189|FG000|Overall Study|Adverse Event|0|||
130259443|NCT01664624|468916190|FG001|Overall Study|Adverse Event|1|||
130259444|NCT01664624|468916191|FG002|Overall Study|Adverse Event|0|||
130259445|NCT01664624|468916192|FG003|Overall Study|Adverse Event|0|||
130259446|NCT01206517|468916193|FG000|Overall Study|Withdrawal by Subject|0|||
130259447|NCT01206517|468916194|FG001|Overall Study|Withdrawal by Subject|0|||
130259448|NCT01206517|468916195|FG002|Overall Study|Withdrawal by Subject|2|||
130259449|NCT01206517|468916196|FG003|Overall Study|Withdrawal by Subject|0|||
130259450|NCT01206517|468916197|FG004|Overall Study|Withdrawal by Subject|1|||
130259451|NCT01206517|468916198|FG005|Overall Study|Withdrawal by Subject|0|||
130259452|NCT01029535|468916199|FG000|Overall Study|Lost to Follow-up|24|||
130259453|NCT01029535|468916199|FG000|Overall Study|Protocol Violation|2|||
130259454|NCT01029535|468916199|FG000|Overall Study|Participant Withdrew Consent|2|||
130259455|NCT01029535|468916199|FG000|Overall Study|Adverse Event|1|||
130259456|NCT01029535|468916199|FG000|Overall Study|Use of Another Treatment|1|||
130034135|NCT00461175|468081082|FG000|Overall Study|Protocol Violation|522|||
130259457|NCT01029535|468916199|FG000|Overall Study|Death|1|||
130259458|NCT01198587|468916203|FG000|Overall Study|Lost to Follow-up|8|||
130259459|NCT01198587|468916204|FG001|Overall Study|Lost to Follow-up|0|||
130259460|NCT01198587|468916205|FG002|Overall Study|Lost to Follow-up|9|||
130259461|NCT01198587|468916206|FG003|Overall Study|Lost to Follow-up|0|||
130259462|NCT00573768|468916207|FG000|Overall Study|Adverse Event|1|||
130259463|NCT00573768|468916208|FG001|Overall Study|Adverse Event|1|||
130259464|NCT00573768|468916209|FG002|Overall Study|Adverse Event|2|||
130259465|NCT00573768|468916207|FG000|Overall Study|Protocol Violation|1|||
130259466|NCT00573768|468916208|FG001|Overall Study|Protocol Violation|0|||
130259467|NCT00573768|468916209|FG002|Overall Study|Protocol Violation|1|||
130259468|NCT00573768|468916207|FG000|Overall Study|Withdrawal by Subject|0|||
130259469|NCT00573768|468916208|FG001|Overall Study|Withdrawal by Subject|1|||
130259470|NCT00573768|468916209|FG002|Overall Study|Withdrawal by Subject|0|||
130259471|NCT00573768|468916207|FG000|Overall Study|Lost to Follow-up|0|||
130259472|NCT00573768|468916208|FG001|Overall Study|Lost to Follow-up|0|||
130259473|NCT00573768|468916209|FG002|Overall Study|Lost to Follow-up|1|||
130259474|NCT04067011|468916215|FG000|Overall Study|Not Treated|8|||
130259475|NCT04067011|468916216|FG001|Overall Study|Not Treated|7|||
130259476|NCT04067011|468916217|FG002|Overall Study|Not Treated|5|||
130259477|NCT04067011|468916215|FG000|Overall Study|Adverse Event|2|||
130259478|NCT04067011|468916216|FG001|Overall Study|Adverse Event|1|||
130259479|NCT04067011|468916217|FG002|Overall Study|Adverse Event|0|||
130259480|NCT04067011|468916215|FG000|Overall Study|Withdrawal by Subject|6|||
130259481|NCT04067011|468916216|FG001|Overall Study|Withdrawal by Subject|2|||
130259482|NCT04067011|468916217|FG002|Overall Study|Withdrawal by Subject|1|||
130259483|NCT04067011|468916215|FG000|Overall Study|Lost to Follow-up|0|||
130259484|NCT04067011|468916216|FG001|Overall Study|Lost to Follow-up|0|||
130259485|NCT04067011|468916217|FG002|Overall Study|Lost to Follow-up|1|||
130259486|NCT04067011|468916215|FG000|Overall Study|Physician Decision|1|||
130259487|NCT04067011|468916216|FG001|Overall Study|Physician Decision|1|||
130259488|NCT04067011|468916217|FG002|Overall Study|Physician Decision|0|||
130259489|NCT04067011|468916215|FG000|Overall Study|Other Reasons|2|||
130259490|NCT04067011|468916216|FG001|Overall Study|Other Reasons|0|||
130259491|NCT04067011|468916217|FG002|Overall Study|Other Reasons|1|||
130259492|NCT04067011|468916215|FG000|Overall Study|Missing|0|||
130259493|NCT04067011|468916216|FG001|Overall Study|Missing|2|||
130259494|NCT04067011|468916217|FG002|Overall Study|Missing|0|||
130259495|NCT03746015|468916218|FG000|Overall Study|Withdrawal of Consent|1|||
130259496|NCT03746015|468916219|FG001|Overall Study|Withdrawal of Consent|0|||
130259497|NCT03746015|468916220|FG002|Overall Study|Withdrawal of Consent|0|||
130259498|NCT05209386|468916221|FG000|Overall Study|Withdrawal by Subject|8|||
130259499|NCT05209386|468916221|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
130259500|NCT05134649|468916222|FG000|Overall Study|Lost to Follow-up|12|||
130259501|NCT05134649|468916222|FG000|Overall Study|Withdrawal by Subject|14|||
130259502|NCT05134649|468916222|FG000|Overall Study|Pregnancy|1|||
130259503|NCT05134649|468916222|FG000|Overall Study|Other, not specified|3|||
130259504|NCT01559935|468916223|FG000|Car Phase|Toxicity|4|||
130259505|NCT01559935|468916223|FG000|Car Phase|Death|1|||
130259506|NCT01559935|468916223|FG000|Car Phase|Lack of Efficacy|2|||
130259507|NCT01559935|468916223|FG000|Car Phase|Lost to Follow-up|1|||
130259508|NCT01559935|468916223|FG000|Car Phase|Physician Decision|1|||
130259509|NCT01559935|468916223|FG000|Car Phase|Withdrawal by Subject|2|||
130034136|NCT00461175|468081083|FG001|Overall Study|Protocol Violation|365|||
130259510|NCT01559935|468916223|FG000|Car Phase|Per protocol|1|||
130259511|NCT01559935|468916223|FG000|Car Phase|Insurance|1|||
130259512|NCT01559935|468916223|FG000|Car Phase|non-compliance|1|||
130259513|NCT01559935|468916223|FG000|BiRD Phase|Toxicity|1|||
130259514|NCT01559935|468916223|FG000|BiRD Phase|Lack of Efficacy|1|||
130259515|NCT01559935|468916223|FG000|BiRD Phase|Withdrawal by Subject|2|||
130259516|NCT01559935|468916223|FG000|Maintenance Phase|Remains on study|28|||
130259517|NCT01559935|468916223|FG000|Maintenance Phase|Toxicity|1|||
130259518|NCT01559935|468916223|FG000|Maintenance Phase|Lack of Efficacy|18|||
130259519|NCT01559935|468916223|FG000|Maintenance Phase|Withdrawal by Subject|5|||
130259520|NCT01559935|468916223|FG000|Maintenance Phase|Non-compliance|2|||
130259521|NCT01143402|468916227|FG000|Overall Study|Rapid clinical decline|1|||
130259522|NCT01143402|468916228|FG001|Overall Study|Rapid clinical decline|1|||
130259523|NCT01143402|468916229|FG002|Overall Study|Rapid clinical decline|0|||
130259524|NCT01143402|468916227|FG000|Overall Study|Not Treated|0|||
130259525|NCT01143402|468916228|FG001|Overall Study|Not Treated|0|||
130259526|NCT01143402|468916229|FG002|Overall Study|Not Treated|1|||
130259527|NCT02526290|468916230|FG000|Overall Study|Adverse Event|3|||
130259528|NCT02526290|468916230|FG000|Overall Study|Withdrawal by Subject|4|||
130259529|NCT02526290|468916230|FG000|Overall Study|Physician Decision|1|||
130034137|NCT02786901|468081084|FG000|Overall Study|Adverse Event|1|||
130034138|NCT02786901|468081085|FG001|Overall Study|Adverse Event|1|||
130034139|NCT02786901|468081086|FG002|Overall Study|Adverse Event|2|||
130034140|NCT02786901|468081084|FG000|Overall Study|Physician Decision|1|||
130259530|NCT02706392|468916231|FG000|Overall Study|Death|1|||
130259531|NCT02706392|468916232|FG001|Overall Study|Death|0|||
130259532|NCT02706392|468916233|FG002|Overall Study|Death|2|||
130259533|NCT02706392|468916234|FG003|Overall Study|Death|2|||
130259534|NCT02706392|468916235|FG004|Overall Study|Death|5|||
130259535|NCT02706392|468916236|FG005|Overall Study|Death|2|||
130259536|NCT00619866|468916239|FG000|Weeks 1 - 12|Adverse Event|0|||
130034141|NCT02786901|468081085|FG001|Overall Study|Physician Decision|0|||
130259537|NCT00619866|468916240|FG001|Weeks 1 - 12|Adverse Event|1|||
130259538|NCT00619866|468916241|FG002|Weeks 1 - 12|Adverse Event|2|||
130259539|NCT00619866|468916242|FG003|Weeks 1 - 12|Adverse Event|0|||
130034142|NCT02786901|468081086|FG002|Overall Study|Physician Decision|0|||
130259540|NCT00619866|468916243|FG004|Weeks 1 - 12|Adverse Event|0|||
130259541|NCT00619866|468916239|FG000|Weeks 1 - 12|Non-compliance|0|||
130259542|NCT00619866|468916240|FG001|Weeks 1 - 12|Non-compliance|0|||
130259543|NCT00619866|468916241|FG002|Weeks 1 - 12|Non-compliance|1|||
130259544|NCT00619866|468916242|FG003|Weeks 1 - 12|Non-compliance|0|||
130259545|NCT00619866|468916243|FG004|Weeks 1 - 12|Non-compliance|0|||
130259546|NCT00619866|468916239|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
130259547|NCT00619866|468916240|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
130259548|NCT00619866|468916241|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
130259549|NCT00619866|468916242|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
130259550|NCT00619866|468916243|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
130259551|NCT00619866|468916239|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
130259552|NCT00619866|468916240|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
130259553|NCT00619866|468916241|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
130259554|NCT00619866|468916242|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
130259555|NCT00619866|468916243|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
130259556|NCT00619866|468916239|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
130259557|NCT00619866|468916240|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
130259558|NCT00619866|468916241|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
130259559|NCT00619866|468916242|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
130259560|NCT00619866|468916243|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
130259561|NCT00619866|468916239|FG000|Weeks 1 - 12|Sponsor Decision|0|||
130259562|NCT00619866|468916240|FG001|Weeks 1 - 12|Sponsor Decision|1|||
130259563|NCT00619866|468916241|FG002|Weeks 1 - 12|Sponsor Decision|0|||
130259564|NCT00619866|468916242|FG003|Weeks 1 - 12|Sponsor Decision|0|||
130259565|NCT00619866|468916243|FG004|Weeks 1 - 12|Sponsor Decision|0|||
130259566|NCT00619866|468916239|FG000|Weeks 13 - 24|Adverse Event|0|||
130259567|NCT00619866|468916240|FG001|Weeks 13 - 24|Adverse Event|0|||
130259568|NCT00619866|468916241|FG002|Weeks 13 - 24|Adverse Event|2|||
130259569|NCT00619866|468916242|FG003|Weeks 13 - 24|Adverse Event|1|||
130259570|NCT00619866|468916243|FG004|Weeks 13 - 24|Adverse Event|0|||
130259571|NCT00619866|468916239|FG000|Weeks 13 - 24|Protocol Deviation|0|||
130259572|NCT00619866|468916240|FG001|Weeks 13 - 24|Protocol Deviation|0|||
130259573|NCT00619866|468916241|FG002|Weeks 13 - 24|Protocol Deviation|0|||
130259574|NCT00619866|468916242|FG003|Weeks 13 - 24|Protocol Deviation|1|||
130259575|NCT00619866|468916243|FG004|Weeks 13 - 24|Protocol Deviation|0|||
130259576|NCT00619866|468916239|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
130259577|NCT00619866|468916240|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
130259578|NCT00619866|468916241|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
130259579|NCT00619866|468916242|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
130259580|NCT00619866|468916243|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
130259581|NCT00619866|468916239|FG000|Weeks 13 - 24|Non-compliance|0|||
130259582|NCT00619866|468916240|FG001|Weeks 13 - 24|Non-compliance|1|||
130259583|NCT00619866|468916241|FG002|Weeks 13 - 24|Non-compliance|1|||
130259584|NCT00619866|468916242|FG003|Weeks 13 - 24|Non-compliance|0|||
130259585|NCT00619866|468916243|FG004|Weeks 13 - 24|Non-compliance|0|||
130259586|NCT00619866|468916239|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
130259587|NCT00619866|468916240|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
130259588|NCT00619866|468916241|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
130259589|NCT00619866|468916242|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
130259590|NCT00619866|468916243|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
130259591|NCT01968980|468916247|FG000|Overall Study|Death|0|||
130259592|NCT01968980|468916248|FG001|Overall Study|Death|1|||
130259593|NCT01968980|468916247|FG000|Overall Study|Adverse Event|1|||
130259594|NCT01968980|468916248|FG001|Overall Study|Adverse Event|3|||
130259595|NCT01968980|468916247|FG000|Overall Study|Does not meet entry criteria|1|||
130259596|NCT01968980|468916248|FG001|Overall Study|Does not meet entry criteria|3|||
130259597|NCT01968980|468916247|FG000|Overall Study|Withdrawal by Subject|13|||
130259598|NCT01968980|468916248|FG001|Overall Study|Withdrawal by Subject|5|||
130259599|NCT01968980|468916247|FG000|Overall Study|Other unspecified|1|||
130259600|NCT01968980|468916248|FG001|Overall Study|Other unspecified|2|||
130259601|NCT02589938|468916254|FG000|Overall Study|Withdrawal by Subject|11|||
130259602|NCT02589938|468916255|FG001|Overall Study|Withdrawal by Subject|5|||
130259603|NCT02589938|468916256|FG002|Overall Study|Withdrawal by Subject|6|||
130259604|NCT02589938|468916254|FG000|Overall Study|Lost to Follow-up|3|||
130259605|NCT02589938|468916255|FG001|Overall Study|Lost to Follow-up|3|||
130259606|NCT02589938|468916256|FG002|Overall Study|Lost to Follow-up|3|||
130259607|NCT02589938|468916254|FG000|Overall Study|Death|1|||
130259608|NCT02589938|468916255|FG001|Overall Study|Death|0|||
130259609|NCT02589938|468916256|FG002|Overall Study|Death|1|||
130034143|NCT02786901|468081084|FG000|Overall Study|Rescue Therapy Use|71|||
130259610|NCT02589938|468916254|FG000|Overall Study|Protocol Violation|6|||
130259611|NCT02589938|468916255|FG001|Overall Study|Protocol Violation|2|||
130259612|NCT02589938|468916256|FG002|Overall Study|Protocol Violation|3|||
130259613|NCT02589938|468916254|FG000|Overall Study|Physician Decision|1|||
130259614|NCT02589938|468916255|FG001|Overall Study|Physician Decision|0|||
130034144|NCT02786901|468081085|FG001|Overall Study|Rescue Therapy Use|49|||
130259615|NCT02589938|468916256|FG002|Overall Study|Physician Decision|0|||
130259616|NCT02589938|468916254|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
130259617|NCT02589938|468916255|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
130259618|NCT02589938|468916256|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
130259619|NCT02521285|468916257|FG000|Overall Study|Lost to Follow-up|1|||
130259620|NCT02521285|468916258|FG001|Overall Study|Lost to Follow-up|1|||
130259621|NCT02521285|468916257|FG000|Overall Study|Withdrawal by Subject|1|||
130259622|NCT02521285|468916258|FG001|Overall Study|Withdrawal by Subject|1|||
130259623|NCT02521285|468916257|FG000|Overall Study|Adverse Event|0|||
130259624|NCT02521285|468916258|FG001|Overall Study|Adverse Event|1|||
130259625|NCT01121757|468916259|FG000|First Drug|Death|1|||
130259626|NCT01121757|468916260|FG001|First Drug|Death|0|||
130259627|NCT01121757|468916259|FG000|First Drug|Disease Progression|0|||
130259628|NCT01121757|468916260|FG001|First Drug|Disease Progression|2|||
130259629|NCT01121757|468916259|FG000|Combination|Physician Decision|0|||
130259630|NCT01121757|468916260|FG001|Combination|Physician Decision|1|||
130259631|NCT01121757|468916259|FG000|Combination|Disease Progression|2|||
130259632|NCT01121757|468916260|FG001|Combination|Disease Progression|0|||
130259633|NCT03636022|468916261|FG000|Overall Study|Withdrawal by Subject|1|||
130259634|NCT03636022|468916262|FG001|Overall Study|Withdrawal by Subject|3|||
130259635|NCT03189719|468916263|FG000|Overall Study|Death|325|||
130259636|NCT03189719|468916264|FG001|Overall Study|Death|361|||
130259637|NCT03189719|468916263|FG000|Overall Study|Physician Decision|1|||
130259638|NCT03189719|468916264|FG001|Overall Study|Physician Decision|0|||
130259639|NCT03189719|468916263|FG000|Overall Study|Sponsor Decision|40|||
130259640|NCT03189719|468916264|FG001|Overall Study|Sponsor Decision|12|||
130259641|NCT03189719|468916263|FG000|Overall Study|Withdrawal by Subject|7|||
130259642|NCT03189719|468916264|FG001|Overall Study|Withdrawal by Subject|3|||
130259643|NCT03012880|468916265|FG000|Overall Study|Withdrawal by Subject|1|||
130259644|NCT03012880|468916266|FG001|Overall Study|Withdrawal by Subject|0|||
130259645|NCT03012880|468916265|FG000|Overall Study|Ineligible|1|||
130259646|NCT03012880|468916266|FG001|Overall Study|Ineligible|0|||
130259647|NCT04569084|468916267|FG000|Overall Study|Adverse Event|10|||
130259648|NCT04569084|468916268|FG001|Overall Study|Adverse Event|14|||
130259649|NCT04569084|468916267|FG000|Overall Study|Death|2|||
130259650|NCT04569084|468916268|FG001|Overall Study|Death|3|||
130259651|NCT04569084|468916267|FG000|Overall Study|Lost to Follow-up|1|||
130259652|NCT04569084|468916268|FG001|Overall Study|Lost to Follow-up|1|||
130259653|NCT04569084|468916267|FG000|Overall Study|Physician Decision|3|||
130259654|NCT04569084|468916268|FG001|Overall Study|Physician Decision|3|||
130259655|NCT04569084|468916267|FG000|Overall Study|Protocol Violation|2|||
130259656|NCT04569084|468916268|FG001|Overall Study|Protocol Violation|1|||
130259657|NCT04569084|468916267|FG000|Overall Study|Withdrawal by Subject|20|||
130259658|NCT04569084|468916268|FG001|Overall Study|Withdrawal by Subject|21|||
130259659|NCT04569084|468916267|FG000|Overall Study|Study terminated by sponsor|26|||
130259660|NCT04569084|468916268|FG001|Overall Study|Study terminated by sponsor|23|||
130259661|NCT04569084|468916267|FG000|Overall Study|Other|3|||
130259662|NCT04569084|468916268|FG001|Overall Study|Other|5|||
130259663|NCT04795531|468917695|FG000|Overall Study|Withdrawal by Subject|4|||
130259664|NCT04795531|468917696|FG001|Overall Study|Withdrawal by Subject|4|||
130259665|NCT04795531|468917695|FG000|Overall Study|Lost to Follow-up|0|||
130259666|NCT04795531|468917696|FG001|Overall Study|Lost to Follow-up|1|||
130259667|NCT04795531|468917695|FG000|Overall Study|Physician Decision|0|||
130259668|NCT04795531|468917696|FG001|Overall Study|Physician Decision|2|||
130259669|NCT04795531|468917695|FG000|Overall Study|Death|2|||
130259670|NCT04795531|468917696|FG001|Overall Study|Death|1|||
130259671|NCT04043286|468917697|FG000|Overall Study|Withdrawal by Subject|2|||
130259672|NCT04043286|468917698|FG001|Overall Study|Withdrawal by Subject|2|||
130259673|NCT01323192|468917699|FG000|Overall Study|Adverse Event|6|||
130259674|NCT01323192|468917700|FG001|Overall Study|Adverse Event|1|||
130259675|NCT01323192|468917699|FG000|Overall Study|Withdrawal by Subject|3|||
130259676|NCT01323192|468917700|FG001|Overall Study|Withdrawal by Subject|1|||
130259677|NCT01323192|468917699|FG000|Overall Study|Noncompliance with study medication|0|||
130259678|NCT01323192|468917700|FG001|Overall Study|Noncompliance with study medication|3|||
130259679|NCT01323192|468917699|FG000|Overall Study|Nonmedical reasons|0|||
130259680|NCT01323192|468917700|FG001|Overall Study|Nonmedical reasons|1|||
130259681|NCT02296476|468917701|FG000|Overall Study|Disease Progression|6|||
130259682|NCT02296476|468917702|FG001|Overall Study|Disease Progression|4|||
130259683|NCT02296476|468917703|FG002|Overall Study|Disease Progression|2|||
130259684|NCT00442702|468917704|FG000|Titration Period|Adverse Event|2|||
130259685|NCT00442702|468917705|FG001|Titration Period|Adverse Event|0|||
130259686|NCT00442702|468917704|FG000|Titration Period|Death|3|||
130259687|NCT00442702|468917705|FG001|Titration Period|Death|2|||
130259688|NCT00442702|468917704|FG000|Titration Period|Insufficient Therapeutic Response|1|||
130259689|NCT00442702|468917705|FG001|Titration Period|Insufficient Therapeutic Response|0|||
130259690|NCT00442702|468917704|FG000|Titration Period|Refused Treatment|4|||
130259691|NCT00442702|468917705|FG001|Titration Period|Refused Treatment|1|||
130259692|NCT00442702|468917704|FG000|Titration Period|Failure to return|1|||
130259693|NCT00442702|468917705|FG001|Titration Period|Failure to return|0|||
130259694|NCT00442702|468917704|FG000|Titration Period|Hospitalized in another hospital|1|||
130259695|NCT00442702|468917705|FG001|Titration Period|Hospitalized in another hospital|0|||
130259696|NCT00442702|468917704|FG000|Evaluation Period|Adverse Event|1|||
130259697|NCT00442702|468917705|FG001|Evaluation Period|Adverse Event|0|||
130259698|NCT00442702|468917704|FG000|Evaluation Period|Death|1|||
130259699|NCT00442702|468917705|FG001|Evaluation Period|Death|1|||
130259700|NCT00442702|468917704|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
130259701|NCT00442702|468917705|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
130259702|NCT00442702|468917704|FG000|Evaluation Period|Refused treatment|1|||
130259703|NCT00442702|468917705|FG001|Evaluation Period|Refused treatment|1|||
130259704|NCT00442702|468917704|FG000|Evaluation Period|Renal transplant|0|||
130259705|NCT00442702|468917705|FG001|Evaluation Period|Renal transplant|1|||
130259706|NCT00442702|468917704|FG000|Evaluation Period|Failure to return|1|||
130259707|NCT00442702|468917705|FG001|Evaluation Period|Failure to return|0|||
130259708|NCT00442702|468917704|FG000|Evaluation Period|Site closure|0|||
130259709|NCT00442702|468917705|FG001|Evaluation Period|Site closure|1|||
130259710|NCT03122184|468917712|FG000|Overall Study|Lost to Follow-up|4|||
130259711|NCT03122184|468917713|FG001|Overall Study|Lost to Follow-up|6|||
130259712|NCT03122184|468917712|FG000|Overall Study|Withdrawal by Subject|3|||
130259713|NCT03122184|468917713|FG001|Overall Study|Withdrawal by Subject|0|||
130259714|NCT03122184|468917712|FG000|Overall Study|Terminated due to cognitive problem|1|||
130259715|NCT03122184|468917713|FG001|Overall Study|Terminated due to cognitive problem|0|||
130259716|NCT02835690|468917714|FG000|Overall Study|Death|12|||
130259717|NCT02835690|468917715|FG001|Overall Study|Death|11|||
130259718|NCT02835690|468917716|FG002|Overall Study|Death|13|||
130259719|NCT02835690|468917714|FG000|Overall Study|Transferred to Extension Study|2|||
130259720|NCT02835690|468917715|FG001|Overall Study|Transferred to Extension Study|2|||
130259721|NCT02835690|468917716|FG002|Overall Study|Transferred to Extension Study|1|||
130259722|NCT02835690|468917714|FG000|Overall Study|Did Not Continue on Extension Study|0|||
130259723|NCT02835690|468917715|FG001|Overall Study|Did Not Continue on Extension Study|0|||
130259724|NCT02835690|468917716|FG002|Overall Study|Did Not Continue on Extension Study|1|||
130259725|NCT02835690|468917714|FG000|Overall Study|Not Treated|0|||
130259726|NCT02835690|468917715|FG001|Overall Study|Not Treated|2|||
130259727|NCT02835690|468917716|FG002|Overall Study|Not Treated|0|||
130259728|NCT00710593|468917717|FG000|Overall Study|Incarceration|1|||
130259729|NCT00710593|468917718|FG001|Overall Study|Incarceration|0|||
130259730|NCT00710593|468917717|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
130259731|NCT00710593|468917718|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
130259732|NCT00710593|468917717|FG000|Overall Study|Lost to Follow-up|3|||
130259733|NCT00710593|468917718|FG001|Overall Study|Lost to Follow-up|1|||
130259734|NCT00710593|468917717|FG000|Overall Study|Moved out of area|1|||
130259735|NCT00710593|468917718|FG001|Overall Study|Moved out of area|0|||
130259736|NCT00710593|468917717|FG000|Overall Study|Failure to adhere or complete study eval|1|||
130259737|NCT00710593|468917718|FG001|Overall Study|Failure to adhere or complete study eval|1|||
130259738|NCT00710593|468917717|FG000|Overall Study|Protocol Violation|1|||
130259739|NCT00710593|468917718|FG001|Overall Study|Protocol Violation|1|||
130259740|NCT00710593|468917717|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
130259741|NCT00710593|468917718|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
130259742|NCT04490278|468917719|FG000|Overall Study|Lost to Follow-up|6|||
130259743|NCT02829996|468917720|FG000|Overall Study|Withdrawal by Subject|1|||
130259744|NCT02829996|468917721|FG001|Overall Study|Withdrawal by Subject|0|||
130259745|NCT02829996|468917722|FG002|Overall Study|Withdrawal by Subject|0|||
130259746|NCT02829996|468917723|FG003|Overall Study|Withdrawal by Subject|0|||
130259747|NCT02829996|468917724|FG004|Overall Study|Withdrawal by Subject|0|||
130259748|NCT03186638|468917725|FG000|Overall Study|Withdrawal by Subject|4|||
130259749|NCT03186638|468917726|FG001|Overall Study|Withdrawal by Subject|4|||
130259750|NCT03186638|468917725|FG000|Overall Study|Withdrawn due to medical problem|3|||
130259751|NCT03186638|468917726|FG001|Overall Study|Withdrawn due to medical problem|2|||
130259752|NCT03186638|468917725|FG000|Overall Study|Lost to Follow-up|1|||
130259753|NCT03186638|468917726|FG001|Overall Study|Lost to Follow-up|0|||
130259754|NCT01263119|468917727|FG000|Period 1|Protocol Violation|2|||
130259755|NCT01263119|468917727|FG000|Period 2|Adverse Event|2|||
130259756|NCT04047446|468917728|FG000|Overall Study|Physician Decision|1|||
130259757|NCT04047446|468917729|FG001|Overall Study|Physician Decision|0|||
130259758|NCT02367456|468917730|FG000|Overall Study|Death|8|||
130259759|NCT02367456|468917731|FG001|Overall Study|Death|24|||
130259760|NCT02367456|468917732|FG002|Overall Study|Death|17|||
130259761|NCT02367456|468917730|FG000|Overall Study|Lost to Follow-up|1|||
130259762|NCT02367456|468917731|FG001|Overall Study|Lost to Follow-up|3|||
130259763|NCT02367456|468917732|FG002|Overall Study|Lost to Follow-up|1|||
130259764|NCT02367456|468917730|FG000|Overall Study|Other reason|3|||
130259765|NCT02367456|468917731|FG001|Overall Study|Other reason|3|||
130259766|NCT02367456|468917732|FG002|Overall Study|Other reason|9|||
130259767|NCT02367456|468917730|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
130259768|NCT02367456|468917731|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
130259769|NCT02367456|468917732|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
130259770|NCT04573972|468917735|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
130259771|NCT04573972|468917736|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
130259772|NCT01517984|468917737|FG000|Overall Study|Lost to Follow-up|0|||
130259773|NCT01517984|468917738|FG001|Overall Study|Lost to Follow-up|1|||
130259774|NCT01517984|468917739|FG002|Overall Study|Lost to Follow-up|0|||
130259775|NCT01517984|468917740|FG003|Overall Study|Lost to Follow-up|0|||
130259776|NCT01517984|468917737|FG000|Overall Study|Withdrawal by Subject|1|||
130259777|NCT01517984|468917738|FG001|Overall Study|Withdrawal by Subject|8|||
130259778|NCT01517984|468917739|FG002|Overall Study|Withdrawal by Subject|4|||
130259779|NCT01517984|468917740|FG003|Overall Study|Withdrawal by Subject|1|||
130259780|NCT01517984|468917737|FG000|Overall Study|Screen Failure|4|||
130259781|NCT01517984|468917738|FG001|Overall Study|Screen Failure|0|||
130259782|NCT01517984|468917739|FG002|Overall Study|Screen Failure|0|||
130259783|NCT01517984|468917740|FG003|Overall Study|Screen Failure|0|||
130259784|NCT01517984|468917737|FG000|Overall Study|Ineligible for randomization|0|||
130259785|NCT01517984|468917738|FG001|Overall Study|Ineligible for randomization|14|||
130259786|NCT01517984|468917739|FG002|Overall Study|Ineligible for randomization|0|||
130259787|NCT01517984|468917740|FG003|Overall Study|Ineligible for randomization|0|||
130259788|NCT01500317|468917741|FG000|Overall Study|Withdrawal by Subject|3|||
130259789|NCT01500317|468917742|FG001|Overall Study|Withdrawal by Subject|2|||
130259790|NCT01500317|468917743|FG002|Overall Study|Withdrawal by Subject|0|||
130259791|NCT00335829|468917744|FG000|Overall Study|Withdrawal by Subject|1|||
130259792|NCT00335829|468917744|FG000|Overall Study|Lost to Follow-up|1|||
130259793|NCT00335829|468917744|FG000|Overall Study|Adverse Event|1|||
130259794|NCT01038323|468917748|FG000|Overall Study|Withdrawal by Subject|3|||
130259795|NCT01038323|468917749|FG001|Overall Study|Withdrawal by Subject|2|||
130259796|NCT01038323|468917750|FG002|Overall Study|Withdrawal by Subject|4|||
130259797|NCT00862940|468917753|FG000|Overall Study|Adverse Event|15|||
130259798|NCT00862940|468917754|FG001|Overall Study|Adverse Event|12|||
130259799|NCT00862940|468917753|FG000|Overall Study|Lack of Efficacy|1|||
130259800|NCT00862940|468917754|FG001|Overall Study|Lack of Efficacy|3|||
130259801|NCT00862940|468917753|FG000|Overall Study|Protocol Violation|2|||
130259802|NCT00862940|468917754|FG001|Overall Study|Protocol Violation|5|||
130259803|NCT00862940|468917753|FG000|Overall Study|Withdrawal by Subject|4|||
130259804|NCT00862940|468917754|FG001|Overall Study|Withdrawal by Subject|6|||
130259805|NCT00862940|468917753|FG000|Overall Study|Non-compliance|4|||
130259806|NCT00862940|468917754|FG001|Overall Study|Non-compliance|0|||
130259807|NCT00862940|468917753|FG000|Overall Study|Lost to Follow-up|0|||
130259808|NCT00862940|468917754|FG001|Overall Study|Lost to Follow-up|1|||
130259809|NCT00862940|468917753|FG000|Overall Study|Administrative or other reason(s)|4|||
130259810|NCT00862940|468917754|FG001|Overall Study|Administrative or other reason(s)|3|||
130259811|NCT05552859|468917755|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
130259812|NCT05552859|468917756|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
130259813|NCT05901636|468917757|FG000|Overall Study|Lost to Follow-up|0|||
130259814|NCT05901636|468917758|FG001|Overall Study|Lost to Follow-up|1|||
130259815|NCT05901636|468917759|FG002|Overall Study|Lost to Follow-up|0|||
130259816|NCT05901636|468917760|FG003|Overall Study|Lost to Follow-up|1|||
130259817|NCT05901636|468917761|FG004|Overall Study|Lost to Follow-up|1|||
130259818|NCT05901636|468917762|FG005|Overall Study|Lost to Follow-up|3|||
130259819|NCT05901636|468917763|FG006|Overall Study|Lost to Follow-up|1|||
130259820|NCT05901636|468917757|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
130259821|NCT05901636|468917758|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
130259822|NCT05901636|468917759|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
130259823|NCT05901636|468917760|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
130259824|NCT05901636|468917761|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
130259825|NCT05901636|468917762|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
130259826|NCT05901636|468917763|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
130259827|NCT05901636|468917757|FG000|Overall Study|Withdrawal by Subject|1|||
130259828|NCT05901636|468917758|FG001|Overall Study|Withdrawal by Subject|1|||
130259829|NCT05901636|468917759|FG002|Overall Study|Withdrawal by Subject|0|||
130259830|NCT05901636|468917760|FG003|Overall Study|Withdrawal by Subject|0|||
130259831|NCT05901636|468917761|FG004|Overall Study|Withdrawal by Subject|1|||
130259832|NCT05901636|468917762|FG005|Overall Study|Withdrawal by Subject|1|||
130259833|NCT05901636|468917763|FG006|Overall Study|Withdrawal by Subject|0|||
130259834|NCT05901636|468917757|FG000|Overall Study|Other|0|||
130259835|NCT05901636|468917758|FG001|Overall Study|Other|0|||
130259836|NCT05901636|468917759|FG002|Overall Study|Other|1|||
130259837|NCT05901636|468917760|FG003|Overall Study|Other|1|||
130259838|NCT05901636|468917761|FG004|Overall Study|Other|0|||
130259839|NCT05901636|468917762|FG005|Overall Study|Other|0|||
130259840|NCT05901636|468917763|FG006|Overall Study|Other|0|||
130259841|NCT00432965|468917764|FG000|Overall Study|Lost to Follow-up|22|||
130259842|NCT00432965|468917765|FG001|Overall Study|Lost to Follow-up|19|||
130259843|NCT00432965|468917764|FG000|Overall Study|Withdrawal by Subject|13|||
130259844|NCT00432965|468917765|FG001|Overall Study|Withdrawal by Subject|13|||
130259845|NCT00432965|468917764|FG000|Overall Study|Physician Decision|14|||
130259846|NCT00432965|468917765|FG001|Overall Study|Physician Decision|13|||
130259847|NCT00432965|468917764|FG000|Overall Study|Lack of Efficacy|8|||
130259848|NCT00432965|468917765|FG001|Overall Study|Lack of Efficacy|13|||
130259849|NCT00432965|468917764|FG000|Overall Study|Non-compliance|7|||
130259850|NCT00432965|468917765|FG001|Overall Study|Non-compliance|0|||
130259851|NCT00432965|468917764|FG000|Overall Study|Adverse Event|22|||
130259852|NCT00432965|468917765|FG001|Overall Study|Adverse Event|19|||
130259853|NCT00432965|468917764|FG000|Overall Study|Death|3|||
130259854|NCT00432965|468917765|FG001|Overall Study|Death|4|||
130259855|NCT00432965|468917764|FG000|Overall Study|Exclusionary Methods|1|||
130259856|NCT00432965|468917765|FG001|Overall Study|Exclusionary Methods|2|||
130259857|NCT00432965|468917764|FG000|Overall Study|Incomplete Data|4|||
130259858|NCT00432965|468917765|FG001|Overall Study|Incomplete Data|3|||
130259859|NCT03330847|468917775|FG000|Overall Study|Patients ongoing study|62|||
130259860|NCT03330847|468917776|FG001|Overall Study|Patients ongoing study|65|||
130259861|NCT03330847|468917777|FG002|Overall Study|Patients ongoing study|15|||
130259862|NCT01355627|468917778|FG000|Overall Study|Request By the Patient to Discontinue|5|||
130259863|NCT01355627|468917779|FG001|Overall Study|Request By the Patient to Discontinue|7|||
130259864|NCT01355627|468917778|FG000|Overall Study|Lost to Follow-up|8|||
130259865|NCT01355627|468917779|FG001|Overall Study|Lost to Follow-up|7|||
130259866|NCT01355627|468917778|FG000|Overall Study|Fatal Adverse Event|19|||
130259867|NCT01355627|468917779|FG001|Overall Study|Fatal Adverse Event|23|||
130259868|NCT01355627|468917778|FG000|Overall Study|Other|1|||
130259869|NCT01355627|468917779|FG001|Overall Study|Other|1|||
130259870|NCT02293551|468917782|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
130259871|NCT02293551|468917783|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
130259872|NCT02293551|468917784|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
130259873|NCT02293551|468917785|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
130259874|NCT02293551|468917786|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
130259875|NCT02293551|468917787|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
130259876|NCT02293551|468917782|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
130259877|NCT02293551|468917783|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
130259878|NCT02293551|468917784|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
130259879|NCT02293551|468917785|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
130259880|NCT02293551|468917786|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
130259881|NCT02293551|468917787|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
130259882|NCT02293551|468917782|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
130259883|NCT02293551|468917783|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
130259884|NCT02293551|468917784|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
129885585|NCT02611830|467540767|FG000|OL Induction Phase|Lack of Efficacy|9|||
130259885|NCT02293551|468917785|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
130259886|NCT02293551|468917786|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
130259887|NCT02293551|468917787|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
130259888|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
130259889|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
130259890|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
130259891|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
130259892|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
130259893|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
130259894|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
130259895|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
130259896|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
130259897|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
130259898|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
130259899|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
130259900|NCT04532749|468917788|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
130259901|NCT04532749|468917789|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
130259902|NCT04532749|468917788|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
130259903|NCT04532749|468917789|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
130259904|NCT04532749|468917788|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
130259905|NCT04532749|468917789|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
130034145|NCT02786901|468081086|FG002|Overall Study|Rescue Therapy Use|33|||
130034146|NCT02786901|468081084|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
130034147|NCT02786901|468081085|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
130034148|NCT02786901|468081086|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
130034149|NCT02786901|468081084|FG000|Overall Study|Disallowed medication|1|||
130259906|NCT04532749|468917788|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
130259907|NCT04532749|468917789|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
130259908|NCT02769481|468917790|FG000|Overall Study|Protocol Violation|1|||
130259909|NCT02769481|468917791|FG001|Overall Study|Protocol Violation|0|||
130259910|NCT02769481|468917790|FG000|Overall Study|Adverse Event|3|||
130259911|NCT02769481|468917791|FG001|Overall Study|Adverse Event|6|||
130259912|NCT02769481|468917790|FG000|Overall Study|Entry Criteria Not Met|1|||
130034150|NCT02786901|468081085|FG001|Overall Study|Disallowed medication|1|||
130259913|NCT02769481|468917791|FG001|Overall Study|Entry Criteria Not Met|2|||
130259914|NCT02769481|468917790|FG000|Overall Study|Withdrawal by Subject|14|||
130259915|NCT02769481|468917791|FG001|Overall Study|Withdrawal by Subject|16|||
130259916|NCT02769481|468917790|FG000|Overall Study|Lost to Follow-up|9|||
130259917|NCT02769481|468917791|FG001|Overall Study|Lost to Follow-up|9|||
130259918|NCT02769481|468917790|FG000|Overall Study|Physician Decision|0|||
130259919|NCT02769481|468917791|FG001|Overall Study|Physician Decision|1|||
130259920|NCT02769481|468917790|FG000|Overall Study|Terminated by Sponsor|1|||
130259921|NCT02769481|468917791|FG001|Overall Study|Terminated by Sponsor|0|||
130259922|NCT02769481|468917790|FG000|Overall Study|Death|0|||
130259923|NCT02769481|468917791|FG001|Overall Study|Death|1|||
130259924|NCT02769481|468917790|FG000|Overall Study|Undefined|4|||
130259925|NCT02769481|468917791|FG001|Overall Study|Undefined|1|||
130259926|NCT00642759|468917792|FG000|Overall Study|Protocol Violation|1|||
130259927|NCT03510715|468917793|FG000|Overall Study|Adverse Event|1|||
130259928|NCT03510715|468917794|FG001|Overall Study|Adverse Event|0|||
130259929|NCT03612570|468917801|FG000|Overall Study|Lost to Follow-up|1|||
130259930|NCT04756531|468917802|FG000|Overall Study|Adverse Event|0|||
130259931|NCT04756531|468917803|FG001|Overall Study|Adverse Event|0|||
130259932|NCT04756531|468917804|FG002|Overall Study|Adverse Event|0|||
130259933|NCT04756531|468917805|FG003|Overall Study|Adverse Event|0|||
130259934|NCT04756531|468917806|FG004|Overall Study|Adverse Event|1|||
130259935|NCT04756531|468917807|FG005|Overall Study|Adverse Event|0|||
130259936|NCT04756531|468917808|FG006|Overall Study|Adverse Event|0|||
130259937|NCT04756531|468917809|FG007|Overall Study|Adverse Event|0|||
130259938|NCT04756531|468917810|FG008|Overall Study|Adverse Event|0|||
130259939|NCT04756531|468917811|FG009|Overall Study|Adverse Event|0|||
130259940|NCT04756531|468917812|FG010|Overall Study|Adverse Event|0|||
130259941|NCT04756531|468917813|FG011|Overall Study|Adverse Event|0|||
130259942|NCT04756531|468917814|FG012|Overall Study|Adverse Event|0|||
130259943|NCT04756531|468917815|FG013|Overall Study|Adverse Event|0|||
130259944|NCT04756531|468917816|FG014|Overall Study|Adverse Event|0|||
130259945|NCT04756531|468917817|FG015|Overall Study|Adverse Event|0|||
130259946|NCT04756531|468917818|FG016|Overall Study|Adverse Event|0|||
130259947|NCT04756531|468917819|FG017|Overall Study|Adverse Event|0|||
130259948|NCT04756531|468917802|FG000|Overall Study|Withdrawal by Subject|0|||
130259949|NCT04756531|468917803|FG001|Overall Study|Withdrawal by Subject|0|||
130259950|NCT04756531|468917804|FG002|Overall Study|Withdrawal by Subject|0|||
130259951|NCT04756531|468917805|FG003|Overall Study|Withdrawal by Subject|0|||
130259952|NCT04756531|468917806|FG004|Overall Study|Withdrawal by Subject|0|||
130259953|NCT04756531|468917807|FG005|Overall Study|Withdrawal by Subject|0|||
130259954|NCT04756531|468917808|FG006|Overall Study|Withdrawal by Subject|1|||
130259955|NCT04756531|468917809|FG007|Overall Study|Withdrawal by Subject|0|||
130259956|NCT04756531|468917810|FG008|Overall Study|Withdrawal by Subject|0|||
130259957|NCT04756531|468917811|FG009|Overall Study|Withdrawal by Subject|0|||
130259958|NCT04756531|468917812|FG010|Overall Study|Withdrawal by Subject|0|||
130259959|NCT04756531|468917813|FG011|Overall Study|Withdrawal by Subject|0|||
130259960|NCT04756531|468917814|FG012|Overall Study|Withdrawal by Subject|0|||
130259961|NCT04756531|468917815|FG013|Overall Study|Withdrawal by Subject|0|||
130259962|NCT04756531|468917816|FG014|Overall Study|Withdrawal by Subject|0|||
130259963|NCT04756531|468917817|FG015|Overall Study|Withdrawal by Subject|0|||
130259964|NCT04756531|468917818|FG016|Overall Study|Withdrawal by Subject|0|||
130259965|NCT04756531|468917819|FG017|Overall Study|Withdrawal by Subject|0|||
130034151|NCT02786901|468081086|FG002|Overall Study|Disallowed medication|0|||
130034152|NCT02786901|468081084|FG000|Overall Study|Randomized in error|2|||
130034153|NCT02786901|468081085|FG001|Overall Study|Randomized in error|0|||
130259966|NCT01994876|468917820|FG000|Test Period 1|Withdrawal by Subject|0|||
130259967|NCT01994876|468917821|FG001|Test Period 1|Withdrawal by Subject|1|||
130259968|NCT01994876|468917820|FG000|Test Period 1|Adverse Event|0|||
130259969|NCT01994876|468917821|FG001|Test Period 1|Adverse Event|1|||
130259970|NCT01994876|468917820|FG000|Test Period 2|Adverse Event|1|||
130259971|NCT01994876|468917821|FG001|Test Period 2|Adverse Event|0|||
130259972|NCT01994876|468917820|FG000|Test Period 2|Protocol Violation|0|||
130259973|NCT01994876|468917821|FG001|Test Period 2|Protocol Violation|1|||
130259974|NCT01346176|468917822|FG000|Recruited|Protocol Violation|1|||
130259975|NCT01346176|468917823|FG001|Recruited|Protocol Violation|0|||
130259976|NCT01346176|468917824|FG002|Recruited|Protocol Violation|0|||
130259977|NCT01346176|468917822|FG000|Completed Advance Directive|Death|3|||
130259978|NCT01346176|468917823|FG001|Completed Advance Directive|Death|2|||
130259979|NCT01346176|468917824|FG002|Completed Advance Directive|Death|2|||
130259980|NCT01346176|468917822|FG000|Completed Advance Directive|Became Ineligible|3|||
130259981|NCT01346176|468917823|FG001|Completed Advance Directive|Became Ineligible|0|||
130259982|NCT01346176|468917824|FG002|Completed Advance Directive|Became Ineligible|1|||
130259983|NCT01346176|468917822|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
130259984|NCT01346176|468917823|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
130259985|NCT01346176|468917824|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
130259986|NCT01346176|468917822|FG000|Completed Satisfaction Survey|Death|3|||
130034154|NCT02786901|468081086|FG002|Overall Study|Randomized in error|1|||
130034155|NCT01075178|468081087|FG000|Subject Matching|eligible but not matched|130|||
130034156|NCT01075178|468081088|FG001|Subject Matching|eligible but not matched|403|||
130034157|NCT01075178|468081087|FG000|Subject Chart Review|died before chart review period|0|||
130034158|NCT01075178|468081088|FG001|Subject Chart Review|died before chart review period|2|||
130034159|NCT01075178|468081087|FG000|Subject Chart Review|no data collected due to site closure|3|||
130034160|NCT01075178|468081088|FG001|Subject Chart Review|no data collected due to site closure|4|||
130034161|NCT01075178|468081087|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
130034162|NCT01075178|468081088|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
130034163|NCT01111604|468081089|FG000|Overall Study|Lost to Follow-up|0|||
130034164|NCT01111604|468081090|FG001|Overall Study|Lost to Follow-up|0|||
130034165|NCT01111604|468081091|FG002|Overall Study|Lost to Follow-up|1|||
130034166|NCT01111604|468081089|FG000|Overall Study|Withdrew Consent|3|||
130034167|NCT01111604|468081090|FG001|Overall Study|Withdrew Consent|0|||
130034168|NCT01111604|468081091|FG002|Overall Study|Withdrew Consent|2|||
130034169|NCT01111604|468081089|FG000|Overall Study|Withdrawal by Subject|2|||
130034170|NCT01111604|468081090|FG001|Overall Study|Withdrawal by Subject|0|||
130034171|NCT01111604|468081091|FG002|Overall Study|Withdrawal by Subject|0|||
130034172|NCT01111604|468081089|FG000|Overall Study|Death|1|||
130034173|NCT01111604|468081090|FG001|Overall Study|Death|0|||
130034174|NCT01111604|468081091|FG002|Overall Study|Death|0|||
130034175|NCT01111604|468081089|FG000|Overall Study|Met Exclusion Criteria|2|||
130034176|NCT01111604|468081090|FG001|Overall Study|Met Exclusion Criteria|0|||
130034177|NCT01111604|468081091|FG002|Overall Study|Met Exclusion Criteria|0|||
130034178|NCT03926143|468081092|FG000|Overall Study|Physician Decision|3|||
130034179|NCT03926143|468081092|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
130034180|NCT03926143|468081092|FG000|Overall Study|Adverse Event|2|||
130034181|NCT03926143|468081092|FG000|Overall Study|Progressive disease|3|||
130034182|NCT02207907|468081099|FG000|Overall Study|Lost to Follow-up|3|||
130034183|NCT02207907|468081100|FG001|Overall Study|Lost to Follow-up|1|||
130034184|NCT02207907|468081099|FG000|Overall Study|Withdrawal by Subject|5|||
130034185|NCT02207907|468081100|FG001|Overall Study|Withdrawal by Subject|6|||
130034186|NCT02207907|468081099|FG000|Overall Study|Did not meet study criteria|3|||
130034187|NCT02207907|468081100|FG001|Overall Study|Did not meet study criteria|0|||
130034188|NCT02207907|468081099|FG000|Overall Study|Pregnancy|0|||
130034189|NCT02207907|468081100|FG001|Overall Study|Pregnancy|1|||
130034190|NCT00158184|468081101|FG000|Overall Study|personal issues|3|||
130034191|NCT00158184|468081102|FG001|Overall Study|personal issues|1|||
130034192|NCT00158184|468081101|FG000|Overall Study|failed for follow unit/study rules|2|||
130034193|NCT00158184|468081102|FG001|Overall Study|failed for follow unit/study rules|0|||
130034194|NCT00158184|468081101|FG000|Overall Study|Adverse Event|1|||
130034195|NCT00158184|468081102|FG001|Overall Study|Adverse Event|1|||
130034196|NCT05340504|468081103|FG000|Overall Study|Withdrawal by Subject|1|||
130034197|NCT05340504|468081104|FG001|Overall Study|Withdrawal by Subject|0|||
130034198|NCT02620020|468081105|FG000|Overall Study|Adverse Event|8|||
130034199|NCT02620020|468081106|FG001|Overall Study|Adverse Event|4|||
130034200|NCT02620020|468081107|FG002|Overall Study|Adverse Event|3|||
130259987|NCT01346176|468917823|FG001|Completed Satisfaction Survey|Death|0|||
130259988|NCT01346176|468917824|FG002|Completed Satisfaction Survey|Death|2|||
130259989|NCT01346176|468917822|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
130259990|NCT01346176|468917823|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
130259991|NCT01346176|468917824|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
130259992|NCT01400412|468917825|FG000|Overall Study|Lost to Follow-up|4|||
130259993|NCT01400412|468917826|FG001|Overall Study|Lost to Follow-up|7|||
130259994|NCT01400412|468917825|FG000|Overall Study|Withdrawal by Subject|3|||
130259995|NCT01400412|468917826|FG001|Overall Study|Withdrawal by Subject|4|||
130259996|NCT01400412|468917825|FG000|Overall Study|Unable to complete|3|||
130259997|NCT01400412|468917826|FG001|Overall Study|Unable to complete|3|||
130259998|NCT01400412|468917825|FG000|Overall Study|Never started study treatment|0|||
130259999|NCT01400412|468917826|FG001|Overall Study|Never started study treatment|3|||
130260000|NCT01276704|468918911|FG000|Overall Study|Lost to Follow-up|2|||
130260001|NCT01276704|468918912|FG001|Overall Study|Lost to Follow-up|3|||
130260002|NCT01276704|468918911|FG000|Overall Study|Non-compliant|2|||
130260003|NCT01276704|468918912|FG001|Overall Study|Non-compliant|2|||
130034201|NCT02620020|468081108|FG003|Overall Study|Adverse Event|5|||
130034202|NCT02620020|468081105|FG000|Overall Study|Lost to Follow-up|4|||
130034203|NCT02620020|468081106|FG001|Overall Study|Lost to Follow-up|8|||
130034204|NCT02620020|468081107|FG002|Overall Study|Lost to Follow-up|1|||
130034205|NCT02620020|468081108|FG003|Overall Study|Lost to Follow-up|4|||
130034206|NCT02620020|468081105|FG000|Overall Study|Physician Decision|7|||
130260004|NCT01276704|468918911|FG000|Overall Study|Withdrawal by Subject|7|||
130260005|NCT01276704|468918912|FG001|Overall Study|Withdrawal by Subject|1|||
130034207|NCT02620020|468081106|FG001|Overall Study|Physician Decision|4|||
130034208|NCT02620020|468081107|FG002|Overall Study|Physician Decision|3|||
130034209|NCT02620020|468081108|FG003|Overall Study|Physician Decision|4|||
130034210|NCT02620020|468081105|FG000|Overall Study|Protocol Violation|5|||
130034211|NCT02620020|468081106|FG001|Overall Study|Protocol Violation|2|||
130034212|NCT02620020|468081107|FG002|Overall Study|Protocol Violation|1|||
130260006|NCT01276704|468918911|FG000|Overall Study|Physician Decision|3|||
130260007|NCT01276704|468918912|FG001|Overall Study|Physician Decision|5|||
130034213|NCT02620020|468081108|FG003|Overall Study|Protocol Violation|1|||
130260008|NCT01441960|468918913|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
130260009|NCT01441960|468918914|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
130260010|NCT01441960|468918913|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
130260011|NCT01441960|468918914|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
130260012|NCT01441960|468918913|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
130260013|NCT01441960|468918914|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
130260014|NCT02986074|468918915|FG000|First Trial Period|Adverse Event|1|||
130260015|NCT02986074|468918916|FG001|First Trial Period|Adverse Event|0|||
130260016|NCT02986074|468918917|FG002|First Trial Period|Adverse Event|0|||
130260017|NCT02986074|468918918|FG003|First Trial Period|Adverse Event|0|||
130260018|NCT02986074|468918915|FG000|Follow up Period|system explant|0|||
130260019|NCT02986074|468918916|FG001|Follow up Period|system explant|0|||
130260020|NCT02986074|468918917|FG002|Follow up Period|system explant|1|||
130260021|NCT02986074|468918918|FG003|Follow up Period|system explant|2|||
130260022|NCT02986074|468918915|FG000|Follow up Period|Physician Decision|0|||
130260023|NCT02986074|468918916|FG001|Follow up Period|Physician Decision|0|||
130260024|NCT02986074|468918917|FG002|Follow up Period|Physician Decision|0|||
130260025|NCT02986074|468918918|FG003|Follow up Period|Physician Decision|1|||
130260026|NCT00069641|468918923|FG000|Overall Study|Death|1|||
130260027|NCT00069641|468918924|FG001|Overall Study|Death|0|||
130260028|NCT00069641|468918925|FG002|Overall Study|Death|1|||
130260029|NCT01645176|468918926|FG000|Overall Study|Lack of Efficacy|4|||
130034214|NCT02620020|468081105|FG000|Overall Study|Withdrawal by Subject|20|||
130034215|NCT02620020|468081106|FG001|Overall Study|Withdrawal by Subject|16|||
130034216|NCT02620020|468081107|FG002|Overall Study|Withdrawal by Subject|17|||
130260030|NCT01645176|468918926|FG000|Overall Study|did not complete final MRI|1|||
130260031|NCT01948427|468918927|FG000|Overall Study|Serious Adverse Event|3|||
130260032|NCT01948427|468918928|FG001|Overall Study|Serious Adverse Event|0|||
130260033|NCT01948427|468918929|FG002|Overall Study|Serious Adverse Event|0|||
130260034|NCT01948427|468918930|FG003|Overall Study|Serious Adverse Event|0|||
130260035|NCT01948427|468918931|FG004|Overall Study|Serious Adverse Event|1|||
130260036|NCT01948427|468918927|FG000|Overall Study|Investigator Request|0|||
130260037|NCT01948427|468918928|FG001|Overall Study|Investigator Request|8|||
130260038|NCT01948427|468918929|FG002|Overall Study|Investigator Request|0|||
130260039|NCT01948427|468918930|FG003|Overall Study|Investigator Request|0|||
130260040|NCT01948427|468918931|FG004|Overall Study|Investigator Request|6|||
130260041|NCT01948427|468918927|FG000|Overall Study|Lost to Follow-up|1|||
130260042|NCT01948427|468918928|FG001|Overall Study|Lost to Follow-up|0|||
130260043|NCT01948427|468918929|FG002|Overall Study|Lost to Follow-up|0|||
130260044|NCT01948427|468918930|FG003|Overall Study|Lost to Follow-up|0|||
130260045|NCT01948427|468918931|FG004|Overall Study|Lost to Follow-up|4|||
130260046|NCT01948427|468918927|FG000|Overall Study|Withdrawal by Subject|2|||
130260047|NCT01948427|468918928|FG001|Overall Study|Withdrawal by Subject|0|||
130260048|NCT01948427|468918929|FG002|Overall Study|Withdrawal by Subject|0|||
130034217|NCT02620020|468081108|FG003|Overall Study|Withdrawal by Subject|12|||
130034218|NCT02620020|468081105|FG000|Overall Study|Death|0|||
130034219|NCT02620020|468081106|FG001|Overall Study|Death|1|||
130034220|NCT02620020|468081107|FG002|Overall Study|Death|0|||
130034221|NCT02620020|468081108|FG003|Overall Study|Death|0|||
130034222|NCT02393209|468081111|FG000|Overall Study|Study Terminated by Sponsor|1|||
130034223|NCT02393209|468081112|FG001|Overall Study|Study Terminated by Sponsor|1|||
130034224|NCT02393209|468081113|FG002|Overall Study|Study Terminated by Sponsor|0|||
130034225|NCT02393209|468081114|FG003|Overall Study|Study Terminated by Sponsor|0|||
130034226|NCT02393209|468081111|FG000|Overall Study|Withdrawal by Patient|1|||
130034227|NCT02393209|468081112|FG001|Overall Study|Withdrawal by Patient|0|||
130034228|NCT02393209|468081113|FG002|Overall Study|Withdrawal by Patient|0|||
130034229|NCT02393209|468081114|FG003|Overall Study|Withdrawal by Patient|0|||
130034230|NCT02393209|468081111|FG000|Overall Study|Death|2|||
130034231|NCT02393209|468081112|FG001|Overall Study|Death|2|||
130034232|NCT02393209|468081113|FG002|Overall Study|Death|0|||
130034233|NCT02393209|468081114|FG003|Overall Study|Death|0|||
130260049|NCT01948427|468918930|FG003|Overall Study|Withdrawal by Subject|0|||
130260050|NCT01948427|468918931|FG004|Overall Study|Withdrawal by Subject|1|||
130260051|NCT01948427|468918927|FG000|Overall Study|Other, Not Specified|1|||
130260052|NCT01948427|468918928|FG001|Overall Study|Other, Not Specified|9|||
130260053|NCT01948427|468918929|FG002|Overall Study|Other, Not Specified|0|||
130034234|NCT02393209|468081111|FG000|Overall Study|Death due to Disease Progression|2|||
130034235|NCT02393209|468081112|FG001|Overall Study|Death due to Disease Progression|2|||
130034236|NCT02393209|468081113|FG002|Overall Study|Death due to Disease Progression|0|||
130260054|NCT01948427|468918930|FG003|Overall Study|Other, Not Specified|0|||
130260055|NCT01948427|468918931|FG004|Overall Study|Other, Not Specified|2|||
130260056|NCT00402987|468918932|FG000|Overall Study|Lack of Efficacy|0|||
130260057|NCT00402987|468918933|FG001|Overall Study|Lack of Efficacy|0|||
130260058|NCT00402987|468918934|FG002|Overall Study|Lack of Efficacy|1|||
130034237|NCT02393209|468081114|FG003|Overall Study|Death due to Disease Progression|0|||
130034238|NCT02393209|468081111|FG000|Overall Study|Death from Legionella Infection|0|||
130034239|NCT02393209|468081112|FG001|Overall Study|Death from Legionella Infection|1|||
130034240|NCT02393209|468081113|FG002|Overall Study|Death from Legionella Infection|0|||
130034241|NCT02393209|468081114|FG003|Overall Study|Death from Legionella Infection|0|||
130034242|NCT02393209|468081111|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
130034243|NCT02393209|468081112|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
130034244|NCT02393209|468081113|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
130034245|NCT02393209|468081114|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
130034246|NCT02393209|468081111|FG000|Overall Study|Lost to Follow-up|0|||
130034247|NCT02393209|468081112|FG001|Overall Study|Lost to Follow-up|1|||
130034248|NCT02393209|468081113|FG002|Overall Study|Lost to Follow-up|0|||
130034249|NCT02393209|468081114|FG003|Overall Study|Lost to Follow-up|0|||
130034250|NCT00755079|468081115|FG000|Overall Study|Lost to Follow-up|1|||
130034251|NCT00755079|468081116|FG001|Overall Study|Lost to Follow-up|3|||
130034252|NCT00755079|468081115|FG000|Overall Study|Adverse Event|0|||
130034253|NCT00755079|468081116|FG001|Overall Study|Adverse Event|1|||
130034254|NCT00755079|468081115|FG000|Overall Study|Withdrawal by Subject|0|||
130034255|NCT00755079|468081116|FG001|Overall Study|Withdrawal by Subject|2|||
130034256|NCT03545282|468081117|FG000|Overall Study|Lost to Follow-up|15|||
130101943|NCT00483717|468330821|FG001|Overall Study|Time of dosing missing|1|||
130101944|NCT00483717|468330820|FG000|Overall Study|No treatment for migraine|16|||
130101945|NCT00483717|468330821|FG001|Overall Study|No treatment for migraine|13|||
130101946|NCT00483717|468330820|FG000|Overall Study|Lost to Follow-up|1|||
130260059|NCT00402987|468918935|FG003|Overall Study|Lack of Efficacy|0|||
130260060|NCT01668004|468918936|FG000|Overall Study|Adverse Event|7|||
130260061|NCT01668004|468918936|FG000|Overall Study|Withdrawal by Subject|2|||
130260062|NCT01668004|468918936|FG000|Overall Study|Lost to Follow-up|5|||
130260063|NCT01668004|468918936|FG000|Overall Study|Lack of Efficacy|9|||
130260064|NCT01668004|468918936|FG000|Overall Study|Non-compliance with treatment|2|||
130260065|NCT02448381|468918941|FG000|Overall Study|Adverse Event|2|||
130260066|NCT02448381|468918942|FG001|Overall Study|Adverse Event|0|||
130260067|NCT02448381|468918941|FG000|Overall Study|Lost to Follow-up|16|||
130260068|NCT02448381|468918942|FG001|Overall Study|Lost to Follow-up|9|||
130260069|NCT02448381|468918941|FG000|Overall Study|Physician Decision|1|||
130260070|NCT02448381|468918942|FG001|Overall Study|Physician Decision|1|||
130260071|NCT02448381|468918941|FG000|Overall Study|Pregnancy|1|||
130260072|NCT02448381|468918942|FG001|Overall Study|Pregnancy|0|||
130260073|NCT02448381|468918941|FG000|Overall Study|Withdrawal by Subject|13|||
130260074|NCT02448381|468918942|FG001|Overall Study|Withdrawal by Subject|9|||
130260075|NCT02448381|468918941|FG000|Overall Study|Noncompliance with Study Procedures|2|||
130260076|NCT02448381|468918942|FG001|Overall Study|Noncompliance with Study Procedures|0|||
130260077|NCT01170663|468918945|FG000|Overall Study|Lost to Follow-up|3|||
130260078|NCT01170663|468918946|FG001|Overall Study|Lost to Follow-up|9|||
130260079|NCT01170663|468918945|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
130260080|NCT01170663|468918946|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
130260081|NCT02303262|468918949|FG000|Overall Study|Withdrawal by Subject|2|||
130260082|NCT04462471|468918950|FG000|Overall Study|Adverse Event|0|||
130260083|NCT04462471|468918951|FG001|Overall Study|Adverse Event|1|||
130260084|NCT04462471|468918952|FG002|Overall Study|Adverse Event|0|||
130260085|NCT04462471|468918953|FG003|Overall Study|Adverse Event|0|||
130260086|NCT04462471|468918950|FG000|Overall Study|Disease progression|1|||
130260087|NCT04462471|468918951|FG001|Overall Study|Disease progression|0|||
130260088|NCT04462471|468918952|FG002|Overall Study|Disease progression|0|||
130101947|NCT00483717|468330821|FG001|Overall Study|Lost to Follow-up|0|||
130101948|NCT00483717|468330820|FG000|Overall Study|Withdrawal by Subject|1|||
130101949|NCT00483717|468330821|FG001|Overall Study|Withdrawal by Subject|0|||
130101950|NCT00909857|468330822|FG000|Overall Study|Withdrawal by Subject|6|||
130101951|NCT00909857|468330823|FG001|Overall Study|Withdrawal by Subject|10|||
130101952|NCT00909857|468330822|FG000|Overall Study|Adverse Event|5|||
130101953|NCT00909857|468330823|FG001|Overall Study|Adverse Event|5|||
130101954|NCT00909857|468330822|FG000|Overall Study|Lost to Follow-up|2|||
130101955|NCT00909857|468330823|FG001|Overall Study|Lost to Follow-up|5|||
130260089|NCT04462471|468918953|FG003|Overall Study|Disease progression|0|||
130260090|NCT04138056|468918958|FG000|Primary Study|Lost to Follow-up|3|||
130260091|NCT04138056|468918959|FG001|Primary Study|Lost to Follow-up|4|||
130260092|NCT04138056|468918960|FG002|Primary Study|Lost to Follow-up|1|||
130260093|NCT04138056|468918961|FG003|Primary Study|Lost to Follow-up|1|||
130034257|NCT03545282|468081118|FG001|Overall Study|Lost to Follow-up|10|||
130034258|NCT03545282|468081117|FG000|Overall Study|Withdrawal by Subject|2|||
130034259|NCT03545282|468081118|FG001|Overall Study|Withdrawal by Subject|2|||
130034260|NCT02582671|468081119|FG000|Overall Study|Failure to return|1|||
130034261|NCT02582671|468081119|FG000|Overall Study|Other, not specified|1|||
130260094|NCT04138056|468918962|FG004|Primary Study|Lost to Follow-up|4|||
130260095|NCT04138056|468918958|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
130101956|NCT00909857|468330822|FG000|Overall Study|Protocol Violation|2|||
130101957|NCT00909857|468330823|FG001|Overall Study|Protocol Violation|1|||
130034262|NCT01287104|468081120|FG000|Overall Study|Patient developed progressive disease|1|||
130034263|NCT01287104|468081121|FG001|Overall Study|Patient developed progressive disease|1|||
130034264|NCT01287104|468081122|FG002|Overall Study|Patient developed progressive disease|3|||
130034265|NCT01287104|468081123|FG003|Overall Study|Patient developed progressive disease|2|||
130034266|NCT01287104|468081120|FG000|Overall Study|Donor anaphylaxis|0|||
130034267|NCT01287104|468081121|FG001|Overall Study|Donor anaphylaxis|1|||
130034268|NCT01287104|468081122|FG002|Overall Study|Donor anaphylaxis|0|||
130034269|NCT01287104|468081123|FG003|Overall Study|Donor anaphylaxis|1|||
130034270|NCT01287104|468081120|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
130034271|NCT01287104|468081121|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
130034272|NCT01287104|468081122|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
130034273|NCT01287104|468081123|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
130034274|NCT01287104|468081120|FG000|Overall Study|Low donor chimerism|0|||
130034275|NCT01287104|468081121|FG001|Overall Study|Low donor chimerism|1|||
130034276|NCT01287104|468081122|FG002|Overall Study|Low donor chimerism|0|||
130034277|NCT01287104|468081123|FG003|Overall Study|Low donor chimerism|0|||
130034278|NCT01287104|468081120|FG000|Overall Study|NK cells did not meet release criteria|0|||
130034279|NCT01287104|468081121|FG001|Overall Study|NK cells did not meet release criteria|1|||
130034280|NCT01287104|468081122|FG002|Overall Study|NK cells did not meet release criteria|0|||
130034281|NCT01287104|468081123|FG003|Overall Study|NK cells did not meet release criteria|0|||
130034282|NCT03068715|468081128|FG000|Overall Study|No longer met inclusion criteria|1|||
130034283|NCT03068715|468081129|FG001|Overall Study|No longer met inclusion criteria|0|||
130034284|NCT01276288|468081130|FG000|Overall Study|Adverse Event|1|||
130034285|NCT01276288|468081131|FG001|Overall Study|Adverse Event|1|||
130034286|NCT01276288|468081132|FG002|Overall Study|Adverse Event|0|||
130034287|NCT01276288|468081133|FG003|Overall Study|Adverse Event|0|||
130034288|NCT01276288|468081130|FG000|Overall Study|not treated|1|||
130034289|NCT01276288|468081131|FG001|Overall Study|not treated|0|||
130034290|NCT01276288|468081132|FG002|Overall Study|not treated|0|||
130034291|NCT01276288|468081133|FG003|Overall Study|not treated|0|||
130034292|NCT03168867|468081134|FG000|Overall Study|Withdrawal by Subject|1|||
130034293|NCT03168867|468081135|FG001|Overall Study|Withdrawal by Subject|5|||
130034294|NCT00481065|468081141|FG000|Overall Study|Adverse event or death|1|||
130101958|NCT00909857|468330822|FG000|Overall Study|Pregnancy|1|||
130260096|NCT04138056|468918959|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
130260097|NCT04138056|468918960|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
130260098|NCT04138056|468918961|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
130260099|NCT04138056|468918962|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
130260100|NCT04138056|468918958|FG000|Extension Study|Lost to Follow-up|1|||
130260101|NCT04138056|468918959|FG001|Extension Study|Lost to Follow-up|2|||
130260102|NCT04138056|468918960|FG002|Extension Study|Lost to Follow-up|1|||
130260103|NCT04138056|468918961|FG003|Extension Study|Lost to Follow-up|0|||
130260104|NCT04138056|468918962|FG004|Extension Study|Lost to Follow-up|1|||
130260105|NCT01656161|468918963|FG000|Overall Study|Death|3|||
130260106|NCT01656161|468918963|FG000|Overall Study|Adverse Event|2|||
130034295|NCT00481065|468081142|FG001|Overall Study|Adverse event or death|1|||
130034296|NCT00481065|468081143|FG002|Overall Study|Adverse event or death|3|||
130034297|NCT00481065|468081144|FG003|Overall Study|Adverse event or death|0|||
130034298|NCT00481065|468081145|FG004|Overall Study|Adverse event or death|2|||
130034299|NCT00481065|468081146|FG005|Overall Study|Adverse event or death|0|||
130034300|NCT00481065|468081147|FG006|Overall Study|Adverse event or death|1|||
130260107|NCT01656161|468918963|FG000|Overall Study|Protocol Violation|1|||
130260108|NCT01656161|468918963|FG000|Overall Study|Withdrawal by Subject|1|||
130260109|NCT01215851|468918964|FG000|Treatment Period|Adverse Event|1|||
130260110|NCT01215851|468918965|FG001|Treatment Period|Adverse Event|1|||
130260111|NCT01215851|468918966|FG002|Treatment Period|Adverse Event|1|||
130260112|NCT01215851|468918967|FG003|Treatment Period|Adverse Event|3|||
130260113|NCT01215851|468918968|FG004|Treatment Period|Adverse Event|0|||
130260114|NCT01215851|468918969|FG005|Treatment Period|Adverse Event|1|||
130260115|NCT01215851|468918964|FG000|Follow up Period|Lost to Follow-up|0|||
130260116|NCT01215851|468918965|FG001|Follow up Period|Lost to Follow-up|0|||
130260117|NCT01215851|468918966|FG002|Follow up Period|Lost to Follow-up|0|||
130034301|NCT00481065|468081148|FG007|Overall Study|Adverse event or death|1|||
130034302|NCT00481065|468081141|FG000|Overall Study|Withdrawal by Subject|11|||
130034303|NCT00481065|468081142|FG001|Overall Study|Withdrawal by Subject|12|||
130034304|NCT00481065|468081143|FG002|Overall Study|Withdrawal by Subject|7|||
130034305|NCT00481065|468081144|FG003|Overall Study|Withdrawal by Subject|11|||
130034306|NCT00481065|468081145|FG004|Overall Study|Withdrawal by Subject|13|||
130260118|NCT01215851|468918967|FG003|Follow up Period|Lost to Follow-up|0|||
130260119|NCT01215851|468918968|FG004|Follow up Period|Lost to Follow-up|0|||
130034307|NCT00481065|468081146|FG005|Overall Study|Withdrawal by Subject|12|||
130260120|NCT01215851|468918969|FG005|Follow up Period|Lost to Follow-up|1|||
130260121|NCT03510273|468918970|FG000|Overall Study|Withdrawal by Subject|2|||
130260122|NCT03510273|468918970|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
130260123|NCT03510273|468918970|FG000|Overall Study|Moved away from study area|4|||
130260124|NCT01276106|468918973|FG000|Overall Study|Adverse Event|3|||
130260125|NCT01276106|468918974|FG001|Overall Study|Adverse Event|3|||
130260126|NCT01276106|468918975|FG002|Overall Study|Adverse Event|11|||
130260127|NCT01276106|468918976|FG003|Overall Study|Adverse Event|3|||
130260128|NCT01276106|468918973|FG000|Overall Study|Withdrawal by Subject|6|||
130260129|NCT01276106|468918974|FG001|Overall Study|Withdrawal by Subject|3|||
130260130|NCT01276106|468918975|FG002|Overall Study|Withdrawal by Subject|1|||
130260131|NCT01276106|468918976|FG003|Overall Study|Withdrawal by Subject|6|||
130260132|NCT01276106|468918973|FG000|Overall Study|Lack of Efficacy|0|||
130260133|NCT01276106|468918974|FG001|Overall Study|Lack of Efficacy|1|||
130260134|NCT01276106|468918975|FG002|Overall Study|Lack of Efficacy|0|||
130260135|NCT01276106|468918976|FG003|Overall Study|Lack of Efficacy|1|||
130260136|NCT01276106|468918973|FG000|Overall Study|Lost to Follow-up|2|||
130260137|NCT01276106|468918974|FG001|Overall Study|Lost to Follow-up|1|||
130260138|NCT01276106|468918975|FG002|Overall Study|Lost to Follow-up|1|||
130260139|NCT01276106|468918976|FG003|Overall Study|Lost to Follow-up|0|||
130260140|NCT01276106|468918973|FG000|Overall Study|Physician Decision|0|||
130260141|NCT01276106|468918974|FG001|Overall Study|Physician Decision|0|||
130260142|NCT01276106|468918975|FG002|Overall Study|Physician Decision|1|||
130260143|NCT01276106|468918976|FG003|Overall Study|Physician Decision|1|||
130260144|NCT01276106|468918973|FG000|Overall Study|Protocol Violation|1|||
130260145|NCT01276106|468918974|FG001|Overall Study|Protocol Violation|1|||
130260146|NCT01276106|468918975|FG002|Overall Study|Protocol Violation|0|||
130260147|NCT01276106|468918976|FG003|Overall Study|Protocol Violation|2|||
130260148|NCT01276106|468918973|FG000|Overall Study|Insufficient therapeutic effects|0|||
130260149|NCT01276106|468918974|FG001|Overall Study|Insufficient therapeutic effects|0|||
130260150|NCT01276106|468918975|FG002|Overall Study|Insufficient therapeutic effects|2|||
130260151|NCT01276106|468918976|FG003|Overall Study|Insufficient therapeutic effects|0|||
130260152|NCT04583618|468918981|FG000|Overall Study|Adverse Event|0|||
130260153|NCT04583618|468918982|FG001|Overall Study|Adverse Event|0|||
130260154|NCT04583618|468918983|FG002|Overall Study|Adverse Event|1|||
130260155|NCT04583618|468918984|FG003|Overall Study|Adverse Event|0|||
130260156|NCT04583618|468918985|FG004|Overall Study|Adverse Event|0|||
130260157|NCT04583618|468918981|FG000|Overall Study|Protocol deviation|1|||
130260158|NCT04583618|468918982|FG001|Overall Study|Protocol deviation|1|||
130260159|NCT04583618|468918983|FG002|Overall Study|Protocol deviation|1|||
130260160|NCT04583618|468918984|FG003|Overall Study|Protocol deviation|0|||
130260161|NCT04583618|468918985|FG004|Overall Study|Protocol deviation|0|||
130260162|NCT04583618|468918981|FG000|Overall Study|Withdrawal by Subject|2|||
130260163|NCT04583618|468918982|FG001|Overall Study|Withdrawal by Subject|1|||
130260164|NCT04583618|468918983|FG002|Overall Study|Withdrawal by Subject|3|||
130260165|NCT04583618|468918984|FG003|Overall Study|Withdrawal by Subject|1|||
130260166|NCT04583618|468918985|FG004|Overall Study|Withdrawal by Subject|1|||
130260167|NCT04583618|468918981|FG000|Overall Study|Lost to Follow-up|0|||
130260168|NCT04583618|468918982|FG001|Overall Study|Lost to Follow-up|1|||
130260169|NCT04583618|468918983|FG002|Overall Study|Lost to Follow-up|3|||
130260170|NCT04583618|468918984|FG003|Overall Study|Lost to Follow-up|1|||
130260171|NCT04583618|468918985|FG004|Overall Study|Lost to Follow-up|1|||
130260172|NCT02711202|468918986|FG000|Overall Study|Adverse Event|3|||
130260173|NCT02711202|468918987|FG001|Overall Study|Adverse Event|0|||
130260174|NCT02711202|468918986|FG000|Overall Study|graft loss|1|||
130260175|NCT02711202|468918987|FG001|Overall Study|graft loss|0|||
130260176|NCT05643495|468918992|FG000|Overall Study|Adverse Event|0|||
130260177|NCT05643495|468918993|FG001|Overall Study|Adverse Event|1|||
130260178|NCT05643495|468918992|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
130260179|NCT05643495|468918993|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130260180|NCT02257528|468918994|FG000|Overall Study|Never received study treatment|1|||
130260181|NCT06272383|468918995|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
130260182|NCT06272383|468918996|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
130260183|NCT02661672|468919002|FG000|Overall Study|Lost to Follow-up|1|||
130260184|NCT02661672|468919002|FG000|Overall Study|Death|4|||
130260185|NCT02581930|468919003|FG000|Overall Study|Withdrawal by Subject|1|||
130260186|NCT02581930|468919003|FG000|Overall Study|patient declined further treatment|1|||
130101959|NCT00909857|468330823|FG001|Overall Study|Pregnancy|0|||
130260187|NCT04696146|468921287|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
130260188|NCT04696146|468921288|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
130260189|NCT04696146|468921287|FG000|Overall Study|Off hours issue with product|1|||
130260190|NCT04696146|468921288|FG001|Overall Study|Off hours issue with product|0|||
130260191|NCT00529633|468921293|FG000|Overall Study|Withdrawal by Subject|1|||
130260192|NCT00529633|468921294|FG001|Overall Study|Withdrawal by Subject|1|||
130260193|NCT01576783|468921298|FG000|Overall Study|Change in Medical Care|1|||
130260194|NCT01576783|468921299|FG001|Overall Study|Change in Medical Care|0|||
130260195|NCT01576783|468921298|FG000|Overall Study|Lost to Follow-up|14|||
130260196|NCT01576783|468921299|FG001|Overall Study|Lost to Follow-up|16|||
130260197|NCT01576783|468921298|FG000|Overall Study|Withdrawal by Subject|5|||
130260198|NCT01576783|468921299|FG001|Overall Study|Withdrawal by Subject|1|||
130260199|NCT01897493|468921300|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
130260200|NCT05489328|468921301|FG000|Overall Study|Lost to Follow-up|0|||
130260201|NCT05489328|468921302|FG001|Overall Study|Lost to Follow-up|0|||
130260202|NCT05489328|468921303|FG002|Overall Study|Lost to Follow-up|1|||
130260203|NCT05489328|468921304|FG003|Overall Study|Lost to Follow-up|0|||
130260204|NCT05489328|468921305|FG004|Overall Study|Lost to Follow-up|2|||
130260205|NCT05489328|468921306|FG005|Overall Study|Lost to Follow-up|0|||
130260206|NCT05489328|468921307|FG006|Overall Study|Lost to Follow-up|0|||
130260207|NCT05489328|468921308|FG007|Overall Study|Lost to Follow-up|1|||
130260208|NCT05489328|468921309|FG008|Overall Study|Lost to Follow-up|0|||
130260209|NCT05489328|468921301|FG000|Overall Study|Withdrawal by Subject|0|||
130260210|NCT05489328|468921302|FG001|Overall Study|Withdrawal by Subject|0|||
130260211|NCT05489328|468921303|FG002|Overall Study|Withdrawal by Subject|0|||
130260212|NCT05489328|468921304|FG003|Overall Study|Withdrawal by Subject|0|||
130260213|NCT05489328|468921305|FG004|Overall Study|Withdrawal by Subject|0|||
130260214|NCT05489328|468921306|FG005|Overall Study|Withdrawal by Subject|0|||
130260215|NCT05489328|468921307|FG006|Overall Study|Withdrawal by Subject|1|||
130260216|NCT05489328|468921308|FG007|Overall Study|Withdrawal by Subject|1|||
130260217|NCT05489328|468921309|FG008|Overall Study|Withdrawal by Subject|0|||
130260218|NCT05489328|468921301|FG000|Overall Study|Other|0|||
130260219|NCT05489328|468921302|FG001|Overall Study|Other|0|||
130260220|NCT05489328|468921303|FG002|Overall Study|Other|0|||
130260221|NCT05489328|468921304|FG003|Overall Study|Other|0|||
130260222|NCT05489328|468921305|FG004|Overall Study|Other|0|||
130260223|NCT05489328|468921306|FG005|Overall Study|Other|0|||
130260224|NCT05489328|468921307|FG006|Overall Study|Other|0|||
130260225|NCT05489328|468921308|FG007|Overall Study|Other|1|||
130260226|NCT05489328|468921309|FG008|Overall Study|Other|1|||
130260227|NCT01083602|468921310|FG000|Overall Study|Adverse Event|11|||
130260228|NCT01083602|468921310|FG000|Overall Study|New Cancer Therapy|2|||
130260229|NCT01083602|468921310|FG000|Overall Study|Death|1|||
130260230|NCT01083602|468921310|FG000|Overall Study|Withdrawal by Subject|5|||
130260231|NCT01083602|468921310|FG000|Overall Study|Lack of Efficacy|36|||
130260232|NCT03698279|468921312|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130260233|NCT03698279|468921313|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130260234|NCT03698279|468921314|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130260235|NCT03698279|468921315|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130260236|NCT03698279|468921316|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130260237|NCT03698279|468921317|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130260238|NCT03698279|468921312|FG000|Overall Study|Protocol deviation|1|||
130260239|NCT03698279|468921313|FG001|Overall Study|Protocol deviation|0|||
130260240|NCT03698279|468921314|FG002|Overall Study|Protocol deviation|1|||
130260241|NCT03698279|468921315|FG003|Overall Study|Protocol deviation|0|||
130260242|NCT03698279|468921316|FG004|Overall Study|Protocol deviation|0|||
130260243|NCT03698279|468921317|FG005|Overall Study|Protocol deviation|0|||
130260244|NCT03698279|468921312|FG000|Overall Study|Withdrawal by Subject|0|||
130260245|NCT03698279|468921313|FG001|Overall Study|Withdrawal by Subject|0|||
130260246|NCT03698279|468921314|FG002|Overall Study|Withdrawal by Subject|1|||
130260247|NCT03698279|468921315|FG003|Overall Study|Withdrawal by Subject|0|||
130260248|NCT03698279|468921316|FG004|Overall Study|Withdrawal by Subject|0|||
130260249|NCT03698279|468921317|FG005|Overall Study|Withdrawal by Subject|0|||
130260250|NCT03698279|468921312|FG000|Overall Study|Lost to Follow-up|3|||
130034308|NCT00481065|468081147|FG006|Overall Study|Withdrawal by Subject|9|||
130260251|NCT03698279|468921313|FG001|Overall Study|Lost to Follow-up|1|||
130260252|NCT03698279|468921314|FG002|Overall Study|Lost to Follow-up|4|||
130260253|NCT03698279|468921315|FG003|Overall Study|Lost to Follow-up|5|||
130260254|NCT03698279|468921316|FG004|Overall Study|Lost to Follow-up|0|||
130260255|NCT03698279|468921317|FG005|Overall Study|Lost to Follow-up|0|||
130260256|NCT02276040|468921320|FG000|Overall Study|Physician Decision|15|||
130260257|NCT03801525|468921321|FG000|Overall Study|Adverse Event|17|||
130260258|NCT03801525|468921322|FG001|Overall Study|Adverse Event|1|||
130260259|NCT03801525|468921323|FG002|Overall Study|Adverse Event|0|||
130260260|NCT03801525|468921321|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
130260261|NCT03801525|468921322|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
130260262|NCT03801525|468921323|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
130260263|NCT03801525|468921321|FG000|Overall Study|Death|29|||
130260264|NCT03801525|468921322|FG001|Overall Study|Death|1|||
130260265|NCT03801525|468921323|FG002|Overall Study|Death|4|||
130260266|NCT03801525|468921321|FG000|Overall Study|Disease Progression|6|||
130260267|NCT03801525|468921322|FG001|Overall Study|Disease Progression|0|||
130260268|NCT03801525|468921323|FG002|Overall Study|Disease Progression|1|||
130260269|NCT03801525|468921321|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
130260270|NCT03801525|468921322|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
130260271|NCT03801525|468921323|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
130260272|NCT03801525|468921321|FG000|Overall Study|Investigator Decision|18|||
130260273|NCT03801525|468921322|FG001|Overall Study|Investigator Decision|1|||
130260274|NCT03801525|468921323|FG002|Overall Study|Investigator Decision|0|||
130260275|NCT03801525|468921321|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
130260276|NCT03801525|468921322|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
130260277|NCT03801525|468921323|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
130260278|NCT03801525|468921321|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
130260279|NCT03801525|468921322|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
130260280|NCT03801525|468921323|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
130260281|NCT03801525|468921321|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
130260282|NCT03801525|468921322|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
130260283|NCT03801525|468921323|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
130260284|NCT03801525|468921321|FG000|Overall Study|Withdrawal of Subject Consent|38|||
130260285|NCT03801525|468921322|FG001|Overall Study|Withdrawal of Subject Consent|2|||
130260286|NCT03801525|468921323|FG002|Overall Study|Withdrawal of Subject Consent|1|||
130260287|NCT03801525|468921321|FG000|Overall Study|Reason not Specified|4|||
130260288|NCT03801525|468921322|FG001|Overall Study|Reason not Specified|0|||
130260289|NCT03801525|468921323|FG002|Overall Study|Reason not Specified|4|||
130260290|NCT04388826|468921325|FG000|Overall Study|Lost to Follow-up|3|||
130260291|NCT04388826|468921326|FG001|Overall Study|Lost to Follow-up|2|||
130260292|NCT04388826|468921325|FG000|Overall Study|Adverse Event|1|||
130260293|NCT04388826|468921326|FG001|Overall Study|Adverse Event|0|||
130260294|NCT00329420|468921327|FG000|Re-induction Phase|Lack of Efficacy|0|||
130260295|NCT00329420|468921328|FG001|Re-induction Phase|Lack of Efficacy|1|||
130260296|NCT00329420|468921329|FG002|Re-induction Phase|Lack of Efficacy|0|||
130260297|NCT00329420|468921327|FG000|Re-induction Phase|Withdrawal of Consent|0|||
130260298|NCT00329420|468921328|FG001|Re-induction Phase|Withdrawal of Consent|0|||
130260299|NCT00329420|468921329|FG002|Re-induction Phase|Withdrawal of Consent|1|||
130260300|NCT00329420|468921327|FG000|Re-induction Phase|Did not respond to re-induction|6|||
130260301|NCT00329420|468921328|FG001|Re-induction Phase|Did not respond to re-induction|5|||
130260302|NCT00329420|468921329|FG002|Re-induction Phase|Did not respond to re-induction|7|||
130260303|NCT00329420|468921327|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
130260304|NCT00329420|468921328|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
130260305|NCT00329420|468921329|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
130260306|NCT00329420|468921327|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
130260307|NCT00329420|468921328|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
130260308|NCT00329420|468921329|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
130260309|NCT00329420|468921327|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
130260310|NCT00329420|468921328|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
130260311|NCT00329420|468921329|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
130260312|NCT02862574|468921330|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130260313|NCT02862574|468921331|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130260314|NCT02862574|468921332|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130260315|NCT02862574|468921330|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
130260316|NCT02862574|468921331|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
130260317|NCT02862574|468921332|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
130260318|NCT02862574|468921330|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
130260319|NCT02862574|468921331|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
130260320|NCT02862574|468921332|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
130260321|NCT03386773|468921333|FG000|Overall Study|Lost to Follow-up|24|||
130260322|NCT03386773|468921334|FG001|Overall Study|Lost to Follow-up|33|||
130260323|NCT03386773|468921333|FG000|Overall Study|Withdrawal by Subject|3|||
130260324|NCT03386773|468921334|FG001|Overall Study|Withdrawal by Subject|2|||
130260325|NCT03639610|468921335|FG000|Overall Study|Adverse Event|7|||
130260326|NCT03639610|468921336|FG001|Overall Study|Adverse Event|1|||
130260327|NCT03639610|468921337|FG002|Overall Study|Adverse Event|0|||
130260328|NCT03639610|468921335|FG000|Overall Study|Physician Decision|3|||
130260329|NCT03639610|468921336|FG001|Overall Study|Physician Decision|1|||
130260330|NCT03639610|468921337|FG002|Overall Study|Physician Decision|0|||
130260331|NCT03639610|468921335|FG000|Overall Study|Disease progression|8|||
130260332|NCT03639610|468921336|FG001|Overall Study|Disease progression|5|||
130260333|NCT03639610|468921337|FG002|Overall Study|Disease progression|3|||
130260334|NCT03639610|468921335|FG000|Overall Study|Study terminated by sponsor|2|||
130260335|NCT03639610|468921336|FG001|Overall Study|Study terminated by sponsor|1|||
130260336|NCT03639610|468921337|FG002|Overall Study|Study terminated by sponsor|1|||
130260337|NCT03639610|468921335|FG000|Overall Study|Patient request to stop treatment|1|||
130260338|NCT03639610|468921336|FG001|Overall Study|Patient request to stop treatment|2|||
130260339|NCT03639610|468921337|FG002|Overall Study|Patient request to stop treatment|0|||
130260340|NCT02410772|468921340|FG000|Overall Study|Death|3|||
130260341|NCT02410772|468921341|FG001|Overall Study|Death|4|||
130260342|NCT02410772|468921342|FG002|Overall Study|Death|8|||
130260343|NCT02410772|468921340|FG000|Overall Study|Lost to Follow-up|31|||
130260344|NCT02410772|468921341|FG001|Overall Study|Lost to Follow-up|23|||
130034309|NCT00481065|468081148|FG007|Overall Study|Withdrawal by Subject|10|||
130034310|NCT00481065|468081141|FG000|Overall Study|Lost to Follow-up|4|||
130034311|NCT00481065|468081142|FG001|Overall Study|Lost to Follow-up|2|||
130034312|NCT00481065|468081143|FG002|Overall Study|Lost to Follow-up|4|||
130034313|NCT00481065|468081144|FG003|Overall Study|Lost to Follow-up|3|||
130034314|NCT00481065|468081145|FG004|Overall Study|Lost to Follow-up|3|||
130034315|NCT00481065|468081146|FG005|Overall Study|Lost to Follow-up|3|||
130034316|NCT00481065|468081147|FG006|Overall Study|Lost to Follow-up|2|||
130034317|NCT00481065|468081148|FG007|Overall Study|Lost to Follow-up|5|||
130034318|NCT00481065|468081141|FG000|Overall Study|Inappropriate enrollment|4|||
130034319|NCT00481065|468081142|FG001|Overall Study|Inappropriate enrollment|0|||
130034320|NCT00481065|468081143|FG002|Overall Study|Inappropriate enrollment|2|||
130034321|NCT00481065|468081144|FG003|Overall Study|Inappropriate enrollment|0|||
130034322|NCT00481065|468081145|FG004|Overall Study|Inappropriate enrollment|2|||
130034323|NCT00481065|468081146|FG005|Overall Study|Inappropriate enrollment|1|||
130034324|NCT00481065|468081147|FG006|Overall Study|Inappropriate enrollment|0|||
130034325|NCT00481065|468081148|FG007|Overall Study|Inappropriate enrollment|1|||
130034326|NCT00481065|468081141|FG000|Overall Study|Administrative reason|0|||
130034327|NCT00481065|468081142|FG001|Overall Study|Administrative reason|0|||
130034328|NCT00481065|468081143|FG002|Overall Study|Administrative reason|0|||
130034329|NCT00481065|468081144|FG003|Overall Study|Administrative reason|0|||
130034330|NCT00481065|468081145|FG004|Overall Study|Administrative reason|0|||
130034331|NCT00481065|468081146|FG005|Overall Study|Administrative reason|2|||
130034332|NCT00481065|468081147|FG006|Overall Study|Administrative reason|1|||
130034333|NCT00481065|468081148|FG007|Overall Study|Administrative reason|0|||
130034334|NCT00481065|468081141|FG000|Overall Study|Protocol Violation|2|||
130034335|NCT00481065|468081142|FG001|Overall Study|Protocol Violation|1|||
130034336|NCT00481065|468081143|FG002|Overall Study|Protocol Violation|1|||
130034337|NCT00481065|468081144|FG003|Overall Study|Protocol Violation|1|||
130034338|NCT00481065|468081145|FG004|Overall Study|Protocol Violation|2|||
130034339|NCT00481065|468081146|FG005|Overall Study|Protocol Violation|6|||
130034340|NCT00481065|468081147|FG006|Overall Study|Protocol Violation|3|||
130034341|NCT00481065|468081148|FG007|Overall Study|Protocol Violation|2|||
130034342|NCT00481065|468081141|FG000|Overall Study|Unable to classify|0|||
130034343|NCT00481065|468081142|FG001|Overall Study|Unable to classify|1|||
130034344|NCT00481065|468081143|FG002|Overall Study|Unable to classify|2|||
130034345|NCT00481065|468081144|FG003|Overall Study|Unable to classify|0|||
130034346|NCT00481065|468081145|FG004|Overall Study|Unable to classify|1|||
130034347|NCT00481065|468081146|FG005|Overall Study|Unable to classify|0|||
130034348|NCT00481065|468081147|FG006|Overall Study|Unable to classify|0|||
130034349|NCT00481065|468081148|FG007|Overall Study|Unable to classify|0|||
130034350|NCT01709331|468081151|FG000|Overall Study|Adverse Event|1|||
130034351|NCT03896295|468081154|FG000|Overall Study|Adverse Event|0|||
130034352|NCT03896295|468081155|FG001|Overall Study|Adverse Event|1|||
130034353|NCT03896295|468081154|FG000|Overall Study|COVID-19|7|||
130034354|NCT03896295|468081155|FG001|Overall Study|COVID-19|29|||
130034355|NCT00700804|468081156|FG000|Overall Study|Withdrawal by Subject|1|||
130034356|NCT00700804|468081157|FG001|Overall Study|Withdrawal by Subject|2|||
130034357|NCT00700804|468081156|FG000|Overall Study|Protocol Violation|1|||
130034358|NCT00700804|468081157|FG001|Overall Study|Protocol Violation|1|||
130034359|NCT00700804|468081156|FG000|Overall Study|Loose Stools|1|||
130034360|NCT00700804|468081157|FG001|Overall Study|Loose Stools|1|||
130034361|NCT02500537|468081158|FG000|Overall Study|Death|2|||
130034362|NCT02500537|468081159|FG001|Overall Study|Death|0|||
130034363|NCT02500537|468081158|FG000|Overall Study|Lost to Follow-up|0|||
130034364|NCT02500537|468081159|FG001|Overall Study|Lost to Follow-up|1|||
130034365|NCT02500537|468081158|FG000|Overall Study|Withdrawal by Subject|1|||
130034366|NCT02500537|468081159|FG001|Overall Study|Withdrawal by Subject|0|||
130034367|NCT02875223|468081164|FG000|Overall Study|Other reasons|0|||
130034368|NCT02875223|468081165|FG001|Overall Study|Other reasons|0|||
130034369|NCT02875223|468081166|FG002|Overall Study|Other reasons|1|||
130034370|NCT02875223|468081167|FG003|Overall Study|Other reasons|0|||
130034371|NCT02875223|468081168|FG004|Overall Study|Other reasons|1|||
130034372|NCT02875223|468081169|FG005|Overall Study|Other reasons|2|||
130034373|NCT02875223|468081170|FG006|Overall Study|Other reasons|0|||
130034374|NCT02875223|468081171|FG007|Overall Study|Other reasons|2|||
130034375|NCT02875223|468081172|FG008|Overall Study|Other reasons|0|||
130034376|NCT02875223|468081173|FG009|Overall Study|Other reasons|0|||
130034377|NCT02875223|468081174|FG010|Overall Study|Other reasons|0|||
130034378|NCT02875223|468081175|FG011|Overall Study|Other reasons|0|||
130034379|NCT02875223|468081176|FG012|Overall Study|Other reasons|0|||
130034380|NCT02875223|468081164|FG000|Overall Study|Withdrawal by Subject|0|||
130034381|NCT02875223|468081165|FG001|Overall Study|Withdrawal by Subject|0|||
130034382|NCT02875223|468081166|FG002|Overall Study|Withdrawal by Subject|0|||
130034383|NCT02875223|468081167|FG003|Overall Study|Withdrawal by Subject|0|||
130034384|NCT02875223|468081168|FG004|Overall Study|Withdrawal by Subject|1|||
130034385|NCT02875223|468081169|FG005|Overall Study|Withdrawal by Subject|1|||
130034386|NCT02875223|468081170|FG006|Overall Study|Withdrawal by Subject|0|||
130034387|NCT02875223|468081171|FG007|Overall Study|Withdrawal by Subject|0|||
130034388|NCT02875223|468081172|FG008|Overall Study|Withdrawal by Subject|1|||
130034389|NCT02875223|468081173|FG009|Overall Study|Withdrawal by Subject|0|||
130034390|NCT02875223|468081174|FG010|Overall Study|Withdrawal by Subject|0|||
130034391|NCT02875223|468081175|FG011|Overall Study|Withdrawal by Subject|0|||
130034392|NCT02875223|468081176|FG012|Overall Study|Withdrawal by Subject|0|||
130034393|NCT02875223|468081164|FG000|Overall Study|Progressive disease|0|||
130034394|NCT02875223|468081165|FG001|Overall Study|Progressive disease|0|||
130034395|NCT02875223|468081166|FG002|Overall Study|Progressive disease|1|||
130034396|NCT02875223|468081167|FG003|Overall Study|Progressive disease|0|||
130034397|NCT02875223|468081168|FG004|Overall Study|Progressive disease|0|||
130034398|NCT02875223|468081169|FG005|Overall Study|Progressive disease|0|||
130034399|NCT02875223|468081170|FG006|Overall Study|Progressive disease|0|||
130034400|NCT02875223|468081171|FG007|Overall Study|Progressive disease|0|||
130034401|NCT02875223|468081172|FG008|Overall Study|Progressive disease|0|||
130034402|NCT02875223|468081173|FG009|Overall Study|Progressive disease|12|||
130034403|NCT02875223|468081174|FG010|Overall Study|Progressive disease|2|||
130034404|NCT02875223|468081175|FG011|Overall Study|Progressive disease|3|||
130034405|NCT02875223|468081176|FG012|Overall Study|Progressive disease|6|||
130034406|NCT02875223|468081164|FG000|Overall Study|Death|4|||
130034407|NCT02875223|468081165|FG001|Overall Study|Death|4|||
130034408|NCT02875223|468081166|FG002|Overall Study|Death|3|||
130034409|NCT02875223|468081167|FG003|Overall Study|Death|4|||
130034410|NCT02875223|468081168|FG004|Overall Study|Death|2|||
130101960|NCT00909857|468330822|FG000|Overall Study|Other|1|||
130101961|NCT00909857|468330823|FG001|Overall Study|Other|0|||
130101962|NCT00909857|468330822|FG000|Overall Study|Did not receive study medication|19|||
130101963|NCT00909857|468330823|FG001|Overall Study|Did not receive study medication|24|||
130101964|NCT03878108|468330824|FG000|Overall Study|Adverse Event|1|||
130260345|NCT02410772|468921342|FG002|Overall Study|Lost to Follow-up|22|||
130260346|NCT02410772|468921340|FG000|Overall Study|Pregnancy|8|||
130260347|NCT02410772|468921341|FG001|Overall Study|Pregnancy|4|||
130260348|NCT02410772|468921342|FG002|Overall Study|Pregnancy|5|||
130260349|NCT02410772|468921340|FG000|Overall Study|Protocol Violation|8|||
130260350|NCT02410772|468921341|FG001|Overall Study|Protocol Violation|8|||
130260351|NCT02410772|468921342|FG002|Overall Study|Protocol Violation|4|||
130260352|NCT02410772|468921340|FG000|Overall Study|Baseline Drug Resistance|49|||
130260353|NCT02410772|468921341|FG001|Overall Study|Baseline Drug Resistance|40|||
130260354|NCT02410772|468921342|FG002|Overall Study|Baseline Drug Resistance|51|||
130260355|NCT02410772|468921340|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
130260356|NCT02410772|468921341|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
130260357|NCT02410772|468921342|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
130260358|NCT02410772|468921340|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
130260359|NCT02410772|468921341|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
130260360|NCT02410772|468921342|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
130260361|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
130260362|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
130260363|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
130260364|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
130260365|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
130260366|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
130260367|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
130260368|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
130260369|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
130260370|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
130260371|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
130260372|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
130034411|NCT02875223|468081169|FG005|Overall Study|Death|3|||
130034412|NCT02875223|468081170|FG006|Overall Study|Death|5|||
130101965|NCT03878108|468330825|FG001|Overall Study|Adverse Event|0|||
130101966|NCT01682681|468330826|FG000|Overall Study|Lack of Efficacy|62|||
130101967|NCT01682681|468330826|FG000|Overall Study|Withdrawal by Subject|1|||
130101968|NCT01682681|468330826|FG000|Overall Study|Moved to other hospital|10|||
130260373|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
130034413|NCT02875223|468081171|FG007|Overall Study|Death|7|||
130034414|NCT02875223|468081172|FG008|Overall Study|Death|3|||
130101969|NCT01682681|468330826|FG000|Overall Study|Lost to Follow-up|174|||
130101970|NCT01682681|468330826|FG000|Overall Study|Adverse Event|46|||
130260374|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129885586|NCT02611830|467540768|FG001|OL Induction Phase|Lack of Efficacy|0|||
130034415|NCT02875223|468081173|FG009|Overall Study|Death|2|||
130034416|NCT02875223|468081174|FG010|Overall Study|Death|0|||
130034417|NCT02875223|468081175|FG011|Overall Study|Death|0|||
130034418|NCT02875223|468081176|FG012|Overall Study|Death|0|||
130034419|NCT02875223|468081164|FG000|Overall Study|Lost to Follow-up|0|||
130101971|NCT01682681|468330826|FG000|Overall Study|tapering of topiramate|5|||
130260375|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130260376|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
130260377|NCT05067335|468921343|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130260378|NCT05067335|468921344|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
130260379|NCT05067335|468921345|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130260380|NCT05067335|468921346|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
130260381|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
130260382|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
130260383|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
130260384|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
130260385|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130260386|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130260387|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
130260388|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
130260389|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130260390|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130260391|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
130260392|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
130260393|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130260394|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130260395|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
130260396|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
130260397|NCT05067335|468921343|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130260398|NCT05067335|468921344|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130260399|NCT05067335|468921345|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
130260400|NCT05067335|468921346|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
130260401|NCT02234362|468921347|FG000|Overall Study|Not eligible after first screening visit|17|||
130260402|NCT02234362|468921347|FG000|Overall Study|Lost to Follow-up|6|||
130260403|NCT02234362|468921347|FG000|Overall Study|Withdrawal by Subject|3|||
130260404|NCT00560417|468921348|FG000|Overall Study|Adverse Event|3|||
130260405|NCT00560417|468921349|FG001|Overall Study|Adverse Event|2|||
130260406|NCT00560417|468921348|FG000|Overall Study|Entry Criteria Not Met|1|||
130260407|NCT00560417|468921349|FG001|Overall Study|Entry Criteria Not Met|0|||
130260408|NCT00560417|468921348|FG000|Overall Study|Lost to Follow-up|0|||
130260409|NCT00560417|468921349|FG001|Overall Study|Lost to Follow-up|1|||
130260410|NCT00560417|468921348|FG000|Overall Study|Physician Decision|2|||
130260411|NCT00560417|468921349|FG001|Overall Study|Physician Decision|6|||
130260412|NCT00560417|468921348|FG000|Overall Study|Protocol Violation|6|||
130260413|NCT00560417|468921349|FG001|Overall Study|Protocol Violation|5|||
130260414|NCT00560417|468921348|FG000|Overall Study|Sponsor Decision|2|||
130260415|NCT00560417|468921349|FG001|Overall Study|Sponsor Decision|0|||
130260416|NCT00560417|468921348|FG000|Overall Study|Withdrawal by Subject|3|||
130260417|NCT00560417|468921349|FG001|Overall Study|Withdrawal by Subject|3|||
130260418|NCT02164864|468921352|FG000|Overall Study|Trial disease worsening|7|||
130260419|NCT02164864|468921353|FG001|Overall Study|Trial disease worsening|5|||
130260420|NCT02164864|468921354|FG002|Overall Study|Trial disease worsening|1|||
130260421|NCT02164864|468921352|FG000|Overall Study|Other pre-existing disease worsening|6|||
130260422|NCT02164864|468921353|FG001|Overall Study|Other pre-existing disease worsening|4|||
130260423|NCT02164864|468921354|FG002|Overall Study|Other pre-existing disease worsening|9|||
130260424|NCT02164864|468921352|FG000|Overall Study|Other Adverse Event (AE)|52|||
130260425|NCT02164864|468921353|FG001|Overall Study|Other Adverse Event (AE)|32|||
130260426|NCT02164864|468921354|FG002|Overall Study|Other Adverse Event (AE)|49|||
130260427|NCT02164864|468921352|FG000|Overall Study|Protocol Violation|2|||
130260428|NCT02164864|468921353|FG001|Overall Study|Protocol Violation|4|||
130260429|NCT02164864|468921354|FG002|Overall Study|Protocol Violation|1|||
130260430|NCT02164864|468921352|FG000|Overall Study|Lost to Follow-up|4|||
130260431|NCT02164864|468921353|FG001|Overall Study|Lost to Follow-up|3|||
130260432|NCT02164864|468921354|FG002|Overall Study|Lost to Follow-up|2|||
130260433|NCT02164864|468921352|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
130260434|NCT02164864|468921353|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
130260435|NCT02164864|468921354|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
130260436|NCT02164864|468921352|FG000|Overall Study|Other than stated|3|||
130260437|NCT02164864|468921353|FG001|Overall Study|Other than stated|4|||
130260438|NCT02164864|468921354|FG002|Overall Study|Other than stated|14|||
130260439|NCT02569853|468921355|FG000|Overall Study|Adverse Event|2|||
130260440|NCT02569853|468921356|FG001|Overall Study|Adverse Event|0|||
130260441|NCT02569853|468921355|FG000|Overall Study|Withdrawal by Subject|3|||
130260442|NCT02569853|468921356|FG001|Overall Study|Withdrawal by Subject|2|||
130260443|NCT02569853|468921355|FG000|Overall Study|Lost to Follow-up|3|||
130260444|NCT02569853|468921356|FG001|Overall Study|Lost to Follow-up|3|||
130260445|NCT02569853|468921355|FG000|Overall Study|Protocol Violation|1|||
130260446|NCT02569853|468921356|FG001|Overall Study|Protocol Violation|1|||
130260447|NCT02569853|468921355|FG000|Overall Study|Did not experience migraine attack|10|||
130260448|NCT02569853|468921356|FG001|Overall Study|Did not experience migraine attack|7|||
130260449|NCT02569853|468921355|FG000|Overall Study|Physician Decision|1|||
130260450|NCT02569853|468921356|FG001|Overall Study|Physician Decision|1|||
130260451|NCT00261833|468921357|FG000|Overall Study|Death|1|||
130260452|NCT00261833|468921358|FG001|Overall Study|Death|3|||
130260453|NCT00261833|468921357|FG000|Overall Study|Adverse Event|1|||
130260454|NCT00261833|468921358|FG001|Overall Study|Adverse Event|4|||
130260455|NCT00261833|468921357|FG000|Overall Study|Withdrawal by Subject|5|||
130260456|NCT00261833|468921358|FG001|Overall Study|Withdrawal by Subject|7|||
130260457|NCT00261833|468921357|FG000|Overall Study|Protocol Violation|0|||
130260458|NCT00261833|468921358|FG001|Overall Study|Protocol Violation|1|||
130260459|NCT00261833|468921357|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
130260460|NCT00261833|468921358|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
130260461|NCT00261833|468921357|FG000|Overall Study|Lung transplantation|1|||
130260462|NCT00261833|468921358|FG001|Overall Study|Lung transplantation|1|||
130260463|NCT00261833|468921357|FG000|Overall Study|Missing reason|1|||
130260464|NCT00261833|468921358|FG001|Overall Study|Missing reason|0|||
130260465|NCT00261833|468921357|FG000|Overall Study|Not interested in being participant|0|||
130260466|NCT00261833|468921358|FG001|Overall Study|Not interested in being participant|1|||
130260467|NCT00622726|468921359|FG000|March, 2008 to August, 2010|Death|5|||
130260468|NCT00622726|468921360|FG001|March, 2008 to August, 2010|Death|2|||
130260469|NCT00622726|468921359|FG000|August, 2010 to April, 2013|Death|1|||
130260470|NCT00622726|468921360|FG001|August, 2010 to April, 2013|Death|5|||
130260471|NCT02434081|468921363|FG000|Overall Study|Death (never started treatment)|2|||
130260472|NCT02434081|468921363|FG000|Overall Study|Death|2|||
130260473|NCT02434081|468921363|FG000|Overall Study|Progression|20|||
130260474|NCT02434081|468921363|FG000|Overall Study|Adverse Event|20|||
130260475|NCT02434081|468921363|FG000|Overall Study|Physician Decision|2|||
130260476|NCT02434081|468921363|FG000|Overall Study|Withdrawal by Subject|1|||
130260477|NCT02434081|468921363|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
130260478|NCT00419744|468921364|FG000|Overall Study|Adverse Event|39|||
130260479|NCT00419744|468921365|FG001|Overall Study|Adverse Event|40|||
130260480|NCT00419744|468921366|FG002|Overall Study|Adverse Event|50|||
130260481|NCT00419744|468921364|FG000|Overall Study|Withdrawal by Subject|45|||
130260482|NCT00419744|468921365|FG001|Overall Study|Withdrawal by Subject|49|||
130260483|NCT00419744|468921366|FG002|Overall Study|Withdrawal by Subject|52|||
130260484|NCT00419744|468921364|FG000|Overall Study|Lost to Follow-up|8|||
130260485|NCT00419744|468921365|FG001|Overall Study|Lost to Follow-up|10|||
130260486|NCT00419744|468921366|FG002|Overall Study|Lost to Follow-up|6|||
130260487|NCT00419744|468921364|FG000|Overall Study|Protocol Violation|4|||
130260488|NCT00419744|468921365|FG001|Overall Study|Protocol Violation|7|||
130260489|NCT00419744|468921366|FG002|Overall Study|Protocol Violation|8|||
130260490|NCT00419744|468921364|FG000|Overall Study|Randomized in error|9|||
130260491|NCT00419744|468921365|FG001|Overall Study|Randomized in error|6|||
130260492|NCT00419744|468921366|FG002|Overall Study|Randomized in error|7|||
130260493|NCT00419744|468921364|FG000|Overall Study|Moving out of state|2|||
130260494|NCT00419744|468921365|FG001|Overall Study|Moving out of state|0|||
130260495|NCT00419744|468921366|FG002|Overall Study|Moving out of state|1|||
130260496|NCT00419744|468921364|FG000|Overall Study|Physician Decision|10|||
130260497|NCT00419744|468921365|FG001|Overall Study|Physician Decision|5|||
130260498|NCT00419744|468921366|FG002|Overall Study|Physician Decision|6|||
130260499|NCT00419744|468921364|FG000|Overall Study|Spirometry mouthpiece issues|0|||
130260500|NCT00419744|468921365|FG001|Overall Study|Spirometry mouthpiece issues|1|||
130034420|NCT02875223|468081165|FG001|Overall Study|Lost to Follow-up|1|||
130034421|NCT02875223|468081166|FG002|Overall Study|Lost to Follow-up|1|||
130034422|NCT02875223|468081167|FG003|Overall Study|Lost to Follow-up|0|||
130034423|NCT02875223|468081168|FG004|Overall Study|Lost to Follow-up|1|||
130034424|NCT02875223|468081169|FG005|Overall Study|Lost to Follow-up|0|||
130260501|NCT00419744|468921366|FG002|Overall Study|Spirometry mouthpiece issues|2|||
130260502|NCT00419744|468921364|FG000|Overall Study|Incorrect medication kit dispensed|0|||
130260503|NCT00419744|468921365|FG001|Overall Study|Incorrect medication kit dispensed|0|||
130260504|NCT00419744|468921366|FG002|Overall Study|Incorrect medication kit dispensed|1|||
130260505|NCT02037529|468921370|FG000|Overall Study|Withdrawal by Subject|1|||
130260506|NCT02037529|468921371|FG001|Overall Study|Withdrawal by Subject|3|||
130260507|NCT02037529|468921370|FG000|Overall Study|Adverse Event|0|||
130260508|NCT02037529|468921371|FG001|Overall Study|Adverse Event|1|||
130260509|NCT02131766|468921372|FG000|Overall Study|Withdrawal by Subject|4|||
130260510|NCT00718315|468921373|FG000|Overall Study|Adverse Event|1|||
130260511|NCT00718315|468921374|FG001|Overall Study|Adverse Event|2|||
130260512|NCT00718315|468921375|FG002|Overall Study|Adverse Event|3|||
130034425|NCT02875223|468081170|FG006|Overall Study|Lost to Follow-up|1|||
130260513|NCT00718315|468921373|FG000|Overall Study|Death|6|||
130260514|NCT00718315|468921374|FG001|Overall Study|Death|6|||
130260515|NCT00718315|468921375|FG002|Overall Study|Death|5|||
130260516|NCT00718315|468921373|FG000|Overall Study|Lost to Follow-up|2|||
130260517|NCT00718315|468921374|FG001|Overall Study|Lost to Follow-up|3|||
130260518|NCT00718315|468921375|FG002|Overall Study|Lost to Follow-up|4|||
130260519|NCT00718315|468921373|FG000|Overall Study|Protocol Violation|5|||
130260520|NCT00718315|468921374|FG001|Overall Study|Protocol Violation|5|||
130260521|NCT00718315|468921375|FG002|Overall Study|Protocol Violation|3|||
130260522|NCT00718315|468921373|FG000|Overall Study|Erlotinib dose decreased|4|||
130260523|NCT00718315|468921374|FG001|Overall Study|Erlotinib dose decreased|3|||
130260524|NCT00718315|468921375|FG002|Overall Study|Erlotinib dose decreased|1|||
130260525|NCT00718315|468921373|FG000|Overall Study|Use of Minocyclin|1|||
130260526|NCT00718315|468921374|FG001|Overall Study|Use of Minocyclin|1|||
130260527|NCT00718315|468921375|FG002|Overall Study|Use of Minocyclin|1|||
130260528|NCT00718315|468921373|FG000|Overall Study|Disease progression|0|||
130260529|NCT00718315|468921374|FG001|Overall Study|Disease progression|1|||
130260530|NCT00718315|468921375|FG002|Overall Study|Disease progression|1|||
130260531|NCT00718315|468921373|FG000|Overall Study|Other|0|||
130260532|NCT00718315|468921374|FG001|Overall Study|Other|0|||
130260533|NCT00718315|468921375|FG002|Overall Study|Other|1|||
130260534|NCT00718315|468921373|FG000|Overall Study|Use of ATB and Corticoids|0|||
130260535|NCT00718315|468921374|FG001|Overall Study|Use of ATB and Corticoids|1|||
130260536|NCT00718315|468921375|FG002|Overall Study|Use of ATB and Corticoids|2|||
130260537|NCT02006927|468921378|FG000|Overall Study|Adverse Event|2|||
130260538|NCT02006927|468921378|FG000|Overall Study|Withdrawal by Subject|1|||
130260539|NCT02746809|468921383|FG000|Enrollment|Inclusion Exclusion not met|9|||
130260540|NCT02746809|468921383|FG000|Enrollment|Withdrawal by Subject|1|||
130260541|NCT02746809|468921383|FG000|Enrollment|Expected Enrollment Met|2|||
130260542|NCT02746809|468921383|FG000|Procedure|Death|1|||
130260543|NCT02746809|468921383|FG000|1-Month|Death|5|||
130260544|NCT02746809|468921383|FG000|6-Month|Death|2|||
130260545|NCT02746809|468921383|FG000|6-Month|Withdrawal by Subject|1|||
130260546|NCT02746809|468921383|FG000|12-Month|Death|3|||
130260547|NCT02746809|468921383|FG000|12-Month|Withdrawal by Subject|2|||
130260548|NCT02746809|468921383|FG000|24-Month|Death|1|||
130260549|NCT02746809|468921383|FG000|24-Month|Withdrawal by Subject|1|||
130260550|NCT02746809|468921383|FG000|36-Month|Death|8|||
130260551|NCT02746809|468921383|FG000|36-Month|Withdrawal by Subject|1|||
130260552|NCT02746809|468921383|FG000|48-Month|Death|7|||
130260553|NCT02746809|468921383|FG000|48-Month|Withdrawal by Subject|1|||
130260554|NCT02746809|468921383|FG000|60-Month|Death|1|||
130260555|NCT02746809|468921383|FG000|60-Month|Lost to Follow-up|2|||
130260556|NCT00673920|468921384|FG000|Baseline up to Week 48|Withdrew consent|1|||
130260557|NCT00673920|468921385|FG001|Baseline up to Week 48|Withdrew consent|0|||
130260558|NCT00673920|468921386|FG002|Baseline up to Week 48|Withdrew consent|2|||
130260559|NCT00673920|468921387|FG003|Baseline up to Week 48|Withdrew consent|0|||
130260560|NCT00673920|468921388|FG004|Baseline up to Week 48|Withdrew consent|0|||
130260561|NCT00673920|468921389|FG005|Baseline up to Week 48|Withdrew consent|0|||
130260562|NCT00673920|468921390|FG006|Baseline up to Week 48|Withdrew consent|0|||
130260563|NCT00673920|468921391|FG007|Baseline up to Week 48|Withdrew consent|0|||
130260564|NCT00673920|468921384|FG000|Baseline up to Week 48|Refused treatment|1|||
130260565|NCT00673920|468921385|FG001|Baseline up to Week 48|Refused treatment|0|||
130260566|NCT00673920|468921386|FG002|Baseline up to Week 48|Refused treatment|0|||
130260567|NCT00673920|468921387|FG003|Baseline up to Week 48|Refused treatment|0|||
130260568|NCT00673920|468921388|FG004|Baseline up to Week 48|Refused treatment|0|||
130260569|NCT00673920|468921389|FG005|Baseline up to Week 48|Refused treatment|0|||
130260570|NCT00673920|468921390|FG006|Baseline up to Week 48|Refused treatment|0|||
130260571|NCT00673920|468921391|FG007|Baseline up to Week 48|Refused treatment|0|||
130260572|NCT00673920|468921384|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
130260573|NCT00673920|468921385|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
130101972|NCT01682681|468330826|FG000|Overall Study|Other|21|||
130260574|NCT00673920|468921386|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260575|NCT00673920|468921387|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260576|NCT00673920|468921388|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260577|NCT00673920|468921389|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260578|NCT00673920|468921390|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260579|NCT00673920|468921391|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
130260580|NCT00673920|468921384|FG000|Baseline up to Week 48|Protocol Violation|0|||
130260581|NCT00673920|468921385|FG001|Baseline up to Week 48|Protocol Violation|0|||
130260582|NCT00673920|468921386|FG002|Baseline up to Week 48|Protocol Violation|1|||
130260583|NCT00673920|468921387|FG003|Baseline up to Week 48|Protocol Violation|0|||
130260584|NCT00673920|468921388|FG004|Baseline up to Week 48|Protocol Violation|0|||
130260585|NCT00673920|468921389|FG005|Baseline up to Week 48|Protocol Violation|0|||
130260586|NCT00673920|468921390|FG006|Baseline up to Week 48|Protocol Violation|0|||
130260587|NCT00673920|468921391|FG007|Baseline up to Week 48|Protocol Violation|0|||
130260588|NCT00673920|468921384|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260589|NCT00673920|468921385|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130034426|NCT02875223|468081171|FG007|Overall Study|Lost to Follow-up|1|||
130034427|NCT02875223|468081172|FG008|Overall Study|Lost to Follow-up|0|||
130034428|NCT02875223|468081173|FG009|Overall Study|Lost to Follow-up|0|||
130034429|NCT02875223|468081174|FG010|Overall Study|Lost to Follow-up|0|||
130034430|NCT02875223|468081175|FG011|Overall Study|Lost to Follow-up|0|||
130034431|NCT02875223|468081176|FG012|Overall Study|Lost to Follow-up|0|||
130034432|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
130034433|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
130034434|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
130034435|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
130034436|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
130034437|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
130034438|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
130034439|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
130034440|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
130034441|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
130034442|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
130034443|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
130034444|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
130034445|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
130034446|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
130034447|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
130034448|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
130034449|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
130260590|NCT00673920|468921386|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
130260591|NCT00673920|468921387|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260592|NCT00673920|468921388|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260593|NCT00673920|468921389|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260594|NCT00673920|468921390|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260595|NCT00673920|468921391|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
130260596|NCT00673920|468921384|FG000|Baseline up to Week 48|Administrative/Other|0|||
130260597|NCT00673920|468921385|FG001|Baseline up to Week 48|Administrative/Other|1|||
130260598|NCT00673920|468921386|FG002|Baseline up to Week 48|Administrative/Other|2|||
130260599|NCT00673920|468921387|FG003|Baseline up to Week 48|Administrative/Other|0|||
130260600|NCT00673920|468921388|FG004|Baseline up to Week 48|Administrative/Other|0|||
130260601|NCT00673920|468921389|FG005|Baseline up to Week 48|Administrative/Other|0|||
130260602|NCT00673920|468921390|FG006|Baseline up to Week 48|Administrative/Other|0|||
130260603|NCT00673920|468921391|FG007|Baseline up to Week 48|Administrative/Other|0|||
130260604|NCT00673920|468921384|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260605|NCT00673920|468921385|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
130260606|NCT00673920|468921386|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
130260607|NCT00673920|468921387|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260608|NCT00673920|468921388|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260609|NCT00673920|468921389|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260610|NCT00673920|468921390|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260611|NCT00673920|468921391|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
130260612|NCT00673920|468921384|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260613|NCT00673920|468921385|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260614|NCT00673920|468921386|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260615|NCT00673920|468921387|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260616|NCT00673920|468921388|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260617|NCT00673920|468921389|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260618|NCT00673920|468921390|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
130260619|NCT00673920|468921391|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
130260620|NCT00673920|468921384|FG000|Week 24 to Week 48|Failure to return|0|||
130034450|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
130034451|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130034452|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130034453|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130034454|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130034455|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
130034456|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
130034457|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
130034458|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
130034459|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
130260621|NCT00673920|468921385|FG001|Week 24 to Week 48|Failure to return|0|||
130260622|NCT00673920|468921386|FG002|Week 24 to Week 48|Failure to return|0|||
130260623|NCT00673920|468921387|FG003|Week 24 to Week 48|Failure to return|0|||
130260624|NCT00673920|468921388|FG004|Week 24 to Week 48|Failure to return|0|||
130260625|NCT00673920|468921389|FG005|Week 24 to Week 48|Failure to return|1|||
130260626|NCT00673920|468921390|FG006|Week 24 to Week 48|Failure to return|0|||
130260627|NCT00673920|468921391|FG007|Week 24 to Week 48|Failure to return|0|||
130260628|NCT00673920|468921384|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260629|NCT00673920|468921385|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260630|NCT00673920|468921386|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260631|NCT00673920|468921387|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260632|NCT00673920|468921388|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260633|NCT00673920|468921389|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
130260634|NCT00673920|468921390|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260635|NCT00673920|468921391|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
130260636|NCT00673920|468921384|FG000|Week 24 to Week 48|Death|0|||
130260637|NCT00673920|468921385|FG001|Week 24 to Week 48|Death|0|||
130260638|NCT00673920|468921386|FG002|Week 24 to Week 48|Death|0|||
130260639|NCT00673920|468921387|FG003|Week 24 to Week 48|Death|0|||
130260640|NCT00673920|468921388|FG004|Week 24 to Week 48|Death|0|||
130260641|NCT00673920|468921389|FG005|Week 24 to Week 48|Death|1|||
130260642|NCT00673920|468921390|FG006|Week 24 to Week 48|Death|0|||
130260643|NCT00673920|468921391|FG007|Week 24 to Week 48|Death|0|||
130260644|NCT00673920|468921384|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
130260645|NCT00673920|468921385|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
130260646|NCT00673920|468921386|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
130260647|NCT00673920|468921387|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
130260648|NCT00673920|468921388|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
130260649|NCT00673920|468921389|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
130260650|NCT00673920|468921390|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
130260651|NCT00673920|468921391|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
130260652|NCT01164007|468921394|FG000|Overall Study|Adverse Event|5|||
130260653|NCT01164007|468921394|FG000|Overall Study|Progression of Disease|30|||
130260654|NCT01164007|468921394|FG000|Overall Study|Protocol Violation|1|||
130260655|NCT01164007|468921394|FG000|Overall Study|Withdrawal by Subject|1|||
130260656|NCT01164007|468921394|FG000|Overall Study|Medical Decision|3|||
130260657|NCT00894387|468921397|FG000|Overall Study|Adverse Event|44|||
130260658|NCT00894387|468921398|FG001|Overall Study|Adverse Event|45|||
130260659|NCT00894387|468921397|FG000|Overall Study|Abnormal Laboratory values|2|||
130260660|NCT00894387|468921398|FG001|Overall Study|Abnormal Laboratory values|2|||
130260661|NCT00894387|468921397|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130260662|NCT00894387|468921398|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130260663|NCT00894387|468921397|FG000|Overall Study|Lost to Follow-up|3|||
130260664|NCT00894387|468921398|FG001|Overall Study|Lost to Follow-up|5|||
130260665|NCT00894387|468921397|FG000|Overall Study|Administrative problems|2|||
130260666|NCT00894387|468921398|FG001|Overall Study|Administrative problems|2|||
130260667|NCT00894387|468921397|FG000|Overall Study|Death|77|||
130260668|NCT00894387|468921398|FG001|Overall Study|Death|76|||
130260669|NCT00894387|468921397|FG000|Overall Study|Protocol Deviation|4|||
130034460|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
130034461|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
130260670|NCT00894387|468921398|FG001|Overall Study|Protocol Deviation|0|||
130260671|NCT00894387|468921397|FG000|Overall Study|Patient's request|25|||
130260672|NCT00894387|468921398|FG001|Overall Study|Patient's request|30|||
130260673|NCT00894387|468921397|FG000|Overall Study|Other (Missing)|5|||
130260674|NCT00894387|468921398|FG001|Overall Study|Other (Missing)|3|||
130260675|NCT00894387|468921397|FG000|Overall Study|Mis-randomized|13|||
130034462|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
130034463|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
130034464|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
130034465|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
130034466|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
130034467|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
130034468|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
130034469|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
130034470|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
130034471|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
130034472|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
130034473|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
130034474|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
130034475|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
130034476|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
130260676|NCT00894387|468921398|FG001|Overall Study|Mis-randomized|9|||
130260677|NCT00894387|468921397|FG000|Overall Study|GCP non-compliance|0|||
130260678|NCT00894387|468921398|FG001|Overall Study|GCP non-compliance|2|||
130260679|NCT04856527|468921399|FG000|Overall Study|Unable to complete experimental task|2|||
130260680|NCT04856527|468921400|FG001|Overall Study|Unable to complete experimental task|0|||
130260681|NCT01816295|468921401|FG000|Double Blind Phase|Adverse Event|11|||
130260682|NCT01816295|468921402|FG001|Double Blind Phase|Adverse Event|8|||
130260683|NCT01816295|468921401|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
130260684|NCT01816295|468921402|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
130260685|NCT01816295|468921401|FG000|Double Blind Phase|Lost to Follow-up|3|||
130260686|NCT01816295|468921402|FG001|Double Blind Phase|Lost to Follow-up|5|||
130260687|NCT01816295|468921401|FG000|Double Blind Phase|Physician Decision|2|||
130260688|NCT01816295|468921402|FG001|Double Blind Phase|Physician Decision|2|||
130260689|NCT01816295|468921401|FG000|Double Blind Phase|Protocol Violation|17|||
130034477|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130034478|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130034479|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
130034480|NCT01707992|468081179|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
130034481|NCT01707992|468081180|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
130034482|NCT01707992|468081181|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
130034483|NCT01707992|468081182|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
130034484|NCT01707992|468081183|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
130034485|NCT01707992|468081184|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
130034486|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
130034487|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
130034488|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
130034489|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
130034490|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
130034491|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
130034492|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
130034493|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
130034494|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
130034495|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
130260690|NCT01816295|468921402|FG001|Double Blind Phase|Protocol Violation|11|||
130260691|NCT01816295|468921401|FG000|Double Blind Phase|Sponsor Decision|8|||
130260692|NCT01816295|468921402|FG001|Double Blind Phase|Sponsor Decision|8|||
130260693|NCT01816295|468921401|FG000|Double Blind Phase|Withdrawal by Subject|22|||
130260694|NCT01816295|468921402|FG001|Double Blind Phase|Withdrawal by Subject|20|||
130260695|NCT01816295|468921401|FG000|OLE Phase|Adverse Event|17|||
130260696|NCT01816295|468921402|FG001|OLE Phase|Adverse Event|15|||
130260697|NCT01816295|468921401|FG000|OLE Phase|Death|1|||
130260698|NCT01816295|468921402|FG001|OLE Phase|Death|0|||
130260699|NCT01816295|468921401|FG000|OLE Phase|Entry Criteria Not Met|3|||
130260700|NCT01816295|468921402|FG001|OLE Phase|Entry Criteria Not Met|5|||
130260701|NCT01816295|468921401|FG000|OLE Phase|Lost to Follow-up|5|||
130260702|NCT01816295|468921402|FG001|OLE Phase|Lost to Follow-up|5|||
130260703|NCT01816295|468921401|FG000|OLE Phase|Physician Decision|3|||
130260704|NCT01816295|468921402|FG001|OLE Phase|Physician Decision|1|||
130260705|NCT01816295|468921401|FG000|OLE Phase|Protocol Violation|4|||
130260706|NCT01816295|468921402|FG001|OLE Phase|Protocol Violation|4|||
130260707|NCT01816295|468921401|FG000|OLE Phase|Sponsor Decision|7|||
130260708|NCT01816295|468921402|FG001|OLE Phase|Sponsor Decision|9|||
130260709|NCT01816295|468921401|FG000|OLE Phase|Withdrawal by Subject|10|||
130260710|NCT01816295|468921402|FG001|OLE Phase|Withdrawal by Subject|10|||
130260711|NCT01816295|468921401|FG000|OLE Phase|Lack of Efficacy|3|||
130260712|NCT01816295|468921402|FG001|OLE Phase|Lack of Efficacy|7|||
130260713|NCT04165824|468921403|FG000|Overall Study|Adverse Event|23|||
130260714|NCT04165824|468921403|FG000|Overall Study|Physician Decision|1|||
130260715|NCT04165824|468921403|FG000|Overall Study|Withdrawal by Subject|17|||
130260716|NCT04165824|468921403|FG000|Overall Study|Other|5|||
130260717|NCT05200845|468921410|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
130260718|NCT05200845|468921411|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
130260719|NCT05200845|468921412|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
130260720|NCT05200845|468921413|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
130260721|NCT05200845|468921410|FG000|Overall Study|Withdrawal by Subject|0|||
130260722|NCT05200845|468921411|FG001|Overall Study|Withdrawal by Subject|1|||
130260723|NCT05200845|468921412|FG002|Overall Study|Withdrawal by Subject|1|||
130260724|NCT05200845|468921413|FG003|Overall Study|Withdrawal by Subject|0|||
130260725|NCT01911260|468921420|FG000|Supplementation Period|transference or evasion of school|7|||
130034496|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
130034497|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
130034498|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
130034499|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
130260726|NCT01911260|468921421|FG001|Supplementation Period|transference or evasion of school|9|||
130260727|NCT01911260|468921422|FG002|Supplementation Period|transference or evasion of school|7|||
130260728|NCT01911260|468921423|FG003|Supplementation Period|transference or evasion of school|6|||
130260729|NCT01911260|468921420|FG000|Supplementation Period|Adverse Event|2|||
130260730|NCT01911260|468921421|FG001|Supplementation Period|Adverse Event|0|||
130260731|NCT01911260|468921422|FG002|Supplementation Period|Adverse Event|1|||
130260732|NCT01911260|468921423|FG003|Supplementation Period|Adverse Event|0|||
130034500|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
130034501|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
130260733|NCT01911260|468921420|FG000|Supplementation Period|refused to receive supplement|1|||
130034502|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
130034503|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
130034504|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
130034505|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
130034506|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
130034507|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
130034508|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
130034509|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
130034510|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130034511|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130260734|NCT01911260|468921421|FG001|Supplementation Period|refused to receive supplement|0|||
130260735|NCT01911260|468921422|FG002|Supplementation Period|refused to receive supplement|1|||
130260736|NCT01911260|468921423|FG003|Supplementation Period|refused to receive supplement|0|||
130260737|NCT01911260|468921420|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
130260738|NCT01911260|468921421|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
130260739|NCT01911260|468921422|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
130260740|NCT01911260|468921423|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
130260741|NCT01911260|468921420|FG000|Follow-up Period|transference or evasion of school|13|||
130260742|NCT01911260|468921421|FG001|Follow-up Period|transference or evasion of school|20|||
130260743|NCT01911260|468921422|FG002|Follow-up Period|transference or evasion of school|15|||
130260744|NCT01911260|468921423|FG003|Follow-up Period|transference or evasion of school|12|||
130260745|NCT01242514|468921432|FG000|Overall Study|e.g., project closure|1042|||
130260746|NCT01242514|468921433|FG001|Overall Study|e.g., project closure|305|||
130260747|NCT01242514|468921434|FG002|Overall Study|e.g., project closure|171|||
130260748|NCT01242514|468921432|FG000|Overall Study|Subject decision|33|||
130260749|NCT01242514|468921433|FG001|Overall Study|Subject decision|8|||
130034512|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
130034513|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
130101973|NCT01682681|468330826|FG000|Overall Study|Low compliance|13|||
130101974|NCT00975000|468330827|FG000|Overall Study|Other|1|||
130101975|NCT00975000|468330828|FG001|Overall Study|Other|0|||
130101976|NCT00975000|468330827|FG000|Overall Study|Adverse Event|1|||
130101977|NCT00975000|468330828|FG001|Overall Study|Adverse Event|1|||
130101978|NCT00975000|468330827|FG000|Overall Study|Withdrawal by Subject|2|||
130101979|NCT00975000|468330828|FG001|Overall Study|Withdrawal by Subject|2|||
130101980|NCT00975000|468330827|FG000|Overall Study|Lost to Follow-up|0|||
130101981|NCT00975000|468330828|FG001|Overall Study|Lost to Follow-up|1|||
130101982|NCT00975000|468330827|FG000|Overall Study|Protocol-specified Criteria|1|||
130101983|NCT00975000|468330828|FG001|Overall Study|Protocol-specified Criteria|0|||
130101984|NCT00975000|468330827|FG000|Overall Study|Non-compliance|0|||
130101985|NCT00975000|468330828|FG001|Overall Study|Non-compliance|1|||
130101986|NCT01126359|468330829|FG000|First Intervention (20-minutes)|Physician Decision|0|||
130101987|NCT01126359|468330830|FG001|First Intervention (20-minutes)|Physician Decision|1|||
130101988|NCT00902486|468330831|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
130101989|NCT00902486|468330832|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
130101990|NCT00902486|468330833|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
130101991|NCT00902486|468330834|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
130101992|NCT00902486|468330835|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
130101993|NCT00902486|468330836|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
130101994|NCT00902486|468330831|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
130101995|NCT00902486|468330832|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130260750|NCT01242514|468921434|FG002|Overall Study|Subject decision|2|||
130260751|NCT01242514|468921432|FG000|Overall Study|Severe non-compliance to protocol|5|||
130260752|NCT01242514|468921433|FG001|Overall Study|Severe non-compliance to protocol|2|||
130260753|NCT01242514|468921434|FG002|Overall Study|Severe non-compliance to protocol|1|||
130260754|NCT01242514|468921432|FG000|Overall Study|Lack of therapeutic response|99|||
130034514|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
130101996|NCT00902486|468330833|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130101997|NCT00902486|468330834|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130101998|NCT00902486|468330835|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
130101999|NCT00902486|468330836|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
130260755|NCT01242514|468921433|FG001|Overall Study|Lack of therapeutic response|16|||
130260756|NCT01242514|468921434|FG002|Overall Study|Lack of therapeutic response|10|||
130260757|NCT01242514|468921432|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
130260758|NCT01242514|468921433|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
130260759|NCT01242514|468921434|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
130260760|NCT01242514|468921432|FG000|Overall Study|Lost to Follow-up|14|||
130260761|NCT01242514|468921433|FG001|Overall Study|Lost to Follow-up|5|||
130260762|NCT01242514|468921434|FG002|Overall Study|Lost to Follow-up|4|||
130260763|NCT01242514|468921432|FG000|Overall Study|Adverse Event|129|||
130260764|NCT01242514|468921433|FG001|Overall Study|Adverse Event|18|||
130260765|NCT01242514|468921434|FG002|Overall Study|Adverse Event|19|||
130260766|NCT04079738|468921448|FG000|Study Treatment|Death|1|||
130260767|NCT04079738|468921449|FG001|Study Treatment|Death|0|||
130260768|NCT04079738|468921450|FG002|Study Treatment|Death|0|||
130260769|NCT04079738|468921451|FG003|Study Treatment|Death|0|||
130260770|NCT04079738|468921448|FG000|Study Treatment|Adverse Event|2|||
130102000|NCT00902486|468330831|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130102001|NCT00902486|468330832|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130102002|NCT00902486|468330833|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130102003|NCT00902486|468330834|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
130102004|NCT00902486|468330835|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
130102005|NCT00902486|468330836|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
130102006|NCT00902486|468330831|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130102007|NCT00902486|468330832|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130102008|NCT00902486|468330833|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130102009|NCT00902486|468330834|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
130102010|NCT00902486|468330835|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130102011|NCT00902486|468330836|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
130102012|NCT00902486|468330831|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130102013|NCT00902486|468330832|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130102014|NCT00902486|468330833|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130102015|NCT00902486|468330834|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
130102016|NCT00902486|468330835|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130102017|NCT00902486|468330836|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
130102018|NCT00902486|468330831|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130102019|NCT00902486|468330832|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130102020|NCT00902486|468330833|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130102021|NCT00902486|468330834|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
130102022|NCT00902486|468330835|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
130102023|NCT00902486|468330836|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
130102024|NCT00902486|468330831|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130102025|NCT00902486|468330832|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130102026|NCT00902486|468330833|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
130102027|NCT00902486|468330834|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
130102028|NCT00902486|468330835|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130102029|NCT00902486|468330836|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
130102030|NCT00902486|468330831|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130102031|NCT00902486|468330832|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130102032|NCT00902486|468330833|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130102033|NCT00902486|468330834|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130102034|NCT00902486|468330835|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
130102035|NCT00902486|468330836|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
130102036|NCT00902486|468330831|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130102037|NCT00902486|468330832|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130102038|NCT00902486|468330833|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130102039|NCT00902486|468330834|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
130102040|NCT00902486|468330835|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130102041|NCT00902486|468330836|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
130102042|NCT00902486|468330831|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130102043|NCT00902486|468330832|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130260771|NCT04079738|468921449|FG001|Study Treatment|Adverse Event|0|||
130260772|NCT04079738|468921450|FG002|Study Treatment|Adverse Event|0|||
130260773|NCT04079738|468921451|FG003|Study Treatment|Adverse Event|0|||
130260774|NCT04079738|468921448|FG000|Study Treatment|withdrawal before treatment|1|||
130260775|NCT04079738|468921449|FG001|Study Treatment|withdrawal before treatment|0|||
130260776|NCT04079738|468921450|FG002|Study Treatment|withdrawal before treatment|0|||
130102044|NCT00902486|468330833|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
130102045|NCT00902486|468330834|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130102046|NCT00902486|468330835|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130102047|NCT00902486|468330836|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
130102048|NCT00902486|468330831|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
130102049|NCT00902486|468330832|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
130102050|NCT00902486|468330833|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
130102051|NCT00902486|468330834|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
130102052|NCT00902486|468330835|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
130102053|NCT00902486|468330836|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
130102054|NCT02332655|468330837|FG000|Overall Study|Lack of Efficacy|1|||
130102055|NCT01298661|468330838|FG000|Overall Study|Withdrawal by Subject|2|||
130102056|NCT01298661|468330839|FG001|Overall Study|Withdrawal by Subject|0|||
130102057|NCT01298661|468330840|FG002|Overall Study|Withdrawal by Subject|2|||
130102058|NCT00366678|468332611|FG000|Infant Series|Withdrawal by Subject|8|||
130102059|NCT00366678|468332612|FG001|Infant Series|Withdrawal by Subject|6|||
130102060|NCT00366678|468332613|FG002|Infant Series|Withdrawal by Subject|0|||
130102061|NCT00366678|468332611|FG000|Infant Series|Protocol Violation|4|||
130102062|NCT00366678|468332612|FG001|Infant Series|Protocol Violation|3|||
130102063|NCT00366678|468332613|FG002|Infant Series|Protocol Violation|0|||
130102064|NCT00366678|468332611|FG000|Infant Series|Failed to return|1|||
130102065|NCT00366678|468332612|FG001|Infant Series|Failed to return|1|||
130102066|NCT00366678|468332613|FG002|Infant Series|Failed to return|0|||
130102067|NCT00366678|468332611|FG000|Infant Series|Adverse Event|1|||
130102068|NCT00366678|468332612|FG001|Infant Series|Adverse Event|0|||
130102069|NCT00366678|468332613|FG002|Infant Series|Adverse Event|0|||
130102070|NCT00366678|468332611|FG000|After Infant|Withdrawal by Subject|8|||
130102071|NCT00366678|468332612|FG001|After Infant|Withdrawal by Subject|4|||
130102072|NCT00366678|468332613|FG002|After Infant|Withdrawal by Subject|0|||
130102073|NCT00366678|468332611|FG000|After Infant|Lost to Follow-up|2|||
130102074|NCT00366678|468332612|FG001|After Infant|Lost to Follow-up|1|||
130102075|NCT00366678|468332613|FG002|After Infant|Lost to Follow-up|0|||
130102076|NCT00366678|468332611|FG000|After Infant|Failed to return|5|||
130102077|NCT00366678|468332612|FG001|After Infant|Failed to return|5|||
130102078|NCT00366678|468332613|FG002|After Infant|Failed to return|0|||
130102079|NCT00366678|468332611|FG000|After Infant|Adverse Event|1|||
130102080|NCT00366678|468332612|FG001|After Infant|Adverse Event|0|||
130102081|NCT00366678|468332613|FG002|After Infant|Adverse Event|0|||
130102082|NCT00366678|468332611|FG000|After Infant|Protocol Violation|1|||
130102083|NCT00366678|468332612|FG001|After Infant|Protocol Violation|0|||
130102084|NCT00366678|468332613|FG002|After Infant|Protocol Violation|0|||
130102085|NCT00366678|468332611|FG000|Toddler Dose|Protocol Violation|2|||
130102086|NCT00366678|468332612|FG001|Toddler Dose|Protocol Violation|1|||
130102087|NCT00366678|468332613|FG002|Toddler Dose|Protocol Violation|0|||
130102088|NCT00366678|468332611|FG000|Toddler Dose|Failed to return|1|||
130260777|NCT04079738|468921451|FG003|Study Treatment|withdrawal before treatment|0|||
130260778|NCT04079738|468921448|FG000|Study Treatment|symptomatic deterioration|2|||
130260779|NCT04079738|468921449|FG001|Study Treatment|symptomatic deterioration|0|||
130260780|NCT04079738|468921450|FG002|Study Treatment|symptomatic deterioration|0|||
130260781|NCT04079738|468921451|FG003|Study Treatment|symptomatic deterioration|0|||
130260782|NCT04079738|468921448|FG000|Study Treatment|Disease Progression|1|||
130260783|NCT04079738|468921449|FG001|Study Treatment|Disease Progression|0|||
130260784|NCT04079738|468921450|FG002|Study Treatment|Disease Progression|0|||
130260785|NCT04079738|468921451|FG003|Study Treatment|Disease Progression|0|||
130260786|NCT04079738|468921448|FG000|Study Treatment|withdrawal after treatment|1|||
130260787|NCT04079738|468921449|FG001|Study Treatment|withdrawal after treatment|0|||
130260788|NCT04079738|468921450|FG002|Study Treatment|withdrawal after treatment|0|||
130260789|NCT04079738|468921451|FG003|Study Treatment|withdrawal after treatment|0|||
130260790|NCT04079738|468921448|FG000|Follow up|Withdrawal by Subject|3|||
130260791|NCT04079738|468921449|FG001|Follow up|Withdrawal by Subject|0|||
130260792|NCT04079738|468921450|FG002|Follow up|Withdrawal by Subject|0|||
130260793|NCT04079738|468921451|FG003|Follow up|Withdrawal by Subject|0|||
130260794|NCT04079738|468921448|FG000|Follow up|Death|5|||
130260795|NCT04079738|468921449|FG001|Follow up|Death|0|||
130102089|NCT00366678|468332612|FG001|Toddler Dose|Failed to return|0|||
130102090|NCT00366678|468332613|FG002|Toddler Dose|Failed to return|0|||
130102091|NCT00366678|468332611|FG000|Toddler Dose|Withdrawal by Subject|1|||
130102092|NCT00366678|468332612|FG001|Toddler Dose|Withdrawal by Subject|0|||
130102093|NCT00366678|468332613|FG002|Toddler Dose|Withdrawal by Subject|0|||
130102094|NCT00366678|468332611|FG000|Toddler Dose|protocol deviation|1|||
130102095|NCT00366678|468332612|FG001|Toddler Dose|protocol deviation|0|||
130260796|NCT04079738|468921450|FG002|Follow up|Death|0|||
130102096|NCT00366678|468332613|FG002|Toddler Dose|protocol deviation|0|||
130102097|NCT04292171|468332614|FG000|Overall Study|Pharmacy error|2|||
130102098|NCT04292171|468332615|FG001|Overall Study|Pharmacy error|0|||
130260797|NCT04079738|468921451|FG003|Follow up|Death|0|||
130260798|NCT00789555|468921452|FG000|Overall Study|Protocol Amendment|78|||
130260799|NCT00789555|468921453|FG001|Overall Study|Protocol Amendment|76|||
130034515|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
130034516|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Death|0|||
130034517|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Death|0|||
130034518|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Death|0|||
130034519|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Death|2|||
130034520|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Death|0|||
130034521|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Death|0|||
130034522|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
130034523|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
130034524|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
130034525|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
130034526|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
130034527|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
130034528|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
130034529|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
130034530|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
130034531|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
130034532|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
130034533|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
130034534|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
130034535|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
130034536|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
130034537|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
130034538|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
130034539|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
130034540|NCT01707992|468081179|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130034541|NCT01707992|468081180|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130034542|NCT01707992|468081181|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130034543|NCT01707992|468081182|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130034544|NCT01707992|468081183|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
130034545|NCT01707992|468081184|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
130034546|NCT02654002|468081188|FG000|Overall Study|Adverse Event|0|||
130034547|NCT02654002|468081189|FG001|Overall Study|Adverse Event|0|||
130102099|NCT04292171|468332614|FG000|Overall Study|Delivered prior to procedure|0|||
130102100|NCT04292171|468332615|FG001|Overall Study|Delivered prior to procedure|1|||
130102101|NCT03976076|468332616|FG000|Overall Study|Withdrawal by Subject|2|||
130260800|NCT00789555|468921454|FG002|Overall Study|Protocol Amendment|80|||
130260801|NCT00789555|468921452|FG000|Overall Study|Adverse Event|17|||
130260802|NCT00789555|468921453|FG001|Overall Study|Adverse Event|7|||
130260803|NCT00789555|468921454|FG002|Overall Study|Adverse Event|10|||
130260804|NCT00789555|468921452|FG000|Overall Study|Lost to Follow-up|9|||
130260805|NCT00789555|468921453|FG001|Overall Study|Lost to Follow-up|10|||
130260806|NCT00789555|468921454|FG002|Overall Study|Lost to Follow-up|18|||
130260807|NCT00789555|468921452|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
130260808|NCT00789555|468921453|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
130260809|NCT00789555|468921454|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
130260810|NCT00789555|468921452|FG000|Overall Study|Treatment failure|11|||
130260811|NCT00789555|468921453|FG001|Overall Study|Treatment failure|8|||
130260812|NCT00789555|468921454|FG002|Overall Study|Treatment failure|12|||
130260813|NCT00789555|468921452|FG000|Overall Study|Protocol Violation|6|||
130260814|NCT00789555|468921453|FG001|Overall Study|Protocol Violation|9|||
130260815|NCT00789555|468921454|FG002|Overall Study|Protocol Violation|13|||
130260816|NCT00404248|468921455|FG000|Overall Study|pts declining status|0|||
130260817|NCT00404248|468921456|FG001|Overall Study|pts declining status|1|||
130260818|NCT00404248|468921457|FG002|Overall Study|pts declining status|0|||
130260819|NCT00404248|468921458|FG003|Overall Study|pts declining status|0|||
130260820|NCT00404248|468921459|FG004|Overall Study|pts declining status|0|||
130260821|NCT00404248|468921460|FG005|Overall Study|pts declining status|0|||
130260822|NCT00404248|468921461|FG006|Overall Study|pts declining status|0|||
130260823|NCT00404248|468921462|FG007|Overall Study|pts declining status|0|||
130260824|NCT00404248|468921463|FG008|Overall Study|pts declining status|0|||
130260825|NCT04646005|468921464|FG000|Overall Study|Adverse Event|1|||
130260826|NCT04646005|468921464|FG000|Overall Study|Progressive Disease|71|||
129885587|NCT02611830|467540769|FG002|OL Induction Phase|Lack of Efficacy|0|||
130034548|NCT02654002|468081190|FG002|Overall Study|Adverse Event|0|||
130034549|NCT02654002|468081191|FG003|Overall Study|Adverse Event|0|||
130034550|NCT02654002|468081192|FG004|Overall Study|Adverse Event|0|||
130034551|NCT02654002|468081193|FG005|Overall Study|Adverse Event|0|||
130260827|NCT04646005|468921464|FG000|Overall Study|Death|20|||
130260828|NCT04646005|468921464|FG000|Overall Study|Withdrawal by Subject|12|||
130260829|NCT04646005|468921464|FG000|Overall Study|Sponsor Request|9|||
130260830|NCT04398706|468921465|FG000|Overall Study|Adverse Event|0|||
130260831|NCT04398706|468921466|FG001|Overall Study|Adverse Event|0|||
130260832|NCT04398706|468921467|FG002|Overall Study|Adverse Event|0|||
130260833|NCT04398706|468921468|FG003|Overall Study|Adverse Event|0|||
130260834|NCT04398706|468921469|FG004|Overall Study|Adverse Event|0|||
130260835|NCT04398706|468921470|FG005|Overall Study|Adverse Event|1|||
130260836|NCT04398706|468921471|FG006|Overall Study|Adverse Event|1|||
130260837|NCT04398706|468921472|FG007|Overall Study|Adverse Event|0|||
130034552|NCT02654002|468081194|FG006|Overall Study|Adverse Event|1|||
130034553|NCT02654002|468081195|FG007|Overall Study|Adverse Event|0|||
130034554|NCT02654002|468081196|FG008|Overall Study|Adverse Event|0|||
130034555|NCT02654002|468081188|FG000|Overall Study|Withdrew Consent|0|||
130034556|NCT02654002|468081189|FG001|Overall Study|Withdrew Consent|0|||
130034557|NCT02654002|468081190|FG002|Overall Study|Withdrew Consent|0|||
130034558|NCT02654002|468081191|FG003|Overall Study|Withdrew Consent|0|||
130034559|NCT02654002|468081192|FG004|Overall Study|Withdrew Consent|0|||
130034560|NCT02654002|468081193|FG005|Overall Study|Withdrew Consent|1|||
130034561|NCT02654002|468081194|FG006|Overall Study|Withdrew Consent|0|||
130034562|NCT02654002|468081195|FG007|Overall Study|Withdrew Consent|1|||
130034563|NCT02654002|468081196|FG008|Overall Study|Withdrew Consent|0|||
130034564|NCT01523873|468081197|FG000|Overall Study|Protocol Violation|422|||
130034565|NCT03313050|468081199|FG000|Stage 2: 12 Months|Adverse Event|0|||
130034566|NCT03313050|468081200|FG001|Stage 2: 12 Months|Adverse Event|0|||
130034567|NCT03313050|468081201|FG002|Stage 2: 12 Months|Adverse Event|0|||
130034568|NCT03313050|468081202|FG003|Stage 2: 12 Months|Adverse Event|1|||
130034569|NCT03313050|468081199|FG000|Stage 2: 12 Months|Death|0|||
130034570|NCT03313050|468081200|FG001|Stage 2: 12 Months|Death|0|||
130034571|NCT03313050|468081201|FG002|Stage 2: 12 Months|Death|3|||
130034572|NCT03313050|468081202|FG003|Stage 2: 12 Months|Death|0|||
130034573|NCT03313050|468081199|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
130034574|NCT03313050|468081200|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
130034575|NCT03313050|468081201|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
130034576|NCT03313050|468081202|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
130034577|NCT03313050|468081199|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
130034578|NCT03313050|468081200|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
130034579|NCT03313050|468081201|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
130260838|NCT04398706|468921465|FG000|Overall Study|Lost to Follow-up|0|||
130260839|NCT04398706|468921466|FG001|Overall Study|Lost to Follow-up|1|||
130260840|NCT04398706|468921467|FG002|Overall Study|Lost to Follow-up|2|||
130260841|NCT04398706|468921468|FG003|Overall Study|Lost to Follow-up|1|||
130260842|NCT04398706|468921469|FG004|Overall Study|Lost to Follow-up|6|||
130034580|NCT03313050|468081202|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
130260843|NCT04398706|468921470|FG005|Overall Study|Lost to Follow-up|3|||
130260844|NCT04398706|468921471|FG006|Overall Study|Lost to Follow-up|8|||
130260845|NCT04398706|468921472|FG007|Overall Study|Lost to Follow-up|2|||
130260846|NCT04398706|468921465|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130260847|NCT04398706|468921466|FG001|Overall Study|Withdrawal by parent/guardian|2|||
130260848|NCT04398706|468921467|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130260849|NCT04398706|468921468|FG003|Overall Study|Withdrawal by parent/guardian|2|||
130260850|NCT04398706|468921469|FG004|Overall Study|Withdrawal by parent/guardian|19|||
130260851|NCT04398706|468921470|FG005|Overall Study|Withdrawal by parent/guardian|23|||
130260852|NCT04398706|468921471|FG006|Overall Study|Withdrawal by parent/guardian|13|||
130260853|NCT04398706|468921472|FG007|Overall Study|Withdrawal by parent/guardian|11|||
130260854|NCT04398706|468921465|FG000|Overall Study|Protocol deviation|0|||
130260855|NCT04398706|468921466|FG001|Overall Study|Protocol deviation|1|||
130260856|NCT04398706|468921467|FG002|Overall Study|Protocol deviation|0|||
130260857|NCT04398706|468921468|FG003|Overall Study|Protocol deviation|0|||
130260858|NCT04398706|468921469|FG004|Overall Study|Protocol deviation|6|||
130260859|NCT04398706|468921470|FG005|Overall Study|Protocol deviation|4|||
130260860|NCT04398706|468921471|FG006|Overall Study|Protocol deviation|6|||
130260861|NCT04398706|468921472|FG007|Overall Study|Protocol deviation|3|||
130260862|NCT04577404|468921473|FG000|Overall Study|Adverse Event|31|||
130260863|NCT04577404|468921473|FG000|Overall Study|Death|1|||
130034581|NCT03313050|468081199|FG000|Stage 2: 12 Months|Protocol deviation|0|||
130034582|NCT03313050|468081200|FG001|Stage 2: 12 Months|Protocol deviation|0|||
130034583|NCT03313050|468081201|FG002|Stage 2: 12 Months|Protocol deviation|7|||
130034584|NCT03313050|468081202|FG003|Stage 2: 12 Months|Protocol deviation|7|||
130034585|NCT03313050|468081199|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
130260864|NCT04577404|468921473|FG000|Overall Study|Lack of Efficacy|3|||
130034586|NCT03313050|468081200|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
130260865|NCT04577404|468921473|FG000|Overall Study|Physician Decision|7|||
130260866|NCT04577404|468921473|FG000|Overall Study|Withdrawal by Subject|21|||
130260867|NCT04577404|468921473|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
130260868|NCT04237584|468921474|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
130260869|NCT04237584|468921475|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
130260870|NCT04237584|468921476|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
130260871|NCT04237584|468921477|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
130260872|NCT04237584|468921474|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130260873|NCT04237584|468921475|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130260874|NCT04237584|468921476|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
130260875|NCT04237584|468921477|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
130260876|NCT04237584|468921474|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130260877|NCT04237584|468921475|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130260878|NCT04237584|468921476|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
130260879|NCT04237584|468921477|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
130260880|NCT04237584|468921474|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
130260881|NCT04237584|468921475|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
130260882|NCT04237584|468921476|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
130260883|NCT04237584|468921477|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
130260884|NCT04237584|468921474|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130260885|NCT04237584|468921475|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130260886|NCT04237584|468921476|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
130260887|NCT04237584|468921477|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
130260888|NCT03586973|468921478|FG000|Overall Study|Death|15|||
130260889|NCT03586973|468921479|FG001|Overall Study|Death|8|||
130260890|NCT03586973|468921478|FG000|Overall Study|Site Terminated by Sponsor|3|||
130260891|NCT03586973|468921479|FG001|Overall Study|Site Terminated by Sponsor|6|||
130260892|NCT03586973|468921478|FG000|Overall Study|Withdrawal by Subject|1|||
130260893|NCT03586973|468921479|FG001|Overall Study|Withdrawal by Subject|0|||
130260894|NCT03586973|468921478|FG000|Overall Study|Lost to Follow-up|1|||
130260895|NCT03586973|468921479|FG001|Overall Study|Lost to Follow-up|0|||
130260896|NCT03423979|468921485|FG000|Overall Study|Death|1|||
130260897|NCT05239221|468921486|FG000|Overall Study|Adverse Event|0|||
130260898|NCT05239221|468921487|FG001|Overall Study|Adverse Event|0|||
130260899|NCT05239221|468921488|FG002|Overall Study|Adverse Event|0|||
130260900|NCT05239221|468921489|FG003|Overall Study|Adverse Event|0|||
130260901|NCT05239221|468921490|FG004|Overall Study|Adverse Event|0|||
130260902|NCT05239221|468921491|FG005|Overall Study|Adverse Event|0|||
130260903|NCT05239221|468921492|FG006|Overall Study|Adverse Event|1|||
130260904|NCT05239221|468921493|FG007|Overall Study|Adverse Event|0|||
130260905|NCT05239221|468921494|FG008|Overall Study|Adverse Event|0|||
130260906|NCT05239221|468921495|FG009|Overall Study|Adverse Event|0|||
130260907|NCT05239221|468921496|FG010|Overall Study|Adverse Event|1|||
130260908|NCT05239221|468921497|FG011|Overall Study|Adverse Event|1|||
130260909|NCT05239221|468921498|FG012|Overall Study|Adverse Event|0|||
130260910|NCT05239221|468921499|FG013|Overall Study|Adverse Event|0|||
130260911|NCT05239221|468921500|FG014|Overall Study|Adverse Event|0|||
130260912|NCT05239221|468921501|FG015|Overall Study|Adverse Event|0|||
130260913|NCT05239221|468921486|FG000|Overall Study|Withdrawal by Subject|0|||
130260914|NCT05239221|468921487|FG001|Overall Study|Withdrawal by Subject|0|||
130260915|NCT05239221|468921488|FG002|Overall Study|Withdrawal by Subject|0|||
130260916|NCT05239221|468921489|FG003|Overall Study|Withdrawal by Subject|0|||
130260917|NCT05239221|468921490|FG004|Overall Study|Withdrawal by Subject|0|||
130260918|NCT05239221|468921491|FG005|Overall Study|Withdrawal by Subject|0|||
130260919|NCT05239221|468921492|FG006|Overall Study|Withdrawal by Subject|0|||
130260920|NCT05239221|468921493|FG007|Overall Study|Withdrawal by Subject|0|||
130260921|NCT05239221|468921494|FG008|Overall Study|Withdrawal by Subject|0|||
130260922|NCT05239221|468921495|FG009|Overall Study|Withdrawal by Subject|0|||
130260923|NCT05239221|468921496|FG010|Overall Study|Withdrawal by Subject|1|||
130260924|NCT05239221|468921497|FG011|Overall Study|Withdrawal by Subject|0|||
130260925|NCT05239221|468921498|FG012|Overall Study|Withdrawal by Subject|0|||
130260926|NCT05239221|468921499|FG013|Overall Study|Withdrawal by Subject|0|||
130260927|NCT05239221|468921500|FG014|Overall Study|Withdrawal by Subject|0|||
130260928|NCT05239221|468921501|FG015|Overall Study|Withdrawal by Subject|1|||
130260929|NCT00805389|468922902|FG000|Overall Study|Adverse Event|0|||
130260930|NCT00805389|468922903|FG001|Overall Study|Adverse Event|0|||
130260931|NCT00805389|468922904|FG002|Overall Study|Adverse Event|1|||
130260932|NCT00805389|468922905|FG003|Overall Study|Adverse Event|2|||
130260933|NCT00805389|468922906|FG004|Overall Study|Adverse Event|0|||
130260934|NCT00805389|468922902|FG000|Overall Study|Lost to Follow-up|4|||
130260935|NCT00805389|468922903|FG001|Overall Study|Lost to Follow-up|3|||
129885588|NCT02611830|467540770|FG003|OL Induction Phase|Lack of Efficacy|0|||
129885589|NCT02611830|467540767|FG000|OL Induction Phase|Reason not specified|3|||
130260936|NCT00805389|468922904|FG002|Overall Study|Lost to Follow-up|6|||
130260937|NCT00805389|468922905|FG003|Overall Study|Lost to Follow-up|10|||
130260938|NCT00805389|468922906|FG004|Overall Study|Lost to Follow-up|9|||
130260939|NCT00805389|468922902|FG000|Overall Study|Protocol Violation|0|||
130260940|NCT00805389|468922903|FG001|Overall Study|Protocol Violation|0|||
130260941|NCT00805389|468922904|FG002|Overall Study|Protocol Violation|1|||
130260942|NCT00805389|468922905|FG003|Overall Study|Protocol Violation|0|||
130034587|NCT03313050|468081201|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
130034588|NCT03313050|468081202|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
130034589|NCT03313050|468081199|FG000|Stage 2: 12 Months|Other|0|||
130034590|NCT03313050|468081200|FG001|Stage 2: 12 Months|Other|0|||
130260943|NCT00805389|468922906|FG004|Overall Study|Protocol Violation|0|||
130260944|NCT00805389|468922902|FG000|Overall Study|Withdrawal by Subject|3|||
130260945|NCT00805389|468922903|FG001|Overall Study|Withdrawal by Subject|2|||
130260946|NCT00805389|468922904|FG002|Overall Study|Withdrawal by Subject|4|||
130260947|NCT00805389|468922905|FG003|Overall Study|Withdrawal by Subject|5|||
130260948|NCT00805389|468922906|FG004|Overall Study|Withdrawal by Subject|4|||
130260949|NCT02239926|468922909|FG000|Overall Study|Withdrawal by Subject|0|||
130260950|NCT02239926|468922910|FG001|Overall Study|Withdrawal by Subject|1|||
130260951|NCT03983421|468922913|FG000|Overall Study|Lost to Follow-up|1|||
130260952|NCT02724839|468922916|FG000|Overall Study|Withdrawal by Subject|1|||
130260953|NCT02724839|468922917|FG001|Overall Study|Withdrawal by Subject|1|||
130260954|NCT02724839|468922918|FG002|Overall Study|Withdrawal by Subject|0|||
130260955|NCT02724839|468922916|FG000|Overall Study|Lost to Follow-up|0|||
130260956|NCT02724839|468922917|FG001|Overall Study|Lost to Follow-up|3|||
130260957|NCT02724839|468922918|FG002|Overall Study|Lost to Follow-up|2|||
130260958|NCT02724839|468922916|FG000|Overall Study|Physician Decision|0|||
130260959|NCT02724839|468922917|FG001|Overall Study|Physician Decision|0|||
130260960|NCT02724839|468922918|FG002|Overall Study|Physician Decision|3|||
130260961|NCT00557193|468922919|FG000|Induction|Adverse Event|2|||
130260962|NCT00557193|468922920|FG001|Induction|Adverse Event|0|||
130260963|NCT00557193|468922921|FG002|Induction|Adverse Event|0|||
130260964|NCT00557193|468922922|FG003|Induction|Adverse Event|0|||
130260965|NCT00557193|468922923|FG004|Induction|Adverse Event|0|||
130260966|NCT00557193|468922924|FG005|Induction|Adverse Event|0|||
130034591|NCT03313050|468081201|FG002|Stage 2: 12 Months|Other|0|||
130034592|NCT03313050|468081202|FG003|Stage 2: 12 Months|Other|1|||
130260967|NCT00557193|468922919|FG000|Induction|Death|6|||
130260968|NCT00557193|468922920|FG001|Induction|Death|0|||
130034593|NCT04211337|468081203|FG000|Overall Study|On Treatment|175|||
130034594|NCT04211337|468081204|FG001|Overall Study|On Treatment|40|||
130034595|NCT04211337|468081203|FG000|Overall Study|Withdrawal by Subject|0|||
130034596|NCT04211337|468081204|FG001|Overall Study|Withdrawal by Subject|2|||
130034597|NCT02847598|468081215|FG000|Overall Study|Adverse Event|0|||
130034598|NCT02847598|468081216|FG001|Overall Study|Adverse Event|0|||
130034599|NCT02847598|468081217|FG002|Overall Study|Adverse Event|0|||
130034600|NCT02847598|468081218|FG003|Overall Study|Adverse Event|0|||
130034601|NCT02847598|468081219|FG004|Overall Study|Adverse Event|0|||
130034602|NCT02847598|468081220|FG005|Overall Study|Adverse Event|0|||
130034603|NCT02847598|468081221|FG006|Overall Study|Adverse Event|0|||
130034604|NCT02847598|468081222|FG007|Overall Study|Adverse Event|1|||
130034605|NCT02847598|468081215|FG000|Overall Study|Consent withdrawn|2|||
130034606|NCT02847598|468081216|FG001|Overall Study|Consent withdrawn|0|||
130102102|NCT03292731|468332617|FG000|Overall Study|Protocol Violation|4|||
130260969|NCT00557193|468922921|FG002|Induction|Death|0|||
130260970|NCT00557193|468922922|FG003|Induction|Death|0|||
130260971|NCT00557193|468922923|FG004|Induction|Death|0|||
130260972|NCT00557193|468922924|FG005|Induction|Death|0|||
130260973|NCT00557193|468922919|FG000|Induction|Physician Decision|3|||
130034607|NCT02847598|468081217|FG002|Overall Study|Consent withdrawn|0|||
130034608|NCT02847598|468081218|FG003|Overall Study|Consent withdrawn|4|||
130260974|NCT00557193|468922920|FG001|Induction|Physician Decision|0|||
130260975|NCT00557193|468922921|FG002|Induction|Physician Decision|0|||
130260976|NCT00557193|468922922|FG003|Induction|Physician Decision|0|||
130260977|NCT00557193|468922923|FG004|Induction|Physician Decision|0|||
130260978|NCT00557193|468922924|FG005|Induction|Physician Decision|0|||
130034609|NCT02847598|468081219|FG004|Overall Study|Consent withdrawn|3|||
130034610|NCT02847598|468081220|FG005|Overall Study|Consent withdrawn|2|||
130034611|NCT02847598|468081221|FG006|Overall Study|Consent withdrawn|1|||
130034612|NCT02847598|468081222|FG007|Overall Study|Consent withdrawn|3|||
130034613|NCT02847598|468081215|FG000|Overall Study|Death|3|||
130260979|NCT00557193|468922919|FG000|Induction|Withdrawal by Subject|1|||
130260980|NCT00557193|468922920|FG001|Induction|Withdrawal by Subject|0|||
130260981|NCT00557193|468922921|FG002|Induction|Withdrawal by Subject|0|||
130260982|NCT00557193|468922922|FG003|Induction|Withdrawal by Subject|0|||
130260983|NCT00557193|468922923|FG004|Induction|Withdrawal by Subject|0|||
130260984|NCT00557193|468922924|FG005|Induction|Withdrawal by Subject|0|||
130260985|NCT00557193|468922919|FG000|Induction|Refusal of Further Protocol Therapy|2|||
130260986|NCT00557193|468922920|FG001|Induction|Refusal of Further Protocol Therapy|0|||
130260987|NCT00557193|468922921|FG002|Induction|Refusal of Further Protocol Therapy|0|||
130260988|NCT00557193|468922922|FG003|Induction|Refusal of Further Protocol Therapy|0|||
130260989|NCT00557193|468922923|FG004|Induction|Refusal of Further Protocol Therapy|0|||
130260990|NCT00557193|468922924|FG005|Induction|Refusal of Further Protocol Therapy|0|||
130260991|NCT00557193|468922919|FG000|Induction|Ineligible|8|||
130260992|NCT00557193|468922920|FG001|Induction|Ineligible|0|||
130260993|NCT00557193|468922921|FG002|Induction|Ineligible|0|||
130102103|NCT03292731|468332618|FG001|Overall Study|Protocol Violation|11|||
130102104|NCT03292731|468332619|FG002|Overall Study|Protocol Violation|1|||
130102105|NCT01965431|468332620|FG000|Overall Study|Adverse Event|0|||
130102106|NCT01965431|468332621|FG001|Overall Study|Adverse Event|1|||
130102107|NCT01965431|468332622|FG002|Overall Study|Adverse Event|0|||
130102108|NCT01965431|468332623|FG003|Overall Study|Adverse Event|0|||
130102109|NCT01965431|468332624|FG004|Overall Study|Adverse Event|0|||
130102110|NCT01965431|468332625|FG005|Overall Study|Adverse Event|0|||
130102111|NCT01965431|468332620|FG000|Overall Study|Other than stated above|6|||
130102112|NCT01965431|468332621|FG001|Overall Study|Other than stated above|5|||
130102113|NCT01965431|468332622|FG002|Overall Study|Other than stated above|6|||
130102114|NCT01965431|468332623|FG003|Overall Study|Other than stated above|6|||
130102115|NCT01965431|468332624|FG004|Overall Study|Other than stated above|6|||
130102116|NCT01965431|468332625|FG005|Overall Study|Other than stated above|6|||
130102117|NCT01803464|468332630|FG000|Overall Study|Incomplete data|0|||
130102118|NCT01803464|468332631|FG001|Overall Study|Incomplete data|0|||
130102119|NCT01803464|468332632|FG002|Overall Study|Incomplete data|4|||
130102120|NCT01803464|468332633|FG003|Overall Study|Incomplete data|0|||
130102121|NCT01803464|468332630|FG000|Overall Study|Withdrawal by Subject|1|||
130102122|NCT01803464|468332631|FG001|Overall Study|Withdrawal by Subject|0|||
130102123|NCT01803464|468332632|FG002|Overall Study|Withdrawal by Subject|0|||
130102124|NCT01803464|468332633|FG003|Overall Study|Withdrawal by Subject|0|||
130102125|NCT02860039|468332639|FG000|Overall Study|Death|4|||
130102126|NCT02860039|468332640|FG001|Overall Study|Death|0|||
130102127|NCT02860039|468332639|FG000|Overall Study|Lost to Follow-up|2|||
130102128|NCT02860039|468332640|FG001|Overall Study|Lost to Follow-up|2|||
130102129|NCT02860039|468332639|FG000|Overall Study|Protocol Violation|3|||
130102130|NCT02860039|468332640|FG001|Overall Study|Protocol Violation|1|||
130102131|NCT02860039|468332639|FG000|Overall Study|Withdrawal by Subject|1|||
130102132|NCT02860039|468332640|FG001|Overall Study|Withdrawal by Subject|0|||
130102133|NCT02860039|468332639|FG000|Overall Study|Not otherwise eligible|1|||
130102134|NCT02860039|468332640|FG001|Overall Study|Not otherwise eligible|1|||
130102135|NCT01360021|468332641|FG000|Overall Study|Eligibility criteria + other|2|||
130102136|NCT01360021|468332642|FG001|Overall Study|Eligibility criteria + other|1|||
130102137|NCT01360021|468332643|FG002|Overall Study|Eligibility criteria + other|1|||
130102138|NCT01360021|468332641|FG000|Overall Study|Protocol Violation|0|||
130102139|NCT01360021|468332642|FG001|Overall Study|Protocol Violation|0|||
130102140|NCT01360021|468332643|FG002|Overall Study|Protocol Violation|1|||
130102141|NCT01360021|468332641|FG000|Overall Study|Withdrawal by Subject|4|||
130102142|NCT01360021|468332642|FG001|Overall Study|Withdrawal by Subject|0|||
130102143|NCT01360021|468332643|FG002|Overall Study|Withdrawal by Subject|2|||
130102144|NCT01360021|468332641|FG000|Overall Study|Adverse Event|2|||
130102145|NCT01360021|468332642|FG001|Overall Study|Adverse Event|3|||
130102146|NCT01360021|468332643|FG002|Overall Study|Adverse Event|3|||
130102147|NCT01257737|468332645|FG000|Overall Study|Lost to Follow-up|1|||
130102148|NCT01257737|468332646|FG001|Overall Study|Lost to Follow-up|2|||
130102149|NCT01257737|468332645|FG000|Overall Study|Liver transplant|1|||
130102150|NCT01257737|468332646|FG001|Overall Study|Liver transplant|0|||
130102151|NCT01257737|468332645|FG000|Overall Study|Relocation out of the country|0|||
130102152|NCT01257737|468332646|FG001|Overall Study|Relocation out of the country|1|||
130102153|NCT01257737|468332645|FG000|Overall Study|Withdrew from study|0|||
130102154|NCT01257737|468332646|FG001|Overall Study|Withdrew from study|1|||
130102155|NCT03170271|468332650|FG000|Overall Study|Adverse Event|7|||
130102156|NCT03170271|468332651|FG001|Overall Study|Adverse Event|2|||
130102157|NCT03170271|468332650|FG000|Overall Study|Lost to Follow-up|0|||
130102158|NCT03170271|468332651|FG001|Overall Study|Lost to Follow-up|1|||
130102159|NCT03170271|468332650|FG000|Overall Study|Physician Decision|1|||
130102160|NCT03170271|468332651|FG001|Overall Study|Physician Decision|0|||
130102161|NCT03170271|468332650|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
130260994|NCT00557193|468922922|FG003|Induction|Ineligible|0|||
130102162|NCT03170271|468332651|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
130102163|NCT03170271|468332650|FG000|Overall Study|Withdrawal by Subject|17|||
130102164|NCT03170271|468332651|FG001|Overall Study|Withdrawal by Subject|5|||
130102165|NCT03170271|468332650|FG000|Overall Study|Other|2|||
130102166|NCT03170271|468332651|FG001|Overall Study|Other|2|||
130102167|NCT03170271|468332650|FG000|Overall Study|Randomized in error|4|||
130102168|NCT03170271|468332651|FG001|Overall Study|Randomized in error|0|||
130102169|NCT03123120|468332653|FG000|Overall Study|Lost to Follow-up|0|||
130102170|NCT03123120|468332654|FG001|Overall Study|Lost to Follow-up|1|||
130260995|NCT00557193|468922923|FG004|Induction|Ineligible|0|||
130260996|NCT00557193|468922924|FG005|Induction|Ineligible|0|||
130260997|NCT00557193|468922919|FG000|Induction|Inevaluable for post Induction|2|||
130260998|NCT00557193|468922920|FG001|Induction|Inevaluable for post Induction|0|||
130260999|NCT00557193|468922921|FG002|Induction|Inevaluable for post Induction|0|||
130261000|NCT00557193|468922922|FG003|Induction|Inevaluable for post Induction|0|||
130261001|NCT00557193|468922923|FG004|Induction|Inevaluable for post Induction|0|||
130034614|NCT02847598|468081216|FG001|Overall Study|Death|0|||
130034615|NCT02847598|468081217|FG002|Overall Study|Death|0|||
130034616|NCT02847598|468081218|FG003|Overall Study|Death|0|||
130034617|NCT02847598|468081219|FG004|Overall Study|Death|0|||
130034618|NCT02847598|468081220|FG005|Overall Study|Death|0|||
130034619|NCT02847598|468081221|FG006|Overall Study|Death|0|||
130034620|NCT02847598|468081222|FG007|Overall Study|Death|0|||
130034621|NCT02847598|468081215|FG000|Overall Study|Lost to Follow-up|0|||
130034622|NCT02847598|468081216|FG001|Overall Study|Lost to Follow-up|0|||
130034623|NCT02847598|468081217|FG002|Overall Study|Lost to Follow-up|0|||
130034624|NCT02847598|468081218|FG003|Overall Study|Lost to Follow-up|0|||
130034625|NCT02847598|468081219|FG004|Overall Study|Lost to Follow-up|0|||
130034626|NCT02847598|468081220|FG005|Overall Study|Lost to Follow-up|1|||
130034627|NCT02847598|468081221|FG006|Overall Study|Lost to Follow-up|1|||
130034628|NCT02847598|468081222|FG007|Overall Study|Lost to Follow-up|0|||
130034629|NCT02848833|468081223|FG000|Overall Study|subject who are duplicated|1|||
130034630|NCT02848833|468081223|FG000|Overall Study|have not taken the study drug|11|||
130034631|NCT02848833|468081223|FG000|Overall Study|follow-up failure|6|||
130034632|NCT02848833|468081223|FG000|Overall Study|Protocol Violation|119|||
130034633|NCT04167345|468081224|FG000|Overall Study|Other|1|||
130034634|NCT04167345|468081225|FG001|Overall Study|Other|1|||
130034635|NCT04167345|468081226|FG002|Overall Study|Other|0|||
130034636|NCT04167345|468081227|FG003|Overall Study|Other|0|||
130034637|NCT04167345|468081228|FG004|Overall Study|Other|0|||
130034638|NCT06119191|468081231|FG000|Overall Study|Adverse Event|0|||
130034639|NCT06119191|468081232|FG001|Overall Study|Adverse Event|1|||
130034640|NCT06119191|468081231|FG000|Overall Study|Protocol Violation|1|||
130034641|NCT06119191|468081232|FG001|Overall Study|Protocol Violation|0|||
130034642|NCT03896581|468083664|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
130034643|NCT03896581|468083665|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
130034644|NCT03896581|468083664|FG000|Overall Study|Withdrawal by Subject|4|||
130034645|NCT03896581|468083665|FG001|Overall Study|Withdrawal by Subject|1|||
130034646|NCT03896581|468083664|FG000|Overall Study|Lost to Follow-up|1|||
130034647|NCT03896581|468083665|FG001|Overall Study|Lost to Follow-up|0|||
130261002|NCT00557193|468922924|FG005|Induction|Inevaluable for post Induction|0|||
130034648|NCT03896581|468083664|FG000|Overall Study|Lack of Efficacy|2|||
130034649|NCT03896581|468083665|FG001|Overall Study|Lack of Efficacy|1|||
130034650|NCT03896581|468083664|FG000|Overall Study|Adverse event, non-fatal|0|||
130034651|NCT03896581|468083665|FG001|Overall Study|Adverse event, non-fatal|2|||
130034652|NCT00960076|468083677|FG000|Overall Study|Adverse Event|1|||
130261003|NCT00557193|468922919|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
130034653|NCT00960076|468083678|FG001|Overall Study|Adverse Event|7|||
130034654|NCT00960076|468083677|FG000|Overall Study|No longer met study criteria|1|||
130034655|NCT00960076|468083678|FG001|Overall Study|No longer met study criteria|5|||
130034656|NCT00960076|468083677|FG000|Overall Study|Withdrawal by Subject|1|||
130034657|NCT00960076|468083678|FG001|Overall Study|Withdrawal by Subject|2|||
130034658|NCT00960076|468083677|FG000|Overall Study|Lost to Follow-up|3|||
130034659|NCT00960076|468083678|FG001|Overall Study|Lost to Follow-up|3|||
130034660|NCT00960076|468083677|FG000|Overall Study|Severe non-compliance to protocol|1|||
130034661|NCT00960076|468083678|FG001|Overall Study|Severe non-compliance to protocol|2|||
130034662|NCT00960076|468083677|FG000|Overall Study|Hyperglycemia|1|||
130034663|NCT00960076|468083678|FG001|Overall Study|Hyperglycemia|5|||
130034664|NCT00960076|468083677|FG000|Overall Study|Did not attend the termination visit|0|||
130034665|NCT00960076|468083678|FG001|Overall Study|Did not attend the termination visit|1|||
130261004|NCT00557193|468922920|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261005|NCT00557193|468922921|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261006|NCT00557193|468922922|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261007|NCT00557193|468922923|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261008|NCT00557193|468922924|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
130261009|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130261010|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
130261011|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
130261012|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
130261013|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
130261014|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
130261015|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
130261016|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
130261017|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
130261018|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
130261019|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
130261020|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
130261021|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
130261022|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
130261023|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
130261024|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
130261025|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
130261026|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
130261027|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
130261028|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
130261029|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
130261030|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
130261031|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
130261032|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
130261033|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
130261034|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
130261035|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
130261036|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
130261037|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
130261038|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
130261039|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261040|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261041|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
130261042|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261043|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130261044|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
130102171|NCT03123120|468332653|FG000|Overall Study|Withdrawal by Subject|0|||
130034666|NCT00500266|468083679|FG000|Overall Study|Death|3|||
130034667|NCT00500266|468083679|FG000|Overall Study|Lost to Follow-up|3|||
130034668|NCT00500266|468083679|FG000|Overall Study|Withdrawal by Subject|3|||
130034669|NCT00500266|468083679|FG000|Overall Study|Assigned, not treated|4|||
130034670|NCT03263806|468083682|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
130034671|NCT03263806|468083683|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
130102172|NCT03123120|468332654|FG001|Overall Study|Withdrawal by Subject|1|||
130102173|NCT00203892|468332657|FG000|Overall Study|Physician Decision|1|||
130102174|NCT00203892|468332658|FG001|Overall Study|Physician Decision|2|||
130034672|NCT03263806|468083682|FG000|Overall Study|Withdrawal by Subject|0|||
130034673|NCT03263806|468083683|FG001|Overall Study|Withdrawal by Subject|1|||
130034674|NCT03263806|468083682|FG000|Overall Study|Study Termination|5|||
130034675|NCT03263806|468083683|FG001|Overall Study|Study Termination|6|||
130261045|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261046|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261047|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
130261048|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261049|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261050|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
130261051|NCT00557193|468922919|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130034676|NCT01412879|468083686|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
130261052|NCT00557193|468922920|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130261053|NCT00557193|468922921|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
130261054|NCT00557193|468922922|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130261055|NCT00557193|468922923|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
130261056|NCT00557193|468922924|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
130261057|NCT03984825|468922925|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
130261058|NCT03984825|468922925|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
130261059|NCT03984825|468922925|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
130261060|NCT00976456|468922928|FG000|Overall Study|Adverse Event|17|||
130261061|NCT00976456|468922929|FG001|Overall Study|Adverse Event|22|||
130261062|NCT00976456|468922928|FG000|Overall Study|Death|7|||
130261063|NCT00976456|468922929|FG001|Overall Study|Death|9|||
130261064|NCT00976456|468922928|FG000|Overall Study|Lack of Efficacy|5|||
130034677|NCT01412879|468083687|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
130034678|NCT01412879|468083688|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
130034679|NCT01412879|468083686|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
130034680|NCT01412879|468083687|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
130034681|NCT01412879|468083688|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
130034682|NCT01412879|468083686|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
130034683|NCT01412879|468083687|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
130034684|NCT01412879|468083688|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
130034685|NCT01412879|468083686|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
130034686|NCT01412879|468083687|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
130034687|NCT01412879|468083688|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
130034688|NCT01412879|468083686|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
130034689|NCT01412879|468083687|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
130034690|NCT01412879|468083688|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
130034691|NCT02109029|468083689|FG000|Part B|Adverse Event|0|||
130034692|NCT02109029|468083690|FG001|Part B|Adverse Event|0|||
130034693|NCT02109029|468083691|FG002|Part B|Adverse Event|0|||
130034694|NCT02109029|468083692|FG003|Part B|Adverse Event|0|||
130034695|NCT02109029|468083693|FG004|Part B|Adverse Event|1|||
130034696|NCT02109029|468083694|FG005|Part B|Adverse Event|1|||
130034697|NCT01445171|468083701|FG000|Overall Study|Lost to Follow-up|11|||
130034698|NCT01445171|468083701|FG000|Overall Study|Withdrawal by Subject|16|||
130034699|NCT01445171|468083701|FG000|Overall Study|Death|51|||
130034700|NCT01445171|468083701|FG000|Overall Study|Subjects declined to return for followup|9|||
130034701|NCT01445171|468083701|FG000|Overall Study|Consented but did not receive device|8|||
130034702|NCT03195894|468083702|FG000|Overall Study|"An example is Started other treatment."|4|||
130034703|NCT03195894|468083703|FG001|Overall Study|"An example is Started other treatment."|5|||
130034704|NCT03195894|468083702|FG000|Overall Study|Withdrawal by Subject|15|||
130034705|NCT03195894|468083703|FG001|Overall Study|Withdrawal by Subject|4|||
130034706|NCT03195894|468083702|FG000|Overall Study|Lost to Follow-up|14|||
130034707|NCT03195894|468083703|FG001|Overall Study|Lost to Follow-up|19|||
130034708|NCT00162773|468083707|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
130034709|NCT00110305|468083708|FG000|Overall Study|Adverse Event|46|||
130034710|NCT00110305|468083709|FG001|Overall Study|Adverse Event|13|||
130034711|NCT00110305|468083708|FG000|Overall Study|Sponsors Decision|1|||
130034712|NCT00110305|468083709|FG001|Overall Study|Sponsors Decision|0|||
130261065|NCT00976456|468922929|FG001|Overall Study|Lack of Efficacy|2|||
130034713|NCT00110305|468083708|FG000|Overall Study|Subject Non-Compliant|9|||
130261066|NCT00976456|468922928|FG000|Overall Study|Withdrawal by Subject|3|||
130261067|NCT00976456|468922929|FG001|Overall Study|Withdrawal by Subject|1|||
130261068|NCT00976456|468922928|FG000|Overall Study|screening failure, unknown|11|||
130261069|NCT00976456|468922929|FG001|Overall Study|screening failure, unknown|4|||
130261070|NCT02735200|468922932|FG000|Overall Study|Lost to Follow-up|0|||
130261071|NCT02735200|468922933|FG001|Overall Study|Lost to Follow-up|5|||
130261072|NCT02735200|468922932|FG000|Overall Study|Withdrawal by Subject|8|||
130261073|NCT02735200|468922933|FG001|Overall Study|Withdrawal by Subject|0|||
130261074|NCT01463527|468922934|FG000|Overall Study|Protocol Violation|1|||
130261075|NCT01463527|468922935|FG001|Overall Study|Protocol Violation|1|||
130261076|NCT01463527|468922934|FG000|Overall Study|Crying >20% of sedation|5|||
130261077|NCT01463527|468922935|FG001|Overall Study|Crying >20% of sedation|6|||
130261078|NCT05136170|468922936|FG000|Overall Study|Withdrawal by Subject|2|||
130261079|NCT05136170|468922937|FG001|Overall Study|Withdrawal by Subject|2|||
130261080|NCT05136170|468922936|FG000|Overall Study|Can no longer make office visits|1|||
130261081|NCT05136170|468922937|FG001|Overall Study|Can no longer make office visits|0|||
130261082|NCT01493414|468922940|FG000|Overall Study|Adverse Event|405|||
130261083|NCT01493414|468922940|FG000|Overall Study|Disease progression|204|||
130261084|NCT01493414|468922940|FG000|Overall Study|Death|101|||
130261085|NCT01493414|468922940|FG000|Overall Study|Physician Decision|93|||
130261086|NCT01493414|468922940|FG000|Overall Study|Withdrawal by Subject|79|||
130261087|NCT01493414|468922940|FG000|Overall Study|Protocol deviation|27|||
130261088|NCT01493414|468922940|FG000|Overall Study|Administrative problems|25|||
130261089|NCT01493414|468922940|FG000|Overall Study|Lost to Follow-up|16|||
130261090|NCT01977222|468922945|FG000|Overall Study|Withdrawal by Subject|1|||
130261091|NCT01612676|468922948|FG000|Overall Study|Adverse Event|2|||
130261092|NCT01612676|468922949|FG001|Overall Study|Adverse Event|3|||
130261093|NCT01612676|468922950|FG002|Overall Study|Adverse Event|1|||
130261094|NCT01612676|468922951|FG003|Overall Study|Adverse Event|3|||
130261095|NCT01612676|468922948|FG000|Overall Study|Protocol Violation|0|||
130034714|NCT00110305|468083709|FG001|Overall Study|Subject Non-Compliant|2|||
130034715|NCT00110305|468083708|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
130034716|NCT00110305|468083709|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
130034717|NCT00110305|468083708|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
130034718|NCT00110305|468083709|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
130034719|NCT00110305|468083708|FG000|Overall Study|Protocol Violation|0|||
130034720|NCT00110305|468083709|FG001|Overall Study|Protocol Violation|1|||
130034721|NCT00110305|468083708|FG000|Overall Study|Withdrawal by Subject|7|||
130034722|NCT00110305|468083709|FG001|Overall Study|Withdrawal by Subject|7|||
130034723|NCT00110305|468083708|FG000|Overall Study|Lost to Follow-up|20|||
130034724|NCT00110305|468083709|FG001|Overall Study|Lost to Follow-up|3|||
130034725|NCT00110305|468083708|FG000|Overall Study|Other|8|||
130034726|NCT00110305|468083709|FG001|Overall Study|Other|2|||
130034727|NCT02468193|468083713|FG000|Overall Study|Adverse Event|4|||
130034728|NCT02468193|468083713|FG000|Overall Study|Subject/ Guardian decision|2|||
130034729|NCT03312218|468083714|FG000|Overall Study|Never signed in to access the app|54|||
130034730|NCT03312218|468083715|FG001|Overall Study|Never signed in to access the app|58|||
130034731|NCT01887912|468083716|FG000|Overall Study|Serious adverse event|400|||
130034732|NCT01887912|468083717|FG001|Overall Study|Serious adverse event|198|||
130034733|NCT01887912|468083716|FG000|Overall Study|Other Adverse Event|34|||
130034734|NCT01887912|468083717|FG001|Overall Study|Other Adverse Event|15|||
130034735|NCT01887912|468083716|FG000|Overall Study|Protocol Violation|67|||
130261096|NCT01612676|468922949|FG001|Overall Study|Protocol Violation|1|||
130261097|NCT01612676|468922950|FG002|Overall Study|Protocol Violation|0|||
130261098|NCT01612676|468922951|FG003|Overall Study|Protocol Violation|0|||
130261099|NCT00107276|468922955|FG000|Overall Study|Progression|46|||
130261100|NCT00107276|468922955|FG000|Overall Study|Adverse Event|6|||
130261101|NCT00107276|468922955|FG000|Overall Study|M.D. decision|2|||
130261102|NCT00107276|468922955|FG000|Overall Study|Patient refusal|1|||
130261103|NCT00107276|468922955|FG000|Overall Study|Death|1|||
130261104|NCT00107276|468922955|FG000|Overall Study|Ineligible|16|||
130261105|NCT02980107|468922956|FG000|Overall Study|Withdrawal by Subject|51|||
130102175|NCT00203892|468332659|FG002|Overall Study|Physician Decision|0|||
130034736|NCT01887912|468083717|FG001|Overall Study|Protocol Violation|37|||
130034737|NCT01887912|468083716|FG000|Overall Study|Lost to Follow-up|163|||
130261106|NCT02980107|468922957|FG001|Overall Study|Withdrawal by Subject|62|||
130261107|NCT00945659|468922958|FG000|Overall Study|Lost to Follow-up|7|||
130261108|NCT00945659|468922959|FG001|Overall Study|Lost to Follow-up|20|||
130034738|NCT01887912|468083717|FG001|Overall Study|Lost to Follow-up|74|||
130034739|NCT01887912|468083716|FG000|Overall Study|Withdrawal by Subject|606|||
130034740|NCT01887912|468083717|FG001|Overall Study|Withdrawal by Subject|349|||
130261109|NCT00945659|468922960|FG002|Overall Study|Lost to Follow-up|17|||
130261110|NCT04562116|468922961|FG000|Overall Study|Lost to Follow-up|1|||
130261111|NCT04562116|468922961|FG000|Overall Study|Withdrawal by Subject|3|||
130261112|NCT02412670|468922964|FG000|Overall Study|Adverse Event|4|||
130261113|NCT02412670|468922965|FG001|Overall Study|Adverse Event|1|||
130261114|NCT02412670|468922964|FG000|Overall Study|Physician Decision|1|||
130261115|NCT02412670|468922965|FG001|Overall Study|Physician Decision|0|||
130261116|NCT02412670|468922964|FG000|Overall Study|Withdrawal by Subject|1|||
130261117|NCT02412670|468922965|FG001|Overall Study|Withdrawal by Subject|0|||
130261118|NCT02412670|468922964|FG000|Overall Study|Ineligible|1|||
130261119|NCT02412670|468922965|FG001|Overall Study|Ineligible|0|||
130261120|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Adverse Event|6|||
130261121|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Adverse Event|15|||
130261122|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Adverse Event|0|||
130261123|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Death|0|||
130261124|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Death|2|||
130261125|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Death|0|||
130261126|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
130261127|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
130261128|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
130261129|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
130261130|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
130261131|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
130261132|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Physician Decision|1|||
130261133|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Physician Decision|1|||
130261134|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Physician Decision|0|||
130261135|NCT02921256|468922971|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
130261136|NCT02921256|468922972|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
130261137|NCT02921256|468922973|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
130261138|NCT02921256|468922971|FG000|Arm Ib v Arm III|Adverse Event|9|||
130261139|NCT02921256|468922972|FG001|Arm Ib v Arm III|Adverse Event|0|||
130261140|NCT02921256|468922973|FG002|Arm Ib v Arm III|Adverse Event|4|||
130261141|NCT02921256|468922971|FG000|Arm Ib v Arm III|Death|1|||
130261142|NCT02921256|468922972|FG001|Arm Ib v Arm III|Death|0|||
130261143|NCT02921256|468922973|FG002|Arm Ib v Arm III|Death|1|||
130261144|NCT02921256|468922971|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
130261145|NCT02921256|468922972|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
130261146|NCT02921256|468922973|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
130261147|NCT02921256|468922971|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
130261148|NCT02921256|468922972|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
130261149|NCT02921256|468922973|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
130261150|NCT02921256|468922971|FG000|Arm Ib v Arm III|Physician Decision|4|||
130261151|NCT02921256|468922972|FG001|Arm Ib v Arm III|Physician Decision|0|||
130261152|NCT02921256|468922973|FG002|Arm Ib v Arm III|Physician Decision|1|||
130261153|NCT02921256|468922971|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
130261154|NCT02921256|468922972|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
130261155|NCT02921256|468922973|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
130261156|NCT02943473|468922974|FG000|Overall Study|enrolled but not dosed|1|||
130261157|NCT02943473|468922974|FG000|Overall Study|screen failure|1|||
130261158|NCT02943473|468922974|FG000|Overall Study|Physician Decision|4|||
130261159|NCT04211363|468922977|FG000|Overall Study|Adverse Event|5|||
130261160|NCT04211363|468922978|FG001|Overall Study|Adverse Event|2|||
130261161|NCT04211363|468922977|FG000|Overall Study|Physician Decision|0|||
130261162|NCT04211363|468922978|FG001|Overall Study|Physician Decision|1|||
130261163|NCT04211363|468922977|FG000|Overall Study|Protocol Violation|1|||
130261164|NCT04211363|468922978|FG001|Overall Study|Protocol Violation|0|||
130261165|NCT04211363|468922977|FG000|Overall Study|Pregnancy|1|||
130261166|NCT04211363|468922978|FG001|Overall Study|Pregnancy|0|||
130261167|NCT04211363|468922977|FG000|Overall Study|Lost to Follow-up|12|||
130261168|NCT04211363|468922978|FG001|Overall Study|Lost to Follow-up|4|||
130261169|NCT04211363|468922977|FG000|Overall Study|Withdrawal by Subject|11|||
130261170|NCT04211363|468922978|FG001|Overall Study|Withdrawal by Subject|11|||
130261171|NCT04211363|468922977|FG000|Overall Study|Other|1|||
130261172|NCT04211363|468922978|FG001|Overall Study|Other|2|||
130261173|NCT03097289|468922979|FG000|Overall Study|Adverse Event|1|||
130261174|NCT03097289|468922979|FG000|Overall Study|Equipment failure|2|||
130261175|NCT03097289|468922979|FG000|Overall Study|Collected platelet product unusable|3|||
130261176|NCT01823289|468922980|FG000|Overall Study|Lost to Follow-up|5|||
130261177|NCT01823289|468922980|FG000|Overall Study|Adverse Event|5|||
130261178|NCT01823289|468922980|FG000|Overall Study|Lack of Efficacy|1|||
130261179|NCT01823289|468922980|FG000|Overall Study|Physician Decision|9|||
130261180|NCT01823289|468922980|FG000|Overall Study|Administered contraindicated medicine|1|||
130261181|NCT01823289|468922980|FG000|Overall Study|Transaminase increased more than 3 times|1|||
130261182|NCT01823289|468922980|FG000|Overall Study|Drug affected efficacy and safety|1|||
130261183|NCT01823289|468922980|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
130261184|NCT01736917|468922981|FG000|Overall Study|Adverse Event|1|||
130261185|NCT01736917|468922981|FG000|Overall Study|Protocol Violation|10|||
130261186|NCT01734902|468922982|FG000|Overall Study|Other than listed|0|||
130261187|NCT01734902|468922983|FG001|Overall Study|Other than listed|2|||
130034741|NCT01887912|468083716|FG000|Overall Study|Other|122|||
130034742|NCT01887912|468083717|FG001|Overall Study|Other|58|||
130261188|NCT00060944|468922984|FG000|Overall Study|Adverse Event|12|||
130261189|NCT00060944|468922985|FG001|Overall Study|Adverse Event|10|||
130261190|NCT00060944|468922984|FG000|Overall Study|Death|2|||
130261191|NCT00060944|468922985|FG001|Overall Study|Death|3|||
130261192|NCT00060944|468922984|FG000|Overall Study|Withdrawal by Subject|18|||
130261193|NCT00060944|468922985|FG001|Overall Study|Withdrawal by Subject|5|||
130261194|NCT00060944|468922984|FG000|Overall Study|Disease Progression|93|||
130261195|NCT00060944|468922985|FG001|Overall Study|Disease Progression|94|||
130261196|NCT00060944|468922984|FG000|Overall Study|Lost to Follow-up|1|||
130261197|NCT00060944|468922985|FG001|Overall Study|Lost to Follow-up|0|||
130261198|NCT00060944|468922984|FG000|Overall Study|Subject Ineligible To Continue|2|||
130261199|NCT00060944|468922985|FG001|Overall Study|Subject Ineligible To Continue|1|||
130261200|NCT00060944|468922984|FG000|Overall Study|Treatment Switch|0|||
130261201|NCT00060944|468922985|FG001|Overall Study|Treatment Switch|13|||
130261202|NCT00060944|468922984|FG000|Overall Study|Other|2|||
130261203|NCT00060944|468922985|FG001|Overall Study|Other|4|||
130261204|NCT00060944|468922984|FG000|Overall Study|randomized but not treated|6|||
130261205|NCT00060944|468922985|FG001|Overall Study|randomized but not treated|4|||
130034743|NCT05113940|468083721|FG000|Part A (18 Days)|Adverse Event|0|||
130034744|NCT05113940|468083722|FG001|Part A (18 Days)|Adverse Event|0|||
130034745|NCT05113940|468083723|FG002|Part A (18 Days)|Adverse Event|1|||
130034746|NCT05113940|468083724|FG003|Part A (18 Days)|Adverse Event|1|||
130034747|NCT05113940|468083725|FG004|Part A (18 Days)|Adverse Event|1|||
130034748|NCT05113940|468083726|FG005|Part A (18 Days)|Adverse Event|0|||
130034749|NCT05113940|468083727|FG006|Part A (18 Days)|Adverse Event|0|||
130034750|NCT05113940|468083728|FG007|Part A (18 Days)|Adverse Event|0|||
130034751|NCT05113940|468083729|FG008|Part A (18 Days)|Adverse Event|0|||
130034752|NCT05113940|468083730|FG009|Part A (18 Days)|Adverse Event|0|||
130034753|NCT05113940|468083731|FG010|Part A (18 Days)|Adverse Event|0|||
130034754|NCT05113940|468083732|FG011|Part A (18 Days)|Adverse Event|2|||
130034755|NCT05113940|468083733|FG012|Part A (18 Days)|Adverse Event|0|||
130034756|NCT05113940|468083734|FG013|Part A (18 Days)|Adverse Event|0|||
130034757|NCT05113940|468083735|FG014|Part A (18 Days)|Adverse Event|0|||
130034758|NCT05113940|468083721|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034759|NCT05113940|468083722|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034760|NCT05113940|468083723|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034761|NCT05113940|468083724|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034762|NCT05113940|468083725|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
130261206|NCT03213509|468922987|FG000|Overall Study|Did not consent for verbal autopsy|4|||
130261207|NCT03213509|468922988|FG001|Overall Study|Did not consent for verbal autopsy|5|||
130261208|NCT04549454|468922991|FG000|T1 to T2|Lost to Follow-up|22|||
130261209|NCT04549454|468922992|FG001|T1 to T2|Lost to Follow-up|26|||
130261210|NCT04549454|468922991|FG000|T1 to T3|Lost to Follow-up|31|||
130261211|NCT04549454|468922992|FG001|T1 to T3|Lost to Follow-up|36|||
130034763|NCT05113940|468083726|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034764|NCT05113940|468083727|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034765|NCT05113940|468083728|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034766|NCT05113940|468083729|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
130261212|NCT00867035|468922993|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
130261213|NCT00867035|468922994|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
130261214|NCT00867035|468922993|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
130261215|NCT00867035|468922994|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
130261216|NCT00016354|468922995|FG000|Overall Study|Lack of Efficacy|0|||
130034767|NCT05113940|468083730|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034768|NCT05113940|468083731|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034769|NCT05113940|468083732|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034770|NCT05113940|468083733|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034771|NCT05113940|468083734|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
130034772|NCT05113940|468083735|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
130034773|NCT03619213|468083738|FG000|Overall Study|Lost to Follow-up|2|||
130034774|NCT03619213|468083739|FG001|Overall Study|Lost to Follow-up|1|||
130261217|NCT00016354|468922996|FG001|Overall Study|Lack of Efficacy|0|||
130261218|NCT00016354|468922997|FG002|Overall Study|Lack of Efficacy|0|||
130261219|NCT00016354|468922998|FG003|Overall Study|Lack of Efficacy|0|||
130261220|NCT00016354|468922999|FG004|Overall Study|Lack of Efficacy|0|||
130261221|NCT00016354|468923000|FG005|Overall Study|Lack of Efficacy|0|||
130261222|NCT00016354|468923001|FG006|Overall Study|Lack of Efficacy|0|||
130261223|NCT00016354|468923002|FG007|Overall Study|Lack of Efficacy|1|||
130034775|NCT03619213|468083738|FG000|Overall Study|Withdrawal by Subject|8|||
130034776|NCT03619213|468083739|FG001|Overall Study|Withdrawal by Subject|10|||
130034777|NCT01262898|468083745|FG000|Overall Study|Protocol Violation|1|||
130034778|NCT01262898|468083746|FG001|Overall Study|Protocol Violation|1|||
130034779|NCT01262898|468083747|FG002|Overall Study|Protocol Violation|0|||
130034780|NCT01262898|468083748|FG003|Overall Study|Protocol Violation|0|||
130034781|NCT01262898|468083745|FG000|Overall Study|Lost to Follow-up|1|||
130034782|NCT01262898|468083746|FG001|Overall Study|Lost to Follow-up|0|||
130034783|NCT01262898|468083747|FG002|Overall Study|Lost to Follow-up|0|||
130034784|NCT01262898|468083748|FG003|Overall Study|Lost to Follow-up|0|||
130034785|NCT01262898|468083745|FG000|Overall Study|Withdrawal by Subject|1|||
130034786|NCT01262898|468083746|FG001|Overall Study|Withdrawal by Subject|1|||
130034787|NCT01262898|468083747|FG002|Overall Study|Withdrawal by Subject|0|||
130034788|NCT01262898|468083748|FG003|Overall Study|Withdrawal by Subject|0|||
130034789|NCT02731742|468083749|FG000|Overall Study|Death|1|||
130034790|NCT02731742|468083750|FG001|Overall Study|Death|2|||
130034791|NCT02731742|468083751|FG002|Overall Study|Death|5|||
130034792|NCT02731742|468083752|FG003|Overall Study|Death|0|||
130034793|NCT02731742|468083749|FG000|Overall Study|Physician Decision|0|||
130034794|NCT02731742|468083750|FG001|Overall Study|Physician Decision|0|||
130034795|NCT02731742|468083751|FG002|Overall Study|Physician Decision|0|||
130034796|NCT02731742|468083752|FG003|Overall Study|Physician Decision|1|||
130034797|NCT02731742|468083749|FG000|Overall Study|Study Terminated by Sponsor|2|||
130034798|NCT02731742|468083750|FG001|Overall Study|Study Terminated by Sponsor|1|||
130034799|NCT02731742|468083751|FG002|Overall Study|Study Terminated by Sponsor|1|||
130034800|NCT02731742|468083752|FG003|Overall Study|Study Terminated by Sponsor|1|||
130034801|NCT00502840|468083753|FG000|Overall Study|Adverse Event|5|||
130034802|NCT00502840|468083753|FG000|Overall Study|Additional or changed therapy|48|||
130034803|NCT00502840|468083753|FG000|Overall Study|Lack of Efficacy|11|||
130034804|NCT00502840|468083753|FG000|Overall Study|Protocol Violation|4|||
130034805|NCT00502840|468083753|FG000|Overall Study|Withdrawal by Subject|5|||
130261224|NCT03110562|468923003|FG000|Initial Treatment Period|Disease Progression|1|||
130034806|NCT00502840|468083753|FG000|Overall Study|Lost to Follow-up|6|||
130034807|NCT00502840|468083753|FG000|Overall Study|Administrative problems|1|||
130034808|NCT00502840|468083753|FG000|Overall Study|Other|20|||
130034809|NCT03093155|468083755|FG000|Overall Study|Not Eligible|1|||
130034810|NCT03093155|468083756|FG001|Overall Study|Not Eligible|0|||
130034811|NCT03093155|468083755|FG000|Overall Study|Withdrawal by Subject|0|||
130034812|NCT03093155|468083756|FG001|Overall Study|Withdrawal by Subject|1|||
130034813|NCT00619229|468083757|FG000|Overall Study|Withdrawal by Subject|1|||
130034814|NCT00619229|468083758|FG001|Overall Study|Withdrawal by Subject|1|||
130034815|NCT00619229|468083757|FG000|Overall Study|Lost to Follow-up|1|||
130261225|NCT03110562|468923004|FG001|Initial Treatment Period|Disease Progression|1|||
130261226|NCT03110562|468923005|FG002|Initial Treatment Period|Disease Progression|0|||
130261227|NCT03110562|468923006|FG003|Initial Treatment Period|Disease Progression|0|||
130261228|NCT03110562|468923003|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
130261229|NCT03110562|468923004|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
130261230|NCT03110562|468923005|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
130261231|NCT03110562|468923006|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
130034816|NCT00619229|468083758|FG001|Overall Study|Lost to Follow-up|0|||
130034817|NCT00619229|468083757|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
130261232|NCT03110562|468923003|FG000|Initial Treatment Period|Adverse Event|1|||
130261233|NCT03110562|468923004|FG001|Initial Treatment Period|Adverse Event|0|||
130261234|NCT03110562|468923005|FG002|Initial Treatment Period|Adverse Event|0|||
130261235|NCT03110562|468923006|FG003|Initial Treatment Period|Adverse Event|0|||
130261236|NCT03110562|468923003|FG000|Initial Treatment Period|Death|74|||
130261237|NCT03110562|468923004|FG001|Initial Treatment Period|Death|82|||
130261238|NCT03110562|468923005|FG002|Initial Treatment Period|Death|0|||
130261239|NCT03110562|468923006|FG003|Initial Treatment Period|Death|0|||
130261240|NCT03110562|468923003|FG000|Initial Treatment Period|Lost to Follow-up|13|||
130261241|NCT03110562|468923004|FG001|Initial Treatment Period|Lost to Follow-up|8|||
130261242|NCT03110562|468923005|FG002|Initial Treatment Period|Lost to Follow-up|0|||
130261243|NCT03110562|468923006|FG003|Initial Treatment Period|Lost to Follow-up|0|||
130261244|NCT03110562|468923003|FG000|Initial Treatment Period|Protocol Deviation|1|||
130261245|NCT03110562|468923004|FG001|Initial Treatment Period|Protocol Deviation|0|||
130261246|NCT03110562|468923005|FG002|Initial Treatment Period|Protocol Deviation|0|||
130261247|NCT03110562|468923006|FG003|Initial Treatment Period|Protocol Deviation|0|||
130261248|NCT03110562|468923003|FG000|Initial Treatment Period|Physician Decision|2|||
130261249|NCT03110562|468923004|FG001|Initial Treatment Period|Physician Decision|1|||
130261250|NCT03110562|468923005|FG002|Initial Treatment Period|Physician Decision|0|||
130261251|NCT03110562|468923006|FG003|Initial Treatment Period|Physician Decision|0|||
130261252|NCT03110562|468923003|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
130261253|NCT03110562|468923004|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
130261254|NCT03110562|468923005|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
130261255|NCT03110562|468923006|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
130261256|NCT03110562|468923003|FG000|Initial Treatment Period|Other|5|||
130261257|NCT03110562|468923004|FG001|Initial Treatment Period|Other|4|||
130261258|NCT03110562|468923005|FG002|Initial Treatment Period|Other|0|||
130261259|NCT03110562|468923006|FG003|Initial Treatment Period|Other|0|||
130261260|NCT03110562|468923003|FG000|Initial Treatment Period|Randomized but never treated|0|||
130261261|NCT03110562|468923004|FG001|Initial Treatment Period|Randomized but never treated|3|||
130261262|NCT03110562|468923005|FG002|Initial Treatment Period|Randomized but never treated|0|||
130261263|NCT03110562|468923006|FG003|Initial Treatment Period|Randomized but never treated|0|||
130261264|NCT03110562|468923003|FG000|Crossover Period|Disease Progression|0|||
130261265|NCT03110562|468923004|FG001|Crossover Period|Disease Progression|0|||
130261266|NCT03110562|468923005|FG002|Crossover Period|Disease Progression|1|||
130261267|NCT03110562|468923006|FG003|Crossover Period|Disease Progression|0|||
130261268|NCT03110562|468923003|FG000|Crossover Period|Withdrawal by Subject|0|||
130261269|NCT03110562|468923004|FG001|Crossover Period|Withdrawal by Subject|0|||
130261270|NCT03110562|468923005|FG002|Crossover Period|Withdrawal by Subject|8|||
130261271|NCT03110562|468923006|FG003|Crossover Period|Withdrawal by Subject|6|||
130261272|NCT03110562|468923003|FG000|Crossover Period|Death|0|||
130261273|NCT03110562|468923004|FG001|Crossover Period|Death|0|||
130261274|NCT03110562|468923005|FG002|Crossover Period|Death|37|||
130261275|NCT03110562|468923006|FG003|Crossover Period|Death|3|||
130261276|NCT03110562|468923003|FG000|Crossover Period|Lost to Follow-up|0|||
130261277|NCT03110562|468923004|FG001|Crossover Period|Lost to Follow-up|0|||
130261278|NCT03110562|468923005|FG002|Crossover Period|Lost to Follow-up|0|||
130261279|NCT03110562|468923006|FG003|Crossover Period|Lost to Follow-up|1|||
130261280|NCT03110562|468923003|FG000|Crossover Period|Other|0|||
130261281|NCT03110562|468923004|FG001|Crossover Period|Other|0|||
130261282|NCT03110562|468923005|FG002|Crossover Period|Other|1|||
130261283|NCT03110562|468923006|FG003|Crossover Period|Other|1|||
130261284|NCT03110562|468923003|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
130034818|NCT00619229|468083758|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
130034819|NCT00619229|468083757|FG000|Overall Study|Investigator planned Cataract Operation|1|||
130034820|NCT00619229|468083758|FG001|Overall Study|Investigator planned Cataract Operation|0|||
130034821|NCT01700829|468083759|FG000|Overall Study|Withdrawal by Subject|1|||
130034822|NCT01700829|468083760|FG001|Overall Study|Withdrawal by Subject|1|||
130261285|NCT03110562|468923004|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
130261286|NCT03110562|468923005|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
130261287|NCT03110562|468923006|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
130261288|NCT02936323|468923009|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261289|NCT02936323|468923010|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130034823|NCT03367871|468083761|FG000|Overall Study|Lost to Follow-up|1|||
130261290|NCT02936323|468923011|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261291|NCT02936323|468923012|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130261292|NCT02936323|468923013|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130261293|NCT02936323|468923014|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
130261294|NCT02936323|468923015|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261295|NCT02936323|468923016|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261296|NCT02936323|468923017|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261297|NCT02936323|468923018|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
130261298|NCT02936323|468923009|FG000|Phase 1 Dose Escalation|Death|2|||
130261299|NCT02936323|468923010|FG001|Phase 1 Dose Escalation|Death|1|||
130261300|NCT02936323|468923011|FG002|Phase 1 Dose Escalation|Death|3|||
130261301|NCT02936323|468923012|FG003|Phase 1 Dose Escalation|Death|1|||
130261302|NCT02936323|468923013|FG004|Phase 1 Dose Escalation|Death|2|||
130261303|NCT02936323|468923014|FG005|Phase 1 Dose Escalation|Death|3|||
130261304|NCT02936323|468923015|FG006|Phase 1 Dose Escalation|Death|3|||
130261305|NCT02936323|468923016|FG007|Phase 1 Dose Escalation|Death|0|||
130261306|NCT02936323|468923017|FG008|Phase 1 Dose Escalation|Death|0|||
130261307|NCT02936323|468923018|FG009|Phase 1 Dose Escalation|Death|0|||
130261308|NCT02936323|468923009|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261309|NCT02936323|468923010|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261310|NCT02936323|468923011|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261311|NCT02936323|468923012|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261312|NCT02936323|468923013|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261313|NCT02936323|468923014|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
130261314|NCT02936323|468923015|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261315|NCT02936323|468923016|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261316|NCT02936323|468923017|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261317|NCT02936323|468923018|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
130261318|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261319|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261320|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261321|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261322|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261323|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261324|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
130261325|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
130261326|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
130261327|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
130261328|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
130261329|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
130261330|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
130261331|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
130261332|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
130261333|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
130261334|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
130261335|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
130261336|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
130261337|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
130261338|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261339|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261340|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261341|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261342|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261343|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261344|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261345|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
130261346|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
130261347|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
130261348|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261349|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261350|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261351|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130034824|NCT02983604|468083762|FG000|Overall Study|Enrolled but not Treated|0|||
130034825|NCT02983604|468083763|FG001|Overall Study|Enrolled but not Treated|0|||
130034826|NCT02983604|468083764|FG002|Overall Study|Enrolled but not Treated|1|||
130034827|NCT02983604|468083765|FG003|Overall Study|Enrolled but not Treated|0|||
130034828|NCT00316264|468083767|FG000|Overall Study|Lost to Follow-up|0|||
130034829|NCT00316264|468083768|FG001|Overall Study|Lost to Follow-up|1|||
130034830|NCT00316264|468083769|FG002|Overall Study|Lost to Follow-up|0|||
129800248|NCT05597020|467236278|FG000|Treatment Period II|Advice from primary care physician|1|||
130034831|NCT00316264|468083767|FG000|Overall Study|Withdrawal of Consent|3|||
130034832|NCT00316264|468083768|FG001|Overall Study|Withdrawal of Consent|5|||
130034833|NCT00316264|468083769|FG002|Overall Study|Withdrawal of Consent|6|||
130034834|NCT00316264|468083767|FG000|Overall Study|Death|2|||
130034835|NCT00316264|468083768|FG001|Overall Study|Death|0|||
130034836|NCT00316264|468083769|FG002|Overall Study|Death|0|||
130034837|NCT00316264|468083767|FG000|Overall Study|Other|1|||
130034838|NCT00316264|468083768|FG001|Overall Study|Other|1|||
130034839|NCT00316264|468083769|FG002|Overall Study|Other|0|||
130034840|NCT00607048|468083770|FG000|Overall Study|Adverse Event|0|||
130034841|NCT00607048|468083771|FG001|Overall Study|Adverse Event|1|||
130034842|NCT00607048|468083772|FG002|Overall Study|Adverse Event|0|||
130034843|NCT00607048|468083773|FG003|Overall Study|Adverse Event|0|||
130034844|NCT00607048|468083774|FG004|Overall Study|Adverse Event|4|||
130034845|NCT00607048|468083775|FG005|Overall Study|Adverse Event|0|||
130034846|NCT00607048|468083770|FG000|Overall Study|Global deterioration of health|1|||
130034847|NCT00607048|468083771|FG001|Overall Study|Global deterioration of health|0|||
130034848|NCT00607048|468083772|FG002|Overall Study|Global deterioration of health|0|||
130034849|NCT00607048|468083773|FG003|Overall Study|Global deterioration of health|0|||
130034850|NCT00607048|468083774|FG004|Overall Study|Global deterioration of health|0|||
130034851|NCT00607048|468083775|FG005|Overall Study|Global deterioration of health|0|||
130034852|NCT00607048|468083770|FG000|Overall Study|Objective disease progression - relapse|1|||
130034853|NCT00607048|468083771|FG001|Overall Study|Objective disease progression - relapse|2|||
130034854|NCT00607048|468083772|FG002|Overall Study|Objective disease progression - relapse|4|||
130034855|NCT00607048|468083773|FG003|Overall Study|Objective disease progression - relapse|2|||
130034856|NCT00607048|468083774|FG004|Overall Study|Objective disease progression - relapse|2|||
130034857|NCT00607048|468083775|FG005|Overall Study|Objective disease progression - relapse|2|||
130034858|NCT00607048|468083770|FG000|Overall Study|Withdrawal by Subject|0|||
130034859|NCT00607048|468083771|FG001|Overall Study|Withdrawal by Subject|0|||
130034860|NCT00607048|468083772|FG002|Overall Study|Withdrawal by Subject|0|||
130034861|NCT00607048|468083773|FG003|Overall Study|Withdrawal by Subject|1|||
130034862|NCT00607048|468083774|FG004|Overall Study|Withdrawal by Subject|0|||
130034863|NCT00607048|468083775|FG005|Overall Study|Withdrawal by Subject|2|||
130034864|NCT00607048|468083770|FG000|Overall Study|Other|1|||
130034865|NCT00607048|468083771|FG001|Overall Study|Other|1|||
130261352|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261353|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261354|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261355|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261356|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
130261357|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
130261358|NCT02936323|468923009|FG000|Phase 2a Dose Expansion|Death|0|||
130261359|NCT02936323|468923010|FG001|Phase 2a Dose Expansion|Death|0|||
130261360|NCT02936323|468923011|FG002|Phase 2a Dose Expansion|Death|0|||
130261361|NCT02936323|468923012|FG003|Phase 2a Dose Expansion|Death|0|||
130261362|NCT02936323|468923013|FG004|Phase 2a Dose Expansion|Death|0|||
130261363|NCT02936323|468923014|FG005|Phase 2a Dose Expansion|Death|0|||
130261364|NCT02936323|468923015|FG006|Phase 2a Dose Expansion|Death|0|||
130261365|NCT02936323|468923016|FG007|Phase 2a Dose Expansion|Death|4|||
130261366|NCT02936323|468923017|FG008|Phase 2a Dose Expansion|Death|8|||
130261367|NCT02936323|468923018|FG009|Phase 2a Dose Expansion|Death|10|||
130261368|NCT01334918|468923904|FG000|Overall Study|Did not receive study drug|6|||
130261369|NCT01334918|468923905|FG001|Overall Study|Did not receive study drug|0|||
130261370|NCT01334918|468923904|FG000|Overall Study|Adverse Event|2|||
130261371|NCT01334918|468923905|FG001|Overall Study|Adverse Event|0|||
130261372|NCT01334918|468923904|FG000|Overall Study|Withdrawal by Subject|0|||
130261373|NCT01334918|468923905|FG001|Overall Study|Withdrawal by Subject|1|||
130261374|NCT05878067|468923908|FG000|Overall Study|Lost to Follow-up|2|||
130261375|NCT00949533|468923909|FG000|Overall Study|Lost to Follow-up|0|||
130261376|NCT00949533|468923910|FG001|Overall Study|Lost to Follow-up|1|||
130261377|NCT01959529|468923911|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
130034866|NCT00607048|468083772|FG002|Overall Study|Other|0|||
130261378|NCT01959529|468923912|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
130261379|NCT01959529|468923911|FG000|Overall Study|Lost to Follow-up|4|||
130261380|NCT01959529|468923912|FG001|Overall Study|Lost to Follow-up|1|||
130261381|NCT01959529|468923911|FG000|Overall Study|Other|70|||
130261382|NCT01959529|468923912|FG001|Overall Study|Other|68|||
130261383|NCT01959529|468923911|FG000|Overall Study|Hypoglycaemia|1|||
130261384|NCT01959529|468923912|FG001|Overall Study|Hypoglycaemia|1|||
130261385|NCT01959529|468923911|FG000|Overall Study|Lack of glycaemic control|1|||
130261386|NCT01959529|468923912|FG001|Overall Study|Lack of glycaemic control|1|||
130261387|NCT00399035|468923920|FG000|Overall Study|Death|289|||
130034867|NCT00607048|468083773|FG003|Overall Study|Other|0|||
130034868|NCT00607048|468083774|FG004|Overall Study|Other|0|||
130261388|NCT00399035|468923921|FG001|Overall Study|Death|141|||
130261389|NCT00399035|468923922|FG002|Overall Study|Death|234|||
130261390|NCT00399035|468923920|FG000|Overall Study|Lost to Follow-up|2|||
130261391|NCT00399035|468923921|FG001|Overall Study|Lost to Follow-up|1|||
130261392|NCT00399035|468923922|FG002|Overall Study|Lost to Follow-up|5|||
130261393|NCT00399035|468923920|FG000|Overall Study|Withdrawal by Subject|19|||
130261394|NCT00399035|468923921|FG001|Overall Study|Withdrawal by Subject|15|||
130261395|NCT00399035|468923922|FG002|Overall Study|Withdrawal by Subject|12|||
130261396|NCT00399035|468923920|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
130261397|NCT00399035|468923921|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
130261398|NCT00399035|468923922|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
130261399|NCT00399035|468923920|FG000|Overall Study|Severe non-compliance with protocol|2|||
130261400|NCT00399035|468923921|FG001|Overall Study|Severe non-compliance with protocol|1|||
130261401|NCT00399035|468923922|FG002|Overall Study|Severe non-compliance with protocol|0|||
130261402|NCT00854360|468923923|FG000|Overall Study|Adverse Event|0|||
130261403|NCT00854360|468923924|FG001|Overall Study|Adverse Event|1|||
130261404|NCT00854360|468923925|FG002|Overall Study|Adverse Event|2|||
130261405|NCT00854360|468923926|FG003|Overall Study|Adverse Event|6|||
130261406|NCT00854360|468923923|FG000|Overall Study|Withdrawal by Subject|0|||
130261407|NCT00854360|468923924|FG001|Overall Study|Withdrawal by Subject|0|||
130261408|NCT00854360|468923925|FG002|Overall Study|Withdrawal by Subject|0|||
130261409|NCT00854360|468923926|FG003|Overall Study|Withdrawal by Subject|1|||
130261410|NCT00854360|468923923|FG000|Overall Study|Pregnancy|0|||
130261411|NCT00854360|468923924|FG001|Overall Study|Pregnancy|1|||
130261412|NCT00854360|468923925|FG002|Overall Study|Pregnancy|0|||
130261413|NCT00854360|468923926|FG003|Overall Study|Pregnancy|0|||
130261414|NCT00854360|468923923|FG000|Overall Study|Lack of Efficacy|2|||
130261415|NCT00854360|468923924|FG001|Overall Study|Lack of Efficacy|1|||
130261416|NCT00854360|468923925|FG002|Overall Study|Lack of Efficacy|0|||
130261417|NCT00854360|468923926|FG003|Overall Study|Lack of Efficacy|0|||
130261418|NCT00854360|468923923|FG000|Overall Study|Other|0|||
130261419|NCT00854360|468923924|FG001|Overall Study|Other|0|||
130261420|NCT00854360|468923925|FG002|Overall Study|Other|0|||
130261421|NCT00854360|468923926|FG003|Overall Study|Other|3|||
130034869|NCT00607048|468083775|FG005|Overall Study|Other|1|||
130261422|NCT01128569|468923930|FG000|Washout Period 1|Adverse Event|0|||
130261423|NCT01128569|468923931|FG001|Washout Period 1|Adverse Event|0|||
130261424|NCT01128569|468923932|FG002|Washout Period 1|Adverse Event|1|||
130261425|NCT01128569|468923933|FG003|Washout Period 1|Adverse Event|0|||
130261426|NCT01128569|468923934|FG004|Washout Period 1|Adverse Event|0|||
130261427|NCT01128569|468923935|FG005|Washout Period 1|Adverse Event|0|||
130261428|NCT01128569|468923930|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130261429|NCT01128569|468923931|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130261430|NCT01128569|468923932|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130261431|NCT01128569|468923933|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130261432|NCT01128569|468923934|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130261433|NCT01128569|468923935|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130261434|NCT02493764|468923939|FG000|Overall Study|Adverse Event|2|||
130261435|NCT02493764|468923940|FG001|Overall Study|Adverse Event|2|||
130261436|NCT02493764|468923939|FG000|Overall Study|Death|44|||
130261437|NCT02493764|468923940|FG001|Overall Study|Death|58|||
130261438|NCT02493764|468923939|FG000|Overall Study|Lost to Follow-up|2|||
130261439|NCT02493764|468923940|FG001|Overall Study|Lost to Follow-up|1|||
130261440|NCT02493764|468923939|FG000|Overall Study|Protocol Violation|6|||
130261441|NCT02493764|468923940|FG001|Overall Study|Protocol Violation|7|||
130261442|NCT02493764|468923939|FG000|Overall Study|Physician Decision|1|||
130261443|NCT02493764|468923940|FG001|Overall Study|Physician Decision|1|||
130261444|NCT02493764|468923939|FG000|Overall Study|Participant moved|17|||
130261445|NCT02493764|468923940|FG001|Overall Study|Participant moved|5|||
130261446|NCT02493764|468923939|FG000|Overall Study|Withdrawal parent/guardian|0|||
130261447|NCT02493764|468923940|FG001|Overall Study|Withdrawal parent/guardian|1|||
130261448|NCT02493764|468923939|FG000|Overall Study|Withdrawal by Subject|11|||
130261449|NCT02493764|468923940|FG001|Overall Study|Withdrawal by Subject|7|||
130261450|NCT01561976|468923943|FG000|Period 1|Adverse Event|0|||
130261451|NCT01561976|468923944|FG001|Period 1|Adverse Event|0|||
130261452|NCT01561976|468923945|FG002|Period 1|Adverse Event|1|||
130261453|NCT01561976|468923946|FG003|Period 1|Adverse Event|0|||
130261454|NCT01561976|468923947|FG004|Period 1|Adverse Event|0|||
130261455|NCT01561976|468923948|FG005|Period 1|Adverse Event|0|||
130261456|NCT01561976|468923943|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130261457|NCT01561976|468923944|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
130261458|NCT01561976|468923945|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130261459|NCT01561976|468923946|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
130261460|NCT01561976|468923947|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
130261461|NCT01561976|468923948|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
130261462|NCT01561976|468923943|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130261463|NCT01561976|468923944|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130261464|NCT01561976|468923945|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
130261465|NCT01561976|468923946|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129885590|NCT02611830|467540768|FG001|OL Induction Phase|Reason not specified|0|||
130261466|NCT01561976|468923947|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129885591|NCT02611830|467540769|FG002|OL Induction Phase|Reason not specified|0|||
129885592|NCT02611830|467540770|FG003|OL Induction Phase|Reason not specified|0|||
130261467|NCT01561976|468923948|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
130261468|NCT01561976|468923943|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
130261469|NCT01561976|468923944|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
130261470|NCT01561976|468923945|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
130261471|NCT01561976|468923946|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
130261472|NCT01561976|468923947|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
130261473|NCT01561976|468923948|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
130261474|NCT04403919|468923949|FG000|Overall Study|Lost to Follow-up|0|||
130261475|NCT04403919|468923950|FG001|Overall Study|Lost to Follow-up|0|||
130261476|NCT04403919|468923951|FG002|Overall Study|Lost to Follow-up|0|||
130261477|NCT04403919|468923952|FG003|Overall Study|Lost to Follow-up|1|||
130261478|NCT01156844|468923953|FG000|Overall Study|Adverse Event|0|||
130261479|NCT01156844|468923954|FG001|Overall Study|Adverse Event|0|||
130261480|NCT01156844|468923955|FG002|Overall Study|Adverse Event|1|||
130261481|NCT01156844|468923956|FG003|Overall Study|Adverse Event|1|||
130261482|NCT01156844|468923953|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130261483|NCT01156844|468923954|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130261484|NCT01156844|468923955|FG002|Overall Study|Abnormal test procedure result(s)|2|||
130034870|NCT00355264|468083776|FG000|Extension (Variable Duration)|Adverse Event|1|||
130034871|NCT00355264|468083776|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
130034872|NCT01157117|468083777|FG000|Overall Study|Dosing Symptoms|0|||
130034873|NCT01157117|468083778|FG001|Overall Study|Dosing Symptoms|4|||
130261485|NCT01156844|468923956|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130261486|NCT01156844|468923953|FG000|Overall Study|Withdrawal by Subject|0|||
130261487|NCT01156844|468923954|FG001|Overall Study|Withdrawal by Subject|0|||
130261488|NCT01156844|468923955|FG002|Overall Study|Withdrawal by Subject|2|||
130261489|NCT01156844|468923956|FG003|Overall Study|Withdrawal by Subject|2|||
130261490|NCT01156844|468923953|FG000|Overall Study|Lost to Follow-up|0|||
130261491|NCT01156844|468923954|FG001|Overall Study|Lost to Follow-up|0|||
130261492|NCT01156844|468923955|FG002|Overall Study|Lost to Follow-up|1|||
130261493|NCT01156844|468923956|FG003|Overall Study|Lost to Follow-up|0|||
130261494|NCT01156844|468923953|FG000|Overall Study|Administrative problems|0|||
130034874|NCT01157117|468083779|FG002|Overall Study|Dosing Symptoms|0|||
130034875|NCT01157117|468083777|FG000|Overall Study|Withdrawal by Subject|4|||
130034876|NCT01157117|468083778|FG001|Overall Study|Withdrawal by Subject|1|||
130034877|NCT01157117|468083779|FG002|Overall Study|Withdrawal by Subject|1|||
130034878|NCT01157117|468083777|FG000|Overall Study|Lack of Efficacy|1|||
130034879|NCT01157117|468083778|FG001|Overall Study|Lack of Efficacy|1|||
130261495|NCT01156844|468923954|FG001|Overall Study|Administrative problems|1|||
130261496|NCT01156844|468923955|FG002|Overall Study|Administrative problems|0|||
130034880|NCT01157117|468083779|FG002|Overall Study|Lack of Efficacy|0|||
130034881|NCT01157117|468083777|FG000|Overall Study|Lost to Follow-up|0|||
130034882|NCT01157117|468083778|FG001|Overall Study|Lost to Follow-up|0|||
130034883|NCT01157117|468083779|FG002|Overall Study|Lost to Follow-up|1|||
130034884|NCT01157117|468083777|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
130034885|NCT01157117|468083778|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
130034886|NCT01157117|468083779|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
130034887|NCT00826514|468083780|FG000|Overall Study|Adverse Event|1|||
130034888|NCT00826514|468083781|FG001|Overall Study|Adverse Event|1|||
130034889|NCT00826514|468083780|FG000|Overall Study|Lack of Efficacy|0|||
130034890|NCT00826514|468083781|FG001|Overall Study|Lack of Efficacy|1|||
130034891|NCT00826514|468083780|FG000|Overall Study|Withdrawal by Subject|2|||
130034892|NCT00826514|468083781|FG001|Overall Study|Withdrawal by Subject|3|||
130034893|NCT03663166|468083784|FG000|Overall Study|Withdrawal by Subject|1|||
130034894|NCT04348851|468083790|FG000|Post-Test 1|Withdrawal by Subject|0|||
130034895|NCT04348851|468083791|FG001|Post-Test 1|Withdrawal by Subject|1|||
130034896|NCT04348851|468083792|FG002|Post-Test 1|Withdrawal by Subject|0|||
130034897|NCT04348851|468083793|FG003|Post-Test 1|Withdrawal by Subject|0|||
130034898|NCT04348851|468083790|FG000|Post-Test 1|Lost to Follow-up|0|||
130034899|NCT04348851|468083791|FG001|Post-Test 1|Lost to Follow-up|1|||
130034900|NCT04348851|468083792|FG002|Post-Test 1|Lost to Follow-up|0|||
130034901|NCT04348851|468083793|FG003|Post-Test 1|Lost to Follow-up|0|||
130261497|NCT01156844|468923956|FG003|Overall Study|Administrative problems|1|||
130261498|NCT01156844|468923953|FG000|Overall Study|Protocol deviation|2|||
130034902|NCT04348851|468083790|FG000|Post-Test 2|Stroke survivor death|0|||
130034903|NCT04348851|468083791|FG001|Post-Test 2|Stroke survivor death|1|||
130034904|NCT04348851|468083792|FG002|Post-Test 2|Stroke survivor death|0|||
130034905|NCT04348851|468083793|FG003|Post-Test 2|Stroke survivor death|1|||
130034906|NCT02965378|468083794|FG000|Overall Study|Progression|16|||
130034907|NCT02965378|468083795|FG001|Overall Study|Progression|4|||
130034908|NCT02965378|468083794|FG000|Overall Study|Adverse Event|5|||
130261499|NCT01156844|468923954|FG001|Overall Study|Protocol deviation|0|||
130261500|NCT01156844|468923955|FG002|Overall Study|Protocol deviation|0|||
130261501|NCT01156844|468923956|FG003|Overall Study|Protocol deviation|0|||
130034909|NCT02965378|468083795|FG001|Overall Study|Adverse Event|2|||
130034910|NCT02965378|468083794|FG000|Overall Study|Death|2|||
130034911|NCT02965378|468083795|FG001|Overall Study|Death|0|||
130261502|NCT04846231|468923959|FG000|Overall Study|Lost to Follow-up|1|||
130261503|NCT04846231|468923960|FG001|Overall Study|Lost to Follow-up|0|||
130261504|NCT04846231|468923961|FG002|Overall Study|Lost to Follow-up|0|||
130261505|NCT04846231|468923962|FG003|Overall Study|Lost to Follow-up|0|||
130261506|NCT04846231|468923963|FG004|Overall Study|Lost to Follow-up|0|||
130034912|NCT02965378|468083794|FG000|Overall Study|Refusal|2|||
130261507|NCT04846231|468923964|FG005|Overall Study|Lost to Follow-up|0|||
130261508|NCT04846231|468923965|FG006|Overall Study|Lost to Follow-up|0|||
130261509|NCT04846231|468923966|FG007|Overall Study|Lost to Follow-up|1|||
130261510|NCT04846231|468923959|FG000|Overall Study|Withdrawal by Subject|0|||
130261511|NCT04846231|468923960|FG001|Overall Study|Withdrawal by Subject|1|||
130261512|NCT04846231|468923961|FG002|Overall Study|Withdrawal by Subject|2|||
130261513|NCT04846231|468923962|FG003|Overall Study|Withdrawal by Subject|1|||
130261514|NCT04846231|468923963|FG004|Overall Study|Withdrawal by Subject|0|||
130261515|NCT04846231|468923964|FG005|Overall Study|Withdrawal by Subject|0|||
130261516|NCT04846231|468923965|FG006|Overall Study|Withdrawal by Subject|0|||
130261517|NCT04846231|468923966|FG007|Overall Study|Withdrawal by Subject|0|||
130261518|NCT04846231|468923959|FG000|Overall Study|Protocol Violation|0|||
130261519|NCT04846231|468923960|FG001|Overall Study|Protocol Violation|1|||
130261520|NCT04846231|468923961|FG002|Overall Study|Protocol Violation|0|||
130261521|NCT04846231|468923962|FG003|Overall Study|Protocol Violation|0|||
130261522|NCT04846231|468923963|FG004|Overall Study|Protocol Violation|0|||
130261523|NCT04846231|468923964|FG005|Overall Study|Protocol Violation|0|||
130261524|NCT04846231|468923965|FG006|Overall Study|Protocol Violation|0|||
130261525|NCT04846231|468923966|FG007|Overall Study|Protocol Violation|0|||
130261526|NCT04846231|468923959|FG000|Overall Study|Adverse Event|0|||
130261527|NCT04846231|468923960|FG001|Overall Study|Adverse Event|0|||
130261528|NCT04846231|468923961|FG002|Overall Study|Adverse Event|0|||
130261529|NCT04846231|468923962|FG003|Overall Study|Adverse Event|0|||
130261530|NCT04846231|468923963|FG004|Overall Study|Adverse Event|0|||
130261531|NCT04846231|468923964|FG005|Overall Study|Adverse Event|0|||
130261532|NCT04846231|468923965|FG006|Overall Study|Adverse Event|1|||
130261533|NCT04846231|468923966|FG007|Overall Study|Adverse Event|1|||
130261534|NCT01448616|468923967|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
130261535|NCT01448616|468923968|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130261536|NCT01448616|468923969|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130261537|NCT01448616|468923970|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
130261538|NCT01448616|468923967|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
130261539|NCT01448616|468923968|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130261540|NCT01448616|468923969|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130261541|NCT01448616|468923970|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
130261542|NCT01448616|468923967|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
130261543|NCT01448616|468923968|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
130261544|NCT01448616|468923969|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
130261545|NCT01448616|468923970|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
130261546|NCT01448616|468923967|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
130261547|NCT01448616|468923968|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
130261548|NCT01448616|468923969|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
130261549|NCT01448616|468923970|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
130261550|NCT01448616|468923967|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
130261551|NCT01448616|468923968|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
130261552|NCT01448616|468923969|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
130261553|NCT01448616|468923970|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
130261554|NCT02170064|468923971|FG000|Overall Study|Withdrawal by Subject|5|||
130261555|NCT02170064|468923972|FG001|Overall Study|Withdrawal by Subject|1|||
130261556|NCT02170064|468923973|FG002|Overall Study|Withdrawal by Subject|1|||
130261557|NCT02170064|468923971|FG000|Overall Study|Physician Decision|1|||
130261558|NCT02170064|468923972|FG001|Overall Study|Physician Decision|1|||
130261559|NCT02170064|468923973|FG002|Overall Study|Physician Decision|0|||
130261560|NCT03323164|468923974|FG000|Overall Study|Poor quality imaging/scans|2|||
130261561|NCT03323164|468923975|FG001|Overall Study|Poor quality imaging/scans|2|||
130261562|NCT00654732|468923976|FG000|Overall Study|Adverse Event|4|||
130261563|NCT00654732|468923977|FG001|Overall Study|Adverse Event|6|||
130261564|NCT01959932|468923978|FG000|Overall Study|Withdrawal by Subject|1|||
130261565|NCT01959932|468923979|FG001|Overall Study|Withdrawal by Subject|0|||
130261566|NCT01959932|468923980|FG002|Overall Study|Withdrawal by Subject|0|||
130261567|NCT00397540|468923981|FG000|Overall Study|short follow-up duration < 12 months|1|||
130261568|NCT00397540|468923982|FG001|Overall Study|short follow-up duration < 12 months|0|||
130261569|NCT00776230|468923985|FG000|Overall Study|Lost to Follow-up|2|||
130261570|NCT00776230|468923986|FG001|Overall Study|Lost to Follow-up|1|||
130034913|NCT02965378|468083795|FG001|Overall Study|Refusal|1|||
130261571|NCT00776230|468923987|FG002|Overall Study|Lost to Follow-up|5|||
130261572|NCT00776230|468923985|FG000|Overall Study|Not vaccinated at Day 0|1|||
130261573|NCT00776230|468923986|FG001|Overall Study|Not vaccinated at Day 0|0|||
130261574|NCT00776230|468923987|FG002|Overall Study|Not vaccinated at Day 0|0|||
130261575|NCT00776230|468923985|FG000|Overall Study|Withdrawal by Subject|0|||
130261576|NCT00776230|468923986|FG001|Overall Study|Withdrawal by Subject|1|||
130261577|NCT00776230|468923987|FG002|Overall Study|Withdrawal by Subject|0|||
130261578|NCT00776230|468923985|FG000|Overall Study|Subject missed Visit 4|0|||
130261579|NCT00776230|468923986|FG001|Overall Study|Subject missed Visit 4|1|||
130034914|NCT02965378|468083794|FG000|Overall Study|Not protocol specified|0|||
130261580|NCT00776230|468923987|FG002|Overall Study|Subject missed Visit 4|0|||
130261581|NCT00746811|468923988|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
130261582|NCT00746811|468923989|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
130261583|NCT02993263|468924001|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
130261584|NCT00545779|468924002|FG000|Overall Study|Violation of selection criteria at entry|8|||
130261585|NCT00545779|468924002|FG000|Overall Study|Other protocol violation|1|||
130261586|NCT00545779|468924002|FG000|Overall Study|Did not cooperate|7|||
130261587|NCT00545779|468924002|FG000|Overall Study|Withdrawal by Subject|20|||
130261588|NCT00545779|468924002|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
130261589|NCT00545779|468924002|FG000|Overall Study|Failure to return|3|||
130261590|NCT01405196|468924003|FG000|Overall Study|Study Terminated by Sponsor|0|||
130261591|NCT01405196|468924004|FG001|Overall Study|Study Terminated by Sponsor|0|||
130261592|NCT01405196|468924005|FG002|Overall Study|Study Terminated by Sponsor|9|||
130261593|NCT01405196|468924006|FG003|Overall Study|Study Terminated by Sponsor|0|||
130261594|NCT01405196|468924003|FG000|Overall Study|Other|2|||
130261595|NCT01405196|468924004|FG001|Overall Study|Other|2|||
130261596|NCT01405196|468924005|FG002|Overall Study|Other|5|||
130261597|NCT01405196|468924006|FG003|Overall Study|Other|0|||
130261598|NCT01405196|468924003|FG000|Overall Study|Withdrawal by Subject|4|||
130261599|NCT01405196|468924004|FG001|Overall Study|Withdrawal by Subject|6|||
130261600|NCT01405196|468924005|FG002|Overall Study|Withdrawal by Subject|3|||
130261601|NCT01405196|468924006|FG003|Overall Study|Withdrawal by Subject|6|||
130261602|NCT01405196|468924003|FG000|Overall Study|Adverse Event|2|||
130261603|NCT01405196|468924004|FG001|Overall Study|Adverse Event|2|||
130261604|NCT01405196|468924005|FG002|Overall Study|Adverse Event|0|||
130261605|NCT01405196|468924006|FG003|Overall Study|Adverse Event|2|||
130261606|NCT01405196|468924003|FG000|Overall Study|Death|1|||
130261607|NCT01405196|468924004|FG001|Overall Study|Death|0|||
130261608|NCT01405196|468924005|FG002|Overall Study|Death|3|||
130261609|NCT01405196|468924006|FG003|Overall Study|Death|0|||
130261610|NCT01405196|468924003|FG000|Overall Study|Lost to Follow-up|2|||
130261611|NCT01405196|468924004|FG001|Overall Study|Lost to Follow-up|2|||
130261612|NCT01405196|468924005|FG002|Overall Study|Lost to Follow-up|3|||
130261613|NCT01405196|468924006|FG003|Overall Study|Lost to Follow-up|1|||
130261614|NCT01729039|468924009|FG000|Overall Study|disqualified|2|||
130261615|NCT01729039|468924010|FG001|Overall Study|disqualified|5|||
130261616|NCT01729039|468924009|FG000|Overall Study|Withdrawal by Subject|8|||
130261617|NCT01729039|468924010|FG001|Overall Study|Withdrawal by Subject|7|||
130261618|NCT00698841|468924011|FG000|Overall Study|Withdrawal by Subject|2|||
130261619|NCT00698841|468924011|FG000|Overall Study|Adverse Event|3|||
130261620|NCT00698841|468924011|FG000|Overall Study|Disease progression|7|||
130261621|NCT00698841|468924011|FG000|Overall Study|Failure to meet eligibility criteria|2|||
130261622|NCT00698841|468924011|FG000|Overall Study|Study drug toxicity|2|||
130261623|NCT00698841|468924011|FG000|Overall Study|Other|2|||
130261624|NCT02611037|468924012|FG000|Overall Study|Withdrawal prior to treatment|2|||
130261625|NCT02611037|468924013|FG001|Overall Study|Withdrawal prior to treatment|0|||
130261626|NCT00829998|468924014|FG000|Washout|Adverse Event|0|||
130261627|NCT00829998|468924015|FG001|Washout|Adverse Event|1|||
130261628|NCT05788991|468924018|FG000|Overall Study|Not treated with study medication|1|||
130261629|NCT05788991|468924019|FG001|Overall Study|Not treated with study medication|3|||
130261630|NCT05788991|468924018|FG000|Overall Study|Withdrawal by Subject|1|||
130261631|NCT05788991|468924019|FG001|Overall Study|Withdrawal by Subject|0|||
130261632|NCT05788991|468924018|FG000|Overall Study|Lack of Efficacy|0|||
130261633|NCT05788991|468924019|FG001|Overall Study|Lack of Efficacy|1|||
130261634|NCT05788991|468924018|FG000|Overall Study|Protocol Violation|1|||
130261635|NCT05788991|468924019|FG001|Overall Study|Protocol Violation|2|||
130261636|NCT05270863|468924020|FG000|Visit 2 First Intervention|Randomization error|0|||
130261637|NCT05270863|468924021|FG001|Visit 2 First Intervention|Randomization error|0|||
130261638|NCT05270863|468924022|FG002|Visit 2 First Intervention|Randomization error|0|||
130261639|NCT05270863|468924023|FG003|Visit 2 First Intervention|Randomization error|1|||
130261640|NCT05270863|468924024|FG004|Visit 2 First Intervention|Randomization error|0|||
130261641|NCT05270863|468924025|FG005|Visit 2 First Intervention|Randomization error|0|||
130261642|NCT05270863|468924020|FG000|First Washout|Withdrawal by Subject|0|||
130102176|NCT00203892|468332657|FG000|Overall Study|Death|1|||
130261643|NCT05270863|468924021|FG001|First Washout|Withdrawal by Subject|0|||
130261644|NCT05270863|468924022|FG002|First Washout|Withdrawal by Subject|0|||
130261645|NCT05270863|468924023|FG003|First Washout|Withdrawal by Subject|0|||
130261646|NCT05270863|468924024|FG004|First Washout|Withdrawal by Subject|1|||
130261647|NCT05270863|468924025|FG005|First Washout|Withdrawal by Subject|1|||
130261648|NCT05270863|468924020|FG000|First Washout|Lost to Follow-up|0|||
130261649|NCT05270863|468924021|FG001|First Washout|Lost to Follow-up|0|||
130261650|NCT05270863|468924022|FG002|First Washout|Lost to Follow-up|0|||
130261651|NCT05270863|468924023|FG003|First Washout|Lost to Follow-up|0|||
130261652|NCT05270863|468924024|FG004|First Washout|Lost to Follow-up|0|||
130261653|NCT05270863|468924025|FG005|First Washout|Lost to Follow-up|1|||
130261654|NCT05270863|468924020|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
130261655|NCT05270863|468924021|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261656|NCT05270863|468924022|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
130261657|NCT05270863|468924023|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261658|NCT05270863|468924024|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261659|NCT05270863|468924025|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
130261660|NCT05270863|468924020|FG000|Second Washout|Withdrawal by Subject|1|||
130261661|NCT05270863|468924021|FG001|Second Washout|Withdrawal by Subject|1|||
130261662|NCT05270863|468924022|FG002|Second Washout|Withdrawal by Subject|0|||
130261663|NCT05270863|468924023|FG003|Second Washout|Withdrawal by Subject|0|||
130261664|NCT05270863|468924024|FG004|Second Washout|Withdrawal by Subject|0|||
130261665|NCT05270863|468924025|FG005|Second Washout|Withdrawal by Subject|0|||
130261666|NCT05270863|468924020|FG000|Second Washout|Lost to Follow-up|0|||
130261667|NCT05270863|468924021|FG001|Second Washout|Lost to Follow-up|0|||
130261668|NCT05270863|468924022|FG002|Second Washout|Lost to Follow-up|0|||
130261669|NCT05270863|468924023|FG003|Second Washout|Lost to Follow-up|1|||
130261670|NCT05270863|468924024|FG004|Second Washout|Lost to Follow-up|0|||
130261671|NCT05270863|468924025|FG005|Second Washout|Lost to Follow-up|0|||
130261672|NCT04464473|468924026|FG000|Overall Study|New piercing could not be removed for scanning|0|||
130261673|NCT04464473|468924027|FG001|Overall Study|New piercing could not be removed for scanning|0|||
130261674|NCT04464473|468924028|FG002|Overall Study|New piercing could not be removed for scanning|0|||
130261675|NCT04464473|468924029|FG003|Overall Study|New piercing could not be removed for scanning|1|||
130261676|NCT04464473|468924030|FG004|Overall Study|New piercing could not be removed for scanning|0|||
130261677|NCT04464473|468924031|FG005|Overall Study|New piercing could not be removed for scanning|0|||
130261678|NCT04464473|468924026|FG000|Overall Study|Adverse Event|0|||
130261679|NCT04464473|468924027|FG001|Overall Study|Adverse Event|0|||
130261680|NCT04464473|468924028|FG002|Overall Study|Adverse Event|0|||
130261681|NCT04464473|468924029|FG003|Overall Study|Adverse Event|1|||
130261682|NCT04464473|468924030|FG004|Overall Study|Adverse Event|0|||
130261683|NCT04464473|468924031|FG005|Overall Study|Adverse Event|0|||
130261684|NCT04464473|468924026|FG000|Overall Study|Lost to Follow-up|0|||
130261685|NCT04464473|468924027|FG001|Overall Study|Lost to Follow-up|0|||
130261686|NCT04464473|468924028|FG002|Overall Study|Lost to Follow-up|0|||
130261687|NCT04464473|468924029|FG003|Overall Study|Lost to Follow-up|1|||
130261688|NCT04464473|468924030|FG004|Overall Study|Lost to Follow-up|0|||
130261689|NCT04464473|468924031|FG005|Overall Study|Lost to Follow-up|0|||
130261690|NCT02114177|468925702|FG000|Overall Study|Lost to Follow-up|1|||
130261691|NCT02114177|468925703|FG001|Overall Study|Lost to Follow-up|2|||
130261692|NCT02114177|468925702|FG000|Overall Study|Withdrawal by Subject|6|||
130261693|NCT02114177|468925703|FG001|Overall Study|Withdrawal by Subject|1|||
130261694|NCT02114177|468925702|FG000|Overall Study|Other|2|||
130261695|NCT02114177|468925703|FG001|Overall Study|Other|1|||
130261696|NCT01585025|468925704|FG000|Overall Study|Withdrawal by Subject|0|||
130261697|NCT01585025|468925705|FG001|Overall Study|Withdrawal by Subject|3|||
130261698|NCT01585025|468925706|FG002|Overall Study|Withdrawal by Subject|4|||
130261699|NCT00503984|468925707|FG000|Overall Study|Protocol Violation|0|||
130261700|NCT00503984|468925708|FG001|Overall Study|Protocol Violation|1|||
130261701|NCT00503984|468925709|FG002|Overall Study|Protocol Violation|0|||
130261702|NCT00503984|468925710|FG003|Overall Study|Protocol Violation|0|||
130261703|NCT00503984|468925711|FG004|Overall Study|Protocol Violation|0|||
130261704|NCT00503984|468925712|FG005|Overall Study|Protocol Violation|0|||
130261705|NCT00503984|468925707|FG000|Overall Study|Adverse Event|0|||
130261706|NCT00503984|468925708|FG001|Overall Study|Adverse Event|1|||
130261707|NCT00503984|468925709|FG002|Overall Study|Adverse Event|0|||
130261708|NCT00503984|468925710|FG003|Overall Study|Adverse Event|0|||
130261709|NCT00503984|468925711|FG004|Overall Study|Adverse Event|0|||
130261710|NCT00503984|468925712|FG005|Overall Study|Adverse Event|0|||
130261711|NCT00503984|468925707|FG000|Overall Study|Death|0|||
130261712|NCT00503984|468925708|FG001|Overall Study|Death|0|||
130261713|NCT00503984|468925709|FG002|Overall Study|Death|0|||
129885593|NCT02611830|467540767|FG000|Maintenance Phase|Lack of Efficacy|0|||
130261714|NCT00503984|468925710|FG003|Overall Study|Death|0|||
130261715|NCT00503984|468925711|FG004|Overall Study|Death|1|||
130261716|NCT00503984|468925712|FG005|Overall Study|Death|0|||
130261717|NCT01246960|468925713|FG000|Overall Study|Lost to Follow-up|3|||
130261718|NCT01246960|468925714|FG001|Overall Study|Lost to Follow-up|1|||
130261719|NCT01246960|468925713|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
129885594|NCT02611830|467540768|FG001|Maintenance Phase|Lack of Efficacy|29|||
130261720|NCT01246960|468925714|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
130261721|NCT00140140|468925721|FG000|Overall Study|Unacceptable toxicity|1|||
130261722|NCT00140140|468925722|FG001|Overall Study|Unacceptable toxicity|1|||
130261723|NCT00140140|468925723|FG002|Overall Study|Unacceptable toxicity|2|||
130261724|NCT00140140|468925721|FG000|Overall Study|Physician Decision|1|||
130261725|NCT00140140|468925722|FG001|Overall Study|Physician Decision|1|||
130261726|NCT00140140|468925723|FG002|Overall Study|Physician Decision|0|||
130261727|NCT03376516|468925724|FG000|Overall Study|Not treated|1|||
130261728|NCT03376516|468925724|FG000|Overall Study|Consent withdrawn|1|||
130261729|NCT01359956|468925725|FG000|Overall Study|Death|58|||
130261730|NCT01359956|468925726|FG001|Overall Study|Death|60|||
130261731|NCT01359956|468925727|FG002|Overall Study|Death|66|||
130261732|NCT01359956|468925728|FG003|Overall Study|Death|57|||
130261733|NCT01359956|468925725|FG000|Overall Study|Lost to Follow-up|3|||
130261734|NCT01359956|468925726|FG001|Overall Study|Lost to Follow-up|4|||
130261735|NCT01359956|468925727|FG002|Overall Study|Lost to Follow-up|1|||
130261736|NCT01359956|468925728|FG003|Overall Study|Lost to Follow-up|1|||
130261737|NCT00582907|468925729|FG000|1st Course|Withdrawal by Subject|1|||
130261738|NCT00582907|468925730|FG001|1st Course|Withdrawal by Subject|0|||
130261739|NCT00582907|468925731|FG002|1st Course|Withdrawal by Subject|0|||
130261740|NCT00582907|468925732|FG003|1st Course|Withdrawal by Subject|0|||
130261741|NCT00582907|468925729|FG000|1st Course|Lost to Follow-up|0|||
130261742|NCT00582907|468925730|FG001|1st Course|Lost to Follow-up|0|||
130261743|NCT00582907|468925731|FG002|1st Course|Lost to Follow-up|0|||
130261744|NCT00582907|468925732|FG003|1st Course|Lost to Follow-up|1|||
130261745|NCT00582907|468925729|FG000|2nd Course|Lack of Efficacy|1|||
130261746|NCT00582907|468925730|FG001|2nd Course|Lack of Efficacy|0|||
130261747|NCT00582907|468925731|FG002|2nd Course|Lack of Efficacy|0|||
130261748|NCT00582907|468925732|FG003|2nd Course|Lack of Efficacy|0|||
130261749|NCT00370292|468925733|FG000|Overall Study|Disease Progression|4|||
130261750|NCT00370292|468925733|FG000|Overall Study|Adverse Event|7|||
130261751|NCT00370292|468925733|FG000|Overall Study|Physician Decision|2|||
130261752|NCT02704208|468925734|FG000|Overall Study|Lost to Follow-up|42|||
130261753|NCT02704208|468925735|FG001|Overall Study|Lost to Follow-up|37|||
130261754|NCT03545672|468925736|FG000|Overall Study|Uncertain diagnosis|2|||
130261755|NCT03545672|468925737|FG001|Overall Study|Uncertain diagnosis|1|||
130261756|NCT03545672|468925736|FG000|Overall Study|Protocol Violation|2|||
130261757|NCT03545672|468925737|FG001|Overall Study|Protocol Violation|2|||
130261758|NCT00598650|468925738|FG000|Overall Study|Withdrawal by Subject|3|||
130261759|NCT00598650|468925738|FG000|Overall Study|Adverse Event|18|||
130261760|NCT00598650|468925738|FG000|Overall Study|No treatment for 3 weeks|1|||
130261761|NCT00598650|468925738|FG000|Overall Study|Not eligible|1|||
130261762|NCT00598650|468925738|FG000|Overall Study|Prohibited Concomitant Medication|2|||
130261763|NCT00598650|468925738|FG000|Overall Study|Physician Decision|2|||
130261764|NCT01628913|468925739|FG000|Overall Study|Adverse Event|12|||
130261765|NCT01628913|468925740|FG001|Overall Study|Adverse Event|5|||
130261766|NCT01628913|468925739|FG000|Overall Study|Disease Progression|11|||
130261767|NCT01628913|468925740|FG001|Overall Study|Disease Progression|14|||
130261768|NCT01628913|468925739|FG000|Overall Study|Protocol Violation|1|||
130261769|NCT01628913|468925740|FG001|Overall Study|Protocol Violation|0|||
130261770|NCT01628913|468925739|FG000|Overall Study|Death|1|||
130261771|NCT01628913|468925740|FG001|Overall Study|Death|0|||
130261772|NCT01628913|468925739|FG000|Overall Study|study terminated by Sponsor|4|||
130034915|NCT02965378|468083795|FG001|Overall Study|Not protocol specified|2|||
130034916|NCT04964258|468083796|FG000|Overall Study|Lost to Follow-up|1|||
130034917|NCT04964258|468083797|FG001|Overall Study|Lost to Follow-up|0|||
130034918|NCT04964258|468083798|FG002|Overall Study|Lost to Follow-up|0|||
130034919|NCT04964258|468083799|FG003|Overall Study|Lost to Follow-up|0|||
130034920|NCT04964258|468083800|FG004|Overall Study|Lost to Follow-up|0|||
130034921|NCT04964258|468083801|FG005|Overall Study|Lost to Follow-up|1|||
130034922|NCT04964258|468083802|FG006|Overall Study|Lost to Follow-up|0|||
130034923|NCT04964258|468083803|FG007|Overall Study|Lost to Follow-up|0|||
130034924|NCT04964258|468083804|FG008|Overall Study|Lost to Follow-up|0|||
130034925|NCT04964258|468083805|FG009|Overall Study|Lost to Follow-up|0|||
130034926|NCT04964258|468083806|FG010|Overall Study|Lost to Follow-up|0|||
130034927|NCT00629083|468083807|FG000|Overall Study|Adverse Event|0|||
130034928|NCT00629083|468083808|FG001|Overall Study|Adverse Event|2|||
130034929|NCT00629083|468083807|FG000|Overall Study|Lack of Efficacy|3|||
130034930|NCT00629083|468083808|FG001|Overall Study|Lack of Efficacy|1|||
130034931|NCT00629083|468083807|FG000|Overall Study|Withdrawal by Subject|10|||
130034932|NCT00629083|468083808|FG001|Overall Study|Withdrawal by Subject|2|||
130034933|NCT00629083|468083807|FG000|Overall Study|Lost to Follow-up|12|||
130034934|NCT00629083|468083808|FG001|Overall Study|Lost to Follow-up|8|||
130034935|NCT00629083|468083807|FG000|Overall Study|Moved out of country/state|2|||
130034936|NCT00629083|468083808|FG001|Overall Study|Moved out of country/state|1|||
130034937|NCT00629083|468083807|FG000|Overall Study|Refused to return for 12 month visit|1|||
130034938|NCT00629083|468083808|FG001|Overall Study|Refused to return for 12 month visit|0|||
130034939|NCT02909153|468083809|FG000|Overall Study|Withdrawal by Subject|0|||
130034940|NCT02909153|468083810|FG001|Overall Study|Withdrawal by Subject|1|||
130261773|NCT01628913|468925740|FG001|Overall Study|study terminated by Sponsor|9|||
130261774|NCT01628913|468925739|FG000|Overall Study|Withdrawal by Subject|1|||
130261775|NCT01628913|468925740|FG001|Overall Study|Withdrawal by Subject|0|||
130261776|NCT01628913|468925739|FG000|Overall Study|Physician Decision|1|||
130261777|NCT01628913|468925740|FG001|Overall Study|Physician Decision|3|||
130034941|NCT02909153|468083811|FG002|Overall Study|Withdrawal by Subject|0|||
130034942|NCT02909153|468083812|FG003|Overall Study|Withdrawal by Subject|0|||
130102177|NCT00203892|468332658|FG001|Overall Study|Death|0|||
130261778|NCT02935192|468925742|FG000|Overall Study|Withdrawal by Subject|8|||
130261779|NCT02935192|468925743|FG001|Overall Study|Withdrawal by Subject|4|||
130102178|NCT00203892|468332659|FG002|Overall Study|Death|0|||
130102179|NCT00806416|468332660|FG000|Period 1 - Part I|Adverse Event|0|||
130102180|NCT00806416|468332661|FG001|Period 1 - Part I|Adverse Event|1|||
130102181|NCT00806416|468332662|FG002|Period 1 - Part I|Adverse Event|0|||
130102182|NCT00806416|468332663|FG003|Period 1 - Part I|Adverse Event|0|||
130102183|NCT00806416|468332660|FG000|Period 1 - Part I|Lost to Follow-up|0|||
130102184|NCT00806416|468332661|FG001|Period 1 - Part I|Lost to Follow-up|2|||
130102185|NCT00806416|468332662|FG002|Period 1 - Part I|Lost to Follow-up|0|||
130102186|NCT00806416|468332663|FG003|Period 1 - Part I|Lost to Follow-up|0|||
130102187|NCT00806416|468332660|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
130102188|NCT00806416|468332661|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
130102189|NCT00806416|468332662|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
130102190|NCT00806416|468332663|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
130102191|NCT00806416|468332660|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
130102192|NCT00806416|468332661|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
130102193|NCT00806416|468332662|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
130102194|NCT00806416|468332663|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
130102195|NCT01244516|468332668|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
130102196|NCT01244516|468332669|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
130102197|NCT01244516|468332670|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
130102198|NCT01244516|468332668|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
130102199|NCT01244516|468332669|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
130102200|NCT01244516|468332670|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
130102201|NCT01244516|468332668|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
130102202|NCT01244516|468332669|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
130102203|NCT01244516|468332670|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
130102204|NCT01244516|468332668|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
130102205|NCT01244516|468332669|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
130102206|NCT01244516|468332670|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
130102207|NCT01244516|468332668|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
130102208|NCT01244516|468332669|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
130102209|NCT01244516|468332670|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
130102210|NCT01244516|468332668|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
130034943|NCT02909153|468083813|FG004|Overall Study|Withdrawal by Subject|0|||
130261780|NCT00560508|468925744|FG000|12 Week Double-blind Period|Adverse Event|3|||
130261781|NCT00560508|468925745|FG001|12 Week Double-blind Period|Adverse Event|2|||
130261782|NCT00560508|468925744|FG000|12 Week Double-blind Period|Protocol Violation|1|||
130261783|NCT00560508|468925745|FG001|12 Week Double-blind Period|Protocol Violation|0|||
130261784|NCT00560508|468925744|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
130261785|NCT00560508|468925745|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
130261786|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
130261787|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
130261788|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
130261789|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
130261790|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
130261791|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
130034944|NCT01147809|468083814|FG000|Phase I (168 Days)|Adverse Event|0|||
130034945|NCT01147809|468083815|FG001|Phase I (168 Days)|Adverse Event|0|||
130034946|NCT01147809|468083816|FG002|Phase I (168 Days)|Adverse Event|0|||
130034947|NCT01147809|468083817|FG003|Phase I (168 Days)|Adverse Event|1|||
130034948|NCT01147809|468083818|FG004|Phase I (168 Days)|Adverse Event|0|||
130034949|NCT01147809|468083819|FG005|Phase I (168 Days)|Adverse Event|0|||
130034950|NCT01147809|468083814|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
130034951|NCT01147809|468083815|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
130034952|NCT01147809|468083816|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
130034953|NCT01147809|468083817|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
130034954|NCT01147809|468083818|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
130034955|NCT01147809|468083819|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
130034956|NCT01147809|468083814|FG000|Phase I (168 Days)|Physician Decision|0|||
130034957|NCT01147809|468083815|FG001|Phase I (168 Days)|Physician Decision|1|||
130102211|NCT01244516|468332669|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
130102212|NCT01244516|468332670|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
130102213|NCT01244516|468332668|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
130102214|NCT01244516|468332669|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
130102215|NCT01244516|468332670|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
130102216|NCT03345485|468332673|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
130261792|NCT00560508|468925744|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
130034958|NCT01147809|468083816|FG002|Phase I (168 Days)|Physician Decision|2|||
130034959|NCT01147809|468083817|FG003|Phase I (168 Days)|Physician Decision|0|||
130034960|NCT01147809|468083818|FG004|Phase I (168 Days)|Physician Decision|0|||
130034961|NCT01147809|468083819|FG005|Phase I (168 Days)|Physician Decision|0|||
130102217|NCT03345485|468332674|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
130034962|NCT01147809|468083814|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
130034963|NCT01147809|468083815|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
130034964|NCT01147809|468083816|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
130034965|NCT01147809|468083817|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
130034966|NCT01147809|468083818|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
130034967|NCT01147809|468083819|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
130034968|NCT01147809|468083814|FG000|Phase II (168 Days)|Adverse Event|0|||
130034969|NCT01147809|468083815|FG001|Phase II (168 Days)|Adverse Event|0|||
130034970|NCT01147809|468083816|FG002|Phase II (168 Days)|Adverse Event|0|||
130034971|NCT01147809|468083817|FG003|Phase II (168 Days)|Adverse Event|0|||
130034972|NCT01147809|468083818|FG004|Phase II (168 Days)|Adverse Event|3|||
130034973|NCT01147809|468083819|FG005|Phase II (168 Days)|Adverse Event|6|||
130034974|NCT01147809|468083814|FG000|Phase II (168 Days)|Protocol Violation|0|||
130034975|NCT01147809|468083815|FG001|Phase II (168 Days)|Protocol Violation|0|||
130034976|NCT01147809|468083816|FG002|Phase II (168 Days)|Protocol Violation|0|||
130034977|NCT01147809|468083817|FG003|Phase II (168 Days)|Protocol Violation|0|||
130034978|NCT01147809|468083818|FG004|Phase II (168 Days)|Protocol Violation|0|||
130034979|NCT01147809|468083819|FG005|Phase II (168 Days)|Protocol Violation|1|||
130034980|NCT01147809|468083814|FG000|Phase II (168 Days)|Physician Decision|0|||
130034981|NCT01147809|468083815|FG001|Phase II (168 Days)|Physician Decision|0|||
130034982|NCT01147809|468083816|FG002|Phase II (168 Days)|Physician Decision|0|||
130034983|NCT01147809|468083817|FG003|Phase II (168 Days)|Physician Decision|0|||
130034984|NCT01147809|468083818|FG004|Phase II (168 Days)|Physician Decision|5|||
130034985|NCT01147809|468083819|FG005|Phase II (168 Days)|Physician Decision|11|||
130034986|NCT01147809|468083814|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
130034987|NCT01147809|468083815|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
130034988|NCT01147809|468083816|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
130034989|NCT01147809|468083817|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
130034990|NCT01147809|468083818|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
130034991|NCT01147809|468083819|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
130034992|NCT01147809|468083814|FG000|Phase II (168 Days)|Ongoing|0|||
130034993|NCT01147809|468083815|FG001|Phase II (168 Days)|Ongoing|0|||
130034994|NCT01147809|468083816|FG002|Phase II (168 Days)|Ongoing|0|||
130034995|NCT01147809|468083817|FG003|Phase II (168 Days)|Ongoing|0|||
130034996|NCT01147809|468083818|FG004|Phase II (168 Days)|Ongoing|1|||
130034997|NCT01147809|468083819|FG005|Phase II (168 Days)|Ongoing|0|||
130034998|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
130034999|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
130035000|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
130035001|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130035002|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130035003|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130035004|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130035005|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130035006|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130035007|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
130035008|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
130035009|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
130035010|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130035011|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130035012|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130035013|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130035014|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130035015|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
130035016|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
130035017|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130035018|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
130035019|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130035020|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130035021|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130035022|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130035023|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130261793|NCT00560508|468925745|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
130261794|NCT04102007|468925746|FG000|Overall Study|Adverse Event|4|||
130261795|NCT04102007|468925746|FG000|Overall Study|Lost to Follow-up|3|||
130261796|NCT04102007|468925746|FG000|Overall Study|Withdrawal by Subject|12|||
130261797|NCT04102007|468925746|FG000|Overall Study|Eligibility Violation|5|||
130261798|NCT04102007|468925746|FG000|Overall Study|Lack of Efficacy|6|||
130261799|NCT04102007|468925746|FG000|Overall Study|Protocol Deviation|5|||
130035024|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
130261800|NCT04102007|468925746|FG000|Overall Study|Protocol Compliance|1|||
130261801|NCT04102007|468925746|FG000|Overall Study|Withdrew Treatment|2|||
130261802|NCT04102007|468925746|FG000|Overall Study|Pregnancy|1|||
130261803|NCT00892008|468925752|FG000|Overall Study|Death|5|||
130261804|NCT00892008|468925752|FG000|Overall Study|Lack of Efficacy|3|||
130261805|NCT00892008|468925752|FG000|Overall Study|Lost to Follow-up|142|||
130261806|NCT00892008|468925752|FG000|Overall Study|Other|378|||
130261807|NCT00892008|468925752|FG000|Overall Study|Adverse Event|37|||
130261808|NCT03610048|468925755|FG000|Overall Study|Study terminated by sponsor|84|||
130261809|NCT03610048|468925755|FG000|Overall Study|Adverse Event|32|||
130261810|NCT03610048|468925755|FG000|Overall Study|Withdrawal by Subject|31|||
130035025|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130035026|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130035027|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
130035028|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130261811|NCT03610048|468925755|FG000|Overall Study|Lost to Follow-up|8|||
130261812|NCT03610048|468925755|FG000|Overall Study|Other|4|||
130261813|NCT03610048|468925755|FG000|Overall Study|Physician Decision|1|||
130261814|NCT03610048|468925755|FG000|Overall Study|Pregnancy|1|||
130261815|NCT01155050|468925756|FG000|Overall Study|Lost to Follow-up|15|||
130261816|NCT01155050|468925757|FG001|Overall Study|Lost to Follow-up|20|||
130261817|NCT01155050|468925758|FG002|Overall Study|Lost to Follow-up|19|||
130261818|NCT01155050|468925759|FG003|Overall Study|Lost to Follow-up|22|||
130261819|NCT00652834|468925760|FG000|Overall Study|Withdrawal by Subject|3|||
130261820|NCT00652834|468925760|FG000|Overall Study|Lost to Follow-up|2|||
130261821|NCT00320606|468925761|FG000|Overall Study|Adverse Event|1|||
130261822|NCT00320606|468925761|FG000|Overall Study|Protocol Violation|1|||
130261823|NCT00320606|468925761|FG000|Overall Study|Withdrawal by Subject|1|||
130261824|NCT00806585|468925762|FG000|Overall Study|Study terminated by Sponsor|0|||
130261825|NCT00806585|468925763|FG001|Overall Study|Study terminated by Sponsor|0|||
130261826|NCT00806585|468925764|FG002|Overall Study|Study terminated by Sponsor|1|||
130261827|NCT00806585|468925765|FG003|Overall Study|Study terminated by Sponsor|2|||
130261828|NCT00806585|468925766|FG004|Overall Study|Study terminated by Sponsor|0|||
130261829|NCT00806585|468925762|FG000|Overall Study|Protocol Violation|3|||
130261830|NCT00806585|468925763|FG001|Overall Study|Protocol Violation|1|||
130261831|NCT00806585|468925764|FG002|Overall Study|Protocol Violation|2|||
130261832|NCT00806585|468925765|FG003|Overall Study|Protocol Violation|0|||
130261833|NCT00806585|468925766|FG004|Overall Study|Protocol Violation|0|||
130261834|NCT00806585|468925762|FG000|Overall Study|Physician Decision|0|||
130261835|NCT00806585|468925763|FG001|Overall Study|Physician Decision|2|||
130261836|NCT00806585|468925764|FG002|Overall Study|Physician Decision|3|||
130261837|NCT00806585|468925765|FG003|Overall Study|Physician Decision|0|||
130261838|NCT00806585|468925766|FG004|Overall Study|Physician Decision|1|||
130261839|NCT00806585|468925762|FG000|Overall Study|Lost to Follow-up|2|||
130261840|NCT00806585|468925763|FG001|Overall Study|Lost to Follow-up|1|||
130261841|NCT00806585|468925764|FG002|Overall Study|Lost to Follow-up|2|||
130035029|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130035030|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130261842|NCT00806585|468925765|FG003|Overall Study|Lost to Follow-up|2|||
130261843|NCT00806585|468925766|FG004|Overall Study|Lost to Follow-up|5|||
130261844|NCT00806585|468925762|FG000|Overall Study|Lack of Efficacy|1|||
130261845|NCT00806585|468925763|FG001|Overall Study|Lack of Efficacy|0|||
130261846|NCT00806585|468925764|FG002|Overall Study|Lack of Efficacy|0|||
130261847|NCT00806585|468925765|FG003|Overall Study|Lack of Efficacy|0|||
130261848|NCT00806585|468925766|FG004|Overall Study|Lack of Efficacy|0|||
130261849|NCT00806585|468925762|FG000|Overall Study|Adverse Event|1|||
130261850|NCT00806585|468925763|FG001|Overall Study|Adverse Event|5|||
130261851|NCT00806585|468925764|FG002|Overall Study|Adverse Event|3|||
130261852|NCT00806585|468925765|FG003|Overall Study|Adverse Event|4|||
130261853|NCT00806585|468925766|FG004|Overall Study|Adverse Event|2|||
130261854|NCT00806585|468925762|FG000|Overall Study|Withdrawal by Subject|10|||
130261855|NCT00806585|468925763|FG001|Overall Study|Withdrawal by Subject|8|||
130261856|NCT00806585|468925764|FG002|Overall Study|Withdrawal by Subject|9|||
130261857|NCT00806585|468925765|FG003|Overall Study|Withdrawal by Subject|3|||
130261858|NCT00806585|468925766|FG004|Overall Study|Withdrawal by Subject|11|||
130261859|NCT00806585|468925762|FG000|Overall Study|Completion status unknown|15|||
130261860|NCT00806585|468925763|FG001|Overall Study|Completion status unknown|14|||
130261861|NCT00806585|468925764|FG002|Overall Study|Completion status unknown|12|||
130261862|NCT00806585|468925765|FG003|Overall Study|Completion status unknown|4|||
130261863|NCT00806585|468925766|FG004|Overall Study|Completion status unknown|12|||
130261864|NCT00474903|468925767|FG000|Overall Study|Protocol Violation|1|||
130261865|NCT00474903|468925768|FG001|Overall Study|Protocol Violation|5|||
130261866|NCT00474903|468925769|FG002|Overall Study|Protocol Violation|2|||
130261867|NCT00399529|468925770|FG000|Overall Study|Off Study Prior to Treatment|2|||
130261868|NCT01936831|468925771|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261869|NCT01936831|468925772|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261870|NCT01936831|468925773|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261871|NCT01936831|468925774|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261872|NCT01936831|468925775|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261873|NCT01936831|468925776|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
130261874|NCT01936831|468925777|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261875|NCT01936831|468925778|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261876|NCT01936831|468925779|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
130261877|NCT03435380|468925780|FG000|Overall Study|Death|1|||
130261878|NCT03435380|468925781|FG001|Overall Study|Death|2|||
130261879|NCT03435380|468925782|FG002|Overall Study|Death|1|||
130261880|NCT03435380|468925780|FG000|Overall Study|Lost to Follow-up|12|||
130261881|NCT03435380|468925781|FG001|Overall Study|Lost to Follow-up|8|||
130261882|NCT03435380|468925782|FG002|Overall Study|Lost to Follow-up|6|||
130102218|NCT03345485|468332675|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
130102219|NCT03345485|468332676|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
130102220|NCT03345485|468332677|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
130102221|NCT03345485|468332678|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
130102222|NCT03345485|468332679|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
130102223|NCT03345485|468332680|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
130102224|NCT03345485|468332681|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
130102225|NCT03345485|468332682|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
130102226|NCT03345485|468332683|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
130102227|NCT03345485|468332684|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
130102228|NCT03345485|468332685|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
130102229|NCT03359473|468332686|FG000|Overall Study|Adverse Event|0|||
130102230|NCT03359473|468332687|FG001|Overall Study|Adverse Event|2|||
130102231|NCT03359473|468332688|FG002|Overall Study|Adverse Event|5|||
130102232|NCT03359473|468332689|FG003|Overall Study|Adverse Event|3|||
130102233|NCT03359473|468332686|FG000|Overall Study|Lost to Follow-up|0|||
130102234|NCT03359473|468332687|FG001|Overall Study|Lost to Follow-up|1|||
130102235|NCT03359473|468332688|FG002|Overall Study|Lost to Follow-up|0|||
130102236|NCT03359473|468332689|FG003|Overall Study|Lost to Follow-up|0|||
130102237|NCT03359473|468332686|FG000|Overall Study|Physician Decision|0|||
130102238|NCT03359473|468332687|FG001|Overall Study|Physician Decision|1|||
130102239|NCT03359473|468332688|FG002|Overall Study|Physician Decision|0|||
130102240|NCT03359473|468332689|FG003|Overall Study|Physician Decision|1|||
130261883|NCT03435380|468925780|FG000|Overall Study|Physician Decision|1|||
130102241|NCT03359473|468332686|FG000|Overall Study|Withdrawal by Subject|1|||
130261884|NCT03435380|468925781|FG001|Overall Study|Physician Decision|0|||
130261885|NCT03435380|468925782|FG002|Overall Study|Physician Decision|0|||
130261886|NCT03435380|468925780|FG000|Overall Study|Withdrawal by Subject|0|||
130261887|NCT03435380|468925781|FG001|Overall Study|Withdrawal by Subject|1|||
130261888|NCT03435380|468925782|FG002|Overall Study|Withdrawal by Subject|1|||
130261889|NCT03435380|468925780|FG000|Overall Study|Ineligible|0|||
130261890|NCT03435380|468925781|FG001|Overall Study|Ineligible|1|||
130261891|NCT03435380|468925782|FG002|Overall Study|Ineligible|1|||
130261892|NCT02133573|468925788|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
130261893|NCT02133573|468925789|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
130261894|NCT02133573|468925788|FG000|Overall Study|Child Deaths|3|||
130261895|NCT02133573|468925789|FG001|Overall Study|Child Deaths|5|||
130261896|NCT02133573|468925788|FG000|Overall Study|Child Declined Follow Ups|2|||
130261897|NCT02133573|468925789|FG001|Overall Study|Child Declined Follow Ups|1|||
130261898|NCT02133573|468925788|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
130261899|NCT02133573|468925789|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
130261900|NCT02519842|468925790|FG000|Base Study: Cycle 1|Screening Failure|1|||
130261901|NCT02519842|468925791|FG001|Base Study: Cycle 1|Screening Failure|1|||
130261902|NCT02519842|468925792|FG002|Base Study: Cycle 1|Screening Failure|0|||
130261903|NCT02519842|468925790|FG000|Base Study: Cycle 1|Adverse Event|1|||
130261904|NCT02519842|468925791|FG001|Base Study: Cycle 1|Adverse Event|0|||
130261905|NCT02519842|468925792|FG002|Base Study: Cycle 1|Adverse Event|0|||
130261906|NCT02519842|468925790|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
130261907|NCT02519842|468925791|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
130261908|NCT02519842|468925792|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
130261909|NCT02519842|468925790|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
130261910|NCT02519842|468925791|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
130261911|NCT02519842|468925792|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
130261912|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
130261913|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
130261914|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
130261915|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
130261916|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
130261917|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
130261918|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130102242|NCT03359473|468332687|FG001|Overall Study|Withdrawal by Subject|2|||
130035031|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130035032|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130035033|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
130035034|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
130035035|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130035036|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
130035037|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130035038|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130035039|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130035040|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130035041|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130035042|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130035043|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130035044|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035045|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035046|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035047|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035048|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035049|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035050|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035051|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
130035052|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
130035053|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
130035054|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130035055|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130261919|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
130261920|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
130261921|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
130261922|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
130261923|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
130261924|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Death|0|||
130261925|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Death|0|||
130261926|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Death|1|||
130261927|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
130261928|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
130261929|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
130261930|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
130261931|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
130261932|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
130261933|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
130261934|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
130261935|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
130261936|NCT02519842|468925790|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
130261937|NCT02519842|468925791|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
130261938|NCT02519842|468925792|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
130261939|NCT02115321|468925795|FG000|Overall Study|Death|1|||
130261940|NCT02115321|468925796|FG001|Overall Study|Death|0|||
130261941|NCT01307449|468925797|FG000|Overall Study|Adverse Event|1|||
130261942|NCT01307449|468925798|FG001|Overall Study|Adverse Event|0|||
130261943|NCT01307449|468925799|FG002|Overall Study|Adverse Event|0|||
130261944|NCT01307449|468925800|FG003|Overall Study|Adverse Event|0|||
130261945|NCT03218917|468925801|FG000|Overall Study|Adverse Event|3|||
130261946|NCT03218917|468925802|FG001|Overall Study|Adverse Event|3|||
130261947|NCT03218917|468925803|FG002|Overall Study|Adverse Event|2|||
130035056|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130035057|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130035058|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130035059|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130035060|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
130035061|NCT01307423|468083820|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130035062|NCT01307423|468083821|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
130035063|NCT01307423|468083822|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
130035064|NCT01307423|468083823|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130102243|NCT03359473|468332688|FG002|Overall Study|Withdrawal by Subject|1|||
130102244|NCT03359473|468332689|FG003|Overall Study|Withdrawal by Subject|0|||
130102245|NCT03359473|468332686|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130102246|NCT03359473|468332687|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130102247|NCT03359473|468332688|FG002|Overall Study|Protocol-defined stopping criteria|0|||
130102248|NCT03359473|468332689|FG003|Overall Study|Protocol-defined stopping criteria|1|||
130102249|NCT05302414|468332690|FG000|Pretest to Posttest|Lost to Follow-up|12|||
130102250|NCT05302414|468332691|FG001|Pretest to Posttest|Lost to Follow-up|8|||
130102251|NCT05302414|468332692|FG002|Pretest to Posttest|Lost to Follow-up|8|||
130102252|NCT05302414|468332690|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
130102253|NCT05302414|468332691|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
130035065|NCT01307423|468083824|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130035066|NCT01307423|468083825|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130035067|NCT01307423|468083826|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130035068|NCT01307423|468083827|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130035069|NCT01307423|468083828|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
130035070|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130035071|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
130035072|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
130035073|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
130035074|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
130035075|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130035076|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130035077|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130102254|NCT05302414|468332692|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
130261948|NCT03218917|468925801|FG000|Overall Study|Subject withdrew consent|2|||
130261949|NCT03218917|468925802|FG001|Overall Study|Subject withdrew consent|4|||
130261950|NCT03218917|468925803|FG002|Overall Study|Subject withdrew consent|10|||
130261951|NCT03218917|468925801|FG000|Overall Study|Physician Decision|0|||
130261952|NCT03218917|468925802|FG001|Overall Study|Physician Decision|1|||
130261953|NCT03218917|468925803|FG002|Overall Study|Physician Decision|1|||
130261954|NCT03218917|468925801|FG000|Overall Study|Lost to Follow-up|1|||
130261955|NCT03218917|468925802|FG001|Overall Study|Lost to Follow-up|0|||
130261956|NCT03218917|468925803|FG002|Overall Study|Lost to Follow-up|0|||
130261957|NCT03218917|468925801|FG000|Overall Study|Reason Missing|0|||
130261958|NCT03218917|468925802|FG001|Overall Study|Reason Missing|2|||
130261959|NCT03218917|468925803|FG002|Overall Study|Reason Missing|0|||
130261960|NCT03218917|468925801|FG000|Overall Study|Death|0|||
130261961|NCT03218917|468925802|FG001|Overall Study|Death|1|||
130261962|NCT03218917|468925803|FG002|Overall Study|Death|0|||
130261963|NCT03218917|468925801|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130261964|NCT03218917|468925802|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130261965|NCT03218917|468925803|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130261966|NCT01788943|468925806|FG000|Overall Study|Withdrawal by Subject|1|||
130261967|NCT01788943|468925807|FG001|Overall Study|Withdrawal by Subject|0|||
130261968|NCT01119287|468925808|FG000|Overall Study|Patient Decision, not related to AE|0|||
130261969|NCT01119287|468925809|FG001|Overall Study|Patient Decision, not related to AE|0|||
130261970|NCT01119287|468925810|FG002|Overall Study|Patient Decision, not related to AE|2|||
130261971|NCT01119287|468925811|FG003|Overall Study|Patient Decision, not related to AE|2|||
130261972|NCT01119287|468925812|FG004|Overall Study|Patient Decision, not related to AE|1|||
130261973|NCT01119287|468925813|FG005|Overall Study|Patient Decision, not related to AE|0|||
130261974|NCT00565409|468925821|FG000|Period 1 Open Label|Adverse Event|17|||
130261975|NCT00565409|468925822|FG001|Period 1 Open Label|Adverse Event|0|||
130261976|NCT00565409|468925823|FG002|Period 1 Open Label|Adverse Event|0|||
130261977|NCT00565409|468925824|FG003|Period 1 Open Label|Adverse Event|0|||
130261978|NCT00565409|468925821|FG000|Period 1 Open Label|Death|2|||
130261979|NCT00565409|468925822|FG001|Period 1 Open Label|Death|0|||
130261980|NCT00565409|468925823|FG002|Period 1 Open Label|Death|0|||
130261981|NCT00565409|468925824|FG003|Period 1 Open Label|Death|0|||
130261982|NCT00565409|468925821|FG000|Period 1 Open Label|Lost to Follow-up|1|||
130261983|NCT00565409|468925822|FG001|Period 1 Open Label|Lost to Follow-up|0|||
130261984|NCT00565409|468925823|FG002|Period 1 Open Label|Lost to Follow-up|0|||
130261985|NCT00565409|468925824|FG003|Period 1 Open Label|Lost to Follow-up|0|||
130261986|NCT00565409|468925821|FG000|Period 1 Open Label|Other|21|||
130261987|NCT00565409|468925822|FG001|Period 1 Open Label|Other|0|||
130102255|NCT01610284|468332693|FG000|Randomization Phase|Adverse Event|1|||
130035078|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
130035079|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130035080|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
130035081|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
130035082|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
130035083|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
130035084|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130035085|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130035086|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130035087|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
130035088|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035089|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035090|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035091|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035092|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035093|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
130035094|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035095|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035096|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
130035097|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130035098|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
130035099|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
130035100|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130035101|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130035102|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
130035103|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
130035104|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130035105|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
130035106|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035107|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035108|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035109|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
130035110|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035111|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035112|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035113|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035114|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
130035115|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
130035116|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
130035117|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
130035118|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
130035119|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
130035120|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
130035121|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
130035122|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
130035123|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
130035124|NCT01307423|468083820|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035125|NCT01307423|468083821|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035126|NCT01307423|468083822|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130102256|NCT01610284|468332694|FG001|Randomization Phase|Adverse Event|0|||
130035127|NCT01307423|468083823|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035128|NCT01307423|468083824|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035129|NCT01307423|468083825|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
130035130|NCT01307423|468083826|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035131|NCT01307423|468083827|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035132|NCT01307423|468083828|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
130035133|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130035134|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
130035135|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
130035136|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130035137|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130035138|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130035139|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
130035140|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
130035141|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
130035142|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130035143|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
130035144|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
130035145|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130035146|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130035147|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130035148|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
130261988|NCT00565409|468925823|FG002|Period 1 Open Label|Other|0|||
130261989|NCT00565409|468925824|FG003|Period 1 Open Label|Other|0|||
130261990|NCT00565409|468925821|FG000|Period 1 Open Label|Protocol Violation|14|||
130261991|NCT00565409|468925822|FG001|Period 1 Open Label|Protocol Violation|0|||
130261992|NCT00565409|468925823|FG002|Period 1 Open Label|Protocol Violation|0|||
130261993|NCT00565409|468925824|FG003|Period 1 Open Label|Protocol Violation|0|||
130261994|NCT00565409|468925821|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
130261995|NCT00565409|468925822|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130261996|NCT00565409|468925823|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130261997|NCT00565409|468925824|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
130261998|NCT00565409|468925821|FG000|Period 1 Open Label|no conclusion of participation record|1|||
130261999|NCT00565409|468925822|FG001|Period 1 Open Label|no conclusion of participation record|0|||
130262000|NCT00565409|468925823|FG002|Period 1 Open Label|no conclusion of participation record|0|||
130262001|NCT00565409|468925824|FG003|Period 1 Open Label|no conclusion of participation record|0|||
130262002|NCT00565409|468925821|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
130262003|NCT00565409|468925822|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
130262004|NCT00565409|468925823|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
130262005|NCT00565409|468925824|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
130262006|NCT00565409|468925821|FG000|Period 2 Double-Blind|Adverse Event|0|||
130262007|NCT00565409|468925822|FG001|Period 2 Double-Blind|Adverse Event|7|||
130262008|NCT00565409|468925823|FG002|Period 2 Double-Blind|Adverse Event|4|||
130262009|NCT00565409|468925824|FG003|Period 2 Double-Blind|Adverse Event|5|||
130262010|NCT00565409|468925821|FG000|Period 2 Double-Blind|Death|0|||
130262011|NCT00565409|468925822|FG001|Period 2 Double-Blind|Death|2|||
130262012|NCT00565409|468925823|FG002|Period 2 Double-Blind|Death|0|||
130262013|NCT00565409|468925824|FG003|Period 2 Double-Blind|Death|0|||
130262014|NCT00565409|468925821|FG000|Period 2 Double-Blind|Protocol Violation|0|||
130262015|NCT00565409|468925822|FG001|Period 2 Double-Blind|Protocol Violation|4|||
130262016|NCT00565409|468925823|FG002|Period 2 Double-Blind|Protocol Violation|6|||
130262017|NCT00565409|468925824|FG003|Period 2 Double-Blind|Protocol Violation|2|||
130262018|NCT00565409|468925821|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
130262019|NCT00565409|468925822|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
130262020|NCT00565409|468925823|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
130262021|NCT00565409|468925824|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
130262022|NCT00565409|468925821|FG000|Period 2 Double-Blind|Other|0|||
130262023|NCT00565409|468925822|FG001|Period 2 Double-Blind|Other|4|||
130262024|NCT00565409|468925823|FG002|Period 2 Double-Blind|Other|5|||
130262025|NCT00565409|468925824|FG003|Period 2 Double-Blind|Other|9|||
130262026|NCT00565409|468925821|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
130262027|NCT00565409|468925822|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
130262028|NCT00565409|468925823|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
130262029|NCT00565409|468925824|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
130262030|NCT02257684|468925826|FG000|Overall Study|Adverse Event|2|||
130262031|NCT02257684|468925826|FG000|Overall Study|Lack of Efficacy|1|||
130262032|NCT02257684|468925826|FG000|Overall Study|Sponsor's Decision|1|||
130262033|NCT01570387|468925827|FG000|Overall Study|Adverse Event|1|||
130262034|NCT01570387|468925828|FG001|Overall Study|Adverse Event|0|||
130262035|NCT01570387|468925829|FG002|Overall Study|Adverse Event|0|||
130262036|NCT01570387|468925830|FG003|Overall Study|Adverse Event|0|||
130262037|NCT01570387|468925827|FG000|Overall Study|Death|0|||
130262038|NCT01570387|468925828|FG001|Overall Study|Death|0|||
130262039|NCT01570387|468925829|FG002|Overall Study|Death|0|||
130262040|NCT01570387|468925830|FG003|Overall Study|Death|1|||
130262041|NCT01570387|468925827|FG000|Overall Study|Withdrawal by Subject|0|||
130262042|NCT01570387|468925828|FG001|Overall Study|Withdrawal by Subject|0|||
130262043|NCT01570387|468925829|FG002|Overall Study|Withdrawal by Subject|0|||
130262044|NCT01570387|468925830|FG003|Overall Study|Withdrawal by Subject|1|||
130262045|NCT01987557|468925831|FG000|Overall Study|Protocol Violation|1|||
130262046|NCT01987557|468925832|FG001|Overall Study|Protocol Violation|0|||
130262047|NCT01987557|468925833|FG002|Overall Study|Protocol Violation|1|||
130262048|NCT01987557|468925831|FG000|Overall Study|Withdrawal by Subject|2|||
130262049|NCT01987557|468925832|FG001|Overall Study|Withdrawal by Subject|1|||
130262050|NCT01987557|468925833|FG002|Overall Study|Withdrawal by Subject|2|||
130262051|NCT01987557|468925831|FG000|Overall Study|Adverse Event|0|||
130262052|NCT01987557|468925832|FG001|Overall Study|Adverse Event|2|||
130262053|NCT01987557|468925833|FG002|Overall Study|Adverse Event|0|||
130262054|NCT00431964|468925842|FG000|Overall Study|Adverse Event|1|||
130262055|NCT00431964|468925843|FG001|Overall Study|Adverse Event|0|||
130262056|NCT00431964|468925842|FG000|Overall Study|Lost to Follow-up|1|||
130262057|NCT00431964|468925843|FG001|Overall Study|Lost to Follow-up|2|||
130262058|NCT00431964|468925842|FG000|Overall Study|Physician Decision|2|||
130262059|NCT00431964|468925843|FG001|Overall Study|Physician Decision|2|||
130262060|NCT00431964|468925842|FG000|Overall Study|Withdrawal by Subject|2|||
130262061|NCT00431964|468925843|FG001|Overall Study|Withdrawal by Subject|1|||
130262062|NCT00431964|468925842|FG000|Overall Study|Parental Consent Withdrawn|0|||
130262063|NCT00431964|468925843|FG001|Overall Study|Parental Consent Withdrawn|2|||
130262064|NCT00431964|468925842|FG000|Overall Study|Due to Unstable Health|0|||
130262065|NCT00431964|468925843|FG001|Overall Study|Due to Unstable Health|1|||
130262066|NCT03434834|468925849|FG000|Overall Study|unable to swallow OCT probe|16|||
130262067|NCT00518180|468925852|FG000|Overall Study|Withdrawal by Subject|29|||
130262068|NCT00518180|468925853|FG001|Overall Study|Withdrawal by Subject|30|||
130262069|NCT00518180|468925854|FG002|Overall Study|Withdrawal by Subject|42|||
130262070|NCT00518180|468925852|FG000|Overall Study|Lost to Follow-up|30|||
130262071|NCT00518180|468925853|FG001|Overall Study|Lost to Follow-up|28|||
130262072|NCT00518180|468925854|FG002|Overall Study|Lost to Follow-up|34|||
130262073|NCT00518180|468925852|FG000|Overall Study|Administrative reason|0|||
130262074|NCT00518180|468925853|FG001|Overall Study|Administrative reason|2|||
130262075|NCT00518180|468925854|FG002|Overall Study|Administrative reason|2|||
130262076|NCT00518180|468925852|FG000|Overall Study|Protocol Violation|5|||
130262077|NCT00518180|468925853|FG001|Overall Study|Protocol Violation|7|||
130262078|NCT00518180|468925854|FG002|Overall Study|Protocol Violation|4|||
130262079|NCT00518180|468925852|FG000|Overall Study|Unable to classify|0|||
130262080|NCT00518180|468925853|FG001|Overall Study|Unable to classify|2|||
130262081|NCT00518180|468925854|FG002|Overall Study|Unable to classify|0|||
130262082|NCT00518180|468925852|FG000|Overall Study|Adverse Event|1|||
130262083|NCT00518180|468925853|FG001|Overall Study|Adverse Event|0|||
130262084|NCT00518180|468925854|FG002|Overall Study|Adverse Event|0|||
130262085|NCT00485173|468925859|FG000|Overall Study|Death|4|||
130262086|NCT00485173|468925860|FG001|Overall Study|Death|3|||
130262087|NCT00485173|468925859|FG000|Overall Study|Lost to Follow-up|32|||
130262088|NCT00485173|468925860|FG001|Overall Study|Lost to Follow-up|61|||
130262089|NCT00829244|468925861|FG000|Overall Study|Adverse Event|1|||
130102257|NCT01610284|468332693|FG000|Randomization Phase|Physician Decision|1|||
130102258|NCT01610284|468332694|FG001|Randomization Phase|Physician Decision|1|||
130102259|NCT01610284|468332693|FG000|Randomization Phase|Death|0|||
130102260|NCT01610284|468332694|FG001|Randomization Phase|Death|1|||
130102261|NCT01610284|468332693|FG000|Treatment Phase|Adverse Event|80|||
130102262|NCT01610284|468332694|FG001|Treatment Phase|Adverse Event|12|||
130102263|NCT01610284|468332693|FG000|Treatment Phase|Lost to Follow-up|1|||
130102264|NCT01610284|468332694|FG001|Treatment Phase|Lost to Follow-up|0|||
130262090|NCT00829244|468925862|FG001|Overall Study|Adverse Event|3|||
130262091|NCT00829244|468925861|FG000|Overall Study|Protocol Violation|1|||
130262092|NCT00829244|468925862|FG001|Overall Study|Protocol Violation|0|||
130262093|NCT00829244|468925861|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
130262094|NCT00829244|468925862|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
130262095|NCT00829244|468925861|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
130262096|NCT00829244|468925862|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
130262097|NCT00829244|468925861|FG000|Overall Study|No fertilization|2|||
130262098|NCT00829244|468925862|FG001|Overall Study|No fertilization|2|||
130262099|NCT00829244|468925861|FG000|Overall Study|All embryos discarded|0|||
130262100|NCT00829244|468925862|FG001|Overall Study|All embryos discarded|3|||
130262101|NCT00829244|468925861|FG000|Overall Study|No embryo cleavage|0|||
130262102|NCT00829244|468925862|FG001|Overall Study|No embryo cleavage|2|||
130102265|NCT01610284|468332693|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
130102266|NCT01610284|468332694|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
130262103|NCT03342560|468925863|FG000|Overall Study|Lost to Follow-up|2|||
130262104|NCT02604511|468925864|FG000|Overall Study|Adverse Event|3|||
130262105|NCT02604511|468925864|FG000|Overall Study|Disease Progression|4|||
130262106|NCT02604511|468925864|FG000|Overall Study|Withdrawal by Subject|3|||
130262107|NCT02604511|468925864|FG000|Overall Study|Participant ineligible|1|||
130262108|NCT02604511|468925864|FG000|Overall Study|Intercurrent illness|1|||
130262109|NCT03770286|468925865|FG000|Overall Study|Lost to Follow-up|6|||
130262110|NCT03770286|468925866|FG001|Overall Study|Lost to Follow-up|4|||
130262111|NCT03770286|468925867|FG002|Overall Study|Lost to Follow-up|3|||
130262112|NCT03770286|468925865|FG000|Overall Study|Protocol Violation|1|||
130262113|NCT03770286|468925866|FG001|Overall Study|Protocol Violation|0|||
130262114|NCT03770286|468925867|FG002|Overall Study|Protocol Violation|2|||
130262115|NCT02297412|468925868|FG000|Overall Study|Canceled|1|||
130262116|NCT02297412|468925869|FG001|Overall Study|Canceled|1|||
130262117|NCT02031302|468925870|FG000|Overall Study|Death|115|||
130262118|NCT02031302|468925871|FG001|Overall Study|Death|0|||
130262119|NCT02031302|468925870|FG000|Overall Study|Not treated with study valve system|18|||
130262120|NCT02031302|468925871|FG001|Overall Study|Not treated with study valve system|0|||
130262121|NCT02031302|468925870|FG000|Overall Study|Missed Follow Up|27|||
130262122|NCT02031302|468925871|FG001|Overall Study|Missed Follow Up|0|||
130262123|NCT02031302|468925870|FG000|Overall Study|Lost to Follow-up|4|||
130262124|NCT02031302|468925871|FG001|Overall Study|Lost to Follow-up|0|||
130262125|NCT04712669|468925876|FG000|Double Blind Phase|Adverse Event|4|||
130262126|NCT04712669|468925877|FG001|Double Blind Phase|Adverse Event|4|||
130262127|NCT04712669|468925878|FG002|Double Blind Phase|Adverse Event|3|||
130262128|NCT04712669|468925879|FG003|Double Blind Phase|Adverse Event|0|||
130262129|NCT04712669|468925880|FG004|Double Blind Phase|Adverse Event|0|||
130262130|NCT04712669|468925881|FG005|Double Blind Phase|Adverse Event|0|||
130262131|NCT04712669|468925882|FG006|Double Blind Phase|Adverse Event|0|||
130262132|NCT04712669|468925883|FG007|Double Blind Phase|Adverse Event|0|||
130262133|NCT04712669|468925876|FG000|Double Blind Phase|Physician Decision|1|||
130262134|NCT04712669|468925877|FG001|Double Blind Phase|Physician Decision|0|||
130262135|NCT04712669|468925878|FG002|Double Blind Phase|Physician Decision|0|||
130262136|NCT04712669|468925879|FG003|Double Blind Phase|Physician Decision|0|||
130262137|NCT04712669|468925880|FG004|Double Blind Phase|Physician Decision|0|||
130262138|NCT04712669|468925881|FG005|Double Blind Phase|Physician Decision|0|||
130262139|NCT04712669|468925882|FG006|Double Blind Phase|Physician Decision|0|||
130262140|NCT04712669|468925883|FG007|Double Blind Phase|Physician Decision|0|||
130262141|NCT04712669|468925876|FG000|Double Blind Phase|Withdrawal by Subject|3|||
130262142|NCT04712669|468925877|FG001|Double Blind Phase|Withdrawal by Subject|6|||
130262143|NCT04712669|468925878|FG002|Double Blind Phase|Withdrawal by Subject|0|||
130262144|NCT04712669|468925879|FG003|Double Blind Phase|Withdrawal by Subject|0|||
130262145|NCT04712669|468925880|FG004|Double Blind Phase|Withdrawal by Subject|0|||
130262146|NCT04712669|468925881|FG005|Double Blind Phase|Withdrawal by Subject|0|||
130262147|NCT04712669|468925882|FG006|Double Blind Phase|Withdrawal by Subject|0|||
130262148|NCT04712669|468925883|FG007|Double Blind Phase|Withdrawal by Subject|0|||
130262149|NCT04712669|468925876|FG000|Double Blind Phase|Termination by Sponsor|0|||
130262150|NCT04712669|468925877|FG001|Double Blind Phase|Termination by Sponsor|0|||
130262151|NCT04712669|468925878|FG002|Double Blind Phase|Termination by Sponsor|1|||
130035149|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
130035150|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
130262152|NCT04712669|468925879|FG003|Double Blind Phase|Termination by Sponsor|0|||
130262153|NCT04712669|468925880|FG004|Double Blind Phase|Termination by Sponsor|0|||
130262154|NCT04712669|468925881|FG005|Double Blind Phase|Termination by Sponsor|0|||
130262155|NCT04712669|468925882|FG006|Double Blind Phase|Termination by Sponsor|0|||
130262156|NCT04712669|468925883|FG007|Double Blind Phase|Termination by Sponsor|0|||
130262157|NCT04712669|468925876|FG000|Open Label Phase|Adverse Event|0|||
130262158|NCT04712669|468925877|FG001|Open Label Phase|Adverse Event|0|||
130262159|NCT04712669|468925878|FG002|Open Label Phase|Adverse Event|0|||
130262160|NCT04712669|468925879|FG003|Open Label Phase|Adverse Event|1|||
130262161|NCT04712669|468925880|FG004|Open Label Phase|Adverse Event|1|||
130102267|NCT01610284|468332693|FG000|Treatment Phase|Physician Decision|27|||
130102268|NCT01610284|468332694|FG001|Treatment Phase|Physician Decision|24|||
130102269|NCT01610284|468332693|FG000|Treatment Phase|Progressive Disease|377|||
130102270|NCT01610284|468332694|FG001|Treatment Phase|Progressive Disease|486|||
130102271|NCT01610284|468332693|FG000|Treatment Phase|Protocol Deviation|2|||
130102272|NCT01610284|468332694|FG001|Treatment Phase|Protocol Deviation|3|||
130102273|NCT01610284|468332693|FG000|Treatment Phase|Study terminated by Sponsor|18|||
130102274|NCT01610284|468332694|FG001|Treatment Phase|Study terminated by Sponsor|15|||
130102275|NCT01610284|468332693|FG000|Treatment Phase|Subject/Guardian Decision|55|||
130102276|NCT01610284|468332694|FG001|Treatment Phase|Subject/Guardian Decision|23|||
130102277|NCT01610284|468332693|FG000|Treatment Phase|Death|6|||
130102278|NCT01610284|468332694|FG001|Treatment Phase|Death|5|||
130102279|NCT01610284|468332693|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
130102280|NCT01610284|468332694|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130102281|NCT01610284|468332693|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
130102282|NCT01610284|468332694|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
130102283|NCT01610284|468332693|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
130102284|NCT01610284|468332694|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
130102285|NCT01610284|468332693|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
130102286|NCT01610284|468332694|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
130102287|NCT01610284|468332693|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
130102288|NCT01610284|468332694|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
130102289|NCT01610284|468332693|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
130102290|NCT01610284|468332694|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
130102291|NCT01125358|468332695|FG000|Overall Study|Adverse Event|3|||
130102292|NCT01125358|468332696|FG001|Overall Study|Adverse Event|0|||
130102293|NCT01125358|468332697|FG002|Overall Study|Adverse Event|0|||
130102294|NCT01125358|468332698|FG003|Overall Study|Adverse Event|2|||
130102295|NCT01125358|468332695|FG000|Overall Study|Perceived Lack of Efficacy|6|||
130102296|NCT01125358|468332696|FG001|Overall Study|Perceived Lack of Efficacy|3|||
130102297|NCT01125358|468332697|FG002|Overall Study|Perceived Lack of Efficacy|7|||
130102298|NCT01125358|468332698|FG003|Overall Study|Perceived Lack of Efficacy|4|||
130102299|NCT01125358|468332695|FG000|Overall Study|Protocol Violation|1|||
130102300|NCT01125358|468332696|FG001|Overall Study|Protocol Violation|0|||
130102301|NCT01125358|468332697|FG002|Overall Study|Protocol Violation|0|||
129885595|NCT02611830|467540769|FG002|Maintenance Phase|Lack of Efficacy|18|||
129885596|NCT02611830|467540770|FG003|Maintenance Phase|Lack of Efficacy|6|||
130102302|NCT01125358|468332698|FG003|Overall Study|Protocol Violation|0|||
130102303|NCT01125358|468332695|FG000|Overall Study|Sponsor Decision|0|||
130102304|NCT01125358|468332696|FG001|Overall Study|Sponsor Decision|0|||
130102305|NCT01125358|468332697|FG002|Overall Study|Sponsor Decision|1|||
130102306|NCT01125358|468332698|FG003|Overall Study|Sponsor Decision|1|||
130102307|NCT01125358|468332695|FG000|Overall Study|Withdrawal by Subject|2|||
130102308|NCT01125358|468332696|FG001|Overall Study|Withdrawal by Subject|1|||
130035151|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035152|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035153|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
130035154|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035155|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035156|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130102309|NCT01125358|468332697|FG002|Overall Study|Withdrawal by Subject|1|||
130102310|NCT01125358|468332698|FG003|Overall Study|Withdrawal by Subject|1|||
130102311|NCT04935931|468332701|FG000|Overall Study|Withdrawal by Subject|1|||
130102312|NCT00962013|468332702|FG000|Overall Study|Did not have surgery|1|||
130102313|NCT00962013|468332702|FG000|Overall Study|Death|8|||
130102314|NCT00962013|468332702|FG000|Overall Study|Lost to Follow-up|12|||
130102315|NCT00962013|468332702|FG000|Overall Study|Unable/Unwilling to return|6|||
130102316|NCT00962013|468332702|FG000|Overall Study|Withdrawal by Subject|8|||
130102317|NCT00962013|468332702|FG000|Overall Study|Removal of study device|3|||
130102318|NCT00962013|468332702|FG000|Overall Study|Site Termination|24|||
130102319|NCT00962013|468332702|FG000|Overall Study|No 5 year evaluation|6|||
130102320|NCT00424632|468332703|FG000|Overall Study|Death|0|||
130102321|NCT00424632|468332704|FG001|Overall Study|Death|0|||
130102322|NCT00424632|468332705|FG002|Overall Study|Death|0|||
130102323|NCT00424632|468332706|FG003|Overall Study|Death|0|||
130102324|NCT00424632|468332707|FG004|Overall Study|Death|0|||
130102325|NCT00424632|468332708|FG005|Overall Study|Death|2|||
130102326|NCT00424632|468332709|FG006|Overall Study|Death|0|||
130102327|NCT00424632|468332710|FG007|Overall Study|Death|0|||
130102328|NCT00424632|468332711|FG008|Overall Study|Death|0|||
130102329|NCT00424632|468332712|FG009|Overall Study|Death|0|||
130035157|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035158|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035159|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
130035160|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130035161|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
130035162|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
130035163|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130035164|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130035165|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130035166|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
130035167|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
130035168|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
130035169|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130035170|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130035171|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130035172|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130035173|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130035174|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130035175|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
130035176|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130035177|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
130035178|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130035179|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
130035180|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
130102330|NCT00424632|468332703|FG000|Overall Study|Adverse Event|0|||
130102331|NCT00424632|468332704|FG001|Overall Study|Adverse Event|0|||
130102332|NCT00424632|468332705|FG002|Overall Study|Adverse Event|0|||
130102333|NCT00424632|468332706|FG003|Overall Study|Adverse Event|0|||
130102334|NCT00424632|468332707|FG004|Overall Study|Adverse Event|0|||
130102335|NCT00424632|468332708|FG005|Overall Study|Adverse Event|0|||
130035181|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130035182|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130035183|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130035184|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
130035185|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
130035186|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
130035187|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130102336|NCT00424632|468332709|FG006|Overall Study|Adverse Event|0|||
130102337|NCT00424632|468332710|FG007|Overall Study|Adverse Event|0|||
130035188|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130102338|NCT00424632|468332711|FG008|Overall Study|Adverse Event|3|||
130102339|NCT00424632|468332712|FG009|Overall Study|Adverse Event|2|||
130102340|NCT00424632|468332703|FG000|Overall Study|Global deterioration of health status|0|||
130102341|NCT00424632|468332704|FG001|Overall Study|Global deterioration of health status|0|||
130102342|NCT00424632|468332705|FG002|Overall Study|Global deterioration of health status|0|||
130102343|NCT00424632|468332706|FG003|Overall Study|Global deterioration of health status|1|||
130102344|NCT00424632|468332707|FG004|Overall Study|Global deterioration of health status|1|||
130102345|NCT00424632|468332708|FG005|Overall Study|Global deterioration of health status|0|||
130102346|NCT00424632|468332709|FG006|Overall Study|Global deterioration of health status|0|||
130102347|NCT00424632|468332710|FG007|Overall Study|Global deterioration of health status|0|||
130102348|NCT00424632|468332711|FG008|Overall Study|Global deterioration of health status|0|||
130102349|NCT00424632|468332712|FG009|Overall Study|Global deterioration of health status|0|||
130102350|NCT00424632|468332703|FG000|Overall Study|Objective progression or relapse|1|||
130102351|NCT00424632|468332704|FG001|Overall Study|Objective progression or relapse|1|||
130102352|NCT00424632|468332705|FG002|Overall Study|Objective progression or relapse|1|||
130102353|NCT00424632|468332706|FG003|Overall Study|Objective progression or relapse|2|||
130102354|NCT00424632|468332707|FG004|Overall Study|Objective progression or relapse|2|||
130102355|NCT00424632|468332708|FG005|Overall Study|Objective progression or relapse|13|||
130102356|NCT00424632|468332709|FG006|Overall Study|Objective progression or relapse|7|||
130102357|NCT00424632|468332710|FG007|Overall Study|Objective progression or relapse|3|||
130102358|NCT00424632|468332711|FG008|Overall Study|Objective progression or relapse|12|||
130102359|NCT00424632|468332712|FG009|Overall Study|Objective progression or relapse|4|||
130102360|NCT00424632|468332703|FG000|Overall Study|Other|0|||
130102361|NCT00424632|468332704|FG001|Overall Study|Other|0|||
130102362|NCT00424632|468332705|FG002|Overall Study|Other|0|||
130102363|NCT00424632|468332706|FG003|Overall Study|Other|1|||
130102364|NCT00424632|468332707|FG004|Overall Study|Other|0|||
130102365|NCT00424632|468332708|FG005|Overall Study|Other|0|||
130102366|NCT00424632|468332709|FG006|Overall Study|Other|0|||
130102367|NCT00424632|468332710|FG007|Overall Study|Other|0|||
130102368|NCT00424632|468332711|FG008|Overall Study|Other|1|||
130102369|NCT00424632|468332712|FG009|Overall Study|Other|0|||
130102370|NCT00445458|468332717|FG000|Overall Study|Disease Progression|3|||
130102371|NCT00445458|468332718|FG001|Overall Study|Disease Progression|4|||
130102372|NCT00445458|468332719|FG002|Overall Study|Disease Progression|54|||
130102373|NCT00445458|468332720|FG003|Overall Study|Disease Progression|27|||
130262162|NCT04712669|468925881|FG005|Open Label Phase|Adverse Event|3|||
130262163|NCT04712669|468925882|FG006|Open Label Phase|Adverse Event|1|||
130262164|NCT04712669|468925883|FG007|Open Label Phase|Adverse Event|2|||
130262165|NCT04712669|468925876|FG000|Open Label Phase|Death|0|||
130262166|NCT04712669|468925877|FG001|Open Label Phase|Death|0|||
130262167|NCT04712669|468925878|FG002|Open Label Phase|Death|0|||
130262168|NCT04712669|468925879|FG003|Open Label Phase|Death|1|||
130262169|NCT04712669|468925880|FG004|Open Label Phase|Death|0|||
130262170|NCT04712669|468925881|FG005|Open Label Phase|Death|0|||
130262171|NCT04712669|468925882|FG006|Open Label Phase|Death|0|||
130262172|NCT04712669|468925883|FG007|Open Label Phase|Death|0|||
130262173|NCT04712669|468925876|FG000|Open Label Phase|Lack of Efficacy|0|||
130262174|NCT04712669|468925877|FG001|Open Label Phase|Lack of Efficacy|0|||
130262175|NCT04712669|468925878|FG002|Open Label Phase|Lack of Efficacy|0|||
130262176|NCT04712669|468925879|FG003|Open Label Phase|Lack of Efficacy|0|||
130262177|NCT04712669|468925880|FG004|Open Label Phase|Lack of Efficacy|1|||
130262178|NCT04712669|468925881|FG005|Open Label Phase|Lack of Efficacy|0|||
130262179|NCT04712669|468925882|FG006|Open Label Phase|Lack of Efficacy|0|||
130262180|NCT04712669|468925883|FG007|Open Label Phase|Lack of Efficacy|0|||
130262181|NCT04712669|468925876|FG000|Open Label Phase|Lost to Follow-up|0|||
130262182|NCT04712669|468925877|FG001|Open Label Phase|Lost to Follow-up|0|||
130262183|NCT04712669|468925878|FG002|Open Label Phase|Lost to Follow-up|0|||
130262184|NCT04712669|468925879|FG003|Open Label Phase|Lost to Follow-up|0|||
130262185|NCT04712669|468925880|FG004|Open Label Phase|Lost to Follow-up|0|||
130262186|NCT04712669|468925881|FG005|Open Label Phase|Lost to Follow-up|0|||
130262187|NCT04712669|468925882|FG006|Open Label Phase|Lost to Follow-up|1|||
130262188|NCT04712669|468925883|FG007|Open Label Phase|Lost to Follow-up|1|||
130262189|NCT04712669|468925876|FG000|Open Label Phase|Physician Decision|0|||
130262190|NCT04712669|468925877|FG001|Open Label Phase|Physician Decision|0|||
130262191|NCT04712669|468925878|FG002|Open Label Phase|Physician Decision|0|||
130102374|NCT00445458|468332717|FG000|Overall Study|Withdrawal by Subject|0|||
130102375|NCT00445458|468332718|FG001|Overall Study|Withdrawal by Subject|0|||
130102376|NCT00445458|468332719|FG002|Overall Study|Withdrawal by Subject|7|||
130102377|NCT00445458|468332720|FG003|Overall Study|Withdrawal by Subject|0|||
130102378|NCT00445458|468332717|FG000|Overall Study|Adverse Event|0|||
130262192|NCT04712669|468925879|FG003|Open Label Phase|Physician Decision|1|||
130262193|NCT04712669|468925880|FG004|Open Label Phase|Physician Decision|0|||
130262194|NCT04712669|468925881|FG005|Open Label Phase|Physician Decision|0|||
130262195|NCT04712669|468925882|FG006|Open Label Phase|Physician Decision|0|||
130262196|NCT04712669|468925883|FG007|Open Label Phase|Physician Decision|0|||
130102379|NCT00445458|468332718|FG001|Overall Study|Adverse Event|0|||
130102380|NCT00445458|468332719|FG002|Overall Study|Adverse Event|3|||
130102381|NCT00445458|468332720|FG003|Overall Study|Adverse Event|0|||
130102382|NCT00445458|468332717|FG000|Overall Study|Death|0|||
130102383|NCT00445458|468332718|FG001|Overall Study|Death|1|||
130262197|NCT04712669|468925876|FG000|Open Label Phase|Withdrawal by Subject|0|||
130262198|NCT04712669|468925877|FG001|Open Label Phase|Withdrawal by Subject|0|||
130102384|NCT00445458|468332719|FG002|Overall Study|Death|2|||
130102385|NCT00445458|468332720|FG003|Overall Study|Death|0|||
130102386|NCT00445458|468332717|FG000|Overall Study|Physician Decision|0|||
130102387|NCT00445458|468332718|FG001|Overall Study|Physician Decision|0|||
130102388|NCT00445458|468332719|FG002|Overall Study|Physician Decision|1|||
130102389|NCT00445458|468332720|FG003|Overall Study|Physician Decision|1|||
130102390|NCT00445458|468332717|FG000|Overall Study|Surgery|0|||
130102391|NCT00445458|468332718|FG001|Overall Study|Surgery|0|||
130102392|NCT00445458|468332719|FG002|Overall Study|Surgery|1|||
130262199|NCT04712669|468925878|FG002|Open Label Phase|Withdrawal by Subject|0|||
130262200|NCT04712669|468925879|FG003|Open Label Phase|Withdrawal by Subject|1|||
130262201|NCT04712669|468925880|FG004|Open Label Phase|Withdrawal by Subject|5|||
130262202|NCT04712669|468925881|FG005|Open Label Phase|Withdrawal by Subject|5|||
130262203|NCT04712669|468925882|FG006|Open Label Phase|Withdrawal by Subject|0|||
130262204|NCT04712669|468925883|FG007|Open Label Phase|Withdrawal by Subject|4|||
130102393|NCT00445458|468332720|FG003|Overall Study|Surgery|0|||
130102394|NCT01071083|468332723|FG000|Overall Study|Adverse Event|1|||
130102395|NCT01071083|468332724|FG001|Overall Study|Adverse Event|0|||
130262205|NCT04712669|468925876|FG000|Open Label Phase|Termination by Sponsor|0|||
130262206|NCT04712669|468925877|FG001|Open Label Phase|Termination by Sponsor|0|||
130262207|NCT04712669|468925878|FG002|Open Label Phase|Termination by Sponsor|0|||
130262208|NCT04712669|468925879|FG003|Open Label Phase|Termination by Sponsor|11|||
130262209|NCT04712669|468925880|FG004|Open Label Phase|Termination by Sponsor|9|||
130262210|NCT04712669|468925881|FG005|Open Label Phase|Termination by Sponsor|14|||
130262211|NCT04712669|468925882|FG006|Open Label Phase|Termination by Sponsor|0|||
130262212|NCT04712669|468925883|FG007|Open Label Phase|Termination by Sponsor|14|||
130262213|NCT03802396|468925884|FG000|Overall Study|Withdrawal by Subject|2|||
130262214|NCT03802396|468925885|FG001|Overall Study|Withdrawal by Subject|0|||
130262215|NCT03802396|468925884|FG000|Overall Study|Surgery Cancelled|1|||
130262216|NCT03802396|468925885|FG001|Overall Study|Surgery Cancelled|0|||
130262217|NCT02561962|468925889|FG000|Overall Study|Withdrawal by Subject|1|||
130262218|NCT02561962|468925890|FG001|Overall Study|Withdrawal by Subject|0|||
130262219|NCT02561962|468925891|FG002|Overall Study|Withdrawal by Subject|0|||
130262220|NCT02561962|468925892|FG003|Overall Study|Withdrawal by Subject|0|||
130262221|NCT02561962|468925893|FG004|Overall Study|Withdrawal by Subject|1|||
130262222|NCT02561962|468925894|FG005|Overall Study|Withdrawal by Subject|1|||
130262223|NCT02561962|468925895|FG006|Overall Study|Withdrawal by Subject|2|||
130262224|NCT02561962|468925896|FG007|Overall Study|Withdrawal by Subject|1|||
130262225|NCT02561962|468925897|FG008|Overall Study|Withdrawal by Subject|0|||
130262226|NCT02561962|468925889|FG000|Overall Study|Decision by sponsor|0|||
130262227|NCT02561962|468925890|FG001|Overall Study|Decision by sponsor|0|||
130262228|NCT02561962|468925891|FG002|Overall Study|Decision by sponsor|0|||
130262229|NCT02561962|468925892|FG003|Overall Study|Decision by sponsor|0|||
130262230|NCT02561962|468925893|FG004|Overall Study|Decision by sponsor|1|||
130262231|NCT02561962|468925894|FG005|Overall Study|Decision by sponsor|1|||
130262232|NCT02561962|468925895|FG006|Overall Study|Decision by sponsor|0|||
130262233|NCT02561962|468925896|FG007|Overall Study|Decision by sponsor|3|||
130262234|NCT02561962|468925897|FG008|Overall Study|Decision by sponsor|0|||
130262235|NCT02561962|468925889|FG000|Overall Study|Lost to Follow-up|0|||
130262236|NCT02561962|468925890|FG001|Overall Study|Lost to Follow-up|0|||
130262237|NCT02561962|468925891|FG002|Overall Study|Lost to Follow-up|0|||
130102396|NCT01071083|468332725|FG002|Overall Study|Adverse Event|1|||
130102397|NCT01071083|468332726|FG003|Overall Study|Adverse Event|0|||
130102398|NCT01071083|468332727|FG004|Overall Study|Adverse Event|1|||
130102399|NCT01071083|468332723|FG000|Overall Study|Withdrawal by Subject|3|||
130102400|NCT01071083|468332724|FG001|Overall Study|Withdrawal by Subject|0|||
130102401|NCT01071083|468332725|FG002|Overall Study|Withdrawal by Subject|2|||
130102402|NCT01071083|468332726|FG003|Overall Study|Withdrawal by Subject|0|||
130102403|NCT01071083|468332727|FG004|Overall Study|Withdrawal by Subject|3|||
130262238|NCT02561962|468925892|FG003|Overall Study|Lost to Follow-up|0|||
130102404|NCT01071083|468332723|FG000|Overall Study|Physician Decision|1|||
130102405|NCT01071083|468332724|FG001|Overall Study|Physician Decision|0|||
130262239|NCT02561962|468925893|FG004|Overall Study|Lost to Follow-up|0|||
130262240|NCT02561962|468925894|FG005|Overall Study|Lost to Follow-up|1|||
130262241|NCT02561962|468925895|FG006|Overall Study|Lost to Follow-up|0|||
130262242|NCT02561962|468925896|FG007|Overall Study|Lost to Follow-up|0|||
130262243|NCT02561962|468925897|FG008|Overall Study|Lost to Follow-up|0|||
130262244|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
130262245|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
130262246|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
130262247|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
130262248|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
130102406|NCT01071083|468332725|FG002|Overall Study|Physician Decision|0|||
130102407|NCT01071083|468332726|FG003|Overall Study|Physician Decision|1|||
130102408|NCT01071083|468332727|FG004|Overall Study|Physician Decision|1|||
130102409|NCT01071083|468332723|FG000|Overall Study|Early Rescue|1|||
130102410|NCT01071083|468332724|FG001|Overall Study|Early Rescue|0|||
130035189|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
130035190|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130035191|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130035192|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130035193|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
130035194|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
130035195|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
130035196|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130035197|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
130035198|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
130035199|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130262249|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
130262250|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
130262251|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
130262252|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
130262253|NCT01150357|468925898|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
130262254|NCT01150357|468925899|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
130262255|NCT01150357|468925900|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
130262256|NCT01150357|468925898|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
130262257|NCT01150357|468925899|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
130262258|NCT01150357|468925900|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
130262259|NCT01150357|468925898|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
130262260|NCT01150357|468925899|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
130262261|NCT01150357|468925900|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
130035200|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130035201|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130035202|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130035203|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130102411|NCT01071083|468332725|FG002|Overall Study|Early Rescue|0|||
130262262|NCT01150357|468925898|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
130262263|NCT01150357|468925899|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
130262264|NCT01150357|468925900|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
130262265|NCT01819272|468927684|FG000|Overall Study|Adverse Event|1|||
130262266|NCT01819272|468927685|FG001|Overall Study|Adverse Event|0|||
130262267|NCT01819272|468927686|FG002|Overall Study|Adverse Event|0|||
130262268|NCT01819272|468927687|FG003|Overall Study|Adverse Event|2|||
130262269|NCT01819272|468927688|FG004|Overall Study|Adverse Event|0|||
130262270|NCT01819272|468927689|FG005|Overall Study|Adverse Event|0|||
130262271|NCT01819272|468927684|FG000|Overall Study|Lost to Follow-up|3|||
130262272|NCT01819272|468927685|FG001|Overall Study|Lost to Follow-up|0|||
130262273|NCT01819272|468927686|FG002|Overall Study|Lost to Follow-up|1|||
130262274|NCT01819272|468927687|FG003|Overall Study|Lost to Follow-up|0|||
130262275|NCT01819272|468927688|FG004|Overall Study|Lost to Follow-up|0|||
130262276|NCT01819272|468927689|FG005|Overall Study|Lost to Follow-up|3|||
130262277|NCT01819272|468927684|FG000|Overall Study|Protocol Violation|0|||
130262278|NCT01819272|468927685|FG001|Overall Study|Protocol Violation|0|||
130262279|NCT01819272|468927686|FG002|Overall Study|Protocol Violation|0|||
130262280|NCT01819272|468927687|FG003|Overall Study|Protocol Violation|1|||
130262281|NCT01819272|468927688|FG004|Overall Study|Protocol Violation|2|||
130262282|NCT01819272|468927689|FG005|Overall Study|Protocol Violation|3|||
130262283|NCT01819272|468927684|FG000|Overall Study|Physician Decision|0|||
130262284|NCT01819272|468927685|FG001|Overall Study|Physician Decision|1|||
130262285|NCT01819272|468927686|FG002|Overall Study|Physician Decision|0|||
130262286|NCT01819272|468927687|FG003|Overall Study|Physician Decision|0|||
130262287|NCT01819272|468927688|FG004|Overall Study|Physician Decision|0|||
130262288|NCT01819272|468927689|FG005|Overall Study|Physician Decision|0|||
130262289|NCT01819272|468927684|FG000|Overall Study|Withdrawal of Consent|0|||
130262290|NCT01819272|468927685|FG001|Overall Study|Withdrawal of Consent|1|||
130262291|NCT01819272|468927686|FG002|Overall Study|Withdrawal of Consent|2|||
130262292|NCT01819272|468927687|FG003|Overall Study|Withdrawal of Consent|1|||
130262293|NCT01819272|468927688|FG004|Overall Study|Withdrawal of Consent|0|||
130262294|NCT01819272|468927689|FG005|Overall Study|Withdrawal of Consent|1|||
130262295|NCT01819272|468927684|FG000|Overall Study|Loss of Glucose Control|2|||
130262296|NCT01819272|468927685|FG001|Overall Study|Loss of Glucose Control|1|||
130262297|NCT01819272|468927686|FG002|Overall Study|Loss of Glucose Control|0|||
130262298|NCT01819272|468927687|FG003|Overall Study|Loss of Glucose Control|1|||
130262299|NCT01819272|468927688|FG004|Overall Study|Loss of Glucose Control|2|||
130262300|NCT01819272|468927689|FG005|Overall Study|Loss of Glucose Control|0|||
130262301|NCT01732536|468927690|FG000|Overall Study|Withdrawal by Subject|1|||
130262302|NCT01732536|468927691|FG001|Overall Study|Withdrawal by Subject|1|||
130262303|NCT01581684|468927692|FG000|Overall Study|Other reason not defined|0|||
130262304|NCT01581684|468927693|FG001|Overall Study|Other reason not defined|0|||
130262305|NCT01581684|468927694|FG002|Overall Study|Other reason not defined|0|||
130262306|NCT01581684|468927695|FG003|Overall Study|Other reason not defined|0|||
130262307|NCT01581684|468927696|FG004|Overall Study|Other reason not defined|0|||
130262308|NCT01581684|468927697|FG005|Overall Study|Other reason not defined|0|||
130262309|NCT01581684|468927698|FG006|Overall Study|Other reason not defined|0|||
130262310|NCT01581684|468927699|FG007|Overall Study|Other reason not defined|0|||
130262311|NCT01581684|468927700|FG008|Overall Study|Other reason not defined|1|||
130262312|NCT01581684|468927701|FG009|Overall Study|Other reason not defined|0|||
130262313|NCT03728933|468927702|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130262314|NCT03728933|468927703|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130262315|NCT03728933|468927704|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130262316|NCT03728933|468927702|FG000|Overall Study|Withdrawal by Subject|0|||
130262317|NCT03728933|468927703|FG001|Overall Study|Withdrawal by Subject|0|||
130262318|NCT03728933|468927704|FG002|Overall Study|Withdrawal by Subject|1|||
130262319|NCT03728933|468927702|FG000|Overall Study|Lost to Follow-up|0|||
130262320|NCT03728933|468927703|FG001|Overall Study|Lost to Follow-up|1|||
130262321|NCT03728933|468927704|FG002|Overall Study|Lost to Follow-up|0|||
130262322|NCT03728933|468927702|FG000|Overall Study|Adverse Event|1|||
130262323|NCT03728933|468927703|FG001|Overall Study|Adverse Event|0|||
130262324|NCT03728933|468927704|FG002|Overall Study|Adverse Event|0|||
130262325|NCT01784029|468927705|FG000|Overall Study|Lost to Follow-up|19|||
130262326|NCT01784029|468927706|FG001|Overall Study|Lost to Follow-up|20|||
130262327|NCT01784029|468927707|FG002|Overall Study|Lost to Follow-up|22|||
130262328|NCT00639457|468927708|FG000|Overall Study|Withdrawal by Subject|2|||
130262329|NCT00639457|468927709|FG001|Overall Study|Withdrawal by Subject|3|||
130262330|NCT03235050|468927710|FG000|Overall Study|Adverse Event|0|||
130262331|NCT03235050|468927711|FG001|Overall Study|Adverse Event|0|||
130262332|NCT03235050|468927712|FG002|Overall Study|Adverse Event|1|||
130262333|NCT03235050|468927713|FG003|Overall Study|Adverse Event|4|||
130262334|NCT03235050|468927714|FG004|Overall Study|Adverse Event|1|||
130262335|NCT03235050|468927710|FG000|Overall Study|Death|0|||
130262336|NCT03235050|468927711|FG001|Overall Study|Death|0|||
130262337|NCT03235050|468927712|FG002|Overall Study|Death|0|||
130262338|NCT03235050|468927713|FG003|Overall Study|Death|2|||
130262339|NCT03235050|468927714|FG004|Overall Study|Death|1|||
130262340|NCT03235050|468927710|FG000|Overall Study|Lost to Follow-up|1|||
130262341|NCT03235050|468927711|FG001|Overall Study|Lost to Follow-up|2|||
130262342|NCT03235050|468927712|FG002|Overall Study|Lost to Follow-up|1|||
130262343|NCT03235050|468927713|FG003|Overall Study|Lost to Follow-up|2|||
130262344|NCT03235050|468927714|FG004|Overall Study|Lost to Follow-up|0|||
130262345|NCT03235050|468927710|FG000|Overall Study|Withdrawal by Subject|3|||
130262346|NCT03235050|468927711|FG001|Overall Study|Withdrawal by Subject|2|||
130262347|NCT03235050|468927712|FG002|Overall Study|Withdrawal by Subject|2|||
130262348|NCT03235050|468927713|FG003|Overall Study|Withdrawal by Subject|5|||
130262349|NCT03235050|468927714|FG004|Overall Study|Withdrawal by Subject|7|||
130262350|NCT03235050|468927710|FG000|Overall Study|Other reasons|0|||
130262351|NCT03235050|468927711|FG001|Overall Study|Other reasons|1|||
130262352|NCT03235050|468927712|FG002|Overall Study|Other reasons|0|||
130262353|NCT03235050|468927713|FG003|Overall Study|Other reasons|1|||
130262354|NCT03235050|468927714|FG004|Overall Study|Other reasons|2|||
130262355|NCT00276419|468927715|FG000|First Intervention|Adverse Event|1|||
130262356|NCT00276419|468927716|FG001|First Intervention|Adverse Event|0|||
130035204|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
130035205|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130035206|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
130035207|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
130035208|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130035209|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130035210|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130035211|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
130035212|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
130262357|NCT00276419|468927715|FG000|First Intervention|Withdrawal by Subject|0|||
130262358|NCT00276419|468927716|FG001|First Intervention|Withdrawal by Subject|2|||
130262359|NCT02415556|468927719|FG000|Overall Study|Adverse Event|3|||
130262360|NCT02415556|468927720|FG001|Overall Study|Adverse Event|4|||
130262361|NCT02415556|468927721|FG002|Overall Study|Adverse Event|2|||
130262362|NCT02415556|468927722|FG003|Overall Study|Adverse Event|4|||
130262363|NCT02415556|468927719|FG000|Overall Study|Lost to Follow-up|4|||
130262364|NCT02415556|468927720|FG001|Overall Study|Lost to Follow-up|5|||
130262365|NCT02415556|468927721|FG002|Overall Study|Lost to Follow-up|4|||
130262366|NCT02415556|468927722|FG003|Overall Study|Lost to Follow-up|1|||
130262367|NCT02415556|468927719|FG000|Overall Study|Withdrawal by Subject|13|||
130262368|NCT02415556|468927720|FG001|Overall Study|Withdrawal by Subject|4|||
130035213|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
130035214|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130035215|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
130035216|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
130035217|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130035218|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130035219|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130035220|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
130035221|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
130035222|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
130035223|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035224|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130035225|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035226|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035227|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035228|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035229|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035230|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
130035231|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130035232|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035233|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
130035234|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035235|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035236|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035237|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035238|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035239|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035240|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
130035241|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035242|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
130035243|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035244|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035245|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035246|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035247|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035248|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
130035249|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
130035250|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130035251|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
130035252|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
130035253|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130035254|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130035255|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130035256|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
130035257|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
130102412|NCT01071083|468332726|FG003|Overall Study|Early Rescue|0|||
130102413|NCT01071083|468332727|FG004|Overall Study|Early Rescue|1|||
130262369|NCT02415556|468927721|FG002|Overall Study|Withdrawal by Subject|14|||
130262370|NCT02415556|468927722|FG003|Overall Study|Withdrawal by Subject|12|||
130262371|NCT02415556|468927719|FG000|Overall Study|Physician Decision|1|||
130262372|NCT02415556|468927720|FG001|Overall Study|Physician Decision|3|||
130262373|NCT02415556|468927721|FG002|Overall Study|Physician Decision|1|||
130262374|NCT02415556|468927722|FG003|Overall Study|Physician Decision|2|||
130262375|NCT02415556|468927719|FG000|Overall Study|Censored - study completion|4|||
130262376|NCT02415556|468927720|FG001|Overall Study|Censored - study completion|5|||
130262377|NCT02415556|468927721|FG002|Overall Study|Censored - study completion|1|||
130262378|NCT02415556|468927722|FG003|Overall Study|Censored - study completion|0|||
130262379|NCT02415556|468927719|FG000|Overall Study|Family-related issues|0|||
130262380|NCT02415556|468927720|FG001|Overall Study|Family-related issues|0|||
130262381|NCT02415556|468927721|FG002|Overall Study|Family-related issues|0|||
130262382|NCT02415556|468927722|FG003|Overall Study|Family-related issues|1|||
130262383|NCT00105534|468927723|FG000|Overall Study|Adverse Event|2|||
130262384|NCT00105534|468927724|FG001|Overall Study|Adverse Event|5|||
130262385|NCT00105534|468927723|FG000|Overall Study|Protocol Violation|1|||
130262386|NCT00105534|468927724|FG001|Overall Study|Protocol Violation|4|||
130035258|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
130262387|NCT00105534|468927723|FG000|Overall Study|Withdrawal by Subject|6|||
130262388|NCT00105534|468927724|FG001|Overall Study|Withdrawal by Subject|6|||
130262389|NCT00105534|468927723|FG000|Overall Study|Lost to Follow-up|5|||
130262390|NCT00105534|468927724|FG001|Overall Study|Lost to Follow-up|1|||
130262391|NCT00105534|468927723|FG000|Overall Study|Lack of Efficacy|7|||
130262392|NCT00105534|468927724|FG001|Overall Study|Lack of Efficacy|15|||
130262393|NCT00105534|468927723|FG000|Overall Study|Treatment unmasked|1|||
130262394|NCT00105534|468927724|FG001|Overall Study|Treatment unmasked|0|||
130262395|NCT00105534|468927723|FG000|Overall Study|Other Reason|0|||
130262396|NCT00105534|468927724|FG001|Overall Study|Other Reason|2|||
130262397|NCT01621178|468927725|FG000|Overall Study|Adverse Event|5|||
130262398|NCT01621178|468927726|FG001|Overall Study|Adverse Event|2|||
130262399|NCT01621178|468927727|FG002|Overall Study|Adverse Event|8|||
130262400|NCT01621178|468927725|FG000|Overall Study|Death|6|||
130262401|NCT01621178|468927726|FG001|Overall Study|Death|7|||
130262402|NCT01621178|468927727|FG002|Overall Study|Death|2|||
130262403|NCT01621178|468927725|FG000|Overall Study|Lost to Follow-up|1|||
130262404|NCT01621178|468927726|FG001|Overall Study|Lost to Follow-up|2|||
130262405|NCT01621178|468927727|FG002|Overall Study|Lost to Follow-up|1|||
130262406|NCT01621178|468927725|FG000|Overall Study|Withdrawal by Subject|14|||
130262407|NCT01621178|468927726|FG001|Overall Study|Withdrawal by Subject|17|||
130262408|NCT01621178|468927727|FG002|Overall Study|Withdrawal by Subject|18|||
130262409|NCT01621178|468927725|FG000|Overall Study|Physician Decision|5|||
130262410|NCT01621178|468927726|FG001|Overall Study|Physician Decision|2|||
130262411|NCT01621178|468927727|FG002|Overall Study|Physician Decision|7|||
130262412|NCT02896257|468927728|FG000|Providers|Without eligible patients|21|||
130262413|NCT02896257|468927729|FG001|Providers|Without eligible patients|28|||
130262414|NCT02896257|468927728|FG000|Patients|PFT entry criteria not met|43|||
130262415|NCT02896257|468927729|FG001|Patients|PFT entry criteria not met|50|||
130262416|NCT02896257|468927728|FG000|Patients|No capacity to review|8|||
130262417|NCT02896257|468927729|FG001|Patients|No capacity to review|11|||
130262418|NCT02896257|468927728|FG000|Patients|Appointment rescheduled/cancelled|5|||
130262419|NCT02896257|468927729|FG001|Patients|Appointment rescheduled/cancelled|7|||
130262420|NCT02896257|468927728|FG000|Patients|PCP not assigned a clinic|4|||
130262421|NCT02896257|468927729|FG001|Patients|PCP not assigned a clinic|0|||
130262422|NCT02896257|468927728|FG000|Patients|No history of COPD|0|||
130262423|NCT02896257|468927729|FG001|Patients|No history of COPD|1|||
130262424|NCT02896257|468927728|FG000|Patients|Deceased between review and index date|0|||
130262425|NCT02896257|468927729|FG001|Patients|Deceased between review and index date|1|||
130262426|NCT02896257|468927728|FG000|Patients|No ICS Rx upon review|1|||
130262427|NCT02896257|468927729|FG001|Patients|No ICS Rx upon review|1|||
130262428|NCT02896257|468927728|FG000|Patients|Protocol Violation|2|||
130262429|NCT02896257|468927729|FG001|Patients|Protocol Violation|1|||
130262430|NCT02896257|468927728|FG000|Patients|Hospice care|0|||
130262431|NCT02896257|468927729|FG001|Patients|Hospice care|1|||
130262432|NCT04778592|468927734|FG000|Overall Study|Adverse Event|1|||
130262433|NCT04778592|468927735|FG001|Overall Study|Adverse Event|2|||
130262434|NCT04778592|468927734|FG000|Overall Study|Withdrawal by Subject|1|||
130262435|NCT04778592|468927735|FG001|Overall Study|Withdrawal by Subject|2|||
130262436|NCT01192126|468927736|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
130262437|NCT01192126|468927737|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
130262438|NCT01192126|468927736|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
130262439|NCT01192126|468927737|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
130262440|NCT02660229|468927738|FG000|Overall Study|Adverse Event|2|||
130262441|NCT02660229|468927739|FG001|Overall Study|Adverse Event|0|||
130262442|NCT02660229|468927738|FG000|Overall Study|Withdrawal by Subject|0|||
130262443|NCT02660229|468927739|FG001|Overall Study|Withdrawal by Subject|1|||
130262444|NCT01146613|468927740|FG000|Overall Study|Lost to Follow-up|3|||
130262445|NCT01146613|468927741|FG001|Overall Study|Lost to Follow-up|8|||
130262446|NCT01146613|468927740|FG000|Overall Study|Lack of Efficacy|0|||
130262447|NCT01146613|468927741|FG001|Overall Study|Lack of Efficacy|1|||
130262448|NCT01146613|468927740|FG000|Overall Study|Death|1|||
130262449|NCT01146613|468927741|FG001|Overall Study|Death|0|||
130262450|NCT01146613|468927740|FG000|Overall Study|Physician Decision|1|||
130262451|NCT01146613|468927741|FG001|Overall Study|Physician Decision|0|||
130262452|NCT01146613|468927740|FG000|Overall Study|Withdrawal by Subject|0|||
130262453|NCT01146613|468927741|FG001|Overall Study|Withdrawal by Subject|3|||
130262454|NCT01146613|468927740|FG000|Overall Study|schedule conflict|1|||
130262455|NCT01146613|468927741|FG001|Overall Study|schedule conflict|0|||
130262456|NCT01146613|468927740|FG000|Overall Study|Outpatient detox|1|||
130262457|NCT01146613|468927741|FG001|Overall Study|Outpatient detox|0|||
130262458|NCT00329030|468927742|FG000|Overall Study|Withdrawal by Subject|1|||
129885597|NCT02611830|467540767|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
130262459|NCT00329030|468927743|FG001|Overall Study|Withdrawal by Subject|3|||
130262460|NCT00329030|468927742|FG000|Overall Study|Progressive Disease|6|||
130262461|NCT00329030|468927743|FG001|Overall Study|Progressive Disease|2|||
130262462|NCT00329030|468927742|FG000|Overall Study|Ineligible Pathology|1|||
130262463|NCT00329030|468927743|FG001|Overall Study|Ineligible Pathology|1|||
130262464|NCT02441218|468927750|FG000|Overall Study|Death|503|||
130262465|NCT02441218|468927751|FG001|Overall Study|Death|553|||
129885598|NCT02611830|467540768|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
130262466|NCT02441218|468927750|FG000|Overall Study|Withdrawal by Subject|73|||
130262467|NCT02441218|468927751|FG001|Overall Study|Withdrawal by Subject|58|||
130262468|NCT02441218|468927750|FG000|Overall Study|Lost to Follow-up|2|||
130262469|NCT02441218|468927751|FG001|Overall Study|Lost to Follow-up|1|||
130262470|NCT01541371|468927752|FG000|Overall Study|Withdrawal by Subject|14|||
130262471|NCT01541371|468927752|FG000|Overall Study|Lost to Follow-up|21|||
130262472|NCT01541371|468927752|FG000|Overall Study|Adverse Event|15|||
130262473|NCT01541371|468927752|FG000|Overall Study|Lack of Efficacy|12|||
130262474|NCT01541371|468927752|FG000|Overall Study|Protocol Violation|6|||
130262475|NCT01541371|468927752|FG000|Overall Study|Study medication non-compliance|3|||
130262476|NCT01541371|468927752|FG000|Overall Study|Other|6|||
130262477|NCT02271880|468927755|FG000|Overall Study|Premature discontinuation of study|3|||
130262478|NCT02271880|468927756|FG001|Overall Study|Premature discontinuation of study|4|||
130262479|NCT02431325|468927757|FG000|Overall Study|Adverse Event|3|||
130262480|NCT02431325|468927758|FG001|Overall Study|Adverse Event|0|||
130262481|NCT02431325|468927757|FG000|Overall Study|Lost to Follow-up|0|||
130262482|NCT02431325|468927758|FG001|Overall Study|Lost to Follow-up|1|||
130262483|NCT02431325|468927757|FG000|Overall Study|Withdrawal by Subject|1|||
130262484|NCT02431325|468927758|FG001|Overall Study|Withdrawal by Subject|2|||
130262485|NCT02431325|468927757|FG000|Overall Study|Declined to take study medication|1|||
130262486|NCT02431325|468927758|FG001|Overall Study|Declined to take study medication|0|||
130262487|NCT02431325|468927757|FG000|Overall Study|Withdrew before starting study medication|1|||
130262488|NCT02431325|468927758|FG001|Overall Study|Withdrew before starting study medication|0|||
130262489|NCT02431325|468927757|FG000|Overall Study|Placebo shortage|2|||
130262490|NCT02431325|468927758|FG001|Overall Study|Placebo shortage|0|||
130262491|NCT00744861|468927759|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
130262492|NCT00744861|468927760|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
130262493|NCT00744861|468927761|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
130262494|NCT00744861|468927762|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
130262495|NCT00744861|468927759|FG000|Feasibility Stage 1|Pregnancy|0|||
130262496|NCT00744861|468927760|FG001|Feasibility Stage 1|Pregnancy|1|||
130262497|NCT00744861|468927761|FG002|Feasibility Stage 1|Pregnancy|0|||
130262498|NCT00744861|468927762|FG003|Feasibility Stage 1|Pregnancy|0|||
130262499|NCT00744861|468927759|FG000|Pivotal Stage 2|Adverse Event|0|||
130262500|NCT00744861|468927760|FG001|Pivotal Stage 2|Adverse Event|0|||
130262501|NCT00744861|468927761|FG002|Pivotal Stage 2|Adverse Event|6|||
130262502|NCT00744861|468927762|FG003|Pivotal Stage 2|Adverse Event|11|||
130262503|NCT00744861|468927759|FG000|Pivotal Stage 2|Death|0|||
130262504|NCT00744861|468927760|FG001|Pivotal Stage 2|Death|0|||
130262505|NCT00744861|468927761|FG002|Pivotal Stage 2|Death|0|||
130262506|NCT00744861|468927762|FG003|Pivotal Stage 2|Death|1|||
130262507|NCT00744861|468927759|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
130262508|NCT00744861|468927760|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
130262509|NCT00744861|468927761|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
130262510|NCT00744861|468927762|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
130262511|NCT00744861|468927759|FG000|Pivotal Stage 2|Physician Decision|0|||
130262512|NCT00744861|468927760|FG001|Pivotal Stage 2|Physician Decision|0|||
130262513|NCT00744861|468927761|FG002|Pivotal Stage 2|Physician Decision|3|||
130262514|NCT00744861|468927762|FG003|Pivotal Stage 2|Physician Decision|1|||
130262515|NCT00744861|468927759|FG000|Pivotal Stage 2|Protocol Violation|0|||
130035259|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130035260|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130262516|NCT00744861|468927760|FG001|Pivotal Stage 2|Protocol Violation|0|||
130262517|NCT00744861|468927761|FG002|Pivotal Stage 2|Protocol Violation|0|||
130262518|NCT00744861|468927762|FG003|Pivotal Stage 2|Protocol Violation|1|||
130262519|NCT00744861|468927759|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
130262520|NCT00744861|468927760|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
130262521|NCT00744861|468927761|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
130262522|NCT00744861|468927762|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
130262523|NCT00744861|468927759|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
130262524|NCT00744861|468927760|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
130262525|NCT00744861|468927761|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
130262526|NCT00744861|468927762|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
130262527|NCT00181844|468927763|FG000|Signed Consent|Withdrawal by Subject|5|||
130262528|NCT00181844|468927763|FG000|Signed Consent|Did not meet entrance criteria|7|||
130262529|NCT00181844|468927763|FG000|Exposed to Study Medication|Adverse Event|10|||
130262530|NCT00181844|468927763|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
130262531|NCT00181844|468927763|FG000|Exposed to Study Medication|Non-compliance|2|||
130262532|NCT00181844|468927763|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
130262533|NCT00181844|468927763|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
130262534|NCT04661033|468927764|FG000|Overall Study|Adverse Event|0|||
130262535|NCT04661033|468927765|FG001|Overall Study|Adverse Event|0|||
130262536|NCT04661033|468927766|FG002|Overall Study|Adverse Event|1|||
130262537|NCT04661033|468927767|FG003|Overall Study|Adverse Event|0|||
130262538|NCT04661033|468927764|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
130262539|NCT04661033|468927765|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130262540|NCT04661033|468927766|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130262541|NCT04661033|468927767|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
130262542|NCT04661033|468927764|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
130262543|NCT04661033|468927765|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
130262544|NCT04661033|468927766|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
130262545|NCT04661033|468927767|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
130262546|NCT04661033|468927764|FG000|Overall Study|Early discontinuation as per PI|1|||
130262547|NCT04661033|468927765|FG001|Overall Study|Early discontinuation as per PI|0|||
130262548|NCT04661033|468927766|FG002|Overall Study|Early discontinuation as per PI|0|||
130262549|NCT04661033|468927767|FG003|Overall Study|Early discontinuation as per PI|0|||
130262550|NCT04064905|468927768|FG000|Overall Study|Lost to Follow-up|0|||
130262551|NCT04064905|468927769|FG001|Overall Study|Lost to Follow-up|3|||
130262552|NCT04064905|468927770|FG002|Overall Study|Lost to Follow-up|1|||
130262553|NCT04064905|468927771|FG003|Overall Study|Lost to Follow-up|4|||
130262554|NCT04064905|468927772|FG004|Overall Study|Lost to Follow-up|2|||
130262555|NCT01567722|468927773|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
130262556|NCT01567722|468927774|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
130262557|NCT01567722|468927775|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
130262558|NCT01567722|468927773|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
130262559|NCT01567722|468927774|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
130262560|NCT01567722|468927775|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
130262561|NCT01567722|468927773|FG000|Overall Study|Protocol closure by the OCG|2|||
130262562|NCT01567722|468927774|FG001|Overall Study|Protocol closure by the OCG|0|||
130262563|NCT01567722|468927775|FG002|Overall Study|Protocol closure by the OCG|0|||
130262564|NCT01567722|468927773|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
130262565|NCT01567722|468927774|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
130262566|NCT01567722|468927775|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
130262567|NCT00382174|468927776|FG000|Overall Study|Lost to Follow-up|1|||
130262568|NCT00382174|468927777|FG001|Overall Study|Lost to Follow-up|4|||
130262569|NCT00382174|468927778|FG002|Overall Study|Lost to Follow-up|5|||
130262570|NCT00382174|468927776|FG000|Overall Study|Adverse Event|1|||
130262571|NCT00382174|468927777|FG001|Overall Study|Adverse Event|4|||
130262572|NCT00382174|468927778|FG002|Overall Study|Adverse Event|5|||
130262573|NCT00382174|468927776|FG000|Overall Study|Withdrawal by Subject|1|||
130262574|NCT00382174|468927777|FG001|Overall Study|Withdrawal by Subject|4|||
130262575|NCT00382174|468927778|FG002|Overall Study|Withdrawal by Subject|5|||
130262576|NCT00382174|468927776|FG000|Overall Study|Non compliance|1|||
130262577|NCT00382174|468927777|FG001|Overall Study|Non compliance|0|||
130102414|NCT01071083|468332723|FG000|Overall Study|Subject Moved|0|||
130102415|NCT01071083|468332724|FG001|Overall Study|Subject Moved|1|||
130102416|NCT01071083|468332725|FG002|Overall Study|Subject Moved|0|||
130102417|NCT01071083|468332726|FG003|Overall Study|Subject Moved|0|||
130262578|NCT00382174|468927778|FG002|Overall Study|Non compliance|1|||
130262579|NCT00382174|468927776|FG000|Overall Study|Physician Decision|0|||
130262580|NCT00382174|468927777|FG001|Overall Study|Physician Decision|2|||
130262581|NCT00382174|468927778|FG002|Overall Study|Physician Decision|2|||
130262582|NCT00382174|468927776|FG000|Overall Study|Failed to meet criteria|0|||
130262583|NCT00382174|468927777|FG001|Overall Study|Failed to meet criteria|1|||
130262584|NCT00382174|468927778|FG002|Overall Study|Failed to meet criteria|1|||
130262585|NCT00382174|468927776|FG000|Overall Study|Wounds merged|0|||
130262586|NCT00382174|468927777|FG001|Overall Study|Wounds merged|2|||
130262587|NCT00382174|468927778|FG002|Overall Study|Wounds merged|2|||
130262588|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
130262589|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
130262590|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
130262591|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Death|0|||
130262592|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Death|0|||
130262593|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Death|1|||
130262594|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
130262595|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
130262596|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
130262597|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
130262598|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
130262599|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
130262600|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
130262601|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
130262602|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
130262603|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Graft loss|0|||
130102418|NCT01071083|468332727|FG004|Overall Study|Subject Moved|0|||
130102419|NCT01071083|468332723|FG000|Overall Study|Images Not Usable (Motion)|0|||
130262604|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Graft loss|0|||
130262605|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Graft loss|7|||
130262606|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
130262607|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
130262608|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
130262609|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
130262610|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
130262611|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
130262612|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
130262613|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
130262614|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
130262615|NCT00956293|468927790|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
130262616|NCT00956293|468927791|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
130262617|NCT00956293|468927792|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
130262618|NCT00956293|468927790|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
130262619|NCT00956293|468927791|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
130262620|NCT00956293|468927792|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
130262621|NCT00956293|468927790|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
130262622|NCT00956293|468927791|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
130262623|NCT00956293|468927792|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
130262624|NCT00956293|468927790|FG000|Main Period (Randomization)|Adverse Event|0|||
130262625|NCT00956293|468927791|FG001|Main Period (Randomization)|Adverse Event|15|||
130262626|NCT00956293|468927792|FG002|Main Period (Randomization)|Adverse Event|0|||
130262627|NCT00956293|468927790|FG000|Follow-up Period|Follow-up period was terminated.|20|||
130262628|NCT00956293|468927791|FG001|Follow-up Period|Follow-up period was terminated.|32|||
130262629|NCT00956293|468927792|FG002|Follow-up Period|Follow-up period was terminated.|0|||
130262630|NCT03383666|468927793|FG000|Overall Study|Withdrawal by Subject|2|||
130262631|NCT03383666|468927793|FG000|Overall Study|Lost to Follow-up|2|||
130262632|NCT03507127|468927796|FG000|Overall Study|Withdrawal by Subject|1|||
130262633|NCT03507127|468927797|FG001|Overall Study|Withdrawal by Subject|0|||
130262634|NCT03507127|468927796|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
130262635|NCT03507127|468927797|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
130262636|NCT03508050|468927798|FG000|Overall Study|Pleural adhesions|1|||
130262637|NCT03508050|468927799|FG001|Overall Study|Pleural adhesions|0|||
130262638|NCT03508050|468927798|FG000|Overall Study|Mucus plug|1|||
130262639|NCT03508050|468927799|FG001|Overall Study|Mucus plug|0|||
130262640|NCT03508050|468927798|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
130262641|NCT03508050|468927799|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
130262642|NCT03508050|468927798|FG000|Overall Study|Sustained desaturation|0|||
130262643|NCT03508050|468927799|FG001|Overall Study|Sustained desaturation|1|||
130262644|NCT01240863|468927800|FG000|Open-label Titration Period|Adverse Event|47|||
130262645|NCT01240863|468927801|FG001|Open-label Titration Period|Adverse Event|0|||
130262646|NCT01240863|468927802|FG002|Open-label Titration Period|Adverse Event|0|||
130262647|NCT01240863|468927800|FG000|Open-label Titration Period|Lack of Efficacy|19|||
130262648|NCT01240863|468927801|FG001|Open-label Titration Period|Lack of Efficacy|0|||
130262649|NCT01240863|468927802|FG002|Open-label Titration Period|Lack of Efficacy|0|||
130262650|NCT01240863|468927800|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
130262651|NCT01240863|468927801|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
130262652|NCT01240863|468927802|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
130262653|NCT01240863|468927800|FG000|Open-label Titration Period|Protocol Violation|7|||
130262654|NCT01240863|468927801|FG001|Open-label Titration Period|Protocol Violation|0|||
130262655|NCT01240863|468927802|FG002|Open-label Titration Period|Protocol Violation|0|||
130262656|NCT01240863|468927800|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
130262657|NCT01240863|468927801|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
130262658|NCT01240863|468927802|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
130262659|NCT01240863|468927800|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
130262660|NCT01240863|468927801|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
130262661|NCT01240863|468927802|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
130262662|NCT01240863|468927800|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
130262663|NCT01240863|468927801|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
130262664|NCT01240863|468927802|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
130262665|NCT01240863|468927800|FG000|Open-label Titration Period|Other|7|||
130262666|NCT01240863|468927801|FG001|Open-label Titration Period|Other|0|||
130262667|NCT01240863|468927802|FG002|Open-label Titration Period|Other|0|||
130262668|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
130262669|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
130262670|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
130262671|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130262672|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
130262673|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
130262674|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130262675|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
130035261|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
130035262|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130262676|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
130262677|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
130262678|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
130262679|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
130262680|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
130262681|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
130262682|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
130262683|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
129885599|NCT02611830|467540769|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
130035263|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130035264|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130035265|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130262684|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
130262685|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
130262686|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
130262687|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
130262688|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
130262689|NCT01240863|468927800|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
130262690|NCT01240863|468927801|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
130262691|NCT01240863|468927802|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
130262692|NCT02081586|468927803|FG000|Overall Study|Lost to Follow-up|0|||
130262693|NCT02081586|468927804|FG001|Overall Study|Lost to Follow-up|1|||
130262694|NCT02081586|468927805|FG002|Overall Study|Lost to Follow-up|0|||
130262695|NCT02081586|468927806|FG003|Overall Study|Lost to Follow-up|1|||
130262696|NCT02081586|468927803|FG000|Overall Study|Head injury not related to study|0|||
130262697|NCT02081586|468927804|FG001|Overall Study|Head injury not related to study|0|||
130262698|NCT02081586|468927805|FG002|Overall Study|Head injury not related to study|1|||
130262699|NCT02081586|468927806|FG003|Overall Study|Head injury not related to study|0|||
130262700|NCT01677988|468927809|FG000|Overall Study|Lack of Efficacy|2|||
130262701|NCT00659425|468927813|FG000|Overall Study|Disease progression|1|||
130262702|NCT00659425|468927814|FG001|Overall Study|Disease progression|0|||
130262703|NCT00659425|468927815|FG002|Overall Study|Disease progression|0|||
130262704|NCT00659425|468927816|FG003|Overall Study|Disease progression|1|||
130262705|NCT00659425|468927817|FG004|Overall Study|Disease progression|0|||
130262706|NCT00659425|468927818|FG005|Overall Study|Disease progression|2|||
130262707|NCT00659425|468927819|FG006|Overall Study|Disease progression|4|||
130262708|NCT00659425|468927820|FG007|Overall Study|Disease progression|3|||
130262709|NCT00659425|468927821|FG008|Overall Study|Disease progression|5|||
130262710|NCT00659425|468927822|FG009|Overall Study|Disease progression|3|||
130035266|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130035267|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
130035268|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130262711|NCT00659425|468927813|FG000|Overall Study|Death|0|||
130262712|NCT00659425|468927814|FG001|Overall Study|Death|0|||
130262713|NCT00659425|468927815|FG002|Overall Study|Death|0|||
130262714|NCT00659425|468927816|FG003|Overall Study|Death|1|||
130262715|NCT00659425|468927817|FG004|Overall Study|Death|0|||
130262716|NCT00659425|468927818|FG005|Overall Study|Death|0|||
130262717|NCT00659425|468927819|FG006|Overall Study|Death|1|||
130035269|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130035270|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130035271|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130035272|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130035273|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130035274|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130035275|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
130102420|NCT01071083|468332724|FG001|Overall Study|Images Not Usable (Motion)|1|||
130262718|NCT00659425|468927820|FG007|Overall Study|Death|0|||
130262719|NCT00659425|468927821|FG008|Overall Study|Death|0|||
130262720|NCT00659425|468927822|FG009|Overall Study|Death|0|||
130262721|NCT00659425|468927813|FG000|Overall Study|Adverse Event|0|||
130262722|NCT00659425|468927814|FG001|Overall Study|Adverse Event|0|||
130262723|NCT00659425|468927815|FG002|Overall Study|Adverse Event|0|||
130262724|NCT00659425|468927816|FG003|Overall Study|Adverse Event|0|||
130262725|NCT00659425|468927817|FG004|Overall Study|Adverse Event|0|||
130262726|NCT00659425|468927818|FG005|Overall Study|Adverse Event|1|||
130262727|NCT00659425|468927819|FG006|Overall Study|Adverse Event|0|||
130262728|NCT00659425|468927820|FG007|Overall Study|Adverse Event|3|||
130262729|NCT00659425|468927821|FG008|Overall Study|Adverse Event|1|||
130262730|NCT00659425|468927822|FG009|Overall Study|Adverse Event|4|||
130262731|NCT00659425|468927813|FG000|Overall Study|Investigator Discretion|0|||
130262732|NCT00659425|468927814|FG001|Overall Study|Investigator Discretion|0|||
130262733|NCT00659425|468927815|FG002|Overall Study|Investigator Discretion|0|||
130262734|NCT00659425|468927816|FG003|Overall Study|Investigator Discretion|0|||
130262735|NCT00659425|468927817|FG004|Overall Study|Investigator Discretion|0|||
130262736|NCT00659425|468927818|FG005|Overall Study|Investigator Discretion|1|||
130262737|NCT00659425|468927819|FG006|Overall Study|Investigator Discretion|0|||
130262738|NCT00659425|468927820|FG007|Overall Study|Investigator Discretion|3|||
130262739|NCT00659425|468927821|FG008|Overall Study|Investigator Discretion|0|||
130262740|NCT00659425|468927822|FG009|Overall Study|Investigator Discretion|0|||
130262741|NCT00659425|468927813|FG000|Overall Study|Other|0|||
130262742|NCT00659425|468927814|FG001|Overall Study|Other|1|||
130262743|NCT00659425|468927815|FG002|Overall Study|Other|1|||
130262744|NCT00659425|468927816|FG003|Overall Study|Other|2|||
130262745|NCT00659425|468927817|FG004|Overall Study|Other|4|||
130262746|NCT00659425|468927818|FG005|Overall Study|Other|0|||
130262747|NCT00659425|468927819|FG006|Overall Study|Other|3|||
130262748|NCT00659425|468927820|FG007|Overall Study|Other|2|||
130262749|NCT00659425|468927821|FG008|Overall Study|Other|0|||
130262750|NCT00659425|468927822|FG009|Overall Study|Other|6|||
130262751|NCT00271544|468927823|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
130262752|NCT00271544|468927823|FG000|Overall Study|Model 4196 lead not attempted|9|||
130262753|NCT00271544|468927823|FG000|Overall Study|Implant not attempted|4|||
130262754|NCT03358030|468927824|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
130262755|NCT03358030|468927825|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
130262756|NCT03358030|468927826|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
130262757|NCT03358030|468927827|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
130262758|NCT03358030|468927824|FG000|Overall Study|Ineligibility|0|||
130262759|NCT03358030|468927825|FG001|Overall Study|Ineligibility|0|||
130262760|NCT03358030|468927826|FG002|Overall Study|Ineligibility|0|||
130262761|NCT03358030|468927827|FG003|Overall Study|Ineligibility|2|||
130262762|NCT03358030|468927824|FG000|Overall Study|Voluntary Withdrawal|1|||
130262763|NCT03358030|468927825|FG001|Overall Study|Voluntary Withdrawal|1|||
130262764|NCT03358030|468927826|FG002|Overall Study|Voluntary Withdrawal|3|||
130262765|NCT03358030|468927827|FG003|Overall Study|Voluntary Withdrawal|1|||
130262766|NCT03358030|468927824|FG000|Overall Study|Other|0|||
130262767|NCT03358030|468927825|FG001|Overall Study|Other|0|||
130262768|NCT03358030|468927826|FG002|Overall Study|Other|1|||
130262769|NCT03358030|468927827|FG003|Overall Study|Other|0|||
130262770|NCT02505425|468927828|FG000|Overall Study|Lost to Follow-up|41|||
130262771|NCT02505425|468927829|FG001|Overall Study|Lost to Follow-up|61|||
130262772|NCT02505425|468927830|FG002|Overall Study|Lost to Follow-up|31|||
130262773|NCT02505425|468927831|FG003|Overall Study|Lost to Follow-up|19|||
130262774|NCT02505425|468927828|FG000|Overall Study|Withdrawal by Subject|39|||
130262775|NCT02505425|468927829|FG001|Overall Study|Withdrawal by Subject|9|||
130262776|NCT02505425|468927830|FG002|Overall Study|Withdrawal by Subject|19|||
130262777|NCT02505425|468927831|FG003|Overall Study|Withdrawal by Subject|7|||
130262778|NCT02505425|468927828|FG000|Overall Study|Death|8|||
130262779|NCT02505425|468927829|FG001|Overall Study|Death|12|||
130262780|NCT02505425|468927830|FG002|Overall Study|Death|0|||
130035276|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
130262781|NCT02505425|468927831|FG003|Overall Study|Death|0|||
130035277|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130035278|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130035279|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130035280|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130262782|NCT02781558|468927835|FG000|Overall Study|Lost to Follow-up|2|||
130262783|NCT02781558|468927836|FG001|Overall Study|Lost to Follow-up|2|||
130262784|NCT02781558|468927835|FG000|Overall Study|Adverse Event|1|||
130262785|NCT02781558|468927836|FG001|Overall Study|Adverse Event|0|||
130262786|NCT04704193|468927837|FG000|Overall Study|Withdrawal by Subject|1|||
130035281|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130262787|NCT01492426|468929184|FG000|Treatment|Death|0|||
130262788|NCT01492426|468929185|FG001|Treatment|Death|1|||
130262789|NCT01492426|468929184|FG000|Treatment|Other|1|||
130262790|NCT01492426|468929185|FG001|Treatment|Other|0|||
130262791|NCT01492426|468929184|FG000|Treatment|Adverse Event|25|||
130262792|NCT01492426|468929185|FG001|Treatment|Adverse Event|25|||
130262793|NCT01492426|468929184|FG000|Treatment|Lack of Efficacy|38|||
130262794|NCT01492426|468929185|FG001|Treatment|Lack of Efficacy|5|||
130262795|NCT01492426|468929184|FG000|Treatment|Participant withdrew consent|1|||
130262796|NCT01492426|468929185|FG001|Treatment|Participant withdrew consent|2|||
130262797|NCT01492426|468929184|FG000|Treatment|Poor compliance/noncompliance|1|||
130262798|NCT01492426|468929185|FG001|Treatment|Poor compliance/noncompliance|0|||
130262799|NCT01492426|468929184|FG000|Treatment|Subject requested discontinue study drug|7|||
130262800|NCT01492426|468929185|FG001|Treatment|Subject requested discontinue study drug|3|||
130262801|NCT01492426|468929184|FG000|Treatment|Lost to Follow-up|9|||
130262802|NCT01492426|468929185|FG001|Treatment|Lost to Follow-up|4|||
130262803|NCT01492426|468929184|FG000|Treatment|Participant does not meet study criteria|1|||
130262804|NCT01492426|468929185|FG001|Treatment|Participant does not meet study criteria|0|||
130262805|NCT01492426|468929184|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
130262806|NCT01492426|468929185|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
130262807|NCT01492426|468929184|FG000|Follow-Up|Death|1|||
130262808|NCT01492426|468929185|FG001|Follow-Up|Death|0|||
130262809|NCT01492426|468929184|FG000|Follow-Up|Other|4|||
130262810|NCT01492426|468929185|FG001|Follow-Up|Other|2|||
130262811|NCT01492426|468929184|FG000|Follow-Up|Participant Withdrew Consent|6|||
130262812|NCT01492426|468929185|FG001|Follow-Up|Participant Withdrew Consent|1|||
130262813|NCT01492426|468929184|FG000|Follow-Up|Lost to Follow-up|12|||
130262814|NCT01492426|468929185|FG001|Follow-Up|Lost to Follow-up|6|||
130262815|NCT01978145|468929186|FG000|Treatment Period 1|Adverse Event|1|||
130262816|NCT01978145|468929187|FG001|Treatment Period 1|Adverse Event|9|||
130262817|NCT01978145|468929186|FG000|Treatment Period 1|Physician Decision|1|||
130262818|NCT01978145|468929187|FG001|Treatment Period 1|Physician Decision|0|||
130262819|NCT01978145|468929186|FG000|Treatment Period 1|Withdrawal by Subject|5|||
130262820|NCT01978145|468929187|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130262821|NCT01978145|468929186|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
130262822|NCT01978145|468929187|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
130262823|NCT01978145|468929186|FG000|Washout Period 1|Adverse Event|0|||
130262824|NCT01978145|468929187|FG001|Washout Period 1|Adverse Event|1|||
130262825|NCT01978145|468929186|FG000|Washout Period 1|Withdrawal by Subject|1|||
130262826|NCT01978145|468929187|FG001|Washout Period 1|Withdrawal by Subject|1|||
130262827|NCT01978145|468929186|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
130262828|NCT01978145|468929187|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
130262829|NCT01978145|468929186|FG000|Treatment Period 2|Adverse Event|3|||
130262830|NCT01978145|468929187|FG001|Treatment Period 2|Adverse Event|3|||
130262831|NCT01978145|468929186|FG000|Treatment Period 2|Protocol Violation|0|||
130262832|NCT01978145|468929187|FG001|Treatment Period 2|Protocol Violation|1|||
130262833|NCT01978145|468929186|FG000|Treatment Period 2|Lost to Follow-up|1|||
130262834|NCT01978145|468929187|FG001|Treatment Period 2|Lost to Follow-up|1|||
130262835|NCT01978145|468929186|FG000|Treatment Period 2|Withdrawal by Subject|7|||
130262836|NCT01978145|468929187|FG001|Treatment Period 2|Withdrawal by Subject|4|||
130262837|NCT01978145|468929186|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
130262838|NCT01978145|468929187|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
130262839|NCT01173679|468929192|FG000|Overall Study|Death|1|||
130262840|NCT01250054|468929193|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
130262841|NCT01250054|468929194|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
130262842|NCT02777086|468929195|FG000|Overall Study|Lost to Follow-up|96|||
130262843|NCT02777086|468929196|FG001|Overall Study|Lost to Follow-up|99|||
130262844|NCT01133665|468929199|FG000|Overall Study|Physician Decision|2|||
130262845|NCT02122380|468929200|FG000|First Intervention (30 Days)|Adverse Event|1|||
130262846|NCT02122380|468929201|FG001|First Intervention (30 Days)|Adverse Event|0|||
130262847|NCT02122380|468929200|FG000|First Intervention (30 Days)|Physician Decision|0|||
130262848|NCT02122380|468929201|FG001|First Intervention (30 Days)|Physician Decision|1|||
130262849|NCT02122380|468929200|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
130262850|NCT02122380|468929201|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
130262851|NCT02122380|468929200|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
130262852|NCT02122380|468929201|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
130262853|NCT02122380|468929200|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
130262854|NCT02122380|468929201|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
130262855|NCT02465931|468929204|FG000|Overall Study|Lost to Follow-up|9|||
130262856|NCT02465931|468929205|FG001|Overall Study|Lost to Follow-up|11|||
130262857|NCT02465931|468929204|FG000|Overall Study|Protocol Violation|1|||
130262858|NCT02465931|468929205|FG001|Overall Study|Protocol Violation|0|||
130262859|NCT02465931|468929204|FG000|Overall Study|Withdrawal by Subject|1|||
130262860|NCT02465931|468929205|FG001|Overall Study|Withdrawal by Subject|0|||
130262861|NCT03423602|468929207|FG000|Overall Study|Death|1|||
130262862|NCT03423602|468929207|FG000|Overall Study|Lost to Follow-up|6|||
130262863|NCT03423602|468929207|FG000|Overall Study|Protocol Violation|1|||
130262864|NCT03423602|468929207|FG000|Overall Study|Withdrawal by Subject|4|||
130262865|NCT03423121|468929208|FG000|Overall Study|Lost to Follow-up|2|||
130262866|NCT03423121|468929209|FG001|Overall Study|Lost to Follow-up|6|||
130262867|NCT03423121|468929208|FG000|Overall Study|Adverse Event|1|||
130262868|NCT03423121|468929209|FG001|Overall Study|Adverse Event|0|||
130262869|NCT02136914|468929215|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
130262870|NCT02136914|468929216|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
130262871|NCT02136914|468929215|FG000|Overall Study|Withdrawal by Subject|3|||
130262872|NCT02136914|468929216|FG001|Overall Study|Withdrawal by Subject|10|||
130262873|NCT02136914|468929215|FG000|Overall Study|Subject Unwilling to Proceed|7|||
130262874|NCT02136914|468929216|FG001|Overall Study|Subject Unwilling to Proceed|2|||
130262875|NCT02136914|468929215|FG000|Overall Study|Lost to Follow-up|1|||
130262876|NCT02136914|468929216|FG001|Overall Study|Lost to Follow-up|1|||
130262877|NCT02136914|468929215|FG000|Overall Study|Did Not Receive Study Drug|2|||
130262878|NCT02136914|468929216|FG001|Overall Study|Did Not Receive Study Drug|0|||
130262879|NCT02136914|468929215|FG000|Overall Study|Lack of Efficacy|1|||
130262880|NCT02136914|468929216|FG001|Overall Study|Lack of Efficacy|0|||
130262881|NCT02136914|468929215|FG000|Overall Study|Death|0|||
130262882|NCT02136914|468929216|FG001|Overall Study|Death|1|||
130262883|NCT01493089|468929219|FG000|Overall Study|Protocol Violation|2|||
130262884|NCT01493089|468929220|FG001|Overall Study|Protocol Violation|2|||
130262885|NCT01493089|468929219|FG000|Overall Study|Withdrawal by Subject|1|||
130262886|NCT01493089|468929220|FG001|Overall Study|Withdrawal by Subject|0|||
130262887|NCT01493089|468929219|FG000|Overall Study|Physician Decision|0|||
130262888|NCT01493089|468929220|FG001|Overall Study|Physician Decision|1|||
130262889|NCT03012334|468929221|FG000|Period 1|Withdrawal by Subject|0|||
130262890|NCT03012334|468929222|FG001|Period 1|Withdrawal by Subject|0|||
130262891|NCT03012334|468929223|FG002|Period 1|Withdrawal by Subject|0|||
130262892|NCT03012334|468929224|FG003|Period 1|Withdrawal by Subject|0|||
130262893|NCT03012334|468929225|FG004|Period 1|Withdrawal by Subject|0|||
130262894|NCT03012334|468929226|FG005|Period 1|Withdrawal by Subject|0|||
130262895|NCT03012334|468929227|FG006|Period 1|Withdrawal by Subject|0|||
130262896|NCT03012334|468929228|FG007|Period 1|Withdrawal by Subject|0|||
130262897|NCT03012334|468929229|FG008|Period 1|Withdrawal by Subject|0|||
130262898|NCT03012334|468929230|FG009|Period 1|Withdrawal by Subject|1|||
130262899|NCT03012334|468929221|FG000|Period 2|Withdrawal by Subject|0|||
130262900|NCT03012334|468929222|FG001|Period 2|Withdrawal by Subject|1|||
130262901|NCT03012334|468929223|FG002|Period 2|Withdrawal by Subject|0|||
130262902|NCT03012334|468929224|FG003|Period 2|Withdrawal by Subject|0|||
130262903|NCT03012334|468929225|FG004|Period 2|Withdrawal by Subject|0|||
130262904|NCT03012334|468929226|FG005|Period 2|Withdrawal by Subject|0|||
130262905|NCT03012334|468929227|FG006|Period 2|Withdrawal by Subject|0|||
130262906|NCT03012334|468929228|FG007|Period 2|Withdrawal by Subject|0|||
130262907|NCT03012334|468929229|FG008|Period 2|Withdrawal by Subject|0|||
130262908|NCT03012334|468929230|FG009|Period 2|Withdrawal by Subject|0|||
130262909|NCT03012334|468929221|FG000|Period 2|Protocol Violation|0|||
130262910|NCT03012334|468929222|FG001|Period 2|Protocol Violation|0|||
130262911|NCT03012334|468929223|FG002|Period 2|Protocol Violation|1|||
130262912|NCT03012334|468929224|FG003|Period 2|Protocol Violation|0|||
130262913|NCT03012334|468929225|FG004|Period 2|Protocol Violation|0|||
130262914|NCT03012334|468929226|FG005|Period 2|Protocol Violation|0|||
130262915|NCT03012334|468929227|FG006|Period 2|Protocol Violation|0|||
130262916|NCT03012334|468929228|FG007|Period 2|Protocol Violation|1|||
130262917|NCT03012334|468929229|FG008|Period 2|Protocol Violation|0|||
130262918|NCT03012334|468929230|FG009|Period 2|Protocol Violation|0|||
130262919|NCT03012334|468929221|FG000|Period 4|Non-Compliance|0|||
130262920|NCT03012334|468929222|FG001|Period 4|Non-Compliance|0|||
130262921|NCT03012334|468929223|FG002|Period 4|Non-Compliance|0|||
130262922|NCT03012334|468929224|FG003|Period 4|Non-Compliance|0|||
130262923|NCT03012334|468929225|FG004|Period 4|Non-Compliance|0|||
130262924|NCT03012334|468929226|FG005|Period 4|Non-Compliance|0|||
130262925|NCT03012334|468929227|FG006|Period 4|Non-Compliance|1|||
130262926|NCT03012334|468929228|FG007|Period 4|Non-Compliance|0|||
130262927|NCT03012334|468929229|FG008|Period 4|Non-Compliance|0|||
130262928|NCT03012334|468929230|FG009|Period 4|Non-Compliance|0|||
130262929|NCT03012334|468929221|FG000|Period 4|Adverse Event|0|||
130262930|NCT03012334|468929222|FG001|Period 4|Adverse Event|0|||
130262931|NCT03012334|468929223|FG002|Period 4|Adverse Event|0|||
130262932|NCT03012334|468929224|FG003|Period 4|Adverse Event|0|||
130262933|NCT03012334|468929225|FG004|Period 4|Adverse Event|0|||
130262934|NCT03012334|468929226|FG005|Period 4|Adverse Event|0|||
130262935|NCT03012334|468929227|FG006|Period 4|Adverse Event|0|||
130262936|NCT03012334|468929228|FG007|Period 4|Adverse Event|0|||
130262937|NCT03012334|468929229|FG008|Period 4|Adverse Event|1|||
130262938|NCT03012334|468929230|FG009|Period 4|Adverse Event|0|||
130262939|NCT00325143|468929231|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
130262940|NCT00325143|468929231|FG000|Overall Study|Migrated/moved from study area|1|||
130262941|NCT00325143|468929231|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
130262942|NCT00325143|468929231|FG000|Overall Study|Withdrawal by Subject|8|||
130262943|NCT01073293|468929232|FG000|Overall Study|Lost to Follow-up|0|||
130262944|NCT01073293|468929233|FG001|Overall Study|Lost to Follow-up|1|||
130262945|NCT01073293|468929232|FG000|Overall Study|Withdrawal by Subject|5|||
130262946|NCT01073293|468929233|FG001|Overall Study|Withdrawal by Subject|10|||
130262947|NCT00256126|468929234|FG000|Overall Study|Adverse Event|1|||
130262948|NCT00256126|468929235|FG001|Overall Study|Adverse Event|0|||
130262949|NCT00256126|468929234|FG000|Overall Study|Other|1|||
130262950|NCT00256126|468929235|FG001|Overall Study|Other|2|||
130262951|NCT00454116|468929238|FG000|Overall Study|Adverse Event|5|||
130262952|NCT00454116|468929239|FG001|Overall Study|Adverse Event|11|||
130262953|NCT00454116|468929240|FG002|Overall Study|Adverse Event|9|||
130262954|NCT00454116|468929238|FG000|Overall Study|Condition under investigation worsened|17|||
130262955|NCT00454116|468929239|FG001|Overall Study|Condition under investigation worsened|13|||
130262956|NCT00454116|468929240|FG002|Overall Study|Condition under investigation worsened|18|||
130262957|NCT00454116|468929238|FG000|Overall Study|Withdrawal by Subject|3|||
130262958|NCT00454116|468929239|FG001|Overall Study|Withdrawal by Subject|3|||
130262959|NCT00454116|468929240|FG002|Overall Study|Withdrawal by Subject|1|||
130035282|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130262960|NCT00454116|468929238|FG000|Overall Study|Other|2|||
130262961|NCT00454116|468929239|FG001|Overall Study|Other|2|||
130262962|NCT00454116|468929240|FG002|Overall Study|Other|0|||
130262963|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Physician Decision|2|||
130262964|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Physician Decision|0|||
130035283|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130035284|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
130035285|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
130035286|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035287|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
130035288|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
130035289|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035290|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035291|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035292|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035293|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035294|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
130035295|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130035296|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
130035297|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
130035298|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130035299|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130035300|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130035301|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130035302|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
130035303|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
130035304|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130035305|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
130035306|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130262965|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Physician Decision|0|||
130262966|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Adverse Event|33|||
130262967|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Adverse Event|0|||
130262968|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Adverse Event|0|||
130262969|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
130262970|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130262971|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
130262972|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
130262973|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130262974|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
130262975|NCT01008618|468929243|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
130262976|NCT01008618|468929244|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
130262977|NCT01008618|468929245|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
130262978|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
130262979|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
130262980|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
130262981|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
130262982|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
130262983|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
130262984|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
130262985|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
130262986|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
130262987|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130035307|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130035308|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130035309|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130262988|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
130262989|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
130262990|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130262991|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
130262992|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
130102421|NCT01071083|468332725|FG002|Overall Study|Images Not Usable (Motion)|0|||
130102422|NCT01071083|468332726|FG003|Overall Study|Images Not Usable (Motion)|0|||
130102423|NCT01071083|468332727|FG004|Overall Study|Images Not Usable (Motion)|0|||
130102424|NCT01071083|468332723|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
130102425|NCT01071083|468332724|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130102426|NCT01071083|468332725|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
130102427|NCT01071083|468332726|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
130102428|NCT01071083|468332727|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
130102429|NCT01071083|468332723|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
130102430|NCT01071083|468332724|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
130102431|NCT01071083|468332725|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
130102432|NCT01071083|468332726|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
130102433|NCT01071083|468332727|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
130102434|NCT01071083|468332723|FG000|Overall Study|Subject Refused to Continue|1|||
130102435|NCT01071083|468332724|FG001|Overall Study|Subject Refused to Continue|0|||
130102436|NCT01071083|468332725|FG002|Overall Study|Subject Refused to Continue|0|||
130102437|NCT01071083|468332726|FG003|Overall Study|Subject Refused to Continue|0|||
130102438|NCT01071083|468332727|FG004|Overall Study|Subject Refused to Continue|0|||
130102439|NCT00728988|468332728|FG000|Overall Study|Not Treated|2|||
130102440|NCT00728988|468332729|FG001|Overall Study|Not Treated|2|||
130102441|NCT00728988|468332728|FG000|Overall Study|Death|1|||
130035310|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130035311|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130035312|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
130035313|NCT01307423|468083820|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130035314|NCT01307423|468083821|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130035315|NCT01307423|468083822|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
130035316|NCT01307423|468083823|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130035317|NCT01307423|468083824|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130035318|NCT01307423|468083825|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130035319|NCT01307423|468083826|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
130035320|NCT01307423|468083827|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
130035321|NCT01307423|468083828|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
130035322|NCT00190775|468083829|FG000|Overall Study|Adverse Event|57|||
130035323|NCT00190775|468083830|FG001|Overall Study|Adverse Event|22|||
130035324|NCT00190775|468083829|FG000|Overall Study|Satisfactory Response|1|||
130035325|NCT00190775|468083830|FG001|Overall Study|Satisfactory Response|0|||
130035326|NCT00190775|468083829|FG000|Overall Study|Lack of Efficacy|28|||
130035327|NCT00190775|468083830|FG001|Overall Study|Lack of Efficacy|32|||
130035328|NCT00190775|468083829|FG000|Overall Study|Lost to Follow-up|31|||
130035329|NCT00190775|468083830|FG001|Overall Study|Lost to Follow-up|23|||
130035330|NCT00190775|468083829|FG000|Overall Study|Participant Moved|0|||
130035331|NCT00190775|468083830|FG001|Overall Study|Participant Moved|1|||
130035332|NCT00190775|468083829|FG000|Overall Study|Withdrawal by Subject|24|||
130035333|NCT00190775|468083830|FG001|Overall Study|Withdrawal by Subject|13|||
130035334|NCT00190775|468083829|FG000|Overall Study|Sponsor Decision|1|||
130035335|NCT00190775|468083830|FG001|Overall Study|Sponsor Decision|0|||
130035336|NCT00190775|468083829|FG000|Overall Study|Physician Decision|3|||
130035337|NCT00190775|468083830|FG001|Overall Study|Physician Decision|0|||
130035338|NCT00190775|468083829|FG000|Overall Study|Noncompliance|3|||
130035339|NCT00190775|468083830|FG001|Overall Study|Noncompliance|5|||
130035340|NCT00190775|468083829|FG000|Overall Study|Protocol Violation|0|||
130035341|NCT00190775|468083830|FG001|Overall Study|Protocol Violation|1|||
130035342|NCT00190775|468083829|FG000|Overall Study|Exclusion Criteria Met|1|||
130035343|NCT00190775|468083830|FG001|Overall Study|Exclusion Criteria Met|3|||
130035344|NCT00519077|468083831|FG000|Overall Study|Death|6|||
130035345|NCT00519077|468083831|FG000|Overall Study|Other|2|||
130102442|NCT00728988|468332729|FG001|Overall Study|Death|1|||
130102443|NCT00728988|468332728|FG000|Overall Study|Adverse Event|3|||
130035346|NCT01967225|468083832|FG000|Overall Study|Adverse Event|3|||
130035347|NCT01967225|468083833|FG001|Overall Study|Adverse Event|1|||
130035348|NCT01967225|468083832|FG000|Overall Study|Withdrawal by Subject|2|||
130035349|NCT01967225|468083833|FG001|Overall Study|Withdrawal by Subject|1|||
130035350|NCT01967225|468083832|FG000|Overall Study|Lack of Efficacy|1|||
130035351|NCT01967225|468083833|FG001|Overall Study|Lack of Efficacy|1|||
130035352|NCT01967225|468083832|FG000|Overall Study|Switching to other therapy|2|||
130035353|NCT01967225|468083833|FG001|Overall Study|Switching to other therapy|0|||
130262993|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
130035354|NCT01967225|468083832|FG000|Overall Study|Protocol driven decision point|1|||
130035355|NCT01967225|468083833|FG001|Overall Study|Protocol driven decision point|0|||
130035356|NCT01967225|468083832|FG000|Overall Study|Logistical difficulties|1|||
130035357|NCT01967225|468083833|FG001|Overall Study|Logistical difficulties|0|||
130102444|NCT00728988|468332729|FG001|Overall Study|Adverse Event|2|||
130035358|NCT01967225|468083832|FG000|Overall Study|Protocol Violation|2|||
130102445|NCT00728988|468332728|FG000|Overall Study|Other|85|||
130102446|NCT00728988|468332729|FG001|Overall Study|Other|77|||
130262994|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
130262995|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
130262996|NCT01008618|468929243|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
130262997|NCT01008618|468929244|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
130262998|NCT01008618|468929245|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
130262999|NCT03338400|468929246|FG000|Overall Study|Lost to Follow-up|1|||
130263000|NCT03338400|468929247|FG001|Overall Study|Lost to Follow-up|2|||
130263001|NCT01627691|468929248|FG000|Overall Study|Death|11|||
130263002|NCT01627691|468929248|FG000|Overall Study|Lost to Follow-up|3|||
130263003|NCT01627691|468929248|FG000|Overall Study|Withdrawal by Subject|1|||
130263004|NCT01627691|468929248|FG000|Overall Study|Missed the visit|3|||
130263005|NCT00186628|468929255|FG000|Overall Study|Death|2|||
130263006|NCT00186628|468929255|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
130263007|NCT02927795|468929256|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
130263008|NCT02927795|468929256|FG000|Overall Study|Not Treated|4|||
130263009|NCT01076010|468929257|FG000|Overall Study|Death|15|||
130263010|NCT01076010|468929258|FG001|Overall Study|Death|1|||
130263011|NCT01076010|468929259|FG002|Overall Study|Death|0|||
130263012|NCT01076010|468929257|FG000|Overall Study|Adverse Event|7|||
130263013|NCT01076010|468929258|FG001|Overall Study|Adverse Event|2|||
130035359|NCT01967225|468083833|FG001|Overall Study|Protocol Violation|0|||
130035360|NCT00327444|468083834|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
130035361|NCT00327444|468083835|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
130035362|NCT00327444|468083834|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
130035363|NCT00327444|468083835|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
130263014|NCT01076010|468929259|FG002|Overall Study|Adverse Event|0|||
130035364|NCT00327444|468083834|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
130035365|NCT00327444|468083835|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
130035366|NCT00327444|468083834|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
130035367|NCT00327444|468083835|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
130035368|NCT00327444|468083834|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
130035369|NCT00327444|468083835|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
130035370|NCT00327444|468083834|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
130035371|NCT00327444|468083835|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
130035372|NCT00327444|468083834|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
130035373|NCT00327444|468083835|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
130035374|NCT00327444|468083834|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
130035375|NCT00327444|468083835|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
130035376|NCT04439344|468083836|FG000|Overall Study|Never started threapy|3|||
130035377|NCT04439344|468083836|FG000|Overall Study|Ineligible|3|||
130035378|NCT04439344|468083836|FG000|Overall Study|Adverse Event|13|||
130035379|NCT04439344|468083836|FG000|Overall Study|Death|2|||
130035380|NCT04439344|468083836|FG000|Overall Study|Disease progression|29|||
130035381|NCT04439344|468083836|FG000|Overall Study|Withdrawal by Subject|2|||
130035382|NCT04439344|468083836|FG000|Overall Study|Alternative therapy|1|||
130035383|NCT01672957|468083837|FG000|Overall Study|Protocol Violation|48|||
130035384|NCT01672957|468083837|FG000|Overall Study|Death|2|||
130035385|NCT01672957|468083837|FG000|Overall Study|ICF Signed After Transplantation|5|||
130035386|NCT01511445|468083838|FG000|Overall Study|Lost to Follow-up|3|||
130035387|NCT01511445|468083839|FG001|Overall Study|Lost to Follow-up|1|||
130035388|NCT01511445|468083838|FG000|Overall Study|Protocol Violation|1|||
130035389|NCT01511445|468083839|FG001|Overall Study|Protocol Violation|3|||
130035390|NCT01511445|468083838|FG000|Overall Study|Protocol Violation|1|||
130035391|NCT01511445|468083839|FG001|Overall Study|Protocol Violation|0|||
130035392|NCT04696861|468083840|FG000|Overall Study|Death|1|||
130035393|NCT04696861|468083841|FG001|Overall Study|Death|0|||
130263015|NCT01076010|468929257|FG000|Overall Study|Progressive disease|90|||
130263016|NCT01076010|468929258|FG001|Overall Study|Progressive disease|30|||
130263017|NCT01076010|468929259|FG002|Overall Study|Progressive disease|1|||
130035394|NCT04696861|468083840|FG000|Overall Study|Lost to Follow-up|3|||
129885600|NCT02611830|467540770|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
130035395|NCT04696861|468083841|FG001|Overall Study|Lost to Follow-up|0|||
130035396|NCT01926626|468083842|FG000|Overall Study|Withdrawal by Subject|15|||
130035397|NCT01926626|468083842|FG000|Overall Study|Lost to Follow-up|7|||
130035398|NCT02382133|468083843|FG000|Overall Study|Death|22|||
130035399|NCT02382133|468083843|FG000|Overall Study|transfer out of ICU|4|||
130035400|NCT02382133|468083843|FG000|Overall Study|Physician Decision|2|||
130035401|NCT02382133|468083843|FG000|Overall Study|arterial catheter loss|4|||
130035402|NCT02382133|468083843|FG000|Overall Study|pressure injury both sites|1|||
130035403|NCT00655928|468083844|FG000|Overall Study|Withdrawal by Subject|2|||
130035404|NCT00655928|468083845|FG001|Overall Study|Withdrawal by Subject|1|||
130263018|NCT01076010|468929257|FG000|Overall Study|Lack of Efficacy|4|||
130263019|NCT01076010|468929258|FG001|Overall Study|Lack of Efficacy|0|||
130263020|NCT01076010|468929259|FG002|Overall Study|Lack of Efficacy|0|||
130035405|NCT00655928|468083844|FG000|Overall Study|Physician Decision|1|||
130035406|NCT00655928|468083845|FG001|Overall Study|Physician Decision|1|||
130263021|NCT01076010|468929257|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
130263022|NCT01076010|468929258|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
130263023|NCT01076010|468929259|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
130263024|NCT01076010|468929257|FG000|Overall Study|Significant Surgical Procedure|0|||
130263025|NCT01076010|468929258|FG001|Overall Study|Significant Surgical Procedure|1|||
130263026|NCT01076010|468929259|FG002|Overall Study|Significant Surgical Procedure|0|||
130263027|NCT01076010|468929257|FG000|Overall Study|Protocol Violation|0|||
130263028|NCT01076010|468929258|FG001|Overall Study|Protocol Violation|1|||
130263029|NCT01076010|468929259|FG002|Overall Study|Protocol Violation|0|||
130263030|NCT01076010|468929257|FG000|Overall Study|Noncompliance|1|||
130263031|NCT01076010|468929258|FG001|Overall Study|Noncompliance|1|||
130263032|NCT01076010|468929259|FG002|Overall Study|Noncompliance|0|||
130263033|NCT01076010|468929257|FG000|Overall Study|Withdrawal by Subject|3|||
130263034|NCT01076010|468929258|FG001|Overall Study|Withdrawal by Subject|0|||
130263035|NCT01076010|468929259|FG002|Overall Study|Withdrawal by Subject|1|||
130263036|NCT01076010|468929257|FG000|Overall Study|Other|5|||
130263037|NCT01076010|468929258|FG001|Overall Study|Other|2|||
130263038|NCT01076010|468929259|FG002|Overall Study|Other|0|||
130263039|NCT00760552|468929281|FG000|Overall Study|Death|2|||
130263040|NCT00760552|468929282|FG001|Overall Study|Death|0|||
130263041|NCT00760552|468929281|FG000|Overall Study|Lost to Follow-up|11|||
130263042|NCT00760552|468929282|FG001|Overall Study|Lost to Follow-up|10|||
130263043|NCT02536664|468929290|FG000|Overall Study|Inadequate completion of documentation|2|||
130263044|NCT02536664|468929291|FG001|Overall Study|Inadequate completion of documentation|4|||
130263045|NCT02536664|468929290|FG000|Overall Study|Progression|13|||
130263046|NCT02536664|468929291|FG001|Overall Study|Progression|18|||
130263047|NCT02536664|468929290|FG000|Overall Study|Death due to lymphoma|2|||
130263048|NCT02536664|468929291|FG001|Overall Study|Death due to lymphoma|1|||
130263049|NCT02536664|468929290|FG000|Overall Study|Death due to other reason|3|||
130263050|NCT02536664|468929291|FG001|Overall Study|Death due to other reason|2|||
130263051|NCT02536664|468929290|FG000|Overall Study|Intolerability|8|||
130263052|NCT02536664|468929291|FG001|Overall Study|Intolerability|6|||
130263053|NCT02536664|468929290|FG000|Overall Study|Withdrawal by Subject|8|||
130263054|NCT02536664|468929291|FG001|Overall Study|Withdrawal by Subject|5|||
130263055|NCT02536664|468929290|FG000|Overall Study|Other|18|||
130263056|NCT02536664|468929291|FG001|Overall Study|Other|24|||
130263057|NCT02536664|468929290|FG000|Overall Study|Missing|53|||
130263058|NCT02536664|468929291|FG001|Overall Study|Missing|20|||
130263059|NCT03961308|468929304|FG000|Overall Study|Withdrawal by Subject|1|||
130263060|NCT03961308|468929305|FG001|Overall Study|Withdrawal by Subject|0|||
130263061|NCT03961308|468929304|FG000|Overall Study|Other|1|||
130263062|NCT03961308|468929305|FG001|Overall Study|Other|0|||
130263063|NCT03961308|468929304|FG000|Overall Study|Lost to Follow-up|0|||
130263064|NCT03961308|468929305|FG001|Overall Study|Lost to Follow-up|1|||
130263065|NCT03961308|468929304|FG000|Overall Study|Adverse Event|0|||
130263066|NCT03961308|468929305|FG001|Overall Study|Adverse Event|1|||
130263067|NCT03710889|468929306|FG000|Overall Study|Adverse Event|2|||
130263068|NCT03710889|468929306|FG000|Overall Study|Protocol Deviation|1|||
130263069|NCT00570713|468929307|FG000|Overall Study|Adverse Event|16|||
130263070|NCT00570713|468929308|FG001|Overall Study|Adverse Event|9|||
130263071|NCT00570713|468929307|FG000|Overall Study|Death|7|||
130263072|NCT00570713|468929308|FG001|Overall Study|Death|7|||
130263073|NCT00570713|468929307|FG000|Overall Study|Lack of Efficacy|40|||
130263074|NCT00570713|468929308|FG001|Overall Study|Lack of Efficacy|49|||
130263075|NCT00570713|468929307|FG000|Overall Study|Physician Decision|2|||
130263076|NCT00570713|468929308|FG001|Overall Study|Physician Decision|2|||
130263077|NCT00570713|468929307|FG000|Overall Study|Withdrawal by Subject|3|||
130263078|NCT00570713|468929308|FG001|Overall Study|Withdrawal by Subject|3|||
130263079|NCT00570713|468929307|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
130263080|NCT00570713|468929308|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
130035407|NCT04906707|468083846|FG000|Overall Study|Withdrawal by Subject|2|||
130035408|NCT04906707|468083847|FG001|Overall Study|Withdrawal by Subject|0|||
130035409|NCT04906707|468083846|FG000|Overall Study|Withdrawal due to PI decision|1|||
130035410|NCT04906707|468083847|FG001|Overall Study|Withdrawal due to PI decision|0|||
130035411|NCT04906707|468083846|FG000|Overall Study|Lost to Follow-up|0|||
130035412|NCT04906707|468083847|FG001|Overall Study|Lost to Follow-up|1|||
130263081|NCT04881760|468929309|FG000|Overall Study|Adverse Event|0|||
130263082|NCT04881760|468929310|FG001|Overall Study|Adverse Event|1|||
130263083|NCT04881760|468929311|FG002|Overall Study|Adverse Event|1|||
130263084|NCT04881760|468929312|FG003|Overall Study|Adverse Event|0|||
130263085|NCT04881760|468929313|FG004|Overall Study|Adverse Event|1|||
130263086|NCT04881760|468929314|FG005|Overall Study|Adverse Event|1|||
130263087|NCT04881760|468929315|FG006|Overall Study|Adverse Event|2|||
130263088|NCT04881760|468929309|FG000|Overall Study|Death|0|||
130263089|NCT04881760|468929310|FG001|Overall Study|Death|0|||
130263090|NCT04881760|468929311|FG002|Overall Study|Death|0|||
130263091|NCT04881760|468929312|FG003|Overall Study|Death|1|||
130263092|NCT04881760|468929313|FG004|Overall Study|Death|0|||
130263093|NCT04881760|468929314|FG005|Overall Study|Death|0|||
130263094|NCT04881760|468929315|FG006|Overall Study|Death|0|||
130263095|NCT04881760|468929309|FG000|Overall Study|Lost to Follow-up|5|||
130263096|NCT04881760|468929310|FG001|Overall Study|Lost to Follow-up|7|||
130263097|NCT04881760|468929311|FG002|Overall Study|Lost to Follow-up|5|||
130263098|NCT04881760|468929312|FG003|Overall Study|Lost to Follow-up|1|||
130263099|NCT04881760|468929313|FG004|Overall Study|Lost to Follow-up|2|||
130263100|NCT04881760|468929314|FG005|Overall Study|Lost to Follow-up|4|||
130263101|NCT04881760|468929315|FG006|Overall Study|Lost to Follow-up|4|||
130263102|NCT04881760|468929309|FG000|Overall Study|Withdrawal by Subject|13|||
130263103|NCT04881760|468929310|FG001|Overall Study|Withdrawal by Subject|1|||
130263104|NCT04881760|468929311|FG002|Overall Study|Withdrawal by Subject|1|||
130263105|NCT04881760|468929312|FG003|Overall Study|Withdrawal by Subject|4|||
130263106|NCT04881760|468929313|FG004|Overall Study|Withdrawal by Subject|2|||
130263107|NCT04881760|468929314|FG005|Overall Study|Withdrawal by Subject|1|||
130263108|NCT04881760|468929315|FG006|Overall Study|Withdrawal by Subject|2|||
130263109|NCT04881760|468929309|FG000|Overall Study|Randomized but Never Treated|0|||
130263110|NCT04881760|468929310|FG001|Overall Study|Randomized but Never Treated|0|||
130263111|NCT04881760|468929311|FG002|Overall Study|Randomized but Never Treated|0|||
130263112|NCT04881760|468929312|FG003|Overall Study|Randomized but Never Treated|1|||
130263113|NCT04881760|468929313|FG004|Overall Study|Randomized but Never Treated|0|||
130263114|NCT04881760|468929314|FG005|Overall Study|Randomized but Never Treated|0|||
130263115|NCT04881760|468929315|FG006|Overall Study|Randomized but Never Treated|0|||
130263116|NCT04881760|468929309|FG000|Overall Study|Inadvertent Enrollment|2|||
130263117|NCT04881760|468929310|FG001|Overall Study|Inadvertent Enrollment|0|||
130263118|NCT04881760|468929311|FG002|Overall Study|Inadvertent Enrollment|0|||
130263119|NCT04881760|468929312|FG003|Overall Study|Inadvertent Enrollment|0|||
130263120|NCT04881760|468929313|FG004|Overall Study|Inadvertent Enrollment|0|||
130263121|NCT04881760|468929314|FG005|Overall Study|Inadvertent Enrollment|0|||
130263122|NCT04881760|468929315|FG006|Overall Study|Inadvertent Enrollment|0|||
130263123|NCT04881760|468929309|FG000|Overall Study|Site Closure|0|||
130263124|NCT04881760|468929310|FG001|Overall Study|Site Closure|0|||
130263125|NCT04881760|468929311|FG002|Overall Study|Site Closure|0|||
130263126|NCT04881760|468929312|FG003|Overall Study|Site Closure|1|||
130263127|NCT04881760|468929313|FG004|Overall Study|Site Closure|0|||
130263128|NCT04881760|468929314|FG005|Overall Study|Site Closure|0|||
130263129|NCT04881760|468929315|FG006|Overall Study|Site Closure|0|||
130263130|NCT01538199|468929319|FG000|Overall Study|Lost to Follow-up|1|||
130263131|NCT01538199|468929320|FG001|Overall Study|Lost to Follow-up|2|||
130263132|NCT01538199|468929321|FG002|Overall Study|Lost to Follow-up|1|||
130263133|NCT01538199|468929322|FG003|Overall Study|Lost to Follow-up|0|||
130263134|NCT01538199|468929319|FG000|Overall Study|participant did not have time|1|||
130263135|NCT01538199|468929320|FG001|Overall Study|participant did not have time|0|||
130263136|NCT01538199|468929321|FG002|Overall Study|participant did not have time|0|||
130263137|NCT01538199|468929322|FG003|Overall Study|participant did not have time|2|||
130263138|NCT01538199|468929319|FG000|Overall Study|Lack of Efficacy|0|||
130263139|NCT01538199|468929320|FG001|Overall Study|Lack of Efficacy|1|||
130263140|NCT01538199|468929321|FG002|Overall Study|Lack of Efficacy|0|||
130263141|NCT01538199|468929322|FG003|Overall Study|Lack of Efficacy|0|||
130263142|NCT05899829|468929325|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
130035413|NCT01976806|468083848|FG000|Overall Study|Lost to Follow-up|1|||
130035414|NCT01976806|468083849|FG001|Overall Study|Lost to Follow-up|4|||
130035415|NCT01976806|468083848|FG000|Overall Study|Adverse Event|1|||
130035416|NCT01976806|468083849|FG001|Overall Study|Adverse Event|1|||
130035417|NCT01976806|468083848|FG000|Overall Study|Withdrawal by Subject|1|||
130035418|NCT01976806|468083849|FG001|Overall Study|Withdrawal by Subject|1|||
130035419|NCT00998738|468083854|FG000|Overall Study|Uknown|1|||
130035420|NCT03946449|468083855|FG000|Treatment Extension II|Rolled over to another study|0|||
130035421|NCT03946449|468083856|FG001|Treatment Extension II|Rolled over to another study|0|||
130035422|NCT03946449|468083857|FG002|Treatment Extension II|Rolled over to another study|2|||
130035423|NCT03946449|468083855|FG000|Treatment Extension II|Withdrawal by Subject|0|||
130035424|NCT03946449|468083856|FG001|Treatment Extension II|Withdrawal by Subject|0|||
130035425|NCT03946449|468083857|FG002|Treatment Extension II|Withdrawal by Subject|1|||
130035426|NCT03019549|468085917|FG000|Washout|DId not meet genotype criteria|11|||
130035427|NCT03019549|468085917|FG000|Period 2|Adverse Event|2|||
130035428|NCT03019549|468085917|FG000|Period 2|Physician Decision|2|||
130035429|NCT03019549|468085917|FG000|Period 2|Withdrawal by Subject|1|||
130035430|NCT02251743|468085919|FG000|Overall Study|Withdrawal by Subject|1|||
130035431|NCT02251743|468085920|FG001|Overall Study|Withdrawal by Subject|1|||
130263143|NCT05899829|468929326|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
130263144|NCT05899829|468929325|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
130263145|NCT05899829|468929326|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
130263146|NCT01280968|468929327|FG000|Overall Study|Lost to Follow-up|8|||
130263147|NCT01280968|468929328|FG001|Overall Study|Lost to Follow-up|2|||
130263148|NCT01280968|468929327|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
130263149|NCT01280968|468929328|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
130263150|NCT01280968|468929327|FG000|Overall Study|Commuting Problems|2|||
130263151|NCT01280968|468929328|FG001|Overall Study|Commuting Problems|0|||
130263152|NCT01280968|468929327|FG000|Overall Study|Anxiety|2|||
130263153|NCT01280968|468929328|FG001|Overall Study|Anxiety|0|||
130263154|NCT01280968|468929327|FG000|Overall Study|Adverse Event|1|||
130263155|NCT01280968|468929328|FG001|Overall Study|Adverse Event|0|||
130263156|NCT01280968|468929327|FG000|Overall Study|Scheduling Conflicts|1|||
130263157|NCT01280968|468929328|FG001|Overall Study|Scheduling Conflicts|1|||
130263158|NCT01280968|468929327|FG000|Overall Study|Pre-existing Neurological Condition|1|||
130263159|NCT01280968|468929328|FG001|Overall Study|Pre-existing Neurological Condition|0|||
130263160|NCT01280968|468929327|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
130263161|NCT01280968|468929328|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
130263162|NCT00542178|468929329|FG000|Overall Study|did not complete year 4 follow-up|75|||
130263163|NCT00542178|468929330|FG001|Overall Study|did not complete year 4 follow-up|80|||
130263164|NCT00542178|468929331|FG002|Overall Study|did not complete year 4 follow-up|74|||
130263165|NCT00542178|468929332|FG003|Overall Study|did not complete year 4 follow-up|62|||
130263166|NCT00542178|468929333|FG004|Overall Study|did not complete year 4 follow-up|64|||
130263167|NCT00542178|468929334|FG005|Overall Study|did not complete year 4 follow-up|89|||
130263168|NCT00542178|468929335|FG006|Overall Study|did not complete year 4 follow-up|87|||
130263169|NCT00542178|468929336|FG007|Overall Study|did not complete year 4 follow-up|85|||
130263170|NCT03984188|468929342|FG000|Overall Study|Death|2|||
130263171|NCT03984188|468929343|FG001|Overall Study|Death|4|||
130263172|NCT03984188|468929342|FG000|Overall Study|Physician Decision|0|||
130263173|NCT03984188|468929343|FG001|Overall Study|Physician Decision|2|||
130263174|NCT03984188|468929342|FG000|Overall Study|Lost to Follow-up|3|||
130263175|NCT03984188|468929343|FG001|Overall Study|Lost to Follow-up|2|||
130263176|NCT03984188|468929342|FG000|Overall Study|Withdrawal by Subject|6|||
130263177|NCT03984188|468929343|FG001|Overall Study|Withdrawal by Subject|0|||
130263178|NCT00652743|468930966|FG000|Months 12-18|Lost to Follow-up|1|||
130263179|NCT00652743|468930967|FG001|Months 12-18|Lost to Follow-up|2|||
130263180|NCT00652743|468930968|FG002|Months 12-18|Lost to Follow-up|7|||
130263181|NCT00652743|468930966|FG000|Months 24-30|Other|5|||
130263182|NCT00652743|468930967|FG001|Months 24-30|Other|1|||
130263183|NCT00652743|468930968|FG002|Months 24-30|Other|11|||
130263184|NCT00652743|468930966|FG000|Months 36-42|Serious Adverse Events|0|||
130263185|NCT00652743|468930967|FG001|Months 36-42|Serious Adverse Events|1|||
130263186|NCT00652743|468930968|FG002|Months 36-42|Serious Adverse Events|1|||
130263187|NCT00652743|468930966|FG000|Months 36-42|Withdrawal by Subject|1|||
130263188|NCT00652743|468930967|FG001|Months 36-42|Withdrawal by Subject|1|||
130263189|NCT00652743|468930968|FG002|Months 36-42|Withdrawal by Subject|0|||
130263190|NCT00652743|468930966|FG000|Months 36-42|Lost to Follow-up|0|||
130263191|NCT00652743|468930967|FG001|Months 36-42|Lost to Follow-up|1|||
130263192|NCT00652743|468930968|FG002|Months 36-42|Lost to Follow-up|0|||
130263193|NCT00652743|468930966|FG000|Months 36-42|Migrated/moved from study area|1|||
130263194|NCT00652743|468930967|FG001|Months 36-42|Migrated/moved from study area|0|||
130263195|NCT00652743|468930968|FG002|Months 36-42|Migrated/moved from study area|0|||
130263196|NCT00652743|468930966|FG000|Months 36-42|Other|4|||
130263197|NCT00652743|468930967|FG001|Months 36-42|Other|2|||
130263198|NCT00652743|468930968|FG002|Months 36-42|Other|8|||
130263199|NCT00272792|468930973|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
130263200|NCT00272792|468930974|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
130263201|NCT00272792|468930973|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
130263202|NCT00272792|468930974|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
130263203|NCT00272792|468930973|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
130263204|NCT00272792|468930974|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
130263205|NCT00272792|468930973|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
130263206|NCT00272792|468930974|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
130263207|NCT05111145|468930975|FG000|Overall Study|Commercial drug is available for participant|76|||
130263208|NCT05111145|468930975|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
130263209|NCT02336815|468930976|FG000|Overall Study|Disease Progression|45|||
130263210|NCT02336815|468930977|FG001|Overall Study|Disease Progression|70|||
130263211|NCT02336815|468930976|FG000|Overall Study|Adverse Event|18|||
130263212|NCT02336815|468930977|FG001|Overall Study|Adverse Event|39|||
130263213|NCT02336815|468930976|FG000|Overall Study|Physician Decision|11|||
130263214|NCT02336815|468930977|FG001|Overall Study|Physician Decision|4|||
130263215|NCT02336815|468930976|FG000|Overall Study|Withdrawal by Subject|3|||
130263216|NCT02336815|468930977|FG001|Overall Study|Withdrawal by Subject|2|||
130263217|NCT02336815|468930976|FG000|Overall Study|Lost to Follow-up|1|||
130263218|NCT02336815|468930977|FG001|Overall Study|Lost to Follow-up|3|||
130263219|NCT02336815|468930976|FG000|Overall Study|Other|1|||
130263220|NCT02336815|468930977|FG001|Overall Study|Other|5|||
130263221|NCT04099277|468930978|FG000|Overall Study|Physician Decision|1|||
130263222|NCT04099277|468930978|FG000|Overall Study|Withdrawal by Subject|1|||
130263223|NCT00492557|468930979|FG000|Overall Study|Subject request|12|||
130263224|NCT00492557|468930980|FG001|Overall Study|Subject request|11|||
130263225|NCT00492557|468930979|FG000|Overall Study|Protocol Violation|7|||
130263226|NCT00492557|468930980|FG001|Overall Study|Protocol Violation|8|||
130263227|NCT00492557|468930979|FG000|Overall Study|Other|2|||
130263228|NCT00492557|468930980|FG001|Overall Study|Other|2|||
130263229|NCT00492557|468930979|FG000|Overall Study|Death|1|||
130263230|NCT00492557|468930980|FG001|Overall Study|Death|1|||
130263231|NCT00492557|468930979|FG000|Overall Study|Adverse Event|1|||
130263232|NCT00492557|468930980|FG001|Overall Study|Adverse Event|0|||
130263233|NCT00492557|468930979|FG000|Overall Study|Failed to return|1|||
130263234|NCT00492557|468930980|FG001|Overall Study|Failed to return|0|||
130263235|NCT00492557|468930979|FG000|Overall Study|Lost to Follow-up|0|||
130263236|NCT00492557|468930980|FG001|Overall Study|Lost to Follow-up|1|||
130263237|NCT01354223|468930981|FG000|Overall Study|Withdrawal by Subject|3|||
130263238|NCT01354223|468930982|FG001|Overall Study|Withdrawal by Subject|1|||
130263239|NCT00948688|468930988|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
130263240|NCT00948688|468930989|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
130263241|NCT00948688|468930988|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
130263242|NCT00948688|468930989|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
130263243|NCT00948688|468930988|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
130263244|NCT00948688|468930989|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
130263245|NCT01135992|468930990|FG000|Overall Study|Adverse Event|1|||
130263246|NCT01135992|468930990|FG000|Overall Study|Lack of Efficacy|1|||
130263247|NCT01135992|468930990|FG000|Overall Study|Protocol Violation|2|||
130263248|NCT01135992|468930990|FG000|Overall Study|Withdrawal criteria|10|||
130263249|NCT01135992|468930990|FG000|Overall Study|Unclassified|7|||
130263250|NCT02852967|468930991|FG000|Overall Study|Adverse Event|3|||
130263251|NCT02852967|468930992|FG001|Overall Study|Adverse Event|1|||
130263252|NCT02852967|468930993|FG002|Overall Study|Adverse Event|0|||
130263253|NCT02852967|468930994|FG003|Overall Study|Adverse Event|1|||
130263254|NCT02852967|468930995|FG004|Overall Study|Adverse Event|0|||
130263255|NCT02852967|468930991|FG000|Overall Study|Death|1|||
130263256|NCT02852967|468930992|FG001|Overall Study|Death|0|||
130263257|NCT02852967|468930993|FG002|Overall Study|Death|0|||
130263258|NCT02852967|468930994|FG003|Overall Study|Death|0|||
130263259|NCT02852967|468930995|FG004|Overall Study|Death|0|||
130263260|NCT02852967|468930991|FG000|Overall Study|Lost to Follow-up|1|||
130263261|NCT02852967|468930992|FG001|Overall Study|Lost to Follow-up|2|||
130263262|NCT02852967|468930993|FG002|Overall Study|Lost to Follow-up|3|||
130263263|NCT02852967|468930994|FG003|Overall Study|Lost to Follow-up|4|||
130263264|NCT02852967|468930995|FG004|Overall Study|Lost to Follow-up|4|||
130263265|NCT02852967|468930991|FG000|Overall Study|Withdrawal by Subject|6|||
130263266|NCT02852967|468930992|FG001|Overall Study|Withdrawal by Subject|12|||
130263267|NCT02852967|468930993|FG002|Overall Study|Withdrawal by Subject|7|||
130263268|NCT02852967|468930994|FG003|Overall Study|Withdrawal by Subject|10|||
130263269|NCT02852967|468930995|FG004|Overall Study|Withdrawal by Subject|10|||
130263270|NCT02852967|468930991|FG000|Overall Study|SAE|0|||
130263271|NCT02852967|468930992|FG001|Overall Study|SAE|0|||
130263272|NCT02852967|468930993|FG002|Overall Study|SAE|0|||
130263273|NCT02852967|468930994|FG003|Overall Study|SAE|3|||
130263274|NCT02852967|468930995|FG004|Overall Study|SAE|0|||
130263275|NCT02852967|468930991|FG000|Overall Study|Elevated Liver Enzymes|2|||
130263276|NCT02852967|468930992|FG001|Overall Study|Elevated Liver Enzymes|0|||
130263277|NCT02852967|468930993|FG002|Overall Study|Elevated Liver Enzymes|0|||
130263278|NCT02852967|468930994|FG003|Overall Study|Elevated Liver Enzymes|2|||
130263279|NCT02852967|468930995|FG004|Overall Study|Elevated Liver Enzymes|2|||
130263280|NCT02852967|468930991|FG000|Overall Study|Physician Decision|0|||
130263281|NCT02852967|468930992|FG001|Overall Study|Physician Decision|0|||
130263282|NCT02852967|468930993|FG002|Overall Study|Physician Decision|0|||
130263283|NCT02852967|468930994|FG003|Overall Study|Physician Decision|1|||
130263284|NCT02852967|468930995|FG004|Overall Study|Physician Decision|0|||
130263285|NCT02852967|468930991|FG000|Overall Study|Lack of Efficacy|0|||
130263286|NCT02852967|468930992|FG001|Overall Study|Lack of Efficacy|1|||
129885601|NCT02611830|467540767|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
130263287|NCT02852967|468930993|FG002|Overall Study|Lack of Efficacy|0|||
130263288|NCT02852967|468930994|FG003|Overall Study|Lack of Efficacy|0|||
130263289|NCT02852967|468930995|FG004|Overall Study|Lack of Efficacy|0|||
130263290|NCT02852967|468930991|FG000|Overall Study|Non-compliance|0|||
130263291|NCT02852967|468930992|FG001|Overall Study|Non-compliance|0|||
130263292|NCT02852967|468930993|FG002|Overall Study|Non-compliance|1|||
130263293|NCT02852967|468930994|FG003|Overall Study|Non-compliance|1|||
130263294|NCT02852967|468930995|FG004|Overall Study|Non-compliance|0|||
130263295|NCT02852967|468930991|FG000|Overall Study|Dispensing Drug Violation|0|||
130263296|NCT02852967|468930992|FG001|Overall Study|Dispensing Drug Violation|0|||
130263297|NCT02852967|468930993|FG002|Overall Study|Dispensing Drug Violation|1|||
130263298|NCT02852967|468930994|FG003|Overall Study|Dispensing Drug Violation|0|||
130263299|NCT02852967|468930995|FG004|Overall Study|Dispensing Drug Violation|0|||
130263300|NCT02852967|468930991|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
130263301|NCT02852967|468930992|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
130263302|NCT02852967|468930993|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
130263303|NCT02852967|468930994|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
130263304|NCT02852967|468930995|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
130263305|NCT01693367|468930996|FG000|Overall Study|Withdrawal by Subject|1|||
130263306|NCT01693367|468930997|FG001|Overall Study|Withdrawal by Subject|1|||
130263307|NCT01693367|468930996|FG000|Overall Study|Physician Decision|0|||
130263308|NCT01693367|468930997|FG001|Overall Study|Physician Decision|1|||
130263309|NCT02286895|468930998|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
130263310|NCT02286895|468930999|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
130263311|NCT02286895|468930998|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
130263312|NCT02286895|468930999|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
130263313|NCT02286895|468930998|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
130263314|NCT02286895|468930999|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
130263315|NCT02949011|468931000|FG000|Overall Study|Adverse Event|6|||
130263316|NCT02949011|468931001|FG001|Overall Study|Adverse Event|7|||
130263317|NCT02949011|468931002|FG002|Overall Study|Adverse Event|3|||
130263318|NCT02949011|468931000|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130263319|NCT02949011|468931001|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130263320|NCT02949011|468931002|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
130263321|NCT02949011|468931000|FG000|Overall Study|Protocol Deviation|5|||
130263322|NCT02949011|468931001|FG001|Overall Study|Protocol Deviation|3|||
130263323|NCT02949011|468931002|FG002|Overall Study|Protocol Deviation|3|||
130263324|NCT02949011|468931000|FG000|Overall Study|Lack of Efficacy|0|||
130263325|NCT02949011|468931001|FG001|Overall Study|Lack of Efficacy|2|||
130263326|NCT02949011|468931002|FG002|Overall Study|Lack of Efficacy|0|||
130263327|NCT02949011|468931000|FG000|Overall Study|Withdrawal by Subject|13|||
130263328|NCT02949011|468931001|FG001|Overall Study|Withdrawal by Subject|13|||
130263329|NCT02949011|468931002|FG002|Overall Study|Withdrawal by Subject|21|||
130263330|NCT02949011|468931000|FG000|Overall Study|Lost to Follow-up|7|||
130263331|NCT02949011|468931001|FG001|Overall Study|Lost to Follow-up|5|||
130263332|NCT02949011|468931002|FG002|Overall Study|Lost to Follow-up|5|||
130263333|NCT02949011|468931000|FG000|Overall Study|Death|0|||
130263334|NCT02949011|468931001|FG001|Overall Study|Death|0|||
130263335|NCT02949011|468931002|FG002|Overall Study|Death|1|||
130263336|NCT02949011|468931000|FG000|Overall Study|Miscellaneous|2|||
130263337|NCT02949011|468931001|FG001|Overall Study|Miscellaneous|4|||
130263338|NCT02949011|468931002|FG002|Overall Study|Miscellaneous|6|||
130263339|NCT00163189|468931003|FG000|Overall Study|Other|6|||
130263340|NCT00163189|468931003|FG000|Overall Study|Lost to Follow-up|1|||
130263341|NCT00163189|468931003|FG000|Overall Study|Protocol Violation|2|||
130263342|NCT00163189|468931003|FG000|Overall Study|Death|3|||
130263343|NCT00163189|468931003|FG000|Overall Study|Adverse Event|6|||
130263344|NCT00163189|468931003|FG000|Overall Study|Lack of Efficacy|7|||
130263345|NCT00163189|468931003|FG000|Overall Study|Study terminated by sponsor|11|||
130263346|NCT00163189|468931003|FG000|Overall Study|Withdrawal by Subject|11|||
130263347|NCT00163189|468931003|FG000|Overall Study|Did not meet continuation criterion|16|||
130035432|NCT00215150|468085921|FG000|Open Label Phase|Lost to Follow-up|7|||
130035433|NCT00215150|468085921|FG000|Open Label Phase|Withdrawal by Subject|1|||
130035434|NCT00215150|468085921|FG000|Open Label Phase|Did not complete a post base visit|13|||
130035435|NCT00215150|468085921|FG000|Open Label Phase|Did not meet randomization criteria|9|||
130035436|NCT00215150|468085921|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
130035437|NCT00215150|468085921|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
130035438|NCT00215150|468085921|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
130035439|NCT01028352|468085926|FG000|Overall Study|Ineligible due to baseline average pain|5|||
130035440|NCT01028352|468085926|FG000|Overall Study|Withdrawal by Subject|1|||
130035441|NCT00260208|468085927|FG000|Overall Study|Subject withdrew consent|11|||
130035442|NCT00260208|468085928|FG001|Overall Study|Subject withdrew consent|7|||
130035443|NCT00260208|468085927|FG000|Overall Study|Lost to Follow-up|6|||
130035444|NCT00260208|468085928|FG001|Overall Study|Lost to Follow-up|1|||
130035445|NCT00260208|468085927|FG000|Overall Study|Death|12|||
130035446|NCT00260208|468085928|FG001|Overall Study|Death|10|||
130035447|NCT00260208|468085927|FG000|Overall Study|Missing|18|||
130035448|NCT00260208|468085928|FG001|Overall Study|Missing|16|||
130035449|NCT02091440|468085929|FG000|Overall Study|Death|2|||
130263348|NCT02154061|468931004|FG000|Overall Study|Pregnancy|1|||
130263349|NCT02154061|468931005|FG001|Overall Study|Pregnancy|0|||
130263350|NCT02154061|468931004|FG000|Overall Study|enrolled but not vaccinated|1|||
130263351|NCT02154061|468931005|FG001|Overall Study|enrolled but not vaccinated|0|||
129885602|NCT02611830|467540768|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
129885603|NCT02611830|467540769|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
130035450|NCT00768222|468085930|FG000|Overall Study|Lost to Follow-up|1|||
130263352|NCT00506142|468931006|FG000|Overall Study|Adverse Event|8|||
130263353|NCT00506142|468931007|FG001|Overall Study|Adverse Event|7|||
130263354|NCT00506142|468931006|FG000|Overall Study|Lack of Efficacy|21|||
130263355|NCT00506142|468931007|FG001|Overall Study|Lack of Efficacy|7|||
130263356|NCT00506142|468931006|FG000|Overall Study|Withdrawal by Subject|4|||
130263357|NCT00506142|468931007|FG001|Overall Study|Withdrawal by Subject|5|||
130263358|NCT00506142|468931006|FG000|Overall Study|Physician Decision|1|||
130263359|NCT00506142|468931007|FG001|Overall Study|Physician Decision|0|||
130263360|NCT00506142|468931006|FG000|Overall Study|New health condition|1|||
130263361|NCT00506142|468931007|FG001|Overall Study|New health condition|0|||
130263362|NCT01917318|468931010|FG000|First Treatment|Withdrawal by Subject|0|||
130263363|NCT01917318|468931011|FG001|First Treatment|Withdrawal by Subject|1|||
130263364|NCT00742625|468931012|FG000|Remission Induction|Progression|6|||
130263365|NCT00742625|468931012|FG000|Remission Induction|Failed induction|8|||
130263366|NCT00742625|468931012|FG000|Remission Induction|Adverse Event|3|||
130263367|NCT00742625|468931012|FG000|Remission Induction|Death|10|||
130263368|NCT00742625|468931012|FG000|Remission Induction|Refusal|5|||
130263369|NCT00742625|468931012|FG000|Remission Induction|Non protocol treatment|17|||
130263370|NCT00742625|468931012|FG000|Remission Induction|Other, not specified|5|||
130263371|NCT00742625|468931012|FG000|Consolidation|Progression|5|||
130263372|NCT00742625|468931012|FG000|Consolidation|Adverse Event|1|||
130263373|NCT00742625|468931012|FG000|Consolidation|Death|1|||
130263374|NCT00742625|468931012|FG000|Consolidation|Refused|1|||
130263375|NCT00742625|468931012|FG000|Consolidation|Non protocol therapy|13|||
130263376|NCT01865487|468931015|FG000|Overall Study|Lost to Follow-up|0|||
130263377|NCT01865487|468931016|FG001|Overall Study|Lost to Follow-up|0|||
130263378|NCT01865487|468931017|FG002|Overall Study|Lost to Follow-up|0|||
130263379|NCT01865487|468931018|FG003|Overall Study|Lost to Follow-up|1|||
130263380|NCT01865487|468931019|FG004|Overall Study|Lost to Follow-up|0|||
130263381|NCT01865487|468931020|FG005|Overall Study|Lost to Follow-up|0|||
130263382|NCT01865487|468931021|FG006|Overall Study|Lost to Follow-up|1|||
130263383|NCT01865487|468931022|FG007|Overall Study|Lost to Follow-up|0|||
130263384|NCT01865487|468931023|FG008|Overall Study|Lost to Follow-up|0|||
130263385|NCT01865487|468931024|FG009|Overall Study|Lost to Follow-up|0|||
130263386|NCT01865487|468931015|FG000|Overall Study|Withdrawal by Subject|0|||
130263387|NCT01865487|468931016|FG001|Overall Study|Withdrawal by Subject|0|||
130263388|NCT01865487|468931017|FG002|Overall Study|Withdrawal by Subject|0|||
130263389|NCT01865487|468931018|FG003|Overall Study|Withdrawal by Subject|0|||
130263390|NCT01865487|468931019|FG004|Overall Study|Withdrawal by Subject|1|||
130263391|NCT01865487|468931020|FG005|Overall Study|Withdrawal by Subject|0|||
130263392|NCT01865487|468931021|FG006|Overall Study|Withdrawal by Subject|0|||
130263393|NCT01865487|468931022|FG007|Overall Study|Withdrawal by Subject|0|||
130263394|NCT01865487|468931023|FG008|Overall Study|Withdrawal by Subject|0|||
130263395|NCT01865487|468931024|FG009|Overall Study|Withdrawal by Subject|0|||
130263396|NCT01213082|468931028|FG000|Overall Study|Lost to Follow-up|6|||
130263397|NCT01213082|468931029|FG001|Overall Study|Lost to Follow-up|7|||
130263398|NCT01213082|468931030|FG002|Overall Study|Lost to Follow-up|4|||
130263399|NCT01213082|468931028|FG000|Overall Study|Physician Decision|0|||
130263400|NCT01213082|468931029|FG001|Overall Study|Physician Decision|0|||
130263401|NCT01213082|468931030|FG002|Overall Study|Physician Decision|1|||
130263402|NCT03848416|468931031|FG000|Overall Study|Withdrawal by Subject|1|||
130263403|NCT03848416|468931032|FG001|Overall Study|Withdrawal by Subject|0|||
130263404|NCT03848416|468931033|FG002|Overall Study|Withdrawal by Subject|0|||
130263405|NCT03848416|468931031|FG000|Overall Study|Death|0|||
130263406|NCT03848416|468931032|FG001|Overall Study|Death|0|||
130263407|NCT03848416|468931033|FG002|Overall Study|Death|1|||
130263408|NCT02639390|468931034|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
130263409|NCT02639390|468931035|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
130263410|NCT01908140|468931036|FG000|Overall Study|Other or Progressive Disease|5|||
130263411|NCT01908140|468931037|FG001|Overall Study|Other or Progressive Disease|12|||
130263412|NCT01908140|468931036|FG000|Overall Study|Lack of Efficacy|7|||
130263413|NCT01908140|468931037|FG001|Overall Study|Lack of Efficacy|5|||
130263414|NCT01908140|468931036|FG000|Overall Study|Withdrawal by Subject|23|||
130263415|NCT01908140|468931037|FG001|Overall Study|Withdrawal by Subject|24|||
130263416|NCT01908140|468931036|FG000|Overall Study|Lost to Follow-up|1|||
130263417|NCT01908140|468931037|FG001|Overall Study|Lost to Follow-up|6|||
130263418|NCT01908140|468931036|FG000|Overall Study|Protocol Violation|8|||
130263419|NCT01908140|468931037|FG001|Overall Study|Protocol Violation|9|||
130263420|NCT01908140|468931036|FG000|Overall Study|Adverse Event|22|||
130263421|NCT01908140|468931037|FG001|Overall Study|Adverse Event|23|||
130263422|NCT02013609|468931038|FG000|Overall Study|Withdrawal by Subject|9|||
130263423|NCT02013609|468931038|FG000|Overall Study|Lost to Follow-up|3|||
130263424|NCT02013609|468931038|FG000|Overall Study|Adverse Event|3|||
130263425|NCT02013609|468931038|FG000|Overall Study|Met Withdrawal Criteria|3|||
130263426|NCT00783432|468931039|FG000|Overall Study|Adverse Event|22|||
130263427|NCT00783432|468931040|FG001|Overall Study|Adverse Event|17|||
130263428|NCT00783432|468931039|FG000|Overall Study|Lack of Efficacy|20|||
130263429|NCT00783432|468931040|FG001|Overall Study|Lack of Efficacy|21|||
130263430|NCT00783432|468931039|FG000|Overall Study|Lost to Follow-up|11|||
130263431|NCT00783432|468931040|FG001|Overall Study|Lost to Follow-up|6|||
130263432|NCT00783432|468931039|FG000|Overall Study|Withdrawal by Subject|23|||
130263433|NCT00783432|468931040|FG001|Overall Study|Withdrawal by Subject|20|||
130263434|NCT00783432|468931039|FG000|Overall Study|subject moved|3|||
130263435|NCT00783432|468931040|FG001|Overall Study|subject moved|5|||
130263436|NCT00783432|468931039|FG000|Overall Study|Protocol Violation|6|||
130263437|NCT00783432|468931040|FG001|Overall Study|Protocol Violation|9|||
130263438|NCT01436110|468931041|FG000|Overall Study|Lack of Efficacy|23|||
130263439|NCT01436110|468931042|FG001|Overall Study|Lack of Efficacy|14|||
130263440|NCT01436110|468931043|FG002|Overall Study|Lack of Efficacy|9|||
130263441|NCT01436110|468931041|FG000|Overall Study|Withdrawal by Subject|6|||
130263442|NCT01436110|468931042|FG001|Overall Study|Withdrawal by Subject|8|||
130263443|NCT01436110|468931043|FG002|Overall Study|Withdrawal by Subject|4|||
130263444|NCT01436110|468931041|FG000|Overall Study|Adverse Event|2|||
130263445|NCT01436110|468931042|FG001|Overall Study|Adverse Event|1|||
130263446|NCT01436110|468931043|FG002|Overall Study|Adverse Event|2|||
130263447|NCT01436110|468931041|FG000|Overall Study|Physician Decision|3|||
130263448|NCT01436110|468931042|FG001|Overall Study|Physician Decision|1|||
130263449|NCT01436110|468931043|FG002|Overall Study|Physician Decision|1|||
130263450|NCT01436110|468931041|FG000|Overall Study|Lost to Follow-up|1|||
130263451|NCT01436110|468931042|FG001|Overall Study|Lost to Follow-up|1|||
130263452|NCT01436110|468931043|FG002|Overall Study|Lost to Follow-up|3|||
130263453|NCT01436110|468931041|FG000|Overall Study|Protocol Violation|3|||
130263454|NCT01436110|468931042|FG001|Overall Study|Protocol Violation|1|||
130263455|NCT01436110|468931043|FG002|Overall Study|Protocol Violation|1|||
130263456|NCT01436110|468931041|FG000|Overall Study|Did Not Receive Trial Medication|1|||
130263457|NCT01436110|468931042|FG001|Overall Study|Did Not Receive Trial Medication|0|||
130263458|NCT01436110|468931043|FG002|Overall Study|Did Not Receive Trial Medication|3|||
130263459|NCT03273907|468931045|FG000|Overall Study|Death|1|||
130263460|NCT03273907|468931045|FG000|Overall Study|Lost to Follow-up|4|||
130263461|NCT03273907|468931045|FG000|Overall Study|Withdrawal by Subject|2|||
130263462|NCT03273907|468931045|FG000|Overall Study|COVID 19|2|||
130263463|NCT01531998|468931046|FG000|Overall Study|Withdrawal by Subject|3|||
130263464|NCT02581891|468931047|FG000|Overall Study|Adverse Event|4|||
130263465|NCT02581891|468931048|FG001|Overall Study|Adverse Event|6|||
130263466|NCT02581891|468931047|FG000|Overall Study|Death|3|||
130263467|NCT02581891|468931048|FG001|Overall Study|Death|4|||
130263468|NCT02581891|468931047|FG000|Overall Study|Lost to Follow-up|1|||
130263469|NCT02581891|468931048|FG001|Overall Study|Lost to Follow-up|2|||
130263470|NCT02581891|468931047|FG000|Overall Study|Physician Decision|0|||
130263471|NCT02581891|468931048|FG001|Overall Study|Physician Decision|1|||
130263472|NCT02581891|468931047|FG000|Overall Study|Withdrawal by Subject|4|||
130263473|NCT02581891|468931048|FG001|Overall Study|Withdrawal by Subject|5|||
130263474|NCT02581891|468931047|FG000|Overall Study|Other Reasons|3|||
130263475|NCT02581891|468931048|FG001|Overall Study|Other Reasons|1|||
130263476|NCT02581891|468931047|FG000|Overall Study|Discontinued during followup|1|||
130263477|NCT02581891|468931048|FG001|Overall Study|Discontinued during followup|0|||
130263478|NCT03440008|468931049|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
130263479|NCT03440008|468931050|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
130263480|NCT03440008|468931049|FG000|Overall Study|Withdrawal by Subject|1|||
130263481|NCT03440008|468931050|FG001|Overall Study|Withdrawal by Subject|0|||
130263482|NCT03498716|468931058|FG000|Overall Study|Withdrawal by Subject|88|||
130263483|NCT03498716|468931059|FG001|Overall Study|Withdrawal by Subject|73|||
130263484|NCT03498716|468931058|FG000|Overall Study|Study Terminated By Sponsor|933|||
130263485|NCT03498716|468931059|FG001|Overall Study|Study Terminated By Sponsor|927|||
130263486|NCT03498716|468931058|FG000|Overall Study|Lost to Follow-up|15|||
130263487|NCT03498716|468931059|FG001|Overall Study|Lost to Follow-up|26|||
130263488|NCT03498716|468931058|FG000|Overall Study|Disease Relapse|0|||
130263489|NCT03498716|468931059|FG001|Overall Study|Disease Relapse|1|||
130263490|NCT03498716|468931058|FG000|Overall Study|Death|58|||
130035451|NCT00768222|468085931|FG001|Overall Study|Lost to Follow-up|1|||
130263491|NCT03498716|468931059|FG001|Overall Study|Death|72|||
130263492|NCT03498716|468931058|FG000|Overall Study|Physician Decision|4|||
130035452|NCT00768222|468085930|FG000|Overall Study|Withdrawal by Subject|3|||
130035453|NCT00768222|468085931|FG001|Overall Study|Withdrawal by Subject|1|||
130263493|NCT03498716|468931059|FG001|Overall Study|Physician Decision|2|||
130263494|NCT01188967|468931063|FG000|Overall Study|Withdrawal by Subject|1|||
130263495|NCT01188967|468931064|FG001|Overall Study|Withdrawal by Subject|1|||
130263496|NCT01188967|468931063|FG000|Overall Study|Physician Decision|1|||
130263497|NCT01188967|468931064|FG001|Overall Study|Physician Decision|1|||
130263498|NCT01188967|468931063|FG000|Overall Study|Lost to Follow-up|3|||
130263499|NCT01188967|468931064|FG001|Overall Study|Lost to Follow-up|2|||
130263500|NCT01657305|468931065|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
130263501|NCT01657305|468931065|FG000|Overall Study|Withdrawal by Subject|4|||
130263502|NCT01657305|468931065|FG000|Overall Study|Adverse Event|1|||
130263503|NCT01657305|468931065|FG000|Overall Study|Lost to Follow-up|1|||
130263504|NCT01657305|468931065|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
130263505|NCT04103450|468931066|FG000|Overall Study|Adverse Event|4|||
130263506|NCT04103450|468931067|FG001|Overall Study|Adverse Event|2|||
130263507|NCT04103450|468931066|FG000|Overall Study|Lack of Efficacy|3|||
130263508|NCT04103450|468931067|FG001|Overall Study|Lack of Efficacy|0|||
130263509|NCT04103450|468931066|FG000|Overall Study|Withdrawal by Subject|5|||
130263510|NCT04103450|468931067|FG001|Overall Study|Withdrawal by Subject|3|||
130263511|NCT04103450|468931066|FG000|Overall Study|Lost to Follow-up|1|||
130263512|NCT04103450|468931067|FG001|Overall Study|Lost to Follow-up|2|||
130263513|NCT04103450|468931066|FG000|Overall Study|Physician Decision|1|||
130263514|NCT04103450|468931067|FG001|Overall Study|Physician Decision|2|||
130263515|NCT04103450|468931066|FG000|Overall Study|Protocol Violation|1|||
130263516|NCT04103450|468931067|FG001|Overall Study|Protocol Violation|0|||
130263517|NCT04103450|468931066|FG000|Overall Study|Other|1|||
130263518|NCT04103450|468931067|FG001|Overall Study|Other|1|||
130263519|NCT01696643|468931072|FG000|Overall Study|Adverse Event|15|||
130263520|NCT01696643|468931073|FG001|Overall Study|Adverse Event|7|||
130263521|NCT01696643|468931072|FG000|Overall Study|Death|1|||
130263522|NCT01696643|468931073|FG001|Overall Study|Death|2|||
130263523|NCT01696643|468931072|FG000|Overall Study|Lack of Efficacy|3|||
130263524|NCT01696643|468931073|FG001|Overall Study|Lack of Efficacy|0|||
130035454|NCT00768222|468085930|FG000|Overall Study|Protocol Violation|0|||
130035455|NCT00768222|468085931|FG001|Overall Study|Protocol Violation|2|||
130035456|NCT00278629|468085938|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
130035457|NCT03323749|468085939|FG000|Double-blind Period|Lost to Follow-up|4|||
130035458|NCT03323749|468085940|FG001|Double-blind Period|Lost to Follow-up|5|||
130035459|NCT03323749|468085939|FG000|Double-blind Period|Adverse Event|3|||
130035460|NCT03323749|468085940|FG001|Double-blind Period|Adverse Event|1|||
130035461|NCT03323749|468085939|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
130035462|NCT03323749|468085940|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
130035463|NCT03323749|468085939|FG000|Open-Label Period|Adverse Event|3|||
130035464|NCT03323749|468085940|FG001|Open-Label Period|Adverse Event|10|||
130035465|NCT03323749|468085939|FG000|Open-Label Period|Withdrawal by Subject|7|||
130035466|NCT03323749|468085940|FG001|Open-Label Period|Withdrawal by Subject|5|||
130035467|NCT03263091|468085941|FG000|OL Component|Withdrawal by Subject|1|||
130035468|NCT03263091|468085942|FG001|OL Component|Withdrawal by Subject|1|||
130035469|NCT03263091|468085943|FG002|OL Component|Withdrawal by Subject|0|||
130035470|NCT03263091|468085944|FG003|OL Component|Withdrawal by Subject|0|||
130035471|NCT03263091|468085945|FG004|OL Component|Withdrawal by Subject|0|||
130035472|NCT03263091|468085946|FG005|OL Component|Withdrawal by Subject|0|||
130035473|NCT03263091|468085941|FG000|OL Component|Physician Decision|0|||
130035474|NCT03263091|468085942|FG001|OL Component|Physician Decision|1|||
130035475|NCT03263091|468085943|FG002|OL Component|Physician Decision|2|||
130035476|NCT03263091|468085944|FG003|OL Component|Physician Decision|0|||
130035477|NCT03263091|468085945|FG004|OL Component|Physician Decision|0|||
130035478|NCT03263091|468085946|FG005|OL Component|Physician Decision|0|||
130035479|NCT03263091|468085941|FG000|OL Component|Death|1|||
130035480|NCT03263091|468085942|FG001|OL Component|Death|0|||
130035481|NCT03263091|468085943|FG002|OL Component|Death|0|||
130035482|NCT03263091|468085944|FG003|OL Component|Death|0|||
130035483|NCT03263091|468085945|FG004|OL Component|Death|0|||
130035484|NCT03263091|468085946|FG005|OL Component|Death|0|||
130035485|NCT03263091|468085941|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
130035486|NCT03263091|468085942|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
130035487|NCT03263091|468085943|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
130035488|NCT03263091|468085944|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
130035489|NCT03263091|468085945|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
130035490|NCT03263091|468085946|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
130035491|NCT03263091|468085941|FG000|OL High-EPO Component|Physician Decision|0|||
130035492|NCT03263091|468085942|FG001|OL High-EPO Component|Physician Decision|0|||
130035493|NCT03263091|468085943|FG002|OL High-EPO Component|Physician Decision|0|||
130035494|NCT03263091|468085944|FG003|OL High-EPO Component|Physician Decision|1|||
130035495|NCT03263091|468085945|FG004|OL High-EPO Component|Physician Decision|0|||
130263525|NCT01696643|468931072|FG000|Overall Study|Lost to Follow-up|67|||
130263526|NCT01696643|468931073|FG001|Overall Study|Lost to Follow-up|67|||
130263527|NCT01696643|468931072|FG000|Overall Study|Physician Decision|3|||
130263528|NCT01696643|468931073|FG001|Overall Study|Physician Decision|2|||
130035496|NCT03263091|468085946|FG005|OL High-EPO Component|Physician Decision|0|||
130035497|NCT03263091|468085941|FG000|OL High-EPO Component|Death|0|||
130263529|NCT01696643|468931072|FG000|Overall Study|Pregnancy|0|||
130263530|NCT01696643|468931073|FG001|Overall Study|Pregnancy|1|||
130263531|NCT01696643|468931072|FG000|Overall Study|Protocol Violation|7|||
130035498|NCT03263091|468085942|FG001|OL High-EPO Component|Death|0|||
130263532|NCT01696643|468931073|FG001|Overall Study|Protocol Violation|7|||
130263533|NCT01696643|468931072|FG000|Overall Study|Study Terminated by Sponsor|286|||
130263534|NCT01696643|468931073|FG001|Overall Study|Study Terminated by Sponsor|294|||
130263535|NCT01696643|468931072|FG000|Overall Study|Withdrawal by Subject|142|||
130263536|NCT01696643|468931073|FG001|Overall Study|Withdrawal by Subject|149|||
130263537|NCT01696643|468931072|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
130263538|NCT01696643|468931073|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
130263539|NCT01696643|468931072|FG000|Overall Study|Site Error|2|||
130263540|NCT01696643|468931073|FG001|Overall Study|Site Error|1|||
130263541|NCT01696643|468931072|FG000|Overall Study|Participant Incarcerated|0|||
130263542|NCT01696643|468931073|FG001|Overall Study|Participant Incarcerated|1|||
130263543|NCT01696643|468931072|FG000|Overall Study|Medical Monitor Decision|0|||
130263544|NCT01696643|468931073|FG001|Overall Study|Medical Monitor Decision|2|||
130263545|NCT01696643|468931072|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
130263546|NCT01696643|468931073|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
130263547|NCT02271529|468931076|FG000|Overall Study|Withdrawal by Subject|1|||
129885604|NCT02611830|467540770|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
129885605|NCT02611830|467540767|FG000|Maintenance Phase|Lost to Follow-up|0|||
130263548|NCT03768427|468931077|FG000|Overall Study|Death|0|||
129885606|NCT02611830|467540768|FG001|Maintenance Phase|Lost to Follow-up|0|||
129885607|NCT02611830|467540769|FG002|Maintenance Phase|Lost to Follow-up|0|||
130263549|NCT03768427|468931078|FG001|Overall Study|Death|0|||
130263550|NCT03768427|468931079|FG002|Overall Study|Death|1|||
130263551|NCT03768427|468931080|FG003|Overall Study|Death|0|||
130263552|NCT03768427|468931077|FG000|Overall Study|Lost to Follow-up|2|||
130263553|NCT03768427|468931078|FG001|Overall Study|Lost to Follow-up|0|||
130263554|NCT03768427|468931079|FG002|Overall Study|Lost to Follow-up|0|||
130263555|NCT03768427|468931080|FG003|Overall Study|Lost to Follow-up|0|||
130263556|NCT03768427|468931077|FG000|Overall Study|Physician Decision|3|||
130263557|NCT03768427|468931078|FG001|Overall Study|Physician Decision|2|||
130263558|NCT03768427|468931079|FG002|Overall Study|Physician Decision|4|||
130263559|NCT03768427|468931080|FG003|Overall Study|Physician Decision|4|||
130263560|NCT03768427|468931077|FG000|Overall Study|Withdrawal by Subject|7|||
130263561|NCT03768427|468931078|FG001|Overall Study|Withdrawal by Subject|2|||
130263562|NCT03768427|468931079|FG002|Overall Study|Withdrawal by Subject|6|||
130263563|NCT03768427|468931080|FG003|Overall Study|Withdrawal by Subject|7|||
130263564|NCT00902330|468931090|FG000|Overall Study|Too overwhelmed by treatment|2|||
130263565|NCT00902330|468931091|FG001|Overall Study|Too overwhelmed by treatment|5|||
129885608|NCT02611830|467540770|FG003|Maintenance Phase|Lost to Follow-up|1|||
129885609|NCT02611830|467540767|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
129885610|NCT02611830|467540768|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
129885611|NCT02611830|467540769|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
129885612|NCT02611830|467540770|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
129885613|NCT02611830|467540767|FG000|Maintenance Phase|Pregnancy|0|||
129885614|NCT02611830|467540768|FG001|Maintenance Phase|Pregnancy|0|||
129885615|NCT02611830|467540769|FG002|Maintenance Phase|Pregnancy|1|||
129885616|NCT02611830|467540770|FG003|Maintenance Phase|Pregnancy|0|||
129885617|NCT02611830|467540767|FG000|Maintenance Phase|Reason not specified|0|||
129885618|NCT02611830|467540768|FG001|Maintenance Phase|Reason not specified|1|||
129885619|NCT02611830|467540769|FG002|Maintenance Phase|Reason not specified|4|||
129885620|NCT02611830|467540770|FG003|Maintenance Phase|Reason not specified|0|||
129885621|NCT02855164|467540771|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129885622|NCT02855164|467540772|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130035499|NCT03263091|468085943|FG002|OL High-EPO Component|Death|0|||
130035500|NCT03263091|468085944|FG003|OL High-EPO Component|Death|3|||
130035501|NCT03263091|468085945|FG004|OL High-EPO Component|Death|0|||
130035502|NCT03263091|468085946|FG005|OL High-EPO Component|Death|0|||
130035503|NCT03263091|468085941|FG000|DB Component|Withdrawal by Subject|0|||
130035504|NCT03263091|468085942|FG001|DB Component|Withdrawal by Subject|0|||
130035505|NCT03263091|468085943|FG002|DB Component|Withdrawal by Subject|0|||
130035506|NCT03263091|468085944|FG003|DB Component|Withdrawal by Subject|0|||
130035507|NCT03263091|468085945|FG004|DB Component|Withdrawal by Subject|22|||
130035508|NCT03263091|468085946|FG005|DB Component|Withdrawal by Subject|8|||
130035509|NCT03263091|468085941|FG000|DB Component|Physician Decision|0|||
130035510|NCT03263091|468085942|FG001|DB Component|Physician Decision|0|||
130035511|NCT03263091|468085943|FG002|DB Component|Physician Decision|0|||
130035512|NCT03263091|468085944|FG003|DB Component|Physician Decision|0|||
129885623|NCT02855164|467540773|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
130035513|NCT03263091|468085945|FG004|DB Component|Physician Decision|3|||
130035514|NCT03263091|468085946|FG005|DB Component|Physician Decision|1|||
130263566|NCT00902330|468931090|FG000|Overall Study|Adverse Event|1|||
130263567|NCT00902330|468931091|FG001|Overall Study|Adverse Event|0|||
130263568|NCT00902330|468931090|FG000|Overall Study|No post baseline data|1|||
130263569|NCT00902330|468931091|FG001|Overall Study|No post baseline data|0|||
130263570|NCT03950856|468931092|FG000|Overall Study|Death|1|||
130263571|NCT03950856|468931093|FG001|Overall Study|Death|2|||
130263572|NCT03950856|468931094|FG002|Overall Study|Death|0|||
130263573|NCT03950856|468931095|FG003|Overall Study|Death|0|||
130263574|NCT03950856|468931092|FG000|Overall Study|Lost to Follow-up|5|||
130263575|NCT03950856|468931093|FG001|Overall Study|Lost to Follow-up|6|||
130263576|NCT03950856|468931094|FG002|Overall Study|Lost to Follow-up|8|||
130263577|NCT03950856|468931095|FG003|Overall Study|Lost to Follow-up|2|||
130263578|NCT03950856|468931092|FG000|Overall Study|Protocol Violation|2|||
130263579|NCT03950856|468931093|FG001|Overall Study|Protocol Violation|0|||
130263580|NCT03950856|468931094|FG002|Overall Study|Protocol Violation|0|||
130263581|NCT03950856|468931095|FG003|Overall Study|Protocol Violation|1|||
130263582|NCT03950856|468931092|FG000|Overall Study|Withdrawal by Subject|4|||
130263583|NCT03950856|468931093|FG001|Overall Study|Withdrawal by Subject|1|||
130263584|NCT03950856|468931094|FG002|Overall Study|Withdrawal by Subject|3|||
130263585|NCT03950856|468931095|FG003|Overall Study|Withdrawal by Subject|1|||
130263586|NCT03950856|468931092|FG000|Overall Study|Unable to phone|7|||
130263587|NCT03950856|468931093|FG001|Overall Study|Unable to phone|6|||
130263588|NCT03950856|468931094|FG002|Overall Study|Unable to phone|7|||
130263589|NCT03950856|468931095|FG003|Overall Study|Unable to phone|2|||
130263590|NCT01816984|468931096|FG000|Overall Study|declining health status|1|||
130263591|NCT02121509|468931097|FG000|Washout Period (35 Days)|Adverse Event|1|||
130263592|NCT02121509|468931098|FG001|Washout Period (35 Days)|Adverse Event|1|||
130263593|NCT02121509|468931099|FG002|Washout Period (35 Days)|Adverse Event|0|||
130263594|NCT02121509|468931100|FG003|Washout Period (35 Days)|Adverse Event|0|||
130263595|NCT02121509|468931097|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
130263596|NCT02121509|468931098|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
130263597|NCT02121509|468931099|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
130263598|NCT02121509|468931100|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
130263599|NCT02121509|468931097|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
130263600|NCT02121509|468931098|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130263601|NCT02121509|468931099|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130263602|NCT02121509|468931100|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
130263603|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
130263604|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
130263605|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
130263606|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
130263607|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
130263608|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
130263609|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
130263610|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
130263611|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
130263612|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
130263613|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
130263614|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
130263615|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
130263616|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
130263617|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
130263618|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
130263619|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
130263620|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
130263621|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
130263622|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
130263623|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
130263624|NCT04021290|468931103|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
130263625|NCT04021290|468931104|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
130263626|NCT04021290|468931105|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
130263627|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
130263628|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
130263629|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
130263630|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
130263631|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
130263632|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
130263633|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
130263634|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
130263635|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
130263636|NCT04021290|468931103|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
130263637|NCT04021290|468931104|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
130263638|NCT04021290|468931105|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
130263639|NCT00636181|468931106|FG000|Overall Study|Withdrawal by Subject|8|||
130263640|NCT00636181|468931107|FG001|Overall Study|Withdrawal by Subject|6|||
130263641|NCT00636181|468931108|FG002|Overall Study|Withdrawal by Subject|10|||
130263642|NCT05076045|468931116|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
130263643|NCT05076045|468931117|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
130263644|NCT01174563|468931124|FG000|Overall Study|Progressive Disease|45|||
130263645|NCT01174563|468931124|FG000|Overall Study|Death|5|||
130263646|NCT01174563|468931124|FG000|Overall Study|Investigator's Discretion|5|||
130263647|NCT01174563|468931124|FG000|Overall Study|Participant Withdrew Consent|3|||
130263648|NCT01174563|468931124|FG000|Overall Study|Rash Adverse Event|1|||
130263649|NCT01174563|468931124|FG000|Overall Study|Sponsor's decision|1|||
130263650|NCT03402841|468931125|FG000|Overall Study|Withdrawal by Subject|3|||
130263651|NCT03402841|468931125|FG000|Overall Study|Lost to Follow-up|2|||
130263652|NCT03402841|468931125|FG000|Overall Study|Death|146|||
130263653|NCT01542788|468931130|FG000|Overall Study|Randomized but Not Treated|2|||
130263654|NCT01542788|468931131|FG001|Overall Study|Randomized but Not Treated|0|||
130263655|NCT01542788|468931130|FG000|Overall Study|Lack of Efficacy|41|||
130263656|NCT01542788|468931131|FG001|Overall Study|Lack of Efficacy|71|||
130263657|NCT01542788|468931130|FG000|Overall Study|Lost to Follow-up|5|||
130263658|NCT01542788|468931131|FG001|Overall Study|Lost to Follow-up|0|||
130263659|NCT01542788|468931130|FG000|Overall Study|Death|3|||
130263660|NCT01542788|468931131|FG001|Overall Study|Death|0|||
130263661|NCT01542788|468931130|FG000|Overall Study|Protocol Violation|2|||
130263662|NCT01542788|468931131|FG001|Overall Study|Protocol Violation|0|||
130263663|NCT01542788|468931130|FG000|Overall Study|Physician Decision|1|||
130263664|NCT01542788|468931131|FG001|Overall Study|Physician Decision|0|||
130263665|NCT01542788|468931130|FG000|Overall Study|Withdrawal by Subject|1|||
130263666|NCT01542788|468931131|FG001|Overall Study|Withdrawal by Subject|0|||
130316213|NCT00683878|469124330|FG001|Overall Study|Withdrawal by Subject|8|||
130316214|NCT00683878|469124331|FG002|Overall Study|Withdrawal by Subject|6|||
130316215|NCT00683878|469124329|FG000|Overall Study|Death|0|||
130316216|NCT00683878|469124330|FG001|Overall Study|Death|1|||
130035515|NCT03263091|468085941|FG000|DB Component|Adverse Event|0|||
130035516|NCT03263091|468085942|FG001|DB Component|Adverse Event|0|||
130035517|NCT03263091|468085943|FG002|DB Component|Adverse Event|0|||
130035518|NCT03263091|468085944|FG003|DB Component|Adverse Event|0|||
130035519|NCT03263091|468085945|FG004|DB Component|Adverse Event|2|||
130035520|NCT03263091|468085946|FG005|DB Component|Adverse Event|1|||
130035521|NCT03263091|468085941|FG000|DB Component|Lost to Follow-up|0|||
130035522|NCT03263091|468085942|FG001|DB Component|Lost to Follow-up|0|||
130035523|NCT03263091|468085943|FG002|DB Component|Lost to Follow-up|0|||
130035524|NCT03263091|468085944|FG003|DB Component|Lost to Follow-up|0|||
130035525|NCT03263091|468085945|FG004|DB Component|Lost to Follow-up|2|||
130035526|NCT03263091|468085946|FG005|DB Component|Lost to Follow-up|1|||
130035527|NCT03263091|468085941|FG000|DB Component|Death|0|||
130035528|NCT03263091|468085942|FG001|DB Component|Death|0|||
130035529|NCT03263091|468085943|FG002|DB Component|Death|0|||
130035530|NCT03263091|468085944|FG003|DB Component|Death|0|||
130035531|NCT03263091|468085945|FG004|DB Component|Death|7|||
130035532|NCT03263091|468085946|FG005|DB Component|Death|4|||
130035533|NCT03263091|468085941|FG000|DB Component|Other than specified|0|||
130035534|NCT03263091|468085942|FG001|DB Component|Other than specified|0|||
130035535|NCT03263091|468085943|FG002|DB Component|Other than specified|0|||
130035536|NCT03263091|468085944|FG003|DB Component|Other than specified|0|||
130035537|NCT03263091|468085945|FG004|DB Component|Other than specified|8|||
130035538|NCT03263091|468085946|FG005|DB Component|Other than specified|6|||
130035539|NCT00826748|468085947|FG000|Overall Study|Withdrawal by Subject|0|||
130035540|NCT00826748|468085948|FG001|Overall Study|Withdrawal by Subject|0|||
130035541|NCT00826748|468085949|FG002|Overall Study|Withdrawal by Subject|2|||
130035542|NCT00826748|468085947|FG000|Overall Study|Physician Decision|0|||
130035543|NCT00826748|468085948|FG001|Overall Study|Physician Decision|0|||
130035544|NCT00826748|468085949|FG002|Overall Study|Physician Decision|1|||
130035545|NCT00826748|468085947|FG000|Overall Study|Samples Did Not pass QC|0|||
130035546|NCT00826748|468085948|FG001|Overall Study|Samples Did Not pass QC|0|||
130035547|NCT00826748|468085949|FG002|Overall Study|Samples Did Not pass QC|1|||
130035548|NCT05067127|468085953|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
130035549|NCT05067127|468085954|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
130035550|NCT05067127|468085955|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
130035551|NCT05067127|468085956|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
130035552|NCT05067127|468085953|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130316217|NCT00683878|469124331|FG002|Overall Study|Death|0|||
130316218|NCT00683878|469124329|FG000|Overall Study|Lost to Follow-up|4|||
130316219|NCT00683878|469124330|FG001|Overall Study|Lost to Follow-up|2|||
130316220|NCT00683878|469124331|FG002|Overall Study|Lost to Follow-up|4|||
130316221|NCT00683878|469124329|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
130316222|NCT00683878|469124330|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
130316223|NCT00683878|469124331|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
130316224|NCT04319198|469124332|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
130316225|NCT04319198|469124333|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
130263667|NCT00269113|468933189|FG000|Overall Study|Adverse Event|14|||
130263668|NCT00269113|468933190|FG001|Overall Study|Adverse Event|7|||
130263669|NCT00269113|468933189|FG000|Overall Study|Lack of Efficacy|35|||
130263670|NCT00269113|468933190|FG001|Overall Study|Lack of Efficacy|18|||
130263671|NCT00269113|468933189|FG000|Overall Study|Early Improvement|2|||
130263672|NCT00269113|468933190|FG001|Overall Study|Early Improvement|0|||
130263673|NCT00269113|468933189|FG000|Overall Study|Withdrawal by Subject|0|||
130263674|NCT00269113|468933190|FG001|Overall Study|Withdrawal by Subject|2|||
130263675|NCT00269113|468933189|FG000|Overall Study|Death|6|||
130263676|NCT00269113|468933190|FG001|Overall Study|Death|2|||
130263677|NCT00269113|468933189|FG000|Overall Study|Lost to Follow-up|2|||
130263678|NCT00269113|468933190|FG001|Overall Study|Lost to Follow-up|1|||
130263679|NCT00269113|468933189|FG000|Overall Study|Protocol Violation|15|||
130263680|NCT00269113|468933190|FG001|Overall Study|Protocol Violation|5|||
130263681|NCT00269113|468933189|FG000|Overall Study|Other|0|||
130263682|NCT00269113|468933190|FG001|Overall Study|Other|2|||
130263683|NCT00322049|468933191|FG000|Overall Study|Moved out of area|0|||
130263684|NCT00322049|468933192|FG001|Overall Study|Moved out of area|0|||
130263685|NCT00322049|468933193|FG002|Overall Study|Moved out of area|0|||
130263686|NCT00322049|468933194|FG003|Overall Study|Moved out of area|1|||
130263687|NCT00322049|468933191|FG000|Overall Study|Infected with Dengue during study|0|||
130263688|NCT00322049|468933192|FG001|Overall Study|Infected with Dengue during study|1|||
130263689|NCT00322049|468933193|FG002|Overall Study|Infected with Dengue during study|0|||
130263690|NCT00322049|468933194|FG003|Overall Study|Infected with Dengue during study|0|||
130263691|NCT02026011|468933195|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
130263692|NCT02026011|468933196|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
130263693|NCT02026011|468933195|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
130263694|NCT02026011|468933196|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
130263695|NCT02026011|468933195|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
130263696|NCT02026011|468933196|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
130263697|NCT02026011|468933195|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
130263698|NCT02026011|468933196|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
130263699|NCT01770743|468933197|FG000|Overall Study|Adverse Event|1|||
130263700|NCT01770743|468933198|FG001|Overall Study|Adverse Event|0|||
130263701|NCT01770743|468933199|FG002|Overall Study|Adverse Event|0|||
130263702|NCT01770743|468933200|FG003|Overall Study|Adverse Event|0|||
130263703|NCT01770743|468933201|FG004|Overall Study|Adverse Event|0|||
130263704|NCT01770743|468933197|FG000|Overall Study|Withdrawal by Subject|0|||
130263705|NCT01770743|468933198|FG001|Overall Study|Withdrawal by Subject|0|||
130263706|NCT01770743|468933199|FG002|Overall Study|Withdrawal by Subject|1|||
130263707|NCT01770743|468933200|FG003|Overall Study|Withdrawal by Subject|1|||
130263708|NCT01770743|468933201|FG004|Overall Study|Withdrawal by Subject|1|||
130263709|NCT01770743|468933197|FG000|Overall Study|Lost to Follow-up|0|||
130263710|NCT01770743|468933198|FG001|Overall Study|Lost to Follow-up|2|||
130263711|NCT01770743|468933199|FG002|Overall Study|Lost to Follow-up|0|||
130263712|NCT01770743|468933200|FG003|Overall Study|Lost to Follow-up|0|||
130263713|NCT01770743|468933201|FG004|Overall Study|Lost to Follow-up|1|||
130263714|NCT01770743|468933197|FG000|Overall Study|Sponsor Terminated Subject|1|||
130263715|NCT01770743|468933198|FG001|Overall Study|Sponsor Terminated Subject|0|||
130263716|NCT01770743|468933199|FG002|Overall Study|Sponsor Terminated Subject|0|||
130263717|NCT01770743|468933200|FG003|Overall Study|Sponsor Terminated Subject|1|||
130263718|NCT01770743|468933201|FG004|Overall Study|Sponsor Terminated Subject|0|||
130263719|NCT01770743|468933197|FG000|Overall Study|Moving Out of State|0|||
130263720|NCT01770743|468933198|FG001|Overall Study|Moving Out of State|1|||
130263721|NCT01770743|468933199|FG002|Overall Study|Moving Out of State|0|||
130263722|NCT01770743|468933200|FG003|Overall Study|Moving Out of State|0|||
130263723|NCT01770743|468933201|FG004|Overall Study|Moving Out of State|0|||
130263724|NCT00755807|468933202|FG000|Acute Phase|Adverse Event|16|||
130263725|NCT00755807|468933203|FG001|Acute Phase|Adverse Event|5|||
130263726|NCT00755807|468933202|FG000|Acute Phase|Protocol Violation|1|||
130263727|NCT00755807|468933203|FG001|Acute Phase|Protocol Violation|3|||
130263728|NCT00755807|468933202|FG000|Acute Phase|Withdrawal by Subject|1|||
130263729|NCT00755807|468933203|FG001|Acute Phase|Withdrawal by Subject|2|||
130263730|NCT00755807|468933202|FG000|Acute Phase|Lack of Efficacy|0|||
130263731|NCT00755807|468933203|FG001|Acute Phase|Lack of Efficacy|1|||
130263732|NCT00755807|468933202|FG000|Acute Phase|Physician Decision|0|||
130263733|NCT00755807|468933203|FG001|Acute Phase|Physician Decision|1|||
130263734|NCT00755807|468933202|FG000|Open-label Extension Phase|Adverse Event|7|||
130263735|NCT00755807|468933203|FG001|Open-label Extension Phase|Adverse Event|7|||
130263736|NCT00755807|468933202|FG000|Open-label Extension Phase|Protocol Violation|5|||
130263737|NCT00755807|468933203|FG001|Open-label Extension Phase|Protocol Violation|2|||
130263738|NCT00755807|468933202|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
130263739|NCT00755807|468933203|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
130263740|NCT00755807|468933202|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
130263741|NCT00755807|468933203|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
130263742|NCT00755807|468933202|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
130263743|NCT00755807|468933203|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
130263744|NCT00755807|468933202|FG000|Open-label Extension Phase|Sponsor Decision|0|||
130263745|NCT00755807|468933203|FG001|Open-label Extension Phase|Sponsor Decision|1|||
130263746|NCT00529243|468933208|FG000|Overall Study|Adverse Event|1|||
130263747|NCT00529243|468933208|FG000|Overall Study|Death|1|||
130263748|NCT00529243|468933208|FG000|Overall Study|Relocated|1|||
130263749|NCT00952705|468933213|FG000|Overall Study|Lost to Follow-up|24|||
130263750|NCT00952705|468933214|FG001|Overall Study|Lost to Follow-up|8|||
130263751|NCT00952705|468933215|FG002|Overall Study|Lost to Follow-up|9|||
130263752|NCT00952705|468933213|FG000|Overall Study|Withdrawal by Subject|2|||
130263753|NCT00952705|468933214|FG001|Overall Study|Withdrawal by Subject|1|||
130263754|NCT00952705|468933215|FG002|Overall Study|Withdrawal by Subject|1|||
130263755|NCT00952705|468933213|FG000|Overall Study|Death|2|||
130263756|NCT00952705|468933214|FG001|Overall Study|Death|0|||
130263757|NCT00952705|468933215|FG002|Overall Study|Death|0|||
130263758|NCT00952705|468933213|FG000|Overall Study|Incarcerated post dose|5|||
130263759|NCT00952705|468933214|FG001|Overall Study|Incarcerated post dose|0|||
130263760|NCT00952705|468933215|FG002|Overall Study|Incarcerated post dose|0|||
130263761|NCT00952705|468933213|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
130263762|NCT00952705|468933214|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
130263763|NCT00952705|468933215|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
130263764|NCT02921789|468933216|FG000|Overall Study|Adverse Event|0|||
130263765|NCT02921789|468933217|FG001|Overall Study|Adverse Event|1|||
130263766|NCT02921789|468933216|FG000|Overall Study|Lost to Follow-up|1|||
130263767|NCT02921789|468933217|FG001|Overall Study|Lost to Follow-up|0|||
130263768|NCT02921789|468933216|FG000|Overall Study|Protocol Deviation|2|||
130263769|NCT02921789|468933217|FG001|Overall Study|Protocol Deviation|0|||
130263770|NCT02921789|468933216|FG000|Overall Study|Withdrawal by Subject|2|||
130263771|NCT02921789|468933217|FG001|Overall Study|Withdrawal by Subject|1|||
130263772|NCT02921789|468933216|FG000|Overall Study|Miscellaneous|3|||
130263773|NCT02921789|468933217|FG001|Overall Study|Miscellaneous|2|||
130263774|NCT03759600|468933220|FG000|Overall Study|Adverse Event|2|||
130263775|NCT03759600|468933220|FG000|Overall Study|Progressive Disease|15|||
130263776|NCT03759600|468933220|FG000|Overall Study|Site Terminated by Sponsor|3|||
130263777|NCT05173974|468933221|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130263778|NCT05173974|468933222|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130263779|NCT05173974|468933223|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
130263780|NCT05173974|468933224|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
130263781|NCT05173974|468933221|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130263782|NCT05173974|468933222|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
130263783|NCT05173974|468933223|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130263784|NCT05173974|468933224|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
130263785|NCT03289143|468933225|FG000|Overall Study|Caregiver Unavailability|1|||
130263786|NCT03289143|468933226|FG001|Overall Study|Caregiver Unavailability|1|||
130263787|NCT03289143|468933227|FG002|Overall Study|Caregiver Unavailability|0|||
130263788|NCT03289143|468933228|FG003|Overall Study|Caregiver Unavailability|0|||
130263789|NCT03289143|468933225|FG000|Overall Study|Research Department Closure|0|||
130263790|NCT03289143|468933226|FG001|Overall Study|Research Department Closure|0|||
130263791|NCT03289143|468933227|FG002|Overall Study|Research Department Closure|1|||
130263792|NCT03289143|468933228|FG003|Overall Study|Research Department Closure|0|||
130263793|NCT03289143|468933225|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130263794|NCT03289143|468933226|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130263795|NCT03289143|468933227|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
130263796|NCT03289143|468933228|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
130263797|NCT03289143|468933225|FG000|Overall Study|Medical Monitor Decision|1|||
130263798|NCT03289143|468933226|FG001|Overall Study|Medical Monitor Decision|0|||
130263799|NCT03289143|468933227|FG002|Overall Study|Medical Monitor Decision|0|||
130263800|NCT03289143|468933228|FG003|Overall Study|Medical Monitor Decision|0|||
130263801|NCT03289143|468933225|FG000|Overall Study|Participant Non-Compliance|0|||
130263802|NCT03289143|468933226|FG001|Overall Study|Participant Non-Compliance|0|||
130263803|NCT03289143|468933227|FG002|Overall Study|Participant Non-Compliance|1|||
130263804|NCT03289143|468933228|FG003|Overall Study|Participant Non-Compliance|0|||
130263805|NCT03289143|468933225|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130263806|NCT03289143|468933226|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130263807|NCT03289143|468933227|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
130263808|NCT03289143|468933228|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
130263809|NCT03289143|468933225|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130263810|NCT03289143|468933226|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130035553|NCT05067127|468085954|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
130263811|NCT03289143|468933227|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
130263812|NCT03289143|468933228|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
130263813|NCT03289143|468933225|FG000|Overall Study|Caregiver Passed Away|1|||
130263814|NCT03289143|468933226|FG001|Overall Study|Caregiver Passed Away|0|||
130263815|NCT03289143|468933227|FG002|Overall Study|Caregiver Passed Away|0|||
130263816|NCT03289143|468933228|FG003|Overall Study|Caregiver Passed Away|0|||
130263817|NCT03289143|468933225|FG000|Overall Study|Physician Decision|0|||
130263818|NCT03289143|468933226|FG001|Overall Study|Physician Decision|2|||
130263819|NCT03289143|468933227|FG002|Overall Study|Physician Decision|2|||
130263820|NCT03289143|468933228|FG003|Overall Study|Physician Decision|2|||
130263821|NCT03289143|468933225|FG000|Overall Study|Protocol Deviation|2|||
130263822|NCT03289143|468933226|FG001|Overall Study|Protocol Deviation|1|||
130263823|NCT03289143|468933227|FG002|Overall Study|Protocol Deviation|3|||
130263824|NCT03289143|468933228|FG003|Overall Study|Protocol Deviation|1|||
130263825|NCT03289143|468933225|FG000|Overall Study|Study Terminated By Sponsor|101|||
130263826|NCT03289143|468933226|FG001|Overall Study|Study Terminated By Sponsor|75|||
130263827|NCT03289143|468933227|FG002|Overall Study|Study Terminated By Sponsor|100|||
130263828|NCT03289143|468933228|FG003|Overall Study|Study Terminated By Sponsor|69|||
130263829|NCT03289143|468933225|FG000|Overall Study|Withdrawal by Subject|14|||
130263830|NCT03289143|468933226|FG001|Overall Study|Withdrawal by Subject|6|||
130263831|NCT03289143|468933227|FG002|Overall Study|Withdrawal by Subject|14|||
130263832|NCT03289143|468933228|FG003|Overall Study|Withdrawal by Subject|12|||
130263833|NCT03289143|468933225|FG000|Overall Study|Adverse Event|10|||
130263834|NCT03289143|468933226|FG001|Overall Study|Adverse Event|7|||
130263835|NCT03289143|468933227|FG002|Overall Study|Adverse Event|6|||
130263836|NCT03289143|468933228|FG003|Overall Study|Adverse Event|5|||
130263837|NCT03289143|468933225|FG000|Overall Study|Death|2|||
130263838|NCT03289143|468933226|FG001|Overall Study|Death|0|||
130263839|NCT03289143|468933227|FG002|Overall Study|Death|2|||
130263840|NCT03289143|468933228|FG003|Overall Study|Death|1|||
130263841|NCT03289143|468933225|FG000|Overall Study|Lost to Follow-up|2|||
130263842|NCT03289143|468933226|FG001|Overall Study|Lost to Follow-up|1|||
130263843|NCT03289143|468933227|FG002|Overall Study|Lost to Follow-up|1|||
130263844|NCT03289143|468933228|FG003|Overall Study|Lost to Follow-up|0|||
130263845|NCT03289143|468933225|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
130263846|NCT03289143|468933226|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
130263847|NCT03289143|468933227|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
130263848|NCT03289143|468933228|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
130263849|NCT03289143|468933225|FG000|Overall Study|Withdrawal by Caregiver|0|||
130263850|NCT03289143|468933226|FG001|Overall Study|Withdrawal by Caregiver|1|||
130263851|NCT03289143|468933227|FG002|Overall Study|Withdrawal by Caregiver|0|||
130263852|NCT03289143|468933228|FG003|Overall Study|Withdrawal by Caregiver|0|||
130263853|NCT03289143|468933225|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130263854|NCT03289143|468933226|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130263855|NCT03289143|468933227|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
130263856|NCT03289143|468933228|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
130263857|NCT03289143|468933225|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130263858|NCT03289143|468933226|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130263859|NCT03289143|468933227|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
130263860|NCT03289143|468933228|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
130263861|NCT00730756|468933229|FG000|Overall Study|Adverse Event|2|||
130263862|NCT00730756|468933230|FG001|Overall Study|Adverse Event|0|||
130263863|NCT00730756|468933229|FG000|Overall Study|Lack of Efficacy|1|||
130263864|NCT00730756|468933230|FG001|Overall Study|Lack of Efficacy|1|||
130263865|NCT00730756|468933229|FG000|Overall Study|Protocol Deviation|1|||
130263866|NCT00730756|468933230|FG001|Overall Study|Protocol Deviation|2|||
130263867|NCT00730756|468933229|FG000|Overall Study|Lost to Follow-up|0|||
130263868|NCT00730756|468933230|FG001|Overall Study|Lost to Follow-up|1|||
130263869|NCT00730756|468933229|FG000|Overall Study|Withdrew Consent|0|||
130263870|NCT00730756|468933230|FG001|Overall Study|Withdrew Consent|1|||
130263871|NCT00305877|468933231|FG000|Overall Study|Lack of Efficacy|6|||
130263872|NCT00305877|468933232|FG001|Overall Study|Lack of Efficacy|9|||
130263873|NCT00305877|468933231|FG000|Overall Study|Adverse Event|9|||
130263874|NCT00305877|468933232|FG001|Overall Study|Adverse Event|14|||
130263875|NCT00305877|468933231|FG000|Overall Study|Death|0|||
130263876|NCT00305877|468933232|FG001|Overall Study|Death|1|||
130263877|NCT00305877|468933231|FG000|Overall Study|Withdrawal by Subject|4|||
130263878|NCT00305877|468933232|FG001|Overall Study|Withdrawal by Subject|2|||
130263879|NCT00305877|468933231|FG000|Overall Study|Physician Decision|1|||
130263880|NCT00305877|468933232|FG001|Overall Study|Physician Decision|1|||
130263881|NCT00305877|468933231|FG000|Overall Study|Never start treatment|2|||
130263882|NCT00305877|468933232|FG001|Overall Study|Never start treatment|5|||
130263883|NCT00305877|468933231|FG000|Overall Study|Ineligible|2|||
130263884|NCT00305877|468933232|FG001|Overall Study|Ineligible|1|||
130263885|NCT00305877|468933231|FG000|Overall Study|Transportation issue with daily RT|0|||
130263886|NCT00305877|468933232|FG001|Overall Study|Transportation issue with daily RT|1|||
130263887|NCT01126190|468933235|FG000|Double-Blind Phase|Death|0|||
130263888|NCT01126190|468933236|FG001|Double-Blind Phase|Death|1|||
130263889|NCT01126190|468933237|FG002|Double-Blind Phase|Death|0|||
130263890|NCT01126190|468933235|FG000|Double-Blind Phase|Adverse Event|1|||
130263891|NCT01126190|468933236|FG001|Double-Blind Phase|Adverse Event|2|||
130263892|NCT01126190|468933237|FG002|Double-Blind Phase|Adverse Event|0|||
130263893|NCT01126190|468933235|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130263894|NCT01126190|468933236|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
130263895|NCT01126190|468933237|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130263896|NCT01126190|468933235|FG000|Double-Blind Phase|Request of Investigator|1|||
130263897|NCT01126190|468933236|FG001|Double-Blind Phase|Request of Investigator|0|||
130263898|NCT01126190|468933237|FG002|Double-Blind Phase|Request of Investigator|0|||
130263899|NCT01126190|468933235|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
130263900|NCT01126190|468933236|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
130263901|NCT01126190|468933237|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
130263902|NCT01126190|468933235|FG000|Double-Blind Phase|Non-compliance|1|||
130263903|NCT01126190|468933236|FG001|Double-Blind Phase|Non-compliance|0|||
130263904|NCT01126190|468933237|FG002|Double-Blind Phase|Non-compliance|0|||
130263905|NCT01126190|468933235|FG000|Double-Blind Phase|Lost to Follow-up|1|||
130263906|NCT01126190|468933236|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130263907|NCT01126190|468933237|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130263908|NCT01126190|468933235|FG000|Open-Label Phase|Death|0|||
130263909|NCT01126190|468933236|FG001|Open-Label Phase|Death|0|||
130263910|NCT01126190|468933237|FG002|Open-Label Phase|Death|1|||
130263911|NCT01126190|468933235|FG000|Open-Label Phase|Adverse Event|0|||
130263912|NCT01126190|468933236|FG001|Open-Label Phase|Adverse Event|0|||
130263913|NCT01126190|468933237|FG002|Open-Label Phase|Adverse Event|4|||
130263914|NCT01126190|468933235|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130263915|NCT01126190|468933236|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130263916|NCT01126190|468933237|FG002|Open-Label Phase|Withdrawal by Subject|6|||
130263917|NCT00524121|468933238|FG000|Overall Study|Disease progression|6|||
130263918|NCT00524121|468933238|FG000|Overall Study|Adverse Event|4|||
130263919|NCT00524121|468933238|FG000|Overall Study|Patient refused|2|||
130263920|NCT00524121|468933238|FG000|Overall Study|Other|1|||
130263921|NCT00524121|468933238|FG000|Overall Study|Death|1|||
130263922|NCT00524121|468933238|FG000|Overall Study|Not treated (became ineligible)|4|||
130263923|NCT00524121|468933238|FG000|Overall Study|Not treated (changed mind)|1|||
130263924|NCT01114737|468933239|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130263925|NCT01114737|468933240|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130263926|NCT01114737|468933239|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
130263927|NCT01114737|468933240|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
130263928|NCT01114737|468933239|FG000|Randomized Treatment Period|Pregnancy|1|||
130263929|NCT01114737|468933240|FG001|Randomized Treatment Period|Pregnancy|0|||
130263930|NCT01114737|468933239|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
130263931|NCT01114737|468933240|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
130263932|NCT01114737|468933239|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
130263933|NCT01114737|468933240|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
130263934|NCT01114737|468933239|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
130263935|NCT01114737|468933240|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
130263936|NCT01446874|468933241|FG000|Overall Study|Not eligible|1|||
130263937|NCT01446874|468933242|FG001|Overall Study|Not eligible|0|||
130263938|NCT01446874|468933243|FG002|Overall Study|Not eligible|0|||
130263939|NCT01446874|468933241|FG000|Overall Study|No surgery/No qualifying surgery|1|||
130263940|NCT01446874|468933242|FG001|Overall Study|No surgery/No qualifying surgery|0|||
130263941|NCT01446874|468933243|FG002|Overall Study|No surgery/No qualifying surgery|12|||
130263942|NCT01446874|468933241|FG000|Overall Study|Non-compliance|0|||
130263943|NCT01446874|468933242|FG001|Overall Study|Non-compliance|4|||
130035554|NCT05067127|468085955|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130035555|NCT05067127|468085956|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
130035556|NCT05067127|468085953|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
130035557|NCT05067127|468085954|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130035558|NCT05067127|468085955|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130035559|NCT05067127|468085956|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130263944|NCT01446874|468933243|FG002|Overall Study|Non-compliance|0|||
130263945|NCT01446874|468933241|FG000|Overall Study|Antibiotics for pre-op infection|0|||
130263946|NCT01446874|468933242|FG001|Overall Study|Antibiotics for pre-op infection|0|||
130263947|NCT01446874|468933243|FG002|Overall Study|Antibiotics for pre-op infection|2|||
130263948|NCT01446874|468933241|FG000|Overall Study|Withdrawal by Subject|0|||
130263949|NCT01446874|468933242|FG001|Overall Study|Withdrawal by Subject|0|||
130263950|NCT01446874|468933243|FG002|Overall Study|Withdrawal by Subject|4|||
130263951|NCT00457392|468933244|FG000|Overall Study|Objective Progression or Relapse|229|||
130263952|NCT00457392|468933245|FG001|Overall Study|Objective Progression or Relapse|296|||
130263953|NCT00457392|468933244|FG000|Overall Study|Death|106|||
130263954|NCT00457392|468933245|FG001|Overall Study|Death|106|||
130263955|NCT00457392|468933244|FG000|Overall Study|Adverse Event|84|||
130263956|NCT00457392|468933245|FG001|Overall Study|Adverse Event|41|||
130263957|NCT00457392|468933244|FG000|Overall Study|Global Deterioration of Health Status|22|||
130263958|NCT00457392|468933245|FG001|Overall Study|Global Deterioration of Health Status|8|||
130263959|NCT00457392|468933244|FG000|Overall Study|Withdrawal by Subject|14|||
130263960|NCT00457392|468933245|FG001|Overall Study|Withdrawal by Subject|8|||
130263961|NCT00457392|468933244|FG000|Overall Study|Lost to Follow-up|6|||
130263962|NCT00457392|468933245|FG001|Overall Study|Lost to Follow-up|7|||
130263963|NCT00457392|468933244|FG000|Overall Study|Protocol Violation|4|||
130263964|NCT00457392|468933245|FG001|Overall Study|Protocol Violation|3|||
130263965|NCT00457392|468933244|FG000|Overall Study|Other|7|||
130263966|NCT00457392|468933245|FG001|Overall Study|Other|4|||
130263967|NCT00457392|468933244|FG000|Overall Study|Study Terminated by Sponsor|1|||
130263968|NCT00457392|468933245|FG001|Overall Study|Study Terminated by Sponsor|4|||
130263969|NCT00457392|468933244|FG000|Overall Study|Randomized, Not Treated|7|||
130263970|NCT00457392|468933245|FG001|Overall Study|Randomized, Not Treated|3|||
130263971|NCT01466491|468933247|FG000|Overall Study|Protocol Violation|0|||
130263972|NCT01466491|468933248|FG001|Overall Study|Protocol Violation|3|||
130263973|NCT01466491|468933249|FG002|Overall Study|Protocol Violation|2|||
130263974|NCT01466491|468933250|FG003|Overall Study|Protocol Violation|0|||
130263975|NCT01466491|468933247|FG000|Overall Study|Missing Data|0|||
130263976|NCT01466491|468933248|FG001|Overall Study|Missing Data|0|||
130263977|NCT01466491|468933249|FG002|Overall Study|Missing Data|1|||
130263978|NCT01466491|468933250|FG003|Overall Study|Missing Data|0|||
130263979|NCT02727322|468933251|FG000|Overall Study|Withdrawal by Subject|1|||
130263980|NCT02727322|468933252|FG001|Overall Study|Withdrawal by Subject|1|||
130263981|NCT02727322|468933251|FG000|Overall Study|Protocol Violation|1|||
130263982|NCT02727322|468933252|FG001|Overall Study|Protocol Violation|0|||
130263983|NCT00339040|468933253|FG000|Stage I|Not able to attend clinic|1|||
130263984|NCT00339040|468933254|FG001|Stage I|Not able to attend clinic|0|||
130263985|NCT00339040|468933253|FG000|Stage I|Protocol Violation|1|||
130263986|NCT00339040|468933254|FG001|Stage I|Protocol Violation|1|||
130263987|NCT00339040|468933253|FG000|Stage II|Lost to Follow-up|3|||
130263988|NCT00339040|468933254|FG001|Stage II|Lost to Follow-up|0|||
130263989|NCT00339040|468933253|FG000|Stage II|Withdrawal by Subject|1|||
130263990|NCT00339040|468933254|FG001|Stage II|Withdrawal by Subject|2|||
130263991|NCT00339040|468933253|FG000|Stage II|Protocol Violation|3|||
130263992|NCT00339040|468933254|FG001|Stage II|Protocol Violation|0|||
130263993|NCT00339040|468933253|FG000|Stage II|Not able to attend clinic|1|||
130263994|NCT00339040|468933254|FG001|Stage II|Not able to attend clinic|0|||
130263995|NCT00339040|468933253|FG000|Stage II|Site closing|2|||
130263996|NCT00339040|468933254|FG001|Stage II|Site closing|0|||
130263997|NCT03046446|468933257|FG000|Overall Study|Lack of Efficacy|7|||
130263998|NCT03046446|468933257|FG000|Overall Study|Adverse Event|6|||
130263999|NCT03046446|468933257|FG000|Overall Study|Lost to Follow-up|3|||
130264000|NCT03046446|468933257|FG000|Overall Study|Withdrawal by Subject|14|||
130264001|NCT03046446|468933257|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
130264002|NCT03046446|468933257|FG000|Overall Study|Disease Progression (see caveats)|25|||
130264003|NCT03046446|468933257|FG000|Overall Study|Non OA related knee surgery|1|||
130264004|NCT02808897|468933258|FG000|Overall Study|Lost to Follow-up|9|||
130264005|NCT02808897|468933259|FG001|Overall Study|Lost to Follow-up|11|||
130264006|NCT01870869|468933260|FG000|Overall Study|Implanted with nonstudy device|1|||
130264007|NCT01870869|468933261|FG001|Overall Study|Implanted with nonstudy device|3|||
130264008|NCT01870869|468933262|FG002|Overall Study|Implanted with nonstudy device|14|||
130264009|NCT01870869|468933263|FG003|Overall Study|Implanted with nonstudy device|4|||
130264010|NCT01870869|468933260|FG000|Overall Study|Death|0|||
130264011|NCT01870869|468933261|FG001|Overall Study|Death|0|||
130264012|NCT01870869|468933262|FG002|Overall Study|Death|7|||
130264013|NCT01870869|468933263|FG003|Overall Study|Death|1|||
130264014|NCT01870869|468933260|FG000|Overall Study|Subject choice|6|||
130264015|NCT01870869|468933261|FG001|Overall Study|Subject choice|2|||
130264016|NCT01870869|468933262|FG002|Overall Study|Subject choice|22|||
130264017|NCT01870869|468933263|FG003|Overall Study|Subject choice|8|||
130264018|NCT01870869|468933260|FG000|Overall Study|Lost to Follow-up|10|||
130264019|NCT01870869|468933261|FG001|Overall Study|Lost to Follow-up|2|||
130264020|NCT01870869|468933262|FG002|Overall Study|Lost to Follow-up|25|||
130264021|NCT01870869|468933263|FG003|Overall Study|Lost to Follow-up|3|||
130264022|NCT01870869|468933260|FG000|Overall Study|Reason not Specified|1|||
130264023|NCT01870869|468933261|FG001|Overall Study|Reason not Specified|2|||
130264024|NCT01870869|468933262|FG002|Overall Study|Reason not Specified|20|||
130264025|NCT01870869|468933263|FG003|Overall Study|Reason not Specified|4|||
130264026|NCT01870869|468933260|FG000|Overall Study|Not evaluable|10|||
130264027|NCT01870869|468933261|FG001|Overall Study|Not evaluable|5|||
130264028|NCT01870869|468933262|FG002|Overall Study|Not evaluable|42|||
130264029|NCT01870869|468933263|FG003|Overall Study|Not evaluable|10|||
130264030|NCT03036852|468933264|FG000|Overall Study|Death|2|||
130264031|NCT03036852|468933264|FG000|Overall Study|Lack of Efficacy|2|||
130264032|NCT03036852|468933264|FG000|Overall Study|Adverse Event|1|||
130264033|NCT03036852|468933264|FG000|Overall Study|Lost to Follow-up|1|||
130264034|NCT00305448|468933267|FG000|Overall Study|Protocol Violation|0|||
130264035|NCT00305448|468933268|FG001|Overall Study|Protocol Violation|1|||
130264036|NCT00305448|468933269|FG002|Overall Study|Protocol Violation|0|||
130264037|NCT00305448|468933267|FG000|Overall Study|Withdrawal by Subject|2|||
130264038|NCT00305448|468933268|FG001|Overall Study|Withdrawal by Subject|0|||
130264039|NCT00305448|468933269|FG002|Overall Study|Withdrawal by Subject|1|||
130264040|NCT00305448|468933267|FG000|Overall Study|Adverse Event|1|||
130264041|NCT00305448|468933268|FG001|Overall Study|Adverse Event|0|||
130035560|NCT05067127|468085953|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
130035561|NCT05067127|468085954|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
130035562|NCT05067127|468085955|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
130035563|NCT05067127|468085956|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
130035564|NCT05067127|468085953|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
130035565|NCT05067127|468085954|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
130035566|NCT05067127|468085955|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
130035567|NCT05067127|468085956|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
130035568|NCT05067127|468085953|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
130035569|NCT05067127|468085954|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
130035570|NCT05067127|468085955|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
130035571|NCT05067127|468085956|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
130035572|NCT05067127|468085953|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130035573|NCT05067127|468085954|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
130035574|NCT05067127|468085955|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
130035575|NCT05067127|468085956|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
130264042|NCT00305448|468933269|FG002|Overall Study|Adverse Event|1|||
130264043|NCT00305448|468933267|FG000|Overall Study|Disease Progression|27|||
130264044|NCT00305448|468933268|FG001|Overall Study|Disease Progression|31|||
130264045|NCT00305448|468933269|FG002|Overall Study|Disease Progression|28|||
130035576|NCT04462536|468085957|FG000|Overall Study|Withdrawal by Subject|3|||
130035577|NCT04462536|468085958|FG001|Overall Study|Withdrawal by Subject|9|||
130035578|NCT04462536|468085957|FG000|Overall Study|Lost to Follow-up|2|||
130035579|NCT04462536|468085958|FG001|Overall Study|Lost to Follow-up|4|||
130035580|NCT04439266|468085987|FG000|Overall Study|Ineligible|1|||
130035581|NCT04439266|468085987|FG000|Overall Study|Adverse Event|1|||
130035582|NCT04439266|468085987|FG000|Overall Study|Death|1|||
130035583|NCT04439266|468085987|FG000|Overall Study|Disease progression|1|||
130264046|NCT00305448|468933267|FG000|Overall Study|Subjective Disease Progression|1|||
130264047|NCT00305448|468933268|FG001|Overall Study|Subjective Disease Progression|2|||
130264048|NCT00305448|468933269|FG002|Overall Study|Subjective Disease Progression|2|||
130264049|NCT00305448|468933267|FG000|Overall Study|Tumor Marker Elevation|0|||
130264050|NCT00305448|468933268|FG001|Overall Study|Tumor Marker Elevation|0|||
130264051|NCT00305448|468933269|FG002|Overall Study|Tumor Marker Elevation|1|||
130264052|NCT00002766|468933270|FG000|Overall Study|Withdrawal by Subject|0|||
130264053|NCT00002766|468933271|FG001|Overall Study|Withdrawal by Subject|1|||
130264054|NCT00002766|468933270|FG000|Overall Study|Patient Not Treated|1|||
130035584|NCT04439266|468085987|FG000|Overall Study|Still on treatment|1|||
130035585|NCT06161012|468085990|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130035586|NCT06161012|468085991|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130035587|NCT02601950|468085992|FG000|Overall Study|Participant enrolled in rollover study|0|||
130035588|NCT02601950|468085993|FG001|Overall Study|Participant enrolled in rollover study|0|||
130264055|NCT00002766|468933271|FG001|Overall Study|Patient Not Treated|2|||
130264056|NCT00002766|468933270|FG000|Overall Study|Adverse Event|1|||
130035589|NCT02601950|468085994|FG002|Overall Study|Participant enrolled in rollover study|1|||
130035590|NCT02601950|468085995|FG003|Overall Study|Participant enrolled in rollover study|0|||
130035591|NCT02601950|468085996|FG004|Overall Study|Participant enrolled in rollover study|1|||
130035592|NCT02601950|468085997|FG005|Overall Study|Participant enrolled in rollover study|1|||
130035593|NCT02601950|468085998|FG006|Overall Study|Participant enrolled in rollover study|1|||
130035594|NCT02601950|468085999|FG007|Overall Study|Participant enrolled in rollover study|0|||
130035595|NCT02601950|468085992|FG000|Overall Study|Disease progression - radiological|21|||
130035596|NCT02601950|468085993|FG001|Overall Study|Disease progression - radiological|26|||
130035597|NCT02601950|468085994|FG002|Overall Study|Disease progression - radiological|22|||
130035598|NCT02601950|468085995|FG003|Overall Study|Disease progression - radiological|11|||
130264057|NCT00002766|468933271|FG001|Overall Study|Adverse Event|1|||
130264058|NCT00002766|468933270|FG000|Overall Study|Protocol Violation|1|||
130264059|NCT00002766|468933271|FG001|Overall Study|Protocol Violation|0|||
130264060|NCT00328172|468933274|FG000|Overall Study|Adverse Event|3|||
130264061|NCT00328172|468933275|FG001|Overall Study|Adverse Event|2|||
130264062|NCT00328172|468933276|FG002|Overall Study|Adverse Event|1|||
130264063|NCT00328172|468933277|FG003|Overall Study|Adverse Event|2|||
130264064|NCT00328172|468933278|FG004|Overall Study|Adverse Event|1|||
130264065|NCT00328172|468933274|FG000|Overall Study|Protocol Violation|0|||
130264066|NCT00328172|468933275|FG001|Overall Study|Protocol Violation|1|||
130264067|NCT00328172|468933276|FG002|Overall Study|Protocol Violation|1|||
130264068|NCT00328172|468933277|FG003|Overall Study|Protocol Violation|0|||
130264069|NCT00328172|468933278|FG004|Overall Study|Protocol Violation|0|||
130264070|NCT00328172|468933274|FG000|Overall Study|Lost to Follow-up|1|||
130264071|NCT00328172|468933275|FG001|Overall Study|Lost to Follow-up|1|||
130264072|NCT00328172|468933276|FG002|Overall Study|Lost to Follow-up|2|||
130264073|NCT00328172|468933277|FG003|Overall Study|Lost to Follow-up|1|||
130264074|NCT00328172|468933278|FG004|Overall Study|Lost to Follow-up|1|||
130264075|NCT00328172|468933274|FG000|Overall Study|Withdrawal by Subject|1|||
130264076|NCT00328172|468933275|FG001|Overall Study|Withdrawal by Subject|1|||
130264077|NCT00328172|468933276|FG002|Overall Study|Withdrawal by Subject|1|||
130264078|NCT00328172|468933277|FG003|Overall Study|Withdrawal by Subject|6|||
130264079|NCT00328172|468933278|FG004|Overall Study|Withdrawal by Subject|0|||
130264080|NCT00328172|468933274|FG000|Overall Study|Lack of Efficacy|14|||
130264081|NCT00328172|468933275|FG001|Overall Study|Lack of Efficacy|9|||
130102447|NCT00728988|468332728|FG000|Overall Study|Withdrawal by Subject|2|||
130102448|NCT00728988|468332729|FG001|Overall Study|Withdrawal by Subject|6|||
130102449|NCT01984229|468332732|FG000|Safety Follow-up Period|Adverse Event|1|||
130264082|NCT00328172|468933276|FG002|Overall Study|Lack of Efficacy|4|||
130264083|NCT00328172|468933277|FG003|Overall Study|Lack of Efficacy|4|||
130264084|NCT00328172|468933278|FG004|Overall Study|Lack of Efficacy|3|||
130035599|NCT02601950|468085996|FG004|Overall Study|Disease progression - radiological|46|||
130035600|NCT02601950|468085997|FG005|Overall Study|Disease progression - radiological|52|||
130035601|NCT02601950|468085998|FG006|Overall Study|Disease progression - radiological|7|||
130035602|NCT02601950|468085999|FG007|Overall Study|Disease progression - radiological|5|||
130102450|NCT01984229|468332733|FG001|Safety Follow-up Period|Adverse Event|1|||
130102451|NCT01984229|468332732|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
130264085|NCT00328172|468933274|FG000|Overall Study|Other reason (not specified)|3|||
130264086|NCT00328172|468933275|FG001|Overall Study|Other reason (not specified)|0|||
130264087|NCT00328172|468933276|FG002|Overall Study|Other reason (not specified)|1|||
130264088|NCT00328172|468933277|FG003|Overall Study|Other reason (not specified)|0|||
130264089|NCT00328172|468933278|FG004|Overall Study|Other reason (not specified)|0|||
130264090|NCT00077974|468933279|FG000|Overall Study|Adverse Event|22|||
130264091|NCT00077974|468933279|FG000|Overall Study|Protocol Violation|1|||
130264092|NCT00077974|468933279|FG000|Overall Study|Withdrawal by Subject|3|||
130264093|NCT00077974|468933279|FG000|Overall Study|Lack of Efficacy|76|||
130264094|NCT00077974|468933279|FG000|Overall Study|Decision of Sponsor|2|||
130264095|NCT00558636|468933290|FG000|Treatment|Adverse Event|9|||
130264096|NCT00558636|468933291|FG001|Treatment|Adverse Event|2|||
130264097|NCT00558636|468933290|FG000|Treatment|Withdrawal by Subject|2|||
130102452|NCT01984229|468332733|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130264098|NCT00558636|468933291|FG001|Treatment|Withdrawal by Subject|0|||
130264099|NCT00558636|468933290|FG000|Treatment|Premature termination of the study|35|||
130264100|NCT00558636|468933291|FG001|Treatment|Premature termination of the study|37|||
130264101|NCT00558636|468933290|FG000|Treatment|Disease progression|1|||
130264102|NCT00558636|468933291|FG001|Treatment|Disease progression|5|||
130264103|NCT00558636|468933290|FG000|Follow-up|Premature termination of the study|12|||
130264104|NCT00558636|468933291|FG001|Follow-up|Premature termination of the study|7|||
130264105|NCT04108273|468933292|FG000|Overall Study|COVID Pandemic|1|||
130035603|NCT02601950|468085992|FG000|Overall Study|Disease progression - clinical|3|||
130264106|NCT04108273|468933293|FG001|Overall Study|COVID Pandemic|0|||
130264107|NCT00698828|468933295|FG000|Overall Study|Adverse Event|3|||
130264108|NCT00698828|468933296|FG001|Overall Study|Adverse Event|4|||
130264109|NCT00698828|468933297|FG002|Overall Study|Adverse Event|4|||
130264110|NCT00698828|468933295|FG000|Overall Study|Death|0|||
130264111|NCT00698828|468933296|FG001|Overall Study|Death|0|||
130264112|NCT00698828|468933297|FG002|Overall Study|Death|1|||
130264113|NCT00698828|468933295|FG000|Overall Study|Exacerbation of COPD|1|||
130264114|NCT00698828|468933296|FG001|Overall Study|Exacerbation of COPD|3|||
130264115|NCT00698828|468933297|FG002|Overall Study|Exacerbation of COPD|0|||
130264116|NCT00698828|468933295|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
130264117|NCT00698828|468933296|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
130264118|NCT00698828|468933297|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
130264119|NCT00698828|468933295|FG000|Overall Study|Investigator/Sponsor decision|1|||
130264120|NCT00698828|468933296|FG001|Overall Study|Investigator/Sponsor decision|0|||
130264121|NCT00698828|468933297|FG002|Overall Study|Investigator/Sponsor decision|2|||
130264122|NCT00698828|468933295|FG000|Overall Study|Lost to Follow-up|1|||
130264123|NCT00698828|468933296|FG001|Overall Study|Lost to Follow-up|1|||
130264124|NCT00698828|468933297|FG002|Overall Study|Lost to Follow-up|0|||
130264125|NCT00698828|468933295|FG000|Overall Study|Withdrew consent|0|||
130264126|NCT00698828|468933296|FG001|Overall Study|Withdrew consent|7|||
130264127|NCT00698828|468933297|FG002|Overall Study|Withdrew consent|4|||
130264128|NCT00698828|468933295|FG000|Overall Study|Withdrew consent (not treated)|2|||
130264129|NCT00698828|468933296|FG001|Overall Study|Withdrew consent (not treated)|0|||
130035604|NCT02601950|468085993|FG001|Overall Study|Disease progression - clinical|5|||
130035605|NCT02601950|468085994|FG002|Overall Study|Disease progression - clinical|4|||
130035606|NCT02601950|468085995|FG003|Overall Study|Disease progression - clinical|2|||
130035607|NCT02601950|468085996|FG004|Overall Study|Disease progression - clinical|6|||
130264130|NCT00698828|468933297|FG002|Overall Study|Withdrew consent (not treated)|0|||
130264131|NCT00856609|468933298|FG000|Overall Study|Adverse Event|1|||
130264132|NCT00856609|468933299|FG001|Overall Study|Adverse Event|0|||
130264133|NCT01088503|468933300|FG000|Overall Study|Withdrawal by Subject|118|||
130264134|NCT01088503|468933301|FG001|Overall Study|Withdrawal by Subject|327|||
130264135|NCT01088503|468933302|FG002|Overall Study|Withdrawal by Subject|10|||
130264136|NCT01088503|468933300|FG000|Overall Study|Death|64|||
130264137|NCT01088503|468933301|FG001|Overall Study|Death|358|||
130264138|NCT01088503|468933302|FG002|Overall Study|Death|7|||
130264139|NCT00110214|468933303|FG000|Overall Study|Never started treatment|21|||
130264140|NCT00110214|468933304|FG001|Overall Study|Never started treatment|20|||
130264141|NCT00110214|468933303|FG000|Overall Study|Disease progression or death|260|||
130264142|NCT00110214|468933304|FG001|Overall Study|Disease progression or death|151|||
130264143|NCT00110214|468933303|FG000|Overall Study|Adverse Event|115|||
130264144|NCT00110214|468933304|FG001|Overall Study|Adverse Event|192|||
130264145|NCT00110214|468933303|FG000|Overall Study|Refused further treatment|52|||
130264146|NCT00110214|468933304|FG001|Overall Study|Refused further treatment|65|||
130264147|NCT00110214|468933303|FG000|Overall Study|Other (not specified)|61|||
130264148|NCT00110214|468933304|FG001|Overall Study|Other (not specified)|75|||
130264149|NCT01016067|468933305|FG000|Overall Study|Lost to Follow-up|1|||
130264150|NCT01016067|468933306|FG001|Overall Study|Lost to Follow-up|2|||
130264151|NCT01016067|468933305|FG000|Overall Study|Physician Decision|1|||
130264152|NCT01016067|468933306|FG001|Overall Study|Physician Decision|1|||
130264153|NCT01016067|468933305|FG000|Overall Study|Withdrew due to Relocation|0|||
130264154|NCT01016067|468933306|FG001|Overall Study|Withdrew due to Relocation|1|||
130264155|NCT01534481|468933313|FG000|Overall Study|Lost to Follow-up|29|||
130264156|NCT01534481|468933314|FG001|Overall Study|Lost to Follow-up|24|||
130264157|NCT01534481|468933313|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
130264158|NCT01534481|468933314|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
130264159|NCT01130337|468933315|FG000|Overall Study|Withdrawal by Subject|3|||
130264160|NCT01130337|468933315|FG000|Overall Study|Principal investigator decision|1|||
130264161|NCT01130337|468933315|FG000|Overall Study|Death|1|||
130264162|NCT01130337|468933315|FG000|Overall Study|Disease progression|1|||
130264163|NCT01130337|468933315|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
130264164|NCT01130337|468933315|FG000|Overall Study|Surgical resection (R2)|1|||
130264165|NCT05525910|468933316|FG000|Period 4|Per sponsor due to study timelines|0|||
130264166|NCT05525910|468933317|FG001|Period 4|Per sponsor due to study timelines|0|||
130035608|NCT02601950|468085997|FG005|Overall Study|Disease progression - clinical|6|||
130264167|NCT05525910|468933318|FG002|Period 4|Per sponsor due to study timelines|1|||
130264168|NCT05525910|468933319|FG003|Period 4|Per sponsor due to study timelines|1|||
130264169|NCT05525910|468933320|FG004|Period 4|Per sponsor due to study timelines|1|||
130264170|NCT03886493|468933321|FG000|Overall Study|Adverse Event|1|||
130264171|NCT03179761|468933323|FG000|Overall Study|Death|2|||
130264172|NCT03179761|468933324|FG001|Overall Study|Death|5|||
130264173|NCT03179761|468933323|FG000|Overall Study|Lost to Follow-up|2|||
130264174|NCT03179761|468933324|FG001|Overall Study|Lost to Follow-up|2|||
130264175|NCT03179761|468933323|FG000|Overall Study|Protocol Violation|1|||
130264176|NCT03179761|468933324|FG001|Overall Study|Protocol Violation|0|||
130264177|NCT03179761|468933323|FG000|Overall Study|Withdrawal by Subject|1|||
130264178|NCT03179761|468933324|FG001|Overall Study|Withdrawal by Subject|4|||
130264179|NCT03179761|468933323|FG000|Overall Study|Investigator Request|0|||
130264180|NCT03179761|468933324|FG001|Overall Study|Investigator Request|2|||
130264181|NCT00448448|468933325|FG000|Overall Study|Withdrawal by Subject|13|||
130264182|NCT00448448|468933326|FG001|Overall Study|Withdrawal by Subject|2|||
130264183|NCT00448448|468933325|FG000|Overall Study|On protocol when study ended|83|||
130264184|NCT00448448|468933326|FG001|Overall Study|On protocol when study ended|36|||
130264185|NCT00448448|468933325|FG000|Overall Study|Lost to Follow-up|2|||
130264186|NCT00448448|468933326|FG001|Overall Study|Lost to Follow-up|1|||
130264187|NCT00448448|468933325|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
130264188|NCT00448448|468933326|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
130264189|NCT00448448|468933325|FG000|Overall Study|Signed consent lost|0|||
130264190|NCT00448448|468933326|FG001|Overall Study|Signed consent lost|1|||
130264191|NCT02284191|468933327|FG000|Overall Study|Withdrawal by Subject|1|||
130264192|NCT02284191|468933328|FG001|Overall Study|Withdrawal by Subject|3|||
130264193|NCT02284191|468933327|FG000|Overall Study|Lost to Follow-up|1|||
130264194|NCT02284191|468933328|FG001|Overall Study|Lost to Follow-up|0|||
130264195|NCT01832727|468933331|FG000|Overall Study|Adverse Event|4|||
130264196|NCT01832727|468933332|FG001|Overall Study|Adverse Event|6|||
130264197|NCT01832727|468933333|FG002|Overall Study|Adverse Event|1|||
130264198|NCT01832727|468933334|FG003|Overall Study|Adverse Event|0|||
130264199|NCT01832727|468933335|FG004|Overall Study|Adverse Event|1|||
130264200|NCT01832727|468933336|FG005|Overall Study|Adverse Event|1|||
130264201|NCT01832727|468933337|FG006|Overall Study|Adverse Event|2|||
130264202|NCT01832727|468933338|FG007|Overall Study|Adverse Event|1|||
130264203|NCT01832727|468933339|FG008|Overall Study|Adverse Event|9|||
130264204|NCT01832727|468933331|FG000|Overall Study|Disease progression|3|||
130264205|NCT01832727|468933332|FG001|Overall Study|Disease progression|0|||
130264206|NCT01832727|468933333|FG002|Overall Study|Disease progression|2|||
130264207|NCT01832727|468933334|FG003|Overall Study|Disease progression|1|||
130264208|NCT01832727|468933335|FG004|Overall Study|Disease progression|3|||
130264209|NCT01832727|468933336|FG005|Overall Study|Disease progression|3|||
130264210|NCT01832727|468933337|FG006|Overall Study|Disease progression|6|||
130264211|NCT01832727|468933338|FG007|Overall Study|Disease progression|2|||
130264212|NCT01832727|468933339|FG008|Overall Study|Disease progression|7|||
130264213|NCT01832727|468933331|FG000|Overall Study|Lost to Follow-up|0|||
130264214|NCT01832727|468933332|FG001|Overall Study|Lost to Follow-up|0|||
130264215|NCT01832727|468933333|FG002|Overall Study|Lost to Follow-up|0|||
130264216|NCT01832727|468933334|FG003|Overall Study|Lost to Follow-up|1|||
130264217|NCT01832727|468933335|FG004|Overall Study|Lost to Follow-up|0|||
130264218|NCT01832727|468933336|FG005|Overall Study|Lost to Follow-up|0|||
130264219|NCT01832727|468933337|FG006|Overall Study|Lost to Follow-up|0|||
130264220|NCT01832727|468933338|FG007|Overall Study|Lost to Follow-up|0|||
130264221|NCT01832727|468933339|FG008|Overall Study|Lost to Follow-up|0|||
130264222|NCT01832727|468933331|FG000|Overall Study|Physician Decision|1|||
130264223|NCT01832727|468933332|FG001|Overall Study|Physician Decision|0|||
130264224|NCT01832727|468933333|FG002|Overall Study|Physician Decision|0|||
130264225|NCT01832727|468933334|FG003|Overall Study|Physician Decision|1|||
130264226|NCT01832727|468933335|FG004|Overall Study|Physician Decision|0|||
130264227|NCT01832727|468933336|FG005|Overall Study|Physician Decision|1|||
130264228|NCT01832727|468933337|FG006|Overall Study|Physician Decision|0|||
130264229|NCT01832727|468933338|FG007|Overall Study|Physician Decision|0|||
130264230|NCT01832727|468933339|FG008|Overall Study|Physician Decision|0|||
130264231|NCT01832727|468933331|FG000|Overall Study|Withdrawal by Subject|1|||
130264232|NCT01832727|468933332|FG001|Overall Study|Withdrawal by Subject|1|||
130264233|NCT01832727|468933333|FG002|Overall Study|Withdrawal by Subject|0|||
130264234|NCT01832727|468933334|FG003|Overall Study|Withdrawal by Subject|1|||
130264235|NCT01832727|468933335|FG004|Overall Study|Withdrawal by Subject|0|||
130264236|NCT01832727|468933336|FG005|Overall Study|Withdrawal by Subject|1|||
130264237|NCT01832727|468933337|FG006|Overall Study|Withdrawal by Subject|0|||
130264238|NCT01832727|468933338|FG007|Overall Study|Withdrawal by Subject|2|||
130264239|NCT01832727|468933339|FG008|Overall Study|Withdrawal by Subject|1|||
130264240|NCT01832727|468933331|FG000|Overall Study|Study terminated by sponsor|0|||
130264241|NCT01832727|468933332|FG001|Overall Study|Study terminated by sponsor|0|||
130264242|NCT01832727|468933333|FG002|Overall Study|Study terminated by sponsor|0|||
130102453|NCT03186794|468332735|FG000|Overall Study|Physician Decision|2|||
130264243|NCT01832727|468933334|FG003|Overall Study|Study terminated by sponsor|0|||
130264244|NCT01832727|468933335|FG004|Overall Study|Study terminated by sponsor|0|||
130102454|NCT03186794|468332735|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
130264245|NCT01832727|468933336|FG005|Overall Study|Study terminated by sponsor|0|||
130264246|NCT01832727|468933337|FG006|Overall Study|Study terminated by sponsor|0|||
130102455|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
130264247|NCT01832727|468933338|FG007|Overall Study|Study terminated by sponsor|1|||
130102456|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
130264248|NCT01832727|468933339|FG008|Overall Study|Study terminated by sponsor|1|||
130102457|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Death|5|||
130264249|NCT02216526|468933340|FG000|Overall Study|Adverse Event|1|||
130264250|NCT02216526|468933341|FG001|Overall Study|Adverse Event|1|||
130264251|NCT02216526|468933342|FG002|Overall Study|Adverse Event|0|||
130264252|NCT02216526|468933340|FG000|Overall Study|Death|0|||
130264253|NCT02216526|468933341|FG001|Overall Study|Death|1|||
130264254|NCT02216526|468933342|FG002|Overall Study|Death|3|||
130264255|NCT02216526|468933340|FG000|Overall Study|Protocol Violation|2|||
130264256|NCT02216526|468933341|FG001|Overall Study|Protocol Violation|0|||
130264257|NCT02216526|468933342|FG002|Overall Study|Protocol Violation|2|||
130264258|NCT02216526|468933340|FG000|Overall Study|Hospitalization|2|||
130264259|NCT02216526|468933341|FG001|Overall Study|Hospitalization|1|||
130264260|NCT02216526|468933342|FG002|Overall Study|Hospitalization|3|||
130264261|NCT01133847|468933349|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
130264262|NCT01133847|468933350|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
130264263|NCT01133847|468933351|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
130264264|NCT01133847|468933349|FG000|Follow-Up Phase|Lost to Follow-up|1|||
130264265|NCT01133847|468933350|FG001|Follow-Up Phase|Lost to Follow-up|3|||
130264266|NCT01133847|468933351|FG002|Follow-Up Phase|Lost to Follow-up|7|||
130264267|NCT04436744|468933352|FG000|Overall Study|Adverse Event|1|||
130264268|NCT04436744|468933353|FG001|Overall Study|Adverse Event|1|||
130264269|NCT04436744|468933352|FG000|Overall Study|Death|1|||
130264270|NCT04436744|468933353|FG001|Overall Study|Death|0|||
130264271|NCT04436744|468933352|FG000|Overall Study|Lost to Follow-up|0|||
130264272|NCT04436744|468933353|FG001|Overall Study|Lost to Follow-up|2|||
130264273|NCT04436744|468933352|FG000|Overall Study|Physician Decision|0|||
130264274|NCT04436744|468933353|FG001|Overall Study|Physician Decision|1|||
130264275|NCT04436744|468933352|FG000|Overall Study|Progressive Disease|0|||
130264276|NCT04436744|468933353|FG001|Overall Study|Progressive Disease|4|||
130264277|NCT04436744|468933352|FG000|Overall Study|Protocol Deviation|1|||
130264278|NCT04436744|468933353|FG001|Overall Study|Protocol Deviation|1|||
130264279|NCT04436744|468933352|FG000|Overall Study|Withdrawal by Subject|1|||
130264280|NCT04436744|468933353|FG001|Overall Study|Withdrawal by Subject|2|||
130264281|NCT01463033|468933354|FG000|Overall Study|Lost to Follow-up|4|||
130264282|NCT01463033|468933355|FG001|Overall Study|Lost to Follow-up|4|||
130264283|NCT01463033|468933354|FG000|Overall Study|Death|3|||
130264284|NCT01463033|468933355|FG001|Overall Study|Death|2|||
130264285|NCT00967616|468933356|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
130264286|NCT00967616|468933357|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
130264287|NCT00967616|468933356|FG000|Overall Study|Death|0|||
130264288|NCT00967616|468933357|FG001|Overall Study|Death|3|||
130264289|NCT00967616|468933356|FG000|Overall Study|Withdrawal by Subject|8|||
130264290|NCT00967616|468933357|FG001|Overall Study|Withdrawal by Subject|4|||
130264291|NCT00967616|468933356|FG000|Overall Study|Progressive Disease|31|||
130264292|NCT00967616|468933357|FG001|Overall Study|Progressive Disease|18|||
130264293|NCT00967616|468933356|FG000|Overall Study|Other|8|||
130264294|NCT00967616|468933357|FG001|Overall Study|Other|8|||
130264295|NCT00967616|468933356|FG000|Overall Study|Protocol Violation|1|||
130264296|NCT00967616|468933357|FG001|Overall Study|Protocol Violation|0|||
130264297|NCT00575666|468933358|FG000|Overall Study|Withdrawal by Subject|3|||
130264298|NCT00575666|468933359|FG001|Overall Study|Withdrawal by Subject|2|||
130264299|NCT00575666|468933358|FG000|Overall Study|Physician Decision|1|||
130264300|NCT00575666|468933359|FG001|Overall Study|Physician Decision|1|||
130264301|NCT01368614|468933360|FG000|Screening Period|Screen Failure|58|||
130264302|NCT01368614|468933361|FG001|Screening Period|Screen Failure|0|||
130264303|NCT01368614|468933362|FG002|Screening Period|Screen Failure|0|||
130264304|NCT01368614|468933363|FG003|Screening Period|Screen Failure|0|||
130264305|NCT01368614|468933360|FG000|Study Period|Withdrawal by Subject|0|||
130264306|NCT01368614|468933361|FG001|Study Period|Withdrawal by Subject|1|||
130264307|NCT01368614|468933362|FG002|Study Period|Withdrawal by Subject|1|||
130264308|NCT01368614|468933363|FG003|Study Period|Withdrawal by Subject|3|||
130264309|NCT01368614|468933360|FG000|Study Period|Lost to Follow-up|0|||
130264310|NCT01368614|468933361|FG001|Study Period|Lost to Follow-up|0|||
130264311|NCT01368614|468933362|FG002|Study Period|Lost to Follow-up|1|||
130264312|NCT01368614|468933363|FG003|Study Period|Lost to Follow-up|0|||
130264313|NCT02951780|468933364|FG000|Period 1|Adverse Event|0|||
130264314|NCT02951780|468933365|FG001|Period 1|Adverse Event|0|||
130264315|NCT02951780|468933366|FG002|Period 1|Adverse Event|0|||
129885624|NCT02855164|467540774|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
129885625|NCT02855164|467540775|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
130102458|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Death|2|||
130264316|NCT02951780|468933367|FG003|Period 1|Adverse Event|1|||
130264317|NCT02951780|468933368|FG004|Period 1|Adverse Event|0|||
130264318|NCT02951780|468933369|FG005|Period 1|Adverse Event|0|||
130264319|NCT02951780|468933370|FG006|Period 1|Adverse Event|0|||
130264320|NCT02951780|468933371|FG007|Period 1|Adverse Event|0|||
130264321|NCT02951780|468933372|FG008|Period 1|Adverse Event|0|||
130264322|NCT02951780|468933364|FG000|Period 1|Scheduling Conflicts|0|||
130102459|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
130264323|NCT02951780|468933365|FG001|Period 1|Scheduling Conflicts|0|||
130264324|NCT02951780|468933366|FG002|Period 1|Scheduling Conflicts|0|||
130264325|NCT02951780|468933367|FG003|Period 1|Scheduling Conflicts|0|||
130264326|NCT02951780|468933368|FG004|Period 1|Scheduling Conflicts|0|||
130264327|NCT02951780|468933369|FG005|Period 1|Scheduling Conflicts|0|||
130264328|NCT02951780|468933370|FG006|Period 1|Scheduling Conflicts|0|||
130264329|NCT02951780|468933371|FG007|Period 1|Scheduling Conflicts|1|||
130264330|NCT02951780|468933372|FG008|Period 1|Scheduling Conflicts|0|||
130264331|NCT02951780|468933364|FG000|Period 2|Scheduling Conflicts|0|||
130264332|NCT02951780|468933365|FG001|Period 2|Scheduling Conflicts|0|||
130264333|NCT02951780|468933366|FG002|Period 2|Scheduling Conflicts|0|||
130264334|NCT02951780|468933367|FG003|Period 2|Scheduling Conflicts|0|||
130264335|NCT02951780|468933368|FG004|Period 2|Scheduling Conflicts|0|||
130264336|NCT02951780|468933369|FG005|Period 2|Scheduling Conflicts|0|||
130264337|NCT02951780|468933370|FG006|Period 2|Scheduling Conflicts|0|||
130264338|NCT02951780|468933371|FG007|Period 2|Scheduling Conflicts|1|||
130264339|NCT02951780|468933372|FG008|Period 2|Scheduling Conflicts|0|||
130264340|NCT01374425|468933373|FG000|Overall Study|Radiographic Disease Progression|86|||
130264341|NCT01374425|468933374|FG001|Overall Study|Radiographic Disease Progression|81|||
130264342|NCT01374425|468933373|FG000|Overall Study|Clinical Disease Progression|9|||
130264343|NCT01374425|468933374|FG001|Overall Study|Clinical Disease Progression|6|||
130264344|NCT01374425|468933373|FG000|Overall Study|Adverse Event|29|||
130264345|NCT01374425|468933374|FG001|Overall Study|Adverse Event|18|||
130264346|NCT01374425|468933373|FG000|Overall Study|Death (Progression of Disease)|1|||
130264347|NCT01374425|468933374|FG001|Overall Study|Death (Progression of Disease)|0|||
130264348|NCT01374425|468933373|FG000|Overall Study|Death (Adverse Event)|2|||
130264349|NCT01374425|468933374|FG001|Overall Study|Death (Adverse Event)|4|||
130264350|NCT01374425|468933373|FG000|Overall Study|Withdrawal by Subject|6|||
130264351|NCT01374425|468933374|FG001|Overall Study|Withdrawal by Subject|7|||
130264352|NCT01374425|468933373|FG000|Overall Study|Refused Treatment|10|||
130264353|NCT01374425|468933374|FG001|Overall Study|Refused Treatment|24|||
130264354|NCT01374425|468933373|FG000|Overall Study|Protocol Violation|2|||
130264355|NCT01374425|468933374|FG001|Overall Study|Protocol Violation|3|||
130264356|NCT01374425|468933373|FG000|Overall Study|Sponsor Decision|0|||
130264357|NCT01374425|468933374|FG001|Overall Study|Sponsor Decision|1|||
130264358|NCT01374425|468933373|FG000|Overall Study|Lost to Follow-up|2|||
130264359|NCT01374425|468933374|FG001|Overall Study|Lost to Follow-up|1|||
130264360|NCT01374425|468933373|FG000|Overall Study|Other|41|||
130264361|NCT01374425|468933374|FG001|Overall Study|Other|43|||
130264362|NCT02359903|468933375|FG000|Overall Study|Adverse Event|0|||
130264363|NCT02359903|468933376|FG001|Overall Study|Adverse Event|2|||
130264364|NCT03783780|468933384|FG000|Overall Study|Withdrawn prior to completion|1|||
130264365|NCT02629861|468933387|FG000|Overall Study|Adverse Event|7|||
130264366|NCT02629861|468933388|FG001|Overall Study|Adverse Event|5|||
130264367|NCT02629861|468933389|FG002|Overall Study|Adverse Event|4|||
130264368|NCT02629861|468933387|FG000|Overall Study|Withdrawal by Subject|5|||
130264369|NCT02629861|468933388|FG001|Overall Study|Withdrawal by Subject|8|||
130264370|NCT02629861|468933389|FG002|Overall Study|Withdrawal by Subject|13|||
130264371|NCT02629861|468933387|FG000|Overall Study|Protocol Violation|2|||
130035609|NCT02601950|468085998|FG006|Overall Study|Disease progression - clinical|5|||
130035610|NCT02601950|468085999|FG007|Overall Study|Disease progression - clinical|1|||
130264372|NCT02629861|468933388|FG001|Overall Study|Protocol Violation|3|||
130264373|NCT02629861|468933389|FG002|Overall Study|Protocol Violation|7|||
130264374|NCT02629861|468933387|FG000|Overall Study|Lost to Follow-up|12|||
130264375|NCT02629861|468933388|FG001|Overall Study|Lost to Follow-up|9|||
130264376|NCT02629861|468933389|FG002|Overall Study|Lost to Follow-up|4|||
130264377|NCT02629861|468933387|FG000|Overall Study|Other|1|||
130264378|NCT02629861|468933388|FG001|Overall Study|Other|1|||
130264379|NCT02629861|468933389|FG002|Overall Study|Other|0|||
130264380|NCT02629861|468933387|FG000|Overall Study|Pregnancy|2|||
130035611|NCT02601950|468085992|FG000|Overall Study|Death|6|||
130264381|NCT02629861|468933388|FG001|Overall Study|Pregnancy|1|||
130264382|NCT02629861|468933389|FG002|Overall Study|Pregnancy|0|||
130264383|NCT00907621|468933390|FG000|Overall Study|Lost to Follow-up|6|||
130264384|NCT00907621|468933391|FG001|Overall Study|Lost to Follow-up|3|||
130264385|NCT00907621|468933390|FG000|Overall Study|intercurrent febrile illness|1|||
130264386|NCT00907621|468933391|FG001|Overall Study|intercurrent febrile illness|1|||
130035612|NCT02601950|468085993|FG001|Overall Study|Death|0|||
130035613|NCT02601950|468085994|FG002|Overall Study|Death|3|||
130264387|NCT01816048|468933394|FG000|Overall Study|Adverse Event|1|||
130264388|NCT01816048|468933394|FG000|Overall Study|Death|1|||
130264389|NCT01816048|468933394|FG000|Overall Study|Withdrawal by Subject|1|||
130264390|NCT01816048|468933394|FG000|Overall Study|Disease Progression|3|||
130264391|NCT03069716|468933395|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
130264392|NCT03069716|468933396|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
130264393|NCT03069716|468933397|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
130264394|NCT03069716|468933395|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
130264395|NCT03069716|468933396|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
130264396|NCT03069716|468933397|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
130264397|NCT03069716|468933395|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
130035614|NCT02601950|468085995|FG003|Overall Study|Death|1|||
130035615|NCT02601950|468085996|FG004|Overall Study|Death|4|||
130035616|NCT02601950|468085997|FG005|Overall Study|Death|1|||
130035617|NCT02601950|468085998|FG006|Overall Study|Death|0|||
130035618|NCT02601950|468085999|FG007|Overall Study|Death|0|||
130264398|NCT03069716|468933396|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130264399|NCT03069716|468933397|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130264400|NCT03069716|468933395|FG000|Randomized Treatment|Withdrawal by Subject|0|||
130264401|NCT03069716|468933396|FG001|Randomized Treatment|Withdrawal by Subject|2|||
130264402|NCT03069716|468933397|FG002|Randomized Treatment|Withdrawal by Subject|0|||
130264403|NCT01088906|468933401|FG000|Overall Study|Inclusion error|1|||
130035619|NCT02601950|468085992|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130035620|NCT02601950|468085993|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130035621|NCT02601950|468085994|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130035622|NCT02601950|468085995|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130035623|NCT02601950|468085996|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130035624|NCT02601950|468085997|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
130035625|NCT02601950|468085998|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130264404|NCT01088906|468933401|FG000|Overall Study|Did not receive study treatment|3|||
130035626|NCT02601950|468085999|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
130264405|NCT01088906|468933401|FG000|Overall Study|Missing data|1|||
130264406|NCT00457626|468933402|FG000|Overall Study|Adverse Event|3|||
130264407|NCT00457626|468933402|FG000|Overall Study|Administrative Problems|2|||
130264408|NCT00457626|468933402|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
130035627|NCT02601950|468085992|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
130035628|NCT02601950|468085993|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
130035629|NCT02601950|468085994|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
130035630|NCT02601950|468085995|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
130035631|NCT02601950|468085996|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
130035632|NCT02601950|468085997|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
130035633|NCT02601950|468085998|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
130035634|NCT02601950|468085999|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
130102460|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
130264409|NCT03384875|468933403|FG000|Overall Study|Death|1|||
130264410|NCT03384875|468933404|FG001|Overall Study|Death|1|||
130264411|NCT03384875|468933405|FG002|Overall Study|Death|0|||
130264412|NCT03384875|468933403|FG000|Overall Study|Reason not provided|1|||
130264413|NCT03384875|468933404|FG001|Overall Study|Reason not provided|0|||
130264414|NCT03384875|468933405|FG002|Overall Study|Reason not provided|0|||
130264415|NCT03549338|468935539|FG000|Overall Study|Progressive Disease|1|||
130264416|NCT03549338|468935540|FG001|Overall Study|Progressive Disease|0|||
130102461|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
130102462|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
130264417|NCT03549338|468935541|FG002|Overall Study|Progressive Disease|0|||
130264418|NCT03549338|468935539|FG000|Overall Study|Clinical Progression|0|||
130264419|NCT03549338|468935540|FG001|Overall Study|Clinical Progression|1|||
130264420|NCT03549338|468935541|FG002|Overall Study|Clinical Progression|0|||
130264421|NCT01944020|468935543|FG000|Overall Study|Withdrawal by Subject|5|||
130264422|NCT01944020|468935544|FG001|Overall Study|Withdrawal by Subject|0|||
130264423|NCT03257358|468935549|FG000|Overall Study|Adverse Event|25|||
130264424|NCT03257358|468935550|FG001|Overall Study|Adverse Event|12|||
130264425|NCT03257358|468935549|FG000|Overall Study|Lack of Efficacy|1|||
130264426|NCT03257358|468935550|FG001|Overall Study|Lack of Efficacy|1|||
130264427|NCT03257358|468935549|FG000|Overall Study|Lost to Follow-up|12|||
130264428|NCT03257358|468935550|FG001|Overall Study|Lost to Follow-up|4|||
130264429|NCT03257358|468935549|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
130264430|NCT03257358|468935550|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
130264431|NCT03257358|468935549|FG000|Overall Study|Physician Decision|2|||
130264432|NCT03257358|468935550|FG001|Overall Study|Physician Decision|2|||
130264433|NCT03257358|468935549|FG000|Overall Study|Protocol Violation|5|||
130264434|NCT03257358|468935550|FG001|Overall Study|Protocol Violation|3|||
130264435|NCT03257358|468935549|FG000|Overall Study|Technical problems|4|||
130264436|NCT03257358|468935550|FG001|Overall Study|Technical problems|1|||
130264437|NCT03257358|468935549|FG000|Overall Study|Withdrawal by Subject|8|||
130264438|NCT03257358|468935550|FG001|Overall Study|Withdrawal by Subject|3|||
130264439|NCT03257358|468935549|FG000|Overall Study|Withdrawal of informed consent|9|||
130264440|NCT03257358|468935550|FG001|Overall Study|Withdrawal of informed consent|5|||
130264441|NCT03257358|468935549|FG000|Overall Study|New therapy for study indication|1|||
130264442|NCT03257358|468935550|FG001|Overall Study|New therapy for study indication|0|||
130264443|NCT03257358|468935549|FG000|Overall Study|No longer requires treatment|0|||
130264444|NCT03257358|468935550|FG001|Overall Study|No longer requires treatment|1|||
130264445|NCT01977898|468935551|FG000|Overall Study|Non functioning catheter|1|||
130264446|NCT01977898|468935552|FG001|Overall Study|Non functioning catheter|1|||
130264447|NCT01049373|468935553|FG000|Overall Study|Protocol Violation|9|||
130264448|NCT01049373|468935554|FG001|Overall Study|Protocol Violation|9|||
130264449|NCT01049373|468935553|FG000|Overall Study|Withdrawal by Subject|8|||
130264450|NCT01049373|468935554|FG001|Overall Study|Withdrawal by Subject|5|||
130264451|NCT01049373|468935553|FG000|Overall Study|Adverse Event|3|||
130264452|NCT01049373|468935554|FG001|Overall Study|Adverse Event|3|||
130264453|NCT01049373|468935553|FG000|Overall Study|Lost to Follow-up|9|||
130264454|NCT01049373|468935554|FG001|Overall Study|Lost to Follow-up|4|||
130264455|NCT01049373|468935553|FG000|Overall Study|no evaluable study values|9|||
130264456|NCT01049373|468935554|FG001|Overall Study|no evaluable study values|21|||
130264457|NCT01049373|468935553|FG000|Overall Study|Other|1|||
130264458|NCT01049373|468935554|FG001|Overall Study|Other|1|||
130264459|NCT01049373|468935553|FG000|Overall Study|Non-cooperation|0|||
130264460|NCT01049373|468935554|FG001|Overall Study|Non-cooperation|1|||
130264461|NCT02391311|468935555|FG000|Overall Study|Lost to Follow-up|2|||
130264462|NCT02391311|468935556|FG001|Overall Study|Lost to Follow-up|1|||
130264463|NCT02391311|468935555|FG000|Overall Study|deemed ineligible after baseline|1|||
130264464|NCT02391311|468935556|FG001|Overall Study|deemed ineligible after baseline|1|||
130264465|NCT02897115|468935557|FG000|Overall Study|Early termination of study by sponsor|11|||
130264466|NCT02897115|468935558|FG001|Overall Study|Early termination of study by sponsor|8|||
130264467|NCT00487981|468935559|FG000|Overall Study|Hypothyroidism diagnosis|1|||
130264468|NCT00856323|468935560|FG000|Overall Study|Withdrawal by Subject|2|||
130264469|NCT02808429|468935565|FG000|Overall Study|Lost to Follow-up|1|||
130264470|NCT02808429|468935566|FG001|Overall Study|Lost to Follow-up|0|||
130264471|NCT02808429|468935567|FG002|Overall Study|Lost to Follow-up|0|||
130264472|NCT02808429|468935565|FG000|Overall Study|Protocol Violation|0|||
130264473|NCT02808429|468935566|FG001|Overall Study|Protocol Violation|1|||
130264474|NCT02808429|468935567|FG002|Overall Study|Protocol Violation|0|||
130264475|NCT02808429|468935565|FG000|Overall Study|Premature study termination by sponsor|2|||
130264476|NCT02808429|468935566|FG001|Overall Study|Premature study termination by sponsor|0|||
130264477|NCT02808429|468935567|FG002|Overall Study|Premature study termination by sponsor|1|||
130264478|NCT02808429|468935565|FG000|Overall Study|Relocation|0|||
130264479|NCT02808429|468935566|FG001|Overall Study|Relocation|0|||
130264480|NCT02808429|468935567|FG002|Overall Study|Relocation|1|||
130264481|NCT00811954|468935573|FG000|Overall Study|Death|10|||
130264482|NCT00811954|468935574|FG001|Overall Study|Death|6|||
130264483|NCT00811954|468935575|FG002|Overall Study|Death|13|||
130264484|NCT00811954|468935573|FG000|Overall Study|Lost to Follow-up|29|||
130264485|NCT00811954|468935574|FG001|Overall Study|Lost to Follow-up|23|||
130264486|NCT00811954|468935575|FG002|Overall Study|Lost to Follow-up|34|||
130264487|NCT00811954|468935573|FG000|Overall Study|Not able to get to clinic|28|||
130264488|NCT00811954|468935574|FG001|Overall Study|Not able to get to clinic|35|||
130264489|NCT00811954|468935575|FG002|Overall Study|Not able to get to clinic|30|||
130264490|NCT00811954|468935573|FG000|Overall Study|Not willing to adhere to requirements|12|||
130264491|NCT00811954|468935574|FG001|Overall Study|Not willing to adhere to requirements|2|||
130264492|NCT00811954|468935575|FG002|Overall Study|Not willing to adhere to requirements|16|||
130264493|NCT00811954|468935573|FG000|Overall Study|Withdraw consent prior study completion|4|||
130264494|NCT00811954|468935574|FG001|Overall Study|Withdraw consent prior study completion|6|||
130264495|NCT00811954|468935575|FG002|Overall Study|Withdraw consent prior study completion|5|||
130264496|NCT00811954|468935573|FG000|Overall Study|Site Closure|4|||
130264497|NCT00811954|468935574|FG001|Overall Study|Site Closure|0|||
130264498|NCT00811954|468935575|FG002|Overall Study|Site Closure|1|||
130264499|NCT00811954|468935573|FG000|Overall Study|Severe Debilitation|2|||
130264500|NCT00811954|468935574|FG001|Overall Study|Severe Debilitation|0|||
130264501|NCT00811954|468935575|FG002|Overall Study|Severe Debilitation|1|||
130264502|NCT00811954|468935573|FG000|Overall Study|Complete Protocol: No follow-up|0|||
130264503|NCT00811954|468935574|FG001|Overall Study|Complete Protocol: No follow-up|0|||
130264504|NCT00811954|468935575|FG002|Overall Study|Complete Protocol: No follow-up|1|||
130264505|NCT01063348|468935578|FG000|Overall Study|Lost to Follow-up|3|||
130264506|NCT01063348|468935579|FG001|Overall Study|Lost to Follow-up|10|||
130035635|NCT02601950|468085992|FG000|Overall Study|Non-compliance|0|||
130035636|NCT02601950|468085993|FG001|Overall Study|Non-compliance|1|||
130035637|NCT02601950|468085994|FG002|Overall Study|Non-compliance|0|||
130035638|NCT02601950|468085995|FG003|Overall Study|Non-compliance|0|||
130035639|NCT02601950|468085996|FG004|Overall Study|Non-compliance|0|||
130264507|NCT05518461|468935580|FG000|Overall Study|Lost to Follow-up|25|||
130264508|NCT04828707|468935581|FG000|Overall Study|Lost to Follow-up|3|||
130264509|NCT04828707|468935582|FG001|Overall Study|Lost to Follow-up|2|||
130264510|NCT04828707|468935581|FG000|Overall Study|Withdrawal by Subject|2|||
130264511|NCT04828707|468935582|FG001|Overall Study|Withdrawal by Subject|1|||
130264512|NCT03139448|468935583|FG000|Overall Study|Lack of Efficacy|6|||
130264513|NCT03139448|468935584|FG001|Overall Study|Lack of Efficacy|7|||
130264514|NCT03139448|468935583|FG000|Overall Study|Location of procedure changed|2|||
130264515|NCT03139448|468935584|FG001|Overall Study|Location of procedure changed|8|||
130264516|NCT03139448|468935583|FG000|Overall Study|Withdrawal by Subject|3|||
130264517|NCT03139448|468935584|FG001|Overall Study|Withdrawal by Subject|6|||
130264518|NCT03139448|468935583|FG000|Overall Study|Screen fail|1|||
130264519|NCT03139448|468935584|FG001|Overall Study|Screen fail|3|||
130264520|NCT03139448|468935583|FG000|Overall Study|Physician Decision|0|||
130264521|NCT03139448|468935584|FG001|Overall Study|Physician Decision|2|||
130264522|NCT00523978|468935587|FG000|Overall Study|Withdrawal by Subject|3|||
130264523|NCT00523978|468935588|FG001|Overall Study|Withdrawal by Subject|7|||
130264524|NCT00523978|468935587|FG000|Overall Study|Screen Failures|5|||
130264525|NCT00523978|468935588|FG001|Overall Study|Screen Failures|1|||
130264526|NCT00523978|468935587|FG000|Overall Study|Death|1|||
130264527|NCT00523978|468935588|FG001|Overall Study|Death|0|||
130264528|NCT00501644|468935590|FG000|Overall Study|Adverse Event|4|||
130264529|NCT00501644|468935590|FG000|Overall Study|Withdrawal by Subject|1|||
130264530|NCT02750514|468935591|FG000|Track 1|Disease progression|20|||
130264531|NCT02750514|468935592|FG001|Track 1|Disease progression|1|||
130264532|NCT02750514|468935593|FG002|Track 1|Disease progression|0|||
130264533|NCT02750514|468935594|FG003|Track 1|Disease progression|1|||
130264534|NCT02750514|468935595|FG004|Track 1|Disease progression|0|||
130264535|NCT02750514|468935591|FG000|Track 1|Adverse event unrelated to study drug|1|||
130264536|NCT02750514|468935592|FG001|Track 1|Adverse event unrelated to study drug|0|||
130264537|NCT02750514|468935593|FG002|Track 1|Adverse event unrelated to study drug|0|||
130264538|NCT02750514|468935594|FG003|Track 1|Adverse event unrelated to study drug|0|||
130264539|NCT02750514|468935595|FG004|Track 1|Adverse event unrelated to study drug|0|||
130264540|NCT02750514|468935591|FG000|Track 1|Study drug toxicity|4|||
130264541|NCT02750514|468935592|FG001|Track 1|Study drug toxicity|1|||
130264542|NCT02750514|468935593|FG002|Track 1|Study drug toxicity|0|||
130264543|NCT02750514|468935594|FG003|Track 1|Study drug toxicity|1|||
130264544|NCT02750514|468935595|FG004|Track 1|Study drug toxicity|0|||
130264545|NCT02750514|468935591|FG000|Track 1|Participant request to discontinue|1|||
130264546|NCT02750514|468935592|FG001|Track 1|Participant request to discontinue|0|||
130264547|NCT02750514|468935593|FG002|Track 1|Participant request to discontinue|0|||
130264548|NCT02750514|468935594|FG003|Track 1|Participant request to discontinue|0|||
130264549|NCT02750514|468935595|FG004|Track 1|Participant request to discontinue|0|||
130264550|NCT02750514|468935591|FG000|Track 1|Other reasons|1|||
130264551|NCT02750514|468935592|FG001|Track 1|Other reasons|0|||
130264552|NCT02750514|468935593|FG002|Track 1|Other reasons|0|||
130264553|NCT02750514|468935594|FG003|Track 1|Other reasons|0|||
130264554|NCT02750514|468935595|FG004|Track 1|Other reasons|0|||
130264555|NCT02750514|468935591|FG000|Track 2|Disease progression|4|||
130264556|NCT02750514|468935592|FG001|Track 2|Disease progression|5|||
130264557|NCT02750514|468935593|FG002|Track 2|Disease progression|2|||
130264558|NCT02750514|468935594|FG003|Track 2|Disease progression|5|||
130264559|NCT02750514|468935595|FG004|Track 2|Disease progression|0|||
130264560|NCT02750514|468935591|FG000|Track 2|Adverse event unrelated to study drug|1|||
130264561|NCT02750514|468935592|FG001|Track 2|Adverse event unrelated to study drug|0|||
130264562|NCT02750514|468935593|FG002|Track 2|Adverse event unrelated to study drug|0|||
130264563|NCT02750514|468935594|FG003|Track 2|Adverse event unrelated to study drug|0|||
130264564|NCT02750514|468935595|FG004|Track 2|Adverse event unrelated to study drug|0|||
130264565|NCT02750514|468935591|FG000|Track 2|Study drug toxicity|1|||
130264566|NCT02750514|468935592|FG001|Track 2|Study drug toxicity|2|||
130264567|NCT02750514|468935593|FG002|Track 2|Study drug toxicity|0|||
130264568|NCT02750514|468935594|FG003|Track 2|Study drug toxicity|2|||
130264569|NCT02750514|468935595|FG004|Track 2|Study drug toxicity|0|||
129885626|NCT02855164|467540776|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130035640|NCT02601950|468085997|FG005|Overall Study|Non-compliance|1|||
130035641|NCT02601950|468085998|FG006|Overall Study|Non-compliance|1|||
130035642|NCT02601950|468085999|FG007|Overall Study|Non-compliance|0|||
130035643|NCT02601950|468085992|FG000|Overall Study|Participant refused further study treatment|0|||
130264570|NCT02750514|468935591|FG000|Track 2|Participant withdrew consent|0|||
130264571|NCT02750514|468935592|FG001|Track 2|Participant withdrew consent|1|||
130264572|NCT02750514|468935593|FG002|Track 2|Participant withdrew consent|0|||
130264573|NCT02750514|468935594|FG003|Track 2|Participant withdrew consent|0|||
130264574|NCT02750514|468935595|FG004|Track 2|Participant withdrew consent|0|||
130264575|NCT02750514|468935591|FG000|Track 3|Disease progression|0|||
130264576|NCT02750514|468935592|FG001|Track 3|Disease progression|24|||
130264577|NCT02750514|468935593|FG002|Track 3|Disease progression|13|||
130264578|NCT02750514|468935594|FG003|Track 3|Disease progression|14|||
130264579|NCT02750514|468935595|FG004|Track 3|Disease progression|0|||
130264580|NCT02750514|468935591|FG000|Track 3|Adverse event unrelated to study drug|0|||
130264581|NCT02750514|468935592|FG001|Track 3|Adverse event unrelated to study drug|1|||
130264582|NCT02750514|468935593|FG002|Track 3|Adverse event unrelated to study drug|1|||
130102463|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
130102464|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
130102465|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Relapse|1|||
130102466|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Relapse|0|||
130102467|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
130102468|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
130102469|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
130102470|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
130102471|NCT00111007|468332737|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
130102472|NCT00111007|468332738|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
130102473|NCT00111007|468332737|FG000|Active Follow-up|Adverse Event|1|||
130102474|NCT00111007|468332738|FG001|Active Follow-up|Adverse Event|0|||
130264583|NCT02750514|468935594|FG003|Track 3|Adverse event unrelated to study drug|1|||
130264584|NCT02750514|468935595|FG004|Track 3|Adverse event unrelated to study drug|0|||
130264585|NCT02750514|468935591|FG000|Track 3|Study drug toxicity|0|||
130264586|NCT02750514|468935592|FG001|Track 3|Study drug toxicity|3|||
130264587|NCT02750514|468935593|FG002|Track 3|Study drug toxicity|0|||
130264588|NCT02750514|468935594|FG003|Track 3|Study drug toxicity|1|||
130264589|NCT02750514|468935595|FG004|Track 3|Study drug toxicity|0|||
130264590|NCT02750514|468935591|FG000|Track 3|Participant request to discontinue|0|||
130264591|NCT02750514|468935592|FG001|Track 3|Participant request to discontinue|2|||
130264592|NCT02750514|468935593|FG002|Track 3|Participant request to discontinue|0|||
130264593|NCT02750514|468935594|FG003|Track 3|Participant request to discontinue|0|||
130264594|NCT02750514|468935595|FG004|Track 3|Participant request to discontinue|0|||
130264595|NCT02750514|468935591|FG000|Track 3|Participant withdrew consent|0|||
130264596|NCT02750514|468935592|FG001|Track 3|Participant withdrew consent|3|||
130264597|NCT02750514|468935593|FG002|Track 3|Participant withdrew consent|1|||
130264598|NCT02750514|468935594|FG003|Track 3|Participant withdrew consent|0|||
130264599|NCT02750514|468935595|FG004|Track 3|Participant withdrew consent|0|||
130264600|NCT02750514|468935591|FG000|Track 3|Other reasons|0|||
130264601|NCT02750514|468935592|FG001|Track 3|Other reasons|3|||
130264602|NCT02750514|468935593|FG002|Track 3|Other reasons|0|||
130264603|NCT02750514|468935594|FG003|Track 3|Other reasons|0|||
130264604|NCT02750514|468935595|FG004|Track 3|Other reasons|0|||
130264605|NCT02750514|468935591|FG000|Track 4|Study drug toxicity|0|||
130264606|NCT02750514|468935592|FG001|Track 4|Study drug toxicity|6|||
130264607|NCT02750514|468935593|FG002|Track 4|Study drug toxicity|0|||
130264608|NCT02750514|468935594|FG003|Track 4|Study drug toxicity|5|||
130264609|NCT02750514|468935595|FG004|Track 4|Study drug toxicity|0|||
130264610|NCT02750514|468935591|FG000|Track 4|Participant request to discontinue|0|||
130264611|NCT02750514|468935592|FG001|Track 4|Participant request to discontinue|1|||
130264612|NCT02750514|468935593|FG002|Track 4|Participant request to discontinue|0|||
130264613|NCT02750514|468935594|FG003|Track 4|Participant request to discontinue|1|||
130264614|NCT02750514|468935595|FG004|Track 4|Participant request to discontinue|0|||
130264615|NCT02750514|468935591|FG000|Track 4|Participant withdrew consent|0|||
130264616|NCT02750514|468935592|FG001|Track 4|Participant withdrew consent|1|||
130264617|NCT02750514|468935593|FG002|Track 4|Participant withdrew consent|0|||
130264618|NCT02750514|468935594|FG003|Track 4|Participant withdrew consent|0|||
130264619|NCT02750514|468935595|FG004|Track 4|Participant withdrew consent|0|||
130264620|NCT02750514|468935591|FG000|Track 4|Other reasons|0|||
130264621|NCT02750514|468935592|FG001|Track 4|Other reasons|5|||
130264622|NCT02750514|468935593|FG002|Track 4|Other reasons|0|||
130264623|NCT02750514|468935594|FG003|Track 4|Other reasons|3|||
130264624|NCT02750514|468935595|FG004|Track 4|Other reasons|0|||
130264625|NCT02750514|468935591|FG000|Track 4|Disease progression|0|||
130264626|NCT02750514|468935592|FG001|Track 4|Disease progression|33|||
130264627|NCT02750514|468935593|FG002|Track 4|Disease progression|0|||
129885627|NCT02855164|467540777|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
130264628|NCT02750514|468935594|FG003|Track 4|Disease progression|32|||
130264629|NCT02750514|468935595|FG004|Track 4|Disease progression|0|||
130264630|NCT02750514|468935591|FG000|Track 4|Adverse event unrelated to study drug|0|||
130264631|NCT02750514|468935592|FG001|Track 4|Adverse event unrelated to study drug|5|||
130264632|NCT02750514|468935593|FG002|Track 4|Adverse event unrelated to study drug|0|||
130264633|NCT02750514|468935594|FG003|Track 4|Adverse event unrelated to study drug|0|||
130264634|NCT02750514|468935595|FG004|Track 4|Adverse event unrelated to study drug|0|||
130264635|NCT02750514|468935591|FG000|Track 4|Death|0|||
130264636|NCT02750514|468935592|FG001|Track 4|Death|0|||
130264637|NCT02750514|468935593|FG002|Track 4|Death|0|||
130264638|NCT02750514|468935594|FG003|Track 4|Death|1|||
130264639|NCT02750514|468935595|FG004|Track 4|Death|0|||
130264640|NCT02750514|468935591|FG000|Track 5|Disease progression|0|||
130264641|NCT02750514|468935592|FG001|Track 5|Disease progression|0|||
130264642|NCT02750514|468935593|FG002|Track 5|Disease progression|0|||
130264643|NCT02750514|468935594|FG003|Track 5|Disease progression|0|||
130264644|NCT02750514|468935595|FG004|Track 5|Disease progression|34|||
130264645|NCT02750514|468935591|FG000|Track 5|Adverse event unrelated to study drug|0|||
130264646|NCT02750514|468935592|FG001|Track 5|Adverse event unrelated to study drug|0|||
130264647|NCT02750514|468935593|FG002|Track 5|Adverse event unrelated to study drug|0|||
130264648|NCT02750514|468935594|FG003|Track 5|Adverse event unrelated to study drug|0|||
130264649|NCT02750514|468935595|FG004|Track 5|Adverse event unrelated to study drug|2|||
130264650|NCT02750514|468935591|FG000|Track 5|Study drug toxicity|0|||
130264651|NCT02750514|468935592|FG001|Track 5|Study drug toxicity|0|||
130264652|NCT02750514|468935593|FG002|Track 5|Study drug toxicity|0|||
130264653|NCT02750514|468935594|FG003|Track 5|Study drug toxicity|0|||
130264654|NCT02750514|468935595|FG004|Track 5|Study drug toxicity|2|||
130264655|NCT02750514|468935591|FG000|Track 5|Participant request to discontinue|0|||
130264656|NCT02750514|468935592|FG001|Track 5|Participant request to discontinue|0|||
130264657|NCT02750514|468935593|FG002|Track 5|Participant request to discontinue|0|||
130264658|NCT02750514|468935594|FG003|Track 5|Participant request to discontinue|0|||
130264659|NCT02750514|468935595|FG004|Track 5|Participant request to discontinue|3|||
130264660|NCT02750514|468935591|FG000|Track 5|Other reasons|0|||
130264661|NCT02750514|468935592|FG001|Track 5|Other reasons|0|||
130264662|NCT02750514|468935593|FG002|Track 5|Other reasons|0|||
130264663|NCT02750514|468935594|FG003|Track 5|Other reasons|0|||
130264664|NCT02750514|468935595|FG004|Track 5|Other reasons|2|||
130264665|NCT02553629|468935596|FG000|Overall Study|Logistic reasons|3|||
130264666|NCT02553629|468935597|FG001|Overall Study|Logistic reasons|6|||
130264667|NCT01812057|468935598|FG000|Overall Study|Protocol Violation|1|||
130264668|NCT01812057|468935599|FG001|Overall Study|Protocol Violation|0|||
130264669|NCT01812057|468935598|FG000|Overall Study|Physician Decision|1|||
130264670|NCT01812057|468935599|FG001|Overall Study|Physician Decision|0|||
130264671|NCT00696878|468935602|FG000|Overall Study|Adverse Event|8|||
130264672|NCT00696878|468935602|FG000|Overall Study|Withdrawal by Subject|87|||
130264673|NCT00696878|468935602|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
130264674|NCT00696878|468935602|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
130264675|NCT00696878|468935602|FG000|Overall Study|Trial stopped|32|||
130264676|NCT00696878|468935602|FG000|Overall Study|Other reason (not specified)|55|||
130264677|NCT02259114|468935603|FG000|Overall Study|Progressive Disease|14|||
130264678|NCT02259114|468935604|FG001|Overall Study|Progressive Disease|2|||
130264679|NCT02259114|468935605|FG002|Overall Study|Progressive Disease|10|||
130264680|NCT02259114|468935606|FG003|Overall Study|Progressive Disease|2|||
130264681|NCT02259114|468935607|FG004|Overall Study|Progressive Disease|5|||
130264682|NCT02259114|468935603|FG000|Overall Study|Adverse Event|2|||
130264683|NCT02259114|468935604|FG001|Overall Study|Adverse Event|1|||
130264684|NCT02259114|468935605|FG002|Overall Study|Adverse Event|0|||
130264685|NCT02259114|468935606|FG003|Overall Study|Adverse Event|0|||
130264686|NCT02259114|468935607|FG004|Overall Study|Adverse Event|1|||
130264687|NCT02259114|468935603|FG000|Overall Study|Death|3|||
130264688|NCT02259114|468935604|FG001|Overall Study|Death|0|||
130264689|NCT02259114|468935605|FG002|Overall Study|Death|1|||
130264690|NCT02259114|468935606|FG003|Overall Study|Death|0|||
130264691|NCT02259114|468935607|FG004|Overall Study|Death|0|||
130264692|NCT02259114|468935603|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264693|NCT02259114|468935604|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264694|NCT02259114|468935605|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
130264695|NCT02259114|468935606|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264696|NCT02259114|468935607|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
130264697|NCT02259114|468935603|FG000|Overall Study|Withdrawal by Subject|0|||
130264698|NCT02259114|468935604|FG001|Overall Study|Withdrawal by Subject|0|||
130264699|NCT02259114|468935605|FG002|Overall Study|Withdrawal by Subject|1|||
130264700|NCT02259114|468935606|FG003|Overall Study|Withdrawal by Subject|1|||
130264701|NCT02259114|468935607|FG004|Overall Study|Withdrawal by Subject|0|||
130264702|NCT02259114|468935603|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
130264703|NCT02259114|468935604|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
130264704|NCT02259114|468935605|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130264705|NCT02259114|468935606|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130264706|NCT02259114|468935607|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
130264707|NCT02259114|468935603|FG000|Overall Study|Not Treated|1|||
130264708|NCT02259114|468935604|FG001|Overall Study|Not Treated|0|||
130264709|NCT02259114|468935605|FG002|Overall Study|Not Treated|0|||
130264710|NCT02259114|468935606|FG003|Overall Study|Not Treated|0|||
130264711|NCT02259114|468935607|FG004|Overall Study|Not Treated|0|||
130264712|NCT03937479|468935608|FG000|Overall Study|Adverse Event|2|||
130264713|NCT03937479|468935609|FG001|Overall Study|Adverse Event|3|||
130264714|NCT03937479|468935610|FG002|Overall Study|Adverse Event|0|||
130264715|NCT03937479|468935611|FG003|Overall Study|Adverse Event|0|||
130264716|NCT03937479|468935612|FG004|Overall Study|Adverse Event|1|||
130264717|NCT03937479|468935608|FG000|Overall Study|Withdrawal by Subject|3|||
130264718|NCT03937479|468935609|FG001|Overall Study|Withdrawal by Subject|5|||
130264719|NCT03937479|468935610|FG002|Overall Study|Withdrawal by Subject|2|||
130264720|NCT03937479|468935611|FG003|Overall Study|Withdrawal by Subject|2|||
130264721|NCT03937479|468935612|FG004|Overall Study|Withdrawal by Subject|1|||
130264722|NCT03937479|468935608|FG000|Overall Study|Protocol Violation|5|||
130264723|NCT03937479|468935609|FG001|Overall Study|Protocol Violation|6|||
130264724|NCT03937479|468935610|FG002|Overall Study|Protocol Violation|4|||
130264725|NCT03937479|468935611|FG003|Overall Study|Protocol Violation|3|||
130264726|NCT03937479|468935612|FG004|Overall Study|Protocol Violation|2|||
130264727|NCT03937479|468935608|FG000|Overall Study|Lost to Follow-up|0|||
130264728|NCT03937479|468935609|FG001|Overall Study|Lost to Follow-up|1|||
130264729|NCT03937479|468935610|FG002|Overall Study|Lost to Follow-up|0|||
130264730|NCT03937479|468935611|FG003|Overall Study|Lost to Follow-up|1|||
130264731|NCT03937479|468935612|FG004|Overall Study|Lost to Follow-up|0|||
130264732|NCT03937479|468935608|FG000|Overall Study|Physician Decision|0|||
130264733|NCT03937479|468935609|FG001|Overall Study|Physician Decision|0|||
130264734|NCT03937479|468935610|FG002|Overall Study|Physician Decision|1|||
130264735|NCT03937479|468935611|FG003|Overall Study|Physician Decision|0|||
130264736|NCT03937479|468935612|FG004|Overall Study|Physician Decision|1|||
130264737|NCT02712788|468935613|FG000|Overall Study|Physician Decision|1|||
130264738|NCT02712788|468935614|FG001|Overall Study|Physician Decision|0|||
130264739|NCT02712788|468935613|FG000|Overall Study|Protocol Violation|1|||
130264740|NCT02712788|468935614|FG001|Overall Study|Protocol Violation|0|||
130264741|NCT00940602|468935615|FG000|Overall Study|Administrative problems|1|||
130264742|NCT00940602|468935616|FG001|Overall Study|Administrative problems|1|||
130264743|NCT00940602|468935615|FG000|Overall Study|Patient/guardian decision|13|||
130264744|NCT00940602|468935616|FG001|Overall Study|Patient/guardian decision|28|||
130264745|NCT00940602|468935615|FG000|Overall Study|Physician Decision|8|||
130264746|NCT00940602|468935616|FG001|Overall Study|Physician Decision|5|||
130264747|NCT00940602|468935615|FG000|Overall Study|Pregnancy|1|||
130264748|NCT00940602|468935616|FG001|Overall Study|Pregnancy|0|||
130264749|NCT00940602|468935615|FG000|Overall Study|Protocol Deviation (untreated)|1|||
130264750|NCT00940602|468935616|FG001|Overall Study|Protocol Deviation (untreated)|0|||
130264751|NCT00940602|468935615|FG000|Overall Study|Disease progression|8|||
130264752|NCT00940602|468935616|FG001|Overall Study|Disease progression|2|||
130264753|NCT00940602|468935615|FG000|Overall Study|Death|38|||
130264754|NCT00940602|468935616|FG001|Overall Study|Death|19|||
130264755|NCT00940602|468935615|FG000|Overall Study|Lost to Follow-up|3|||
130264756|NCT00940602|468935616|FG001|Overall Study|Lost to Follow-up|1|||
130264757|NCT00940602|468935615|FG000|Overall Study|Patient withdrew consent|26|||
130264758|NCT00940602|468935616|FG001|Overall Study|Patient withdrew consent|13|||
130264759|NCT00940602|468935615|FG000|Overall Study|Adverse Event|7|||
130264760|NCT00940602|468935616|FG001|Overall Study|Adverse Event|2|||
130264761|NCT00940602|468935615|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
130264762|NCT00940602|468935616|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
130264763|NCT01880957|468935617|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
130264764|NCT01880957|468935618|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
130264765|NCT01880957|468935617|FG000|Overall Study|Lost to Follow-up|11|||
130264766|NCT01880957|468935618|FG001|Overall Study|Lost to Follow-up|0|||
130264767|NCT01880957|468935617|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
130264768|NCT01880957|468935618|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
130264769|NCT00508482|468935621|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
130264770|NCT00508482|468935622|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
130264771|NCT00508482|468935623|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
130264772|NCT00508482|468935621|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
130264773|NCT00508482|468935622|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
130264774|NCT00508482|468935623|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
130264775|NCT00508482|468935621|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
130264776|NCT00508482|468935622|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
130264777|NCT00508482|468935623|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
130264778|NCT02289469|468935624|FG000|Overall Study|Unable to match a control|6|||
130264779|NCT02289469|468935625|FG001|Overall Study|Unable to match a control|0|||
130264780|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
130264781|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
130264782|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
130264783|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
130264784|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
130264785|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
130264786|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
130264787|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
130264788|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
130264789|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
130264790|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
130264791|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
130264792|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
130264793|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
130264794|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
130264795|NCT00546481|468935626|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
130264796|NCT00546481|468935627|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
130264797|NCT00546481|468935628|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
130264798|NCT00546481|468935626|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
130264799|NCT00546481|468935627|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
130264800|NCT00546481|468935628|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
130264801|NCT00546481|468935626|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
130264802|NCT00546481|468935627|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
130264803|NCT00546481|468935628|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
130264804|NCT00546481|468935626|FG000|Maintenance Phase (CERA)|Other Reason|0|||
130264805|NCT00546481|468935627|FG001|Maintenance Phase (CERA)|Other Reason|0|||
130264806|NCT00546481|468935628|FG002|Maintenance Phase (CERA)|Other Reason|1|||
130264807|NCT01077063|468935629|FG000|Overall Study|Adverse Event|3|||
130264808|NCT01077063|468935630|FG001|Overall Study|Adverse Event|0|||
130264809|NCT01077063|468935629|FG000|Overall Study|Death|1|||
130264810|NCT01077063|468935630|FG001|Overall Study|Death|1|||
130264811|NCT01077063|468935629|FG000|Overall Study|Withdrawal by Subject|0|||
130264812|NCT01077063|468935630|FG001|Overall Study|Withdrawal by Subject|2|||
130264813|NCT02750930|468935631|FG000|Overall Study|Study closed/terminated|8|||
130264814|NCT02761642|468935633|FG000|Overall Study|Did not Receive Study Treatment|3|||
130264815|NCT02761642|468935633|FG000|Overall Study|Adverse Event|13|||
130264816|NCT02761642|468935633|FG000|Overall Study|Withdrawal by Subject|2|||
130264817|NCT02761642|468935633|FG000|Overall Study|Non-compliant|7|||
130264818|NCT02761642|468935633|FG000|Overall Study|Death|3|||
130264819|NCT02761642|468935633|FG000|Overall Study|Lack of Efficacy|20|||
130264820|NCT02761642|468935633|FG000|Overall Study|Physician Decision|1|||
130264821|NCT02761642|468935633|FG000|Overall Study|Reason Unspecified|21|||
130264822|NCT02756403|468935638|FG000|Overall Study|Unable to swallow medication|0|||
130264823|NCT02756403|468935639|FG001|Overall Study|Unable to swallow medication|1|||
130264824|NCT02756403|468935640|FG002|Overall Study|Unable to swallow medication|1|||
130264825|NCT02756403|468935641|FG003|Overall Study|Unable to swallow medication|1|||
130264826|NCT02756403|468935638|FG000|Overall Study|Did not complete Procedure|0|||
130264827|NCT02756403|468935639|FG001|Overall Study|Did not complete Procedure|1|||
130264828|NCT02756403|468935640|FG002|Overall Study|Did not complete Procedure|0|||
130264829|NCT02756403|468935641|FG003|Overall Study|Did not complete Procedure|0|||
130264830|NCT02756403|468935638|FG000|Overall Study|Changed Mind About Procedure|0|||
130264831|NCT02756403|468935639|FG001|Overall Study|Changed Mind About Procedure|0|||
130264832|NCT02756403|468935640|FG002|Overall Study|Changed Mind About Procedure|1|||
130264833|NCT02756403|468935641|FG003|Overall Study|Changed Mind About Procedure|0|||
130264834|NCT02756403|468935638|FG000|Overall Study|Protocol Violation|0|||
130264835|NCT02756403|468935639|FG001|Overall Study|Protocol Violation|1|||
130264836|NCT02756403|468935640|FG002|Overall Study|Protocol Violation|0|||
130264837|NCT02756403|468935641|FG003|Overall Study|Protocol Violation|1|||
130264838|NCT01644643|468935642|FG000|Overall Study|Death|1|||
130264839|NCT01644643|468935643|FG001|Overall Study|Death|0|||
130264840|NCT01644643|468935644|FG002|Overall Study|Death|3|||
130264841|NCT01644643|468935645|FG003|Overall Study|Death|3|||
130264842|NCT01644643|468935642|FG000|Overall Study|Lost to Follow-up|0|||
130264843|NCT01644643|468935643|FG001|Overall Study|Lost to Follow-up|0|||
130264844|NCT01644643|468935644|FG002|Overall Study|Lost to Follow-up|0|||
130264845|NCT01644643|468935645|FG003|Overall Study|Lost to Follow-up|4|||
130264846|NCT01644643|468935642|FG000|Overall Study|Withdrawal by Subject|1|||
130264847|NCT01644643|468935643|FG001|Overall Study|Withdrawal by Subject|0|||
130264848|NCT01644643|468935644|FG002|Overall Study|Withdrawal by Subject|2|||
130264849|NCT01644643|468935645|FG003|Overall Study|Withdrawal by Subject|1|||
130264850|NCT01644643|468935642|FG000|Overall Study|Other Eligibility criteria|0|||
130264851|NCT01644643|468935643|FG001|Overall Study|Other Eligibility criteria|0|||
130264852|NCT01644643|468935644|FG002|Overall Study|Other Eligibility criteria|0|||
130264853|NCT01644643|468935645|FG003|Overall Study|Other Eligibility criteria|2|||
130264854|NCT00776789|468935650|FG000|Overall Study|Consent refusal|2|||
130264855|NCT00776789|468935651|FG001|Overall Study|Consent refusal|2|||
130264856|NCT00776789|468935650|FG000|Overall Study|Poor quality video|1|||
130264857|NCT00776789|468935651|FG001|Overall Study|Poor quality video|1|||
130264858|NCT02850978|468935652|FG000|Overall Study|Uncollectable CRF|27|||
130264859|NCT02850978|468935652|FG000|Overall Study|No visit since the first visit|35|||
130264860|NCT02850978|468935652|FG000|Overall Study|Adverse Event|81|||
130264861|NCT02850978|468935652|FG000|Overall Study|Lack of Efficacy|40|||
130264862|NCT02850978|468935652|FG000|Overall Study|Improvement in condition|34|||
130264863|NCT02850978|468935652|FG000|Overall Study|Lost to Follow-up|121|||
130264864|NCT02850978|468935652|FG000|Overall Study|Reason not listed|88|||
130264865|NCT00165789|468935656|FG000|Overall Study|Adverse Event|0|||
130264866|NCT00165789|468935657|FG001|Overall Study|Adverse Event|3|||
130264867|NCT00165789|468935658|FG002|Overall Study|Adverse Event|0|||
130264868|NCT00165789|468935659|FG003|Overall Study|Adverse Event|12|||
130264869|NCT00165789|468935656|FG000|Overall Study|Withdrawal by Subject|0|||
130264870|NCT00165789|468935657|FG001|Overall Study|Withdrawal by Subject|1|||
130264871|NCT00165789|468935658|FG002|Overall Study|Withdrawal by Subject|1|||
130264872|NCT00165789|468935659|FG003|Overall Study|Withdrawal by Subject|2|||
130264873|NCT00656370|468935664|FG000|Overall Study|Screen Failures|7|||
130264874|NCT00656370|468935664|FG000|Overall Study|Alternates|3|||
130264875|NCT01342094|468935665|FG000|Overall Study|Adverse Event|5|||
130264876|NCT01342094|468935666|FG001|Overall Study|Adverse Event|0|||
130264877|NCT01342094|468935665|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130264878|NCT01342094|468935666|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130264879|NCT01342094|468935665|FG000|Overall Study|Withdrawal by Subject|0|||
130264880|NCT01342094|468935666|FG001|Overall Study|Withdrawal by Subject|2|||
130264881|NCT03391882|468935671|FG000|Study Overall|Adverse Event|3|||
130264882|NCT03391882|468935672|FG001|Study Overall|Adverse Event|6|||
130264883|NCT03391882|468935673|FG002|Study Overall|Adverse Event|1|||
130264884|NCT03391882|468935674|FG003|Study Overall|Adverse Event|1|||
130264885|NCT03391882|468935675|FG004|Study Overall|Adverse Event|3|||
130264886|NCT03391882|468935676|FG005|Study Overall|Adverse Event|1|||
130264887|NCT03391882|468935671|FG000|Study Overall|Lack of Efficacy|13|||
130264888|NCT03391882|468935672|FG001|Study Overall|Lack of Efficacy|9|||
130264889|NCT03391882|468935673|FG002|Study Overall|Lack of Efficacy|0|||
130264890|NCT03391882|468935674|FG003|Study Overall|Lack of Efficacy|0|||
130264891|NCT03391882|468935675|FG004|Study Overall|Lack of Efficacy|0|||
130264892|NCT03391882|468935676|FG005|Study Overall|Lack of Efficacy|0|||
130264893|NCT03391882|468935671|FG000|Study Overall|Withdrawal by Subject|3|||
130264894|NCT03391882|468935672|FG001|Study Overall|Withdrawal by Subject|3|||
130264895|NCT03391882|468935673|FG002|Study Overall|Withdrawal by Subject|2|||
130264896|NCT03391882|468935674|FG003|Study Overall|Withdrawal by Subject|2|||
130264897|NCT03391882|468935675|FG004|Study Overall|Withdrawal by Subject|1|||
130264898|NCT03391882|468935676|FG005|Study Overall|Withdrawal by Subject|3|||
130264899|NCT03391882|468935671|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264900|NCT03391882|468935672|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
130264901|NCT03391882|468935673|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264902|NCT03391882|468935674|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264903|NCT03391882|468935675|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264904|NCT03391882|468935676|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
130264905|NCT03391882|468935671|FG000|Study Overall|Protocol Violation|1|||
130264906|NCT03391882|468935672|FG001|Study Overall|Protocol Violation|0|||
130264907|NCT03391882|468935673|FG002|Study Overall|Protocol Violation|0|||
130264908|NCT03391882|468935674|FG003|Study Overall|Protocol Violation|0|||
130264909|NCT03391882|468935675|FG004|Study Overall|Protocol Violation|0|||
130264910|NCT03391882|468935676|FG005|Study Overall|Protocol Violation|0|||
130264911|NCT03391882|468935671|FG000|Part A - Titration Phase|Adverse Event|3|||
130264912|NCT03391882|468935672|FG001|Part A - Titration Phase|Adverse Event|6|||
130264913|NCT03391882|468935673|FG002|Part A - Titration Phase|Adverse Event|0|||
130264914|NCT03391882|468935674|FG003|Part A - Titration Phase|Adverse Event|0|||
130264915|NCT03391882|468935675|FG004|Part A - Titration Phase|Adverse Event|0|||
130264916|NCT03391882|468935676|FG005|Part A - Titration Phase|Adverse Event|0|||
130264917|NCT03391882|468935671|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
130264918|NCT03391882|468935672|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
130264919|NCT03391882|468935673|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
130264920|NCT03391882|468935674|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
130264921|NCT03391882|468935675|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
130264922|NCT03391882|468935676|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
130264923|NCT03391882|468935671|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
130264924|NCT03391882|468935672|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
130264925|NCT03391882|468935673|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
130264926|NCT03391882|468935674|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
130264927|NCT03391882|468935675|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
130264928|NCT03391882|468935676|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
130264929|NCT03391882|468935671|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264930|NCT03391882|468935672|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
130264931|NCT03391882|468935673|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264932|NCT03391882|468935674|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264933|NCT03391882|468935675|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264934|NCT03391882|468935676|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
130264935|NCT03391882|468935671|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
130264936|NCT03391882|468935672|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
130264937|NCT03391882|468935673|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264938|NCT03391882|468935674|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264939|NCT03391882|468935675|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264940|NCT03391882|468935676|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
130264941|NCT03391882|468935671|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
130264942|NCT03391882|468935672|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
130264943|NCT03391882|468935673|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
130264944|NCT03391882|468935674|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
130264945|NCT03391882|468935675|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
130264946|NCT03391882|468935676|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
130264947|NCT03391882|468935671|FG000|Part B - Treatment Phase|Adverse Event|0|||
130264948|NCT03391882|468935672|FG001|Part B - Treatment Phase|Adverse Event|0|||
130264949|NCT03391882|468935673|FG002|Part B - Treatment Phase|Adverse Event|1|||
130264950|NCT03391882|468935674|FG003|Part B - Treatment Phase|Adverse Event|1|||
130264951|NCT03391882|468935675|FG004|Part B - Treatment Phase|Adverse Event|3|||
130264952|NCT03391882|468935676|FG005|Part B - Treatment Phase|Adverse Event|1|||
130264953|NCT03391882|468935671|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
130264954|NCT03391882|468935672|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
130264955|NCT03391882|468935673|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
130264956|NCT03391882|468935674|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
130264957|NCT03391882|468935675|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
130264958|NCT03391882|468935676|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
130264959|NCT03913130|468935677|FG000|Overall Study|Sponsor Decision|1|||
130264960|NCT01085214|468935680|FG000|Overall Study|Alternate treatment required|1|||
130264961|NCT01634152|468935694|FG000|Overall Study|Adverse Event|2|||
130264962|NCT01634152|468935695|FG001|Overall Study|Adverse Event|0|||
130264963|NCT01634152|468935696|FG002|Overall Study|Adverse Event|2|||
130264964|NCT01634152|468935694|FG000|Overall Study|Consent withdrawn not due to AE|1|||
130264965|NCT01634152|468935695|FG001|Overall Study|Consent withdrawn not due to AE|0|||
130264966|NCT01634152|468935696|FG002|Overall Study|Consent withdrawn not due to AE|1|||
130264967|NCT01634152|468935694|FG000|Overall Study|Not treated|0|||
130264968|NCT01634152|468935695|FG001|Overall Study|Not treated|1|||
130264969|NCT01634152|468935696|FG002|Overall Study|Not treated|0|||
130264970|NCT01634152|468935694|FG000|Overall Study|Other reason not defined above|1|||
130264971|NCT01634152|468935695|FG001|Overall Study|Other reason not defined above|0|||
130264972|NCT01634152|468935696|FG002|Overall Study|Other reason not defined above|1|||
130264973|NCT01152437|468935697|FG000|Overall Study|Other Adverse Event|8|||
130264974|NCT01152437|468935698|FG001|Overall Study|Other Adverse Event|1|||
130264975|NCT01152437|468935699|FG002|Overall Study|Other Adverse Event|7|||
130264976|NCT01152437|468935697|FG000|Overall Study|Not treated|0|||
130264977|NCT01152437|468935698|FG001|Overall Study|Not treated|1|||
130264978|NCT01152437|468935699|FG002|Overall Study|Not treated|2|||
130264979|NCT01152437|468935697|FG000|Overall Study|Progressive disease|27|||
130264980|NCT01152437|468935698|FG001|Overall Study|Progressive disease|13|||
130102475|NCT00111007|468332737|FG000|Active Follow-up|Death|2|||
130264981|NCT01152437|468935699|FG002|Overall Study|Progressive disease|32|||
130264982|NCT01152437|468935697|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
130264983|NCT01152437|468935698|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
130264984|NCT01152437|468935699|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
130264985|NCT01985022|468935700|FG000|Overall Study|Lost to Follow-up|0|||
130264986|NCT01985022|468935701|FG001|Overall Study|Lost to Follow-up|1|||
130264987|NCT01985022|468935700|FG000|Overall Study|Protocol Violation|0|||
130264988|NCT01985022|468935701|FG001|Overall Study|Protocol Violation|1|||
130264989|NCT01985022|468935700|FG000|Overall Study|Withdrawal by Subject|4|||
129885628|NCT02855164|467540778|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129885629|NCT02855164|467540771|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
130264990|NCT01985022|468935701|FG001|Overall Study|Withdrawal by Subject|1|||
130264991|NCT02317627|468935704|FG000|Overall Study|Withdrawal by Subject|0|||
130264992|NCT02317627|468935705|FG001|Overall Study|Withdrawal by Subject|1|||
130264993|NCT02317627|468935706|FG002|Overall Study|Withdrawal by Subject|1|||
130102476|NCT00111007|468332738|FG001|Active Follow-up|Death|0|||
130264994|NCT02317627|468935704|FG000|Overall Study|Lost to Follow-up|2|||
130264995|NCT02317627|468935705|FG001|Overall Study|Lost to Follow-up|0|||
130264996|NCT02317627|468935706|FG002|Overall Study|Lost to Follow-up|0|||
130264997|NCT02317627|468935704|FG000|Overall Study|Stopped by Investigator|0|||
130264998|NCT02317627|468935705|FG001|Overall Study|Stopped by Investigator|1|||
130264999|NCT02317627|468935706|FG002|Overall Study|Stopped by Investigator|0|||
130265000|NCT02317627|468935704|FG000|Overall Study|Adverse Event|0|||
130265001|NCT02317627|468935705|FG001|Overall Study|Adverse Event|2|||
130265002|NCT02317627|468935706|FG002|Overall Study|Adverse Event|3|||
130265003|NCT02317627|468935704|FG000|Overall Study|Non-compliance with study drug|0|||
130265004|NCT02317627|468935705|FG001|Overall Study|Non-compliance with study drug|1|||
130265005|NCT02317627|468935706|FG002|Overall Study|Non-compliance with study drug|0|||
130265006|NCT00279214|468935707|FG000|Overall Study|Physician Decision|3|||
130102477|NCT00111007|468332737|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
130102478|NCT00111007|468332738|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
130102479|NCT00111007|468332737|FG000|Long Term Follow-up|Death|34|||
130102480|NCT00111007|468332738|FG001|Long Term Follow-up|Death|39|||
130265007|NCT00279214|468935708|FG001|Overall Study|Physician Decision|2|||
130265008|NCT01214837|468935710|FG000|Overall Study|Death|0|||
130265009|NCT01214837|468935711|FG001|Overall Study|Death|0|||
130265010|NCT01214837|468935712|FG002|Overall Study|Death|1|||
130265011|NCT01214837|468935710|FG000|Overall Study|Adverse Event|1|||
130265012|NCT01214837|468935711|FG001|Overall Study|Adverse Event|2|||
130265013|NCT01214837|468935712|FG002|Overall Study|Adverse Event|1|||
130265014|NCT01214837|468935710|FG000|Overall Study|Withdrawal by Subject|27|||
130265015|NCT01214837|468935711|FG001|Overall Study|Withdrawal by Subject|36|||
130265016|NCT01214837|468935712|FG002|Overall Study|Withdrawal by Subject|28|||
130265017|NCT01214837|468935710|FG000|Overall Study|Lost to Follow-up|20|||
130265018|NCT01214837|468935711|FG001|Overall Study|Lost to Follow-up|15|||
130265019|NCT01214837|468935712|FG002|Overall Study|Lost to Follow-up|21|||
130265020|NCT01214837|468935710|FG000|Overall Study|Inappropriate Enrolment|0|||
130265021|NCT01214837|468935711|FG001|Overall Study|Inappropriate Enrolment|1|||
130265022|NCT01214837|468935712|FG002|Overall Study|Inappropriate Enrolment|2|||
130265023|NCT01214837|468935710|FG000|Overall Study|Administrative Reason|2|||
130265024|NCT01214837|468935711|FG001|Overall Study|Administrative Reason|6|||
130265025|NCT01214837|468935712|FG002|Overall Study|Administrative Reason|4|||
130265026|NCT01214837|468935710|FG000|Overall Study|Protocol Violation|3|||
130265027|NCT01214837|468935711|FG001|Overall Study|Protocol Violation|1|||
130265028|NCT01214837|468935712|FG002|Overall Study|Protocol Violation|5|||
130265029|NCT01214837|468935710|FG000|Overall Study|Unable to Classify|1|||
130265030|NCT01214837|468935711|FG001|Overall Study|Unable to Classify|3|||
130265031|NCT01214837|468935712|FG002|Overall Study|Unable to Classify|0|||
130265032|NCT00027560|468935713|FG000|Overall Study|Withdrawal by Subject|1|||
130265033|NCT00939107|468937191|FG000|Overall Study|Lost to Follow-up|14|||
130265034|NCT00939107|468937192|FG001|Overall Study|Lost to Follow-up|12|||
130265035|NCT02903823|468937193|FG000|Overall Study|Physician Decision|5|||
130265036|NCT02903823|468937193|FG000|Overall Study|Could not advance catheter|1|||
130265037|NCT02903823|468937193|FG000|Overall Study|Catheter dislodgement|1|||
130265038|NCT01123148|468937200|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
130265039|NCT01123148|468937200|FG000|Overall Study|Didn't meet milestone criteria|1|||
130265040|NCT00355030|468937201|FG000|Study Period 1 Treatment|Adverse Event|1|||
130265041|NCT00355030|468937202|FG001|Study Period 1 Treatment|Adverse Event|1|||
130265042|NCT00355030|468937201|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
130265043|NCT00355030|468937202|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
130265044|NCT00355030|468937201|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
130265045|NCT00355030|468937202|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
130265046|NCT00355030|468937201|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
130265047|NCT00355030|468937202|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
130265048|NCT00355030|468937201|FG000|Study Period 1 Treatment|Physician Decision|0|||
130265049|NCT00355030|468937202|FG001|Study Period 1 Treatment|Physician Decision|1|||
130265050|NCT00355030|468937201|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
130265051|NCT00355030|468937202|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
130265052|NCT00355030|468937201|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
130265053|NCT00355030|468937202|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
130265054|NCT00355030|468937201|FG000|Study Period 1 Treatment|Other|2|||
130265055|NCT00355030|468937202|FG001|Study Period 1 Treatment|Other|6|||
130265056|NCT00355030|468937201|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
130265057|NCT00355030|468937202|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
130102481|NCT00111007|468332737|FG000|Long Term Follow-up|Lost to Follow-up|1|||
130102482|NCT00111007|468332738|FG001|Long Term Follow-up|Lost to Follow-up|1|||
130102483|NCT00111007|468332737|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
130102484|NCT00111007|468332738|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
130102485|NCT00111007|468332737|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
130102486|NCT00111007|468332738|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
130102487|NCT00111007|468332737|FG000|Long Term Follow-up|Missing|10|||
130102488|NCT00111007|468332738|FG001|Long Term Follow-up|Missing|3|||
130102489|NCT00834366|468332739|FG000|Treatment Period 1|Adverse Event|1|||
130102490|NCT00834366|468332740|FG001|Treatment Period 1|Adverse Event|1|||
130102491|NCT02380248|468332742|FG000|Overall Study|Lost to Follow-up|11|||
130102492|NCT02380248|468332742|FG000|Overall Study|Withdrawal by Subject|3|||
130102493|NCT01275170|468332743|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
130102494|NCT01275170|468332744|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102495|NCT01275170|468332745|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102496|NCT01275170|468332746|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102497|NCT01275170|468332747|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102498|NCT01275170|468332748|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102499|NCT01275170|468332749|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102500|NCT01275170|468332750|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
130102501|NCT00621309|468332751|FG000|Overall Study|Withdrawal by Subject|2|||
130102502|NCT00621309|468332752|FG001|Overall Study|Withdrawal by Subject|0|||
130102503|NCT00621309|468332753|FG002|Overall Study|Withdrawal by Subject|1|||
130102504|NCT00621309|468332754|FG003|Overall Study|Withdrawal by Subject|1|||
130102505|NCT00621309|468332755|FG004|Overall Study|Withdrawal by Subject|1|||
130102506|NCT00621309|468332756|FG005|Overall Study|Withdrawal by Subject|1|||
130102507|NCT02949219|468332758|FG000|Overall Study|Withdrawal by Subject|1|||
130102508|NCT00314262|468332765|FG000|Overall Study|Adverse Event|2|||
130102509|NCT00314262|468332765|FG000|Overall Study|Withdrawal by Subject|2|||
130102510|NCT00314262|468332765|FG000|Overall Study|Physician Decision|1|||
130102511|NCT00083226|468332766|FG000|Overall Study|Lack of Efficacy|19|||
130102512|NCT00083226|468332766|FG000|Overall Study|Adverse Event|9|||
130102513|NCT00083226|468332766|FG000|Overall Study|Death|4|||
130102514|NCT00083226|468332766|FG000|Overall Study|Withdrawal by Subject|4|||
130102515|NCT00083226|468332766|FG000|Overall Study|Other|2|||
130102516|NCT00083226|468332766|FG000|Overall Study|ineligible or not receiving treatment|4|||
130102517|NCT00604175|468332773|FG000|Entry Through Week 28|Death|2|||
130102518|NCT00604175|468332774|FG001|Entry Through Week 28|Death|0|||
130102519|NCT00604175|468332775|FG002|Entry Through Week 28|Death|0|||
130102520|NCT00604175|468332773|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
130102521|NCT00604175|468332774|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
130102522|NCT00604175|468332775|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
130102523|NCT00604175|468332773|FG000|Entry Through Week 28|Lost to Follow-up|4|||
130102524|NCT00604175|468332774|FG001|Entry Through Week 28|Lost to Follow-up|3|||
130102525|NCT00604175|468332775|FG002|Entry Through Week 28|Lost to Follow-up|0|||
130102526|NCT00604175|468332773|FG000|Entry Through Week 28|Ineligible|1|||
130102527|NCT00604175|468332774|FG001|Entry Through Week 28|Ineligible|0|||
130265058|NCT00355030|468937201|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
130265059|NCT00355030|468937202|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
130265060|NCT01747915|468937203|FG000|Overall Study|Other|1|||
130265061|NCT01747915|468937204|FG001|Overall Study|Other|1|||
130265062|NCT01747915|468937205|FG002|Overall Study|Other|1|||
130265063|NCT01747915|468937203|FG000|Overall Study|Adverse Event|8|||
130265064|NCT01747915|468937204|FG001|Overall Study|Adverse Event|5|||
130265065|NCT01747915|468937205|FG002|Overall Study|Adverse Event|2|||
130265066|NCT01747915|468937203|FG000|Overall Study|Death|0|||
130265067|NCT01747915|468937204|FG001|Overall Study|Death|0|||
130265068|NCT01747915|468937205|FG002|Overall Study|Death|1|||
130265069|NCT01747915|468937203|FG000|Overall Study|Lack of Efficacy|0|||
130102528|NCT00604175|468332775|FG002|Entry Through Week 28|Ineligible|0|||
130102529|NCT00604175|468332773|FG000|Entry Through Week 28|Did not start intervention|2|||
130102530|NCT00604175|468332774|FG001|Entry Through Week 28|Did not start intervention|0|||
130102531|NCT00604175|468332775|FG002|Entry Through Week 28|Did not start intervention|1|||
130102532|NCT00604175|468332773|FG000|Week 29 Through Week 72|Death|0|||
130102533|NCT00604175|468332774|FG001|Week 29 Through Week 72|Death|0|||
130102534|NCT00604175|468332775|FG002|Week 29 Through Week 72|Death|1|||
130102535|NCT00604175|468332773|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
130102536|NCT00604175|468332774|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
130265070|NCT01747915|468937204|FG001|Overall Study|Lack of Efficacy|1|||
130265071|NCT01747915|468937205|FG002|Overall Study|Lack of Efficacy|0|||
130265072|NCT01747915|468937203|FG000|Overall Study|Lost to Follow-up|1|||
130265073|NCT01747915|468937204|FG001|Overall Study|Lost to Follow-up|0|||
130265074|NCT01747915|468937205|FG002|Overall Study|Lost to Follow-up|0|||
130265075|NCT01747915|468937203|FG000|Overall Study|Withdrawal by Subject|4|||
130265076|NCT01747915|468937204|FG001|Overall Study|Withdrawal by Subject|4|||
130265077|NCT01747915|468937205|FG002|Overall Study|Withdrawal by Subject|1|||
130265078|NCT01747915|468937203|FG000|Overall Study|Protocol Violation|1|||
130265079|NCT01747915|468937204|FG001|Overall Study|Protocol Violation|0|||
130265080|NCT01747915|468937205|FG002|Overall Study|Protocol Violation|0|||
130265081|NCT01747915|468937203|FG000|Overall Study|Pregnancy|0|||
130265082|NCT01747915|468937204|FG001|Overall Study|Pregnancy|0|||
130265083|NCT01747915|468937205|FG002|Overall Study|Pregnancy|1|||
130265084|NCT00812955|468937210|FG000|Overall Study|Adverse Event|7|||
130265085|NCT00812955|468937211|FG001|Overall Study|Adverse Event|6|||
130265086|NCT00812955|468937212|FG002|Overall Study|Adverse Event|3|||
130265087|NCT00812955|468937213|FG003|Overall Study|Adverse Event|4|||
130265088|NCT00812955|468937210|FG000|Overall Study|Lost to Follow-up|2|||
130265089|NCT00812955|468937211|FG001|Overall Study|Lost to Follow-up|1|||
130265090|NCT00812955|468937212|FG002|Overall Study|Lost to Follow-up|1|||
130265091|NCT00812955|468937213|FG003|Overall Study|Lost to Follow-up|2|||
130265092|NCT00812955|468937210|FG000|Overall Study|Withdrawal by Subject|1|||
130265093|NCT00812955|468937211|FG001|Overall Study|Withdrawal by Subject|0|||
130265094|NCT00812955|468937212|FG002|Overall Study|Withdrawal by Subject|1|||
130265095|NCT00812955|468937213|FG003|Overall Study|Withdrawal by Subject|2|||
130265096|NCT00812955|468937210|FG000|Overall Study|randomized in error|0|||
130265097|NCT00812955|468937211|FG001|Overall Study|randomized in error|0|||
130265098|NCT00812955|468937212|FG002|Overall Study|randomized in error|1|||
130265099|NCT00812955|468937213|FG003|Overall Study|randomized in error|0|||
130265100|NCT01772550|468937214|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
130265101|NCT01772550|468937215|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
130265102|NCT01772550|468937216|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
130265103|NCT01772550|468937214|FG000|Overall Study|Adverse Event|0|||
130265104|NCT01772550|468937215|FG001|Overall Study|Adverse Event|0|||
130265105|NCT01772550|468937216|FG002|Overall Study|Adverse Event|1|||
130265106|NCT01815424|468937217|FG000|Week 0 to 16|Adverse Event|1|||
130265107|NCT01815424|468937218|FG001|Week 0 to 16|Adverse Event|3|||
130265108|NCT01815424|468937219|FG002|Week 0 to 16|Adverse Event|3|||
130265109|NCT01815424|468937220|FG003|Week 0 to 16|Adverse Event|0|||
130265110|NCT01815424|468937221|FG004|Week 0 to 16|Adverse Event|0|||
130265111|NCT01815424|468937217|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
130265112|NCT01815424|468937218|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265113|NCT01815424|468937219|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265114|NCT01815424|468937220|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265115|NCT01815424|468937221|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
130265116|NCT01815424|468937217|FG000|Week 0 to 16|Lost to Follow-up|0|||
130265117|NCT01815424|468937218|FG001|Week 0 to 16|Lost to Follow-up|1|||
130265118|NCT01815424|468937219|FG002|Week 0 to 16|Lost to Follow-up|0|||
130265119|NCT01815424|468937220|FG003|Week 0 to 16|Lost to Follow-up|0|||
130265120|NCT01815424|468937221|FG004|Week 0 to 16|Lost to Follow-up|0|||
130265121|NCT01815424|468937217|FG000|Week 0 to 16|Withdrawal by Subject|0|||
130265122|NCT01815424|468937218|FG001|Week 0 to 16|Withdrawal by Subject|0|||
130265123|NCT01815424|468937219|FG002|Week 0 to 16|Withdrawal by Subject|1|||
130265124|NCT01815424|468937220|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130265125|NCT01815424|468937221|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130265126|NCT01815424|468937217|FG000|Week 0 to 16|Other|1|||
130265127|NCT01815424|468937218|FG001|Week 0 to 16|Other|0|||
130265128|NCT01815424|468937219|FG002|Week 0 to 16|Other|3|||
130265129|NCT01815424|468937220|FG003|Week 0 to 16|Other|0|||
130265130|NCT01815424|468937221|FG004|Week 0 to 16|Other|0|||
130265131|NCT01815424|468937217|FG000|Week 0 to 16|Protocol Violation|1|||
130265132|NCT01815424|468937218|FG001|Week 0 to 16|Protocol Violation|0|||
130265133|NCT01815424|468937219|FG002|Week 0 to 16|Protocol Violation|0|||
130265134|NCT01815424|468937220|FG003|Week 0 to 16|Protocol Violation|0|||
130265135|NCT01815424|468937221|FG004|Week 0 to 16|Protocol Violation|0|||
130265136|NCT01815424|468937217|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
130265137|NCT01815424|468937218|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
130265138|NCT01815424|468937219|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
130265139|NCT01815424|468937220|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
130265140|NCT01815424|468937221|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
130265141|NCT01815424|468937217|FG000|Week 16 to 52|Other|0|||
130265142|NCT01815424|468937218|FG001|Week 16 to 52|Other|1|||
130265143|NCT01815424|468937219|FG002|Week 16 to 52|Other|0|||
130265144|NCT01815424|468937220|FG003|Week 16 to 52|Other|0|||
130265145|NCT01815424|468937221|FG004|Week 16 to 52|Other|0|||
130265146|NCT01815424|468937217|FG000|Week 16 to 52|Adverse Event|0|||
130265147|NCT01815424|468937218|FG001|Week 16 to 52|Adverse Event|0|||
130265148|NCT01815424|468937219|FG002|Week 16 to 52|Adverse Event|0|||
130265149|NCT01815424|468937220|FG003|Week 16 to 52|Adverse Event|0|||
130265150|NCT01815424|468937221|FG004|Week 16 to 52|Adverse Event|1|||
130265151|NCT01815424|468937217|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
130265152|NCT01815424|468937218|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
130265153|NCT01815424|468937219|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
130265154|NCT01815424|468937220|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
130265155|NCT01815424|468937221|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
130265156|NCT01815424|468937217|FG000|Week 16 to 52|Lost to Follow-up|0|||
130265157|NCT01815424|468937218|FG001|Week 16 to 52|Lost to Follow-up|2|||
130265158|NCT01815424|468937219|FG002|Week 16 to 52|Lost to Follow-up|0|||
130265159|NCT01815424|468937220|FG003|Week 16 to 52|Lost to Follow-up|2|||
130265160|NCT01815424|468937221|FG004|Week 16 to 52|Lost to Follow-up|1|||
130265161|NCT01815424|468937217|FG000|Week 16 to 52|Withdrawal by Subject|1|||
130265162|NCT01815424|468937218|FG001|Week 16 to 52|Withdrawal by Subject|2|||
130265163|NCT01815424|468937219|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130265164|NCT01815424|468937220|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130265165|NCT01815424|468937221|FG004|Week 16 to 52|Withdrawal by Subject|0|||
130265166|NCT01309204|468937222|FG000|Overall Study|Adverse Event|48|||
130265167|NCT01309204|468937223|FG001|Overall Study|Adverse Event|58|||
130265168|NCT01309204|468937222|FG000|Overall Study|Lost to Follow-up|2|||
130265169|NCT01309204|468937223|FG001|Overall Study|Lost to Follow-up|2|||
130265170|NCT01309204|468937222|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
130265171|NCT01309204|468937223|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
130265172|NCT01309204|468937222|FG000|Overall Study|Inadequate control of IOP|4|||
130265173|NCT01309204|468937223|FG001|Overall Study|Inadequate control of IOP|4|||
130265174|NCT01309204|468937222|FG000|Overall Study|Other|4|||
130265175|NCT01309204|468937223|FG001|Overall Study|Other|1|||
130265176|NCT03374358|468937224|FG000|Overall Study|Withdrawal by Subject|0|||
130265177|NCT03374358|468937225|FG001|Overall Study|Withdrawal by Subject|2|||
130265178|NCT03183063|468937226|FG000|Overall Study|Withdrawal by Subject|2|||
130265179|NCT03183063|468937227|FG001|Overall Study|Withdrawal by Subject|0|||
130265180|NCT03183063|468937228|FG002|Overall Study|Withdrawal by Subject|0|||
130265181|NCT03183063|468937226|FG000|Overall Study|Physician Decision|3|||
130265182|NCT03183063|468937227|FG001|Overall Study|Physician Decision|4|||
130265183|NCT03183063|468937228|FG002|Overall Study|Physician Decision|4|||
130265184|NCT01127633|468937229|FG000|Overall Study|Adverse Event|74|||
130265185|NCT01127633|468937230|FG001|Overall Study|Adverse Event|73|||
130265186|NCT01127633|468937229|FG000|Overall Study|Death|40|||
130265187|NCT01127633|468937230|FG001|Overall Study|Death|43|||
130265188|NCT01127633|468937229|FG000|Overall Study|Lost to Follow-up|4|||
130265189|NCT01127633|468937230|FG001|Overall Study|Lost to Follow-up|0|||
130265190|NCT01127633|468937229|FG000|Overall Study|Parent/Caregiver Decision|246|||
130265191|NCT01127633|468937230|FG001|Overall Study|Parent/Caregiver Decision|228|||
130265192|NCT01127633|468937229|FG000|Overall Study|Physician Decision|60|||
130265193|NCT01127633|468937230|FG001|Overall Study|Physician Decision|45|||
130265194|NCT01127633|468937229|FG000|Overall Study|Withdrawal by Subject|57|||
130265195|NCT01127633|468937230|FG001|Overall Study|Withdrawal by Subject|72|||
130265196|NCT01127633|468937229|FG000|Overall Study|Sponsor Decision|163|||
130265197|NCT01127633|468937230|FG001|Overall Study|Sponsor Decision|195|||
130265198|NCT01127633|468937229|FG000|Overall Study|Protocol Violation|8|||
130265199|NCT01127633|468937230|FG001|Overall Study|Protocol Violation|16|||
130265200|NCT01127633|468937229|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
130265201|NCT01127633|468937230|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
130265202|NCT01127633|468937229|FG000|Overall Study|Not treated|1|||
130265203|NCT01127633|468937230|FG001|Overall Study|Not treated|0|||
130265204|NCT00688467|468937231|FG000|Treatment Period 1|Adverse Event|2|||
130265205|NCT00688467|468937232|FG001|Treatment Period 1|Adverse Event|1|||
130265206|NCT00688467|468937231|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
130265207|NCT00688467|468937232|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
130265208|NCT00688467|468937231|FG000|Treatment Period 2|Protocol Violation|0|||
130265209|NCT00688467|468937232|FG001|Treatment Period 2|Protocol Violation|1|||
130265210|NCT00688467|468937231|FG000|Treatment Period 2|Adverse Event|0|||
130265211|NCT00688467|468937232|FG001|Treatment Period 2|Adverse Event|1|||
130265212|NCT00925002|468937233|FG000|Overall Study|Other|1|||
130265213|NCT00925002|468937234|FG001|Overall Study|Other|4|||
130265214|NCT00925002|468937235|FG002|Overall Study|Other|0|||
130265215|NCT00925002|468937233|FG000|Overall Study|Death|1|||
130265216|NCT00925002|468937234|FG001|Overall Study|Death|1|||
130265217|NCT00925002|468937235|FG002|Overall Study|Death|5|||
130265218|NCT00925002|468937233|FG000|Overall Study|Adverse Event|3|||
130265219|NCT00925002|468937234|FG001|Overall Study|Adverse Event|1|||
130265220|NCT00925002|468937235|FG002|Overall Study|Adverse Event|2|||
130265221|NCT00925002|468937233|FG000|Overall Study|Participant withdrew consent|1|||
130265222|NCT00925002|468937234|FG001|Overall Study|Participant withdrew consent|3|||
130265223|NCT00925002|468937235|FG002|Overall Study|Participant withdrew consent|3|||
130265224|NCT00690794|468937236|FG000|Overall Study|Adverse Event|12|||
130265225|NCT00690794|468937237|FG001|Overall Study|Adverse Event|10|||
130265226|NCT00690794|468937236|FG000|Overall Study|Lost to Follow-up|1|||
130265227|NCT00690794|468937237|FG001|Overall Study|Lost to Follow-up|4|||
130265228|NCT00690794|468937236|FG000|Overall Study|Withdrawal by Subject|0|||
130265229|NCT00690794|468937237|FG001|Overall Study|Withdrawal by Subject|9|||
130265230|NCT00690794|468937236|FG000|Overall Study|Protocol Violation|6|||
130265231|NCT00690794|468937237|FG001|Overall Study|Protocol Violation|7|||
130265232|NCT00690794|468937236|FG000|Overall Study|Noncompliance|1|||
130265233|NCT00690794|468937237|FG001|Overall Study|Noncompliance|2|||
130265234|NCT00690794|468937236|FG000|Overall Study|Other not specified|1|||
130265235|NCT00690794|468937237|FG001|Overall Study|Other not specified|3|||
130265236|NCT01496287|468937238|FG000|Overall Study|Lost to Follow-up|1|||
130265237|NCT01496287|468937238|FG000|Overall Study|Incomplete anesthesia|5|||
130265238|NCT01343888|468937239|FG000|Overall Study|Adverse Event|12|||
130265239|NCT01343888|468937240|FG001|Overall Study|Adverse Event|22|||
130265240|NCT01343888|468937241|FG002|Overall Study|Adverse Event|5|||
130265241|NCT01343888|468937239|FG000|Overall Study|Lack of Efficacy|9|||
129885630|NCT02855164|467540772|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
129885631|NCT02855164|467540773|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
129885632|NCT02855164|467540774|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
130265242|NCT01343888|468937240|FG001|Overall Study|Lack of Efficacy|9|||
130265243|NCT01343888|468937241|FG002|Overall Study|Lack of Efficacy|13|||
130265244|NCT01343888|468937239|FG000|Overall Study|Lost to Follow-up|0|||
130265245|NCT01343888|468937240|FG001|Overall Study|Lost to Follow-up|2|||
130265246|NCT01343888|468937241|FG002|Overall Study|Lost to Follow-up|1|||
130265247|NCT01343888|468937239|FG000|Overall Study|Protocol Violation|0|||
130265248|NCT01343888|468937240|FG001|Overall Study|Protocol Violation|2|||
129885633|NCT02855164|467540775|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
130265249|NCT01343888|468937241|FG002|Overall Study|Protocol Violation|0|||
130265250|NCT01343888|468937239|FG000|Overall Study|Withdrawal by Subject|4|||
130265251|NCT01343888|468937240|FG001|Overall Study|Withdrawal by Subject|4|||
130265252|NCT01343888|468937241|FG002|Overall Study|Withdrawal by Subject|2|||
130265253|NCT01343888|468937239|FG000|Overall Study|other than stated above|0|||
130265254|NCT01343888|468937240|FG001|Overall Study|other than stated above|0|||
130265255|NCT01343888|468937241|FG002|Overall Study|other than stated above|1|||
130265256|NCT01990742|468937242|FG000|Overall Study|Withdrawal by facility|407|||
130265257|NCT01990742|468937243|FG001|Overall Study|Withdrawal by facility|1083|||
130265258|NCT01990742|468937242|FG000|Overall Study|Facility closed|0|||
130265259|NCT01990742|468937243|FG001|Overall Study|Facility closed|270|||
130265260|NCT03443687|468937244|FG000|Overall Study|Lost to Follow-up|3|||
130265261|NCT03443687|468937245|FG001|Overall Study|Lost to Follow-up|5|||
130265262|NCT03443687|468937244|FG000|Overall Study|Withdrawal by Subject|1|||
130265263|NCT03443687|468937245|FG001|Overall Study|Withdrawal by Subject|0|||
130265264|NCT03443687|468937244|FG000|Overall Study|Discontinued intervention|1|||
130265265|NCT03443687|468937245|FG001|Overall Study|Discontinued intervention|1|||
130265266|NCT00800735|468937247|FG000|Overall Study|Administrative/Other|2|||
130265267|NCT00800735|468937247|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130265268|NCT00800735|468937247|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
130265269|NCT00800735|468937247|FG000|Overall Study|Withdrew Consent|3|||
130265270|NCT02805790|468937248|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
130265271|NCT02805790|468937249|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
130265272|NCT04460183|468937252|FG000|Overall Study|Lost to Follow-up|3|||
130265273|NCT04460183|468937253|FG001|Overall Study|Lost to Follow-up|1|||
130265274|NCT04460183|468937252|FG000|Overall Study|Withdrawal by Subject|1|||
130265275|NCT04460183|468937253|FG001|Overall Study|Withdrawal by Subject|0|||
130265276|NCT00825994|468937254|FG000|Overall Study|Withdrawal by Subject|2|||
130265277|NCT00825994|468937254|FG000|Overall Study|Lost to Follow-up|1|||
130265278|NCT00825994|468937254|FG000|Overall Study|Protocol Violation|1|||
130265279|NCT00825994|468937254|FG000|Overall Study|Placebo Responder at V2|1|||
130265280|NCT00332696|468937255|FG000|Overall Study|Death|24|||
130265281|NCT00332696|468937256|FG001|Overall Study|Death|14|||
130265282|NCT00332696|468937255|FG000|Overall Study|Insufficient therapeutic effect|4|||
130265283|NCT00332696|468937256|FG001|Overall Study|Insufficient therapeutic effect|11|||
130265284|NCT00332696|468937255|FG000|Overall Study|Adverse Event|1|||
130265285|NCT00332696|468937256|FG001|Overall Study|Adverse Event|2|||
130265286|NCT00332696|468937255|FG000|Overall Study|Condition does not justify treatment|0|||
130265287|NCT00332696|468937256|FG001|Overall Study|Condition does not justify treatment|2|||
130265288|NCT00332696|468937255|FG000|Overall Study|Lost to Follow-up|0|||
130265289|NCT00332696|468937256|FG001|Overall Study|Lost to Follow-up|1|||
130265290|NCT00332696|468937255|FG000|Overall Study|Withdrawal by Subject|1|||
130265291|NCT00332696|468937256|FG001|Overall Study|Withdrawal by Subject|0|||
130265292|NCT02394561|468937257|FG000|CORE Phase|Adverse Event|7|||
130265293|NCT02394561|468937258|FG001|CORE Phase|Adverse Event|9|||
130265294|NCT02394561|468937257|FG000|CORE Phase|Death|0|||
130265295|NCT02394561|468937258|FG001|CORE Phase|Death|1|||
130265296|NCT02394561|468937257|FG000|CORE Phase|Pregnancy|1|||
130265297|NCT02394561|468937258|FG001|CORE Phase|Pregnancy|0|||
130265298|NCT02394561|468937257|FG000|CORE Phase|Lost to Follow-up|1|||
130265299|NCT02394561|468937258|FG001|CORE Phase|Lost to Follow-up|0|||
130265300|NCT02394561|468937257|FG000|CORE Phase|Physician Decision|1|||
130265301|NCT02394561|468937258|FG001|CORE Phase|Physician Decision|1|||
130265302|NCT02394561|468937257|FG000|CORE Phase|Withdrawal by Subject|2|||
130265303|NCT02394561|468937258|FG001|CORE Phase|Withdrawal by Subject|2|||
130265304|NCT02394561|468937257|FG000|CORE Phase|Lack of Efficacy|1|||
130265305|NCT02394561|468937258|FG001|CORE Phase|Lack of Efficacy|6|||
130265306|NCT02394561|468937257|FG000|Extension Phase|Adverse Event|6|||
130265307|NCT02394561|468937258|FG001|Extension Phase|Adverse Event|1|||
130265308|NCT02394561|468937257|FG000|Extension Phase|Death|0|||
130265309|NCT02394561|468937258|FG001|Extension Phase|Death|1|||
130265310|NCT02394561|468937257|FG000|Extension Phase|Protocol Violation|1|||
130265311|NCT02394561|468937258|FG001|Extension Phase|Protocol Violation|0|||
130265312|NCT02394561|468937257|FG000|Extension Phase|Lost to Follow-up|1|||
130265313|NCT02394561|468937258|FG001|Extension Phase|Lost to Follow-up|0|||
130265314|NCT02394561|468937257|FG000|Extension Phase|Physician Decision|0|||
130265315|NCT02394561|468937258|FG001|Extension Phase|Physician Decision|2|||
130265316|NCT02394561|468937257|FG000|Extension Phase|Withdrawal by Subject|0|||
130265317|NCT02394561|468937258|FG001|Extension Phase|Withdrawal by Subject|5|||
130265318|NCT02394561|468937257|FG000|Extension Phase|Lack of Efficacy|3|||
130265319|NCT02394561|468937258|FG001|Extension Phase|Lack of Efficacy|3|||
130265320|NCT01882465|468937259|FG000|Period 1|Lens Discomfort|0|||
130265321|NCT01882465|468937260|FG001|Period 1|Lens Discomfort|0|||
130265322|NCT01882465|468937261|FG002|Period 1|Lens Discomfort|0|||
130265323|NCT01882465|468937262|FG003|Period 1|Lens Discomfort|1|||
130265324|NCT01882465|468937263|FG004|Period 1|Lens Discomfort|0|||
130265325|NCT01882465|468937264|FG005|Period 1|Lens Discomfort|0|||
130265326|NCT01882465|468937265|FG006|Period 1|Lens Discomfort|0|||
130265327|NCT01882465|468937259|FG000|Period 1|Withdrawal by Subject|0|||
130265328|NCT01882465|468937260|FG001|Period 1|Withdrawal by Subject|0|||
130265329|NCT01882465|468937261|FG002|Period 1|Withdrawal by Subject|0|||
130265330|NCT01882465|468937262|FG003|Period 1|Withdrawal by Subject|0|||
130265331|NCT01882465|468937263|FG004|Period 1|Withdrawal by Subject|0|||
130265332|NCT01882465|468937264|FG005|Period 1|Withdrawal by Subject|0|||
130265333|NCT01882465|468937265|FG006|Period 1|Withdrawal by Subject|1|||
130265334|NCT01882465|468937259|FG000|Period 2|Protocol Violation|0|||
130265335|NCT01882465|468937260|FG001|Period 2|Protocol Violation|0|||
130265336|NCT01882465|468937261|FG002|Period 2|Protocol Violation|0|||
130265337|NCT01882465|468937262|FG003|Period 2|Protocol Violation|0|||
130265338|NCT01882465|468937263|FG004|Period 2|Protocol Violation|1|||
130265339|NCT01882465|468937264|FG005|Period 2|Protocol Violation|0|||
130265340|NCT01882465|468937265|FG006|Period 2|Protocol Violation|0|||
130265341|NCT01378117|468937272|FG000|Overall Study|withdrawal|2|||
130265342|NCT01378117|468937273|FG001|Overall Study|withdrawal|1|||
130265343|NCT01378117|468937274|FG002|Overall Study|withdrawal|2|||
130265344|NCT01378117|468937272|FG000|Overall Study|discharged before med given|2|||
130265345|NCT01378117|468937273|FG001|Overall Study|discharged before med given|0|||
130265346|NCT01378117|468937274|FG002|Overall Study|discharged before med given|1|||
130265347|NCT02961244|468937276|FG000|Overall Study|Protocol Violation|0|||
130265348|NCT02961244|468937277|FG001|Overall Study|Protocol Violation|1|||
130265349|NCT02961244|468937276|FG000|Overall Study|Withdrawal by Subject|1|||
130265350|NCT02961244|468937277|FG001|Overall Study|Withdrawal by Subject|2|||
130265351|NCT02961244|468937276|FG000|Overall Study|Surgery plan change after study approval|0|||
130265352|NCT02961244|468937277|FG001|Overall Study|Surgery plan change after study approval|2|||
130265353|NCT02961244|468937276|FG000|Overall Study|Lost to Follow-up|0|||
130265354|NCT02961244|468937277|FG001|Overall Study|Lost to Follow-up|2|||
130265355|NCT02961244|468937276|FG000|Overall Study|İnadequate data|0|||
130102537|NCT00604175|468332775|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
130265356|NCT02961244|468937277|FG001|Overall Study|İnadequate data|2|||
130265357|NCT01854528|468937278|FG000|Overall Study|Adverse Event|0|||
130265358|NCT01854528|468937279|FG001|Overall Study|Adverse Event|4|||
130265359|NCT01854528|468937278|FG000|Overall Study|Withdrawal by Subject|0|||
130265360|NCT01854528|468937279|FG001|Overall Study|Withdrawal by Subject|2|||
130265361|NCT01854528|468937278|FG000|Overall Study|Virologic Failure|0|||
130265362|NCT01854528|468937279|FG001|Overall Study|Virologic Failure|9|||
130265363|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
130265364|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
130265365|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
130265366|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
130265367|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
130265368|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
130265369|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
130265370|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
130265371|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
130265372|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
130265373|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
130265374|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
130265375|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
130265376|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
130102538|NCT00604175|468332773|FG000|Week 29 Through Week 72|Site closure|0|||
130102539|NCT00604175|468332774|FG001|Week 29 Through Week 72|Site closure|1|||
130102540|NCT00604175|468332775|FG002|Week 29 Through Week 72|Site closure|0|||
130265377|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
130265378|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
130265379|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
130265380|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
130265381|NCT03789292|468937280|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
130265382|NCT03789292|468937281|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
130265383|NCT03789292|468937282|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
130265384|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
130265385|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
130265386|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
130265387|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
130265388|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
130265389|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
130265390|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
130265391|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
130265392|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
130265393|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
130265394|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
130265395|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
130265396|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
130265397|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
130265398|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
130265399|NCT03789292|468937280|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
130265400|NCT03789292|468937281|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
130265401|NCT03789292|468937282|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
130265402|NCT01904721|468937284|FG000|Overall Study|Other Reasons|0|||
130265403|NCT01904721|468937285|FG001|Overall Study|Other Reasons|0|||
130265404|NCT01904721|468937286|FG002|Overall Study|Other Reasons|1|||
130265405|NCT01904721|468937287|FG003|Overall Study|Other Reasons|1|||
130265406|NCT01904721|468937288|FG004|Overall Study|Other Reasons|2|||
130265407|NCT01904721|468937289|FG005|Overall Study|Other Reasons|2|||
130265408|NCT01904721|468937290|FG006|Overall Study|Other Reasons|2|||
130265409|NCT01904721|468937284|FG000|Overall Study|Personal Reasons|0|||
130265410|NCT01904721|468937285|FG001|Overall Study|Personal Reasons|0|||
130265411|NCT01904721|468937286|FG002|Overall Study|Personal Reasons|0|||
130265412|NCT01904721|468937287|FG003|Overall Study|Personal Reasons|0|||
130265413|NCT01904721|468937288|FG004|Overall Study|Personal Reasons|2|||
130265414|NCT01904721|468937289|FG005|Overall Study|Personal Reasons|3|||
130265415|NCT01904721|468937290|FG006|Overall Study|Personal Reasons|3|||
130265416|NCT01904721|468937284|FG000|Overall Study|Lost to Follow-up|0|||
130265417|NCT01904721|468937285|FG001|Overall Study|Lost to Follow-up|0|||
130265418|NCT01904721|468937286|FG002|Overall Study|Lost to Follow-up|0|||
130265419|NCT01904721|468937287|FG003|Overall Study|Lost to Follow-up|0|||
130265420|NCT01904721|468937288|FG004|Overall Study|Lost to Follow-up|1|||
130265421|NCT01904721|468937289|FG005|Overall Study|Lost to Follow-up|3|||
130265422|NCT01904721|468937290|FG006|Overall Study|Lost to Follow-up|1|||
130265423|NCT01904721|468937284|FG000|Overall Study|Lack of Efficacy|0|||
130265424|NCT01904721|468937285|FG001|Overall Study|Lack of Efficacy|0|||
130265425|NCT01904721|468937286|FG002|Overall Study|Lack of Efficacy|0|||
130265426|NCT01904721|468937287|FG003|Overall Study|Lack of Efficacy|0|||
130265427|NCT01904721|468937288|FG004|Overall Study|Lack of Efficacy|0|||
130265428|NCT01904721|468937289|FG005|Overall Study|Lack of Efficacy|0|||
130265429|NCT01904721|468937290|FG006|Overall Study|Lack of Efficacy|1|||
130265430|NCT01904721|468937284|FG000|Overall Study|Adverse Event|0|||
130265431|NCT01904721|468937285|FG001|Overall Study|Adverse Event|0|||
130265432|NCT01904721|468937286|FG002|Overall Study|Adverse Event|0|||
130265433|NCT01904721|468937287|FG003|Overall Study|Adverse Event|0|||
130265434|NCT01904721|468937288|FG004|Overall Study|Adverse Event|3|||
130265435|NCT01904721|468937289|FG005|Overall Study|Adverse Event|1|||
130265436|NCT01904721|468937290|FG006|Overall Study|Adverse Event|0|||
130265437|NCT01957865|468937291|FG000|Overall Study|Found HIV negative|0|||
130265438|NCT01957865|468937292|FG001|Overall Study|Found HIV negative|0|||
130265439|NCT01957865|468937293|FG002|Overall Study|Found HIV negative|1|||
130265440|NCT01957865|468937291|FG000|Overall Study|Lost to Follow-up|0|||
130265441|NCT01957865|468937292|FG001|Overall Study|Lost to Follow-up|2|||
130265442|NCT01957865|468937293|FG002|Overall Study|Lost to Follow-up|2|||
130265443|NCT01082614|468937294|FG000|Overall Study|Adverse Event|1|||
130265444|NCT01082614|468937295|FG001|Overall Study|Adverse Event|4|||
130265445|NCT01082614|468937294|FG000|Overall Study|Equipment Malfunction|0|||
130265446|NCT01082614|468937295|FG001|Overall Study|Equipment Malfunction|1|||
130265447|NCT01082614|468937294|FG000|Overall Study|Physician Decision|2|||
130265448|NCT01082614|468937295|FG001|Overall Study|Physician Decision|0|||
130265449|NCT00811720|468937299|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
130265450|NCT00811720|468937300|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
130265451|NCT00811720|468937299|FG000|All Treated Patients|Adverse Event|20|||
130265452|NCT00811720|468937300|FG001|All Treated Patients|Adverse Event|62|||
130265453|NCT00811720|468937299|FG000|All Treated Patients|Lack of Efficacy|22|||
130265454|NCT00811720|468937300|FG001|All Treated Patients|Lack of Efficacy|18|||
130102541|NCT00604175|468332773|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
130265455|NCT00811720|468937299|FG000|All Treated Patients|Non-compliance|0|||
130265456|NCT00811720|468937300|FG001|All Treated Patients|Non-compliance|14|||
130265457|NCT00811720|468937299|FG000|All Treated Patients|Protocol Violation|9|||
130265458|NCT00811720|468937300|FG001|All Treated Patients|Protocol Violation|16|||
130265459|NCT00811720|468937299|FG000|All Treated Patients|Withdrawal by Subject|28|||
130265460|NCT00811720|468937300|FG001|All Treated Patients|Withdrawal by Subject|34|||
130265461|NCT00811720|468937299|FG000|All Treated Patients|Lost to Follow-up|10|||
130265462|NCT00811720|468937300|FG001|All Treated Patients|Lost to Follow-up|16|||
130265463|NCT00811720|468937299|FG000|All Treated Patients|Other Reason|7|||
130265464|NCT00811720|468937300|FG001|All Treated Patients|Other Reason|4|||
130265465|NCT00553631|468937301|FG000|Overall Study|Withdrawal by Subject|0|||
130265466|NCT00553631|468937302|FG001|Overall Study|Withdrawal by Subject|1|||
130265467|NCT00553631|468937301|FG000|Overall Study|Lost to Follow-up|1|||
130265468|NCT00553631|468937302|FG001|Overall Study|Lost to Follow-up|0|||
130265469|NCT01055613|468937303|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
130265470|NCT01055613|468937304|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130265471|NCT01055613|468937303|FG000|Overall Study|Unacceptable lens fit|1|||
130265472|NCT01055613|468937304|FG001|Overall Study|Unacceptable lens fit|0|||
130265473|NCT01055613|468937303|FG000|Overall Study|Discomfort|2|||
130265474|NCT01055613|468937304|FG001|Overall Study|Discomfort|1|||
130265475|NCT01055613|468937303|FG000|Overall Study|Lost to Follow-up|1|||
130265476|NCT01055613|468937304|FG001|Overall Study|Lost to Follow-up|1|||
130265477|NCT01055613|468937303|FG000|Overall Study|Protocol Violation|1|||
130265478|NCT01055613|468937304|FG001|Overall Study|Protocol Violation|1|||
130265479|NCT01055613|468937303|FG000|Overall Study|Subject Disinterest|1|||
130265480|NCT01055613|468937304|FG001|Overall Study|Subject Disinterest|1|||
130265481|NCT02765399|468937307|FG000|Overall Study|Nausea|1|||
130265482|NCT02765399|468937308|FG001|Overall Study|Nausea|0|||
130265483|NCT01182298|468937313|FG000|Overall Study|Lack of Efficacy|4|||
130265484|NCT01182298|468937313|FG000|Overall Study|Withdrawal by Subject|2|||
130265485|NCT01822665|468937329|FG000|Overall Study|Adverse Event|3|||
130265486|NCT01822665|468937329|FG000|Overall Study|Other Reason|5|||
130265487|NCT04540367|468937330|FG000|Overall Study|Withdrawal by Subject|0|||
130265488|NCT04540367|468937331|FG001|Overall Study|Withdrawal by Subject|0|||
130265489|NCT04540367|468937332|FG002|Overall Study|Withdrawal by Subject|0|||
130265490|NCT04540367|468937333|FG003|Overall Study|Withdrawal by Subject|2|||
130265491|NCT04540367|468937330|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
130265492|NCT04540367|468937331|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
130265493|NCT04540367|468937332|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
130265494|NCT04540367|468937333|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
130265495|NCT04540367|468937330|FG000|Overall Study|Adverse Event|0|||
130265496|NCT04540367|468937331|FG001|Overall Study|Adverse Event|0|||
130265497|NCT04540367|468937332|FG002|Overall Study|Adverse Event|1|||
130265498|NCT04540367|468937333|FG003|Overall Study|Adverse Event|1|||
130265499|NCT00959907|468937336|FG000|Overall Study|Protocol Violation|0|||
130265500|NCT00959907|468937337|FG001|Overall Study|Protocol Violation|1|||
130265501|NCT00959907|468937336|FG000|Overall Study|Adverse Event|1|||
130265502|NCT00959907|468937337|FG001|Overall Study|Adverse Event|0|||
130265503|NCT00959907|468937336|FG000|Overall Study|Withdrawal by Subject|2|||
130265504|NCT00959907|468937337|FG001|Overall Study|Withdrawal by Subject|0|||
130265505|NCT03958331|468937338|FG000|Overall Study|Withdrawal by Subject|3|||
130265506|NCT03958331|468937339|FG001|Overall Study|Withdrawal by Subject|1|||
130265507|NCT03958331|468937340|FG002|Overall Study|Withdrawal by Subject|5|||
130265508|NCT03958331|468937338|FG000|Overall Study|Weaned from medicine|2|||
130265509|NCT03958331|468937339|FG001|Overall Study|Weaned from medicine|0|||
130265510|NCT03958331|468937340|FG002|Overall Study|Weaned from medicine|0|||
130265511|NCT03958331|468937338|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
130265512|NCT03958331|468937339|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
130265513|NCT03958331|468937340|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
130265514|NCT04290624|468937341|FG000|Overall Study|Adverse Event|1|||
130265515|NCT04290624|468937342|FG001|Overall Study|Adverse Event|0|||
130265516|NCT04422431|468937343|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
130265517|NCT04422431|468937343|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
130265518|NCT04422431|468937343|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
130265519|NCT04422431|468937343|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
130265520|NCT04422431|468937343|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
130265521|NCT04422431|468937343|FG000|Extension Period (48 Weeks)|Other than specified|2|||
130265522|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
130265523|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
130265524|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
130265525|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
130265526|NCT02735421|468938760|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
130265527|NCT02735421|468938760|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
130265528|NCT02735421|468938760|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
130265529|NCT05010070|468938761|FG000|Overall Study|Lost to Follow-up|1|||
130265530|NCT05010070|468938761|FG000|Overall Study|Withdrawal by Subject|1|||
130265531|NCT03247829|468938763|FG000|Overall Study|Death|3|||
130265532|NCT03247829|468938764|FG001|Overall Study|Death|4|||
130265533|NCT03247829|468938763|FG000|Overall Study|Enter Hospice Care|1|||
130265534|NCT03247829|468938764|FG001|Overall Study|Enter Hospice Care|0|||
130265535|NCT03247829|468938763|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
130265536|NCT03247829|468938764|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
130265537|NCT03247829|468938763|FG000|Overall Study|LVAD Explant|1|||
130265538|NCT03247829|468938764|FG001|Overall Study|LVAD Explant|1|||
130265539|NCT03247829|468938763|FG000|Overall Study|Transplant|1|||
130265540|NCT03247829|468938764|FG001|Overall Study|Transplant|1|||
130265541|NCT01783444|468938765|FG000|Treatment Phase|Adverse Event|9|||
130265542|NCT01783444|468938766|FG001|Treatment Phase|Adverse Event|20|||
130265543|NCT01783444|468938767|FG002|Treatment Phase|Adverse Event|19|||
130265544|NCT01783444|468938765|FG000|Treatment Phase|Disease Progression|76|||
130265545|NCT01783444|468938766|FG001|Treatment Phase|Disease Progression|66|||
130265546|NCT01783444|468938767|FG002|Treatment Phase|Disease Progression|64|||
130265547|NCT01783444|468938765|FG000|Treatment Phase|Death|2|||
130265548|NCT01783444|468938766|FG001|Treatment Phase|Death|2|||
130265549|NCT01783444|468938767|FG002|Treatment Phase|Death|2|||
130265550|NCT01783444|468938765|FG000|Treatment Phase|Protocol Violation|1|||
130265551|NCT01783444|468938766|FG001|Treatment Phase|Protocol Violation|1|||
130265552|NCT01783444|468938767|FG002|Treatment Phase|Protocol Violation|2|||
130265553|NCT01783444|468938765|FG000|Treatment Phase|Withdrawal by Subject|6|||
130265554|NCT01783444|468938766|FG001|Treatment Phase|Withdrawal by Subject|8|||
130265555|NCT01783444|468938767|FG002|Treatment Phase|Withdrawal by Subject|9|||
130265556|NCT01783444|468938765|FG000|Treatment Phase|Administrative problems|2|||
130265557|NCT01783444|468938766|FG001|Treatment Phase|Administrative problems|0|||
130265558|NCT01783444|468938767|FG002|Treatment Phase|Administrative problems|1|||
130265559|NCT01783444|468938765|FG000|Treatment Phase|Physician Decision|8|||
130265560|NCT01783444|468938766|FG001|Treatment Phase|Physician Decision|6|||
130265561|NCT01783444|468938767|FG002|Treatment Phase|Physician Decision|5|||
130265562|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
130265563|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
130265564|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
130265565|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
130265566|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
130265567|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
130265568|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
130265569|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
130265570|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
130265571|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
130265572|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
130265573|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
130265574|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
130265575|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
130265576|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
130265577|NCT01783444|468938765|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
130265578|NCT01783444|468938766|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
130265579|NCT01783444|468938767|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
130265580|NCT01047007|468938773|FG000|Overall Study|Adverse Event|0|||
130265581|NCT01047007|468938774|FG001|Overall Study|Adverse Event|2|||
130265582|NCT01047007|468938775|FG002|Overall Study|Adverse Event|1|||
130265583|NCT01047007|468938776|FG003|Overall Study|Adverse Event|0|||
130265584|NCT01047007|468938773|FG000|Overall Study|Progressive Disease|2|||
130265585|NCT01047007|468938774|FG001|Overall Study|Progressive Disease|4|||
130265586|NCT01047007|468938775|FG002|Overall Study|Progressive Disease|1|||
130265587|NCT01047007|468938776|FG003|Overall Study|Progressive Disease|0|||
130265588|NCT01334554|468938777|FG000|Overall Study|Adverse Event|4|||
130102542|NCT00604175|468332774|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
130102543|NCT00604175|468332775|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
130102544|NCT02044094|468332776|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
130265589|NCT01334554|468938778|FG001|Overall Study|Adverse Event|2|||
130265590|NCT02393859|468938779|FG000|Overall Study|Decision by Sponsor|2|||
130265591|NCT02393859|468938780|FG001|Overall Study|Decision by Sponsor|4|||
130265592|NCT02393859|468938779|FG000|Overall Study|Withdrawal by Subject|11|||
130265593|NCT02393859|468938780|FG001|Overall Study|Withdrawal by Subject|6|||
130265594|NCT02393859|468938779|FG000|Overall Study|Death|27|||
130265595|NCT02393859|468938780|FG001|Overall Study|Death|10|||
130265596|NCT02393859|468938779|FG000|Overall Study|Lost to Follow-up|1|||
130265597|NCT02393859|468938780|FG001|Overall Study|Lost to Follow-up|1|||
130265598|NCT00954447|468938781|FG000|Overall Study|Adverse Event|33|||
130265599|NCT00954447|468938782|FG001|Overall Study|Adverse Event|25|||
130102545|NCT02044094|468332776|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
130102546|NCT02044094|468332776|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
130102547|NCT02044094|468332776|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
130102548|NCT02044094|468332776|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
130102549|NCT02044094|468332776|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
130102550|NCT02044094|468332776|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
130102551|NCT02044094|468332776|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
130102552|NCT02392377|468332777|FG000|Overall Study|Withdrawal by Subject|0|||
130102553|NCT02392377|468332778|FG001|Overall Study|Withdrawal by Subject|1|||
130102554|NCT03205163|468332781|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
130265600|NCT00954447|468938781|FG000|Overall Study|Lack of Efficacy|17|||
130265601|NCT00954447|468938782|FG001|Overall Study|Lack of Efficacy|3|||
130265602|NCT00954447|468938781|FG000|Overall Study|Protocol Violation|5|||
130265603|NCT00954447|468938782|FG001|Overall Study|Protocol Violation|7|||
130265604|NCT00954447|468938781|FG000|Overall Study|Lost to Follow-up|8|||
130265605|NCT00954447|468938782|FG001|Overall Study|Lost to Follow-up|14|||
130265606|NCT00954447|468938781|FG000|Overall Study|Withdrawal by Subject|26|||
130265607|NCT00954447|468938782|FG001|Overall Study|Withdrawal by Subject|21|||
130265608|NCT00954447|468938781|FG000|Overall Study|Other|21|||
130265609|NCT00954447|468938782|FG001|Overall Study|Other|18|||
130102555|NCT03205163|468332782|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
130102556|NCT02545868|468334311|FG000|Overall Study|Lack of Efficacy|1|||
130102557|NCT02545868|468334312|FG001|Overall Study|Lack of Efficacy|1|||
130102558|NCT02545868|468334313|FG002|Overall Study|Lack of Efficacy|0|||
130102559|NCT02545868|468334311|FG000|Overall Study|Lost to Follow-up|1|||
130102560|NCT02545868|468334312|FG001|Overall Study|Lost to Follow-up|5|||
130102561|NCT02545868|468334313|FG002|Overall Study|Lost to Follow-up|1|||
130102562|NCT02545868|468334311|FG000|Overall Study|Non-compliance|1|||
130102563|NCT02545868|468334312|FG001|Overall Study|Non-compliance|1|||
130102564|NCT02545868|468334313|FG002|Overall Study|Non-compliance|1|||
130102565|NCT02545868|468334311|FG000|Overall Study|Treatment change|21|||
130102566|NCT02545868|468334312|FG001|Overall Study|Treatment change|19|||
130102567|NCT02545868|468334313|FG002|Overall Study|Treatment change|22|||
130102568|NCT02545868|468334311|FG000|Overall Study|Physician Decision|1|||
130102569|NCT02545868|468334312|FG001|Overall Study|Physician Decision|1|||
130102570|NCT02545868|468334313|FG002|Overall Study|Physician Decision|1|||
130102571|NCT02545868|468334311|FG000|Overall Study|Withdrawal by Subject|6|||
130265610|NCT04592341|468938783|FG000|Overall Study|Physician Decision|5|||
130265611|NCT04592341|468938783|FG000|Overall Study|Study Terminated by Sponsor|5|||
130265612|NCT04592341|468938783|FG000|Overall Study|Withdrawal by Subject|53|||
130265613|NCT04592341|468938783|FG000|Overall Study|Lost to Follow-up|3|||
130265614|NCT04592341|468938783|FG000|Overall Study|Death|1|||
130102572|NCT02545868|468334312|FG001|Overall Study|Withdrawal by Subject|7|||
130102573|NCT02545868|468334313|FG002|Overall Study|Withdrawal by Subject|9|||
130102574|NCT04465916|468334318|FG000|Overall Study|Withdrawal by Subject|0|||
130265615|NCT04592341|468938783|FG000|Overall Study|Adverse Event|5|||
130265616|NCT04592341|468938783|FG000|Overall Study|other|4|||
130265617|NCT00692003|468938784|FG000|Overall Study|Sponsor Decision|5|||
130265618|NCT00692003|468938785|FG001|Overall Study|Sponsor Decision|1|||
130265619|NCT01248793|468938786|FG000|Overall Study|Lost to Follow-up|0|||
130265620|NCT01248793|468938787|FG001|Overall Study|Lost to Follow-up|1|||
130265621|NCT01248793|468938786|FG000|Overall Study|Adverse Event|1|||
130265622|NCT01248793|468938787|FG001|Overall Study|Adverse Event|1|||
130265623|NCT01248793|468938786|FG000|Overall Study|Protocol Violation|0|||
130265624|NCT01248793|468938787|FG001|Overall Study|Protocol Violation|1|||
130102575|NCT04465916|468334319|FG001|Overall Study|Withdrawal by Subject|1|||
130102576|NCT01325701|468334321|FG000|Overall Study|Adverse Event|12|||
130102577|NCT01325701|468334322|FG001|Overall Study|Adverse Event|0|||
130102578|NCT01325701|468334321|FG000|Overall Study|Protocol Violation|1|||
130265625|NCT01248793|468938786|FG000|Overall Study|Withdrawal by Subject|3|||
130265626|NCT01248793|468938787|FG001|Overall Study|Withdrawal by Subject|3|||
130265627|NCT01840943|468938788|FG000|Overall Study|Withdrawal by Subject|5|||
130265628|NCT01840943|468938789|FG001|Overall Study|Withdrawal by Subject|6|||
130265629|NCT01840943|468938788|FG000|Overall Study|Physician Decision|4|||
130265630|NCT01840943|468938789|FG001|Overall Study|Physician Decision|2|||
130265631|NCT01840943|468938788|FG000|Overall Study|Lost to Follow-up|4|||
130265632|NCT01840943|468938789|FG001|Overall Study|Lost to Follow-up|4|||
130265633|NCT02580877|468938792|FG000|Overall Study|Withdrawal by Subject|1|||
130265634|NCT02580877|468938793|FG001|Overall Study|Withdrawal by Subject|3|||
130265635|NCT02580877|468938792|FG000|Overall Study|Adverse Event|0|||
130265636|NCT02580877|468938793|FG001|Overall Study|Adverse Event|1|||
130265637|NCT03341637|468938794|FG000|Overall Study|Lost to Follow-up|1|||
130265638|NCT03341637|468938795|FG001|Overall Study|Lost to Follow-up|0|||
130265639|NCT03341637|468938794|FG000|Overall Study|Withdrawal by Subject|3|||
130265640|NCT03341637|468938795|FG001|Overall Study|Withdrawal by Subject|3|||
130265641|NCT03341637|468938794|FG000|Overall Study|Reason not Specified|1|||
130265642|NCT03341637|468938795|FG001|Overall Study|Reason not Specified|1|||
130265643|NCT00887159|468938802|FG000|Overall Study|Disease progression|6|||
130265644|NCT00887159|468938803|FG001|Overall Study|Disease progression|39|||
130265645|NCT00887159|468938804|FG002|Overall Study|Disease progression|33|||
130265646|NCT00887159|468938802|FG000|Overall Study|Adverse Event|3|||
130265647|NCT00887159|468938803|FG001|Overall Study|Adverse Event|4|||
130265648|NCT00887159|468938804|FG002|Overall Study|Adverse Event|17|||
130265649|NCT00887159|468938802|FG000|Overall Study|Death|2|||
130265650|NCT00887159|468938803|FG001|Overall Study|Death|2|||
130265651|NCT00887159|468938804|FG002|Overall Study|Death|0|||
130265652|NCT00887159|468938802|FG000|Overall Study|Withdrawal by Subject|4|||
130265653|NCT00887159|468938803|FG001|Overall Study|Withdrawal by Subject|4|||
130265654|NCT00887159|468938804|FG002|Overall Study|Withdrawal by Subject|2|||
130265655|NCT00887159|468938802|FG000|Overall Study|Alternative therapy|2|||
130265656|NCT00887159|468938803|FG001|Overall Study|Alternative therapy|0|||
130265657|NCT00887159|468938804|FG002|Overall Study|Alternative therapy|0|||
130265658|NCT00887159|468938802|FG000|Overall Study|Physician Decision|1|||
130265659|NCT00887159|468938803|FG001|Overall Study|Physician Decision|1|||
130265660|NCT00887159|468938804|FG002|Overall Study|Physician Decision|0|||
130265661|NCT00887159|468938802|FG000|Overall Study|Sympomatic deterioration|1|||
130265662|NCT00887159|468938803|FG001|Overall Study|Sympomatic deterioration|0|||
130265663|NCT00887159|468938804|FG002|Overall Study|Sympomatic deterioration|0|||
130265664|NCT00887159|468938802|FG000|Overall Study|Treatment delayed|1|||
130265665|NCT00887159|468938803|FG001|Overall Study|Treatment delayed|1|||
130265666|NCT00887159|468938804|FG002|Overall Study|Treatment delayed|0|||
130265667|NCT00887159|468938802|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
130265668|NCT00887159|468938803|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
130265669|NCT00887159|468938804|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
130265670|NCT00887159|468938802|FG000|Overall Study|Received more tx instead of observation|1|||
130265671|NCT00887159|468938803|FG001|Overall Study|Received more tx instead of observation|0|||
130265672|NCT00887159|468938804|FG002|Overall Study|Received more tx instead of observation|0|||
130265673|NCT00887159|468938802|FG000|Overall Study|Ineligible|5|||
130265674|NCT00887159|468938803|FG001|Overall Study|Ineligible|1|||
130265675|NCT00887159|468938804|FG002|Overall Study|Ineligible|0|||
130265676|NCT00887159|468938802|FG000|Overall Study|Never started assigned therapy|3|||
130265677|NCT00887159|468938803|FG001|Overall Study|Never started assigned therapy|3|||
130265678|NCT00887159|468938804|FG002|Overall Study|Never started assigned therapy|4|||
130265679|NCT01823107|468938814|FG000|Overall Study|Withdrawal by Subject|1|||
130265680|NCT01847092|468938816|FG000|Overall Study|Adverse Event|12|||
130265681|NCT01847092|468938817|FG001|Overall Study|Adverse Event|3|||
130265682|NCT01847092|468938816|FG000|Overall Study|Withdrawal by Subject|5|||
130265683|NCT01847092|468938817|FG001|Overall Study|Withdrawal by Subject|5|||
130265684|NCT01847092|468938816|FG000|Overall Study|Protocol Specified|8|||
130265685|NCT01847092|468938817|FG001|Overall Study|Protocol Specified|0|||
130265686|NCT01847092|468938816|FG000|Overall Study|Physician Decision|1|||
130265687|NCT01847092|468938817|FG001|Overall Study|Physician Decision|1|||
130265688|NCT01847092|468938816|FG000|Overall Study|Protocol Violation|0|||
130265689|NCT01847092|468938817|FG001|Overall Study|Protocol Violation|2|||
130265690|NCT01331681|468938818|FG000|Overall Study|Adverse Event|10|||
130265691|NCT01331681|468938819|FG001|Overall Study|Adverse Event|13|||
130265692|NCT01331681|468938820|FG002|Overall Study|Adverse Event|10|||
130265693|NCT01331681|468938818|FG000|Overall Study|Death|6|||
130265694|NCT01331681|468938819|FG001|Overall Study|Death|6|||
130265695|NCT01331681|468938820|FG002|Overall Study|Death|2|||
130265696|NCT01331681|468938818|FG000|Overall Study|Lack of Efficacy|0|||
130265697|NCT01331681|468938819|FG001|Overall Study|Lack of Efficacy|1|||
130265698|NCT01331681|468938820|FG002|Overall Study|Lack of Efficacy|0|||
130265699|NCT01331681|468938818|FG000|Overall Study|Withdrawal by Subject|12|||
130265700|NCT01331681|468938819|FG001|Overall Study|Withdrawal by Subject|8|||
130265701|NCT01331681|468938820|FG002|Overall Study|Withdrawal by Subject|15|||
130265702|NCT01331681|468938818|FG000|Overall Study|Protocol Violation|1|||
130265703|NCT01331681|468938819|FG001|Overall Study|Protocol Violation|1|||
130265704|NCT01331681|468938820|FG002|Overall Study|Protocol Violation|0|||
130265705|NCT01331681|468938818|FG000|Overall Study|Lost to Follow-up|2|||
130265706|NCT01331681|468938819|FG001|Overall Study|Lost to Follow-up|4|||
130265707|NCT01331681|468938820|FG002|Overall Study|Lost to Follow-up|1|||
130265708|NCT01331681|468938818|FG000|Overall Study|Physician Decision|2|||
130265709|NCT01331681|468938819|FG001|Overall Study|Physician Decision|0|||
130265710|NCT01331681|468938820|FG002|Overall Study|Physician Decision|4|||
130265711|NCT01331681|468938818|FG000|Overall Study|Therapeutic procedure required|1|||
130265712|NCT01331681|468938819|FG001|Overall Study|Therapeutic procedure required|0|||
130265713|NCT01331681|468938820|FG002|Overall Study|Therapeutic procedure required|0|||
130265714|NCT01331681|468938818|FG000|Overall Study|Sponsor decision|1|||
130265715|NCT01331681|468938819|FG001|Overall Study|Sponsor decision|1|||
130265716|NCT01331681|468938820|FG002|Overall Study|Sponsor decision|0|||
130265717|NCT01331681|468938818|FG000|Overall Study|Switching to other therapy|0|||
130265718|NCT01331681|468938819|FG001|Overall Study|Switching to other therapy|0|||
130265719|NCT01331681|468938820|FG002|Overall Study|Switching to other therapy|1|||
130265720|NCT01331681|468938818|FG000|Overall Study|Not Received Study Treatment|0|||
130265721|NCT01331681|468938819|FG001|Overall Study|Not Received Study Treatment|0|||
130265722|NCT01331681|468938820|FG002|Overall Study|Not Received Study Treatment|2|||
130265723|NCT00658541|468938822|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130265724|NCT00658541|468938823|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130265725|NCT00658541|468938822|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130265726|NCT00658541|468938823|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130265727|NCT03326063|468938824|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
130265728|NCT03326063|468938825|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
130265729|NCT01876381|468938826|FG000|Overall Study|Lack of Efficacy|5|||
130265730|NCT01876381|468938826|FG000|Overall Study|Physician Decision|1|||
130265731|NCT01876381|468938826|FG000|Overall Study|Withdrawal by Subject|1|||
130265732|NCT00461708|468938827|FG000|Overall Study|Adverse Event|17|||
130265733|NCT00461708|468938828|FG001|Overall Study|Adverse Event|7|||
130265734|NCT00461708|468938827|FG000|Overall Study|Lack of Efficacy|68|||
130265735|NCT00461708|468938828|FG001|Overall Study|Lack of Efficacy|20|||
130265736|NCT00461708|468938827|FG000|Overall Study|Physician Decision|10|||
130265737|NCT00461708|468938828|FG001|Overall Study|Physician Decision|4|||
130265738|NCT00461708|468938827|FG000|Overall Study|Withdrawal by Subject|8|||
130265739|NCT00461708|468938828|FG001|Overall Study|Withdrawal by Subject|2|||
130265740|NCT00461708|468938827|FG000|Overall Study|Other|4|||
130265741|NCT00461708|468938828|FG001|Overall Study|Other|4|||
130102579|NCT01325701|468334322|FG001|Overall Study|Protocol Violation|0|||
130102580|NCT01325701|468334321|FG000|Overall Study|Physician Decision|2|||
130102581|NCT01325701|468334322|FG001|Overall Study|Physician Decision|2|||
130102582|NCT01325701|468334321|FG000|Overall Study|Withdrawal by Subject|2|||
130265742|NCT00461708|468938827|FG000|Overall Study|Death|8|||
130265743|NCT00461708|468938828|FG001|Overall Study|Death|1|||
130265744|NCT02803203|468938829|FG000|Overall Study|Adverse Event|4|||
130265745|NCT02803203|468938829|FG000|Overall Study|Death|4|||
130265746|NCT02803203|468938829|FG000|Overall Study|Progressive disease|29|||
130265747|NCT02803203|468938829|FG000|Overall Study|Withdrawal by Subject|8|||
130265748|NCT02803203|468938829|FG000|Overall Study|Complete resection of target disease|2|||
130265749|NCT02803203|468938829|FG000|Overall Study|Switched to commercial Osi|1|||
130265750|NCT02803203|468938829|FG000|Overall Study|Participant moved away|1|||
130265751|NCT04577781|468938830|FG000|Overall Study|Adverse Event|2|||
130265752|NCT04577781|468938831|FG001|Overall Study|Adverse Event|2|||
130265753|NCT04577781|468938830|FG000|Overall Study|Physician Decision|1|||
130265754|NCT04577781|468938831|FG001|Overall Study|Physician Decision|0|||
130265755|NCT03894891|468938832|FG000|Overall Study|Withdrawal by Subject|1|||
130265756|NCT03894891|468938832|FG000|Overall Study|Completed protocol treatment per protocol|5|||
130265757|NCT00950651|468938836|FG000|Overall Study|Adverse Event|17|||
130265758|NCT00950651|468938837|FG001|Overall Study|Adverse Event|20|||
130265759|NCT00950651|468938836|FG000|Overall Study|Death|1|||
130102583|NCT01325701|468334322|FG001|Overall Study|Withdrawal by Subject|1|||
130265760|NCT00950651|468938837|FG001|Overall Study|Death|0|||
130265761|NCT00950651|468938836|FG000|Overall Study|Lack of Efficacy|2|||
130265762|NCT00950651|468938837|FG001|Overall Study|Lack of Efficacy|2|||
130265763|NCT00950651|468938836|FG000|Overall Study|Protocol Violation|3|||
130265764|NCT00950651|468938837|FG001|Overall Study|Protocol Violation|4|||
130265765|NCT00950651|468938836|FG000|Overall Study|Withdrawal by Subject|8|||
130265766|NCT00950651|468938837|FG001|Overall Study|Withdrawal by Subject|9|||
130265767|NCT01824290|468938839|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
130265768|NCT01824290|468938840|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
130265769|NCT01824290|468938841|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
130265770|NCT01824290|468938842|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
130265771|NCT01824290|468938839|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
130265772|NCT01824290|468938840|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
130265773|NCT01824290|468938841|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
130265774|NCT01824290|468938842|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
130265775|NCT01824290|468938839|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
130102584|NCT01325701|468334321|FG000|Overall Study|Rollerover Extension Study|4|||
130265776|NCT01824290|468938840|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
130265777|NCT01824290|468938841|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
130102585|NCT01325701|468334322|FG001|Overall Study|Rollerover Extension Study|0|||
130102586|NCT00388674|468334329|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
130102587|NCT00388674|468334330|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
130102588|NCT00388674|468334329|FG000|Initial Treatment|Adverse Event|22|||
130102589|NCT00388674|468334330|FG001|Initial Treatment|Adverse Event|87|||
130102590|NCT00388674|468334329|FG000|Initial Treatment|Death|215|||
130102591|NCT00388674|468334330|FG001|Initial Treatment|Death|216|||
130102592|NCT00388674|468334329|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
130102593|NCT00388674|468334330|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
130102594|NCT00388674|468334329|FG000|Initial Treatment|HCC|12|||
130102595|NCT00388674|468334330|FG001|Initial Treatment|HCC|20|||
130102596|NCT00388674|468334329|FG000|Initial Treatment|Lost to Follow-up|526|||
130102597|NCT00388674|468334330|FG001|Initial Treatment|Lost to Follow-up|624|||
130102598|NCT00388674|468334329|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
130102599|NCT00388674|468334330|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
130265778|NCT01824290|468938842|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
130265779|NCT01824290|468938839|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
130265780|NCT01824290|468938840|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
130265781|NCT01824290|468938841|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
130265782|NCT01824290|468938842|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
130265783|NCT01824290|468938839|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
130265784|NCT01824290|468938840|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
130265785|NCT01824290|468938841|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
130265786|NCT01824290|468938842|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
130265787|NCT01824290|468938839|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
130265788|NCT01824290|468938840|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
130265789|NCT01824290|468938841|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
130265790|NCT01824290|468938842|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
130265791|NCT00527618|468938843|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
130265792|NCT00527618|468938844|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
130265793|NCT00527618|468938843|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
130265794|NCT00527618|468938844|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
130265795|NCT00527618|468938843|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
130265796|NCT00527618|468938844|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
130265797|NCT00527618|468938843|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
130265798|NCT00527618|468938844|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
130265799|NCT00527618|468938843|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
130265800|NCT00527618|468938844|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
130265801|NCT00527618|468938843|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
130265802|NCT00527618|468938844|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
130265803|NCT00114127|468938848|FG000|Overall Study|Adverse Event|2|||
130265804|NCT00114127|468938849|FG001|Overall Study|Adverse Event|1|||
130102600|NCT00388674|468334329|FG000|Initial Treatment|Never Treated with Study Medication|1|||
130102601|NCT00388674|468334330|FG001|Initial Treatment|Never Treated with Study Medication|7|||
130102602|NCT00388674|468334329|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
130102603|NCT00388674|468334330|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
130265805|NCT00114127|468938848|FG000|Overall Study|Lost to Follow-up|1|||
130265806|NCT00114127|468938849|FG001|Overall Study|Lost to Follow-up|0|||
130265807|NCT00114127|468938848|FG000|Overall Study|Withdrawal by Subject|1|||
130265808|NCT00114127|468938849|FG001|Overall Study|Withdrawal by Subject|3|||
130265809|NCT03188263|468938850|FG000|Overall Study|Withdrawal by Subject|3|||
130265810|NCT03188263|468938851|FG001|Overall Study|Withdrawal by Subject|0|||
130265811|NCT03188263|468938850|FG000|Overall Study|Physician Decision|1|||
130265812|NCT03188263|468938851|FG001|Overall Study|Physician Decision|0|||
130265813|NCT00881894|468938852|FG000|Overall Study|Consent withdrawn|0|||
130265814|NCT00881894|468938853|FG001|Overall Study|Consent withdrawn|1|||
130265815|NCT00881894|468938852|FG000|Overall Study|Other reasons for premature termination|1|||
130265816|NCT00881894|468938853|FG001|Overall Study|Other reasons for premature termination|2|||
130265817|NCT00421148|468938854|FG000|Overall Study|Lost to Follow-up|0|||
130265818|NCT00421148|468938855|FG001|Overall Study|Lost to Follow-up|0|||
130265819|NCT00421148|468938856|FG002|Overall Study|Lost to Follow-up|0|||
130265820|NCT00421148|468938857|FG003|Overall Study|Lost to Follow-up|0|||
130265821|NCT00421148|468938858|FG004|Overall Study|Lost to Follow-up|0|||
130265822|NCT00421148|468938859|FG005|Overall Study|Lost to Follow-up|0|||
130265823|NCT00421148|468938860|FG006|Overall Study|Lost to Follow-up|0|||
130102604|NCT00388674|468334329|FG000|Initial Treatment|Not Defined|125|||
130102605|NCT00388674|468334330|FG001|Initial Treatment|Not Defined|172|||
130102606|NCT00388674|468334329|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
130102607|NCT00388674|468334330|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
130102608|NCT00388674|468334329|FG000|Initial Treatment|Pregnancy|26|||
130102609|NCT00388674|468334330|FG001|Initial Treatment|Pregnancy|16|||
130102610|NCT00388674|468334329|FG000|Initial Treatment|Study Drug Toxicity|5|||
130102611|NCT00388674|468334330|FG001|Initial Treatment|Study Drug Toxicity|92|||
130102612|NCT00388674|468334329|FG000|Initial Treatment|Participant Request|501|||
130102613|NCT00388674|468334330|FG001|Initial Treatment|Participant Request|673|||
130102614|NCT00388674|468334329|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
130102615|NCT00388674|468334330|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
130102616|NCT00388674|468334329|FG000|Initial Treatment|Not Reported|10|||
130102617|NCT00388674|468334330|FG001|Initial Treatment|Not Reported|12|||
130102618|NCT00388674|468334329|FG000|End of Study|Administrative Reason By Sponsor|299|||
130102619|NCT00388674|468334330|FG001|End of Study|Administrative Reason By Sponsor|253|||
130102620|NCT00388674|468334329|FG000|End of Study|Death|239|||
130102621|NCT00388674|468334330|FG001|End of Study|Death|262|||
130102622|NCT00388674|468334329|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
130102623|NCT00388674|468334330|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
130102624|NCT00388674|468334329|FG000|End of Study|HCC|8|||
130102625|NCT00388674|468334330|FG001|End of Study|HCC|7|||
130102626|NCT00388674|468334329|FG000|End of Study|Lost to Follow-up|587|||
130102627|NCT00388674|468334330|FG001|End of Study|Lost to Follow-up|715|||
130102628|NCT00388674|468334329|FG000|End of Study|Malignancy (Non-HCC)|1|||
130102629|NCT00388674|468334330|FG001|End of Study|Malignancy (Non-HCC)|1|||
130102630|NCT00388674|468334329|FG000|End of Study|Non-Study Related Comorbidities|3|||
130102631|NCT00388674|468334330|FG001|End of Study|Non-Study Related Comorbidities|4|||
130102632|NCT00388674|468334329|FG000|End of Study|Not Defined|135|||
130102633|NCT00388674|468334330|FG001|End of Study|Not Defined|214|||
130102634|NCT00388674|468334329|FG000|End of Study|Participant Withdrew Consent|437|||
130102635|NCT00388674|468334330|FG001|End of Study|Participant Withdrew Consent|673|||
130265824|NCT00421148|468938861|FG007|Overall Study|Lost to Follow-up|0|||
130265825|NCT00421148|468938862|FG008|Overall Study|Lost to Follow-up|0|||
130265826|NCT00421148|468938863|FG009|Overall Study|Lost to Follow-up|0|||
130265827|NCT00421148|468938864|FG010|Overall Study|Lost to Follow-up|0|||
130265828|NCT00421148|468938865|FG011|Overall Study|Lost to Follow-up|0|||
130265829|NCT00421148|468938866|FG012|Overall Study|Lost to Follow-up|0|||
130265830|NCT00421148|468938867|FG013|Overall Study|Lost to Follow-up|0|||
130265831|NCT00421148|468938868|FG014|Overall Study|Lost to Follow-up|0|||
130265832|NCT00421148|468938869|FG015|Overall Study|Lost to Follow-up|0|||
130265833|NCT00421148|468938870|FG016|Overall Study|Lost to Follow-up|0|||
130265834|NCT00421148|468938871|FG017|Overall Study|Lost to Follow-up|1|||
130265835|NCT00421148|468938872|FG018|Overall Study|Lost to Follow-up|0|||
130265836|NCT00421148|468938873|FG019|Overall Study|Lost to Follow-up|0|||
130265837|NCT00421148|468938854|FG000|Overall Study|Withdrawal by Subject|0|||
130265838|NCT00421148|468938855|FG001|Overall Study|Withdrawal by Subject|0|||
130265839|NCT00421148|468938856|FG002|Overall Study|Withdrawal by Subject|0|||
130265840|NCT00421148|468938857|FG003|Overall Study|Withdrawal by Subject|0|||
130265841|NCT00421148|468938858|FG004|Overall Study|Withdrawal by Subject|0|||
130265842|NCT00421148|468938859|FG005|Overall Study|Withdrawal by Subject|0|||
130265843|NCT00421148|468938860|FG006|Overall Study|Withdrawal by Subject|0|||
130265844|NCT00421148|468938861|FG007|Overall Study|Withdrawal by Subject|0|||
130265845|NCT00421148|468938862|FG008|Overall Study|Withdrawal by Subject|0|||
130265846|NCT00421148|468938863|FG009|Overall Study|Withdrawal by Subject|0|||
130265847|NCT00421148|468938864|FG010|Overall Study|Withdrawal by Subject|0|||
130265848|NCT00421148|468938865|FG011|Overall Study|Withdrawal by Subject|0|||
130265849|NCT00421148|468938866|FG012|Overall Study|Withdrawal by Subject|0|||
130265850|NCT00421148|468938867|FG013|Overall Study|Withdrawal by Subject|0|||
130265851|NCT00421148|468938868|FG014|Overall Study|Withdrawal by Subject|0|||
130265852|NCT00421148|468938869|FG015|Overall Study|Withdrawal by Subject|0|||
130265853|NCT00421148|468938870|FG016|Overall Study|Withdrawal by Subject|0|||
130265854|NCT00421148|468938871|FG017|Overall Study|Withdrawal by Subject|1|||
130265855|NCT00421148|468938872|FG018|Overall Study|Withdrawal by Subject|0|||
129885634|NCT02855164|467540776|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
130102636|NCT00388674|468334329|FG000|End of Study|No Off-Treatment Status Data|22|||
130102637|NCT00388674|468334330|FG001|End of Study|No Off-Treatment Status Data|30|||
130102638|NCT00388674|468334329|FG000|End of Study|Not Reported|0|||
130102639|NCT00388674|468334330|FG001|End of Study|Not Reported|1|||
130102640|NCT00568776|468334331|FG000|Overall Study|Adverse Event|8|||
130102641|NCT00568776|468334332|FG001|Overall Study|Adverse Event|8|||
130102642|NCT00568776|468334333|FG002|Overall Study|Adverse Event|10|||
130102643|NCT00568776|468334334|FG003|Overall Study|Adverse Event|8|||
130102644|NCT00568776|468334331|FG000|Overall Study|Death|0|||
130102645|NCT00568776|468334332|FG001|Overall Study|Death|1|||
130102646|NCT00568776|468334333|FG002|Overall Study|Death|4|||
130265856|NCT00421148|468938873|FG019|Overall Study|Withdrawal by Subject|0|||
130265857|NCT00421148|468938854|FG000|Overall Study|Protocol Violation|0|||
130265858|NCT00421148|468938855|FG001|Overall Study|Protocol Violation|0|||
130265859|NCT00421148|468938856|FG002|Overall Study|Protocol Violation|0|||
130265860|NCT00421148|468938857|FG003|Overall Study|Protocol Violation|0|||
130102647|NCT00568776|468334334|FG003|Overall Study|Death|3|||
130102648|NCT00568776|468334331|FG000|Overall Study|Physician Decision|0|||
130102649|NCT00568776|468334332|FG001|Overall Study|Physician Decision|2|||
130102650|NCT00568776|468334333|FG002|Overall Study|Physician Decision|0|||
130102651|NCT00568776|468334334|FG003|Overall Study|Physician Decision|0|||
130102652|NCT00568776|468334331|FG000|Overall Study|Lack of Efficacy|2|||
130102653|NCT00568776|468334332|FG001|Overall Study|Lack of Efficacy|2|||
130102654|NCT00568776|468334333|FG002|Overall Study|Lack of Efficacy|2|||
130102655|NCT00568776|468334334|FG003|Overall Study|Lack of Efficacy|4|||
130102656|NCT00568776|468334331|FG000|Overall Study|Lost to Follow-up|1|||
130102657|NCT00568776|468334332|FG001|Overall Study|Lost to Follow-up|1|||
130102658|NCT00568776|468334333|FG002|Overall Study|Lost to Follow-up|1|||
130102659|NCT00568776|468334334|FG003|Overall Study|Lost to Follow-up|1|||
130102660|NCT00568776|468334331|FG000|Overall Study|Protocol Violation|1|||
130102661|NCT00568776|468334332|FG001|Overall Study|Protocol Violation|0|||
130102662|NCT00568776|468334333|FG002|Overall Study|Protocol Violation|1|||
130102663|NCT00568776|468334334|FG003|Overall Study|Protocol Violation|1|||
130102664|NCT00568776|468334331|FG000|Overall Study|Withdrawal by Subject|13|||
130102665|NCT00568776|468334332|FG001|Overall Study|Withdrawal by Subject|15|||
130102666|NCT00568776|468334333|FG002|Overall Study|Withdrawal by Subject|13|||
130102667|NCT00568776|468334334|FG003|Overall Study|Withdrawal by Subject|7|||
130102668|NCT00568776|468334331|FG000|Overall Study|Loss of Caregiver|0|||
130102669|NCT00568776|468334332|FG001|Overall Study|Loss of Caregiver|2|||
130102670|NCT00568776|468334333|FG002|Overall Study|Loss of Caregiver|1|||
130102671|NCT00568776|468334334|FG003|Overall Study|Loss of Caregiver|2|||
130102672|NCT00568776|468334331|FG000|Overall Study|Sponsor Decision|2|||
130102673|NCT00568776|468334332|FG001|Overall Study|Sponsor Decision|2|||
130102674|NCT00568776|468334333|FG002|Overall Study|Sponsor Decision|41|||
130102675|NCT00568776|468334334|FG003|Overall Study|Sponsor Decision|42|||
130102676|NCT00568776|468334331|FG000|Overall Study|Miscellaeneous|3|||
130102677|NCT00568776|468334332|FG001|Overall Study|Miscellaeneous|3|||
130102678|NCT00568776|468334333|FG002|Overall Study|Miscellaeneous|1|||
130102679|NCT00568776|468334334|FG003|Overall Study|Miscellaeneous|4|||
130102680|NCT01005680|468334335|FG000|Overall Study|Lost to Follow-up|4|||
130102681|NCT01005680|468334336|FG001|Overall Study|Lost to Follow-up|6|||
130102682|NCT01005680|468334335|FG000|Overall Study|Withdrawal by Subject|1|||
130102683|NCT01005680|468334336|FG001|Overall Study|Withdrawal by Subject|4|||
130102684|NCT01005680|468334335|FG000|Overall Study|Physician Decision|1|||
130102685|NCT01005680|468334336|FG001|Overall Study|Physician Decision|1|||
130102686|NCT00996632|468334337|FG000|Overall Study|Physician Decision|0|||
130102687|NCT00996632|468334338|FG001|Overall Study|Physician Decision|0|||
130102688|NCT02118896|468334351|FG000|Overall Study|Death|4|||
130102689|NCT02118896|468334352|FG001|Overall Study|Death|0|||
130102690|NCT02118896|468334353|FG002|Overall Study|Death|4|||
130102691|NCT02118896|468334354|FG003|Overall Study|Death|6|||
130102692|NCT02118896|468334355|FG004|Overall Study|Death|3|||
130102693|NCT02118896|468334356|FG005|Overall Study|Death|1|||
130102694|NCT02118896|468334357|FG006|Overall Study|Death|0|||
130102695|NCT02118896|468334358|FG007|Overall Study|Death|0|||
130102696|NCT02118896|468334359|FG008|Overall Study|Death|0|||
130102697|NCT02118896|468334360|FG009|Overall Study|Death|0|||
130102698|NCT02118896|468334351|FG000|Overall Study|Adverse Event|5|||
130102699|NCT02118896|468334352|FG001|Overall Study|Adverse Event|4|||
130102700|NCT02118896|468334353|FG002|Overall Study|Adverse Event|4|||
130102701|NCT02118896|468334354|FG003|Overall Study|Adverse Event|5|||
130102702|NCT02118896|468334355|FG004|Overall Study|Adverse Event|5|||
130102703|NCT02118896|468334356|FG005|Overall Study|Adverse Event|9|||
130102704|NCT02118896|468334357|FG006|Overall Study|Adverse Event|1|||
130102705|NCT02118896|468334358|FG007|Overall Study|Adverse Event|1|||
130102706|NCT02118896|468334359|FG008|Overall Study|Adverse Event|4|||
130102707|NCT02118896|468334360|FG009|Overall Study|Adverse Event|0|||
130102708|NCT02118896|468334351|FG000|Overall Study|Consent withdrawn|2|||
130102709|NCT02118896|468334352|FG001|Overall Study|Consent withdrawn|0|||
130102710|NCT02118896|468334353|FG002|Overall Study|Consent withdrawn|3|||
130102711|NCT02118896|468334354|FG003|Overall Study|Consent withdrawn|4|||
130102712|NCT02118896|468334355|FG004|Overall Study|Consent withdrawn|1|||
130102713|NCT02118896|468334356|FG005|Overall Study|Consent withdrawn|4|||
130102714|NCT02118896|468334357|FG006|Overall Study|Consent withdrawn|0|||
130102715|NCT02118896|468334358|FG007|Overall Study|Consent withdrawn|0|||
130102716|NCT02118896|468334359|FG008|Overall Study|Consent withdrawn|0|||
130102717|NCT02118896|468334360|FG009|Overall Study|Consent withdrawn|0|||
130102718|NCT02118896|468334351|FG000|Overall Study|Non-compliance|2|||
130102719|NCT02118896|468334352|FG001|Overall Study|Non-compliance|1|||
130102720|NCT02118896|468334353|FG002|Overall Study|Non-compliance|1|||
130102721|NCT02118896|468334354|FG003|Overall Study|Non-compliance|5|||
130102722|NCT02118896|468334355|FG004|Overall Study|Non-compliance|0|||
130102723|NCT02118896|468334356|FG005|Overall Study|Non-compliance|1|||
130102724|NCT02118896|468334357|FG006|Overall Study|Non-compliance|0|||
130102725|NCT02118896|468334358|FG007|Overall Study|Non-compliance|1|||
130102726|NCT02118896|468334359|FG008|Overall Study|Non-compliance|0|||
130102727|NCT02118896|468334360|FG009|Overall Study|Non-compliance|0|||
130265861|NCT00421148|468938858|FG004|Overall Study|Protocol Violation|0|||
130265862|NCT00421148|468938859|FG005|Overall Study|Protocol Violation|1|||
130265863|NCT00421148|468938860|FG006|Overall Study|Protocol Violation|0|||
130265864|NCT00421148|468938861|FG007|Overall Study|Protocol Violation|0|||
130265865|NCT00421148|468938862|FG008|Overall Study|Protocol Violation|0|||
130265866|NCT00421148|468938863|FG009|Overall Study|Protocol Violation|0|||
130265867|NCT00421148|468938864|FG010|Overall Study|Protocol Violation|0|||
130265868|NCT00421148|468938865|FG011|Overall Study|Protocol Violation|0|||
130265869|NCT00421148|468938866|FG012|Overall Study|Protocol Violation|0|||
130265870|NCT00421148|468938867|FG013|Overall Study|Protocol Violation|0|||
130265871|NCT00421148|468938868|FG014|Overall Study|Protocol Violation|0|||
130265872|NCT00421148|468938869|FG015|Overall Study|Protocol Violation|0|||
130265873|NCT00421148|468938870|FG016|Overall Study|Protocol Violation|0|||
130265874|NCT00421148|468938871|FG017|Overall Study|Protocol Violation|0|||
130265875|NCT00421148|468938872|FG018|Overall Study|Protocol Violation|1|||
130265876|NCT00421148|468938873|FG019|Overall Study|Protocol Violation|0|||
130265877|NCT00469833|468938874|FG000|Overall Study|No IV access|2|||
130265878|NCT01253369|468938875|FG000|Overall Study|Adverse Event|4|||
130265879|NCT01253369|468938875|FG000|Overall Study|Withdrawal by Subject|2|||
130265880|NCT01253369|468938875|FG000|Overall Study|Death|1|||
130265881|NCT01253369|468938875|FG000|Overall Study|Progressive disease|23|||
130265882|NCT01253369|468938875|FG000|Overall Study|Not Evaluable|3|||
130265883|NCT03289533|468938876|FG000|Overall Study|Death|12|||
130265884|NCT03289533|468938876|FG000|Overall Study|Terminated from study by sponsor|10|||
130265885|NCT01030822|468938877|FG000|Overall Study|Moved/migrated from study area|6|||
130265886|NCT01030822|468938878|FG001|Overall Study|Moved/migrated from study area|7|||
130265887|NCT01030822|468938879|FG002|Overall Study|Moved/migrated from study area|3|||
130265888|NCT01030822|468938877|FG000|Overall Study|Withdrawal by Subject|16|||
130265889|NCT01030822|468938878|FG001|Overall Study|Withdrawal by Subject|13|||
130265890|NCT01030822|468938879|FG002|Overall Study|Withdrawal by Subject|16|||
130265891|NCT01030822|468938877|FG000|Overall Study|Lost to Follow-up|9|||
130265892|NCT01030822|468938878|FG001|Overall Study|Lost to Follow-up|4|||
130265893|NCT01030822|468938879|FG002|Overall Study|Lost to Follow-up|7|||
130265894|NCT00539240|468938880|FG000|Overall Study|Withdrawal by Subject|0|||
130265895|NCT00539240|468938881|FG001|Overall Study|Withdrawal by Subject|2|||
130265896|NCT00539240|468938882|FG002|Overall Study|Withdrawal by Subject|0|||
130265897|NCT00539240|468938880|FG000|Overall Study|Protocol Violation|1|||
130265898|NCT00539240|468938881|FG001|Overall Study|Protocol Violation|1|||
130265899|NCT00539240|468938882|FG002|Overall Study|Protocol Violation|4|||
130265900|NCT00539240|468938880|FG000|Overall Study|Lost to Follow-up|2|||
130265901|NCT00539240|468938881|FG001|Overall Study|Lost to Follow-up|3|||
130265902|NCT00539240|468938882|FG002|Overall Study|Lost to Follow-up|1|||
130265903|NCT00539240|468938880|FG000|Overall Study|Adverse Event|3|||
130265904|NCT00539240|468938881|FG001|Overall Study|Adverse Event|1|||
130265905|NCT00539240|468938882|FG002|Overall Study|Adverse Event|10|||
130265906|NCT00363311|468938883|FG000|Overall Study|Adverse Event|6|||
130265907|NCT00363311|468938884|FG001|Overall Study|Adverse Event|4|||
130265908|NCT00363311|468938883|FG000|Overall Study|Lost to Follow-up|3|||
130265909|NCT00363311|468938884|FG001|Overall Study|Lost to Follow-up|0|||
130265910|NCT00363311|468938883|FG000|Overall Study|Protocol Violation|1|||
130265911|NCT00363311|468938884|FG001|Overall Study|Protocol Violation|2|||
130265912|NCT00363311|468938883|FG000|Overall Study|Withdrawal by Subject|12|||
130265913|NCT00363311|468938884|FG001|Overall Study|Withdrawal by Subject|6|||
130265914|NCT00363311|468938883|FG000|Overall Study|Physician Decision|1|||
130265915|NCT00363311|468938884|FG001|Overall Study|Physician Decision|1|||
130265916|NCT00363311|468938883|FG000|Overall Study|Sponsor Terminated Study|2|||
130265917|NCT00363311|468938884|FG001|Overall Study|Sponsor Terminated Study|2|||
130265918|NCT00363311|468938883|FG000|Overall Study|Disease Progression|46|||
130265919|NCT00363311|468938884|FG001|Overall Study|Disease Progression|26|||
130265920|NCT00363311|468938883|FG000|Overall Study|Non-Compliance|1|||
130265921|NCT00363311|468938884|FG001|Overall Study|Non-Compliance|1|||
130265922|NCT00363311|468938883|FG000|Overall Study|Participant Refused Biopsy|1|||
130102728|NCT02118896|468334351|FG000|Overall Study|Pregnancy|1|||
130265923|NCT00363311|468938884|FG001|Overall Study|Participant Refused Biopsy|0|||
130265924|NCT00363311|468938883|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
130265925|NCT00363311|468938884|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
130035644|NCT02601950|468085993|FG001|Overall Study|Participant refused further study treatment|1|||
130035645|NCT02601950|468085994|FG002|Overall Study|Participant refused further study treatment|1|||
130035646|NCT02601950|468085995|FG003|Overall Study|Participant refused further study treatment|0|||
130035647|NCT02601950|468085996|FG004|Overall Study|Participant refused further study treatment|2|||
130035648|NCT02601950|468085997|FG005|Overall Study|Participant refused further study treatment|2|||
130265926|NCT00363311|468938883|FG000|Overall Study|Participant Opted for Treatment|1|||
130265927|NCT00363311|468938884|FG001|Overall Study|Participant Opted for Treatment|0|||
130265928|NCT00363311|468938883|FG000|Overall Study|Participant Moved to Another Country|1|||
130265929|NCT00363311|468938884|FG001|Overall Study|Participant Moved to Another Country|0|||
130265930|NCT00363311|468938883|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
130265931|NCT00363311|468938884|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
130265932|NCT00363311|468938883|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
130265933|NCT00363311|468938884|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
130265934|NCT00363311|468938883|FG000|Overall Study|Participant Moved to Louisiana|0|||
130265935|NCT00363311|468938884|FG001|Overall Study|Participant Moved to Louisiana|1|||
130265936|NCT01595529|468938885|FG000|Overall Study|Adverse Event|2|||
130265937|NCT01595529|468938886|FG001|Overall Study|Adverse Event|0|||
130265938|NCT01595529|468938885|FG000|Overall Study|Subject Non-Compliant|2|||
130265939|NCT01595529|468938886|FG001|Overall Study|Subject Non-Compliant|0|||
130265940|NCT01595529|468938885|FG000|Overall Study|Lost to Follow-up|8|||
130265941|NCT01595529|468938886|FG001|Overall Study|Lost to Follow-up|14|||
130265942|NCT01595529|468938885|FG000|Overall Study|Protocol Violation|1|||
130265943|NCT01595529|468938886|FG001|Overall Study|Protocol Violation|2|||
130265944|NCT01595529|468938885|FG000|Overall Study|Physician Decision|1|||
130265945|NCT01595529|468938886|FG001|Overall Study|Physician Decision|0|||
130265946|NCT01595529|468938885|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
130265947|NCT01595529|468938886|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
130265948|NCT01595529|468938885|FG000|Overall Study|Administrative Decision|1|||
130265949|NCT01595529|468938886|FG001|Overall Study|Administrative Decision|0|||
130265950|NCT01595529|468938885|FG000|Overall Study|Entry Failure/Screening Failure|6|||
130265951|NCT01595529|468938886|FG001|Overall Study|Entry Failure/Screening Failure|1|||
130265952|NCT04016714|468938887|FG000|Overall Study|Death|1|||
130265953|NCT04016714|468938888|FG001|Overall Study|Death|0|||
130265954|NCT04016714|468938887|FG000|Overall Study|Lost to Follow-up|3|||
130265955|NCT04016714|468938888|FG001|Overall Study|Lost to Follow-up|1|||
130265956|NCT04016714|468938887|FG000|Overall Study|Physician Decision|3|||
130265957|NCT04016714|468938888|FG001|Overall Study|Physician Decision|3|||
130265958|NCT04016714|468938887|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
130265959|NCT04016714|468938888|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
130265960|NCT00730886|468938891|FG000|Overall Study|Lost to Follow-up|1|||
130265961|NCT00730886|468938892|FG001|Overall Study|Lost to Follow-up|0|||
130265962|NCT00730886|468938891|FG000|Overall Study|Physician Decision|1|||
130265963|NCT00730886|468938892|FG001|Overall Study|Physician Decision|0|||
130265964|NCT01991483|468938893|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
130265965|NCT01991483|468938894|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
130265966|NCT01991483|468938895|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
130265967|NCT01991483|468938896|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
130265968|NCT01991483|468938893|FG000|Dose Level 600 mg|Physician Decision|0|||
130265969|NCT01991483|468938894|FG001|Dose Level 600 mg|Physician Decision|0|||
130265970|NCT01991483|468938895|FG002|Dose Level 600 mg|Physician Decision|1|||
130265971|NCT01991483|468938896|FG003|Dose Level 600 mg|Physician Decision|0|||
130265972|NCT01991483|468938893|FG000|Dose Level 1000 mg|Protocol Violation|0|||
130265973|NCT01991483|468938894|FG001|Dose Level 1000 mg|Protocol Violation|0|||
130265974|NCT01991483|468938895|FG002|Dose Level 1000 mg|Protocol Violation|0|||
130265975|NCT01991483|468938896|FG003|Dose Level 1000 mg|Protocol Violation|1|||
130265976|NCT01932788|468938904|FG000|Overall Study|Protocol Violation|18|||
130265977|NCT01932788|468938905|FG001|Overall Study|Protocol Violation|0|||
130265978|NCT01932788|468938904|FG000|Overall Study|Lost to Follow-up|18|||
130265979|NCT01932788|468938905|FG001|Overall Study|Lost to Follow-up|46|||
130265980|NCT01932788|468938904|FG000|Overall Study|Lack of Efficacy|2|||
130265981|NCT01932788|468938905|FG001|Overall Study|Lack of Efficacy|0|||
130265982|NCT01932788|468938904|FG000|Overall Study|Withdrawal by Subject|0|||
130035649|NCT02601950|468085998|FG006|Overall Study|Participant refused further study treatment|2|||
130265983|NCT01932788|468938905|FG001|Overall Study|Withdrawal by Subject|5|||
130265984|NCT01171677|468938906|FG000|Overall Study|Withdrawal by Subject|0|||
130265985|NCT01171677|468938907|FG001|Overall Study|Withdrawal by Subject|3|||
130265986|NCT01171677|468938906|FG000|Overall Study|Adverse Event|1|||
130265987|NCT01171677|468938907|FG001|Overall Study|Adverse Event|0|||
130265988|NCT01171677|468938906|FG000|Overall Study|completed <70% IntenSati classes|5|||
130265989|NCT01171677|468938907|FG001|Overall Study|completed <70% IntenSati classes|0|||
130265990|NCT01847443|468938908|FG000|Study Period 1|Withdrawal by Subject|0|||
130265991|NCT01847443|468938909|FG001|Study Period 1|Withdrawal by Subject|1|||
130265992|NCT01847443|468938910|FG002|Study Period 1|Withdrawal by Subject|0|||
130102729|NCT02118896|468334352|FG001|Overall Study|Pregnancy|1|||
130265993|NCT01847443|468938911|FG003|Study Period 1|Withdrawal by Subject|0|||
130265994|NCT01847443|468938908|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
130265995|NCT01847443|468938909|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
130265996|NCT01847443|468938910|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
130265997|NCT01847443|468938911|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
130265998|NCT01847443|468938908|FG000|Washout Period Before Study Period 2|Other reason|1|||
130265999|NCT01847443|468938909|FG001|Washout Period Before Study Period 2|Other reason|0|||
130266000|NCT01847443|468938910|FG002|Washout Period Before Study Period 2|Other reason|0|||
130266001|NCT01847443|468938911|FG003|Washout Period Before Study Period 2|Other reason|0|||
130266002|NCT01847443|468938908|FG000|Washout Period Before Study Period 3|Other reason|1|||
130266003|NCT01847443|468938909|FG001|Washout Period Before Study Period 3|Other reason|0|||
130266004|NCT01847443|468938910|FG002|Washout Period Before Study Period 3|Other reason|0|||
130266005|NCT01847443|468938911|FG003|Washout Period Before Study Period 3|Other reason|0|||
130266006|NCT01847443|468938908|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
130266007|NCT01847443|468938909|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130266008|NCT01847443|468938910|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130266009|NCT01847443|468938911|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
130266010|NCT01847443|468938908|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
130266011|NCT01847443|468938909|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
130266012|NCT01847443|468938910|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
130266013|NCT01847443|468938911|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
130266014|NCT03571971|468938912|FG000|Overall Study|Lost to Follow-up|2|||
130266015|NCT03571971|468938913|FG001|Overall Study|Lost to Follow-up|2|||
130266016|NCT03571971|468938912|FG000|Overall Study|Protocol Violation|2|||
130266017|NCT03571971|468938913|FG001|Overall Study|Protocol Violation|3|||
130266018|NCT03571971|468938912|FG000|Overall Study|Withdrawal by Subject|2|||
130266019|NCT03571971|468938913|FG001|Overall Study|Withdrawal by Subject|0|||
130266020|NCT03571971|468938912|FG000|Overall Study|Incomplete primary outcome data|2|||
130266021|NCT03571971|468938913|FG001|Overall Study|Incomplete primary outcome data|0|||
130266022|NCT02806414|468938921|FG000|Overall Study|Lost to Follow-up|2|||
130266023|NCT00038948|468938926|FG000|Overall Study|Adverse Event|131|||
130266024|NCT00038948|468938927|FG001|Overall Study|Adverse Event|43|||
130266025|NCT00038948|468938926|FG000|Overall Study|Lost to Follow-up|4|||
130266026|NCT00038948|468938927|FG001|Overall Study|Lost to Follow-up|4|||
130266027|NCT00038948|468938926|FG000|Overall Study|Nonmedical event|5|||
130266028|NCT00038948|468938927|FG001|Overall Study|Nonmedical event|7|||
130266029|NCT00038948|468938926|FG000|Overall Study|Withdrawal by Subject|23|||
130266030|NCT00038948|468938927|FG001|Overall Study|Withdrawal by Subject|10|||
130266031|NCT00038948|468938926|FG000|Overall Study|Protocol Violation|3|||
130266032|NCT00038948|468938927|FG001|Overall Study|Protocol Violation|7|||
130266033|NCT00038948|468938926|FG000|Overall Study|Lack of Efficacy|3|||
130266034|NCT00038948|468938927|FG001|Overall Study|Lack of Efficacy|6|||
130266035|NCT00937495|468940505|FG000|Overall Study|Protocol Violation|2|||
130266036|NCT00441272|468940506|FG000|Overall Study|Study terminated prior to enrollment|25|||
130266037|NCT00441272|468940507|FG001|Overall Study|Study terminated prior to enrollment|25|||
130266038|NCT01856322|468940508|FG000|Overall Study|off study due to lack of accrual|0|||
130266039|NCT01856322|468940509|FG001|Overall Study|off study due to lack of accrual|0|||
130266040|NCT01856322|468940510|FG002|Overall Study|off study due to lack of accrual|3|||
130266041|NCT00427011|468940511|FG000|Overall Study|Adverse Event|10|||
130266042|NCT00427011|468940511|FG000|Overall Study|Withdrawal by Subject|1|||
130266043|NCT00427011|468940511|FG000|Overall Study|Lack of Efficacy|2|||
130266044|NCT00427011|468940511|FG000|Overall Study|Other|12|||
130266045|NCT00288015|468940515|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
130266046|NCT00288015|468940515|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
130266047|NCT00288015|468940515|FG000|First Response Assessment|Withdrawal by Subject|1|||
130266048|NCT00288015|468940515|FG000|First Response Assessment|Death|1|||
130266049|NCT00288015|468940515|FG000|First Response Assessment|Physician Decision|2|||
130266050|NCT00288015|468940515|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
130266051|NCT00288015|468940515|FG000|Follow up for Survival x 2 Years|Death|13|||
130266052|NCT00288015|468940515|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
130266053|NCT00288015|468940515|FG000|Follow up for Survival x 2 Years|Other|9|||
130266054|NCT00443703|468940516|FG000|Overall Study|Never Treated|3|||
130102730|NCT02118896|468334353|FG002|Overall Study|Pregnancy|0|||
130266055|NCT00443703|468940517|FG001|Overall Study|Never Treated|1|||
130102731|NCT02118896|468334354|FG003|Overall Study|Pregnancy|0|||
130266056|NCT00443703|468940516|FG000|Overall Study|Adverse Event|7|||
130266057|NCT00443703|468940517|FG001|Overall Study|Adverse Event|3|||
130266058|NCT00443703|468940516|FG000|Overall Study|Lack of Efficacy|3|||
130266059|NCT00443703|468940517|FG001|Overall Study|Lack of Efficacy|1|||
130266060|NCT00443703|468940516|FG000|Overall Study|Lost to Follow-up|0|||
130266061|NCT00443703|468940517|FG001|Overall Study|Lost to Follow-up|4|||
130266062|NCT00443703|468940516|FG000|Overall Study|Physician Decision|4|||
130266063|NCT00443703|468940517|FG001|Overall Study|Physician Decision|2|||
130266064|NCT00443703|468940516|FG000|Overall Study|Protocol Violation|1|||
130266065|NCT00443703|468940517|FG001|Overall Study|Protocol Violation|1|||
130266066|NCT00443703|468940516|FG000|Overall Study|Withdrawal by Subject|9|||
130266067|NCT00443703|468940517|FG001|Overall Study|Withdrawal by Subject|6|||
130266068|NCT00443703|468940516|FG000|Overall Study|Progressive Disease|1|||
130266069|NCT00443703|468940517|FG001|Overall Study|Progressive Disease|0|||
130266070|NCT01333722|468940518|FG000|Overall Study|Lack of Efficacy|0|||
130266071|NCT01333722|468940519|FG001|Overall Study|Lack of Efficacy|2|||
130266072|NCT01333722|468940518|FG000|Overall Study|Withdrawal by Subject|0|||
130266073|NCT01333722|468940519|FG001|Overall Study|Withdrawal by Subject|1|||
130266074|NCT04776161|468940521|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
130266075|NCT04776161|468940522|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
130266076|NCT04776161|468940523|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
130266077|NCT04776161|468940521|FG000|Overall Study|Withdrawal by Subject|1|||
130266078|NCT04776161|468940522|FG001|Overall Study|Withdrawal by Subject|0|||
130266079|NCT04776161|468940523|FG002|Overall Study|Withdrawal by Subject|1|||
130266080|NCT04776161|468940521|FG000|Overall Study|Adverse Event|0|||
130266081|NCT04776161|468940522|FG001|Overall Study|Adverse Event|1|||
130266082|NCT04776161|468940523|FG002|Overall Study|Adverse Event|1|||
130266083|NCT00661830|468940527|FG000|Overall Study|Death|37|||
130266084|NCT00661830|468940528|FG001|Overall Study|Death|33|||
130266085|NCT00661830|468940527|FG000|Overall Study|Lost to Follow-up|1|||
130266086|NCT00661830|468940528|FG001|Overall Study|Lost to Follow-up|3|||
130266087|NCT00661830|468940527|FG000|Overall Study|Withdrawal by Subject|1|||
130266088|NCT00661830|468940528|FG001|Overall Study|Withdrawal by Subject|1|||
130266089|NCT00661830|468940527|FG000|Overall Study|Other reason|1|||
130266090|NCT00661830|468940528|FG001|Overall Study|Other reason|5|||
130266091|NCT00488514|468940529|FG000|Overall Study|Adverse Event|41|||
130266092|NCT00488514|468940529|FG000|Overall Study|Lost to Follow-up|44|||
130266093|NCT00488514|468940529|FG000|Overall Study|Protocol Violation|32|||
130266094|NCT00488514|468940529|FG000|Overall Study|Withdrawal by Subject|106|||
130266095|NCT00488514|468940529|FG000|Overall Study|Lack of Efficacy|28|||
130266096|NCT00488514|468940529|FG000|Overall Study|Did not meet criteria for treatment|30|||
130266097|NCT00488514|468940529|FG000|Overall Study|Postive drug screen|1|||
130266098|NCT00488514|468940529|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
130266099|NCT00488514|468940529|FG000|Overall Study|Investigator decision|1|||
130266100|NCT00488514|468940529|FG000|Overall Study|Participant had too few migraines|5|||
130266101|NCT00488514|468940529|FG000|Overall Study|Increase in number of migraines|2|||
130266102|NCT00488514|468940529|FG000|Overall Study|Increased use of concomitant medication|1|||
130266103|NCT00517699|468940530|FG000|Overall Study|Withdrawal by Subject|1|||
130266104|NCT00517699|468940530|FG000|Overall Study|Lack of Efficacy|1|||
130266105|NCT00517699|468940530|FG000|Overall Study|Administrative error|1|||
130266106|NCT00517699|468940530|FG000|Overall Study|Study terminated by Sponsor|2|||
130266107|NCT02332187|468940531|FG000|Overall Study|Withdrawal by Subject|2|||
130266108|NCT02332187|468940532|FG001|Overall Study|Withdrawal by Subject|2|||
130266109|NCT02332187|468940531|FG000|Overall Study|Adverse Event|0|||
130266110|NCT02332187|468940532|FG001|Overall Study|Adverse Event|1|||
130266111|NCT00980148|468940533|FG000|Overall Study|Discharged from facility|89|||
130266112|NCT00980148|468940534|FG001|Overall Study|Discharged from facility|96|||
130266113|NCT00980148|468940533|FG000|Overall Study|Received other antichlamydia treatment|20|||
130266114|NCT00980148|468940534|FG001|Overall Study|Received other antichlamydia treatment|14|||
130266115|NCT00980148|468940533|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
130266116|NCT00980148|468940534|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
130266117|NCT00980148|468940533|FG000|Overall Study|Various other reasons|8|||
130035650|NCT02601950|468085999|FG007|Overall Study|Participant refused further study treatment|1|||
130266118|NCT00980148|468940534|FG001|Overall Study|Various other reasons|9|||
130266119|NCT03500211|468940535|FG000|Overall Study|Withdrawal by Subject|1|||
130266120|NCT03500211|468940536|FG001|Overall Study|Withdrawal by Subject|1|||
130266121|NCT01119443|468940540|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
130266122|NCT01119443|468940541|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
130035651|NCT02601950|468085992|FG000|Overall Study|Investigator discretion|1|||
130035652|NCT02601950|468085993|FG001|Overall Study|Investigator discretion|0|||
130035653|NCT02601950|468085994|FG002|Overall Study|Investigator discretion|1|||
130266123|NCT02329743|468940544|FG000|Overall Study|Adverse Event|1|||
130266124|NCT02329743|468940545|FG001|Overall Study|Adverse Event|1|||
130266125|NCT02329743|468940546|FG002|Overall Study|Adverse Event|3|||
130266126|NCT02329743|468940544|FG000|Overall Study|Lost to Follow-up|1|||
130266127|NCT02329743|468940545|FG001|Overall Study|Lost to Follow-up|0|||
130266128|NCT02329743|468940546|FG002|Overall Study|Lost to Follow-up|1|||
130266129|NCT02329743|468940544|FG000|Overall Study|Withdrawal by Subject|4|||
130266130|NCT02329743|468940545|FG001|Overall Study|Withdrawal by Subject|4|||
130266131|NCT02329743|468940546|FG002|Overall Study|Withdrawal by Subject|1|||
130266132|NCT02329743|468940544|FG000|Overall Study|Other|0|||
130266133|NCT02329743|468940545|FG001|Overall Study|Other|2|||
130266134|NCT02329743|468940546|FG002|Overall Study|Other|3|||
130266135|NCT00775268|468940550|FG000|Baseline|Drug not synthesize dose|1|||
130266136|NCT00775268|468940551|FG001|Baseline|Drug not synthesize dose|0|||
130266137|NCT00775268|468940550|FG000|Baseline|Not treated-ineligible per CT|0|||
130266138|NCT00775268|468940551|FG001|Baseline|Not treated-ineligible per CT|1|||
130266139|NCT00775268|468940550|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
130266140|NCT00775268|468940551|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
130266141|NCT00775268|468940550|FG000|After Completion|Participant missed scan appointment|1|||
130266142|NCT00775268|468940551|FG001|After Completion|Participant missed scan appointment|0|||
130266143|NCT03604497|468940552|FG000|Overall Study|Protocol Violation|52|||
130266144|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
130266145|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266146|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266147|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266148|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
130266149|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
130266150|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266151|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266152|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266153|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
130266154|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
130266155|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266156|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266157|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266158|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
130266159|NCT01194245|468940558|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
130266160|NCT01194245|468940559|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266161|NCT01194245|468940560|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266162|NCT01194245|468940561|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266163|NCT01194245|468940562|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
130266164|NCT01194245|468940558|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266165|NCT01194245|468940559|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266166|NCT01194245|468940560|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266167|NCT01194245|468940561|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130266168|NCT01194245|468940562|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130266169|NCT01194245|468940558|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130266170|NCT01194245|468940559|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130266171|NCT01194245|468940560|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130266172|NCT01194245|468940561|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130266173|NCT01194245|468940562|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
130266174|NCT00269087|468940563|FG000|Overall Study|Adverse Event|20|||
130035654|NCT02601950|468085995|FG003|Overall Study|Investigator discretion|0|||
130035655|NCT02601950|468085996|FG004|Overall Study|Investigator discretion|1|||
130035656|NCT02601950|468085997|FG005|Overall Study|Investigator discretion|1|||
130035657|NCT02601950|468085998|FG006|Overall Study|Investigator discretion|1|||
130035658|NCT02601950|468085999|FG007|Overall Study|Investigator discretion|0|||
130035659|NCT02601950|468085992|FG000|Overall Study|Other|0|||
130035660|NCT02601950|468085993|FG001|Overall Study|Other|0|||
130035661|NCT02601950|468085994|FG002|Overall Study|Other|0|||
130035662|NCT02601950|468085995|FG003|Overall Study|Other|0|||
130035663|NCT02601950|468085996|FG004|Overall Study|Other|2|||
130266175|NCT00269087|468940563|FG000|Overall Study|Withdrawal by Subject|1|||
130266176|NCT00269087|468940563|FG000|Overall Study|Exacerbation of COPD|13|||
130266177|NCT02651116|468940566|FG000|Overall Study|Adverse Event|0|||
130266178|NCT02651116|468940567|FG001|Overall Study|Adverse Event|1|||
130266179|NCT02651116|468940566|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
130266180|NCT02651116|468940567|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
130266181|NCT00041470|468940576|FG000|Overall Study|Loss of Funding|38|||
130266182|NCT01193101|468940580|FG000|Overall Study|Adverse Event|0|||
130266183|NCT01193101|468940581|FG001|Overall Study|Adverse Event|1|||
130266184|NCT01193101|468940582|FG002|Overall Study|Adverse Event|1|||
130266185|NCT01193101|468940583|FG003|Overall Study|Adverse Event|3|||
130035664|NCT02601950|468085997|FG005|Overall Study|Other|2|||
130035665|NCT02601950|468085998|FG006|Overall Study|Other|1|||
130035666|NCT02601950|468085999|FG007|Overall Study|Other|0|||
130266186|NCT01193101|468940580|FG000|Overall Study|Lack of Efficacy|3|||
130266187|NCT01193101|468940581|FG001|Overall Study|Lack of Efficacy|1|||
130035667|NCT05817045|468086000|FG000|Overall Study|Protocol Violation|0|||
130035668|NCT05817045|468086001|FG001|Overall Study|Protocol Violation|3|||
130035669|NCT05817045|468086000|FG000|Overall Study|Withdrawal by Subject|10|||
130035670|NCT05817045|468086001|FG001|Overall Study|Withdrawal by Subject|7|||
130035671|NCT05817045|468086000|FG000|Overall Study|Physician Decision|3|||
130035672|NCT05817045|468086001|FG001|Overall Study|Physician Decision|0|||
130035673|NCT05817045|468086000|FG000|Overall Study|Lost to Follow-up|0|||
130035674|NCT05817045|468086001|FG001|Overall Study|Lost to Follow-up|1|||
130035675|NCT05817045|468086000|FG000|Overall Study|Device Deficiency|1|||
130035676|NCT05817045|468086001|FG001|Overall Study|Device Deficiency|0|||
130035677|NCT05817045|468086000|FG000|Overall Study|System Error|1|||
130035678|NCT05817045|468086001|FG001|Overall Study|System Error|0|||
130035679|NCT02688647|468086008|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
130035680|NCT02688647|468086009|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
130035681|NCT02688647|468086008|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
130035682|NCT02688647|468086009|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
130035683|NCT02688647|468086008|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
130035684|NCT02688647|468086009|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
130035685|NCT02688647|468086008|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
130035686|NCT02688647|468086009|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
130035687|NCT02688647|468086008|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
130035688|NCT02688647|468086009|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
130035689|NCT02688647|468086008|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
130035690|NCT02688647|468086009|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
130035691|NCT02688647|468086008|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
130035692|NCT02688647|468086009|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
130035693|NCT00382967|468086010|FG000|Overall Study|Protocol Violation|1|||
130266188|NCT01193101|468940582|FG002|Overall Study|Lack of Efficacy|0|||
130266189|NCT01193101|468940583|FG003|Overall Study|Lack of Efficacy|8|||
130266190|NCT01193101|468940580|FG000|Overall Study|Withdrawal by Subject|2|||
130266191|NCT01193101|468940581|FG001|Overall Study|Withdrawal by Subject|4|||
130266192|NCT01193101|468940582|FG002|Overall Study|Withdrawal by Subject|1|||
130266193|NCT01193101|468940583|FG003|Overall Study|Withdrawal by Subject|1|||
130266194|NCT01193101|468940580|FG000|Overall Study|Administrative problems|0|||
130266195|NCT01193101|468940581|FG001|Overall Study|Administrative problems|0|||
130266196|NCT01193101|468940582|FG002|Overall Study|Administrative problems|1|||
130266197|NCT01193101|468940583|FG003|Overall Study|Administrative problems|0|||
130266198|NCT01193101|468940580|FG000|Overall Study|Abnormal test procedure results|0|||
130266199|NCT01193101|468940581|FG001|Overall Study|Abnormal test procedure results|1|||
130266200|NCT01193101|468940582|FG002|Overall Study|Abnormal test procedure results|0|||
130266201|NCT01193101|468940583|FG003|Overall Study|Abnormal test procedure results|0|||
130266202|NCT02347085|468940586|FG000|Overall Study|Adverse Event|2|||
130266203|NCT02347085|468940586|FG000|Overall Study|Lack of Efficacy|1|||
130266204|NCT02347085|468940586|FG000|Overall Study|Withdrawal by Subject|4|||
130266205|NCT02347085|468940586|FG000|Overall Study|Lost to Follow-up|1|||
130266206|NCT02347085|468940586|FG000|Overall Study|Protocol Criteria|2|||
130266207|NCT00800982|468940587|FG000|Overall Study|Lost to Follow-up|1|||
130266208|NCT00800982|468940588|FG001|Overall Study|Lost to Follow-up|2|||
130266209|NCT00800982|468940587|FG000|Overall Study|Withdrawal by Subject|0|||
130266210|NCT00800982|468940588|FG001|Overall Study|Withdrawal by Subject|1|||
130266211|NCT00800982|468940587|FG000|Overall Study|Patient moved out of state|1|||
130266212|NCT00800982|468940588|FG001|Overall Study|Patient moved out of state|0|||
130266213|NCT00648037|468940589|FG000|Overall Study|Not Treated|1|||
130266214|NCT00648037|468940589|FG000|Overall Study|Withdrawal by Subject|1|||
130266215|NCT00648037|468940589|FG000|Overall Study|Adverse Event|11|||
130266216|NCT00648037|468940589|FG000|Overall Study|Relapse|2|||
130266217|NCT00648037|468940589|FG000|Overall Study|Other|1|||
130266218|NCT00699413|468940600|FG000|Overall Study|Withdrawal by Subject|0|||
130266219|NCT00699413|468940601|FG001|Overall Study|Withdrawal by Subject|2|||
130035694|NCT00382967|468086011|FG001|Overall Study|Protocol Violation|1|||
130266220|NCT00699413|468940600|FG000|Overall Study|Study terminated by sponsor|4|||
130266221|NCT00699413|468940601|FG001|Overall Study|Study terminated by sponsor|2|||
130102732|NCT02118896|468334355|FG004|Overall Study|Pregnancy|1|||
130102733|NCT02118896|468334356|FG005|Overall Study|Pregnancy|3|||
130266222|NCT02103062|468940603|FG000|Overall Study|Adverse Event|1|||
130266223|NCT02103062|468940604|FG001|Overall Study|Adverse Event|2|||
130266224|NCT02103062|468940603|FG000|Overall Study|Progressive Disease|17|||
130266225|NCT02103062|468940604|FG001|Overall Study|Progressive Disease|20|||
130266226|NCT02103062|468940603|FG000|Overall Study|Death|0|||
130266227|NCT02103062|468940604|FG001|Overall Study|Death|1|||
130266228|NCT00120627|468940605|FG000|Overall Study|Withdrawal by Subject|5|||
130266229|NCT00120627|468940606|FG001|Overall Study|Withdrawal by Subject|5|||
130102734|NCT02118896|468334357|FG006|Overall Study|Pregnancy|1|||
130266230|NCT02030821|468940607|FG000|Overall Study|Physician Decision|2|||
130266231|NCT02030821|468940608|FG001|Overall Study|Physician Decision|2|||
130266232|NCT02030821|468940609|FG002|Overall Study|Physician Decision|5|||
130266233|NCT02030821|468940610|FG003|Overall Study|Physician Decision|2|||
130266234|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
130266235|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266236|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266237|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266238|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266239|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
130266240|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
130266241|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
130266242|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
130266243|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
130266244|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
130266245|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
130266246|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
130266247|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266248|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266249|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266250|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266251|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
130266252|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
130266253|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
130266254|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
130266255|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
130266256|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
130266257|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
130266258|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
130266259|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
130266260|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266261|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266262|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266263|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
130266264|NCT00716274|468940613|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266265|NCT00716274|468940614|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
130266266|NCT00716274|468940615|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266267|NCT00716274|468940616|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266268|NCT00716274|468940617|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266269|NCT00716274|468940618|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
130266270|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266271|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266272|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
130266273|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266274|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266275|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
130266276|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
130266277|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
130266278|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
130266279|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
130266280|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
130266281|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
130266282|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266283|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266284|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266285|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
130102735|NCT02118896|468334358|FG007|Overall Study|Pregnancy|0|||
130102736|NCT02118896|468334359|FG008|Overall Study|Pregnancy|0|||
130266286|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
130266287|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
130266288|NCT00716274|468940613|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
130266289|NCT00716274|468940614|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
130266290|NCT00716274|468940615|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
130266291|NCT00716274|468940616|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
130266292|NCT00716274|468940617|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
130102737|NCT02118896|468334360|FG009|Overall Study|Pregnancy|0|||
130266293|NCT00716274|468940618|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
130266294|NCT03092479|468940630|FG000|Overall Study|Lost to Follow-up|3|||
130266295|NCT03092479|468940631|FG001|Overall Study|Lost to Follow-up|2|||
130266296|NCT03092479|468940630|FG000|Overall Study|Withdrawal by Subject|4|||
130266297|NCT03092479|468940631|FG001|Overall Study|Withdrawal by Subject|0|||
130266298|NCT00543985|468940634|FG000|Overall Study|Withdrawal by Subject|4|||
130266299|NCT02015039|468940635|FG000|Overall Study|Not eligible|0|||
130266300|NCT02015039|468940636|FG001|Overall Study|Not eligible|1|||
130266301|NCT04046939|468940640|FG000|Primary Assessment Period|Adverse Event|1|||
130266302|NCT04046939|468940641|FG001|Primary Assessment Period|Adverse Event|0|||
130266303|NCT04046939|468940642|FG002|Primary Assessment Period|Adverse Event|0|||
130266304|NCT04046939|468940643|FG003|Primary Assessment Period|Adverse Event|0|||
130266305|NCT04046939|468940640|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
130266306|NCT04046939|468940641|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
130266307|NCT04046939|468940642|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
130266308|NCT04046939|468940643|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
130266309|NCT04046939|468940640|FG000|Primary Assessment Period|Physician Decision|0|||
130266310|NCT04046939|468940641|FG001|Primary Assessment Period|Physician Decision|0|||
130266311|NCT04046939|468940642|FG002|Primary Assessment Period|Physician Decision|1|||
130266312|NCT04046939|468940643|FG003|Primary Assessment Period|Physician Decision|0|||
130266313|NCT04046939|468940640|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
130266314|NCT04046939|468940641|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
130266315|NCT04046939|468940642|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
130266316|NCT04046939|468940643|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
130266317|NCT00403130|468940644|FG000|2 Years From Start of Treatment|Not Eligible|3|||
130266318|NCT00403130|468940644|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
130266319|NCT00403130|468940644|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
130266320|NCT00403130|468940644|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
130266321|NCT00806260|468940645|FG000|Period 1 (1 Day)|Adverse Event|0|||
130266322|NCT00806260|468940646|FG001|Period 1 (1 Day)|Adverse Event|0|||
130266323|NCT00806260|468940647|FG002|Period 1 (1 Day)|Adverse Event|0|||
130266324|NCT00806260|468940648|FG003|Period 1 (1 Day)|Adverse Event|0|||
130266325|NCT00806260|468940649|FG004|Period 1 (1 Day)|Adverse Event|3|||
130266326|NCT00806260|468940650|FG005|Period 1 (1 Day)|Adverse Event|0|||
130266327|NCT00806260|468940645|FG000|Period 2|Adverse Event|0|||
130266328|NCT00806260|468940646|FG001|Period 2|Adverse Event|0|||
130266329|NCT00806260|468940647|FG002|Period 2|Adverse Event|0|||
130266330|NCT00806260|468940648|FG003|Period 2|Adverse Event|1|||
130266331|NCT00806260|468940649|FG004|Period 2|Adverse Event|0|||
130266332|NCT00806260|468940650|FG005|Period 2|Adverse Event|0|||
130266333|NCT00806260|468940645|FG000|Period 2|Protocol Violation|1|||
130266334|NCT00806260|468940646|FG001|Period 2|Protocol Violation|0|||
130266335|NCT00806260|468940647|FG002|Period 2|Protocol Violation|1|||
130266336|NCT00806260|468940648|FG003|Period 2|Protocol Violation|0|||
130266337|NCT00806260|468940649|FG004|Period 2|Protocol Violation|0|||
130266338|NCT00806260|468940650|FG005|Period 2|Protocol Violation|0|||
130266339|NCT00806260|468940645|FG000|Period 2|Need to take concomitant medication|1|||
130266340|NCT00806260|468940646|FG001|Period 2|Need to take concomitant medication|0|||
130266341|NCT00806260|468940647|FG002|Period 2|Need to take concomitant medication|0|||
130266342|NCT00806260|468940648|FG003|Period 2|Need to take concomitant medication|0|||
130266343|NCT00806260|468940649|FG004|Period 2|Need to take concomitant medication|0|||
130266344|NCT00806260|468940650|FG005|Period 2|Need to take concomitant medication|0|||
130266345|NCT00806260|468940645|FG000|Period 2|sponsor request|0|||
130266346|NCT00806260|468940646|FG001|Period 2|sponsor request|0|||
130266347|NCT00806260|468940647|FG002|Period 2|sponsor request|1|||
130266348|NCT00806260|468940648|FG003|Period 2|sponsor request|1|||
130266349|NCT00806260|468940649|FG004|Period 2|sponsor request|0|||
130266350|NCT00806260|468940650|FG005|Period 2|sponsor request|0|||
129885635|NCT02855164|467540777|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
130266351|NCT00806260|468940645|FG000|Period 3|Protocol Violation|0|||
130266352|NCT00806260|468940646|FG001|Period 3|Protocol Violation|1|||
130266353|NCT00806260|468940647|FG002|Period 3|Protocol Violation|1|||
130266354|NCT00806260|468940648|FG003|Period 3|Protocol Violation|0|||
130266355|NCT00806260|468940649|FG004|Period 3|Protocol Violation|0|||
130266356|NCT00806260|468940650|FG005|Period 3|Protocol Violation|0|||
130266357|NCT00806260|468940645|FG000|Period 3|Pregnancy|1|||
130266358|NCT00806260|468940646|FG001|Period 3|Pregnancy|0|||
130266359|NCT00806260|468940647|FG002|Period 3|Pregnancy|0|||
130266360|NCT00806260|468940648|FG003|Period 3|Pregnancy|0|||
130266361|NCT00806260|468940649|FG004|Period 3|Pregnancy|0|||
130266362|NCT00806260|468940650|FG005|Period 3|Pregnancy|0|||
130266363|NCT00237042|468940653|FG000|Treatment|Became ineligible post-randomization|0|||
130266364|NCT00237042|468940654|FG001|Treatment|Became ineligible post-randomization|1|||
130266365|NCT00237042|468940655|FG002|Treatment|Became ineligible post-randomization|16|||
130266366|NCT00237042|468940653|FG000|Treatment|Moved out of state|1|||
130266367|NCT00237042|468940654|FG001|Treatment|Moved out of state|1|||
130266368|NCT00237042|468940655|FG002|Treatment|Moved out of state|1|||
130266369|NCT00237042|468940653|FG000|Treatment|Completed no treatment|5|||
130266370|NCT00237042|468940654|FG001|Treatment|Completed no treatment|5|||
130266371|NCT00237042|468940655|FG002|Treatment|Completed no treatment|21|||
130266372|NCT00237042|468940653|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
130266373|NCT00237042|468940654|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
130266374|NCT00237042|468940655|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
130266375|NCT00237042|468940653|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
130266376|NCT00237042|468940654|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
130266377|NCT00237042|468940655|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
130266378|NCT01897532|468940656|FG000|Discontinuation From Treatment|Not Treated|7|||
130266379|NCT01897532|468940657|FG001|Discontinuation From Treatment|Not Treated|5|||
130266380|NCT01897532|468940656|FG000|Discontinuation From Treatment|Other reason than specified|196|||
130266381|NCT01897532|468940657|FG001|Discontinuation From Treatment|Other reason than specified|176|||
130266382|NCT01897532|468940656|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
130266383|NCT01897532|468940657|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
130266384|NCT01897532|468940656|FG000|Discontinuation From Treatment|Non compliance|24|||
130266385|NCT01897532|468940657|FG001|Discontinuation From Treatment|Non compliance|15|||
130266386|NCT01897532|468940656|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
130266387|NCT01897532|468940657|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
130266388|NCT01897532|468940656|FG000|Discontinuation From Trial|Not Treated|7|||
130266389|NCT01897532|468940657|FG001|Discontinuation From Trial|Not Treated|5|||
130266390|NCT01897532|468940656|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
130266391|NCT01897532|468940657|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
130266392|NCT03132467|468940658|FG000|Overall Study|Adverse Event|2|||
130266393|NCT03132467|468940658|FG000|Overall Study|Withdrawal by Subject|2|||
130266394|NCT02670473|468940661|FG000|Overall Study|Withdrawal by Subject|1|||
130266395|NCT05223673|468940662|FG000|Overall Study|Protocol Violation|1|||
130266396|NCT05223673|468940662|FG000|Overall Study|Study termination|6|||
130266397|NCT03559270|468940663|FG000|Overall Study|Adverse Event|6|||
130266398|NCT03559270|468940664|FG001|Overall Study|Adverse Event|5|||
130266399|NCT03559270|468940665|FG002|Overall Study|Adverse Event|3|||
130266400|NCT03559270|468940666|FG003|Overall Study|Adverse Event|0|||
130266401|NCT03559270|468940663|FG000|Overall Study|Lack of Efficacy|34|||
130266402|NCT03559270|468940664|FG001|Overall Study|Lack of Efficacy|52|||
130266403|NCT03559270|468940665|FG002|Overall Study|Lack of Efficacy|37|||
130266404|NCT03559270|468940666|FG003|Overall Study|Lack of Efficacy|2|||
130266405|NCT03559270|468940663|FG000|Overall Study|Death|0|||
130266406|NCT03559270|468940664|FG001|Overall Study|Death|2|||
130266407|NCT03559270|468940665|FG002|Overall Study|Death|0|||
130266408|NCT03559270|468940666|FG003|Overall Study|Death|0|||
130266409|NCT03559270|468940663|FG000|Overall Study|Lost to Follow-up|16|||
130266410|NCT03559270|468940664|FG001|Overall Study|Lost to Follow-up|4|||
130266411|NCT03559270|468940665|FG002|Overall Study|Lost to Follow-up|12|||
130266412|NCT03559270|468940666|FG003|Overall Study|Lost to Follow-up|3|||
130266413|NCT03559270|468940663|FG000|Overall Study|Sponsor Decision|38|||
130266414|NCT03559270|468940664|FG001|Overall Study|Sponsor Decision|31|||
130266415|NCT03559270|468940665|FG002|Overall Study|Sponsor Decision|35|||
130266416|NCT03559270|468940666|FG003|Overall Study|Sponsor Decision|18|||
130266417|NCT03559270|468940663|FG000|Overall Study|Withdrawal by Subject|19|||
130266418|NCT03559270|468940664|FG001|Overall Study|Withdrawal by Subject|21|||
130266419|NCT03559270|468940665|FG002|Overall Study|Withdrawal by Subject|18|||
130266420|NCT03559270|468940666|FG003|Overall Study|Withdrawal by Subject|7|||
130266421|NCT03559270|468940663|FG000|Overall Study|Physician Decision|3|||
130266422|NCT03559270|468940664|FG001|Overall Study|Physician Decision|2|||
130266423|NCT03559270|468940665|FG002|Overall Study|Physician Decision|1|||
130266424|NCT03559270|468940666|FG003|Overall Study|Physician Decision|0|||
130266425|NCT03559270|468940663|FG000|Overall Study|Pregnancy|0|||
130266426|NCT03559270|468940664|FG001|Overall Study|Pregnancy|1|||
130266427|NCT03559270|468940665|FG002|Overall Study|Pregnancy|0|||
130266428|NCT03559270|468940666|FG003|Overall Study|Pregnancy|0|||
130266429|NCT03559270|468940663|FG000|Overall Study|Protocol Violation|1|||
130266430|NCT03559270|468940664|FG001|Overall Study|Protocol Violation|0|||
130266431|NCT03559270|468940665|FG002|Overall Study|Protocol Violation|2|||
130266432|NCT03559270|468940666|FG003|Overall Study|Protocol Violation|0|||
130266433|NCT04472650|468942649|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
130266434|NCT04472650|468942650|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
130266435|NCT01669902|468942655|FG000|Overall Study|Adverse Event|11|||
130266436|NCT01669902|468942655|FG000|Overall Study|Lack of Efficacy|10|||
130102738|NCT02118896|468334351|FG000|Overall Study|Lost to Follow-up|1|||
130102739|NCT02118896|468334352|FG001|Overall Study|Lost to Follow-up|2|||
130102740|NCT02118896|468334353|FG002|Overall Study|Lost to Follow-up|1|||
130102741|NCT02118896|468334354|FG003|Overall Study|Lost to Follow-up|0|||
130102742|NCT02118896|468334355|FG004|Overall Study|Lost to Follow-up|2|||
130102743|NCT02118896|468334356|FG005|Overall Study|Lost to Follow-up|1|||
130102744|NCT02118896|468334357|FG006|Overall Study|Lost to Follow-up|0|||
130266437|NCT01669902|468942655|FG000|Overall Study|Other|8|||
130266438|NCT01535287|468942658|FG000|Overall Study|drug not prepared in time|5|||
130266439|NCT01535287|468942659|FG001|Overall Study|drug not prepared in time|6|||
130102745|NCT02118896|468334358|FG007|Overall Study|Lost to Follow-up|0|||
130102746|NCT02118896|468334359|FG008|Overall Study|Lost to Follow-up|0|||
130102747|NCT02118896|468334360|FG009|Overall Study|Lost to Follow-up|0|||
130102748|NCT02118896|468334351|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
130266440|NCT00551031|468942662|FG000|Overall Study|Adverse Event|0|||
130266441|NCT00551031|468942663|FG001|Overall Study|Adverse Event|1|||
130266442|NCT00551031|468942664|FG002|Overall Study|Adverse Event|0|||
130266443|NCT00551031|468942665|FG003|Overall Study|Adverse Event|0|||
130266444|NCT00551031|468942666|FG004|Overall Study|Adverse Event|0|||
130266445|NCT00551031|468942662|FG000|Overall Study|Protocol Violation|1|||
130266446|NCT00551031|468942663|FG001|Overall Study|Protocol Violation|1|||
130266447|NCT00551031|468942664|FG002|Overall Study|Protocol Violation|0|||
130266448|NCT00551031|468942665|FG003|Overall Study|Protocol Violation|0|||
130266449|NCT00551031|468942666|FG004|Overall Study|Protocol Violation|0|||
130266450|NCT00551031|468942662|FG000|Overall Study|Lost to Follow-up|0|||
130266451|NCT00551031|468942663|FG001|Overall Study|Lost to Follow-up|1|||
130266452|NCT00551031|468942664|FG002|Overall Study|Lost to Follow-up|0|||
130266453|NCT00551031|468942665|FG003|Overall Study|Lost to Follow-up|1|||
130266454|NCT00551031|468942666|FG004|Overall Study|Lost to Follow-up|1|||
130266455|NCT00551031|468942662|FG000|Overall Study|Withdrawal by Subject|0|||
130266456|NCT00551031|468942663|FG001|Overall Study|Withdrawal by Subject|4|||
130266457|NCT00551031|468942664|FG002|Overall Study|Withdrawal by Subject|1|||
130266458|NCT00551031|468942665|FG003|Overall Study|Withdrawal by Subject|2|||
130266459|NCT00551031|468942666|FG004|Overall Study|Withdrawal by Subject|0|||
130266460|NCT00551031|468942662|FG000|Overall Study|Serious Adverse Event|0|||
130266461|NCT00551031|468942663|FG001|Overall Study|Serious Adverse Event|2|||
130266462|NCT00551031|468942664|FG002|Overall Study|Serious Adverse Event|1|||
130266463|NCT00551031|468942665|FG003|Overall Study|Serious Adverse Event|0|||
130266464|NCT00551031|468942666|FG004|Overall Study|Serious Adverse Event|0|||
130266465|NCT00551031|468942662|FG000|Overall Study|Did not receive vaccine|1|||
130266466|NCT00551031|468942663|FG001|Overall Study|Did not receive vaccine|2|||
130266467|NCT00551031|468942664|FG002|Overall Study|Did not receive vaccine|0|||
130266468|NCT00551031|468942665|FG003|Overall Study|Did not receive vaccine|0|||
130266469|NCT00551031|468942666|FG004|Overall Study|Did not receive vaccine|0|||
130266470|NCT04567524|468942667|FG000|Overall Study|Adverse Event|1|||
130266471|NCT04567524|468942668|FG001|Overall Study|Adverse Event|1|||
130266472|NCT04567524|468942669|FG002|Overall Study|Adverse Event|0|||
130266473|NCT04567524|468942670|FG003|Overall Study|Adverse Event|0|||
130266474|NCT04567524|468942667|FG000|Overall Study|Withdrawal by Subject|2|||
130266475|NCT04567524|468942668|FG001|Overall Study|Withdrawal by Subject|0|||
130266476|NCT04567524|468942669|FG002|Overall Study|Withdrawal by Subject|0|||
130266477|NCT04567524|468942670|FG003|Overall Study|Withdrawal by Subject|1|||
130266478|NCT02078752|468942680|FG000|Overall Study|Death|0|||
130266479|NCT02078752|468942681|FG001|Overall Study|Death|3|||
130266480|NCT02078752|468942682|FG002|Overall Study|Death|0|||
130266481|NCT02078752|468942683|FG003|Overall Study|Death|0|||
130266482|NCT02078752|468942684|FG004|Overall Study|Death|0|||
130266483|NCT02078752|468942685|FG005|Overall Study|Death|1|||
130266484|NCT02078752|468942686|FG006|Overall Study|Death|0|||
130266485|NCT02078752|468942687|FG007|Overall Study|Death|1|||
130266486|NCT02078752|468942688|FG008|Overall Study|Death|0|||
130266487|NCT02078752|468942689|FG009|Overall Study|Death|4|||
130266488|NCT02078752|468942680|FG000|Overall Study|Lost to Follow-up|1|||
130266489|NCT02078752|468942681|FG001|Overall Study|Lost to Follow-up|0|||
130266490|NCT02078752|468942682|FG002|Overall Study|Lost to Follow-up|0|||
130266491|NCT02078752|468942683|FG003|Overall Study|Lost to Follow-up|1|||
130266492|NCT02078752|468942684|FG004|Overall Study|Lost to Follow-up|0|||
130266493|NCT02078752|468942685|FG005|Overall Study|Lost to Follow-up|0|||
130266494|NCT02078752|468942686|FG006|Overall Study|Lost to Follow-up|0|||
130266495|NCT02078752|468942687|FG007|Overall Study|Lost to Follow-up|0|||
130266496|NCT02078752|468942688|FG008|Overall Study|Lost to Follow-up|0|||
130266497|NCT02078752|468942689|FG009|Overall Study|Lost to Follow-up|0|||
130266498|NCT02078752|468942680|FG000|Overall Study|Withdrawal by Subject|1|||
130266499|NCT02078752|468942681|FG001|Overall Study|Withdrawal by Subject|1|||
130266500|NCT02078752|468942682|FG002|Overall Study|Withdrawal by Subject|1|||
130266501|NCT02078752|468942683|FG003|Overall Study|Withdrawal by Subject|1|||
130266502|NCT02078752|468942684|FG004|Overall Study|Withdrawal by Subject|0|||
130266503|NCT02078752|468942685|FG005|Overall Study|Withdrawal by Subject|3|||
130266504|NCT02078752|468942686|FG006|Overall Study|Withdrawal by Subject|2|||
130035695|NCT03049449|468086012|FG000|Overall Study|Did not receive treatment.|0|||
130035696|NCT03049449|468086013|FG001|Overall Study|Did not receive treatment.|0|||
130035697|NCT03049449|468086014|FG002|Overall Study|Did not receive treatment.|0|||
130035698|NCT03049449|468086015|FG003|Overall Study|Did not receive treatment.|0|||
130266505|NCT02078752|468942687|FG007|Overall Study|Withdrawal by Subject|1|||
130266506|NCT02078752|468942688|FG008|Overall Study|Withdrawal by Subject|0|||
130266507|NCT02078752|468942689|FG009|Overall Study|Withdrawal by Subject|1|||
130266508|NCT02078752|468942680|FG000|Overall Study|Other|0|||
130266509|NCT02078752|468942681|FG001|Overall Study|Other|3|||
130266510|NCT02078752|468942682|FG002|Overall Study|Other|0|||
130266511|NCT02078752|468942683|FG003|Overall Study|Other|0|||
130266512|NCT02078752|468942684|FG004|Overall Study|Other|1|||
130266513|NCT02078752|468942685|FG005|Overall Study|Other|0|||
130266514|NCT02078752|468942686|FG006|Overall Study|Other|0|||
130266515|NCT02078752|468942687|FG007|Overall Study|Other|1|||
130266516|NCT02078752|468942688|FG008|Overall Study|Other|0|||
130266517|NCT02078752|468942689|FG009|Overall Study|Other|0|||
130266518|NCT02078752|468942680|FG000|Overall Study|Study terminated by sponsor|0|||
130266519|NCT02078752|468942681|FG001|Overall Study|Study terminated by sponsor|0|||
130266520|NCT02078752|468942682|FG002|Overall Study|Study terminated by sponsor|0|||
130266521|NCT02078752|468942683|FG003|Overall Study|Study terminated by sponsor|0|||
130266522|NCT02078752|468942684|FG004|Overall Study|Study terminated by sponsor|0|||
130266523|NCT02078752|468942685|FG005|Overall Study|Study terminated by sponsor|0|||
130266524|NCT02078752|468942686|FG006|Overall Study|Study terminated by sponsor|0|||
130266525|NCT02078752|468942687|FG007|Overall Study|Study terminated by sponsor|0|||
130266526|NCT02078752|468942688|FG008|Overall Study|Study terminated by sponsor|0|||
130266527|NCT02078752|468942689|FG009|Overall Study|Study terminated by sponsor|5|||
130266528|NCT00616642|468942695|FG000|Overall Study|Withdrawal by Subject|0|||
130266529|NCT00616642|468942696|FG001|Overall Study|Withdrawal by Subject|1|||
130266530|NCT01023217|468942705|FG000|Overall Study|Withdrawal by Subject|1|||
130266531|NCT01023217|468942706|FG001|Overall Study|Withdrawal by Subject|0|||
130266532|NCT00589797|468942707|FG000|Overall Study|Death|1|||
130266533|NCT00589797|468942708|FG001|Overall Study|Death|0|||
130266534|NCT00589797|468942707|FG000|Overall Study|Lost to Follow-up|12|||
130266535|NCT00589797|468942708|FG001|Overall Study|Lost to Follow-up|9|||
130266536|NCT00589797|468942707|FG000|Overall Study|Physician Decision|8|||
130266537|NCT00589797|468942708|FG001|Overall Study|Physician Decision|3|||
130266538|NCT00589797|468942707|FG000|Overall Study|Withdrawal by Subject|6|||
130266539|NCT00589797|468942708|FG001|Overall Study|Withdrawal by Subject|5|||
130266540|NCT00589797|468942707|FG000|Overall Study|Non-Randomized Training Subjects|46|||
130266541|NCT00589797|468942708|FG001|Overall Study|Non-Randomized Training Subjects|6|||
130266542|NCT01881009|468942709|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
130266543|NCT01881009|468942710|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
130266544|NCT02457247|468942711|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
130266545|NCT02457247|468942712|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
130266546|NCT02457247|468942713|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
130266547|NCT02457247|468942714|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
130266548|NCT02457247|468942711|FG000|Period 1|Significant Protocol Deviation|1|||
130266549|NCT02457247|468942712|FG001|Period 1|Significant Protocol Deviation|1|||
130266550|NCT02457247|468942713|FG002|Period 1|Significant Protocol Deviation|0|||
130266551|NCT02457247|468942714|FG003|Period 1|Significant Protocol Deviation|0|||
130266552|NCT02457247|468942711|FG000|Period 1|Voluntary Withdrawal|1|||
130266553|NCT02457247|468942712|FG001|Period 1|Voluntary Withdrawal|0|||
130266554|NCT02457247|468942713|FG002|Period 1|Voluntary Withdrawal|0|||
130266555|NCT02457247|468942714|FG003|Period 1|Voluntary Withdrawal|0|||
130266556|NCT02457247|468942711|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
130266557|NCT02457247|468942712|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
130266558|NCT02457247|468942713|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
130266559|NCT02457247|468942714|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
130266560|NCT02457247|468942711|FG000|Period 2|Significant Protocol Deviation|1|||
130266561|NCT02457247|468942712|FG001|Period 2|Significant Protocol Deviation|0|||
130266562|NCT02457247|468942713|FG002|Period 2|Significant Protocol Deviation|0|||
130266563|NCT02457247|468942714|FG003|Period 2|Significant Protocol Deviation|0|||
130266564|NCT02457247|468942711|FG000|Period 2|Lost to Follow-up|0|||
130266565|NCT02457247|468942712|FG001|Period 2|Lost to Follow-up|1|||
130266566|NCT02457247|468942713|FG002|Period 2|Lost to Follow-up|0|||
130035699|NCT03049449|468086016|FG004|Overall Study|Did not receive treatment.|0|||
130266567|NCT02457247|468942714|FG003|Period 2|Lost to Follow-up|0|||
130266568|NCT02457247|468942711|FG000|Period 2|Voluntary Withdrawal|1|||
130266569|NCT02457247|468942712|FG001|Period 2|Voluntary Withdrawal|1|||
130266570|NCT02457247|468942713|FG002|Period 2|Voluntary Withdrawal|0|||
130266571|NCT02457247|468942714|FG003|Period 2|Voluntary Withdrawal|0|||
130266572|NCT01061385|468942715|FG000|Overall Study|Lost to Follow-up|1|||
130266573|NCT01061385|468942716|FG001|Overall Study|Lost to Follow-up|0|||
130035700|NCT03049449|468086017|FG005|Overall Study|Did not receive treatment.|0|||
129885636|NCT02855164|467540778|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
130266574|NCT01061385|468942715|FG000|Overall Study|subject decision not related to AE|0|||
130266575|NCT01061385|468942716|FG001|Overall Study|subject decision not related to AE|1|||
130035701|NCT03049449|468086018|FG006|Overall Study|Did not receive treatment.|0|||
130266576|NCT01492088|468942717|FG000|Overall Study|Withdrawal by Patient|0|||
130266577|NCT01492088|468942718|FG001|Overall Study|Withdrawal by Patient|2|||
130266578|NCT01492088|468942719|FG002|Overall Study|Withdrawal by Patient|0|||
130266579|NCT01492088|468942717|FG000|Overall Study|Death|1|||
130266580|NCT01492088|468942718|FG001|Overall Study|Death|6|||
130266581|NCT01492088|468942719|FG002|Overall Study|Death|2|||
130266582|NCT01492088|468942717|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
130266583|NCT01492088|468942718|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
130266584|NCT01492088|468942719|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
130266585|NCT01492088|468942717|FG000|Overall Study|Alive at Last Follow-up|0|||
130266586|NCT01492088|468942718|FG001|Overall Study|Alive at Last Follow-up|6|||
130266587|NCT01492088|468942719|FG002|Overall Study|Alive at Last Follow-up|11|||
130266588|NCT00533429|468942720|FG000|Overall Study|Adverse Event|3|||
130266589|NCT00533429|468942721|FG001|Overall Study|Adverse Event|1|||
130266590|NCT00533429|468942720|FG000|Overall Study|Death|1|||
130266591|NCT00533429|468942721|FG001|Overall Study|Death|0|||
130266592|NCT00533429|468942720|FG000|Overall Study|Withdrawal by Subject|2|||
130266593|NCT00533429|468942721|FG001|Overall Study|Withdrawal by Subject|0|||
130266594|NCT00533429|468942720|FG000|Overall Study|Progressive Disease|12|||
130266595|NCT00533429|468942721|FG001|Overall Study|Progressive Disease|13|||
130266596|NCT00533429|468942720|FG000|Overall Study|Symptomatic deterioration|1|||
130266597|NCT00533429|468942721|FG001|Overall Study|Symptomatic deterioration|2|||
130266598|NCT01464879|468942722|FG000|Overall Study|Physician Decision|1|||
130266599|NCT01464879|468942722|FG000|Overall Study|Non-compliance|1|||
130266600|NCT03824392|468942729|FG000|Overall Study|Adverse Event|1|||
130266601|NCT03824392|468942730|FG001|Overall Study|Adverse Event|0|||
130266602|NCT03824392|468942731|FG002|Overall Study|Adverse Event|0|||
130266603|NCT03824392|468942732|FG003|Overall Study|Adverse Event|0|||
130266604|NCT03824392|468942729|FG000|Overall Study|Investigator Decision|0|||
130266605|NCT03824392|468942730|FG001|Overall Study|Investigator Decision|1|||
130266606|NCT03824392|468942731|FG002|Overall Study|Investigator Decision|0|||
130266607|NCT03824392|468942732|FG003|Overall Study|Investigator Decision|0|||
130266608|NCT03824392|468942729|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
130266609|NCT03824392|468942730|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
130266610|NCT03824392|468942731|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
130266611|NCT03824392|468942732|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
130266612|NCT02230189|468942733|FG000|Overall Study|Withdrawal by Subject|3|||
130266613|NCT02230189|468942734|FG001|Overall Study|Withdrawal by Subject|0|||
130266614|NCT02230189|468942735|FG002|Overall Study|Withdrawal by Subject|1|||
130266615|NCT02230189|468942733|FG000|Overall Study|Lost to Follow-up|1|||
130266616|NCT02230189|468942734|FG001|Overall Study|Lost to Follow-up|0|||
130266617|NCT02230189|468942735|FG002|Overall Study|Lost to Follow-up|0|||
130266618|NCT02230189|468942733|FG000|Overall Study|Physician Decision|1|||
130266619|NCT02230189|468942734|FG001|Overall Study|Physician Decision|0|||
130266620|NCT02230189|468942735|FG002|Overall Study|Physician Decision|0|||
130266621|NCT01887717|468942736|FG000|Overall Study|Withdrawal by Subject|1|||
130266622|NCT01887717|468942737|FG001|Overall Study|Withdrawal by Subject|7|||
130266623|NCT01887717|468942736|FG000|Overall Study|Physician Decision|0|||
130266624|NCT01887717|468942737|FG001|Overall Study|Physician Decision|2|||
130266625|NCT01887717|468942736|FG000|Overall Study|Administrative reasons|5|||
130266626|NCT01887717|468942737|FG001|Overall Study|Administrative reasons|2|||
130266627|NCT00244621|468942738|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130266628|NCT00244621|468942739|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130266629|NCT00244621|468942740|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130266630|NCT00244621|468942738|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130266631|NCT00244621|468942739|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130266632|NCT00244621|468942740|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130266633|NCT00244621|468942738|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130266634|NCT00244621|468942739|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130266635|NCT00244621|468942740|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130266636|NCT00244621|468942738|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
130266637|NCT00244621|468942739|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
130266638|NCT00244621|468942740|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
130266639|NCT00244621|468942738|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130266640|NCT00244621|468942739|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
130266641|NCT00244621|468942740|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130266642|NCT00244621|468942738|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
130266643|NCT00244621|468942739|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129885637|NCT02855164|467540771|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
130266644|NCT00244621|468942740|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130266645|NCT00244621|468942738|FG000|Open-label Treatment Period|Adverse Event|0|||
130266646|NCT00244621|468942739|FG001|Open-label Treatment Period|Adverse Event|0|||
130266647|NCT00244621|468942740|FG002|Open-label Treatment Period|Adverse Event|1|||
130266648|NCT00244621|468942738|FG000|Open-label Treatment Period|Moved abroad|0|||
130266649|NCT00244621|468942739|FG001|Open-label Treatment Period|Moved abroad|0|||
130266650|NCT00244621|468942740|FG002|Open-label Treatment Period|Moved abroad|1|||
130266651|NCT02834819|468942741|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
130266652|NCT02834819|468942742|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
130266653|NCT04389866|468942745|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
130266654|NCT04389866|468942746|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
130266655|NCT01490918|468942749|FG000|Overall Study|Lost to Follow-up|2|||
130266656|NCT01490918|468942750|FG001|Overall Study|Lost to Follow-up|1|||
130266657|NCT01490918|468942751|FG002|Overall Study|Lost to Follow-up|0|||
130266658|NCT01490918|468942749|FG000|Overall Study|Withdrawal by Subject|7|||
130266659|NCT01490918|468942750|FG001|Overall Study|Withdrawal by Subject|8|||
130266660|NCT01490918|468942751|FG002|Overall Study|Withdrawal by Subject|3|||
130266661|NCT01490918|468942749|FG000|Overall Study|Adverse Event|0|||
130266662|NCT01490918|468942750|FG001|Overall Study|Adverse Event|0|||
130266663|NCT01490918|468942751|FG002|Overall Study|Adverse Event|1|||
130266664|NCT01490918|468942749|FG000|Overall Study|other cause|4|||
130266665|NCT01490918|468942750|FG001|Overall Study|other cause|5|||
130266666|NCT01490918|468942751|FG002|Overall Study|other cause|8|||
130266667|NCT02967679|468942754|FG000|Overall Study|Adverse Event|1|||
130035702|NCT03049449|468086019|FG007|Overall Study|Did not receive treatment.|0|||
130035703|NCT03049449|468086020|FG008|Overall Study|Did not receive treatment.|1|||
130266668|NCT00003631|468942757|FG000|Overall Study|Patient not treated|1|||
130266669|NCT00003631|468942758|FG001|Overall Study|Patient not treated|0|||
130266670|NCT00003631|468942759|FG002|Overall Study|Patient not treated|1|||
130266671|NCT00003631|468942757|FG000|Overall Study|Protocol Violation|1|||
130266672|NCT00003631|468942758|FG001|Overall Study|Protocol Violation|0|||
130266673|NCT00003631|468942759|FG002|Overall Study|Protocol Violation|0|||
130266674|NCT00003631|468942757|FG000|Overall Study|Adverse Event|1|||
130266675|NCT00003631|468942758|FG001|Overall Study|Adverse Event|1|||
130266676|NCT00003631|468942759|FG002|Overall Study|Adverse Event|5|||
130266677|NCT00003631|468942757|FG000|Overall Study|Death|0|||
130266678|NCT00003631|468942758|FG001|Overall Study|Death|0|||
130266679|NCT00003631|468942759|FG002|Overall Study|Death|1|||
130266680|NCT00003631|468942757|FG000|Overall Study|Evaluable for toxicity only|0|||
130266681|NCT00003631|468942758|FG001|Overall Study|Evaluable for toxicity only|0|||
130266682|NCT00003631|468942759|FG002|Overall Study|Evaluable for toxicity only|2|||
130266683|NCT00600067|468942760|FG000|Overall Study|Adverse Event|0|||
130266684|NCT00600067|468942761|FG001|Overall Study|Adverse Event|1|||
130266685|NCT00600067|468942760|FG000|Overall Study|Lost to Follow-up|2|||
130266686|NCT00600067|468942761|FG001|Overall Study|Lost to Follow-up|3|||
130266687|NCT00600067|468942760|FG000|Overall Study|protocol non-compliance|0|||
130266688|NCT00600067|468942761|FG001|Overall Study|protocol non-compliance|3|||
130266689|NCT00600067|468942760|FG000|Overall Study|Lack of Efficacy|1|||
130266690|NCT00600067|468942761|FG001|Overall Study|Lack of Efficacy|0|||
130266691|NCT04339413|468942764|FG000|Overall Study|Reason Not Specified|2|||
130266692|NCT04339413|468942765|FG001|Overall Study|Reason Not Specified|7|||
130266693|NCT04339413|468942764|FG000|Overall Study|Study Terminated by Sponsor|30|||
130266694|NCT04339413|468942765|FG001|Overall Study|Study Terminated by Sponsor|33|||
130266695|NCT04339413|468942764|FG000|Overall Study|Progressive Disease|9|||
130266696|NCT04339413|468942765|FG001|Overall Study|Progressive Disease|6|||
130266697|NCT04339413|468942764|FG000|Overall Study|Withdrawal by Subject|9|||
130266698|NCT04339413|468942765|FG001|Overall Study|Withdrawal by Subject|10|||
130266699|NCT04339413|468942764|FG000|Overall Study|Physician Decision|3|||
130266700|NCT04339413|468942765|FG001|Overall Study|Physician Decision|1|||
130266701|NCT04339413|468942764|FG000|Overall Study|Death|2|||
130266702|NCT04339413|468942765|FG001|Overall Study|Death|0|||
130266703|NCT04339413|468942764|FG000|Overall Study|Adverse Event|3|||
130266704|NCT04339413|468942765|FG001|Overall Study|Adverse Event|0|||
130266705|NCT00251693|468942771|FG000|Overall Study|Adverse Event|17|||
130266706|NCT00251693|468942772|FG001|Overall Study|Adverse Event|9|||
130266707|NCT00251693|468942773|FG002|Overall Study|Adverse Event|9|||
130266708|NCT00251693|468942771|FG000|Overall Study|Protocol Violation|2|||
130266709|NCT00251693|468942772|FG001|Overall Study|Protocol Violation|0|||
130266710|NCT00251693|468942773|FG002|Overall Study|Protocol Violation|2|||
130266711|NCT00251693|468942771|FG000|Overall Study|Lost to Follow-up|12|||
130266712|NCT00251693|468942772|FG001|Overall Study|Lost to Follow-up|7|||
130266713|NCT00251693|468942773|FG002|Overall Study|Lost to Follow-up|8|||
130266714|NCT00251693|468942771|FG000|Overall Study|Withdrawal by Subject|11|||
130266715|NCT00251693|468942772|FG001|Overall Study|Withdrawal by Subject|17|||
130266716|NCT00251693|468942773|FG002|Overall Study|Withdrawal by Subject|14|||
130266717|NCT00251693|468942771|FG000|Overall Study|Lack of Efficacy|0|||
130266718|NCT00251693|468942772|FG001|Overall Study|Lack of Efficacy|1|||
130266719|NCT00251693|468942773|FG002|Overall Study|Lack of Efficacy|0|||
130266720|NCT00251693|468942771|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
130266721|NCT00251693|468942772|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
130266722|NCT00251693|468942773|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
130266723|NCT00251693|468942771|FG000|Overall Study|Noncompliant|0|||
130266724|NCT00251693|468942772|FG001|Overall Study|Noncompliant|0|||
130266725|NCT00251693|468942773|FG002|Overall Study|Noncompliant|2|||
130266726|NCT00251693|468942771|FG000|Overall Study|Possible Barrett's esophagus|3|||
130266727|NCT00251693|468942772|FG001|Overall Study|Possible Barrett's esophagus|5|||
130266728|NCT00251693|468942773|FG002|Overall Study|Possible Barrett's esophagus|2|||
130266729|NCT00251693|468942771|FG000|Overall Study|Subject request/subject unavailable|1|||
130266730|NCT00251693|468942772|FG001|Overall Study|Subject request/subject unavailable|2|||
130266731|NCT00251693|468942773|FG002|Overall Study|Subject request/subject unavailable|0|||
130266732|NCT00251693|468942771|FG000|Overall Study|Abnormal laboratory findings|0|||
130266733|NCT00251693|468942772|FG001|Overall Study|Abnormal laboratory findings|0|||
130266734|NCT00251693|468942773|FG002|Overall Study|Abnormal laboratory findings|1|||
130266735|NCT01284959|468942774|FG000|Overall Study|Withdrawal by Subject|1|||
130266736|NCT01284959|468942775|FG001|Overall Study|Withdrawal by Subject|0|||
130266737|NCT01284959|468942776|FG002|Overall Study|Withdrawal by Subject|0|||
130266738|NCT01284959|468942774|FG000|Overall Study|Adverse Event|0|||
130266739|NCT01284959|468942775|FG001|Overall Study|Adverse Event|0|||
130266740|NCT01284959|468942776|FG002|Overall Study|Adverse Event|1|||
130266741|NCT00401843|468942777|FG000|Overall Study|Achieved Complete Response|1|||
130266742|NCT00401843|468942778|FG001|Overall Study|Achieved Complete Response|5|||
130266743|NCT00401843|468942779|FG002|Overall Study|Achieved Complete Response|11|||
130266744|NCT00401843|468942777|FG000|Overall Study|Adverse Event|7|||
130266745|NCT00401843|468942778|FG001|Overall Study|Adverse Event|26|||
130266746|NCT00401843|468942779|FG002|Overall Study|Adverse Event|27|||
130266747|NCT00401843|468942777|FG000|Overall Study|Death|0|||
130266748|NCT00401843|468942778|FG001|Overall Study|Death|8|||
130266749|NCT00401843|468942779|FG002|Overall Study|Death|10|||
130266750|NCT00401843|468942777|FG000|Overall Study|Disease progression|10|||
130266751|NCT00401843|468942778|FG001|Overall Study|Disease progression|60|||
130266752|NCT00401843|468942779|FG002|Overall Study|Disease progression|49|||
130266753|NCT00401843|468942777|FG000|Overall Study|End of Study|1|||
130266754|NCT00401843|468942778|FG001|Overall Study|End of Study|1|||
130266755|NCT00401843|468942779|FG002|Overall Study|End of Study|2|||
130266756|NCT00401843|468942777|FG000|Overall Study|Lost to Follow-up|0|||
130266757|NCT00401843|468942778|FG001|Overall Study|Lost to Follow-up|0|||
130266758|NCT00401843|468942779|FG002|Overall Study|Lost to Follow-up|2|||
130266759|NCT00401843|468942777|FG000|Overall Study|Other Unspecified|0|||
130266760|NCT00401843|468942778|FG001|Overall Study|Other Unspecified|3|||
130266761|NCT00401843|468942779|FG002|Overall Study|Other Unspecified|5|||
130266762|NCT00401843|468942777|FG000|Overall Study|Physician Decision|0|||
130266763|NCT00401843|468942778|FG001|Overall Study|Physician Decision|16|||
130266764|NCT00401843|468942779|FG002|Overall Study|Physician Decision|10|||
130266765|NCT00401843|468942777|FG000|Overall Study|Protocol Violation|0|||
130266766|NCT00401843|468942778|FG001|Overall Study|Protocol Violation|0|||
130266767|NCT00401843|468942779|FG002|Overall Study|Protocol Violation|1|||
130266768|NCT00401843|468942777|FG000|Overall Study|Withdrawal by Subject|1|||
130266769|NCT00401843|468942778|FG001|Overall Study|Withdrawal by Subject|5|||
130266770|NCT00401843|468942779|FG002|Overall Study|Withdrawal by Subject|5|||
130266771|NCT00401843|468942777|FG000|Overall Study|Withdrawal of consent to study agent|1|||
130266772|NCT00401843|468942778|FG001|Overall Study|Withdrawal of consent to study agent|15|||
130266773|NCT00401843|468942779|FG002|Overall Study|Withdrawal of consent to study agent|17|||
130266774|NCT00401843|468942777|FG000|Overall Study|Randomized but not Treated|0|||
130266775|NCT00401843|468942778|FG001|Overall Study|Randomized but not Treated|2|||
130266776|NCT00401843|468942779|FG002|Overall Study|Randomized but not Treated|3|||
130266777|NCT00401843|468942777|FG000|Overall Study|Received incorrect treatment|0|||
130266778|NCT00401843|468942778|FG001|Overall Study|Received incorrect treatment|3|||
130266779|NCT00401843|468942779|FG002|Overall Study|Received incorrect treatment|0|||
130266780|NCT01508910|468942782|FG000|Treatment|Death|2|||
130266781|NCT01508910|468942783|FG001|Treatment|Death|3|||
130266782|NCT01508910|468942784|FG002|Treatment|Death|2|||
130266783|NCT01508910|468942785|FG003|Treatment|Death|0|||
130266784|NCT01508910|468942782|FG000|Treatment|Lost to Follow-up|0|||
130266785|NCT01508910|468942783|FG001|Treatment|Lost to Follow-up|0|||
130266786|NCT01508910|468942784|FG002|Treatment|Lost to Follow-up|2|||
130266787|NCT01508910|468942785|FG003|Treatment|Lost to Follow-up|1|||
130266788|NCT01508910|468942782|FG000|Treatment|Withdrawal by Subject|0|||
130266789|NCT01508910|468942783|FG001|Treatment|Withdrawal by Subject|1|||
130266790|NCT01508910|468942784|FG002|Treatment|Withdrawal by Subject|6|||
130266791|NCT01508910|468942785|FG003|Treatment|Withdrawal by Subject|1|||
130266792|NCT01508910|468942782|FG000|Treatment|Sponsor Decision|0|||
130266793|NCT01508910|468942783|FG001|Treatment|Sponsor Decision|0|||
130266794|NCT01508910|468942784|FG002|Treatment|Sponsor Decision|0|||
130266795|NCT01508910|468942785|FG003|Treatment|Sponsor Decision|1|||
130266796|NCT03192137|468942789|FG000|Overall Study|Adverse Event|10|||
130266797|NCT03192137|468942790|FG001|Overall Study|Adverse Event|11|||
130266798|NCT03192137|468942789|FG000|Overall Study|Physician Decision|1|||
130266799|NCT03192137|468942790|FG001|Overall Study|Physician Decision|0|||
130266800|NCT03192137|468942789|FG000|Overall Study|Lack of Efficacy|20|||
130266801|NCT03192137|468942790|FG001|Overall Study|Lack of Efficacy|37|||
130266802|NCT03192137|468942789|FG000|Overall Study|Withdrawal by Subject|3|||
130266803|NCT03192137|468942790|FG001|Overall Study|Withdrawal by Subject|3|||
130266804|NCT03192137|468942789|FG000|Overall Study|Protocol Violation|4|||
129885638|NCT02855164|467540772|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
130035704|NCT03049449|468086021|FG009|Overall Study|Did not receive treatment.|0|||
130266805|NCT03192137|468942790|FG001|Overall Study|Protocol Violation|3|||
130266806|NCT03192137|468942789|FG000|Overall Study|Surgery Cancelled|4|||
130266807|NCT03192137|468942790|FG001|Overall Study|Surgery Cancelled|1|||
130266808|NCT03192137|468942789|FG000|Overall Study|Other - Various Administrative Reasons|8|||
130266809|NCT03192137|468942790|FG001|Overall Study|Other - Various Administrative Reasons|3|||
130266810|NCT00657267|468942791|FG000|Overall Study|Progressive disease|45|||
130266811|NCT00657267|468942791|FG000|Overall Study|Adverse Event|9|||
130266812|NCT02737501|468942795|FG000|Randomized Phase|Died|41|||
130266813|NCT02737501|468942796|FG001|Randomized Phase|Died|29|||
130266814|NCT02737501|468942797|FG002|Randomized Phase|Died|0|||
130266815|NCT02737501|468942795|FG000|Randomized Phase|Withdrawal by Subject|16|||
130266816|NCT02737501|468942796|FG001|Randomized Phase|Withdrawal by Subject|6|||
130266817|NCT02737501|468942797|FG002|Randomized Phase|Withdrawal by Subject|0|||
130266818|NCT02737501|468942795|FG000|Randomized Phase|Lost to Follow-up|0|||
130266819|NCT02737501|468942796|FG001|Randomized Phase|Lost to Follow-up|1|||
130266820|NCT02737501|468942797|FG002|Randomized Phase|Lost to Follow-up|0|||
130266821|NCT02737501|468942795|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
130266822|NCT02737501|468942796|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
130266823|NCT02737501|468942797|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
130266824|NCT02737501|468942795|FG000|Randomized Phase|Reason not Specified|1|||
130266825|NCT02737501|468942796|FG001|Randomized Phase|Reason not Specified|1|||
130266826|NCT02737501|468942797|FG002|Randomized Phase|Reason not Specified|0|||
130266827|NCT02737501|468942795|FG000|Randomized Phase|Never Treated|1|||
130266828|NCT02737501|468942796|FG001|Randomized Phase|Never Treated|1|||
130266829|NCT02737501|468942797|FG002|Randomized Phase|Never Treated|0|||
130266830|NCT02737501|468942795|FG000|Crossover Phase|Died|0|||
130266831|NCT02737501|468942796|FG001|Crossover Phase|Died|0|||
130266832|NCT02737501|468942797|FG002|Crossover Phase|Died|22|||
130266833|NCT02737501|468942795|FG000|Crossover Phase|Withdrew Consent|0|||
130266834|NCT02737501|468942796|FG001|Crossover Phase|Withdrew Consent|0|||
130266835|NCT02737501|468942797|FG002|Crossover Phase|Withdrew Consent|9|||
130266836|NCT02737501|468942795|FG000|Crossover Phase|Physician Decision|0|||
130266837|NCT02737501|468942796|FG001|Crossover Phase|Physician Decision|0|||
130266838|NCT02737501|468942797|FG002|Crossover Phase|Physician Decision|1|||
130266839|NCT02737501|468942795|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
130266840|NCT02737501|468942796|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
130266841|NCT02737501|468942797|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
130266842|NCT01261975|468942798|FG000|Overall Study|Surgical complication|1|||
130266843|NCT04819113|468942801|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130266844|NCT04819113|468942801|FG000|Overall Study|Lost to Follow-up|1|||
130266845|NCT04819113|468942801|FG000|Overall Study|Withdrawn before vaccination|2|||
130266846|NCT04067492|468942802|FG000|Overall Study|Lost to Follow-up|0|||
130266847|NCT04067492|468942803|FG001|Overall Study|Lost to Follow-up|0|||
130266848|NCT04067492|468942804|FG002|Overall Study|Lost to Follow-up|0|||
130266849|NCT04067492|468942805|FG003|Overall Study|Lost to Follow-up|0|||
130266850|NCT04067492|468942806|FG004|Overall Study|Lost to Follow-up|0|||
130266851|NCT04067492|468942807|FG005|Overall Study|Lost to Follow-up|1|||
130266852|NCT04067492|468942802|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266853|NCT04067492|468942803|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
130266854|NCT04067492|468942804|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266855|NCT04067492|468942805|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266856|NCT04067492|468942806|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266857|NCT04067492|468942807|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
130266858|NCT04067492|468942802|FG000|Overall Study|COVID-19 epidemiological situation|0|||
130266859|NCT04067492|468942803|FG001|Overall Study|COVID-19 epidemiological situation|0|||
130266860|NCT04067492|468942804|FG002|Overall Study|COVID-19 epidemiological situation|0|||
130266861|NCT04067492|468942805|FG003|Overall Study|COVID-19 epidemiological situation|1|||
130266862|NCT04067492|468942806|FG004|Overall Study|COVID-19 epidemiological situation|0|||
130266863|NCT04067492|468942807|FG005|Overall Study|COVID-19 epidemiological situation|0|||
130266864|NCT00833027|468942808|FG000|Overall Study|Adverse Event|33|||
130266865|NCT00833027|468942808|FG000|Overall Study|Death|1|||
130266866|NCT00833027|468942808|FG000|Overall Study|Lack of Efficacy|12|||
130266867|NCT00833027|468942808|FG000|Overall Study|Lost to Follow-up|24|||
130266868|NCT00833027|468942808|FG000|Overall Study|Protocol Violation|115|||
130266869|NCT00833027|468942808|FG000|Overall Study|Withdrawal by Subject|16|||
130266870|NCT00833027|468942808|FG000|Overall Study|Missing|10|||
130266871|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Death|2|||
130266872|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
130266873|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
130266874|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Physician Decision|1|||
130266875|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
130266876|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
130266877|NCT00786422|468942810|FG000|Rivaroxaban Treatment|Adverse Event|2|||
130266878|NCT00786422|468942810|FG000|Follow-up Period|Death|1|||
130266879|NCT00786422|468942810|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
130266880|NCT00444106|468942815|FG000|Overall Study|Lost to Follow-up|2|||
130266881|NCT00444106|468942816|FG001|Overall Study|Lost to Follow-up|1|||
130266882|NCT00444106|468942817|FG002|Overall Study|Lost to Follow-up|0|||
130266883|NCT00444106|468942815|FG000|Overall Study|Abnormal Test Procedure Results|0|||
130266884|NCT00444106|468942816|FG001|Overall Study|Abnormal Test Procedure Results|0|||
130266885|NCT00444106|468942817|FG002|Overall Study|Abnormal Test Procedure Results|1|||
130266886|NCT04570384|468942818|FG000|Overall Study|Adverse Event|2|||
130266887|NCT04570384|468942819|FG001|Overall Study|Adverse Event|1|||
130266888|NCT04570384|468942818|FG000|Overall Study|Death|2|||
130266889|NCT04570384|468942819|FG001|Overall Study|Death|5|||
130266890|NCT04570384|468942818|FG000|Overall Study|Lost to Follow-up|1|||
130266891|NCT04570384|468942819|FG001|Overall Study|Lost to Follow-up|0|||
130266892|NCT04570384|468942818|FG000|Overall Study|Other|1|||
130266893|NCT04570384|468942819|FG001|Overall Study|Other|0|||
130266894|NCT04570384|468942818|FG000|Overall Study|Protocol Violation|0|||
130266895|NCT04570384|468942819|FG001|Overall Study|Protocol Violation|1|||
130266896|NCT04570384|468942818|FG000|Overall Study|Sponsor Decision|1|||
130266897|NCT04570384|468942819|FG001|Overall Study|Sponsor Decision|0|||
130266898|NCT04570384|468942818|FG000|Overall Study|Withdrawal by Subject|4|||
130266899|NCT04570384|468942819|FG001|Overall Study|Withdrawal by Subject|2|||
130266900|NCT01900665|468942820|FG000|Placebo Controlled Period|Death|9|||
130266901|NCT01900665|468942821|FG001|Placebo Controlled Period|Death|16|||
130266902|NCT01900665|468942820|FG000|Placebo Controlled Period|Adverse Event|48|||
130266903|NCT01900665|468942821|FG001|Placebo Controlled Period|Adverse Event|39|||
130266904|NCT01900665|468942820|FG000|Placebo Controlled Period|Protocol Violation|1|||
130266905|NCT01900665|468942821|FG001|Placebo Controlled Period|Protocol Violation|7|||
130266906|NCT01900665|468942820|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
130266907|NCT01900665|468942821|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
130266908|NCT01900665|468942820|FG000|Placebo Controlled Period|Physician Decision|11|||
130266909|NCT01900665|468942821|FG001|Placebo Controlled Period|Physician Decision|7|||
130266910|NCT01900665|468942820|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
130266911|NCT01900665|468942821|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
130266912|NCT01900665|468942820|FG000|Placebo Controlled Period|Caregiver Decision|33|||
130266913|NCT01900665|468942821|FG001|Placebo Controlled Period|Caregiver Decision|41|||
130266914|NCT01900665|468942820|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
130266915|NCT01900665|468942821|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
130266916|NCT01900665|468942820|FG000|Open Label Period|Adverse Event|16|||
130266917|NCT01900665|468942821|FG001|Open Label Period|Adverse Event|20|||
130266918|NCT01900665|468942820|FG000|Open Label Period|Death|5|||
130266919|NCT01900665|468942821|FG001|Open Label Period|Death|6|||
130266920|NCT01900665|468942820|FG000|Open Label Period|Lost to Follow-up|1|||
130266921|NCT01900665|468942821|FG001|Open Label Period|Lost to Follow-up|1|||
130266922|NCT01900665|468942820|FG000|Open Label Period|Parent/Caregiver Decision|33|||
130266923|NCT01900665|468942821|FG001|Open Label Period|Parent/Caregiver Decision|34|||
130266924|NCT01900665|468942820|FG000|Open Label Period|Physician Decision|4|||
130266925|NCT01900665|468942821|FG001|Open Label Period|Physician Decision|4|||
130266926|NCT01900665|468942820|FG000|Open Label Period|Protocol Violation|0|||
130266927|NCT01900665|468942821|FG001|Open Label Period|Protocol Violation|1|||
130266928|NCT01900665|468942820|FG000|Open Label Period|Sponsor Decision|802|||
130266929|NCT01900665|468942821|FG001|Open Label Period|Sponsor Decision|765|||
130266930|NCT01900665|468942820|FG000|Open Label Period|Withdrawal by Subject|20|||
130266931|NCT01900665|468942821|FG001|Open Label Period|Withdrawal by Subject|28|||
130266932|NCT04749914|468942822|FG000|Period 1|Adverse Event|1|||
130266933|NCT04749914|468942823|FG001|Period 1|Adverse Event|0|||
130266934|NCT04749914|468942824|FG002|Period 1|Adverse Event|0|||
130266935|NCT04749914|468942825|FG003|Period 1|Adverse Event|0|||
130266936|NCT04749914|468942822|FG000|Period 1|Withdrawal by Subject|1|||
130266937|NCT04749914|468942823|FG001|Period 1|Withdrawal by Subject|0|||
130266938|NCT04749914|468942824|FG002|Period 1|Withdrawal by Subject|1|||
130266939|NCT04749914|468942825|FG003|Period 1|Withdrawal by Subject|0|||
130266940|NCT01673126|468942826|FG000|Overall Study|change of diagnosis|4|||
130266941|NCT01673126|468942827|FG001|Overall Study|change of diagnosis|3|||
130266942|NCT01074931|468942832|FG000|Overall Study|Economic reasons|1|||
130266943|NCT01074931|468942832|FG000|Overall Study|Death|5|||
130266944|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
130266945|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
130266946|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
130266947|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
130266948|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130266949|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
130266950|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130266951|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
130266952|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130266953|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
130266954|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130266955|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
130266956|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130266957|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
130266958|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130266959|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
130266960|NCT00953706|468942833|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130266961|NCT00953706|468942834|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
130266962|NCT00953706|468942835|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130266963|NCT00953706|468942836|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
130266964|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130266965|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130266966|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
130266967|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
130266968|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130266969|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130266970|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
130266971|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
130266972|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130266973|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130266974|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
130266975|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
130266976|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
130266977|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
130266978|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
130266979|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
130266980|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
130266981|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
130266982|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
130266983|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
130266984|NCT00953706|468942833|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
130266985|NCT00953706|468942834|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
130266986|NCT00953706|468942835|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
130266987|NCT00953706|468942836|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
130266988|NCT01404234|468942837|FG000|Overall Study|Withdrawal by Subject|2|||
130266989|NCT01475721|468944320|FG000|Overall Study|Death|3|||
130266990|NCT01475721|468944321|FG001|Overall Study|Death|6|||
130266991|NCT01475721|468944320|FG000|Overall Study|Withdrawal by Subject|8|||
130266992|NCT01475721|468944321|FG001|Overall Study|Withdrawal by Subject|8|||
130266993|NCT00803738|468944323|FG000|Overall Study|Adverse Event|3|||
130266994|NCT00803738|468944324|FG001|Overall Study|Adverse Event|5|||
130266995|NCT00803738|468944323|FG000|Overall Study|Lost to Follow-up|4|||
130266996|NCT00803738|468944324|FG001|Overall Study|Lost to Follow-up|4|||
130266997|NCT00803738|468944323|FG000|Overall Study|Protocol Violation|18|||
130266998|NCT00803738|468944324|FG001|Overall Study|Protocol Violation|10|||
130266999|NCT00803738|468944323|FG000|Overall Study|Withdrawal by Subject|1|||
130267000|NCT00803738|468944324|FG001|Overall Study|Withdrawal by Subject|4|||
130267001|NCT00803738|468944323|FG000|Overall Study|Lack of Efficacy|10|||
130267002|NCT00803738|468944324|FG001|Overall Study|Lack of Efficacy|16|||
130267003|NCT00803738|468944323|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
130267004|NCT00803738|468944324|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
130267005|NCT00803738|468944323|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
130267006|NCT00803738|468944324|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
130267007|NCT02364037|468944325|FG000|Overall Study|Withdrawal by Subject|7|||
130267008|NCT02364037|468944326|FG001|Overall Study|Withdrawal by Subject|4|||
130267009|NCT02364037|468944325|FG000|Overall Study|Lost to Follow-up|37|||
130267010|NCT02364037|468944326|FG001|Overall Study|Lost to Follow-up|49|||
130267011|NCT00387088|468944329|FG000|Overall Study|Adverse Event|143|||
130267012|NCT00387088|468944330|FG001|Overall Study|Adverse Event|156|||
130267013|NCT00387088|468944329|FG000|Overall Study|Protocol Violation|47|||
130102749|NCT02118896|468334352|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
130267014|NCT00387088|468944330|FG001|Overall Study|Protocol Violation|35|||
130267015|NCT00387088|468944329|FG000|Overall Study|Withdrawal by Subject|20|||
130267016|NCT00387088|468944330|FG001|Overall Study|Withdrawal by Subject|35|||
130267017|NCT00387088|468944329|FG000|Overall Study|Lack of Efficacy|28|||
130035705|NCT03049449|468086012|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
130035706|NCT03049449|468086013|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
130267018|NCT00387088|468944330|FG001|Overall Study|Lack of Efficacy|67|||
130267019|NCT00387088|468944329|FG000|Overall Study|Lost to Follow-up|22|||
130267020|NCT00387088|468944330|FG001|Overall Study|Lost to Follow-up|28|||
130267021|NCT00387088|468944329|FG000|Overall Study|Other|58|||
130267022|NCT00387088|468944330|FG001|Overall Study|Other|52|||
130267023|NCT02848092|468944333|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
130267024|NCT02848092|468944334|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
130267025|NCT02848092|468944333|FG000|1-month Post-training Follow-up|Adverse Event|2|||
130267026|NCT02848092|468944334|FG001|1-month Post-training Follow-up|Adverse Event|1|||
130267027|NCT02848092|468944333|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
130267028|NCT02848092|468944334|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
130267029|NCT02848092|468944333|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
130267030|NCT02848092|468944334|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
130267031|NCT02848092|468944333|FG000|1-month Post-training Follow-up|fatigue|0|||
130267032|NCT02848092|468944334|FG001|1-month Post-training Follow-up|fatigue|1|||
130267033|NCT02848092|468944333|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
130267034|NCT02848092|468944334|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
130267035|NCT02848092|468944333|FG000|6-month Post-training Follow-up|Adverse Event|1|||
130267036|NCT02848092|468944334|FG001|6-month Post-training Follow-up|Adverse Event|1|||
130267037|NCT02848092|468944333|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
130267038|NCT02848092|468944334|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
130267039|NCT02848092|468944333|FG000|6-month Post-training Follow-up|frustrated with task|1|||
130267040|NCT02848092|468944334|FG001|6-month Post-training Follow-up|frustrated with task|0|||
130267041|NCT02848092|468944333|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
130267042|NCT02848092|468944334|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
130267043|NCT02848092|468944333|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
130267044|NCT02848092|468944334|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
130267045|NCT01639469|468944335|FG000|Overall Study|Death|4|||
130267046|NCT01639469|468944336|FG001|Overall Study|Death|2|||
130267047|NCT01639469|468944335|FG000|Overall Study|Lost to Follow-up|1|||
130267048|NCT01639469|468944336|FG001|Overall Study|Lost to Follow-up|1|||
130267049|NCT00420381|468944337|FG000|Overall Study|Protocol Violation|1|||
130267050|NCT00592631|468944338|FG000|Overall Study|Lost to Follow-up|0|||
130267051|NCT00592631|468944339|FG001|Overall Study|Lost to Follow-up|2|||
130267052|NCT02383862|468944342|FG000|3 Month Follow up|Lost to Follow-up|23|||
130267053|NCT02383862|468944343|FG001|3 Month Follow up|Lost to Follow-up|21|||
130267054|NCT01833494|468944344|FG000|Overall Study|Adverse Event|24|||
130267055|NCT01833494|468944344|FG000|Overall Study|Physician Decision|6|||
130267056|NCT01833494|468944344|FG000|Overall Study|Withdrawal by Subject|6|||
130267057|NCT01833494|468944344|FG000|Overall Study|Decrease in serum phosphorus|4|||
130267058|NCT01833494|468944344|FG000|Overall Study|Decrease in serum calcium|4|||
130035707|NCT03049449|468086014|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
130035708|NCT03049449|468086015|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
130035709|NCT03049449|468086016|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
130267059|NCT01833494|468944344|FG000|Overall Study|Increase in serum ferritin|1|||
130267060|NCT01694433|468944345|FG000|Overall Study|Adverse Event|7|||
130267061|NCT01694433|468944346|FG001|Overall Study|Adverse Event|0|||
130267062|NCT01694433|468944345|FG000|Overall Study|Physician Decision|1|||
130267063|NCT01694433|468944346|FG001|Overall Study|Physician Decision|0|||
130267064|NCT01694433|468944345|FG000|Overall Study|Withdrawal by Subject|3|||
130267065|NCT01694433|468944346|FG001|Overall Study|Withdrawal by Subject|4|||
130267066|NCT00374595|468944349|FG000|Overall Study|Death|23|||
130267067|NCT00374595|468944349|FG000|Overall Study|Withdrawal by Subject|39|||
130267068|NCT00374595|468944349|FG000|Overall Study|Lost to Follow-up|3|||
130267069|NCT00374595|468944349|FG000|Overall Study|too much time commitment|1|||
130267070|NCT00374595|468944349|FG000|Overall Study|transfer care to other clinical site|1|||
130267071|NCT00374595|468944349|FG000|Overall Study|relocation|3|||
130267072|NCT03745768|468944351|FG000|Overall Study|discontinued study|2|||
130267073|NCT03745768|468944352|FG001|Overall Study|discontinued study|0|||
130267074|NCT00443118|468944353|FG000|Overall Study|unknown primary outcome|3|||
130267075|NCT00443118|468944354|FG001|Overall Study|unknown primary outcome|1|||
130267076|NCT00443118|468944355|FG002|Overall Study|unknown primary outcome|0|||
130267077|NCT00443118|468944353|FG000|Overall Study|Withdrawal by Subject|1|||
130267078|NCT00443118|468944354|FG001|Overall Study|Withdrawal by Subject|0|||
130267079|NCT00443118|468944355|FG002|Overall Study|Withdrawal by Subject|0|||
130267080|NCT01664247|468944358|FG000|Overall Study|Adverse Event|5|||
130267081|NCT01664247|468944359|FG001|Overall Study|Adverse Event|3|||
130267082|NCT01664247|468944358|FG000|Overall Study|Protocol Violation|3|||
130267083|NCT01664247|468944359|FG001|Overall Study|Protocol Violation|5|||
130267084|NCT01664247|468944358|FG000|Overall Study|Withdrawal Criteria|1|||
130267085|NCT01664247|468944359|FG001|Overall Study|Withdrawal Criteria|4|||
130267086|NCT01664247|468944358|FG000|Overall Study|Unclassified|5|||
130267087|NCT01664247|468944359|FG001|Overall Study|Unclassified|29|||
130267088|NCT01106157|468944360|FG000|Overall Study|Withdrawal by Subject|1|||
130267089|NCT01106157|468944361|FG001|Overall Study|Withdrawal by Subject|0|||
130267090|NCT01673646|468944365|FG000|Overall Study|Adverse Event|2|||
130267091|NCT01673646|468944366|FG001|Overall Study|Adverse Event|1|||
130267092|NCT01673646|468944367|FG002|Overall Study|Adverse Event|1|||
130267093|NCT01673646|468944365|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130267094|NCT01673646|468944366|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130267095|NCT01673646|468944367|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130267096|NCT01673646|468944365|FG000|Overall Study|Condition no longer requires study drug|0|||
130267097|NCT01673646|468944366|FG001|Overall Study|Condition no longer requires study drug|1|||
130267098|NCT01673646|468944367|FG002|Overall Study|Condition no longer requires study drug|0|||
130267099|NCT01673646|468944365|FG000|Overall Study|Withdrawal by Subject|0|||
130267100|NCT01673646|468944366|FG001|Overall Study|Withdrawal by Subject|2|||
130267101|NCT01673646|468944367|FG002|Overall Study|Withdrawal by Subject|2|||
130267102|NCT01673646|468944365|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
130267103|NCT01673646|468944366|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
130267104|NCT01673646|468944367|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
130267105|NCT03064074|468944368|FG000|Overall Study|Physician Decision|0|||
130267106|NCT03064074|468944369|FG001|Overall Study|Physician Decision|0|||
130267107|NCT03064074|468944370|FG002|Overall Study|Physician Decision|0|||
130267108|NCT03064074|468944371|FG003|Overall Study|Physician Decision|1|||
130267109|NCT02141672|468944375|FG000|Overall Study|Adverse Event|0|||
130267110|NCT02141672|468944376|FG001|Overall Study|Adverse Event|1|||
130267111|NCT02141672|468944377|FG002|Overall Study|Adverse Event|0|||
130267112|NCT02141672|468944375|FG000|Overall Study|Death|10|||
130267113|NCT02141672|468944376|FG001|Overall Study|Death|2|||
130267114|NCT02141672|468944377|FG002|Overall Study|Death|1|||
130267115|NCT02141672|468944375|FG000|Overall Study|Lack of Efficacy|0|||
130267116|NCT02141672|468944376|FG001|Overall Study|Lack of Efficacy|0|||
130267117|NCT02141672|468944377|FG002|Overall Study|Lack of Efficacy|2|||
130267118|NCT02141672|468944375|FG000|Overall Study|Lost to Follow-up|1|||
130267119|NCT02141672|468944376|FG001|Overall Study|Lost to Follow-up|1|||
130267120|NCT02141672|468944377|FG002|Overall Study|Lost to Follow-up|3|||
130267121|NCT02141672|468944375|FG000|Overall Study|Physician Decision|1|||
130267122|NCT02141672|468944376|FG001|Overall Study|Physician Decision|2|||
130267123|NCT02141672|468944377|FG002|Overall Study|Physician Decision|5|||
130267124|NCT02141672|468944375|FG000|Overall Study|Protocol Violation|0|||
130267125|NCT02141672|468944376|FG001|Overall Study|Protocol Violation|0|||
130267126|NCT02141672|468944377|FG002|Overall Study|Protocol Violation|1|||
130267127|NCT02141672|468944375|FG000|Overall Study|Withdrawal by Subject|3|||
130267128|NCT02141672|468944376|FG001|Overall Study|Withdrawal by Subject|2|||
130267129|NCT02141672|468944377|FG002|Overall Study|Withdrawal by Subject|5|||
130267130|NCT02141672|468944375|FG000|Overall Study|refused to follow-up|1|||
130267131|NCT02141672|468944376|FG001|Overall Study|refused to follow-up|0|||
130267132|NCT02141672|468944377|FG002|Overall Study|refused to follow-up|1|||
130267133|NCT01118780|468944378|FG000|Overall Study|Adverse Event|15|||
130267134|NCT01118780|468944379|FG001|Overall Study|Adverse Event|15|||
130267135|NCT01118780|468944378|FG000|Overall Study|Death|1|||
130267136|NCT01118780|468944379|FG001|Overall Study|Death|0|||
130267137|NCT01118780|468944378|FG000|Overall Study|Lack of Efficacy|2|||
130267138|NCT01118780|468944379|FG001|Overall Study|Lack of Efficacy|6|||
130267139|NCT01118780|468944378|FG000|Overall Study|Physician Decision|2|||
130267140|NCT01118780|468944379|FG001|Overall Study|Physician Decision|0|||
130267141|NCT01118780|468944378|FG000|Overall Study|Protocol Violation|3|||
130267142|NCT01118780|468944379|FG001|Overall Study|Protocol Violation|6|||
130267143|NCT01118780|468944378|FG000|Overall Study|Withdrawal by Subject|13|||
130267144|NCT01118780|468944379|FG001|Overall Study|Withdrawal by Subject|8|||
130267145|NCT03962855|468944387|FG000|Overall Study|Death|0|||
130267146|NCT03962855|468944388|FG001|Overall Study|Death|1|||
130267147|NCT03962855|468944387|FG000|Overall Study|Lost to Follow-up|0|||
130267148|NCT03962855|468944388|FG001|Overall Study|Lost to Follow-up|1|||
130267149|NCT03962855|468944387|FG000|Overall Study|Adverse Event|0|||
130267150|NCT03962855|468944388|FG001|Overall Study|Adverse Event|1|||
130267151|NCT03962855|468944387|FG000|Overall Study|Physician Decision|0|||
130267152|NCT03962855|468944388|FG001|Overall Study|Physician Decision|2|||
130267153|NCT00127855|468944389|FG000|Primary Vaccination Course|Adverse Event|0|||
130267154|NCT00127855|468944390|FG001|Primary Vaccination Course|Adverse Event|0|||
130267155|NCT00127855|468944391|FG002|Primary Vaccination Course|Adverse Event|1|||
130267156|NCT00127855|468944392|FG003|Primary Vaccination Course|Adverse Event|0|||
130267157|NCT00127855|468944393|FG004|Primary Vaccination Course|Adverse Event|0|||
130267158|NCT00127855|468944389|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
130267159|NCT00127855|468944390|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
130267160|NCT00127855|468944391|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
130267161|NCT00127855|468944392|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
130267162|NCT00127855|468944393|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
130267163|NCT00127855|468944389|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
130267164|NCT00127855|468944390|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
130267165|NCT00127855|468944391|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
130267166|NCT00127855|468944392|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
130267167|NCT00127855|468944393|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
130267168|NCT00127855|468944389|FG000|Primary Vaccination Course|Other|0|||
130267169|NCT00127855|468944390|FG001|Primary Vaccination Course|Other|0|||
130267170|NCT00127855|468944391|FG002|Primary Vaccination Course|Other|0|||
130267171|NCT00127855|468944392|FG003|Primary Vaccination Course|Other|0|||
130267172|NCT00127855|468944393|FG004|Primary Vaccination Course|Other|1|||
130267173|NCT02343302|468944394|FG000|Overall Study|Physician Decision|1|||
130267174|NCT02343302|468944395|FG001|Overall Study|Physician Decision|1|||
130267175|NCT02655887|468944396|FG000|Overall Study|Lost to Follow-up|3|||
130267176|NCT02655887|468944396|FG000|Overall Study|Death|4|||
130267177|NCT02655887|468944396|FG000|Overall Study|Withdrawal by Subject|3|||
130267178|NCT02655887|468944396|FG000|Overall Study|Missed 12-month follow-up visit|4|||
130267179|NCT03465722|468944402|FG000|Overall Study|Withdrawal by Subject|21|||
130267180|NCT03465722|468944403|FG001|Overall Study|Withdrawal by Subject|14|||
130267181|NCT03465722|468944402|FG000|Overall Study|Death|89|||
130267182|NCT03465722|468944403|FG001|Overall Study|Death|87|||
130267183|NCT03465722|468944402|FG000|Overall Study|Lost to Follow-up|5|||
130267184|NCT03465722|468944403|FG001|Overall Study|Lost to Follow-up|3|||
130267185|NCT03465722|468944402|FG000|Overall Study|Administrative/Other|33|||
130267186|NCT03465722|468944403|FG001|Overall Study|Administrative/Other|32|||
130267187|NCT03465722|468944402|FG000|Overall Study|Not treated|1|||
130267188|NCT03465722|468944403|FG001|Overall Study|Not treated|2|||
130267189|NCT03465722|468944402|FG000|Overall Study|Sponsor decision|91|||
130267190|NCT03465722|468944403|FG001|Overall Study|Sponsor decision|98|||
130267191|NCT04940130|468944404|FG000|Overall Study|Travel|1|||
130267192|NCT04940130|468944405|FG001|Overall Study|Travel|0|||
130267193|NCT04940130|468944406|FG002|Overall Study|Travel|2|||
130267194|NCT04940130|468944404|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
130267195|NCT04940130|468944405|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
130267196|NCT04940130|468944406|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
130267197|NCT04940130|468944404|FG000|Overall Study|Adverse Event|0|||
130267198|NCT04940130|468944405|FG001|Overall Study|Adverse Event|0|||
130267199|NCT04940130|468944406|FG002|Overall Study|Adverse Event|2|||
130267200|NCT04940130|468944404|FG000|Overall Study|Disease progression/treatment failure|0|||
130267201|NCT04940130|468944405|FG001|Overall Study|Disease progression/treatment failure|0|||
130267202|NCT04940130|468944406|FG002|Overall Study|Disease progression/treatment failure|1|||
130267203|NCT04940130|468944404|FG000|Overall Study|Participant refusal|0|||
130267204|NCT04940130|468944405|FG001|Overall Study|Participant refusal|0|||
130267205|NCT04940130|468944406|FG002|Overall Study|Participant refusal|1|||
130267206|NCT02240121|468944409|FG000|Overall Study|Protocol Violation|1|||
130267207|NCT02240121|468944410|FG001|Overall Study|Protocol Violation|2|||
130267208|NCT02240121|468944409|FG000|Overall Study|Physician Decision|0|||
130267209|NCT02240121|468944410|FG001|Overall Study|Physician Decision|1|||
130267210|NCT02240121|468944409|FG000|Overall Study|Change in protocol interpretation|1|||
130267211|NCT02240121|468944410|FG001|Overall Study|Change in protocol interpretation|0|||
130267212|NCT02240121|468944409|FG000|Overall Study|Lack of Efficacy|2|||
130267213|NCT02240121|468944410|FG001|Overall Study|Lack of Efficacy|3|||
130267214|NCT02240121|468944409|FG000|Overall Study|Site closed|1|||
130267215|NCT02240121|468944410|FG001|Overall Study|Site closed|1|||
130267216|NCT02240121|468944409|FG000|Overall Study|Pregnancy|1|||
130267217|NCT02240121|468944410|FG001|Overall Study|Pregnancy|0|||
130267218|NCT02240121|468944409|FG000|Overall Study|Adverse Event|2|||
130267219|NCT02240121|468944410|FG001|Overall Study|Adverse Event|4|||
130267220|NCT02240121|468944409|FG000|Overall Study|Withdrawal by Subject|6|||
130267221|NCT02240121|468944410|FG001|Overall Study|Withdrawal by Subject|2|||
130267222|NCT02240121|468944409|FG000|Overall Study|Lost to Follow-up|3|||
130267223|NCT02240121|468944410|FG001|Overall Study|Lost to Follow-up|4|||
130267224|NCT02240121|468944409|FG000|Overall Study|Other than specified|1|||
130267225|NCT02240121|468944410|FG001|Overall Study|Other than specified|3|||
130267226|NCT04419467|468944413|FG000|Overall Study|Not treated with IP|0|||
130267227|NCT04419467|468944414|FG001|Overall Study|Not treated with IP|0|||
130267228|NCT04419467|468944415|FG002|Overall Study|Not treated with IP|2|||
130267229|NCT04419467|468944413|FG000|Overall Study|Adverse Event|0|||
130267230|NCT04419467|468944414|FG001|Overall Study|Adverse Event|2|||
130267231|NCT04419467|468944415|FG002|Overall Study|Adverse Event|0|||
130267232|NCT04419467|468944413|FG000|Overall Study|Death|1|||
130267233|NCT04419467|468944414|FG001|Overall Study|Death|0|||
130267234|NCT04419467|468944415|FG002|Overall Study|Death|0|||
130267235|NCT04419467|468944413|FG000|Overall Study|Lost to Follow-up|0|||
130267236|NCT04419467|468944414|FG001|Overall Study|Lost to Follow-up|1|||
130267237|NCT04419467|468944415|FG002|Overall Study|Lost to Follow-up|2|||
130267238|NCT04419467|468944413|FG000|Overall Study|Withdrawal by Subject|0|||
130267239|NCT04419467|468944414|FG001|Overall Study|Withdrawal by Subject|0|||
130267240|NCT04419467|468944415|FG002|Overall Study|Withdrawal by Subject|4|||
130267241|NCT04419467|468944413|FG000|Overall Study|Pandemic related|0|||
130267242|NCT04419467|468944414|FG001|Overall Study|Pandemic related|0|||
130267243|NCT04419467|468944415|FG002|Overall Study|Pandemic related|1|||
130267244|NCT04419467|468944413|FG000|Overall Study|Reason not known|1|||
130267245|NCT04419467|468944414|FG001|Overall Study|Reason not known|0|||
130267246|NCT04419467|468944415|FG002|Overall Study|Reason not known|0|||
130267247|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
130267248|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
130267249|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
130267250|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
130267251|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
130267252|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
130267253|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
130267254|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
130267255|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
130267256|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
130267257|NCT01925768|468944416|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
130267258|NCT01925768|468944417|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
130267259|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
130267260|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
130267261|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
130267262|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
130035710|NCT03049449|468086017|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
130035711|NCT03049449|468086018|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
130035712|NCT03049449|468086019|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
130035713|NCT03049449|468086020|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
130267263|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
130267264|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
130267265|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
130267266|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
130267267|NCT01925768|468944416|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
130267268|NCT01925768|468944417|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
130267269|NCT02779777|468944418|FG000|Overall Study|Disease Progression|1|||
130267270|NCT02779777|468944419|FG001|Overall Study|Disease Progression|0|||
130267271|NCT02779777|468944420|FG002|Overall Study|Disease Progression|0|||
130267272|NCT02779777|468944418|FG000|Overall Study|Adverse Event|3|||
130267273|NCT02779777|468944419|FG001|Overall Study|Adverse Event|1|||
130267274|NCT02779777|468944420|FG002|Overall Study|Adverse Event|0|||
130267275|NCT02779777|468944418|FG000|Overall Study|Physician Decision|9|||
130267276|NCT02779777|468944419|FG001|Overall Study|Physician Decision|0|||
130267277|NCT02779777|468944420|FG002|Overall Study|Physician Decision|1|||
130267278|NCT02779777|468944418|FG000|Overall Study|Withdrawal by Subject|1|||
130267279|NCT02779777|468944419|FG001|Overall Study|Withdrawal by Subject|0|||
130267280|NCT02779777|468944420|FG002|Overall Study|Withdrawal by Subject|0|||
130267281|NCT04571060|468944421|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
130267282|NCT04571060|468944422|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
130267283|NCT04571060|468944421|FG000|Overall Study|Never treated migraine|47|||
130267284|NCT04571060|468944422|FG001|Overall Study|Never treated migraine|36|||
130267285|NCT04571060|468944421|FG000|Overall Study|Protocol Violation|4|||
130267286|NCT04571060|468944422|FG001|Overall Study|Protocol Violation|2|||
130267287|NCT04571060|468944421|FG000|Overall Study|Withdrawal by Subject|6|||
130267288|NCT04571060|468944422|FG001|Overall Study|Withdrawal by Subject|2|||
130267289|NCT04571060|468944421|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
130267290|NCT04571060|468944422|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
130267291|NCT00442416|468944423|FG000|Overall Study|Adverse Event|4|||
130267292|NCT00442416|468944424|FG001|Overall Study|Adverse Event|1|||
130267293|NCT00442416|468944423|FG000|Overall Study|Death|1|||
130267294|NCT00442416|468944424|FG001|Overall Study|Death|0|||
130267295|NCT00442416|468944423|FG000|Overall Study|Lack of Efficacy|2|||
130267296|NCT00442416|468944424|FG001|Overall Study|Lack of Efficacy|0|||
130267297|NCT00442416|468944423|FG000|Overall Study|Protocol Violation|2|||
130267298|NCT00442416|468944424|FG001|Overall Study|Protocol Violation|3|||
130267299|NCT00442416|468944423|FG000|Overall Study|Withdrew consent|1|||
130267300|NCT00442416|468944424|FG001|Overall Study|Withdrew consent|2|||
130267301|NCT00442416|468944423|FG000|Overall Study|Administrative/Other|27|||
130267302|NCT00442416|468944424|FG001|Overall Study|Administrative/Other|33|||
130267303|NCT00087698|468944425|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
130267304|NCT00087698|468944425|FG000|Overall Study|Death from Other Causes|3|||
130267305|NCT00087698|468944425|FG000|Overall Study|Adverse Event|4|||
130267306|NCT00087698|468944425|FG000|Overall Study|Withdrawal by Subject|4|||
130267307|NCT00087698|468944425|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
130267308|NCT00087698|468944425|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
130267309|NCT00087698|468944425|FG000|Overall Study|Clinical Relapse|1|||
130267310|NCT00087698|468944425|FG000|Overall Study|Death from Study Disease|2|||
130267311|NCT00087698|468944425|FG000|Overall Study|Death from Study Drug Toxicity|2|||
130267312|NCT00087698|468944425|FG000|Overall Study|Protocol Violation|1|||
130267313|NCT00142792|468944429|FG000|Overall Study|Death|0|||
130267314|NCT00142792|468944430|FG001|Overall Study|Death|0|||
130267315|NCT00142792|468944431|FG002|Overall Study|Death|1|||
130267316|NCT00142792|468944429|FG000|Overall Study|Withdrawal by Subject|3|||
130267317|NCT00142792|468944430|FG001|Overall Study|Withdrawal by Subject|2|||
130035714|NCT03049449|468086021|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
130035715|NCT03049449|468086012|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035716|NCT03049449|468086013|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130267318|NCT00142792|468944431|FG002|Overall Study|Withdrawal by Subject|3|||
130267319|NCT00142792|468944429|FG000|Overall Study|Lost to Follow-up|8|||
130267320|NCT00142792|468944430|FG001|Overall Study|Lost to Follow-up|11|||
130267321|NCT00142792|468944431|FG002|Overall Study|Lost to Follow-up|7|||
130267322|NCT00142792|468944429|FG000|Overall Study|No category|1|||
130267323|NCT00142792|468944430|FG001|Overall Study|No category|2|||
130267324|NCT00142792|468944431|FG002|Overall Study|No category|1|||
130267325|NCT01913327|468944438|FG000|Overall Study|Withdrawal by Subject|0|||
130267326|NCT01913327|468944439|FG001|Overall Study|Withdrawal by Subject|1|||
130267327|NCT03816176|468944441|FG000|Overall Study|Miscellaneous|5|||
130267328|NCT03816176|468944441|FG000|Overall Study|Lack of Efficacy|4|||
130267329|NCT03816176|468944441|FG000|Overall Study|Adverse Event|3|||
130267330|NCT00756275|468945708|FG000|Overall Study|Lost to Follow-up|25|||
130267331|NCT00756275|468945709|FG001|Overall Study|Lost to Follow-up|21|||
130267332|NCT00756275|468945708|FG000|Overall Study|Withdrawal by Subject|4|||
130267333|NCT00756275|468945709|FG001|Overall Study|Withdrawal by Subject|7|||
130267334|NCT00938912|468945710|FG000|Overall Study|Withdrawal by Subject|28|||
130267335|NCT00938912|468945710|FG000|Overall Study|Lost to Follow-up|4|||
130267336|NCT00938912|468945710|FG000|Overall Study|Lack of Efficacy|43|||
130267337|NCT00938912|468945710|FG000|Overall Study|Adverse event, non-fatal|24|||
130267338|NCT00938912|468945710|FG000|Overall Study|Adverse event, fatal|1|||
130267339|NCT00938912|468945710|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
130267340|NCT00938912|468945710|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
130267341|NCT00938912|468945710|FG000|Overall Study|Participant needed prohibit medication|1|||
130267342|NCT00938912|468945710|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
130267343|NCT00938912|468945710|FG000|Overall Study|Did not meet Eligibility criteria|1|||
130267344|NCT00938912|468945710|FG000|Overall Study|Participant relocated not related to AE|1|||
130267345|NCT00938912|468945710|FG000|Overall Study|Participant moved to another city|1|||
130267346|NCT00938912|468945710|FG000|Overall Study|Participant experienced break through seizures|1|||
130267347|NCT00938912|468945710|FG000|Overall Study|No longer wished to participate in the study|1|||
130267348|NCT00938912|468945710|FG000|Overall Study|Protocol Deviation|2|||
130267349|NCT00456755|468945714|FG000|Overall Study|Lost to Follow-up|2|||
130267350|NCT00456755|468945715|FG001|Overall Study|Lost to Follow-up|1|||
130267351|NCT06164691|468945716|FG000|Overall Study|Withdrawal by Subject|2|||
130267352|NCT06164691|468945717|FG001|Overall Study|Withdrawal by Subject|0|||
130267353|NCT06164691|468945718|FG002|Overall Study|Withdrawal by Subject|0|||
130267354|NCT02477527|468945721|FG000|Overall Study|Lost to Follow-up|2|||
130267355|NCT02477527|468945721|FG000|Overall Study|Withdrawal by Subject|1|||
130267356|NCT02477527|468945721|FG000|Overall Study|Screen Failure|3|||
130267357|NCT01428219|468945737|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
130267358|NCT03432494|468945746|FG000|Overall Study|Death|1|||
130267359|NCT03432494|468945746|FG000|Overall Study|Noncompliance|1|||
130267360|NCT01696773|468945747|FG000|Days 15-27, Washout|Adverse Event|1|||
130267361|NCT01696773|468945748|FG001|Days 15-27, Washout|Adverse Event|0|||
130267362|NCT00347932|468945751|FG000|Overall Study|Adverse Event|4|||
130267363|NCT00347932|468945752|FG001|Overall Study|Adverse Event|5|||
130267364|NCT00347932|468945751|FG000|Overall Study|Lack of Efficacy|3|||
130267365|NCT00347932|468945752|FG001|Overall Study|Lack of Efficacy|14|||
130267366|NCT00347932|468945751|FG000|Overall Study|Lost to Follow-up|10|||
130267367|NCT00347932|468945752|FG001|Overall Study|Lost to Follow-up|9|||
130267368|NCT00347932|468945751|FG000|Overall Study|Withdrawal by Subject|10|||
130267369|NCT00347932|468945752|FG001|Overall Study|Withdrawal by Subject|16|||
130267370|NCT00347932|468945751|FG000|Overall Study|Did not meet inclusion criteria|4|||
130267371|NCT00347932|468945752|FG001|Overall Study|Did not meet inclusion criteria|8|||
130267372|NCT04512001|468945753|FG000|Week 0 to Week 24|Adverse Event|14|||
130267373|NCT04512001|468945754|FG001|Week 0 to Week 24|Adverse Event|10|||
130267374|NCT04512001|468945755|FG002|Week 0 to Week 24|Adverse Event|0|||
130267375|NCT04512001|468945756|FG003|Week 0 to Week 24|Adverse Event|0|||
130267376|NCT04512001|468945757|FG004|Week 0 to Week 24|Adverse Event|0|||
130267377|NCT04512001|468945753|FG000|Week 0 to Week 24|Death|0|||
130267378|NCT04512001|468945754|FG001|Week 0 to Week 24|Death|2|||
130267379|NCT04512001|468945755|FG002|Week 0 to Week 24|Death|0|||
130267380|NCT04512001|468945756|FG003|Week 0 to Week 24|Death|0|||
130267381|NCT04512001|468945757|FG004|Week 0 to Week 24|Death|0|||
130267382|NCT04512001|468945753|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
130102750|NCT02118896|468334353|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
130267383|NCT04512001|468945754|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
130267384|NCT04512001|468945755|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
130267385|NCT04512001|468945756|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
130267386|NCT04512001|468945757|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
130267387|NCT04512001|468945753|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
130267388|NCT04512001|468945754|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
130267389|NCT04512001|468945755|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130267390|NCT04512001|468945756|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130267391|NCT04512001|468945757|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
130267392|NCT04512001|468945753|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
130035717|NCT03049449|468086014|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035718|NCT03049449|468086015|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035719|NCT03049449|468086016|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035720|NCT03049449|468086017|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035721|NCT03049449|468086018|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035722|NCT03049449|468086019|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
130267393|NCT04512001|468945754|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267394|NCT04512001|468945755|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267395|NCT04512001|468945756|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267396|NCT04512001|468945757|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
130267397|NCT04512001|468945753|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267398|NCT04512001|468945754|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
130267399|NCT04512001|468945755|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267400|NCT04512001|468945756|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267401|NCT04512001|468945757|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
130267402|NCT04512001|468945753|FG000|Week 24 to Week 63|Adverse Event|0|||
130267403|NCT04512001|468945754|FG001|Week 24 to Week 63|Adverse Event|0|||
130267404|NCT04512001|468945755|FG002|Week 24 to Week 63|Adverse Event|13|||
130267405|NCT04512001|468945756|FG003|Week 24 to Week 63|Adverse Event|8|||
130267406|NCT04512001|468945757|FG004|Week 24 to Week 63|Adverse Event|6|||
130267407|NCT04512001|468945753|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
130267408|NCT04512001|468945754|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
130267409|NCT04512001|468945755|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
130267410|NCT04512001|468945756|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
130267411|NCT04512001|468945757|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
130267412|NCT04512001|468945753|FG000|Week 24 to Week 63|Death|0|||
130267413|NCT04512001|468945754|FG001|Week 24 to Week 63|Death|0|||
130267414|NCT04512001|468945755|FG002|Week 24 to Week 63|Death|0|||
130267415|NCT04512001|468945756|FG003|Week 24 to Week 63|Death|1|||
130267416|NCT04512001|468945757|FG004|Week 24 to Week 63|Death|1|||
130267417|NCT04512001|468945753|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
130267418|NCT04512001|468945754|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
130267419|NCT04512001|468945755|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
130267420|NCT04512001|468945756|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
130267421|NCT04512001|468945757|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
130267422|NCT04512001|468945753|FG000|Week 24 to Week 63|Miscellaneous|0|||
130267423|NCT04512001|468945754|FG001|Week 24 to Week 63|Miscellaneous|0|||
130267424|NCT04512001|468945755|FG002|Week 24 to Week 63|Miscellaneous|3|||
130267425|NCT04512001|468945756|FG003|Week 24 to Week 63|Miscellaneous|2|||
130267426|NCT04512001|468945757|FG004|Week 24 to Week 63|Miscellaneous|1|||
130267427|NCT02776683|468945758|FG000|Pre-switch Period|Protocol Violation|1|||
130267428|NCT02776683|468945759|FG001|Pre-switch Period|Protocol Violation|0|||
130267429|NCT02776683|468945758|FG000|Pre-switch Period|Adverse Event|21|||
130267430|NCT02776683|468945759|FG001|Pre-switch Period|Adverse Event|0|||
130267431|NCT02776683|468945758|FG000|Pre-switch Period|Withdrawal by Subject|9|||
130267432|NCT02776683|468945759|FG001|Pre-switch Period|Withdrawal by Subject|0|||
130267433|NCT02776683|468945758|FG000|Pre-switch Period|Physician Decision|7|||
130267434|NCT02776683|468945759|FG001|Pre-switch Period|Physician Decision|0|||
130267435|NCT02776683|468945758|FG000|Pre-switch Period|Progressive disease|39|||
130267436|NCT02776683|468945759|FG001|Pre-switch Period|Progressive disease|0|||
130267437|NCT02776683|468945758|FG000|Pre-switch Period|Other than listed|3|||
130267438|NCT02776683|468945759|FG001|Pre-switch Period|Other than listed|0|||
130267439|NCT02776683|468945758|FG000|Post-switch Period|Adverse Event|0|||
130267440|NCT02776683|468945759|FG001|Post-switch Period|Adverse Event|3|||
130267441|NCT02776683|468945758|FG000|Post-switch Period|Withdrawal by Subject|0|||
130267442|NCT02776683|468945759|FG001|Post-switch Period|Withdrawal by Subject|2|||
130267443|NCT02776683|468945758|FG000|Post-switch Period|Physician Decision|0|||
130267444|NCT02776683|468945759|FG001|Post-switch Period|Physician Decision|3|||
130267445|NCT02776683|468945758|FG000|Post-switch Period|Progressive disease|0|||
130267446|NCT02776683|468945759|FG001|Post-switch Period|Progressive disease|20|||
130267447|NCT02776683|468945758|FG000|Post-switch Period|Other than listed|0|||
130267448|NCT02776683|468945759|FG001|Post-switch Period|Other than listed|15|||
130267449|NCT04232943|468945764|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
130267450|NCT04232943|468945765|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
130267451|NCT04232943|468945766|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
130267452|NCT04232943|468945764|FG000|Overall Study|Withdrawal by Subject|1|||
130267453|NCT04232943|468945765|FG001|Overall Study|Withdrawal by Subject|1|||
130267454|NCT04232943|468945766|FG002|Overall Study|Withdrawal by Subject|0|||
130267455|NCT02298868|468945768|FG000|Overall Study|Adverse Event|1|||
130267456|NCT02298868|468945768|FG000|Overall Study|Death|1|||
130267457|NCT02298868|468945768|FG000|Overall Study|Patient underwent transplant|1|||
130267458|NCT01000506|468945769|FG000|Overall Study|Adverse Event|6|||
130267459|NCT01000506|468945770|FG001|Overall Study|Adverse Event|5|||
130267460|NCT01000506|468945771|FG002|Overall Study|Adverse Event|8|||
130267461|NCT01000506|468945772|FG003|Overall Study|Adverse Event|9|||
130267462|NCT01000506|468945769|FG000|Overall Study|Lack of Efficacy|8|||
130267463|NCT01000506|468945770|FG001|Overall Study|Lack of Efficacy|6|||
130267464|NCT01000506|468945771|FG002|Overall Study|Lack of Efficacy|4|||
130267465|NCT01000506|468945772|FG003|Overall Study|Lack of Efficacy|4|||
130267466|NCT01000506|468945769|FG000|Overall Study|Protocol Violation|1|||
130267467|NCT01000506|468945770|FG001|Overall Study|Protocol Violation|1|||
130267468|NCT01000506|468945771|FG002|Overall Study|Protocol Violation|0|||
130267469|NCT01000506|468945772|FG003|Overall Study|Protocol Violation|0|||
130267470|NCT01000506|468945769|FG000|Overall Study|Lost to Follow-up|1|||
130267471|NCT01000506|468945770|FG001|Overall Study|Lost to Follow-up|1|||
130267472|NCT01000506|468945771|FG002|Overall Study|Lost to Follow-up|4|||
130267473|NCT01000506|468945772|FG003|Overall Study|Lost to Follow-up|0|||
130267474|NCT01000506|468945769|FG000|Overall Study|Physician Decision|1|||
130267475|NCT01000506|468945770|FG001|Overall Study|Physician Decision|3|||
130267476|NCT01000506|468945771|FG002|Overall Study|Physician Decision|3|||
130267477|NCT01000506|468945772|FG003|Overall Study|Physician Decision|3|||
130267478|NCT01000506|468945769|FG000|Overall Study|Withdrawal by Subject|11|||
130267479|NCT01000506|468945770|FG001|Overall Study|Withdrawal by Subject|8|||
130267480|NCT01000506|468945771|FG002|Overall Study|Withdrawal by Subject|2|||
130267481|NCT01000506|468945772|FG003|Overall Study|Withdrawal by Subject|7|||
130267482|NCT02379052|468945773|FG000|Overall Study|Protocol Violation|0|||
130267483|NCT02379052|468945774|FG001|Overall Study|Protocol Violation|1|||
130267484|NCT02379052|468945773|FG000|Overall Study|Adverse Event|0|||
130267485|NCT02379052|468945774|FG001|Overall Study|Adverse Event|1|||
130267486|NCT02379052|468945773|FG000|Overall Study|Physician Decision|1|||
130267487|NCT02379052|468945774|FG001|Overall Study|Physician Decision|1|||
130267488|NCT02379052|468945773|FG000|Overall Study|Withdrawal by Subject|2|||
130267489|NCT02379052|468945774|FG001|Overall Study|Withdrawal by Subject|0|||
130267490|NCT02379052|468945773|FG000|Overall Study|Lost to Follow-up|2|||
130267491|NCT02379052|468945774|FG001|Overall Study|Lost to Follow-up|1|||
130267492|NCT02379052|468945773|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
130267493|NCT02379052|468945774|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
130267494|NCT02379052|468945773|FG000|Overall Study|Subject was Incarcerated|0|||
130267495|NCT02379052|468945774|FG001|Overall Study|Subject was Incarcerated|1|||
130267496|NCT00532844|468945775|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
130267497|NCT00532844|468945776|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
130267498|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
130267499|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
130267500|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
130267501|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
130267502|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
130267503|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
130267504|NCT00532844|468945775|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
130267505|NCT00532844|468945776|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
130267506|NCT03637491|468945777|FG000|Overall Study|Death|9|||
130267507|NCT03637491|468945778|FG001|Overall Study|Death|9|||
130267508|NCT03637491|468945779|FG002|Overall Study|Death|5|||
130267509|NCT03637491|468945780|FG003|Overall Study|Death|3|||
130267510|NCT03637491|468945777|FG000|Overall Study|Lost to Follow-up|0|||
130267511|NCT03637491|468945778|FG001|Overall Study|Lost to Follow-up|1|||
130267512|NCT03637491|468945779|FG002|Overall Study|Lost to Follow-up|0|||
130267513|NCT03637491|468945780|FG003|Overall Study|Lost to Follow-up|1|||
130267514|NCT03637491|468945777|FG000|Overall Study|Study Terminated By Sponsor|0|||
130267515|NCT03637491|468945778|FG001|Overall Study|Study Terminated By Sponsor|2|||
130267516|NCT03637491|468945779|FG002|Overall Study|Study Terminated By Sponsor|1|||
130267517|NCT03637491|468945780|FG003|Overall Study|Study Terminated By Sponsor|0|||
129885639|NCT02855164|467540773|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
130267518|NCT03637491|468945777|FG000|Overall Study|Withdrawal by Subject|1|||
130267519|NCT03637491|468945778|FG001|Overall Study|Withdrawal by Subject|0|||
130267520|NCT03637491|468945779|FG002|Overall Study|Withdrawal by Subject|1|||
130267521|NCT03637491|468945780|FG003|Overall Study|Withdrawal by Subject|2|||
130267522|NCT00003869|468945796|FG000|Overall Study|Adverse Event|14|||
130267523|NCT00003869|468945797|FG001|Overall Study|Adverse Event|3|||
130267524|NCT00003869|468945796|FG000|Overall Study|Withdrawal by Subject|21|||
130267525|NCT00003869|468945797|FG001|Overall Study|Withdrawal by Subject|3|||
130267526|NCT00003869|468945796|FG000|Overall Study|Death|1|||
130267527|NCT00003869|468945797|FG001|Overall Study|Death|2|||
130267528|NCT00003869|468945796|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
130267529|NCT00003869|468945797|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
130267530|NCT03364231|468945798|FG000|Overall Study|Adverse Event|1|||
130267531|NCT03364231|468945799|FG001|Overall Study|Adverse Event|4|||
130267532|NCT03364231|468945798|FG000|Overall Study|Death|1|||
130267533|NCT03364231|468945799|FG001|Overall Study|Death|0|||
130267534|NCT03364231|468945798|FG000|Overall Study|Investigator Decision|2|||
130267535|NCT03364231|468945799|FG001|Overall Study|Investigator Decision|2|||
130267536|NCT03364231|468945798|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
130267537|NCT03364231|468945799|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
130267538|NCT03364231|468945798|FG000|Overall Study|Withdrawal of Subject Consent|1|||
130267539|NCT03364231|468945799|FG001|Overall Study|Withdrawal of Subject Consent|0|||
130267540|NCT03364231|468945798|FG000|Overall Study|Reason Not Specified|1|||
130267541|NCT03364231|468945799|FG001|Overall Study|Reason Not Specified|0|||
130267542|NCT03364231|468945798|FG000|Overall Study|Disease Progression|0|||
130267543|NCT03364231|468945799|FG001|Overall Study|Disease Progression|6|||
130267544|NCT04068922|468945800|FG000|Overall Study|Lost to Follow-up|5|||
130267545|NCT04068922|468945800|FG000|Overall Study|Withdrawal by Subject|7|||
130267546|NCT04068922|468945800|FG000|Overall Study|Adverse Event|1|||
130267547|NCT03542266|468945801|FG000|Treatment Phase|Withdrawal by Subject|1|||
130267548|NCT03542266|468945801|FG000|Treatment Phase|Adverse Event|1|||
130267549|NCT03542266|468945801|FG000|Treatment Phase|PD|1|||
130267550|NCT01070979|468945809|FG000|Overall Study|Adverse Event|2|||
130267551|NCT01070979|468945810|FG001|Overall Study|Adverse Event|3|||
130267552|NCT01070979|468945811|FG002|Overall Study|Adverse Event|3|||
130267553|NCT01070979|468945809|FG000|Overall Study|Lost to Follow-up|2|||
130267554|NCT01070979|468945810|FG001|Overall Study|Lost to Follow-up|1|||
130267555|NCT01070979|468945811|FG002|Overall Study|Lost to Follow-up|1|||
130267556|NCT01070979|468945809|FG000|Overall Study|Protocol Violation|0|||
130267557|NCT01070979|468945810|FG001|Overall Study|Protocol Violation|2|||
130267558|NCT01070979|468945811|FG002|Overall Study|Protocol Violation|6|||
130267559|NCT01070979|468945809|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
130267560|NCT01070979|468945810|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
130267561|NCT01070979|468945811|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
130267562|NCT01070979|468945809|FG000|Overall Study|Withdrawal by Subject|3|||
130267563|NCT01070979|468945810|FG001|Overall Study|Withdrawal by Subject|1|||
130267564|NCT01070979|468945811|FG002|Overall Study|Withdrawal by Subject|1|||
130267565|NCT01070979|468945809|FG000|Overall Study|No study drug taken|0|||
130267566|NCT01070979|468945810|FG001|Overall Study|No study drug taken|1|||
130267567|NCT01070979|468945811|FG002|Overall Study|No study drug taken|0|||
130267568|NCT03484429|468945813|FG000|Overall Study|Withdrawal by Subject|1|||
130267569|NCT03484429|468945814|FG001|Overall Study|Withdrawal by Subject|0|||
130267570|NCT03484429|468945813|FG000|Overall Study|Adverse Event|2|||
130267571|NCT03484429|468945814|FG001|Overall Study|Adverse Event|0|||
130267572|NCT05653700|468945815|FG000|Overall Study|Non Responders|9|||
130267573|NCT05653700|468945816|FG001|Overall Study|Non Responders|0|||
130267574|NCT02573948|468945819|FG000|Longitudinal Cohort|Death|9|||
130267575|NCT02573948|468945819|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
130267576|NCT02573948|468945819|FG000|Longitudinal Cohort|Incarcerated|25|||
130267577|NCT00707993|468945822|FG000|Overall Study|Adverse Event|16|||
130267578|NCT00707993|468945823|FG001|Overall Study|Adverse Event|20|||
130267579|NCT00707993|468945822|FG000|Overall Study|Protocol Violation|4|||
130267580|NCT00707993|468945823|FG001|Overall Study|Protocol Violation|7|||
130267581|NCT00707993|468945822|FG000|Overall Study|Lost to Follow-up|0|||
130267582|NCT00707993|468945823|FG001|Overall Study|Lost to Follow-up|4|||
130267583|NCT00707993|468945822|FG000|Overall Study|Withdrawal by Subject|12|||
130267584|NCT00707993|468945823|FG001|Overall Study|Withdrawal by Subject|16|||
130267585|NCT00707993|468945822|FG000|Overall Study|Hyperglycemic Rescue|55|||
130267586|NCT00707993|468945823|FG001|Overall Study|Hyperglycemic Rescue|47|||
130267587|NCT00707993|468945822|FG000|Overall Study|Other|2|||
130267588|NCT00707993|468945823|FG001|Overall Study|Other|0|||
130267589|NCT05414175|468945829|FG000|Overall Study|Withdrawal by Subject|1|||
130267590|NCT05414175|468945829|FG000|Overall Study|Other Reasons|1|||
130267591|NCT02112656|468945832|FG000|Overall Study|Death|78|||
130267592|NCT02112656|468945833|FG001|Overall Study|Death|82|||
130267593|NCT02112656|468945832|FG000|Overall Study|Withdrawal by Subject|9|||
130267594|NCT02112656|468945833|FG001|Overall Study|Withdrawal by Subject|11|||
130267595|NCT02112656|468945832|FG000|Overall Study|Lost to Follow-up|2|||
130267596|NCT02112656|468945833|FG001|Overall Study|Lost to Follow-up|4|||
130267597|NCT02112656|468945832|FG000|Overall Study|Noncompliance|1|||
130267598|NCT02112656|468945833|FG001|Overall Study|Noncompliance|2|||
130267599|NCT03761056|468945834|FG000|Overall Study|Death|8|||
130267600|NCT03761056|468945834|FG000|Overall Study|Enrolled but never treated|2|||
130267601|NCT03761056|468945834|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
130267602|NCT03761056|468945834|FG000|Overall Study|Investigator decision|1|||
130267603|NCT04749745|468945835|FG000|Overall Study|Withdrawal by Subject|1|||
130267604|NCT04749745|468945836|FG001|Overall Study|Withdrawal by Subject|0|||
130267605|NCT03965403|468945843|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
130267606|NCT00552071|468947040|FG000|Overall Study|Adverse Event|1|||
130267607|NCT00552071|468947041|FG001|Overall Study|Adverse Event|0|||
130267608|NCT00552071|468947040|FG000|Overall Study|Lack of Efficacy|1|||
130267609|NCT00552071|468947041|FG001|Overall Study|Lack of Efficacy|0|||
130267610|NCT00552071|468947040|FG000|Overall Study|Physician Decision|1|||
130267611|NCT00552071|468947041|FG001|Overall Study|Physician Decision|0|||
130267612|NCT00552071|468947040|FG000|Overall Study|Pregnancy|1|||
130267613|NCT00552071|468947041|FG001|Overall Study|Pregnancy|0|||
130267614|NCT00552071|468947040|FG000|Overall Study|Death|0|||
130267615|NCT00552071|468947041|FG001|Overall Study|Death|1|||
130267616|NCT00552071|468947040|FG000|Overall Study|Withdrawal by Subject|0|||
130267617|NCT00552071|468947041|FG001|Overall Study|Withdrawal by Subject|1|||
130267618|NCT01979614|468947042|FG000|Overall Study|Adverse Event|1|||
130267619|NCT01979614|468947043|FG001|Overall Study|Adverse Event|1|||
130267620|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
130267621|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
130267622|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
130267623|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
130267624|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
130267625|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
130035723|NCT03049449|468086020|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
130035724|NCT03049449|468086021|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
130035725|NCT00442598|468086022|FG000|Overall Study|Adverse Event|1|||
130267626|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
130267627|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
130267628|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
130267629|NCT03333928|468947044|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
130267630|NCT03333928|468947045|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
130267631|NCT03333928|468947046|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
130267632|NCT03333928|468947044|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
130267633|NCT03333928|468947045|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
130267634|NCT03333928|468947046|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
130267635|NCT03333928|468947044|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
130267636|NCT03333928|468947045|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
130267637|NCT03333928|468947046|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
130267638|NCT03333928|468947044|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
130267639|NCT03333928|468947045|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
130267640|NCT03333928|468947046|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
130267641|NCT03333928|468947044|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
130267642|NCT03333928|468947045|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
130267643|NCT03333928|468947046|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
130267644|NCT04072835|468947047|FG000|Overall Study|Overall trial ended|603|||
130267645|NCT04072835|468947047|FG000|Overall Study|Ablation|97|||
130267646|NCT04072835|468947047|FG000|Overall Study|Withdrawal of consent|66|||
130267647|NCT04072835|468947047|FG000|Overall Study|Physician Decision|50|||
130267648|NCT04072835|468947047|FG000|Overall Study|Lost to Follow-up|39|||
130267649|NCT04072835|468947047|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
130267650|NCT04072835|468947047|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
130267651|NCT04072835|468947047|FG000|Overall Study|Adverse Event|25|||
130267652|NCT04072835|468947047|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
130267653|NCT04072835|468947047|FG000|Overall Study|Death|11|||
130267654|NCT04072835|468947047|FG000|Overall Study|Participant felt the drug did not work|8|||
130267655|NCT04072835|468947047|FG000|Overall Study|Participant tolerability|5|||
130267656|NCT04072835|468947047|FG000|Overall Study|Missing|5|||
130035726|NCT00442598|468086023|FG001|Overall Study|Adverse Event|0|||
130035727|NCT00442598|468086024|FG002|Overall Study|Adverse Event|0|||
130035728|NCT00442598|468086022|FG000|Overall Study|Tumor progression|3|||
130035729|NCT00442598|468086023|FG001|Overall Study|Tumor progression|4|||
130035730|NCT00442598|468086024|FG002|Overall Study|Tumor progression|0|||
130035731|NCT00442598|468086022|FG000|Overall Study|Clinical deterioration|1|||
130035732|NCT00442598|468086023|FG001|Overall Study|Clinical deterioration|2|||
130267657|NCT04072835|468947047|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
130267658|NCT04072835|468947047|FG000|Overall Study|Pregnancy|3|||
130267659|NCT04723355|468947048|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
130267660|NCT04723355|468947048|FG000|Overall Study|Errors in the informed consent form|2|||
130267661|NCT00841776|468947051|FG000|Overall Study|Lack of Efficacy|0|||
130267662|NCT00841776|468947052|FG001|Overall Study|Lack of Efficacy|1|||
130267663|NCT00841776|468947051|FG000|Overall Study|Lost to Follow-up|2|||
130267664|NCT00841776|468947052|FG001|Overall Study|Lost to Follow-up|1|||
130267665|NCT00841776|468947051|FG000|Overall Study|Withdrawal by Subject|0|||
130267666|NCT00841776|468947052|FG001|Overall Study|Withdrawal by Subject|1|||
130267667|NCT02479880|468947055|FG000|Overall Study|Study Terminated by Sponsor|13|||
130035733|NCT00442598|468086024|FG002|Overall Study|Clinical deterioration|0|||
130035734|NCT00442598|468086022|FG000|Overall Study|CA125 progression|0|||
130035735|NCT00442598|468086023|FG001|Overall Study|CA125 progression|1|||
130035736|NCT00442598|468086024|FG002|Overall Study|CA125 progression|0|||
130035737|NCT00442598|468086022|FG000|Overall Study|Reduced creatinine clearance|1|||
130035738|NCT00442598|468086023|FG001|Overall Study|Reduced creatinine clearance|0|||
130035739|NCT00442598|468086024|FG002|Overall Study|Reduced creatinine clearance|0|||
130035740|NCT00442598|468086022|FG000|Overall Study|Death|0|||
130035741|NCT00442598|468086023|FG001|Overall Study|Death|1|||
130267668|NCT02479880|468947056|FG001|Overall Study|Study Terminated by Sponsor|12|||
130267669|NCT02479880|468947055|FG000|Overall Study|Pregnancy|0|||
130267670|NCT02479880|468947056|FG001|Overall Study|Pregnancy|1|||
130267671|NCT00856635|468947062|FG000|Overall Study|Lost to Follow-up|2|||
130267672|NCT00856635|468947063|FG001|Overall Study|Lost to Follow-up|5|||
130267673|NCT00856635|468947062|FG000|Overall Study|Pregnancy|1|||
130267674|NCT00856635|468947063|FG001|Overall Study|Pregnancy|0|||
130267675|NCT00856635|468947062|FG000|Overall Study|Withdrawal by Subject|3|||
130267676|NCT00856635|468947063|FG001|Overall Study|Withdrawal by Subject|1|||
130267677|NCT00856635|468947062|FG000|Overall Study|Serious Adverse Event|1|||
130035742|NCT00442598|468086024|FG002|Overall Study|Death|0|||
130035743|NCT01147497|468086025|FG000|Overall Study|failed insertion|2|||
130035744|NCT01147497|468086026|FG001|Overall Study|failed insertion|0|||
130035745|NCT04026568|468086031|FG000|Overall Study|study terminated|0|||
130267678|NCT00856635|468947063|FG001|Overall Study|Serious Adverse Event|0|||
130267679|NCT00856635|468947062|FG000|Overall Study|Other|1|||
130267680|NCT00856635|468947063|FG001|Overall Study|Other|0|||
130267681|NCT00856635|468947062|FG000|Overall Study|Discontinued at Randomization|2|||
130267682|NCT00856635|468947063|FG001|Overall Study|Discontinued at Randomization|2|||
130267683|NCT01244035|468947064|FG000|Part 1: Period 1|Adverse Event|0|||
130267684|NCT01244035|468947065|FG001|Part 1: Period 1|Adverse Event|0|||
130267685|NCT01244035|468947066|FG002|Part 1: Period 1|Adverse Event|0|||
130267686|NCT01244035|468947067|FG003|Part 1: Period 1|Adverse Event|0|||
130267687|NCT01244035|468947068|FG004|Part 1: Period 1|Adverse Event|0|||
130267688|NCT01244035|468947069|FG005|Part 1: Period 1|Adverse Event|1|||
130267689|NCT01244035|468947064|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
130267690|NCT01244035|468947065|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
130267691|NCT01244035|468947066|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
130267692|NCT01244035|468947067|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
130267693|NCT01244035|468947068|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
130267694|NCT01244035|468947069|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
130267695|NCT01244035|468947064|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130267696|NCT01244035|468947065|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
130267697|NCT01244035|468947066|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
130267698|NCT01244035|468947067|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
130267699|NCT01244035|468947068|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130267700|NCT01244035|468947069|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
130267701|NCT01244035|468947064|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130035746|NCT04026568|468086032|FG001|Overall Study|study terminated|1|||
130035747|NCT02197377|468086033|FG000|Overall Study|Insertion Failure|0|||
130035748|NCT02197377|468086034|FG001|Overall Study|Insertion Failure|3|||
130035749|NCT02561156|468086035|FG000|Part 2|Adverse Event|0|||
130035750|NCT02561156|468086036|FG001|Part 2|Adverse Event|0|||
130035751|NCT02561156|468086037|FG002|Part 2|Adverse Event|0|||
130035752|NCT02561156|468086038|FG003|Part 2|Adverse Event|0|||
130035753|NCT02561156|468086039|FG004|Part 2|Adverse Event|0|||
130035754|NCT02561156|468086040|FG005|Part 2|Adverse Event|0|||
130035755|NCT02561156|468086041|FG006|Part 2|Adverse Event|0|||
130035756|NCT02561156|468086042|FG007|Part 2|Adverse Event|0|||
130267702|NCT01244035|468947065|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267703|NCT01244035|468947066|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
130035757|NCT02561156|468086043|FG008|Part 2|Adverse Event|0|||
130035758|NCT02561156|468086044|FG009|Part 2|Adverse Event|0|||
130035759|NCT02561156|468086045|FG010|Part 2|Adverse Event|0|||
130035760|NCT02561156|468086046|FG011|Part 2|Adverse Event|1|||
130035761|NCT02561156|468086047|FG012|Part 2|Adverse Event|0|||
130035762|NCT02209506|468086053|FG000|Overall Study|Withdrawal by Subject|0|||
130035763|NCT02209506|468086054|FG001|Overall Study|Withdrawal by Subject|0|||
130035764|NCT02209506|468086055|FG002|Overall Study|Withdrawal by Subject|0|||
130035765|NCT02209506|468086056|FG003|Overall Study|Withdrawal by Subject|0|||
130267704|NCT01244035|468947067|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267705|NCT01244035|468947068|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267706|NCT01244035|468947069|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
130267707|NCT01244035|468947064|FG000|Part 1: Period 3|Adverse Event|0|||
130267708|NCT01244035|468947065|FG001|Part 1: Period 3|Adverse Event|0|||
130267709|NCT01244035|468947066|FG002|Part 1: Period 3|Adverse Event|0|||
130267710|NCT01244035|468947067|FG003|Part 1: Period 3|Adverse Event|0|||
130267711|NCT01244035|468947068|FG004|Part 1: Period 3|Adverse Event|0|||
130267712|NCT01244035|468947069|FG005|Part 1: Period 3|Adverse Event|1|||
130267713|NCT01244035|468947064|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
130267714|NCT01244035|468947065|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
130267715|NCT01244035|468947066|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
130267716|NCT01244035|468947067|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
130267717|NCT01244035|468947068|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
130267718|NCT01244035|468947069|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
130267719|NCT01244035|468947064|FG000|Part 1: Period 3|Protocol Deviation|0|||
130267720|NCT01244035|468947065|FG001|Part 1: Period 3|Protocol Deviation|1|||
130267721|NCT01244035|468947066|FG002|Part 1: Period 3|Protocol Deviation|0|||
130267722|NCT01244035|468947067|FG003|Part 1: Period 3|Protocol Deviation|0|||
130267723|NCT01244035|468947068|FG004|Part 1: Period 3|Protocol Deviation|0|||
130267724|NCT01244035|468947069|FG005|Part 1: Period 3|Protocol Deviation|0|||
130267725|NCT03688919|468947072|FG000|Overall Study|Lost to Follow-up|2|||
130267726|NCT03688919|468947073|FG001|Overall Study|Lost to Follow-up|1|||
130035766|NCT02209506|468086057|FG004|Overall Study|Withdrawal by Subject|1|||
130035767|NCT00098787|468086058|FG000|Overall Study|Never started treatment|3|||
130035768|NCT00098787|468086059|FG001|Overall Study|Never started treatment|2|||
130035769|NCT00098787|468086060|FG002|Overall Study|Never started treatment|1|||
130035770|NCT00098787|468086058|FG000|Overall Study|Ineligible|9|||
130035771|NCT00098787|468086059|FG001|Overall Study|Ineligible|7|||
130035772|NCT00098787|468086060|FG002|Overall Study|Ineligible|3|||
130035773|NCT00098787|468086058|FG000|Overall Study|Disease progression|28|||
130035774|NCT00098787|468086059|FG001|Overall Study|Disease progression|17|||
130035775|NCT00098787|468086060|FG002|Overall Study|Disease progression|23|||
130035776|NCT00098787|468086058|FG000|Overall Study|Adverse Event|8|||
130267727|NCT03688919|468947072|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
130035777|NCT00098787|468086059|FG001|Overall Study|Adverse Event|17|||
130035778|NCT00098787|468086060|FG002|Overall Study|Adverse Event|8|||
130035779|NCT00098787|468086058|FG000|Overall Study|Death|6|||
130035780|NCT00098787|468086059|FG001|Overall Study|Death|1|||
130035781|NCT00098787|468086060|FG002|Overall Study|Death|0|||
130035782|NCT00098787|468086058|FG000|Overall Study|Withdrawal by Subject|4|||
130035783|NCT00098787|468086059|FG001|Overall Study|Withdrawal by Subject|12|||
130035784|NCT00098787|468086060|FG002|Overall Study|Withdrawal by Subject|6|||
130035785|NCT00098787|468086058|FG000|Overall Study|Alternative therapy|8|||
130035786|NCT00098787|468086059|FG001|Overall Study|Alternative therapy|13|||
130035787|NCT00098787|468086060|FG002|Overall Study|Alternative therapy|13|||
130035788|NCT00098787|468086058|FG000|Overall Study|Other|7|||
130035789|NCT00098787|468086059|FG001|Overall Study|Other|6|||
130035790|NCT00098787|468086060|FG002|Overall Study|Other|9|||
130035791|NCT02537678|468086063|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
130035792|NCT02537678|468086064|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
130035793|NCT02537678|468086063|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
130035794|NCT02537678|468086064|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
130035795|NCT02537678|468086063|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
130035796|NCT02537678|468086064|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
130035797|NCT02537678|468086063|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
130035798|NCT02537678|468086064|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
130035799|NCT02537678|468086063|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
130052126|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
130267728|NCT03688919|468947073|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
130267729|NCT02370368|468947074|FG000|Overall Study|Adverse Event|1|||
130267730|NCT02370368|468947075|FG001|Overall Study|Adverse Event|2|||
130267731|NCT02370368|468947074|FG000|Overall Study|Withdrawal by Subject|5|||
130267732|NCT02370368|468947075|FG001|Overall Study|Withdrawal by Subject|4|||
130267733|NCT03389308|468947078|FG000|Overall Study|Withdrawal by Subject|5|||
130035800|NCT02537678|468086064|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
130267734|NCT03389308|468947078|FG000|Overall Study|Lost to Follow-up|3|||
130267735|NCT03389308|468947078|FG000|Overall Study|Adverse Event|2|||
130267736|NCT03389308|468947078|FG000|Overall Study|Sponsor Request|2|||
130267737|NCT03198767|468947079|FG000|Overall Study|Protocol Violation|0|||
130267738|NCT03198767|468947080|FG001|Overall Study|Protocol Violation|0|||
130267739|NCT03198767|468947081|FG002|Overall Study|Protocol Violation|0|||
130267740|NCT03198767|468947082|FG003|Overall Study|Protocol Violation|6|||
130267741|NCT03198767|468947083|FG004|Overall Study|Protocol Violation|0|||
130267742|NCT03198767|468947084|FG005|Overall Study|Protocol Violation|0|||
130267743|NCT03198767|468947085|FG006|Overall Study|Protocol Violation|0|||
130267744|NCT00570323|468947086|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
130267745|NCT00570323|468947087|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
130267746|NCT00570323|468947086|FG000|Started Treatment After Randomization|Protocol Violation|1|||
130267747|NCT00570323|468947087|FG001|Started Treatment After Randomization|Protocol Violation|0|||
130267748|NCT00570323|468947086|FG000|Started Treatment After Randomization|Physician Decision|1|||
130267749|NCT00570323|468947087|FG001|Started Treatment After Randomization|Physician Decision|0|||
130267750|NCT00570323|468947086|FG000|Complete Study After Start|Lost to Follow-up|0|||
130267751|NCT00570323|468947087|FG001|Complete Study After Start|Lost to Follow-up|1|||
130267752|NCT00570323|468947086|FG000|Complete Study After Start|Withdrawal by Subject|2|||
130267753|NCT00570323|468947087|FG001|Complete Study After Start|Withdrawal by Subject|0|||
130267754|NCT00570323|468947086|FG000|Complete Study After Start|Physician Decision|1|||
130267755|NCT00570323|468947087|FG001|Complete Study After Start|Physician Decision|0|||
130267756|NCT03896477|468947088|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
130267757|NCT03896477|468947089|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
130267758|NCT03896477|468947090|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
130267759|NCT03896477|468947088|FG000|Overall Study|Parent Requested Withdrawal|8|||
130267760|NCT03896477|468947089|FG001|Overall Study|Parent Requested Withdrawal|12|||
130267761|NCT03896477|468947090|FG002|Overall Study|Parent Requested Withdrawal|9|||
130267762|NCT03896477|468947088|FG000|Overall Study|Adverse Event|0|||
130267763|NCT03896477|468947089|FG001|Overall Study|Adverse Event|0|||
130267764|NCT03896477|468947090|FG002|Overall Study|Adverse Event|1|||
130267765|NCT03896477|468947088|FG000|Overall Study|Death|1|||
130267766|NCT03896477|468947089|FG001|Overall Study|Death|0|||
130267767|NCT03896477|468947090|FG002|Overall Study|Death|0|||
130267768|NCT03896477|468947088|FG000|Overall Study|Other|5|||
130267769|NCT03896477|468947089|FG001|Overall Study|Other|6|||
130267770|NCT03896477|468947090|FG002|Overall Study|Other|7|||
130267771|NCT03896477|468947088|FG000|Overall Study|Lost to Follow-up|2|||
130267772|NCT03896477|468947089|FG001|Overall Study|Lost to Follow-up|1|||
130267773|NCT03896477|468947090|FG002|Overall Study|Lost to Follow-up|1|||
130267774|NCT01791517|468947091|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
130267775|NCT01791517|468947092|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
130267776|NCT01791517|468947093|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
130267777|NCT01791517|468947094|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
130267778|NCT01791517|468947095|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
130267779|NCT01791517|468947096|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
130267780|NCT01791517|468947097|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
130267781|NCT01791517|468947098|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
130267782|NCT01791517|468947099|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
130267783|NCT01791517|468947100|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
130267784|NCT01791517|468947101|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
130267785|NCT01791517|468947102|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
130267786|NCT01791517|468947091|FG000|Phase I: Period 1|Adverse Event|0|||
130267787|NCT01791517|468947092|FG001|Phase I: Period 1|Adverse Event|0|||
130267788|NCT01791517|468947093|FG002|Phase I: Period 1|Adverse Event|1|||
130267789|NCT01791517|468947094|FG003|Phase I: Period 1|Adverse Event|1|||
130267790|NCT01791517|468947095|FG004|Phase I: Period 1|Adverse Event|0|||
130267791|NCT01791517|468947096|FG005|Phase I: Period 1|Adverse Event|0|||
130267792|NCT01791517|468947097|FG006|Phase I: Period 1|Adverse Event|0|||
130267793|NCT01791517|468947098|FG007|Phase I: Period 1|Adverse Event|0|||
130267794|NCT01791517|468947099|FG008|Phase I: Period 1|Adverse Event|0|||
130267795|NCT01791517|468947100|FG009|Phase I: Period 1|Adverse Event|0|||
130267796|NCT01791517|468947101|FG010|Phase I: Period 1|Adverse Event|0|||
130267797|NCT01791517|468947102|FG011|Phase I: Period 1|Adverse Event|0|||
130267798|NCT01791517|468947091|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
130267799|NCT01791517|468947092|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267800|NCT01791517|468947093|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267801|NCT01791517|468947094|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267802|NCT01791517|468947095|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267803|NCT01791517|468947096|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267804|NCT01791517|468947097|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267805|NCT01791517|468947098|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267806|NCT01791517|468947099|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267807|NCT01791517|468947100|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267808|NCT01791517|468947101|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267809|NCT01791517|468947102|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
130267810|NCT01791517|468947091|FG000|Phase I: Period 1|Protocol Violation|0|||
130267811|NCT01791517|468947092|FG001|Phase I: Period 1|Protocol Violation|1|||
130267812|NCT01791517|468947093|FG002|Phase I: Period 1|Protocol Violation|0|||
130267813|NCT01791517|468947094|FG003|Phase I: Period 1|Protocol Violation|0|||
130267814|NCT01791517|468947095|FG004|Phase I: Period 1|Protocol Violation|0|||
130267815|NCT01791517|468947096|FG005|Phase I: Period 1|Protocol Violation|0|||
130267816|NCT01791517|468947097|FG006|Phase I: Period 1|Protocol Violation|0|||
130267817|NCT01791517|468947098|FG007|Phase I: Period 1|Protocol Violation|0|||
130267818|NCT01791517|468947099|FG008|Phase I: Period 1|Protocol Violation|0|||
130267819|NCT01791517|468947100|FG009|Phase I: Period 1|Protocol Violation|0|||
130267820|NCT01791517|468947101|FG010|Phase I: Period 1|Protocol Violation|0|||
130267821|NCT01791517|468947102|FG011|Phase I: Period 1|Protocol Violation|0|||
130267822|NCT01791517|468947091|FG000|Phase I: Period 1|Lost to Follow-up|0|||
130267823|NCT01791517|468947092|FG001|Phase I: Period 1|Lost to Follow-up|0|||
130267824|NCT01791517|468947093|FG002|Phase I: Period 1|Lost to Follow-up|0|||
130267825|NCT01791517|468947094|FG003|Phase I: Period 1|Lost to Follow-up|1|||
130267826|NCT01791517|468947095|FG004|Phase I: Period 1|Lost to Follow-up|0|||
130267827|NCT01791517|468947096|FG005|Phase I: Period 1|Lost to Follow-up|0|||
130267828|NCT01791517|468947097|FG006|Phase I: Period 1|Lost to Follow-up|1|||
130267829|NCT01791517|468947098|FG007|Phase I: Period 1|Lost to Follow-up|0|||
130267830|NCT01791517|468947099|FG008|Phase I: Period 1|Lost to Follow-up|1|||
130267831|NCT01791517|468947100|FG009|Phase I: Period 1|Lost to Follow-up|1|||
130267832|NCT01791517|468947101|FG010|Phase I: Period 1|Lost to Follow-up|0|||
130267833|NCT01791517|468947102|FG011|Phase I: Period 1|Lost to Follow-up|0|||
130267834|NCT01791517|468947091|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267835|NCT01791517|468947092|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267836|NCT01791517|468947093|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
130035801|NCT02537678|468086063|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
130267837|NCT01791517|468947094|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267838|NCT01791517|468947095|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267839|NCT01791517|468947096|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267840|NCT01791517|468947097|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267841|NCT01791517|468947098|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267842|NCT01791517|468947099|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267843|NCT01791517|468947100|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267844|NCT01791517|468947101|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
130267845|NCT01791517|468947102|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
130267846|NCT01791517|468947091|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
130267847|NCT01791517|468947092|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267848|NCT01791517|468947093|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267849|NCT01791517|468947094|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267850|NCT01791517|468947095|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267851|NCT01791517|468947096|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267852|NCT01791517|468947097|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267853|NCT01791517|468947098|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267854|NCT01791517|468947099|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267855|NCT01791517|468947100|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267856|NCT01791517|468947101|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267857|NCT01791517|468947102|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
130267858|NCT01791517|468947091|FG000|Phase I: Period 2|Protocol Violation|0|||
130267859|NCT01791517|468947092|FG001|Phase I: Period 2|Protocol Violation|0|||
130267860|NCT01791517|468947093|FG002|Phase I: Period 2|Protocol Violation|0|||
130267861|NCT01791517|468947094|FG003|Phase I: Period 2|Protocol Violation|1|||
130267862|NCT01791517|468947095|FG004|Phase I: Period 2|Protocol Violation|0|||
130267863|NCT01791517|468947096|FG005|Phase I: Period 2|Protocol Violation|0|||
130267864|NCT01791517|468947097|FG006|Phase I: Period 2|Protocol Violation|0|||
130267865|NCT01791517|468947098|FG007|Phase I: Period 2|Protocol Violation|0|||
130267866|NCT01791517|468947099|FG008|Phase I: Period 2|Protocol Violation|0|||
130267867|NCT01791517|468947100|FG009|Phase I: Period 2|Protocol Violation|0|||
130267868|NCT01791517|468947101|FG010|Phase I: Period 2|Protocol Violation|0|||
130267869|NCT01791517|468947102|FG011|Phase I: Period 2|Protocol Violation|0|||
130267870|NCT01791517|468947091|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
130267871|NCT01791517|468947092|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
130267872|NCT01791517|468947093|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
130267873|NCT01791517|468947094|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
130267874|NCT01791517|468947095|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
130267875|NCT01791517|468947096|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
130267876|NCT01791517|468947097|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
130267877|NCT01791517|468947098|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
130267878|NCT01791517|468947099|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
130267879|NCT01791517|468947100|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
130035802|NCT02537678|468086064|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
130035803|NCT02537678|468086063|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
130035804|NCT02537678|468086064|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
130267880|NCT01791517|468947101|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
130267881|NCT01791517|468947102|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
130267882|NCT01791517|468947091|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267883|NCT01791517|468947092|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267884|NCT01791517|468947093|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267885|NCT01791517|468947094|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267886|NCT01791517|468947095|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267887|NCT01791517|468947096|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267888|NCT01791517|468947097|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267889|NCT01791517|468947098|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267890|NCT01791517|468947099|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267891|NCT01791517|468947100|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267892|NCT01791517|468947101|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
130267893|NCT01791517|468947102|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
130267894|NCT01791517|468947091|FG000|Phase I: Period 2|Lens Discomfort|0|||
130267895|NCT01791517|468947092|FG001|Phase I: Period 2|Lens Discomfort|0|||
130267896|NCT01791517|468947093|FG002|Phase I: Period 2|Lens Discomfort|0|||
130267897|NCT01791517|468947094|FG003|Phase I: Period 2|Lens Discomfort|0|||
130267898|NCT01791517|468947095|FG004|Phase I: Period 2|Lens Discomfort|0|||
130267899|NCT01791517|468947096|FG005|Phase I: Period 2|Lens Discomfort|1|||
130267900|NCT01791517|468947097|FG006|Phase I: Period 2|Lens Discomfort|0|||
130267901|NCT01791517|468947098|FG007|Phase I: Period 2|Lens Discomfort|0|||
130267902|NCT01791517|468947099|FG008|Phase I: Period 2|Lens Discomfort|0|||
130267903|NCT01791517|468947100|FG009|Phase I: Period 2|Lens Discomfort|0|||
130267904|NCT01791517|468947101|FG010|Phase I: Period 2|Lens Discomfort|0|||
130267905|NCT01791517|468947102|FG011|Phase I: Period 2|Lens Discomfort|0|||
130267906|NCT01791517|468947091|FG000|Phase I: Period 2|Lost to Follow-up|0|||
130267907|NCT01791517|468947092|FG001|Phase I: Period 2|Lost to Follow-up|3|||
130267908|NCT01791517|468947093|FG002|Phase I: Period 2|Lost to Follow-up|2|||
130267909|NCT01791517|468947094|FG003|Phase I: Period 2|Lost to Follow-up|0|||
130267910|NCT01791517|468947095|FG004|Phase I: Period 2|Lost to Follow-up|0|||
130267911|NCT01791517|468947096|FG005|Phase I: Period 2|Lost to Follow-up|0|||
130267912|NCT01791517|468947097|FG006|Phase I: Period 2|Lost to Follow-up|0|||
130267913|NCT01791517|468947098|FG007|Phase I: Period 2|Lost to Follow-up|0|||
130267914|NCT01791517|468947099|FG008|Phase I: Period 2|Lost to Follow-up|0|||
130267915|NCT01791517|468947100|FG009|Phase I: Period 2|Lost to Follow-up|0|||
130267916|NCT01791517|468947101|FG010|Phase I: Period 2|Lost to Follow-up|0|||
130267917|NCT01791517|468947102|FG011|Phase I: Period 2|Lost to Follow-up|0|||
130267918|NCT01791517|468947091|FG000|Phase I: Period 3|Lens Discomfort|0|||
130267919|NCT01791517|468947092|FG001|Phase I: Period 3|Lens Discomfort|0|||
130267920|NCT01791517|468947093|FG002|Phase I: Period 3|Lens Discomfort|0|||
130267921|NCT01791517|468947094|FG003|Phase I: Period 3|Lens Discomfort|0|||
130267922|NCT01791517|468947095|FG004|Phase I: Period 3|Lens Discomfort|0|||
130267923|NCT01791517|468947096|FG005|Phase I: Period 3|Lens Discomfort|0|||
130267924|NCT01791517|468947097|FG006|Phase I: Period 3|Lens Discomfort|0|||
130267925|NCT01791517|468947098|FG007|Phase I: Period 3|Lens Discomfort|0|||
130267926|NCT01791517|468947099|FG008|Phase I: Period 3|Lens Discomfort|0|||
130267927|NCT01791517|468947100|FG009|Phase I: Period 3|Lens Discomfort|0|||
130267928|NCT01791517|468947101|FG010|Phase I: Period 3|Lens Discomfort|0|||
130267929|NCT01791517|468947102|FG011|Phase I: Period 3|Lens Discomfort|1|||
130267930|NCT01791517|468947091|FG000|Phase I: Period 3|Lost to Follow-up|0|||
130267931|NCT01791517|468947092|FG001|Phase I: Period 3|Lost to Follow-up|1|||
130267932|NCT01791517|468947093|FG002|Phase I: Period 3|Lost to Follow-up|0|||
130267933|NCT01791517|468947094|FG003|Phase I: Period 3|Lost to Follow-up|0|||
130267934|NCT01791517|468947095|FG004|Phase I: Period 3|Lost to Follow-up|1|||
130267935|NCT01791517|468947096|FG005|Phase I: Period 3|Lost to Follow-up|0|||
130267936|NCT01791517|468947097|FG006|Phase I: Period 3|Lost to Follow-up|0|||
130267937|NCT01791517|468947098|FG007|Phase I: Period 3|Lost to Follow-up|0|||
130267938|NCT01791517|468947099|FG008|Phase I: Period 3|Lost to Follow-up|0|||
130267939|NCT01791517|468947100|FG009|Phase I: Period 3|Lost to Follow-up|0|||
130267940|NCT01791517|468947101|FG010|Phase I: Period 3|Lost to Follow-up|0|||
130267941|NCT01791517|468947102|FG011|Phase I: Period 3|Lost to Follow-up|0|||
130267942|NCT01791517|468947091|FG000|Phase I: Period 3|Adverse Event|0|||
130267943|NCT01791517|468947092|FG001|Phase I: Period 3|Adverse Event|0|||
130267944|NCT01791517|468947093|FG002|Phase I: Period 3|Adverse Event|0|||
130267945|NCT01791517|468947094|FG003|Phase I: Period 3|Adverse Event|1|||
130267946|NCT01791517|468947095|FG004|Phase I: Period 3|Adverse Event|0|||
130267947|NCT01791517|468947096|FG005|Phase I: Period 3|Adverse Event|0|||
130267948|NCT01791517|468947097|FG006|Phase I: Period 3|Adverse Event|0|||
130267949|NCT01791517|468947098|FG007|Phase I: Period 3|Adverse Event|0|||
130267950|NCT01791517|468947099|FG008|Phase I: Period 3|Adverse Event|0|||
130267951|NCT01791517|468947100|FG009|Phase I: Period 3|Adverse Event|0|||
130267952|NCT01791517|468947101|FG010|Phase I: Period 3|Adverse Event|0|||
130267953|NCT01791517|468947102|FG011|Phase I: Period 3|Adverse Event|0|||
130267954|NCT01791517|468947091|FG000|Phase II|Lost to Follow-up|1|||
130267955|NCT01791517|468947092|FG001|Phase II|Lost to Follow-up|0|||
130267956|NCT01791517|468947093|FG002|Phase II|Lost to Follow-up|1|||
130267957|NCT01791517|468947094|FG003|Phase II|Lost to Follow-up|0|||
130267958|NCT01791517|468947095|FG004|Phase II|Lost to Follow-up|1|||
130267959|NCT01791517|468947096|FG005|Phase II|Lost to Follow-up|2|||
130267960|NCT01791517|468947097|FG006|Phase II|Lost to Follow-up|0|||
130267961|NCT01791517|468947098|FG007|Phase II|Lost to Follow-up|1|||
130267962|NCT01791517|468947099|FG008|Phase II|Lost to Follow-up|1|||
130267963|NCT01791517|468947100|FG009|Phase II|Lost to Follow-up|1|||
130267964|NCT01791517|468947101|FG010|Phase II|Lost to Follow-up|0|||
130267965|NCT01791517|468947102|FG011|Phase II|Lost to Follow-up|0|||
129885640|NCT02855164|467540774|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
130267966|NCT01791517|468947091|FG000|Phase II|Withdrawal by Subject|1|||
130267967|NCT01791517|468947092|FG001|Phase II|Withdrawal by Subject|0|||
130267968|NCT01791517|468947093|FG002|Phase II|Withdrawal by Subject|0|||
130267969|NCT01791517|468947094|FG003|Phase II|Withdrawal by Subject|0|||
130267970|NCT01791517|468947095|FG004|Phase II|Withdrawal by Subject|0|||
130267971|NCT01791517|468947096|FG005|Phase II|Withdrawal by Subject|2|||
130267972|NCT01791517|468947097|FG006|Phase II|Withdrawal by Subject|0|||
130267973|NCT01791517|468947098|FG007|Phase II|Withdrawal by Subject|1|||
130267974|NCT01791517|468947099|FG008|Phase II|Withdrawal by Subject|0|||
130267975|NCT01791517|468947100|FG009|Phase II|Withdrawal by Subject|0|||
130267976|NCT01791517|468947101|FG010|Phase II|Withdrawal by Subject|1|||
130267977|NCT01791517|468947102|FG011|Phase II|Withdrawal by Subject|0|||
130267978|NCT01791517|468947091|FG000|Phase II|Lack of Efficacy|0|||
130267979|NCT01791517|468947092|FG001|Phase II|Lack of Efficacy|0|||
130267980|NCT01791517|468947093|FG002|Phase II|Lack of Efficacy|0|||
130267981|NCT01791517|468947094|FG003|Phase II|Lack of Efficacy|0|||
130267982|NCT01791517|468947095|FG004|Phase II|Lack of Efficacy|1|||
130267983|NCT01791517|468947096|FG005|Phase II|Lack of Efficacy|0|||
130267984|NCT01791517|468947097|FG006|Phase II|Lack of Efficacy|0|||
130267985|NCT01791517|468947098|FG007|Phase II|Lack of Efficacy|0|||
130267986|NCT01791517|468947099|FG008|Phase II|Lack of Efficacy|0|||
130267987|NCT01791517|468947100|FG009|Phase II|Lack of Efficacy|0|||
130267988|NCT01791517|468947101|FG010|Phase II|Lack of Efficacy|0|||
130267989|NCT01791517|468947102|FG011|Phase II|Lack of Efficacy|0|||
130267990|NCT01791517|468947091|FG000|Phase II|Adverse Event|0|||
130267991|NCT01791517|468947092|FG001|Phase II|Adverse Event|0|||
130267992|NCT01791517|468947093|FG002|Phase II|Adverse Event|0|||
130267993|NCT01791517|468947094|FG003|Phase II|Adverse Event|0|||
130267994|NCT01791517|468947095|FG004|Phase II|Adverse Event|0|||
130267995|NCT01791517|468947096|FG005|Phase II|Adverse Event|0|||
130267996|NCT01791517|468947097|FG006|Phase II|Adverse Event|2|||
130267997|NCT01791517|468947098|FG007|Phase II|Adverse Event|1|||
130267998|NCT01791517|468947099|FG008|Phase II|Adverse Event|0|||
130267999|NCT01791517|468947100|FG009|Phase II|Adverse Event|1|||
130268000|NCT01791517|468947101|FG010|Phase II|Adverse Event|0|||
130268001|NCT01791517|468947102|FG011|Phase II|Adverse Event|0|||
130268002|NCT01791517|468947091|FG000|Phase II|Lens Handling Difficulties|0|||
130268003|NCT01791517|468947092|FG001|Phase II|Lens Handling Difficulties|0|||
130268004|NCT01791517|468947093|FG002|Phase II|Lens Handling Difficulties|0|||
130268005|NCT01791517|468947094|FG003|Phase II|Lens Handling Difficulties|0|||
130268006|NCT01791517|468947095|FG004|Phase II|Lens Handling Difficulties|0|||
130268007|NCT01791517|468947096|FG005|Phase II|Lens Handling Difficulties|0|||
130268008|NCT01791517|468947097|FG006|Phase II|Lens Handling Difficulties|0|||
130268009|NCT01791517|468947098|FG007|Phase II|Lens Handling Difficulties|0|||
130268010|NCT01791517|468947099|FG008|Phase II|Lens Handling Difficulties|1|||
130268011|NCT01791517|468947100|FG009|Phase II|Lens Handling Difficulties|0|||
130268012|NCT01791517|468947101|FG010|Phase II|Lens Handling Difficulties|0|||
130268013|NCT01791517|468947102|FG011|Phase II|Lens Handling Difficulties|0|||
130268014|NCT01791517|468947091|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
130268015|NCT01791517|468947092|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
130268016|NCT01791517|468947093|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
130268017|NCT01791517|468947094|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
130268018|NCT01791517|468947095|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
130268019|NCT01791517|468947096|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
130268020|NCT01791517|468947097|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
130268021|NCT01791517|468947098|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
130268022|NCT01791517|468947099|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
130268023|NCT01791517|468947100|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
130268024|NCT01791517|468947101|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
130268025|NCT01791517|468947102|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
130268026|NCT01791517|468947091|FG000|Phase II|Pre-Existing Ocular Issue|0|||
130268027|NCT01791517|468947092|FG001|Phase II|Pre-Existing Ocular Issue|0|||
130268028|NCT01791517|468947093|FG002|Phase II|Pre-Existing Ocular Issue|0|||
130268029|NCT01791517|468947094|FG003|Phase II|Pre-Existing Ocular Issue|0|||
130268030|NCT01791517|468947095|FG004|Phase II|Pre-Existing Ocular Issue|0|||
130268031|NCT01791517|468947096|FG005|Phase II|Pre-Existing Ocular Issue|0|||
130268032|NCT01791517|468947097|FG006|Phase II|Pre-Existing Ocular Issue|0|||
130268033|NCT01791517|468947098|FG007|Phase II|Pre-Existing Ocular Issue|0|||
130268034|NCT01791517|468947099|FG008|Phase II|Pre-Existing Ocular Issue|0|||
130268035|NCT01791517|468947100|FG009|Phase II|Pre-Existing Ocular Issue|0|||
130268036|NCT01791517|468947101|FG010|Phase II|Pre-Existing Ocular Issue|0|||
130268037|NCT01791517|468947102|FG011|Phase II|Pre-Existing Ocular Issue|1|||
130268038|NCT04011735|468947103|FG000|Overall Study|Withdrawal by Subject|1|||
130268039|NCT04011735|468947104|FG001|Overall Study|Withdrawal by Subject|0|||
130268040|NCT04011735|468947105|FG002|Overall Study|Withdrawal by Subject|1|||
130268041|NCT04011735|468947103|FG000|Overall Study|Met exclusion criteria after study entry|0|||
130268042|NCT04011735|468947104|FG001|Overall Study|Met exclusion criteria after study entry|1|||
130268043|NCT04011735|468947105|FG002|Overall Study|Met exclusion criteria after study entry|0|||
130268044|NCT00739310|468947110|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
130035805|NCT01360996|468086065|FG000|Overall Study|Withdrawal by Subject|4|||
130035806|NCT01360996|468086066|FG001|Overall Study|Withdrawal by Subject|3|||
130035807|NCT01360996|468086067|FG002|Overall Study|Withdrawal by Subject|2|||
130035808|NCT01360996|468086065|FG000|Overall Study|Noncompliant|2|||
130035809|NCT01360996|468086066|FG001|Overall Study|Noncompliant|0|||
130035810|NCT01360996|468086067|FG002|Overall Study|Noncompliant|0|||
130035811|NCT01499290|468086071|FG000|Overall Study|Withdrawal by Subject|22|||
130035812|NCT01499290|468086072|FG001|Overall Study|Withdrawal by Subject|15|||
130035813|NCT01499290|468086071|FG000|Overall Study|Not specified in study report|11|||
130035814|NCT01499290|468086072|FG001|Overall Study|Not specified in study report|5|||
130035815|NCT01499290|468086071|FG000|Overall Study|Condition improved/subject recovered|1|||
130035816|NCT01499290|468086072|FG001|Overall Study|Condition improved/subject recovered|0|||
130035817|NCT01499290|468086071|FG000|Overall Study|Lack of Efficacy|7|||
130035818|NCT01499290|468086072|FG001|Overall Study|Lack of Efficacy|8|||
130035819|NCT01499290|468086071|FG000|Overall Study|Adverse Event|14|||
130035820|NCT01499290|468086072|FG001|Overall Study|Adverse Event|7|||
130035821|NCT04052139|468086073|FG000|Overall Study|Lost to Follow-up|2|||
130035822|NCT04052139|468086074|FG001|Overall Study|Lost to Follow-up|0|||
130035823|NCT04052139|468086075|FG002|Overall Study|Lost to Follow-up|0|||
130035824|NCT04052139|468086073|FG000|Overall Study|Withdrawal by Subject|1|||
130035825|NCT04052139|468086074|FG001|Overall Study|Withdrawal by Subject|0|||
130035826|NCT04052139|468086075|FG002|Overall Study|Withdrawal by Subject|0|||
130035827|NCT03406962|468086076|FG000|Overall Study|Death|2|||
130035828|NCT03406962|468086076|FG000|Overall Study|Adverse Event|1|||
130035829|NCT00552110|468086077|FG000|Overall Study|Serious or Life-Threatening AE|0|||
130035830|NCT00552110|468086078|FG001|Overall Study|Serious or Life-Threatening AE|0|||
130035831|NCT00552110|468086079|FG002|Overall Study|Serious or Life-Threatening AE|1|||
130035832|NCT00552110|468086080|FG003|Overall Study|Serious or Life-Threatening AE|0|||
130035833|NCT00552110|468086081|FG004|Overall Study|Serious or Life-Threatening AE|0|||
130035834|NCT00552110|468086077|FG000|Overall Study|Lack of Efficacy|1|||
130035835|NCT00552110|468086078|FG001|Overall Study|Lack of Efficacy|0|||
130035836|NCT00552110|468086079|FG002|Overall Study|Lack of Efficacy|0|||
130035837|NCT00552110|468086080|FG003|Overall Study|Lack of Efficacy|1|||
130035838|NCT00552110|468086081|FG004|Overall Study|Lack of Efficacy|4|||
130035839|NCT00552110|468086077|FG000|Overall Study|Withdrawal by Subject|0|||
130035840|NCT00552110|468086078|FG001|Overall Study|Withdrawal by Subject|2|||
130035841|NCT00552110|468086079|FG002|Overall Study|Withdrawal by Subject|0|||
130035842|NCT00552110|468086080|FG003|Overall Study|Withdrawal by Subject|3|||
130035843|NCT00552110|468086081|FG004|Overall Study|Withdrawal by Subject|2|||
130035844|NCT00552110|468086077|FG000|Overall Study|Lost to Follow-up|0|||
130035845|NCT00552110|468086078|FG001|Overall Study|Lost to Follow-up|0|||
130035846|NCT00552110|468086079|FG002|Overall Study|Lost to Follow-up|0|||
130035847|NCT00552110|468086080|FG003|Overall Study|Lost to Follow-up|1|||
130035848|NCT00552110|468086081|FG004|Overall Study|Lost to Follow-up|1|||
130035849|NCT00552110|468086077|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
130035850|NCT00552110|468086078|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
130035851|NCT00552110|468086079|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
130268045|NCT00739310|468947110|FG000|Overall Study|Withdrawal by Subject|1|||
130268046|NCT00739310|468947110|FG000|Overall Study|Lost to Follow-up|2|||
130268047|NCT02954887|468947111|FG000|Overall Study|Withdrawal by Subject|3|||
130268048|NCT02954887|468947111|FG000|Overall Study|Lack of Efficacy|3|||
130268049|NCT02954887|468947111|FG000|Overall Study|Other|1|||
130268050|NCT01071954|468947112|FG000|Overall Study|Noncompliance|4|||
130268051|NCT01071954|468947112|FG000|Overall Study|Adverse Event|1|||
130268052|NCT01071954|468947112|FG000|Overall Study|Withdrawal by Subject|11|||
130035852|NCT00552110|468086080|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
130035853|NCT00552110|468086081|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
130035854|NCT00552110|468086077|FG000|Overall Study|Withdrawn per Sponsor|0|||
130035855|NCT00552110|468086078|FG001|Overall Study|Withdrawn per Sponsor|1|||
130035856|NCT00552110|468086079|FG002|Overall Study|Withdrawn per Sponsor|0|||
130035857|NCT00552110|468086080|FG003|Overall Study|Withdrawn per Sponsor|0|||
130035858|NCT00552110|468086081|FG004|Overall Study|Withdrawn per Sponsor|1|||
130035859|NCT00552110|468086077|FG000|Overall Study|Use of Prohibited Medication|1|||
130035860|NCT00552110|468086078|FG001|Overall Study|Use of Prohibited Medication|1|||
130035861|NCT00552110|468086079|FG002|Overall Study|Use of Prohibited Medication|0|||
130035862|NCT00552110|468086080|FG003|Overall Study|Use of Prohibited Medication|0|||
130035863|NCT00552110|468086081|FG004|Overall Study|Use of Prohibited Medication|0|||
130035864|NCT00552110|468086077|FG000|Overall Study|Delay of Study due to Relabeling|0|||
130035865|NCT00552110|468086078|FG001|Overall Study|Delay of Study due to Relabeling|0|||
130035866|NCT00552110|468086079|FG002|Overall Study|Delay of Study due to Relabeling|0|||
130035867|NCT00552110|468086080|FG003|Overall Study|Delay of Study due to Relabeling|1|||
130035868|NCT00552110|468086081|FG004|Overall Study|Delay of Study due to Relabeling|0|||
130035869|NCT00552110|468086077|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
130268053|NCT01071954|468947112|FG000|Overall Study|Requirement for Alternative Therapy|5|||
130268054|NCT01071954|468947112|FG000|Overall Study|Administrative Decision|5|||
130035870|NCT00552110|468086078|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
130268055|NCT01071954|468947112|FG000|Overall Study|Protocol Specified Criteria|1|||
130268056|NCT01459666|468947113|FG000|Overall Study|PI left institution|5|||
130268057|NCT01459666|468947114|FG001|Overall Study|PI left institution|4|||
130268058|NCT00590967|468947116|FG000|Overall Study|Withdrawal by Subject|1|||
130268059|NCT00590967|468947117|FG001|Overall Study|Withdrawal by Subject|1|||
130268060|NCT00590967|468947116|FG000|Overall Study|Ineligible|1|||
130268061|NCT00590967|468947117|FG001|Overall Study|Ineligible|0|||
130268062|NCT00590967|468947116|FG000|Overall Study|Poor performance status|0|||
130268063|NCT00590967|468947117|FG001|Overall Study|Poor performance status|1|||
130268064|NCT00590967|468947116|FG000|Overall Study|Non-compliant|0|||
130268065|NCT00590967|468947117|FG001|Overall Study|Non-compliant|2|||
130268066|NCT00590967|468947116|FG000|Overall Study|Did not sign consent form|0|||
130268067|NCT00590967|468947117|FG001|Overall Study|Did not sign consent form|1|||
130035871|NCT00552110|468086079|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
130035872|NCT00552110|468086080|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
130035873|NCT00552110|468086081|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
130268068|NCT00590967|468947116|FG000|Overall Study|Did not receive chemo per protocol|1|||
130268069|NCT00590967|468947117|FG001|Overall Study|Did not receive chemo per protocol|0|||
130268070|NCT01847755|468947120|FG000|Overall Study|Adverse Event|2|||
130268071|NCT01847755|468947120|FG000|Overall Study|Withdrawal by Subject|2|||
130268072|NCT01847755|468947120|FG000|Overall Study|Physician Decision|1|||
130268073|NCT00920556|468947121|FG000|Overall Study|Adverse Event|16|||
130268074|NCT00920556|468947121|FG000|Overall Study|Physician Decision|7|||
130268075|NCT00920556|468947121|FG000|Overall Study|Withdrawal by Subject|1|||
130268076|NCT01299389|468947122|FG000|Double-blind|Adverse Event|45|||
130268077|NCT01299389|468947123|FG001|Double-blind|Adverse Event|27|||
130268078|NCT01299389|468947124|FG002|Double-blind|Adverse Event|0|||
130268079|NCT01299389|468947125|FG003|Double-blind|Adverse Event|0|||
130268080|NCT01299389|468947122|FG000|Double-blind|Lack of Efficacy|45|||
130268081|NCT01299389|468947123|FG001|Double-blind|Lack of Efficacy|21|||
130268082|NCT01299389|468947124|FG002|Double-blind|Lack of Efficacy|0|||
130268083|NCT01299389|468947125|FG003|Double-blind|Lack of Efficacy|0|||
130268084|NCT01299389|468947122|FG000|Double-blind|Lost to Follow-up|2|||
130268085|NCT01299389|468947123|FG001|Double-blind|Lost to Follow-up|1|||
130268086|NCT01299389|468947124|FG002|Double-blind|Lost to Follow-up|0|||
130268087|NCT01299389|468947125|FG003|Double-blind|Lost to Follow-up|0|||
130268088|NCT01299389|468947122|FG000|Double-blind|Withdrawal by Subject|16|||
130268089|NCT01299389|468947123|FG001|Double-blind|Withdrawal by Subject|13|||
130268090|NCT01299389|468947124|FG002|Double-blind|Withdrawal by Subject|0|||
130268091|NCT01299389|468947125|FG003|Double-blind|Withdrawal by Subject|0|||
130035874|NCT00552110|468086077|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
130035875|NCT00552110|468086078|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
130035876|NCT00552110|468086079|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
130268092|NCT01299389|468947122|FG000|Double-blind|Other|1|||
130268093|NCT01299389|468947123|FG001|Double-blind|Other|1|||
130268094|NCT01299389|468947124|FG002|Double-blind|Other|0|||
130268095|NCT01299389|468947125|FG003|Double-blind|Other|0|||
130268096|NCT01299389|468947122|FG000|Double-blind|"fail to meet study population criteria"|0|||
130035877|NCT00552110|468086080|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
130268097|NCT01299389|468947123|FG001|Double-blind|"fail to meet study population criteria"|1|||
130268098|NCT01299389|468947124|FG002|Double-blind|"fail to meet study population criteria"|0|||
130268099|NCT01299389|468947125|FG003|Double-blind|"fail to meet study population criteria"|0|||
130268100|NCT01299389|468947122|FG000|Post-observational|Other|0|||
130268101|NCT01299389|468947123|FG001|Post-observational|Other|0|||
130268102|NCT01299389|468947124|FG002|Post-observational|Other|12|||
130268103|NCT01299389|468947125|FG003|Post-observational|Other|6|||
130268104|NCT04245709|468947126|FG000|Overall Study|Adverse Event|13|||
130268105|NCT04245709|468947126|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
130268106|NCT00889707|468947130|FG000|Overall Study|Adverse Event|1|||
130268107|NCT00889707|468947131|FG001|Overall Study|Adverse Event|0|||
130268108|NCT00889707|468947130|FG000|Overall Study|Withdrawal by Subject|4|||
130268109|NCT00889707|468947131|FG001|Overall Study|Withdrawal by Subject|3|||
130268110|NCT00889707|468947130|FG000|Overall Study|Lost to Follow-up|0|||
130268111|NCT00889707|468947131|FG001|Overall Study|Lost to Follow-up|2|||
130268112|NCT00889707|468947130|FG000|Overall Study|Lack of Efficacy|2|||
130268113|NCT00889707|468947131|FG001|Overall Study|Lack of Efficacy|5|||
130268114|NCT02185534|468947132|FG000|First Period|Withdrawal by Subject|0|||
130268115|NCT02185534|468947133|FG001|First Period|Withdrawal by Subject|0|||
130268116|NCT02185534|468947134|FG002|First Period|Withdrawal by Subject|0|||
130268117|NCT02185534|468947135|FG003|First Period|Withdrawal by Subject|1|||
130268118|NCT02185534|468947136|FG004|First Period|Withdrawal by Subject|0|||
130268119|NCT02185534|468947137|FG005|First Period|Withdrawal by Subject|0|||
130268120|NCT02185534|468947132|FG000|First Washout Period|Withdrawal by Subject|1|||
130268121|NCT02185534|468947133|FG001|First Washout Period|Withdrawal by Subject|0|||
130268122|NCT02185534|468947134|FG002|First Washout Period|Withdrawal by Subject|0|||
130268123|NCT02185534|468947135|FG003|First Washout Period|Withdrawal by Subject|0|||
130268124|NCT02185534|468947136|FG004|First Washout Period|Withdrawal by Subject|1|||
130268125|NCT02185534|468947137|FG005|First Washout Period|Withdrawal by Subject|0|||
130268126|NCT02185534|468947132|FG000|First Washout Period|Protocol Violation|0|||
130268127|NCT02185534|468947133|FG001|First Washout Period|Protocol Violation|0|||
130268128|NCT02185534|468947134|FG002|First Washout Period|Protocol Violation|0|||
130268129|NCT02185534|468947135|FG003|First Washout Period|Protocol Violation|0|||
130268130|NCT02185534|468947136|FG004|First Washout Period|Protocol Violation|0|||
130035878|NCT00552110|468086081|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
130268131|NCT02185534|468947137|FG005|First Washout Period|Protocol Violation|1|||
130268132|NCT02948582|468947138|FG000|Washout Period 1|Adverse Event|0|||
130268133|NCT02948582|468947139|FG001|Washout Period 1|Adverse Event|2|||
130268134|NCT02948582|468947140|FG002|Washout Period 1|Adverse Event|0|||
130268135|NCT02948582|468947141|FG003|Washout Period 1|Adverse Event|0|||
130268136|NCT02948582|468947142|FG004|Washout Period 1|Adverse Event|0|||
130268137|NCT02948582|468947143|FG005|Washout Period 1|Adverse Event|0|||
130035879|NCT02272790|468086084|FG000|Overall Study|Physician Decision|0|||
130035880|NCT02272790|468086085|FG001|Overall Study|Physician Decision|1|||
130268138|NCT02948582|468947138|FG000|Washout Period 1|Protocol Violation|0|||
130268139|NCT02948582|468947139|FG001|Washout Period 1|Protocol Violation|0|||
130268140|NCT02948582|468947140|FG002|Washout Period 1|Protocol Violation|0|||
130268141|NCT02948582|468947141|FG003|Washout Period 1|Protocol Violation|0|||
130268142|NCT02948582|468947142|FG004|Washout Period 1|Protocol Violation|0|||
130268143|NCT02948582|468947143|FG005|Washout Period 1|Protocol Violation|1|||
130268144|NCT02948582|468947138|FG000|Washout Period 2|Adverse Event|0|||
130268145|NCT02948582|468947139|FG001|Washout Period 2|Adverse Event|1|||
130268146|NCT02948582|468947140|FG002|Washout Period 2|Adverse Event|0|||
130268147|NCT02948582|468947141|FG003|Washout Period 2|Adverse Event|0|||
130268148|NCT02948582|468947142|FG004|Washout Period 2|Adverse Event|0|||
130268149|NCT02948582|468947143|FG005|Washout Period 2|Adverse Event|0|||
130268150|NCT02948582|468947138|FG000|Washout Period 2|personal reasons|0|||
130268151|NCT02948582|468947139|FG001|Washout Period 2|personal reasons|0|||
130268152|NCT02948582|468947140|FG002|Washout Period 2|personal reasons|0|||
130268153|NCT02948582|468947141|FG003|Washout Period 2|personal reasons|1|||
130268154|NCT02948582|468947142|FG004|Washout Period 2|personal reasons|0|||
130035881|NCT02272790|468086086|FG002|Overall Study|Physician Decision|0|||
130268155|NCT02948582|468947143|FG005|Washout Period 2|personal reasons|0|||
130035882|NCT02272790|468086087|FG003|Overall Study|Physician Decision|0|||
130035883|NCT02272790|468086088|FG004|Overall Study|Physician Decision|0|||
130035884|NCT02272790|468086089|FG005|Overall Study|Physician Decision|0|||
130035885|NCT00332202|468086090|FG000|Overall Study|Adverse Event|72|||
130102751|NCT02118896|468334354|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
130268156|NCT02948582|468947138|FG000|Washout Period 4|Adverse Event|1|||
130268157|NCT02948582|468947139|FG001|Washout Period 4|Adverse Event|0|||
130268158|NCT02948582|468947140|FG002|Washout Period 4|Adverse Event|1|||
130268159|NCT02948582|468947141|FG003|Washout Period 4|Adverse Event|0|||
130268160|NCT02948582|468947142|FG004|Washout Period 4|Adverse Event|0|||
130268161|NCT02948582|468947143|FG005|Washout Period 4|Adverse Event|0|||
130268162|NCT01151020|468947147|FG000|Overall Study|Death|25|||
130268163|NCT01151020|468947147|FG000|Overall Study|Conversion to open repair|1|||
130102752|NCT02118896|468334355|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
130268164|NCT01151020|468947147|FG000|Overall Study|Lost to Follow-up|4|||
130268165|NCT01151020|468947147|FG000|Overall Study|Withdrawal by Subject|22|||
130268166|NCT01151020|468947147|FG000|Overall Study|Patients did not receive the device|2|||
130268167|NCT02389465|468947148|FG000|Overall Study|Lost to Follow-up|1|||
129885641|NCT02855164|467540775|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
129885642|NCT02855164|467540776|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
129885643|NCT02855164|467540777|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
129885644|NCT02855164|467540778|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
129885645|NCT02855164|467540771|FG000|Part C (Randomized Set)|Adverse Event|0|||
129885646|NCT02855164|467540772|FG001|Part C (Randomized Set)|Adverse Event|0|||
129885647|NCT02855164|467540773|FG002|Part C (Randomized Set)|Adverse Event|0|||
129885648|NCT02855164|467540774|FG003|Part C (Randomized Set)|Adverse Event|0|||
129885649|NCT02855164|467540775|FG004|Part C (Randomized Set)|Adverse Event|0|||
129885650|NCT02855164|467540776|FG005|Part C (Randomized Set)|Adverse Event|5|||
129885651|NCT02855164|467540777|FG006|Part C (Randomized Set)|Adverse Event|9|||
129885652|NCT02855164|467540778|FG007|Part C (Randomized Set)|Adverse Event|2|||
129885653|NCT02855164|467540771|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
129885654|NCT02855164|467540772|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
129885655|NCT02855164|467540773|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
129885656|NCT02855164|467540774|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
129885657|NCT02855164|467540775|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
129885658|NCT02855164|467540776|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
129885659|NCT02855164|467540777|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
129885660|NCT02855164|467540778|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
129885661|NCT02855164|467540771|FG000|Part C (Randomized Set)|Physician Decision|0|||
129885662|NCT02855164|467540772|FG001|Part C (Randomized Set)|Physician Decision|0|||
129885663|NCT02855164|467540773|FG002|Part C (Randomized Set)|Physician Decision|0|||
129885664|NCT02855164|467540774|FG003|Part C (Randomized Set)|Physician Decision|0|||
129885665|NCT02855164|467540775|FG004|Part C (Randomized Set)|Physician Decision|0|||
129885666|NCT02855164|467540776|FG005|Part C (Randomized Set)|Physician Decision|1|||
129885667|NCT02855164|467540777|FG006|Part C (Randomized Set)|Physician Decision|0|||
129885668|NCT02855164|467540778|FG007|Part C (Randomized Set)|Physician Decision|1|||
129885669|NCT02855164|467540771|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885670|NCT02855164|467540772|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885671|NCT02855164|467540773|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885672|NCT02855164|467540774|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885673|NCT02855164|467540775|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885674|NCT02855164|467540776|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
129885675|NCT02855164|467540777|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
129885676|NCT02855164|467540778|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
129885677|NCT00581113|467542765|FG000|Overall Study|Withdrawal by Subject|0|||
129885678|NCT00581113|467542766|FG001|Overall Study|Withdrawal by Subject|1|||
129885679|NCT00619476|467542767|FG000|Overall Study|Adverse Event|12|||
129885680|NCT00619476|467542768|FG001|Overall Study|Adverse Event|6|||
129885681|NCT00619476|467542769|FG002|Overall Study|Adverse Event|12|||
129885682|NCT00619476|467542770|FG003|Overall Study|Adverse Event|16|||
129885683|NCT00619476|467542767|FG000|Overall Study|Lack of Efficacy|6|||
129885684|NCT00619476|467542768|FG001|Overall Study|Lack of Efficacy|1|||
130268168|NCT02389465|468947149|FG001|Overall Study|Lost to Follow-up|3|||
130268169|NCT02389465|468947150|FG002|Overall Study|Lost to Follow-up|3|||
130268170|NCT02389465|468947151|FG003|Overall Study|Lost to Follow-up|0|||
130268171|NCT02389465|468947148|FG000|Overall Study|Physician Decision|0|||
130268172|NCT02389465|468947149|FG001|Overall Study|Physician Decision|0|||
130268173|NCT02389465|468947150|FG002|Overall Study|Physician Decision|0|||
130268174|NCT02389465|468947151|FG003|Overall Study|Physician Decision|1|||
130268175|NCT02389465|468947148|FG000|Overall Study|Withdrawal by Subject|0|||
130268176|NCT02389465|468947149|FG001|Overall Study|Withdrawal by Subject|1|||
130268177|NCT02389465|468947150|FG002|Overall Study|Withdrawal by Subject|2|||
130268178|NCT02389465|468947151|FG003|Overall Study|Withdrawal by Subject|2|||
130268179|NCT00846846|468947152|FG000|Overall Study|Death|56|||
130268180|NCT00846846|468947152|FG000|Overall Study|Withdrawal by Subject|19|||
130268181|NCT01220401|468947156|FG000|Overall Study|Withdrawal by Subject|2|||
130268182|NCT01220401|468947156|FG000|Overall Study|Protocol Violation|1|||
130268183|NCT04179305|468947158|FG000|Overall Study|Death|1|||
130268184|NCT04179305|468947159|FG001|Overall Study|Death|1|||
130268185|NCT04179305|468947160|FG002|Overall Study|Death|0|||
129885685|NCT00619476|467542769|FG002|Overall Study|Lack of Efficacy|1|||
129885686|NCT00619476|467542770|FG003|Overall Study|Lack of Efficacy|4|||
130268186|NCT04179305|468947161|FG003|Overall Study|Death|0|||
130268187|NCT04179305|468947158|FG000|Overall Study|Lost to Follow-up|1|||
129885687|NCT00619476|467542767|FG000|Overall Study|Protocol Violation|5|||
129885688|NCT00619476|467542768|FG001|Overall Study|Protocol Violation|4|||
130268188|NCT04179305|468947159|FG001|Overall Study|Lost to Follow-up|1|||
130268189|NCT04179305|468947160|FG002|Overall Study|Lost to Follow-up|0|||
129885689|NCT00619476|467542769|FG002|Overall Study|Protocol Violation|4|||
129885690|NCT00619476|467542770|FG003|Overall Study|Protocol Violation|9|||
129885691|NCT00619476|467542767|FG000|Overall Study|Lost to Follow-up|1|||
130268190|NCT04179305|468947161|FG003|Overall Study|Lost to Follow-up|0|||
129885692|NCT00619476|467542768|FG001|Overall Study|Lost to Follow-up|2|||
129885693|NCT00619476|467542769|FG002|Overall Study|Lost to Follow-up|0|||
130035886|NCT00332202|468086091|FG001|Overall Study|Adverse Event|28|||
130035887|NCT00332202|468086090|FG000|Overall Study|Lost to Follow-up|2|||
130035888|NCT00332202|468086091|FG001|Overall Study|Lost to Follow-up|1|||
130035889|NCT00332202|468086090|FG000|Overall Study|Physician Decision|6|||
130035890|NCT00332202|468086091|FG001|Overall Study|Physician Decision|8|||
130035891|NCT00332202|468086090|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
130035892|NCT00332202|468086091|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
130268191|NCT04179305|468947158|FG000|Overall Study|Withdrawal by Subject|0|||
130268192|NCT04179305|468947159|FG001|Overall Study|Withdrawal by Subject|1|||
130268193|NCT04179305|468947160|FG002|Overall Study|Withdrawal by Subject|0|||
130268194|NCT04179305|468947161|FG003|Overall Study|Withdrawal by Subject|0|||
130268195|NCT04179305|468947158|FG000|Overall Study|Did not have scan|1|||
130268196|NCT04179305|468947159|FG001|Overall Study|Did not have scan|0|||
130268197|NCT04179305|468947160|FG002|Overall Study|Did not have scan|0|||
130268198|NCT04179305|468947161|FG003|Overall Study|Did not have scan|0|||
130268199|NCT04179305|468947158|FG000|Overall Study|In hospice care|3|||
130268200|NCT04179305|468947159|FG001|Overall Study|In hospice care|0|||
130268201|NCT04179305|468947160|FG002|Overall Study|In hospice care|0|||
130268202|NCT04179305|468947161|FG003|Overall Study|In hospice care|0|||
130268203|NCT00503425|468947164|FG000|Overall Study|Participant files lost|6|||
130268204|NCT00503425|468947164|FG000|Overall Study|Adverse Event|5|||
130268205|NCT00503425|468947164|FG000|Overall Study|Lack of Efficacy|25|||
130268206|NCT00503425|468947164|FG000|Overall Study|Withdrawal by Subject|8|||
130268207|NCT00503425|468947164|FG000|Overall Study|Lost to Follow-up|3|||
130268208|NCT00503425|468947164|FG000|Overall Study|Death|3|||
130268209|NCT00503425|468947164|FG000|Overall Study|Missing Data/Unknown|4|||
130268210|NCT00326599|468947165|FG000|Overall Study|Withdrawal by Subject|1|||
130268211|NCT00326599|468947166|FG001|Overall Study|Withdrawal by Subject|0|||
130268212|NCT00326599|468947167|FG002|Overall Study|Withdrawal by Subject|5|||
130268213|NCT00326599|468947168|FG003|Overall Study|Withdrawal by Subject|2|||
130268214|NCT00326599|468947165|FG000|Overall Study|Adverse Event|1|||
130268215|NCT00326599|468947166|FG001|Overall Study|Adverse Event|0|||
130268216|NCT00326599|468947167|FG002|Overall Study|Adverse Event|32|||
130268217|NCT00326599|468947168|FG003|Overall Study|Adverse Event|3|||
130268218|NCT00326599|468947165|FG000|Overall Study|Disease Progression|3|||
130268219|NCT00326599|468947166|FG001|Overall Study|Disease Progression|1|||
130268220|NCT00326599|468947167|FG002|Overall Study|Disease Progression|13|||
130268221|NCT00326599|468947168|FG003|Overall Study|Disease Progression|11|||
130268222|NCT00326599|468947165|FG000|Overall Study|Alternate Treatment|1|||
130268223|NCT00326599|468947166|FG001|Overall Study|Alternate Treatment|0|||
130268224|NCT00326599|468947167|FG002|Overall Study|Alternate Treatment|0|||
130268225|NCT00326599|468947168|FG003|Overall Study|Alternate Treatment|0|||
130268226|NCT00326599|468947165|FG000|Overall Study|Death|0|||
130268227|NCT00326599|468947166|FG001|Overall Study|Death|0|||
130268228|NCT00326599|468947167|FG002|Overall Study|Death|1|||
130268229|NCT00326599|468947168|FG003|Overall Study|Death|2|||
130268230|NCT00326599|468947165|FG000|Overall Study|Other Unspecified Reason|0|||
130268231|NCT00326599|468947166|FG001|Overall Study|Other Unspecified Reason|0|||
130268232|NCT00326599|468947167|FG002|Overall Study|Other Unspecified Reason|2|||
130268233|NCT00326599|468947168|FG003|Overall Study|Other Unspecified Reason|1|||
130268234|NCT00437268|468947173|FG000|Overall Study|Adverse Event|1|||
130268235|NCT00437268|468947174|FG001|Overall Study|Adverse Event|1|||
130268236|NCT00437268|468947173|FG000|Overall Study|Withdrawal by Subject|2|||
130268237|NCT00437268|468947174|FG001|Overall Study|Withdrawal by Subject|2|||
130268238|NCT00437268|468947173|FG000|Overall Study|Progressive disease|9|||
130268239|NCT00437268|468947174|FG001|Overall Study|Progressive disease|9|||
130268240|NCT00437268|468947173|FG000|Overall Study|Physician Decision|1|||
130268241|NCT00437268|468947174|FG001|Overall Study|Physician Decision|0|||
130268242|NCT00437268|468947173|FG000|Overall Study|Death|0|||
130268243|NCT00437268|468947174|FG001|Overall Study|Death|1|||
130268244|NCT00444925|468947175|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
130268245|NCT00444925|468947176|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
130268246|NCT00444925|468947177|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
130268247|NCT00444925|468947175|FG000|Double-blind Treatment Period|Death|2|||
130268248|NCT00444925|468947176|FG001|Double-blind Treatment Period|Death|0|||
130268249|NCT00444925|468947177|FG002|Double-blind Treatment Period|Death|0|||
130268250|NCT00444925|468947175|FG000|Double-blind Treatment Period|Adverse Event|6|||
130268251|NCT00444925|468947176|FG001|Double-blind Treatment Period|Adverse Event|28|||
130268252|NCT00444925|468947177|FG002|Double-blind Treatment Period|Adverse Event|44|||
130268253|NCT00444925|468947175|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
130268254|NCT00444925|468947176|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
130268255|NCT00444925|468947177|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
130268256|NCT00444925|468947175|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
130268257|NCT00444925|468947176|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
130268258|NCT00444925|468947177|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130268259|NCT00444925|468947175|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
130268260|NCT00444925|468947176|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
130268261|NCT00444925|468947177|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
130268262|NCT00444925|468947175|FG000|Double-blind Treatment Period|Other|7|||
130268263|NCT00444925|468947176|FG001|Double-blind Treatment Period|Other|7|||
130268264|NCT00444925|468947177|FG002|Double-blind Treatment Period|Other|12|||
130268265|NCT00714948|468947184|FG000|Overall Study|Adverse Event|2|||
130268266|NCT03382912|468947185|FG000|Overall Study|Physician Decision|0|||
130268267|NCT03382912|468947186|FG001|Overall Study|Physician Decision|1|||
130268268|NCT03382912|468947185|FG000|Overall Study|Sponsor Decision|6|||
130268269|NCT03382912|468947186|FG001|Overall Study|Sponsor Decision|6|||
130268270|NCT03382912|468947185|FG000|Overall Study|Withdrawal by Subject|0|||
130268271|NCT03382912|468947186|FG001|Overall Study|Withdrawal by Subject|5|||
130268272|NCT05588440|468947187|FG000|Overall Study|Sponsor Decision|2|||
129885694|NCT00619476|467542770|FG003|Overall Study|Lost to Follow-up|1|||
129885695|NCT00619476|467542767|FG000|Overall Study|Investigator Discretion|2|||
129885696|NCT00619476|467542768|FG001|Overall Study|Investigator Discretion|2|||
129885697|NCT00619476|467542769|FG002|Overall Study|Investigator Discretion|2|||
129885698|NCT00619476|467542770|FG003|Overall Study|Investigator Discretion|0|||
129885699|NCT00619476|467542767|FG000|Overall Study|Withdrawal by Subject|5|||
129885700|NCT00619476|467542768|FG001|Overall Study|Withdrawal by Subject|7|||
129885701|NCT00619476|467542769|FG002|Overall Study|Withdrawal by Subject|5|||
129885702|NCT00619476|467542770|FG003|Overall Study|Withdrawal by Subject|4|||
129885703|NCT01625910|467542771|FG000|Overall Study|Lost to Follow-up|3|||
129885704|NCT01625910|467542772|FG001|Overall Study|Lost to Follow-up|4|||
129885705|NCT02959138|467542773|FG000|Overall Study|Enrolled but Never Treated|0|||
129885706|NCT02959138|467542774|FG001|Overall Study|Enrolled but Never Treated|1|||
129885707|NCT02959138|467542775|FG002|Overall Study|Enrolled but Never Treated|0|||
129885708|NCT01811563|467542776|FG000|Overall Study|Lost to Follow-up|5|||
129885709|NCT01811563|467542777|FG001|Overall Study|Lost to Follow-up|2|||
129885710|NCT01811563|467542776|FG000|Overall Study|Incorrect Randomization procedure|0|||
129885711|NCT01811563|467542777|FG001|Overall Study|Incorrect Randomization procedure|1|||
129885712|NCT01327547|467542778|FG000|Overall Study|Adverse Event|4|||
129885713|NCT01327547|467542779|FG001|Overall Study|Adverse Event|1|||
129885714|NCT01327547|467542778|FG000|Overall Study|Death|1|||
129885715|NCT01327547|467542779|FG001|Overall Study|Death|2|||
129885716|NCT01327547|467542778|FG000|Overall Study|Lost to Follow-up|6|||
129885717|NCT01327547|467542779|FG001|Overall Study|Lost to Follow-up|6|||
129885718|NCT01327547|467542778|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
129885719|NCT01327547|467542779|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
129885720|NCT01327547|467542778|FG000|Overall Study|Withdrawal by Subject|3|||
129885721|NCT01327547|467542779|FG001|Overall Study|Withdrawal by Subject|7|||
129885722|NCT01327547|467542778|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
129885723|NCT01327547|467542779|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
129885724|NCT01327547|467542778|FG000|Overall Study|Protocol Violation|1|||
129885725|NCT01327547|467542779|FG001|Overall Study|Protocol Violation|0|||
129885726|NCT01327547|467542778|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
129885727|NCT01327547|467542779|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
129885728|NCT01327547|467542778|FG000|Overall Study|Required prohibited medication|2|||
129885729|NCT01327547|467542779|FG001|Overall Study|Required prohibited medication|0|||
129885730|NCT01327547|467542778|FG000|Overall Study|Non-compliance with study procedures|1|||
130268273|NCT05588440|468947188|FG001|Overall Study|Sponsor Decision|0|||
130268274|NCT05588440|468947189|FG002|Overall Study|Sponsor Decision|1|||
130268275|NCT05588440|468947187|FG000|Overall Study|Death|1|||
130268276|NCT05588440|468947188|FG001|Overall Study|Death|1|||
130268277|NCT05588440|468947189|FG002|Overall Study|Death|1|||
130268278|NCT05588440|468947187|FG000|Overall Study|Screen Fail|0|||
130268279|NCT05588440|468947188|FG001|Overall Study|Screen Fail|1|||
130268280|NCT05588440|468947189|FG002|Overall Study|Screen Fail|1|||
129885731|NCT01327547|467542779|FG001|Overall Study|Non-compliance with study procedures|0|||
129885732|NCT01327547|467542778|FG000|Overall Study|By investigator in subject's interest|0|||
129885733|NCT01327547|467542779|FG001|Overall Study|By investigator in subject's interest|1|||
129885734|NCT00329719|467542780|FG000|Overall Study|Lost to Follow-up|0|||
129885735|NCT00329719|467542781|FG001|Overall Study|Lost to Follow-up|0|||
129885736|NCT00329719|467542782|FG002|Overall Study|Lost to Follow-up|0|||
129885737|NCT00329719|467542783|FG003|Overall Study|Lost to Follow-up|1|||
130268281|NCT05588440|468947187|FG000|Overall Study|Withdrawal by Subject|0|||
130268282|NCT05588440|468947188|FG001|Overall Study|Withdrawal by Subject|0|||
130268283|NCT05588440|468947189|FG002|Overall Study|Withdrawal by Subject|1|||
129885738|NCT01155388|467542790|FG000|Overall Study|Adverse Event|1|||
129885739|NCT01155388|467542791|FG001|Overall Study|Adverse Event|0|||
129885740|NCT02462083|467542792|FG000|Overall Study|Sponsor request|39|||
129885741|NCT02462083|467542792|FG000|Overall Study|Withdrawal by Subject|87|||
129885742|NCT02462083|467542792|FG000|Overall Study|Lost to Follow-up|41|||
129885743|NCT02462083|467542792|FG000|Overall Study|Lack of Efficacy|151|||
129885744|NCT02462083|467542792|FG000|Overall Study|Pregnancy|1|||
129885745|NCT02462083|467542792|FG000|Overall Study|Protocol Violation|6|||
129885746|NCT02462083|467542792|FG000|Overall Study|Adverse Event|33|||
129885747|NCT02462083|467542792|FG000|Overall Study|Worsening condition|16|||
130268284|NCT02137070|468947190|FG000|Overall Study|Adverse Event|12|||
130268285|NCT02137070|468947191|FG001|Overall Study|Adverse Event|3|||
130268286|NCT02137070|468947190|FG000|Overall Study|Death|2|||
130268287|NCT02137070|468947191|FG001|Overall Study|Death|0|||
129885748|NCT02462083|467542792|FG000|Overall Study|Other than specified|45|||
129885749|NCT02291289|467542793|FG000|Induction Treatment|Withdrawal by Subject|0|||
129885750|NCT02291289|467542794|FG001|Induction Treatment|Withdrawal by Subject|0|||
129885751|NCT02291289|467542795|FG002|Induction Treatment|Withdrawal by Subject|0|||
129885752|NCT02291289|467542796|FG003|Induction Treatment|Withdrawal by Subject|24|||
129885753|NCT02291289|467542797|FG004|Induction Treatment|Withdrawal by Subject|0|||
129885754|NCT02291289|467542798|FG005|Induction Treatment|Withdrawal by Subject|0|||
129885755|NCT02291289|467542799|FG006|Induction Treatment|Withdrawal by Subject|0|||
129885756|NCT02291289|467542800|FG007|Induction Treatment|Withdrawal by Subject|0|||
129885757|NCT02291289|467542801|FG008|Induction Treatment|Withdrawal by Subject|0|||
129885758|NCT02291289|467542802|FG009|Induction Treatment|Withdrawal by Subject|18|||
129885759|NCT02291289|467542803|FG010|Induction Treatment|Withdrawal by Subject|0|||
129885760|NCT02291289|467542804|FG011|Induction Treatment|Withdrawal by Subject|0|||
130035893|NCT00332202|468086090|FG000|Overall Study|Protocol Violation|7|||
130035894|NCT00332202|468086091|FG001|Overall Study|Protocol Violation|2|||
130035895|NCT00332202|468086090|FG000|Overall Study|Sponsor Decision|1|||
130035896|NCT00332202|468086091|FG001|Overall Study|Sponsor Decision|2|||
130035897|NCT00332202|468086090|FG000|Overall Study|Withdrawal by Subject|36|||
130035898|NCT00332202|468086091|FG001|Overall Study|Withdrawal by Subject|17|||
129885761|NCT02291289|467542805|FG012|Induction Treatment|Withdrawal by Subject|0|||
130035899|NCT00332202|468086090|FG000|Overall Study|Progressive Disease|106|||
130035900|NCT00332202|468086091|FG001|Overall Study|Progressive Disease|60|||
129885762|NCT02291289|467542793|FG000|Induction Treatment|Adverse Event|0|||
130102753|NCT02118896|468334356|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
129885763|NCT02291289|467542794|FG001|Induction Treatment|Adverse Event|0|||
130035901|NCT00332202|468086090|FG000|Overall Study|Death|5|||
130102754|NCT02118896|468334357|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
130035902|NCT00332202|468086091|FG001|Overall Study|Death|2|||
130102755|NCT02118896|468334358|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
130268288|NCT02137070|468947190|FG000|Overall Study|Lost to Follow-up|24|||
129885764|NCT02291289|467542795|FG002|Induction Treatment|Adverse Event|0|||
129885765|NCT02291289|467542796|FG003|Induction Treatment|Adverse Event|3|||
129885766|NCT02291289|467542797|FG004|Induction Treatment|Adverse Event|0|||
130035903|NCT00490542|468086096|FG000|Overall Study|Lost to Follow-up|3|||
130102756|NCT02118896|468334359|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
130102757|NCT02118896|468334360|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
130102758|NCT02118896|468334351|FG000|Overall Study|Prohibited medication|0|||
130102759|NCT02118896|468334352|FG001|Overall Study|Prohibited medication|0|||
130102760|NCT02118896|468334353|FG002|Overall Study|Prohibited medication|0|||
130102761|NCT02118896|468334354|FG003|Overall Study|Prohibited medication|0|||
130102762|NCT02118896|468334355|FG004|Overall Study|Prohibited medication|1|||
130102763|NCT02118896|468334356|FG005|Overall Study|Prohibited medication|3|||
130102764|NCT02118896|468334357|FG006|Overall Study|Prohibited medication|0|||
130102765|NCT02118896|468334358|FG007|Overall Study|Prohibited medication|0|||
130102766|NCT02118896|468334359|FG008|Overall Study|Prohibited medication|0|||
130102767|NCT02118896|468334360|FG009|Overall Study|Prohibited medication|0|||
130102768|NCT02118896|468334351|FG000|Overall Study|Miscellaneous|1|||
130102769|NCT02118896|468334352|FG001|Overall Study|Miscellaneous|2|||
130102770|NCT02118896|468334353|FG002|Overall Study|Miscellaneous|0|||
130102771|NCT02118896|468334354|FG003|Overall Study|Miscellaneous|2|||
130102772|NCT02118896|468334355|FG004|Overall Study|Miscellaneous|0|||
130102773|NCT02118896|468334356|FG005|Overall Study|Miscellaneous|4|||
130268289|NCT02137070|468947191|FG001|Overall Study|Lost to Follow-up|9|||
130268290|NCT02137070|468947190|FG000|Overall Study|Physician Decision|0|||
130268291|NCT02137070|468947191|FG001|Overall Study|Physician Decision|1|||
130268292|NCT02137070|468947190|FG000|Overall Study|Protocol Violation|18|||
130268293|NCT02137070|468947191|FG001|Overall Study|Protocol Violation|4|||
130268294|NCT02137070|468947190|FG000|Overall Study|Withdrawal by Subject|18|||
130268295|NCT02137070|468947191|FG001|Overall Study|Withdrawal by Subject|1|||
130268296|NCT00678288|468949619|FG000|Overall Study|Adverse Event|0|||
130268297|NCT00678288|468949620|FG001|Overall Study|Adverse Event|2|||
130268298|NCT00678288|468949619|FG000|Overall Study|Withdrawal by Subject|1|||
130268299|NCT00678288|468949620|FG001|Overall Study|Withdrawal by Subject|1|||
130268300|NCT00678288|468949619|FG000|Overall Study|Study terminated by the sponsor|2|||
130268301|NCT00678288|468949620|FG001|Overall Study|Study terminated by the sponsor|0|||
130268302|NCT00678288|468949619|FG000|Overall Study|Not compliant with study medication|0|||
130268303|NCT00678288|468949620|FG001|Overall Study|Not compliant with study medication|1|||
130268304|NCT00678288|468949619|FG000|Overall Study|Switch to commercial drug|0|||
130268305|NCT00678288|468949620|FG001|Overall Study|Switch to commercial drug|1|||
130268306|NCT00678288|468949619|FG000|Overall Study|Reason not reported|1|||
130268307|NCT00678288|468949620|FG001|Overall Study|Reason not reported|0|||
130268308|NCT00678288|468949619|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
130268309|NCT00678288|468949620|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
130268310|NCT02549989|468949621|FG000|Overall Study|Adverse Event|4|||
130268311|NCT02549989|468949621|FG000|Overall Study|Death|1|||
130268312|NCT02549989|468949621|FG000|Overall Study|Lack of Efficacy|19|||
130268313|NCT02549989|468949621|FG000|Overall Study|Withdrawal by Subject|3|||
130268314|NCT00972023|468949622|FG000|Overall Study|Withdrawal by Subject|1|||
130268315|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
130268316|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129885767|NCT02291289|467542798|FG005|Induction Treatment|Adverse Event|0|||
130268317|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268318|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268319|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268320|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268321|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268322|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268323|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
130268324|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268325|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
130268326|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
130268327|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268328|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268329|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268330|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268331|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268332|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
130268333|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
130268334|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
130268335|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
130268336|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268337|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268338|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268339|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268340|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268341|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268342|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
130268343|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
130268344|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
130268345|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268346|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268347|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268348|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268349|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130268350|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
130035904|NCT00490542|468086097|FG001|Overall Study|Lost to Follow-up|0|||
130035905|NCT00490542|468086096|FG000|Overall Study|Adverse Event|3|||
130035906|NCT00490542|468086097|FG001|Overall Study|Adverse Event|3|||
129885768|NCT02291289|467542799|FG006|Induction Treatment|Adverse Event|0|||
130035907|NCT00490542|468086096|FG000|Overall Study|Lack of Efficacy|1|||
130035908|NCT00490542|468086097|FG001|Overall Study|Lack of Efficacy|1|||
130035909|NCT00818259|468086098|FG000|Part I|Withdrawal by Subject|1|||
130035910|NCT00818259|468086099|FG001|Part I|Withdrawal by Subject|0|||
130035911|NCT00818259|468086100|FG002|Part I|Withdrawal by Subject|0|||
130035912|NCT00818259|468086101|FG003|Part I|Withdrawal by Subject|0|||
130035913|NCT00818259|468086102|FG004|Part I|Withdrawal by Subject|0|||
130035914|NCT00818259|468086103|FG005|Part I|Withdrawal by Subject|0|||
130035915|NCT00818259|468086104|FG006|Part I|Withdrawal by Subject|0|||
130035916|NCT00818259|468086105|FG007|Part I|Withdrawal by Subject|0|||
130035917|NCT00818259|468086106|FG008|Part I|Withdrawal by Subject|0|||
130035918|NCT00818259|468086098|FG000|Part II|Physician Decision|0|||
130035919|NCT00818259|468086099|FG001|Part II|Physician Decision|0|||
130035920|NCT00818259|468086100|FG002|Part II|Physician Decision|1|||
130035921|NCT00818259|468086101|FG003|Part II|Physician Decision|0|||
130035922|NCT00818259|468086102|FG004|Part II|Physician Decision|0|||
130035923|NCT00818259|468086103|FG005|Part II|Physician Decision|0|||
130035924|NCT00818259|468086104|FG006|Part II|Physician Decision|0|||
130035925|NCT00818259|468086105|FG007|Part II|Physician Decision|0|||
130035926|NCT00818259|468086106|FG008|Part II|Physician Decision|0|||
130035927|NCT00818259|468086098|FG000|Part II|Lack of Efficacy|0|||
130035928|NCT00818259|468086099|FG001|Part II|Lack of Efficacy|0|||
130035929|NCT00818259|468086100|FG002|Part II|Lack of Efficacy|0|||
130035930|NCT00818259|468086101|FG003|Part II|Lack of Efficacy|1|||
130035931|NCT00818259|468086102|FG004|Part II|Lack of Efficacy|0|||
130035932|NCT00818259|468086103|FG005|Part II|Lack of Efficacy|0|||
130035933|NCT00818259|468086104|FG006|Part II|Lack of Efficacy|0|||
130035934|NCT00818259|468086105|FG007|Part II|Lack of Efficacy|0|||
130035935|NCT00818259|468086106|FG008|Part II|Lack of Efficacy|0|||
130035936|NCT00818259|468086098|FG000|Part II|Not Treated|0|||
130035937|NCT00818259|468086099|FG001|Part II|Not Treated|0|||
130035938|NCT00818259|468086100|FG002|Part II|Not Treated|0|||
130035939|NCT00818259|468086101|FG003|Part II|Not Treated|1|||
130035940|NCT00818259|468086102|FG004|Part II|Not Treated|0|||
130035941|NCT00818259|468086103|FG005|Part II|Not Treated|0|||
130035942|NCT00818259|468086104|FG006|Part II|Not Treated|0|||
130035943|NCT00818259|468086105|FG007|Part II|Not Treated|0|||
130035944|NCT00818259|468086106|FG008|Part II|Not Treated|0|||
130035945|NCT00818259|468086098|FG000|Part IV|Physician Decision|0|||
130035946|NCT00818259|468086099|FG001|Part IV|Physician Decision|0|||
130035947|NCT00818259|468086100|FG002|Part IV|Physician Decision|0|||
130035948|NCT00818259|468086101|FG003|Part IV|Physician Decision|0|||
130035949|NCT00818259|468086102|FG004|Part IV|Physician Decision|0|||
130035950|NCT00818259|468086103|FG005|Part IV|Physician Decision|1|||
130035951|NCT00818259|468086104|FG006|Part IV|Physician Decision|0|||
130035952|NCT00818259|468086105|FG007|Part IV|Physician Decision|0|||
130035953|NCT00818259|468086106|FG008|Part IV|Physician Decision|0|||
130035954|NCT00818259|468086098|FG000|Part V|Adverse Event|0|||
130035955|NCT00818259|468086099|FG001|Part V|Adverse Event|0|||
130035956|NCT00818259|468086100|FG002|Part V|Adverse Event|0|||
130035957|NCT00818259|468086101|FG003|Part V|Adverse Event|0|||
130035958|NCT00818259|468086102|FG004|Part V|Adverse Event|0|||
129885769|NCT02291289|467542800|FG007|Induction Treatment|Adverse Event|0|||
129885770|NCT02291289|467542801|FG008|Induction Treatment|Adverse Event|0|||
130035959|NCT00818259|468086103|FG005|Part V|Adverse Event|0|||
130035960|NCT00818259|468086104|FG006|Part V|Adverse Event|0|||
130035961|NCT00818259|468086105|FG007|Part V|Adverse Event|1|||
130035962|NCT00818259|468086106|FG008|Part V|Adverse Event|0|||
130035963|NCT01053429|468086109|FG000|Overall Study|Adverse Event|64|||
130035964|NCT01053429|468086109|FG000|Overall Study|Other|309|||
130035965|NCT01237951|468086110|FG000|Overall Study|Death|1|||
130035966|NCT00752986|468086111|FG000|Overall Study|Withdrawal by Subject|2|||
130035967|NCT00752986|468086112|FG001|Overall Study|Withdrawal by Subject|1|||
130035968|NCT00752986|468086113|FG002|Overall Study|Withdrawal by Subject|2|||
130035969|NCT00752986|468086111|FG000|Overall Study|Protocol Violation|3|||
130035970|NCT00752986|468086112|FG001|Overall Study|Protocol Violation|0|||
130035971|NCT00752986|468086113|FG002|Overall Study|Protocol Violation|0|||
130035972|NCT00924703|468086117|FG000|Overall Study|Withdrawal by Subject|11|||
130035973|NCT00924703|468086117|FG000|Overall Study|Physician Decision|5|||
130035974|NCT00924703|468086117|FG000|Overall Study|Lost to Follow-up|3|||
130035975|NCT00924703|468086117|FG000|Overall Study|Adverse Event|2|||
130035976|NCT00924703|468086117|FG000|Overall Study|Withdrawal by Sponsor|1|||
130035977|NCT00666562|468086118|FG000|Overall Study|Withdrawal by Subject|0|||
130035978|NCT00666562|468086119|FG001|Overall Study|Withdrawal by Subject|1|||
130035979|NCT00666562|468086120|FG002|Overall Study|Withdrawal by Subject|0|||
130035980|NCT00666562|468086118|FG000|Overall Study|Concomitant Medication|0|||
130035981|NCT00666562|468086119|FG001|Overall Study|Concomitant Medication|1|||
130035982|NCT00666562|468086120|FG002|Overall Study|Concomitant Medication|0|||
130035983|NCT01587989|468086122|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
130035984|NCT01587989|468086123|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
130035985|NCT01587989|468086124|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
130035986|NCT01587989|468086122|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
130035987|NCT01587989|468086123|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
130035988|NCT01587989|468086124|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
130035989|NCT01587989|468086122|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
130035990|NCT01587989|468086123|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
130035991|NCT01587989|468086124|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
130035992|NCT01587989|468086122|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
130035993|NCT01587989|468086123|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
130035994|NCT01587989|468086124|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
130035995|NCT01587989|468086122|FG000|Randomized Study Treatment|Screening failure|0|||
130035996|NCT01587989|468086123|FG001|Randomized Study Treatment|Screening failure|1|||
130035997|NCT01587989|468086124|FG002|Randomized Study Treatment|Screening failure|0|||
130035998|NCT01587989|468086122|FG000|Randomized Study Treatment|Physician Decision|0|||
130035999|NCT01587989|468086123|FG001|Randomized Study Treatment|Physician Decision|0|||
130036000|NCT01587989|468086124|FG002|Randomized Study Treatment|Physician Decision|1|||
130036001|NCT00684177|468086134|FG000|Overall Study|Adverse Event|4|||
130036002|NCT00684177|468086135|FG001|Overall Study|Adverse Event|3|||
130036003|NCT00684177|468086134|FG000|Overall Study|Lack of Efficacy|10|||
130036004|NCT00684177|468086135|FG001|Overall Study|Lack of Efficacy|15|||
130036005|NCT00684177|468086134|FG000|Overall Study|Protocol Violation|1|||
130036006|NCT00684177|468086135|FG001|Overall Study|Protocol Violation|0|||
130036007|NCT00684177|468086134|FG000|Overall Study|Lost to Follow-up|2|||
130036008|NCT00684177|468086135|FG001|Overall Study|Lost to Follow-up|1|||
130036009|NCT00684177|468086134|FG000|Overall Study|Physician Decision|2|||
130036010|NCT00684177|468086135|FG001|Overall Study|Physician Decision|0|||
130036011|NCT00684177|468086134|FG000|Overall Study|Withdrawal by Subject|1|||
130036012|NCT00684177|468086135|FG001|Overall Study|Withdrawal by Subject|2|||
130036013|NCT00684177|468086134|FG000|Overall Study|Other|1|||
130036014|NCT00684177|468086135|FG001|Overall Study|Other|2|||
130036015|NCT04375761|468088156|FG000|Overall Study|Death|1|||
130036016|NCT04375761|468088157|FG001|Overall Study|Death|2|||
130036017|NCT04375761|468088156|FG000|Overall Study|Lost to Follow-up|203|||
130036018|NCT04375761|468088157|FG001|Overall Study|Lost to Follow-up|380|||
130036019|NCT04375761|468088156|FG000|Overall Study|Withdrawal by Subject|47|||
130036020|NCT04375761|468088157|FG001|Overall Study|Withdrawal by Subject|98|||
130036021|NCT04375761|468088156|FG000|Overall Study|Noncompliance with study procedure|121|||
130036022|NCT04375761|468088157|FG001|Overall Study|Noncompliance with study procedure|251|||
130036023|NCT04375761|468088156|FG000|Overall Study|Reimbursement not enough|1|||
130036024|NCT04375761|468088157|FG001|Overall Study|Reimbursement not enough|2|||
130036025|NCT04375761|468088156|FG000|Overall Study|Unforeseen family circumstances|1|||
130036026|NCT04375761|468088157|FG001|Overall Study|Unforeseen family circumstances|3|||
130036027|NCT04375761|468088156|FG000|Overall Study|Test too painful|1|||
130036028|NCT04375761|468088157|FG001|Overall Study|Test too painful|1|||
130036029|NCT04375761|468088156|FG000|Overall Study|Moved|0|||
130036030|NCT04375761|468088157|FG001|Overall Study|Moved|2|||
130036031|NCT04375761|468088156|FG000|Overall Study|Nonresponsive|0|||
130036032|NCT04375761|468088157|FG001|Overall Study|Nonresponsive|5|||
130036033|NCT03797001|468088158|FG000|Overall Study|Withdrawn due to COVID19|4|||
130036034|NCT03797001|468088159|FG001|Overall Study|Withdrawn due to COVID19|0|||
130036035|NCT03797001|468088158|FG000|Overall Study|Withdrawal by Subject|7|||
130036036|NCT03797001|468088159|FG001|Overall Study|Withdrawal by Subject|6|||
130036037|NCT03797001|468088158|FG000|Overall Study|Adverse Event|0|||
130036038|NCT03797001|468088159|FG001|Overall Study|Adverse Event|1|||
130036039|NCT05630846|468088162|FG000|Overall Study|Death|1|||
130036040|NCT05630846|468088163|FG001|Overall Study|Death|0|||
130036041|NCT05630846|468088164|FG002|Overall Study|Death|0|||
130036042|NCT05630846|468088165|FG003|Overall Study|Death|0|||
130036043|NCT05630846|468088162|FG000|Overall Study|Withdrawal by Subject|3|||
130036044|NCT05630846|468088163|FG001|Overall Study|Withdrawal by Subject|3|||
129885771|NCT02291289|467542802|FG009|Induction Treatment|Adverse Event|1|||
130268351|NCT02628444|468949623|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
130268352|NCT02628444|468949624|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
130268353|NCT02628444|468949625|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
130268354|NCT02628444|468949626|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268355|NCT02628444|468949627|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268356|NCT02628444|468949628|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268357|NCT02628444|468949629|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268358|NCT02628444|468949630|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268359|NCT02628444|468949631|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
130268360|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268361|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268362|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268363|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
130268364|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268365|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268366|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268367|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268368|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
130268369|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130268370|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130268371|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
130268372|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130268373|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130036045|NCT05630846|468088164|FG002|Overall Study|Withdrawal by Subject|4|||
130036046|NCT05630846|468088165|FG003|Overall Study|Withdrawal by Subject|1|||
130036047|NCT05630846|468088162|FG000|Overall Study|Lost to Follow-up|6|||
130036048|NCT05630846|468088163|FG001|Overall Study|Lost to Follow-up|5|||
130036049|NCT05630846|468088164|FG002|Overall Study|Lost to Follow-up|2|||
130268374|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
130036050|NCT05630846|468088165|FG003|Overall Study|Lost to Follow-up|5|||
130036051|NCT05630846|468088162|FG000|Overall Study|Other|1|||
130036052|NCT05630846|468088163|FG001|Overall Study|Other|0|||
130036053|NCT05630846|468088164|FG002|Overall Study|Other|0|||
130036054|NCT05630846|468088165|FG003|Overall Study|Other|0|||
130036055|NCT05556616|468088166|FG000|Overall Study|Withdrawal by Subject|1|||
130036056|NCT05556616|468088167|FG001|Overall Study|Withdrawal by Subject|0|||
130036057|NCT05556616|468088168|FG002|Overall Study|Withdrawal by Subject|0|||
130036058|NCT05556616|468088169|FG003|Overall Study|Withdrawal by Subject|0|||
130036059|NCT05556616|468088170|FG004|Overall Study|Withdrawal by Subject|0|||
130036060|NCT05556616|468088171|FG005|Overall Study|Withdrawal by Subject|0|||
130036061|NCT05556616|468088172|FG006|Overall Study|Withdrawal by Subject|0|||
130036062|NCT05556616|468088166|FG000|Overall Study|Death|0|||
130036063|NCT05556616|468088167|FG001|Overall Study|Death|0|||
130036064|NCT05556616|468088168|FG002|Overall Study|Death|2|||
130036065|NCT05556616|468088169|FG003|Overall Study|Death|1|||
130036066|NCT05556616|468088170|FG004|Overall Study|Death|0|||
130036067|NCT05556616|468088171|FG005|Overall Study|Death|0|||
130036068|NCT05556616|468088172|FG006|Overall Study|Death|0|||
130036069|NCT05556616|468088166|FG000|Overall Study|Study Terminated by Sponsor|0|||
130036070|NCT05556616|468088167|FG001|Overall Study|Study Terminated by Sponsor|3|||
130036071|NCT05556616|468088168|FG002|Overall Study|Study Terminated by Sponsor|0|||
130036072|NCT05556616|468088169|FG003|Overall Study|Study Terminated by Sponsor|0|||
130036073|NCT05556616|468088170|FG004|Overall Study|Study Terminated by Sponsor|0|||
130036074|NCT05556616|468088171|FG005|Overall Study|Study Terminated by Sponsor|0|||
130036075|NCT05556616|468088172|FG006|Overall Study|Study Terminated by Sponsor|0|||
130036076|NCT00075881|468088175|FG000|Overall Study|Lack of Efficacy|18|||
130036077|NCT00075881|468088175|FG000|Overall Study|Adverse Event|7|||
130036078|NCT00075881|468088175|FG000|Overall Study|Death|1|||
130036079|NCT00075881|468088175|FG000|Overall Study|Withdrawal by Subject|2|||
130036080|NCT00075881|468088175|FG000|Overall Study|Protocol Violation|4|||
130036081|NCT00075881|468088175|FG000|Overall Study|other complicating disease|3|||
130036082|NCT00075881|468088175|FG000|Overall Study|other|4|||
130036083|NCT00075881|468088175|FG000|Overall Study|missing data|2|||
130036084|NCT00075881|468088175|FG000|Overall Study|Ineligible|1|||
130036085|NCT00075881|468088175|FG000|Overall Study|never start protocol therapy|1|||
130036086|NCT02031679|468088176|FG000|Overall Study|Protocol Violation|0|||
130036087|NCT02031679|468088177|FG001|Overall Study|Protocol Violation|1|||
130036088|NCT02031679|468088176|FG000|Overall Study|Lack of Efficacy|0|||
130036089|NCT02031679|468088177|FG001|Overall Study|Lack of Efficacy|1|||
130036090|NCT04030195|468088178|FG000|Overall Study|Withdrawal by Subject|2|||
130036091|NCT04030195|468088179|FG001|Overall Study|Withdrawal by Subject|0|||
130036092|NCT04030195|468088180|FG002|Overall Study|Withdrawal by Subject|0|||
130036093|NCT00742781|468088182|FG000|Overall Study|Withdrawal by Subject|3|||
130036094|NCT03095703|468088189|FG000|Overall Study|Withdrawal by Subject|1|||
130036095|NCT03539432|468088190|FG000|Overall Study|Lost to Follow-up|0|||
130036096|NCT03539432|468088191|FG001|Overall Study|Lost to Follow-up|1|||
130036097|NCT02443402|468088192|FG000|Overall Study|Withdrawal by Subject|3|||
130036098|NCT02443402|468088193|FG001|Overall Study|Withdrawal by Subject|1|||
130036099|NCT02443402|468088192|FG000|Overall Study|Screen Failure|1|||
130036100|NCT02443402|468088193|FG001|Overall Study|Screen Failure|2|||
130036101|NCT02665689|468088195|FG000|Overall Study|Adverse Event|1|||
130036102|NCT02665689|468088196|FG001|Overall Study|Adverse Event|0|||
130036103|NCT02665689|468088195|FG000|Overall Study|Trial termination|1|||
130036104|NCT02665689|468088196|FG001|Overall Study|Trial termination|1|||
130036105|NCT02665689|468088195|FG000|Overall Study|Lost to Follow-up|0|||
129885772|NCT02291289|467542803|FG010|Induction Treatment|Adverse Event|0|||
129885773|NCT02291289|467542804|FG011|Induction Treatment|Adverse Event|0|||
130036106|NCT02665689|468088196|FG001|Overall Study|Lost to Follow-up|1|||
130036107|NCT00824564|468088197|FG000|Overall Study|Lost to Follow-up|5|||
130036108|NCT00824564|468088198|FG001|Overall Study|Lost to Follow-up|7|||
130268375|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
130268376|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
130268377|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
130036109|NCT00824564|468088197|FG000|Overall Study|Withdrawal by Subject|1|||
130036110|NCT00824564|468088198|FG001|Overall Study|Withdrawal by Subject|1|||
129885774|NCT02291289|467542805|FG012|Induction Treatment|Adverse Event|0|||
129885775|NCT02291289|467542793|FG000|Induction Treatment|Death|25|||
129885776|NCT02291289|467542794|FG001|Induction Treatment|Death|0|||
129885777|NCT02291289|467542795|FG002|Induction Treatment|Death|0|||
129885778|NCT02291289|467542796|FG003|Induction Treatment|Death|111|||
129885779|NCT02291289|467542797|FG004|Induction Treatment|Death|0|||
129885780|NCT02291289|467542798|FG005|Induction Treatment|Death|0|||
129885781|NCT02291289|467542799|FG006|Induction Treatment|Death|1|||
129885782|NCT02291289|467542800|FG007|Induction Treatment|Death|0|||
129885783|NCT02291289|467542801|FG008|Induction Treatment|Death|0|||
129885784|NCT02291289|467542802|FG009|Induction Treatment|Death|82|||
129885785|NCT02291289|467542803|FG010|Induction Treatment|Death|0|||
129885786|NCT02291289|467542804|FG011|Induction Treatment|Death|0|||
129885787|NCT02291289|467542805|FG012|Induction Treatment|Death|0|||
130036111|NCT00824564|468088197|FG000|Overall Study|Other|1|||
130036112|NCT00824564|468088198|FG001|Overall Study|Other|2|||
130268378|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268379|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268380|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
130268381|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
130268382|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
130268383|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
130268384|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
130268385|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
130268386|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
130268387|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268388|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268389|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268390|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268391|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
130268392|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268393|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
130268394|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
130268395|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
130268396|NCT02628444|468949623|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130268397|NCT02628444|468949624|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130268398|NCT02628444|468949625|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
130268399|NCT02628444|468949626|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130268400|NCT02628444|468949627|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130268401|NCT02628444|468949628|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
130268402|NCT02628444|468949629|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
130268403|NCT02628444|468949630|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
130268404|NCT02628444|468949631|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
130268405|NCT00532129|468949634|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
130268406|NCT00532129|468949634|FG000|Treatment Period|Physician Decision|15|||
130268407|NCT00532129|468949634|FG000|Treatment Period|Disease progression|3|||
130268408|NCT00532129|468949634|FG000|Treatment Period|Protocol Violation|1|||
129885788|NCT02291289|467542793|FG000|Induction Treatment|Lost to Follow-up|1|||
129885789|NCT02291289|467542794|FG001|Induction Treatment|Lost to Follow-up|0|||
129885790|NCT02291289|467542795|FG002|Induction Treatment|Lost to Follow-up|0|||
129885791|NCT02291289|467542796|FG003|Induction Treatment|Lost to Follow-up|12|||
130036113|NCT00824564|468088197|FG000|Overall Study|Randomized, but not treated|1|||
130036114|NCT00824564|468088198|FG001|Overall Study|Randomized, but not treated|0|||
129885792|NCT02291289|467542797|FG004|Induction Treatment|Lost to Follow-up|0|||
130036115|NCT00486902|468088199|FG000|Overall Study|Withdrawal by Subject|1|||
130036116|NCT00486902|468088200|FG001|Overall Study|Withdrawal by Subject|2|||
130036117|NCT00486902|468088199|FG000|Overall Study|decision for postpartum tubal ligation|3|||
130036118|NCT00486902|468088200|FG001|Overall Study|decision for postpartum tubal ligation|1|||
130036119|NCT00486902|468088199|FG000|Overall Study|spinal anesthetic protocal violation|1|||
130036120|NCT00486902|468088200|FG001|Overall Study|spinal anesthetic protocal violation|1|||
130036121|NCT00486902|468088199|FG000|Overall Study|Did not meet inclusion criteria|1|||
129885793|NCT02291289|467542798|FG005|Induction Treatment|Lost to Follow-up|0|||
129885794|NCT02291289|467542799|FG006|Induction Treatment|Lost to Follow-up|0|||
130036122|NCT00486902|468088200|FG001|Overall Study|Did not meet inclusion criteria|0|||
130102774|NCT02118896|468334357|FG006|Overall Study|Miscellaneous|0|||
130102775|NCT02118896|468334358|FG007|Overall Study|Miscellaneous|0|||
129885795|NCT02291289|467542800|FG007|Induction Treatment|Lost to Follow-up|0|||
130036123|NCT00486902|468088199|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
130036124|NCT00486902|468088200|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
130102776|NCT02118896|468334359|FG008|Overall Study|Miscellaneous|0|||
130268409|NCT00532129|468949634|FG000|Treatment Period|Other|5|||
130268410|NCT00532129|468949634|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
130268411|NCT00532129|468949634|FG000|Follow-up Period|Disease progression|57|||
130268412|NCT00532129|468949634|FG000|Follow-up Period|Lost to Follow-up|1|||
130268413|NCT00532129|468949634|FG000|Follow-up Period|Other|6|||
130268414|NCT00784368|468949635|FG000|Overall Study|Physician Decision|0|||
130268415|NCT00784368|468949636|FG001|Overall Study|Physician Decision|0|||
130268416|NCT00784368|468949637|FG002|Overall Study|Physician Decision|6|||
130268417|NCT00784368|468949635|FG000|Overall Study|Lack of Efficacy|2|||
130268418|NCT00784368|468949636|FG001|Overall Study|Lack of Efficacy|0|||
130268419|NCT00784368|468949637|FG002|Overall Study|Lack of Efficacy|1|||
130268420|NCT00784368|468949635|FG000|Overall Study|Adverse Event|6|||
130268421|NCT00784368|468949636|FG001|Overall Study|Adverse Event|9|||
130268422|NCT00784368|468949637|FG002|Overall Study|Adverse Event|2|||
130268423|NCT00784368|468949635|FG000|Overall Study|Diagnosis of fever|0|||
130268424|NCT00784368|468949636|FG001|Overall Study|Diagnosis of fever|0|||
130268425|NCT00784368|468949637|FG002|Overall Study|Diagnosis of fever|1|||
130268426|NCT00784368|468949635|FG000|Overall Study|Worsening of complications|0|||
130268427|NCT00784368|468949636|FG001|Overall Study|Worsening of complications|0|||
130268428|NCT00784368|468949637|FG002|Overall Study|Worsening of complications|1|||
130268429|NCT00784368|468949635|FG000|Overall Study|Worsening of symptoms|0|||
130268430|NCT00784368|468949636|FG001|Overall Study|Worsening of symptoms|1|||
130268431|NCT00784368|468949637|FG002|Overall Study|Worsening of symptoms|0|||
130268432|NCT00784368|468949635|FG000|Overall Study|Withdrawal of informed consent|0|||
130268433|NCT00784368|468949636|FG001|Overall Study|Withdrawal of informed consent|1|||
130268434|NCT00784368|468949637|FG002|Overall Study|Withdrawal of informed consent|0|||
130268435|NCT02237001|468949638|FG000|Overall Study|Lost to Follow-up|2|||
130268436|NCT02237001|468949638|FG000|Overall Study|Withdrawal by Subject|1|||
130268437|NCT02237001|468949638|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
130268438|NCT02237001|468949638|FG000|Overall Study|Re-operation|4|||
130268439|NCT02237001|468949638|FG000|Overall Study|Incarceration|1|||
130268440|NCT01713582|468949639|FG000|Overall Study|Disease progression|3|||
130268441|NCT01713582|468949640|FG001|Overall Study|Disease progression|3|||
130268442|NCT01713582|468949641|FG002|Overall Study|Disease progression|3|||
130268443|NCT01713582|468949642|FG003|Overall Study|Disease progression|2|||
130268444|NCT01713582|468949643|FG004|Overall Study|Disease progression|3|||
130036125|NCT01552057|468088207|FG000|Overall Study|Adverse Event|14|||
130268445|NCT01713582|468949644|FG005|Overall Study|Disease progression|3|||
130268446|NCT01713582|468949645|FG006|Overall Study|Disease progression|3|||
130268447|NCT01713582|468949646|FG007|Overall Study|Disease progression|3|||
130268448|NCT01713582|468949647|FG008|Overall Study|Disease progression|3|||
130268449|NCT01713582|468949648|FG009|Overall Study|Disease progression|11|||
130268450|NCT01713582|468949649|FG010|Overall Study|Disease progression|10|||
130268451|NCT01713582|468949650|FG011|Overall Study|Disease progression|5|||
130268452|NCT01713582|468949651|FG012|Overall Study|Disease progression|3|||
130268453|NCT01713582|468949652|FG013|Overall Study|Disease progression|3|||
130268454|NCT01713582|468949653|FG014|Overall Study|Disease progression|6|||
129885796|NCT02291289|467542801|FG008|Induction Treatment|Lost to Follow-up|0|||
129885797|NCT02291289|467542802|FG009|Induction Treatment|Lost to Follow-up|9|||
129885798|NCT02291289|467542803|FG010|Induction Treatment|Lost to Follow-up|0|||
129885799|NCT02291289|467542804|FG011|Induction Treatment|Lost to Follow-up|0|||
129885800|NCT02291289|467542805|FG012|Induction Treatment|Lost to Follow-up|0|||
129885801|NCT02291289|467542793|FG000|Induction Treatment|Non-Compliance|0|||
129885802|NCT02291289|467542794|FG001|Induction Treatment|Non-Compliance|0|||
129885803|NCT02291289|467542795|FG002|Induction Treatment|Non-Compliance|0|||
129885804|NCT02291289|467542796|FG003|Induction Treatment|Non-Compliance|1|||
129885805|NCT02291289|467542797|FG004|Induction Treatment|Non-Compliance|0|||
129885806|NCT02291289|467542798|FG005|Induction Treatment|Non-Compliance|0|||
129885807|NCT02291289|467542799|FG006|Induction Treatment|Non-Compliance|0|||
129885808|NCT02291289|467542800|FG007|Induction Treatment|Non-Compliance|0|||
129885809|NCT02291289|467542801|FG008|Induction Treatment|Non-Compliance|0|||
129885810|NCT02291289|467542802|FG009|Induction Treatment|Non-Compliance|1|||
129885811|NCT02291289|467542803|FG010|Induction Treatment|Non-Compliance|0|||
129885812|NCT02291289|467542804|FG011|Induction Treatment|Non-Compliance|0|||
129885813|NCT02291289|467542805|FG012|Induction Treatment|Non-Compliance|0|||
129885814|NCT02291289|467542793|FG000|Induction Treatment|Reason Not Specified|0|||
129885815|NCT02291289|467542794|FG001|Induction Treatment|Reason Not Specified|0|||
129885816|NCT02291289|467542795|FG002|Induction Treatment|Reason Not Specified|0|||
129885817|NCT02291289|467542796|FG003|Induction Treatment|Reason Not Specified|4|||
129885818|NCT02291289|467542797|FG004|Induction Treatment|Reason Not Specified|0|||
129885819|NCT02291289|467542798|FG005|Induction Treatment|Reason Not Specified|0|||
129885820|NCT02291289|467542799|FG006|Induction Treatment|Reason Not Specified|0|||
130036126|NCT01552057|468088208|FG001|Overall Study|Adverse Event|15|||
130036127|NCT01552057|468088207|FG000|Overall Study|Lack of Efficacy|8|||
130268455|NCT01713582|468949654|FG015|Overall Study|Disease progression|6|||
130268456|NCT01713582|468949655|FG016|Overall Study|Disease progression|5|||
130268457|NCT01713582|468949656|FG017|Overall Study|Disease progression|2|||
130268458|NCT01713582|468949657|FG018|Overall Study|Disease progression|3|||
130268459|NCT01713582|468949658|FG019|Overall Study|Disease progression|5|||
130268460|NCT01713582|468949659|FG020|Overall Study|Disease progression|15|||
130268461|NCT01713582|468949639|FG000|Overall Study|Death|0|||
130268462|NCT01713582|468949640|FG001|Overall Study|Death|0|||
129885821|NCT02291289|467542800|FG007|Induction Treatment|Reason Not Specified|0|||
130268463|NCT01713582|468949641|FG002|Overall Study|Death|0|||
130268464|NCT01713582|468949642|FG003|Overall Study|Death|1|||
129885822|NCT02291289|467542801|FG008|Induction Treatment|Reason Not Specified|0|||
130268465|NCT01713582|468949643|FG004|Overall Study|Death|1|||
129885823|NCT02291289|467542802|FG009|Induction Treatment|Reason Not Specified|7|||
130036128|NCT01552057|468088208|FG001|Overall Study|Lack of Efficacy|23|||
130268466|NCT01713582|468949644|FG005|Overall Study|Death|3|||
130268467|NCT01713582|468949645|FG006|Overall Study|Death|3|||
130102777|NCT02118896|468334360|FG009|Overall Study|Miscellaneous|0|||
130102778|NCT03901352|468334361|FG000|Double-blind Phase|Adverse Event|6|||
130102779|NCT03901352|468334362|FG001|Double-blind Phase|Adverse Event|4|||
130102780|NCT03901352|468334361|FG000|Double-blind Phase|Death|1|||
130102781|NCT03901352|468334362|FG001|Double-blind Phase|Death|0|||
130102782|NCT03901352|468334361|FG000|Double-blind Phase|Lack of Efficacy|0|||
130102783|NCT03901352|468334362|FG001|Double-blind Phase|Lack of Efficacy|1|||
130102784|NCT03901352|468334361|FG000|Double-blind Phase|Protocol Violation|0|||
130102785|NCT03901352|468334362|FG001|Double-blind Phase|Protocol Violation|1|||
130102786|NCT03901352|468334361|FG000|Double-blind Phase|Withdrawal by Subject|10|||
130102787|NCT03901352|468334362|FG001|Double-blind Phase|Withdrawal by Subject|8|||
130102788|NCT03901352|468334361|FG000|Open-label Extension Phase|Adverse Event|24|||
130102789|NCT03901352|468334362|FG001|Open-label Extension Phase|Adverse Event|0|||
130102790|NCT03901352|468334361|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
130102791|NCT03901352|468334362|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
130102792|NCT03901352|468334361|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
130102793|NCT03901352|468334362|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
130102794|NCT03901352|468334361|FG000|Open-label Extension Phase|Other|1|||
130102795|NCT03901352|468334362|FG001|Open-label Extension Phase|Other|0|||
130102796|NCT04635631|468334363|FG000|Overall Study|Adverse Event|1|||
130102797|NCT04635631|468334363|FG000|Overall Study|Progressive disease|13|||
130102798|NCT04635631|468334363|FG000|Overall Study|Withdrawal by Subject|1|||
130102799|NCT02050373|468334364|FG000|Overall Study|Adverse Event|4|||
130102800|NCT02050373|468334365|FG001|Overall Study|Adverse Event|7|||
130102801|NCT02050373|468334364|FG000|Overall Study|Death|3|||
130102802|NCT02050373|468334365|FG001|Overall Study|Death|3|||
130102803|NCT03901339|468334367|FG000|Overall Study|Death|220|||
130102804|NCT03901339|468334368|FG001|Overall Study|Death|192|||
130102805|NCT03901339|468334367|FG000|Overall Study|Informed consent withdrawn|13|||
130102806|NCT03901339|468334368|FG001|Overall Study|Informed consent withdrawn|40|||
130102807|NCT03901339|468334367|FG000|Overall Study|Sponsor request|30|||
130102808|NCT03901339|468334368|FG001|Overall Study|Sponsor request|23|||
130102809|NCT03901339|468334367|FG000|Overall Study|Reason not specified|5|||
130102810|NCT03901339|468334368|FG001|Overall Study|Reason not specified|7|||
130102811|NCT03901339|468334367|FG000|Overall Study|Lost to Follow-up|4|||
130102812|NCT03901339|468334368|FG001|Overall Study|Lost to Follow-up|7|||
130102813|NCT03901339|468334367|FG000|Overall Study|Covid19|0|||
130102814|NCT03901339|468334368|FG001|Overall Study|Covid19|2|||
130036129|NCT01552057|468088207|FG000|Overall Study|Withdrawal by Subject|5|||
130036130|NCT01552057|468088208|FG001|Overall Study|Withdrawal by Subject|8|||
130036131|NCT01552057|468088207|FG000|Overall Study|Entry Criteria Not Met|2|||
130036132|NCT01552057|468088208|FG001|Overall Study|Entry Criteria Not Met|2|||
130268468|NCT01713582|468949646|FG007|Overall Study|Death|2|||
130268469|NCT01713582|468949647|FG008|Overall Study|Death|3|||
130268470|NCT01713582|468949648|FG009|Overall Study|Death|4|||
130268471|NCT01713582|468949649|FG010|Overall Study|Death|3|||
130268472|NCT01713582|468949650|FG011|Overall Study|Death|0|||
130268473|NCT01713582|468949651|FG012|Overall Study|Death|0|||
130268474|NCT01713582|468949652|FG013|Overall Study|Death|0|||
130268475|NCT01713582|468949653|FG014|Overall Study|Death|0|||
130268476|NCT01713582|468949654|FG015|Overall Study|Death|0|||
130268477|NCT01713582|468949655|FG016|Overall Study|Death|0|||
130268478|NCT01713582|468949656|FG017|Overall Study|Death|0|||
130268479|NCT01713582|468949657|FG018|Overall Study|Death|0|||
130268480|NCT01713582|468949658|FG019|Overall Study|Death|0|||
130268481|NCT01713582|468949659|FG020|Overall Study|Death|0|||
130268482|NCT01713582|468949639|FG000|Overall Study|Adverse event-related|0|||
130268483|NCT01713582|468949640|FG001|Overall Study|Adverse event-related|0|||
130268484|NCT01713582|468949641|FG002|Overall Study|Adverse event-related|0|||
130268485|NCT01713582|468949642|FG003|Overall Study|Adverse event-related|0|||
130268486|NCT01713582|468949643|FG004|Overall Study|Adverse event-related|0|||
130268487|NCT01713582|468949644|FG005|Overall Study|Adverse event-related|0|||
130268488|NCT01713582|468949645|FG006|Overall Study|Adverse event-related|0|||
130268489|NCT01713582|468949646|FG007|Overall Study|Adverse event-related|0|||
130268490|NCT01713582|468949647|FG008|Overall Study|Adverse event-related|0|||
130268491|NCT01713582|468949648|FG009|Overall Study|Adverse event-related|1|||
130268492|NCT01713582|468949649|FG010|Overall Study|Adverse event-related|1|||
130268493|NCT01713582|468949650|FG011|Overall Study|Adverse event-related|0|||
130268494|NCT01713582|468949651|FG012|Overall Study|Adverse event-related|0|||
130268495|NCT01713582|468949652|FG013|Overall Study|Adverse event-related|0|||
130268496|NCT01713582|468949653|FG014|Overall Study|Adverse event-related|0|||
130268497|NCT01713582|468949654|FG015|Overall Study|Adverse event-related|0|||
130268498|NCT01713582|468949655|FG016|Overall Study|Adverse event-related|0|||
130268499|NCT01713582|468949656|FG017|Overall Study|Adverse event-related|0|||
130268500|NCT01713582|468949657|FG018|Overall Study|Adverse event-related|1|||
130268501|NCT01713582|468949658|FG019|Overall Study|Adverse event-related|0|||
130268502|NCT01713582|468949659|FG020|Overall Study|Adverse event-related|0|||
130268503|NCT01713582|468949639|FG000|Overall Study|Adverse event-unrelated|0|||
130268504|NCT01713582|468949640|FG001|Overall Study|Adverse event-unrelated|0|||
130268505|NCT01713582|468949641|FG002|Overall Study|Adverse event-unrelated|0|||
130268506|NCT01713582|468949642|FG003|Overall Study|Adverse event-unrelated|0|||
130036133|NCT01552057|468088207|FG000|Overall Study|Physician Decision|1|||
130036134|NCT01552057|468088208|FG001|Overall Study|Physician Decision|0|||
130036135|NCT00476086|468088209|FG000|Overall Study|Alternative therapy|1|||
130268507|NCT01713582|468949643|FG004|Overall Study|Adverse event-unrelated|0|||
130268508|NCT01713582|468949644|FG005|Overall Study|Adverse event-unrelated|1|||
130268509|NCT01713582|468949645|FG006|Overall Study|Adverse event-unrelated|1|||
130268510|NCT01713582|468949646|FG007|Overall Study|Adverse event-unrelated|1|||
130268511|NCT01713582|468949647|FG008|Overall Study|Adverse event-unrelated|0|||
130268512|NCT01713582|468949648|FG009|Overall Study|Adverse event-unrelated|0|||
130268513|NCT01713582|468949649|FG010|Overall Study|Adverse event-unrelated|0|||
130268514|NCT01713582|468949650|FG011|Overall Study|Adverse event-unrelated|0|||
130036136|NCT00476086|468088209|FG000|Overall Study|Progressive Disease|4|||
130036137|NCT02900092|468088210|FG000|Overall Study|Adverse Event|1|||
130268515|NCT01713582|468949651|FG012|Overall Study|Adverse event-unrelated|0|||
130268516|NCT01713582|468949652|FG013|Overall Study|Adverse event-unrelated|1|||
130268517|NCT01713582|468949653|FG014|Overall Study|Adverse event-unrelated|1|||
130268518|NCT01713582|468949654|FG015|Overall Study|Adverse event-unrelated|0|||
130268519|NCT01713582|468949655|FG016|Overall Study|Adverse event-unrelated|0|||
130268520|NCT01713582|468949656|FG017|Overall Study|Adverse event-unrelated|0|||
130268521|NCT01713582|468949657|FG018|Overall Study|Adverse event-unrelated|0|||
130102815|NCT00572910|468334369|FG000|Overall Study|Adverse Event|1|||
130268522|NCT01713582|468949658|FG019|Overall Study|Adverse event-unrelated|0|||
130268523|NCT01713582|468949659|FG020|Overall Study|Adverse event-unrelated|0|||
130268524|NCT01713582|468949639|FG000|Overall Study|Withdrawal of consent|0|||
130268525|NCT01713582|468949640|FG001|Overall Study|Withdrawal of consent|0|||
130268526|NCT01713582|468949641|FG002|Overall Study|Withdrawal of consent|1|||
130268527|NCT01713582|468949642|FG003|Overall Study|Withdrawal of consent|0|||
130268528|NCT01713582|468949643|FG004|Overall Study|Withdrawal of consent|0|||
130268529|NCT01713582|468949644|FG005|Overall Study|Withdrawal of consent|1|||
130268530|NCT01713582|468949645|FG006|Overall Study|Withdrawal of consent|0|||
130268531|NCT01713582|468949646|FG007|Overall Study|Withdrawal of consent|0|||
130268532|NCT01713582|468949647|FG008|Overall Study|Withdrawal of consent|0|||
130102816|NCT00572910|468334370|FG001|Overall Study|Adverse Event|2|||
130268533|NCT01713582|468949648|FG009|Overall Study|Withdrawal of consent|1|||
130268534|NCT01713582|468949649|FG010|Overall Study|Withdrawal of consent|0|||
130268535|NCT01713582|468949650|FG011|Overall Study|Withdrawal of consent|0|||
130268536|NCT01713582|468949651|FG012|Overall Study|Withdrawal of consent|0|||
130268537|NCT01713582|468949652|FG013|Overall Study|Withdrawal of consent|0|||
130268538|NCT01713582|468949653|FG014|Overall Study|Withdrawal of consent|0|||
130268539|NCT01713582|468949654|FG015|Overall Study|Withdrawal of consent|0|||
130268540|NCT01713582|468949655|FG016|Overall Study|Withdrawal of consent|0|||
130268541|NCT01713582|468949656|FG017|Overall Study|Withdrawal of consent|0|||
130268542|NCT01713582|468949657|FG018|Overall Study|Withdrawal of consent|1|||
130268543|NCT01713582|468949658|FG019|Overall Study|Withdrawal of consent|0|||
130268544|NCT01713582|468949659|FG020|Overall Study|Withdrawal of consent|0|||
130268545|NCT01713582|468949639|FG000|Overall Study|Lack of Efficacy|0|||
130268546|NCT01713582|468949640|FG001|Overall Study|Lack of Efficacy|0|||
130268547|NCT01713582|468949641|FG002|Overall Study|Lack of Efficacy|0|||
130268548|NCT01713582|468949642|FG003|Overall Study|Lack of Efficacy|0|||
130268549|NCT01713582|468949643|FG004|Overall Study|Lack of Efficacy|0|||
130268550|NCT01713582|468949644|FG005|Overall Study|Lack of Efficacy|0|||
130268551|NCT01713582|468949645|FG006|Overall Study|Lack of Efficacy|0|||
130268552|NCT01713582|468949646|FG007|Overall Study|Lack of Efficacy|0|||
130268553|NCT01713582|468949647|FG008|Overall Study|Lack of Efficacy|0|||
130268554|NCT01713582|468949648|FG009|Overall Study|Lack of Efficacy|1|||
130268555|NCT01713582|468949649|FG010|Overall Study|Lack of Efficacy|2|||
130268556|NCT01713582|468949650|FG011|Overall Study|Lack of Efficacy|0|||
130102817|NCT00572910|468334371|FG002|Overall Study|Adverse Event|0|||
130268557|NCT01713582|468949651|FG012|Overall Study|Lack of Efficacy|0|||
130268558|NCT01713582|468949652|FG013|Overall Study|Lack of Efficacy|0|||
130268559|NCT01713582|468949653|FG014|Overall Study|Lack of Efficacy|0|||
130268560|NCT01713582|468949654|FG015|Overall Study|Lack of Efficacy|0|||
130268561|NCT01713582|468949655|FG016|Overall Study|Lack of Efficacy|0|||
130268562|NCT01713582|468949656|FG017|Overall Study|Lack of Efficacy|0|||
130268563|NCT01713582|468949657|FG018|Overall Study|Lack of Efficacy|0|||
130268564|NCT01713582|468949658|FG019|Overall Study|Lack of Efficacy|0|||
130268565|NCT01713582|468949659|FG020|Overall Study|Lack of Efficacy|0|||
130268566|NCT01713582|468949639|FG000|Overall Study|Withdrawal by Subject|0|||
130268567|NCT01713582|468949640|FG001|Overall Study|Withdrawal by Subject|0|||
130268568|NCT01713582|468949641|FG002|Overall Study|Withdrawal by Subject|0|||
130268569|NCT01713582|468949642|FG003|Overall Study|Withdrawal by Subject|0|||
130268570|NCT01713582|468949643|FG004|Overall Study|Withdrawal by Subject|0|||
130268571|NCT01713582|468949644|FG005|Overall Study|Withdrawal by Subject|0|||
130268572|NCT01713582|468949645|FG006|Overall Study|Withdrawal by Subject|0|||
130268573|NCT01713582|468949646|FG007|Overall Study|Withdrawal by Subject|0|||
130268574|NCT01713582|468949647|FG008|Overall Study|Withdrawal by Subject|0|||
130268575|NCT01713582|468949648|FG009|Overall Study|Withdrawal by Subject|0|||
130268576|NCT01713582|468949649|FG010|Overall Study|Withdrawal by Subject|0|||
130268577|NCT01713582|468949650|FG011|Overall Study|Withdrawal by Subject|0|||
130268578|NCT01713582|468949651|FG012|Overall Study|Withdrawal by Subject|0|||
130268579|NCT01713582|468949652|FG013|Overall Study|Withdrawal by Subject|0|||
130268580|NCT01713582|468949653|FG014|Overall Study|Withdrawal by Subject|0|||
130268581|NCT01713582|468949654|FG015|Overall Study|Withdrawal by Subject|0|||
130268582|NCT01713582|468949655|FG016|Overall Study|Withdrawal by Subject|0|||
130268583|NCT01713582|468949656|FG017|Overall Study|Withdrawal by Subject|1|||
130268584|NCT01713582|468949657|FG018|Overall Study|Withdrawal by Subject|0|||
130268585|NCT01713582|468949658|FG019|Overall Study|Withdrawal by Subject|0|||
130268586|NCT01713582|468949659|FG020|Overall Study|Withdrawal by Subject|0|||
130102818|NCT00572910|468334372|FG003|Overall Study|Adverse Event|2|||
130268587|NCT01713582|468949639|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
130268588|NCT01713582|468949640|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
130268589|NCT01713582|468949641|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
130268590|NCT01713582|468949642|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
130268591|NCT01713582|468949643|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
130268592|NCT01713582|468949644|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
130268593|NCT01713582|468949645|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
130268594|NCT01713582|468949646|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
130268595|NCT01713582|468949647|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
130268596|NCT01713582|468949648|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
130268597|NCT01713582|468949649|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
130268598|NCT01713582|468949650|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
130268599|NCT01713582|468949651|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
130268600|NCT01713582|468949652|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
130268601|NCT01713582|468949653|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
130268602|NCT01713582|468949654|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
130268603|NCT01713582|468949655|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
130268604|NCT01713582|468949656|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
130268605|NCT01713582|468949657|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
130268606|NCT01713582|468949658|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
130036138|NCT05127486|468088212|FG000|Overall Study|Adverse Event|2|||
130036139|NCT05127486|468088213|FG001|Overall Study|Adverse Event|4|||
130036140|NCT05127486|468088212|FG000|Overall Study|Lack of Efficacy|1|||
130036141|NCT05127486|468088213|FG001|Overall Study|Lack of Efficacy|0|||
130036142|NCT05127486|468088212|FG000|Overall Study|Pregnancy|0|||
130036143|NCT05127486|468088213|FG001|Overall Study|Pregnancy|1|||
130268607|NCT01713582|468949659|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
130268608|NCT01713582|468949639|FG000|Overall Study|Disease progression and adverse event|0|||
130268609|NCT01713582|468949640|FG001|Overall Study|Disease progression and adverse event|0|||
130268610|NCT01713582|468949641|FG002|Overall Study|Disease progression and adverse event|0|||
130268611|NCT01713582|468949642|FG003|Overall Study|Disease progression and adverse event|0|||
130268612|NCT01713582|468949643|FG004|Overall Study|Disease progression and adverse event|0|||
130268613|NCT01713582|468949644|FG005|Overall Study|Disease progression and adverse event|0|||
130036144|NCT05127486|468088212|FG000|Overall Study|Physician Decision|4|||
130268614|NCT01713582|468949645|FG006|Overall Study|Disease progression and adverse event|0|||
130268615|NCT01713582|468949646|FG007|Overall Study|Disease progression and adverse event|0|||
130268616|NCT01713582|468949647|FG008|Overall Study|Disease progression and adverse event|0|||
130036145|NCT05127486|468088213|FG001|Overall Study|Physician Decision|1|||
130036146|NCT05127486|468088212|FG000|Overall Study|Withdrawal by Subject|14|||
130268617|NCT01713582|468949648|FG009|Overall Study|Disease progression and adverse event|0|||
130268618|NCT01713582|468949649|FG010|Overall Study|Disease progression and adverse event|0|||
130268619|NCT01713582|468949650|FG011|Overall Study|Disease progression and adverse event|0|||
130268620|NCT01713582|468949651|FG012|Overall Study|Disease progression and adverse event|0|||
130268621|NCT01713582|468949652|FG013|Overall Study|Disease progression and adverse event|0|||
130268622|NCT01713582|468949653|FG014|Overall Study|Disease progression and adverse event|0|||
130268623|NCT01713582|468949654|FG015|Overall Study|Disease progression and adverse event|0|||
130102819|NCT00572910|468334373|FG004|Overall Study|Adverse Event|0|||
130102820|NCT00572910|468334374|FG005|Overall Study|Adverse Event|0|||
130102821|NCT00572910|468334375|FG006|Overall Study|Adverse Event|4|||
130102822|NCT00572910|468334376|FG007|Overall Study|Adverse Event|2|||
130102823|NCT00572910|468334377|FG008|Overall Study|Adverse Event|1|||
130102824|NCT00572910|468334378|FG009|Overall Study|Adverse Event|3|||
130102825|NCT00572910|468334379|FG010|Overall Study|Adverse Event|2|||
130102826|NCT00572910|468334369|FG000|Overall Study|Lost to Follow-up|0|||
130102827|NCT00572910|468334370|FG001|Overall Study|Lost to Follow-up|1|||
130102828|NCT00572910|468334371|FG002|Overall Study|Lost to Follow-up|1|||
130102829|NCT00572910|468334372|FG003|Overall Study|Lost to Follow-up|2|||
130102830|NCT00572910|468334373|FG004|Overall Study|Lost to Follow-up|1|||
130102831|NCT00572910|468334374|FG005|Overall Study|Lost to Follow-up|0|||
130102832|NCT00572910|468334375|FG006|Overall Study|Lost to Follow-up|0|||
130102833|NCT00572910|468334376|FG007|Overall Study|Lost to Follow-up|0|||
130102834|NCT00572910|468334377|FG008|Overall Study|Lost to Follow-up|0|||
130036147|NCT05127486|468088213|FG001|Overall Study|Withdrawal by Subject|13|||
130036148|NCT05127486|468088212|FG000|Overall Study|Lost to Follow-up|5|||
130036149|NCT05127486|468088213|FG001|Overall Study|Lost to Follow-up|8|||
130036150|NCT01287754|468088214|FG000|Overall Study|Death|2|||
130036151|NCT01287754|468088215|FG001|Overall Study|Death|12|||
130036152|NCT01287754|468088214|FG000|Overall Study|Lost to Follow-up|1|||
130036153|NCT01287754|468088215|FG001|Overall Study|Lost to Follow-up|6|||
130036154|NCT01287754|468088214|FG000|Overall Study|Protocol Violation|0|||
130036155|NCT01287754|468088215|FG001|Overall Study|Protocol Violation|3|||
130036156|NCT04971226|468088216|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130036157|NCT04971226|468088217|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130036158|NCT04971226|468088218|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
130036159|NCT04971226|468088219|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
130036160|NCT04971226|468088216|FG000|Overall Study|Adverse Event|6|||
130036161|NCT04971226|468088217|FG001|Overall Study|Adverse Event|5|||
130036162|NCT04971226|468088218|FG002|Overall Study|Adverse Event|11|||
130036163|NCT04971226|468088219|FG003|Overall Study|Adverse Event|10|||
130036164|NCT04971226|468088216|FG000|Overall Study|Progressive disease|2|||
130036165|NCT04971226|468088217|FG001|Overall Study|Progressive disease|0|||
130036166|NCT04971226|468088218|FG002|Overall Study|Progressive disease|3|||
130036167|NCT04971226|468088219|FG003|Overall Study|Progressive disease|1|||
130036168|NCT04971226|468088216|FG000|Overall Study|Protocol Deviation|1|||
130036169|NCT04971226|468088217|FG001|Overall Study|Protocol Deviation|0|||
130036170|NCT04971226|468088218|FG002|Overall Study|Protocol Deviation|1|||
130102835|NCT00572910|468334378|FG009|Overall Study|Lost to Follow-up|1|||
130102836|NCT00572910|468334379|FG010|Overall Study|Lost to Follow-up|0|||
130102837|NCT00572910|468334369|FG000|Overall Study|Withdrawal by Subject|3|||
130102838|NCT00572910|468334370|FG001|Overall Study|Withdrawal by Subject|0|||
130102839|NCT00572910|468334371|FG002|Overall Study|Withdrawal by Subject|1|||
130102840|NCT00572910|468334372|FG003|Overall Study|Withdrawal by Subject|0|||
130102841|NCT00572910|468334373|FG004|Overall Study|Withdrawal by Subject|1|||
130102842|NCT00572910|468334374|FG005|Overall Study|Withdrawal by Subject|3|||
130102843|NCT00572910|468334375|FG006|Overall Study|Withdrawal by Subject|0|||
130102844|NCT00572910|468334376|FG007|Overall Study|Withdrawal by Subject|2|||
130102845|NCT00572910|468334377|FG008|Overall Study|Withdrawal by Subject|2|||
130102846|NCT00572910|468334378|FG009|Overall Study|Withdrawal by Subject|2|||
130102847|NCT00572910|468334379|FG010|Overall Study|Withdrawal by Subject|1|||
130102848|NCT00457418|468334384|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
130102849|NCT00457418|468334384|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
130102850|NCT00457418|468334384|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
130268624|NCT01713582|468949655|FG016|Overall Study|Disease progression and adverse event|1|||
130268625|NCT01713582|468949656|FG017|Overall Study|Disease progression and adverse event|0|||
130268626|NCT01713582|468949657|FG018|Overall Study|Disease progression and adverse event|0|||
130268627|NCT01713582|468949658|FG019|Overall Study|Disease progression and adverse event|0|||
130268628|NCT01713582|468949659|FG020|Overall Study|Disease progression and adverse event|0|||
130268629|NCT00342628|468949660|FG000|Overall Study|Withdrawal by Subject|19|||
130268630|NCT00342628|468949661|FG001|Overall Study|Withdrawal by Subject|19|||
130268631|NCT00342628|468949662|FG002|Overall Study|Withdrawal by Subject|18|||
130102851|NCT00457418|468334384|FG000|Post PK Maintenance|Adverse Event|10|||
130102852|NCT00457418|468334384|FG000|Post PK Maintenance|Progression of Disease|6|||
130102853|NCT00457418|468334384|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
130102854|NCT00457418|468334384|FG000|Post PK Maintenance|Lost to Follow-up|1|||
130102855|NCT00592007|468334385|FG000|Overall Study|Withdrawal by Subject|1|||
130102856|NCT00592007|468334385|FG000|Overall Study|patient ineligible (out of lab range)|1|||
130102857|NCT00595127|468334386|FG000|Overall Study|Death|6|||
130102858|NCT00595127|468334386|FG000|Overall Study|Relapsed|3|||
130102859|NCT00595127|468334386|FG000|Overall Study|joined another trial|1|||
130102860|NCT01785472|468334387|FG000|Overall Study|Adverse Event|5|||
130102861|NCT01785472|468334388|FG001|Overall Study|Adverse Event|4|||
130102862|NCT01785472|468334389|FG002|Overall Study|Adverse Event|6|||
130102863|NCT01785472|468334387|FG000|Overall Study|Lack of Efficacy|2|||
130102864|NCT01785472|468334388|FG001|Overall Study|Lack of Efficacy|0|||
130102865|NCT01785472|468334389|FG002|Overall Study|Lack of Efficacy|1|||
130102866|NCT01785472|468334387|FG000|Overall Study|Lost to Follow-up|1|||
130102867|NCT01785472|468334388|FG001|Overall Study|Lost to Follow-up|2|||
130102868|NCT01785472|468334389|FG002|Overall Study|Lost to Follow-up|0|||
130102869|NCT01785472|468334387|FG000|Overall Study|Physician Decision|1|||
130102870|NCT01785472|468334388|FG001|Overall Study|Physician Decision|1|||
130102871|NCT01785472|468334389|FG002|Overall Study|Physician Decision|1|||
130102872|NCT01785472|468334387|FG000|Overall Study|Protocol deviation|0|||
130102873|NCT01785472|468334388|FG001|Overall Study|Protocol deviation|2|||
130102874|NCT01785472|468334389|FG002|Overall Study|Protocol deviation|2|||
130102875|NCT01785472|468334387|FG000|Overall Study|Subject/guardian decision|15|||
130102876|NCT01785472|468334388|FG001|Overall Study|Subject/guardian decision|10|||
130102877|NCT01785472|468334389|FG002|Overall Study|Subject/guardian decision|11|||
130102878|NCT01785472|468334387|FG000|Overall Study|Technical problems|0|||
130102879|NCT01785472|468334388|FG001|Overall Study|Technical problems|0|||
130102880|NCT01785472|468334389|FG002|Overall Study|Technical problems|1|||
130102881|NCT02086968|468334391|FG000|Overall Study|Adverse Event|1|||
130102882|NCT02086968|468334392|FG001|Overall Study|Adverse Event|5|||
130102883|NCT02086968|468334391|FG000|Overall Study|Lost to Follow-up|2|||
130102884|NCT02086968|468334392|FG001|Overall Study|Lost to Follow-up|3|||
130102885|NCT02086968|468334391|FG000|Overall Study|Study drug received outside protocol|0|||
130102886|NCT02086968|468334392|FG001|Overall Study|Study drug received outside protocol|1|||
130102887|NCT02086968|468334391|FG000|Overall Study|Physician Decision|4|||
130102888|NCT02086968|468334392|FG001|Overall Study|Physician Decision|0|||
130102889|NCT02086968|468334391|FG000|Overall Study|Withdrawal by Subject|1|||
130102890|NCT02086968|468334392|FG001|Overall Study|Withdrawal by Subject|4|||
130102891|NCT01569074|468334396|FG000|Overall Study|Study stopped|6|||
130102892|NCT01569074|468334397|FG001|Overall Study|Study stopped|6|||
130102893|NCT01569074|468334398|FG002|Overall Study|Study stopped|8|||
130102894|NCT01569074|468334399|FG003|Overall Study|Study stopped|7|||
130102895|NCT01569074|468334400|FG004|Overall Study|Study stopped|7|||
130102896|NCT01569074|468334396|FG000|Overall Study|Study-specific discontinuation criteria|0|||
130102897|NCT01569074|468334397|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130102898|NCT01569074|468334398|FG002|Overall Study|Study-specific discontinuation criteria|0|||
130102899|NCT01569074|468334399|FG003|Overall Study|Study-specific discontinuation criteria|0|||
130102900|NCT01569074|468334400|FG004|Overall Study|Study-specific discontinuation criteria|0|||
130102901|NCT01569074|468334396|FG000|Overall Study|Severe non-compliance to protocol|0|||
130102902|NCT01569074|468334397|FG001|Overall Study|Severe non-compliance to protocol|0|||
130102903|NCT01569074|468334398|FG002|Overall Study|Severe non-compliance to protocol|1|||
130036171|NCT04971226|468088219|FG003|Overall Study|Protocol Deviation|1|||
130036172|NCT04971226|468088216|FG000|Overall Study|Subject Decision|0|||
130036173|NCT04971226|468088217|FG001|Overall Study|Subject Decision|1|||
130036174|NCT04971226|468088218|FG002|Overall Study|Subject Decision|1|||
130036175|NCT04971226|468088219|FG003|Overall Study|Subject Decision|1|||
130036176|NCT04971226|468088216|FG000|Overall Study|Pregnancy|0|||
130036177|NCT04971226|468088217|FG001|Overall Study|Pregnancy|0|||
130036178|NCT04971226|468088218|FG002|Overall Study|Pregnancy|0|||
130036179|NCT04971226|468088219|FG003|Overall Study|Pregnancy|1|||
130036180|NCT04971226|468088216|FG000|Overall Study|Participants not treated|1|||
130036181|NCT04971226|468088217|FG001|Overall Study|Participants not treated|0|||
130036182|NCT04971226|468088218|FG002|Overall Study|Participants not treated|2|||
130036183|NCT04971226|468088219|FG003|Overall Study|Participants not treated|1|||
130036184|NCT00001337|468088221|FG000|Overall Study|Switched to alternate treatment|2|||
130036185|NCT00001337|468088222|FG001|Overall Study|Switched to alternate treatment|2|||
130036186|NCT00001337|468088223|FG002|Overall Study|Switched to alternate treatment|0|||
130036187|NCT00001337|468088221|FG000|Overall Study|Refused further treatment|2|||
130036188|NCT00001337|468088222|FG001|Overall Study|Refused further treatment|1|||
130036189|NCT00001337|468088223|FG002|Overall Study|Refused further treatment|0|||
130036190|NCT00001337|468088221|FG000|Overall Study|Began other Tx|1|||
130036191|NCT00001337|468088222|FG001|Overall Study|Began other Tx|0|||
130036192|NCT00001337|468088223|FG002|Overall Study|Began other Tx|0|||
130036193|NCT00001337|468088221|FG000|Overall Study|Physician Decision|3|||
130036194|NCT00001337|468088222|FG001|Overall Study|Physician Decision|1|||
130036195|NCT00001337|468088223|FG002|Overall Study|Physician Decision|0|||
130036196|NCT00001337|468088221|FG000|Overall Study|Doesn't have NHL|0|||
130036197|NCT00001337|468088222|FG001|Overall Study|Doesn't have NHL|1|||
130036198|NCT00001337|468088223|FG002|Overall Study|Doesn't have NHL|0|||
130036199|NCT00001337|468088221|FG000|Overall Study|Non protocol tx needed|3|||
130036200|NCT00001337|468088222|FG001|Overall Study|Non protocol tx needed|1|||
130036201|NCT00001337|468088223|FG002|Overall Study|Non protocol tx needed|0|||
130036202|NCT00001337|468088221|FG000|Overall Study|Protocol change|1|||
130036203|NCT00001337|468088222|FG001|Overall Study|Protocol change|0|||
130036204|NCT00001337|468088223|FG002|Overall Study|Protocol change|0|||
130036205|NCT00001337|468088221|FG000|Overall Study|2nd primary disease|0|||
130036206|NCT00001337|468088222|FG001|Overall Study|2nd primary disease|0|||
130036207|NCT00001337|468088223|FG002|Overall Study|2nd primary disease|1|||
130036208|NCT00001337|468088221|FG000|Overall Study|Death during follow up period|9|||
130036209|NCT00001337|468088222|FG001|Overall Study|Death during follow up period|4|||
130036210|NCT00001337|468088223|FG002|Overall Study|Death during follow up period|0|||
130036211|NCT00001337|468088221|FG000|Overall Study|Death on study|19|||
130036212|NCT00001337|468088222|FG001|Overall Study|Death on study|9|||
130036213|NCT00001337|468088223|FG002|Overall Study|Death on study|0|||
130036214|NCT00001337|468088221|FG000|Overall Study|Disease progression during follow-up period|3|||
130036215|NCT00001337|468088222|FG001|Overall Study|Disease progression during follow-up period|1|||
130036216|NCT00001337|468088223|FG002|Overall Study|Disease progression during follow-up period|0|||
130036217|NCT00001337|468088221|FG000|Overall Study|Disease progression on study|33|||
130036218|NCT00001337|468088222|FG001|Overall Study|Disease progression on study|41|||
130036219|NCT00001337|468088223|FG002|Overall Study|Disease progression on study|0|||
130036220|NCT00001337|468088221|FG000|Overall Study|Lost to further follow-up|10|||
130036221|NCT00001337|468088222|FG001|Overall Study|Lost to further follow-up|6|||
130036222|NCT00001337|468088223|FG002|Overall Study|Lost to further follow-up|0|||
130036223|NCT00001337|468088221|FG000|Overall Study|2nd malignancy|1|||
130036224|NCT00001337|468088222|FG001|Overall Study|2nd malignancy|0|||
130036225|NCT00001337|468088223|FG002|Overall Study|2nd malignancy|0|||
130036226|NCT00001337|468088221|FG000|Overall Study|Treatment for second lymphoma|0|||
130036227|NCT00001337|468088222|FG001|Overall Study|Treatment for second lymphoma|1|||
130036228|NCT00001337|468088223|FG002|Overall Study|Treatment for second lymphoma|0|||
130036229|NCT00001337|468088221|FG000|Overall Study|Transfer to transplant|0|||
130036230|NCT00001337|468088222|FG001|Overall Study|Transfer to transplant|1|||
130036231|NCT00001337|468088223|FG002|Overall Study|Transfer to transplant|0|||
130036232|NCT04889209|468088230|FG000|All Cohorts Except 15E|Adverse Event|0|||
130102904|NCT01569074|468334399|FG003|Overall Study|Severe non-compliance to protocol|0|||
130102905|NCT01569074|468334400|FG004|Overall Study|Severe non-compliance to protocol|0|||
130102906|NCT01569074|468334396|FG000|Overall Study|eg change in circumstances|0|||
130102907|NCT01569074|468334397|FG001|Overall Study|eg change in circumstances|2|||
130102908|NCT01569074|468334398|FG002|Overall Study|eg change in circumstances|0|||
130102909|NCT01569074|468334399|FG003|Overall Study|eg change in circumstances|1|||
130102910|NCT01569074|468334400|FG004|Overall Study|eg change in circumstances|1|||
130102911|NCT01569074|468334396|FG000|Overall Study|Adverse Event|1|||
130102912|NCT01569074|468334397|FG001|Overall Study|Adverse Event|0|||
130102913|NCT01569074|468334398|FG002|Overall Study|Adverse Event|3|||
130268632|NCT00342628|468949660|FG000|Overall Study|Death|1|||
130268633|NCT00342628|468949661|FG001|Overall Study|Death|1|||
130268634|NCT00342628|468949662|FG002|Overall Study|Death|0|||
130268635|NCT00342628|468949660|FG000|Overall Study|moved residence|0|||
130268636|NCT00342628|468949661|FG001|Overall Study|moved residence|1|||
130268637|NCT00342628|468949662|FG002|Overall Study|moved residence|1|||
130268638|NCT04551898|468949663|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
130102914|NCT01569074|468334399|FG003|Overall Study|Adverse Event|0|||
130102915|NCT01569074|468334400|FG004|Overall Study|Adverse Event|0|||
130102916|NCT03099161|468334401|FG000|Overall Study|Adverse Event|0|||
130102917|NCT03099161|468334402|FG001|Overall Study|Adverse Event|0|||
130268639|NCT04551898|468949664|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
130102918|NCT03099161|468334403|FG002|Overall Study|Adverse Event|2|||
130102919|NCT03099161|468334401|FG000|Overall Study|Physician Decision|2|||
130102920|NCT03099161|468334402|FG001|Overall Study|Physician Decision|0|||
130102921|NCT03099161|468334403|FG002|Overall Study|Physician Decision|0|||
130102922|NCT03099161|468334401|FG000|Overall Study|Progressive Disease|1|||
130102923|NCT03099161|468334402|FG001|Overall Study|Progressive Disease|4|||
130102924|NCT03099161|468334403|FG002|Overall Study|Progressive Disease|1|||
130102925|NCT02723786|468334405|FG000|Overall Study|Lost to Follow-up|1|||
130268640|NCT04551898|468949665|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
130268641|NCT04551898|468949666|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
130268642|NCT04551898|468949663|FG000|Overall Study|Withdrawal by Subject|5|||
130268643|NCT04551898|468949664|FG001|Overall Study|Withdrawal by Subject|1|||
130268644|NCT04551898|468949665|FG002|Overall Study|Withdrawal by Subject|2|||
130268645|NCT04551898|468949666|FG003|Overall Study|Withdrawal by Subject|2|||
130268646|NCT04551898|468949663|FG000|Overall Study|Lost to Follow-up|2|||
130268647|NCT04551898|468949664|FG001|Overall Study|Lost to Follow-up|1|||
130102926|NCT00556166|468334417|FG000|Overall Study|Withdrawal by Subject|1|||
130102927|NCT02985515|468334420|FG000|Olfaction Testing|Lost to Follow-up|0|||
130102928|NCT02985515|468334421|FG001|Olfaction Testing|Lost to Follow-up|5|||
130102929|NCT02985515|468334420|FG000|Olfaction Testing|Protocol Violation|0|||
130102930|NCT02985515|468334421|FG001|Olfaction Testing|Protocol Violation|3|||
130102931|NCT00742859|468334426|FG000|Overall Study|Adverse Event|5|||
130102932|NCT00742859|468334427|FG001|Overall Study|Adverse Event|6|||
130102933|NCT00742859|468334428|FG002|Overall Study|Adverse Event|3|||
130102934|NCT00742859|468334429|FG003|Overall Study|Adverse Event|1|||
130102935|NCT00742859|468334426|FG000|Overall Study|Death|1|||
130102936|NCT00742859|468334427|FG001|Overall Study|Death|0|||
130102937|NCT00742859|468334428|FG002|Overall Study|Death|0|||
130102938|NCT00742859|468334429|FG003|Overall Study|Death|1|||
130102939|NCT00742859|468334426|FG000|Overall Study|Physician Decision|1|||
130102940|NCT00742859|468334427|FG001|Overall Study|Physician Decision|2|||
130102941|NCT00742859|468334428|FG002|Overall Study|Physician Decision|0|||
130102942|NCT00742859|468334429|FG003|Overall Study|Physician Decision|0|||
130102943|NCT00742859|468334426|FG000|Overall Study|Withdrawal by Subject|4|||
130102944|NCT00742859|468334427|FG001|Overall Study|Withdrawal by Subject|2|||
130102945|NCT00742859|468334428|FG002|Overall Study|Withdrawal by Subject|4|||
130102946|NCT00742859|468334429|FG003|Overall Study|Withdrawal by Subject|1|||
130102947|NCT00742859|468334426|FG000|Overall Study|Endpoint|0|||
130036233|NCT04889209|468088231|FG001|All Cohorts Except 15E|Adverse Event|0|||
130036234|NCT04889209|468088232|FG002|All Cohorts Except 15E|Adverse Event|0|||
130102948|NCT00742859|468334427|FG001|Overall Study|Endpoint|1|||
130102949|NCT00742859|468334428|FG002|Overall Study|Endpoint|1|||
130102950|NCT00742859|468334429|FG003|Overall Study|Endpoint|2|||
130102951|NCT00742859|468334426|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
130102952|NCT00742859|468334427|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
130102953|NCT00742859|468334428|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
130102954|NCT00742859|468334429|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
130102955|NCT00742859|468334426|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
130102956|NCT00742859|468334427|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
130102957|NCT00742859|468334428|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
130102958|NCT00742859|468334429|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
130102959|NCT00742859|468334426|FG000|Overall Study|Sponsor request patient out of town|0|||
130102960|NCT00742859|468334427|FG001|Overall Study|Sponsor request patient out of town|0|||
130102961|NCT00742859|468334428|FG002|Overall Study|Sponsor request patient out of town|1|||
130102962|NCT00742859|468334429|FG003|Overall Study|Sponsor request patient out of town|1|||
130102963|NCT00742859|468334426|FG000|Overall Study|Site error|0|||
130102964|NCT00742859|468334427|FG001|Overall Study|Site error|0|||
130102965|NCT00742859|468334428|FG002|Overall Study|Site error|1|||
130102966|NCT00742859|468334429|FG003|Overall Study|Site error|1|||
130102967|NCT03972709|468334440|FG000|Overall Study|Withdrawal by Subject|18|||
130102968|NCT03972709|468334441|FG001|Overall Study|Withdrawal by Subject|7|||
130102969|NCT03972709|468334442|FG002|Overall Study|Withdrawal by Subject|14|||
130102970|NCT03972709|468334440|FG000|Overall Study|Study Terminated by Sponsor|48|||
130102971|NCT03972709|468334441|FG001|Overall Study|Study Terminated by Sponsor|25|||
130102972|NCT03972709|468334442|FG002|Overall Study|Study Terminated by Sponsor|50|||
130102973|NCT03972709|468334440|FG000|Overall Study|Physician Decision|1|||
130102974|NCT03972709|468334441|FG001|Overall Study|Physician Decision|0|||
130102975|NCT03972709|468334442|FG002|Overall Study|Physician Decision|0|||
130102976|NCT03972709|468334440|FG000|Overall Study|COVID-19|0|||
130102977|NCT03972709|468334441|FG001|Overall Study|COVID-19|1|||
130102978|NCT03972709|468334442|FG002|Overall Study|COVID-19|1|||
130102979|NCT03972709|468334440|FG000|Overall Study|Lost to Follow-up|6|||
130102980|NCT03972709|468334441|FG001|Overall Study|Lost to Follow-up|1|||
130102981|NCT03972709|468334442|FG002|Overall Study|Lost to Follow-up|2|||
130102982|NCT03972709|468334440|FG000|Overall Study|Death|5|||
130102983|NCT03972709|468334441|FG001|Overall Study|Death|1|||
130102984|NCT03972709|468334442|FG002|Overall Study|Death|4|||
130268648|NCT04551898|468949665|FG002|Overall Study|Lost to Follow-up|2|||
130268649|NCT04551898|468949666|FG003|Overall Study|Lost to Follow-up|2|||
130268650|NCT04551898|468949663|FG000|Overall Study|Death|1|||
130268651|NCT04551898|468949664|FG001|Overall Study|Death|0|||
130268652|NCT04551898|468949665|FG002|Overall Study|Death|0|||
130268653|NCT04551898|468949666|FG003|Overall Study|Death|0|||
130268654|NCT04551898|468949663|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130268655|NCT04551898|468949664|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130268656|NCT04551898|468949665|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
130268657|NCT04551898|468949666|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
130268658|NCT03427814|468949667|FG000|Overall Study|Withdrawal by Subject|4|||
130268659|NCT03427814|468949668|FG001|Overall Study|Withdrawal by Subject|4|||
130268660|NCT03427814|468949667|FG000|Overall Study|Lost to Follow-up|0|||
130268661|NCT03427814|468949668|FG001|Overall Study|Lost to Follow-up|2|||
130268662|NCT03427814|468949667|FG000|Overall Study|Death|42|||
130268663|NCT03427814|468949668|FG001|Overall Study|Death|31|||
130268664|NCT03427814|468949667|FG000|Overall Study|Sponsor's Decision|1|||
130268665|NCT03427814|468949668|FG001|Overall Study|Sponsor's Decision|0|||
130268666|NCT03427814|468949667|FG000|Overall Study|Investigator's Decision|1|||
130268667|NCT03427814|468949668|FG001|Overall Study|Investigator's Decision|2|||
130268668|NCT03427814|468949667|FG000|Overall Study|Disease progression|1|||
130268669|NCT03427814|468949668|FG001|Overall Study|Disease progression|0|||
130036235|NCT04889209|468088233|FG003|All Cohorts Except 15E|Adverse Event|0|||
130036236|NCT04889209|468088234|FG004|All Cohorts Except 15E|Adverse Event|0|||
130036237|NCT04889209|468088235|FG005|All Cohorts Except 15E|Adverse Event|0|||
130036238|NCT04889209|468088236|FG006|All Cohorts Except 15E|Adverse Event|1|||
130036239|NCT04889209|468088237|FG007|All Cohorts Except 15E|Adverse Event|0|||
130036240|NCT04889209|468088238|FG008|All Cohorts Except 15E|Adverse Event|0|||
130036241|NCT04889209|468088239|FG009|All Cohorts Except 15E|Adverse Event|0|||
130036242|NCT04889209|468088240|FG010|All Cohorts Except 15E|Adverse Event|0|||
130268670|NCT03427814|468949667|FG000|Overall Study|Treatment Completed|0|||
130268671|NCT03427814|468949668|FG001|Overall Study|Treatment Completed|1|||
130268672|NCT03427814|468949667|FG000|Overall Study|Sponsor's Decision to End study|21|||
130268673|NCT03427814|468949668|FG001|Overall Study|Sponsor's Decision to End study|25|||
130036243|NCT04889209|468088241|FG011|All Cohorts Except 15E|Adverse Event|0|||
130036244|NCT04889209|468088242|FG012|All Cohorts Except 15E|Adverse Event|0|||
130036245|NCT04889209|468088243|FG013|All Cohorts Except 15E|Adverse Event|0|||
130036246|NCT04889209|468088244|FG014|All Cohorts Except 15E|Adverse Event|0|||
130036247|NCT04889209|468088245|FG015|All Cohorts Except 15E|Adverse Event|0|||
130036248|NCT04889209|468088246|FG016|All Cohorts Except 15E|Adverse Event|0|||
130036249|NCT04889209|468088247|FG017|All Cohorts Except 15E|Adverse Event|0|||
130036250|NCT04889209|468088230|FG000|All Cohorts Except 15E|Death|0|||
130036251|NCT04889209|468088231|FG001|All Cohorts Except 15E|Death|1|||
130036252|NCT04889209|468088232|FG002|All Cohorts Except 15E|Death|0|||
130036253|NCT04889209|468088233|FG003|All Cohorts Except 15E|Death|0|||
130036254|NCT04889209|468088234|FG004|All Cohorts Except 15E|Death|0|||
130036255|NCT04889209|468088235|FG005|All Cohorts Except 15E|Death|0|||
130102985|NCT03972709|468334440|FG000|Overall Study|Adverse Event|3|||
130102986|NCT03972709|468334441|FG001|Overall Study|Adverse Event|1|||
130102987|NCT03972709|468334442|FG002|Overall Study|Adverse Event|4|||
130102988|NCT03972709|468334440|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
130102989|NCT03972709|468334441|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
130102990|NCT03972709|468334442|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
130102991|NCT03972709|468334440|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
130102992|NCT03972709|468334441|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
130102993|NCT03972709|468334442|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
130036256|NCT04889209|468088236|FG006|All Cohorts Except 15E|Death|0|||
130036257|NCT04889209|468088237|FG007|All Cohorts Except 15E|Death|0|||
130036258|NCT04889209|468088238|FG008|All Cohorts Except 15E|Death|0|||
130036259|NCT04889209|468088239|FG009|All Cohorts Except 15E|Death|0|||
130036260|NCT04889209|468088240|FG010|All Cohorts Except 15E|Death|0|||
130036261|NCT04889209|468088241|FG011|All Cohorts Except 15E|Death|0|||
130036262|NCT04889209|468088242|FG012|All Cohorts Except 15E|Death|0|||
130036263|NCT04889209|468088243|FG013|All Cohorts Except 15E|Death|0|||
130036264|NCT04889209|468088244|FG014|All Cohorts Except 15E|Death|0|||
130036265|NCT04889209|468088245|FG015|All Cohorts Except 15E|Death|0|||
130036266|NCT04889209|468088246|FG016|All Cohorts Except 15E|Death|0|||
130036267|NCT04889209|468088247|FG017|All Cohorts Except 15E|Death|0|||
130036268|NCT04889209|468088230|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
130036269|NCT04889209|468088231|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
130036270|NCT04889209|468088232|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
130102994|NCT03972709|468334440|FG000|Overall Study|Subject Unable to be Contacted|0|||
130102995|NCT03972709|468334441|FG001|Overall Study|Subject Unable to be Contacted|1|||
130102996|NCT03972709|468334442|FG002|Overall Study|Subject Unable to be Contacted|0|||
130102997|NCT03972709|468334440|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
130110722|NCT03705169|468365849|FG004|Overall Study|Did not receive study treatment|0|||
130036271|NCT04889209|468088233|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
130036272|NCT04889209|468088234|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
130036273|NCT04889209|468088235|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
130036274|NCT04889209|468088236|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
130036275|NCT04889209|468088237|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
130036276|NCT04889209|468088238|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
130036277|NCT04889209|468088239|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
130036278|NCT04889209|468088240|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
130268674|NCT03427814|468949667|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
130268675|NCT03427814|468949668|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
130102998|NCT03972709|468334441|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
130102999|NCT03972709|468334442|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
130268676|NCT03846427|468949669|FG000|Overall Study|Death|13|||
130268677|NCT03846427|468949669|FG000|Overall Study|Withdrawal by Subject|3|||
130268678|NCT03846427|468949669|FG000|Overall Study|Physician Decision|1|||
130268679|NCT04971967|468949672|FG000|Overall Study|Lost to Follow-up|6|||
130268680|NCT04971967|468949673|FG001|Overall Study|Lost to Follow-up|7|||
130268681|NCT00682929|468949676|FG000|Overall Study|Adverse Event|4|||
130268682|NCT00682929|468949677|FG001|Overall Study|Adverse Event|1|||
130103000|NCT03972709|468334440|FG000|Overall Study|Subject Moved|0|||
130103001|NCT03972709|468334441|FG001|Overall Study|Subject Moved|1|||
130103002|NCT03972709|468334442|FG002|Overall Study|Subject Moved|0|||
130103003|NCT03972709|468334440|FG000|Overall Study|Missed Study Visits|1|||
130268683|NCT00682929|468949678|FG002|Overall Study|Adverse Event|1|||
130268684|NCT00682929|468949676|FG000|Overall Study|Withdrawal by Subject|1|||
130268685|NCT00682929|468949677|FG001|Overall Study|Withdrawal by Subject|2|||
130268686|NCT00682929|468949678|FG002|Overall Study|Withdrawal by Subject|1|||
130268687|NCT00682929|468949676|FG000|Overall Study|dosing compliance < 80%|0|||
130268688|NCT00682929|468949677|FG001|Overall Study|dosing compliance < 80%|2|||
130036279|NCT04889209|468088241|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
130036280|NCT04889209|468088242|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
130036281|NCT04889209|468088243|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
130036282|NCT04889209|468088244|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
130036283|NCT04889209|468088245|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
130036284|NCT04889209|468088246|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
130036285|NCT04889209|468088247|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
130036286|NCT04889209|468088230|FG000|All Cohorts Except 15E|Physician Decision|0|||
130036287|NCT04889209|468088231|FG001|All Cohorts Except 15E|Physician Decision|0|||
130036288|NCT04889209|468088232|FG002|All Cohorts Except 15E|Physician Decision|0|||
130036289|NCT04889209|468088233|FG003|All Cohorts Except 15E|Physician Decision|0|||
130036290|NCT04889209|468088234|FG004|All Cohorts Except 15E|Physician Decision|1|||
130036291|NCT04889209|468088235|FG005|All Cohorts Except 15E|Physician Decision|0|||
130036292|NCT04889209|468088236|FG006|All Cohorts Except 15E|Physician Decision|0|||
130036293|NCT04889209|468088237|FG007|All Cohorts Except 15E|Physician Decision|1|||
130036294|NCT04889209|468088238|FG008|All Cohorts Except 15E|Physician Decision|0|||
130036295|NCT04889209|468088239|FG009|All Cohorts Except 15E|Physician Decision|1|||
130036296|NCT04889209|468088240|FG010|All Cohorts Except 15E|Physician Decision|0|||
130036297|NCT04889209|468088241|FG011|All Cohorts Except 15E|Physician Decision|1|||
130036298|NCT04889209|468088242|FG012|All Cohorts Except 15E|Physician Decision|1|||
130036299|NCT04889209|468088243|FG013|All Cohorts Except 15E|Physician Decision|0|||
130036300|NCT04889209|468088244|FG014|All Cohorts Except 15E|Physician Decision|0|||
130036301|NCT04889209|468088245|FG015|All Cohorts Except 15E|Physician Decision|0|||
130036302|NCT04889209|468088246|FG016|All Cohorts Except 15E|Physician Decision|0|||
130036303|NCT04889209|468088247|FG017|All Cohorts Except 15E|Physician Decision|0|||
130036304|NCT04889209|468088230|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
130036305|NCT04889209|468088231|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
130036306|NCT04889209|468088232|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
130036307|NCT04889209|468088233|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
130036308|NCT04889209|468088234|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
130036309|NCT04889209|468088235|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036310|NCT04889209|468088236|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036311|NCT04889209|468088237|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
130036312|NCT04889209|468088238|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036313|NCT04889209|468088239|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036314|NCT04889209|468088240|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036315|NCT04889209|468088241|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036316|NCT04889209|468088242|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036317|NCT04889209|468088243|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
130036318|NCT04889209|468088244|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
130036319|NCT04889209|468088245|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
130036320|NCT04889209|468088246|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
130036321|NCT04889209|468088247|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
130036322|NCT04889209|468088230|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
130036323|NCT04889209|468088231|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
130036324|NCT04889209|468088232|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130103004|NCT03972709|468334441|FG001|Overall Study|Missed Study Visits|0|||
130103005|NCT03972709|468334442|FG002|Overall Study|Missed Study Visits|0|||
130110723|NCT03705169|468365850|FG005|Overall Study|Did not receive study treatment|0|||
130268689|NCT00682929|468949678|FG002|Overall Study|dosing compliance < 80%|0|||
130268690|NCT00682929|468949676|FG000|Overall Study|lag in DEA renewal|1|||
130268691|NCT00682929|468949677|FG001|Overall Study|lag in DEA renewal|0|||
130036325|NCT04889209|468088233|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036326|NCT04889209|468088234|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036327|NCT04889209|468088235|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130036328|NCT04889209|468088236|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036329|NCT04889209|468088237|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130036330|NCT04889209|468088238|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036331|NCT04889209|468088239|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130036332|NCT04889209|468088240|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036333|NCT04889209|468088241|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036334|NCT04889209|468088242|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036335|NCT04889209|468088243|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036336|NCT04889209|468088244|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036337|NCT04889209|468088245|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036338|NCT04889209|468088246|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
130036339|NCT04889209|468088247|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
130036340|NCT04889209|468088230|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036341|NCT04889209|468088231|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036342|NCT04889209|468088232|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036343|NCT04889209|468088233|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
130036344|NCT04889209|468088234|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036345|NCT04889209|468088235|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036346|NCT04889209|468088236|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036347|NCT04889209|468088237|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036348|NCT04889209|468088238|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036349|NCT04889209|468088239|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036350|NCT04889209|468088240|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036351|NCT04889209|468088241|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036352|NCT04889209|468088242|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036353|NCT04889209|468088243|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036354|NCT04889209|468088244|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036355|NCT04889209|468088245|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036356|NCT04889209|468088246|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036357|NCT04889209|468088247|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
130036358|NCT04889209|468088230|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036359|NCT04889209|468088231|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036360|NCT04889209|468088232|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036361|NCT04889209|468088233|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036362|NCT04889209|468088234|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036363|NCT04889209|468088235|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036364|NCT04889209|468088236|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036365|NCT04889209|468088237|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036366|NCT04889209|468088238|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036367|NCT04889209|468088239|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036368|NCT04889209|468088240|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036369|NCT04889209|468088241|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036370|NCT04889209|468088242|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036371|NCT04889209|468088243|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036372|NCT04889209|468088244|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036373|NCT04889209|468088245|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036374|NCT04889209|468088246|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
130036375|NCT04889209|468088247|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
130036376|NCT04889209|468088230|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036377|NCT04889209|468088231|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130103006|NCT05013749|468334443|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
130268692|NCT00682929|468949678|FG002|Overall Study|lag in DEA renewal|0|||
130268693|NCT01462929|468949679|FG000|Overall Study|Adverse Event|3|||
130268694|NCT01462929|468949680|FG001|Overall Study|Adverse Event|3|||
130036378|NCT04889209|468088232|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036379|NCT04889209|468088233|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036380|NCT04889209|468088234|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036381|NCT04889209|468088235|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036382|NCT04889209|468088236|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036383|NCT04889209|468088237|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036384|NCT04889209|468088238|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036385|NCT04889209|468088239|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036386|NCT04889209|468088240|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036387|NCT04889209|468088241|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130103007|NCT05013749|468334444|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
130103008|NCT05013749|468334443|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
130036388|NCT04889209|468088242|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036389|NCT04889209|468088243|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036390|NCT04889209|468088244|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036391|NCT04889209|468088245|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130268695|NCT01462929|468949681|FG002|Overall Study|Adverse Event|4|||
130103009|NCT05013749|468334444|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
130103010|NCT02017535|468334447|FG000|Overall Study|Withdrawal by Subject|1|||
130103011|NCT02017535|468334448|FG001|Overall Study|Withdrawal by Subject|0|||
130103012|NCT02017535|468334449|FG002|Overall Study|Withdrawal by Subject|0|||
130103013|NCT02017535|468334450|FG003|Overall Study|Withdrawal by Subject|0|||
130103014|NCT00090259|468334451|FG000|Overall Study|Lost to Follow-up|30|||
130103015|NCT00090259|468334452|FG001|Overall Study|Lost to Follow-up|26|||
130103016|NCT00090259|468334451|FG000|Overall Study|Withdrawal by Subject|21|||
130103017|NCT00090259|468334452|FG001|Overall Study|Withdrawal by Subject|15|||
130103018|NCT00090259|468334451|FG000|Overall Study|Investigator site closed|11|||
130103019|NCT00090259|468334452|FG001|Overall Study|Investigator site closed|7|||
130103020|NCT04278872|468334457|FG000|Overall Study|Adverse Event|1|||
130103021|NCT04278872|468334458|FG001|Overall Study|Adverse Event|0|||
130103022|NCT04278872|468334457|FG000|Overall Study|Protocol Violation|0|||
130103023|NCT04278872|468334458|FG001|Overall Study|Protocol Violation|1|||
130103024|NCT04278872|468334457|FG000|Overall Study|Study Termination|2|||
130103025|NCT04278872|468334458|FG001|Overall Study|Study Termination|0|||
130103026|NCT00752895|468334459|FG000|Overall Study|Withdrawal by Subject|8|||
130103027|NCT00752895|468334460|FG001|Overall Study|Withdrawal by Subject|3|||
130103028|NCT00096031|468334461|FG000|Overall Study|Adverse Event|3|||
130103029|NCT00096031|468334461|FG000|Overall Study|Lack of Efficacy|42|||
130103030|NCT00096031|468334461|FG000|Overall Study|Death|4|||
130103031|NCT00096031|468334461|FG000|Overall Study|Withdrawal by Subject|1|||
130103032|NCT00096031|468334461|FG000|Overall Study|Ineligible|8|||
130103033|NCT00096031|468334461|FG000|Overall Study|Not protocol specified|5|||
130103034|NCT03353415|468334464|FG000|Masked CGM Wear|Lost to Follow-up|2|||
130103035|NCT03353415|468334464|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
130103036|NCT05257109|468334465|FG000|Overall Study|Withdrawal by Subject|1|||
130103037|NCT05257109|468334466|FG001|Overall Study|Withdrawal by Subject|0|||
130103038|NCT05257109|468334467|FG002|Overall Study|Withdrawal by Subject|0|||
130103039|NCT05257109|468334468|FG003|Overall Study|Withdrawal by Subject|0|||
130103040|NCT00359073|468336369|FG000|Overall Study|Withdrawal by Subject|1|||
130103041|NCT00359073|468336370|FG001|Overall Study|Withdrawal by Subject|1|||
130103042|NCT00359073|468336369|FG000|Overall Study|Eligibility criteria no longer met|3|||
130103043|NCT00359073|468336370|FG001|Overall Study|Eligibility criteria no longer met|0|||
130103044|NCT00359073|468336369|FG000|Overall Study|developed RV16 antibody|0|||
130103045|NCT00359073|468336370|FG001|Overall Study|developed RV16 antibody|1|||
129885824|NCT02291289|467542803|FG010|Induction Treatment|Reason Not Specified|0|||
129885825|NCT02291289|467542804|FG011|Induction Treatment|Reason Not Specified|0|||
129885826|NCT02291289|467542805|FG012|Induction Treatment|Reason Not Specified|0|||
129885827|NCT02291289|467542793|FG000|Induction Treatment|Physician Decision|0|||
129885828|NCT02291289|467542794|FG001|Induction Treatment|Physician Decision|0|||
129885829|NCT02291289|467542795|FG002|Induction Treatment|Physician Decision|0|||
129885830|NCT02291289|467542796|FG003|Induction Treatment|Physician Decision|3|||
129885831|NCT02291289|467542797|FG004|Induction Treatment|Physician Decision|0|||
129885832|NCT02291289|467542798|FG005|Induction Treatment|Physician Decision|0|||
129885833|NCT02291289|467542799|FG006|Induction Treatment|Physician Decision|0|||
129885834|NCT02291289|467542800|FG007|Induction Treatment|Physician Decision|0|||
129885835|NCT02291289|467542801|FG008|Induction Treatment|Physician Decision|0|||
129885836|NCT02291289|467542802|FG009|Induction Treatment|Physician Decision|1|||
129885837|NCT02291289|467542803|FG010|Induction Treatment|Physician Decision|0|||
129885838|NCT02291289|467542804|FG011|Induction Treatment|Physician Decision|0|||
129885839|NCT02291289|467542805|FG012|Induction Treatment|Physician Decision|0|||
130103046|NCT03387423|468336371|FG000|Overall Study|Lost to Follow-up|16|||
130103047|NCT03387423|468336372|FG001|Overall Study|Lost to Follow-up|12|||
130103048|NCT03387423|468336373|FG002|Overall Study|Lost to Follow-up|1|||
130103049|NCT03387423|468336374|FG003|Overall Study|Lost to Follow-up|0|||
130103050|NCT03387423|468336371|FG000|Overall Study|Other|0|||
130103051|NCT03387423|468336372|FG001|Overall Study|Other|3|||
130103052|NCT03387423|468336373|FG002|Overall Study|Other|0|||
129885840|NCT02291289|467542793|FG000|Induction Treatment|Protocol Violation|0|||
129885841|NCT02291289|467542794|FG001|Induction Treatment|Protocol Violation|0|||
129885842|NCT02291289|467542795|FG002|Induction Treatment|Protocol Violation|0|||
129885843|NCT02291289|467542796|FG003|Induction Treatment|Protocol Violation|3|||
130103053|NCT03387423|468336374|FG003|Overall Study|Other|0|||
130103054|NCT03387423|468336371|FG000|Overall Study|Administrative Reason|166|||
130036392|NCT04889209|468088246|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
130036393|NCT04889209|468088247|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
130036394|NCT04889209|468088230|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036395|NCT04889209|468088231|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036396|NCT04889209|468088232|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036397|NCT04889209|468088233|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036398|NCT04889209|468088234|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036399|NCT04889209|468088235|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036400|NCT04889209|468088236|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036401|NCT04889209|468088237|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036402|NCT04889209|468088238|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036403|NCT04889209|468088239|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130103055|NCT03387423|468336372|FG001|Overall Study|Administrative Reason|89|||
129885844|NCT02291289|467542797|FG004|Induction Treatment|Protocol Violation|0|||
130103056|NCT03387423|468336373|FG002|Overall Study|Administrative Reason|17|||
130103057|NCT03387423|468336374|FG003|Overall Study|Administrative Reason|19|||
130103058|NCT03387423|468336371|FG000|Overall Study|Revocation Consent|76|||
130103059|NCT03387423|468336372|FG001|Overall Study|Revocation Consent|32|||
130103060|NCT03387423|468336373|FG002|Overall Study|Revocation Consent|3|||
130103061|NCT03387423|468336374|FG003|Overall Study|Revocation Consent|5|||
130103062|NCT01371006|468336375|FG000|Overall Study|Adverse Event|1|||
130103063|NCT01371006|468336376|FG001|Overall Study|Adverse Event|0|||
130103064|NCT03993288|468336377|FG000|Overall Study|Lost to Follow-up|2|||
130103065|NCT03993288|468336378|FG001|Overall Study|Lost to Follow-up|1|||
130103066|NCT03993288|468336377|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
130103067|NCT03993288|468336378|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
130103068|NCT03993288|468336377|FG000|Overall Study|wrong randomization|0|||
130103069|NCT03993288|468336378|FG001|Overall Study|wrong randomization|1|||
130103070|NCT03993288|468336377|FG000|Overall Study|improper enrollment|0|||
130103071|NCT03993288|468336378|FG001|Overall Study|improper enrollment|1|||
130103072|NCT03993288|468336377|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
130103073|NCT03993288|468336378|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
130103074|NCT03993288|468336377|FG000|Overall Study|developed SAE|2|||
130103075|NCT03993288|468336378|FG001|Overall Study|developed SAE|0|||
130103076|NCT03993288|468336377|FG000|Overall Study|consent withdrawal|1|||
130103077|NCT03993288|468336378|FG001|Overall Study|consent withdrawal|0|||
130103078|NCT03993288|468336377|FG000|Overall Study|did not follow the treatment schedule|1|||
130103079|NCT03993288|468336378|FG001|Overall Study|did not follow the treatment schedule|0|||
130103080|NCT03993288|468336377|FG000|Overall Study|did not follow the treatment regimen|1|||
130103081|NCT03993288|468336378|FG001|Overall Study|did not follow the treatment regimen|0|||
130103082|NCT03993288|468336377|FG000|Overall Study|Adverse Event|1|||
130103083|NCT03993288|468336378|FG001|Overall Study|Adverse Event|0|||
130103084|NCT03993288|468336377|FG000|Overall Study|Withdrawal by Subject|1|||
130103085|NCT03993288|468336378|FG001|Overall Study|Withdrawal by Subject|1|||
129885845|NCT02291289|467542798|FG005|Induction Treatment|Protocol Violation|0|||
129885846|NCT02291289|467542799|FG006|Induction Treatment|Protocol Violation|0|||
129885847|NCT02291289|467542800|FG007|Induction Treatment|Protocol Violation|0|||
130103086|NCT00915473|468336380|FG000|Screening|Withdrawal by Subject|1|||
130103087|NCT00915473|468336381|FG001|Screening|Withdrawal by Subject|0|||
130103088|NCT00915473|468336380|FG000|4-week Follow Up|Lost to Follow-up|1|||
129885848|NCT02291289|467542801|FG008|Induction Treatment|Protocol Violation|0|||
129885849|NCT02291289|467542802|FG009|Induction Treatment|Protocol Violation|2|||
129885850|NCT02291289|467542803|FG010|Induction Treatment|Protocol Violation|0|||
130103089|NCT00915473|468336381|FG001|4-week Follow Up|Lost to Follow-up|5|||
130103090|NCT03515837|468336382|FG000|Overall Study|Death|219|||
130103091|NCT03515837|468336383|FG001|Overall Study|Death|227|||
130103092|NCT03515837|468336382|FG000|Overall Study|Lost to Follow-up|0|||
130103093|NCT03515837|468336383|FG001|Overall Study|Lost to Follow-up|1|||
130103094|NCT03515837|468336382|FG000|Overall Study|Withdrawal by Subject|0|||
130103095|NCT03515837|468336383|FG001|Overall Study|Withdrawal by Subject|4|||
130103096|NCT03515837|468336382|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
130103097|NCT03515837|468336383|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
130103098|NCT01964898|468336384|FG000|Overall Study|ineligible post-randomization|1|||
130103099|NCT01964898|468336385|FG001|Overall Study|ineligible post-randomization|1|||
130103100|NCT01964898|468336384|FG000|Overall Study|did not receive the allocated interventi|2|||
130103101|NCT01964898|468336385|FG001|Overall Study|did not receive the allocated interventi|1|||
130103102|NCT01964898|468336384|FG000|Overall Study|Lost to Follow-up|3|||
130036404|NCT04889209|468088240|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036405|NCT04889209|468088241|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130103103|NCT01964898|468336385|FG001|Overall Study|Lost to Follow-up|5|||
130103104|NCT01964898|468336384|FG000|Overall Study|Withdrawal by Subject|1|||
130103105|NCT01964898|468336385|FG001|Overall Study|Withdrawal by Subject|0|||
130036406|NCT04889209|468088242|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036407|NCT04889209|468088243|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036408|NCT04889209|468088244|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036409|NCT04889209|468088245|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036410|NCT04889209|468088246|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
130036411|NCT04889209|468088247|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
130036412|NCT04889209|468088230|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036413|NCT04889209|468088231|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036414|NCT04889209|468088232|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036415|NCT04889209|468088233|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036416|NCT04889209|468088234|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036417|NCT04889209|468088235|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036418|NCT04889209|468088236|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036419|NCT04889209|468088237|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036420|NCT04889209|468088238|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036421|NCT04889209|468088239|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036422|NCT04889209|468088240|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036423|NCT04889209|468088241|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036424|NCT04889209|468088242|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036425|NCT04889209|468088243|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036426|NCT04889209|468088244|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
130036427|NCT04889209|468088245|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036428|NCT04889209|468088246|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036429|NCT04889209|468088247|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
130036430|NCT01725165|468088248|FG000|Overall Study|Death|11|||
130103106|NCT02325401|468336388|FG000|Overall Study|Withdrawal by Subject|0|||
130103107|NCT02325401|468336389|FG001|Overall Study|Withdrawal by Subject|1|||
130103108|NCT02325401|468336390|FG002|Overall Study|Withdrawal by Subject|1|||
130103109|NCT03526679|468336391|FG000|Overall Study|still under treatment|2|||
130036431|NCT01725165|468088249|FG001|Overall Study|Death|18|||
130036432|NCT00474240|468088255|FG000|Overall Study|Withdrawal by Subject|1|||
130103110|NCT03443973|468336392|FG000|Double-blind Treatment Period|Adverse Event|5|||
130103111|NCT03443973|468336393|FG001|Double-blind Treatment Period|Adverse Event|19|||
130103112|NCT03443973|468336394|FG002|Double-blind Treatment Period|Adverse Event|0|||
130103113|NCT03443973|468336395|FG003|Double-blind Treatment Period|Adverse Event|0|||
130103114|NCT03443973|468336392|FG000|Double-blind Treatment Period|Death|5|||
130103115|NCT03443973|468336393|FG001|Double-blind Treatment Period|Death|7|||
130103116|NCT03443973|468336394|FG002|Double-blind Treatment Period|Death|0|||
130103117|NCT03443973|468336395|FG003|Double-blind Treatment Period|Death|0|||
130103118|NCT03443973|468336392|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
130103119|NCT03443973|468336393|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130103120|NCT03443973|468336394|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130103121|NCT03443973|468336395|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
130103122|NCT03443973|468336392|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130103123|NCT03443973|468336393|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130103124|NCT03443973|468336394|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130103125|NCT03443973|468336395|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130103126|NCT03443973|468336392|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
130103127|NCT03443973|468336393|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
130103128|NCT03443973|468336394|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
130103129|NCT03443973|468336395|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
130103130|NCT03443973|468336392|FG000|Double-blind Treatment Period|Physician Decision|5|||
130103131|NCT03443973|468336393|FG001|Double-blind Treatment Period|Physician Decision|6|||
130103132|NCT03443973|468336394|FG002|Double-blind Treatment Period|Physician Decision|0|||
130103133|NCT03443973|468336395|FG003|Double-blind Treatment Period|Physician Decision|0|||
130103134|NCT03443973|468336392|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
130103135|NCT03443973|468336393|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
130103136|NCT03443973|468336394|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
130103137|NCT03443973|468336395|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
130103138|NCT03443973|468336392|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
130103139|NCT03443973|468336393|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
130103140|NCT03443973|468336394|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130103141|NCT03443973|468336395|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
130103142|NCT03443973|468336392|FG000|Open-label Extension Period|Reason Not Specified|0|||
130103143|NCT03443973|468336393|FG001|Open-label Extension Period|Reason Not Specified|0|||
130103144|NCT03443973|468336394|FG002|Open-label Extension Period|Reason Not Specified|3|||
130103145|NCT03443973|468336395|FG003|Open-label Extension Period|Reason Not Specified|0|||
130103146|NCT03443973|468336392|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130103147|NCT03443973|468336393|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130103148|NCT03443973|468336394|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
130103149|NCT03443973|468336395|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
130103150|NCT01956123|468336396|FG000|COS Cycle 2|Protocol Violation|8|||
130103151|NCT01956123|468336397|FG001|COS Cycle 2|Protocol Violation|3|||
130103152|NCT01956123|468336398|FG002|COS Cycle 2|Protocol Violation|0|||
130103153|NCT01956123|468336399|FG003|COS Cycle 2|Protocol Violation|0|||
130103154|NCT01956123|468336396|FG000|COS Cycle 2|Adverse Event|3|||
130103155|NCT01956123|468336397|FG001|COS Cycle 2|Adverse Event|4|||
130103156|NCT01956123|468336398|FG002|COS Cycle 2|Adverse Event|0|||
130103157|NCT01956123|468336399|FG003|COS Cycle 2|Adverse Event|0|||
130103158|NCT01956123|468336396|FG000|COS Cycle 2|Personal Reasons|2|||
130103159|NCT01956123|468336397|FG001|COS Cycle 2|Personal Reasons|0|||
130103160|NCT01956123|468336398|FG002|COS Cycle 2|Personal Reasons|0|||
130103161|NCT01956123|468336399|FG003|COS Cycle 2|Personal Reasons|0|||
130103162|NCT01956123|468336396|FG000|COS Cycle 2|Withdrawal by Subject|1|||
130103163|NCT01956123|468336397|FG001|COS Cycle 2|Withdrawal by Subject|0|||
130103164|NCT01956123|468336398|FG002|COS Cycle 2|Withdrawal by Subject|0|||
130103165|NCT01956123|468336399|FG003|COS Cycle 2|Withdrawal by Subject|0|||
130103166|NCT01956123|468336396|FG000|COS Cycle 3|Protocol Violation|0|||
130103167|NCT01956123|468336397|FG001|COS Cycle 3|Protocol Violation|0|||
130103168|NCT01956123|468336398|FG002|COS Cycle 3|Protocol Violation|2|||
130103169|NCT01956123|468336399|FG003|COS Cycle 3|Protocol Violation|1|||
130103170|NCT01956123|468336396|FG000|COS Cycle 3|Adverse Event|0|||
130103171|NCT01956123|468336397|FG001|COS Cycle 3|Adverse Event|0|||
130103172|NCT01956123|468336398|FG002|COS Cycle 3|Adverse Event|3|||
130103173|NCT01956123|468336399|FG003|COS Cycle 3|Adverse Event|0|||
130103174|NCT01956123|468336396|FG000|COS Cycle 3|Personal Reasons|0|||
130103175|NCT01956123|468336397|FG001|COS Cycle 3|Personal Reasons|0|||
130103176|NCT01956123|468336398|FG002|COS Cycle 3|Personal Reasons|1|||
130103177|NCT01956123|468336399|FG003|COS Cycle 3|Personal Reasons|0|||
130103178|NCT01956123|468336396|FG000|COS Cycle 3|Withdrawal by Subject|0|||
130103179|NCT01956123|468336397|FG001|COS Cycle 3|Withdrawal by Subject|0|||
130103180|NCT01956123|468336398|FG002|COS Cycle 3|Withdrawal by Subject|0|||
130103181|NCT01956123|468336399|FG003|COS Cycle 3|Withdrawal by Subject|1|||
129885851|NCT02291289|467542804|FG011|Induction Treatment|Protocol Violation|0|||
129885852|NCT02291289|467542805|FG012|Induction Treatment|Protocol Violation|0|||
129885853|NCT02291289|467542793|FG000|Induction Treatment|Missing|4|||
129885854|NCT02291289|467542794|FG001|Induction Treatment|Missing|0|||
130103182|NCT02209454|468336403|FG000|Second Period|Adverse Event|1|||
130036433|NCT00474240|468088256|FG001|Overall Study|Withdrawal by Subject|1|||
130103183|NCT02209454|468336404|FG001|Second Period|Adverse Event|0|||
130103184|NCT01777191|468336407|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
130103185|NCT01777191|468336408|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
130103186|NCT01777191|468336407|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
130103187|NCT01777191|468336408|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
130103188|NCT01777191|468336407|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
130103189|NCT01777191|468336408|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
130103190|NCT01777191|468336407|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
130103191|NCT01777191|468336408|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
130103192|NCT01777191|468336407|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
130103193|NCT01777191|468336408|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
130103194|NCT01777191|468336407|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
130103195|NCT01777191|468336408|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
130103196|NCT01777191|468336407|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
130103197|NCT01777191|468336408|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
130103198|NCT01777191|468336407|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
130103199|NCT01777191|468336408|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
130103200|NCT01777191|468336407|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
130268696|NCT01462929|468949679|FG000|Overall Study|Withdrawal by Subject|2|||
130268697|NCT01462929|468949680|FG001|Overall Study|Withdrawal by Subject|1|||
130268698|NCT01462929|468949681|FG002|Overall Study|Withdrawal by Subject|0|||
130268699|NCT01462929|468949679|FG000|Overall Study|Lack of Efficacy|0|||
130268700|NCT01462929|468949680|FG001|Overall Study|Lack of Efficacy|0|||
130268701|NCT01462929|468949681|FG002|Overall Study|Lack of Efficacy|1|||
130268702|NCT00399568|468949682|FG000|Overall Study|Adverse Event|1|||
130268703|NCT00399568|468949683|FG001|Overall Study|Adverse Event|2|||
130268704|NCT00399568|468949682|FG000|Overall Study|Withdrawal by Subject|7|||
130268705|NCT00399568|468949683|FG001|Overall Study|Withdrawal by Subject|3|||
130268706|NCT00399568|468949682|FG000|Overall Study|Protocol non-compliance|2|||
130268707|NCT00399568|468949683|FG001|Overall Study|Protocol non-compliance|2|||
130268708|NCT00399568|468949682|FG000|Overall Study|Lost to Follow-up|2|||
130268709|NCT00399568|468949683|FG001|Overall Study|Lost to Follow-up|2|||
130268710|NCT00506779|468949685|FG000|Overall Study|Withdrawal by Subject|1|||
130268711|NCT00506779|468949686|FG001|Overall Study|Withdrawal by Subject|0|||
130268712|NCT00506779|468949687|FG002|Overall Study|Withdrawal by Subject|1|||
130268713|NCT00506779|468949688|FG003|Overall Study|Withdrawal by Subject|0|||
130268714|NCT00506779|468949685|FG000|Overall Study|Adverse Event|0|||
130268715|NCT00506779|468949686|FG001|Overall Study|Adverse Event|1|||
130268716|NCT00506779|468949687|FG002|Overall Study|Adverse Event|1|||
130268717|NCT00506779|468949688|FG003|Overall Study|Adverse Event|1|||
129885855|NCT02291289|467542795|FG002|Induction Treatment|Missing|0|||
129885856|NCT02291289|467542796|FG003|Induction Treatment|Missing|14|||
130036434|NCT00474240|468088257|FG002|Overall Study|Withdrawal by Subject|0|||
130036435|NCT00474240|468088258|FG003|Overall Study|Withdrawal by Subject|2|||
130036436|NCT00474240|468088259|FG004|Overall Study|Withdrawal by Subject|3|||
130036437|NCT00474240|468088260|FG005|Overall Study|Withdrawal by Subject|1|||
130036438|NCT00474240|468088255|FG000|Overall Study|Adverse Event|0|||
130036439|NCT00474240|468088256|FG001|Overall Study|Adverse Event|0|||
130036440|NCT00474240|468088257|FG002|Overall Study|Adverse Event|9|||
130036441|NCT00474240|468088258|FG003|Overall Study|Adverse Event|14|||
130036442|NCT00474240|468088259|FG004|Overall Study|Adverse Event|5|||
130036443|NCT00474240|468088260|FG005|Overall Study|Adverse Event|16|||
130036444|NCT00474240|468088255|FG000|Overall Study|Removed due to lab value|0|||
130036445|NCT00474240|468088256|FG001|Overall Study|Removed due to lab value|0|||
130036446|NCT00474240|468088257|FG002|Overall Study|Removed due to lab value|0|||
130036447|NCT00474240|468088258|FG003|Overall Study|Removed due to lab value|0|||
130268718|NCT02639247|468949691|FG000|Overall Study|Lost to Follow-up|2|||
130036448|NCT00474240|468088259|FG004|Overall Study|Removed due to lab value|0|||
130036449|NCT00474240|468088260|FG005|Overall Study|Removed due to lab value|1|||
130268719|NCT02639247|468949692|FG001|Overall Study|Lost to Follow-up|1|||
130268720|NCT02639247|468949691|FG000|Overall Study|Death|2|||
130268721|NCT02639247|468949692|FG001|Overall Study|Death|0|||
130268722|NCT02639247|468949691|FG000|Overall Study|Withdrew Consent|0|||
130268723|NCT02639247|468949692|FG001|Overall Study|Withdrew Consent|1|||
129885857|NCT02291289|467542797|FG004|Induction Treatment|Missing|0|||
129885858|NCT02291289|467542798|FG005|Induction Treatment|Missing|0|||
130036450|NCT00699192|468088261|FG000|Overall Study|Missing|1|||
130036451|NCT00699192|468088262|FG001|Overall Study|Missing|1|||
130036452|NCT00699192|468088263|FG002|Overall Study|Missing|1|||
130268724|NCT02639247|468949691|FG000|Overall Study|Protocol Violation|1|||
130036453|NCT00699192|468088261|FG000|Overall Study|Adverse Event|9|||
130036454|NCT00699192|468088262|FG001|Overall Study|Adverse Event|4|||
130036455|NCT00699192|468088263|FG002|Overall Study|Adverse Event|3|||
130036456|NCT00699192|468088261|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130268725|NCT02639247|468949692|FG001|Overall Study|Protocol Violation|0|||
130268726|NCT03462758|468949693|FG000|Overall Study|Chose no or other method of contraception|20|||
130268727|NCT03462758|468949694|FG001|Overall Study|Chose no or other method of contraception|23|||
130268728|NCT03462758|468949693|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
130268729|NCT03462758|468949694|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
130268730|NCT03462758|468949693|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
130268731|NCT03462758|468949694|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
130268732|NCT03462758|468949693|FG000|Overall Study|Medical contraindication|2|||
130036457|NCT00699192|468088262|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130036458|NCT00699192|468088263|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130036459|NCT00699192|468088261|FG000|Overall Study|Lack of Efficacy|0|||
130036460|NCT00699192|468088262|FG001|Overall Study|Lack of Efficacy|0|||
130036461|NCT00699192|468088263|FG002|Overall Study|Lack of Efficacy|1|||
130036462|NCT00699192|468088261|FG000|Overall Study|Withdrawal by Subject|3|||
130036463|NCT00699192|468088262|FG001|Overall Study|Withdrawal by Subject|2|||
130036464|NCT00699192|468088263|FG002|Overall Study|Withdrawal by Subject|4|||
130036465|NCT00699192|468088261|FG000|Overall Study|Administrative problems|1|||
130036466|NCT00699192|468088262|FG001|Overall Study|Administrative problems|3|||
130036467|NCT00699192|468088263|FG002|Overall Study|Administrative problems|1|||
130036468|NCT00699192|468088261|FG000|Overall Study|Protocol Violation|2|||
130036469|NCT00699192|468088262|FG001|Overall Study|Protocol Violation|2|||
130036470|NCT00699192|468088263|FG002|Overall Study|Protocol Violation|0|||
130036471|NCT01773473|468088264|FG000|Overall Study|Adverse Event|3|||
130036472|NCT01773473|468088265|FG001|Overall Study|Adverse Event|2|||
130036473|NCT01773473|468088264|FG000|Overall Study|Protocol Violation|0|||
130036474|NCT01773473|468088265|FG001|Overall Study|Protocol Violation|4|||
130036475|NCT01773473|468088264|FG000|Overall Study|Physician Decision|3|||
130036476|NCT01773473|468088265|FG001|Overall Study|Physician Decision|5|||
130036477|NCT01773473|468088264|FG000|Overall Study|Sponsor Decision|2|||
130036478|NCT01773473|468088265|FG001|Overall Study|Sponsor Decision|0|||
130036479|NCT01773473|468088264|FG000|Overall Study|Lack of Efficacy|0|||
130036480|NCT01773473|468088265|FG001|Overall Study|Lack of Efficacy|1|||
130036481|NCT01773473|468088264|FG000|Overall Study|Non-Compliance with study drug|1|||
130036482|NCT01773473|468088265|FG001|Overall Study|Non-Compliance with study drug|4|||
130036483|NCT01773473|468088264|FG000|Overall Study|Withdrawal by Subject|5|||
130036484|NCT01773473|468088265|FG001|Overall Study|Withdrawal by Subject|3|||
130036485|NCT01773473|468088264|FG000|Overall Study|Lost to Follow-up|2|||
130036486|NCT01773473|468088265|FG001|Overall Study|Lost to Follow-up|0|||
130036487|NCT01071070|468088269|FG000|Overall Study|Adverse Event|0|||
130036488|NCT01071070|468088270|FG001|Overall Study|Adverse Event|3|||
130036489|NCT01071070|468088269|FG000|Overall Study|Withdrawal by Subject|1|||
130036490|NCT01071070|468088270|FG001|Overall Study|Withdrawal by Subject|0|||
130036491|NCT01071070|468088269|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
130036492|NCT01071070|468088270|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
130036493|NCT01071070|468088269|FG000|Overall Study|Hypercalcemia|1|||
130036494|NCT01071070|468088270|FG001|Overall Study|Hypercalcemia|0|||
130036495|NCT02203149|468088271|FG000|Part 1|Adverse Event|0|||
130036496|NCT02203149|468088272|FG001|Part 1|Adverse Event|1|||
130036497|NCT02203149|468088273|FG002|Part 1|Adverse Event|0|||
130036498|NCT02203149|468088274|FG003|Part 1|Adverse Event|0|||
130036499|NCT02203149|468088275|FG004|Part 1|Adverse Event|0|||
130036500|NCT02203149|468088271|FG000|Part 2|Death|0|||
130036501|NCT02203149|468088272|FG001|Part 2|Death|0|||
130036502|NCT02203149|468088273|FG002|Part 2|Death|1|||
130036503|NCT02203149|468088274|FG003|Part 2|Death|1|||
130036504|NCT02203149|468088275|FG004|Part 2|Death|0|||
130036505|NCT02203149|468088271|FG000|Part 2|Withdrawal by Subject|0|||
130036506|NCT02203149|468088272|FG001|Part 2|Withdrawal by Subject|0|||
130036507|NCT02203149|468088273|FG002|Part 2|Withdrawal by Subject|0|||
130036508|NCT02203149|468088274|FG003|Part 2|Withdrawal by Subject|1|||
130036509|NCT02203149|468088275|FG004|Part 2|Withdrawal by Subject|0|||
130036510|NCT02203149|468088271|FG000|Part 2|Adverse Event|0|||
130036511|NCT02203149|468088272|FG001|Part 2|Adverse Event|0|||
130036512|NCT02203149|468088273|FG002|Part 2|Adverse Event|0|||
130036513|NCT02203149|468088274|FG003|Part 2|Adverse Event|1|||
130036514|NCT02203149|468088275|FG004|Part 2|Adverse Event|1|||
130036515|NCT01454076|468088276|FG000|Overall Study|Other|2|||
130036516|NCT01454076|468088277|FG001|Overall Study|Other|0|||
130036517|NCT01454076|468088278|FG002|Overall Study|Other|0|||
130036518|NCT01454076|468088279|FG003|Overall Study|Other|1|||
130036519|NCT01454076|468088280|FG004|Overall Study|Other|2|||
130036520|NCT01454076|468088276|FG000|Overall Study|Withdrawal by Subject|3|||
130036521|NCT01454076|468088277|FG001|Overall Study|Withdrawal by Subject|4|||
130036522|NCT01454076|468088278|FG002|Overall Study|Withdrawal by Subject|2|||
130036523|NCT01454076|468088279|FG003|Overall Study|Withdrawal by Subject|1|||
130036524|NCT01454076|468088280|FG004|Overall Study|Withdrawal by Subject|2|||
130036525|NCT01454076|468088276|FG000|Overall Study|Adverse Event|8|||
130036526|NCT01454076|468088277|FG001|Overall Study|Adverse Event|2|||
130036527|NCT01454076|468088278|FG002|Overall Study|Adverse Event|7|||
130036528|NCT01454076|468088279|FG003|Overall Study|Adverse Event|0|||
130036529|NCT01454076|468088280|FG004|Overall Study|Adverse Event|2|||
130036530|NCT01478958|468088281|FG000|Overall Study|Withdrawal by Subject|1|||
130036531|NCT01478958|468088282|FG001|Overall Study|Withdrawal by Subject|1|||
130036532|NCT01478958|468088283|FG002|Overall Study|Withdrawal by Subject|1|||
130036533|NCT01478958|468088281|FG000|Overall Study|Weight loss|1|||
130036534|NCT01478958|468088282|FG001|Overall Study|Weight loss|0|||
130036535|NCT01478958|468088283|FG002|Overall Study|Weight loss|0|||
130036536|NCT01478958|468088281|FG000|Overall Study|Re-located|0|||
130036537|NCT01478958|468088282|FG001|Overall Study|Re-located|1|||
130036538|NCT01478958|468088283|FG002|Overall Study|Re-located|0|||
130036539|NCT01478958|468088281|FG000|Overall Study|Unable to comply|0|||
130036540|NCT01478958|468088282|FG001|Overall Study|Unable to comply|0|||
130036541|NCT01478958|468088283|FG002|Overall Study|Unable to comply|2|||
130036542|NCT01193686|468088284|FG000|Overall Study|Withdrawal by Subject|4|||
130036543|NCT01193686|468088285|FG001|Overall Study|Withdrawal by Subject|1|||
129885859|NCT02291289|467542799|FG006|Induction Treatment|Missing|0|||
130036544|NCT01193686|468088284|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
130103201|NCT01777191|468336408|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
130103202|NCT01777191|468336407|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
130103203|NCT01777191|468336408|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
130103204|NCT01777191|468336407|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
130103205|NCT01777191|468336408|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
130103206|NCT00468312|468336413|FG000|Overall Study|Adverse Event|2|||
130103207|NCT00468312|468336414|FG001|Overall Study|Adverse Event|1|||
130103208|NCT00468312|468336413|FG000|Overall Study|Lack of Efficacy|0|||
130103209|NCT00468312|468336414|FG001|Overall Study|Lack of Efficacy|1|||
130103210|NCT00468312|468336413|FG000|Overall Study|Withdrawal by Subject|0|||
130103211|NCT00468312|468336414|FG001|Overall Study|Withdrawal by Subject|1|||
130103212|NCT00468312|468336413|FG000|Overall Study|Protocol Violation|2|||
130103213|NCT00468312|468336414|FG001|Overall Study|Protocol Violation|1|||
130103214|NCT00468312|468336413|FG000|Overall Study|Did not meet protocol eligibility|0|||
130103215|NCT00468312|468336414|FG001|Overall Study|Did not meet protocol eligibility|1|||
130103216|NCT01052038|468336415|FG000|Overall Study|Lost to Follow-up|2|||
130103217|NCT01052038|468336416|FG001|Overall Study|Lost to Follow-up|3|||
130103218|NCT01052038|468336417|FG002|Overall Study|Lost to Follow-up|1|||
130103219|NCT01052038|468336415|FG000|Overall Study|Protocol Violation|2|||
130103220|NCT01052038|468336416|FG001|Overall Study|Protocol Violation|3|||
130103221|NCT01052038|468336417|FG002|Overall Study|Protocol Violation|3|||
130103222|NCT02962739|468336418|FG000|Overall Study|Withdrawal by Subject|0|||
130103223|NCT02962739|468336419|FG001|Overall Study|Withdrawal by Subject|1|||
130103224|NCT02962739|468336420|FG002|Overall Study|Withdrawal by Subject|0|||
130103225|NCT02962739|468336421|FG003|Overall Study|Withdrawal by Subject|0|||
130103226|NCT02962739|468336422|FG004|Overall Study|Withdrawal by Subject|0|||
130103227|NCT02962739|468336423|FG005|Overall Study|Withdrawal by Subject|0|||
130103228|NCT02962739|468336418|FG000|Overall Study|Protocol Violation|0|||
130103229|NCT02962739|468336419|FG001|Overall Study|Protocol Violation|0|||
130103230|NCT02962739|468336420|FG002|Overall Study|Protocol Violation|1|||
130103231|NCT02962739|468336421|FG003|Overall Study|Protocol Violation|0|||
130103232|NCT02962739|468336422|FG004|Overall Study|Protocol Violation|1|||
130103233|NCT02962739|468336423|FG005|Overall Study|Protocol Violation|0|||
130103234|NCT00734617|468336424|FG000|Overall Study|Adverse Event|4|||
130103235|NCT00734617|468336425|FG001|Overall Study|Adverse Event|7|||
130103236|NCT00734617|468336424|FG000|Overall Study|Withdrawal by Subject|103|||
130103237|NCT00734617|468336425|FG001|Overall Study|Withdrawal by Subject|95|||
130103238|NCT02406742|468336428|FG000|Overall Study|Progression of Disease|5|||
130103239|NCT02406742|468336429|FG001|Overall Study|Progression of Disease|1|||
130103240|NCT02406742|468336430|FG002|Overall Study|Progression of Disease|6|||
130103241|NCT02406742|468336428|FG000|Overall Study|Adverse Event|3|||
130103242|NCT02406742|468336429|FG001|Overall Study|Adverse Event|0|||
130103243|NCT02406742|468336430|FG002|Overall Study|Adverse Event|2|||
130103244|NCT02406742|468336428|FG000|Overall Study|Death|1|||
130103245|NCT02406742|468336429|FG001|Overall Study|Death|0|||
130103246|NCT02406742|468336430|FG002|Overall Study|Death|0|||
130103247|NCT02406742|468336428|FG000|Overall Study|Lack of Efficacy|0|||
130103248|NCT02406742|468336429|FG001|Overall Study|Lack of Efficacy|0|||
130103249|NCT02406742|468336430|FG002|Overall Study|Lack of Efficacy|1|||
130103250|NCT02406742|468336428|FG000|Overall Study|Withdrawal by Participant|1|||
130103251|NCT02406742|468336429|FG001|Overall Study|Withdrawal by Participant|2|||
130103252|NCT02406742|468336430|FG002|Overall Study|Withdrawal by Participant|0|||
130103253|NCT02406742|468336428|FG000|Overall Study|Physician Decision|1|||
130103254|NCT02406742|468336429|FG001|Overall Study|Physician Decision|2|||
130103255|NCT02406742|468336430|FG002|Overall Study|Physician Decision|1|||
130103256|NCT02406742|468336428|FG000|Overall Study|Transition to other treatment|2|||
130103257|NCT02406742|468336429|FG001|Overall Study|Transition to other treatment|0|||
130103258|NCT02406742|468336430|FG002|Overall Study|Transition to other treatment|1|||
130103259|NCT02406742|468336428|FG000|Overall Study|Other Reasons|1|||
130103260|NCT02406742|468336429|FG001|Overall Study|Other Reasons|11|||
130103261|NCT02406742|468336430|FG002|Overall Study|Other Reasons|5|||
130103262|NCT02367729|468336432|FG000|Overall Study|Organic disorder diagnosed|2|||
130103263|NCT02367729|468336433|FG001|Overall Study|Organic disorder diagnosed|1|||
130103264|NCT02367729|468336432|FG000|Overall Study|Adverse Event|1|||
130103265|NCT02367729|468336433|FG001|Overall Study|Adverse Event|2|||
130103266|NCT02367729|468336432|FG000|Overall Study|Withdrawal by Subject|0|||
130103267|NCT02367729|468336433|FG001|Overall Study|Withdrawal by Subject|5|||
130103268|NCT00759174|468336438|FG000|Overall Study|Other|0|||
130103269|NCT00759174|468336439|FG001|Overall Study|Other|2|||
130103270|NCT01890109|468336440|FG000|Overall Study|Withdrawal by Subject|0|||
130103271|NCT01890109|468336441|FG001|Overall Study|Withdrawal by Subject|3|||
130103272|NCT01890109|468336440|FG000|Overall Study|Lost to Follow-up|1|||
130103273|NCT01890109|468336441|FG001|Overall Study|Lost to Follow-up|2|||
130103274|NCT01643928|468336444|FG000|Overall Study|Lost to Follow-up|1|||
130103275|NCT01643928|468336445|FG001|Overall Study|Lost to Follow-up|0|||
130103276|NCT01643928|468336446|FG002|Overall Study|Lost to Follow-up|2|||
130103277|NCT01643928|468336447|FG003|Overall Study|Lost to Follow-up|0|||
130103278|NCT01643928|468336448|FG004|Overall Study|Lost to Follow-up|0|||
130103279|NCT01643928|468336444|FG000|Overall Study|Withdrawal by Subject|2|||
130103280|NCT01643928|468336445|FG001|Overall Study|Withdrawal by Subject|0|||
130103281|NCT01643928|468336446|FG002|Overall Study|Withdrawal by Subject|0|||
130103282|NCT01643928|468336447|FG003|Overall Study|Withdrawal by Subject|1|||
130103283|NCT01643928|468336448|FG004|Overall Study|Withdrawal by Subject|0|||
130103284|NCT01643928|468336444|FG000|Overall Study|Pregnancy|0|||
130103285|NCT01643928|468336445|FG001|Overall Study|Pregnancy|0|||
130103286|NCT01643928|468336446|FG002|Overall Study|Pregnancy|0|||
130103287|NCT01643928|468336447|FG003|Overall Study|Pregnancy|1|||
130103288|NCT01643928|468336448|FG004|Overall Study|Pregnancy|0|||
130103289|NCT01643928|468336444|FG000|Overall Study|Other|5|||
130103290|NCT01643928|468336445|FG001|Overall Study|Other|1|||
130103291|NCT01643928|468336446|FG002|Overall Study|Other|1|||
130103292|NCT01643928|468336447|FG003|Overall Study|Other|0|||
130103293|NCT01643928|468336448|FG004|Overall Study|Other|0|||
130103294|NCT01643928|468336444|FG000|Overall Study|Adverse Event|2|||
130103295|NCT01643928|468336445|FG001|Overall Study|Adverse Event|1|||
130103296|NCT01643928|468336446|FG002|Overall Study|Adverse Event|0|||
130103297|NCT01643928|468336447|FG003|Overall Study|Adverse Event|1|||
130103298|NCT01643928|468336448|FG004|Overall Study|Adverse Event|2|||
130103299|NCT03576131|468336449|FG000|Overall Study|Investigator decision|0|||
130103300|NCT03576131|468336450|FG001|Overall Study|Investigator decision|0|||
130103301|NCT03576131|468336451|FG002|Overall Study|Investigator decision|0|||
130103302|NCT03576131|468336452|FG003|Overall Study|Investigator decision|1|||
130103303|NCT03576131|468336453|FG004|Overall Study|Investigator decision|0|||
130103304|NCT03576131|468336454|FG005|Overall Study|Investigator decision|1|||
130103305|NCT03576131|468336455|FG006|Overall Study|Investigator decision|0|||
130103306|NCT03576131|468336456|FG007|Overall Study|Investigator decision|0|||
130103307|NCT03576131|468336449|FG000|Overall Study|Withdrawal by Subject|1|||
130103308|NCT03576131|468336450|FG001|Overall Study|Withdrawal by Subject|1|||
130103309|NCT03576131|468336451|FG002|Overall Study|Withdrawal by Subject|0|||
130103310|NCT03576131|468336452|FG003|Overall Study|Withdrawal by Subject|1|||
130103311|NCT03576131|468336453|FG004|Overall Study|Withdrawal by Subject|2|||
130103312|NCT03576131|468336454|FG005|Overall Study|Withdrawal by Subject|3|||
130103313|NCT03576131|468336455|FG006|Overall Study|Withdrawal by Subject|1|||
130103314|NCT03576131|468336456|FG007|Overall Study|Withdrawal by Subject|0|||
130103315|NCT03576131|468336449|FG000|Overall Study|Death|3|||
130103316|NCT03576131|468336450|FG001|Overall Study|Death|3|||
130103317|NCT03576131|468336451|FG002|Overall Study|Death|1|||
130103318|NCT03576131|468336452|FG003|Overall Study|Death|5|||
130103319|NCT03576131|468336453|FG004|Overall Study|Death|4|||
130103320|NCT03576131|468336454|FG005|Overall Study|Death|1|||
130103321|NCT03576131|468336455|FG006|Overall Study|Death|0|||
130103322|NCT03576131|468336456|FG007|Overall Study|Death|1|||
130103323|NCT03576131|468336449|FG000|Overall Study|New anti-cancer treatment|5|||
130103324|NCT03576131|468336450|FG001|Overall Study|New anti-cancer treatment|1|||
130103325|NCT03576131|468336451|FG002|Overall Study|New anti-cancer treatment|2|||
130103326|NCT03576131|468336452|FG003|Overall Study|New anti-cancer treatment|3|||
130103327|NCT03576131|468336453|FG004|Overall Study|New anti-cancer treatment|0|||
130103328|NCT03576131|468336454|FG005|Overall Study|New anti-cancer treatment|0|||
130103329|NCT03576131|468336455|FG006|Overall Study|New anti-cancer treatment|0|||
130103330|NCT03576131|468336456|FG007|Overall Study|New anti-cancer treatment|0|||
130103331|NCT03576131|468336449|FG000|Overall Study|Unspecified reason|0|||
130103332|NCT03576131|468336450|FG001|Overall Study|Unspecified reason|0|||
130103333|NCT03576131|468336451|FG002|Overall Study|Unspecified reason|1|||
130103334|NCT03576131|468336452|FG003|Overall Study|Unspecified reason|1|||
130103335|NCT03576131|468336453|FG004|Overall Study|Unspecified reason|1|||
130103336|NCT03576131|468336454|FG005|Overall Study|Unspecified reason|1|||
130103337|NCT03576131|468336455|FG006|Overall Study|Unspecified reason|0|||
130268733|NCT03462758|468949694|FG001|Overall Study|Medical contraindication|2|||
130268734|NCT03462758|468949693|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
130103338|NCT03576131|468336456|FG007|Overall Study|Unspecified reason|0|||
130103339|NCT03576131|468336449|FG000|Overall Study|Subject non-compliance|0|||
130103340|NCT03576131|468336450|FG001|Overall Study|Subject non-compliance|0|||
130103341|NCT03576131|468336451|FG002|Overall Study|Subject non-compliance|0|||
130103342|NCT03576131|468336452|FG003|Overall Study|Subject non-compliance|0|||
130103343|NCT03576131|468336453|FG004|Overall Study|Subject non-compliance|0|||
130103344|NCT03576131|468336454|FG005|Overall Study|Subject non-compliance|1|||
130103345|NCT03576131|468336455|FG006|Overall Study|Subject non-compliance|0|||
130268735|NCT03462758|468949694|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
130268736|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
130268737|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
130268738|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268739|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268740|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268741|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
130268742|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
130268743|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
130268744|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268745|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268746|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268747|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
130268748|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268749|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
130268750|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268751|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268752|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268753|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
130268754|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
130103346|NCT03576131|468336456|FG007|Overall Study|Subject non-compliance|0|||
130103347|NCT03069365|468336465|FG000|Overall Study|Adverse Event|1|||
130103348|NCT02886494|468336466|FG000|Overall Study|Adverse Event|1|||
130103349|NCT02886494|468336467|FG001|Overall Study|Adverse Event|0|||
130036545|NCT01193686|468088285|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
130036546|NCT03401749|468088286|FG000|Overall Study|Lost to Follow-up|20|||
130036547|NCT03401749|468088287|FG001|Overall Study|Lost to Follow-up|16|||
130036548|NCT03401749|468088288|FG002|Overall Study|Lost to Follow-up|26|||
130036549|NCT03075839|468088289|FG000|Overall Study|Lost to Follow-up|4|||
130036550|NCT00707577|468088290|FG000|Overall Study|Withdrawal by Subject|3|||
130036551|NCT00707577|468088291|FG001|Overall Study|Withdrawal by Subject|2|||
130036552|NCT00707577|468088290|FG000|Overall Study|Lost to Follow-up|34|||
130036553|NCT00707577|468088291|FG001|Overall Study|Lost to Follow-up|25|||
130036554|NCT00707577|468088290|FG000|Overall Study|Left employment|13|||
130036555|NCT00707577|468088291|FG001|Overall Study|Left employment|10|||
130036556|NCT00707577|468088290|FG000|Overall Study|Pregnancy|4|||
130036557|NCT00707577|468088291|FG001|Overall Study|Pregnancy|1|||
130036558|NCT03853694|468088292|FG000|Overall Study|Protocol Violation|3|||
130036559|NCT03853694|468088293|FG001|Overall Study|Protocol Violation|5|||
130036560|NCT03853694|468088294|FG002|Overall Study|Protocol Violation|3|||
130036561|NCT03853694|468088292|FG000|Overall Study|Delivered early|0|||
130036562|NCT03853694|468088293|FG001|Overall Study|Delivered early|1|||
130036563|NCT03853694|468088294|FG002|Overall Study|Delivered early|0|||
130036564|NCT03853694|468088292|FG000|Overall Study|not suitable to proceed|0|||
130036565|NCT03853694|468088293|FG001|Overall Study|not suitable to proceed|1|||
130036566|NCT03853694|468088294|FG002|Overall Study|not suitable to proceed|0|||
130036567|NCT03853694|468088292|FG000|Overall Study|difficult surgery|0|||
130036568|NCT03853694|468088293|FG001|Overall Study|difficult surgery|0|||
130036569|NCT03853694|468088294|FG002|Overall Study|difficult surgery|1|||
130036570|NCT03853694|468088292|FG000|Overall Study|Lost to Follow-up|0|||
130036571|NCT03853694|468088293|FG001|Overall Study|Lost to Follow-up|1|||
130036572|NCT03853694|468088294|FG002|Overall Study|Lost to Follow-up|0|||
130036573|NCT03853694|468088292|FG000|Overall Study|Withdrawal by Subject|0|||
130036574|NCT03853694|468088293|FG001|Overall Study|Withdrawal by Subject|1|||
130036575|NCT03853694|468088294|FG002|Overall Study|Withdrawal by Subject|0|||
130036576|NCT05089708|468088295|FG000|Overall Study|Lost to Follow-up|9|||
130036577|NCT05089708|468088296|FG001|Overall Study|Lost to Follow-up|7|||
130036578|NCT05089708|468088295|FG000|Overall Study|Withdrawal by Subject|3|||
130036579|NCT05089708|468088296|FG001|Overall Study|Withdrawal by Subject|1|||
130036580|NCT05089708|468088295|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
130036581|NCT05089708|468088296|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
130036582|NCT05089708|468088295|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
130036583|NCT05089708|468088296|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
130036584|NCT00064701|468088298|FG000|One Year Post-transplant|Did not receive study drug|7|||
130036585|NCT00064701|468088299|FG001|One Year Post-transplant|Did not receive study drug|12|||
130036586|NCT00064701|468088300|FG002|One Year Post-transplant|Did not receive study drug|11|||
130036587|NCT00064701|468088298|FG000|One Year Post-transplant|Adverse Event|23|||
130036588|NCT00064701|468088299|FG001|One Year Post-transplant|Adverse Event|19|||
130036589|NCT00064701|468088300|FG002|One Year Post-transplant|Adverse Event|37|||
130036590|NCT00064701|468088298|FG000|One Year Post-transplant|Rejection|0|||
130036591|NCT00064701|468088299|FG001|One Year Post-transplant|Rejection|1|||
130036592|NCT00064701|468088300|FG002|One Year Post-transplant|Rejection|16|||
130036593|NCT00064701|468088298|FG000|One Year Post-transplant|Non-compliance|4|||
130036594|NCT00064701|468088299|FG001|One Year Post-transplant|Non-compliance|2|||
130036595|NCT00064701|468088300|FG002|One Year Post-transplant|Non-compliance|5|||
130036596|NCT00064701|468088298|FG000|One Year Post-transplant|Graft Failure|3|||
130036597|NCT00064701|468088299|FG001|One Year Post-transplant|Graft Failure|2|||
130036598|NCT00064701|468088300|FG002|One Year Post-transplant|Graft Failure|1|||
130036599|NCT00064701|468088298|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
130036600|NCT00064701|468088299|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
130036601|NCT00064701|468088300|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
130036602|NCT00064701|468088298|FG000|One Year Post-transplant|Lost to Follow-up|1|||
130036603|NCT00064701|468088299|FG001|One Year Post-transplant|Lost to Follow-up|0|||
130036604|NCT00064701|468088300|FG002|One Year Post-transplant|Lost to Follow-up|0|||
130036605|NCT00064701|468088298|FG000|One Year Post-transplant|Converted to rapamycin|1|||
130036606|NCT00064701|468088299|FG001|One Year Post-transplant|Converted to rapamycin|0|||
130103350|NCT02886494|468336466|FG000|Overall Study|Withdrawal by Subject|12|||
129885860|NCT02291289|467542800|FG007|Induction Treatment|Missing|0|||
130036607|NCT00064701|468088300|FG002|One Year Post-transplant|Converted to rapamycin|0|||
130036608|NCT00064701|468088298|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
130036609|NCT00064701|468088299|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
130036610|NCT00064701|468088300|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
130036611|NCT00064701|468088298|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
130036612|NCT00064701|468088299|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
130036613|NCT00064701|468088300|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
130103351|NCT02886494|468336467|FG001|Overall Study|Withdrawal by Subject|3|||
130103352|NCT02886494|468336466|FG000|Overall Study|Protocol Violation|4|||
130103353|NCT02886494|468336467|FG001|Overall Study|Protocol Violation|1|||
130103354|NCT02780115|468336468|FG000|Overall Study|Withdrawal by Subject|0|||
130103355|NCT02780115|468336469|FG001|Overall Study|Withdrawal by Subject|1|||
130103356|NCT02780115|468336470|FG002|Overall Study|Withdrawal by Subject|1|||
130103357|NCT02780115|468336471|FG003|Overall Study|Withdrawal by Subject|0|||
130103358|NCT02780115|468336472|FG004|Overall Study|Withdrawal by Subject|0|||
130103359|NCT02780115|468336468|FG000|Overall Study|Adverse Event|0|||
130103360|NCT02780115|468336469|FG001|Overall Study|Adverse Event|0|||
130103361|NCT02780115|468336470|FG002|Overall Study|Adverse Event|0|||
130103362|NCT02780115|468336471|FG003|Overall Study|Adverse Event|1|||
130103363|NCT02780115|468336472|FG004|Overall Study|Adverse Event|1|||
130103364|NCT01179191|468336473|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
130103365|NCT01179191|468336473|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
130103366|NCT01179191|468336473|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
130103367|NCT01179191|468336473|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
130103368|NCT01179191|468336473|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
130103369|NCT01179191|468336473|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
130103370|NCT01179191|468336473|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
130036614|NCT00064701|468088298|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
130036615|NCT00064701|468088299|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
130036616|NCT00064701|468088300|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
130103371|NCT01179191|468336473|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
130103372|NCT01179191|468336473|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
130103373|NCT01179191|468336473|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
130036617|NCT00064701|468088298|FG000|One Year Post-transplant|Poor absorption|0|||
130036618|NCT00064701|468088299|FG001|One Year Post-transplant|Poor absorption|1|||
130036619|NCT00064701|468088300|FG002|One Year Post-transplant|Poor absorption|0|||
130036620|NCT00064701|468088298|FG000|One Year Post-transplant|Pancreas transplant|0|||
130036621|NCT00064701|468088299|FG001|One Year Post-transplant|Pancreas transplant|0|||
130036622|NCT00064701|468088300|FG002|One Year Post-transplant|Pancreas transplant|1|||
130036623|NCT00064701|468088298|FG000|Clinical Continuation Phase|Adverse Event|12|||
130036624|NCT00064701|468088299|FG001|Clinical Continuation Phase|Adverse Event|21|||
130036625|NCT00064701|468088300|FG002|Clinical Continuation Phase|Adverse Event|14|||
130036626|NCT00064701|468088298|FG000|Clinical Continuation Phase|Non-compliance|8|||
130036627|NCT00064701|468088299|FG001|Clinical Continuation Phase|Non-compliance|6|||
130036628|NCT00064701|468088300|FG002|Clinical Continuation Phase|Non-compliance|7|||
130036629|NCT00064701|468088298|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
130036630|NCT00064701|468088299|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
130036631|NCT00064701|468088300|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
130036632|NCT00064701|468088298|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
130036633|NCT00064701|468088299|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
130036634|NCT00064701|468088300|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
130036635|NCT00064701|468088298|FG000|Clinical Continuation Phase|Graft Failure|5|||
130036636|NCT00064701|468088299|FG001|Clinical Continuation Phase|Graft Failure|5|||
130036637|NCT00064701|468088300|FG002|Clinical Continuation Phase|Graft Failure|2|||
130036638|NCT00064701|468088298|FG000|Clinical Continuation Phase|Rejection|1|||
130036639|NCT00064701|468088299|FG001|Clinical Continuation Phase|Rejection|2|||
130036640|NCT00064701|468088300|FG002|Clinical Continuation Phase|Rejection|2|||
130036641|NCT00064701|468088298|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
130036642|NCT00064701|468088299|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
130036643|NCT00064701|468088300|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
130036644|NCT00064701|468088298|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
130036645|NCT00064701|468088299|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
130036646|NCT00064701|468088300|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
130103374|NCT01179191|468336473|FG000|Maintenance Phase (8 Weeks)|Other|66|||
130103375|NCT02742818|468336477|FG000|Overall Study|Adverse Event|0|||
130103376|NCT02742818|468336478|FG001|Overall Study|Adverse Event|1|||
130103377|NCT02742818|468336477|FG000|Overall Study|Protocol Violation|0|||
130036647|NCT00064701|468088298|FG000|Clinical Continuation Phase|Physician Decision|1|||
130268755|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
130268756|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268757|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268758|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268759|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
130268760|NCT02820844|468949695|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
130268761|NCT02820844|468949696|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268762|NCT02820844|468949697|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268763|NCT02820844|468949698|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268764|NCT02820844|468949699|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268765|NCT02820844|468949700|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
130268766|NCT02820844|468949695|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268767|NCT02820844|468949696|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268768|NCT02820844|468949697|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
130268769|NCT02820844|468949698|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
130268770|NCT02820844|468949699|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130268771|NCT02820844|468949700|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
130103378|NCT02742818|468336478|FG001|Overall Study|Protocol Violation|1|||
130103379|NCT01393626|468336490|FG000|Overall Study|Adverse Event|2|||
130268772|NCT02820844|468949695|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268773|NCT02820844|468949696|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130103380|NCT01393626|468336491|FG001|Overall Study|Adverse Event|1|||
130103381|NCT01393626|468336492|FG002|Overall Study|Adverse Event|5|||
130103382|NCT01393626|468336493|FG003|Overall Study|Adverse Event|0|||
130103383|NCT01393626|468336490|FG000|Overall Study|Did not meet entrance criteria|1|||
130103384|NCT01393626|468336491|FG001|Overall Study|Did not meet entrance criteria|0|||
130103385|NCT01393626|468336492|FG002|Overall Study|Did not meet entrance criteria|0|||
130103386|NCT01393626|468336493|FG003|Overall Study|Did not meet entrance criteria|0|||
130103387|NCT01393626|468336490|FG000|Overall Study|Lack of Efficacy|6|||
130103388|NCT01393626|468336491|FG001|Overall Study|Lack of Efficacy|6|||
130103389|NCT01393626|468336492|FG002|Overall Study|Lack of Efficacy|4|||
130103390|NCT01393626|468336493|FG003|Overall Study|Lack of Efficacy|1|||
130103391|NCT01393626|468336490|FG000|Overall Study|Lost to Follow-up|1|||
130103392|NCT01393626|468336491|FG001|Overall Study|Lost to Follow-up|1|||
130103393|NCT01393626|468336492|FG002|Overall Study|Lost to Follow-up|1|||
130103394|NCT01393626|468336493|FG003|Overall Study|Lost to Follow-up|0|||
130103395|NCT01393626|468336490|FG000|Overall Study|Withdrawal by Subject|6|||
130103396|NCT01393626|468336491|FG001|Overall Study|Withdrawal by Subject|4|||
130103397|NCT01393626|468336492|FG002|Overall Study|Withdrawal by Subject|0|||
130103398|NCT01393626|468336493|FG003|Overall Study|Withdrawal by Subject|0|||
130103399|NCT01393626|468336490|FG000|Overall Study|Other|1|||
130103400|NCT01393626|468336491|FG001|Overall Study|Other|0|||
130103401|NCT01393626|468336492|FG002|Overall Study|Other|0|||
130103402|NCT01393626|468336493|FG003|Overall Study|Other|0|||
130103403|NCT01393626|468336490|FG000|Overall Study|Protocol Violation|1|||
130103404|NCT01393626|468336491|FG001|Overall Study|Protocol Violation|0|||
130103405|NCT01393626|468336492|FG002|Overall Study|Protocol Violation|2|||
130103406|NCT01393626|468336493|FG003|Overall Study|Protocol Violation|0|||
130103407|NCT02426125|468336494|FG000|Overall Study|Lost to Follow-up|14|||
130103408|NCT02426125|468336495|FG001|Overall Study|Lost to Follow-up|12|||
130103409|NCT02426125|468336494|FG000|Overall Study|Withdrawal by Subject|13|||
130103410|NCT02426125|468336495|FG001|Overall Study|Withdrawal by Subject|14|||
130103411|NCT02426125|468336494|FG000|Overall Study|Death|185|||
130103412|NCT02426125|468336495|FG001|Overall Study|Death|200|||
130103413|NCT02426125|468336494|FG000|Overall Study|Randomized, But Never Treated|5|||
130103414|NCT02426125|468336495|FG001|Overall Study|Randomized, But Never Treated|2|||
130103415|NCT02858076|468336496|FG000|Overall Study|Death|6|||
130103416|NCT02858076|468336497|FG001|Overall Study|Death|3|||
130103417|NCT02858076|468336496|FG000|Overall Study|Withdrawal by Subject|1|||
130103418|NCT02858076|468336497|FG001|Overall Study|Withdrawal by Subject|5|||
130103419|NCT02858076|468336496|FG000|Overall Study|Lost to Follow-up|2|||
130103420|NCT02858076|468336497|FG001|Overall Study|Lost to Follow-up|7|||
130103421|NCT02858076|468336496|FG000|Overall Study|Completed Out of Window|1|||
130103422|NCT02858076|468336497|FG001|Overall Study|Completed Out of Window|3|||
130103423|NCT03506425|468336498|FG000|Overall Study|Adverse Event|1|||
130103424|NCT03506425|468336499|FG001|Overall Study|Adverse Event|3|||
130103425|NCT03506425|468336500|FG002|Overall Study|Adverse Event|0|||
130103426|NCT03506425|468336498|FG000|Overall Study|Death|1|||
130103427|NCT03506425|468336499|FG001|Overall Study|Death|0|||
130103428|NCT03506425|468336500|FG002|Overall Study|Death|0|||
130268774|NCT02820844|468949697|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
130268775|NCT02820844|468949698|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268776|NCT02820844|468949699|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268777|NCT02820844|468949700|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
130268778|NCT02820844|468949695|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268779|NCT02820844|468949696|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268780|NCT02820844|468949697|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
130268781|NCT02820844|468949698|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
130268782|NCT02820844|468949699|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268783|NCT02820844|468949700|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268784|NCT02820844|468949695|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268785|NCT02820844|468949696|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268786|NCT02820844|468949697|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268787|NCT02820844|468949698|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130036648|NCT00064701|468088299|FG001|Clinical Continuation Phase|Physician Decision|3|||
130036649|NCT00064701|468088300|FG002|Clinical Continuation Phase|Physician Decision|0|||
130036650|NCT00064701|468088298|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
130036651|NCT00064701|468088299|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
130036652|NCT00064701|468088300|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
130036653|NCT00064701|468088298|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
130036654|NCT00064701|468088299|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
130036655|NCT00064701|468088300|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
130036656|NCT00064701|468088298|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
130036657|NCT00064701|468088299|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
130036658|NCT00064701|468088300|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
130036659|NCT00064701|468088298|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
130036660|NCT00064701|468088299|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
130036661|NCT00064701|468088300|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
130036662|NCT00064701|468088298|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
130036663|NCT00064701|468088299|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
130036664|NCT00064701|468088300|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
130036665|NCT00064701|468088298|FG000|Clinical Continuation Phase|Patient opted out|0|||
130036666|NCT00064701|468088299|FG001|Clinical Continuation Phase|Patient opted out|0|||
130036667|NCT00064701|468088300|FG002|Clinical Continuation Phase|Patient opted out|1|||
130036668|NCT01491945|468088301|FG000|Overall Study|Death|30|||
130036669|NCT01491945|468088301|FG000|Overall Study|Withdrwan/LTF|16|||
130036670|NCT01491945|468088301|FG000|Overall Study|Conversion|4|||
130036671|NCT01491945|468088301|FG000|Overall Study|Missed Visit|1|||
130036672|NCT05681715|468088302|FG000|Training Period (6-weeks)|Adverse Event|3|||
130036673|NCT05681715|468088303|FG001|Training Period (6-weeks)|Adverse Event|0|||
130036674|NCT05681715|468088304|FG002|Training Period (6-weeks)|Adverse Event|0|||
130036675|NCT05681715|468088302|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
130036676|NCT05681715|468088303|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
130036677|NCT05681715|468088304|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
130036678|NCT05681715|468088302|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
130036679|NCT05681715|468088303|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
130036680|NCT05681715|468088304|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
130036681|NCT05681715|468088302|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
130036682|NCT05681715|468088303|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
130036683|NCT05681715|468088304|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
130036684|NCT05681715|468088302|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
130036685|NCT05681715|468088303|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
130036686|NCT05681715|468088304|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
130036687|NCT05681715|468088302|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
130036688|NCT05681715|468088303|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
130036689|NCT05681715|468088304|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
130036690|NCT05681715|468088302|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
130036691|NCT05681715|468088303|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
130036692|NCT05681715|468088304|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
130036693|NCT05681715|468088302|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
130268788|NCT02820844|468949699|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
130268789|NCT02820844|468949700|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
130268790|NCT02820844|468949695|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268791|NCT02820844|468949696|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268792|NCT02820844|468949697|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268793|NCT02820844|468949698|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268794|NCT02820844|468949699|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
130268795|NCT02820844|468949700|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
130268796|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Physician Decision|0|||
130268797|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Physician Decision|0|||
130103429|NCT03506425|468336498|FG000|Overall Study|Withdrawal by Subject|0|||
130103430|NCT03506425|468336499|FG001|Overall Study|Withdrawal by Subject|0|||
130103431|NCT03506425|468336500|FG002|Overall Study|Withdrawal by Subject|1|||
130103432|NCT04088734|468336503|FG000|Overall Study|Other, Not Specified|5|||
130103433|NCT00096200|468336504|FG000|Overall Study|Adverse Event|0|||
130103434|NCT00096200|468336505|FG001|Overall Study|Adverse Event|4|||
130103435|NCT00096200|468336506|FG002|Overall Study|Adverse Event|0|||
130103436|NCT00096200|468336504|FG000|Overall Study|Withdrawal by Subject|1|||
130103437|NCT00096200|468336505|FG001|Overall Study|Withdrawal by Subject|2|||
130103438|NCT00096200|468336506|FG002|Overall Study|Withdrawal by Subject|0|||
130103439|NCT00096200|468336504|FG000|Overall Study|Ineligible pathology|0|||
130103440|NCT00096200|468336505|FG001|Overall Study|Ineligible pathology|1|||
130103441|NCT00096200|468336506|FG002|Overall Study|Ineligible pathology|0|||
130103442|NCT00938015|468336510|FG000|Overall Study|Death|2|||
130103443|NCT00938015|468336510|FG000|Overall Study|Lost to Follow-up|32|||
130103444|NCT00938015|468336510|FG000|Overall Study|Adverse Event|32|||
130103445|NCT00938015|468336510|FG000|Overall Study|Non-responder|52|||
130103446|NCT00938015|468336510|FG000|Overall Study|Reason not related to Etanercept|29|||
130103447|NCT02341482|468336511|FG000|Overall Study|Adverse Event|1|||
130103448|NCT00981019|468336517|FG000|Overall Study|Did not respond|65|||
130103449|NCT00981019|468336517|FG000|Overall Study|Did not match target population|94|||
130103450|NCT00981019|468336517|FG000|Overall Study|Inadvertent exclusion|239|||
130103451|NCT00981019|468336517|FG000|Overall Study|Hit the survey after closure|79|||
130103452|NCT00358670|468336518|FG000|Overall Study|Adverse Event|26|||
130103453|NCT00358670|468336519|FG001|Overall Study|Adverse Event|29|||
130103454|NCT00358670|468336518|FG000|Overall Study|Lack of Efficacy|20|||
130103455|NCT00358670|468336519|FG001|Overall Study|Lack of Efficacy|23|||
130103456|NCT00358670|468336518|FG000|Overall Study|Protocol Violation|6|||
130103457|NCT00358670|468336519|FG001|Overall Study|Protocol Violation|9|||
130103458|NCT00358670|468336518|FG000|Overall Study|Lost to Follow-up|4|||
130103459|NCT00358670|468336519|FG001|Overall Study|Lost to Follow-up|5|||
130103460|NCT00358670|468336518|FG000|Overall Study|Withdrawal by Subject|13|||
130103461|NCT00358670|468336519|FG001|Overall Study|Withdrawal by Subject|24|||
130103462|NCT00358670|468336518|FG000|Overall Study|Protocol Defined Clinical Event|0|||
130103463|NCT00358670|468336519|FG001|Overall Study|Protocol Defined Clinical Event|1|||
130103464|NCT00358670|468336518|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
130103465|NCT00358670|468336519|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
130103466|NCT00358670|468336518|FG000|Overall Study|Administrative|153|||
130103467|NCT00358670|468336519|FG001|Overall Study|Administrative|125|||
130103468|NCT00960687|468336520|FG000|Washout Period of 7 Days|Adverse Event|3|||
130103469|NCT00960687|468336521|FG001|Washout Period of 7 Days|Adverse Event|2|||
130103470|NCT00960687|468336520|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130103471|NCT00960687|468336521|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130103472|NCT02704130|468336522|FG000|Overall Study|Physician Decision|5|||
130103473|NCT02704130|468336523|FG001|Overall Study|Physician Decision|3|||
130103474|NCT02666768|468336524|FG000|Overall Study|Withdrawal by Subject|4|||
130103475|NCT00285012|468336525|FG000|Assigned to Study Treatment (Tx)|Other|2|||
130103476|NCT00285012|468336526|FG001|Assigned to Study Treatment (Tx)|Other|3|||
130103477|NCT00285012|468336525|FG000|Received Study Tx|Death|2|||
130103478|NCT00285012|468336526|FG001|Received Study Tx|Death|1|||
130103479|NCT00285012|468336525|FG000|Received Study Tx|Adverse Event|5|||
130103480|NCT00285012|468336526|FG001|Received Study Tx|Adverse Event|11|||
130103481|NCT00285012|468336525|FG000|Received Study Tx|Lack of Efficacy|0|||
130103482|NCT00285012|468336526|FG001|Received Study Tx|Lack of Efficacy|3|||
130103483|NCT00285012|468336525|FG000|Received Study Tx|Lost to Follow-up|29|||
130103484|NCT00285012|468336526|FG001|Received Study Tx|Lost to Follow-up|31|||
130103485|NCT00285012|468336525|FG000|Received Study Tx|Withdrawal by Subject|31|||
130103486|NCT00285012|468336526|FG001|Received Study Tx|Withdrawal by Subject|43|||
130103487|NCT00285012|468336525|FG000|Received Study Tx|Other|5|||
130103488|NCT00285012|468336526|FG001|Received Study Tx|Other|5|||
130103489|NCT02873195|468336529|FG000|Overall Study|Ineligible|5|||
130103490|NCT02873195|468336530|FG001|Overall Study|Ineligible|0|||
130103491|NCT05004181|468336531|FG000|Overall Study|Withdrawal of consent|0|||
130103492|NCT05004181|468336532|FG001|Overall Study|Withdrawal of consent|0|||
130103493|NCT05004181|468336533|FG002|Overall Study|Withdrawal of consent|1|||
130103494|NCT05004181|468336534|FG003|Overall Study|Withdrawal of consent|3|||
130103495|NCT05004181|468336535|FG004|Overall Study|Withdrawal of consent|3|||
130103496|NCT05004181|468336536|FG005|Overall Study|Withdrawal of consent|0|||
130103497|NCT05004181|468336537|FG006|Overall Study|Withdrawal of consent|30|||
130103498|NCT05004181|468336538|FG007|Overall Study|Withdrawal of consent|9|||
130103499|NCT05004181|468336539|FG008|Overall Study|Withdrawal of consent|3|||
130103500|NCT05004181|468336540|FG009|Overall Study|Withdrawal of consent|2|||
130036694|NCT05681715|468088303|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
130036695|NCT05681715|468088304|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
130036696|NCT03770403|468088305|FG000|Overall Study|Adverse Event|8|||
130036697|NCT03770403|468088305|FG000|Overall Study|Death|5|||
130036698|NCT03770403|468088305|FG000|Overall Study|Physician Decision|1|||
130036699|NCT03770403|468088305|FG000|Overall Study|Sponsor decision|1|||
130036700|NCT03770403|468088305|FG000|Overall Study|Study terminated by Sponsor|1|||
130036701|NCT03770403|468088305|FG000|Overall Study|Withdrawal by Subject|13|||
130036702|NCT03770403|468088305|FG000|Overall Study|Other|88|||
130036703|NCT02305563|468088318|FG000|Treatment Period|Disease progression|0|||
130036704|NCT02305563|468088319|FG001|Treatment Period|Disease progression|0|||
130036705|NCT02305563|468088320|FG002|Treatment Period|Disease progression|15|||
130036706|NCT02305563|468088321|FG003|Treatment Period|Disease progression|6|||
130036707|NCT02305563|468088322|FG004|Treatment Period|Disease progression|6|||
130036708|NCT02305563|468088318|FG000|Treatment Period|Study drug toxicity|0|||
130036709|NCT02305563|468088319|FG001|Treatment Period|Study drug toxicity|0|||
130036710|NCT02305563|468088320|FG002|Treatment Period|Study drug toxicity|0|||
130036711|NCT02305563|468088321|FG003|Treatment Period|Study drug toxicity|1|||
130036712|NCT02305563|468088322|FG004|Treatment Period|Study drug toxicity|2|||
130036713|NCT02305563|468088318|FG000|Treatment Period|Death|0|||
130036714|NCT02305563|468088319|FG001|Treatment Period|Death|0|||
130036715|NCT02305563|468088320|FG002|Treatment Period|Death|1|||
130036716|NCT02305563|468088321|FG003|Treatment Period|Death|2|||
130036717|NCT02305563|468088322|FG004|Treatment Period|Death|1|||
130036718|NCT02305563|468088318|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
130036719|NCT02305563|468088319|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
130036720|NCT02305563|468088320|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
130036721|NCT02305563|468088321|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
130036722|NCT02305563|468088322|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
130036723|NCT02305563|468088318|FG000|Treatment Period|Participant request to stop therapy|0|||
130036724|NCT02305563|468088319|FG001|Treatment Period|Participant request to stop therapy|2|||
130036725|NCT02305563|468088320|FG002|Treatment Period|Participant request to stop therapy|0|||
130036726|NCT02305563|468088321|FG003|Treatment Period|Participant request to stop therapy|1|||
130036727|NCT02305563|468088322|FG004|Treatment Period|Participant request to stop therapy|0|||
130036728|NCT02305563|468088318|FG000|Treatment Period|Participant withdrew consent|0|||
130036729|NCT02305563|468088319|FG001|Treatment Period|Participant withdrew consent|0|||
130036730|NCT02305563|468088320|FG002|Treatment Period|Participant withdrew consent|1|||
130036731|NCT02305563|468088321|FG003|Treatment Period|Participant withdrew consent|1|||
130036732|NCT02305563|468088322|FG004|Treatment Period|Participant withdrew consent|1|||
130036733|NCT02305563|468088318|FG000|Treatment Period|Maximum clinical benefit|0|||
130036734|NCT02305563|468088319|FG001|Treatment Period|Maximum clinical benefit|0|||
130036735|NCT02305563|468088320|FG002|Treatment Period|Maximum clinical benefit|0|||
130036736|NCT02305563|468088321|FG003|Treatment Period|Maximum clinical benefit|0|||
130036737|NCT02305563|468088322|FG004|Treatment Period|Maximum clinical benefit|1|||
130036738|NCT02305563|468088318|FG000|Treatment Period|Poor/non-compliance|0|||
130036739|NCT02305563|468088319|FG001|Treatment Period|Poor/non-compliance|0|||
130036740|NCT02305563|468088320|FG002|Treatment Period|Poor/non-compliance|0|||
130036741|NCT02305563|468088321|FG003|Treatment Period|Poor/non-compliance|0|||
130036742|NCT02305563|468088322|FG004|Treatment Period|Poor/non-compliance|1|||
130036743|NCT02305563|468088318|FG000|Treatment Period|Administrative reason by Sponsor|0|||
130036744|NCT02305563|468088319|FG001|Treatment Period|Administrative reason by Sponsor|0|||
130036745|NCT02305563|468088320|FG002|Treatment Period|Administrative reason by Sponsor|0|||
130036746|NCT02305563|468088321|FG003|Treatment Period|Administrative reason by Sponsor|0|||
130036747|NCT02305563|468088322|FG004|Treatment Period|Administrative reason by Sponsor|1|||
130036748|NCT02305563|468088318|FG000|Treatment Period|other reason|2|||
130036749|NCT02305563|468088319|FG001|Treatment Period|other reason|0|||
130036750|NCT02305563|468088320|FG002|Treatment Period|other reason|2|||
130036751|NCT02305563|468088321|FG003|Treatment Period|other reason|2|||
130036752|NCT02305563|468088322|FG004|Treatment Period|other reason|1|||
130036753|NCT02305563|468088318|FG000|Treatment Period|Randomized but not treated|0|||
130103501|NCT05004181|468336541|FG010|Overall Study|Withdrawal of consent|5|||
130103502|NCT05004181|468336542|FG011|Overall Study|Withdrawal of consent|1|||
130036754|NCT02305563|468088319|FG001|Treatment Period|Randomized but not treated|0|||
130036755|NCT02305563|468088320|FG002|Treatment Period|Randomized but not treated|0|||
130036756|NCT02305563|468088321|FG003|Treatment Period|Randomized but not treated|0|||
130036757|NCT02305563|468088322|FG004|Treatment Period|Randomized but not treated|2|||
130103503|NCT05004181|468336531|FG000|Overall Study|Lost to Follow-up|2|||
130103504|NCT05004181|468336532|FG001|Overall Study|Lost to Follow-up|4|||
130036758|NCT02305563|468088318|FG000|Treatment Period|added ULO, then disease progression|0|||
130036759|NCT02305563|468088319|FG001|Treatment Period|added ULO, then disease progression|0|||
130036760|NCT02305563|468088320|FG002|Treatment Period|added ULO, then disease progression|0|||
130036761|NCT02305563|468088321|FG003|Treatment Period|added ULO, then disease progression|0|||
130103505|NCT05004181|468336533|FG002|Overall Study|Lost to Follow-up|2|||
130103506|NCT05004181|468336534|FG003|Overall Study|Lost to Follow-up|3|||
130103507|NCT05004181|468336535|FG004|Overall Study|Lost to Follow-up|5|||
130103508|NCT05004181|468336536|FG005|Overall Study|Lost to Follow-up|2|||
130268798|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Physician Decision|1|||
130103509|NCT05004181|468336537|FG006|Overall Study|Lost to Follow-up|15|||
130103510|NCT05004181|468336538|FG007|Overall Study|Lost to Follow-up|12|||
130103511|NCT05004181|468336539|FG008|Overall Study|Lost to Follow-up|38|||
130103512|NCT05004181|468336540|FG009|Overall Study|Lost to Follow-up|6|||
129885861|NCT02291289|467542801|FG008|Induction Treatment|Missing|0|||
129885862|NCT02291289|467542802|FG009|Induction Treatment|Missing|54|||
129885863|NCT02291289|467542803|FG010|Induction Treatment|Missing|0|||
129885864|NCT02291289|467542804|FG011|Induction Treatment|Missing|0|||
129885865|NCT02291289|467542805|FG012|Induction Treatment|Missing|0|||
129885866|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885867|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885868|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885869|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885870|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
129885871|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
129885872|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885873|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885874|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885875|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885876|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
129885877|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
129885878|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885879|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Death|0|||
129885880|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Death|29|||
129885881|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Death|16|||
129885882|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Death|0|||
129885883|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Death|188|||
129885884|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Death|107|||
129885885|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Death|0|||
129885886|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Death|1|||
129885887|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Death|1|||
129885888|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Death|0|||
129885889|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Death|46|||
129885890|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Death|19|||
129885891|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Death|0|||
130036762|NCT02305563|468088322|FG004|Treatment Period|added ULO, then disease progression|4|||
130036763|NCT02305563|468088318|FG000|Treatment Period|added ULO; then other reason|0|||
130036764|NCT02305563|468088319|FG001|Treatment Period|added ULO; then other reason|0|||
130036765|NCT02305563|468088320|FG002|Treatment Period|added ULO; then other reason|0|||
130036766|NCT02305563|468088321|FG003|Treatment Period|added ULO; then other reason|0|||
130036767|NCT02305563|468088322|FG004|Treatment Period|added ULO; then other reason|1|||
130036768|NCT02305563|468088318|FG000|Treatment Period|added ULO, then request to stop|0|||
130036769|NCT02305563|468088319|FG001|Treatment Period|added ULO, then request to stop|0|||
130036770|NCT02305563|468088320|FG002|Treatment Period|added ULO, then request to stop|0|||
130036771|NCT02305563|468088321|FG003|Treatment Period|added ULO, then request to stop|0|||
130036772|NCT02305563|468088322|FG004|Treatment Period|added ULO, then request to stop|1|||
130036773|NCT02305563|468088318|FG000|Follow-up Period|Death|0|||
130036774|NCT02305563|468088319|FG001|Follow-up Period|Death|0|||
130036775|NCT02305563|468088320|FG002|Follow-up Period|Death|5|||
130036776|NCT02305563|468088321|FG003|Follow-up Period|Death|4|||
130036777|NCT02305563|468088322|FG004|Follow-up Period|Death|7|||
130036778|NCT02305563|468088318|FG000|Follow-up Period|Participant withdrew consent|0|||
130036779|NCT02305563|468088319|FG001|Follow-up Period|Participant withdrew consent|0|||
130036780|NCT02305563|468088320|FG002|Follow-up Period|Participant withdrew consent|2|||
130036781|NCT02305563|468088321|FG003|Follow-up Period|Participant withdrew consent|1|||
130036782|NCT02305563|468088322|FG004|Follow-up Period|Participant withdrew consent|0|||
130036783|NCT02305563|468088318|FG000|Follow-up Period|other reason|0|||
130036784|NCT02305563|468088319|FG001|Follow-up Period|other reason|0|||
130036785|NCT02305563|468088320|FG002|Follow-up Period|other reason|0|||
130103513|NCT05004181|468336541|FG010|Overall Study|Lost to Follow-up|6|||
130103514|NCT05004181|468336542|FG011|Overall Study|Lost to Follow-up|0|||
130036786|NCT02305563|468088321|FG003|Follow-up Period|other reason|0|||
130036787|NCT02305563|468088322|FG004|Follow-up Period|other reason|1|||
130036788|NCT02305563|468088318|FG000|Follow-up Period|Followup no longer required per protocol|3|||
130036789|NCT02305563|468088319|FG001|Follow-up Period|Followup no longer required per protocol|3|||
130103515|NCT05004181|468336531|FG000|Overall Study|Death|0|||
130103516|NCT05004181|468336532|FG001|Overall Study|Death|0|||
130103517|NCT05004181|468336533|FG002|Overall Study|Death|0|||
130103518|NCT05004181|468336534|FG003|Overall Study|Death|0|||
130103519|NCT05004181|468336535|FG004|Overall Study|Death|0|||
129885892|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130036790|NCT02305563|468088320|FG002|Follow-up Period|Followup no longer required per protocol|4|||
130036791|NCT02305563|468088321|FG003|Follow-up Period|Followup no longer required per protocol|1|||
130036792|NCT02305563|468088322|FG004|Follow-up Period|Followup no longer required per protocol|4|||
130036793|NCT02700451|468088323|FG000|Overall Study|Protocol Violation|2|||
130036794|NCT02700451|468088324|FG001|Overall Study|Protocol Violation|2|||
130036795|NCT02700451|468088325|FG002|Overall Study|Protocol Violation|3|||
130036796|NCT02700451|468088323|FG000|Overall Study|Discontinued intervention|14|||
130036797|NCT02700451|468088324|FG001|Overall Study|Discontinued intervention|15|||
130036798|NCT02700451|468088325|FG002|Overall Study|Discontinued intervention|14|||
130036799|NCT04373460|468088326|FG000|Overall Study|Did not receive tranfusion|18|||
130036800|NCT04373460|468088327|FG001|Overall Study|Did not receive tranfusion|26|||
130036801|NCT00454207|468088328|FG000|Overall Study|Adverse Event|3|||
130036802|NCT00454207|468088329|FG001|Overall Study|Adverse Event|1|||
130036803|NCT00454207|468088328|FG000|Overall Study|Lack of Efficacy|1|||
130036804|NCT00454207|468088329|FG001|Overall Study|Lack of Efficacy|0|||
130036805|NCT00454207|468088328|FG000|Overall Study|Protocol Violation|0|||
130036806|NCT00454207|468088329|FG001|Overall Study|Protocol Violation|1|||
130036807|NCT00642642|468088331|FG000|Treatment & Follow Up|Adverse Event|2|||
130036808|NCT00642642|468088331|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
130036809|NCT00642642|468088331|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
130036810|NCT02337387|468088334|FG000|Overall Study|Adverse Event|0|||
130103520|NCT05004181|468336536|FG005|Overall Study|Death|0|||
130103521|NCT05004181|468336537|FG006|Overall Study|Death|1|||
130103522|NCT05004181|468336538|FG007|Overall Study|Death|0|||
130103523|NCT05004181|468336539|FG008|Overall Study|Death|2|||
130103524|NCT05004181|468336540|FG009|Overall Study|Death|0|||
130103525|NCT05004181|468336541|FG010|Overall Study|Death|0|||
130103526|NCT05004181|468336542|FG011|Overall Study|Death|0|||
130103527|NCT05004181|468336531|FG000|Overall Study|Physician Decision|0|||
130103528|NCT05004181|468336532|FG001|Overall Study|Physician Decision|0|||
130103529|NCT05004181|468336533|FG002|Overall Study|Physician Decision|0|||
130103530|NCT05004181|468336534|FG003|Overall Study|Physician Decision|0|||
130103531|NCT05004181|468336535|FG004|Overall Study|Physician Decision|0|||
130103532|NCT05004181|468336536|FG005|Overall Study|Physician Decision|0|||
130103533|NCT05004181|468336537|FG006|Overall Study|Physician Decision|2|||
130268799|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Physician Decision|0|||
130268800|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
130268801|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
130268802|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
130268803|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
130268804|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
130103534|NCT05004181|468336538|FG007|Overall Study|Physician Decision|0|||
130103535|NCT05004181|468336539|FG008|Overall Study|Physician Decision|7|||
130103536|NCT05004181|468336540|FG009|Overall Study|Physician Decision|0|||
130103537|NCT05004181|468336541|FG010|Overall Study|Physician Decision|0|||
130103538|NCT05004181|468336542|FG011|Overall Study|Physician Decision|0|||
130103539|NCT05004181|468336531|FG000|Overall Study|Withdrawal by Subject|2|||
130103540|NCT05004181|468336532|FG001|Overall Study|Withdrawal by Subject|3|||
130103541|NCT05004181|468336533|FG002|Overall Study|Withdrawal by Subject|2|||
130103542|NCT05004181|468336534|FG003|Overall Study|Withdrawal by Subject|2|||
130103543|NCT05004181|468336535|FG004|Overall Study|Withdrawal by Subject|4|||
130103544|NCT05004181|468336536|FG005|Overall Study|Withdrawal by Subject|2|||
130103545|NCT05004181|468336537|FG006|Overall Study|Withdrawal by Subject|4|||
130103546|NCT05004181|468336538|FG007|Overall Study|Withdrawal by Subject|22|||
130103547|NCT05004181|468336539|FG008|Overall Study|Withdrawal by Subject|8|||
130103548|NCT05004181|468336540|FG009|Overall Study|Withdrawal by Subject|1|||
130103549|NCT05004181|468336541|FG010|Overall Study|Withdrawal by Subject|3|||
130103550|NCT05004181|468336542|FG011|Overall Study|Withdrawal by Subject|2|||
130103551|NCT05004181|468336531|FG000|Overall Study|Protocol Violation|2|||
130103552|NCT05004181|468336532|FG001|Overall Study|Protocol Violation|3|||
130103553|NCT05004181|468336533|FG002|Overall Study|Protocol Violation|0|||
130103554|NCT05004181|468336534|FG003|Overall Study|Protocol Violation|0|||
130103555|NCT05004181|468336535|FG004|Overall Study|Protocol Violation|1|||
130103556|NCT05004181|468336536|FG005|Overall Study|Protocol Violation|0|||
130036811|NCT02337387|468088335|FG001|Overall Study|Adverse Event|1|||
130036812|NCT02337387|468088336|FG002|Overall Study|Adverse Event|0|||
130036813|NCT02337387|468088337|FG003|Overall Study|Adverse Event|0|||
130036814|NCT02337387|468088334|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
130036815|NCT02337387|468088335|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
130103557|NCT05004181|468336537|FG006|Overall Study|Protocol Violation|16|||
130268805|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
130268806|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
130268807|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
130268808|NCT02266147|468949702|FG000|PART 1: Dose Escalation|Other|1|||
130268809|NCT02266147|468949703|FG001|PART 1: Dose Escalation|Other|1|||
130036816|NCT02337387|468088336|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
130036817|NCT02337387|468088337|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
130036818|NCT01856114|468088338|FG000|Overall Study|Withdrawal by Subject|1|||
130036819|NCT01856114|468088339|FG001|Overall Study|Withdrawal by Subject|0|||
130036820|NCT01856114|468088338|FG000|Overall Study|Adverse Event|1|||
130036821|NCT01856114|468088339|FG001|Overall Study|Adverse Event|0|||
130036822|NCT03871491|468088340|FG000|Overall Study|Withdrawal by Subject|14|||
130036823|NCT03871491|468088341|FG001|Overall Study|Withdrawal by Subject|14|||
130036824|NCT03871491|468088342|FG002|Overall Study|Withdrawal by Subject|14|||
130036825|NCT03871491|468088343|FG003|Overall Study|Withdrawal by Subject|14|||
130036826|NCT03871491|468088340|FG000|Overall Study|Physician Decision|0|||
130036827|NCT03871491|468088341|FG001|Overall Study|Physician Decision|0|||
130036828|NCT03871491|468088342|FG002|Overall Study|Physician Decision|1|||
130036829|NCT03871491|468088343|FG003|Overall Study|Physician Decision|1|||
130036830|NCT03871491|468088340|FG000|Overall Study|Lost to Follow-up|50|||
130036831|NCT03871491|468088341|FG001|Overall Study|Lost to Follow-up|15|||
130036832|NCT03871491|468088342|FG002|Overall Study|Lost to Follow-up|36|||
130036833|NCT03871491|468088343|FG003|Overall Study|Lost to Follow-up|11|||
130036834|NCT05202808|468088344|FG000|Overall Study|Lost to Follow-up|3|||
130036835|NCT05202808|468088345|FG001|Overall Study|Lost to Follow-up|1|||
130036836|NCT02495948|468088346|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
130036837|NCT02495948|468088347|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
130036838|NCT02495948|468088346|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
130036839|NCT02495948|468088347|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
130036840|NCT02747004|468088348|FG000|Overall Study|Withdrawal by Subject|8|||
130036841|NCT02747004|468088349|FG001|Overall Study|Withdrawal by Subject|5|||
130036842|NCT02747004|468088350|FG002|Overall Study|Withdrawal by Subject|4|||
130036843|NCT02747004|468088348|FG000|Overall Study|Lost to Follow-up|1|||
130036844|NCT02747004|468088349|FG001|Overall Study|Lost to Follow-up|2|||
130036845|NCT02747004|468088350|FG002|Overall Study|Lost to Follow-up|2|||
130268810|NCT02266147|468949704|FG002|PART 1: Dose Escalation|Other|0|||
130268811|NCT02266147|468949705|FG003|PART 1: Dose Escalation|Other|0|||
130268812|NCT02266147|468949702|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
130268813|NCT02266147|468949703|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
130268814|NCT02266147|468949704|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
130268815|NCT02266147|468949705|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
130036846|NCT02747004|468088348|FG000|Overall Study|on study treatment/follow-up|48|||
130036847|NCT02747004|468088349|FG001|Overall Study|on study treatment/follow-up|42|||
130036848|NCT02747004|468088350|FG002|Overall Study|on study treatment/follow-up|41|||
130036849|NCT01444300|468088351|FG000|Overall Study|Adverse Event|4|||
130036850|NCT01444300|468088352|FG001|Overall Study|Adverse Event|0|||
130036851|NCT00275561|468088359|FG000|Overall Study|Withdrawal by Subject|0|||
130036852|NCT00275561|468088360|FG001|Overall Study|Withdrawal by Subject|1|||
130036853|NCT00275561|468088359|FG000|Overall Study|Travel|1|||
130036854|NCT00275561|468088360|FG001|Overall Study|Travel|1|||
130036855|NCT00275561|468088359|FG000|Overall Study|Scheduling|1|||
130036856|NCT00275561|468088360|FG001|Overall Study|Scheduling|2|||
130036857|NCT00275561|468088359|FG000|Overall Study|Family Issues|0|||
130036858|NCT00275561|468088360|FG001|Overall Study|Family Issues|2|||
130036859|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
130036860|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
130036861|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
130268816|NCT02266147|468949702|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
130036862|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
130036863|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
130036864|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
130036865|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
130036866|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
130268817|NCT02266147|468949703|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
130036867|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
130036868|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
130036869|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
130036870|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130036871|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130268818|NCT02266147|468949704|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
130036872|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130036873|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
130268819|NCT02266147|468949705|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
130268820|NCT01456130|468949706|FG000|Overall Study|Adverse Event|4|||
130268821|NCT01456130|468949706|FG000|Overall Study|Voluntary Withdrawal|1|||
130268822|NCT01456130|468949706|FG000|Overall Study|Lack of Efficacy|4|||
130268823|NCT01456130|468949706|FG000|Overall Study|Other|1|||
130268824|NCT00413660|468949711|FG000|Up To Week 12|Adverse Event|1|||
130268825|NCT00413660|468949712|FG001|Up To Week 12|Adverse Event|3|||
130268826|NCT00413660|468949713|FG002|Up To Week 12|Adverse Event|1|||
130103558|NCT05004181|468336538|FG007|Overall Study|Protocol Violation|18|||
130103559|NCT05004181|468336539|FG008|Overall Study|Protocol Violation|2|||
130103560|NCT05004181|468336540|FG009|Overall Study|Protocol Violation|2|||
130103561|NCT05004181|468336541|FG010|Overall Study|Protocol Violation|2|||
130103562|NCT05004181|468336542|FG011|Overall Study|Protocol Violation|1|||
130103563|NCT05004181|468336531|FG000|Overall Study|Not further specified|1|||
130103564|NCT05004181|468336532|FG001|Overall Study|Not further specified|0|||
130103565|NCT05004181|468336533|FG002|Overall Study|Not further specified|0|||
130103566|NCT05004181|468336534|FG003|Overall Study|Not further specified|0|||
130103567|NCT05004181|468336535|FG004|Overall Study|Not further specified|0|||
130103568|NCT05004181|468336536|FG005|Overall Study|Not further specified|0|||
130103569|NCT05004181|468336537|FG006|Overall Study|Not further specified|1|||
130103570|NCT05004181|468336538|FG007|Overall Study|Not further specified|0|||
130103571|NCT05004181|468336539|FG008|Overall Study|Not further specified|2|||
130103572|NCT05004181|468336540|FG009|Overall Study|Not further specified|1|||
130103573|NCT05004181|468336541|FG010|Overall Study|Not further specified|0|||
130103574|NCT05004181|468336542|FG011|Overall Study|Not further specified|1|||
130103575|NCT01652573|468338659|FG000|Overall Study|Adverse Event|0|||
130103576|NCT01652573|468338660|FG001|Overall Study|Adverse Event|1|||
130103577|NCT00740480|468338661|FG000|Overall Study|Adverse Event|1|||
130103578|NCT00740480|468338661|FG000|Overall Study|Physician Decision|1|||
130103579|NCT00934622|468338662|FG000|Overall Study|Lost to Follow-up|7|||
130103580|NCT00934622|468338662|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
130103581|NCT01856686|468338666|FG000|Overall Study|Lost to Follow-up|5|||
130103582|NCT01856686|468338667|FG001|Overall Study|Lost to Follow-up|11|||
130103583|NCT00602979|468338670|FG000|Overall Study|Lost to Follow-up|3|||
130103584|NCT00602979|468338671|FG001|Overall Study|Lost to Follow-up|2|||
130103585|NCT00602979|468338672|FG002|Overall Study|Lost to Follow-up|3|||
130103586|NCT00602979|468338673|FG003|Overall Study|Lost to Follow-up|2|||
130103587|NCT00602979|468338674|FG004|Overall Study|Lost to Follow-up|3|||
130268827|NCT00413660|468949714|FG003|Up To Week 12|Adverse Event|4|||
130103588|NCT00602979|468338670|FG000|Overall Study|Failed Intubation|0|||
130103589|NCT00602979|468338671|FG001|Overall Study|Failed Intubation|1|||
130103590|NCT00602979|468338672|FG002|Overall Study|Failed Intubation|0|||
130103591|NCT00602979|468338673|FG003|Overall Study|Failed Intubation|1|||
130103592|NCT00602979|468338674|FG004|Overall Study|Failed Intubation|0|||
130103593|NCT03349437|468338677|FG000|Screening|Screen Fail|4|||
130103594|NCT03349437|468338678|FG001|Screening|Screen Fail|0|||
129885893|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Adverse Event|0|||
129885894|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Adverse Event|0|||
129885895|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Adverse Event|0|||
129885896|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Adverse Event|1|||
129885897|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Adverse Event|1|||
129885898|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Adverse Event|0|||
129885899|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Adverse Event|0|||
129885900|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Adverse Event|0|||
129885901|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Adverse Event|0|||
129885902|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Adverse Event|0|||
130103595|NCT03349437|468338679|FG002|Screening|Screen Fail|0|||
129885903|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Adverse Event|0|||
129885904|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Adverse Event|0|||
130036874|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130036875|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
130103596|NCT03349437|468338677|FG000|Screening|Withdrawn|1|||
130103597|NCT03349437|468338678|FG001|Screening|Withdrawn|0|||
130268828|NCT00413660|468949715|FG004|Up To Week 12|Adverse Event|6|||
130268829|NCT00413660|468949716|FG005|Up To Week 12|Adverse Event|4|||
130268830|NCT00413660|468949717|FG006|Up To Week 12|Adverse Event|1|||
130268831|NCT00413660|468949718|FG007|Up To Week 12|Adverse Event|0|||
130268832|NCT00413660|468949719|FG008|Up To Week 12|Adverse Event|0|||
130268833|NCT00413660|468949720|FG009|Up To Week 12|Adverse Event|0|||
130268834|NCT00413660|468949721|FG010|Up To Week 12|Adverse Event|0|||
130268835|NCT00413660|468949711|FG000|Up To Week 12|Lack of Efficacy|2|||
130268836|NCT00413660|468949712|FG001|Up To Week 12|Lack of Efficacy|0|||
130268837|NCT00413660|468949713|FG002|Up To Week 12|Lack of Efficacy|0|||
130103598|NCT03349437|468338679|FG002|Screening|Withdrawn|0|||
130103599|NCT01461369|468338680|FG000|Overall Study|Lack of Efficacy|2|||
130103600|NCT01461369|468338681|FG001|Overall Study|Lack of Efficacy|0|||
130103601|NCT01461369|468338682|FG002|Overall Study|Lack of Efficacy|6|||
130103602|NCT01461369|468338680|FG000|Overall Study|Lost to Follow-up|0|||
130103603|NCT01461369|468338681|FG001|Overall Study|Lost to Follow-up|0|||
130103604|NCT01461369|468338682|FG002|Overall Study|Lost to Follow-up|3|||
130103605|NCT01461369|468338680|FG000|Overall Study|Adverse Event|9|||
130103606|NCT01461369|468338681|FG001|Overall Study|Adverse Event|12|||
130103607|NCT01461369|468338682|FG002|Overall Study|Adverse Event|4|||
130103608|NCT01461369|468338680|FG000|Overall Study|Protocol Violation|1|||
130103609|NCT01461369|468338681|FG001|Overall Study|Protocol Violation|2|||
130103610|NCT01461369|468338682|FG002|Overall Study|Protocol Violation|2|||
130103611|NCT01461369|468338680|FG000|Overall Study|Withdrawal by Subject|1|||
130268838|NCT00413660|468949714|FG003|Up To Week 12|Lack of Efficacy|0|||
130268839|NCT00413660|468949715|FG004|Up To Week 12|Lack of Efficacy|0|||
130268840|NCT00413660|468949716|FG005|Up To Week 12|Lack of Efficacy|0|||
130036876|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130036877|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130036878|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
130036879|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
130036880|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
130036881|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
130036882|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
130036883|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
130036884|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
130268841|NCT00413660|468949717|FG006|Up To Week 12|Lack of Efficacy|5|||
130268842|NCT00413660|468949718|FG007|Up To Week 12|Lack of Efficacy|0|||
130268843|NCT00413660|468949719|FG008|Up To Week 12|Lack of Efficacy|0|||
130268844|NCT00413660|468949720|FG009|Up To Week 12|Lack of Efficacy|0|||
130268845|NCT00413660|468949721|FG010|Up To Week 12|Lack of Efficacy|0|||
130268846|NCT00413660|468949711|FG000|Up To Week 12|Lost to Follow-up|0|||
130268847|NCT00413660|468949712|FG001|Up To Week 12|Lost to Follow-up|1|||
130268848|NCT00413660|468949713|FG002|Up To Week 12|Lost to Follow-up|0|||
130268849|NCT00413660|468949714|FG003|Up To Week 12|Lost to Follow-up|0|||
130268850|NCT00413660|468949715|FG004|Up To Week 12|Lost to Follow-up|1|||
130268851|NCT00413660|468949716|FG005|Up To Week 12|Lost to Follow-up|0|||
130268852|NCT00413660|468949717|FG006|Up To Week 12|Lost to Follow-up|0|||
130103612|NCT01461369|468338681|FG001|Overall Study|Withdrawal by Subject|3|||
130103613|NCT01461369|468338682|FG002|Overall Study|Withdrawal by Subject|2|||
130103614|NCT03692078|468338685|FG000|Overall Study|Adverse Event|0|||
130103615|NCT03692078|468338686|FG001|Overall Study|Adverse Event|0|||
130103616|NCT03692078|468338687|FG002|Overall Study|Adverse Event|0|||
130103617|NCT03692078|468338688|FG003|Overall Study|Adverse Event|0|||
130103618|NCT03692078|468338689|FG004|Overall Study|Adverse Event|0|||
130103619|NCT03692078|468338690|FG005|Overall Study|Adverse Event|1|||
130103620|NCT03692078|468338691|FG006|Overall Study|Adverse Event|0|||
130103621|NCT03692078|468338685|FG000|Overall Study|Enrollment Closed|5|||
130103622|NCT03692078|468338686|FG001|Overall Study|Enrollment Closed|0|||
130103623|NCT03692078|468338687|FG002|Overall Study|Enrollment Closed|0|||
130103624|NCT03692078|468338688|FG003|Overall Study|Enrollment Closed|0|||
130103625|NCT03692078|468338689|FG004|Overall Study|Enrollment Closed|0|||
130103626|NCT03692078|468338690|FG005|Overall Study|Enrollment Closed|0|||
130103627|NCT03692078|468338691|FG006|Overall Study|Enrollment Closed|0|||
130103628|NCT03692078|468338685|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
130103629|NCT03692078|468338686|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
130268853|NCT00413660|468949718|FG007|Up To Week 12|Lost to Follow-up|0|||
130268854|NCT00413660|468949719|FG008|Up To Week 12|Lost to Follow-up|0|||
130268855|NCT00413660|468949720|FG009|Up To Week 12|Lost to Follow-up|0|||
130268856|NCT00413660|468949721|FG010|Up To Week 12|Lost to Follow-up|0|||
130268857|NCT00413660|468949711|FG000|Up To Week 12|Withdrawal by Subject|0|||
130268858|NCT00413660|468949712|FG001|Up To Week 12|Withdrawal by Subject|2|||
130268859|NCT00413660|468949713|FG002|Up To Week 12|Withdrawal by Subject|0|||
130268860|NCT00413660|468949714|FG003|Up To Week 12|Withdrawal by Subject|2|||
130268861|NCT00413660|468949715|FG004|Up To Week 12|Withdrawal by Subject|0|||
130268862|NCT00413660|468949716|FG005|Up To Week 12|Withdrawal by Subject|2|||
130268863|NCT00413660|468949717|FG006|Up To Week 12|Withdrawal by Subject|2|||
130268864|NCT00413660|468949718|FG007|Up To Week 12|Withdrawal by Subject|0|||
130268865|NCT00413660|468949719|FG008|Up To Week 12|Withdrawal by Subject|0|||
130268866|NCT00413660|468949720|FG009|Up To Week 12|Withdrawal by Subject|0|||
130268867|NCT00413660|468949721|FG010|Up To Week 12|Withdrawal by Subject|0|||
130268868|NCT00413660|468949711|FG000|Up To Week 12|Randomized, Not Treated|1|||
130268869|NCT00413660|468949712|FG001|Up To Week 12|Randomized, Not Treated|0|||
130268870|NCT00413660|468949713|FG002|Up To Week 12|Randomized, Not Treated|0|||
130268871|NCT00413660|468949714|FG003|Up To Week 12|Randomized, Not Treated|1|||
130268872|NCT00413660|468949715|FG004|Up To Week 12|Randomized, Not Treated|0|||
130268873|NCT00413660|468949716|FG005|Up To Week 12|Randomized, Not Treated|0|||
130268874|NCT00413660|468949717|FG006|Up To Week 12|Randomized, Not Treated|0|||
130268875|NCT00413660|468949718|FG007|Up To Week 12|Randomized, Not Treated|0|||
130268876|NCT00413660|468949719|FG008|Up To Week 12|Randomized, Not Treated|0|||
130268877|NCT00413660|468949720|FG009|Up To Week 12|Randomized, Not Treated|0|||
130268878|NCT00413660|468949721|FG010|Up To Week 12|Randomized, Not Treated|0|||
130268879|NCT00413660|468949711|FG000|Up To Week 12|Other|3|||
130268880|NCT00413660|468949712|FG001|Up To Week 12|Other|1|||
130268881|NCT00413660|468949713|FG002|Up To Week 12|Other|6|||
130268882|NCT00413660|468949714|FG003|Up To Week 12|Other|1|||
130268883|NCT00413660|468949715|FG004|Up To Week 12|Other|2|||
130268884|NCT00413660|468949716|FG005|Up To Week 12|Other|4|||
130268885|NCT00413660|468949717|FG006|Up To Week 12|Other|3|||
130268886|NCT00413660|468949718|FG007|Up To Week 12|Other|0|||
130268887|NCT00413660|468949719|FG008|Up To Week 12|Other|0|||
130268888|NCT00413660|468949720|FG009|Up To Week 12|Other|0|||
130268889|NCT00413660|468949721|FG010|Up To Week 12|Other|0|||
130036885|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
130036886|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
130036887|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
130103630|NCT03692078|468338687|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
130268890|NCT00413660|468949711|FG000|Post Week 12|Adverse Event|2|||
130268891|NCT00413660|468949712|FG001|Post Week 12|Adverse Event|0|||
130268892|NCT00413660|468949713|FG002|Post Week 12|Adverse Event|2|||
130268893|NCT00413660|468949714|FG003|Post Week 12|Adverse Event|1|||
130268894|NCT00413660|468949715|FG004|Post Week 12|Adverse Event|4|||
130268895|NCT00413660|468949716|FG005|Post Week 12|Adverse Event|2|||
130268896|NCT00413660|468949717|FG006|Post Week 12|Adverse Event|2|||
130268897|NCT00413660|468949718|FG007|Post Week 12|Adverse Event|0|||
130268898|NCT00413660|468949719|FG008|Post Week 12|Adverse Event|0|||
130268899|NCT00413660|468949720|FG009|Post Week 12|Adverse Event|0|||
130268900|NCT00413660|468949721|FG010|Post Week 12|Adverse Event|0|||
130268901|NCT00413660|468949711|FG000|Post Week 12|Lack of Efficacy|0|||
130268902|NCT00413660|468949712|FG001|Post Week 12|Lack of Efficacy|0|||
130268903|NCT00413660|468949713|FG002|Post Week 12|Lack of Efficacy|1|||
130268904|NCT00413660|468949714|FG003|Post Week 12|Lack of Efficacy|0|||
130268905|NCT00413660|468949715|FG004|Post Week 12|Lack of Efficacy|0|||
130268906|NCT00413660|468949716|FG005|Post Week 12|Lack of Efficacy|0|||
130268907|NCT00413660|468949717|FG006|Post Week 12|Lack of Efficacy|0|||
130268908|NCT00413660|468949718|FG007|Post Week 12|Lack of Efficacy|0|||
130268909|NCT00413660|468949719|FG008|Post Week 12|Lack of Efficacy|0|||
130268910|NCT00413660|468949720|FG009|Post Week 12|Lack of Efficacy|1|||
130268911|NCT00413660|468949721|FG010|Post Week 12|Lack of Efficacy|0|||
130268912|NCT00413660|468949711|FG000|Post Week 12|Lost to Follow-up|0|||
130268913|NCT00413660|468949712|FG001|Post Week 12|Lost to Follow-up|1|||
130268914|NCT00413660|468949713|FG002|Post Week 12|Lost to Follow-up|1|||
130268915|NCT00413660|468949714|FG003|Post Week 12|Lost to Follow-up|0|||
130268916|NCT00413660|468949715|FG004|Post Week 12|Lost to Follow-up|0|||
130268917|NCT00413660|468949716|FG005|Post Week 12|Lost to Follow-up|0|||
130268918|NCT00413660|468949717|FG006|Post Week 12|Lost to Follow-up|0|||
130268919|NCT00413660|468949718|FG007|Post Week 12|Lost to Follow-up|0|||
130268920|NCT00413660|468949719|FG008|Post Week 12|Lost to Follow-up|0|||
130268921|NCT00413660|468949720|FG009|Post Week 12|Lost to Follow-up|0|||
130268922|NCT00413660|468949721|FG010|Post Week 12|Lost to Follow-up|0|||
130268923|NCT00413660|468949711|FG000|Post Week 12|Withdrawal by Subject|0|||
130268924|NCT00413660|468949712|FG001|Post Week 12|Withdrawal by Subject|1|||
130268925|NCT00413660|468949713|FG002|Post Week 12|Withdrawal by Subject|1|||
130268926|NCT00413660|468949714|FG003|Post Week 12|Withdrawal by Subject|0|||
130268927|NCT00413660|468949715|FG004|Post Week 12|Withdrawal by Subject|1|||
130268928|NCT00413660|468949716|FG005|Post Week 12|Withdrawal by Subject|0|||
130268929|NCT00413660|468949717|FG006|Post Week 12|Withdrawal by Subject|0|||
130268930|NCT00413660|468949718|FG007|Post Week 12|Withdrawal by Subject|0|||
130268931|NCT00413660|468949719|FG008|Post Week 12|Withdrawal by Subject|0|||
130268932|NCT00413660|468949720|FG009|Post Week 12|Withdrawal by Subject|0|||
130268933|NCT00413660|468949721|FG010|Post Week 12|Withdrawal by Subject|1|||
130268934|NCT00413660|468949711|FG000|Post Week 12|Other|1|||
130268935|NCT00413660|468949712|FG001|Post Week 12|Other|2|||
130268936|NCT00413660|468949713|FG002|Post Week 12|Other|3|||
130268937|NCT00413660|468949714|FG003|Post Week 12|Other|0|||
130268938|NCT00413660|468949715|FG004|Post Week 12|Other|1|||
130268939|NCT00413660|468949716|FG005|Post Week 12|Other|1|||
130268940|NCT00413660|468949717|FG006|Post Week 12|Other|1|||
130268941|NCT00413660|468949718|FG007|Post Week 12|Other|0|||
130268942|NCT00413660|468949719|FG008|Post Week 12|Other|0|||
130268943|NCT00413660|468949720|FG009|Post Week 12|Other|0|||
130268944|NCT00413660|468949721|FG010|Post Week 12|Other|0|||
130268945|NCT00400517|468949723|FG000|Overall Study|Withdrawal by Subject|1|||
130268946|NCT00400517|468949723|FG000|Overall Study|Physician Decision|1|||
130268947|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
130268948|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
130268949|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
130268950|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
130268951|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
130268952|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
130268953|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
130268954|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
130268955|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
130268956|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
130268957|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
130268958|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
130268959|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
130268960|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
130268961|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
130268962|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
130268963|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
130268964|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
130103631|NCT03692078|468338688|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
130268965|NCT02831855|468949728|FG000|Open Label Phase (24 Weeks)|Other|4|||
130268966|NCT02831855|468949729|FG001|Open Label Phase (24 Weeks)|Other|0|||
130103632|NCT03692078|468338689|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
130103633|NCT03692078|468338690|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
130103634|NCT03692078|468338691|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
130103635|NCT03692078|468338685|FG000|Overall Study|Withdrawal by Subject|0|||
130268967|NCT02831855|468949730|FG002|Open Label Phase (24 Weeks)|Other|0|||
130268968|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
130268969|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
130268970|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
130268971|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Death|0|||
130268972|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Death|0|||
130268973|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Death|2|||
130268974|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
130268975|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
130268976|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
130268977|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
130268978|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
130268979|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
130268980|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
130268981|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
130268982|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
130268983|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Other|0|||
130268984|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Other|2|||
130268985|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Other|5|||
130268986|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
130268987|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
130268988|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
130268989|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
130268990|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
130268991|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
130268992|NCT02831855|468949728|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
130268993|NCT02831855|468949729|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
130268994|NCT02831855|468949730|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
130268995|NCT01722994|468949731|FG000|Overall Study|Missing data|25|||
130268996|NCT01722994|468949732|FG001|Overall Study|Missing data|17|||
130268997|NCT01803880|468949736|FG000|Overall Study|Adverse Event|1|||
130268998|NCT01803880|468949737|FG001|Overall Study|Adverse Event|0|||
130268999|NCT01803880|468949738|FG002|Overall Study|Adverse Event|0|||
130269000|NCT01803880|468949736|FG000|Overall Study|Withdrawal by Subject|1|||
130269001|NCT01803880|468949737|FG001|Overall Study|Withdrawal by Subject|1|||
130269002|NCT01803880|468949738|FG002|Overall Study|Withdrawal by Subject|4|||
130269003|NCT01803880|468949736|FG000|Overall Study|Physician Decision|0|||
130269004|NCT01803880|468949737|FG001|Overall Study|Physician Decision|0|||
130269005|NCT01803880|468949738|FG002|Overall Study|Physician Decision|1|||
130269006|NCT01803880|468949736|FG000|Overall Study|Unable to return for follow-up visits|0|||
130269007|NCT01803880|468949737|FG001|Overall Study|Unable to return for follow-up visits|1|||
130269008|NCT01803880|468949738|FG002|Overall Study|Unable to return for follow-up visits|2|||
130269009|NCT01803880|468949736|FG000|Overall Study|Lost to Follow-up|1|||
130269010|NCT01803880|468949737|FG001|Overall Study|Lost to Follow-up|2|||
130269011|NCT01803880|468949738|FG002|Overall Study|Lost to Follow-up|3|||
130269012|NCT01803880|468949736|FG000|Overall Study|Protocol Violation|1|||
130269013|NCT01803880|468949737|FG001|Overall Study|Protocol Violation|0|||
130269014|NCT01803880|468949738|FG002|Overall Study|Protocol Violation|0|||
130269015|NCT01803880|468949736|FG000|Overall Study|Early study termination|0|||
130269016|NCT01803880|468949737|FG001|Overall Study|Early study termination|6|||
130269017|NCT01803880|468949738|FG002|Overall Study|Early study termination|5|||
130269018|NCT01803880|468949736|FG000|Overall Study|Incomplete data entry by sites|2|||
130269019|NCT01803880|468949737|FG001|Overall Study|Incomplete data entry by sites|0|||
130269020|NCT01803880|468949738|FG002|Overall Study|Incomplete data entry by sites|0|||
130269021|NCT05384834|468949739|FG000|Overall Study|Lost to Follow-up|43|||
130269022|NCT05384834|468949739|FG000|Overall Study|Withdrawal by Subject|5|||
130269023|NCT01881789|468949741|FG000|Overall Study|Withdrawal by Subject|0|||
130269024|NCT01881789|468949742|FG001|Overall Study|Withdrawal by Subject|2|||
130269025|NCT01881789|468949743|FG002|Overall Study|Withdrawal by Subject|1|||
130269026|NCT01881789|468949744|FG003|Overall Study|Withdrawal by Subject|0|||
130269027|NCT01881789|468949745|FG004|Overall Study|Withdrawal by Subject|1|||
130269028|NCT01881789|468949746|FG005|Overall Study|Withdrawal by Subject|1|||
129885905|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885906|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
129885907|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885908|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
130269029|NCT01881789|468949741|FG000|Overall Study|Study Terminated by Sponsor|0|||
130269030|NCT01881789|468949742|FG001|Overall Study|Study Terminated by Sponsor|0|||
130269031|NCT01881789|468949743|FG002|Overall Study|Study Terminated by Sponsor|0|||
130269032|NCT01881789|468949744|FG003|Overall Study|Study Terminated by Sponsor|0|||
130269033|NCT01881789|468949745|FG004|Overall Study|Study Terminated by Sponsor|0|||
130269034|NCT01881789|468949746|FG005|Overall Study|Study Terminated by Sponsor|1|||
130269035|NCT01881789|468949741|FG000|Overall Study|Other|3|||
130269036|NCT01881789|468949742|FG001|Overall Study|Other|5|||
130269037|NCT01881789|468949743|FG002|Overall Study|Other|2|||
130269038|NCT01881789|468949744|FG003|Overall Study|Other|3|||
130269039|NCT01881789|468949745|FG004|Overall Study|Other|1|||
130269040|NCT01881789|468949746|FG005|Overall Study|Other|1|||
130269041|NCT02041299|468949749|FG000|Overall Study|Adverse Event|9|||
130269042|NCT02041299|468949750|FG001|Overall Study|Adverse Event|3|||
130269043|NCT02041299|468949749|FG000|Overall Study|Lost to Follow-up|4|||
129885909|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
129885910|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
130103636|NCT03692078|468338686|FG001|Overall Study|Withdrawal by Subject|2|||
130269044|NCT02041299|468949750|FG001|Overall Study|Lost to Follow-up|1|||
130269045|NCT02041299|468949749|FG000|Overall Study|Physician Decision|1|||
130269046|NCT02041299|468949750|FG001|Overall Study|Physician Decision|1|||
130269047|NCT02041299|468949749|FG000|Overall Study|Withdrawal by Subject|13|||
130269048|NCT02041299|468949750|FG001|Overall Study|Withdrawal by Subject|7|||
130269049|NCT02041299|468949749|FG000|Overall Study|Protocol Violation|11|||
130269050|NCT02041299|468949750|FG001|Overall Study|Protocol Violation|4|||
130269051|NCT02041299|468949749|FG000|Overall Study|Termination of the study|7|||
130269052|NCT02041299|468949750|FG001|Overall Study|Termination of the study|3|||
130269053|NCT02041299|468949749|FG000|Overall Study|Required bone marrow transplant|0|||
130269054|NCT02041299|468949750|FG001|Overall Study|Required bone marrow transplant|1|||
130269055|NCT02041299|468949749|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
130269056|NCT02041299|468949750|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
130269057|NCT01635998|468949751|FG000|Overall Study|Death|1|||
130269058|NCT01635998|468949752|FG001|Overall Study|Death|1|||
130269059|NCT01635998|468949751|FG000|Overall Study|Lost to Follow-up|2|||
130269060|NCT01635998|468949752|FG001|Overall Study|Lost to Follow-up|1|||
130269061|NCT01635998|468949751|FG000|Overall Study|Withdrawal by Subject|1|||
130269062|NCT01635998|468949752|FG001|Overall Study|Withdrawal by Subject|5|||
130269063|NCT01162473|468949756|FG000|Overall Study|Adverse Event|2|||
130269064|NCT01162473|468949757|FG001|Overall Study|Adverse Event|1|||
130269065|NCT01162473|468949756|FG000|Overall Study|Withdrawal by Subject|0|||
130269066|NCT01162473|468949757|FG001|Overall Study|Withdrawal by Subject|4|||
130269067|NCT00943761|468949768|FG000|Overall Study|Lost to Follow-up|2|||
130269068|NCT00943761|468949769|FG001|Overall Study|Lost to Follow-up|0|||
130269069|NCT00943761|468949768|FG000|Overall Study|Withdrawal by Subject|2|||
130269070|NCT00943761|468949769|FG001|Overall Study|Withdrawal by Subject|1|||
130269071|NCT02268383|468949770|FG000|Overall Study|Death|12|||
130269072|NCT02268383|468949770|FG000|Overall Study|Lost to Follow-up|2|||
130269073|NCT02268383|468949770|FG000|Overall Study|Withdrawal by Subject|9|||
130269074|NCT02268383|468949770|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
130269075|NCT02268383|468949770|FG000|Overall Study|Protocol deviation|3|||
130269076|NCT02268383|468949770|FG000|Overall Study|Sponsor decision|22|||
130269077|NCT02268383|468949770|FG000|Overall Study|Not reported|12|||
130269078|NCT02708680|468949771|FG000|Overall Study|Withdrawal by Subject|4|||
130269079|NCT02708680|468949772|FG001|Overall Study|Withdrawal by Subject|12|||
130269080|NCT02708680|468949773|FG002|Overall Study|Withdrawal by Subject|12|||
130269081|NCT02708680|468949771|FG000|Overall Study|Death|4|||
130269082|NCT02708680|468949772|FG001|Overall Study|Death|19|||
130269083|NCT02708680|468949773|FG002|Overall Study|Death|21|||
130269084|NCT02708680|468949771|FG000|Overall Study|Lost to Follow-up|0|||
130269085|NCT02708680|468949772|FG001|Overall Study|Lost to Follow-up|3|||
130269086|NCT02708680|468949773|FG002|Overall Study|Lost to Follow-up|3|||
130269087|NCT02708680|468949771|FG000|Overall Study|Study Terminated By Sponsor|0|||
130269088|NCT02708680|468949772|FG001|Overall Study|Study Terminated By Sponsor|5|||
130269089|NCT02708680|468949773|FG002|Overall Study|Study Terminated By Sponsor|4|||
130269090|NCT02708680|468949771|FG000|Overall Study|Other than Specified|0|||
130269091|NCT02708680|468949772|FG001|Overall Study|Other than Specified|0|||
130269092|NCT02708680|468949773|FG002|Overall Study|Other than Specified|1|||
130269093|NCT02708680|468949771|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
130269094|NCT02708680|468949772|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
130269095|NCT02708680|468949773|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
130269096|NCT01342926|468949774|FG000|Overall Study|Adverse Event|5|||
130269097|NCT01342926|468949775|FG001|Overall Study|Adverse Event|8|||
130269098|NCT01342926|468949776|FG002|Overall Study|Adverse Event|10|||
130269099|NCT01342926|468949777|FG003|Overall Study|Adverse Event|7|||
130269100|NCT01342926|468949774|FG000|Overall Study|Lost to Follow-up|0|||
130269101|NCT01342926|468949775|FG001|Overall Study|Lost to Follow-up|1|||
130269102|NCT01342926|468949776|FG002|Overall Study|Lost to Follow-up|1|||
130269103|NCT01342926|468949777|FG003|Overall Study|Lost to Follow-up|0|||
130269104|NCT01342926|468949774|FG000|Overall Study|Investigator Discretion|2|||
130269105|NCT01342926|468949775|FG001|Overall Study|Investigator Discretion|2|||
130269106|NCT01342926|468949776|FG002|Overall Study|Investigator Discretion|0|||
130269107|NCT01342926|468949777|FG003|Overall Study|Investigator Discretion|0|||
130269108|NCT01342926|468949774|FG000|Overall Study|Withdrawal by Subject|2|||
130269109|NCT01342926|468949775|FG001|Overall Study|Withdrawal by Subject|4|||
130269110|NCT01342926|468949776|FG002|Overall Study|Withdrawal by Subject|3|||
130269111|NCT01342926|468949777|FG003|Overall Study|Withdrawal by Subject|5|||
130269112|NCT04162470|468949778|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
130269113|NCT01544348|468949785|FG000|Overall Study|Lost to Follow-up|1|||
130269114|NCT01544348|468949786|FG001|Overall Study|Lost to Follow-up|0|||
130269115|NCT01544348|468949787|FG002|Overall Study|Lost to Follow-up|0|||
130269116|NCT01544348|468949788|FG003|Overall Study|Lost to Follow-up|0|||
130269117|NCT01544348|468949789|FG004|Overall Study|Lost to Follow-up|0|||
130269118|NCT01544348|468949790|FG005|Overall Study|Lost to Follow-up|0|||
130269119|NCT01544348|468949791|FG006|Overall Study|Lost to Follow-up|1|||
130269120|NCT01544348|468949792|FG007|Overall Study|Lost to Follow-up|0|||
130269121|NCT01544348|468949785|FG000|Overall Study|Withdrawal by Subject|1|||
130269122|NCT01544348|468949786|FG001|Overall Study|Withdrawal by Subject|0|||
130269123|NCT01544348|468949787|FG002|Overall Study|Withdrawal by Subject|0|||
130269124|NCT01544348|468949788|FG003|Overall Study|Withdrawal by Subject|0|||
130269125|NCT01544348|468949789|FG004|Overall Study|Withdrawal by Subject|1|||
130269126|NCT01544348|468949790|FG005|Overall Study|Withdrawal by Subject|2|||
130269127|NCT01544348|468949791|FG006|Overall Study|Withdrawal by Subject|1|||
130269128|NCT01544348|468949792|FG007|Overall Study|Withdrawal by Subject|0|||
130269129|NCT01544348|468949785|FG000|Overall Study|Physician Decision|0|||
130269130|NCT01544348|468949786|FG001|Overall Study|Physician Decision|0|||
130269131|NCT01544348|468949787|FG002|Overall Study|Physician Decision|0|||
130269132|NCT01544348|468949788|FG003|Overall Study|Physician Decision|0|||
130269133|NCT01544348|468949789|FG004|Overall Study|Physician Decision|0|||
130269134|NCT01544348|468949790|FG005|Overall Study|Physician Decision|1|||
130269135|NCT01544348|468949791|FG006|Overall Study|Physician Decision|0|||
130269136|NCT01544348|468949792|FG007|Overall Study|Physician Decision|0|||
130269137|NCT01445847|468949793|FG000|Overall Study|Protocol Violation|13|||
130269138|NCT01445847|468949794|FG001|Overall Study|Protocol Violation|14|||
130269139|NCT01445847|468949793|FG000|Overall Study|Missed Data|1|||
130269140|NCT01445847|468949794|FG001|Overall Study|Missed Data|0|||
130269141|NCT03008070|468949797|FG000|Overall Study|Adverse Event|3|||
130269142|NCT03008070|468949798|FG001|Overall Study|Adverse Event|3|||
130269143|NCT03008070|468949799|FG002|Overall Study|Adverse Event|3|||
130269144|NCT03008070|468949797|FG000|Overall Study|Lost to Follow-up|1|||
130269145|NCT03008070|468949798|FG001|Overall Study|Lost to Follow-up|1|||
130269146|NCT03008070|468949799|FG002|Overall Study|Lost to Follow-up|0|||
130269147|NCT03008070|468949797|FG000|Overall Study|Non compliance|0|||
130269148|NCT03008070|468949798|FG001|Overall Study|Non compliance|1|||
130269149|NCT03008070|468949799|FG002|Overall Study|Non compliance|1|||
130269150|NCT03008070|468949797|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
130269151|NCT03008070|468949798|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
130269152|NCT03008070|468949799|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
130269153|NCT03008070|468949797|FG000|Overall Study|Withdrawal by Subject|2|||
130269154|NCT03008070|468949798|FG001|Overall Study|Withdrawal by Subject|0|||
130269155|NCT03008070|468949799|FG002|Overall Study|Withdrawal by Subject|1|||
130269156|NCT03008070|468949797|FG000|Overall Study|Use of prohibited drug|0|||
130269157|NCT03008070|468949798|FG001|Overall Study|Use of prohibited drug|0|||
130269158|NCT03008070|468949799|FG002|Overall Study|Use of prohibited drug|2|||
130269159|NCT04409834|468949802|FG000|Overall Study|Death|55|||
130269160|NCT04409834|468949803|FG001|Overall Study|Death|62|||
130269161|NCT01365455|468949804|FG000|Induction Period|Adverse Event|5|||
130269162|NCT01365455|468949805|FG001|Induction Period|Adverse Event|3|||
130269163|NCT01365455|468949806|FG002|Induction Period|Adverse Event|4|||
130269164|NCT01365455|468949807|FG003|Induction Period|Adverse Event|0|||
130269165|NCT01365455|468949808|FG004|Induction Period|Adverse Event|0|||
130269166|NCT01365455|468949804|FG000|Induction Period|Lack of Efficacy|1|||
130269167|NCT01365455|468949805|FG001|Induction Period|Lack of Efficacy|1|||
130269168|NCT01365455|468949806|FG002|Induction Period|Lack of Efficacy|0|||
130269169|NCT01365455|468949807|FG003|Induction Period|Lack of Efficacy|0|||
130269170|NCT01365455|468949808|FG004|Induction Period|Lack of Efficacy|0|||
130269171|NCT01365455|468949804|FG000|Induction Period|Pregnancy|0|||
130269172|NCT01365455|468949805|FG001|Induction Period|Pregnancy|1|||
130269173|NCT01365455|468949806|FG002|Induction Period|Pregnancy|0|||
130269174|NCT01365455|468949807|FG003|Induction Period|Pregnancy|0|||
130269175|NCT01365455|468949808|FG004|Induction Period|Pregnancy|0|||
130269176|NCT01365455|468949804|FG000|Induction Period|Protocol deviation|0|||
130269177|NCT01365455|468949805|FG001|Induction Period|Protocol deviation|1|||
130269178|NCT01365455|468949806|FG002|Induction Period|Protocol deviation|1|||
130269179|NCT01365455|468949807|FG003|Induction Period|Protocol deviation|0|||
130269180|NCT01365455|468949808|FG004|Induction Period|Protocol deviation|0|||
130269181|NCT01365455|468949804|FG000|Induction Period|Subject/guardian decision|9|||
130269182|NCT01365455|468949805|FG001|Induction Period|Subject/guardian decision|1|||
130269183|NCT01365455|468949806|FG002|Induction Period|Subject/guardian decision|8|||
130269184|NCT01365455|468949807|FG003|Induction Period|Subject/guardian decision|0|||
130269185|NCT01365455|468949808|FG004|Induction Period|Subject/guardian decision|0|||
130269186|NCT01365455|468949804|FG000|Induction Period|Lost to Follow-up|0|||
130269187|NCT01365455|468949805|FG001|Induction Period|Lost to Follow-up|0|||
130269188|NCT01365455|468949806|FG002|Induction Period|Lost to Follow-up|3|||
130269189|NCT01365455|468949807|FG003|Induction Period|Lost to Follow-up|0|||
130269190|NCT01365455|468949808|FG004|Induction Period|Lost to Follow-up|0|||
130269191|NCT01365455|468949804|FG000|Maintenance Period|Adverse Event|12|||
130269192|NCT01365455|468949805|FG001|Maintenance Period|Adverse Event|5|||
130269193|NCT01365455|468949806|FG002|Maintenance Period|Adverse Event|1|||
130269194|NCT01365455|468949807|FG003|Maintenance Period|Adverse Event|2|||
130269195|NCT01365455|468949808|FG004|Maintenance Period|Adverse Event|4|||
130269196|NCT01365455|468949804|FG000|Maintenance Period|Lack of Efficacy|10|||
130269197|NCT01365455|468949805|FG001|Maintenance Period|Lack of Efficacy|2|||
130269198|NCT01365455|468949806|FG002|Maintenance Period|Lack of Efficacy|0|||
130269199|NCT01365455|468949807|FG003|Maintenance Period|Lack of Efficacy|2|||
130269200|NCT01365455|468949808|FG004|Maintenance Period|Lack of Efficacy|2|||
130269201|NCT01365455|468949804|FG000|Maintenance Period|Lost to Follow-up|2|||
130269202|NCT01365455|468949805|FG001|Maintenance Period|Lost to Follow-up|4|||
130269203|NCT01365455|468949806|FG002|Maintenance Period|Lost to Follow-up|0|||
130269204|NCT01365455|468949807|FG003|Maintenance Period|Lost to Follow-up|0|||
129885911|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885912|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
130269205|NCT01365455|468949808|FG004|Maintenance Period|Lost to Follow-up|3|||
130269206|NCT01365455|468949804|FG000|Maintenance Period|Non-compliance with study treatment|0|||
130269207|NCT01365455|468949805|FG001|Maintenance Period|Non-compliance with study treatment|0|||
130269208|NCT01365455|468949806|FG002|Maintenance Period|Non-compliance with study treatment|0|||
130269209|NCT01365455|468949807|FG003|Maintenance Period|Non-compliance with study treatment|1|||
130269210|NCT01365455|468949808|FG004|Maintenance Period|Non-compliance with study treatment|0|||
130269211|NCT01365455|468949804|FG000|Maintenance Period|Physician Decision|0|||
130269212|NCT01365455|468949805|FG001|Maintenance Period|Physician Decision|1|||
130269213|NCT01365455|468949806|FG002|Maintenance Period|Physician Decision|0|||
130269214|NCT01365455|468949807|FG003|Maintenance Period|Physician Decision|0|||
130269215|NCT01365455|468949808|FG004|Maintenance Period|Physician Decision|1|||
130269216|NCT01365455|468949804|FG000|Maintenance Period|Pregnancy|0|||
130269217|NCT01365455|468949805|FG001|Maintenance Period|Pregnancy|4|||
130269218|NCT01365455|468949806|FG002|Maintenance Period|Pregnancy|0|||
130269219|NCT01365455|468949807|FG003|Maintenance Period|Pregnancy|0|||
130269220|NCT01365455|468949808|FG004|Maintenance Period|Pregnancy|2|||
130269221|NCT01365455|468949804|FG000|Maintenance Period|Protocol deviation|1|||
130269222|NCT01365455|468949805|FG001|Maintenance Period|Protocol deviation|1|||
130269223|NCT01365455|468949806|FG002|Maintenance Period|Protocol deviation|0|||
130269224|NCT01365455|468949807|FG003|Maintenance Period|Protocol deviation|0|||
130269225|NCT01365455|468949808|FG004|Maintenance Period|Protocol deviation|0|||
130269226|NCT01365455|468949804|FG000|Maintenance Period|Subject/guardian decision|4|||
130269227|NCT01365455|468949805|FG001|Maintenance Period|Subject/guardian decision|6|||
130269228|NCT01365455|468949806|FG002|Maintenance Period|Subject/guardian decision|2|||
130269229|NCT01365455|468949807|FG003|Maintenance Period|Subject/guardian decision|4|||
130269230|NCT01365455|468949808|FG004|Maintenance Period|Subject/guardian decision|1|||
130269231|NCT00928187|468949809|FG000|Overall Study|Death|1|||
130269232|NCT00928187|468949810|FG001|Overall Study|Death|2|||
130269233|NCT00928187|468949811|FG002|Overall Study|Death|3|||
130269234|NCT00928187|468949809|FG000|Overall Study|Lost to Follow-up|1|||
130269235|NCT00928187|468949810|FG001|Overall Study|Lost to Follow-up|2|||
130269236|NCT00928187|468949811|FG002|Overall Study|Lost to Follow-up|1|||
130269237|NCT00928187|468949809|FG000|Overall Study|Withdrawal by Subject|0|||
130269238|NCT00928187|468949810|FG001|Overall Study|Withdrawal by Subject|1|||
130269239|NCT00928187|468949811|FG002|Overall Study|Withdrawal by Subject|1|||
130269240|NCT00928187|468949809|FG000|Overall Study|Protocol Violation|0|||
130269241|NCT00928187|468949810|FG001|Overall Study|Protocol Violation|1|||
130269242|NCT00928187|468949811|FG002|Overall Study|Protocol Violation|0|||
130269243|NCT04790279|468950846|FG000|Overall Study|Did not meet medication start criteria|27|||
130269244|NCT04790279|468950847|FG001|Overall Study|Did not meet medication start criteria|15|||
130269245|NCT04790279|468950846|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
130269246|NCT04790279|468950847|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
130269247|NCT04790279|468950846|FG000|Overall Study|Protocol Violation|8|||
130269248|NCT04790279|468950847|FG001|Overall Study|Protocol Violation|3|||
130269249|NCT04790279|468950846|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
130269250|NCT04790279|468950847|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
130269251|NCT00810277|468950860|FG000|Overall Study|Adverse Event|1|||
130269252|NCT02079909|468950863|FG000|Overall Study|Adverse Event|23|||
130269253|NCT02079909|468950864|FG001|Overall Study|Adverse Event|23|||
130103637|NCT03692078|468338687|FG002|Overall Study|Withdrawal by Subject|0|||
130269254|NCT02079909|468950865|FG002|Overall Study|Adverse Event|7|||
130269255|NCT02079909|468950863|FG000|Overall Study|Withdrawal by Subject|9|||
130269256|NCT02079909|468950864|FG001|Overall Study|Withdrawal by Subject|17|||
130269257|NCT02079909|468950865|FG002|Overall Study|Withdrawal by Subject|4|||
130269258|NCT02079909|468950863|FG000|Overall Study|Lost to Follow-up|2|||
130269259|NCT02079909|468950864|FG001|Overall Study|Lost to Follow-up|3|||
130269260|NCT02079909|468950865|FG002|Overall Study|Lost to Follow-up|1|||
129885913|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885914|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885915|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
130036888|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
130036889|NCT02660580|468090362|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
130036890|NCT02660580|468090363|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
130269261|NCT02079909|468950863|FG000|Overall Study|Death|2|||
130269262|NCT02079909|468950864|FG001|Overall Study|Death|2|||
130269263|NCT02079909|468950865|FG002|Overall Study|Death|0|||
130269264|NCT02079909|468950863|FG000|Overall Study|Lack of Efficacy|0|||
130269265|NCT02079909|468950864|FG001|Overall Study|Lack of Efficacy|0|||
130269266|NCT02079909|468950865|FG002|Overall Study|Lack of Efficacy|1|||
130269267|NCT02079909|468950863|FG000|Overall Study|Protocol Violation|0|||
130269268|NCT02079909|468950864|FG001|Overall Study|Protocol Violation|1|||
130269269|NCT02079909|468950865|FG002|Overall Study|Protocol Violation|1|||
130269270|NCT02079909|468950863|FG000|Overall Study|Physician Decision|0|||
130269271|NCT02079909|468950864|FG001|Overall Study|Physician Decision|1|||
130269272|NCT02079909|468950865|FG002|Overall Study|Physician Decision|1|||
130269273|NCT02079909|468950863|FG000|Overall Study|Relocation etc.|2|||
130036891|NCT02660580|468090364|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
130036892|NCT02660580|468090365|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
130036893|NCT02660580|468090366|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
130036894|NCT02660580|468090362|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
130269274|NCT02079909|468950864|FG001|Overall Study|Relocation etc.|2|||
130269275|NCT02079909|468950865|FG002|Overall Study|Relocation etc.|3|||
130269276|NCT00720356|468950870|FG000|Registration to Study|Determined to have methylated MGMT|67|||
130269277|NCT00720356|468950870|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130269278|NCT00720356|468950870|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
130269279|NCT00720356|468950870|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
130269280|NCT00720356|468950870|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
130269281|NCT00720356|468950870|FG000|Follow up Until Death|Withdrawal by Subject|1|||
130269282|NCT00720356|468950870|FG000|Follow up Until Death|Alive at last data collection|4|||
130269283|NCT03145064|468950875|FG000|Overall Study|Death|24|||
130269284|NCT03145064|468950875|FG000|Overall Study|Lost to Follow-up|3|||
130269285|NCT03145064|468950875|FG000|Overall Study|Withdrawal by Subject|6|||
130269286|NCT03145064|468950875|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
130269287|NCT03145064|468950875|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
130269288|NCT01693250|468950876|FG000|Overall Study|Lost to Follow-up|2|||
130269289|NCT01693250|468950877|FG001|Overall Study|Lost to Follow-up|2|||
130269290|NCT00628446|468950878|FG000|Overall Study|Lost to Follow-up|3|||
130269291|NCT00628446|468950878|FG000|Overall Study|Withdrawal by Subject|1|||
130269292|NCT00628446|468950878|FG000|Overall Study|Protocol Violation|3|||
130269293|NCT01396187|468950879|FG000|Overall Study|Adverse Event|0|||
130269294|NCT01396187|468950880|FG001|Overall Study|Adverse Event|1|||
130269295|NCT01396187|468950881|FG002|Overall Study|Adverse Event|0|||
130269296|NCT01396187|468950882|FG003|Overall Study|Adverse Event|0|||
130269297|NCT01396187|468950883|FG004|Overall Study|Adverse Event|0|||
130269298|NCT01396187|468950879|FG000|Overall Study|Withdrawal by Subject|0|||
130103638|NCT03692078|468338688|FG003|Overall Study|Withdrawal by Subject|1|||
130269299|NCT01396187|468950880|FG001|Overall Study|Withdrawal by Subject|1|||
129885916|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
129885917|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
130269300|NCT01396187|468950881|FG002|Overall Study|Withdrawal by Subject|1|||
130269301|NCT01396187|468950882|FG003|Overall Study|Withdrawal by Subject|0|||
130269302|NCT01396187|468950883|FG004|Overall Study|Withdrawal by Subject|0|||
130269303|NCT01396187|468950879|FG000|Overall Study|Other|1|||
130269304|NCT01396187|468950880|FG001|Overall Study|Other|1|||
130269305|NCT01396187|468950881|FG002|Overall Study|Other|0|||
130269306|NCT01396187|468950882|FG003|Overall Study|Other|0|||
130269307|NCT01396187|468950883|FG004|Overall Study|Other|1|||
130269308|NCT01898286|468950884|FG000|Overall Study|Withdrawal by Subject|1|||
130269309|NCT01898286|468950884|FG000|Overall Study|Protocol Violation|1|||
130269310|NCT01898286|468950884|FG000|Overall Study|Lost to Follow-up|1|||
130269311|NCT02257242|468950885|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
130269312|NCT02257242|468950886|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269313|NCT02257242|468950887|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269314|NCT02257242|468950888|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129885918|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
129885919|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
129885920|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
129885921|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
130269315|NCT02257242|468950889|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269316|NCT02257242|468950890|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269317|NCT02257242|468950891|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269318|NCT02257242|468950892|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269319|NCT02257242|468950893|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
130269320|NCT01650831|468950900|FG000|Overall Study|Screen failure|1|||
130269321|NCT01048242|468950903|FG000|Overall Study|See study flow chart|4|||
130269322|NCT01048242|468950904|FG001|Overall Study|See study flow chart|2|||
130269323|NCT02964273|468950905|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
130269324|NCT02964273|468950906|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130269325|NCT02964273|468950907|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129885922|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
129885923|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
130269326|NCT02964273|468950908|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
130269327|NCT02964273|468950905|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130269328|NCT02964273|468950906|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
130269329|NCT02964273|468950907|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
130269330|NCT02964273|468950908|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129885924|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
130036895|NCT02660580|468090363|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
130036896|NCT02660580|468090364|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
130036897|NCT02660580|468090365|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
130036898|NCT02660580|468090366|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
130269331|NCT02964273|468950905|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
130269332|NCT02964273|468950906|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
130269333|NCT02964273|468950907|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
130269334|NCT02964273|468950908|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
129885925|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
129885926|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
129885927|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
129885928|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
129885929|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
130269335|NCT02964273|468950905|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130269336|NCT02964273|468950906|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130269337|NCT02964273|468950907|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
130269338|NCT02964273|468950908|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
130269339|NCT02964273|468950905|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
129885930|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
129885931|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Physician Decision|0|||
129885932|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Physician Decision|2|||
129885933|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Physician Decision|0|||
130036899|NCT02660580|468090362|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
130036900|NCT02660580|468090363|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
130036901|NCT02660580|468090364|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
130269340|NCT02964273|468950906|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
130269341|NCT02964273|468950907|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
130269342|NCT02964273|468950908|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
130269343|NCT02964273|468950905|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
130269344|NCT02964273|468950906|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
130269345|NCT02964273|468950907|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
130269346|NCT02964273|468950908|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
130269347|NCT01453036|468950910|FG000|Overall Study|Lost to Follow-up|26|||
130269348|NCT01453036|468950911|FG001|Overall Study|Lost to Follow-up|115|||
130269349|NCT01453036|468950912|FG002|Overall Study|Lost to Follow-up|31|||
130269350|NCT00559104|468950913|FG000|Overall Study|Lack of Efficacy|9|||
130269351|NCT00559104|468950914|FG001|Overall Study|Lack of Efficacy|0|||
130269352|NCT01336712|468950915|FG000|Overall Study|Death|2|||
130269353|NCT01336712|468950915|FG000|Overall Study|Lack of Efficacy|1|||
130269354|NCT00620373|468950917|FG000|Overall Study|Unverified cancer status|33|||
130269355|NCT03073525|468950918|FG000|Overall Study|Withdrawal by Subject|0|||
130269356|NCT03073525|468950919|FG001|Overall Study|Withdrawal by Subject|0|||
130269357|NCT03073525|468950920|FG002|Overall Study|Withdrawal by Subject|3|||
130269358|NCT01273038|468950921|FG000|Second Intervention (14 Days)|Adverse Event|0|||
130269359|NCT01273038|468950922|FG001|Second Intervention (14 Days)|Adverse Event|1|||
130269360|NCT01273038|468950921|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
130036902|NCT02660580|468090365|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
130036903|NCT02660580|468090366|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
130036904|NCT02660580|468090362|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
130036905|NCT02660580|468090363|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
130036906|NCT02660580|468090364|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
130036907|NCT02660580|468090365|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
130036908|NCT02660580|468090366|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
130036909|NCT02660580|468090362|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
130036910|NCT02660580|468090363|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
130036911|NCT02660580|468090364|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
130036912|NCT02660580|468090365|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
130036913|NCT02660580|468090366|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
130036914|NCT02660580|468090362|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
130036915|NCT02660580|468090363|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
130036916|NCT02660580|468090364|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
130036917|NCT02660580|468090365|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
130036918|NCT02660580|468090366|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
130036919|NCT02660580|468090362|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
130036920|NCT02660580|468090363|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
130036921|NCT02660580|468090364|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
130036922|NCT02660580|468090365|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
130036923|NCT02660580|468090366|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
130036924|NCT00377962|468090367|FG000|Core Study: 0-12 Months|Adverse Event|18|||
130036925|NCT00377962|468090368|FG001|Core Study: 0-12 Months|Adverse Event|2|||
130036926|NCT00377962|468090367|FG000|Core Study: 0-12 Months|Death|3|||
130036927|NCT00377962|468090368|FG001|Core Study: 0-12 Months|Death|0|||
130036928|NCT00377962|468090367|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
130036929|NCT00377962|468090368|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
130036930|NCT00377962|468090367|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
130036931|NCT00377962|468090368|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
130036932|NCT00377962|468090367|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
130036933|NCT00377962|468090368|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
130036934|NCT00377962|468090367|FG000|Extension Study: 12-24 Months|Death|1|||
130036935|NCT00377962|468090368|FG001|Extension Study: 12-24 Months|Death|1|||
130036936|NCT00377962|468090367|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
130036937|NCT00377962|468090368|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
130036938|NCT00377962|468090367|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
130036939|NCT00377962|468090368|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
130036940|NCT00377962|468090367|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
130036941|NCT00377962|468090368|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
130036942|NCT01381094|468090369|FG000|Overall Study|Adverse Event|1|||
130036943|NCT01381094|468090370|FG001|Overall Study|Adverse Event|2|||
130036944|NCT01381094|468090371|FG002|Overall Study|Adverse Event|0|||
130036945|NCT01381094|468090372|FG003|Overall Study|Adverse Event|1|||
130036946|NCT01381094|468090373|FG004|Overall Study|Adverse Event|0|||
130036947|NCT01381094|468090369|FG000|Overall Study|Lost to Follow-up|0|||
130269361|NCT01273038|468950922|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
130269362|NCT01976299|468950923|FG000|Overall Study|Withdrawal by Subject|3|||
130269363|NCT01976299|468950924|FG001|Overall Study|Withdrawal by Subject|1|||
130269364|NCT01976299|468950923|FG000|Overall Study|Death|4|||
130036948|NCT01381094|468090370|FG001|Overall Study|Lost to Follow-up|0|||
130036949|NCT01381094|468090371|FG002|Overall Study|Lost to Follow-up|0|||
130036950|NCT01381094|468090372|FG003|Overall Study|Lost to Follow-up|0|||
130036951|NCT01381094|468090373|FG004|Overall Study|Lost to Follow-up|1|||
130036952|NCT01381094|468090369|FG000|Overall Study|Withdrawal of informed consent|0|||
130036953|NCT01381094|468090370|FG001|Overall Study|Withdrawal of informed consent|1|||
130036954|NCT01381094|468090371|FG002|Overall Study|Withdrawal of informed consent|0|||
130269365|NCT01976299|468950924|FG001|Overall Study|Death|2|||
130269366|NCT01976299|468950923|FG000|Overall Study|Lost to Follow-up|7|||
130269367|NCT01976299|468950924|FG001|Overall Study|Lost to Follow-up|1|||
130269368|NCT01976299|468950923|FG000|Overall Study|See clarification above in comments|9|||
130269369|NCT01976299|468950924|FG001|Overall Study|See clarification above in comments|2|||
130269370|NCT01306643|468950925|FG000|Overall Study|Adverse Event|5|||
130269371|NCT01306643|468950925|FG000|Overall Study|Disease Progression|7|||
130269372|NCT01306643|468950925|FG000|Overall Study|Other: Change in Eligibility Status|1|||
130269373|NCT02071771|468950928|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
130269374|NCT02071771|468950929|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
130269375|NCT02071771|468950928|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
130269376|NCT02071771|468950929|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
130269377|NCT00355368|468950933|FG000|Overall Study|Protocol Violation|8|||
130269378|NCT00355368|468950934|FG001|Overall Study|Protocol Violation|7|||
130269379|NCT00355368|468950933|FG000|Overall Study|cardiac arrest prior to intubation|2|||
130269380|NCT00355368|468950934|FG001|Overall Study|cardiac arrest prior to intubation|2|||
130269381|NCT01152788|468950938|FG000|Overall Study|Withdrawal by Subject|0|||
130269382|NCT01152788|468950939|FG001|Overall Study|Withdrawal by Subject|3|||
130269383|NCT01152788|468950938|FG000|Overall Study|No treatment|0|||
130269384|NCT01152788|468950939|FG001|Overall Study|No treatment|1|||
130269385|NCT01282866|468950940|FG000|Overall Study|Adverse Event|1|||
130269386|NCT01964378|468950945|FG000|Overall Study|Disc. due to death before first dosing|0|||
130269387|NCT01964378|468950946|FG001|Overall Study|Disc. due to death before first dosing|1|||
130269388|NCT01964378|468950945|FG000|Overall Study|Disc. due to AE before first dosing|1|||
130269389|NCT01964378|468950946|FG001|Overall Study|Disc. due to AE before first dosing|0|||
130269390|NCT01964378|468950945|FG000|Overall Study|Death|3|||
130269391|NCT01964378|468950946|FG001|Overall Study|Death|2|||
130269392|NCT01964378|468950945|FG000|Overall Study|Adverse Event|12|||
130269393|NCT01964378|468950946|FG001|Overall Study|Adverse Event|5|||
130269394|NCT01964378|468950945|FG000|Overall Study|Lack of Efficacy|0|||
130269395|NCT01964378|468950946|FG001|Overall Study|Lack of Efficacy|1|||
130269396|NCT01964378|468950945|FG000|Overall Study|Protocol Violation|0|||
130269397|NCT01964378|468950946|FG001|Overall Study|Protocol Violation|1|||
130269398|NCT01964378|468950945|FG000|Overall Study|Lost to Follow-up|0|||
130269399|NCT01964378|468950946|FG001|Overall Study|Lost to Follow-up|1|||
130269400|NCT01964378|468950945|FG000|Overall Study|Withdrawal by Subject|7|||
130269401|NCT01964378|468950946|FG001|Overall Study|Withdrawal by Subject|5|||
130269402|NCT01964378|468950945|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130269403|NCT01964378|468950946|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
130269404|NCT01964378|468950945|FG000|Overall Study|Other|1|||
130269405|NCT01964378|468950946|FG001|Overall Study|Other|2|||
130269406|NCT01928433|468950953|FG000|Overall Study|Adverse Event|5|||
130269407|NCT01928433|468950954|FG001|Overall Study|Adverse Event|2|||
130269408|NCT01928433|468950955|FG002|Overall Study|Adverse Event|5|||
130269409|NCT01928433|468950953|FG000|Overall Study|Protocol Violation|0|||
130269410|NCT01928433|468950954|FG001|Overall Study|Protocol Violation|0|||
130269411|NCT01928433|468950955|FG002|Overall Study|Protocol Violation|2|||
130269412|NCT01928433|468950953|FG000|Overall Study|Lack of Efficacy|5|||
130269413|NCT01928433|468950954|FG001|Overall Study|Lack of Efficacy|4|||
130269414|NCT01928433|468950955|FG002|Overall Study|Lack of Efficacy|4|||
130269415|NCT01928433|468950953|FG000|Overall Study|Withdrawal by Subject|0|||
130269416|NCT01928433|468950954|FG001|Overall Study|Withdrawal by Subject|4|||
130269417|NCT01928433|468950955|FG002|Overall Study|Withdrawal by Subject|0|||
130269418|NCT01928433|468950953|FG000|Overall Study|Negative screening urine culture|7|||
130269419|NCT01928433|468950954|FG001|Overall Study|Negative screening urine culture|6|||
130269420|NCT01928433|468950955|FG002|Overall Study|Negative screening urine culture|10|||
130269421|NCT01928433|468950953|FG000|Overall Study|Lost to Follow-up|0|||
130269422|NCT01928433|468950954|FG001|Overall Study|Lost to Follow-up|2|||
130269423|NCT01928433|468950955|FG002|Overall Study|Lost to Follow-up|3|||
130269424|NCT01928433|468950953|FG000|Overall Study|Other reasons|3|||
130269425|NCT01928433|468950954|FG001|Overall Study|Other reasons|3|||
130269426|NCT01928433|468950955|FG002|Overall Study|Other reasons|4|||
130269427|NCT01392573|468950956|FG000|Overall Study|Adverse Event|1|||
130269428|NCT01392573|468950957|FG001|Overall Study|Adverse Event|3|||
130269429|NCT01392573|468950956|FG000|Overall Study|Lack of Efficacy|1|||
130269430|NCT01392573|468950957|FG001|Overall Study|Lack of Efficacy|2|||
130269431|NCT01392573|468950956|FG000|Overall Study|Protocol Violation|0|||
130269432|NCT01392573|468950957|FG001|Overall Study|Protocol Violation|2|||
130103639|NCT03692078|468338689|FG004|Overall Study|Withdrawal by Subject|5|||
130269433|NCT01392573|468950956|FG000|Overall Study|Withdrawal Criteria|13|||
130269434|NCT01392573|468950957|FG001|Overall Study|Withdrawal Criteria|15|||
130269435|NCT01392573|468950956|FG000|Overall Study|Site closure|8|||
130269436|NCT01392573|468950957|FG001|Overall Study|Site closure|7|||
130269437|NCT01392573|468950956|FG000|Overall Study|Unclassified|9|||
130269438|NCT01392573|468950957|FG001|Overall Study|Unclassified|6|||
130269439|NCT00436436|468950958|FG000|Overall Study|Progression|4|||
130269440|NCT00436436|468950958|FG000|Overall Study|Adverse Event|2|||
130269441|NCT00436436|468950958|FG000|Overall Study|Death|6|||
130269442|NCT01102491|468950965|FG000|Overall Study|Protocol Violation|11|||
130269443|NCT01102491|468950966|FG001|Overall Study|Protocol Violation|12|||
130269444|NCT02151786|468950967|FG000|Overall Study|Unavailability of Case Report Form|26|||
130269445|NCT02151786|468950967|FG000|Overall Study|Outside the Contract Period|1|||
130269446|NCT02151786|468950967|FG000|Overall Study|Randomized, not Treated|1|||
130269447|NCT02151786|468950967|FG000|Overall Study|Unavailability of Information|8|||
130269448|NCT03533660|468950968|FG000|Overall Study|Withdrawal by Subject|2|||
130269449|NCT03533660|468950969|FG001|Overall Study|Withdrawal by Subject|2|||
130269450|NCT03533660|468950968|FG000|Overall Study|Death|2|||
130269451|NCT03533660|468950969|FG001|Overall Study|Death|4|||
130269452|NCT03533660|468950968|FG000|Overall Study|Adverse Event|0|||
130269453|NCT03533660|468950969|FG001|Overall Study|Adverse Event|2|||
130269454|NCT00996658|468950970|FG000|Overall Study|Adverse Event|2|||
130269455|NCT00996658|468950971|FG001|Overall Study|Adverse Event|5|||
130269456|NCT00996658|468950970|FG000|Overall Study|Protocol Violation|0|||
130269457|NCT00996658|468950971|FG001|Overall Study|Protocol Violation|1|||
130269458|NCT00996658|468950970|FG000|Overall Study|Lost to Follow-up|2|||
130269459|NCT00996658|468950971|FG001|Overall Study|Lost to Follow-up|5|||
130269460|NCT00996658|468950970|FG000|Overall Study|Non-compliance issues|3|||
130269461|NCT00996658|468950971|FG001|Overall Study|Non-compliance issues|3|||
130269462|NCT00996658|468950970|FG000|Overall Study|Other|9|||
130269463|NCT00996658|468950971|FG001|Overall Study|Other|7|||
130269464|NCT03692403|468953032|FG000|Overall Study|Withdrawal by Subject|1|||
130269465|NCT03692403|468953033|FG001|Overall Study|Withdrawal by Subject|0|||
130269466|NCT03692403|468953034|FG002|Overall Study|Withdrawal by Subject|1|||
130269467|NCT03692403|468953035|FG003|Overall Study|Withdrawal by Subject|0|||
130269468|NCT03692403|468953032|FG000|Overall Study|Adverse Event|0|||
130269469|NCT03692403|468953033|FG001|Overall Study|Adverse Event|0|||
130269470|NCT03692403|468953034|FG002|Overall Study|Adverse Event|0|||
130269471|NCT03692403|468953035|FG003|Overall Study|Adverse Event|1|||
130269472|NCT03692403|468953032|FG000|Overall Study|Pregnancy|0|||
130269473|NCT03692403|468953033|FG001|Overall Study|Pregnancy|1|||
130269474|NCT03692403|468953034|FG002|Overall Study|Pregnancy|0|||
130269475|NCT03692403|468953035|FG003|Overall Study|Pregnancy|0|||
130269476|NCT03692403|468953032|FG000|Overall Study|Other|0|||
130269477|NCT03692403|468953033|FG001|Overall Study|Other|0|||
130269478|NCT03692403|468953034|FG002|Overall Study|Other|1|||
130269479|NCT03692403|468953035|FG003|Overall Study|Other|0|||
130269480|NCT01147393|468953036|FG000|Dose Level 1|Dose limiting Toxicity|2|||
130269481|NCT01147393|468953036|FG000|Dose Level -1|Dose Limited Toxicity|1|||
130269482|NCT01408277|468953040|FG000|Overall Study|Adverse Event|3|||
129885934|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Physician Decision|0|||
129885935|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Physician Decision|3|||
129885936|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Physician Decision|0|||
129885937|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Physician Decision|0|||
129885938|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Physician Decision|0|||
129885939|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Physician Decision|0|||
129885940|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Physician Decision|0|||
129885941|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Physician Decision|1|||
129885942|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Physician Decision|3|||
129885943|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Physician Decision|0|||
129885944|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Not Treated|0|||
129885945|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Not Treated|0|||
129885946|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Not Treated|2|||
129885947|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Not Treated|0|||
129885948|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Not Treated|0|||
129885949|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Not Treated|0|||
129885950|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Not Treated|0|||
129885951|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Not Treated|0|||
129885952|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Not Treated|0|||
129885953|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Not Treated|0|||
129885954|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Not Treated|0|||
129885955|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Not Treated|0|||
129885956|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Not Treated|0|||
129885957|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885958|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
129885959|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885960|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885961|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885962|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885963|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885964|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885965|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885966|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885967|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885968|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885969|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
130036955|NCT01381094|468090372|FG003|Overall Study|Withdrawal of informed consent|0|||
130036956|NCT01381094|468090373|FG004|Overall Study|Withdrawal of informed consent|0|||
130036957|NCT01381094|468090369|FG000|Overall Study|Participant given Aranesp injection|1|||
130036958|NCT01381094|468090370|FG001|Overall Study|Participant given Aranesp injection|0|||
130036959|NCT01381094|468090371|FG002|Overall Study|Participant given Aranesp injection|0|||
130036960|NCT01381094|468090372|FG003|Overall Study|Participant given Aranesp injection|0|||
130036961|NCT01381094|468090373|FG004|Overall Study|Participant given Aranesp injection|0|||
130036962|NCT04178590|468090376|FG000|Overall Study|Pregnancy|1|||
130036963|NCT04178590|468090376|FG000|Overall Study|Lost to Follow-up|1|||
130036964|NCT01389245|468090377|FG000|Overall Study|Protocol Violation|10|||
130036965|NCT01389245|468090377|FG000|Overall Study|Lost to Follow-up|3|||
130036966|NCT01389245|468090377|FG000|Overall Study|Withdrawal by Subject|2|||
130036967|NCT02292849|468090378|FG000|Overall Study|Lost to Follow-up|0|||
130036968|NCT02292849|468090379|FG001|Overall Study|Lost to Follow-up|2|||
130036969|NCT02292849|468090380|FG002|Overall Study|Lost to Follow-up|2|||
130036970|NCT02292849|468090378|FG000|Overall Study|Physician Decision|4|||
130036971|NCT02292849|468090379|FG001|Overall Study|Physician Decision|0|||
130036972|NCT02292849|468090380|FG002|Overall Study|Physician Decision|0|||
130036973|NCT00886938|468090381|FG000|Overall Study|Adverse Event|1|||
130036974|NCT00886938|468090381|FG000|Overall Study|Withdrawal by Subject|1|||
130036975|NCT00364793|468090382|FG000|Overall Study|Adverse Event|2|||
130036976|NCT00364793|468090383|FG001|Overall Study|Adverse Event|0|||
130036977|NCT00364793|468090384|FG002|Overall Study|Adverse Event|0|||
130036978|NCT00364793|468090385|FG003|Overall Study|Adverse Event|0|||
130036979|NCT00364793|468090382|FG000|Overall Study|Death|1|||
130036980|NCT00364793|468090383|FG001|Overall Study|Death|0|||
130036981|NCT00364793|468090384|FG002|Overall Study|Death|1|||
130036982|NCT00364793|468090385|FG003|Overall Study|Death|0|||
130036983|NCT00364793|468090382|FG000|Overall Study|Lack of Efficacy|3|||
130036984|NCT00364793|468090383|FG001|Overall Study|Lack of Efficacy|3|||
130036985|NCT00364793|468090384|FG002|Overall Study|Lack of Efficacy|1|||
130036986|NCT00364793|468090385|FG003|Overall Study|Lack of Efficacy|1|||
130036987|NCT00364793|468090382|FG000|Overall Study|Lost to Follow-up|1|||
130036988|NCT00364793|468090383|FG001|Overall Study|Lost to Follow-up|0|||
130036989|NCT00364793|468090384|FG002|Overall Study|Lost to Follow-up|2|||
130036990|NCT00364793|468090385|FG003|Overall Study|Lost to Follow-up|0|||
130036991|NCT00364793|468090382|FG000|Overall Study|Poor or non-compliance|1|||
130036992|NCT00364793|468090383|FG001|Overall Study|Poor or non-compliance|1|||
130103640|NCT03692078|468338690|FG005|Overall Study|Withdrawal by Subject|3|||
130103641|NCT03692078|468338691|FG006|Overall Study|Withdrawal by Subject|3|||
130103642|NCT01563029|468338692|FG000|Overall Study|Adverse Event|1|||
130103643|NCT01563029|468338693|FG001|Overall Study|Adverse Event|0|||
130103644|NCT01563029|468338694|FG002|Overall Study|Adverse Event|1|||
130103645|NCT01563029|468338695|FG003|Overall Study|Adverse Event|2|||
130269483|NCT01408277|468953041|FG001|Overall Study|Adverse Event|4|||
130269484|NCT01408277|468953040|FG000|Overall Study|Lost to Follow-up|1|||
130269485|NCT01408277|468953041|FG001|Overall Study|Lost to Follow-up|0|||
130269486|NCT01408277|468953040|FG000|Overall Study|Withdrawal by Subject|2|||
130269487|NCT01408277|468953041|FG001|Overall Study|Withdrawal by Subject|0|||
130269488|NCT01408277|468953040|FG000|Overall Study|Protocol Violation|2|||
130269489|NCT01408277|468953041|FG001|Overall Study|Protocol Violation|0|||
130269490|NCT01349673|468953042|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
130269491|NCT01349673|468953042|FG000|Overall Study|No Longer Qualified For Study|1|||
130269492|NCT01349673|468953042|FG000|Overall Study|Site Closure|10|||
130269493|NCT01349673|468953042|FG000|Overall Study|Withdrawal by Subject|21|||
130269494|NCT01349673|468953042|FG000|Overall Study|Lost to Follow-up|6|||
130269495|NCT01349673|468953042|FG000|Overall Study|Adverse Event|17|||
130269496|NCT01349673|468953042|FG000|Overall Study|Study Terminated By Sponsor|50|||
130269497|NCT01349673|468953042|FG000|Overall Study|Lack of Efficacy|8|||
130269498|NCT04263766|468953045|FG000|Overall Study|Withdrawal by Subject|6|||
130269499|NCT04263766|468953046|FG001|Overall Study|Withdrawal by Subject|4|||
130269500|NCT04263766|468953045|FG000|Overall Study|Lack of Efficacy|1|||
130269501|NCT04263766|468953046|FG001|Overall Study|Lack of Efficacy|3|||
130269502|NCT01891396|468953048|FG000|Overall Study|Withdrawal by Subject|4|||
130269503|NCT01891396|468953049|FG001|Overall Study|Withdrawal by Subject|4|||
130269504|NCT01891396|468953050|FG002|Overall Study|Withdrawal by Subject|3|||
130269505|NCT01891396|468953048|FG000|Overall Study|Lost to Follow-up|0|||
130269506|NCT01891396|468953049|FG001|Overall Study|Lost to Follow-up|1|||
130269507|NCT01891396|468953050|FG002|Overall Study|Lost to Follow-up|0|||
130269508|NCT00540592|468953051|FG000|Overall Study|Adverse Event|0|||
130269509|NCT00540592|468953052|FG001|Overall Study|Adverse Event|1|||
130269510|NCT00540592|468953053|FG002|Overall Study|Adverse Event|0|||
130269511|NCT00540592|468953054|FG003|Overall Study|Adverse Event|0|||
130269512|NCT00540592|468953055|FG004|Overall Study|Adverse Event|1|||
130269513|NCT00540592|468953056|FG005|Overall Study|Adverse Event|0|||
130269514|NCT00540592|468953057|FG006|Overall Study|Adverse Event|0|||
130269515|NCT00540592|468953058|FG007|Overall Study|Adverse Event|1|||
130269516|NCT00540592|468953059|FG008|Overall Study|Adverse Event|1|||
130269517|NCT00540592|468953060|FG009|Overall Study|Adverse Event|2|||
130269518|NCT00540592|468953051|FG000|Overall Study|Lost to Follow-up|2|||
129885970|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
130103646|NCT01563029|468338696|FG004|Overall Study|Adverse Event|1|||
130103647|NCT01563029|468338692|FG000|Overall Study|Lack of Efficacy|42|||
130103648|NCT01563029|468338693|FG001|Overall Study|Lack of Efficacy|16|||
130103649|NCT01563029|468338694|FG002|Overall Study|Lack of Efficacy|23|||
130103650|NCT01563029|468338695|FG003|Overall Study|Lack of Efficacy|21|||
130269519|NCT00540592|468953052|FG001|Overall Study|Lost to Follow-up|0|||
130269520|NCT00540592|468953053|FG002|Overall Study|Lost to Follow-up|0|||
130269521|NCT00540592|468953054|FG003|Overall Study|Lost to Follow-up|0|||
130269522|NCT00540592|468953055|FG004|Overall Study|Lost to Follow-up|0|||
130269523|NCT00540592|468953056|FG005|Overall Study|Lost to Follow-up|0|||
130269524|NCT00540592|468953057|FG006|Overall Study|Lost to Follow-up|0|||
130269525|NCT00540592|468953058|FG007|Overall Study|Lost to Follow-up|0|||
130103651|NCT01563029|468338696|FG004|Overall Study|Lack of Efficacy|19|||
130103652|NCT01563029|468338692|FG000|Overall Study|Protocol Violation|1|||
130269526|NCT00540592|468953059|FG008|Overall Study|Lost to Follow-up|0|||
130269527|NCT00540592|468953060|FG009|Overall Study|Lost to Follow-up|0|||
130269528|NCT00540592|468953051|FG000|Overall Study|Withdrawal by Subject|0|||
130269529|NCT00540592|468953052|FG001|Overall Study|Withdrawal by Subject|0|||
130269530|NCT00540592|468953053|FG002|Overall Study|Withdrawal by Subject|1|||
130269531|NCT00540592|468953054|FG003|Overall Study|Withdrawal by Subject|1|||
130269532|NCT00540592|468953055|FG004|Overall Study|Withdrawal by Subject|0|||
130269533|NCT00540592|468953056|FG005|Overall Study|Withdrawal by Subject|0|||
130269534|NCT00540592|468953057|FG006|Overall Study|Withdrawal by Subject|0|||
130269535|NCT00540592|468953058|FG007|Overall Study|Withdrawal by Subject|0|||
130269536|NCT00540592|468953059|FG008|Overall Study|Withdrawal by Subject|0|||
130103653|NCT01563029|468338693|FG001|Overall Study|Protocol Violation|2|||
130103654|NCT01563029|468338694|FG002|Overall Study|Protocol Violation|3|||
130269537|NCT00540592|468953060|FG009|Overall Study|Withdrawal by Subject|0|||
130269538|NCT01766037|468953061|FG000|Overall Study|Adverse Event|1|||
130269539|NCT01766037|468953062|FG001|Overall Study|Adverse Event|0|||
130269540|NCT01766037|468953061|FG000|Overall Study|Lack of Efficacy|1|||
130269541|NCT01766037|468953062|FG001|Overall Study|Lack of Efficacy|0|||
130269542|NCT01766037|468953061|FG000|Overall Study|Lost to Follow-up|0|||
130269543|NCT01766037|468953062|FG001|Overall Study|Lost to Follow-up|10|||
130269544|NCT01766037|468953061|FG000|Overall Study|Physician Decision|0|||
130269545|NCT01766037|468953062|FG001|Overall Study|Physician Decision|1|||
130269546|NCT01766037|468953061|FG000|Overall Study|Withdrawal by Subject|18|||
130269547|NCT01766037|468953062|FG001|Overall Study|Withdrawal by Subject|16|||
130269548|NCT01766037|468953061|FG000|Overall Study|Moved from area|5|||
130269549|NCT01766037|468953062|FG001|Overall Study|Moved from area|0|||
130269550|NCT01766037|468953061|FG000|Overall Study|medical - unrelated|1|||
130269551|NCT01766037|468953062|FG001|Overall Study|medical - unrelated|2|||
130269552|NCT01766037|468953061|FG000|Overall Study|nausea / discomfort|3|||
130269553|NCT01766037|468953062|FG001|Overall Study|nausea / discomfort|0|||
130269554|NCT02413996|468953063|FG000|Overall Study|not comfortable with the intervention|9|||
130103655|NCT01563029|468338695|FG003|Overall Study|Protocol Violation|1|||
130103656|NCT01563029|468338696|FG004|Overall Study|Protocol Violation|3|||
130103657|NCT01563029|468338692|FG000|Overall Study|Protocol defined stopping criteria|1|||
130103658|NCT01563029|468338693|FG001|Overall Study|Protocol defined stopping criteria|0|||
130103659|NCT01563029|468338694|FG002|Overall Study|Protocol defined stopping criteria|0|||
130103660|NCT01563029|468338695|FG003|Overall Study|Protocol defined stopping criteria|0|||
130103661|NCT01563029|468338696|FG004|Overall Study|Protocol defined stopping criteria|0|||
130103662|NCT01563029|468338692|FG000|Overall Study|Lost to Follow-up|1|||
130103663|NCT01563029|468338693|FG001|Overall Study|Lost to Follow-up|0|||
130103664|NCT01563029|468338694|FG002|Overall Study|Lost to Follow-up|1|||
130103665|NCT01563029|468338695|FG003|Overall Study|Lost to Follow-up|1|||
130103666|NCT01563029|468338696|FG004|Overall Study|Lost to Follow-up|1|||
130103667|NCT01563029|468338692|FG000|Overall Study|Physician Decision|3|||
130103668|NCT01563029|468338693|FG001|Overall Study|Physician Decision|5|||
130103669|NCT01563029|468338694|FG002|Overall Study|Physician Decision|2|||
130103670|NCT01563029|468338695|FG003|Overall Study|Physician Decision|4|||
130103671|NCT01563029|468338696|FG004|Overall Study|Physician Decision|2|||
130103672|NCT01563029|468338692|FG000|Overall Study|Withdrawal by Subject|4|||
130103673|NCT01563029|468338693|FG001|Overall Study|Withdrawal by Subject|1|||
130103674|NCT01563029|468338694|FG002|Overall Study|Withdrawal by Subject|3|||
130103675|NCT01563029|468338695|FG003|Overall Study|Withdrawal by Subject|4|||
130103676|NCT01563029|468338696|FG004|Overall Study|Withdrawal by Subject|3|||
130103677|NCT01569594|468338697|FG000|Overall Study|Physician Decision|4|||
130103678|NCT01569594|468338697|FG000|Overall Study|Death|13|||
130103679|NCT01569594|468338697|FG000|Overall Study|Lost to Follow-up|22|||
130103680|NCT01569594|468338697|FG000|Overall Study|Adverse Event|2|||
130103681|NCT01569594|468338697|FG000|Overall Study|Withdrawal by Subject|13|||
130103682|NCT01569594|468338697|FG000|Overall Study|Other|4|||
130103683|NCT01569594|468338697|FG000|Overall Study|No ECM used|9|||
130103684|NCT01826201|468338700|FG000|Overall Study|Non compliance with protocol|4|||
130103685|NCT01615822|468338701|FG000|Period 1|Withdrawal by Subject|0|||
130103686|NCT01615822|468338702|FG001|Period 1|Withdrawal by Subject|1|||
130103687|NCT01615822|468338703|FG002|Period 1|Withdrawal by Subject|0|||
130103688|NCT01615822|468338701|FG000|Period 1|Adverse Event|1|||
130103689|NCT01615822|468338702|FG001|Period 1|Adverse Event|1|||
130103690|NCT01615822|468338703|FG002|Period 1|Adverse Event|0|||
130103691|NCT01615822|468338701|FG000|Period 2|Lost to Follow-up|0|||
130103692|NCT01615822|468338702|FG001|Period 2|Lost to Follow-up|1|||
130103693|NCT01615822|468338703|FG002|Period 2|Lost to Follow-up|2|||
130103694|NCT02861534|468338704|FG000|Overall Study|Death|541|||
130103695|NCT02861534|468338705|FG001|Overall Study|Death|552|||
130103696|NCT02861534|468338704|FG000|Overall Study|Lost to Follow-up|14|||
130103697|NCT02861534|468338705|FG001|Overall Study|Lost to Follow-up|14|||
130103698|NCT02861534|468338704|FG000|Overall Study|Site Terminated by Sponsor|4|||
130103699|NCT02861534|468338705|FG001|Overall Study|Site Terminated by Sponsor|3|||
130269555|NCT02413996|468953064|FG001|Overall Study|not comfortable with the intervention|2|||
130269556|NCT03810014|468953067|FG000|Overall Study|Pregnancy|2|||
130269557|NCT03810014|468953068|FG001|Overall Study|Pregnancy|2|||
130269558|NCT03810014|468953069|FG002|Overall Study|Pregnancy|0|||
130269559|NCT03810014|468953070|FG003|Overall Study|Pregnancy|2|||
130103700|NCT02861534|468338704|FG000|Overall Study|Withdrawal by Subject|15|||
130103701|NCT02861534|468338705|FG001|Overall Study|Withdrawal by Subject|18|||
130269560|NCT03606486|468953071|FG000|Overall Study|Unable to collect sample|5|||
130269561|NCT01853462|468953080|FG000|Overall Study|Withdrawal by Subject|1|||
130269562|NCT01853462|468953081|FG001|Overall Study|Withdrawal by Subject|1|||
130269563|NCT03943290|468953082|FG000|Overall Study|Sponsor Terminated Study|6|||
130269564|NCT03943290|468953083|FG001|Overall Study|Sponsor Terminated Study|1|||
130269565|NCT03943290|468953084|FG002|Overall Study|Sponsor Terminated Study|11|||
130269566|NCT03943290|468953085|FG003|Overall Study|Sponsor Terminated Study|6|||
130269567|NCT03943290|468953086|FG004|Overall Study|Sponsor Terminated Study|7|||
130269568|NCT03943290|468953087|FG005|Overall Study|Sponsor Terminated Study|6|||
130269569|NCT03943290|468953088|FG006|Overall Study|Sponsor Terminated Study|6|||
130269570|NCT03943290|468953089|FG007|Overall Study|Sponsor Terminated Study|7|||
130269571|NCT03943290|468953090|FG008|Overall Study|Sponsor Terminated Study|8|||
130269572|NCT03943290|468953082|FG000|Overall Study|Lost to Follow-up|1|||
130269573|NCT03943290|468953083|FG001|Overall Study|Lost to Follow-up|0|||
130269574|NCT03943290|468953084|FG002|Overall Study|Lost to Follow-up|1|||
130269575|NCT03943290|468953085|FG003|Overall Study|Lost to Follow-up|0|||
130269576|NCT03943290|468953086|FG004|Overall Study|Lost to Follow-up|0|||
130269577|NCT03943290|468953087|FG005|Overall Study|Lost to Follow-up|0|||
130269578|NCT03943290|468953088|FG006|Overall Study|Lost to Follow-up|0|||
130269579|NCT03943290|468953089|FG007|Overall Study|Lost to Follow-up|1|||
130269580|NCT03943290|468953090|FG008|Overall Study|Lost to Follow-up|0|||
130269581|NCT03943290|468953082|FG000|Overall Study|Withdrawal by Subject|0|||
130269582|NCT03943290|468953083|FG001|Overall Study|Withdrawal by Subject|0|||
130269583|NCT03943290|468953084|FG002|Overall Study|Withdrawal by Subject|1|||
130269584|NCT03943290|468953085|FG003|Overall Study|Withdrawal by Subject|0|||
130269585|NCT03943290|468953086|FG004|Overall Study|Withdrawal by Subject|0|||
130269586|NCT03943290|468953087|FG005|Overall Study|Withdrawal by Subject|0|||
130269587|NCT03943290|468953088|FG006|Overall Study|Withdrawal by Subject|0|||
130269588|NCT03943290|468953089|FG007|Overall Study|Withdrawal by Subject|0|||
130269589|NCT03943290|468953090|FG008|Overall Study|Withdrawal by Subject|0|||
130269590|NCT00955474|468953091|FG000|Overall Study|Physician Decision|7|||
130269591|NCT00955474|468953092|FG001|Overall Study|Physician Decision|5|||
130269592|NCT01737762|468953093|FG000|Overall Study|Adverse Event|2|||
130269593|NCT01737762|468953094|FG001|Overall Study|Adverse Event|2|||
130269594|NCT01737762|468953093|FG000|Overall Study|Lost to Follow-up|1|||
130269595|NCT01737762|468953094|FG001|Overall Study|Lost to Follow-up|0|||
130269596|NCT01737762|468953093|FG000|Overall Study|Withdrawal by Subject|2|||
130269597|NCT01737762|468953094|FG001|Overall Study|Withdrawal by Subject|2|||
130269598|NCT01737762|468953093|FG000|Overall Study|Progressive disease|1|||
130269599|NCT01737762|468953094|FG001|Overall Study|Progressive disease|2|||
130269600|NCT01737762|468953093|FG000|Overall Study|Physician Decision|1|||
130269601|NCT01737762|468953094|FG001|Overall Study|Physician Decision|1|||
130269602|NCT01737762|468953093|FG000|Overall Study|Moved from area|2|||
130269603|NCT01737762|468953094|FG001|Overall Study|Moved from area|1|||
130269604|NCT01737762|468953093|FG000|Overall Study|Trial termination|11|||
130269605|NCT01737762|468953094|FG001|Overall Study|Trial termination|9|||
130269606|NCT02148263|468953095|FG000|Overall Study|Withdrawal by Subject|3|||
130269607|NCT02148263|468953096|FG001|Overall Study|Withdrawal by Subject|2|||
130269608|NCT03386435|468953097|FG000|Overall Study|Protocol Violation|5|||
130269609|NCT03386435|468953098|FG001|Overall Study|Protocol Violation|7|||
130269610|NCT00625586|468953099|FG000|Overall Study|Adverse Event|1|||
130269611|NCT00625586|468953099|FG000|Overall Study|Progressive disease|1|||
129885971|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
129885972|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
129885973|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
129885974|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
129885975|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
129885976|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
129885977|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
129885978|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
129885979|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
129885980|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
129885981|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
130103702|NCT00916617|468338708|FG000|Overall Study|Adverse Event|3|||
130269696|NCT01467466|468953108|FG000|Overall Study|Withdrawal by Subject|15|||
130269697|NCT01467466|468953109|FG001|Overall Study|Withdrawal by Subject|18|||
130269698|NCT01467466|468953110|FG002|Overall Study|Withdrawal by Subject|13|||
130269699|NCT01467466|468953111|FG003|Overall Study|Withdrawal by Subject|11|||
130269700|NCT01467466|468953108|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
130269701|NCT01467466|468953109|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
130269702|NCT01467466|468953110|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
130269703|NCT01467466|468953111|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
130269704|NCT01467466|468953108|FG000|Overall Study|Procedure Cancelled|46|||
130269705|NCT01467466|468953109|FG001|Overall Study|Procedure Cancelled|45|||
130269706|NCT01467466|468953110|FG002|Overall Study|Procedure Cancelled|25|||
130269707|NCT01467466|468953111|FG003|Overall Study|Procedure Cancelled|29|||
130269708|NCT01467466|468953108|FG000|Overall Study|No Endpoint Blood Draw|38|||
130269709|NCT01467466|468953109|FG001|Overall Study|No Endpoint Blood Draw|32|||
130269710|NCT01467466|468953110|FG002|Overall Study|No Endpoint Blood Draw|51|||
130269711|NCT01467466|468953111|FG003|Overall Study|No Endpoint Blood Draw|43|||
130269712|NCT01144416|468953116|FG000|Intervention Period|Adverse Event|5|||
130269713|NCT01144416|468953117|FG001|Intervention Period|Adverse Event|6|||
130269714|NCT01144416|468953116|FG000|Intervention Period|Insufficient ovarian response|11|||
130269715|NCT01144416|468953117|FG001|Intervention Period|Insufficient ovarian response|17|||
130269716|NCT01144416|468953116|FG000|Intervention Period|Risk of OHSS|0|||
130269717|NCT01144416|468953117|FG001|Intervention Period|Risk of OHSS|1|||
130269718|NCT01144416|468953116|FG000|Intervention Period|Too high ovarian response|4|||
130269719|NCT01144416|468953117|FG001|Intervention Period|Too high ovarian response|2|||
130269720|NCT01144416|468953116|FG000|Intervention Period|No/too few/bad oocytes|7|||
130269721|NCT01144416|468953117|FG001|Intervention Period|No/too few/bad oocytes|5|||
130269722|NCT01144416|468953116|FG000|Intervention Period|No or abnormal fertilization|25|||
130269723|NCT01144416|468953117|FG001|Intervention Period|No or abnormal fertilization|10|||
130269724|NCT01144416|468953116|FG000|Intervention Period|No/too few/bad quality embryos|3|||
130269725|NCT01144416|468953117|FG001|Intervention Period|No/too few/bad quality embryos|3|||
130269726|NCT01144416|468953116|FG000|Intervention Period|Other|7|||
130269727|NCT01144416|468953117|FG001|Intervention Period|Other|5|||
130269728|NCT00124072|468953118|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
130269729|NCT00124072|468953119|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
130269730|NCT00124072|468953120|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
130269731|NCT00124072|468953121|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
130269732|NCT00124072|468953118|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
130269733|NCT00124072|468953119|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
130269734|NCT00124072|468953120|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
130269735|NCT00124072|468953121|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
130269736|NCT00124072|468953118|FG000|Overall Study|Death|499|||
130269737|NCT00124072|468953119|FG001|Overall Study|Death|484|||
130269738|NCT00124072|468953120|FG002|Overall Study|Death|471|||
130269739|NCT00124072|468953121|FG003|Overall Study|Death|480|||
130269740|NCT02534883|468953122|FG000|Overall Study|Early Termination|8|||
130269741|NCT02534883|468953123|FG001|Overall Study|Early Termination|3|||
130269742|NCT03328832|468953124|FG000|Overall Study|Lost to Follow-up|0|||
130269743|NCT03328832|468953125|FG001|Overall Study|Lost to Follow-up|1|||
130269744|NCT00886769|468953126|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130269745|NCT00886769|468953127|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
130269746|NCT00778336|468953128|FG000|Index Procedure-Discharge|Death|6|||
130269747|NCT00778336|468953129|FG001|Index Procedure-Discharge|Death|3|||
130269748|NCT00778336|468953130|FG002|Index Procedure-Discharge|Death|2|||
130269749|NCT00778336|468953131|FG003|Index Procedure-Discharge|Death|0|||
130269750|NCT00778336|468953128|FG000|3 Month Follow Up|Lost to Follow-up|15|||
130269751|NCT00778336|468953129|FG001|3 Month Follow Up|Lost to Follow-up|20|||
130269752|NCT00778336|468953130|FG002|3 Month Follow Up|Lost to Follow-up|3|||
130269753|NCT00778336|468953131|FG003|3 Month Follow Up|Lost to Follow-up|0|||
130269754|NCT00778336|468953128|FG000|3 Month Follow Up|Death|8|||
130269755|NCT00778336|468953129|FG001|3 Month Follow Up|Death|3|||
130269756|NCT00778336|468953130|FG002|3 Month Follow Up|Death|2|||
130269757|NCT00778336|468953131|FG003|3 Month Follow Up|Death|0|||
130269758|NCT00414076|468953134|FG000|Overall Study|Progression|1|||
130269759|NCT00414076|468953135|FG001|Overall Study|Progression|2|||
130269760|NCT00414076|468953134|FG000|Overall Study|Withdrawal by Subject|1|||
130269761|NCT00414076|468953135|FG001|Overall Study|Withdrawal by Subject|3|||
130036993|NCT00364793|468090384|FG002|Overall Study|Poor or non-compliance|0|||
130036994|NCT00364793|468090385|FG003|Overall Study|Poor or non-compliance|1|||
130036995|NCT00364793|468090382|FG000|Overall Study|No longer meets criteria|0|||
130269762|NCT00414076|468953134|FG000|Overall Study|Adverse Event|1|||
130269763|NCT00414076|468953135|FG001|Overall Study|Adverse Event|0|||
130269764|NCT00049257|468953136|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
130269765|NCT00049257|468953136|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
130269766|NCT00049257|468953136|FG000|Carboplatin, Paclitaxel|Death|2|||
130269767|NCT00049257|468953136|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
130269768|NCT04721158|468953137|FG000|Overall Study|Lost to Follow-up|4|||
130269769|NCT04721158|468953137|FG000|Overall Study|Device did not connect|1|||
130269770|NCT03929913|468953138|FG000|Overall Study|Death|4|||
130269771|NCT03929913|468953138|FG000|Overall Study|Lost to Follow-up|1|||
130036996|NCT00364793|468090383|FG001|Overall Study|No longer meets criteria|0|||
130036997|NCT00364793|468090384|FG002|Overall Study|No longer meets criteria|0|||
130269772|NCT03929913|468953138|FG000|Overall Study|Failed Procedure|2|||
130269773|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
130036998|NCT00364793|468090385|FG003|Overall Study|No longer meets criteria|1|||
130269774|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
130269775|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
130269776|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269777|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269778|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269779|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130036999|NCT00364793|468090382|FG000|Overall Study|Withdrawal by Subject|0|||
130037000|NCT00364793|468090383|FG001|Overall Study|Withdrawal by Subject|1|||
130037001|NCT00364793|468090384|FG002|Overall Study|Withdrawal by Subject|0|||
130037002|NCT00364793|468090385|FG003|Overall Study|Withdrawal by Subject|0|||
130269780|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269781|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269782|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269783|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269784|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269785|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269786|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269787|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269788|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
130269789|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130269790|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
130269791|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269792|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269793|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269794|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269795|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269796|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269797|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269798|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269799|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269800|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269801|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269802|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269803|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269804|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
130269805|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269806|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269807|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269808|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
130269809|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269810|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269811|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269812|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269813|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269814|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269815|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269816|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269817|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269818|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269819|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
130269820|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129885982|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
129885983|NCT02291289|467542793|FG000|Early Disease Progression|Death|0|||
129885984|NCT02291289|467542794|FG001|Early Disease Progression|Death|0|||
129885985|NCT02291289|467542795|FG002|Early Disease Progression|Death|0|||
129885986|NCT02291289|467542796|FG003|Early Disease Progression|Death|0|||
129885987|NCT02291289|467542797|FG004|Early Disease Progression|Death|0|||
129885988|NCT02291289|467542798|FG005|Early Disease Progression|Death|0|||
129885989|NCT02291289|467542799|FG006|Early Disease Progression|Death|0|||
129885990|NCT02291289|467542800|FG007|Early Disease Progression|Death|0|||
130037003|NCT00363415|468090388|FG000|Overall Study|Progressive Disease|196|||
130269821|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269822|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269823|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
130269824|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269825|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269826|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130037004|NCT00363415|468090389|FG001|Overall Study|Progressive Disease|107|||
130037005|NCT00363415|468090388|FG000|Overall Study|Sponsor Decision|67|||
130269827|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269828|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269829|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269830|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269831|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269832|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269833|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130037006|NCT00363415|468090389|FG001|Overall Study|Sponsor Decision|31|||
129885991|NCT02291289|467542801|FG008|Early Disease Progression|Death|0|||
129885992|NCT02291289|467542802|FG009|Early Disease Progression|Death|0|||
130037007|NCT00363415|468090388|FG000|Overall Study|Death|32|||
130037008|NCT00363415|468090389|FG001|Overall Study|Death|29|||
130269834|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269835|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269836|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
130269837|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269838|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269839|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269840|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
130269841|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269842|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269843|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269844|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269845|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269846|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269847|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269848|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269849|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269850|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269851|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269852|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
130269853|NCT02891226|468953139|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269854|NCT02891226|468953140|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269855|NCT02891226|468953141|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269856|NCT02891226|468953142|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
130269857|NCT02891226|468953143|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269858|NCT02891226|468953144|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269859|NCT02891226|468953145|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269860|NCT02891226|468953146|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269861|NCT02891226|468953147|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269862|NCT02891226|468953148|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269863|NCT02891226|468953149|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269864|NCT02891226|468953150|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269865|NCT02891226|468953151|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269866|NCT02891226|468953152|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269867|NCT02891226|468953153|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269868|NCT02891226|468953154|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
130269869|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269870|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269871|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269872|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269873|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269874|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269875|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
130269876|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
130269877|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
130269878|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
130269879|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269880|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269881|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269882|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269883|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269884|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
130269885|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269886|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269887|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269888|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269889|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269890|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
130269891|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269892|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269893|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269894|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
130269895|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269896|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129885993|NCT02291289|467542803|FG010|Early Disease Progression|Death|0|||
130269897|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269898|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
130269899|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129885994|NCT02291289|467542804|FG011|Early Disease Progression|Death|0|||
129885995|NCT02291289|467542805|FG012|Early Disease Progression|Death|10|||
130037009|NCT00363415|468090388|FG000|Overall Study|Adverse Event|24|||
130269900|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129885996|NCT02291289|467542793|FG000|Early Disease Progression|Lost to Follow-up|0|||
130037010|NCT00363415|468090389|FG001|Overall Study|Adverse Event|15|||
130037011|NCT00363415|468090388|FG000|Overall Study|Physician Decision|18|||
130037012|NCT00363415|468090389|FG001|Overall Study|Physician Decision|35|||
130037013|NCT00363415|468090388|FG000|Overall Study|Entry Criteria Not Met|11|||
130037014|NCT00363415|468090389|FG001|Overall Study|Entry Criteria Not Met|10|||
130037015|NCT00363415|468090388|FG000|Overall Study|Withdrawal by Subject|9|||
130037016|NCT00363415|468090389|FG001|Overall Study|Withdrawal by Subject|15|||
130037017|NCT00363415|468090388|FG000|Overall Study|Lost to Follow-up|3|||
130037018|NCT00363415|468090389|FG001|Overall Study|Lost to Follow-up|3|||
130037019|NCT00363415|468090388|FG000|Overall Study|Protocol Violation|1|||
130037020|NCT00363415|468090389|FG001|Overall Study|Protocol Violation|4|||
130037021|NCT05027802|468090392|FG000|Overall Study|Adverse Event|2|||
130037022|NCT05027802|468090392|FG000|Overall Study|Withdrawal by Subject|18|||
130037023|NCT05027802|468090392|FG000|Overall Study|Death|2|||
130037024|NCT05027802|468090392|FG000|Overall Study|Other|1|||
130037025|NCT02725788|468090393|FG000|Overall Study|Lost to Follow-up|1|||
130037026|NCT02725788|468090394|FG001|Overall Study|Lost to Follow-up|1|||
130037027|NCT02725788|468090393|FG000|Overall Study|Protocol Violation|0|||
130037028|NCT02725788|468090394|FG001|Overall Study|Protocol Violation|1|||
130037029|NCT05590377|468090395|FG000|Overall Study|Death|1|||
130037030|NCT05590377|468090396|FG001|Overall Study|Death|1|||
130037031|NCT05590377|468090397|FG002|Overall Study|Death|2|||
130037032|NCT05590377|468090398|FG003|Overall Study|Death|0|||
130037033|NCT05590377|468090399|FG004|Overall Study|Death|0|||
130037034|NCT05590377|468090395|FG000|Overall Study|Study Terminated by Sponsor|1|||
130037035|NCT05590377|468090396|FG001|Overall Study|Study Terminated by Sponsor|5|||
130037036|NCT05590377|468090397|FG002|Overall Study|Study Terminated by Sponsor|4|||
130037037|NCT05590377|468090398|FG003|Overall Study|Study Terminated by Sponsor|0|||
130037038|NCT05590377|468090399|FG004|Overall Study|Study Terminated by Sponsor|0|||
130037039|NCT05590377|468090395|FG000|Overall Study|Withdrawal by Subject|1|||
130037040|NCT05590377|468090396|FG001|Overall Study|Withdrawal by Subject|0|||
130269901|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269902|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269903|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269904|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269905|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269906|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269907|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
130269908|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
130269909|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
130269910|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
130269911|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269912|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269913|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269914|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269915|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269916|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
130269917|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269918|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269919|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269920|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269921|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
130269922|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269923|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269924|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269925|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269926|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269927|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269928|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130037041|NCT05590377|468090397|FG002|Overall Study|Withdrawal by Subject|0|||
130037042|NCT05590377|468090398|FG003|Overall Study|Withdrawal by Subject|0|||
130037043|NCT05590377|468090399|FG004|Overall Study|Withdrawal by Subject|0|||
130037044|NCT00828464|468090400|FG000|Overall Study|Withdrawal by Subject|1|||
130037045|NCT02599402|468090401|FG000|Overall Study|Disease progression|153|||
130037046|NCT02599402|468090401|FG000|Overall Study|Study drug toxicity|201|||
130037047|NCT02599402|468090401|FG000|Overall Study|Death|26|||
130037048|NCT02599402|468090401|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
130037049|NCT02599402|468090401|FG000|Overall Study|Participant request to discontinue study treatment|13|||
130037050|NCT02599402|468090401|FG000|Overall Study|Participant withdrew consent|5|||
130037051|NCT02599402|468090401|FG000|Overall Study|Lost to Follow-up|1|||
130037052|NCT02599402|468090401|FG000|Overall Study|Maximum Clinical Benefit|7|||
130037053|NCT02599402|468090401|FG000|Overall Study|Poor/non-compliance|1|||
130037054|NCT02599402|468090401|FG000|Overall Study|Pregnancy|1|||
130269929|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269930|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269931|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269932|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
130269933|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269934|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269935|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269936|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269937|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269938|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269939|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
130269940|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269941|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269942|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269943|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269944|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269945|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269946|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269947|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269948|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
130269949|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269950|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269951|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269952|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269953|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269954|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269955|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269956|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130269957|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130269958|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
130269959|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269960|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269961|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269962|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269963|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269964|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
130269965|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269966|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269967|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269968|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269969|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269970|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269971|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269972|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
130269973|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269974|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269975|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269976|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269977|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269978|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269979|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269980|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
130269981|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269982|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269983|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269984|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269985|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269986|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269987|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269988|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269989|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
130269990|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269991|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269992|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269993|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269994|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269995|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269996|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
130269997|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130269998|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130269999|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270000|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270001|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270002|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270003|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270004|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270005|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270006|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
130270007|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130103703|NCT00916617|468338709|FG001|Overall Study|Adverse Event|2|||
130270008|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270009|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270010|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270011|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270012|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
130270013|NCT02891226|468953139|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270014|NCT02891226|468953140|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270015|NCT02891226|468953141|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270016|NCT02891226|468953142|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270017|NCT02891226|468953143|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270018|NCT02891226|468953144|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270019|NCT02891226|468953145|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270020|NCT02891226|468953146|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270021|NCT02891226|468953147|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270022|NCT02891226|468953148|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
130270023|NCT02891226|468953149|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270024|NCT02891226|468953150|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270025|NCT02891226|468953151|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270026|NCT02891226|468953152|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270027|NCT02891226|468953153|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270028|NCT02891226|468953154|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
130270029|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270030|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270031|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270032|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270033|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270034|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270035|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270036|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270037|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270038|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270039|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
130270040|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270041|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270042|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270043|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270044|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
130270045|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270046|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270047|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270048|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270049|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270050|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270051|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270052|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270053|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270054|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270055|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
130270056|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270057|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270058|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270059|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270060|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
130270061|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270062|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270063|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270064|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270065|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270066|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270067|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270068|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270069|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270070|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270071|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
130270072|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270073|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270074|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270075|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130037055|NCT02599402|468090401|FG000|Overall Study|Participant no longer met study criteria|7|||
130037056|NCT02599402|468090401|FG000|Overall Study|Other Reasons|95|||
130037057|NCT00809133|468090402|FG000|Overall Study|Progressive disease|2|||
130037058|NCT00809133|468090403|FG001|Overall Study|Progressive disease|5|||
130103704|NCT00916617|468338710|FG002|Overall Study|Adverse Event|6|||
130103705|NCT00916617|468338711|FG003|Overall Study|Adverse Event|3|||
130103706|NCT00916617|468338708|FG000|Overall Study|Withdrawal by Subject|3|||
130103707|NCT00916617|468338709|FG001|Overall Study|Withdrawal by Subject|2|||
130103708|NCT00916617|468338710|FG002|Overall Study|Withdrawal by Subject|0|||
130103709|NCT00916617|468338711|FG003|Overall Study|Withdrawal by Subject|1|||
130103710|NCT00916617|468338708|FG000|Overall Study|Caregiver Request|3|||
130103711|NCT00916617|468338709|FG001|Overall Study|Caregiver Request|2|||
130103712|NCT00916617|468338710|FG002|Overall Study|Caregiver Request|1|||
130103713|NCT00916617|468338711|FG003|Overall Study|Caregiver Request|0|||
130103714|NCT00916617|468338708|FG000|Overall Study|Physician Decision|1|||
130103715|NCT00916617|468338709|FG001|Overall Study|Physician Decision|1|||
130037059|NCT00809133|468090404|FG002|Overall Study|Progressive disease|5|||
130037060|NCT00809133|468090405|FG003|Overall Study|Progressive disease|3|||
130037061|NCT00809133|468090406|FG004|Overall Study|Progressive disease|4|||
130103716|NCT00916617|468338710|FG002|Overall Study|Physician Decision|0|||
130103717|NCT00916617|468338711|FG003|Overall Study|Physician Decision|0|||
130103718|NCT00916617|468338708|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
130103719|NCT00916617|468338709|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
130103720|NCT00916617|468338710|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
130103721|NCT00916617|468338711|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
130103722|NCT00916617|468338708|FG000|Overall Study|Lost to Follow-up|2|||
130103723|NCT00916617|468338709|FG001|Overall Study|Lost to Follow-up|1|||
130037062|NCT00809133|468090407|FG005|Overall Study|Progressive disease|1|||
130037063|NCT00809133|468090408|FG006|Overall Study|Progressive disease|3|||
130037064|NCT00809133|468090409|FG007|Overall Study|Progressive disease|3|||
130037065|NCT00809133|468090410|FG008|Overall Study|Progressive disease|3|||
130037066|NCT00809133|468090411|FG009|Overall Study|Progressive disease|9|||
130037067|NCT00809133|468090412|FG010|Overall Study|Progressive disease|5|||
130037068|NCT00809133|468090413|FG011|Overall Study|Progressive disease|7|||
130037069|NCT00809133|468090414|FG012|Overall Study|Progressive disease|5|||
130037070|NCT00809133|468090415|FG013|Overall Study|Progressive disease|4|||
130037071|NCT00809133|468090402|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037072|NCT00809133|468090403|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037073|NCT00809133|468090404|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037074|NCT00809133|468090405|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037075|NCT00809133|468090406|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037076|NCT00809133|468090407|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130037077|NCT00809133|468090408|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130037078|NCT00809133|468090409|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130037079|NCT00809133|468090410|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037080|NCT00809133|468090411|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037081|NCT00809133|468090412|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037082|NCT00809133|468090413|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037083|NCT00809133|468090414|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130037084|NCT00809133|468090415|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
130037085|NCT00809133|468090402|FG000|Overall Study|Other adverse event|1|||
130037086|NCT00809133|468090403|FG001|Overall Study|Other adverse event|1|||
130037087|NCT00809133|468090404|FG002|Overall Study|Other adverse event|1|||
130037088|NCT00809133|468090405|FG003|Overall Study|Other adverse event|0|||
130037089|NCT00809133|468090406|FG004|Overall Study|Other adverse event|0|||
130037090|NCT00809133|468090407|FG005|Overall Study|Other adverse event|3|||
130037091|NCT00809133|468090408|FG006|Overall Study|Other adverse event|2|||
130037092|NCT00809133|468090409|FG007|Overall Study|Other adverse event|4|||
130037093|NCT00809133|468090410|FG008|Overall Study|Other adverse event|0|||
130037094|NCT00809133|468090411|FG009|Overall Study|Other adverse event|0|||
130103724|NCT00916617|468338710|FG002|Overall Study|Lost to Follow-up|0|||
130103725|NCT00916617|468338711|FG003|Overall Study|Lost to Follow-up|0|||
130103726|NCT00916617|468338708|FG000|Overall Study|Lack of Efficacy|1|||
130270076|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
130270077|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270078|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270079|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270080|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270081|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270082|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130037095|NCT00809133|468090412|FG010|Overall Study|Other adverse event|1|||
130037096|NCT00809133|468090413|FG011|Overall Study|Other adverse event|1|||
130037097|NCT00809133|468090414|FG012|Overall Study|Other adverse event|0|||
130037098|NCT00809133|468090415|FG013|Overall Study|Other adverse event|1|||
130037099|NCT00809133|468090402|FG000|Overall Study|Lost to Follow-up|0|||
130103727|NCT00916617|468338709|FG001|Overall Study|Lack of Efficacy|0|||
130103728|NCT00916617|468338710|FG002|Overall Study|Lack of Efficacy|0|||
130037100|NCT00809133|468090403|FG001|Overall Study|Lost to Follow-up|0|||
130037101|NCT00809133|468090404|FG002|Overall Study|Lost to Follow-up|0|||
130270083|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270084|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270085|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270086|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270087|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
130270088|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270089|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270090|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270091|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270092|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
130270093|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270094|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270095|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270096|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270097|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270098|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270099|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270100|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270101|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270102|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270103|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
130270104|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270105|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270106|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270107|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270108|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
130270109|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270110|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270111|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270112|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270113|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270114|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270115|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270116|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270117|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270118|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270119|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
130270120|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270121|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270122|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270123|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270124|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
130270125|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270126|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270127|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270128|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270129|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270130|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270131|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270132|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270133|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270134|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270135|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
130270136|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270137|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270138|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130103729|NCT00916617|468338711|FG003|Overall Study|Lack of Efficacy|0|||
130270139|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270140|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
130270141|NCT02891226|468953139|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270142|NCT02891226|468953140|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270143|NCT02891226|468953141|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270144|NCT02891226|468953142|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130037102|NCT00809133|468090405|FG003|Overall Study|Lost to Follow-up|0|||
130037103|NCT00809133|468090406|FG004|Overall Study|Lost to Follow-up|0|||
130037104|NCT00809133|468090407|FG005|Overall Study|Lost to Follow-up|1|||
130037105|NCT00809133|468090408|FG006|Overall Study|Lost to Follow-up|0|||
130270145|NCT02891226|468953143|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270146|NCT02891226|468953144|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270147|NCT02891226|468953145|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270148|NCT02891226|468953146|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270149|NCT02891226|468953147|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270150|NCT02891226|468953148|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270151|NCT02891226|468953149|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
130270152|NCT02891226|468953150|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270153|NCT02891226|468953151|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270154|NCT02891226|468953152|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270155|NCT02891226|468953153|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270156|NCT02891226|468953154|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
130270157|NCT02891226|468953139|FG000|Follow-up Period|Withdrawal by Subject|0|||
130270158|NCT02891226|468953140|FG001|Follow-up Period|Withdrawal by Subject|0|||
130270159|NCT02891226|468953141|FG002|Follow-up Period|Withdrawal by Subject|0|||
130270160|NCT02891226|468953142|FG003|Follow-up Period|Withdrawal by Subject|0|||
130270161|NCT02891226|468953143|FG004|Follow-up Period|Withdrawal by Subject|0|||
130270162|NCT02891226|468953144|FG005|Follow-up Period|Withdrawal by Subject|0|||
130270163|NCT02891226|468953145|FG006|Follow-up Period|Withdrawal by Subject|0|||
130270164|NCT02891226|468953146|FG007|Follow-up Period|Withdrawal by Subject|0|||
130270165|NCT02891226|468953147|FG008|Follow-up Period|Withdrawal by Subject|0|||
130270166|NCT02891226|468953148|FG009|Follow-up Period|Withdrawal by Subject|0|||
130270167|NCT02891226|468953149|FG010|Follow-up Period|Withdrawal by Subject|0|||
130270168|NCT02891226|468953150|FG011|Follow-up Period|Withdrawal by Subject|1|||
130037106|NCT00809133|468090409|FG007|Overall Study|Lost to Follow-up|0|||
130037107|NCT00809133|468090410|FG008|Overall Study|Lost to Follow-up|0|||
130037108|NCT00809133|468090411|FG009|Overall Study|Lost to Follow-up|0|||
130037109|NCT00809133|468090412|FG010|Overall Study|Lost to Follow-up|0|||
130037110|NCT00809133|468090413|FG011|Overall Study|Lost to Follow-up|0|||
130037111|NCT00809133|468090414|FG012|Overall Study|Lost to Follow-up|0|||
130037112|NCT00809133|468090415|FG013|Overall Study|Lost to Follow-up|0|||
130037113|NCT00809133|468090402|FG000|Overall Study|Consent withdrawn|0|||
130037114|NCT00809133|468090403|FG001|Overall Study|Consent withdrawn|0|||
130037115|NCT00809133|468090404|FG002|Overall Study|Consent withdrawn|0|||
130037116|NCT00809133|468090405|FG003|Overall Study|Consent withdrawn|0|||
130037117|NCT00809133|468090406|FG004|Overall Study|Consent withdrawn|1|||
130037118|NCT00809133|468090407|FG005|Overall Study|Consent withdrawn|0|||
130037119|NCT00809133|468090408|FG006|Overall Study|Consent withdrawn|0|||
130037120|NCT00809133|468090409|FG007|Overall Study|Consent withdrawn|0|||
130037121|NCT00809133|468090410|FG008|Overall Study|Consent withdrawn|0|||
130103730|NCT00916617|468338708|FG000|Overall Study|Other|2|||
130270169|NCT02891226|468953151|FG012|Follow-up Period|Withdrawal by Subject|0|||
130270170|NCT02891226|468953152|FG013|Follow-up Period|Withdrawal by Subject|0|||
129885997|NCT02291289|467542794|FG001|Early Disease Progression|Lost to Follow-up|0|||
130037122|NCT00809133|468090411|FG009|Overall Study|Consent withdrawn|0|||
130270171|NCT02891226|468953153|FG014|Follow-up Period|Withdrawal by Subject|1|||
130270172|NCT02891226|468953154|FG015|Follow-up Period|Withdrawal by Subject|1|||
130270173|NCT00145626|468953155|FG000|Overall Study|Did not have NK infusions|2|||
130270174|NCT00145626|468953155|FG000|Overall Study|Turned 2 years old before treatment|1|||
130270175|NCT00145626|468953155|FG000|Overall Study|Death|1|||
130270176|NCT00145626|468953155|FG000|Overall Study|Withdrawal by Subject|1|||
130270177|NCT03381287|468953156|FG000|Overall Study|Withdrawal by Subject|0|||
130270178|NCT03381287|468953157|FG001|Overall Study|Withdrawal by Subject|1|||
130270179|NCT03381287|468953158|FG002|Overall Study|Withdrawal by Subject|0|||
130270180|NCT03381287|468953159|FG003|Overall Study|Withdrawal by Subject|0|||
130270181|NCT03381287|468953156|FG000|Overall Study|Adverse Event|0|||
130270182|NCT03381287|468953157|FG001|Overall Study|Adverse Event|0|||
130270183|NCT03381287|468953158|FG002|Overall Study|Adverse Event|0|||
130270184|NCT03381287|468953159|FG003|Overall Study|Adverse Event|1|||
130270185|NCT03381287|468953156|FG000|Overall Study|Physician Decision|0|||
130270186|NCT03381287|468953157|FG001|Overall Study|Physician Decision|0|||
130270187|NCT03381287|468953158|FG002|Overall Study|Physician Decision|0|||
130270188|NCT03381287|468953159|FG003|Overall Study|Physician Decision|1|||
130270189|NCT03654274|468953160|FG000|Overall Study|Adverse Event|19|||
130270190|NCT03654274|468953161|FG001|Overall Study|Adverse Event|23|||
130270191|NCT03654274|468953162|FG002|Overall Study|Adverse Event|24|||
130270192|NCT03654274|468953160|FG000|Overall Study|Protocol Deviation|0|||
130270193|NCT03654274|468953161|FG001|Overall Study|Protocol Deviation|2|||
130270194|NCT03654274|468953162|FG002|Overall Study|Protocol Deviation|0|||
130270195|NCT03654274|468953160|FG000|Overall Study|Lost to Follow-up|8|||
130270196|NCT03654274|468953161|FG001|Overall Study|Lost to Follow-up|6|||
130270197|NCT03654274|468953162|FG002|Overall Study|Lost to Follow-up|5|||
130270198|NCT03654274|468953160|FG000|Overall Study|Withdrawal by Subject|46|||
130270199|NCT03654274|468953161|FG001|Overall Study|Withdrawal by Subject|25|||
130270200|NCT03654274|468953162|FG002|Overall Study|Withdrawal by Subject|33|||
130270201|NCT03654274|468953160|FG000|Overall Study|Lack of Efficacy|4|||
130270202|NCT03654274|468953161|FG001|Overall Study|Lack of Efficacy|5|||
130270203|NCT03654274|468953162|FG002|Overall Study|Lack of Efficacy|7|||
130270204|NCT03654274|468953160|FG000|Overall Study|Pregnancy|2|||
130270205|NCT03654274|468953161|FG001|Overall Study|Pregnancy|2|||
130270206|NCT03654274|468953162|FG002|Overall Study|Pregnancy|1|||
130270207|NCT03654274|468953160|FG000|Overall Study|Other|27|||
130270208|NCT03654274|468953161|FG001|Overall Study|Other|29|||
130270209|NCT03654274|468953162|FG002|Overall Study|Other|32|||
130270210|NCT03654274|468953160|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
130270211|NCT03654274|468953161|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
130270212|NCT03654274|468953162|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
130103731|NCT00916617|468338709|FG001|Overall Study|Other|0|||
130103732|NCT00916617|468338710|FG002|Overall Study|Other|0|||
130103733|NCT00916617|468338711|FG003|Overall Study|Other|2|||
130270213|NCT01265992|468953163|FG000|Overall Study|Lost to Follow-up|1|||
130270214|NCT01265992|468953163|FG000|Overall Study|Withdrawal by Subject|1|||
130270215|NCT01265992|468953163|FG000|Overall Study|Adverse Event|1|||
130270216|NCT01265992|468953163|FG000|Overall Study|Administrative reasons|2|||
130270217|NCT01265992|468953163|FG000|Overall Study|Stopped treatment|3|||
130270218|NCT01265992|468953163|FG000|Overall Study|Did not receive treatment|1|||
130270219|NCT05005273|468953164|FG000|Overall Study|Study Terminated|1|||
130270220|NCT05005273|468953165|FG001|Overall Study|Study Terminated|0|||
130270221|NCT02685826|468953170|FG000|Overall Study|Adverse Event|2|||
130270222|NCT02685826|468953171|FG001|Overall Study|Adverse Event|0|||
130270223|NCT02685826|468953172|FG002|Overall Study|Adverse Event|1|||
130037123|NCT00809133|468090412|FG010|Overall Study|Consent withdrawn|0|||
130270224|NCT02685826|468953170|FG000|Overall Study|Progressive Disease|2|||
130270225|NCT02685826|468953171|FG001|Overall Study|Progressive Disease|1|||
130270226|NCT02685826|468953172|FG002|Overall Study|Progressive Disease|0|||
130270227|NCT02685826|468953170|FG000|Overall Study|Withdrawal by Subject|2|||
130270228|NCT02685826|468953171|FG001|Overall Study|Withdrawal by Subject|0|||
130270229|NCT02685826|468953172|FG002|Overall Study|Withdrawal by Subject|0|||
130270230|NCT02685826|468953170|FG000|Overall Study|Full Clinical Hold by FDA|19|||
130270231|NCT02685826|468953171|FG001|Overall Study|Full Clinical Hold by FDA|9|||
130270232|NCT02685826|468953172|FG002|Overall Study|Full Clinical Hold by FDA|20|||
130270233|NCT03154476|468953173|FG000|Overall Study|Lost to Follow-up|4|||
130270234|NCT03154476|468953174|FG001|Overall Study|Lost to Follow-up|4|||
130270235|NCT00200967|468953175|FG000|First Treatment Period|Withdrawal by Subject|5|||
130270236|NCT00200967|468953176|FG001|First Treatment Period|Withdrawal by Subject|1|||
130270237|NCT00200967|468953175|FG000|First Treatment Period|Pregnancy|1|||
130270238|NCT00200967|468953176|FG001|First Treatment Period|Pregnancy|0|||
130270239|NCT00200967|468953175|FG000|Wash-out Period|Lost to Follow-up|0|||
130270240|NCT00200967|468953176|FG001|Wash-out Period|Lost to Follow-up|1|||
130270241|NCT00200967|468953175|FG000|Second Treatment Period|Withdrawal by Subject|1|||
130270242|NCT00200967|468953176|FG001|Second Treatment Period|Withdrawal by Subject|2|||
130270243|NCT00200967|468953175|FG000|Run-out Period|Lost to Follow-up|1|||
130270244|NCT00200967|468953176|FG001|Run-out Period|Lost to Follow-up|0|||
130270245|NCT01444430|468953179|FG000|Overall Study|Withdrawal by Subject|53|||
130270246|NCT01444430|468953180|FG001|Overall Study|Withdrawal by Subject|72|||
130270247|NCT01444430|468953179|FG000|Overall Study|Death|6|||
130270248|NCT01444430|468953180|FG001|Overall Study|Death|8|||
130270249|NCT01444430|468953179|FG000|Overall Study|Lost to Follow-up|2|||
130270250|NCT01444430|468953180|FG001|Overall Study|Lost to Follow-up|0|||
130270251|NCT01444430|468953179|FG000|Overall Study|CRF termination module not completed.|0|||
130037124|NCT00809133|468090413|FG011|Overall Study|Consent withdrawn|0|||
130037125|NCT00809133|468090414|FG012|Overall Study|Consent withdrawn|0|||
130037126|NCT00809133|468090415|FG013|Overall Study|Consent withdrawn|0|||
130270252|NCT01444430|468953180|FG001|Overall Study|CRF termination module not completed.|1|||
130270253|NCT04245449|468954534|FG000|Overall Study|COVID shutdown|7|||
130270254|NCT02197572|468954539|FG000|Overall Study|Progressive Disease|28|||
130270255|NCT02197572|468954539|FG000|Overall Study|Withdrawal by Subject|9|||
130270256|NCT02197572|468954539|FG000|Overall Study|Adverse Event|3|||
130270257|NCT02197572|468954539|FG000|Overall Study|Reason Not Specified|4|||
130270258|NCT03801928|468954540|FG000|Overall Study|Adverse Event|1|||
130270259|NCT03801928|468954541|FG001|Overall Study|Adverse Event|0|||
130270260|NCT03801928|468954542|FG002|Overall Study|Adverse Event|1|||
130270261|NCT03801928|468954543|FG003|Overall Study|Adverse Event|2|||
130270262|NCT03801928|468954544|FG004|Overall Study|Adverse Event|0|||
130103734|NCT01988337|468338714|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
130103735|NCT01260194|468338715|FG000|Overall Study|Withdrawal of Consent|1|||
130103736|NCT04854707|468338718|FG000|Overall Study|Lack of Efficacy|78|||
130103737|NCT04854707|468338719|FG001|Overall Study|Lack of Efficacy|59|||
130103738|NCT04854707|468338720|FG002|Overall Study|Lack of Efficacy|30|||
130103739|NCT01612780|468338726|FG000|Overall Study|Treatment not completed|1|||
130103740|NCT01612780|468338726|FG000|Overall Study|Withdrawal by Subject|5|||
130103741|NCT03466060|468338727|FG000|Period 1|Test Lens Damage|0|||
130103742|NCT03466060|468338728|FG001|Period 1|Test Lens Damage|2|||
130103743|NCT03466060|468338729|FG002|Period 1|Test Lens Damage|0|||
130103744|NCT03466060|468338730|FG003|Period 1|Test Lens Damage|0|||
130103745|NCT03466060|468338731|FG004|Period 1|Test Lens Damage|0|||
130103746|NCT03466060|468338732|FG005|Period 1|Test Lens Damage|0|||
130103747|NCT03466060|468338727|FG000|Period 1|Withdrawal by Subject|0|||
130103748|NCT03466060|468338728|FG001|Period 1|Withdrawal by Subject|0|||
130103749|NCT03466060|468338729|FG002|Period 1|Withdrawal by Subject|2|||
130103750|NCT03466060|468338730|FG003|Period 1|Withdrawal by Subject|0|||
130037127|NCT00809133|468090402|FG000|Overall Study|Other not mentioned above|0|||
130037128|NCT00809133|468090403|FG001|Overall Study|Other not mentioned above|1|||
130037129|NCT00809133|468090404|FG002|Overall Study|Other not mentioned above|0|||
130037130|NCT00809133|468090405|FG003|Overall Study|Other not mentioned above|0|||
130037131|NCT00809133|468090406|FG004|Overall Study|Other not mentioned above|0|||
130037132|NCT00809133|468090407|FG005|Overall Study|Other not mentioned above|1|||
130037133|NCT00809133|468090408|FG006|Overall Study|Other not mentioned above|0|||
130037134|NCT00809133|468090409|FG007|Overall Study|Other not mentioned above|0|||
130037135|NCT00809133|468090410|FG008|Overall Study|Other not mentioned above|0|||
130037136|NCT00809133|468090411|FG009|Overall Study|Other not mentioned above|0|||
130037137|NCT00809133|468090412|FG010|Overall Study|Other not mentioned above|0|||
130037138|NCT00809133|468090413|FG011|Overall Study|Other not mentioned above|0|||
130037139|NCT00809133|468090414|FG012|Overall Study|Other not mentioned above|0|||
130037140|NCT00809133|468090415|FG013|Overall Study|Other not mentioned above|0|||
130037141|NCT00833092|468090416|FG000|Overall Study|Withdrawal by Subject|2|||
130037142|NCT00833092|468090417|FG001|Overall Study|Withdrawal by Subject|3|||
130103751|NCT03466060|468338731|FG004|Period 1|Withdrawal by Subject|0|||
130103752|NCT03466060|468338732|FG005|Period 1|Withdrawal by Subject|0|||
130037143|NCT00833092|468090416|FG000|Overall Study|Protocol Violation|2|||
130103753|NCT03466060|468338727|FG000|Period 1|Lost to Follow-up|0|||
130037144|NCT00833092|468090417|FG001|Overall Study|Protocol Violation|1|||
130103754|NCT03466060|468338728|FG001|Period 1|Lost to Follow-up|0|||
130103755|NCT03466060|468338729|FG002|Period 1|Lost to Follow-up|0|||
130270263|NCT03801928|468954545|FG005|Overall Study|Adverse Event|2|||
130270264|NCT03801928|468954540|FG000|Overall Study|Lack of Efficacy|0|||
130270265|NCT03801928|468954541|FG001|Overall Study|Lack of Efficacy|0|||
130270266|NCT03801928|468954542|FG002|Overall Study|Lack of Efficacy|1|||
130270267|NCT03801928|468954543|FG003|Overall Study|Lack of Efficacy|0|||
130270268|NCT03801928|468954544|FG004|Overall Study|Lack of Efficacy|0|||
130270269|NCT03801928|468954545|FG005|Overall Study|Lack of Efficacy|0|||
129885998|NCT02291289|467542795|FG002|Early Disease Progression|Lost to Follow-up|0|||
129885999|NCT02291289|467542796|FG003|Early Disease Progression|Lost to Follow-up|0|||
130270270|NCT03801928|468954540|FG000|Overall Study|Lost to Follow-up|5|||
130270271|NCT03801928|468954541|FG001|Overall Study|Lost to Follow-up|1|||
130270272|NCT03801928|468954542|FG002|Overall Study|Lost to Follow-up|1|||
130270273|NCT03801928|468954543|FG003|Overall Study|Lost to Follow-up|4|||
130270274|NCT03801928|468954544|FG004|Overall Study|Lost to Follow-up|4|||
130270275|NCT03801928|468954545|FG005|Overall Study|Lost to Follow-up|2|||
130270276|NCT03801928|468954540|FG000|Overall Study|Withdrawal by Subject|0|||
130270277|NCT03801928|468954541|FG001|Overall Study|Withdrawal by Subject|0|||
130270278|NCT03801928|468954542|FG002|Overall Study|Withdrawal by Subject|2|||
130270279|NCT03801928|468954543|FG003|Overall Study|Withdrawal by Subject|1|||
130270280|NCT03801928|468954544|FG004|Overall Study|Withdrawal by Subject|0|||
130270281|NCT03801928|468954545|FG005|Overall Study|Withdrawal by Subject|0|||
130270282|NCT03801928|468954540|FG000|Overall Study|Other|0|||
130270283|NCT03801928|468954541|FG001|Overall Study|Other|2|||
130270284|NCT03801928|468954542|FG002|Overall Study|Other|0|||
130270285|NCT03801928|468954543|FG003|Overall Study|Other|1|||
130270286|NCT03801928|468954544|FG004|Overall Study|Other|0|||
130270287|NCT03801928|468954545|FG005|Overall Study|Other|1|||
130270288|NCT00564733|468954550|FG000|Overall Study|Withdrawal by Subject|4|||
130270289|NCT00564733|468954550|FG000|Overall Study|Ineligible|5|||
130270290|NCT01014767|468954551|FG000|Overall Study|PI left institution, data unavailable|12|||
130270291|NCT01014767|468954552|FG001|Overall Study|PI left institution, data unavailable|1|||
130270292|NCT01014767|468954553|FG002|Overall Study|PI left institution, data unavailable|4|||
130270293|NCT01014767|468954554|FG003|Overall Study|PI left institution, data unavailable|1|||
130270294|NCT01484496|468954555|FG000|Period 1|Protocol Violation|3|||
130270295|NCT01484496|468954556|FG001|Period 1|Protocol Violation|4|||
130270296|NCT01484496|468954557|FG002|Period 1|Protocol Violation|0|||
130270297|NCT01484496|468954558|FG003|Period 1|Protocol Violation|0|||
130270298|NCT01484496|468954555|FG000|Period 1|Physician Decision|5|||
130270299|NCT01484496|468954556|FG001|Period 1|Physician Decision|1|||
130270300|NCT01484496|468954557|FG002|Period 1|Physician Decision|0|||
130270301|NCT01484496|468954558|FG003|Period 1|Physician Decision|0|||
130270302|NCT01484496|468954555|FG000|Period 1|Lack of Efficacy|10|||
130270303|NCT01484496|468954556|FG001|Period 1|Lack of Efficacy|15|||
130270304|NCT01484496|468954557|FG002|Period 1|Lack of Efficacy|0|||
130270305|NCT01484496|468954558|FG003|Period 1|Lack of Efficacy|0|||
130270306|NCT01484496|468954555|FG000|Period 1|Adverse Event|25|||
130270307|NCT01484496|468954556|FG001|Period 1|Adverse Event|40|||
130270308|NCT01484496|468954557|FG002|Period 1|Adverse Event|0|||
130270309|NCT01484496|468954558|FG003|Period 1|Adverse Event|0|||
130270310|NCT01484496|468954555|FG000|Period 1|Withdrawal by Subject|15|||
130270311|NCT01484496|468954556|FG001|Period 1|Withdrawal by Subject|12|||
130270312|NCT01484496|468954557|FG002|Period 1|Withdrawal by Subject|0|||
130270313|NCT01484496|468954558|FG003|Period 1|Withdrawal by Subject|0|||
130270314|NCT01484496|468954555|FG000|Period 1|Lost to Follow-up|2|||
130270315|NCT01484496|468954556|FG001|Period 1|Lost to Follow-up|6|||
130270316|NCT01484496|468954557|FG002|Period 1|Lost to Follow-up|0|||
130270317|NCT01484496|468954558|FG003|Period 1|Lost to Follow-up|0|||
130270318|NCT01484496|468954555|FG000|Period 1|Positive Pregnancy|1|||
130270319|NCT01484496|468954556|FG001|Period 1|Positive Pregnancy|6|||
130270320|NCT01484496|468954557|FG002|Period 1|Positive Pregnancy|0|||
130270321|NCT01484496|468954558|FG003|Period 1|Positive Pregnancy|0|||
130270322|NCT01484496|468954555|FG000|Period 1|Treatment Failure|3|||
130270323|NCT01484496|468954556|FG001|Period 1|Treatment Failure|6|||
130270324|NCT01484496|468954557|FG002|Period 1|Treatment Failure|0|||
130270325|NCT01484496|468954558|FG003|Period 1|Treatment Failure|0|||
130270326|NCT01484496|468954555|FG000|Period 1|Lack of Compliance|2|||
129886000|NCT02291289|467542797|FG004|Early Disease Progression|Lost to Follow-up|0|||
130270327|NCT01484496|468954556|FG001|Period 1|Lack of Compliance|1|||
130270328|NCT01484496|468954557|FG002|Period 1|Lack of Compliance|0|||
130270329|NCT01484496|468954558|FG003|Period 1|Lack of Compliance|0|||
130270330|NCT01484496|468954555|FG000|Period 1|Unable to Visit Site|0|||
130270331|NCT01484496|468954556|FG001|Period 1|Unable to Visit Site|2|||
130270332|NCT01484496|468954557|FG002|Period 1|Unable to Visit Site|0|||
130270333|NCT01484496|468954558|FG003|Period 1|Unable to Visit Site|0|||
130270334|NCT01484496|468954555|FG000|Period 2|Lack of Efficacy|0|||
130270335|NCT01484496|468954556|FG001|Period 2|Lack of Efficacy|0|||
130270336|NCT01484496|468954557|FG002|Period 2|Lack of Efficacy|1|||
130270337|NCT01484496|468954558|FG003|Period 2|Lack of Efficacy|3|||
130270338|NCT01484496|468954555|FG000|Period 2|Adverse Event|0|||
130270339|NCT01484496|468954556|FG001|Period 2|Adverse Event|0|||
130270340|NCT01484496|468954557|FG002|Period 2|Adverse Event|5|||
130270341|NCT01484496|468954558|FG003|Period 2|Adverse Event|13|||
130270342|NCT01484496|468954555|FG000|Period 2|Other|0|||
130270343|NCT01484496|468954556|FG001|Period 2|Other|0|||
130270344|NCT01484496|468954557|FG002|Period 2|Other|9|||
130270345|NCT01484496|468954558|FG003|Period 2|Other|6|||
130270346|NCT01645735|468954559|FG000|Overall Study|Physician Decision|2|||
130270347|NCT01645735|468954560|FG001|Overall Study|Physician Decision|0|||
130270348|NCT01645735|468954559|FG000|Overall Study|Withdrawal by Subject|1|||
130270349|NCT01645735|468954560|FG001|Overall Study|Withdrawal by Subject|0|||
130270350|NCT01645735|468954559|FG000|Overall Study|Protocol Violation|1|||
130270351|NCT01645735|468954560|FG001|Overall Study|Protocol Violation|0|||
130270352|NCT01645735|468954559|FG000|Overall Study|Adverse Event|0|||
130270353|NCT01645735|468954560|FG001|Overall Study|Adverse Event|1|||
130270354|NCT00573391|468954563|FG000|Overall Study|study stopped|2|||
130270355|NCT00573391|468954564|FG001|Overall Study|study stopped|2|||
130270356|NCT00573391|468954563|FG000|Overall Study|Death|1|||
130270357|NCT00573391|468954564|FG001|Overall Study|Death|0|||
130270358|NCT03369665|468954565|FG000|Overall Study|Adverse Event|3|||
130270359|NCT03369665|468954565|FG000|Overall Study|Lost to Follow-up|7|||
130270360|NCT03369665|468954565|FG000|Overall Study|Withdrawal by Subject|15|||
130270361|NCT03369665|468954565|FG000|Overall Study|Progression Disease|2|||
130270362|NCT03369665|468954565|FG000|Overall Study|Not classified|3|||
130270363|NCT02553928|468954566|FG000|Overall Study|Adverse Event|2|||
130270364|NCT02553928|468954567|FG001|Overall Study|Adverse Event|1|||
130270365|NCT02553928|468954566|FG000|Overall Study|Lost to Follow-up|0|||
130270366|NCT02553928|468954567|FG001|Overall Study|Lost to Follow-up|1|||
130270367|NCT02553928|468954566|FG000|Overall Study|Administrative reason(s)|0|||
130270368|NCT02553928|468954567|FG001|Overall Study|Administrative reason(s)|1|||
130270369|NCT01206140|468954573|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
130270370|NCT01206140|468954574|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
130270371|NCT02688192|468954575|FG000|Overall Study|Lost to Follow-up|11|||
130270372|NCT02688192|468954576|FG001|Overall Study|Lost to Follow-up|5|||
130270373|NCT02688192|468954575|FG000|Overall Study|Physician Decision|1|||
130270374|NCT02688192|468954576|FG001|Overall Study|Physician Decision|0|||
130270375|NCT00075764|468954577|FG000|Overall Study|Adverse Event|5|||
130270376|NCT00075764|468954578|FG001|Overall Study|Adverse Event|12|||
130270377|NCT00075764|468954577|FG000|Overall Study|Death|4|||
130270378|NCT00075764|468954578|FG001|Overall Study|Death|8|||
130270379|NCT00075764|468954577|FG000|Overall Study|Withdrawal by Subject|28|||
130270380|NCT00075764|468954578|FG001|Overall Study|Withdrawal by Subject|18|||
130270381|NCT00075764|468954577|FG000|Overall Study|Progression|269|||
130270382|NCT00075764|468954578|FG001|Overall Study|Progression|274|||
130270383|NCT00075764|468954577|FG000|Overall Study|Still on treatment|8|||
130270384|NCT00075764|468954578|FG001|Overall Study|Still on treatment|15|||
130270385|NCT00075764|468954577|FG000|Overall Study|Delinquent|4|||
130270386|NCT00075764|468954578|FG001|Overall Study|Delinquent|2|||
130270387|NCT00075764|468954577|FG000|Overall Study|Not protocol specified|27|||
130270388|NCT00075764|468954578|FG001|Overall Study|Not protocol specified|19|||
130270389|NCT00075764|468954577|FG000|Overall Study|Under review|0|||
130270390|NCT00075764|468954578|FG001|Overall Study|Under review|1|||
130270391|NCT02817594|468954579|FG000|Overall Study|Withdrawal by Subject|1|||
130270392|NCT02817594|468954579|FG000|Overall Study|Other|1|||
130270393|NCT02817594|468954579|FG000|Overall Study|Did Not Receive Treatment|1|||
130270394|NCT02010593|468954580|FG000|Overall Study|Lost to Follow-up|1|||
130270395|NCT02010593|468954581|FG001|Overall Study|Lost to Follow-up|0|||
130270396|NCT02010593|468954580|FG000|Overall Study|Physician Decision|1|||
130270397|NCT02010593|468954581|FG001|Overall Study|Physician Decision|0|||
130270398|NCT02010593|468954580|FG000|Overall Study|Unable to adhere to visit schedule|0|||
130270399|NCT02010593|468954581|FG001|Overall Study|Unable to adhere to visit schedule|2|||
130270400|NCT01773967|468954582|FG000|Overall Study|Lost to Follow-up|15|||
130270401|NCT01773967|468954583|FG001|Overall Study|Lost to Follow-up|13|||
130270402|NCT01135459|468954584|FG000|Overall Study|Adverse Event|8|||
130270403|NCT01135459|468954585|FG001|Overall Study|Adverse Event|10|||
130270404|NCT01135459|468954584|FG000|Overall Study|Lack of Efficacy|3|||
130270405|NCT01135459|468954585|FG001|Overall Study|Lack of Efficacy|1|||
130270406|NCT01135459|468954584|FG000|Overall Study|Withdrawal by Subject|2|||
130270407|NCT01135459|468954585|FG001|Overall Study|Withdrawal by Subject|3|||
130270408|NCT01135459|468954584|FG000|Overall Study|Protocol Violation|5|||
130270409|NCT01135459|468954585|FG001|Overall Study|Protocol Violation|3|||
130270410|NCT01135459|468954584|FG000|Overall Study|Lost to Follow-up|2|||
130270411|NCT01135459|468954585|FG001|Overall Study|Lost to Follow-up|1|||
130270412|NCT01135459|468954584|FG000|Overall Study|Non-compliance to study procedures|0|||
130270413|NCT01135459|468954585|FG001|Overall Study|Non-compliance to study procedures|1|||
130270414|NCT01135459|468954584|FG000|Overall Study|Other than specified|1|||
130270415|NCT01135459|468954585|FG001|Overall Study|Other than specified|1|||
130270416|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
130270417|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
130270418|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270419|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270420|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130037145|NCT00833092|468090416|FG000|Overall Study|Diarrhea|0|||
130037146|NCT00833092|468090417|FG001|Overall Study|Diarrhea|2|||
130037147|NCT00833092|468090416|FG000|Overall Study|constipation|0|||
130037148|NCT00833092|468090417|FG001|Overall Study|constipation|1|||
130037149|NCT01025635|468090427|FG000|Overall Study|Withdrawal by Subject|6|||
130270421|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270422|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270423|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270424|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270425|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
130270426|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
130037150|NCT01025635|468090428|FG001|Overall Study|Withdrawal by Subject|7|||
130037151|NCT01025635|468090427|FG000|Overall Study|Protocol Violation|4|||
130037152|NCT01025635|468090428|FG001|Overall Study|Protocol Violation|2|||
130037153|NCT01025635|468090427|FG000|Overall Study|Lack of Efficacy|0|||
130037154|NCT01025635|468090428|FG001|Overall Study|Lack of Efficacy|1|||
130037155|NCT01025635|468090427|FG000|Overall Study|Lost to Follow-up|9|||
130037156|NCT01025635|468090428|FG001|Overall Study|Lost to Follow-up|13|||
130037157|NCT01025635|468090427|FG000|Overall Study|Reason not known|4|||
130037158|NCT01025635|468090428|FG001|Overall Study|Reason not known|2|||
130037159|NCT00727402|468090429|FG000|Overall Study|Physician Decision|116|||
130037160|NCT00929240|468090430|FG000|Initial Treatment Phase|Adverse Event|31|||
130037161|NCT00929240|468090431|FG001|Initial Treatment Phase|Adverse Event|0|||
130037162|NCT00929240|468090432|FG002|Initial Treatment Phase|Adverse Event|0|||
130037163|NCT00929240|468090430|FG000|Initial Treatment Phase|Disease progression|41|||
130037164|NCT00929240|468090431|FG001|Initial Treatment Phase|Disease progression|0|||
130037165|NCT00929240|468090432|FG002|Initial Treatment Phase|Disease progression|0|||
130037166|NCT00929240|468090430|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
130037167|NCT00929240|468090431|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
130037168|NCT00929240|468090432|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
130270427|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
130270428|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270429|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270430|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270431|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270432|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270433|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270434|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270435|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
130270436|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
130270437|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270438|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270439|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270440|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270441|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270442|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270443|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270444|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270445|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
130270446|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
130270447|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
130270448|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270449|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270450|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270451|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270452|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270453|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270454|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270455|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
130270456|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270457|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
130270458|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270459|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270460|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270461|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270462|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270463|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270464|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270465|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
130270466|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
130270467|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
130270468|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270469|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270470|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270471|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270472|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130037169|NCT00929240|468090430|FG000|Initial Treatment Phase|Protocol Violation|5|||
130037170|NCT00929240|468090431|FG001|Initial Treatment Phase|Protocol Violation|0|||
130037171|NCT00929240|468090432|FG002|Initial Treatment Phase|Protocol Violation|0|||
130037172|NCT00929240|468090430|FG000|Initial Treatment Phase|Death|2|||
130037173|NCT00929240|468090431|FG001|Initial Treatment Phase|Death|0|||
130037174|NCT00929240|468090432|FG002|Initial Treatment Phase|Death|0|||
130037175|NCT00929240|468090430|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
130037176|NCT00929240|468090431|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
130037177|NCT00929240|468090432|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
130037178|NCT00929240|468090430|FG000|Initial Treatment Phase|Physician Decision|4|||
130037179|NCT00929240|468090431|FG001|Initial Treatment Phase|Physician Decision|0|||
130037180|NCT00929240|468090432|FG002|Initial Treatment Phase|Physician Decision|0|||
130037181|NCT00929240|468090430|FG000|Maintenance Phase|Disease progression|0|||
130037182|NCT00929240|468090431|FG001|Maintenance Phase|Disease progression|73|||
130037183|NCT00929240|468090432|FG002|Maintenance Phase|Disease progression|60|||
130270473|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270474|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270475|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
130270476|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
130037184|NCT00929240|468090430|FG000|Maintenance Phase|Adverse Event|0|||
130037185|NCT00929240|468090431|FG001|Maintenance Phase|Adverse Event|9|||
130037186|NCT00929240|468090432|FG002|Maintenance Phase|Adverse Event|12|||
130037187|NCT00929240|468090430|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130037188|NCT00929240|468090431|FG001|Maintenance Phase|Withdrawal by Subject|2|||
130037189|NCT00929240|468090432|FG002|Maintenance Phase|Withdrawal by Subject|6|||
130037190|NCT00929240|468090430|FG000|Maintenance Phase|Protocol Violation|0|||
130037191|NCT00929240|468090431|FG001|Maintenance Phase|Protocol Violation|1|||
130037192|NCT00929240|468090432|FG002|Maintenance Phase|Protocol Violation|0|||
130037193|NCT00929240|468090430|FG000|Maintenance Phase|Health authority/Study termination|0|||
130037194|NCT00929240|468090431|FG001|Maintenance Phase|Health authority/Study termination|1|||
130037195|NCT00929240|468090432|FG002|Maintenance Phase|Health authority/Study termination|2|||
130037196|NCT00929240|468090430|FG000|Maintenance Phase|Physician Decision|0|||
130037197|NCT00929240|468090431|FG001|Maintenance Phase|Physician Decision|2|||
130037198|NCT00929240|468090432|FG002|Maintenance Phase|Physician Decision|1|||
130037199|NCT00929240|468090430|FG000|Maintenance Phase|Change of treatment|0|||
130037200|NCT00929240|468090431|FG001|Maintenance Phase|Change of treatment|4|||
130037201|NCT00929240|468090432|FG002|Maintenance Phase|Change of treatment|0|||
130037202|NCT00929240|468090430|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
130037203|NCT00929240|468090431|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
130037204|NCT00929240|468090432|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
130037205|NCT00929240|468090430|FG000|Maintenance Phase|Participant not treated|0|||
130037206|NCT00929240|468090431|FG001|Maintenance Phase|Participant not treated|2|||
130037207|NCT00929240|468090432|FG002|Maintenance Phase|Participant not treated|0|||
130037208|NCT05292755|468090433|FG000|Overall Study|Lost to Follow-up|5|||
130037209|NCT05292755|468090434|FG001|Overall Study|Lost to Follow-up|9|||
130037210|NCT00432809|468090435|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
130037211|NCT00432809|468090436|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
130037212|NCT00432809|468090437|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
130037213|NCT00432809|468090435|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
130037214|NCT00432809|468090436|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
130037215|NCT00432809|468090437|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
130037216|NCT04433117|468090438|FG000|Overall Study|Withdrawal by Subject|1|||
130037217|NCT04433117|468090439|FG001|Overall Study|Withdrawal by Subject|0|||
130037218|NCT01051739|468090440|FG000|Overall Study|Death|3|||
130037219|NCT01051739|468090441|FG001|Overall Study|Death|3|||
130037220|NCT01051739|468090440|FG000|Overall Study|Withdrawal by Subject|25|||
130037221|NCT01051739|468090441|FG001|Overall Study|Withdrawal by Subject|10|||
130037222|NCT02499952|468090442|FG000|Overall Study|Lost to Follow-up|1|||
130037223|NCT02499952|468090442|FG000|Overall Study|Death|9|||
130037224|NCT02209766|468090443|FG000|Overall Study|Withdrawal by Subject|0|||
130037225|NCT02209766|468090444|FG001|Overall Study|Withdrawal by Subject|0|||
130037226|NCT02209766|468090445|FG002|Overall Study|Withdrawal by Subject|0|||
130037227|NCT02209766|468090446|FG003|Overall Study|Withdrawal by Subject|1|||
130037228|NCT02209766|468090447|FG004|Overall Study|Withdrawal by Subject|0|||
130037229|NCT00805207|468090448|FG000|Overall Study|Protocol Violation|0|||
130037230|NCT00805207|468090449|FG001|Overall Study|Protocol Violation|0|||
130037231|NCT00805207|468090450|FG002|Overall Study|Protocol Violation|1|||
130037232|NCT00805207|468090451|FG003|Overall Study|Protocol Violation|0|||
130037233|NCT00805207|468090452|FG004|Overall Study|Protocol Violation|0|||
130037234|NCT00805207|468090453|FG005|Overall Study|Protocol Violation|0|||
130037235|NCT00805207|468090454|FG006|Overall Study|Protocol Violation|0|||
130270477|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
130270478|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270479|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270480|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130037236|NCT00805207|468090455|FG007|Overall Study|Protocol Violation|0|||
130037237|NCT00805207|468090456|FG008|Overall Study|Protocol Violation|0|||
130037238|NCT00805207|468090448|FG000|Overall Study|Physician Decision|0|||
130270481|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270482|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270483|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130037239|NCT00805207|468090449|FG001|Overall Study|Physician Decision|1|||
130037240|NCT00805207|468090450|FG002|Overall Study|Physician Decision|0|||
130037241|NCT00805207|468090451|FG003|Overall Study|Physician Decision|0|||
130037242|NCT00805207|468090452|FG004|Overall Study|Physician Decision|0|||
130037243|NCT00805207|468090453|FG005|Overall Study|Physician Decision|1|||
130037244|NCT00805207|468090454|FG006|Overall Study|Physician Decision|0|||
130037245|NCT00805207|468090455|FG007|Overall Study|Physician Decision|0|||
130037246|NCT00805207|468090456|FG008|Overall Study|Physician Decision|0|||
130037247|NCT00805207|468090448|FG000|Overall Study|Withdrawal by Subject|0|||
130037248|NCT00805207|468090449|FG001|Overall Study|Withdrawal by Subject|1|||
130037249|NCT00805207|468090450|FG002|Overall Study|Withdrawal by Subject|0|||
130037250|NCT00805207|468090451|FG003|Overall Study|Withdrawal by Subject|0|||
130037251|NCT00805207|468090452|FG004|Overall Study|Withdrawal by Subject|1|||
130037252|NCT00805207|468090453|FG005|Overall Study|Withdrawal by Subject|2|||
130270484|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270485|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
130270486|NCT01194219|468954586|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
130270487|NCT01194219|468954587|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
130270488|NCT01194219|468954588|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270489|NCT01194219|468954589|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270490|NCT01194219|468954590|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270491|NCT01194219|468954591|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270492|NCT01194219|468954592|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270493|NCT01194219|468954593|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270494|NCT01194219|468954594|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270495|NCT01194219|468954595|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
130270496|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270497|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270498|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
130270499|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
130270500|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270501|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270502|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270503|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270504|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270505|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
130270506|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270507|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270508|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
130270509|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
130270510|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270511|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270512|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270513|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270514|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270515|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
130270516|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270517|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270518|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
130270519|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
130270520|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270521|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270522|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270523|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270524|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270525|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
130270526|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270527|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270528|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
130270529|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
130037253|NCT00805207|468090454|FG006|Overall Study|Withdrawal by Subject|0|||
130037254|NCT00805207|468090455|FG007|Overall Study|Withdrawal by Subject|0|||
130037255|NCT00805207|468090456|FG008|Overall Study|Withdrawal by Subject|0|||
130037256|NCT02115308|468090463|FG000|Overall Study|Safety Screening|2|||
130037257|NCT02115308|468090464|FG001|Overall Study|Safety Screening|2|||
130270530|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270531|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270532|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270533|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270534|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270535|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
130270536|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270537|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270538|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
130270539|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270540|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270541|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270542|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130037258|NCT04325503|468090472|FG000|Overall Study|Withdrawal by Subject|1|||
130037259|NCT04325503|468090472|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
130037260|NCT00981526|468090473|FG000|Overall Study|Withdrawal by Subject|0|||
130037261|NCT00981526|468090474|FG001|Overall Study|Withdrawal by Subject|2|||
130270543|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270544|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270545|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
130270546|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270547|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270548|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270549|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
130270550|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270551|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270552|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270553|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270554|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270555|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
130270556|NCT01194219|468954586|FG000|Maintenance Phase Weeks16-32|Other|0|||
130270557|NCT01194219|468954587|FG001|Maintenance Phase Weeks16-32|Other|0|||
130270558|NCT01194219|468954588|FG002|Maintenance Phase Weeks16-32|Other|2|||
130270559|NCT01194219|468954589|FG003|Maintenance Phase Weeks16-32|Other|1|||
130270560|NCT01194219|468954590|FG004|Maintenance Phase Weeks16-32|Other|0|||
130270561|NCT01194219|468954591|FG005|Maintenance Phase Weeks16-32|Other|0|||
130270562|NCT01194219|468954592|FG006|Maintenance Phase Weeks16-32|Other|0|||
130270563|NCT01194219|468954593|FG007|Maintenance Phase Weeks16-32|Other|0|||
130270564|NCT01194219|468954594|FG008|Maintenance Phase Weeks16-32|Other|0|||
130270565|NCT01194219|468954595|FG009|Maintenance Phase Weeks16-32|Other|0|||
130270566|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270567|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270568|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270569|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270570|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270571|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
130270572|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
130270573|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
130270574|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270575|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
130270576|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270577|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270578|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270579|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270580|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
130270581|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
130270582|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
130270583|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
130270584|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270585|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
130270586|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270587|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270588|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270589|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270590|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
130270591|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130037262|NCT00981526|468090473|FG000|Overall Study|Physician Decision|4|||
130103756|NCT03466060|468338730|FG003|Period 1|Lost to Follow-up|1|||
130103757|NCT03466060|468338731|FG004|Period 1|Lost to Follow-up|0|||
130103758|NCT03466060|468338732|FG005|Period 1|Lost to Follow-up|0|||
130103759|NCT03466060|468338727|FG000|Period 1|Grade 2 Conjunctivitis|0|||
130103760|NCT03466060|468338728|FG001|Period 1|Grade 2 Conjunctivitis|0|||
130103761|NCT03466060|468338729|FG002|Period 1|Grade 2 Conjunctivitis|1|||
130103762|NCT03466060|468338730|FG003|Period 1|Grade 2 Conjunctivitis|0|||
130103763|NCT03466060|468338731|FG004|Period 1|Grade 2 Conjunctivitis|0|||
130103764|NCT03466060|468338732|FG005|Period 1|Grade 2 Conjunctivitis|0|||
130103765|NCT03466060|468338727|FG000|Period 2|Lens Handling Difficulties|0|||
130103766|NCT03466060|468338728|FG001|Period 2|Lens Handling Difficulties|0|||
130103767|NCT03466060|468338729|FG002|Period 2|Lens Handling Difficulties|1|||
130103768|NCT03466060|468338730|FG003|Period 2|Lens Handling Difficulties|0|||
130103769|NCT03466060|468338731|FG004|Period 2|Lens Handling Difficulties|0|||
130103770|NCT03466060|468338732|FG005|Period 2|Lens Handling Difficulties|0|||
130103771|NCT04732728|468338736|FG000|Overall Study|Death|12|||
130103772|NCT04732728|468338736|FG000|Overall Study|Withdrawn|136|||
130103773|NCT01339000|468338739|FG000|Overall Study|study closed due to lack of drug supply|1|||
130103774|NCT01339000|468338740|FG001|Overall Study|study closed due to lack of drug supply|0|||
130103775|NCT02072174|468338741|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
130103776|NCT02072174|468338742|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
130103777|NCT02072174|468338741|FG000|Overall Study|Protocol Violation|16|||
130270592|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
130270593|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270594|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270595|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
130270596|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270597|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270598|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270599|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270600|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
130270601|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270602|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
130270603|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
130270604|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270605|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
130270606|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270607|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270608|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270609|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270610|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
130270611|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
130270612|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
130270613|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270614|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270615|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
130270616|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270617|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270618|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270619|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270620|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270621|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270622|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270623|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
130270624|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130270625|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
130103778|NCT02072174|468338742|FG001|Overall Study|Protocol Violation|23|||
130103779|NCT02072174|468338741|FG000|Overall Study|Physician Decision|0|||
130103780|NCT02072174|468338742|FG001|Overall Study|Physician Decision|1|||
130103781|NCT02072174|468338741|FG000|Overall Study|Non-compliance with protocol requirement|2|||
130103782|NCT02072174|468338742|FG001|Overall Study|Non-compliance with protocol requirement|0|||
130037263|NCT00981526|468090474|FG001|Overall Study|Physician Decision|4|||
130037264|NCT01564784|468090475|FG000|Overall Study|Other|1|||
130037265|NCT01564784|468090476|FG001|Overall Study|Other|0|||
130037266|NCT01564784|468090475|FG000|Overall Study|Subject refused further follow-up|1|||
130037267|NCT01564784|468090476|FG001|Overall Study|Subject refused further follow-up|6|||
130037268|NCT01564784|468090475|FG000|Overall Study|Lost to Follow-up|1|||
130037269|NCT01564784|468090476|FG001|Overall Study|Lost to Follow-up|1|||
130037270|NCT01564784|468090475|FG000|Overall Study|Death|131|||
130037271|NCT01564784|468090476|FG001|Overall Study|Death|126|||
130037272|NCT04439331|468090477|FG000|Overall Study|Never Start Protocol Therapy|2|||
130037273|NCT04439331|468090477|FG000|Overall Study|Ineligible|2|||
130037274|NCT04439331|468090477|FG000|Overall Study|Mutation Status Not Confirmed|1|||
130037275|NCT04439331|468090477|FG000|Overall Study|Adverse Event|1|||
130037276|NCT04439331|468090477|FG000|Overall Study|Death|1|||
130037277|NCT04439331|468090477|FG000|Overall Study|Disease Progression|20|||
130037278|NCT04439331|468090477|FG000|Overall Study|Withdrawal by Subject|6|||
130037279|NCT04439331|468090477|FG000|Overall Study|Physician Decision|1|||
130037280|NCT04439331|468090477|FG000|Overall Study|Other Complicating Disease|1|||
130037281|NCT06218251|468090479|FG000|Overall Study|Lost to Follow-up|4|||
130037282|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
130037283|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
130037284|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
130037285|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
130037286|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
130037287|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
130037288|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
130037289|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
130037290|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
130037291|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
130037292|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
130037293|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130037294|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130037295|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130037296|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
130037297|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
130037298|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130037299|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130037300|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130037301|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
130037302|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Death|0|||
130037303|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Death|1|||
130037304|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Death|0|||
130037305|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Death|0|||
130037306|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Death|0|||
130037307|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130037308|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
130037309|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130037310|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130037311|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
130037312|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
130037313|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130037314|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130037315|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130037316|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
130037317|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
130037318|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130037319|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130037320|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130037321|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
130037322|NCT05087030|468090480|FG000|Main Period (Week 0 to Week 52)|Other|1|||
130037323|NCT05087030|468090481|FG001|Main Period (Week 0 to Week 52)|Other|2|||
130037324|NCT05087030|468090482|FG002|Main Period (Week 0 to Week 52)|Other|0|||
130037325|NCT05087030|468090483|FG003|Main Period (Week 0 to Week 52)|Other|0|||
130103783|NCT05674721|468338744|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
130037326|NCT05087030|468090484|FG004|Main Period (Week 0 to Week 52)|Other|0|||
130037327|NCT05087030|468090480|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130037328|NCT05087030|468090481|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130037329|NCT05087030|468090482|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130037330|NCT05087030|468090483|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
130037331|NCT05087030|468090484|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
130037332|NCT00609622|468090485|FG000|Overall Study|Adverse Event|14|||
130037333|NCT00609622|468090486|FG001|Overall Study|Adverse Event|10|||
130037334|NCT00609622|468090485|FG000|Overall Study|Withdrawal by Subject|4|||
130037335|NCT00609622|468090486|FG001|Overall Study|Withdrawal by Subject|20|||
130037336|NCT00609622|468090485|FG000|Overall Study|Death|1|||
130037337|NCT00609622|468090486|FG001|Overall Study|Death|4|||
130037338|NCT00609622|468090485|FG000|Overall Study|Protocol Violation|1|||
130037339|NCT00609622|468090486|FG001|Overall Study|Protocol Violation|1|||
130037340|NCT00609622|468090485|FG000|Overall Study|Objective progression or relapse|47|||
130037341|NCT00609622|468090486|FG001|Overall Study|Objective progression or relapse|41|||
130037342|NCT00609622|468090485|FG000|Overall Study|Study terminated by sponsor|16|||
130037343|NCT00609622|468090486|FG001|Overall Study|Study terminated by sponsor|3|||
130037344|NCT00609622|468090485|FG000|Overall Study|Other|7|||
130037345|NCT00609622|468090486|FG001|Overall Study|Other|14|||
130037346|NCT00609622|468090485|FG000|Overall Study|Global deterioration of health status|6|||
130037347|NCT00609622|468090486|FG001|Overall Study|Global deterioration of health status|2|||
130037348|NCT00686543|468090487|FG000|Overall Study|Adverse Event|9|||
130037349|NCT00686543|468090488|FG001|Overall Study|Adverse Event|1|||
130037350|NCT00686543|468090489|FG002|Overall Study|Adverse Event|3|||
130037351|NCT00686543|468090490|FG003|Overall Study|Adverse Event|2|||
130037352|NCT00686543|468090487|FG000|Overall Study|Withdrawal by Subject|2|||
130037353|NCT00686543|468090488|FG001|Overall Study|Withdrawal by Subject|0|||
130037354|NCT00686543|468090489|FG002|Overall Study|Withdrawal by Subject|0|||
130037355|NCT00686543|468090490|FG003|Overall Study|Withdrawal by Subject|0|||
130037356|NCT00686543|468090487|FG000|Overall Study|Protocol Violation|3|||
130037357|NCT00686543|468090488|FG001|Overall Study|Protocol Violation|0|||
130037358|NCT00686543|468090489|FG002|Overall Study|Protocol Violation|2|||
130037359|NCT00686543|468090490|FG003|Overall Study|Protocol Violation|1|||
130037360|NCT02370121|468090491|FG000|Overall Study|Lost to Follow-up|1|||
130037361|NCT02370121|468090492|FG001|Overall Study|Lost to Follow-up|1|||
130037362|NCT04429022|468090494|FG000|Overall Study|Protocol Violation|18|||
130037363|NCT04429022|468090495|FG001|Overall Study|Protocol Violation|1|||
130037364|NCT01769105|468090496|FG000|First Intervention|Protocol Violation|2|||
130037365|NCT01769105|468090497|FG001|First Intervention|Protocol Violation|2|||
130037366|NCT01769105|468090496|FG000|Cross-over|Lost to Follow-up|5|||
130037367|NCT01769105|468090497|FG001|Cross-over|Lost to Follow-up|0|||
130037368|NCT00963807|468090498|FG000|Overall Study|Physician Decision|2|||
130037369|NCT00963807|468090498|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
130037370|NCT00963807|468090498|FG000|Overall Study|Disease progression|15|||
130037371|NCT00045032|468090506|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
130037372|NCT00045032|468090507|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
130037373|NCT00045032|468090508|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
130037374|NCT00045032|468090506|FG000|Overall Study|Death|22|||
130037375|NCT00045032|468090507|FG001|Overall Study|Death|24|||
130037376|NCT00045032|468090508|FG002|Overall Study|Death|17|||
130037377|NCT00045032|468090506|FG000|Overall Study|Insufficient Therapeutic Response|542|||
130037378|NCT00045032|468090507|FG001|Overall Study|Insufficient Therapeutic Response|437|||
130037379|NCT00045032|468090508|FG002|Overall Study|Insufficient Therapeutic Response|445|||
130037380|NCT00045032|468090506|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
130037381|NCT00045032|468090507|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
130037382|NCT00045032|468090508|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
130037383|NCT00045032|468090506|FG000|Overall Study|Other Protocol Violation|2|||
130037384|NCT00045032|468090507|FG001|Overall Study|Other Protocol Violation|0|||
130037385|NCT00045032|468090508|FG002|Overall Study|Other Protocol Violation|1|||
130037386|NCT00045032|468090506|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
130037387|NCT00045032|468090507|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
130037388|NCT00045032|468090508|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
130037389|NCT00045032|468090506|FG000|Overall Study|Failure to Return|57|||
130037390|NCT00045032|468090507|FG001|Overall Study|Failure to Return|62|||
130037391|NCT00045032|468090508|FG002|Overall Study|Failure to Return|61|||
130037392|NCT00045032|468090506|FG000|Overall Study|Other|93|||
130037393|NCT00045032|468090507|FG001|Overall Study|Other|84|||
130037394|NCT00045032|468090508|FG002|Overall Study|Other|105|||
130037395|NCT01024244|468092642|FG000|Overall Study|Adverse Event|1|||
130037396|NCT01024244|468092643|FG001|Overall Study|Adverse Event|2|||
130037397|NCT01024244|468092644|FG002|Overall Study|Adverse Event|0|||
130037398|NCT01024244|468092645|FG003|Overall Study|Adverse Event|1|||
130037399|NCT01024244|468092646|FG004|Overall Study|Adverse Event|2|||
130037400|NCT01024244|468092642|FG000|Overall Study|Entry Criteria Not Met|0|||
130037401|NCT01024244|468092643|FG001|Overall Study|Entry Criteria Not Met|1|||
130037402|NCT01024244|468092644|FG002|Overall Study|Entry Criteria Not Met|0|||
130037403|NCT01024244|468092645|FG003|Overall Study|Entry Criteria Not Met|0|||
129886001|NCT02291289|467542798|FG005|Early Disease Progression|Lost to Follow-up|0|||
130270626|NCT01194219|468954586|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270627|NCT01194219|468954587|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270628|NCT01194219|468954588|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270629|NCT01194219|468954589|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270630|NCT01194219|468954590|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270631|NCT01194219|468954591|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270632|NCT01194219|468954592|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
130270633|NCT01194219|468954593|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270634|NCT01194219|468954594|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270635|NCT01194219|468954595|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
130270636|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270637|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270638|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270639|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270640|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270641|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270642|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270643|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
130270644|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
130270645|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
130270646|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270647|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270648|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270649|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270650|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270651|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270652|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270653|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
130270654|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
130270655|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
130270656|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270657|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270658|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270659|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270660|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270661|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270662|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270663|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
130270664|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
130270665|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
130270666|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270667|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270668|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270669|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270670|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270671|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270672|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270673|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
130270674|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
130270675|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
130270676|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
130270677|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
130270678|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
130270679|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
129886002|NCT02291289|467542799|FG006|Early Disease Progression|Lost to Follow-up|0|||
130270680|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
130270681|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
130270682|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
130270683|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
130270684|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
130270685|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
130270686|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270687|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270688|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270689|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270690|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270691|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270692|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270693|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
130270694|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
130270695|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
130270696|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270697|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270698|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270699|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270700|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270701|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270702|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270703|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270704|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
130270705|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
130270706|NCT01194219|468954586|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270707|NCT01194219|468954587|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270708|NCT01194219|468954588|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270709|NCT01194219|468954589|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270710|NCT01194219|468954590|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270711|NCT01194219|468954591|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270712|NCT01194219|468954592|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270713|NCT01194219|468954593|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
130270714|NCT01194219|468954594|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
130270715|NCT01194219|468954595|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
130270716|NCT00292045|468954596|FG000|Core Study (Through Week 13)|Adverse Event|1|||
130270717|NCT00292045|468954596|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
130270718|NCT04474197|468954597|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130270719|NCT04474197|468954598|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
130270720|NCT04474197|468954599|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130270721|NCT04474197|468954600|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
130270722|NCT01871545|468954601|FG000|Overall Study|Death|2|||
130270723|NCT01871545|468954602|FG001|Overall Study|Death|0|||
130270724|NCT01871545|468954601|FG000|Overall Study|Lack of Efficacy|11|||
130270725|NCT01871545|468954602|FG001|Overall Study|Lack of Efficacy|2|||
130270726|NCT01871545|468954601|FG000|Overall Study|Physician Decision|4|||
130270727|NCT01871545|468954602|FG001|Overall Study|Physician Decision|0|||
130270728|NCT01871545|468954601|FG000|Overall Study|Withdrawal by Subject|0|||
130270729|NCT01871545|468954602|FG001|Overall Study|Withdrawal by Subject|1|||
130270730|NCT04834726|468954605|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
130270731|NCT04834726|468954606|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
130270732|NCT04834726|468954607|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
130270733|NCT04834726|468954608|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
130270734|NCT04834726|468954609|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
130270735|NCT04834726|468954610|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
130270736|NCT04834726|468954611|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
130270737|NCT04834726|468954612|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
130270738|NCT04834726|468954613|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
130270739|NCT00363142|468954614|FG000|Overall Study|Adverse Event|2|||
130270740|NCT00363142|468954615|FG001|Overall Study|Adverse Event|0|||
130270741|NCT00363142|468954614|FG000|Overall Study|Lack of Efficacy|0|||
130270742|NCT00363142|468954615|FG001|Overall Study|Lack of Efficacy|1|||
130270743|NCT00363142|468954614|FG000|Overall Study|Lost to Follow-up|1|||
130270744|NCT00363142|468954615|FG001|Overall Study|Lost to Follow-up|0|||
130270745|NCT00363142|468954614|FG000|Overall Study|Non-compliance|1|||
130270746|NCT00363142|468954615|FG001|Overall Study|Non-compliance|1|||
130270747|NCT00363142|468954614|FG000|Overall Study|Withdrawal by Subject|3|||
130270748|NCT00363142|468954615|FG001|Overall Study|Withdrawal by Subject|1|||
130270749|NCT00132301|468954622|FG000|Overall Study|Death|7|||
130270750|NCT00132301|468954623|FG001|Overall Study|Death|6|||
130270751|NCT00132301|468954622|FG000|Overall Study|Withdrawal by Subject|5|||
130270752|NCT00132301|468954623|FG001|Overall Study|Withdrawal by Subject|2|||
130270753|NCT00132301|468954622|FG000|Overall Study|Physician Decision|1|||
130270754|NCT00132301|468954623|FG001|Overall Study|Physician Decision|1|||
130270755|NCT00132301|468954622|FG000|Overall Study|Lost to Follow-up|5|||
130270756|NCT00132301|468954623|FG001|Overall Study|Lost to Follow-up|3|||
130270757|NCT00132301|468954622|FG000|Overall Study|Other|1|||
130270758|NCT00132301|468954623|FG001|Overall Study|Other|1|||
130270759|NCT00132301|468954622|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
130270760|NCT00132301|468954623|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
130270761|NCT02012218|468954624|FG000|Overall Study|Withdrawal by Subject|1|||
130270762|NCT02012218|468954625|FG001|Overall Study|Withdrawal by Subject|0|||
130270763|NCT02012218|468954626|FG002|Overall Study|Withdrawal by Subject|1|||
130270764|NCT02012218|468954627|FG003|Overall Study|Withdrawal by Subject|1|||
130270765|NCT02012218|468954628|FG004|Overall Study|Withdrawal by Subject|1|||
130270766|NCT02012218|468954624|FG000|Overall Study|Adverse Event|1|||
130270767|NCT02012218|468954625|FG001|Overall Study|Adverse Event|0|||
130270768|NCT02012218|468954626|FG002|Overall Study|Adverse Event|0|||
130270769|NCT02012218|468954627|FG003|Overall Study|Adverse Event|1|||
130270770|NCT02012218|468954628|FG004|Overall Study|Adverse Event|0|||
130270771|NCT02012218|468954624|FG000|Overall Study|Lost to Follow-up|0|||
130270772|NCT02012218|468954625|FG001|Overall Study|Lost to Follow-up|1|||
130270773|NCT02012218|468954626|FG002|Overall Study|Lost to Follow-up|1|||
130270774|NCT02012218|468954627|FG003|Overall Study|Lost to Follow-up|0|||
130270775|NCT02012218|468954628|FG004|Overall Study|Lost to Follow-up|0|||
130270776|NCT02012218|468954624|FG000|Overall Study|Protocol Specified|1|||
130270777|NCT02012218|468954625|FG001|Overall Study|Protocol Specified|0|||
130270778|NCT02012218|468954626|FG002|Overall Study|Protocol Specified|0|||
130270779|NCT02012218|468954627|FG003|Overall Study|Protocol Specified|0|||
130270780|NCT02012218|468954628|FG004|Overall Study|Protocol Specified|0|||
130270781|NCT02012218|468954624|FG000|Overall Study|Protocol Deviation|1|||
130270782|NCT02012218|468954625|FG001|Overall Study|Protocol Deviation|0|||
130270783|NCT02012218|468954626|FG002|Overall Study|Protocol Deviation|0|||
130270784|NCT02012218|468954627|FG003|Overall Study|Protocol Deviation|0|||
130270785|NCT02012218|468954628|FG004|Overall Study|Protocol Deviation|0|||
130270786|NCT04872569|468954632|FG000|Overall Study|Withdrawal by Subject|2|||
130270787|NCT02382991|468954639|FG000|Overall Study|Adverse Event|1|||
130270788|NCT02382991|468954640|FG001|Overall Study|Adverse Event|2|||
130270789|NCT02382991|468954639|FG000|Overall Study|Lost to Follow-up|1|||
130270790|NCT02382991|468954640|FG001|Overall Study|Lost to Follow-up|0|||
130270791|NCT02382991|468954639|FG000|Overall Study|Withdrawal by Subject|0|||
130270792|NCT02382991|468954640|FG001|Overall Study|Withdrawal by Subject|1|||
130270793|NCT01890265|468954641|FG000|Overall Study|Other (Unspecified reason)|0|||
130270794|NCT01890265|468954642|FG001|Overall Study|Other (Unspecified reason)|1|||
130270795|NCT01890265|468954643|FG002|Overall Study|Other (Unspecified reason)|0|||
130270796|NCT01890265|468954644|FG003|Overall Study|Other (Unspecified reason)|0|||
130270797|NCT01890265|468954645|FG004|Overall Study|Other (Unspecified reason)|0|||
130270798|NCT01890265|468954646|FG005|Overall Study|Other (Unspecified reason)|0|||
130103784|NCT05674721|468338745|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
130103785|NCT05674721|468338744|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
130270799|NCT01890265|468954641|FG000|Overall Study|Progressive disease|6|||
130270800|NCT01890265|468954642|FG001|Overall Study|Progressive disease|6|||
130270801|NCT01890265|468954643|FG002|Overall Study|Progressive disease|0|||
130270802|NCT01890265|468954644|FG003|Overall Study|Progressive disease|0|||
130270803|NCT01890265|468954645|FG004|Overall Study|Progressive disease|0|||
130270804|NCT01890265|468954646|FG005|Overall Study|Progressive disease|0|||
130270805|NCT01890265|468954641|FG000|Overall Study|Adverse Event|2|||
130270806|NCT01890265|468954642|FG001|Overall Study|Adverse Event|1|||
130270807|NCT01890265|468954643|FG002|Overall Study|Adverse Event|0|||
130270808|NCT01890265|468954644|FG003|Overall Study|Adverse Event|0|||
130270809|NCT01890265|468954645|FG004|Overall Study|Adverse Event|0|||
130270810|NCT01890265|468954646|FG005|Overall Study|Adverse Event|0|||
130270811|NCT01890265|468954641|FG000|Overall Study|Death|2|||
130270812|NCT01890265|468954642|FG001|Overall Study|Death|3|||
130270813|NCT01890265|468954643|FG002|Overall Study|Death|1|||
130270814|NCT01890265|468954644|FG003|Overall Study|Death|0|||
130270815|NCT01890265|468954645|FG004|Overall Study|Death|0|||
130270816|NCT01890265|468954646|FG005|Overall Study|Death|0|||
130270817|NCT01890265|468954641|FG000|Overall Study|Withdrawal by Subject|0|||
130270818|NCT01890265|468954642|FG001|Overall Study|Withdrawal by Subject|2|||
130270819|NCT01890265|468954643|FG002|Overall Study|Withdrawal by Subject|3|||
130270820|NCT01890265|468954644|FG003|Overall Study|Withdrawal by Subject|0|||
130270821|NCT01890265|468954645|FG004|Overall Study|Withdrawal by Subject|2|||
130270822|NCT01890265|468954646|FG005|Overall Study|Withdrawal by Subject|0|||
130270823|NCT01445613|468954647|FG000|30-day Follow-up|Withdrawal by Subject|6|||
130270824|NCT01445613|468954647|FG000|30-day Follow-up|Physician Decision|3|||
130270825|NCT01445613|468954647|FG000|30-day Follow-up|Missed visit|23|||
130270826|NCT01445613|468954647|FG000|30-day Follow-up|Death|3|||
130270827|NCT01445613|468954647|FG000|1-year Follow-up|Withdrawal by Subject|12|||
130270828|NCT01445613|468954647|FG000|1-year Follow-up|Missed visit|29|||
130270829|NCT01445613|468954647|FG000|1-year Follow-up|Lost to Follow-up|2|||
130270830|NCT01445613|468954647|FG000|1-year Follow-up|Death|30|||
130270831|NCT01445613|468954647|FG000|1-year Follow-up|Physician Decision|2|||
130270832|NCT01445613|468954647|FG000|1-year Follow-up|Received a non-study stent|2|||
130270833|NCT04466384|468954648|FG000|First Phase|Protocol Violation|1|||
130270834|NCT04466384|468954649|FG001|First Phase|Protocol Violation|0|||
130270835|NCT04466384|468954648|FG000|First Phase|Missing data|1|||
130270836|NCT04466384|468954649|FG001|First Phase|Missing data|0|||
130270837|NCT04466384|468954648|FG000|Cross Over Phase|Physician Decision|1|||
130270838|NCT04466384|468954649|FG001|Cross Over Phase|Physician Decision|0|||
130270839|NCT04466384|468954648|FG000|Cross Over Phase|Withdrawal by Subject|0|||
130270840|NCT04466384|468954649|FG001|Cross Over Phase|Withdrawal by Subject|1|||
130270841|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270842|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
130270843|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
130270844|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270845|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270846|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
130270847|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Other|0|||
130270848|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Other|1|||
130270849|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Other|1|||
130270850|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Other|0|||
130270851|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Other|0|||
130270852|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Other|0|||
130270853|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
130270854|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
130270855|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
130270856|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
130270857|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
130270858|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
130270859|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270860|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270861|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
130270862|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270863|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270864|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
130270865|NCT03666988|468954650|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
130270866|NCT03666988|468954651|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270867|NCT03666988|468954652|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270868|NCT03666988|468954653|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270869|NCT03666988|468954654|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270870|NCT03666988|468954655|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
130270871|NCT03554018|468954664|FG000|Overall Study|Lost to Follow-up|3|||
130270872|NCT03554018|468954665|FG001|Overall Study|Lost to Follow-up|7|||
130270873|NCT01402869|468954666|FG000|Overall Study|Required Tooth Extraction|0|||
130270874|NCT01402869|468954667|FG001|Overall Study|Required Tooth Extraction|0|||
130270875|NCT01402869|468954668|FG002|Overall Study|Required Tooth Extraction|1|||
130270876|NCT01154452|468954669|FG000|Phase Ib|Not Treated|1|||
130270877|NCT01154452|468954670|FG001|Phase Ib|Not Treated|0|||
130270878|NCT01154452|468954671|FG002|Phase Ib|Not Treated|0|||
130270879|NCT01154452|468954672|FG003|Phase Ib|Not Treated|0|||
130270880|NCT01154452|468954669|FG000|Phase Ib|Adverse Event|2|||
130270881|NCT01154452|468954670|FG001|Phase Ib|Adverse Event|1|||
130270882|NCT01154452|468954671|FG002|Phase Ib|Adverse Event|0|||
130270883|NCT01154452|468954672|FG003|Phase Ib|Adverse Event|0|||
130270884|NCT01154452|468954669|FG000|Phase II|Withdrawal by Subject|0|||
130270885|NCT01154452|468954670|FG001|Phase II|Withdrawal by Subject|0|||
130037404|NCT01024244|468092646|FG004|Overall Study|Entry Criteria Not Met|0|||
130270886|NCT01154452|468954671|FG002|Phase II|Withdrawal by Subject|1|||
130270887|NCT01154452|468954672|FG003|Phase II|Withdrawal by Subject|2|||
130270888|NCT01154452|468954669|FG000|Phase II|Adverse Event|0|||
130270889|NCT01154452|468954670|FG001|Phase II|Adverse Event|0|||
130270890|NCT01154452|468954671|FG002|Phase II|Adverse Event|4|||
130270891|NCT01154452|468954672|FG003|Phase II|Adverse Event|4|||
130270892|NCT01837680|468954675|FG000|Overall Study|Lost to Follow-up|2|||
130270893|NCT01837680|468954676|FG001|Overall Study|Lost to Follow-up|2|||
130270894|NCT01837680|468954675|FG000|Overall Study|lack of insurance|0|||
130270895|NCT01837680|468954676|FG001|Overall Study|lack of insurance|2|||
130270896|NCT01837680|468954675|FG000|Overall Study|allergic reaction|6|||
130037405|NCT01024244|468092642|FG000|Overall Study|Lack of Efficacy|1|||
130037406|NCT01024244|468092643|FG001|Overall Study|Lack of Efficacy|0|||
130037407|NCT01024244|468092644|FG002|Overall Study|Lack of Efficacy|0|||
130037408|NCT01024244|468092645|FG003|Overall Study|Lack of Efficacy|0|||
130037409|NCT01024244|468092646|FG004|Overall Study|Lack of Efficacy|0|||
130037410|NCT01024244|468092642|FG000|Overall Study|Protocol Violation|1|||
130037411|NCT01024244|468092643|FG001|Overall Study|Protocol Violation|0|||
130037412|NCT01024244|468092644|FG002|Overall Study|Protocol Violation|0|||
130037413|NCT01024244|468092645|FG003|Overall Study|Protocol Violation|0|||
130037414|NCT01024244|468092646|FG004|Overall Study|Protocol Violation|2|||
130037415|NCT01024244|468092642|FG000|Overall Study|Sponsor Decision|14|||
130037416|NCT01024244|468092643|FG001|Overall Study|Sponsor Decision|7|||
130037417|NCT01024244|468092644|FG002|Overall Study|Sponsor Decision|14|||
130037418|NCT01024244|468092645|FG003|Overall Study|Sponsor Decision|12|||
130037419|NCT01024244|468092646|FG004|Overall Study|Sponsor Decision|10|||
130037420|NCT01024244|468092642|FG000|Overall Study|Withdrawal by Subject|0|||
130037421|NCT01024244|468092643|FG001|Overall Study|Withdrawal by Subject|1|||
130037422|NCT01024244|468092644|FG002|Overall Study|Withdrawal by Subject|0|||
130037423|NCT01024244|468092645|FG003|Overall Study|Withdrawal by Subject|0|||
130037424|NCT01024244|468092646|FG004|Overall Study|Withdrawal by Subject|0|||
130037425|NCT00473694|468092650|FG000|Overall Study|Adverse Event|0|||
130037426|NCT00473694|468092651|FG001|Overall Study|Adverse Event|1|||
130037427|NCT00473694|468092652|FG002|Overall Study|Adverse Event|0|||
130037428|NCT00473694|468092653|FG003|Overall Study|Adverse Event|0|||
130037429|NCT00473694|468092650|FG000|Overall Study|Participants did not receive treatment|11|||
130037430|NCT00473694|468092651|FG001|Overall Study|Participants did not receive treatment|3|||
130037431|NCT00473694|468092652|FG002|Overall Study|Participants did not receive treatment|5|||
130037432|NCT00473694|468092653|FG003|Overall Study|Participants did not receive treatment|6|||
130037433|NCT00473694|468092650|FG000|Overall Study|Lost to Follow-up|0|||
130037434|NCT00473694|468092651|FG001|Overall Study|Lost to Follow-up|0|||
130037435|NCT00473694|468092652|FG002|Overall Study|Lost to Follow-up|0|||
130037436|NCT00473694|468092653|FG003|Overall Study|Lost to Follow-up|1|||
130037437|NCT00506389|468092661|FG000|In-treatment Period|Other|3|||
130037438|NCT00506389|468092662|FG001|In-treatment Period|Other|3|||
130037439|NCT00506389|468092663|FG002|In-treatment Period|Other|4|||
130037440|NCT00506389|468092661|FG000|In-treatment Period|Lost to Follow-up|0|||
130037441|NCT00506389|468092662|FG001|In-treatment Period|Lost to Follow-up|0|||
130037442|NCT00506389|468092663|FG002|In-treatment Period|Lost to Follow-up|1|||
130037443|NCT00506389|468092661|FG000|In-treatment Period|Lack of compliance|1|||
130037444|NCT00506389|468092662|FG001|In-treatment Period|Lack of compliance|0|||
130037445|NCT00506389|468092663|FG002|In-treatment Period|Lack of compliance|0|||
130037446|NCT00506389|468092661|FG000|In-treatment Period|Reasons not related to trial|4|||
130037447|NCT00506389|468092662|FG001|In-treatment Period|Reasons not related to trial|1|||
130037448|NCT00506389|468092663|FG002|In-treatment Period|Reasons not related to trial|0|||
130037449|NCT00506389|468092661|FG000|In-treatment Period|Withdrawal by Subject|3|||
130037450|NCT00506389|468092662|FG001|In-treatment Period|Withdrawal by Subject|3|||
130037451|NCT00506389|468092663|FG002|In-treatment Period|Withdrawal by Subject|4|||
130037452|NCT00506389|468092661|FG000|In-treatment Period|Lack of Efficacy|0|||
130037453|NCT00506389|468092662|FG001|In-treatment Period|Lack of Efficacy|2|||
130037454|NCT00506389|468092663|FG002|In-treatment Period|Lack of Efficacy|0|||
130037455|NCT00506389|468092661|FG000|In-treatment Period|Adverse Event|11|||
130037456|NCT00506389|468092662|FG001|In-treatment Period|Adverse Event|5|||
130037457|NCT00506389|468092663|FG002|In-treatment Period|Adverse Event|2|||
130037458|NCT00506389|468092661|FG000|In-treatment Period|Randomized but not treated|4|||
130037459|NCT00506389|468092662|FG001|In-treatment Period|Randomized but not treated|1|||
130037460|NCT00506389|468092663|FG002|In-treatment Period|Randomized but not treated|1|||
130037461|NCT05224258|468092664|FG000|Overall Study|Withdrawal by Subject|1|||
130037462|NCT05224258|468092665|FG001|Overall Study|Withdrawal by Subject|1|||
130037463|NCT05224258|468092664|FG000|Overall Study|Physician Decision|1|||
130037464|NCT05224258|468092665|FG001|Overall Study|Physician Decision|1|||
130037465|NCT05224258|468092664|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130037466|NCT05224258|468092665|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130037467|NCT05224258|468092664|FG000|Overall Study|Study Product No Longer in Use|1|||
130037468|NCT05224258|468092665|FG001|Overall Study|Study Product No Longer in Use|0|||
130037469|NCT05224258|468092664|FG000|Overall Study|Adverse Event|0|||
130037470|NCT05224258|468092665|FG001|Overall Study|Adverse Event|1|||
130037471|NCT05224258|468092664|FG000|Overall Study|Protocol Deviation|0|||
130037472|NCT05224258|468092665|FG001|Overall Study|Protocol Deviation|1|||
130037473|NCT01934504|468092668|FG000|Overall Study|Protocol Deviation|0|||
130037474|NCT01934504|468092669|FG001|Overall Study|Protocol Deviation|0|||
130037475|NCT01934504|468092670|FG002|Overall Study|Protocol Deviation|0|||
130037476|NCT01934504|468092671|FG003|Overall Study|Protocol Deviation|2|||
130037477|NCT01934504|468092668|FG000|Overall Study|Study Terminated by Sponsor|1|||
130037478|NCT01934504|468092669|FG001|Overall Study|Study Terminated by Sponsor|0|||
130037479|NCT01934504|468092670|FG002|Overall Study|Study Terminated by Sponsor|5|||
130103786|NCT05674721|468338745|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
130103787|NCT02643394|468338752|FG000|Overall Study|Protocol Violation|4|||
130103788|NCT02643394|468338753|FG001|Overall Study|Protocol Violation|5|||
130103789|NCT00664066|468338754|FG000|Overall Study|Study terminated|3|||
130103790|NCT03701516|468338755|FG000|Period 1|Lost to Follow-up|0|||
130103791|NCT03701516|468338756|FG001|Period 1|Lost to Follow-up|1|||
130103792|NCT03701516|468338755|FG000|Period 1|Adverse Event|0|||
130103793|NCT03701516|468338756|FG001|Period 1|Adverse Event|2|||
130103794|NCT03701516|468338755|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
130103795|NCT03701516|468338756|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130103796|NCT03701516|468338755|FG000|Period 1|Non Compliance to Protocol|2|||
130103797|NCT03701516|468338756|FG001|Period 1|Non Compliance to Protocol|1|||
130270897|NCT01837680|468954676|FG001|Overall Study|allergic reaction|0|||
130270898|NCT01837680|468954675|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
130270899|NCT01837680|468954676|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
130270900|NCT02297815|468955937|FG000|Overall Study|Lost to Follow-up|236|||
130270901|NCT02297815|468955938|FG001|Overall Study|Lost to Follow-up|140|||
130270902|NCT00662831|468955939|FG000|Overall Study|Death|4|||
130270903|NCT00662831|468955940|FG001|Overall Study|Death|1|||
130270904|NCT00662831|468955939|FG000|Overall Study|Lack of Efficacy|6|||
130270905|NCT00662831|468955940|FG001|Overall Study|Lack of Efficacy|6|||
130270906|NCT00662831|468955939|FG000|Overall Study|Lost to Follow-up|1|||
130270907|NCT00662831|468955940|FG001|Overall Study|Lost to Follow-up|0|||
130270908|NCT00662831|468955939|FG000|Overall Study|Withdrawal by Subject|2|||
130270909|NCT00662831|468955940|FG001|Overall Study|Withdrawal by Subject|1|||
130270910|NCT00662831|468955939|FG000|Overall Study|Other|62|||
130270911|NCT00662831|468955940|FG001|Overall Study|Other|31|||
130270912|NCT00662831|468955939|FG000|Overall Study|Protocol Violation|8|||
130270913|NCT00662831|468955940|FG001|Overall Study|Protocol Violation|4|||
130270914|NCT00662831|468955939|FG000|Overall Study|Adverse Event|23|||
130270915|NCT00662831|468955940|FG001|Overall Study|Adverse Event|16|||
130037480|NCT01934504|468092671|FG003|Overall Study|Study Terminated by Sponsor|5|||
130037481|NCT00541307|468092672|FG000|Overall Study|Death|5|||
130037482|NCT00541307|468092672|FG000|Overall Study|Physician Decision|3|||
130037483|NCT00541307|468092672|FG000|Overall Study|Withdrawal by Subject|6|||
130037484|NCT00541307|468092672|FG000|Overall Study|Lost to Follow-up|4|||
130037485|NCT00541307|468092672|FG000|Overall Study|Subject returned early (outside window)|1|||
130037486|NCT00541307|468092672|FG000|Overall Study|Surgical Bypass|5|||
130037487|NCT03615222|468092677|FG000|Overall Study|Ineligible|26|||
130037488|NCT03615222|468092677|FG000|Overall Study|Withdrawal by Subject|7|||
130037489|NCT03615222|468092677|FG000|Overall Study|Death|1|||
130037490|NCT03895203|468092678|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
130037491|NCT03895203|468092679|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
130037492|NCT03895203|468092680|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
130037493|NCT03895203|468092681|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
130037494|NCT03895203|468092682|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
130037495|NCT03895203|468092683|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
130270916|NCT00600106|468955941|FG000|Overall Study|Withdrawal by Subject|1|||
130270917|NCT00600106|468955942|FG001|Overall Study|Withdrawal by Subject|1|||
130270918|NCT01061723|468955945|FG000|Overall Study|Adverse Event|0|||
130270919|NCT01061723|468955946|FG001|Overall Study|Adverse Event|2|||
130270920|NCT01061723|468955947|FG002|Overall Study|Adverse Event|5|||
130037496|NCT03895203|468092678|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
130103798|NCT03701516|468338755|FG000|Period 1|Withdrawal by Subject|0|||
130103799|NCT03701516|468338756|FG001|Period 1|Withdrawal by Subject|1|||
130103800|NCT03701516|468338755|FG000|Period 2|failed to meet all eligibility creiteria|1|||
130270921|NCT01061723|468955948|FG003|Overall Study|Adverse Event|5|||
130103801|NCT03701516|468338756|FG001|Period 2|failed to meet all eligibility creiteria|0|||
130103802|NCT03701516|468338755|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
130103803|NCT03701516|468338756|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
130103804|NCT03083639|468338757|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
130103805|NCT03083639|468338758|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
130270922|NCT01061723|468955949|FG004|Overall Study|Adverse Event|2|||
130270923|NCT01061723|468955950|FG005|Overall Study|Adverse Event|6|||
130270924|NCT01061723|468955945|FG000|Overall Study|Lack of Efficacy|2|||
130270925|NCT01061723|468955946|FG001|Overall Study|Lack of Efficacy|3|||
130270926|NCT01061723|468955947|FG002|Overall Study|Lack of Efficacy|4|||
130270927|NCT01061723|468955948|FG003|Overall Study|Lack of Efficacy|2|||
130270928|NCT01061723|468955949|FG004|Overall Study|Lack of Efficacy|1|||
130270929|NCT01061723|468955950|FG005|Overall Study|Lack of Efficacy|1|||
130270930|NCT01061723|468955945|FG000|Overall Study|Randomized but not treated|0|||
130270931|NCT01061723|468955946|FG001|Overall Study|Randomized but not treated|0|||
130270932|NCT01061723|468955947|FG002|Overall Study|Randomized but not treated|0|||
130270933|NCT01061723|468955948|FG003|Overall Study|Randomized but not treated|0|||
130270934|NCT01061723|468955949|FG004|Overall Study|Randomized but not treated|0|||
130270935|NCT01061723|468955950|FG005|Overall Study|Randomized but not treated|1|||
130270936|NCT01061723|468955945|FG000|Overall Study|Other than specified above|2|||
130270937|NCT01061723|468955946|FG001|Overall Study|Other than specified above|1|||
130270938|NCT01061723|468955947|FG002|Overall Study|Other than specified above|1|||
130270939|NCT01061723|468955948|FG003|Overall Study|Other than specified above|1|||
130103806|NCT03083639|468338757|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
130103807|NCT03083639|468338758|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
130103808|NCT01591499|468338759|FG000|Baseline Visit|Withdrawal by Subject|0|||
130270940|NCT01061723|468955949|FG004|Overall Study|Other than specified above|0|||
130270941|NCT01061723|468955950|FG005|Overall Study|Other than specified above|1|||
130270942|NCT02840253|468955951|FG000|Overall Study|Unsuccessful block|4|||
130270943|NCT03783962|468955952|FG000|Overall Study|Lost to Follow-up|3|||
130270944|NCT03783962|468955953|FG001|Overall Study|Lost to Follow-up|6|||
130270945|NCT03783962|468955952|FG000|Overall Study|Protocol Violation|0|||
130270946|NCT03783962|468955953|FG001|Overall Study|Protocol Violation|1|||
130270947|NCT03458325|468955954|FG000|Overall Study|Withdrawal by Subject|1|||
130270948|NCT00460655|468955959|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
130270949|NCT00460655|468955960|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130270950|NCT00460655|468955961|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130270951|NCT00460655|468955962|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
130270952|NCT00460655|468955959|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
130103809|NCT01591499|468338760|FG001|Baseline Visit|Withdrawal by Subject|2|||
130103810|NCT01591499|468338761|FG002|Baseline Visit|Withdrawal by Subject|0|||
130103811|NCT01591499|468338762|FG003|Baseline Visit|Withdrawal by Subject|2|||
130103812|NCT01591499|468338759|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
130103813|NCT01591499|468338760|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
130103814|NCT01591499|468338761|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
130103815|NCT01591499|468338762|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
130103816|NCT01591499|468338759|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
130103817|NCT01591499|468338760|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
130103818|NCT01591499|468338761|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
130103819|NCT01591499|468338762|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
130103820|NCT05083559|468338763|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
130103821|NCT05083559|468338764|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
130103822|NCT05083559|468338763|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
130103823|NCT05083559|468338764|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
130103824|NCT05083559|468338763|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
130103825|NCT05083559|468338764|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
130103826|NCT03940742|468338766|FG000|Overall Study|Lost to Follow-up|0|||
130103827|NCT03940742|468338767|FG001|Overall Study|Lost to Follow-up|0|||
130103828|NCT03940742|468338768|FG002|Overall Study|Lost to Follow-up|0|||
130103829|NCT03940742|468338769|FG003|Overall Study|Lost to Follow-up|1|||
130270953|NCT00460655|468955960|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130270954|NCT00460655|468955961|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130270955|NCT00460655|468955962|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
130103830|NCT02032823|468338770|FG000|Overall Study|Death|75|||
130270956|NCT00460655|468955959|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130270957|NCT00460655|468955960|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
130270958|NCT00460655|468955961|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130270959|NCT00460655|468955962|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
130270960|NCT00460655|468955959|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130270961|NCT00460655|468955960|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
130270962|NCT00460655|468955961|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
130270963|NCT00460655|468955962|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
130270964|NCT00460655|468955959|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130270965|NCT00460655|468955960|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130270966|NCT00460655|468955961|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
130270967|NCT00460655|468955962|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
130270968|NCT00460655|468955959|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130270969|NCT00460655|468955960|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130270970|NCT00460655|468955961|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
130270971|NCT00460655|468955962|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
130270972|NCT01724216|468955963|FG000|Overall Study|Scan was not completed|1|||
130270973|NCT00175916|468955964|FG000|Overall Study|Death|19|||
130270974|NCT00175916|468955964|FG000|Overall Study|Adverse Event|81|||
130270975|NCT00175916|468955964|FG000|Overall Study|Lack of Efficacy|354|||
130270976|NCT00175916|468955964|FG000|Overall Study|Lost to Follow-up|17|||
130270977|NCT00175916|468955964|FG000|Overall Study|Subject Choice|98|||
130270978|NCT00175916|468955964|FG000|Overall Study|Lack of compliance|8|||
130270979|NCT00175916|468955964|FG000|Overall Study|Patient cannot record seizures|1|||
130270980|NCT00175916|468955964|FG000|Overall Study|Sponsor decision|17|||
130037497|NCT03895203|468092679|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130270981|NCT00175916|468955964|FG000|Overall Study|Vigabatrin intake|1|||
130270982|NCT00175916|468955964|FG000|Overall Study|Suicidal behaviour|1|||
130270983|NCT00175916|468955964|FG000|Overall Study|Withdrawal by Subject|1|||
130270984|NCT00175916|468955964|FG000|Overall Study|Seizure - free|4|||
130270985|NCT00175916|468955964|FG000|Overall Study|Administrative reason|1|||
130270986|NCT00175916|468955964|FG000|Overall Study|Pregnancy|1|||
130270987|NCT00175916|468955964|FG000|Overall Study|Patient's request|2|||
130270988|NCT00175916|468955964|FG000|Overall Study|Treating physiciant's choice|1|||
130270989|NCT00175916|468955964|FG000|Overall Study|Moved overseas|1|||
130270990|NCT00175916|468955964|FG000|Overall Study|Loss of job and economic burden|1|||
130270991|NCT00175916|468955964|FG000|Overall Study|Site was closed|9|||
130270992|NCT00175916|468955964|FG000|Overall Study|Patient went to prison|1|||
130270993|NCT03650413|468955965|FG000|Overall Study|Adverse Event|1|||
130270994|NCT03650413|468955965|FG000|Overall Study|Lack of Efficacy|17|||
130270995|NCT03650413|468955965|FG000|Overall Study|Other|9|||
130270996|NCT03650413|468955965|FG000|Overall Study|Physician Decision|2|||
130270997|NCT03650413|468955965|FG000|Overall Study|Study Terminated By Sponsor|16|||
130270998|NCT03650413|468955965|FG000|Overall Study|Withdrawal by Subject|16|||
130270999|NCT03654040|468955966|FG000|Overall Study|Death|1|||
130271000|NCT03654040|468955967|FG001|Overall Study|Death|0|||
130271001|NCT03654040|468955966|FG000|Overall Study|Withdrawal by Subject|1|||
130271002|NCT03654040|468955967|FG001|Overall Study|Withdrawal by Subject|0|||
130271003|NCT03654040|468955966|FG000|Overall Study|Study terminated by sponsor|8|||
130271004|NCT03654040|468955967|FG001|Overall Study|Study terminated by sponsor|2|||
130271005|NCT03654040|468955966|FG000|Overall Study|Failure to initiate study therapy|2|||
130271006|NCT03654040|468955967|FG001|Overall Study|Failure to initiate study therapy|0|||
130271007|NCT03654040|468955966|FG000|Overall Study|Transplanted at another center|2|||
130271008|NCT03654040|468955967|FG001|Overall Study|Transplanted at another center|0|||
130271009|NCT03654040|468955966|FG000|Overall Study|Failure to meet eligibility criteria|14|||
130271010|NCT03654040|468955967|FG001|Overall Study|Failure to meet eligibility criteria|2|||
130271011|NCT03654040|468955966|FG000|Overall Study|No longer transplant candidate|1|||
130271012|NCT03654040|468955967|FG001|Overall Study|No longer transplant candidate|0|||
130271013|NCT03654040|468955966|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
130271014|NCT03654040|468955967|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
130271015|NCT03654040|468955966|FG000|Overall Study|Recipient ineligible|0|||
130271016|NCT03654040|468955967|FG001|Overall Study|Recipient ineligible|2|||
130271017|NCT03654040|468955966|FG000|Overall Study|Received deceased liver|0|||
130271018|NCT03654040|468955967|FG001|Overall Study|Received deceased liver|1|||
130271019|NCT00310375|468955973|FG000|Primary Reporting Phase|Adverse Event|28|||
130271020|NCT00310375|468955974|FG001|Primary Reporting Phase|Adverse Event|22|||
130271021|NCT00310375|468955975|FG002|Primary Reporting Phase|Adverse Event|0|||
130271022|NCT00310375|468955973|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
130271023|NCT00310375|468955974|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
130271024|NCT00310375|468955975|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
130271025|NCT00310375|468955973|FG000|Primary Reporting Phase|Pregnancy|2|||
130271026|NCT00310375|468955974|FG001|Primary Reporting Phase|Pregnancy|2|||
130271027|NCT00310375|468955975|FG002|Primary Reporting Phase|Pregnancy|0|||
130271028|NCT00310375|468955973|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
130271029|NCT00310375|468955974|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
130271030|NCT00310375|468955975|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
130271031|NCT00310375|468955973|FG000|Primary Reporting Phase|Protocol Violation|8|||
130271032|NCT00310375|468955974|FG001|Primary Reporting Phase|Protocol Violation|5|||
130271033|NCT00310375|468955975|FG002|Primary Reporting Phase|Protocol Violation|0|||
130271034|NCT00310375|468955973|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
130271035|NCT00310375|468955974|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
130271036|NCT00310375|468955975|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
130271037|NCT00310375|468955973|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
130271038|NCT00310375|468955974|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
130271039|NCT00310375|468955975|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
130271040|NCT00310375|468955973|FG000|Primary Reporting Phase|Physician Decision|5|||
130271041|NCT00310375|468955974|FG001|Primary Reporting Phase|Physician Decision|3|||
130271042|NCT00310375|468955975|FG002|Primary Reporting Phase|Physician Decision|0|||
130271043|NCT00310375|468955973|FG000|Primary Reporting Phase|Request of the sponsor|2|||
130271044|NCT00310375|468955974|FG001|Primary Reporting Phase|Request of the sponsor|2|||
130271045|NCT00310375|468955975|FG002|Primary Reporting Phase|Request of the sponsor|0|||
130271046|NCT00310375|468955973|FG000|Primary Reporting Phase|Failed to return|1|||
130271047|NCT00310375|468955974|FG001|Primary Reporting Phase|Failed to return|3|||
130271048|NCT00310375|468955975|FG002|Primary Reporting Phase|Failed to return|0|||
130271049|NCT00310375|468955973|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
130271050|NCT00310375|468955974|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
130271051|NCT00310375|468955975|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
130271052|NCT00310375|468955973|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
130271053|NCT00310375|468955974|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
130271054|NCT00310375|468955975|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
130271055|NCT00310375|468955973|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
130271056|NCT00310375|468955974|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
130271057|NCT00310375|468955975|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
130271058|NCT00310375|468955973|FG000|Primary Reporting Phase|Site closure|3|||
130271059|NCT00310375|468955974|FG001|Primary Reporting Phase|Site closure|0|||
130271060|NCT00310375|468955975|FG002|Primary Reporting Phase|Site closure|0|||
130271061|NCT00310375|468955973|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
130271062|NCT00310375|468955974|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
130271063|NCT00310375|468955975|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
130271064|NCT00310375|468955973|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
130271065|NCT00310375|468955974|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
130271066|NCT00310375|468955975|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
130271067|NCT00310375|468955973|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
130271068|NCT00310375|468955974|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
130271069|NCT00310375|468955975|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
130271070|NCT00310375|468955973|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
130271071|NCT00310375|468955974|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
130271072|NCT00310375|468955975|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
130271073|NCT00131352|468955976|FG000|Initial Treatment Period|Adverse Event|1|||
130271074|NCT00131352|468955977|FG001|Initial Treatment Period|Adverse Event|3|||
130271075|NCT00131352|468955976|FG000|Initial Treatment Period|Non-compliant|1|||
130271076|NCT00131352|468955977|FG001|Initial Treatment Period|Non-compliant|2|||
130271077|NCT00131352|468955976|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
130271078|NCT00131352|468955977|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
130271079|NCT00131352|468955976|FG000|Initial Treatment Period|Lack of Efficacy|6|||
130271080|NCT00131352|468955977|FG001|Initial Treatment Period|Lack of Efficacy|4|||
130271081|NCT00131352|468955976|FG000|Initial Treatment Period|Other|0|||
130271082|NCT00131352|468955977|FG001|Initial Treatment Period|Other|2|||
130271083|NCT00131352|468955976|FG000|Repeat Treatment Period|Adverse Event|1|||
130271084|NCT00131352|468955977|FG001|Repeat Treatment Period|Adverse Event|0|||
130271085|NCT00131352|468955976|FG000|Repeat Treatment Period|Other|1|||
130271086|NCT00131352|468955977|FG001|Repeat Treatment Period|Other|0|||
130271087|NCT03230318|468955978|FG000|Overall Study|Radiographic disease progression|72|||
130271088|NCT03230318|468955979|FG001|Overall Study|Radiographic disease progression|19|||
130271089|NCT03230318|468955978|FG000|Overall Study|Clinical progression|17|||
130271090|NCT03230318|468955979|FG001|Overall Study|Clinical progression|7|||
130271091|NCT03230318|468955978|FG000|Overall Study|Adverse Event|5|||
130271092|NCT03230318|468955979|FG001|Overall Study|Adverse Event|3|||
130271093|NCT03230318|468955978|FG000|Overall Study|Physician Decision|2|||
130271094|NCT03230318|468955979|FG001|Overall Study|Physician Decision|3|||
130271095|NCT03230318|468955978|FG000|Overall Study|Death|3|||
130271096|NCT03230318|468955979|FG001|Overall Study|Death|2|||
130103831|NCT02032823|468338771|FG001|Overall Study|Death|109|||
130103832|NCT02032823|468338770|FG000|Overall Study|Lost to Follow-up|18|||
130103833|NCT02032823|468338771|FG001|Overall Study|Lost to Follow-up|17|||
130103834|NCT02032823|468338770|FG000|Overall Study|Withdrawal by Subject|70|||
130103835|NCT02032823|468338771|FG001|Overall Study|Withdrawal by Subject|53|||
130103836|NCT02032823|468338770|FG000|Overall Study|Ongoing study at data cut-off|755|||
130103837|NCT02032823|468338771|FG001|Overall Study|Ongoing study at data cut-off|731|||
130103838|NCT02032823|468338770|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
130103839|NCT02032823|468338771|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
130103840|NCT03428217|468338772|FG000|Overall Study|Death|89|||
130103841|NCT03428217|468338773|FG001|Overall Study|Death|93|||
130103842|NCT03428217|468338772|FG000|Overall Study|Withdrawal by Subject|8|||
130103843|NCT03428217|468338773|FG001|Overall Study|Withdrawal by Subject|7|||
130103844|NCT03428217|468338772|FG000|Overall Study|Lost to Follow-up|1|||
130103845|NCT03428217|468338773|FG001|Overall Study|Lost to Follow-up|3|||
130103846|NCT03428217|468338772|FG000|Overall Study|Study terminated by sponsor|124|||
130103847|NCT03428217|468338773|FG001|Overall Study|Study terminated by sponsor|118|||
130103848|NCT03428217|468338772|FG000|Overall Study|Other, Not Specified|1|||
130103849|NCT03428217|468338773|FG001|Overall Study|Other, Not Specified|0|||
130103850|NCT03889197|468338774|FG000|Overall Study|Withdrawal by Subject|1|||
130103851|NCT03889197|468338775|FG001|Overall Study|Withdrawal by Subject|0|||
130103852|NCT03889197|468338774|FG000|Overall Study|Physician Decision|0|||
130103853|NCT03889197|468338775|FG001|Overall Study|Physician Decision|1|||
130103854|NCT03889197|468338774|FG000|Overall Study|met exclusion criteria|0|||
130103855|NCT03889197|468338775|FG001|Overall Study|met exclusion criteria|1|||
130103856|NCT03889197|468338774|FG000|Overall Study|Protocol Violation|1|||
130103857|NCT03889197|468338775|FG001|Overall Study|Protocol Violation|0|||
130103858|NCT05899218|468338776|FG000|Overall Study|Lost to Follow-up|2|||
130103859|NCT05899218|468338777|FG001|Overall Study|Lost to Follow-up|2|||
130103860|NCT05899218|468338776|FG000|Overall Study|deemed ineligible out of country|1|||
130103861|NCT05899218|468338777|FG001|Overall Study|deemed ineligible out of country|0|||
130103862|NCT05246111|468338778|FG000|Period 01|NOT ELIGIBLE IC5|1|||
130103863|NCT05246111|468338779|FG001|Period 01|NOT ELIGIBLE IC5|0|||
130103864|NCT03151226|468338780|FG000|Overall Study|Withdrawal by Subject|2|||
130103865|NCT03151226|468338780|FG000|Overall Study|not wear device correctly|1|||
130103866|NCT02304302|468338781|FG000|Overall Study|Adverse Event|2|||
130103867|NCT02304302|468338782|FG001|Overall Study|Adverse Event|3|||
130103868|NCT02304302|468338781|FG000|Overall Study|Lost to Follow-up|1|||
130103869|NCT02304302|468338782|FG001|Overall Study|Lost to Follow-up|4|||
130103870|NCT02304302|468338781|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
130103871|NCT02304302|468338782|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
130103872|NCT00391118|468338783|FG000|Overall Study|Adverse Event|3|||
130103873|NCT00391118|468338784|FG001|Overall Study|Adverse Event|10|||
130271097|NCT03230318|468955978|FG000|Overall Study|Lost to Follow-up|1|||
130271098|NCT03230318|468955979|FG001|Overall Study|Lost to Follow-up|0|||
130271099|NCT03230318|468955978|FG000|Overall Study|Withdrawal by Subject|1|||
130271100|NCT03230318|468955979|FG001|Overall Study|Withdrawal by Subject|3|||
130271101|NCT03230318|468955978|FG000|Overall Study|Other|3|||
130271102|NCT03230318|468955979|FG001|Overall Study|Other|7|||
130271103|NCT00211172|468955981|FG000|Overall Study|Died or lost health plan eligibility|39|||
130103874|NCT00391118|468338785|FG002|Overall Study|Adverse Event|7|||
130103875|NCT00391118|468338783|FG000|Overall Study|Lost to Follow-up|0|||
130103876|NCT00391118|468338784|FG001|Overall Study|Lost to Follow-up|2|||
130271104|NCT00211172|468955982|FG001|Overall Study|Died or lost health plan eligibility|32|||
130271105|NCT00770562|468955986|FG000|Overall Study|Did not take treatment|1|||
130271106|NCT00770562|468955987|FG001|Overall Study|Did not take treatment|1|||
130271107|NCT01643408|468955990|FG000|Overall Study|Adverse Event|12|||
130271108|NCT01643408|468955990|FG000|Overall Study|Other|2|||
130271109|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
130271110|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
130271111|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
130271112|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
130271113|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
130271114|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
130271115|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
130271116|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
130271117|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
130103877|NCT00391118|468338785|FG002|Overall Study|Lost to Follow-up|3|||
130103878|NCT00391118|468338783|FG000|Overall Study|Withdrawal by Subject|0|||
130271118|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
130271119|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
130271120|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
130271121|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
130271122|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
129886003|NCT02291289|467542800|FG007|Early Disease Progression|Lost to Follow-up|0|||
130271123|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
130271124|NCT01057693|468955993|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
130271125|NCT01057693|468955994|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
130271126|NCT01057693|468955995|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
130271127|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
130271128|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
130271129|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
130271130|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
130271131|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
130271132|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
130271133|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
130271134|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
130271135|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
130271136|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
130271137|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
130271138|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
130271139|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
130271140|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
130271141|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
130271142|NCT01057693|468955993|FG000|Between Single-Blind and Double-Blind|Other|6|||
130271143|NCT01057693|468955994|FG001|Between Single-Blind and Double-Blind|Other|0|||
130271144|NCT01057693|468955995|FG002|Between Single-Blind and Double-Blind|Other|0|||
130271145|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
130271146|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
130271147|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
130271148|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
130271149|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
130271150|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
130271151|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
130271152|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
130271153|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
130271154|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
130271155|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
130271156|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
130271157|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
130271158|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
130271159|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
130271160|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
130271161|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
130271162|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
130271163|NCT01057693|468955993|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
130271164|NCT01057693|468955994|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
130271165|NCT01057693|468955995|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
130271166|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
130271167|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
130271168|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
130271169|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
130271170|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
130271171|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
130271172|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
130271173|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
130271174|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
130037498|NCT03895203|468092680|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130271175|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
130037499|NCT03895203|468092681|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130271176|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
130271177|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
130271178|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
130271179|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
130271180|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
130271181|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
130271182|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
130271183|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
130271184|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
130271185|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
130271186|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
130037500|NCT03895203|468092682|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130037501|NCT03895203|468092683|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
130037502|NCT03895203|468092678|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
130037503|NCT03895203|468092679|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130037504|NCT03895203|468092680|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130037505|NCT03895203|468092681|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130037506|NCT03895203|468092682|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130037507|NCT03895203|468092683|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
130037508|NCT03895203|468092678|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
130037509|NCT03895203|468092679|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
130037510|NCT03895203|468092680|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
130037511|NCT03895203|468092681|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
130037512|NCT03895203|468092682|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
130037513|NCT03895203|468092683|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
130037514|NCT03895203|468092678|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130037515|NCT03895203|468092679|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
130037516|NCT03895203|468092680|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130037517|NCT03895203|468092681|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130037518|NCT03895203|468092682|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130037519|NCT03895203|468092683|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
130037520|NCT03895203|468092678|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130037521|NCT03895203|468092679|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
130037522|NCT03895203|468092680|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130037523|NCT03895203|468092681|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130037524|NCT03895203|468092682|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130037525|NCT03895203|468092683|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
130037526|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130037527|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130037528|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130037529|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
130037530|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130037531|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
130037532|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
130037533|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
130037534|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
130037535|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
130037536|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
130037537|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
130037538|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
130037539|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
130037540|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
130037541|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
130037542|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
130037543|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
130037544|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130037545|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130037546|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130037547|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
130037548|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
130037549|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
130037550|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
130037551|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
130037552|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
130037553|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
130037554|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
130037555|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
130037556|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130037557|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130037558|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130271187|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
130271188|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
130271189|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
130271190|NCT01672879|468956003|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
130271191|NCT01672879|468956004|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
130271192|NCT01672879|468956005|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
130271193|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
130271194|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
130271195|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
130271196|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
130271197|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
130271198|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
130271199|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
130271200|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
130271201|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
130271202|NCT01672879|468956003|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
130271203|NCT01672879|468956004|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
130271204|NCT01672879|468956005|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
130271205|NCT04860869|468956006|FG000|Overall Study|Withdrawal by Subject|1|||
130271206|NCT04860869|468956007|FG001|Overall Study|Withdrawal by Subject|0|||
130271207|NCT03951766|468956008|FG000|Treatment Phase|Lost to Follow-up|1|||
130271208|NCT03951766|468956008|FG000|Follow-up Phase|Lost to Follow-up|10|||
130271209|NCT01541865|468956010|FG000|Overall Study|Lost to Follow-up|11|||
130271210|NCT01541865|468956010|FG000|Overall Study|Withdrawal by Subject|9|||
130271211|NCT01541865|468956010|FG000|Overall Study|Adverse Event|1|||
130271212|NCT01541865|468956010|FG000|Overall Study|Protocol Violation|1|||
130271213|NCT00295646|468956012|FG000|Overall Study|Protocol Violation|18|||
130271214|NCT00295646|468956013|FG001|Overall Study|Protocol Violation|20|||
130271215|NCT00295646|468956014|FG002|Overall Study|Protocol Violation|20|||
130271216|NCT00295646|468956015|FG003|Overall Study|Protocol Violation|18|||
130271217|NCT00295646|468956012|FG000|Overall Study|Withdrawal by Subject|8|||
130271218|NCT00295646|468956013|FG001|Overall Study|Withdrawal by Subject|9|||
130271219|NCT00295646|468956014|FG002|Overall Study|Withdrawal by Subject|11|||
130271220|NCT00295646|468956015|FG003|Overall Study|Withdrawal by Subject|14|||
130271221|NCT00295646|468956012|FG000|Overall Study|Lost to Follow-up|0|||
130271222|NCT00295646|468956013|FG001|Overall Study|Lost to Follow-up|5|||
130271223|NCT00295646|468956014|FG002|Overall Study|Lost to Follow-up|1|||
130271224|NCT00295646|468956015|FG003|Overall Study|Lost to Follow-up|5|||
130271225|NCT00295646|468956012|FG000|Overall Study|Death|9|||
130271226|NCT00295646|468956013|FG001|Overall Study|Death|7|||
130271227|NCT00295646|468956014|FG002|Overall Study|Death|18|||
130271228|NCT00295646|468956015|FG003|Overall Study|Death|8|||
130271229|NCT01232127|468956020|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
130271230|NCT01232127|468956021|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
130271231|NCT01232127|468956022|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
130271232|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
130052127|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130271233|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271234|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
130271235|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
130271236|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271237|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271238|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
130271239|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
130271240|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271241|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271242|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271243|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271244|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271245|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130271246|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
130271247|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271248|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271249|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271250|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271251|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271252|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
130271253|NCT02720523|468956023|FG000|Period 1: Placebo-controlled Period|Other|0|||
130271254|NCT02720523|468956024|FG001|Period 1: Placebo-controlled Period|Other|0|||
130271255|NCT02720523|468956025|FG002|Period 1: Placebo-controlled Period|Other|1|||
130271256|NCT02720523|468956026|FG003|Period 1: Placebo-controlled Period|Other|1|||
130271257|NCT02720523|468956027|FG004|Period 1: Placebo-controlled Period|Other|0|||
130271258|NCT02720523|468956028|FG005|Period 1: Placebo-controlled Period|Other|0|||
130271259|NCT02720523|468956029|FG006|Period 1: Placebo-controlled Period|Other|0|||
130271260|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
130271261|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
130271262|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
130271263|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
130271264|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
130037559|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
130037560|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130037561|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
130037562|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130037563|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130037564|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130037565|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
130271265|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
130271266|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
130271267|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
130271268|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
130271269|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
130271270|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
130271271|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
130271272|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
130271273|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
130271274|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271275|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271276|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271277|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
130271278|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
130271279|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
130271280|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
130271281|NCT02720523|468956023|FG000|Period 2: Long-term Extension Period|Other|0|||
130271282|NCT02720523|468956024|FG001|Period 2: Long-term Extension Period|Other|0|||
130271283|NCT02720523|468956025|FG002|Period 2: Long-term Extension Period|Other|0|||
130271284|NCT02720523|468956026|FG003|Period 2: Long-term Extension Period|Other|0|||
130271285|NCT02720523|468956027|FG004|Period 2: Long-term Extension Period|Other|2|||
130271286|NCT02720523|468956028|FG005|Period 2: Long-term Extension Period|Other|0|||
130271287|NCT02720523|468956029|FG006|Period 2: Long-term Extension Period|Other|3|||
130271288|NCT01740687|468956036|FG000|Overall Study|Lost to Follow-up|11|||
130271289|NCT01740687|468956036|FG000|Overall Study|Withdrawal by Subject|2|||
130271290|NCT01740687|468956036|FG000|Overall Study|other reason|22|||
130271291|NCT01740687|468956036|FG000|Overall Study|treatment not received|2|||
130271292|NCT00326001|468956040|FG000|Overall Study|Adverse Event|4|||
130271293|NCT00326001|468956041|FG001|Overall Study|Adverse Event|5|||
130271294|NCT00326001|468956040|FG000|Overall Study|Physician Decision|3|||
130271295|NCT00326001|468956041|FG001|Overall Study|Physician Decision|3|||
130271296|NCT00104728|468956042|FG000|Overall Study|screen failures|19|||
130271297|NCT01963767|468956043|FG000|Overall Study|Withdrawal by Subject|4|||
130271298|NCT01963767|468956044|FG001|Overall Study|Withdrawal by Subject|2|||
130271299|NCT01963767|468956043|FG000|Overall Study|Adverse Event|2|||
130037566|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130037567|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
130037568|NCT03895203|468092678|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130037569|NCT03895203|468092679|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130037570|NCT03895203|468092680|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130037571|NCT03895203|468092681|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130037572|NCT03895203|468092682|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
130037573|NCT03895203|468092683|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
130037574|NCT00996840|468092684|FG000|Overall Study|Adverse Event|0|||
130037575|NCT00996840|468092685|FG001|Overall Study|Adverse Event|1|||
130037576|NCT00996840|468092686|FG002|Overall Study|Adverse Event|0|||
130037577|NCT00996840|468092687|FG003|Overall Study|Adverse Event|0|||
130037578|NCT00996840|468092688|FG004|Overall Study|Adverse Event|0|||
130037579|NCT00996840|468092684|FG000|Overall Study|Physician Decision|0|||
130037580|NCT00996840|468092685|FG001|Overall Study|Physician Decision|0|||
130037581|NCT00996840|468092686|FG002|Overall Study|Physician Decision|1|||
130037582|NCT00996840|468092687|FG003|Overall Study|Physician Decision|1|||
130037583|NCT00996840|468092688|FG004|Overall Study|Physician Decision|2|||
130037584|NCT00996840|468092684|FG000|Overall Study|Withdrawal by Subject|1|||
130037585|NCT00996840|468092685|FG001|Overall Study|Withdrawal by Subject|1|||
130271300|NCT01963767|468956044|FG001|Overall Study|Adverse Event|0|||
130271301|NCT03960684|468956045|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
130271302|NCT03941483|468956046|FG000|Overall Study|Miscellaneous|2|||
130271303|NCT03941483|468956047|FG001|Overall Study|Miscellaneous|3|||
130271304|NCT03941483|468956048|FG002|Overall Study|Miscellaneous|0|||
130271305|NCT03941483|468956046|FG000|Overall Study|Study Terminated by Sponsor|1|||
130271306|NCT03941483|468956047|FG001|Overall Study|Study Terminated by Sponsor|0|||
130271307|NCT03941483|468956048|FG002|Overall Study|Study Terminated by Sponsor|0|||
130271308|NCT03941483|468956046|FG000|Overall Study|Withdrawal by Subject|1|||
130271309|NCT03941483|468956047|FG001|Overall Study|Withdrawal by Subject|4|||
130271310|NCT03941483|468956048|FG002|Overall Study|Withdrawal by Subject|1|||
130271311|NCT03941483|468956046|FG000|Overall Study|Lost to Follow-up|2|||
130271312|NCT03941483|468956047|FG001|Overall Study|Lost to Follow-up|1|||
130271313|NCT03941483|468956048|FG002|Overall Study|Lost to Follow-up|8|||
130271314|NCT03941483|468956046|FG000|Overall Study|Death|3|||
130271315|NCT03941483|468956047|FG001|Overall Study|Death|2|||
130271316|NCT03941483|468956048|FG002|Overall Study|Death|6|||
130271317|NCT01082081|468956049|FG000|Overall Study|Lost to Follow-up|0|||
130271318|NCT01082081|468956050|FG001|Overall Study|Lost to Follow-up|0|||
130271319|NCT01082081|468956051|FG002|Overall Study|Lost to Follow-up|1|||
130271320|NCT01082081|468956049|FG000|Overall Study|Withdrawal by Subject|0|||
130271321|NCT01082081|468956050|FG001|Overall Study|Withdrawal by Subject|0|||
130271322|NCT01082081|468956051|FG002|Overall Study|Withdrawal by Subject|1|||
130271323|NCT01082081|468956049|FG000|Overall Study|Other Reason|0|||
130271324|NCT01082081|468956050|FG001|Overall Study|Other Reason|1|||
130271325|NCT01082081|468956051|FG002|Overall Study|Other Reason|0|||
130271326|NCT00670930|468956054|FG000|Overall Study|Adminstrative Problem|0|||
130271327|NCT00670930|468956055|FG001|Overall Study|Adminstrative Problem|1|||
130271328|NCT00670930|468956054|FG000|Overall Study|Lost to Follow-up|1|||
130271329|NCT00670930|468956055|FG001|Overall Study|Lost to Follow-up|0|||
130271330|NCT03493451|468957262|FG000|Overall Study|Death|11|||
130271331|NCT03493451|468957263|FG001|Overall Study|Death|26|||
130271332|NCT03493451|468957264|FG002|Overall Study|Death|3|||
130271333|NCT03493451|468957262|FG000|Overall Study|Lost to Follow-up|1|||
130271334|NCT03493451|468957263|FG001|Overall Study|Lost to Follow-up|4|||
130271335|NCT03493451|468957264|FG002|Overall Study|Lost to Follow-up|1|||
130271336|NCT03493451|468957262|FG000|Overall Study|Withdrawal by Subject|1|||
130271337|NCT03493451|468957263|FG001|Overall Study|Withdrawal by Subject|1|||
130271338|NCT03493451|468957264|FG002|Overall Study|Withdrawal by Subject|2|||
130271339|NCT03493451|468957262|FG000|Overall Study|Progressive Disease|1|||
130271340|NCT03493451|468957263|FG001|Overall Study|Progressive Disease|0|||
130271341|NCT03493451|468957264|FG002|Overall Study|Progressive Disease|0|||
130271342|NCT03493451|468957262|FG000|Overall Study|Transferred to long term extension study|8|||
130271343|NCT03493451|468957263|FG001|Overall Study|Transferred to long term extension study|13|||
130271344|NCT03493451|468957264|FG002|Overall Study|Transferred to long term extension study|5|||
130271345|NCT01238991|468957265|FG000|Overall Study|Adverse Event|1|||
130271346|NCT01238991|468957266|FG001|Overall Study|Adverse Event|0|||
130271347|NCT01238991|468957267|FG002|Overall Study|Adverse Event|3|||
130271348|NCT01238991|468957268|FG003|Overall Study|Adverse Event|1|||
130271349|NCT01238991|468957269|FG004|Overall Study|Adverse Event|1|||
130271350|NCT01238991|468957270|FG005|Overall Study|Adverse Event|0|||
130271351|NCT01238991|468957271|FG006|Overall Study|Adverse Event|1|||
130271352|NCT01238991|468957272|FG007|Overall Study|Adverse Event|1|||
130271353|NCT01238991|468957273|FG008|Overall Study|Adverse Event|0|||
130271354|NCT01238991|468957274|FG009|Overall Study|Adverse Event|0|||
130271355|NCT01238991|468957265|FG000|Overall Study|Death|0|||
130271356|NCT01238991|468957266|FG001|Overall Study|Death|0|||
130271357|NCT01238991|468957267|FG002|Overall Study|Death|0|||
130271358|NCT01238991|468957268|FG003|Overall Study|Death|1|||
130271359|NCT01238991|468957269|FG004|Overall Study|Death|0|||
130271360|NCT01238991|468957270|FG005|Overall Study|Death|0|||
130271361|NCT01238991|468957271|FG006|Overall Study|Death|0|||
130271362|NCT01238991|468957272|FG007|Overall Study|Death|0|||
130271363|NCT01238991|468957273|FG008|Overall Study|Death|0|||
130271364|NCT01238991|468957274|FG009|Overall Study|Death|0|||
130271365|NCT01238991|468957265|FG000|Overall Study|Lack of Efficacy|0|||
130271366|NCT01238991|468957266|FG001|Overall Study|Lack of Efficacy|0|||
130271367|NCT01238991|468957267|FG002|Overall Study|Lack of Efficacy|1|||
130271368|NCT01238991|468957268|FG003|Overall Study|Lack of Efficacy|0|||
130271369|NCT01238991|468957269|FG004|Overall Study|Lack of Efficacy|0|||
130271370|NCT01238991|468957270|FG005|Overall Study|Lack of Efficacy|0|||
130037586|NCT00996840|468092686|FG002|Overall Study|Withdrawal by Subject|0|||
130037587|NCT00996840|468092687|FG003|Overall Study|Withdrawal by Subject|0|||
130037588|NCT00996840|468092688|FG004|Overall Study|Withdrawal by Subject|0|||
130037589|NCT04645797|468092689|FG000|Overall Study|Disease Progression|3|||
130037590|NCT04645797|468092690|FG001|Overall Study|Disease Progression|3|||
130037591|NCT04645797|468092691|FG002|Overall Study|Disease Progression|1|||
130037592|NCT04645797|468092692|FG003|Overall Study|Disease Progression|0|||
130037593|NCT04645797|468092693|FG004|Overall Study|Disease Progression|0|||
130037594|NCT04645797|468092694|FG005|Overall Study|Disease Progression|0|||
130037595|NCT04645797|468092695|FG006|Overall Study|Disease Progression|0|||
130037596|NCT04645797|468092689|FG000|Overall Study|Death|3|||
130037597|NCT04645797|468092690|FG001|Overall Study|Death|1|||
130037598|NCT04645797|468092691|FG002|Overall Study|Death|0|||
130037599|NCT04645797|468092692|FG003|Overall Study|Death|0|||
130037600|NCT04645797|468092693|FG004|Overall Study|Death|0|||
130037601|NCT04645797|468092694|FG005|Overall Study|Death|0|||
130037602|NCT04645797|468092695|FG006|Overall Study|Death|0|||
130037603|NCT00733902|468092697|FG000|Overall Study|Death|0|||
130037604|NCT00733902|468092698|FG001|Overall Study|Death|0|||
130037605|NCT00733902|468092699|FG002|Overall Study|Death|0|||
130037606|NCT00733902|468092700|FG003|Overall Study|Death|1|||
130037607|NCT00733902|468092697|FG000|Overall Study|Adverse Event|3|||
130037608|NCT00733902|468092698|FG001|Overall Study|Adverse Event|4|||
130037609|NCT00733902|468092699|FG002|Overall Study|Adverse Event|7|||
130037610|NCT00733902|468092700|FG003|Overall Study|Adverse Event|11|||
130037611|NCT00733902|468092697|FG000|Overall Study|Lack of Efficacy|56|||
130037612|NCT00733902|468092698|FG001|Overall Study|Lack of Efficacy|21|||
130037613|NCT00733902|468092699|FG002|Overall Study|Lack of Efficacy|34|||
130037614|NCT00733902|468092700|FG003|Overall Study|Lack of Efficacy|23|||
130037615|NCT00733902|468092697|FG000|Overall Study|Protocol Violation|4|||
130037616|NCT00733902|468092698|FG001|Overall Study|Protocol Violation|6|||
130037617|NCT00733902|468092699|FG002|Overall Study|Protocol Violation|3|||
130037618|NCT00733902|468092700|FG003|Overall Study|Protocol Violation|3|||
130037619|NCT00733902|468092697|FG000|Overall Study|Withdrawal by Subject|10|||
130037620|NCT00733902|468092698|FG001|Overall Study|Withdrawal by Subject|5|||
130037621|NCT00733902|468092699|FG002|Overall Study|Withdrawal by Subject|4|||
130037622|NCT00733902|468092700|FG003|Overall Study|Withdrawal by Subject|16|||
130037623|NCT00733902|468092697|FG000|Overall Study|Entered extension study|89|||
130037624|NCT00733902|468092698|FG001|Overall Study|Entered extension study|124|||
130037625|NCT00733902|468092699|FG002|Overall Study|Entered extension study|111|||
130037626|NCT00733902|468092700|FG003|Overall Study|Entered extension study|109|||
130037627|NCT00733902|468092697|FG000|Overall Study|Randomized but not treated|2|||
130037628|NCT00733902|468092698|FG001|Overall Study|Randomized but not treated|2|||
130037629|NCT00733902|468092699|FG002|Overall Study|Randomized but not treated|2|||
130037630|NCT00733902|468092700|FG003|Overall Study|Randomized but not treated|1|||
130037631|NCT00775021|468092701|FG000|First Intervention|Lost to Follow-up|1|||
130037632|NCT00775021|468092702|FG001|First Intervention|Lost to Follow-up|0|||
130037633|NCT00775021|468092701|FG000|Second Intervention|Adverse Event|0|||
130037634|NCT00775021|468092702|FG001|Second Intervention|Adverse Event|1|||
130037635|NCT00870688|468092703|FG000|Overall Study|Lost to Follow-up|2|||
130037636|NCT00870688|468092703|FG000|Overall Study|Death, Unrelated|1|||
130037637|NCT00870688|468092703|FG000|Overall Study|Granules in the Stools|1|||
130037638|NCT03872180|468092712|FG000|Overall Study|Adverse Event|4|||
130037639|NCT03872180|468092712|FG000|Overall Study|Lack of Efficacy|2|||
130037640|NCT01506141|468092713|FG000|Overall Study|Adverse Event|0|||
130037641|NCT01506141|468092714|FG001|Overall Study|Adverse Event|2|||
130037642|NCT01506141|468092713|FG000|Overall Study|Participation Terminated by Investigator|1|||
130037643|NCT01506141|468092714|FG001|Overall Study|Participation Terminated by Investigator|1|||
130037644|NCT01506141|468092713|FG000|Overall Study|Site Terminated by Sponsor|2|||
130037645|NCT01506141|468092714|FG001|Overall Study|Site Terminated by Sponsor|0|||
130037646|NCT01506141|468092713|FG000|Overall Study|Reason Not Specified|4|||
130037647|NCT01506141|468092714|FG001|Overall Study|Reason Not Specified|2|||
130037648|NCT04607408|468092715|FG000|Overall Study|Lost to Follow-up|0|||
130037649|NCT04607408|468092716|FG001|Overall Study|Lost to Follow-up|0|||
130037650|NCT04607408|468092717|FG002|Overall Study|Lost to Follow-up|0|||
130037651|NCT04607408|468092718|FG003|Overall Study|Lost to Follow-up|1|||
130037652|NCT04607408|468092719|FG004|Overall Study|Lost to Follow-up|0|||
130037653|NCT04607408|468092715|FG000|Overall Study|Withdrawal by Subject|0|||
130037654|NCT04607408|468092716|FG001|Overall Study|Withdrawal by Subject|1|||
130037655|NCT04607408|468092717|FG002|Overall Study|Withdrawal by Subject|0|||
130037656|NCT04607408|468092718|FG003|Overall Study|Withdrawal by Subject|1|||
130037657|NCT04607408|468092719|FG004|Overall Study|Withdrawal by Subject|0|||
130037658|NCT04919564|468092726|FG000|Overall Study|Lost to Follow-up|1|||
129886004|NCT02291289|467542801|FG008|Early Disease Progression|Lost to Follow-up|0|||
129886005|NCT02291289|467542802|FG009|Early Disease Progression|Lost to Follow-up|0|||
129886006|NCT02291289|467542803|FG010|Early Disease Progression|Lost to Follow-up|0|||
129886007|NCT02291289|467542804|FG011|Early Disease Progression|Lost to Follow-up|0|||
129886008|NCT02291289|467542805|FG012|Early Disease Progression|Lost to Follow-up|1|||
129886009|NCT00962585|467542819|FG000|Overall Study|Adverse Event|0|||
129886010|NCT00962585|467542820|FG001|Overall Study|Adverse Event|2|||
129886011|NCT00962585|467542821|FG002|Overall Study|Adverse Event|1|||
129886012|NCT00962585|467542822|FG003|Overall Study|Adverse Event|0|||
129886013|NCT00962585|467542819|FG000|Overall Study|Lost to Follow-up|3|||
129886014|NCT00962585|467542820|FG001|Overall Study|Lost to Follow-up|0|||
129886015|NCT00962585|467542821|FG002|Overall Study|Lost to Follow-up|1|||
129886016|NCT00962585|467542822|FG003|Overall Study|Lost to Follow-up|0|||
129886017|NCT00962585|467542819|FG000|Overall Study|Protocol Violation|0|||
129886018|NCT00962585|467542820|FG001|Overall Study|Protocol Violation|0|||
129886019|NCT00962585|467542821|FG002|Overall Study|Protocol Violation|1|||
129886020|NCT00962585|467542822|FG003|Overall Study|Protocol Violation|0|||
130271371|NCT01238991|468957271|FG006|Overall Study|Lack of Efficacy|0|||
130271372|NCT01238991|468957272|FG007|Overall Study|Lack of Efficacy|0|||
130271373|NCT01238991|468957273|FG008|Overall Study|Lack of Efficacy|1|||
130271374|NCT01238991|468957274|FG009|Overall Study|Lack of Efficacy|0|||
130271375|NCT01238991|468957265|FG000|Overall Study|Withdrawal by Subject|0|||
130271376|NCT01238991|468957266|FG001|Overall Study|Withdrawal by Subject|0|||
130271377|NCT01238991|468957267|FG002|Overall Study|Withdrawal by Subject|1|||
130271378|NCT01238991|468957268|FG003|Overall Study|Withdrawal by Subject|0|||
130271379|NCT01238991|468957269|FG004|Overall Study|Withdrawal by Subject|0|||
130271380|NCT01238991|468957270|FG005|Overall Study|Withdrawal by Subject|0|||
130271381|NCT01238991|468957271|FG006|Overall Study|Withdrawal by Subject|0|||
130271382|NCT01238991|468957272|FG007|Overall Study|Withdrawal by Subject|0|||
130271383|NCT01238991|468957273|FG008|Overall Study|Withdrawal by Subject|0|||
130271384|NCT01238991|468957274|FG009|Overall Study|Withdrawal by Subject|0|||
130271385|NCT01238991|468957265|FG000|Overall Study|Study Terminated by Sponsor|0|||
130271386|NCT01238991|468957266|FG001|Overall Study|Study Terminated by Sponsor|0|||
130271387|NCT01238991|468957267|FG002|Overall Study|Study Terminated by Sponsor|0|||
130271388|NCT01238991|468957268|FG003|Overall Study|Study Terminated by Sponsor|0|||
130271389|NCT01238991|468957269|FG004|Overall Study|Study Terminated by Sponsor|1|||
130271390|NCT01238991|468957270|FG005|Overall Study|Study Terminated by Sponsor|0|||
130271391|NCT01238991|468957271|FG006|Overall Study|Study Terminated by Sponsor|7|||
130271392|NCT01238991|468957272|FG007|Overall Study|Study Terminated by Sponsor|4|||
130271393|NCT01238991|468957273|FG008|Overall Study|Study Terminated by Sponsor|2|||
130271394|NCT01238991|468957274|FG009|Overall Study|Study Terminated by Sponsor|2|||
130271395|NCT01238991|468957265|FG000|Overall Study|Caregiver's request|0|||
130271396|NCT01238991|468957266|FG001|Overall Study|Caregiver's request|0|||
130271397|NCT01238991|468957267|FG002|Overall Study|Caregiver's request|0|||
130271398|NCT01238991|468957268|FG003|Overall Study|Caregiver's request|0|||
130271399|NCT01238991|468957269|FG004|Overall Study|Caregiver's request|0|||
130271400|NCT01238991|468957270|FG005|Overall Study|Caregiver's request|0|||
130271401|NCT01238991|468957271|FG006|Overall Study|Caregiver's request|0|||
130271402|NCT01238991|468957272|FG007|Overall Study|Caregiver's request|0|||
130271403|NCT01238991|468957273|FG008|Overall Study|Caregiver's request|1|||
130271404|NCT01238991|468957274|FG009|Overall Study|Caregiver's request|0|||
130271405|NCT01238991|468957265|FG000|Overall Study|Admission to a nursing home|1|||
130271406|NCT01238991|468957266|FG001|Overall Study|Admission to a nursing home|0|||
130271407|NCT01238991|468957267|FG002|Overall Study|Admission to a nursing home|1|||
130271408|NCT01238991|468957268|FG003|Overall Study|Admission to a nursing home|0|||
130271409|NCT01238991|468957269|FG004|Overall Study|Admission to a nursing home|0|||
130271410|NCT01238991|468957270|FG005|Overall Study|Admission to a nursing home|0|||
130271411|NCT01238991|468957271|FG006|Overall Study|Admission to a nursing home|0|||
130271412|NCT01238991|468957272|FG007|Overall Study|Admission to a nursing home|0|||
130271413|NCT01238991|468957273|FG008|Overall Study|Admission to a nursing home|0|||
129886021|NCT00962585|467542819|FG000|Overall Study|Withdrawal by Subject|1|||
130271414|NCT01238991|468957274|FG009|Overall Study|Admission to a nursing home|0|||
130271415|NCT03370419|468957275|FG000|Overall Study|Lost to Follow-up|16|||
130271416|NCT01897727|468957278|FG000|Overall Study|Exclusion: central sleep apnea|0|||
129886022|NCT00962585|467542820|FG001|Overall Study|Withdrawal by Subject|0|||
129886023|NCT00962585|467542821|FG002|Overall Study|Withdrawal by Subject|0|||
129886024|NCT00962585|467542822|FG003|Overall Study|Withdrawal by Subject|0|||
130271417|NCT01897727|468957279|FG001|Overall Study|Exclusion: central sleep apnea|1|||
130271418|NCT03015363|468957280|FG000|Overall Study|Physician Decision|14|||
130271419|NCT03015363|468957280|FG000|Overall Study|Withdrawal by Subject|3|||
130271420|NCT00078806|468957281|FG000|Part 1A|Adverse Event|2|||
130271421|NCT00078806|468957282|FG001|Part 1A|Adverse Event|0|||
130271422|NCT00078806|468957283|FG002|Part 1A|Adverse Event|0|||
130271423|NCT00078806|468957284|FG003|Part 1A|Adverse Event|0|||
130271424|NCT00078806|468957281|FG000|Part 1A|Lack of Efficacy|7|||
130271425|NCT00078806|468957282|FG001|Part 1A|Lack of Efficacy|0|||
130271426|NCT00078806|468957283|FG002|Part 1A|Lack of Efficacy|0|||
130271427|NCT00078806|468957284|FG003|Part 1A|Lack of Efficacy|0|||
130271428|NCT00078806|468957281|FG000|Part 1A|Other|1|||
130271429|NCT00078806|468957282|FG001|Part 1A|Other|0|||
130271430|NCT00078806|468957283|FG002|Part 1A|Other|0|||
130271431|NCT00078806|468957284|FG003|Part 1A|Other|0|||
130271432|NCT00078806|468957281|FG000|Part 1B|Adverse Event|1|||
130271433|NCT00078806|468957282|FG001|Part 1B|Adverse Event|0|||
130271434|NCT00078806|468957283|FG002|Part 1B|Adverse Event|0|||
130271435|NCT00078806|468957284|FG003|Part 1B|Adverse Event|0|||
130271436|NCT00078806|468957281|FG000|Part 1B|Lack of Efficacy|7|||
130271437|NCT00078806|468957282|FG001|Part 1B|Lack of Efficacy|0|||
130271438|NCT00078806|468957283|FG002|Part 1B|Lack of Efficacy|0|||
130271439|NCT00078806|468957284|FG003|Part 1B|Lack of Efficacy|0|||
130271440|NCT00078806|468957281|FG000|Part 2|Adverse Event|0|||
130271441|NCT00078806|468957282|FG001|Part 2|Adverse Event|1|||
130271442|NCT00078806|468957283|FG002|Part 2|Adverse Event|0|||
130271443|NCT00078806|468957284|FG003|Part 2|Adverse Event|0|||
130271444|NCT01734785|468957287|FG000|Open-Label Period|Adverse Event|0|||
130271445|NCT01734785|468957288|FG001|Open-Label Period|Adverse Event|0|||
130271446|NCT01734785|468957289|FG002|Open-Label Period|Adverse Event|0|||
130271447|NCT01734785|468957290|FG003|Open-Label Period|Adverse Event|9|||
130271448|NCT01734785|468957287|FG000|Open-Label Period|Lack of Efficacy|0|||
130271449|NCT01734785|468957288|FG001|Open-Label Period|Lack of Efficacy|0|||
130271450|NCT01734785|468957289|FG002|Open-Label Period|Lack of Efficacy|0|||
130271451|NCT01734785|468957290|FG003|Open-Label Period|Lack of Efficacy|1|||
130271452|NCT01734785|468957287|FG000|Open-Label Period|Protocol Violation|0|||
130271453|NCT01734785|468957288|FG001|Open-Label Period|Protocol Violation|0|||
130271454|NCT01734785|468957289|FG002|Open-Label Period|Protocol Violation|0|||
130271455|NCT01734785|468957290|FG003|Open-Label Period|Protocol Violation|13|||
130271456|NCT01734785|468957287|FG000|Open-Label Period|Lost to Follow-up|0|||
130271457|NCT01734785|468957288|FG001|Open-Label Period|Lost to Follow-up|0|||
130271458|NCT01734785|468957289|FG002|Open-Label Period|Lost to Follow-up|0|||
130271459|NCT01734785|468957290|FG003|Open-Label Period|Lost to Follow-up|14|||
130271460|NCT01734785|468957287|FG000|Open-Label Period|Withdrawal by Subject|0|||
130271461|NCT01734785|468957288|FG001|Open-Label Period|Withdrawal by Subject|0|||
130271462|NCT01734785|468957289|FG002|Open-Label Period|Withdrawal by Subject|0|||
130271463|NCT01734785|468957290|FG003|Open-Label Period|Withdrawal by Subject|12|||
130271464|NCT01734785|468957287|FG000|Open-Label Period|Other Reasons|0|||
130271465|NCT01734785|468957288|FG001|Open-Label Period|Other Reasons|0|||
130271466|NCT01734785|468957289|FG002|Open-Label Period|Other Reasons|0|||
130271467|NCT01734785|468957290|FG003|Open-Label Period|Other Reasons|224|||
130271468|NCT01734785|468957287|FG000|Double-Blind Period|Adverse Event|0|||
130271469|NCT01734785|468957288|FG001|Double-Blind Period|Adverse Event|3|||
130271470|NCT01734785|468957289|FG002|Double-Blind Period|Adverse Event|2|||
130271471|NCT01734785|468957290|FG003|Double-Blind Period|Adverse Event|0|||
130271472|NCT01734785|468957287|FG000|Double-Blind Period|Lack of Efficacy|0|||
130271473|NCT01734785|468957288|FG001|Double-Blind Period|Lack of Efficacy|1|||
130271474|NCT01734785|468957289|FG002|Double-Blind Period|Lack of Efficacy|0|||
129886025|NCT00962585|467542819|FG000|Overall Study|Withdrew Consent|2|||
129886026|NCT00962585|467542820|FG001|Overall Study|Withdrew Consent|0|||
129886027|NCT00962585|467542821|FG002|Overall Study|Withdrew Consent|0|||
129886028|NCT00962585|467542822|FG003|Overall Study|Withdrew Consent|0|||
130271475|NCT01734785|468957290|FG003|Double-Blind Period|Lack of Efficacy|0|||
130271476|NCT01734785|468957287|FG000|Double-Blind Period|Protocol Violation|0|||
130271477|NCT01734785|468957288|FG001|Double-Blind Period|Protocol Violation|1|||
130271478|NCT01734785|468957289|FG002|Double-Blind Period|Protocol Violation|1|||
130271479|NCT01734785|468957290|FG003|Double-Blind Period|Protocol Violation|0|||
130271480|NCT01734785|468957287|FG000|Double-Blind Period|Lost to Follow-up|2|||
130271481|NCT01734785|468957288|FG001|Double-Blind Period|Lost to Follow-up|4|||
130271482|NCT01734785|468957289|FG002|Double-Blind Period|Lost to Follow-up|2|||
130271483|NCT01734785|468957290|FG003|Double-Blind Period|Lost to Follow-up|0|||
130271484|NCT01734785|468957287|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130271485|NCT01734785|468957288|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130271486|NCT01734785|468957289|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130271487|NCT01734785|468957290|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130271488|NCT01734785|468957287|FG000|Double-Blind Period|Not treated|1|||
130271489|NCT01734785|468957288|FG001|Double-Blind Period|Not treated|0|||
130271490|NCT01734785|468957289|FG002|Double-Blind Period|Not treated|0|||
130271491|NCT01734785|468957290|FG003|Double-Blind Period|Not treated|0|||
130271492|NCT00566982|468957291|FG000|Overall Study|Adverse Event|6|||
130271493|NCT00566982|468957292|FG001|Overall Study|Adverse Event|48|||
130271494|NCT00566982|468957291|FG000|Overall Study|Withdrawal by Subject|1|||
130271495|NCT00566982|468957292|FG001|Overall Study|Withdrawal by Subject|14|||
130271496|NCT00566982|468957291|FG000|Overall Study|Protocol Violation|1|||
130271497|NCT00566982|468957292|FG001|Overall Study|Protocol Violation|4|||
130271498|NCT00566982|468957291|FG000|Overall Study|Lost to Follow-up|0|||
130271499|NCT00566982|468957292|FG001|Overall Study|Lost to Follow-up|1|||
130271500|NCT00566982|468957291|FG000|Overall Study|Other-family problems & doctor's request|0|||
130271501|NCT00566982|468957292|FG001|Overall Study|Other-family problems & doctor's request|2|||
130271502|NCT02013778|468957298|FG000|Overall Study|Death|4|||
130271503|NCT02013778|468957298|FG000|Overall Study|Withdrawal by Subject|1|||
130271504|NCT02013778|468957298|FG000|Overall Study|Physician Decision|1|||
130271505|NCT02013778|468957298|FG000|Overall Study|Adverse Event|1|||
130271506|NCT00293813|468957299|FG000|Overall Study|Physician Decision|0|||
130271507|NCT00293813|468957300|FG001|Overall Study|Physician Decision|1|||
130271508|NCT00293813|468957301|FG002|Overall Study|Physician Decision|0|||
130271509|NCT00293813|468957299|FG000|Overall Study|Adverse Event|3|||
130271510|NCT00293813|468957300|FG001|Overall Study|Adverse Event|1|||
130271511|NCT00293813|468957301|FG002|Overall Study|Adverse Event|1|||
130271512|NCT00293813|468957299|FG000|Overall Study|Withdrawal by Subject|7|||
130271513|NCT00293813|468957300|FG001|Overall Study|Withdrawal by Subject|4|||
130271514|NCT00293813|468957301|FG002|Overall Study|Withdrawal by Subject|4|||
130271515|NCT00293813|468957299|FG000|Overall Study|Lost to Follow-up|3|||
130271516|NCT00293813|468957300|FG001|Overall Study|Lost to Follow-up|2|||
130271517|NCT00293813|468957301|FG002|Overall Study|Lost to Follow-up|3|||
130271518|NCT00293813|468957299|FG000|Overall Study|Noncompliance|0|||
130271519|NCT00293813|468957300|FG001|Overall Study|Noncompliance|1|||
130271520|NCT00293813|468957301|FG002|Overall Study|Noncompliance|0|||
130271521|NCT01465386|468957305|FG000|Overall Study|Lack of Efficacy|3|||
130271522|NCT01465386|468957305|FG000|Overall Study|Adverse Event|1|||
130271523|NCT00473889|468957306|FG000|Overall Study|Did not receive study medication|1|||
130271524|NCT00473889|468957307|FG001|Overall Study|Did not receive study medication|4|||
130271525|NCT00473889|468957306|FG000|Overall Study|Adverse Event|30|||
130271526|NCT00473889|468957307|FG001|Overall Study|Adverse Event|17|||
130271527|NCT00473889|468957306|FG000|Overall Study|Protocol Violation|4|||
130271528|NCT00473889|468957307|FG001|Overall Study|Protocol Violation|2|||
130271529|NCT00473889|468957306|FG000|Overall Study|Lack of Efficacy|28|||
130271530|NCT00473889|468957307|FG001|Overall Study|Lack of Efficacy|29|||
130271531|NCT00473889|468957306|FG000|Overall Study|Lost to Follow-up|2|||
130271532|NCT00473889|468957307|FG001|Overall Study|Lost to Follow-up|1|||
130271533|NCT00473889|468957306|FG000|Overall Study|Physician Decision|10|||
130271534|NCT00473889|468957307|FG001|Overall Study|Physician Decision|5|||
130271535|NCT00473889|468957306|FG000|Overall Study|Trial Terminated|3|||
130271536|NCT00473889|468957307|FG001|Overall Study|Trial Terminated|6|||
130271537|NCT00473889|468957306|FG000|Overall Study|Withdrawal by Subject|5|||
130271538|NCT00473889|468957307|FG001|Overall Study|Withdrawal by Subject|0|||
130271539|NCT00833469|468957308|FG000|Overall Study|Withdrawal by Subject|1|||
130271540|NCT00833469|468957308|FG000|Overall Study|Lost to Follow-up|1|||
130271541|NCT03592771|468957309|FG000|Overall Study|Adverse Event|2|||
130271542|NCT03592771|468957310|FG001|Overall Study|Adverse Event|0|||
130271543|NCT03592771|468957311|FG002|Overall Study|Adverse Event|1|||
130271544|NCT03592771|468957309|FG000|Overall Study|Death|0|||
130271545|NCT03592771|468957310|FG001|Overall Study|Death|1|||
130271546|NCT03592771|468957311|FG002|Overall Study|Death|1|||
130271547|NCT03592771|468957309|FG000|Overall Study|Lost to Follow-up|5|||
130271548|NCT03592771|468957310|FG001|Overall Study|Lost to Follow-up|11|||
130271549|NCT03592771|468957311|FG002|Overall Study|Lost to Follow-up|15|||
130271550|NCT03592771|468957309|FG000|Overall Study|Withdrawal by Subject|0|||
130271551|NCT03592771|468957310|FG001|Overall Study|Withdrawal by Subject|2|||
130271552|NCT03592771|468957311|FG002|Overall Study|Withdrawal by Subject|0|||
130271553|NCT04830215|468957312|FG000|Overall Study|Adverse Event|6|||
130271554|NCT04830215|468957312|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
130271555|NCT04830215|468957312|FG000|Overall Study|Withdrawal by Subject|3|||
130271556|NCT04830215|468957312|FG000|Overall Study|Protocol Deviation|1|||
130271557|NCT02236572|468957313|FG000|Overall Study|Withdrawal by Subject|1|||
130271558|NCT02236572|468957313|FG000|Overall Study|Protocol Violation|1|||
130271559|NCT02236572|468957313|FG000|Overall Study|Lost to Follow-up|1|||
130271560|NCT02443337|468957314|FG000|Overall Study|Adverse Event|0|||
130271561|NCT02443337|468957315|FG001|Overall Study|Adverse Event|1|||
130271562|NCT02443337|468957314|FG000|Overall Study|Clinical Progressive Disease|3|||
130271563|NCT02443337|468957315|FG001|Overall Study|Clinical Progressive Disease|0|||
130271564|NCT02443337|468957314|FG000|Overall Study|Withdrawal by Subject|2|||
130271565|NCT02443337|468957315|FG001|Overall Study|Withdrawal by Subject|1|||
130271566|NCT00709319|468957316|FG000|Overall Study|Death|4|||
130271567|NCT00709319|468957316|FG000|Overall Study|Withdrawal by Subject|2|||
130271568|NCT00579553|468957317|FG000|Overall Study|Lost to Follow-up|16|||
130271569|NCT00579553|468957318|FG001|Overall Study|Lost to Follow-up|13|||
130271570|NCT00635349|468957319|FG000|Overall Study|Other|8|||
130271571|NCT00635349|468957320|FG001|Overall Study|Other|6|||
130271572|NCT00635349|468957319|FG000|Overall Study|Protocol Violation|18|||
130271573|NCT00635349|468957320|FG001|Overall Study|Protocol Violation|22|||
130271574|NCT00635349|468957319|FG000|Overall Study|Withdrawal by Subject|3|||
130271575|NCT00635349|468957320|FG001|Overall Study|Withdrawal by Subject|8|||
130271576|NCT00635349|468957319|FG000|Overall Study|Lost to Follow-up|4|||
130271577|NCT00635349|468957320|FG001|Overall Study|Lost to Follow-up|3|||
130271578|NCT00635349|468957319|FG000|Overall Study|Adverse Event|11|||
130271579|NCT00635349|468957320|FG001|Overall Study|Adverse Event|9|||
130271580|NCT00049322|468957322|FG000|Overall Study|disease burden|0|||
130271581|NCT00049322|468957323|FG001|Overall Study|disease burden|3|||
130271582|NCT00049322|468957322|FG000|Overall Study|Adverse Event|1|||
130271583|NCT00049322|468957323|FG001|Overall Study|Adverse Event|0|||
130271584|NCT00049322|468957322|FG000|Overall Study|refused angio|0|||
130271585|NCT00049322|468957323|FG001|Overall Study|refused angio|3|||
130271586|NCT03072043|468957324|FG000|Overall Study|Death|0|||
130271587|NCT03072043|468957325|FG001|Overall Study|Death|0|||
130271588|NCT03072043|468957326|FG002|Overall Study|Death|3|||
130271589|NCT03072043|468957324|FG000|Overall Study|Adverse Event|0|||
130271590|NCT03072043|468957325|FG001|Overall Study|Adverse Event|0|||
130271591|NCT03072043|468957326|FG002|Overall Study|Adverse Event|2|||
130271592|NCT03072043|468957324|FG000|Overall Study|Withdrawal by Subject|0|||
130271593|NCT03072043|468957325|FG001|Overall Study|Withdrawal by Subject|0|||
130271594|NCT03072043|468957326|FG002|Overall Study|Withdrawal by Subject|4|||
130271595|NCT01340664|468957327|FG000|Overall Study|Adverse Event|0|||
130271596|NCT01340664|468957328|FG001|Overall Study|Adverse Event|1|||
130271597|NCT01340664|468957329|FG002|Overall Study|Adverse Event|7|||
130271598|NCT01340664|468957327|FG000|Overall Study|Lost to Follow-up|2|||
130271599|NCT01340664|468957328|FG001|Overall Study|Lost to Follow-up|0|||
130271600|NCT01340664|468957329|FG002|Overall Study|Lost to Follow-up|2|||
130271601|NCT01340664|468957327|FG000|Overall Study|Withdrawal by Subject|2|||
130271602|NCT01340664|468957328|FG001|Overall Study|Withdrawal by Subject|4|||
130271603|NCT01340664|468957329|FG002|Overall Study|Withdrawal by Subject|0|||
130271604|NCT01340664|468957327|FG000|Overall Study|Glycemic withdrawal criteria|2|||
130271605|NCT01340664|468957328|FG001|Overall Study|Glycemic withdrawal criteria|0|||
130271606|NCT01340664|468957329|FG002|Overall Study|Glycemic withdrawal criteria|0|||
130271607|NCT01340664|468957327|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
130271608|NCT01340664|468957328|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
130271609|NCT01340664|468957329|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
130271610|NCT01340664|468957327|FG000|Overall Study|Other|1|||
130271611|NCT01340664|468957328|FG001|Overall Study|Other|2|||
130271612|NCT01340664|468957329|FG002|Overall Study|Other|2|||
130271613|NCT03994211|468957332|FG000|Core Phase|Adverse Event|0|||
130271614|NCT03994211|468957333|FG001|Core Phase|Adverse Event|1|||
130271615|NCT03994211|468957334|FG002|Core Phase|Adverse Event|0|||
130271616|NCT03994211|468957332|FG000|Extension Phase|Adverse Event|0|||
130271617|NCT03994211|468957333|FG001|Extension Phase|Adverse Event|0|||
130271618|NCT03994211|468957334|FG002|Extension Phase|Adverse Event|1|||
130271619|NCT03994211|468957332|FG000|Extension Phase|Physician Decision|0|||
130271620|NCT03994211|468957333|FG001|Extension Phase|Physician Decision|0|||
130271621|NCT03994211|468957334|FG002|Extension Phase|Physician Decision|1|||
130271622|NCT03994211|468957332|FG000|Extension Phase|Progressive Disease|0|||
130271623|NCT03994211|468957333|FG001|Extension Phase|Progressive Disease|0|||
130271624|NCT03994211|468957334|FG002|Extension Phase|Progressive Disease|20|||
130271625|NCT03994211|468957332|FG000|Extension Phase|Withdrawal by Subject|0|||
130271626|NCT03994211|468957333|FG001|Extension Phase|Withdrawal by Subject|0|||
130103879|NCT00391118|468338784|FG001|Overall Study|Withdrawal by Subject|9|||
130103880|NCT00391118|468338785|FG002|Overall Study|Withdrawal by Subject|1|||
130271627|NCT03994211|468957334|FG002|Extension Phase|Withdrawal by Subject|2|||
130271628|NCT01140867|468957335|FG000|Overall Study|Adverse Event|22|||
130271629|NCT01140867|468957335|FG000|Overall Study|Lack of Efficacy|3|||
130271630|NCT01140867|468957335|FG000|Overall Study|Lost to Follow-up|2|||
130271631|NCT01140867|468957335|FG000|Overall Study|Withdrawal by Subject|1|||
130271632|NCT01140867|468957335|FG000|Overall Study|Protocol Violation|1|||
130271633|NCT01140867|468957335|FG000|Overall Study|Uncooperative patient|2|||
130271634|NCT01140867|468957335|FG000|Overall Study|Medication Noncompliance|2|||
130271635|NCT02997865|468957337|FG000|Overall Study|Death|2|||
130271636|NCT02997865|468957338|FG001|Overall Study|Death|1|||
130271637|NCT02997865|468957337|FG000|Overall Study|Lost to Follow-up|6|||
130271638|NCT02997865|468957338|FG001|Overall Study|Lost to Follow-up|3|||
129886029|NCT02254421|467542825|FG000|Overall Study|Randomized but Not Treated|1|||
129886030|NCT02254421|467542826|FG001|Overall Study|Randomized but Not Treated|0|||
130103881|NCT00391118|468338783|FG000|Overall Study|Death|0|||
130103882|NCT00391118|468338784|FG001|Overall Study|Death|1|||
130103883|NCT00391118|468338785|FG002|Overall Study|Death|0|||
130103884|NCT00391118|468338783|FG000|Overall Study|Physician Decision|0|||
130103885|NCT00391118|468338784|FG001|Overall Study|Physician Decision|3|||
130103886|NCT00391118|468338785|FG002|Overall Study|Physician Decision|0|||
130103887|NCT00391118|468338783|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
130103888|NCT00391118|468338784|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
130103889|NCT00391118|468338785|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
130103890|NCT00391118|468338783|FG000|Overall Study|Progressive Disease|7|||
130103891|NCT00391118|468338784|FG001|Overall Study|Progressive Disease|26|||
130103892|NCT00391118|468338785|FG002|Overall Study|Progressive Disease|43|||
130103893|NCT00391118|468338783|FG000|Overall Study|Sponsor Decision|0|||
130103894|NCT00391118|468338784|FG001|Overall Study|Sponsor Decision|1|||
130103895|NCT00391118|468338785|FG002|Overall Study|Sponsor Decision|3|||
130103896|NCT00391118|468338783|FG000|Overall Study|Protocol Violation|1|||
130103897|NCT00391118|468338784|FG001|Overall Study|Protocol Violation|0|||
130103898|NCT00391118|468338785|FG002|Overall Study|Protocol Violation|0|||
130103899|NCT03078192|468338787|FG000|Overall Study|Withdrawal by Subject|2|||
130103900|NCT03078192|468338788|FG001|Overall Study|Withdrawal by Subject|1|||
130103901|NCT03078192|468338787|FG000|Overall Study|screen failure|0|||
130103902|NCT03078192|468338788|FG001|Overall Study|screen failure|3|||
130103903|NCT03107715|468338791|FG000|Overall Study|did not deliver at the home hospital|4|||
130103904|NCT03107715|468338792|FG001|Overall Study|did not deliver at the home hospital|6|||
130103905|NCT03107715|468338791|FG000|Overall Study|infant stillborn|0|||
130103906|NCT03107715|468338792|FG001|Overall Study|infant stillborn|1|||
130103907|NCT02508649|468338793|FG000|Overall Study|Withdrawal by Subject|4|||
130103908|NCT02508649|468338794|FG001|Overall Study|Withdrawal by Subject|6|||
130103909|NCT02508649|468338795|FG002|Overall Study|Withdrawal by Subject|5|||
130103910|NCT02508649|468338796|FG003|Overall Study|Withdrawal by Subject|6|||
130103911|NCT02508649|468338793|FG000|Overall Study|Investigator withdrew the subject|1|||
130103912|NCT02508649|468338794|FG001|Overall Study|Investigator withdrew the subject|2|||
130103913|NCT02508649|468338795|FG002|Overall Study|Investigator withdrew the subject|1|||
130103914|NCT02508649|468338796|FG003|Overall Study|Investigator withdrew the subject|0|||
130103915|NCT02508649|468338793|FG000|Overall Study|Post randomization screening failure|12|||
129886031|NCT02254421|467542825|FG000|Overall Study|Death|0|||
129886032|NCT02254421|467542826|FG001|Overall Study|Death|2|||
130103916|NCT02508649|468338794|FG001|Overall Study|Post randomization screening failure|4|||
130103917|NCT02508649|468338795|FG002|Overall Study|Post randomization screening failure|9|||
130103918|NCT02508649|468338796|FG003|Overall Study|Post randomization screening failure|3|||
130103919|NCT02508649|468338793|FG000|Overall Study|Lost to Follow-up|1|||
130103920|NCT02508649|468338794|FG001|Overall Study|Lost to Follow-up|1|||
130103921|NCT02508649|468338795|FG002|Overall Study|Lost to Follow-up|0|||
130271639|NCT02997865|468957337|FG000|Overall Study|Withdrawal by Subject|5|||
130271640|NCT02997865|468957338|FG001|Overall Study|Withdrawal by Subject|0|||
130271641|NCT01926444|468957339|FG000|Overall Study|Colonoscopy not performed|0|||
130271642|NCT01926444|468957340|FG001|Overall Study|Colonoscopy not performed|0|||
130271643|NCT01926444|468957341|FG002|Overall Study|Colonoscopy not performed|4|||
130271644|NCT01926444|468957342|FG003|Overall Study|Colonoscopy not performed|2|||
130271645|NCT02441101|468957349|FG000|Overall Study|Withdrawal by Subject|1|||
130271646|NCT02441101|468957350|FG001|Overall Study|Withdrawal by Subject|0|||
130271647|NCT02441101|468957349|FG000|Overall Study|Lost to Follow-up|1|||
130271648|NCT02441101|468957350|FG001|Overall Study|Lost to Follow-up|0|||
130271649|NCT02441101|468957349|FG000|Overall Study|PI relocated and study terminated|1|||
130271650|NCT02441101|468957350|FG001|Overall Study|PI relocated and study terminated|0|||
130271651|NCT02528942|468957352|FG000|Overall Study|Did not meet imaging criteria|9|||
130271652|NCT02528942|468957352|FG000|Overall Study|Lost to Follow-up|25|||
130271653|NCT00881530|468957353|FG000|Overall Study|Adverse Event|5|||
130271654|NCT00881530|468957354|FG001|Overall Study|Adverse Event|1|||
130271655|NCT00881530|468957355|FG002|Overall Study|Adverse Event|1|||
130271656|NCT00881530|468957356|FG003|Overall Study|Adverse Event|4|||
130271657|NCT00881530|468957357|FG004|Overall Study|Adverse Event|10|||
130271658|NCT00881530|468957358|FG005|Overall Study|Adverse Event|2|||
130271659|NCT00881530|468957353|FG000|Overall Study|Lack of Efficacy|1|||
130271660|NCT00881530|468957354|FG001|Overall Study|Lack of Efficacy|0|||
130271661|NCT00881530|468957355|FG002|Overall Study|Lack of Efficacy|0|||
130271662|NCT00881530|468957356|FG003|Overall Study|Lack of Efficacy|0|||
130271663|NCT00881530|468957357|FG004|Overall Study|Lack of Efficacy|1|||
130271664|NCT00881530|468957358|FG005|Overall Study|Lack of Efficacy|1|||
130271665|NCT00881530|468957353|FG000|Overall Study|Not compliant with the protocol|0|||
130271666|NCT00881530|468957354|FG001|Overall Study|Not compliant with the protocol|0|||
130271667|NCT00881530|468957355|FG002|Overall Study|Not compliant with the protocol|0|||
130271668|NCT00881530|468957356|FG003|Overall Study|Not compliant with the protocol|0|||
130271669|NCT00881530|468957357|FG004|Overall Study|Not compliant with the protocol|2|||
130271670|NCT00881530|468957358|FG005|Overall Study|Not compliant with the protocol|0|||
130271671|NCT00881530|468957353|FG000|Overall Study|Lost to Follow-up|0|||
130271672|NCT00881530|468957354|FG001|Overall Study|Lost to Follow-up|1|||
130271673|NCT00881530|468957355|FG002|Overall Study|Lost to Follow-up|1|||
130271674|NCT00881530|468957356|FG003|Overall Study|Lost to Follow-up|3|||
130271675|NCT00881530|468957357|FG004|Overall Study|Lost to Follow-up|1|||
130271676|NCT00881530|468957358|FG005|Overall Study|Lost to Follow-up|0|||
130271677|NCT00881530|468957353|FG000|Overall Study|Refused to continue medication|7|||
130271678|NCT00881530|468957354|FG001|Overall Study|Refused to continue medication|2|||
130271679|NCT00881530|468957355|FG002|Overall Study|Refused to continue medication|1|||
130271680|NCT00881530|468957356|FG003|Overall Study|Refused to continue medication|2|||
130271681|NCT00881530|468957357|FG004|Overall Study|Refused to continue medication|0|||
130271682|NCT00881530|468957358|FG005|Overall Study|Refused to continue medication|0|||
130271683|NCT00881530|468957353|FG000|Overall Study|Other reason not defined above|1|||
130037659|NCT04919564|468092727|FG001|Overall Study|Lost to Follow-up|0|||
130037660|NCT04919564|468092726|FG000|Overall Study|Physician Decision|1|||
130037661|NCT04919564|468092727|FG001|Overall Study|Physician Decision|1|||
130037662|NCT01241786|468092728|FG000|Overall Study|Lack of Efficacy|5|||
130037663|NCT01440101|468092730|FG000|Overall Study|Adverse Event|2|||
130037664|NCT01440101|468092731|FG001|Overall Study|Adverse Event|0|||
130271684|NCT00881530|468957354|FG001|Overall Study|Other reason not defined above|1|||
130271685|NCT00881530|468957355|FG002|Overall Study|Other reason not defined above|2|||
129886033|NCT02254421|467542825|FG000|Overall Study|Withdrew Consent|1|||
130037665|NCT01440101|468092732|FG002|Overall Study|Adverse Event|0|||
130037666|NCT01440101|468092730|FG000|Overall Study|Withdrawal by Subject|0|||
130037667|NCT01440101|468092731|FG001|Overall Study|Withdrawal by Subject|3|||
130037668|NCT01440101|468092732|FG002|Overall Study|Withdrawal by Subject|1|||
130271686|NCT00881530|468957356|FG003|Overall Study|Other reason not defined above|0|||
130271687|NCT00881530|468957357|FG004|Overall Study|Other reason not defined above|0|||
130271688|NCT00881530|468957358|FG005|Overall Study|Other reason not defined above|2|||
130271689|NCT01509846|468957359|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
130271690|NCT01509846|468957360|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130037669|NCT01440101|468092730|FG000|Overall Study|Other|0|||
130271691|NCT01509846|468957361|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
130271692|NCT01509846|468957362|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130271693|NCT01509846|468957363|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130037670|NCT01440101|468092731|FG001|Overall Study|Other|1|||
130037671|NCT01440101|468092732|FG002|Overall Study|Other|0|||
130037672|NCT00636818|468092736|FG000|Overall Study|Adverse Event|1|||
130271694|NCT01509846|468957359|FG000|Received Vaccination 2|Illness|0|||
130271695|NCT01509846|468957360|FG001|Received Vaccination 2|Illness|0|||
130271696|NCT01509846|468957361|FG002|Received Vaccination 2|Illness|0|||
130271697|NCT01509846|468957362|FG003|Received Vaccination 2|Illness|0|||
130271698|NCT01509846|468957363|FG004|Received Vaccination 2|Illness|1|||
130271699|NCT01509846|468957359|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
130271700|NCT01509846|468957360|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
130271701|NCT01509846|468957361|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
130271702|NCT01509846|468957362|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
130271703|NCT01509846|468957363|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
130271704|NCT01509846|468957359|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
130271705|NCT01509846|468957360|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
130037673|NCT00636818|468092736|FG000|Overall Study|Lost to Follow-up|2|||
130037674|NCT00636818|468092736|FG000|Overall Study|Entry Criteria Exclusion|3|||
130037675|NCT00636818|468092736|FG000|Overall Study|Protocol Violation|1|||
130037676|NCT00636818|468092736|FG000|Overall Study|Withdrawal by Subject|4|||
130037677|NCT00074958|468092737|FG000|Overall Study|Adverse Event|1|||
130037678|NCT01658514|468092742|FG000|Overall Study|Protocol Violation|1|||
130037679|NCT01658514|468092743|FG001|Overall Study|Protocol Violation|0|||
130037680|NCT01658514|468092744|FG002|Overall Study|Protocol Violation|2|||
130037681|NCT02344576|468092748|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
130037682|NCT02344576|468092749|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
130037683|NCT02344576|468092750|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
130037684|NCT02344576|468092751|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
130037685|NCT02344576|468092748|FG000|1-Month Follow-Up|Death|13|||
130037686|NCT02344576|468092749|FG001|1-Month Follow-Up|Death|8|||
130103922|NCT02508649|468338796|FG003|Overall Study|Lost to Follow-up|1|||
130103923|NCT03594175|468338804|FG000|Overall Study|Not treated|8|||
130103924|NCT03594175|468338805|FG001|Overall Study|Not treated|1|||
130103925|NCT03594175|468338806|FG002|Overall Study|Not treated|5|||
130103926|NCT03594175|468338804|FG000|Overall Study|Adverse Event|3|||
130103927|NCT03594175|468338805|FG001|Overall Study|Adverse Event|0|||
130103928|NCT03594175|468338806|FG002|Overall Study|Adverse Event|0|||
130103929|NCT03594175|468338804|FG000|Overall Study|Withdrawal by Subject|3|||
130103930|NCT03594175|468338805|FG001|Overall Study|Withdrawal by Subject|0|||
130271706|NCT01509846|468957361|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
130037687|NCT02344576|468092750|FG002|1-Month Follow-Up|Death|0|||
130037688|NCT02344576|468092751|FG003|1-Month Follow-Up|Death|0|||
130037689|NCT02344576|468092748|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
130037690|NCT02344576|468092749|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
130037691|NCT02344576|468092750|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
130037692|NCT02344576|468092751|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
130037693|NCT02344576|468092748|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
130037694|NCT02344576|468092749|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
130037695|NCT02344576|468092750|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
130037696|NCT02344576|468092751|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
130037697|NCT02344576|468092748|FG000|6-Month Follow-Up|Death|14|||
130037698|NCT02344576|468092749|FG001|6-Month Follow-Up|Death|14|||
130037699|NCT02344576|468092750|FG002|6-Month Follow-Up|Death|0|||
130037700|NCT02344576|468092751|FG003|6-Month Follow-Up|Death|0|||
130037701|NCT02344576|468092748|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
130037702|NCT02344576|468092749|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
130037703|NCT02344576|468092750|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
130037704|NCT02344576|468092751|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
130037705|NCT02344576|468092748|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
130037706|NCT02344576|468092749|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
130037707|NCT02344576|468092750|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
130037708|NCT02344576|468092751|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
130037709|NCT03832387|468092766|FG000|Overall Study|Protocol Violation|2|||
130103931|NCT03594175|468338806|FG002|Overall Study|Withdrawal by Subject|0|||
130271707|NCT01509846|468957362|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
130271708|NCT01509846|468957363|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
130271709|NCT01509846|468957359|FG000|Received Vaccination 3|Pregnancy|0|||
130271710|NCT01509846|468957360|FG001|Received Vaccination 3|Pregnancy|0|||
130271711|NCT01509846|468957361|FG002|Received Vaccination 3|Pregnancy|0|||
130271712|NCT01509846|468957362|FG003|Received Vaccination 3|Pregnancy|1|||
130103932|NCT03594175|468338804|FG000|Overall Study|Protocol Violation|2|||
130103933|NCT03594175|468338805|FG001|Overall Study|Protocol Violation|2|||
130103934|NCT03594175|468338806|FG002|Overall Study|Protocol Violation|2|||
130103935|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130271713|NCT01509846|468957363|FG004|Received Vaccination 3|Pregnancy|0|||
130037710|NCT03832387|468092767|FG001|Overall Study|Protocol Violation|6|||
130037711|NCT03832387|468092766|FG000|Overall Study|EXCLUSION CRITERIA|3|||
130037712|NCT03832387|468092767|FG001|Overall Study|EXCLUSION CRITERIA|1|||
130037713|NCT00144170|468092768|FG000|Overall Study|Adverse Event|84|||
130103936|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103937|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130271714|NCT01509846|468957359|FG000|Received Vaccination 3|Lost to Follow-up|0|||
130271715|NCT01509846|468957360|FG001|Received Vaccination 3|Lost to Follow-up|0|||
130271716|NCT01509846|468957361|FG002|Received Vaccination 3|Lost to Follow-up|1|||
130271717|NCT01509846|468957362|FG003|Received Vaccination 3|Lost to Follow-up|0|||
130271718|NCT01509846|468957363|FG004|Received Vaccination 3|Lost to Follow-up|0|||
130271719|NCT01637584|468957364|FG000|Overall Study|Withdrawal by Subject|1|||
130271720|NCT01637584|468957365|FG001|Overall Study|Withdrawal by Subject|3|||
130271721|NCT02969915|468957367|FG000|Overall Study|Death|104|||
130271722|NCT02969915|468957368|FG001|Overall Study|Death|125|||
130271723|NCT02969915|468957367|FG000|Overall Study|Lost to Follow-up|108|||
130271724|NCT02969915|468957368|FG001|Overall Study|Lost to Follow-up|112|||
130271725|NCT02969915|468957367|FG000|Overall Study|Censored due to COVID-19|481|||
130271726|NCT02969915|468957368|FG001|Overall Study|Censored due to COVID-19|471|||
130271727|NCT01393899|468957371|FG000|Overall Study|Study terminated by sponsor|1|||
130271728|NCT01393899|468957372|FG001|Overall Study|Study terminated by sponsor|0|||
130271729|NCT01393899|468957373|FG002|Overall Study|Study terminated by sponsor|1|||
130271730|NCT01393899|468957371|FG000|Overall Study|Other|1|||
130271731|NCT01393899|468957372|FG001|Overall Study|Other|0|||
130271732|NCT01393899|468957373|FG002|Overall Study|Other|0|||
130271733|NCT01393899|468957371|FG000|Overall Study|Withdrawal by Subject|2|||
130271734|NCT01393899|468957372|FG001|Overall Study|Withdrawal by Subject|2|||
130271735|NCT01393899|468957373|FG002|Overall Study|Withdrawal by Subject|1|||
130271736|NCT01393899|468957371|FG000|Overall Study|Lost to Follow-up|0|||
130271737|NCT01393899|468957372|FG001|Overall Study|Lost to Follow-up|0|||
130271738|NCT01393899|468957373|FG002|Overall Study|Lost to Follow-up|1|||
130271739|NCT01393899|468957371|FG000|Overall Study|Does not meet entrance criteria|1|||
130271740|NCT01393899|468957372|FG001|Overall Study|Does not meet entrance criteria|0|||
130271741|NCT01393899|468957373|FG002|Overall Study|Does not meet entrance criteria|1|||
130271742|NCT01393899|468957371|FG000|Overall Study|Lack of Efficacy|26|||
130271743|NCT01393899|468957372|FG001|Overall Study|Lack of Efficacy|21|||
130271744|NCT01393899|468957373|FG002|Overall Study|Lack of Efficacy|16|||
130271745|NCT01393899|468957371|FG000|Overall Study|Adverse Event|1|||
130271746|NCT01393899|468957372|FG001|Overall Study|Adverse Event|5|||
130271747|NCT01393899|468957373|FG002|Overall Study|Adverse Event|3|||
130271748|NCT02503085|468957374|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
130271749|NCT02503085|468957375|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
130271750|NCT02503085|468957376|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
130271751|NCT02503085|468957377|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
130271752|NCT00995436|468957378|FG000|Overall Study|Withdrawal by Subject|2|||
130271753|NCT00995436|468957379|FG001|Overall Study|Withdrawal by Subject|5|||
130271754|NCT00995436|468957380|FG002|Overall Study|Withdrawal by Subject|0|||
130103938|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130103939|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130103940|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103941|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130271755|NCT02131662|468957381|FG000|Overall Study|Protocol Violation|1|||
130271756|NCT02131662|468957382|FG001|Overall Study|Protocol Violation|0|||
130271757|NCT02131662|468957383|FG002|Overall Study|Protocol Violation|0|||
130271758|NCT02131662|468957384|FG003|Overall Study|Protocol Violation|0|||
130271759|NCT02131662|468957385|FG004|Overall Study|Protocol Violation|0|||
130271760|NCT02131662|468957381|FG000|Overall Study|Other|2|||
130271761|NCT02131662|468957382|FG001|Overall Study|Other|4|||
130271762|NCT02131662|468957383|FG002|Overall Study|Other|3|||
130271763|NCT02131662|468957384|FG003|Overall Study|Other|3|||
130271764|NCT02131662|468957385|FG004|Overall Study|Other|4|||
130271765|NCT02131662|468957381|FG000|Overall Study|Adverse Event|0|||
130271766|NCT02131662|468957382|FG001|Overall Study|Adverse Event|1|||
130271767|NCT02131662|468957383|FG002|Overall Study|Adverse Event|1|||
130271768|NCT02131662|468957384|FG003|Overall Study|Adverse Event|1|||
130271769|NCT02131662|468957385|FG004|Overall Study|Adverse Event|3|||
130271770|NCT02131662|468957381|FG000|Overall Study|Pregnancy|0|||
130271771|NCT02131662|468957382|FG001|Overall Study|Pregnancy|1|||
130271772|NCT02131662|468957383|FG002|Overall Study|Pregnancy|0|||
130271773|NCT02131662|468957384|FG003|Overall Study|Pregnancy|1|||
130271774|NCT02131662|468957385|FG004|Overall Study|Pregnancy|0|||
130271775|NCT02131662|468957381|FG000|Overall Study|Wish for pregnancy|0|||
130271776|NCT02131662|468957382|FG001|Overall Study|Wish for pregnancy|0|||
130271777|NCT02131662|468957383|FG002|Overall Study|Wish for pregnancy|0|||
130271778|NCT02131662|468957384|FG003|Overall Study|Wish for pregnancy|0|||
130271779|NCT02131662|468957385|FG004|Overall Study|Wish for pregnancy|1|||
130271780|NCT02131662|468957381|FG000|Overall Study|Lack of Efficacy|1|||
130271781|NCT02131662|468957382|FG001|Overall Study|Lack of Efficacy|0|||
130271782|NCT02131662|468957383|FG002|Overall Study|Lack of Efficacy|0|||
130271783|NCT02131662|468957384|FG003|Overall Study|Lack of Efficacy|0|||
130271784|NCT02131662|468957385|FG004|Overall Study|Lack of Efficacy|1|||
130271785|NCT02131662|468957381|FG000|Overall Study|Withdrawal by Subject|1|||
130037714|NCT00144170|468092769|FG001|Overall Study|Adverse Event|41|||
130037715|NCT00144170|468092768|FG000|Overall Study|Protocol Violation|23|||
130037716|NCT00144170|468092769|FG001|Overall Study|Protocol Violation|16|||
130037717|NCT00144170|468092768|FG000|Overall Study|Lost to Follow-up|5|||
130037718|NCT00144170|468092769|FG001|Overall Study|Lost to Follow-up|10|||
130037719|NCT00144170|468092768|FG000|Overall Study|Withdrawal by Subject|29|||
130037720|NCT00144170|468092769|FG001|Overall Study|Withdrawal by Subject|13|||
130037721|NCT00144170|468092768|FG000|Overall Study|Other reason not defined above|211|||
130037722|NCT00144170|468092769|FG001|Overall Study|Other reason not defined above|316|||
130037723|NCT00702143|468092770|FG000|Overall Study|Lost to Follow-up|0|||
130037724|NCT00702143|468092771|FG001|Overall Study|Lost to Follow-up|0|||
130037725|NCT00702143|468092772|FG002|Overall Study|Lost to Follow-up|1|||
130037726|NCT04826900|468092773|FG000|Overall Study|Family factor|1|||
130037727|NCT04826900|468092774|FG001|Overall Study|Family factor|1|||
130037728|NCT03372941|468092775|FG000|Overall Study|Lost to Follow-up|2|||
130037729|NCT03372941|468092776|FG001|Overall Study|Lost to Follow-up|4|||
130037730|NCT00741819|468092777|FG000|Overall Study|Adverse Event|3|||
130037731|NCT00741819|468092777|FG000|Overall Study|Withdrawal by Subject|3|||
130037732|NCT00741819|468092777|FG000|Overall Study|Death|1|||
130037733|NCT00741819|468092777|FG000|Overall Study|Disease progression|1|||
130037734|NCT01126580|468092778|FG000|Overall Study|Adverse Event|14|||
130037735|NCT01126580|468092779|FG001|Overall Study|Adverse Event|8|||
130037736|NCT01126580|468092780|FG002|Overall Study|Adverse Event|12|||
130037737|NCT01126580|468092778|FG000|Overall Study|Withdrawal by Subject|11|||
130037738|NCT01126580|468092779|FG001|Overall Study|Withdrawal by Subject|19|||
130037739|NCT01126580|468092780|FG002|Overall Study|Withdrawal by Subject|14|||
130037740|NCT01126580|468092778|FG000|Overall Study|Sponsor Decision|5|||
130037741|NCT01126580|468092779|FG001|Overall Study|Sponsor Decision|4|||
130037742|NCT01126580|468092780|FG002|Overall Study|Sponsor Decision|7|||
130037743|NCT01126580|468092778|FG000|Overall Study|Physician Decision|1|||
130037744|NCT01126580|468092779|FG001|Overall Study|Physician Decision|1|||
130037745|NCT01126580|468092780|FG002|Overall Study|Physician Decision|2|||
130037746|NCT01126580|468092778|FG000|Overall Study|Entry Criteria Not Met|1|||
130037747|NCT01126580|468092779|FG001|Overall Study|Entry Criteria Not Met|1|||
130037748|NCT01126580|468092780|FG002|Overall Study|Entry Criteria Not Met|2|||
130037749|NCT01126580|468092778|FG000|Overall Study|Lack of Efficacy|2|||
130037750|NCT01126580|468092779|FG001|Overall Study|Lack of Efficacy|3|||
130037751|NCT01126580|468092780|FG002|Overall Study|Lack of Efficacy|4|||
130037752|NCT01126580|468092778|FG000|Overall Study|Protocol Violation|0|||
130037753|NCT01126580|468092779|FG001|Overall Study|Protocol Violation|1|||
130037754|NCT01126580|468092780|FG002|Overall Study|Protocol Violation|2|||
130037755|NCT01126580|468092778|FG000|Overall Study|Lost to Follow-up|15|||
130037756|NCT01126580|468092779|FG001|Overall Study|Lost to Follow-up|13|||
129886034|NCT02254421|467542826|FG001|Overall Study|Withdrew Consent|1|||
129886035|NCT03354637|467542829|FG000|Double-blind Period|Protocol Violation|2|||
129886036|NCT03354637|467542830|FG001|Double-blind Period|Protocol Violation|0|||
129886037|NCT03354637|467542831|FG002|Double-blind Period|Protocol Violation|0|||
129886038|NCT03354637|467542829|FG000|Double-blind Period|Adverse Event|1|||
129886039|NCT03354637|467542830|FG001|Double-blind Period|Adverse Event|2|||
129886040|NCT03354637|467542831|FG002|Double-blind Period|Adverse Event|0|||
129886041|NCT03354637|467542829|FG000|Double-blind Period|Lost to Follow-up|3|||
129886042|NCT03354637|467542830|FG001|Double-blind Period|Lost to Follow-up|4|||
129886043|NCT03354637|467542831|FG002|Double-blind Period|Lost to Follow-up|3|||
129886044|NCT03354637|467542829|FG000|Double-blind Period|Withdrawal by Subject|10|||
129886045|NCT03354637|467542830|FG001|Double-blind Period|Withdrawal by Subject|6|||
129886046|NCT03354637|467542831|FG002|Double-blind Period|Withdrawal by Subject|4|||
129886047|NCT03354637|467542829|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
129886048|NCT03354637|467542830|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
129886049|NCT03354637|467542831|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
129886050|NCT03354637|467542829|FG000|Open Label Extension|Adverse Event|0|||
129886051|NCT03354637|467542830|FG001|Open Label Extension|Adverse Event|0|||
129886052|NCT03354637|467542831|FG002|Open Label Extension|Adverse Event|1|||
129886053|NCT03354637|467542829|FG000|Open Label Extension|Lost to Follow-up|0|||
129886054|NCT03354637|467542830|FG001|Open Label Extension|Lost to Follow-up|0|||
129886055|NCT03354637|467542831|FG002|Open Label Extension|Lost to Follow-up|2|||
129886056|NCT03354637|467542829|FG000|Open Label Extension|Withdrawal by Subject|0|||
129886057|NCT03354637|467542830|FG001|Open Label Extension|Withdrawal by Subject|0|||
129886058|NCT03354637|467542831|FG002|Open Label Extension|Withdrawal by Subject|5|||
129886059|NCT03354637|467542829|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
129886060|NCT03354637|467542830|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
129886061|NCT03354637|467542831|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
129886062|NCT03354637|467542829|FG000|Open Label Extension|Subject Noncompliance|0|||
129886063|NCT03354637|467542830|FG001|Open Label Extension|Subject Noncompliance|0|||
129886064|NCT03354637|467542831|FG002|Open Label Extension|Subject Noncompliance|1|||
129886065|NCT03354637|467542829|FG000|Open Label Extension|Lack of Efficacy|0|||
129886066|NCT03354637|467542830|FG001|Open Label Extension|Lack of Efficacy|0|||
129886067|NCT03354637|467542831|FG002|Open Label Extension|Lack of Efficacy|1|||
129886068|NCT03354637|467542829|FG000|Open Label Extension|Physician Decision|0|||
129886069|NCT03354637|467542830|FG001|Open Label Extension|Physician Decision|0|||
129886070|NCT03354637|467542831|FG002|Open Label Extension|Physician Decision|1|||
130103942|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103943|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103944|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130103945|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103946|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103947|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130103948|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
130103949|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
130271786|NCT02131662|468957382|FG001|Overall Study|Withdrawal by Subject|5|||
130271787|NCT02131662|468957383|FG002|Overall Study|Withdrawal by Subject|1|||
130271788|NCT02131662|468957384|FG003|Overall Study|Withdrawal by Subject|5|||
130271789|NCT02131662|468957385|FG004|Overall Study|Withdrawal by Subject|6|||
130271790|NCT02131662|468957381|FG000|Overall Study|Lost to Follow-up|1|||
130271791|NCT02131662|468957382|FG001|Overall Study|Lost to Follow-up|3|||
130271792|NCT02131662|468957383|FG002|Overall Study|Lost to Follow-up|0|||
130271793|NCT02131662|468957384|FG003|Overall Study|Lost to Follow-up|9|||
130271794|NCT02131662|468957385|FG004|Overall Study|Lost to Follow-up|0|||
130271795|NCT02131662|468957381|FG000|Overall Study|Not treated|2|||
130271796|NCT02131662|468957382|FG001|Overall Study|Not treated|0|||
130271797|NCT02131662|468957383|FG002|Overall Study|Not treated|2|||
130271798|NCT02131662|468957384|FG003|Overall Study|Not treated|2|||
130271799|NCT02131662|468957385|FG004|Overall Study|Not treated|3|||
130271800|NCT00809926|468957387|FG000|Overall Study|Adverse Event|18|||
130271801|NCT00809926|468957388|FG001|Overall Study|Adverse Event|10|||
130271802|NCT00809926|468957387|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130271803|NCT00809926|468957388|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130271804|NCT00809926|468957387|FG000|Overall Study|Patient withdrew consent|8|||
129886071|NCT02726399|467542832|FG000|Overall Study|Participant Non-Compliance|1|||
130271805|NCT00809926|468957388|FG001|Overall Study|Patient withdrew consent|6|||
129886072|NCT02726399|467542832|FG000|Overall Study|Adverse Event|2|||
129886073|NCT02726399|467542832|FG000|Overall Study|Progression of disease|4|||
130271806|NCT00809926|468957387|FG000|Overall Study|Lost to Follow-up|2|||
129886074|NCT02564055|467542847|FG000|Overall Study|Adverse Event|1|||
130271807|NCT00809926|468957388|FG001|Overall Study|Lost to Follow-up|1|||
130271808|NCT00809926|468957387|FG000|Overall Study|Administrative Problems|0|||
130271809|NCT00809926|468957388|FG001|Overall Study|Administrative Problems|1|||
130271810|NCT00809926|468957387|FG000|Overall Study|Protocol deviation|0|||
130037757|NCT01126580|468092780|FG002|Overall Study|Lost to Follow-up|9|||
130271811|NCT00809926|468957388|FG001|Overall Study|Protocol deviation|2|||
130271812|NCT00130039|468957389|FG000|Overall Study|Withdrawal by Subject|15|||
130271813|NCT00130039|468957390|FG001|Overall Study|Withdrawal by Subject|11|||
130271814|NCT00130039|468957389|FG000|Overall Study|Lost to Follow-up|3|||
130271815|NCT00130039|468957390|FG001|Overall Study|Lost to Follow-up|1|||
130271816|NCT00130039|468957389|FG000|Overall Study|Adverse Event|4|||
130271817|NCT00130039|468957390|FG001|Overall Study|Adverse Event|2|||
130271818|NCT00130039|468957389|FG000|Overall Study|Physician Decision|3|||
130271819|NCT00130039|468957390|FG001|Overall Study|Physician Decision|0|||
130271820|NCT00130039|468957389|FG000|Overall Study|clinical events without follow up MRI|5|||
130271821|NCT00130039|468957390|FG001|Overall Study|clinical events without follow up MRI|4|||
130271822|NCT00100802|468957406|FG000|Overall Study|Adverse Event|9|||
130271823|NCT00100802|468957406|FG000|Overall Study|Death|1|||
130271824|NCT00100802|468957406|FG000|Overall Study|Lack of Efficacy|47|||
130271825|NCT00100802|468957406|FG000|Overall Study|Physician Decision|5|||
130271826|NCT00100802|468957406|FG000|Overall Study|Protocol Violation|1|||
130271827|NCT00100802|468957406|FG000|Overall Study|Withdrawal by Subject|5|||
130271828|NCT00100802|468957406|FG000|Overall Study|Ineligible|12|||
130271829|NCT02712996|468957407|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
130271830|NCT02712996|468957408|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
130271831|NCT02709720|468957410|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
130271832|NCT02709720|468957410|FG000|Overall Study|Protocol Violation|1|||
130271833|NCT02709720|468957410|FG000|Overall Study|Not take study medication|1|||
130271834|NCT03265145|468957412|FG000|Overall Study|Protocol Violation|2|||
130271835|NCT03265145|468957413|FG001|Overall Study|Protocol Violation|0|||
130271836|NCT03265145|468957412|FG000|Overall Study|Adverse Event|1|||
130271837|NCT03265145|468957413|FG001|Overall Study|Adverse Event|0|||
130271838|NCT03265145|468957412|FG000|Overall Study|Withdrawal by Subject|23|||
130271839|NCT03265145|468957413|FG001|Overall Study|Withdrawal by Subject|19|||
130271840|NCT03265145|468957412|FG000|Overall Study|Death|12|||
130271841|NCT03265145|468957413|FG001|Overall Study|Death|12|||
130271842|NCT03265145|468957412|FG000|Overall Study|Lost to Follow-up|13|||
130271843|NCT03265145|468957413|FG001|Overall Study|Lost to Follow-up|9|||
130271844|NCT03265145|468957412|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
130271845|NCT03265145|468957413|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
130271846|NCT03265145|468957412|FG000|Overall Study|Switched back to previous medication|1|||
130271847|NCT03265145|468957413|FG001|Overall Study|Switched back to previous medication|0|||
130271848|NCT03265145|468957412|FG000|Overall Study|Did not want to take medication|1|||
130271849|NCT03265145|468957413|FG001|Overall Study|Did not want to take medication|0|||
130271850|NCT03265145|468957412|FG000|Overall Study|Subject could not afford medication|0|||
130271851|NCT03265145|468957413|FG001|Overall Study|Subject could not afford medication|1|||
130271852|NCT03265145|468957412|FG000|Overall Study|Site closed|2|||
130271853|NCT03265145|468957413|FG001|Overall Study|Site closed|3|||
130271854|NCT03265145|468957412|FG000|Overall Study|Incorrectly randomized|16|||
130271855|NCT03265145|468957413|FG001|Overall Study|Incorrectly randomized|6|||
130271856|NCT03265145|468957412|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
130271857|NCT03265145|468957413|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
130271858|NCT03265145|468957412|FG000|Overall Study|Physician Decision|0|||
130271859|NCT03265145|468957413|FG001|Overall Study|Physician Decision|3|||
130271860|NCT03265145|468957412|FG000|Overall Study|Subject transferred to another facility|0|||
130271861|NCT03265145|468957413|FG001|Overall Study|Subject transferred to another facility|1|||
130271862|NCT00283803|468959301|FG000|Overall Study|Physician Decision|9|||
130271863|NCT00283803|468959301|FG000|Overall Study|Withdrawal by Subject|4|||
130271864|NCT01127607|468959302|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
130271865|NCT01127607|468959303|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
130271866|NCT01127607|468959302|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
130271867|NCT01127607|468959303|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
130271868|NCT03640325|468959304|FG000|Overall Study|Withdrawal by Subject|4|||
130271869|NCT03640325|468959305|FG001|Overall Study|Withdrawal by Subject|1|||
130037758|NCT01126580|468092778|FG000|Overall Study|Treatment Non-compliance|0|||
130037759|NCT01126580|468092779|FG001|Overall Study|Treatment Non-compliance|2|||
130037760|NCT01126580|468092780|FG002|Overall Study|Treatment Non-compliance|3|||
130037761|NCT02582658|468092782|FG000|Overall Study|Failure to Return|10|||
130271870|NCT03640325|468959306|FG002|Overall Study|Withdrawal by Subject|0|||
130271871|NCT03640325|468959304|FG000|Overall Study|Lost to Follow-up|4|||
130271872|NCT03640325|468959305|FG001|Overall Study|Lost to Follow-up|5|||
130271873|NCT03640325|468959306|FG002|Overall Study|Lost to Follow-up|21|||
130271874|NCT03640325|468959304|FG000|Overall Study|Death|5|||
130271875|NCT03640325|468959305|FG001|Overall Study|Death|5|||
130271876|NCT03640325|468959306|FG002|Overall Study|Death|0|||
130271877|NCT01133756|468959310|FG000|Overall Study|Adverse Event|1|||
130271878|NCT01133756|468959311|FG001|Overall Study|Adverse Event|2|||
130271879|NCT01133756|468959312|FG002|Overall Study|Adverse Event|1|||
130037762|NCT02582658|468092782|FG000|Overall Study|Insufficient Virological Response|2|||
130103950|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
130103951|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
130103952|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
130103953|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
130103954|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130271880|NCT01133756|468959310|FG000|Overall Study|Investigator Decision|1|||
130271881|NCT01133756|468959311|FG001|Overall Study|Investigator Decision|0|||
129886075|NCT02564055|467542848|FG001|Overall Study|Adverse Event|0|||
129886076|NCT02564055|467542849|FG002|Overall Study|Adverse Event|4|||
129886077|NCT02564055|467542850|FG003|Overall Study|Adverse Event|1|||
129886078|NCT02564055|467542851|FG004|Overall Study|Adverse Event|4|||
129886079|NCT02564055|467542852|FG005|Overall Study|Adverse Event|1|||
129886080|NCT02564055|467542847|FG000|Overall Study|Protocol Violation|1|||
129886081|NCT02564055|467542848|FG001|Overall Study|Protocol Violation|0|||
129886082|NCT02564055|467542849|FG002|Overall Study|Protocol Violation|0|||
130037763|NCT02582658|468092782|FG000|Overall Study|Withdrawn Consent|1|||
130037764|NCT02582658|468092782|FG000|Overall Study|Death|1|||
130037765|NCT02582658|468092782|FG000|Overall Study|Not further specified|11|||
130037766|NCT02581995|468092790|FG000|Overall Study|Unspecified other|3|||
130037767|NCT02581995|468092790|FG000|Overall Study|Adverse Event|6|||
130037768|NCT02581995|468092790|FG000|Overall Study|Lost to Follow-up|5|||
130037769|NCT02581995|468092790|FG000|Overall Study|Withdrawal by participant|12|||
130037770|NCT02581995|468092790|FG000|Overall Study|Physician Decision|1|||
130037771|NCT02581995|468092790|FG000|Overall Study|Death|4|||
130037772|NCT01324830|468094724|FG000|Overall Study|Progressive Disease|3|||
130037773|NCT01324830|468094725|FG001|Overall Study|Progressive Disease|2|||
130037774|NCT01324830|468094726|FG002|Overall Study|Progressive Disease|3|||
130037775|NCT01324830|468094727|FG003|Overall Study|Progressive Disease|3|||
130037776|NCT01324830|468094728|FG004|Overall Study|Progressive Disease|6|||
130037777|NCT01324830|468094729|FG005|Overall Study|Progressive Disease|6|||
130037778|NCT01324830|468094730|FG006|Overall Study|Progressive Disease|3|||
130037779|NCT01324830|468094731|FG007|Overall Study|Progressive Disease|3|||
130037780|NCT01324830|468094732|FG008|Overall Study|Progressive Disease|3|||
130037781|NCT01324830|468094733|FG009|Overall Study|Progressive Disease|6|||
130037782|NCT01324830|468094734|FG010|Overall Study|Progressive Disease|2|||
130037783|NCT01324830|468094735|FG011|Overall Study|Progressive Disease|1|||
130037784|NCT01324830|468094736|FG012|Overall Study|Progressive Disease|1|||
130037785|NCT01324830|468094737|FG013|Overall Study|Progressive Disease|1|||
130037786|NCT01324830|468094738|FG014|Overall Study|Progressive Disease|1|||
130037787|NCT01324830|468094739|FG015|Overall Study|Progressive Disease|3|||
130037788|NCT01324830|468094740|FG016|Overall Study|Progressive Disease|2|||
130037789|NCT01324830|468094741|FG017|Overall Study|Progressive Disease|3|||
130037790|NCT01324830|468094742|FG018|Overall Study|Progressive Disease|4|||
130037791|NCT01324830|468094724|FG000|Overall Study|Dose limiting toxicity|0|||
130037792|NCT01324830|468094725|FG001|Overall Study|Dose limiting toxicity|0|||
130037793|NCT01324830|468094726|FG002|Overall Study|Dose limiting toxicity|0|||
130037794|NCT01324830|468094727|FG003|Overall Study|Dose limiting toxicity|0|||
130037795|NCT01324830|468094728|FG004|Overall Study|Dose limiting toxicity|1|||
130037796|NCT01324830|468094729|FG005|Overall Study|Dose limiting toxicity|0|||
130037797|NCT01324830|468094730|FG006|Overall Study|Dose limiting toxicity|0|||
130037798|NCT01324830|468094731|FG007|Overall Study|Dose limiting toxicity|0|||
130271882|NCT01133756|468959312|FG002|Overall Study|Investigator Decision|0|||
130271883|NCT01133756|468959310|FG000|Overall Study|Withdrawal by Subject|0|||
130271884|NCT01133756|468959311|FG001|Overall Study|Withdrawal by Subject|1|||
130271885|NCT01133756|468959312|FG002|Overall Study|Withdrawal by Subject|0|||
130271886|NCT01133756|468959310|FG000|Overall Study|Progression of Disease|0|||
130271887|NCT01133756|468959311|FG001|Overall Study|Progression of Disease|0|||
130271888|NCT01133756|468959312|FG002|Overall Study|Progression of Disease|1|||
130271889|NCT01566149|468959313|FG000|Overall Study|Adverse Event|0|||
130271890|NCT01566149|468959314|FG001|Overall Study|Adverse Event|1|||
130271891|NCT01566149|468959313|FG000|Overall Study|Non-compliance with study medication|2|||
130271892|NCT01566149|468959314|FG001|Overall Study|Non-compliance with study medication|0|||
130271893|NCT01566149|468959313|FG000|Overall Study|Protocol Violation|0|||
130271894|NCT01566149|468959314|FG001|Overall Study|Protocol Violation|1|||
130271895|NCT01566149|468959313|FG000|Overall Study|Withdrawal by Subject|1|||
130037799|NCT01324830|468094732|FG008|Overall Study|Dose limiting toxicity|0|||
130037800|NCT01324830|468094733|FG009|Overall Study|Dose limiting toxicity|0|||
130037801|NCT01324830|468094734|FG010|Overall Study|Dose limiting toxicity|0|||
130037802|NCT01324830|468094735|FG011|Overall Study|Dose limiting toxicity|0|||
130037803|NCT01324830|468094736|FG012|Overall Study|Dose limiting toxicity|0|||
130271896|NCT01566149|468959314|FG001|Overall Study|Withdrawal by Subject|0|||
129886083|NCT02564055|467542850|FG003|Overall Study|Protocol Violation|0|||
129886084|NCT02564055|467542851|FG004|Overall Study|Protocol Violation|0|||
130037804|NCT01324830|468094737|FG013|Overall Study|Dose limiting toxicity|0|||
130037805|NCT01324830|468094738|FG014|Overall Study|Dose limiting toxicity|0|||
130037806|NCT01324830|468094739|FG015|Overall Study|Dose limiting toxicity|0|||
130037807|NCT01324830|468094740|FG016|Overall Study|Dose limiting toxicity|1|||
130037808|NCT01324830|468094741|FG017|Overall Study|Dose limiting toxicity|1|||
130037809|NCT01324830|468094742|FG018|Overall Study|Dose limiting toxicity|1|||
130037810|NCT01324830|468094724|FG000|Overall Study|Reason not mentioned above|0|||
130037811|NCT01324830|468094725|FG001|Overall Study|Reason not mentioned above|0|||
130037812|NCT01324830|468094726|FG002|Overall Study|Reason not mentioned above|0|||
130271897|NCT03276728|468959318|FG000|Overall Study|Lost to Follow-up|0|||
130271898|NCT03276728|468959319|FG001|Overall Study|Lost to Follow-up|0|||
130271899|NCT03276728|468959320|FG002|Overall Study|Lost to Follow-up|2|||
130271900|NCT03276728|468959321|FG003|Overall Study|Lost to Follow-up|2|||
130271901|NCT03276728|468959322|FG004|Overall Study|Lost to Follow-up|0|||
130271902|NCT03276728|468959323|FG005|Overall Study|Lost to Follow-up|0|||
130271903|NCT03276728|468959324|FG006|Overall Study|Lost to Follow-up|0|||
130271904|NCT03276728|468959325|FG007|Overall Study|Lost to Follow-up|0|||
130271905|NCT03276728|468959318|FG000|Overall Study|Withdrawal by Subject|0|||
130271906|NCT03276728|468959319|FG001|Overall Study|Withdrawal by Subject|0|||
130271907|NCT03276728|468959320|FG002|Overall Study|Withdrawal by Subject|0|||
130271908|NCT03276728|468959321|FG003|Overall Study|Withdrawal by Subject|3|||
130271909|NCT03276728|468959322|FG004|Overall Study|Withdrawal by Subject|0|||
130271910|NCT03276728|468959323|FG005|Overall Study|Withdrawal by Subject|0|||
130271911|NCT03276728|468959324|FG006|Overall Study|Withdrawal by Subject|0|||
130271912|NCT03276728|468959325|FG007|Overall Study|Withdrawal by Subject|0|||
130271913|NCT03276728|468959318|FG000|Overall Study|Decision by sponsor|0|||
130271914|NCT03276728|468959319|FG001|Overall Study|Decision by sponsor|0|||
130271915|NCT03276728|468959320|FG002|Overall Study|Decision by sponsor|0|||
130271916|NCT03276728|468959321|FG003|Overall Study|Decision by sponsor|0|||
130271917|NCT03276728|468959322|FG004|Overall Study|Decision by sponsor|1|||
130271918|NCT03276728|468959323|FG005|Overall Study|Decision by sponsor|0|||
130271919|NCT03276728|468959324|FG006|Overall Study|Decision by sponsor|2|||
130271920|NCT03276728|468959325|FG007|Overall Study|Decision by sponsor|1|||
130271921|NCT03941873|468959332|FG000|Overall Study|Death|0|||
130271922|NCT03941873|468959333|FG001|Overall Study|Death|12|||
130271923|NCT03941873|468959334|FG002|Overall Study|Death|2|||
130271924|NCT03941873|468959335|FG003|Overall Study|Death|53|||
130271925|NCT03941873|468959332|FG000|Overall Study|Withdrawal by Subject|1|||
130271926|NCT03941873|468959333|FG001|Overall Study|Withdrawal by Subject|1|||
130271927|NCT03941873|468959334|FG002|Overall Study|Withdrawal by Subject|0|||
130271928|NCT03941873|468959335|FG003|Overall Study|Withdrawal by Subject|5|||
130271929|NCT03941873|468959332|FG000|Overall Study|Lost to Follow-up|1|||
130271930|NCT03941873|468959333|FG001|Overall Study|Lost to Follow-up|2|||
130271931|NCT03941873|468959334|FG002|Overall Study|Lost to Follow-up|0|||
130271932|NCT03941873|468959335|FG003|Overall Study|Lost to Follow-up|0|||
130271933|NCT03941873|468959332|FG000|Overall Study|Sponsor Decision|0|||
130271934|NCT03941873|468959333|FG001|Overall Study|Sponsor Decision|6|||
130271935|NCT03941873|468959334|FG002|Overall Study|Sponsor Decision|0|||
130271936|NCT03941873|468959335|FG003|Overall Study|Sponsor Decision|15|||
130271937|NCT02982772|468959338|FG000|Intervention|Lost to Follow-up|19|||
130271938|NCT02982772|468959339|FG001|Intervention|Lost to Follow-up|13|||
130271939|NCT02982772|468959338|FG000|1M Follow-Up|Lost to Follow-up|21|||
130271940|NCT02982772|468959339|FG001|1M Follow-Up|Lost to Follow-up|18|||
130271941|NCT02982772|468959338|FG000|3M Follow-Up|Lost to Follow-up|17|||
130271942|NCT02982772|468959339|FG001|3M Follow-Up|Lost to Follow-up|11|||
130271943|NCT02982772|468959338|FG000|6M Follow-Up|Lost to Follow-up|11|||
130271944|NCT02982772|468959339|FG001|6M Follow-Up|Lost to Follow-up|9|||
130271945|NCT02982772|468959338|FG000|12M Follow-Up|Lost to Follow-up|11|||
130271946|NCT02982772|468959339|FG001|12M Follow-Up|Lost to Follow-up|5|||
130271947|NCT01234480|468959340|FG000|Overall Study|Pregnancy|88|||
130271948|NCT01234480|468959340|FG000|Overall Study|>36/Normal History|50|||
130271949|NCT01234480|468959340|FG000|Overall Study|Age|3|||
130271950|NCT01234480|468959340|FG000|Overall Study|HPV Vaccine History|28|||
130037813|NCT01324830|468094727|FG003|Overall Study|Reason not mentioned above|0|||
130037814|NCT01324830|468094728|FG004|Overall Study|Reason not mentioned above|0|||
130103955|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103956|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130037815|NCT01324830|468094729|FG005|Overall Study|Reason not mentioned above|0|||
130271951|NCT01234480|468959340|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
130271952|NCT01234480|468959340|FG000|Overall Study|Hysterectomy|2|||
130037816|NCT01324830|468094730|FG006|Overall Study|Reason not mentioned above|0|||
130271953|NCT01234480|468959340|FG000|Overall Study|Hysterectomy post enrollment|1|||
130271954|NCT01234480|468959340|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
130271955|NCT01234480|468959340|FG000|Overall Study|Informed Consent Form Violation|30|||
130271956|NCT01234480|468959340|FG000|Overall Study|Incorrect Visit|3|||
130271957|NCT01234480|468959340|FG000|Overall Study|No Florida Lab License|20|||
130271958|NCT01234480|468959340|FG000|Overall Study|Out of Window|42|||
130271959|NCT01234480|468959340|FG000|Overall Study|Sample Processing/Storage|92|||
130271960|NCT01234480|468959340|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
130271961|NCT01234480|468959340|FG000|Overall Study|Site/Subject non-compliance|44|||
130271962|NCT01234480|468959340|FG000|Overall Study|Missing Sample|9|||
130271963|NCT02974140|468959341|FG000|Overall Study|Adverse Event|2|||
130037817|NCT01324830|468094731|FG007|Overall Study|Reason not mentioned above|0|||
130037818|NCT01324830|468094732|FG008|Overall Study|Reason not mentioned above|0|||
130037819|NCT01324830|468094733|FG009|Overall Study|Reason not mentioned above|0|||
130037820|NCT01324830|468094734|FG010|Overall Study|Reason not mentioned above|0|||
130037821|NCT01324830|468094735|FG011|Overall Study|Reason not mentioned above|0|||
130037822|NCT01324830|468094736|FG012|Overall Study|Reason not mentioned above|0|||
130037823|NCT01324830|468094737|FG013|Overall Study|Reason not mentioned above|0|||
130037824|NCT01324830|468094738|FG014|Overall Study|Reason not mentioned above|0|||
130037825|NCT01324830|468094739|FG015|Overall Study|Reason not mentioned above|0|||
130037826|NCT01324830|468094740|FG016|Overall Study|Reason not mentioned above|0|||
130037827|NCT01324830|468094741|FG017|Overall Study|Reason not mentioned above|1|||
130037828|NCT01324830|468094742|FG018|Overall Study|Reason not mentioned above|0|||
130037829|NCT01324830|468094724|FG000|Overall Study|Adverse Event, serious fatal|0|||
130037830|NCT01324830|468094725|FG001|Overall Study|Adverse Event, serious fatal|1|||
130103957|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103958|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130271964|NCT02974140|468959341|FG000|Overall Study|Lost to Follow-up|1|||
130271965|NCT02974140|468959341|FG000|Overall Study|Study Terminated by Sponsor|36|||
130271966|NCT00617084|468959342|FG000|Overall Study|Withdrawal by Subject|5|||
130271967|NCT00617084|468959343|FG001|Overall Study|Withdrawal by Subject|7|||
130271968|NCT00617084|468959342|FG000|Overall Study|Missed 12 Months visit|16|||
130271969|NCT00617084|468959343|FG001|Overall Study|Missed 12 Months visit|19|||
130271970|NCT02522429|468959344|FG000|Overall Study|Lost to Follow-up|8|||
130271971|NCT02522429|468959344|FG000|Overall Study|Adverse Event|2|||
130271972|NCT02522429|468959344|FG000|Overall Study|Death|1|||
130271973|NCT02522429|468959344|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
130271974|NCT01521923|468959350|FG000|Overall Study|AE, serious fatal|1|||
130271975|NCT01521923|468959351|FG001|Overall Study|AE, serious fatal|0|||
130271976|NCT01521923|468959352|FG002|Overall Study|AE, serious fatal|0|||
130271977|NCT01521923|468959353|FG003|Overall Study|AE, serious fatal|0|||
130271978|NCT01521923|468959350|FG000|Overall Study|SAE, non-fatal|0|||
130271979|NCT01521923|468959351|FG001|Overall Study|SAE, non-fatal|2|||
130271980|NCT01521923|468959352|FG002|Overall Study|SAE, non-fatal|2|||
130271981|NCT01521923|468959353|FG003|Overall Study|SAE, non-fatal|0|||
130271982|NCT01521923|468959350|FG000|Overall Study|AE, non-serious, non-fatal|1|||
130271983|NCT01521923|468959351|FG001|Overall Study|AE, non-serious, non-fatal|3|||
130271984|NCT01521923|468959352|FG002|Overall Study|AE, non-serious, non-fatal|6|||
130271985|NCT01521923|468959353|FG003|Overall Study|AE, non-serious, non-fatal|2|||
130271986|NCT01521923|468959350|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130271987|NCT01521923|468959351|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130271988|NCT01521923|468959352|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
130271989|NCT01521923|468959353|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
130271990|NCT01521923|468959350|FG000|Overall Study|Lack of Efficacy|1|||
130271991|NCT01521923|468959351|FG001|Overall Study|Lack of Efficacy|1|||
130271992|NCT01521923|468959352|FG002|Overall Study|Lack of Efficacy|0|||
130037831|NCT01324830|468094726|FG002|Overall Study|Adverse Event, serious fatal|0|||
130271993|NCT01521923|468959353|FG003|Overall Study|Lack of Efficacy|0|||
130271994|NCT01521923|468959350|FG000|Overall Study|Protocol Violation|0|||
130037832|NCT01324830|468094727|FG003|Overall Study|Adverse Event, serious fatal|0|||
130037833|NCT01324830|468094728|FG004|Overall Study|Adverse Event, serious fatal|0|||
130271995|NCT01521923|468959351|FG001|Overall Study|Protocol Violation|0|||
130271996|NCT01521923|468959352|FG002|Overall Study|Protocol Violation|1|||
130271997|NCT01521923|468959353|FG003|Overall Study|Protocol Violation|0|||
130271998|NCT01521923|468959350|FG000|Overall Study|Lost to Follow-up|1|||
130271999|NCT01521923|468959351|FG001|Overall Study|Lost to Follow-up|0|||
130272000|NCT01521923|468959352|FG002|Overall Study|Lost to Follow-up|2|||
130272001|NCT01521923|468959353|FG003|Overall Study|Lost to Follow-up|1|||
130272002|NCT01521923|468959350|FG000|Overall Study|Withdrawal by Subject|1|||
130272003|NCT01521923|468959351|FG001|Overall Study|Withdrawal by Subject|1|||
130272004|NCT01521923|468959352|FG002|Overall Study|Withdrawal by Subject|1|||
130272005|NCT01521923|468959353|FG003|Overall Study|Withdrawal by Subject|2|||
130272006|NCT01521923|468959350|FG000|Overall Study|Other|2|||
130272007|NCT01521923|468959351|FG001|Overall Study|Other|1|||
130272008|NCT01521923|468959352|FG002|Overall Study|Other|3|||
130272009|NCT01521923|468959353|FG003|Overall Study|Other|6|||
130272010|NCT01521923|468959350|FG000|Overall Study|AE, captured in Period 1|0|||
130272011|NCT01521923|468959351|FG001|Overall Study|AE, captured in Period 1|1|||
130272012|NCT01521923|468959352|FG002|Overall Study|AE, captured in Period 1|0|||
130272013|NCT01521923|468959353|FG003|Overall Study|AE, captured in Period 1|1|||
130272014|NCT01279044|468959354|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
130272015|NCT01279044|468959355|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
130272016|NCT01279044|468959356|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
130272017|NCT01279044|468959354|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
130272018|NCT01279044|468959355|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
130272019|NCT01279044|468959356|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
130272020|NCT01279044|468959354|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
130272021|NCT01279044|468959355|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
130272022|NCT01279044|468959356|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
130272023|NCT01582009|468959357|FG000|Overall Study|Withdrawal by Subject|1|||
130272024|NCT01582009|468959357|FG000|Overall Study|Physician Decision|1|||
130272025|NCT01665911|468959358|FG000|Overall Study|Protocol Violation|4|||
130272026|NCT01665911|468959358|FG000|Overall Study|Withdrawal by Subject|1|||
130272027|NCT01665911|468959358|FG000|Overall Study|Adverse Event|1|||
130272028|NCT00735553|468959359|FG000|Overall Study|Study prematurely terminated|77|||
130272029|NCT03726658|468959365|FG000|Overall Study|Lost to Follow-up|0|||
130272030|NCT03726658|468959366|FG001|Overall Study|Lost to Follow-up|0|||
130272031|NCT03726658|468959367|FG002|Overall Study|Lost to Follow-up|2|||
130272032|NCT03726658|468959368|FG003|Overall Study|Lost to Follow-up|0|||
130272033|NCT03726658|468959369|FG004|Overall Study|Lost to Follow-up|0|||
130272034|NCT03726658|468959370|FG005|Overall Study|Lost to Follow-up|1|||
130272035|NCT03726658|468959371|FG006|Overall Study|Lost to Follow-up|1|||
130272036|NCT03726658|468959365|FG000|Overall Study|Withdrawal by Subject|1|||
130272037|NCT03726658|468959366|FG001|Overall Study|Withdrawal by Subject|0|||
130272038|NCT03726658|468959367|FG002|Overall Study|Withdrawal by Subject|0|||
130272039|NCT03726658|468959368|FG003|Overall Study|Withdrawal by Subject|0|||
130272040|NCT03726658|468959369|FG004|Overall Study|Withdrawal by Subject|6|||
130272041|NCT03726658|468959370|FG005|Overall Study|Withdrawal by Subject|4|||
130272042|NCT03726658|468959371|FG006|Overall Study|Withdrawal by Subject|2|||
130272043|NCT03726658|468959365|FG000|Overall Study|Pregnancy|0|||
130272044|NCT03726658|468959366|FG001|Overall Study|Pregnancy|0|||
130272045|NCT03726658|468959367|FG002|Overall Study|Pregnancy|0|||
130272046|NCT03726658|468959368|FG003|Overall Study|Pregnancy|0|||
130272047|NCT03726658|468959369|FG004|Overall Study|Pregnancy|0|||
130272048|NCT03726658|468959370|FG005|Overall Study|Pregnancy|0|||
130272049|NCT03726658|468959371|FG006|Overall Study|Pregnancy|1|||
130272050|NCT03726658|468959365|FG000|Overall Study|Not Reported|0|||
130272051|NCT03726658|468959366|FG001|Overall Study|Not Reported|0|||
130272052|NCT03726658|468959367|FG002|Overall Study|Not Reported|0|||
130272053|NCT03726658|468959368|FG003|Overall Study|Not Reported|0|||
130272054|NCT03726658|468959369|FG004|Overall Study|Not Reported|0|||
130272055|NCT03726658|468959370|FG005|Overall Study|Not Reported|0|||
130272056|NCT03726658|468959371|FG006|Overall Study|Not Reported|1|||
130272057|NCT01318135|468959372|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
130272058|NCT01318135|468959373|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272059|NCT01318135|468959374|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272060|NCT01318135|468959375|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130103959|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
130272061|NCT01318135|468959376|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272062|NCT01318135|468959377|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272063|NCT01318135|468959378|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130103960|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103961|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103962|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103963|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130103964|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103965|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103966|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103967|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
130037834|NCT01324830|468094729|FG005|Overall Study|Adverse Event, serious fatal|0|||
130037835|NCT01324830|468094730|FG006|Overall Study|Adverse Event, serious fatal|0|||
130037836|NCT01324830|468094731|FG007|Overall Study|Adverse Event, serious fatal|0|||
130037837|NCT01324830|468094732|FG008|Overall Study|Adverse Event, serious fatal|0|||
130037838|NCT01324830|468094733|FG009|Overall Study|Adverse Event, serious fatal|0|||
130037839|NCT01324830|468094734|FG010|Overall Study|Adverse Event, serious fatal|0|||
130103968|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130103969|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
130103970|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130103971|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
130103972|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
130103973|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130103974|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103975|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103976|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103977|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103978|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130103979|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103980|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103981|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103982|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103983|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103984|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103985|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103986|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103987|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
130103988|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130037840|NCT01324830|468094735|FG011|Overall Study|Adverse Event, serious fatal|0|||
130037841|NCT01324830|468094736|FG012|Overall Study|Adverse Event, serious fatal|0|||
130037842|NCT01324830|468094737|FG013|Overall Study|Adverse Event, serious fatal|0|||
130037843|NCT01324830|468094738|FG014|Overall Study|Adverse Event, serious fatal|0|||
130037844|NCT01324830|468094739|FG015|Overall Study|Adverse Event, serious fatal|0|||
130037845|NCT01324830|468094740|FG016|Overall Study|Adverse Event, serious fatal|0|||
130037846|NCT01324830|468094741|FG017|Overall Study|Adverse Event, serious fatal|0|||
130037847|NCT01324830|468094742|FG018|Overall Study|Adverse Event, serious fatal|0|||
130037848|NCT01324830|468094724|FG000|Overall Study|Adverse Event, non-fatal|0|||
130037849|NCT01324830|468094725|FG001|Overall Study|Adverse Event, non-fatal|0|||
130037850|NCT01324830|468094726|FG002|Overall Study|Adverse Event, non-fatal|0|||
130037851|NCT01324830|468094727|FG003|Overall Study|Adverse Event, non-fatal|0|||
130037852|NCT01324830|468094728|FG004|Overall Study|Adverse Event, non-fatal|0|||
130037853|NCT01324830|468094729|FG005|Overall Study|Adverse Event, non-fatal|0|||
130037854|NCT01324830|468094730|FG006|Overall Study|Adverse Event, non-fatal|0|||
130037855|NCT01324830|468094731|FG007|Overall Study|Adverse Event, non-fatal|0|||
130037856|NCT01324830|468094732|FG008|Overall Study|Adverse Event, non-fatal|2|||
130037857|NCT01324830|468094733|FG009|Overall Study|Adverse Event, non-fatal|0|||
130037858|NCT01324830|468094734|FG010|Overall Study|Adverse Event, non-fatal|1|||
130037859|NCT01324830|468094735|FG011|Overall Study|Adverse Event, non-fatal|0|||
130037860|NCT01324830|468094736|FG012|Overall Study|Adverse Event, non-fatal|0|||
130037861|NCT01324830|468094737|FG013|Overall Study|Adverse Event, non-fatal|0|||
130272064|NCT01318135|468959379|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
130272065|NCT01318135|468959372|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
130272066|NCT01318135|468959373|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272067|NCT01318135|468959374|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272068|NCT01318135|468959375|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272069|NCT01318135|468959376|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272070|NCT01318135|468959377|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272071|NCT01318135|468959378|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272072|NCT01318135|468959379|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
130272073|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
130272074|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
130272075|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
130272076|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
130272077|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
130272078|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
130272079|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
130272080|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
130272081|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
130272082|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
130272083|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272084|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272085|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
130272086|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272087|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272088|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
130272089|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272090|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272091|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272092|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130272093|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
130272094|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130272095|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
130272096|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
130272097|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
130272098|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
130272099|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130272100|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
130272101|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130272102|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
130272103|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130272104|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
130272105|NCT01318135|468959372|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272106|NCT01318135|468959373|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272107|NCT01318135|468959374|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272108|NCT01318135|468959375|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272109|NCT01318135|468959376|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272110|NCT01318135|468959377|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272111|NCT01318135|468959378|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
130272112|NCT01318135|468959379|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
130272113|NCT00090779|468959380|FG000|Step 1|Withdrawal by Subject|4|||
130272114|NCT00090779|468959381|FG001|Step 1|Withdrawal by Subject|2|||
130272115|NCT00090779|468959380|FG000|Step 1|Lost to Follow-up|3|||
130272116|NCT00090779|468959381|FG001|Step 1|Lost to Follow-up|2|||
130272117|NCT00090779|468959380|FG000|Step 1|Death|0|||
130272118|NCT00090779|468959381|FG001|Step 1|Death|2|||
130272119|NCT00090779|468959380|FG000|Step 1|Physician Decision|1|||
130272120|NCT00090779|468959381|FG001|Step 1|Physician Decision|0|||
130272121|NCT00090779|468959380|FG000|Step 1|Pregnancy|1|||
130272122|NCT00090779|468959381|FG001|Step 1|Pregnancy|0|||
130272123|NCT00090779|468959380|FG000|Step 1|Non-compliance to study requirements|0|||
130272124|NCT00090779|468959381|FG001|Step 1|Non-compliance to study requirements|1|||
130272125|NCT00090779|468959380|FG000|Step 1|Subject relocated|2|||
130103989|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103990|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
130103991|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
130103992|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103993|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103994|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103995|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103996|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103997|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103998|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130103999|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130037862|NCT01324830|468094738|FG014|Overall Study|Adverse Event, non-fatal|0|||
130037863|NCT01324830|468094739|FG015|Overall Study|Adverse Event, non-fatal|0|||
130037864|NCT01324830|468094740|FG016|Overall Study|Adverse Event, non-fatal|0|||
130037865|NCT01324830|468094741|FG017|Overall Study|Adverse Event, non-fatal|1|||
130037866|NCT01324830|468094742|FG018|Overall Study|Adverse Event, non-fatal|0|||
130037867|NCT01324830|468094724|FG000|Overall Study|Withdrawal by Subject|0|||
130037868|NCT01324830|468094725|FG001|Overall Study|Withdrawal by Subject|0|||
130037869|NCT01324830|468094726|FG002|Overall Study|Withdrawal by Subject|0|||
130037870|NCT01324830|468094727|FG003|Overall Study|Withdrawal by Subject|0|||
130037871|NCT01324830|468094728|FG004|Overall Study|Withdrawal by Subject|0|||
130037872|NCT01324830|468094729|FG005|Overall Study|Withdrawal by Subject|1|||
130037873|NCT01324830|468094730|FG006|Overall Study|Withdrawal by Subject|0|||
130037874|NCT01324830|468094731|FG007|Overall Study|Withdrawal by Subject|0|||
130037875|NCT01324830|468094732|FG008|Overall Study|Withdrawal by Subject|0|||
130037876|NCT01324830|468094733|FG009|Overall Study|Withdrawal by Subject|0|||
130037877|NCT01324830|468094734|FG010|Overall Study|Withdrawal by Subject|1|||
130037878|NCT01324830|468094735|FG011|Overall Study|Withdrawal by Subject|0|||
130037879|NCT01324830|468094736|FG012|Overall Study|Withdrawal by Subject|0|||
130037880|NCT01324830|468094737|FG013|Overall Study|Withdrawal by Subject|0|||
130037881|NCT01324830|468094738|FG014|Overall Study|Withdrawal by Subject|0|||
130037882|NCT01324830|468094739|FG015|Overall Study|Withdrawal by Subject|0|||
130104000|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104001|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104002|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130104003|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104004|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104005|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130104006|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104007|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104008|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130104009|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
130104010|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
130104011|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130104012|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
130104013|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130104014|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130104015|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130272126|NCT00090779|468959381|FG001|Step 1|Subject relocated|8|||
130272127|NCT00090779|468959380|FG000|Step 2|Off study per study closure|6|||
130272128|NCT00090779|468959381|FG001|Step 2|Off study per study closure|16|||
130272129|NCT00090779|468959380|FG000|Step 2|Subject relocated|0|||
130272130|NCT00090779|468959381|FG001|Step 2|Subject relocated|1|||
130272131|NCT00090779|468959380|FG000|Step 2|Non-compliance to study requirements|0|||
130272132|NCT00090779|468959381|FG001|Step 2|Non-compliance to study requirements|1|||
130272133|NCT00090779|468959380|FG000|Step 3|Initiation of ART and off extended study|3|||
130272134|NCT00090779|468959381|FG001|Step 3|Initiation of ART and off extended study|2|||
130272135|NCT00090779|468959380|FG000|Step 3|Off extended study due to study closure|4|||
130272136|NCT00090779|468959381|FG001|Step 3|Off extended study due to study closure|3|||
130272137|NCT01775553|468959386|FG000|Overall Study|Adverse Event|1|||
130272138|NCT01775553|468959386|FG000|Overall Study|Disease Progression|12|||
130272139|NCT00988052|468959387|FG000|Overall Study|Missing|1|||
130272140|NCT00988052|468959388|FG001|Overall Study|Missing|0|||
130272141|NCT00988052|468959387|FG000|Overall Study|Teva requested subject withdrawal|3|||
130272142|NCT00988052|468959388|FG001|Overall Study|Teva requested subject withdrawal|1|||
130272143|NCT00988052|468959387|FG000|Overall Study|Death|1|||
130104016|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130104017|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130104018|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130104019|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130272144|NCT00988052|468959388|FG001|Overall Study|Death|3|||
130272145|NCT00988052|468959387|FG000|Overall Study|Protocol Violation|6|||
130272146|NCT00988052|468959388|FG001|Overall Study|Protocol Violation|5|||
130272147|NCT00988052|468959387|FG000|Overall Study|Pregnancy|6|||
130272148|NCT00988052|468959388|FG001|Overall Study|Pregnancy|6|||
130272149|NCT00988052|468959387|FG000|Overall Study|Lack of Efficacy|8|||
130272150|NCT00988052|468959388|FG001|Overall Study|Lack of Efficacy|7|||
130272151|NCT00988052|468959387|FG000|Overall Study|Lost to Follow-up|6|||
130272152|NCT00988052|468959388|FG001|Overall Study|Lost to Follow-up|11|||
130272153|NCT00988052|468959387|FG000|Overall Study|Physician Decision|27|||
130272154|NCT00988052|468959388|FG001|Overall Study|Physician Decision|28|||
130272155|NCT00988052|468959387|FG000|Overall Study|Adverse Event|35|||
130272156|NCT00988052|468959388|FG001|Overall Study|Adverse Event|28|||
130272157|NCT00988052|468959387|FG000|Overall Study|Withdrawal by Subject|90|||
130272158|NCT00988052|468959388|FG001|Overall Study|Withdrawal by Subject|91|||
130272159|NCT00988052|468959387|FG000|Overall Study|Study terminated by sponsor|240|||
130272160|NCT00988052|468959388|FG001|Overall Study|Study terminated by sponsor|236|||
130272161|NCT01523743|468959389|FG000|Period 1|Adverse Event|1|||
130272162|NCT01523743|468959390|FG001|Period 1|Adverse Event|0|||
130272163|NCT01523743|468959389|FG000|Period 1|Withdrawal by Subject|6|||
130272164|NCT01523743|468959390|FG001|Period 1|Withdrawal by Subject|2|||
130272165|NCT01523743|468959389|FG000|Period 1|Lost to Follow-up|1|||
130272166|NCT01523743|468959390|FG001|Period 1|Lost to Follow-up|0|||
130272167|NCT01523743|468959389|FG000|Period 1|Lack of Efficacy|1|||
130272168|NCT01523743|468959390|FG001|Period 1|Lack of Efficacy|0|||
130272169|NCT01523743|468959389|FG000|Period 1|Felt unable to empty bladder|1|||
130272170|NCT01523743|468959390|FG001|Period 1|Felt unable to empty bladder|0|||
130272171|NCT01523743|468959389|FG000|Period 2|Withdrawal by Subject|0|||
130272172|NCT01523743|468959390|FG001|Period 2|Withdrawal by Subject|2|||
129886085|NCT02564055|467542852|FG005|Overall Study|Protocol Violation|0|||
130272173|NCT01523743|468959389|FG000|Period 2|Adverse Event|1|||
130272174|NCT01523743|468959390|FG001|Period 2|Adverse Event|0|||
130272175|NCT02569476|468959391|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
130272176|NCT02569476|468959391|FG000|Overall Study|Death|33|||
130272177|NCT02569476|468959391|FG000|Overall Study|Withdrawal by Subject|9|||
130272178|NCT02569476|468959391|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
130037883|NCT01324830|468094740|FG016|Overall Study|Withdrawal by Subject|0|||
130037884|NCT01324830|468094741|FG017|Overall Study|Withdrawal by Subject|0|||
130037885|NCT01324830|468094742|FG018|Overall Study|Withdrawal by Subject|1|||
130037886|NCT01485614|468094743|FG000|Randomization|Not Treated|1|||
130037887|NCT01485614|468094744|FG001|Randomization|Not Treated|0|||
130037888|NCT01485614|468094745|FG002|Randomization|Not Treated|0|||
130037889|NCT01485614|468094746|FG003|Randomization|Not Treated|0|||
130037890|NCT01485614|468094743|FG000|Weeks 0-20|Lost to Follow-up|2|||
130272179|NCT02569476|468959391|FG000|Overall Study|Palliative care|1|||
130272180|NCT02569476|468959391|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
130272181|NCT02569476|468959391|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
130272182|NCT01434654|468959392|FG000|Overall Study|Withdrawal by Subject|1|||
130272183|NCT01434654|468959393|FG001|Overall Study|Withdrawal by Subject|0|||
130272184|NCT01434654|468959392|FG000|Overall Study|Lost to Follow-up|1|||
130272185|NCT01434654|468959393|FG001|Overall Study|Lost to Follow-up|0|||
130272186|NCT03782064|468959394|FG000|Overall Study|Lack of Efficacy|2|||
130272187|NCT03782064|468959394|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
130272188|NCT02446769|468959397|FG000|Screening Period|Screen Failure|11|||
130272189|NCT02446769|468959398|FG001|Screening Period|Screen Failure|0|||
130272190|NCT02446769|468959399|FG002|Screening Period|Screen Failure|0|||
130272191|NCT02446769|468959397|FG000|Study Period|Randomized in Error|0|||
130272192|NCT02446769|468959398|FG001|Study Period|Randomized in Error|2|||
130272193|NCT02446769|468959399|FG002|Study Period|Randomized in Error|0|||
130272194|NCT00703963|468959400|FG000|Overall Study|Withdrawal by Subject|7|||
130272195|NCT00703963|468959401|FG001|Overall Study|Withdrawal by Subject|13|||
130272196|NCT00703963|468959400|FG000|Overall Study|Physician Decision|0|||
130272197|NCT00703963|468959401|FG001|Overall Study|Physician Decision|1|||
130272198|NCT00645840|468959402|FG000|Overall Study|Protocol Violation|3|||
130272199|NCT00402324|468959403|FG000|Overall Study|Lost to Follow-up|11|||
130272200|NCT00402324|468959404|FG001|Overall Study|Lost to Follow-up|11|||
130272201|NCT00402324|468959403|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
130272202|NCT00402324|468959404|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
130272203|NCT00402324|468959403|FG000|Overall Study|Protocol Violation|8|||
130272204|NCT00402324|468959404|FG001|Overall Study|Protocol Violation|7|||
130272205|NCT00402324|468959403|FG000|Overall Study|Withdrawal by Subject|5|||
130272206|NCT00402324|468959404|FG001|Overall Study|Withdrawal by Subject|2|||
130272207|NCT00402324|468959403|FG000|Overall Study|Physician Decision|2|||
130272208|NCT00402324|468959404|FG001|Overall Study|Physician Decision|4|||
130272209|NCT00402324|468959403|FG000|Overall Study|Sponsor Decision|4|||
130272210|NCT00402324|468959404|FG001|Overall Study|Sponsor Decision|5|||
130272211|NCT00402324|468959403|FG000|Overall Study|Lack of Efficacy|1|||
130272212|NCT00402324|468959404|FG001|Overall Study|Lack of Efficacy|4|||
130272213|NCT00402324|468959403|FG000|Overall Study|Adverse Event|6|||
130272214|NCT00402324|468959404|FG001|Overall Study|Adverse Event|4|||
130272215|NCT00402324|468959403|FG000|Overall Study|Death|1|||
129886086|NCT02564055|467542847|FG000|Overall Study|Reached stopping criteria|0|||
130037891|NCT01485614|468094744|FG001|Weeks 0-20|Lost to Follow-up|0|||
130037892|NCT01485614|468094745|FG002|Weeks 0-20|Lost to Follow-up|0|||
130037893|NCT01485614|468094746|FG003|Weeks 0-20|Lost to Follow-up|0|||
130272216|NCT00402324|468959404|FG001|Overall Study|Death|0|||
130272217|NCT02625220|468959405|FG000|Overall Study|Adverse Event|2|||
130272218|NCT02625220|468959405|FG000|Overall Study|Lost to Follow-up|2|||
130272219|NCT02625220|468959405|FG000|Overall Study|Protocol Violation|1|||
130272220|NCT02625220|468959405|FG000|Overall Study|Study discontinued at site|2|||
130037894|NCT01485614|468094743|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
130037895|NCT01485614|468094744|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
130272221|NCT04599803|468959408|FG000|Overall Study|Withdrawal by Subject|5|||
130272222|NCT04599803|468959408|FG000|Overall Study|Lost to Follow-up|26|||
130272223|NCT02484443|468959409|FG000|Overall Study|Lack of Efficacy|28|||
130272224|NCT02484443|468959409|FG000|Overall Study|Physician Decision|2|||
130272225|NCT02484443|468959409|FG000|Overall Study|Ineligible|2|||
130272226|NCT04677543|468959410|FG000|Overall Study|Withdrawal by Subject|4|||
130272227|NCT04677543|468959411|FG001|Overall Study|Withdrawal by Subject|1|||
130272228|NCT04677543|468959410|FG000|Overall Study|Physician Decision|0|||
130272229|NCT04677543|468959411|FG001|Overall Study|Physician Decision|1|||
130272230|NCT04677543|468959410|FG000|Overall Study|Adverse Event|0|||
130272231|NCT04677543|468959411|FG001|Overall Study|Adverse Event|1|||
130272232|NCT03799952|468959412|FG000|Overall Study|Program was too easy, discontinued|1|||
130272233|NCT03799952|468959413|FG001|Overall Study|Program was too easy, discontinued|0|||
130272234|NCT03799952|468959412|FG000|Overall Study|Lost to Follow-up|0|||
130272235|NCT03799952|468959413|FG001|Overall Study|Lost to Follow-up|2|||
130272236|NCT02595866|468959414|FG000|Overall Study|Adverse Event|2|||
130272237|NCT02595866|468959415|FG001|Overall Study|Adverse Event|5|||
130272238|NCT02595866|468959414|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
130272239|NCT02595866|468959415|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
130272240|NCT02595866|468959414|FG000|Overall Study|Death|0|||
130272241|NCT02595866|468959415|FG001|Overall Study|Death|1|||
130272242|NCT02595866|468959414|FG000|Overall Study|Incarceration|1|||
130272243|NCT02595866|468959415|FG001|Overall Study|Incarceration|0|||
130272244|NCT02595866|468959414|FG000|Overall Study|Lack of Efficacy|17|||
130272245|NCT02595866|468959415|FG001|Overall Study|Lack of Efficacy|7|||
130272246|NCT02595866|468959414|FG000|Overall Study|Physician Decision|4|||
130272247|NCT02595866|468959415|FG001|Overall Study|Physician Decision|3|||
130272248|NCT02595866|468959414|FG000|Overall Study|Switched to Alternative Treatment|1|||
130272249|NCT02595866|468959415|FG001|Overall Study|Switched to Alternative Treatment|0|||
130272250|NCT02595866|468959414|FG000|Overall Study|Study Terminated|0|||
130272251|NCT02595866|468959415|FG001|Overall Study|Study Terminated|4|||
130272252|NCT02595866|468959414|FG000|Overall Study|Withdrawal by Subject|6|||
130272253|NCT02595866|468959415|FG001|Overall Study|Withdrawal by Subject|1|||
130272254|NCT02520388|468959416|FG000|Overall Study|Physician Decision|1|||
130272255|NCT02520388|468959417|FG001|Overall Study|Physician Decision|0|||
130272256|NCT02520388|468959416|FG000|Overall Study|Subject or parent/guardian request|0|||
130272257|NCT02520388|468959417|FG001|Overall Study|Subject or parent/guardian request|6|||
130272258|NCT02520388|468959416|FG000|Overall Study|Adverse Event|1|||
130272259|NCT02520388|468959417|FG001|Overall Study|Adverse Event|4|||
130272260|NCT02520388|468959416|FG000|Overall Study|Lost to Follow-up|3|||
130272261|NCT02520388|468959417|FG001|Overall Study|Lost to Follow-up|2|||
130272262|NCT02520388|468959416|FG000|Overall Study|Other (reason not defined)|4|||
130272263|NCT02520388|468959417|FG001|Overall Study|Other (reason not defined)|4|||
130272264|NCT03035864|468959421|FG000|Treatment Period|Adverse Event|1|||
130272265|NCT03035864|468959422|FG001|Treatment Period|Adverse Event|0|||
130272266|NCT03035864|468959421|FG000|Treatment Period|Other|3|||
130272267|NCT03035864|468959422|FG001|Treatment Period|Other|1|||
130272268|NCT03035864|468959421|FG000|Follow-up Period|Adverse Event|1|||
130272269|NCT03035864|468959422|FG001|Follow-up Period|Adverse Event|0|||
130272270|NCT03035864|468959421|FG000|Follow-up Period|Lost to Follow-up|6|||
130272271|NCT03035864|468959422|FG001|Follow-up Period|Lost to Follow-up|2|||
130272272|NCT03035864|468959421|FG000|Follow-up Period|Physician Decision|1|||
130272273|NCT03035864|468959422|FG001|Follow-up Period|Physician Decision|0|||
130272274|NCT03035864|468959421|FG000|Follow-up Period|Other|3|||
130272275|NCT03035864|468959422|FG001|Follow-up Period|Other|2|||
130272276|NCT02375373|468959423|FG000|Overall Study|Withdrawal by Subject|11|||
130272277|NCT00577707|468959424|FG000|Overall Study|Withdrawal by Subject|3|||
130272278|NCT03299244|468959425|FG000|Overall Study|Withdrawal by Subject|34|||
130272279|NCT03299244|468959426|FG001|Overall Study|Withdrawal by Subject|29|||
130272280|NCT03299244|468959425|FG000|Overall Study|Decision by Sponsor|4|||
130272281|NCT03299244|468959426|FG001|Overall Study|Decision by Sponsor|5|||
130272282|NCT03299244|468959425|FG000|Overall Study|Death|9|||
130272283|NCT03299244|468959426|FG001|Overall Study|Death|4|||
130272284|NCT00431444|468959427|FG000|Overall Study|Protocol Violation|1|||
130272285|NCT00431444|468959428|FG001|Overall Study|Protocol Violation|4|||
130272286|NCT00431444|468959427|FG000|Overall Study|Adverse Event|2|||
130272287|NCT00431444|468959428|FG001|Overall Study|Adverse Event|1|||
130272288|NCT00431444|468959427|FG000|Overall Study|Withdrawal by Subject|1|||
130272289|NCT00431444|468959428|FG001|Overall Study|Withdrawal by Subject|1|||
130272290|NCT00431444|468959427|FG000|Overall Study|Lost to Follow-up|1|||
130272291|NCT00431444|468959428|FG001|Overall Study|Lost to Follow-up|0|||
130272292|NCT00431444|468959427|FG000|Overall Study|Administrative Problems|0|||
130272293|NCT00431444|468959428|FG001|Overall Study|Administrative Problems|1|||
130272294|NCT01603043|468959429|FG000|Overall Study|Study Futility|7|||
130272295|NCT01603043|468959430|FG001|Overall Study|Study Futility|3|||
130272296|NCT00642707|468959445|FG000|Overall Study|Adverse Event|0|||
130272297|NCT00642707|468959446|FG001|Overall Study|Adverse Event|0|||
130272298|NCT00642707|468959447|FG002|Overall Study|Adverse Event|0|||
130272299|NCT00642707|468959448|FG003|Overall Study|Adverse Event|2|||
130272300|NCT00642707|468959445|FG000|Overall Study|Withdrawal by Subject|1|||
130272301|NCT00642707|468959446|FG001|Overall Study|Withdrawal by Subject|0|||
130272302|NCT00642707|468959447|FG002|Overall Study|Withdrawal by Subject|0|||
130272303|NCT00642707|468959448|FG003|Overall Study|Withdrawal by Subject|0|||
130272304|NCT01016132|468959449|FG000|Overall Study|Discomfort|1|||
130272305|NCT01451749|468959452|FG000|Overall Study|Protocol Violation|14|||
130272306|NCT01451749|468959453|FG001|Overall Study|Protocol Violation|7|||
130272307|NCT01451749|468959452|FG000|Overall Study|Lost to Follow-up|15|||
130272308|NCT01451749|468959453|FG001|Overall Study|Lost to Follow-up|5|||
130272309|NCT01451749|468959452|FG000|Overall Study|Meet the exclusion criteria,and|1|||
130272310|NCT01451749|468959453|FG001|Overall Study|Meet the exclusion criteria,and|1|||
130272311|NCT01451749|468959452|FG000|Overall Study|Adverse Event|2|||
130272312|NCT01451749|468959453|FG001|Overall Study|Adverse Event|0|||
130272313|NCT01451749|468959452|FG000|Overall Study|Withdrawal by Subject|0|||
130272314|NCT01451749|468959453|FG001|Overall Study|Withdrawal by Subject|1|||
130272315|NCT01198574|468959461|FG000|Overall Study|Resigned from schools|4|||
130272316|NCT01198574|468959462|FG001|Overall Study|Resigned from schools|1|||
130272317|NCT01198574|468959463|FG002|Overall Study|Resigned from schools|1|||
130037896|NCT01485614|468094745|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
130272318|NCT01198574|468959464|FG003|Overall Study|Resigned from schools|4|||
130272319|NCT00556439|468959494|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
130272320|NCT00556439|468959495|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
130272321|NCT00556439|468959496|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
130272322|NCT00556439|468959497|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
130272323|NCT00556439|468959494|FG000|Study Entry to Week 12|Physician Decision|1|||
130272324|NCT00556439|468959495|FG001|Study Entry to Week 12|Physician Decision|0|||
130272325|NCT00556439|468959496|FG002|Study Entry to Week 12|Physician Decision|0|||
130272326|NCT00556439|468959497|FG003|Study Entry to Week 12|Physician Decision|0|||
130272327|NCT00556439|468959494|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
130272328|NCT00556439|468959495|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
130272329|NCT00556439|468959496|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
130272330|NCT00556439|468959497|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
130272331|NCT00556439|468959494|FG000|Study Entry to Week 12|Recurrent infection|1|||
130272332|NCT00556439|468959495|FG001|Study Entry to Week 12|Recurrent infection|0|||
130272333|NCT00556439|468959496|FG002|Study Entry to Week 12|Recurrent infection|0|||
130272334|NCT00556439|468959497|FG003|Study Entry to Week 12|Recurrent infection|0|||
130272335|NCT00556439|468959494|FG000|Study Entry to Week 12|Malignancy|0|||
130272336|NCT00556439|468959495|FG001|Study Entry to Week 12|Malignancy|0|||
130272337|NCT00556439|468959496|FG002|Study Entry to Week 12|Malignancy|1|||
130272338|NCT00556439|468959497|FG003|Study Entry to Week 12|Malignancy|0|||
130272339|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
130272340|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
130272341|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
130272342|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
130272343|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
130272344|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130272345|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130272346|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
130272347|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
130272348|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
130272349|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
130272350|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
130272351|NCT00556439|468959494|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
130272352|NCT00556439|468959495|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
130272353|NCT00556439|468959496|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
130272354|NCT00556439|468959497|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
130272355|NCT02100423|468959498|FG000|Overall Study|Death|1|||
130272356|NCT02100423|468959498|FG000|Overall Study|Withdrawal by Subject|3|||
130272357|NCT02100423|468959498|FG000|Overall Study|Adverse Event|1|||
130272358|NCT02100423|468959498|FG000|Overall Study|Physician Decision|1|||
130272359|NCT02454530|468959499|FG000|Overall Study|Other|8|||
130272360|NCT02454530|468959500|FG001|Overall Study|Other|13|||
130272361|NCT02454530|468959499|FG000|Overall Study|Missing information|56|||
130037897|NCT01485614|468094746|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
130272362|NCT02454530|468959500|FG001|Overall Study|Missing information|69|||
130272363|NCT02454530|468959499|FG000|Overall Study|Death|2|||
130272364|NCT02454530|468959500|FG001|Overall Study|Death|41|||
130272365|NCT02454530|468959499|FG000|Overall Study|Lost to Follow-up|4|||
130272366|NCT02454530|468959500|FG001|Overall Study|Lost to Follow-up|4|||
130272367|NCT00325130|468959501|FG000|Overall Study|Lost to Follow-up|6|||
130272368|NCT00325130|468959502|FG001|Overall Study|Lost to Follow-up|14|||
130272369|NCT00325130|468959501|FG000|Overall Study|Withdrawal by Subject|12|||
130272370|NCT00325130|468959502|FG001|Overall Study|Withdrawal by Subject|14|||
130272371|NCT00325130|468959501|FG000|Overall Study|Protocol Deviation|0|||
130272372|NCT00325130|468959502|FG001|Overall Study|Protocol Deviation|1|||
130272373|NCT00325130|468959501|FG000|Overall Study|Moved|0|||
130272374|NCT00325130|468959502|FG001|Overall Study|Moved|1|||
130272375|NCT00325130|468959501|FG000|Overall Study|Patient Discontinued for Other|1|||
130272376|NCT00325130|468959502|FG001|Overall Study|Patient Discontinued for Other|0|||
130272377|NCT02949024|468959505|FG000|Overall Study|Withdrawal by Subject|0|||
130272378|NCT02949024|468959506|FG001|Overall Study|Withdrawal by Subject|1|||
130272379|NCT03159468|468959507|FG000|Overall Study|Withdrawal by Subject|0|||
130272380|NCT03159468|468959508|FG001|Overall Study|Withdrawal by Subject|0|||
130272381|NCT03159468|468959509|FG002|Overall Study|Withdrawal by Subject|3|||
130272382|NCT03159468|468959510|FG003|Overall Study|Withdrawal by Subject|0|||
130272383|NCT03159468|468959511|FG004|Overall Study|Withdrawal by Subject|0|||
130272384|NCT03159468|468959512|FG005|Overall Study|Withdrawal by Subject|0|||
130272385|NCT02524145|468959513|FG000|Overall Study|Withdrawal by Subject|2|||
130272386|NCT02524145|468959514|FG001|Overall Study|Withdrawal by Subject|2|||
130272387|NCT02524145|468959515|FG002|Overall Study|Withdrawal by Subject|3|||
130272388|NCT00500357|468961187|FG000|Overall Study|Death|1|||
130272389|NCT00161616|468961188|FG000|Overall Study|Withdrawal by Subject|6|||
130272390|NCT00161616|468961189|FG001|Overall Study|Withdrawal by Subject|5|||
130272391|NCT00161616|468961188|FG000|Overall Study|Physician Decision|1|||
130272392|NCT00161616|468961189|FG001|Overall Study|Physician Decision|0|||
130272393|NCT00161616|468961188|FG000|Overall Study|Death|1|||
130272394|NCT00161616|468961189|FG001|Overall Study|Death|1|||
130272395|NCT00161616|468961188|FG000|Overall Study|Lost to Follow-up|17|||
130272396|NCT00161616|468961189|FG001|Overall Study|Lost to Follow-up|13|||
130272397|NCT00161616|468961188|FG000|Overall Study|Protocol deviation|1|||
130272398|NCT00161616|468961189|FG001|Overall Study|Protocol deviation|0|||
130272399|NCT00854724|468961190|FG000|First Intervention|Withdrawal by Subject|1|||
130272400|NCT00854724|468961191|FG001|First Intervention|Withdrawal by Subject|1|||
130272401|NCT00854724|468961190|FG000|Washout|Protocol Violation|1|||
130272402|NCT00854724|468961191|FG001|Washout|Protocol Violation|0|||
130272403|NCT00854724|468961190|FG000|Washout|Withdrawal by Subject|0|||
130272404|NCT00854724|468961191|FG001|Washout|Withdrawal by Subject|1|||
130272405|NCT00854724|468961190|FG000|Second Intervention|Protocol Violation|1|||
130272406|NCT00854724|468961191|FG001|Second Intervention|Protocol Violation|0|||
130272407|NCT00854724|468961190|FG000|Second Intervention|Physician Decision|0|||
130272408|NCT00854724|468961191|FG001|Second Intervention|Physician Decision|1|||
130272409|NCT02141633|468961192|FG000|Overall Study|Physician Decision|1|||
130272410|NCT02141633|468961193|FG001|Overall Study|Physician Decision|0|||
130272411|NCT02140970|468961203|FG000|Overall Study|Lost to Follow-up|1|||
130272412|NCT02140970|468961204|FG001|Overall Study|Lost to Follow-up|2|||
130272413|NCT02140970|468961203|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
130272414|NCT02140970|468961204|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
130272415|NCT02140970|468961203|FG000|Overall Study|Did not meet inclusion criteria|0|||
130272416|NCT02140970|468961204|FG001|Overall Study|Did not meet inclusion criteria|1|||
130272417|NCT01947283|468961208|FG000|Overall Study|Death|1|||
130272418|NCT01947283|468961209|FG001|Overall Study|Death|1|||
130272419|NCT01947283|468961210|FG002|Overall Study|Death|1|||
130272420|NCT01947283|468961211|FG003|Overall Study|Death|0|||
130272421|NCT01947283|468961212|FG004|Overall Study|Death|0|||
130272422|NCT01947283|468961213|FG005|Overall Study|Death|0|||
130272423|NCT01947283|468961214|FG006|Overall Study|Death|0|||
130272424|NCT01947283|468961208|FG000|Overall Study|Lost to Follow-up|4|||
130104020|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130272425|NCT01947283|468961209|FG001|Overall Study|Lost to Follow-up|6|||
130272426|NCT01947283|468961210|FG002|Overall Study|Lost to Follow-up|5|||
130272427|NCT01947283|468961211|FG003|Overall Study|Lost to Follow-up|5|||
130272428|NCT01947283|468961212|FG004|Overall Study|Lost to Follow-up|0|||
130272429|NCT01947283|468961213|FG005|Overall Study|Lost to Follow-up|2|||
130272430|NCT01947283|468961214|FG006|Overall Study|Lost to Follow-up|5|||
130272431|NCT01947283|468961208|FG000|Overall Study|Withdrawal by Subject|10|||
130272432|NCT01947283|468961209|FG001|Overall Study|Withdrawal by Subject|8|||
130272433|NCT01947283|468961210|FG002|Overall Study|Withdrawal by Subject|4|||
130272434|NCT01947283|468961211|FG003|Overall Study|Withdrawal by Subject|1|||
130272435|NCT01947283|468961212|FG004|Overall Study|Withdrawal by Subject|0|||
130272436|NCT01947283|468961213|FG005|Overall Study|Withdrawal by Subject|0|||
130272437|NCT01947283|468961214|FG006|Overall Study|Withdrawal by Subject|2|||
130272438|NCT01947283|468961208|FG000|Overall Study|No Clinical Recording|12|||
130272439|NCT01947283|468961209|FG001|Overall Study|No Clinical Recording|6|||
130272440|NCT01947283|468961210|FG002|Overall Study|No Clinical Recording|8|||
130272441|NCT01947283|468961211|FG003|Overall Study|No Clinical Recording|10|||
130272442|NCT01947283|468961212|FG004|Overall Study|No Clinical Recording|0|||
130272443|NCT01947283|468961213|FG005|Overall Study|No Clinical Recording|0|||
130272444|NCT01947283|468961214|FG006|Overall Study|No Clinical Recording|0|||
130272445|NCT01947283|468961208|FG000|Overall Study|Non-coding Clinical Recording language|0|||
130272446|NCT01947283|468961209|FG001|Overall Study|Non-coding Clinical Recording language|0|||
130272447|NCT01947283|468961210|FG002|Overall Study|Non-coding Clinical Recording language|0|||
130272448|NCT01947283|468961211|FG003|Overall Study|Non-coding Clinical Recording language|1|||
130272449|NCT01947283|468961212|FG004|Overall Study|Non-coding Clinical Recording language|0|||
130272450|NCT01947283|468961213|FG005|Overall Study|Non-coding Clinical Recording language|0|||
130272451|NCT01947283|468961214|FG006|Overall Study|Non-coding Clinical Recording language|0|||
130272452|NCT01947283|468961208|FG000|Overall Study|Missing Follow-up Assessment|2|||
130272453|NCT01947283|468961209|FG001|Overall Study|Missing Follow-up Assessment|2|||
130272454|NCT01947283|468961210|FG002|Overall Study|Missing Follow-up Assessment|3|||
130272455|NCT01947283|468961211|FG003|Overall Study|Missing Follow-up Assessment|0|||
130272456|NCT01947283|468961212|FG004|Overall Study|Missing Follow-up Assessment|0|||
130272457|NCT01947283|468961213|FG005|Overall Study|Missing Follow-up Assessment|2|||
130272458|NCT01947283|468961214|FG006|Overall Study|Missing Follow-up Assessment|0|||
130272459|NCT01947283|468961208|FG000|Overall Study|No patients were enrolled in study|0|||
130272460|NCT01947283|468961209|FG001|Overall Study|No patients were enrolled in study|0|||
130272461|NCT01947283|468961210|FG002|Overall Study|No patients were enrolled in study|0|||
130272462|NCT01947283|468961211|FG003|Overall Study|No patients were enrolled in study|0|||
130272463|NCT01947283|468961212|FG004|Overall Study|No patients were enrolled in study|0|||
130272464|NCT01947283|468961213|FG005|Overall Study|No patients were enrolled in study|3|||
130272465|NCT01947283|468961214|FG006|Overall Study|No patients were enrolled in study|1|||
130272466|NCT03782259|468961215|FG000|Overall Study|Lost to Follow-up|1|||
130272467|NCT03782259|468961216|FG001|Overall Study|Lost to Follow-up|1|||
130272468|NCT03782259|468961215|FG000|Overall Study|Moved out of state|0|||
130272469|NCT03782259|468961216|FG001|Overall Study|Moved out of state|2|||
130272470|NCT03782259|468961215|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
130272471|NCT03782259|468961216|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
130272472|NCT03782259|468961215|FG000|Overall Study|Subject discontinued intervention|1|||
130272473|NCT03782259|468961216|FG001|Overall Study|Subject discontinued intervention|0|||
130272474|NCT00603941|468961220|FG000|Overall Study|Disease progression|6|||
130272475|NCT00603941|468961221|FG001|Overall Study|Disease progression|7|||
130272476|NCT00603941|468961222|FG002|Overall Study|Disease progression|1|||
130272477|NCT00603941|468961220|FG000|Overall Study|Adverse Event|1|||
130272478|NCT00603941|468961221|FG001|Overall Study|Adverse Event|0|||
130272479|NCT00603941|468961222|FG002|Overall Study|Adverse Event|1|||
130272480|NCT00603941|468961220|FG000|Overall Study|Physician Decision|0|||
130272481|NCT00603941|468961221|FG001|Overall Study|Physician Decision|1|||
130272482|NCT00603941|468961222|FG002|Overall Study|Physician Decision|0|||
130272483|NCT00603941|468961220|FG000|Overall Study|Withdrawal by Subject|0|||
130272484|NCT00603941|468961221|FG001|Overall Study|Withdrawal by Subject|2|||
130272485|NCT00603941|468961222|FG002|Overall Study|Withdrawal by Subject|0|||
130272486|NCT05069597|468961223|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
130272487|NCT05069597|468961224|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
130272488|NCT02705105|468961225|FG000|Treatment|Objective Disease Progression|1|||
130272489|NCT02705105|468961226|FG001|Treatment|Objective Disease Progression|50|||
130272490|NCT02705105|468961225|FG000|Treatment|Withdrawal by Subject|3|||
130272491|NCT02705105|468961226|FG001|Treatment|Withdrawal by Subject|5|||
130272492|NCT02705105|468961225|FG000|Treatment|Adverse Event|0|||
130272493|NCT02705105|468961226|FG001|Treatment|Adverse Event|17|||
130272494|NCT02705105|468961225|FG000|Treatment|Clinical Disease Progression|0|||
130272495|NCT02705105|468961226|FG001|Treatment|Clinical Disease Progression|32|||
130272496|NCT02705105|468961225|FG000|Treatment|Physician Decision|0|||
130272497|NCT02705105|468961226|FG001|Treatment|Physician Decision|3|||
130272498|NCT02705105|468961225|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
130272499|NCT02705105|468961226|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
130272500|NCT02705105|468961225|FG000|Follow-Up|Death|3|||
130272501|NCT02705105|468961226|FG001|Follow-Up|Death|68|||
130272502|NCT02705105|468961225|FG000|Follow-Up|Withdrawal by Subject|1|||
130272503|NCT02705105|468961226|FG001|Follow-Up|Withdrawal by Subject|14|||
130037898|NCT01485614|468094743|FG000|Weeks 0-20|Withdrawal by Subject|3|||
130272504|NCT02705105|468961225|FG000|Follow-Up|Study Terminated|0|||
130037899|NCT01485614|468094744|FG001|Weeks 0-20|Withdrawal by Subject|2|||
130037900|NCT01485614|468094745|FG002|Weeks 0-20|Withdrawal by Subject|1|||
130272505|NCT02705105|468961226|FG001|Follow-Up|Study Terminated|26|||
130272506|NCT02705105|468961225|FG000|Follow-Up|Discontinued per Amendment 3|0|||
130272507|NCT02705105|468961226|FG001|Follow-Up|Discontinued per Amendment 3|2|||
130272508|NCT01709110|468961227|FG000|Overall Study|Adverse Event|56|||
130272509|NCT01709110|468961228|FG001|Overall Study|Adverse Event|48|||
130272510|NCT01709110|468961227|FG000|Overall Study|Death|14|||
130272511|NCT01709110|468961228|FG001|Overall Study|Death|6|||
130272512|NCT01709110|468961227|FG000|Overall Study|Lost to Follow-up|7|||
130272513|NCT01709110|468961228|FG001|Overall Study|Lost to Follow-up|5|||
130272514|NCT01709110|468961227|FG000|Overall Study|Protocol Violation|4|||
130272515|NCT01709110|468961228|FG001|Overall Study|Protocol Violation|6|||
130272516|NCT01709110|468961227|FG000|Overall Study|Withdrawal by Subject|96|||
130272517|NCT01709110|468961228|FG001|Overall Study|Withdrawal by Subject|89|||
130272518|NCT01709110|468961227|FG000|Overall Study|Physician Decision|4|||
130272519|NCT01709110|468961228|FG001|Overall Study|Physician Decision|10|||
130272520|NCT01709110|468961227|FG000|Overall Study|Sponsor Decision|2|||
130272521|NCT01709110|468961228|FG001|Overall Study|Sponsor Decision|2|||
130272522|NCT01709110|468961227|FG000|Overall Study|Lack of Efficacy|1|||
130272523|NCT01709110|468961228|FG001|Overall Study|Lack of Efficacy|1|||
130272524|NCT01709110|468961227|FG000|Overall Study|Caregiver Decision|1|||
130272525|NCT01709110|468961228|FG001|Overall Study|Caregiver Decision|1|||
130272526|NCT04556591|468961229|FG000|Overall Study|Lost to Follow-up|1|||
130272527|NCT04556591|468961230|FG001|Overall Study|Lost to Follow-up|0|||
130272528|NCT04556591|468961229|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
130272529|NCT04556591|468961230|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
130272530|NCT03332173|468961231|FG000|Overall Study|Death|7|||
130272531|NCT03332173|468961231|FG000|Overall Study|Withdrawal by Subject|6|||
130272532|NCT03332173|468961231|FG000|Overall Study|Lost to Follow-up|2|||
130272533|NCT03332173|468961231|FG000|Overall Study|Transferred to long-term extension study|29|||
130272534|NCT02168101|468961232|FG000|Overall Study|Death|2|||
130272535|NCT02168101|468961233|FG001|Overall Study|Death|2|||
130272536|NCT02168101|468961234|FG002|Overall Study|Death|1|||
130272537|NCT05507567|468961235|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
130272538|NCT05507567|468961236|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
130272539|NCT05507567|468961237|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
130272540|NCT05507567|468961235|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
130272541|NCT05507567|468961236|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
130272542|NCT05507567|468961237|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
130272543|NCT05507567|468961235|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
130272544|NCT05507567|468961236|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
130272545|NCT05507567|468961237|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
130272546|NCT05507567|468961235|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
130272547|NCT05507567|468961236|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
130272548|NCT05507567|468961237|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
130272549|NCT00910910|468961238|FG000|Overall Study|Adverse Event|63|||
130272550|NCT00910910|468961239|FG001|Overall Study|Adverse Event|35|||
130272551|NCT00910910|468961238|FG000|Overall Study|PD without histologic change|27|||
130272552|NCT00910910|468961239|FG001|Overall Study|PD without histologic change|23|||
130272553|NCT00910910|468961238|FG000|Overall Study|PD with histologic change|0|||
130272554|NCT00910910|468961239|FG001|Overall Study|PD with histologic change|2|||
130272555|NCT00910910|468961238|FG000|Overall Study|Withdrawal by Subject|7|||
130272556|NCT00910910|468961239|FG001|Overall Study|Withdrawal by Subject|5|||
130272557|NCT00910910|468961238|FG000|Overall Study|Lost to Follow-up|2|||
130272558|NCT00910910|468961239|FG001|Overall Study|Lost to Follow-up|2|||
130272559|NCT00910910|468961238|FG000|Overall Study|Death|9|||
130272560|NCT00910910|468961239|FG001|Overall Study|Death|3|||
130272561|NCT00910910|468961238|FG000|Overall Study|Protocol Violation|2|||
130272562|NCT00910910|468961239|FG001|Overall Study|Protocol Violation|2|||
130272563|NCT00910910|468961238|FG000|Overall Study|Completed 13 cycles of treatment|0|||
130272564|NCT00910910|468961239|FG001|Overall Study|Completed 13 cycles of treatment|118|||
130272565|NCT00910910|468961238|FG000|Overall Study|Other|114|||
130272566|NCT00910910|468961239|FG001|Overall Study|Other|32|||
130272567|NCT00910910|468961238|FG000|Overall Study|Untreated before cycle 1|1|||
130272568|NCT00910910|468961239|FG001|Overall Study|Untreated before cycle 1|2|||
130272569|NCT01973231|468961240|FG000|Overall Study|Protocol Violation|1|||
130272570|NCT01973231|468961241|FG001|Overall Study|Protocol Violation|1|||
130272571|NCT01973231|468961240|FG000|Overall Study|Lost to Follow-up|1|||
130272572|NCT01973231|468961241|FG001|Overall Study|Lost to Follow-up|1|||
130272573|NCT01973231|468961240|FG000|Overall Study|unclassified|2|||
130272574|NCT01973231|468961241|FG001|Overall Study|unclassified|1|||
130272575|NCT01973231|468961240|FG000|Overall Study|Withdrawal by Subject|7|||
130272576|NCT01973231|468961241|FG001|Overall Study|Withdrawal by Subject|9|||
130272577|NCT01277822|468961246|FG000|Overall Study|Adverse Event|2|||
130272578|NCT01277822|468961247|FG001|Overall Study|Adverse Event|1|||
130272579|NCT01277822|468961246|FG000|Overall Study|Withdrawal by Subject|6|||
130272580|NCT01277822|468961247|FG001|Overall Study|Withdrawal by Subject|7|||
130272581|NCT01277822|468961246|FG000|Overall Study|Physician Decision|1|||
130272582|NCT01277822|468961247|FG001|Overall Study|Physician Decision|1|||
130272583|NCT01277822|468961246|FG000|Overall Study|Protocol Violation|1|||
130272584|NCT01277822|468961247|FG001|Overall Study|Protocol Violation|0|||
130272585|NCT01277822|468961246|FG000|Overall Study|Lost to Follow-up|2|||
130272586|NCT01277822|468961247|FG001|Overall Study|Lost to Follow-up|1|||
130272587|NCT01277822|468961246|FG000|Overall Study|Contraindicated medication used|2|||
130272588|NCT01277822|468961247|FG001|Overall Study|Contraindicated medication used|1|||
130272589|NCT01277822|468961246|FG000|Overall Study|Participant moved|1|||
130272590|NCT01277822|468961247|FG001|Overall Study|Participant moved|0|||
130272591|NCT02923531|468961248|FG000|Overall Study|Adverse Event|4|||
130272592|NCT02923531|468961248|FG000|Overall Study|Clinical Deterioration|1|||
130272593|NCT02923531|468961248|FG000|Overall Study|Disease Progression|3|||
130272594|NCT02923531|468961248|FG000|Overall Study|Study Termination|1|||
130272595|NCT00997984|468961249|FG000|Overall Study|Adverse Event|1|||
130272596|NCT00997984|468961250|FG001|Overall Study|Adverse Event|8|||
130272597|NCT00997984|468961251|FG002|Overall Study|Adverse Event|8|||
130272598|NCT00997984|468961249|FG000|Overall Study|Protocol Violation|1|||
130272599|NCT00997984|468961250|FG001|Overall Study|Protocol Violation|3|||
130272600|NCT00997984|468961251|FG002|Overall Study|Protocol Violation|0|||
130272601|NCT00997984|468961249|FG000|Overall Study|Withdrawal by Subject|6|||
130272602|NCT00997984|468961250|FG001|Overall Study|Withdrawal by Subject|9|||
130272603|NCT00997984|468961251|FG002|Overall Study|Withdrawal by Subject|5|||
130272604|NCT00997984|468961249|FG000|Overall Study|Lost to Follow-up|8|||
130272605|NCT00997984|468961250|FG001|Overall Study|Lost to Follow-up|5|||
130272606|NCT00997984|468961251|FG002|Overall Study|Lost to Follow-up|4|||
130272607|NCT00997984|468961249|FG000|Overall Study|Lack of Efficacy|20|||
130272608|NCT00997984|468961250|FG001|Overall Study|Lack of Efficacy|6|||
130272609|NCT00997984|468961251|FG002|Overall Study|Lack of Efficacy|3|||
130272610|NCT00997984|468961249|FG000|Overall Study|Met exclusion criteria|1|||
130272611|NCT00997984|468961250|FG001|Overall Study|Met exclusion criteria|0|||
130272612|NCT00997984|468961251|FG002|Overall Study|Met exclusion criteria|0|||
130272613|NCT00997984|468961249|FG000|Overall Study|non-compliance|0|||
130272614|NCT00997984|468961250|FG001|Overall Study|non-compliance|2|||
130272615|NCT00997984|468961251|FG002|Overall Study|non-compliance|3|||
130272616|NCT00997984|468961249|FG000|Overall Study|Wrong medication dispensed|0|||
130272617|NCT00997984|468961250|FG001|Overall Study|Wrong medication dispensed|1|||
130272618|NCT00997984|468961251|FG002|Overall Study|Wrong medication dispensed|0|||
130272619|NCT00997984|468961249|FG000|Overall Study|Suicidal ideation|0|||
130272620|NCT00997984|468961250|FG001|Overall Study|Suicidal ideation|0|||
130272621|NCT00997984|468961251|FG002|Overall Study|Suicidal ideation|1|||
130272622|NCT00997984|468961249|FG000|Overall Study|Work schedule|0|||
130272623|NCT00997984|468961250|FG001|Overall Study|Work schedule|0|||
130272624|NCT00997984|468961251|FG002|Overall Study|Work schedule|2|||
130272625|NCT01119066|468961253|FG000|Overall Study|Withdrawal by Subject|4|||
130272626|NCT01119066|468961254|FG001|Overall Study|Withdrawal by Subject|6|||
130272627|NCT01119066|468961255|FG002|Overall Study|Withdrawal by Subject|0|||
130272628|NCT01119066|468961256|FG003|Overall Study|Withdrawal by Subject|0|||
130272629|NCT01119066|468961253|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
130272630|NCT01119066|468961254|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
130272631|NCT01119066|468961255|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
130272632|NCT01119066|468961256|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
130272633|NCT01119066|468961253|FG000|Overall Study|Relapse identified before transplant|1|||
130272634|NCT01119066|468961254|FG001|Overall Study|Relapse identified before transplant|0|||
130272635|NCT01119066|468961255|FG002|Overall Study|Relapse identified before transplant|0|||
130272636|NCT01119066|468961256|FG003|Overall Study|Relapse identified before transplant|0|||
130272637|NCT01119066|468961253|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130272638|NCT01119066|468961254|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
130272639|NCT01119066|468961255|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130272640|NCT01119066|468961256|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
130272641|NCT01119066|468961253|FG000|Overall Study|Relapse identified before transplant|0|||
130272642|NCT01119066|468961254|FG001|Overall Study|Relapse identified before transplant|4|||
130272643|NCT01119066|468961255|FG002|Overall Study|Relapse identified before transplant|0|||
130272644|NCT01119066|468961256|FG003|Overall Study|Relapse identified before transplant|0|||
130272645|NCT00271856|468961259|FG000|Overall Study|Withdrawal by Subject|1|||
130272646|NCT00271856|468961260|FG001|Overall Study|Withdrawal by Subject|7|||
130272647|NCT00271856|468961259|FG000|Overall Study|Lost to Follow-up|10|||
130272648|NCT00271856|468961260|FG001|Overall Study|Lost to Follow-up|11|||
130272649|NCT02366923|468961261|FG000|Overall Study|Withdrawal by Subject|1|||
130272650|NCT02366923|468961261|FG000|Overall Study|Positive Slit Lamp Findings|2|||
130272651|NCT02366923|468961261|FG000|Overall Study|High Astigmatism|3|||
130272652|NCT01437111|468961267|FG000|Overall Study|Adverse Event|2|||
130272653|NCT01437111|468961267|FG000|Overall Study|Withdrawal by Subject|4|||
130272654|NCT01437111|468961267|FG000|Overall Study|Not reported|5|||
130272655|NCT01437111|468961267|FG000|Overall Study|Physician Decision|1|||
130272656|NCT01437111|468961267|FG000|Overall Study|Lost to Follow-up|5|||
130272657|NCT01437111|468961267|FG000|Overall Study|Protocol Violation|1|||
130272658|NCT02131311|468961268|FG000|Overall Study|Adverse Event|2|||
130272659|NCT02131311|468961268|FG000|Overall Study|Protocol Violation|1|||
130272660|NCT02131311|468961268|FG000|Overall Study|Lost to Follow-up|1|||
130272661|NCT02623205|468961270|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
130272662|NCT02623205|468961271|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
130272663|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
130272664|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
130272665|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
130272666|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
130272667|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
130272668|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
130272669|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
130272670|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
130272671|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
130272672|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
130272673|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130272674|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
130272675|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
130272676|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
130272677|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
130272678|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
130272679|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130272680|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
130272681|NCT03162796|468961272|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
130272682|NCT03162796|468961273|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
130272683|NCT03162796|468961274|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
130272684|NCT03162796|468961272|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
130272685|NCT03162796|468961273|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
130272686|NCT03162796|468961274|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
130272687|NCT03162796|468961272|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
130272688|NCT03162796|468961273|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
130272689|NCT03162796|468961274|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
130272690|NCT03162796|468961272|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
130272691|NCT03162796|468961273|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
130272692|NCT03162796|468961274|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
130272693|NCT03162796|468961272|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
130272694|NCT03162796|468961273|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
130272695|NCT03162796|468961274|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
130272696|NCT02342288|468961275|FG000|Overall Study|no protocol anesthesiologist available|3|||
130272697|NCT02342288|468961276|FG001|Overall Study|no protocol anesthesiologist available|2|||
130272698|NCT02342288|468961275|FG000|Overall Study|anesthesia leak in system|1|||
130272699|NCT02342288|468961276|FG001|Overall Study|anesthesia leak in system|0|||
130272700|NCT02342288|468961275|FG000|Overall Study|Withdrawal by Subject|1|||
130272701|NCT02342288|468961276|FG001|Overall Study|Withdrawal by Subject|0|||
130272702|NCT02342288|468961275|FG000|Overall Study|coordinator contaminated with blood|0|||
130272703|NCT02342288|468961276|FG001|Overall Study|coordinator contaminated with blood|1|||
130272704|NCT02342288|468961275|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
130272705|NCT02342288|468961276|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
130272706|NCT02342288|468961275|FG000|Overall Study|coordinator not available|0|||
130272707|NCT02342288|468961276|FG001|Overall Study|coordinator not available|2|||
130272708|NCT03082677|468961277|FG000|Overall Study|Not Treated|2|||
130272709|NCT01916824|468961284|FG000|Overall Study|Lost to Follow-up|3|||
130272710|NCT01916824|468961285|FG001|Overall Study|Lost to Follow-up|6|||
130272711|NCT01916824|468961284|FG000|Overall Study|Physician Decision|2|||
130272712|NCT01916824|468961285|FG001|Overall Study|Physician Decision|0|||
130272713|NCT01916824|468961284|FG000|Overall Study|Withdrawal by Subject|2|||
130272714|NCT01916824|468961285|FG001|Overall Study|Withdrawal by Subject|3|||
130272715|NCT00771927|468961286|FG000|Overall Study|Adverse Event|100|||
130272716|NCT00771927|468961287|FG001|Overall Study|Adverse Event|105|||
130272717|NCT00771927|468961286|FG000|Overall Study|Lack of Efficacy|70|||
130272718|NCT00771927|468961287|FG001|Overall Study|Lack of Efficacy|42|||
130272719|NCT00771927|468961286|FG000|Overall Study|Lost to Follow-up|46|||
130272720|NCT00771927|468961287|FG001|Overall Study|Lost to Follow-up|46|||
130272721|NCT00771927|468961286|FG000|Overall Study|Withdrawal by Subject|16|||
130272722|NCT00771927|468961287|FG001|Overall Study|Withdrawal by Subject|17|||
130272723|NCT00771927|468961286|FG000|Overall Study|Other reason|23|||
130272724|NCT00771927|468961287|FG001|Overall Study|Other reason|27|||
130272725|NCT03711370|468961288|FG000|Overall Study|Lost to Follow-up|16|||
130272726|NCT03711370|468961289|FG001|Overall Study|Lost to Follow-up|10|||
130272727|NCT03711370|468961288|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
130272728|NCT03711370|468961289|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
130272729|NCT00407602|468961290|FG000|Overall Study|Death - unrelated to device|1|||
130272730|NCT00407602|468961290|FG000|Overall Study|Device explanted|5|||
130272731|NCT00407602|468961290|FG000|Overall Study|Withdrawal by Subject|1|||
130272732|NCT02063984|468961291|FG000|Overall Study|Lost to Follow-up|6|||
130272733|NCT02063984|468961292|FG001|Overall Study|Lost to Follow-up|5|||
130272734|NCT02517398|468961293|FG000|Overall Study|Death|2|||
130272735|NCT02517398|468961294|FG001|Overall Study|Death|3|||
130272736|NCT02517398|468961295|FG002|Overall Study|Death|4|||
130272737|NCT02517398|468961296|FG003|Overall Study|Death|2|||
130272738|NCT02517398|468961297|FG004|Overall Study|Death|3|||
130272739|NCT02517398|468961298|FG005|Overall Study|Death|8|||
130272740|NCT02517398|468961299|FG006|Overall Study|Death|3|||
130272741|NCT02517398|468961300|FG007|Overall Study|Death|2|||
130272742|NCT02517398|468961301|FG008|Overall Study|Death|6|||
130272743|NCT02517398|468961302|FG009|Overall Study|Death|24|||
130272744|NCT02517398|468961303|FG010|Overall Study|Death|53|||
130272745|NCT02517398|468961304|FG011|Overall Study|Death|25|||
130272746|NCT02517398|468961305|FG012|Overall Study|Death|73|||
130272747|NCT02517398|468961306|FG013|Overall Study|Death|29|||
130272748|NCT02517398|468961307|FG014|Overall Study|Death|26|||
130272749|NCT02517398|468961308|FG015|Overall Study|Death|23|||
130272750|NCT02517398|468961309|FG016|Overall Study|Death|26|||
130272751|NCT02517398|468961310|FG017|Overall Study|Death|25|||
130272752|NCT02517398|468961311|FG018|Overall Study|Death|22|||
130272753|NCT02517398|468961312|FG019|Overall Study|Death|7|||
130272754|NCT02517398|468961313|FG020|Overall Study|Death|26|||
130272755|NCT02517398|468961314|FG021|Overall Study|Death|30|||
130272756|NCT02517398|468961315|FG022|Overall Study|Death|20|||
130272757|NCT02517398|468961293|FG000|Overall Study|Other|0|||
130272758|NCT02517398|468961294|FG001|Overall Study|Other|0|||
130272759|NCT02517398|468961295|FG002|Overall Study|Other|0|||
130272760|NCT02517398|468961296|FG003|Overall Study|Other|1|||
130272761|NCT02517398|468961297|FG004|Overall Study|Other|0|||
130272762|NCT02517398|468961298|FG005|Overall Study|Other|0|||
130272763|NCT02517398|468961299|FG006|Overall Study|Other|0|||
130272764|NCT02517398|468961300|FG007|Overall Study|Other|0|||
130272765|NCT02517398|468961301|FG008|Overall Study|Other|0|||
130272766|NCT02517398|468961302|FG009|Overall Study|Other|1|||
130272767|NCT02517398|468961303|FG010|Overall Study|Other|0|||
130272768|NCT02517398|468961304|FG011|Overall Study|Other|0|||
130272769|NCT02517398|468961305|FG012|Overall Study|Other|0|||
130272770|NCT02517398|468961306|FG013|Overall Study|Other|1|||
130272771|NCT02517398|468961307|FG014|Overall Study|Other|0|||
130272772|NCT02517398|468961308|FG015|Overall Study|Other|1|||
130272773|NCT02517398|468961309|FG016|Overall Study|Other|1|||
130272774|NCT02517398|468961310|FG017|Overall Study|Other|0|||
130272775|NCT02517398|468961311|FG018|Overall Study|Other|0|||
130272776|NCT02517398|468961312|FG019|Overall Study|Other|1|||
130272777|NCT02517398|468961313|FG020|Overall Study|Other|0|||
130272778|NCT02517398|468961314|FG021|Overall Study|Other|0|||
130272779|NCT02517398|468961315|FG022|Overall Study|Other|0|||
130272780|NCT02517398|468961293|FG000|Overall Study|Lost to Follow-up|0|||
130272781|NCT02517398|468961294|FG001|Overall Study|Lost to Follow-up|0|||
130272782|NCT02517398|468961295|FG002|Overall Study|Lost to Follow-up|0|||
130110724|NCT03705169|468365851|FG006|Overall Study|Did not receive study treatment|0|||
130272783|NCT02517398|468961296|FG003|Overall Study|Lost to Follow-up|0|||
130272784|NCT02517398|468961297|FG004|Overall Study|Lost to Follow-up|0|||
130272785|NCT02517398|468961298|FG005|Overall Study|Lost to Follow-up|0|||
130272786|NCT02517398|468961299|FG006|Overall Study|Lost to Follow-up|0|||
130272787|NCT02517398|468961300|FG007|Overall Study|Lost to Follow-up|0|||
130272788|NCT02517398|468961301|FG008|Overall Study|Lost to Follow-up|0|||
130272789|NCT02517398|468961302|FG009|Overall Study|Lost to Follow-up|1|||
130272790|NCT02517398|468961303|FG010|Overall Study|Lost to Follow-up|0|||
130272791|NCT02517398|468961304|FG011|Overall Study|Lost to Follow-up|2|||
130272792|NCT02517398|468961305|FG012|Overall Study|Lost to Follow-up|2|||
130272793|NCT02517398|468961306|FG013|Overall Study|Lost to Follow-up|0|||
130272794|NCT02517398|468961307|FG014|Overall Study|Lost to Follow-up|1|||
130272795|NCT02517398|468961308|FG015|Overall Study|Lost to Follow-up|1|||
130272796|NCT02517398|468961309|FG016|Overall Study|Lost to Follow-up|0|||
130272797|NCT02517398|468961310|FG017|Overall Study|Lost to Follow-up|3|||
130272798|NCT02517398|468961311|FG018|Overall Study|Lost to Follow-up|1|||
130272799|NCT02517398|468961312|FG019|Overall Study|Lost to Follow-up|0|||
130037901|NCT01485614|468094746|FG003|Weeks 0-20|Withdrawal by Subject|0|||
130037902|NCT01485614|468094743|FG000|Weeks 20-54|Lost to Follow-up|4|||
130037903|NCT01485614|468094744|FG001|Weeks 20-54|Lost to Follow-up|3|||
130037904|NCT01485614|468094745|FG002|Weeks 20-54|Lost to Follow-up|1|||
130037905|NCT01485614|468094746|FG003|Weeks 20-54|Lost to Follow-up|0|||
130037906|NCT01485614|468094743|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
130272800|NCT02517398|468961313|FG020|Overall Study|Lost to Follow-up|1|||
130272801|NCT02517398|468961314|FG021|Overall Study|Lost to Follow-up|0|||
130272802|NCT02517398|468961315|FG022|Overall Study|Lost to Follow-up|2|||
130272803|NCT02517398|468961293|FG000|Overall Study|Withdrew Consent|0|||
130272804|NCT02517398|468961294|FG001|Overall Study|Withdrew Consent|0|||
130272805|NCT02517398|468961295|FG002|Overall Study|Withdrew Consent|0|||
130272806|NCT02517398|468961296|FG003|Overall Study|Withdrew Consent|0|||
130272807|NCT02517398|468961297|FG004|Overall Study|Withdrew Consent|0|||
130272808|NCT02517398|468961298|FG005|Overall Study|Withdrew Consent|0|||
130272809|NCT02517398|468961299|FG006|Overall Study|Withdrew Consent|1|||
130272810|NCT02517398|468961300|FG007|Overall Study|Withdrew Consent|0|||
130272811|NCT02517398|468961301|FG008|Overall Study|Withdrew Consent|0|||
130272812|NCT02517398|468961302|FG009|Overall Study|Withdrew Consent|2|||
130272813|NCT02517398|468961303|FG010|Overall Study|Withdrew Consent|7|||
130272814|NCT02517398|468961304|FG011|Overall Study|Withdrew Consent|1|||
130272815|NCT02517398|468961305|FG012|Overall Study|Withdrew Consent|5|||
130272816|NCT02517398|468961306|FG013|Overall Study|Withdrew Consent|4|||
130272817|NCT02517398|468961307|FG014|Overall Study|Withdrew Consent|2|||
130272818|NCT02517398|468961308|FG015|Overall Study|Withdrew Consent|5|||
130272819|NCT02517398|468961309|FG016|Overall Study|Withdrew Consent|4|||
130272820|NCT02517398|468961310|FG017|Overall Study|Withdrew Consent|2|||
130272821|NCT02517398|468961311|FG018|Overall Study|Withdrew Consent|3|||
130272822|NCT02517398|468961312|FG019|Overall Study|Withdrew Consent|2|||
130272823|NCT02517398|468961313|FG020|Overall Study|Withdrew Consent|9|||
130272824|NCT02517398|468961314|FG021|Overall Study|Withdrew Consent|3|||
130272825|NCT02517398|468961315|FG022|Overall Study|Withdrew Consent|1|||
130272826|NCT00005947|468961317|FG000|Overall Study|Death|54|||
130272827|NCT00005947|468961318|FG001|Overall Study|Death|40|||
130272828|NCT00005947|468961317|FG000|Overall Study|Patient Refused to Continue|2|||
130272829|NCT00005947|468961318|FG001|Overall Study|Patient Refused to Continue|1|||
130272830|NCT00005947|468961317|FG000|Overall Study|Site Closure|1|||
130272831|NCT00005947|468961318|FG001|Overall Study|Site Closure|0|||
130272832|NCT00429182|468961319|FG000|Overall Study|Not evaluable, Disease Progression|2|||
130272833|NCT00429182|468961319|FG000|Overall Study|Not eligible|5|||
130272834|NCT00790582|468961321|FG000|Overall Study|Death|14|||
130272835|NCT00790582|468961322|FG001|Overall Study|Death|32|||
130272836|NCT00790582|468961321|FG000|Overall Study|Physician Decision|7|||
130272837|NCT00790582|468961322|FG001|Overall Study|Physician Decision|1|||
130272838|NCT00790582|468961321|FG000|Overall Study|Lost to Follow-up|3|||
130272839|NCT00790582|468961322|FG001|Overall Study|Lost to Follow-up|3|||
130272840|NCT00790582|468961321|FG000|Overall Study|Withdrawal by Subject|7|||
130272841|NCT00790582|468961322|FG001|Overall Study|Withdrawal by Subject|51|||
130272842|NCT02195700|468961324|FG000|Overall Study|Protocol Violation|0|||
130272843|NCT02195700|468961325|FG001|Overall Study|Protocol Violation|2|||
130272844|NCT02195700|468961324|FG000|Overall Study|Noncompliance|1|||
130272845|NCT02195700|468961325|FG001|Overall Study|Noncompliance|0|||
130272846|NCT02195700|468961324|FG000|Overall Study|Adverse Event|1|||
130272847|NCT02195700|468961325|FG001|Overall Study|Adverse Event|2|||
130272848|NCT02195700|468961324|FG000|Overall Study|Withdrawal by Subject|3|||
130272849|NCT02195700|468961325|FG001|Overall Study|Withdrawal by Subject|2|||
130272850|NCT02195700|468961324|FG000|Overall Study|Lost to Follow-up|1|||
130272851|NCT02195700|468961325|FG001|Overall Study|Lost to Follow-up|1|||
130272852|NCT02931838|468961326|FG000|Overall Study|Reason not provided by investigator|1|||
130272853|NCT02931838|468961327|FG001|Overall Study|Reason not provided by investigator|0|||
130272854|NCT02931838|468961328|FG002|Overall Study|Reason not provided by investigator|1|||
130272855|NCT02931838|468961329|FG003|Overall Study|Reason not provided by investigator|0|||
130272856|NCT02931838|468961330|FG004|Overall Study|Reason not provided by investigator|0|||
130272857|NCT02931838|468961331|FG005|Overall Study|Reason not provided by investigator|0|||
130272858|NCT02931838|468961326|FG000|Overall Study|Poor/non-compliance|0|||
130272859|NCT02931838|468961327|FG001|Overall Study|Poor/non-compliance|0|||
130272860|NCT02931838|468961328|FG002|Overall Study|Poor/non-compliance|1|||
130272861|NCT02931838|468961329|FG003|Overall Study|Poor/non-compliance|0|||
130272862|NCT02931838|468961330|FG004|Overall Study|Poor/non-compliance|0|||
130272863|NCT02931838|468961331|FG005|Overall Study|Poor/non-compliance|0|||
130272864|NCT02931838|468961326|FG000|Overall Study|Lack of Efficacy|5|||
130272865|NCT02931838|468961327|FG001|Overall Study|Lack of Efficacy|4|||
130272866|NCT02931838|468961328|FG002|Overall Study|Lack of Efficacy|0|||
130272867|NCT02931838|468961329|FG003|Overall Study|Lack of Efficacy|0|||
130272868|NCT02931838|468961330|FG004|Overall Study|Lack of Efficacy|0|||
130272869|NCT02931838|468961331|FG005|Overall Study|Lack of Efficacy|1|||
130272870|NCT02931838|468961326|FG000|Overall Study|Lost to Follow-up|1|||
130272871|NCT02931838|468961327|FG001|Overall Study|Lost to Follow-up|0|||
130272872|NCT02931838|468961328|FG002|Overall Study|Lost to Follow-up|1|||
130272873|NCT02931838|468961329|FG003|Overall Study|Lost to Follow-up|1|||
130272874|NCT02931838|468961330|FG004|Overall Study|Lost to Follow-up|2|||
130272875|NCT02931838|468961331|FG005|Overall Study|Lost to Follow-up|0|||
130272876|NCT02931838|468961326|FG000|Overall Study|Subject request to discontinue treatment|4|||
130272877|NCT02931838|468961327|FG001|Overall Study|Subject request to discontinue treatment|3|||
130272878|NCT02931838|468961328|FG002|Overall Study|Subject request to discontinue treatment|3|||
130272879|NCT02931838|468961329|FG003|Overall Study|Subject request to discontinue treatment|0|||
130272880|NCT02931838|468961330|FG004|Overall Study|Subject request to discontinue treatment|1|||
130272881|NCT02931838|468961331|FG005|Overall Study|Subject request to discontinue treatment|0|||
130272882|NCT02931838|468961326|FG000|Overall Study|Withdrawal by Subject|1|||
130272883|NCT02931838|468961327|FG001|Overall Study|Withdrawal by Subject|2|||
130272884|NCT02931838|468961328|FG002|Overall Study|Withdrawal by Subject|0|||
130272885|NCT02931838|468961329|FG003|Overall Study|Withdrawal by Subject|1|||
130272886|NCT02931838|468961330|FG004|Overall Study|Withdrawal by Subject|0|||
130272887|NCT02931838|468961331|FG005|Overall Study|Withdrawal by Subject|0|||
130272888|NCT02931838|468961326|FG000|Overall Study|Adverse Event|2|||
130272889|NCT02931838|468961327|FG001|Overall Study|Adverse Event|1|||
130272890|NCT02931838|468961328|FG002|Overall Study|Adverse Event|2|||
130272891|NCT02931838|468961329|FG003|Overall Study|Adverse Event|1|||
130272892|NCT02931838|468961330|FG004|Overall Study|Adverse Event|3|||
130272893|NCT02931838|468961331|FG005|Overall Study|Adverse Event|1|||
130272894|NCT03110029|468961332|FG000|Overall Study|Withdrawal by Subject|1|||
130272895|NCT03110029|468961333|FG001|Overall Study|Withdrawal by Subject|1|||
130272896|NCT01042158|468961334|FG000|Overall Study|Physician Decision|1|||
130272897|NCT05823974|468963646|FG000|Overall Study|Lost to Follow-up|0|||
130272898|NCT05823974|468963647|FG001|Overall Study|Lost to Follow-up|3|||
130272899|NCT05823974|468963648|FG002|Overall Study|Lost to Follow-up|1|||
130272900|NCT05823974|468963649|FG003|Overall Study|Lost to Follow-up|0|||
130272901|NCT05823974|468963650|FG004|Overall Study|Lost to Follow-up|1|||
130272902|NCT05823974|468963651|FG005|Overall Study|Lost to Follow-up|0|||
130272903|NCT05823974|468963652|FG006|Overall Study|Lost to Follow-up|1|||
130272904|NCT05823974|468963653|FG007|Overall Study|Lost to Follow-up|0|||
130272905|NCT05823974|468963654|FG008|Overall Study|Lost to Follow-up|0|||
130272906|NCT05823974|468963655|FG009|Overall Study|Lost to Follow-up|1|||
130272907|NCT05823974|468963656|FG010|Overall Study|Lost to Follow-up|1|||
130272908|NCT05823974|468963657|FG011|Overall Study|Lost to Follow-up|0|||
130272909|NCT05823974|468963658|FG012|Overall Study|Lost to Follow-up|1|||
130272910|NCT05823974|468963659|FG013|Overall Study|Lost to Follow-up|2|||
130272911|NCT05823974|468963660|FG014|Overall Study|Lost to Follow-up|1|||
130272912|NCT05823974|468963661|FG015|Overall Study|Lost to Follow-up|1|||
130272913|NCT05823974|468963662|FG016|Overall Study|Lost to Follow-up|1|||
130272914|NCT05823974|468963663|FG017|Overall Study|Lost to Follow-up|0|||
130272915|NCT05823974|468963664|FG018|Overall Study|Lost to Follow-up|0|||
130272916|NCT05823974|468963665|FG019|Overall Study|Lost to Follow-up|2|||
130272917|NCT05823974|468963666|FG020|Overall Study|Lost to Follow-up|0|||
130272918|NCT05823974|468963646|FG000|Overall Study|Physician Decision|0|||
130272919|NCT05823974|468963647|FG001|Overall Study|Physician Decision|0|||
130272920|NCT05823974|468963648|FG002|Overall Study|Physician Decision|0|||
130272921|NCT05823974|468963649|FG003|Overall Study|Physician Decision|0|||
130272922|NCT05823974|468963650|FG004|Overall Study|Physician Decision|0|||
130272923|NCT05823974|468963651|FG005|Overall Study|Physician Decision|0|||
130272924|NCT05823974|468963652|FG006|Overall Study|Physician Decision|0|||
130272925|NCT05823974|468963653|FG007|Overall Study|Physician Decision|0|||
130272926|NCT05823974|468963654|FG008|Overall Study|Physician Decision|0|||
130272927|NCT05823974|468963655|FG009|Overall Study|Physician Decision|0|||
130272928|NCT05823974|468963656|FG010|Overall Study|Physician Decision|0|||
130272929|NCT05823974|468963657|FG011|Overall Study|Physician Decision|0|||
130272930|NCT05823974|468963658|FG012|Overall Study|Physician Decision|0|||
130272931|NCT05823974|468963659|FG013|Overall Study|Physician Decision|0|||
130272932|NCT05823974|468963660|FG014|Overall Study|Physician Decision|0|||
130272933|NCT05823974|468963661|FG015|Overall Study|Physician Decision|1|||
130272934|NCT05823974|468963662|FG016|Overall Study|Physician Decision|0|||
130272935|NCT05823974|468963663|FG017|Overall Study|Physician Decision|1|||
130272936|NCT05823974|468963664|FG018|Overall Study|Physician Decision|1|||
130272937|NCT05823974|468963665|FG019|Overall Study|Physician Decision|0|||
130272938|NCT05823974|468963666|FG020|Overall Study|Physician Decision|0|||
130272939|NCT05823974|468963646|FG000|Overall Study|Withdrawal by Subject|1|||
130272940|NCT05823974|468963647|FG001|Overall Study|Withdrawal by Subject|1|||
130272941|NCT05823974|468963648|FG002|Overall Study|Withdrawal by Subject|2|||
130272942|NCT05823974|468963649|FG003|Overall Study|Withdrawal by Subject|0|||
130272943|NCT05823974|468963650|FG004|Overall Study|Withdrawal by Subject|2|||
130272944|NCT05823974|468963651|FG005|Overall Study|Withdrawal by Subject|3|||
130272945|NCT05823974|468963652|FG006|Overall Study|Withdrawal by Subject|1|||
130272946|NCT05823974|468963653|FG007|Overall Study|Withdrawal by Subject|1|||
130272947|NCT05823974|468963654|FG008|Overall Study|Withdrawal by Subject|2|||
130272948|NCT05823974|468963655|FG009|Overall Study|Withdrawal by Subject|1|||
130272949|NCT05823974|468963656|FG010|Overall Study|Withdrawal by Subject|1|||
130272950|NCT05823974|468963657|FG011|Overall Study|Withdrawal by Subject|0|||
130272951|NCT05823974|468963658|FG012|Overall Study|Withdrawal by Subject|0|||
130272952|NCT05823974|468963659|FG013|Overall Study|Withdrawal by Subject|1|||
130272953|NCT05823974|468963660|FG014|Overall Study|Withdrawal by Subject|1|||
130272954|NCT05823974|468963661|FG015|Overall Study|Withdrawal by Subject|3|||
130272955|NCT05823974|468963662|FG016|Overall Study|Withdrawal by Subject|0|||
130272956|NCT05823974|468963663|FG017|Overall Study|Withdrawal by Subject|2|||
130272957|NCT05823974|468963664|FG018|Overall Study|Withdrawal by Subject|2|||
130272958|NCT05823974|468963665|FG019|Overall Study|Withdrawal by Subject|0|||
130272959|NCT05823974|468963666|FG020|Overall Study|Withdrawal by Subject|1|||
130272960|NCT05823974|468963646|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272961|NCT05823974|468963647|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272962|NCT05823974|468963648|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130272963|NCT05823974|468963649|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272964|NCT05823974|468963650|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272965|NCT05823974|468963651|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272966|NCT05823974|468963652|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272967|NCT05823974|468963653|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272968|NCT05823974|468963654|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272969|NCT05823974|468963655|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272970|NCT05823974|468963656|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272971|NCT05823974|468963657|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272972|NCT05823974|468963658|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272973|NCT05823974|468963659|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272974|NCT05823974|468963660|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130272975|NCT05823974|468963661|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272976|NCT05823974|468963662|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272977|NCT05823974|468963663|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272978|NCT05823974|468963664|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272979|NCT05823974|468963665|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272980|NCT05823974|468963666|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130272981|NCT05823974|468963646|FG000|Overall Study|Other|0|||
130272982|NCT05823974|468963647|FG001|Overall Study|Other|1|||
130272983|NCT05823974|468963648|FG002|Overall Study|Other|1|||
130272984|NCT05823974|468963649|FG003|Overall Study|Other|1|||
130272985|NCT05823974|468963650|FG004|Overall Study|Other|0|||
130272986|NCT05823974|468963651|FG005|Overall Study|Other|1|||
130272987|NCT05823974|468963652|FG006|Overall Study|Other|1|||
130272988|NCT05823974|468963653|FG007|Overall Study|Other|1|||
130272989|NCT05823974|468963654|FG008|Overall Study|Other|1|||
130272990|NCT05823974|468963655|FG009|Overall Study|Other|0|||
130272991|NCT05823974|468963656|FG010|Overall Study|Other|0|||
130272992|NCT05823974|468963657|FG011|Overall Study|Other|0|||
130272993|NCT05823974|468963658|FG012|Overall Study|Other|2|||
130272994|NCT05823974|468963659|FG013|Overall Study|Other|1|||
130272995|NCT05823974|468963660|FG014|Overall Study|Other|0|||
130272996|NCT05823974|468963661|FG015|Overall Study|Other|1|||
130272997|NCT05823974|468963662|FG016|Overall Study|Other|0|||
130272998|NCT05823974|468963663|FG017|Overall Study|Other|0|||
130272999|NCT05823974|468963664|FG018|Overall Study|Other|0|||
130273000|NCT05823974|468963665|FG019|Overall Study|Other|0|||
130273001|NCT05823974|468963666|FG020|Overall Study|Other|0|||
130273002|NCT00316706|468963667|FG000|Overall Study|Lost to Follow-up|38|||
130273003|NCT00316706|468963668|FG001|Overall Study|Lost to Follow-up|48|||
130273004|NCT02220855|468963669|FG000|Overall Study|Adverse Event|8|||
130273005|NCT02220855|468963669|FG000|Overall Study|Disease Progression|5|||
130273006|NCT02220855|468963669|FG000|Overall Study|Withdrawal by Subject|1|||
130273007|NCT03280303|468963670|FG000|Overall Study|Death|505|||
130273008|NCT03280303|468963670|FG000|Overall Study|Study terminated by sponsor|383|||
130273009|NCT03280303|468963670|FG000|Overall Study|Other|148|||
130273010|NCT03280303|468963670|FG000|Overall Study|No longer willing to participate in study|101|||
130273011|NCT03280303|468963670|FG000|Overall Study|Lost to follow up|39|||
130273012|NCT03280303|468963670|FG000|Overall Study|Adverse Event|20|||
130273013|NCT03419897|468963671|FG000|Overall Study|Death|180|||
130273014|NCT03419897|468963671|FG000|Overall Study|Lost to Follow-up|1|||
130273015|NCT03419897|468963671|FG000|Overall Study|Withdrawal by Subject|6|||
130273016|NCT03419897|468963671|FG000|Overall Study|Sponsor Decision|61|||
130037907|NCT01485614|468094744|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
130037908|NCT01485614|468094745|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
130037909|NCT01485614|468094746|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
130273017|NCT03419897|468963671|FG000|Overall Study|Physician Decision|1|||
130273018|NCT02222688|468963684|FG000|Overall Study|Withdrawal by Subject|0|||
130273019|NCT02222688|468963685|FG001|Overall Study|Withdrawal by Subject|0|||
130273020|NCT02222688|468963686|FG002|Overall Study|Withdrawal by Subject|0|||
130273021|NCT02222688|468963687|FG003|Overall Study|Withdrawal by Subject|2|||
130273022|NCT02222688|468963688|FG004|Overall Study|Withdrawal by Subject|1|||
130273023|NCT02222688|468963689|FG005|Overall Study|Withdrawal by Subject|0|||
130273024|NCT02222688|468963690|FG006|Overall Study|Withdrawal by Subject|1|||
130273025|NCT02222688|468963684|FG000|Overall Study|Disease progression|1|||
130273026|NCT02222688|468963685|FG001|Overall Study|Disease progression|0|||
130273027|NCT02222688|468963686|FG002|Overall Study|Disease progression|0|||
130273028|NCT02222688|468963687|FG003|Overall Study|Disease progression|0|||
130273029|NCT02222688|468963688|FG004|Overall Study|Disease progression|0|||
130273030|NCT02222688|468963689|FG005|Overall Study|Disease progression|0|||
130110725|NCT03705169|468365852|FG007|Overall Study|Did not receive study treatment|0|||
130273031|NCT02222688|468963690|FG006|Overall Study|Disease progression|0|||
130273032|NCT00958360|468963700|FG000|Overall Study|Withdrawal by Subject|3|||
130273033|NCT00958360|468963701|FG001|Overall Study|Withdrawal by Subject|1|||
130273034|NCT00958360|468963700|FG000|Overall Study|Death|6|||
130273035|NCT00958360|468963701|FG001|Overall Study|Death|7|||
130273036|NCT00958360|468963700|FG000|Overall Study|Physician Decision|2|||
130273037|NCT00958360|468963701|FG001|Overall Study|Physician Decision|1|||
130273038|NCT00958360|468963700|FG000|Overall Study|Lost to Follow-up|0|||
130273039|NCT00958360|468963701|FG001|Overall Study|Lost to Follow-up|1|||
130273040|NCT03107052|468963702|FG000|Overall Study|Adverse Event|6|||
130273041|NCT03107052|468963703|FG001|Overall Study|Adverse Event|1|||
130273042|NCT03107052|468963704|FG002|Overall Study|Adverse Event|2|||
130273043|NCT03107052|468963702|FG000|Overall Study|Withdrawal by Subject|9|||
130273044|NCT03107052|468963703|FG001|Overall Study|Withdrawal by Subject|5|||
130273045|NCT03107052|468963704|FG002|Overall Study|Withdrawal by Subject|8|||
130273046|NCT03107052|468963702|FG000|Overall Study|Protocol Violation|6|||
130273047|NCT03107052|468963703|FG001|Overall Study|Protocol Violation|0|||
130273048|NCT03107052|468963704|FG002|Overall Study|Protocol Violation|3|||
130273049|NCT03107052|468963702|FG000|Overall Study|Lost to Follow-up|4|||
130273050|NCT03107052|468963703|FG001|Overall Study|Lost to Follow-up|0|||
130273051|NCT03107052|468963704|FG002|Overall Study|Lost to Follow-up|1|||
130273052|NCT03107052|468963702|FG000|Overall Study|Lack of Efficacy|23|||
130273053|NCT03107052|468963703|FG001|Overall Study|Lack of Efficacy|7|||
130273054|NCT03107052|468963704|FG002|Overall Study|Lack of Efficacy|4|||
130273055|NCT03107052|468963702|FG000|Overall Study|Other than specified|4|||
130273056|NCT03107052|468963703|FG001|Overall Study|Other than specified|2|||
130273057|NCT03107052|468963704|FG002|Overall Study|Other than specified|0|||
130273058|NCT03107052|468963702|FG000|Overall Study|Study terminated due to futility|67|||
130273059|NCT03107052|468963703|FG001|Overall Study|Study terminated due to futility|31|||
130273060|NCT03107052|468963704|FG002|Overall Study|Study terminated due to futility|23|||
130273061|NCT02719691|468963706|FG000|Overall Study|Physician Decision|0|||
130273062|NCT02719691|468963707|FG001|Overall Study|Physician Decision|0|||
130273063|NCT02719691|468963708|FG002|Overall Study|Physician Decision|1|||
130273064|NCT02719691|468963709|FG003|Overall Study|Physician Decision|0|||
130273065|NCT02719691|468963710|FG004|Overall Study|Physician Decision|0|||
130273066|NCT02719691|468963711|FG005|Overall Study|Physician Decision|0|||
130273067|NCT02719691|468963712|FG006|Overall Study|Physician Decision|0|||
130273068|NCT02719691|468963706|FG000|Overall Study|Withdrawal by Subject|0|||
130273069|NCT02719691|468963707|FG001|Overall Study|Withdrawal by Subject|0|||
130273070|NCT02719691|468963708|FG002|Overall Study|Withdrawal by Subject|0|||
130273071|NCT02719691|468963709|FG003|Overall Study|Withdrawal by Subject|0|||
130273072|NCT02719691|468963710|FG004|Overall Study|Withdrawal by Subject|0|||
130273073|NCT02719691|468963711|FG005|Overall Study|Withdrawal by Subject|1|||
130273074|NCT02719691|468963712|FG006|Overall Study|Withdrawal by Subject|0|||
130273075|NCT00336284|468963715|FG000|Overall Study|Death|52|||
130273076|NCT00336284|468963716|FG001|Overall Study|Death|26|||
130273077|NCT00336284|468963715|FG000|Overall Study|Lost to Follow-up|82|||
130273078|NCT00336284|468963716|FG001|Overall Study|Lost to Follow-up|61|||
130273079|NCT00336284|468963715|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
130273080|NCT00336284|468963716|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
130273081|NCT00861757|468963719|FG000|Overall Study|Adverse Event|1|||
130273082|NCT00861757|468963720|FG001|Overall Study|Adverse Event|5|||
130273083|NCT00861757|468963721|FG002|Overall Study|Adverse Event|7|||
130273084|NCT00861757|468963722|FG003|Overall Study|Adverse Event|2|||
130273085|NCT00861757|468963719|FG000|Overall Study|Entry Criteria Not Met|1|||
130273086|NCT00861757|468963720|FG001|Overall Study|Entry Criteria Not Met|2|||
130273087|NCT00861757|468963721|FG002|Overall Study|Entry Criteria Not Met|1|||
130273088|NCT00861757|468963722|FG003|Overall Study|Entry Criteria Not Met|1|||
130273089|NCT00861757|468963719|FG000|Overall Study|Lack of Efficacy|3|||
130273090|NCT00861757|468963720|FG001|Overall Study|Lack of Efficacy|1|||
130273091|NCT00861757|468963721|FG002|Overall Study|Lack of Efficacy|0|||
130273092|NCT00861757|468963722|FG003|Overall Study|Lack of Efficacy|1|||
130273093|NCT00861757|468963719|FG000|Overall Study|Lost to Follow-up|1|||
130273094|NCT00861757|468963720|FG001|Overall Study|Lost to Follow-up|0|||
130273095|NCT00861757|468963721|FG002|Overall Study|Lost to Follow-up|1|||
130273096|NCT00861757|468963722|FG003|Overall Study|Lost to Follow-up|1|||
130273097|NCT00861757|468963719|FG000|Overall Study|Physician Decision|0|||
130273098|NCT00861757|468963720|FG001|Overall Study|Physician Decision|0|||
130273099|NCT00861757|468963721|FG002|Overall Study|Physician Decision|0|||
130273100|NCT00861757|468963722|FG003|Overall Study|Physician Decision|1|||
130273101|NCT00861757|468963719|FG000|Overall Study|Protocol Violation|2|||
130273102|NCT00861757|468963720|FG001|Overall Study|Protocol Violation|2|||
130273103|NCT00861757|468963721|FG002|Overall Study|Protocol Violation|4|||
130273104|NCT00861757|468963722|FG003|Overall Study|Protocol Violation|1|||
130273105|NCT00861757|468963719|FG000|Overall Study|Withdrawal by Subject|1|||
130273106|NCT00861757|468963720|FG001|Overall Study|Withdrawal by Subject|5|||
130273107|NCT00861757|468963721|FG002|Overall Study|Withdrawal by Subject|5|||
130273108|NCT00861757|468963722|FG003|Overall Study|Withdrawal by Subject|2|||
130273109|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
130273110|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
130273111|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
130273112|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
130273113|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
130273114|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
130273115|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
130273116|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
130273117|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
130273118|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
130273119|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
130273120|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
130273121|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
130273122|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
130273123|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
130273124|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
130273125|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
130273126|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
130273127|NCT03308968|468963723|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
130273128|NCT03308968|468963724|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
130273129|NCT03308968|468963725|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
130273130|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
130273131|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
130273132|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
130273133|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
130273134|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
130273135|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
130273136|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
130273137|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
130273138|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
130273139|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
130273140|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
130273141|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
130273142|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
130273143|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
130273144|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
130273145|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
130273146|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
130273147|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
130273148|NCT03308968|468963723|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
130273149|NCT03308968|468963724|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
130273150|NCT03308968|468963725|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
130273151|NCT01961297|468963731|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
130273152|NCT01961297|468963732|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
130273153|NCT02482298|468963733|FG000|Overall Study|Withdrawal by Subject|2|||
130273154|NCT02482298|468963734|FG001|Overall Study|Withdrawal by Subject|1|||
130273155|NCT02482298|468963735|FG002|Overall Study|Withdrawal by Subject|2|||
130273156|NCT02482298|468963733|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
130273157|NCT02482298|468963734|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
130273158|NCT02482298|468963735|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
130273159|NCT02482298|468963733|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
130273160|NCT02482298|468963734|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
130273161|NCT02482298|468963735|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
130273162|NCT02482298|468963733|FG000|Overall Study|Lost to Follow-up|0|||
130273163|NCT02482298|468963734|FG001|Overall Study|Lost to Follow-up|1|||
130273164|NCT02482298|468963735|FG002|Overall Study|Lost to Follow-up|0|||
130273165|NCT01188551|468963736|FG000|Overall Study|Pharmacy issues|1|||
130273166|NCT01188551|468963737|FG001|Overall Study|Pharmacy issues|0|||
130273167|NCT01188551|468963738|FG002|Overall Study|Pharmacy issues|0|||
130273168|NCT01188551|468963739|FG003|Overall Study|Pharmacy issues|0|||
130273169|NCT03012828|468963748|FG000|Overall Study|Lost to Follow-up|1|||
130273170|NCT03012828|468963749|FG001|Overall Study|Lost to Follow-up|0|||
130273171|NCT03012828|468963750|FG002|Overall Study|Lost to Follow-up|1|||
130273172|NCT03012828|468963751|FG003|Overall Study|Lost to Follow-up|0|||
130273173|NCT03012828|468963752|FG004|Overall Study|Lost to Follow-up|1|||
130273174|NCT03012828|468963753|FG005|Overall Study|Lost to Follow-up|0|||
130273175|NCT03012828|468963748|FG000|Overall Study|Withdrawal by Subject|0|||
130273176|NCT03012828|468963749|FG001|Overall Study|Withdrawal by Subject|0|||
130273177|NCT03012828|468963750|FG002|Overall Study|Withdrawal by Subject|1|||
130273178|NCT03012828|468963751|FG003|Overall Study|Withdrawal by Subject|0|||
130273179|NCT03012828|468963752|FG004|Overall Study|Withdrawal by Subject|0|||
130273180|NCT03012828|468963753|FG005|Overall Study|Withdrawal by Subject|1|||
130273181|NCT03012828|468963748|FG000|Overall Study|Non-compliance with protocol|0|||
130273182|NCT03012828|468963749|FG001|Overall Study|Non-compliance with protocol|0|||
130273183|NCT03012828|468963750|FG002|Overall Study|Non-compliance with protocol|0|||
130273184|NCT03012828|468963751|FG003|Overall Study|Non-compliance with protocol|0|||
130273185|NCT03012828|468963752|FG004|Overall Study|Non-compliance with protocol|1|||
130273186|NCT03012828|468963753|FG005|Overall Study|Non-compliance with protocol|0|||
130273187|NCT03012828|468963748|FG000|Overall Study|Delay to last visit would delay DBL|0|||
130273188|NCT03012828|468963749|FG001|Overall Study|Delay to last visit would delay DBL|0|||
130273189|NCT03012828|468963750|FG002|Overall Study|Delay to last visit would delay DBL|0|||
130273190|NCT03012828|468963751|FG003|Overall Study|Delay to last visit would delay DBL|0|||
130273191|NCT03012828|468963752|FG004|Overall Study|Delay to last visit would delay DBL|0|||
130273192|NCT03012828|468963753|FG005|Overall Study|Delay to last visit would delay DBL|1|||
130273193|NCT03900728|468963754|FG000|Overall Study|No text responses|0|||
130273194|NCT03900728|468963755|FG001|Overall Study|No text responses|0|||
130273195|NCT03900728|468963756|FG002|Overall Study|No text responses|4|||
130273196|NCT00763256|468963758|FG000|Overall Study|Didn't return for appointments|7|||
130273197|NCT00763256|468963759|FG001|Overall Study|Didn't return for appointments|10|||
130273198|NCT02544750|468963761|FG000|Overall Study|Physician Decision|3|||
130273199|NCT02544750|468963762|FG001|Overall Study|Physician Decision|1|||
130273200|NCT02544750|468963761|FG000|Overall Study|Other reasons|69|||
130273201|NCT02544750|468963762|FG001|Overall Study|Other reasons|39|||
130273202|NCT02544750|468963761|FG000|Overall Study|Met withdrawal criteria|2|||
130273203|NCT02544750|468963762|FG001|Overall Study|Met withdrawal criteria|2|||
130273204|NCT02544750|468963761|FG000|Overall Study|Transition To Commercial Product|1|||
130273205|NCT02544750|468963762|FG001|Overall Study|Transition To Commercial Product|0|||
130273206|NCT02544750|468963761|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
130273207|NCT02544750|468963762|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
130273208|NCT02544750|468963761|FG000|Overall Study|Adverse Event|8|||
130273209|NCT02544750|468963762|FG001|Overall Study|Adverse Event|10|||
130273210|NCT02544750|468963761|FG000|Overall Study|Withdrawal by Subject|10|||
130273211|NCT02544750|468963762|FG001|Overall Study|Withdrawal by Subject|4|||
130273212|NCT02544750|468963761|FG000|Overall Study|Lost to Follow-up|1|||
130273213|NCT02544750|468963762|FG001|Overall Study|Lost to Follow-up|0|||
130273214|NCT04396795|468963765|FG000|Month 1|Lost to Follow-up|2|||
130273215|NCT04396795|468963766|FG001|Month 1|Lost to Follow-up|3|||
130273216|NCT04396795|468963765|FG000|Month 3|Lost to Follow-up|1|||
130273217|NCT04396795|468963766|FG001|Month 3|Lost to Follow-up|3|||
130273218|NCT04396795|468963765|FG000|Month 6|Lost to Follow-up|3|||
130273219|NCT04396795|468963766|FG001|Month 6|Lost to Follow-up|3|||
130273220|NCT03902392|468963770|FG000|Overall Study|Lost to Follow-up|7|||
130273221|NCT03902392|468963771|FG001|Overall Study|Lost to Follow-up|7|||
130273222|NCT00244725|468963772|FG000|Overall Study|Lost to Follow-up|3|||
130037910|NCT01485614|468094743|FG000|Weeks 20-54|Withdrawal by Subject|5|||
130273223|NCT00244725|468963773|FG001|Overall Study|Lost to Follow-up|4|||
130273224|NCT00244725|468963774|FG002|Overall Study|Lost to Follow-up|9|||
130273225|NCT00244725|468963775|FG003|Overall Study|Lost to Follow-up|2|||
130273226|NCT00244725|468963772|FG000|Overall Study|Withdrawal by Subject|9|||
130273227|NCT00244725|468963773|FG001|Overall Study|Withdrawal by Subject|7|||
130273228|NCT00244725|468963774|FG002|Overall Study|Withdrawal by Subject|7|||
130273229|NCT00244725|468963775|FG003|Overall Study|Withdrawal by Subject|8|||
130273230|NCT00244725|468963772|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
130273231|NCT00244725|468963773|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
130273232|NCT00244725|468963774|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
130273233|NCT00244725|468963775|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
130273234|NCT00244725|468963772|FG000|Overall Study|Physician Decision|3|||
130273235|NCT00244725|468963773|FG001|Overall Study|Physician Decision|0|||
130273236|NCT00244725|468963774|FG002|Overall Study|Physician Decision|1|||
130273237|NCT00244725|468963775|FG003|Overall Study|Physician Decision|2|||
130273238|NCT00244725|468963772|FG000|Overall Study|Adverse Events|3|||
130037911|NCT01485614|468094744|FG001|Weeks 20-54|Withdrawal by Subject|3|||
130037912|NCT01485614|468094745|FG002|Weeks 20-54|Withdrawal by Subject|0|||
130273239|NCT00244725|468963773|FG001|Overall Study|Adverse Events|1|||
130273240|NCT00244725|468963774|FG002|Overall Study|Adverse Events|4|||
130273241|NCT00244725|468963775|FG003|Overall Study|Adverse Events|4|||
130273242|NCT00244725|468963772|FG000|Overall Study|Withdrwal by participant|1|||
130273243|NCT00244725|468963773|FG001|Overall Study|Withdrwal by participant|0|||
130273244|NCT00244725|468963774|FG002|Overall Study|Withdrwal by participant|0|||
130273245|NCT00244725|468963775|FG003|Overall Study|Withdrwal by participant|1|||
130273246|NCT00244725|468963772|FG000|Overall Study|Liver function test abnormality|2|||
130273247|NCT00244725|468963773|FG001|Overall Study|Liver function test abnormality|0|||
130273248|NCT00244725|468963774|FG002|Overall Study|Liver function test abnormality|0|||
130273249|NCT00244725|468963775|FG003|Overall Study|Liver function test abnormality|1|||
130273250|NCT00244725|468963772|FG000|Overall Study|Sponsor withdrew the participant|1|||
130273251|NCT00244725|468963773|FG001|Overall Study|Sponsor withdrew the participant|0|||
130273252|NCT00244725|468963774|FG002|Overall Study|Sponsor withdrew the participant|0|||
130273253|NCT00244725|468963775|FG003|Overall Study|Sponsor withdrew the participant|1|||
130273254|NCT00244725|468963772|FG000|Overall Study|Mediciation Error|0|||
130273255|NCT00244725|468963773|FG001|Overall Study|Mediciation Error|1|||
130273256|NCT00244725|468963774|FG002|Overall Study|Mediciation Error|0|||
130273257|NCT00244725|468963775|FG003|Overall Study|Mediciation Error|0|||
130273258|NCT00244725|468963772|FG000|Overall Study|Rehab Refused to allow participantion|0|||
130273259|NCT00244725|468963773|FG001|Overall Study|Rehab Refused to allow participantion|1|||
130273260|NCT00244725|468963774|FG002|Overall Study|Rehab Refused to allow participantion|0|||
130273261|NCT00244725|468963775|FG003|Overall Study|Rehab Refused to allow participantion|0|||
130273262|NCT00244725|468963772|FG000|Overall Study|Headache|0|||
130273263|NCT00244725|468963773|FG001|Overall Study|Headache|1|||
130273264|NCT00244725|468963774|FG002|Overall Study|Headache|0|||
130273265|NCT00244725|468963775|FG003|Overall Study|Headache|0|||
130273266|NCT00244725|468963772|FG000|Overall Study|Received prohibited medication|0|||
130273267|NCT00244725|468963773|FG001|Overall Study|Received prohibited medication|1|||
130273268|NCT00244725|468963774|FG002|Overall Study|Received prohibited medication|0|||
130273269|NCT00244725|468963775|FG003|Overall Study|Received prohibited medication|1|||
130273270|NCT00244725|468963772|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130273271|NCT00244725|468963773|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
130273272|NCT00244725|468963774|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130273273|NCT00244725|468963775|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
130273274|NCT00244725|468963772|FG000|Overall Study|Administrative reason|0|||
130273275|NCT00244725|468963773|FG001|Overall Study|Administrative reason|0|||
130273276|NCT00244725|468963774|FG002|Overall Study|Administrative reason|1|||
130273277|NCT00244725|468963775|FG003|Overall Study|Administrative reason|0|||
130273278|NCT00244725|468963772|FG000|Overall Study|Vomit|0|||
130273279|NCT00244725|468963773|FG001|Overall Study|Vomit|0|||
130273280|NCT00244725|468963774|FG002|Overall Study|Vomit|1|||
130273281|NCT00244725|468963775|FG003|Overall Study|Vomit|0|||
130273282|NCT00244725|468963772|FG000|Overall Study|Failed to follow-up|0|||
130273283|NCT00244725|468963773|FG001|Overall Study|Failed to follow-up|0|||
130273284|NCT00244725|468963774|FG002|Overall Study|Failed to follow-up|1|||
130273285|NCT00244725|468963775|FG003|Overall Study|Failed to follow-up|1|||
130273286|NCT03248167|468963776|FG000|Overall Study|Withdrawal by Subject|2|||
130273287|NCT03248167|468963777|FG001|Overall Study|Withdrawal by Subject|2|||
130273288|NCT03248167|468963776|FG000|Overall Study|Physician Decision|0|||
130273289|NCT03248167|468963777|FG001|Overall Study|Physician Decision|1|||
130273290|NCT03248167|468963776|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
130273291|NCT03248167|468963777|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
130273292|NCT03248167|468963776|FG000|Overall Study|Lost to Follow-up|1|||
130273293|NCT03248167|468963777|FG001|Overall Study|Lost to Follow-up|0|||
130273294|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Death|0|||
130273295|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Death|1|||
130273296|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Death|1|||
130273297|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Death|0|||
130273298|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Death|0|||
130273299|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Death|0|||
130273300|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Death|0|||
130273301|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Death|0|||
130273302|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273303|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273304|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
130273305|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130037913|NCT01485614|468094746|FG003|Weeks 20-54|Withdrawal by Subject|0|||
130037914|NCT02210780|468094747|FG000|Overall Study|Adverse Event|0|||
130273306|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
130273307|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273308|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273309|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
130273310|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273311|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273312|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273313|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130037915|NCT02210780|468094748|FG001|Overall Study|Adverse Event|5|||
130273314|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273315|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273316|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273317|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130273318|NCT02122146|468963778|FG000|Part 1: Dose Escalation|Other|1|||
130273319|NCT02122146|468963779|FG001|Part 1: Dose Escalation|Other|0|||
130273320|NCT02122146|468963780|FG002|Part 1: Dose Escalation|Other|0|||
130273321|NCT02122146|468963781|FG003|Part 1: Dose Escalation|Other|0|||
130273322|NCT02122146|468963782|FG004|Part 1: Dose Escalation|Other|0|||
130273323|NCT02122146|468963783|FG005|Part 1: Dose Escalation|Other|1|||
130273324|NCT02122146|468963784|FG006|Part 1: Dose Escalation|Other|1|||
130273325|NCT02122146|468963785|FG007|Part 1: Dose Escalation|Other|2|||
130273326|NCT03472495|468963786|FG000|Overall Study|Treatment no longer indicated|1|||
130273327|NCT03472495|468963787|FG001|Overall Study|Treatment no longer indicated|2|||
130273328|NCT03472495|468963786|FG000|Overall Study|Physician Decision|0|||
130273329|NCT03472495|468963787|FG001|Overall Study|Physician Decision|2|||
130273330|NCT01107392|468963789|FG000|Overall Study|Adverse Event|2|||
130273331|NCT01107392|468963790|FG001|Overall Study|Adverse Event|0|||
130273332|NCT01107392|468963789|FG000|Overall Study|Personal Reasons|2|||
130273333|NCT01107392|468963790|FG001|Overall Study|Personal Reasons|3|||
130273334|NCT01107392|468963789|FG000|Overall Study|Administrative decision|1|||
130273335|NCT01107392|468963790|FG001|Overall Study|Administrative decision|0|||
130273336|NCT02998671|468963793|FG000|Period 1|Study Terminated By Sponsor|2|||
130273337|NCT02998671|468963794|FG001|Period 1|Study Terminated By Sponsor|1|||
130273338|NCT02998671|468963795|FG002|Period 1|Study Terminated By Sponsor|0|||
130273339|NCT02998671|468963796|FG003|Period 1|Study Terminated By Sponsor|0|||
130273340|NCT02998671|468963797|FG004|Period 1|Study Terminated By Sponsor|1|||
130273341|NCT02998671|468963793|FG000|Period 1|Withdrawal by Subject|1|||
130273342|NCT02998671|468963794|FG001|Period 1|Withdrawal by Subject|2|||
130273343|NCT02998671|468963795|FG002|Period 1|Withdrawal by Subject|0|||
130273344|NCT02998671|468963796|FG003|Period 1|Withdrawal by Subject|0|||
130273345|NCT02998671|468963797|FG004|Period 1|Withdrawal by Subject|2|||
130273346|NCT02998671|468963793|FG000|Period 1|Pregnancy|1|||
130273347|NCT02998671|468963794|FG001|Period 1|Pregnancy|0|||
130273348|NCT02998671|468963795|FG002|Period 1|Pregnancy|0|||
130273349|NCT02998671|468963796|FG003|Period 1|Pregnancy|0|||
130273350|NCT02998671|468963797|FG004|Period 1|Pregnancy|0|||
130273351|NCT02998671|468963793|FG000|Period 1|Adverse Event|0|||
130273352|NCT02998671|468963794|FG001|Period 1|Adverse Event|0|||
130273353|NCT02998671|468963795|FG002|Period 1|Adverse Event|0|||
130273354|NCT02998671|468963796|FG003|Period 1|Adverse Event|0|||
130273355|NCT02998671|468963797|FG004|Period 1|Adverse Event|1|||
130273356|NCT02998671|468963793|FG000|Period 2|Adverse Event|0|||
130273357|NCT02998671|468963794|FG001|Period 2|Adverse Event|1|||
130273358|NCT02998671|468963795|FG002|Period 2|Adverse Event|0|||
130273359|NCT02998671|468963796|FG003|Period 2|Adverse Event|0|||
130273360|NCT02998671|468963797|FG004|Period 2|Adverse Event|0|||
130273361|NCT02998671|468963793|FG000|Period 2|Study Terminated By Sponsor|3|||
130273362|NCT02998671|468963794|FG001|Period 2|Study Terminated By Sponsor|5|||
130273363|NCT02998671|468963795|FG002|Period 2|Study Terminated By Sponsor|1|||
130273364|NCT02998671|468963796|FG003|Period 2|Study Terminated By Sponsor|3|||
130273365|NCT02998671|468963797|FG004|Period 2|Study Terminated By Sponsor|0|||
130273366|NCT02998671|468963793|FG000|Period 2|Withdrawal by Subject|0|||
130273367|NCT02998671|468963794|FG001|Period 2|Withdrawal by Subject|1|||
130273368|NCT02998671|468963795|FG002|Period 2|Withdrawal by Subject|0|||
130273369|NCT02998671|468963796|FG003|Period 2|Withdrawal by Subject|0|||
130273370|NCT02998671|468963797|FG004|Period 2|Withdrawal by Subject|0|||
130273371|NCT02998671|468963793|FG000|Period 2|Lost to Follow-up|0|||
130273372|NCT02998671|468963794|FG001|Period 2|Lost to Follow-up|0|||
130273373|NCT02998671|468963795|FG002|Period 2|Lost to Follow-up|0|||
130273374|NCT02998671|468963796|FG003|Period 2|Lost to Follow-up|1|||
130273375|NCT02998671|468963797|FG004|Period 2|Lost to Follow-up|0|||
130273376|NCT02038946|468963799|FG000|Overall Study|Death|5|||
130273377|NCT02038946|468963799|FG000|Overall Study|Withdrawal by Subject|3|||
130273378|NCT02038946|468963799|FG000|Overall Study|Lost to Follow-up|2|||
130273379|NCT02038946|468963799|FG000|Overall Study|Other reasons|2|||
130273380|NCT02473471|468963800|FG000|Overall Study|poor oral hygiene|2|||
130273381|NCT02473471|468963800|FG000|Overall Study|Lost to Follow-up|1|||
130273382|NCT02725476|468963803|FG000|Overall Study|Physician Decision|2|||
130273383|NCT02725476|468963804|FG001|Overall Study|Physician Decision|0|||
130273384|NCT02725476|468963803|FG000|Overall Study|Adverse Event|1|||
130273385|NCT02725476|468963804|FG001|Overall Study|Adverse Event|1|||
130273386|NCT02455336|468963809|FG000|Overall Study|Withdrawal by Subject|0|||
130273387|NCT02455336|468963810|FG001|Overall Study|Withdrawal by Subject|2|||
130273388|NCT02455336|468963809|FG000|Overall Study|Adverse Event|3|||
130273389|NCT02455336|468963810|FG001|Overall Study|Adverse Event|0|||
130273390|NCT02455336|468963809|FG000|Overall Study|Non-responder to treatment|2|||
130273391|NCT02455336|468963810|FG001|Overall Study|Non-responder to treatment|0|||
130273392|NCT00391430|468963811|FG000|Overall Study|Withdrawal by Subject|3|||
130273393|NCT00391430|468963812|FG001|Overall Study|Withdrawal by Subject|0|||
130273394|NCT00391430|468963813|FG002|Overall Study|Withdrawal by Subject|12|||
130273395|NCT02467192|468963814|FG000|Overall Study|Death|1|||
130273396|NCT02467192|468963814|FG000|Overall Study|revealed to have pneumonia before|2|||
130273397|NCT03146663|468963818|FG000|Overall Study|Did not receive study treatment|1|||
130273398|NCT03146663|468963819|FG001|Overall Study|Did not receive study treatment|1|||
130273399|NCT03089047|468963820|FG000|Overall Study|Lost to Follow-up|1|||
130273400|NCT03089047|468963821|FG001|Overall Study|Lost to Follow-up|0|||
130273401|NCT03599518|468963822|FG000|Overall Study|Clinical progression|0|||
130273402|NCT03599518|468963823|FG001|Overall Study|Clinical progression|0|||
130273403|NCT03599518|468963824|FG002|Overall Study|Clinical progression|0|||
130273404|NCT03599518|468963825|FG003|Overall Study|Clinical progression|0|||
130273405|NCT03599518|468963826|FG004|Overall Study|Clinical progression|1|||
130273406|NCT03599518|468963822|FG000|Overall Study|Adverse Event|0|||
130273407|NCT03599518|468963823|FG001|Overall Study|Adverse Event|0|||
130273408|NCT03599518|468963824|FG002|Overall Study|Adverse Event|0|||
130273409|NCT03599518|468963825|FG003|Overall Study|Adverse Event|0|||
130273410|NCT03599518|468963826|FG004|Overall Study|Adverse Event|1|||
130273411|NCT03599518|468963822|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
130273412|NCT03599518|468963823|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
130273413|NCT03599518|468963824|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
130273414|NCT03599518|468963825|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
130273415|NCT03599518|468963826|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
130273416|NCT03599518|468963822|FG000|Overall Study|Participant withdrawal from study treatment|0|||
130273417|NCT03599518|468963823|FG001|Overall Study|Participant withdrawal from study treatment|0|||
130273418|NCT03599518|468963824|FG002|Overall Study|Participant withdrawal from study treatment|1|||
130273419|NCT03599518|468963825|FG003|Overall Study|Participant withdrawal from study treatment|0|||
130273420|NCT03599518|468963826|FG004|Overall Study|Participant withdrawal from study treatment|0|||
130273421|NCT02701764|468963831|FG000|Overall Study|Lost to Follow-up|0|||
130273422|NCT02701764|468963832|FG001|Overall Study|Lost to Follow-up|1|||
130273423|NCT01027650|468963833|FG000|Overall Study|Personal Reasons|0|||
130273424|NCT01027650|468963834|FG001|Overall Study|Personal Reasons|0|||
130273425|NCT01027650|468963835|FG002|Overall Study|Personal Reasons|0|||
130273426|NCT01027650|468963836|FG003|Overall Study|Personal Reasons|0|||
130273427|NCT01027650|468963837|FG004|Overall Study|Personal Reasons|2|||
130273428|NCT01027650|468963838|FG005|Overall Study|Personal Reasons|1|||
130273429|NCT01027650|468963839|FG006|Overall Study|Personal Reasons|0|||
130273430|NCT01027650|468963840|FG007|Overall Study|Personal Reasons|0|||
130273431|NCT01027650|468963833|FG000|Overall Study|Lost to Follow-up|0|||
130273432|NCT01027650|468963834|FG001|Overall Study|Lost to Follow-up|0|||
130273433|NCT01027650|468963835|FG002|Overall Study|Lost to Follow-up|0|||
130273434|NCT01027650|468963836|FG003|Overall Study|Lost to Follow-up|0|||
130273435|NCT01027650|468963837|FG004|Overall Study|Lost to Follow-up|0|||
130273436|NCT01027650|468963838|FG005|Overall Study|Lost to Follow-up|0|||
130273437|NCT01027650|468963839|FG006|Overall Study|Lost to Follow-up|1|||
130273438|NCT01027650|468963840|FG007|Overall Study|Lost to Follow-up|0|||
130273439|NCT01027650|468963833|FG000|Overall Study|Lack of Efficacy|0|||
130273440|NCT01027650|468963834|FG001|Overall Study|Lack of Efficacy|0|||
130273441|NCT01027650|468963835|FG002|Overall Study|Lack of Efficacy|0|||
130273442|NCT01027650|468963836|FG003|Overall Study|Lack of Efficacy|0|||
130273443|NCT01027650|468963837|FG004|Overall Study|Lack of Efficacy|0|||
130273444|NCT01027650|468963838|FG005|Overall Study|Lack of Efficacy|1|||
130273445|NCT01027650|468963839|FG006|Overall Study|Lack of Efficacy|0|||
130273446|NCT01027650|468963840|FG007|Overall Study|Lack of Efficacy|0|||
130273447|NCT00912782|468963841|FG000|Overall Study|Death|2|||
130273448|NCT00912782|468963842|FG001|Overall Study|Death|1|||
130273449|NCT00912782|468963841|FG000|Overall Study|Lost to Follow-up|0|||
130273450|NCT00912782|468963842|FG001|Overall Study|Lost to Follow-up|1|||
130273451|NCT00912782|468963841|FG000|Overall Study|Did not receive vascular access type|1|||
130273452|NCT00912782|468963842|FG001|Overall Study|Did not receive vascular access type|2|||
130273453|NCT00912782|468963841|FG000|Overall Study|Relocated before study completion|0|||
130273454|NCT00912782|468963842|FG001|Overall Study|Relocated before study completion|1|||
130273455|NCT00294671|468965552|FG000|Overall Study|Lack of Efficacy|11|||
130273456|NCT00294671|468965553|FG001|Overall Study|Lack of Efficacy|23|||
130273457|NCT00294671|468965552|FG000|Overall Study|Liver transplant|7|||
130273458|NCT00294671|468965553|FG001|Overall Study|Liver transplant|9|||
130273459|NCT00294671|468965552|FG000|Overall Study|Drug related adverse event (AE)|4|||
130273460|NCT00294671|468965553|FG001|Overall Study|Drug related adverse event (AE)|2|||
130273461|NCT00294671|468965552|FG000|Overall Study|Non-drug related AE|3|||
130273462|NCT00294671|468965553|FG001|Overall Study|Non-drug related AE|2|||
130273463|NCT00294671|468965552|FG000|Overall Study|Lost to Follow-up|1|||
130273464|NCT00294671|468965553|FG001|Overall Study|Lost to Follow-up|3|||
130273465|NCT00294671|468965552|FG000|Overall Study|Non-compliance|1|||
130273466|NCT00294671|468965553|FG001|Overall Study|Non-compliance|0|||
130104021|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130104022|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130273467|NCT00294671|468965552|FG000|Overall Study|Death|0|||
130273468|NCT00294671|468965553|FG001|Overall Study|Death|1|||
130273469|NCT02263326|468965560|FG000|Overall Study|Lost to Follow-up|1|||
130273470|NCT02263326|468965561|FG001|Overall Study|Lost to Follow-up|1|||
130273471|NCT01893411|468965562|FG000|Overall Study|Protocol Violation|1|||
130273472|NCT01893411|468965563|FG001|Overall Study|Protocol Violation|0|||
130273473|NCT01893411|468965564|FG002|Overall Study|Protocol Violation|0|||
130273474|NCT01893411|468965562|FG000|Overall Study|Physician Decision|1|||
130273475|NCT01893411|468965563|FG001|Overall Study|Physician Decision|1|||
130273476|NCT01893411|468965564|FG002|Overall Study|Physician Decision|2|||
130273477|NCT01893411|468965562|FG000|Overall Study|Lack of Efficacy|2|||
130273478|NCT01893411|468965563|FG001|Overall Study|Lack of Efficacy|1|||
130273479|NCT01893411|468965564|FG002|Overall Study|Lack of Efficacy|0|||
130273480|NCT01893411|468965562|FG000|Overall Study|Other|3|||
130273481|NCT01893411|468965563|FG001|Overall Study|Other|1|||
130273482|NCT01893411|468965564|FG002|Overall Study|Other|3|||
130273483|NCT01893411|468965562|FG000|Overall Study|Adverse Event|1|||
130273484|NCT01893411|468965563|FG001|Overall Study|Adverse Event|0|||
130273485|NCT01893411|468965564|FG002|Overall Study|Adverse Event|0|||
130273486|NCT01893411|468965562|FG000|Overall Study|Withdrawal by Subject|7|||
130273487|NCT01893411|468965563|FG001|Overall Study|Withdrawal by Subject|4|||
130273488|NCT01893411|468965564|FG002|Overall Study|Withdrawal by Subject|3|||
130273489|NCT01893411|468965562|FG000|Overall Study|Lost to Follow-up|2|||
130273490|NCT01893411|468965563|FG001|Overall Study|Lost to Follow-up|0|||
130273491|NCT01893411|468965564|FG002|Overall Study|Lost to Follow-up|1|||
130273492|NCT02397915|468965565|FG000|Period 1|Protocol Violation|0|||
130273493|NCT02397915|468965566|FG001|Period 1|Protocol Violation|1|||
130273494|NCT02397915|468965567|FG002|Period 1|Protocol Violation|0|||
130273495|NCT02397915|468965568|FG003|Period 1|Protocol Violation|0|||
130273496|NCT02397915|468965565|FG000|Period 1|Physician Decision|1|||
130273497|NCT02397915|468965566|FG001|Period 1|Physician Decision|0|||
130273498|NCT02397915|468965567|FG002|Period 1|Physician Decision|0|||
130273499|NCT02397915|468965568|FG003|Period 1|Physician Decision|0|||
130273500|NCT03292874|468965569|FG000|Overall Study|Due to pandemic|5|||
130273501|NCT00933608|468965570|FG000|Overall Study|Adverse Event|4|||
130273502|NCT00933608|468965571|FG001|Overall Study|Adverse Event|2|||
130273503|NCT00933608|468965570|FG000|Overall Study|Physician Decision|1|||
130273504|NCT00933608|468965571|FG001|Overall Study|Physician Decision|0|||
130273505|NCT03053440|468965574|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
130273506|NCT03053440|468965575|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
130273507|NCT03053440|468965574|FG000|Overall Study|Death|18|||
130273508|NCT03053440|468965575|FG001|Overall Study|Death|14|||
130273509|NCT03053440|468965574|FG000|Overall Study|Withdrawal by Subject|9|||
130273510|NCT03053440|468965575|FG001|Overall Study|Withdrawal by Subject|8|||
130273511|NCT03053440|468965574|FG000|Overall Study|Lost to Follow-up|1|||
130273512|NCT03053440|468965575|FG001|Overall Study|Lost to Follow-up|0|||
130273513|NCT03053440|468965574|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
130273514|NCT03053440|468965575|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
130273515|NCT03053440|468965574|FG000|Overall Study|Physician Decision|2|||
130273516|NCT03053440|468965575|FG001|Overall Study|Physician Decision|1|||
130273517|NCT03053440|468965574|FG000|Overall Study|Participant Randomized but died before dosing|1|||
130273518|NCT03053440|468965575|FG001|Overall Study|Participant Randomized but died before dosing|0|||
130273519|NCT00391053|468965576|FG000|Overall Study|Serious Adverse Events|1|||
130273520|NCT00391053|468965577|FG001|Overall Study|Serious Adverse Events|0|||
130273521|NCT00391053|468965578|FG002|Overall Study|Serious Adverse Events|1|||
130273522|NCT00391053|468965579|FG003|Overall Study|Serious Adverse Events|4|||
130273523|NCT00391053|468965576|FG000|Overall Study|Protocol Violation|2|||
130273524|NCT00391053|468965577|FG001|Overall Study|Protocol Violation|0|||
130273525|NCT00391053|468965578|FG002|Overall Study|Protocol Violation|0|||
130273526|NCT00391053|468965579|FG003|Overall Study|Protocol Violation|0|||
130273527|NCT00391053|468965576|FG000|Overall Study|Lost to Follow-up|1|||
130273528|NCT00391053|468965577|FG001|Overall Study|Lost to Follow-up|0|||
130273529|NCT00391053|468965578|FG002|Overall Study|Lost to Follow-up|0|||
130273530|NCT00391053|468965579|FG003|Overall Study|Lost to Follow-up|5|||
130273531|NCT00391053|468965576|FG000|Overall Study|Withdrawal by Subject|5|||
130273532|NCT00391053|468965577|FG001|Overall Study|Withdrawal by Subject|1|||
130273533|NCT00391053|468965578|FG002|Overall Study|Withdrawal by Subject|1|||
130273534|NCT00391053|468965579|FG003|Overall Study|Withdrawal by Subject|1|||
130104023|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
130273535|NCT05002985|468965580|FG000|Overall Study|Withdrawal by Subject|1|||
130273536|NCT02943070|468965581|FG000|Overall Study|Physician Decision|1|||
130273537|NCT02943070|468965581|FG000|Overall Study|Adverse Event|2|||
130273538|NCT02943070|468965581|FG000|Overall Study|Death|2|||
130273539|NCT02943070|468965581|FG000|Overall Study|Withdrawal by Subject|3|||
130273540|NCT02943070|468965581|FG000|Overall Study|Lost to Follow-up|4|||
130273541|NCT02943070|468965581|FG000|Overall Study|Retreatment or TURP|13|||
130273542|NCT02943070|468965581|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
130273543|NCT04123093|468965582|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
130273544|NCT04123093|468965583|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
130273545|NCT04123093|468965582|FG000|Phase 2|Physician Decision|0|||
130273546|NCT04123093|468965583|FG001|Phase 2|Physician Decision|1|||
130273547|NCT04123093|468965582|FG000|Phase 2|Withdrawal by Subject|0|||
130273548|NCT04123093|468965583|FG001|Phase 2|Withdrawal by Subject|1|||
130273549|NCT01485796|468965585|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
130273550|NCT01485796|468965585|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
130273551|NCT01485796|468965585|FG000|Period 2: Epoch 2|Adverse Event|3|||
130273552|NCT01485796|468965585|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
130273553|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
130273554|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
130273555|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
130273556|NCT01485796|468965585|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
130273557|NCT00606411|468965595|FG000|Overall Study|Adverse Event|1|||
130273558|NCT00606411|468965596|FG001|Overall Study|Adverse Event|2|||
130273559|NCT00606411|468965595|FG000|Overall Study|Lack of Adherence|1|||
130273560|NCT00606411|468965596|FG001|Overall Study|Lack of Adherence|1|||
130273561|NCT00606411|468965595|FG000|Overall Study|Lack of Efficacy|1|||
130273562|NCT00606411|468965596|FG001|Overall Study|Lack of Efficacy|1|||
130273563|NCT00606411|468965595|FG000|Overall Study|Withdrawal by Subject|2|||
130273564|NCT00606411|468965596|FG001|Overall Study|Withdrawal by Subject|0|||
130273565|NCT00606411|468965595|FG000|Overall Study|Lost to Follow-up|1|||
130273566|NCT00606411|468965596|FG001|Overall Study|Lost to Follow-up|2|||
130037916|NCT02210780|468094747|FG000|Overall Study|Lost to Follow-up|2|||
130037917|NCT02210780|468094748|FG001|Overall Study|Lost to Follow-up|1|||
130037918|NCT02210780|468094747|FG000|Overall Study|Withdrawal by Subject|1|||
130037919|NCT02210780|468094748|FG001|Overall Study|Withdrawal by Subject|1|||
130104024|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
130104025|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
130104026|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
130104027|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
130104028|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
130104029|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
130104030|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130037920|NCT02210780|468094747|FG000|Overall Study|Physician Decision|1|||
130037921|NCT02210780|468094748|FG001|Overall Study|Physician Decision|0|||
130273567|NCT00606411|468965595|FG000|Overall Study|Move out of state|0|||
130273568|NCT00606411|468965596|FG001|Overall Study|Move out of state|1|||
130037922|NCT02210780|468094747|FG000|Overall Study|Protocol Violation|1|||
130037923|NCT02210780|468094748|FG001|Overall Study|Protocol Violation|0|||
130037924|NCT02210780|468094747|FG000|Overall Study|Other than specified above|0|||
130037925|NCT02210780|468094748|FG001|Overall Study|Other than specified above|1|||
130037926|NCT00942409|468094749|FG000|Overall Study|Lack of Efficacy|1|||
130037927|NCT00942409|468094749|FG000|Overall Study|study drug unavailable|2|||
130037928|NCT00049127|468094752|FG000|Overall Study|Withdrawal by Subject|0|||
130037929|NCT00049127|468094753|FG001|Overall Study|Withdrawal by Subject|0|||
130037930|NCT00049127|468094754|FG002|Overall Study|Withdrawal by Subject|1|||
130037931|NCT00049127|468094755|FG003|Overall Study|Withdrawal by Subject|0|||
130037932|NCT00049127|468094756|FG004|Overall Study|Withdrawal by Subject|0|||
130037933|NCT02582515|468094757|FG000|Overall Study|Withdrawal by Subject|0|||
130037934|NCT02582515|468094758|FG001|Overall Study|Withdrawal by Subject|1|||
130037935|NCT04927312|468094759|FG000|Overall Study|Adverse Event|1|||
130037936|NCT04927312|468094759|FG000|Overall Study|Death|1|||
130037937|NCT04927312|468094759|FG000|Overall Study|Withdrawal by Subject|1|||
130037938|NCT04927312|468094759|FG000|Overall Study|Other|1|||
130037939|NCT01122927|468094765|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
130037940|NCT01122927|468094766|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
130037941|NCT01122927|468094765|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
130037942|NCT01122927|468094766|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
130037943|NCT01122927|468094765|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
130037944|NCT01122927|468094766|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
130037945|NCT01122927|468094765|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
130037946|NCT01122927|468094766|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
130037947|NCT01122927|468094765|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
130037948|NCT01122927|468094766|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
130037949|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
130037950|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
130037951|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
130037952|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
130037953|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
130037954|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
130037955|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
130037956|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
130037957|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
130037958|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
130037959|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
130037960|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
130037961|NCT01122927|468094765|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
130037962|NCT01122927|468094766|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
130037963|NCT00684814|468094767|FG000|Washout Period of 7 Days|Adverse Event|1|||
130037964|NCT00684814|468094768|FG001|Washout Period of 7 Days|Adverse Event|2|||
130037965|NCT00684814|468094767|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130037966|NCT00684814|468094768|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
130037967|NCT00684814|468094767|FG000|Second Intervention|Adverse Event|1|||
130037968|NCT00684814|468094768|FG001|Second Intervention|Adverse Event|0|||
130037969|NCT01676961|468094771|FG000|Overall Study|Death|3|||
130037970|NCT01676961|468094771|FG000|Overall Study|Lost to Follow-up|1|||
130037971|NCT01676961|468094771|FG000|Overall Study|Withdrawal by Subject|1|||
130037972|NCT00117312|468094772|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
130037973|NCT00117312|468094773|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
130037974|NCT00117312|468094774|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
130037975|NCT00117312|468094775|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
130037976|NCT00117312|468094772|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
130037977|NCT00117312|468094773|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
130037978|NCT00117312|468094774|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
130037979|NCT00117312|468094775|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
130037980|NCT00117312|468094772|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
130037981|NCT00117312|468094773|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
130037982|NCT00117312|468094774|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
130037983|NCT00117312|468094775|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
130037984|NCT00117312|468094772|FG000|Overall Study|Other|0|||
130037985|NCT00117312|468094773|FG001|Overall Study|Other|1|||
130037986|NCT00117312|468094774|FG002|Overall Study|Other|3|||
130037987|NCT00117312|468094775|FG003|Overall Study|Other|1|||
130037988|NCT00117312|468094772|FG000|Overall Study|Patient choice|0|||
130037989|NCT00117312|468094773|FG001|Overall Study|Patient choice|0|||
130037990|NCT00117312|468094774|FG002|Overall Study|Patient choice|2|||
130037991|NCT00117312|468094775|FG003|Overall Study|Patient choice|1|||
130037992|NCT00117312|468094772|FG000|Overall Study|Adverse Event|0|||
130037993|NCT00117312|468094773|FG001|Overall Study|Adverse Event|2|||
130037994|NCT00117312|468094774|FG002|Overall Study|Adverse Event|0|||
130037995|NCT00117312|468094775|FG003|Overall Study|Adverse Event|0|||
130037996|NCT00117312|468094772|FG000|Overall Study|Protocol Violation|0|||
130037997|NCT00117312|468094773|FG001|Overall Study|Protocol Violation|1|||
130037998|NCT00117312|468094774|FG002|Overall Study|Protocol Violation|3|||
130037999|NCT00117312|468094775|FG003|Overall Study|Protocol Violation|0|||
130038000|NCT00117312|468094772|FG000|Overall Study|PSA decrease <=50%|0|||
130038001|NCT00117312|468094773|FG001|Overall Study|PSA decrease <=50%|2|||
130038002|NCT00117312|468094774|FG002|Overall Study|PSA decrease <=50%|2|||
130038003|NCT00117312|468094775|FG003|Overall Study|PSA decrease <=50%|4|||
130038004|NCT00117312|468094772|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
130038005|NCT00117312|468094773|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
130038006|NCT00117312|468094774|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
130038007|NCT00117312|468094775|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
130038008|NCT00117312|468094772|FG000|Overall Study|Hepatic abnormality|0|||
130038009|NCT00117312|468094773|FG001|Overall Study|Hepatic abnormality|1|||
130038010|NCT00117312|468094774|FG002|Overall Study|Hepatic abnormality|0|||
130038011|NCT00117312|468094775|FG003|Overall Study|Hepatic abnormality|1|||
130038012|NCT00117312|468094772|FG000|Overall Study|Withdrawal by Subject|0|||
130038013|NCT00117312|468094773|FG001|Overall Study|Withdrawal by Subject|2|||
130038014|NCT00117312|468094774|FG002|Overall Study|Withdrawal by Subject|0|||
130038015|NCT00117312|468094775|FG003|Overall Study|Withdrawal by Subject|0|||
130038016|NCT00195650|468094776|FG000|Overall Study|Adverse Event|194|||
130038017|NCT00195650|468094776|FG000|Overall Study|Lack of Efficacy|99|||
130038018|NCT00195650|468094776|FG000|Overall Study|Withdrawal by Subject|67|||
130038019|NCT00195650|468094776|FG000|Overall Study|Lost to Follow-up|44|||
130038020|NCT00195650|468094776|FG000|Overall Study|Death|23|||
130038021|NCT00195650|468094776|FG000|Overall Study|Protocol Violation|15|||
130038022|NCT00195650|468094776|FG000|Overall Study|Administrative reasons|83|||
130038023|NCT02371629|468094782|FG000|Overall Study|Patient decision|14|||
130038024|NCT02371629|468094783|FG001|Overall Study|Patient decision|10|||
130038025|NCT02371629|468094782|FG000|Overall Study|Adverse Event|8|||
130038026|NCT02371629|468094783|FG001|Overall Study|Adverse Event|8|||
130038027|NCT02371629|468094782|FG000|Overall Study|Physician Decision|2|||
130038028|NCT02371629|468094783|FG001|Overall Study|Physician Decision|3|||
130038029|NCT02371629|468094782|FG000|Overall Study|Death|1|||
130038030|NCT02371629|468094783|FG001|Overall Study|Death|1|||
130038031|NCT02371629|468094782|FG000|Overall Study|Noncompliance with study treatment|1|||
130038032|NCT02371629|468094783|FG001|Overall Study|Noncompliance with study treatment|0|||
130038033|NCT02371629|468094782|FG000|Overall Study|Lack of Efficacy|0|||
130038034|NCT02371629|468094783|FG001|Overall Study|Lack of Efficacy|2|||
130038035|NCT02371629|468094782|FG000|Overall Study|Protocol deviation|0|||
130038036|NCT02371629|468094783|FG001|Overall Study|Protocol deviation|1|||
130038037|NCT00201851|468094784|FG000|Overall Study|Lost to Follow-up|2|||
130038038|NCT00201851|468094785|FG001|Overall Study|Lost to Follow-up|1|||
130038039|NCT00201851|468094786|FG002|Overall Study|Lost to Follow-up|0|||
130038040|NCT00201851|468094784|FG000|Overall Study|Ineligible post enrollment|6|||
130038041|NCT00201851|468094785|FG001|Overall Study|Ineligible post enrollment|1|||
130038042|NCT00201851|468094786|FG002|Overall Study|Ineligible post enrollment|1|||
130038043|NCT02469246|468094787|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
130038044|NCT02469246|468094788|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
130038045|NCT02469246|468094787|FG000|Double-Blind Phase|Adverse Event|12|||
130038046|NCT02469246|468094788|FG001|Double-Blind Phase|Adverse Event|9|||
130038047|NCT02469246|468094787|FG000|Double-Blind Phase|Death|2|||
130038048|NCT02469246|468094788|FG001|Double-Blind Phase|Death|0|||
130038049|NCT02469246|468094787|FG000|Double-Blind Phase|Lack of Efficacy|2|||
130038050|NCT02469246|468094788|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130038051|NCT02469246|468094787|FG000|Double-Blind Phase|Investigator's Discretion|8|||
130038052|NCT02469246|468094788|FG001|Double-Blind Phase|Investigator's Discretion|8|||
130038053|NCT02469246|468094787|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
130038054|NCT02469246|468094788|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130038055|NCT02469246|468094787|FG000|Double-Blind Phase|Protocol Violation|1|||
130038056|NCT02469246|468094788|FG001|Double-Blind Phase|Protocol Violation|1|||
130038057|NCT02469246|468094787|FG000|Double-Blind Phase|Withdrew Consent|25|||
130038058|NCT02469246|468094788|FG001|Double-Blind Phase|Withdrew Consent|25|||
130038059|NCT02469246|468094787|FG000|Double-Blind Phase|Lost to Follow-up|9|||
130038060|NCT02469246|468094788|FG001|Double-Blind Phase|Lost to Follow-up|5|||
130038061|NCT00749203|468094792|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
130038062|NCT00749203|468094793|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
130038063|NCT00749203|468094792|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
130038064|NCT00749203|468094793|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
130038065|NCT00749203|468094792|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
130038066|NCT00749203|468094793|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
130038067|NCT00749203|468094792|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
130038068|NCT00749203|468094793|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
130038069|NCT00749203|468094792|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
130038070|NCT00749203|468094793|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
130038071|NCT00749203|468094792|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
130038072|NCT00749203|468094793|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
130038073|NCT02853760|468094794|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
130038074|NCT02853760|468094795|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
130038075|NCT02853760|468094796|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
130038076|NCT02853760|468094797|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
130038077|NCT02853760|468094798|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
130038078|NCT02853760|468094799|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
130038079|NCT01642212|468094800|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
130038080|NCT01642212|468094801|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130038081|NCT01642212|468094802|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130038082|NCT01642212|468094803|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130038083|NCT01642212|468094804|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
130038084|NCT01642212|468094800|FG000|Double-blind Treatment|Other|0|||
130038085|NCT01642212|468094801|FG001|Double-blind Treatment|Other|2|||
130273569|NCT02526212|468965597|FG000|Overall Study|Incarceration|1|||
130273570|NCT02526212|468965598|FG001|Overall Study|Incarceration|0|||
130273571|NCT02526212|468965597|FG000|Overall Study|Lost to Follow-up|1|||
130038086|NCT01642212|468094802|FG002|Double-blind Treatment|Other|1|||
130038087|NCT01642212|468094803|FG003|Double-blind Treatment|Other|0|||
130038088|NCT01642212|468094804|FG004|Double-blind Treatment|Other|0|||
130038089|NCT01642212|468094800|FG000|Double-blind Treatment|Non-compliance|0|||
130273572|NCT02526212|468965598|FG001|Overall Study|Lost to Follow-up|0|||
130273573|NCT02526212|468965597|FG000|Overall Study|Death|0|||
130038090|NCT01642212|468094801|FG001|Double-blind Treatment|Non-compliance|1|||
130038091|NCT01642212|468094802|FG002|Double-blind Treatment|Non-compliance|0|||
130038092|NCT01642212|468094803|FG003|Double-blind Treatment|Non-compliance|0|||
130038093|NCT01642212|468094804|FG004|Double-blind Treatment|Non-compliance|0|||
130038094|NCT01642212|468094800|FG000|Double-blind Treatment|Adverse Event|0|||
130038095|NCT01642212|468094801|FG001|Double-blind Treatment|Adverse Event|0|||
130038096|NCT01642212|468094802|FG002|Double-blind Treatment|Adverse Event|1|||
130038097|NCT01642212|468094803|FG003|Double-blind Treatment|Adverse Event|0|||
130038098|NCT01642212|468094804|FG004|Double-blind Treatment|Adverse Event|0|||
130038099|NCT01642212|468094800|FG000|Open-label Extension|Adverse Event|0|||
130038100|NCT01642212|468094801|FG001|Open-label Extension|Adverse Event|0|||
130038101|NCT01642212|468094802|FG002|Open-label Extension|Adverse Event|0|||
130038102|NCT01642212|468094803|FG003|Open-label Extension|Adverse Event|3|||
130038103|NCT01642212|468094804|FG004|Open-label Extension|Adverse Event|0|||
130038104|NCT01642212|468094800|FG000|Open-label Extension|Sponsor Decision|0|||
130038105|NCT01642212|468094801|FG001|Open-label Extension|Sponsor Decision|0|||
130038106|NCT01642212|468094802|FG002|Open-label Extension|Sponsor Decision|0|||
130038107|NCT01642212|468094803|FG003|Open-label Extension|Sponsor Decision|7|||
130038108|NCT01642212|468094804|FG004|Open-label Extension|Sponsor Decision|4|||
130038109|NCT01642212|468094800|FG000|Open-label Extension|Consent Withdrawn|0|||
130038110|NCT01642212|468094801|FG001|Open-label Extension|Consent Withdrawn|0|||
130038111|NCT01642212|468094802|FG002|Open-label Extension|Consent Withdrawn|0|||
130038112|NCT01642212|468094803|FG003|Open-label Extension|Consent Withdrawn|0|||
130038113|NCT01642212|468094804|FG004|Open-label Extension|Consent Withdrawn|2|||
130038114|NCT01642212|468094800|FG000|Open-label Extension|Lost to Follow-up|0|||
130038115|NCT01642212|468094801|FG001|Open-label Extension|Lost to Follow-up|0|||
130038116|NCT01642212|468094802|FG002|Open-label Extension|Lost to Follow-up|0|||
130038117|NCT01642212|468094803|FG003|Open-label Extension|Lost to Follow-up|0|||
130038118|NCT01642212|468094804|FG004|Open-label Extension|Lost to Follow-up|1|||
130038119|NCT01642212|468094800|FG000|Open-label Extension|Other|0|||
130038120|NCT01642212|468094801|FG001|Open-label Extension|Other|0|||
130038121|NCT01642212|468094802|FG002|Open-label Extension|Other|0|||
130038122|NCT01642212|468094803|FG003|Open-label Extension|Other|0|||
130038123|NCT01642212|468094804|FG004|Open-label Extension|Other|1|||
130038124|NCT01243268|468094805|FG000|Overall Study|Lost to Follow-up|4|||
130038125|NCT01243268|468094805|FG000|Overall Study|Protocol Violation|51|||
130038126|NCT01243268|468094805|FG000|Overall Study|Deviation with contract date|7|||
130038127|NCT01243268|468094805|FG000|Overall Study|Duplicate subject|2|||
129886087|NCT02564055|467542848|FG001|Overall Study|Reached stopping criteria|0|||
129886088|NCT02564055|467542849|FG002|Overall Study|Reached stopping criteria|0|||
129886089|NCT02564055|467542850|FG003|Overall Study|Reached stopping criteria|0|||
129886090|NCT02564055|467542851|FG004|Overall Study|Reached stopping criteria|0|||
129886091|NCT02564055|467542852|FG005|Overall Study|Reached stopping criteria|1|||
129886092|NCT02564055|467542847|FG000|Overall Study|Lost to Follow-up|0|||
129886093|NCT02564055|467542848|FG001|Overall Study|Lost to Follow-up|1|||
129886094|NCT02564055|467542849|FG002|Overall Study|Lost to Follow-up|4|||
129886095|NCT02564055|467542850|FG003|Overall Study|Lost to Follow-up|2|||
129886096|NCT02564055|467542851|FG004|Overall Study|Lost to Follow-up|1|||
129886097|NCT02564055|467542852|FG005|Overall Study|Lost to Follow-up|0|||
129886098|NCT02564055|467542847|FG000|Overall Study|Physician Decision|0|||
129886099|NCT02564055|467542848|FG001|Overall Study|Physician Decision|0|||
129886100|NCT02564055|467542849|FG002|Overall Study|Physician Decision|1|||
129886101|NCT02564055|467542850|FG003|Overall Study|Physician Decision|0|||
129886102|NCT02564055|467542851|FG004|Overall Study|Physician Decision|0|||
129886103|NCT02564055|467542852|FG005|Overall Study|Physician Decision|0|||
129886104|NCT02564055|467542847|FG000|Overall Study|Withdrawal by Subject|4|||
130038128|NCT00957853|468094806|FG000|Overall Study|Withdrawal by Subject|1|||
129886105|NCT02564055|467542848|FG001|Overall Study|Withdrawal by Subject|4|||
129886106|NCT02564055|467542849|FG002|Overall Study|Withdrawal by Subject|3|||
130038129|NCT00957853|468094807|FG001|Overall Study|Withdrawal by Subject|0|||
130038130|NCT00957853|468094808|FG002|Overall Study|Withdrawal by Subject|0|||
130038131|NCT00004980|468094809|FG000|Overall Study|Withdrawal by Subject|1|||
130038132|NCT00004980|468094810|FG001|Overall Study|Withdrawal by Subject|0|||
130273574|NCT02526212|468965598|FG001|Overall Study|Death|1|||
130273575|NCT01390298|468965599|FG000|Overall Study|Death|1|||
130273576|NCT01390298|468965599|FG000|Overall Study|long term ICU admission|1|||
130273577|NCT01390298|468965599|FG000|Overall Study|Withdrawal by Subject|14|||
130038133|NCT00004980|468094809|FG000|Overall Study|memory difficulties|1|||
130038134|NCT00004980|468094810|FG001|Overall Study|memory difficulties|1|||
130038135|NCT00004980|468094809|FG000|Overall Study|Physician Decision|0|||
130038136|NCT00004980|468094810|FG001|Overall Study|Physician Decision|1|||
130038137|NCT03577990|468094811|FG000|Overall Study|Lost to Follow-up|4|||
130038138|NCT03577990|468094812|FG001|Overall Study|Lost to Follow-up|6|||
130273578|NCT01390298|468965599|FG000|Overall Study|Lost to Follow-up|7|||
129886107|NCT02564055|467542850|FG003|Overall Study|Withdrawal by Subject|3|||
129886108|NCT02564055|467542851|FG004|Overall Study|Withdrawal by Subject|10|||
129886109|NCT02564055|467542852|FG005|Overall Study|Withdrawal by Subject|10|||
130038139|NCT03577990|468094811|FG000|Overall Study|Withdrawal by Subject|4|||
130038140|NCT03577990|468094812|FG001|Overall Study|Withdrawal by Subject|7|||
130038141|NCT04996797|468094817|FG000|Overall Study|Adverse Event|0|||
129886110|NCT00531011|467542853|FG000|Overall Study|Withdrawal by Subject|2|||
129886111|NCT00531011|467542854|FG001|Overall Study|Withdrawal by Subject|4|||
129886112|NCT00531011|467542853|FG000|Overall Study|Death|1|||
129886113|NCT00531011|467542854|FG001|Overall Study|Death|0|||
130038142|NCT04996797|468094818|FG001|Overall Study|Adverse Event|2|||
130038143|NCT04996797|468094819|FG002|Overall Study|Adverse Event|0|||
130038144|NCT04996797|468094820|FG003|Overall Study|Adverse Event|1|||
130038145|NCT04996797|468094817|FG000|Overall Study|Lack of Efficacy|0|||
130038146|NCT04996797|468094818|FG001|Overall Study|Lack of Efficacy|2|||
130273579|NCT01390298|468965599|FG000|Overall Study|Surgery cancelled|1|||
130273580|NCT00040742|468965606|FG000|Overall Study|Death|0|||
130273581|NCT00040742|468965607|FG001|Overall Study|Death|0|||
130038147|NCT04996797|468094819|FG002|Overall Study|Lack of Efficacy|0|||
130038148|NCT04996797|468094820|FG003|Overall Study|Lack of Efficacy|0|||
130273582|NCT00040742|468965608|FG002|Overall Study|Death|1|||
129886114|NCT00531011|467542853|FG000|Overall Study|Lost to Follow-up|1|||
130038149|NCT04996797|468094817|FG000|Overall Study|Prohibited Medication|0|||
130038150|NCT04996797|468094818|FG001|Overall Study|Prohibited Medication|1|||
130038151|NCT04996797|468094819|FG002|Overall Study|Prohibited Medication|0|||
130038152|NCT04996797|468094820|FG003|Overall Study|Prohibited Medication|0|||
130038153|NCT04996797|468094817|FG000|Overall Study|Ongoing|68|||
130038154|NCT04996797|468094818|FG001|Overall Study|Ongoing|60|||
130038155|NCT04996797|468094819|FG002|Overall Study|Ongoing|22|||
130038156|NCT04996797|468094820|FG003|Overall Study|Ongoing|20|||
130038157|NCT04996797|468094817|FG000|Overall Study|Withdrawal by Subject|0|||
130038158|NCT04996797|468094818|FG001|Overall Study|Withdrawal by Subject|2|||
130038159|NCT04996797|468094819|FG002|Overall Study|Withdrawal by Subject|0|||
130038160|NCT04996797|468094820|FG003|Overall Study|Withdrawal by Subject|0|||
130038161|NCT02793544|468094821|FG000|Overall Study|Death|10|||
130038162|NCT02793544|468094822|FG001|Overall Study|Death|8|||
130038163|NCT02793544|468094821|FG000|Overall Study|Lost to Follow-up|2|||
130038164|NCT02793544|468094822|FG001|Overall Study|Lost to Follow-up|0|||
130038165|NCT02793544|468094821|FG000|Overall Study|Withdrawal by Subject|1|||
130038166|NCT02793544|468094822|FG001|Overall Study|Withdrawal by Subject|0|||
130038167|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
130038168|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130038169|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130038170|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130038171|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
130038172|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
130038173|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
130038174|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
130038175|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
130038176|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
130038177|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
130038178|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
130038179|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
130038180|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
130038181|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
130038182|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
130038183|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
130038184|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
130038185|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
130038186|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
130038187|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
130038188|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
130038189|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
130038190|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
130038191|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
130038192|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
130038193|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
130038194|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
130038195|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
130038196|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
130038197|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
130038198|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
130038199|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
130038200|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
130038201|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
130038202|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
130038203|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
130038204|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
130038205|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
130038206|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
130038207|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
130038208|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
130038209|NCT00100048|468094825|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130038210|NCT00100048|468094826|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130038211|NCT00100048|468094827|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130038212|NCT00100048|468094828|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
130038213|NCT00100048|468094829|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130038214|NCT00100048|468094830|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
130038215|NCT01624142|468094831|FG000|Overall Study|Withdrawal by Subject|14|||
130038216|NCT01624142|468094832|FG001|Overall Study|Withdrawal by Subject|4|||
130104031|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130104032|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
130104033|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104034|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104035|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104036|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104037|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130038217|NCT01624142|468094831|FG000|Overall Study|Death|3|||
130038218|NCT01624142|468094832|FG001|Overall Study|Death|6|||
130038219|NCT01624142|468094831|FG000|Overall Study|Study Closure|12|||
130038220|NCT01624142|468094832|FG001|Overall Study|Study Closure|6|||
130038221|NCT01624142|468094831|FG000|Overall Study|Lost to Follow-up|2|||
130038222|NCT01624142|468094832|FG001|Overall Study|Lost to Follow-up|0|||
130038223|NCT01624142|468094831|FG000|Overall Study|Other|1|||
130038224|NCT01624142|468094832|FG001|Overall Study|Other|0|||
130038225|NCT01708057|468094838|FG000|Overall Study|Withdrawal due to study termination.|1|||
130038226|NCT01708057|468094839|FG001|Overall Study|Withdrawal due to study termination.|1|||
130038227|NCT01708057|468094840|FG002|Overall Study|Withdrawal due to study termination.|1|||
130038228|NCT00947349|468094843|FG000|Triple Treatment Combination Period|Adverse Event|0|||
130038229|NCT00947349|468094844|FG001|Triple Treatment Combination Period|Adverse Event|1|||
130038230|NCT00947349|468094845|FG002|Triple Treatment Combination Period|Adverse Event|0|||
130038231|NCT00947349|468094846|FG003|Triple Treatment Combination Period|Adverse Event|0|||
130038232|NCT00947349|468094843|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
130038233|NCT00947349|468094844|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
130038234|NCT00947349|468094845|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
130038235|NCT00947349|468094846|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
130038236|NCT00947349|468094843|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
130038237|NCT00947349|468094844|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
130038238|NCT00947349|468094845|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
130104038|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130104039|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130104040|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104041|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130038239|NCT00947349|468094846|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
130104042|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130273583|NCT00040742|468965609|FG003|Overall Study|Death|0|||
130273584|NCT00040742|468965606|FG000|Overall Study|Adverse Event|15|||
130273585|NCT00040742|468965607|FG001|Overall Study|Adverse Event|16|||
130273586|NCT00040742|468965608|FG002|Overall Study|Adverse Event|21|||
130273587|NCT00040742|468965609|FG003|Overall Study|Adverse Event|9|||
130273588|NCT00040742|468965606|FG000|Overall Study|Withdrawal by Subject|7|||
130273589|NCT00040742|468965607|FG001|Overall Study|Withdrawal by Subject|15|||
130273590|NCT00040742|468965608|FG002|Overall Study|Withdrawal by Subject|10|||
130273591|NCT00040742|468965609|FG003|Overall Study|Withdrawal by Subject|13|||
130273592|NCT00040742|468965606|FG000|Overall Study|Chemotoxicity|4|||
130273593|NCT00040742|468965607|FG001|Overall Study|Chemotoxicity|3|||
130273594|NCT00040742|468965608|FG002|Overall Study|Chemotoxicity|5|||
130273595|NCT00040742|468965609|FG003|Overall Study|Chemotoxicity|2|||
130273596|NCT00040742|468965606|FG000|Overall Study|Incomplete Forms|6|||
130273597|NCT00040742|468965607|FG001|Overall Study|Incomplete Forms|10|||
130273598|NCT00040742|468965608|FG002|Overall Study|Incomplete Forms|4|||
130273599|NCT00040742|468965609|FG003|Overall Study|Incomplete Forms|5|||
130273600|NCT00040742|468965606|FG000|Overall Study|Other medical|7|||
130273601|NCT00040742|468965607|FG001|Overall Study|Other medical|5|||
130273602|NCT00040742|468965608|FG002|Overall Study|Other medical|5|||
130273603|NCT00040742|468965609|FG003|Overall Study|Other medical|5|||
130273604|NCT03520920|468965612|FG000|Overall Study|Death|13|||
130273605|NCT03520920|468965613|FG001|Overall Study|Death|1|||
130273606|NCT03520920|468965614|FG002|Overall Study|Death|0|||
130273607|NCT03520920|468965612|FG000|Overall Study|Withdrawal by Subject|2|||
130273608|NCT03520920|468965613|FG001|Overall Study|Withdrawal by Subject|1|||
130273609|NCT03520920|468965614|FG002|Overall Study|Withdrawal by Subject|0|||
130273610|NCT03520920|468965612|FG000|Overall Study|Study Terminated by the Sponsor|5|||
130273611|NCT03520920|468965613|FG001|Overall Study|Study Terminated by the Sponsor|14|||
130273612|NCT03520920|468965614|FG002|Overall Study|Study Terminated by the Sponsor|5|||
130273613|NCT00405392|468965615|FG000|Overall Study|Adverse Event|15|||
130273614|NCT00405392|468965616|FG001|Overall Study|Adverse Event|14|||
130273615|NCT00405392|468965615|FG000|Overall Study|Did not meet Eligibility criteria|7|||
130273616|NCT00405392|468965616|FG001|Overall Study|Did not meet Eligibility criteria|2|||
130273617|NCT00405392|468965615|FG000|Overall Study|Withdrawal by Subject|4|||
130273618|NCT00405392|468965616|FG001|Overall Study|Withdrawal by Subject|3|||
130038240|NCT00947349|468094843|FG000|Overall Study Standard of Care|Other|0|||
130038241|NCT00947349|468094844|FG001|Overall Study Standard of Care|Other|0|||
130038242|NCT00947349|468094845|FG002|Overall Study Standard of Care|Other|0|||
130038243|NCT00947349|468094846|FG003|Overall Study Standard of Care|Other|1|||
130038244|NCT00538681|468094847|FG000|Overall Study|Progressive Disease|7|||
130038245|NCT00538681|468094848|FG001|Overall Study|Progressive Disease|0|||
130038246|NCT00538681|468094849|FG002|Overall Study|Progressive Disease|1|||
130038247|NCT00538681|468094850|FG003|Overall Study|Progressive Disease|0|||
130038248|NCT00538681|468094847|FG000|Overall Study|Sponsor Decision|1|||
130038249|NCT00538681|468094848|FG001|Overall Study|Sponsor Decision|3|||
130038250|NCT00538681|468094849|FG002|Overall Study|Sponsor Decision|8|||
130038251|NCT00538681|468094850|FG003|Overall Study|Sponsor Decision|9|||
130038252|NCT00538681|468094847|FG000|Overall Study|Adverse Event|1|||
130038253|NCT00538681|468094848|FG001|Overall Study|Adverse Event|1|||
130038254|NCT00538681|468094849|FG002|Overall Study|Adverse Event|1|||
130038255|NCT00538681|468094850|FG003|Overall Study|Adverse Event|0|||
130038256|NCT00538681|468094847|FG000|Overall Study|Death|0|||
130038257|NCT00538681|468094848|FG001|Overall Study|Death|0|||
130038258|NCT00538681|468094849|FG002|Overall Study|Death|1|||
130038259|NCT00538681|468094850|FG003|Overall Study|Death|1|||
130038260|NCT00538681|468094847|FG000|Overall Study|Investigator Decision|0|||
130038261|NCT00538681|468094848|FG001|Overall Study|Investigator Decision|0|||
130038262|NCT00538681|468094849|FG002|Overall Study|Investigator Decision|0|||
130038263|NCT00538681|468094850|FG003|Overall Study|Investigator Decision|1|||
130038264|NCT02970929|468094851|FG000|Overall Study|Adverse Event|18|||
130038265|NCT02970929|468094851|FG000|Overall Study|Lack of Efficacy|8|||
130038266|NCT02970929|468094851|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
130038267|NCT02970929|468094851|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
130038268|NCT02970929|468094851|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
130038269|NCT02970929|468094851|FG000|Overall Study|LOST TO FOLLOWUP|6|||
130038270|NCT02970929|468094851|FG000|Overall Study|MOVED OUT OF STATE|1|||
130038271|NCT02970929|468094851|FG000|Overall Study|Withdrawal by Subject|16|||
130038272|NCT05369806|468094854|FG000|Overall Study|Lost to Follow-up|1|||
130038273|NCT00140855|468094855|FG000|Overall Study|Progressive disease|2|||
130038274|NCT03929250|468094863|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
130038275|NCT03929250|468094864|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
130038276|NCT01097044|468094865|FG000|Overall Study|Withdrawal by Subject|4|||
130038277|NCT01097044|468094866|FG001|Overall Study|Withdrawal by Subject|4|||
130038278|NCT01097044|468094865|FG000|Overall Study|Lost to Follow-up|1|||
130038279|NCT01097044|468094866|FG001|Overall Study|Lost to Follow-up|0|||
130038280|NCT01097044|468094865|FG000|Overall Study|Withdrawal by Sponsor|0|||
130038281|NCT01097044|468094866|FG001|Overall Study|Withdrawal by Sponsor|1|||
130038282|NCT01331161|468094867|FG000|Overall Study|Physician Decision|1|||
130038283|NCT01331161|468094868|FG001|Overall Study|Physician Decision|0|||
130038284|NCT01331161|468094867|FG000|Overall Study|Lost to Follow-up|0|||
130038285|NCT01331161|468094868|FG001|Overall Study|Lost to Follow-up|1|||
130038286|NCT01331161|468094867|FG000|Overall Study|Pregnancy|0|||
130038287|NCT01331161|468094868|FG001|Overall Study|Pregnancy|1|||
130038288|NCT04194944|468094869|FG000|Overall Study|Lost to Follow-up|3|||
130038289|NCT04194944|468094870|FG001|Overall Study|Lost to Follow-up|0|||
130038290|NCT04194944|468094869|FG000|Overall Study|Withdrawal by Subject|2|||
130038291|NCT04194944|468094870|FG001|Overall Study|Withdrawal by Subject|2|||
130038292|NCT04194944|468094869|FG000|Overall Study|On Treatment|93|||
130038293|NCT04194944|468094870|FG001|Overall Study|On Treatment|30|||
130038294|NCT03277196|468094877|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
130038295|NCT03277196|468094877|FG000|Overall Study|Lost to Follow-up|3|||
130038296|NCT03277196|468094877|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
130038297|NCT03277196|468094877|FG000|Overall Study|Other|2|||
130038298|NCT01821963|468096576|FG000|Overall Study|Adverse Event|1|||
130038299|NCT00783289|468096577|FG000|Overall Study|Protocol Violation|0|||
130038300|NCT00783289|468096578|FG001|Overall Study|Protocol Violation|1|||
130038301|NCT00783289|468096579|FG002|Overall Study|Protocol Violation|0|||
130038302|NCT00783289|468096580|FG003|Overall Study|Protocol Violation|0|||
130038303|NCT01896232|468096581|FG000|Overall Study|Death|6|||
130038304|NCT01896232|468096582|FG001|Overall Study|Death|10|||
130038305|NCT01896232|468096581|FG000|Overall Study|Withdrawal by Subject|32|||
130038306|NCT01896232|468096582|FG001|Overall Study|Withdrawal by Subject|31|||
130038307|NCT01896232|468096581|FG000|Overall Study|Sponsor Decision|2|||
130038308|NCT01896232|468096582|FG001|Overall Study|Sponsor Decision|0|||
130038309|NCT01896232|468096581|FG000|Overall Study|Lost to Follow-up|9|||
130038310|NCT01896232|468096582|FG001|Overall Study|Lost to Follow-up|12|||
130038311|NCT03976401|468096584|FG000|Overall Study|Adverse Event|2|||
130038312|NCT03976401|468096585|FG001|Overall Study|Adverse Event|0|||
130038313|NCT03976401|468096586|FG002|Overall Study|Adverse Event|4|||
130038314|NCT03976401|468096587|FG003|Overall Study|Adverse Event|1|||
130038315|NCT03976401|468096588|FG004|Overall Study|Adverse Event|1|||
130038316|NCT03976401|468096589|FG005|Overall Study|Adverse Event|0|||
130038317|NCT03976401|468096584|FG000|Overall Study|Withdrawal by Subject|0|||
130038318|NCT03976401|468096585|FG001|Overall Study|Withdrawal by Subject|1|||
130038319|NCT03976401|468096586|FG002|Overall Study|Withdrawal by Subject|0|||
130038320|NCT03976401|468096587|FG003|Overall Study|Withdrawal by Subject|0|||
130038321|NCT03976401|468096588|FG004|Overall Study|Withdrawal by Subject|0|||
130038322|NCT03976401|468096589|FG005|Overall Study|Withdrawal by Subject|1|||
130038323|NCT03976401|468096584|FG000|Overall Study|Physician Decision|0|||
130038324|NCT03976401|468096585|FG001|Overall Study|Physician Decision|0|||
130038325|NCT03976401|468096586|FG002|Overall Study|Physician Decision|1|||
130038326|NCT03976401|468096587|FG003|Overall Study|Physician Decision|0|||
130038327|NCT03976401|468096588|FG004|Overall Study|Physician Decision|0|||
130038328|NCT03976401|468096589|FG005|Overall Study|Physician Decision|0|||
130038329|NCT03976401|468096584|FG000|Overall Study|Lost to Follow-up|1|||
130038330|NCT03976401|468096585|FG001|Overall Study|Lost to Follow-up|2|||
130038331|NCT03976401|468096586|FG002|Overall Study|Lost to Follow-up|0|||
130038332|NCT03976401|468096587|FG003|Overall Study|Lost to Follow-up|0|||
130038333|NCT03976401|468096588|FG004|Overall Study|Lost to Follow-up|0|||
130038334|NCT03976401|468096589|FG005|Overall Study|Lost to Follow-up|0|||
130038335|NCT03976401|468096584|FG000|Overall Study|Protocol Violation|0|||
130038336|NCT03976401|468096585|FG001|Overall Study|Protocol Violation|1|||
130038337|NCT03976401|468096586|FG002|Overall Study|Protocol Violation|0|||
130038338|NCT03976401|468096587|FG003|Overall Study|Protocol Violation|0|||
130038339|NCT03976401|468096588|FG004|Overall Study|Protocol Violation|0|||
130038340|NCT03976401|468096589|FG005|Overall Study|Protocol Violation|0|||
130038341|NCT03976401|468096584|FG000|Overall Study|Withdrew Consent|0|||
130038342|NCT03976401|468096585|FG001|Overall Study|Withdrew Consent|0|||
130038343|NCT03976401|468096586|FG002|Overall Study|Withdrew Consent|0|||
130038344|NCT03976401|468096587|FG003|Overall Study|Withdrew Consent|1|||
130038345|NCT03976401|468096588|FG004|Overall Study|Withdrew Consent|0|||
130038346|NCT03976401|468096589|FG005|Overall Study|Withdrew Consent|0|||
130038347|NCT01503021|468096598|FG000|Overall Study|Adverse Event|7|||
130038348|NCT01503021|468096599|FG001|Overall Study|Adverse Event|6|||
130038349|NCT01503021|468096598|FG000|Overall Study|Death|0|||
130038350|NCT01503021|468096599|FG001|Overall Study|Death|2|||
130038351|NCT01503021|468096598|FG000|Overall Study|Lost to Follow-up|2|||
130038352|NCT01503021|468096599|FG001|Overall Study|Lost to Follow-up|0|||
130038353|NCT01503021|468096598|FG000|Overall Study|Physician Decision|3|||
130038354|NCT01503021|468096599|FG001|Overall Study|Physician Decision|0|||
130038355|NCT01503021|468096598|FG000|Overall Study|Protocol Violation|1|||
130038356|NCT01503021|468096599|FG001|Overall Study|Protocol Violation|3|||
130038357|NCT01503021|468096598|FG000|Overall Study|Withdrawal by Subject|9|||
130038358|NCT01503021|468096599|FG001|Overall Study|Withdrawal by Subject|8|||
130038359|NCT01503021|468096598|FG000|Overall Study|Moved, received transplant, etc.|5|||
130038360|NCT01503021|468096599|FG001|Overall Study|Moved, received transplant, etc.|7|||
130038361|NCT00817414|468096600|FG000|Overall Study|Adverse Event|1|||
130038362|NCT00817414|468096601|FG001|Overall Study|Adverse Event|1|||
130038363|NCT00817414|468096602|FG002|Overall Study|Adverse Event|1|||
130038364|NCT00817414|468096603|FG003|Overall Study|Adverse Event|0|||
130038365|NCT00817414|468096604|FG004|Overall Study|Adverse Event|0|||
130038366|NCT00817414|468096600|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
130038367|NCT00817414|468096601|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
130038368|NCT00817414|468096602|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
130038369|NCT00817414|468096603|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
130038370|NCT00817414|468096604|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
130038371|NCT00817414|468096600|FG000|Overall Study|Withdrawal by Subject|1|||
130038372|NCT00817414|468096601|FG001|Overall Study|Withdrawal by Subject|1|||
130038373|NCT00817414|468096602|FG002|Overall Study|Withdrawal by Subject|0|||
130038374|NCT00817414|468096603|FG003|Overall Study|Withdrawal by Subject|0|||
130038375|NCT00817414|468096604|FG004|Overall Study|Withdrawal by Subject|0|||
130038376|NCT00817414|468096600|FG000|Overall Study|Lost to Follow-up|0|||
130038377|NCT00817414|468096601|FG001|Overall Study|Lost to Follow-up|0|||
130038378|NCT00817414|468096602|FG002|Overall Study|Lost to Follow-up|1|||
130038379|NCT00817414|468096603|FG003|Overall Study|Lost to Follow-up|1|||
130038380|NCT00817414|468096604|FG004|Overall Study|Lost to Follow-up|1|||
130038381|NCT00817414|468096600|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130038382|NCT00817414|468096601|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130038383|NCT00817414|468096602|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130038384|NCT00817414|468096603|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
130038385|NCT00817414|468096604|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
130038386|NCT00817414|468096600|FG000|Overall Study|Protocol Violation|0|||
130038387|NCT00817414|468096601|FG001|Overall Study|Protocol Violation|0|||
130038388|NCT00817414|468096602|FG002|Overall Study|Protocol Violation|0|||
130038389|NCT00817414|468096603|FG003|Overall Study|Protocol Violation|0|||
130038390|NCT00817414|468096604|FG004|Overall Study|Protocol Violation|1|||
130038391|NCT00097539|468096605|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
130038392|NCT00097539|468096606|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
130038393|NCT00097539|468096607|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
130038394|NCT00097539|468096608|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
130038395|NCT00097539|468096609|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
130038396|NCT00097539|468096610|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
130038397|NCT00097539|468096611|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
130038398|NCT00097539|468096605|FG000|Overall Study|Withdrawal by Subject|925|||
130038399|NCT00097539|468096606|FG001|Overall Study|Withdrawal by Subject|323|||
130038400|NCT00097539|468096607|FG002|Overall Study|Withdrawal by Subject|346|||
130038401|NCT00097539|468096608|FG003|Overall Study|Withdrawal by Subject|217|||
130038402|NCT00097539|468096609|FG004|Overall Study|Withdrawal by Subject|68|||
130038403|NCT00097539|468096610|FG005|Overall Study|Withdrawal by Subject|229|||
130038404|NCT00097539|468096611|FG006|Overall Study|Withdrawal by Subject|3|||
130038405|NCT00097539|468096605|FG000|Overall Study|Participant Non-compliant|2140|||
130038406|NCT00097539|468096606|FG001|Overall Study|Participant Non-compliant|567|||
130038407|NCT00097539|468096607|FG002|Overall Study|Participant Non-compliant|1067|||
130038408|NCT00097539|468096608|FG003|Overall Study|Participant Non-compliant|353|||
130038409|NCT00097539|468096609|FG004|Overall Study|Participant Non-compliant|136|||
130038410|NCT00097539|468096610|FG005|Overall Study|Participant Non-compliant|543|||
130038411|NCT00097539|468096611|FG006|Overall Study|Participant Non-compliant|18|||
130038412|NCT00097539|468096605|FG000|Overall Study|Lack of Efficacy|249|||
130038413|NCT00097539|468096606|FG001|Overall Study|Lack of Efficacy|122|||
130038414|NCT00097539|468096607|FG002|Overall Study|Lack of Efficacy|202|||
130038415|NCT00097539|468096608|FG003|Overall Study|Lack of Efficacy|105|||
130038416|NCT00097539|468096609|FG004|Overall Study|Lack of Efficacy|45|||
130038417|NCT00097539|468096610|FG005|Overall Study|Lack of Efficacy|228|||
130038418|NCT00097539|468096611|FG006|Overall Study|Lack of Efficacy|5|||
130038419|NCT00097539|468096605|FG000|Overall Study|Adverse Event|78|||
130038420|NCT00097539|468096606|FG001|Overall Study|Adverse Event|133|||
130038421|NCT00097539|468096607|FG002|Overall Study|Adverse Event|37|||
130038422|NCT00097539|468096608|FG003|Overall Study|Adverse Event|27|||
130038423|NCT00097539|468096609|FG004|Overall Study|Adverse Event|30|||
130038424|NCT00097539|468096610|FG005|Overall Study|Adverse Event|59|||
130038425|NCT00097539|468096611|FG006|Overall Study|Adverse Event|1|||
130038426|NCT00097539|468096605|FG000|Overall Study|Death|2|||
130038427|NCT00097539|468096606|FG001|Overall Study|Death|7|||
130038428|NCT00097539|468096607|FG002|Overall Study|Death|0|||
130038429|NCT00097539|468096608|FG003|Overall Study|Death|0|||
130038430|NCT00097539|468096609|FG004|Overall Study|Death|1|||
130038431|NCT00097539|468096610|FG005|Overall Study|Death|3|||
130038432|NCT00097539|468096611|FG006|Overall Study|Death|0|||
130038433|NCT00097539|468096605|FG000|Overall Study|Reasons Other Than Above|3602|||
130038434|NCT00097539|468096606|FG001|Overall Study|Reasons Other Than Above|1382|||
130038435|NCT00097539|468096607|FG002|Overall Study|Reasons Other Than Above|1757|||
130038436|NCT00097539|468096608|FG003|Overall Study|Reasons Other Than Above|692|||
130038437|NCT00097539|468096609|FG004|Overall Study|Reasons Other Than Above|361|||
130038438|NCT00097539|468096610|FG005|Overall Study|Reasons Other Than Above|1244|||
130038439|NCT00097539|468096611|FG006|Overall Study|Reasons Other Than Above|34|||
130038440|NCT00097539|468096605|FG000|Overall Study|Reason not Specified|111|||
130038441|NCT00097539|468096606|FG001|Overall Study|Reason not Specified|49|||
130038442|NCT00097539|468096607|FG002|Overall Study|Reason not Specified|53|||
130038443|NCT00097539|468096608|FG003|Overall Study|Reason not Specified|21|||
130038444|NCT00097539|468096609|FG004|Overall Study|Reason not Specified|11|||
130038445|NCT00097539|468096610|FG005|Overall Study|Reason not Specified|40|||
130038446|NCT00097539|468096611|FG006|Overall Study|Reason not Specified|2|||
130038447|NCT01486264|468096614|FG000|Overall Study|Death|1|||
130038448|NCT01486264|468096615|FG001|Overall Study|Death|1|||
130038449|NCT01486264|468096614|FG000|Overall Study|Adverse Event|3|||
130038450|NCT01486264|468096615|FG001|Overall Study|Adverse Event|3|||
130038451|NCT01486264|468096614|FG000|Overall Study|Lack of Efficacy|6|||
130038452|NCT01486264|468096615|FG001|Overall Study|Lack of Efficacy|10|||
130038453|NCT01486264|468096614|FG000|Overall Study|Withdrawal by Subject|7|||
130038454|NCT01486264|468096615|FG001|Overall Study|Withdrawal by Subject|18|||
130038455|NCT01486264|468096614|FG000|Overall Study|Physician Decision|1|||
130038456|NCT01486264|468096615|FG001|Overall Study|Physician Decision|1|||
130038457|NCT01486264|468096614|FG000|Overall Study|Protocol Violation|3|||
130038458|NCT01486264|468096615|FG001|Overall Study|Protocol Violation|0|||
130038459|NCT01486264|468096614|FG000|Overall Study|Lost to Follow-up|3|||
130038460|NCT01486264|468096615|FG001|Overall Study|Lost to Follow-up|2|||
130038461|NCT01486264|468096614|FG000|Overall Study|Other|5|||
130038462|NCT01486264|468096615|FG001|Overall Study|Other|11|||
130038463|NCT01486264|468096614|FG000|Overall Study|Not treated|0|||
130038464|NCT01486264|468096615|FG001|Overall Study|Not treated|1|||
130038465|NCT03812510|468096620|FG000|Overall Study|Lost to Follow-up|39|||
130038466|NCT03812510|468096620|FG000|Overall Study|Withdrawal by Subject|42|||
130038467|NCT03812510|468096620|FG000|Overall Study|Physician Decision|2|||
130038468|NCT03812510|468096620|FG000|Overall Study|Study Terminated by Sponsor|9|||
130038469|NCT03812510|468096620|FG000|Overall Study|Did Not Start Study Medication|55|||
130038470|NCT03812510|468096620|FG000|Overall Study|Adverse Event|5|||
130038471|NCT00768560|468096621|FG000|Intervention Set 1|Adverse Event|0|||
130038472|NCT00768560|468096622|FG001|Intervention Set 1|Adverse Event|1|||
130038473|NCT00768560|468096623|FG002|Intervention Set 1|Adverse Event|0|||
130038474|NCT00768560|468096624|FG003|Intervention Set 1|Adverse Event|0|||
130038475|NCT00768560|468096625|FG004|Intervention Set 1|Adverse Event|0|||
130038476|NCT00768560|468096626|FG005|Intervention Set 1|Adverse Event|0|||
130038477|NCT01128387|468096627|FG000|Overall Study|Physician Decision|0|||
130038478|NCT01128387|468096628|FG001|Overall Study|Physician Decision|1|||
130038479|NCT02635204|468096629|FG000|Overall Study|Adverse Event|1|||
130038480|NCT02635204|468096630|FG001|Overall Study|Adverse Event|0|||
130038481|NCT02635204|468096629|FG000|Overall Study|Lost to Follow-up|1|||
130038482|NCT02635204|468096630|FG001|Overall Study|Lost to Follow-up|1|||
130038483|NCT01535235|468096632|FG000|Overall Study|Adverse Event|1|||
130038484|NCT01535235|468096633|FG001|Overall Study|Adverse Event|0|||
130038485|NCT00858832|468096634|FG000|Overall Study|became ineligible: delivered vaginally|1|||
130038486|NCT00858832|468096635|FG001|Overall Study|became ineligible: delivered vaginally|0|||
130038487|NCT00858832|468096634|FG000|Overall Study|Adverse Event|0|||
130038488|NCT00858832|468096635|FG001|Overall Study|Adverse Event|1|||
130038489|NCT00389207|468096636|FG000|Overall Study|Adverse Event|26|||
130038490|NCT00389207|468096637|FG001|Overall Study|Adverse Event|32|||
130038491|NCT00389207|468096638|FG002|Overall Study|Adverse Event|10|||
130038492|NCT00389207|468096636|FG000|Overall Study|Protocol Violation|3|||
130038493|NCT00389207|468096637|FG001|Overall Study|Protocol Violation|1|||
130038494|NCT00389207|468096638|FG002|Overall Study|Protocol Violation|4|||
130038495|NCT00389207|468096636|FG000|Overall Study|Lost to Follow-up|12|||
130038496|NCT00389207|468096637|FG001|Overall Study|Lost to Follow-up|9|||
130038497|NCT00389207|468096638|FG002|Overall Study|Lost to Follow-up|7|||
130038498|NCT00389207|468096636|FG000|Overall Study|Withdrawal by Subject|5|||
130038499|NCT00389207|468096637|FG001|Overall Study|Withdrawal by Subject|7|||
130038500|NCT00389207|468096638|FG002|Overall Study|Withdrawal by Subject|11|||
130038501|NCT00389207|468096636|FG000|Overall Study|Other|17|||
130038502|NCT00389207|468096637|FG001|Overall Study|Other|23|||
130038503|NCT00389207|468096638|FG002|Overall Study|Other|9|||
130038504|NCT01073943|468096652|FG000|Overall Study|Withdrawal by Subject|8|||
130038505|NCT01073943|468096653|FG001|Overall Study|Withdrawal by Subject|2|||
130038506|NCT01073943|468096652|FG000|Overall Study|Protocol Violation|2|||
130038507|NCT01073943|468096653|FG001|Overall Study|Protocol Violation|1|||
130038508|NCT01073943|468096652|FG000|Overall Study|Adverse Event|1|||
130038509|NCT01073943|468096653|FG001|Overall Study|Adverse Event|1|||
130038510|NCT01073943|468096652|FG000|Overall Study|Lost to Follow-up|0|||
130038511|NCT01073943|468096653|FG001|Overall Study|Lost to Follow-up|2|||
130038512|NCT01073943|468096652|FG000|Overall Study|Power outage; colonoscopy not done|1|||
130038513|NCT01073943|468096653|FG001|Overall Study|Power outage; colonoscopy not done|0|||
130038514|NCT01073943|468096652|FG000|Overall Study|Subject forgot|0|||
130038515|NCT01073943|468096653|FG001|Overall Study|Subject forgot|1|||
130038516|NCT01073943|468096652|FG000|Overall Study|Unable to return for follow-up|0|||
130038517|NCT01073943|468096653|FG001|Overall Study|Unable to return for follow-up|1|||
130038518|NCT01073943|468096652|FG000|Overall Study|Could not tolerate prep|1|||
130038519|NCT01073943|468096653|FG001|Overall Study|Could not tolerate prep|0|||
130038520|NCT01794780|468096656|FG000|Overall Study|Adverse Event|0|||
130038521|NCT01794780|468096657|FG001|Overall Study|Adverse Event|1|||
130038522|NCT01794780|468096658|FG002|Overall Study|Adverse Event|2|||
130038523|NCT01794780|468096659|FG003|Overall Study|Adverse Event|0|||
130038524|NCT01794780|468096660|FG004|Overall Study|Adverse Event|0|||
130038525|NCT01794780|468096661|FG005|Overall Study|Adverse Event|0|||
130038526|NCT01794780|468096662|FG006|Overall Study|Adverse Event|0|||
130038527|NCT01794780|468096663|FG007|Overall Study|Adverse Event|0|||
130038528|NCT01794780|468096656|FG000|Overall Study|Death|0|||
130038529|NCT01794780|468096657|FG001|Overall Study|Death|2|||
130038530|NCT01794780|468096658|FG002|Overall Study|Death|14|||
130038531|NCT01794780|468096659|FG003|Overall Study|Death|1|||
130038532|NCT01794780|468096660|FG004|Overall Study|Death|0|||
130038533|NCT01794780|468096661|FG005|Overall Study|Death|9|||
130038534|NCT01794780|468096662|FG006|Overall Study|Death|4|||
130038535|NCT01794780|468096663|FG007|Overall Study|Death|0|||
130038536|NCT01794780|468096656|FG000|Overall Study|Lost to Follow-up|10|||
130038537|NCT01794780|468096657|FG001|Overall Study|Lost to Follow-up|64|||
130038538|NCT01794780|468096658|FG002|Overall Study|Lost to Follow-up|165|||
130038539|NCT01794780|468096659|FG003|Overall Study|Lost to Follow-up|53|||
130038540|NCT01794780|468096660|FG004|Overall Study|Lost to Follow-up|2|||
130038541|NCT01794780|468096661|FG005|Overall Study|Lost to Follow-up|99|||
130038542|NCT01794780|468096662|FG006|Overall Study|Lost to Follow-up|30|||
130038543|NCT01794780|468096663|FG007|Overall Study|Lost to Follow-up|5|||
130038544|NCT01794780|468096656|FG000|Overall Study|Withdrew informed consent|7|||
130038545|NCT01794780|468096657|FG001|Overall Study|Withdrew informed consent|17|||
130038546|NCT01794780|468096658|FG002|Overall Study|Withdrew informed consent|36|||
130038547|NCT01794780|468096659|FG003|Overall Study|Withdrew informed consent|9|||
130038548|NCT01794780|468096660|FG004|Overall Study|Withdrew informed consent|0|||
130038549|NCT01794780|468096661|FG005|Overall Study|Withdrew informed consent|48|||
130038550|NCT01794780|468096662|FG006|Overall Study|Withdrew informed consent|4|||
130038551|NCT01794780|468096663|FG007|Overall Study|Withdrew informed consent|3|||
130038552|NCT01794780|468096656|FG000|Overall Study|Other|0|||
130038553|NCT01794780|468096657|FG001|Overall Study|Other|12|||
130038554|NCT01794780|468096658|FG002|Overall Study|Other|25|||
130038555|NCT01794780|468096659|FG003|Overall Study|Other|20|||
130038556|NCT01794780|468096660|FG004|Overall Study|Other|1|||
130038557|NCT01794780|468096661|FG005|Overall Study|Other|24|||
130038558|NCT01794780|468096662|FG006|Overall Study|Other|4|||
130038559|NCT01794780|468096663|FG007|Overall Study|Other|1|||
130038560|NCT03527043|468096665|FG000|Overall Study|Withdrawal by Subject|1|||
130038561|NCT03527043|468096666|FG001|Overall Study|Withdrawal by Subject|0|||
130038562|NCT02286102|468096667|FG000|Overall Study|Screen Failure|1|||
130038563|NCT02286102|468096668|FG001|Overall Study|Screen Failure|1|||
130038564|NCT02120417|468096669|FG000|Overall Study|Death|5|||
130038565|NCT02120417|468096670|FG001|Overall Study|Death|1|||
130038566|NCT02120417|468096669|FG000|Overall Study|Adverse Event|3|||
130038567|NCT02120417|468096670|FG001|Overall Study|Adverse Event|9|||
130038568|NCT02120417|468096669|FG000|Overall Study|Participant decision|4|||
130038569|NCT02120417|468096670|FG001|Overall Study|Participant decision|4|||
130038570|NCT02120417|468096669|FG000|Overall Study|Disease progression|41|||
130104043|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130038571|NCT02120417|468096670|FG001|Overall Study|Disease progression|45|||
130038572|NCT02120417|468096669|FG000|Overall Study|Noncompliance with study treatment|0|||
130038573|NCT02120417|468096670|FG001|Overall Study|Noncompliance with study treatment|2|||
130038574|NCT02120417|468096669|FG000|Overall Study|Physician Decision|2|||
130038575|NCT02120417|468096670|FG001|Overall Study|Physician Decision|3|||
130038576|NCT02120417|468096669|FG000|Overall Study|Other unspecified|5|||
130038577|NCT02120417|468096670|FG001|Overall Study|Other unspecified|4|||
130038578|NCT03293680|468096671|FG000|Overall Study|Death|1|||
130038579|NCT03293680|468096671|FG000|Overall Study|Did not meet inclusion criteria|8|||
130038580|NCT02690701|468096674|FG000|Treatment Period 1|Adverse Event|2|||
130038581|NCT02690701|468096675|FG001|Treatment Period 1|Adverse Event|2|||
130038582|NCT02690701|468096674|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130038583|NCT02690701|468096675|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130038584|NCT02690701|468096674|FG000|Treatment Period 2|Adverse Event|2|||
130038585|NCT02690701|468096675|FG001|Treatment Period 2|Adverse Event|0|||
130038586|NCT02690701|468096674|FG000|Treatment Period 2|Lack of Efficacy|1|||
130038587|NCT02690701|468096675|FG001|Treatment Period 2|Lack of Efficacy|0|||
130038588|NCT02690701|468096674|FG000|Treatment Period 2|Lost to Follow-up|0|||
130038589|NCT02690701|468096675|FG001|Treatment Period 2|Lost to Follow-up|2|||
130038590|NCT02690701|468096674|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130038591|NCT02690701|468096675|FG001|Treatment Period 2|Withdrawal by Subject|2|||
130038592|NCT02690701|468096674|FG000|Treatment Period 2|Protocol Violation|0|||
130038593|NCT02690701|468096675|FG001|Treatment Period 2|Protocol Violation|1|||
130038594|NCT01309737|468096676|FG000|Week 0 to 16|Death|1|||
130038595|NCT01309737|468096677|FG001|Week 0 to 16|Death|0|||
130038596|NCT01309737|468096678|FG002|Week 0 to 16|Death|1|||
130038597|NCT01309737|468096679|FG003|Week 0 to 16|Death|0|||
130038598|NCT01309737|468096680|FG004|Week 0 to 16|Death|0|||
130038599|NCT01309737|468096676|FG000|Week 0 to 16|Adverse Event|11|||
130038600|NCT01309737|468096677|FG001|Week 0 to 16|Adverse Event|10|||
130038601|NCT01309737|468096678|FG002|Week 0 to 16|Adverse Event|5|||
130038602|NCT01309737|468096679|FG003|Week 0 to 16|Adverse Event|0|||
130038603|NCT01309737|468096680|FG004|Week 0 to 16|Adverse Event|0|||
130038604|NCT01309737|468096676|FG000|Week 0 to 16|Lack of Efficacy|15|||
130038605|NCT01309737|468096677|FG001|Week 0 to 16|Lack of Efficacy|2|||
130038606|NCT01309737|468096678|FG002|Week 0 to 16|Lack of Efficacy|24|||
130038607|NCT01309737|468096679|FG003|Week 0 to 16|Lack of Efficacy|0|||
130038608|NCT01309737|468096680|FG004|Week 0 to 16|Lack of Efficacy|0|||
130038609|NCT01309737|468096676|FG000|Week 0 to 16|Lost to Follow-up|7|||
130038610|NCT01309737|468096677|FG001|Week 0 to 16|Lost to Follow-up|8|||
130038611|NCT01309737|468096678|FG002|Week 0 to 16|Lost to Follow-up|3|||
130038612|NCT01309737|468096679|FG003|Week 0 to 16|Lost to Follow-up|0|||
130038613|NCT01309737|468096680|FG004|Week 0 to 16|Lost to Follow-up|0|||
130038614|NCT01309737|468096676|FG000|Week 0 to 16|Withdrawal by Subject|7|||
130038615|NCT01309737|468096677|FG001|Week 0 to 16|Withdrawal by Subject|6|||
130038616|NCT01309737|468096678|FG002|Week 0 to 16|Withdrawal by Subject|7|||
130038617|NCT01309737|468096679|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130038618|NCT01309737|468096680|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130038619|NCT01309737|468096676|FG000|Week 0 to 16|Other|10|||
130038620|NCT01309737|468096677|FG001|Week 0 to 16|Other|14|||
130038621|NCT01309737|468096678|FG002|Week 0 to 16|Other|4|||
130038622|NCT01309737|468096679|FG003|Week 0 to 16|Other|0|||
130038623|NCT01309737|468096680|FG004|Week 0 to 16|Other|0|||
130038624|NCT01309737|468096676|FG000|Week 0 to 16|Randomized, but not treated|1|||
130038625|NCT01309737|468096677|FG001|Week 0 to 16|Randomized, but not treated|0|||
130038626|NCT01309737|468096678|FG002|Week 0 to 16|Randomized, but not treated|0|||
130038627|NCT01309737|468096679|FG003|Week 0 to 16|Randomized, but not treated|0|||
130038628|NCT01309737|468096680|FG004|Week 0 to 16|Randomized, but not treated|0|||
130038629|NCT01309737|468096676|FG000|Week 16 to 52|Death|0|||
130038630|NCT01309737|468096677|FG001|Week 16 to 52|Death|0|||
130038631|NCT01309737|468096678|FG002|Week 16 to 52|Death|0|||
130038632|NCT01309737|468096679|FG003|Week 16 to 52|Death|0|||
130038633|NCT01309737|468096680|FG004|Week 16 to 52|Death|1|||
130038634|NCT01309737|468096676|FG000|Week 16 to 52|Adverse Event|7|||
130038635|NCT01309737|468096677|FG001|Week 16 to 52|Adverse Event|7|||
130038636|NCT01309737|468096678|FG002|Week 16 to 52|Adverse Event|0|||
130038637|NCT01309737|468096679|FG003|Week 16 to 52|Adverse Event|6|||
130038638|NCT01309737|468096680|FG004|Week 16 to 52|Adverse Event|5|||
130038639|NCT01309737|468096676|FG000|Week 16 to 52|Lack of Efficacy|107|||
130038640|NCT01309737|468096677|FG001|Week 16 to 52|Lack of Efficacy|76|||
130038641|NCT01309737|468096678|FG002|Week 16 to 52|Lack of Efficacy|0|||
130038642|NCT01309737|468096679|FG003|Week 16 to 52|Lack of Efficacy|25|||
130038643|NCT01309737|468096680|FG004|Week 16 to 52|Lack of Efficacy|21|||
130038644|NCT01309737|468096676|FG000|Week 16 to 52|Lost to Follow-up|4|||
130038645|NCT01309737|468096677|FG001|Week 16 to 52|Lost to Follow-up|2|||
130038646|NCT01309737|468096678|FG002|Week 16 to 52|Lost to Follow-up|0|||
130038647|NCT01309737|468096679|FG003|Week 16 to 52|Lost to Follow-up|1|||
130038648|NCT01309737|468096680|FG004|Week 16 to 52|Lost to Follow-up|4|||
130038649|NCT01309737|468096676|FG000|Week 16 to 52|Withdrawal by Subject|5|||
130038650|NCT01309737|468096677|FG001|Week 16 to 52|Withdrawal by Subject|6|||
130038651|NCT01309737|468096678|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130038652|NCT01309737|468096679|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130038653|NCT01309737|468096680|FG004|Week 16 to 52|Withdrawal by Subject|2|||
130038654|NCT01309737|468096676|FG000|Week 16 to 52|Other|10|||
130038655|NCT01309737|468096677|FG001|Week 16 to 52|Other|12|||
130038656|NCT01309737|468096678|FG002|Week 16 to 52|Other|0|||
130038657|NCT01309737|468096679|FG003|Week 16 to 52|Other|2|||
130038658|NCT01309737|468096680|FG004|Week 16 to 52|Other|0|||
130038659|NCT01442181|468096681|FG000|Overall Study|patient refused surgery|1|||
130038660|NCT01442181|468096682|FG001|Overall Study|patient refused surgery|0|||
130038661|NCT01442181|468096681|FG000|Overall Study|no insurance for surgery|1|||
130038662|NCT01442181|468096682|FG001|Overall Study|no insurance for surgery|0|||
130038663|NCT01442181|468096681|FG000|Overall Study|low ejection factor|0|||
130038664|NCT01442181|468096682|FG001|Overall Study|low ejection factor|1|||
130038665|NCT01442181|468096681|FG000|Overall Study|Lost to Follow-up|1|||
130038666|NCT01442181|468096682|FG001|Overall Study|Lost to Follow-up|1|||
130038667|NCT01442181|468096681|FG000|Overall Study|patient in an additional study|1|||
130038668|NCT01442181|468096682|FG001|Overall Study|patient in an additional study|0|||
130038669|NCT01442181|468096681|FG000|Overall Study|atrial fibrillation not noted|0|||
130038670|NCT01442181|468096682|FG001|Overall Study|atrial fibrillation not noted|1|||
130038671|NCT00709202|468096683|FG000|Overall Study|Withdrawal by Subject|6|||
130038672|NCT00709202|468096684|FG001|Overall Study|Withdrawal by Subject|6|||
130038673|NCT01822561|468096686|FG000|Overall Study|Withdrawal by Subject|2|||
130038674|NCT02597062|468096687|FG000|Overall Study|Ineligible|1|||
130038675|NCT05262764|468096692|FG000|Overall Study|Case report form not collected|9|||
130038676|NCT05262764|468096692|FG000|Overall Study|No patient visits after entry|23|||
130038677|NCT05262764|468096692|FG000|Overall Study|Registration rule not followed|2|||
130038678|NCT05262764|468096692|FG000|Overall Study|Patient of non-chronic heart failure|1|||
130038679|NCT01392183|468096693|FG000|First Drug Administration|Adverse Event|3|||
130038680|NCT01392183|468096694|FG001|First Drug Administration|Adverse Event|2|||
130038681|NCT01392183|468096693|FG000|First Drug Administration|Death|1|||
130038682|NCT01392183|468096694|FG001|First Drug Administration|Death|0|||
130038683|NCT01392183|468096693|FG000|First Drug Administration|Withdrawal by Subject|10|||
130038684|NCT01392183|468096694|FG001|First Drug Administration|Withdrawal by Subject|17|||
130038685|NCT04321343|468096695|FG000|Overall Study|Adverse Event|0|||
130038686|NCT04321343|468096696|FG001|Overall Study|Adverse Event|0|||
130038687|NCT04321343|468096697|FG002|Overall Study|Adverse Event|1|||
130038688|NCT04321343|468096698|FG003|Overall Study|Adverse Event|0|||
130038689|NCT04321343|468096695|FG000|Overall Study|Death|0|||
130038690|NCT04321343|468096696|FG001|Overall Study|Death|0|||
130038691|NCT04321343|468096697|FG002|Overall Study|Death|0|||
130038692|NCT04321343|468096698|FG003|Overall Study|Death|1|||
130038693|NCT04321343|468096695|FG000|Overall Study|Pregnancy|1|||
130038694|NCT04321343|468096696|FG001|Overall Study|Pregnancy|0|||
130038695|NCT04321343|468096697|FG002|Overall Study|Pregnancy|0|||
130038696|NCT04321343|468096698|FG003|Overall Study|Pregnancy|0|||
130038697|NCT04321343|468096695|FG000|Overall Study|Protocol Violation|1|||
130038698|NCT04321343|468096696|FG001|Overall Study|Protocol Violation|1|||
130038699|NCT04321343|468096697|FG002|Overall Study|Protocol Violation|1|||
130038700|NCT04321343|468096698|FG003|Overall Study|Protocol Violation|1|||
130038701|NCT04321343|468096695|FG000|Overall Study|Withdrawal by Subject|0|||
130038702|NCT04321343|468096696|FG001|Overall Study|Withdrawal by Subject|6|||
130038703|NCT04321343|468096697|FG002|Overall Study|Withdrawal by Subject|0|||
130038704|NCT04321343|468096698|FG003|Overall Study|Withdrawal by Subject|2|||
130038705|NCT04321343|468096695|FG000|Overall Study|Lost to Follow-up|2|||
130038706|NCT04321343|468096696|FG001|Overall Study|Lost to Follow-up|2|||
130038707|NCT04321343|468096697|FG002|Overall Study|Lost to Follow-up|1|||
130038708|NCT04321343|468096698|FG003|Overall Study|Lost to Follow-up|3|||
130038709|NCT03430310|468096699|FG000|Overall Study|Protocol Violation|2|||
130038710|NCT03430310|468096700|FG001|Overall Study|Protocol Violation|0|||
130038711|NCT03430310|468096699|FG000|Overall Study|Withdrawal by Subject|3|||
130038712|NCT03430310|468096700|FG001|Overall Study|Withdrawal by Subject|2|||
130038713|NCT03430310|468096699|FG000|Overall Study|COVID shutdown March 2020|0|||
130038714|NCT03430310|468096700|FG001|Overall Study|COVID shutdown March 2020|1|||
130038715|NCT03476239|468096702|FG000|Overall Study|Withdrawal by Subject|10|||
130038716|NCT03476239|468096702|FG000|Overall Study|Death|80|||
130038717|NCT03476239|468096702|FG000|Overall Study|Lost to Follow-up|8|||
130038718|NCT01446809|468096706|FG000|Overall Study|Adverse Event|0|||
130038719|NCT01446809|468096707|FG001|Overall Study|Adverse Event|0|||
130038720|NCT01446809|468096708|FG002|Overall Study|Adverse Event|1|||
130038721|NCT01446809|468096706|FG000|Overall Study|Failure to complete study procedures|0|||
130038722|NCT01446809|468096707|FG001|Overall Study|Failure to complete study procedures|0|||
130038723|NCT01446809|468096708|FG002|Overall Study|Failure to complete study procedures|1|||
130038724|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
130038725|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
130038726|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
130038727|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
130038728|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
130038729|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130038730|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130038731|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130038732|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
130038733|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
130038734|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130038735|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130038736|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130038737|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
130038738|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
130038739|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
130038740|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
130038741|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
130273619|NCT00405392|468965615|FG000|Overall Study|Lost to Follow-up|1|||
130038742|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
130038743|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
130038744|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
130038745|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
130038746|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
130038747|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
130038748|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
130038749|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
130038750|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
130038751|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
129886115|NCT00531011|467542854|FG001|Overall Study|Lost to Follow-up|0|||
130038752|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
130038753|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
130038754|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
130038755|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
130038756|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
130038757|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
130038758|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
130038759|NCT00785577|468096709|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
130038760|NCT00785577|468096710|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
130038761|NCT00785577|468096711|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
130038762|NCT00785577|468096712|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
130038763|NCT00785577|468096713|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
130038764|NCT00785577|468096709|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130038765|NCT00785577|468096710|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130038766|NCT00785577|468096711|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130038767|NCT00785577|468096712|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
130038768|NCT00785577|468096713|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
130038769|NCT00785577|468096709|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
130038770|NCT00785577|468096710|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
130038771|NCT00785577|468096711|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
130038772|NCT00785577|468096712|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
130038773|NCT00785577|468096713|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
130038774|NCT01682044|468096714|FG000|Overall Study|Death|1|||
130038775|NCT01682044|468096714|FG000|Overall Study|Progression|3|||
130038776|NCT02770807|468096715|FG000|Overall Study|Adverse Event|3|||
130038777|NCT02770807|468096716|FG001|Overall Study|Adverse Event|3|||
130038778|NCT02770807|468096717|FG002|Overall Study|Adverse Event|1|||
130038779|NCT02770807|468096715|FG000|Overall Study|Withdrawal by Subject|7|||
130038780|NCT02770807|468096716|FG001|Overall Study|Withdrawal by Subject|3|||
130038781|NCT02770807|468096717|FG002|Overall Study|Withdrawal by Subject|4|||
130038782|NCT02770807|468096715|FG000|Overall Study|Other|0|||
130038783|NCT02770807|468096716|FG001|Overall Study|Other|1|||
130038784|NCT02770807|468096717|FG002|Overall Study|Other|0|||
130038785|NCT02770807|468096715|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
130038786|NCT02770807|468096716|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
130038787|NCT02770807|468096717|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
130038788|NCT02770807|468096715|FG000|Overall Study|Physician Decision|0|||
130038789|NCT02770807|468096716|FG001|Overall Study|Physician Decision|0|||
130038790|NCT02770807|468096717|FG002|Overall Study|Physician Decision|1|||
130038791|NCT01826214|468098055|FG000|Overall Study|Adverse Event|7|||
130038792|NCT01826214|468098056|FG001|Overall Study|Adverse Event|6|||
130038793|NCT01826214|468098055|FG000|Overall Study|Death|3|||
130038794|NCT01826214|468098056|FG001|Overall Study|Death|1|||
130038795|NCT01826214|468098055|FG000|Overall Study|Lost to Follow-up|1|||
130038796|NCT01826214|468098056|FG001|Overall Study|Lost to Follow-up|0|||
130038797|NCT01826214|468098055|FG000|Overall Study|Physician Decision|0|||
130038798|NCT01826214|468098056|FG001|Overall Study|Physician Decision|2|||
130038799|NCT01826214|468098055|FG000|Overall Study|Progressive disease|22|||
130038800|NCT01826214|468098056|FG001|Overall Study|Progressive disease|21|||
130038801|NCT01826214|468098055|FG000|Overall Study|Study terminated by Sponsor|0|||
130038802|NCT01826214|468098056|FG001|Overall Study|Study terminated by Sponsor|1|||
130038803|NCT01826214|468098055|FG000|Overall Study|Subject/guardian decision|2|||
130038804|NCT01826214|468098056|FG001|Overall Study|Subject/guardian decision|3|||
130038805|NCT01056107|468098059|FG000|Overall Study|Withdrawal by Subject|0|||
130038806|NCT01056107|468098060|FG001|Overall Study|Withdrawal by Subject|1|||
130038807|NCT01056107|468098061|FG002|Overall Study|Withdrawal by Subject|3|||
130038808|NCT01056107|468098062|FG003|Overall Study|Withdrawal by Subject|0|||
130038809|NCT02017444|468098063|FG000|Overall Study|Physician Decision|1|||
130038810|NCT02017444|468098064|FG001|Overall Study|Physician Decision|0|||
130038811|NCT02017444|468098063|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
130038812|NCT02017444|468098064|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
130038813|NCT01614457|468098065|FG000|Overall Study|Non-Compliance|1|||
130038814|NCT01614457|468098066|FG001|Overall Study|Non-Compliance|0|||
130038815|NCT01614457|468098065|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
130038816|NCT01614457|468098066|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
130038817|NCT00374556|468098069|FG000|Overall Study|Lost to Follow-up|1|||
130038818|NCT00374556|468098070|FG001|Overall Study|Lost to Follow-up|0|||
130038819|NCT00374556|468098069|FG000|Overall Study|Removed at baseline due to medical cond|0|||
130038820|NCT00374556|468098070|FG001|Overall Study|Removed at baseline due to medical cond|1|||
130038821|NCT03874234|468098076|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038822|NCT03874234|468098077|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038823|NCT03874234|468098078|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038824|NCT03874234|468098079|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
130038825|NCT03874234|468098080|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038826|NCT03874234|468098081|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038827|NCT03874234|468098082|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038828|NCT03874234|468098083|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038829|NCT03874234|468098084|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038830|NCT03874234|468098085|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038831|NCT03874234|468098086|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038832|NCT03874234|468098087|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038833|NCT03874234|468098088|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
130038834|NCT03874234|468098076|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
130038835|NCT03874234|468098077|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038836|NCT03874234|468098078|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038837|NCT03874234|468098079|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038838|NCT03874234|468098080|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038839|NCT03874234|468098081|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038840|NCT03874234|468098082|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038841|NCT03874234|468098083|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038842|NCT03874234|468098084|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038843|NCT03874234|468098085|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038844|NCT03874234|468098086|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038845|NCT03874234|468098087|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038846|NCT03874234|468098088|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
130038847|NCT03874234|468098076|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038848|NCT03874234|468098077|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038849|NCT03874234|468098078|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038850|NCT03874234|468098079|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
130038851|NCT03874234|468098080|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038852|NCT03874234|468098081|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038853|NCT03874234|468098082|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038854|NCT03874234|468098083|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038855|NCT03874234|468098084|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038856|NCT03874234|468098085|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038857|NCT03874234|468098086|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038858|NCT03874234|468098087|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038859|NCT03874234|468098088|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
130038860|NCT03874234|468098076|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038861|NCT03874234|468098077|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038862|NCT03874234|468098078|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038863|NCT03874234|468098079|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038864|NCT03874234|468098080|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
130038865|NCT03874234|468098081|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038866|NCT03874234|468098082|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038867|NCT03874234|468098083|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038868|NCT03874234|468098084|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038869|NCT03874234|468098085|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038870|NCT03874234|468098086|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038871|NCT03874234|468098087|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038872|NCT03874234|468098088|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
130038873|NCT03874234|468098076|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038874|NCT03874234|468098077|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038875|NCT03874234|468098078|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038876|NCT03874234|468098079|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038877|NCT03874234|468098080|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038878|NCT03874234|468098081|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038879|NCT03874234|468098082|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038880|NCT03874234|468098083|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
130038881|NCT03874234|468098084|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038882|NCT03874234|468098085|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038883|NCT03874234|468098086|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038884|NCT03874234|468098087|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038885|NCT03874234|468098088|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
130038886|NCT03874234|468098076|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038887|NCT03874234|468098077|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038888|NCT03874234|468098078|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038889|NCT03874234|468098079|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038890|NCT03874234|468098080|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
130038891|NCT03874234|468098081|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
130038892|NCT03874234|468098082|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038893|NCT03874234|468098083|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038894|NCT03874234|468098084|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038895|NCT03874234|468098085|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038896|NCT03874234|468098086|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038897|NCT03874234|468098087|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038898|NCT03874234|468098088|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
130038899|NCT03874234|468098076|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038900|NCT03874234|468098077|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038901|NCT03874234|468098078|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038902|NCT03874234|468098079|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038903|NCT03874234|468098080|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038904|NCT03874234|468098081|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038905|NCT03874234|468098082|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
130038906|NCT03874234|468098083|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038907|NCT03874234|468098084|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038908|NCT03874234|468098085|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038909|NCT03874234|468098086|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038910|NCT03874234|468098087|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038911|NCT03874234|468098088|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
130038912|NCT03874234|468098076|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038913|NCT03874234|468098077|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038914|NCT03874234|468098078|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038915|NCT03874234|468098079|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038916|NCT03874234|468098080|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
130038917|NCT03874234|468098081|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038918|NCT03874234|468098082|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038919|NCT03874234|468098083|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038920|NCT03874234|468098084|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038921|NCT03874234|468098085|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038922|NCT03874234|468098086|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038923|NCT03874234|468098087|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038924|NCT03874234|468098088|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
130038925|NCT00686205|468098090|FG000|Overall Study|Protocol Violation|127|||
130038926|NCT00686205|468098091|FG001|Overall Study|Protocol Violation|0|||
130038927|NCT00686205|468098090|FG000|Overall Study|Withdrawal by Subject|2|||
130038928|NCT00686205|468098091|FG001|Overall Study|Withdrawal by Subject|0|||
130038929|NCT00686205|468098090|FG000|Overall Study|Specimen handling procedure altered|5878|||
130038930|NCT00686205|468098091|FG001|Overall Study|Specimen handling procedure altered|0|||
130038931|NCT00686205|468098090|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
130038932|NCT00686205|468098091|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
130038933|NCT00265941|468098092|FG000|Overall Study|Protocol Violation|22|||
130038934|NCT00265941|468098093|FG001|Overall Study|Protocol Violation|25|||
130038935|NCT00265941|468098092|FG000|Overall Study|Lost to Follow-up|1|||
130038936|NCT00265941|468098093|FG001|Overall Study|Lost to Follow-up|1|||
130038937|NCT03816995|468098096|FG000|Overall Study|Withdrawal by Subject|3|||
130038938|NCT03816995|468098097|FG001|Overall Study|Withdrawal by Subject|1|||
130038939|NCT03816995|468098096|FG000|Overall Study|Cancelled Surgery|8|||
130038940|NCT03816995|468098097|FG001|Overall Study|Cancelled Surgery|12|||
130038941|NCT03816995|468098096|FG000|Overall Study|No wound protector used|11|||
130038942|NCT03816995|468098097|FG001|Overall Study|No wound protector used|17|||
130038943|NCT03816995|468098096|FG000|Overall Study|Protocol Violation|2|||
130038944|NCT03816995|468098097|FG001|Overall Study|Protocol Violation|3|||
130038945|NCT03941548|468098098|FG000|Overall Study|Adverse Event|0|||
130104044|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104045|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
130104046|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
130104047|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
130104048|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
130104049|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104050|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104051|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104052|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104053|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
130104054|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104055|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104056|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104057|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104058|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
130104059|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104060|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104061|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104062|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104063|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104064|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104065|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104066|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104067|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
130104068|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
130104069|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130104070|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130104071|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130104072|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130104073|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
130104074|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130104075|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130104076|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130104077|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130104078|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
130104079|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130104080|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130104081|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
130104082|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
130104083|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
130104084|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
130104085|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
130104086|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
130104087|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104088|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104089|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104090|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104091|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104092|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104093|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104094|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104095|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104096|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104097|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
130104098|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104099|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104100|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104101|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104102|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104103|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104104|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104105|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
130104106|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130104107|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130104108|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130104109|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130104110|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130038946|NCT03941548|468098099|FG001|Overall Study|Adverse Event|1|||
130038947|NCT03941548|468098098|FG000|Overall Study|Lost to Follow-up|0|||
130038948|NCT03941548|468098099|FG001|Overall Study|Lost to Follow-up|1|||
130038949|NCT03941548|468098098|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
130038950|NCT03941548|468098099|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
130038951|NCT01242111|468098102|FG000|Overall Study|Adverse Event|1|||
130038952|NCT01242111|468098102|FG000|Overall Study|Withdrawal by Subject|1|||
130038953|NCT01242111|468098102|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
130038954|NCT02015819|468098103|FG000|Overall Study|Rickham catheter was misaligned|0|||
130038955|NCT02015819|468098104|FG001|Overall Study|Rickham catheter was misaligned|0|||
130038956|NCT02015819|468098105|FG002|Overall Study|Rickham catheter was misaligned|0|||
130038957|NCT02015819|468098106|FG003|Overall Study|Rickham catheter was misaligned|1|||
130038958|NCT02945657|468098107|FG000|Overall Study|Adverse Event|1|||
130038959|NCT02945657|468098107|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
130038960|NCT00813748|468098109|FG000|Skin Test Substudy|Physician Decision|0|||
130038961|NCT00813748|468098110|FG001|Skin Test Substudy|Physician Decision|1|||
130038962|NCT00283387|468098111|FG000|First Intervention|Subject non-compliant|1|||
130038963|NCT00283387|468098112|FG001|First Intervention|Subject non-compliant|1|||
130038964|NCT00283387|468098111|FG000|First Intervention|Withdrawal by Subject|0|||
130038965|NCT00283387|468098112|FG001|First Intervention|Withdrawal by Subject|1|||
130038966|NCT03584009|468098117|FG000|Overall Study|Death|25|||
130038967|NCT03584009|468098118|FG001|Overall Study|Death|18|||
130038968|NCT03584009|468098117|FG000|Overall Study|Lost to Follow-up|0|||
130038969|NCT03584009|468098118|FG001|Overall Study|Lost to Follow-up|1|||
130038970|NCT03584009|468098117|FG000|Overall Study|Physician Decision|1|||
130038971|NCT03584009|468098118|FG001|Overall Study|Physician Decision|1|||
130038972|NCT03584009|468098117|FG000|Overall Study|Study Terminated by Sponsor|22|||
130104111|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130038973|NCT03584009|468098118|FG001|Overall Study|Study Terminated by Sponsor|30|||
130038974|NCT03584009|468098117|FG000|Overall Study|Withdrawal by Subject|3|||
130038975|NCT03584009|468098118|FG001|Overall Study|Withdrawal by Subject|2|||
130038976|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
130038977|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
130038978|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
130038979|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
130038980|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
130038981|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
130038982|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
130038983|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
130038984|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
130038985|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
130038986|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
130038987|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
130038988|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
130038989|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
130038990|NCT00446030|468098119|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
130038991|NCT00446030|468098120|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
130038992|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
130038993|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
130038994|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
130038995|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
130038996|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
130038997|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
130038998|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
130038999|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
130039000|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
130039001|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
130039002|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
130039003|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
130039004|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
130039005|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
130039006|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
130039007|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
130039008|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
130039009|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
130039010|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
130039011|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
130039012|NCT00446030|468098119|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
130039013|NCT00446030|468098120|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
130039014|NCT02886715|468098121|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130039015|NCT02886715|468098122|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130039016|NCT02886715|468098123|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130039017|NCT02886715|468098121|FG000|Overall Study|Adverse Event|4|||
130039018|NCT02886715|468098122|FG001|Overall Study|Adverse Event|2|||
130039019|NCT02886715|468098123|FG002|Overall Study|Adverse Event|0|||
130039020|NCT02886715|468098121|FG000|Overall Study|Lack of Efficacy|0|||
130039021|NCT02886715|468098122|FG001|Overall Study|Lack of Efficacy|2|||
130039022|NCT02886715|468098123|FG002|Overall Study|Lack of Efficacy|1|||
130039023|NCT02886715|468098121|FG000|Overall Study|Lost to Follow-up|29|||
130039024|NCT02886715|468098122|FG001|Overall Study|Lost to Follow-up|26|||
130039025|NCT02886715|468098123|FG002|Overall Study|Lost to Follow-up|10|||
130039026|NCT02886715|468098121|FG000|Overall Study|Pregnancy|1|||
130039027|NCT02886715|468098122|FG001|Overall Study|Pregnancy|1|||
130039028|NCT02886715|468098123|FG002|Overall Study|Pregnancy|1|||
130039029|NCT02886715|468098121|FG000|Overall Study|Protocol Violation|3|||
130039030|NCT02886715|468098122|FG001|Overall Study|Protocol Violation|2|||
130039031|NCT02886715|468098123|FG002|Overall Study|Protocol Violation|1|||
130039032|NCT02886715|468098121|FG000|Overall Study|Withdrawal by Subject|20|||
130039033|NCT02886715|468098122|FG001|Overall Study|Withdrawal by Subject|18|||
130039034|NCT02886715|468098123|FG002|Overall Study|Withdrawal by Subject|5|||
130039035|NCT02886715|468098121|FG000|Overall Study|missing|7|||
130039036|NCT02886715|468098122|FG001|Overall Study|missing|2|||
130039037|NCT02886715|468098123|FG002|Overall Study|missing|2|||
130039038|NCT00222105|468098124|FG000|Overall Study|Removed due to wrong diagnosis|1|||
130039039|NCT00222105|468098124|FG000|Overall Study|Withdrawal by Subject|1|||
130039040|NCT00222105|468098124|FG000|Overall Study|Adverse Event|8|||
130039041|NCT00222105|468098124|FG000|Overall Study|Treatment delays|2|||
130039042|NCT00222105|468098124|FG000|Overall Study|Death|2|||
130039043|NCT00503399|468098125|FG000|Overall Study|Death|2|||
130039044|NCT00503399|468098126|FG001|Overall Study|Death|1|||
130039045|NCT00503399|468098125|FG000|Overall Study|Protocol Violation|1|||
130039046|NCT00503399|468098126|FG001|Overall Study|Protocol Violation|0|||
130039047|NCT00503399|468098125|FG000|Overall Study|Withdrawal by Subject|4|||
130039048|NCT00503399|468098126|FG001|Overall Study|Withdrawal by Subject|2|||
130039049|NCT00503399|468098125|FG000|Overall Study|Adverse Event|0|||
130039050|NCT00503399|468098126|FG001|Overall Study|Adverse Event|3|||
130039051|NCT00503399|468098125|FG000|Overall Study|Lost to Follow-up|0|||
130039052|NCT00503399|468098126|FG001|Overall Study|Lost to Follow-up|2|||
130039053|NCT01120626|468098129|FG000|Overall Study|Withdrawal by Subject|1|||
130039054|NCT01120626|468098130|FG001|Overall Study|Withdrawal by Subject|0|||
130039055|NCT00824421|468098131|FG000|Overall Study|Adverse Event|6|||
130039056|NCT00824421|468098132|FG001|Overall Study|Adverse Event|6|||
130039057|NCT00824421|468098133|FG002|Overall Study|Adverse Event|6|||
130039058|NCT00824421|468098131|FG000|Overall Study|Death|0|||
130039059|NCT00824421|468098132|FG001|Overall Study|Death|1|||
130039060|NCT00824421|468098133|FG002|Overall Study|Death|0|||
130039061|NCT00824421|468098131|FG000|Overall Study|Lack of Efficacy|5|||
130039062|NCT00824421|468098132|FG001|Overall Study|Lack of Efficacy|7|||
130039063|NCT00824421|468098133|FG002|Overall Study|Lack of Efficacy|4|||
130039064|NCT00824421|468098131|FG000|Overall Study|Lost to Follow-up|2|||
130039065|NCT00824421|468098132|FG001|Overall Study|Lost to Follow-up|3|||
130039066|NCT00824421|468098133|FG002|Overall Study|Lost to Follow-up|0|||
130039067|NCT00824421|468098131|FG000|Overall Study|Pregnancy|1|||
130039068|NCT00824421|468098132|FG001|Overall Study|Pregnancy|0|||
130039069|NCT00824421|468098133|FG002|Overall Study|Pregnancy|1|||
130039070|NCT00824421|468098131|FG000|Overall Study|Withdrawal by Subject|2|||
130039071|NCT00824421|468098132|FG001|Overall Study|Withdrawal by Subject|3|||
130039072|NCT00824421|468098133|FG002|Overall Study|Withdrawal by Subject|3|||
130039073|NCT00824421|468098131|FG000|Overall Study|Randomized but not Treated|1|||
130039074|NCT00824421|468098132|FG001|Overall Study|Randomized but not Treated|1|||
130039075|NCT00824421|468098133|FG002|Overall Study|Randomized but not Treated|0|||
130039076|NCT00824421|468098131|FG000|Overall Study|Other|0|||
130039077|NCT00824421|468098132|FG001|Overall Study|Other|1|||
130039078|NCT00824421|468098133|FG002|Overall Study|Other|0|||
130039079|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
130039080|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
130039081|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
130039082|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
130039083|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
130039084|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
130039085|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Personal issues|2|||
130039086|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Personal issues|0|||
130039087|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Personal issues|0|||
130039088|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Too busy|7|||
130039089|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Too busy|1|||
130039090|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Too busy|0|||
130039091|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Pain|2|||
130039092|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Pain|0|||
130039093|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Pain|0|||
130039094|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Moved|1|||
130039095|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Moved|0|||
130039096|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Moved|0|||
130039097|NCT00594399|468098135|FG000|Initial 3 Month Counseling|Family illness|1|||
130039098|NCT00594399|468098136|FG001|Initial 3 Month Counseling|Family illness|0|||
130039099|NCT00594399|468098137|FG002|Initial 3 Month Counseling|Family illness|0|||
130039100|NCT00594399|468098135|FG000|Rerandomization Arm 1 Only|Death|2|||
130039101|NCT00594399|468098136|FG001|Rerandomization Arm 1 Only|Death|1|||
130039102|NCT00594399|468098137|FG002|Rerandomization Arm 1 Only|Death|0|||
130039103|NCT00594399|468098135|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
130039104|NCT00594399|468098136|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
130039105|NCT00594399|468098137|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
130039106|NCT03830281|468098138|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
130039107|NCT03830281|468098139|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
130039108|NCT03830281|468098138|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
130039109|NCT03830281|468098139|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
130039110|NCT03830281|468098138|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
130039111|NCT03830281|468098139|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
130039112|NCT03830281|468098138|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
130039113|NCT03830281|468098139|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
130039114|NCT03830281|468098138|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
130039115|NCT03830281|468098139|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
130039116|NCT03830281|468098138|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
130039117|NCT03830281|468098139|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
130039118|NCT03830281|468098138|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
130039119|NCT03830281|468098139|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
130039120|NCT03830281|468098138|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
130039121|NCT03830281|468098139|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
130039122|NCT03830281|468098138|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
130039123|NCT03830281|468098139|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
130039124|NCT01985321|468098141|FG000|Overall Study|Protocol Violation|4|||
130039125|NCT01985321|468098142|FG001|Overall Study|Protocol Violation|3|||
130039126|NCT01985321|468098141|FG000|Overall Study|Withdrawal by Subject|1|||
130039127|NCT01985321|468098142|FG001|Overall Study|Withdrawal by Subject|0|||
130039128|NCT01985321|468098141|FG000|Overall Study|Lost to Follow-up|5|||
130039129|NCT01985321|468098142|FG001|Overall Study|Lost to Follow-up|2|||
130039130|NCT01985321|468098141|FG000|Overall Study|Subject treated wrong type of sore|1|||
130039131|NCT01985321|468098142|FG001|Overall Study|Subject treated wrong type of sore|0|||
130039132|NCT00659438|468098143|FG000|Overall Study|Withdrawal by Subject|2|||
130039133|NCT00659438|468098144|FG001|Overall Study|Withdrawal by Subject|2|||
130039134|NCT00659438|468098143|FG000|Overall Study|Death|11|||
130039135|NCT00659438|468098144|FG001|Overall Study|Death|6|||
130039136|NCT00659438|468098143|FG000|Overall Study|Lost to Follow-up|1|||
130039137|NCT00659438|468098144|FG001|Overall Study|Lost to Follow-up|0|||
130039138|NCT02201940|468098145|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
130039139|NCT02201940|468098146|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
130039140|NCT02201940|468098145|FG000|Overall Study|Lack of Efficacy|2|||
130039141|NCT02201940|468098146|FG001|Overall Study|Lack of Efficacy|113|||
130039142|NCT02201940|468098145|FG000|Overall Study|Lost to Follow-up|5|||
130039143|NCT02201940|468098146|FG001|Overall Study|Lost to Follow-up|0|||
130039144|NCT02201940|468098145|FG000|Overall Study|Withdrew Consent|2|||
130039145|NCT02201940|468098146|FG001|Overall Study|Withdrew Consent|1|||
130039146|NCT02201940|468098145|FG000|Overall Study|Investigator's Discretion|1|||
130039147|NCT02201940|468098146|FG001|Overall Study|Investigator's Discretion|1|||
130039148|NCT02201940|468098145|FG000|Overall Study|Death|1|||
130039149|NCT02201940|468098146|FG001|Overall Study|Death|0|||
130039150|NCT02201940|468098145|FG000|Overall Study|Adverse Event|0|||
130039151|NCT02201940|468098146|FG001|Overall Study|Adverse Event|1|||
130039152|NCT03953118|468098147|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
130039153|NCT03953118|468098148|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
130039154|NCT03192904|468098149|FG000|Overall Study|Physician Decision|3|||
130039155|NCT03192904|468098150|FG001|Overall Study|Physician Decision|1|||
130039156|NCT03192904|468098149|FG000|Overall Study|Lost to Follow-up|0|||
130039157|NCT03192904|468098150|FG001|Overall Study|Lost to Follow-up|1|||
130039158|NCT00424398|468098151|FG000|Overall Study|Withdrawal by Subject|2|||
130039159|NCT00424398|468098152|FG001|Overall Study|Withdrawal by Subject|1|||
130039160|NCT00424398|468098153|FG002|Overall Study|Withdrawal by Subject|0|||
130039161|NCT00424398|468098151|FG000|Overall Study|Subject met exclusion criteria|1|||
130039162|NCT00424398|468098152|FG001|Overall Study|Subject met exclusion criteria|0|||
130039163|NCT00424398|468098153|FG002|Overall Study|Subject met exclusion criteria|0|||
130039164|NCT01023789|468098154|FG000|3 - Year Visit|Death|29|||
130039165|NCT01023789|468098154|FG000|3 - Year Visit|Withdrawal of consent|1|||
130039166|NCT01023789|468098154|FG000|3 - Year Visit|Lost to Follow-up|13|||
130039167|NCT03133767|468098158|FG000|Overall Study|Lost to Follow-up|38|||
130039168|NCT03133767|468098159|FG001|Overall Study|Lost to Follow-up|24|||
130039169|NCT03133767|468098158|FG000|Overall Study|Protocol Violation|0|||
130039170|NCT03133767|468098159|FG001|Overall Study|Protocol Violation|1|||
130039171|NCT02240706|468098162|FG000|Overall Study|Lack of Efficacy|2|||
130039172|NCT02240706|468098163|FG001|Overall Study|Lack of Efficacy|2|||
130039173|NCT02240706|468098164|FG002|Overall Study|Lack of Efficacy|2|||
130039174|NCT02240706|468098165|FG003|Overall Study|Lack of Efficacy|2|||
130039175|NCT02240706|468098166|FG004|Overall Study|Lack of Efficacy|5|||
130039176|NCT02240706|468098167|FG005|Overall Study|Lack of Efficacy|0|||
130039177|NCT02240706|468098168|FG006|Overall Study|Lack of Efficacy|0|||
130039178|NCT02240706|468098162|FG000|Overall Study|Adverse Event|1|||
130039179|NCT02240706|468098163|FG001|Overall Study|Adverse Event|0|||
130039180|NCT02240706|468098164|FG002|Overall Study|Adverse Event|1|||
130039181|NCT02240706|468098165|FG003|Overall Study|Adverse Event|0|||
130039182|NCT02240706|468098166|FG004|Overall Study|Adverse Event|2|||
130039183|NCT02240706|468098167|FG005|Overall Study|Adverse Event|0|||
130039184|NCT02240706|468098168|FG006|Overall Study|Adverse Event|0|||
130039185|NCT02240706|468098162|FG000|Overall Study|Progressive disease|0|||
130104112|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130039186|NCT02240706|468098163|FG001|Overall Study|Progressive disease|0|||
130039187|NCT02240706|468098164|FG002|Overall Study|Progressive disease|0|||
130039188|NCT02240706|468098165|FG003|Overall Study|Progressive disease|0|||
130039189|NCT02240706|468098166|FG004|Overall Study|Progressive disease|1|||
130039190|NCT02240706|468098167|FG005|Overall Study|Progressive disease|0|||
130039191|NCT02240706|468098168|FG006|Overall Study|Progressive disease|0|||
130039192|NCT02240706|468098162|FG000|Overall Study|Dose limiting toxicity|0|||
130039193|NCT02240706|468098163|FG001|Overall Study|Dose limiting toxicity|0|||
130039194|NCT02240706|468098164|FG002|Overall Study|Dose limiting toxicity|0|||
130039195|NCT02240706|468098165|FG003|Overall Study|Dose limiting toxicity|0|||
130039196|NCT02240706|468098166|FG004|Overall Study|Dose limiting toxicity|1|||
130039197|NCT02240706|468098167|FG005|Overall Study|Dose limiting toxicity|0|||
130039198|NCT02240706|468098168|FG006|Overall Study|Dose limiting toxicity|0|||
130039199|NCT02240706|468098162|FG000|Overall Study|Refused to continue taking medication|0|||
130039200|NCT02240706|468098163|FG001|Overall Study|Refused to continue taking medication|1|||
130039201|NCT02240706|468098164|FG002|Overall Study|Refused to continue taking medication|3|||
130039202|NCT02240706|468098165|FG003|Overall Study|Refused to continue taking medication|1|||
130039203|NCT02240706|468098166|FG004|Overall Study|Refused to continue taking medication|2|||
130039204|NCT02240706|468098167|FG005|Overall Study|Refused to continue taking medication|0|||
130039205|NCT02240706|468098168|FG006|Overall Study|Refused to continue taking medication|0|||
130039206|NCT02240706|468098162|FG000|Overall Study|Insurance billing concerns|0|||
130039207|NCT02240706|468098163|FG001|Overall Study|Insurance billing concerns|0|||
130039208|NCT02240706|468098164|FG002|Overall Study|Insurance billing concerns|0|||
130039209|NCT02240706|468098165|FG003|Overall Study|Insurance billing concerns|1|||
130039210|NCT02240706|468098166|FG004|Overall Study|Insurance billing concerns|0|||
130039211|NCT02240706|468098167|FG005|Overall Study|Insurance billing concerns|0|||
130039212|NCT02240706|468098168|FG006|Overall Study|Insurance billing concerns|0|||
130039213|NCT03934684|468098170|FG000|Overall Study|Participants continuing in study|11|||
130039214|NCT03934684|468098171|FG001|Overall Study|Participants continuing in study|4|||
130039215|NCT03934684|468098170|FG000|Overall Study|Discontinuation of carfilzomib|20|||
130039216|NCT03934684|468098171|FG001|Overall Study|Discontinuation of carfilzomib|30|||
130039217|NCT03934684|468098170|FG000|Overall Study|Death|2|||
130039218|NCT03934684|468098171|FG001|Overall Study|Death|2|||
130039219|NCT03934684|468098170|FG000|Overall Study|Lost to Follow-up|2|||
130039220|NCT03934684|468098171|FG001|Overall Study|Lost to Follow-up|5|||
130039221|NCT03934684|468098170|FG000|Overall Study|Withdrawal by Subject|7|||
130039222|NCT03934684|468098171|FG001|Overall Study|Withdrawal by Subject|8|||
130039223|NCT05662332|468098172|FG000|Overall Study|Death|3|||
130039224|NCT05662332|468098173|FG001|Overall Study|Death|3|||
130039225|NCT05662332|468098172|FG000|Overall Study|Lost to Follow-up|3|||
130039226|NCT05662332|468098173|FG001|Overall Study|Lost to Follow-up|8|||
130039227|NCT05662332|468098172|FG000|Overall Study|Physician Decision|1|||
130039228|NCT05662332|468098173|FG001|Overall Study|Physician Decision|2|||
130039229|NCT05662332|468098172|FG000|Overall Study|Protocol Deviation|2|||
130039230|NCT05662332|468098173|FG001|Overall Study|Protocol Deviation|1|||
130039231|NCT05662332|468098172|FG000|Overall Study|Withdrawal by Subject|14|||
130039232|NCT05662332|468098173|FG001|Overall Study|Withdrawal by Subject|14|||
130039233|NCT05662332|468098172|FG000|Overall Study|Assigned Treatment by Mistake|5|||
130039234|NCT05662332|468098173|FG001|Overall Study|Assigned Treatment by Mistake|7|||
130039235|NCT05662332|468098172|FG000|Overall Study|Non-compliance with study drug|4|||
130039236|NCT05662332|468098173|FG001|Overall Study|Non-compliance with study drug|1|||
130039237|NCT05662332|468098172|FG000|Overall Study|Due to Bariatric surgery|1|||
130039238|NCT05662332|468098173|FG001|Overall Study|Due to Bariatric surgery|0|||
130039239|NCT05662332|468098172|FG000|Overall Study|Subject Moving out of State|0|||
130039240|NCT05662332|468098173|FG001|Overall Study|Subject Moving out of State|1|||
130039241|NCT05662332|468098172|FG000|Overall Study|Subject Missed the Schedule|1|||
130039242|NCT05662332|468098173|FG001|Overall Study|Subject Missed the Schedule|0|||
130039243|NCT05662332|468098172|FG000|Overall Study|The Patient Moved to Another City|1|||
130039244|NCT05662332|468098173|FG001|Overall Study|The Patient Moved to Another City|0|||
130039245|NCT00256295|468098174|FG000|Overall Study|Withdrawal by Subject|3|||
130039246|NCT00256295|468098174|FG000|Overall Study|Death|1|||
130039247|NCT01731002|468098184|FG000|Overall Study|Adverse Event|0|||
130039248|NCT01731002|468098185|FG001|Overall Study|Adverse Event|2|||
129886116|NCT00531011|467542853|FG000|Overall Study|Physician Decision|0|||
130039249|NCT01731002|468098186|FG002|Overall Study|Adverse Event|2|||
130039250|NCT01731002|468098184|FG000|Overall Study|Non-Compliant|0|||
130039251|NCT01731002|468098185|FG001|Overall Study|Non-Compliant|1|||
130039252|NCT01731002|468098186|FG002|Overall Study|Non-Compliant|0|||
130039253|NCT01731002|468098184|FG000|Overall Study|Lost to Follow-up|1|||
130039254|NCT01731002|468098185|FG001|Overall Study|Lost to Follow-up|0|||
130039255|NCT01731002|468098186|FG002|Overall Study|Lost to Follow-up|0|||
130039256|NCT01731002|468098184|FG000|Overall Study|Test Agent Discontinuation|0|||
130039257|NCT01731002|468098185|FG001|Overall Study|Test Agent Discontinuation|1|||
130039258|NCT01731002|468098186|FG002|Overall Study|Test Agent Discontinuation|0|||
130039259|NCT01731002|468098184|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
130039260|NCT01731002|468098185|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
130039261|NCT01731002|468098186|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
130039262|NCT01731002|468098184|FG000|Overall Study|Elevated IOP|1|||
130039263|NCT01731002|468098185|FG001|Overall Study|Elevated IOP|0|||
130039264|NCT01731002|468098186|FG002|Overall Study|Elevated IOP|0|||
130039265|NCT01731002|468098184|FG000|Overall Study|Inappropriate use of study medications|0|||
130039266|NCT01731002|468098185|FG001|Overall Study|Inappropriate use of study medications|0|||
130039267|NCT01731002|468098186|FG002|Overall Study|Inappropriate use of study medications|1|||
130039268|NCT01697345|468098189|FG000|Overall Study|Withdrawal by Subject|1|||
130039269|NCT03972488|468098190|FG000|Overall Study|Progressive disease|42|||
129886117|NCT00531011|467542854|FG001|Overall Study|Physician Decision|3|||
130039270|NCT03972488|468098191|FG001|Overall Study|Progressive disease|44|||
130039271|NCT03972488|468098190|FG000|Overall Study|Physician Decision|13|||
130039272|NCT03972488|468098191|FG001|Overall Study|Physician Decision|7|||
130039273|NCT03972488|468098190|FG000|Overall Study|Adverse Event|8|||
130039274|NCT03972488|468098191|FG001|Overall Study|Adverse Event|1|||
130039275|NCT03972488|468098190|FG000|Overall Study|Death|4|||
130039276|NCT03972488|468098191|FG001|Overall Study|Death|4|||
130039277|NCT03972488|468098190|FG000|Overall Study|Withdrawal by Subject|3|||
130039278|NCT03972488|468098191|FG001|Overall Study|Withdrawal by Subject|4|||
130039279|NCT03972488|468098190|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
130039280|NCT03972488|468098191|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
130039281|NCT04865731|468098192|FG000|Overall Study|Physician Decision|2|||
130039282|NCT04865731|468098193|FG001|Overall Study|Physician Decision|1|||
130039283|NCT04865731|468098192|FG000|Overall Study|Adverse Event|1|||
130039284|NCT04865731|468098193|FG001|Overall Study|Adverse Event|0|||
130039285|NCT04865731|468098192|FG000|Overall Study|Withdrawal by Subject|0|||
130039286|NCT04865731|468098193|FG001|Overall Study|Withdrawal by Subject|1|||
130039287|NCT00942162|468099770|FG000|Overall Study|Death|45|||
130039288|NCT00942162|468099771|FG001|Overall Study|Death|35|||
130039289|NCT00942162|468099772|FG002|Overall Study|Death|0|||
130039290|NCT00942162|468099770|FG000|Overall Study|Withdrawal by Subject|7|||
130039291|NCT00942162|468099771|FG001|Overall Study|Withdrawal by Subject|2|||
130039292|NCT00942162|468099772|FG002|Overall Study|Withdrawal by Subject|0|||
130039293|NCT00942162|468099770|FG000|Overall Study|Lost to Follow-up|4|||
130039294|NCT00942162|468099771|FG001|Overall Study|Lost to Follow-up|0|||
130039295|NCT00942162|468099772|FG002|Overall Study|Lost to Follow-up|0|||
130039296|NCT00942162|468099770|FG000|Overall Study|Other|14|||
130039297|NCT00942162|468099771|FG001|Overall Study|Other|13|||
130039298|NCT00942162|468099772|FG002|Overall Study|Other|2|||
130039299|NCT01006356|468099776|FG000|Overall Study|Adverse Event|6|||
130039300|NCT01006356|468099776|FG000|Overall Study|Physician Decision|1|||
130039301|NCT01006356|468099776|FG000|Overall Study|Paticipants did not cooperate|6|||
130039302|NCT01006356|468099776|FG000|Overall Study|Withdrawal by Subject|1|||
130039303|NCT01006356|468099776|FG000|Overall Study|Choice by participants|2|||
130039304|NCT01006356|468099776|FG000|Overall Study|Protocol Violation|3|||
130039305|NCT01006356|468099776|FG000|Overall Study|Other|23|||
130039306|NCT01756157|468099784|FG000|First Intervention Period|Withdrawal by Subject|1|||
130039307|NCT01756157|468099785|FG001|First Intervention Period|Withdrawal by Subject|0|||
130039308|NCT01756157|468099784|FG000|First Intervention Period|Lost to Follow-up|0|||
130039309|NCT01756157|468099785|FG001|First Intervention Period|Lost to Follow-up|2|||
130039310|NCT02799381|468099788|FG000|Overall Study|Withdrew consent|3|||
130039311|NCT02799381|468099789|FG001|Overall Study|Withdrew consent|2|||
130039312|NCT02799381|468099788|FG000|Overall Study|Adverse Event|0|||
130039313|NCT02799381|468099789|FG001|Overall Study|Adverse Event|1|||
130039314|NCT02799381|468099788|FG000|Overall Study|Participant did not take any study drug|1|||
130039315|NCT02799381|468099789|FG001|Overall Study|Participant did not take any study drug|0|||
130039316|NCT03368859|468099790|FG000|Overall Study|Withdrew Consent|5|||
130039317|NCT03368859|468099791|FG001|Overall Study|Withdrew Consent|4|||
130039318|NCT03368859|468099790|FG000|Overall Study|Death|12|||
130039319|NCT03368859|468099791|FG001|Overall Study|Death|6|||
130273620|NCT00405392|468965616|FG001|Overall Study|Lost to Follow-up|2|||
130039320|NCT03368859|468099790|FG000|Overall Study|Study terminated by Sponsor|18|||
130039321|NCT03368859|468099791|FG001|Overall Study|Study terminated by Sponsor|23|||
130039322|NCT03368859|468099790|FG000|Overall Study|Other|1|||
130039323|NCT03368859|468099791|FG001|Overall Study|Other|1|||
130039324|NCT03952130|468099792|FG000|Overall Study|Adverse Event|0|||
130039325|NCT03952130|468099793|FG001|Overall Study|Adverse Event|1|||
130273621|NCT00405392|468965615|FG000|Overall Study|Data missing|2|||
130273622|NCT00405392|468965616|FG001|Overall Study|Data missing|0|||
130273623|NCT00405392|468965615|FG000|Overall Study|Non-compliance|0|||
130273624|NCT00405392|468965616|FG001|Overall Study|Non-compliance|1|||
130273625|NCT00405392|468965615|FG000|Overall Study|Other|1|||
130273626|NCT00405392|468965616|FG001|Overall Study|Other|5|||
130273627|NCT00412958|468965617|FG000|Overall Study|Withdrawal by Subject|3|||
130273628|NCT00412958|468965618|FG001|Overall Study|Withdrawal by Subject|0|||
130273629|NCT00412958|468965619|FG002|Overall Study|Withdrawal by Subject|0|||
130273630|NCT00412958|468965620|FG003|Overall Study|Withdrawal by Subject|1|||
130273631|NCT00412958|468965617|FG000|Overall Study|Adverse Event|0|||
130273632|NCT00412958|468965618|FG001|Overall Study|Adverse Event|1|||
130273633|NCT00412958|468965619|FG002|Overall Study|Adverse Event|0|||
130039326|NCT03952130|468099792|FG000|Overall Study|Lost to Follow-up|1|||
130039327|NCT03952130|468099793|FG001|Overall Study|Lost to Follow-up|0|||
130039328|NCT03952130|468099792|FG000|Overall Study|Withdrawal by Subject|1|||
130039329|NCT03952130|468099793|FG001|Overall Study|Withdrawal by Subject|5|||
130273634|NCT00412958|468965620|FG003|Overall Study|Adverse Event|0|||
130039330|NCT01713348|468099794|FG000|Overall Study|Withdrawal by Subject|3|||
130039331|NCT01713348|468099795|FG001|Overall Study|Withdrawal by Subject|2|||
130273635|NCT00412958|468965617|FG000|Overall Study|Lost to Follow-up|0|||
130039332|NCT01713348|468099796|FG002|Overall Study|Withdrawal by Subject|2|||
130039333|NCT01713348|468099797|FG003|Overall Study|Withdrawal by Subject|0|||
130039334|NCT01713348|468099794|FG000|Overall Study|Lost to Follow-up|1|||
130039335|NCT01713348|468099795|FG001|Overall Study|Lost to Follow-up|0|||
130039336|NCT01713348|468099796|FG002|Overall Study|Lost to Follow-up|0|||
130039337|NCT01713348|468099797|FG003|Overall Study|Lost to Follow-up|0|||
130039338|NCT05882890|468099800|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
130039339|NCT00613314|468099803|FG000|Overall Study|Adverse Event|5|||
130039340|NCT00613314|468099803|FG000|Overall Study|Protocol Violation|14|||
130039341|NCT00613314|468099803|FG000|Overall Study|Lost to Follow-up|46|||
130039342|NCT00613314|468099803|FG000|Overall Study|Other reason not defined above|90|||
130039343|NCT01584024|468099804|FG000|Overall Study|Lost to Follow-up|10|||
130039344|NCT01584024|468099804|FG000|Overall Study|Withdrawal by Subject|3|||
130039345|NCT01217606|468099805|FG000|Initial Treatment Phase|Other Reasons|0|||
130039346|NCT01217606|468099806|FG001|Initial Treatment Phase|Other Reasons|2|||
130039347|NCT01217606|468099805|FG000|Initial Treatment Phase|Protocol Violation|3|||
130039348|NCT01217606|468099806|FG001|Initial Treatment Phase|Protocol Violation|2|||
130039349|NCT01217606|468099805|FG000|Initial Treatment Phase|Personal Reasons|0|||
130039350|NCT01217606|468099806|FG001|Initial Treatment Phase|Personal Reasons|2|||
130039351|NCT01217606|468099805|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
130039352|NCT01217606|468099806|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
130039353|NCT01217606|468099805|FG000|Initial Treatment Phase|Adverse Event|10|||
130039354|NCT01217606|468099806|FG001|Initial Treatment Phase|Adverse Event|6|||
130039355|NCT01217606|468099805|FG000|9-Month Masked Extension|Adverse Event|3|||
130039356|NCT01217606|468099806|FG001|9-Month Masked Extension|Adverse Event|6|||
130039357|NCT01217606|468099805|FG000|9-Month Masked Extension|Other Reasons|4|||
130039358|NCT01217606|468099806|FG001|9-Month Masked Extension|Other Reasons|4|||
130039359|NCT01217606|468099805|FG000|9-Month Masked Extension|Personal Reasons|2|||
130039360|NCT01217606|468099806|FG001|9-Month Masked Extension|Personal Reasons|1|||
130039361|NCT01217606|468099805|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
130039362|NCT01217606|468099806|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
130039363|NCT01217606|468099805|FG000|9-Month Masked Extension|Pregnancy|1|||
130039364|NCT01217606|468099806|FG001|9-Month Masked Extension|Pregnancy|0|||
130039365|NCT01217606|468099805|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
130039366|NCT01217606|468099806|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
130039367|NCT02424539|468099813|FG000|Overall Study|Adverse Event|0|||
130039368|NCT02424539|468099814|FG001|Overall Study|Adverse Event|0|||
130039369|NCT02424539|468099815|FG002|Overall Study|Adverse Event|1|||
130039370|NCT02424539|468099813|FG000|Overall Study|Physician Decision|0|||
130039371|NCT02424539|468099814|FG001|Overall Study|Physician Decision|0|||
130039372|NCT02424539|468099815|FG002|Overall Study|Physician Decision|1|||
130039373|NCT02424539|468099813|FG000|Overall Study|Withdrawal by Subject|3|||
130039374|NCT02424539|468099814|FG001|Overall Study|Withdrawal by Subject|1|||
130039375|NCT02424539|468099815|FG002|Overall Study|Withdrawal by Subject|0|||
130039376|NCT02424539|468099813|FG000|Overall Study|Other: Reached stopping criteria|11|||
130039377|NCT02424539|468099814|FG001|Overall Study|Other: Reached stopping criteria|7|||
130039378|NCT02424539|468099815|FG002|Overall Study|Other: Reached stopping criteria|6|||
130039379|NCT04893265|468099816|FG000|Overall Study|Withdrawal by Subject|2|||
130039380|NCT04893265|468099817|FG001|Overall Study|Withdrawal by Subject|5|||
130039381|NCT04893265|468099816|FG000|Overall Study|Lost to Follow-up|0|||
130039382|NCT04893265|468099817|FG001|Overall Study|Lost to Follow-up|4|||
130039383|NCT03090191|468099822|FG000|Overall Study|Adverse Event|90|||
130039384|NCT03090191|468099823|FG001|Overall Study|Adverse Event|72|||
130039385|NCT03090191|468099822|FG000|Overall Study|Death|365|||
130039386|NCT03090191|468099823|FG001|Overall Study|Death|358|||
130039387|NCT03090191|468099822|FG000|Overall Study|Lost to Follow-up|382|||
130039388|NCT03090191|468099823|FG001|Overall Study|Lost to Follow-up|394|||
130039389|NCT03090191|468099822|FG000|Overall Study|Physician Decision|77|||
130039390|NCT03090191|468099823|FG001|Overall Study|Physician Decision|66|||
130039391|NCT03090191|468099822|FG000|Overall Study|Protocol Violation|43|||
130039392|NCT03090191|468099823|FG001|Overall Study|Protocol Violation|52|||
129886118|NCT02206152|467542877|FG000|Pre-Randomization|Withdrawal by Subject|2|||
129886119|NCT00478608|467542878|FG000|Overall Study|Adverse Event|1|||
129886120|NCT00478608|467542878|FG000|Overall Study|Serious Adverse Event|14|||
129886121|NCT00478608|467542878|FG000|Overall Study|Withdrawal by Subject|2|||
129886122|NCT00478608|467542878|FG000|Overall Study|Protocol Violation|3|||
129886123|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
129886124|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
129886125|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
129886126|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
129886127|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129886128|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
129886129|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129886130|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129886131|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
129886132|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
129886133|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129886134|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129886135|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
129886136|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
129886137|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129886138|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129886139|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
129886140|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
129886141|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
129886142|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
129886143|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
129886144|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
129886145|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
129886146|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
129886147|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
129886148|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
129886149|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
129886150|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
129886151|NCT03230864|467542885|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
129886152|NCT03230864|467542886|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
129886153|NCT03230864|467542887|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
129886154|NCT03230864|467542888|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
129886155|NCT03230864|467542885|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129886156|NCT03230864|467542886|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129886157|NCT03230864|467542887|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
129886158|NCT03230864|467542888|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
129886159|NCT03230864|467542885|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
129886160|NCT03230864|467542886|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
129886161|NCT03230864|467542887|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
129886162|NCT03230864|467542888|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
129886163|NCT01744496|467542893|FG000|Titration Period|Adverse Event|2|||
129886164|NCT01744496|467542894|FG001|Titration Period|Adverse Event|1|||
129886165|NCT01744496|467542893|FG000|Titration Period|Personal reasons|0|||
129886166|NCT01744496|467542894|FG001|Titration Period|Personal reasons|1|||
129886167|NCT01744496|467542893|FG000|Maintenance Period|Adverse Event|1|||
129886168|NCT01744496|467542894|FG001|Maintenance Period|Adverse Event|3|||
129886169|NCT01744496|467542893|FG000|Maintenance Period|Protocol Violation|1|||
129886170|NCT01744496|467542894|FG001|Maintenance Period|Protocol Violation|0|||
129886171|NCT01744496|467542893|FG000|Maintenance Period|Withdrawal by Subject|1|||
129886172|NCT01744496|467542894|FG001|Maintenance Period|Withdrawal by Subject|1|||
130104113|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
130104114|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129886173|NCT01744496|467542893|FG000|Maintenance Period|Subject left town|1|||
129886174|NCT01744496|467542894|FG001|Maintenance Period|Subject left town|0|||
129886175|NCT02374593|467542900|FG000|Overall Study|non-compliant|2|||
129886176|NCT02374593|467542901|FG001|Overall Study|non-compliant|0|||
129886177|NCT00579982|467542902|FG000|Overall Study|Adverse Event|4|||
129886178|NCT00579982|467542902|FG000|Overall Study|Protocol Violation|4|||
129886179|NCT04827134|467542903|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
129886180|NCT04827134|467542904|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
129886181|NCT04827134|467542905|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
129886182|NCT04827134|467542906|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
129886183|NCT00287469|467542910|FG000|Overall Study|serious adverse event|1|||
129886184|NCT00287469|467542911|FG001|Overall Study|serious adverse event|6|||
130039393|NCT03090191|468099822|FG000|Overall Study|Withdrawal by Subject|2160|||
130039394|NCT03090191|468099823|FG001|Overall Study|Withdrawal by Subject|2133|||
130039395|NCT03090191|468099822|FG000|Overall Study|Site terminated|7|||
130039396|NCT03090191|468099823|FG001|Overall Study|Site terminated|8|||
130039397|NCT03090191|468099822|FG000|Overall Study|Other|66|||
130039398|NCT03090191|468099823|FG001|Overall Study|Other|60|||
130039399|NCT03090191|468099822|FG000|Overall Study|Withdrawn before any study vaccination|43|||
130039400|NCT03090191|468099823|FG001|Overall Study|Withdrawn before any study vaccination|52|||
130039401|NCT04723537|468099825|FG000|Overall Study|Withdrawal by Subject|3|||
130039402|NCT04723537|468099826|FG001|Overall Study|Withdrawal by Subject|0|||
130039403|NCT04723537|468099827|FG002|Overall Study|Withdrawal by Subject|0|||
130039404|NCT04723537|468099825|FG000|Overall Study|Physician Decision|0|||
130039405|NCT04723537|468099826|FG001|Overall Study|Physician Decision|0|||
130039406|NCT04723537|468099827|FG002|Overall Study|Physician Decision|1|||
130039407|NCT04723537|468099825|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
130039408|NCT04723537|468099826|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
130039409|NCT04723537|468099827|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
130039410|NCT02432807|468099828|FG000|Overall Study|Adverse Event|0|||
130039411|NCT02432807|468099829|FG001|Overall Study|Adverse Event|2|||
130039412|NCT02432807|468099828|FG000|Overall Study|Lost to Follow-up|1|||
130039413|NCT02432807|468099829|FG001|Overall Study|Lost to Follow-up|0|||
130039414|NCT02432807|468099828|FG000|Overall Study|Withdrawal by Subject|1|||
130039415|NCT02432807|468099829|FG001|Overall Study|Withdrawal by Subject|1|||
130039416|NCT02432807|468099828|FG000|Overall Study|Other|1|||
130039417|NCT02432807|468099829|FG001|Overall Study|Other|1|||
130039418|NCT04419506|468099830|FG000|Overall Study|Adverse Event|0|||
130039419|NCT04419506|468099831|FG001|Overall Study|Adverse Event|10|||
130039420|NCT04419506|468099832|FG002|Overall Study|Adverse Event|0|||
130039421|NCT04419506|468099833|FG003|Overall Study|Adverse Event|3|||
130039422|NCT04419506|468099830|FG000|Overall Study|Withdrawal by Subject|0|||
130039423|NCT04419506|468099831|FG001|Overall Study|Withdrawal by Subject|0|||
130039424|NCT04419506|468099832|FG002|Overall Study|Withdrawal by Subject|0|||
130039425|NCT04419506|468099833|FG003|Overall Study|Withdrawal by Subject|1|||
130039426|NCT04419506|468099830|FG000|Overall Study|poor-compliance|0|||
130039427|NCT04419506|468099831|FG001|Overall Study|poor-compliance|0|||
130039428|NCT04419506|468099832|FG002|Overall Study|poor-compliance|0|||
130039429|NCT04419506|468099833|FG003|Overall Study|poor-compliance|1|||
130039430|NCT01845025|468099834|FG000|Overall Study|Adverse Event|6|||
130039431|NCT01845025|468099835|FG001|Overall Study|Adverse Event|3|||
130039432|NCT01845025|468099834|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130039433|NCT01845025|468099835|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130039434|NCT01845025|468099834|FG000|Overall Study|Withdrawal by Subject|48|||
130039435|NCT01845025|468099835|FG001|Overall Study|Withdrawal by Subject|44|||
130039436|NCT01845025|468099834|FG000|Overall Study|Lost to Follow-up|13|||
130039437|NCT01845025|468099835|FG001|Overall Study|Lost to Follow-up|13|||
130039438|NCT01845025|468099834|FG000|Overall Study|Administrative problems|8|||
130039439|NCT01845025|468099835|FG001|Overall Study|Administrative problems|8|||
130039440|NCT01845025|468099834|FG000|Overall Study|Death|2|||
130039441|NCT01845025|468099835|FG001|Overall Study|Death|0|||
130039442|NCT01845025|468099834|FG000|Overall Study|Protocol deviation|3|||
130039443|NCT01845025|468099835|FG001|Overall Study|Protocol deviation|6|||
130273636|NCT00412958|468965618|FG001|Overall Study|Lost to Follow-up|1|||
129800249|NCT05597020|467236279|FG001|Treatment Period II|Advice from primary care physician|0|||
129800250|NCT05597020|467236278|FG000|Treatment Period II|Subject lost investigational product|1|||
129800251|NCT05597020|467236279|FG001|Treatment Period II|Subject lost investigational product|0|||
129800252|NCT05597020|467236278|FG000|Treatment Period II|Private reasons|0|||
129800253|NCT05597020|467236279|FG001|Treatment Period II|Private reasons|1|||
129800254|NCT02445391|467236290|FG000|Overall Study|No active protocol treatment|3|||
130039444|NCT01845025|468099834|FG000|Overall Study|Missing|1|||
130039445|NCT01845025|468099835|FG001|Overall Study|Missing|1|||
130039446|NCT02966314|468099837|FG000|Overall Study|Lost to Follow-up|1|||
130039447|NCT02966314|468099838|FG001|Overall Study|Lost to Follow-up|0|||
130039448|NCT01021007|468099841|FG000|Overall Study|Lost to Follow-up|1|||
130039449|NCT01021007|468099842|FG001|Overall Study|Lost to Follow-up|1|||
130039450|NCT01021007|468099841|FG000|Overall Study|Adverse Event|1|||
130039451|NCT01021007|468099842|FG001|Overall Study|Adverse Event|3|||
129800255|NCT02445391|467236291|FG001|Overall Study|No active protocol treatment|0|||
129800256|NCT02445391|467236292|FG002|Overall Study|No active protocol treatment|0|||
129800257|NCT02445391|467236290|FG000|Overall Study|Adverse Event|0|||
130039452|NCT00728416|468099853|FG000|Overall Study|Adverse Event|1|||
130039453|NCT00728416|468099854|FG001|Overall Study|Adverse Event|1|||
130039454|NCT00728416|468099853|FG000|Overall Study|Treatment Failure|0|||
130039455|NCT00728416|468099854|FG001|Overall Study|Treatment Failure|1|||
130039456|NCT00728416|468099853|FG000|Overall Study|Withdrawal by Subject|1|||
130039457|NCT00728416|468099854|FG001|Overall Study|Withdrawal by Subject|0|||
130039458|NCT00356915|468099859|FG000|Overall Study|Non compliance|1|||
130039459|NCT00356915|468099860|FG001|Overall Study|Non compliance|2|||
130039460|NCT00356915|468099861|FG002|Overall Study|Non compliance|1|||
130039461|NCT00356915|468099859|FG000|Overall Study|Protocol Violation|2|||
130039462|NCT00356915|468099860|FG001|Overall Study|Protocol Violation|3|||
130039463|NCT00356915|468099861|FG002|Overall Study|Protocol Violation|2|||
130039464|NCT00356915|468099859|FG000|Overall Study|Withdrawal by Subject|14|||
130039465|NCT00356915|468099860|FG001|Overall Study|Withdrawal by Subject|14|||
130039466|NCT00356915|468099861|FG002|Overall Study|Withdrawal by Subject|10|||
130039467|NCT00356915|468099859|FG000|Overall Study|Lack of Efficacy|0|||
130039468|NCT00356915|468099860|FG001|Overall Study|Lack of Efficacy|0|||
130039469|NCT00356915|468099861|FG002|Overall Study|Lack of Efficacy|3|||
130039470|NCT00356915|468099859|FG000|Overall Study|Lost to Follow-up|27|||
130039471|NCT00356915|468099860|FG001|Overall Study|Lost to Follow-up|34|||
130039472|NCT00356915|468099861|FG002|Overall Study|Lost to Follow-up|14|||
130039473|NCT00356915|468099859|FG000|Overall Study|Administrative Decision|0|||
130039474|NCT00356915|468099860|FG001|Overall Study|Administrative Decision|0|||
130039475|NCT00356915|468099861|FG002|Overall Study|Administrative Decision|1|||
130039476|NCT00356915|468099859|FG000|Overall Study|Physician Decision|0|||
130039477|NCT00356915|468099860|FG001|Overall Study|Physician Decision|2|||
130039478|NCT00356915|468099861|FG002|Overall Study|Physician Decision|0|||
130039479|NCT00356915|468099859|FG000|Overall Study|Adverse Event|21|||
130039480|NCT00356915|468099860|FG001|Overall Study|Adverse Event|31|||
130039481|NCT00356915|468099861|FG002|Overall Study|Adverse Event|8|||
130039482|NCT00356915|468099859|FG000|Overall Study|Miscellaneous reasons|11|||
130039483|NCT00356915|468099860|FG001|Overall Study|Miscellaneous reasons|8|||
130039484|NCT00356915|468099861|FG002|Overall Study|Miscellaneous reasons|3|||
130039485|NCT00509106|468099862|FG000|Overall Study|Adverse Event|3|||
130039486|NCT00509106|468099863|FG001|Overall Study|Adverse Event|2|||
130039487|NCT00509106|468099862|FG000|Overall Study|Noncompliance|0|||
130039488|NCT00509106|468099863|FG001|Overall Study|Noncompliance|1|||
130039489|NCT00509106|468099862|FG000|Overall Study|At the request of sponsor/investigator|1|||
130039490|NCT00509106|468099863|FG001|Overall Study|At the request of sponsor/investigator|2|||
130039491|NCT00509106|468099862|FG000|Overall Study|Withdrew consent|4|||
130039492|NCT00509106|468099863|FG001|Overall Study|Withdrew consent|8|||
130039493|NCT00509106|468099862|FG000|Overall Study|Lost to Follow-up|16|||
130039494|NCT00509106|468099863|FG001|Overall Study|Lost to Follow-up|10|||
130039495|NCT00509106|468099862|FG000|Overall Study|Other|1|||
130039496|NCT00509106|468099863|FG001|Overall Study|Other|0|||
130039497|NCT00509106|468099862|FG000|Overall Study|Death|6|||
130039498|NCT00509106|468099863|FG001|Overall Study|Death|6|||
130039499|NCT00488631|468099870|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
130039500|NCT00488631|468099871|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
130039501|NCT00488631|468099872|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
130039502|NCT00488631|468099873|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
130039503|NCT00488631|468099874|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
130039504|NCT00488631|468099875|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
130039505|NCT00488631|468099876|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
130039506|NCT00488631|468099877|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
130039507|NCT00488631|468099878|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
130039508|NCT00488631|468099879|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
130039509|NCT00488631|468099870|FG000|Double Blind Period (Week 0-54)|Death|0|||
130039510|NCT00488631|468099871|FG001|Double Blind Period (Week 0-54)|Death|0|||
130039511|NCT00488631|468099872|FG002|Double Blind Period (Week 0-54)|Death|0|||
130039512|NCT00488631|468099873|FG003|Double Blind Period (Week 0-54)|Death|0|||
130039513|NCT00488631|468099874|FG004|Double Blind Period (Week 0-54)|Death|0|||
130039514|NCT00488631|468099875|FG005|Double Blind Period (Week 0-54)|Death|1|||
130039515|NCT00488631|468099876|FG006|Double Blind Period (Week 0-54)|Death|0|||
130039516|NCT00488631|468099877|FG007|Double Blind Period (Week 0-54)|Death|0|||
130039517|NCT00488631|468099878|FG008|Double Blind Period (Week 0-54)|Death|0|||
130039518|NCT00488631|468099879|FG009|Double Blind Period (Week 0-54)|Death|0|||
130039519|NCT00488631|468099870|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
130039520|NCT00488631|468099871|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
130039521|NCT00488631|468099872|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
130039522|NCT00488631|468099873|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
130039523|NCT00488631|468099874|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
130039524|NCT00488631|468099875|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
130039525|NCT00488631|468099876|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130039526|NCT00488631|468099877|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130039527|NCT00488631|468099878|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130104115|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130273637|NCT00412958|468965619|FG002|Overall Study|Lost to Follow-up|0|||
130039528|NCT00488631|468099879|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
130039529|NCT00488631|468099870|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
130039530|NCT00488631|468099871|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
130039531|NCT00488631|468099872|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
130039532|NCT00488631|468099873|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130039533|NCT00488631|468099874|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
130039534|NCT00488631|468099875|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
130039535|NCT00488631|468099876|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130039536|NCT00488631|468099877|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130039537|NCT00488631|468099878|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130039538|NCT00488631|468099879|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
130039539|NCT00488631|468099870|FG000|Double Blind Period (Week 0-54)|Other|6|||
130039540|NCT00488631|468099871|FG001|Double Blind Period (Week 0-54)|Other|12|||
130039541|NCT00488631|468099872|FG002|Double Blind Period (Week 0-54)|Other|10|||
130039542|NCT00488631|468099873|FG003|Double Blind Period (Week 0-54)|Other|11|||
130039543|NCT00488631|468099874|FG004|Double Blind Period (Week 0-54)|Other|14|||
130039544|NCT00488631|468099875|FG005|Double Blind Period (Week 0-54)|Other|34|||
130039545|NCT00488631|468099876|FG006|Double Blind Period (Week 0-54)|Other|0|||
130039546|NCT00488631|468099877|FG007|Double Blind Period (Week 0-54)|Other|0|||
130039547|NCT00488631|468099878|FG008|Double Blind Period (Week 0-54)|Other|0|||
130039548|NCT00488631|468099879|FG009|Double Blind Period (Week 0-54)|Other|0|||
130039549|NCT00488631|468099870|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039550|NCT00488631|468099871|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039551|NCT00488631|468099872|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039552|NCT00488631|468099873|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039553|NCT00488631|468099874|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039554|NCT00488631|468099875|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039555|NCT00488631|468099876|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
130039556|NCT00488631|468099877|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
130039557|NCT00488631|468099878|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
130039558|NCT00488631|468099879|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
130039559|NCT00488631|468099870|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
130039560|NCT00488631|468099871|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
130039561|NCT00488631|468099872|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
130039562|NCT00488631|468099873|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
130039563|NCT00488631|468099874|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
130039564|NCT00488631|468099875|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
130039565|NCT00488631|468099876|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
130039566|NCT00488631|468099877|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
130039567|NCT00488631|468099878|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
130039568|NCT00488631|468099879|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
130039569|NCT00488631|468099870|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130039570|NCT00488631|468099871|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130039571|NCT00488631|468099872|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130039572|NCT00488631|468099873|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130039573|NCT00488631|468099874|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130039574|NCT00488631|468099875|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
130039575|NCT00488631|468099876|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
130039576|NCT00488631|468099877|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
130039577|NCT00488631|468099878|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
130039578|NCT00488631|468099879|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
130039579|NCT00488631|468099870|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039580|NCT00488631|468099871|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039581|NCT00488631|468099872|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039582|NCT00488631|468099873|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039583|NCT00488631|468099874|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039584|NCT00488631|468099875|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039585|NCT00488631|468099876|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
130039586|NCT00488631|468099877|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039587|NCT00488631|468099878|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
130039588|NCT00488631|468099879|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
130039589|NCT00488631|468099870|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039590|NCT00488631|468099871|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039591|NCT00488631|468099872|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039592|NCT00488631|468099873|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039593|NCT00488631|468099874|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039594|NCT00488631|468099875|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039595|NCT00488631|468099876|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
130039596|NCT00488631|468099877|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
130039597|NCT00488631|468099878|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
130039598|NCT00488631|468099879|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
130039599|NCT00927485|468099880|FG000|Overall Study|Adverse Event|4|||
130039600|NCT00927485|468099881|FG001|Overall Study|Adverse Event|2|||
130039601|NCT00927485|468099880|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
130039602|NCT00927485|468099881|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
130039603|NCT03486314|468099882|FG000|Part A|Adverse Event|1|||
130039604|NCT03486314|468099883|FG001|Part A|Adverse Event|0|||
130039605|NCT03486314|468099884|FG002|Part A|Adverse Event|0|||
130039606|NCT03486314|468099882|FG000|Part A|Symptomatic Deterioration|2|||
130039607|NCT03486314|468099883|FG001|Part A|Symptomatic Deterioration|0|||
130039608|NCT03486314|468099884|FG002|Part A|Symptomatic Deterioration|0|||
130039609|NCT02034123|468099888|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039610|NCT02034123|468099889|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039611|NCT02034123|468099890|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039612|NCT02034123|468099891|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039613|NCT02034123|468099892|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
130039614|NCT02034123|468099893|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039615|NCT02034123|468099894|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039616|NCT02034123|468099895|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
130039617|NCT02034123|468099896|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
130039618|NCT02034123|468099897|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039619|NCT02034123|468099898|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039620|NCT02034123|468099899|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039621|NCT02034123|468099900|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039622|NCT02034123|468099901|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039623|NCT02034123|468099902|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039624|NCT02034123|468099903|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039625|NCT02034123|468099904|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039626|NCT02034123|468099905|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
130039627|NCT02034123|468099888|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039628|NCT02034123|468099889|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039629|NCT02034123|468099890|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039630|NCT02034123|468099891|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
130039631|NCT02034123|468099892|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039632|NCT02034123|468099893|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039633|NCT02034123|468099894|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039634|NCT02034123|468099895|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039635|NCT02034123|468099896|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039636|NCT02034123|468099897|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039637|NCT02034123|468099898|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039638|NCT02034123|468099899|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039639|NCT02034123|468099900|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039640|NCT02034123|468099901|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039641|NCT02034123|468099902|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039642|NCT02034123|468099903|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039643|NCT02034123|468099904|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039644|NCT02034123|468099905|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
130039645|NCT02034123|468099888|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039646|NCT02034123|468099889|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039647|NCT02034123|468099890|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039648|NCT02034123|468099891|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039649|NCT02034123|468099892|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039650|NCT02034123|468099893|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039651|NCT02034123|468099894|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130104116|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130104117|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
130104118|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130039652|NCT02034123|468099895|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039653|NCT02034123|468099896|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
130039654|NCT02034123|468099897|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039655|NCT02034123|468099898|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039656|NCT02034123|468099899|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039657|NCT02034123|468099900|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039658|NCT02034123|468099901|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039659|NCT02034123|468099902|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039660|NCT02034123|468099903|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039661|NCT02034123|468099904|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039662|NCT02034123|468099905|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
130039663|NCT02034123|468099888|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039664|NCT02034123|468099889|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039665|NCT02034123|468099890|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039666|NCT02034123|468099891|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
130039667|NCT02034123|468099892|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
130039668|NCT02034123|468099893|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039669|NCT02034123|468099894|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039670|NCT02034123|468099895|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039671|NCT02034123|468099896|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039672|NCT02034123|468099897|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039673|NCT02034123|468099898|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039674|NCT02034123|468099899|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039675|NCT02034123|468099900|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039676|NCT02034123|468099901|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039677|NCT02034123|468099902|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039678|NCT02034123|468099903|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039679|NCT02034123|468099904|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039680|NCT02034123|468099905|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
130039681|NCT00246259|468099906|FG000|Overall Study|Other|3|||
130039682|NCT00246259|468099907|FG001|Overall Study|Other|3|||
130039683|NCT00246259|468099906|FG000|Overall Study|Not stable by Week 18|2|||
130039684|NCT00246259|468099907|FG001|Overall Study|Not stable by Week 18|1|||
130039685|NCT00246259|468099906|FG000|Overall Study|Participant non-compliant|4|||
130039686|NCT00246259|468099907|FG001|Overall Study|Participant non-compliant|9|||
130039687|NCT00246259|468099906|FG000|Overall Study|Lack of Efficacy|2|||
130039688|NCT00246259|468099907|FG001|Overall Study|Lack of Efficacy|2|||
130039689|NCT00246259|468099906|FG000|Overall Study|Investigator withdrew participant|2|||
130039690|NCT00246259|468099907|FG001|Overall Study|Investigator withdrew participant|0|||
130039691|NCT00246259|468099906|FG000|Overall Study|Adverse Event|5|||
130039692|NCT00246259|468099907|FG001|Overall Study|Adverse Event|0|||
130039693|NCT00246259|468099906|FG000|Overall Study|Lost to Follow-up|3|||
130039694|NCT00246259|468099907|FG001|Overall Study|Lost to Follow-up|4|||
130039695|NCT00246259|468099906|FG000|Overall Study|Withdrawal by Subject|5|||
130039696|NCT00246259|468099907|FG001|Overall Study|Withdrawal by Subject|1|||
130039697|NCT00246259|468099906|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
130273638|NCT00412958|468965620|FG003|Overall Study|Lost to Follow-up|0|||
129886185|NCT00287469|467542910|FG000|Overall Study|Adverse Event|1|||
129886186|NCT00287469|467542911|FG001|Overall Study|Adverse Event|1|||
129886187|NCT00287469|467542910|FG000|Overall Study|moved from area|144|||
129886188|NCT00287469|467542911|FG001|Overall Study|moved from area|138|||
129886189|NCT00287469|467542910|FG000|Overall Study|Lost to Follow-up|74|||
129886190|NCT00287469|467542911|FG001|Overall Study|Lost to Follow-up|69|||
129886191|NCT00507026|467542917|FG000|Overall Study|Lack of Efficacy|6|||
129886192|NCT00507026|467542918|FG001|Overall Study|Lack of Efficacy|4|||
129886193|NCT00507026|467542919|FG002|Overall Study|Lack of Efficacy|21|||
129886194|NCT00507026|467542917|FG000|Overall Study|Withdrawal by Subject|2|||
130039698|NCT00246259|468099907|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
130039699|NCT03301857|468099908|FG000|Overall Study|Death|0|||
130039700|NCT03301857|468099909|FG001|Overall Study|Death|2|||
130039701|NCT03301857|468099908|FG000|Overall Study|Lost to Follow-up|4|||
130039702|NCT03301857|468099909|FG001|Overall Study|Lost to Follow-up|2|||
130039703|NCT03301857|468099908|FG000|Overall Study|Decision by Sponsor|6|||
130039704|NCT03301857|468099909|FG001|Overall Study|Decision by Sponsor|0|||
130039705|NCT03301857|468099908|FG000|Overall Study|Withdrawal by Subject|12|||
130039706|NCT03301857|468099909|FG001|Overall Study|Withdrawal by Subject|4|||
130039707|NCT00855439|468099910|FG000|Overall Study|Withdrawal by Subject|2|||
130039708|NCT00855439|468099911|FG001|Overall Study|Withdrawal by Subject|0|||
130039709|NCT00855439|468099910|FG000|Overall Study|Pregnancy|1|||
130039710|NCT00855439|468099911|FG001|Overall Study|Pregnancy|0|||
130039711|NCT00613626|468099917|FG000|Overall Study|Ineligible|0|||
130039712|NCT00613626|468099918|FG001|Overall Study|Ineligible|1|||
130039713|NCT00613626|468099919|FG002|Overall Study|Ineligible|0|||
130039714|NCT02333227|468099920|FG000|Overall Study|Lost to Follow-up|137|||
130039715|NCT02333227|468099921|FG001|Overall Study|Lost to Follow-up|106|||
130039716|NCT02333227|468099920|FG000|Overall Study|Pregnancy Interrupted|42|||
130039717|NCT02333227|468099921|FG001|Overall Study|Pregnancy Interrupted|89|||
130039718|NCT02333227|468099920|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
130039719|NCT02333227|468099921|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
130039720|NCT01299025|468099922|FG000|Overall Study|Withdrawal by Subject|2|||
130039721|NCT01299025|468099923|FG001|Overall Study|Withdrawal by Subject|1|||
130039722|NCT01299025|468099922|FG000|Overall Study|Lost to Follow-up|1|||
130039723|NCT01299025|468099923|FG001|Overall Study|Lost to Follow-up|0|||
130039724|NCT01624194|468099924|FG000|Overall Study|Lost to Follow-up|1|||
130039725|NCT01624194|468099925|FG001|Overall Study|Lost to Follow-up|0|||
130039726|NCT01624194|468099924|FG000|Overall Study|Withdrawal by Subject|1|||
130039727|NCT01624194|468099925|FG001|Overall Study|Withdrawal by Subject|0|||
130039728|NCT01076179|468099926|FG000|Overall Study|Withdrawal by Subject|1|||
130039729|NCT05480514|468099927|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
130039730|NCT05480514|468099928|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
130039731|NCT05480514|468099927|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
130039732|NCT05480514|468099928|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
130039733|NCT05480514|468099927|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
130039734|NCT05480514|468099928|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
130039735|NCT05480514|468099927|FG000|Period 1|Covid-19 Related|1|||
130039736|NCT05480514|468099928|FG001|Period 1|Covid-19 Related|0|||
130039737|NCT05480514|468099927|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
130039738|NCT05480514|468099928|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
130039739|NCT04091217|468099929|FG000|Overall Study|Lost to Follow-up|2|||
130039740|NCT04885257|468099930|FG000|Overall Study|Withdrawal by Subject|1|||
130039741|NCT04885257|468099931|FG001|Overall Study|Withdrawal by Subject|0|||
130039742|NCT03542682|468099932|FG000|Overall Study|COVID-19 Protocol|0|||
130039743|NCT03542682|468099933|FG001|Overall Study|COVID-19 Protocol|1|||
130039744|NCT01659151|468099937|FG000|Overall Study|Inadequate TIL growth|1|||
130039745|NCT01901328|468099938|FG000|Overall Study|Lost to Follow-up|1|||
130039746|NCT01901328|468099939|FG001|Overall Study|Lost to Follow-up|0|||
130039747|NCT01901328|468099938|FG000|Overall Study|Physician Decision|0|||
130104119|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
130104120|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129886195|NCT00507026|467542918|FG001|Overall Study|Withdrawal by Subject|0|||
130039748|NCT01901328|468099939|FG001|Overall Study|Physician Decision|1|||
130039749|NCT01901328|468099938|FG000|Overall Study|Protocol Violation|1|||
130039750|NCT01901328|468099939|FG001|Overall Study|Protocol Violation|1|||
130039751|NCT01901328|468099938|FG000|Overall Study|Study Terminated by Sponsor|19|||
130039752|NCT01901328|468099939|FG001|Overall Study|Study Terminated by Sponsor|16|||
130039753|NCT01901328|468099938|FG000|Overall Study|Withdrawal by Subject|1|||
130039754|NCT01901328|468099939|FG001|Overall Study|Withdrawal by Subject|2|||
130039755|NCT01901328|468099938|FG000|Overall Study|Lack of Efficacy|0|||
130039756|NCT01901328|468099939|FG001|Overall Study|Lack of Efficacy|1|||
130039757|NCT03232073|468099940|FG000|Overall Study|Death|1|||
130039758|NCT03232073|468099941|FG001|Overall Study|Death|0|||
130039759|NCT03232073|468099940|FG000|Overall Study|Adverse Event|7|||
130039760|NCT03232073|468099941|FG001|Overall Study|Adverse Event|12|||
130039761|NCT03232073|468099940|FG000|Overall Study|Lost to Follow-up|6|||
130039762|NCT03232073|468099941|FG001|Overall Study|Lost to Follow-up|6|||
130039763|NCT03232073|468099940|FG000|Overall Study|Lack of Efficacy|10|||
130039764|NCT03232073|468099941|FG001|Overall Study|Lack of Efficacy|8|||
130039765|NCT03232073|468099940|FG000|Overall Study|Physician Decision|9|||
130039766|NCT03232073|468099941|FG001|Overall Study|Physician Decision|2|||
130039767|NCT03232073|468099940|FG000|Overall Study|Withdrawal by Subject|54|||
130039768|NCT03232073|468099941|FG001|Overall Study|Withdrawal by Subject|39|||
130039769|NCT01672892|468101138|FG000|Overall Study|Protocol Violation|7|||
130039770|NCT01672892|468101139|FG001|Overall Study|Protocol Violation|3|||
130039771|NCT00886821|468101151|FG000|Stage 2|Adverse Event|0|||
130039772|NCT00886821|468101152|FG001|Stage 2|Adverse Event|0|||
130039773|NCT00886821|468101153|FG002|Stage 2|Adverse Event|0|||
130039774|NCT00886821|468101154|FG003|Stage 2|Adverse Event|0|||
130039775|NCT00886821|468101155|FG004|Stage 2|Adverse Event|0|||
130039776|NCT00886821|468101156|FG005|Stage 2|Adverse Event|0|||
130039777|NCT00886821|468101157|FG006|Stage 2|Adverse Event|0|||
130039778|NCT00886821|468101158|FG007|Stage 2|Adverse Event|0|||
130039779|NCT00886821|468101159|FG008|Stage 2|Adverse Event|0|||
130039780|NCT00886821|468101160|FG009|Stage 2|Adverse Event|0|||
130039781|NCT00886821|468101161|FG010|Stage 2|Adverse Event|0|||
130039782|NCT00886821|468101162|FG011|Stage 2|Adverse Event|1|||
130039783|NCT00886821|468101163|FG012|Stage 2|Adverse Event|3|||
130039784|NCT00886821|468101164|FG013|Stage 2|Adverse Event|0|||
130039785|NCT00886821|468101151|FG000|Stage 2|Lost to Follow-up|0|||
130039786|NCT00886821|468101152|FG001|Stage 2|Lost to Follow-up|0|||
130039787|NCT00886821|468101153|FG002|Stage 2|Lost to Follow-up|0|||
130039788|NCT00886821|468101154|FG003|Stage 2|Lost to Follow-up|0|||
130039789|NCT00886821|468101155|FG004|Stage 2|Lost to Follow-up|0|||
130039790|NCT00886821|468101156|FG005|Stage 2|Lost to Follow-up|0|||
130039791|NCT00886821|468101157|FG006|Stage 2|Lost to Follow-up|0|||
130039792|NCT00886821|468101158|FG007|Stage 2|Lost to Follow-up|0|||
130039793|NCT00886821|468101159|FG008|Stage 2|Lost to Follow-up|0|||
130039794|NCT00886821|468101160|FG009|Stage 2|Lost to Follow-up|0|||
130039795|NCT00886821|468101161|FG010|Stage 2|Lost to Follow-up|0|||
130039796|NCT00886821|468101162|FG011|Stage 2|Lost to Follow-up|0|||
130039797|NCT00886821|468101163|FG012|Stage 2|Lost to Follow-up|2|||
130039798|NCT00886821|468101164|FG013|Stage 2|Lost to Follow-up|1|||
130039799|NCT00914628|468101165|FG000|Overall Study|Death|35|||
130039800|NCT00914628|468101166|FG001|Overall Study|Death|17|||
130039801|NCT00914628|468101165|FG000|Overall Study|Medical decision|4|||
130039802|NCT00914628|468101166|FG001|Overall Study|Medical decision|0|||
130039803|NCT00914628|468101165|FG000|Overall Study|Protocol Violation|1|||
130039804|NCT00914628|468101166|FG001|Overall Study|Protocol Violation|0|||
130039805|NCT00914628|468101165|FG000|Overall Study|Lack of Efficacy|1|||
130039806|NCT00914628|468101166|FG001|Overall Study|Lack of Efficacy|0|||
130039807|NCT00914628|468101165|FG000|Overall Study|non-randomized|1|||
130039808|NCT00914628|468101166|FG001|Overall Study|non-randomized|0|||
130039809|NCT00914628|468101165|FG000|Overall Study|Relapse|1|||
130039810|NCT00914628|468101166|FG001|Overall Study|Relapse|2|||
130039811|NCT00914628|468101165|FG000|Overall Study|Study terminated by Sponsor|14|||
130039812|NCT00914628|468101166|FG001|Overall Study|Study terminated by Sponsor|8|||
130039813|NCT00914628|468101165|FG000|Overall Study|Patients who did not receive a single dose|7|||
130039814|NCT00914628|468101166|FG001|Overall Study|Patients who did not receive a single dose|1|||
130039815|NCT03311126|468101167|FG000|Induction|Death|1|||
130039816|NCT03311126|468101167|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
130039817|NCT02579603|468101168|FG000|Overall Study|Not treated|1|||
130039818|NCT02579603|468101169|FG001|Overall Study|Not treated|0|||
130039819|NCT02579603|468101168|FG000|Overall Study|Adverse Event|2|||
130039820|NCT02579603|468101169|FG001|Overall Study|Adverse Event|2|||
130039821|NCT02579603|468101168|FG000|Overall Study|Other than stated|1|||
130039822|NCT02579603|468101169|FG001|Overall Study|Other than stated|0|||
130039823|NCT00469079|468101170|FG000|Overall Study|Lack of Efficacy|3|||
130039824|NCT00469079|468101171|FG001|Overall Study|Lack of Efficacy|8|||
130039825|NCT00469079|468101172|FG002|Overall Study|Lack of Efficacy|5|||
130039826|NCT00469079|468101170|FG000|Overall Study|Adverse Event|1|||
130039827|NCT00469079|468101171|FG001|Overall Study|Adverse Event|3|||
129886196|NCT00507026|467542919|FG002|Overall Study|Withdrawal by Subject|0|||
129886197|NCT00507026|467542917|FG000|Overall Study|Investigator Decision|1|||
129886198|NCT00507026|467542918|FG001|Overall Study|Investigator Decision|0|||
129886199|NCT00507026|467542919|FG002|Overall Study|Investigator Decision|0|||
129886200|NCT00507026|467542917|FG000|Overall Study|Adverse Event|2|||
129886201|NCT00507026|467542918|FG001|Overall Study|Adverse Event|0|||
129886202|NCT00507026|467542919|FG002|Overall Study|Adverse Event|0|||
129886203|NCT00507026|467542917|FG000|Overall Study|Protocol Violation|1|||
129886204|NCT00507026|467542918|FG001|Overall Study|Protocol Violation|0|||
129886205|NCT00507026|467542919|FG002|Overall Study|Protocol Violation|0|||
129886206|NCT00507026|467542917|FG000|Overall Study|Other|1|||
129886207|NCT00507026|467542918|FG001|Overall Study|Other|0|||
129886208|NCT00507026|467542919|FG002|Overall Study|Other|0|||
129886209|NCT02372058|467542920|FG000|Overall Study|Withdrawal by Subject|3|||
129886210|NCT00972179|467542924|FG000|Overall Study|Noncompliance|1|||
129886211|NCT00972179|467542925|FG001|Overall Study|Noncompliance|0|||
129886212|NCT00972179|467542926|FG002|Overall Study|Noncompliance|0|||
129886213|NCT00972179|467542927|FG003|Overall Study|Noncompliance|0|||
129886214|NCT00972179|467542928|FG004|Overall Study|Noncompliance|1|||
129886215|NCT00972179|467542929|FG005|Overall Study|Noncompliance|0|||
129886216|NCT00972179|467542930|FG006|Overall Study|Noncompliance|1|||
129886217|NCT00972179|467542924|FG000|Overall Study|Withdrawal by Subject|0|||
129886218|NCT00972179|467542925|FG001|Overall Study|Withdrawal by Subject|3|||
129886219|NCT00972179|467542926|FG002|Overall Study|Withdrawal by Subject|0|||
129886220|NCT00972179|467542927|FG003|Overall Study|Withdrawal by Subject|1|||
129886221|NCT00972179|467542928|FG004|Overall Study|Withdrawal by Subject|0|||
129886222|NCT00972179|467542929|FG005|Overall Study|Withdrawal by Subject|0|||
129886223|NCT00972179|467542930|FG006|Overall Study|Withdrawal by Subject|2|||
129886224|NCT00972179|467542924|FG000|Overall Study|Administrative Decision|0|||
129886225|NCT00972179|467542925|FG001|Overall Study|Administrative Decision|0|||
129886226|NCT00972179|467542926|FG002|Overall Study|Administrative Decision|0|||
129886227|NCT00972179|467542927|FG003|Overall Study|Administrative Decision|0|||
129886228|NCT00972179|467542928|FG004|Overall Study|Administrative Decision|1|||
129886229|NCT00972179|467542929|FG005|Overall Study|Administrative Decision|0|||
129886230|NCT00972179|467542930|FG006|Overall Study|Administrative Decision|0|||
129886231|NCT00972179|467542924|FG000|Overall Study|Lost to Follow-up|0|||
129886232|NCT00972179|467542925|FG001|Overall Study|Lost to Follow-up|0|||
129886233|NCT00972179|467542926|FG002|Overall Study|Lost to Follow-up|1|||
130039828|NCT00469079|468101172|FG002|Overall Study|Adverse Event|2|||
130039829|NCT00469079|468101170|FG000|Overall Study|Lost to Follow-up|4|||
130039830|NCT00469079|468101171|FG001|Overall Study|Lost to Follow-up|8|||
130039831|NCT00469079|468101172|FG002|Overall Study|Lost to Follow-up|10|||
130039832|NCT00469079|468101170|FG000|Overall Study|Withdrawal by Subject|1|||
130039833|NCT00469079|468101171|FG001|Overall Study|Withdrawal by Subject|2|||
130039834|NCT00469079|468101172|FG002|Overall Study|Withdrawal by Subject|2|||
129886234|NCT00972179|467542927|FG003|Overall Study|Lost to Follow-up|0|||
129886235|NCT00972179|467542928|FG004|Overall Study|Lost to Follow-up|0|||
129886236|NCT00972179|467542929|FG005|Overall Study|Lost to Follow-up|3|||
129886237|NCT00972179|467542930|FG006|Overall Study|Lost to Follow-up|1|||
129886238|NCT02061761|467542931|FG000|Overall Study|Disease progression|2|||
129886239|NCT02061761|467542932|FG001|Overall Study|Disease progression|8|||
130039835|NCT00469079|468101170|FG000|Overall Study|Ineligible|0|||
129886240|NCT02061761|467542933|FG002|Overall Study|Disease progression|4|||
130039836|NCT00469079|468101171|FG001|Overall Study|Ineligible|1|||
130039837|NCT00469079|468101172|FG002|Overall Study|Ineligible|0|||
130039838|NCT00573131|468101173|FG000|Overall Study|Withdrawal by Subject|10|||
130039839|NCT00573131|468101174|FG001|Overall Study|Withdrawal by Subject|8|||
130039840|NCT00893789|468101175|FG000|Overall Study|Withdrawal by Subject|3|||
130039841|NCT00893789|468101176|FG001|Overall Study|Withdrawal by Subject|1|||
130039842|NCT00893789|468101177|FG002|Overall Study|Withdrawal by Subject|3|||
130039843|NCT00893789|468101178|FG003|Overall Study|Withdrawal by Subject|1|||
130039844|NCT00893789|468101175|FG000|Overall Study|Noncompliance With Study Drug|1|||
130039845|NCT00893789|468101176|FG001|Overall Study|Noncompliance With Study Drug|0|||
130039846|NCT00893789|468101177|FG002|Overall Study|Noncompliance With Study Drug|1|||
130039847|NCT00893789|468101178|FG003|Overall Study|Noncompliance With Study Drug|2|||
130039848|NCT00893789|468101175|FG000|Overall Study|Noncompliance With Study Procedures|1|||
130039849|NCT00893789|468101176|FG001|Overall Study|Noncompliance With Study Procedures|0|||
130039850|NCT00893789|468101177|FG002|Overall Study|Noncompliance With Study Procedures|0|||
130039851|NCT00893789|468101178|FG003|Overall Study|Noncompliance With Study Procedures|0|||
130039852|NCT00893789|468101175|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
130039853|NCT00893789|468101176|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
130039854|NCT00893789|468101177|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
130039855|NCT00893789|468101178|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
130039856|NCT00893789|468101175|FG000|Overall Study|Adverse Event|0|||
130039857|NCT00893789|468101176|FG001|Overall Study|Adverse Event|2|||
130039858|NCT00893789|468101177|FG002|Overall Study|Adverse Event|1|||
130039859|NCT00893789|468101178|FG003|Overall Study|Adverse Event|5|||
130039860|NCT00893789|468101175|FG000|Overall Study|Protocol Violation|0|||
130039861|NCT00893789|468101176|FG001|Overall Study|Protocol Violation|1|||
130039862|NCT00893789|468101177|FG002|Overall Study|Protocol Violation|1|||
130039863|NCT00893789|468101178|FG003|Overall Study|Protocol Violation|4|||
130039864|NCT00893789|468101175|FG000|Overall Study|Lost to Follow-up|0|||
130039865|NCT00893789|468101176|FG001|Overall Study|Lost to Follow-up|0|||
130039866|NCT00893789|468101177|FG002|Overall Study|Lost to Follow-up|0|||
130039867|NCT00893789|468101178|FG003|Overall Study|Lost to Follow-up|1|||
130039868|NCT02024464|468101179|FG000|Overall Study|Discontinued|5|||
130039869|NCT02024464|468101180|FG001|Overall Study|Discontinued|4|||
130039870|NCT02024464|468101179|FG000|Overall Study|Missed Visits|1|||
130039871|NCT02024464|468101180|FG001|Overall Study|Missed Visits|0|||
130039872|NCT02024464|468101179|FG000|Overall Study|Lost to Follow-up|4|||
130039873|NCT02024464|468101180|FG001|Overall Study|Lost to Follow-up|7|||
130039874|NCT01973283|468101183|FG000|Overall Study|Lost to Follow-up|4|||
130039875|NCT01929083|468101189|FG000|Intervention 1|Lost to Follow-up|2|||
130039876|NCT01929083|468101190|FG001|Intervention 1|Lost to Follow-up|0|||
130039877|NCT01929083|468101189|FG000|Intervention 1|Nonadherent to study medications|1|||
130039878|NCT01929083|468101190|FG001|Intervention 1|Nonadherent to study medications|0|||
130039879|NCT01929083|468101189|FG000|Intervention 2|Adverse Event|0|||
130039880|NCT01929083|468101190|FG001|Intervention 2|Adverse Event|1|||
130039881|NCT00087438|468101192|FG000|Overall Study|Ineligible / No protocol treatment|4|||
130039882|NCT00466505|468101193|FG000|Overall Study|disease progression|13|||
130039883|NCT00466505|468101193|FG000|Overall Study|Adverse Event|4|||
130039884|NCT00811252|468101194|FG000|Overall Study|Adverse Event|6|||
130039885|NCT00811252|468101195|FG001|Overall Study|Adverse Event|10|||
130039886|NCT00811252|468101196|FG002|Overall Study|Adverse Event|15|||
130039887|NCT00811252|468101194|FG000|Overall Study|Lack of Efficacy|7|||
130039888|NCT00811252|468101195|FG001|Overall Study|Lack of Efficacy|2|||
129886241|NCT02061761|467542934|FG003|Overall Study|Disease progression|5|||
130039889|NCT00811252|468101196|FG002|Overall Study|Lack of Efficacy|0|||
130039890|NCT00811252|468101194|FG000|Overall Study|Protocol Violation|3|||
130039891|NCT00811252|468101195|FG001|Overall Study|Protocol Violation|3|||
130039892|NCT00811252|468101196|FG002|Overall Study|Protocol Violation|2|||
130039893|NCT00811252|468101194|FG000|Overall Study|Withdrawal of Consent|1|||
130039894|NCT00811252|468101195|FG001|Overall Study|Withdrawal of Consent|2|||
130039895|NCT00811252|468101196|FG002|Overall Study|Withdrawal of Consent|2|||
130039896|NCT00811252|468101194|FG000|Overall Study|Lost to Follow-up|0|||
130039897|NCT00811252|468101195|FG001|Overall Study|Lost to Follow-up|0|||
130039898|NCT00811252|468101196|FG002|Overall Study|Lost to Follow-up|2|||
130039899|NCT00811252|468101194|FG000|Overall Study|Administrative or Other Reasons|0|||
130039900|NCT00811252|468101195|FG001|Overall Study|Administrative or Other Reasons|3|||
130039901|NCT00811252|468101196|FG002|Overall Study|Administrative or Other Reasons|2|||
130039902|NCT01931865|468101197|FG000|Overall Study|Lost to Follow-up|2|||
130039903|NCT01931865|468101197|FG000|Overall Study|Withdrawal by Subject|2|||
130039904|NCT01244737|468101210|FG000|Overall Study|Physician Decision|2|||
130039905|NCT01244737|468101211|FG001|Overall Study|Physician Decision|18|||
130039906|NCT01244737|468101212|FG002|Overall Study|Physician Decision|5|||
130039907|NCT01244737|468101210|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
130039908|NCT01244737|468101211|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
130039909|NCT01244737|468101212|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
130039910|NCT01244737|468101210|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
130039911|NCT01244737|468101211|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
130039912|NCT01244737|468101212|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
130039913|NCT01244737|468101210|FG000|Overall Study|MIB immunopathology results not available|3|||
130039914|NCT01244737|468101211|FG001|Overall Study|MIB immunopathology results not available|2|||
130039915|NCT01244737|468101212|FG002|Overall Study|MIB immunopathology results not available|0|||
130039916|NCT01244737|468101210|FG000|Overall Study|PET data failure|0|||
130039917|NCT01244737|468101211|FG001|Overall Study|PET data failure|1|||
130039918|NCT01244737|468101212|FG002|Overall Study|PET data failure|0|||
130039919|NCT01244737|468101210|FG000|Overall Study|Withdrawal by Subject|0|||
130039920|NCT01244737|468101211|FG001|Overall Study|Withdrawal by Subject|0|||
130039921|NCT01244737|468101212|FG002|Overall Study|Withdrawal by Subject|1|||
130039922|NCT00730236|468101213|FG000|Overall Study|Adverse Event|4|||
130039923|NCT00730236|468101213|FG000|Overall Study|Withdrawal by Subject|1|||
130039924|NCT00730236|468101213|FG000|Overall Study|Non-compliance|1|||
130039925|NCT01772134|468101218|FG000|Overall Study|Adverse Event|6|||
130039926|NCT01772134|468101219|FG001|Overall Study|Adverse Event|5|||
130039927|NCT01772134|468101220|FG002|Overall Study|Adverse Event|10|||
130039928|NCT01772134|468101218|FG000|Overall Study|Withdrew Consent|3|||
130039929|NCT01772134|468101219|FG001|Overall Study|Withdrew Consent|1|||
130039930|NCT01772134|468101220|FG002|Overall Study|Withdrew Consent|5|||
130039931|NCT01772134|468101218|FG000|Overall Study|Lost to Follow-up|2|||
130039932|NCT01772134|468101219|FG001|Overall Study|Lost to Follow-up|0|||
130039933|NCT01772134|468101220|FG002|Overall Study|Lost to Follow-up|0|||
130039934|NCT01772134|468101218|FG000|Overall Study|Protocol Deviation|4|||
130039935|NCT01772134|468101219|FG001|Overall Study|Protocol Deviation|3|||
130039936|NCT01772134|468101220|FG002|Overall Study|Protocol Deviation|3|||
130039937|NCT01772134|468101218|FG000|Overall Study|Lack of Efficacy|11|||
130039938|NCT01772134|468101219|FG001|Overall Study|Lack of Efficacy|5|||
130039939|NCT01772134|468101220|FG002|Overall Study|Lack of Efficacy|3|||
130039940|NCT01772134|468101218|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
130039941|NCT01772134|468101219|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
130039942|NCT01772134|468101220|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
130039943|NCT01772134|468101218|FG000|Overall Study|Randomized Study Medication Not Received|2|||
130039944|NCT01772134|468101219|FG001|Overall Study|Randomized Study Medication Not Received|0|||
130039945|NCT01772134|468101220|FG002|Overall Study|Randomized Study Medication Not Received|1|||
130039946|NCT02604264|468101227|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
130039947|NCT02604264|468101228|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
130104121|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
130104122|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
130039948|NCT04003610|468101229|FG000|Overall Study|Lost to Follow-up|0|||
130039949|NCT04003610|468101230|FG001|Overall Study|Lost to Follow-up|1|||
130039950|NCT04003610|468101231|FG002|Overall Study|Lost to Follow-up|0|||
130104123|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
130039951|NCT04003610|468101229|FG000|Overall Study|Death|0|||
130039952|NCT04003610|468101230|FG001|Overall Study|Death|0|||
130039953|NCT04003610|468101231|FG002|Overall Study|Death|3|||
130039954|NCT04003610|468101229|FG000|Overall Study|Study Terminated by Sponsor|0|||
130039955|NCT04003610|468101230|FG001|Overall Study|Study Terminated by Sponsor|0|||
130039956|NCT04003610|468101231|FG002|Overall Study|Study Terminated by Sponsor|3|||
130039957|NCT05502289|468101236|FG000|Period 1|Out Of Window|1|||
130039958|NCT05502289|468101237|FG001|Period 1|Out Of Window|0|||
130104124|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
130104125|NCT01915498|468338807|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
130104126|NCT01915498|468338808|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130104127|NCT01915498|468338809|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130104128|NCT01915498|468338810|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
130104129|NCT01915498|468338811|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
130104130|NCT01915498|468338812|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
130104131|NCT01915498|468338813|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
130104132|NCT01915498|468338814|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
130104133|NCT01915498|468338815|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
130104134|NCT01915498|468338816|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
130104135|NCT01915498|468338817|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130104136|NCT01915498|468338818|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
130104137|NCT01915498|468338819|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
130104138|NCT01915498|468338820|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
130104139|NCT01915498|468338821|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
130104140|NCT01915498|468338822|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
130104141|NCT01915498|468338823|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
130104142|NCT01915498|468338824|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
130104143|NCT01915498|468338825|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
130104144|NCT01915498|468338807|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104145|NCT01915498|468338808|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104146|NCT01915498|468338809|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104147|NCT01915498|468338810|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104148|NCT01915498|468338811|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104149|NCT01915498|468338812|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104150|NCT01915498|468338813|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104151|NCT01915498|468338814|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104152|NCT01915498|468338815|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104153|NCT01915498|468338816|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104154|NCT01915498|468338817|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104155|NCT01915498|468338818|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104156|NCT01915498|468338819|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104157|NCT01915498|468338820|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104158|NCT01915498|468338821|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104159|NCT01915498|468338822|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104160|NCT01915498|468338823|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104161|NCT01915498|468338824|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
130104162|NCT01915498|468338825|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
130104163|NCT01915498|468338807|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104164|NCT01915498|468338808|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104165|NCT01915498|468338809|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104166|NCT01915498|468338810|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104167|NCT01915498|468338811|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104168|NCT01915498|468338812|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104169|NCT01915498|468338813|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104170|NCT01915498|468338814|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104171|NCT01915498|468338815|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104172|NCT01915498|468338816|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104173|NCT01915498|468338817|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104174|NCT01915498|468338818|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104175|NCT01915498|468338819|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104176|NCT01915498|468338820|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104177|NCT01915498|468338821|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104178|NCT01915498|468338822|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104179|NCT01915498|468338823|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104180|NCT01915498|468338824|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
130104181|NCT01915498|468338825|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
130104182|NCT01915498|468338807|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104183|NCT01915498|468338808|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130273639|NCT00412958|468965617|FG000|Overall Study|Death|0|||
130273640|NCT00412958|468965618|FG001|Overall Study|Death|1|||
130273641|NCT00412958|468965619|FG002|Overall Study|Death|0|||
130273642|NCT00412958|468965620|FG003|Overall Study|Death|0|||
130273643|NCT00412958|468965617|FG000|Overall Study|Transport issue|0|||
129886242|NCT02061761|467542935|FG004|Overall Study|Disease progression|9|||
129886243|NCT02061761|467542936|FG005|Overall Study|Disease progression|3|||
129886244|NCT02061761|467542937|FG006|Overall Study|Disease progression|1|||
129886245|NCT02061761|467542938|FG007|Overall Study|Disease progression|2|||
129886246|NCT02061761|467542939|FG008|Overall Study|Disease progression|28|||
129886247|NCT02061761|467542931|FG000|Overall Study|Study Drug toxicity|0|||
129886248|NCT02061761|467542932|FG001|Overall Study|Study Drug toxicity|0|||
129886249|NCT02061761|467542933|FG002|Overall Study|Study Drug toxicity|0|||
130039959|NCT00816036|468101245|FG000|Overall Study|Death|47|||
130039960|NCT00816036|468101246|FG001|Overall Study|Death|28|||
130039961|NCT00816036|468101245|FG000|Overall Study|Lost to Follow-up|75|||
130039962|NCT00816036|468101246|FG001|Overall Study|Lost to Follow-up|57|||
130039963|NCT00816036|468101245|FG000|Overall Study|Withdrawal by Subject|54|||
130039964|NCT00816036|468101246|FG001|Overall Study|Withdrawal by Subject|23|||
130039965|NCT03212261|468101247|FG000|Overall Study|Became ineligible d/t tech|2|||
130039966|NCT03212261|468101247|FG000|Overall Study|Tech Trouble- No first study visit|1|||
130039967|NCT03212261|468101247|FG000|Overall Study|Lost to Follow-up|7|||
130039968|NCT03212261|468101247|FG000|Overall Study|Family Emergency|1|||
130039969|NCT03212261|468101247|FG000|Overall Study|Too busy/ No time|5|||
130039970|NCT03815175|468101248|FG000|Overall Study|Subject Lost to Follow-up|6|||
130039971|NCT03815175|468101248|FG000|Overall Study|Subject Withdrew Consent|48|||
130039972|NCT03815175|468101248|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
130039973|NCT03815175|468101248|FG000|Overall Study|Death|86|||
130039974|NCT03815175|468101248|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
130039975|NCT03815175|468101248|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
130039976|NCT03815175|468101248|FG000|Overall Study|Other Status Change Reason|1|||
130039977|NCT03815175|468101248|FG000|Overall Study|Missed Visit|12|||
130039978|NCT00457639|468101249|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
130039979|NCT00457639|468101250|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
130039980|NCT00457639|468101249|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
130039981|NCT00457639|468101250|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
130039982|NCT00457639|468101249|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
130039983|NCT00457639|468101250|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
130039984|NCT00628355|468101253|FG000|Overall Study|Withdrawal by Subject|1|||
130039985|NCT00628355|468101254|FG001|Overall Study|Withdrawal by Subject|1|||
130039986|NCT04909463|468102846|FG000|Overall Study|Withdrawal by Subject|0|||
130039987|NCT04909463|468102847|FG001|Overall Study|Withdrawal by Subject|1|||
130039988|NCT04909463|468102848|FG002|Overall Study|Withdrawal by Subject|0|||
130039989|NCT04909463|468102849|FG003|Overall Study|Withdrawal by Subject|0|||
130039990|NCT04909463|468102846|FG000|Overall Study|Lost to Follow-up|2|||
130039991|NCT04909463|468102847|FG001|Overall Study|Lost to Follow-up|1|||
130039992|NCT04909463|468102848|FG002|Overall Study|Lost to Follow-up|1|||
130039993|NCT04909463|468102849|FG003|Overall Study|Lost to Follow-up|0|||
130039994|NCT00853632|468102850|FG000|Overall Study|Death|88|||
130039995|NCT00853632|468102850|FG000|Overall Study|Withdrawal by Subject|45|||
130039996|NCT00853632|468102850|FG000|Overall Study|Lost to Follow-up|30|||
130039997|NCT00853632|468102850|FG000|Overall Study|Reoperation/Explant|17|||
130039998|NCT00853632|468102850|FG000|Overall Study|Exit with other reason|22|||
130039999|NCT02698410|468102851|FG000|Overall Study|Adverse Event|2|||
130040000|NCT02698410|468102851|FG000|Overall Study|Withdrawal by Subject|1|||
130040001|NCT02698410|468102851|FG000|Overall Study|Other|1|||
130040002|NCT04331899|468102859|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
130040003|NCT04331899|468102860|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
130040004|NCT00719810|468102863|FG000|Overall Study|Adverse Event|0|||
130040005|NCT00719810|468102864|FG001|Overall Study|Adverse Event|2|||
130040006|NCT00719810|468102865|FG002|Overall Study|Adverse Event|3|||
130040007|NCT00719810|468102863|FG000|Overall Study|Lost to Follow-up|2|||
130040008|NCT00719810|468102864|FG001|Overall Study|Lost to Follow-up|0|||
130040009|NCT00719810|468102865|FG002|Overall Study|Lost to Follow-up|3|||
130040010|NCT00719810|468102863|FG000|Overall Study|Physician Decision|0|||
130040011|NCT00719810|468102864|FG001|Overall Study|Physician Decision|1|||
130040012|NCT00719810|468102865|FG002|Overall Study|Physician Decision|0|||
130040013|NCT00719810|468102863|FG000|Overall Study|Withdrawal by Subject|1|||
129886250|NCT02061761|467542934|FG003|Overall Study|Study Drug toxicity|0|||
130273644|NCT00412958|468965618|FG001|Overall Study|Transport issue|1|||
129886251|NCT02061761|467542935|FG004|Overall Study|Study Drug toxicity|0|||
129886252|NCT02061761|467542936|FG005|Overall Study|Study Drug toxicity|1|||
129886253|NCT02061761|467542937|FG006|Overall Study|Study Drug toxicity|0|||
130040014|NCT00719810|468102864|FG001|Overall Study|Withdrawal by Subject|1|||
130040015|NCT00719810|468102865|FG002|Overall Study|Withdrawal by Subject|2|||
130040016|NCT05408858|468102870|FG000|Overall Study|no longer met eligibility criteria|1|||
130040017|NCT02037919|468102874|FG000|Overall Study|Lost to Follow-up|30|||
130040018|NCT02037919|468102875|FG001|Overall Study|Lost to Follow-up|45|||
130040019|NCT03717922|468102883|FG000|Overall Study|Lost to Follow-up|2|||
130040020|NCT03717922|468102884|FG001|Overall Study|Lost to Follow-up|2|||
130040021|NCT01697215|468102895|FG000|Overall Study|Physician Decision|5|||
130273645|NCT00412958|468965619|FG002|Overall Study|Transport issue|0|||
130273646|NCT00412958|468965620|FG003|Overall Study|Transport issue|0|||
129886254|NCT02061761|467542938|FG007|Overall Study|Study Drug toxicity|2|||
129886255|NCT02061761|467542939|FG008|Overall Study|Study Drug toxicity|6|||
129886256|NCT02061761|467542931|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
129886257|NCT02061761|467542932|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
129886258|NCT02061761|467542933|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
129886259|NCT02061761|467542934|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
129886260|NCT02061761|467542935|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
129886261|NCT02061761|467542936|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
129886262|NCT02061761|467542937|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
129886263|NCT02061761|467542938|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
129886264|NCT02061761|467542939|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
129886265|NCT02061761|467542931|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129886266|NCT02061761|467542932|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129886267|NCT02061761|467542933|FG002|Overall Study|Participant request to discontinue study treatment|2|||
129886268|NCT02061761|467542934|FG003|Overall Study|Participant request to discontinue study treatment|2|||
129886269|NCT02061761|467542935|FG004|Overall Study|Participant request to discontinue study treatment|0|||
129886270|NCT02061761|467542936|FG005|Overall Study|Participant request to discontinue study treatment|1|||
129886271|NCT02061761|467542937|FG006|Overall Study|Participant request to discontinue study treatment|0|||
129886272|NCT02061761|467542938|FG007|Overall Study|Participant request to discontinue study treatment|0|||
129886273|NCT02061761|467542939|FG008|Overall Study|Participant request to discontinue study treatment|2|||
130040022|NCT01697215|468102895|FG000|Overall Study|Malfunction|9|||
130040023|NCT01697215|468102895|FG000|Overall Study|CXR not available|9|||
130040024|NCT00900796|468102898|FG000|Phase 1|Lacked sufficient information|4|||
130040025|NCT00900796|468102898|FG000|Phase 1|Missing information at Week 16|7|||
130040026|NCT00900796|468102898|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
130040027|NCT00900796|468102898|FG000|Phase 2|Lost to Follow-up|5|||
130040028|NCT02586805|468102902|FG000|Overall Study|Withdrawal by Subject|3|||
130040029|NCT02586805|468102903|FG001|Overall Study|Withdrawal by Subject|1|||
130040030|NCT02586805|468102904|FG002|Overall Study|Withdrawal by Subject|1|||
130040031|NCT02586805|468102905|FG003|Overall Study|Withdrawal by Subject|2|||
130040032|NCT02586805|468102902|FG000|Overall Study|Adverse Event|2|||
130040033|NCT02586805|468102903|FG001|Overall Study|Adverse Event|0|||
130040034|NCT02586805|468102904|FG002|Overall Study|Adverse Event|1|||
130040035|NCT02586805|468102905|FG003|Overall Study|Adverse Event|0|||
130040036|NCT02586805|468102902|FG000|Overall Study|Lost to Follow-up|0|||
130040037|NCT02586805|468102903|FG001|Overall Study|Lost to Follow-up|0|||
130040038|NCT02586805|468102904|FG002|Overall Study|Lost to Follow-up|1|||
130040039|NCT02586805|468102905|FG003|Overall Study|Lost to Follow-up|0|||
130040040|NCT02586805|468102902|FG000|Overall Study|Physician Decision|1|||
130040041|NCT02586805|468102903|FG001|Overall Study|Physician Decision|0|||
130040042|NCT02586805|468102904|FG002|Overall Study|Physician Decision|0|||
130040043|NCT02586805|468102905|FG003|Overall Study|Physician Decision|0|||
130040044|NCT01859403|468102906|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
130040045|NCT01859403|468102907|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
130040046|NCT01859403|468102906|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
130040047|NCT01859403|468102907|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
130040048|NCT01859403|468102906|FG000|Primary Endpoint Measure|Physician Decision|0|||
130040049|NCT01859403|468102907|FG001|Primary Endpoint Measure|Physician Decision|1|||
130040050|NCT01859403|468102906|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
130040051|NCT01859403|468102907|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
130040052|NCT01829048|468102909|FG000|Overall Study|Withdrawal by Subject|0|||
130040053|NCT01829048|468102910|FG001|Overall Study|Withdrawal by Subject|0|||
130040054|NCT01829048|468102911|FG002|Overall Study|Withdrawal by Subject|0|||
130040055|NCT01829048|468102912|FG003|Overall Study|Withdrawal by Subject|2|||
130040056|NCT01829048|468102913|FG004|Overall Study|Withdrawal by Subject|0|||
130040057|NCT00504257|468102914|FG000|Overall Study|Withdrawal by Subject|2|||
130040058|NCT00504257|468102914|FG000|Overall Study|ineligible histology|2|||
130040059|NCT02504541|468102915|FG000|Overall Study|Adverse Event|4|||
130040060|NCT02504541|468102915|FG000|Overall Study|Withdrawal by Subject|4|||
130040061|NCT02504541|468102915|FG000|Overall Study|Lost to Follow-up|1|||
129886274|NCT02061761|467542931|FG000|Overall Study|Withdrawal by Subject|0|||
130040062|NCT02504541|468102915|FG000|Overall Study|Met Stopping Criteria|1|||
130040063|NCT02504541|468102915|FG000|Overall Study|Protocol Violation|2|||
130040064|NCT02504541|468102915|FG000|Overall Study|Termination by Sponsor|1|||
130040065|NCT02504541|468102915|FG000|Overall Study|Other|2|||
130040066|NCT02504541|468102915|FG000|Overall Study|Multiple|5|||
130104184|NCT01915498|468338809|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130040067|NCT01531725|468102916|FG000|Overall Study|Protocol Violation|5|||
130040068|NCT02317510|468102917|FG000|Overall Study|Adverse Event|0|||
130040069|NCT02317510|468102918|FG001|Overall Study|Adverse Event|1|||
130040070|NCT00500071|468102919|FG000|Screening and Washout Phase|Protocol Violation|1|||
130040071|NCT00500071|468102919|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
130273647|NCT01703091|468965631|FG000|Overall Study|Adverse Event|5|||
130040072|NCT00500071|468102919|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
130040073|NCT00500071|468102919|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
130040074|NCT00500071|468102919|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
130040075|NCT00500071|468102919|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
130040076|NCT00500071|468102919|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
130040077|NCT00472303|468102920|FG000|Titration Phase|Adverse Event|22|||
130040078|NCT00472303|468102921|FG001|Titration Phase|Adverse Event|12|||
130040079|NCT00472303|468102922|FG002|Titration Phase|Adverse Event|0|||
130040080|NCT00472303|468102920|FG000|Titration Phase|Death|4|||
130040081|NCT00472303|468102921|FG001|Titration Phase|Death|2|||
130040082|NCT00472303|468102922|FG002|Titration Phase|Death|0|||
130040083|NCT00472303|468102920|FG000|Titration Phase|Lack of Efficacy|10|||
130040084|NCT00472303|468102921|FG001|Titration Phase|Lack of Efficacy|0|||
130040085|NCT00472303|468102922|FG002|Titration Phase|Lack of Efficacy|0|||
130040086|NCT00472303|468102920|FG000|Titration Phase|Withdrawal by Subject|16|||
130040087|NCT00472303|468102921|FG001|Titration Phase|Withdrawal by Subject|13|||
130040088|NCT00472303|468102922|FG002|Titration Phase|Withdrawal by Subject|0|||
130040089|NCT00472303|468102920|FG000|Titration Phase|Trial Medication non-compliant|4|||
130040090|NCT00472303|468102921|FG001|Titration Phase|Trial Medication non-compliant|1|||
130040091|NCT00472303|468102922|FG002|Titration Phase|Trial Medication non-compliant|0|||
130040092|NCT00472303|468102920|FG000|Titration Phase|Other|3|||
130040093|NCT00472303|468102921|FG001|Titration Phase|Other|1|||
130040094|NCT00472303|468102922|FG002|Titration Phase|Other|0|||
130040095|NCT00472303|468102920|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
130040096|NCT00472303|468102921|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
130040097|NCT00472303|468102922|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
130040098|NCT00472303|468102920|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
130040099|NCT00472303|468102921|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
130104185|NCT01915498|468338810|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130273648|NCT01703091|468965632|FG001|Overall Study|Adverse Event|3|||
130273649|NCT01703091|468965631|FG000|Overall Study|Physician Decision|2|||
130273650|NCT01703091|468965632|FG001|Overall Study|Physician Decision|1|||
130273651|NCT01703091|468965631|FG000|Overall Study|Withdrawal by Subject|1|||
130273652|NCT01703091|468965632|FG001|Overall Study|Withdrawal by Subject|0|||
130273653|NCT01703091|468965631|FG000|Overall Study|Sponsor Decision|1|||
130273654|NCT01703091|468965632|FG001|Overall Study|Sponsor Decision|0|||
130273655|NCT02819297|468965638|FG000|Overall Study|Withdrawal by Subject|25|||
130273656|NCT02819297|468965639|FG001|Overall Study|Withdrawal by Subject|13|||
130273657|NCT02819297|468965638|FG000|Overall Study|Lost to Follow-up|12|||
130273658|NCT02819297|468965639|FG001|Overall Study|Lost to Follow-up|14|||
130273659|NCT02819297|468965638|FG000|Overall Study|Adverse Event|12|||
130273660|NCT02819297|468965639|FG001|Overall Study|Adverse Event|10|||
130273661|NCT02819297|468965638|FG000|Overall Study|Physician Decision|5|||
130273662|NCT02819297|468965639|FG001|Overall Study|Physician Decision|5|||
130273663|NCT02819297|468965638|FG000|Overall Study|Lack of Efficacy|5|||
130273664|NCT02819297|468965639|FG001|Overall Study|Lack of Efficacy|8|||
130273665|NCT02819297|468965638|FG000|Overall Study|Protocol Violation|1|||
130273666|NCT02819297|468965639|FG001|Overall Study|Protocol Violation|2|||
130273667|NCT02858440|468965640|FG000|Overall Study|Lost to Follow-up|3|||
130273668|NCT02858440|468965640|FG000|Overall Study|Protocol Violation|2|||
130273669|NCT02858440|468965640|FG000|Overall Study|Consent withdrawal|3|||
130273670|NCT02858440|468965640|FG000|Overall Study|Migrated/moved from study area|4|||
130273671|NCT01670279|468965641|FG000|Overall Study|Adverse Event|0|||
130273672|NCT01670279|468965642|FG001|Overall Study|Adverse Event|1|||
130273673|NCT01670279|468965643|FG002|Overall Study|Adverse Event|0|||
130273674|NCT01670279|468965644|FG003|Overall Study|Adverse Event|0|||
130273675|NCT01670279|468965641|FG000|Overall Study|Physician Decision|0|||
130273676|NCT01670279|468965642|FG001|Overall Study|Physician Decision|1|||
130273677|NCT01670279|468965643|FG002|Overall Study|Physician Decision|0|||
130040100|NCT00472303|468102922|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
130040101|NCT00472303|468102920|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
130040102|NCT00472303|468102921|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
130040103|NCT00472303|468102922|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
130040104|NCT00472303|468102920|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
130040105|NCT00472303|468102921|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
130040106|NCT00472303|468102922|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
130104186|NCT01915498|468338811|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104187|NCT01915498|468338812|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104188|NCT01915498|468338813|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104189|NCT01915498|468338814|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104190|NCT01915498|468338815|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104191|NCT01915498|468338816|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104192|NCT01915498|468338817|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104193|NCT01915498|468338818|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104194|NCT01915498|468338819|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104195|NCT01915498|468338820|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104196|NCT01915498|468338821|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104197|NCT01915498|468338822|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104198|NCT01915498|468338823|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104199|NCT01915498|468338824|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
130104200|NCT01915498|468338825|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
130104201|NCT01907516|468338826|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
130104202|NCT01907516|468338827|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
130104203|NCT01907516|468338826|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
130104204|NCT01907516|468338827|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
130104205|NCT01907516|468338826|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
130104206|NCT01907516|468338827|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
130104207|NCT01907516|468338826|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
130104208|NCT01907516|468338827|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
130104209|NCT05022121|468338832|FG000|Overall Study|Lack of Efficacy|1|||
130104210|NCT05022121|468338833|FG001|Overall Study|Lack of Efficacy|0|||
130104211|NCT05022121|468338832|FG000|Overall Study|Lost to Follow-up|0|||
130104212|NCT05022121|468338833|FG001|Overall Study|Lost to Follow-up|2|||
130104213|NCT00891527|468340962|FG000|Overall Study|Withdrawal by Subject|2|||
130104214|NCT01186744|468340963|FG000|Overall Study|Lack of Efficacy|156|||
130104215|NCT01186744|468340964|FG001|Overall Study|Lack of Efficacy|99|||
130104216|NCT01186744|468340965|FG002|Overall Study|Lack of Efficacy|0|||
130104217|NCT01186744|468340966|FG003|Overall Study|Lack of Efficacy|2|||
130104218|NCT01186744|468340967|FG004|Overall Study|Lack of Efficacy|2|||
130104219|NCT01186744|468340968|FG005|Overall Study|Lack of Efficacy|5|||
130104220|NCT01186744|468340963|FG000|Overall Study|Protocol Violation|1|||
130104221|NCT01186744|468340964|FG001|Overall Study|Protocol Violation|2|||
130104222|NCT01186744|468340965|FG002|Overall Study|Protocol Violation|0|||
130104223|NCT01186744|468340966|FG003|Overall Study|Protocol Violation|1|||
130104224|NCT01186744|468340967|FG004|Overall Study|Protocol Violation|1|||
130104225|NCT01186744|468340968|FG005|Overall Study|Protocol Violation|2|||
130104226|NCT01186744|468340963|FG000|Overall Study|Lost to Follow-up|15|||
130104227|NCT01186744|468340964|FG001|Overall Study|Lost to Follow-up|16|||
130104228|NCT01186744|468340965|FG002|Overall Study|Lost to Follow-up|2|||
130104229|NCT01186744|468340966|FG003|Overall Study|Lost to Follow-up|1|||
130104230|NCT01186744|468340967|FG004|Overall Study|Lost to Follow-up|1|||
130104231|NCT01186744|468340968|FG005|Overall Study|Lost to Follow-up|4|||
130104232|NCT01186744|468340963|FG000|Overall Study|Screen failure|1|||
130104233|NCT01186744|468340964|FG001|Overall Study|Screen failure|1|||
130104234|NCT01186744|468340965|FG002|Overall Study|Screen failure|0|||
130104235|NCT01186744|468340966|FG003|Overall Study|Screen failure|1|||
130104236|NCT01186744|468340967|FG004|Overall Study|Screen failure|0|||
130104237|NCT01186744|468340968|FG005|Overall Study|Screen failure|0|||
130104238|NCT01186744|468340963|FG000|Overall Study|Withdrawal by Subject|14|||
130104239|NCT01186744|468340964|FG001|Overall Study|Withdrawal by Subject|10|||
130104240|NCT01186744|468340965|FG002|Overall Study|Withdrawal by Subject|2|||
130104241|NCT01186744|468340966|FG003|Overall Study|Withdrawal by Subject|5|||
130104242|NCT01186744|468340967|FG004|Overall Study|Withdrawal by Subject|0|||
130104243|NCT01186744|468340968|FG005|Overall Study|Withdrawal by Subject|6|||
130104244|NCT01186744|468340963|FG000|Overall Study|Study terminated by Sponsor|1|||
130104245|NCT01186744|468340964|FG001|Overall Study|Study terminated by Sponsor|0|||
130104246|NCT01186744|468340965|FG002|Overall Study|Study terminated by Sponsor|0|||
130104247|NCT01186744|468340966|FG003|Overall Study|Study terminated by Sponsor|0|||
130104248|NCT01186744|468340967|FG004|Overall Study|Study terminated by Sponsor|0|||
130104249|NCT01186744|468340968|FG005|Overall Study|Study terminated by Sponsor|0|||
130104250|NCT01186744|468340963|FG000|Overall Study|Other|9|||
130104251|NCT01186744|468340964|FG001|Overall Study|Other|10|||
130104252|NCT01186744|468340965|FG002|Overall Study|Other|1|||
130104253|NCT01186744|468340966|FG003|Overall Study|Other|2|||
130104254|NCT01186744|468340967|FG004|Overall Study|Other|1|||
130104255|NCT01186744|468340968|FG005|Overall Study|Other|5|||
130104256|NCT01186744|468340963|FG000|Overall Study|Adverse Event|10|||
130104257|NCT01186744|468340964|FG001|Overall Study|Adverse Event|14|||
130104258|NCT01186744|468340965|FG002|Overall Study|Adverse Event|1|||
130104259|NCT01186744|468340966|FG003|Overall Study|Adverse Event|0|||
130104260|NCT01186744|468340967|FG004|Overall Study|Adverse Event|1|||
130104261|NCT01186744|468340968|FG005|Overall Study|Adverse Event|4|||
130104262|NCT01186744|468340963|FG000|Overall Study|Death|1|||
130104263|NCT01186744|468340964|FG001|Overall Study|Death|0|||
130104264|NCT01186744|468340965|FG002|Overall Study|Death|0|||
130273678|NCT01670279|468965644|FG003|Overall Study|Physician Decision|0|||
130104265|NCT01186744|468340966|FG003|Overall Study|Death|0|||
130104266|NCT01186744|468340967|FG004|Overall Study|Death|0|||
130273679|NCT01670279|468965641|FG000|Overall Study|Participant met withdrawal criteria|0|||
130273680|NCT01670279|468965642|FG001|Overall Study|Participant met withdrawal criteria|0|||
130273681|NCT01670279|468965643|FG002|Overall Study|Participant met withdrawal criteria|0|||
130273682|NCT01670279|468965644|FG003|Overall Study|Participant met withdrawal criteria|1|||
130273683|NCT01901614|468965645|FG000|Overall Study|Adverse Event|0|||
130273684|NCT01901614|468965646|FG001|Overall Study|Adverse Event|1|||
130273685|NCT01901614|468965645|FG000|Overall Study|Lost to Follow-up|1|||
130273686|NCT01901614|468965646|FG001|Overall Study|Lost to Follow-up|0|||
130273687|NCT01901614|468965645|FG000|Overall Study|Screen Fail|1|||
130273688|NCT01901614|468965646|FG001|Overall Study|Screen Fail|0|||
130273689|NCT01823198|468965648|FG000|Overall Study|Physician Decision|0|||
130273690|NCT01823198|468965649|FG001|Overall Study|Physician Decision|1|||
130273691|NCT01823198|468965650|FG002|Overall Study|Physician Decision|0|||
130273692|NCT01823198|468965651|FG003|Overall Study|Physician Decision|0|||
130273693|NCT01823198|468965652|FG004|Overall Study|Physician Decision|0|||
130273694|NCT01823198|468965653|FG005|Overall Study|Physician Decision|3|||
130273695|NCT01823198|468965654|FG006|Overall Study|Physician Decision|3|||
130273696|NCT01262638|468965655|FG000|Overall Study|Adverse Event|3|||
130273697|NCT01262638|468965656|FG001|Overall Study|Adverse Event|4|||
130273698|NCT01262638|468965657|FG002|Overall Study|Adverse Event|3|||
130273699|NCT01262638|468965658|FG003|Overall Study|Adverse Event|4|||
130273700|NCT01262638|468965655|FG000|Overall Study|Protocol Violation|1|||
130273701|NCT01262638|468965656|FG001|Overall Study|Protocol Violation|0|||
130273702|NCT01262638|468965657|FG002|Overall Study|Protocol Violation|0|||
130273703|NCT01262638|468965658|FG003|Overall Study|Protocol Violation|1|||
130273704|NCT01262638|468965655|FG000|Overall Study|Withdrawal by Subject|2|||
130273705|NCT01262638|468965656|FG001|Overall Study|Withdrawal by Subject|1|||
130273706|NCT01262638|468965657|FG002|Overall Study|Withdrawal by Subject|0|||
130273707|NCT01262638|468965658|FG003|Overall Study|Withdrawal by Subject|1|||
130273708|NCT01262638|468965655|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130273709|NCT01262638|468965656|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130273710|NCT01262638|468965657|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
130273711|NCT01262638|468965658|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130273712|NCT01262638|468965655|FG000|Overall Study|Lost to Follow-up|1|||
130273713|NCT01262638|468965656|FG001|Overall Study|Lost to Follow-up|1|||
130273714|NCT01262638|468965657|FG002|Overall Study|Lost to Follow-up|1|||
130273715|NCT01262638|468965658|FG003|Overall Study|Lost to Follow-up|1|||
130273716|NCT01262638|468965655|FG000|Overall Study|Participant Went Out of Town|0|||
130273717|NCT01262638|468965656|FG001|Overall Study|Participant Went Out of Town|0|||
130273718|NCT01262638|468965657|FG002|Overall Study|Participant Went Out of Town|1|||
130273719|NCT01262638|468965658|FG003|Overall Study|Participant Went Out of Town|0|||
130273720|NCT02243371|468965663|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
130273721|NCT02243371|468965664|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
130273722|NCT02243371|468965663|FG000|Overall Study|Death (unrelated)|2|||
130273723|NCT02243371|468965664|FG001|Overall Study|Death (unrelated)|4|||
130273724|NCT02243371|468965663|FG000|Overall Study|Adverse Event (unrelated)|0|||
130273725|NCT02243371|468965664|FG001|Overall Study|Adverse Event (unrelated)|1|||
130273726|NCT02243371|468965663|FG000|Overall Study|Lack of Clinical Benefit|0|||
130273727|NCT02243371|468965664|FG001|Overall Study|Lack of Clinical Benefit|1|||
130273728|NCT02243371|468965663|FG000|Overall Study|Withdrawal by Subject|0|||
130273729|NCT02243371|468965664|FG001|Overall Study|Withdrawal by Subject|2|||
130273730|NCT01369199|468965665|FG000|Overall Study|Withdrawal by Subject|1|||
130273731|NCT01369199|468965665|FG000|Overall Study|Lost to Follow-up|2|||
130273732|NCT01071252|468965666|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
130273733|NCT01071252|468965667|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
130273734|NCT01071252|468965668|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
130104267|NCT01186744|468340968|FG005|Overall Study|Death|0|||
130104268|NCT01020773|468340971|FG000|Overall Study|Withdrawal by Subject|4|||
130273735|NCT01071252|468965669|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
130104269|NCT01020773|468340972|FG001|Overall Study|Withdrawal by Subject|3|||
130273736|NCT01071252|468965670|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
130273737|NCT01071252|468965666|FG000|Overall Study|Withdrawal by Subject|8|||
130273738|NCT01071252|468965667|FG001|Overall Study|Withdrawal by Subject|2|||
130273739|NCT01071252|468965668|FG002|Overall Study|Withdrawal by Subject|1|||
130273740|NCT01071252|468965669|FG003|Overall Study|Withdrawal by Subject|2|||
130273741|NCT01071252|468965670|FG004|Overall Study|Withdrawal by Subject|3|||
130273742|NCT01071252|468965666|FG000|Overall Study|administrative problems|1|||
130273743|NCT01071252|468965667|FG001|Overall Study|administrative problems|1|||
130273744|NCT01071252|468965668|FG002|Overall Study|administrative problems|0|||
130273745|NCT01071252|468965669|FG003|Overall Study|administrative problems|2|||
130273746|NCT01071252|468965670|FG004|Overall Study|administrative problems|1|||
130273747|NCT01071252|468965666|FG000|Overall Study|Lost to Follow-up|1|||
130273748|NCT01071252|468965667|FG001|Overall Study|Lost to Follow-up|0|||
130273749|NCT01071252|468965668|FG002|Overall Study|Lost to Follow-up|1|||
130273750|NCT01071252|468965669|FG003|Overall Study|Lost to Follow-up|2|||
130273751|NCT01071252|468965670|FG004|Overall Study|Lost to Follow-up|0|||
130273752|NCT01071252|468965666|FG000|Overall Study|Adverse Event|1|||
130273753|NCT01071252|468965667|FG001|Overall Study|Adverse Event|1|||
130273754|NCT01071252|468965668|FG002|Overall Study|Adverse Event|0|||
130273755|NCT01071252|468965669|FG003|Overall Study|Adverse Event|1|||
130273756|NCT01071252|468965670|FG004|Overall Study|Adverse Event|0|||
130273757|NCT01071252|468965666|FG000|Overall Study|Death|0|||
130273758|NCT01071252|468965667|FG001|Overall Study|Death|0|||
130273759|NCT01071252|468965668|FG002|Overall Study|Death|0|||
130273760|NCT01071252|468965669|FG003|Overall Study|Death|0|||
130273761|NCT01071252|468965670|FG004|Overall Study|Death|1|||
130273762|NCT03928418|468965671|FG000|Overall Study|Lost to Follow-up|5|||
130273763|NCT03928418|468965672|FG001|Overall Study|Lost to Follow-up|3|||
130273764|NCT03928418|468965673|FG002|Overall Study|Lost to Follow-up|5|||
130273765|NCT03928418|468965671|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
130273766|NCT03928418|468965672|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
130273767|NCT03928418|468965673|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
130273768|NCT00470262|468965674|FG000|Overall Study|Withdrawal by Subject|2|||
130273769|NCT00470262|468965675|FG001|Overall Study|Withdrawal by Subject|0|||
130273770|NCT00553436|468965678|FG000|Overall Study|Conversion to another procedure|1|||
130273771|NCT04188834|468965679|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
130273772|NCT01030952|468965680|FG000|Overall Study|Protocol Violation|0|||
130273773|NCT01030952|468965681|FG001|Overall Study|Protocol Violation|1|||
130273774|NCT01030952|468965680|FG000|Overall Study|Informed consent withdrawal|1|||
130273775|NCT01030952|468965681|FG001|Overall Study|Informed consent withdrawal|0|||
130273776|NCT01030952|468965680|FG000|Overall Study|Lost to Follow-up|0|||
130273777|NCT01030952|468965681|FG001|Overall Study|Lost to Follow-up|1|||
130273778|NCT01030952|468965680|FG000|Overall Study|Unexplained|1|||
130273779|NCT01030952|468965681|FG001|Overall Study|Unexplained|1|||
130273780|NCT01814046|468965686|FG000|Drug Administration|Death due to complications of RSV|1|||
130273781|NCT01814046|468965687|FG001|Drug Administration|Death due to complications of RSV|0|||
130273782|NCT01814046|468965688|FG002|Drug Administration|Death due to complications of RSV|0|||
130273783|NCT00958347|468965689|FG000|Overall Study|Death|43|||
130273784|NCT00958347|468965689|FG000|Overall Study|Withdrawal by Subject|23|||
130273785|NCT00958347|468965689|FG000|Overall Study|Lost to Follow-up|15|||
130273786|NCT00958347|468965689|FG000|Overall Study|revision/removal|10|||
130273787|NCT00958347|468965689|FG000|Overall Study|study termination|135|||
130273788|NCT01831466|468965699|FG000|Overall Study|Protocol Violation|1|||
130273789|NCT01831466|468965700|FG001|Overall Study|Protocol Violation|1|||
130273790|NCT01831466|468965701|FG002|Overall Study|Protocol Violation|2|||
130273791|NCT01831466|468965702|FG003|Overall Study|Protocol Violation|0|||
130273792|NCT01831466|468965703|FG004|Overall Study|Protocol Violation|0|||
130273793|NCT01831466|468965704|FG005|Overall Study|Protocol Violation|1|||
130273794|NCT01831466|468965705|FG006|Overall Study|Protocol Violation|0|||
130273795|NCT01831466|468965706|FG007|Overall Study|Protocol Violation|0|||
130273796|NCT01831466|468965707|FG008|Overall Study|Protocol Violation|0|||
130273797|NCT01831466|468965708|FG009|Overall Study|Protocol Violation|0|||
130273798|NCT01831466|468965709|FG010|Overall Study|Protocol Violation|0|||
130273799|NCT01831466|468965710|FG011|Overall Study|Protocol Violation|0|||
130273800|NCT01831466|468965699|FG000|Overall Study|Other|2|||
130273801|NCT01831466|468965700|FG001|Overall Study|Other|3|||
130273802|NCT01831466|468965701|FG002|Overall Study|Other|2|||
130273803|NCT01831466|468965702|FG003|Overall Study|Other|2|||
130273804|NCT01831466|468965703|FG004|Overall Study|Other|2|||
130273805|NCT01831466|468965704|FG005|Overall Study|Other|1|||
130273806|NCT01831466|468965705|FG006|Overall Study|Other|0|||
130273807|NCT01831466|468965706|FG007|Overall Study|Other|0|||
130273808|NCT01831466|468965707|FG008|Overall Study|Other|0|||
130273809|NCT01831466|468965708|FG009|Overall Study|Other|0|||
130273810|NCT01831466|468965709|FG010|Overall Study|Other|0|||
130273811|NCT01831466|468965710|FG011|Overall Study|Other|0|||
130273812|NCT01831466|468965699|FG000|Overall Study|Non-compliance with study treatment|2|||
130273813|NCT01831466|468965700|FG001|Overall Study|Non-compliance with study treatment|1|||
130273814|NCT01831466|468965701|FG002|Overall Study|Non-compliance with study treatment|1|||
130273815|NCT01831466|468965702|FG003|Overall Study|Non-compliance with study treatment|0|||
130273816|NCT01831466|468965703|FG004|Overall Study|Non-compliance with study treatment|0|||
130273817|NCT01831466|468965704|FG005|Overall Study|Non-compliance with study treatment|1|||
130273818|NCT01831466|468965705|FG006|Overall Study|Non-compliance with study treatment|0|||
130273819|NCT01831466|468965706|FG007|Overall Study|Non-compliance with study treatment|0|||
130273820|NCT01831466|468965707|FG008|Overall Study|Non-compliance with study treatment|0|||
130273821|NCT01831466|468965708|FG009|Overall Study|Non-compliance with study treatment|0|||
130273822|NCT01831466|468965709|FG010|Overall Study|Non-compliance with study treatment|0|||
130273823|NCT01831466|468965710|FG011|Overall Study|Non-compliance with study treatment|0|||
130273824|NCT01831466|468965699|FG000|Overall Study|Death|0|||
130273825|NCT01831466|468965700|FG001|Overall Study|Death|1|||
130273826|NCT01831466|468965701|FG002|Overall Study|Death|0|||
130273827|NCT01831466|468965702|FG003|Overall Study|Death|0|||
130273828|NCT01831466|468965703|FG004|Overall Study|Death|0|||
130273829|NCT01831466|468965704|FG005|Overall Study|Death|0|||
130273830|NCT01831466|468965705|FG006|Overall Study|Death|0|||
130273831|NCT01831466|468965706|FG007|Overall Study|Death|0|||
130273832|NCT01831466|468965707|FG008|Overall Study|Death|0|||
130273833|NCT01831466|468965708|FG009|Overall Study|Death|0|||
130273834|NCT01831466|468965709|FG010|Overall Study|Death|0|||
130273835|NCT01831466|468965710|FG011|Overall Study|Death|0|||
130273836|NCT01831466|468965699|FG000|Overall Study|Withdrawal by Subject|6|||
130273837|NCT01831466|468965700|FG001|Overall Study|Withdrawal by Subject|3|||
130273838|NCT01831466|468965701|FG002|Overall Study|Withdrawal by Subject|3|||
130273839|NCT01831466|468965702|FG003|Overall Study|Withdrawal by Subject|3|||
130273840|NCT01831466|468965703|FG004|Overall Study|Withdrawal by Subject|3|||
130273841|NCT01831466|468965704|FG005|Overall Study|Withdrawal by Subject|5|||
130273842|NCT01831466|468965705|FG006|Overall Study|Withdrawal by Subject|0|||
130273843|NCT01831466|468965706|FG007|Overall Study|Withdrawal by Subject|0|||
130273844|NCT01831466|468965707|FG008|Overall Study|Withdrawal by Subject|0|||
130273845|NCT01831466|468965708|FG009|Overall Study|Withdrawal by Subject|1|||
130273846|NCT01831466|468965709|FG010|Overall Study|Withdrawal by Subject|0|||
130273847|NCT01831466|468965710|FG011|Overall Study|Withdrawal by Subject|1|||
130273848|NCT01831466|468965699|FG000|Overall Study|Lost to Follow-up|0|||
130273849|NCT01831466|468965700|FG001|Overall Study|Lost to Follow-up|1|||
130273850|NCT01831466|468965701|FG002|Overall Study|Lost to Follow-up|4|||
130273851|NCT01831466|468965702|FG003|Overall Study|Lost to Follow-up|2|||
130273852|NCT01831466|468965703|FG004|Overall Study|Lost to Follow-up|0|||
130273853|NCT01831466|468965704|FG005|Overall Study|Lost to Follow-up|3|||
130273854|NCT01831466|468965705|FG006|Overall Study|Lost to Follow-up|0|||
130273855|NCT01831466|468965706|FG007|Overall Study|Lost to Follow-up|0|||
130273856|NCT01831466|468965707|FG008|Overall Study|Lost to Follow-up|0|||
130273857|NCT01831466|468965708|FG009|Overall Study|Lost to Follow-up|1|||
130273858|NCT01831466|468965709|FG010|Overall Study|Lost to Follow-up|0|||
130273859|NCT01831466|468965710|FG011|Overall Study|Lost to Follow-up|1|||
130273860|NCT01831466|468965699|FG000|Overall Study|Lack of Efficacy|5|||
130273861|NCT01831466|468965700|FG001|Overall Study|Lack of Efficacy|8|||
130273862|NCT01831466|468965701|FG002|Overall Study|Lack of Efficacy|7|||
130273863|NCT01831466|468965702|FG003|Overall Study|Lack of Efficacy|6|||
130273864|NCT01831466|468965703|FG004|Overall Study|Lack of Efficacy|9|||
130273865|NCT01831466|468965704|FG005|Overall Study|Lack of Efficacy|8|||
130273866|NCT01831466|468965705|FG006|Overall Study|Lack of Efficacy|1|||
130273867|NCT01831466|468965706|FG007|Overall Study|Lack of Efficacy|1|||
130273868|NCT01831466|468965707|FG008|Overall Study|Lack of Efficacy|2|||
130273869|NCT01831466|468965708|FG009|Overall Study|Lack of Efficacy|2|||
130273870|NCT01831466|468965709|FG010|Overall Study|Lack of Efficacy|2|||
130273871|NCT01831466|468965710|FG011|Overall Study|Lack of Efficacy|0|||
130273872|NCT01831466|468965699|FG000|Overall Study|Adverse Event|0|||
130273873|NCT01831466|468965700|FG001|Overall Study|Adverse Event|0|||
130273874|NCT01831466|468965701|FG002|Overall Study|Adverse Event|4|||
130273875|NCT01831466|468965702|FG003|Overall Study|Adverse Event|6|||
130273876|NCT01831466|468965703|FG004|Overall Study|Adverse Event|3|||
130273877|NCT01831466|468965704|FG005|Overall Study|Adverse Event|7|||
130273878|NCT01831466|468965705|FG006|Overall Study|Adverse Event|0|||
130273879|NCT01831466|468965706|FG007|Overall Study|Adverse Event|1|||
130273880|NCT01831466|468965707|FG008|Overall Study|Adverse Event|1|||
130273881|NCT01831466|468965708|FG009|Overall Study|Adverse Event|1|||
130273882|NCT01831466|468965709|FG010|Overall Study|Adverse Event|0|||
130273883|NCT01831466|468965710|FG011|Overall Study|Adverse Event|2|||
130273884|NCT02311881|468965725|FG000|Overall Study|Did not meet the study criteria|2|||
130273885|NCT02311881|468965726|FG001|Overall Study|Did not meet the study criteria|2|||
130273886|NCT02311881|468965727|FG002|Overall Study|Did not meet the study criteria|0|||
130273887|NCT02311881|468965725|FG000|Overall Study|Adverse Event|7|||
130273888|NCT02311881|468965726|FG001|Overall Study|Adverse Event|15|||
130273889|NCT02311881|468965727|FG002|Overall Study|Adverse Event|8|||
130273890|NCT02311881|468965725|FG000|Overall Study|Lost to Follow-up|3|||
130273891|NCT02311881|468965726|FG001|Overall Study|Lost to Follow-up|3|||
130273892|NCT02311881|468965727|FG002|Overall Study|Lost to Follow-up|2|||
130273893|NCT02311881|468965725|FG000|Overall Study|Protocol Violation|1|||
130273894|NCT02311881|468965726|FG001|Overall Study|Protocol Violation|2|||
130273895|NCT02311881|468965727|FG002|Overall Study|Protocol Violation|3|||
130273896|NCT02311881|468965725|FG000|Overall Study|Withdrawal of consent|14|||
130273897|NCT02311881|468965726|FG001|Overall Study|Withdrawal of consent|16|||
130273898|NCT02311881|468965727|FG002|Overall Study|Withdrawal of consent|17|||
130273899|NCT02311881|468965725|FG000|Overall Study|Other|0|||
130273900|NCT02311881|468965726|FG001|Overall Study|Other|0|||
130273901|NCT02311881|468965727|FG002|Overall Study|Other|1|||
130104270|NCT01389024|468340973|FG000|Overall Study|Withdrawal by Subject|0|||
130104271|NCT01389024|468340974|FG001|Overall Study|Withdrawal by Subject|1|||
130104272|NCT01389024|468340973|FG000|Overall Study|Lost to Follow-up|1|||
130104273|NCT01389024|468340974|FG001|Overall Study|Lost to Follow-up|0|||
130104274|NCT02038959|468340977|FG000|Overall Study|Withdrawal by Subject|6|||
130104275|NCT02038959|468340978|FG001|Overall Study|Withdrawal by Subject|8|||
130104276|NCT00819091|468340985|FG000|Overall Study|Adverse Event|3|||
130104277|NCT00819091|468340986|FG001|Overall Study|Adverse Event|5|||
130104278|NCT00819091|468340985|FG000|Overall Study|Protocol Violation|0|||
130104279|NCT00819091|468340986|FG001|Overall Study|Protocol Violation|1|||
130104280|NCT00819091|468340985|FG000|Overall Study|Lost to Follow-up|2|||
130104281|NCT00819091|468340986|FG001|Overall Study|Lost to Follow-up|0|||
130104282|NCT00819091|468340985|FG000|Overall Study|Withdrawal by Subject|1|||
130104283|NCT00819091|468340986|FG001|Overall Study|Withdrawal by Subject|2|||
130104284|NCT00819091|468340985|FG000|Overall Study|Other|1|||
130104285|NCT00819091|468340986|FG001|Overall Study|Other|2|||
130104286|NCT02675426|468340990|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
130104287|NCT02675426|468340991|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
130104288|NCT02675426|468340992|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
130104289|NCT02675426|468340993|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
130104290|NCT02675426|468340990|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
130104291|NCT02675426|468340991|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
130104292|NCT02675426|468340992|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
130104293|NCT02675426|468340993|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
130104294|NCT02675426|468340990|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
130104295|NCT02675426|468340991|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
130104296|NCT02675426|468340992|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
130104297|NCT02675426|468340993|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
130104298|NCT02675426|468340990|FG000|Period 1: Week 1 to Week 12|Other|2|||
130104299|NCT02675426|468340991|FG001|Period 1: Week 1 to Week 12|Other|1|||
130104300|NCT02675426|468340992|FG002|Period 1: Week 1 to Week 12|Other|0|||
130104301|NCT02675426|468340993|FG003|Period 1: Week 1 to Week 12|Other|2|||
130104302|NCT02675426|468340990|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
130104303|NCT02675426|468340991|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
130104304|NCT02675426|468340992|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
130273902|NCT02311881|468965725|FG000|Overall Study|Lack of Efficacy|1|||
130273903|NCT02311881|468965726|FG001|Overall Study|Lack of Efficacy|2|||
130273904|NCT02311881|468965727|FG002|Overall Study|Lack of Efficacy|0|||
130273905|NCT02311881|468965725|FG000|Overall Study|Subject has border line pregnancy test|1|||
130273906|NCT02311881|468965726|FG001|Overall Study|Subject has border line pregnancy test|0|||
130273907|NCT02311881|468965727|FG002|Overall Study|Subject has border line pregnancy test|0|||
130273908|NCT02311881|468965725|FG000|Overall Study|Withdrawal by Subject|3|||
130273909|NCT02311881|468965726|FG001|Overall Study|Withdrawal by Subject|1|||
130273910|NCT02311881|468965727|FG002|Overall Study|Withdrawal by Subject|4|||
130273911|NCT02311881|468965725|FG000|Overall Study|Sponsor Decision|1|||
130104305|NCT02675426|468340993|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
130273912|NCT02311881|468965726|FG001|Overall Study|Sponsor Decision|1|||
130104306|NCT02675426|468340990|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
130273913|NCT02311881|468965727|FG002|Overall Study|Sponsor Decision|1|||
130104307|NCT02675426|468340991|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
130273914|NCT02311881|468965725|FG000|Overall Study|Protocol Deviation|1|||
130273915|NCT02311881|468965726|FG001|Overall Study|Protocol Deviation|0|||
130273916|NCT02311881|468965727|FG002|Overall Study|Protocol Deviation|0|||
130273917|NCT02311881|468965725|FG000|Overall Study|Non-Compliance|1|||
130273918|NCT02311881|468965726|FG001|Overall Study|Non-Compliance|0|||
130273919|NCT02311881|468965727|FG002|Overall Study|Non-Compliance|2|||
130273920|NCT02311881|468965725|FG000|Overall Study|Physician Decision|0|||
130273921|NCT02311881|468965726|FG001|Overall Study|Physician Decision|0|||
130273922|NCT02311881|468965727|FG002|Overall Study|Physician Decision|1|||
130273923|NCT02311881|468965725|FG000|Overall Study|Medical Monitor Discretion|0|||
130273924|NCT02311881|468965726|FG001|Overall Study|Medical Monitor Discretion|0|||
130273925|NCT02311881|468965727|FG002|Overall Study|Medical Monitor Discretion|1|||
130273926|NCT02311881|468965725|FG000|Overall Study|Participant taking another medication|0|||
130273927|NCT02311881|468965726|FG001|Overall Study|Participant taking another medication|0|||
130273928|NCT02311881|468965727|FG002|Overall Study|Participant taking another medication|1|||
130273929|NCT02311881|468965725|FG000|Overall Study|Serious Adverse Event|0|||
130273930|NCT02311881|468965726|FG001|Overall Study|Serious Adverse Event|1|||
130273931|NCT02311881|468965727|FG002|Overall Study|Serious Adverse Event|0|||
130273932|NCT00819156|468965728|FG000|Overall Study|Adverse Event|1|||
130273933|NCT00819156|468965729|FG001|Overall Study|Adverse Event|4|||
130273934|NCT00819156|468965730|FG002|Overall Study|Adverse Event|2|||
130273935|NCT00819156|468965731|FG003|Overall Study|Adverse Event|1|||
130273936|NCT00819156|468965732|FG004|Overall Study|Adverse Event|2|||
130273937|NCT00819156|468965733|FG005|Overall Study|Adverse Event|3|||
130273938|NCT00819156|468965728|FG000|Overall Study|Withdrawal by Subject|0|||
130273939|NCT00819156|468965729|FG001|Overall Study|Withdrawal by Subject|3|||
130273940|NCT00819156|468965730|FG002|Overall Study|Withdrawal by Subject|2|||
130040107|NCT00472303|468102920|FG000|Discontinuations After Titration Phase|Other|5|||
130040108|NCT00472303|468102921|FG001|Discontinuations After Titration Phase|Other|0|||
130040109|NCT00472303|468102922|FG002|Discontinuations After Titration Phase|Other|0|||
130273941|NCT00819156|468965731|FG003|Overall Study|Withdrawal by Subject|0|||
130273942|NCT00819156|468965732|FG004|Overall Study|Withdrawal by Subject|1|||
130273943|NCT00819156|468965733|FG005|Overall Study|Withdrawal by Subject|0|||
130273944|NCT00819156|468965728|FG000|Overall Study|Protocol Violation|1|||
130273945|NCT00819156|468965729|FG001|Overall Study|Protocol Violation|0|||
130273946|NCT00819156|468965730|FG002|Overall Study|Protocol Violation|1|||
130273947|NCT00819156|468965731|FG003|Overall Study|Protocol Violation|0|||
130273948|NCT00819156|468965732|FG004|Overall Study|Protocol Violation|0|||
130273949|NCT00819156|468965733|FG005|Overall Study|Protocol Violation|1|||
130273950|NCT00819156|468965728|FG000|Overall Study|Lost to Follow-up|0|||
130273951|NCT00819156|468965729|FG001|Overall Study|Lost to Follow-up|1|||
130273952|NCT00819156|468965730|FG002|Overall Study|Lost to Follow-up|0|||
130273953|NCT00819156|468965731|FG003|Overall Study|Lost to Follow-up|0|||
130273954|NCT00819156|468965732|FG004|Overall Study|Lost to Follow-up|0|||
130273955|NCT00819156|468965733|FG005|Overall Study|Lost to Follow-up|2|||
130273956|NCT00819156|468965728|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
130273957|NCT00819156|468965729|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
130273958|NCT00819156|468965730|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130273959|NCT00819156|468965731|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130273960|NCT00819156|468965732|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
130273961|NCT00819156|468965733|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
130273962|NCT00819156|468965728|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
130273963|NCT00819156|468965729|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273964|NCT00819156|468965730|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273965|NCT00819156|468965731|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273966|NCT00819156|468965732|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
130273967|NCT00819156|468965733|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
130273968|NCT00819156|468965728|FG000|Overall Study|Prostate-specific antigen progression|0|||
130273969|NCT00819156|468965729|FG001|Overall Study|Prostate-specific antigen progression|0|||
130273970|NCT00819156|468965730|FG002|Overall Study|Prostate-specific antigen progression|0|||
130273971|NCT00819156|468965731|FG003|Overall Study|Prostate-specific antigen progression|0|||
130273972|NCT00819156|468965732|FG004|Overall Study|Prostate-specific antigen progression|1|||
130273973|NCT00819156|468965733|FG005|Overall Study|Prostate-specific antigen progression|0|||
130273974|NCT00803595|468965734|FG000|Overall Study|Adverse Event|3|||
130273975|NCT00803595|468965735|FG001|Overall Study|Adverse Event|4|||
130273976|NCT00803595|468965736|FG002|Overall Study|Adverse Event|1|||
130273977|NCT00803595|468965734|FG000|Overall Study|Protocol Violation|7|||
130273978|NCT00803595|468965735|FG001|Overall Study|Protocol Violation|2|||
130273979|NCT00803595|468965736|FG002|Overall Study|Protocol Violation|12|||
130273980|NCT00803595|468965734|FG000|Overall Study|Withdrawal by Subject|5|||
130273981|NCT00803595|468965735|FG001|Overall Study|Withdrawal by Subject|2|||
130273982|NCT00803595|468965736|FG002|Overall Study|Withdrawal by Subject|3|||
130273983|NCT01575808|468965739|FG000|Overall Study|Death|2|||
130273984|NCT01575808|468965740|FG001|Overall Study|Death|0|||
130273985|NCT01575808|468965739|FG000|Overall Study|Withdrawal by Subject|1|||
130273986|NCT01575808|468965740|FG001|Overall Study|Withdrawal by Subject|0|||
130273987|NCT02403817|468967302|FG000|Overall Study|Withdrawal by Subject|5|||
130273988|NCT02403817|468967303|FG001|Overall Study|Withdrawal by Subject|0|||
130273989|NCT04908384|468967304|FG000|Overall Study|Lost to Follow-up|4|||
130273990|NCT04908384|468967305|FG001|Overall Study|Lost to Follow-up|4|||
130273991|NCT04908384|468967306|FG002|Overall Study|Lost to Follow-up|0|||
130273992|NCT04908384|468967307|FG003|Overall Study|Lost to Follow-up|0|||
130273993|NCT00430989|468967308|FG000|Overall Study|Lost to Follow-up|2|||
130273994|NCT00430989|468967309|FG001|Overall Study|Lost to Follow-up|3|||
130273995|NCT00430989|468967308|FG000|Overall Study|Withdrawal by Subject|15|||
130273996|NCT00430989|468967309|FG001|Overall Study|Withdrawal by Subject|14|||
130040110|NCT00472303|468102920|FG000|Maintenance Phase|Adverse Event|5|||
130040111|NCT00472303|468102921|FG001|Maintenance Phase|Adverse Event|6|||
130040112|NCT00472303|468102922|FG002|Maintenance Phase|Adverse Event|6|||
130040113|NCT00472303|468102920|FG000|Maintenance Phase|Death|3|||
130040114|NCT00472303|468102921|FG001|Maintenance Phase|Death|0|||
130040115|NCT00472303|468102922|FG002|Maintenance Phase|Death|2|||
130040116|NCT00472303|468102920|FG000|Maintenance Phase|Lack of Efficacy|2|||
130273997|NCT00430989|468967308|FG000|Overall Study|Protocol Violation|30|||
130273998|NCT00430989|468967309|FG001|Overall Study|Protocol Violation|37|||
130273999|NCT00430989|468967308|FG000|Overall Study|Not eligible|13|||
130274000|NCT00430989|468967309|FG001|Overall Study|Not eligible|6|||
130274001|NCT03050450|468967310|FG000|Overall Study|Physician Decision|1|||
130274002|NCT03050450|468967311|FG001|Overall Study|Physician Decision|0|||
130274003|NCT03050450|468967312|FG002|Overall Study|Physician Decision|0|||
130274004|NCT03050450|468967313|FG003|Overall Study|Physician Decision|0|||
130274005|NCT03050450|468967314|FG004|Overall Study|Physician Decision|0|||
130040117|NCT00472303|468102921|FG001|Maintenance Phase|Lack of Efficacy|2|||
130274006|NCT01642901|468967315|FG000|12-month Follow-up|Withdrawal by Subject|1|||
130274007|NCT01642901|468967316|FG001|12-month Follow-up|Withdrawal by Subject|0|||
130274008|NCT01701362|468967318|FG000|Overall Study|Adverse events not related to study drug|1|||
130274009|NCT01701362|468967319|FG001|Overall Study|Adverse events not related to study drug|6|||
130274010|NCT01701362|468967318|FG000|Overall Study|Adverse events related to study drug|12|||
130274011|NCT01701362|468967319|FG001|Overall Study|Adverse events related to study drug|10|||
130274012|NCT01701362|468967318|FG000|Overall Study|Protocol Violation|5|||
130274013|NCT01701362|468967319|FG001|Overall Study|Protocol Violation|3|||
130274014|NCT01701362|468967318|FG000|Overall Study|No longer willing to participate|8|||
130274015|NCT01701362|468967319|FG001|Overall Study|No longer willing to participate|14|||
130274016|NCT01701362|468967318|FG000|Overall Study|Lost to Follow-up|6|||
130274017|NCT01701362|468967319|FG001|Overall Study|Lost to Follow-up|9|||
130274018|NCT01701362|468967318|FG000|Overall Study|Insufficient clinical response|6|||
130274019|NCT01701362|468967319|FG001|Overall Study|Insufficient clinical response|6|||
130274020|NCT01701362|468967318|FG000|Overall Study|Death|0|||
130274021|NCT01701362|468967319|FG001|Overall Study|Death|1|||
130274022|NCT01701362|468967318|FG000|Overall Study|Randomized but not treated|1|||
130274023|NCT01701362|468967319|FG001|Overall Study|Randomized but not treated|2|||
130274024|NCT01701362|468967318|FG000|Overall Study|Reasons other than those mentioned above|3|||
130274025|NCT01701362|468967319|FG001|Overall Study|Reasons other than those mentioned above|5|||
130274026|NCT00570778|468967320|FG000|Overall Study|Protocol deviation|2|||
130274027|NCT00570778|468967321|FG001|Overall Study|Protocol deviation|1|||
130274028|NCT00570778|468967322|FG002|Overall Study|Protocol deviation|2|||
130274029|NCT00570778|468967323|FG003|Overall Study|Protocol deviation|2|||
130274030|NCT00570778|468967320|FG000|Overall Study|Adverse Event|0|||
130274031|NCT00570778|468967321|FG001|Overall Study|Adverse Event|1|||
130274032|NCT00570778|468967322|FG002|Overall Study|Adverse Event|4|||
130274033|NCT00570778|468967323|FG003|Overall Study|Adverse Event|1|||
130274034|NCT00570778|468967320|FG000|Overall Study|Subject withdrew consent|0|||
130274035|NCT00570778|468967321|FG001|Overall Study|Subject withdrew consent|1|||
130274036|NCT00570778|468967322|FG002|Overall Study|Subject withdrew consent|0|||
130274037|NCT00570778|468967323|FG003|Overall Study|Subject withdrew consent|1|||
130274038|NCT00570778|468967320|FG000|Overall Study|Abnormal test procedure|1|||
130274039|NCT00570778|468967321|FG001|Overall Study|Abnormal test procedure|0|||
130274040|NCT00570778|468967322|FG002|Overall Study|Abnormal test procedure|0|||
130274041|NCT00570778|468967323|FG003|Overall Study|Abnormal test procedure|0|||
130274042|NCT00570778|468967320|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130274043|NCT00570778|468967321|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130274044|NCT00570778|468967322|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130274045|NCT00570778|468967323|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130274046|NCT00570778|468967320|FG000|Overall Study|Lost to Follow-up|0|||
130274047|NCT00570778|468967321|FG001|Overall Study|Lost to Follow-up|0|||
130274048|NCT00570778|468967322|FG002|Overall Study|Lost to Follow-up|1|||
130274049|NCT00570778|468967323|FG003|Overall Study|Lost to Follow-up|0|||
130040118|NCT00472303|468102922|FG002|Maintenance Phase|Lack of Efficacy|4|||
130040119|NCT00472303|468102920|FG000|Maintenance Phase|Withdrawal by Subject|6|||
130040120|NCT00472303|468102921|FG001|Maintenance Phase|Withdrawal by Subject|7|||
130040121|NCT00472303|468102922|FG002|Maintenance Phase|Withdrawal by Subject|3|||
130274050|NCT00570778|468967320|FG000|Overall Study|Subject no longer requires study drug|0|||
130274051|NCT00570778|468967321|FG001|Overall Study|Subject no longer requires study drug|1|||
130274052|NCT00570778|468967322|FG002|Overall Study|Subject no longer requires study drug|0|||
130274053|NCT00570778|468967323|FG003|Overall Study|Subject no longer requires study drug|0|||
130274054|NCT00711594|468967324|FG000|Overall Study|Progressive disease|2|||
130274055|NCT00711594|468967325|FG001|Overall Study|Progressive disease|2|||
130274056|NCT00711594|468967326|FG002|Overall Study|Progressive disease|6|||
130274057|NCT00711594|468967327|FG003|Overall Study|Progressive disease|44|||
130274058|NCT00711594|468967324|FG000|Overall Study|Other Adverse Event|1|||
130274059|NCT00711594|468967325|FG001|Overall Study|Other Adverse Event|0|||
130274060|NCT00711594|468967326|FG002|Overall Study|Other Adverse Event|0|||
130274061|NCT00711594|468967327|FG003|Overall Study|Other Adverse Event|16|||
130274062|NCT00711594|468967324|FG000|Overall Study|Withdrawal by Subject|0|||
130274063|NCT00711594|468967325|FG001|Overall Study|Withdrawal by Subject|1|||
130274064|NCT00711594|468967326|FG002|Overall Study|Withdrawal by Subject|0|||
130274065|NCT00711594|468967327|FG003|Overall Study|Withdrawal by Subject|2|||
130274066|NCT00443872|468967328|FG000|Overall Study|Protocol Violation|7|||
130274067|NCT00443872|468967328|FG000|Overall Study|Lost to Follow-up|2|||
130274068|NCT00443872|468967328|FG000|Overall Study|Adverse Event|8|||
130274069|NCT00485758|468967334|FG000|Overall Study|Adverse Event|102|||
130274070|NCT00485758|468967335|FG001|Overall Study|Adverse Event|31|||
130274071|NCT00485758|468967334|FG000|Overall Study|Death|0|||
130274072|NCT00485758|468967335|FG001|Overall Study|Death|1|||
130274073|NCT00485758|468967334|FG000|Overall Study|Lost to Follow-up|5|||
130274074|NCT00485758|468967335|FG001|Overall Study|Lost to Follow-up|1|||
130274075|NCT00485758|468967334|FG000|Overall Study|Physician Decision|3|||
130274076|NCT00485758|468967335|FG001|Overall Study|Physician Decision|3|||
130274077|NCT00485758|468967334|FG000|Overall Study|Protocol Violation|11|||
130274078|NCT00485758|468967335|FG001|Overall Study|Protocol Violation|2|||
130274079|NCT00485758|468967334|FG000|Overall Study|Withdrawal by Subject|32|||
130274080|NCT00485758|468967335|FG001|Overall Study|Withdrawal by Subject|27|||
130274081|NCT00485758|468967334|FG000|Overall Study|Study Terminated by Sponsor|3|||
130274082|NCT00485758|468967335|FG001|Overall Study|Study Terminated by Sponsor|0|||
130274083|NCT04551963|468967336|FG000|Overall Study|Physician Decision|1|||
130274084|NCT04551963|468967337|FG001|Overall Study|Physician Decision|1|||
130274085|NCT04551963|468967336|FG000|Overall Study|Death|1|||
130274086|NCT04551963|468967337|FG001|Overall Study|Death|0|||
130274087|NCT03379259|468967338|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
130274088|NCT03379259|468967339|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
130274089|NCT03379259|468967340|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
130274090|NCT03379259|468967341|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
130274091|NCT03379259|468967342|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
130274092|NCT03379259|468967343|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
130274093|NCT03379259|468967338|FG000|Overall Study|Death|0|||
130274094|NCT03379259|468967339|FG001|Overall Study|Death|1|||
130274095|NCT03379259|468967340|FG002|Overall Study|Death|2|||
130274096|NCT03379259|468967341|FG003|Overall Study|Death|1|||
130274097|NCT03379259|468967342|FG004|Overall Study|Death|4|||
130274098|NCT03379259|468967343|FG005|Overall Study|Death|2|||
130274099|NCT03379259|468967338|FG000|Overall Study|Withdrawal by Subject|0|||
130274100|NCT03379259|468967339|FG001|Overall Study|Withdrawal by Subject|0|||
130274101|NCT03379259|468967340|FG002|Overall Study|Withdrawal by Subject|1|||
130274102|NCT03379259|468967341|FG003|Overall Study|Withdrawal by Subject|0|||
130274103|NCT03379259|468967342|FG004|Overall Study|Withdrawal by Subject|2|||
130274104|NCT03379259|468967343|FG005|Overall Study|Withdrawal by Subject|0|||
130274105|NCT03379259|468967338|FG000|Overall Study|Study terminated by sponsor|0|||
130274106|NCT03379259|468967339|FG001|Overall Study|Study terminated by sponsor|0|||
130274107|NCT03379259|468967340|FG002|Overall Study|Study terminated by sponsor|0|||
130274108|NCT03379259|468967341|FG003|Overall Study|Study terminated by sponsor|1|||
130274109|NCT03379259|468967342|FG004|Overall Study|Study terminated by sponsor|1|||
130274110|NCT03379259|468967343|FG005|Overall Study|Study terminated by sponsor|4|||
130274111|NCT03379259|468967338|FG000|Overall Study|Disease progression|0|||
130274112|NCT03379259|468967339|FG001|Overall Study|Disease progression|0|||
130274113|NCT03379259|468967340|FG002|Overall Study|Disease progression|0|||
130274114|NCT03379259|468967341|FG003|Overall Study|Disease progression|1|||
130104308|NCT02675426|468340992|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
130104309|NCT02675426|468340993|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
130104310|NCT02675426|468340990|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
130274115|NCT03379259|468967342|FG004|Overall Study|Disease progression|0|||
130274116|NCT03379259|468967343|FG005|Overall Study|Disease progression|1|||
130274117|NCT03379259|468967338|FG000|Overall Study|Lost to Follow-up|0|||
130274118|NCT03379259|468967339|FG001|Overall Study|Lost to Follow-up|0|||
130274119|NCT03379259|468967340|FG002|Overall Study|Lost to Follow-up|0|||
130274120|NCT03379259|468967341|FG003|Overall Study|Lost to Follow-up|0|||
130274121|NCT03379259|468967342|FG004|Overall Study|Lost to Follow-up|1|||
130274122|NCT03379259|468967343|FG005|Overall Study|Lost to Follow-up|0|||
130274123|NCT03379259|468967338|FG000|Overall Study|Deteriorating condition|0|||
130274124|NCT03379259|468967339|FG001|Overall Study|Deteriorating condition|0|||
130274125|NCT03379259|468967340|FG002|Overall Study|Deteriorating condition|0|||
130274126|NCT03379259|468967341|FG003|Overall Study|Deteriorating condition|0|||
130274127|NCT03379259|468967342|FG004|Overall Study|Deteriorating condition|1|||
130274128|NCT03379259|468967343|FG005|Overall Study|Deteriorating condition|0|||
130274129|NCT00700622|468967344|FG000|Overall Study|Adverse Event|4|||
130274130|NCT00700622|468967345|FG001|Overall Study|Adverse Event|0|||
130274131|NCT00700622|468967344|FG000|Overall Study|Lost to Follow-up|0|||
130274132|NCT00700622|468967345|FG001|Overall Study|Lost to Follow-up|1|||
130274133|NCT00700622|468967344|FG000|Overall Study|Physician Decision|2|||
130274134|NCT00700622|468967345|FG001|Overall Study|Physician Decision|1|||
130274135|NCT00700622|468967344|FG000|Overall Study|Protocol Violation|0|||
130274136|NCT00700622|468967345|FG001|Overall Study|Protocol Violation|1|||
130274137|NCT00700622|468967344|FG000|Overall Study|Withdrawal by Subject|4|||
130274138|NCT00700622|468967345|FG001|Overall Study|Withdrawal by Subject|1|||
130274139|NCT00700622|468967344|FG000|Overall Study|Other|3|||
130274140|NCT00700622|468967345|FG001|Overall Study|Other|1|||
130274141|NCT00383331|468967346|FG000|Overall Study|Protocol Violation|0|||
130274142|NCT00383331|468967347|FG001|Overall Study|Protocol Violation|1|||
130274143|NCT00375427|468967348|FG000|Overall Study|Adverse Event|21|||
130274144|NCT00375427|468967349|FG001|Overall Study|Adverse Event|27|||
130274145|NCT00375427|468967348|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130274146|NCT00375427|468967349|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130104311|NCT02675426|468340991|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
130104312|NCT02675426|468340992|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
130104313|NCT02675426|468340993|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
130104314|NCT02675426|468340990|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
130104315|NCT02675426|468340991|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
130104316|NCT02675426|468340992|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
130274147|NCT00375427|468967348|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130274148|NCT00375427|468967349|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130274149|NCT00375427|468967348|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130274150|NCT00375427|468967349|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
130274151|NCT00375427|468967348|FG000|Overall Study|Patient no longer requires study drug|3|||
130274152|NCT00375427|468967349|FG001|Overall Study|Patient no longer requires study drug|7|||
130274153|NCT00375427|468967348|FG000|Overall Study|Protocol Violation|10|||
130274154|NCT00375427|468967349|FG001|Overall Study|Protocol Violation|8|||
130274155|NCT00375427|468967348|FG000|Overall Study|Withdrawal by Subject|9|||
130274156|NCT00375427|468967349|FG001|Overall Study|Withdrawal by Subject|13|||
130274157|NCT00375427|468967348|FG000|Overall Study|Lost to Follow-up|1|||
130274158|NCT00375427|468967349|FG001|Overall Study|Lost to Follow-up|1|||
130274159|NCT00375427|468967348|FG000|Overall Study|Administrative reasons|0|||
130274160|NCT00375427|468967349|FG001|Overall Study|Administrative reasons|1|||
130274161|NCT00375427|468967348|FG000|Overall Study|Death|11|||
130274162|NCT00375427|468967349|FG001|Overall Study|Death|10|||
130274163|NCT03850093|468967350|FG000|Overall Study|Withdrawal by Subject|1|||
130274164|NCT03850093|468967351|FG001|Overall Study|Withdrawal by Subject|0|||
130274165|NCT03850093|468967352|FG002|Overall Study|Withdrawal by Subject|2|||
130274166|NCT03226249|468967358|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
130274167|NCT03226249|468967358|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
130274168|NCT03226249|468967358|FG000|Survival Follow-up|Patients still in follow-up.|30|||
130274169|NCT01532921|468967359|FG000|Overall Study|Death|3|||
130274170|NCT01532921|468967359|FG000|Overall Study|Withdrawal by Subject|2|||
130274171|NCT01532921|468967359|FG000|Overall Study|Lost to Follow-up|3|||
130274172|NCT01532921|468967359|FG000|Overall Study|Physician Decision|7|||
130274173|NCT01532921|468967359|FG000|Overall Study|Device was explanted during procedure|1|||
130274174|NCT00070109|468967360|FG000|Overall Study|Death|1|||
130274175|NCT00070109|468967361|FG001|Overall Study|Death|1|||
130274176|NCT00070109|468967362|FG002|Overall Study|Death|0|||
130274177|NCT00070109|468967363|FG003|Overall Study|Death|0|||
130274178|NCT00070109|468967364|FG004|Overall Study|Death|1|||
130274179|NCT00070109|468967360|FG000|Overall Study|Lack of Efficacy|6|||
130274180|NCT00070109|468967361|FG001|Overall Study|Lack of Efficacy|4|||
130274181|NCT00070109|468967362|FG002|Overall Study|Lack of Efficacy|5|||
130274182|NCT00070109|468967363|FG003|Overall Study|Lack of Efficacy|15|||
130274183|NCT00070109|468967364|FG004|Overall Study|Lack of Efficacy|5|||
130274184|NCT00070109|468967360|FG000|Overall Study|Physician Decision|1|||
130274185|NCT00070109|468967361|FG001|Overall Study|Physician Decision|0|||
130274186|NCT00070109|468967362|FG002|Overall Study|Physician Decision|0|||
130274187|NCT00070109|468967363|FG003|Overall Study|Physician Decision|0|||
130274188|NCT00070109|468967364|FG004|Overall Study|Physician Decision|0|||
130274189|NCT00070109|468967360|FG000|Overall Study|Withdrawal by Subject|0|||
130274190|NCT00070109|468967361|FG001|Overall Study|Withdrawal by Subject|1|||
130274191|NCT00070109|468967362|FG002|Overall Study|Withdrawal by Subject|1|||
130274192|NCT00070109|468967363|FG003|Overall Study|Withdrawal by Subject|0|||
130274193|NCT00070109|468967364|FG004|Overall Study|Withdrawal by Subject|0|||
130274194|NCT00070109|468967360|FG000|Overall Study|Adverse Event|0|||
130274195|NCT00070109|468967361|FG001|Overall Study|Adverse Event|0|||
130274196|NCT00070109|468967362|FG002|Overall Study|Adverse Event|2|||
130274197|NCT00070109|468967363|FG003|Overall Study|Adverse Event|4|||
130274198|NCT00070109|468967364|FG004|Overall Study|Adverse Event|2|||
130274199|NCT00070109|468967360|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
130274200|NCT00070109|468967361|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
130274201|NCT00070109|468967362|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
130274202|NCT00070109|468967363|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
130274203|NCT00070109|468967364|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
130274204|NCT00624468|468967367|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
130274205|NCT00624468|468967368|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
130274206|NCT00624468|468967369|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
130274207|NCT00624468|468967370|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
130274208|NCT00624468|468967367|FG000|Double-blind Period|Withdrew Prematurely|1|||
130274209|NCT00624468|468967368|FG001|Double-blind Period|Withdrew Prematurely|1|||
130274210|NCT00624468|468967369|FG002|Double-blind Period|Withdrew Prematurely|0|||
130274211|NCT00624468|468967370|FG003|Double-blind Period|Withdrew Prematurely|0|||
130274212|NCT00624468|468967367|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
130274213|NCT00624468|468967368|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
130274214|NCT00624468|468967369|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
130274215|NCT00624468|468967370|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
130274216|NCT00624468|468967367|FG000|Safety Follow-up (SFU) Period|Other|0|||
130274217|NCT00624468|468967368|FG001|Safety Follow-up (SFU) Period|Other|0|||
130274218|NCT00624468|468967369|FG002|Safety Follow-up (SFU) Period|Other|1|||
130274219|NCT00624468|468967370|FG003|Safety Follow-up (SFU) Period|Other|1|||
130274220|NCT02550288|468967371|FG000|Overall Study|Adverse Event|0|||
130274221|NCT02550288|468967372|FG001|Overall Study|Adverse Event|1|||
130274222|NCT02550288|468967373|FG002|Overall Study|Adverse Event|0|||
130274223|NCT02550288|468967374|FG003|Overall Study|Adverse Event|0|||
130274224|NCT02550288|468967375|FG004|Overall Study|Adverse Event|0|||
130274225|NCT02550288|468967371|FG000|Overall Study|Physician Decision|0|||
130274226|NCT02550288|468967372|FG001|Overall Study|Physician Decision|0|||
130274227|NCT02550288|468967373|FG002|Overall Study|Physician Decision|0|||
130274228|NCT02550288|468967374|FG003|Overall Study|Physician Decision|1|||
130274229|NCT02550288|468967375|FG004|Overall Study|Physician Decision|0|||
130274230|NCT02550288|468967371|FG000|Overall Study|Protocol Violation|2|||
130274231|NCT02550288|468967372|FG001|Overall Study|Protocol Violation|2|||
130274232|NCT02550288|468967373|FG002|Overall Study|Protocol Violation|1|||
130274233|NCT02550288|468967374|FG003|Overall Study|Protocol Violation|0|||
130274234|NCT02550288|468967375|FG004|Overall Study|Protocol Violation|3|||
130274235|NCT02550288|468967371|FG000|Overall Study|Participant moved|0|||
130274236|NCT02550288|468967372|FG001|Overall Study|Participant moved|0|||
130274237|NCT02550288|468967373|FG002|Overall Study|Participant moved|0|||
130274238|NCT02550288|468967374|FG003|Overall Study|Participant moved|1|||
130274239|NCT02550288|468967375|FG004|Overall Study|Participant moved|0|||
130274240|NCT02550288|468967371|FG000|Overall Study|Withdrawal by Subject|0|||
130274241|NCT02550288|468967372|FG001|Overall Study|Withdrawal by Subject|0|||
130274242|NCT02550288|468967373|FG002|Overall Study|Withdrawal by Subject|0|||
130274243|NCT02550288|468967374|FG003|Overall Study|Withdrawal by Subject|1|||
130274244|NCT02550288|468967375|FG004|Overall Study|Withdrawal by Subject|0|||
130274245|NCT00803361|468967377|FG000|Overall Study|Adverse Event|13|||
130274246|NCT00803361|468967378|FG001|Overall Study|Adverse Event|3|||
130274247|NCT00803361|468967377|FG000|Overall Study|Lack of Efficacy|4|||
130274248|NCT00803361|468967378|FG001|Overall Study|Lack of Efficacy|13|||
130274249|NCT00803361|468967377|FG000|Overall Study|Lost to Follow-up|1|||
130274250|NCT00803361|468967378|FG001|Overall Study|Lost to Follow-up|2|||
130274251|NCT00803361|468967377|FG000|Overall Study|Physician Decision|1|||
130274252|NCT00803361|468967378|FG001|Overall Study|Physician Decision|0|||
130274253|NCT00803361|468967377|FG000|Overall Study|Protocol Violation|2|||
130274254|NCT00803361|468967378|FG001|Overall Study|Protocol Violation|4|||
130274255|NCT00803361|468967377|FG000|Overall Study|Withdrawal by Subject|5|||
130274256|NCT00803361|468967378|FG001|Overall Study|Withdrawal by Subject|6|||
130274257|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
130040122|NCT00472303|468102920|FG000|Maintenance Phase|Trial medication non-compliant|0|||
130040123|NCT00472303|468102921|FG001|Maintenance Phase|Trial medication non-compliant|0|||
130040124|NCT00472303|468102922|FG002|Maintenance Phase|Trial medication non-compliant|1|||
130040125|NCT00472303|468102920|FG000|Maintenance Phase|Resolution of pain|0|||
130040126|NCT00472303|468102921|FG001|Maintenance Phase|Resolution of pain|0|||
130040127|NCT00472303|468102922|FG002|Maintenance Phase|Resolution of pain|1|||
130040128|NCT00472303|468102920|FG000|Maintenance Phase|Other|1|||
130040129|NCT00472303|468102921|FG001|Maintenance Phase|Other|1|||
130274258|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
130274259|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
130040130|NCT00472303|468102922|FG002|Maintenance Phase|Other|0|||
130274260|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
130040131|NCT03596164|468102932|FG000|Overall Study|Adverse Event|0|||
130274261|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
130274262|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
130274263|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274264|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274265|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274266|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
130274267|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274268|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
130274269|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274270|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
130274271|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274272|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274273|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274274|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
130274275|NCT03629223|468967379|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274276|NCT03629223|468967380|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
130274277|NCT03629223|468967381|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274278|NCT03629223|468967382|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274279|NCT03629223|468967383|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274280|NCT03629223|468967384|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
130274281|NCT03629223|468967379|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
130274282|NCT03629223|468967380|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274283|NCT03629223|468967381|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274284|NCT03629223|468967382|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274285|NCT03629223|468967383|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274286|NCT03629223|468967384|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
130274287|NCT01534351|468967385|FG000|Overall Study|Study Terminated Early|1|||
130274288|NCT01534351|468967386|FG001|Overall Study|Study Terminated Early|0|||
130274289|NCT01534351|468967387|FG002|Overall Study|Study Terminated Early|0|||
130274290|NCT02702609|468967388|FG000|Overall Study|Lost to Follow-up|8|||
130274291|NCT02702609|468967389|FG001|Overall Study|Lost to Follow-up|4|||
130274292|NCT02702609|468967388|FG000|Overall Study|Physician Decision|1|||
130274293|NCT02702609|468967389|FG001|Overall Study|Physician Decision|0|||
130274294|NCT02674464|468967390|FG000|Overall Study|Death|10|||
130274295|NCT02674464|468967391|FG001|Overall Study|Death|21|||
130274296|NCT02674464|468967390|FG000|Overall Study|Withdrawal by Subject|24|||
130274297|NCT02674464|468967391|FG001|Overall Study|Withdrawal by Subject|44|||
130274298|NCT02674464|468967390|FG000|Overall Study|Lost to Follow-up|97|||
130274299|NCT02674464|468967391|FG001|Overall Study|Lost to Follow-up|92|||
130274300|NCT02674464|468967390|FG000|Overall Study|Outside survey window|6|||
130274301|NCT02674464|468967391|FG001|Overall Study|Outside survey window|3|||
130274302|NCT00783835|468967392|FG000|Overall Study|Adverse Event|3|||
130274303|NCT00783835|468967392|FG000|Overall Study|Medical Criteria|1|||
130274304|NCT00783835|468967392|FG000|Overall Study|Withdrawal by Subject|2|||
130274305|NCT00783835|468967392|FG000|Overall Study|Lost to Follow-up|1|||
130274306|NCT00783835|468967392|FG000|Overall Study|Participant not Adherent|3|||
130274307|NCT03835481|468967393|FG000|Double-blind Period|Other not stated below|0|||
130274308|NCT03835481|468967394|FG001|Double-blind Period|Other not stated below|0|||
130274309|NCT03835481|468967395|FG002|Double-blind Period|Other not stated below|0|||
130274310|NCT03835481|468967396|FG003|Double-blind Period|Other not stated below|1|||
130274311|NCT03835481|468967397|FG004|Double-blind Period|Other not stated below|1|||
130274312|NCT03835481|468967393|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
130274313|NCT03835481|468967394|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
130274314|NCT03835481|468967395|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
130274315|NCT03835481|468967396|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
130274316|NCT03835481|468967397|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
130274317|NCT03835481|468967393|FG000|Double-blind Period|Withdrawal by Subject|0|||
130274318|NCT03835481|468967394|FG001|Double-blind Period|Withdrawal by Subject|0|||
130274319|NCT03835481|468967395|FG002|Double-blind Period|Withdrawal by Subject|1|||
130274320|NCT03835481|468967396|FG003|Double-blind Period|Withdrawal by Subject|0|||
130274321|NCT03835481|468967397|FG004|Double-blind Period|Withdrawal by Subject|5|||
130274322|NCT03835481|468967393|FG000|Double-blind Period|Lost to Follow-up|0|||
130274323|NCT03835481|468967394|FG001|Double-blind Period|Lost to Follow-up|0|||
130274324|NCT03835481|468967395|FG002|Double-blind Period|Lost to Follow-up|0|||
130274325|NCT03835481|468967396|FG003|Double-blind Period|Lost to Follow-up|1|||
130274326|NCT03835481|468967397|FG004|Double-blind Period|Lost to Follow-up|0|||
130274327|NCT03835481|468967393|FG000|Double-blind Period|Protocol Violation|0|||
130274328|NCT03835481|468967394|FG001|Double-blind Period|Protocol Violation|2|||
130274329|NCT03835481|468967395|FG002|Double-blind Period|Protocol Violation|0|||
130274330|NCT03835481|468967396|FG003|Double-blind Period|Protocol Violation|1|||
130274331|NCT03835481|468967397|FG004|Double-blind Period|Protocol Violation|0|||
130274332|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
130104317|NCT02675426|468340993|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
130104318|NCT02675426|468340990|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
130104319|NCT02675426|468340991|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
130104320|NCT02675426|468340992|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
130104321|NCT02675426|468340993|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
130104322|NCT02675426|468340990|FG000|Period 2: Week 12 to Week 260|Other|8|||
130104323|NCT02675426|468340991|FG001|Period 2: Week 12 to Week 260|Other|12|||
130104324|NCT02675426|468340992|FG002|Period 2: Week 12 to Week 260|Other|23|||
130104325|NCT02675426|468340993|FG003|Period 2: Week 12 to Week 260|Other|15|||
130104326|NCT02156466|468340994|FG000|Overall Study|Adverse Event|0|||
130104327|NCT02156466|468340995|FG001|Overall Study|Adverse Event|0|||
130104328|NCT02156466|468340996|FG002|Overall Study|Adverse Event|1|||
130104329|NCT02156466|468340997|FG003|Overall Study|Adverse Event|1|||
130104330|NCT02156466|468340998|FG004|Overall Study|Adverse Event|0|||
130104331|NCT02156466|468340994|FG000|Overall Study|Quantiferon Positivity|0|||
130104332|NCT02156466|468340995|FG001|Overall Study|Quantiferon Positivity|0|||
130104333|NCT02156466|468340996|FG002|Overall Study|Quantiferon Positivity|0|||
130104334|NCT02156466|468340997|FG003|Overall Study|Quantiferon Positivity|1|||
130104335|NCT02156466|468340998|FG004|Overall Study|Quantiferon Positivity|0|||
130104336|NCT02237118|468340999|FG000|Overall Study|Protocol Violation|0|||
130104337|NCT02237118|468341000|FG001|Overall Study|Protocol Violation|1|||
130104338|NCT02237118|468340999|FG000|Overall Study|consent withdrawn|1|||
130104339|NCT02237118|468341000|FG001|Overall Study|consent withdrawn|0|||
130104340|NCT02953262|468341001|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
130104341|NCT02953262|468341002|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
130104342|NCT02953262|468341003|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
130104343|NCT02953262|468341004|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
130104344|NCT03284424|468341005|FG000|Overall Study|Death|70|||
130104345|NCT03284424|468341006|FG001|Overall Study|Death|24|||
130104346|NCT03284424|468341005|FG000|Overall Study|Lost to Follow-up|3|||
130104347|NCT03284424|468341006|FG001|Overall Study|Lost to Follow-up|1|||
130104348|NCT03284424|468341005|FG000|Overall Study|Physician Decision|1|||
130104349|NCT03284424|468341006|FG001|Overall Study|Physician Decision|2|||
130104350|NCT03284424|468341005|FG000|Overall Study|Withdrawal by Subject|4|||
130104351|NCT03284424|468341006|FG001|Overall Study|Withdrawal by Subject|5|||
130104352|NCT03284424|468341005|FG000|Overall Study|Sponsor's decision|27|||
130104353|NCT03284424|468341006|FG001|Overall Study|Sponsor's decision|22|||
130104354|NCT03891875|468341020|FG000|Overall Study|Withdrawal by Subject|20|||
130104355|NCT03891875|468341021|FG001|Overall Study|Withdrawal by Subject|3|||
130104356|NCT03891875|468341020|FG000|Overall Study|Adverse Event|10|||
130104357|NCT03891875|468341021|FG001|Overall Study|Adverse Event|4|||
130104358|NCT03891875|468341020|FG000|Overall Study|Physician Decision|1|||
130104359|NCT03891875|468341021|FG001|Overall Study|Physician Decision|1|||
130104360|NCT03891875|468341020|FG000|Overall Study|Protocol Violation|1|||
130274333|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
130274334|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
130274335|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
130274336|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
130274337|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
130274338|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
130274339|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
130274340|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
130274341|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
130274342|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130274343|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130274344|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
130274345|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
129800258|NCT02445391|467236291|FG001|Overall Study|Adverse Event|21|||
130104361|NCT03891875|468341021|FG001|Overall Study|Protocol Violation|0|||
130104362|NCT03891875|468341020|FG000|Overall Study|Lost to Follow-up|1|||
130104363|NCT03891875|468341021|FG001|Overall Study|Lost to Follow-up|0|||
130104364|NCT03891875|468341020|FG000|Overall Study|COVID-19 infection|1|||
130104365|NCT03891875|468341021|FG001|Overall Study|COVID-19 infection|0|||
130104366|NCT01787188|468341022|FG000|Overall Study|Adverse Event|2|||
130104367|NCT01787188|468341023|FG001|Overall Study|Adverse Event|4|||
130040132|NCT03596164|468102933|FG001|Overall Study|Adverse Event|1|||
130040133|NCT03596164|468102932|FG000|Overall Study|Death|1|||
130040134|NCT03596164|468102933|FG001|Overall Study|Death|0|||
130040135|NCT01873950|468102935|FG000|Period 5|Withdrawal by Subject|0|||
130040136|NCT01873950|468102936|FG001|Period 5|Withdrawal by Subject|0|||
130040137|NCT01873950|468102937|FG002|Period 5|Withdrawal by Subject|0|||
130040138|NCT01873950|468102938|FG003|Period 5|Withdrawal by Subject|1|||
130040139|NCT01873950|468102939|FG004|Period 5|Withdrawal by Subject|0|||
130040140|NCT01254344|468102940|FG000|Overall Study|Adverse Event|2|||
130040141|NCT01254344|468102941|FG001|Overall Study|Adverse Event|5|||
130040142|NCT01254344|468102940|FG000|Overall Study|Physician Decision|7|||
130040143|NCT01254344|468102941|FG001|Overall Study|Physician Decision|4|||
130040144|NCT01254344|468102940|FG000|Overall Study|Protocol Violation|1|||
130040145|NCT01254344|468102941|FG001|Overall Study|Protocol Violation|4|||
130040146|NCT01254344|468102940|FG000|Overall Study|Withdrawal by Subject|3|||
130040147|NCT01254344|468102941|FG001|Overall Study|Withdrawal by Subject|6|||
130040148|NCT03022461|468102942|FG000|Overall Study|Death|3|||
130040149|NCT03459040|468102943|FG000|Overall Study|Death|8|||
130040150|NCT03459040|468102943|FG000|Overall Study|Withdrawal by Subject|1|||
130040151|NCT00986349|468102946|FG000|Overall Study|Unsuccessful implant procedure|3|||
130040152|NCT00986349|468102946|FG000|Overall Study|Adverse Event|2|||
130040153|NCT00986349|468102946|FG000|Overall Study|Physician Decision|1|||
130040154|NCT00986349|468102946|FG000|Overall Study|device migration|1|||
130040155|NCT02299934|468102947|FG000|Overall Study|Termination of study|13|||
130040156|NCT00561353|468102948|FG000|Overall Study|Subject reached a virologic endpoint|2|||
130040157|NCT00561353|468102949|FG001|Overall Study|Subject reached a virologic endpoint|1|||
130040158|NCT00561353|468102950|FG002|Overall Study|Subject reached a virologic endpoint|1|||
130040159|NCT00561353|468102951|FG003|Overall Study|Subject reached a virologic endpoint|4|||
130040160|NCT00561353|468102952|FG004|Overall Study|Subject reached a virologic endpoint|1|||
130040161|NCT00561353|468102953|FG005|Overall Study|Subject reached a virologic endpoint|3|||
130040162|NCT00561353|468102954|FG006|Overall Study|Subject reached a virologic endpoint|4|||
130040163|NCT00561353|468102955|FG007|Overall Study|Subject reached a virologic endpoint|4|||
130040164|NCT00561353|468102956|FG008|Overall Study|Subject reached a virologic endpoint|5|||
130040165|NCT00561353|468102957|FG009|Overall Study|Subject reached a virologic endpoint|0|||
129886275|NCT02061761|467542932|FG001|Overall Study|Withdrawal by Subject|0|||
129886276|NCT02061761|467542933|FG002|Overall Study|Withdrawal by Subject|0|||
130104368|NCT01787188|468341024|FG002|Overall Study|Adverse Event|6|||
130104369|NCT01787188|468341022|FG000|Overall Study|Lack of Efficacy|7|||
130104370|NCT01787188|468341023|FG001|Overall Study|Lack of Efficacy|3|||
130274346|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
130274347|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
130274348|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
130274349|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
130274350|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
130274351|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
130274352|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274353|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274354|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274355|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
130274356|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
130274357|NCT03835481|468967393|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
130274358|NCT03835481|468967394|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
130274359|NCT03835481|468967395|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
130274360|NCT03835481|468967396|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
130274361|NCT03835481|468967397|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
130274362|NCT00255723|468967400|FG000|Overall Study|Adverse Event|1|||
130274363|NCT00255723|468967401|FG001|Overall Study|Adverse Event|1|||
130274364|NCT00255723|468967400|FG000|Overall Study|Death|0|||
130274365|NCT00255723|468967401|FG001|Overall Study|Death|1|||
130274366|NCT00255723|468967400|FG000|Overall Study|Response Data Not Available|1|||
130274367|NCT00255723|468967401|FG001|Overall Study|Response Data Not Available|0|||
130274368|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
130274369|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
130274370|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
130274371|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
130274372|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
130274373|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
130274374|NCT00191945|468967402|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
130274375|NCT00191945|468967403|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
130274376|NCT01169701|468967417|FG000|Overall Study|Lost to Follow-up|1|||
130274377|NCT01169701|468967418|FG001|Overall Study|Lost to Follow-up|1|||
130274378|NCT01169701|468967417|FG000|Overall Study|Withdrawal by Subject|1|||
130274379|NCT01169701|468967418|FG001|Overall Study|Withdrawal by Subject|3|||
130274380|NCT01169701|468967417|FG000|Overall Study|Adverse Event|1|||
130274381|NCT01169701|468967418|FG001|Overall Study|Adverse Event|2|||
130274382|NCT01169701|468967417|FG000|Overall Study|Exclusion criteria|2|||
130274383|NCT01169701|468967418|FG001|Overall Study|Exclusion criteria|0|||
130274384|NCT01169701|468967417|FG000|Overall Study|Death|0|||
130274385|NCT01169701|468967418|FG001|Overall Study|Death|1|||
130274386|NCT01169701|468967417|FG000|Overall Study|Administrative problems|0|||
130274387|NCT01169701|468967418|FG001|Overall Study|Administrative problems|1|||
130274388|NCT01169701|468967417|FG000|Overall Study|Serious adverse event|0|||
130274389|NCT01169701|468967418|FG001|Overall Study|Serious adverse event|1|||
130274390|NCT01169701|468967417|FG000|Overall Study|Sponsor decision|0|||
130274391|NCT01169701|468967418|FG001|Overall Study|Sponsor decision|1|||
130274392|NCT00564902|468967419|FG000|Overall Study|Withdrawal by Subject|0|||
130104371|NCT01787188|468341024|FG002|Overall Study|Lack of Efficacy|5|||
130104372|NCT01787188|468341022|FG000|Overall Study|Non-compliance with Study Drug|0|||
130104373|NCT01787188|468341023|FG001|Overall Study|Non-compliance with Study Drug|1|||
130104374|NCT01787188|468341024|FG002|Overall Study|Non-compliance with Study Drug|0|||
130274393|NCT00564902|468967420|FG001|Overall Study|Withdrawal by Subject|3|||
130274394|NCT00564902|468967421|FG002|Overall Study|Withdrawal by Subject|4|||
130274395|NCT00564902|468967419|FG000|Overall Study|Death|1|||
130274396|NCT00564902|468967420|FG001|Overall Study|Death|1|||
130274397|NCT00564902|468967421|FG002|Overall Study|Death|0|||
130274398|NCT03583359|468967424|FG000|Overall Study|Withdrawal by Subject|15|||
130274399|NCT03583359|468967425|FG001|Overall Study|Withdrawal by Subject|6|||
129886277|NCT02061761|467542934|FG003|Overall Study|Withdrawal by Subject|0|||
130274400|NCT03583359|468967424|FG000|Overall Study|Lost to Follow-up|12|||
130274401|NCT03583359|468967425|FG001|Overall Study|Lost to Follow-up|3|||
130274402|NCT03583359|468967424|FG000|Overall Study|Adverse Event|0|||
130274403|NCT03583359|468967425|FG001|Overall Study|Adverse Event|1|||
130274404|NCT03583359|468967424|FG000|Overall Study|Protocol Violation|0|||
130274405|NCT03583359|468967425|FG001|Overall Study|Protocol Violation|1|||
130040166|NCT00561353|468102948|FG000|Overall Study|Subject ineligible to continue the trial|0|||
130040167|NCT00561353|468102949|FG001|Overall Study|Subject ineligible to continue the trial|0|||
130040168|NCT00561353|468102950|FG002|Overall Study|Subject ineligible to continue the trial|0|||
130040169|NCT00561353|468102951|FG003|Overall Study|Subject ineligible to continue the trial|0|||
130040170|NCT00561353|468102952|FG004|Overall Study|Subject ineligible to continue the trial|0|||
130040171|NCT00561353|468102953|FG005|Overall Study|Subject ineligible to continue the trial|1|||
130040172|NCT00561353|468102954|FG006|Overall Study|Subject ineligible to continue the trial|1|||
130040173|NCT00561353|468102955|FG007|Overall Study|Subject ineligible to continue the trial|0|||
130040174|NCT00561353|468102956|FG008|Overall Study|Subject ineligible to continue the trial|2|||
130040175|NCT00561353|468102957|FG009|Overall Study|Subject ineligible to continue the trial|1|||
130040176|NCT00561353|468102948|FG000|Overall Study|Other|1|||
130040177|NCT00561353|468102949|FG001|Overall Study|Other|0|||
130040178|NCT00561353|468102950|FG002|Overall Study|Other|1|||
130040179|NCT00561353|468102951|FG003|Overall Study|Other|0|||
130040180|NCT00561353|468102952|FG004|Overall Study|Other|0|||
130040181|NCT00561353|468102953|FG005|Overall Study|Other|2|||
130040182|NCT00561353|468102954|FG006|Overall Study|Other|0|||
130040183|NCT00561353|468102955|FG007|Overall Study|Other|0|||
130040184|NCT00561353|468102956|FG008|Overall Study|Other|0|||
130040185|NCT00561353|468102957|FG009|Overall Study|Other|0|||
130040186|NCT00561353|468102948|FG000|Overall Study|Adverse Event|0|||
130040187|NCT00561353|468102949|FG001|Overall Study|Adverse Event|0|||
130040188|NCT00561353|468102950|FG002|Overall Study|Adverse Event|0|||
130040189|NCT00561353|468102951|FG003|Overall Study|Adverse Event|2|||
130040190|NCT00561353|468102952|FG004|Overall Study|Adverse Event|0|||
130040191|NCT00561353|468102953|FG005|Overall Study|Adverse Event|0|||
130040192|NCT00561353|468102954|FG006|Overall Study|Adverse Event|1|||
130040193|NCT00561353|468102955|FG007|Overall Study|Adverse Event|0|||
130040194|NCT00561353|468102956|FG008|Overall Study|Adverse Event|0|||
130274406|NCT03583359|468967424|FG000|Overall Study|Other|2|||
130274407|NCT03583359|468967425|FG001|Overall Study|Other|1|||
130274408|NCT00375505|468967426|FG000|Overall Study|Adverse Event|1|||
130274409|NCT00375505|468967427|FG001|Overall Study|Adverse Event|2|||
130274410|NCT02470585|468967428|FG000|Overall Study|Death|224|||
130274411|NCT02470585|468967429|FG001|Overall Study|Death|227|||
130274412|NCT02470585|468967430|FG002|Overall Study|Death|199|||
130274413|NCT02470585|468967428|FG000|Overall Study|Withdrew consent|21|||
130274414|NCT02470585|468967429|FG001|Overall Study|Withdrew consent|22|||
130274415|NCT02470585|468967430|FG002|Overall Study|Withdrew consent|31|||
130274416|NCT02470585|468967428|FG000|Overall Study|Lost to Follow-up|8|||
130274417|NCT02470585|468967429|FG001|Overall Study|Lost to Follow-up|15|||
130274418|NCT02470585|468967430|FG002|Overall Study|Lost to Follow-up|13|||
130274419|NCT02470585|468967428|FG000|Overall Study|Sponsor discontinued study|117|||
130274420|NCT02470585|468967429|FG001|Overall Study|Sponsor discontinued study|110|||
130274421|NCT02470585|468967430|FG002|Overall Study|Sponsor discontinued study|122|||
130274422|NCT02470585|468967428|FG000|Overall Study|Other, not specified|5|||
130274423|NCT02470585|468967429|FG001|Overall Study|Other, not specified|7|||
130274424|NCT02470585|468967430|FG002|Overall Study|Other, not specified|14|||
130274425|NCT02470585|468967428|FG000|Overall Study|Missing due to site non-compliance|0|||
130274426|NCT02470585|468967429|FG001|Overall Study|Missing due to site non-compliance|2|||
130274427|NCT02470585|468967430|FG002|Overall Study|Missing due to site non-compliance|3|||
130274428|NCT03497039|468967431|FG000|Overall Study|Withdrawal by Subject|1|||
130274429|NCT03497039|468967432|FG001|Overall Study|Withdrawal by Subject|0|||
130274430|NCT03497039|468967431|FG000|Overall Study|Protocol Violation|0|||
130274431|NCT03497039|468967432|FG001|Overall Study|Protocol Violation|1|||
130274432|NCT02146131|468967433|FG000|Overall Study|Physician Decision|61|||
130274433|NCT02146131|468967434|FG001|Overall Study|Physician Decision|56|||
129886278|NCT02061761|467542935|FG004|Overall Study|Withdrawal by Subject|0|||
130040195|NCT00561353|468102957|FG009|Overall Study|Adverse Event|1|||
130040196|NCT00561353|468102948|FG000|Overall Study|Lost to Follow-up|2|||
130104375|NCT01787188|468341022|FG000|Overall Study|Withdrawal by Subject|4|||
129886279|NCT02061761|467542936|FG005|Overall Study|Withdrawal by Subject|0|||
129886280|NCT02061761|467542937|FG006|Overall Study|Withdrawal by Subject|0|||
130040197|NCT00561353|468102949|FG001|Overall Study|Lost to Follow-up|0|||
130104376|NCT01787188|468341023|FG001|Overall Study|Withdrawal by Subject|3|||
130104377|NCT01787188|468341024|FG002|Overall Study|Withdrawal by Subject|2|||
130274434|NCT00465972|468967437|FG000|Overall Study|Withdrawal by Subject|2|||
130274435|NCT00465972|468967438|FG001|Overall Study|Withdrawal by Subject|1|||
130274436|NCT00861692|468967439|FG000|Overall Study|Death|6|||
130040198|NCT00561353|468102950|FG002|Overall Study|Lost to Follow-up|1|||
130040199|NCT00561353|468102951|FG003|Overall Study|Lost to Follow-up|0|||
130040200|NCT00561353|468102952|FG004|Overall Study|Lost to Follow-up|0|||
130040201|NCT00561353|468102953|FG005|Overall Study|Lost to Follow-up|0|||
130274437|NCT03292640|468967440|FG000|Overall Study|Withdrawal by Subject|17|||
130274438|NCT03292640|468967441|FG001|Overall Study|Withdrawal by Subject|16|||
130274439|NCT03292640|468967440|FG000|Overall Study|Adverse Event|20|||
130274440|NCT03292640|468967441|FG001|Overall Study|Adverse Event|2|||
130040202|NCT00561353|468102954|FG006|Overall Study|Lost to Follow-up|0|||
130274441|NCT03292640|468967440|FG000|Overall Study|Lost to Follow-up|24|||
130274442|NCT03292640|468967441|FG001|Overall Study|Lost to Follow-up|24|||
130274443|NCT02218697|468967442|FG000|Overall Study|Adverse Event|0|||
130274444|NCT02218697|468967443|FG001|Overall Study|Adverse Event|2|||
130274445|NCT02218697|468967442|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
130274446|NCT02218697|468967443|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
130274447|NCT02218697|468967442|FG000|Overall Study|Withdrawal by Subject|2|||
130274448|NCT02218697|468967443|FG001|Overall Study|Withdrawal by Subject|3|||
130274449|NCT04380753|468967444|FG000|Overall Study|Participants continuing study|4|||
130274450|NCT04380753|468967444|FG000|Overall Study|Death|2|||
130274451|NCT03306433|468967447|FG000|Overall Study|Lost to Follow-up|3|||
130274452|NCT03306433|468967447|FG000|Overall Study|Patient did not have teeth extracted|1|||
130274453|NCT03306433|468967447|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
130274454|NCT01597908|468967448|FG000|Randomized Phase|Death|217|||
130274455|NCT01597908|468967449|FG001|Randomized Phase|Death|238|||
130274456|NCT01597908|468967450|FG002|Randomized Phase|Death|0|||
130274457|NCT01597908|468967448|FG000|Randomized Phase|Sponsor Decision|93|||
130274458|NCT01597908|468967449|FG001|Randomized Phase|Sponsor Decision|39|||
130274459|NCT01597908|468967450|FG002|Randomized Phase|Sponsor Decision|0|||
130274460|NCT01597908|468967448|FG000|Randomized Phase|Lost to Follow-up|9|||
130274461|NCT01597908|468967449|FG001|Randomized Phase|Lost to Follow-up|16|||
130274462|NCT01597908|468967450|FG002|Randomized Phase|Lost to Follow-up|0|||
130274463|NCT01597908|468967448|FG000|Randomized Phase|Physician Decision|6|||
130274464|NCT01597908|468967449|FG001|Randomized Phase|Physician Decision|3|||
130274465|NCT01597908|468967450|FG002|Randomized Phase|Physician Decision|0|||
130274466|NCT01597908|468967448|FG000|Randomized Phase|Withdrawal by Subject|26|||
130274467|NCT01597908|468967449|FG001|Randomized Phase|Withdrawal by Subject|22|||
130274468|NCT01597908|468967450|FG002|Randomized Phase|Withdrawal by Subject|0|||
130274469|NCT01597908|468967448|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
130040203|NCT00561353|468102955|FG007|Overall Study|Lost to Follow-up|0|||
130040204|NCT00561353|468102956|FG008|Overall Study|Lost to Follow-up|0|||
130040205|NCT00561353|468102957|FG009|Overall Study|Lost to Follow-up|0|||
130040206|NCT00561353|468102948|FG000|Overall Study|Withdrawal by Subject|0|||
130040207|NCT00561353|468102949|FG001|Overall Study|Withdrawal by Subject|2|||
130040208|NCT00561353|468102950|FG002|Overall Study|Withdrawal by Subject|0|||
130040209|NCT00561353|468102951|FG003|Overall Study|Withdrawal by Subject|0|||
130040210|NCT00561353|468102952|FG004|Overall Study|Withdrawal by Subject|0|||
130040211|NCT00561353|468102953|FG005|Overall Study|Withdrawal by Subject|0|||
130040212|NCT00561353|468102954|FG006|Overall Study|Withdrawal by Subject|0|||
130040213|NCT00561353|468102955|FG007|Overall Study|Withdrawal by Subject|0|||
130040214|NCT00561353|468102956|FG008|Overall Study|Withdrawal by Subject|0|||
130040215|NCT00561353|468102957|FG009|Overall Study|Withdrawal by Subject|0|||
130104378|NCT01787188|468341022|FG000|Overall Study|Protocol Violation|3|||
130104379|NCT01787188|468341023|FG001|Overall Study|Protocol Violation|2|||
130104380|NCT01787188|468341024|FG002|Overall Study|Protocol Violation|3|||
130274470|NCT01597908|468967449|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
130274471|NCT01597908|468967450|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
130274472|NCT01597908|468967448|FG000|Crossover Phase|Death|0|||
130274473|NCT01597908|468967449|FG001|Crossover Phase|Death|0|||
130274474|NCT01597908|468967450|FG002|Crossover Phase|Death|11|||
130274475|NCT01597908|468967448|FG000|Crossover Phase|Withdrawal by Subject|0|||
130274476|NCT01597908|468967449|FG001|Crossover Phase|Withdrawal by Subject|0|||
130274477|NCT01597908|468967450|FG002|Crossover Phase|Withdrawal by Subject|3|||
130274478|NCT01597908|468967448|FG000|Crossover Phase|Sponsor Decision|0|||
130274479|NCT01597908|468967449|FG001|Crossover Phase|Sponsor Decision|0|||
130274480|NCT01597908|468967450|FG002|Crossover Phase|Sponsor Decision|20|||
130274481|NCT02709577|468967451|FG000|Overall Study|non-accommodating anatomy|0|||
130274482|NCT02709577|468967452|FG001|Overall Study|non-accommodating anatomy|1|||
130274483|NCT02709577|468967453|FG002|Overall Study|non-accommodating anatomy|0|||
130274484|NCT02709577|468967454|FG003|Overall Study|non-accommodating anatomy|0|||
130274485|NCT02709577|468967451|FG000|Overall Study|procedural complication|0|||
130274486|NCT02709577|468967452|FG001|Overall Study|procedural complication|1|||
130274487|NCT02709577|468967453|FG002|Overall Study|procedural complication|0|||
130274488|NCT02709577|468967454|FG003|Overall Study|procedural complication|0|||
130274489|NCT02709577|468967451|FG000|Overall Study|Withdrawal by Subject|2|||
130274490|NCT02709577|468967452|FG001|Overall Study|Withdrawal by Subject|3|||
130274491|NCT02709577|468967453|FG002|Overall Study|Withdrawal by Subject|2|||
130274492|NCT02709577|468967454|FG003|Overall Study|Withdrawal by Subject|0|||
130274493|NCT00948857|468969196|FG000|Overall Study|Lost to Follow-up|1|||
130274494|NCT00948857|468969197|FG001|Overall Study|Lost to Follow-up|0|||
130274495|NCT02120781|468969202|FG000|Overall Study|Physician Decision|2|||
130274496|NCT02120781|468969203|FG001|Overall Study|Physician Decision|0|||
130274497|NCT02120781|468969202|FG000|Overall Study|Completion not documented|2|||
130274498|NCT02120781|468969203|FG001|Overall Study|Completion not documented|1|||
130274499|NCT00654745|468969206|FG000|Overall Study|Adverse Event|12|||
130040216|NCT01273818|468102958|FG000|Overall Study|Physician Decision|13|||
130040217|NCT01273818|468102959|FG001|Overall Study|Physician Decision|2|||
130040218|NCT01273818|468102960|FG002|Overall Study|Physician Decision|9|||
130040219|NCT03822468|468102961|FG000|Treatment Period|Progressive disease|98|||
130040220|NCT03822468|468102962|FG001|Treatment Period|Progressive disease|94|||
130040221|NCT03822468|468102961|FG000|Treatment Period|Adverse Event|21|||
130040222|NCT03822468|468102962|FG001|Treatment Period|Adverse Event|24|||
130040223|NCT03822468|468102961|FG000|Treatment Period|Withdrawal by Subject|9|||
130040224|NCT03822468|468102962|FG001|Treatment Period|Withdrawal by Subject|5|||
130040225|NCT03822468|468102961|FG000|Treatment Period|Physician Decision|9|||
130040226|NCT03822468|468102962|FG001|Treatment Period|Physician Decision|7|||
130040227|NCT03822468|468102961|FG000|Treatment Period|Protocol Violation|2|||
130040228|NCT03822468|468102962|FG001|Treatment Period|Protocol Violation|1|||
130040229|NCT03822468|468102961|FG000|Treatment Period|Death|2|||
130040230|NCT03822468|468102962|FG001|Treatment Period|Death|3|||
130040231|NCT03822468|468102961|FG000|Treatment Period|Lost to Follow-up|1|||
130040232|NCT03822468|468102962|FG001|Treatment Period|Lost to Follow-up|1|||
130040233|NCT03822468|468102961|FG000|Treatment Period|Sponsor decision|46|||
130040234|NCT03822468|468102962|FG001|Treatment Period|Sponsor decision|53|||
130040235|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
130040236|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
130040237|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
130040238|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
130040239|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Death|1|||
130040240|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Death|0|||
130274500|NCT00654745|468969206|FG000|Overall Study|Lost to Follow-up|7|||
130274501|NCT00654745|468969206|FG000|Overall Study|Protocol Violation|11|||
130040241|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130040242|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130040243|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
130040244|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
130040245|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
130040246|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
130040247|NCT03822468|468102961|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
130274502|NCT00654745|468969206|FG000|Overall Study|Withdrawal by Subject|10|||
130274503|NCT00654745|468969206|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
130274504|NCT00984165|468969207|FG000|Overall Study|Death on study|2|||
130274505|NCT00984165|468969208|FG001|Overall Study|Death on study|0|||
130274506|NCT00984165|468969209|FG002|Overall Study|Death on study|0|||
130274507|NCT00984165|468969210|FG003|Overall Study|Death on study|0|||
130274508|NCT00984165|468969207|FG000|Overall Study|Disease progression on study|5|||
130274509|NCT00984165|468969208|FG001|Overall Study|Disease progression on study|1|||
130274510|NCT00984165|468969209|FG002|Overall Study|Disease progression on study|0|||
130040248|NCT03822468|468102962|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
130040249|NCT02117687|468102963|FG000|Overall Study|Lost to Follow-up|0|||
130040250|NCT02117687|468102964|FG001|Overall Study|Lost to Follow-up|1|||
130040251|NCT02117687|468102963|FG000|Overall Study|Adverse Event|0|||
130040252|NCT02117687|468102964|FG001|Overall Study|Adverse Event|2|||
130040253|NCT02117687|468102963|FG000|Overall Study|Other Reasons|1|||
130040254|NCT02117687|468102964|FG001|Overall Study|Other Reasons|1|||
130040255|NCT03528681|468104932|FG000|Open-Label Phase|Physician Decision|2|||
130040256|NCT03528681|468104933|FG001|Open-Label Phase|Physician Decision|0|||
130040257|NCT03528681|468104934|FG002|Open-Label Phase|Physician Decision|0|||
130040258|NCT03528681|468104935|FG003|Open-Label Phase|Physician Decision|0|||
130040259|NCT03528681|468104932|FG000|Open-Label Phase|Withdrawal by Subject|8|||
130040260|NCT03528681|468104933|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130040261|NCT03528681|468104934|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130040262|NCT03528681|468104935|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130040263|NCT03528681|468104932|FG000|Open-Label Phase|(Not collected)|4|||
130040264|NCT03528681|468104933|FG001|Open-Label Phase|(Not collected)|0|||
130040265|NCT03528681|468104934|FG002|Open-Label Phase|(Not collected)|0|||
130040266|NCT03528681|468104935|FG003|Open-Label Phase|(Not collected)|0|||
130040267|NCT03528681|468104932|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
130040268|NCT03528681|468104933|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
130040269|NCT03528681|468104934|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
130040270|NCT03528681|468104935|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
130040271|NCT03528681|468104932|FG000|Randomized Treatment Phase|Physician Decision|0|||
130040272|NCT03528681|468104933|FG001|Randomized Treatment Phase|Physician Decision|5|||
130040273|NCT03528681|468104934|FG002|Randomized Treatment Phase|Physician Decision|1|||
130040274|NCT03528681|468104935|FG003|Randomized Treatment Phase|Physician Decision|2|||
130040275|NCT03528681|468104932|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
130274511|NCT00984165|468969210|FG003|Overall Study|Disease progression on study|0|||
130274512|NCT00984165|468969207|FG000|Overall Study|Death of recipient|0|||
130274513|NCT00984165|468969208|FG001|Overall Study|Death of recipient|0|||
130274514|NCT00984165|468969209|FG002|Overall Study|Death of recipient|0|||
130104381|NCT01787188|468341022|FG000|Overall Study|Lost to Follow-up|1|||
130104382|NCT01787188|468341023|FG001|Overall Study|Lost to Follow-up|2|||
130104383|NCT01787188|468341024|FG002|Overall Study|Lost to Follow-up|2|||
129886281|NCT02061761|467542938|FG007|Overall Study|Withdrawal by Subject|0|||
129886282|NCT02061761|467542939|FG008|Overall Study|Withdrawal by Subject|2|||
129886283|NCT02061761|467542931|FG000|Overall Study|Maximum clinical benefit|0|||
129886284|NCT02061761|467542932|FG001|Overall Study|Maximum clinical benefit|0|||
129886285|NCT02061761|467542933|FG002|Overall Study|Maximum clinical benefit|0|||
129886286|NCT02061761|467542934|FG003|Overall Study|Maximum clinical benefit|1|||
129886287|NCT02061761|467542935|FG004|Overall Study|Maximum clinical benefit|0|||
129886288|NCT02061761|467542936|FG005|Overall Study|Maximum clinical benefit|0|||
129886289|NCT02061761|467542937|FG006|Overall Study|Maximum clinical benefit|0|||
129886290|NCT02061761|467542938|FG007|Overall Study|Maximum clinical benefit|0|||
129886291|NCT02061761|467542939|FG008|Overall Study|Maximum clinical benefit|6|||
129886292|NCT02061761|467542931|FG000|Overall Study|Participant no longer meets study criteria|0|||
129886293|NCT02061761|467542932|FG001|Overall Study|Participant no longer meets study criteria|0|||
129886294|NCT02061761|467542933|FG002|Overall Study|Participant no longer meets study criteria|0|||
129886295|NCT02061761|467542934|FG003|Overall Study|Participant no longer meets study criteria|0|||
129886296|NCT02061761|467542935|FG004|Overall Study|Participant no longer meets study criteria|0|||
129886297|NCT02061761|467542936|FG005|Overall Study|Participant no longer meets study criteria|0|||
129886298|NCT02061761|467542937|FG006|Overall Study|Participant no longer meets study criteria|0|||
129886299|NCT02061761|467542938|FG007|Overall Study|Participant no longer meets study criteria|0|||
129886300|NCT02061761|467542939|FG008|Overall Study|Participant no longer meets study criteria|1|||
129886301|NCT02061761|467542931|FG000|Overall Study|Other reasons|0|||
129886302|NCT02061761|467542932|FG001|Overall Study|Other reasons|0|||
129886303|NCT02061761|467542933|FG002|Overall Study|Other reasons|0|||
129886304|NCT02061761|467542934|FG003|Overall Study|Other reasons|0|||
129886305|NCT02061761|467542935|FG004|Overall Study|Other reasons|2|||
129886306|NCT02061761|467542936|FG005|Overall Study|Other reasons|0|||
129886307|NCT02061761|467542937|FG006|Overall Study|Other reasons|0|||
129886308|NCT02061761|467542938|FG007|Overall Study|Other reasons|0|||
130104384|NCT01787188|468341022|FG000|Overall Study|Other, including patient moved|0|||
130104385|NCT01787188|468341023|FG001|Overall Study|Other, including patient moved|3|||
130104386|NCT01787188|468341024|FG002|Overall Study|Other, including patient moved|0|||
129886309|NCT02061761|467542939|FG008|Overall Study|Other reasons|6|||
130104387|NCT05349188|468341027|FG000|Overall Study|Withdrawal by Subject|1|||
130104388|NCT05349188|468341028|FG001|Overall Study|Withdrawal by Subject|0|||
130104389|NCT02756078|468341029|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
130040276|NCT03528681|468104933|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
130040277|NCT03528681|468104934|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
130040278|NCT03528681|468104935|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
130040279|NCT03528681|468104932|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
130040280|NCT03528681|468104933|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
130040281|NCT03528681|468104934|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
130040282|NCT03528681|468104935|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
130040283|NCT03528681|468104932|FG000|Randomized Treatment Phase|(Not collected)|0|||
130040284|NCT03528681|468104933|FG001|Randomized Treatment Phase|(Not collected)|4|||
130040285|NCT03528681|468104934|FG002|Randomized Treatment Phase|(Not collected)|6|||
130040286|NCT03528681|468104935|FG003|Randomized Treatment Phase|(Not collected)|5|||
130040287|NCT00955110|468104936|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
130040288|NCT00955110|468104936|FG000|Treatment Phase|Adverse Event|2|||
130040289|NCT00955110|468104936|FG000|Treatment Phase|Administrative reasons|2|||
130040290|NCT00955110|468104936|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
130040291|NCT00955110|468104936|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
130040292|NCT01416181|468104946|FG000|Part 1|Other|10|||
130040293|NCT01416181|468104947|FG001|Part 1|Other|24|||
130040294|NCT01416181|468104946|FG000|Part 1|Death|0|||
130040295|NCT01416181|468104947|FG001|Part 1|Death|1|||
130040296|NCT01416181|468104946|FG000|Part 1|Investigator Decision|7|||
130040297|NCT01416181|468104947|FG001|Part 1|Investigator Decision|6|||
130040298|NCT01416181|468104946|FG000|Part 1|Withdrawal by Subject|74|||
130040299|NCT01416181|468104947|FG001|Part 1|Withdrawal by Subject|48|||
130040300|NCT01416181|468104946|FG000|Part 1|Lack of Efficacy|16|||
130040301|NCT01416181|468104947|FG001|Part 1|Lack of Efficacy|8|||
130040302|NCT01416181|468104946|FG000|Part 1|Lost to Follow-up|1|||
130040303|NCT01416181|468104947|FG001|Part 1|Lost to Follow-up|1|||
130040304|NCT01416181|468104946|FG000|Part 1|Adverse Event|15|||
130040305|NCT01416181|468104947|FG001|Part 1|Adverse Event|18|||
130040306|NCT01416181|468104946|FG000|Part 1|Ongoing in Follow-Up|14|||
130040307|NCT01416181|468104947|FG001|Part 1|Ongoing in Follow-Up|8|||
130040308|NCT01416181|468104946|FG000|Part 2|Adverse Event|11|||
130040309|NCT01416181|468104947|FG001|Part 2|Adverse Event|4|||
130040310|NCT01416181|468104946|FG000|Part 2|Other|234|||
130274515|NCT00984165|468969210|FG003|Overall Study|Death of recipient|1|||
130274516|NCT00984165|468969207|FG000|Overall Study|New protocol|0|||
130274517|NCT00984165|468969208|FG001|Overall Study|New protocol|0|||
130274518|NCT00984165|468969209|FG002|Overall Study|New protocol|0|||
130274519|NCT00984165|468969210|FG003|Overall Study|New protocol|1|||
130274520|NCT00984165|468969207|FG000|Overall Study|P+/donor pair removed from protocol|0|||
130274521|NCT00984165|468969208|FG001|Overall Study|P+/donor pair removed from protocol|0|||
130040311|NCT01416181|468104947|FG001|Part 2|Other|267|||
130040312|NCT01416181|468104946|FG000|Part 2|Investigator Decision|6|||
130040313|NCT01416181|468104947|FG001|Part 2|Investigator Decision|7|||
130040314|NCT01416181|468104946|FG000|Part 2|Withdrawal by Subject|14|||
130274522|NCT00984165|468969209|FG002|Overall Study|P+/donor pair removed from protocol|0|||
130274523|NCT00984165|468969210|FG003|Overall Study|P+/donor pair removed from protocol|1|||
130274524|NCT00984165|468969207|FG000|Overall Study|removed with a pair recipient|0|||
130274525|NCT00984165|468969208|FG001|Overall Study|removed with a pair recipient|0|||
130040315|NCT01416181|468104947|FG001|Part 2|Withdrawal by Subject|5|||
130274526|NCT00984165|468969209|FG002|Overall Study|removed with a pair recipient|0|||
130274527|NCT00984165|468969210|FG003|Overall Study|removed with a pair recipient|1|||
130274528|NCT00466947|468969211|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
130274529|NCT00466947|468969212|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
130274530|NCT00466947|468969211|FG000|Study End Analysis Period|Adverse Event|35|||
130274531|NCT00466947|468969212|FG001|Study End Analysis Period|Adverse Event|43|||
130274532|NCT00466947|468969211|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
130274533|NCT00466947|468969212|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
130274534|NCT00466947|468969211|FG000|Study End Analysis Period|Physician Decision|29|||
130274535|NCT00466947|468969212|FG001|Study End Analysis Period|Physician Decision|29|||
130274536|NCT00466947|468969211|FG000|Study End Analysis Period|Protocol Violation|9|||
130274537|NCT00466947|468969212|FG001|Study End Analysis Period|Protocol Violation|17|||
130274538|NCT00466947|468969211|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
130274539|NCT00466947|468969212|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
130274540|NCT00466947|468969211|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
130274541|NCT00466947|468969212|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
130274542|NCT00466947|468969211|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
130274543|NCT00466947|468969212|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
130040316|NCT01416181|468104946|FG000|Part 2|Lack of Efficacy|4|||
130040317|NCT01416181|468104947|FG001|Part 2|Lack of Efficacy|1|||
130040318|NCT01416181|468104946|FG000|Part 2|Lost to Follow-up|2|||
130040319|NCT01416181|468104947|FG001|Part 2|Lost to Follow-up|2|||
130040320|NCT02981472|468104948|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
130040321|NCT02981472|468104949|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
130040322|NCT02981472|468104948|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130040323|NCT02981472|468104949|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130040324|NCT02981472|468104948|FG000|Treatment Period|Adverse Event|6|||
130040325|NCT02981472|468104949|FG001|Treatment Period|Adverse Event|1|||
130040326|NCT02981472|468104948|FG000|Treatment Period|Participant withdrew consent|1|||
130040327|NCT02981472|468104949|FG001|Treatment Period|Participant withdrew consent|0|||
130040328|NCT02981472|468104948|FG000|Treatment Period|Lost to Follow-up|0|||
130040329|NCT02981472|468104949|FG001|Treatment Period|Lost to Follow-up|1|||
130040330|NCT00621023|468104952|FG000|Overall Study|Death|5|||
130040331|NCT00621023|468104952|FG000|Overall Study|Follow up discontinued|1|||
130040332|NCT04430348|468104963|FG000|Overall Study|Death|3|||
130040333|NCT04430348|468104964|FG001|Overall Study|Death|2|||
130040334|NCT04430348|468104965|FG002|Overall Study|Death|2|||
130040335|NCT04430348|468104966|FG003|Overall Study|Death|2|||
130040336|NCT04430348|468104967|FG004|Overall Study|Death|2|||
130040337|NCT04430348|468104968|FG005|Overall Study|Death|3|||
130040338|NCT04430348|468104963|FG000|Overall Study|Lost to Follow-up|0|||
130040339|NCT04430348|468104964|FG001|Overall Study|Lost to Follow-up|0|||
130040340|NCT04430348|468104965|FG002|Overall Study|Lost to Follow-up|0|||
130040341|NCT04430348|468104966|FG003|Overall Study|Lost to Follow-up|1|||
130040342|NCT04430348|468104967|FG004|Overall Study|Lost to Follow-up|0|||
130040343|NCT04430348|468104968|FG005|Overall Study|Lost to Follow-up|0|||
130040344|NCT04430348|468104963|FG000|Overall Study|Adverse Event|0|||
130040345|NCT04430348|468104964|FG001|Overall Study|Adverse Event|0|||
130040346|NCT04430348|468104965|FG002|Overall Study|Adverse Event|0|||
130040347|NCT04430348|468104966|FG003|Overall Study|Adverse Event|0|||
130040348|NCT04430348|468104967|FG004|Overall Study|Adverse Event|0|||
130040349|NCT04430348|468104968|FG005|Overall Study|Adverse Event|1|||
130040350|NCT04430348|468104963|FG000|Overall Study|Withdrawal by Subject|0|||
130040351|NCT04430348|468104964|FG001|Overall Study|Withdrawal by Subject|1|||
130040352|NCT04430348|468104965|FG002|Overall Study|Withdrawal by Subject|0|||
130040353|NCT04430348|468104966|FG003|Overall Study|Withdrawal by Subject|0|||
130040354|NCT04430348|468104967|FG004|Overall Study|Withdrawal by Subject|0|||
130040355|NCT04430348|468104968|FG005|Overall Study|Withdrawal by Subject|1|||
130040356|NCT04430348|468104963|FG000|Overall Study|Study Terminated by Sponsor|0|||
130040357|NCT04430348|468104964|FG001|Overall Study|Study Terminated by Sponsor|0|||
130040358|NCT04430348|468104965|FG002|Overall Study|Study Terminated by Sponsor|2|||
130040359|NCT04430348|468104966|FG003|Overall Study|Study Terminated by Sponsor|0|||
130040360|NCT04430348|468104967|FG004|Overall Study|Study Terminated by Sponsor|1|||
130040361|NCT04430348|468104968|FG005|Overall Study|Study Terminated by Sponsor|1|||
130040362|NCT02559505|468104969|FG000|Overall Study|Lost to Follow-up|23|||
130040363|NCT02559505|468104970|FG001|Overall Study|Lost to Follow-up|20|||
130040364|NCT02559505|468104969|FG000|Overall Study|Withdrawal by Subject|4|||
130040365|NCT02559505|468104970|FG001|Overall Study|Withdrawal by Subject|2|||
130040366|NCT00698516|468104971|FG000|Overall Study|Study Termination|2|||
130040367|NCT00698516|468104971|FG000|Overall Study|Withdrawal by Subject|3|||
130040368|NCT00756002|468104982|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
130040369|NCT00756002|468104983|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130040370|NCT00756002|468104982|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130040371|NCT00756002|468104983|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130040372|NCT00756002|468104982|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
130040373|NCT00756002|468104983|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
130274544|NCT00466947|468969211|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
130274545|NCT00466947|468969212|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
130274546|NCT01995526|468969213|FG000|Overall Study|Physician Decision|1|||
130040374|NCT00756002|468104982|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
130040375|NCT00756002|468104983|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
130040376|NCT00756002|468104982|FG000|Double-Blind Treatment Period|Other|2|||
130040377|NCT00756002|468104983|FG001|Double-Blind Treatment Period|Other|2|||
130040378|NCT01121406|468104992|FG000|Overall Study|Progressive disease RECIST|44|||
130040379|NCT01121406|468104993|FG001|Overall Study|Progressive disease RECIST|28|||
130040380|NCT01121406|468104992|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
130040381|NCT01121406|468104993|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
130040382|NCT01121406|468104992|FG000|Overall Study|Other AE|3|||
130040383|NCT01121406|468104993|FG001|Overall Study|Other AE|10|||
130040384|NCT01121406|468104992|FG000|Overall Study|Non-compliant with protocol|0|||
130274547|NCT02229825|468969219|FG000|Overall Study|Personal Reasons|0|||
129886310|NCT00903786|467542946|FG000|Overall Study|Physician Decision|6|||
129886311|NCT00903786|467542946|FG000|Overall Study|Lack of Efficacy|5|||
129886312|NCT00903786|467542946|FG000|Overall Study|Reason other than lack of efficacy|4|||
129886313|NCT01163747|467542951|FG000|Overall Study|Adverse Event|0|||
129886314|NCT01163747|467542952|FG001|Overall Study|Adverse Event|5|||
129886315|NCT01163747|467542951|FG000|Overall Study|Insufficient Therapeutic Response|0|||
129886316|NCT01163747|467542952|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129886317|NCT01163747|467542951|FG000|Overall Study|Protocol Violation|0|||
129886318|NCT01163747|467542952|FG001|Overall Study|Protocol Violation|1|||
129886319|NCT01163747|467542951|FG000|Overall Study|Refused Treatment|6|||
129886320|NCT01163747|467542952|FG001|Overall Study|Refused Treatment|4|||
130274548|NCT02229825|468969220|FG001|Overall Study|Personal Reasons|1|||
130274549|NCT02229825|468969219|FG000|Overall Study|Refused continuing medication|7|||
130274550|NCT02229825|468969220|FG001|Overall Study|Refused continuing medication|6|||
130274551|NCT02229825|468969219|FG000|Overall Study|Lost to Follow-up|1|||
130274552|NCT02229825|468969220|FG001|Overall Study|Lost to Follow-up|2|||
130274553|NCT02229825|468969219|FG000|Overall Study|Protocol Violation|1|||
130274554|NCT02229825|468969220|FG001|Overall Study|Protocol Violation|1|||
130274555|NCT02229825|468969219|FG000|Overall Study|Lack of Efficacy|4|||
130274556|NCT02229825|468969220|FG001|Overall Study|Lack of Efficacy|10|||
130274557|NCT02229825|468969219|FG000|Overall Study|Adverse Event|11|||
130274558|NCT02229825|468969220|FG001|Overall Study|Adverse Event|9|||
130274559|NCT02229825|468969219|FG000|Overall Study|Not treated|0|||
130274560|NCT02229825|468969220|FG001|Overall Study|Not treated|1|||
129886321|NCT03363659|467542953|FG000|Overall Study|Adverse Event|1|||
129886322|NCT03363659|467542953|FG000|Overall Study|Screen fail|1|||
129886323|NCT03363659|467542953|FG000|Overall Study|Withdrawal by Subject|1|||
129886324|NCT03872388|467542954|FG000|Overall Study|Disease Progression|0|||
129886325|NCT03872388|467542955|FG001|Overall Study|Disease Progression|0|||
129886326|NCT03872388|467542956|FG002|Overall Study|Disease Progression|0|||
129886327|NCT03872388|467542957|FG003|Overall Study|Disease Progression|0|||
129886328|NCT03872388|467542958|FG004|Overall Study|Disease Progression|0|||
129886329|NCT03872388|467542959|FG005|Overall Study|Disease Progression|0|||
129886330|NCT03872388|467542960|FG006|Overall Study|Disease Progression|1|||
129886331|NCT03872388|467542961|FG007|Overall Study|Disease Progression|1|||
129886332|NCT03681639|467545554|FG000|Overall Study|Death|4|||
129886333|NCT03681639|467545554|FG000|Overall Study|Lost to Follow-up|2|||
130040385|NCT01121406|468104993|FG001|Overall Study|Non-compliant with protocol|2|||
130040386|NCT01121406|468104992|FG000|Overall Study|Lost to Follow-up|0|||
130040387|NCT01121406|468104993|FG001|Overall Study|Lost to Follow-up|1|||
130040388|NCT01121406|468104992|FG000|Overall Study|Refused continuation of study med.|1|||
130040389|NCT01121406|468104993|FG001|Overall Study|Refused continuation of study med.|2|||
130040390|NCT01121406|468104992|FG000|Overall Study|Reason other than specified above|2|||
130040391|NCT01121406|468104993|FG001|Overall Study|Reason other than specified above|6|||
130040392|NCT01121406|468104992|FG000|Overall Study|Not treated|1|||
130040393|NCT01121406|468104993|FG001|Overall Study|Not treated|0|||
130040394|NCT00892437|468104994|FG000|Randomized Phase|Randomized but not treated|6|||
130040395|NCT00892437|468104995|FG001|Randomized Phase|Randomized but not treated|0|||
130040396|NCT00892437|468104994|FG000|Randomized Phase|Adverse Event|2|||
130040397|NCT00892437|468104995|FG001|Randomized Phase|Adverse Event|2|||
130040398|NCT00892437|468104994|FG000|Randomized Phase|Lost to Follow-up|1|||
130040399|NCT00892437|468104995|FG001|Randomized Phase|Lost to Follow-up|3|||
130040400|NCT00892437|468104994|FG000|Randomized Phase|Investigator's Discretion|1|||
130040401|NCT00892437|468104995|FG001|Randomized Phase|Investigator's Discretion|0|||
130040402|NCT00892437|468104994|FG000|Randomized Phase|Withdrew Consent|1|||
130040403|NCT00892437|468104995|FG001|Randomized Phase|Withdrew Consent|0|||
130040404|NCT00892437|468104994|FG000|Open-Label Extension Phase|Adverse Event|4|||
130040405|NCT00892437|468104995|FG001|Open-Label Extension Phase|Adverse Event|2|||
129886334|NCT03681639|467545554|FG000|Overall Study|Withdrawal by Subject|1|||
130040406|NCT00892437|468104994|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
130040407|NCT00892437|468104995|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
130040408|NCT00892437|468104994|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
130040409|NCT00892437|468104995|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
129886335|NCT03681639|467545554|FG000|Overall Study|Adverse Event|2|||
129886336|NCT00654940|467545555|FG000|Period 1|Adverse Event|0|||
130040410|NCT00892437|468104994|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
130274561|NCT00104416|468969221|FG000|Double-Blind Phase|Adverse Event|2|||
130274562|NCT00104416|468969222|FG001|Double-Blind Phase|Adverse Event|1|||
130274563|NCT00104416|468969223|FG002|Double-Blind Phase|Adverse Event|0|||
130274564|NCT00104416|468969224|FG003|Double-Blind Phase|Adverse Event|0|||
130274565|NCT00104416|468969225|FG004|Double-Blind Phase|Adverse Event|0|||
130274566|NCT00104416|468969221|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130274567|NCT00104416|468969222|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130274568|NCT00104416|468969223|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130274569|NCT00104416|468969224|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130274570|NCT00104416|468969225|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130274571|NCT00104416|468969221|FG000|Double-Blind Phase|Protocol Violation|0|||
130274572|NCT00104416|468969222|FG001|Double-Blind Phase|Protocol Violation|1|||
130274573|NCT00104416|468969223|FG002|Double-Blind Phase|Protocol Violation|0|||
130274574|NCT00104416|468969224|FG003|Double-Blind Phase|Protocol Violation|0|||
130274575|NCT00104416|468969225|FG004|Double-Blind Phase|Protocol Violation|0|||
130274576|NCT00104416|468969221|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130274577|NCT00104416|468969222|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
130274578|NCT00104416|468969223|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130274579|NCT00104416|468969224|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130274580|NCT00104416|468969225|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130274581|NCT00104416|468969221|FG000|Double-Blind Phase|Pregnancy|1|||
130274582|NCT00104416|468969222|FG001|Double-Blind Phase|Pregnancy|0|||
130274583|NCT00104416|468969223|FG002|Double-Blind Phase|Pregnancy|0|||
130274584|NCT00104416|468969224|FG003|Double-Blind Phase|Pregnancy|0|||
130274585|NCT00104416|468969225|FG004|Double-Blind Phase|Pregnancy|0|||
130274586|NCT00104416|468969221|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
130274587|NCT00104416|468969222|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
130274588|NCT00104416|468969223|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
130274589|NCT00104416|468969224|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
130274590|NCT00104416|468969225|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
130274591|NCT00104416|468969221|FG000|Continuation Phase|Adverse Event|0|||
130274592|NCT00104416|468969222|FG001|Continuation Phase|Adverse Event|0|||
130274593|NCT00104416|468969223|FG002|Continuation Phase|Adverse Event|2|||
130274594|NCT00104416|468969224|FG003|Continuation Phase|Adverse Event|0|||
130274595|NCT00104416|468969225|FG004|Continuation Phase|Adverse Event|2|||
130274596|NCT00104416|468969221|FG000|Continuation Phase|Lost to Follow-up|0|||
130274597|NCT00104416|468969222|FG001|Continuation Phase|Lost to Follow-up|0|||
130274598|NCT00104416|468969223|FG002|Continuation Phase|Lost to Follow-up|1|||
130274599|NCT00104416|468969224|FG003|Continuation Phase|Lost to Follow-up|0|||
130274600|NCT00104416|468969225|FG004|Continuation Phase|Lost to Follow-up|1|||
130274601|NCT00104416|468969221|FG000|Continuation Phase|Withdrawal by Subject|0|||
130274602|NCT00104416|468969222|FG001|Continuation Phase|Withdrawal by Subject|0|||
130274603|NCT00104416|468969223|FG002|Continuation Phase|Withdrawal by Subject|2|||
130274604|NCT00104416|468969224|FG003|Continuation Phase|Withdrawal by Subject|1|||
130274605|NCT00104416|468969225|FG004|Continuation Phase|Withdrawal by Subject|1|||
130274606|NCT00104416|468969221|FG000|Continuation Phase|Pregnancy|0|||
130040411|NCT00892437|468104995|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
130040412|NCT00892437|468104994|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
130040413|NCT00892437|468104995|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
130040414|NCT03185130|468104997|FG000|Overall Study|Withdrawal by Subject|0|||
130040415|NCT03185130|468104998|FG001|Overall Study|Withdrawal by Subject|2|||
130040416|NCT01925703|468104999|FG000|Overall Study|Physician Decision|1|||
130040417|NCT01925703|468104999|FG000|Overall Study|Lost to Follow-up|2|||
130040418|NCT01925703|468104999|FG000|Overall Study|Discharge prior to full iron repletion|1|||
130040419|NCT02750410|468105000|FG000|Double-Blind Treatment Period|Adverse Event|2|||
130040420|NCT02750410|468105001|FG001|Double-Blind Treatment Period|Adverse Event|2|||
130040421|NCT02750410|468105000|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130040422|NCT02750410|468105001|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130040423|NCT02750410|468105000|FG000|Open-Label Extension Period|Adverse Event|5|||
130040424|NCT02750410|468105001|FG001|Open-Label Extension Period|Adverse Event|3|||
130040425|NCT02750410|468105000|FG000|Open-Label Extension Period|Protocol Violation|0|||
130274607|NCT00104416|468969222|FG001|Continuation Phase|Pregnancy|0|||
130040426|NCT02750410|468105001|FG001|Open-Label Extension Period|Protocol Violation|1|||
130040427|NCT02750410|468105000|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
130274608|NCT00104416|468969223|FG002|Continuation Phase|Pregnancy|1|||
130274609|NCT00104416|468969224|FG003|Continuation Phase|Pregnancy|1|||
130274610|NCT00104416|468969225|FG004|Continuation Phase|Pregnancy|0|||
130274611|NCT00104416|468969221|FG000|Continuation Phase|Non-compliance|0|||
130274612|NCT00104416|468969222|FG001|Continuation Phase|Non-compliance|0|||
130274613|NCT00104416|468969223|FG002|Continuation Phase|Non-compliance|0|||
130274614|NCT00104416|468969224|FG003|Continuation Phase|Non-compliance|0|||
130274615|NCT00104416|468969225|FG004|Continuation Phase|Non-compliance|1|||
130104390|NCT02756078|468341030|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
130104391|NCT02756078|468341029|FG000|Period 1|Lost to Follow-up|0|||
130104392|NCT02756078|468341030|FG001|Period 1|Lost to Follow-up|2|||
130104393|NCT02756078|468341029|FG000|Period 1|Protocol Violation|0|||
130104394|NCT02756078|468341030|FG001|Period 1|Protocol Violation|1|||
130104395|NCT02756078|468341029|FG000|Period 1|Adverse Event|1|||
130104396|NCT02756078|468341030|FG001|Period 1|Adverse Event|10|||
130104397|NCT02756078|468341029|FG000|Period 1|Withdrawal by Subject|6|||
130104398|NCT02756078|468341030|FG001|Period 1|Withdrawal by Subject|6|||
130104399|NCT02756078|468341029|FG000|Period 1|Lens Discomfort|2|||
130104400|NCT02756078|468341030|FG001|Period 1|Lens Discomfort|2|||
130104401|NCT02756078|468341029|FG000|Period 2|Adverse Event|3|||
130104402|NCT02756078|468341030|FG001|Period 2|Adverse Event|5|||
130104403|NCT02756078|468341029|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
130104404|NCT02756078|468341030|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
130104405|NCT02756078|468341029|FG000|Period 2|Withdrawal by Subject|3|||
130104406|NCT02756078|468341030|FG001|Period 2|Withdrawal by Subject|1|||
130104407|NCT00943384|468341031|FG000|Overall Study|Dispositioned prior to treatment|23|||
130104408|NCT00943384|468341031|FG000|Overall Study|Treated off protocol-protocol violation|5|||
130104409|NCT00943384|468341031|FG000|Overall Study|Lost to Follow-up|16|||
130104410|NCT00943384|468341031|FG000|Overall Study|Withdrawal by Subject|5|||
130104411|NCT00835068|468341034|FG000|Overall Study|Death|1|||
130104412|NCT00835068|468341035|FG001|Overall Study|Death|0|||
130104413|NCT00835068|468341034|FG000|Overall Study|Adverse Event|0|||
130104414|NCT00835068|468341035|FG001|Overall Study|Adverse Event|1|||
130104415|NCT00835068|468341034|FG000|Overall Study|Other|8|||
130104416|NCT00835068|468341035|FG001|Overall Study|Other|0|||
130104417|NCT00835068|468341034|FG000|Overall Study|Withdrawal by Subject|1|||
130104418|NCT00835068|468341035|FG001|Overall Study|Withdrawal by Subject|0|||
130104419|NCT02575807|468341036|FG000|Overall Study|Death|8|||
130104420|NCT02575807|468341037|FG001|Overall Study|Death|3|||
130104421|NCT02575807|468341038|FG002|Overall Study|Death|7|||
130104422|NCT02575807|468341039|FG003|Overall Study|Death|0|||
130104423|NCT02575807|468341040|FG004|Overall Study|Death|1|||
130104424|NCT02575807|468341036|FG000|Overall Study|Study terminated by Sponsor|0|||
130104425|NCT02575807|468341037|FG001|Overall Study|Study terminated by Sponsor|1|||
130104426|NCT02575807|468341038|FG002|Overall Study|Study terminated by Sponsor|7|||
130104427|NCT02575807|468341039|FG003|Overall Study|Study terminated by Sponsor|0|||
130104428|NCT02575807|468341040|FG004|Overall Study|Study terminated by Sponsor|1|||
130104429|NCT02575807|468341036|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
130104430|NCT02575807|468341037|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
130104431|NCT02575807|468341038|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
130104432|NCT02575807|468341039|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
130104433|NCT02575807|468341040|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
130104434|NCT02575807|468341036|FG000|Overall Study|Terminated due to physician decision|0|||
130104435|NCT02575807|468341037|FG001|Overall Study|Terminated due to physician decision|0|||
130104436|NCT02575807|468341038|FG002|Overall Study|Terminated due to physician decision|1|||
130104437|NCT02575807|468341039|FG003|Overall Study|Terminated due to physician decision|0|||
130104438|NCT02575807|468341040|FG004|Overall Study|Terminated due to physician decision|0|||
130104439|NCT02575807|468341036|FG000|Overall Study|Subject ineligible - medical implant|0|||
130104440|NCT02575807|468341037|FG001|Overall Study|Subject ineligible - medical implant|0|||
130104441|NCT02575807|468341038|FG002|Overall Study|Subject ineligible - medical implant|0|||
130274616|NCT01309997|468969226|FG000|Overall Study|Adverse Event|1|||
130274617|NCT01309997|468969227|FG001|Overall Study|Adverse Event|0|||
130274618|NCT01309997|468969226|FG000|Overall Study|Death|1|||
130274619|NCT01309997|468969227|FG001|Overall Study|Death|3|||
130274620|NCT01309997|468969226|FG000|Overall Study|Lack of Efficacy|2|||
130274621|NCT01309997|468969227|FG001|Overall Study|Lack of Efficacy|2|||
130274622|NCT01309997|468969226|FG000|Overall Study|Withdrawal by Subject|1|||
130274623|NCT01309997|468969227|FG001|Overall Study|Withdrawal by Subject|1|||
130274624|NCT03462641|468969230|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
130274625|NCT03462641|468969231|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
130274626|NCT03462641|468969230|FG000|Visit 2|Withdrawal by Subject|0|||
130274627|NCT03462641|468969231|FG001|Visit 2|Withdrawal by Subject|1|||
130274628|NCT02096952|468969235|FG000|Overall Study|Adverse Event|1|||
130274629|NCT02684617|468969236|FG000|Overall Study|Adverse Event|1|||
130274630|NCT02684617|468969237|FG001|Overall Study|Adverse Event|0|||
130274631|NCT02684617|468969238|FG002|Overall Study|Adverse Event|1|||
130274632|NCT02684617|468969236|FG000|Overall Study|Death|8|||
130274633|NCT02684617|468969237|FG001|Overall Study|Death|16|||
130274634|NCT02684617|468969238|FG002|Overall Study|Death|28|||
130274635|NCT02684617|468969236|FG000|Overall Study|Withdrawal by Subject|2|||
130274636|NCT02684617|468969237|FG001|Overall Study|Withdrawal by Subject|0|||
130274637|NCT02684617|468969238|FG002|Overall Study|Withdrawal by Subject|4|||
130274638|NCT02684617|468969236|FG000|Overall Study|Screen Failure|1|||
130274639|NCT02684617|468969237|FG001|Overall Study|Screen Failure|0|||
130274640|NCT02684617|468969238|FG002|Overall Study|Screen Failure|2|||
130274641|NCT02684617|468969236|FG000|Overall Study|Study Terminated by Sponsor|6|||
130274642|NCT02684617|468969237|FG001|Overall Study|Study Terminated by Sponsor|1|||
130274643|NCT02684617|468969238|FG002|Overall Study|Study Terminated by Sponsor|5|||
130274644|NCT04482439|468969247|FG000|Overall Study|Lost to Follow-up|1|||
130274645|NCT04482439|468969247|FG000|Overall Study|Unrelated illness|1|||
130274646|NCT02318368|468969248|FG000|Overall Study|Withdrawal by Subject|2|||
130274647|NCT02318368|468969249|FG001|Overall Study|Withdrawal by Subject|0|||
130274648|NCT02318368|468969248|FG000|Overall Study|Study terminated by the sponsor|5|||
130274649|NCT02318368|468969249|FG001|Overall Study|Study terminated by the sponsor|2|||
130274650|NCT02318368|468969248|FG000|Overall Study|Death|0|||
130274651|NCT02318368|468969249|FG001|Overall Study|Death|1|||
130274652|NCT02201329|468969250|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
130274653|NCT02201329|468969250|FG000|Overall Study|Withdrawal by Subject|2|||
130274654|NCT01945996|468969251|FG000|Overall Study|Lost to Follow-up|3|||
130274655|NCT01945996|468969252|FG001|Overall Study|Lost to Follow-up|5|||
130274656|NCT01066104|468969253|FG000|Overall Study|Adverse Event|1|||
130274657|NCT01066104|468969254|FG001|Overall Study|Adverse Event|1|||
130274658|NCT01066104|468969253|FG000|Overall Study|Protocol Violation|1|||
130274659|NCT01066104|468969254|FG001|Overall Study|Protocol Violation|0|||
130274660|NCT04660552|468969255|FG000|Overall Study|Withdrawal by Subject|3|||
130274661|NCT04660552|468969256|FG001|Overall Study|Withdrawal by Subject|1|||
130274662|NCT02091362|468969264|FG000|Period 1|Protocol Violation|1|||
130274663|NCT02091362|468969265|FG001|Period 1|Protocol Violation|0|||
130274664|NCT02091362|468969264|FG000|Period 1|Withdrawal by Subject|2|||
130274665|NCT02091362|468969265|FG001|Period 1|Withdrawal by Subject|3|||
130274666|NCT02091362|468969264|FG000|Period 1|Lost to Follow-up|0|||
130274667|NCT02091362|468969265|FG001|Period 1|Lost to Follow-up|1|||
130274668|NCT02091362|468969264|FG000|Period 1|Adverse Event|2|||
130274669|NCT02091362|468969265|FG001|Period 1|Adverse Event|0|||
130274670|NCT02091362|468969264|FG000|Wash-out|Lost to Follow-up|1|||
130274671|NCT02091362|468969265|FG001|Wash-out|Lost to Follow-up|1|||
130274672|NCT02091362|468969264|FG000|Wash-out|Withdrawal by Subject|0|||
130274673|NCT02091362|468969265|FG001|Wash-out|Withdrawal by Subject|2|||
130274674|NCT02091362|468969264|FG000|Period 2|Adverse Event|1|||
130274675|NCT02091362|468969265|FG001|Period 2|Adverse Event|0|||
130274676|NCT02091362|468969264|FG000|Period 2|Lost to Follow-up|0|||
130274677|NCT02091362|468969265|FG001|Period 2|Lost to Follow-up|1|||
130274678|NCT02091362|468969264|FG000|Period 2|Withdrawal by Subject|1|||
130274679|NCT02091362|468969265|FG001|Period 2|Withdrawal by Subject|1|||
130274680|NCT00690430|468969266|FG000|Core Phase|Abnormal Laboratory value|0|||
130274681|NCT00690430|468969267|FG001|Core Phase|Abnormal Laboratory value|1|||
130274682|NCT00690430|468969268|FG002|Core Phase|Abnormal Laboratory value|0|||
130274683|NCT00690430|468969266|FG000|Core Phase|Adverse Event|5|||
130274684|NCT00690430|468969267|FG001|Core Phase|Adverse Event|1|||
130274685|NCT00690430|468969268|FG002|Core Phase|Adverse Event|0|||
130274686|NCT00690430|468969266|FG000|Core Phase|Death|0|||
130274687|NCT00690430|468969267|FG001|Core Phase|Death|2|||
130040428|NCT02750410|468105001|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
130040429|NCT03182738|468105006|FG000|Overall Study|Lost to Follow-up|9|||
130040430|NCT03182738|468105007|FG001|Overall Study|Lost to Follow-up|3|||
130040431|NCT03182738|468105006|FG000|Overall Study|Pregnancy|0|||
130040432|NCT03182738|468105007|FG001|Overall Study|Pregnancy|1|||
130040433|NCT03182738|468105006|FG000|Overall Study|Withdrawal by Subject|0|||
130040434|NCT03182738|468105007|FG001|Overall Study|Withdrawal by Subject|1|||
130040435|NCT04112914|468105009|FG000|Overall Study|Lost to Follow-up|13|||
130040436|NCT04112914|468105010|FG001|Overall Study|Lost to Follow-up|9|||
130040437|NCT04112914|468105009|FG000|Overall Study|Withdrawal by Subject|1|||
130040438|NCT04112914|468105010|FG001|Overall Study|Withdrawal by Subject|0|||
130040439|NCT03427073|468105011|FG000|Overall Study|Disease Progression|1|||
130040440|NCT03427073|468105012|FG001|Overall Study|Disease Progression|1|||
130040441|NCT03427073|468105013|FG002|Overall Study|Disease Progression|1|||
130040442|NCT03427073|468105014|FG003|Overall Study|Disease Progression|3|||
130040443|NCT03427073|468105015|FG004|Overall Study|Disease Progression|3|||
130040444|NCT03427073|468105016|FG005|Overall Study|Disease Progression|4|||
130040445|NCT03427073|468105017|FG006|Overall Study|Disease Progression|2|||
130040446|NCT03427073|468105018|FG007|Overall Study|Disease Progression|3|||
130040447|NCT03427073|468105011|FG000|Overall Study|Physician Decision|0|||
130040448|NCT03427073|468105012|FG001|Overall Study|Physician Decision|0|||
130040449|NCT03427073|468105013|FG002|Overall Study|Physician Decision|0|||
130040450|NCT03427073|468105014|FG003|Overall Study|Physician Decision|0|||
130040451|NCT03427073|468105015|FG004|Overall Study|Physician Decision|0|||
130040452|NCT03427073|468105016|FG005|Overall Study|Physician Decision|0|||
130040453|NCT03427073|468105017|FG006|Overall Study|Physician Decision|1|||
130040454|NCT03427073|468105018|FG007|Overall Study|Physician Decision|1|||
130040455|NCT01486238|468105022|FG000|Overall Study|Death|0|||
130040456|NCT01486238|468105023|FG001|Overall Study|Death|2|||
130040457|NCT01486238|468105022|FG000|Overall Study|Withdrawal by Subject|2|||
130040458|NCT01486238|468105023|FG001|Overall Study|Withdrawal by Subject|1|||
130040459|NCT01486238|468105022|FG000|Overall Study|Lost to Follow-up|0|||
130040460|NCT01486238|468105023|FG001|Overall Study|Lost to Follow-up|3|||
130040461|NCT02835495|468105025|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
130040462|NCT02835495|468105026|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
130040463|NCT02835495|468105025|FG000|Overall Study|Declined in-person follow-up visit|4|||
130040464|NCT02835495|468105026|FG001|Overall Study|Declined in-person follow-up visit|2|||
130040465|NCT02318602|468105027|FG000|Overall Study|Adverse Event|0|||
130040466|NCT02318602|468105028|FG001|Overall Study|Adverse Event|1|||
130040467|NCT02318602|468105029|FG002|Overall Study|Adverse Event|1|||
130040468|NCT02318602|468105027|FG000|Overall Study|Withdrawal by Subject|0|||
130040469|NCT02318602|468105028|FG001|Overall Study|Withdrawal by Subject|3|||
130040470|NCT02318602|468105029|FG002|Overall Study|Withdrawal by Subject|0|||
130040471|NCT02318602|468105027|FG000|Overall Study|Death|1|||
130040472|NCT02318602|468105028|FG001|Overall Study|Death|0|||
130040473|NCT02318602|468105029|FG002|Overall Study|Death|0|||
130040474|NCT02318602|468105027|FG000|Overall Study|Guardian decision to withdraw|0|||
130040475|NCT02318602|468105028|FG001|Overall Study|Guardian decision to withdraw|0|||
130274688|NCT00690430|468969268|FG002|Core Phase|Death|0|||
130274689|NCT00690430|468969266|FG000|Core Phase|Protocol Violation|1|||
130274690|NCT00690430|468969267|FG001|Core Phase|Protocol Violation|0|||
130274691|NCT00690430|468969268|FG002|Core Phase|Protocol Violation|0|||
130274692|NCT00690430|468969266|FG000|Core Phase|Withdrawal by Subject|3|||
130274693|NCT00690430|468969267|FG001|Core Phase|Withdrawal by Subject|3|||
130040476|NCT02318602|468105029|FG002|Overall Study|Guardian decision to withdraw|1|||
130040477|NCT00693706|468105030|FG000|Overall Study|Protocol Violation|0|||
130040478|NCT00693706|468105031|FG001|Overall Study|Protocol Violation|1|||
130040479|NCT05421754|468105032|FG000|Overall Study|Technical issue with sensor|1|||
130040480|NCT02580058|468105033|FG000|Overall Study|Adverse Event|16|||
130040481|NCT02580058|468105034|FG001|Overall Study|Adverse Event|30|||
130040482|NCT02580058|468105035|FG002|Overall Study|Adverse Event|20|||
130040483|NCT02580058|468105033|FG000|Overall Study|Death|4|||
130040484|NCT02580058|468105034|FG001|Overall Study|Death|4|||
130040485|NCT02580058|468105035|FG002|Overall Study|Death|5|||
130040486|NCT02580058|468105033|FG000|Overall Study|Physician Decision|1|||
130040487|NCT02580058|468105034|FG001|Overall Study|Physician Decision|3|||
130040488|NCT02580058|468105035|FG002|Overall Study|Physician Decision|11|||
130040489|NCT02580058|468105033|FG000|Overall Study|Other|5|||
130040490|NCT02580058|468105034|FG001|Overall Study|Other|1|||
130040491|NCT02580058|468105035|FG002|Overall Study|Other|3|||
130040492|NCT02580058|468105033|FG000|Overall Study|Withdrawal by Subject|4|||
130040493|NCT02580058|468105034|FG001|Overall Study|Withdrawal by Subject|7|||
130040494|NCT02580058|468105035|FG002|Overall Study|Withdrawal by Subject|31|||
130040495|NCT02580058|468105033|FG000|Overall Study|Global Deterioration of Health Status|19|||
130040496|NCT02580058|468105034|FG001|Overall Study|Global Deterioration of Health Status|18|||
130040497|NCT02580058|468105035|FG002|Overall Study|Global Deterioration of Health Status|24|||
130040498|NCT02580058|468105033|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
130040499|NCT02580058|468105034|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130040500|NCT02580058|468105035|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
130040501|NCT02580058|468105033|FG000|Overall Study|Progressive Disease|137|||
130040502|NCT02580058|468105034|FG001|Overall Study|Progressive Disease|125|||
130040503|NCT02580058|468105035|FG002|Overall Study|Progressive Disease|94|||
130040504|NCT02580058|468105033|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130040505|NCT02580058|468105034|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130040506|NCT02580058|468105035|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130040507|NCT01193335|468105036|FG000|After Infant Series|Lost to Follow-up|1|||
130040508|NCT01193335|468105037|FG001|After Infant Series|Lost to Follow-up|2|||
130040509|NCT01193335|468105036|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
130040510|NCT01193335|468105037|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
130040511|NCT01193335|468105036|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
130040512|NCT01193335|468105037|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
130040513|NCT01193335|468105036|FG000|1-Year Follow-up|Lost to Follow-up|4|||
130040514|NCT01193335|468105037|FG001|1-Year Follow-up|Lost to Follow-up|0|||
130040515|NCT01193335|468105036|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
130040516|NCT01193335|468105037|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
130040517|NCT01193335|468105036|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
130040518|NCT01193335|468105037|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
130040519|NCT01733329|468105039|FG000|Overall Study|Protocol Violation|1|||
130040520|NCT01733329|468105040|FG001|Overall Study|Protocol Violation|1|||
130040521|NCT01733329|468105039|FG000|Overall Study|Uterine artery injury|1|||
130040522|NCT01733329|468105040|FG001|Overall Study|Uterine artery injury|0|||
130040523|NCT02388776|468105042|FG000|Overall Study|Death|1|||
130040524|NCT02388776|468105042|FG000|Overall Study|Lost to Follow-up|1|||
130040525|NCT03826914|468105043|FG000|Overall Study|Withdrawal by Subject|1|||
130040526|NCT03826914|468105044|FG001|Overall Study|Withdrawal by Subject|1|||
130040527|NCT00542828|468105047|FG000|Overall Study|Physician Decision|1|||
130040528|NCT00542828|468105047|FG000|Overall Study|Need for Prohibited Treatment|3|||
130040529|NCT00542828|468105047|FG000|Overall Study|Study Prematurely Discontinued|7|||
130040530|NCT00542828|468105047|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
130040531|NCT03228186|468105048|FG000|Overall Study|Patient never started treatment|1|||
130040532|NCT04246047|468105049|FG000|Overall Study|Death|50|||
130040533|NCT04246047|468105050|FG001|Overall Study|Death|77|||
130040534|NCT04246047|468105049|FG000|Overall Study|Lost to Follow-up|1|||
130040535|NCT04246047|468105050|FG001|Overall Study|Lost to Follow-up|3|||
130104442|NCT02575807|468341039|FG003|Overall Study|Subject ineligible - medical implant|1|||
130104443|NCT02575807|468341040|FG004|Overall Study|Subject ineligible - medical implant|0|||
130104444|NCT02575807|468341036|FG000|Overall Study|Withdrawal by Subject|0|||
130104445|NCT02575807|468341037|FG001|Overall Study|Withdrawal by Subject|0|||
130104446|NCT02575807|468341038|FG002|Overall Study|Withdrawal by Subject|1|||
130104447|NCT02575807|468341039|FG003|Overall Study|Withdrawal by Subject|1|||
130104448|NCT02575807|468341040|FG004|Overall Study|Withdrawal by Subject|2|||
130104449|NCT02180659|468341041|FG000|Overall Study|Adverse Event|1|||
130104450|NCT02180659|468341042|FG001|Overall Study|Adverse Event|0|||
130104451|NCT02180659|468341041|FG000|Overall Study|Lost to Follow-up|4|||
130104452|NCT02180659|468341042|FG001|Overall Study|Lost to Follow-up|2|||
130104453|NCT02180659|468341041|FG000|Overall Study|Subject incarcerated during conduct|1|||
130104454|NCT02180659|468341042|FG001|Overall Study|Subject incarcerated during conduct|0|||
130104455|NCT02180659|468341041|FG000|Overall Study|Withdrawal by Subject|0|||
130104456|NCT02180659|468341042|FG001|Overall Study|Withdrawal by Subject|2|||
130104457|NCT02180659|468341041|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
130104458|NCT02180659|468341042|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
130104459|NCT01495793|468341043|FG000|Overall Study|Lost to Follow-up|1|||
130104460|NCT01495793|468341043|FG000|Overall Study|Violation of inclusion criteria|1|||
130104461|NCT03014570|468341046|FG000|Overall Study|COVID-19 Restrictions|38|||
130104462|NCT03014570|468341047|FG001|Overall Study|COVID-19 Restrictions|24|||
130104463|NCT03014570|468341046|FG000|Overall Study|Death|70|||
130104464|NCT03014570|468341047|FG001|Overall Study|Death|79|||
130104465|NCT03014570|468341046|FG000|Overall Study|Transfer from facility|11|||
130104466|NCT03014570|468341047|FG001|Overall Study|Transfer from facility|14|||
130104467|NCT03014570|468341046|FG000|Overall Study|Hospitalized|5|||
130104468|NCT03014570|468341047|FG001|Overall Study|Hospitalized|3|||
130104469|NCT03014570|468341046|FG000|Overall Study|Transfer within facility|1|||
130104470|NCT03014570|468341047|FG001|Overall Study|Transfer within facility|0|||
130104471|NCT03014570|468341046|FG000|Overall Study|Site refusal|0|||
130104472|NCT03014570|468341047|FG001|Overall Study|Site refusal|11|||
130104473|NCT00478673|468341053|FG000|30-Days Post-Procedure|Death|2|||
130104474|NCT00478673|468341053|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
130104475|NCT00478673|468341053|FG000|30-Days Post-Procedure|Missed Visit|7|||
130104476|NCT00478673|468341053|FG000|12-Months Post-Procedure|Death|23|||
130104477|NCT00478673|468341053|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
130104478|NCT00478673|468341053|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
130104479|NCT00478673|468341053|FG000|12-Months Post-Procedure|Missed Visit|25|||
130104480|NCT00478673|468341053|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
130104481|NCT00481871|468341054|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
130104482|NCT00481871|468341055|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
130104483|NCT00481871|468341056|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
130104484|NCT00481871|468341057|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
130104485|NCT00481871|468341058|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
130104486|NCT03332212|468341059|FG000|Overall Study|Not treated|0|||
130104487|NCT03332212|468341060|FG001|Overall Study|Not treated|1|||
130104488|NCT03332212|468341061|FG002|Overall Study|Not treated|0|||
130104489|NCT03332212|468341062|FG003|Overall Study|Not treated|0|||
130104490|NCT03332212|468341059|FG000|Overall Study|Adverse Event|0|||
130104491|NCT03332212|468341060|FG001|Overall Study|Adverse Event|0|||
130104492|NCT03332212|468341061|FG002|Overall Study|Adverse Event|0|||
130104493|NCT03332212|468341062|FG003|Overall Study|Adverse Event|1|||
130104494|NCT03332212|468341059|FG000|Overall Study|worsening of disease under study|1|||
130104495|NCT03332212|468341060|FG001|Overall Study|worsening of disease under study|1|||
130104496|NCT03332212|468341061|FG002|Overall Study|worsening of disease under study|0|||
130104497|NCT03332212|468341062|FG003|Overall Study|worsening of disease under study|0|||
130104498|NCT02125734|468341066|FG000|Period 2|Adverse Event|0|||
130104499|NCT02125734|468341067|FG001|Period 2|Adverse Event|1|||
130104500|NCT01308762|468341068|FG000|Overall Study|Protocol Violation|0|||
130104501|NCT01308762|468341069|FG001|Overall Study|Protocol Violation|1|||
130104502|NCT01308762|468341070|FG002|Overall Study|Protocol Violation|0|||
130104503|NCT01216319|468341076|FG000|Overall Study|Lost to Follow-up|2|||
130104504|NCT01216319|468341076|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
130104505|NCT00929864|468341080|FG000|Overall Study|Death|1|||
130104506|NCT00929864|468341081|FG001|Overall Study|Death|1|||
129886337|NCT00654940|467545556|FG001|Period 1|Adverse Event|1|||
130104507|NCT00929864|468341080|FG000|Overall Study|Adverse Event|11|||
130104508|NCT00929864|468341081|FG001|Overall Study|Adverse Event|30|||
130104509|NCT00929864|468341080|FG000|Overall Study|Lack of Efficacy|19|||
130104510|NCT00929864|468341081|FG001|Overall Study|Lack of Efficacy|16|||
130104511|NCT00929864|468341080|FG000|Overall Study|Lost to Follow-up|7|||
130104512|NCT00929864|468341081|FG001|Overall Study|Lost to Follow-up|12|||
130104513|NCT00929864|468341080|FG000|Overall Study|Withdrawal by Subject|20|||
130104514|NCT00929864|468341081|FG001|Overall Study|Withdrawal by Subject|9|||
130274694|NCT00690430|468969268|FG002|Core Phase|Withdrawal by Subject|0|||
129886338|NCT00654940|467545555|FG000|Period 1|Intolerable Pain Level|1|||
130104515|NCT00929864|468341080|FG000|Overall Study|No longer met criteria|2|||
130104516|NCT00929864|468341081|FG001|Overall Study|No longer met criteria|1|||
130104517|NCT00929864|468341080|FG000|Overall Study|Poor or non-compliance|3|||
130104518|NCT00929864|468341081|FG001|Overall Study|Poor or non-compliance|3|||
130104519|NCT00929864|468341080|FG000|Overall Study|Pregnancy|0|||
130104520|NCT00929864|468341081|FG001|Overall Study|Pregnancy|3|||
130274695|NCT00690430|468969266|FG000|Core Phase|Subject no longer requires study drug|1|||
130274696|NCT00690430|468969267|FG001|Core Phase|Subject no longer requires study drug|0|||
130274697|NCT00690430|468969268|FG002|Core Phase|Subject no longer requires study drug|0|||
130274698|NCT00690430|468969266|FG000|Core Phase|Lack of Efficacy|8|||
130274699|NCT00690430|468969267|FG001|Core Phase|Lack of Efficacy|10|||
130274700|NCT00690430|468969268|FG002|Core Phase|Lack of Efficacy|0|||
130274701|NCT00690430|468969266|FG000|Core Phase|Administrative Problems|0|||
130274702|NCT00690430|468969267|FG001|Core Phase|Administrative Problems|1|||
130274703|NCT00690430|468969268|FG002|Core Phase|Administrative Problems|0|||
130274704|NCT00690430|468969266|FG000|Core Phase|Early Termination|0|||
130274705|NCT00690430|468969267|FG001|Core Phase|Early Termination|5|||
130274706|NCT00690430|468969268|FG002|Core Phase|Early Termination|0|||
130274707|NCT00690430|468969266|FG000|Extension Phase|Lack of Efficacy|3|||
130274708|NCT00690430|468969267|FG001|Extension Phase|Lack of Efficacy|1|||
130274709|NCT00690430|468969268|FG002|Extension Phase|Lack of Efficacy|4|||
130274710|NCT00690430|468969266|FG000|Extension Phase|Abnormal Lab Values|1|||
130274711|NCT00690430|468969267|FG001|Extension Phase|Abnormal Lab Values|0|||
130274712|NCT00690430|468969268|FG002|Extension Phase|Abnormal Lab Values|0|||
130274713|NCT00690430|468969266|FG000|Extension Phase|Abnormal test procedure results|1|||
130274714|NCT00690430|468969267|FG001|Extension Phase|Abnormal test procedure results|0|||
130274715|NCT00690430|468969268|FG002|Extension Phase|Abnormal test procedure results|0|||
130274716|NCT00690430|468969266|FG000|Extension Phase|Administrative Problems|0|||
130274717|NCT00690430|468969267|FG001|Extension Phase|Administrative Problems|1|||
130274718|NCT00690430|468969268|FG002|Extension Phase|Administrative Problems|1|||
130274719|NCT00690430|468969266|FG000|Extension Phase|Adverse Event|2|||
130274720|NCT00690430|468969267|FG001|Extension Phase|Adverse Event|1|||
130274721|NCT00690430|468969268|FG002|Extension Phase|Adverse Event|2|||
130274722|NCT00690430|468969266|FG000|Extension Phase|Death|1|||
130274723|NCT00690430|468969267|FG001|Extension Phase|Death|1|||
130274724|NCT00690430|468969268|FG002|Extension Phase|Death|1|||
130274725|NCT00690430|468969266|FG000|Extension Phase|Withdrawal by Subject|0|||
130274726|NCT00690430|468969267|FG001|Extension Phase|Withdrawal by Subject|0|||
130274727|NCT00690430|468969268|FG002|Extension Phase|Withdrawal by Subject|2|||
130274728|NCT00690430|468969266|FG000|Extension Phase|Early Termination|10|||
130274729|NCT00690430|468969267|FG001|Extension Phase|Early Termination|1|||
130274730|NCT00690430|468969268|FG002|Extension Phase|Early Termination|3|||
130274731|NCT02125838|468969277|FG000|Overall Study|Lost to Follow-up|4|||
130274732|NCT02125838|468969278|FG001|Overall Study|Lost to Follow-up|4|||
130274733|NCT00787839|468969279|FG000|Overall Study|Failure to have the OGTT was most common|404|||
130274734|NCT01970241|468969284|FG000|Overall Study|Withdrawal by Subject|2|||
130274735|NCT01970241|468969285|FG001|Overall Study|Withdrawal by Subject|0|||
130274736|NCT01970241|468969284|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
130274737|NCT01970241|468969285|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
130274738|NCT01001767|468969288|FG000|Overall Study|no baseline study performed|1|||
130274739|NCT01001767|468969289|FG001|Overall Study|no baseline study performed|0|||
130274740|NCT01001767|468969288|FG000|Overall Study|Protocol Violation|1|||
130274741|NCT01001767|468969289|FG001|Overall Study|Protocol Violation|0|||
130274742|NCT01001767|468969288|FG000|Overall Study|Lost to Follow-up|1|||
130274743|NCT01001767|468969289|FG001|Overall Study|Lost to Follow-up|0|||
130274744|NCT01001767|468969288|FG000|Overall Study|Physician Decision|1|||
130274745|NCT01001767|468969289|FG001|Overall Study|Physician Decision|0|||
130274746|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
130274747|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
130274748|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
130274749|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
130274750|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
130274751|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
130274752|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
130274753|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
130274754|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
130274755|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
130274756|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
130274757|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
130274758|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274759|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130104521|NCT00929864|468341080|FG000|Overall Study|Administrative reason by Sponsor|1|||
130274760|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
130274761|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274762|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274763|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130040536|NCT04246047|468105049|FG000|Overall Study|Physician Decision|4|||
130040537|NCT04246047|468105050|FG001|Overall Study|Physician Decision|10|||
130040538|NCT04246047|468105049|FG000|Overall Study|Withdrawal by Subject|19|||
130040539|NCT04246047|468105050|FG001|Overall Study|Withdrawal by Subject|26|||
130040540|NCT04246047|468105049|FG000|Overall Study|Ongoing|169|||
130040541|NCT04246047|468105050|FG001|Overall Study|Ongoing|135|||
130040542|NCT05139030|468105054|FG000|Overall Study|Withdrawal by Subject|1|||
130040543|NCT05139030|468105055|FG001|Overall Study|Withdrawal by Subject|3|||
130040544|NCT05139030|468105054|FG000|Overall Study|Adverse Event|0|||
130040545|NCT05139030|468105055|FG001|Overall Study|Adverse Event|1|||
130040546|NCT05139030|468105054|FG000|Overall Study|Failure to meet continuation criteria|0|||
130040547|NCT05139030|468105055|FG001|Overall Study|Failure to meet continuation criteria|1|||
130040548|NCT02502864|468105063|FG000|Overall Study|Withdrawal by Subject|1|||
130040549|NCT03772327|468105064|FG000|Overall Study|Lost to Follow-up|3|||
130040550|NCT03772327|468105065|FG001|Overall Study|Lost to Follow-up|4|||
130040551|NCT03772327|468105064|FG000|Overall Study|Withdrawal by Subject|2|||
130040552|NCT03772327|468105065|FG001|Overall Study|Withdrawal by Subject|3|||
130040553|NCT04233424|468105073|FG000|Overall Study|Death|15|||
130040554|NCT04233424|468105074|FG001|Overall Study|Death|16|||
130040555|NCT04233424|468105073|FG000|Overall Study|Withdrawal by Subject|2|||
130040556|NCT04233424|468105074|FG001|Overall Study|Withdrawal by Subject|8|||
130040557|NCT04233424|468105073|FG000|Overall Study|Physician Decision|1|||
130040558|NCT04233424|468105074|FG001|Overall Study|Physician Decision|3|||
130040559|NCT04233424|468105073|FG000|Overall Study|Protocol Violation|3|||
130040560|NCT04233424|468105074|FG001|Overall Study|Protocol Violation|1|||
130040561|NCT04233424|468105073|FG000|Overall Study|Lost to Follow-up|1|||
130040562|NCT04233424|468105074|FG001|Overall Study|Lost to Follow-up|3|||
130040563|NCT04233424|468105073|FG000|Overall Study|subject refuse to visit site|2|||
130040564|NCT04233424|468105074|FG001|Overall Study|subject refuse to visit site|0|||
130040565|NCT03517436|468105075|FG000|Overall Study|Death|3|||
130040566|NCT03517436|468105075|FG000|Overall Study|Withdrawal by Subject|4|||
130040567|NCT03517436|468105075|FG000|Overall Study|Did not receive study valve.|1|||
130040568|NCT02698189|468105076|FG000|Overall Study|Physician Decision|3|||
130104522|NCT00929864|468341081|FG001|Overall Study|Administrative reason by Sponsor|1|||
130104523|NCT00929864|468341080|FG000|Overall Study|Non-specified|2|||
130104524|NCT00929864|468341081|FG001|Overall Study|Non-specified|7|||
130104525|NCT05473247|468341084|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
130104526|NCT02392559|468341085|FG000|Overall Study|Withdrawal by Subject|0|||
130104527|NCT02392559|468341086|FG001|Overall Study|Withdrawal by Subject|1|||
130104528|NCT00633217|468341089|FG000|Overall Study|Adverse Event|5|||
130104529|NCT00633217|468341090|FG001|Overall Study|Adverse Event|9|||
130104530|NCT00633217|468341089|FG000|Overall Study|Lack of Efficacy|0|||
130104531|NCT00633217|468341090|FG001|Overall Study|Lack of Efficacy|2|||
130104532|NCT00633217|468341089|FG000|Overall Study|Protocol Violation|3|||
130104533|NCT00633217|468341090|FG001|Overall Study|Protocol Violation|7|||
130104534|NCT00633217|468341089|FG000|Overall Study|Lost to Follow-up|2|||
130104535|NCT00633217|468341090|FG001|Overall Study|Lost to Follow-up|2|||
130104536|NCT00633217|468341089|FG000|Overall Study|Investigator Discretion|2|||
130104537|NCT00633217|468341090|FG001|Overall Study|Investigator Discretion|0|||
130104538|NCT00633217|468341089|FG000|Overall Study|Withdrew Consent|3|||
130104539|NCT00633217|468341090|FG001|Overall Study|Withdrew Consent|3|||
130104540|NCT04881448|468341091|FG000|Overall Study|Study cancelled by sponsor|220|||
130104541|NCT04881448|468341091|FG000|Overall Study|Withdrawal by Subject|2|||
130104542|NCT04881448|468341091|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
130104543|NCT00005879|468341092|FG000|Overall Study|Withdrawal by Subject|8|||
130104544|NCT00005879|468341093|FG001|Overall Study|Withdrawal by Subject|10|||
130104545|NCT00689273|468341094|FG000|Overall Study|Adverse Event|3|||
130104546|NCT00689273|468341095|FG001|Overall Study|Adverse Event|1|||
130104547|NCT00689273|468341094|FG000|Overall Study|Lack of Efficacy|3|||
130104548|NCT00689273|468341095|FG001|Overall Study|Lack of Efficacy|0|||
130104549|NCT00689273|468341094|FG000|Overall Study|Lost to Follow-up|0|||
130104550|NCT00689273|468341095|FG001|Overall Study|Lost to Follow-up|2|||
130104551|NCT00689273|468341094|FG000|Overall Study|Other|6|||
130104552|NCT00689273|468341095|FG001|Overall Study|Other|2|||
130104553|NCT00689273|468341094|FG000|Overall Study|Randomized but not Treated|1|||
130104554|NCT00689273|468341095|FG001|Overall Study|Randomized but not Treated|0|||
130104555|NCT01238172|468341097|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
130104556|NCT01238172|468341098|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
130104557|NCT01238172|468341097|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
130104558|NCT01238172|468341098|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
130104559|NCT02531698|468341101|FG000|Overall Study|Adverse Event|2|||
130104560|NCT02531698|468341102|FG001|Overall Study|Adverse Event|1|||
130104561|NCT02531698|468341101|FG000|Overall Study|Withdrawal by Subject|6|||
130104562|NCT02531698|468341102|FG001|Overall Study|Withdrawal by Subject|1|||
130104563|NCT02531698|468341101|FG000|Overall Study|Protocol Violation|2|||
130104564|NCT02531698|468341102|FG001|Overall Study|Protocol Violation|0|||
130104565|NCT02531698|468341101|FG000|Overall Study|Lost to Follow-up|1|||
130104566|NCT02531698|468341102|FG001|Overall Study|Lost to Follow-up|0|||
130104567|NCT02395536|468341103|FG000|Overall Study|Lost to Follow-up|4|||
130104568|NCT02395536|468341104|FG001|Overall Study|Lost to Follow-up|4|||
130104569|NCT02395536|468341103|FG000|Overall Study|Death|2|||
130104570|NCT02395536|468341104|FG001|Overall Study|Death|0|||
130104571|NCT02395536|468341103|FG000|Overall Study|Physician Decision|4|||
130104572|NCT02395536|468341104|FG001|Overall Study|Physician Decision|6|||
130104573|NCT02395536|468341103|FG000|Overall Study|Withdrawal by Subject|9|||
130104574|NCT02395536|468341104|FG001|Overall Study|Withdrawal by Subject|17|||
130104575|NCT02395536|468341103|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
130104576|NCT02395536|468341104|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
130104577|NCT02395536|468341103|FG000|Overall Study|Insurance issue|0|||
130274764|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274765|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274766|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274767|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274768|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274769|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
130274770|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
130274771|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
130274772|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
130274773|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
130104578|NCT02395536|468341104|FG001|Overall Study|Insurance issue|1|||
130104579|NCT01788163|468343100|FG000|Overall Study|Other|53|||
130104580|NCT01788163|468343101|FG001|Overall Study|Other|0|||
130104581|NCT01788163|468343102|FG002|Overall Study|Other|0|||
130104582|NCT01788163|468343103|FG003|Overall Study|Other|0|||
130104583|NCT01788163|468343104|FG004|Overall Study|Other|0|||
130274774|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
130104584|NCT01788163|468343105|FG005|Overall Study|Other|7|||
130104585|NCT01788163|468343106|FG006|Overall Study|Other|1|||
130040569|NCT02698189|468105077|FG001|Overall Study|Physician Decision|0|||
130040570|NCT02698189|468105076|FG000|Overall Study|Progressive disease|0|||
130040571|NCT02698189|468105077|FG001|Overall Study|Progressive disease|5|||
130040572|NCT02698189|468105076|FG000|Overall Study|Study terminated by sponsor|0|||
130040573|NCT02698189|468105077|FG001|Overall Study|Study terminated by sponsor|1|||
130040574|NCT01982630|468105080|FG000|Overall Study|Adverse Event|2|||
130040575|NCT01982630|468105081|FG001|Overall Study|Adverse Event|0|||
130040576|NCT01982630|468105082|FG002|Overall Study|Adverse Event|1|||
130040577|NCT01982630|468105083|FG003|Overall Study|Adverse Event|0|||
130040578|NCT01982630|468105084|FG004|Overall Study|Adverse Event|1|||
130040579|NCT01982630|468105085|FG005|Overall Study|Adverse Event|2|||
130040580|NCT01982630|468105086|FG006|Overall Study|Adverse Event|1|||
130040581|NCT01982630|468105087|FG007|Overall Study|Adverse Event|0|||
130040582|NCT01982630|468105080|FG000|Overall Study|Physician Decision|1|||
130040583|NCT01982630|468105081|FG001|Overall Study|Physician Decision|0|||
130040584|NCT01982630|468105082|FG002|Overall Study|Physician Decision|2|||
130040585|NCT01982630|468105083|FG003|Overall Study|Physician Decision|1|||
130040586|NCT01982630|468105084|FG004|Overall Study|Physician Decision|2|||
130040587|NCT01982630|468105085|FG005|Overall Study|Physician Decision|0|||
130040588|NCT01982630|468105086|FG006|Overall Study|Physician Decision|0|||
130040589|NCT01982630|468105087|FG007|Overall Study|Physician Decision|0|||
130040590|NCT01982630|468105080|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040591|NCT01982630|468105081|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040592|NCT01982630|468105082|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
130040593|NCT01982630|468105083|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040594|NCT01982630|468105084|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040595|NCT01982630|468105085|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040596|NCT01982630|468105086|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040597|NCT01982630|468105087|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
130040598|NCT01982630|468105080|FG000|Overall Study|Withdrawal by Subject|0|||
130040599|NCT01982630|468105081|FG001|Overall Study|Withdrawal by Subject|0|||
130040600|NCT01982630|468105082|FG002|Overall Study|Withdrawal by Subject|0|||
130040601|NCT01982630|468105083|FG003|Overall Study|Withdrawal by Subject|0|||
130040602|NCT01982630|468105084|FG004|Overall Study|Withdrawal by Subject|0|||
130040603|NCT01982630|468105085|FG005|Overall Study|Withdrawal by Subject|1|||
130040604|NCT01982630|468105086|FG006|Overall Study|Withdrawal by Subject|0|||
130040605|NCT01982630|468105087|FG007|Overall Study|Withdrawal by Subject|0|||
130040606|NCT00820040|468105088|FG000|Overall Study|Death|1|||
130040607|NCT00820040|468105088|FG000|Overall Study|Sponsor terminated study|1|||
130040608|NCT00820040|468105088|FG000|Overall Study|Screen failure|1|||
130040609|NCT02493751|468105091|FG000|Overall Study|Withdrawal by Subject|2|||
130040610|NCT02493751|468105092|FG001|Overall Study|Withdrawal by Subject|8|||
130040611|NCT02493751|468105091|FG000|Overall Study|Death|6|||
130040612|NCT02493751|468105092|FG001|Overall Study|Death|13|||
130040613|NCT02493751|468105091|FG000|Overall Study|Lost to Follow-up|2|||
130040614|NCT02493751|468105092|FG001|Overall Study|Lost to Follow-up|3|||
130040615|NCT02493751|468105091|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
130040616|NCT02493751|468105092|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
130040617|NCT03248128|468105095|FG000|Overall Study|Lost to Follow-up|1|||
130040618|NCT03248128|468105096|FG001|Overall Study|Lost to Follow-up|0|||
130040619|NCT03248128|468105095|FG000|Overall Study|Withdrawal by Subject|16|||
130040620|NCT03248128|468105096|FG001|Overall Study|Withdrawal by Subject|14|||
130040621|NCT03248128|468105095|FG000|Overall Study|Site Closed|4|||
130040622|NCT03248128|468105096|FG001|Overall Study|Site Closed|3|||
130040623|NCT03248128|468105095|FG000|Overall Study|Randomized, but did not receive treatment|1|||
130040624|NCT03248128|468105096|FG001|Overall Study|Randomized, but did not receive treatment|3|||
130040625|NCT01914679|468105097|FG000|Overall Study|Lack of Efficacy|1|||
130040626|NCT01914679|468105097|FG000|Overall Study|Sponsor terminated study|4|||
130040627|NCT02722044|468105098|FG000|Overall Study|Adverse Event|2|||
130040628|NCT02722044|468105098|FG000|Overall Study|Physician Decision|1|||
130040629|NCT02722044|468105098|FG000|Overall Study|Withdrawal by Subject|1|||
130040630|NCT02722044|468105098|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
130040631|NCT00002850|468105100|FG000|Overall Study|Death|4|||
130040632|NCT00002850|468105101|FG001|Overall Study|Death|1|||
130040633|NCT00002850|468105102|FG002|Overall Study|Death|3|||
130040634|NCT00002850|468105100|FG000|Overall Study|Protocol Violation|1|||
130040635|NCT00002850|468105101|FG001|Overall Study|Protocol Violation|0|||
130040636|NCT00002850|468105102|FG002|Overall Study|Protocol Violation|1|||
130040637|NCT00002850|468105100|FG000|Overall Study|Withdrawal by Subject|0|||
130040638|NCT00002850|468105101|FG001|Overall Study|Withdrawal by Subject|1|||
130040639|NCT00002850|468105102|FG002|Overall Study|Withdrawal by Subject|0|||
130040640|NCT01084252|468106838|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040641|NCT01084252|468106839|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040642|NCT01084252|468106840|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040643|NCT01084252|468106841|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040644|NCT01084252|468106842|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040645|NCT01084252|468106843|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040646|NCT01084252|468106844|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040647|NCT01084252|468106845|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040648|NCT01084252|468106846|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040649|NCT01084252|468106847|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040650|NCT01084252|468106848|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040651|NCT01084252|468106849|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040652|NCT01084252|468106850|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
130040653|NCT01084252|468106851|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
130040654|NCT03715465|468106853|FG000|Overall Study|Withdrawal by Subject|1|||
130104586|NCT01788163|468343107|FG007|Overall Study|Other|48|||
130104587|NCT01788163|468343108|FG008|Overall Study|Other|15|||
130104588|NCT01788163|468343100|FG000|Overall Study|Withdrawal by Subject|2|||
130104589|NCT01788163|468343101|FG001|Overall Study|Withdrawal by Subject|0|||
130104590|NCT01788163|468343102|FG002|Overall Study|Withdrawal by Subject|0|||
130104591|NCT01788163|468343103|FG003|Overall Study|Withdrawal by Subject|0|||
130104592|NCT01788163|468343104|FG004|Overall Study|Withdrawal by Subject|0|||
130104593|NCT01788163|468343105|FG005|Overall Study|Withdrawal by Subject|0|||
130104594|NCT01788163|468343106|FG006|Overall Study|Withdrawal by Subject|0|||
130104595|NCT01788163|468343107|FG007|Overall Study|Withdrawal by Subject|0|||
130104596|NCT01788163|468343108|FG008|Overall Study|Withdrawal by Subject|1|||
130104597|NCT00545441|468343109|FG000|Overall Study|Fistula draining at 6 months|2|||
130104598|NCT00545441|468343110|FG001|Overall Study|Fistula draining at 6 months|4|||
130104599|NCT00545441|468343109|FG000|Overall Study|Lost to Follow-up|9|||
130104600|NCT00545441|468343110|FG001|Overall Study|Lost to Follow-up|5|||
130104601|NCT00545441|468343109|FG000|Overall Study|Technical failure|0|||
130104602|NCT00545441|468343110|FG001|Overall Study|Technical failure|1|||
130104603|NCT00545441|468343109|FG000|Overall Study|Withdrawal by Subject|1|||
130104604|NCT00545441|468343110|FG001|Overall Study|Withdrawal by Subject|1|||
130104605|NCT00545441|468343109|FG000|Overall Study|Persistence or recurrence of fistula|5|||
130104606|NCT00545441|468343110|FG001|Overall Study|Persistence or recurrence of fistula|2|||
130104607|NCT00545441|468343109|FG000|Overall Study|Patients were not treated|1|||
130104608|NCT00545441|468343110|FG001|Overall Study|Patients were not treated|3|||
130104609|NCT00265239|468343111|FG000|Overall Study|Adverse Event|2|||
130104610|NCT00265239|468343112|FG001|Overall Study|Adverse Event|1|||
130104611|NCT02803138|468343115|FG000|Overall Study|Failure to return|38|||
130104612|NCT02803138|468343115|FG000|Overall Study|Insufficient virological response|2|||
130104613|NCT02803138|468343115|FG000|Overall Study|Withdrawn consent|1|||
130104614|NCT02803138|468343115|FG000|Overall Study|Death|1|||
130104615|NCT02803138|468343115|FG000|Overall Study|Other, not specified|28|||
130104616|NCT00424515|468343116|FG000|Overall Study|Progressive Disease|10|||
130104617|NCT00424515|468343117|FG001|Overall Study|Progressive Disease|11|||
130104618|NCT00424515|468343116|FG000|Overall Study|Adverse Event|0|||
130104619|NCT00424515|468343117|FG001|Overall Study|Adverse Event|1|||
130104620|NCT00424515|468343116|FG000|Overall Study|Intercurrent Illness|0|||
130104621|NCT00424515|468343117|FG001|Overall Study|Intercurrent Illness|1|||
130104622|NCT00424515|468343116|FG000|Overall Study|Withdrawal by Subject|1|||
130104623|NCT00424515|468343117|FG001|Overall Study|Withdrawal by Subject|0|||
130104624|NCT00267020|468343118|FG000|Overall Study|Adverse Event|22|||
130104625|NCT00267020|468343119|FG001|Overall Study|Adverse Event|5|||
130104626|NCT00267020|468343118|FG000|Overall Study|Death|2|||
130104627|NCT00267020|468343119|FG001|Overall Study|Death|1|||
130104628|NCT00267020|468343118|FG000|Overall Study|Withdrawal by Subject|17|||
130104629|NCT00267020|468343119|FG001|Overall Study|Withdrawal by Subject|7|||
130104630|NCT00267020|468343118|FG000|Overall Study|Physician Decision|3|||
130104631|NCT00267020|468343119|FG001|Overall Study|Physician Decision|2|||
130274775|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
130040655|NCT03715465|468106854|FG001|Overall Study|Withdrawal by Subject|2|||
130040656|NCT02158533|468106862|FG000|Stage 1|Adverse Event|6|||
130040657|NCT02158533|468106863|FG001|Stage 1|Adverse Event|4|||
130040658|NCT02158533|468106864|FG002|Stage 1|Adverse Event|7|||
130040659|NCT02158533|468106865|FG003|Stage 1|Adverse Event|0|||
130040660|NCT02158533|468106866|FG004|Stage 1|Adverse Event|0|||
130040661|NCT02158533|468106867|FG005|Stage 1|Adverse Event|0|||
130274776|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
130040662|NCT02158533|468106862|FG000|Stage 1|Withdrawal by Subject|3|||
130040663|NCT02158533|468106863|FG001|Stage 1|Withdrawal by Subject|2|||
130040664|NCT02158533|468106864|FG002|Stage 1|Withdrawal by Subject|1|||
130040665|NCT02158533|468106865|FG003|Stage 1|Withdrawal by Subject|0|||
130040666|NCT02158533|468106866|FG004|Stage 1|Withdrawal by Subject|0|||
130040667|NCT02158533|468106867|FG005|Stage 1|Withdrawal by Subject|0|||
130040668|NCT02158533|468106862|FG000|Stage 1|Lack of Efficacy|1|||
130040669|NCT02158533|468106863|FG001|Stage 1|Lack of Efficacy|0|||
130040670|NCT02158533|468106864|FG002|Stage 1|Lack of Efficacy|0|||
130040671|NCT02158533|468106865|FG003|Stage 1|Lack of Efficacy|0|||
130040672|NCT02158533|468106866|FG004|Stage 1|Lack of Efficacy|0|||
130040673|NCT02158533|468106867|FG005|Stage 1|Lack of Efficacy|0|||
130040674|NCT02158533|468106862|FG000|Stage 1|Lost to Follow-up|3|||
130040675|NCT02158533|468106863|FG001|Stage 1|Lost to Follow-up|1|||
130040676|NCT02158533|468106864|FG002|Stage 1|Lost to Follow-up|0|||
130040677|NCT02158533|468106865|FG003|Stage 1|Lost to Follow-up|0|||
130040678|NCT02158533|468106866|FG004|Stage 1|Lost to Follow-up|0|||
130040679|NCT02158533|468106867|FG005|Stage 1|Lost to Follow-up|0|||
130040680|NCT02158533|468106862|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
130040681|NCT02158533|468106863|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
130040682|NCT02158533|468106864|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
130040683|NCT02158533|468106865|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
130040684|NCT02158533|468106866|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
130040685|NCT02158533|468106867|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
130040686|NCT02158533|468106862|FG000|Stage 1|Non-compliance with study visits|1|||
130040687|NCT02158533|468106863|FG001|Stage 1|Non-compliance with study visits|0|||
130040688|NCT02158533|468106864|FG002|Stage 1|Non-compliance with study visits|0|||
130040689|NCT02158533|468106865|FG003|Stage 1|Non-compliance with study visits|0|||
130040690|NCT02158533|468106866|FG004|Stage 1|Non-compliance with study visits|0|||
130040691|NCT02158533|468106867|FG005|Stage 1|Non-compliance with study visits|0|||
130040692|NCT02158533|468106862|FG000|Stage 2|Adverse Event|0|||
130040693|NCT02158533|468106863|FG001|Stage 2|Adverse Event|0|||
130040694|NCT02158533|468106864|FG002|Stage 2|Adverse Event|0|||
130040695|NCT02158533|468106865|FG003|Stage 2|Adverse Event|0|||
130040696|NCT02158533|468106866|FG004|Stage 2|Adverse Event|0|||
130040697|NCT02158533|468106867|FG005|Stage 2|Adverse Event|1|||
130040698|NCT02158533|468106862|FG000|Stage 2|Lack of Efficacy|0|||
130040699|NCT02158533|468106863|FG001|Stage 2|Lack of Efficacy|0|||
130040700|NCT02158533|468106864|FG002|Stage 2|Lack of Efficacy|0|||
130040701|NCT02158533|468106865|FG003|Stage 2|Lack of Efficacy|0|||
130040702|NCT02158533|468106866|FG004|Stage 2|Lack of Efficacy|1|||
130040703|NCT02158533|468106867|FG005|Stage 2|Lack of Efficacy|0|||
130040704|NCT02158533|468106862|FG000|Stage 2|Lost to Follow-up|0|||
129800259|NCT02445391|467236292|FG002|Overall Study|Adverse Event|12|||
130040705|NCT02158533|468106863|FG001|Stage 2|Lost to Follow-up|0|||
130040706|NCT02158533|468106864|FG002|Stage 2|Lost to Follow-up|0|||
130040707|NCT02158533|468106865|FG003|Stage 2|Lost to Follow-up|1|||
130040708|NCT02158533|468106866|FG004|Stage 2|Lost to Follow-up|1|||
130040709|NCT02158533|468106867|FG005|Stage 2|Lost to Follow-up|2|||
130040710|NCT02158533|468106862|FG000|Stage 2|Withdrawal by Subject|0|||
130040711|NCT02158533|468106863|FG001|Stage 2|Withdrawal by Subject|0|||
130040712|NCT02158533|468106864|FG002|Stage 2|Withdrawal by Subject|0|||
130040713|NCT02158533|468106865|FG003|Stage 2|Withdrawal by Subject|0|||
130040714|NCT02158533|468106866|FG004|Stage 2|Withdrawal by Subject|1|||
130040715|NCT02158533|468106867|FG005|Stage 2|Withdrawal by Subject|2|||
130040716|NCT02158533|468106862|FG000|Stage 2|Physician Decision|0|||
130040717|NCT02158533|468106863|FG001|Stage 2|Physician Decision|0|||
130040718|NCT02158533|468106864|FG002|Stage 2|Physician Decision|0|||
130040719|NCT02158533|468106865|FG003|Stage 2|Physician Decision|0|||
130040720|NCT02158533|468106866|FG004|Stage 2|Physician Decision|1|||
130040721|NCT02158533|468106867|FG005|Stage 2|Physician Decision|0|||
130040722|NCT02158533|468106862|FG000|Stage 2|Pregnancy|0|||
130040723|NCT02158533|468106863|FG001|Stage 2|Pregnancy|0|||
130040724|NCT02158533|468106864|FG002|Stage 2|Pregnancy|0|||
130040725|NCT02158533|468106865|FG003|Stage 2|Pregnancy|1|||
130040726|NCT02158533|468106866|FG004|Stage 2|Pregnancy|0|||
130040727|NCT02158533|468106867|FG005|Stage 2|Pregnancy|0|||
130040728|NCT02158533|468106862|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
130040729|NCT02158533|468106863|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
130040730|NCT02158533|468106864|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
130040731|NCT02158533|468106865|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
130040732|NCT02158533|468106866|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
130040733|NCT02158533|468106867|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
130040734|NCT02158533|468106862|FG000|Stage 2|Non-adherence with study visits|0|||
130040735|NCT02158533|468106863|FG001|Stage 2|Non-adherence with study visits|0|||
130040736|NCT02158533|468106864|FG002|Stage 2|Non-adherence with study visits|0|||
130040737|NCT02158533|468106865|FG003|Stage 2|Non-adherence with study visits|0|||
130040738|NCT02158533|468106866|FG004|Stage 2|Non-adherence with study visits|0|||
130040739|NCT02158533|468106867|FG005|Stage 2|Non-adherence with study visits|1|||
130040740|NCT00917384|468106868|FG000|Overall Study|Lost to Follow-up|4|||
130040741|NCT00917384|468106869|FG001|Overall Study|Lost to Follow-up|2|||
130040742|NCT00917384|468106868|FG000|Overall Study|Withdrawal by Subject|10|||
130040743|NCT00917384|468106869|FG001|Overall Study|Withdrawal by Subject|2|||
130040744|NCT00174941|468106871|FG000|Overall Study|Adverse Event|1|||
130040745|NCT00174941|468106872|FG001|Overall Study|Adverse Event|10|||
130040746|NCT00174941|468106873|FG002|Overall Study|Adverse Event|2|||
130040747|NCT00174941|468106874|FG003|Overall Study|Adverse Event|13|||
130040748|NCT00174941|468106871|FG000|Overall Study|Protocol Violation|0|||
130040749|NCT00174941|468106872|FG001|Overall Study|Protocol Violation|1|||
130040750|NCT00174941|468106873|FG002|Overall Study|Protocol Violation|0|||
130040751|NCT00174941|468106874|FG003|Overall Study|Protocol Violation|1|||
130040752|NCT00174941|468106871|FG000|Overall Study|Lost to Follow-up|0|||
130040753|NCT00174941|468106872|FG001|Overall Study|Lost to Follow-up|3|||
130040754|NCT00174941|468106873|FG002|Overall Study|Lost to Follow-up|2|||
130040755|NCT00174941|468106874|FG003|Overall Study|Lost to Follow-up|5|||
130040756|NCT00174941|468106871|FG000|Overall Study|Personal Reason(s)|0|||
130040757|NCT00174941|468106872|FG001|Overall Study|Personal Reason(s)|14|||
130040758|NCT00174941|468106873|FG002|Overall Study|Personal Reason(s)|8|||
130040759|NCT00174941|468106874|FG003|Overall Study|Personal Reason(s)|22|||
130040760|NCT00174941|468106871|FG000|Overall Study|Gout Flare|0|||
130040761|NCT00174941|468106872|FG001|Overall Study|Gout Flare|4|||
130040762|NCT00174941|468106873|FG002|Overall Study|Gout Flare|4|||
130040763|NCT00174941|468106874|FG003|Overall Study|Gout Flare|8|||
130040764|NCT00174941|468106871|FG000|Overall Study|Reason Not Specified|1|||
130040765|NCT00174941|468106872|FG001|Overall Study|Reason Not Specified|6|||
130040766|NCT00174941|468106873|FG002|Overall Study|Reason Not Specified|2|||
130040767|NCT00174941|468106874|FG003|Overall Study|Reason Not Specified|9|||
130040768|NCT01126619|468106879|FG000|Overall Study|Not eligible for the study|2|||
130040769|NCT01126619|468106879|FG000|Overall Study|Investigator decision|4|||
130040770|NCT01126619|468106879|FG000|Overall Study|Serious adverse event|1|||
130040771|NCT01126619|468106879|FG000|Overall Study|Withdrawal by Subject|9|||
130040772|NCT01126619|468106879|FG000|Overall Study|Non-compliance|1|||
130040773|NCT03351244|468106880|FG000|Overall Study|Adverse Event|7|||
130040774|NCT03351244|468106881|FG001|Overall Study|Adverse Event|11|||
130040775|NCT03351244|468106882|FG002|Overall Study|Adverse Event|12|||
130040776|NCT03351244|468106880|FG000|Overall Study|Investigator's decision|0|||
130040777|NCT03351244|468106881|FG001|Overall Study|Investigator's decision|0|||
130040778|NCT03351244|468106882|FG002|Overall Study|Investigator's decision|2|||
130040779|NCT03351244|468106880|FG000|Overall Study|System error|0|||
130040780|NCT03351244|468106881|FG001|Overall Study|System error|0|||
130040781|NCT03351244|468106882|FG002|Overall Study|System error|2|||
130040782|NCT03351244|468106880|FG000|Overall Study|COVID-19 restrictions|3|||
130040783|NCT03351244|468106881|FG001|Overall Study|COVID-19 restrictions|0|||
130040784|NCT03351244|468106882|FG002|Overall Study|COVID-19 restrictions|1|||
130040785|NCT03351244|468106880|FG000|Overall Study|Non-compliance|2|||
130040786|NCT03351244|468106881|FG001|Overall Study|Non-compliance|5|||
130040787|NCT03351244|468106882|FG002|Overall Study|Non-compliance|0|||
130040788|NCT03351244|468106880|FG000|Overall Study|Withdrawal by Subject|11|||
130040789|NCT03351244|468106881|FG001|Overall Study|Withdrawal by Subject|16|||
130040790|NCT03351244|468106882|FG002|Overall Study|Withdrawal by Subject|13|||
130040791|NCT03351244|468106880|FG000|Overall Study|Lost to Follow-up|2|||
130040792|NCT03351244|468106881|FG001|Overall Study|Lost to Follow-up|6|||
130040793|NCT03351244|468106882|FG002|Overall Study|Lost to Follow-up|4|||
130040794|NCT03351244|468106880|FG000|Overall Study|Protocol Violation|2|||
130040795|NCT03351244|468106881|FG001|Overall Study|Protocol Violation|2|||
130040796|NCT03351244|468106882|FG002|Overall Study|Protocol Violation|0|||
130040797|NCT04899271|468106883|FG000|Overall Study|Lost to Follow-up|1|||
130040798|NCT04899271|468106884|FG001|Overall Study|Lost to Follow-up|0|||
130040799|NCT04899271|468106883|FG000|Overall Study|Subject request/consent withdrawal|2|||
130040800|NCT04899271|468106884|FG001|Overall Study|Subject request/consent withdrawal|0|||
130040801|NCT03215277|468106886|FG000|Overall Study|Adverse Event|2|||
130040802|NCT03215277|468106887|FG001|Overall Study|Adverse Event|3|||
130040803|NCT03215277|468106886|FG000|Overall Study|Death|1|||
130040804|NCT03215277|468106887|FG001|Overall Study|Death|0|||
130040805|NCT03215277|468106886|FG000|Overall Study|Lost to Follow-up|0|||
130040806|NCT03215277|468106887|FG001|Overall Study|Lost to Follow-up|1|||
130040807|NCT03215277|468106886|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
130040808|NCT03215277|468106887|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
129886339|NCT00654940|467545556|FG001|Period 1|Intolerable Pain Level|0|||
130040809|NCT01238120|468106889|FG000|Overall Study|Withdrawal by Subject|4|||
130040810|NCT01238120|468106890|FG001|Overall Study|Withdrawal by Subject|1|||
130040811|NCT01238120|468106891|FG002|Overall Study|Withdrawal by Subject|2|||
130040812|NCT01238120|468106892|FG003|Overall Study|Withdrawal by Subject|5|||
129886340|NCT01642186|467545557|FG000|Overall Study|Death|0|||
130104632|NCT00267020|468343118|FG000|Overall Study|Disease Progression|39|||
130104633|NCT00267020|468343119|FG001|Overall Study|Disease Progression|25|||
130104634|NCT00267020|468343118|FG000|Overall Study|Unrelated Complication|1|||
130104635|NCT00267020|468343119|FG001|Overall Study|Unrelated Complication|1|||
130104636|NCT00267020|468343118|FG000|Overall Study|Sponsor Request|1|||
130104637|NCT00267020|468343119|FG001|Overall Study|Sponsor Request|0|||
130104638|NCT00267020|468343118|FG000|Overall Study|Other|1|||
130104639|NCT00267020|468343119|FG001|Overall Study|Other|2|||
130104640|NCT04071366|468343120|FG000|Part 1: Open-label (29 Days)|Death|4|||
130104641|NCT04071366|468343121|FG001|Part 1: Open-label (29 Days)|Death|2|||
130104642|NCT04071366|468343122|FG002|Part 1: Open-label (29 Days)|Death|8|||
130104643|NCT04071366|468343123|FG003|Part 1: Open-label (29 Days)|Death|0|||
130104644|NCT04071366|468343124|FG004|Part 1: Open-label (29 Days)|Death|0|||
130104645|NCT04071366|468343120|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130104646|NCT04071366|468343121|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130104647|NCT04071366|468343122|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
130104648|NCT04071366|468343123|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130104649|NCT04071366|468343124|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
130104650|NCT04071366|468343120|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
130104651|NCT04071366|468343121|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
130104652|NCT04071366|468343122|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
130104653|NCT04071366|468343123|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
130104654|NCT04071366|468343124|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
130104655|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Death|0|||
130104656|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Death|0|||
130104657|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Death|0|||
130104658|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Death|2|||
130104659|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Death|2|||
130104660|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130104661|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130104662|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130104663|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
130104664|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
130104665|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
130104666|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
130104667|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
130104668|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
130104669|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
130104670|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
130104671|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
130104672|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
130104673|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
130104674|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
130104675|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130104676|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130104677|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130104678|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
130104679|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
130104680|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130104681|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
129886341|NCT01642186|467545558|FG001|Overall Study|Death|2|||
130104682|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130104683|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
129886342|NCT01642186|467545559|FG002|Overall Study|Death|2|||
130104684|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
130104685|NCT04071366|468343120|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130104686|NCT04071366|468343121|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130104687|NCT04071366|468343122|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130040813|NCT01238120|468106889|FG000|Overall Study|Lost to Follow-up|2|||
130040814|NCT01238120|468106890|FG001|Overall Study|Lost to Follow-up|0|||
130040815|NCT01238120|468106891|FG002|Overall Study|Lost to Follow-up|1|||
130040816|NCT01238120|468106892|FG003|Overall Study|Lost to Follow-up|1|||
130040817|NCT01238120|468106889|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
130040818|NCT01238120|468106890|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
130040819|NCT01238120|468106891|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
130040820|NCT01238120|468106892|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
130040821|NCT02498652|468106895|FG000|Overall Study|Protocol Violation|0|||
130040822|NCT02498652|468106896|FG001|Overall Study|Protocol Violation|1|||
130040823|NCT02500550|468106903|FG000|Overall Study|Death|7|||
130040824|NCT04334148|468106904|FG000|Overall Study|positive nasal swab at baseline|0|||
130040825|NCT04334148|468106905|FG001|Overall Study|positive nasal swab at baseline|1|||
130040826|NCT00922935|468106906|FG000|Overall Study|Protocol Violation|0|||
130040827|NCT00922935|468106907|FG001|Overall Study|Protocol Violation|3|||
130040828|NCT00922935|468106908|FG002|Overall Study|Protocol Violation|0|||
130040829|NCT00922935|468106906|FG000|Overall Study|Physician Decision|1|||
130040830|NCT00922935|468106907|FG001|Overall Study|Physician Decision|1|||
130040831|NCT00922935|468106908|FG002|Overall Study|Physician Decision|0|||
130040832|NCT00922935|468106906|FG000|Overall Study|Lost to Follow-up|0|||
130040833|NCT00922935|468106907|FG001|Overall Study|Lost to Follow-up|1|||
130040834|NCT00922935|468106908|FG002|Overall Study|Lost to Follow-up|0|||
130040835|NCT01499576|468106911|FG000|Overall Study|Physician Decision|12|||
130274777|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
130274778|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
130040836|NCT01499576|468106911|FG000|Overall Study|Withdrawal by Subject|9|||
130040837|NCT04283461|468106912|FG000|Overall Study|Enrolled in separate trial|0|||
130040838|NCT04283461|468106913|FG001|Overall Study|Enrolled in separate trial|0|||
130040839|NCT04283461|468106914|FG002|Overall Study|Enrolled in separate trial|8|||
130040840|NCT04283461|468106915|FG003|Overall Study|Enrolled in separate trial|13|||
130040841|NCT04283461|468106916|FG004|Overall Study|Enrolled in separate trial|12|||
130040842|NCT04283461|468106917|FG005|Overall Study|Enrolled in separate trial|0|||
130040843|NCT04283461|468106918|FG006|Overall Study|Enrolled in separate trial|0|||
130040844|NCT04283461|468106919|FG007|Overall Study|Enrolled in separate trial|8|||
130040845|NCT04283461|468106920|FG008|Overall Study|Enrolled in separate trial|0|||
130040846|NCT04283461|468106921|FG009|Overall Study|Enrolled in separate trial|0|||
130040847|NCT04283461|468106922|FG010|Overall Study|Enrolled in separate trial|0|||
130040848|NCT04283461|468106923|FG011|Overall Study|Enrolled in separate trial|7|||
130040849|NCT04283461|468106924|FG012|Overall Study|Enrolled in separate trial|0|||
130040850|NCT04375878|468106929|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
130040851|NCT04375878|468106930|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
130040852|NCT04375878|468106931|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130040853|NCT04375878|468106932|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130040854|NCT04375878|468106933|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130040855|NCT04375878|468106934|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
130040856|NCT04375878|468106929|FG000|Crossover First and Second Interventions|Adverse Event|0|||
130040857|NCT04375878|468106930|FG001|Crossover First and Second Interventions|Adverse Event|0|||
130040858|NCT04375878|468106931|FG002|Crossover First and Second Interventions|Adverse Event|1|||
130040859|NCT04375878|468106932|FG003|Crossover First and Second Interventions|Adverse Event|0|||
130040860|NCT04375878|468106933|FG004|Crossover First and Second Interventions|Adverse Event|0|||
130040861|NCT04375878|468106934|FG005|Crossover First and Second Interventions|Adverse Event|0|||
130040862|NCT04375878|468106929|FG000|Extension Phase|Withdrawal by Subject|0|||
130040863|NCT04375878|468106930|FG001|Extension Phase|Withdrawal by Subject|0|||
130040864|NCT04375878|468106931|FG002|Extension Phase|Withdrawal by Subject|0|||
130040865|NCT04375878|468106932|FG003|Extension Phase|Withdrawal by Subject|0|||
130040866|NCT04375878|468106933|FG004|Extension Phase|Withdrawal by Subject|1|||
130040867|NCT04375878|468106934|FG005|Extension Phase|Withdrawal by Subject|0|||
130040868|NCT00195351|468106935|FG000|Overall Study|Lost to Follow-up|9|||
130040869|NCT00195351|468106936|FG001|Overall Study|Lost to Follow-up|9|||
130040870|NCT00195351|468106935|FG000|Overall Study|Withdrawal by Subject|6|||
130274779|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
130274780|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
130274781|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
130274782|NCT01667133|468969291|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274783|NCT01667133|468969292|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274784|NCT01667133|468969293|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274785|NCT01667133|468969294|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
130040871|NCT00195351|468106936|FG001|Overall Study|Withdrawal by Subject|3|||
130040872|NCT00195351|468106935|FG000|Overall Study|Protocol Deviation|3|||
130040873|NCT00195351|468106936|FG001|Overall Study|Protocol Deviation|2|||
130040874|NCT00195351|468106935|FG000|Overall Study|Death|3|||
130040875|NCT00195351|468106936|FG001|Overall Study|Death|1|||
130040876|NCT00195351|468106935|FG000|Overall Study|Lack of Efficacy|0|||
130040877|NCT00195351|468106936|FG001|Overall Study|Lack of Efficacy|1|||
129886343|NCT01642186|467545557|FG000|Overall Study|Lost to Follow-up|0|||
130040878|NCT01259466|468106937|FG000|Overall Study|Withdrawal by Subject|1|||
130040879|NCT01259466|468106938|FG001|Overall Study|Withdrawal by Subject|9|||
130040880|NCT01824602|468106939|FG000|Overall Study|Withdrawal by Subject|0|||
130040881|NCT01824602|468106940|FG001|Overall Study|Withdrawal by Subject|0|||
130040882|NCT01824602|468106941|FG002|Overall Study|Withdrawal by Subject|1|||
130040883|NCT01824602|468106942|FG003|Overall Study|Withdrawal by Subject|2|||
130040884|NCT01824602|468106939|FG000|Overall Study|Patient non-compliance|0|||
130040885|NCT01824602|468106940|FG001|Overall Study|Patient non-compliance|0|||
130040886|NCT01824602|468106941|FG002|Overall Study|Patient non-compliance|1|||
130040887|NCT01824602|468106942|FG003|Overall Study|Patient non-compliance|0|||
130040888|NCT01824602|468106939|FG000|Overall Study|Adverse Event|1|||
130040889|NCT01824602|468106940|FG001|Overall Study|Adverse Event|0|||
130040890|NCT01824602|468106941|FG002|Overall Study|Adverse Event|2|||
130040891|NCT01824602|468106942|FG003|Overall Study|Adverse Event|2|||
130040892|NCT01824602|468106939|FG000|Overall Study|Treatment failure|0|||
130040893|NCT01824602|468106940|FG001|Overall Study|Treatment failure|0|||
130040894|NCT01824602|468106941|FG002|Overall Study|Treatment failure|0|||
130040895|NCT01824602|468106942|FG003|Overall Study|Treatment failure|1|||
130040896|NCT02485717|468106945|FG000|Overall Study|Lost to Follow-up|6|||
130040897|NCT02485717|468106946|FG001|Overall Study|Lost to Follow-up|0|||
130040898|NCT02485717|468106947|FG002|Overall Study|Lost to Follow-up|0|||
130040899|NCT02485717|468106945|FG000|Overall Study|Withdrawal by Subject|0|||
130040900|NCT02485717|468106946|FG001|Overall Study|Withdrawal by Subject|0|||
130040901|NCT02485717|468106947|FG002|Overall Study|Withdrawal by Subject|1|||
130040902|NCT02485717|468106945|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
130040903|NCT02485717|468106946|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
130040904|NCT02485717|468106947|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
130040905|NCT02485717|468106945|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
130040906|NCT02485717|468106946|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
130040907|NCT02485717|468106947|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
130040908|NCT05300087|468106952|FG000|Overall Study|Withdrawal by Subject|0|||
130040909|NCT05300087|468106953|FG001|Overall Study|Withdrawal by Subject|1|||
130040910|NCT00761215|468106954|FG000|Overall Study|Randomized but didn't receive drug|1|||
130040911|NCT00761215|468106955|FG001|Overall Study|Randomized but didn't receive drug|1|||
130040912|NCT00761215|468106956|FG002|Overall Study|Randomized but didn't receive drug|2|||
130040913|NCT00761215|468106954|FG000|Overall Study|Lost to Follow-up|6|||
130040914|NCT00761215|468106955|FG001|Overall Study|Lost to Follow-up|3|||
130040915|NCT00761215|468106956|FG002|Overall Study|Lost to Follow-up|6|||
130040916|NCT00761215|468106954|FG000|Overall Study|Withdrawal by Subject|1|||
130040917|NCT00761215|468106955|FG001|Overall Study|Withdrawal by Subject|0|||
130040918|NCT00761215|468106956|FG002|Overall Study|Withdrawal by Subject|0|||
130040919|NCT00761215|468106954|FG000|Overall Study|Bacteremia|1|||
130040920|NCT00761215|468106955|FG001|Overall Study|Bacteremia|0|||
130040921|NCT00761215|468106956|FG002|Overall Study|Bacteremia|0|||
130040922|NCT01450137|468106960|FG000|Up to Week 12|Adverse Event|2|||
130040923|NCT01450137|468106961|FG001|Up to Week 12|Adverse Event|1|||
130040924|NCT01450137|468106960|FG000|Up to Week 12|Withdrawal by Subject|0|||
130040925|NCT01450137|468106961|FG001|Up to Week 12|Withdrawal by Subject|2|||
130040926|NCT01450137|468106960|FG000|Week 12 to Study End|Death|0|||
130040927|NCT01450137|468106961|FG001|Week 12 to Study End|Death|1|||
130040928|NCT01450137|468106960|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
129886344|NCT01642186|467545558|FG001|Overall Study|Lost to Follow-up|0|||
130040929|NCT01450137|468106961|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
130040930|NCT01687673|468106974|FG000|Overall Study|Physician Decision|1|||
130040931|NCT02234622|468106975|FG000|Overall Study|Withdrawal by Subject|16|||
130040932|NCT02234622|468106976|FG001|Overall Study|Withdrawal by Subject|22|||
130040933|NCT02234622|468106975|FG000|Overall Study|Lost to Follow-up|27|||
130104688|NCT04071366|468343123|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
130040934|NCT02234622|468106976|FG001|Overall Study|Lost to Follow-up|14|||
130040935|NCT00618956|468106977|FG000|Overall Study|Adverse Event|10|||
130040936|NCT00618956|468106978|FG001|Overall Study|Adverse Event|34|||
130040937|NCT00618956|468106977|FG000|Overall Study|Lack of Efficacy|2|||
130040938|NCT00618956|468106978|FG001|Overall Study|Lack of Efficacy|1|||
130040939|NCT00618956|468106977|FG000|Overall Study|Withdrawal by Subject|5|||
130040940|NCT00618956|468106978|FG001|Overall Study|Withdrawal by Subject|7|||
130040941|NCT00618956|468106977|FG000|Overall Study|Lost to Follow-up|4|||
130040942|NCT00618956|468106978|FG001|Overall Study|Lost to Follow-up|5|||
130040943|NCT00618956|468106977|FG000|Overall Study|Protocol Violation|2|||
130040944|NCT00618956|468106978|FG001|Overall Study|Protocol Violation|2|||
130040945|NCT00618956|468106977|FG000|Overall Study|did not meet criteria, non-compliance|2|||
130040946|NCT00618956|468106978|FG001|Overall Study|did not meet criteria, non-compliance|1|||
130040947|NCT02006576|468106980|FG000|Overall Study|Withdrawal by Subject|4|||
130040948|NCT02006576|468106981|FG001|Overall Study|Withdrawal by Subject|6|||
130040949|NCT02006576|468106982|FG002|Overall Study|Withdrawal by Subject|2|||
130040950|NCT02006576|468106980|FG000|Overall Study|Death|0|||
130040951|NCT02006576|468106981|FG001|Overall Study|Death|0|||
130040952|NCT02006576|468106982|FG002|Overall Study|Death|1|||
130104689|NCT04071366|468343124|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
130104690|NCT00858234|468343125|FG000|Overall Study|Adverse Event|6|||
130104691|NCT00858234|468343125|FG000|Overall Study|Progressive disease|2|||
130104692|NCT00858234|468343125|FG000|Overall Study|Status unknown|1|||
130104693|NCT01678924|468343126|FG000|Overall Study|Adverse Event|1|||
130104694|NCT01678924|468343127|FG001|Overall Study|Adverse Event|1|||
130104695|NCT01678924|468343128|FG002|Overall Study|Adverse Event|0|||
130274786|NCT01667133|468969295|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274787|NCT01667133|468969296|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274788|NCT01667133|468969297|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274789|NCT01667133|468969298|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274790|NCT01667133|468969299|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274791|NCT01667133|468969300|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274792|NCT01667133|468969301|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274793|NCT01667133|468969302|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
130274794|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
130274795|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
130274796|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
130274797|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
130274798|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
130274799|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
130274800|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
130274801|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
130274802|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
130274803|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
130274804|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
130274805|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
130274806|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274807|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274808|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274809|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274810|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274811|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274812|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130104696|NCT01678924|468343129|FG003|Overall Study|Adverse Event|1|||
130040953|NCT02006576|468106980|FG000|Overall Study|Lost to Follow-up|1|||
130040954|NCT02006576|468106981|FG001|Overall Study|Lost to Follow-up|0|||
130040955|NCT02006576|468106982|FG002|Overall Study|Lost to Follow-up|1|||
130274813|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274814|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130104697|NCT01678924|468343126|FG000|Overall Study|Lack of Efficacy|7|||
130104698|NCT01678924|468343127|FG001|Overall Study|Lack of Efficacy|2|||
130104699|NCT01678924|468343128|FG002|Overall Study|Lack of Efficacy|0|||
130104700|NCT01678924|468343129|FG003|Overall Study|Lack of Efficacy|5|||
130104701|NCT01678924|468343126|FG000|Overall Study|Lost to Follow-up|0|||
130104702|NCT01678924|468343127|FG001|Overall Study|Lost to Follow-up|4|||
130104703|NCT01678924|468343128|FG002|Overall Study|Lost to Follow-up|0|||
130104704|NCT01678924|468343129|FG003|Overall Study|Lost to Follow-up|2|||
130104705|NCT01678924|468343126|FG000|Overall Study|Personal Reasons|2|||
130104706|NCT01678924|468343127|FG001|Overall Study|Personal Reasons|2|||
130104707|NCT01678924|468343128|FG002|Overall Study|Personal Reasons|2|||
130104708|NCT01678924|468343129|FG003|Overall Study|Personal Reasons|7|||
130104709|NCT01678924|468343126|FG000|Overall Study|Withdrawal by Subject|0|||
130104710|NCT01678924|468343127|FG001|Overall Study|Withdrawal by Subject|3|||
130104711|NCT01678924|468343128|FG002|Overall Study|Withdrawal by Subject|0|||
130104712|NCT01678924|468343129|FG003|Overall Study|Withdrawal by Subject|2|||
130104713|NCT01678924|468343126|FG000|Overall Study|Unable to attend scheduled visits|0|||
130104714|NCT01678924|468343127|FG001|Overall Study|Unable to attend scheduled visits|0|||
130104715|NCT01678924|468343128|FG002|Overall Study|Unable to attend scheduled visits|0|||
130104716|NCT01678924|468343129|FG003|Overall Study|Unable to attend scheduled visits|1|||
130104717|NCT00640614|468343133|FG000|Overall Study|Lost to Follow-up|1|||
130104718|NCT00640614|468343134|FG001|Overall Study|Lost to Follow-up|0|||
130104719|NCT00529802|468343135|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
130104720|NCT00529802|468343135|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
130104721|NCT00529802|468343135|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
130104722|NCT00529802|468343135|FG000|Evaluable for Primary Endpoint|Death|1|||
130104723|NCT00529802|468343135|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
130104724|NCT00529802|468343135|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
130104725|NCT00529802|468343135|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
130104726|NCT00021229|468343136|FG000|Overall Study|Adverse Event|10|||
130104727|NCT00021229|468343137|FG001|Overall Study|Adverse Event|5|||
130104728|NCT00021229|468343138|FG002|Overall Study|Adverse Event|2|||
130104729|NCT00021229|468343136|FG000|Overall Study|Death|0|||
130104730|NCT00021229|468343137|FG001|Overall Study|Death|1|||
130104731|NCT00021229|468343138|FG002|Overall Study|Death|0|||
130104732|NCT00021229|468343136|FG000|Overall Study|Withdrawal by Subject|7|||
130104733|NCT00021229|468343137|FG001|Overall Study|Withdrawal by Subject|7|||
130104734|NCT00021229|468343138|FG002|Overall Study|Withdrawal by Subject|1|||
130104735|NCT00021229|468343136|FG000|Overall Study|Progressive Disease|15|||
129886345|NCT01642186|467545559|FG002|Overall Study|Lost to Follow-up|1|||
129886346|NCT00506285|467545561|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
129886347|NCT00506285|467545562|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
130104736|NCT00021229|468343137|FG001|Overall Study|Progressive Disease|19|||
130104737|NCT00021229|468343138|FG002|Overall Study|Progressive Disease|12|||
130104738|NCT00021229|468343136|FG000|Overall Study|Protocol Violation|1|||
130104739|NCT00021229|468343137|FG001|Overall Study|Protocol Violation|1|||
130104740|NCT00021229|468343138|FG002|Overall Study|Protocol Violation|0|||
130104741|NCT00021229|468343136|FG000|Overall Study|Physician Decision|0|||
130104742|NCT00021229|468343137|FG001|Overall Study|Physician Decision|0|||
130104743|NCT00021229|468343138|FG002|Overall Study|Physician Decision|1|||
130104744|NCT00021229|468343136|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
130104745|NCT00021229|468343137|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
130104746|NCT00021229|468343138|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
129886348|NCT00506285|467545561|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
129886349|NCT00506285|467545562|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
130104747|NCT02428231|468343144|FG000|Overall Study|Other|10|||
130104748|NCT02428231|468343145|FG001|Overall Study|Other|16|||
130104749|NCT02428231|468343144|FG000|Overall Study|Required Symptomatic Therapy|0|||
130104750|NCT02428231|468343145|FG001|Overall Study|Required Symptomatic Therapy|1|||
130104751|NCT02428231|468343144|FG000|Overall Study|Adverse Event|3|||
130104752|NCT02428231|468343145|FG001|Overall Study|Adverse Event|0|||
130104753|NCT01784419|468343148|FG000|Overall Study|Adverse Event|3|||
130040956|NCT02006576|468106980|FG000|Overall Study|Screen Failure, too sick, other|13|||
130040957|NCT02006576|468106981|FG001|Overall Study|Screen Failure, too sick, other|1|||
130040958|NCT02006576|468106982|FG002|Overall Study|Screen Failure, too sick, other|13|||
130040959|NCT03478683|468106983|FG000|Overall Study|Adverse Event|5|||
130040960|NCT03478683|468106984|FG001|Overall Study|Adverse Event|3|||
130040961|NCT03478683|468106983|FG000|Overall Study|Lost to Follow-up|0|||
130040962|NCT03478683|468106984|FG001|Overall Study|Lost to Follow-up|5|||
130040963|NCT03478683|468106983|FG000|Overall Study|Physician Decision|1|||
130040964|NCT03478683|468106984|FG001|Overall Study|Physician Decision|3|||
130040965|NCT03478683|468106983|FG000|Overall Study|Withdrawal by Subject|7|||
130040966|NCT03478683|468106984|FG001|Overall Study|Withdrawal by Subject|7|||
130040967|NCT01877655|468106991|FG000|Overall Study|Death|57|||
130040968|NCT01877655|468106992|FG001|Overall Study|Death|52|||
130040969|NCT01877655|468106991|FG000|Overall Study|Withdrawal by Subject|18|||
130040970|NCT01877655|468106992|FG001|Overall Study|Withdrawal by Subject|26|||
130040971|NCT01877655|468106991|FG000|Overall Study|Physician Decision|11|||
130040972|NCT01877655|468106992|FG001|Overall Study|Physician Decision|10|||
130040973|NCT01877655|468106991|FG000|Overall Study|Miscellaneous|4|||
130040974|NCT01877655|468106992|FG001|Overall Study|Miscellaneous|4|||
130040975|NCT01877655|468106991|FG000|Overall Study|Randomized but Never Received Drug|8|||
130040976|NCT01877655|468106992|FG001|Overall Study|Randomized but Never Received Drug|5|||
130040977|NCT02332915|468106993|FG000|Overall Study|Moved out of region|3|||
130040978|NCT02332915|468106994|FG001|Overall Study|Moved out of region|0|||
130040979|NCT02332915|468106993|FG000|Overall Study|Unrelated illness|1|||
130040980|NCT02332915|468106994|FG001|Overall Study|Unrelated illness|1|||
130040981|NCT02332915|468106993|FG000|Overall Study|Travel distance prohibitive|0|||
130040982|NCT02332915|468106994|FG001|Overall Study|Travel distance prohibitive|1|||
130040983|NCT02332915|468106993|FG000|Overall Study|did not meet inclusion criteria|2|||
130040984|NCT02332915|468106994|FG001|Overall Study|did not meet inclusion criteria|4|||
130040985|NCT03497689|468106995|FG000|Overall Study|Adverse Event|2|||
130040986|NCT03497689|468106995|FG000|Overall Study|Death|1|||
130040987|NCT03497689|468106995|FG000|Overall Study|Physician Decision|1|||
130040988|NCT03497689|468106995|FG000|Overall Study|Withdrawal by Subject|1|||
130040989|NCT03497689|468106995|FG000|Overall Study|Protocol Violation|2|||
130040990|NCT03191786|468106996|FG000|Overall Study|Death|236|||
130040991|NCT03191786|468106997|FG001|Overall Study|Death|127|||
130040992|NCT03191786|468106996|FG000|Overall Study|Lost to Follow-up|9|||
130040993|NCT03191786|468106997|FG001|Overall Study|Lost to Follow-up|3|||
130040994|NCT03191786|468106996|FG000|Overall Study|Physician Decision|1|||
130040995|NCT03191786|468106997|FG001|Overall Study|Physician Decision|0|||
130040996|NCT03191786|468106996|FG000|Overall Study|Moved to Post Trial Access Program|30|||
130040997|NCT03191786|468106997|FG001|Overall Study|Moved to Post Trial Access Program|5|||
130040998|NCT03191786|468106996|FG000|Overall Study|Withdrawal by Subject|26|||
130040999|NCT03191786|468106997|FG001|Overall Study|Withdrawal by Subject|16|||
130274815|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
130274816|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274817|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
130274818|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
130041000|NCT05847881|468106998|FG000|Overall Study|Principal Investigator Decision|8|||
130041001|NCT05847881|468106998|FG000|Overall Study|Withdrawal by Subject|2|||
130041002|NCT04513158|468107001|FG000|Overall Study|Screen Failure|1|||
130052128|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
130052129|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130052130|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130052131|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
130052132|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130052133|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
130052134|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
130052135|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
130052136|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
130052137|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
130052138|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
130052139|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
130052140|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
130052141|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Other|0|||
130052142|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Other|1|||
130052143|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Other|0|||
130052144|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Other|0|||
130052145|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Other|0|||
130052146|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Other|0|||
130052147|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Other|0|||
130052148|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
130052149|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
130052150|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
130274819|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
130274820|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
130274821|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
130274822|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
130274823|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
130274824|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
130274825|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
130274826|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
130274827|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
130274828|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
130274829|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
130274830|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274831|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274832|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274833|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274834|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274835|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274836|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274837|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274838|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274839|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
130274840|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274841|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
130274842|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Death|0|||
130274843|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Death|0|||
130041003|NCT04493619|468108266|FG000|Overall Study|Death|4|||
130041004|NCT04493619|468108267|FG001|Overall Study|Death|3|||
130041005|NCT04493619|468108268|FG002|Overall Study|Death|3|||
130041006|NCT04493619|468108269|FG003|Overall Study|Death|4|||
130041007|NCT04493619|468108266|FG000|Overall Study|Study discontinued early|10|||
130041008|NCT04493619|468108267|FG001|Overall Study|Study discontinued early|0|||
130041009|NCT04493619|468108268|FG002|Overall Study|Study discontinued early|4|||
130041010|NCT04493619|468108269|FG003|Overall Study|Study discontinued early|8|||
130041011|NCT04493619|468108266|FG000|Overall Study|Lost to Follow-up|0|||
130041012|NCT04493619|468108267|FG001|Overall Study|Lost to Follow-up|0|||
130041013|NCT04493619|468108268|FG002|Overall Study|Lost to Follow-up|0|||
130041014|NCT04493619|468108269|FG003|Overall Study|Lost to Follow-up|1|||
130041015|NCT02128490|468108272|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130041016|NCT02128490|468108273|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130041017|NCT02128490|468108274|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130041018|NCT02128490|468108275|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
130041019|NCT02128490|468108276|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130041020|NCT02128490|468108272|FG000|Overall Study|Major Protocol Deviation|1|||
130041021|NCT02128490|468108273|FG001|Overall Study|Major Protocol Deviation|2|||
130041022|NCT02128490|468108274|FG002|Overall Study|Major Protocol Deviation|0|||
130041023|NCT02128490|468108275|FG003|Overall Study|Major Protocol Deviation|2|||
130041024|NCT02128490|468108276|FG004|Overall Study|Major Protocol Deviation|2|||
130041025|NCT02128490|468108272|FG000|Overall Study|Lost to Follow-up|0|||
130041026|NCT02128490|468108273|FG001|Overall Study|Lost to Follow-up|0|||
130274844|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Death|0|||
130274845|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Death|0|||
130274846|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Death|0|||
130274847|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Death|0|||
130274848|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Death|0|||
130274849|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Death|0|||
130274850|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Death|0|||
130274851|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Death|1|||
130274852|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Death|0|||
130274853|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Death|0|||
130041027|NCT02128490|468108274|FG002|Overall Study|Lost to Follow-up|1|||
130041028|NCT02128490|468108275|FG003|Overall Study|Lost to Follow-up|1|||
130041029|NCT02128490|468108276|FG004|Overall Study|Lost to Follow-up|1|||
130041030|NCT02128490|468108272|FG000|Overall Study|Voluntary Withdrawal|3|||
130041031|NCT02128490|468108273|FG001|Overall Study|Voluntary Withdrawal|3|||
130041032|NCT02128490|468108274|FG002|Overall Study|Voluntary Withdrawal|1|||
130274854|NCT01667133|468969291|FG000|Phase 2: Dose-expansion|Other|0|||
130274855|NCT01667133|468969292|FG001|Phase 2: Dose-expansion|Other|0|||
130274856|NCT01667133|468969293|FG002|Phase 2: Dose-expansion|Other|0|||
130274857|NCT01667133|468969294|FG003|Phase 2: Dose-expansion|Other|0|||
130274858|NCT01667133|468969295|FG004|Phase 2: Dose-expansion|Other|0|||
130274859|NCT01667133|468969296|FG005|Phase 2: Dose-expansion|Other|0|||
130274860|NCT01667133|468969297|FG006|Phase 2: Dose-expansion|Other|0|||
130274861|NCT01667133|468969298|FG007|Phase 2: Dose-expansion|Other|0|||
130274862|NCT01667133|468969299|FG008|Phase 2: Dose-expansion|Other|0|||
130274863|NCT01667133|468969300|FG009|Phase 2: Dose-expansion|Other|0|||
130274864|NCT01667133|468969301|FG010|Phase 2: Dose-expansion|Other|0|||
130041033|NCT02128490|468108275|FG003|Overall Study|Voluntary Withdrawal|1|||
130041034|NCT02128490|468108276|FG004|Overall Study|Voluntary Withdrawal|2|||
130041035|NCT02128490|468108272|FG000|Overall Study|Lack of Efficacy|0|||
130041036|NCT02128490|468108273|FG001|Overall Study|Lack of Efficacy|1|||
130041037|NCT02128490|468108274|FG002|Overall Study|Lack of Efficacy|0|||
130041038|NCT02128490|468108275|FG003|Overall Study|Lack of Efficacy|0|||
130041039|NCT02128490|468108276|FG004|Overall Study|Lack of Efficacy|0|||
130041040|NCT02128490|468108272|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130041041|NCT02128490|468108273|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130041042|NCT02128490|468108274|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130041043|NCT02128490|468108275|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
130041044|NCT02128490|468108276|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
130041045|NCT02128490|468108272|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130041046|NCT02128490|468108273|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130041047|NCT02128490|468108274|FG002|Overall Study|Other Miscellaneous Reasons|2|||
130041048|NCT02128490|468108275|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130041049|NCT02128490|468108276|FG004|Overall Study|Other Miscellaneous Reasons|1|||
130041050|NCT02243176|468108277|FG000|Overall Study|Other reason|1|||
130041051|NCT02243176|468108278|FG001|Overall Study|Other reason|2|||
130041052|NCT02243176|468108277|FG000|Overall Study|protocol specified withdrawal critera|1|||
130041053|NCT02243176|468108278|FG001|Overall Study|protocol specified withdrawal critera|3|||
130274865|NCT01667133|468969302|FG011|Phase 2: Dose-expansion|Other|1|||
130274866|NCT00289289|468969307|FG000|Overall Study|Withdrawal by Subject|5|||
130274867|NCT00289289|468969308|FG001|Overall Study|Withdrawal by Subject|3|||
130274868|NCT00289289|468969309|FG002|Overall Study|Withdrawal by Subject|15|||
130274869|NCT00289289|468969307|FG000|Overall Study|Lost to Follow-up|1|||
130274870|NCT00289289|468969308|FG001|Overall Study|Lost to Follow-up|0|||
130274871|NCT00289289|468969309|FG002|Overall Study|Lost to Follow-up|1|||
130274872|NCT00289289|468969307|FG000|Overall Study|Death|4|||
130274873|NCT00289289|468969308|FG001|Overall Study|Death|2|||
130274874|NCT00289289|468969309|FG002|Overall Study|Death|5|||
130274875|NCT00289289|468969307|FG000|Overall Study|No implant attempted|0|||
130274876|NCT00289289|468969308|FG001|Overall Study|No implant attempted|0|||
130274877|NCT00289289|468969309|FG002|Overall Study|No implant attempted|1|||
130274878|NCT00289289|468969307|FG000|Overall Study|Physician Decision|1|||
130274879|NCT00289289|468969308|FG001|Overall Study|Physician Decision|0|||
130274880|NCT00289289|468969309|FG002|Overall Study|Physician Decision|6|||
130274881|NCT00289289|468969307|FG000|Overall Study|Non-study device implanted|2|||
130274882|NCT00289289|468969308|FG001|Overall Study|Non-study device implanted|1|||
130274883|NCT00289289|468969309|FG002|Overall Study|Non-study device implanted|3|||
130274884|NCT00289289|468969307|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
130274885|NCT00289289|468969308|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
130274886|NCT00289289|468969309|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
130274887|NCT00289289|468969307|FG000|Overall Study|Other Exit Reason|6|||
130274888|NCT00289289|468969308|FG001|Overall Study|Other Exit Reason|4|||
130041054|NCT02243176|468108277|FG000|Overall Study|Protocol Violation|2|||
130041055|NCT02243176|468108278|FG001|Overall Study|Protocol Violation|1|||
130041056|NCT02243176|468108277|FG000|Overall Study|Withdrawal by Subject|8|||
130041057|NCT02243176|468108278|FG001|Overall Study|Withdrawal by Subject|7|||
130041058|NCT02243176|468108277|FG000|Overall Study|Adverse Event|2|||
130041059|NCT02243176|468108278|FG001|Overall Study|Adverse Event|2|||
130041060|NCT02342171|468108282|FG000|Overall Study|Death|4|||
130041061|NCT02342171|468108283|FG001|Overall Study|Death|87|||
130041062|NCT02342171|468108282|FG000|Overall Study|Received favipiravir|10|||
130274889|NCT00289289|468969309|FG002|Overall Study|Other Exit Reason|12|||
130274890|NCT02567799|468969310|FG000|Concurrent Chemoradiotherapy|Death|1|||
130274891|NCT02567799|468969311|FG001|Concurrent Chemoradiotherapy|Death|0|||
130274892|NCT02567799|468969312|FG002|Concurrent Chemoradiotherapy|Death|0|||
130104754|NCT01336608|468343149|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
130274893|NCT02567799|468969310|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
130274894|NCT02567799|468969311|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
130274895|NCT02567799|468969312|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
130274896|NCT02567799|468969310|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
130041063|NCT02342171|468108283|FG001|Overall Study|Received favipiravir|0|||
130041064|NCT02342171|468108282|FG000|Overall Study|Missing cycle treshold value|1|||
130041065|NCT02342171|468108283|FG001|Overall Study|Missing cycle treshold value|0|||
130041066|NCT02342171|468108282|FG000|Overall Study|Unknown outcome|0|||
130041067|NCT02342171|468108283|FG001|Overall Study|Unknown outcome|1|||
130041068|NCT02342171|468108282|FG000|Overall Study|Missing age data|0|||
130274897|NCT02567799|468969311|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
130274898|NCT02567799|468969312|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
130274899|NCT02567799|468969310|FG000|Follow-up|Death|1|||
130274900|NCT02567799|468969311|FG001|Follow-up|Death|0|||
130274901|NCT02567799|468969312|FG002|Follow-up|Death|1|||
130274902|NCT02567799|468969310|FG000|Follow-up|Progressive Disease|1|||
130274903|NCT02567799|468969311|FG001|Follow-up|Progressive Disease|1|||
130041069|NCT02342171|468108283|FG001|Overall Study|Missing age data|1|||
130041070|NCT03518840|468108286|FG000|Overall Study|Lost to Follow-up|6|||
130041071|NCT03704051|468108287|FG000|Overall Study|Withdrawal by Subject|4|||
130041072|NCT03704051|468108288|FG001|Overall Study|Withdrawal by Subject|0|||
130041073|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
130041074|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
130041075|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
130104755|NCT01336608|468343150|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130104756|NCT01336608|468343151|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130104757|NCT01336608|468343152|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130104758|NCT01336608|468343149|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
130104759|NCT01336608|468343150|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130104760|NCT01336608|468343151|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130104761|NCT01336608|468343152|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130104762|NCT01336608|468343149|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
130104763|NCT01336608|468343150|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130104764|NCT01336608|468343151|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130104765|NCT01336608|468343152|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130104766|NCT01336608|468343149|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
130104767|NCT01336608|468343150|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130104768|NCT01336608|468343151|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130104769|NCT01336608|468343152|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130104770|NCT01336608|468343149|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
130104771|NCT01336608|468343150|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130104772|NCT01336608|468343151|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130104773|NCT01336608|468343152|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130104774|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130274904|NCT02567799|468969312|FG002|Follow-up|Progressive Disease|3|||
130274905|NCT00349349|468969314|FG000|Overall Study|Adverse Event|5|||
130104775|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
130104776|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
130104777|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
130104778|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130104779|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130104780|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130104781|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130104782|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130104783|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130104784|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130104785|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
130104786|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130104787|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130104788|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130104789|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130274906|NCT00349349|468969315|FG001|Overall Study|Adverse Event|6|||
130274907|NCT00349349|468969316|FG002|Overall Study|Adverse Event|2|||
130274908|NCT00349349|468969314|FG000|Overall Study|Withdrawal by Subject|5|||
130274909|NCT00349349|468969315|FG001|Overall Study|Withdrawal by Subject|2|||
130274910|NCT00349349|468969316|FG002|Overall Study|Withdrawal by Subject|1|||
130274911|NCT00349349|468969314|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
130274912|NCT00349349|468969315|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
130274913|NCT00349349|468969316|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
130041076|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
130274914|NCT00349349|468969314|FG000|Overall Study|Death|13|||
130274915|NCT00349349|468969315|FG001|Overall Study|Death|10|||
130274916|NCT00349349|468969316|FG002|Overall Study|Death|1|||
130274917|NCT00349349|468969314|FG000|Overall Study|Other Treatment Selected|2|||
130274918|NCT00349349|468969315|FG001|Overall Study|Other Treatment Selected|0|||
130274919|NCT00349349|468969316|FG002|Overall Study|Other Treatment Selected|0|||
130274920|NCT00349349|468969314|FG000|Overall Study|Participant Reduced General Condition|0|||
130274921|NCT00349349|468969315|FG001|Overall Study|Participant Reduced General Condition|1|||
130274922|NCT00349349|468969316|FG002|Overall Study|Participant Reduced General Condition|0|||
130274923|NCT00349349|468969314|FG000|Overall Study|Physician Decision|1|||
130274924|NCT00349349|468969315|FG001|Overall Study|Physician Decision|2|||
130274925|NCT00349349|468969316|FG002|Overall Study|Physician Decision|1|||
130274926|NCT00349349|468969314|FG000|Overall Study|No Response|0|||
130274927|NCT00349349|468969315|FG001|Overall Study|No Response|3|||
130274928|NCT00349349|468969316|FG002|Overall Study|No Response|0|||
130274929|NCT00349349|468969314|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
130274930|NCT00349349|468969315|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
130041077|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
130041078|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
130041079|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
130041080|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
130041081|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
130041082|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
130041083|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
130041084|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
130041085|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
130041086|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
130041087|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
130041088|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
130041089|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
130041090|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
130041091|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Death|0|||
130041092|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Death|1|||
130041093|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Death|0|||
130041094|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
130041095|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
130041096|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
130041097|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
130041098|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
130041099|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
130041100|NCT00430781|468108291|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
130041101|NCT00430781|468108292|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
130041102|NCT00430781|468108293|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
130041103|NCT00430781|468108291|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
130041104|NCT00430781|468108292|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
130041105|NCT00430781|468108293|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
130041106|NCT00430781|468108291|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
130041107|NCT00430781|468108292|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
130041108|NCT00430781|468108293|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
130041109|NCT00430781|468108291|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
130041110|NCT00430781|468108292|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
130041111|NCT00430781|468108293|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
130041112|NCT00430781|468108291|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
130041113|NCT00430781|468108292|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
130041114|NCT00430781|468108293|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
130041115|NCT00430781|468108291|FG000|Final Analysis; 31 July 2008|Other|0|||
130041116|NCT00430781|468108292|FG001|Final Analysis; 31 July 2008|Other|1|||
130041117|NCT00430781|468108293|FG002|Final Analysis; 31 July 2008|Other|0|||
130274931|NCT00349349|468969316|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
130274932|NCT01854775|468969321|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
130274933|NCT01854775|468969322|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
129886350|NCT00506285|467545561|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
130041118|NCT00430781|468108291|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
130041119|NCT00430781|468108292|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
130041120|NCT00430781|468108293|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
130041121|NCT00430781|468108291|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
130041122|NCT00430781|468108292|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
130274934|NCT01854775|468969323|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
130274935|NCT01854775|468969321|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
130274936|NCT01854775|468969322|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
130041123|NCT00430781|468108293|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
130041124|NCT00430781|468108291|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
130041125|NCT00430781|468108292|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
130104790|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
130104791|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
130104792|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
130104793|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
130104794|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130104795|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130104796|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130104797|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130104798|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130104799|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
130104800|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130104801|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
130104802|NCT01336608|468343149|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130104803|NCT01336608|468343150|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130104804|NCT01336608|468343151|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
130104805|NCT01336608|468343152|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
130104806|NCT00080288|468343153|FG000|Overall Study|Adverse Event|7|||
130104807|NCT00080288|468343154|FG001|Overall Study|Adverse Event|4|||
130104808|NCT00080288|468343153|FG000|Overall Study|Lost to Follow-up|3|||
130104809|NCT00080288|468343154|FG001|Overall Study|Lost to Follow-up|5|||
130104810|NCT00080288|468343153|FG000|Overall Study|Physician Decision|6|||
130104811|NCT00080288|468343154|FG001|Overall Study|Physician Decision|2|||
130104812|NCT00080288|468343153|FG000|Overall Study|Withdrawal by Subject|3|||
130104813|NCT00080288|468343154|FG001|Overall Study|Withdrawal by Subject|16|||
130104814|NCT00080288|468343153|FG000|Overall Study|Miscellaneous|11|||
130104815|NCT00080288|468343154|FG001|Overall Study|Miscellaneous|11|||
130104816|NCT04470622|468343155|FG000|Overall Study|Withdrawal by Subject|0|||
130104817|NCT04470622|468343156|FG001|Overall Study|Withdrawal by Subject|1|||
130104818|NCT04470622|468343155|FG000|Overall Study|Screen Failure|0|||
130104819|NCT04470622|468343156|FG001|Overall Study|Screen Failure|1|||
130104820|NCT04470622|468343155|FG000|Overall Study|Death|0|||
130104821|NCT04470622|468343156|FG001|Overall Study|Death|1|||
130104822|NCT00953927|468343157|FG000|Overall Study|Lost to Follow-up|61|||
130104823|NCT00953927|468343158|FG001|Overall Study|Lost to Follow-up|65|||
130104824|NCT00953927|468343157|FG000|Overall Study|Withdrawal by Subject|36|||
130104825|NCT00953927|468343158|FG001|Overall Study|Withdrawal by Subject|25|||
130104826|NCT00953927|468343157|FG000|Overall Study|Death|7|||
130104827|NCT00953927|468343158|FG001|Overall Study|Death|4|||
130104828|NCT00953927|468343157|FG000|Overall Study|Other study discontinuation|1|||
130104829|NCT00953927|468343158|FG001|Overall Study|Other study discontinuation|1|||
130104830|NCT00765999|468343162|FG000|Overall Study|Adverse Event|203|||
130104831|NCT00765999|468343162|FG000|Overall Study|Insufficient Therapeutic Response|100|||
130104832|NCT00765999|468343162|FG000|Overall Study|Protocol Violation|95|||
130104833|NCT00765999|468343162|FG000|Overall Study|Consent Withdrawn|202|||
130104834|NCT00765999|468343162|FG000|Overall Study|Lost to Follow-up|131|||
130104835|NCT00765999|468343162|FG000|Overall Study|Study Terminated by Sponsor|2|||
130104836|NCT00765999|468343162|FG000|Overall Study|Other Miscellaneous Reasons|51|||
130104837|NCT04840901|468343165|FG000|Overall Study|Lost to Follow-up|3|||
130041126|NCT00430781|468108293|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
130041127|NCT00430781|468108291|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
130041128|NCT00430781|468108292|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
130041129|NCT00430781|468108293|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
130041130|NCT00430781|468108291|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
130041131|NCT00430781|468108292|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
130041132|NCT00430781|468108293|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
130041133|NCT00430781|468108291|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
130041134|NCT00430781|468108292|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
130104838|NCT04840901|468343166|FG001|Overall Study|Lost to Follow-up|1|||
130104839|NCT04840901|468343165|FG000|Overall Study|Moved|1|||
130104840|NCT04840901|468343166|FG001|Overall Study|Moved|0|||
130104841|NCT04840901|468343165|FG000|Overall Study|Unable to comply with study schedule|0|||
130104842|NCT04840901|468343166|FG001|Overall Study|Unable to comply with study schedule|1|||
130104843|NCT04840901|468343165|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
130041135|NCT00430781|468108293|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
130041136|NCT00430781|468108291|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
130104844|NCT04840901|468343166|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
130041137|NCT00430781|468108292|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
130041138|NCT00430781|468108293|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
130041139|NCT04329949|468108296|FG000|Overall Study|Death|36|||
130041140|NCT04329949|468108296|FG000|Overall Study|Withdrawal by Subject|4|||
130041141|NCT04329949|468108296|FG000|Overall Study|Termination of study by sponsor|3|||
130041142|NCT01335971|468108301|FG000|Overall Study|Withdrawal by Subject|1|||
130041143|NCT01335971|468108302|FG001|Overall Study|Withdrawal by Subject|0|||
130041144|NCT01335971|468108303|FG002|Overall Study|Withdrawal by Subject|0|||
130041145|NCT01335971|468108301|FG000|Overall Study|Did not complete bronchoscopy|1|||
130041146|NCT01335971|468108302|FG001|Overall Study|Did not complete bronchoscopy|1|||
130041147|NCT01335971|468108303|FG002|Overall Study|Did not complete bronchoscopy|1|||
130041148|NCT00384956|468108304|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
130041149|NCT00149214|468108308|FG000|Overall Study|Adverse Event|12|||
130041150|NCT00149214|468108309|FG001|Overall Study|Adverse Event|9|||
130041151|NCT00149214|468108308|FG000|Overall Study|Withdrawal by Subject|4|||
130041152|NCT00149214|468108309|FG001|Overall Study|Withdrawal by Subject|1|||
130041153|NCT00149214|468108308|FG000|Overall Study|Physician Decision|3|||
130041154|NCT00149214|468108309|FG001|Overall Study|Physician Decision|3|||
130041155|NCT00149214|468108308|FG000|Overall Study|Sponsor Decision|0|||
130041156|NCT00149214|468108309|FG001|Overall Study|Sponsor Decision|1|||
130041157|NCT00149214|468108308|FG000|Overall Study|Progressive Disease|7|||
130041158|NCT00149214|468108309|FG001|Overall Study|Progressive Disease|3|||
130041159|NCT01451515|468108310|FG000|Overall Study|Death|0|||
130041160|NCT01451515|468108311|FG001|Overall Study|Death|1|||
130041161|NCT01451515|468108312|FG002|Overall Study|Death|0|||
130041162|NCT01451515|468108310|FG000|Overall Study|Withdrawal by Subject|0|||
130041163|NCT01451515|468108311|FG001|Overall Study|Withdrawal by Subject|1|||
130041164|NCT01451515|468108312|FG002|Overall Study|Withdrawal by Subject|0|||
130041165|NCT01451515|468108310|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
130041166|NCT01451515|468108311|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
130041167|NCT01451515|468108312|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
130041168|NCT01451515|468108310|FG000|Overall Study|Relapse (except CNS)|1|||
130041169|NCT01451515|468108311|FG001|Overall Study|Relapse (except CNS)|1|||
130041170|NCT01451515|468108312|FG002|Overall Study|Relapse (except CNS)|0|||
130041171|NCT03126227|468108315|FG000|Overall Study|Adverse Event|43|||
130041172|NCT03126227|468108316|FG001|Overall Study|Adverse Event|4|||
130041173|NCT03126227|468108315|FG000|Overall Study|Death|0|||
130041174|NCT03126227|468108316|FG001|Overall Study|Death|1|||
130041175|NCT03126227|468108315|FG000|Overall Study|Lost to Follow-up|0|||
130041176|NCT03126227|468108316|FG001|Overall Study|Lost to Follow-up|1|||
130041177|NCT03126227|468108315|FG000|Overall Study|Physician Decision|2|||
130041178|NCT03126227|468108316|FG001|Overall Study|Physician Decision|0|||
130041179|NCT03126227|468108315|FG000|Overall Study|Protocol Violation|1|||
130041180|NCT03126227|468108316|FG001|Overall Study|Protocol Violation|0|||
130041181|NCT03126227|468108315|FG000|Overall Study|Withdrawal by Subject|19|||
130041182|NCT03126227|468108316|FG001|Overall Study|Withdrawal by Subject|3|||
130041183|NCT03126227|468108315|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
130041184|NCT03126227|468108316|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
130041185|NCT03126227|468108315|FG000|Overall Study|Lack of dosing compliance|2|||
130041186|NCT03126227|468108316|FG001|Overall Study|Lack of dosing compliance|0|||
130041187|NCT03126227|468108315|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
130041188|NCT03126227|468108316|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
130041189|NCT03126227|468108315|FG000|Overall Study|Scheduling conflict|1|||
130041190|NCT03126227|468108316|FG001|Overall Study|Scheduling conflict|0|||
130041191|NCT03230097|468108319|FG000|Overall Study|Adverse Event|2|||
130041192|NCT03230097|468108320|FG001|Overall Study|Adverse Event|1|||
130041193|NCT03230097|468108319|FG000|Overall Study|non-compliance|0|||
130041194|NCT03230097|468108320|FG001|Overall Study|non-compliance|1|||
130041195|NCT03230097|468108319|FG000|Overall Study|Lost to Follow-up|2|||
130041196|NCT03230097|468108320|FG001|Overall Study|Lost to Follow-up|4|||
130041197|NCT03230097|468108319|FG000|Overall Study|Withdrawal by Subject|7|||
130041198|NCT03230097|468108320|FG001|Overall Study|Withdrawal by Subject|3|||
130274937|NCT01854775|468969323|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
130041199|NCT03230097|468108319|FG000|Overall Study|Trial termination|4|||
130041200|NCT03230097|468108320|FG001|Overall Study|Trial termination|5|||
130041201|NCT03230097|468108319|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
130041202|NCT03230097|468108320|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
130041203|NCT03230097|468108319|FG000|Overall Study|outcome event|0|||
130041204|NCT03230097|468108320|FG001|Overall Study|outcome event|1|||
130041205|NCT03794986|468108321|FG000|Overall Study|0 Sessions Attended|34|||
130041206|NCT03794986|468108322|FG001|Overall Study|0 Sessions Attended|37|||
130041207|NCT03794986|468108321|FG000|Overall Study|Withdrawal by Subject|4|||
130041208|NCT03794986|468108322|FG001|Overall Study|Withdrawal by Subject|6|||
130041209|NCT03794986|468108321|FG000|Overall Study|Protocol Violation|1|||
130041210|NCT03794986|468108322|FG001|Overall Study|Protocol Violation|0|||
130041211|NCT05309083|468108323|FG000|Overall Study|Withdrawal by Subject|2|||
130041212|NCT01165229|468108324|FG000|Overall Study|Serious Adverse Event|456|||
130041213|NCT01165229|468108325|FG001|Overall Study|Serious Adverse Event|487|||
130041214|NCT01165229|468108324|FG000|Overall Study|Non-Serious Adverse Event|47|||
130041215|NCT01165229|468108325|FG001|Overall Study|Non-Serious Adverse Event|15|||
130041216|NCT01165229|468108324|FG000|Overall Study|Protocol Violation|6|||
130041217|NCT01165229|468108325|FG001|Overall Study|Protocol Violation|8|||
130104845|NCT01268683|468343167|FG000|Overall Study|Lost to Follow-up|1|||
130104846|NCT01268683|468343167|FG000|Overall Study|Death|1|||
130274938|NCT01854775|468969321|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
130274939|NCT01854775|468969322|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
130274940|NCT01854775|468969323|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
130274941|NCT01854775|468969321|FG000|Extension Phase|Pregnancy|3|||
130274942|NCT01854775|468969322|FG001|Extension Phase|Pregnancy|0|||
130274943|NCT01854775|468969323|FG002|Extension Phase|Pregnancy|0|||
130274944|NCT01854775|468969321|FG000|Extension Phase|Investigator's Discretion|1|||
130274945|NCT01854775|468969322|FG001|Extension Phase|Investigator's Discretion|0|||
130274946|NCT01854775|468969323|FG002|Extension Phase|Investigator's Discretion|0|||
130274947|NCT01854775|468969321|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
130274948|NCT01854775|468969322|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
130041218|NCT01165229|468108324|FG000|Overall Study|Withdrawal by Subject|387|||
130041219|NCT01165229|468108325|FG001|Overall Study|Withdrawal by Subject|396|||
130041220|NCT01165229|468108324|FG000|Overall Study|Migrated/moved from study area|51|||
130041221|NCT01165229|468108325|FG001|Overall Study|Migrated/moved from study area|46|||
130041222|NCT01165229|468108324|FG000|Overall Study|Lost to Follow-up|123|||
130104847|NCT02216214|468343168|FG000|Overall Study|Randomized Never Received Study Drug|1|||
130104848|NCT02216214|468343169|FG001|Overall Study|Randomized Never Received Study Drug|0|||
130104849|NCT02216214|468343168|FG000|Overall Study|Adverse Event|10|||
130104850|NCT02216214|468343169|FG001|Overall Study|Adverse Event|8|||
130104851|NCT02216214|468343168|FG000|Overall Study|Lack of Efficacy|2|||
130104852|NCT02216214|468343169|FG001|Overall Study|Lack of Efficacy|2|||
130104853|NCT02216214|468343168|FG000|Overall Study|Lost to Follow-up|3|||
130104854|NCT02216214|468343169|FG001|Overall Study|Lost to Follow-up|2|||
130104855|NCT02216214|468343168|FG000|Overall Study|Protocol Violation|4|||
130104856|NCT02216214|468343169|FG001|Overall Study|Protocol Violation|2|||
130104857|NCT02216214|468343168|FG000|Overall Study|Withdrawal by Subject|22|||
130104858|NCT02216214|468343169|FG001|Overall Study|Withdrawal by Subject|20|||
130104859|NCT02216214|468343168|FG000|Overall Study|Study Terminated By Sponsor|0|||
130104860|NCT02216214|468343169|FG001|Overall Study|Study Terminated By Sponsor|1|||
130104861|NCT02216214|468343168|FG000|Overall Study|Miscellaneous|1|||
130104862|NCT02216214|468343169|FG001|Overall Study|Miscellaneous|1|||
130104863|NCT00713830|468343170|FG000|Overall Study|Adverse Event|23|||
130104864|NCT00713830|468343171|FG001|Overall Study|Adverse Event|71|||
130104865|NCT00713830|468343170|FG000|Overall Study|Lack of Efficacy|24|||
130041223|NCT01165229|468108325|FG001|Overall Study|Lost to Follow-up|133|||
130041224|NCT01165229|468108324|FG000|Overall Study|Suspected HZ Episode|2|||
130041225|NCT01165229|468108325|FG001|Overall Study|Suspected HZ Episode|2|||
130041226|NCT01165229|468108324|FG000|Overall Study|No reason from the subject|108|||
130041227|NCT01165229|468108325|FG001|Overall Study|No reason from the subject|102|||
130041228|NCT01165229|468108324|FG000|Overall Study|Unknown completion status|0|||
130041229|NCT01165229|468108325|FG001|Overall Study|Unknown completion status|1|||
130041230|NCT00881205|468108329|FG000|Overall Study|Adverse Event|8|||
130041231|NCT00881205|468108330|FG001|Overall Study|Adverse Event|3|||
130041232|NCT00881205|468108329|FG000|Overall Study|Withdrawal by Subject|1|||
130041233|NCT00881205|468108330|FG001|Overall Study|Withdrawal by Subject|2|||
130041234|NCT00881205|468108329|FG000|Overall Study|Lost to Follow-up|0|||
130104866|NCT00713830|468343171|FG001|Overall Study|Lack of Efficacy|16|||
130104867|NCT00713830|468343170|FG000|Overall Study|Lost to Follow-up|2|||
130104868|NCT00713830|468343171|FG001|Overall Study|Lost to Follow-up|9|||
130041235|NCT00881205|468108330|FG001|Overall Study|Lost to Follow-up|1|||
130104869|NCT00713830|468343170|FG000|Overall Study|Withdrawal by Subject|13|||
130104870|NCT00713830|468343171|FG001|Overall Study|Withdrawal by Subject|23|||
130104871|NCT00713830|468343170|FG000|Overall Study|Poor Compliance to Protocol|7|||
130041236|NCT00881205|468108329|FG000|Overall Study|Administrative problems|1|||
130041237|NCT00881205|468108330|FG001|Overall Study|Administrative problems|1|||
130041238|NCT00881205|468108329|FG000|Overall Study|Condition no longer requires drug|1|||
130041239|NCT00881205|468108330|FG001|Overall Study|Condition no longer requires drug|0|||
130041240|NCT00465569|468108333|FG000|Overall Study|persistent eczema during dose escalation|1|||
130041241|NCT00465569|468108334|FG001|Overall Study|persistent eczema during dose escalation|0|||
130041242|NCT04786210|468108335|FG000|Overall Study|Lost to Follow-up|2|||
130041243|NCT04786210|468108335|FG000|Overall Study|Withdrawal by Subject|4|||
130041244|NCT00095303|468108336|FG000|Main Study|Lost to Follow-up|91|||
130041245|NCT00095303|468108337|FG001|Main Study|Lost to Follow-up|87|||
130041246|NCT00095303|468108336|FG000|Follow Up Study|Lost to Follow-up|59|||
130041247|NCT00095303|468108337|FG001|Follow Up Study|Lost to Follow-up|58|||
130041248|NCT01364467|468108338|FG000|Overall Study|Lost to Follow-up|1|||
130041249|NCT01364467|468108339|FG001|Overall Study|Lost to Follow-up|2|||
130041250|NCT01634243|468108340|FG000|Overall Study|Adverse Event|5|||
130041251|NCT01634243|468108341|FG001|Overall Study|Adverse Event|5|||
130041252|NCT01634243|468108340|FG000|Overall Study|Lack of Efficacy|1|||
130041253|NCT01634243|468108341|FG001|Overall Study|Lack of Efficacy|0|||
130041254|NCT00587223|468108348|FG000|Overall Study|Adverse Event|1|||
130041255|NCT00883753|468108349|FG000|Overall Study|Adverse Event|37|||
130041256|NCT00883753|468108349|FG000|Overall Study|Death|2|||
130041257|NCT00883753|468108349|FG000|Overall Study|Insufficient therapeutic response|16|||
130041258|NCT00883753|468108349|FG000|Overall Study|Lost to Follow-up|4|||
130041259|NCT00883753|468108349|FG000|Overall Study|Violation of selection criteria at entry|7|||
130041260|NCT00883753|468108349|FG000|Overall Study|Protocol Violation|2|||
130041261|NCT00883753|468108349|FG000|Overall Study|Refused treatment|4|||
130041262|NCT00883753|468108349|FG000|Overall Study|Withdrew consent|10|||
130041263|NCT00883753|468108349|FG000|Overall Study|Investigator's decision|17|||
130041264|NCT00883753|468108349|FG000|Overall Study|Administrative/Other|8|||
130041265|NCT00971321|468108352|FG000|Up to Month 7|Withdrawal by Subject|1|||
130041266|NCT00971321|468108353|FG001|Up to Month 7|Withdrawal by Subject|0|||
130041267|NCT00971321|468108352|FG000|Up to Month 7|Migrated/moved from study area|3|||
130041268|NCT00971321|468108353|FG001|Up to Month 7|Migrated/moved from study area|2|||
130041269|NCT00971321|468108352|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
130041270|NCT00971321|468108353|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
130041271|NCT00971321|468108352|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
130041272|NCT00971321|468108353|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
130041273|NCT00971321|468108352|FG000|Up to Month 11-12|Lost to Follow-up|1|||
130041274|NCT00971321|468108353|FG001|Up to Month 11-12|Lost to Follow-up|0|||
130041275|NCT00519623|468108356|FG000|Overall Study|Adverse Event|1|||
130041276|NCT02296840|468108360|FG000|Overall Study|Adverse Event|1|||
130041277|NCT02296840|468108361|FG001|Overall Study|Adverse Event|1|||
130041278|NCT02296840|468108360|FG000|Overall Study|Protocol Violation|2|||
130041279|NCT02296840|468108361|FG001|Overall Study|Protocol Violation|1|||
130041280|NCT02296840|468108360|FG000|Overall Study|Lost to Follow-up|6|||
130041281|NCT02296840|468108361|FG001|Overall Study|Lost to Follow-up|17|||
130041282|NCT00104871|468108362|FG000|Overall Study|Not evaluable|1|||
130041283|NCT01476787|468108370|FG000|Treatment|Progression|64|||
130041284|NCT01476787|468108371|FG001|Treatment|Progression|71|||
130041285|NCT01476787|468108370|FG000|Treatment|Toxicity|44|||
130041286|NCT01476787|468108371|FG001|Treatment|Toxicity|16|||
130041287|NCT01476787|468108370|FG000|Treatment|Death|0|||
130041288|NCT01476787|468108371|FG001|Treatment|Death|1|||
130041289|NCT01476787|468108370|FG000|Treatment|Withdrawal by Subject|3|||
130041290|NCT01476787|468108371|FG001|Treatment|Withdrawal by Subject|14|||
130274949|NCT01854775|468969323|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
130274950|NCT01854775|468969321|FG000|Extension Phase|Lost to Follow-up|2|||
130274951|NCT01854775|468969322|FG001|Extension Phase|Lost to Follow-up|0|||
130274952|NCT01854775|468969323|FG002|Extension Phase|Lost to Follow-up|0|||
130274953|NCT01854775|468969321|FG000|Extension Phase|Still on Study|32|||
130274954|NCT01854775|468969322|FG001|Extension Phase|Still on Study|47|||
130274955|NCT01854775|468969323|FG002|Extension Phase|Still on Study|18|||
130274956|NCT05111002|468969324|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
130274957|NCT05111002|468969325|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
130274958|NCT05111002|468969324|FG000|Secondary Outcome|Lost to Follow-up|1|||
130041291|NCT01476787|468108370|FG000|Treatment|Major protocol violation|1|||
130041292|NCT01476787|468108371|FG001|Treatment|Major protocol violation|6|||
130041293|NCT01476787|468108370|FG000|Treatment|Other reasons|10|||
130041294|NCT01476787|468108371|FG001|Treatment|Other reasons|22|||
130041295|NCT01476787|468108370|FG000|Treatment|Concurrent illness|12|||
130041296|NCT01476787|468108371|FG001|Treatment|Concurrent illness|9|||
130041297|NCT01476787|468108370|FG000|Treatment|Insufficient response|15|||
130274959|NCT05111002|468969325|FG001|Secondary Outcome|Lost to Follow-up|0|||
130274960|NCT04776720|468969328|FG000|Overall Study|COVID Related|4|||
130041298|NCT01476787|468108371|FG001|Treatment|Insufficient response|3|||
130041299|NCT01476787|468108370|FG000|Treatment|Voluntary treatment discontinuation|8|||
130274961|NCT04776720|468969329|FG001|Overall Study|COVID Related|2|||
130041300|NCT01476787|468108371|FG001|Treatment|Voluntary treatment discontinuation|4|||
130041301|NCT01926886|468108372|FG000|Overall Study|Administrative/other|1|||
130041302|NCT01926886|468108373|FG001|Overall Study|Administrative/other|0|||
130041303|NCT01926886|468108372|FG000|Overall Study|Adverse event/intercurrent illness|4|||
130041304|NCT01926886|468108373|FG001|Overall Study|Adverse event/intercurrent illness|0|||
130041305|NCT01926886|468108372|FG000|Overall Study|Disease progression/recurrence|4|||
130041306|NCT01926886|468108373|FG001|Overall Study|Disease progression/recurrence|0|||
130041307|NCT01926886|468108372|FG000|Overall Study|Withdrawal by Subject|15|||
130041308|NCT01926886|468108373|FG001|Overall Study|Withdrawal by Subject|0|||
130041309|NCT01926886|468108372|FG000|Overall Study|Failure to return|3|||
130041310|NCT01926886|468108373|FG001|Overall Study|Failure to return|0|||
130041311|NCT01926886|468108372|FG000|Overall Study|Recurrence of disease|1|||
130041312|NCT01926886|468108373|FG001|Overall Study|Recurrence of disease|0|||
130041313|NCT01926886|468108372|FG000|Overall Study|Progression of disease|2|||
130041314|NCT01926886|468108373|FG001|Overall Study|Progression of disease|0|||
130041315|NCT01926886|468108372|FG000|Overall Study|Death|1|||
130041316|NCT01926886|468108373|FG001|Overall Study|Death|0|||
130041317|NCT01926886|468108372|FG000|Overall Study|Did not cooperate|1|||
130041318|NCT01926886|468108373|FG001|Overall Study|Did not cooperate|0|||
130041319|NCT01450540|468108374|FG000|Overall Study|Withdrawal by Subject|19|||
130041320|NCT01450540|468108375|FG001|Overall Study|Withdrawal by Subject|13|||
130041321|NCT01450540|468108374|FG000|Overall Study|protocol deviation|3|||
130041322|NCT01450540|468108375|FG001|Overall Study|protocol deviation|23|||
130041323|NCT01662999|468108384|FG000|Period 3|Withdrawal by Subject|0|||
130041324|NCT01662999|468108385|FG001|Period 3|Withdrawal by Subject|1|||
130041325|NCT01662999|468108386|FG002|Period 3|Withdrawal by Subject|0|||
130041326|NCT01662999|468108387|FG003|Period 3|Withdrawal by Subject|0|||
130041327|NCT01662999|468108388|FG004|Period 3|Withdrawal by Subject|0|||
130041328|NCT01662999|468108389|FG005|Period 3|Withdrawal by Subject|0|||
130041329|NCT04090164|468108390|FG000|Overall Study|incomplete data on file|245|||
130041330|NCT04090164|468108391|FG001|Overall Study|incomplete data on file|0|||
130041331|NCT01650805|468108392|FG000|Overall Study|Withdrawal by Subject|1|||
130041332|NCT01650805|468108393|FG001|Overall Study|Withdrawal by Subject|0|||
130041333|NCT02452359|468108394|FG000|Overall Study|Adverse Event|1|||
130041334|NCT02452359|468108394|FG000|Overall Study|Lost to Follow-up|15|||
130041335|NCT02452359|468108394|FG000|Overall Study|Pregnancy|1|||
130041336|NCT02452359|468108394|FG000|Overall Study|Withdrawal by Subject|4|||
130041337|NCT01887210|468108395|FG000|Overall Study|Withdrawal by Subject|1|||
130041338|NCT01887210|468108396|FG001|Overall Study|Withdrawal by Subject|3|||
130041339|NCT01887210|468108395|FG000|Overall Study|Lost to Follow-up|0|||
130041340|NCT01887210|468108396|FG001|Overall Study|Lost to Follow-up|1|||
130041341|NCT03439345|468110507|FG000|Overall Study|Lost to Follow-up|0|||
130041342|NCT03439345|468110508|FG001|Overall Study|Lost to Follow-up|1|||
130041343|NCT03439345|468110507|FG000|Overall Study|Consent withdrawn|0|||
130041344|NCT03439345|468110508|FG001|Overall Study|Consent withdrawn|1|||
130041345|NCT05635838|468110511|FG000|16-Week DBVC Period|Adverse Event|2|||
130041346|NCT05635838|468110512|FG001|16-Week DBVC Period|Adverse Event|0|||
130041347|NCT05635838|468110513|FG002|16-Week DBVC Period|Adverse Event|0|||
130041348|NCT05635838|468110514|FG003|16-Week DBVC Period|Adverse Event|0|||
130041349|NCT05635838|468110511|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
130041350|NCT05635838|468110512|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
130041351|NCT05635838|468110513|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
130041352|NCT05635838|468110514|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
130041353|NCT05635838|468110511|FG000|16-Week DBVC Period|Physician Decision|0|||
130041354|NCT05635838|468110512|FG001|16-Week DBVC Period|Physician Decision|1|||
130041355|NCT05635838|468110513|FG002|16-Week DBVC Period|Physician Decision|0|||
130041356|NCT05635838|468110514|FG003|16-Week DBVC Period|Physician Decision|0|||
130041357|NCT05635838|468110511|FG000|16-Week DBVC Period|Protocol Violation|1|||
130041358|NCT05635838|468110512|FG001|16-Week DBVC Period|Protocol Violation|0|||
130041359|NCT05635838|468110513|FG002|16-Week DBVC Period|Protocol Violation|0|||
130041360|NCT05635838|468110514|FG003|16-Week DBVC Period|Protocol Violation|0|||
130041361|NCT05635838|468110511|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
130041362|NCT05635838|468110512|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
130041363|NCT05635838|468110513|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
130041364|NCT05635838|468110514|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
130041365|NCT05635838|468110511|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
130041366|NCT05635838|468110512|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
130041367|NCT05635838|468110513|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
130041368|NCT05635838|468110514|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
130041369|NCT05635838|468110511|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
130041370|NCT05635838|468110512|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
130041371|NCT05635838|468110513|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
130041372|NCT05635838|468110514|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
130041373|NCT05635838|468110511|FG000|16-Week OLE Period|Adverse Event|0|||
130041374|NCT05635838|468110512|FG001|16-Week OLE Period|Adverse Event|0|||
130041375|NCT05635838|468110513|FG002|16-Week OLE Period|Adverse Event|0|||
130041376|NCT05635838|468110514|FG003|16-Week OLE Period|Adverse Event|2|||
130041377|NCT05635838|468110511|FG000|16-Week OLE Period|Lost to Follow-up|0|||
130041378|NCT05635838|468110512|FG001|16-Week OLE Period|Lost to Follow-up|0|||
130041379|NCT05635838|468110513|FG002|16-Week OLE Period|Lost to Follow-up|1|||
130041380|NCT05635838|468110514|FG003|16-Week OLE Period|Lost to Follow-up|3|||
130041381|NCT05635838|468110511|FG000|16-Week OLE Period|Physician Decision|0|||
130041382|NCT05635838|468110512|FG001|16-Week OLE Period|Physician Decision|0|||
130041383|NCT05635838|468110513|FG002|16-Week OLE Period|Physician Decision|0|||
130041384|NCT05635838|468110514|FG003|16-Week OLE Period|Physician Decision|1|||
130041385|NCT05635838|468110511|FG000|16-Week OLE Period|Protocol Violation|0|||
130041386|NCT05635838|468110512|FG001|16-Week OLE Period|Protocol Violation|0|||
130041387|NCT05635838|468110513|FG002|16-Week OLE Period|Protocol Violation|1|||
130041388|NCT05635838|468110514|FG003|16-Week OLE Period|Protocol Violation|1|||
130041389|NCT05635838|468110511|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
130041390|NCT05635838|468110512|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
130041391|NCT05635838|468110513|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
130041392|NCT05635838|468110514|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
130041393|NCT05635838|468110511|FG000|16-Week OLE Period|Pregnancy|0|||
130041394|NCT05635838|468110512|FG001|16-Week OLE Period|Pregnancy|0|||
130041395|NCT05635838|468110513|FG002|16-Week OLE Period|Pregnancy|1|||
130041396|NCT05635838|468110514|FG003|16-Week OLE Period|Pregnancy|0|||
130041397|NCT05165394|468110517|FG000|Overall Study|Withdrawal by Subject|5|||
130041398|NCT05165394|468110518|FG001|Overall Study|Withdrawal by Subject|1|||
130041399|NCT05165394|468110517|FG000|Overall Study|Lost to Follow-up|1|||
130041400|NCT05165394|468110518|FG001|Overall Study|Lost to Follow-up|2|||
130041401|NCT05165394|468110517|FG000|Overall Study|Other Than Specified|0|||
130041402|NCT05165394|468110518|FG001|Overall Study|Other Than Specified|1|||
130041403|NCT00875420|468110521|FG000|Overall Study|Adverse Event|0|||
130041404|NCT00875420|468110522|FG001|Overall Study|Adverse Event|1|||
130041405|NCT00875420|468110523|FG002|Overall Study|Adverse Event|1|||
130041406|NCT00875420|468110524|FG003|Overall Study|Adverse Event|0|||
130041407|NCT00875420|468110525|FG004|Overall Study|Adverse Event|0|||
130041408|NCT00875420|468110521|FG000|Overall Study|Inability to complete study procedures|1|||
130041409|NCT00875420|468110522|FG001|Overall Study|Inability to complete study procedures|0|||
129886351|NCT00506285|467545562|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
129886352|NCT00506285|467545561|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
129886353|NCT00506285|467545562|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
129886354|NCT00506285|467545561|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
129886355|NCT00506285|467545562|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
129886356|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
129886357|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
129886358|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886359|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886360|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886361|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886362|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
129886363|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
129886364|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886365|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886366|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886367|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886368|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
129886369|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
129886370|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886371|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886372|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886373|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886374|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886375|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
129886376|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886377|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886378|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886379|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886380|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
129886381|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886382|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886383|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886384|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886385|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886386|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
129886387|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
129886388|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
130104872|NCT00713830|468343171|FG001|Overall Study|Poor Compliance to Protocol|14|||
130104873|NCT00713830|468343170|FG000|Overall Study|Familial and Personal Reasons|9|||
130104874|NCT00713830|468343171|FG001|Overall Study|Familial and Personal Reasons|34|||
130104875|NCT00713830|468343170|FG000|Overall Study|Sponsor Decision|4|||
130104876|NCT00713830|468343171|FG001|Overall Study|Sponsor Decision|10|||
130104877|NCT03981614|468343174|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
130104878|NCT03981614|468343175|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
130104879|NCT03981614|468343176|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
130104880|NCT00499252|468343177|FG000|Overall Study|Adverse Event|3|||
130104881|NCT00499252|468343177|FG000|Overall Study|Refused further treatment|2|||
130104882|NCT00499252|468343177|FG000|Overall Study|Ineligible|4|||
130104883|NCT00499252|468343177|FG000|Overall Study|<no further label>|3|||
130104884|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
130104885|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
130104886|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
130104887|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
130104888|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
130104889|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
130104890|NCT00566631|468343178|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
130104891|NCT00566631|468343178|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
130104892|NCT00566631|468343178|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
130104893|NCT00566631|468343178|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
130104894|NCT00566631|468343178|FG000|Part 2: Extension Phase|Adverse Event|11|||
130104895|NCT00566631|468343178|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
130104896|NCT00566631|468343178|FG000|Part 2: Extension Phase|Death|1|||
130104897|NCT00566631|468343178|FG000|Part 2: Extension Phase|Other|5|||
130104898|NCT03387735|468343179|FG000|Overall Study|Lost to Follow-up|4|||
130104899|NCT03387735|468343180|FG001|Overall Study|Lost to Follow-up|8|||
130104900|NCT03387735|468343179|FG000|Overall Study|Death|4|||
130104901|NCT03387735|468343180|FG001|Overall Study|Death|8|||
130104902|NCT00110084|468343181|FG000|Overall Study|Adverse Event|9|||
130104903|NCT00110084|468343181|FG000|Overall Study|Death|1|||
130104904|NCT00110084|468343181|FG000|Overall Study|Patient Refusal|10|||
130104905|NCT00110084|468343181|FG000|Overall Study|Alternate Therapy|5|||
130104906|NCT00110084|468343181|FG000|Overall Study|Intercurrent Illness|1|||
130104907|NCT00110084|468343181|FG000|Overall Study|Other|2|||
130104908|NCT00537056|468343182|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
130104909|NCT03020966|468343186|FG000|Overall Study|Withdrawal by Subject|2|||
130104910|NCT03020966|468343187|FG001|Overall Study|Withdrawal by Subject|0|||
130104911|NCT01346501|468343192|FG000|Overall Study|Initiated Other Biological Agents|3|||
130104912|NCT01346501|468343193|FG001|Overall Study|Initiated Other Biological Agents|1|||
130104913|NCT01346501|468343192|FG000|Overall Study|Other|8|||
130104914|NCT01346501|468343193|FG001|Overall Study|Other|12|||
130104915|NCT02628418|468343194|FG000|Overall Study|Lost to Follow-up|1|||
130104916|NCT02628418|468343195|FG001|Overall Study|Lost to Follow-up|2|||
130104917|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
130104918|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
130104919|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
130104920|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
130104921|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
130274962|NCT04776720|468969328|FG000|Overall Study|Adverse Event|2|||
130274963|NCT04776720|468969329|FG001|Overall Study|Adverse Event|0|||
130274964|NCT04776720|468969328|FG000|Overall Study|Serious Adverse Event|0|||
130274965|NCT04776720|468969329|FG001|Overall Study|Serious Adverse Event|1|||
130274966|NCT04776720|468969328|FG000|Overall Study|Too Busy|3|||
130274967|NCT04776720|468969329|FG001|Overall Study|Too Busy|1|||
130274968|NCT04776720|468969328|FG000|Overall Study|Lost to Follow-up|1|||
130274969|NCT04776720|468969329|FG001|Overall Study|Lost to Follow-up|2|||
130274970|NCT04776720|468969328|FG000|Overall Study|Family|2|||
130104922|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
130274971|NCT04776720|468969329|FG001|Overall Study|Family|2|||
130104923|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
130104924|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
130104925|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
130104926|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
130104927|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
130274972|NCT04776720|468969328|FG000|Overall Study|No remote technology access|0|||
130274973|NCT04776720|468969329|FG001|Overall Study|No remote technology access|1|||
130274974|NCT04776720|468969328|FG000|Overall Study|Withdrawal by Subject|1|||
130274975|NCT04776720|468969329|FG001|Overall Study|Withdrawal by Subject|0|||
130274976|NCT04776720|468969328|FG000|Overall Study|Cannot tolerate intervention|1|||
130274977|NCT04776720|468969329|FG001|Overall Study|Cannot tolerate intervention|0|||
130274978|NCT04776720|468969328|FG000|Overall Study|Incomplete outcome data|6|||
130274979|NCT04776720|468969329|FG001|Overall Study|Incomplete outcome data|1|||
130274980|NCT05356910|468969330|FG000|Overall Study|Lost to Follow-up|10|||
130274981|NCT05356910|468969331|FG001|Overall Study|Lost to Follow-up|19|||
130274982|NCT05356910|468969332|FG002|Overall Study|Lost to Follow-up|0|||
130274983|NCT05356910|468969333|FG003|Overall Study|Lost to Follow-up|0|||
130274984|NCT05356910|468969330|FG000|Overall Study|Withdrawal by Subject|4|||
130274985|NCT05356910|468969331|FG001|Overall Study|Withdrawal by Subject|2|||
130274986|NCT05356910|468969332|FG002|Overall Study|Withdrawal by Subject|0|||
130274987|NCT05356910|468969333|FG003|Overall Study|Withdrawal by Subject|0|||
130274988|NCT03122145|468969335|FG000|Overall Study|Concurrent respiratory disease|3|||
130274989|NCT03122145|468969336|FG001|Overall Study|Concurrent respiratory disease|0|||
130274990|NCT00837161|468969337|FG000|Overall Study|refused hysterectomy|2|||
130274991|NCT01659996|468969340|FG000|Overall Study|Protocol Violation|3|||
130274992|NCT01659996|468969341|FG001|Overall Study|Protocol Violation|3|||
130274993|NCT01659996|468969342|FG002|Overall Study|Protocol Violation|3|||
130274994|NCT01659996|468969340|FG000|Overall Study|Lost to Follow-up|1|||
130274995|NCT01659996|468969341|FG001|Overall Study|Lost to Follow-up|3|||
130274996|NCT01659996|468969342|FG002|Overall Study|Lost to Follow-up|2|||
130274997|NCT01659996|468969340|FG000|Overall Study|Adverse Event|0|||
130274998|NCT01659996|468969341|FG001|Overall Study|Adverse Event|0|||
130274999|NCT01659996|468969342|FG002|Overall Study|Adverse Event|1|||
130275000|NCT01659996|468969340|FG000|Overall Study|Withdrawal by Subject|4|||
130275001|NCT01659996|468969341|FG001|Overall Study|Withdrawal by Subject|1|||
129886389|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129886390|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129886391|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129886392|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
129886393|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
129886394|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886395|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886396|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886397|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886398|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
129886399|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
129886400|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886401|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886402|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886403|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886404|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
129886405|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
129886406|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
129886407|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
129886408|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
129886409|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
129886410|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
129886411|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
129886412|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886413|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886414|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886415|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886416|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886417|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886418|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886419|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
129886420|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
129886421|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886422|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886423|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886424|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
129886425|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886426|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886427|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886428|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129886429|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129886430|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
129886431|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130275002|NCT01659996|468969342|FG002|Overall Study|Withdrawal by Subject|5|||
130275003|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Adverse Event|21|||
130275004|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Adverse Event|34|||
130275005|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Adverse Event|14|||
130275006|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Adverse Event|17|||
130275007|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Adverse Event|0|||
130275008|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
129886432|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
130104928|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
130104929|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
130275009|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
130275010|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
130275011|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
130275012|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
130275013|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
130275014|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
130275015|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
130275016|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
130275017|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
130275018|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Physician Decision|2|||
130275019|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Physician Decision|4|||
130275020|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Physician Decision|4|||
130275021|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Physician Decision|4|||
130275022|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Physician Decision|0|||
130275023|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
130275024|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
130275025|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
130275026|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
130275027|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
130275028|NCT00451958|468969345|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
130275029|NCT00451958|468969346|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
130275030|NCT00451958|468969347|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
130275031|NCT00451958|468969348|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
130275032|NCT00451958|468969349|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
130275033|NCT03108521|468969350|FG000|Overall Study|Lost to Follow-up|3|||
130275034|NCT03108521|468969351|FG001|Overall Study|Lost to Follow-up|0|||
130275035|NCT03108521|468969350|FG000|Overall Study|Lack of Efficacy|2|||
130275036|NCT03108521|468969351|FG001|Overall Study|Lack of Efficacy|0|||
130275037|NCT03108521|468969350|FG000|Overall Study|Physician Decision|4|||
130275038|NCT03108521|468969351|FG001|Overall Study|Physician Decision|0|||
130275039|NCT03108521|468969350|FG000|Overall Study|Adverse Event|3|||
129886433|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129886434|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
129886435|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
129886436|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
129886437|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
129886438|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
129886439|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
129886440|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
129886441|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
129886442|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
129886443|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
129886444|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
129886445|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
129886446|NCT01238575|467545569|FG000|Overall Study|Lack of Efficacy|2|||
129886447|NCT01238575|467545570|FG001|Overall Study|Lack of Efficacy|4|||
130104930|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
130275040|NCT03108521|468969351|FG001|Overall Study|Adverse Event|0|||
130275041|NCT06899737|468969356|FG000|Overall Study|Lost to Follow-up|19|||
130275042|NCT06899737|468969357|FG001|Overall Study|Lost to Follow-up|7|||
130275043|NCT03281629|468969359|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
130275044|NCT03281629|468969360|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
130275045|NCT03281629|468969359|FG000|Overall Study|Death|0|||
130275046|NCT03281629|468969360|FG001|Overall Study|Death|1|||
129886448|NCT01238575|467545569|FG000|Overall Study|Adverse Event|2|||
129886449|NCT01238575|467545570|FG001|Overall Study|Adverse Event|0|||
129886450|NCT01950273|467545573|FG000|Overall Study|Protocol Violation|1|||
129886451|NCT01950273|467545574|FG001|Overall Study|Protocol Violation|0|||
129886452|NCT01950273|467545573|FG000|Overall Study|Withdrawal by Subject|2|||
129886453|NCT01950273|467545574|FG001|Overall Study|Withdrawal by Subject|0|||
129886454|NCT01950273|467545573|FG000|Overall Study|Other not defined above|1|||
129886455|NCT01950273|467545574|FG001|Overall Study|Other not defined above|0|||
129886456|NCT01591460|467545579|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
129886457|NCT01591460|467545579|FG000|Overall Study|Futility Rule (Week 12)|7|||
129886458|NCT01591460|467545579|FG000|Overall Study|Futility Rule (Week 24)|3|||
129886459|NCT01591460|467545579|FG000|Overall Study|Rebound or Breakthrough|3|||
129886460|NCT01591460|467545579|FG000|Overall Study|Treatment Discontinued by Error|1|||
129886461|NCT01591460|467545579|FG000|Overall Study|Lost to Follow-up|1|||
129886462|NCT01591460|467545579|FG000|Overall Study|Noncompliance|1|||
129886463|NCT01591460|467545579|FG000|Overall Study|Participant Refusal|3|||
129886464|NCT01591460|467545579|FG000|Overall Study|Withdrawal by Subject|1|||
129886465|NCT01591460|467545579|FG000|Overall Study|Protocol Violation|1|||
129886466|NCT00432679|467545582|FG000|Overall Study|Adverse Event|2|||
129886467|NCT00432679|467545583|FG001|Overall Study|Adverse Event|1|||
129886468|NCT00432679|467545582|FG000|Overall Study|Withdrawal by Subject|3|||
129886469|NCT00432679|467545583|FG001|Overall Study|Withdrawal by Subject|2|||
129886470|NCT01567163|467545584|FG000|Overall Study|Progressive Disease|2|||
129886471|NCT01567163|467545584|FG000|Overall Study|Lost to Follow-up|2|||
129886472|NCT03405662|467545585|FG000|Overall Study|COVID-19 restriction|1|||
129886473|NCT03405662|467545586|FG001|Overall Study|COVID-19 restriction|0|||
129886474|NCT03405662|467545585|FG000|Overall Study|unblinding|0|||
129886475|NCT03405662|467545586|FG001|Overall Study|unblinding|1|||
129886476|NCT03405662|467545585|FG000|Overall Study|placement in memory care facility|0|||
129886477|NCT03405662|467545586|FG001|Overall Study|placement in memory care facility|2|||
129886478|NCT01177813|467545587|FG000|Overall Study|Adverse Event|8|||
129886479|NCT01177813|467545588|FG001|Overall Study|Adverse Event|2|||
129886480|NCT01177813|467545589|FG002|Overall Study|Adverse Event|4|||
129886481|NCT01177813|467545590|FG003|Overall Study|Adverse Event|6|||
129886482|NCT01177813|467545591|FG004|Overall Study|Adverse Event|3|||
129886483|NCT01177813|467545587|FG000|Overall Study|Lack of Efficacy|1|||
129886484|NCT01177813|467545588|FG001|Overall Study|Lack of Efficacy|0|||
129886485|NCT01177813|467545589|FG002|Overall Study|Lack of Efficacy|0|||
129886486|NCT01177813|467545590|FG003|Overall Study|Lack of Efficacy|0|||
129886487|NCT01177813|467545591|FG004|Overall Study|Lack of Efficacy|0|||
129886488|NCT01177813|467545587|FG000|Overall Study|Protocol Violation|3|||
129886489|NCT01177813|467545588|FG001|Overall Study|Protocol Violation|2|||
129886490|NCT01177813|467545589|FG002|Overall Study|Protocol Violation|2|||
129886491|NCT01177813|467545590|FG003|Overall Study|Protocol Violation|0|||
129886492|NCT01177813|467545591|FG004|Overall Study|Protocol Violation|1|||
129886493|NCT01177813|467545587|FG000|Overall Study|Lost to Follow-up|12|||
129886494|NCT01177813|467545588|FG001|Overall Study|Lost to Follow-up|5|||
129886495|NCT01177813|467545589|FG002|Overall Study|Lost to Follow-up|6|||
129886496|NCT01177813|467545590|FG003|Overall Study|Lost to Follow-up|3|||
129886497|NCT01177813|467545591|FG004|Overall Study|Lost to Follow-up|0|||
129886498|NCT01177813|467545587|FG000|Overall Study|Withdrawal by Subject|12|||
129886499|NCT01177813|467545588|FG001|Overall Study|Withdrawal by Subject|7|||
129886500|NCT01177813|467545589|FG002|Overall Study|Withdrawal by Subject|6|||
130275047|NCT03281629|468969359|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
130275048|NCT03281629|468969360|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
130275049|NCT02175277|468969362|FG000|Overall Study|Protocol-specified Criteria|1|||
130275050|NCT00375674|468969367|FG000|Overall Study|Other|26|||
130275051|NCT00375674|468969368|FG001|Overall Study|Other|18|||
130275052|NCT00375674|468969367|FG000|Overall Study|Death|67|||
130275053|NCT00375674|468969368|FG001|Overall Study|Death|76|||
130275054|NCT00375674|468969367|FG000|Overall Study|Participants refused further follow-up|31|||
130275055|NCT00375674|468969368|FG001|Overall Study|Participants refused further follow-up|30|||
130275056|NCT00375674|468969367|FG000|Overall Study|Lost to Follow-up|17|||
129886501|NCT01177813|467545590|FG003|Overall Study|Withdrawal by Subject|5|||
129886502|NCT01177813|467545591|FG004|Overall Study|Withdrawal by Subject|3|||
129886503|NCT01177813|467545587|FG000|Overall Study|Other reason not defined above|5|||
129886504|NCT01177813|467545588|FG001|Overall Study|Other reason not defined above|2|||
130275057|NCT00375674|468969368|FG001|Overall Study|Lost to Follow-up|15|||
130275058|NCT00375674|468969367|FG000|Overall Study|Enrolled but not treated|3|||
129886505|NCT01177813|467545589|FG002|Overall Study|Other reason not defined above|2|||
129886506|NCT01177813|467545590|FG003|Overall Study|Other reason not defined above|3|||
129886507|NCT01177813|467545591|FG004|Overall Study|Other reason not defined above|2|||
129886508|NCT00109928|467545594|FG000|Overall Study|Adverse Event|2|||
130275059|NCT00375674|468969368|FG001|Overall Study|Enrolled but not treated|2|||
129886509|NCT00109928|467545594|FG000|Overall Study|Progression|6|||
129886510|NCT00109928|467545594|FG000|Overall Study|Death|2|||
129886511|NCT00109928|467545594|FG000|Overall Study|not protocol specified|2|||
129886512|NCT00109928|467545594|FG000|Overall Study|not eligible|1|||
129886513|NCT01196104|467545595|FG000|Overall Study|Lost to Follow-up|1|||
130275060|NCT03744910|468971892|FG000|Overall Study|Withdrew Consent|1|||
129886514|NCT01196104|467545596|FG001|Overall Study|Lost to Follow-up|0|||
130275061|NCT03744910|468971893|FG001|Overall Study|Withdrew Consent|8|||
130275062|NCT03744910|468971892|FG000|Overall Study|Physician Decision|5|||
130275063|NCT03744910|468971893|FG001|Overall Study|Physician Decision|4|||
130275064|NCT03744910|468971892|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
130275065|NCT03744910|468971893|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
130275066|NCT03744910|468971892|FG000|Overall Study|Lost to Follow-up|0|||
130275067|NCT03744910|468971893|FG001|Overall Study|Lost to Follow-up|1|||
130275068|NCT03744910|468971892|FG000|Overall Study|Other-unspecified|4|||
130275069|NCT03744910|468971893|FG001|Overall Study|Other-unspecified|1|||
130275070|NCT00064259|468971894|FG000|Overall Study|Adverse Event|1|||
130275071|NCT00064259|468971895|FG001|Overall Study|Adverse Event|0|||
130275072|NCT00064259|468971896|FG002|Overall Study|Adverse Event|0|||
130275073|NCT00064259|468971897|FG003|Overall Study|Adverse Event|1|||
130275074|NCT01132651|468971900|FG000|Overall Study|Lost to Follow-up|1|||
130275075|NCT01132651|468971901|FG001|Overall Study|Lost to Follow-up|1|||
130275076|NCT03430843|468971904|FG000|Overall Study|Death|233|||
130275077|NCT03430843|468971905|FG001|Overall Study|Death|233|||
130275078|NCT03430843|468971904|FG000|Overall Study|Sponsor Decision|17|||
130275079|NCT03430843|468971905|FG001|Overall Study|Sponsor Decision|6|||
130275080|NCT03430843|468971904|FG000|Overall Study|Withdrawal by Subject|5|||
130275081|NCT03430843|468971905|FG001|Overall Study|Withdrawal by Subject|14|||
130275082|NCT03430843|468971904|FG000|Overall Study|Lost to Follow-up|1|||
130275083|NCT03430843|468971905|FG001|Overall Study|Lost to Follow-up|3|||
130275084|NCT01905943|468971912|FG000|Overall Study|Withdrawal of consent|90|||
130275085|NCT01905943|468971912|FG000|Overall Study|Lost to Follow-up|16|||
130275086|NCT01905943|468971912|FG000|Overall Study|Investigator discretion|7|||
130275087|NCT01905943|468971912|FG000|Overall Study|Death|186|||
130275088|NCT01905943|468971912|FG000|Overall Study|Adverse Event|3|||
130275089|NCT01905943|468971912|FG000|Overall Study|Other|12|||
130275090|NCT02574078|468971913|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275091|NCT02574078|468971914|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275092|NCT02574078|468971915|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275093|NCT02574078|468971916|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275094|NCT02574078|468971917|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275095|NCT02574078|468971918|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130275096|NCT02574078|468971919|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
130275097|NCT02574078|468971920|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275098|NCT02574078|468971921|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130275099|NCT02574078|468971922|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275100|NCT02574078|468971923|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275101|NCT02574078|468971924|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275102|NCT02574078|468971925|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130275103|NCT02574078|468971913|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130275104|NCT02574078|468971914|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130275105|NCT02574078|468971915|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
130275106|NCT02574078|468971916|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
130275107|NCT02574078|468971917|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
130275108|NCT02574078|468971918|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
130275109|NCT02574078|468971919|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
130275110|NCT02574078|468971920|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
130275111|NCT02574078|468971921|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
130275112|NCT02574078|468971922|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
130275113|NCT02574078|468971923|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
129886515|NCT01196104|467545595|FG000|Overall Study|Physician Decision|0|||
129886516|NCT01196104|467545596|FG001|Overall Study|Physician Decision|1|||
129886517|NCT01196104|467545595|FG000|Overall Study|Withdrawal by Subject|3|||
129886518|NCT01196104|467545596|FG001|Overall Study|Withdrawal by Subject|3|||
129886519|NCT01196104|467545595|FG000|Overall Study|Various|0|||
129886520|NCT01196104|467545596|FG001|Overall Study|Various|1|||
129886521|NCT00610675|467545597|FG000|Overall Study|Untreated|4|||
130275114|NCT02574078|468971924|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
130275115|NCT02574078|468971925|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
130275116|NCT02574078|468971913|FG000|Pre-Treatment Period|Other reasons|0|||
130275117|NCT02574078|468971914|FG001|Pre-Treatment Period|Other reasons|0|||
129886522|NCT00610675|467545597|FG000|Overall Study|Adverse Event|67|||
129886523|NCT00610675|467545597|FG000|Overall Study|Insufficient Effect|31|||
130275118|NCT02574078|468971915|FG002|Pre-Treatment Period|Other reasons|0|||
130275119|NCT02574078|468971916|FG003|Pre-Treatment Period|Other reasons|0|||
130275120|NCT02574078|468971917|FG004|Pre-Treatment Period|Other reasons|0|||
130275121|NCT02574078|468971918|FG005|Pre-Treatment Period|Other reasons|0|||
129886524|NCT00610675|467545597|FG000|Overall Study|Withdrawal by Subject|28|||
129886525|NCT00610675|467545597|FG000|Overall Study|Reasons unrelated to trial|27|||
130104931|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
130104932|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
130104933|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
130104934|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
130104935|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
130104936|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
130104937|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
130104938|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
130104939|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
130104940|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
130104941|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
130104942|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
130104943|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
130104944|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
130104945|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
130104946|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
130104947|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
130104948|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
130104949|NCT03747939|468343196|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
130104950|NCT03747939|468343197|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
130104951|NCT03747939|468343198|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
130104952|NCT03747939|468343199|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
130104953|NCT03747939|468343196|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
130104954|NCT03747939|468343197|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
130104955|NCT03747939|468343198|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
130104956|NCT03747939|468343199|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
130104957|NCT03747939|468343196|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
130104958|NCT03747939|468343197|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
130104959|NCT03747939|468343198|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
130104960|NCT03747939|468343199|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
130104961|NCT03747939|468343196|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
130104962|NCT03747939|468343197|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
130104963|NCT03747939|468343198|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
130104964|NCT03747939|468343199|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
130104965|NCT03747939|468343196|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
130104966|NCT03747939|468343197|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
130104967|NCT03747939|468343198|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
130104968|NCT03747939|468343199|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
130104969|NCT03747939|468343196|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
130104970|NCT03747939|468343197|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
130104971|NCT03747939|468343198|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
130104972|NCT03747939|468343199|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
130104973|NCT01215955|468343200|FG000|Overall Study|Adverse Event|1|||
130104974|NCT01215955|468343201|FG001|Overall Study|Adverse Event|4|||
129886526|NCT00610675|467545597|FG000|Overall Study|Lack of Compliance|7|||
129886527|NCT00610675|467545597|FG000|Overall Study|Lost to Follow-up|31|||
129886528|NCT00610675|467545597|FG000|Overall Study|Other reason (not specified)|25|||
129886529|NCT01316692|467545600|FG000|Overall Study|Adverse Event|5|||
129886530|NCT01316692|467545600|FG000|Overall Study|Disease Progression|7|||
129886531|NCT00983619|467545601|FG000|Overall Study|Lost to Follow-up|0|||
129886532|NCT00983619|467545602|FG001|Overall Study|Lost to Follow-up|1|||
129886533|NCT00983619|467545603|FG002|Overall Study|Lost to Follow-up|0|||
129886534|NCT00983619|467545604|FG003|Overall Study|Lost to Follow-up|0|||
129886535|NCT00983619|467545605|FG004|Overall Study|Lost to Follow-up|0|||
130104975|NCT01215955|468343202|FG002|Overall Study|Adverse Event|2|||
130275122|NCT02574078|468971919|FG006|Pre-Treatment Period|Other reasons|2|||
130275123|NCT02574078|468971920|FG007|Pre-Treatment Period|Other reasons|0|||
130275124|NCT02574078|468971921|FG008|Pre-Treatment Period|Other reasons|0|||
130275125|NCT02574078|468971922|FG009|Pre-Treatment Period|Other reasons|0|||
130275126|NCT02574078|468971923|FG010|Pre-Treatment Period|Other reasons|2|||
130275127|NCT02574078|468971924|FG011|Pre-Treatment Period|Other reasons|0|||
130275128|NCT02574078|468971925|FG012|Pre-Treatment Period|Other reasons|0|||
130275129|NCT02574078|468971913|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
130275130|NCT02574078|468971914|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
130275131|NCT02574078|468971915|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
130275132|NCT02574078|468971916|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
130275133|NCT02574078|468971917|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
130275134|NCT02574078|468971918|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
130275135|NCT02574078|468971919|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
130275136|NCT02574078|468971920|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
130275137|NCT02574078|468971921|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
130275138|NCT02574078|468971922|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
130275139|NCT02574078|468971923|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
130275140|NCT02574078|468971924|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
129886536|NCT00983619|467545606|FG005|Overall Study|Lost to Follow-up|2|||
129886537|NCT00983619|467545607|FG006|Overall Study|Lost to Follow-up|0|||
129886538|NCT00983619|467545608|FG007|Overall Study|Lost to Follow-up|0|||
129886539|NCT00983619|467545609|FG008|Overall Study|Lost to Follow-up|0|||
129886540|NCT00983619|467545610|FG009|Overall Study|Lost to Follow-up|0|||
129886541|NCT00983619|467545611|FG010|Overall Study|Lost to Follow-up|0|||
129886542|NCT00983619|467545612|FG011|Overall Study|Lost to Follow-up|2|||
129886543|NCT00983619|467545601|FG000|Overall Study|Withdrawal by Subject|2|||
129886544|NCT00983619|467545602|FG001|Overall Study|Withdrawal by Subject|1|||
129886545|NCT00983619|467545603|FG002|Overall Study|Withdrawal by Subject|1|||
129886546|NCT00983619|467545604|FG003|Overall Study|Withdrawal by Subject|3|||
129886547|NCT00983619|467545605|FG004|Overall Study|Withdrawal by Subject|1|||
129886548|NCT00983619|467545606|FG005|Overall Study|Withdrawal by Subject|23|||
129886549|NCT00983619|467545607|FG006|Overall Study|Withdrawal by Subject|0|||
129886550|NCT00983619|467545608|FG007|Overall Study|Withdrawal by Subject|0|||
129886551|NCT00983619|467545609|FG008|Overall Study|Withdrawal by Subject|0|||
129886552|NCT00983619|467545610|FG009|Overall Study|Withdrawal by Subject|0|||
129886553|NCT00983619|467545611|FG010|Overall Study|Withdrawal by Subject|1|||
129886554|NCT00983619|467545612|FG011|Overall Study|Withdrawal by Subject|1|||
129886555|NCT00983619|467545601|FG000|Overall Study|Death|0|||
129886556|NCT00983619|467545602|FG001|Overall Study|Death|2|||
129886557|NCT00983619|467545603|FG002|Overall Study|Death|2|||
129886558|NCT00983619|467545604|FG003|Overall Study|Death|1|||
129886559|NCT00983619|467545605|FG004|Overall Study|Death|2|||
129886560|NCT00983619|467545606|FG005|Overall Study|Death|30|||
129886561|NCT00983619|467545607|FG006|Overall Study|Death|1|||
129886562|NCT00983619|467545608|FG007|Overall Study|Death|0|||
129886563|NCT00983619|467545609|FG008|Overall Study|Death|1|||
129886564|NCT00983619|467545610|FG009|Overall Study|Death|2|||
129886565|NCT00983619|467545611|FG010|Overall Study|Death|9|||
129886566|NCT00983619|467545612|FG011|Overall Study|Death|8|||
129886567|NCT00983619|467545601|FG000|Overall Study|Other|1|||
129886568|NCT00983619|467545602|FG001|Overall Study|Other|0|||
129886569|NCT00983619|467545603|FG002|Overall Study|Other|0|||
129886570|NCT00983619|467545604|FG003|Overall Study|Other|1|||
129886571|NCT00983619|467545605|FG004|Overall Study|Other|0|||
129886572|NCT00983619|467545606|FG005|Overall Study|Other|12|||
129886573|NCT00983619|467545607|FG006|Overall Study|Other|2|||
129886574|NCT00983619|467545608|FG007|Overall Study|Other|2|||
129886575|NCT00983619|467545609|FG008|Overall Study|Other|0|||
129886576|NCT00983619|467545610|FG009|Overall Study|Other|1|||
129886577|NCT00983619|467545611|FG010|Overall Study|Other|1|||
129886578|NCT00983619|467545612|FG011|Overall Study|Other|0|||
129886579|NCT03772314|467545619|FG000|Overall Study|Adverse Event|7|||
129886580|NCT03772314|467545620|FG001|Overall Study|Adverse Event|2|||
129886581|NCT01536145|467545621|FG000|Overall Study|Progressive disease|3|||
129886582|NCT01536145|467545622|FG001|Overall Study|Progressive disease|4|||
129886583|NCT01536145|467545623|FG002|Overall Study|Progressive disease|1|||
130275141|NCT02574078|468971925|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
130275142|NCT02574078|468971913|FG000|Treatment Period|Disease progression|6|||
129886584|NCT01536145|467545624|FG003|Overall Study|Progressive disease|2|||
129886585|NCT01536145|467545625|FG004|Overall Study|Progressive disease|1|||
129886586|NCT01536145|467545626|FG005|Overall Study|Progressive disease|2|||
129886587|NCT01536145|467545627|FG006|Overall Study|Progressive disease|1|||
129886588|NCT01536145|467545628|FG007|Overall Study|Progressive disease|2|||
129886589|NCT01536145|467545629|FG008|Overall Study|Progressive disease|1|||
129886590|NCT01536145|467545630|FG009|Overall Study|Progressive disease|3|||
129886591|NCT01536145|467545631|FG010|Overall Study|Progressive disease|3|||
129886592|NCT01536145|467545621|FG000|Overall Study|Withdrawal by Subject|0|||
129886593|NCT01536145|467545622|FG001|Overall Study|Withdrawal by Subject|0|||
130275143|NCT02574078|468971914|FG001|Treatment Period|Disease progression|4|||
130104976|NCT01215955|468343203|FG003|Overall Study|Adverse Event|3|||
130104977|NCT01215955|468343200|FG000|Overall Study|Death|2|||
130104978|NCT01215955|468343201|FG001|Overall Study|Death|0|||
130104979|NCT01215955|468343202|FG002|Overall Study|Death|1|||
130104980|NCT01215955|468343203|FG003|Overall Study|Death|3|||
130104981|NCT01215955|468343200|FG000|Overall Study|Entry Criteria Not Met|1|||
130104982|NCT01215955|468343201|FG001|Overall Study|Entry Criteria Not Met|3|||
130104983|NCT01215955|468343202|FG002|Overall Study|Entry Criteria Not Met|4|||
130104984|NCT01215955|468343203|FG003|Overall Study|Entry Criteria Not Met|7|||
130104985|NCT01215955|468343200|FG000|Overall Study|Lack of Efficacy|1|||
130104986|NCT01215955|468343201|FG001|Overall Study|Lack of Efficacy|2|||
130104987|NCT01215955|468343202|FG002|Overall Study|Lack of Efficacy|1|||
130104988|NCT01215955|468343203|FG003|Overall Study|Lack of Efficacy|0|||
130104989|NCT01215955|468343200|FG000|Overall Study|Lost to Follow-up|4|||
130104990|NCT01215955|468343201|FG001|Overall Study|Lost to Follow-up|4|||
130104991|NCT01215955|468343202|FG002|Overall Study|Lost to Follow-up|8|||
130104992|NCT01215955|468343203|FG003|Overall Study|Lost to Follow-up|9|||
130104993|NCT01215955|468343200|FG000|Overall Study|Physician Decision|4|||
130104994|NCT01215955|468343201|FG001|Overall Study|Physician Decision|10|||
130104995|NCT01215955|468343202|FG002|Overall Study|Physician Decision|8|||
130104996|NCT01215955|468343203|FG003|Overall Study|Physician Decision|11|||
130104997|NCT01215955|468343200|FG000|Overall Study|Protocol Violation|17|||
130104998|NCT01215955|468343201|FG001|Overall Study|Protocol Violation|13|||
130104999|NCT01215955|468343202|FG002|Overall Study|Protocol Violation|8|||
130105000|NCT01215955|468343203|FG003|Overall Study|Protocol Violation|8|||
130105001|NCT01215955|468343200|FG000|Overall Study|Sponsor Decision|1|||
130105002|NCT01215955|468343201|FG001|Overall Study|Sponsor Decision|2|||
130105003|NCT01215955|468343202|FG002|Overall Study|Sponsor Decision|0|||
130105004|NCT01215955|468343203|FG003|Overall Study|Sponsor Decision|1|||
130105005|NCT01215955|468343200|FG000|Overall Study|Withdrawal by Subject|14|||
130105006|NCT01215955|468343201|FG001|Overall Study|Withdrawal by Subject|15|||
130105007|NCT01215955|468343202|FG002|Overall Study|Withdrawal by Subject|13|||
130105008|NCT01215955|468343203|FG003|Overall Study|Withdrawal by Subject|9|||
130105009|NCT01215955|468343200|FG000|Overall Study|Quality Issues|0|||
130275144|NCT02574078|468971915|FG002|Treatment Period|Disease progression|7|||
130105010|NCT01215955|468343201|FG001|Overall Study|Quality Issues|0|||
130105011|NCT01215955|468343202|FG002|Overall Study|Quality Issues|3|||
130105012|NCT01215955|468343203|FG003|Overall Study|Quality Issues|2|||
130105013|NCT01523301|468343204|FG000|Overall Study|Adverse Event|25|||
130105014|NCT01523301|468343205|FG001|Overall Study|Adverse Event|16|||
130105015|NCT01523301|468343204|FG000|Overall Study|Lack of Efficacy|0|||
130105016|NCT01523301|468343205|FG001|Overall Study|Lack of Efficacy|2|||
130105017|NCT01523301|468343204|FG000|Overall Study|Protocol Violation|3|||
130105018|NCT01523301|468343205|FG001|Overall Study|Protocol Violation|4|||
130105019|NCT01523301|468343204|FG000|Overall Study|Lost to Follow-up|1|||
130105020|NCT01523301|468343205|FG001|Overall Study|Lost to Follow-up|0|||
130105021|NCT01523301|468343204|FG000|Overall Study|Withdrawal by Subject|6|||
130105022|NCT01523301|468343205|FG001|Overall Study|Withdrawal by Subject|8|||
130275145|NCT02574078|468971916|FG003|Treatment Period|Disease progression|18|||
130275146|NCT02574078|468971917|FG004|Treatment Period|Disease progression|16|||
130275147|NCT02574078|468971918|FG005|Treatment Period|Disease progression|26|||
130275148|NCT02574078|468971919|FG006|Treatment Period|Disease progression|5|||
130275149|NCT02574078|468971920|FG007|Treatment Period|Disease progression|9|||
130275150|NCT02574078|468971921|FG008|Treatment Period|Disease progression|8|||
130275151|NCT02574078|468971922|FG009|Treatment Period|Disease progression|5|||
130275152|NCT02574078|468971923|FG010|Treatment Period|Disease progression|20|||
130275153|NCT02574078|468971924|FG011|Treatment Period|Disease progression|29|||
130275154|NCT02574078|468971925|FG012|Treatment Period|Disease progression|2|||
130275155|NCT02574078|468971913|FG000|Treatment Period|Study drug toxicity|1|||
130275156|NCT02574078|468971914|FG001|Treatment Period|Study drug toxicity|1|||
130275157|NCT02574078|468971915|FG002|Treatment Period|Study drug toxicity|0|||
130275158|NCT02574078|468971916|FG003|Treatment Period|Study drug toxicity|5|||
130275159|NCT02574078|468971917|FG004|Treatment Period|Study drug toxicity|3|||
130275160|NCT02574078|468971918|FG005|Treatment Period|Study drug toxicity|1|||
130275161|NCT02574078|468971919|FG006|Treatment Period|Study drug toxicity|2|||
130275162|NCT02574078|468971920|FG007|Treatment Period|Study drug toxicity|0|||
130275163|NCT02574078|468971921|FG008|Treatment Period|Study drug toxicity|2|||
130275164|NCT02574078|468971922|FG009|Treatment Period|Study drug toxicity|1|||
130275165|NCT02574078|468971923|FG010|Treatment Period|Study drug toxicity|16|||
130275166|NCT02574078|468971924|FG011|Treatment Period|Study drug toxicity|2|||
130275167|NCT02574078|468971925|FG012|Treatment Period|Study drug toxicity|4|||
130275168|NCT02574078|468971913|FG000|Treatment Period|Death|2|||
130275169|NCT02574078|468971914|FG001|Treatment Period|Death|0|||
130275170|NCT02574078|468971915|FG002|Treatment Period|Death|0|||
130275171|NCT02574078|468971916|FG003|Treatment Period|Death|0|||
130275172|NCT02574078|468971917|FG004|Treatment Period|Death|1|||
130275173|NCT02574078|468971918|FG005|Treatment Period|Death|1|||
130275174|NCT02574078|468971919|FG006|Treatment Period|Death|1|||
130275175|NCT02574078|468971920|FG007|Treatment Period|Death|1|||
130275176|NCT02574078|468971921|FG008|Treatment Period|Death|7|||
130275177|NCT02574078|468971922|FG009|Treatment Period|Death|1|||
130275178|NCT02574078|468971923|FG010|Treatment Period|Death|0|||
130275179|NCT02574078|468971924|FG011|Treatment Period|Death|2|||
130275180|NCT02574078|468971925|FG012|Treatment Period|Death|1|||
130275181|NCT02574078|468971913|FG000|Treatment Period|Adverse event unrelated to drug|0|||
130275182|NCT02574078|468971914|FG001|Treatment Period|Adverse event unrelated to drug|0|||
130275183|NCT02574078|468971915|FG002|Treatment Period|Adverse event unrelated to drug|1|||
130275184|NCT02574078|468971916|FG003|Treatment Period|Adverse event unrelated to drug|0|||
130275185|NCT02574078|468971917|FG004|Treatment Period|Adverse event unrelated to drug|2|||
130275186|NCT02574078|468971918|FG005|Treatment Period|Adverse event unrelated to drug|3|||
130275187|NCT02574078|468971919|FG006|Treatment Period|Adverse event unrelated to drug|0|||
130275188|NCT02574078|468971920|FG007|Treatment Period|Adverse event unrelated to drug|0|||
130275189|NCT02574078|468971921|FG008|Treatment Period|Adverse event unrelated to drug|1|||
130275190|NCT02574078|468971922|FG009|Treatment Period|Adverse event unrelated to drug|2|||
130275191|NCT02574078|468971923|FG010|Treatment Period|Adverse event unrelated to drug|4|||
130275192|NCT02574078|468971924|FG011|Treatment Period|Adverse event unrelated to drug|1|||
130275193|NCT02574078|468971925|FG012|Treatment Period|Adverse event unrelated to drug|0|||
130275194|NCT02574078|468971913|FG000|Treatment Period|Administrative reason by Sponsor|0|||
130275195|NCT02574078|468971914|FG001|Treatment Period|Administrative reason by Sponsor|1|||
130275196|NCT02574078|468971915|FG002|Treatment Period|Administrative reason by Sponsor|0|||
130105023|NCT01523301|468343204|FG000|Overall Study|Other Reason|0|||
130105024|NCT01523301|468343205|FG001|Overall Study|Other Reason|2|||
130105025|NCT01447628|468343206|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
130275197|NCT02574078|468971916|FG003|Treatment Period|Administrative reason by Sponsor|0|||
130275198|NCT02574078|468971917|FG004|Treatment Period|Administrative reason by Sponsor|0|||
130275199|NCT02574078|468971918|FG005|Treatment Period|Administrative reason by Sponsor|0|||
130275200|NCT02574078|468971919|FG006|Treatment Period|Administrative reason by Sponsor|1|||
130105026|NCT01447628|468343207|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
130105027|NCT01447628|468343208|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
130275201|NCT02574078|468971920|FG007|Treatment Period|Administrative reason by Sponsor|0|||
130105028|NCT01447628|468343209|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
130105029|NCT00185731|468343210|FG000|Overall Study|Withdrawal by Subject|1|||
130105030|NCT00185731|468343210|FG000|Overall Study|Not Eligible|1|||
130105031|NCT03087773|468343211|FG000|Overall Study|Withdrawal by Subject|8|||
130105032|NCT03087773|468343212|FG001|Overall Study|Withdrawal by Subject|4|||
130105033|NCT03087773|468343211|FG000|Overall Study|Lost to Follow-up|12|||
130105034|NCT03087773|468343212|FG001|Overall Study|Lost to Follow-up|8|||
130105035|NCT03454672|468343215|FG000|Overall Study|Adverse Event|1|||
130105036|NCT03454672|468343216|FG001|Overall Study|Adverse Event|1|||
130105037|NCT03454672|468343215|FG000|Overall Study|Lost to Follow-up|1|||
130105038|NCT03454672|468343216|FG001|Overall Study|Lost to Follow-up|3|||
130105039|NCT03454672|468343215|FG000|Overall Study|painful|1|||
130105040|NCT03454672|468343216|FG001|Overall Study|painful|2|||
130105041|NCT03454672|468343215|FG000|Overall Study|Non-compliance|2|||
130105042|NCT03454672|468343216|FG001|Overall Study|Non-compliance|4|||
130105043|NCT03454672|468343215|FG000|Overall Study|personal reasons|3|||
130105044|NCT03454672|468343216|FG001|Overall Study|personal reasons|2|||
130105045|NCT03454672|468343215|FG000|Overall Study|Withdrawal by Subject|1|||
130105046|NCT03454672|468343216|FG001|Overall Study|Withdrawal by Subject|0|||
130105047|NCT00402779|468343217|FG000|Overall Study|Screen Failure|77|||
129886594|NCT01536145|467545623|FG002|Overall Study|Withdrawal by Subject|1|||
129886595|NCT01536145|467545624|FG003|Overall Study|Withdrawal by Subject|0|||
129886596|NCT01536145|467545625|FG004|Overall Study|Withdrawal by Subject|0|||
130105048|NCT00402779|468343218|FG001|Overall Study|Screen Failure|76|||
130105049|NCT02149199|468343220|FG000|Overall Study|Study specific withdrawal criteria|4|||
130105050|NCT02149199|468343221|FG001|Overall Study|Study specific withdrawal criteria|21|||
130105051|NCT02149199|468343222|FG002|Overall Study|Study specific withdrawal criteria|6|||
130105052|NCT02149199|468343220|FG000|Overall Study|Other|20|||
130105053|NCT02149199|468343221|FG001|Overall Study|Other|25|||
130105054|NCT02149199|468343222|FG002|Overall Study|Other|20|||
130105055|NCT02149199|468343220|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
130105056|NCT02149199|468343221|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
130105057|NCT02149199|468343222|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
130105058|NCT02149199|468343220|FG000|Overall Study|Withdrawal by Subject|75|||
130105059|NCT02149199|468343221|FG001|Overall Study|Withdrawal by Subject|93|||
130105060|NCT02149199|468343222|FG002|Overall Study|Withdrawal by Subject|77|||
130105061|NCT02149199|468343220|FG000|Overall Study|Protocol Violation|16|||
130105062|NCT02149199|468343221|FG001|Overall Study|Protocol Violation|13|||
130105063|NCT02149199|468343222|FG002|Overall Study|Protocol Violation|15|||
130275202|NCT02574078|468971921|FG008|Treatment Period|Administrative reason by Sponsor|0|||
130275203|NCT02574078|468971922|FG009|Treatment Period|Administrative reason by Sponsor|0|||
130275204|NCT02574078|468971923|FG010|Treatment Period|Administrative reason by Sponsor|0|||
130275205|NCT02574078|468971924|FG011|Treatment Period|Administrative reason by Sponsor|0|||
130275206|NCT02574078|468971925|FG012|Treatment Period|Administrative reason by Sponsor|3|||
130275207|NCT02574078|468971913|FG000|Treatment Period|Other reasons|1|||
130275208|NCT02574078|468971914|FG001|Treatment Period|Other reasons|0|||
130275209|NCT02574078|468971915|FG002|Treatment Period|Other reasons|1|||
130275210|NCT02574078|468971916|FG003|Treatment Period|Other reasons|3|||
130275211|NCT02574078|468971917|FG004|Treatment Period|Other reasons|3|||
130275212|NCT02574078|468971918|FG005|Treatment Period|Other reasons|1|||
130275213|NCT02574078|468971919|FG006|Treatment Period|Other reasons|2|||
130275214|NCT02574078|468971920|FG007|Treatment Period|Other reasons|1|||
130275215|NCT02574078|468971921|FG008|Treatment Period|Other reasons|3|||
130275216|NCT02574078|468971922|FG009|Treatment Period|Other reasons|1|||
130275217|NCT02574078|468971923|FG010|Treatment Period|Other reasons|1|||
130275218|NCT02574078|468971924|FG011|Treatment Period|Other reasons|3|||
130275219|NCT02574078|468971925|FG012|Treatment Period|Other reasons|1|||
130275220|NCT02574078|468971913|FG000|Treatment Period|Participant request to stop drug|0|||
130275221|NCT02574078|468971914|FG001|Treatment Period|Participant request to stop drug|0|||
130275222|NCT02574078|468971915|FG002|Treatment Period|Participant request to stop drug|0|||
130275223|NCT02574078|468971916|FG003|Treatment Period|Participant request to stop drug|2|||
130275224|NCT02574078|468971917|FG004|Treatment Period|Participant request to stop drug|4|||
130275225|NCT02574078|468971918|FG005|Treatment Period|Participant request to stop drug|0|||
130275226|NCT02574078|468971919|FG006|Treatment Period|Participant request to stop drug|1|||
130275227|NCT02574078|468971920|FG007|Treatment Period|Participant request to stop drug|0|||
130275228|NCT02574078|468971921|FG008|Treatment Period|Participant request to stop drug|3|||
130275229|NCT02574078|468971922|FG009|Treatment Period|Participant request to stop drug|2|||
130275230|NCT02574078|468971923|FG010|Treatment Period|Participant request to stop drug|2|||
129886597|NCT01536145|467545626|FG005|Overall Study|Withdrawal by Subject|1|||
130105064|NCT02149199|468343220|FG000|Overall Study|Lost to Follow-up|3|||
130105065|NCT02149199|468343221|FG001|Overall Study|Lost to Follow-up|12|||
130105066|NCT02149199|468343222|FG002|Overall Study|Lost to Follow-up|11|||
130105067|NCT02149199|468343220|FG000|Overall Study|Death|0|||
130275231|NCT02574078|468971924|FG011|Treatment Period|Participant request to stop drug|4|||
130275232|NCT02574078|468971925|FG012|Treatment Period|Participant request to stop drug|1|||
130275233|NCT02574078|468971913|FG000|Treatment Period|Participant withdrew consent|0|||
130105068|NCT02149199|468343221|FG001|Overall Study|Death|0|||
130105069|NCT02149199|468343222|FG002|Overall Study|Death|1|||
130105070|NCT02149199|468343220|FG000|Overall Study|Adverse Event|6|||
130105071|NCT02149199|468343221|FG001|Overall Study|Adverse Event|15|||
130105072|NCT02149199|468343222|FG002|Overall Study|Adverse Event|9|||
130105073|NCT03252756|468343223|FG000|Overall Study|Protocol Violation|2|||
130105074|NCT03252756|468343224|FG001|Overall Study|Protocol Violation|4|||
130105075|NCT03252756|468343223|FG000|Overall Study|COVID-19 Pandemic|1|||
130105076|NCT03252756|468343224|FG001|Overall Study|COVID-19 Pandemic|1|||
130105077|NCT03252756|468343223|FG000|Overall Study|Study Drug Expiration|0|||
130105078|NCT03252756|468343224|FG001|Overall Study|Study Drug Expiration|1|||
130105079|NCT01500434|468343227|FG000|Overall Study|Death|1|||
130105080|NCT01500434|468343227|FG000|Overall Study|Withdrawal by Subject|1|||
130105081|NCT01500434|468343227|FG000|Overall Study|Missed 12-month follow-up|5|||
130105082|NCT01966107|468343231|FG000|Overall Study|excluded from FAS|21|||
130105083|NCT01966107|468343232|FG001|Overall Study|excluded from FAS|20|||
130105084|NCT01966107|468343231|FG000|Overall Study|discontinued treatment|345|||
130105085|NCT01966107|468343232|FG001|Overall Study|discontinued treatment|372|||
130105086|NCT01966107|468343231|FG000|Overall Study|due to study closure|164|||
130105087|NCT01966107|468343232|FG001|Overall Study|due to study closure|186|||
130105088|NCT01966107|468343231|FG000|Overall Study|withdrew from the study|272|||
130105089|NCT01966107|468343232|FG001|Overall Study|withdrew from the study|303|||
130105090|NCT00532779|468343233|FG000|Overall Study|Adverse Event|122|||
130105091|NCT00532779|468343234|FG001|Overall Study|Adverse Event|112|||
130105092|NCT00532779|468343235|FG002|Overall Study|Adverse Event|56|||
130105093|NCT00532779|468343233|FG000|Overall Study|Lost to Follow-up|76|||
130105094|NCT00532779|468343234|FG001|Overall Study|Lost to Follow-up|65|||
130105095|NCT00532779|468343235|FG002|Overall Study|Lost to Follow-up|66|||
130105096|NCT00532779|468343233|FG000|Overall Study|Withdrawal by Subject|63|||
130105097|NCT00532779|468343234|FG001|Overall Study|Withdrawal by Subject|60|||
130105098|NCT00532779|468343235|FG002|Overall Study|Withdrawal by Subject|90|||
130105099|NCT00532779|468343233|FG000|Overall Study|Lack of Efficacy|12|||
130105100|NCT00532779|468343234|FG001|Overall Study|Lack of Efficacy|12|||
130105101|NCT00532779|468343235|FG002|Overall Study|Lack of Efficacy|40|||
130105102|NCT00532779|468343233|FG000|Overall Study|Protocol Violation|5|||
130105103|NCT00532779|468343234|FG001|Overall Study|Protocol Violation|9|||
130105104|NCT00532779|468343235|FG002|Overall Study|Protocol Violation|7|||
130105105|NCT00532779|468343233|FG000|Overall Study|Pregnancy|2|||
130105106|NCT00532779|468343234|FG001|Overall Study|Pregnancy|5|||
130105107|NCT00532779|468343235|FG002|Overall Study|Pregnancy|3|||
130105108|NCT00532779|468343233|FG000|Overall Study|Death|0|||
130105109|NCT00532779|468343234|FG001|Overall Study|Death|1|||
130105110|NCT00532779|468343235|FG002|Overall Study|Death|0|||
130105111|NCT00532779|468343233|FG000|Overall Study|Drug noncompliance, moved, other|14|||
130105112|NCT00532779|468343234|FG001|Overall Study|Drug noncompliance, moved, other|23|||
130105113|NCT00532779|468343235|FG002|Overall Study|Drug noncompliance, moved, other|29|||
130105114|NCT02662556|468343236|FG000|Overall Study|Adverse Event|4|||
130105115|NCT02662556|468343236|FG000|Overall Study|Lack of Efficacy|4|||
130105116|NCT01556165|468343237|FG000|Overall Study|Adverse Event|5|||
130105117|NCT01556165|468343238|FG001|Overall Study|Adverse Event|3|||
130105118|NCT01556165|468343237|FG000|Overall Study|Protocol Violation|0|||
130105119|NCT01556165|468343238|FG001|Overall Study|Protocol Violation|3|||
130275234|NCT02574078|468971914|FG001|Treatment Period|Participant withdrew consent|0|||
130275235|NCT02574078|468971915|FG002|Treatment Period|Participant withdrew consent|0|||
130275236|NCT02574078|468971916|FG003|Treatment Period|Participant withdrew consent|0|||
130275237|NCT02574078|468971917|FG004|Treatment Period|Participant withdrew consent|1|||
130275238|NCT02574078|468971918|FG005|Treatment Period|Participant withdrew consent|1|||
130275239|NCT02574078|468971919|FG006|Treatment Period|Participant withdrew consent|0|||
130275240|NCT02574078|468971920|FG007|Treatment Period|Participant withdrew consent|1|||
130275241|NCT02574078|468971921|FG008|Treatment Period|Participant withdrew consent|0|||
130275242|NCT02574078|468971922|FG009|Treatment Period|Participant withdrew consent|2|||
130275243|NCT02574078|468971923|FG010|Treatment Period|Participant withdrew consent|1|||
130275244|NCT02574078|468971924|FG011|Treatment Period|Participant withdrew consent|4|||
130275245|NCT02574078|468971925|FG012|Treatment Period|Participant withdrew consent|1|||
130275246|NCT02574078|468971913|FG000|Treatment Period|Participant no longer meets criteria|0|||
130105120|NCT01556165|468343237|FG000|Overall Study|Withdrawal of Consent|7|||
130105121|NCT01556165|468343238|FG001|Overall Study|Withdrawal of Consent|1|||
130275247|NCT02574078|468971914|FG001|Treatment Period|Participant no longer meets criteria|0|||
130275248|NCT02574078|468971915|FG002|Treatment Period|Participant no longer meets criteria|0|||
130105122|NCT00701558|468343239|FG000|Overall Study|Death|7|||
130105123|NCT00701558|468343239|FG000|Overall Study|Lost to Follow-up|8|||
130105124|NCT00131937|468343240|FG000|Overall Study|Adverse Event|3|||
130105125|NCT00131937|468343240|FG000|Overall Study|Withdrawal by Subject|2|||
130105126|NCT00131937|468343240|FG000|Overall Study|Physician Decision|1|||
130105127|NCT00131937|468343240|FG000|Overall Study|Disease Progression|7|||
130105128|NCT00131937|468343240|FG000|Overall Study|Alternative therapy|1|||
130105129|NCT01640964|468343241|FG000|Overall Study|Lost to Follow-up|0|||
130105130|NCT01640964|468343242|FG001|Overall Study|Lost to Follow-up|0|||
130275249|NCT02574078|468971916|FG003|Treatment Period|Participant no longer meets criteria|0|||
130275250|NCT02574078|468971917|FG004|Treatment Period|Participant no longer meets criteria|1|||
130275251|NCT02574078|468971918|FG005|Treatment Period|Participant no longer meets criteria|0|||
130275252|NCT02574078|468971919|FG006|Treatment Period|Participant no longer meets criteria|0|||
130275253|NCT02574078|468971920|FG007|Treatment Period|Participant no longer meets criteria|0|||
130275254|NCT02574078|468971921|FG008|Treatment Period|Participant no longer meets criteria|0|||
130275255|NCT02574078|468971922|FG009|Treatment Period|Participant no longer meets criteria|1|||
130275256|NCT02574078|468971923|FG010|Treatment Period|Participant no longer meets criteria|1|||
130275257|NCT02574078|468971924|FG011|Treatment Period|Participant no longer meets criteria|1|||
130275258|NCT02574078|468971925|FG012|Treatment Period|Participant no longer meets criteria|0|||
130275259|NCT02574078|468971913|FG000|Treatment Period|Lost to Follow-up|0|||
130275260|NCT02574078|468971914|FG001|Treatment Period|Lost to Follow-up|0|||
130275261|NCT02574078|468971915|FG002|Treatment Period|Lost to Follow-up|0|||
130275262|NCT02574078|468971916|FG003|Treatment Period|Lost to Follow-up|0|||
130275263|NCT02574078|468971917|FG004|Treatment Period|Lost to Follow-up|0|||
130275264|NCT02574078|468971918|FG005|Treatment Period|Lost to Follow-up|0|||
130275265|NCT02574078|468971919|FG006|Treatment Period|Lost to Follow-up|0|||
130275266|NCT02574078|468971920|FG007|Treatment Period|Lost to Follow-up|0|||
130275267|NCT02574078|468971921|FG008|Treatment Period|Lost to Follow-up|0|||
130275268|NCT02574078|468971922|FG009|Treatment Period|Lost to Follow-up|1|||
130275269|NCT02574078|468971923|FG010|Treatment Period|Lost to Follow-up|0|||
130275270|NCT02574078|468971924|FG011|Treatment Period|Lost to Follow-up|1|||
130275271|NCT02574078|468971925|FG012|Treatment Period|Lost to Follow-up|0|||
130275272|NCT02574078|468971913|FG000|Treatment Period|Maximum clinical benefit|0|||
130275273|NCT02574078|468971914|FG001|Treatment Period|Maximum clinical benefit|0|||
130275274|NCT02574078|468971915|FG002|Treatment Period|Maximum clinical benefit|0|||
130275275|NCT02574078|468971916|FG003|Treatment Period|Maximum clinical benefit|0|||
130275276|NCT02574078|468971917|FG004|Treatment Period|Maximum clinical benefit|0|||
130275277|NCT02574078|468971918|FG005|Treatment Period|Maximum clinical benefit|0|||
130275278|NCT02574078|468971919|FG006|Treatment Period|Maximum clinical benefit|0|||
130275279|NCT02574078|468971920|FG007|Treatment Period|Maximum clinical benefit|0|||
130275280|NCT02574078|468971921|FG008|Treatment Period|Maximum clinical benefit|0|||
130275281|NCT02574078|468971922|FG009|Treatment Period|Maximum clinical benefit|1|||
130275282|NCT02574078|468971923|FG010|Treatment Period|Maximum clinical benefit|0|||
130275283|NCT02574078|468971924|FG011|Treatment Period|Maximum clinical benefit|0|||
130275284|NCT02574078|468971925|FG012|Treatment Period|Maximum clinical benefit|0|||
130275285|NCT03037476|468971926|FG000|Overall Study|Lost to Follow-up|63|||
130275286|NCT03037476|468971927|FG001|Overall Study|Lost to Follow-up|46|||
130275287|NCT01498692|468971935|FG000|Overall Study|Death|4|||
130275288|NCT01498692|468971935|FG000|Overall Study|Withdrawal by Subject|1|||
130275289|NCT01498692|468971935|FG000|Overall Study|Missed 12-month visit|3|||
130275290|NCT00590122|468971936|FG000|Overall Study|swallowed oral dissolving dose|1|||
130105131|NCT01640964|468343243|FG002|Overall Study|Lost to Follow-up|1|||
130105132|NCT01640964|468343241|FG000|Overall Study|Protocol Deviation|1|||
130105133|NCT01640964|468343242|FG001|Overall Study|Protocol Deviation|1|||
130105134|NCT01640964|468343243|FG002|Overall Study|Protocol Deviation|2|||
130105135|NCT02787746|468343244|FG000|Overall Study|Adverse Event|42|||
130105136|NCT02787746|468343244|FG000|Overall Study|Withdrawal by Subject|65|||
130105137|NCT02787746|468343244|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
130105138|NCT02253654|468344494|FG000|Overall Study|Withdrawal by Subject|12|||
130105139|NCT02253654|468344495|FG001|Overall Study|Withdrawal by Subject|4|||
130105140|NCT02253654|468344494|FG000|Overall Study|Decision by Sponsor|1|||
130105141|NCT02253654|468344495|FG001|Overall Study|Decision by Sponsor|1|||
130105142|NCT02253654|468344494|FG000|Overall Study|Lost to Follow-up|2|||
130105143|NCT02253654|468344495|FG001|Overall Study|Lost to Follow-up|5|||
130105144|NCT02253654|468344494|FG000|Overall Study|Death|4|||
130105145|NCT02253654|468344495|FG001|Overall Study|Death|7|||
130105146|NCT02253654|468344494|FG000|Overall Study|Did Not Receive Study Treatment|4|||
130105147|NCT02253654|468344495|FG001|Overall Study|Did Not Receive Study Treatment|1|||
130105148|NCT03044431|468344498|FG000|Overall Study|Lost to Follow-up|59|||
130275291|NCT00590122|468971937|FG001|Overall Study|swallowed oral dissolving dose|0|||
130275292|NCT01208324|468971938|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
130275293|NCT01208324|468971939|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
130275294|NCT01208324|468971940|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
130105149|NCT03456726|468344499|FG000|Overall Study|Disease Progression|6|||
130105150|NCT03456726|468344500|FG001|Overall Study|Disease Progression|1|||
130105151|NCT03456726|468344499|FG000|Overall Study|Adverse Event|4|||
130105152|NCT03456726|468344500|FG001|Overall Study|Adverse Event|2|||
130275295|NCT01208324|468971941|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
130275296|NCT02707965|468971942|FG000|Overall Study|Withdrawal by Subject|0|||
130275297|NCT02707965|468971943|FG001|Overall Study|Withdrawal by Subject|0|||
130275298|NCT02707965|468971944|FG002|Overall Study|Withdrawal by Subject|1|||
130275299|NCT02707965|468971945|FG003|Overall Study|Withdrawal by Subject|0|||
130275300|NCT02707965|468971946|FG004|Overall Study|Withdrawal by Subject|0|||
130275301|NCT02707965|468971947|FG005|Overall Study|Withdrawal by Subject|0|||
130275302|NCT02707965|468971948|FG006|Overall Study|Withdrawal by Subject|0|||
130275303|NCT02707965|468971949|FG007|Overall Study|Withdrawal by Subject|2|||
130275304|NCT02707965|468971950|FG008|Overall Study|Withdrawal by Subject|0|||
130275305|NCT02707965|468971951|FG009|Overall Study|Withdrawal by Subject|0|||
130275306|NCT02707965|468971952|FG010|Overall Study|Withdrawal by Subject|0|||
130275307|NCT02707965|468971953|FG011|Overall Study|Withdrawal by Subject|0|||
130105153|NCT03456726|468344499|FG000|Overall Study|Withdrawal by Subject|1|||
130105154|NCT03456726|468344500|FG001|Overall Study|Withdrawal by Subject|0|||
130105155|NCT03456726|468344499|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
130105156|NCT03456726|468344500|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
130105157|NCT00399490|468344501|FG000|Overall Study|Adverse Event|19|||
130105158|NCT00399490|468344501|FG000|Overall Study|Lack of Efficacy|31|||
130105159|NCT00399490|468344501|FG000|Overall Study|Lost to Follow-up|5|||
130105160|NCT00399490|468344501|FG000|Overall Study|Withdrawal by Subject|18|||
130105161|NCT00399490|468344501|FG000|Overall Study|Other|25|||
130105162|NCT02328547|468344502|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
130105163|NCT02328547|468344503|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
130105164|NCT02328547|468344502|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130105165|NCT02328547|468344503|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
130105166|NCT02576054|468344504|FG000|Overall Study|Withdrawal by Subject|1|||
130105167|NCT01190098|468344508|FG000|Overall Study|Adverse Event|2|||
130105168|NCT01190098|468344509|FG001|Overall Study|Adverse Event|0|||
130105169|NCT01190098|468344508|FG000|Overall Study|Patient coomorbidity|0|||
130275308|NCT02707965|468971954|FG012|Overall Study|Withdrawal by Subject|0|||
130275309|NCT02707965|468971955|FG013|Overall Study|Withdrawal by Subject|0|||
130275310|NCT02707965|468971956|FG014|Overall Study|Withdrawal by Subject|0|||
130275311|NCT02707965|468971957|FG015|Overall Study|Withdrawal by Subject|0|||
130275312|NCT02707965|468971942|FG000|Overall Study|PI decisions|0|||
130275313|NCT02707965|468971943|FG001|Overall Study|PI decisions|0|||
130275314|NCT02707965|468971944|FG002|Overall Study|PI decisions|0|||
130275315|NCT02707965|468971945|FG003|Overall Study|PI decisions|0|||
130275316|NCT02707965|468971946|FG004|Overall Study|PI decisions|0|||
130275317|NCT02707965|468971947|FG005|Overall Study|PI decisions|0|||
130275318|NCT02707965|468971948|FG006|Overall Study|PI decisions|0|||
130275319|NCT02707965|468971949|FG007|Overall Study|PI decisions|0|||
130275320|NCT02707965|468971950|FG008|Overall Study|PI decisions|0|||
130275321|NCT02707965|468971951|FG009|Overall Study|PI decisions|0|||
130275322|NCT02707965|468971952|FG010|Overall Study|PI decisions|0|||
130105170|NCT01190098|468344509|FG001|Overall Study|Patient coomorbidity|1|||
130105171|NCT01190098|468344508|FG000|Overall Study|Lack of transportation|1|||
130105172|NCT01190098|468344509|FG001|Overall Study|Lack of transportation|0|||
130105173|NCT01190098|468344508|FG000|Overall Study|Other|0|||
130105174|NCT01190098|468344509|FG001|Overall Study|Other|1|||
130105175|NCT00344305|468344510|FG000|Overall Study|Lost to Follow-up|2|||
130105176|NCT00344305|468344511|FG001|Overall Study|Lost to Follow-up|0|||
130105177|NCT00344305|468344510|FG000|Overall Study|Participant was not contacted in window|0|||
130105178|NCT00344305|468344511|FG001|Overall Study|Participant was not contacted in window|1|||
130105179|NCT02957682|468344512|FG000|Overall Study|Adverse Event|64|||
130105180|NCT02957682|468344513|FG001|Overall Study|Adverse Event|67|||
130105181|NCT02957682|468344512|FG000|Overall Study|Poor Compliance to Protocol|30|||
130105182|NCT02957682|468344513|FG001|Overall Study|Poor Compliance to Protocol|26|||
130105183|NCT02957682|468344512|FG000|Overall Study|Physician Decision|4|||
130105184|NCT02957682|468344513|FG001|Overall Study|Physician Decision|4|||
130105185|NCT02957682|468344512|FG000|Overall Study|Study Terminated by Sponsor|4|||
130105186|NCT02957682|468344513|FG001|Overall Study|Study Terminated by Sponsor|3|||
130105187|NCT02957682|468344512|FG000|Overall Study|Subject Moved|10|||
130105188|NCT02957682|468344513|FG001|Overall Study|Subject Moved|16|||
130105189|NCT02957682|468344512|FG000|Overall Study|Withdrawal by Subject|64|||
130105190|NCT02957682|468344513|FG001|Overall Study|Withdrawal by Subject|33|||
130105191|NCT02957682|468344512|FG000|Overall Study|Related to IMP Administration|3|||
130105192|NCT02957682|468344513|FG001|Overall Study|Related to IMP Administration|6|||
130105193|NCT02957682|468344512|FG000|Overall Study|Non-disclosed|16|||
130105194|NCT02957682|468344513|FG001|Overall Study|Non-disclosed|12|||
130105195|NCT02957682|468344512|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
130105196|NCT02957682|468344513|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
130275323|NCT02707965|468971953|FG011|Overall Study|PI decisions|0|||
130275324|NCT02707965|468971954|FG012|Overall Study|PI decisions|0|||
130275325|NCT02707965|468971955|FG013|Overall Study|PI decisions|0|||
130275326|NCT02707965|468971956|FG014|Overall Study|PI decisions|2|||
130275327|NCT02707965|468971957|FG015|Overall Study|PI decisions|0|||
130275328|NCT02707965|468971942|FG000|Overall Study|Protocol deviation|1|||
130275329|NCT02707965|468971943|FG001|Overall Study|Protocol deviation|1|||
130275330|NCT02707965|468971944|FG002|Overall Study|Protocol deviation|0|||
130275331|NCT02707965|468971945|FG003|Overall Study|Protocol deviation|0|||
130275332|NCT02707965|468971946|FG004|Overall Study|Protocol deviation|0|||
130275333|NCT02707965|468971947|FG005|Overall Study|Protocol deviation|0|||
130275334|NCT02707965|468971948|FG006|Overall Study|Protocol deviation|0|||
130275335|NCT02707965|468971949|FG007|Overall Study|Protocol deviation|1|||
130275336|NCT02707965|468971950|FG008|Overall Study|Protocol deviation|0|||
130275337|NCT02707965|468971951|FG009|Overall Study|Protocol deviation|0|||
130275338|NCT02707965|468971952|FG010|Overall Study|Protocol deviation|0|||
130275339|NCT02707965|468971953|FG011|Overall Study|Protocol deviation|0|||
130275340|NCT02707965|468971954|FG012|Overall Study|Protocol deviation|0|||
130275341|NCT02707965|468971955|FG013|Overall Study|Protocol deviation|0|||
130275342|NCT02707965|468971956|FG014|Overall Study|Protocol deviation|0|||
130275343|NCT02707965|468971957|FG015|Overall Study|Protocol deviation|0|||
130275344|NCT00249808|468971958|FG000|Overall Study|Other|27|||
130275345|NCT00249808|468971958|FG000|Overall Study|Protocol Violation|3|||
130275346|NCT00249808|468971958|FG000|Overall Study|Lost to Follow-up|8|||
130275347|NCT00249808|468971958|FG000|Overall Study|Adverse Event|81|||
129886598|NCT01536145|467545627|FG006|Overall Study|Withdrawal by Subject|0|||
129886599|NCT01536145|467545628|FG007|Overall Study|Withdrawal by Subject|0|||
129886600|NCT01536145|467545629|FG008|Overall Study|Withdrawal by Subject|2|||
129886601|NCT01536145|467545630|FG009|Overall Study|Withdrawal by Subject|0|||
129886602|NCT01536145|467545631|FG010|Overall Study|Withdrawal by Subject|2|||
129886603|NCT01536145|467545621|FG000|Overall Study|Other|0|||
129886604|NCT01536145|467545622|FG001|Overall Study|Other|0|||
129886605|NCT01536145|467545623|FG002|Overall Study|Other|0|||
129886606|NCT01536145|467545624|FG003|Overall Study|Other|0|||
129886607|NCT01536145|467545625|FG004|Overall Study|Other|1|||
129886608|NCT01536145|467545626|FG005|Overall Study|Other|0|||
129886609|NCT01536145|467545627|FG006|Overall Study|Other|0|||
129886610|NCT01536145|467545628|FG007|Overall Study|Other|0|||
129886611|NCT01536145|467545629|FG008|Overall Study|Other|0|||
129886612|NCT01536145|467545630|FG009|Overall Study|Other|3|||
129886613|NCT01536145|467545631|FG010|Overall Study|Other|2|||
129886614|NCT01536145|467545621|FG000|Overall Study|Death|0|||
129886615|NCT01536145|467545622|FG001|Overall Study|Death|0|||
129886616|NCT01536145|467545623|FG002|Overall Study|Death|0|||
129886617|NCT01536145|467545624|FG003|Overall Study|Death|0|||
129886618|NCT01536145|467545625|FG004|Overall Study|Death|0|||
129886619|NCT01536145|467545626|FG005|Overall Study|Death|0|||
129886620|NCT01536145|467545627|FG006|Overall Study|Death|1|||
129886621|NCT01536145|467545628|FG007|Overall Study|Death|0|||
130275348|NCT00249808|468971958|FG000|Overall Study|Lack of Efficacy|52|||
130275349|NCT00249808|468971958|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
130275350|NCT02789345|468971959|FG000|Overall Study|Adverse Event|0|||
129886622|NCT01536145|467545629|FG008|Overall Study|Death|0|||
129886623|NCT01536145|467545630|FG009|Overall Study|Death|0|||
129886624|NCT01536145|467545631|FG010|Overall Study|Death|0|||
129886625|NCT01536145|467545621|FG000|Overall Study|Adverse Event|0|||
129886626|NCT01536145|467545622|FG001|Overall Study|Adverse Event|0|||
129886627|NCT01536145|467545623|FG002|Overall Study|Adverse Event|0|||
129886628|NCT01536145|467545624|FG003|Overall Study|Adverse Event|0|||
129886629|NCT01536145|467545625|FG004|Overall Study|Adverse Event|0|||
129886630|NCT01536145|467545626|FG005|Overall Study|Adverse Event|0|||
130275351|NCT02789345|468971960|FG001|Overall Study|Adverse Event|0|||
130275352|NCT02789345|468971961|FG002|Overall Study|Adverse Event|1|||
130275353|NCT02789345|468971959|FG000|Overall Study|Death|0|||
130275354|NCT02789345|468971960|FG001|Overall Study|Death|0|||
130275355|NCT02789345|468971961|FG002|Overall Study|Death|1|||
130275356|NCT02789345|468971959|FG000|Overall Study|Physician Decision|2|||
130105197|NCT00791154|468344522|FG000|Overall Study|Noncompliance|0|||
130105198|NCT00791154|468344523|FG001|Overall Study|Noncompliance|1|||
130105199|NCT00791154|468344524|FG002|Overall Study|Noncompliance|0|||
130105200|NCT00791154|468344525|FG003|Overall Study|Noncompliance|0|||
130105201|NCT00791154|468344526|FG004|Overall Study|Noncompliance|1|||
130275357|NCT02789345|468971960|FG001|Overall Study|Physician Decision|0|||
130275358|NCT02789345|468971961|FG002|Overall Study|Physician Decision|1|||
130275359|NCT02789345|468971959|FG000|Overall Study|Progressive Disease|1|||
130275360|NCT02789345|468971960|FG001|Overall Study|Progressive Disease|3|||
130275361|NCT02789345|468971961|FG002|Overall Study|Progressive Disease|14|||
130275362|NCT00135330|468971963|FG000|Overall Study|Adverse Event|2|||
130275363|NCT00135330|468971964|FG001|Overall Study|Adverse Event|5|||
130275364|NCT00135330|468971965|FG002|Overall Study|Adverse Event|1|||
130275365|NCT00135330|468971963|FG000|Overall Study|Lost to Follow-up|0|||
130275366|NCT00135330|468971964|FG001|Overall Study|Lost to Follow-up|2|||
130275367|NCT00135330|468971965|FG002|Overall Study|Lost to Follow-up|3|||
130275368|NCT00135330|468971963|FG000|Overall Study|Physician Decision|1|||
130275369|NCT00135330|468971964|FG001|Overall Study|Physician Decision|1|||
130275370|NCT00135330|468971965|FG002|Overall Study|Physician Decision|0|||
130275371|NCT00135330|468971963|FG000|Overall Study|Protocol Violation|4|||
130275372|NCT00135330|468971964|FG001|Overall Study|Protocol Violation|3|||
130275373|NCT00135330|468971965|FG002|Overall Study|Protocol Violation|3|||
130275374|NCT00135330|468971963|FG000|Overall Study|Patient Decision|5|||
130275375|NCT00135330|468971964|FG001|Overall Study|Patient Decision|1|||
130275376|NCT00135330|468971965|FG002|Overall Study|Patient Decision|4|||
130275377|NCT00135330|468971963|FG000|Overall Study|Sponsor Decision|0|||
130275378|NCT00135330|468971964|FG001|Overall Study|Sponsor Decision|1|||
130275379|NCT00135330|468971965|FG002|Overall Study|Sponsor Decision|0|||
130275380|NCT00372619|468971966|FG000|Overall Study|Ineligible|0|||
130275381|NCT00372619|468971967|FG001|Overall Study|Ineligible|0|||
130275382|NCT00372619|468971968|FG002|Overall Study|Ineligible|0|||
130275383|NCT00372619|468971969|FG003|Overall Study|Ineligible|0|||
130275384|NCT00372619|468971970|FG004|Overall Study|Ineligible|0|||
130275385|NCT00372619|468971971|FG005|Overall Study|Ineligible|2|||
130275386|NCT00372619|468971972|FG006|Overall Study|Ineligible|0|||
130275387|NCT00372619|468971966|FG000|Overall Study|Inevaluable|0|||
130275388|NCT00372619|468971967|FG001|Overall Study|Inevaluable|0|||
130275389|NCT00372619|468971968|FG002|Overall Study|Inevaluable|0|||
130275390|NCT00372619|468971969|FG003|Overall Study|Inevaluable|0|||
130275391|NCT00372619|468971970|FG004|Overall Study|Inevaluable|0|||
130275392|NCT00372619|468971971|FG005|Overall Study|Inevaluable|1|||
130275393|NCT00372619|468971972|FG006|Overall Study|Inevaluable|0|||
130275394|NCT00066222|468971973|FG000|Overall Study|No protocol treatment received|1|||
130275395|NCT01524224|468971980|FG000|Overall Study|Progressive Disease|1|||
130275396|NCT01524224|468971981|FG001|Overall Study|Progressive Disease|0|||
130275397|NCT01524224|468971982|FG002|Overall Study|Progressive Disease|2|||
130275398|NCT01524224|468971983|FG003|Overall Study|Progressive Disease|1|||
130275399|NCT01524224|468971984|FG004|Overall Study|Progressive Disease|2|||
130275400|NCT01524224|468971985|FG005|Overall Study|Progressive Disease|1|||
130275401|NCT01524224|468971986|FG006|Overall Study|Progressive Disease|1|||
130275402|NCT01524224|468971987|FG007|Overall Study|Progressive Disease|5|||
130275403|NCT01524224|468971980|FG000|Overall Study|Withdrawal by Subject|2|||
130275404|NCT01524224|468971981|FG001|Overall Study|Withdrawal by Subject|0|||
130275405|NCT01524224|468971982|FG002|Overall Study|Withdrawal by Subject|0|||
130275406|NCT01524224|468971983|FG003|Overall Study|Withdrawal by Subject|0|||
130275407|NCT01524224|468971984|FG004|Overall Study|Withdrawal by Subject|0|||
130275408|NCT01524224|468971985|FG005|Overall Study|Withdrawal by Subject|0|||
130275409|NCT01524224|468971986|FG006|Overall Study|Withdrawal by Subject|2|||
130275410|NCT01524224|468971987|FG007|Overall Study|Withdrawal by Subject|0|||
130275411|NCT01524224|468971980|FG000|Overall Study|Adverse Event|0|||
130105202|NCT00791154|468344527|FG005|Overall Study|Noncompliance|1|||
130105203|NCT00791154|468344528|FG006|Overall Study|Noncompliance|1|||
130105204|NCT00791154|468344522|FG000|Overall Study|Adverse Event|0|||
130105205|NCT00791154|468344523|FG001|Overall Study|Adverse Event|0|||
130105206|NCT00791154|468344524|FG002|Overall Study|Adverse Event|0|||
130105207|NCT00791154|468344525|FG003|Overall Study|Adverse Event|0|||
130275412|NCT01524224|468971981|FG001|Overall Study|Adverse Event|1|||
130275413|NCT01524224|468971982|FG002|Overall Study|Adverse Event|0|||
130275414|NCT01524224|468971983|FG003|Overall Study|Adverse Event|0|||
130275415|NCT01524224|468971984|FG004|Overall Study|Adverse Event|0|||
130275416|NCT01524224|468971985|FG005|Overall Study|Adverse Event|1|||
130275417|NCT01524224|468971986|FG006|Overall Study|Adverse Event|0|||
130275418|NCT01524224|468971987|FG007|Overall Study|Adverse Event|0|||
130275419|NCT01524224|468971980|FG000|Overall Study|Physician Decision|0|||
130275420|NCT01524224|468971981|FG001|Overall Study|Physician Decision|0|||
130275421|NCT01524224|468971982|FG002|Overall Study|Physician Decision|0|||
130275422|NCT01524224|468971983|FG003|Overall Study|Physician Decision|1|||
130275423|NCT01524224|468971984|FG004|Overall Study|Physician Decision|1|||
130275424|NCT01524224|468971985|FG005|Overall Study|Physician Decision|0|||
130275425|NCT01524224|468971986|FG006|Overall Study|Physician Decision|0|||
130275426|NCT01524224|468971987|FG007|Overall Study|Physician Decision|1|||
130275427|NCT01524224|468971980|FG000|Overall Study|Sponsor Decision|0|||
130275428|NCT01524224|468971981|FG001|Overall Study|Sponsor Decision|0|||
130275429|NCT01524224|468971982|FG002|Overall Study|Sponsor Decision|0|||
130275430|NCT01524224|468971983|FG003|Overall Study|Sponsor Decision|0|||
130275431|NCT01524224|468971984|FG004|Overall Study|Sponsor Decision|1|||
130275432|NCT01524224|468971985|FG005|Overall Study|Sponsor Decision|0|||
130275433|NCT01524224|468971986|FG006|Overall Study|Sponsor Decision|0|||
129886631|NCT01536145|467545627|FG006|Overall Study|Adverse Event|0|||
129886632|NCT01536145|467545628|FG007|Overall Study|Adverse Event|2|||
129886633|NCT01536145|467545629|FG008|Overall Study|Adverse Event|0|||
129886634|NCT01536145|467545630|FG009|Overall Study|Adverse Event|0|||
129886635|NCT01536145|467545631|FG010|Overall Study|Adverse Event|3|||
129886636|NCT01284140|467545634|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
129886637|NCT01284140|467545635|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
129886638|NCT01284140|467545634|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
129886639|NCT01284140|467545635|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
129886640|NCT00088205|467545636|FG000|Overall Study|Adverse Event|4|||
129886641|NCT00088205|467545636|FG000|Overall Study|Progressive Disease|51|||
129886642|NCT00088205|467545636|FG000|Overall Study|Physician Decision|1|||
129886643|NCT00088205|467545636|FG000|Overall Study|Death Due to Study Disease|4|||
129886644|NCT03192215|467545637|FG000|Overall Study|Death|28|||
129886645|NCT03192215|467545638|FG001|Overall Study|Death|23|||
129886646|NCT03192215|467545637|FG000|Overall Study|Lost to Follow-up|10|||
129886647|NCT03192215|467545638|FG001|Overall Study|Lost to Follow-up|15|||
129886648|NCT03192215|467545637|FG000|Overall Study|Withdrawal by Subject|49|||
129886649|NCT03192215|467545638|FG001|Overall Study|Withdrawal by Subject|48|||
129886650|NCT03192215|467545637|FG000|Overall Study|Other as reported in analysis|4|||
129886651|NCT03192215|467545638|FG001|Overall Study|Other as reported in analysis|1|||
129886652|NCT05199233|467545641|FG000|Overall Study|Lack of Efficacy|1|||
129886653|NCT02443103|467545648|FG000|Overall Study|Adverse Event|2|||
129886654|NCT02443103|467545648|FG000|Overall Study|Noncompliance|1|||
129886655|NCT01630590|467545649|FG000|Overall Study|Adverse Event|9|||
129886656|NCT01630590|467545649|FG000|Overall Study|Lack of Efficacy|37|||
129886657|NCT01630590|467545649|FG000|Overall Study|Withdrawal by Subject|4|||
129886658|NCT01630590|467545649|FG000|Overall Study|2nd primary tumor|2|||
129886659|NCT01630590|467545649|FG000|Overall Study|Automobile accident|1|||
129886660|NCT01630590|467545649|FG000|Overall Study|Maximum benefit|4|||
129886661|NCT02366936|467545650|FG000|Overall Study|Withdrawal by Subject|2|||
129886662|NCT02366936|467545650|FG000|Overall Study|Lost to Follow-up|4|||
129886663|NCT02366936|467545650|FG000|Overall Study|Physician Decision|2|||
129886664|NCT03358329|467545653|FG000|Overall Study|Lost to Follow-up|2|||
129886665|NCT03358329|467545653|FG000|Overall Study|Withdrawal by Subject|2|||
129886666|NCT02982720|467545654|FG000|Overall Study|Adverse Event|3|||
129886667|NCT02982720|467545654|FG000|Overall Study|Death|1|||
129886668|NCT00750893|467545657|FG000|Overall Study|Adverse Event|5|||
129886669|NCT00750893|467545657|FG000|Overall Study|Withdrawal by Subject|10|||
129886670|NCT00750893|467545657|FG000|Overall Study|Lost to Follow-up|510|||
129886671|NCT00750893|467545657|FG000|Overall Study|Other|17|||
129886672|NCT02420327|467545658|FG000|Overall Study|Adverse Event|7|||
129886673|NCT02420327|467545658|FG000|Overall Study|Pregnancy|1|||
129886674|NCT02420327|467545658|FG000|Overall Study|Withdrawal by Subject|6|||
129886675|NCT02420327|467545658|FG000|Overall Study|Lost to Follow-up|1|||
129886676|NCT02420327|467545658|FG000|Overall Study|Protocol Violation|1|||
129886677|NCT02589392|467545660|FG000|Overall Study|Adverse Event|1|||
129886678|NCT02589392|467545661|FG001|Overall Study|Adverse Event|1|||
129886679|NCT02589392|467545660|FG000|Overall Study|Withdrawal by Subject|1|||
129886680|NCT02589392|467545661|FG001|Overall Study|Withdrawal by Subject|2|||
129886681|NCT02589392|467545660|FG000|Overall Study|Protocol Violation|1|||
129886682|NCT02589392|467545661|FG001|Overall Study|Protocol Violation|1|||
129886683|NCT02589392|467545660|FG000|Overall Study|Lost to Follow-up|2|||
129886684|NCT02589392|467545661|FG001|Overall Study|Lost to Follow-up|2|||
129886685|NCT02589392|467545660|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
129886686|NCT02589392|467545661|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
129886687|NCT00393094|467545666|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
129886688|NCT00393094|467545666|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
129886689|NCT04230980|467545667|FG000|Overall Study|Lost to Follow-up|1|||
129886690|NCT04230980|467545668|FG001|Overall Study|Lost to Follow-up|2|||
129886691|NCT04230980|467545667|FG000|Overall Study|Adverse Event|0|||
129886692|NCT04230980|467545668|FG001|Overall Study|Adverse Event|1|||
129886693|NCT03523871|467545669|FG000|Overall Study|Death|1|||
129886694|NCT01994720|467545670|FG000|Overall Study|Withdrawal by Subject|46|||
129886695|NCT01994720|467545671|FG001|Overall Study|Withdrawal by Subject|56|||
129886696|NCT04285229|467545675|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129886697|NCT04285229|467545676|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129886698|NCT04285229|467545677|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129886699|NCT04285229|467545678|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130275434|NCT01524224|468971987|FG007|Overall Study|Sponsor Decision|0|||
130105208|NCT00791154|468344526|FG004|Overall Study|Adverse Event|2|||
130105209|NCT00791154|468344527|FG005|Overall Study|Adverse Event|0|||
130105210|NCT00791154|468344528|FG006|Overall Study|Adverse Event|1|||
130105211|NCT00791154|468344522|FG000|Overall Study|Full Consent withdrawn|1|||
130105212|NCT00791154|468344523|FG001|Overall Study|Full Consent withdrawn|3|||
130105213|NCT00791154|468344524|FG002|Overall Study|Full Consent withdrawn|0|||
130105214|NCT00791154|468344525|FG003|Overall Study|Full Consent withdrawn|0|||
130105215|NCT00791154|468344526|FG004|Overall Study|Full Consent withdrawn|1|||
130105216|NCT00791154|468344527|FG005|Overall Study|Full Consent withdrawn|3|||
130105217|NCT00791154|468344528|FG006|Overall Study|Full Consent withdrawn|1|||
130105218|NCT00791154|468344522|FG000|Overall Study|Lost to Follow-up|0|||
130105219|NCT00791154|468344523|FG001|Overall Study|Lost to Follow-up|0|||
130105220|NCT00791154|468344524|FG002|Overall Study|Lost to Follow-up|0|||
130105221|NCT00791154|468344525|FG003|Overall Study|Lost to Follow-up|1|||
130105222|NCT00791154|468344526|FG004|Overall Study|Lost to Follow-up|2|||
130105223|NCT00791154|468344527|FG005|Overall Study|Lost to Follow-up|0|||
130105224|NCT00791154|468344528|FG006|Overall Study|Lost to Follow-up|4|||
130105225|NCT00791154|468344522|FG000|Overall Study|Death|5|||
130105226|NCT00791154|468344523|FG001|Overall Study|Death|4|||
130105227|NCT00791154|468344524|FG002|Overall Study|Death|4|||
130105228|NCT00791154|468344525|FG003|Overall Study|Death|7|||
130105229|NCT00791154|468344526|FG004|Overall Study|Death|54|||
130105230|NCT00791154|468344527|FG005|Overall Study|Death|54|||
130105231|NCT00791154|468344528|FG006|Overall Study|Death|52|||
130105232|NCT00791154|468344522|FG000|Overall Study|Other event|0|||
130105233|NCT00791154|468344523|FG001|Overall Study|Other event|0|||
130105234|NCT00791154|468344524|FG002|Overall Study|Other event|2|||
130105235|NCT00791154|468344525|FG003|Overall Study|Other event|0|||
130105236|NCT00791154|468344526|FG004|Overall Study|Other event|2|||
130105237|NCT00791154|468344527|FG005|Overall Study|Other event|4|||
130105238|NCT00791154|468344528|FG006|Overall Study|Other event|2|||
130105239|NCT03578276|468344531|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
130105240|NCT03578276|468344532|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
130105241|NCT00981409|468344533|FG000|Overall Study|Adverse Event|4|||
130105242|NCT00981409|468344534|FG001|Overall Study|Adverse Event|0|||
130105243|NCT00981409|468344533|FG000|Overall Study|Protocol Violation|0|||
130105244|NCT00981409|468344534|FG001|Overall Study|Protocol Violation|1|||
130105245|NCT00981409|468344533|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
130105246|NCT00981409|468344534|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
130105247|NCT00078312|468344543|FG000|Overall Study|Adverse Event|43|||
130105248|NCT00078312|468344543|FG000|Overall Study|Lack of Efficacy|15|||
130105249|NCT00078312|468344543|FG000|Overall Study|Lost to Follow-up|41|||
130105250|NCT00078312|468344543|FG000|Overall Study|Physician Decision|9|||
130105251|NCT00078312|468344543|FG000|Overall Study|Protocol Violation|3|||
130105252|NCT00078312|468344543|FG000|Overall Study|Withdrawal by Subject|33|||
130105253|NCT00078312|468344543|FG000|Overall Study|Miscellaneous|33|||
130105254|NCT05354206|468344544|FG000|Overall Study|Withdrawal by Subject|1|||
130105255|NCT05354206|468344545|FG001|Overall Study|Withdrawal by Subject|0|||
130105256|NCT00902265|468344546|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
130105257|NCT00902265|468344546|FG000|Overall Study|Adverse Event|2|||
130105258|NCT00902265|468344546|FG000|Overall Study|Lack of Efficacy|2|||
130105259|NCT00902265|468344546|FG000|Overall Study|Protocol Violation|1|||
130105260|NCT04701658|468344547|FG000|Overall Study|Lost to Follow-up|6|||
130105261|NCT05016765|468344548|FG000|Overall Study|Lost to Follow-up|4|||
130105262|NCT04101721|468344551|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
130105263|NCT04101721|468344552|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
130105264|NCT04101721|468344551|FG000|Overall Study|Death|0|||
130105265|NCT04101721|468344552|FG001|Overall Study|Death|1|||
130105266|NCT04101721|468344551|FG000|Overall Study|Lost to Follow-up|0|||
130105267|NCT04101721|468344552|FG001|Overall Study|Lost to Follow-up|3|||
130105268|NCT02494583|468344555|FG000|Overall Study|Death|224|||
130105269|NCT02494583|468344556|FG001|Overall Study|Death|214|||
130105270|NCT02494583|468344557|FG002|Overall Study|Death|225|||
130105271|NCT02494583|468344555|FG000|Overall Study|Lost to Follow-up|1|||
130275435|NCT00615719|468971989|FG000|Overall Study|Physician Decision|5|||
130275436|NCT03517371|468971990|FG000|Overall Study|Adverse Event|8|||
130275437|NCT03517371|468971991|FG001|Overall Study|Adverse Event|9|||
129886700|NCT04285229|467545679|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129886701|NCT04285229|467545680|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130275438|NCT03517371|468971990|FG000|Overall Study|Lost to Follow-up|1|||
130275439|NCT03517371|468971991|FG001|Overall Study|Lost to Follow-up|2|||
130275440|NCT03517371|468971990|FG000|Overall Study|Withdrawal by Subject|4|||
130275441|NCT03517371|468971991|FG001|Overall Study|Withdrawal by Subject|4|||
130275442|NCT03517371|468971990|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
130275443|NCT03517371|468971991|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
130275444|NCT03517371|468971990|FG000|Overall Study|COVID restrictions|2|||
130275445|NCT03517371|468971991|FG001|Overall Study|COVID restrictions|0|||
130275446|NCT03517371|468971990|FG000|Overall Study|Receiving DBS Surgery|0|||
130275447|NCT03517371|468971991|FG001|Overall Study|Receiving DBS Surgery|1|||
130275448|NCT05420961|468971992|FG000|Overall Study|Withdrawal by Subject|2|||
130275449|NCT05420961|468971993|FG001|Overall Study|Withdrawal by Subject|1|||
130275450|NCT05420961|468971994|FG002|Overall Study|Withdrawal by Subject|1|||
130275451|NCT05420961|468971995|FG003|Overall Study|Withdrawal by Subject|0|||
130275452|NCT05420961|468971996|FG004|Overall Study|Withdrawal by Subject|0|||
130275453|NCT05420961|468971992|FG000|Overall Study|Lost to Follow-up|0|||
130275454|NCT05420961|468971993|FG001|Overall Study|Lost to Follow-up|0|||
130275455|NCT05420961|468971994|FG002|Overall Study|Lost to Follow-up|1|||
130275456|NCT05420961|468971995|FG003|Overall Study|Lost to Follow-up|0|||
130275457|NCT05420961|468971996|FG004|Overall Study|Lost to Follow-up|0|||
130275458|NCT05420961|468971992|FG000|Overall Study|Randomized by mistake without study treatment|0|||
130275459|NCT05420961|468971993|FG001|Overall Study|Randomized by mistake without study treatment|0|||
130275460|NCT05420961|468971994|FG002|Overall Study|Randomized by mistake without study treatment|1|||
130275461|NCT05420961|468971995|FG003|Overall Study|Randomized by mistake without study treatment|0|||
130275462|NCT05420961|468971996|FG004|Overall Study|Randomized by mistake without study treatment|1|||
130275463|NCT04283656|468971997|FG000|Overall Study|Adverse Event|1|||
130275464|NCT04283656|468971998|FG001|Overall Study|Adverse Event|0|||
130275465|NCT04283656|468971997|FG000|Overall Study|Lost to Follow-up|0|||
130275466|NCT04283656|468971998|FG001|Overall Study|Lost to Follow-up|1|||
130275467|NCT00935493|468972003|FG000|Overall Study|Lost to Follow-up|1|||
130275468|NCT00935493|468972004|FG001|Overall Study|Lost to Follow-up|1|||
130275469|NCT00935493|468972005|FG002|Overall Study|Lost to Follow-up|1|||
130275470|NCT00935493|468972003|FG000|Overall Study|Treatment Discontinued|0|||
130275471|NCT00935493|468972004|FG001|Overall Study|Treatment Discontinued|1|||
130275472|NCT00935493|468972005|FG002|Overall Study|Treatment Discontinued|0|||
130275473|NCT01555073|468972006|FG000|Overall Study|Lost to Follow-up|1|||
130275474|NCT01555073|468972007|FG001|Overall Study|Lost to Follow-up|2|||
130275475|NCT01555073|468972008|FG002|Overall Study|Lost to Follow-up|0|||
130275476|NCT01555073|468972009|FG003|Overall Study|Lost to Follow-up|5|||
130275477|NCT02565147|468972017|FG000|Overall Study|Withdrawal by Subject|5|||
130275478|NCT02565147|468972018|FG001|Overall Study|Withdrawal by Subject|1|||
130275479|NCT02565147|468972017|FG000|Overall Study|Lost to Follow-up|0|||
129886702|NCT04285229|467545675|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
129886703|NCT04285229|467545676|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
129886704|NCT04285229|467545677|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
129886705|NCT04285229|467545678|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
129886706|NCT04285229|467545679|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
129886707|NCT04285229|467545680|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
129886708|NCT04285229|467545675|FG000|Extended Treatment Period|Adverse Event|0|||
129886709|NCT04285229|467545676|FG001|Extended Treatment Period|Adverse Event|0|||
129886710|NCT04285229|467545677|FG002|Extended Treatment Period|Adverse Event|0|||
129886711|NCT04285229|467545678|FG003|Extended Treatment Period|Adverse Event|1|||
129886712|NCT04285229|467545679|FG004|Extended Treatment Period|Adverse Event|0|||
129886713|NCT04285229|467545680|FG005|Extended Treatment Period|Adverse Event|0|||
129886714|NCT04285229|467545675|FG000|Extended Treatment Period|Physician Decision|0|||
129886715|NCT04285229|467545676|FG001|Extended Treatment Period|Physician Decision|0|||
129886716|NCT04285229|467545677|FG002|Extended Treatment Period|Physician Decision|1|||
129886717|NCT04285229|467545678|FG003|Extended Treatment Period|Physician Decision|0|||
129886718|NCT04285229|467545679|FG004|Extended Treatment Period|Physician Decision|0|||
130275480|NCT02565147|468972018|FG001|Overall Study|Lost to Follow-up|1|||
130275481|NCT02565147|468972017|FG000|Overall Study|Death|1|||
130275482|NCT02565147|468972018|FG001|Overall Study|Death|1|||
130275483|NCT02936869|468972025|FG000|Overall Study|Lost to Follow-up|1|||
130275484|NCT02936869|468972026|FG001|Overall Study|Lost to Follow-up|3|||
130275485|NCT02936869|468972025|FG000|Overall Study|Death|0|||
130275486|NCT02936869|468972026|FG001|Overall Study|Death|1|||
130275487|NCT02936869|468972025|FG000|Overall Study|Legal Case|0|||
130275488|NCT02936869|468972026|FG001|Overall Study|Legal Case|1|||
130275489|NCT02936869|468972025|FG000|Overall Study|Protocol Violation|1|||
130105272|NCT02494583|468344556|FG001|Overall Study|Lost to Follow-up|0|||
130105273|NCT02494583|468344557|FG002|Overall Study|Lost to Follow-up|0|||
130105274|NCT02494583|468344555|FG000|Overall Study|Protocol Violation|1|||
130105275|NCT02494583|468344556|FG001|Overall Study|Protocol Violation|2|||
130105276|NCT02494583|468344557|FG002|Overall Study|Protocol Violation|0|||
130105277|NCT02494583|468344555|FG000|Overall Study|Screen Failure|0|||
130105278|NCT02494583|468344556|FG001|Overall Study|Screen Failure|1|||
130105279|NCT02494583|468344557|FG002|Overall Study|Screen Failure|0|||
130105280|NCT02494583|468344555|FG000|Overall Study|Transferred to Extension Study|15|||
130105281|NCT02494583|468344556|FG001|Overall Study|Transferred to Extension Study|15|||
130105282|NCT02494583|468344557|FG002|Overall Study|Transferred to Extension Study|6|||
130105283|NCT02494583|468344555|FG000|Overall Study|Did Not Continue on Extension Study|8|||
130105284|NCT02494583|468344556|FG001|Overall Study|Did Not Continue on Extension Study|10|||
130105285|NCT02494583|468344557|FG002|Overall Study|Did Not Continue on Extension Study|4|||
130105286|NCT02494583|468344555|FG000|Overall Study|Withdrawal by Subject|7|||
130105287|NCT02494583|468344556|FG001|Overall Study|Withdrawal by Subject|15|||
130105288|NCT02494583|468344557|FG002|Overall Study|Withdrawal by Subject|15|||
130105289|NCT03151707|468344560|FG000|Overall Study|Lost to Follow-up|6|||
130105290|NCT02362646|468344564|FG000|Overall Study|Death|15|||
130105291|NCT02362646|468344565|FG001|Overall Study|Death|8|||
130105292|NCT02362646|468344564|FG000|Overall Study|Withdrawal by Subject|2|||
130105293|NCT02362646|468344565|FG001|Overall Study|Withdrawal by Subject|2|||
130105294|NCT02362646|468344564|FG000|Overall Study|received transplant|21|||
130105295|NCT02362646|468344565|FG001|Overall Study|received transplant|14|||
130105296|NCT00865306|468344566|FG000|Controlled Trial|Lost to Follow-up|1|||
130105297|NCT00865306|468344567|FG001|Controlled Trial|Lost to Follow-up|1|||
130105298|NCT00865306|468344566|FG000|Controlled Trial|Difficulty commuting|2|||
130105299|NCT00865306|468344567|FG001|Controlled Trial|Difficulty commuting|0|||
130105300|NCT00865306|468344566|FG000|Controlled Trial|Improved btw baseline and first session|1|||
130105301|NCT00865306|468344567|FG001|Controlled Trial|Improved btw baseline and first session|0|||
130105302|NCT00865306|468344566|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
130105303|NCT00865306|468344567|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
130105304|NCT00865306|468344566|FG000|Controlled Trial|Withdrawal by Subject|0|||
130105305|NCT00865306|468344567|FG001|Controlled Trial|Withdrawal by Subject|1|||
130105306|NCT02058368|468344569|FG000|Overall Study|Adverse Event|15|||
130105307|NCT02058368|468344570|FG001|Overall Study|Adverse Event|20|||
130105308|NCT02058368|468344569|FG000|Overall Study|Lack of Efficacy|0|||
130105309|NCT02058368|468344570|FG001|Overall Study|Lack of Efficacy|1|||
130105310|NCT02058368|468344569|FG000|Overall Study|Protocol Violation|0|||
130105311|NCT02058368|468344570|FG001|Overall Study|Protocol Violation|4|||
130105312|NCT02058368|468344569|FG000|Overall Study|Lost to Follow-up|2|||
130105313|NCT02058368|468344570|FG001|Overall Study|Lost to Follow-up|0|||
130275490|NCT02936869|468972026|FG001|Overall Study|Protocol Violation|0|||
130275491|NCT00335738|468972027|FG000|Overall Study|Physician Decision|6|||
130275492|NCT00335738|468972028|FG001|Overall Study|Physician Decision|0|||
130275493|NCT00335738|468972027|FG000|Overall Study|Withdrawal by Subject|2|||
130275494|NCT00335738|468972028|FG001|Overall Study|Withdrawal by Subject|0|||
130275495|NCT00335738|468972027|FG000|Overall Study|Ineligible|3|||
130275496|NCT00335738|468972028|FG001|Overall Study|Ineligible|4|||
130275497|NCT03423238|468972035|FG000|Overall Study|Lost to Follow-up|1|||
130275498|NCT03423238|468972036|FG001|Overall Study|Lost to Follow-up|0|||
130275499|NCT03423238|468972035|FG000|Overall Study|Withdrawal by Subject|1|||
130275500|NCT03423238|468972036|FG001|Overall Study|Withdrawal by Subject|0|||
130275501|NCT00992056|468972037|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
130275502|NCT00992056|468972038|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
130275503|NCT00992056|468972037|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
130275504|NCT00992056|468972038|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
130275505|NCT00902850|468972039|FG000|Overall Study|Physician Decision|2|||
130275506|NCT00902850|468972040|FG001|Overall Study|Physician Decision|2|||
130275507|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
130275508|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
130275509|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
130275510|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130105314|NCT02058368|468344569|FG000|Overall Study|Physician Decision|2|||
130105315|NCT02058368|468344570|FG001|Overall Study|Physician Decision|3|||
130105316|NCT02058368|468344569|FG000|Overall Study|Withdrawal by Subject|22|||
130105317|NCT02058368|468344570|FG001|Overall Study|Withdrawal by Subject|26|||
130105318|NCT02181842|468344571|FG000|Overall Study|Case Report Forms Uncollected|2|||
130105319|NCT01652872|468344572|FG000|Overall Study|Death|36|||
130105320|NCT01652872|468344573|FG001|Overall Study|Death|39|||
130105321|NCT01652872|468344572|FG000|Overall Study|Lost to Follow-up|28|||
130105322|NCT01652872|468344573|FG001|Overall Study|Lost to Follow-up|23|||
130275511|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275512|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275513|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130275514|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
130275515|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275516|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275517|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275518|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275519|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
130275520|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129886719|NCT04285229|467545680|FG005|Extended Treatment Period|Physician Decision|0|||
129886720|NCT04285229|467545675|FG000|Follow-up Period|Adverse Event|0|||
129886721|NCT04285229|467545676|FG001|Follow-up Period|Adverse Event|0|||
129886722|NCT04285229|467545677|FG002|Follow-up Period|Adverse Event|0|||
129886723|NCT04285229|467545678|FG003|Follow-up Period|Adverse Event|0|||
129886724|NCT04285229|467545679|FG004|Follow-up Period|Adverse Event|1|||
129886725|NCT04285229|467545680|FG005|Follow-up Period|Adverse Event|4|||
129886726|NCT04285229|467545675|FG000|Follow-up Period|Withdrawal by Subject|0|||
129886727|NCT04285229|467545676|FG001|Follow-up Period|Withdrawal by Subject|0|||
129886728|NCT04285229|467545677|FG002|Follow-up Period|Withdrawal by Subject|0|||
129886729|NCT04285229|467545678|FG003|Follow-up Period|Withdrawal by Subject|0|||
129886730|NCT04285229|467545679|FG004|Follow-up Period|Withdrawal by Subject|0|||
129886731|NCT04285229|467545680|FG005|Follow-up Period|Withdrawal by Subject|5|||
129886732|NCT04285229|467545675|FG000|Follow-up Period|Covid-19|0|||
129886733|NCT04285229|467545676|FG001|Follow-up Period|Covid-19|0|||
129886734|NCT04285229|467545677|FG002|Follow-up Period|Covid-19|0|||
129886735|NCT04285229|467545678|FG003|Follow-up Period|Covid-19|0|||
129886736|NCT04285229|467545679|FG004|Follow-up Period|Covid-19|0|||
129886737|NCT04285229|467545680|FG005|Follow-up Period|Covid-19|2|||
129886738|NCT04285229|467545675|FG000|Follow-up Period|Physician Decision|0|||
129886739|NCT04285229|467545676|FG001|Follow-up Period|Physician Decision|0|||
129886740|NCT04285229|467545677|FG002|Follow-up Period|Physician Decision|0|||
129886741|NCT04285229|467545678|FG003|Follow-up Period|Physician Decision|0|||
129886742|NCT04285229|467545679|FG004|Follow-up Period|Physician Decision|0|||
129886743|NCT04285229|467545680|FG005|Follow-up Period|Physician Decision|1|||
129886744|NCT03257995|467545681|FG000|Overall Study|Adverse Event|0|||
129886745|NCT03257995|467545682|FG001|Overall Study|Adverse Event|1|||
129886746|NCT03257995|467545683|FG002|Overall Study|Adverse Event|0|||
129886747|NCT03257995|467545684|FG003|Overall Study|Adverse Event|0|||
129886748|NCT03257995|467545685|FG004|Overall Study|Adverse Event|0|||
129886749|NCT03257995|467545686|FG005|Overall Study|Adverse Event|0|||
129886750|NCT03257995|467545681|FG000|Overall Study|Protocol deviation|0|||
129886751|NCT03257995|467545682|FG001|Overall Study|Protocol deviation|0|||
129886752|NCT03257995|467545683|FG002|Overall Study|Protocol deviation|0|||
129886753|NCT03257995|467545684|FG003|Overall Study|Protocol deviation|0|||
129886754|NCT03257995|467545685|FG004|Overall Study|Protocol deviation|0|||
129886755|NCT03257995|467545686|FG005|Overall Study|Protocol deviation|2|||
129886756|NCT01556763|467545690|FG000|Overall Study|Withdrawal by Subject|0|||
129886757|NCT01556763|467545691|FG001|Overall Study|Withdrawal by Subject|1|||
129886758|NCT01556763|467545692|FG002|Overall Study|Withdrawal by Subject|0|||
129886759|NCT02258464|467545693|FG000|Overall Study|Progressive disease (PD)|9|||
129886760|NCT02258464|467545694|FG001|Overall Study|Progressive disease (PD)|17|||
129886761|NCT02258464|467545693|FG000|Overall Study|Study drug never administered|1|||
129886762|NCT02258464|467545694|FG001|Overall Study|Study drug never administered|1|||
129886763|NCT02258464|467545693|FG000|Overall Study|AE not related to clinical PD|1|||
129886764|NCT02258464|467545694|FG001|Overall Study|AE not related to clinical PD|3|||
129886765|NCT02258464|467545693|FG000|Overall Study|Withdrawal by Subject|5|||
129886766|NCT02258464|467545694|FG001|Overall Study|Withdrawal by Subject|4|||
129886767|NCT02258464|467545693|FG000|Overall Study|AE related to clinical PD|1|||
129886768|NCT02258464|467545694|FG001|Overall Study|AE related to clinical PD|0|||
129886769|NCT02138747|467545695|FG000|Treatment Period 1|Adverse Event|10|||
129886770|NCT02138747|467545696|FG001|Treatment Period 1|Adverse Event|14|||
129886771|NCT02138747|467545697|FG002|Treatment Period 1|Adverse Event|2|||
129886772|NCT02138747|467545698|FG003|Treatment Period 1|Adverse Event|1|||
129886773|NCT02138747|467545695|FG000|Treatment Period 1|Lost to Follow-up|0|||
129886774|NCT02138747|467545696|FG001|Treatment Period 1|Lost to Follow-up|1|||
129886775|NCT02138747|467545697|FG002|Treatment Period 1|Lost to Follow-up|1|||
129886776|NCT02138747|467545698|FG003|Treatment Period 1|Lost to Follow-up|0|||
129886777|NCT02138747|467545695|FG000|Treatment Period 1|Protocol Violation|0|||
129886778|NCT02138747|467545696|FG001|Treatment Period 1|Protocol Violation|2|||
129886779|NCT02138747|467545697|FG002|Treatment Period 1|Protocol Violation|0|||
129886780|NCT02138747|467545698|FG003|Treatment Period 1|Protocol Violation|0|||
129886781|NCT02138747|467545695|FG000|Treatment Period 1|Withdrawal by Subject|8|||
129886782|NCT02138747|467545696|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129886783|NCT02138747|467545697|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129886784|NCT02138747|467545698|FG003|Treatment Period 1|Withdrawal by Subject|3|||
129886785|NCT02138747|467545695|FG000|Treatment Period 1|Other - Miscellaneous|2|||
129886786|NCT02138747|467545696|FG001|Treatment Period 1|Other - Miscellaneous|4|||
129886787|NCT02138747|467545697|FG002|Treatment Period 1|Other - Miscellaneous|0|||
129886788|NCT02138747|467545698|FG003|Treatment Period 1|Other - Miscellaneous|0|||
130105323|NCT01652872|468344572|FG000|Overall Study|Decision by sponsor|5|||
130105324|NCT01652872|468344573|FG001|Overall Study|Decision by sponsor|7|||
130105325|NCT01652872|468344572|FG000|Overall Study|Withdrawal by Subject|76|||
130105326|NCT01652872|468344573|FG001|Overall Study|Withdrawal by Subject|84|||
130105327|NCT04529096|468344574|FG000|Overall Study|Adverse Event|6|||
130105328|NCT04529096|468344575|FG001|Overall Study|Adverse Event|1|||
130105329|NCT04529096|468344574|FG000|Overall Study|Lack of Efficacy|1|||
130105330|NCT04529096|468344575|FG001|Overall Study|Lack of Efficacy|0|||
130105331|NCT04529096|468344574|FG000|Overall Study|Lost to Follow-up|1|||
130105332|NCT04529096|468344575|FG001|Overall Study|Lost to Follow-up|1|||
130105333|NCT04529096|468344574|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130105334|NCT04529096|468344575|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130105335|NCT04529096|468344574|FG000|Overall Study|Physician Decision|1|||
130105336|NCT04529096|468344575|FG001|Overall Study|Physician Decision|3|||
130105337|NCT04529096|468344574|FG000|Overall Study|Withdrawal by Subject|5|||
130105338|NCT04529096|468344575|FG001|Overall Study|Withdrawal by Subject|0|||
130105339|NCT03985293|468344586|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
130105340|NCT03985293|468344587|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
130105341|NCT03985293|468344588|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
130105342|NCT03985293|468344589|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
130105343|NCT03985293|468344590|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
130105344|NCT03985293|468344591|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
130105345|NCT03985293|468344586|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
130105346|NCT03985293|468344587|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
130105347|NCT03985293|468344588|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
130105348|NCT03985293|468344589|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
130105349|NCT03985293|468344590|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
130105350|NCT03985293|468344591|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
130105351|NCT03985293|468344586|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
130105352|NCT03985293|468344587|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
130105353|NCT03985293|468344588|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
130105354|NCT03985293|468344589|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
130105355|NCT03985293|468344590|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
130105356|NCT03985293|468344591|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
130105357|NCT03985293|468344586|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
130105358|NCT03985293|468344587|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
130105359|NCT03985293|468344588|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
130105360|NCT03985293|468344589|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
130105361|NCT03985293|468344590|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
130105362|NCT03985293|468344591|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
130105363|NCT03985293|468344586|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
130105364|NCT03985293|468344587|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
130105365|NCT03985293|468344588|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
130105366|NCT03985293|468344589|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
130105367|NCT03985293|468344590|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
130105368|NCT03985293|468344591|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
130105369|NCT03985293|468344586|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
130105370|NCT03985293|468344587|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
130105371|NCT03985293|468344588|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
130105372|NCT03985293|468344589|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
130105373|NCT03985293|468344590|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
130105374|NCT03985293|468344591|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
130105375|NCT03985293|468344586|FG000|FOLLOW-UP|Lost to Follow-up|0|||
130105376|NCT03985293|468344587|FG001|FOLLOW-UP|Lost to Follow-up|0|||
130105377|NCT03985293|468344588|FG002|FOLLOW-UP|Lost to Follow-up|1|||
130105378|NCT03985293|468344589|FG003|FOLLOW-UP|Lost to Follow-up|0|||
130105379|NCT03985293|468344590|FG004|FOLLOW-UP|Lost to Follow-up|0|||
130275521|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
130275522|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
130275523|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
130275524|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275525|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275526|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275527|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
130275528|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130105380|NCT03985293|468344591|FG005|FOLLOW-UP|Lost to Follow-up|0|||
130105381|NCT00390572|468344592|FG000|Overall Study|Lost to Follow-up|8|||
130105382|NCT00390572|468344593|FG001|Overall Study|Lost to Follow-up|4|||
130105383|NCT00390572|468344592|FG000|Overall Study|health condition|0|||
130105384|NCT00390572|468344593|FG001|Overall Study|health condition|1|||
130105385|NCT01345058|468344600|FG000|Overall Study|Withdrawal by Subject|1|||
130105386|NCT01345058|468344601|FG001|Overall Study|Withdrawal by Subject|0|||
130275529|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
130275530|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275531|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275532|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275533|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275534|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
130275535|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
130275536|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275537|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275538|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275539|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275540|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275541|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
130275542|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275543|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
130275544|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275545|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275546|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275547|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275548|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
130275549|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
130275550|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
130275551|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
130275552|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275553|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275554|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275555|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
130275556|NCT03745638|468972041|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
130275557|NCT03745638|468972042|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
130275558|NCT03745638|468972043|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275559|NCT03745638|468972044|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275560|NCT03745638|468972045|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275561|NCT03745638|468972046|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275562|NCT03745638|468972047|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
130275563|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275564|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275565|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275566|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275567|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
130275568|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
130275569|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
130275570|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275571|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275572|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275573|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
130275574|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
130275575|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129886789|NCT02138747|467545695|FG000|Treatment Period 2|Adverse Event|6|||
129886790|NCT02138747|467545696|FG001|Treatment Period 2|Adverse Event|3|||
129886791|NCT02138747|467545697|FG002|Treatment Period 2|Adverse Event|1|||
129886792|NCT02138747|467545698|FG003|Treatment Period 2|Adverse Event|1|||
129886793|NCT02138747|467545695|FG000|Treatment Period 2|Lost to Follow-up|2|||
129886794|NCT02138747|467545696|FG001|Treatment Period 2|Lost to Follow-up|0|||
129886795|NCT02138747|467545697|FG002|Treatment Period 2|Lost to Follow-up|0|||
129886796|NCT02138747|467545698|FG003|Treatment Period 2|Lost to Follow-up|0|||
129886797|NCT02138747|467545695|FG000|Treatment Period 2|Protocol Violation|1|||
129886798|NCT02138747|467545696|FG001|Treatment Period 2|Protocol Violation|0|||
129886799|NCT02138747|467545697|FG002|Treatment Period 2|Protocol Violation|0|||
130275576|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
130275577|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130275578|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130275579|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
130275580|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
130275581|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
130275582|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
129886800|NCT02138747|467545698|FG003|Treatment Period 2|Protocol Violation|0|||
129886801|NCT02138747|467545695|FG000|Treatment Period 2|Withdrawal by Subject|5|||
129886802|NCT02138747|467545696|FG001|Treatment Period 2|Withdrawal by Subject|4|||
129886803|NCT02138747|467545697|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129886804|NCT02138747|467545698|FG003|Treatment Period 2|Withdrawal by Subject|2|||
129886805|NCT02138747|467545695|FG000|Treatment Period 2|Other - Miscellaneous|3|||
129886806|NCT02138747|467545696|FG001|Treatment Period 2|Other - Miscellaneous|0|||
130275583|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
129886807|NCT02138747|467545697|FG002|Treatment Period 2|Other - Miscellaneous|0|||
129886808|NCT02138747|467545698|FG003|Treatment Period 2|Other - Miscellaneous|0|||
129886809|NCT00932646|467545699|FG000|Overall Study|Adverse Event|2|||
129886810|NCT00932646|467545700|FG001|Overall Study|Adverse Event|1|||
129886811|NCT00932646|467545701|FG002|Overall Study|Adverse Event|1|||
129886812|NCT00932646|467545702|FG003|Overall Study|Adverse Event|1|||
130275584|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275585|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275586|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275587|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275588|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
130275589|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
130275590|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
130275591|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275592|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275593|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130105387|NCT01345058|468344600|FG000|Overall Study|Participant Reported Increase in Events|1|||
130105388|NCT01345058|468344601|FG001|Overall Study|Participant Reported Increase in Events|0|||
130105389|NCT01345058|468344600|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
130105390|NCT01345058|468344601|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
130105391|NCT01345058|468344600|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
130105392|NCT01345058|468344601|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
130105393|NCT01345058|468344600|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
130105394|NCT01345058|468344601|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
130105395|NCT01892020|468344608|FG000|Period 1|Adverse Event|1|||
130105396|NCT01892020|468344609|FG001|Period 1|Adverse Event|1|||
130105397|NCT01892020|468344608|FG000|Period 1|Protocol Violation|2|||
130105398|NCT01892020|468344609|FG001|Period 1|Protocol Violation|4|||
130105399|NCT01892020|468344608|FG000|Period 1|Unclassified|0|||
130105400|NCT01892020|468344609|FG001|Period 1|Unclassified|1|||
130105401|NCT01892020|468344608|FG000|Period 2|Protocol Violation|1|||
130105402|NCT01892020|468344609|FG001|Period 2|Protocol Violation|0|||
130105403|NCT01726335|468345992|FG000|Overall Study|Lost to Follow-up|2|||
130105404|NCT01726335|468345992|FG000|Overall Study|Withdrawal by Subject|15|||
130105405|NCT01726335|468345992|FG000|Overall Study|Adverse Event|4|||
130105406|NCT01726335|468345992|FG000|Overall Study|Lost to Follow-up|2|||
130105407|NCT01726335|468345992|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
130105408|NCT01796860|468345998|FG000|Overall Study|Withdrawal by Subject|3|||
130105409|NCT02703454|468346003|FG000|Overall Study|Not treated|1|||
130105410|NCT02703454|468346004|FG001|Overall Study|Not treated|3|||
130105411|NCT02703454|468346003|FG000|Overall Study|Withdrawal by Subject|4|||
130105412|NCT02703454|468346004|FG001|Overall Study|Withdrawal by Subject|3|||
130105413|NCT02703454|468346003|FG000|Overall Study|Lost to Follow-up|1|||
130105414|NCT02703454|468346004|FG001|Overall Study|Lost to Follow-up|2|||
130105415|NCT02703454|468346003|FG000|Overall Study|Study discontinuation|5|||
130105416|NCT02703454|468346004|FG001|Overall Study|Study discontinuation|8|||
130105417|NCT02284373|468346005|FG000|Overall Study|Withdrawal by Subject|0|||
130105418|NCT02284373|468346006|FG001|Overall Study|Withdrawal by Subject|1|||
130105419|NCT02284373|468346007|FG002|Overall Study|Withdrawal by Subject|0|||
130105420|NCT02284373|468346005|FG000|Overall Study|Other|0|||
130275594|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275595|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275596|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
130275597|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
130275598|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130275599|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130275600|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
130275601|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
130105421|NCT02284373|468346006|FG001|Overall Study|Other|1|||
130105422|NCT02284373|468346007|FG002|Overall Study|Other|0|||
130105423|NCT02284373|468346005|FG000|Overall Study|Lost to Follow-up|0|||
130105424|NCT02284373|468346006|FG001|Overall Study|Lost to Follow-up|1|||
130105425|NCT02284373|468346007|FG002|Overall Study|Lost to Follow-up|0|||
130105426|NCT02499406|468346008|FG000|Overall Study|missed 3 treatment sessions|4|||
130105427|NCT01396161|468346009|FG000|Overall Study|Withdrawal by Subject|0|||
130105428|NCT01396161|468346010|FG001|Overall Study|Withdrawal by Subject|0|||
130275602|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
130275603|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
130105429|NCT01396161|468346011|FG002|Overall Study|Withdrawal by Subject|0|||
130105430|NCT01396161|468346012|FG003|Overall Study|Withdrawal by Subject|0|||
130105431|NCT01396161|468346013|FG004|Overall Study|Withdrawal by Subject|1|||
130105432|NCT01396161|468346014|FG005|Overall Study|Withdrawal by Subject|0|||
130105433|NCT01396161|468346015|FG006|Overall Study|Withdrawal by Subject|0|||
130105434|NCT01396161|468346009|FG000|Overall Study|Other|0|||
130105435|NCT01396161|468346010|FG001|Overall Study|Other|0|||
130105436|NCT01396161|468346011|FG002|Overall Study|Other|0|||
130105437|NCT01396161|468346012|FG003|Overall Study|Other|0|||
130105438|NCT01396161|468346013|FG004|Overall Study|Other|0|||
130105439|NCT01396161|468346014|FG005|Overall Study|Other|0|||
130105440|NCT01396161|468346015|FG006|Overall Study|Other|1|||
130105441|NCT04651218|468346016|FG000|Overall Study|Withdrawal by Subject|0|||
130105442|NCT04651218|468346017|FG001|Overall Study|Withdrawal by Subject|2|||
130105443|NCT00414011|468346018|FG000|Overall Study|Physician Decision|3|||
130105444|NCT00414011|468346018|FG000|Overall Study|Withdrawal by Subject|2|||
130105445|NCT02476851|468346019|FG000|Overall Study|Protocol Violation|1|||
130105446|NCT02476851|468346020|FG001|Overall Study|Protocol Violation|1|||
130105447|NCT01399125|468346021|FG000|Overall Study|Adverse Event|32|||
130105448|NCT01399125|468346022|FG001|Overall Study|Adverse Event|30|||
130105449|NCT01399125|468346021|FG000|Overall Study|Abnormal Lab values|0|||
130105450|NCT01399125|468346022|FG001|Overall Study|Abnormal Lab values|1|||
130105451|NCT01399125|468346021|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130105452|NCT01399125|468346022|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130105453|NCT01399125|468346021|FG000|Overall Study|Withdrawal by Subject|5|||
130105454|NCT01399125|468346022|FG001|Overall Study|Withdrawal by Subject|8|||
130275604|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
130275605|NCT03745638|468972041|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275606|NCT03745638|468972042|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275607|NCT03745638|468972043|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275608|NCT03745638|468972044|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275609|NCT03745638|468972045|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
130275610|NCT03745638|468972046|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
130275611|NCT03745638|468972047|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
130275612|NCT04470050|468972048|FG000|Double-blind Treatment Phase|Adverse Event|0|||
130275613|NCT04470050|468972049|FG001|Double-blind Treatment Phase|Adverse Event|0|||
130275614|NCT04470050|468972050|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130275615|NCT04470050|468972051|FG003|Double-blind Treatment Phase|Adverse Event|1|||
130275616|NCT04470050|468972052|FG004|Double-blind Treatment Phase|Adverse Event|0|||
130275617|NCT04470050|468972053|FG005|Double-blind Treatment Phase|Adverse Event|0|||
130275618|NCT04470050|468972054|FG006|Double-blind Treatment Phase|Adverse Event|0|||
130275619|NCT04470050|468972048|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275620|NCT04470050|468972049|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275621|NCT04470050|468972050|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275622|NCT04470050|468972051|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275623|NCT04470050|468972052|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
130275624|NCT04470050|468972053|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275625|NCT04470050|468972054|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
130275626|NCT04470050|468972048|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
130275627|NCT04470050|468972049|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
130275628|NCT04470050|468972050|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
130275629|NCT04470050|468972051|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
130275630|NCT04470050|468972052|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
130275631|NCT04470050|468972053|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
130275632|NCT04470050|468972054|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
130275633|NCT03604172|468972056|FG000|Overall Study|Lost to Follow-up|1|||
130275634|NCT03604172|468972057|FG001|Overall Study|Lost to Follow-up|2|||
130275635|NCT02676895|468972058|FG000|Overall Study|Administrative reason|1|||
130275636|NCT02676895|468972059|FG001|Overall Study|Administrative reason|0|||
130275637|NCT02676895|468972060|FG002|Overall Study|Administrative reason|0|||
130275638|NCT02676895|468972058|FG000|Overall Study|Protocol Violation|1|||
130275639|NCT02676895|468972059|FG001|Overall Study|Protocol Violation|0|||
130275640|NCT02676895|468972060|FG002|Overall Study|Protocol Violation|0|||
130275641|NCT02676895|468972058|FG000|Overall Study|Adverse Event|0|||
130275642|NCT02676895|468972059|FG001|Overall Study|Adverse Event|3|||
130275643|NCT02676895|468972060|FG002|Overall Study|Adverse Event|1|||
130275644|NCT02676895|468972058|FG000|Overall Study|Lost to Follow-up|0|||
130275645|NCT02676895|468972059|FG001|Overall Study|Lost to Follow-up|0|||
130105455|NCT01399125|468346021|FG000|Overall Study|Lost to Follow-up|2|||
130105456|NCT01399125|468346022|FG001|Overall Study|Lost to Follow-up|3|||
130105457|NCT01399125|468346021|FG000|Overall Study|Administrative Problems|7|||
130105458|NCT01399125|468346022|FG001|Overall Study|Administrative Problems|11|||
130105459|NCT01399125|468346021|FG000|Overall Study|Death|0|||
130275646|NCT02676895|468972060|FG002|Overall Study|Lost to Follow-up|1|||
130275647|NCT02676895|468972058|FG000|Overall Study|Withdrawal by Subject|0|||
130275648|NCT02676895|468972059|FG001|Overall Study|Withdrawal by Subject|0|||
130275649|NCT02676895|468972060|FG002|Overall Study|Withdrawal by Subject|1|||
130275650|NCT00976716|468972066|FG000|Overall Study|Adverse Event|1|||
130275651|NCT03028129|468972072|FG000|Overall Study|Adverse Event|13|||
130275652|NCT03028129|468972073|FG001|Overall Study|Adverse Event|2|||
130275653|NCT03028129|468972072|FG000|Overall Study|Lost to Follow-up|50|||
130275654|NCT03028129|468972073|FG001|Overall Study|Lost to Follow-up|38|||
130275655|NCT03028129|468972072|FG000|Overall Study|Physician Decision|0|||
130275656|NCT03028129|468972073|FG001|Overall Study|Physician Decision|1|||
130275657|NCT03028129|468972072|FG000|Overall Study|Protocol Violation|1|||
130275658|NCT03028129|468972073|FG001|Overall Study|Protocol Violation|1|||
130275659|NCT03028129|468972072|FG000|Overall Study|Withdrawal by Subject|62|||
130275660|NCT03028129|468972073|FG001|Overall Study|Withdrawal by Subject|45|||
129886813|NCT00932646|467545699|FG000|Overall Study|Lost to Follow-up|2|||
129886814|NCT00932646|467545700|FG001|Overall Study|Lost to Follow-up|1|||
129886815|NCT00932646|467545701|FG002|Overall Study|Lost to Follow-up|0|||
129886816|NCT00932646|467545702|FG003|Overall Study|Lost to Follow-up|0|||
129886817|NCT00932646|467545699|FG000|Overall Study|Withdrawal by Subject|1|||
129886818|NCT00932646|467545700|FG001|Overall Study|Withdrawal by Subject|1|||
129886819|NCT00932646|467545701|FG002|Overall Study|Withdrawal by Subject|3|||
129886820|NCT00932646|467545702|FG003|Overall Study|Withdrawal by Subject|0|||
129886821|NCT04170296|467545703|FG000|Overall Study|Adverse Event|1|||
129886822|NCT04170296|467545704|FG001|Overall Study|Adverse Event|0|||
129886823|NCT04170296|467545703|FG000|Overall Study|Withdrawal by Subject|3|||
129886824|NCT04170296|467545704|FG001|Overall Study|Withdrawal by Subject|2|||
129886825|NCT04170296|467545703|FG000|Overall Study|Lost to Follow-up|4|||
129886826|NCT04170296|467545704|FG001|Overall Study|Lost to Follow-up|2|||
129886827|NCT00653263|467545705|FG000|Overall Study|Withdrawal by Subject|1|||
129886828|NCT00653263|467545705|FG000|Overall Study|Physician Decision|1|||
129886829|NCT00776100|467545716|FG000|Overall Study|Disease Progression|1|||
129886830|NCT00776100|467545717|FG001|Overall Study|Disease Progression|0|||
129886831|NCT03567993|467545718|FG000|Overall Study|Lost to Follow-up|4|||
129886832|NCT03567993|467545719|FG001|Overall Study|Lost to Follow-up|2|||
129886833|NCT03567993|467545718|FG000|Overall Study|Death|1|||
129886834|NCT03567993|467545719|FG001|Overall Study|Death|1|||
129886835|NCT03567993|467545718|FG000|Overall Study|Withdrawal by Subject|1|||
129886836|NCT03567993|467545719|FG001|Overall Study|Withdrawal by Subject|0|||
129886837|NCT04793464|467545720|FG000|Overall Study|Lost to Follow-up|458|||
129886838|NCT04793464|467545721|FG001|Overall Study|Lost to Follow-up|168|||
129886839|NCT04793464|467545722|FG002|Overall Study|Lost to Follow-up|5|||
129886840|NCT04793464|467545720|FG000|Overall Study|Withdrawal by Subject|43|||
129886841|NCT04793464|467545721|FG001|Overall Study|Withdrawal by Subject|15|||
129886842|NCT04793464|467545722|FG002|Overall Study|Withdrawal by Subject|0|||
129886843|NCT02285595|467545723|FG000|Overall Study|Lost to Follow-up|14|||
129886844|NCT02285595|467545723|FG000|Overall Study|Withdrawal by Subject|1|||
129886845|NCT00195715|467545724|FG000|Overall Study|Adverse Event|122|||
129886846|NCT00195715|467545724|FG000|Overall Study|Withdrawal by Subject|58|||
129886847|NCT00195715|467545724|FG000|Overall Study|Lost to Follow-up|27|||
129886848|NCT00195715|467545724|FG000|Overall Study|Protocol Violation|13|||
129886849|NCT00195715|467545724|FG000|Overall Study|Lack of Efficacy|93|||
129886850|NCT00195715|467545724|FG000|Overall Study|Pregnancy|14|||
129886851|NCT00195715|467545724|FG000|Overall Study|Investigative site closure|8|||
129886852|NCT00195715|467545724|FG000|Overall Study|Subject moved/relocated|7|||
129886853|NCT00195715|467545724|FG000|Overall Study|Subject non-compliance|6|||
129886854|NCT00195715|467545724|FG000|Overall Study|Subject started commercial Humira|5|||
129886855|NCT00195715|467545724|FG000|Overall Study|Subject choice|3|||
129886856|NCT00195715|467545724|FG000|Overall Study|Loss of response/no improvement|3|||
129886857|NCT00195715|467545724|FG000|Overall Study|Sponsor stopped study|1|||
129886858|NCT00195715|467545724|FG000|Overall Study|Administrative reasons|2|||
129886859|NCT00195715|467545724|FG000|Overall Study|Investigator's decision|2|||
129886860|NCT00195715|467545724|FG000|Overall Study|Subject wants to get pregnant|4|||
129886861|NCT00195715|467545724|FG000|Overall Study|Use of prohibited medication|2|||
129886862|NCT00195715|467545724|FG000|Overall Study|Planned surgery|2|||
129886863|NCT00195715|467545724|FG000|Overall Study|Increased infection rate|1|||
129886864|NCT00195715|467545724|FG000|Overall Study|Ineligible|1|||
129886865|NCT00195715|467545724|FG000|Overall Study|Colonic stricture|1|||
129886866|NCT00195715|467545724|FG000|Overall Study|Sponsor discontinued trial|1|||
129886867|NCT00195715|467545724|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
129886868|NCT00845871|467545729|FG000|Assessment Period|Adverse Event|2|||
129886869|NCT00845871|467545729|FG000|Assessment Period|Abnormal laboratory values|1|||
129886870|NCT00845871|467545729|FG000|Assessment Period|Abnormal test procedure results|1|||
129886871|NCT00845871|467545729|FG000|Assessment Period|Patient withdrew consent|3|||
129886872|NCT00064025|467545739|FG000|Overall Study|Ineligible|4|||
129886873|NCT00064025|467545739|FG000|Overall Study|Inevaluable|3|||
129886874|NCT02468934|467545742|FG000|Overall Study|Withdrawal by Subject|4|||
129886875|NCT02468934|467545742|FG000|Overall Study|Screen Failure|3|||
129886876|NCT01370603|467545743|FG000|Period 1|Adverse Event|5|||
130275661|NCT04222699|468972074|FG000|Overall Study|Lost to Follow-up|2|||
130275662|NCT00923351|468972075|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
129886877|NCT01370603|467545744|FG001|Period 1|Adverse Event|3|||
129886878|NCT01370603|467545743|FG000|Period 1|Lost to Follow-up|2|||
129886879|NCT01370603|467545744|FG001|Period 1|Lost to Follow-up|0|||
129886880|NCT01370603|467545743|FG000|Period 1|Protocol Violation|2|||
129886881|NCT01370603|467545744|FG001|Period 1|Protocol Violation|2|||
129886882|NCT01370603|467545743|FG000|Period 1|Withdrawal by Subject|5|||
129886883|NCT01370603|467545744|FG001|Period 1|Withdrawal by Subject|5|||
130275663|NCT00923351|468972076|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
129886884|NCT01370603|467545743|FG000|Crossover Washout|Adverse Event|2|||
129886885|NCT01370603|467545744|FG001|Crossover Washout|Adverse Event|1|||
129886886|NCT01370603|467545743|FG000|Crossover Washout|Lost to Follow-up|2|||
129886887|NCT01370603|467545744|FG001|Crossover Washout|Lost to Follow-up|0|||
130275664|NCT00923351|468972077|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
130275665|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
130275666|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
130105460|NCT01399125|468346022|FG001|Overall Study|Death|1|||
130105461|NCT01399125|468346021|FG000|Overall Study|Protocol Deviation|5|||
130105462|NCT01399125|468346022|FG001|Overall Study|Protocol Deviation|2|||
130105463|NCT00647426|468346023|FG000|Overall Study|Withdrawal by Subject|2|||
130105464|NCT03543046|468346028|FG000|Overall Study|Adverse Event|1|||
130105465|NCT03543046|468346029|FG001|Overall Study|Adverse Event|1|||
130105466|NCT03543046|468346028|FG000|Overall Study|Physician Decision|1|||
130105467|NCT03543046|468346029|FG001|Overall Study|Physician Decision|1|||
130105468|NCT03543046|468346028|FG000|Overall Study|Protocol Violation|1|||
130105469|NCT03543046|468346029|FG001|Overall Study|Protocol Violation|0|||
130105470|NCT04056299|468346030|FG000|Overall Study|Sponsor discontinued study|3|||
130105471|NCT04056299|468346031|FG001|Overall Study|Sponsor discontinued study|3|||
130275667|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
130275668|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
130275669|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
130275670|NCT01536561|468972082|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
130275671|NCT00972517|468972085|FG000|Overall Study|Adverse Event|0|||
130105472|NCT01227954|468346036|FG000|Overall Study|Protocol Violation|6|||
130105473|NCT01227954|468346036|FG000|Overall Study|No protocol treatment|7|||
130105474|NCT01296152|468346037|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130105475|NCT01414062|468346042|FG000|Overall Study|Lost to Follow-up|3|||
130105476|NCT01414062|468346043|FG001|Overall Study|Lost to Follow-up|2|||
130105477|NCT01414062|468346042|FG000|Overall Study|Left Country|1|||
130105478|NCT01414062|468346043|FG001|Overall Study|Left Country|1|||
130105479|NCT01414062|468346042|FG000|Overall Study|Family Disapproval|1|||
130105480|NCT01414062|468346043|FG001|Overall Study|Family Disapproval|0|||
130105481|NCT01414062|468346042|FG000|Overall Study|Withdrawal by Subject|0|||
130105482|NCT01414062|468346043|FG001|Overall Study|Withdrawal by Subject|1|||
130105483|NCT04285983|468346044|FG000|Overall Study|Protocol Violation|6|||
130105484|NCT04936334|468346045|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
130105485|NCT00422058|468346046|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
130105486|NCT00422058|468346047|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
130105487|NCT00422058|468346048|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
130105488|NCT00422058|468346049|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
130105489|NCT00422058|468346050|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
130105490|NCT00422058|468346051|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
130105491|NCT00422058|468346046|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
130105492|NCT00422058|468346047|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
130105493|NCT00422058|468346048|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
130105494|NCT00422058|468346049|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
130105495|NCT00422058|468346050|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
130105496|NCT00422058|468346051|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
130105497|NCT00422058|468346046|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
130105498|NCT00422058|468346047|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
130105499|NCT00422058|468346048|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
130105500|NCT00422058|468346049|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
130105501|NCT00422058|468346050|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
130275672|NCT00972517|468972086|FG001|Overall Study|Adverse Event|0|||
130275673|NCT00972517|468972087|FG002|Overall Study|Adverse Event|0|||
130275674|NCT00972517|468972088|FG003|Overall Study|Adverse Event|1|||
130275675|NCT00972517|468972089|FG004|Overall Study|Adverse Event|0|||
130105502|NCT00422058|468346051|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
130105503|NCT00422058|468346046|FG000|Double-Blind, Week 0-20|Other|11|||
130105504|NCT00422058|468346047|FG001|Double-Blind, Week 0-20|Other|3|||
129800260|NCT02445391|467236290|FG000|Overall Study|Alternative therapy|0|||
130105505|NCT00422058|468346048|FG002|Double-Blind, Week 0-20|Other|8|||
130105506|NCT00422058|468346049|FG003|Double-Blind, Week 0-20|Other|8|||
130275676|NCT00972517|468972090|FG005|Overall Study|Adverse Event|0|||
130275677|NCT00972517|468972085|FG000|Overall Study|Withdrawal by Subject|0|||
130105507|NCT00422058|468346050|FG004|Double-Blind, Week 0-20|Other|4|||
130105508|NCT00422058|468346051|FG005|Double-Blind, Week 0-20|Other|10|||
130105509|NCT00422058|468346046|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
130105510|NCT00422058|468346047|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
130105511|NCT00422058|468346048|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
130105512|NCT00422058|468346049|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
130105513|NCT00422058|468346050|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
130105514|NCT00422058|468346051|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
130105515|NCT00422058|468346046|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
130105516|NCT00422058|468346047|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
130105517|NCT00422058|468346048|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
130105518|NCT00422058|468346049|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
130105519|NCT00422058|468346050|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
130105520|NCT00422058|468346051|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
130105521|NCT00422058|468346046|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
130105522|NCT00422058|468346047|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
130105523|NCT00422058|468346048|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
130105524|NCT00422058|468346049|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
130105525|NCT00422058|468346050|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
130105526|NCT00422058|468346051|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
130105527|NCT00422058|468346046|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
130105528|NCT00422058|468346047|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
130105529|NCT00422058|468346048|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
130105530|NCT00422058|468346049|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
130105531|NCT00422058|468346050|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
130105532|NCT00422058|468346051|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
130105533|NCT00422058|468346046|FG000|Open-Label Extension, Week 20-104|Other|13|||
130105534|NCT00422058|468346047|FG001|Open-Label Extension, Week 20-104|Other|14|||
130105535|NCT00422058|468346048|FG002|Open-Label Extension, Week 20-104|Other|6|||
130105536|NCT00422058|468346049|FG003|Open-Label Extension, Week 20-104|Other|13|||
130105537|NCT00422058|468346050|FG004|Open-Label Extension, Week 20-104|Other|16|||
130105538|NCT00422058|468346051|FG005|Open-Label Extension, Week 20-104|Other|18|||
130105539|NCT02787785|468346056|FG000|Overall Study|Death|3|||
130105540|NCT02787785|468346057|FG001|Overall Study|Death|4|||
130105541|NCT02787785|468346056|FG000|Overall Study|Lost to Follow-up|1|||
130105542|NCT02787785|468346057|FG001|Overall Study|Lost to Follow-up|1|||
130105543|NCT02787785|468346056|FG000|Overall Study|Withdrawal by Subject|0|||
130105544|NCT02787785|468346057|FG001|Overall Study|Withdrawal by Subject|5|||
130105545|NCT00103259|468346061|FG000|Overall Study|Death|3|||
130105546|NCT00103259|468346062|FG001|Overall Study|Death|2|||
130105547|NCT00103259|468346061|FG000|Overall Study|Withdrawal by Subject|2|||
130105548|NCT00103259|468346062|FG001|Overall Study|Withdrawal by Subject|3|||
130105549|NCT00103259|468346061|FG000|Overall Study|alternative therapy|1|||
130105550|NCT00103259|468346062|FG001|Overall Study|alternative therapy|0|||
130105551|NCT00103259|468346061|FG000|Overall Study|other (reasons were not specified)|2|||
130105552|NCT00103259|468346062|FG001|Overall Study|other (reasons were not specified)|1|||
130105553|NCT00103259|468346061|FG000|Overall Study|ineligible/no protocol therapy|4|||
130105554|NCT00103259|468346062|FG001|Overall Study|ineligible/no protocol therapy|6|||
130105555|NCT03224234|468346067|FG000|Main Study|Lost to Follow-up|5|||
130105556|NCT03224234|468346068|FG001|Main Study|Lost to Follow-up|5|||
130105557|NCT02866695|468346069|FG000|Overall Study|Adverse Event|1|||
130105558|NCT02866695|468346069|FG000|Overall Study|Lost to Follow-up|1|||
130105559|NCT02610842|468346070|FG000|Overall Study|Lost to Follow-up|5|||
130105560|NCT00756652|468346071|FG000|Original Phase|Withdrawal by Subject|864|||
130105561|NCT00756652|468346072|FG001|Original Phase|Withdrawal by Subject|23|||
130105562|NCT00756652|468346071|FG000|Original Phase|Lost to Follow-up|601|||
130105563|NCT00756652|468346072|FG001|Original Phase|Lost to Follow-up|0|||
130105564|NCT00756652|468346071|FG000|Original Phase|Other Discontinuation|797|||
130105565|NCT00756652|468346072|FG001|Original Phase|Other Discontinuation|5|||
130105566|NCT00756652|468346071|FG000|Original Phase|Participant Noncompliance|18622|||
130105567|NCT00756652|468346072|FG001|Original Phase|Participant Noncompliance|424|||
130105568|NCT00756652|468346071|FG000|Original Phase|Unknown Discontinuation Reason|2|||
130105569|NCT00756652|468346072|FG001|Original Phase|Unknown Discontinuation Reason|0|||
130105570|NCT00756652|468346071|FG000|Original Phase|Participants without data|3259|||
130105571|NCT00756652|468346072|FG001|Original Phase|Participants without data|466|||
130275678|NCT00972517|468972086|FG001|Overall Study|Withdrawal by Subject|1|||
130275679|NCT00972517|468972087|FG002|Overall Study|Withdrawal by Subject|0|||
130275680|NCT00972517|468972088|FG003|Overall Study|Withdrawal by Subject|2|||
130275681|NCT00972517|468972089|FG004|Overall Study|Withdrawal by Subject|1|||
130275682|NCT00972517|468972090|FG005|Overall Study|Withdrawal by Subject|0|||
130275683|NCT00984594|468972091|FG000|Overall Study|Lost to Follow-up|1|||
130275684|NCT00984594|468972092|FG001|Overall Study|Lost to Follow-up|0|||
130275685|NCT00984594|468972091|FG000|Overall Study|Withdrawal by Subject|0|||
130275686|NCT00984594|468972092|FG001|Overall Study|Withdrawal by Subject|1|||
130275687|NCT00851890|468972093|FG000|Overall Study|Lost to Follow-up|0|||
130275688|NCT00851890|468972094|FG001|Overall Study|Lost to Follow-up|1|||
130275689|NCT00851890|468972095|FG002|Overall Study|Lost to Follow-up|0|||
130275690|NCT00851890|468972096|FG003|Overall Study|Lost to Follow-up|1|||
130105572|NCT00756652|468346071|FG000|Original Phase|Death|168|||
130105573|NCT00756652|468346072|FG001|Original Phase|Death|1|||
130275691|NCT03135431|468972097|FG000|Overall Study|Study Surgeon not available|2|||
130275692|NCT03135431|468972098|FG001|Overall Study|Study Surgeon not available|0|||
130275693|NCT00281099|468972101|FG000|Overall Study|Death|46|||
130275694|NCT00281099|468972102|FG001|Overall Study|Death|57|||
130105574|NCT00756652|468346071|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
130105575|NCT00756652|468346072|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
130105576|NCT00756652|468346071|FG000|Re-Op Phase|Withdrawal by Subject|62|||
130105577|NCT00756652|468346072|FG001|Re-Op Phase|Withdrawal by Subject|0|||
130105578|NCT00756652|468346071|FG000|Re-Op Phase|Death|6|||
130105579|NCT00756652|468346072|FG001|Re-Op Phase|Death|0|||
130105580|NCT00756652|468346071|FG000|Re-Op Phase|Lost to Follow-up|340|||
130105581|NCT00756652|468346072|FG001|Re-Op Phase|Lost to Follow-up|0|||
130105582|NCT00756652|468346071|FG000|Re-Op Phase|Site Closed|2454|||
130105583|NCT00756652|468346072|FG001|Re-Op Phase|Site Closed|0|||
130105584|NCT00756652|468346071|FG000|Re-Op Phase|Withdrawn after explant|14|||
130105585|NCT00756652|468346072|FG001|Re-Op Phase|Withdrawn after explant|0|||
130105586|NCT02564952|468346073|FG000|Overall Study|Adverse Event|6|||
130105587|NCT02564952|468346073|FG000|Overall Study|Lost to Follow-up|1|||
130105588|NCT02564952|468346073|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
130105589|NCT02564952|468346073|FG000|Overall Study|Withdrawal by Subject|1|||
130105590|NCT02564952|468346073|FG000|Overall Study|Low Efficacy|1|||
130105591|NCT02564952|468346073|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130105592|NCT00038467|468346074|FG000|Overall Study|Adverse Event|170|||
130105593|NCT00038467|468346075|FG001|Overall Study|Adverse Event|145|||
130105594|NCT00038467|468346074|FG000|Overall Study|Withdrawal by Subject|150|||
130105595|NCT00038467|468346075|FG001|Overall Study|Withdrawal by Subject|107|||
130105596|NCT00038467|468346074|FG000|Overall Study|Protocol Violation|19|||
130105597|NCT00038467|468346075|FG001|Overall Study|Protocol Violation|22|||
130105598|NCT00038467|468346074|FG000|Overall Study|Death|22|||
130105599|NCT00038467|468346075|FG001|Overall Study|Death|16|||
130105600|NCT00038467|468346074|FG000|Overall Study|Lost to Follow-up|15|||
130105601|NCT00038467|468346075|FG001|Overall Study|Lost to Follow-up|10|||
130105602|NCT00038467|468346074|FG000|Overall Study|Recurrence|109|||
130105603|NCT00038467|468346075|FG001|Overall Study|Recurrence|179|||
130105604|NCT00038467|468346074|FG000|Overall Study|Randomized, but not treated|31|||
130105605|NCT00038467|468346075|FG001|Overall Study|Randomized, but not treated|35|||
130105606|NCT00038467|468346074|FG000|Overall Study|Other|26|||
130105607|NCT00038467|468346075|FG001|Overall Study|Other|28|||
130105608|NCT01988493|468346076|FG000|Overall Study|Randomized but not treated|0|||
130105609|NCT01988493|468346077|FG001|Overall Study|Randomized but not treated|0|||
130105610|NCT01988493|468346078|FG002|Overall Study|Randomized but not treated|0|||
130105611|NCT01988493|468346079|FG003|Overall Study|Randomized but not treated|0|||
130105612|NCT01988493|468346080|FG004|Overall Study|Randomized but not treated|1|||
130105613|NCT00627458|468346081|FG000|Overall Study|Migrated from study area|1|||
130105614|NCT00627458|468346082|FG001|Overall Study|Migrated from study area|0|||
130105615|NCT00627458|468346083|FG002|Overall Study|Migrated from study area|1|||
130105616|NCT00627458|468346081|FG000|Overall Study|Withdrawal by Subject|2|||
130105617|NCT00627458|468346082|FG001|Overall Study|Withdrawal by Subject|6|||
130105618|NCT00627458|468346083|FG002|Overall Study|Withdrawal by Subject|5|||
130105619|NCT00627458|468346081|FG000|Overall Study|Lost to Follow-up|1|||
130105620|NCT00627458|468346082|FG001|Overall Study|Lost to Follow-up|1|||
130105621|NCT00627458|468346083|FG002|Overall Study|Lost to Follow-up|0|||
130105622|NCT02268045|468346085|FG000|Overall Study|Death|4|||
130105623|NCT02268045|468346086|FG001|Overall Study|Death|4|||
130105624|NCT02268045|468346085|FG000|Overall Study|Disease Progression|2|||
130105625|NCT02268045|468346086|FG001|Overall Study|Disease Progression|1|||
130105626|NCT02268045|468346085|FG000|Overall Study|Adverse Event|7|||
130275695|NCT00281099|468972101|FG000|Overall Study|Lost to Follow-up|10|||
130275696|NCT00281099|468972102|FG001|Overall Study|Lost to Follow-up|19|||
130275697|NCT00281099|468972101|FG000|Overall Study|Withdrawal by Subject|65|||
130105627|NCT02268045|468346086|FG001|Overall Study|Adverse Event|7|||
130275698|NCT00281099|468972102|FG001|Overall Study|Withdrawal by Subject|70|||
130105628|NCT02268045|468346085|FG000|Overall Study|Withdrawal by Subject|2|||
130105629|NCT02268045|468346086|FG001|Overall Study|Withdrawal by Subject|6|||
130105630|NCT02268045|468346085|FG000|Overall Study|Physician Decision|0|||
130105631|NCT02268045|468346086|FG001|Overall Study|Physician Decision|1|||
130105632|NCT02268045|468346085|FG000|Overall Study|Protocol Violation|1|||
130105633|NCT02268045|468346086|FG001|Overall Study|Protocol Violation|1|||
130105634|NCT01766310|468346087|FG000|Overall Study|Lost to Follow-up|1|||
130105635|NCT01766310|468346088|FG001|Overall Study|Lost to Follow-up|3|||
130105636|NCT01154673|468346089|FG000|Overall Study|Lost to Follow-up|1|||
130105637|NCT01154673|468346090|FG001|Overall Study|Lost to Follow-up|0|||
130105638|NCT01154673|468346089|FG000|Overall Study|moved out of province|1|||
130105639|NCT01154673|468346090|FG001|Overall Study|moved out of province|0|||
130105640|NCT00646282|468346093|FG000|Overall Study|Protocol terminated|4|||
130105641|NCT00646282|468346094|FG001|Overall Study|Protocol terminated|4|||
130105642|NCT02617446|468346095|FG000|Overall Study|Withdrawal by Subject|0|||
130275699|NCT00281099|468972101|FG000|Overall Study|Physician Decision|79|||
130105643|NCT02617446|468346096|FG001|Overall Study|Withdrawal by Subject|2|||
130275700|NCT00281099|468972102|FG001|Overall Study|Physician Decision|72|||
130275701|NCT00281099|468972101|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
130275702|NCT00281099|468972102|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
130275703|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Adverse Event|7|||
130275704|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Adverse Event|0|||
130275705|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Adverse Event|0|||
130275706|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
130275707|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
130275708|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
130275709|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
130275710|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
130275711|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
130275712|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
130275713|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
130275714|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
130275715|NCT01059864|468972107|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
130275716|NCT01059864|468972108|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
130275717|NCT01059864|468972109|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
130275718|NCT01059864|468972107|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130275719|NCT01059864|468972108|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130275720|NCT01059864|468972109|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
130275721|NCT00962741|468974119|FG000|Overall Study|Failed to return|3|||
129886888|NCT01370603|467545743|FG000|Crossover Washout|Protocol Violation|1|||
130275722|NCT00962741|468974119|FG000|Overall Study|Lost to Follow-up|2|||
130275723|NCT00962741|468974119|FG000|Overall Study|Withdrawal by Subject|1|||
130275724|NCT00962741|468974119|FG000|Overall Study|Lack of Efficacy|1|||
130275725|NCT00962741|468974119|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
130275726|NCT01814878|468974122|FG000|Overall Study|Adverse Event|16|||
130275727|NCT01814878|468974123|FG001|Overall Study|Adverse Event|5|||
130275728|NCT01814878|468974122|FG000|Overall Study|Withdrawal by Subject|20|||
130275729|NCT01814878|468974123|FG001|Overall Study|Withdrawal by Subject|16|||
129886889|NCT01370603|467545744|FG001|Crossover Washout|Protocol Violation|0|||
129886890|NCT01370603|467545743|FG000|Crossover Washout|Withdrawal by Subject|4|||
129886891|NCT01370603|467545744|FG001|Crossover Washout|Withdrawal by Subject|1|||
129886892|NCT01370603|467545743|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
129886893|NCT01370603|467545744|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
129886894|NCT01370603|467545743|FG000|Period 2|Adverse Event|1|||
129886895|NCT01370603|467545744|FG001|Period 2|Adverse Event|4|||
129886896|NCT01370603|467545743|FG000|Period 2|Lost to Follow-up|1|||
129886897|NCT01370603|467545744|FG001|Period 2|Lost to Follow-up|0|||
129886898|NCT01370603|467545743|FG000|Period 2|Withdrawal by Subject|1|||
129886899|NCT01370603|467545744|FG001|Period 2|Withdrawal by Subject|0|||
129886900|NCT00641186|467545749|FG000|Overall Study|Adverse Event|3|||
129886901|NCT02218489|467545752|FG000|Overall Study|Withdrawal by Subject|4|||
129886902|NCT02218489|467545753|FG001|Overall Study|Withdrawal by Subject|3|||
129886903|NCT02218489|467545752|FG000|Overall Study|Lost to Follow-up|1|||
129886904|NCT02218489|467545753|FG001|Overall Study|Lost to Follow-up|0|||
130105644|NCT02617446|468346097|FG002|Overall Study|Withdrawal by Subject|0|||
130105645|NCT02617446|468346095|FG000|Overall Study|Adverse Event|1|||
130105646|NCT02617446|468346096|FG001|Overall Study|Adverse Event|0|||
130275730|NCT01814878|468974122|FG000|Overall Study|Protocol Violation|5|||
130275731|NCT01814878|468974123|FG001|Overall Study|Protocol Violation|5|||
130275732|NCT01814878|468974122|FG000|Overall Study|Physician Decision|3|||
130275733|NCT01814878|468974123|FG001|Overall Study|Physician Decision|1|||
130275734|NCT01814878|468974122|FG000|Overall Study|Screening failure (drop-out)|0|||
129886905|NCT05221749|467545754|FG000|Overall Study|Lost to Follow-up|2|||
129886906|NCT05221749|467545755|FG001|Overall Study|Lost to Follow-up|3|||
129886907|NCT02404493|467545756|FG000|Overall Study|Adverse Event|1|||
129886908|NCT02404493|467545757|FG001|Overall Study|Adverse Event|1|||
130105647|NCT02617446|468346097|FG002|Overall Study|Adverse Event|5|||
129886909|NCT04714216|467547193|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
129886910|NCT04714216|467547193|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
129886911|NCT01818141|467547194|FG000|Overall Study|Withdrawal by Subject|2|||
129886912|NCT01818141|467547195|FG001|Overall Study|Withdrawal by Subject|0|||
129886913|NCT01818141|467547194|FG000|Overall Study|No baseline C.diff colonies|1|||
129886914|NCT01818141|467547195|FG001|Overall Study|No baseline C.diff colonies|1|||
129886915|NCT01818141|467547194|FG000|Overall Study|Lost to Follow-up|0|||
129886916|NCT01818141|467547195|FG001|Overall Study|Lost to Follow-up|2|||
129886917|NCT02169830|467547201|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
129886918|NCT02169830|467547202|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
129886919|NCT02169830|467547203|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
129886920|NCT02169830|467547201|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
129886921|NCT02169830|467547202|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129886922|NCT02169830|467547203|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129886923|NCT02169830|467547201|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129886924|NCT02169830|467547202|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
129886925|NCT02169830|467547203|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129886926|NCT02169830|467547201|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
129886927|NCT02169830|467547202|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
129886928|NCT02169830|467547203|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
129886929|NCT02169830|467547201|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
129886930|NCT02169830|467547202|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
129886931|NCT02169830|467547203|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
129886932|NCT03204695|467547204|FG000|Overall Study|Death|1|||
129886933|NCT03204695|467547204|FG000|Overall Study|Participant was treated with another device|1|||
129886934|NCT03204695|467547204|FG000|Overall Study|Physician Decision|2|||
129886935|NCT04834362|467547205|FG000|Overall Study|Death|1|||
129886936|NCT04834362|467547206|FG001|Overall Study|Death|2|||
129886937|NCT01349829|467547209|FG000|Overall Study|Lost to Follow-up|4|||
129886938|NCT01349829|467547210|FG001|Overall Study|Lost to Follow-up|8|||
129886939|NCT01349829|467547209|FG000|Overall Study|Consent withdrawal|3|||
129886940|NCT01349829|467547210|FG001|Overall Study|Consent withdrawal|8|||
129886941|NCT01349829|467547209|FG000|Overall Study|Migrated/moved|2|||
129886942|NCT01349829|467547210|FG001|Overall Study|Migrated/moved|7|||
129886943|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
129886944|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886945|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886946|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886947|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886948|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
129886949|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129886950|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129886951|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129886952|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
130041410|NCT00875420|468110523|FG002|Overall Study|Inability to complete study procedures|1|||
130041411|NCT00875420|468110524|FG003|Overall Study|Inability to complete study procedures|1|||
130041412|NCT00875420|468110525|FG004|Overall Study|Inability to complete study procedures|1|||
130041413|NCT00875420|468110521|FG000|Overall Study|Lost to Follow-up|1|||
130041414|NCT00875420|468110522|FG001|Overall Study|Lost to Follow-up|0|||
130041415|NCT00875420|468110523|FG002|Overall Study|Lost to Follow-up|0|||
130041416|NCT00875420|468110524|FG003|Overall Study|Lost to Follow-up|0|||
130041417|NCT00875420|468110525|FG004|Overall Study|Lost to Follow-up|0|||
130041418|NCT00875420|468110521|FG000|Overall Study|Personal reason|0|||
130041419|NCT00875420|468110522|FG001|Overall Study|Personal reason|0|||
130041420|NCT00875420|468110523|FG002|Overall Study|Personal reason|0|||
130041421|NCT00875420|468110524|FG003|Overall Study|Personal reason|0|||
130041422|NCT00875420|468110525|FG004|Overall Study|Personal reason|1|||
130041423|NCT00875420|468110521|FG000|Overall Study|Prohibited medication|0|||
130041424|NCT00875420|468110522|FG001|Overall Study|Prohibited medication|0|||
130041425|NCT00875420|468110523|FG002|Overall Study|Prohibited medication|0|||
130041426|NCT00875420|468110524|FG003|Overall Study|Prohibited medication|1|||
130041427|NCT00875420|468110525|FG004|Overall Study|Prohibited medication|0|||
130041428|NCT00875420|468110521|FG000|Overall Study|Sponsor decision|0|||
130041429|NCT00875420|468110522|FG001|Overall Study|Sponsor decision|1|||
130041430|NCT00875420|468110523|FG002|Overall Study|Sponsor decision|0|||
130041431|NCT00875420|468110524|FG003|Overall Study|Sponsor decision|0|||
130041432|NCT00875420|468110525|FG004|Overall Study|Sponsor decision|0|||
130041433|NCT00875420|468110521|FG000|Overall Study|Withdrawal by Subject|0|||
130041434|NCT00875420|468110522|FG001|Overall Study|Withdrawal by Subject|0|||
130041435|NCT00875420|468110523|FG002|Overall Study|Withdrawal by Subject|1|||
130041436|NCT00875420|468110524|FG003|Overall Study|Withdrawal by Subject|0|||
130041437|NCT00875420|468110525|FG004|Overall Study|Withdrawal by Subject|0|||
130041438|NCT00001259|468110526|FG000|Study 2|Adverse Event|0|||
130041439|NCT00001259|468110527|FG001|Study 2|Adverse Event|0|||
130041440|NCT00001259|468110528|FG002|Study 2|Adverse Event|0|||
130041441|NCT00001259|468110529|FG003|Study 2|Adverse Event|0|||
130041442|NCT00001259|468110530|FG004|Study 2|Adverse Event|2|||
130041443|NCT00001259|468110531|FG005|Study 2|Adverse Event|0|||
130041444|NCT00001259|468110532|FG006|Study 2|Adverse Event|0|||
130041445|NCT03705494|468110533|FG000|Overall Study|Lost to Follow-up|2|||
130041446|NCT03705494|468110534|FG001|Overall Study|Lost to Follow-up|1|||
130041447|NCT03705494|468110533|FG000|Overall Study|Withdrawal by Subject|5|||
130041448|NCT03705494|468110534|FG001|Overall Study|Withdrawal by Subject|2|||
130041449|NCT02629393|468110540|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
130041450|NCT02629393|468110540|FG000|Overall Study|Physician Decision|1|||
130041451|NCT02517515|468110542|FG000|Overall Study|Adverse Event|0|||
130041452|NCT02517515|468110543|FG001|Overall Study|Adverse Event|1|||
130041453|NCT02517515|468110542|FG000|Overall Study|Withdrew Consent|0|||
130041454|NCT02517515|468110543|FG001|Overall Study|Withdrew Consent|1|||
130041455|NCT02517515|468110542|FG000|Overall Study|Lost to Follow-up|1|||
130041456|NCT02517515|468110543|FG001|Overall Study|Lost to Follow-up|0|||
130041457|NCT02517515|468110542|FG000|Overall Study|Other|1|||
130041458|NCT02517515|468110543|FG001|Overall Study|Other|0|||
130041459|NCT03716726|468110546|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
130041460|NCT03716726|468110547|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
130041461|NCT03716726|468110546|FG000|12 Months Followup|Lost to Follow-up|10|||
130041462|NCT03716726|468110547|FG001|12 Months Followup|Lost to Follow-up|17|||
130041463|NCT02786537|468110550|FG000|As Randomized|Adverse Event|0|||
130041464|NCT02786537|468110551|FG001|As Randomized|Adverse Event|11|||
130041465|NCT02786537|468110552|FG002|As Randomized|Adverse Event|0|||
130041466|NCT02786537|468110553|FG003|As Randomized|Adverse Event|4|||
130041467|NCT02786537|468110554|FG004|As Randomized|Adverse Event|6|||
130041468|NCT02786537|468110555|FG005|As Randomized|Adverse Event|2|||
130041469|NCT02786537|468110550|FG000|As Randomized|Lack of Efficacy|0|||
130041470|NCT02786537|468110551|FG001|As Randomized|Lack of Efficacy|0|||
130041471|NCT02786537|468110552|FG002|As Randomized|Lack of Efficacy|0|||
130041472|NCT02786537|468110553|FG003|As Randomized|Lack of Efficacy|1|||
130041473|NCT02786537|468110554|FG004|As Randomized|Lack of Efficacy|0|||
130041474|NCT02786537|468110555|FG005|As Randomized|Lack of Efficacy|0|||
130041475|NCT02786537|468110550|FG000|As Randomized|Withdrawal by Subject|1|||
130041476|NCT02786537|468110551|FG001|As Randomized|Withdrawal by Subject|2|||
130041477|NCT02786537|468110552|FG002|As Randomized|Withdrawal by Subject|0|||
130041478|NCT02786537|468110553|FG003|As Randomized|Withdrawal by Subject|1|||
130041479|NCT02786537|468110554|FG004|As Randomized|Withdrawal by Subject|1|||
130041480|NCT02786537|468110555|FG005|As Randomized|Withdrawal by Subject|0|||
130041481|NCT02786537|468110550|FG000|As Randomized|Death|0|||
130041482|NCT02786537|468110551|FG001|As Randomized|Death|2|||
130041483|NCT02786537|468110552|FG002|As Randomized|Death|0|||
130041484|NCT02786537|468110553|FG003|As Randomized|Death|3|||
130041485|NCT02786537|468110554|FG004|As Randomized|Death|1|||
130041486|NCT02786537|468110555|FG005|As Randomized|Death|0|||
130041487|NCT02786537|468110550|FG000|As Randomized|Non-compliance with study drug|1|||
130041488|NCT02786537|468110551|FG001|As Randomized|Non-compliance with study drug|11|||
130041489|NCT02786537|468110552|FG002|As Randomized|Non-compliance with study drug|0|||
130041490|NCT02786537|468110553|FG003|As Randomized|Non-compliance with study drug|1|||
130041491|NCT02786537|468110554|FG004|As Randomized|Non-compliance with study drug|0|||
130105648|NCT02617446|468346095|FG000|Overall Study|Lost to Follow-up|3|||
130105649|NCT02617446|468346096|FG001|Overall Study|Lost to Follow-up|0|||
130105650|NCT02617446|468346097|FG002|Overall Study|Lost to Follow-up|0|||
130105651|NCT02617446|468346095|FG000|Overall Study|Death|0|||
130105652|NCT02617446|468346096|FG001|Overall Study|Death|0|||
130105653|NCT02617446|468346097|FG002|Overall Study|Death|2|||
130105654|NCT01556490|468346106|FG000|Randomized Patients Summary|Protocol Violation|22|||
130105655|NCT01556490|468346107|FG001|Randomized Patients Summary|Protocol Violation|23|||
130105656|NCT01556490|468346106|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
130105657|NCT01556490|468346107|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
130105658|NCT00530088|468346108|FG000|Overall Study|Disease Progression|4|||
130105659|NCT00530088|468346108|FG000|Overall Study|Physician Decision|4|||
130105660|NCT00530088|468346108|FG000|Overall Study|Other Not Specified|2|||
130105661|NCT00902278|468346109|FG000|Overall Study|Physician Decision|1|||
130105662|NCT00902278|468346110|FG001|Overall Study|Physician Decision|0|||
130105663|NCT00902278|468346111|FG002|Overall Study|Physician Decision|2|||
130105664|NCT00902278|468346112|FG003|Overall Study|Physician Decision|0|||
130105665|NCT00902278|468346113|FG004|Overall Study|Physician Decision|1|||
130105666|NCT00902278|468346109|FG000|Overall Study|Lost to Follow-up|3|||
129886953|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
129886954|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886955|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886956|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886957|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886958|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
129886959|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
129886960|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130041492|NCT02786537|468110555|FG005|As Randomized|Non-compliance with study drug|1|||
130041493|NCT02786537|468110550|FG000|As Randomized|Lost to treatment follow-up|4|||
130041494|NCT02786537|468110551|FG001|As Randomized|Lost to treatment follow-up|32|||
130041495|NCT02786537|468110552|FG002|As Randomized|Lost to treatment follow-up|0|||
130105667|NCT00902278|468346110|FG001|Overall Study|Lost to Follow-up|2|||
130105668|NCT00902278|468346111|FG002|Overall Study|Lost to Follow-up|3|||
130105669|NCT00902278|468346112|FG003|Overall Study|Lost to Follow-up|0|||
130105670|NCT00902278|468346113|FG004|Overall Study|Lost to Follow-up|1|||
130105671|NCT04822701|468346122|FG000|Overall Study|Not treated|2|||
130105672|NCT04822701|468346123|FG001|Overall Study|Not treated|0|||
130105673|NCT04822701|468346122|FG000|Overall Study|Lost to Follow-up|1|||
130105674|NCT04822701|468346123|FG001|Overall Study|Lost to Follow-up|0|||
130105675|NCT04822701|468346122|FG000|Overall Study|Withdrawal by Subject|1|||
130105676|NCT04822701|468346123|FG001|Overall Study|Withdrawal by Subject|0|||
130105677|NCT00391092|468347981|FG000|Overall Study|Death|78|||
130041496|NCT02786537|468110553|FG003|As Randomized|Lost to treatment follow-up|24|||
130041497|NCT02786537|468110554|FG004|As Randomized|Lost to treatment follow-up|4|||
130041498|NCT02786537|468110555|FG005|As Randomized|Lost to treatment follow-up|4|||
130041499|NCT02786537|468110550|FG000|As Randomized|Incarceration|0|||
130105678|NCT00391092|468347982|FG001|Overall Study|Death|81|||
130105679|NCT00391092|468347981|FG000|Overall Study|Lost to Follow-up|13|||
130105680|NCT00391092|468347982|FG001|Overall Study|Lost to Follow-up|18|||
130105681|NCT00391092|468347981|FG000|Overall Study|Alive on treatment|29|||
130105682|NCT00391092|468347982|FG001|Overall Study|Alive on treatment|33|||
130105683|NCT00391092|468347981|FG000|Overall Study|Alive in follow-up|88|||
130105684|NCT00391092|468347982|FG001|Overall Study|Alive in follow-up|84|||
130105685|NCT00303316|468347985|FG000|Overall Study|Protocol Violation|1|||
130105686|NCT00303316|468347986|FG001|Overall Study|Protocol Violation|0|||
130105687|NCT00303316|468347985|FG000|Overall Study|Lost to Follow-up|0|||
130105688|NCT00303316|468347986|FG001|Overall Study|Lost to Follow-up|1|||
130105689|NCT00303316|468347985|FG000|Overall Study|Withdrawal by Subject|1|||
130105690|NCT00303316|468347986|FG001|Overall Study|Withdrawal by Subject|2|||
130105691|NCT01586624|468347987|FG000|Overall Study|Adverse Event|3|||
130105692|NCT01586624|468347988|FG001|Overall Study|Adverse Event|0|||
130105693|NCT01586624|468347989|FG002|Overall Study|Adverse Event|2|||
129886961|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
130041500|NCT02786537|468110551|FG001|As Randomized|Incarceration|1|||
130105694|NCT01586624|468347990|FG003|Overall Study|Adverse Event|1|||
130105695|NCT01586624|468347991|FG004|Overall Study|Adverse Event|3|||
130041501|NCT02786537|468110552|FG002|As Randomized|Incarceration|0|||
130105696|NCT01586624|468347992|FG005|Overall Study|Adverse Event|3|||
130105697|NCT01586624|468347993|FG006|Overall Study|Adverse Event|2|||
130105698|NCT01586624|468347994|FG007|Overall Study|Adverse Event|3|||
130275735|NCT01814878|468974123|FG001|Overall Study|Screening failure (drop-out)|3|||
130275736|NCT01814878|468974122|FG000|Overall Study|Other|2|||
130275737|NCT01814878|468974123|FG001|Overall Study|Other|0|||
130275738|NCT03645421|468974124|FG000|Overall Study|Adverse Event|0|||
130275739|NCT03645421|468974125|FG001|Overall Study|Adverse Event|0|||
130275740|NCT03645421|468974126|FG002|Overall Study|Adverse Event|4|||
130275741|NCT03645421|468974127|FG003|Overall Study|Adverse Event|1|||
130275742|NCT03645421|468974124|FG000|Overall Study|Withdrawal by patient|0|||
130275743|NCT03645421|468974125|FG001|Overall Study|Withdrawal by patient|0|||
130275744|NCT03645421|468974126|FG002|Overall Study|Withdrawal by patient|0|||
130275745|NCT03645421|468974127|FG003|Overall Study|Withdrawal by patient|3|||
130275746|NCT03645421|468974124|FG000|Overall Study|Study specific withdrawal criteria|0|||
130275747|NCT03645421|468974125|FG001|Overall Study|Study specific withdrawal criteria|0|||
130275748|NCT03645421|468974126|FG002|Overall Study|Study specific withdrawal criteria|1|||
130275749|NCT03645421|468974127|FG003|Overall Study|Study specific withdrawal criteria|0|||
130041502|NCT02786537|468110553|FG003|As Randomized|Incarceration|0|||
130041503|NCT02786537|468110554|FG004|As Randomized|Incarceration|0|||
130041504|NCT02786537|468110555|FG005|As Randomized|Incarceration|0|||
130041505|NCT02786537|468110550|FG000|As Randomized|Opiate Dependency Relapse|0|||
130105699|NCT01586624|468347987|FG000|Overall Study|Physician Decision|0|||
130041506|NCT02786537|468110551|FG001|As Randomized|Opiate Dependency Relapse|1|||
130041507|NCT02786537|468110552|FG002|As Randomized|Opiate Dependency Relapse|0|||
130041508|NCT02786537|468110553|FG003|As Randomized|Opiate Dependency Relapse|0|||
130041509|NCT02786537|468110554|FG004|As Randomized|Opiate Dependency Relapse|0|||
130041510|NCT02786537|468110555|FG005|As Randomized|Opiate Dependency Relapse|0|||
130041511|NCT02786537|468110550|FG000|As Randomized|HCV drugs stolen from pt|0|||
130041512|NCT02786537|468110551|FG001|As Randomized|HCV drugs stolen from pt|1|||
130041513|NCT02786537|468110552|FG002|As Randomized|HCV drugs stolen from pt|0|||
130041514|NCT02786537|468110553|FG003|As Randomized|HCV drugs stolen from pt|0|||
130041515|NCT02786537|468110554|FG004|As Randomized|HCV drugs stolen from pt|0|||
130041516|NCT02786537|468110555|FG005|As Randomized|HCV drugs stolen from pt|0|||
130041517|NCT02786537|468110550|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
130041518|NCT02786537|468110551|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
130041519|NCT02786537|468110552|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
130041520|NCT02786537|468110553|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
130041521|NCT02786537|468110554|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
130041522|NCT02786537|468110555|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
130041523|NCT02786537|468110550|FG000|As Randomized|Subject lost insurance|0|||
130041524|NCT02786537|468110551|FG001|As Randomized|Subject lost insurance|0|||
130041525|NCT02786537|468110552|FG002|As Randomized|Subject lost insurance|0|||
130041526|NCT02786537|468110553|FG003|As Randomized|Subject lost insurance|1|||
130041527|NCT02786537|468110554|FG004|As Randomized|Subject lost insurance|0|||
130041528|NCT02786537|468110555|FG005|As Randomized|Subject lost insurance|0|||
130041529|NCT02786537|468110550|FG000|As Treated|Adverse Event|0|||
130041530|NCT02786537|468110551|FG001|As Treated|Adverse Event|11|||
130041531|NCT02786537|468110552|FG002|As Treated|Adverse Event|0|||
130041532|NCT02786537|468110553|FG003|As Treated|Adverse Event|4|||
130041533|NCT02786537|468110554|FG004|As Treated|Adverse Event|6|||
130041534|NCT02786537|468110555|FG005|As Treated|Adverse Event|2|||
130041535|NCT02786537|468110550|FG000|As Treated|Death|0|||
130041536|NCT02786537|468110551|FG001|As Treated|Death|2|||
130041537|NCT02786537|468110552|FG002|As Treated|Death|0|||
130041538|NCT02786537|468110553|FG003|As Treated|Death|3|||
130041539|NCT02786537|468110554|FG004|As Treated|Death|1|||
130041540|NCT02786537|468110555|FG005|As Treated|Death|0|||
130041541|NCT02786537|468110550|FG000|As Treated|Lack of Efficacy|0|||
130041542|NCT02786537|468110551|FG001|As Treated|Lack of Efficacy|0|||
130041543|NCT02786537|468110552|FG002|As Treated|Lack of Efficacy|0|||
130041544|NCT02786537|468110553|FG003|As Treated|Lack of Efficacy|1|||
130041545|NCT02786537|468110554|FG004|As Treated|Lack of Efficacy|0|||
130041546|NCT02786537|468110555|FG005|As Treated|Lack of Efficacy|0|||
130041547|NCT02786537|468110550|FG000|As Treated|Lost to Follow-up|4|||
130105700|NCT01586624|468347988|FG001|Overall Study|Physician Decision|1|||
130275750|NCT00748618|468974130|FG000|Overall Study|Adverse Event|1|||
130275751|NCT00748618|468974131|FG001|Overall Study|Adverse Event|0|||
130275752|NCT02854436|468974135|FG000|Overall Study|Adverse Event|1|||
130275753|NCT02854436|468974135|FG000|Overall Study|Death|208|||
130275754|NCT02854436|468974135|FG000|Overall Study|Lost to Follow-up|5|||
130275755|NCT02854436|468974135|FG000|Overall Study|Withdrawal by Subject|24|||
130275756|NCT02854436|468974135|FG000|Overall Study|Other|45|||
130275757|NCT02854436|468974135|FG000|Overall Study|Physician Decision|6|||
130041548|NCT02786537|468110551|FG001|As Treated|Lost to Follow-up|32|||
130041549|NCT02786537|468110552|FG002|As Treated|Lost to Follow-up|0|||
130041550|NCT02786537|468110553|FG003|As Treated|Lost to Follow-up|25|||
130041551|NCT02786537|468110554|FG004|As Treated|Lost to Follow-up|4|||
130041552|NCT02786537|468110555|FG005|As Treated|Lost to Follow-up|4|||
130041553|NCT02786537|468110550|FG000|As Treated|Non-compliance with study drug|1|||
130041554|NCT02786537|468110551|FG001|As Treated|Non-compliance with study drug|11|||
130105701|NCT01586624|468347989|FG002|Overall Study|Physician Decision|1|||
130275758|NCT01977729|468974137|FG000|Overall Study|Study terminated|1|||
130275759|NCT01268046|468974138|FG000|Overall Study|Withdrawal by Subject|1|||
130275760|NCT01268046|468974139|FG001|Overall Study|Withdrawal by Subject|0|||
130275761|NCT01268046|468974140|FG002|Overall Study|Withdrawal by Subject|0|||
130275762|NCT01268046|468974141|FG003|Overall Study|Withdrawal by Subject|1|||
130275763|NCT01268046|468974138|FG000|Overall Study|Lost to Follow-up|0|||
130275764|NCT01268046|468974139|FG001|Overall Study|Lost to Follow-up|0|||
130275765|NCT01268046|468974140|FG002|Overall Study|Lost to Follow-up|1|||
130275766|NCT01268046|468974141|FG003|Overall Study|Lost to Follow-up|0|||
130275767|NCT02253433|468974142|FG000|Overall Study|Unable to Contact|9|||
130275768|NCT02253433|468974143|FG001|Overall Study|Unable to Contact|16|||
130275769|NCT02253433|468974142|FG000|Overall Study|Death|1|||
130275770|NCT02253433|468974143|FG001|Overall Study|Death|1|||
130275771|NCT02253433|468974142|FG000|Overall Study|No Longer Interested|3|||
130275772|NCT02253433|468974143|FG001|Overall Study|No Longer Interested|15|||
130275773|NCT02253433|468974142|FG000|Overall Study|Out of Study Area|2|||
130275774|NCT02253433|468974143|FG001|Overall Study|Out of Study Area|7|||
130275775|NCT02253433|468974142|FG000|Overall Study|Uncomfortable with home visitors|0|||
130275776|NCT02253433|468974143|FG001|Overall Study|Uncomfortable with home visitors|3|||
130275777|NCT02253433|468974142|FG000|Overall Study|Unstable Housing/Homeless|0|||
130275778|NCT02253433|468974143|FG001|Overall Study|Unstable Housing/Homeless|7|||
130275779|NCT02253433|468974142|FG000|Overall Study|Too Busy|0|||
130275780|NCT02253433|468974143|FG001|Overall Study|Too Busy|4|||
130275781|NCT02253433|468974142|FG000|Overall Study|Medical or Other Concerns|1|||
130275782|NCT02253433|468974143|FG001|Overall Study|Medical or Other Concerns|2|||
130275783|NCT02836717|468974146|FG000|Test Phase|Lack of Efficacy|14|||
130275784|NCT02836717|468974147|FG001|Test Phase|Lack of Efficacy|8|||
130275785|NCT02836717|468974148|FG002|Test Phase|Lack of Efficacy|0|||
130275786|NCT02836717|468974146|FG000|Study Phase|Adverse Event|2|||
130275787|NCT02836717|468974147|FG001|Study Phase|Adverse Event|0|||
130275788|NCT02836717|468974148|FG002|Study Phase|Adverse Event|0|||
130275789|NCT02836717|468974146|FG000|Study Phase|Lack of Efficacy|8|||
130275790|NCT02836717|468974147|FG001|Study Phase|Lack of Efficacy|6|||
130275791|NCT02836717|468974148|FG002|Study Phase|Lack of Efficacy|1|||
130275792|NCT02836717|468974146|FG000|Study Phase|Withdrawal by Subject|1|||
130275793|NCT02836717|468974147|FG001|Study Phase|Withdrawal by Subject|0|||
130275794|NCT02836717|468974148|FG002|Study Phase|Withdrawal by Subject|0|||
130275795|NCT02836717|468974146|FG000|Study Phase|Death|1|||
130275796|NCT02836717|468974147|FG001|Study Phase|Death|0|||
130275797|NCT02836717|468974148|FG002|Study Phase|Death|0|||
130275798|NCT02836717|468974146|FG000|Study Phase|abdominal surgeries|2|||
130275799|NCT02836717|468974147|FG001|Study Phase|abdominal surgeries|1|||
130275800|NCT02836717|468974148|FG002|Study Phase|abdominal surgeries|0|||
130275801|NCT00224120|468974149|FG000|Overall Study|Adverse Event|10|||
130275802|NCT00224120|468974150|FG001|Overall Study|Adverse Event|4|||
130275803|NCT00224120|468974149|FG000|Overall Study|Protocol Violation|1|||
130275804|NCT00224120|468974150|FG001|Overall Study|Protocol Violation|0|||
130275805|NCT00224120|468974149|FG000|Overall Study|Withdrawal by Subject|5|||
130275806|NCT00224120|468974150|FG001|Overall Study|Withdrawal by Subject|10|||
130275807|NCT00224120|468974149|FG000|Overall Study|Lack of Efficacy|0|||
130275808|NCT00224120|468974150|FG001|Overall Study|Lack of Efficacy|2|||
130275809|NCT00224120|468974149|FG000|Overall Study|Lost to Follow-up|2|||
130275810|NCT00224120|468974150|FG001|Overall Study|Lost to Follow-up|3|||
130275811|NCT00224120|468974149|FG000|Overall Study|Other|4|||
130275812|NCT00224120|468974150|FG001|Overall Study|Other|5|||
130275813|NCT00438360|468974151|FG000|Overall Study|Adverse Event|6|||
130041555|NCT02786537|468110552|FG002|As Treated|Non-compliance with study drug|0|||
130041556|NCT02786537|468110553|FG003|As Treated|Non-compliance with study drug|1|||
130041557|NCT02786537|468110554|FG004|As Treated|Non-compliance with study drug|0|||
130041558|NCT02786537|468110555|FG005|As Treated|Non-compliance with study drug|1|||
130041559|NCT02786537|468110550|FG000|As Treated|Lost insurance|0|||
130041560|NCT02786537|468110551|FG001|As Treated|Lost insurance|0|||
130275814|NCT00438360|468974152|FG001|Overall Study|Adverse Event|1|||
130275815|NCT00438360|468974151|FG000|Overall Study|Lack of Efficacy|42|||
130275816|NCT00438360|468974152|FG001|Overall Study|Lack of Efficacy|27|||
130275817|NCT00438360|468974151|FG000|Overall Study|Other|24|||
130275818|NCT00438360|468974152|FG001|Overall Study|Other|15|||
130275819|NCT00282087|468974153|FG000|Overall Study|Death|1|||
130041561|NCT02786537|468110552|FG002|As Treated|Lost insurance|0|||
130275820|NCT01147250|468974158|FG000|Overall Study|Lost to Follow-up|14|||
130275821|NCT01147250|468974159|FG001|Overall Study|Lost to Follow-up|11|||
130275822|NCT01147250|468974158|FG000|Overall Study|Withdrawal by Subject|83|||
130275823|NCT01147250|468974159|FG001|Overall Study|Withdrawal by Subject|88|||
130041562|NCT02786537|468110553|FG003|As Treated|Lost insurance|1|||
130275824|NCT01147250|468974158|FG000|Overall Study|Site termination by sponsor|13|||
130275825|NCT01147250|468974159|FG001|Overall Study|Site termination by sponsor|5|||
130275826|NCT01147250|468974158|FG000|Overall Study|Other than specified|0|||
130275827|NCT01147250|468974159|FG001|Overall Study|Other than specified|1|||
130275828|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130041563|NCT02786537|468110554|FG004|As Treated|Lost insurance|0|||
130041564|NCT02786537|468110555|FG005|As Treated|Lost insurance|0|||
130041565|NCT02786537|468110550|FG000|As Treated|Withdrawal by Subject|1|||
130275829|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
130275830|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275831|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275832|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275833|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
130275834|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
130275835|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
130275836|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275837|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275838|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275839|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130275840|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
130275841|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
130275842|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275843|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275844|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275845|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130275846|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
130275847|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
130275848|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275849|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275850|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275851|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
130275852|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275853|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
130275854|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275855|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275856|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275857|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130275858|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
130275859|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
130275860|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275861|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275862|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275863|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
130275864|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275865|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
130275866|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275867|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275868|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275869|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
130275870|NCT03985943|468974162|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275871|NCT03985943|468974163|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
130275872|NCT03985943|468974164|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275873|NCT03985943|468974165|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275874|NCT03985943|468974166|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275875|NCT03985943|468974167|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
130275876|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130275877|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130275878|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
130275879|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130275880|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
130275881|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
130275882|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130275883|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130275884|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130275885|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130041566|NCT02786537|468110551|FG001|As Treated|Withdrawal by Subject|2|||
130041567|NCT02786537|468110552|FG002|As Treated|Withdrawal by Subject|0|||
130041568|NCT02786537|468110553|FG003|As Treated|Withdrawal by Subject|0|||
130041569|NCT02786537|468110554|FG004|As Treated|Withdrawal by Subject|1|||
130041570|NCT02786537|468110555|FG005|As Treated|Withdrawal by Subject|0|||
130041571|NCT02786537|468110550|FG000|As Treated|Incarceration|0|||
130041572|NCT02786537|468110551|FG001|As Treated|Incarceration|1|||
130041573|NCT02786537|468110552|FG002|As Treated|Incarceration|0|||
130041574|NCT02786537|468110553|FG003|As Treated|Incarceration|0|||
130041575|NCT02786537|468110554|FG004|As Treated|Incarceration|0|||
130041576|NCT02786537|468110555|FG005|As Treated|Incarceration|0|||
130041577|NCT02786537|468110550|FG000|As Treated|Opiate dependency relapse|0|||
130275886|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130275887|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
130275888|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
130275889|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
130275890|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
130275891|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
130275892|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
130275893|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
130275894|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130275895|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130275896|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130275897|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130275898|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130275899|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130275900|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275901|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275902|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
130275903|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275904|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
130275905|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
130275906|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
130275907|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
130275908|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
130275909|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
130275910|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
130275911|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
130275912|NCT03985943|468974162|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
130275913|NCT03985943|468974163|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
130275914|NCT03985943|468974164|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
130275915|NCT03985943|468974165|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
130275916|NCT03985943|468974166|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
130275917|NCT03985943|468974167|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
130275918|NCT00338286|468974168|FG000|Overall Study|Withdrawal by Subject|50|||
130275919|NCT00338286|468974169|FG001|Overall Study|Withdrawal by Subject|54|||
130275920|NCT00338286|468974168|FG000|Overall Study|Lost to Follow-up|80|||
130275921|NCT00338286|468974169|FG001|Overall Study|Lost to Follow-up|66|||
130275922|NCT00338286|468974168|FG000|Overall Study|Other|103|||
130275923|NCT00338286|468974169|FG001|Overall Study|Other|93|||
130275924|NCT00022763|468974173|FG000|Overall Study|Adverse Event|1|||
130275925|NCT00022763|468974174|FG001|Overall Study|Adverse Event|2|||
130275926|NCT00022763|468974173|FG000|Overall Study|Injection Site Reactions|0|||
130275927|NCT00022763|468974174|FG001|Overall Study|Injection Site Reactions|2|||
130275928|NCT00022763|468974173|FG000|Overall Study|Death|0|||
130275929|NCT00022763|468974174|FG001|Overall Study|Death|1|||
130275930|NCT00022763|468974173|FG000|Overall Study|Lost to Follow-up|0|||
130275931|NCT00022763|468974174|FG001|Overall Study|Lost to Follow-up|3|||
130105702|NCT01586624|468347990|FG003|Overall Study|Physician Decision|0|||
130105703|NCT01586624|468347991|FG004|Overall Study|Physician Decision|2|||
130105704|NCT01586624|468347992|FG005|Overall Study|Physician Decision|0|||
130041578|NCT02786537|468110551|FG001|As Treated|Opiate dependency relapse|1|||
130041579|NCT02786537|468110552|FG002|As Treated|Opiate dependency relapse|0|||
130105705|NCT01586624|468347993|FG006|Overall Study|Physician Decision|1|||
130041580|NCT02786537|468110553|FG003|As Treated|Opiate dependency relapse|0|||
130041581|NCT02786537|468110554|FG004|As Treated|Opiate dependency relapse|0|||
130105706|NCT01586624|468347994|FG007|Overall Study|Physician Decision|1|||
130105707|NCT01586624|468347987|FG000|Overall Study|Withdrawal by Subject|0|||
130105708|NCT01586624|468347988|FG001|Overall Study|Withdrawal by Subject|0|||
130275932|NCT00022763|468974173|FG000|Overall Study|Withdrawal by Subject|4|||
130041582|NCT02786537|468110555|FG005|As Treated|Opiate dependency relapse|0|||
130105709|NCT01586624|468347989|FG002|Overall Study|Withdrawal by Subject|0|||
130105710|NCT01586624|468347990|FG003|Overall Study|Withdrawal by Subject|1|||
130105711|NCT01586624|468347991|FG004|Overall Study|Withdrawal by Subject|0|||
130275933|NCT00022763|468974174|FG001|Overall Study|Withdrawal by Subject|7|||
130041583|NCT02786537|468110550|FG000|As Treated|Drugs stolen from patient|0|||
130105712|NCT01586624|468347992|FG005|Overall Study|Withdrawal by Subject|0|||
130275934|NCT00022763|468974173|FG000|Overall Study|Insufficient Therapy|1|||
130275935|NCT00022763|468974174|FG001|Overall Study|Insufficient Therapy|0|||
130275936|NCT00022763|468974173|FG000|Overall Study|Admin|3|||
130275937|NCT00022763|468974174|FG001|Overall Study|Admin|2|||
130275938|NCT00716482|468974175|FG000|Overall Study|Lost to Follow-up|6|||
130041584|NCT02786537|468110551|FG001|As Treated|Drugs stolen from patient|1|||
130041585|NCT02786537|468110552|FG002|As Treated|Drugs stolen from patient|0|||
130041586|NCT02786537|468110553|FG003|As Treated|Drugs stolen from patient|0|||
130041587|NCT02786537|468110554|FG004|As Treated|Drugs stolen from patient|0|||
130041588|NCT02786537|468110555|FG005|As Treated|Drugs stolen from patient|0|||
130041589|NCT02786537|468110550|FG000|As Treated|Advised to stop tx after loss of meds|0|||
130041590|NCT02786537|468110551|FG001|As Treated|Advised to stop tx after loss of meds|1|||
130041591|NCT02786537|468110552|FG002|As Treated|Advised to stop tx after loss of meds|0|||
130041592|NCT02786537|468110553|FG003|As Treated|Advised to stop tx after loss of meds|0|||
130041593|NCT02786537|468110554|FG004|As Treated|Advised to stop tx after loss of meds|0|||
130041594|NCT02786537|468110555|FG005|As Treated|Advised to stop tx after loss of meds|0|||
130041595|NCT01981187|468110556|FG000|Overall Study|Participant/guardian decision|2|||
130041596|NCT01981187|468110556|FG000|Overall Study|Physician Decision|1|||
130041597|NCT01981187|468110556|FG000|Overall Study|Disease progression|2|||
130041598|NCT01981187|468110556|FG000|Overall Study|Adverse Event|7|||
130041599|NCT02638012|468110557|FG000|Overall Study|Lost to Follow-up|1|||
130275939|NCT00716482|468974175|FG000|Overall Study|Inadequate acquisition or analysis|50|||
130275940|NCT00716482|468974175|FG000|Overall Study|no pathology obtained|10|||
130275941|NCT00716482|468974175|FG000|Overall Study|technical/machine error|28|||
130275942|NCT00716482|468974175|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
130275943|NCT03248531|468974176|FG000|Overall Study|Adverse Event|0|||
130275944|NCT03248531|468974177|FG001|Overall Study|Adverse Event|0|||
130275945|NCT03248531|468974178|FG002|Overall Study|Adverse Event|1|||
130275946|NCT03248531|468974176|FG000|Overall Study|Lost to Follow-up|1|||
130275947|NCT03248531|468974177|FG001|Overall Study|Lost to Follow-up|0|||
130275948|NCT03248531|468974178|FG002|Overall Study|Lost to Follow-up|5|||
130275949|NCT03248531|468974176|FG000|Overall Study|Withdrawal by Subject|3|||
130275950|NCT03248531|468974177|FG001|Overall Study|Withdrawal by Subject|3|||
130275951|NCT03248531|468974178|FG002|Overall Study|Withdrawal by Subject|2|||
130275952|NCT03248531|468974176|FG000|Overall Study|Sponsor Request|0|||
130275953|NCT03248531|468974177|FG001|Overall Study|Sponsor Request|2|||
130275954|NCT03248531|468974178|FG002|Overall Study|Sponsor Request|0|||
130275955|NCT04075513|468974179|FG000|Overall Study|Withdrawal by Subject|2|||
130275956|NCT04075513|468974180|FG001|Overall Study|Withdrawal by Subject|2|||
130275957|NCT04075513|468974179|FG000|Overall Study|Lack of Efficacy|1|||
130275958|NCT04075513|468974180|FG001|Overall Study|Lack of Efficacy|0|||
130275959|NCT04075513|468974179|FG000|Overall Study|Lost to Follow-up|4|||
130275960|NCT04075513|468974180|FG001|Overall Study|Lost to Follow-up|2|||
130275961|NCT04075513|468974179|FG000|Overall Study|Switch to insulin pump|1|||
130275962|NCT04075513|468974180|FG001|Overall Study|Switch to insulin pump|0|||
130275963|NCT03748706|468974182|FG000|Overall Study|Lost to Follow-up|1|||
130275964|NCT04153981|468974185|FG000|Overall Study|Death|1|||
130275965|NCT04153981|468974185|FG000|Overall Study|Withdrawal by Subject|24|||
130275966|NCT04153981|468974185|FG000|Overall Study|Lost to Follow-up|1|||
130275967|NCT04153981|468974185|FG000|Overall Study|Physician Decision|1|||
130275968|NCT04153981|468974185|FG000|Overall Study|Due to Unavailable Glucometer|1|||
130275969|NCT04153981|468974185|FG000|Overall Study|Covid 19|52|||
130275970|NCT04153981|468974185|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
130275971|NCT04153981|468974185|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
130275972|NCT01355679|468974186|FG000|Overall Study|benign tumor types found at biopsy|2|||
130275973|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
130275974|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
130041600|NCT00443560|468110561|FG000|Overall Study|No intrathecal dose|58|||
130041601|NCT00443560|468110562|FG001|Overall Study|No intrathecal dose|26|||
130041602|NCT00443560|468110561|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
130041603|NCT00443560|468110562|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
130041604|NCT01943539|468110563|FG000|Overall Study|Non-compliance with at-home intervention|4|||
130041605|NCT01943539|468110564|FG001|Overall Study|Non-compliance with at-home intervention|0|||
130041606|NCT02413255|468110565|FG000|Overall Study|Voluntary Withdrawal|0|||
130041607|NCT02413255|468110566|FG001|Overall Study|Voluntary Withdrawal|0|||
130041608|NCT02413255|468110567|FG002|Overall Study|Voluntary Withdrawal|0|||
130041609|NCT02413255|468110568|FG003|Overall Study|Voluntary Withdrawal|0|||
130041610|NCT02413255|468110569|FG004|Overall Study|Voluntary Withdrawal|0|||
130041611|NCT02413255|468110570|FG005|Overall Study|Voluntary Withdrawal|0|||
130275975|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
130275976|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
130275977|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
130041612|NCT02413255|468110571|FG006|Overall Study|Voluntary Withdrawal|0|||
130275978|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
130275979|NCT03490292|468974187|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
130275980|NCT03490292|468974188|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
130275981|NCT03490292|468974187|FG000|1 Year Follow Up Post Last Dose|Death|1|||
130275982|NCT03490292|468974188|FG001|1 Year Follow Up Post Last Dose|Death|1|||
130275983|NCT00964002|468974189|FG000|Overall Study|Protocol Violation|8|||
130275984|NCT00904670|468974190|FG000|Open Label Phase|Withdrawal by Subject|2|||
130275985|NCT00904670|468974191|FG001|Open Label Phase|Withdrawal by Subject|0|||
130275986|NCT00904670|468974190|FG000|Open Label Phase|Adverse Event|2|||
130275987|NCT00904670|468974191|FG001|Open Label Phase|Adverse Event|0|||
130275988|NCT00904670|468974190|FG000|Open Label Phase|Lack of Efficacy|1|||
130275989|NCT00904670|468974191|FG001|Open Label Phase|Lack of Efficacy|0|||
130275990|NCT00904670|468974190|FG000|Open Label Phase|Lost to Follow-up|1|||
130275991|NCT00904670|468974191|FG001|Open Label Phase|Lost to Follow-up|0|||
130275992|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
130275993|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
130275994|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
130275995|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
130275996|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Death|58|||
130275997|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Death|65|||
130275998|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Adverse Event|28|||
130275999|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Adverse Event|40|||
130276000|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Disease Progression|22|||
130276001|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Disease Progression|35|||
130276002|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Other|25|||
130276003|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Other|33|||
130276004|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
130276005|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
130276006|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Noncompliance|8|||
130276007|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Noncompliance|8|||
130276008|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
130276009|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
130276010|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
130276011|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
130276012|NCT00286091|468974192|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
130276013|NCT00286091|468974193|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
130276014|NCT00286091|468974192|FG000|Open-label Treatment Phase|Physician Decision|24|||
130276015|NCT00286091|468974193|FG001|Open-label Treatment Phase|Physician Decision|21|||
130276016|NCT00286091|468974192|FG000|Open-label Treatment Phase|Adverse Event|5|||
130276017|NCT00286091|468974193|FG001|Open-label Treatment Phase|Adverse Event|16|||
130276018|NCT00286091|468974192|FG000|Open-label Treatment Phase|Other|11|||
130276019|NCT00286091|468974193|FG001|Open-label Treatment Phase|Other|11|||
130276020|NCT00286091|468974192|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
130276021|NCT00286091|468974193|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
130276022|NCT00286091|468974192|FG000|Open-label Treatment Phase|Death|10|||
130276023|NCT00286091|468974193|FG001|Open-label Treatment Phase|Death|7|||
130276024|NCT00286091|468974192|FG000|Open-label Treatment Phase|Disease Progression|9|||
130276025|NCT00286091|468974193|FG001|Open-label Treatment Phase|Disease Progression|3|||
130276026|NCT00286091|468974192|FG000|Open-label Treatment Phase|Noncompliance|3|||
130276027|NCT00286091|468974193|FG001|Open-label Treatment Phase|Noncompliance|1|||
130276028|NCT00286091|468974192|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130276029|NCT00286091|468974193|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
130276030|NCT00286091|468974192|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
130276031|NCT00286091|468974193|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
130276032|NCT00286091|468974192|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
130276033|NCT00286091|468974193|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
130276034|NCT04004221|468974194|FG000|Overall Study|Death|89|||
130276035|NCT04004221|468974194|FG000|Overall Study|Withdrawal by Subject|5|||
130276036|NCT04004221|468974194|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
130276037|NCT04004221|468974194|FG000|Overall Study|Sponsor Decision|9|||
130276038|NCT04004221|468974194|FG000|Overall Study|Participant refused to enter LTE|1|||
130041613|NCT02413255|468110572|FG007|Overall Study|Voluntary Withdrawal|0|||
130276039|NCT02036580|468974195|FG000|Overall Study|Withdrawal by Subject|0|||
130276040|NCT02036580|468974196|FG001|Overall Study|Withdrawal by Subject|1|||
130276041|NCT02036580|468974197|FG002|Overall Study|Withdrawal by Subject|0|||
130276042|NCT02036580|468974195|FG000|Overall Study|Adverse Event|1|||
130276043|NCT02036580|468974196|FG001|Overall Study|Adverse Event|0|||
130041614|NCT02413255|468110573|FG008|Overall Study|Voluntary Withdrawal|0|||
130276044|NCT02036580|468974197|FG002|Overall Study|Adverse Event|0|||
130276045|NCT00506454|468974198|FG000|Overall Study|Withdrawal by Subject|1|||
130276046|NCT00506454|468974199|FG001|Overall Study|Withdrawal by Subject|1|||
130276047|NCT02584452|468974202|FG000|Overall Study|Physician Decision|1|||
130276048|NCT02584452|468974203|FG001|Overall Study|Physician Decision|1|||
130276049|NCT02584452|468974202|FG000|Overall Study|Lost to Follow-up|1|||
130276050|NCT02584452|468974203|FG001|Overall Study|Lost to Follow-up|1|||
130276051|NCT02689206|468974204|FG000|Overall Study|Adverse Event|0|||
130276052|NCT02689206|468974205|FG001|Overall Study|Adverse Event|0|||
130276053|NCT02689206|468974206|FG002|Overall Study|Adverse Event|1|||
130276054|NCT02689206|468974207|FG003|Overall Study|Adverse Event|0|||
130276055|NCT02689206|468974208|FG004|Overall Study|Adverse Event|2|||
130276056|NCT02689206|468974204|FG000|Overall Study|Protocol Violation|1|||
130276057|NCT02689206|468974205|FG001|Overall Study|Protocol Violation|0|||
130276058|NCT02689206|468974206|FG002|Overall Study|Protocol Violation|0|||
130276059|NCT02689206|468974207|FG003|Overall Study|Protocol Violation|1|||
130276060|NCT02689206|468974208|FG004|Overall Study|Protocol Violation|2|||
130276061|NCT02689206|468974204|FG000|Overall Study|Other: Reached stopping criteria|0|||
130276062|NCT02689206|468974205|FG001|Overall Study|Other: Reached stopping criteria|1|||
130276063|NCT02689206|468974206|FG002|Overall Study|Other: Reached stopping criteria|2|||
130276064|NCT02689206|468974207|FG003|Overall Study|Other: Reached stopping criteria|3|||
130276065|NCT02689206|468974208|FG004|Overall Study|Other: Reached stopping criteria|4|||
130276066|NCT02689206|468974204|FG000|Overall Study|Physician Decision|1|||
130276067|NCT02689206|468974205|FG001|Overall Study|Physician Decision|0|||
130276068|NCT02689206|468974206|FG002|Overall Study|Physician Decision|0|||
130276069|NCT02689206|468974207|FG003|Overall Study|Physician Decision|0|||
130276070|NCT02689206|468974208|FG004|Overall Study|Physician Decision|0|||
130276071|NCT02689206|468974204|FG000|Overall Study|Withdrawal by Subject|1|||
130276072|NCT02689206|468974205|FG001|Overall Study|Withdrawal by Subject|0|||
130276073|NCT02689206|468974206|FG002|Overall Study|Withdrawal by Subject|1|||
130276074|NCT02689206|468974207|FG003|Overall Study|Withdrawal by Subject|0|||
130276075|NCT02689206|468974208|FG004|Overall Study|Withdrawal by Subject|0|||
130276076|NCT01558596|468974211|FG000|Overall Study|Withdrawal by Subject|1|||
130276077|NCT01558596|468974212|FG001|Overall Study|Withdrawal by Subject|0|||
130276078|NCT01558596|468974211|FG000|Overall Study|surgery elsewhere or cancelled|1|||
130276079|NCT01558596|468974212|FG001|Overall Study|surgery elsewhere or cancelled|1|||
130276080|NCT01558596|468974211|FG000|Overall Study|Protocol Violation|1|||
130276081|NCT01558596|468974212|FG001|Overall Study|Protocol Violation|0|||
130276082|NCT01479764|468974214|FG000|Randomized|Adverse Event|1|||
130276083|NCT01479764|468974215|FG001|Randomized|Adverse Event|1|||
130276084|NCT01479764|468974214|FG000|Randomized|Withdrawal by Subject|1|||
130276085|NCT01479764|468974215|FG001|Randomized|Withdrawal by Subject|0|||
130276086|NCT01479764|468974214|FG000|Treated|Lost to Follow-up|0|||
130276087|NCT01479764|468974215|FG001|Treated|Lost to Follow-up|2|||
130276088|NCT00260832|468974217|FG000|Overall Study|Adverse Event|26|||
130276089|NCT00260832|468974218|FG001|Overall Study|Adverse Event|19|||
130276090|NCT00260832|468974217|FG000|Overall Study|Progression|116|||
130276091|NCT00260832|468974218|FG001|Overall Study|Progression|96|||
130276092|NCT00260832|468974217|FG000|Overall Study|Withdrawal by Subject|15|||
130276093|NCT00260832|468974218|FG001|Overall Study|Withdrawal by Subject|17|||
130276094|NCT00260832|468974217|FG000|Overall Study|Physician Decision|15|||
130276095|NCT00260832|468974218|FG001|Overall Study|Physician Decision|9|||
130276096|NCT00260832|468974217|FG000|Overall Study|Death|43|||
130276097|NCT00260832|468974218|FG001|Overall Study|Death|62|||
130276098|NCT00260832|468974217|FG000|Overall Study|Other|10|||
130276099|NCT00260832|468974218|FG001|Overall Study|Other|7|||
130276100|NCT00260832|468974217|FG000|Overall Study|Protocol Violation|3|||
130276101|NCT00260832|468974218|FG001|Overall Study|Protocol Violation|1|||
130276102|NCT03098433|468974221|FG000|Overall Study|Withdrawal by Subject|10|||
130276103|NCT01104545|468974222|FG000|Overall Study|Adverse Event|0|||
130276104|NCT01104545|468974223|FG001|Overall Study|Adverse Event|1|||
130276105|NCT01104545|468974224|FG002|Overall Study|Adverse Event|2|||
130276106|NCT03585764|468974227|FG000|Overall Study|Death|3|||
130276107|NCT03585764|468974228|FG001|Overall Study|Death|2|||
130276108|NCT03585764|468974229|FG002|Overall Study|Death|3|||
130276109|NCT03585764|468974230|FG003|Overall Study|Death|0|||
130276110|NCT03585764|468974227|FG000|Overall Study|Lost to Follow-up|0|||
130276111|NCT03585764|468974228|FG001|Overall Study|Lost to Follow-up|1|||
130276112|NCT03585764|468974229|FG002|Overall Study|Lost to Follow-up|0|||
130276113|NCT03585764|468974230|FG003|Overall Study|Lost to Follow-up|0|||
130276114|NCT03585764|468974227|FG000|Overall Study|Physician Decision|0|||
130276115|NCT03585764|468974228|FG001|Overall Study|Physician Decision|0|||
130276116|NCT03585764|468974229|FG002|Overall Study|Physician Decision|2|||
130276117|NCT03585764|468974230|FG003|Overall Study|Physician Decision|0|||
130276118|NCT03640507|468974231|FG000|Overall Study|Withdrawal by Subject|0|||
130276119|NCT03640507|468974232|FG001|Overall Study|Withdrawal by Subject|0|||
130276120|NCT03640507|468974233|FG002|Overall Study|Withdrawal by Subject|1|||
130276121|NCT02993822|468974234|FG000|Overall Study|Lack of Efficacy|1|||
130276122|NCT02993822|468974235|FG001|Overall Study|Lack of Efficacy|1|||
130276123|NCT02993822|468974236|FG002|Overall Study|Lack of Efficacy|0|||
130276124|NCT02993822|468974237|FG003|Overall Study|Lack of Efficacy|0|||
130276125|NCT02993822|468974234|FG000|Overall Study|Protocol Violation|1|||
130276126|NCT02993822|468974235|FG001|Overall Study|Protocol Violation|0|||
130276127|NCT02993822|468974236|FG002|Overall Study|Protocol Violation|0|||
130276128|NCT02993822|468974237|FG003|Overall Study|Protocol Violation|0|||
130276129|NCT02993822|468974234|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
130276130|NCT02993822|468974235|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
130276131|NCT02993822|468974236|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
130276132|NCT02993822|468974237|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
130276133|NCT02993822|468974234|FG000|Overall Study|Adverse Event|3|||
130276134|NCT02993822|468974235|FG001|Overall Study|Adverse Event|1|||
130276135|NCT02993822|468974236|FG002|Overall Study|Adverse Event|7|||
130276136|NCT02993822|468974237|FG003|Overall Study|Adverse Event|0|||
130276137|NCT02993822|468974234|FG000|Overall Study|Withdrawal by Subject|4|||
130276138|NCT02993822|468974235|FG001|Overall Study|Withdrawal by Subject|2|||
130276139|NCT02993822|468974236|FG002|Overall Study|Withdrawal by Subject|2|||
130276140|NCT02993822|468974237|FG003|Overall Study|Withdrawal by Subject|3|||
130276141|NCT02993822|468974234|FG000|Overall Study|Lost to Follow-up|1|||
130276142|NCT02993822|468974235|FG001|Overall Study|Lost to Follow-up|0|||
130276143|NCT02993822|468974236|FG002|Overall Study|Lost to Follow-up|1|||
130276144|NCT02993822|468974237|FG003|Overall Study|Lost to Follow-up|0|||
130276145|NCT01221753|468974238|FG000|Overall Study|Adverse Event|1|||
130276146|NCT01939977|468974242|FG000|Overall Study|Adverse Event|4|||
130276147|NCT01939977|468974243|FG001|Overall Study|Adverse Event|3|||
130276148|NCT01939977|468974242|FG000|Overall Study|Lack of Efficacy|3|||
130276149|NCT01939977|468974243|FG001|Overall Study|Lack of Efficacy|0|||
130276150|NCT01939977|468974242|FG000|Overall Study|Physician Decision|1|||
130276151|NCT01939977|468974243|FG001|Overall Study|Physician Decision|1|||
130276152|NCT01939977|468974242|FG000|Overall Study|Withdrawal by Subject|0|||
130276153|NCT01939977|468974243|FG001|Overall Study|Withdrawal by Subject|2|||
130276154|NCT01939977|468974242|FG000|Overall Study|Did not meet inclusion criteria|1|||
130276155|NCT01939977|468974243|FG001|Overall Study|Did not meet inclusion criteria|0|||
130276156|NCT01939977|468974242|FG000|Overall Study|Did not receive study medication|0|||
130276157|NCT01939977|468974243|FG001|Overall Study|Did not receive study medication|1|||
130276158|NCT04552288|468974247|FG000|Overall Study|Death|3|||
130276159|NCT04552288|468974247|FG000|Overall Study|Lost to Follow-up|6|||
130276160|NCT04552288|468974247|FG000|Overall Study|Physician Decision|3|||
130276161|NCT04552288|468974247|FG000|Overall Study|Protocol Violation|9|||
130276162|NCT04552288|468974247|FG000|Overall Study|Withdrawal by Subject|6|||
130276163|NCT04552288|468974247|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
130276164|NCT05285644|468974248|FG000|Overall Study|Adverse Event|3|||
130276165|NCT05285644|468974249|FG001|Overall Study|Adverse Event|3|||
130276166|NCT05285644|468974248|FG000|Overall Study|Withdrawal of Consent|2|||
130276167|NCT05285644|468974249|FG001|Overall Study|Withdrawal of Consent|5|||
130276168|NCT05285644|468974248|FG000|Overall Study|Noncompliance|0|||
130276169|NCT05285644|468974249|FG001|Overall Study|Noncompliance|4|||
130276170|NCT05285644|468974248|FG000|Overall Study|Lost to Follow-up|4|||
130041615|NCT02413255|468110574|FG009|Overall Study|Voluntary Withdrawal|0|||
130041616|NCT02413255|468110575|FG010|Overall Study|Voluntary Withdrawal|0|||
130041617|NCT02413255|468110576|FG011|Overall Study|Voluntary Withdrawal|0|||
130276171|NCT05285644|468974249|FG001|Overall Study|Lost to Follow-up|6|||
130276172|NCT05285644|468974248|FG000|Overall Study|Disallowed Concurrent Medication|1|||
130276173|NCT05285644|468974249|FG001|Overall Study|Disallowed Concurrent Medication|1|||
130276174|NCT05285644|468974248|FG000|Overall Study|Investigator Decision|2|||
130276175|NCT05285644|468974249|FG001|Overall Study|Investigator Decision|0|||
130276176|NCT05285644|468974248|FG000|Overall Study|Protocol Deviation|1|||
130276177|NCT05285644|468974249|FG001|Overall Study|Protocol Deviation|0|||
130276178|NCT05285644|468974248|FG000|Overall Study|As specified in the Clinical Study Report|7|||
130276179|NCT05285644|468974249|FG001|Overall Study|As specified in the Clinical Study Report|3|||
130276180|NCT04532294|468974250|FG000|Overall Study|Withdrawal by Subject|0|||
130276181|NCT04532294|468974251|FG001|Overall Study|Withdrawal by Subject|0|||
130276182|NCT04532294|468974252|FG002|Overall Study|Withdrawal by Subject|1|||
130276183|NCT04532294|468974250|FG000|Overall Study|Participants Not Dosed|0|||
130276184|NCT04532294|468974251|FG001|Overall Study|Participants Not Dosed|0|||
130276185|NCT04532294|468974252|FG002|Overall Study|Participants Not Dosed|2|||
130276186|NCT04295759|468974253|FG000|Overall Study|Lack of Efficacy|9|||
130276187|NCT04295759|468974253|FG000|Overall Study|Death|1|||
130276188|NCT04295759|468974253|FG000|Overall Study|Withdrawal by Subject|2|||
130276189|NCT04295759|468974253|FG000|Overall Study|Deemed ineligible|1|||
130276190|NCT01696981|468974254|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
130276191|NCT01696981|468974255|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
130276192|NCT01696981|468974254|FG000|Overall Study|Died Before Randomization|3|||
130276193|NCT01696981|468974255|FG001|Overall Study|Died Before Randomization|8|||
130276194|NCT01696981|468974254|FG000|Overall Study|Died Before ASU (Control)|278|||
130276195|NCT01696981|468974255|FG001|Overall Study|Died Before ASU (Control)|0|||
130276196|NCT01696981|468974254|FG000|Overall Study|Refused ASU (Control)|920|||
130276197|NCT01696981|468974255|FG001|Overall Study|Refused ASU (Control)|0|||
130276198|NCT01696981|468974254|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
130276199|NCT01696981|468974255|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
130276200|NCT02798315|468974256|FG000|Overall Study|Failure to return|1|||
130276201|NCT03335150|468974258|FG000|Overall Study|Withdrawal by Subject|10|||
130276202|NCT03335150|468974259|FG001|Overall Study|Withdrawal by Subject|4|||
130276203|NCT03335150|468974258|FG000|Overall Study|Adverse Event|0|||
130276204|NCT03335150|468974259|FG001|Overall Study|Adverse Event|1|||
130276205|NCT02097719|468974260|FG000|Overall Study|Subject Withdrew Consent|1|||
130276206|NCT02097719|468974261|FG001|Overall Study|Subject Withdrew Consent|0|||
130276207|NCT02097719|468974260|FG000|Overall Study|Lost to Follow-up|0|||
130276208|NCT02097719|468974261|FG001|Overall Study|Lost to Follow-up|1|||
130276209|NCT02097719|468974260|FG000|Overall Study|Adverse Event|2|||
130276210|NCT02097719|468974261|FG001|Overall Study|Adverse Event|0|||
130276211|NCT04601532|468974262|FG000|Overall Study|Lost to Follow-up|1|||
130276212|NCT04601532|468974263|FG001|Overall Study|Lost to Follow-up|2|||
130276213|NCT04601532|468974262|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
130276214|NCT04601532|468974263|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
130276215|NCT03823287|468974264|FG000|Overall Study|Withdrawal by Subject|25|||
130276216|NCT03823287|468974265|FG001|Overall Study|Withdrawal by Subject|17|||
130276217|NCT03823287|468974264|FG000|Overall Study|Death|13|||
130276218|NCT03823287|468974265|FG001|Overall Study|Death|7|||
130276219|NCT03823287|468974264|FG000|Overall Study|Lost to Follow-up|7|||
130276220|NCT03823287|468974265|FG001|Overall Study|Lost to Follow-up|8|||
130276221|NCT03823287|468974264|FG000|Overall Study|Adverse Event|6|||
130276222|NCT03823287|468974265|FG001|Overall Study|Adverse Event|8|||
130276223|NCT03823287|468974264|FG000|Overall Study|Physician Decision|5|||
130276224|NCT03823287|468974265|FG001|Overall Study|Physician Decision|2|||
130276225|NCT03823287|468974264|FG000|Overall Study|Lack of Efficacy|2|||
130276226|NCT03823287|468974265|FG001|Overall Study|Lack of Efficacy|0|||
130276227|NCT03823287|468974264|FG000|Overall Study|Other|2|||
130276228|NCT03823287|468974265|FG001|Overall Study|Other|4|||
130276229|NCT02744612|468976194|FG000|Overall Study|Withdrawal by Subject|0|||
130276230|NCT02744612|468976195|FG001|Overall Study|Withdrawal by Subject|2|||
130276231|NCT02712983|468976197|FG000|Treatment Phase|Adverse Event|3|||
130276232|NCT02712983|468976198|FG001|Treatment Phase|Adverse Event|1|||
130276233|NCT02712983|468976199|FG002|Treatment Phase|Adverse Event|1|||
130276234|NCT02712983|468976200|FG003|Treatment Phase|Adverse Event|4|||
130276235|NCT02712983|468976201|FG004|Treatment Phase|Adverse Event|3|||
130276236|NCT02712983|468976202|FG005|Treatment Phase|Adverse Event|0|||
130276237|NCT02712983|468976203|FG006|Treatment Phase|Adverse Event|6|||
130276238|NCT02712983|468976204|FG007|Treatment Phase|Adverse Event|6|||
130276239|NCT02712983|468976205|FG008|Treatment Phase|Adverse Event|1|||
130276240|NCT02712983|468976197|FG000|Treatment Phase|Protocol Deviation|0|||
130276241|NCT02712983|468976198|FG001|Treatment Phase|Protocol Deviation|0|||
130276242|NCT02712983|468976199|FG002|Treatment Phase|Protocol Deviation|0|||
130276243|NCT02712983|468976200|FG003|Treatment Phase|Protocol Deviation|2|||
130276244|NCT02712983|468976201|FG004|Treatment Phase|Protocol Deviation|0|||
130276245|NCT02712983|468976202|FG005|Treatment Phase|Protocol Deviation|0|||
130276246|NCT02712983|468976203|FG006|Treatment Phase|Protocol Deviation|1|||
130276247|NCT02712983|468976204|FG007|Treatment Phase|Protocol Deviation|0|||
130276248|NCT02712983|468976205|FG008|Treatment Phase|Protocol Deviation|0|||
130276249|NCT02712983|468976197|FG000|Treatment Phase|Technical Problems|0|||
130276250|NCT02712983|468976198|FG001|Treatment Phase|Technical Problems|0|||
130276251|NCT02712983|468976199|FG002|Treatment Phase|Technical Problems|0|||
130276252|NCT02712983|468976200|FG003|Treatment Phase|Technical Problems|0|||
130276253|NCT02712983|468976201|FG004|Treatment Phase|Technical Problems|0|||
130276254|NCT02712983|468976202|FG005|Treatment Phase|Technical Problems|0|||
130276255|NCT02712983|468976203|FG006|Treatment Phase|Technical Problems|1|||
130276256|NCT02712983|468976204|FG007|Treatment Phase|Technical Problems|0|||
130276257|NCT02712983|468976205|FG008|Treatment Phase|Technical Problems|0|||
130276258|NCT02712983|468976197|FG000|Treatment Phase|Physician Decision|0|||
130276259|NCT02712983|468976198|FG001|Treatment Phase|Physician Decision|0|||
130276260|NCT02712983|468976199|FG002|Treatment Phase|Physician Decision|0|||
130276261|NCT02712983|468976200|FG003|Treatment Phase|Physician Decision|0|||
130276262|NCT02712983|468976201|FG004|Treatment Phase|Physician Decision|0|||
130276263|NCT02712983|468976202|FG005|Treatment Phase|Physician Decision|0|||
130276264|NCT02712983|468976203|FG006|Treatment Phase|Physician Decision|0|||
130276265|NCT02712983|468976204|FG007|Treatment Phase|Physician Decision|1|||
130276266|NCT02712983|468976205|FG008|Treatment Phase|Physician Decision|1|||
130276267|NCT02712983|468976197|FG000|Treatment Phase|Subject Decision|2|||
130276268|NCT02712983|468976198|FG001|Treatment Phase|Subject Decision|0|||
130276269|NCT02712983|468976199|FG002|Treatment Phase|Subject Decision|0|||
130276270|NCT02712983|468976200|FG003|Treatment Phase|Subject Decision|2|||
130276271|NCT02712983|468976201|FG004|Treatment Phase|Subject Decision|1|||
130276272|NCT02712983|468976202|FG005|Treatment Phase|Subject Decision|0|||
130276273|NCT02712983|468976203|FG006|Treatment Phase|Subject Decision|1|||
130276274|NCT02712983|468976204|FG007|Treatment Phase|Subject Decision|2|||
130276275|NCT02712983|468976205|FG008|Treatment Phase|Subject Decision|0|||
130276276|NCT02712983|468976197|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276277|NCT02712983|468976198|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130276278|NCT02712983|468976199|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276279|NCT02712983|468976200|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276280|NCT02712983|468976201|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276281|NCT02712983|468976202|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276282|NCT02712983|468976203|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130276283|NCT02712983|468976204|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
130276284|NCT02712983|468976205|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130276285|NCT02712983|468976197|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276286|NCT02712983|468976198|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276287|NCT02712983|468976199|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276288|NCT02712983|468976200|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
130276289|NCT02712983|468976201|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276290|NCT02712983|468976202|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276291|NCT02712983|468976203|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276292|NCT02712983|468976204|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276293|NCT02712983|468976205|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
130276294|NCT02712983|468976197|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276295|NCT02712983|468976198|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276296|NCT02712983|468976199|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276297|NCT02712983|468976200|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276298|NCT02712983|468976201|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
130276299|NCT02712983|468976202|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
130276300|NCT02712983|468976203|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
130276301|NCT02712983|468976204|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
130276302|NCT02712983|468976205|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
130276303|NCT01945216|468976206|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
130276304|NCT01945216|468976206|FG000|Overall Study|Protocol Violation|42|||
130276305|NCT01945216|468976206|FG000|Overall Study|CRF not assured by investigators|5|||
130276306|NCT05360966|468976210|FG000|Overall Study|Adverse Event|5|||
130276307|NCT05360966|468976211|FG001|Overall Study|Adverse Event|5|||
130276308|NCT05360966|468976210|FG000|Overall Study|Withdrawal of Consent|5|||
130276309|NCT05360966|468976211|FG001|Overall Study|Withdrawal of Consent|3|||
130276310|NCT05360966|468976210|FG000|Overall Study|Noncompliance|2|||
130276311|NCT05360966|468976211|FG001|Overall Study|Noncompliance|1|||
130276312|NCT05360966|468976210|FG000|Overall Study|Lost to Follow-up|2|||
130276313|NCT05360966|468976211|FG001|Overall Study|Lost to Follow-up|3|||
130276314|NCT05360966|468976210|FG000|Overall Study|Protocol Deviation|2|||
130276315|NCT05360966|468976211|FG001|Overall Study|Protocol Deviation|1|||
130276316|NCT05360966|468976210|FG000|Overall Study|As specified in the Clinical Study Report|1|||
130276317|NCT05360966|468976211|FG001|Overall Study|As specified in the Clinical Study Report|3|||
130276318|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
130276319|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276320|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276321|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276322|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276323|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276324|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276325|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276326|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276327|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276328|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276329|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276330|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276331|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
130276332|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276333|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276334|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276335|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276336|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276337|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276338|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276339|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276340|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276341|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276342|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276343|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276344|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
130276345|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276346|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276347|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276348|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276349|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276350|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276351|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276352|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276353|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276354|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276355|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276356|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276357|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
130276358|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276359|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276360|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
130276361|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
130276362|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276363|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276364|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276365|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276366|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276367|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276368|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276369|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276370|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276371|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276372|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276373|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276374|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
130276375|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276376|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276377|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276378|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276379|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130105713|NCT01586624|468347993|FG006|Overall Study|Withdrawal by Subject|0|||
130105714|NCT01586624|468347994|FG007|Overall Study|Withdrawal by Subject|0|||
130105715|NCT01586624|468347987|FG000|Overall Study|Evidence of disease progression|1|||
130105716|NCT01586624|468347988|FG001|Overall Study|Evidence of disease progression|3|||
130105717|NCT01586624|468347989|FG002|Overall Study|Evidence of disease progression|2|||
130105718|NCT01586624|468347990|FG003|Overall Study|Evidence of disease progression|5|||
130105719|NCT01586624|468347991|FG004|Overall Study|Evidence of disease progression|3|||
130105720|NCT01586624|468347992|FG005|Overall Study|Evidence of disease progression|5|||
130105721|NCT01586624|468347993|FG006|Overall Study|Evidence of disease progression|4|||
130105722|NCT01586624|468347994|FG007|Overall Study|Evidence of disease progression|6|||
130105723|NCT01586624|468347987|FG000|Overall Study|Screen failure (no treatment received)|0|||
130105724|NCT01586624|468347988|FG001|Overall Study|Screen failure (no treatment received)|0|||
130105725|NCT01586624|468347989|FG002|Overall Study|Screen failure (no treatment received)|0|||
130105726|NCT01586624|468347990|FG003|Overall Study|Screen failure (no treatment received)|0|||
130105727|NCT01586624|468347991|FG004|Overall Study|Screen failure (no treatment received)|0|||
130105728|NCT01586624|468347992|FG005|Overall Study|Screen failure (no treatment received)|0|||
130105729|NCT01586624|468347993|FG006|Overall Study|Screen failure (no treatment received)|1|||
130276380|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276381|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276382|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276383|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276384|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276385|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276386|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276387|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
130276388|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276389|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276390|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276391|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276392|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276393|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276394|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276395|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276396|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276397|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276398|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276399|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129886962|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
129886963|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
130276400|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
130276401|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130041618|NCT02413255|468110577|FG012|Overall Study|Voluntary Withdrawal|0|||
130041619|NCT02413255|468110578|FG013|Overall Study|Voluntary Withdrawal|0|||
130041620|NCT02413255|468110579|FG014|Overall Study|Voluntary Withdrawal|1|||
130041621|NCT02413255|468110580|FG015|Overall Study|Voluntary Withdrawal|0|||
130041622|NCT02413255|468110581|FG016|Overall Study|Voluntary Withdrawal|0|||
130041623|NCT03199911|468110582|FG000|Overall Study|Lost to Follow-up|5|||
130041624|NCT03199911|468110583|FG001|Overall Study|Lost to Follow-up|5|||
130041625|NCT03199911|468110582|FG000|Overall Study|Did not proceed with surgery|2|||
130041626|NCT03199911|468110583|FG001|Overall Study|Did not proceed with surgery|1|||
130041627|NCT01009463|468110584|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
130041628|NCT01009463|468110585|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130041629|NCT01009463|468110586|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130041630|NCT01009463|468110587|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130041631|NCT01009463|468110588|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
130041632|NCT01009463|468110584|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
130041633|NCT01009463|468110585|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
130041634|NCT01009463|468110586|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
130041635|NCT01009463|468110587|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
130041636|NCT01009463|468110588|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
130041637|NCT01009463|468110584|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
130041638|NCT01009463|468110585|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130041639|NCT01009463|468110586|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130041640|NCT01009463|468110587|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130041641|NCT01009463|468110588|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
130041642|NCT01009463|468110584|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
130041643|NCT01009463|468110585|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
130041644|NCT01009463|468110586|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
130041645|NCT01009463|468110587|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
130041646|NCT01009463|468110588|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
130041647|NCT01009463|468110584|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
130041648|NCT01009463|468110585|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130041649|NCT01009463|468110586|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130041650|NCT01009463|468110587|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130041651|NCT01009463|468110588|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
130041652|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
130041653|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
130041654|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
130041655|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
130041656|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
130041657|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130041658|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
130041659|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
129886964|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
129886965|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130276402|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276403|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
130276404|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130276405|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276406|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276407|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276408|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276409|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276410|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276411|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276412|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276413|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276414|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276415|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276416|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276417|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130276418|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276419|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276420|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276421|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276422|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276423|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276424|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276425|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276426|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276427|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276428|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276429|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276430|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
130276431|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276432|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276433|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276434|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276435|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276436|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276437|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276438|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276439|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276440|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276441|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276442|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276443|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
130276444|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276445|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276446|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
130276447|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276448|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276449|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276450|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276451|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276452|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276453|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276454|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276455|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276456|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276457|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276458|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130041660|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
130276459|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276460|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276461|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276462|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276463|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276464|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276465|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276466|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276467|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276468|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276469|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276470|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276471|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276472|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276473|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
130276474|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276475|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276476|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276477|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276478|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276479|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276480|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276481|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276482|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276483|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276484|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276485|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276486|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
130276487|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276488|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276489|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
130276490|NCT05396014|468976212|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276491|NCT05396014|468976213|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276492|NCT05396014|468976214|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276493|NCT05396014|468976215|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276494|NCT05396014|468976216|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276495|NCT05396014|468976217|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276496|NCT05396014|468976218|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276497|NCT05396014|468976219|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276498|NCT05396014|468976220|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276499|NCT05396014|468976221|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276500|NCT05396014|468976222|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276501|NCT05396014|468976223|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276502|NCT05396014|468976224|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276503|NCT05396014|468976225|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276504|NCT05396014|468976226|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276505|NCT05396014|468976227|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276506|NCT05396014|468976228|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276507|NCT05396014|468976229|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276508|NCT05396014|468976230|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276509|NCT05396014|468976231|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276510|NCT05396014|468976232|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276511|NCT05396014|468976233|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276512|NCT05396014|468976234|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276513|NCT05396014|468976235|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276514|NCT05396014|468976236|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276515|NCT05396014|468976237|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276516|NCT05396014|468976238|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
130276517|NCT05396014|468976239|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276518|NCT05396014|468976240|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276519|NCT05396014|468976241|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276520|NCT05396014|468976242|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276521|NCT05396014|468976243|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276522|NCT05396014|468976244|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276523|NCT05396014|468976245|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276524|NCT05396014|468976246|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276525|NCT05396014|468976247|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276526|NCT05396014|468976248|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276527|NCT05396014|468976249|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276528|NCT05396014|468976250|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276529|NCT05396014|468976251|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276530|NCT05396014|468976252|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276531|NCT05396014|468976253|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276532|NCT05396014|468976254|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
130276533|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276534|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276535|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276536|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276537|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276538|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276539|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276540|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276541|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276542|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276543|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276544|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276545|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276546|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
130276547|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276548|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276549|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276550|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276551|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276552|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276553|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276554|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276555|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276556|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276557|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276558|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276559|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276560|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276561|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276562|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276563|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276564|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276565|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276566|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276567|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276568|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276569|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276570|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276571|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276572|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276573|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276574|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276575|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
130276576|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
130276577|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276578|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276579|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276580|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276581|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276582|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276583|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276584|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276585|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276586|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276587|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276588|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276589|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
130276590|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276591|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276592|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276593|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276594|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276595|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276596|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130105730|NCT01586624|468347994|FG007|Overall Study|Screen failure (no treatment received)|0|||
130105731|NCT02016755|468347995|FG000|Overall Study|Major amputation of index limb|2|||
130105732|NCT02016755|468347995|FG000|Overall Study|Adverse Event|2|||
130276597|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276598|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276599|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276600|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276601|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276602|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276603|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276604|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276605|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276606|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276607|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276608|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276609|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276610|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276611|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276612|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276613|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276614|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276615|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
130276616|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276617|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276618|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
130276619|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
130276620|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276621|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276622|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276623|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276624|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276625|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276626|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276627|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276628|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276629|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276630|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276631|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276632|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276633|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276634|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276635|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276636|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276637|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276638|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276639|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276640|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276641|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276642|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276643|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130105733|NCT02016755|468347995|FG000|Overall Study|Physician Decision|1|||
130276644|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276645|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
130276646|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276647|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276648|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276649|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276650|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276651|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276652|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276653|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276654|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276655|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276656|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276657|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276658|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276659|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276660|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276661|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
130276662|NCT05396014|468976212|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276663|NCT05396014|468976213|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276664|NCT05396014|468976214|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276665|NCT05396014|468976215|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276666|NCT05396014|468976216|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276667|NCT05396014|468976217|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276668|NCT05396014|468976218|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276669|NCT05396014|468976219|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276670|NCT05396014|468976220|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276671|NCT05396014|468976221|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276672|NCT05396014|468976222|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276673|NCT05396014|468976223|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276674|NCT05396014|468976224|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276675|NCT05396014|468976225|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
130276676|NCT05396014|468976226|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276677|NCT05396014|468976227|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276678|NCT05396014|468976228|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276679|NCT05396014|468976229|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276680|NCT05396014|468976230|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276681|NCT05396014|468976231|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276682|NCT05396014|468976232|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276683|NCT05396014|468976233|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276684|NCT05396014|468976234|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276685|NCT05396014|468976235|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276686|NCT05396014|468976236|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276687|NCT05396014|468976237|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276688|NCT05396014|468976238|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276689|NCT05396014|468976239|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276690|NCT05396014|468976240|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276691|NCT05396014|468976241|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276692|NCT05396014|468976242|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276693|NCT05396014|468976243|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276694|NCT05396014|468976244|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276695|NCT05396014|468976245|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276696|NCT05396014|468976246|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276697|NCT05396014|468976247|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276698|NCT05396014|468976248|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276699|NCT05396014|468976249|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276700|NCT05396014|468976250|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276701|NCT05396014|468976251|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276702|NCT05396014|468976252|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276703|NCT05396014|468976253|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276704|NCT05396014|468976254|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
130276705|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276706|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276707|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276708|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276709|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276710|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276711|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276712|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276713|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276714|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276715|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276716|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276717|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276718|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276719|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276720|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276721|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276722|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276723|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276724|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276725|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276726|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276727|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276728|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276729|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276730|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276731|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276732|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276733|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276734|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276735|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276736|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276737|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276738|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276739|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276740|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276741|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276742|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276743|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276744|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
130276745|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
130276746|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
130276747|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
130276748|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276749|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276750|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276751|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276752|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276753|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276754|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276755|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276756|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130276757|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276758|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276759|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276760|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276761|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276762|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276763|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276764|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276765|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276766|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276767|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276768|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276769|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276770|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130276771|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276772|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276773|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276774|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276775|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276776|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276777|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276778|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276779|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276780|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276781|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276782|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276783|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
130276784|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276785|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276786|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276787|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
130276788|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276789|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
130276790|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
130276791|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276792|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276793|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276794|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276795|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276796|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276797|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276798|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276799|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276800|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276801|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276802|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276803|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276804|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276805|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276806|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276807|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276808|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276809|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276810|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276811|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276812|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276813|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276814|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276815|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276816|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276817|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276818|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276819|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276820|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276821|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276822|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276823|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276824|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276825|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276826|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276827|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276828|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276829|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276830|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276831|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276832|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
130276833|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
130276834|NCT05396014|468976212|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276835|NCT05396014|468976213|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276836|NCT05396014|468976214|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276837|NCT05396014|468976215|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276838|NCT05396014|468976216|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276839|NCT05396014|468976217|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276840|NCT05396014|468976218|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276841|NCT05396014|468976219|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276842|NCT05396014|468976220|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276843|NCT05396014|468976221|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276844|NCT05396014|468976222|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276845|NCT05396014|468976223|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276846|NCT05396014|468976224|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276847|NCT05396014|468976225|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276848|NCT05396014|468976226|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276849|NCT05396014|468976227|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276850|NCT05396014|468976228|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276851|NCT05396014|468976229|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276852|NCT05396014|468976230|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276853|NCT05396014|468976231|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276854|NCT05396014|468976232|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276855|NCT05396014|468976233|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276856|NCT05396014|468976234|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276857|NCT05396014|468976235|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276858|NCT05396014|468976236|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276859|NCT05396014|468976237|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276860|NCT05396014|468976238|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
130276861|NCT05396014|468976239|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276862|NCT05396014|468976240|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276863|NCT05396014|468976241|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276864|NCT05396014|468976242|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276865|NCT05396014|468976243|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276866|NCT05396014|468976244|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276867|NCT05396014|468976245|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276868|NCT05396014|468976246|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276869|NCT05396014|468976247|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276870|NCT05396014|468976248|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276871|NCT05396014|468976249|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276872|NCT05396014|468976250|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276873|NCT05396014|468976251|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276874|NCT05396014|468976252|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276875|NCT05396014|468976253|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276876|NCT05396014|468976254|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
130276877|NCT03062280|468976255|FG000|Overall Study|Adverse Event|1|||
130276878|NCT03062280|468976255|FG000|Overall Study|Death|1|||
130276879|NCT03062280|468976255|FG000|Overall Study|Fertility Treatment|2|||
130276880|NCT03062280|468976255|FG000|Overall Study|Physician Decision|2|||
130276881|NCT03062280|468976255|FG000|Overall Study|Pregnancy|5|||
130276882|NCT03062280|468976255|FG000|Overall Study|Withdrawal by Subject|11|||
130041661|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
130276883|NCT04299308|468976256|FG000|Overall Study|Withdrawal by Subject|1|||
130276884|NCT04299308|468976257|FG001|Overall Study|Withdrawal by Subject|0|||
130276885|NCT04299308|468976256|FG000|Overall Study|issue with PET image (1)|1|||
130276886|NCT04299308|468976257|FG001|Overall Study|issue with PET image (1)|0|||
130276887|NCT05258890|468976258|FG000|Overall Study|Patient withdrawal|6|||
130276888|NCT05258890|468976259|FG001|Overall Study|Patient withdrawal|7|||
130276889|NCT05258890|468976258|FG000|Overall Study|Patient lost to follow-up|10|||
130276890|NCT05258890|468976259|FG001|Overall Study|Patient lost to follow-up|3|||
130276891|NCT05258890|468976258|FG000|Overall Study|Social network member withdrawal|1|||
130276892|NCT05258890|468976259|FG001|Overall Study|Social network member withdrawal|0|||
130276893|NCT05258890|468976258|FG000|Overall Study|Social network member lost to follow-up|5|||
130276894|NCT05258890|468976259|FG001|Overall Study|Social network member lost to follow-up|0|||
130276895|NCT04493424|468976260|FG000|Overall Study|Termination of the trial by the sponsor|89|||
130276896|NCT04493424|468976260|FG000|Overall Study|Withdrawal by Subject|9|||
130276897|NCT04493424|468976260|FG000|Overall Study|Lost to Follow-up|2|||
130276898|NCT04493424|468976260|FG000|Overall Study|Lack of Efficacy|3|||
130276899|NCT04493424|468976260|FG000|Overall Study|Adverse Event|5|||
130276900|NCT00516893|468976263|FG000|Overall Study|Lost to Follow-up|4|||
130276901|NCT00516893|468976263|FG000|Overall Study|Adverse Event|3|||
130276902|NCT00516893|468976263|FG000|Overall Study|Withdrawal by Subject|2|||
130276903|NCT00516893|468976263|FG000|Overall Study|Noncompliance|2|||
130276904|NCT00516893|468976263|FG000|Overall Study|Death|1|||
130276905|NCT00516893|468976263|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
130276906|NCT00516893|468976263|FG000|Overall Study|Relocated|1|||
130276907|NCT00516893|468976263|FG000|Overall Study|Pregnancy|1|||
130276908|NCT00516893|468976263|FG000|Overall Study|Received Medication From Another Study|1|||
130276909|NCT05935878|468976269|FG000|Overall Study|Death|1|||
130276910|NCT05935878|468976270|FG001|Overall Study|Death|2|||
130276911|NCT05935878|468976269|FG000|Overall Study|Withdrawal by Subject|5|||
130276912|NCT05935878|468976270|FG001|Overall Study|Withdrawal by Subject|5|||
130276913|NCT05935878|468976269|FG000|Overall Study|Revision of implant|1|||
130276914|NCT05935878|468976270|FG001|Overall Study|Revision of implant|1|||
130276915|NCT05935878|468976269|FG000|Overall Study|Mobile bearing dislocation|0|||
130276916|NCT05935878|468976270|FG001|Overall Study|Mobile bearing dislocation|1|||
130276917|NCT05924165|468976271|FG000|Overall Study|Physician Decision|2|||
130276918|NCT05924165|468976272|FG001|Overall Study|Physician Decision|3|||
130276919|NCT05959447|468976273|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
130276920|NCT05959447|468976274|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
130276921|NCT05959447|468976273|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
130276922|NCT05959447|468976274|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
130276923|NCT05959447|468976273|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
130276924|NCT05959447|468976274|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
130276925|NCT05959447|468976273|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
130276926|NCT05959447|468976274|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
130276927|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Adverse Event|1|||
130276928|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Adverse Event|0|||
130276929|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
130276930|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
130276931|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
130276932|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
130276933|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
130276934|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
130276935|NCT00301262|468976275|FG000|Double Blind Phase (DB)|Other|1|||
130276936|NCT00301262|468976276|FG001|Double Blind Phase (DB)|Other|4|||
130276937|NCT00301262|468976275|FG000|Open Label Phase (OL)|Adverse Event|1|||
130276938|NCT00301262|468976276|FG001|Open Label Phase (OL)|Adverse Event|0|||
130276939|NCT00301262|468976275|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
130276940|NCT00301262|468976276|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
130276941|NCT00301262|468976275|FG000|Open Label Phase (OL)|Other|2|||
130276942|NCT00301262|468976276|FG001|Open Label Phase (OL)|Other|0|||
130276943|NCT00368745|468976277|FG000|Double-blind Treatment Period|Adverse Event|6|||
130276944|NCT00368745|468976278|FG001|Double-blind Treatment Period|Adverse Event|6|||
130276945|NCT00368745|468976277|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
130276946|NCT00368745|468976278|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
130105734|NCT02016755|468347995|FG000|Overall Study|Death|2|||
130276947|NCT00368745|468976277|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130276948|NCT00368745|468976278|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130276949|NCT00368745|468976277|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
130276950|NCT00368745|468976278|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
130276951|NCT00368745|468976277|FG000|Double-blind Treatment Period|Other|7|||
130276952|NCT00368745|468976278|FG001|Double-blind Treatment Period|Other|6|||
130276953|NCT01436656|468976279|FG000|Dose Escalation|Death|1|||
130276954|NCT01436656|468976280|FG001|Dose Escalation|Death|3|||
130276955|NCT01436656|468976281|FG002|Dose Escalation|Death|1|||
130276956|NCT01436656|468976282|FG003|Dose Escalation|Death|0|||
130276957|NCT01436656|468976283|FG004|Dose Escalation|Death|2|||
130276958|NCT01436656|468976284|FG005|Dose Escalation|Death|1|||
130276959|NCT01436656|468976285|FG006|Dose Escalation|Death|1|||
130276960|NCT01436656|468976286|FG007|Dose Escalation|Death|1|||
130276961|NCT01436656|468976287|FG008|Dose Escalation|Death|1|||
130276962|NCT01436656|468976288|FG009|Dose Escalation|Death|0|||
130276963|NCT01436656|468976289|FG010|Dose Escalation|Death|0|||
130276964|NCT01436656|468976290|FG011|Dose Escalation|Death|0|||
130276965|NCT01436656|468976291|FG012|Dose Escalation|Death|0|||
130276966|NCT01436656|468976292|FG013|Dose Escalation|Death|0|||
130276967|NCT01436656|468976293|FG014|Dose Escalation|Death|0|||
130276968|NCT01436656|468976294|FG015|Dose Escalation|Death|0|||
130276969|NCT01436656|468976295|FG016|Dose Escalation|Death|0|||
130276970|NCT01436656|468976296|FG017|Dose Escalation|Death|0|||
130276971|NCT01436656|468976279|FG000|Dose Escalation|Protocol Violation|0|||
130276972|NCT01436656|468976280|FG001|Dose Escalation|Protocol Violation|0|||
130276973|NCT01436656|468976281|FG002|Dose Escalation|Protocol Violation|0|||
130276974|NCT01436656|468976282|FG003|Dose Escalation|Protocol Violation|0|||
130276975|NCT01436656|468976283|FG004|Dose Escalation|Protocol Violation|0|||
130276976|NCT01436656|468976284|FG005|Dose Escalation|Protocol Violation|1|||
130276977|NCT01436656|468976285|FG006|Dose Escalation|Protocol Violation|0|||
130276978|NCT01436656|468976286|FG007|Dose Escalation|Protocol Violation|0|||
130276979|NCT01436656|468976287|FG008|Dose Escalation|Protocol Violation|0|||
130276980|NCT01436656|468976288|FG009|Dose Escalation|Protocol Violation|0|||
130276981|NCT01436656|468976289|FG010|Dose Escalation|Protocol Violation|0|||
130276982|NCT01436656|468976290|FG011|Dose Escalation|Protocol Violation|0|||
130276983|NCT01436656|468976291|FG012|Dose Escalation|Protocol Violation|0|||
130276984|NCT01436656|468976292|FG013|Dose Escalation|Protocol Violation|0|||
130276985|NCT01436656|468976293|FG014|Dose Escalation|Protocol Violation|0|||
130276986|NCT01436656|468976294|FG015|Dose Escalation|Protocol Violation|0|||
130276987|NCT01436656|468976295|FG016|Dose Escalation|Protocol Violation|0|||
130276988|NCT01436656|468976296|FG017|Dose Escalation|Protocol Violation|0|||
130276989|NCT01436656|468976279|FG000|Dose Escalation|Withdrawal by Subject|0|||
130276990|NCT01436656|468976280|FG001|Dose Escalation|Withdrawal by Subject|0|||
130276991|NCT01436656|468976281|FG002|Dose Escalation|Withdrawal by Subject|0|||
130276992|NCT01436656|468976282|FG003|Dose Escalation|Withdrawal by Subject|0|||
130276993|NCT01436656|468976283|FG004|Dose Escalation|Withdrawal by Subject|1|||
130276994|NCT01436656|468976284|FG005|Dose Escalation|Withdrawal by Subject|0|||
130276995|NCT01436656|468976285|FG006|Dose Escalation|Withdrawal by Subject|0|||
130276996|NCT01436656|468976286|FG007|Dose Escalation|Withdrawal by Subject|2|||
130276997|NCT01436656|468976287|FG008|Dose Escalation|Withdrawal by Subject|0|||
130276998|NCT01436656|468976288|FG009|Dose Escalation|Withdrawal by Subject|1|||
130276999|NCT01436656|468976289|FG010|Dose Escalation|Withdrawal by Subject|1|||
130277000|NCT01436656|468976290|FG011|Dose Escalation|Withdrawal by Subject|0|||
130277001|NCT01436656|468976291|FG012|Dose Escalation|Withdrawal by Subject|0|||
130277002|NCT01436656|468976292|FG013|Dose Escalation|Withdrawal by Subject|0|||
130277003|NCT01436656|468976293|FG014|Dose Escalation|Withdrawal by Subject|0|||
130277004|NCT01436656|468976294|FG015|Dose Escalation|Withdrawal by Subject|0|||
130277005|NCT01436656|468976295|FG016|Dose Escalation|Withdrawal by Subject|0|||
130277006|NCT01436656|468976296|FG017|Dose Escalation|Withdrawal by Subject|0|||
130277007|NCT01436656|468976279|FG000|Dose Escalation|Administrative problems|0|||
130277008|NCT01436656|468976280|FG001|Dose Escalation|Administrative problems|1|||
130277009|NCT01436656|468976281|FG002|Dose Escalation|Administrative problems|0|||
130277010|NCT01436656|468976282|FG003|Dose Escalation|Administrative problems|0|||
130277011|NCT01436656|468976283|FG004|Dose Escalation|Administrative problems|0|||
130105735|NCT00306852|468348003|FG000|Overall Study|Death|14|||
130105736|NCT00306852|468348004|FG001|Overall Study|Death|14|||
130105737|NCT00306852|468348003|FG000|Overall Study|Lost to Follow-up|15|||
130105738|NCT00306852|468348004|FG001|Overall Study|Lost to Follow-up|24|||
130105739|NCT00883740|468348005|FG000|First Intervention|Lost to Follow-up|1|||
130105740|NCT00883740|468348006|FG001|First Intervention|Lost to Follow-up|0|||
130105741|NCT00883740|468348005|FG000|First Intervention|No longer willing to participate|2|||
130105742|NCT00883740|468348006|FG001|First Intervention|No longer willing to participate|0|||
130105743|NCT00883740|468348005|FG000|First Intervention|Protocol Violation|3|||
130105744|NCT00883740|468348006|FG001|First Intervention|Protocol Violation|6|||
130105745|NCT00883740|468348005|FG000|First Intervention|Adverse Event|1|||
130105746|NCT00883740|468348006|FG001|First Intervention|Adverse Event|2|||
130105747|NCT00883740|468348005|FG000|Second Intervention|Protocol Violation|1|||
130105748|NCT00883740|468348006|FG001|Second Intervention|Protocol Violation|0|||
130105749|NCT00883740|468348005|FG000|Second Intervention|No longer willing to participate|0|||
130105750|NCT00883740|468348006|FG001|Second Intervention|No longer willing to participate|1|||
130105751|NCT03869684|468348009|FG000|Overall Study|Adverse Event|0|||
130105752|NCT03869684|468348010|FG001|Overall Study|Adverse Event|3|||
130105753|NCT03869684|468348011|FG002|Overall Study|Adverse Event|1|||
130105754|NCT03869684|468348009|FG000|Overall Study|Withdrawal by Subject|1|||
130105755|NCT03869684|468348010|FG001|Overall Study|Withdrawal by Subject|0|||
130277012|NCT01436656|468976284|FG005|Dose Escalation|Administrative problems|0|||
130277013|NCT01436656|468976285|FG006|Dose Escalation|Administrative problems|0|||
130277014|NCT01436656|468976286|FG007|Dose Escalation|Administrative problems|0|||
130277015|NCT01436656|468976287|FG008|Dose Escalation|Administrative problems|0|||
130277016|NCT01436656|468976288|FG009|Dose Escalation|Administrative problems|0|||
130277017|NCT01436656|468976289|FG010|Dose Escalation|Administrative problems|0|||
130277018|NCT01436656|468976290|FG011|Dose Escalation|Administrative problems|0|||
130277019|NCT01436656|468976291|FG012|Dose Escalation|Administrative problems|0|||
130277020|NCT01436656|468976292|FG013|Dose Escalation|Administrative problems|0|||
130277021|NCT01436656|468976293|FG014|Dose Escalation|Administrative problems|0|||
130277022|NCT01436656|468976294|FG015|Dose Escalation|Administrative problems|0|||
130277023|NCT01436656|468976295|FG016|Dose Escalation|Administrative problems|0|||
130277024|NCT01436656|468976296|FG017|Dose Escalation|Administrative problems|0|||
130277025|NCT01436656|468976279|FG000|Dose Escalation|Lost to Follow-up|1|||
130277026|NCT01436656|468976280|FG001|Dose Escalation|Lost to Follow-up|0|||
130277027|NCT01436656|468976281|FG002|Dose Escalation|Lost to Follow-up|0|||
130277028|NCT01436656|468976282|FG003|Dose Escalation|Lost to Follow-up|0|||
130277029|NCT01436656|468976283|FG004|Dose Escalation|Lost to Follow-up|1|||
130277030|NCT01436656|468976284|FG005|Dose Escalation|Lost to Follow-up|0|||
130277031|NCT01436656|468976285|FG006|Dose Escalation|Lost to Follow-up|0|||
130277032|NCT01436656|468976286|FG007|Dose Escalation|Lost to Follow-up|0|||
130277033|NCT01436656|468976287|FG008|Dose Escalation|Lost to Follow-up|0|||
130277034|NCT01436656|468976288|FG009|Dose Escalation|Lost to Follow-up|0|||
130277035|NCT01436656|468976289|FG010|Dose Escalation|Lost to Follow-up|0|||
130277036|NCT01436656|468976290|FG011|Dose Escalation|Lost to Follow-up|0|||
130277037|NCT01436656|468976291|FG012|Dose Escalation|Lost to Follow-up|0|||
130277038|NCT01436656|468976292|FG013|Dose Escalation|Lost to Follow-up|0|||
130277039|NCT01436656|468976293|FG014|Dose Escalation|Lost to Follow-up|0|||
130277040|NCT01436656|468976294|FG015|Dose Escalation|Lost to Follow-up|0|||
130277041|NCT01436656|468976295|FG016|Dose Escalation|Lost to Follow-up|0|||
130277042|NCT01436656|468976296|FG017|Dose Escalation|Lost to Follow-up|0|||
130277043|NCT01436656|468976279|FG000|Dose Escalation|New anti-cancer therapy|1|||
130277044|NCT01436656|468976280|FG001|Dose Escalation|New anti-cancer therapy|0|||
130277045|NCT01436656|468976281|FG002|Dose Escalation|New anti-cancer therapy|0|||
130277046|NCT01436656|468976282|FG003|Dose Escalation|New anti-cancer therapy|0|||
130277047|NCT01436656|468976283|FG004|Dose Escalation|New anti-cancer therapy|0|||
130277048|NCT01436656|468976284|FG005|Dose Escalation|New anti-cancer therapy|0|||
130277049|NCT01436656|468976285|FG006|Dose Escalation|New anti-cancer therapy|0|||
130105756|NCT03869684|468348011|FG002|Overall Study|Withdrawal by Subject|0|||
130105757|NCT03869684|468348009|FG000|Overall Study|Lost to Follow-up|1|||
130105758|NCT03869684|468348010|FG001|Overall Study|Lost to Follow-up|0|||
130277050|NCT01436656|468976286|FG007|Dose Escalation|New anti-cancer therapy|0|||
130277051|NCT01436656|468976287|FG008|Dose Escalation|New anti-cancer therapy|1|||
130277052|NCT01436656|468976288|FG009|Dose Escalation|New anti-cancer therapy|1|||
130277053|NCT01436656|468976289|FG010|Dose Escalation|New anti-cancer therapy|0|||
130105759|NCT03869684|468348011|FG002|Overall Study|Lost to Follow-up|0|||
130277054|NCT01436656|468976290|FG011|Dose Escalation|New anti-cancer therapy|0|||
130277055|NCT01436656|468976291|FG012|Dose Escalation|New anti-cancer therapy|0|||
130105760|NCT03869684|468348009|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
130105761|NCT03869684|468348010|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
130277056|NCT01436656|468976292|FG013|Dose Escalation|New anti-cancer therapy|0|||
130277057|NCT01436656|468976293|FG014|Dose Escalation|New anti-cancer therapy|0|||
130277058|NCT01436656|468976294|FG015|Dose Escalation|New anti-cancer therapy|0|||
130277059|NCT01436656|468976295|FG016|Dose Escalation|New anti-cancer therapy|0|||
130277060|NCT01436656|468976296|FG017|Dose Escalation|New anti-cancer therapy|0|||
130277061|NCT01436656|468976279|FG000|Dose Expansion|Adverse Event|0|||
130277062|NCT01436656|468976280|FG001|Dose Expansion|Adverse Event|0|||
130277063|NCT01436656|468976281|FG002|Dose Expansion|Adverse Event|0|||
130277064|NCT01436656|468976282|FG003|Dose Expansion|Adverse Event|0|||
130277065|NCT01436656|468976283|FG004|Dose Expansion|Adverse Event|0|||
130277066|NCT01436656|468976284|FG005|Dose Expansion|Adverse Event|0|||
130277067|NCT01436656|468976285|FG006|Dose Expansion|Adverse Event|0|||
130277068|NCT01436656|468976286|FG007|Dose Expansion|Adverse Event|0|||
130277069|NCT01436656|468976287|FG008|Dose Expansion|Adverse Event|0|||
130277070|NCT01436656|468976288|FG009|Dose Expansion|Adverse Event|0|||
130277071|NCT01436656|468976289|FG010|Dose Expansion|Adverse Event|0|||
130277072|NCT01436656|468976290|FG011|Dose Expansion|Adverse Event|1|||
130277073|NCT01436656|468976291|FG012|Dose Expansion|Adverse Event|0|||
130277074|NCT01436656|468976292|FG013|Dose Expansion|Adverse Event|0|||
130277075|NCT01436656|468976293|FG014|Dose Expansion|Adverse Event|0|||
130277076|NCT01436656|468976294|FG015|Dose Expansion|Adverse Event|0|||
130277077|NCT01436656|468976295|FG016|Dose Expansion|Adverse Event|0|||
130277078|NCT01436656|468976296|FG017|Dose Expansion|Adverse Event|0|||
130277079|NCT01436656|468976279|FG000|Dose Expansion|Withdrawal by Subject|0|||
130277080|NCT01436656|468976280|FG001|Dose Expansion|Withdrawal by Subject|0|||
130277081|NCT01436656|468976281|FG002|Dose Expansion|Withdrawal by Subject|0|||
130277082|NCT01436656|468976282|FG003|Dose Expansion|Withdrawal by Subject|0|||
130277083|NCT01436656|468976283|FG004|Dose Expansion|Withdrawal by Subject|0|||
130277084|NCT01436656|468976284|FG005|Dose Expansion|Withdrawal by Subject|0|||
130277085|NCT01436656|468976285|FG006|Dose Expansion|Withdrawal by Subject|0|||
130277086|NCT01436656|468976286|FG007|Dose Expansion|Withdrawal by Subject|0|||
130277087|NCT01436656|468976287|FG008|Dose Expansion|Withdrawal by Subject|0|||
130277088|NCT01436656|468976288|FG009|Dose Expansion|Withdrawal by Subject|0|||
130277089|NCT01436656|468976289|FG010|Dose Expansion|Withdrawal by Subject|0|||
130277090|NCT01436656|468976290|FG011|Dose Expansion|Withdrawal by Subject|1|||
130277091|NCT01436656|468976291|FG012|Dose Expansion|Withdrawal by Subject|3|||
130277092|NCT01436656|468976292|FG013|Dose Expansion|Withdrawal by Subject|1|||
130277093|NCT01436656|468976293|FG014|Dose Expansion|Withdrawal by Subject|2|||
130277094|NCT01436656|468976294|FG015|Dose Expansion|Withdrawal by Subject|0|||
130277095|NCT01436656|468976295|FG016|Dose Expansion|Withdrawal by Subject|1|||
130277096|NCT01436656|468976296|FG017|Dose Expansion|Withdrawal by Subject|1|||
130277097|NCT01436656|468976279|FG000|Dose Expansion|Death|0|||
130277098|NCT01436656|468976280|FG001|Dose Expansion|Death|0|||
130277099|NCT01436656|468976281|FG002|Dose Expansion|Death|0|||
130277100|NCT01436656|468976282|FG003|Dose Expansion|Death|0|||
130277101|NCT01436656|468976283|FG004|Dose Expansion|Death|0|||
130277102|NCT01436656|468976284|FG005|Dose Expansion|Death|0|||
130277103|NCT01436656|468976285|FG006|Dose Expansion|Death|0|||
130277104|NCT01436656|468976286|FG007|Dose Expansion|Death|0|||
130277105|NCT01436656|468976287|FG008|Dose Expansion|Death|0|||
130277106|NCT01436656|468976288|FG009|Dose Expansion|Death|0|||
130277107|NCT01436656|468976289|FG010|Dose Expansion|Death|0|||
130277108|NCT01436656|468976290|FG011|Dose Expansion|Death|0|||
130277109|NCT01436656|468976291|FG012|Dose Expansion|Death|1|||
130277110|NCT01436656|468976292|FG013|Dose Expansion|Death|0|||
130277111|NCT01436656|468976293|FG014|Dose Expansion|Death|3|||
130277112|NCT01436656|468976294|FG015|Dose Expansion|Death|0|||
130277113|NCT01436656|468976295|FG016|Dose Expansion|Death|3|||
130277114|NCT01436656|468976296|FG017|Dose Expansion|Death|3|||
130277115|NCT01436656|468976279|FG000|Dose Expansion|Lost to Follow-up|0|||
130277116|NCT01436656|468976280|FG001|Dose Expansion|Lost to Follow-up|0|||
130277117|NCT01436656|468976281|FG002|Dose Expansion|Lost to Follow-up|0|||
130277118|NCT01436656|468976282|FG003|Dose Expansion|Lost to Follow-up|0|||
130277119|NCT01436656|468976283|FG004|Dose Expansion|Lost to Follow-up|0|||
130277120|NCT01436656|468976284|FG005|Dose Expansion|Lost to Follow-up|0|||
130277121|NCT01436656|468976285|FG006|Dose Expansion|Lost to Follow-up|0|||
130277122|NCT01436656|468976286|FG007|Dose Expansion|Lost to Follow-up|0|||
130277123|NCT01436656|468976287|FG008|Dose Expansion|Lost to Follow-up|0|||
130277124|NCT01436656|468976288|FG009|Dose Expansion|Lost to Follow-up|0|||
130277125|NCT01436656|468976289|FG010|Dose Expansion|Lost to Follow-up|0|||
130277126|NCT01436656|468976290|FG011|Dose Expansion|Lost to Follow-up|0|||
130277127|NCT01436656|468976291|FG012|Dose Expansion|Lost to Follow-up|0|||
130277128|NCT01436656|468976292|FG013|Dose Expansion|Lost to Follow-up|0|||
130277129|NCT01436656|468976293|FG014|Dose Expansion|Lost to Follow-up|0|||
130277130|NCT01436656|468976294|FG015|Dose Expansion|Lost to Follow-up|0|||
130277131|NCT01436656|468976295|FG016|Dose Expansion|Lost to Follow-up|0|||
130277132|NCT01436656|468976296|FG017|Dose Expansion|Lost to Follow-up|3|||
130277133|NCT01436656|468976279|FG000|Dose Expansion|Disease progression|0|||
130277134|NCT01436656|468976280|FG001|Dose Expansion|Disease progression|0|||
130277135|NCT01436656|468976281|FG002|Dose Expansion|Disease progression|0|||
130277136|NCT01436656|468976282|FG003|Dose Expansion|Disease progression|0|||
130277137|NCT01436656|468976283|FG004|Dose Expansion|Disease progression|0|||
130277138|NCT01436656|468976284|FG005|Dose Expansion|Disease progression|0|||
130277139|NCT01436656|468976285|FG006|Dose Expansion|Disease progression|0|||
130277140|NCT01436656|468976286|FG007|Dose Expansion|Disease progression|0|||
130277141|NCT01436656|468976287|FG008|Dose Expansion|Disease progression|0|||
130277142|NCT01436656|468976288|FG009|Dose Expansion|Disease progression|0|||
130277143|NCT01436656|468976289|FG010|Dose Expansion|Disease progression|0|||
130277144|NCT01436656|468976290|FG011|Dose Expansion|Disease progression|3|||
130277145|NCT01436656|468976291|FG012|Dose Expansion|Disease progression|1|||
130277146|NCT01436656|468976292|FG013|Dose Expansion|Disease progression|0|||
130277147|NCT01436656|468976293|FG014|Dose Expansion|Disease progression|1|||
130277148|NCT01436656|468976294|FG015|Dose Expansion|Disease progression|0|||
130277149|NCT01436656|468976295|FG016|Dose Expansion|Disease progression|0|||
130277150|NCT01436656|468976296|FG017|Dose Expansion|Disease progression|1|||
130277151|NCT01436656|468976279|FG000|Dose Expansion|New cancer therapy|0|||
130277152|NCT01436656|468976280|FG001|Dose Expansion|New cancer therapy|0|||
130277153|NCT01436656|468976281|FG002|Dose Expansion|New cancer therapy|0|||
130277154|NCT01436656|468976282|FG003|Dose Expansion|New cancer therapy|0|||
130277155|NCT01436656|468976283|FG004|Dose Expansion|New cancer therapy|0|||
130277156|NCT01436656|468976284|FG005|Dose Expansion|New cancer therapy|0|||
130277157|NCT01436656|468976285|FG006|Dose Expansion|New cancer therapy|0|||
130277158|NCT01436656|468976286|FG007|Dose Expansion|New cancer therapy|0|||
130277159|NCT01436656|468976287|FG008|Dose Expansion|New cancer therapy|0|||
130277160|NCT01436656|468976288|FG009|Dose Expansion|New cancer therapy|0|||
130277161|NCT01436656|468976289|FG010|Dose Expansion|New cancer therapy|0|||
130277162|NCT01436656|468976290|FG011|Dose Expansion|New cancer therapy|1|||
130277163|NCT01436656|468976291|FG012|Dose Expansion|New cancer therapy|1|||
130277164|NCT01436656|468976292|FG013|Dose Expansion|New cancer therapy|0|||
130277165|NCT01436656|468976293|FG014|Dose Expansion|New cancer therapy|2|||
130277166|NCT01436656|468976294|FG015|Dose Expansion|New cancer therapy|0|||
130277167|NCT01436656|468976295|FG016|Dose Expansion|New cancer therapy|0|||
130277168|NCT01436656|468976296|FG017|Dose Expansion|New cancer therapy|0|||
130277169|NCT04729972|468976297|FG000|Overall Study|Adverse Event|1|||
130277170|NCT00576628|468976299|FG000|Overall Study|Adverse Event|11|||
130277171|NCT00576628|468976299|FG000|Overall Study|Death|2|||
130277172|NCT00576628|468976299|FG000|Overall Study|Failure to return|1|||
130277173|NCT00576628|468976299|FG000|Overall Study|Refused Treatment|8|||
130277174|NCT00576628|468976299|FG000|Overall Study|Pregnancy|1|||
130277175|NCT00576628|468976299|FG000|Overall Study|RBC transfusion|1|||
130277176|NCT00576628|468976299|FG000|Overall Study|Progression of Kidney Disease|1|||
130277177|NCT00576628|468976299|FG000|Overall Study|Progression of Renal Failure|1|||
130277178|NCT00576628|468976299|FG000|Overall Study|The patient move into other town|1|||
130277179|NCT00576628|468976299|FG000|Overall Study|Transplantation|1|||
130277180|NCT00576628|468976299|FG000|Overall Study|Dialysis|15|||
130277181|NCT03206970|468976300|FG000|Overall Study|Death|21|||
130277182|NCT03206970|468976300|FG000|Overall Study|Withdrawal by Subject|13|||
130277183|NCT03206970|468976300|FG000|Overall Study|Lost to Follow-up|3|||
130277184|NCT03206970|468976300|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
130277185|NCT02516982|468976301|FG000|Overall Study|Called in to antenatal appointment|32|||
130277186|NCT02516982|468976302|FG001|Overall Study|Called in to antenatal appointment|35|||
130277187|NCT02516982|468976303|FG002|Overall Study|Called in to antenatal appointment|0|||
130277188|NCT02516982|468976304|FG003|Overall Study|Called in to antenatal appointment|0|||
130277189|NCT02516982|468976301|FG000|Overall Study|Withdrawal by Subject|0|||
130277190|NCT02516982|468976302|FG001|Overall Study|Withdrawal by Subject|0|||
130277191|NCT02516982|468976303|FG002|Overall Study|Withdrawal by Subject|1|||
130277192|NCT02516982|468976304|FG003|Overall Study|Withdrawal by Subject|2|||
130277193|NCT02516982|468976301|FG000|Overall Study|Protocol Violation|0|||
130277194|NCT02516982|468976302|FG001|Overall Study|Protocol Violation|0|||
130277195|NCT02516982|468976303|FG002|Overall Study|Protocol Violation|1|||
130277196|NCT02516982|468976304|FG003|Overall Study|Protocol Violation|1|||
130277197|NCT02516982|468976301|FG000|Overall Study|Did not install the app|0|||
130277198|NCT02516982|468976302|FG001|Overall Study|Did not install the app|0|||
130277199|NCT02516982|468976303|FG002|Overall Study|Did not install the app|46|||
130277200|NCT02516982|468976304|FG003|Overall Study|Did not install the app|47|||
130277201|NCT01804049|468976312|FG000|Overall Study|Adverse Event|2|||
130277202|NCT01804049|468976313|FG001|Overall Study|Adverse Event|10|||
130277203|NCT01804049|468976312|FG000|Overall Study|Lost to Follow-up|2|||
130277204|NCT01804049|468976313|FG001|Overall Study|Lost to Follow-up|1|||
130041662|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130041663|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
130041664|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
130277205|NCT01804049|468976312|FG000|Overall Study|Decreased interest/personal|4|||
130277206|NCT01804049|468976313|FG001|Overall Study|Decreased interest/personal|5|||
130277207|NCT01804049|468976312|FG000|Overall Study|Other health concerns|2|||
130277208|NCT01804049|468976313|FG001|Overall Study|Other health concerns|7|||
130277209|NCT01804049|468976312|FG000|Overall Study|Moved out of area|0|||
130277210|NCT01804049|468976313|FG001|Overall Study|Moved out of area|7|||
130277211|NCT01804049|468976312|FG000|Overall Study|other MD recommended|1|||
130277212|NCT01804049|468976313|FG001|Overall Study|other MD recommended|1|||
130277213|NCT01804049|468976312|FG000|Overall Study|Enrollment in dual studies|0|||
130277214|NCT01804049|468976313|FG001|Overall Study|Enrollment in dual studies|1|||
130277215|NCT03249909|468976315|FG000|Overall Study|Withdrawal by Subject|3|||
130277216|NCT03249909|468976316|FG001|Overall Study|Withdrawal by Subject|0|||
130277217|NCT03249909|468976317|FG002|Overall Study|Withdrawal by Subject|0|||
130277218|NCT03249909|468976315|FG000|Overall Study|Adverse Event|3|||
130277219|NCT03249909|468976316|FG001|Overall Study|Adverse Event|0|||
130277220|NCT03249909|468976317|FG002|Overall Study|Adverse Event|0|||
130277221|NCT03249909|468976315|FG000|Overall Study|Lost to Follow-up|0|||
130277222|NCT03249909|468976316|FG001|Overall Study|Lost to Follow-up|1|||
130277223|NCT03249909|468976317|FG002|Overall Study|Lost to Follow-up|0|||
130277224|NCT05286658|468976318|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
130277225|NCT05286658|468976318|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
130277226|NCT01035463|468976319|FG000|Overall Study|Adverse Event|0|||
130277227|NCT01035463|468976320|FG001|Overall Study|Adverse Event|0|||
130277228|NCT01035463|468976321|FG002|Overall Study|Adverse Event|4|||
130277229|NCT01035463|468976322|FG003|Overall Study|Adverse Event|1|||
130277230|NCT01035463|468976323|FG004|Overall Study|Adverse Event|5|||
130277231|NCT01035463|468976324|FG005|Overall Study|Adverse Event|7|||
130277232|NCT01035463|468976319|FG000|Overall Study|Withdrawal by Subject|0|||
130277233|NCT01035463|468976320|FG001|Overall Study|Withdrawal by Subject|2|||
130277234|NCT01035463|468976321|FG002|Overall Study|Withdrawal by Subject|1|||
130277235|NCT01035463|468976322|FG003|Overall Study|Withdrawal by Subject|0|||
130277236|NCT01035463|468976323|FG004|Overall Study|Withdrawal by Subject|1|||
130277237|NCT01035463|468976324|FG005|Overall Study|Withdrawal by Subject|4|||
130277238|NCT01035463|468976319|FG000|Overall Study|Disease progression|0|||
130277239|NCT01035463|468976320|FG001|Overall Study|Disease progression|0|||
130277240|NCT01035463|468976321|FG002|Overall Study|Disease progression|0|||
130277241|NCT01035463|468976322|FG003|Overall Study|Disease progression|0|||
130277242|NCT01035463|468976323|FG004|Overall Study|Disease progression|0|||
130277243|NCT01035463|468976324|FG005|Overall Study|Disease progression|3|||
130277244|NCT01035463|468976319|FG000|Overall Study|Other Malignancy|0|||
130277245|NCT01035463|468976320|FG001|Overall Study|Other Malignancy|0|||
130277246|NCT01035463|468976321|FG002|Overall Study|Other Malignancy|0|||
130277247|NCT01035463|468976322|FG003|Overall Study|Other Malignancy|0|||
130277248|NCT01035463|468976323|FG004|Overall Study|Other Malignancy|0|||
130277249|NCT01035463|468976324|FG005|Overall Study|Other Malignancy|2|||
130277250|NCT01035463|468976319|FG000|Overall Study|Other|0|||
130277251|NCT01035463|468976320|FG001|Overall Study|Other|0|||
130277252|NCT01035463|468976321|FG002|Overall Study|Other|0|||
130277253|NCT01035463|468976322|FG003|Overall Study|Other|1|||
130277254|NCT01035463|468976323|FG004|Overall Study|Other|0|||
130277255|NCT01035463|468976324|FG005|Overall Study|Other|2|||
130277256|NCT01092780|468976325|FG000|Washout Period 1|Adverse Event|0|||
130277257|NCT01092780|468976326|FG001|Washout Period 1|Adverse Event|1|||
130277258|NCT01092780|468976327|FG002|Washout Period 1|Adverse Event|0|||
130277259|NCT01092780|468976328|FG003|Washout Period 1|Adverse Event|0|||
130277260|NCT01092780|468976325|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
130277261|NCT01092780|468976326|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
130277262|NCT01092780|468976327|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
130041665|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
130041666|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
130277263|NCT01092780|468976328|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
130277264|NCT01092780|468976325|FG000|Washout Period 2|Adverse Event|0|||
130277265|NCT01092780|468976326|FG001|Washout Period 2|Adverse Event|1|||
130277266|NCT01092780|468976327|FG002|Washout Period 2|Adverse Event|1|||
130277267|NCT01092780|468976328|FG003|Washout Period 2|Adverse Event|0|||
130277268|NCT00851552|468976338|FG000|Overall Study|Death|2|||
130277269|NCT00851552|468976338|FG000|Overall Study|Adverse Event|1|||
130277270|NCT00851552|468976338|FG000|Overall Study|Disease Progression|4|||
130277271|NCT01270880|468976340|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
130277272|NCT00182078|468976341|FG000|Overall Study|Withdrawal by Subject|1|||
130277273|NCT00182078|468976342|FG001|Overall Study|Withdrawal by Subject|0|||
130277274|NCT01606176|468976343|FG000|Overall Study|Adverse Event|2|||
130277275|NCT01606176|468976344|FG001|Overall Study|Adverse Event|3|||
130277276|NCT01606176|468976343|FG000|Overall Study|Disease progression|1|||
130277277|NCT01606176|468976344|FG001|Overall Study|Disease progression|0|||
130277278|NCT01606176|468976343|FG000|Overall Study|Withdrawal by Subject|1|||
130277279|NCT01606176|468976344|FG001|Overall Study|Withdrawal by Subject|0|||
130277280|NCT01076205|468976345|FG000|Overall Study|Adverse Drug Reaction|299|||
130277281|NCT01076205|468976345|FG000|Overall Study|Lack of Effectiveness|1423|||
130277282|NCT01076205|468976345|FG000|Overall Study|Other Reason|1075|||
130277283|NCT01076205|468976345|FG000|Overall Study|Unknown Reason|71|||
130277284|NCT01076205|468976345|FG000|Overall Study|Lost to Follow-up|3151|||
130277285|NCT01832493|468976347|FG000|Overall Study|Physician Decision|2|||
130277286|NCT01832493|468976347|FG000|Overall Study|Protocol Violation|4|||
130277287|NCT01832493|468976347|FG000|Overall Study|Unable to place LV lead|2|||
130277288|NCT01732510|468976348|FG000|Overall Study|Adverse Event|0|||
130277289|NCT01732510|468976349|FG001|Overall Study|Adverse Event|1|||
130277290|NCT01732510|468976350|FG002|Overall Study|Adverse Event|1|||
130277291|NCT01732510|468976351|FG003|Overall Study|Adverse Event|0|||
130277292|NCT01732510|468976352|FG004|Overall Study|Adverse Event|0|||
130277293|NCT01732510|468976353|FG005|Overall Study|Adverse Event|0|||
130277294|NCT01732510|468976354|FG006|Overall Study|Adverse Event|1|||
129886966|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
129886967|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
130105762|NCT03869684|468348011|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
130105763|NCT01850108|468348014|FG000|Overall Study|Lost to Follow-up|4|||
130277295|NCT01732510|468976348|FG000|Overall Study|Protocol Violation|0|||
130277296|NCT01732510|468976349|FG001|Overall Study|Protocol Violation|0|||
130277297|NCT01732510|468976350|FG002|Overall Study|Protocol Violation|0|||
130277298|NCT01732510|468976351|FG003|Overall Study|Protocol Violation|1|||
130277299|NCT01732510|468976352|FG004|Overall Study|Protocol Violation|0|||
130277300|NCT01732510|468976353|FG005|Overall Study|Protocol Violation|0|||
130277301|NCT01732510|468976354|FG006|Overall Study|Protocol Violation|0|||
130277302|NCT01732510|468976348|FG000|Overall Study|Withdrawal by Subject|1|||
130277303|NCT01732510|468976349|FG001|Overall Study|Withdrawal by Subject|3|||
130277304|NCT01732510|468976350|FG002|Overall Study|Withdrawal by Subject|2|||
130277305|NCT01732510|468976351|FG003|Overall Study|Withdrawal by Subject|1|||
130277306|NCT01732510|468976352|FG004|Overall Study|Withdrawal by Subject|5|||
130277307|NCT01732510|468976353|FG005|Overall Study|Withdrawal by Subject|0|||
130277308|NCT01732510|468976354|FG006|Overall Study|Withdrawal by Subject|1|||
130277309|NCT01732510|468976348|FG000|Overall Study|Lost to Follow-up|0|||
130277310|NCT01732510|468976349|FG001|Overall Study|Lost to Follow-up|0|||
130277311|NCT01732510|468976350|FG002|Overall Study|Lost to Follow-up|1|||
130277312|NCT01732510|468976351|FG003|Overall Study|Lost to Follow-up|1|||
130277313|NCT01732510|468976352|FG004|Overall Study|Lost to Follow-up|0|||
130277314|NCT01732510|468976353|FG005|Overall Study|Lost to Follow-up|1|||
130277315|NCT01732510|468976354|FG006|Overall Study|Lost to Follow-up|0|||
130277316|NCT01732510|468976348|FG000|Overall Study|Physician Decision|0|||
130277317|NCT01732510|468976349|FG001|Overall Study|Physician Decision|1|||
130277318|NCT01732510|468976350|FG002|Overall Study|Physician Decision|0|||
130277319|NCT01732510|468976351|FG003|Overall Study|Physician Decision|0|||
130277320|NCT01732510|468976352|FG004|Overall Study|Physician Decision|0|||
130277321|NCT01732510|468976353|FG005|Overall Study|Physician Decision|0|||
130277322|NCT01732510|468976354|FG006|Overall Study|Physician Decision|0|||
130277323|NCT01732510|468976348|FG000|Overall Study|Pregnancy|0|||
130277324|NCT01732510|468976349|FG001|Overall Study|Pregnancy|0|||
130277325|NCT01732510|468976350|FG002|Overall Study|Pregnancy|0|||
130277326|NCT01732510|468976351|FG003|Overall Study|Pregnancy|1|||
130277327|NCT01732510|468976352|FG004|Overall Study|Pregnancy|0|||
130277328|NCT01732510|468976353|FG005|Overall Study|Pregnancy|0|||
130277329|NCT01732510|468976354|FG006|Overall Study|Pregnancy|0|||
130277330|NCT01732510|468976348|FG000|Overall Study|Study Terminated By Sponsor|0|||
130105764|NCT01850108|468348014|FG000|Overall Study|Not eligible|1|||
130105765|NCT01850108|468348014|FG000|Overall Study|Failed engraftment|2|||
130105766|NCT01850108|468348014|FG000|Overall Study|Physician Decision|1|||
130105767|NCT04330482|468348019|FG000|Overall Study|Lost to Follow-up|2|||
130105768|NCT04330482|468348020|FG001|Overall Study|Lost to Follow-up|1|||
130105769|NCT04330482|468348019|FG000|Overall Study|Withdrawal by Subject|0|||
130277331|NCT01732510|468976349|FG001|Overall Study|Study Terminated By Sponsor|0|||
130277332|NCT01732510|468976350|FG002|Overall Study|Study Terminated By Sponsor|0|||
130277333|NCT01732510|468976351|FG003|Overall Study|Study Terminated By Sponsor|1|||
130277334|NCT01732510|468976352|FG004|Overall Study|Study Terminated By Sponsor|0|||
130277335|NCT01732510|468976353|FG005|Overall Study|Study Terminated By Sponsor|12|||
130277336|NCT01732510|468976354|FG006|Overall Study|Study Terminated By Sponsor|6|||
130277337|NCT01262560|468976358|FG000|Overall Study|Protocol Violation|0|||
130277338|NCT01262560|468976359|FG001|Overall Study|Protocol Violation|1|||
130277339|NCT01262560|468976360|FG002|Overall Study|Protocol Violation|2|||
130277340|NCT03213938|468976361|FG000|Overall Study|Lost to Follow-up|4|||
130277341|NCT03213938|468976362|FG001|Overall Study|Lost to Follow-up|3|||
130277342|NCT03213938|468976361|FG000|Overall Study|Lack of Efficacy|1|||
130277343|NCT03213938|468976362|FG001|Overall Study|Lack of Efficacy|0|||
130105770|NCT04330482|468348020|FG001|Overall Study|Withdrawal by Subject|3|||
130277344|NCT03213938|468976361|FG000|Overall Study|Decline to participate|5|||
130277345|NCT03213938|468976362|FG001|Overall Study|Decline to participate|4|||
130277346|NCT03213938|468976361|FG000|Overall Study|Without reason|4|||
130277347|NCT03213938|468976362|FG001|Overall Study|Without reason|5|||
130277348|NCT04238481|468976363|FG000|Overall Study|Miscellaneous|0|||
130277349|NCT04238481|468976364|FG001|Overall Study|Miscellaneous|1|||
130277350|NCT04238481|468976365|FG002|Overall Study|Miscellaneous|0|||
130277351|NCT04238481|468976366|FG003|Overall Study|Miscellaneous|0|||
130277352|NCT00673231|468976367|FG000|Overall Study|Withdrawal by Subject|14|||
130277353|NCT00673231|468976368|FG001|Overall Study|Withdrawal by Subject|10|||
130277354|NCT00673231|468976369|FG002|Overall Study|Withdrawal by Subject|8|||
130277355|NCT00673231|468976370|FG003|Overall Study|Withdrawal by Subject|6|||
130277356|NCT00673231|468976367|FG000|Overall Study|Adverse Event|6|||
130277357|NCT00673231|468976368|FG001|Overall Study|Adverse Event|5|||
130277358|NCT00673231|468976369|FG002|Overall Study|Adverse Event|9|||
130277359|NCT00673231|468976370|FG003|Overall Study|Adverse Event|6|||
130277360|NCT00673231|468976367|FG000|Overall Study|Lost to Follow-up|1|||
130277361|NCT00673231|468976368|FG001|Overall Study|Lost to Follow-up|2|||
130277362|NCT00673231|468976369|FG002|Overall Study|Lost to Follow-up|1|||
130277363|NCT00673231|468976370|FG003|Overall Study|Lost to Follow-up|2|||
130277364|NCT00673231|468976367|FG000|Overall Study|Death|0|||
130277365|NCT00673231|468976368|FG001|Overall Study|Death|0|||
130277366|NCT00673231|468976369|FG002|Overall Study|Death|1|||
130277367|NCT00673231|468976370|FG003|Overall Study|Death|0|||
130277368|NCT00673231|468976367|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
130277369|NCT00673231|468976368|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
130277370|NCT00673231|468976369|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
130277371|NCT00673231|468976370|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
130277372|NCT02952313|468976371|FG000|Primary Endpoint|Lost to Follow-up|4|||
130041667|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
130041668|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
130041669|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
130041670|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
130041671|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
130041672|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130277373|NCT02952313|468976371|FG000|Primary Endpoint|Withdrawal by Subject|1|||
130277374|NCT02952313|468976371|FG000|Primary Endpoint|Lack of Efficacy|1|||
130277375|NCT02952313|468976371|FG000|Primary Endpoint|Missed visit|1|||
130277376|NCT02952313|468976371|FG000|Long-term Follow-up|Lost to Follow-up|12|||
130277377|NCT02952313|468976371|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
130277378|NCT02952313|468976371|FG000|Long-term Follow-up|Lack of Efficacy|6|||
130277379|NCT02952313|468976371|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
130277380|NCT02952313|468976371|FG000|Long-term Follow-up|Physician Decision|1|||
130277381|NCT02952313|468976371|FG000|Long-term Follow-up|Death|1|||
130277382|NCT03594747|468976372|FG000|Overall Study|Death|78|||
130277383|NCT03594747|468976373|FG001|Overall Study|Death|86|||
130277384|NCT03594747|468976374|FG002|Overall Study|Death|87|||
130277385|NCT03594747|468976372|FG000|Overall Study|Withdrawal by Subject|5|||
130277386|NCT03594747|468976373|FG001|Overall Study|Withdrawal by Subject|2|||
130277387|NCT03594747|468976374|FG002|Overall Study|Withdrawal by Subject|11|||
130277388|NCT03594747|468976372|FG000|Overall Study|Lost to Follow-up|4|||
130277389|NCT03594747|468976373|FG001|Overall Study|Lost to Follow-up|1|||
130277390|NCT03594747|468976374|FG002|Overall Study|Lost to Follow-up|1|||
130277391|NCT03594747|468976372|FG000|Overall Study|Physician Decision|0|||
130277392|NCT03594747|468976373|FG001|Overall Study|Physician Decision|1|||
130277393|NCT03594747|468976374|FG002|Overall Study|Physician Decision|0|||
130277394|NCT03594747|468976372|FG000|Overall Study|Sponsor decision|23|||
130105771|NCT05144477|468348022|FG000|Overall Study|Withdrawal by Subject|1|||
130105772|NCT05144477|468348023|FG001|Overall Study|Withdrawal by Subject|1|||
130105773|NCT04333199|468348024|FG000|Evaluated Patients|Lost to Follow-up|0|||
130105774|NCT04333199|468348025|FG001|Evaluated Patients|Lost to Follow-up|1|||
130277395|NCT03594747|468976373|FG001|Overall Study|Sponsor decision|17|||
130105775|NCT04333199|468348026|FG002|Evaluated Patients|Lost to Follow-up|2|||
130277396|NCT03594747|468976374|FG002|Overall Study|Sponsor decision|16|||
130277397|NCT03594747|468976372|FG000|Overall Study|Did not meet inclusion criteria|0|||
130277398|NCT03594747|468976373|FG001|Overall Study|Did not meet inclusion criteria|0|||
130277399|NCT03594747|468976374|FG002|Overall Study|Did not meet inclusion criteria|1|||
130277400|NCT03594747|468976372|FG000|Overall Study|Transfer to long term extension study|10|||
130041673|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
130041674|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
130277401|NCT03594747|468976373|FG001|Overall Study|Transfer to long term extension study|12|||
130277402|NCT03594747|468976374|FG002|Overall Study|Transfer to long term extension study|5|||
130277403|NCT02095873|468976375|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130277404|NCT02095873|468976376|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130277405|NCT02095873|468976375|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
130277406|NCT02095873|468976376|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
130277407|NCT02095873|468976375|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
130277408|NCT02095873|468976376|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
130277409|NCT00792740|468976377|FG000|Overall Study|Disease Worsening|3|||
130277410|NCT00792740|468976378|FG001|Overall Study|Disease Worsening|2|||
130277411|NCT00792740|468976377|FG000|Overall Study|Personal Reason|1|||
130277412|NCT00792740|468976378|FG001|Overall Study|Personal Reason|0|||
130277413|NCT00792740|468976377|FG000|Overall Study|Adverse Event|1|||
130277414|NCT00792740|468976378|FG001|Overall Study|Adverse Event|3|||
130277415|NCT00792740|468976377|FG000|Overall Study|Patient's withdrawal of consent|0|||
130277416|NCT00792740|468976378|FG001|Overall Study|Patient's withdrawal of consent|1|||
130277417|NCT00792740|468976377|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
130277418|NCT00792740|468976378|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
130277419|NCT00792740|468976377|FG000|Overall Study|Other reasons|0|||
130277420|NCT00792740|468976378|FG001|Overall Study|Other reasons|1|||
130277421|NCT00703846|468976379|FG000|Overall Study|Adverse Event|8|||
130277422|NCT00703846|468976379|FG000|Overall Study|Lost to Follow-up|55|||
130277423|NCT00703846|468976379|FG000|Overall Study|Lack of Efficacy|15|||
130277424|NCT00703846|468976379|FG000|Overall Study|Noncompliance with Study Treatment|2|||
130277425|NCT00703846|468976379|FG000|Overall Study|Withdrawal by Subject|40|||
130277426|NCT00703846|468976379|FG000|Overall Study|Death|1|||
130277427|NCT00703846|468976379|FG000|Overall Study|Other|14|||
130277428|NCT00703846|468976379|FG000|Overall Study|Did Not Receive Study Drug|2|||
130041675|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130041676|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
130277429|NCT02485639|468976382|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
130277430|NCT02485639|468976382|FG000|Overall Study|Early termination|4|||
130277431|NCT02485639|468976382|FG000|Overall Study|Withdrawal by Subject|4|||
130277432|NCT02015481|468976383|FG000|Overall Study|Death|1|||
130277433|NCT02566785|468976384|FG000|Overall Study|Lost to Follow-up|0|||
130277434|NCT02566785|468976385|FG001|Overall Study|Lost to Follow-up|2|||
130277435|NCT02566785|468976384|FG000|Overall Study|Worsening condition|1|||
130277436|NCT02566785|468976385|FG001|Overall Study|Worsening condition|1|||
130277437|NCT01170273|468976389|FG000|Overall Study|Lost to Follow-up|6|||
130277438|NCT01170273|468976390|FG001|Overall Study|Lost to Follow-up|8|||
130277439|NCT01170273|468976389|FG000|Overall Study|Protocol Violation|1|||
130277440|NCT01170273|468976390|FG001|Overall Study|Protocol Violation|0|||
130277441|NCT01170273|468976389|FG000|Overall Study|Death|1|||
130277442|NCT01170273|468976390|FG001|Overall Study|Death|0|||
130277443|NCT01170273|468976389|FG000|Overall Study|Adverse Event|0|||
130277444|NCT01170273|468976390|FG001|Overall Study|Adverse Event|1|||
130277445|NCT00334737|468976391|FG000|Hospital Phase|Death|1|||
130277446|NCT00334737|468976392|FG001|Hospital Phase|Death|2|||
129886968|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130277447|NCT00334737|468976393|FG002|Hospital Phase|Death|3|||
130277448|NCT00334737|468976391|FG000|Hospital Phase|Withdrawal by Subject|0|||
130277449|NCT00334737|468976392|FG001|Hospital Phase|Withdrawal by Subject|0|||
130277450|NCT00334737|468976393|FG002|Hospital Phase|Withdrawal by Subject|1|||
130277451|NCT00334737|468976391|FG000|Hospital Phase|Did not receive study drug|1|||
130277452|NCT00334737|468976392|FG001|Hospital Phase|Did not receive study drug|0|||
130277453|NCT00334737|468976393|FG002|Hospital Phase|Did not receive study drug|0|||
130277454|NCT00334737|468976391|FG000|Follow up Phase|Lost to Follow-up|5|||
130277455|NCT00334737|468976392|FG001|Follow up Phase|Lost to Follow-up|3|||
130277456|NCT00334737|468976393|FG002|Follow up Phase|Lost to Follow-up|6|||
130277457|NCT00583752|468976394|FG000|Overall Study|Lost to Follow-up|5|||
130277458|NCT00583752|468976395|FG001|Overall Study|Lost to Follow-up|5|||
130277459|NCT02316353|468976396|FG000|Overall Study|Pregnancy|1|||
130277460|NCT02316353|468976397|FG001|Overall Study|Pregnancy|3|||
130277461|NCT02316353|468976396|FG000|Overall Study|Adverse Event|1|||
130277462|NCT02316353|468976397|FG001|Overall Study|Adverse Event|3|||
130277463|NCT02316353|468976396|FG000|Overall Study|Withdrawal by Subject|6|||
130277464|NCT02316353|468976397|FG001|Overall Study|Withdrawal by Subject|2|||
130277465|NCT02147197|468976398|FG000|Overall Study|Adverse Event|1|||
130277466|NCT02147197|468976399|FG001|Overall Study|Adverse Event|0|||
130277467|NCT02147197|468976400|FG002|Overall Study|Adverse Event|0|||
130277468|NCT02147197|468976398|FG000|Overall Study|Withdrawal of Consent|4|||
130277469|NCT02147197|468976399|FG001|Overall Study|Withdrawal of Consent|3|||
130277470|NCT02147197|468976400|FG002|Overall Study|Withdrawal of Consent|2|||
130105776|NCT01155284|468348037|FG000|Overall Study|Withdrawal by Subject|4|||
130277471|NCT02147197|468976398|FG000|Overall Study|Lost to Follow-up|2|||
130277472|NCT02147197|468976399|FG001|Overall Study|Lost to Follow-up|3|||
130277473|NCT02147197|468976400|FG002|Overall Study|Lost to Follow-up|1|||
130277474|NCT02147197|468976398|FG000|Overall Study|Protocol Violation|1|||
130277475|NCT02147197|468976399|FG001|Overall Study|Protocol Violation|0|||
130277476|NCT02147197|468976400|FG002|Overall Study|Protocol Violation|3|||
130277477|NCT02147197|468976398|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130277478|NCT02147197|468976399|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130277479|NCT02147197|468976400|FG002|Overall Study|Other Miscellaneous Reasons|3|||
130277480|NCT03522246|468978160|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
130277481|NCT03522246|468978161|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
130277482|NCT03522246|468978162|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
130105777|NCT01155284|468348038|FG001|Overall Study|Withdrawal by Subject|3|||
130277483|NCT03522246|468978163|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
130277484|NCT03522246|468978164|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
130277485|NCT04683029|468978165|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
130277486|NCT04683029|468978166|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130277487|NCT04683029|468978167|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130277488|NCT04683029|468978168|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
130277489|NCT04683029|468978165|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130277490|NCT04683029|468978166|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130277491|NCT04683029|468978167|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
130277492|NCT04683029|468978168|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
130277493|NCT04683029|468978165|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130277494|NCT04683029|468978166|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130277495|NCT04683029|468978167|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
130277496|NCT04683029|468978168|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
130277497|NCT00814580|468978169|FG000|Overall Study|Adverse Event|6|||
130277498|NCT00814580|468978170|FG001|Overall Study|Adverse Event|15|||
130277499|NCT00814580|468978169|FG000|Overall Study|Lack of Efficacy|18|||
130277500|NCT00814580|468978170|FG001|Overall Study|Lack of Efficacy|25|||
130277501|NCT00814580|468978169|FG000|Overall Study|Protocol Violation|2|||
130277502|NCT00814580|468978170|FG001|Overall Study|Protocol Violation|0|||
130277503|NCT00814580|468978169|FG000|Overall Study|Withdrawal by Subject|2|||
130277504|NCT00814580|468978170|FG001|Overall Study|Withdrawal by Subject|2|||
130277505|NCT00814580|468978169|FG000|Overall Study|Other|1|||
130277506|NCT00814580|468978170|FG001|Overall Study|Other|3|||
130277507|NCT00814580|468978169|FG000|Overall Study|Did Not Take Drug|2|||
130277508|NCT00814580|468978170|FG001|Overall Study|Did Not Take Drug|2|||
130277509|NCT02482428|468978171|FG000|Overall Study|Lost to Follow-up|4|||
130277510|NCT02482428|468978172|FG001|Overall Study|Lost to Follow-up|9|||
130277511|NCT02482428|468978173|FG002|Overall Study|Lost to Follow-up|1|||
130277512|NCT02482428|468978174|FG003|Overall Study|Lost to Follow-up|2|||
130277513|NCT02482428|468978175|FG004|Overall Study|Lost to Follow-up|4|||
130277514|NCT02482428|468978171|FG000|Overall Study|Physician Decision|0|||
130277515|NCT02482428|468978172|FG001|Overall Study|Physician Decision|0|||
130277516|NCT02482428|468978173|FG002|Overall Study|Physician Decision|0|||
130277517|NCT02482428|468978174|FG003|Overall Study|Physician Decision|0|||
130277518|NCT02482428|468978175|FG004|Overall Study|Physician Decision|1|||
130277519|NCT02482428|468978171|FG000|Overall Study|protocol deviation|1|||
130277520|NCT02482428|468978172|FG001|Overall Study|protocol deviation|1|||
130277521|NCT02482428|468978173|FG002|Overall Study|protocol deviation|0|||
130277522|NCT02482428|468978174|FG003|Overall Study|protocol deviation|0|||
130277523|NCT02482428|468978175|FG004|Overall Study|protocol deviation|0|||
130277524|NCT02482428|468978171|FG000|Overall Study|subject/guardian decision|4|||
130277525|NCT02482428|468978172|FG001|Overall Study|subject/guardian decision|2|||
130277526|NCT02482428|468978173|FG002|Overall Study|subject/guardian decision|0|||
130277527|NCT02482428|468978174|FG003|Overall Study|subject/guardian decision|0|||
130277528|NCT02482428|468978175|FG004|Overall Study|subject/guardian decision|2|||
130277529|NCT00459875|468978178|FG000|Overall Study|Ineligible participant|1|||
130277530|NCT00459875|468978178|FG000|Overall Study|Adverse Event|2|||
130277531|NCT01406938|468978181|FG000|Induction Period|Subject/guardian decision|6|||
130277532|NCT01406938|468978182|FG001|Induction Period|Subject/guardian decision|8|||
130277533|NCT01406938|468978183|FG002|Induction Period|Subject/guardian decision|0|||
130277534|NCT01406938|468978184|FG003|Induction Period|Subject/guardian decision|0|||
130277535|NCT01406938|468978185|FG004|Induction Period|Subject/guardian decision|0|||
130277536|NCT01406938|468978186|FG005|Induction Period|Subject/guardian decision|0|||
130277537|NCT01406938|468978181|FG000|Induction Period|Protocol deviation|1|||
130277538|NCT01406938|468978182|FG001|Induction Period|Protocol deviation|0|||
130277539|NCT01406938|468978183|FG002|Induction Period|Protocol deviation|0|||
130277540|NCT01406938|468978184|FG003|Induction Period|Protocol deviation|0|||
130277541|NCT01406938|468978185|FG004|Induction Period|Protocol deviation|0|||
130277542|NCT01406938|468978186|FG005|Induction Period|Protocol deviation|0|||
130277543|NCT01406938|468978181|FG000|Induction Period|Adverse Event|8|||
130277544|NCT01406938|468978182|FG001|Induction Period|Adverse Event|9|||
130277545|NCT01406938|468978183|FG002|Induction Period|Adverse Event|0|||
130277546|NCT01406938|468978184|FG003|Induction Period|Adverse Event|0|||
130277547|NCT01406938|468978185|FG004|Induction Period|Adverse Event|0|||
130277548|NCT01406938|468978186|FG005|Induction Period|Adverse Event|0|||
130277549|NCT01406938|468978181|FG000|Induction Period|Lack of Efficacy|1|||
130277550|NCT01406938|468978182|FG001|Induction Period|Lack of Efficacy|0|||
130277551|NCT01406938|468978183|FG002|Induction Period|Lack of Efficacy|0|||
130277552|NCT01406938|468978184|FG003|Induction Period|Lack of Efficacy|0|||
130277553|NCT01406938|468978185|FG004|Induction Period|Lack of Efficacy|0|||
130277554|NCT01406938|468978186|FG005|Induction Period|Lack of Efficacy|0|||
130277555|NCT01406938|468978181|FG000|Induction Period|Lost to Follow-up|2|||
130277556|NCT01406938|468978182|FG001|Induction Period|Lost to Follow-up|3|||
130277557|NCT01406938|468978183|FG002|Induction Period|Lost to Follow-up|0|||
130277558|NCT01406938|468978184|FG003|Induction Period|Lost to Follow-up|0|||
130277559|NCT01406938|468978185|FG004|Induction Period|Lost to Follow-up|0|||
130277560|NCT01406938|468978186|FG005|Induction Period|Lost to Follow-up|0|||
130277561|NCT01406938|468978181|FG000|Maintenance Period|Adverse Event|0|||
130277562|NCT01406938|468978182|FG001|Maintenance Period|Adverse Event|0|||
130277563|NCT01406938|468978183|FG002|Maintenance Period|Adverse Event|2|||
130277564|NCT01406938|468978184|FG003|Maintenance Period|Adverse Event|8|||
130277565|NCT01406938|468978185|FG004|Maintenance Period|Adverse Event|4|||
130277566|NCT01406938|468978186|FG005|Maintenance Period|Adverse Event|2|||
130277567|NCT01406938|468978181|FG000|Maintenance Period|Death|0|||
130277568|NCT01406938|468978182|FG001|Maintenance Period|Death|0|||
130277569|NCT01406938|468978183|FG002|Maintenance Period|Death|0|||
130277570|NCT01406938|468978184|FG003|Maintenance Period|Death|0|||
130277571|NCT01406938|468978185|FG004|Maintenance Period|Death|1|||
130277572|NCT01406938|468978186|FG005|Maintenance Period|Death|0|||
130277573|NCT01406938|468978181|FG000|Maintenance Period|Subject/guardian decision|0|||
130277574|NCT01406938|468978182|FG001|Maintenance Period|Subject/guardian decision|0|||
130277575|NCT01406938|468978183|FG002|Maintenance Period|Subject/guardian decision|11|||
130277576|NCT01406938|468978184|FG003|Maintenance Period|Subject/guardian decision|7|||
130277577|NCT01406938|468978185|FG004|Maintenance Period|Subject/guardian decision|10|||
130277578|NCT01406938|468978186|FG005|Maintenance Period|Subject/guardian decision|7|||
130277579|NCT01406938|468978181|FG000|Maintenance Period|Protocol Violation|0|||
130277580|NCT01406938|468978182|FG001|Maintenance Period|Protocol Violation|0|||
130277581|NCT01406938|468978183|FG002|Maintenance Period|Protocol Violation|2|||
130277582|NCT01406938|468978184|FG003|Maintenance Period|Protocol Violation|2|||
130277583|NCT01406938|468978185|FG004|Maintenance Period|Protocol Violation|2|||
130277584|NCT01406938|468978186|FG005|Maintenance Period|Protocol Violation|2|||
130277585|NCT01406938|468978181|FG000|Maintenance Period|Pregnancy|0|||
130277586|NCT01406938|468978182|FG001|Maintenance Period|Pregnancy|0|||
130277587|NCT01406938|468978183|FG002|Maintenance Period|Pregnancy|0|||
130277588|NCT01406938|468978184|FG003|Maintenance Period|Pregnancy|0|||
130277589|NCT01406938|468978185|FG004|Maintenance Period|Pregnancy|1|||
130277590|NCT01406938|468978186|FG005|Maintenance Period|Pregnancy|0|||
130277591|NCT01406938|468978181|FG000|Maintenance Period|Lost to Follow-up|0|||
130277592|NCT01406938|468978182|FG001|Maintenance Period|Lost to Follow-up|0|||
130277593|NCT01406938|468978183|FG002|Maintenance Period|Lost to Follow-up|0|||
130277594|NCT01406938|468978184|FG003|Maintenance Period|Lost to Follow-up|0|||
130277595|NCT01406938|468978185|FG004|Maintenance Period|Lost to Follow-up|4|||
130277596|NCT01406938|468978186|FG005|Maintenance Period|Lost to Follow-up|0|||
130277597|NCT01406938|468978181|FG000|Maintenance Period|Lack of Efficacy|0|||
130277598|NCT01406938|468978182|FG001|Maintenance Period|Lack of Efficacy|0|||
130277599|NCT01406938|468978183|FG002|Maintenance Period|Lack of Efficacy|2|||
130277600|NCT01406938|468978184|FG003|Maintenance Period|Lack of Efficacy|1|||
130277601|NCT01406938|468978185|FG004|Maintenance Period|Lack of Efficacy|3|||
130277602|NCT01406938|468978186|FG005|Maintenance Period|Lack of Efficacy|5|||
130277603|NCT01406938|468978181|FG000|Follow up|Lack of Efficacy|3|||
130277604|NCT01406938|468978182|FG001|Follow up|Lack of Efficacy|2|||
130277605|NCT01406938|468978183|FG002|Follow up|Lack of Efficacy|1|||
130277606|NCT01406938|468978184|FG003|Follow up|Lack of Efficacy|0|||
130277607|NCT01406938|468978185|FG004|Follow up|Lack of Efficacy|0|||
130277608|NCT01406938|468978186|FG005|Follow up|Lack of Efficacy|0|||
130277609|NCT01406938|468978181|FG000|Follow up|Patient/guardian decision|4|||
130277610|NCT01406938|468978182|FG001|Follow up|Patient/guardian decision|2|||
130277611|NCT01406938|468978183|FG002|Follow up|Patient/guardian decision|4|||
130277612|NCT01406938|468978184|FG003|Follow up|Patient/guardian decision|2|||
130277613|NCT01406938|468978185|FG004|Follow up|Patient/guardian decision|4|||
130277614|NCT01406938|468978186|FG005|Follow up|Patient/guardian decision|1|||
130277615|NCT01406938|468978181|FG000|Follow up|Protocol Violation|0|||
130277616|NCT01406938|468978182|FG001|Follow up|Protocol Violation|0|||
130277617|NCT01406938|468978183|FG002|Follow up|Protocol Violation|1|||
130277618|NCT01406938|468978184|FG003|Follow up|Protocol Violation|0|||
130277619|NCT01406938|468978185|FG004|Follow up|Protocol Violation|0|||
130277620|NCT01406938|468978186|FG005|Follow up|Protocol Violation|0|||
130277621|NCT01406938|468978181|FG000|Follow up|Physician Decision|0|||
130277622|NCT01406938|468978182|FG001|Follow up|Physician Decision|0|||
130277623|NCT01406938|468978183|FG002|Follow up|Physician Decision|2|||
130277624|NCT01406938|468978184|FG003|Follow up|Physician Decision|0|||
130277625|NCT01406938|468978185|FG004|Follow up|Physician Decision|3|||
130277626|NCT01406938|468978186|FG005|Follow up|Physician Decision|1|||
130277627|NCT01406938|468978181|FG000|Follow up|Lost to Follow-up|1|||
130277628|NCT01406938|468978182|FG001|Follow up|Lost to Follow-up|1|||
130277629|NCT01406938|468978183|FG002|Follow up|Lost to Follow-up|0|||
130277630|NCT01406938|468978184|FG003|Follow up|Lost to Follow-up|1|||
130277631|NCT01406938|468978185|FG004|Follow up|Lost to Follow-up|2|||
130277632|NCT01406938|468978186|FG005|Follow up|Lost to Follow-up|1|||
130277633|NCT01951586|468978194|FG000|Overall Study|Death|61|||
130277634|NCT01951586|468978195|FG001|Overall Study|Death|120|||
130277635|NCT01951586|468978194|FG000|Overall Study|Withdrawal by Subject|8|||
130277636|NCT01951586|468978195|FG001|Overall Study|Withdrawal by Subject|17|||
130277637|NCT01951586|468978194|FG000|Overall Study|Lost to Follow-up|0|||
130277638|NCT01951586|468978195|FG001|Overall Study|Lost to Follow-up|1|||
130277639|NCT01951586|468978194|FG000|Overall Study|Sponsor Decision|9|||
130277640|NCT01951586|468978195|FG001|Overall Study|Sponsor Decision|10|||
130277641|NCT00878254|468978197|FG000|Overall Study|Physician Decision|1|||
130277642|NCT00878254|468978197|FG000|Overall Study|Death|1|||
130277643|NCT00878254|468978197|FG000|Overall Study|Withdrawal by Subject|1|||
130277644|NCT04560816|468978199|FG000|Overall Study|Withdrawal by Subject|1|||
130277645|NCT04560816|468978200|FG001|Overall Study|Withdrawal by Subject|1|||
130277646|NCT04560816|468978201|FG002|Overall Study|Withdrawal by Subject|1|||
130277647|NCT04560816|468978202|FG003|Overall Study|Withdrawal by Subject|0|||
130277648|NCT04560816|468978203|FG004|Overall Study|Withdrawal by Subject|3|||
130277649|NCT04560816|468978204|FG005|Overall Study|Withdrawal by Subject|0|||
130277650|NCT04560816|468978199|FG000|Overall Study|Lost to Follow-up|1|||
130277651|NCT04560816|468978200|FG001|Overall Study|Lost to Follow-up|0|||
130277652|NCT04560816|468978201|FG002|Overall Study|Lost to Follow-up|0|||
130277653|NCT04560816|468978202|FG003|Overall Study|Lost to Follow-up|0|||
130277654|NCT04560816|468978203|FG004|Overall Study|Lost to Follow-up|0|||
130277655|NCT04560816|468978204|FG005|Overall Study|Lost to Follow-up|0|||
130277656|NCT04560816|468978199|FG000|Overall Study|Protocol Violation|1|||
130277657|NCT04560816|468978200|FG001|Overall Study|Protocol Violation|0|||
130277658|NCT04560816|468978201|FG002|Overall Study|Protocol Violation|0|||
130277659|NCT04560816|468978202|FG003|Overall Study|Protocol Violation|0|||
130277660|NCT04560816|468978203|FG004|Overall Study|Protocol Violation|0|||
130277661|NCT04560816|468978204|FG005|Overall Study|Protocol Violation|0|||
130277662|NCT02277691|468978205|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
130277663|NCT02277691|468978205|FG000|Overall Study|Voluntary Withdrawal|7|||
130277664|NCT02277691|468978205|FG000|Overall Study|Lack of Efficacy|5|||
130277665|NCT02277691|468978205|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
130277666|NCT00441142|468978207|FG000|Overall Study|Adverse Event|2|||
130277667|NCT00441142|468978208|FG001|Overall Study|Adverse Event|3|||
130277668|NCT00441142|468978209|FG002|Overall Study|Adverse Event|3|||
130277669|NCT00441142|468978210|FG003|Overall Study|Adverse Event|22|||
130277670|NCT00441142|468978207|FG000|Overall Study|Lack of Efficacy|3|||
130277671|NCT00441142|468978208|FG001|Overall Study|Lack of Efficacy|3|||
130277672|NCT00441142|468978209|FG002|Overall Study|Lack of Efficacy|17|||
130277673|NCT00441142|468978210|FG003|Overall Study|Lack of Efficacy|32|||
130277674|NCT00441142|468978207|FG000|Overall Study|Withdrawal by Subject|0|||
130277675|NCT00441142|468978208|FG001|Overall Study|Withdrawal by Subject|0|||
130277676|NCT00441142|468978209|FG002|Overall Study|Withdrawal by Subject|2|||
130277677|NCT00441142|468978210|FG003|Overall Study|Withdrawal by Subject|10|||
130277678|NCT00441142|468978207|FG000|Overall Study|Patient still receiving active study tx|1|||
130277679|NCT00441142|468978208|FG001|Overall Study|Patient still receiving active study tx|0|||
130277680|NCT00441142|468978209|FG002|Overall Study|Patient still receiving active study tx|0|||
130277681|NCT00441142|468978210|FG003|Overall Study|Patient still receiving active study tx|2|||
130277682|NCT00441142|468978207|FG000|Overall Study|Physician Decision|0|||
130277683|NCT00441142|468978208|FG001|Overall Study|Physician Decision|1|||
130277684|NCT00441142|468978209|FG002|Overall Study|Physician Decision|0|||
130277685|NCT00441142|468978210|FG003|Overall Study|Physician Decision|1|||
130277686|NCT00441142|468978207|FG000|Overall Study|Death|0|||
130277687|NCT00441142|468978208|FG001|Overall Study|Death|0|||
130277688|NCT00441142|468978209|FG002|Overall Study|Death|0|||
130277689|NCT00441142|468978210|FG003|Overall Study|Death|1|||
130277690|NCT04952597|468978211|FG000|Overall Study|Death|12|||
130277691|NCT04952597|468978212|FG001|Overall Study|Death|13|||
130277692|NCT04952597|468978213|FG002|Overall Study|Death|14|||
130277693|NCT04952597|468978211|FG000|Overall Study|Withdrawal by Subject|1|||
130105778|NCT01155284|468348037|FG000|Overall Study|Lost to Follow-up|1|||
130105779|NCT01155284|468348038|FG001|Overall Study|Lost to Follow-up|2|||
130105780|NCT01155284|468348037|FG000|Overall Study|Physician Decision|1|||
130105781|NCT01155284|468348038|FG001|Overall Study|Physician Decision|0|||
130105782|NCT01155284|468348037|FG000|Overall Study|Adverse Event|1|||
130105783|NCT01155284|468348038|FG001|Overall Study|Adverse Event|0|||
130105784|NCT01289990|468348044|FG000|Overall Study|Death|0|||
130105785|NCT01289990|468348045|FG001|Overall Study|Death|0|||
130105786|NCT01289990|468348046|FG002|Overall Study|Death|0|||
130105787|NCT01289990|468348047|FG003|Overall Study|Death|1|||
130105788|NCT01289990|468348048|FG004|Overall Study|Death|2|||
130105789|NCT01289990|468348049|FG005|Overall Study|Death|1|||
130105790|NCT01289990|468348050|FG006|Overall Study|Death|0|||
130105791|NCT01289990|468348051|FG007|Overall Study|Death|0|||
130105792|NCT01289990|468348052|FG008|Overall Study|Death|0|||
130105793|NCT01289990|468348053|FG009|Overall Study|Death|0|||
130105794|NCT01289990|468348054|FG010|Overall Study|Death|0|||
130105795|NCT01289990|468348055|FG011|Overall Study|Death|1|||
130105796|NCT01289990|468348056|FG012|Overall Study|Death|0|||
130105797|NCT01289990|468348044|FG000|Overall Study|Lost to Follow-up|3|||
130105798|NCT01289990|468348045|FG001|Overall Study|Lost to Follow-up|2|||
130105799|NCT01289990|468348046|FG002|Overall Study|Lost to Follow-up|5|||
130105800|NCT01289990|468348047|FG003|Overall Study|Lost to Follow-up|5|||
130105801|NCT01289990|468348048|FG004|Overall Study|Lost to Follow-up|3|||
130105802|NCT01289990|468348049|FG005|Overall Study|Lost to Follow-up|4|||
130105803|NCT01289990|468348050|FG006|Overall Study|Lost to Follow-up|2|||
130105804|NCT01289990|468348051|FG007|Overall Study|Lost to Follow-up|2|||
130105805|NCT01289990|468348052|FG008|Overall Study|Lost to Follow-up|1|||
130105806|NCT01289990|468348053|FG009|Overall Study|Lost to Follow-up|4|||
130277694|NCT04952597|468978212|FG001|Overall Study|Withdrawal by Subject|0|||
130277695|NCT04952597|468978213|FG002|Overall Study|Withdrawal by Subject|3|||
130277696|NCT04952597|468978211|FG000|Overall Study|Lost to Follow-up|0|||
130277697|NCT04952597|468978212|FG001|Overall Study|Lost to Follow-up|1|||
130277698|NCT04952597|468978213|FG002|Overall Study|Lost to Follow-up|1|||
130277699|NCT01265563|468978214|FG000|Overall Study|Withdrawal by Subject|0|||
130277700|NCT01265563|468978215|FG001|Overall Study|Withdrawal by Subject|1|||
130277701|NCT01265563|468978216|FG002|Overall Study|Withdrawal by Subject|1|||
130277702|NCT01265563|468978217|FG003|Overall Study|Withdrawal by Subject|0|||
130277703|NCT01265563|468978218|FG004|Overall Study|Withdrawal by Subject|2|||
130277704|NCT04908865|468978223|FG000|Overall Study|Adverse Event|2|||
130277705|NCT04908865|468978223|FG000|Overall Study|Lack of Efficacy|5|||
130277706|NCT04908865|468978223|FG000|Overall Study|Lost to Follow-up|1|||
130277707|NCT02141399|468978226|FG000|Overall Study|Adverse Event|158|||
130277708|NCT02141399|468978226|FG000|Overall Study|Lack of Efficacy|62|||
130277709|NCT02141399|468978226|FG000|Overall Study|Lost to Follow-up|151|||
130277710|NCT02141399|468978226|FG000|Overall Study|Non-compliance with study drug|18|||
130277711|NCT02141399|468978226|FG000|Overall Study|Other|45|||
130277712|NCT02141399|468978226|FG000|Overall Study|Physician Decision|17|||
130277713|NCT02141399|468978226|FG000|Overall Study|Pregnancy|3|||
130277714|NCT02141399|468978226|FG000|Overall Study|Protocol Violation|38|||
130277715|NCT02141399|468978226|FG000|Overall Study|Withdrawal by Subject|238|||
130277716|NCT02141399|468978226|FG000|Overall Study|Failure to meet eligibility criteria|14|||
130105807|NCT01289990|468348054|FG010|Overall Study|Lost to Follow-up|2|||
130105808|NCT01289990|468348055|FG011|Overall Study|Lost to Follow-up|1|||
130105809|NCT01289990|468348056|FG012|Overall Study|Lost to Follow-up|2|||
130105810|NCT01289990|468348044|FG000|Overall Study|Withdrawal by Subject|15|||
130105811|NCT01289990|468348045|FG001|Overall Study|Withdrawal by Subject|14|||
130277717|NCT05730335|468978227|FG000|Overall Study|Lost to Follow-up|8|||
130041677|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130041678|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
130041679|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130041680|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
130041681|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
130041682|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130041683|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
130041684|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
130041685|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
130105812|NCT01289990|468348046|FG002|Overall Study|Withdrawal by Subject|12|||
130105813|NCT01289990|468348047|FG003|Overall Study|Withdrawal by Subject|13|||
130105814|NCT01289990|468348048|FG004|Overall Study|Withdrawal by Subject|8|||
130105815|NCT01289990|468348049|FG005|Overall Study|Withdrawal by Subject|7|||
130105816|NCT01289990|468348050|FG006|Overall Study|Withdrawal by Subject|13|||
130105817|NCT01289990|468348051|FG007|Overall Study|Withdrawal by Subject|9|||
130041686|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
130105818|NCT01289990|468348052|FG008|Overall Study|Withdrawal by Subject|12|||
130105819|NCT01289990|468348053|FG009|Overall Study|Withdrawal by Subject|13|||
130105820|NCT01289990|468348054|FG010|Overall Study|Withdrawal by Subject|11|||
130105821|NCT01289990|468348055|FG011|Overall Study|Withdrawal by Subject|13|||
130105822|NCT01289990|468348056|FG012|Overall Study|Withdrawal by Subject|16|||
130105823|NCT01289990|468348044|FG000|Overall Study|discontinued in preceding trial|18|||
130105824|NCT01289990|468348045|FG001|Overall Study|discontinued in preceding trial|20|||
130105825|NCT01289990|468348046|FG002|Overall Study|discontinued in preceding trial|41|||
130105826|NCT01289990|468348047|FG003|Overall Study|discontinued in preceding trial|17|||
130105827|NCT01289990|468348048|FG004|Overall Study|discontinued in preceding trial|11|||
130105828|NCT01289990|468348049|FG005|Overall Study|discontinued in preceding trial|12|||
130105829|NCT01289990|468348050|FG006|Overall Study|discontinued in preceding trial|18|||
130105830|NCT01289990|468348051|FG007|Overall Study|discontinued in preceding trial|8|||
130105831|NCT01289990|468348052|FG008|Overall Study|discontinued in preceding trial|17|||
130105832|NCT01289990|468348053|FG009|Overall Study|discontinued in preceding trial|21|||
130277718|NCT05730335|468978227|FG000|Overall Study|Withdrawal by Subject|6|||
130277719|NCT01296711|468978228|FG000|Overall Study|Adverse Event|3|||
130105833|NCT01289990|468348054|FG010|Overall Study|discontinued in preceding trial|17|||
130105834|NCT01289990|468348055|FG011|Overall Study|discontinued in preceding trial|17|||
130105835|NCT01289990|468348056|FG012|Overall Study|discontinued in preceding trial|24|||
130105836|NCT01289990|468348044|FG000|Overall Study|did not continue in extension|41|||
130105837|NCT01289990|468348045|FG001|Overall Study|did not continue in extension|45|||
130105838|NCT01289990|468348046|FG002|Overall Study|did not continue in extension|51|||
130105839|NCT01289990|468348047|FG003|Overall Study|did not continue in extension|51|||
130041687|NCT01009463|468110584|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
130105840|NCT01289990|468348048|FG004|Overall Study|did not continue in extension|48|||
130105841|NCT01289990|468348049|FG005|Overall Study|did not continue in extension|50|||
130105842|NCT01289990|468348050|FG006|Overall Study|did not continue in extension|54|||
130105843|NCT01289990|468348051|FG007|Overall Study|did not continue in extension|36|||
130105844|NCT01289990|468348052|FG008|Overall Study|did not continue in extension|44|||
130105845|NCT01289990|468348053|FG009|Overall Study|did not continue in extension|48|||
130105846|NCT01289990|468348054|FG010|Overall Study|did not continue in extension|45|||
130105847|NCT01289990|468348055|FG011|Overall Study|did not continue in extension|34|||
130277720|NCT01296711|468978229|FG001|Overall Study|Adverse Event|1|||
130277721|NCT01296711|468978230|FG002|Overall Study|Adverse Event|4|||
130277722|NCT01296711|468978231|FG003|Overall Study|Adverse Event|3|||
130277723|NCT01296711|468978232|FG004|Overall Study|Adverse Event|1|||
130277724|NCT01296711|468978233|FG005|Overall Study|Adverse Event|6|||
130277725|NCT01296711|468978234|FG006|Overall Study|Adverse Event|11|||
130277726|NCT01296711|468978235|FG007|Overall Study|Adverse Event|3|||
130277727|NCT01296711|468978228|FG000|Overall Study|Lack of Efficacy|1|||
130277728|NCT01296711|468978229|FG001|Overall Study|Lack of Efficacy|4|||
130277729|NCT01296711|468978230|FG002|Overall Study|Lack of Efficacy|1|||
130277730|NCT01296711|468978231|FG003|Overall Study|Lack of Efficacy|1|||
130277731|NCT01296711|468978232|FG004|Overall Study|Lack of Efficacy|1|||
130277732|NCT01296711|468978233|FG005|Overall Study|Lack of Efficacy|0|||
130277733|NCT01296711|468978234|FG006|Overall Study|Lack of Efficacy|2|||
130277734|NCT01296711|468978235|FG007|Overall Study|Lack of Efficacy|3|||
130277735|NCT01296711|468978228|FG000|Overall Study|Lost to Follow-up|0|||
130277736|NCT01296711|468978229|FG001|Overall Study|Lost to Follow-up|0|||
130277737|NCT01296711|468978230|FG002|Overall Study|Lost to Follow-up|1|||
130277738|NCT01296711|468978231|FG003|Overall Study|Lost to Follow-up|1|||
130277739|NCT01296711|468978232|FG004|Overall Study|Lost to Follow-up|2|||
130277740|NCT01296711|468978233|FG005|Overall Study|Lost to Follow-up|0|||
130277741|NCT01296711|468978234|FG006|Overall Study|Lost to Follow-up|4|||
130277742|NCT01296711|468978235|FG007|Overall Study|Lost to Follow-up|2|||
130277743|NCT01296711|468978228|FG000|Overall Study|Protocol Violation|0|||
130277744|NCT01296711|468978229|FG001|Overall Study|Protocol Violation|0|||
130277745|NCT01296711|468978230|FG002|Overall Study|Protocol Violation|0|||
130277746|NCT01296711|468978231|FG003|Overall Study|Protocol Violation|1|||
130277747|NCT01296711|468978232|FG004|Overall Study|Protocol Violation|1|||
130277748|NCT01296711|468978233|FG005|Overall Study|Protocol Violation|0|||
130277749|NCT01296711|468978234|FG006|Overall Study|Protocol Violation|0|||
130277750|NCT01296711|468978235|FG007|Overall Study|Protocol Violation|0|||
130277751|NCT01296711|468978228|FG000|Overall Study|Withdrawal by Subject|4|||
130277752|NCT01296711|468978229|FG001|Overall Study|Withdrawal by Subject|2|||
130277753|NCT01296711|468978230|FG002|Overall Study|Withdrawal by Subject|2|||
130277754|NCT01296711|468978231|FG003|Overall Study|Withdrawal by Subject|1|||
130277755|NCT01296711|468978232|FG004|Overall Study|Withdrawal by Subject|1|||
130277756|NCT01296711|468978233|FG005|Overall Study|Withdrawal by Subject|1|||
130277757|NCT01296711|468978234|FG006|Overall Study|Withdrawal by Subject|2|||
130277758|NCT01296711|468978235|FG007|Overall Study|Withdrawal by Subject|1|||
130277759|NCT01296711|468978228|FG000|Overall Study|Study termination|8|||
130277760|NCT01296711|468978229|FG001|Overall Study|Study termination|1|||
130277761|NCT01296711|468978230|FG002|Overall Study|Study termination|5|||
130277762|NCT01296711|468978231|FG003|Overall Study|Study termination|4|||
130277763|NCT01296711|468978232|FG004|Overall Study|Study termination|4|||
130277764|NCT01296711|468978233|FG005|Overall Study|Study termination|4|||
130277765|NCT01296711|468978234|FG006|Overall Study|Study termination|8|||
130277766|NCT01296711|468978235|FG007|Overall Study|Study termination|10|||
130277767|NCT01296711|468978228|FG000|Overall Study|Continued elevated liver enzymes|0|||
130277768|NCT01296711|468978229|FG001|Overall Study|Continued elevated liver enzymes|0|||
130277769|NCT01296711|468978230|FG002|Overall Study|Continued elevated liver enzymes|0|||
130277770|NCT01296711|468978231|FG003|Overall Study|Continued elevated liver enzymes|1|||
130277771|NCT01296711|468978232|FG004|Overall Study|Continued elevated liver enzymes|0|||
130277772|NCT01296711|468978233|FG005|Overall Study|Continued elevated liver enzymes|0|||
130041688|NCT01009463|468110585|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
130041689|NCT01009463|468110586|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
130041690|NCT01009463|468110587|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
130041691|NCT01009463|468110588|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
130041692|NCT02333331|468110589|FG000|Overall Study|Adverse Event|1|||
130041693|NCT02333331|468110590|FG001|Overall Study|Adverse Event|0|||
130041694|NCT02333331|468110591|FG002|Overall Study|Adverse Event|4|||
130041695|NCT02333331|468110592|FG003|Overall Study|Adverse Event|1|||
130041696|NCT02333331|468110589|FG000|Overall Study|Death|0|||
130041697|NCT02333331|468110590|FG001|Overall Study|Death|0|||
130041698|NCT02333331|468110591|FG002|Overall Study|Death|2|||
130041699|NCT02333331|468110592|FG003|Overall Study|Death|0|||
130041700|NCT02333331|468110589|FG000|Overall Study|Lost to Follow-up|0|||
130041701|NCT02333331|468110590|FG001|Overall Study|Lost to Follow-up|0|||
130041702|NCT02333331|468110591|FG002|Overall Study|Lost to Follow-up|1|||
130041703|NCT02333331|468110592|FG003|Overall Study|Lost to Follow-up|0|||
130041704|NCT02333331|468110589|FG000|Overall Study|Physician Decision|0|||
130041705|NCT02333331|468110590|FG001|Overall Study|Physician Decision|1|||
130041706|NCT02333331|468110591|FG002|Overall Study|Physician Decision|0|||
130041707|NCT02333331|468110592|FG003|Overall Study|Physician Decision|0|||
130041708|NCT02333331|468110589|FG000|Overall Study|Protocol Deviation|0|||
130041709|NCT02333331|468110590|FG001|Overall Study|Protocol Deviation|3|||
130041710|NCT02333331|468110591|FG002|Overall Study|Protocol Deviation|2|||
130041711|NCT02333331|468110592|FG003|Overall Study|Protocol Deviation|1|||
130041712|NCT02333331|468110589|FG000|Overall Study|Patient/Guardian Decision|1|||
130041713|NCT02333331|468110590|FG001|Overall Study|Patient/Guardian Decision|2|||
130041714|NCT02333331|468110591|FG002|Overall Study|Patient/Guardian Decision|9|||
130041715|NCT02333331|468110592|FG003|Overall Study|Patient/Guardian Decision|1|||
130041716|NCT01494038|468110593|FG000|Overall Study|Protocol Violation|1|||
130041717|NCT01494038|468110594|FG001|Overall Study|Protocol Violation|1|||
130041718|NCT01494038|468110593|FG000|Overall Study|Lost to Follow-up|18|||
130041719|NCT01494038|468110594|FG001|Overall Study|Lost to Follow-up|20|||
130041720|NCT01494038|468110593|FG000|Overall Study|Withdrawal by Subject|44|||
130041721|NCT01494038|468110594|FG001|Overall Study|Withdrawal by Subject|34|||
130041722|NCT01494038|468110593|FG000|Overall Study|Not able to get to clinic|21|||
130041723|NCT01494038|468110594|FG001|Overall Study|Not able to get to clinic|15|||
130041724|NCT01494038|468110593|FG000|Overall Study|Not willing to adhere to reqs|2|||
130041725|NCT01494038|468110594|FG001|Overall Study|Not willing to adhere to reqs|9|||
130041726|NCT01494038|468110593|FG000|Overall Study|Death|2|||
130041727|NCT01494038|468110594|FG001|Overall Study|Death|4|||
130041728|NCT02874794|468110595|FG000|Overall Study|Physician Decision|3|||
130041729|NCT02874794|468110596|FG001|Overall Study|Physician Decision|2|||
130041730|NCT02874794|468110595|FG000|Overall Study|Withdrawal by Subject|2|||
130041731|NCT02874794|468110596|FG001|Overall Study|Withdrawal by Subject|8|||
130041732|NCT02874794|468110595|FG000|Overall Study|Death|2|||
130041733|NCT02874794|468110596|FG001|Overall Study|Death|1|||
130277773|NCT01296711|468978234|FG006|Overall Study|Continued elevated liver enzymes|0|||
130041734|NCT00537940|468110597|FG000|Overall Study|Adverse Event|20|||
130277774|NCT01296711|468978235|FG007|Overall Study|Continued elevated liver enzymes|0|||
130277775|NCT01296711|468978228|FG000|Overall Study|Methotrexate discontinued|0|||
130277776|NCT01296711|468978229|FG001|Overall Study|Methotrexate discontinued|0|||
130277777|NCT01296711|468978230|FG002|Overall Study|Methotrexate discontinued|0|||
130277778|NCT01296711|468978231|FG003|Overall Study|Methotrexate discontinued|1|||
130277779|NCT01296711|468978232|FG004|Overall Study|Methotrexate discontinued|0|||
130277780|NCT01296711|468978233|FG005|Overall Study|Methotrexate discontinued|0|||
130041735|NCT00537940|468110598|FG001|Overall Study|Adverse Event|19|||
130041736|NCT00537940|468110597|FG000|Overall Study|Lack of Efficacy|8|||
130041737|NCT00537940|468110598|FG001|Overall Study|Lack of Efficacy|16|||
130041738|NCT00537940|468110597|FG000|Overall Study|Lost to Follow-up|23|||
130041739|NCT00537940|468110598|FG001|Overall Study|Lost to Follow-up|29|||
130041740|NCT00537940|468110597|FG000|Overall Study|Withdrawal by Subject|113|||
130041741|NCT00537940|468110598|FG001|Overall Study|Withdrawal by Subject|95|||
130041742|NCT00537940|468110597|FG000|Overall Study|Protocol Violation|6|||
130041743|NCT00537940|468110598|FG001|Overall Study|Protocol Violation|4|||
130041744|NCT00537940|468110597|FG000|Overall Study|Pregnancy|1|||
130041745|NCT00537940|468110598|FG001|Overall Study|Pregnancy|1|||
130041746|NCT00537940|468110597|FG000|Overall Study|Study terminated by sponsor|2|||
130041747|NCT00537940|468110598|FG001|Overall Study|Study terminated by sponsor|3|||
130041748|NCT00537940|468110597|FG000|Overall Study|Other|10|||
130041749|NCT00537940|468110598|FG001|Overall Study|Other|12|||
130041750|NCT05309668|468110600|FG000|Overall Study|Ongoing at data cut-off|14|||
130041751|NCT05309668|468110601|FG001|Overall Study|Ongoing at data cut-off|17|||
130041752|NCT05309668|468110602|FG002|Overall Study|Ongoing at data cut-off|4|||
130041753|NCT02401256|468110603|FG000|Overall Study|Adverse Event|5|||
130041754|NCT02401256|468110603|FG000|Overall Study|Withdrawal by Subject|12|||
130041755|NCT00345605|468110607|FG000|Arm 1|Adverse Event|0|||
130041756|NCT00345605|468110608|FG001|Arm 1|Adverse Event|1|||
130041757|NCT00345605|468110607|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
130041758|NCT00345605|468110608|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
130041759|NCT01389128|468110609|FG000|Overall Study|Fetal distress|1|||
130041760|NCT01389128|468110610|FG001|Overall Study|Fetal distress|0|||
130041761|NCT01389128|468110609|FG000|Overall Study|Cervix dilation stop|1|||
130041762|NCT01389128|468110610|FG001|Overall Study|Cervix dilation stop|2|||
130041763|NCT01389128|468110609|FG000|Overall Study|Rapid labor evolution|3|||
130041764|NCT01389128|468110610|FG001|Overall Study|Rapid labor evolution|2|||
130041765|NCT01389128|468110609|FG000|Overall Study|Intolerance to procedure|0|||
130041766|NCT01389128|468110610|FG001|Overall Study|Intolerance to procedure|2|||
130041767|NCT01059812|468110611|FG000|Overall Study|Adverse Event|9|||
130041768|NCT01059812|468110612|FG001|Overall Study|Adverse Event|5|||
130041769|NCT01059812|468110611|FG000|Overall Study|Lack of Efficacy|2|||
130041770|NCT01059812|468110612|FG001|Overall Study|Lack of Efficacy|2|||
130041771|NCT01059812|468110611|FG000|Overall Study|Protocol Violation|3|||
130041772|NCT01059812|468110612|FG001|Overall Study|Protocol Violation|1|||
130041773|NCT01059812|468110611|FG000|Overall Study|Withdrawal Criteria|9|||
130041774|NCT01059812|468110612|FG001|Overall Study|Withdrawal Criteria|4|||
130041775|NCT01059812|468110611|FG000|Overall Study|Unclassified|14|||
130041776|NCT01059812|468110612|FG001|Overall Study|Unclassified|4|||
130041777|NCT03180736|468110613|FG000|Overall Study|Adverse Event|3|||
130041778|NCT03180736|468110614|FG001|Overall Study|Adverse Event|4|||
130041779|NCT03180736|468110613|FG000|Overall Study|Death|10|||
130041780|NCT03180736|468110614|FG001|Overall Study|Death|7|||
130041781|NCT03180736|468110613|FG000|Overall Study|Withdrawal by Subject|5|||
130041782|NCT03180736|468110614|FG001|Overall Study|Withdrawal by Subject|12|||
130041783|NCT03180736|468110613|FG000|Overall Study|Lost to Follow-up|1|||
130041784|NCT03180736|468110614|FG001|Overall Study|Lost to Follow-up|0|||
130041785|NCT03180736|468110613|FG000|Overall Study|Lack of Efficacy|66|||
130041786|NCT03180736|468110614|FG001|Overall Study|Lack of Efficacy|87|||
130041787|NCT03180736|468110613|FG000|Overall Study|Physician Decision|4|||
130041788|NCT03180736|468110614|FG001|Overall Study|Physician Decision|7|||
130041789|NCT03180736|468110613|FG000|Overall Study|randomized but not treated|2|||
130041790|NCT03180736|468110614|FG001|Overall Study|randomized but not treated|3|||
130041791|NCT01458340|468110619|FG000|Overall Study|Adverse Event|5|||
130041792|NCT01458340|468110620|FG001|Overall Study|Adverse Event|4|||
130041793|NCT01458340|468110621|FG002|Overall Study|Adverse Event|2|||
130041794|NCT01458340|468110619|FG000|Overall Study|Lost to Follow-up|3|||
130041795|NCT01458340|468110620|FG001|Overall Study|Lost to Follow-up|3|||
130041796|NCT01458340|468110621|FG002|Overall Study|Lost to Follow-up|10|||
130041797|NCT01458340|468110619|FG000|Overall Study|Miscellaneous|0|||
130041798|NCT01458340|468110620|FG001|Overall Study|Miscellaneous|1|||
130041799|NCT01458340|468110621|FG002|Overall Study|Miscellaneous|0|||
130041800|NCT01458340|468110619|FG000|Overall Study|Physician Decision|1|||
130041801|NCT01458340|468110620|FG001|Overall Study|Physician Decision|1|||
130041802|NCT01458340|468110621|FG002|Overall Study|Physician Decision|2|||
130041803|NCT01458340|468110619|FG000|Overall Study|Protocol Violation|6|||
130041804|NCT01458340|468110620|FG001|Overall Study|Protocol Violation|6|||
130041805|NCT01458340|468110621|FG002|Overall Study|Protocol Violation|5|||
130041806|NCT01458340|468110619|FG000|Overall Study|Withdrawal by Subject|12|||
130277781|NCT01296711|468978234|FG006|Overall Study|Methotrexate discontinued|0|||
130277782|NCT01296711|468978235|FG007|Overall Study|Methotrexate discontinued|0|||
130277783|NCT01296711|468978228|FG000|Overall Study|Investigator discretion|0|||
130277784|NCT01296711|468978229|FG001|Overall Study|Investigator discretion|0|||
130277785|NCT01296711|468978230|FG002|Overall Study|Investigator discretion|0|||
130277786|NCT01296711|468978231|FG003|Overall Study|Investigator discretion|0|||
130277787|NCT01296711|468978232|FG004|Overall Study|Investigator discretion|0|||
130277788|NCT01296711|468978233|FG005|Overall Study|Investigator discretion|0|||
130277789|NCT01296711|468978234|FG006|Overall Study|Investigator discretion|1|||
130277790|NCT01296711|468978235|FG007|Overall Study|Investigator discretion|0|||
130277791|NCT01296711|468978228|FG000|Overall Study|Other|0|||
130277792|NCT01296711|468978229|FG001|Overall Study|Other|0|||
130277793|NCT01296711|468978230|FG002|Overall Study|Other|0|||
130277794|NCT01296711|468978231|FG003|Overall Study|Other|0|||
130277795|NCT01296711|468978232|FG004|Overall Study|Other|0|||
130277796|NCT01296711|468978233|FG005|Overall Study|Other|0|||
130277797|NCT01296711|468978234|FG006|Overall Study|Other|1|||
130277798|NCT01296711|468978235|FG007|Overall Study|Other|0|||
130277799|NCT01296711|468978228|FG000|Overall Study|Required restricted steroid injections|0|||
130277800|NCT01296711|468978229|FG001|Overall Study|Required restricted steroid injections|0|||
130277801|NCT01296711|468978230|FG002|Overall Study|Required restricted steroid injections|0|||
130277802|NCT01296711|468978231|FG003|Overall Study|Required restricted steroid injections|0|||
130277803|NCT01296711|468978232|FG004|Overall Study|Required restricted steroid injections|0|||
130277804|NCT01296711|468978233|FG005|Overall Study|Required restricted steroid injections|0|||
130277805|NCT01296711|468978234|FG006|Overall Study|Required restricted steroid injections|1|||
130277806|NCT01296711|468978235|FG007|Overall Study|Required restricted steroid injections|0|||
130277807|NCT01296711|468978228|FG000|Overall Study|Ongoing missed appointments|0|||
130277808|NCT01296711|468978229|FG001|Overall Study|Ongoing missed appointments|0|||
130277809|NCT01296711|468978230|FG002|Overall Study|Ongoing missed appointments|0|||
130277810|NCT01296711|468978231|FG003|Overall Study|Ongoing missed appointments|0|||
130277811|NCT01296711|468978232|FG004|Overall Study|Ongoing missed appointments|0|||
130277812|NCT01296711|468978233|FG005|Overall Study|Ongoing missed appointments|0|||
130277813|NCT01296711|468978234|FG006|Overall Study|Ongoing missed appointments|1|||
130277814|NCT01296711|468978235|FG007|Overall Study|Ongoing missed appointments|0|||
130277815|NCT01296711|468978228|FG000|Overall Study|Failure to comply with visits|0|||
130277816|NCT01296711|468978229|FG001|Overall Study|Failure to comply with visits|0|||
130277817|NCT01296711|468978230|FG002|Overall Study|Failure to comply with visits|0|||
130041807|NCT01458340|468110620|FG001|Overall Study|Withdrawal by Subject|6|||
130041808|NCT01458340|468110621|FG002|Overall Study|Withdrawal by Subject|4|||
130041809|NCT03056287|468110622|FG000|Overall Study|Withdrawal by Subject|0|||
130041810|NCT03056287|468110623|FG001|Overall Study|Withdrawal by Subject|1|||
130041811|NCT03056287|468110624|FG002|Overall Study|Withdrawal by Subject|0|||
130041812|NCT03056287|468110625|FG003|Overall Study|Withdrawal by Subject|0|||
130041813|NCT03056287|468110622|FG000|Overall Study|move out of area|0|||
130041814|NCT03056287|468110623|FG001|Overall Study|move out of area|0|||
130041815|NCT03056287|468110624|FG002|Overall Study|move out of area|1|||
130041816|NCT03056287|468110625|FG003|Overall Study|move out of area|1|||
130041817|NCT00947154|468110629|FG000|Overall Study|Lost to Follow-up|1|||
130041818|NCT00091793|468110632|FG000|Overall Study|Adverse Event|1|||
130041819|NCT00091793|468110633|FG001|Overall Study|Adverse Event|2|||
130041820|NCT00091793|468110632|FG000|Overall Study|Withdrawal by Subject|10|||
130041821|NCT00091793|468110633|FG001|Overall Study|Withdrawal by Subject|15|||
130041822|NCT00091793|468110632|FG000|Overall Study|Ineligibility determined|2|||
130041823|NCT00091793|468110633|FG001|Overall Study|Ineligibility determined|0|||
130041824|NCT00091793|468110632|FG000|Overall Study|Lost to Follow-up|7|||
130041825|NCT00091793|468110633|FG001|Overall Study|Lost to Follow-up|5|||
130041826|NCT00091793|468110632|FG000|Overall Study|Noncompliance|2|||
130041827|NCT00091793|468110633|FG001|Overall Study|Noncompliance|0|||
130041828|NCT00091793|468110632|FG000|Overall Study|Other|2|||
130041829|NCT00091793|468110633|FG001|Overall Study|Other|0|||
130041830|NCT00849212|468110634|FG000|Overall Study|Lack of Efficacy|1|||
130041831|NCT00849212|468110634|FG000|Overall Study|Withdrawal by Subject|3|||
130041832|NCT00849212|468110634|FG000|Overall Study|Adverse Event|2|||
130041833|NCT00849212|468110634|FG000|Overall Study|Miscellaneous|1|||
130041834|NCT00845429|468110642|FG000|Overall Study|Protocol Violation|5|||
130041835|NCT00845429|468110643|FG001|Overall Study|Protocol Violation|4|||
130041836|NCT00845429|468110644|FG002|Overall Study|Protocol Violation|7|||
130041837|NCT00845429|468110642|FG000|Overall Study|Lost to Follow-up|7|||
130041838|NCT00845429|468110643|FG001|Overall Study|Lost to Follow-up|9|||
130041839|NCT00845429|468110644|FG002|Overall Study|Lost to Follow-up|10|||
130041840|NCT00845429|468110642|FG000|Overall Study|Withdrawal by Subject|2|||
130041841|NCT00845429|468110643|FG001|Overall Study|Withdrawal by Subject|2|||
130105848|NCT01289990|468348056|FG012|Overall Study|did not continue in extension|56|||
130105849|NCT01289990|468348044|FG000|Overall Study|Not treated|0|||
130105850|NCT01289990|468348045|FG001|Overall Study|Not treated|0|||
130105851|NCT01289990|468348046|FG002|Overall Study|Not treated|0|||
130105852|NCT01289990|468348047|FG003|Overall Study|Not treated|0|||
130105853|NCT01289990|468348048|FG004|Overall Study|Not treated|0|||
130105854|NCT01289990|468348049|FG005|Overall Study|Not treated|0|||
130105855|NCT01289990|468348050|FG006|Overall Study|Not treated|1|||
130105856|NCT01289990|468348051|FG007|Overall Study|Not treated|0|||
130105857|NCT01289990|468348052|FG008|Overall Study|Not treated|1|||
130105858|NCT01289990|468348053|FG009|Overall Study|Not treated|0|||
130105859|NCT01289990|468348054|FG010|Overall Study|Not treated|1|||
130105860|NCT01289990|468348055|FG011|Overall Study|Not treated|2|||
130105861|NCT01289990|468348056|FG012|Overall Study|Not treated|0|||
130105862|NCT04529499|468348057|FG000|Overall Study|Withdrawal by Subject|9|||
130105863|NCT04529499|468348058|FG001|Overall Study|Withdrawal by Subject|11|||
130105864|NCT04529499|468348057|FG000|Overall Study|Physician Decision|1|||
130105865|NCT04529499|468348058|FG001|Overall Study|Physician Decision|2|||
130105866|NCT04529499|468348057|FG000|Overall Study|Adverse Event|4|||
130105867|NCT04529499|468348058|FG001|Overall Study|Adverse Event|4|||
130277818|NCT01296711|468978231|FG003|Overall Study|Failure to comply with visits|0|||
130277819|NCT01296711|468978232|FG004|Overall Study|Failure to comply with visits|0|||
130277820|NCT01296711|468978233|FG005|Overall Study|Failure to comply with visits|0|||
130277821|NCT01296711|468978234|FG006|Overall Study|Failure to comply with visits|0|||
130277822|NCT01296711|468978235|FG007|Overall Study|Failure to comply with visits|1|||
130277823|NCT01296711|468978228|FG000|Overall Study|Patient decision due to transport|0|||
130277824|NCT01296711|468978229|FG001|Overall Study|Patient decision due to transport|0|||
130277825|NCT01296711|468978230|FG002|Overall Study|Patient decision due to transport|0|||
130277826|NCT01296711|468978231|FG003|Overall Study|Patient decision due to transport|0|||
130277827|NCT01296711|468978232|FG004|Overall Study|Patient decision due to transport|0|||
130277828|NCT01296711|468978233|FG005|Overall Study|Patient decision due to transport|0|||
130277829|NCT01296711|468978234|FG006|Overall Study|Patient decision due to transport|0|||
130277830|NCT01296711|468978235|FG007|Overall Study|Patient decision due to transport|1|||
130277831|NCT05411822|468978241|FG000|Overall Study|Withdrawal by Subject|2|||
130277832|NCT05411822|468978242|FG001|Overall Study|Withdrawal by Subject|1|||
130277833|NCT01864148|468978244|FG000|Overall Study|Other|2|||
130277834|NCT01864148|468978245|FG001|Overall Study|Other|1|||
130277835|NCT01864148|468978246|FG002|Overall Study|Other|1|||
130277836|NCT01864148|468978247|FG003|Overall Study|Other|3|||
130277837|NCT01864148|468978248|FG004|Overall Study|Other|1|||
130277838|NCT01864148|468978244|FG000|Overall Study|Death|0|||
130277839|NCT01864148|468978245|FG001|Overall Study|Death|0|||
130277840|NCT01864148|468978246|FG002|Overall Study|Death|0|||
130277841|NCT01864148|468978247|FG003|Overall Study|Death|1|||
130277842|NCT01864148|468978248|FG004|Overall Study|Death|0|||
130277843|NCT01864148|468978244|FG000|Overall Study|Investigator Decision|5|||
130277844|NCT01864148|468978245|FG001|Overall Study|Investigator Decision|0|||
130277845|NCT01864148|468978246|FG002|Overall Study|Investigator Decision|0|||
130277846|NCT01864148|468978247|FG003|Overall Study|Investigator Decision|4|||
130277847|NCT01864148|468978248|FG004|Overall Study|Investigator Decision|6|||
130277848|NCT01864148|468978244|FG000|Overall Study|Withdrawal by Subject|9|||
130277849|NCT01864148|468978245|FG001|Overall Study|Withdrawal by Subject|2|||
130277850|NCT01864148|468978246|FG002|Overall Study|Withdrawal by Subject|6|||
130277851|NCT01864148|468978247|FG003|Overall Study|Withdrawal by Subject|8|||
130277852|NCT01864148|468978248|FG004|Overall Study|Withdrawal by Subject|8|||
130277853|NCT01864148|468978244|FG000|Overall Study|Lost to Follow-up|0|||
130277854|NCT01864148|468978245|FG001|Overall Study|Lost to Follow-up|0|||
130277855|NCT01864148|468978246|FG002|Overall Study|Lost to Follow-up|0|||
130277856|NCT01864148|468978247|FG003|Overall Study|Lost to Follow-up|2|||
130277857|NCT01864148|468978248|FG004|Overall Study|Lost to Follow-up|1|||
130277858|NCT01864148|468978244|FG000|Overall Study|Adverse Event|4|||
130277859|NCT01864148|468978245|FG001|Overall Study|Adverse Event|2|||
130277860|NCT01864148|468978246|FG002|Overall Study|Adverse Event|4|||
130277861|NCT01864148|468978247|FG003|Overall Study|Adverse Event|7|||
130277862|NCT01864148|468978248|FG004|Overall Study|Adverse Event|7|||
130277863|NCT01864148|468978244|FG000|Overall Study|Not Dosed|0|||
130277864|NCT01864148|468978245|FG001|Overall Study|Not Dosed|0|||
130277865|NCT01864148|468978246|FG002|Overall Study|Not Dosed|0|||
130277866|NCT01864148|468978247|FG003|Overall Study|Not Dosed|1|||
130277867|NCT01864148|468978248|FG004|Overall Study|Not Dosed|0|||
130277868|NCT02027311|468978249|FG000|Overall Study|Protocol Violation|3|||
130277869|NCT02027311|468978250|FG001|Overall Study|Protocol Violation|2|||
130277870|NCT02466425|468978253|FG000|Overall Study|Adverse Event|3|||
130277871|NCT02466425|468978254|FG001|Overall Study|Adverse Event|11|||
130277872|NCT02466425|468978253|FG000|Overall Study|Lack of Efficacy|4|||
130277873|NCT02466425|468978254|FG001|Overall Study|Lack of Efficacy|1|||
130105868|NCT04529499|468348057|FG000|Overall Study|Death|14|||
130277874|NCT02466425|468978253|FG000|Overall Study|Lost to Follow-up|3|||
130105869|NCT04529499|468348058|FG001|Overall Study|Death|11|||
130105870|NCT04529499|468348057|FG000|Overall Study|Lost to Follow-up|1|||
130041842|NCT00845429|468110644|FG002|Overall Study|Withdrawal by Subject|2|||
130041843|NCT00845429|468110642|FG000|Overall Study|Serious adverse event|0|||
130041844|NCT00845429|468110643|FG001|Overall Study|Serious adverse event|0|||
130277875|NCT02466425|468978254|FG001|Overall Study|Lost to Follow-up|0|||
130277876|NCT02466425|468978253|FG000|Overall Study|Protocol Violation|1|||
130277877|NCT02466425|468978254|FG001|Overall Study|Protocol Violation|0|||
130277878|NCT02466425|468978253|FG000|Overall Study|Withdrawal by Subject|0|||
130277879|NCT02466425|468978254|FG001|Overall Study|Withdrawal by Subject|1|||
130277880|NCT02466425|468978253|FG000|Overall Study|Other|1|||
130277881|NCT02466425|468978254|FG001|Overall Study|Other|3|||
130277882|NCT02466425|468978253|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130277883|NCT02466425|468978254|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130277884|NCT01721486|468978259|FG000|Overall Study|Protocol Violation|1|||
130277885|NCT01721486|468978260|FG001|Overall Study|Protocol Violation|0|||
130277886|NCT01721486|468978259|FG000|Overall Study|Physician Decision|0|||
130277887|NCT01721486|468978260|FG001|Overall Study|Physician Decision|1|||
130277888|NCT00582712|468978261|FG000|Overall Study|Adverse Event|1|||
130277889|NCT00582712|468978261|FG000|Overall Study|Lack of Efficacy|1|||
130277890|NCT00582712|468978261|FG000|Overall Study|Withdrawal by Subject|1|||
130277891|NCT00582712|468978261|FG000|Overall Study|Complicating disease requiring treatment|1|||
130277892|NCT01901289|468978263|FG000|Overall Study|Death|32|||
130277893|NCT01901289|468978263|FG000|Overall Study|Lost to Follow-up|16|||
130277894|NCT01901289|468978263|FG000|Overall Study|Withdrawal by Subject|35|||
130277895|NCT01901289|468978263|FG000|Overall Study|Other type of endpoint met|2|||
130277896|NCT01813058|468978264|FG000|Overall Study|Withdrawal by Subject|5|||
130277897|NCT01813058|468978265|FG001|Overall Study|Withdrawal by Subject|4|||
130277898|NCT00395486|468978266|FG000|Overall Study|Adverse Event|1|||
130277899|NCT00395486|468978267|FG001|Overall Study|Adverse Event|2|||
130277900|NCT00395486|468978266|FG000|Overall Study|Withdrawal by Subject|5|||
130277901|NCT00395486|468978267|FG001|Overall Study|Withdrawal by Subject|2|||
130041845|NCT00845429|468110644|FG002|Overall Study|Serious adverse event|1|||
130041846|NCT02111369|468110648|FG000|Overall Study|Lost to Follow-up|2|||
130041847|NCT02111369|468110648|FG000|Overall Study|Withdrawal by Subject|1|||
130041848|NCT03240081|468110652|FG000|Overall Study|Withdrawal by Subject|0|||
130041849|NCT03240081|468110653|FG001|Overall Study|Withdrawal by Subject|2|||
130041850|NCT03240081|468110652|FG000|Overall Study|Lost to Follow-up|0|||
130041851|NCT03240081|468110653|FG001|Overall Study|Lost to Follow-up|1|||
130041852|NCT01480180|468110654|FG000|Main Phase|Withdrawal criteria|12|||
130277902|NCT00395486|468978266|FG000|Overall Study|Lost to Follow-up|0|||
130277903|NCT00395486|468978267|FG001|Overall Study|Lost to Follow-up|1|||
130277904|NCT00361231|468978272|FG000|Overall Study|Physician Decision|3|||
130277905|NCT00361231|468978272|FG000|Overall Study|Symptomatic deterioration|5|||
130277906|NCT00361231|468978272|FG000|Overall Study|Radiographic disease progression|16|||
130277907|NCT00361231|468978272|FG000|Overall Study|Withdrawal by Subject|4|||
130277908|NCT00361231|468978272|FG000|Overall Study|Adverse Event|6|||
130277909|NCT01814397|468978275|FG000|Overall Study|Adverse Event|7|||
130277910|NCT01814397|468978275|FG000|Overall Study|Withdrawal by Subject|7|||
130277911|NCT00313144|468978276|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
130277912|NCT00313144|468978276|FG000|Overall Study|Death|7|||
130277913|NCT00313144|468978276|FG000|Overall Study|Lost to Follow-up|5|||
130277914|NCT00313144|468978276|FG000|Overall Study|Withdrawal by Subject|4|||
130277915|NCT00313144|468978276|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
130277916|NCT00313144|468978276|FG000|Overall Study|Physician Decision|4|||
130277917|NCT00313144|468978276|FG000|Overall Study|Adverse event - transient|5|||
130277918|NCT00313144|468978276|FG000|Overall Study|Liver transplant|1|||
130277919|NCT00313144|468978276|FG000|Overall Study|Insurance (homecare provider) change|1|||
130277920|NCT00313144|468978276|FG000|Overall Study|Change to different product|1|||
130277921|NCT00313144|468978276|FG000|Overall Study|Due to termination of the study|66|||
130277922|NCT01932372|468978290|FG000|Overall Study|Not meeting eligibility criteria|33|||
130277923|NCT01932372|468978291|FG001|Overall Study|Not meeting eligibility criteria|179|||
130277924|NCT01917929|468978292|FG000|Overall Study|Death|8|||
130277925|NCT01917929|468978292|FG000|Overall Study|Lost to Follow-up|19|||
130277926|NCT01917929|468978292|FG000|Overall Study|Withdrawal by Subject|33|||
130277927|NCT01917929|468978292|FG000|Overall Study|Adverse Event|6|||
130277928|NCT01917929|468978292|FG000|Overall Study|Investigative Site Terminated|35|||
130277929|NCT01917929|468978292|FG000|Overall Study|Censored because study device not implanted|6|||
130277930|NCT01917929|468978292|FG000|Overall Study|Censored because surgery not performed|3|||
130277931|NCT01917929|468978292|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
130277932|NCT01917929|468978292|FG000|Overall Study|Sponsor terminated study|175|||
130277933|NCT03028415|468978293|FG000|Overall Study|Lost to Follow-up|6|||
130277934|NCT03028415|468978294|FG001|Overall Study|Lost to Follow-up|3|||
130277935|NCT03028415|468978293|FG000|Overall Study|Withdrawal by Subject|1|||
130277936|NCT03028415|468978294|FG001|Overall Study|Withdrawal by Subject|0|||
130105871|NCT04529499|468348058|FG001|Overall Study|Lost to Follow-up|1|||
130105872|NCT04529499|468348057|FG000|Overall Study|Others|7|||
130277937|NCT03028415|468978293|FG000|Overall Study|Discontinued due to COVID-19|1|||
130277938|NCT03028415|468978294|FG001|Overall Study|Discontinued due to COVID-19|0|||
130277939|NCT02907216|468978295|FG000|Overall Study|No benefit to be obtained by continuing|0|||
130277940|NCT02907216|468978296|FG001|Overall Study|No benefit to be obtained by continuing|1|||
130277941|NCT02907216|468978295|FG000|Overall Study|Withdrawal by Subject|1|||
130277942|NCT02907216|468978296|FG001|Overall Study|Withdrawal by Subject|0|||
130277943|NCT02241733|468978299|FG000|Overall Study|Lost to Follow-up|9|||
130277944|NCT02241733|468978300|FG001|Overall Study|Lost to Follow-up|4|||
130277945|NCT02241733|468978299|FG000|Overall Study|Physician Decision|6|||
130277946|NCT02241733|468978300|FG001|Overall Study|Physician Decision|2|||
130277947|NCT02241733|468978299|FG000|Overall Study|Withdrawal by Subject|0|||
130277948|NCT02241733|468978300|FG001|Overall Study|Withdrawal by Subject|2|||
130277949|NCT02241733|468978299|FG000|Overall Study|Death|0|||
130277950|NCT02241733|468978300|FG001|Overall Study|Death|2|||
130277951|NCT01063062|468978311|FG000|Overall Study|Patient withdrew consent|0|||
130277952|NCT01063062|468978312|FG001|Overall Study|Patient withdrew consent|1|||
130277953|NCT01063062|468978311|FG000|Overall Study|Adverse Event|2|||
130277954|NCT01063062|468978312|FG001|Overall Study|Adverse Event|4|||
130277955|NCT01063062|468978311|FG000|Overall Study|Protocol Violation|5|||
130041853|NCT01480180|468110655|FG001|Main Phase|Withdrawal criteria|1|||
130277956|NCT01063062|468978312|FG001|Overall Study|Protocol Violation|4|||
130277957|NCT01063062|468978311|FG000|Overall Study|Investigator's request|1|||
130277958|NCT01063062|468978312|FG001|Overall Study|Investigator's request|0|||
130277959|NCT01063062|468978311|FG000|Overall Study|Lost to Follow-up|0|||
130277960|NCT01063062|468978312|FG001|Overall Study|Lost to Follow-up|2|||
130277961|NCT01063062|468978311|FG000|Overall Study|Miscellaneous reason|0|||
130277962|NCT01063062|468978312|FG001|Overall Study|Miscellaneous reason|1|||
130041854|NCT01480180|468110656|FG002|Main Phase|Withdrawal criteria|0|||
130105873|NCT04529499|468348058|FG001|Overall Study|Others|11|||
130277963|NCT02597452|468978315|FG000|Overall Study|testing incomplete|30|||
130277964|NCT04621240|468978322|FG000|Overall Study|Withdrawal by Subject|36|||
130277965|NCT03206918|468978323|FG000|Overall Study|Death|11|||
130277966|NCT03206918|468978323|FG000|Overall Study|Withdrawal by Subject|5|||
130277967|NCT03206918|468978323|FG000|Overall Study|Study terminated by sponsor|12|||
130277968|NCT03206918|468978323|FG000|Overall Study|Lost to Follow-up|3|||
130277969|NCT03206918|468978323|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
130277970|NCT02954406|468979498|FG000|Overall Study|Adverse Event|0|||
130277971|NCT02954406|468979499|FG001|Overall Study|Adverse Event|1|||
130277972|NCT02954406|468979500|FG002|Overall Study|Adverse Event|0|||
130277973|NCT02954406|468979501|FG003|Overall Study|Adverse Event|0|||
130277974|NCT02954406|468979502|FG004|Overall Study|Adverse Event|1|||
130277975|NCT02954406|468979503|FG005|Overall Study|Adverse Event|0|||
130277976|NCT02954406|468979504|FG006|Overall Study|Adverse Event|0|||
130277977|NCT02954406|468979505|FG007|Overall Study|Adverse Event|0|||
130277978|NCT02954406|468979506|FG008|Overall Study|Adverse Event|1|||
130277979|NCT02954406|468979507|FG009|Overall Study|Adverse Event|1|||
130277980|NCT02954406|468979508|FG010|Overall Study|Adverse Event|0|||
130277981|NCT02954406|468979498|FG000|Overall Study|Progressive Disease|3|||
130277982|NCT02954406|468979499|FG001|Overall Study|Progressive Disease|4|||
130277983|NCT02954406|468979500|FG002|Overall Study|Progressive Disease|3|||
130277984|NCT02954406|468979501|FG003|Overall Study|Progressive Disease|4|||
130277985|NCT02954406|468979502|FG004|Overall Study|Progressive Disease|3|||
130277986|NCT02954406|468979503|FG005|Overall Study|Progressive Disease|3|||
130277987|NCT02954406|468979504|FG006|Overall Study|Progressive Disease|2|||
130277988|NCT02954406|468979505|FG007|Overall Study|Progressive Disease|2|||
130277989|NCT02954406|468979506|FG008|Overall Study|Progressive Disease|1|||
130105874|NCT00683904|468348059|FG000|Dose Level 1|Disease progression|2|||
130105875|NCT00683904|468348060|FG001|Dose Level 1|Disease progression|0|||
130105876|NCT00683904|468348059|FG000|Dose Level 1|Adverse Event|1|||
130105877|NCT00683904|468348060|FG001|Dose Level 1|Adverse Event|0|||
130105878|NCT00683904|468348059|FG000|Dose Level 2|Adverse Event|0|||
130105879|NCT00683904|468348060|FG001|Dose Level 2|Adverse Event|2|||
130105880|NCT00758706|468348061|FG000|Overall Study|Adverse Event|4|||
130105881|NCT00758706|468348062|FG001|Overall Study|Adverse Event|4|||
130105882|NCT03611751|468348063|FG000|Pre-treatment|Randomized but not treated|1|||
130105883|NCT03611751|468348064|FG001|Pre-treatment|Randomized but not treated|1|||
130105884|NCT03611751|468348065|FG002|Pre-treatment|Randomized but not treated|0|||
130105885|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
130105886|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
130105887|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
130105888|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
130105889|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
130277990|NCT02954406|468979507|FG009|Overall Study|Progressive Disease|1|||
130277991|NCT02954406|468979508|FG010|Overall Study|Progressive Disease|0|||
130277992|NCT02954406|468979498|FG000|Overall Study|Symptomatic Deterioration|0|||
130277993|NCT02954406|468979499|FG001|Overall Study|Symptomatic Deterioration|1|||
130277994|NCT02954406|468979500|FG002|Overall Study|Symptomatic Deterioration|0|||
130277995|NCT02954406|468979501|FG003|Overall Study|Symptomatic Deterioration|0|||
130277996|NCT02954406|468979502|FG004|Overall Study|Symptomatic Deterioration|0|||
130277997|NCT02954406|468979503|FG005|Overall Study|Symptomatic Deterioration|0|||
130277998|NCT02954406|468979504|FG006|Overall Study|Symptomatic Deterioration|0|||
130277999|NCT02954406|468979505|FG007|Overall Study|Symptomatic Deterioration|0|||
130278000|NCT02954406|468979506|FG008|Overall Study|Symptomatic Deterioration|0|||
130278001|NCT02954406|468979507|FG009|Overall Study|Symptomatic Deterioration|0|||
130278002|NCT02954406|468979508|FG010|Overall Study|Symptomatic Deterioration|0|||
130278003|NCT02954406|468979498|FG000|Overall Study|Death|0|||
130278004|NCT02954406|468979499|FG001|Overall Study|Death|0|||
130278005|NCT02954406|468979500|FG002|Overall Study|Death|0|||
130278006|NCT02954406|468979501|FG003|Overall Study|Death|0|||
130278007|NCT02954406|468979502|FG004|Overall Study|Death|1|||
130278008|NCT02954406|468979503|FG005|Overall Study|Death|0|||
130278009|NCT02954406|468979504|FG006|Overall Study|Death|0|||
130278010|NCT02954406|468979505|FG007|Overall Study|Death|0|||
130278011|NCT02954406|468979506|FG008|Overall Study|Death|1|||
130278012|NCT02954406|468979507|FG009|Overall Study|Death|1|||
130278013|NCT02954406|468979508|FG010|Overall Study|Death|0|||
130278014|NCT02954406|468979498|FG000|Overall Study|Reason Not Specified|0|||
130278015|NCT02954406|468979499|FG001|Overall Study|Reason Not Specified|0|||
130278016|NCT02954406|468979500|FG002|Overall Study|Reason Not Specified|3|||
130278017|NCT02954406|468979501|FG003|Overall Study|Reason Not Specified|2|||
130278018|NCT02954406|468979502|FG004|Overall Study|Reason Not Specified|2|||
130105890|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
130278019|NCT02954406|468979503|FG005|Overall Study|Reason Not Specified|0|||
130278020|NCT02954406|468979504|FG006|Overall Study|Reason Not Specified|1|||
130278021|NCT02954406|468979505|FG007|Overall Study|Reason Not Specified|0|||
130278022|NCT02954406|468979506|FG008|Overall Study|Reason Not Specified|1|||
130278023|NCT02954406|468979507|FG009|Overall Study|Reason Not Specified|0|||
130278024|NCT02954406|468979508|FG010|Overall Study|Reason Not Specified|0|||
130278025|NCT00782171|468979509|FG000|Overall Study|Lost to Follow-up|2|||
130278026|NCT00782171|468979510|FG001|Overall Study|Lost to Follow-up|2|||
130278027|NCT00782171|468979509|FG000|Overall Study|Withdrawal by Subject|2|||
130278028|NCT00782171|468979510|FG001|Overall Study|Withdrawal by Subject|1|||
130278029|NCT00782171|468979509|FG000|Overall Study|complications|3|||
130278030|NCT00782171|468979510|FG001|Overall Study|complications|1|||
130278031|NCT00782171|468979509|FG000|Overall Study|others|7|||
130278032|NCT00782171|468979510|FG001|Overall Study|others|9|||
130278033|NCT00782171|468979509|FG000|Overall Study|not eligible|8|||
130278034|NCT00782171|468979510|FG001|Overall Study|not eligible|6|||
130278035|NCT04075292|468979515|FG000|Overall Study|Withdrawal by Subject|1|||
130278036|NCT04075292|468979516|FG001|Overall Study|Withdrawal by Subject|9|||
130278037|NCT04075292|468979515|FG000|Overall Study|Death|2|||
130278038|NCT04075292|468979516|FG001|Overall Study|Death|5|||
130278039|NCT04075292|468979515|FG000|Overall Study|Remained on study at time of DCO|74|||
130278040|NCT04075292|468979516|FG001|Overall Study|Remained on study at time of DCO|64|||
130278041|NCT04308239|468979517|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
130041855|NCT01480180|468110657|FG003|Main Phase|Withdrawal criteria|0|||
130041856|NCT01480180|468110658|FG004|Main Phase|Withdrawal criteria|0|||
130041857|NCT01480180|468110659|FG005|Main Phase|Withdrawal criteria|0|||
130041858|NCT01480180|468110654|FG000|Main Phase|Lack of Efficacy|1|||
130041859|NCT01480180|468110655|FG001|Main Phase|Lack of Efficacy|0|||
130041860|NCT01480180|468110656|FG002|Main Phase|Lack of Efficacy|0|||
130041861|NCT01480180|468110657|FG003|Main Phase|Lack of Efficacy|0|||
130041862|NCT01480180|468110658|FG004|Main Phase|Lack of Efficacy|0|||
130041863|NCT01480180|468110659|FG005|Main Phase|Lack of Efficacy|0|||
130041864|NCT01480180|468110654|FG000|Main Phase|Non-compliance|3|||
130041865|NCT01480180|468110655|FG001|Main Phase|Non-compliance|0|||
130041866|NCT01480180|468110656|FG002|Main Phase|Non-compliance|0|||
130041867|NCT01480180|468110657|FG003|Main Phase|Non-compliance|0|||
130041868|NCT01480180|468110658|FG004|Main Phase|Non-compliance|0|||
130041869|NCT01480180|468110659|FG005|Main Phase|Non-compliance|0|||
130278042|NCT04308239|468979518|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
130278043|NCT04308239|468979517|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
130278044|NCT04308239|468979518|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
130278045|NCT04308239|468979517|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
130278046|NCT04308239|468979518|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
130278047|NCT04308239|468979517|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
130278048|NCT04308239|468979518|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
130278049|NCT01443364|468979519|FG000|Overall Study|Lack of Efficacy|14|||
130278050|NCT01443364|468979519|FG000|Overall Study|Lost to Follow-up|3|||
130278051|NCT01443364|468979519|FG000|Overall Study|Withdrawal by Subject|5|||
130278052|NCT01443364|468979519|FG000|Overall Study|Other Reason|4|||
130278053|NCT01443364|468979519|FG000|Overall Study|SAE, non-fatal|6|||
130278054|NCT01443364|468979519|FG000|Overall Study|AE, non-serious non-fatal|8|||
130278055|NCT01443364|468979519|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130278056|NCT00559845|468979522|FG000|Overall Study|Withdrew Consent|1|||
130278057|NCT00559845|468979522|FG000|Overall Study|Disease Progression|1|||
130278058|NCT00559845|468979522|FG000|Overall Study|Adverse Event|3|||
130278059|NCT00559845|468979522|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
130278060|NCT00559845|468979522|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
130278061|NCT03367403|468979525|FG000|Overall Study|Adverse Event|20|||
130278062|NCT03367403|468979526|FG001|Overall Study|Adverse Event|6|||
130278063|NCT03367403|468979527|FG002|Overall Study|Adverse Event|2|||
130278064|NCT03367403|468979525|FG000|Overall Study|Withdrawal by Subject|12|||
130278065|NCT03367403|468979526|FG001|Overall Study|Withdrawal by Subject|13|||
130278066|NCT03367403|468979527|FG002|Overall Study|Withdrawal by Subject|1|||
130278067|NCT03367403|468979525|FG000|Overall Study|Death|1|||
130041870|NCT01480180|468110654|FG000|Main Phase|Unclassified|3|||
130041871|NCT01480180|468110655|FG001|Main Phase|Unclassified|0|||
130278068|NCT03367403|468979526|FG001|Overall Study|Death|2|||
130278069|NCT03367403|468979527|FG002|Overall Study|Death|0|||
130278070|NCT03367403|468979525|FG000|Overall Study|Physician Decision|0|||
130278071|NCT03367403|468979526|FG001|Overall Study|Physician Decision|1|||
130278072|NCT03367403|468979527|FG002|Overall Study|Physician Decision|0|||
130278073|NCT03367403|468979525|FG000|Overall Study|Protocol Violation|1|||
130278074|NCT03367403|468979526|FG001|Overall Study|Protocol Violation|1|||
130278075|NCT03367403|468979527|FG002|Overall Study|Protocol Violation|0|||
130278076|NCT03367403|468979525|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
130278077|NCT03367403|468979526|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
130278078|NCT03367403|468979527|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
130278079|NCT03367403|468979525|FG000|Overall Study|COVID-19|3|||
130278080|NCT03367403|468979526|FG001|Overall Study|COVID-19|6|||
130278081|NCT03367403|468979527|FG002|Overall Study|COVID-19|0|||
130278082|NCT03367403|468979525|FG000|Overall Study|Abuse of Alcohol Intake|0|||
130278083|NCT03367403|468979526|FG001|Overall Study|Abuse of Alcohol Intake|1|||
130278084|NCT03367403|468979527|FG002|Overall Study|Abuse of Alcohol Intake|0|||
130278085|NCT03367403|468979525|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
130278086|NCT03367403|468979526|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
130278087|NCT03367403|468979527|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
130278088|NCT00194077|468979528|FG000|Overall Study|Lack of Efficacy|22|||
130278089|NCT00194077|468979529|FG001|Overall Study|Lack of Efficacy|29|||
130278090|NCT00194077|468979528|FG000|Overall Study|Study nonadherence|1|||
130278091|NCT00194077|468979529|FG001|Overall Study|Study nonadherence|0|||
130278092|NCT00194077|468979528|FG000|Overall Study|Withdrawal by Subject|1|||
130278093|NCT00194077|468979529|FG001|Overall Study|Withdrawal by Subject|1|||
130278094|NCT03470194|468979532|FG000|Overall Study|Lost to Follow-up|11|||
130278095|NCT03470194|468979533|FG001|Overall Study|Lost to Follow-up|17|||
130278096|NCT03286543|468979534|FG000|Consented|Screen failure before randomization|2|||
130278097|NCT03286543|468979535|FG001|Consented|Screen failure before randomization|0|||
130278098|NCT03286543|468979536|FG002|Consented|Screen failure before randomization|0|||
130278099|NCT03286543|468979534|FG000|Consented|Screen failure before enrollment|4|||
130278100|NCT03286543|468979535|FG001|Consented|Screen failure before enrollment|0|||
130278101|NCT03286543|468979536|FG002|Consented|Screen failure before enrollment|0|||
130278102|NCT03286543|468979534|FG000|Consented|TKA cancelled after enrollment|1|||
130278103|NCT03286543|468979535|FG001|Consented|TKA cancelled after enrollment|0|||
130278104|NCT03286543|468979536|FG002|Consented|TKA cancelled after enrollment|0|||
130278105|NCT03286543|468979534|FG000|Consented|Withdrawn from study|12|||
130278106|NCT03286543|468979535|FG001|Consented|Withdrawn from study|0|||
130278107|NCT03286543|468979536|FG002|Consented|Withdrawn from study|0|||
130278108|NCT03286543|468979534|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
130278109|NCT03286543|468979535|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
130278110|NCT03286543|468979536|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
130278111|NCT03286543|468979534|FG000|Study Enrollment|Withdrawn from study|0|||
130278112|NCT03286543|468979535|FG001|Study Enrollment|Withdrawn from study|6|||
130278113|NCT03286543|468979536|FG002|Study Enrollment|Withdrawn from study|6|||
130278114|NCT01822899|468979537|FG000|Overall Study|Adverse Event|6|||
130278115|NCT01822899|468979538|FG001|Overall Study|Adverse Event|5|||
130278116|NCT01822899|468979537|FG000|Overall Study|Lack of Efficacy|6|||
130278117|NCT01822899|468979538|FG001|Overall Study|Lack of Efficacy|3|||
130278118|NCT01822899|468979537|FG000|Overall Study|Protocol Violation|6|||
130278119|NCT01822899|468979538|FG001|Overall Study|Protocol Violation|3|||
130278120|NCT01822899|468979537|FG000|Overall Study|Lost to Follow-up|1|||
130278121|NCT01822899|468979538|FG001|Overall Study|Lost to Follow-up|0|||
130278122|NCT01822899|468979537|FG000|Overall Study|Withdrawal by Subject|5|||
130278123|NCT01822899|468979538|FG001|Overall Study|Withdrawal by Subject|7|||
130278124|NCT05332392|468979539|FG000|Overall Study|Did not meet inclusion criteria|25|||
130278125|NCT05332392|468979539|FG000|Overall Study|Principal Investigator's decision|17|||
130105891|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
130105892|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
130105893|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
130105894|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
130105895|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
130105896|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
130105897|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
130105898|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
130105899|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
130105900|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
130105901|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
130105902|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
130105903|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
130105904|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
130105905|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
130105906|NCT03611751|468348063|FG000|Treatment Week 0 - Week 16|Death|0|||
130105907|NCT03611751|468348064|FG001|Treatment Week 0 - Week 16|Death|0|||
130105908|NCT03611751|468348065|FG002|Treatment Week 0 - Week 16|Death|1|||
130105909|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
130105910|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
130105911|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
130278126|NCT05332392|468979539|FG000|Overall Study|Adverse Event|1|||
130278127|NCT05332392|468979539|FG000|Overall Study|Subject's decision|1|||
130278128|NCT00759876|468979543|FG000|Overall Study|Sponsor terminated study early|36|||
130278129|NCT03636893|468979544|FG000|Overall Study|Death|0|||
130278130|NCT03636893|468979545|FG001|Overall Study|Death|1|||
130278131|NCT03636893|468979544|FG000|Overall Study|Protocol Violation|0|||
130278132|NCT03636893|468979545|FG001|Overall Study|Protocol Violation|3|||
130278133|NCT03636893|468979544|FG000|Overall Study|Withdrawal by Subject|1|||
130278134|NCT03636893|468979545|FG001|Overall Study|Withdrawal by Subject|2|||
130278135|NCT03636893|468979544|FG000|Overall Study|Refusal to surgery|4|||
130278136|NCT03636893|468979545|FG001|Overall Study|Refusal to surgery|3|||
130278137|NCT03636893|468979544|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
130278138|NCT03636893|468979545|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
130278139|NCT03636893|468979544|FG000|Overall Study|Adverse Event|1|||
130278140|NCT03636893|468979545|FG001|Overall Study|Adverse Event|1|||
130278141|NCT00758069|468979546|FG000|Overall Study|Lack of Efficacy|0|||
130278142|NCT00758069|468979547|FG001|Overall Study|Lack of Efficacy|0|||
130278143|NCT00758069|468979548|FG002|Overall Study|Lack of Efficacy|1|||
130278144|NCT00758069|468979546|FG000|Overall Study|Incorrect Study Drug|1|||
130278145|NCT00758069|468979547|FG001|Overall Study|Incorrect Study Drug|0|||
130278146|NCT00758069|468979548|FG002|Overall Study|Incorrect Study Drug|0|||
130278147|NCT03818607|468979550|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
130278148|NCT03818607|468979551|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
130278149|NCT03818607|468979550|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
130278150|NCT03818607|468979551|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
130278151|NCT03818607|468979550|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
130278152|NCT03818607|468979551|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
130278153|NCT00588237|468979552|FG000|Overall Study|Evaluable for toxicity only|3|||
130278154|NCT00588237|468979552|FG000|Overall Study|Patien not treated|1|||
129886969|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
130105912|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
130105913|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130105914|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
130105915|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
130105916|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130105917|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130105918|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
130105919|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
130105920|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
130105921|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
130105922|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
130105923|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
130278155|NCT05059301|468979553|FG000|Overall Study|Adverse Event|0|||
130278156|NCT05059301|468979554|FG001|Overall Study|Adverse Event|2|||
130278157|NCT05059301|468979555|FG002|Overall Study|Adverse Event|2|||
130278158|NCT05059301|468979553|FG000|Overall Study|Lost to Follow-up|2|||
130278159|NCT05059301|468979554|FG001|Overall Study|Lost to Follow-up|3|||
130278160|NCT05059301|468979555|FG002|Overall Study|Lost to Follow-up|3|||
130278161|NCT01164891|468979559|FG000|Overall Study|Disease Progression|5|||
130278162|NCT01164891|468979559|FG000|Overall Study|Adverse Event|1|||
130278163|NCT00606034|468979562|FG000|Overall Study|incarceration|1|||
130105924|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
130105925|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
130041872|NCT01480180|468110656|FG002|Main Phase|Unclassified|0|||
130041873|NCT01480180|468110657|FG003|Main Phase|Unclassified|0|||
130041874|NCT01480180|468110658|FG004|Main Phase|Unclassified|0|||
130041875|NCT01480180|468110659|FG005|Main Phase|Unclassified|0|||
130041876|NCT01480180|468110654|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
130041877|NCT01480180|468110655|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
130041878|NCT01480180|468110656|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
130041879|NCT01480180|468110657|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
130041880|NCT01480180|468110658|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
130041881|NCT01480180|468110659|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
130041882|NCT01480180|468110654|FG000|Extension Phase, Part 1|Unclassified|0|||
130041883|NCT01480180|468110655|FG001|Extension Phase, Part 1|Unclassified|0|||
130041884|NCT01480180|468110656|FG002|Extension Phase, Part 1|Unclassified|1|||
130041885|NCT01480180|468110657|FG003|Extension Phase, Part 1|Unclassified|0|||
130041886|NCT01480180|468110658|FG004|Extension Phase, Part 1|Unclassified|0|||
130041887|NCT01480180|468110659|FG005|Extension Phase, Part 1|Unclassified|0|||
130041888|NCT01480180|468110654|FG000|Extension Phase, Part 1|Adverse Event|0|||
130041889|NCT01480180|468110655|FG001|Extension Phase, Part 1|Adverse Event|0|||
130041890|NCT01480180|468110656|FG002|Extension Phase, Part 1|Adverse Event|4|||
130041891|NCT01480180|468110657|FG003|Extension Phase, Part 1|Adverse Event|1|||
130041892|NCT01480180|468110658|FG004|Extension Phase, Part 1|Adverse Event|0|||
130041893|NCT01480180|468110659|FG005|Extension Phase, Part 1|Adverse Event|0|||
130105926|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
130105927|NCT03611751|468348063|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
130105928|NCT03611751|468348064|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
130105929|NCT03611751|468348065|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
130105930|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
130105931|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
130105932|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
130105933|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
130105934|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
130105935|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130105936|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
130105937|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
130105938|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
130105939|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
130105940|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
130105941|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
130105942|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
130105943|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
130105944|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130105945|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
130105946|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
130105947|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
130105948|NCT03611751|468348063|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
130105949|NCT03611751|468348064|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
130105950|NCT03611751|468348065|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
130105951|NCT03467971|468348066|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130105952|NCT03467971|468348067|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130105953|NCT01488071|468348072|FG000|Overall Study|Adverse Event|15|||
130105954|NCT01488071|468348073|FG001|Overall Study|Adverse Event|23|||
130105955|NCT01488071|468348072|FG000|Overall Study|Lack of Efficacy|11|||
130105956|NCT01488071|468348073|FG001|Overall Study|Lack of Efficacy|17|||
130105957|NCT01488071|468348072|FG000|Overall Study|Non-compliance with study drug|2|||
130105958|NCT01488071|468348073|FG001|Overall Study|Non-compliance with study drug|0|||
130105959|NCT01488071|468348072|FG000|Overall Study|Protocol Violation|5|||
130105960|NCT01488071|468348073|FG001|Overall Study|Protocol Violation|7|||
130105961|NCT01488071|468348072|FG000|Overall Study|Withdrawal of Consent|14|||
130105962|NCT01488071|468348073|FG001|Overall Study|Withdrawal of Consent|12|||
130105963|NCT01488071|468348072|FG000|Overall Study|Lost to Follow-up|1|||
130105964|NCT01488071|468348073|FG001|Overall Study|Lost to Follow-up|0|||
130105965|NCT01488071|468348072|FG000|Overall Study|Administrative or Other Reason(s)|5|||
130105966|NCT01488071|468348073|FG001|Overall Study|Administrative or Other Reason(s)|4|||
130105967|NCT05789420|468348074|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
130105968|NCT05789420|468348074|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
130105969|NCT02587325|468348075|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
130105970|NCT02587325|468348076|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
130105971|NCT02587325|468348077|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
130105972|NCT02587325|468348078|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
130105973|NCT02587325|468348079|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
130105974|NCT02587325|468348075|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130105975|NCT02587325|468348076|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130105976|NCT02587325|468348077|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130105977|NCT02587325|468348078|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
130105978|NCT02587325|468348079|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
130105979|NCT02587325|468348075|FG000|32-Week Optional Extension Part|Adverse Event|0|||
130105980|NCT02587325|468348076|FG001|32-Week Optional Extension Part|Adverse Event|0|||
130041894|NCT01480180|468110654|FG000|Extension Phase, Part 1|Change of treatment|0|||
130105981|NCT02587325|468348077|FG002|32-Week Optional Extension Part|Adverse Event|1|||
130041895|NCT01480180|468110655|FG001|Extension Phase, Part 1|Change of treatment|0|||
130041896|NCT01480180|468110656|FG002|Extension Phase, Part 1|Change of treatment|0|||
130105982|NCT02587325|468348078|FG003|32-Week Optional Extension Part|Adverse Event|0|||
130105983|NCT02587325|468348079|FG004|32-Week Optional Extension Part|Adverse Event|0|||
130041897|NCT01480180|468110657|FG003|Extension Phase, Part 1|Change of treatment|9|||
130105984|NCT02587325|468348075|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
130105985|NCT02587325|468348076|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
130105986|NCT02587325|468348077|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
130105987|NCT02587325|468348078|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
130105988|NCT02587325|468348079|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
130105989|NCT01220128|468348080|FG000|Overall Study|Progressive disease|0|||
130105990|NCT01220128|468348081|FG001|Overall Study|Progressive disease|0|||
130105991|NCT01220128|468348082|FG002|Overall Study|Progressive disease|2|||
130105992|NCT01220128|468348083|FG003|Overall Study|Progressive disease|0|||
130278164|NCT01126268|468979565|FG000|Overall Study|Adverse Event|1|||
130278165|NCT01988662|468979566|FG000|Overall Study|Subject/guardian decision|1|||
130278166|NCT01988662|468979567|FG001|Overall Study|Subject/guardian decision|1|||
130278167|NCT01988662|468979566|FG000|Overall Study|Adverse Event|3|||
130278168|NCT01988662|468979567|FG001|Overall Study|Adverse Event|1|||
130278169|NCT00842153|468979571|FG000|Overall Study|Adverse Event|0|||
130278170|NCT00842153|468979572|FG001|Overall Study|Adverse Event|1|||
130278171|NCT00842153|468979571|FG000|Overall Study|Lost to Follow-up|1|||
130278172|NCT00842153|468979572|FG001|Overall Study|Lost to Follow-up|2|||
130278173|NCT00002540|468979573|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
130278174|NCT00002540|468979574|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
130278175|NCT00002540|468979573|FG000|Overall Study|Died Before Randomization|2|||
130278176|NCT00002540|468979574|FG001|Overall Study|Died Before Randomization|6|||
130278177|NCT00002540|468979573|FG000|Overall Study|Died Before ASU (Control)|202|||
130278178|NCT00002540|468979574|FG001|Overall Study|Died Before ASU (Control)|0|||
130278179|NCT00002540|468979573|FG000|Overall Study|Refused ASU (Control)|597|||
130278180|NCT00002540|468979574|FG001|Overall Study|Refused ASU (Control)|0|||
130278181|NCT00002540|468979573|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
130278182|NCT00002540|468979574|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
130278183|NCT05312697|468979575|FG000|Overall Study|Sponsor Terminated Trial|2|||
130278184|NCT04445519|468979576|FG000|Overall Study|Due to adaptive design|3|||
130105993|NCT01220128|468348084|FG004|Overall Study|Progressive disease|0|||
130105994|NCT01220128|468348085|FG005|Overall Study|Progressive disease|0|||
130105995|NCT01220128|468348086|FG006|Overall Study|Progressive disease|0|||
130105996|NCT01220128|468348080|FG000|Overall Study|Sponsor study termination|0|||
130105997|NCT01220128|468348081|FG001|Overall Study|Sponsor study termination|1|||
130105998|NCT01220128|468348082|FG002|Overall Study|Sponsor study termination|0|||
130105999|NCT01220128|468348083|FG003|Overall Study|Sponsor study termination|0|||
130106000|NCT01220128|468348084|FG004|Overall Study|Sponsor study termination|0|||
130106001|NCT01220128|468348085|FG005|Overall Study|Sponsor study termination|0|||
130106002|NCT01220128|468348086|FG006|Overall Study|Sponsor study termination|1|||
130106003|NCT01220128|468348080|FG000|Overall Study|Adverse event, serious fatal|2|||
130106004|NCT01220128|468348081|FG001|Overall Study|Adverse event, serious fatal|0|||
130106005|NCT01220128|468348082|FG002|Overall Study|Adverse event, serious fatal|0|||
130106006|NCT01220128|468348083|FG003|Overall Study|Adverse event, serious fatal|0|||
130106007|NCT01220128|468348084|FG004|Overall Study|Adverse event, serious fatal|0|||
130106008|NCT01220128|468348085|FG005|Overall Study|Adverse event, serious fatal|0|||
130106009|NCT01220128|468348086|FG006|Overall Study|Adverse event, serious fatal|1|||
130106010|NCT01220128|468348080|FG000|Overall Study|Adverse event, non-fatal|1|||
130106011|NCT01220128|468348081|FG001|Overall Study|Adverse event, non-fatal|0|||
130106012|NCT01220128|468348082|FG002|Overall Study|Adverse event, non-fatal|0|||
130106013|NCT01220128|468348083|FG003|Overall Study|Adverse event, non-fatal|0|||
130106014|NCT01220128|468348084|FG004|Overall Study|Adverse event, non-fatal|0|||
130106015|NCT01220128|468348085|FG005|Overall Study|Adverse event, non-fatal|0|||
130106016|NCT01220128|468348086|FG006|Overall Study|Adverse event, non-fatal|3|||
130106017|NCT01220128|468348080|FG000|Overall Study|Other|0|||
130106018|NCT01220128|468348081|FG001|Overall Study|Other|0|||
130106019|NCT01220128|468348082|FG002|Overall Study|Other|1|||
130106020|NCT01220128|468348083|FG003|Overall Study|Other|0|||
130106021|NCT01220128|468348084|FG004|Overall Study|Other|0|||
130106022|NCT01220128|468348085|FG005|Overall Study|Other|0|||
130106023|NCT01220128|468348086|FG006|Overall Study|Other|0|||
130106024|NCT01220128|468348080|FG000|Overall Study|Consent withdrawn by subject|1|||
130106025|NCT01220128|468348081|FG001|Overall Study|Consent withdrawn by subject|0|||
130106026|NCT01220128|468348082|FG002|Overall Study|Consent withdrawn by subject|0|||
130106027|NCT01220128|468348083|FG003|Overall Study|Consent withdrawn by subject|0|||
130106028|NCT01220128|468348084|FG004|Overall Study|Consent withdrawn by subject|0|||
130278185|NCT04445519|468979577|FG001|Overall Study|Due to adaptive design|0|||
130278186|NCT04445519|468979578|FG002|Overall Study|Due to adaptive design|0|||
130278187|NCT04445519|468979576|FG000|Overall Study|Lost to Follow-up|0|||
130278188|NCT04445519|468979577|FG001|Overall Study|Lost to Follow-up|1|||
130278189|NCT04445519|468979578|FG002|Overall Study|Lost to Follow-up|4|||
130041898|NCT01480180|468110658|FG004|Extension Phase, Part 1|Change of treatment|0|||
130106029|NCT01220128|468348085|FG005|Overall Study|Consent withdrawn by subject|0|||
130106030|NCT01220128|468348086|FG006|Overall Study|Consent withdrawn by subject|0|||
130106031|NCT00000135|468348109|FG000|Overall Study|Death|27|||
130106032|NCT00000135|468348110|FG001|Overall Study|Death|14|||
130041899|NCT01480180|468110659|FG005|Extension Phase, Part 1|Change of treatment|0|||
130041900|NCT01480180|468110654|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
130041901|NCT01480180|468110655|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
130041902|NCT01480180|468110656|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
130041903|NCT01480180|468110657|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
130041904|NCT01480180|468110658|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
130041905|NCT01480180|468110659|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
130041906|NCT01480180|468110654|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
130041907|NCT01480180|468110655|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
130041908|NCT01480180|468110656|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
130041909|NCT01480180|468110657|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
130041910|NCT01480180|468110658|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
130041911|NCT01480180|468110659|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
130041912|NCT01480180|468110654|FG000|Extension Phase, Part 2|Unclassified|0|||
130041913|NCT01480180|468110655|FG001|Extension Phase, Part 2|Unclassified|0|||
130041914|NCT01480180|468110656|FG002|Extension Phase, Part 2|Unclassified|3|||
130041915|NCT01480180|468110657|FG003|Extension Phase, Part 2|Unclassified|1|||
130041916|NCT01480180|468110658|FG004|Extension Phase, Part 2|Unclassified|1|||
130041917|NCT01480180|468110659|FG005|Extension Phase, Part 2|Unclassified|0|||
130041918|NCT02932267|468110664|FG000|Overall Study|Withdrawal by Subject|3|||
130041919|NCT02932267|468110664|FG000|Overall Study|Lost to Follow-up|4|||
130041920|NCT02932267|468110664|FG000|Overall Study|Pregnancy|1|||
130041921|NCT01919411|468110665|FG000|Overall Study|Lost to Follow-up|2|||
130041922|NCT01919411|468110666|FG001|Overall Study|Lost to Follow-up|4|||
130041923|NCT01919411|468110665|FG000|Overall Study|Physician Decision|1|||
130106033|NCT02340078|468348111|FG000|Overall Study|Protocol Violation|1|||
130106034|NCT01831596|468348112|FG000|Overall Study|Other|8|||
130106035|NCT01311505|468348113|FG000|First Intervention Period|Protocol Violation|0|||
130106036|NCT01311505|468348114|FG001|First Intervention Period|Protocol Violation|1|||
130106037|NCT00567996|468348118|FG000|Overall Study|Adverse Event|18|||
130106038|NCT00567996|468348119|FG001|Overall Study|Adverse Event|16|||
130106039|NCT00567996|468348120|FG002|Overall Study|Adverse Event|13|||
130106040|NCT00567996|468348118|FG000|Overall Study|Protocol Deviation|9|||
130106041|NCT00567996|468348119|FG001|Overall Study|Protocol Deviation|11|||
130106042|NCT00567996|468348120|FG002|Overall Study|Protocol Deviation|13|||
130106043|NCT00567996|468348118|FG000|Overall Study|Withdrawal by Subject|8|||
130106044|NCT00567996|468348119|FG001|Overall Study|Withdrawal by Subject|12|||
130106045|NCT00567996|468348120|FG002|Overall Study|Withdrawal by Subject|22|||
130106046|NCT00567996|468348118|FG000|Overall Study|Abnormal Lab value(s)|2|||
130106047|NCT00567996|468348119|FG001|Overall Study|Abnormal Lab value(s)|1|||
130106048|NCT00567996|468348120|FG002|Overall Study|Abnormal Lab value(s)|2|||
130106049|NCT00567996|468348118|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130106050|NCT00567996|468348119|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130106051|NCT00567996|468348120|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130106052|NCT00567996|468348118|FG000|Overall Study|Lost to Follow-up|2|||
130106053|NCT00567996|468348119|FG001|Overall Study|Lost to Follow-up|5|||
130106054|NCT00567996|468348120|FG002|Overall Study|Lost to Follow-up|2|||
130106055|NCT00567996|468348118|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130106056|NCT00567996|468348119|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130106057|NCT00567996|468348120|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
130106058|NCT00567996|468348118|FG000|Overall Study|Administrative problems|1|||
130106059|NCT00567996|468348119|FG001|Overall Study|Administrative problems|1|||
130106060|NCT00567996|468348120|FG002|Overall Study|Administrative problems|0|||
130106061|NCT00567996|468348118|FG000|Overall Study|Death|1|||
130106062|NCT00567996|468348119|FG001|Overall Study|Death|0|||
130106063|NCT00567996|468348120|FG002|Overall Study|Death|2|||
130041924|NCT01919411|468110666|FG001|Overall Study|Physician Decision|0|||
130041925|NCT01919411|468110665|FG000|Overall Study|Protocol Violation|2|||
130041926|NCT01919411|468110666|FG001|Overall Study|Protocol Violation|1|||
130041927|NCT00524303|468110667|FG000|Overall Study|Lost to Follow-up|6|||
130041928|NCT00524303|468110668|FG001|Overall Study|Lost to Follow-up|0|||
130106064|NCT00567996|468348118|FG000|Overall Study|Patient's inability to use the device|0|||
130106065|NCT00567996|468348119|FG001|Overall Study|Patient's inability to use the device|1|||
130106066|NCT00567996|468348120|FG002|Overall Study|Patient's inability to use the device|0|||
130106067|NCT02956005|468348121|FG000|Overall Study|Not eligible|1|||
130106068|NCT02956005|468348121|FG000|Overall Study|Withdrawal by Subject|3|||
130041929|NCT00524303|468110669|FG002|Overall Study|Lost to Follow-up|3|||
130041930|NCT00524303|468110667|FG000|Overall Study|Protocol Violation|0|||
130041931|NCT00524303|468110668|FG001|Overall Study|Protocol Violation|1|||
130041932|NCT00524303|468110669|FG002|Overall Study|Protocol Violation|1|||
130041933|NCT00524303|468110667|FG000|Overall Study|Withdrawal by Subject|3|||
130041934|NCT00524303|468110668|FG001|Overall Study|Withdrawal by Subject|0|||
130041935|NCT00524303|468110669|FG002|Overall Study|Withdrawal by Subject|4|||
130041936|NCT00524303|468110667|FG000|Overall Study|Death|0|||
130041937|NCT00524303|468110668|FG001|Overall Study|Death|2|||
130106069|NCT02956005|468348121|FG000|Overall Study|Physician Decision|12|||
130106070|NCT02524665|468348124|FG000|Overall Study|Lost to Follow-up|1|||
130106071|NCT02602080|468348125|FG000|Overall Study|Protocol Violation|6|||
130106072|NCT02602080|468348126|FG001|Overall Study|Protocol Violation|1|||
130106073|NCT02602080|468348127|FG002|Overall Study|Protocol Violation|3|||
130106074|NCT04355767|468348133|FG000|Overall Study|Withdrawal by Subject|2|||
130106075|NCT04355767|468348134|FG001|Overall Study|Withdrawal by Subject|2|||
130106076|NCT04355767|468348133|FG000|Overall Study|Death|5|||
130106077|NCT04355767|468348134|FG001|Overall Study|Death|1|||
130106078|NCT01999322|468348135|FG000|Overall Study|Adverse Event|1|||
130106079|NCT01999322|468348136|FG001|Overall Study|Adverse Event|0|||
130106080|NCT02200614|468348137|FG000|Double Blind Treatment|Adverse Event|86|||
130106081|NCT02200614|468348138|FG001|Double Blind Treatment|Adverse Event|48|||
130106082|NCT02200614|468348137|FG000|Double Blind Treatment|Confirmed metastasis|120|||
130106083|NCT02200614|468348138|FG001|Double Blind Treatment|Confirmed metastasis|140|||
130106084|NCT02200614|468348137|FG000|Double Blind Treatment|Judgment of the investigator|59|||
130106085|NCT02200614|468348138|FG001|Double Blind Treatment|Judgment of the investigator|99|||
130106086|NCT02200614|468348137|FG000|Double Blind Treatment|Metastasis by local reading|1|||
130106087|NCT02200614|468348138|FG001|Double Blind Treatment|Metastasis by local reading|3|||
130106088|NCT02200614|468348137|FG000|Double Blind Treatment|Other reason|6|||
130106089|NCT02200614|468348138|FG001|Double Blind Treatment|Other reason|2|||
130106090|NCT02200614|468348137|FG000|Double Blind Treatment|Personal reason|77|||
130106091|NCT02200614|468348138|FG001|Double Blind Treatment|Personal reason|85|||
130106092|NCT02200614|468348137|FG000|Double Blind Treatment|Protocol deviation|14|||
130106093|NCT02200614|468348138|FG001|Double Blind Treatment|Protocol deviation|7|||
130106094|NCT02200614|468348137|FG000|Double Blind Treatment|Not treated|1|||
130106095|NCT02200614|468348138|FG001|Double Blind Treatment|Not treated|0|||
130106096|NCT02200614|468348137|FG000|Open Label|Adverse Event|41|||
130106097|NCT02200614|468348138|FG001|Open Label|Adverse Event|11|||
130106098|NCT02200614|468348137|FG000|Open Label|Confirmed metastasis|1|||
130106099|NCT02200614|468348138|FG001|Open Label|Confirmed metastasis|0|||
130106100|NCT02200614|468348137|FG000|Open Label|Judgment of the investigator|29|||
130106101|NCT02200614|468348138|FG001|Open Label|Judgment of the investigator|2|||
130106102|NCT02200614|468348137|FG000|Open Label|Metastasis by local reading|138|||
130106103|NCT02200614|468348138|FG001|Open Label|Metastasis by local reading|27|||
130106104|NCT02200614|468348137|FG000|Open Label|Other reason|22|||
130106105|NCT02200614|468348138|FG001|Open Label|Other reason|4|||
130106106|NCT02200614|468348137|FG000|Open Label|Personal reason|60|||
130106107|NCT02200614|468348138|FG001|Open Label|Personal reason|8|||
130106108|NCT02200614|468348137|FG000|Open Label|Protocol deviation|3|||
130106109|NCT02200614|468348138|FG001|Open Label|Protocol deviation|2|||
130106110|NCT02200614|468348137|FG000|Open Label|Missing|2|||
130106111|NCT02200614|468348138|FG001|Open Label|Missing|2|||
130106112|NCT03302299|468349904|FG000|Overall Study|Protocol Violation|1|||
130106113|NCT02239692|468349905|FG000|Overall Study|Incomplete colonoscopy|1|||
130106114|NCT02239692|468349906|FG001|Overall Study|Incomplete colonoscopy|2|||
130106115|NCT02239692|468349905|FG000|Overall Study|Adverse Event|0|||
130106116|NCT02239692|468349906|FG001|Overall Study|Adverse Event|1|||
130106117|NCT02239692|468349905|FG000|Overall Study|Physician Decision|0|||
130106118|NCT02239692|468349906|FG001|Overall Study|Physician Decision|1|||
130106119|NCT02239692|468349905|FG000|Overall Study|Lost to Follow-up|1|||
130106120|NCT02239692|468349906|FG001|Overall Study|Lost to Follow-up|4|||
130106121|NCT02239692|468349905|FG000|Overall Study|Withdrawal by Subject|3|||
130106122|NCT02239692|468349906|FG001|Overall Study|Withdrawal by Subject|5|||
130106123|NCT02239692|468349905|FG000|Overall Study|Other reason|1|||
130106124|NCT02239692|468349906|FG001|Overall Study|Other reason|0|||
130106125|NCT04318535|468349907|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
130106126|NCT04318535|468349908|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
130106127|NCT04318535|468349909|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
130106128|NCT01901146|468349911|FG000|Neoadjuvant Phase|Death|1|||
130106129|NCT01901146|468349912|FG001|Neoadjuvant Phase|Death|2|||
130106130|NCT01901146|468349913|FG002|Neoadjuvant Phase|Death|0|||
130106131|NCT01901146|468349914|FG003|Neoadjuvant Phase|Death|0|||
130106132|NCT01901146|468349915|FG004|Neoadjuvant Phase|Death|0|||
130106133|NCT01901146|468349911|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
130106134|NCT01901146|468349912|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
130106135|NCT01901146|468349913|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
130106136|NCT01901146|468349914|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
130106137|NCT01901146|468349915|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
130106138|NCT01901146|468349911|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
130106139|NCT01901146|468349912|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
130106140|NCT01901146|468349913|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
130106141|NCT01901146|468349914|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
130041938|NCT00524303|468110669|FG002|Overall Study|Death|3|||
130041939|NCT00524303|468110667|FG000|Overall Study|Adverse Event|1|||
130278190|NCT04445519|468979576|FG000|Overall Study|Sponsor or IRB Decision|0|||
130278191|NCT04445519|468979577|FG001|Overall Study|Sponsor or IRB Decision|1|||
130278192|NCT04445519|468979578|FG002|Overall Study|Sponsor or IRB Decision|2|||
130278193|NCT04445519|468979576|FG000|Overall Study|Withdrawal by Subject|0|||
130278194|NCT04445519|468979577|FG001|Overall Study|Withdrawal by Subject|3|||
130278195|NCT04445519|468979578|FG002|Overall Study|Withdrawal by Subject|3|||
130278196|NCT04445519|468979576|FG000|Overall Study|Adverse Event|0|||
130278197|NCT04445519|468979577|FG001|Overall Study|Adverse Event|8|||
130278198|NCT04445519|468979578|FG002|Overall Study|Adverse Event|6|||
130278199|NCT04445519|468979576|FG000|Overall Study|Other Reason|0|||
130278200|NCT04445519|468979577|FG001|Overall Study|Other Reason|1|||
130278201|NCT04445519|468979578|FG002|Overall Study|Other Reason|1|||
130278202|NCT04445519|468979576|FG000|Overall Study|Protocol Violation|0|||
130278203|NCT04445519|468979577|FG001|Overall Study|Protocol Violation|0|||
130278204|NCT04445519|468979578|FG002|Overall Study|Protocol Violation|1|||
130278205|NCT01345929|468979579|FG000|Overall Study|Withdrawal by Subject|9|||
130278206|NCT01345929|468979580|FG001|Overall Study|Withdrawal by Subject|8|||
130278207|NCT01345929|468979579|FG000|Overall Study|Lost to Follow-up|9|||
130278208|NCT01345929|468979580|FG001|Overall Study|Lost to Follow-up|9|||
130278209|NCT01345929|468979579|FG000|Overall Study|Adverse Event|0|||
130278210|NCT01345929|468979580|FG001|Overall Study|Adverse Event|1|||
130278211|NCT01345929|468979579|FG000|Overall Study|Didn't meet eligibility criteria|2|||
129886970|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
129886971|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130041940|NCT00524303|468110668|FG001|Overall Study|Adverse Event|2|||
130041941|NCT00524303|468110669|FG002|Overall Study|Adverse Event|3|||
130041942|NCT00524303|468110667|FG000|Overall Study|Did not Complete Study Dosing|1|||
130041943|NCT00524303|468110668|FG001|Overall Study|Did not Complete Study Dosing|0|||
130041944|NCT00524303|468110669|FG002|Overall Study|Did not Complete Study Dosing|0|||
130041945|NCT00524303|468110667|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
130041946|NCT00524303|468110668|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
130041947|NCT00524303|468110669|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
130041948|NCT00524303|468110667|FG000|Overall Study|Disease Progression|0|||
130041949|NCT00524303|468110668|FG001|Overall Study|Disease Progression|4|||
130041950|NCT00524303|468110669|FG002|Overall Study|Disease Progression|1|||
130041951|NCT00524303|468110667|FG000|Overall Study|Disease Recurrence|0|||
130041952|NCT00524303|468110668|FG001|Overall Study|Disease Recurrence|1|||
130041953|NCT00524303|468110669|FG002|Overall Study|Disease Recurrence|0|||
130041954|NCT00524303|468110667|FG000|Overall Study|Sponsor Request|0|||
130041955|NCT00524303|468110668|FG001|Overall Study|Sponsor Request|0|||
130041956|NCT00524303|468110669|FG002|Overall Study|Sponsor Request|1|||
130041957|NCT00524303|468110667|FG000|Overall Study|Physician Decision|0|||
130041958|NCT00524303|468110668|FG001|Overall Study|Physician Decision|0|||
130041959|NCT00524303|468110669|FG002|Overall Study|Physician Decision|1|||
130041960|NCT00524303|468110667|FG000|Overall Study|Completed 5 years|0|||
130041961|NCT00524303|468110668|FG001|Overall Study|Completed 5 years|0|||
130041962|NCT00524303|468110669|FG002|Overall Study|Completed 5 years|1|||
130041963|NCT00840463|468110670|FG000|Overall Study|Adverse Event|1|||
130041964|NCT00840463|468110671|FG001|Overall Study|Adverse Event|0|||
130041965|NCT02515669|468110674|FG000|228 Week Open-Label Phase|Other|0|||
130041966|NCT02515669|468110675|FG001|228 Week Open-Label Phase|Other|0|||
130041967|NCT02515669|468110676|FG002|228 Week Open-Label Phase|Other|1|||
130041968|NCT02515669|468110677|FG003|228 Week Open-Label Phase|Other|4|||
130041969|NCT02515669|468110674|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
130041970|NCT02515669|468110675|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
130041971|NCT02515669|468110676|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
130041972|NCT02515669|468110677|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
130041973|NCT02515669|468110674|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
130041974|NCT02515669|468110675|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
130041975|NCT02515669|468110676|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
130041976|NCT02515669|468110677|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
130041977|NCT02515669|468110674|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
130041978|NCT02515669|468110675|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
130041979|NCT02515669|468110676|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
130041980|NCT02515669|468110677|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
130041981|NCT02515669|468110674|FG000|228 Week Open-Label Phase|Missing|0|||
130041982|NCT02515669|468110675|FG001|228 Week Open-Label Phase|Missing|2|||
130041983|NCT02515669|468110676|FG002|228 Week Open-Label Phase|Missing|2|||
130278212|NCT01345929|468979580|FG001|Overall Study|Didn't meet eligibility criteria|0|||
130278213|NCT01345929|468979579|FG000|Overall Study|40,000 CFU/ML|1|||
130278214|NCT01345929|468979580|FG001|Overall Study|40,000 CFU/ML|0|||
130278215|NCT01345929|468979579|FG000|Overall Study|Patient withdrawal|0|||
130278216|NCT01345929|468979580|FG001|Overall Study|Patient withdrawal|1|||
130278217|NCT02151903|468979581|FG000|Overall Study|Withdrawal by Subject|1|||
130278218|NCT02151903|468979582|FG001|Overall Study|Withdrawal by Subject|0|||
130278219|NCT02151903|468979581|FG000|Overall Study|Progressive disease|2|||
130278220|NCT02151903|468979582|FG001|Overall Study|Progressive disease|1|||
130278221|NCT03768089|468979583|FG000|Part A|Lost to Follow-up|0|||
130278222|NCT03768089|468979584|FG001|Part A|Lost to Follow-up|0|||
130278223|NCT03768089|468979585|FG002|Part A|Lost to Follow-up|0|||
130278224|NCT03768089|468979586|FG003|Part A|Lost to Follow-up|0|||
130278225|NCT03768089|468979587|FG004|Part A|Lost to Follow-up|1|||
130278226|NCT03768089|468979588|FG005|Part A|Lost to Follow-up|0|||
130278227|NCT03768089|468979589|FG006|Part A|Lost to Follow-up|0|||
130278228|NCT03768089|468979590|FG007|Part A|Lost to Follow-up|0|||
130278229|NCT03768089|468979591|FG008|Part A|Lost to Follow-up|0|||
130278230|NCT03768089|468979592|FG009|Part A|Lost to Follow-up|0|||
130278231|NCT03768089|468979593|FG010|Part A|Lost to Follow-up|0|||
130278232|NCT03768089|468979594|FG011|Part A|Lost to Follow-up|0|||
130278233|NCT03768089|468979595|FG012|Part A|Lost to Follow-up|0|||
130278234|NCT03768089|468979596|FG013|Part A|Lost to Follow-up|0|||
130278235|NCT03768089|468979597|FG014|Part A|Lost to Follow-up|0|||
130041984|NCT02515669|468110677|FG003|228 Week Open-Label Phase|Missing|2|||
130041985|NCT03750838|468110678|FG000|Overall Study|Lost to Follow-up|10|||
130041986|NCT03750838|468110679|FG001|Overall Study|Lost to Follow-up|6|||
130041987|NCT00630032|468110681|FG000|Overall Study|Death|55|||
130041988|NCT00630032|468110682|FG001|Overall Study|Death|49|||
130041989|NCT00630032|468110681|FG000|Overall Study|Withdrawal by Subject|3|||
130041990|NCT00630032|468110682|FG001|Overall Study|Withdrawal by Subject|2|||
130041991|NCT00630032|468110681|FG000|Overall Study|Lost to Follow-up|18|||
130041992|NCT00630032|468110682|FG001|Overall Study|Lost to Follow-up|31|||
130041993|NCT00630032|468110681|FG000|Overall Study|Protocol Violation|1|||
130041994|NCT00630032|468110682|FG001|Overall Study|Protocol Violation|0|||
130041995|NCT00630032|468110681|FG000|Overall Study|Patient has moved|1|||
130041996|NCT00630032|468110682|FG001|Overall Study|Patient has moved|1|||
130041997|NCT00630032|468110681|FG000|Overall Study|Disease progression|1|||
130041998|NCT00630032|468110682|FG001|Overall Study|Disease progression|1|||
130041999|NCT00630032|468110681|FG000|Overall Study|End of monitoring in US centers|11|||
130042000|NCT00630032|468110682|FG001|Overall Study|End of monitoring in US centers|11|||
130042001|NCT01769404|468110687|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
130042002|NCT01769404|468110688|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
130042003|NCT01769404|468110687|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130042004|NCT01769404|468110688|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130042005|NCT01769404|468110687|FG000|Treatment Period 1|Sponsor decision|1|||
130042006|NCT01769404|468110688|FG001|Treatment Period 1|Sponsor decision|0|||
130042007|NCT01769404|468110687|FG000|Treatment Period 2|Sponsor decision|7|||
130042008|NCT01769404|468110688|FG001|Treatment Period 2|Sponsor decision|0|||
130042009|NCT00538733|468110689|FG000|Overall Study|Adverse Event|8|||
130042010|NCT00538733|468110689|FG000|Overall Study|Death|1|||
130042011|NCT00538733|468110689|FG000|Overall Study|declined to participate|2|||
130042012|NCT00538733|468110689|FG000|Overall Study|still on therapy|1|||
130042013|NCT00095121|468110692|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
130042014|NCT00095121|468110693|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
130042015|NCT00095121|468110692|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
130042016|NCT00095121|468110693|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
130042017|NCT02089737|468112151|FG000|Overall Study|Survey form not completed|5|||
130042018|NCT02089737|468112151|FG000|Overall Study|Not treated|1|||
130042019|NCT01362322|468112156|FG000|Overall Study|Withdrawal by Subject|3|||
130042020|NCT01362322|468112157|FG001|Overall Study|Withdrawal by Subject|1|||
130042021|NCT01362322|468112156|FG000|Overall Study|Lost to Follow-up|2|||
130042022|NCT01362322|468112157|FG001|Overall Study|Lost to Follow-up|6|||
130042023|NCT02413398|468112160|FG000|Overall Study|Lost to Follow-up|2|||
130042024|NCT02413398|468112161|FG001|Overall Study|Lost to Follow-up|4|||
130042025|NCT02413398|468112160|FG000|Overall Study|Withdrawal by Subject|1|||
130042026|NCT02413398|468112161|FG001|Overall Study|Withdrawal by Subject|1|||
130042027|NCT02413398|468112160|FG000|Overall Study|Other Eligibility criteria|1|||
130042028|NCT02413398|468112161|FG001|Overall Study|Other Eligibility criteria|2|||
130278236|NCT03768089|468979598|FG015|Part A|Lost to Follow-up|0|||
130278237|NCT03768089|468979599|FG016|Part A|Lost to Follow-up|0|||
130278238|NCT03768089|468979600|FG017|Part A|Lost to Follow-up|0|||
130278239|NCT03768089|468979583|FG000|Part C|Randomized, Never Dosed|0|||
130278240|NCT03768089|468979584|FG001|Part C|Randomized, Never Dosed|0|||
130278241|NCT03768089|468979585|FG002|Part C|Randomized, Never Dosed|0|||
130042029|NCT02286960|468112177|FG000|Overall Study|Lost to Follow-up|3|||
130042030|NCT02286960|468112178|FG001|Overall Study|Lost to Follow-up|3|||
130278242|NCT03768089|468979586|FG003|Part C|Randomized, Never Dosed|0|||
130278243|NCT03768089|468979587|FG004|Part C|Randomized, Never Dosed|0|||
130278244|NCT03768089|468979588|FG005|Part C|Randomized, Never Dosed|0|||
130278245|NCT03768089|468979589|FG006|Part C|Randomized, Never Dosed|0|||
130278246|NCT03768089|468979590|FG007|Part C|Randomized, Never Dosed|0|||
130278247|NCT03768089|468979591|FG008|Part C|Randomized, Never Dosed|0|||
130278248|NCT03768089|468979592|FG009|Part C|Randomized, Never Dosed|0|||
130278249|NCT03768089|468979593|FG010|Part C|Randomized, Never Dosed|0|||
130278250|NCT03768089|468979594|FG011|Part C|Randomized, Never Dosed|0|||
130278251|NCT03768089|468979595|FG012|Part C|Randomized, Never Dosed|0|||
130278252|NCT03768089|468979596|FG013|Part C|Randomized, Never Dosed|0|||
130278253|NCT03768089|468979597|FG014|Part C|Randomized, Never Dosed|1|||
130278254|NCT03768089|468979598|FG015|Part C|Randomized, Never Dosed|0|||
130278255|NCT03768089|468979599|FG016|Part C|Randomized, Never Dosed|0|||
130278256|NCT03768089|468979600|FG017|Part C|Randomized, Never Dosed|0|||
130278257|NCT05141175|468979605|FG000|Overall Study|Withdrawal by Subject|1|||
130278258|NCT00177294|468979606|FG000|Overall Study|Withdrawal by Subject|7|||
130278259|NCT00177294|468979607|FG001|Overall Study|Withdrawal by Subject|5|||
130278260|NCT02443116|468979608|FG000|Part 1|Adverse Event|2|||
130278261|NCT02443116|468979609|FG001|Part 1|Adverse Event|3|||
130278262|NCT02443116|468979610|FG002|Part 1|Adverse Event|0|||
130278263|NCT02443116|468979611|FG003|Part 1|Adverse Event|0|||
130278264|NCT02443116|468979612|FG004|Part 1|Adverse Event|0|||
130278265|NCT02443116|468979613|FG005|Part 1|Adverse Event|0|||
130278266|NCT02443116|468979614|FG006|Part 1|Adverse Event|0|||
130278267|NCT02443116|468979615|FG007|Part 1|Adverse Event|0|||
130278268|NCT02443116|468979616|FG008|Part 1|Adverse Event|0|||
130278269|NCT02443116|468979608|FG000|Part 1|Withdrew informed consent|0|||
130278270|NCT02443116|468979609|FG001|Part 1|Withdrew informed consent|1|||
130278271|NCT02443116|468979610|FG002|Part 1|Withdrew informed consent|0|||
130278272|NCT02443116|468979611|FG003|Part 1|Withdrew informed consent|0|||
130278273|NCT02443116|468979612|FG004|Part 1|Withdrew informed consent|0|||
130278274|NCT02443116|468979613|FG005|Part 1|Withdrew informed consent|0|||
130278275|NCT02443116|468979614|FG006|Part 1|Withdrew informed consent|0|||
130278276|NCT02443116|468979615|FG007|Part 1|Withdrew informed consent|0|||
130278277|NCT02443116|468979616|FG008|Part 1|Withdrew informed consent|0|||
130278278|NCT02443116|468979608|FG000|Part 1|Lost to Follow-up|0|||
130278279|NCT02443116|468979609|FG001|Part 1|Lost to Follow-up|0|||
130278280|NCT02443116|468979610|FG002|Part 1|Lost to Follow-up|2|||
130278281|NCT02443116|468979611|FG003|Part 1|Lost to Follow-up|0|||
130278282|NCT02443116|468979612|FG004|Part 1|Lost to Follow-up|0|||
130278283|NCT02443116|468979613|FG005|Part 1|Lost to Follow-up|0|||
130278284|NCT02443116|468979614|FG006|Part 1|Lost to Follow-up|0|||
130278285|NCT02443116|468979615|FG007|Part 1|Lost to Follow-up|0|||
130278286|NCT02443116|468979616|FG008|Part 1|Lost to Follow-up|0|||
130278287|NCT02443116|468979608|FG000|Part 1|Participant moved out of state|0|||
130278288|NCT02443116|468979609|FG001|Part 1|Participant moved out of state|0|||
130278289|NCT02443116|468979610|FG002|Part 1|Participant moved out of state|1|||
130278290|NCT02443116|468979611|FG003|Part 1|Participant moved out of state|0|||
130278291|NCT02443116|468979612|FG004|Part 1|Participant moved out of state|0|||
130278292|NCT02443116|468979613|FG005|Part 1|Participant moved out of state|0|||
130278293|NCT02443116|468979614|FG006|Part 1|Participant moved out of state|0|||
130278294|NCT02443116|468979615|FG007|Part 1|Participant moved out of state|0|||
130278295|NCT02443116|468979616|FG008|Part 1|Participant moved out of state|0|||
130278296|NCT02443116|468979608|FG000|Part 1|Participant enrolled in another clinical trial|0|||
130042031|NCT00440401|468112179|FG000|Overall Study|Adverse Event|2|||
130042032|NCT00440401|468112180|FG001|Overall Study|Adverse Event|1|||
130042033|NCT00440401|468112179|FG000|Overall Study|Other|2|||
130042034|NCT00440401|468112180|FG001|Overall Study|Other|5|||
130042035|NCT00550238|468112182|FG000|Overall Study|Adverse Event|88|||
130278297|NCT02443116|468979609|FG001|Part 1|Participant enrolled in another clinical trial|0|||
130278298|NCT02443116|468979610|FG002|Part 1|Participant enrolled in another clinical trial|1|||
130278299|NCT02443116|468979611|FG003|Part 1|Participant enrolled in another clinical trial|0|||
130278300|NCT02443116|468979612|FG004|Part 1|Participant enrolled in another clinical trial|0|||
130278301|NCT02443116|468979613|FG005|Part 1|Participant enrolled in another clinical trial|0|||
130278302|NCT02443116|468979614|FG006|Part 1|Participant enrolled in another clinical trial|0|||
130278303|NCT02443116|468979615|FG007|Part 1|Participant enrolled in another clinical trial|0|||
130278304|NCT02443116|468979616|FG008|Part 1|Participant enrolled in another clinical trial|0|||
130278305|NCT02443116|468979608|FG000|Part 2|Adverse Event|0|||
130278306|NCT02443116|468979609|FG001|Part 2|Adverse Event|0|||
130042036|NCT00550238|468112182|FG000|Overall Study|Death|34|||
130042037|NCT00550238|468112182|FG000|Overall Study|Disease progression|46|||
130278307|NCT02443116|468979610|FG002|Part 2|Adverse Event|0|||
130278308|NCT02443116|468979611|FG003|Part 2|Adverse Event|0|||
130278309|NCT02443116|468979612|FG004|Part 2|Adverse Event|1|||
130278310|NCT02443116|468979613|FG005|Part 2|Adverse Event|1|||
130278311|NCT02443116|468979614|FG006|Part 2|Adverse Event|2|||
130278312|NCT02443116|468979615|FG007|Part 2|Adverse Event|0|||
130278313|NCT02443116|468979616|FG008|Part 2|Adverse Event|0|||
130278314|NCT02443116|468979608|FG000|Part 2|Withdrew informed consent|0|||
130278315|NCT02443116|468979609|FG001|Part 2|Withdrew informed consent|0|||
130278316|NCT02443116|468979610|FG002|Part 2|Withdrew informed consent|0|||
130278317|NCT02443116|468979611|FG003|Part 2|Withdrew informed consent|0|||
130278318|NCT02443116|468979612|FG004|Part 2|Withdrew informed consent|0|||
130278319|NCT02443116|468979613|FG005|Part 2|Withdrew informed consent|1|||
130278320|NCT02443116|468979614|FG006|Part 2|Withdrew informed consent|1|||
130278321|NCT02443116|468979615|FG007|Part 2|Withdrew informed consent|0|||
130278322|NCT02443116|468979616|FG008|Part 2|Withdrew informed consent|0|||
130278323|NCT02443116|468979608|FG000|Part 2|Inability to comply with protocol|0|||
130278324|NCT02443116|468979609|FG001|Part 2|Inability to comply with protocol|0|||
130278325|NCT02443116|468979610|FG002|Part 2|Inability to comply with protocol|0|||
130278326|NCT02443116|468979611|FG003|Part 2|Inability to comply with protocol|1|||
130278327|NCT02443116|468979612|FG004|Part 2|Inability to comply with protocol|0|||
130278328|NCT02443116|468979613|FG005|Part 2|Inability to comply with protocol|0|||
130278329|NCT02443116|468979614|FG006|Part 2|Inability to comply with protocol|0|||
130278330|NCT02443116|468979615|FG007|Part 2|Inability to comply with protocol|0|||
130278331|NCT02443116|468979616|FG008|Part 2|Inability to comply with protocol|0|||
130278332|NCT02443116|468979608|FG000|Part 2|Lost to Follow-up|0|||
130278333|NCT02443116|468979609|FG001|Part 2|Lost to Follow-up|0|||
130278334|NCT02443116|468979610|FG002|Part 2|Lost to Follow-up|0|||
130278335|NCT02443116|468979611|FG003|Part 2|Lost to Follow-up|1|||
130278336|NCT02443116|468979612|FG004|Part 2|Lost to Follow-up|0|||
130278337|NCT02443116|468979613|FG005|Part 2|Lost to Follow-up|0|||
130278338|NCT02443116|468979614|FG006|Part 2|Lost to Follow-up|0|||
130278339|NCT02443116|468979615|FG007|Part 2|Lost to Follow-up|0|||
130278340|NCT02443116|468979616|FG008|Part 2|Lost to Follow-up|0|||
130278341|NCT02443116|468979608|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278342|NCT02443116|468979609|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278343|NCT02443116|468979610|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278344|NCT02443116|468979611|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278345|NCT02443116|468979612|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278346|NCT02443116|468979613|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
130278347|NCT02443116|468979614|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278348|NCT02443116|468979615|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278349|NCT02443116|468979616|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
130278350|NCT02443116|468979608|FG000|Part 3|Adverse Event|0|||
130278351|NCT02443116|468979609|FG001|Part 3|Adverse Event|0|||
130278352|NCT02443116|468979610|FG002|Part 3|Adverse Event|0|||
130278353|NCT02443116|468979611|FG003|Part 3|Adverse Event|0|||
130278354|NCT02443116|468979612|FG004|Part 3|Adverse Event|0|||
130278355|NCT02443116|468979613|FG005|Part 3|Adverse Event|0|||
130278356|NCT02443116|468979614|FG006|Part 3|Adverse Event|0|||
130278357|NCT02443116|468979615|FG007|Part 3|Adverse Event|0|||
130278358|NCT02443116|468979616|FG008|Part 3|Adverse Event|1|||
130278359|NCT02443116|468979608|FG000|Part 3|Withdrew informed consent|0|||
130278360|NCT02443116|468979609|FG001|Part 3|Withdrew informed consent|0|||
130278361|NCT02443116|468979610|FG002|Part 3|Withdrew informed consent|0|||
130278362|NCT02443116|468979611|FG003|Part 3|Withdrew informed consent|0|||
130278363|NCT02443116|468979612|FG004|Part 3|Withdrew informed consent|0|||
130278364|NCT02443116|468979613|FG005|Part 3|Withdrew informed consent|0|||
130278365|NCT02443116|468979614|FG006|Part 3|Withdrew informed consent|0|||
130278366|NCT02443116|468979615|FG007|Part 3|Withdrew informed consent|3|||
130278367|NCT02443116|468979616|FG008|Part 3|Withdrew informed consent|2|||
130278368|NCT02443116|468979608|FG000|Part 3|Lost to Follow-up|0|||
130278369|NCT02443116|468979609|FG001|Part 3|Lost to Follow-up|0|||
130278370|NCT02443116|468979610|FG002|Part 3|Lost to Follow-up|0|||
130278371|NCT02443116|468979611|FG003|Part 3|Lost to Follow-up|0|||
130278372|NCT02443116|468979612|FG004|Part 3|Lost to Follow-up|0|||
130278373|NCT02443116|468979613|FG005|Part 3|Lost to Follow-up|0|||
130278374|NCT02443116|468979614|FG006|Part 3|Lost to Follow-up|0|||
130278375|NCT02443116|468979615|FG007|Part 3|Lost to Follow-up|1|||
130278376|NCT02443116|468979616|FG008|Part 3|Lost to Follow-up|2|||
130278377|NCT03100539|468981314|FG000|Overall Study|Lost to Follow-up|60|||
130278378|NCT03100539|468981315|FG001|Overall Study|Lost to Follow-up|54|||
130278379|NCT03100539|468981316|FG002|Overall Study|Lost to Follow-up|17|||
130278380|NCT03100539|468981314|FG000|Overall Study|Uncollected|8|||
130278381|NCT03100539|468981315|FG001|Overall Study|Uncollected|8|||
130278382|NCT03100539|468981316|FG002|Overall Study|Uncollected|0|||
130278383|NCT03100539|468981314|FG000|Overall Study|Ally Health|0|||
130278384|NCT03100539|468981315|FG001|Overall Study|Ally Health|0|||
130278385|NCT03100539|468981316|FG002|Overall Study|Ally Health|3|||
130278386|NCT03100539|468981314|FG000|Overall Study|Disinterest|0|||
130278387|NCT03100539|468981315|FG001|Overall Study|Disinterest|0|||
130278388|NCT03100539|468981316|FG002|Overall Study|Disinterest|22|||
130278389|NCT03100539|468981314|FG000|Overall Study|Veteran Health|0|||
130278390|NCT03100539|468981315|FG001|Overall Study|Veteran Health|0|||
130042038|NCT00550238|468112182|FG000|Overall Study|Withdrawal by Subject|167|||
130042039|NCT00550238|468112182|FG000|Overall Study|Physician Decision|31|||
130042040|NCT00550238|468112182|FG000|Overall Study|Patient noncompliance|25|||
130042041|NCT00550238|468112182|FG000|Overall Study|Lost to Follow-up|13|||
130042042|NCT00550238|468112182|FG000|Overall Study|Sponsor decision|55|||
130042043|NCT00779038|468112183|FG000|Overall Study|Study Prematurely Terminated|13|||
130042044|NCT00537745|468112184|FG000|Overall Study|Did not meet eligibility criteria|2|||
130042045|NCT00537745|468112184|FG000|Overall Study|Withdrawal by Subject|2|||
130042046|NCT00537745|468112184|FG000|Overall Study|Subject unable to provide Interlock info|1|||
130278391|NCT03100539|468981316|FG002|Overall Study|Veteran Health|8|||
130278392|NCT03100539|468981314|FG000|Overall Study|Moved|0|||
130278393|NCT03100539|468981315|FG001|Overall Study|Moved|0|||
130278394|NCT03100539|468981316|FG002|Overall Study|Moved|1|||
130278395|NCT03100539|468981314|FG000|Overall Study|Scheduling Conflicts|0|||
130278396|NCT03100539|468981315|FG001|Overall Study|Scheduling Conflicts|0|||
130278397|NCT03100539|468981316|FG002|Overall Study|Scheduling Conflicts|12|||
130278398|NCT00809835|468981319|FG000|Overall Study|Lost to Follow-up|7|||
130278399|NCT00809835|468981320|FG001|Overall Study|Lost to Follow-up|6|||
130278400|NCT00809835|468981321|FG002|Overall Study|Lost to Follow-up|10|||
130278401|NCT00809835|468981322|FG003|Overall Study|Lost to Follow-up|2|||
130278402|NCT00809835|468981319|FG000|Overall Study|Withdrawal by Subject|1|||
130278403|NCT00809835|468981320|FG001|Overall Study|Withdrawal by Subject|1|||
130278404|NCT00809835|468981321|FG002|Overall Study|Withdrawal by Subject|1|||
130278405|NCT00809835|468981322|FG003|Overall Study|Withdrawal by Subject|0|||
130278406|NCT05659719|468981323|FG000|Overall Study|At sponsor's request|0|||
130278407|NCT05659719|468981324|FG001|Overall Study|At sponsor's request|0|||
130278408|NCT05659719|468981325|FG002|Overall Study|At sponsor's request|0|||
130278409|NCT05659719|468981326|FG003|Overall Study|At sponsor's request|95|||
130278410|NCT05659719|468981323|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130278411|NCT05659719|468981324|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130278412|NCT05659719|468981325|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
130278413|NCT05659719|468981326|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
130278414|NCT05659719|468981323|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
130278415|NCT05659719|468981324|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
130278416|NCT05659719|468981325|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
130278417|NCT05659719|468981326|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
130278418|NCT05659719|468981323|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130278419|NCT05659719|468981324|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130278420|NCT05659719|468981325|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
130278421|NCT05659719|468981326|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
130278422|NCT05659719|468981323|FG000|Overall Study|Lost to Follow-up|0|||
130278423|NCT05659719|468981324|FG001|Overall Study|Lost to Follow-up|0|||
130278424|NCT05659719|468981325|FG002|Overall Study|Lost to Follow-up|0|||
130278425|NCT05659719|468981326|FG003|Overall Study|Lost to Follow-up|2|||
130278426|NCT05659719|468981323|FG000|Overall Study|Moved to another observational study|0|||
130278427|NCT05659719|468981324|FG001|Overall Study|Moved to another observational study|0|||
130278428|NCT05659719|468981325|FG002|Overall Study|Moved to another observational study|0|||
130278429|NCT05659719|468981326|FG003|Overall Study|Moved to another observational study|1|||
130278430|NCT05659719|468981323|FG000|Overall Study|The child was enrolled in an interventional study|0|||
130106142|NCT01901146|468349915|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
130278431|NCT05659719|468981324|FG001|Overall Study|The child was enrolled in an interventional study|0|||
130278432|NCT05659719|468981325|FG002|Overall Study|The child was enrolled in an interventional study|0|||
130278433|NCT05659719|468981326|FG003|Overall Study|The child was enrolled in an interventional study|55|||
130106143|NCT01901146|468349911|FG000|Neoadjuvant Phase|Physician Decision|1|||
130106144|NCT01901146|468349912|FG001|Neoadjuvant Phase|Physician Decision|2|||
130278434|NCT05659719|468981323|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130278435|NCT05659719|468981324|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130278436|NCT05659719|468981325|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
130278437|NCT05659719|468981326|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
130278438|NCT05659719|468981323|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130278439|NCT05659719|468981324|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130278440|NCT05659719|468981325|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
130278441|NCT05659719|468981326|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
130278442|NCT01681186|468981327|FG000|Washout Period From Second Intervention|Adverse Event|0|||
130278443|NCT01681186|468981328|FG001|Washout Period From Second Intervention|Adverse Event|0|||
130278444|NCT01681186|468981329|FG002|Washout Period From Second Intervention|Adverse Event|0|||
130278445|NCT01681186|468981330|FG003|Washout Period From Second Intervention|Adverse Event|0|||
130278446|NCT01681186|468981331|FG004|Washout Period From Second Intervention|Adverse Event|0|||
130278447|NCT01681186|468981332|FG005|Washout Period From Second Intervention|Adverse Event|0|||
130278448|NCT01681186|468981333|FG006|Washout Period From Second Intervention|Adverse Event|1|||
130278449|NCT01681186|468981334|FG007|Washout Period From Second Intervention|Adverse Event|0|||
130278450|NCT01681186|468981327|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
130278451|NCT01681186|468981328|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
130278452|NCT01681186|468981329|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
130278453|NCT01681186|468981330|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
130278454|NCT01681186|468981331|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
130278455|NCT01681186|468981332|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
130278456|NCT01681186|468981333|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
130278457|NCT01681186|468981334|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
130278458|NCT01681186|468981327|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278459|NCT01681186|468981328|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278460|NCT01681186|468981329|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278461|NCT01681186|468981330|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278462|NCT01681186|468981331|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278463|NCT01681186|468981332|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278464|NCT01681186|468981333|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
130278465|NCT01681186|468981334|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
130278466|NCT01681186|468981327|FG000|Fourth Intervention|Protocol Violation|0|||
130278467|NCT01681186|468981328|FG001|Fourth Intervention|Protocol Violation|0|||
130278468|NCT01681186|468981329|FG002|Fourth Intervention|Protocol Violation|0|||
130278469|NCT01681186|468981330|FG003|Fourth Intervention|Protocol Violation|0|||
130278470|NCT01681186|468981331|FG004|Fourth Intervention|Protocol Violation|0|||
130278471|NCT01681186|468981332|FG005|Fourth Intervention|Protocol Violation|0|||
130278472|NCT01681186|468981333|FG006|Fourth Intervention|Protocol Violation|0|||
130278473|NCT01681186|468981334|FG007|Fourth Intervention|Protocol Violation|1|||
130278474|NCT05160415|468981335|FG000|Overall Study|Withdrawal by Subject|3|||
130278475|NCT02582814|468981336|FG000|Overall Study|Study-specific withdrawal criteria|1|||
130278476|NCT02582814|468981337|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130278477|NCT02582814|468981336|FG000|Overall Study|Withdrawal by Subject|4|||
130278478|NCT02582814|468981337|FG001|Overall Study|Withdrawal by Subject|3|||
130278479|NCT02582814|468981336|FG000|Overall Study|Adverse Event|4|||
130278480|NCT02582814|468981337|FG001|Overall Study|Adverse Event|4|||
130278481|NCT03530995|468981338|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
130278482|NCT03530995|468981339|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
130278483|NCT03530995|468981338|FG000|Part 1 Period 3|Protocol Violation|1|||
130278484|NCT03530995|468981339|FG001|Part 1 Period 3|Protocol Violation|0|||
130278485|NCT03530995|468981338|FG000|Part 1 Period 4|Physician Decision|1|||
130278486|NCT03530995|468981339|FG001|Part 1 Period 4|Physician Decision|0|||
130278487|NCT03530995|468981338|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
130278488|NCT03530995|468981339|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
130278489|NCT01986231|468981343|FG000|Overall Study|Adverse Event|1|||
130278490|NCT00623233|468981344|FG000|Overall Study|Adverse Event|10|||
130278491|NCT00623233|468981344|FG000|Overall Study|Physician Decision|10|||
130278492|NCT00623233|468981344|FG000|Overall Study|Lost to Follow-up|1|||
130042047|NCT01570491|468112185|FG000|Overall Study|Lost to Follow-up|3|||
130042048|NCT01570491|468112186|FG001|Overall Study|Lost to Follow-up|1|||
130042049|NCT01570491|468112185|FG000|Overall Study|treatment: not given or discontinued|2|||
130042050|NCT01570491|468112186|FG001|Overall Study|treatment: not given or discontinued|0|||
130042051|NCT00482001|468112187|FG000|Overall Study|Protocol Violation|1|||
130278493|NCT00623233|468981344|FG000|Overall Study|Withdrawal by Subject|3|||
130278494|NCT01751906|468981345|FG000|Overall Study|Lost to Follow-up|151|||
130278495|NCT01751906|468981346|FG001|Overall Study|Lost to Follow-up|68|||
130278496|NCT01751906|468981345|FG000|Overall Study|Withdrawal by Subject|22|||
130278497|NCT01751906|468981346|FG001|Overall Study|Withdrawal by Subject|18|||
130278498|NCT01751906|468981345|FG000|Overall Study|Physician Decision|5|||
130278499|NCT01751906|468981346|FG001|Overall Study|Physician Decision|2|||
130278500|NCT01751906|468981345|FG000|Overall Study|Death|84|||
130278501|NCT01751906|468981346|FG001|Overall Study|Death|43|||
130278502|NCT01751906|468981345|FG000|Overall Study|Denied on premises for follow-up by law|1|||
130278503|NCT01751906|468981346|FG001|Overall Study|Denied on premises for follow-up by law|0|||
130278504|NCT01110330|468981347|FG000|Overall Study|Adverse Event|0|||
130278505|NCT01110330|468981348|FG001|Overall Study|Adverse Event|4|||
130278506|NCT01110330|468981349|FG002|Overall Study|Adverse Event|3|||
130278507|NCT01110330|468981347|FG000|Overall Study|Lack of Efficacy|3|||
130278508|NCT01110330|468981348|FG001|Overall Study|Lack of Efficacy|1|||
130278509|NCT01110330|468981349|FG002|Overall Study|Lack of Efficacy|1|||
130278510|NCT01110330|468981347|FG000|Overall Study|Lost to Follow-up|9|||
130278511|NCT01110330|468981348|FG001|Overall Study|Lost to Follow-up|10|||
130278512|NCT01110330|468981349|FG002|Overall Study|Lost to Follow-up|15|||
130278513|NCT01110330|468981347|FG000|Overall Study|Physician Decision|0|||
130278514|NCT01110330|468981348|FG001|Overall Study|Physician Decision|1|||
130278515|NCT01110330|468981349|FG002|Overall Study|Physician Decision|0|||
130278516|NCT01110330|468981347|FG000|Overall Study|Protocol Violation|2|||
130278517|NCT01110330|468981348|FG001|Overall Study|Protocol Violation|0|||
130278518|NCT01110330|468981349|FG002|Overall Study|Protocol Violation|4|||
130278519|NCT01110330|468981347|FG000|Overall Study|Withdrawal by Subject|0|||
130278520|NCT01110330|468981348|FG001|Overall Study|Withdrawal by Subject|6|||
130278521|NCT01110330|468981349|FG002|Overall Study|Withdrawal by Subject|2|||
130278522|NCT01110330|468981347|FG000|Overall Study|Other|1|||
130278523|NCT01110330|468981348|FG001|Overall Study|Other|1|||
130278524|NCT01110330|468981349|FG002|Overall Study|Other|1|||
130278525|NCT02557100|468981350|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
130278526|NCT02557100|468981351|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
130278527|NCT02557100|468981352|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
130278528|NCT02557100|468981350|FG000|Single Blind Treatment Period|Death|0|||
130278529|NCT02557100|468981351|FG001|Single Blind Treatment Period|Death|1|||
130278530|NCT02557100|468981352|FG002|Single Blind Treatment Period|Death|0|||
130278531|NCT02557100|468981350|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
130278532|NCT02557100|468981351|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
130278533|NCT02557100|468981352|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
130278534|NCT02557100|468981350|FG000|Single Blind Treatment Period|Adverse Event|0|||
130278535|NCT02557100|468981351|FG001|Single Blind Treatment Period|Adverse Event|1|||
130278536|NCT02557100|468981352|FG002|Single Blind Treatment Period|Adverse Event|0|||
130278537|NCT02557100|468981350|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
130278538|NCT02557100|468981351|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
130278539|NCT02557100|468981352|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
130278540|NCT02557100|468981350|FG000|Cumulative Abatacept Period|Other Reasons|0|||
130278541|NCT02557100|468981351|FG001|Cumulative Abatacept Period|Other Reasons|0|||
130278542|NCT02557100|468981352|FG002|Cumulative Abatacept Period|Other Reasons|1|||
130278543|NCT02557100|468981350|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
130278544|NCT02557100|468981351|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
130278545|NCT02557100|468981352|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
130278546|NCT02557100|468981350|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
130278547|NCT02557100|468981351|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
130278548|NCT02557100|468981352|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
130278549|NCT04644276|468981354|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
130278550|NCT04644276|468981355|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
130278551|NCT04644276|468981356|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
130278552|NCT01667224|468981358|FG000|Overall Study|Withdrawal by Subject|3|||
130278553|NCT01667224|468981359|FG001|Overall Study|Withdrawal by Subject|1|||
130278554|NCT01667224|468981358|FG000|Overall Study|Protocol Violation|1|||
130278555|NCT01667224|468981359|FG001|Overall Study|Protocol Violation|1|||
130042052|NCT00482001|468112188|FG001|Overall Study|Protocol Violation|1|||
130278556|NCT02314156|468981367|FG000|Overall Study|Adverse Event|1|||
130278557|NCT02314156|468981368|FG001|Overall Study|Adverse Event|0|||
130278558|NCT02314156|468981367|FG000|Overall Study|Withdrawal by Subject|1|||
130278559|NCT02314156|468981368|FG001|Overall Study|Withdrawal by Subject|0|||
130278560|NCT02752633|468981369|FG000|Overall Study|Withdrawal by Subject|1|||
130278561|NCT02846389|468981370|FG000|Overall Study|Withdrawal by Subject|1|||
130278562|NCT02846389|468981371|FG001|Overall Study|Withdrawal by Subject|1|||
130278563|NCT00433966|468981374|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
130278564|NCT00433966|468981375|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
130278565|NCT00433966|468981376|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
130278566|NCT00433966|468981377|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
130278567|NCT00433966|468981374|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
130278568|NCT00433966|468981375|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
130278569|NCT00433966|468981376|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
130278570|NCT00433966|468981377|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
130278571|NCT00433966|468981374|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
130278572|NCT00433966|468981375|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
130278573|NCT00433966|468981376|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
130278574|NCT00433966|468981377|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
130278575|NCT00433966|468981374|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
130278576|NCT00433966|468981375|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
130278577|NCT00433966|468981376|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
130278578|NCT00433966|468981377|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
130278579|NCT00433966|468981374|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
130278580|NCT00433966|468981375|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
130278581|NCT00433966|468981376|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
130278582|NCT00433966|468981377|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
130106145|NCT01901146|468349913|FG002|Neoadjuvant Phase|Physician Decision|0|||
130106146|NCT01901146|468349914|FG003|Neoadjuvant Phase|Physician Decision|0|||
130106147|NCT01901146|468349915|FG004|Neoadjuvant Phase|Physician Decision|0|||
130106148|NCT01901146|468349911|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
130106149|NCT01901146|468349912|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
130106150|NCT01901146|468349913|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
130106151|NCT01901146|468349914|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
130106152|NCT01901146|468349915|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
130106153|NCT01901146|468349911|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130278583|NCT00853242|468981379|FG000|Overall Study|Adverse Event|0|||
130278584|NCT00853242|468981380|FG001|Overall Study|Adverse Event|1|||
130278585|NCT00853242|468981381|FG002|Overall Study|Adverse Event|1|||
130278586|NCT00853242|468981382|FG003|Overall Study|Adverse Event|0|||
130278587|NCT00853242|468981383|FG004|Overall Study|Adverse Event|3|||
130278588|NCT00853242|468981384|FG005|Overall Study|Adverse Event|1|||
130278589|NCT00853242|468981385|FG006|Overall Study|Adverse Event|1|||
130278590|NCT00853242|468981379|FG000|Overall Study|Noncompliant|0|||
130278591|NCT00853242|468981380|FG001|Overall Study|Noncompliant|0|||
130278592|NCT00853242|468981381|FG002|Overall Study|Noncompliant|0|||
130278593|NCT00853242|468981382|FG003|Overall Study|Noncompliant|0|||
130278594|NCT00853242|468981383|FG004|Overall Study|Noncompliant|1|||
130278595|NCT00853242|468981384|FG005|Overall Study|Noncompliant|0|||
130278596|NCT00853242|468981385|FG006|Overall Study|Noncompliant|0|||
130278597|NCT00853242|468981379|FG000|Overall Study|Withdrawal by Subject|1|||
130278598|NCT00853242|468981380|FG001|Overall Study|Withdrawal by Subject|2|||
130278599|NCT00853242|468981381|FG002|Overall Study|Withdrawal by Subject|0|||
130278600|NCT00853242|468981382|FG003|Overall Study|Withdrawal by Subject|4|||
130278601|NCT00853242|468981383|FG004|Overall Study|Withdrawal by Subject|0|||
130278602|NCT00853242|468981384|FG005|Overall Study|Withdrawal by Subject|0|||
130278603|NCT00853242|468981385|FG006|Overall Study|Withdrawal by Subject|2|||
130278604|NCT00853242|468981379|FG000|Overall Study|Other|2|||
130278605|NCT00853242|468981380|FG001|Overall Study|Other|0|||
130278606|NCT00853242|468981381|FG002|Overall Study|Other|2|||
130278607|NCT00853242|468981382|FG003|Overall Study|Other|0|||
130278608|NCT00853242|468981383|FG004|Overall Study|Other|0|||
130106154|NCT01901146|468349912|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
130106155|NCT01901146|468349913|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130278609|NCT00853242|468981384|FG005|Overall Study|Other|1|||
130278610|NCT00853242|468981385|FG006|Overall Study|Other|2|||
130278611|NCT03497975|468981386|FG000|Overall Study|Withdrew Consent|34|||
130278612|NCT03497975|468981387|FG001|Overall Study|Withdrew Consent|35|||
130042053|NCT05370157|468112189|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
130042054|NCT05370157|468112190|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
130052151|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
130278613|NCT03497975|468981386|FG000|Overall Study|Lost to Follow-up|7|||
130278614|NCT03497975|468981387|FG001|Overall Study|Lost to Follow-up|7|||
130278615|NCT03497975|468981386|FG000|Overall Study|Physician Decision|4|||
130278616|NCT03497975|468981387|FG001|Overall Study|Physician Decision|5|||
130278617|NCT03497975|468981386|FG000|Overall Study|Discontinued|42|||
130278618|NCT03497975|468981387|FG001|Overall Study|Discontinued|39|||
130278619|NCT03497975|468981386|FG000|Overall Study|Reason Not Specified|15|||
130278620|NCT03497975|468981387|FG001|Overall Study|Reason Not Specified|14|||
130278621|NCT04026009|468981388|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130278622|NCT04026009|468981389|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130278623|NCT04026009|468981390|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130278624|NCT04026009|468981391|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130278625|NCT04026009|468981392|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130278626|NCT04026009|468981388|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278627|NCT04026009|468981389|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278628|NCT04026009|468981390|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278629|NCT04026009|468981391|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
130278630|NCT04026009|468981392|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
130278631|NCT01500252|468981396|FG000|Overall Study|Death|4|||
130278632|NCT01500252|468981397|FG001|Overall Study|Death|2|||
130278633|NCT01500252|468981396|FG000|Overall Study|Lost to Follow-up|5|||
130278634|NCT01500252|468981397|FG001|Overall Study|Lost to Follow-up|4|||
130278635|NCT05319600|468981399|FG000|Overall Study|Withdrawal by Subject|1|||
130278636|NCT05319600|468981400|FG001|Overall Study|Withdrawal by Subject|0|||
130278637|NCT05319600|468981399|FG000|Overall Study|Lost to Follow-up|0|||
130278638|NCT05319600|468981400|FG001|Overall Study|Lost to Follow-up|4|||
130278639|NCT02120300|468981404|FG000|Overall Study|Enrolled but Never Treated|2|||
130278640|NCT02120300|468981405|FG001|Overall Study|Enrolled but Never Treated|0|||
130278641|NCT02120300|468981406|FG002|Overall Study|Enrolled but Never Treated|0|||
130278642|NCT02120300|468981407|FG003|Overall Study|Enrolled but Never Treated|0|||
130278643|NCT02120300|468981404|FG000|Overall Study|Lack of Efficacy|0|||
130278644|NCT02120300|468981405|FG001|Overall Study|Lack of Efficacy|0|||
130278645|NCT02120300|468981406|FG002|Overall Study|Lack of Efficacy|0|||
130278646|NCT02120300|468981407|FG003|Overall Study|Lack of Efficacy|1|||
130278647|NCT02120300|468981404|FG000|Overall Study|Lost to Follow-up|1|||
130278648|NCT02120300|468981405|FG001|Overall Study|Lost to Follow-up|0|||
130278649|NCT02120300|468981406|FG002|Overall Study|Lost to Follow-up|0|||
130278650|NCT02120300|468981407|FG003|Overall Study|Lost to Follow-up|0|||
130278651|NCT02059499|468981416|FG000|Upto Week 20|Lost to Follow-up|2|||
130278652|NCT02059499|468981417|FG001|Upto Week 20|Lost to Follow-up|6|||
130278653|NCT02059499|468981418|FG002|Upto Week 20|Lost to Follow-up|0|||
130278654|NCT02059499|468981416|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
130278655|NCT02059499|468981417|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
130278656|NCT02059499|468981418|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
130278657|NCT02059499|468981416|FG000|Upto Week 20|Withdrawal by Subject|1|||
130278658|NCT02059499|468981417|FG001|Upto Week 20|Withdrawal by Subject|1|||
130278659|NCT02059499|468981418|FG002|Upto Week 20|Withdrawal by Subject|0|||
130278660|NCT02059499|468981416|FG000|Upto Week 20|No treatment per protocol criteria|0|||
130278661|NCT02059499|468981417|FG001|Upto Week 20|No treatment per protocol criteria|0|||
130278662|NCT02059499|468981418|FG002|Upto Week 20|No treatment per protocol criteria|5|||
130278663|NCT02059499|468981416|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
130278664|NCT02059499|468981417|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
130278665|NCT02059499|468981418|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
130278666|NCT02059499|468981416|FG000|Post-week 20|Lost to Follow-up|0|||
130278667|NCT02059499|468981417|FG001|Post-week 20|Lost to Follow-up|2|||
130278668|NCT02059499|468981418|FG002|Post-week 20|Lost to Follow-up|0|||
130278669|NCT02059499|468981416|FG000|Post-week 20|Withdrawal by Subject|0|||
130278670|NCT02059499|468981417|FG001|Post-week 20|Withdrawal by Subject|1|||
130278671|NCT02059499|468981418|FG002|Post-week 20|Withdrawal by Subject|0|||
130278672|NCT02059499|468981416|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
130278673|NCT02059499|468981417|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
130278674|NCT02059499|468981418|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
130278675|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
130278676|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278677|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278678|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130042055|NCT05370157|468112189|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
130042056|NCT05370157|468112190|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
130042057|NCT03700892|468112191|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
130042058|NCT03700892|468112192|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
130042059|NCT03700892|468112193|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
130278679|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278680|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
130278681|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
130278682|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
130278683|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278684|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278685|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278686|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
130278687|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
130278688|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
130278689|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278690|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278691|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278692|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
130278693|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
130278694|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
130278695|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278696|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278697|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278698|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
130278699|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
130278700|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
130278701|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278702|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278703|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278704|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
130278705|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
130278706|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278707|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278708|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278709|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278710|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
130278711|NCT03989349|468981419|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
130278712|NCT03989349|468981420|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
130278713|NCT03989349|468981421|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278714|NCT03989349|468981422|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278715|NCT03989349|468981423|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278716|NCT03989349|468981424|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
130278717|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130278718|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130278719|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
130278720|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
130278721|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130278722|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
130278723|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130278724|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130278725|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130278726|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
130278727|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
130278728|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
130278729|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130278730|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130278731|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
130278732|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
130278733|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
130278734|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
130278735|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278736|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278737|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130278738|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278739|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
130278740|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130278741|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130278742|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130278743|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130278744|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130278745|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130278746|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130278747|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
130278748|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
130278749|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
130278750|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
130278751|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
130278752|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
130278753|NCT03989349|468981419|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130278754|NCT03989349|468981420|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130278755|NCT03989349|468981421|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130278756|NCT03989349|468981422|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
130278757|NCT03989349|468981423|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130278758|NCT03989349|468981424|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
130278759|NCT01352221|468981425|FG000|Double-blind Phase|Adverse Event|6|||
130278760|NCT01352221|468981426|FG001|Double-blind Phase|Adverse Event|4|||
130278761|NCT01352221|468981427|FG002|Double-blind Phase|Adverse Event|0|||
130278762|NCT01352221|468981428|FG003|Double-blind Phase|Adverse Event|0|||
130278763|NCT01352221|468981425|FG000|Double-blind Phase|Withdrawal by Subject|3|||
130278764|NCT01352221|468981426|FG001|Double-blind Phase|Withdrawal by Subject|5|||
130278765|NCT01352221|468981427|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130278766|NCT01352221|468981428|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130278767|NCT01352221|468981425|FG000|Double-blind Phase|Lost to Follow-up|0|||
130278768|NCT01352221|468981426|FG001|Double-blind Phase|Lost to Follow-up|1|||
130278769|NCT01352221|468981427|FG002|Double-blind Phase|Lost to Follow-up|0|||
130278770|NCT01352221|468981428|FG003|Double-blind Phase|Lost to Follow-up|0|||
130278771|NCT01352221|468981425|FG000|Double-blind Phase|Protocol Violation|0|||
130278772|NCT01352221|468981426|FG001|Double-blind Phase|Protocol Violation|1|||
130278773|NCT01352221|468981427|FG002|Double-blind Phase|Protocol Violation|0|||
130278774|NCT01352221|468981428|FG003|Double-blind Phase|Protocol Violation|0|||
130278775|NCT01352221|468981425|FG000|Open-label Phase|Physician Decision|0|||
130278776|NCT01352221|468981426|FG001|Open-label Phase|Physician Decision|0|||
130278777|NCT01352221|468981427|FG002|Open-label Phase|Physician Decision|2|||
130278778|NCT01352221|468981428|FG003|Open-label Phase|Physician Decision|1|||
130278779|NCT01352221|468981425|FG000|Open-label Phase|Pregnancy|0|||
130278780|NCT01352221|468981426|FG001|Open-label Phase|Pregnancy|0|||
130278781|NCT01352221|468981427|FG002|Open-label Phase|Pregnancy|1|||
130278782|NCT01352221|468981428|FG003|Open-label Phase|Pregnancy|0|||
130278783|NCT01352221|468981425|FG000|Open-label Phase|Adverse Event|0|||
130278784|NCT01352221|468981426|FG001|Open-label Phase|Adverse Event|0|||
130278785|NCT01352221|468981427|FG002|Open-label Phase|Adverse Event|8|||
130278786|NCT01352221|468981428|FG003|Open-label Phase|Adverse Event|4|||
130278787|NCT01352221|468981425|FG000|Open-label Phase|Withdrawal by Subject|0|||
130278788|NCT01352221|468981426|FG001|Open-label Phase|Withdrawal by Subject|0|||
130278789|NCT01352221|468981427|FG002|Open-label Phase|Withdrawal by Subject|1|||
130278790|NCT01352221|468981428|FG003|Open-label Phase|Withdrawal by Subject|6|||
130278791|NCT01352221|468981425|FG000|Open-label Phase|Worsening of IBD|0|||
130278792|NCT01352221|468981426|FG001|Open-label Phase|Worsening of IBD|0|||
130278793|NCT01352221|468981427|FG002|Open-label Phase|Worsening of IBD|1|||
130278794|NCT01352221|468981428|FG003|Open-label Phase|Worsening of IBD|0|||
130278795|NCT02016716|468981429|FG000|Overall Study|Withdrawal by Subject|5|||
130278796|NCT02016716|468981430|FG001|Overall Study|Withdrawal by Subject|5|||
130278797|NCT02016716|468981431|FG002|Overall Study|Withdrawal by Subject|5|||
130278798|NCT02016716|468981429|FG000|Overall Study|Protocol-specified Criteria|0|||
130278799|NCT02016716|468981430|FG001|Overall Study|Protocol-specified Criteria|1|||
130278800|NCT02016716|468981431|FG002|Overall Study|Protocol-specified Criteria|0|||
129886972|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
130278801|NCT02016716|468981429|FG000|Overall Study|Lost to Follow-up|1|||
130278802|NCT02016716|468981430|FG001|Overall Study|Lost to Follow-up|2|||
130278803|NCT02016716|468981431|FG002|Overall Study|Lost to Follow-up|1|||
130278804|NCT02248649|468981432|FG000|Overall Study|Death|7|||
129886973|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129886974|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
129886975|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
129886976|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129886977|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129886978|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886979|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
129886980|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886981|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886982|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886983|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
129886984|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
129886985|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
129886986|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
129886987|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
129886988|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886989|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886990|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886991|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
129886992|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886993|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886994|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886995|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886996|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
129886997|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886998|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129886999|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129887000|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129887001|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129887002|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
129887003|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
129887004|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130278805|NCT02248649|468981433|FG001|Overall Study|Death|11|||
130278806|NCT02248649|468981432|FG000|Overall Study|Lost to Follow-up|14|||
130278807|NCT02248649|468981433|FG001|Overall Study|Lost to Follow-up|10|||
130278808|NCT01439971|468981434|FG000|Overall Study|Required number in cohort dosed|0|||
130278809|NCT01439971|468981435|FG001|Overall Study|Required number in cohort dosed|1|||
130278810|NCT01439971|468981436|FG002|Overall Study|Required number in cohort dosed|2|||
130278811|NCT01439971|468981437|FG003|Overall Study|Required number in cohort dosed|0|||
130278812|NCT01439971|468981438|FG004|Overall Study|Required number in cohort dosed|1|||
130278813|NCT01221623|468981442|FG000|Overall Study|Withdrawal by Subject|19|||
130278814|NCT01221623|468981443|FG001|Overall Study|Withdrawal by Subject|8|||
129887005|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
129887006|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
130278815|NCT01221623|468981442|FG000|Overall Study|Lost to Follow-up|7|||
130278816|NCT01221623|468981443|FG001|Overall Study|Lost to Follow-up|1|||
130278817|NCT01221623|468981442|FG000|Overall Study|Adverse Event|6|||
130278818|NCT01221623|468981443|FG001|Overall Study|Adverse Event|3|||
130278819|NCT01221623|468981442|FG000|Overall Study|Death|1|||
130278820|NCT01221623|468981443|FG001|Overall Study|Death|0|||
130278821|NCT01221623|468981442|FG000|Overall Study|Other|5|||
130278822|NCT01221623|468981443|FG001|Overall Study|Other|2|||
130278823|NCT03479541|468981444|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
130278824|NCT03479541|468981445|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
130278825|NCT03479541|468981446|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
130278826|NCT03479541|468981447|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
130278827|NCT03479541|468981444|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
130278828|NCT03479541|468981445|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
130278829|NCT03479541|468981446|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
130278830|NCT03479541|468981447|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
130278831|NCT03479541|468981444|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
130278832|NCT03479541|468981445|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
130278833|NCT03479541|468981446|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
130278834|NCT03479541|468981447|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
130278835|NCT03479541|468981444|FG000|Home Monitoring|Lost to Follow-up|0|||
130278836|NCT03479541|468981445|FG001|Home Monitoring|Lost to Follow-up|0|||
130278837|NCT03479541|468981446|FG002|Home Monitoring|Lost to Follow-up|8|||
130278838|NCT03479541|468981447|FG003|Home Monitoring|Lost to Follow-up|12|||
130278839|NCT03479541|468981444|FG000|Home Monitoring|Withdrawal by Subject|0|||
130278840|NCT03479541|468981445|FG001|Home Monitoring|Withdrawal by Subject|0|||
130278841|NCT03479541|468981446|FG002|Home Monitoring|Withdrawal by Subject|17|||
130278842|NCT03479541|468981447|FG003|Home Monitoring|Withdrawal by Subject|30|||
130278843|NCT03479541|468981444|FG000|Home Monitoring|Early Termination - PI Decision|0|||
130278844|NCT03479541|468981445|FG001|Home Monitoring|Early Termination - PI Decision|0|||
130278845|NCT03479541|468981446|FG002|Home Monitoring|Early Termination - PI Decision|4|||
130278846|NCT03479541|468981447|FG003|Home Monitoring|Early Termination - PI Decision|6|||
130278847|NCT00661726|468981448|FG000|Overall Study|Adverse Event|1|||
130278848|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
130278849|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
130278850|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
130278851|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
130278852|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
130278853|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
130278854|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
130278855|NCT01673854|468981449|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
130278856|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
130278857|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
130278858|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
130278859|NCT01673854|468981449|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
130278860|NCT00107900|468981452|FG000|Overall Study|Adverse Event|3|||
130278861|NCT00107900|468981453|FG001|Overall Study|Adverse Event|2|||
130278862|NCT00107900|468981454|FG002|Overall Study|Adverse Event|10|||
130278863|NCT00107900|468981455|FG003|Overall Study|Adverse Event|3|||
130278864|NCT00107900|468981456|FG004|Overall Study|Adverse Event|5|||
130278865|NCT00107900|468981457|FG005|Overall Study|Adverse Event|3|||
130278866|NCT00107900|468981452|FG000|Overall Study|Death|0|||
130278867|NCT00107900|468981453|FG001|Overall Study|Death|0|||
130278868|NCT00107900|468981454|FG002|Overall Study|Death|0|||
130278869|NCT00107900|468981455|FG003|Overall Study|Death|0|||
130278870|NCT00107900|468981456|FG004|Overall Study|Death|1|||
130278871|NCT00107900|468981457|FG005|Overall Study|Death|0|||
130278872|NCT00107900|468981452|FG000|Overall Study|Lost to Follow-up|4|||
130278873|NCT00107900|468981453|FG001|Overall Study|Lost to Follow-up|1|||
130278874|NCT00107900|468981454|FG002|Overall Study|Lost to Follow-up|3|||
130278875|NCT00107900|468981455|FG003|Overall Study|Lost to Follow-up|2|||
130278876|NCT00107900|468981456|FG004|Overall Study|Lost to Follow-up|5|||
130278877|NCT00107900|468981457|FG005|Overall Study|Lost to Follow-up|5|||
130278878|NCT00107900|468981452|FG000|Overall Study|Protocol Violation|1|||
130278879|NCT00107900|468981453|FG001|Overall Study|Protocol Violation|0|||
130278880|NCT00107900|468981454|FG002|Overall Study|Protocol Violation|5|||
130278881|NCT00107900|468981455|FG003|Overall Study|Protocol Violation|5|||
130278882|NCT00107900|468981456|FG004|Overall Study|Protocol Violation|7|||
130278883|NCT00107900|468981457|FG005|Overall Study|Protocol Violation|0|||
130278884|NCT00107900|468981452|FG000|Overall Study|Withdrawal by Subject|1|||
130278885|NCT00107900|468981453|FG001|Overall Study|Withdrawal by Subject|0|||
130278886|NCT00107900|468981454|FG002|Overall Study|Withdrawal by Subject|5|||
130278887|NCT00107900|468981455|FG003|Overall Study|Withdrawal by Subject|0|||
130278888|NCT00107900|468981456|FG004|Overall Study|Withdrawal by Subject|1|||
130278889|NCT00107900|468981457|FG005|Overall Study|Withdrawal by Subject|1|||
130278890|NCT00107900|468981452|FG000|Overall Study|Administrative Reasons|1|||
130278891|NCT00107900|468981453|FG001|Overall Study|Administrative Reasons|0|||
130278892|NCT00107900|468981454|FG002|Overall Study|Administrative Reasons|2|||
130278893|NCT00107900|468981455|FG003|Overall Study|Administrative Reasons|2|||
130278894|NCT00107900|468981456|FG004|Overall Study|Administrative Reasons|2|||
130278895|NCT00107900|468981457|FG005|Overall Study|Administrative Reasons|0|||
130278896|NCT01700959|468981461|FG000|Overall Study|Adverse Event|0|||
130278897|NCT01700959|468981462|FG001|Overall Study|Adverse Event|1|||
130278898|NCT01700959|468981463|FG002|Overall Study|Adverse Event|1|||
130278899|NCT01700959|468981464|FG003|Overall Study|Adverse Event|2|||
130278900|NCT01700959|468981465|FG004|Overall Study|Adverse Event|0|||
130278901|NCT01700959|468981466|FG005|Overall Study|Adverse Event|2|||
130278902|NCT01700959|468981461|FG000|Overall Study|Withdrawal by Subject|15|||
130278903|NCT01700959|468981462|FG001|Overall Study|Withdrawal by Subject|9|||
130278904|NCT01700959|468981463|FG002|Overall Study|Withdrawal by Subject|12|||
130278905|NCT01700959|468981464|FG003|Overall Study|Withdrawal by Subject|11|||
130278906|NCT01700959|468981465|FG004|Overall Study|Withdrawal by Subject|8|||
130278907|NCT01700959|468981466|FG005|Overall Study|Withdrawal by Subject|12|||
130278908|NCT01700959|468981461|FG000|Overall Study|Ineligible|2|||
130278909|NCT01700959|468981462|FG001|Overall Study|Ineligible|1|||
130278910|NCT01700959|468981463|FG002|Overall Study|Ineligible|2|||
130278911|NCT01700959|468981464|FG003|Overall Study|Ineligible|0|||
130278912|NCT01700959|468981465|FG004|Overall Study|Ineligible|0|||
130278913|NCT01700959|468981466|FG005|Overall Study|Ineligible|1|||
130278914|NCT01700959|468981461|FG000|Overall Study|Noncompliant|9|||
130278915|NCT01700959|468981462|FG001|Overall Study|Noncompliant|9|||
130278916|NCT01700959|468981463|FG002|Overall Study|Noncompliant|17|||
130278917|NCT01700959|468981464|FG003|Overall Study|Noncompliant|18|||
130278918|NCT01700959|468981465|FG004|Overall Study|Noncompliant|15|||
130278919|NCT01700959|468981466|FG005|Overall Study|Noncompliant|9|||
130278920|NCT01700959|468981461|FG000|Overall Study|Side effects|1|||
130278921|NCT01700959|468981462|FG001|Overall Study|Side effects|4|||
130278922|NCT01700959|468981463|FG002|Overall Study|Side effects|8|||
130278923|NCT01700959|468981464|FG003|Overall Study|Side effects|4|||
130278924|NCT01700959|468981465|FG004|Overall Study|Side effects|4|||
130278925|NCT01700959|468981466|FG005|Overall Study|Side effects|1|||
130278926|NCT00830375|468981467|FG000|Overall Study|Lost to Follow-up|1|||
130278927|NCT00875485|468984271|FG000|Challenge Dose Epoch|Pregnancy|1|||
130278928|NCT00875485|468984272|FG001|Challenge Dose Epoch|Pregnancy|0|||
130278929|NCT01271010|468984273|FG000|Overall Study|Reason not specified|11|||
130278930|NCT01271010|468984273|FG000|Overall Study|Start of new CLL therapy|1|||
130278931|NCT01271010|468984273|FG000|Overall Study|Protocol Violation|1|||
130278932|NCT01271010|468984273|FG000|Overall Study|Death|2|||
130278933|NCT01271010|468984273|FG000|Overall Study|Progression and relapse of disease|1|||
130278934|NCT01271010|468984273|FG000|Overall Study|Withdrawal by Subject|18|||
130278935|NCT01271010|468984273|FG000|Overall Study|Disease progression|27|||
130278936|NCT01631747|468984274|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
130278937|NCT01631747|468984275|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
130278938|NCT01631747|468984274|FG000|Live Birth|Pregnancy Termination|1|||
130278939|NCT01631747|468984275|FG001|Live Birth|Pregnancy Termination|0|||
130278940|NCT01631747|468984274|FG000|Live Birth|MIscarriage|2|||
130278941|NCT01631747|468984275|FG001|Live Birth|MIscarriage|0|||
130278942|NCT01631747|468984274|FG000|Live Birth|Stillbirth|1|||
130278943|NCT01631747|468984275|FG001|Live Birth|Stillbirth|1|||
130278944|NCT01631747|468984274|FG000|One Year Infant Outcomes|Patient Refused|13|||
130278945|NCT01631747|468984275|FG001|One Year Infant Outcomes|Patient Refused|9|||
130278946|NCT01456195|468984276|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130278947|NCT01456195|468984277|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
130278948|NCT01456195|468984278|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
130278949|NCT01456195|468984276|FG000|Overall Study|Lost to Follow-up|3|||
130278950|NCT01456195|468984277|FG001|Overall Study|Lost to Follow-up|1|||
130278951|NCT01456195|468984278|FG002|Overall Study|Lost to Follow-up|3|||
130278952|NCT01456195|468984276|FG000|Overall Study|Voluntary Withdrawal|5|||
130278953|NCT01456195|468984277|FG001|Overall Study|Voluntary Withdrawal|3|||
130278954|NCT01456195|468984278|FG002|Overall Study|Voluntary Withdrawal|7|||
130278955|NCT01456195|468984276|FG000|Overall Study|Lack of Efficacy|0|||
130278956|NCT01456195|468984277|FG001|Overall Study|Lack of Efficacy|1|||
130278957|NCT01456195|468984278|FG002|Overall Study|Lack of Efficacy|0|||
130278958|NCT01456195|468984276|FG000|Overall Study|Other Reasons|2|||
130278959|NCT01456195|468984277|FG001|Overall Study|Other Reasons|1|||
130278960|NCT01456195|468984278|FG002|Overall Study|Other Reasons|3|||
130278961|NCT04848220|468984281|FG000|Overall Study|Unable to proceed to study procedure|0|||
130278962|NCT04848220|468984282|FG001|Overall Study|Unable to proceed to study procedure|1|||
130278963|NCT04848220|468984283|FG002|Overall Study|Unable to proceed to study procedure|0|||
130278964|NCT04848220|468984281|FG000|Overall Study|Fractional flow not significant|0|||
130278965|NCT04848220|468984282|FG001|Overall Study|Fractional flow not significant|1|||
130278966|NCT04848220|468984283|FG002|Overall Study|Fractional flow not significant|0|||
130278967|NCT02923830|468984284|FG000|Overall Study|Physician Decision|13|||
130278968|NCT02923830|468984285|FG001|Overall Study|Physician Decision|15|||
130278969|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
130278970|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
130278971|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
130278972|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
130278973|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
130278974|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
130278975|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
130278976|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
130278977|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
130278978|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
130278979|NCT00510718|468984286|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
130278980|NCT00510718|468984287|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
130278981|NCT02150057|468984296|FG000|Overall Study|Lost to Follow-up|6|||
130278982|NCT02150057|468984297|FG001|Overall Study|Lost to Follow-up|4|||
130278983|NCT00489424|468984298|FG000|Overall Study|Adverse Event|3|||
130278984|NCT00489424|468984299|FG001|Overall Study|Adverse Event|3|||
130278985|NCT00489424|468984300|FG002|Overall Study|Adverse Event|4|||
130278986|NCT00489424|468984298|FG000|Overall Study|Lack of Efficacy|1|||
130278987|NCT00489424|468984299|FG001|Overall Study|Lack of Efficacy|0|||
130278988|NCT00489424|468984300|FG002|Overall Study|Lack of Efficacy|0|||
130278989|NCT00489424|468984298|FG000|Overall Study|Administrative problems|0|||
130278990|NCT00489424|468984299|FG001|Overall Study|Administrative problems|2|||
130278991|NCT00489424|468984300|FG002|Overall Study|Administrative problems|1|||
130278992|NCT00394251|468984301|FG000|Overall Study|Adverse Event|7|||
130278993|NCT00394251|468984302|FG001|Overall Study|Adverse Event|5|||
130278994|NCT00394251|468984301|FG000|Overall Study|Unacceptable Toxicity|20|||
130278995|NCT00394251|468984302|FG001|Overall Study|Unacceptable Toxicity|18|||
130278996|NCT00394251|468984301|FG000|Overall Study|Physician Decision|1|||
130278997|NCT00394251|468984302|FG001|Overall Study|Physician Decision|1|||
130278998|NCT00394251|468984301|FG000|Overall Study|Protocol Violation|0|||
130278999|NCT00394251|468984302|FG001|Overall Study|Protocol Violation|1|||
130279000|NCT00394251|468984301|FG000|Overall Study|Withdrawal by Subject|7|||
130042060|NCT00258154|468112203|FG000|Overall Study|Adverse Event|1|||
130042061|NCT00258154|468112204|FG001|Overall Study|Adverse Event|0|||
130042062|NCT00258154|468112203|FG000|Overall Study|Lost to Follow-up|0|||
130042063|NCT00258154|468112204|FG001|Overall Study|Lost to Follow-up|1|||
130279001|NCT00394251|468984302|FG001|Overall Study|Withdrawal by Subject|11|||
130279002|NCT00394251|468984301|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
130279003|NCT00394251|468984302|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
130279004|NCT05791565|468984303|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
130279005|NCT05791565|468984304|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
130279006|NCT01558115|468984305|FG000|Overall Study|Withdrawal by Subject|3|||
130279007|NCT01558115|468984305|FG000|Overall Study|Study closed due to poor enrollment|4|||
130279008|NCT01696994|468984306|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
130279009|NCT01696994|468984307|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
130279010|NCT01696994|468984306|FG000|Overall Study|Died Before Randomization|1|||
130279011|NCT01696994|468984307|FG001|Overall Study|Died Before Randomization|2|||
130279012|NCT01696994|468984306|FG000|Overall Study|Died Before ASU (Control)|73|||
130279013|NCT01696994|468984307|FG001|Overall Study|Died Before ASU (Control)|0|||
130279014|NCT01696994|468984306|FG000|Overall Study|No Ovaries at Baseline|4807|||
130279015|NCT01696994|468984307|FG001|Overall Study|No Ovaries at Baseline|4851|||
130279016|NCT01696994|468984306|FG000|Overall Study|Refused ASU (Control)|311|||
130279017|NCT01696994|468984307|FG001|Overall Study|Refused ASU (Control)|0|||
130279018|NCT01696994|468984306|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
130279019|NCT01696994|468984307|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
130279020|NCT02388165|468984308|FG000|Overall Study|Study terminated by sponsor|5|||
130279021|NCT02388165|468984309|FG001|Overall Study|Study terminated by sponsor|5|||
130279022|NCT02388165|468984308|FG000|Overall Study|Other|11|||
130279023|NCT02388165|468984309|FG001|Overall Study|Other|13|||
130279024|NCT02388165|468984308|FG000|Overall Study|No longer meet eligibility criteria|40|||
130279025|NCT02388165|468984309|FG001|Overall Study|No longer meet eligibility criteria|43|||
130279026|NCT02388165|468984308|FG000|Overall Study|Withdrawal of consent|31|||
130279027|NCT02388165|468984309|FG001|Overall Study|Withdrawal of consent|32|||
130279028|NCT02388165|468984308|FG000|Overall Study|Lost to Follow-up|19|||
130279029|NCT02388165|468984309|FG001|Overall Study|Lost to Follow-up|20|||
130279030|NCT02388165|468984308|FG000|Overall Study|Death|13|||
130279031|NCT02388165|468984309|FG001|Overall Study|Death|10|||
130279032|NCT02388165|468984308|FG000|Overall Study|Adverse Event|3|||
130279033|NCT02388165|468984309|FG001|Overall Study|Adverse Event|5|||
130279034|NCT02388165|468984308|FG000|Overall Study|Did not meet entrance criteria|5|||
130279035|NCT02388165|468984309|FG001|Overall Study|Did not meet entrance criteria|2|||
130279036|NCT00705250|468984310|FG000|Overall Study|Withdrawal by Subject|1|||
130279037|NCT00705250|468984310|FG000|Overall Study|Patient died in car accident|1|||
130279038|NCT00880269|468984311|FG000|Overall Study|Protocol Violation|1|||
130279039|NCT00880269|468984312|FG001|Overall Study|Protocol Violation|0|||
130279040|NCT00880269|468984311|FG000|Overall Study|Disease Progression|13|||
130279041|NCT00880269|468984312|FG001|Overall Study|Disease Progression|11|||
130279042|NCT00880269|468984311|FG000|Overall Study|New Cancer Therapy|1|||
130279043|NCT00880269|468984312|FG001|Overall Study|New Cancer Therapy|0|||
130279044|NCT00880269|468984311|FG000|Overall Study|Death|4|||
130279045|NCT00880269|468984312|FG001|Overall Study|Death|2|||
130042064|NCT00258154|468112203|FG000|Overall Study|Protocol Violation|2|||
130279046|NCT00880269|468984311|FG000|Overall Study|Lost to Follow-up|0|||
130279047|NCT00880269|468984312|FG001|Overall Study|Lost to Follow-up|1|||
130279048|NCT00880269|468984311|FG000|Overall Study|Withdrawal by Subject|3|||
130279049|NCT00880269|468984312|FG001|Overall Study|Withdrawal by Subject|4|||
130279050|NCT00880269|468984311|FG000|Overall Study|Adverse Event|10|||
130279051|NCT00880269|468984312|FG001|Overall Study|Adverse Event|9|||
130042065|NCT00258154|468112204|FG001|Overall Study|Protocol Violation|1|||
130106156|NCT01901146|468349914|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130106157|NCT01901146|468349915|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
130279052|NCT01576146|468984313|FG000|Extension Period 1|Adverse Event|2|||
130279053|NCT01576146|468984313|FG000|Extension Period 1|Death|2|||
130279054|NCT01576146|468984313|FG000|Extension Period 1|Physician Decision|2|||
130279055|NCT01576146|468984313|FG000|Extension Period 1|Withdrawal by Subject|1|||
130279056|NCT01576146|468984313|FG000|Extension Period 1|Lost to Follow-up|1|||
130279057|NCT01576146|468984313|FG000|Extension Period 1|Parathyroidectomy|1|||
130279058|NCT01576146|468984313|FG000|Extension Period 1|Renal Transplant|1|||
130279059|NCT01576146|468984313|FG000|Extension Period 2|Sponsor Decision|13|||
130279060|NCT01576146|468984313|FG000|Extension Period 2|Death|1|||
130279061|NCT01576146|468984313|FG000|Extension Period 2|Adverse Event|1|||
130279062|NCT01576146|468984313|FG000|Extension Period 2|Renal Transplant|1|||
130279063|NCT01576146|468984313|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
130279064|NCT00316225|468984314|FG000|Overall Study|Adverse Event|2|||
130279065|NCT00316225|468984314|FG000|Overall Study|Physician Decision|3|||
130279066|NCT00316225|468984314|FG000|Overall Study|Progressive Disease|15|||
130279067|NCT00316225|468984314|FG000|Overall Study|Withdrawal by Subject|3|||
130279068|NCT00316225|468984314|FG000|Overall Study|Death|2|||
130279069|NCT01811485|468984315|FG000|Overall Study|Adverse Event|1|||
130279070|NCT01811485|468984316|FG001|Overall Study|Adverse Event|3|||
130279071|NCT01811485|468984317|FG002|Overall Study|Adverse Event|2|||
130279072|NCT01811485|468984315|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130279073|NCT01811485|468984316|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130279074|NCT01811485|468984317|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130279075|NCT01811485|468984315|FG000|Overall Study|Administrative problems|1|||
130279076|NCT01811485|468984316|FG001|Overall Study|Administrative problems|0|||
130279077|NCT01811485|468984317|FG002|Overall Study|Administrative problems|0|||
130279078|NCT01811485|468984315|FG000|Overall Study|Protocol Deviation|0|||
130279079|NCT01811485|468984316|FG001|Overall Study|Protocol Deviation|1|||
130279080|NCT01811485|468984317|FG002|Overall Study|Protocol Deviation|0|||
130279081|NCT01545934|468984318|FG000|Overall Study|Withdrawal by Subject|4|||
130279082|NCT01545934|468984319|FG001|Overall Study|Withdrawal by Subject|3|||
130279083|NCT01545934|468984318|FG000|Overall Study|Lost to Follow-up|1|||
130279084|NCT01545934|468984319|FG001|Overall Study|Lost to Follow-up|0|||
130279085|NCT03654404|468984320|FG000|Overall Study|Death|1|||
130279086|NCT03654404|468984320|FG000|Overall Study|Lost to Follow-up|2|||
130279087|NCT03654404|468984320|FG000|Overall Study|Withdrawal by Subject|5|||
130279088|NCT03215758|468984323|FG000|Overall Study|Technical Problems|1|||
130279089|NCT03215758|468984324|FG001|Overall Study|Technical Problems|0|||
130279090|NCT03215758|468984323|FG000|Overall Study|Protocol deviation|0|||
130279091|NCT03215758|468984324|FG001|Overall Study|Protocol deviation|1|||
130279092|NCT03215758|468984323|FG000|Overall Study|Physician Decision|0|||
130279093|NCT03215758|468984324|FG001|Overall Study|Physician Decision|1|||
130279094|NCT03215758|468984323|FG000|Overall Study|Death|0|||
130279095|NCT03215758|468984324|FG001|Overall Study|Death|1|||
130279096|NCT03215758|468984323|FG000|Overall Study|Adverse Event|1|||
130279097|NCT03215758|468984324|FG001|Overall Study|Adverse Event|2|||
130279098|NCT03215758|468984323|FG000|Overall Study|Subject/Guardian Decision|3|||
130279099|NCT03215758|468984324|FG001|Overall Study|Subject/Guardian Decision|3|||
130279100|NCT02003638|468984325|FG000|Overall Study|Withdrawal by Subject|1|||
130279101|NCT02003638|468984326|FG001|Overall Study|Withdrawal by Subject|0|||
130279102|NCT04115748|468984332|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
130279103|NCT04115748|468984333|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
130279104|NCT04115748|468984334|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
130279105|NCT04115748|468984335|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
130279106|NCT04115748|468984336|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279107|NCT04115748|468984337|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279108|NCT04115748|468984338|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279109|NCT04115748|468984339|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279110|NCT04115748|468984340|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279111|NCT04115748|468984341|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
130279112|NCT04115748|468984332|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130106158|NCT01901146|468349911|FG000|Adjuvant Phase|Other|0|||
130106159|NCT01901146|468349912|FG001|Adjuvant Phase|Other|0|||
130279113|NCT04115748|468984333|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279114|NCT04115748|468984334|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279115|NCT04115748|468984335|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
130279116|NCT04115748|468984336|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279117|NCT04115748|468984337|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279118|NCT04115748|468984338|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279119|NCT04115748|468984339|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279120|NCT04115748|468984340|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279121|NCT04115748|468984341|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
130279122|NCT04115748|468984332|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279123|NCT04115748|468984333|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279124|NCT04115748|468984334|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279125|NCT04115748|468984335|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
130279126|NCT04115748|468984336|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
130279127|NCT04115748|468984337|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
130279128|NCT04115748|468984338|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130279129|NCT04115748|468984339|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130279130|NCT04115748|468984340|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
130279131|NCT04115748|468984341|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
130279132|NCT04115748|468984332|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279133|NCT04115748|468984333|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279134|NCT04115748|468984334|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279135|NCT04115748|468984335|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279136|NCT04115748|468984336|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279137|NCT04115748|468984337|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279138|NCT04115748|468984338|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279139|NCT04115748|468984339|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279140|NCT04115748|468984340|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
130279141|NCT04115748|468984341|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
130279142|NCT00713349|468984342|FG000|Overall Study|Protocol Violation|1|||
130279143|NCT03764631|468984343|FG000|Overall Study|Personal Reasons|3|||
130279144|NCT03764631|468984344|FG001|Overall Study|Personal Reasons|2|||
130279145|NCT03764631|468984343|FG000|Overall Study|Switching Therapy|3|||
130279146|NCT03764631|468984344|FG001|Overall Study|Switching Therapy|3|||
130279147|NCT03764631|468984343|FG000|Overall Study|Adverse Event|0|||
130279148|NCT03764631|468984344|FG001|Overall Study|Adverse Event|1|||
130279149|NCT03764631|468984343|FG000|Overall Study|Lost to Follow-up|33|||
130279150|NCT03764631|468984344|FG001|Overall Study|Lost to Follow-up|41|||
130279151|NCT03764631|468984343|FG000|Overall Study|No data as study site was closed|2|||
130279152|NCT03764631|468984344|FG001|Overall Study|No data as study site was closed|6|||
130279153|NCT01200407|468984345|FG000|Overall Study|Lost to Follow-up|56|||
130279154|NCT01200407|468984345|FG000|Overall Study|Adverse Event|3|||
130279155|NCT01200407|468984345|FG000|Overall Study|Withdrawal by Subject|4|||
130279156|NCT01200407|468984345|FG000|Overall Study|Other|19|||
130279157|NCT03299881|468984346|FG000|Overall Study|Study Termination|17|||
130279158|NCT03299881|468984347|FG001|Overall Study|Study Termination|13|||
130279159|NCT01450696|468984348|FG000|Overall Study|Never Treated|1|||
130279160|NCT01450696|468984349|FG001|Overall Study|Never Treated|1|||
130279161|NCT01450696|468984348|FG000|Overall Study|Death|77|||
130279162|NCT01450696|468984349|FG001|Overall Study|Death|84|||
130279163|NCT01450696|468984348|FG000|Overall Study|Lost to Follow-up|3|||
130279164|NCT01450696|468984349|FG001|Overall Study|Lost to Follow-up|3|||
130279165|NCT01450696|468984348|FG000|Overall Study|Non-Compliance|1|||
130279166|NCT01450696|468984349|FG001|Overall Study|Non-Compliance|0|||
129887007|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
130279167|NCT01450696|468984348|FG000|Overall Study|Withdrawal by Subject|13|||
130279168|NCT01450696|468984349|FG001|Overall Study|Withdrawal by Subject|2|||
130279169|NCT01450696|468984348|FG000|Overall Study|Study Terminated by Sponsor|53|||
130279170|NCT01450696|468984349|FG001|Overall Study|Study Terminated by Sponsor|58|||
130279171|NCT01843673|468984350|FG000|Overall Study|Lack of Efficacy|2|||
130279172|NCT01843673|468984350|FG000|Overall Study|Withdrawal by Subject|4|||
130279173|NCT02321319|468984351|FG000|Overall Study|Product discontinued|5|||
130279174|NCT02249091|468984352|FG000|Overall Study|Lack of Efficacy|8|||
130279175|NCT02249091|468984353|FG001|Overall Study|Lack of Efficacy|3|||
130279176|NCT02249091|468984352|FG000|Overall Study|Physician Decision|4|||
130279177|NCT02249091|468984353|FG001|Overall Study|Physician Decision|1|||
130279178|NCT02249091|468984352|FG000|Overall Study|Withdrawal by Subject|2|||
130279179|NCT02249091|468984353|FG001|Overall Study|Withdrawal by Subject|2|||
130279180|NCT02249091|468984352|FG000|Overall Study|Death|3|||
130279181|NCT02249091|468984353|FG001|Overall Study|Death|4|||
130279182|NCT02249091|468984352|FG000|Overall Study|Adverse Event|1|||
130279183|NCT02249091|468984353|FG001|Overall Study|Adverse Event|0|||
130279184|NCT02249091|468984352|FG000|Overall Study|Stable disease with following SCT|0|||
130279185|NCT02249091|468984353|FG001|Overall Study|Stable disease with following SCT|1|||
130279186|NCT02249091|468984352|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
130279187|NCT02249091|468984353|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
130279188|NCT02249091|468984352|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
130279189|NCT02249091|468984353|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
130279190|NCT02249091|468984352|FG000|Overall Study|Refractory AML|1|||
130279191|NCT02249091|468984353|FG001|Overall Study|Refractory AML|1|||
130279192|NCT01257230|468984356|FG000|Overall Study|Not Treated|0|||
130279193|NCT01257230|468984357|FG001|Overall Study|Not Treated|0|||
130279194|NCT01257230|468984358|FG002|Overall Study|Not Treated|1|||
130279195|NCT01257230|468984356|FG000|Overall Study|Adverse Event|2|||
130279196|NCT01257230|468984357|FG001|Overall Study|Adverse Event|0|||
130279197|NCT01257230|468984358|FG002|Overall Study|Adverse Event|0|||
130279198|NCT01257230|468984356|FG000|Overall Study|Lack of Efficacy|0|||
130279199|NCT01257230|468984357|FG001|Overall Study|Lack of Efficacy|1|||
130279200|NCT01257230|468984358|FG002|Overall Study|Lack of Efficacy|0|||
130279201|NCT01257230|468984356|FG000|Overall Study|Protocol Violation|3|||
130279202|NCT01257230|468984357|FG001|Overall Study|Protocol Violation|0|||
130279203|NCT01257230|468984358|FG002|Overall Study|Protocol Violation|1|||
130279204|NCT01257230|468984356|FG000|Overall Study|Withdrawal by Subject|0|||
130279205|NCT01257230|468984357|FG001|Overall Study|Withdrawal by Subject|4|||
130279206|NCT01257230|468984358|FG002|Overall Study|Withdrawal by Subject|1|||
130279207|NCT01257230|468984356|FG000|Overall Study|Other reason not defined above|1|||
130279208|NCT01257230|468984357|FG001|Overall Study|Other reason not defined above|5|||
130279209|NCT01257230|468984358|FG002|Overall Study|Other reason not defined above|3|||
130279210|NCT01205061|468984361|FG000|Overall Study|Adverse Event|4|||
130279211|NCT01205061|468984361|FG000|Overall Study|Withdrawal by Subject|11|||
130279212|NCT01205061|468984361|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
130279213|NCT01205061|468984361|FG000|Overall Study|Lost to Follow-up|9|||
130279214|NCT01205061|468984361|FG000|Overall Study|Other|1|||
130279215|NCT00765037|468984362|FG000|Overall Study|Lost to Follow-up|5|||
130279216|NCT00765037|468984362|FG000|Overall Study|Adverse Event|1|||
130279217|NCT03070171|468984369|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
130279218|NCT03070171|468984370|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
130279219|NCT03070171|468984369|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
130279220|NCT03070171|468984370|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
130279221|NCT01471028|468984374|FG000|VTI-208|Adverse Event|39|||
130279222|NCT01471028|468984375|FG001|VTI-208|Adverse Event|41|||
130279223|NCT01471028|468984374|FG000|VTI-208|Withdrawal by Subject|0|||
130279224|NCT01471028|468984375|FG001|VTI-208|Withdrawal by Subject|2|||
130279225|NCT01471028|468984374|FG000|VTI-208|Lost to Follow-up|1|||
130279226|NCT01471028|468984375|FG001|VTI-208|Lost to Follow-up|1|||
130279227|NCT01471028|468984374|FG000|VTI-208E|Death|7|||
130279228|NCT01471028|468984375|FG001|VTI-208E|Death|10|||
130279229|NCT01471028|468984374|FG000|VTI-208E|Withdrawal by Subject|1|||
130279230|NCT01471028|468984375|FG001|VTI-208E|Withdrawal by Subject|0|||
130279231|NCT01471028|468984374|FG000|VTI-208E|Lost to Follow-up|0|||
130279232|NCT01471028|468984375|FG001|VTI-208E|Lost to Follow-up|2|||
130279233|NCT00610857|468984377|FG000|Overall Study|Not evaluable for response|2|||
130279234|NCT01626118|468984378|FG000|Overall Study|Lack of Efficacy|1|||
130279235|NCT01626118|468984379|FG001|Overall Study|Lack of Efficacy|0|||
130279236|NCT01626118|468984380|FG002|Overall Study|Lack of Efficacy|1|||
130279237|NCT01626118|468984381|FG003|Overall Study|Lack of Efficacy|3|||
130279238|NCT01626118|468984378|FG000|Overall Study|Lost to Follow-up|1|||
130279239|NCT01626118|468984379|FG001|Overall Study|Lost to Follow-up|0|||
130279240|NCT01626118|468984380|FG002|Overall Study|Lost to Follow-up|0|||
130279241|NCT01626118|468984381|FG003|Overall Study|Lost to Follow-up|0|||
130279242|NCT01626118|468984378|FG000|Overall Study|Adverse Event|0|||
130279243|NCT01626118|468984379|FG001|Overall Study|Adverse Event|1|||
130279244|NCT01626118|468984380|FG002|Overall Study|Adverse Event|1|||
130279245|NCT01626118|468984381|FG003|Overall Study|Adverse Event|0|||
130279246|NCT01626118|468984378|FG000|Overall Study|Investigator Decision|0|||
130279247|NCT01626118|468984379|FG001|Overall Study|Investigator Decision|1|||
130279248|NCT01626118|468984380|FG002|Overall Study|Investigator Decision|0|||
130279249|NCT01626118|468984381|FG003|Overall Study|Investigator Decision|0|||
130279250|NCT04826094|468984382|FG000|Overall Study|Lost to Follow-up|2|||
130279251|NCT04826094|468984383|FG001|Overall Study|Lost to Follow-up|1|||
130279252|NCT04826094|468984384|FG002|Overall Study|Lost to Follow-up|0|||
130279253|NCT04826094|468984385|FG003|Overall Study|Lost to Follow-up|0|||
130279254|NCT04826094|468984386|FG004|Overall Study|Lost to Follow-up|1|||
130279255|NCT04826094|468984387|FG005|Overall Study|Lost to Follow-up|3|||
130279256|NCT04826094|468984388|FG006|Overall Study|Lost to Follow-up|1|||
130279257|NCT04826094|468984389|FG007|Overall Study|Lost to Follow-up|1|||
130279258|NCT04826094|468984382|FG000|Overall Study|Participant withdrew consent|1|||
130279259|NCT04826094|468984383|FG001|Overall Study|Participant withdrew consent|0|||
130279260|NCT04826094|468984384|FG002|Overall Study|Participant withdrew consent|0|||
130279261|NCT04826094|468984385|FG003|Overall Study|Participant withdrew consent|1|||
130279262|NCT04826094|468984386|FG004|Overall Study|Participant withdrew consent|1|||
130279263|NCT04826094|468984387|FG005|Overall Study|Participant withdrew consent|1|||
130279264|NCT04826094|468984388|FG006|Overall Study|Participant withdrew consent|0|||
130279265|NCT04826094|468984389|FG007|Overall Study|Participant withdrew consent|1|||
130279266|NCT04826094|468984382|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
130279267|NCT04826094|468984383|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
130279268|NCT04826094|468984384|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
130279269|NCT04826094|468984385|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
130279270|NCT04826094|468984386|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
130279271|NCT04826094|468984387|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
130279272|NCT04826094|468984388|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
130279273|NCT04826094|468984389|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
130279274|NCT04826094|468984382|FG000|Overall Study|Withdrawn by Investigator|0|||
130279275|NCT04826094|468984383|FG001|Overall Study|Withdrawn by Investigator|0|||
130279276|NCT04826094|468984384|FG002|Overall Study|Withdrawn by Investigator|0|||
130279277|NCT04826094|468984385|FG003|Overall Study|Withdrawn by Investigator|0|||
130279278|NCT04826094|468984386|FG004|Overall Study|Withdrawn by Investigator|0|||
130279279|NCT04826094|468984387|FG005|Overall Study|Withdrawn by Investigator|1|||
130279280|NCT04826094|468984388|FG006|Overall Study|Withdrawn by Investigator|0|||
130279281|NCT04826094|468984389|FG007|Overall Study|Withdrawn by Investigator|1|||
130279282|NCT04826094|468984382|FG000|Overall Study|Other: Moved from area|1|||
130279283|NCT04826094|468984383|FG001|Overall Study|Other: Moved from area|1|||
130279284|NCT04826094|468984384|FG002|Overall Study|Other: Moved from area|1|||
130279285|NCT04826094|468984385|FG003|Overall Study|Other: Moved from area|0|||
130279286|NCT04826094|468984386|FG004|Overall Study|Other: Moved from area|0|||
130279287|NCT04826094|468984387|FG005|Overall Study|Other: Moved from area|0|||
130279288|NCT04826094|468984388|FG006|Overall Study|Other: Moved from area|0|||
130279289|NCT04826094|468984389|FG007|Overall Study|Other: Moved from area|0|||
130279290|NCT04826094|468984382|FG000|Overall Study|Other: Declined|0|||
130279291|NCT04826094|468984383|FG001|Overall Study|Other: Declined|0|||
130279292|NCT04826094|468984384|FG002|Overall Study|Other: Declined|0|||
130279293|NCT04826094|468984385|FG003|Overall Study|Other: Declined|0|||
130279294|NCT04826094|468984386|FG004|Overall Study|Other: Declined|1|||
130279295|NCT04826094|468984387|FG005|Overall Study|Other: Declined|0|||
130279296|NCT04826094|468984388|FG006|Overall Study|Other: Declined|0|||
130279297|NCT04826094|468984389|FG007|Overall Study|Other: Declined|0|||
130279298|NCT04826094|468984382|FG000|Overall Study|Other: Vaccine not administered|0|||
130279299|NCT04826094|468984383|FG001|Overall Study|Other: Vaccine not administered|0|||
130279300|NCT04826094|468984384|FG002|Overall Study|Other: Vaccine not administered|1|||
130279301|NCT04826094|468984385|FG003|Overall Study|Other: Vaccine not administered|0|||
130279302|NCT04826094|468984386|FG004|Overall Study|Other: Vaccine not administered|0|||
130279303|NCT04826094|468984387|FG005|Overall Study|Other: Vaccine not administered|1|||
130279304|NCT04826094|468984388|FG006|Overall Study|Other: Vaccine not administered|1|||
130279305|NCT04826094|468984389|FG007|Overall Study|Other: Vaccine not administered|3|||
130279306|NCT00700882|468984392|FG000|Overall Study|Never received treatment|6|||
130279307|NCT00700882|468984392|FG000|Overall Study|Ineligible|2|||
130279308|NCT00700882|468984392|FG000|Overall Study|No KIT mutation|51|||
130279309|NCT04154293|468984396|FG000|Overall Study|Withdrawal by Subject|2|||
130279310|NCT04154293|468984397|FG001|Overall Study|Withdrawal by Subject|3|||
130279311|NCT04154293|468984398|FG002|Overall Study|Withdrawal by Subject|1|||
130279312|NCT04154293|468984396|FG000|Overall Study|Physician Decision|0|||
130279313|NCT04154293|468984397|FG001|Overall Study|Physician Decision|0|||
130279314|NCT04154293|468984398|FG002|Overall Study|Physician Decision|1|||
130279315|NCT04731298|468984399|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
130279316|NCT04731298|468984400|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
130279317|NCT01208961|468984401|FG000|High-Fat Period III|Protocol Violation|1|||
130279318|NCT01208961|468984402|FG001|High-Fat Period III|Protocol Violation|0|||
130279319|NCT03403361|468984403|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
130279320|NCT02152371|468984405|FG000|Overall Study|Adverse Event|6|||
130279321|NCT02152371|468984406|FG001|Overall Study|Adverse Event|2|||
130279322|NCT02152371|468984405|FG000|Overall Study|Withdrawal by Subject|3|||
130279323|NCT02152371|468984406|FG001|Overall Study|Withdrawal by Subject|7|||
130279324|NCT02152371|468984405|FG000|Overall Study|Protocol Violation|2|||
130279325|NCT02152371|468984406|FG001|Overall Study|Protocol Violation|3|||
130279326|NCT02152371|468984405|FG000|Overall Study|Lost to Follow-up|1|||
130279327|NCT02152371|468984406|FG001|Overall Study|Lost to Follow-up|0|||
130279328|NCT02152371|468984405|FG000|Overall Study|Lack of Efficacy|0|||
130279329|NCT02152371|468984406|FG001|Overall Study|Lack of Efficacy|1|||
130279330|NCT02152371|468984405|FG000|Overall Study|Physician Decision|0|||
130279331|NCT02152371|468984406|FG001|Overall Study|Physician Decision|2|||
130279332|NCT02152371|468984405|FG000|Overall Study|Reason Not Given|0|||
130279333|NCT02152371|468984406|FG001|Overall Study|Reason Not Given|1|||
130279334|NCT04382586|468984411|FG000|Overall Study|Death|3|||
130279335|NCT04382586|468984412|FG001|Overall Study|Death|4|||
130279336|NCT04382586|468984411|FG000|Overall Study|Lost to Follow-up|11|||
130279337|NCT04382586|468984412|FG001|Overall Study|Lost to Follow-up|8|||
130279338|NCT04382586|468984411|FG000|Overall Study|Withdrawal by Subject|3|||
130279339|NCT04382586|468984412|FG001|Overall Study|Withdrawal by Subject|1|||
130279340|NCT04382586|468984411|FG000|Overall Study|Physician Decision|0|||
130279341|NCT04382586|468984412|FG001|Overall Study|Physician Decision|3|||
130279342|NCT06099223|468984418|FG000|Overall Study|Preoperative surveys missed|0|||
130279343|NCT06099223|468984419|FG001|Overall Study|Preoperative surveys missed|1|||
130279344|NCT00079391|468984420|FG000|Overall Study|Withdrawal by Subject|1|||
130279345|NCT02628600|468984424|FG000|Overall Study|Death|2|||
130279346|NCT02628600|468984425|FG001|Overall Study|Death|1|||
130279347|NCT02628600|468984424|FG000|Overall Study|Adverse Event|3|||
130279348|NCT02628600|468984425|FG001|Overall Study|Adverse Event|20|||
130279349|NCT02628600|468984424|FG000|Overall Study|Protocol Violation|0|||
130279350|NCT02628600|468984425|FG001|Overall Study|Protocol Violation|1|||
130279351|NCT02628600|468984424|FG000|Overall Study|Lack of Efficacy|2|||
130279352|NCT02628600|468984425|FG001|Overall Study|Lack of Efficacy|0|||
130279353|NCT02628600|468984424|FG000|Overall Study|Withdrawal by Subject|13|||
130279354|NCT02628600|468984425|FG001|Overall Study|Withdrawal by Subject|8|||
130279355|NCT02628600|468984424|FG000|Overall Study|Lost to Follow-up|1|||
130279356|NCT02628600|468984425|FG001|Overall Study|Lost to Follow-up|0|||
130279357|NCT02628600|468984424|FG000|Overall Study|Physician Decision|2|||
130279358|NCT02628600|468984425|FG001|Overall Study|Physician Decision|2|||
130279359|NCT02628600|468984424|FG000|Overall Study|Other not specified|1|||
130279360|NCT02628600|468984425|FG001|Overall Study|Other not specified|0|||
130279361|NCT02644096|468984426|FG000|Overall Study|Withdrawal by Subject|28|||
130279362|NCT02644096|468984427|FG001|Overall Study|Withdrawal by Subject|25|||
130279363|NCT02461290|468984428|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
130279364|NCT02461290|468984428|FG000|Overall Study|Lost to Follow-up|3|||
130279365|NCT00526656|468984429|FG000|Overall Study|Death|1|||
130279366|NCT00526656|468984429|FG000|Overall Study|Refused surgery|1|||
130279367|NCT02109432|468986650|FG000|Overall Study|Withdrawal by Subject|1|||
130279368|NCT02908685|468986651|FG000|Part 1 OLE|Withdrawal by Subject|0|||
130279369|NCT02908685|468986652|FG001|Part 1 OLE|Withdrawal by Subject|0|||
130279370|NCT02908685|468986653|FG002|Part 1 OLE|Withdrawal by Subject|0|||
130279371|NCT02908685|468986654|FG003|Part 1 OLE|Withdrawal by Subject|0|||
130279372|NCT02908685|468986655|FG004|Part 1 OLE|Withdrawal by Subject|0|||
130279373|NCT02908685|468986656|FG005|Part 1 OLE|Withdrawal by Subject|0|||
130279374|NCT02908685|468986657|FG006|Part 1 OLE|Withdrawal by Subject|0|||
130279375|NCT02908685|468986658|FG007|Part 1 OLE|Withdrawal by Subject|0|||
130279376|NCT02908685|468986659|FG008|Part 1 OLE|Withdrawal by Subject|0|||
130042066|NCT00258154|468112203|FG000|Overall Study|Withdrawal by Subject|3|||
130042067|NCT00258154|468112204|FG001|Overall Study|Withdrawal by Subject|4|||
130279377|NCT02908685|468986660|FG009|Part 1 OLE|Withdrawal by Subject|0|||
130279378|NCT02908685|468986661|FG010|Part 1 OLE|Withdrawal by Subject|2|||
130279379|NCT02908685|468986662|FG011|Part 1 OLE|Withdrawal by Subject|1|||
130279380|NCT02908685|468986663|FG012|Part 1 OLE|Withdrawal by Subject|0|||
130279381|NCT02908685|468986664|FG013|Part 1 OLE|Withdrawal by Subject|0|||
130279382|NCT02908685|468986651|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279383|NCT02908685|468986652|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279384|NCT02908685|468986653|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279385|NCT02908685|468986654|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279386|NCT02908685|468986655|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279387|NCT02908685|468986656|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279388|NCT02908685|468986657|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279389|NCT02908685|468986658|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279390|NCT02908685|468986659|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279391|NCT02908685|468986660|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279392|NCT02908685|468986661|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279393|NCT02908685|468986662|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
130279394|NCT02908685|468986663|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
130279395|NCT02908685|468986664|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
130279396|NCT02908685|468986651|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279397|NCT02908685|468986652|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279398|NCT02908685|468986653|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279399|NCT02908685|468986654|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279400|NCT02908685|468986655|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279401|NCT02908685|468986656|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279402|NCT02908685|468986657|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279403|NCT02908685|468986658|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279404|NCT02908685|468986659|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279405|NCT02908685|468986660|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279406|NCT02908685|468986661|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279407|NCT02908685|468986662|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279408|NCT02908685|468986663|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
130279409|NCT02908685|468986664|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
130279410|NCT02908685|468986651|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279411|NCT02908685|468986652|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279412|NCT02908685|468986653|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279413|NCT02908685|468986654|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279414|NCT02908685|468986655|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279415|NCT02908685|468986656|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279416|NCT02908685|468986657|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279417|NCT02908685|468986658|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279418|NCT02908685|468986659|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279419|NCT02908685|468986660|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279420|NCT02908685|468986661|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279421|NCT02908685|468986662|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279422|NCT02908685|468986663|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
130279423|NCT02908685|468986664|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
130279424|NCT02908685|468986651|FG000|Part 2 OLE: > Month 24|Death|0|||
130279425|NCT02908685|468986652|FG001|Part 2 OLE: > Month 24|Death|0|||
130279426|NCT02908685|468986653|FG002|Part 2 OLE: > Month 24|Death|0|||
130279427|NCT02908685|468986654|FG003|Part 2 OLE: > Month 24|Death|0|||
130279428|NCT02908685|468986655|FG004|Part 2 OLE: > Month 24|Death|0|||
130279429|NCT02908685|468986656|FG005|Part 2 OLE: > Month 24|Death|0|||
130279430|NCT02908685|468986657|FG006|Part 2 OLE: > Month 24|Death|0|||
130279431|NCT02908685|468986658|FG007|Part 2 OLE: > Month 24|Death|0|||
130279432|NCT02908685|468986659|FG008|Part 2 OLE: > Month 24|Death|0|||
130279433|NCT02908685|468986660|FG009|Part 2 OLE: > Month 24|Death|0|||
130279434|NCT02908685|468986661|FG010|Part 2 OLE: > Month 24|Death|0|||
130279435|NCT02908685|468986662|FG011|Part 2 OLE: > Month 24|Death|0|||
130279436|NCT02908685|468986663|FG012|Part 2 OLE: > Month 24|Death|1|||
130279437|NCT02908685|468986664|FG013|Part 2 OLE: > Month 24|Death|0|||
130279438|NCT02908685|468986651|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
130279439|NCT02908685|468986652|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
130279440|NCT02908685|468986653|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
130279441|NCT02908685|468986654|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
130279442|NCT02908685|468986655|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
130279443|NCT02908685|468986656|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
130279444|NCT02908685|468986657|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
130279445|NCT02908685|468986658|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
130279446|NCT02908685|468986659|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
130279447|NCT02908685|468986660|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
130279448|NCT02908685|468986661|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
130279449|NCT02908685|468986662|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
130279450|NCT02908685|468986663|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
130279451|NCT02908685|468986664|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
130279452|NCT02908685|468986651|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279453|NCT02908685|468986652|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279454|NCT02908685|468986653|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279455|NCT02908685|468986654|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129800261|NCT02445391|467236291|FG001|Overall Study|Alternative therapy|0|||
129800262|NCT02445391|467236292|FG002|Overall Study|Alternative therapy|1|||
129800263|NCT02445391|467236290|FG000|Overall Study|Disease progression|0|||
129800264|NCT02445391|467236291|FG001|Overall Study|Disease progression|7|||
129800265|NCT02445391|467236292|FG002|Overall Study|Disease progression|22|||
129800266|NCT02445391|467236290|FG000|Overall Study|Complicating disease|0|||
130042068|NCT00258154|468112203|FG000|Overall Study|Patient Moved|3|||
130042069|NCT00258154|468112204|FG001|Overall Study|Patient Moved|1|||
130042070|NCT01856673|468112205|FG000|Overall Study|Withdrawal by Subject|44|||
130279456|NCT02908685|468986655|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279457|NCT02908685|468986656|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279458|NCT02908685|468986657|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279459|NCT02908685|468986658|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279460|NCT02908685|468986659|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279461|NCT02908685|468986660|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279462|NCT02908685|468986661|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130279463|NCT02908685|468986662|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
130042071|NCT01856673|468112206|FG001|Overall Study|Withdrawal by Subject|50|||
130042072|NCT01856673|468112207|FG002|Overall Study|Withdrawal by Subject|33|||
130279464|NCT02908685|468986663|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
130279465|NCT02908685|468986664|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
130279466|NCT01691014|468986666|FG000|Overall Study|Premature Termination|1|||
130279467|NCT01691014|468986667|FG001|Overall Study|Premature Termination|6|||
130279468|NCT01691014|468986668|FG002|Overall Study|Premature Termination|0|||
130279469|NCT01691014|468986669|FG003|Overall Study|Premature Termination|3|||
130279470|NCT01691014|468986666|FG000|Overall Study|Other|0|||
130279471|NCT01691014|468986667|FG001|Overall Study|Other|0|||
130279472|NCT01691014|468986668|FG002|Overall Study|Other|2|||
130279473|NCT01691014|468986669|FG003|Overall Study|Other|0|||
130279474|NCT01691014|468986666|FG000|Overall Study|Withdrawal by Subject|0|||
130279475|NCT01691014|468986667|FG001|Overall Study|Withdrawal by Subject|1|||
130279476|NCT01691014|468986668|FG002|Overall Study|Withdrawal by Subject|1|||
130279477|NCT01691014|468986669|FG003|Overall Study|Withdrawal by Subject|1|||
130279478|NCT01691014|468986666|FG000|Overall Study|Adverse Event|0|||
130279479|NCT01691014|468986667|FG001|Overall Study|Adverse Event|5|||
130279480|NCT01691014|468986668|FG002|Overall Study|Adverse Event|1|||
130279481|NCT01691014|468986669|FG003|Overall Study|Adverse Event|1|||
130279482|NCT01691014|468986666|FG000|Overall Study|Lack of Efficacy|2|||
130279483|NCT01691014|468986667|FG001|Overall Study|Lack of Efficacy|3|||
130279484|NCT01691014|468986668|FG002|Overall Study|Lack of Efficacy|7|||
130279485|NCT01691014|468986669|FG003|Overall Study|Lack of Efficacy|0|||
130279486|NCT02370537|468986670|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
130279487|NCT02370537|468986671|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
130279488|NCT02370537|468986672|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
130279489|NCT02370537|468986670|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
130279490|NCT02370537|468986671|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
130279491|NCT02370537|468986672|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
130279492|NCT02370537|468986670|FG000|Part B|Not randomised to receive treatment|1|||
130279493|NCT02370537|468986671|FG001|Part B|Not randomised to receive treatment|2|||
130279494|NCT02370537|468986672|FG002|Part B|Not randomised to receive treatment|259|||
130279495|NCT02370537|468986670|FG000|Part B|Withdrawal by Subject|0|||
130279496|NCT02370537|468986671|FG001|Part B|Withdrawal by Subject|1|||
130279497|NCT02370537|468986672|FG002|Part B|Withdrawal by Subject|0|||
130279498|NCT05897242|468986673|FG000|Overall Study|Lost to Follow-up|6|||
130279499|NCT05897242|468986674|FG001|Overall Study|Lost to Follow-up|1|||
130279500|NCT05897242|468986673|FG000|Overall Study|Incomplete|1|||
130279501|NCT05897242|468986674|FG001|Overall Study|Incomplete|0|||
130279502|NCT05897242|468986673|FG000|Overall Study|Withdrawal by Subject|1|||
130279503|NCT05897242|468986674|FG001|Overall Study|Withdrawal by Subject|0|||
130279504|NCT04439539|468986678|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
130279505|NCT04439539|468986679|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
130279506|NCT04439539|468986680|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
130279507|NCT04439539|468986678|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
130279508|NCT04439539|468986679|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
130279509|NCT04439539|468986680|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
130279510|NCT04439539|468986678|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
130279511|NCT04439539|468986679|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
130279512|NCT04439539|468986680|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
130279513|NCT02920528|468986681|FG000|Overall Study|Incomplete Data|1|||
130279514|NCT02920528|468986682|FG001|Overall Study|Incomplete Data|1|||
130279515|NCT02920528|468986683|FG002|Overall Study|Incomplete Data|1|||
130279516|NCT02920528|468986681|FG000|Overall Study|Adverse Event|0|||
130279517|NCT02920528|468986682|FG001|Overall Study|Adverse Event|0|||
130279518|NCT02920528|468986683|FG002|Overall Study|Adverse Event|3|||
130279519|NCT02920528|468986681|FG000|Overall Study|Did not meet inclusion criteria|2|||
130279520|NCT02920528|468986682|FG001|Overall Study|Did not meet inclusion criteria|0|||
130279521|NCT02920528|468986683|FG002|Overall Study|Did not meet inclusion criteria|1|||
130279522|NCT02547038|468986684|FG000|Overall Study|Lost to Follow-up|3|||
130279523|NCT02547038|468986685|FG001|Overall Study|Lost to Follow-up|2|||
130279524|NCT01340625|468986686|FG000|First Intervention|Adverse Event|1|||
130279525|NCT01340625|468986687|FG001|First Intervention|Adverse Event|0|||
130042073|NCT01856673|468112205|FG000|Overall Study|Lost to Follow-up|31|||
130279526|NCT01340625|468986686|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
130279527|NCT01340625|468986687|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
130279528|NCT00066703|468986688|FG000|Overall Study|Adverse Event|80|||
130279529|NCT00066703|468986689|FG001|Overall Study|Adverse Event|111|||
130279530|NCT00066703|468986688|FG000|Overall Study|Death|3|||
130279531|NCT00066703|468986689|FG001|Overall Study|Death|0|||
130042074|NCT01856673|468112206|FG001|Overall Study|Lost to Follow-up|34|||
130279532|NCT00066703|468986688|FG000|Overall Study|Lack of Efficacy|114|||
130279533|NCT00066703|468986689|FG001|Overall Study|Lack of Efficacy|69|||
130279534|NCT00066703|468986688|FG000|Overall Study|Lost to Follow-up|31|||
130279535|NCT00066703|468986689|FG001|Overall Study|Lost to Follow-up|28|||
130279536|NCT00066703|468986688|FG000|Overall Study|Withdrawal by Subject|38|||
130279537|NCT00066703|468986689|FG001|Overall Study|Withdrawal by Subject|63|||
130279538|NCT00066703|468986688|FG000|Overall Study|Treatment ongoing|346|||
130279539|NCT00066703|468986689|FG001|Overall Study|Treatment ongoing|311|||
130279540|NCT01696968|468986690|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
130279541|NCT01696968|468986691|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
130279542|NCT01696968|468986690|FG000|Overall Study|Died Before Randomization|3|||
130279543|NCT01696968|468986691|FG001|Overall Study|Died Before Randomization|8|||
130279544|NCT01696968|468986690|FG000|Overall Study|Died Before ASU (Control)|278|||
130279545|NCT01696968|468986691|FG001|Overall Study|Died Before ASU (Control)|0|||
130279546|NCT01696968|468986690|FG000|Overall Study|Refused ASU (Control)|920|||
130279547|NCT01696968|468986691|FG001|Overall Study|Refused ASU (Control)|0|||
130279548|NCT01696968|468986690|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
130279549|NCT01696968|468986691|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
130279550|NCT01519791|468986704|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
130279551|NCT01519791|468986705|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
130279552|NCT01519791|468986704|FG000|Overall Study|Protocol Violation|6|||
130279553|NCT01519791|468986705|FG001|Overall Study|Protocol Violation|19|||
130279554|NCT01519791|468986704|FG000|Overall Study|Other Reason|87|||
130279555|NCT01519791|468986705|FG001|Overall Study|Other Reason|222|||
130279556|NCT01519791|468986704|FG000|Overall Study|subjects randomized in error|2|||
130279557|NCT01519791|468986705|FG001|Overall Study|subjects randomized in error|0|||
130279558|NCT01519791|468986704|FG000|Overall Study|Lack of Efficacy|16|||
130279559|NCT01519791|468986705|FG001|Overall Study|Lack of Efficacy|20|||
130279560|NCT01519791|468986704|FG000|Overall Study|SAE, non-fatal|6|||
130279561|NCT01519791|468986705|FG001|Overall Study|SAE, non-fatal|22|||
130279562|NCT01519791|468986704|FG000|Overall Study|AE, serious fatal|0|||
130279563|NCT01519791|468986705|FG001|Overall Study|AE, serious fatal|1|||
130279564|NCT01519791|468986704|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
130279565|NCT01519791|468986705|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
130279566|NCT01519791|468986704|FG000|Overall Study|AE, non-serious non-fatal|12|||
130279567|NCT01519791|468986705|FG001|Overall Study|AE, non-serious non-fatal|31|||
130279568|NCT01519791|468986704|FG000|Overall Study|Withdrawal by Subject|15|||
130279569|NCT01519791|468986705|FG001|Overall Study|Withdrawal by Subject|37|||
130279570|NCT01519791|468986704|FG000|Overall Study|Lost to Follow-up|6|||
130279571|NCT01519791|468986705|FG001|Overall Study|Lost to Follow-up|14|||
130279572|NCT01289353|468986723|FG000|Overall Study|Lost to Follow-up|2|||
130279573|NCT01549886|468986724|FG000|Overall Study|Sponsor's decision|2|||
130279574|NCT01549886|468986725|FG001|Overall Study|Sponsor's decision|3|||
130279575|NCT06004895|468986726|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
130279576|NCT06004895|468986726|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
130279577|NCT00967694|468986727|FG000|Overall Study|Withdrawal by Subject|6|||
130279578|NCT02957747|468986728|FG000|Overall Study|Withdrawal by Subject|0|||
130279579|NCT02957747|468986729|FG001|Overall Study|Withdrawal by Subject|3|||
130279580|NCT02957747|468986728|FG000|Overall Study|Lost to Follow-up|10|||
130279581|NCT02957747|468986729|FG001|Overall Study|Lost to Follow-up|5|||
130279582|NCT00632827|468986730|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
130279583|NCT00632827|468986730|FG000|Overall Study|Death|2|||
130279584|NCT00632827|468986730|FG000|Overall Study|Adverse Event|5|||
130279585|NCT00632827|468986730|FG000|Overall Study|Lost to Follow-up|1|||
130279586|NCT03425006|468986733|FG000|Overall Study|Withdrawal by Subject|1|||
130279587|NCT03425006|468986733|FG000|Overall Study|Physician Decision|1|||
130279588|NCT03425006|468986733|FG000|Overall Study|Death|1|||
130279589|NCT00888329|468986737|FG000|Overall Study|Physician Decision|6|||
130279590|NCT00888329|468986738|FG001|Overall Study|Physician Decision|9|||
130279591|NCT03931382|468986739|FG000|Overall Study|Equipment malfunction|2|||
130279592|NCT03931382|468986740|FG001|Overall Study|Equipment malfunction|0|||
130279593|NCT03931382|468986741|FG002|Overall Study|Equipment malfunction|2|||
130279594|NCT03931382|468986739|FG000|Overall Study|Withdrawal by Subject|0|||
130279595|NCT03931382|468986740|FG001|Overall Study|Withdrawal by Subject|1|||
130279596|NCT03931382|468986741|FG002|Overall Study|Withdrawal by Subject|0|||
130279597|NCT00778375|468986747|FG000|Overall Study|Ineligible|3|||
130279598|NCT00939029|468986748|FG000|Overall Study|Withdrawal by Subject|3|||
130279599|NCT00939029|468986749|FG001|Overall Study|Withdrawal by Subject|7|||
130279600|NCT00939029|468986748|FG000|Overall Study|Lost to Follow-up|3|||
130279601|NCT00939029|468986749|FG001|Overall Study|Lost to Follow-up|4|||
130279602|NCT00939029|468986748|FG000|Overall Study|Adverse Event|0|||
130279603|NCT00939029|468986749|FG001|Overall Study|Adverse Event|1|||
130279604|NCT01421303|468986750|FG000|Overall Study|Lost to Follow-up|13|||
130279605|NCT01421303|468986750|FG000|Overall Study|Non compliance with study procedure|1|||
130279606|NCT01421303|468986750|FG000|Overall Study|Other|7|||
130279607|NCT01421303|468986750|FG000|Overall Study|Withdrawal by Subject|1|||
130279608|NCT06003777|468986752|FG000|Period 1|Adverse Event|0|||
130279609|NCT06003777|468986753|FG001|Period 1|Adverse Event|0|||
130279610|NCT06003777|468986754|FG002|Period 1|Adverse Event|1|||
130279611|NCT06003777|468986755|FG003|Period 1|Adverse Event|0|||
130279612|NCT06003777|468986756|FG004|Period 1|Adverse Event|0|||
130279613|NCT06003777|468986757|FG005|Period 1|Adverse Event|0|||
130279614|NCT06003777|468986758|FG006|Period 1|Adverse Event|0|||
130279615|NCT06003777|468986759|FG007|Period 1|Adverse Event|0|||
130279616|NCT06003777|468986760|FG008|Period 1|Adverse Event|0|||
130279617|NCT06003777|468986761|FG009|Period 1|Adverse Event|0|||
130279618|NCT06003777|468986762|FG010|Period 1|Adverse Event|0|||
130279619|NCT06003777|468986763|FG011|Period 1|Adverse Event|0|||
130279620|NCT06003777|468986752|FG000|Period 1|Withdrawal by Subject|0|||
130279621|NCT06003777|468986753|FG001|Period 1|Withdrawal by Subject|0|||
130279622|NCT06003777|468986754|FG002|Period 1|Withdrawal by Subject|0|||
130279623|NCT06003777|468986755|FG003|Period 1|Withdrawal by Subject|0|||
130279624|NCT06003777|468986756|FG004|Period 1|Withdrawal by Subject|1|||
130279625|NCT06003777|468986757|FG005|Period 1|Withdrawal by Subject|0|||
130279626|NCT06003777|468986758|FG006|Period 1|Withdrawal by Subject|0|||
130279627|NCT06003777|468986759|FG007|Period 1|Withdrawal by Subject|0|||
130279628|NCT06003777|468986760|FG008|Period 1|Withdrawal by Subject|0|||
130279629|NCT06003777|468986761|FG009|Period 1|Withdrawal by Subject|0|||
130279630|NCT06003777|468986762|FG010|Period 1|Withdrawal by Subject|0|||
130279631|NCT06003777|468986763|FG011|Period 1|Withdrawal by Subject|0|||
130279632|NCT06003777|468986752|FG000|Period 2|Withdrawal by Subject|0|||
130279633|NCT06003777|468986753|FG001|Period 2|Withdrawal by Subject|0|||
130279634|NCT06003777|468986754|FG002|Period 2|Withdrawal by Subject|0|||
130279635|NCT06003777|468986755|FG003|Period 2|Withdrawal by Subject|0|||
130279636|NCT06003777|468986756|FG004|Period 2|Withdrawal by Subject|0|||
130279637|NCT06003777|468986757|FG005|Period 2|Withdrawal by Subject|0|||
130279638|NCT06003777|468986758|FG006|Period 2|Withdrawal by Subject|0|||
130279639|NCT06003777|468986759|FG007|Period 2|Withdrawal by Subject|0|||
130279640|NCT06003777|468986760|FG008|Period 2|Withdrawal by Subject|1|||
130279641|NCT06003777|468986761|FG009|Period 2|Withdrawal by Subject|0|||
130279642|NCT06003777|468986762|FG010|Period 2|Withdrawal by Subject|0|||
130279643|NCT06003777|468986763|FG011|Period 2|Withdrawal by Subject|0|||
130279644|NCT06003777|468986752|FG000|Period 3|Adverse Event|0|||
130279645|NCT06003777|468986753|FG001|Period 3|Adverse Event|0|||
130279646|NCT06003777|468986754|FG002|Period 3|Adverse Event|0|||
130279647|NCT06003777|468986755|FG003|Period 3|Adverse Event|0|||
130279648|NCT06003777|468986756|FG004|Period 3|Adverse Event|0|||
130279649|NCT06003777|468986757|FG005|Period 3|Adverse Event|0|||
130279650|NCT06003777|468986758|FG006|Period 3|Adverse Event|1|||
130279651|NCT06003777|468986759|FG007|Period 3|Adverse Event|0|||
130279652|NCT06003777|468986760|FG008|Period 3|Adverse Event|0|||
130279653|NCT06003777|468986761|FG009|Period 3|Adverse Event|0|||
130279654|NCT06003777|468986762|FG010|Period 3|Adverse Event|0|||
130279655|NCT06003777|468986763|FG011|Period 3|Adverse Event|0|||
130279656|NCT06003777|468986752|FG000|Period 4|No longer met eligibility criteria|0|||
130279657|NCT06003777|468986753|FG001|Period 4|No longer met eligibility criteria|0|||
130279658|NCT06003777|468986754|FG002|Period 4|No longer met eligibility criteria|1|||
130279659|NCT06003777|468986755|FG003|Period 4|No longer met eligibility criteria|0|||
130279660|NCT06003777|468986756|FG004|Period 4|No longer met eligibility criteria|0|||
130279661|NCT06003777|468986757|FG005|Period 4|No longer met eligibility criteria|0|||
130279662|NCT06003777|468986758|FG006|Period 4|No longer met eligibility criteria|0|||
130279663|NCT06003777|468986759|FG007|Period 4|No longer met eligibility criteria|0|||
130279664|NCT06003777|468986760|FG008|Period 4|No longer met eligibility criteria|0|||
130279665|NCT06003777|468986761|FG009|Period 4|No longer met eligibility criteria|0|||
130279666|NCT06003777|468986762|FG010|Period 4|No longer met eligibility criteria|0|||
130279667|NCT06003777|468986763|FG011|Period 4|No longer met eligibility criteria|0|||
130279668|NCT06003777|468986752|FG000|Period 4|Withdrawal by Subject|0|||
130279669|NCT06003777|468986753|FG001|Period 4|Withdrawal by Subject|1|||
130279670|NCT06003777|468986754|FG002|Period 4|Withdrawal by Subject|0|||
130279671|NCT06003777|468986755|FG003|Period 4|Withdrawal by Subject|0|||
130279672|NCT06003777|468986756|FG004|Period 4|Withdrawal by Subject|0|||
130279673|NCT06003777|468986757|FG005|Period 4|Withdrawal by Subject|0|||
130279674|NCT06003777|468986758|FG006|Period 4|Withdrawal by Subject|0|||
130279675|NCT06003777|468986759|FG007|Period 4|Withdrawal by Subject|0|||
130279676|NCT06003777|468986760|FG008|Period 4|Withdrawal by Subject|0|||
130279677|NCT06003777|468986761|FG009|Period 4|Withdrawal by Subject|0|||
130279678|NCT06003777|468986762|FG010|Period 4|Withdrawal by Subject|0|||
130279679|NCT06003777|468986763|FG011|Period 4|Withdrawal by Subject|0|||
130279680|NCT04154605|468986766|FG000|Overall Study|Procedure Canceled|1|||
130279681|NCT04154605|468986767|FG001|Overall Study|Procedure Canceled|1|||
130279682|NCT04154605|468986766|FG000|Overall Study|Missed follow up|1|||
130279683|NCT04154605|468986767|FG001|Overall Study|Missed follow up|1|||
130279684|NCT04154605|468986766|FG000|Overall Study|Withdrawal by Subject|1|||
130279685|NCT04154605|468986767|FG001|Overall Study|Withdrawal by Subject|0|||
130279686|NCT00675441|468986768|FG000|Overall Study|Withdrawal by Subject|2|||
130279687|NCT00675441|468986768|FG000|Overall Study|Death|1|||
130279688|NCT00344318|468986772|FG000|Overall Study|Adverse Event|0|||
130279689|NCT00344318|468986773|FG001|Overall Study|Adverse Event|3|||
130279690|NCT00344318|468986774|FG002|Overall Study|Adverse Event|0|||
130279691|NCT00344318|468986775|FG003|Overall Study|Adverse Event|1|||
130279692|NCT00344318|468986772|FG000|Overall Study|Withdrawal by Subject|2|||
130279693|NCT00344318|468986773|FG001|Overall Study|Withdrawal by Subject|2|||
130279694|NCT00344318|468986774|FG002|Overall Study|Withdrawal by Subject|0|||
130279695|NCT00344318|468986775|FG003|Overall Study|Withdrawal by Subject|2|||
130279696|NCT00344318|468986772|FG000|Overall Study|Lost to Follow-up|2|||
130279697|NCT00344318|468986773|FG001|Overall Study|Lost to Follow-up|0|||
130279698|NCT00344318|468986774|FG002|Overall Study|Lost to Follow-up|1|||
130279699|NCT00344318|468986775|FG003|Overall Study|Lost to Follow-up|0|||
130279700|NCT01923363|468986776|FG000|Overall Study|Protocol Violation|1|||
130279701|NCT00656058|468986780|FG000|Overall Study|Withdrawal by Subject|2|||
130279702|NCT00656058|468986780|FG000|Overall Study|Withdrawal by Subject|4|||
130279703|NCT06359028|468986781|FG000|Overall Study|Adverse Event|1|||
130279704|NCT06359028|468986782|FG001|Overall Study|Adverse Event|0|||
130279705|NCT06359028|468986781|FG000|Overall Study|Withdrawal by Subject|1|||
130279706|NCT06359028|468986782|FG001|Overall Study|Withdrawal by Subject|0|||
130279707|NCT03515551|468986783|FG000|Overall Study|Death|4|||
130279708|NCT03515551|468986784|FG001|Overall Study|Death|1|||
130279709|NCT03515551|468986785|FG002|Overall Study|Death|2|||
130042075|NCT01856673|468112207|FG002|Overall Study|Lost to Follow-up|0|||
130279710|NCT03515551|468986786|FG003|Overall Study|Death|2|||
130279711|NCT03515551|468986787|FG004|Overall Study|Death|2|||
130279712|NCT03515551|468986788|FG005|Overall Study|Death|4|||
130279713|NCT03515551|468986789|FG006|Overall Study|Death|1|||
130279714|NCT03515551|468986783|FG000|Overall Study|Lost to Follow-up|0|||
130279715|NCT03515551|468986784|FG001|Overall Study|Lost to Follow-up|0|||
130279716|NCT03515551|468986785|FG002|Overall Study|Lost to Follow-up|1|||
130279717|NCT03515551|468986786|FG003|Overall Study|Lost to Follow-up|0|||
130279718|NCT03515551|468986787|FG004|Overall Study|Lost to Follow-up|0|||
130279719|NCT03515551|468986788|FG005|Overall Study|Lost to Follow-up|0|||
130279720|NCT03515551|468986789|FG006|Overall Study|Lost to Follow-up|0|||
130279721|NCT03515551|468986783|FG000|Overall Study|Withdrawal by Subject|0|||
130279722|NCT03515551|468986784|FG001|Overall Study|Withdrawal by Subject|1|||
130279723|NCT03515551|468986785|FG002|Overall Study|Withdrawal by Subject|0|||
130279724|NCT03515551|468986786|FG003|Overall Study|Withdrawal by Subject|0|||
130279725|NCT03515551|468986787|FG004|Overall Study|Withdrawal by Subject|0|||
130279726|NCT03515551|468986788|FG005|Overall Study|Withdrawal by Subject|0|||
130279727|NCT03515551|468986789|FG006|Overall Study|Withdrawal by Subject|1|||
130279728|NCT03515551|468986783|FG000|Overall Study|Study ended by sponsor|0|||
130279729|NCT03515551|468986784|FG001|Overall Study|Study ended by sponsor|0|||
130279730|NCT03515551|468986785|FG002|Overall Study|Study ended by sponsor|2|||
130279731|NCT03515551|468986786|FG003|Overall Study|Study ended by sponsor|1|||
130279732|NCT03515551|468986787|FG004|Overall Study|Study ended by sponsor|3|||
130279733|NCT03515551|468986788|FG005|Overall Study|Study ended by sponsor|0|||
130279734|NCT03515551|468986789|FG006|Overall Study|Study ended by sponsor|3|||
130279735|NCT03515551|468986783|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279736|NCT03515551|468986784|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
130279737|NCT03515551|468986785|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279738|NCT03515551|468986786|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279739|NCT03515551|468986787|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279740|NCT03515551|468986788|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279741|NCT03515551|468986789|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
130279742|NCT00920387|468986790|FG000|Stage 1|Adverse Event|1|||
130279743|NCT00920387|468986791|FG001|Stage 1|Adverse Event|0|||
130279744|NCT00920387|468986792|FG002|Stage 1|Adverse Event|0|||
130279745|NCT02265536|468986793|FG000|Overall Study|Adverse Event|1|||
130279746|NCT02265536|468986794|FG001|Overall Study|Adverse Event|0|||
130279747|NCT02265536|468986795|FG002|Overall Study|Adverse Event|0|||
130279748|NCT02265536|468986796|FG003|Overall Study|Adverse Event|0|||
130279749|NCT02265536|468986797|FG004|Overall Study|Adverse Event|1|||
130279750|NCT02265536|468986798|FG005|Overall Study|Adverse Event|0|||
130279751|NCT02265536|468986793|FG000|Overall Study|Physician Decision|0|||
130279752|NCT02265536|468986794|FG001|Overall Study|Physician Decision|0|||
130279753|NCT02265536|468986795|FG002|Overall Study|Physician Decision|0|||
130279754|NCT02265536|468986796|FG003|Overall Study|Physician Decision|0|||
130279755|NCT02265536|468986797|FG004|Overall Study|Physician Decision|2|||
130279756|NCT02265536|468986798|FG005|Overall Study|Physician Decision|0|||
130279757|NCT02265536|468986793|FG000|Overall Study|Withdrawal by Subject|0|||
130279758|NCT02265536|468986794|FG001|Overall Study|Withdrawal by Subject|3|||
130279759|NCT02265536|468986795|FG002|Overall Study|Withdrawal by Subject|0|||
130279760|NCT02265536|468986796|FG003|Overall Study|Withdrawal by Subject|0|||
130279761|NCT02265536|468986797|FG004|Overall Study|Withdrawal by Subject|0|||
130279762|NCT02265536|468986798|FG005|Overall Study|Withdrawal by Subject|0|||
130279763|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
130279764|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
130279765|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
130279766|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
130279767|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
130279768|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
130279769|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
130279770|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
130279771|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
130279772|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
130279773|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
130279774|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
130279775|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
130279776|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
130279777|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
130279778|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
130279779|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130279780|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130279781|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
130279782|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
130279783|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
130279784|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130279785|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130279786|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
130279787|NCT01866111|468986799|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
130279788|NCT01866111|468986800|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
130279789|NCT01866111|468986801|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
130279790|NCT01866111|468986802|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
130279791|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
130279792|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
130279793|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
130279794|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
130279795|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
130279796|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
130279797|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
130279798|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
130279799|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
130279800|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
130279801|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
130279802|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
130279803|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
130279804|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
130279805|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
130279806|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
130279807|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Death|1|||
130279808|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Death|1|||
130279809|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Death|3|||
130279810|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Death|2|||
130279811|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
130279812|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
130279813|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
130279814|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
130279815|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
130279816|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
130279817|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
130279818|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
130279819|NCT01866111|468986799|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130279820|NCT01866111|468986800|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130279821|NCT01866111|468986801|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
130279822|NCT01866111|468986802|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
130279823|NCT05596734|468986803|FG000|Substudy A|Withdrawal by Subject|1|||
130279824|NCT05596734|468986804|FG001|Substudy A|Withdrawal by Subject|0|||
130279825|NCT05596734|468986805|FG002|Substudy A|Withdrawal by Subject|0|||
130279826|NCT05596734|468986806|FG003|Substudy A|Withdrawal by Subject|0|||
130279827|NCT05596734|468986807|FG004|Substudy A|Withdrawal by Subject|0|||
130279828|NCT05596734|468986808|FG005|Substudy A|Withdrawal by Subject|0|||
130279829|NCT05596734|468986809|FG006|Substudy A|Withdrawal by Subject|1|||
130279830|NCT05596734|468986810|FG007|Substudy A|Withdrawal by Subject|0|||
130279831|NCT05596734|468986811|FG008|Substudy A|Withdrawal by Subject|0|||
130279832|NCT05596734|468986812|FG009|Substudy A|Withdrawal by Subject|0|||
130279833|NCT05596734|468986813|FG010|Substudy A|Withdrawal by Subject|0|||
130279834|NCT05596734|468986814|FG011|Substudy A|Withdrawal by Subject|0|||
130279835|NCT05596734|468986815|FG012|Substudy A|Withdrawal by Subject|0|||
130279836|NCT05596734|468986816|FG013|Substudy A|Withdrawal by Subject|0|||
130279837|NCT05596734|468986817|FG014|Substudy A|Withdrawal by Subject|0|||
130279838|NCT05596734|468986818|FG015|Substudy A|Withdrawal by Subject|0|||
130279839|NCT05596734|468986819|FG016|Substudy A|Withdrawal by Subject|0|||
130279840|NCT05596734|468986820|FG017|Substudy A|Withdrawal by Subject|0|||
130279841|NCT05596734|468986821|FG018|Substudy A|Withdrawal by Subject|0|||
130279842|NCT05596734|468986822|FG019|Substudy A|Withdrawal by Subject|0|||
130279843|NCT05596734|468986823|FG020|Substudy A|Withdrawal by Subject|0|||
130279844|NCT05596734|468986824|FG021|Substudy A|Withdrawal by Subject|0|||
130279845|NCT05596734|468986825|FG022|Substudy A|Withdrawal by Subject|0|||
130279846|NCT05596734|468986826|FG023|Substudy A|Withdrawal by Subject|0|||
130279847|NCT05596734|468986803|FG000|Substudy A|Lost to Follow-up|1|||
130279848|NCT05596734|468986804|FG001|Substudy A|Lost to Follow-up|0|||
130279849|NCT05596734|468986805|FG002|Substudy A|Lost to Follow-up|1|||
130279850|NCT05596734|468986806|FG003|Substudy A|Lost to Follow-up|0|||
130279851|NCT05596734|468986807|FG004|Substudy A|Lost to Follow-up|0|||
130042076|NCT01856673|468112205|FG000|Overall Study|Unknown reasons|9|||
130279852|NCT05596734|468986808|FG005|Substudy A|Lost to Follow-up|0|||
130279853|NCT05596734|468986809|FG006|Substudy A|Lost to Follow-up|0|||
130279854|NCT05596734|468986810|FG007|Substudy A|Lost to Follow-up|0|||
130279855|NCT05596734|468986811|FG008|Substudy A|Lost to Follow-up|0|||
130279856|NCT05596734|468986812|FG009|Substudy A|Lost to Follow-up|0|||
130279857|NCT05596734|468986813|FG010|Substudy A|Lost to Follow-up|0|||
130279858|NCT05596734|468986814|FG011|Substudy A|Lost to Follow-up|0|||
130279859|NCT05596734|468986815|FG012|Substudy A|Lost to Follow-up|0|||
130279860|NCT05596734|468986816|FG013|Substudy A|Lost to Follow-up|0|||
130279861|NCT05596734|468986817|FG014|Substudy A|Lost to Follow-up|0|||
130279862|NCT05596734|468986818|FG015|Substudy A|Lost to Follow-up|0|||
130279863|NCT05596734|468986819|FG016|Substudy A|Lost to Follow-up|0|||
130279864|NCT05596734|468986820|FG017|Substudy A|Lost to Follow-up|0|||
130279865|NCT05596734|468986821|FG018|Substudy A|Lost to Follow-up|0|||
130279866|NCT05596734|468986822|FG019|Substudy A|Lost to Follow-up|0|||
130279867|NCT05596734|468986823|FG020|Substudy A|Lost to Follow-up|0|||
130279868|NCT05596734|468986824|FG021|Substudy A|Lost to Follow-up|0|||
130279869|NCT05596734|468986825|FG022|Substudy A|Lost to Follow-up|0|||
130279870|NCT05596734|468986826|FG023|Substudy A|Lost to Follow-up|0|||
130279871|NCT05596734|468986803|FG000|Substudy B|Withdrawal by Subject|0|||
130279872|NCT05596734|468986804|FG001|Substudy B|Withdrawal by Subject|0|||
130279873|NCT05596734|468986805|FG002|Substudy B|Withdrawal by Subject|0|||
130279874|NCT05596734|468986806|FG003|Substudy B|Withdrawal by Subject|0|||
130279875|NCT05596734|468986807|FG004|Substudy B|Withdrawal by Subject|0|||
130279876|NCT05596734|468986808|FG005|Substudy B|Withdrawal by Subject|0|||
130279877|NCT05596734|468986809|FG006|Substudy B|Withdrawal by Subject|0|||
130279878|NCT05596734|468986810|FG007|Substudy B|Withdrawal by Subject|0|||
130279879|NCT05596734|468986811|FG008|Substudy B|Withdrawal by Subject|0|||
130279880|NCT05596734|468986812|FG009|Substudy B|Withdrawal by Subject|0|||
130279881|NCT05596734|468986813|FG010|Substudy B|Withdrawal by Subject|0|||
130279882|NCT05596734|468986814|FG011|Substudy B|Withdrawal by Subject|0|||
130279883|NCT05596734|468986815|FG012|Substudy B|Withdrawal by Subject|1|||
130279884|NCT05596734|468986816|FG013|Substudy B|Withdrawal by Subject|0|||
130279885|NCT05596734|468986817|FG014|Substudy B|Withdrawal by Subject|1|||
130279886|NCT05596734|468986818|FG015|Substudy B|Withdrawal by Subject|2|||
130279887|NCT05596734|468986819|FG016|Substudy B|Withdrawal by Subject|2|||
130279888|NCT05596734|468986820|FG017|Substudy B|Withdrawal by Subject|1|||
130279889|NCT05596734|468986821|FG018|Substudy B|Withdrawal by Subject|2|||
130279890|NCT05596734|468986822|FG019|Substudy B|Withdrawal by Subject|0|||
130279891|NCT05596734|468986823|FG020|Substudy B|Withdrawal by Subject|0|||
130279892|NCT05596734|468986824|FG021|Substudy B|Withdrawal by Subject|0|||
130279893|NCT05596734|468986825|FG022|Substudy B|Withdrawal by Subject|0|||
130279894|NCT05596734|468986826|FG023|Substudy B|Withdrawal by Subject|1|||
130279895|NCT05596734|468986803|FG000|Substudy B|Physician Decision|0|||
130279896|NCT05596734|468986804|FG001|Substudy B|Physician Decision|0|||
130279897|NCT05596734|468986805|FG002|Substudy B|Physician Decision|0|||
130279898|NCT05596734|468986806|FG003|Substudy B|Physician Decision|0|||
130279899|NCT05596734|468986807|FG004|Substudy B|Physician Decision|0|||
130279900|NCT05596734|468986808|FG005|Substudy B|Physician Decision|0|||
130279901|NCT05596734|468986809|FG006|Substudy B|Physician Decision|0|||
130279902|NCT05596734|468986810|FG007|Substudy B|Physician Decision|0|||
130279903|NCT05596734|468986811|FG008|Substudy B|Physician Decision|0|||
130279904|NCT05596734|468986812|FG009|Substudy B|Physician Decision|0|||
130279905|NCT05596734|468986813|FG010|Substudy B|Physician Decision|0|||
130279906|NCT05596734|468986814|FG011|Substudy B|Physician Decision|0|||
130279907|NCT05596734|468986815|FG012|Substudy B|Physician Decision|0|||
130279908|NCT05596734|468986816|FG013|Substudy B|Physician Decision|0|||
130279909|NCT05596734|468986817|FG014|Substudy B|Physician Decision|0|||
130279910|NCT05596734|468986818|FG015|Substudy B|Physician Decision|1|||
130279911|NCT05596734|468986819|FG016|Substudy B|Physician Decision|0|||
130279912|NCT05596734|468986820|FG017|Substudy B|Physician Decision|0|||
130279913|NCT05596734|468986821|FG018|Substudy B|Physician Decision|0|||
130279914|NCT05596734|468986822|FG019|Substudy B|Physician Decision|0|||
130279915|NCT05596734|468986823|FG020|Substudy B|Physician Decision|0|||
130279916|NCT05596734|468986824|FG021|Substudy B|Physician Decision|0|||
130279917|NCT05596734|468986825|FG022|Substudy B|Physician Decision|0|||
130279918|NCT05596734|468986826|FG023|Substudy B|Physician Decision|0|||
130279919|NCT05596734|468986803|FG000|Substudy B|Lost to Follow-up|0|||
130279920|NCT05596734|468986804|FG001|Substudy B|Lost to Follow-up|0|||
130279921|NCT05596734|468986805|FG002|Substudy B|Lost to Follow-up|0|||
130279922|NCT05596734|468986806|FG003|Substudy B|Lost to Follow-up|0|||
130279923|NCT05596734|468986807|FG004|Substudy B|Lost to Follow-up|0|||
130279924|NCT05596734|468986808|FG005|Substudy B|Lost to Follow-up|0|||
130279925|NCT05596734|468986809|FG006|Substudy B|Lost to Follow-up|0|||
130279926|NCT05596734|468986810|FG007|Substudy B|Lost to Follow-up|0|||
130279927|NCT05596734|468986811|FG008|Substudy B|Lost to Follow-up|0|||
130279928|NCT05596734|468986812|FG009|Substudy B|Lost to Follow-up|0|||
130279929|NCT05596734|468986813|FG010|Substudy B|Lost to Follow-up|0|||
130279930|NCT05596734|468986814|FG011|Substudy B|Lost to Follow-up|0|||
130279931|NCT05596734|468986815|FG012|Substudy B|Lost to Follow-up|1|||
130279932|NCT05596734|468986816|FG013|Substudy B|Lost to Follow-up|0|||
130279933|NCT05596734|468986817|FG014|Substudy B|Lost to Follow-up|1|||
130279934|NCT05596734|468986818|FG015|Substudy B|Lost to Follow-up|1|||
130279935|NCT05596734|468986819|FG016|Substudy B|Lost to Follow-up|0|||
130279936|NCT05596734|468986820|FG017|Substudy B|Lost to Follow-up|0|||
130279937|NCT05596734|468986821|FG018|Substudy B|Lost to Follow-up|0|||
130279938|NCT05596734|468986822|FG019|Substudy B|Lost to Follow-up|0|||
130279939|NCT05596734|468986823|FG020|Substudy B|Lost to Follow-up|0|||
130279940|NCT05596734|468986824|FG021|Substudy B|Lost to Follow-up|0|||
130279941|NCT05596734|468986825|FG022|Substudy B|Lost to Follow-up|0|||
130279942|NCT05596734|468986826|FG023|Substudy B|Lost to Follow-up|0|||
130279943|NCT04113018|468986827|FG000|Overall Study|Death|2|||
130279944|NCT04113018|468986827|FG000|Overall Study|Lost to Follow-up|1|||
130279945|NCT04113018|468986827|FG000|Overall Study|Still On Study (on study treatment)|24|||
130279946|NCT04113018|468986827|FG000|Overall Study|Still On Study (in follow up)|12|||
130279947|NCT05005013|468986828|FG000|Overall Study|Withdrawal by Subject|5|||
130279948|NCT05005013|468986829|FG001|Overall Study|Withdrawal by Subject|1|||
130279949|NCT05005013|468986828|FG000|Overall Study|Lost to Follow-up|3|||
130279950|NCT05005013|468986829|FG001|Overall Study|Lost to Follow-up|1|||
130279951|NCT05005013|468986828|FG000|Overall Study|Ineligibility|1|||
130279952|NCT05005013|468986829|FG001|Overall Study|Ineligibility|1|||
130279953|NCT01802580|468986830|FG000|Overall Study|Physician Decision|1|||
130279954|NCT01802580|468986831|FG001|Overall Study|Physician Decision|0|||
130279955|NCT01802580|468986830|FG000|Overall Study|Protocol Violation|2|||
130279956|NCT01802580|468986831|FG001|Overall Study|Protocol Violation|0|||
130279957|NCT01802580|468986830|FG000|Overall Study|Withdrawal by Subject|5|||
130279958|NCT01802580|468986831|FG001|Overall Study|Withdrawal by Subject|6|||
130279959|NCT01802580|468986830|FG000|Overall Study|Other|1|||
130279960|NCT01802580|468986831|FG001|Overall Study|Other|3|||
130279961|NCT01802580|468986830|FG000|Overall Study|Lack of Efficacy|0|||
130279962|NCT01802580|468986831|FG001|Overall Study|Lack of Efficacy|2|||
130279963|NCT02791516|468986832|FG000|Overall Study|Withdrawal by Subject|1|||
130279964|NCT02791516|468986833|FG001|Overall Study|Withdrawal by Subject|1|||
130279965|NCT00211757|468986839|FG000|Overall Study|Withdrawal by Subject|1|||
130279966|NCT00211757|468986840|FG001|Overall Study|Withdrawal by Subject|1|||
130279967|NCT00211757|468986839|FG000|Overall Study|Lack of Efficacy|0|||
130279968|NCT00211757|468986840|FG001|Overall Study|Lack of Efficacy|1|||
130279969|NCT00322452|468986841|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130279970|NCT00322452|468986842|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130279971|NCT00322452|468986841|FG000|Overall Study|Lost to Follow-up|5|||
130279972|NCT00322452|468986842|FG001|Overall Study|Lost to Follow-up|2|||
130279973|NCT00322452|468986841|FG000|Overall Study|Withdrawal by Subject|19|||
130279974|NCT00322452|468986842|FG001|Overall Study|Withdrawal by Subject|46|||
130279975|NCT00322452|468986841|FG000|Overall Study|Death|223|||
130279976|NCT00322452|468986842|FG001|Overall Study|Death|227|||
130279977|NCT04091581|468986843|FG000|Overall Study|Lost to Follow-up|0|||
130279978|NCT04091581|468986844|FG001|Overall Study|Lost to Follow-up|1|||
130279979|NCT03372551|468988637|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
130279980|NCT03372551|468988638|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
130279981|NCT03727646|468988639|FG000|Overall Study|Adverse Event|1|||
130279982|NCT03727646|468988640|FG001|Overall Study|Adverse Event|0|||
130279983|NCT00327015|468988643|FG000|Overall Study|Lack of Efficacy|18|||
130279984|NCT00327015|468988644|FG001|Overall Study|Lack of Efficacy|18|||
130279985|NCT00327015|468988645|FG002|Overall Study|Lack of Efficacy|35|||
130279986|NCT00327015|468988646|FG003|Overall Study|Lack of Efficacy|29|||
130279987|NCT00327015|468988643|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
130279988|NCT00327015|468988644|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
130279989|NCT00327015|468988645|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
130279990|NCT00327015|468988646|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
130279991|NCT00327015|468988643|FG000|Overall Study|Lost to Follow-up|22|||
130279992|NCT00327015|468988644|FG001|Overall Study|Lost to Follow-up|23|||
130279993|NCT00327015|468988645|FG002|Overall Study|Lost to Follow-up|29|||
130279994|NCT00327015|468988646|FG003|Overall Study|Lost to Follow-up|22|||
130279995|NCT00327015|468988643|FG000|Overall Study|Adverse Event|14|||
130279996|NCT00327015|468988644|FG001|Overall Study|Adverse Event|10|||
130279997|NCT00327015|468988645|FG002|Overall Study|Adverse Event|14|||
130279998|NCT00327015|468988646|FG003|Overall Study|Adverse Event|14|||
130279999|NCT00327015|468988643|FG000|Overall Study|Subject no longer meets study criteria|4|||
130280000|NCT00327015|468988644|FG001|Overall Study|Subject no longer meets study criteria|2|||
130280001|NCT00327015|468988645|FG002|Overall Study|Subject no longer meets study criteria|8|||
130280002|NCT00327015|468988646|FG003|Overall Study|Subject no longer meets study criteria|7|||
130280003|NCT00327015|468988643|FG000|Overall Study|Poor/Noncompliance|11|||
130280004|NCT00327015|468988644|FG001|Overall Study|Poor/Noncompliance|8|||
130280005|NCT00327015|468988645|FG002|Overall Study|Poor/Noncompliance|4|||
130280006|NCT00327015|468988646|FG003|Overall Study|Poor/Noncompliance|5|||
130280007|NCT00327015|468988643|FG000|Overall Study|Physician Decision|0|||
130280008|NCT00327015|468988644|FG001|Overall Study|Physician Decision|1|||
130280009|NCT00327015|468988645|FG002|Overall Study|Physician Decision|3|||
130280010|NCT00327015|468988646|FG003|Overall Study|Physician Decision|2|||
130280011|NCT00327015|468988643|FG000|Overall Study|Death|1|||
130280012|NCT00327015|468988644|FG001|Overall Study|Death|2|||
130280013|NCT00327015|468988645|FG002|Overall Study|Death|2|||
130280014|NCT00327015|468988646|FG003|Overall Study|Death|3|||
130280015|NCT00327015|468988643|FG000|Overall Study|Pregnancy|0|||
130280016|NCT00327015|468988644|FG001|Overall Study|Pregnancy|2|||
130280017|NCT00327015|468988645|FG002|Overall Study|Pregnancy|1|||
130280018|NCT00327015|468988646|FG003|Overall Study|Pregnancy|1|||
130280019|NCT00327015|468988643|FG000|Overall Study|Administrative Reason by Sponsor|1|||
130280020|NCT00327015|468988644|FG001|Overall Study|Administrative Reason by Sponsor|2|||
130280021|NCT00327015|468988645|FG002|Overall Study|Administrative Reason by Sponsor|2|||
130280022|NCT00327015|468988646|FG003|Overall Study|Administrative Reason by Sponsor|1|||
130280023|NCT00837265|468988647|FG000|Pilot Phase|Withdrawal by Subject|0|||
130280024|NCT00837265|468988648|FG001|Pilot Phase|Withdrawal by Subject|2|||
130280025|NCT00837265|468988649|FG002|Pilot Phase|Withdrawal by Subject|3|||
130280026|NCT00837265|468988650|FG003|Pilot Phase|Withdrawal by Subject|2|||
130280027|NCT00837265|468988651|FG004|Pilot Phase|Withdrawal by Subject|0|||
130280028|NCT00837265|468988652|FG005|Pilot Phase|Withdrawal by Subject|0|||
130280029|NCT00837265|468988653|FG006|Pilot Phase|Withdrawal by Subject|0|||
130280030|NCT00837265|468988647|FG000|Pilot Phase|Decision of the investigator|2|||
130280031|NCT00837265|468988648|FG001|Pilot Phase|Decision of the investigator|1|||
130280032|NCT00837265|468988649|FG002|Pilot Phase|Decision of the investigator|0|||
130280033|NCT00837265|468988650|FG003|Pilot Phase|Decision of the investigator|0|||
130280034|NCT00837265|468988651|FG004|Pilot Phase|Decision of the investigator|0|||
130280035|NCT00837265|468988652|FG005|Pilot Phase|Decision of the investigator|0|||
130280036|NCT00837265|468988653|FG006|Pilot Phase|Decision of the investigator|0|||
130280037|NCT00837265|468988647|FG000|Pilot Phase|Adverse Event|1|||
130280038|NCT00837265|468988648|FG001|Pilot Phase|Adverse Event|0|||
130280039|NCT00837265|468988649|FG002|Pilot Phase|Adverse Event|0|||
130280040|NCT00837265|468988650|FG003|Pilot Phase|Adverse Event|0|||
130280041|NCT00837265|468988651|FG004|Pilot Phase|Adverse Event|0|||
130280042|NCT00837265|468988652|FG005|Pilot Phase|Adverse Event|0|||
130280043|NCT00837265|468988653|FG006|Pilot Phase|Adverse Event|0|||
130280044|NCT00837265|468988647|FG000|Pilot Phase|Disease progression|0|||
130280045|NCT00837265|468988648|FG001|Pilot Phase|Disease progression|0|||
130280046|NCT00837265|468988649|FG002|Pilot Phase|Disease progression|0|||
130280047|NCT00837265|468988650|FG003|Pilot Phase|Disease progression|1|||
130280048|NCT00837265|468988651|FG004|Pilot Phase|Disease progression|0|||
130280049|NCT00837265|468988652|FG005|Pilot Phase|Disease progression|0|||
130280050|NCT00837265|468988653|FG006|Pilot Phase|Disease progression|0|||
130280051|NCT00837265|468988647|FG000|Pilot Phase|Participant left the city|0|||
130280052|NCT00837265|468988648|FG001|Pilot Phase|Participant left the city|0|||
130280053|NCT00837265|468988649|FG002|Pilot Phase|Participant left the city|0|||
130280054|NCT00837265|468988650|FG003|Pilot Phase|Participant left the city|1|||
130280055|NCT00837265|468988651|FG004|Pilot Phase|Participant left the city|0|||
130280056|NCT00837265|468988652|FG005|Pilot Phase|Participant left the city|0|||
130280057|NCT00837265|468988653|FG006|Pilot Phase|Participant left the city|0|||
130280058|NCT00837265|468988647|FG000|Main Phase|Withdrawal by Subject|0|||
130280059|NCT00837265|468988648|FG001|Main Phase|Withdrawal by Subject|0|||
130280060|NCT00837265|468988649|FG002|Main Phase|Withdrawal by Subject|0|||
130280061|NCT00837265|468988650|FG003|Main Phase|Withdrawal by Subject|0|||
130042077|NCT01856673|468112206|FG001|Overall Study|Unknown reasons|0|||
130042078|NCT01856673|468112207|FG002|Overall Study|Unknown reasons|0|||
130042079|NCT01856673|468112205|FG000|Overall Study|Psychologist decision|1|||
130042080|NCT01856673|468112206|FG001|Overall Study|Psychologist decision|0|||
130042081|NCT01856673|468112207|FG002|Overall Study|Psychologist decision|0|||
130042082|NCT01856673|468112205|FG000|Overall Study|Paperwork errors|8|||
130042083|NCT01856673|468112206|FG001|Overall Study|Paperwork errors|0|||
130042084|NCT01856673|468112207|FG002|Overall Study|Paperwork errors|0|||
130042085|NCT01856673|468112205|FG000|Overall Study|Death|1|||
130042086|NCT01856673|468112206|FG001|Overall Study|Death|1|||
130042087|NCT01856673|468112207|FG002|Overall Study|Death|0|||
130042088|NCT01856673|468112205|FG000|Overall Study|Protocol Violation|1|||
130042089|NCT01856673|468112206|FG001|Overall Study|Protocol Violation|0|||
130042090|NCT01856673|468112207|FG002|Overall Study|Protocol Violation|1|||
130280062|NCT00837265|468988651|FG004|Main Phase|Withdrawal by Subject|4|||
130280063|NCT00837265|468988652|FG005|Main Phase|Withdrawal by Subject|2|||
130280064|NCT00837265|468988653|FG006|Main Phase|Withdrawal by Subject|1|||
130042091|NCT00184054|468112208|FG000|Overall Study|Adverse Event|1|||
130042092|NCT04925570|468112209|FG000|Overall Study|Protocol Violation|24|||
130042093|NCT04925570|468112210|FG001|Overall Study|Protocol Violation|30|||
130280065|NCT00837265|468988647|FG000|Main Phase|Decision of the investigator|0|||
130280066|NCT00837265|468988648|FG001|Main Phase|Decision of the investigator|0|||
130280067|NCT00837265|468988649|FG002|Main Phase|Decision of the investigator|0|||
130042094|NCT04925570|468112209|FG000|Overall Study|Withdrawal by Subject|0|||
130280068|NCT00837265|468988650|FG003|Main Phase|Decision of the investigator|0|||
130280069|NCT00837265|468988651|FG004|Main Phase|Decision of the investigator|0|||
130280070|NCT00837265|468988652|FG005|Main Phase|Decision of the investigator|2|||
130042095|NCT04925570|468112210|FG001|Overall Study|Withdrawal by Subject|2|||
130042096|NCT00667277|468112213|FG000|Overall Study|Withdrawal by Subject|2|||
130042097|NCT05121103|468112214|FG000|Overall Study|Progressive disease|2|||
130280071|NCT00837265|468988653|FG006|Main Phase|Decision of the investigator|1|||
130280072|NCT00837265|468988647|FG000|Main Phase|Adverse Event|0|||
130280073|NCT00837265|468988648|FG001|Main Phase|Adverse Event|0|||
130280074|NCT00837265|468988649|FG002|Main Phase|Adverse Event|0|||
130280075|NCT00837265|468988650|FG003|Main Phase|Adverse Event|0|||
130280076|NCT00837265|468988651|FG004|Main Phase|Adverse Event|0|||
130280077|NCT00837265|468988652|FG005|Main Phase|Adverse Event|1|||
130280078|NCT00837265|468988653|FG006|Main Phase|Adverse Event|0|||
130280079|NCT00837265|468988647|FG000|Main Phase|Death|0|||
130280080|NCT00837265|468988648|FG001|Main Phase|Death|0|||
130280081|NCT00837265|468988649|FG002|Main Phase|Death|0|||
130280082|NCT00837265|468988650|FG003|Main Phase|Death|0|||
130280083|NCT00837265|468988651|FG004|Main Phase|Death|2|||
130280084|NCT00837265|468988652|FG005|Main Phase|Death|0|||
130280085|NCT00837265|468988653|FG006|Main Phase|Death|1|||
130280086|NCT00837265|468988647|FG000|Main Phase|Lost to Follow-up|0|||
130280087|NCT00837265|468988648|FG001|Main Phase|Lost to Follow-up|0|||
130280088|NCT00837265|468988649|FG002|Main Phase|Lost to Follow-up|0|||
130280089|NCT00837265|468988650|FG003|Main Phase|Lost to Follow-up|0|||
130280090|NCT00837265|468988651|FG004|Main Phase|Lost to Follow-up|1|||
130280091|NCT00837265|468988652|FG005|Main Phase|Lost to Follow-up|0|||
130280092|NCT00837265|468988653|FG006|Main Phase|Lost to Follow-up|0|||
130280093|NCT00837265|468988647|FG000|Main Phase|Principal investigator resignation|0|||
130280094|NCT00837265|468988648|FG001|Main Phase|Principal investigator resignation|0|||
130280095|NCT00837265|468988649|FG002|Main Phase|Principal investigator resignation|0|||
130280096|NCT00837265|468988650|FG003|Main Phase|Principal investigator resignation|0|||
130280097|NCT00837265|468988651|FG004|Main Phase|Principal investigator resignation|2|||
130280098|NCT00837265|468988652|FG005|Main Phase|Principal investigator resignation|0|||
130280099|NCT00837265|468988653|FG006|Main Phase|Principal investigator resignation|0|||
130280100|NCT00837265|468988647|FG000|Main Phase|Participant's personal reason|0|||
130280101|NCT00837265|468988648|FG001|Main Phase|Participant's personal reason|0|||
130280102|NCT00837265|468988649|FG002|Main Phase|Participant's personal reason|0|||
130280103|NCT00837265|468988650|FG003|Main Phase|Participant's personal reason|0|||
130280104|NCT00837265|468988651|FG004|Main Phase|Participant's personal reason|1|||
130280105|NCT00837265|468988652|FG005|Main Phase|Participant's personal reason|0|||
130280106|NCT00837265|468988653|FG006|Main Phase|Participant's personal reason|0|||
130280107|NCT00473668|468988656|FG000|Overall Study|Withdrawal by Subject|0|||
130280108|NCT00473668|468988657|FG001|Overall Study|Withdrawal by Subject|2|||
130280109|NCT00473668|468988658|FG002|Overall Study|Withdrawal by Subject|0|||
130280110|NCT00473668|468988656|FG000|Overall Study|Migrated/moved from study area|3|||
130280111|NCT00473668|468988657|FG001|Overall Study|Migrated/moved from study area|2|||
130280112|NCT00473668|468988658|FG002|Overall Study|Migrated/moved from study area|0|||
130280113|NCT00473668|468988656|FG000|Overall Study|Lost to Follow-up|0|||
130280114|NCT00473668|468988657|FG001|Overall Study|Lost to Follow-up|4|||
130280115|NCT00473668|468988658|FG002|Overall Study|Lost to Follow-up|6|||
130280116|NCT00473668|468988656|FG000|Overall Study|Other|2|||
130280117|NCT00473668|468988657|FG001|Overall Study|Other|3|||
130280118|NCT00473668|468988658|FG002|Overall Study|Other|4|||
130280119|NCT02226562|468988659|FG000|Overall Study|Lost to Follow-up|0|||
130280120|NCT02226562|468988660|FG001|Overall Study|Lost to Follow-up|1|||
130280121|NCT01474772|468988662|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
130280122|NCT01474772|468988663|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
130280123|NCT01474772|468988662|FG000|Period 1|AE not Related to Study Drug|1|||
130280124|NCT01474772|468988663|FG001|Period 1|AE not Related to Study Drug|0|||
130280125|NCT01474772|468988662|FG000|Period 1|Withdrawal by Subject|3|||
130280126|NCT01474772|468988663|FG001|Period 1|Withdrawal by Subject|1|||
130042098|NCT05121103|468112215|FG001|Overall Study|Progressive disease|1|||
130042099|NCT05121103|468112216|FG002|Overall Study|Progressive disease|6|||
130042100|NCT05121103|468112214|FG000|Overall Study|Physician Decision|2|||
130280127|NCT01474772|468988662|FG000|Period 1|Lost to Follow-up|1|||
130280128|NCT01474772|468988663|FG001|Period 1|Lost to Follow-up|0|||
130280129|NCT01474772|468988662|FG000|Period 1|Reason not Specified|1|||
130042101|NCT05121103|468112215|FG001|Overall Study|Physician Decision|1|||
130280130|NCT01474772|468988663|FG001|Period 1|Reason not Specified|1|||
130280131|NCT01474772|468988662|FG000|Washout|AE not Related to Study Drug|2|||
130042102|NCT05121103|468112216|FG002|Overall Study|Physician Decision|0|||
130106160|NCT01901146|468349913|FG002|Adjuvant Phase|Other|1|||
130280132|NCT01474772|468988663|FG001|Washout|AE not Related to Study Drug|0|||
130280133|NCT01474772|468988662|FG000|Washout|Withdrawal by Subject|1|||
130280134|NCT01474772|468988663|FG001|Washout|Withdrawal by Subject|0|||
130280135|NCT01474772|468988662|FG000|Washout|Lost to Follow-up|0|||
130280136|NCT01474772|468988663|FG001|Washout|Lost to Follow-up|1|||
130280137|NCT01474772|468988662|FG000|Washout|Reason not Specified|0|||
130280138|NCT01474772|468988663|FG001|Washout|Reason not Specified|1|||
130280139|NCT01474772|468988662|FG000|Period 2|Death|0|||
130280140|NCT01474772|468988663|FG001|Period 2|Death|1|||
130280141|NCT01474772|468988662|FG000|Period 2|AE Related to Study Drug|0|||
130280142|NCT01474772|468988663|FG001|Period 2|AE Related to Study Drug|1|||
130280143|NCT01474772|468988662|FG000|Period 2|AE not Related to Study Drug|4|||
130280144|NCT01474772|468988663|FG001|Period 2|AE not Related to Study Drug|1|||
130280145|NCT01474772|468988662|FG000|Period 2|Lack of Efficacy|1|||
130280146|NCT01474772|468988663|FG001|Period 2|Lack of Efficacy|0|||
130280147|NCT01474772|468988662|FG000|Period 2|Withdrawal by Subject|3|||
130280148|NCT01474772|468988663|FG001|Period 2|Withdrawal by Subject|4|||
130280149|NCT01474772|468988662|FG000|Period 2|Lost to Follow-up|1|||
130280150|NCT01474772|468988663|FG001|Period 2|Lost to Follow-up|1|||
130280151|NCT01474772|468988662|FG000|Period 2|Reason not Specified|0|||
130280152|NCT01474772|468988663|FG001|Period 2|Reason not Specified|2|||
130280153|NCT01474772|468988662|FG000|Follow-up|AE not Related to Study Drug|0|||
130280154|NCT01474772|468988663|FG001|Follow-up|AE not Related to Study Drug|1|||
130280155|NCT00223808|468988664|FG000|Overall Study|<5 hrs therapy before discharge|3|||
130280156|NCT00223808|468988665|FG001|Overall Study|<5 hrs therapy before discharge|5|||
130280157|NCT00223808|468988666|FG002|Overall Study|<5 hrs therapy before discharge|5|||
130280158|NCT03195660|468988667|FG000|Overall Study|The study was terminated|2|||
130280159|NCT05260073|468988669|FG000|Overall Study|Physician Decision|1|||
130280160|NCT05260073|468988669|FG000|Overall Study|Withdrawal by Subject|6|||
130280161|NCT05260073|468988669|FG000|Overall Study|Lost to Follow-up|14|||
130280162|NCT03458910|468988670|FG000|Overall Study|Withdrawal by Subject|7|||
130280163|NCT03458910|468988671|FG001|Overall Study|Withdrawal by Subject|8|||
130280164|NCT03458910|468988672|FG002|Overall Study|Withdrawal by Subject|6|||
130280165|NCT03458910|468988673|FG003|Overall Study|Withdrawal by Subject|4|||
130280166|NCT03458910|468988670|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
130280167|NCT03458910|468988671|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
130280168|NCT03458910|468988672|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
130280169|NCT03458910|468988673|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
130280170|NCT04484649|468988674|FG000|Overall Study|Lost to Follow-up|2|||
130280171|NCT04484649|468988675|FG001|Overall Study|Lost to Follow-up|1|||
130280172|NCT04484649|468988674|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
130280173|NCT04484649|468988675|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
130280174|NCT00152477|468988680|FG000|Chemotherapy Period|Adverse Event|9|||
130280175|NCT00152477|468988681|FG001|Chemotherapy Period|Adverse Event|4|||
130280176|NCT00152477|468988682|FG002|Chemotherapy Period|Adverse Event|5|||
130280177|NCT00152477|468988680|FG000|Chemotherapy Period|Death|1|||
130280178|NCT00152477|468988681|FG001|Chemotherapy Period|Death|3|||
130280179|NCT00152477|468988682|FG002|Chemotherapy Period|Death|3|||
130280180|NCT00152477|468988680|FG000|Chemotherapy Period|Lack of Efficacy|4|||
130280181|NCT00152477|468988681|FG001|Chemotherapy Period|Lack of Efficacy|5|||
130280182|NCT00152477|468988682|FG002|Chemotherapy Period|Lack of Efficacy|6|||
130280183|NCT00152477|468988680|FG000|Chemotherapy Period|Lost to Follow-up|1|||
130280184|NCT00152477|468988681|FG001|Chemotherapy Period|Lost to Follow-up|0|||
130280185|NCT00152477|468988682|FG002|Chemotherapy Period|Lost to Follow-up|1|||
130280186|NCT00152477|468988680|FG000|Chemotherapy Period|Protocol Violation|1|||
130280187|NCT00152477|468988681|FG001|Chemotherapy Period|Protocol Violation|1|||
130280188|NCT00152477|468988682|FG002|Chemotherapy Period|Protocol Violation|0|||
130280189|NCT00152477|468988680|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
130280190|NCT00152477|468988681|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
130280191|NCT00152477|468988682|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
130280192|NCT00152477|468988680|FG000|Chemotherapy Period|Progression of Disease|6|||
130280193|NCT00152477|468988681|FG001|Chemotherapy Period|Progression of Disease|8|||
130280194|NCT00152477|468988682|FG002|Chemotherapy Period|Progression of Disease|4|||
130280195|NCT00152477|468988680|FG000|Chemotherapy Period|Investigator decision|0|||
130280196|NCT00152477|468988681|FG001|Chemotherapy Period|Investigator decision|0|||
130280197|NCT00152477|468988682|FG002|Chemotherapy Period|Investigator decision|1|||
130280198|NCT00152477|468988680|FG000|Chemotherapy Period|Patient condition worsened|1|||
130280199|NCT00152477|468988681|FG001|Chemotherapy Period|Patient condition worsened|0|||
130280200|NCT00152477|468988682|FG002|Chemotherapy Period|Patient condition worsened|0|||
130280201|NCT00152477|468988680|FG000|Monotherapy Period|Adverse Event|1|||
130280202|NCT00152477|468988681|FG001|Monotherapy Period|Adverse Event|0|||
130280203|NCT00152477|468988682|FG002|Monotherapy Period|Adverse Event|5|||
130280204|NCT00152477|468988680|FG000|Monotherapy Period|Death|2|||
130280205|NCT00152477|468988681|FG001|Monotherapy Period|Death|0|||
130280206|NCT00152477|468988682|FG002|Monotherapy Period|Death|1|||
130280207|NCT00152477|468988680|FG000|Monotherapy Period|Lack of Efficacy|7|||
130042103|NCT05121103|468112214|FG000|Overall Study|Withdrawal by Subject|0|||
130042104|NCT05121103|468112215|FG001|Overall Study|Withdrawal by Subject|1|||
130280208|NCT00152477|468988681|FG001|Monotherapy Period|Lack of Efficacy|16|||
130280209|NCT00152477|468988682|FG002|Monotherapy Period|Lack of Efficacy|10|||
130280210|NCT00152477|468988680|FG000|Monotherapy Period|Protocol Violation|0|||
130280211|NCT00152477|468988681|FG001|Monotherapy Period|Protocol Violation|1|||
130280212|NCT00152477|468988682|FG002|Monotherapy Period|Protocol Violation|0|||
130280213|NCT00152477|468988680|FG000|Monotherapy Period|Withdrawal by Subject|0|||
130280214|NCT00152477|468988681|FG001|Monotherapy Period|Withdrawal by Subject|0|||
130280215|NCT00152477|468988682|FG002|Monotherapy Period|Withdrawal by Subject|4|||
130280216|NCT00152477|468988680|FG000|Monotherapy Period|Progression of Disease|5|||
130280217|NCT00152477|468988681|FG001|Monotherapy Period|Progression of Disease|11|||
130280218|NCT00152477|468988682|FG002|Monotherapy Period|Progression of Disease|12|||
130280219|NCT00152477|468988680|FG000|Monotherapy Period|Patient decision|0|||
130280220|NCT00152477|468988681|FG001|Monotherapy Period|Patient decision|1|||
130280221|NCT00152477|468988682|FG002|Monotherapy Period|Patient decision|1|||
130280222|NCT00152477|468988680|FG000|Monotherapy Period|Study personel decision|0|||
130280223|NCT00152477|468988681|FG001|Monotherapy Period|Study personel decision|0|||
130280224|NCT00152477|468988682|FG002|Monotherapy Period|Study personel decision|1|||
130280225|NCT02570152|468988683|FG000|Overall Study|Protocol Violation|2|||
130280226|NCT02570152|468988683|FG000|Overall Study|Migrated/moved from study area|13|||
130280227|NCT00923975|468988685|FG000|Overall Study|Did not meet inclusion criteria|1|||
130280228|NCT01328535|468988686|FG000|Overall Study|Ineligible|1|||
130280229|NCT01005316|468988687|FG000|Overall Study|Adverse Event|0|||
130280230|NCT01005316|468988688|FG001|Overall Study|Adverse Event|0|||
130280231|NCT01005316|468988689|FG002|Overall Study|Adverse Event|0|||
130280232|NCT01005316|468988690|FG003|Overall Study|Adverse Event|1|||
130280233|NCT01005316|468988687|FG000|Overall Study|Death|20|||
130280234|NCT01005316|468988688|FG001|Overall Study|Death|5|||
130280235|NCT01005316|468988689|FG002|Overall Study|Death|1|||
130280236|NCT01005316|468988690|FG003|Overall Study|Death|15|||
130280237|NCT01005316|468988687|FG000|Overall Study|Study Termination|5|||
130280238|NCT01005316|468988688|FG001|Overall Study|Study Termination|63|||
130280239|NCT01005316|468988689|FG002|Overall Study|Study Termination|9|||
130280240|NCT01005316|468988690|FG003|Overall Study|Study Termination|85|||
130280241|NCT01005316|468988687|FG000|Overall Study|Lost to Follow-up|1|||
130280242|NCT01005316|468988688|FG001|Overall Study|Lost to Follow-up|3|||
130280243|NCT01005316|468988689|FG002|Overall Study|Lost to Follow-up|0|||
130280244|NCT01005316|468988690|FG003|Overall Study|Lost to Follow-up|2|||
130280245|NCT01005316|468988687|FG000|Overall Study|Physician Decision|6|||
130280246|NCT01005316|468988688|FG001|Overall Study|Physician Decision|0|||
130280247|NCT01005316|468988689|FG002|Overall Study|Physician Decision|0|||
130280248|NCT01005316|468988690|FG003|Overall Study|Physician Decision|0|||
130280249|NCT01005316|468988687|FG000|Overall Study|Sponsor Decision|6|||
130280250|NCT01005316|468988688|FG001|Overall Study|Sponsor Decision|3|||
130280251|NCT01005316|468988689|FG002|Overall Study|Sponsor Decision|0|||
130280252|NCT01005316|468988690|FG003|Overall Study|Sponsor Decision|0|||
130280253|NCT01005316|468988687|FG000|Overall Study|Withdrawal by Subject|1|||
130280254|NCT01005316|468988688|FG001|Overall Study|Withdrawal by Subject|1|||
130280255|NCT01005316|468988689|FG002|Overall Study|Withdrawal by Subject|0|||
130280256|NCT01005316|468988690|FG003|Overall Study|Withdrawal by Subject|2|||
130280257|NCT01005316|468988687|FG000|Overall Study|Consented to Another Study|2|||
130280258|NCT01005316|468988688|FG001|Overall Study|Consented to Another Study|0|||
130280259|NCT01005316|468988689|FG002|Overall Study|Consented to Another Study|0|||
130280260|NCT01005316|468988690|FG003|Overall Study|Consented to Another Study|0|||
130280261|NCT01005316|468988687|FG000|Overall Study|Delisted|8|||
130280262|NCT01005316|468988688|FG001|Overall Study|Delisted|0|||
130280263|NCT01005316|468988689|FG002|Overall Study|Delisted|0|||
130280264|NCT01005316|468988690|FG003|Overall Study|Delisted|0|||
130280265|NCT01005316|468988687|FG000|Overall Study|Transferred Care|1|||
130280266|NCT01005316|468988688|FG001|Overall Study|Transferred Care|0|||
130280267|NCT01005316|468988689|FG002|Overall Study|Transferred Care|1|||
130280268|NCT01005316|468988690|FG003|Overall Study|Transferred Care|3|||
130280269|NCT01005316|468988687|FG000|Overall Study|Retransplanted|0|||
130280270|NCT01005316|468988688|FG001|Overall Study|Retransplanted|1|||
130280271|NCT01005316|468988689|FG002|Overall Study|Retransplanted|0|||
130280272|NCT01005316|468988690|FG003|Overall Study|Retransplanted|0|||
130280273|NCT00960011|468988691|FG000|Overall Study|Death|5|||
130280274|NCT00960011|468988692|FG001|Overall Study|Death|0|||
130280275|NCT00960011|468988691|FG000|Overall Study|Lost to Follow-up|6|||
130280276|NCT00960011|468988692|FG001|Overall Study|Lost to Follow-up|2|||
130280277|NCT04417218|468988693|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
130280278|NCT04417218|468988694|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
130280279|NCT01734395|468988697|FG000|Overall Study|Other|65|||
130280280|NCT01734395|468988697|FG000|Overall Study|Lost to Follow-up|287|||
130280281|NCT01734395|468988697|FG000|Overall Study|Lack of Efficacy|5|||
130280282|NCT01734395|468988697|FG000|Overall Study|Adverse Event|40|||
130280283|NCT01734395|468988697|FG000|Overall Study|Withdrawal by Subject|10|||
130280284|NCT01734395|468988697|FG000|Overall Study|Missing the reasons for not completed|3|||
130280285|NCT01032291|468988698|FG000|Safety Lead-in|Adverse Event|1|||
130280286|NCT01032291|468988699|FG001|Safety Lead-in|Adverse Event|0|||
130280287|NCT01032291|468988700|FG002|Safety Lead-in|Adverse Event|0|||
130280288|NCT01032291|468988698|FG000|Safety Lead-in|Death|1|||
130280289|NCT01032291|468988699|FG001|Safety Lead-in|Death|0|||
130280290|NCT01032291|468988700|FG002|Safety Lead-in|Death|0|||
130280291|NCT01032291|468988698|FG000|Proof of Concept|Adverse Event|0|||
130280292|NCT01032291|468988699|FG001|Proof of Concept|Adverse Event|5|||
130280293|NCT01032291|468988700|FG002|Proof of Concept|Adverse Event|1|||
130280294|NCT01032291|468988698|FG000|Proof of Concept|Death|0|||
130280295|NCT01032291|468988699|FG001|Proof of Concept|Death|1|||
130280296|NCT01032291|468988700|FG002|Proof of Concept|Death|2|||
130280297|NCT01032291|468988698|FG000|Proof of Concept|Lack of Efficacy|0|||
130280298|NCT01032291|468988699|FG001|Proof of Concept|Lack of Efficacy|1|||
130280299|NCT01032291|468988700|FG002|Proof of Concept|Lack of Efficacy|0|||
130280300|NCT01032291|468988698|FG000|Proof of Concept|Never Received Study Drug|0|||
130280301|NCT01032291|468988699|FG001|Proof of Concept|Never Received Study Drug|1|||
130280302|NCT01032291|468988700|FG002|Proof of Concept|Never Received Study Drug|0|||
130280303|NCT00313313|468988701|FG000|Overall Study|Lack of Efficacy|14|||
130280304|NCT00313313|468988702|FG001|Overall Study|Lack of Efficacy|9|||
130280305|NCT00313313|468988703|FG002|Overall Study|Lack of Efficacy|20|||
130280306|NCT00313313|468988701|FG000|Overall Study|Withdrawal of consent by subject|18|||
130280307|NCT00313313|468988702|FG001|Overall Study|Withdrawal of consent by subject|17|||
130280308|NCT00313313|468988703|FG002|Overall Study|Withdrawal of consent by subject|31|||
130280309|NCT00313313|468988701|FG000|Overall Study|Lost to Follow-up|10|||
130280310|NCT00313313|468988702|FG001|Overall Study|Lost to Follow-up|7|||
130280311|NCT00313313|468988703|FG002|Overall Study|Lost to Follow-up|9|||
130280312|NCT00313313|468988701|FG000|Overall Study|Adverse Event|15|||
130280313|NCT00313313|468988702|FG001|Overall Study|Adverse Event|16|||
130280314|NCT00313313|468988703|FG002|Overall Study|Adverse Event|12|||
130280315|NCT00313313|468988701|FG000|Overall Study|Physician Decision|2|||
130280316|NCT00313313|468988702|FG001|Overall Study|Physician Decision|6|||
130280317|NCT00313313|468988703|FG002|Overall Study|Physician Decision|4|||
130280318|NCT00313313|468988701|FG000|Overall Study|Poor/Noncompliance|3|||
130280319|NCT00313313|468988702|FG001|Overall Study|Poor/Noncompliance|6|||
130280320|NCT00313313|468988703|FG002|Overall Study|Poor/Noncompliance|2|||
130280321|NCT00313313|468988701|FG000|Overall Study|Pregnancy|1|||
130280322|NCT00313313|468988702|FG001|Overall Study|Pregnancy|2|||
130280323|NCT00313313|468988703|FG002|Overall Study|Pregnancy|0|||
130280324|NCT00313313|468988701|FG000|Overall Study|Death|0|||
130280325|NCT00313313|468988702|FG001|Overall Study|Death|0|||
130280326|NCT00313313|468988703|FG002|Overall Study|Death|2|||
130280327|NCT00313313|468988701|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
130280328|NCT00313313|468988702|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
130280329|NCT00313313|468988703|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
130280330|NCT00758264|468988704|FG000|Active Phase|Withdrawal by Subject|0|||
130280331|NCT00758264|468988705|FG001|Active Phase|Withdrawal by Subject|0|||
130280332|NCT00758264|468988706|FG002|Active Phase|Withdrawal by Subject|1|||
130280333|NCT00758264|468988704|FG000|Active Phase|Lost to Follow-up|1|||
130280334|NCT00758264|468988705|FG001|Active Phase|Lost to Follow-up|0|||
130280335|NCT00758264|468988706|FG002|Active Phase|Lost to Follow-up|0|||
130280336|NCT00758264|468988704|FG000|Active Phase|Other|0|||
130280337|NCT00758264|468988705|FG001|Active Phase|Other|0|||
130280338|NCT00758264|468988706|FG002|Active Phase|Other|4|||
130280339|NCT01177553|468988707|FG000|Overall Study|babies not yet 6 months of age|1|||
130280340|NCT01177553|468988708|FG001|Overall Study|babies not yet 6 months of age|0|||
130280341|NCT00695955|468988712|FG000|Cohort 1|Adverse Event|26|||
130280342|NCT00695955|468988712|FG000|Cohort 1|Protocol Violation|2|||
130280343|NCT00695955|468988712|FG000|Cohort 1|Lost to Follow-up|30|||
130280344|NCT00695955|468988712|FG000|Cohort 1|Withdrawal by Subject|25|||
130280345|NCT00695955|468988712|FG000|Cohort 1|Lack of Efficacy|3|||
130280346|NCT00695955|468988712|FG000|Cohort 1|Other|16|||
130280347|NCT00695955|468988712|FG000|Cohort 2|Adverse Event|24|||
130280348|NCT00695955|468988712|FG000|Cohort 2|Protocol Violation|5|||
130280349|NCT00695955|468988712|FG000|Cohort 2|Lost to Follow-up|38|||
130280350|NCT00695955|468988712|FG000|Cohort 2|Withdrawal by Subject|28|||
130280351|NCT00695955|468988712|FG000|Cohort 2|Lack of Efficacy|4|||
130280352|NCT00695955|468988712|FG000|Cohort 2|Other|5|||
130280353|NCT01106651|468988713|FG000|Overall Study|Adverse Event|17|||
130042105|NCT05121103|468112216|FG002|Overall Study|Withdrawal by Subject|0|||
130042106|NCT03138564|468112217|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
130042107|NCT03138564|468112218|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
130042108|NCT03138564|468112217|FG000|Overall Study|Lost to Follow-up|16|||
130042109|NCT03138564|468112218|FG001|Overall Study|Lost to Follow-up|2|||
130280354|NCT01106651|468988714|FG001|Overall Study|Adverse Event|9|||
130280355|NCT01106651|468988715|FG002|Overall Study|Adverse Event|23|||
130280356|NCT01106651|468988713|FG000|Overall Study|Lost to Follow-up|8|||
130280357|NCT01106651|468988714|FG001|Overall Study|Lost to Follow-up|2|||
130042110|NCT03138564|468112217|FG000|Overall Study|Withdrawal by Subject|48|||
130280358|NCT01106651|468988715|FG002|Overall Study|Lost to Follow-up|6|||
130280359|NCT01106651|468988713|FG000|Overall Study|Physician Decision|4|||
130280360|NCT01106651|468988714|FG001|Overall Study|Physician Decision|3|||
130280361|NCT01106651|468988715|FG002|Overall Study|Physician Decision|1|||
130280362|NCT01106651|468988713|FG000|Overall Study|Protocol Violation|1|||
130042111|NCT03138564|468112218|FG001|Overall Study|Withdrawal by Subject|4|||
130280363|NCT01106651|468988714|FG001|Overall Study|Protocol Violation|2|||
130280364|NCT01106651|468988715|FG002|Overall Study|Protocol Violation|1|||
130280365|NCT01106651|468988713|FG000|Overall Study|Withdrawal by Subject|14|||
130280366|NCT01106651|468988714|FG001|Overall Study|Withdrawal by Subject|7|||
130280367|NCT01106651|468988715|FG002|Overall Study|Withdrawal by Subject|4|||
130280368|NCT01106651|468988713|FG000|Overall Study|Noncompliance with study drug|1|||
130280369|NCT01106651|468988714|FG001|Overall Study|Noncompliance with study drug|0|||
130280370|NCT01106651|468988715|FG002|Overall Study|Noncompliance with study drug|2|||
130280371|NCT01106651|468988713|FG000|Overall Study|Other|34|||
130280372|NCT01106651|468988714|FG001|Overall Study|Other|31|||
130280373|NCT01106651|468988715|FG002|Overall Study|Other|21|||
130280374|NCT01106651|468988713|FG000|Overall Study|Death|0|||
130280375|NCT01106651|468988714|FG001|Overall Study|Death|3|||
130280376|NCT01106651|468988715|FG002|Overall Study|Death|0|||
130280377|NCT04590404|468988716|FG000|Overall Study|Death|16|||
130280378|NCT04590404|468988717|FG001|Overall Study|Death|17|||
130280379|NCT04590404|468988716|FG000|Overall Study|Withdrawal by Subject|7|||
130280380|NCT04590404|468988717|FG001|Overall Study|Withdrawal by Subject|2|||
130280381|NCT01581021|468988719|FG000|Overall Study|Lost to Follow-up|4|||
130280382|NCT01581021|468988720|FG001|Overall Study|Lost to Follow-up|6|||
130280383|NCT01581021|468988719|FG000|Overall Study|More than 2 hooks in thoracic|3|||
130280384|NCT01581021|468988720|FG001|Overall Study|More than 2 hooks in thoracic|0|||
130280385|NCT01581021|468988719|FG000|Overall Study|Neuromuscular|2|||
130280386|NCT01581021|468988720|FG001|Overall Study|Neuromuscular|1|||
130280387|NCT01581021|468988719|FG000|Overall Study|Not Randomized|1|||
130280388|NCT01581021|468988720|FG001|Overall Study|Not Randomized|2|||
130280389|NCT01581021|468988719|FG000|Overall Study|Lenke 6 Classification|0|||
130280390|NCT01581021|468988720|FG001|Overall Study|Lenke 6 Classification|1|||
130280391|NCT01581021|468988719|FG000|Overall Study|Lack of Efficacy|0|||
130280392|NCT01581021|468988720|FG001|Overall Study|Lack of Efficacy|1|||
130280393|NCT00054327|468988723|FG000|Overall Study|Engraftment failure|1|||
130280394|NCT00054327|468988724|FG001|Overall Study|Engraftment failure|0|||
130280395|NCT00054327|468988725|FG002|Overall Study|Engraftment failure|0|||
130280396|NCT00054327|468988726|FG003|Overall Study|Engraftment failure|0|||
130280397|NCT00054327|468988727|FG004|Overall Study|Engraftment failure|0|||
130280398|NCT00054327|468988728|FG005|Overall Study|Engraftment failure|0|||
130280399|NCT00290771|468988735|FG000|Overall Study|Disease progression|95|||
130280400|NCT00290771|468988736|FG001|Overall Study|Disease progression|73|||
130280401|NCT00290771|468988735|FG000|Overall Study|Death|11|||
130280402|NCT00290771|468988736|FG001|Overall Study|Death|10|||
130280403|NCT00290771|468988735|FG000|Overall Study|Adverse Event|12|||
130280404|NCT00290771|468988736|FG001|Overall Study|Adverse Event|6|||
130280405|NCT00290771|468988735|FG000|Overall Study|Withdrawal by Subject|5|||
130280406|NCT00290771|468988736|FG001|Overall Study|Withdrawal by Subject|6|||
130280407|NCT00290771|468988735|FG000|Overall Study|Administrative problems|2|||
130280408|NCT00290771|468988736|FG001|Overall Study|Administrative problems|1|||
130280409|NCT00290771|468988735|FG000|Overall Study|Protocol Violation|2|||
130280410|NCT00290771|468988736|FG001|Overall Study|Protocol Violation|0|||
130280411|NCT00290771|468988735|FG000|Overall Study|Lost to Follow-up|0|||
130280412|NCT00290771|468988736|FG001|Overall Study|Lost to Follow-up|1|||
130280413|NCT00244933|468988739|FG000|Overall Study|Not response evaluable|2|||
130280414|NCT02487654|468988741|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
130280415|NCT02487654|468988742|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
130280416|NCT02487654|468988741|FG000|Overall Study|Withdrawal by Subject|3|||
130280417|NCT02487654|468988742|FG001|Overall Study|Withdrawal by Subject|7|||
130280418|NCT02247011|468988743|FG000|Overall Study|Poor quality of radiological results|125|||
130280419|NCT00616018|468988744|FG000|Overall Study|Protocol Violation|3|||
130280420|NCT03718884|468988745|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
130280421|NCT03718884|468988746|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
130042112|NCT03138564|468112217|FG000|Overall Study|No longer met eligibility criteria|2|||
130042113|NCT03138564|468112218|FG001|Overall Study|No longer met eligibility criteria|0|||
130042114|NCT03138564|468112217|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
130042115|NCT03138564|468112218|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
130042116|NCT03138564|468112217|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
130042117|NCT03138564|468112218|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
130042118|NCT03138564|468112217|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
130042119|NCT03138564|468112218|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
130042120|NCT03138564|468112217|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
130042121|NCT03138564|468112218|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
130042122|NCT00814710|468112219|FG000|Overall Study|Adverse Event|1|||
130042123|NCT00814710|468112220|FG001|Overall Study|Adverse Event|0|||
130042124|NCT00814710|468112219|FG000|Overall Study|Lost to Follow-up|7|||
130042125|NCT00814710|468112220|FG001|Overall Study|Lost to Follow-up|3|||
130042126|NCT01548638|468112222|FG000|Overall Study|Protocol Violation|3|||
130042127|NCT01548638|468112222|FG000|Overall Study|Withdrawal by Subject|1|||
130042128|NCT05593432|468112223|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
130042129|NCT05593432|468112224|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
130042130|NCT05593432|468112225|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
130042131|NCT05593432|468112226|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
130042132|NCT05593432|468112223|FG000|16-Week OLE Period|Lack of Efficacy|0|||
130042133|NCT05593432|468112224|FG001|16-Week OLE Period|Lack of Efficacy|0|||
130042134|NCT05593432|468112225|FG002|16-Week OLE Period|Lack of Efficacy|0|||
130042135|NCT05593432|468112226|FG003|16-Week OLE Period|Lack of Efficacy|1|||
130280422|NCT03718884|468988745|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
130280423|NCT03718884|468988746|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
130280424|NCT00349921|468988747|FG000|First Spinal Injection|Physician Decision|1|||
130280425|NCT00349921|468988748|FG001|First Spinal Injection|Physician Decision|0|||
130280426|NCT00349921|468988749|FG002|First Spinal Injection|Physician Decision|0|||
130280427|NCT00349921|468988750|FG003|First Spinal Injection|Physician Decision|0|||
130280428|NCT00349921|468988747|FG000|First Spinal Injection|Adverse Event|0|||
130280429|NCT00349921|468988748|FG001|First Spinal Injection|Adverse Event|0|||
130280430|NCT00349921|468988749|FG002|First Spinal Injection|Adverse Event|1|||
130280431|NCT00349921|468988750|FG003|First Spinal Injection|Adverse Event|0|||
130280432|NCT04700540|468988751|FG000|Overall Study|Withdrawal by Subject|12|||
130280433|NCT04700540|468988752|FG001|Overall Study|Withdrawal by Subject|8|||
130280434|NCT04700540|468988751|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
130280435|NCT04700540|468988752|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
130280436|NCT02602275|468988771|FG000|Day 1|Physician Decision|0|||
130280437|NCT02602275|468988772|FG001|Day 1|Physician Decision|1|||
130280438|NCT03802630|468988775|FG000|Overall Study|Study terminated by sponsor|130|||
130280439|NCT03802630|468988776|FG001|Overall Study|Study terminated by sponsor|134|||
130280440|NCT03802630|468988775|FG000|Overall Study|Subject decision|16|||
130280441|NCT03802630|468988776|FG001|Overall Study|Subject decision|9|||
130280442|NCT03802630|468988775|FG000|Overall Study|Adverse Event|3|||
130280443|NCT03802630|468988776|FG001|Overall Study|Adverse Event|1|||
130280444|NCT03802630|468988775|FG000|Overall Study|Lost to Follow-up|2|||
130280445|NCT03802630|468988776|FG001|Overall Study|Lost to Follow-up|2|||
130280446|NCT03802630|468988775|FG000|Overall Study|Physician Decision|2|||
130280447|NCT03802630|468988776|FG001|Overall Study|Physician Decision|0|||
130280448|NCT03802630|468988775|FG000|Overall Study|Death|0|||
130280449|NCT03802630|468988776|FG001|Overall Study|Death|2|||
130280450|NCT01108731|468988777|FG000|Overall Study|Withdrawal by Subject|1|||
130280451|NCT01108731|468988778|FG001|Overall Study|Withdrawal by Subject|1|||
130280452|NCT01108731|468988777|FG000|Overall Study|Adverse Event|3|||
130042136|NCT05593432|468112223|FG000|16-Week OLE Period|Lost to Follow-up|0|||
130042137|NCT05593432|468112224|FG001|16-Week OLE Period|Lost to Follow-up|0|||
130042138|NCT05593432|468112225|FG002|16-Week OLE Period|Lost to Follow-up|1|||
130042139|NCT05593432|468112226|FG003|16-Week OLE Period|Lost to Follow-up|2|||
130042140|NCT05593432|468112223|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
130042141|NCT05593432|468112224|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
130042142|NCT05593432|468112225|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
130042143|NCT05593432|468112226|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
130042144|NCT03885284|468112227|FG000|Overall Study|Disease Progression|1|||
130042145|NCT03885284|468112228|FG001|Overall Study|Disease Progression|3|||
130042146|NCT03885284|468112227|FG000|Overall Study|Physician Decision|0|||
130042147|NCT03885284|468112228|FG001|Overall Study|Physician Decision|1|||
130280453|NCT01108731|468988778|FG001|Overall Study|Adverse Event|3|||
130280454|NCT00157196|468988779|FG000|Overall Study|Ongoing at data cut-off|9|||
130042148|NCT01591330|468112231|FG000|Period 1|Adverse Event|1|||
130042149|NCT01591330|468112232|FG001|Period 1|Adverse Event|0|||
130042150|NCT01591330|468112233|FG002|Period 1|Adverse Event|0|||
130042151|NCT01591330|468112234|FG003|Period 1|Adverse Event|0|||
130042152|NCT01591330|468112231|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
130042153|NCT01591330|468112232|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
130042154|NCT01591330|468112233|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
130042155|NCT01591330|468112234|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
130042156|NCT01591330|468112231|FG000|Period 2|Adverse Event|1|||
130280455|NCT04210245|468988780|FG000|Overall Study|Adverse Event|0|||
130280456|NCT04210245|468988781|FG001|Overall Study|Adverse Event|3|||
130280457|NCT04210245|468988782|FG002|Overall Study|Adverse Event|6|||
130280458|NCT04210245|468988783|FG003|Overall Study|Adverse Event|0|||
130280459|NCT04210245|468988780|FG000|Overall Study|Withdrawal by Subject|0|||
130280460|NCT04210245|468988781|FG001|Overall Study|Withdrawal by Subject|1|||
130280461|NCT04210245|468988782|FG002|Overall Study|Withdrawal by Subject|4|||
130280462|NCT04210245|468988783|FG003|Overall Study|Withdrawal by Subject|4|||
130280463|NCT04210245|468988780|FG000|Overall Study|Lost to Follow-up|0|||
130280464|NCT04210245|468988781|FG001|Overall Study|Lost to Follow-up|1|||
130280465|NCT04210245|468988782|FG002|Overall Study|Lost to Follow-up|1|||
130280466|NCT04210245|468988783|FG003|Overall Study|Lost to Follow-up|1|||
130280467|NCT04210245|468988780|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130280468|NCT04210245|468988781|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130280469|NCT04210245|468988782|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
130280470|NCT04210245|468988783|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
130280485|NCT01252186|468988788|FG000|Overall Study|Adverse Event|9|||
130280486|NCT01252186|468988789|FG001|Overall Study|Adverse Event|6|||
130280487|NCT01252186|468988790|FG002|Overall Study|Adverse Event|8|||
130280488|NCT01252186|468988788|FG000|Overall Study|Withdrawal by Subject|2|||
130280489|NCT01252186|468988789|FG001|Overall Study|Withdrawal by Subject|5|||
130280490|NCT01252186|468988790|FG002|Overall Study|Withdrawal by Subject|2|||
130280491|NCT01252186|468988788|FG000|Overall Study|Physician Decision|0|||
130106161|NCT01901146|468349914|FG003|Adjuvant Phase|Other|0|||
130106162|NCT01901146|468349915|FG004|Adjuvant Phase|Other|0|||
130106163|NCT01901146|468349911|FG000|Adjuvant Phase|Death|0|||
130106164|NCT01901146|468349912|FG001|Adjuvant Phase|Death|0|||
130280492|NCT01252186|468988789|FG001|Overall Study|Physician Decision|0|||
130280493|NCT01252186|468988790|FG002|Overall Study|Physician Decision|1|||
130280494|NCT01252186|468988788|FG000|Overall Study|Non-compliance|0|||
130280495|NCT01252186|468988789|FG001|Overall Study|Non-compliance|3|||
130280496|NCT01252186|468988790|FG002|Overall Study|Non-compliance|4|||
130280497|NCT01252186|468988788|FG000|Overall Study|Protocol Violation|0|||
130280498|NCT01252186|468988789|FG001|Overall Study|Protocol Violation|0|||
130042157|NCT01591330|468112232|FG001|Period 2|Adverse Event|0|||
130042158|NCT01591330|468112233|FG002|Period 2|Adverse Event|0|||
130106165|NCT01901146|468349913|FG002|Adjuvant Phase|Death|0|||
130280499|NCT01252186|468988790|FG002|Overall Study|Protocol Violation|1|||
130280500|NCT01252186|468988788|FG000|Overall Study|Pregnancy|2|||
130280501|NCT01252186|468988789|FG001|Overall Study|Pregnancy|2|||
130280502|NCT01252186|468988790|FG002|Overall Study|Pregnancy|0|||
130106166|NCT01901146|468349914|FG003|Adjuvant Phase|Death|0|||
130042159|NCT01591330|468112234|FG003|Period 2|Adverse Event|0|||
130042160|NCT02609399|468112241|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
130042161|NCT02609399|468112242|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
130280503|NCT01252186|468988788|FG000|Overall Study|Sponsor Request|2|||
130280504|NCT01252186|468988789|FG001|Overall Study|Sponsor Request|1|||
130280505|NCT01252186|468988790|FG002|Overall Study|Sponsor Request|0|||
130280506|NCT01252186|468988788|FG000|Overall Study|Lost to Follow-up|10|||
130280507|NCT01252186|468988789|FG001|Overall Study|Lost to Follow-up|10|||
130280508|NCT01252186|468988790|FG002|Overall Study|Lost to Follow-up|11|||
130106167|NCT01901146|468349915|FG004|Adjuvant Phase|Death|3|||
130106168|NCT01901146|468349911|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
130106169|NCT01901146|468349912|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
130106170|NCT01901146|468349913|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
130042162|NCT02609399|468112241|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
130042163|NCT02609399|468112242|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
130042164|NCT02609399|468112241|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
130042165|NCT02609399|468112242|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
130042166|NCT04800315|468112243|FG000|Randomization|Did not receive study treatment|1|||
130042167|NCT04800315|468112244|FG001|Randomization|Did not receive study treatment|0|||
130042168|NCT04800315|468112245|FG002|Randomization|Did not receive study treatment|0|||
130042169|NCT04800315|468112246|FG003|Randomization|Did not receive study treatment|0|||
130042170|NCT04800315|468112243|FG000|Treatment Period|Adverse Event|4|||
130042171|NCT04800315|468112244|FG001|Treatment Period|Adverse Event|2|||
130042172|NCT04800315|468112245|FG002|Treatment Period|Adverse Event|1|||
130042173|NCT04800315|468112246|FG003|Treatment Period|Adverse Event|2|||
130042174|NCT04800315|468112243|FG000|Treatment Period|Lack of Efficacy|1|||
130042175|NCT04800315|468112244|FG001|Treatment Period|Lack of Efficacy|0|||
130042176|NCT04800315|468112245|FG002|Treatment Period|Lack of Efficacy|0|||
130042177|NCT04800315|468112246|FG003|Treatment Period|Lack of Efficacy|3|||
130042178|NCT04800315|468112243|FG000|Treatment Period|Lost to Follow-up|0|||
130280509|NCT01252186|468988788|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
130280510|NCT01252186|468988789|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
130280511|NCT01252186|468988790|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
130280512|NCT02524275|468988791|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
130280513|NCT04283994|468988792|FG000|Overall Study|Death|11|||
130280514|NCT04283994|468988793|FG001|Overall Study|Death|20|||
130280515|NCT04283994|468988794|FG002|Overall Study|Death|11|||
130280516|NCT04283994|468988795|FG003|Overall Study|Death|0|||
130280517|NCT04283994|468988796|FG004|Overall Study|Death|0|||
130280518|NCT04283994|468988797|FG005|Overall Study|Death|0|||
130280519|NCT04283994|468988798|FG006|Overall Study|Death|0|||
130280520|NCT04283994|468988792|FG000|Overall Study|Withdrawal by Subject|16|||
130280521|NCT04283994|468988793|FG001|Overall Study|Withdrawal by Subject|4|||
130280522|NCT04283994|468988794|FG002|Overall Study|Withdrawal by Subject|6|||
130280523|NCT04283994|468988795|FG003|Overall Study|Withdrawal by Subject|1|||
130280524|NCT04283994|468988796|FG004|Overall Study|Withdrawal by Subject|0|||
130280525|NCT04283994|468988797|FG005|Overall Study|Withdrawal by Subject|1|||
130280526|NCT04283994|468988798|FG006|Overall Study|Withdrawal by Subject|0|||
130280527|NCT03763656|468988799|FG000|Overall Study|Physician Decision|1|||
130280528|NCT03763656|468988799|FG000|Overall Study|Protocol Violation|1|||
130280529|NCT03763656|468988799|FG000|Overall Study|Withdrawal by Subject|7|||
130280530|NCT01795495|468988802|FG000|Overall Study|Protocol Violation|1|||
130280531|NCT01795495|468988803|FG001|Overall Study|Protocol Violation|0|||
130280532|NCT01795495|468988804|FG002|Overall Study|Protocol Violation|1|||
130280533|NCT01795495|468988802|FG000|Overall Study|Physician Decision|0|||
130280534|NCT01795495|468988803|FG001|Overall Study|Physician Decision|0|||
130280535|NCT01795495|468988804|FG002|Overall Study|Physician Decision|1|||
130280536|NCT01331837|468988805|FG000|Overall Study|Death|30|||
130280537|NCT01331837|468988806|FG001|Overall Study|Death|34|||
130280538|NCT01331837|468988805|FG000|Overall Study|Lost to Follow-up|3|||
130280539|NCT01331837|468988806|FG001|Overall Study|Lost to Follow-up|1|||
130280540|NCT01331837|468988805|FG000|Overall Study|Info not recorded|10|||
130280541|NCT01331837|468988806|FG001|Overall Study|Info not recorded|16|||
130280542|NCT01331837|468988805|FG000|Overall Study|Withdrawal by Subject|13|||
130280543|NCT01331837|468988806|FG001|Overall Study|Withdrawal by Subject|16|||
130280544|NCT03724981|468990365|FG000|First Device|Protocol Violation|1|||
130280545|NCT03724981|468990366|FG001|First Device|Protocol Violation|1|||
130280546|NCT00197145|468990367|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
130280547|NCT00197145|468990368|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
130280548|NCT00197145|468990367|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
130280549|NCT00197145|468990368|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
130042179|NCT04800315|468112244|FG001|Treatment Period|Lost to Follow-up|1|||
130042180|NCT04800315|468112245|FG002|Treatment Period|Lost to Follow-up|2|||
130042181|NCT04800315|468112246|FG003|Treatment Period|Lost to Follow-up|2|||
130042182|NCT04800315|468112243|FG000|Treatment Period|Withdrawal by participant|0|||
130042183|NCT04800315|468112244|FG001|Treatment Period|Withdrawal by participant|0|||
130042184|NCT04800315|468112245|FG002|Treatment Period|Withdrawal by participant|0|||
130042185|NCT04800315|468112246|FG003|Treatment Period|Withdrawal by participant|4|||
130280550|NCT00197145|468990367|FG000|Period 1: Randomized Treatment Phase|Other|2|||
130280551|NCT00197145|468990368|FG001|Period 1: Randomized Treatment Phase|Other|2|||
130280552|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
130280553|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
130280554|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
130280555|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
130280556|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
130280557|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
130280558|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
130042186|NCT04800315|468112243|FG000|Treatment Period|Other Reasons|0|||
130042187|NCT04800315|468112244|FG001|Treatment Period|Other Reasons|2|||
130042188|NCT04800315|468112245|FG002|Treatment Period|Other Reasons|0|||
130042189|NCT04800315|468112246|FG003|Treatment Period|Other Reasons|1|||
130042190|NCT00753922|468112247|FG000|Overall Study|Lost to Follow-up|155|||
130042191|NCT00753922|468112248|FG001|Overall Study|Lost to Follow-up|24|||
130042192|NCT00753922|468112249|FG002|Overall Study|Lost to Follow-up|28|||
130042193|NCT00753922|468112250|FG003|Overall Study|Lost to Follow-up|5|||
130042194|NCT00753922|468112247|FG000|Overall Study|Withdrawal by Subject|9|||
130042195|NCT00753922|468112248|FG001|Overall Study|Withdrawal by Subject|11|||
130042196|NCT00753922|468112249|FG002|Overall Study|Withdrawal by Subject|4|||
130042197|NCT00753922|468112250|FG003|Overall Study|Withdrawal by Subject|2|||
130042198|NCT00753922|468112247|FG000|Overall Study|Patient Non-compliance|55|||
130042199|NCT00753922|468112248|FG001|Overall Study|Patient Non-compliance|22|||
130042200|NCT00753922|468112249|FG002|Overall Study|Patient Non-compliance|14|||
130042201|NCT00753922|468112250|FG003|Overall Study|Patient Non-compliance|11|||
130042202|NCT00753922|468112247|FG000|Overall Study|Patients Not Completing Visit|11|||
130042203|NCT00753922|468112248|FG001|Overall Study|Patients Not Completing Visit|0|||
130042204|NCT00753922|468112249|FG002|Overall Study|Patients Not Completing Visit|1|||
130042205|NCT00753922|468112250|FG003|Overall Study|Patients Not Completing Visit|0|||
130042206|NCT00753922|468112247|FG000|Overall Study|Death|2|||
130042207|NCT00753922|468112248|FG001|Overall Study|Death|23|||
130042208|NCT00753922|468112249|FG002|Overall Study|Death|2|||
130042209|NCT00753922|468112250|FG003|Overall Study|Death|1|||
130042210|NCT00753922|468112247|FG000|Overall Study|Discontinuation Due to Explantation|14|||
130042211|NCT00753922|468112248|FG001|Overall Study|Discontinuation Due to Explantation|14|||
130042212|NCT00753922|468112249|FG002|Overall Study|Discontinuation Due to Explantation|14|||
130042213|NCT00753922|468112250|FG003|Overall Study|Discontinuation Due to Explantation|4|||
130042214|NCT02453841|468112255|FG000|Overall Study|Protocol Violation|1|||
130042215|NCT02453841|468112255|FG000|Overall Study|Unable to obtain blood samples|2|||
130042216|NCT02190591|468112256|FG000|Overall Study|Withdrawal by Subject|1|||
130042217|NCT02190591|468112257|FG001|Overall Study|Withdrawal by Subject|8|||
130042218|NCT02190591|468112256|FG000|Overall Study|Protocol Violation|1|||
130042219|NCT02190591|468112257|FG001|Overall Study|Protocol Violation|0|||
130042220|NCT02190591|468112256|FG000|Overall Study|did not use peanut ball as instructed|0|||
130042221|NCT02190591|468112257|FG001|Overall Study|did not use peanut ball as instructed|2|||
130042222|NCT02190591|468112256|FG000|Overall Study|face presentation so she was ineligible|0|||
130042223|NCT02190591|468112257|FG001|Overall Study|face presentation so she was ineligible|1|||
130042224|NCT03851510|468112258|FG000|Overall Study|Screen Fail|1|||
130042225|NCT03851510|468112258|FG000|Overall Study|Adverse Event|1|||
130042226|NCT03851510|468112258|FG000|Overall Study|Withdrawal by Subject|1|||
130042227|NCT03598777|468112259|FG000|Overall Study|Study Terminated by Sponsor|3|||
130042228|NCT03598777|468112260|FG001|Overall Study|Study Terminated by Sponsor|0|||
130042229|NCT03598777|468112261|FG002|Overall Study|Study Terminated by Sponsor|0|||
130042230|NCT03598777|468112262|FG003|Overall Study|Study Terminated by Sponsor|0|||
130042231|NCT03598777|468112263|FG004|Overall Study|Study Terminated by Sponsor|15|||
130042232|NCT03598777|468112259|FG000|Overall Study|Withdrawal by Subject|1|||
130042233|NCT03598777|468112260|FG001|Overall Study|Withdrawal by Subject|1|||
130042234|NCT03598777|468112261|FG002|Overall Study|Withdrawal by Subject|0|||
130042235|NCT03598777|468112262|FG003|Overall Study|Withdrawal by Subject|0|||
130042236|NCT03598777|468112263|FG004|Overall Study|Withdrawal by Subject|0|||
130042237|NCT03598777|468112259|FG000|Overall Study|Adverse Event|1|||
130042238|NCT03598777|468112260|FG001|Overall Study|Adverse Event|0|||
130280559|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
130280560|NCT00197145|468990367|FG000|Period 2 : Open Label Phase|Other|1|||
130280561|NCT00197145|468990368|FG001|Period 2 : Open Label Phase|Other|0|||
130280562|NCT02578680|468990371|FG000|Overall Study|Death|329|||
130280563|NCT02578680|468990372|FG001|Overall Study|Death|181|||
130280564|NCT02578680|468990371|FG000|Overall Study|Lost to Follow-up|3|||
130280565|NCT02578680|468990372|FG001|Overall Study|Lost to Follow-up|1|||
130280566|NCT02578680|468990371|FG000|Overall Study|Physician Decision|0|||
130280567|NCT02578680|468990372|FG001|Overall Study|Physician Decision|1|||
130280568|NCT02578680|468990371|FG000|Overall Study|Protocol Violation|1|||
130042239|NCT03598777|468112261|FG002|Overall Study|Adverse Event|0|||
130042240|NCT03598777|468112262|FG003|Overall Study|Adverse Event|0|||
130042241|NCT03598777|468112263|FG004|Overall Study|Adverse Event|0|||
130042242|NCT03598777|468112259|FG000|Overall Study|Lost to Follow-up|1|||
130042243|NCT03598777|468112260|FG001|Overall Study|Lost to Follow-up|0|||
130042244|NCT03598777|468112261|FG002|Overall Study|Lost to Follow-up|0|||
130042245|NCT03598777|468112262|FG003|Overall Study|Lost to Follow-up|0|||
130280569|NCT02578680|468990372|FG001|Overall Study|Protocol Violation|1|||
130042246|NCT03598777|468112263|FG004|Overall Study|Lost to Follow-up|0|||
130042247|NCT01151137|468112264|FG000|Overall Study|Death|15|||
130042248|NCT01151137|468112265|FG001|Overall Study|Death|27|||
130042249|NCT01151137|468112264|FG000|Overall Study|Lost to Follow-up|1|||
130042250|NCT01151137|468112265|FG001|Overall Study|Lost to Follow-up|1|||
130280570|NCT02578680|468990371|FG000|Overall Study|Sponsor Decision|64|||
130042251|NCT00072189|468112266|FG000|Overall Study|Withdrawal by Subject|1|||
130042252|NCT00144300|468112267|FG000|Overall Study|Adverse Event|18|||
130042253|NCT00144300|468112268|FG001|Overall Study|Adverse Event|16|||
130042254|NCT00144300|468112267|FG000|Overall Study|Protocol Violation|1|||
130042255|NCT00144300|468112268|FG001|Overall Study|Protocol Violation|3|||
130042256|NCT00144300|468112267|FG000|Overall Study|Lost to Follow-up|3|||
130042257|NCT00144300|468112268|FG001|Overall Study|Lost to Follow-up|0|||
130042258|NCT00144300|468112267|FG000|Overall Study|Withdrawal by Subject|6|||
130042259|NCT00144300|468112268|FG001|Overall Study|Withdrawal by Subject|6|||
130042260|NCT00144300|468112267|FG000|Overall Study|Other reason (not specified)|1|||
130042261|NCT00144300|468112268|FG001|Overall Study|Other reason (not specified)|3|||
130042262|NCT01933672|468112270|FG000|Metformin Run-in Period|Adverse Event|1|||
130042263|NCT01933672|468112271|FG001|Metformin Run-in Period|Adverse Event|0|||
130042264|NCT01933672|468112272|FG002|Metformin Run-in Period|Adverse Event|0|||
130042265|NCT01933672|468112273|FG003|Metformin Run-in Period|Adverse Event|0|||
130042266|NCT01933672|468112274|FG004|Metformin Run-in Period|Adverse Event|0|||
130042267|NCT01933672|468112275|FG005|Metformin Run-in Period|Adverse Event|0|||
130042268|NCT01933672|468112276|FG006|Metformin Run-in Period|Adverse Event|0|||
130042269|NCT01933672|468112270|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
130042270|NCT01933672|468112271|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130042271|NCT01933672|468112272|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130042272|NCT01933672|468112273|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130042273|NCT01933672|468112274|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130042274|NCT01933672|468112275|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130042275|NCT01933672|468112276|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
130042276|NCT01933672|468112270|FG000|Metformin Run-in Period|Other|5|||
130042277|NCT01933672|468112271|FG001|Metformin Run-in Period|Other|0|||
130042278|NCT01933672|468112272|FG002|Metformin Run-in Period|Other|0|||
130042279|NCT01933672|468112273|FG003|Metformin Run-in Period|Other|0|||
130042280|NCT01933672|468112274|FG004|Metformin Run-in Period|Other|0|||
130042281|NCT01933672|468112275|FG005|Metformin Run-in Period|Other|0|||
130042282|NCT01933672|468112276|FG006|Metformin Run-in Period|Other|0|||
130042283|NCT01933672|468112270|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042284|NCT01933672|468112271|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042285|NCT01933672|468112272|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042286|NCT01933672|468112273|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042287|NCT01933672|468112274|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
130042288|NCT01933672|468112275|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042289|NCT01933672|468112276|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042290|NCT01933672|468112270|FG000|First Intervention Period (12-16 Days)|Other|0|||
130042291|NCT01933672|468112271|FG001|First Intervention Period (12-16 Days)|Other|0|||
130042292|NCT01933672|468112272|FG002|First Intervention Period (12-16 Days)|Other|1|||
130042293|NCT01933672|468112273|FG003|First Intervention Period (12-16 Days)|Other|0|||
130042294|NCT01933672|468112274|FG004|First Intervention Period (12-16 Days)|Other|0|||
130042295|NCT01933672|468112275|FG005|First Intervention Period (12-16 Days)|Other|1|||
130042296|NCT01933672|468112276|FG006|First Intervention Period (12-16 Days)|Other|0|||
130042297|NCT01933672|468112270|FG000|Second Intervention Period (12-16 Days)|Other|0|||
130280571|NCT02578680|468990372|FG001|Overall Study|Sponsor Decision|13|||
130280572|NCT02578680|468990371|FG000|Overall Study|Withdrawal by Subject|13|||
130280573|NCT02578680|468990372|FG001|Overall Study|Withdrawal by Subject|9|||
130280574|NCT03596047|468990373|FG000|Overall Study|Withdrawal by Subject|7|||
130280575|NCT03596047|468990374|FG001|Overall Study|Withdrawal by Subject|4|||
130280576|NCT03596047|468990373|FG000|Overall Study|Lost to Follow-up|0|||
130280577|NCT03596047|468990374|FG001|Overall Study|Lost to Follow-up|2|||
130280578|NCT02290691|468990375|FG000|Overall Study|Noncompliance|0|||
130280579|NCT02290691|468990376|FG001|Overall Study|Noncompliance|1|||
130280580|NCT02290691|468990375|FG000|Overall Study|Withdrawal by Subject|1|||
130280581|NCT02290691|468990376|FG001|Overall Study|Withdrawal by Subject|1|||
130280582|NCT02290691|468990375|FG000|Overall Study|Lost to Follow-up|7|||
130042298|NCT01933672|468112271|FG001|Second Intervention Period (12-16 Days)|Other|1|||
130280583|NCT02290691|468990376|FG001|Overall Study|Lost to Follow-up|7|||
130042299|NCT01933672|468112272|FG002|Second Intervention Period (12-16 Days)|Other|1|||
130042300|NCT01933672|468112273|FG003|Second Intervention Period (12-16 Days)|Other|0|||
130042301|NCT01933672|468112274|FG004|Second Intervention Period (12-16 Days)|Other|0|||
130042302|NCT01933672|468112275|FG005|Second Intervention Period (12-16 Days)|Other|0|||
130042303|NCT01933672|468112276|FG006|Second Intervention Period (12-16 Days)|Other|0|||
130042304|NCT01933672|468112270|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042305|NCT01933672|468112271|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042306|NCT01933672|468112272|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130280584|NCT00734604|468990381|FG000|Overall Study|Adverse Event|0|||
130280585|NCT00734604|468990382|FG001|Overall Study|Adverse Event|2|||
130280586|NCT00734604|468990383|FG002|Overall Study|Adverse Event|0|||
130042307|NCT01933672|468112273|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
130042308|NCT01933672|468112274|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042309|NCT01933672|468112275|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042310|NCT01933672|468112276|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
130042311|NCT01933672|468112270|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130042312|NCT01933672|468112271|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
130042313|NCT01933672|468112272|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130042314|NCT01933672|468112273|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130280587|NCT00734604|468990384|FG003|Overall Study|Adverse Event|2|||
130280588|NCT00734604|468990385|FG004|Overall Study|Adverse Event|1|||
130280589|NCT00734604|468990386|FG005|Overall Study|Adverse Event|1|||
130280590|NCT00734604|468990381|FG000|Overall Study|Serious Adverse Event|1|||
130280591|NCT00734604|468990382|FG001|Overall Study|Serious Adverse Event|0|||
130280592|NCT00734604|468990383|FG002|Overall Study|Serious Adverse Event|1|||
130280593|NCT00734604|468990384|FG003|Overall Study|Serious Adverse Event|2|||
130280594|NCT00734604|468990385|FG004|Overall Study|Serious Adverse Event|0|||
130280595|NCT00734604|468990386|FG005|Overall Study|Serious Adverse Event|1|||
130280596|NCT00734604|468990381|FG000|Overall Study|Lost to Follow-up|1|||
130280597|NCT00734604|468990382|FG001|Overall Study|Lost to Follow-up|2|||
130280598|NCT00734604|468990383|FG002|Overall Study|Lost to Follow-up|2|||
130280599|NCT00734604|468990384|FG003|Overall Study|Lost to Follow-up|4|||
130280600|NCT00734604|468990385|FG004|Overall Study|Lost to Follow-up|2|||
130280601|NCT00734604|468990386|FG005|Overall Study|Lost to Follow-up|3|||
130280602|NCT00734604|468990381|FG000|Overall Study|Physician Decision|0|||
130280603|NCT00734604|468990382|FG001|Overall Study|Physician Decision|1|||
130280604|NCT00734604|468990383|FG002|Overall Study|Physician Decision|1|||
130280605|NCT00734604|468990384|FG003|Overall Study|Physician Decision|0|||
130280606|NCT00734604|468990385|FG004|Overall Study|Physician Decision|0|||
130280607|NCT00734604|468990386|FG005|Overall Study|Physician Decision|0|||
130280608|NCT00734604|468990381|FG000|Overall Study|Protocol Violation|0|||
130280609|NCT00734604|468990382|FG001|Overall Study|Protocol Violation|2|||
130280610|NCT00734604|468990383|FG002|Overall Study|Protocol Violation|0|||
130280611|NCT00734604|468990384|FG003|Overall Study|Protocol Violation|0|||
130280612|NCT00734604|468990385|FG004|Overall Study|Protocol Violation|1|||
130280613|NCT00734604|468990386|FG005|Overall Study|Protocol Violation|0|||
130280614|NCT00734604|468990381|FG000|Overall Study|Sponsor Decision|1|||
130280615|NCT00734604|468990382|FG001|Overall Study|Sponsor Decision|2|||
130280616|NCT00734604|468990383|FG002|Overall Study|Sponsor Decision|1|||
130280617|NCT00734604|468990384|FG003|Overall Study|Sponsor Decision|0|||
130280618|NCT00734604|468990385|FG004|Overall Study|Sponsor Decision|2|||
130280619|NCT00734604|468990386|FG005|Overall Study|Sponsor Decision|0|||
130280620|NCT00734604|468990381|FG000|Overall Study|Withdrawal by Subject|0|||
130280621|NCT00734604|468990382|FG001|Overall Study|Withdrawal by Subject|2|||
130280622|NCT00734604|468990383|FG002|Overall Study|Withdrawal by Subject|0|||
130280623|NCT00734604|468990384|FG003|Overall Study|Withdrawal by Subject|1|||
130280624|NCT00734604|468990385|FG004|Overall Study|Withdrawal by Subject|2|||
130280625|NCT00734604|468990386|FG005|Overall Study|Withdrawal by Subject|1|||
130280626|NCT00734604|468990381|FG000|Overall Study|Lack of Efficacy|0|||
130280627|NCT00734604|468990382|FG001|Overall Study|Lack of Efficacy|1|||
130042315|NCT01933672|468112274|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130042316|NCT01933672|468112275|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130280628|NCT00734604|468990383|FG002|Overall Study|Lack of Efficacy|1|||
130280629|NCT00734604|468990384|FG003|Overall Study|Lack of Efficacy|0|||
130280630|NCT00734604|468990385|FG004|Overall Study|Lack of Efficacy|0|||
130280631|NCT00734604|468990386|FG005|Overall Study|Lack of Efficacy|0|||
130280632|NCT02589665|468990387|FG000|Induction Period|Did not receive drug|0|||
130280633|NCT02589665|468990388|FG001|Induction Period|Did not receive drug|0|||
130280634|NCT02589665|468990389|FG002|Induction Period|Did not receive drug|0|||
130280635|NCT02589665|468990390|FG003|Induction Period|Did not receive drug|1|||
130280636|NCT02589665|468990391|FG004|Induction Period|Did not receive drug|0|||
130280637|NCT02589665|468990392|FG005|Induction Period|Did not receive drug|0|||
130042317|NCT01933672|468112276|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
130042318|NCT02426086|468112279|FG000|Overall Study|Death|33|||
130042319|NCT02426086|468112280|FG001|Overall Study|Death|36|||
130042320|NCT02426086|468112279|FG000|Overall Study|Lost to Follow-up|2|||
130042321|NCT02426086|468112280|FG001|Overall Study|Lost to Follow-up|0|||
130042322|NCT02426086|468112279|FG000|Overall Study|Study Terminated by Sponsor|5|||
130042323|NCT02426086|468112280|FG001|Overall Study|Study Terminated by Sponsor|14|||
130280638|NCT02589665|468990393|FG006|Induction Period|Did not receive drug|0|||
130280639|NCT02589665|468990394|FG007|Induction Period|Did not receive drug|0|||
130280640|NCT02589665|468990395|FG008|Induction Period|Did not receive drug|0|||
130280641|NCT02589665|468990396|FG009|Induction Period|Did not receive drug|0|||
130280642|NCT02589665|468990387|FG000|Induction Period|Adverse Event|3|||
130280643|NCT02589665|468990388|FG001|Induction Period|Adverse Event|0|||
130280644|NCT02589665|468990389|FG002|Induction Period|Adverse Event|2|||
130280645|NCT02589665|468990390|FG003|Induction Period|Adverse Event|2|||
130280646|NCT02589665|468990391|FG004|Induction Period|Adverse Event|0|||
130280647|NCT02589665|468990392|FG005|Induction Period|Adverse Event|0|||
130280648|NCT02589665|468990393|FG006|Induction Period|Adverse Event|0|||
130280649|NCT02589665|468990394|FG007|Induction Period|Adverse Event|0|||
130280650|NCT02589665|468990395|FG008|Induction Period|Adverse Event|0|||
130280651|NCT02589665|468990396|FG009|Induction Period|Adverse Event|0|||
130280652|NCT02589665|468990387|FG000|Induction Period|Withdrawal by Subject|0|||
130280653|NCT02589665|468990388|FG001|Induction Period|Withdrawal by Subject|1|||
130280654|NCT02589665|468990389|FG002|Induction Period|Withdrawal by Subject|0|||
130280655|NCT02589665|468990390|FG003|Induction Period|Withdrawal by Subject|1|||
130280656|NCT02589665|468990391|FG004|Induction Period|Withdrawal by Subject|0|||
130280657|NCT02589665|468990392|FG005|Induction Period|Withdrawal by Subject|0|||
130280658|NCT02589665|468990393|FG006|Induction Period|Withdrawal by Subject|0|||
130280659|NCT02589665|468990394|FG007|Induction Period|Withdrawal by Subject|0|||
130280660|NCT02589665|468990395|FG008|Induction Period|Withdrawal by Subject|0|||
130280661|NCT02589665|468990396|FG009|Induction Period|Withdrawal by Subject|0|||
130280662|NCT02589665|468990387|FG000|Induction Period|Protocol Violation|0|||
130280663|NCT02589665|468990388|FG001|Induction Period|Protocol Violation|1|||
130280664|NCT02589665|468990389|FG002|Induction Period|Protocol Violation|0|||
130280665|NCT02589665|468990390|FG003|Induction Period|Protocol Violation|0|||
130280666|NCT02589665|468990391|FG004|Induction Period|Protocol Violation|0|||
130280667|NCT02589665|468990392|FG005|Induction Period|Protocol Violation|0|||
130280668|NCT02589665|468990393|FG006|Induction Period|Protocol Violation|0|||
130280669|NCT02589665|468990394|FG007|Induction Period|Protocol Violation|0|||
130280670|NCT02589665|468990395|FG008|Induction Period|Protocol Violation|0|||
130280671|NCT02589665|468990396|FG009|Induction Period|Protocol Violation|0|||
130280672|NCT02589665|468990387|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280673|NCT02589665|468990388|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280674|NCT02589665|468990389|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280675|NCT02589665|468990390|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280676|NCT02589665|468990391|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
130280677|NCT02589665|468990392|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
130280678|NCT02589665|468990393|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
130280679|NCT02589665|468990394|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280680|NCT02589665|468990395|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280681|NCT02589665|468990396|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280682|NCT02589665|468990387|FG000|Maintenance Period|Withdrawal by Subject|0|||
130280683|NCT02589665|468990388|FG001|Maintenance Period|Withdrawal by Subject|0|||
130280684|NCT02589665|468990389|FG002|Maintenance Period|Withdrawal by Subject|0|||
130280685|NCT02589665|468990390|FG003|Maintenance Period|Withdrawal by Subject|0|||
130280686|NCT02589665|468990391|FG004|Maintenance Period|Withdrawal by Subject|4|||
130280687|NCT02589665|468990392|FG005|Maintenance Period|Withdrawal by Subject|2|||
130280688|NCT02589665|468990393|FG006|Maintenance Period|Withdrawal by Subject|4|||
130280689|NCT02589665|468990394|FG007|Maintenance Period|Withdrawal by Subject|0|||
130280690|NCT02589665|468990395|FG008|Maintenance Period|Withdrawal by Subject|0|||
130042324|NCT02426086|468112279|FG000|Overall Study|Withdrawal by Subject|8|||
130042325|NCT02426086|468112280|FG001|Overall Study|Withdrawal by Subject|9|||
130042326|NCT01739595|468112287|FG000|Overall Study|Adverse Event|3|||
130280691|NCT02589665|468990396|FG009|Maintenance Period|Withdrawal by Subject|0|||
130280692|NCT02589665|468990387|FG000|Maintenance Period|Lack of Efficacy|0|||
130280693|NCT02589665|468990388|FG001|Maintenance Period|Lack of Efficacy|0|||
130280694|NCT02589665|468990389|FG002|Maintenance Period|Lack of Efficacy|0|||
130280695|NCT02589665|468990390|FG003|Maintenance Period|Lack of Efficacy|0|||
130280696|NCT02589665|468990391|FG004|Maintenance Period|Lack of Efficacy|2|||
130280697|NCT02589665|468990392|FG005|Maintenance Period|Lack of Efficacy|1|||
130280698|NCT02589665|468990393|FG006|Maintenance Period|Lack of Efficacy|0|||
130042327|NCT01739595|468112288|FG001|Overall Study|Adverse Event|0|||
130042328|NCT01739595|468112289|FG002|Overall Study|Adverse Event|0|||
130042329|NCT01739595|468112287|FG000|Overall Study|Lost to Follow-up|2|||
130042330|NCT01739595|468112288|FG001|Overall Study|Lost to Follow-up|0|||
130280699|NCT02589665|468990394|FG007|Maintenance Period|Lack of Efficacy|0|||
130280700|NCT02589665|468990395|FG008|Maintenance Period|Lack of Efficacy|0|||
130280701|NCT02589665|468990396|FG009|Maintenance Period|Lack of Efficacy|0|||
130280702|NCT02589665|468990387|FG000|Maintenance Period|Adverse Event|0|||
130280703|NCT02589665|468990388|FG001|Maintenance Period|Adverse Event|0|||
130280704|NCT02589665|468990389|FG002|Maintenance Period|Adverse Event|0|||
130280705|NCT02589665|468990390|FG003|Maintenance Period|Adverse Event|0|||
130280706|NCT02589665|468990391|FG004|Maintenance Period|Adverse Event|0|||
130280707|NCT02589665|468990392|FG005|Maintenance Period|Adverse Event|0|||
130280708|NCT02589665|468990393|FG006|Maintenance Period|Adverse Event|2|||
130280709|NCT02589665|468990394|FG007|Maintenance Period|Adverse Event|0|||
130280710|NCT02589665|468990395|FG008|Maintenance Period|Adverse Event|0|||
130280711|NCT02589665|468990396|FG009|Maintenance Period|Adverse Event|0|||
130280712|NCT02589665|468990387|FG000|Maintenance Period|Lost to Follow-up|0|||
130280713|NCT02589665|468990388|FG001|Maintenance Period|Lost to Follow-up|0|||
130280714|NCT02589665|468990389|FG002|Maintenance Period|Lost to Follow-up|0|||
130280715|NCT02589665|468990390|FG003|Maintenance Period|Lost to Follow-up|0|||
130280716|NCT02589665|468990391|FG004|Maintenance Period|Lost to Follow-up|0|||
130280717|NCT02589665|468990392|FG005|Maintenance Period|Lost to Follow-up|1|||
130280718|NCT02589665|468990393|FG006|Maintenance Period|Lost to Follow-up|0|||
130280719|NCT02589665|468990394|FG007|Maintenance Period|Lost to Follow-up|0|||
130280720|NCT02589665|468990395|FG008|Maintenance Period|Lost to Follow-up|0|||
130280721|NCT02589665|468990396|FG009|Maintenance Period|Lost to Follow-up|0|||
130280722|NCT02589665|468990387|FG000|Maintenance Period|Physician Decision|0|||
130280723|NCT02589665|468990388|FG001|Maintenance Period|Physician Decision|0|||
130280724|NCT02589665|468990389|FG002|Maintenance Period|Physician Decision|0|||
130280725|NCT02589665|468990390|FG003|Maintenance Period|Physician Decision|0|||
130280726|NCT02589665|468990391|FG004|Maintenance Period|Physician Decision|0|||
130280727|NCT02589665|468990392|FG005|Maintenance Period|Physician Decision|1|||
130280728|NCT02589665|468990393|FG006|Maintenance Period|Physician Decision|0|||
130280729|NCT02589665|468990394|FG007|Maintenance Period|Physician Decision|0|||
130280730|NCT02589665|468990395|FG008|Maintenance Period|Physician Decision|0|||
130280731|NCT02589665|468990396|FG009|Maintenance Period|Physician Decision|0|||
130280732|NCT02589665|468990387|FG000|Maintenance Period|Reason Not Collected|0|||
130280733|NCT02589665|468990388|FG001|Maintenance Period|Reason Not Collected|0|||
130280734|NCT02589665|468990389|FG002|Maintenance Period|Reason Not Collected|0|||
130280735|NCT02589665|468990390|FG003|Maintenance Period|Reason Not Collected|0|||
130280736|NCT02589665|468990391|FG004|Maintenance Period|Reason Not Collected|0|||
130280737|NCT02589665|468990392|FG005|Maintenance Period|Reason Not Collected|1|||
130280738|NCT02589665|468990393|FG006|Maintenance Period|Reason Not Collected|1|||
130280739|NCT02589665|468990394|FG007|Maintenance Period|Reason Not Collected|0|||
130280740|NCT02589665|468990395|FG008|Maintenance Period|Reason Not Collected|0|||
130280741|NCT02589665|468990396|FG009|Maintenance Period|Reason Not Collected|0|||
130280742|NCT02589665|468990387|FG000|Induction Extension Period|Adverse Event|0|||
130280743|NCT02589665|468990388|FG001|Induction Extension Period|Adverse Event|0|||
130280744|NCT02589665|468990389|FG002|Induction Extension Period|Adverse Event|0|||
130280745|NCT02589665|468990390|FG003|Induction Extension Period|Adverse Event|0|||
130280746|NCT02589665|468990391|FG004|Induction Extension Period|Adverse Event|0|||
130280747|NCT02589665|468990392|FG005|Induction Extension Period|Adverse Event|0|||
130280748|NCT02589665|468990393|FG006|Induction Extension Period|Adverse Event|0|||
130280749|NCT02589665|468990394|FG007|Induction Extension Period|Adverse Event|0|||
130280750|NCT02589665|468990395|FG008|Induction Extension Period|Adverse Event|4|||
130280751|NCT02589665|468990396|FG009|Induction Extension Period|Adverse Event|0|||
130280752|NCT02589665|468990387|FG000|Induction Extension Period|Lack of Efficacy|0|||
130280753|NCT02589665|468990388|FG001|Induction Extension Period|Lack of Efficacy|0|||
130280754|NCT02589665|468990389|FG002|Induction Extension Period|Lack of Efficacy|0|||
130280755|NCT02589665|468990390|FG003|Induction Extension Period|Lack of Efficacy|0|||
130280756|NCT02589665|468990391|FG004|Induction Extension Period|Lack of Efficacy|0|||
130280757|NCT02589665|468990392|FG005|Induction Extension Period|Lack of Efficacy|0|||
130280758|NCT02589665|468990393|FG006|Induction Extension Period|Lack of Efficacy|0|||
130280759|NCT02589665|468990394|FG007|Induction Extension Period|Lack of Efficacy|0|||
130280760|NCT02589665|468990395|FG008|Induction Extension Period|Lack of Efficacy|3|||
130280761|NCT02589665|468990396|FG009|Induction Extension Period|Lack of Efficacy|0|||
130280762|NCT02589665|468990387|FG000|Induction Extension Period|Withdrawal by Subject|0|||
130280763|NCT02589665|468990388|FG001|Induction Extension Period|Withdrawal by Subject|0|||
130280764|NCT02589665|468990389|FG002|Induction Extension Period|Withdrawal by Subject|0|||
130042331|NCT01739595|468112289|FG002|Overall Study|Lost to Follow-up|0|||
130280765|NCT02589665|468990390|FG003|Induction Extension Period|Withdrawal by Subject|0|||
130280766|NCT02589665|468990391|FG004|Induction Extension Period|Withdrawal by Subject|0|||
130280767|NCT02589665|468990392|FG005|Induction Extension Period|Withdrawal by Subject|0|||
130280768|NCT02589665|468990393|FG006|Induction Extension Period|Withdrawal by Subject|0|||
130280769|NCT02589665|468990394|FG007|Induction Extension Period|Withdrawal by Subject|2|||
130280770|NCT02589665|468990395|FG008|Induction Extension Period|Withdrawal by Subject|3|||
130280771|NCT02589665|468990396|FG009|Induction Extension Period|Withdrawal by Subject|0|||
130042332|NCT01739595|468112287|FG000|Overall Study|Withdrawal by Subject|2|||
130042333|NCT01739595|468112288|FG001|Overall Study|Withdrawal by Subject|1|||
130042334|NCT01739595|468112289|FG002|Overall Study|Withdrawal by Subject|2|||
130042335|NCT01739595|468112287|FG000|Overall Study|Eligibility issue|3|||
130042336|NCT01739595|468112288|FG001|Overall Study|Eligibility issue|0|||
130042337|NCT01739595|468112289|FG002|Overall Study|Eligibility issue|0|||
130042338|NCT01739595|468112287|FG000|Overall Study|Protocol Violation|1|||
130042339|NCT01739595|468112288|FG001|Overall Study|Protocol Violation|0|||
130042340|NCT01739595|468112289|FG002|Overall Study|Protocol Violation|0|||
130042341|NCT01739595|468112287|FG000|Overall Study|Lab assessment|1|||
130042342|NCT01739595|468112288|FG001|Overall Study|Lab assessment|0|||
130042343|NCT01739595|468112289|FG002|Overall Study|Lab assessment|0|||
130106171|NCT01901146|468349914|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
130280772|NCT02589665|468990387|FG000|Induction Extension Period|Physician Decision|0|||
130280773|NCT02589665|468990388|FG001|Induction Extension Period|Physician Decision|0|||
130280774|NCT02589665|468990389|FG002|Induction Extension Period|Physician Decision|0|||
130280775|NCT02589665|468990390|FG003|Induction Extension Period|Physician Decision|0|||
130280776|NCT02589665|468990391|FG004|Induction Extension Period|Physician Decision|0|||
130280777|NCT02589665|468990392|FG005|Induction Extension Period|Physician Decision|0|||
130280778|NCT02589665|468990393|FG006|Induction Extension Period|Physician Decision|0|||
130280779|NCT02589665|468990394|FG007|Induction Extension Period|Physician Decision|0|||
130280780|NCT02589665|468990395|FG008|Induction Extension Period|Physician Decision|1|||
130280781|NCT02589665|468990396|FG009|Induction Extension Period|Physician Decision|0|||
130280782|NCT02589665|468990387|FG000|Induction Extension Period|Reason Not Collected|0|||
130280783|NCT02589665|468990388|FG001|Induction Extension Period|Reason Not Collected|0|||
130280784|NCT02589665|468990389|FG002|Induction Extension Period|Reason Not Collected|0|||
130280785|NCT02589665|468990390|FG003|Induction Extension Period|Reason Not Collected|0|||
130280786|NCT02589665|468990391|FG004|Induction Extension Period|Reason Not Collected|0|||
130280787|NCT02589665|468990392|FG005|Induction Extension Period|Reason Not Collected|0|||
130280788|NCT02589665|468990393|FG006|Induction Extension Period|Reason Not Collected|0|||
130280789|NCT02589665|468990394|FG007|Induction Extension Period|Reason Not Collected|0|||
130280790|NCT02589665|468990395|FG008|Induction Extension Period|Reason Not Collected|1|||
130280791|NCT02589665|468990396|FG009|Induction Extension Period|Reason Not Collected|0|||
130280792|NCT02589665|468990387|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280793|NCT02589665|468990388|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280794|NCT02589665|468990389|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280795|NCT02589665|468990390|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280796|NCT02589665|468990391|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280797|NCT02589665|468990392|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280798|NCT02589665|468990393|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280799|NCT02589665|468990394|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280800|NCT02589665|468990395|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
130280801|NCT02589665|468990396|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
130280802|NCT02589665|468990387|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
130280803|NCT02589665|468990388|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
130280804|NCT02589665|468990389|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
130280805|NCT02589665|468990390|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
130280806|NCT02589665|468990391|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
130280807|NCT02589665|468990392|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
130280808|NCT02589665|468990393|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
130280809|NCT02589665|468990394|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
130280810|NCT02589665|468990395|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
130280811|NCT02589665|468990396|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
130280812|NCT02589665|468990387|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
130280813|NCT02589665|468990388|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
130106172|NCT01901146|468349915|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
130106173|NCT01901146|468349911|FG000|Adjuvant Phase|Physician Decision|0|||
130106174|NCT01901146|468349912|FG001|Adjuvant Phase|Physician Decision|0|||
130106175|NCT01901146|468349913|FG002|Adjuvant Phase|Physician Decision|9|||
130106176|NCT01901146|468349914|FG003|Adjuvant Phase|Physician Decision|2|||
130106177|NCT01901146|468349915|FG004|Adjuvant Phase|Physician Decision|4|||
130280814|NCT02589665|468990389|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
130280815|NCT02589665|468990390|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
130280816|NCT02589665|468990391|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
130280817|NCT02589665|468990392|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
130042344|NCT01739595|468112287|FG000|Overall Study|Drug discrepancy|1|||
130042345|NCT01739595|468112288|FG001|Overall Study|Drug discrepancy|0|||
130042346|NCT01739595|468112289|FG002|Overall Study|Drug discrepancy|0|||
130042347|NCT01287117|468112292|FG000|Overall Study|Adverse Event|2|||
130042348|NCT01287117|468112293|FG001|Overall Study|Adverse Event|1|||
130280818|NCT02589665|468990393|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
130280819|NCT02589665|468990394|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
130280820|NCT02589665|468990395|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
130280821|NCT02589665|468990396|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
130280822|NCT02589665|468990387|FG000|Maintenance Extension Period|Adverse Event|0|||
130280823|NCT02589665|468990388|FG001|Maintenance Extension Period|Adverse Event|0|||
130280824|NCT02589665|468990389|FG002|Maintenance Extension Period|Adverse Event|0|||
130280825|NCT02589665|468990390|FG003|Maintenance Extension Period|Adverse Event|0|||
130280826|NCT02589665|468990391|FG004|Maintenance Extension Period|Adverse Event|0|||
130280827|NCT02589665|468990392|FG005|Maintenance Extension Period|Adverse Event|0|||
130280828|NCT02589665|468990393|FG006|Maintenance Extension Period|Adverse Event|0|||
130280829|NCT02589665|468990394|FG007|Maintenance Extension Period|Adverse Event|0|||
130280830|NCT02589665|468990395|FG008|Maintenance Extension Period|Adverse Event|0|||
130280831|NCT02589665|468990396|FG009|Maintenance Extension Period|Adverse Event|2|||
130280832|NCT02589665|468990387|FG000|Maintenance Extension Period|Non-responder|0|||
130280833|NCT02589665|468990388|FG001|Maintenance Extension Period|Non-responder|0|||
130280834|NCT02589665|468990389|FG002|Maintenance Extension Period|Non-responder|0|||
130280835|NCT02589665|468990390|FG003|Maintenance Extension Period|Non-responder|0|||
130280836|NCT02589665|468990391|FG004|Maintenance Extension Period|Non-responder|0|||
130280837|NCT02589665|468990392|FG005|Maintenance Extension Period|Non-responder|0|||
130280838|NCT02589665|468990393|FG006|Maintenance Extension Period|Non-responder|0|||
130280839|NCT02589665|468990394|FG007|Maintenance Extension Period|Non-responder|0|||
130280840|NCT02589665|468990395|FG008|Maintenance Extension Period|Non-responder|0|||
130280841|NCT02589665|468990396|FG009|Maintenance Extension Period|Non-responder|1|||
130280842|NCT00978380|468990397|FG000|Overall Study|Protocol Violation|2|||
130280843|NCT00978380|468990397|FG000|Overall Study|Withdrawal criteria|9|||
130280844|NCT00978380|468990397|FG000|Overall Study|Unclassified|8|||
130280845|NCT01681069|468990405|FG000|Overall Study|Withdrawal by Subject|4|||
130280846|NCT01681069|468990406|FG001|Overall Study|Withdrawal by Subject|5|||
130280847|NCT01681069|468990405|FG000|Overall Study|Protocol Violation|1|||
130280848|NCT01681069|468990406|FG001|Overall Study|Protocol Violation|1|||
130280849|NCT01681069|468990405|FG000|Overall Study|Adverse Event|0|||
130280850|NCT01681069|468990406|FG001|Overall Study|Adverse Event|1|||
130280851|NCT03883165|468990407|FG000|Overall Study|Withdrawal by Subject|4|||
130280852|NCT03883165|468990408|FG001|Overall Study|Withdrawal by Subject|3|||
130280853|NCT00245050|468990412|FG000|Overall Study|Adverse Event|3|||
130280854|NCT00245050|468990413|FG001|Overall Study|Adverse Event|2|||
130280855|NCT00425698|468990414|FG000|Overall Study|Adverse Event|3|||
130280856|NCT00425698|468990415|FG001|Overall Study|Adverse Event|1|||
130280857|NCT00425698|468990414|FG000|Overall Study|Withdrawal by Subject|0|||
130280858|NCT00425698|468990415|FG001|Overall Study|Withdrawal by Subject|1|||
130280859|NCT03275246|468990422|FG000|Overall Study|Protocol Violation|5|||
130280860|NCT03275246|468990422|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
130280861|NCT02516098|468990431|FG000|Period 1|Protocol Violation|1|||
130280862|NCT02516098|468990432|FG001|Period 1|Protocol Violation|0|||
130280863|NCT02516098|468990431|FG000|Washout After Period 1|Adverse Event|0|||
130280864|NCT02516098|468990432|FG001|Washout After Period 1|Adverse Event|1|||
130280865|NCT02516098|468990431|FG000|Period 2|Withdrawal by Subject|0|||
130280866|NCT02516098|468990432|FG001|Period 2|Withdrawal by Subject|1|||
130280867|NCT00873041|468990433|FG000|Core Study|Adverse Event|2|||
130280868|NCT00873041|468990434|FG001|Core Study|Adverse Event|3|||
130280869|NCT00873041|468990435|FG002|Core Study|Adverse Event|1|||
130280870|NCT00873041|468990433|FG000|Core Study|Withdrawal by Subject|1|||
130280871|NCT00873041|468990434|FG001|Core Study|Withdrawal by Subject|2|||
130280872|NCT00873041|468990435|FG002|Core Study|Withdrawal by Subject|2|||
130280873|NCT00873041|468990433|FG000|Core Study|Lost to Follow-up|3|||
130280874|NCT00873041|468990434|FG001|Core Study|Lost to Follow-up|1|||
130280875|NCT00873041|468990435|FG002|Core Study|Lost to Follow-up|0|||
130280876|NCT00873041|468990433|FG000|Core Study|Abnormal laboratory value|0|||
130280877|NCT00873041|468990434|FG001|Core Study|Abnormal laboratory value|0|||
130106178|NCT01901146|468349911|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
130280878|NCT00873041|468990435|FG002|Core Study|Abnormal laboratory value|1|||
130280879|NCT00873041|468990433|FG000|Core Study|Protocol deviation|1|||
130280880|NCT00873041|468990434|FG001|Core Study|Protocol deviation|0|||
130280881|NCT00873041|468990435|FG002|Core Study|Protocol deviation|1|||
130280882|NCT00873041|468990433|FG000|Extension Study|Adverse Event|1|||
130280883|NCT00873041|468990434|FG001|Extension Study|Adverse Event|0|||
130280884|NCT00873041|468990435|FG002|Extension Study|Adverse Event|1|||
130280885|NCT00873041|468990433|FG000|Extension Study|Administrative reasons|0|||
130280886|NCT00873041|468990434|FG001|Extension Study|Administrative reasons|0|||
130280887|NCT00873041|468990435|FG002|Extension Study|Administrative reasons|1|||
130280888|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
130280889|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
130042349|NCT01287117|468112294|FG002|Overall Study|Adverse Event|1|||
130042350|NCT01287117|468112295|FG003|Overall Study|Adverse Event|1|||
130042351|NCT01287117|468112292|FG000|Overall Study|Lost to Follow-up|1|||
130042352|NCT01287117|468112293|FG001|Overall Study|Lost to Follow-up|1|||
130280890|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
130280891|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
130280892|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
130280893|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
130280894|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
130280895|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
130280896|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
130280897|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
130280898|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
130280899|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
130280900|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
130280901|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
130280902|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
130280903|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
130280904|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
130280905|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280906|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280907|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280908|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280909|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280910|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280911|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280912|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280913|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280914|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280915|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280916|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280917|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
130280918|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
130280919|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
130280920|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
130280921|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
130280922|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
130280923|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
130280924|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
130280925|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
130280926|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
130280927|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
130280928|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
130280929|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
130280930|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
130280931|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
130280932|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
130280933|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
130280934|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
130280935|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
130280936|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
130280937|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
130280938|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
130280939|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
130280940|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
130280941|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
130280942|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
130280943|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
130280944|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
130280945|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
130280946|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
130280947|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
130280948|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
130280949|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
130280950|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
130280951|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
130280952|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280953|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280954|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280955|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130042353|NCT01287117|468112294|FG002|Overall Study|Lost to Follow-up|0|||
130042354|NCT01287117|468112295|FG003|Overall Study|Lost to Follow-up|0|||
130280956|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280957|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280958|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280959|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280960|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280961|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280962|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130280963|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
130280964|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
130280965|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
130280966|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
130280967|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280968|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280969|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280970|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280971|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280972|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280973|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280974|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280975|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280976|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280977|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
130280978|NCT03831191|468990436|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280979|NCT03831191|468990437|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280980|NCT03831191|468990438|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280981|NCT03831191|468990439|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
130280982|NCT03831191|468990440|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280983|NCT03831191|468990441|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280984|NCT03831191|468990442|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280985|NCT03831191|468990443|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280986|NCT03831191|468990444|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280987|NCT03831191|468990445|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280988|NCT03831191|468990446|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280989|NCT03831191|468990447|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280990|NCT03831191|468990448|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280991|NCT03831191|468990449|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280992|NCT03831191|468990450|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
130280993|NCT03831191|468990436|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280994|NCT03831191|468990437|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280995|NCT03831191|468990438|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280996|NCT03831191|468990439|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
130280997|NCT03831191|468990440|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130280998|NCT03831191|468990441|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
130280999|NCT03831191|468990442|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
130042355|NCT01287117|468112292|FG000|Overall Study|Physician Decision|0|||
130042356|NCT01287117|468112293|FG001|Overall Study|Physician Decision|1|||
130042357|NCT01287117|468112294|FG002|Overall Study|Physician Decision|1|||
130042358|NCT01287117|468112295|FG003|Overall Study|Physician Decision|1|||
130042359|NCT01287117|468112292|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
130042360|NCT01287117|468112293|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
130042361|NCT01287117|468112294|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
130042362|NCT01287117|468112295|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
130042363|NCT01287117|468112292|FG000|Overall Study|Disease Progression|10|||
130042364|NCT01287117|468112293|FG001|Overall Study|Disease Progression|5|||
130042365|NCT01287117|468112294|FG002|Overall Study|Disease Progression|6|||
130042366|NCT01287117|468112295|FG003|Overall Study|Disease Progression|5|||
130042367|NCT01676116|468112296|FG000|Overall Study|Withdrawal criteria|2|||
130042368|NCT01676116|468112297|FG001|Overall Study|Withdrawal criteria|14|||
130042369|NCT01676116|468112296|FG000|Overall Study|Adverse Event|1|||
130042370|NCT01676116|468112297|FG001|Overall Study|Adverse Event|2|||
130042371|NCT01676116|468112296|FG000|Overall Study|Unclassified|4|||
130042372|NCT01676116|468112297|FG001|Overall Study|Unclassified|10|||
130042373|NCT01676116|468112296|FG000|Overall Study|Protocol Violation|9|||
130042374|NCT01676116|468112297|FG001|Overall Study|Protocol Violation|3|||
130042375|NCT01266148|468114265|FG000|Overall Study|Adverse Event|2|||
130042376|NCT01266148|468114266|FG001|Overall Study|Adverse Event|0|||
130042377|NCT01266148|468114265|FG000|Overall Study|Ongoing rejection|1|||
130042378|NCT01266148|468114266|FG001|Overall Study|Ongoing rejection|0|||
130042379|NCT01266148|468114265|FG000|Overall Study|2 2R rejections|1|||
130042380|NCT01266148|468114266|FG001|Overall Study|2 2R rejections|0|||
130042381|NCT01266148|468114265|FG000|Overall Study|Death|2|||
130042382|NCT01266148|468114266|FG001|Overall Study|Death|3|||
130042383|NCT01266148|468114265|FG000|Overall Study|missing mGFR value + AE|1|||
130042384|NCT01266148|468114266|FG001|Overall Study|missing mGFR value + AE|0|||
130042385|NCT01853228|468114267|FG000|Phase 1|Lack of Efficacy|8|||
130042386|NCT01853228|468114268|FG001|Phase 1|Lack of Efficacy|0|||
130042387|NCT01853228|468114267|FG000|Phase 1|Other|1|||
130042388|NCT01853228|468114268|FG001|Phase 1|Other|0|||
130042389|NCT01853228|468114267|FG000|Phase 2|Physician Decision|0|||
130042390|NCT01853228|468114268|FG001|Phase 2|Physician Decision|1|||
130042391|NCT01853228|468114267|FG000|Phase 2|Proceed To Transplant|0|||
130042392|NCT01853228|468114268|FG001|Phase 2|Proceed To Transplant|3|||
130042393|NCT01853228|468114267|FG000|Phase 2|Lack of Efficacy|0|||
130042394|NCT01853228|468114268|FG001|Phase 2|Lack of Efficacy|4|||
130042395|NCT03167619|468114269|FG000|Overall Study|Death|11|||
130042396|NCT03167619|468114270|FG001|Overall Study|Death|8|||
130042397|NCT03167619|468114269|FG000|Overall Study|Withdrawal by Subject|1|||
130042398|NCT03167619|468114270|FG001|Overall Study|Withdrawal by Subject|2|||
130042399|NCT03167619|468114269|FG000|Overall Study|Physician Decision|0|||
130042400|NCT03167619|468114270|FG001|Overall Study|Physician Decision|1|||
130042401|NCT01348919|468114272|FG000|Overall Study|Adverse Event|3|||
130042402|NCT01348919|468114273|FG001|Overall Study|Adverse Event|1|||
130042403|NCT01348919|468114274|FG002|Overall Study|Adverse Event|0|||
130042404|NCT01348919|468114272|FG000|Overall Study|Withdrawal by Subject|0|||
130042405|NCT01348919|468114273|FG001|Overall Study|Withdrawal by Subject|1|||
130042406|NCT01348919|468114274|FG002|Overall Study|Withdrawal by Subject|0|||
130042407|NCT01348919|468114272|FG000|Overall Study|Disease progression|0|||
130042408|NCT01348919|468114273|FG001|Overall Study|Disease progression|1|||
130042409|NCT01348919|468114274|FG002|Overall Study|Disease progression|1|||
130042410|NCT02082184|468114278|FG000|Overall Study|Adverse Event|1|||
130042411|NCT02082184|468114279|FG001|Overall Study|Adverse Event|0|||
130042412|NCT02082184|468114278|FG000|Overall Study|Medical diagnosis|1|||
130042413|NCT02082184|468114279|FG001|Overall Study|Medical diagnosis|2|||
130042414|NCT02082184|468114278|FG000|Overall Study|Device associated symptoms|5|||
130042415|NCT02082184|468114279|FG001|Overall Study|Device associated symptoms|0|||
130042416|NCT02082184|468114278|FG000|Overall Study|Withdrawal by Subject|3|||
130042417|NCT02082184|468114279|FG001|Overall Study|Withdrawal by Subject|2|||
130042418|NCT02082184|468114278|FG000|Overall Study|Protocol Violation|0|||
130042419|NCT02082184|468114279|FG001|Overall Study|Protocol Violation|6|||
130042420|NCT02082184|468114278|FG000|Overall Study|Lost to Follow-up|0|||
130042421|NCT02082184|468114279|FG001|Overall Study|Lost to Follow-up|2|||
130042422|NCT02082184|468114278|FG000|Overall Study|Subject non-compliance|0|||
130106179|NCT01901146|468349912|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
130106180|NCT01901146|468349913|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
130281000|NCT03831191|468990443|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130042423|NCT02082184|468114279|FG001|Overall Study|Subject non-compliance|1|||
130042424|NCT01062399|468114286|FG000|Overall Study|Protocol Violation|0|||
130042425|NCT01062399|468114287|FG001|Overall Study|Protocol Violation|1|||
130042426|NCT01062399|468114288|FG002|Overall Study|Protocol Violation|0|||
130042427|NCT01062399|468114289|FG003|Overall Study|Protocol Violation|6|||
130042428|NCT01062399|468114290|FG004|Overall Study|Protocol Violation|4|||
130042429|NCT00634543|468114291|FG000|Overall Study|Other|1|||
130042430|NCT00634543|468114292|FG001|Overall Study|Other|2|||
130042431|NCT00634543|468114291|FG000|Overall Study|Protocol Violation|3|||
130042432|NCT00634543|468114292|FG001|Overall Study|Protocol Violation|3|||
130042433|NCT00634543|468114291|FG000|Overall Study|Adverse Event|11|||
130042434|NCT00634543|468114292|FG001|Overall Study|Adverse Event|11|||
130042435|NCT00634543|468114291|FG000|Overall Study|Withdrawal by Subject|4|||
130281001|NCT03831191|468990444|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
130281002|NCT03831191|468990445|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130281003|NCT03831191|468990446|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
130281004|NCT03831191|468990447|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
130281005|NCT03831191|468990448|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130281006|NCT03831191|468990449|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
130281007|NCT03831191|468990450|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
130281008|NCT03831191|468990436|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281009|NCT03831191|468990437|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281010|NCT03831191|468990438|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281011|NCT03831191|468990439|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281012|NCT03831191|468990440|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281013|NCT03831191|468990441|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281014|NCT03831191|468990442|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281015|NCT03831191|468990443|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281016|NCT03831191|468990444|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281017|NCT03831191|468990445|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281018|NCT03831191|468990446|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281019|NCT03831191|468990447|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281020|NCT03831191|468990448|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281021|NCT03831191|468990449|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130281022|NCT03831191|468990450|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
130281023|NCT03831191|468990436|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281024|NCT03831191|468990437|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281025|NCT03831191|468990438|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281026|NCT03831191|468990439|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281027|NCT03831191|468990440|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281028|NCT03831191|468990441|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281029|NCT03831191|468990442|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281030|NCT03831191|468990443|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281031|NCT03831191|468990444|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281032|NCT03831191|468990445|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281033|NCT03831191|468990446|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281034|NCT03831191|468990447|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281035|NCT03831191|468990448|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281036|NCT03831191|468990449|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130281037|NCT03831191|468990450|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
130281038|NCT02300558|468990451|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
130281039|NCT02300558|468990451|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
130281040|NCT02300558|468990451|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
130281041|NCT02300558|468990451|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
130281042|NCT01054560|468990454|FG000|Overall Study|Death|10|||
130281043|NCT01054560|468990455|FG001|Overall Study|Death|21|||
130281044|NCT01054560|468990454|FG000|Overall Study|Lost to Follow-up|2|||
130281045|NCT01054560|468990455|FG001|Overall Study|Lost to Follow-up|5|||
130281046|NCT01054560|468990454|FG000|Overall Study|Withdrawal by Subject|0|||
130281047|NCT01054560|468990455|FG001|Overall Study|Withdrawal by Subject|2|||
130281048|NCT01054560|468990454|FG000|Overall Study|Physician Decision|1|||
130281049|NCT01054560|468990455|FG001|Overall Study|Physician Decision|0|||
130281050|NCT02135029|468990459|FG000|Overall Study|Adverse Event|2|||
130281051|NCT02135029|468990460|FG001|Overall Study|Adverse Event|2|||
130281052|NCT02135029|468990461|FG002|Overall Study|Adverse Event|2|||
130281053|NCT02135029|468990459|FG000|Overall Study|Lost to Follow-up|0|||
130281054|NCT02135029|468990460|FG001|Overall Study|Lost to Follow-up|1|||
130281055|NCT02135029|468990461|FG002|Overall Study|Lost to Follow-up|0|||
130281056|NCT02135029|468990459|FG000|Overall Study|Withdrawal by Subject|2|||
130281057|NCT02135029|468990460|FG001|Overall Study|Withdrawal by Subject|0|||
130281058|NCT02135029|468990461|FG002|Overall Study|Withdrawal by Subject|1|||
130281059|NCT02135029|468990459|FG000|Overall Study|Other|0|||
130281060|NCT02135029|468990460|FG001|Overall Study|Other|1|||
130281061|NCT02135029|468990461|FG002|Overall Study|Other|0|||
130281062|NCT02135029|468990459|FG000|Overall Study|Death|0|||
130281063|NCT02135029|468990460|FG001|Overall Study|Death|1|||
130042436|NCT00634543|468114292|FG001|Overall Study|Withdrawal by Subject|4|||
130042437|NCT00634543|468114291|FG000|Overall Study|Lost to Follow-up|0|||
130042438|NCT00634543|468114292|FG001|Overall Study|Lost to Follow-up|1|||
130042439|NCT02465034|468114295|FG000|Overall Study|Withdrawal by Subject|1|||
130042440|NCT02465034|468114296|FG001|Overall Study|Withdrawal by Subject|1|||
130042441|NCT02465034|468114295|FG000|Overall Study|Screen fail|2|||
130042442|NCT02465034|468114296|FG001|Overall Study|Screen fail|0|||
130042443|NCT02465034|468114295|FG000|Overall Study|Could not be scheduled for study visit|0|||
130042444|NCT02465034|468114296|FG001|Overall Study|Could not be scheduled for study visit|5|||
130042445|NCT05299892|468114303|FG000|Overall Study|Withdrawal by Subject|2|||
130042446|NCT02397655|468114304|FG000|Overall Study|data not completed|1301|||
130042447|NCT01736683|468114305|FG000|Overall Study|Disease Relapse|0|||
130042448|NCT01736683|468114306|FG001|Overall Study|Disease Relapse|0|||
130042449|NCT01736683|468114307|FG002|Overall Study|Disease Relapse|2|||
130042450|NCT01736683|468114308|FG003|Overall Study|Disease Relapse|1|||
130106181|NCT01901146|468349914|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
130106182|NCT01901146|468349915|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
130281064|NCT02135029|468990461|FG002|Overall Study|Death|0|||
130281065|NCT00712725|468990462|FG000|Overall Study|Adverse Event|1|||
130281066|NCT00712725|468990463|FG001|Overall Study|Adverse Event|0|||
130281067|NCT00712725|468990464|FG002|Overall Study|Adverse Event|0|||
130281068|NCT00712725|468990465|FG003|Overall Study|Adverse Event|1|||
130281069|NCT00712725|468990466|FG004|Overall Study|Adverse Event|0|||
130281070|NCT00712725|468990467|FG005|Overall Study|Adverse Event|0|||
130281071|NCT00712725|468990468|FG006|Overall Study|Adverse Event|0|||
130281072|NCT00712725|468990469|FG007|Overall Study|Adverse Event|0|||
130281073|NCT00712725|468990462|FG000|Overall Study|Lost to Follow-up|3|||
130281074|NCT00712725|468990463|FG001|Overall Study|Lost to Follow-up|2|||
130281075|NCT00712725|468990464|FG002|Overall Study|Lost to Follow-up|1|||
130281076|NCT00712725|468990465|FG003|Overall Study|Lost to Follow-up|1|||
130281077|NCT00712725|468990466|FG004|Overall Study|Lost to Follow-up|2|||
130281078|NCT00712725|468990467|FG005|Overall Study|Lost to Follow-up|2|||
130281079|NCT00712725|468990468|FG006|Overall Study|Lost to Follow-up|3|||
130281080|NCT00712725|468990469|FG007|Overall Study|Lost to Follow-up|1|||
130281081|NCT00712725|468990462|FG000|Overall Study|Physician Decision|2|||
130281082|NCT00712725|468990463|FG001|Overall Study|Physician Decision|0|||
130281083|NCT00712725|468990464|FG002|Overall Study|Physician Decision|0|||
130281084|NCT00712725|468990465|FG003|Overall Study|Physician Decision|0|||
130281085|NCT00712725|468990466|FG004|Overall Study|Physician Decision|1|||
130281086|NCT00712725|468990467|FG005|Overall Study|Physician Decision|0|||
130281087|NCT00712725|468990468|FG006|Overall Study|Physician Decision|2|||
130281088|NCT00712725|468990469|FG007|Overall Study|Physician Decision|0|||
130281089|NCT00712725|468990462|FG000|Overall Study|Pregnancy|0|||
130281090|NCT00712725|468990463|FG001|Overall Study|Pregnancy|1|||
130281091|NCT00712725|468990464|FG002|Overall Study|Pregnancy|0|||
130281092|NCT00712725|468990465|FG003|Overall Study|Pregnancy|0|||
130281093|NCT00712725|468990466|FG004|Overall Study|Pregnancy|1|||
130281094|NCT00712725|468990467|FG005|Overall Study|Pregnancy|0|||
130281095|NCT00712725|468990468|FG006|Overall Study|Pregnancy|2|||
130281096|NCT00712725|468990469|FG007|Overall Study|Pregnancy|0|||
130281097|NCT00712725|468990462|FG000|Overall Study|Protocol Violation|2|||
130281098|NCT00712725|468990463|FG001|Overall Study|Protocol Violation|0|||
130281099|NCT00712725|468990464|FG002|Overall Study|Protocol Violation|1|||
130281100|NCT00712725|468990465|FG003|Overall Study|Protocol Violation|3|||
130281101|NCT00712725|468990466|FG004|Overall Study|Protocol Violation|2|||
130281102|NCT00712725|468990467|FG005|Overall Study|Protocol Violation|0|||
130042451|NCT01736683|468114309|FG004|Overall Study|Disease Relapse|0|||
130042452|NCT01736683|468114305|FG000|Overall Study|Adverse Event|0|||
130042453|NCT01736683|468114306|FG001|Overall Study|Adverse Event|2|||
130106183|NCT01614925|468349916|FG000|Overall Study|Withdrawal by Subject|1|||
130106184|NCT01614925|468349917|FG001|Overall Study|Withdrawal by Subject|0|||
130281103|NCT00712725|468990468|FG006|Overall Study|Protocol Violation|1|||
130281104|NCT00712725|468990469|FG007|Overall Study|Protocol Violation|1|||
130281105|NCT00712725|468990462|FG000|Overall Study|Withdrawal by Subject|2|||
130281106|NCT00712725|468990463|FG001|Overall Study|Withdrawal by Subject|1|||
130281107|NCT00712725|468990464|FG002|Overall Study|Withdrawal by Subject|1|||
130281108|NCT00712725|468990465|FG003|Overall Study|Withdrawal by Subject|2|||
130281109|NCT00712725|468990466|FG004|Overall Study|Withdrawal by Subject|1|||
130281110|NCT00712725|468990467|FG005|Overall Study|Withdrawal by Subject|1|||
130281111|NCT00712725|468990468|FG006|Overall Study|Withdrawal by Subject|1|||
130281112|NCT00712725|468990469|FG007|Overall Study|Withdrawal by Subject|2|||
130042454|NCT01736683|468114307|FG002|Overall Study|Adverse Event|2|||
130042455|NCT01736683|468114308|FG003|Overall Study|Adverse Event|3|||
130042456|NCT01736683|468114309|FG004|Overall Study|Adverse Event|2|||
130042457|NCT01736683|468114305|FG000|Overall Study|Withdrawal by Subject|0|||
130042458|NCT01736683|468114306|FG001|Overall Study|Withdrawal by Subject|0|||
130281113|NCT00712725|468990462|FG000|Overall Study|Lack of Qualifying Event|16|||
130281114|NCT00712725|468990463|FG001|Overall Study|Lack of Qualifying Event|2|||
130281115|NCT00712725|468990464|FG002|Overall Study|Lack of Qualifying Event|6|||
130042459|NCT01736683|468114307|FG002|Overall Study|Withdrawal by Subject|3|||
130042460|NCT01736683|468114308|FG003|Overall Study|Withdrawal by Subject|1|||
130042461|NCT01736683|468114309|FG004|Overall Study|Withdrawal by Subject|1|||
130042462|NCT01736683|468114305|FG000|Overall Study|Lack of Therapeutic Effect|7|||
130042463|NCT01736683|468114306|FG001|Overall Study|Lack of Therapeutic Effect|4|||
130042464|NCT01736683|468114307|FG002|Overall Study|Lack of Therapeutic Effect|13|||
130042465|NCT01736683|468114308|FG003|Overall Study|Lack of Therapeutic Effect|20|||
130042466|NCT01736683|468114309|FG004|Overall Study|Lack of Therapeutic Effect|1|||
130042467|NCT01736683|468114305|FG000|Overall Study|Progressive Disease|0|||
130042468|NCT01736683|468114306|FG001|Overall Study|Progressive Disease|0|||
130042469|NCT01736683|468114307|FG002|Overall Study|Progressive Disease|0|||
130042470|NCT01736683|468114308|FG003|Overall Study|Progressive Disease|1|||
130042471|NCT01736683|468114309|FG004|Overall Study|Progressive Disease|0|||
130042472|NCT01736683|468114305|FG000|Overall Study|Other|0|||
130042473|NCT01736683|468114306|FG001|Overall Study|Other|0|||
130042474|NCT01736683|468114307|FG002|Overall Study|Other|1|||
130042475|NCT01736683|468114308|FG003|Overall Study|Other|9|||
130042476|NCT01736683|468114309|FG004|Overall Study|Other|1|||
130042477|NCT03334214|468114310|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130042478|NCT03334214|468114311|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
130042479|NCT03334214|468114310|FG000|Overall Study|Withdrawal by Subject|0|||
130042480|NCT03334214|468114311|FG001|Overall Study|Withdrawal by Subject|1|||
130042481|NCT03334214|468114310|FG000|Overall Study|Other|1|||
130042482|NCT03334214|468114311|FG001|Overall Study|Other|0|||
130042483|NCT01588197|468114314|FG000|Overall Study|Lack of Efficacy|0|||
130042484|NCT01588197|468114315|FG001|Overall Study|Lack of Efficacy|1|||
130042485|NCT01588197|468114314|FG000|Overall Study|No MRI|1|||
130042486|NCT01588197|468114315|FG001|Overall Study|No MRI|0|||
130042487|NCT00474253|468114316|FG000|Overall Study|Withdrew consent|2|||
130042488|NCT00474253|468114317|FG001|Overall Study|Withdrew consent|0|||
130042489|NCT00474253|468114316|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
130042490|NCT00474253|468114317|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
130042491|NCT00474253|468114316|FG000|Overall Study|Lost to Follow-up|1|||
130042492|NCT00474253|468114317|FG001|Overall Study|Lost to Follow-up|0|||
130042493|NCT00474253|468114316|FG000|Overall Study|Discharged prior to study completion|0|||
130281116|NCT00712725|468990465|FG003|Overall Study|Lack of Qualifying Event|8|||
130281117|NCT00712725|468990466|FG004|Overall Study|Lack of Qualifying Event|11|||
130281118|NCT00712725|468990467|FG005|Overall Study|Lack of Qualifying Event|13|||
130281119|NCT00712725|468990468|FG006|Overall Study|Lack of Qualifying Event|11|||
130281120|NCT00712725|468990469|FG007|Overall Study|Lack of Qualifying Event|6|||
130281121|NCT00712725|468990462|FG000|Overall Study|Protocol Specified Criteria|3|||
130281122|NCT00712725|468990463|FG001|Overall Study|Protocol Specified Criteria|0|||
130281123|NCT00712725|468990464|FG002|Overall Study|Protocol Specified Criteria|1|||
130281124|NCT00712725|468990465|FG003|Overall Study|Protocol Specified Criteria|2|||
130281125|NCT00712725|468990466|FG004|Overall Study|Protocol Specified Criteria|1|||
130281126|NCT00712725|468990467|FG005|Overall Study|Protocol Specified Criteria|0|||
130281127|NCT00712725|468990468|FG006|Overall Study|Protocol Specified Criteria|2|||
130281128|NCT00712725|468990469|FG007|Overall Study|Protocol Specified Criteria|1|||
130281129|NCT03466099|468990470|FG000|Overall Study|Adverse Event|1|||
130281130|NCT03466099|468990471|FG001|Overall Study|Adverse Event|1|||
130281131|NCT03466099|468990472|FG002|Overall Study|Adverse Event|1|||
130281132|NCT03466099|468990470|FG000|Overall Study|Withdrawal by Subject|2|||
130281133|NCT03466099|468990471|FG001|Overall Study|Withdrawal by Subject|3|||
130281134|NCT03466099|468990472|FG002|Overall Study|Withdrawal by Subject|1|||
130281135|NCT03466099|468990470|FG000|Overall Study|Use of rescue medication|8|||
130042494|NCT00474253|468114317|FG001|Overall Study|Discharged prior to study completion|1|||
130042495|NCT03133481|468114318|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
130042496|NCT03133481|468114319|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
130042497|NCT00637728|468114330|FG000|Double-blind Phase|Adverse Event|1|||
130042498|NCT00637728|468114331|FG001|Double-blind Phase|Adverse Event|0|||
130042499|NCT00637728|468114332|FG002|Double-blind Phase|Adverse Event|0|||
130042500|NCT00637728|468114330|FG000|Double-blind Phase|Non-compliance|2|||
130042501|NCT00637728|468114331|FG001|Double-blind Phase|Non-compliance|0|||
130042502|NCT00637728|468114332|FG002|Double-blind Phase|Non-compliance|0|||
130042503|NCT00637728|468114330|FG000|Double-blind Phase|Study Discontinued|1|||
130042504|NCT00637728|468114331|FG001|Double-blind Phase|Study Discontinued|1|||
130042505|NCT00637728|468114332|FG002|Double-blind Phase|Study Discontinued|0|||
130042506|NCT00593112|468114335|FG000|Overall Study|Scan Anxiety|3|||
130042507|NCT00593112|468114336|FG001|Overall Study|Scan Anxiety|0|||
130281136|NCT03466099|468990471|FG001|Overall Study|Use of rescue medication|9|||
130281137|NCT03466099|468990472|FG002|Overall Study|Use of rescue medication|13|||
130281138|NCT03466099|468990470|FG000|Overall Study|Rescued without meeting criteria|4|||
130281139|NCT03466099|468990471|FG001|Overall Study|Rescued without meeting criteria|1|||
130281140|NCT03466099|468990472|FG002|Overall Study|Rescued without meeting criteria|1|||
130281141|NCT03466099|468990470|FG000|Overall Study|Subject compliance|2|||
130281142|NCT03466099|468990471|FG001|Overall Study|Subject compliance|0|||
130281143|NCT03466099|468990472|FG002|Overall Study|Subject compliance|0|||
130281144|NCT03466099|468990470|FG000|Overall Study|Worsening disease|0|||
130281145|NCT03466099|468990471|FG001|Overall Study|Worsening disease|0|||
130281146|NCT03466099|468990472|FG002|Overall Study|Worsening disease|1|||
130281147|NCT00613327|468990475|FG000|Overall Study|Adverse Event|38|||
130281148|NCT00613327|468990475|FG000|Overall Study|Lost to Follow-up|8|||
130281149|NCT00613327|468990475|FG000|Overall Study|Withdrawal by Subject|6|||
130281150|NCT00613327|468990475|FG000|Overall Study|Protocol Violation|2|||
130281151|NCT00613327|468990475|FG000|Overall Study|Other|47|||
130281152|NCT03832322|468990478|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
130281153|NCT03832322|468990479|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
130281154|NCT00404755|468990480|FG000|Phase I (Bupropion)|Adverse Event|3|||
130281155|NCT00404755|468990480|FG000|Phase I (Bupropion)|Other|1|||
130281156|NCT00404755|468990480|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
130281157|NCT00350870|468990481|FG000|Overall Study|Withdrawal by Subject|21|||
130281158|NCT00350870|468990482|FG001|Overall Study|Withdrawal by Subject|17|||
130281159|NCT00350870|468990483|FG002|Overall Study|Withdrawal by Subject|15|||
130281160|NCT00350870|468990484|FG003|Overall Study|Withdrawal by Subject|14|||
130281161|NCT00350870|468990481|FG000|Overall Study|Physician Decision|1|||
130281162|NCT00350870|468990482|FG001|Overall Study|Physician Decision|0|||
130281163|NCT00350870|468990483|FG002|Overall Study|Physician Decision|1|||
130281164|NCT00350870|468990484|FG003|Overall Study|Physician Decision|1|||
130281165|NCT03194568|468990485|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
130281166|NCT01453205|468990486|FG000|Overall Study|Lost to Follow-up|3|||
130281167|NCT01453205|468990487|FG001|Overall Study|Lost to Follow-up|0|||
130281168|NCT01453205|468990488|FG002|Overall Study|Lost to Follow-up|1|||
130281169|NCT01453205|468990486|FG000|Overall Study|Withdrawal by Subject|8|||
130281170|NCT01453205|468990487|FG001|Overall Study|Withdrawal by Subject|3|||
130281171|NCT01453205|468990488|FG002|Overall Study|Withdrawal by Subject|0|||
130281172|NCT01453205|468990486|FG000|Overall Study|Death|24|||
130281173|NCT01453205|468990487|FG001|Overall Study|Death|22|||
130281174|NCT01453205|468990488|FG002|Overall Study|Death|18|||
130281175|NCT01453205|468990486|FG000|Overall Study|Other|45|||
130281176|NCT01453205|468990487|FG001|Overall Study|Other|27|||
130281177|NCT01453205|468990488|FG002|Overall Study|Other|35|||
130281178|NCT00487942|468990496|FG000|Overall Study|Adverse Event|1|||
130281179|NCT00487942|468990497|FG001|Overall Study|Adverse Event|1|||
130281180|NCT00487942|468990498|FG002|Overall Study|Adverse Event|1|||
130281181|NCT00487942|468990499|FG003|Overall Study|Adverse Event|1|||
130281182|NCT00487942|468990496|FG000|Overall Study|Lost to Follow-up|1|||
130281183|NCT00487942|468990497|FG001|Overall Study|Lost to Follow-up|0|||
130281184|NCT00487942|468990498|FG002|Overall Study|Lost to Follow-up|0|||
130281185|NCT00487942|468990499|FG003|Overall Study|Lost to Follow-up|1|||
130281186|NCT00487942|468990496|FG000|Overall Study|Protocol Violation|1|||
130281187|NCT00487942|468990497|FG001|Overall Study|Protocol Violation|1|||
130281188|NCT00487942|468990498|FG002|Overall Study|Protocol Violation|0|||
130281189|NCT00487942|468990499|FG003|Overall Study|Protocol Violation|0|||
129887008|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
129887009|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130042508|NCT00593112|468114335|FG000|Overall Study|Abnormal Scan|1|||
130281190|NCT00487942|468990496|FG000|Overall Study|Withdrawal by Subject|0|||
130281191|NCT00487942|468990497|FG001|Overall Study|Withdrawal by Subject|1|||
130281192|NCT00487942|468990498|FG002|Overall Study|Withdrawal by Subject|2|||
130281193|NCT00487942|468990499|FG003|Overall Study|Withdrawal by Subject|0|||
130281194|NCT00082368|468990500|FG000|Overall Study|Not treated-pt had poor IV access|1|||
130281195|NCT03319953|468990503|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
130042509|NCT00593112|468114336|FG001|Overall Study|Abnormal Scan|0|||
130042510|NCT00593112|468114335|FG000|Overall Study|Unreadable Scan|1|||
130281196|NCT03319953|468990504|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130281197|NCT03319953|468990505|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130281198|NCT03319953|468990506|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
130281199|NCT03319953|468990503|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
130281200|NCT03319953|468990504|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
130281201|NCT03319953|468990505|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
130281202|NCT03319953|468990506|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
130281203|NCT00790868|468992453|FG000|Overall Study|Withdrawal by Subject|4|||
130281204|NCT00790868|468992454|FG001|Overall Study|Withdrawal by Subject|5|||
130281205|NCT00790868|468992453|FG000|Overall Study|Lost to Follow-up|2|||
130281206|NCT00790868|468992454|FG001|Overall Study|Lost to Follow-up|12|||
130281207|NCT01380535|468992455|FG000|Overall Study|Adverse Event|3|||
130281208|NCT01380535|468992456|FG001|Overall Study|Adverse Event|3|||
130281209|NCT01380535|468992455|FG000|Overall Study|Death|3|||
130281210|NCT01380535|468992456|FG001|Overall Study|Death|0|||
130281211|NCT01380535|468992455|FG000|Overall Study|Study site closed|0|||
130281212|NCT01380535|468992456|FG001|Overall Study|Study site closed|5|||
130281213|NCT01380535|468992455|FG000|Overall Study|Withdrawal by Subject|1|||
130281214|NCT01380535|468992456|FG001|Overall Study|Withdrawal by Subject|2|||
130281215|NCT01380535|468992455|FG000|Overall Study|Protocol Violation|0|||
130281216|NCT01380535|468992456|FG001|Overall Study|Protocol Violation|2|||
130281217|NCT01380535|468992455|FG000|Overall Study|Lack of Efficacy|0|||
130281218|NCT01380535|468992456|FG001|Overall Study|Lack of Efficacy|3|||
130281219|NCT04753658|468992462|FG000|Overall Study|Progressive disease|7|||
130281220|NCT04753658|468992462|FG000|Overall Study|Other|7|||
130281221|NCT04753658|468992462|FG000|Overall Study|Adverse Event|1|||
130281222|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
130281223|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
130281224|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
130281225|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
130281226|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
130281227|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
130281228|NCT00306293|468992463|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
130281229|NCT00306293|468992464|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
130281230|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
130281231|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
130281232|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
130281233|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
130281234|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
130281235|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
130281236|NCT00306293|468992463|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
130281237|NCT00306293|468992464|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
130281238|NCT00218634|468992465|FG000|Overall Study|Lost to Follow-up|8|||
130281239|NCT00218634|468992466|FG001|Overall Study|Lost to Follow-up|15|||
130281240|NCT05243745|468992467|FG000|Overall Study|Withdrawal by Subject|0|||
130281241|NCT05243745|468992468|FG001|Overall Study|Withdrawal by Subject|0|||
130281242|NCT05243745|468992469|FG002|Overall Study|Withdrawal by Subject|0|||
130281243|NCT05243745|468992470|FG003|Overall Study|Withdrawal by Subject|1|||
130281244|NCT05243745|468992467|FG000|Overall Study|Unable to Attend Visit 6|0|||
130281245|NCT05243745|468992468|FG001|Overall Study|Unable to Attend Visit 6|0|||
130281246|NCT05243745|468992469|FG002|Overall Study|Unable to Attend Visit 6|1|||
130281247|NCT05243745|468992470|FG003|Overall Study|Unable to Attend Visit 6|0|||
130281248|NCT00420004|468992481|FG000|Overall Study|Adverse Event|4|||
130281249|NCT00420004|468992482|FG001|Overall Study|Adverse Event|1|||
130281250|NCT00420004|468992483|FG002|Overall Study|Adverse Event|1|||
130281251|NCT00420004|468992481|FG000|Overall Study|Lack of Efficacy|5|||
130281252|NCT00420004|468992482|FG001|Overall Study|Lack of Efficacy|4|||
130281253|NCT00420004|468992483|FG002|Overall Study|Lack of Efficacy|1|||
130042511|NCT00593112|468114336|FG001|Overall Study|Unreadable Scan|0|||
130042512|NCT00593112|468114335|FG000|Overall Study|Withdrawal by Subject|5|||
130042513|NCT00593112|468114336|FG001|Overall Study|Withdrawal by Subject|0|||
130042514|NCT02723630|468114337|FG000|Intervention Period 1|Adverse Event|1|||
130042515|NCT02723630|468114338|FG001|Intervention Period 1|Adverse Event|0|||
130042516|NCT02723630|468114339|FG002|Intervention Period 1|Adverse Event|0|||
130042517|NCT02723630|468114340|FG003|Intervention Period 1|Adverse Event|0|||
130106185|NCT01614925|468349916|FG000|Overall Study|Protocol Violation|3|||
130281254|NCT00420004|468992481|FG000|Overall Study|Lost to Follow-up|31|||
130281255|NCT00420004|468992482|FG001|Overall Study|Lost to Follow-up|12|||
130281256|NCT00420004|468992483|FG002|Overall Study|Lost to Follow-up|10|||
130281257|NCT00420004|468992481|FG000|Overall Study|Entry Criteria Not Met|0|||
130281258|NCT00420004|468992482|FG001|Overall Study|Entry Criteria Not Met|1|||
130281259|NCT00420004|468992483|FG002|Overall Study|Entry Criteria Not Met|0|||
130281260|NCT00420004|468992481|FG000|Overall Study|Physician Decision|14|||
130281261|NCT00420004|468992482|FG001|Overall Study|Physician Decision|4|||
130281262|NCT00420004|468992483|FG002|Overall Study|Physician Decision|2|||
130281263|NCT00420004|468992481|FG000|Overall Study|Protocol Violation|5|||
130281264|NCT00420004|468992482|FG001|Overall Study|Protocol Violation|4|||
130281265|NCT00420004|468992483|FG002|Overall Study|Protocol Violation|3|||
130281266|NCT00420004|468992481|FG000|Overall Study|Withdrawal by Subject|67|||
130281267|NCT00420004|468992482|FG001|Overall Study|Withdrawal by Subject|42|||
130281268|NCT00420004|468992483|FG002|Overall Study|Withdrawal by Subject|14|||
130281269|NCT00420004|468992481|FG000|Overall Study|Sponsor Decision|3|||
130281270|NCT00420004|468992482|FG001|Overall Study|Sponsor Decision|3|||
130281271|NCT00420004|468992483|FG002|Overall Study|Sponsor Decision|1|||
130281272|NCT00591149|468992485|FG000|Overall Study|Adverse Event|4|||
130281273|NCT00591149|468992485|FG000|Overall Study|Withdrawal by Subject|1|||
130281274|NCT00470093|468992486|FG000|Overall Study|Adverse Event|2|||
130281275|NCT00664560|468992487|FG000|Overall Study|Adverse Event|19|||
130281276|NCT00664560|468992488|FG001|Overall Study|Adverse Event|16|||
130281277|NCT00664560|468992489|FG002|Overall Study|Adverse Event|7|||
130281278|NCT00664560|468992487|FG000|Overall Study|Withdrawal by Subject|9|||
130281279|NCT00664560|468992488|FG001|Overall Study|Withdrawal by Subject|13|||
130281280|NCT00664560|468992489|FG002|Overall Study|Withdrawal by Subject|7|||
130281281|NCT00664560|468992487|FG000|Overall Study|Lost to Follow-up|0|||
130281282|NCT00664560|468992488|FG001|Overall Study|Lost to Follow-up|2|||
130281283|NCT00664560|468992489|FG002|Overall Study|Lost to Follow-up|0|||
130281284|NCT00664560|468992487|FG000|Overall Study|Other|11|||
130281285|NCT00664560|468992488|FG001|Overall Study|Other|4|||
130281286|NCT00664560|468992489|FG002|Overall Study|Other|5|||
130281287|NCT02456636|468992490|FG000|Overall Study|Death|0|||
130281288|NCT02456636|468992491|FG001|Overall Study|Death|3|||
130281289|NCT02456636|468992492|FG002|Overall Study|Death|0|||
130281290|NCT02456636|468992490|FG000|Overall Study|Pregnancy|1|||
130281291|NCT02456636|468992491|FG001|Overall Study|Pregnancy|3|||
130281292|NCT02456636|468992492|FG002|Overall Study|Pregnancy|5|||
130281293|NCT02456636|468992490|FG000|Overall Study|Physician Decision|4|||
130281294|NCT02456636|468992491|FG001|Overall Study|Physician Decision|5|||
130281295|NCT02456636|468992492|FG002|Overall Study|Physician Decision|4|||
130281296|NCT02456636|468992490|FG000|Overall Study|Withdrawal by Subject|13|||
130042518|NCT02723630|468114341|FG004|Intervention Period 1|Adverse Event|0|||
130042519|NCT02723630|468114342|FG005|Intervention Period 1|Adverse Event|0|||
130042520|NCT02723630|468114337|FG000|Intervention Period 3|consumption of restricted item|0|||
130281297|NCT02456636|468992491|FG001|Overall Study|Withdrawal by Subject|14|||
130281298|NCT02456636|468992492|FG002|Overall Study|Withdrawal by Subject|16|||
130281299|NCT02456636|468992490|FG000|Overall Study|Lost to Follow-up|50|||
130281300|NCT02456636|468992491|FG001|Overall Study|Lost to Follow-up|44|||
130106186|NCT01614925|468349917|FG001|Overall Study|Protocol Violation|2|||
130281301|NCT02456636|468992492|FG002|Overall Study|Lost to Follow-up|50|||
130281302|NCT03350035|468992493|FG000|Overall Study|Lack of Efficacy|2|||
130281303|NCT03350035|468992494|FG001|Overall Study|Lack of Efficacy|0|||
130281304|NCT03350035|468992495|FG002|Overall Study|Lack of Efficacy|0|||
130281305|NCT03350035|468992493|FG000|Overall Study|Subject discharged to hospice|0|||
130106187|NCT02996448|468349920|FG000|Overall Study|Study terminated due to adverse effects|3|||
130106188|NCT00606801|468349921|FG000|Intervention|Protocol Violation|3|||
130106189|NCT00606801|468349922|FG001|Intervention|Protocol Violation|3|||
130106190|NCT01160198|468349925|FG000|Overall Study|Withdrawal by Subject|2|||
130106191|NCT01160198|468349926|FG001|Overall Study|Withdrawal by Subject|1|||
130106192|NCT01160198|468349927|FG002|Overall Study|Withdrawal by Subject|0|||
130106193|NCT01160198|468349925|FG000|Overall Study|Adverse Event|0|||
130106194|NCT01160198|468349926|FG001|Overall Study|Adverse Event|1|||
130281306|NCT03350035|468992494|FG001|Overall Study|Subject discharged to hospice|0|||
130281307|NCT03350035|468992495|FG002|Overall Study|Subject discharged to hospice|1|||
130281308|NCT01610557|468992496|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281309|NCT01610557|468992497|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
130281310|NCT01610557|468992498|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281311|NCT01610557|468992499|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281312|NCT01610557|468992500|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
130281313|NCT01610557|468992496|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281314|NCT01610557|468992497|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281315|NCT01610557|468992498|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281316|NCT01610557|468992499|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
130281317|NCT01610557|468992500|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
130281318|NCT02039219|468992501|FG000|Treatment|Withdrawal by Subject|1|||
130281319|NCT02039219|468992502|FG001|Treatment|Withdrawal by Subject|0|||
130281320|NCT02039219|468992501|FG000|Treatment|Adverse Event|0|||
130281321|NCT02039219|468992502|FG001|Treatment|Adverse Event|1|||
130281322|NCT02039219|468992501|FG000|Treatment|Physician Decision|1|||
130281323|NCT02039219|468992502|FG001|Treatment|Physician Decision|0|||
130281324|NCT02039219|468992501|FG000|Treatment|Lost to Follow-up|0|||
130281325|NCT02039219|468992502|FG001|Treatment|Lost to Follow-up|1|||
130281326|NCT02039219|468992501|FG000|Treatment|Protocol Violation|1|||
130281327|NCT02039219|468992502|FG001|Treatment|Protocol Violation|0|||
130281328|NCT02039219|468992501|FG000|Treatment|Death|1|||
130281329|NCT02039219|468992502|FG001|Treatment|Death|0|||
130281330|NCT02039219|468992501|FG000|Follow up|Adverse Event|0|||
130281331|NCT02039219|468992502|FG001|Follow up|Adverse Event|1|||
130281332|NCT02974855|468992503|FG000|Overall Study|Adverse Event|0|||
130281333|NCT02974855|468992504|FG001|Overall Study|Adverse Event|1|||
130281334|NCT02974855|468992505|FG002|Overall Study|Adverse Event|0|||
130281335|NCT02974855|468992506|FG003|Overall Study|Adverse Event|1|||
130281336|NCT00129701|468992507|FG000|Overall Study|Withdrawal by Subject|33|||
130281337|NCT03576066|468992508|FG000|Overall Study|Noncompliance with study drug|0|||
130281338|NCT03576066|468992509|FG001|Overall Study|Noncompliance with study drug|1|||
130281339|NCT02750345|468992510|FG000|Intervention 1|Adverse Event|0|||
130281340|NCT02750345|468992511|FG001|Intervention 1|Adverse Event|0|||
130281341|NCT02750345|468992512|FG002|Intervention 1|Adverse Event|0|||
130281342|NCT02750345|468992513|FG003|Intervention 1|Adverse Event|0|||
130281343|NCT02750345|468992514|FG004|Intervention 1|Adverse Event|1|||
130281344|NCT02750345|468992515|FG005|Intervention 1|Adverse Event|0|||
130281345|NCT00006164|468992516|FG000|Overall Study|Withdrew or lost to follow-up|70|||
130281346|NCT00006164|468992517|FG001|Overall Study|Withdrew or lost to follow-up|81|||
130281347|NCT00633074|468992520|FG000|Overall Study|Adverse Event|1|||
130281348|NCT00633074|468992521|FG001|Overall Study|Adverse Event|0|||
130281349|NCT00365105|468992522|FG000|Overall Study|Protocol Violation|5|||
130281350|NCT00365105|468992523|FG001|Overall Study|Protocol Violation|8|||
130281351|NCT00608023|468992524|FG000|Overall Study|Withdrawal by Subject|8|||
130281352|NCT00608023|468992525|FG001|Overall Study|Withdrawal by Subject|10|||
130281353|NCT00608023|468992526|FG002|Overall Study|Withdrawal by Subject|7|||
130281354|NCT00608023|468992524|FG000|Overall Study|Adverse Event|1|||
130281355|NCT00608023|468992525|FG001|Overall Study|Adverse Event|4|||
130106195|NCT01160198|468349927|FG002|Overall Study|Adverse Event|0|||
130281356|NCT00608023|468992526|FG002|Overall Study|Adverse Event|5|||
130281357|NCT00608023|468992524|FG000|Overall Study|Lost to Follow-up|2|||
130281358|NCT00608023|468992525|FG001|Overall Study|Lost to Follow-up|2|||
130281359|NCT00608023|468992526|FG002|Overall Study|Lost to Follow-up|1|||
130281360|NCT00608023|468992524|FG000|Overall Study|Protocol Violation|1|||
130281361|NCT00608023|468992525|FG001|Overall Study|Protocol Violation|3|||
130281362|NCT00608023|468992526|FG002|Overall Study|Protocol Violation|1|||
130281363|NCT00608023|468992524|FG000|Overall Study|Unknown reason|0|||
130281364|NCT00608023|468992525|FG001|Overall Study|Unknown reason|3|||
130106196|NCT01160198|468349925|FG000|Overall Study|Lost to Follow-up|0|||
130106197|NCT01160198|468349926|FG001|Overall Study|Lost to Follow-up|1|||
130106198|NCT01160198|468349927|FG002|Overall Study|Lost to Follow-up|0|||
130281365|NCT00608023|468992526|FG002|Overall Study|Unknown reason|0|||
130281366|NCT06422364|468992527|FG000|Overall Study|Withdrawn due to study closure|0|||
130281367|NCT06422364|468992528|FG001|Overall Study|Withdrawn due to study closure|2|||
130281368|NCT01463696|468992533|FG000|Overall Study|Adverse Event|0|||
130281369|NCT01463696|468992534|FG001|Overall Study|Adverse Event|1|||
130042521|NCT02723630|468114338|FG001|Intervention Period 3|consumption of restricted item|1|||
130042522|NCT02723630|468114339|FG002|Intervention Period 3|consumption of restricted item|0|||
130042523|NCT02723630|468114340|FG003|Intervention Period 3|consumption of restricted item|0|||
130281370|NCT01463696|468992535|FG002|Overall Study|Adverse Event|0|||
130281371|NCT01463696|468992536|FG003|Overall Study|Adverse Event|2|||
130281372|NCT01463696|468992537|FG004|Overall Study|Adverse Event|0|||
130281373|NCT01463696|468992538|FG005|Overall Study|Adverse Event|1|||
130281374|NCT01463696|468992539|FG006|Overall Study|Adverse Event|3|||
130281375|NCT01463696|468992540|FG007|Overall Study|Adverse Event|2|||
130281376|NCT01463696|468992533|FG000|Overall Study|Lost to Follow-up|0|||
130281377|NCT01463696|468992534|FG001|Overall Study|Lost to Follow-up|0|||
130281378|NCT01463696|468992535|FG002|Overall Study|Lost to Follow-up|1|||
130281379|NCT01463696|468992536|FG003|Overall Study|Lost to Follow-up|0|||
130281380|NCT01463696|468992537|FG004|Overall Study|Lost to Follow-up|0|||
130281381|NCT01463696|468992538|FG005|Overall Study|Lost to Follow-up|0|||
130281382|NCT01463696|468992539|FG006|Overall Study|Lost to Follow-up|0|||
130281383|NCT01463696|468992540|FG007|Overall Study|Lost to Follow-up|0|||
130281384|NCT01463696|468992533|FG000|Overall Study|Progressive Disease|0|||
130281385|NCT01463696|468992534|FG001|Overall Study|Progressive Disease|1|||
130281386|NCT01463696|468992535|FG002|Overall Study|Progressive Disease|0|||
130281387|NCT01463696|468992536|FG003|Overall Study|Progressive Disease|1|||
130281388|NCT01463696|468992537|FG004|Overall Study|Progressive Disease|0|||
130281389|NCT01463696|468992538|FG005|Overall Study|Progressive Disease|1|||
130281390|NCT01463696|468992539|FG006|Overall Study|Progressive Disease|4|||
130281391|NCT01463696|468992540|FG007|Overall Study|Progressive Disease|2|||
130281392|NCT01463696|468992533|FG000|Overall Study|Withdrawal by Subject|0|||
130281393|NCT01463696|468992534|FG001|Overall Study|Withdrawal by Subject|0|||
130281394|NCT01463696|468992535|FG002|Overall Study|Withdrawal by Subject|0|||
130281395|NCT01463696|468992536|FG003|Overall Study|Withdrawal by Subject|1|||
130281396|NCT01463696|468992537|FG004|Overall Study|Withdrawal by Subject|1|||
130281397|NCT01463696|468992538|FG005|Overall Study|Withdrawal by Subject|1|||
130281398|NCT01463696|468992539|FG006|Overall Study|Withdrawal by Subject|2|||
130281399|NCT01463696|468992540|FG007|Overall Study|Withdrawal by Subject|0|||
130281400|NCT01463696|468992533|FG000|Overall Study|Not Treated|0|||
130281401|NCT01463696|468992534|FG001|Overall Study|Not Treated|0|||
130281402|NCT01463696|468992535|FG002|Overall Study|Not Treated|0|||
130281403|NCT01463696|468992536|FG003|Overall Study|Not Treated|0|||
130281404|NCT01463696|468992537|FG004|Overall Study|Not Treated|0|||
130281405|NCT01463696|468992538|FG005|Overall Study|Not Treated|0|||
130281406|NCT01463696|468992539|FG006|Overall Study|Not Treated|1|||
130281407|NCT01463696|468992540|FG007|Overall Study|Not Treated|0|||
130281408|NCT03905265|468992542|FG000|Overall Study|Withdrawal by Subject|1|||
130281409|NCT03905265|468992543|FG001|Overall Study|Withdrawal by Subject|1|||
130281410|NCT03905265|468992544|FG002|Overall Study|Withdrawal by Subject|0|||
130281411|NCT03905265|468992545|FG003|Overall Study|Withdrawal by Subject|0|||
130281412|NCT01973387|468992549|FG000|Overall Study|Adverse Event|14|||
130281413|NCT01973387|468992550|FG001|Overall Study|Adverse Event|4|||
130281414|NCT01973387|468992549|FG000|Overall Study|Withdrawal by Subject|7|||
130281415|NCT01973387|468992550|FG001|Overall Study|Withdrawal by Subject|4|||
130281416|NCT01973387|468992549|FG000|Overall Study|Study terminated by sponsor|63|||
130281417|NCT01973387|468992550|FG001|Overall Study|Study terminated by sponsor|0|||
130281418|NCT01973387|468992549|FG000|Overall Study|Progressive disease or relapse|16|||
130281419|NCT01973387|468992550|FG001|Overall Study|Progressive disease or relapse|5|||
130281420|NCT01973387|468992549|FG000|Overall Study|Death|4|||
130281421|NCT01973387|468992550|FG001|Overall Study|Death|3|||
130281422|NCT01973387|468992549|FG000|Overall Study|Randomized, not treated|2|||
130281423|NCT01973387|468992550|FG001|Overall Study|Randomized, not treated|2|||
130281424|NCT03888235|468992559|FG000|Overall Study|Lost to Follow-up|1|||
130281425|NCT03888235|468992560|FG001|Overall Study|Lost to Follow-up|1|||
130281426|NCT03888235|468992561|FG002|Overall Study|Lost to Follow-up|0|||
130281427|NCT03525600|468992566|FG000|Overall Study|Adverse Event|9|||
130281428|NCT03525600|468992567|FG001|Overall Study|Adverse Event|6|||
130281429|NCT03525600|468992568|FG002|Overall Study|Adverse Event|5|||
130281430|NCT03525600|468992569|FG003|Overall Study|Adverse Event|3|||
130281431|NCT03525600|468992566|FG000|Overall Study|Lost to Follow-up|2|||
130281432|NCT03525600|468992567|FG001|Overall Study|Lost to Follow-up|4|||
130281433|NCT03525600|468992568|FG002|Overall Study|Lost to Follow-up|4|||
130281434|NCT03525600|468992569|FG003|Overall Study|Lost to Follow-up|0|||
130281435|NCT03525600|468992566|FG000|Overall Study|Physician Decision|1|||
130281436|NCT03525600|468992567|FG001|Overall Study|Physician Decision|0|||
130281437|NCT03525600|468992568|FG002|Overall Study|Physician Decision|2|||
130281438|NCT03525600|468992569|FG003|Overall Study|Physician Decision|0|||
130281439|NCT03525600|468992566|FG000|Overall Study|Consent withdrawal|36|||
130281440|NCT03525600|468992567|FG001|Overall Study|Consent withdrawal|20|||
130281441|NCT03525600|468992568|FG002|Overall Study|Consent withdrawal|6|||
130281442|NCT03525600|468992569|FG003|Overall Study|Consent withdrawal|13|||
130281443|NCT03525600|468992566|FG000|Overall Study|Death|7|||
130281444|NCT03525600|468992567|FG001|Overall Study|Death|6|||
130281445|NCT03525600|468992568|FG002|Overall Study|Death|4|||
130281446|NCT03525600|468992569|FG003|Overall Study|Death|3|||
130281447|NCT03525600|468992566|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
130281448|NCT03525600|468992567|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
130281449|NCT03525600|468992568|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
130042524|NCT02723630|468114341|FG004|Intervention Period 3|consumption of restricted item|0|||
130042525|NCT02723630|468114342|FG005|Intervention Period 3|consumption of restricted item|0|||
130042526|NCT01184989|468114343|FG000|Overall Study|Adverse Event|11|||
130042527|NCT01184989|468114343|FG000|Overall Study|Withdrawal by Subject|1|||
130042528|NCT03047213|468114344|FG000|Overall Study|Withdrawal by Subject|2|||
130281450|NCT03525600|468992569|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
130281451|NCT03525600|468992566|FG000|Overall Study|Other|0|||
130281452|NCT03525600|468992567|FG001|Overall Study|Other|1|||
130281453|NCT03525600|468992568|FG002|Overall Study|Other|0|||
130281454|NCT03525600|468992569|FG003|Overall Study|Other|0|||
130281455|NCT03703817|468992579|FG000|Overall Study|Not meeting eligibility criteria|7|||
130281456|NCT03703817|468992580|FG001|Overall Study|Not meeting eligibility criteria|4|||
130281457|NCT05248997|468992584|FG000|Overall Study|Lost to Follow-up|1|||
130281458|NCT05248997|468992585|FG001|Overall Study|Lost to Follow-up|1|||
130281459|NCT05248997|468992584|FG000|Overall Study|Randomized but not treated|32|||
130281460|NCT05248997|468992585|FG001|Overall Study|Randomized but not treated|25|||
130281461|NCT04262882|468992587|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
130281462|NCT04262882|468992588|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
130281463|NCT04262882|468992587|FG000|Overall Study|Lost to Follow-up|1|||
130281464|NCT04262882|468992588|FG001|Overall Study|Lost to Follow-up|0|||
130281465|NCT01301066|468992589|FG000|Overall Study|Lost to Follow-up|5|||
130281466|NCT01301066|468992590|FG001|Overall Study|Lost to Follow-up|11|||
130281467|NCT01301066|468992589|FG000|Overall Study|Protocol Violation|8|||
130281468|NCT01301066|468992590|FG001|Overall Study|Protocol Violation|7|||
130281469|NCT01301066|468992589|FG000|Overall Study|Withdrawal by Subject|4|||
130281470|NCT01301066|468992590|FG001|Overall Study|Withdrawal by Subject|9|||
130281471|NCT01301066|468992589|FG000|Overall Study|Adverse Event|6|||
130281472|NCT01301066|468992590|FG001|Overall Study|Adverse Event|6|||
130281473|NCT01301066|468992589|FG000|Overall Study|Sponsor Decision|2|||
130281474|NCT01301066|468992590|FG001|Overall Study|Sponsor Decision|1|||
130281475|NCT01301066|468992589|FG000|Overall Study|Physician Decision|0|||
130281476|NCT01301066|468992590|FG001|Overall Study|Physician Decision|1|||
130281477|NCT01301066|468992589|FG000|Overall Study|Other|2|||
130281478|NCT01301066|468992590|FG001|Overall Study|Other|0|||
130281479|NCT03268954|468992595|FG000|Overall Study|Ongoing|23|||
130281480|NCT03268954|468992596|FG001|Overall Study|Ongoing|31|||
130281481|NCT03268954|468992595|FG000|Overall Study|Adverse Event|53|||
130281482|NCT03268954|468992596|FG001|Overall Study|Adverse Event|62|||
130281483|NCT03268954|468992595|FG000|Overall Study|Withdrawal by Subject|25|||
130281484|NCT03268954|468992596|FG001|Overall Study|Withdrawal by Subject|16|||
130281485|NCT03268954|468992595|FG000|Overall Study|Progressive Disease|61|||
130281486|NCT03268954|468992596|FG001|Overall Study|Progressive Disease|48|||
130281487|NCT03268954|468992595|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
130281488|NCT03268954|468992596|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
130281489|NCT03268954|468992595|FG000|Overall Study|Reason not Specified|40|||
130281490|NCT03268954|468992596|FG001|Overall Study|Reason not Specified|40|||
130281491|NCT03255967|468992597|FG000|Overall Study|Adverse Event|26|||
130281492|NCT03255967|468992598|FG001|Overall Study|Adverse Event|30|||
130281493|NCT03255967|468992597|FG000|Overall Study|Withdrawal by Subject|6|||
130281494|NCT03255967|468992598|FG001|Overall Study|Withdrawal by Subject|6|||
130281495|NCT03255967|468992597|FG000|Overall Study|Schedule conflict|6|||
130281496|NCT03255967|468992598|FG001|Overall Study|Schedule conflict|4|||
130281497|NCT03255967|468992597|FG000|Overall Study|POA did not sign consent form|2|||
130281498|NCT03255967|468992598|FG001|Overall Study|POA did not sign consent form|0|||
130281499|NCT00778258|468992599|FG000|Overall Study|Adverse Event|1|||
130281500|NCT00778258|468992600|FG001|Overall Study|Adverse Event|0|||
130281501|NCT00778258|468992601|FG002|Overall Study|Adverse Event|0|||
130281502|NCT00778258|468992602|FG003|Overall Study|Adverse Event|0|||
130281503|NCT00778258|468992603|FG004|Overall Study|Adverse Event|0|||
130042529|NCT03047213|468114345|FG001|Overall Study|Withdrawal by Subject|0|||
130042530|NCT03047213|468114344|FG000|Overall Study|Adverse Event|2|||
130281504|NCT00778258|468992604|FG005|Overall Study|Adverse Event|1|||
130281505|NCT00778258|468992605|FG006|Overall Study|Adverse Event|0|||
130281506|NCT00778258|468992606|FG007|Overall Study|Adverse Event|0|||
130281507|NCT00778258|468992607|FG008|Overall Study|Adverse Event|0|||
130281508|NCT00778258|468992599|FG000|Overall Study|Lost to Follow-up|0|||
130281509|NCT00778258|468992600|FG001|Overall Study|Lost to Follow-up|0|||
130042531|NCT03047213|468114345|FG001|Overall Study|Adverse Event|0|||
130042532|NCT04407507|468114348|FG000|Overall Study|Withdrawal by Subject|0|||
130281510|NCT00778258|468992601|FG002|Overall Study|Lost to Follow-up|2|||
130281511|NCT00778258|468992602|FG003|Overall Study|Lost to Follow-up|0|||
130281512|NCT00778258|468992603|FG004|Overall Study|Lost to Follow-up|0|||
130281513|NCT00778258|468992604|FG005|Overall Study|Lost to Follow-up|3|||
130281514|NCT00778258|468992605|FG006|Overall Study|Lost to Follow-up|2|||
130281515|NCT00778258|468992606|FG007|Overall Study|Lost to Follow-up|2|||
130281516|NCT00778258|468992607|FG008|Overall Study|Lost to Follow-up|0|||
130281517|NCT00778258|468992599|FG000|Overall Study|Withdrawal by Subject|6|||
130281518|NCT00778258|468992600|FG001|Overall Study|Withdrawal by Subject|2|||
130281519|NCT00778258|468992601|FG002|Overall Study|Withdrawal by Subject|8|||
130281520|NCT00778258|468992602|FG003|Overall Study|Withdrawal by Subject|2|||
130281521|NCT00778258|468992603|FG004|Overall Study|Withdrawal by Subject|0|||
130281522|NCT00778258|468992604|FG005|Overall Study|Withdrawal by Subject|6|||
130281523|NCT00778258|468992605|FG006|Overall Study|Withdrawal by Subject|12|||
130281524|NCT00778258|468992606|FG007|Overall Study|Withdrawal by Subject|12|||
130281525|NCT00778258|468992607|FG008|Overall Study|Withdrawal by Subject|4|||
130281526|NCT00778258|468992599|FG000|Overall Study|New Contraindication|0|||
130281527|NCT00778258|468992600|FG001|Overall Study|New Contraindication|0|||
130281528|NCT00778258|468992601|FG002|Overall Study|New Contraindication|0|||
130281529|NCT00778258|468992602|FG003|Overall Study|New Contraindication|0|||
130281530|NCT00778258|468992603|FG004|Overall Study|New Contraindication|0|||
130281531|NCT00778258|468992604|FG005|Overall Study|New Contraindication|0|||
130281532|NCT00778258|468992605|FG006|Overall Study|New Contraindication|0|||
130281533|NCT00778258|468992606|FG007|Overall Study|New Contraindication|1|||
130281534|NCT00778258|468992607|FG008|Overall Study|New Contraindication|0|||
130281535|NCT00778258|468992599|FG000|Overall Study|Non-compliance|0|||
130281536|NCT00778258|468992600|FG001|Overall Study|Non-compliance|0|||
130281537|NCT00778258|468992601|FG002|Overall Study|Non-compliance|0|||
130281538|NCT00778258|468992602|FG003|Overall Study|Non-compliance|1|||
130281539|NCT00778258|468992603|FG004|Overall Study|Non-compliance|0|||
130281540|NCT00778258|468992604|FG005|Overall Study|Non-compliance|0|||
130281541|NCT00778258|468992605|FG006|Overall Study|Non-compliance|0|||
130281542|NCT00778258|468992606|FG007|Overall Study|Non-compliance|0|||
130281543|NCT00778258|468992607|FG008|Overall Study|Non-compliance|0|||
130281544|NCT00778258|468992599|FG000|Overall Study|Other|0|||
130281545|NCT00778258|468992600|FG001|Overall Study|Other|0|||
130281546|NCT00778258|468992601|FG002|Overall Study|Other|0|||
130281547|NCT00778258|468992602|FG003|Overall Study|Other|0|||
130281548|NCT00778258|468992603|FG004|Overall Study|Other|0|||
130281549|NCT00778258|468992604|FG005|Overall Study|Other|0|||
130281550|NCT00778258|468992605|FG006|Overall Study|Other|1|||
130281551|NCT00778258|468992606|FG007|Overall Study|Other|0|||
130281552|NCT00778258|468992607|FG008|Overall Study|Other|0|||
130281553|NCT01202188|468992611|FG000|Overall Study|Protocol deviation|14|||
130281554|NCT01202188|468992612|FG001|Overall Study|Protocol deviation|8|||
130281555|NCT01202188|468992613|FG002|Overall Study|Protocol deviation|12|||
130281556|NCT01202188|468992614|FG003|Overall Study|Protocol deviation|10|||
130281557|NCT01202188|468992615|FG004|Overall Study|Protocol deviation|11|||
130281558|NCT01202188|468992611|FG000|Overall Study|Subject withdrew consent|12|||
130281559|NCT01202188|468992612|FG001|Overall Study|Subject withdrew consent|13|||
130281560|NCT01202188|468992613|FG002|Overall Study|Subject withdrew consent|22|||
130281561|NCT01202188|468992614|FG003|Overall Study|Subject withdrew consent|11|||
130281562|NCT01202188|468992615|FG004|Overall Study|Subject withdrew consent|13|||
130281563|NCT01202188|468992611|FG000|Overall Study|Adverse Event|5|||
130281564|NCT01202188|468992612|FG001|Overall Study|Adverse Event|23|||
130281565|NCT01202188|468992613|FG002|Overall Study|Adverse Event|13|||
130281566|NCT01202188|468992614|FG003|Overall Study|Adverse Event|10|||
130281567|NCT01202188|468992615|FG004|Overall Study|Adverse Event|10|||
130281568|NCT01202188|468992611|FG000|Overall Study|Administrative problems|3|||
130281569|NCT01202188|468992612|FG001|Overall Study|Administrative problems|2|||
130281570|NCT01202188|468992613|FG002|Overall Study|Administrative problems|1|||
130281571|NCT01202188|468992614|FG003|Overall Study|Administrative problems|1|||
130281572|NCT01202188|468992615|FG004|Overall Study|Administrative problems|2|||
130281573|NCT01202188|468992611|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130281574|NCT01202188|468992612|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130281575|NCT01202188|468992613|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130281576|NCT01202188|468992614|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
130281577|NCT01202188|468992615|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
130281578|NCT01202188|468992611|FG000|Overall Study|Lost to Follow-up|1|||
130281579|NCT01202188|468992612|FG001|Overall Study|Lost to Follow-up|1|||
130281580|NCT01202188|468992613|FG002|Overall Study|Lost to Follow-up|0|||
130281581|NCT01202188|468992614|FG003|Overall Study|Lost to Follow-up|4|||
130281582|NCT01202188|468992615|FG004|Overall Study|Lost to Follow-up|1|||
130281583|NCT01202188|468992611|FG000|Overall Study|Death|1|||
130281584|NCT01202188|468992612|FG001|Overall Study|Death|1|||
130281585|NCT01202188|468992613|FG002|Overall Study|Death|1|||
130281586|NCT01202188|468992614|FG003|Overall Study|Death|1|||
130281587|NCT01202188|468992615|FG004|Overall Study|Death|0|||
130281588|NCT01202188|468992611|FG000|Overall Study|Abnormal test procedure result (s)|0|||
130281589|NCT01202188|468992612|FG001|Overall Study|Abnormal test procedure result (s)|0|||
130281590|NCT01202188|468992613|FG002|Overall Study|Abnormal test procedure result (s)|2|||
130281591|NCT01202188|468992614|FG003|Overall Study|Abnormal test procedure result (s)|0|||
130281592|NCT01202188|468992615|FG004|Overall Study|Abnormal test procedure result (s)|0|||
130281593|NCT00780143|468992622|FG000|Overall Study|Progressive disease|1|||
130281594|NCT00780143|468992622|FG000|Overall Study|Toxicity|1|||
130281595|NCT00780143|468992622|FG000|Overall Study|Adverse Event|1|||
130281596|NCT02438384|468992623|FG000|Overall Study|Lost to Follow-up|8|||
130281597|NCT02438384|468992624|FG001|Overall Study|Lost to Follow-up|6|||
130281598|NCT02438384|468992625|FG002|Overall Study|Lost to Follow-up|4|||
130281599|NCT02640625|468994449|FG000|Overall Study|Adverse Event|1|||
130281600|NCT00511433|468994450|FG000|Overall Study|Adverse Event|5|||
130281601|NCT00511433|468994451|FG001|Overall Study|Adverse Event|0|||
130281602|NCT00511433|468994450|FG000|Overall Study|Other Reason|1|||
130281603|NCT00511433|468994451|FG001|Overall Study|Other Reason|1|||
130281604|NCT01740089|468994452|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
130281605|NCT01740089|468994453|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
130281606|NCT01740089|468994454|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
130281607|NCT01740089|468994452|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
130281608|NCT01740089|468994453|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
130281609|NCT01740089|468994454|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
130281610|NCT01740089|468994452|FG000|After 12 Weeks|Lack of Efficacy|3|||
130281611|NCT01740089|468994453|FG001|After 12 Weeks|Lack of Efficacy|1|||
130281612|NCT01740089|468994454|FG002|After 12 Weeks|Lack of Efficacy|4|||
130281613|NCT01740089|468994452|FG000|After 12 Weeks|Adverse Event|2|||
130281614|NCT01740089|468994453|FG001|After 12 Weeks|Adverse Event|0|||
130281615|NCT01740089|468994454|FG002|After 12 Weeks|Adverse Event|5|||
130281616|NCT01740089|468994452|FG000|After 12 Weeks|Protocol Violation|1|||
130281617|NCT01740089|468994453|FG001|After 12 Weeks|Protocol Violation|1|||
130281618|NCT01740089|468994454|FG002|After 12 Weeks|Protocol Violation|1|||
130281619|NCT01740089|468994452|FG000|After 12 Weeks|Withdrawal by Subject|1|||
130281620|NCT01740089|468994453|FG001|After 12 Weeks|Withdrawal by Subject|1|||
130281621|NCT01740089|468994454|FG002|After 12 Weeks|Withdrawal by Subject|1|||
130281622|NCT01579565|468994457|FG000|Randomized|Adverse Event|1|||
130281623|NCT01579565|468994458|FG001|Randomized|Adverse Event|3|||
130281624|NCT01579565|468994457|FG000|Randomized|Withdrawal by Subject|3|||
130281625|NCT01579565|468994458|FG001|Randomized|Withdrawal by Subject|0|||
130281626|NCT01579565|468994457|FG000|Randomized|inadequate preoperative pupil dilation|0|||
130281627|NCT01579565|468994458|FG001|Randomized|inadequate preoperative pupil dilation|1|||
130281628|NCT01579565|468994457|FG000|Randomized|prohibited preoperative eating|1|||
130281629|NCT01579565|468994458|FG001|Randomized|prohibited preoperative eating|0|||
130281630|NCT01579565|468994457|FG000|Randomized|prohibited preoperative medication|0|||
130281631|NCT01579565|468994458|FG001|Randomized|prohibited preoperative medication|1|||
130281632|NCT01579565|468994457|FG000|Treated|Physician Decision|0|||
130281633|NCT01579565|468994458|FG001|Treated|Physician Decision|1|||
130281634|NCT01579565|468994457|FG000|Treated|Lost to Follow-up|2|||
130281635|NCT01579565|468994458|FG001|Treated|Lost to Follow-up|1|||
130281636|NCT01579565|468994457|FG000|Treated|declined to return for final visit|0|||
130281637|NCT01579565|468994458|FG001|Treated|declined to return for final visit|1|||
130281638|NCT02867813|468994462|FG000|Overall Study|Withdrawal by Subject|57|||
130281639|NCT02867813|468994463|FG001|Overall Study|Withdrawal by Subject|56|||
130281640|NCT02867813|468994462|FG000|Overall Study|Decision by Sponsor|7|||
130281641|NCT02867813|468994463|FG001|Overall Study|Decision by Sponsor|7|||
130281642|NCT02867813|468994462|FG000|Overall Study|Lost to Follow-up|91|||
130281643|NCT02867813|468994463|FG001|Overall Study|Lost to Follow-up|78|||
130281644|NCT02867813|468994462|FG000|Overall Study|Missing|2|||
130281645|NCT02867813|468994463|FG001|Overall Study|Missing|1|||
130281646|NCT02867813|468994462|FG000|Overall Study|Death|294|||
130281647|NCT02867813|468994463|FG001|Overall Study|Death|268|||
130281648|NCT01463111|468994467|FG000|Overall Study|Withdrawal by Subject|2|||
130281649|NCT01463111|468994467|FG000|Overall Study|Lost to Follow-up|5|||
130281650|NCT01463111|468994467|FG000|Overall Study|Physician Decision|2|||
130281651|NCT03285958|468994468|FG000|Overall Study|Lost to Follow-up|1|||
130281652|NCT03285958|468994469|FG001|Overall Study|Lost to Follow-up|1|||
130281653|NCT03285958|468994468|FG000|Overall Study|Withdrawal by Subject|1|||
130281654|NCT03285958|468994469|FG001|Overall Study|Withdrawal by Subject|0|||
130281655|NCT03285958|468994468|FG000|Overall Study|Not able to attend required orientation|3|||
130281656|NCT03285958|468994469|FG001|Overall Study|Not able to attend required orientation|0|||
130281657|NCT03116828|468994472|FG000|Overall Study|Adverse Event|1|||
130281658|NCT03116828|468994473|FG001|Overall Study|Adverse Event|10|||
130281659|NCT03116828|468994472|FG000|Overall Study|Withdrawal by Subject|4|||
130281660|NCT03116828|468994473|FG001|Overall Study|Withdrawal by Subject|8|||
130281661|NCT03116828|468994472|FG000|Overall Study|OTHER|3|||
130281662|NCT03116828|468994473|FG001|Overall Study|OTHER|3|||
130281663|NCT00882583|468994474|FG000|Overall Study|Physician Decision|1|||
130281664|NCT00882583|468994475|FG001|Overall Study|Physician Decision|0|||
130281665|NCT00882583|468994474|FG000|Overall Study|Adverse Event|0|||
130281666|NCT00882583|468994475|FG001|Overall Study|Adverse Event|1|||
130281667|NCT00176488|468994492|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
130281668|NCT01044745|468994493|FG000|Overall Study|Ineiligible|2|||
130281669|NCT01159171|468994498|FG000|Overall Study|Adverse Event|11|||
130281670|NCT01159171|468994498|FG000|Overall Study|Progression of Disease|28|||
130281671|NCT01159171|468994498|FG000|Overall Study|Protocol Violation|1|||
130281672|NCT01159171|468994498|FG000|Overall Study|Need for Surgery|5|||
130281673|NCT01159171|468994498|FG000|Overall Study|Medical Decision|4|||
130281674|NCT01159171|468994498|FG000|Overall Study|Death|1|||
130281675|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Adverse Event|76|||
130281676|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Adverse Event|0|||
130281677|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Adverse Event|0|||
130281678|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Death|3|||
130281679|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Death|0|||
130281680|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Death|0|||
130281681|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
130281682|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
130281683|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
130281684|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Physician Decision|9|||
130281685|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Physician Decision|0|||
130281686|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Physician Decision|0|||
130281687|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
130281688|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
130281689|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
130281690|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Disease progression|45|||
130281691|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Disease progression|0|||
130281692|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Disease progression|0|||
130281693|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
130281694|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
130281695|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
130281696|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
130281697|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
130281698|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
130281699|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
130281700|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
130281701|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
130281702|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
130281703|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
130281704|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
130281705|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
130281706|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
130281707|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
130281708|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
130281709|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
130281710|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
130281711|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
130281712|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
130281713|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
130281714|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
130281715|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
130281716|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
130281717|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
130281718|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
130281719|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
130281720|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Promotor request|1|||
130281721|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Promotor request|0|||
130281722|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Promotor request|0|||
130281723|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
130042533|NCT04407507|468114349|FG001|Overall Study|Withdrawal by Subject|1|||
130281724|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
130281725|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
130281726|NCT01461928|468994499|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
130281727|NCT01461928|468994500|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
130281728|NCT01461928|468994501|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
130281729|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Death|3|||
130281730|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Death|0|||
130281731|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Death|0|||
130281732|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
130281733|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
130281734|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
130281735|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
130281736|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
130281737|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
130281738|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Diseases progression|91|||
130281739|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Diseases progression|0|||
130281740|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Diseases progression|0|||
130281741|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Adverse Event|70|||
130281742|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Adverse Event|0|||
130281743|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Adverse Event|0|||
130281744|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Physician Decision|9|||
130281745|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Physician Decision|0|||
130281746|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Physician Decision|0|||
130281747|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
130281748|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
130281749|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
130281750|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
130281751|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
130281752|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
130281753|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
130281754|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
130281755|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
130281756|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Not compliant|1|||
130281757|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Not compliant|0|||
130281758|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Not compliant|0|||
130281759|NCT01461928|468994499|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
130281760|NCT01461928|468994500|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
130281761|NCT01461928|468994501|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
130281762|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Adverse Event|0|||
130281763|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Adverse Event|2|||
130281764|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Adverse Event|0|||
130281765|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Death|0|||
130281766|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Death|10|||
130281767|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Death|8|||
130281768|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Physician Decision|0|||
130281769|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Physician Decision|0|||
130281770|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Physician Decision|4|||
130281771|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
130281772|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
130281773|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
130281774|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Moved to another town|0|||
130281775|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Moved to another town|1|||
130281776|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Moved to another town|0|||
130281777|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Disease progression|0|||
130281778|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Disease progression|0|||
130281779|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Disease progression|3|||
130281780|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
130281781|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
130281782|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
130281783|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
130281784|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
130281785|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
130281786|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
130281787|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
130281788|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
130281789|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
130281790|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
130042534|NCT00847613|468114354|FG000|Overall Study|Ongoing at cut-off date|250|||
130042535|NCT00847613|468114355|FG001|Overall Study|Ongoing at cut-off date|265|||
130042536|NCT00847613|468114356|FG002|Overall Study|Ongoing at cut-off date|64|||
130042537|NCT00847613|468114357|FG003|Overall Study|Ongoing at cut-off date|64|||
130042538|NCT00847613|468114354|FG000|Overall Study|Death|1|||
130281791|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
130281792|NCT01461928|468994499|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
130281793|NCT01461928|468994500|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
130281794|NCT01461928|468994501|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
130281795|NCT02242435|468994510|FG000|Overall Study|Lost to Follow-up|3|||
130281796|NCT02242435|468994511|FG001|Overall Study|Lost to Follow-up|4|||
130281797|NCT02242435|468994510|FG000|Overall Study|Adverse Event|3|||
130281798|NCT02242435|468994511|FG001|Overall Study|Adverse Event|2|||
130281799|NCT02242435|468994510|FG000|Overall Study|Withdrawal by Subject|13|||
130281800|NCT02242435|468994511|FG001|Overall Study|Withdrawal by Subject|8|||
130281801|NCT02242435|468994510|FG000|Overall Study|Death|0|||
130281802|NCT02242435|468994511|FG001|Overall Study|Death|1|||
130281803|NCT02242435|468994510|FG000|Overall Study|Protocol Violation|1|||
130281804|NCT02242435|468994511|FG001|Overall Study|Protocol Violation|0|||
130281805|NCT02242435|468994510|FG000|Overall Study|Physician Decision|0|||
130281806|NCT02242435|468994511|FG001|Overall Study|Physician Decision|1|||
130281807|NCT03895086|468994514|FG000|Overall Study|Early termination study|1|||
130281808|NCT03895086|468994515|FG001|Overall Study|Early termination study|0|||
130281809|NCT01089413|468994519|FG000|Overall Study|Lost to Follow-up|1|||
130281810|NCT01089413|468994519|FG000|Overall Study|Progressive Disease|93|||
130281811|NCT01089413|468994519|FG000|Overall Study|Participant Withdrew Consent|1|||
130281812|NCT01089413|468994519|FG000|Overall Study|Unacceptable Toxicity|12|||
130281813|NCT01089413|468994519|FG000|Overall Study|Death|10|||
130281814|NCT01089413|468994519|FG000|Overall Study|Metastasectomy|13|||
130281815|NCT01089413|468994519|FG000|Overall Study|Other|71|||
130281816|NCT02513485|468994523|FG000|Overall Study|Adverse Event|1|||
130281817|NCT02513485|468994524|FG001|Overall Study|Adverse Event|0|||
130281818|NCT02526524|468994531|FG000|Overall Study|Withdrawal by Subject|3|||
130281819|NCT02526524|468994532|FG001|Overall Study|Withdrawal by Subject|3|||
130281820|NCT02526524|468994533|FG002|Overall Study|Withdrawal by Subject|6|||
130281821|NCT02526524|468994534|FG003|Overall Study|Withdrawal by Subject|1|||
130281822|NCT02526524|468994535|FG004|Overall Study|Withdrawal by Subject|9|||
130281823|NCT02526524|468994536|FG005|Overall Study|Withdrawal by Subject|5|||
130281824|NCT02526524|468994531|FG000|Overall Study|Adverse Event|3|||
130281825|NCT02526524|468994532|FG001|Overall Study|Adverse Event|2|||
130281826|NCT02526524|468994533|FG002|Overall Study|Adverse Event|4|||
130281827|NCT02526524|468994534|FG003|Overall Study|Adverse Event|2|||
130281828|NCT02526524|468994535|FG004|Overall Study|Adverse Event|6|||
130281829|NCT02526524|468994536|FG005|Overall Study|Adverse Event|8|||
130281830|NCT02526524|468994531|FG000|Overall Study|Lost to Follow-up|2|||
130281831|NCT02526524|468994532|FG001|Overall Study|Lost to Follow-up|3|||
130281832|NCT02526524|468994533|FG002|Overall Study|Lost to Follow-up|8|||
130281833|NCT02526524|468994534|FG003|Overall Study|Lost to Follow-up|1|||
130281834|NCT02526524|468994535|FG004|Overall Study|Lost to Follow-up|2|||
130281835|NCT02526524|468994536|FG005|Overall Study|Lost to Follow-up|5|||
130281836|NCT02526524|468994531|FG000|Overall Study|Protocol Violation|3|||
130281837|NCT02526524|468994532|FG001|Overall Study|Protocol Violation|1|||
130281838|NCT02526524|468994533|FG002|Overall Study|Protocol Violation|5|||
130281839|NCT02526524|468994534|FG003|Overall Study|Protocol Violation|3|||
130281840|NCT02526524|468994535|FG004|Overall Study|Protocol Violation|4|||
130281841|NCT02526524|468994536|FG005|Overall Study|Protocol Violation|3|||
130281842|NCT02526524|468994531|FG000|Overall Study|Loss of Glucose Control|0|||
130281843|NCT02526524|468994532|FG001|Overall Study|Loss of Glucose Control|0|||
130281844|NCT02526524|468994533|FG002|Overall Study|Loss of Glucose Control|3|||
130281845|NCT02526524|468994534|FG003|Overall Study|Loss of Glucose Control|0|||
130281846|NCT02526524|468994535|FG004|Overall Study|Loss of Glucose Control|2|||
130281847|NCT02526524|468994536|FG005|Overall Study|Loss of Glucose Control|0|||
130281848|NCT02526524|468994531|FG000|Overall Study|Physician Decision|0|||
130042539|NCT00847613|468114355|FG001|Overall Study|Death|1|||
130042540|NCT00847613|468114356|FG002|Overall Study|Death|0|||
130042541|NCT00847613|468114357|FG003|Overall Study|Death|0|||
130281849|NCT02526524|468994532|FG001|Overall Study|Physician Decision|0|||
130281850|NCT02526524|468994533|FG002|Overall Study|Physician Decision|0|||
130281851|NCT02526524|468994534|FG003|Overall Study|Physician Decision|0|||
130281852|NCT02526524|468994535|FG004|Overall Study|Physician Decision|1|||
130042542|NCT00847613|468114354|FG000|Overall Study|Adverse Event|36|||
130042543|NCT00847613|468114355|FG001|Overall Study|Adverse Event|26|||
130281853|NCT02526524|468994536|FG005|Overall Study|Physician Decision|0|||
130281854|NCT02526524|468994531|FG000|Overall Study|Sponsor Decision|1|||
130042544|NCT00847613|468114356|FG002|Overall Study|Adverse Event|5|||
130042545|NCT00847613|468114357|FG003|Overall Study|Adverse Event|6|||
130042546|NCT00847613|468114354|FG000|Overall Study|Lack of Efficacy|7|||
130042547|NCT00847613|468114355|FG001|Overall Study|Lack of Efficacy|3|||
130042548|NCT00847613|468114356|FG002|Overall Study|Lack of Efficacy|3|||
130042549|NCT00847613|468114357|FG003|Overall Study|Lack of Efficacy|1|||
130042550|NCT00847613|468114354|FG000|Overall Study|Study terminated by Sponsor|1|||
130042551|NCT00847613|468114355|FG001|Overall Study|Study terminated by Sponsor|0|||
130042552|NCT00847613|468114356|FG002|Overall Study|Study terminated by Sponsor|2|||
130042553|NCT00847613|468114357|FG003|Overall Study|Study terminated by Sponsor|1|||
130042554|NCT00847613|468114354|FG000|Overall Study|Lost to Follow-up|5|||
130042555|NCT00847613|468114355|FG001|Overall Study|Lost to Follow-up|0|||
130042556|NCT00847613|468114356|FG002|Overall Study|Lost to Follow-up|0|||
130042557|NCT00847613|468114357|FG003|Overall Study|Lost to Follow-up|3|||
130042558|NCT00847613|468114354|FG000|Overall Study|Protocol Violation|6|||
130042559|NCT00847613|468114355|FG001|Overall Study|Protocol Violation|6|||
130042560|NCT00847613|468114356|FG002|Overall Study|Protocol Violation|3|||
130042561|NCT00847613|468114357|FG003|Overall Study|Protocol Violation|1|||
130042562|NCT00847613|468114354|FG000|Overall Study|Pregnancy|1|||
130042563|NCT00847613|468114355|FG001|Overall Study|Pregnancy|1|||
130042564|NCT00847613|468114356|FG002|Overall Study|Pregnancy|0|||
130042565|NCT00847613|468114357|FG003|Overall Study|Pregnancy|0|||
130042566|NCT00847613|468114354|FG000|Overall Study|Site closure|1|||
130042567|NCT00847613|468114355|FG001|Overall Study|Site closure|0|||
130042568|NCT00847613|468114356|FG002|Overall Study|Site closure|0|||
130042569|NCT00847613|468114357|FG003|Overall Study|Site closure|1|||
130042570|NCT00847613|468114354|FG000|Overall Study|Withdrawal by Subject|8|||
130042571|NCT00847613|468114355|FG001|Overall Study|Withdrawal by Subject|11|||
130042572|NCT00847613|468114356|FG002|Overall Study|Withdrawal by Subject|2|||
130042573|NCT00847613|468114357|FG003|Overall Study|Withdrawal by Subject|2|||
130042574|NCT00847613|468114354|FG000|Overall Study|Participant moved|4|||
130042575|NCT00847613|468114355|FG001|Overall Study|Participant moved|1|||
130042576|NCT00847613|468114356|FG002|Overall Study|Participant moved|0|||
130042577|NCT00847613|468114357|FG003|Overall Study|Participant moved|0|||
130042578|NCT00847613|468114354|FG000|Overall Study|Sponsor request|0|||
130042579|NCT00847613|468114355|FG001|Overall Study|Sponsor request|1|||
130042580|NCT00847613|468114356|FG002|Overall Study|Sponsor request|0|||
130042581|NCT00847613|468114357|FG003|Overall Study|Sponsor request|0|||
130042582|NCT00847613|468114354|FG000|Overall Study|Randomized, but not treated|0|||
130042583|NCT00847613|468114355|FG001|Overall Study|Randomized, but not treated|3|||
130042584|NCT00847613|468114356|FG002|Overall Study|Randomized, but not treated|0|||
130042585|NCT00847613|468114357|FG003|Overall Study|Randomized, but not treated|0|||
130281855|NCT02526524|468994532|FG001|Overall Study|Sponsor Decision|0|||
130281856|NCT02526524|468994533|FG002|Overall Study|Sponsor Decision|0|||
130281857|NCT02526524|468994534|FG003|Overall Study|Sponsor Decision|0|||
130281858|NCT02526524|468994535|FG004|Overall Study|Sponsor Decision|0|||
130281859|NCT02526524|468994536|FG005|Overall Study|Sponsor Decision|0|||
130281860|NCT05312632|468994540|FG000|Overall Study|Adverse Event|12|||
130281861|NCT05312632|468994540|FG000|Overall Study|Withdrawal by Subject|10|||
130281862|NCT05312632|468994540|FG000|Overall Study|Lack of Efficacy|4|||
130281863|NCT05312632|468994540|FG000|Overall Study|Non-compliance with study procedures|9|||
130281864|NCT05312632|468994540|FG000|Overall Study|Other|4|||
130281865|NCT02379221|468994541|FG000|Overall Study|Lost to Follow-up|1|||
130281866|NCT00519376|468994544|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281867|NCT00519376|468994545|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281868|NCT00519376|468994546|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130042586|NCT00847613|468114354|FG000|Overall Study|Other|1|||
130042587|NCT00847613|468114355|FG001|Overall Study|Other|1|||
130042588|NCT00847613|468114356|FG002|Overall Study|Other|2|||
130042589|NCT00847613|468114357|FG003|Overall Study|Other|0|||
130281869|NCT00519376|468994547|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281870|NCT00519376|468994548|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281871|NCT00519376|468994549|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281872|NCT00519376|468994550|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281873|NCT00519376|468994551|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281874|NCT00519376|468994552|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130042590|NCT00754390|468114358|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
130042591|NCT00754390|468114358|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
130042592|NCT00754390|468114358|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
130042593|NCT00754390|468114358|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
130042594|NCT01009294|468114359|FG000|Overall Study|Study discontinued by Sponsor|6|||
130042595|NCT04332419|468114360|FG000|Overall Study|Withdrawal by Subject|1|||
130042596|NCT04222725|468114363|FG000|Overall Study|Adverse Event|0|||
130042597|NCT04222725|468114364|FG001|Overall Study|Adverse Event|1|||
130042598|NCT04222725|468114365|FG002|Overall Study|Adverse Event|0|||
130042599|NCT04222725|468114366|FG003|Overall Study|Adverse Event|0|||
130042600|NCT00658333|468114367|FG000|Overall Study|Adverse Event|2|||
130042601|NCT00658333|468114368|FG001|Overall Study|Adverse Event|1|||
130281875|NCT00519376|468994553|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281876|NCT00519376|468994554|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281877|NCT00519376|468994555|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281878|NCT00519376|468994556|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
130281879|NCT00519376|468994557|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281880|NCT00519376|468994558|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281881|NCT00519376|468994559|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
130281882|NCT00519376|468994544|FG000|Treatment Period 4|Lost to Follow-up|0|||
130281883|NCT00519376|468994545|FG001|Treatment Period 4|Lost to Follow-up|0|||
130281884|NCT00519376|468994546|FG002|Treatment Period 4|Lost to Follow-up|1|||
130281885|NCT00519376|468994547|FG003|Treatment Period 4|Lost to Follow-up|0|||
130281886|NCT00519376|468994548|FG004|Treatment Period 4|Lost to Follow-up|0|||
130281887|NCT00519376|468994549|FG005|Treatment Period 4|Lost to Follow-up|0|||
130281888|NCT00519376|468994550|FG006|Treatment Period 4|Lost to Follow-up|0|||
130281889|NCT00519376|468994551|FG007|Treatment Period 4|Lost to Follow-up|0|||
130281890|NCT00519376|468994552|FG008|Treatment Period 4|Lost to Follow-up|0|||
130281891|NCT00519376|468994553|FG009|Treatment Period 4|Lost to Follow-up|0|||
130281892|NCT00519376|468994554|FG010|Treatment Period 4|Lost to Follow-up|0|||
130281893|NCT00519376|468994555|FG011|Treatment Period 4|Lost to Follow-up|0|||
130281894|NCT00519376|468994556|FG012|Treatment Period 4|Lost to Follow-up|0|||
130281895|NCT00519376|468994557|FG013|Treatment Period 4|Lost to Follow-up|0|||
130281896|NCT00519376|468994558|FG014|Treatment Period 4|Lost to Follow-up|0|||
130281897|NCT00519376|468994559|FG015|Treatment Period 4|Lost to Follow-up|0|||
130281898|NCT02650128|468994560|FG000|Overall Study|Death|2|||
130281899|NCT01801436|468994574|FG000|Overall Study|Withdrawal by Subject|3|||
130281900|NCT01801436|468994574|FG000|Overall Study|Adverse Event|2|||
130281901|NCT01801436|468994574|FG000|Overall Study|Progressive disease|4|||
130281902|NCT01885208|468994575|FG000|Overall Study|Unclassified|32|||
130281903|NCT01885208|468994576|FG001|Overall Study|Unclassified|38|||
130281904|NCT01498575|468994577|FG000|Overall Sample|Withdrawal by Subject|60|||
130281905|NCT01498575|468994578|FG001|Overall Sample|Withdrawal by Subject|14|||
130281906|NCT01498575|468994577|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
130281907|NCT01498575|468994578|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
130281908|NCT01498575|468994577|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
130281909|NCT01498575|468994578|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
130281910|NCT01126437|468994584|FG000|Overall Study|Not treated|11|||
130281911|NCT01126437|468994585|FG001|Overall Study|Not treated|18|||
130042602|NCT00828451|468114371|FG000|Overall Study|Death|2|||
130042603|NCT00828451|468114371|FG000|Overall Study|Lack of intravenous line|7|||
130281912|NCT01126437|468994586|FG002|Overall Study|Not treated|19|||
130281913|NCT01126437|468994584|FG000|Overall Study|Sites with data irregularities/fraud|6|||
130281914|NCT01126437|468994585|FG001|Overall Study|Sites with data irregularities/fraud|6|||
130281915|NCT01126437|468994586|FG002|Overall Study|Sites with data irregularities/fraud|7|||
130281916|NCT01126437|468994584|FG000|Overall Study|Adverse Event|602|||
130281917|NCT01126437|468994585|FG001|Overall Study|Adverse Event|606|||
130281918|NCT01126437|468994586|FG002|Overall Study|Adverse Event|635|||
130281919|NCT01126437|468994584|FG000|Overall Study|Lack of Efficacy|65|||
130281920|NCT01126437|468994585|FG001|Overall Study|Lack of Efficacy|60|||
130281921|NCT01126437|468994586|FG002|Overall Study|Lack of Efficacy|59|||
130281922|NCT01126437|468994584|FG000|Overall Study|Protocol Violation|64|||
130281923|NCT01126437|468994585|FG001|Overall Study|Protocol Violation|66|||
130281924|NCT01126437|468994586|FG002|Overall Study|Protocol Violation|41|||
130281925|NCT01126437|468994584|FG000|Overall Study|Lost to Follow-up|52|||
130281926|NCT01126437|468994585|FG001|Overall Study|Lost to Follow-up|63|||
130281927|NCT01126437|468994586|FG002|Overall Study|Lost to Follow-up|55|||
130281928|NCT01126437|468994584|FG000|Overall Study|Withdrawal by Subject|331|||
130281929|NCT01126437|468994585|FG001|Overall Study|Withdrawal by Subject|335|||
130281930|NCT01126437|468994586|FG002|Overall Study|Withdrawal by Subject|319|||
130281931|NCT01126437|468994584|FG000|Overall Study|Other reason not specified|210|||
130281932|NCT01126437|468994585|FG001|Overall Study|Other reason not specified|176|||
130281933|NCT01126437|468994586|FG002|Overall Study|Other reason not specified|178|||
130281934|NCT01972308|468994593|FG000|Overall Study|Withdrawal by Subject|0|||
130281935|NCT01972308|468994594|FG001|Overall Study|Withdrawal by Subject|1|||
130281936|NCT01972308|468994593|FG000|Overall Study|Lost to Follow-up|4|||
130281937|NCT01972308|468994594|FG001|Overall Study|Lost to Follow-up|6|||
130281938|NCT01972308|468994593|FG000|Overall Study|Death|4|||
130281939|NCT01972308|468994594|FG001|Overall Study|Death|1|||
130281940|NCT01846663|468994599|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
130281941|NCT01846663|468994600|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
130281942|NCT01846663|468994599|FG000|Overall Study|Withdrawal by Subject|1|||
130281943|NCT01846663|468994600|FG001|Overall Study|Withdrawal by Subject|0|||
130281944|NCT01846663|468994599|FG000|Overall Study|Adverse Event|1|||
130281945|NCT01846663|468994600|FG001|Overall Study|Adverse Event|2|||
130281946|NCT01562314|468994601|FG000|Overall Study|Adverse Event|10|||
130281947|NCT01562314|468994602|FG001|Overall Study|Adverse Event|5|||
130281948|NCT01562314|468994601|FG000|Overall Study|Met Withdrawal Criteria|3|||
130281949|NCT01562314|468994602|FG001|Overall Study|Met Withdrawal Criteria|2|||
130281950|NCT01562314|468994601|FG000|Overall Study|Withdrawal by Subject|0|||
130281951|NCT01562314|468994602|FG001|Overall Study|Withdrawal by Subject|1|||
130281952|NCT02851797|468994603|FG000|Overall Study|Withdrawal by Subject|4|||
130281953|NCT02851797|468994604|FG001|Overall Study|Withdrawal by Subject|2|||
130281954|NCT02851797|468994603|FG000|Overall Study|Adverse Event|3|||
130281955|NCT02851797|468994604|FG001|Overall Study|Adverse Event|0|||
130281956|NCT03655054|468994605|FG000|Overall Study|Lost to Follow-up|1|||
130281957|NCT00813865|468994609|FG000|Overall Study|Failure to Respond|3|||
130281958|NCT00813865|468994609|FG000|Overall Study|Lost to Follow-up|3|||
130281959|NCT00813865|468994609|FG000|Overall Study|Withdrawal by Subject|1|||
130281960|NCT00543803|468994610|FG000|Overall Study|Adverse Event|14|||
130281961|NCT00543803|468994610|FG000|Overall Study|Lack of Efficacy|22|||
130281962|NCT00543803|468994610|FG000|Overall Study|Lost to Follow-up|20|||
130281963|NCT00543803|468994610|FG000|Overall Study|Other|86|||
130281964|NCT02256384|468994626|FG000|Overall Study|Withdrawal by Subject|12|||
130281965|NCT02256384|468994626|FG000|Overall Study|Equipment not capturing data|2|||
130281966|NCT04295681|468994628|FG000|Overall Study|Eligibility error|1|||
130281967|NCT04295681|468994629|FG001|Overall Study|Eligibility error|3|||
130281968|NCT03070223|468994641|FG000|Overall Study|Lost to Follow-up|34|||
130281969|NCT03070223|468994642|FG001|Overall Study|Lost to Follow-up|27|||
130281970|NCT03070223|468994641|FG000|Overall Study|Withdrawal by Subject|12|||
130281971|NCT03070223|468994642|FG001|Overall Study|Withdrawal by Subject|22|||
130281972|NCT03070223|468994641|FG000|Overall Study|Protocol Violation|0|||
130281973|NCT03070223|468994642|FG001|Overall Study|Protocol Violation|1|||
130281974|NCT03219034|468994643|FG000|Overall Study|Lost to Follow-up|9|||
130281975|NCT03219034|468994644|FG001|Overall Study|Lost to Follow-up|13|||
130281976|NCT03219034|468994643|FG000|Overall Study|Additional dental work needed|1|||
130281977|NCT03219034|468994644|FG001|Overall Study|Additional dental work needed|0|||
130281978|NCT03219034|468994643|FG000|Overall Study|UPPP Surgery|1|||
130281979|NCT03219034|468994644|FG001|Overall Study|UPPP Surgery|0|||
130281980|NCT03219034|468994643|FG000|Overall Study|Dental sensitivity|0|||
130281981|NCT03219034|468994644|FG001|Overall Study|Dental sensitivity|1|||
130281982|NCT03219034|468994643|FG000|Overall Study|Death in family|0|||
130281983|NCT03219034|468994644|FG001|Overall Study|Death in family|1|||
130281984|NCT02438683|468994645|FG000|Overall Study|Adverse Event|1|||
130042604|NCT00828451|468114371|FG000|Overall Study|Withdrawal by Subject|1|||
130281985|NCT02438683|468994646|FG001|Overall Study|Adverse Event|0|||
130281986|NCT02438683|468994647|FG002|Overall Study|Adverse Event|0|||
130281987|NCT02438683|468994648|FG003|Overall Study|Adverse Event|0|||
130281988|NCT02438683|468994649|FG004|Overall Study|Adverse Event|0|||
130281989|NCT02438683|468994650|FG005|Overall Study|Adverse Event|0|||
130281990|NCT03315793|468994651|FG000|Overall Study|Adverse Event|4|||
130281991|NCT03315793|468994652|FG001|Overall Study|Adverse Event|2|||
130281992|NCT03315793|468994651|FG000|Overall Study|Protocol Deviation|1|||
130281993|NCT03315793|468994652|FG001|Overall Study|Protocol Deviation|0|||
130281994|NCT03315793|468994651|FG000|Overall Study|Difficult for regular visit|0|||
130281995|NCT03315793|468994652|FG001|Overall Study|Difficult for regular visit|1|||
130281996|NCT01952665|468996513|FG000|Overall Study|Physician Decision|3|||
130281997|NCT01952665|468996514|FG001|Overall Study|Physician Decision|2|||
130281998|NCT01952665|468996513|FG000|Overall Study|Lost to Follow-up|1|||
130281999|NCT01952665|468996514|FG001|Overall Study|Lost to Follow-up|2|||
130282000|NCT01952665|468996513|FG000|Overall Study|Adverse Event|2|||
130282001|NCT01952665|468996514|FG001|Overall Study|Adverse Event|1|||
130282002|NCT01952665|468996513|FG000|Overall Study|Protocol Violation|0|||
130282003|NCT01952665|468996514|FG001|Overall Study|Protocol Violation|1|||
130282004|NCT01537081|468996515|FG000|Overall Study|Adverse Event|5|||
130282005|NCT01537081|468996516|FG001|Overall Study|Adverse Event|2|||
130282006|NCT01537081|468996517|FG002|Overall Study|Adverse Event|2|||
130282007|NCT01537081|468996515|FG000|Overall Study|Lack of Efficacy|2|||
130282008|NCT01537081|468996516|FG001|Overall Study|Lack of Efficacy|1|||
130282009|NCT01537081|468996517|FG002|Overall Study|Lack of Efficacy|0|||
130282010|NCT01537081|468996515|FG000|Overall Study|Lost to Follow-up|17|||
130282011|NCT01537081|468996516|FG001|Overall Study|Lost to Follow-up|15|||
130282012|NCT01537081|468996517|FG002|Overall Study|Lost to Follow-up|9|||
130282013|NCT01537081|468996515|FG000|Overall Study|Protocol Violation|3|||
130282014|NCT01537081|468996516|FG001|Overall Study|Protocol Violation|2|||
130282015|NCT01537081|468996517|FG002|Overall Study|Protocol Violation|2|||
130282016|NCT01537081|468996515|FG000|Overall Study|Withdrawal by Subject|6|||
130282017|NCT01537081|468996516|FG001|Overall Study|Withdrawal by Subject|11|||
130282018|NCT01537081|468996517|FG002|Overall Study|Withdrawal by Subject|3|||
130282019|NCT01537081|468996515|FG000|Overall Study|Physician Decision|5|||
130282020|NCT01537081|468996516|FG001|Overall Study|Physician Decision|6|||
130282021|NCT01537081|468996517|FG002|Overall Study|Physician Decision|0|||
130282022|NCT01537081|468996515|FG000|Overall Study|Sponsor decision|0|||
130282023|NCT01537081|468996516|FG001|Overall Study|Sponsor decision|1|||
130282024|NCT01537081|468996517|FG002|Overall Study|Sponsor decision|0|||
130282025|NCT01537081|468996515|FG000|Overall Study|Assigned but never dosed|1|||
130282026|NCT01537081|468996516|FG001|Overall Study|Assigned but never dosed|0|||
130282027|NCT01537081|468996517|FG002|Overall Study|Assigned but never dosed|0|||
130282028|NCT02596958|468996520|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
130282029|NCT02596958|468996520|FG000|Overall Study|Cancer Progression|441|||
130282030|NCT02596958|468996520|FG000|Overall Study|Death From Cancer|112|||
130282031|NCT02596958|468996520|FG000|Overall Study|Death From Other Cause|33|||
130282032|NCT02596958|468996520|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
130282033|NCT02596958|468996520|FG000|Overall Study|Administrative Reasons/Other|231|||
130282034|NCT02596958|468996520|FG000|Overall Study|Lost to Follow-up|33|||
130282035|NCT02596958|468996520|FG000|Overall Study|Missing|32|||
130282036|NCT02596958|468996520|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
130282037|NCT01559259|468996521|FG000|Overall Study|Withdrawal by Subject|0|||
130282038|NCT01559259|468996522|FG001|Overall Study|Withdrawal by Subject|0|||
130282039|NCT01559259|468996523|FG002|Overall Study|Withdrawal by Subject|0|||
130282040|NCT01559259|468996524|FG003|Overall Study|Withdrawal by Subject|1|||
130282041|NCT01559259|468996525|FG004|Overall Study|Withdrawal by Subject|0|||
130282042|NCT01559259|468996521|FG000|Overall Study|Adverse Event|0|||
130042605|NCT00828451|468114371|FG000|Overall Study|Deterioration in clinical status|1|||
130042606|NCT00519532|468114374|FG000|Overall Study|Adverse Event|11|||
130282043|NCT01559259|468996522|FG001|Overall Study|Adverse Event|1|||
130282044|NCT01559259|468996523|FG002|Overall Study|Adverse Event|1|||
130282045|NCT01559259|468996524|FG003|Overall Study|Adverse Event|0|||
130282046|NCT01559259|468996525|FG004|Overall Study|Adverse Event|0|||
130282047|NCT00185380|468996527|FG000|Overall Study|Adverse Event|41|||
130282048|NCT00185380|468996528|FG001|Overall Study|Adverse Event|43|||
130282049|NCT00185380|468996529|FG002|Overall Study|Adverse Event|48|||
130282050|NCT00185380|468996527|FG000|Overall Study|Lost to Follow-up|0|||
130282051|NCT00185380|468996528|FG001|Overall Study|Lost to Follow-up|4|||
130282052|NCT00185380|468996529|FG002|Overall Study|Lost to Follow-up|3|||
130282053|NCT00185380|468996527|FG000|Overall Study|Pregnancy|1|||
130282054|NCT00185380|468996528|FG001|Overall Study|Pregnancy|4|||
130282055|NCT00185380|468996529|FG002|Overall Study|Pregnancy|0|||
130042607|NCT00519532|468114374|FG000|Overall Study|Withdrawal by Subject|5|||
130042608|NCT00519532|468114374|FG000|Overall Study|Lost to Follow-up|2|||
130042609|NCT03443024|468114377|FG000|Overall Study|Adverse Event|2|||
130042610|NCT03443024|468114378|FG001|Overall Study|Adverse Event|4|||
130042611|NCT03443024|468114379|FG002|Overall Study|Adverse Event|3|||
130042612|NCT03443024|468114380|FG003|Overall Study|Adverse Event|1|||
130106199|NCT01160198|468349925|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
130106200|NCT01160198|468349926|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
130106201|NCT01160198|468349927|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
130042613|NCT03443024|468114377|FG000|Overall Study|Lost to Follow-up|9|||
130042614|NCT03443024|468114378|FG001|Overall Study|Lost to Follow-up|9|||
130042615|NCT03443024|468114379|FG002|Overall Study|Lost to Follow-up|7|||
130042616|NCT03443024|468114380|FG003|Overall Study|Lost to Follow-up|5|||
130042617|NCT03443024|468114377|FG000|Overall Study|Withdrawal by Subject|8|||
130042618|NCT03443024|468114378|FG001|Overall Study|Withdrawal by Subject|15|||
130042619|NCT03443024|468114379|FG002|Overall Study|Withdrawal by Subject|9|||
130042620|NCT03443024|468114380|FG003|Overall Study|Withdrawal by Subject|23|||
130042621|NCT03443024|468114377|FG000|Overall Study|Physician Decision|1|||
130042622|NCT03443024|468114378|FG001|Overall Study|Physician Decision|2|||
130042623|NCT03443024|468114379|FG002|Overall Study|Physician Decision|0|||
130042624|NCT03443024|468114380|FG003|Overall Study|Physician Decision|1|||
130042625|NCT03443024|468114377|FG000|Overall Study|Sponsor Decision|1|||
130042626|NCT03443024|468114378|FG001|Overall Study|Sponsor Decision|1|||
130042627|NCT03443024|468114379|FG002|Overall Study|Sponsor Decision|0|||
130106202|NCT03343054|468349930|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
130106203|NCT03343054|468349931|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
130042628|NCT03443024|468114380|FG003|Overall Study|Sponsor Decision|0|||
130282056|NCT00185380|468996527|FG000|Overall Study|Protocol Violation|2|||
130042629|NCT03443024|468114377|FG000|Overall Study|Protocol Deviation|0|||
130042630|NCT03443024|468114378|FG001|Overall Study|Protocol Deviation|0|||
130042631|NCT03443024|468114379|FG002|Overall Study|Protocol Deviation|0|||
130042632|NCT03443024|468114380|FG003|Overall Study|Protocol Deviation|2|||
130282057|NCT00185380|468996528|FG001|Overall Study|Protocol Violation|2|||
130282058|NCT00185380|468996529|FG002|Overall Study|Protocol Violation|1|||
130282059|NCT00185380|468996527|FG000|Overall Study|Withdrawal by Subject|1|||
130282060|NCT00185380|468996528|FG001|Overall Study|Withdrawal by Subject|2|||
130282061|NCT00185380|468996529|FG002|Overall Study|Withdrawal by Subject|0|||
130282062|NCT00185380|468996527|FG000|Overall Study|Failed insertion|1|||
130282063|NCT00185380|468996528|FG001|Overall Study|Failed insertion|1|||
130282064|NCT00185380|468996529|FG002|Overall Study|Failed insertion|2|||
130282065|NCT00185380|468996527|FG000|Overall Study|Planned pregnancy|9|||
130282066|NCT00185380|468996528|FG001|Overall Study|Planned pregnancy|12|||
130282067|NCT00185380|468996529|FG002|Overall Study|Planned pregnancy|12|||
130282068|NCT00185380|468996527|FG000|Overall Study|No need for contraception|3|||
130282069|NCT00185380|468996528|FG001|Overall Study|No need for contraception|3|||
130282070|NCT00185380|468996529|FG002|Overall Study|No need for contraception|3|||
130282071|NCT00185380|468996527|FG000|Overall Study|Could not attend visits|2|||
130282072|NCT00185380|468996528|FG001|Overall Study|Could not attend visits|0|||
130282073|NCT00185380|468996529|FG002|Overall Study|Could not attend visits|4|||
130282074|NCT00185380|468996527|FG000|Overall Study|personal reason|6|||
130282075|NCT00185380|468996528|FG001|Overall Study|personal reason|1|||
130282076|NCT00185380|468996529|FG002|Overall Study|personal reason|1|||
130282077|NCT02199314|468996530|FG000|Overall Study|Withdrawal by Subject|6|||
130282078|NCT02199314|468996530|FG000|Overall Study|Physician Decision|10|||
130282079|NCT03842969|468996531|FG000|Overall Study|Participant declined follow-up visit|0|||
130282080|NCT03842969|468996532|FG001|Overall Study|Participant declined follow-up visit|1|||
130282081|NCT03842969|468996533|FG002|Overall Study|Participant declined follow-up visit|0|||
130282082|NCT03842969|468996531|FG000|Overall Study|Sponsor's decision|12|||
130282083|NCT03842969|468996532|FG001|Overall Study|Sponsor's decision|99|||
130282084|NCT03842969|468996533|FG002|Overall Study|Sponsor's decision|61|||
130282085|NCT03842969|468996531|FG000|Overall Study|Pregnancy|0|||
130282086|NCT03842969|468996532|FG001|Overall Study|Pregnancy|0|||
130282087|NCT03842969|468996533|FG002|Overall Study|Pregnancy|1|||
130282088|NCT03842969|468996531|FG000|Overall Study|Death|1|||
130282089|NCT03842969|468996532|FG001|Overall Study|Death|0|||
130282090|NCT03842969|468996533|FG002|Overall Study|Death|1|||
130282091|NCT03842969|468996531|FG000|Overall Study|Withdrawal by Subject|3|||
130282092|NCT03842969|468996532|FG001|Overall Study|Withdrawal by Subject|30|||
130282093|NCT03842969|468996533|FG002|Overall Study|Withdrawal by Subject|18|||
130282094|NCT03842969|468996531|FG000|Overall Study|Protocol Violation|1|||
130282095|NCT03842969|468996532|FG001|Overall Study|Protocol Violation|1|||
130282096|NCT03842969|468996533|FG002|Overall Study|Protocol Violation|0|||
130282097|NCT03842969|468996531|FG000|Overall Study|Physician Decision|0|||
130282098|NCT03842969|468996532|FG001|Overall Study|Physician Decision|3|||
130282099|NCT03842969|468996533|FG002|Overall Study|Physician Decision|0|||
130282100|NCT03842969|468996531|FG000|Overall Study|Lost to Follow-up|0|||
130042633|NCT00624338|468114381|FG000|Overall Study|Adverse Event|14|||
130042634|NCT00624338|468114382|FG001|Overall Study|Adverse Event|14|||
130042635|NCT00624338|468114383|FG002|Overall Study|Adverse Event|18|||
130042636|NCT00624338|468114381|FG000|Overall Study|Lost to Follow-up|1|||
130042637|NCT00624338|468114382|FG001|Overall Study|Lost to Follow-up|0|||
130042638|NCT00624338|468114383|FG002|Overall Study|Lost to Follow-up|0|||
130042639|NCT00624338|468114381|FG000|Overall Study|Lack of Efficacy|11|||
130282101|NCT03842969|468996532|FG001|Overall Study|Lost to Follow-up|2|||
130282102|NCT03842969|468996533|FG002|Overall Study|Lost to Follow-up|0|||
130282103|NCT03842969|468996531|FG000|Overall Study|Adverse Event|0|||
130282104|NCT03842969|468996532|FG001|Overall Study|Adverse Event|2|||
130042640|NCT00624338|468114382|FG001|Overall Study|Lack of Efficacy|3|||
130282105|NCT03842969|468996533|FG002|Overall Study|Adverse Event|0|||
130282106|NCT01892436|468996534|FG000|Overall Study|Withdrawal by Subject|8|||
130282107|NCT01892436|468996535|FG001|Overall Study|Withdrawal by Subject|15|||
130282108|NCT01892436|468996536|FG002|Overall Study|Withdrawal by Subject|4|||
130282109|NCT01892436|468996537|FG003|Overall Study|Withdrawal by Subject|4|||
130282110|NCT01892436|468996534|FG000|Overall Study|Death|1|||
130282111|NCT01892436|468996535|FG001|Overall Study|Death|1|||
130282112|NCT01892436|468996536|FG002|Overall Study|Death|0|||
130282113|NCT01892436|468996537|FG003|Overall Study|Death|0|||
130282114|NCT01892436|468996534|FG000|Overall Study|Physician Decision|2|||
130282115|NCT01892436|468996535|FG001|Overall Study|Physician Decision|1|||
130282116|NCT01892436|468996536|FG002|Overall Study|Physician Decision|0|||
130282117|NCT01892436|468996537|FG003|Overall Study|Physician Decision|1|||
130282118|NCT01892436|468996534|FG000|Overall Study|Pregnancy|0|||
130282119|NCT01892436|468996535|FG001|Overall Study|Pregnancy|2|||
130282120|NCT01892436|468996536|FG002|Overall Study|Pregnancy|1|||
130282121|NCT01892436|468996537|FG003|Overall Study|Pregnancy|0|||
130282122|NCT01892436|468996534|FG000|Overall Study|Technical problems|2|||
130282123|NCT01892436|468996535|FG001|Overall Study|Technical problems|1|||
130282124|NCT01892436|468996536|FG002|Overall Study|Technical problems|1|||
130282125|NCT01892436|468996537|FG003|Overall Study|Technical problems|1|||
130282126|NCT01892436|468996534|FG000|Overall Study|Lack of Efficacy|1|||
130282127|NCT01892436|468996535|FG001|Overall Study|Lack of Efficacy|2|||
130282128|NCT01892436|468996536|FG002|Overall Study|Lack of Efficacy|2|||
130282129|NCT01892436|468996537|FG003|Overall Study|Lack of Efficacy|2|||
130282130|NCT01892436|468996534|FG000|Overall Study|Lost to Follow-up|1|||
130282131|NCT01892436|468996535|FG001|Overall Study|Lost to Follow-up|1|||
130282132|NCT01892436|468996536|FG002|Overall Study|Lost to Follow-up|1|||
130282133|NCT01892436|468996537|FG003|Overall Study|Lost to Follow-up|3|||
130282134|NCT01892436|468996534|FG000|Overall Study|non-compliance with treatment|1|||
130282135|NCT01892436|468996535|FG001|Overall Study|non-compliance with treatment|0|||
130282136|NCT01892436|468996536|FG002|Overall Study|non-compliance with treatment|0|||
130282137|NCT01892436|468996537|FG003|Overall Study|non-compliance with treatment|0|||
130282138|NCT01892436|468996534|FG000|Overall Study|Adverse Event|7|||
130282139|NCT01892436|468996535|FG001|Overall Study|Adverse Event|6|||
130282140|NCT01892436|468996536|FG002|Overall Study|Adverse Event|2|||
130282141|NCT01892436|468996537|FG003|Overall Study|Adverse Event|3|||
130282142|NCT00733291|468996539|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
130282143|NCT00733291|468996540|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130282144|NCT00733291|468996541|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130282145|NCT00733291|468996542|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
130282146|NCT02759107|468996544|FG000|Overall Study|Adverse Event|0|||
130282147|NCT02759107|468996545|FG001|Overall Study|Adverse Event|0|||
130282148|NCT02759107|468996546|FG002|Overall Study|Adverse Event|0|||
130282149|NCT02759107|468996547|FG003|Overall Study|Adverse Event|0|||
130282150|NCT02759107|468996548|FG004|Overall Study|Adverse Event|0|||
130282151|NCT02759107|468996549|FG005|Overall Study|Adverse Event|0|||
130282152|NCT02759107|468996550|FG006|Overall Study|Adverse Event|0|||
130282153|NCT02759107|468996551|FG007|Overall Study|Adverse Event|0|||
130282154|NCT02759107|468996552|FG008|Overall Study|Adverse Event|0|||
130042641|NCT00624338|468114383|FG002|Overall Study|Lack of Efficacy|14|||
130282155|NCT02759107|468996553|FG009|Overall Study|Adverse Event|0|||
130282156|NCT02759107|468996554|FG010|Overall Study|Adverse Event|0|||
130282157|NCT02759107|468996555|FG011|Overall Study|Adverse Event|0|||
130042642|NCT00624338|468114381|FG000|Overall Study|Protocol Violation|3|||
130282158|NCT02759107|468996556|FG012|Overall Study|Adverse Event|2|||
130282159|NCT02759107|468996557|FG013|Overall Study|Adverse Event|0|||
130282160|NCT02759107|468996558|FG014|Overall Study|Adverse Event|0|||
130282161|NCT02759107|468996559|FG015|Overall Study|Adverse Event|1|||
130042643|NCT00624338|468114382|FG001|Overall Study|Protocol Violation|3|||
130042644|NCT00624338|468114383|FG002|Overall Study|Protocol Violation|2|||
130042645|NCT00624338|468114381|FG000|Overall Study|Death|0|||
130042646|NCT00624338|468114382|FG001|Overall Study|Death|2|||
130042647|NCT00624338|468114383|FG002|Overall Study|Death|0|||
130042648|NCT00624338|468114381|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
130282162|NCT02759107|468996560|FG016|Overall Study|Adverse Event|0|||
130282163|NCT02759107|468996561|FG017|Overall Study|Adverse Event|2|||
130282164|NCT02759107|468996544|FG000|Overall Study|Scheduling Conflict|0|||
130282165|NCT02759107|468996545|FG001|Overall Study|Scheduling Conflict|0|||
130282166|NCT02759107|468996546|FG002|Overall Study|Scheduling Conflict|0|||
130282167|NCT02759107|468996547|FG003|Overall Study|Scheduling Conflict|0|||
130282168|NCT02759107|468996548|FG004|Overall Study|Scheduling Conflict|0|||
130282169|NCT02759107|468996549|FG005|Overall Study|Scheduling Conflict|0|||
130282170|NCT02759107|468996550|FG006|Overall Study|Scheduling Conflict|0|||
130282171|NCT02759107|468996551|FG007|Overall Study|Scheduling Conflict|0|||
130282172|NCT02759107|468996552|FG008|Overall Study|Scheduling Conflict|0|||
130282173|NCT02759107|468996553|FG009|Overall Study|Scheduling Conflict|1|||
130282174|NCT02759107|468996554|FG010|Overall Study|Scheduling Conflict|0|||
130282175|NCT02759107|468996555|FG011|Overall Study|Scheduling Conflict|0|||
130282176|NCT02759107|468996556|FG012|Overall Study|Scheduling Conflict|0|||
130282177|NCT02759107|468996557|FG013|Overall Study|Scheduling Conflict|0|||
130282178|NCT02759107|468996558|FG014|Overall Study|Scheduling Conflict|0|||
130042649|NCT00624338|468114382|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
130282179|NCT02759107|468996559|FG015|Overall Study|Scheduling Conflict|0|||
130282180|NCT02759107|468996560|FG016|Overall Study|Scheduling Conflict|0|||
130282181|NCT02759107|468996561|FG017|Overall Study|Scheduling Conflict|0|||
130282182|NCT02019108|468996564|FG000|Overall Study|Lost to Follow-up|5|||
130282183|NCT02019108|468996565|FG001|Overall Study|Lost to Follow-up|7|||
130282184|NCT04569136|468996571|FG000|Overall Study|Lost to Follow-up|2|||
130282185|NCT04569136|468996572|FG001|Overall Study|Lost to Follow-up|0|||
130282186|NCT04569136|468996573|FG002|Overall Study|Lost to Follow-up|1|||
130282187|NCT01466660|468996578|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
130282188|NCT01466660|468996579|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
130282189|NCT01466660|468996578|FG000|Overall Study|Worsening of underlying cancer disease|5|||
130282190|NCT01466660|468996579|FG001|Overall Study|Worsening of underlying cancer disease|2|||
130282191|NCT01466660|468996578|FG000|Overall Study|Other adverse event|19|||
130282192|NCT01466660|468996579|FG001|Overall Study|Other adverse event|18|||
130282193|NCT01466660|468996578|FG000|Overall Study|Protocol Violation|2|||
130282194|NCT01466660|468996579|FG001|Overall Study|Protocol Violation|1|||
130282195|NCT01466660|468996578|FG000|Overall Study|Refused continuation of trial medication|4|||
130282196|NCT01466660|468996579|FG001|Overall Study|Refused continuation of trial medication|3|||
130282197|NCT01466660|468996578|FG000|Overall Study|Other reason not defined above|10|||
130282198|NCT01466660|468996579|FG001|Overall Study|Other reason not defined above|8|||
130282199|NCT00191724|468996580|FG000|Overall Study|Adverse Event|0|||
130282200|NCT00191724|468996581|FG001|Overall Study|Adverse Event|0|||
130282201|NCT00191724|468996582|FG002|Overall Study|Adverse Event|1|||
130282202|NCT00191724|468996583|FG003|Overall Study|Adverse Event|0|||
130282203|NCT00191724|468996584|FG004|Overall Study|Adverse Event|0|||
130282204|NCT00191724|468996580|FG000|Overall Study|Lost to Follow-up|1|||
130282205|NCT00191724|468996581|FG001|Overall Study|Lost to Follow-up|1|||
130282206|NCT00191724|468996582|FG002|Overall Study|Lost to Follow-up|0|||
130282207|NCT00191724|468996583|FG003|Overall Study|Lost to Follow-up|2|||
130282208|NCT00191724|468996584|FG004|Overall Study|Lost to Follow-up|3|||
130282209|NCT00191724|468996580|FG000|Overall Study|Withdrawal by Subject|0|||
130282210|NCT00191724|468996581|FG001|Overall Study|Withdrawal by Subject|0|||
130282211|NCT00191724|468996582|FG002|Overall Study|Withdrawal by Subject|0|||
130282212|NCT00191724|468996583|FG003|Overall Study|Withdrawal by Subject|1|||
130282213|NCT00191724|468996584|FG004|Overall Study|Withdrawal by Subject|0|||
130282214|NCT02301546|468996587|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
130282215|NCT02301546|468996588|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
130282216|NCT02301546|468996587|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
130282217|NCT02301546|468996588|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
130282218|NCT02301546|468996587|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
130282219|NCT02301546|468996588|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
130282220|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
130282221|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
130282222|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
130282223|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
130282224|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
130282225|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
130282226|NCT02301546|468996587|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
130282227|NCT02301546|468996588|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
130282228|NCT04085458|468996593|FG000|Overall Study|Other|1|||
130282229|NCT04085458|468996593|FG000|Overall Study|Withdrawal by Subject|2|||
130282230|NCT04085458|468996593|FG000|Overall Study|Adverse Event|2|||
130282231|NCT02447250|468996594|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
130282232|NCT02447250|468996594|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
130282233|NCT02447250|468996594|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
130282234|NCT03632993|468996595|FG000|Overall Study|Withdrawal by Subject|1|||
130282235|NCT03632993|468996596|FG001|Overall Study|Withdrawal by Subject|0|||
130282236|NCT03632993|468996597|FG002|Overall Study|Withdrawal by Subject|0|||
130282237|NCT03632993|468996598|FG003|Overall Study|Withdrawal by Subject|0|||
130282238|NCT03632993|468996599|FG004|Overall Study|Withdrawal by Subject|0|||
130282239|NCT03632993|468996600|FG005|Overall Study|Withdrawal by Subject|0|||
130282240|NCT03632993|468996601|FG006|Overall Study|Withdrawal by Subject|0|||
130282241|NCT03632993|468996602|FG007|Overall Study|Withdrawal by Subject|0|||
130282242|NCT03632993|468996603|FG008|Overall Study|Withdrawal by Subject|0|||
130282243|NCT03632993|468996604|FG009|Overall Study|Withdrawal by Subject|1|||
130282244|NCT03632993|468996595|FG000|Overall Study|Protocol Non-compliance|0|||
130282245|NCT03632993|468996596|FG001|Overall Study|Protocol Non-compliance|1|||
130282246|NCT03632993|468996597|FG002|Overall Study|Protocol Non-compliance|0|||
130042650|NCT00624338|468114383|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
130042651|NCT00624338|468114381|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
130282247|NCT03632993|468996598|FG003|Overall Study|Protocol Non-compliance|0|||
130282248|NCT03632993|468996599|FG004|Overall Study|Protocol Non-compliance|0|||
130282249|NCT03632993|468996600|FG005|Overall Study|Protocol Non-compliance|0|||
130282250|NCT03632993|468996601|FG006|Overall Study|Protocol Non-compliance|0|||
130282251|NCT03632993|468996602|FG007|Overall Study|Protocol Non-compliance|0|||
130282252|NCT03632993|468996603|FG008|Overall Study|Protocol Non-compliance|0|||
130282253|NCT03632993|468996604|FG009|Overall Study|Protocol Non-compliance|0|||
130282254|NCT03632993|468996595|FG000|Overall Study|Lost to Follow-up|0|||
130282255|NCT03632993|468996596|FG001|Overall Study|Lost to Follow-up|0|||
130282256|NCT03632993|468996597|FG002|Overall Study|Lost to Follow-up|0|||
130282257|NCT03632993|468996598|FG003|Overall Study|Lost to Follow-up|0|||
130282258|NCT03632993|468996599|FG004|Overall Study|Lost to Follow-up|0|||
130282259|NCT03632993|468996600|FG005|Overall Study|Lost to Follow-up|1|||
130282260|NCT03632993|468996601|FG006|Overall Study|Lost to Follow-up|0|||
130282261|NCT03632993|468996602|FG007|Overall Study|Lost to Follow-up|1|||
130282262|NCT03632993|468996603|FG008|Overall Study|Lost to Follow-up|0|||
130282263|NCT03632993|468996604|FG009|Overall Study|Lost to Follow-up|0|||
130282264|NCT03632993|468996595|FG000|Overall Study|Adverse Event|0|||
130282265|NCT03632993|468996596|FG001|Overall Study|Adverse Event|0|||
130282266|NCT03632993|468996597|FG002|Overall Study|Adverse Event|0|||
130282267|NCT03632993|468996598|FG003|Overall Study|Adverse Event|0|||
130282268|NCT03632993|468996599|FG004|Overall Study|Adverse Event|0|||
130282269|NCT03632993|468996600|FG005|Overall Study|Adverse Event|1|||
130282270|NCT03632993|468996601|FG006|Overall Study|Adverse Event|0|||
130282271|NCT03632993|468996602|FG007|Overall Study|Adverse Event|1|||
130282272|NCT03632993|468996603|FG008|Overall Study|Adverse Event|0|||
130282273|NCT03632993|468996604|FG009|Overall Study|Adverse Event|0|||
130282274|NCT03224507|468996605|FG000|Overall Study|Death|3|||
130282275|NCT03224507|468996606|FG001|Overall Study|Death|0|||
130282276|NCT03224507|468996605|FG000|Overall Study|Lack of Efficacy|6|||
130282277|NCT03224507|468996606|FG001|Overall Study|Lack of Efficacy|0|||
130282278|NCT03224507|468996605|FG000|Overall Study|Withdrawal by Subject|6|||
130282279|NCT03224507|468996606|FG001|Overall Study|Withdrawal by Subject|0|||
130282280|NCT00075946|468996609|FG000|Overall Study|Path ineligible: undetermined histology|0|||
130282281|NCT00075946|468996610|FG001|Overall Study|Path ineligible: undetermined histology|0|||
130282282|NCT00075946|468996611|FG002|Overall Study|Path ineligible: undetermined histology|0|||
130282283|NCT00075946|468996612|FG003|Overall Study|Path ineligible: undetermined histology|0|||
130282284|NCT00075946|468996613|FG004|Overall Study|Path ineligible: undetermined histology|6|||
130282285|NCT00075946|468996609|FG000|Overall Study|Did not achieve response after induction|0|||
130282286|NCT00075946|468996610|FG001|Overall Study|Did not achieve response after induction|0|||
130282287|NCT00075946|468996611|FG002|Overall Study|Did not achieve response after induction|0|||
130282288|NCT00075946|468996612|FG003|Overall Study|Did not achieve response after induction|0|||
130282289|NCT00075946|468996613|FG004|Overall Study|Did not achieve response after induction|182|||
130282290|NCT00075946|468996609|FG000|Overall Study|Incorrectly randomized (no response)|5|||
130282291|NCT00075946|468996610|FG001|Overall Study|Incorrectly randomized (no response)|5|||
130282292|NCT00075946|468996611|FG002|Overall Study|Incorrectly randomized (no response)|5|||
130282293|NCT00075946|468996612|FG003|Overall Study|Incorrectly randomized (no response)|1|||
130282294|NCT00075946|468996613|FG004|Overall Study|Incorrectly randomized (no response)|0|||
130282295|NCT00075946|468996609|FG000|Overall Study|Adverse Event|2|||
130282296|NCT00075946|468996610|FG001|Overall Study|Adverse Event|10|||
129887010|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130042652|NCT00624338|468114382|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
130042653|NCT00624338|468114383|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
130042654|NCT00624338|468114381|FG000|Overall Study|Other|15|||
130042655|NCT00624338|468114382|FG001|Overall Study|Other|5|||
130282297|NCT00075946|468996611|FG002|Overall Study|Adverse Event|0|||
130282298|NCT00075946|468996612|FG003|Overall Study|Adverse Event|2|||
130282299|NCT00075946|468996613|FG004|Overall Study|Adverse Event|0|||
130282300|NCT00075946|468996609|FG000|Overall Study|Death|0|||
130282301|NCT00075946|468996610|FG001|Overall Study|Death|1|||
130282302|NCT00075946|468996611|FG002|Overall Study|Death|0|||
130282303|NCT00075946|468996612|FG003|Overall Study|Death|0|||
130282304|NCT00075946|468996613|FG004|Overall Study|Death|0|||
130282305|NCT00075946|468996609|FG000|Overall Study|Withdrawal by Subject|23|||
130282306|NCT00075946|468996610|FG001|Overall Study|Withdrawal by Subject|58|||
130282307|NCT00075946|468996611|FG002|Overall Study|Withdrawal by Subject|4|||
129887011|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
129887012|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
130042656|NCT00624338|468114383|FG002|Overall Study|Other|9|||
130282308|NCT00075946|468996612|FG003|Overall Study|Withdrawal by Subject|9|||
130282309|NCT00075946|468996613|FG004|Overall Study|Withdrawal by Subject|0|||
130282310|NCT00075946|468996609|FG000|Overall Study|Alternative therapy|16|||
130282311|NCT00075946|468996610|FG001|Overall Study|Alternative therapy|2|||
130282312|NCT00075946|468996611|FG002|Overall Study|Alternative therapy|5|||
130106204|NCT03343054|468349932|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
130106205|NCT03343054|468349930|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
130282313|NCT00075946|468996612|FG003|Overall Study|Alternative therapy|0|||
130282314|NCT00075946|468996613|FG004|Overall Study|Alternative therapy|0|||
130282315|NCT00075946|468996609|FG000|Overall Study|Other complicating disease|7|||
130282316|NCT00075946|468996610|FG001|Overall Study|Other complicating disease|13|||
130282317|NCT00075946|468996611|FG002|Overall Study|Other complicating disease|1|||
130282318|NCT00075946|468996612|FG003|Overall Study|Other complicating disease|4|||
130282319|NCT00075946|468996613|FG004|Overall Study|Other complicating disease|0|||
130282320|NCT00075946|468996609|FG000|Overall Study|No response to retreatment|23|||
130282321|NCT00075946|468996610|FG001|Overall Study|No response to retreatment|0|||
130282322|NCT00075946|468996611|FG002|Overall Study|No response to retreatment|2|||
130282323|NCT00075946|468996612|FG003|Overall Study|No response to retreatment|0|||
130282324|NCT00075946|468996613|FG004|Overall Study|No response to retreatment|0|||
130282325|NCT00075946|468996609|FG000|Overall Study|Time to progression less than 6 months|15|||
130282326|NCT00075946|468996610|FG001|Overall Study|Time to progression less than 6 months|30|||
130282327|NCT00075946|468996611|FG002|Overall Study|Time to progression less than 6 months|8|||
130282328|NCT00075946|468996612|FG003|Overall Study|Time to progression less than 6 months|3|||
130282329|NCT00075946|468996613|FG004|Overall Study|Time to progression less than 6 months|0|||
130282330|NCT00075946|468996609|FG000|Overall Study|Other|57|||
130282331|NCT00075946|468996610|FG001|Overall Study|Other|32|||
130282332|NCT00075946|468996611|FG002|Overall Study|Other|3|||
130282333|NCT00075946|468996612|FG003|Overall Study|Other|11|||
130282334|NCT00075946|468996613|FG004|Overall Study|Other|0|||
130282335|NCT01229254|468996616|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
130282336|NCT01229254|468996617|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
130282337|NCT01229254|468996618|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
130282338|NCT01229254|468996616|FG000|Overall Study|Adverse Event|4|||
130282339|NCT01229254|468996617|FG001|Overall Study|Adverse Event|5|||
130282340|NCT01229254|468996618|FG002|Overall Study|Adverse Event|3|||
130282341|NCT01229254|468996616|FG000|Overall Study|Lost to Follow-up|3|||
130282342|NCT01229254|468996617|FG001|Overall Study|Lost to Follow-up|0|||
130282343|NCT01229254|468996618|FG002|Overall Study|Lost to Follow-up|1|||
130282344|NCT01229254|468996616|FG000|Overall Study|Physician Decision|0|||
130282345|NCT01229254|468996617|FG001|Overall Study|Physician Decision|3|||
130282346|NCT01229254|468996618|FG002|Overall Study|Physician Decision|0|||
130282347|NCT01229254|468996616|FG000|Overall Study|Protocol Violation|4|||
130282348|NCT01229254|468996617|FG001|Overall Study|Protocol Violation|6|||
130282349|NCT01229254|468996618|FG002|Overall Study|Protocol Violation|5|||
130282350|NCT01229254|468996616|FG000|Overall Study|Withdrawal by Subject|1|||
130282351|NCT01229254|468996617|FG001|Overall Study|Withdrawal by Subject|0|||
130282352|NCT01229254|468996618|FG002|Overall Study|Withdrawal by Subject|1|||
130282353|NCT01229254|468996616|FG000|Overall Study|Non-compliance with Study Drug|0|||
130282354|NCT01229254|468996617|FG001|Overall Study|Non-compliance with Study Drug|1|||
130282355|NCT01229254|468996618|FG002|Overall Study|Non-compliance with Study Drug|1|||
130282356|NCT02231892|468996619|FG000|Overall Study|Lost to Follow-up|1|||
130282357|NCT02231892|468996620|FG001|Overall Study|Lost to Follow-up|0|||
130282358|NCT02231892|468996621|FG002|Overall Study|Lost to Follow-up|3|||
130282359|NCT02231892|468996619|FG000|Overall Study|Withdrawal by Subject|4|||
130282360|NCT02231892|468996620|FG001|Overall Study|Withdrawal by Subject|3|||
130282361|NCT02231892|468996621|FG002|Overall Study|Withdrawal by Subject|15|||
130282362|NCT02231892|468996619|FG000|Overall Study|Physician Decision|0|||
130282363|NCT02231892|468996620|FG001|Overall Study|Physician Decision|2|||
130282364|NCT02231892|468996621|FG002|Overall Study|Physician Decision|4|||
130282365|NCT02231892|468996619|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
130282366|NCT02231892|468996620|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
130282367|NCT02231892|468996621|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
130282368|NCT02231892|468996619|FG000|Overall Study|Participant motor threshold was >83%|0|||
130282369|NCT02231892|468996620|FG001|Overall Study|Participant motor threshold was >83%|0|||
130282370|NCT02231892|468996621|FG002|Overall Study|Participant motor threshold was >83%|9|||
130282371|NCT02231892|468996619|FG000|Overall Study|Could not find motor threshold|2|||
130282372|NCT02231892|468996620|FG001|Overall Study|Could not find motor threshold|0|||
130282373|NCT02231892|468996621|FG002|Overall Study|Could not find motor threshold|1|||
130282374|NCT02231892|468996619|FG000|Overall Study|Could not find reliable motor hotspot|0|||
130282375|NCT02231892|468996620|FG001|Overall Study|Could not find reliable motor hotspot|0|||
130282376|NCT02231892|468996621|FG002|Overall Study|Could not find reliable motor hotspot|1|||
130282377|NCT02680041|468996623|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
130106206|NCT03343054|468349931|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
130282378|NCT02680041|468996623|FG000|Overall Study|Lost to Follow-up|2|||
130282379|NCT02186652|468996624|FG000|Overall Study|Lost to Follow-up|2|||
130282380|NCT02186652|468996625|FG001|Overall Study|Lost to Follow-up|0|||
130282381|NCT00744978|468996626|FG000|Period 1|Lost to Follow-up|1|||
130282382|NCT00744978|468996627|FG001|Period 1|Lost to Follow-up|0|||
130282383|NCT00744978|468996626|FG000|Period 1|Withdrawal by Subject|0|||
130282384|NCT00744978|468996627|FG001|Period 1|Withdrawal by Subject|2|||
130282385|NCT00744978|468996626|FG000|Period 1|Other|0|||
130282386|NCT00744978|468996627|FG001|Period 1|Other|2|||
130282387|NCT00744978|468996626|FG000|Period 1|Adverse Event|4|||
130282388|NCT00744978|468996627|FG001|Period 1|Adverse Event|0|||
130282389|NCT00744978|468996626|FG000|Period 1|Randomized but not Treated|1|||
130282390|NCT00744978|468996627|FG001|Period 1|Randomized but not Treated|1|||
130282391|NCT00744978|468996626|FG000|Period 2|Adverse Event|0|||
130282392|NCT00744978|468996627|FG001|Period 2|Adverse Event|1|||
130282393|NCT00515294|468996631|FG000|Overall Study|Lost to Follow-up|3|||
130282394|NCT00515294|468996632|FG001|Overall Study|Lost to Follow-up|2|||
130282395|NCT00515294|468996633|FG002|Overall Study|Lost to Follow-up|3|||
130282396|NCT00515294|468996634|FG003|Overall Study|Lost to Follow-up|1|||
130282397|NCT00515294|468996631|FG000|Overall Study|Driver simulator problems|1|||
130282398|NCT00515294|468996632|FG001|Overall Study|Driver simulator problems|1|||
130282399|NCT00515294|468996633|FG002|Overall Study|Driver simulator problems|1|||
130282400|NCT00515294|468996634|FG003|Overall Study|Driver simulator problems|3|||
130282401|NCT00515294|468996631|FG000|Overall Study|Caffeine amount inaccurate|5|||
130282402|NCT00515294|468996632|FG001|Overall Study|Caffeine amount inaccurate|0|||
130282403|NCT00515294|468996633|FG002|Overall Study|Caffeine amount inaccurate|7|||
130282404|NCT00515294|468996634|FG003|Overall Study|Caffeine amount inaccurate|0|||
130282405|NCT03943550|468996641|FG000|Overall Study|Adverse Event|0|||
130282406|NCT03943550|468996642|FG001|Overall Study|Adverse Event|0|||
130282407|NCT03943550|468996643|FG002|Overall Study|Adverse Event|1|||
130282408|NCT03943550|468996641|FG000|Overall Study|Lost to Follow-up|0|||
130282409|NCT03943550|468996642|FG001|Overall Study|Lost to Follow-up|0|||
130282410|NCT03943550|468996643|FG002|Overall Study|Lost to Follow-up|1|||
130282411|NCT03943550|468996641|FG000|Overall Study|Progressive Disease|0|||
130282412|NCT03943550|468996642|FG001|Overall Study|Progressive Disease|0|||
130282413|NCT03943550|468996643|FG002|Overall Study|Progressive Disease|2|||
130282414|NCT03943550|468996641|FG000|Overall Study|Participant Moved Out of the Country|0|||
130282415|NCT03943550|468996642|FG001|Overall Study|Participant Moved Out of the Country|1|||
130282416|NCT03943550|468996643|FG002|Overall Study|Participant Moved Out of the Country|0|||
130282417|NCT03359785|468996644|FG000|Overall Study|Protocol Violation|0|||
130282418|NCT03359785|468996645|FG001|Overall Study|Protocol Violation|1|||
130282419|NCT03359785|468996646|FG002|Overall Study|Protocol Violation|0|||
130282420|NCT03359785|468996647|FG003|Overall Study|Protocol Violation|0|||
130282421|NCT03359785|468996644|FG000|Overall Study|Early study termination due to study pause|0|||
130282422|NCT03359785|468996645|FG001|Overall Study|Early study termination due to study pause|0|||
130282423|NCT03359785|468996646|FG002|Overall Study|Early study termination due to study pause|2|||
130282424|NCT03359785|468996647|FG003|Overall Study|Early study termination due to study pause|0|||
130282425|NCT03359785|468996644|FG000|Overall Study|Withdrawal by Subject|2|||
130282426|NCT03359785|468996645|FG001|Overall Study|Withdrawal by Subject|2|||
130282427|NCT03359785|468996646|FG002|Overall Study|Withdrawal by Subject|0|||
130282428|NCT03359785|468996647|FG003|Overall Study|Withdrawal by Subject|0|||
130282429|NCT02099344|468996653|FG000|Overall Study|Physician Decision|1|||
130282430|NCT02099344|468996654|FG001|Overall Study|Physician Decision|0|||
130282431|NCT02839720|468996655|FG000|Overall Study|Adverse Event|2|||
130282432|NCT02839720|468996655|FG000|Overall Study|Non-compliance|2|||
130282433|NCT02839720|468996655|FG000|Overall Study|Intercurrent Illness|1|||
130282434|NCT02839720|468996655|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
130282435|NCT02649218|468996656|FG000|Overall Study|Adverse Event|8|||
130282436|NCT02649218|468996656|FG000|Overall Study|Lack of Efficacy|8|||
130282437|NCT02649218|468996656|FG000|Overall Study|Pregnancy|3|||
130282438|NCT02649218|468996656|FG000|Overall Study|Protocol Violation|3|||
130282439|NCT02649218|468996656|FG000|Overall Study|Physician Decision|1|||
130282440|NCT02649218|468996656|FG000|Overall Study|Withdrawal by Subject|2|||
130282441|NCT00503581|468996657|FG000|Overall Study|Study closed|3|||
130282442|NCT00503581|468996658|FG001|Overall Study|Study closed|4|||
130282443|NCT00503581|468996659|FG002|Overall Study|Study closed|2|||
130282444|NCT06107803|468996661|FG000|Overall Study|Adverse Event|1|||
130282445|NCT06107803|468996661|FG000|Overall Study|Withdrawal by Subject|2|||
130282446|NCT06107803|468996661|FG000|Overall Study|Protocol Violation|1|||
130282447|NCT04730635|468996663|FG000|Overall Study|Lost to Follow-up|1|||
130282448|NCT04730635|468996664|FG001|Overall Study|Lost to Follow-up|0|||
130282449|NCT04730635|468996663|FG000|Overall Study|Withdrawal by Subject|0|||
130282450|NCT04730635|468996664|FG001|Overall Study|Withdrawal by Subject|1|||
130282451|NCT01096368|468996665|FG000|Overall Study|Death|0|||
130282452|NCT01096368|468996666|FG001|Overall Study|Death|1|||
130282453|NCT01096368|468996667|FG002|Overall Study|Death|0|||
130282454|NCT01096368|468996668|FG003|Overall Study|Death|0|||
130282455|NCT01096368|468996669|FG004|Overall Study|Death|0|||
130282456|NCT01096368|468996665|FG000|Overall Study|Physician Decision|0|||
130282457|NCT01096368|468996666|FG001|Overall Study|Physician Decision|13|||
130282458|NCT01096368|468996667|FG002|Overall Study|Physician Decision|2|||
130282459|NCT01096368|468996668|FG003|Overall Study|Physician Decision|4|||
130282460|NCT01096368|468996669|FG004|Overall Study|Physician Decision|6|||
130282461|NCT01096368|468996665|FG000|Overall Study|Withdrawal by Subject|0|||
130282462|NCT01096368|468996666|FG001|Overall Study|Withdrawal by Subject|52|||
130282463|NCT01096368|468996667|FG002|Overall Study|Withdrawal by Subject|0|||
130282464|NCT01096368|468996668|FG003|Overall Study|Withdrawal by Subject|10|||
130282465|NCT01096368|468996669|FG004|Overall Study|Withdrawal by Subject|14|||
130282466|NCT01096368|468996665|FG000|Overall Study|Ineligible|0|||
130282467|NCT01096368|468996666|FG001|Overall Study|Ineligible|3|||
130282468|NCT01096368|468996667|FG002|Overall Study|Ineligible|2|||
130282469|NCT01096368|468996668|FG003|Overall Study|Ineligible|0|||
130282470|NCT01096368|468996669|FG004|Overall Study|Ineligible|25|||
130282471|NCT01096368|468996665|FG000|Overall Study|Did not start treatment|0|||
130282472|NCT01096368|468996666|FG001|Overall Study|Did not start treatment|4|||
130282473|NCT01096368|468996667|FG002|Overall Study|Did not start treatment|4|||
130282474|NCT01096368|468996668|FG003|Overall Study|Did not start treatment|0|||
130282475|NCT01096368|468996669|FG004|Overall Study|Did not start treatment|0|||
130282476|NCT01096368|468996665|FG000|Overall Study|Progressive disease|0|||
130282477|NCT01096368|468996666|FG001|Overall Study|Progressive disease|6|||
130282478|NCT01096368|468996667|FG002|Overall Study|Progressive disease|0|||
130282479|NCT01096368|468996668|FG003|Overall Study|Progressive disease|10|||
130282480|NCT01096368|468996669|FG004|Overall Study|Progressive disease|3|||
130282481|NCT01096368|468996665|FG000|Overall Study|Other|0|||
130282482|NCT01096368|468996666|FG001|Overall Study|Other|0|||
130282483|NCT01096368|468996667|FG002|Overall Study|Other|1|||
130282484|NCT01096368|468996668|FG003|Overall Study|Other|0|||
130282485|NCT01096368|468996669|FG004|Overall Study|Other|0|||
130282486|NCT01096368|468996665|FG000|Overall Study|Treated with institutional review|0|||
130282487|NCT01096368|468996666|FG001|Overall Study|Treated with institutional review|0|||
130282488|NCT01096368|468996667|FG002|Overall Study|Treated with institutional review|0|||
130282489|NCT01096368|468996668|FG003|Overall Study|Treated with institutional review|0|||
130282490|NCT01096368|468996669|FG004|Overall Study|Treated with institutional review|1|||
130282491|NCT04934800|468996670|FG000|Overall Study|Other|1|||
130282492|NCT04934800|468996670|FG000|Overall Study|Withdrawal by Subject|5|||
130282493|NCT04934800|468996670|FG000|Overall Study|Lack of Efficacy|1|||
130282494|NCT04934800|468996670|FG000|Overall Study|Adverse Event|9|||
130282495|NCT04934800|468996670|FG000|Overall Study|Lost to Follow-up|5|||
130282496|NCT04934800|468996670|FG000|Overall Study|Enrolled but not treated|1|||
130282497|NCT00516906|468996671|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
130282498|NCT00516906|468996672|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
130282499|NCT01974206|468996675|FG000|Overall Study|Did Not Take Study Drug|0|||
130282500|NCT01974206|468996676|FG001|Overall Study|Did Not Take Study Drug|1|||
130282501|NCT01974206|468996675|FG000|Overall Study|Physician Decision|1|||
130282502|NCT01974206|468996676|FG001|Overall Study|Physician Decision|0|||
130282503|NCT01974206|468996675|FG000|Overall Study|Withdrawal by Subject|3|||
130282504|NCT01974206|468996676|FG001|Overall Study|Withdrawal by Subject|0|||
130282505|NCT01974206|468996675|FG000|Overall Study|Lost to Follow-up|1|||
130282506|NCT01974206|468996676|FG001|Overall Study|Lost to Follow-up|0|||
130282507|NCT01974206|468996675|FG000|Overall Study|Death|1|||
130282508|NCT01974206|468996676|FG001|Overall Study|Death|0|||
130282509|NCT02118766|468996681|FG000|Overall Study|Adverse Event|7|||
130282510|NCT02118766|468996682|FG001|Overall Study|Adverse Event|2|||
130282511|NCT02118766|468996681|FG000|Overall Study|Withdrawal by Subject|3|||
130282512|NCT02118766|468996682|FG001|Overall Study|Withdrawal by Subject|6|||
130282513|NCT02118766|468996681|FG000|Overall Study|Lost to Follow-up|5|||
130282514|NCT02118766|468996682|FG001|Overall Study|Lost to Follow-up|4|||
130282515|NCT02118766|468996681|FG000|Overall Study|Withdrawal by parent/guardian|12|||
130282516|NCT02118766|468996682|FG001|Overall Study|Withdrawal by parent/guardian|18|||
130282517|NCT02118766|468996681|FG000|Overall Study|Other|3|||
130282518|NCT02118766|468996682|FG001|Overall Study|Other|1|||
130282519|NCT04669262|468996700|FG000|Overall Study|Withdrawal by Subject|0|||
130282520|NCT04669262|468996701|FG001|Overall Study|Withdrawal by Subject|0|||
130282521|NCT04669262|468996702|FG002|Overall Study|Withdrawal by Subject|0|||
130282522|NCT04669262|468996703|FG003|Overall Study|Withdrawal by Subject|1|||
130282523|NCT04669262|468996700|FG000|Overall Study|Randomized but Not Treated|0|||
130282524|NCT04669262|468996701|FG001|Overall Study|Randomized but Not Treated|1|||
130282525|NCT04669262|468996702|FG002|Overall Study|Randomized but Not Treated|0|||
130282526|NCT04669262|468996703|FG003|Overall Study|Randomized but Not Treated|0|||
130282527|NCT01638013|468996704|FG000|Overall Study|Adverse Event|36|||
130282528|NCT01638013|468996705|FG001|Overall Study|Adverse Event|29|||
130282529|NCT01638013|468996706|FG002|Overall Study|Adverse Event|48|||
130282530|NCT01638013|468996704|FG000|Overall Study|Lack of Efficacy|39|||
130042657|NCT00624338|468114381|FG000|Overall Study|Randomized but not treated|2|||
130042658|NCT00624338|468114382|FG001|Overall Study|Randomized but not treated|1|||
130042659|NCT00624338|468114383|FG002|Overall Study|Randomized but not treated|3|||
130042660|NCT05897853|468114384|FG000|Overall Study|Lost to Follow-up|2|||
130042661|NCT05897853|468114385|FG001|Overall Study|Lost to Follow-up|0|||
130042662|NCT05897853|468114384|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
130042663|NCT05897853|468114385|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
130042664|NCT04458857|468114389|FG000|Overall Study|Adverse Event|0|||
130042665|NCT04458857|468114390|FG001|Overall Study|Adverse Event|1|||
130042666|NCT04458857|468114391|FG002|Overall Study|Adverse Event|0|||
130042667|NCT04458857|468114389|FG000|Overall Study|Withdrawal by Subject|2|||
130042668|NCT04458857|468114390|FG001|Overall Study|Withdrawal by Subject|0|||
130042669|NCT04458857|468114391|FG002|Overall Study|Withdrawal by Subject|0|||
130042670|NCT04458857|468114389|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130042671|NCT04458857|468114390|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130042672|NCT04458857|468114391|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130042673|NCT04458857|468114389|FG000|Overall Study|Non-compliance with study drug|0|||
130042674|NCT04458857|468114390|FG001|Overall Study|Non-compliance with study drug|1|||
130042675|NCT04458857|468114391|FG002|Overall Study|Non-compliance with study drug|0|||
130042676|NCT04458857|468114389|FG000|Overall Study|Lost to Follow-up|4|||
130042677|NCT04458857|468114390|FG001|Overall Study|Lost to Follow-up|1|||
130042678|NCT04458857|468114391|FG002|Overall Study|Lost to Follow-up|0|||
130282531|NCT01638013|468996705|FG001|Overall Study|Lack of Efficacy|11|||
129887013|NCT03095599|467547216|FG000|Overall Study|Withdrawal by Subject|1|||
130042679|NCT02986373|468114392|FG000|Overall Study|Adverse Event|4|||
130042680|NCT02986373|468114392|FG000|Overall Study|Lost to Follow-up|1|||
130042681|NCT02986373|468114392|FG000|Overall Study|Withdrawal by Subject|10|||
130042682|NCT02986373|468114392|FG000|Overall Study|Other|24|||
130282532|NCT01638013|468996706|FG002|Overall Study|Lack of Efficacy|14|||
130282533|NCT01638013|468996704|FG000|Overall Study|Protocol Violation|10|||
130282534|NCT01638013|468996705|FG001|Overall Study|Protocol Violation|7|||
130282535|NCT01638013|468996706|FG002|Overall Study|Protocol Violation|11|||
130282536|NCT01638013|468996704|FG000|Overall Study|Met discontinuation criteria|4|||
130282537|NCT01638013|468996705|FG001|Overall Study|Met discontinuation criteria|0|||
130282538|NCT01638013|468996706|FG002|Overall Study|Met discontinuation criteria|7|||
130282539|NCT01638013|468996704|FG000|Overall Study|Subject Lost to Follow up|1|||
130282540|NCT01638013|468996705|FG001|Overall Study|Subject Lost to Follow up|0|||
130282541|NCT01638013|468996706|FG002|Overall Study|Subject Lost to Follow up|1|||
130282542|NCT01638013|468996704|FG000|Overall Study|Miscellaneous|25|||
130282543|NCT01638013|468996705|FG001|Overall Study|Miscellaneous|19|||
130282544|NCT01638013|468996706|FG002|Overall Study|Miscellaneous|23|||
130282545|NCT01638013|468996704|FG000|Overall Study|Withdrawal of Consent|16|||
130282546|NCT01638013|468996705|FG001|Overall Study|Withdrawal of Consent|12|||
130282547|NCT01638013|468996706|FG002|Overall Study|Withdrawal of Consent|16|||
130282548|NCT01638013|468996704|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
130282549|NCT01638013|468996705|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
130282550|NCT01638013|468996706|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
130282551|NCT01846299|468996709|FG000|Overall Study|Physician Decision|4|||
130282552|NCT01846299|468996710|FG001|Overall Study|Physician Decision|2|||
130282553|NCT01846299|468996709|FG000|Overall Study|Protocol deviation|1|||
130282554|NCT01846299|468996710|FG001|Overall Study|Protocol deviation|0|||
130282555|NCT01846299|468996709|FG000|Overall Study|Death|1|||
130282556|NCT01846299|468996710|FG001|Overall Study|Death|2|||
130282557|NCT01846299|468996709|FG000|Overall Study|Lost to Follow-up|3|||
130282558|NCT01846299|468996710|FG001|Overall Study|Lost to Follow-up|0|||
130282559|NCT01846299|468996709|FG000|Overall Study|Withdrawal by Subject|1|||
130282560|NCT01846299|468996710|FG001|Overall Study|Withdrawal by Subject|6|||
130282561|NCT01846299|468996709|FG000|Overall Study|Adverse Event|2|||
130042683|NCT03414359|468114395|FG000|Overall Study|Lack of Efficacy|1|||
130042684|NCT03414359|468114396|FG001|Overall Study|Lack of Efficacy|1|||
130042685|NCT03414359|468114395|FG000|Overall Study|Protocol Violation|0|||
130042686|NCT03414359|468114396|FG001|Overall Study|Protocol Violation|1|||
130042687|NCT02273973|468114397|FG000|Overall Study|Adverse Event|4|||
130042688|NCT02273973|468114398|FG001|Overall Study|Adverse Event|0|||
130042689|NCT02273973|468114397|FG000|Overall Study|Withdrawal by Subject|2|||
130282562|NCT01846299|468996710|FG001|Overall Study|Adverse Event|0|||
130282563|NCT03559517|468996711|FG000|Overall Study|Withdrawal by Subject|1|||
130282564|NCT03559517|468996712|FG001|Overall Study|Withdrawal by Subject|0|||
130282565|NCT03559517|468996713|FG002|Overall Study|Withdrawal by Subject|0|||
130282566|NCT01330628|468996715|FG000|Overall Study|Death|2|||
130282567|NCT01330628|468996716|FG001|Overall Study|Death|3|||
130282568|NCT01330628|468996715|FG000|Overall Study|Lost to Follow-up|5|||
130282569|NCT01330628|468996716|FG001|Overall Study|Lost to Follow-up|6|||
130282570|NCT01330628|468996715|FG000|Overall Study|Adverse Event|44|||
130282571|NCT01330628|468996716|FG001|Overall Study|Adverse Event|25|||
130282572|NCT01330628|468996715|FG000|Overall Study|Withdrawn|18|||
130282573|NCT01330628|468996716|FG001|Overall Study|Withdrawn|6|||
130282574|NCT01330628|468996715|FG000|Overall Study|Didn't receive study treatment|1|||
130282575|NCT01330628|468996716|FG001|Overall Study|Didn't receive study treatment|0|||
130282576|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Death|5|||
130282577|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Death|0|||
130282578|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Death|0|||
130282579|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
130282580|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
130282581|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
130282582|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
130282583|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
130282584|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
130282585|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
130282586|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
130282587|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
130282588|NCT01357161|468996717|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
130282589|NCT01357161|468996718|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
130282590|NCT01357161|468996719|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
130282591|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
130282592|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
130282593|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
130282594|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
130282595|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
130282596|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
130282597|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
130282598|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
130282599|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
130282600|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
130282601|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
130282602|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
130282603|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
130282604|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
130282605|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
130282606|NCT01357161|468996717|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
130282607|NCT01357161|468996718|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
130282608|NCT01357161|468996719|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
130282609|NCT02013206|468998552|FG000|Overall Study|Progressive disease (PD)|14|||
130282610|NCT02013206|468998553|FG001|Overall Study|Progressive disease (PD)|17|||
130282611|NCT02013206|468998552|FG000|Overall Study|Symptomatic deterioration|3|||
130282612|NCT02013206|468998553|FG001|Overall Study|Symptomatic deterioration|1|||
130282613|NCT02013206|468998552|FG000|Overall Study|Adverse Event|1|||
130282614|NCT02013206|468998553|FG001|Overall Study|Adverse Event|0|||
130282615|NCT02013206|468998552|FG000|Overall Study|Patient refusal|2|||
130282616|NCT02013206|468998553|FG001|Overall Study|Patient refusal|0|||
130282617|NCT02013206|468998552|FG000|Overall Study|Patient non-compliance|1|||
130282618|NCT02013206|468998553|FG001|Overall Study|Patient non-compliance|0|||
130282619|NCT02013206|468998552|FG000|Overall Study|Death|1|||
130282620|NCT02013206|468998553|FG001|Overall Study|Death|2|||
130282621|NCT02013206|468998552|FG000|Overall Study|Other reasons off treatment|5|||
130282622|NCT02013206|468998553|FG001|Overall Study|Other reasons off treatment|2|||
130282623|NCT02791191|468998554|FG000|Overall Study|Adverse Event|2|||
130282624|NCT02791191|468998555|FG001|Overall Study|Adverse Event|4|||
129887014|NCT03095599|467547217|FG001|Overall Study|Withdrawal by Subject|0|||
130282625|NCT02791191|468998556|FG002|Overall Study|Adverse Event|5|||
130282626|NCT02791191|468998554|FG000|Overall Study|Lack of Efficacy|0|||
130282627|NCT02791191|468998555|FG001|Overall Study|Lack of Efficacy|1|||
130282628|NCT02791191|468998556|FG002|Overall Study|Lack of Efficacy|0|||
130282629|NCT02791191|468998554|FG000|Overall Study|Study Drug Non-Compliance|0|||
130282630|NCT02791191|468998555|FG001|Overall Study|Study Drug Non-Compliance|2|||
130042690|NCT02273973|468114398|FG001|Overall Study|Withdrawal by Subject|3|||
130042691|NCT02273973|468114397|FG000|Overall Study|Death|1|||
130282631|NCT02791191|468998556|FG002|Overall Study|Study Drug Non-Compliance|0|||
130042692|NCT02273973|468114398|FG001|Overall Study|Death|0|||
129887015|NCT03095599|467547216|FG000|Overall Study|Lost to Follow-up|1|||
130042693|NCT02273973|468114397|FG000|Overall Study|Non-compliance|1|||
130042694|NCT02273973|468114398|FG001|Overall Study|Non-compliance|0|||
130042695|NCT02273973|468114397|FG000|Overall Study|Protocol Violation|1|||
130042696|NCT02273973|468114398|FG001|Overall Study|Protocol Violation|0|||
130042697|NCT02273973|468114397|FG000|Overall Study|Progression of disease|0|||
130042698|NCT02273973|468114398|FG001|Overall Study|Progression of disease|2|||
130042699|NCT02273973|468114397|FG000|Overall Study|Lost to Follow-up|0|||
130042700|NCT02273973|468114398|FG001|Overall Study|Lost to Follow-up|1|||
130282632|NCT02791191|468998554|FG000|Overall Study|Site Closed by Sponsor|1|||
130282633|NCT02791191|468998555|FG001|Overall Study|Site Closed by Sponsor|1|||
130282634|NCT02791191|468998556|FG002|Overall Study|Site Closed by Sponsor|3|||
130282635|NCT02791191|468998554|FG000|Overall Study|Progressive Disease|1|||
130282636|NCT02791191|468998555|FG001|Overall Study|Progressive Disease|0|||
130282637|NCT02791191|468998556|FG002|Overall Study|Progressive Disease|0|||
130282638|NCT02791191|468998554|FG000|Overall Study|Study Terminated by Sponsor|29|||
130282639|NCT02791191|468998555|FG001|Overall Study|Study Terminated by Sponsor|101|||
130282640|NCT02791191|468998556|FG002|Overall Study|Study Terminated by Sponsor|109|||
130282641|NCT02791191|468998554|FG000|Overall Study|Withdrawal by Subject|3|||
130282642|NCT02791191|468998555|FG001|Overall Study|Withdrawal by Subject|1|||
130282643|NCT02791191|468998556|FG002|Overall Study|Withdrawal by Subject|3|||
130282644|NCT02791191|468998554|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
130282645|NCT02791191|468998555|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
130282646|NCT02791191|468998556|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
130282647|NCT01448824|468998557|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282648|NCT01448824|468998558|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282649|NCT01448824|468998559|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282650|NCT01448824|468998560|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282651|NCT01448824|468998561|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282652|NCT01448824|468998562|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282653|NCT01448824|468998563|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
130282654|NCT01448824|468998564|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
130282655|NCT01448824|468998557|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282656|NCT01448824|468998558|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282657|NCT01448824|468998559|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282658|NCT01448824|468998560|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
130282659|NCT01448824|468998561|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
130282660|NCT01448824|468998562|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
130282661|NCT01448824|468998563|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282662|NCT01448824|468998564|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
130282663|NCT01448824|468998557|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282664|NCT01448824|468998558|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282665|NCT01448824|468998559|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282666|NCT01448824|468998560|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282667|NCT01448824|468998561|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282668|NCT01448824|468998562|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
130282669|NCT01448824|468998563|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282670|NCT01448824|468998564|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
130282671|NCT01448824|468998557|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
130282672|NCT01448824|468998558|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
130282673|NCT01448824|468998559|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
130282674|NCT01448824|468998560|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
130282675|NCT01448824|468998561|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
130282676|NCT01448824|468998562|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
130282677|NCT01448824|468998563|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
130282678|NCT01448824|468998564|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
130282679|NCT01448824|468998557|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282680|NCT01448824|468998558|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282681|NCT01448824|468998559|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282682|NCT01448824|468998560|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282683|NCT01448824|468998561|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282684|NCT01448824|468998562|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282685|NCT01448824|468998563|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
130282686|NCT01448824|468998564|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
130282687|NCT01448824|468998557|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282688|NCT01448824|468998558|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282689|NCT01448824|468998559|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130106207|NCT03343054|468349932|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
130042701|NCT02273973|468114397|FG000|Overall Study|Physician Decision|0|||
130282690|NCT01448824|468998560|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282691|NCT01448824|468998561|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282692|NCT01448824|468998562|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282693|NCT01448824|468998563|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
130282694|NCT01448824|468998564|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
130282695|NCT01448824|468998557|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282696|NCT01448824|468998558|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282697|NCT01448824|468998559|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282698|NCT01448824|468998560|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282699|NCT01448824|468998561|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282700|NCT01448824|468998562|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282701|NCT01448824|468998563|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
130282702|NCT01448824|468998564|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
130282703|NCT01448824|468998557|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282704|NCT01448824|468998558|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282705|NCT01448824|468998559|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282706|NCT01448824|468998560|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282707|NCT01448824|468998561|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282708|NCT01448824|468998562|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282709|NCT01448824|468998563|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
130282710|NCT01448824|468998564|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
130282711|NCT01995669|468998567|FG000|Overall Study|Progression|2|||
130282712|NCT01995669|468998568|FG001|Overall Study|Progression|1|||
130282713|NCT01995669|468998569|FG002|Overall Study|Progression|1|||
130282714|NCT01995669|468998570|FG003|Overall Study|Progression|13|||
130282715|NCT01995669|468998567|FG000|Overall Study|Adverse Event|0|||
130282716|NCT01995669|468998568|FG001|Overall Study|Adverse Event|0|||
130282717|NCT01995669|468998569|FG002|Overall Study|Adverse Event|0|||
130282718|NCT01995669|468998570|FG003|Overall Study|Adverse Event|3|||
130282719|NCT01995669|468998567|FG000|Overall Study|Death|0|||
130282720|NCT01995669|468998568|FG001|Overall Study|Death|0|||
130282721|NCT01995669|468998569|FG002|Overall Study|Death|0|||
130282722|NCT01995669|468998570|FG003|Overall Study|Death|6|||
130282723|NCT01995669|468998567|FG000|Overall Study|Withdrawal by Subject|0|||
130282724|NCT01995669|468998568|FG001|Overall Study|Withdrawal by Subject|0|||
130282725|NCT01995669|468998569|FG002|Overall Study|Withdrawal by Subject|0|||
130282726|NCT01995669|468998570|FG003|Overall Study|Withdrawal by Subject|6|||
130282727|NCT01995669|468998567|FG000|Overall Study|Insurance Expired|0|||
130282728|NCT01995669|468998568|FG001|Overall Study|Insurance Expired|0|||
130282729|NCT01995669|468998569|FG002|Overall Study|Insurance Expired|0|||
130282730|NCT01995669|468998570|FG003|Overall Study|Insurance Expired|1|||
130282731|NCT05425732|468998571|FG000|Overall Study|Death|4|||
130282732|NCT05425732|468998572|FG001|Overall Study|Death|2|||
130282733|NCT05425732|468998573|FG002|Overall Study|Death|0|||
130282734|NCT05425732|468998574|FG003|Overall Study|Death|0|||
130282735|NCT05425732|468998571|FG000|Overall Study|Lost to Follow-up|10|||
130282736|NCT05425732|468998572|FG001|Overall Study|Lost to Follow-up|15|||
130282737|NCT05425732|468998573|FG002|Overall Study|Lost to Follow-up|5|||
130282738|NCT05425732|468998574|FG003|Overall Study|Lost to Follow-up|3|||
130282739|NCT05425732|468998571|FG000|Overall Study|Physician Decision|0|||
130282740|NCT05425732|468998572|FG001|Overall Study|Physician Decision|2|||
130282741|NCT05425732|468998573|FG002|Overall Study|Physician Decision|0|||
129887016|NCT03095599|467547217|FG001|Overall Study|Lost to Follow-up|0|||
130282742|NCT05425732|468998574|FG003|Overall Study|Physician Decision|0|||
130282743|NCT05425732|468998571|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130042702|NCT02273973|468114398|FG001|Overall Study|Physician Decision|1|||
130042703|NCT02273973|468114397|FG000|Overall Study|Reason not specified|0|||
130042704|NCT02273973|468114398|FG001|Overall Study|Reason not specified|1|||
130042705|NCT00957372|468114399|FG000|PART I|Lost to Follow-up|0|||
130042706|NCT00957372|468114400|FG001|PART I|Lost to Follow-up|0|||
130042707|NCT00957372|468114401|FG002|PART I|Lost to Follow-up|1|||
130282744|NCT05425732|468998572|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
130282745|NCT05425732|468998573|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130282746|NCT05425732|468998574|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130282747|NCT05425732|468998571|FG000|Overall Study|Withdrawal by Subject|4|||
130282748|NCT05425732|468998572|FG001|Overall Study|Withdrawal by Subject|8|||
130282749|NCT05425732|468998573|FG002|Overall Study|Withdrawal by Subject|1|||
130282750|NCT05425732|468998574|FG003|Overall Study|Withdrawal by Subject|1|||
130282751|NCT05425732|468998571|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
130282752|NCT05425732|468998572|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130282753|NCT05425732|468998573|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130282754|NCT05425732|468998574|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
130282755|NCT02998203|468998575|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
130282756|NCT02998203|468998576|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
130282757|NCT02998203|468998575|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
130282758|NCT02998203|468998576|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
130282759|NCT04187144|468998577|FG000|Overall Study|Lost to Follow-up|12|||
130282760|NCT04187144|468998578|FG001|Overall Study|Lost to Follow-up|11|||
130282761|NCT04187144|468998577|FG000|Overall Study|Withdrawal by Subject|20|||
130282762|NCT04187144|468998578|FG001|Overall Study|Withdrawal by Subject|18|||
130282763|NCT04187144|468998577|FG000|Overall Study|Adverse Event|19|||
130282764|NCT04187144|468998578|FG001|Overall Study|Adverse Event|4|||
130282765|NCT04187144|468998577|FG000|Overall Study|Physician Decision|5|||
130282766|NCT04187144|468998578|FG001|Overall Study|Physician Decision|3|||
130282767|NCT04187144|468998577|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
130282768|NCT04187144|468998578|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
130282769|NCT04187144|468998577|FG000|Overall Study|Protocol Deviation|1|||
130282770|NCT04187144|468998578|FG001|Overall Study|Protocol Deviation|4|||
130282771|NCT02650804|468998579|FG000|Overall Study|Adverse Event|3|||
130282772|NCT02650804|468998580|FG001|Overall Study|Adverse Event|2|||
130282773|NCT02650804|468998579|FG000|Overall Study|Death|1|||
130282774|NCT02650804|468998580|FG001|Overall Study|Death|2|||
130282775|NCT02650804|468998579|FG000|Overall Study|Progressive Disease|7|||
130282776|NCT02650804|468998580|FG001|Overall Study|Progressive Disease|10|||
130282777|NCT02650804|468998579|FG000|Overall Study|Physician Decision|0|||
130282778|NCT02650804|468998580|FG001|Overall Study|Physician Decision|2|||
130282779|NCT02650804|468998579|FG000|Overall Study|Withdrawal by Subject|1|||
130282780|NCT02650804|468998580|FG001|Overall Study|Withdrawal by Subject|4|||
130282781|NCT02650804|468998579|FG000|Overall Study|Symptomatic deterioration|5|||
130282782|NCT02650804|468998580|FG001|Overall Study|Symptomatic deterioration|7|||
130282783|NCT02650804|468998579|FG000|Overall Study|Protocol Violation|0|||
130282784|NCT02650804|468998580|FG001|Overall Study|Protocol Violation|1|||
130282785|NCT02743949|468998581|FG000|Overall Study|Adverse Event|0|||
130282786|NCT02743949|468998582|FG001|Overall Study|Adverse Event|0|||
130282787|NCT02743949|468998583|FG002|Overall Study|Adverse Event|2|||
130282788|NCT02743949|468998581|FG000|Overall Study|Significant Protocol Deviation|2|||
130282789|NCT02743949|468998582|FG001|Overall Study|Significant Protocol Deviation|0|||
130282790|NCT02743949|468998583|FG002|Overall Study|Significant Protocol Deviation|1|||
130282791|NCT02743949|468998581|FG000|Overall Study|Voluntary Withdrawal|2|||
130282792|NCT02743949|468998582|FG001|Overall Study|Voluntary Withdrawal|1|||
130282793|NCT02743949|468998583|FG002|Overall Study|Voluntary Withdrawal|0|||
130282794|NCT03389555|468998584|FG000|Overall Study|Protocol Violation|1|||
130282795|NCT03389555|468998585|FG001|Overall Study|Protocol Violation|3|||
130282796|NCT03389555|468998584|FG000|Overall Study|Death|1|||
130282797|NCT03389555|468998585|FG001|Overall Study|Death|0|||
130282798|NCT00920218|468998586|FG000|Overall Study|Serious Adverse Event|2|||
130282799|NCT00920218|468998587|FG001|Overall Study|Serious Adverse Event|0|||
130282800|NCT00920218|468998588|FG002|Overall Study|Serious Adverse Event|2|||
130282801|NCT00920218|468998589|FG003|Overall Study|Serious Adverse Event|1|||
130282802|NCT00920218|468998586|FG000|Overall Study|Withdrawal by Subject|0|||
130282803|NCT00920218|468998587|FG001|Overall Study|Withdrawal by Subject|3|||
130282804|NCT00920218|468998588|FG002|Overall Study|Withdrawal by Subject|2|||
130282805|NCT00920218|468998589|FG003|Overall Study|Withdrawal by Subject|0|||
130282806|NCT00920218|468998586|FG000|Overall Study|Migrated/moved from study area|0|||
130282807|NCT00920218|468998587|FG001|Overall Study|Migrated/moved from study area|0|||
130282808|NCT00920218|468998588|FG002|Overall Study|Migrated/moved from study area|1|||
130282809|NCT00920218|468998589|FG003|Overall Study|Migrated/moved from study area|0|||
130282810|NCT00920218|468998586|FG000|Overall Study|Lost to Follow-up|0|||
130282811|NCT00920218|468998587|FG001|Overall Study|Lost to Follow-up|1|||
130282812|NCT00920218|468998588|FG002|Overall Study|Lost to Follow-up|0|||
130282813|NCT00920218|468998589|FG003|Overall Study|Lost to Follow-up|3|||
130282814|NCT00920218|468998586|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
130282815|NCT00920218|468998587|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
130282816|NCT00920218|468998588|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
130282817|NCT00920218|468998589|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
130282818|NCT00920218|468998586|FG000|Overall Study|Other|0|||
130282819|NCT00920218|468998587|FG001|Overall Study|Other|0|||
130282820|NCT00920218|468998588|FG002|Overall Study|Other|1|||
130282821|NCT00920218|468998589|FG003|Overall Study|Other|0|||
130282822|NCT01007435|468998590|FG000|Overall Study|Adverse Event|16|||
130282823|NCT01007435|468998591|FG001|Overall Study|Adverse Event|25|||
130282824|NCT01007435|468998592|FG002|Overall Study|Adverse Event|47|||
130282825|NCT01007435|468998593|FG003|Overall Study|Adverse Event|31|||
130282826|NCT01007435|468998590|FG000|Overall Study|Death|2|||
130282827|NCT01007435|468998591|FG001|Overall Study|Death|4|||
130282828|NCT01007435|468998592|FG002|Overall Study|Death|2|||
130282829|NCT01007435|468998593|FG003|Overall Study|Death|1|||
130282830|NCT01007435|468998590|FG000|Overall Study|Insufficient Therapeutic Response|21|||
130282831|NCT01007435|468998591|FG001|Overall Study|Insufficient Therapeutic Response|7|||
130282832|NCT01007435|468998592|FG002|Overall Study|Insufficient Therapeutic Response|2|||
130282833|NCT01007435|468998593|FG003|Overall Study|Insufficient Therapeutic Response|9|||
130282834|NCT01007435|468998590|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
130042708|NCT00957372|468114402|FG003|PART I|Lost to Follow-up|0|||
130282835|NCT01007435|468998591|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
130282836|NCT01007435|468998592|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
130282837|NCT01007435|468998593|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
130282838|NCT01007435|468998590|FG000|Overall Study|Other Protocol Violation|2|||
130282839|NCT01007435|468998591|FG001|Overall Study|Other Protocol Violation|0|||
130282840|NCT01007435|468998592|FG002|Overall Study|Other Protocol Violation|1|||
130282841|NCT01007435|468998593|FG003|Overall Study|Other Protocol Violation|0|||
130282842|NCT01007435|468998590|FG000|Overall Study|Refused Treatment|13|||
130282843|NCT01007435|468998591|FG001|Overall Study|Refused Treatment|13|||
130282844|NCT01007435|468998592|FG002|Overall Study|Refused Treatment|5|||
130282845|NCT01007435|468998593|FG003|Overall Study|Refused Treatment|8|||
130282846|NCT01007435|468998590|FG000|Overall Study|Failure to Return|5|||
130282847|NCT01007435|468998591|FG001|Overall Study|Failure to Return|4|||
130282848|NCT01007435|468998592|FG002|Overall Study|Failure to Return|3|||
130282849|NCT01007435|468998593|FG003|Overall Study|Failure to Return|6|||
130282850|NCT01007435|468998590|FG000|Overall Study|Reason not Specified|1|||
130282851|NCT01007435|468998591|FG001|Overall Study|Reason not Specified|1|||
130282852|NCT01007435|468998592|FG002|Overall Study|Reason not Specified|2|||
130282853|NCT01007435|468998593|FG003|Overall Study|Reason not Specified|1|||
130282854|NCT01345591|468998596|FG000|Overall Study|Lost to Follow-up|1|||
130282855|NCT00847665|468998603|FG000|Overall Study|Withdrawal by Subject|1|||
130282856|NCT00847665|468998604|FG001|Overall Study|Withdrawal by Subject|0|||
130282857|NCT03077438|468998611|FG000|Overall Study|Protocol Violation|3|||
130282858|NCT03077438|468998612|FG001|Overall Study|Protocol Violation|5|||
130282859|NCT03077438|468998611|FG000|Overall Study|Withdrawal by Subject|3|||
130282860|NCT03077438|468998612|FG001|Overall Study|Withdrawal by Subject|6|||
130282861|NCT03077438|468998611|FG000|Overall Study|Lost to Follow-up|6|||
130282862|NCT03077438|468998612|FG001|Overall Study|Lost to Follow-up|3|||
130282863|NCT01190475|468998613|FG000|Overall Study|Withdrawal by Subject|0|||
130282864|NCT01190475|468998614|FG001|Overall Study|Withdrawal by Subject|0|||
130282865|NCT01190475|468998615|FG002|Overall Study|Withdrawal by Subject|1|||
130282866|NCT00624585|468998616|FG000|Overall Study|Death|3|||
130282867|NCT00624585|468998616|FG000|Overall Study|Disease Progression|6|||
130282868|NCT00624585|468998616|FG000|Overall Study|Adverse Event|3|||
130282869|NCT00676520|468998620|FG000|Overall Study|Withdrawal by Subject|163|||
130282870|NCT00676520|468998620|FG000|Overall Study|Lost to Follow-up|162|||
130282871|NCT00676520|468998620|FG000|Overall Study|Death|159|||
130042709|NCT00957372|468114399|FG000|PART II|Withdrawal by Subject|0|||
130042710|NCT00957372|468114400|FG001|PART II|Withdrawal by Subject|0|||
130042711|NCT00957372|468114401|FG002|PART II|Withdrawal by Subject|0|||
130042712|NCT00957372|468114402|FG003|PART II|Withdrawal by Subject|8|||
130282872|NCT00676520|468998620|FG000|Overall Study|Physician Decision|20|||
130282873|NCT00676520|468998620|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
130282874|NCT00676520|468998620|FG000|Overall Study|Other Reason|18|||
130282875|NCT01425359|468998621|FG000|Overall Study|Randomized but Not Treated|2|||
130282876|NCT01425359|468998622|FG001|Overall Study|Randomized but Not Treated|3|||
130042713|NCT00957372|468114399|FG000|PART II|Physician Decision|0|||
130282877|NCT01425359|468998621|FG000|Overall Study|Adverse Event|9|||
130282878|NCT01425359|468998622|FG001|Overall Study|Adverse Event|8|||
130282879|NCT01425359|468998621|FG000|Overall Study|Revascularization|0|||
130282880|NCT01425359|468998622|FG001|Overall Study|Revascularization|1|||
130282881|NCT01425359|468998621|FG000|Overall Study|Death|0|||
130282882|NCT01425359|468998622|FG001|Overall Study|Death|1|||
130282883|NCT01425359|468998621|FG000|Overall Study|Unsatisfactory Response|1|||
130282884|NCT01425359|468998622|FG001|Overall Study|Unsatisfactory Response|0|||
130282885|NCT01425359|468998621|FG000|Overall Study|Protocol Violation|1|||
130282886|NCT01425359|468998622|FG001|Overall Study|Protocol Violation|2|||
130282887|NCT01425359|468998621|FG000|Overall Study|Subject Withdrew Consent|1|||
130282888|NCT01425359|468998622|FG001|Overall Study|Subject Withdrew Consent|2|||
130282889|NCT01425359|468998621|FG000|Overall Study|Investigator's Discretion|2|||
130282890|NCT01425359|468998622|FG001|Overall Study|Investigator's Discretion|0|||
130282891|NCT01425359|468998621|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
130282892|NCT01425359|468998622|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
130282893|NCT03172325|468998623|FG000|Overall Study|Adverse Event|2|||
130282894|NCT03172325|468998624|FG001|Overall Study|Adverse Event|3|||
130282895|NCT03172325|468998623|FG000|Overall Study|Positive PPD|1|||
130282896|NCT03172325|468998624|FG001|Overall Study|Positive PPD|0|||
130282897|NCT03172325|468998623|FG000|Overall Study|Poor Compliance|1|||
130282898|NCT03172325|468998624|FG001|Overall Study|Poor Compliance|1|||
130282899|NCT03305419|468998640|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282900|NCT03305419|468998641|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
130282901|NCT03305419|468998642|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282902|NCT03305419|468998643|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282903|NCT03305419|468998644|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282904|NCT03305419|468998645|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282905|NCT03305419|468998646|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282906|NCT03305419|468998647|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
130282907|NCT03305419|468998640|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
130282908|NCT03305419|468998641|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282909|NCT03305419|468998642|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282910|NCT03305419|468998643|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282911|NCT03305419|468998644|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282912|NCT03305419|468998645|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282913|NCT03305419|468998646|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282914|NCT03305419|468998647|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
130282915|NCT03305419|468998640|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
130282916|NCT03305419|468998641|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282917|NCT03305419|468998642|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282918|NCT03305419|468998643|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282919|NCT03305419|468998644|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282920|NCT03305419|468998645|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282921|NCT03305419|468998646|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282922|NCT03305419|468998647|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
130282923|NCT03305419|468998640|FG000|Part B (14 Days)|Adverse Event|0|||
130282924|NCT03305419|468998641|FG001|Part B (14 Days)|Adverse Event|0|||
130282925|NCT03305419|468998642|FG002|Part B (14 Days)|Adverse Event|0|||
130282926|NCT03305419|468998643|FG003|Part B (14 Days)|Adverse Event|0|||
130282927|NCT03305419|468998644|FG004|Part B (14 Days)|Adverse Event|1|||
130282928|NCT03305419|468998645|FG005|Part B (14 Days)|Adverse Event|2|||
130282929|NCT03305419|468998646|FG006|Part B (14 Days)|Adverse Event|4|||
130282930|NCT03305419|468998647|FG007|Part B (14 Days)|Adverse Event|0|||
130282931|NCT03305419|468998640|FG000|Part B (14 Days)|Physician Decision|0|||
130282932|NCT03305419|468998641|FG001|Part B (14 Days)|Physician Decision|0|||
130282933|NCT03305419|468998642|FG002|Part B (14 Days)|Physician Decision|0|||
130282934|NCT03305419|468998643|FG003|Part B (14 Days)|Physician Decision|0|||
130282935|NCT03305419|468998644|FG004|Part B (14 Days)|Physician Decision|2|||
130282936|NCT03305419|468998645|FG005|Part B (14 Days)|Physician Decision|8|||
130282937|NCT03305419|468998646|FG006|Part B (14 Days)|Physician Decision|1|||
130282938|NCT03305419|468998647|FG007|Part B (14 Days)|Physician Decision|0|||
130282939|NCT00889603|468998649|FG000|Overall Study|Adverse Event|7|||
130282940|NCT00889603|468998649|FG000|Overall Study|Death|3|||
130282941|NCT00889603|468998649|FG000|Overall Study|Lost to Follow-up|19|||
130282942|NCT00889603|468998649|FG000|Overall Study|No longer willing to participant in stud|4|||
130282943|NCT00889603|468998649|FG000|Overall Study|Other|4|||
130282944|NCT01895543|468998650|FG000|Overall Study|Withdrawal by Subject|43|||
130282945|NCT01895543|468998650|FG000|Overall Study|Lost to Follow-up|25|||
130282946|NCT01895543|468998650|FG000|Overall Study|Adverse Event|28|||
130282947|NCT01895543|468998650|FG000|Overall Study|Subject's substantial non-compliance|6|||
130282948|NCT01895543|468998650|FG000|Overall Study|Protocol Violation|1|||
130282949|NCT01895543|468998650|FG000|Overall Study|Physician Decision|2|||
130282950|NCT01895543|468998650|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
130282951|NCT04659174|468998655|FG000|Overall Study|Sponsor decision to discontinue study|0|||
130282952|NCT04659174|468998656|FG001|Overall Study|Sponsor decision to discontinue study|2|||
130282953|NCT04659174|468998655|FG000|Overall Study|Lost to Follow-up|9|||
130282954|NCT04659174|468998656|FG001|Overall Study|Lost to Follow-up|11|||
130282955|NCT04659174|468998655|FG000|Overall Study|Adverse Event|8|||
130282956|NCT04659174|468998656|FG001|Overall Study|Adverse Event|5|||
130282957|NCT04659174|468998655|FG000|Overall Study|Withdrawal by Subject|17|||
130282958|NCT04659174|468998656|FG001|Overall Study|Withdrawal by Subject|33|||
130282959|NCT04659174|468998655|FG000|Overall Study|Progressive disease|0|||
130282960|NCT04659174|468998656|FG001|Overall Study|Progressive disease|2|||
130282961|NCT04659174|468998655|FG000|Overall Study|Other reasons|0|||
130282962|NCT04659174|468998656|FG001|Overall Study|Other reasons|2|||
130282963|NCT04659174|468998655|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
130282964|NCT04659174|468998656|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
130282965|NCT04659174|468998655|FG000|Overall Study|Alcohol or illegal drug use|0|||
130282966|NCT04659174|468998656|FG001|Overall Study|Alcohol or illegal drug use|3|||
130282967|NCT04659174|468998655|FG000|Overall Study|Violation of entry criteria|1|||
130282968|NCT04659174|468998656|FG001|Overall Study|Violation of entry criteria|0|||
130282969|NCT04659174|468998655|FG000|Overall Study|Death|0|||
130282970|NCT04659174|468998656|FG001|Overall Study|Death|1|||
130282971|NCT05129449|468998657|FG000|Overall Study|Protocol Violation|1|||
130282972|NCT03650803|468998659|FG000|Overall Study|Lost to Follow-up|6|||
130282973|NCT02901054|468998660|FG000|Overall Study|Physician Decision|1|||
130282974|NCT02901054|468998660|FG000|Overall Study|Withdrawal by Subject|3|||
130282975|NCT01534260|468998661|FG000|Overall Study|Adverse Event|1|||
130282976|NCT01534260|468998662|FG001|Overall Study|Adverse Event|8|||
130282977|NCT01534260|468998661|FG000|Overall Study|Death|2|||
130282978|NCT01534260|468998662|FG001|Overall Study|Death|0|||
130282979|NCT01534260|468998661|FG000|Overall Study|Lack of Efficacy|1|||
130282980|NCT01534260|468998662|FG001|Overall Study|Lack of Efficacy|1|||
130282981|NCT01534260|468998661|FG000|Overall Study|Withdrawal by Subject|1|||
130282982|NCT01534260|468998662|FG001|Overall Study|Withdrawal by Subject|3|||
130282983|NCT01534260|468998661|FG000|Overall Study|Disease Progression|8|||
130282984|NCT01534260|468998662|FG001|Overall Study|Disease Progression|6|||
130282985|NCT01534260|468998661|FG000|Overall Study|Physician Decision|3|||
130282986|NCT01534260|468998662|FG001|Overall Study|Physician Decision|1|||
130282987|NCT01534260|468998661|FG000|Overall Study|No treatment, per protocol|0|||
130282988|NCT01534260|468998662|FG001|Overall Study|No treatment, per protocol|1|||
130282989|NCT01818258|468998665|FG000|Overall Study|Death|3|||
130282990|NCT01818258|468998666|FG001|Overall Study|Death|0|||
130282991|NCT01818258|468998665|FG000|Overall Study|Withdrawal by Subject|0|||
130282992|NCT01818258|468998666|FG001|Overall Study|Withdrawal by Subject|1|||
130282993|NCT01818258|468998665|FG000|Overall Study|Lost to Follow-up|0|||
130282994|NCT01818258|468998666|FG001|Overall Study|Lost to Follow-up|1|||
130282995|NCT01818258|468998665|FG000|Overall Study|Unable to Travel to Clinic|0|||
130282996|NCT01818258|468998666|FG001|Overall Study|Unable to Travel to Clinic|1|||
130282997|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
130282998|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
130282999|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
130283000|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
130283001|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
130283002|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
130283003|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
130283004|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
130283005|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
130283006|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
130283007|NCT01639339|468998671|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
130283008|NCT01639339|468998672|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
130283009|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
130283010|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
130283011|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
130283012|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
130283013|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
130042714|NCT00957372|468114400|FG001|PART II|Physician Decision|0|||
130042715|NCT00957372|468114401|FG002|PART II|Physician Decision|0|||
130283014|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
130283015|NCT01639339|468998671|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
130283016|NCT01639339|468998672|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
130283017|NCT05145322|468998676|FG000|Overall Study|Lost to Follow-up|4|||
130042716|NCT00957372|468114402|FG003|PART II|Physician Decision|1|||
130042717|NCT00957372|468114399|FG000|PART II|Pregnancy|0|||
130283018|NCT05145322|468998677|FG001|Overall Study|Lost to Follow-up|5|||
130283019|NCT03022097|468998678|FG000|Overall Study|Adverse Event|3|||
130283020|NCT03022097|468998679|FG001|Overall Study|Adverse Event|4|||
130283021|NCT03022097|468998680|FG002|Overall Study|Adverse Event|1|||
130283022|NCT03022097|468998681|FG003|Overall Study|Adverse Event|3|||
130283023|NCT03022097|468998678|FG000|Overall Study|Progressive Disease|2|||
130283024|NCT03022097|468998679|FG001|Overall Study|Progressive Disease|0|||
130283025|NCT03022097|468998680|FG002|Overall Study|Progressive Disease|5|||
129887017|NCT03095599|467547216|FG000|Overall Study|Withdrawal prior to vaccination|1|||
130283026|NCT03022097|468998681|FG003|Overall Study|Progressive Disease|2|||
130283027|NCT03022097|468998678|FG000|Overall Study|Lack of Efficacy|0|||
130283028|NCT03022097|468998679|FG001|Overall Study|Lack of Efficacy|0|||
130283029|NCT03022097|468998680|FG002|Overall Study|Lack of Efficacy|3|||
130283030|NCT03022097|468998681|FG003|Overall Study|Lack of Efficacy|3|||
130283031|NCT03022097|468998678|FG000|Overall Study|Protocol Violation|1|||
130283032|NCT03022097|468998679|FG001|Overall Study|Protocol Violation|0|||
130283033|NCT03022097|468998680|FG002|Overall Study|Protocol Violation|1|||
130283034|NCT03022097|468998681|FG003|Overall Study|Protocol Violation|0|||
130283035|NCT03022097|468998678|FG000|Overall Study|Withdrawal by Subject|11|||
130283036|NCT03022097|468998679|FG001|Overall Study|Withdrawal by Subject|13|||
130283037|NCT03022097|468998680|FG002|Overall Study|Withdrawal by Subject|15|||
130283038|NCT03022097|468998681|FG003|Overall Study|Withdrawal by Subject|21|||
130283039|NCT03022097|468998678|FG000|Overall Study|Lost to Follow-up|0|||
130283040|NCT03022097|468998679|FG001|Overall Study|Lost to Follow-up|0|||
130283041|NCT03022097|468998680|FG002|Overall Study|Lost to Follow-up|1|||
130283042|NCT03022097|468998681|FG003|Overall Study|Lost to Follow-up|1|||
130283043|NCT03022097|468998678|FG000|Overall Study|Other|4|||
130283044|NCT03022097|468998679|FG001|Overall Study|Other|1|||
130283045|NCT03022097|468998680|FG002|Overall Study|Other|6|||
130283046|NCT03022097|468998681|FG003|Overall Study|Other|4|||
130283047|NCT03022097|468998678|FG000|Overall Study|Due to COVID-19 pandemic|0|||
130283048|NCT03022097|468998679|FG001|Overall Study|Due to COVID-19 pandemic|1|||
130283049|NCT03022097|468998680|FG002|Overall Study|Due to COVID-19 pandemic|0|||
130283050|NCT03022097|468998681|FG003|Overall Study|Due to COVID-19 pandemic|0|||
130283051|NCT01349322|468998684|FG000|Overall Study|Protocol Violation|45|||
130283052|NCT01349322|468998685|FG001|Overall Study|Protocol Violation|47|||
130283053|NCT05593913|468998690|FG000|Overall Study|Insufficient image quality|39|||
130283054|NCT04470908|468998691|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
130283055|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
130283056|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
130283057|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
130283058|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
130283059|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
130283060|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
130283061|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
130283062|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
130283063|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
130283064|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
130283065|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
130283066|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
130283067|NCT04376684|468998692|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
130283068|NCT04376684|468998693|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
130283069|NCT04376684|468998694|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
130283070|NCT04376684|468998695|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
130283071|NCT04376684|468998692|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
130283072|NCT04376684|468998693|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
130283073|NCT04376684|468998694|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
130283074|NCT04376684|468998695|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
130283075|NCT04376684|468998692|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
130283076|NCT04376684|468998693|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
130283077|NCT04376684|468998694|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
130283078|NCT04376684|468998695|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
130283079|NCT04376684|468998692|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
130283080|NCT04376684|468998693|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
130283081|NCT04376684|468998694|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
130283082|NCT04376684|468998695|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
130283083|NCT02136680|468998698|FG000|Overall Study|No Longer Interested|1|||
130283084|NCT02136680|468998699|FG001|Overall Study|No Longer Interested|1|||
130283085|NCT02136680|468998698|FG000|Overall Study|No longer receiving care at clinic|3|||
130283086|NCT02136680|468998699|FG001|Overall Study|No longer receiving care at clinic|5|||
130283087|NCT02136680|468998698|FG000|Overall Study|Moved away|5|||
130283088|NCT02136680|468998699|FG001|Overall Study|Moved away|4|||
130283089|NCT02136680|468998698|FG000|Overall Study|Unable to schedule|17|||
130283090|NCT02136680|468998699|FG001|Overall Study|Unable to schedule|16|||
130283091|NCT02136680|468998698|FG000|Overall Study|Study ended before interview due|6|||
130283092|NCT02136680|468998699|FG001|Overall Study|Study ended before interview due|3|||
130283093|NCT05151445|468998700|FG000|Overall Study|Withdrawal by Subject|3|||
130283094|NCT01457014|468998701|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
130283095|NCT01457014|468998702|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
130283096|NCT01457014|468998703|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
130283097|NCT01457014|468998704|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
130283098|NCT01457014|468998701|FG000|First Night|Withdrawal by Subject|3|||
130283099|NCT01457014|468998702|FG001|First Night|Withdrawal by Subject|0|||
130283100|NCT01457014|468998703|FG002|First Night|Withdrawal by Subject|0|||
130283101|NCT01457014|468998704|FG003|First Night|Withdrawal by Subject|0|||
130283102|NCT05463744|468998705|FG000|Treatment Period|Withdrawal by Subject|19|||
130283103|NCT05463744|468998706|FG001|Treatment Period|Withdrawal by Subject|16|||
130283104|NCT05463744|468998705|FG000|Treatment Period|Adverse Event|4|||
130283105|NCT05463744|468998706|FG001|Treatment Period|Adverse Event|4|||
130283106|NCT05463744|468998705|FG000|Treatment Period|Pregnancy|0|||
130283107|NCT05463744|468998706|FG001|Treatment Period|Pregnancy|3|||
130283108|NCT05463744|468998705|FG000|Treatment Period|Lost to Follow-up|1|||
130283109|NCT05463744|468998706|FG001|Treatment Period|Lost to Follow-up|3|||
130283110|NCT05463744|468998705|FG000|Treatment Period|Inadvertent enrollment|2|||
130283111|NCT05463744|468998706|FG001|Treatment Period|Inadvertent enrollment|1|||
130283112|NCT05463744|468998705|FG000|Treatment Period|Death|0|||
130283113|NCT05463744|468998706|FG001|Treatment Period|Death|1|||
130283114|NCT05463744|468998705|FG000|Treatment Period|Non-compliance with Study Drug|1|||
130283115|NCT05463744|468998706|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130283116|NCT05463744|468998705|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
130283117|NCT05463744|468998706|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
130283118|NCT05463744|468998705|FG000|Treatment Period|Physician Decision|0|||
130283119|NCT05463744|468998706|FG001|Treatment Period|Physician Decision|1|||
130283120|NCT05463744|468998705|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130283121|NCT05463744|468998706|FG001|Follow-Up Period|Withdrawal by Subject|1|||
130283122|NCT05463744|468998705|FG000|Follow-Up Period|Lost to Follow-up|1|||
130283123|NCT05463744|468998706|FG001|Follow-Up Period|Lost to Follow-up|1|||
130283124|NCT02825420|468998709|FG000|Overall Study|Death|30|||
130283125|NCT02825420|468998710|FG001|Overall Study|Death|12|||
130283126|NCT02825420|468998709|FG000|Overall Study|Progressive disease|6|||
130283127|NCT02825420|468998710|FG001|Overall Study|Progressive disease|1|||
130283128|NCT02825420|468998709|FG000|Overall Study|Lost to Follow-up|2|||
130283129|NCT02825420|468998710|FG001|Overall Study|Lost to Follow-up|2|||
130283130|NCT02825420|468998709|FG000|Overall Study|Withdrawal by Subject|1|||
130283131|NCT02825420|468998710|FG001|Overall Study|Withdrawal by Subject|1|||
130283132|NCT02825420|468998709|FG000|Overall Study|Protocol amendment not signed|1|||
130283133|NCT02825420|468998710|FG001|Overall Study|Protocol amendment not signed|1|||
130283134|NCT02825420|468998709|FG000|Overall Study|Physician Decision|1|||
130283135|NCT02825420|468998710|FG001|Overall Study|Physician Decision|0|||
130283136|NCT02825420|468998709|FG000|Overall Study|Did not receive PLD|2|||
130283137|NCT02825420|468998710|FG001|Overall Study|Did not receive PLD|0|||
130283138|NCT04027049|468998711|FG000|Overall Study|Withdrawn by family|1|||
130283139|NCT04027049|468998712|FG001|Overall Study|Withdrawn by family|0|||
130283140|NCT04027049|468998711|FG000|Overall Study|Participant safety|1|||
130283141|NCT04027049|468998712|FG001|Overall Study|Participant safety|0|||
130283142|NCT02264665|469000398|FG000|Overall Study|Other|0|||
130283143|NCT02264665|469000399|FG001|Overall Study|Other|0|||
130283144|NCT02264665|469000400|FG002|Overall Study|Other|3|||
130283145|NCT02264665|469000401|FG003|Overall Study|Other|0|||
130283146|NCT02264665|469000402|FG004|Overall Study|Other|0|||
130283147|NCT02264665|469000403|FG005|Overall Study|Other|0|||
130042718|NCT00957372|468114400|FG001|PART II|Pregnancy|0|||
130283148|NCT02264665|469000404|FG006|Overall Study|Other|0|||
130283149|NCT02264665|469000398|FG000|Overall Study|Death|9|||
130283150|NCT02264665|469000399|FG001|Overall Study|Death|8|||
130283151|NCT02264665|469000400|FG002|Overall Study|Death|13|||
130283152|NCT02264665|469000401|FG003|Overall Study|Death|5|||
130283153|NCT02264665|469000402|FG004|Overall Study|Death|0|||
130283154|NCT02264665|469000403|FG005|Overall Study|Death|0|||
130283155|NCT02264665|469000404|FG006|Overall Study|Death|1|||
130283156|NCT02264665|469000398|FG000|Overall Study|Lost to Follow-up|1|||
130283157|NCT02264665|469000399|FG001|Overall Study|Lost to Follow-up|0|||
130283158|NCT02264665|469000400|FG002|Overall Study|Lost to Follow-up|2|||
130283159|NCT02264665|469000401|FG003|Overall Study|Lost to Follow-up|1|||
130283160|NCT02264665|469000402|FG004|Overall Study|Lost to Follow-up|0|||
130283161|NCT02264665|469000403|FG005|Overall Study|Lost to Follow-up|0|||
130283162|NCT02264665|469000404|FG006|Overall Study|Lost to Follow-up|0|||
130283163|NCT02264665|469000398|FG000|Overall Study|Participant decision|0|||
130283164|NCT02264665|469000399|FG001|Overall Study|Participant decision|0|||
130283165|NCT02264665|469000400|FG002|Overall Study|Participant decision|0|||
130283166|NCT02264665|469000401|FG003|Overall Study|Participant decision|1|||
130283167|NCT02264665|469000402|FG004|Overall Study|Participant decision|0|||
130283168|NCT02264665|469000403|FG005|Overall Study|Participant decision|0|||
130283169|NCT02264665|469000404|FG006|Overall Study|Participant decision|0|||
130283170|NCT02264665|469000398|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
130283171|NCT02264665|469000399|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130283172|NCT02264665|469000400|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130283173|NCT02264665|469000401|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130283174|NCT02264665|469000402|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130283175|NCT02264665|469000403|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
130283176|NCT02264665|469000404|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
130283177|NCT02264665|469000398|FG000|Overall Study|Data Missing|0|||
130283178|NCT02264665|469000399|FG001|Overall Study|Data Missing|0|||
130283179|NCT02264665|469000400|FG002|Overall Study|Data Missing|1|||
130283180|NCT02264665|469000401|FG003|Overall Study|Data Missing|0|||
130283181|NCT02264665|469000402|FG004|Overall Study|Data Missing|0|||
130283182|NCT02264665|469000403|FG005|Overall Study|Data Missing|0|||
130283183|NCT02264665|469000404|FG006|Overall Study|Data Missing|0|||
130283184|NCT00789581|469000410|FG000|AC Therapy|Adverse Event|2|||
130283185|NCT00789581|469000411|FG001|AC Therapy|Adverse Event|3|||
130283186|NCT00789581|469000410|FG000|AC Therapy|Withdrawal by Subject|4|||
130283187|NCT00789581|469000411|FG001|AC Therapy|Withdrawal by Subject|7|||
130283188|NCT00789581|469000410|FG000|AC Therapy|Disease recurrence|3|||
130283189|NCT00789581|469000411|FG001|AC Therapy|Disease recurrence|1|||
130283190|NCT00789581|469000410|FG000|AC Therapy|Intercurrent Illness|1|||
130283191|NCT00789581|469000411|FG001|AC Therapy|Intercurrent Illness|0|||
130283192|NCT00789581|469000410|FG000|AC Therapy|Never Treated|1|||
130283193|NCT00789581|469000411|FG001|AC Therapy|Never Treated|4|||
130283194|NCT00789581|469000410|FG000|AC Therapy|Other|0|||
130283195|NCT00789581|469000411|FG001|AC Therapy|Other|2|||
130283196|NCT00789581|469000410|FG000|Adjuvant Therapy|Never treated|2|||
130283197|NCT00789581|469000411|FG001|Adjuvant Therapy|Never treated|2|||
130283198|NCT00789581|469000410|FG000|Adjuvant Therapy|Adverse Event|20|||
130283199|NCT00789581|469000411|FG001|Adjuvant Therapy|Adverse Event|44|||
130283200|NCT00789581|469000410|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
130283201|NCT00789581|469000411|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
130283202|NCT00789581|469000410|FG000|Adjuvant Therapy|Disease recurrence|2|||
130283203|NCT00789581|469000411|FG001|Adjuvant Therapy|Disease recurrence|1|||
130283204|NCT00789581|469000410|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
130283205|NCT00789581|469000411|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
130283206|NCT00789581|469000410|FG000|Adjuvant Therapy|Protocol Violation|1|||
130283207|NCT00789581|469000411|FG001|Adjuvant Therapy|Protocol Violation|1|||
130283208|NCT00789581|469000410|FG000|Adjuvant Therapy|Other|0|||
130283209|NCT00789581|469000411|FG001|Adjuvant Therapy|Other|1|||
130042719|NCT00957372|468114401|FG002|PART II|Pregnancy|0|||
130283210|NCT01468207|469000412|FG000|Treatment Period 1|Adverse Event|1|||
130283211|NCT01468207|469000413|FG001|Treatment Period 1|Adverse Event|0|||
130283212|NCT01468207|469000414|FG002|Treatment Period 1|Adverse Event|0|||
130283213|NCT01468207|469000415|FG003|Treatment Period 1|Adverse Event|0|||
130283214|NCT01468207|469000416|FG004|Treatment Period 1|Adverse Event|0|||
130283215|NCT01468207|469000417|FG005|Treatment Period 1|Adverse Event|0|||
130283216|NCT01468207|469000412|FG000|Treatment Period 1|Protocol Violation|1|||
130283217|NCT01468207|469000413|FG001|Treatment Period 1|Protocol Violation|1|||
130283218|NCT01468207|469000414|FG002|Treatment Period 1|Protocol Violation|0|||
130283219|NCT01468207|469000415|FG003|Treatment Period 1|Protocol Violation|0|||
130283220|NCT01468207|469000416|FG004|Treatment Period 1|Protocol Violation|0|||
130283221|NCT01468207|469000417|FG005|Treatment Period 1|Protocol Violation|0|||
130283222|NCT01468207|469000412|FG000|Treatment Period 1|Withdrawal by Subject|5|||
130283223|NCT01468207|469000413|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130283224|NCT01468207|469000414|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130283225|NCT01468207|469000415|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130283226|NCT01468207|469000416|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130283227|NCT01468207|469000417|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130283228|NCT01468207|469000412|FG000|Treatment Period 1|Lost to Follow-up|2|||
130283229|NCT01468207|469000413|FG001|Treatment Period 1|Lost to Follow-up|1|||
130283230|NCT01468207|469000414|FG002|Treatment Period 1|Lost to Follow-up|0|||
130283231|NCT01468207|469000415|FG003|Treatment Period 1|Lost to Follow-up|0|||
130283232|NCT01468207|469000416|FG004|Treatment Period 1|Lost to Follow-up|0|||
130283233|NCT01468207|469000417|FG005|Treatment Period 1|Lost to Follow-up|0|||
130283234|NCT01468207|469000412|FG000|Treatment Period 1|Other|0|||
130283235|NCT01468207|469000413|FG001|Treatment Period 1|Other|2|||
130283236|NCT01468207|469000414|FG002|Treatment Period 1|Other|0|||
130283237|NCT01468207|469000415|FG003|Treatment Period 1|Other|0|||
130283238|NCT01468207|469000416|FG004|Treatment Period 1|Other|0|||
130283239|NCT01468207|469000417|FG005|Treatment Period 1|Other|0|||
130283240|NCT01468207|469000412|FG000|Treatment Period 2|Adverse Event|0|||
130283241|NCT01468207|469000413|FG001|Treatment Period 2|Adverse Event|0|||
130283242|NCT01468207|469000414|FG002|Treatment Period 2|Adverse Event|6|||
130283243|NCT01468207|469000415|FG003|Treatment Period 2|Adverse Event|1|||
130283244|NCT01468207|469000416|FG004|Treatment Period 2|Adverse Event|2|||
130283245|NCT01468207|469000417|FG005|Treatment Period 2|Adverse Event|1|||
130283246|NCT01468207|469000412|FG000|Treatment Period 2|Lack of Efficacy|0|||
130283247|NCT01468207|469000413|FG001|Treatment Period 2|Lack of Efficacy|0|||
130283248|NCT01468207|469000414|FG002|Treatment Period 2|Lack of Efficacy|1|||
130283249|NCT01468207|469000415|FG003|Treatment Period 2|Lack of Efficacy|1|||
130283250|NCT01468207|469000416|FG004|Treatment Period 2|Lack of Efficacy|0|||
130283251|NCT01468207|469000417|FG005|Treatment Period 2|Lack of Efficacy|2|||
130283252|NCT01468207|469000412|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130283253|NCT01468207|469000413|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130283254|NCT01468207|469000414|FG002|Treatment Period 2|Withdrawal by Subject|5|||
130283255|NCT01468207|469000415|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130283256|NCT01468207|469000416|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130283257|NCT01468207|469000417|FG005|Treatment Period 2|Withdrawal by Subject|2|||
130283258|NCT01468207|469000412|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
130283259|NCT01468207|469000413|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
130283260|NCT01468207|469000414|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
130283261|NCT01468207|469000415|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
130283262|NCT01468207|469000416|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
130283263|NCT01468207|469000417|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
130283264|NCT01468207|469000412|FG000|Treatment Period 2|Lost to Follow-up|0|||
130283265|NCT01468207|469000413|FG001|Treatment Period 2|Lost to Follow-up|0|||
130283266|NCT01468207|469000414|FG002|Treatment Period 2|Lost to Follow-up|5|||
130283267|NCT01468207|469000415|FG003|Treatment Period 2|Lost to Follow-up|1|||
130283268|NCT01468207|469000416|FG004|Treatment Period 2|Lost to Follow-up|0|||
130283269|NCT01468207|469000417|FG005|Treatment Period 2|Lost to Follow-up|0|||
130283270|NCT01468207|469000412|FG000|Treatment Period 2|Other|0|||
130283271|NCT01468207|469000413|FG001|Treatment Period 2|Other|0|||
130283272|NCT01468207|469000414|FG002|Treatment Period 2|Other|5|||
130283273|NCT01468207|469000415|FG003|Treatment Period 2|Other|1|||
130283274|NCT01468207|469000416|FG004|Treatment Period 2|Other|1|||
130283275|NCT01468207|469000417|FG005|Treatment Period 2|Other|2|||
130283276|NCT00539513|469000420|FG000|Overall Study|Withdrawal by Subject|2|||
130283277|NCT00539513|469000421|FG001|Overall Study|Withdrawal by Subject|1|||
130283278|NCT00539513|469000420|FG000|Overall Study|Lost to Follow-up|0|||
130283279|NCT00539513|469000421|FG001|Overall Study|Lost to Follow-up|1|||
130283280|NCT01328041|469000422|FG000|Overall Study|Adverse Event|7|||
130283281|NCT01328041|469000422|FG000|Overall Study|Lack of Efficacy|27|||
130283282|NCT01328041|469000422|FG000|Overall Study|Protocol Violation|7|||
130042720|NCT00957372|468114402|FG003|PART II|Pregnancy|1|||
130042721|NCT00957372|468114399|FG000|PART II|Not Know|0|||
130283283|NCT01328041|469000422|FG000|Overall Study|Lost to Follow-up|7|||
130283284|NCT01328041|469000422|FG000|Overall Study|Physician Decision|2|||
130283285|NCT01328041|469000422|FG000|Overall Study|Withdrawal by Subject|7|||
130283286|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283287|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
130283288|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283289|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283290|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
130283291|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283292|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
130042722|NCT00957372|468114400|FG001|PART II|Not Know|0|||
130106208|NCT03343054|468349930|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
130106209|NCT03343054|468349931|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
130106210|NCT03343054|468349932|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
130283293|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283294|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283295|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
130283296|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283297|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
130283298|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283299|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283300|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
130283301|NCT02688088|469000426|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283302|NCT02688088|469000427|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
130283303|NCT02688088|469000428|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283304|NCT02688088|469000429|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283305|NCT02688088|469000430|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
130283306|NCT02688088|469000426|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283307|NCT02688088|469000427|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283308|NCT02688088|469000428|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
130283309|NCT02688088|469000429|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283310|NCT02688088|469000430|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
130283311|NCT02688088|469000426|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283312|NCT02688088|469000427|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283313|NCT02688088|469000428|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
130283314|NCT02688088|469000429|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283315|NCT02688088|469000430|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
130283316|NCT02688088|469000426|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283317|NCT02688088|469000427|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283318|NCT02688088|469000428|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283319|NCT02688088|469000429|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
130283320|NCT02688088|469000430|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
130283321|NCT02688088|469000426|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283322|NCT02688088|469000427|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283323|NCT02688088|469000428|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283324|NCT02688088|469000429|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
130283325|NCT02688088|469000430|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
130283326|NCT02688088|469000426|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283327|NCT02688088|469000427|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283328|NCT02688088|469000428|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283329|NCT02688088|469000429|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
130283330|NCT02688088|469000430|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
130283331|NCT04021524|469000433|FG000|Overall Study|Change in surgical intervention|0|||
130283332|NCT04021524|469000434|FG001|Overall Study|Change in surgical intervention|1|||
130283333|NCT05275010|469000435|FG000|Overall Study|Reason Not Specified|4|||
130283334|NCT05275010|469000436|FG001|Overall Study|Reason Not Specified|1|||
130283335|NCT05275010|469000435|FG000|Overall Study|Withdrawal by Subject|1|||
130283336|NCT05275010|469000436|FG001|Overall Study|Withdrawal by Subject|0|||
130283337|NCT05275010|469000435|FG000|Overall Study|Lost to Follow-up|0|||
130283338|NCT05275010|469000436|FG001|Overall Study|Lost to Follow-up|1|||
130283339|NCT00730041|469000437|FG000|Overall Study|Lost to Follow-up|0|||
130106211|NCT03343054|468349930|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
130106212|NCT03343054|468349931|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
130106213|NCT03343054|468349932|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
130106214|NCT01467570|468349933|FG000|Overall Study|Lost to Follow-up|8|||
130106215|NCT01467570|468349934|FG001|Overall Study|Lost to Follow-up|9|||
130106216|NCT02626182|468349935|FG000|Overall Study|Adverse Event|2|||
130106217|NCT02626182|468349936|FG001|Overall Study|Adverse Event|0|||
130106218|NCT02766088|468349939|FG000|Overall Study|Sponsor study termination|498|||
130106219|NCT02766088|468349939|FG000|Overall Study|Migrated/moved from the study area|1|||
130283340|NCT00730041|469000438|FG001|Overall Study|Lost to Follow-up|2|||
130106220|NCT02766088|468349939|FG000|Overall Study|Lost to Follow-up|5|||
130106221|NCT02766088|468349939|FG000|Overall Study|Other|1|||
130283341|NCT05526781|469000439|FG000|Overall Study|Lost to Follow-up|1|||
130283342|NCT01921218|469000440|FG000|Overall Study|Death|2|||
130283343|NCT01921218|469000441|FG001|Overall Study|Death|1|||
130283344|NCT01921218|469000440|FG000|Overall Study|Withdrawal by Subject|0|||
130283345|NCT01921218|469000441|FG001|Overall Study|Withdrawal by Subject|2|||
130283346|NCT01921218|469000440|FG000|Overall Study|Kidney transplant|1|||
130106222|NCT02766088|468349939|FG000|Overall Study|Death|1|||
130283347|NCT01921218|469000441|FG001|Overall Study|Kidney transplant|1|||
130283348|NCT02449889|469000442|FG000|Overall Study|Adverse Event|1|||
130283349|NCT02449889|469000443|FG001|Overall Study|Adverse Event|2|||
130283350|NCT02449889|469000444|FG002|Overall Study|Adverse Event|0|||
130283351|NCT02449889|469000442|FG000|Overall Study|Protocol Violation|0|||
130283352|NCT02449889|469000443|FG001|Overall Study|Protocol Violation|4|||
130283353|NCT02449889|469000444|FG002|Overall Study|Protocol Violation|1|||
130283354|NCT03327220|469000445|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
130283355|NCT03327220|469000446|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
130283356|NCT03327220|469000445|FG000|Overall Study|Investigator Decision|2|||
130283357|NCT03327220|469000446|FG001|Overall Study|Investigator Decision|0|||
130283358|NCT03327220|469000445|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
130283359|NCT03327220|469000446|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
130283360|NCT03327220|469000445|FG000|Overall Study|Fungal infection|1|||
130283361|NCT03327220|469000446|FG001|Overall Study|Fungal infection|0|||
130283362|NCT03327220|469000445|FG000|Overall Study|Discharged to Rehabilitation|0|||
130283363|NCT03327220|469000446|FG001|Overall Study|Discharged to Rehabilitation|1|||
130283364|NCT03327220|469000445|FG000|Overall Study|Missing|1|||
130283365|NCT03327220|469000446|FG001|Overall Study|Missing|0|||
130283366|NCT00368836|469000449|FG000|Phase II|Screen Failure|1|||
130283367|NCT00368836|469000449|FG000|Phase II|Withdrawal by Subject|1|||
130283368|NCT00368836|469000449|FG000|Phase II|unable to collect blood and/or breath|17|||
130283369|NCT00368836|469000449|FG000|Phase II|Protocol Violation|2|||
130283370|NCT01082874|469000451|FG000|Overall Study|Lost to Follow-up|10|||
130283371|NCT01082874|469000452|FG001|Overall Study|Lost to Follow-up|10|||
130283372|NCT01082874|469000453|FG002|Overall Study|Lost to Follow-up|6|||
130283373|NCT01082874|469000454|FG003|Overall Study|Lost to Follow-up|10|||
130283374|NCT01082874|469000451|FG000|Overall Study|Withdrawal by Subject|1|||
130283375|NCT01082874|469000452|FG001|Overall Study|Withdrawal by Subject|2|||
130283376|NCT01082874|469000453|FG002|Overall Study|Withdrawal by Subject|5|||
130283377|NCT01082874|469000454|FG003|Overall Study|Withdrawal by Subject|3|||
130283378|NCT00090142|469000455|FG000|Treatment Period I|Lost to Follow-up|1|||
130283379|NCT00090142|469000456|FG001|Treatment Period I|Lost to Follow-up|2|||
130283380|NCT00090142|469000455|FG000|Treatment Period I|Protocol Violation|2|||
130283381|NCT00090142|469000456|FG001|Treatment Period I|Protocol Violation|0|||
130283382|NCT00090142|469000455|FG000|Treatment Period I|Withdrawal by Subject|2|||
130283383|NCT00090142|469000456|FG001|Treatment Period I|Withdrawal by Subject|0|||
130283384|NCT00090142|469000455|FG000|Treatment Period I|Other|0|||
130283385|NCT00090142|469000456|FG001|Treatment Period I|Other|1|||
130283386|NCT00090142|469000455|FG000|Treatment Period II|Other|1|||
130283387|NCT00090142|469000456|FG001|Treatment Period II|Other|0|||
130283388|NCT02442310|469000457|FG000|Overall Study|Adverse Event|2|||
130283389|NCT02442310|469000457|FG000|Overall Study|Withdrawal by Subject|1|||
130283390|NCT00688324|469000458|FG000|Overall Study|Withdrawal by Subject|2|||
130283391|NCT00688324|469000458|FG000|Overall Study|Physician Decision|5|||
130283392|NCT00688324|469000458|FG000|Overall Study|Lost to Follow-up|1|||
130283393|NCT00006046|469000459|FG000|Overall Study|Adverse Event|3|||
130283394|NCT00006046|469000460|FG001|Overall Study|Adverse Event|0|||
130283395|NCT00006046|469000461|FG002|Overall Study|Adverse Event|0|||
130283396|NCT00006046|469000462|FG003|Overall Study|Adverse Event|0|||
130283397|NCT00006046|469000463|FG004|Overall Study|Adverse Event|0|||
130283398|NCT00006046|469000459|FG000|Overall Study|Disease Progression|2|||
130283399|NCT00006046|469000460|FG001|Overall Study|Disease Progression|0|||
130283400|NCT00006046|469000461|FG002|Overall Study|Disease Progression|0|||
130283401|NCT00006046|469000462|FG003|Overall Study|Disease Progression|0|||
130283402|NCT00006046|469000463|FG004|Overall Study|Disease Progression|0|||
130283403|NCT03176472|469000464|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
130283404|NCT03176472|469000465|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
130283405|NCT03176472|469000464|FG000|Double Blind Treatment Period|Adverse Event|0|||
130283406|NCT03176472|469000465|FG001|Double Blind Treatment Period|Adverse Event|5|||
130283407|NCT03176472|469000464|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
130283408|NCT03176472|469000465|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130283409|NCT03176472|469000464|FG000|Double Blind Treatment Period|Physician Decision|0|||
130283410|NCT03176472|469000465|FG001|Double Blind Treatment Period|Physician Decision|1|||
130283411|NCT03176472|469000464|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130283412|NCT03176472|469000465|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130283413|NCT03176472|469000464|FG000|Double Blind Treatment Period|Not Provided|1|||
130283414|NCT03176472|469000465|FG001|Double Blind Treatment Period|Not Provided|0|||
130283415|NCT03176472|469000464|FG000|Open Label Extension|Withdrawal by Subject|3|||
130283416|NCT03176472|469000465|FG001|Open Label Extension|Withdrawal by Subject|4|||
130283417|NCT03176472|469000464|FG000|Open Label Extension|Adverse Event|2|||
130283418|NCT03176472|469000465|FG001|Open Label Extension|Adverse Event|4|||
130283419|NCT03176472|469000464|FG000|Open Label Extension|Lost to Follow-up|1|||
130283420|NCT03176472|469000465|FG001|Open Label Extension|Lost to Follow-up|2|||
130283421|NCT03176472|469000464|FG000|Open Label Extension|Protocol Violation|0|||
130283422|NCT03176472|469000465|FG001|Open Label Extension|Protocol Violation|1|||
130283423|NCT03176472|469000464|FG000|Open Label Extension|Not Provided|2|||
130283424|NCT03176472|469000465|FG001|Open Label Extension|Not Provided|1|||
130283425|NCT00596154|469000466|FG000|Overall Study|Not Evaluable|2|||
130283426|NCT00642369|469000467|FG000|Overall Study|Adverse Event|2|||
130283427|NCT00642369|469000468|FG001|Overall Study|Adverse Event|3|||
130283428|NCT00642369|469000467|FG000|Overall Study|Withdrawal by Subject|1|||
130283429|NCT00642369|469000468|FG001|Overall Study|Withdrawal by Subject|0|||
130283430|NCT00642369|469000467|FG000|Overall Study|misdiagnosis|0|||
130283431|NCT00642369|469000468|FG001|Overall Study|misdiagnosis|1|||
130283432|NCT00642369|469000467|FG000|Overall Study|Lack of Efficacy|2|||
130283433|NCT00642369|469000468|FG001|Overall Study|Lack of Efficacy|2|||
130283434|NCT00585546|469000469|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
130283435|NCT00585546|469000469|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
130283436|NCT04154345|469000470|FG000|Overall Study|Covid-19 pandemic|4|||
130283437|NCT03622112|469000473|FG000|Overall Study|Withdrawal by Subject|6|||
130283438|NCT03622112|469000474|FG001|Overall Study|Withdrawal by Subject|2|||
130283439|NCT03622112|469000475|FG002|Overall Study|Withdrawal by Subject|4|||
130283440|NCT03622112|469000476|FG003|Overall Study|Withdrawal by Subject|2|||
130283441|NCT03622112|469000477|FG004|Overall Study|Withdrawal by Subject|1|||
130283442|NCT03622112|469000478|FG005|Overall Study|Withdrawal by Subject|2|||
130283443|NCT03622112|469000479|FG006|Overall Study|Withdrawal by Subject|2|||
130283444|NCT03622112|469000473|FG000|Overall Study|Death|0|||
130283445|NCT03622112|469000474|FG001|Overall Study|Death|0|||
130283446|NCT03622112|469000475|FG002|Overall Study|Death|0|||
130283447|NCT03622112|469000476|FG003|Overall Study|Death|1|||
130283448|NCT03622112|469000477|FG004|Overall Study|Death|0|||
130283449|NCT03622112|469000478|FG005|Overall Study|Death|0|||
130283450|NCT03622112|469000479|FG006|Overall Study|Death|0|||
130283451|NCT03622112|469000473|FG000|Overall Study|Lost to Follow-up|1|||
130283452|NCT03622112|469000474|FG001|Overall Study|Lost to Follow-up|1|||
130283453|NCT03622112|469000475|FG002|Overall Study|Lost to Follow-up|0|||
130283454|NCT03622112|469000476|FG003|Overall Study|Lost to Follow-up|0|||
130283455|NCT03622112|469000477|FG004|Overall Study|Lost to Follow-up|0|||
130283456|NCT03622112|469000478|FG005|Overall Study|Lost to Follow-up|0|||
130283457|NCT03622112|469000479|FG006|Overall Study|Lost to Follow-up|0|||
130042723|NCT00957372|468114401|FG002|PART II|Not Know|0|||
130042724|NCT00957372|468114402|FG003|PART II|Not Know|20|||
130042725|NCT00957372|468114399|FG000|PART II|Adverse Event|0|||
130042726|NCT00957372|468114400|FG001|PART II|Adverse Event|0|||
130042727|NCT00957372|468114401|FG002|PART II|Adverse Event|0|||
130042728|NCT00957372|468114402|FG003|PART II|Adverse Event|10|||
130042729|NCT00957372|468114399|FG000|PART II|Patient non-compliance|0|||
130283458|NCT03622112|469000473|FG000|Overall Study|Study-specific withdrawal criteria|10|||
130283459|NCT03622112|469000474|FG001|Overall Study|Study-specific withdrawal criteria|8|||
130283460|NCT03622112|469000475|FG002|Overall Study|Study-specific withdrawal criteria|7|||
130283461|NCT03622112|469000476|FG003|Overall Study|Study-specific withdrawal criteria|6|||
130283462|NCT03622112|469000477|FG004|Overall Study|Study-specific withdrawal criteria|4|||
130283463|NCT03622112|469000478|FG005|Overall Study|Study-specific withdrawal criteria|18|||
130283464|NCT03622112|469000479|FG006|Overall Study|Study-specific withdrawal criteria|4|||
130283465|NCT03622112|469000473|FG000|Overall Study|Protocol Violation|2|||
130283466|NCT03622112|469000474|FG001|Overall Study|Protocol Violation|0|||
130283467|NCT03622112|469000475|FG002|Overall Study|Protocol Violation|1|||
130283468|NCT03622112|469000476|FG003|Overall Study|Protocol Violation|1|||
130283469|NCT03622112|469000477|FG004|Overall Study|Protocol Violation|0|||
130283470|NCT03622112|469000478|FG005|Overall Study|Protocol Violation|0|||
130283471|NCT03622112|469000479|FG006|Overall Study|Protocol Violation|0|||
130283472|NCT03622112|469000473|FG000|Overall Study|Adverse Event|6|||
130283473|NCT03622112|469000474|FG001|Overall Study|Adverse Event|8|||
130283474|NCT03622112|469000475|FG002|Overall Study|Adverse Event|4|||
130283475|NCT03622112|469000476|FG003|Overall Study|Adverse Event|11|||
130283476|NCT03622112|469000477|FG004|Overall Study|Adverse Event|4|||
130283477|NCT03622112|469000478|FG005|Overall Study|Adverse Event|20|||
130283478|NCT03622112|469000479|FG006|Overall Study|Adverse Event|2|||
130283479|NCT03622112|469000473|FG000|Overall Study|Reason not specified|0|||
130283480|NCT03622112|469000474|FG001|Overall Study|Reason not specified|1|||
130283481|NCT03622112|469000475|FG002|Overall Study|Reason not specified|0|||
130283482|NCT03622112|469000476|FG003|Overall Study|Reason not specified|1|||
130283483|NCT03622112|469000477|FG004|Overall Study|Reason not specified|1|||
130283484|NCT03622112|469000478|FG005|Overall Study|Reason not specified|2|||
130283485|NCT03622112|469000479|FG006|Overall Study|Reason not specified|1|||
130283486|NCT02210689|469000480|FG000|Overall Study|Withdrawal by Subject|7|||
130283487|NCT02210689|469000481|FG001|Overall Study|Withdrawal by Subject|4|||
130283488|NCT02210689|469000482|FG002|Overall Study|Withdrawal by Subject|2|||
130042730|NCT00957372|468114400|FG001|PART II|Patient non-compliance|0|||
130042731|NCT00957372|468114401|FG002|PART II|Patient non-compliance|0|||
130042732|NCT00957372|468114402|FG003|PART II|Patient non-compliance|4|||
130042733|NCT01282814|468114403|FG000|First Intervention|Emesis During Dosing Interval|0|||
130283489|NCT02210689|469000480|FG000|Overall Study|Adverse Event|0|||
130283490|NCT02210689|469000481|FG001|Overall Study|Adverse Event|1|||
130042734|NCT01282814|468114404|FG001|First Intervention|Emesis During Dosing Interval|3|||
130042735|NCT01282814|468114403|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
130042736|NCT01282814|468114404|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130042737|NCT02403206|468114405|FG000|Overall Study|Lost to Follow-up|4|||
130042738|NCT02403206|468114406|FG001|Overall Study|Lost to Follow-up|3|||
130042739|NCT02403206|468114405|FG000|Overall Study|Physician Decision|2|||
130042740|NCT02403206|468114406|FG001|Overall Study|Physician Decision|0|||
130042741|NCT02403206|468114405|FG000|Overall Study|Withdrawal by Subject|3|||
130042742|NCT02403206|468114406|FG001|Overall Study|Withdrawal by Subject|3|||
130042743|NCT02403206|468114405|FG000|Overall Study|Reason not given|2|||
130042744|NCT02403206|468114406|FG001|Overall Study|Reason not given|4|||
130042745|NCT00778999|468114413|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
130106223|NCT01222715|468349940|FG000|Overall Study|Adverse Event|0|||
130283491|NCT02210689|469000482|FG002|Overall Study|Adverse Event|0|||
130283492|NCT02210689|469000480|FG000|Overall Study|Protocol Violation|1|||
130283493|NCT02210689|469000481|FG001|Overall Study|Protocol Violation|0|||
130283494|NCT02210689|469000482|FG002|Overall Study|Protocol Violation|0|||
130283495|NCT02210689|469000480|FG000|Overall Study|Lost to Follow-up|11|||
130283496|NCT02210689|469000481|FG001|Overall Study|Lost to Follow-up|9|||
130283497|NCT02210689|469000482|FG002|Overall Study|Lost to Follow-up|5|||
130283498|NCT02210689|469000480|FG000|Overall Study|Pregnancy|0|||
130283499|NCT02210689|469000481|FG001|Overall Study|Pregnancy|1|||
130283500|NCT02210689|469000482|FG002|Overall Study|Pregnancy|0|||
130283501|NCT02210689|469000480|FG000|Overall Study|Lack of Efficacy|0|||
130283502|NCT02210689|469000481|FG001|Overall Study|Lack of Efficacy|1|||
130283503|NCT02210689|469000482|FG002|Overall Study|Lack of Efficacy|5|||
130283504|NCT02210689|469000480|FG000|Overall Study|Prohibited medication|2|||
130283505|NCT02210689|469000481|FG001|Overall Study|Prohibited medication|8|||
130283506|NCT02210689|469000482|FG002|Overall Study|Prohibited medication|1|||
130283507|NCT02210689|469000480|FG000|Overall Study|Negative Nugent score at baseline|6|||
130283508|NCT02210689|469000481|FG001|Overall Study|Negative Nugent score at baseline|2|||
130283509|NCT02210689|469000482|FG002|Overall Study|Negative Nugent score at baseline|2|||
130283510|NCT02210689|469000480|FG000|Overall Study|Other|25|||
130283511|NCT02210689|469000481|FG001|Overall Study|Other|21|||
130283512|NCT02210689|469000482|FG002|Overall Study|Other|8|||
130283513|NCT01694121|469000484|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
130283514|NCT01694121|469000485|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
130283515|NCT00521599|469000486|FG000|Overall Study|Adverse Event|5|||
130283516|NCT00521599|469000487|FG001|Overall Study|Adverse Event|7|||
130283517|NCT00521599|469000488|FG002|Overall Study|Adverse Event|6|||
130283518|NCT00521599|469000486|FG000|Overall Study|Treatment Failure|8|||
130283519|NCT00521599|469000487|FG001|Overall Study|Treatment Failure|9|||
130283520|NCT00521599|469000488|FG002|Overall Study|Treatment Failure|22|||
130283521|NCT00521599|469000486|FG000|Overall Study|Lost to Follow-up|2|||
130283522|NCT00521599|469000487|FG001|Overall Study|Lost to Follow-up|1|||
130283523|NCT00521599|469000488|FG002|Overall Study|Lost to Follow-up|2|||
130283524|NCT00521599|469000486|FG000|Overall Study|Withdrawal by Subject|3|||
130283525|NCT00521599|469000487|FG001|Overall Study|Withdrawal by Subject|5|||
130283526|NCT00521599|469000488|FG002|Overall Study|Withdrawal by Subject|1|||
130283527|NCT00521599|469000486|FG000|Overall Study|Withdrawal by subject treatment related|3|||
130283528|NCT00521599|469000487|FG001|Overall Study|Withdrawal by subject treatment related|1|||
130283529|NCT00521599|469000488|FG002|Overall Study|Withdrawal by subject treatment related|2|||
130283530|NCT00521599|469000486|FG000|Overall Study|Protocol Violation|2|||
130283531|NCT00521599|469000487|FG001|Overall Study|Protocol Violation|4|||
130283532|NCT00521599|469000488|FG002|Overall Study|Protocol Violation|2|||
130283533|NCT00521599|469000486|FG000|Overall Study|Did not meet protocol eligibility|2|||
130283534|NCT00521599|469000487|FG001|Overall Study|Did not meet protocol eligibility|2|||
130283535|NCT00521599|469000488|FG002|Overall Study|Did not meet protocol eligibility|1|||
130283536|NCT00866047|469000489|FG000|Treatment Period|Progressive disease|13|||
130283537|NCT00866047|469000489|FG000|Treatment Period|Adverse Event|16|||
130283538|NCT00866047|469000489|FG000|Treatment Period|Physician Decision|14|||
130283539|NCT00866047|469000489|FG000|Treatment Period|Withdrawal by Subject|5|||
130283540|NCT00866047|469000489|FG000|Follow-up Period|Lost to Follow-up|5|||
130283541|NCT02928029|469000490|FG000|Overall Study|Withdrawal by Subject|0|||
130283542|NCT02928029|469000491|FG001|Overall Study|Withdrawal by Subject|1|||
130283543|NCT02928029|469000490|FG000|Overall Study|Radiological progression|1|||
130283544|NCT02928029|469000491|FG001|Overall Study|Radiological progression|0|||
130283545|NCT02928029|469000490|FG000|Overall Study|Clinical progression|1|||
130283546|NCT02928029|469000491|FG001|Overall Study|Clinical progression|2|||
130283547|NCT02928029|469000490|FG000|Overall Study|AE not related to clinical progression|1|||
130283548|NCT02928029|469000491|FG001|Overall Study|AE not related to clinical progression|1|||
130042746|NCT00778999|468114414|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
130042747|NCT00778999|468114413|FG000|Overall Study|Did not receive recFSH|14|||
130042748|NCT00778999|468114414|FG001|Overall Study|Did not receive recFSH|20|||
130042749|NCT02032524|468114415|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
130042750|NCT02032524|468114416|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
130106224|NCT01222715|468349941|FG001|Overall Study|Adverse Event|4|||
130042751|NCT02032524|468114417|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
130042752|NCT02032524|468114418|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
130042753|NCT02032524|468114419|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
130042754|NCT02032524|468114420|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
130042755|NCT02032524|468114415|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130042756|NCT02032524|468114416|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130042757|NCT02032524|468114417|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130042758|NCT02032524|468114418|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
130042759|NCT02032524|468114419|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
130042760|NCT02032524|468114420|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
130042761|NCT02032524|468114415|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
130042762|NCT02032524|468114416|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
130042763|NCT02032524|468114417|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
130042764|NCT02032524|468114418|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
130042765|NCT02032524|468114419|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
130283549|NCT01610713|469000492|FG000|Overall Study|Adverse Event|3|||
130283550|NCT01610713|469000493|FG001|Overall Study|Adverse Event|0|||
130283551|NCT01610713|469000492|FG000|Overall Study|Lack of Efficacy|1|||
130283552|NCT01610713|469000493|FG001|Overall Study|Lack of Efficacy|0|||
130283553|NCT01610713|469000492|FG000|Overall Study|low mood and poor motivation|1|||
130283554|NCT01610713|469000493|FG001|Overall Study|low mood and poor motivation|0|||
130283555|NCT01610713|469000492|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
130283556|NCT01610713|469000493|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
130283557|NCT01610713|469000492|FG000|Overall Study|Lost to Follow-up|0|||
130283558|NCT01610713|469000493|FG001|Overall Study|Lost to Follow-up|1|||
130283559|NCT03770728|469000498|FG000|Overall Study|Adverse Event|1|||
130283560|NCT03770728|469000499|FG001|Overall Study|Adverse Event|0|||
130283561|NCT03770728|469000500|FG002|Overall Study|Adverse Event|1|||
130283562|NCT03770728|469000501|FG003|Overall Study|Adverse Event|0|||
130283563|NCT03770728|469000498|FG000|Overall Study|Poor compliance to protocol|0|||
130283564|NCT03770728|469000499|FG001|Overall Study|Poor compliance to protocol|0|||
130283565|NCT03770728|469000500|FG002|Overall Study|Poor compliance to protocol|1|||
130283566|NCT03770728|469000501|FG003|Overall Study|Poor compliance to protocol|0|||
130283567|NCT03770728|469000498|FG000|Overall Study|Withdrawal by Subject|13|||
130283568|NCT03770728|469000499|FG001|Overall Study|Withdrawal by Subject|8|||
130283569|NCT03770728|469000500|FG002|Overall Study|Withdrawal by Subject|9|||
130283570|NCT03770728|469000501|FG003|Overall Study|Withdrawal by Subject|13|||
130283571|NCT03770728|469000498|FG000|Overall Study|Other than specified|24|||
130283572|NCT03770728|469000499|FG001|Overall Study|Other than specified|23|||
130283573|NCT03770728|469000500|FG002|Overall Study|Other than specified|21|||
130283574|NCT03770728|469000501|FG003|Overall Study|Other than specified|22|||
130283575|NCT00503776|469000502|FG000|Overall Study|Withdrawal by Subject|1|||
130283576|NCT00503776|469000503|FG001|Overall Study|Withdrawal by Subject|0|||
130283577|NCT00503776|469000504|FG002|Overall Study|Withdrawal by Subject|1|||
130283578|NCT00503776|469000505|FG003|Overall Study|Withdrawal by Subject|1|||
130283579|NCT00503776|469000502|FG000|Overall Study|Physician Decision|0|||
130283580|NCT00503776|469000503|FG001|Overall Study|Physician Decision|0|||
130283581|NCT00503776|469000504|FG002|Overall Study|Physician Decision|1|||
130283582|NCT00503776|469000505|FG003|Overall Study|Physician Decision|1|||
130283583|NCT02778555|469000506|FG000|Overall Study|Withdrawal by Subject|55|||
130283584|NCT02778555|469000507|FG001|Overall Study|Withdrawal by Subject|32|||
130283585|NCT02778555|469000508|FG002|Overall Study|Withdrawal by Subject|107|||
130283586|NCT02379988|469000509|FG000|Overall Study|Not eligible|1|||
130283587|NCT05427539|469000514|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130283588|NCT05427539|469000515|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130283589|NCT05427539|469000514|FG000|Period 1|Withdrawal by Subject|1|||
130283590|NCT05427539|469000515|FG001|Period 1|Withdrawal by Subject|0|||
130283591|NCT00223977|469000516|FG000|Overall Study|Adverse Event|7|||
130283592|NCT00223977|469000517|FG001|Overall Study|Adverse Event|10|||
130283593|NCT00223977|469000518|FG002|Overall Study|Adverse Event|0|||
130283594|NCT00223977|469000516|FG000|Overall Study|Protocol Violation|0|||
130283595|NCT00223977|469000517|FG001|Overall Study|Protocol Violation|0|||
130283596|NCT00223977|469000518|FG002|Overall Study|Protocol Violation|1|||
130283597|NCT00223977|469000516|FG000|Overall Study|Withdrawal by Subject|1|||
130283598|NCT00223977|469000517|FG001|Overall Study|Withdrawal by Subject|1|||
130283599|NCT00223977|469000518|FG002|Overall Study|Withdrawal by Subject|2|||
130283600|NCT00223977|469000516|FG000|Overall Study|Other|1|||
130283601|NCT00223977|469000517|FG001|Overall Study|Other|0|||
130283602|NCT00223977|469000518|FG002|Overall Study|Other|0|||
130283603|NCT00934947|469000519|FG000|Overall Study|Adverse Event|0|||
130283604|NCT00934947|469000520|FG001|Overall Study|Adverse Event|2|||
130283605|NCT01451931|469000526|FG000|Overall Study|Lost to Follow-up|17|||
130283606|NCT01451931|469000527|FG001|Overall Study|Lost to Follow-up|36|||
130042766|NCT02032524|468114420|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
130042767|NCT02032524|468114415|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130042768|NCT02032524|468114416|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
130283607|NCT01451931|469000528|FG002|Overall Study|Lost to Follow-up|21|||
130283608|NCT01451931|469000526|FG000|Overall Study|Withdrawal by Subject|16|||
130283609|NCT01451931|469000527|FG001|Overall Study|Withdrawal by Subject|22|||
130283610|NCT01451931|469000528|FG002|Overall Study|Withdrawal by Subject|22|||
130283611|NCT02979093|469000531|FG000|First Scan Session|Scanning data problems|1|||
130283612|NCT02979093|469000532|FG001|First Scan Session|Scanning data problems|2|||
130283613|NCT02979093|469000533|FG002|First Scan Session|Scanning data problems|2|||
130283614|NCT02979093|469000534|FG003|First Scan Session|Scanning data problems|0|||
130283615|NCT02979093|469000531|FG000|Second Scan Session|Scanning data problems|3|||
130283616|NCT02979093|469000532|FG001|Second Scan Session|Scanning data problems|0|||
130283617|NCT02979093|469000533|FG002|Second Scan Session|Scanning data problems|1|||
130283618|NCT02979093|469000534|FG003|Second Scan Session|Scanning data problems|3|||
130283619|NCT03099174|469000535|FG000|Overall Study|Withdrawal by Subject|0|||
130283620|NCT03099174|469000536|FG001|Overall Study|Withdrawal by Subject|0|||
130283621|NCT03099174|469000537|FG002|Overall Study|Withdrawal by Subject|1|||
130283622|NCT03099174|469000538|FG003|Overall Study|Withdrawal by Subject|0|||
130283623|NCT03099174|469000539|FG004|Overall Study|Withdrawal by Subject|2|||
130283624|NCT03099174|469000540|FG005|Overall Study|Withdrawal by Subject|2|||
130283625|NCT03099174|469000541|FG006|Overall Study|Withdrawal by Subject|1|||
130283626|NCT03099174|469000542|FG007|Overall Study|Withdrawal by Subject|4|||
130283627|NCT03099174|469000535|FG000|Overall Study|Adverse Event|0|||
130283628|NCT03099174|469000536|FG001|Overall Study|Adverse Event|1|||
130283629|NCT03099174|469000537|FG002|Overall Study|Adverse Event|1|||
130283630|NCT03099174|469000538|FG003|Overall Study|Adverse Event|2|||
130283631|NCT03099174|469000539|FG004|Overall Study|Adverse Event|5|||
130283632|NCT03099174|469000540|FG005|Overall Study|Adverse Event|3|||
130283633|NCT03099174|469000541|FG006|Overall Study|Adverse Event|6|||
130283634|NCT03099174|469000542|FG007|Overall Study|Adverse Event|4|||
130283635|NCT03099174|469000535|FG000|Overall Study|Other than listed|6|||
130283636|NCT03099174|469000536|FG001|Overall Study|Other than listed|6|||
130283637|NCT03099174|469000537|FG002|Overall Study|Other than listed|5|||
130283638|NCT03099174|469000538|FG003|Overall Study|Other than listed|6|||
130283639|NCT03099174|469000539|FG004|Overall Study|Other than listed|19|||
130283640|NCT03099174|469000540|FG005|Overall Study|Other than listed|10|||
130283641|NCT03099174|469000541|FG006|Overall Study|Other than listed|26|||
130283642|NCT03099174|469000542|FG007|Overall Study|Other than listed|23|||
130283643|NCT02378298|469000543|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
130283644|NCT02378298|469000544|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
130283645|NCT02378298|469000545|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
130283646|NCT02378298|469000543|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
130283647|NCT02378298|469000544|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
130283648|NCT02378298|469000545|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
130283649|NCT02378298|469000543|FG000|Surveillance (19-68 Weeks)|Death|1|||
130283650|NCT02378298|469000544|FG001|Surveillance (19-68 Weeks)|Death|0|||
130283651|NCT02378298|469000545|FG002|Surveillance (19-68 Weeks)|Death|0|||
130283652|NCT04173260|469000546|FG000|Overall Study|Early termination|4|||
130283653|NCT02308163|469000547|FG000|Overall Study|Not fulfill eligible criteria|1|||
130042769|NCT02032524|468114417|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130042770|NCT02032524|468114418|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130042771|NCT02032524|468114419|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
130042772|NCT02032524|468114420|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
130042773|NCT02032524|468114415|FG000|Period 2: LTS13769 Study|Other|0|||
130042774|NCT02032524|468114416|FG001|Period 2: LTS13769 Study|Other|0|||
130042775|NCT02032524|468114417|FG002|Period 2: LTS13769 Study|Other|0|||
130042776|NCT02032524|468114418|FG003|Period 2: LTS13769 Study|Other|0|||
130042777|NCT02032524|468114419|FG004|Period 2: LTS13769 Study|Other|0|||
130042778|NCT02032524|468114420|FG005|Period 2: LTS13769 Study|Other|1|||
130042779|NCT02975349|468114421|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130042780|NCT02975349|468114422|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130042781|NCT02975349|468114423|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130042782|NCT02975349|468114424|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130106225|NCT01222715|468349940|FG000|Overall Study|Death|0|||
130106226|NCT01222715|468349941|FG001|Overall Study|Death|1|||
130283654|NCT02308163|469000548|FG001|Overall Study|Not fulfill eligible criteria|2|||
130283655|NCT02308163|469000549|FG002|Overall Study|Not fulfill eligible criteria|0|||
130283656|NCT02308163|469000550|FG003|Overall Study|Not fulfill eligible criteria|1|||
130283657|NCT02308163|469000551|FG004|Overall Study|Not fulfill eligible criteria|1|||
130283658|NCT02308163|469000547|FG000|Overall Study|Adverse Event|9|||
130283659|NCT02308163|469000548|FG001|Overall Study|Adverse Event|5|||
130283660|NCT02308163|469000549|FG002|Overall Study|Adverse Event|2|||
130283661|NCT02308163|469000550|FG003|Overall Study|Adverse Event|2|||
130283662|NCT02308163|469000551|FG004|Overall Study|Adverse Event|11|||
130283663|NCT02308163|469000547|FG000|Overall Study|Lack of Efficacy|11|||
130283664|NCT02308163|469000548|FG001|Overall Study|Lack of Efficacy|3|||
130283665|NCT02308163|469000549|FG002|Overall Study|Lack of Efficacy|8|||
130283666|NCT02308163|469000550|FG003|Overall Study|Lack of Efficacy|4|||
130283667|NCT02308163|469000551|FG004|Overall Study|Lack of Efficacy|6|||
130283668|NCT02308163|469000547|FG000|Overall Study|Withdrawal of consent|2|||
130283669|NCT02308163|469000548|FG001|Overall Study|Withdrawal of consent|3|||
130283670|NCT02308163|469000549|FG002|Overall Study|Withdrawal of consent|0|||
130283671|NCT02308163|469000550|FG003|Overall Study|Withdrawal of consent|2|||
130283672|NCT02308163|469000551|FG004|Overall Study|Withdrawal of consent|6|||
130283673|NCT02308163|469000547|FG000|Overall Study|Protocol Violation|3|||
130283674|NCT02308163|469000548|FG001|Overall Study|Protocol Violation|3|||
130283675|NCT02308163|469000549|FG002|Overall Study|Protocol Violation|3|||
130283676|NCT02308163|469000550|FG003|Overall Study|Protocol Violation|2|||
130283677|NCT02308163|469000551|FG004|Overall Study|Protocol Violation|5|||
130283678|NCT02308163|469000547|FG000|Overall Study|Lab data met discontinuation criteria|3|||
130283679|NCT02308163|469000548|FG001|Overall Study|Lab data met discontinuation criteria|0|||
130283680|NCT02308163|469000549|FG002|Overall Study|Lab data met discontinuation criteria|0|||
130283681|NCT02308163|469000550|FG003|Overall Study|Lab data met discontinuation criteria|2|||
130283682|NCT02308163|469000551|FG004|Overall Study|Lab data met discontinuation criteria|0|||
130283683|NCT02308163|469000547|FG000|Overall Study|Miscellaneous|2|||
130283684|NCT02308163|469000548|FG001|Overall Study|Miscellaneous|2|||
130283685|NCT02308163|469000549|FG002|Overall Study|Miscellaneous|1|||
130283686|NCT02308163|469000550|FG003|Overall Study|Miscellaneous|0|||
130283687|NCT02308163|469000551|FG004|Overall Study|Miscellaneous|5|||
130283688|NCT02684058|469000552|FG000|Treatment Period|Progressive disease|4|||
130283689|NCT02684058|469000553|FG001|Treatment Period|Progressive disease|10|||
130283690|NCT02684058|469000554|FG002|Treatment Period|Progressive disease|19|||
130283691|NCT02684058|469000552|FG000|Treatment Period|Adverse Event|3|||
130283692|NCT02684058|469000553|FG001|Treatment Period|Adverse Event|8|||
130283693|NCT02684058|469000554|FG002|Treatment Period|Adverse Event|1|||
130283694|NCT02684058|469000552|FG000|Treatment Period|Physician Decision|5|||
130283695|NCT02684058|469000553|FG001|Treatment Period|Physician Decision|1|||
130283696|NCT02684058|469000554|FG002|Treatment Period|Physician Decision|2|||
130283697|NCT02684058|469000552|FG000|Treatment Period|New therapy for study indication|1|||
130283698|NCT02684058|469000553|FG001|Treatment Period|New therapy for study indication|0|||
130283699|NCT02684058|469000554|FG002|Treatment Period|New therapy for study indication|0|||
130283700|NCT02684058|469000552|FG000|Treatment Period|Protocol deviation|0|||
130283701|NCT02684058|469000553|FG001|Treatment Period|Protocol deviation|1|||
130283702|NCT02684058|469000554|FG002|Treatment Period|Protocol deviation|0|||
130283703|NCT02684058|469000552|FG000|Treatment Period|Subject/guardian decision|4|||
130283704|NCT02684058|469000553|FG001|Treatment Period|Subject/guardian decision|3|||
130283705|NCT02684058|469000554|FG002|Treatment Period|Subject/guardian decision|0|||
130283706|NCT02684058|469000552|FG000|Treatment Period|Death|0|||
130283707|NCT02684058|469000553|FG001|Treatment Period|Death|0|||
130283708|NCT02684058|469000554|FG002|Treatment Period|Death|2|||
130283709|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130283710|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
130283711|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
130283712|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
130283713|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
130283714|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
130283715|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130283716|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130042783|NCT02975349|468114425|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130042784|NCT02975349|468114426|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130042785|NCT02975349|468114427|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130042786|NCT02975349|468114421|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130042787|NCT02975349|468114422|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130042788|NCT02975349|468114423|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130042789|NCT02975349|468114424|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130106227|NCT01222715|468349940|FG000|Overall Study|Lack of Efficacy|22|||
130106228|NCT01222715|468349941|FG001|Overall Study|Lack of Efficacy|14|||
130283717|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
130283718|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130283719|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|Death|0|||
130283720|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|Death|3|||
130283721|NCT02684058|469000552|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
130283722|NCT02684058|469000553|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
130283723|NCT02684058|469000554|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
130283724|NCT02684058|469000552|FG000|Post-treatment Survival Follow-up|Death|0|||
130283725|NCT02684058|469000553|FG001|Post-treatment Survival Follow-up|Death|0|||
130283726|NCT02684058|469000554|FG002|Post-treatment Survival Follow-up|Death|7|||
130283727|NCT02684058|469000552|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
130283728|NCT02684058|469000553|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
130283729|NCT02684058|469000554|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
130283730|NCT02684058|469000552|FG000|Crossover Treatment Period|Progressive disease|0|||
130283731|NCT02684058|469000553|FG001|Crossover Treatment Period|Progressive disease|1|||
130283732|NCT02684058|469000554|FG002|Crossover Treatment Period|Progressive disease|0|||
130283733|NCT01730339|469002001|FG000|Overall Study|Withdrawal by Subject|3|||
130283734|NCT01730339|469002002|FG001|Overall Study|Withdrawal by Subject|2|||
130106229|NCT01222715|468349940|FG000|Overall Study|Physician Decision|12|||
130106230|NCT01222715|468349941|FG001|Overall Study|Physician Decision|2|||
130106231|NCT01222715|468349940|FG000|Overall Study|Refusal of further protocol therapy|0|||
130106232|NCT01222715|468349941|FG001|Overall Study|Refusal of further protocol therapy|4|||
130106233|NCT01222715|468349940|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
130106234|NCT01222715|468349941|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
130106235|NCT01222715|468349940|FG000|Overall Study|Ineligible|0|||
130106236|NCT01222715|468349941|FG001|Overall Study|Ineligible|1|||
130106237|NCT01222715|468349940|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
130106238|NCT01222715|468349941|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
130106239|NCT03555890|468349950|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130106240|NCT03555890|468349951|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130106241|NCT03555890|468349952|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130106242|NCT03555890|468349953|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130106243|NCT03372369|468349954|FG000|Qualification Period|Withdrawal by Subject|16|||
130283735|NCT01730339|469002001|FG000|Overall Study|Lost to Follow-up|1|||
130283736|NCT01730339|469002002|FG001|Overall Study|Lost to Follow-up|1|||
130283737|NCT01730339|469002001|FG000|Overall Study|Un-specified|1|||
130283738|NCT01730339|469002002|FG001|Overall Study|Un-specified|0|||
130283739|NCT03095027|469002003|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
130283740|NCT03095027|469002004|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
130283741|NCT04143217|469002005|FG000|Overall Study|Withdrawal by Subject|42|||
130283742|NCT04143217|469002005|FG000|Overall Study|Adverse Event|29|||
130283743|NCT04143217|469002005|FG000|Overall Study|Lost to Follow-up|29|||
130283744|NCT04143217|469002005|FG000|Overall Study|Lack of Efficacy|15|||
130283745|NCT04143217|469002005|FG000|Overall Study|Physician Decision|1|||
130283746|NCT04143217|469002005|FG000|Overall Study|Non-Compliance With Study Drug|6|||
130283747|NCT04143217|469002005|FG000|Overall Study|Other, Multiple Categories|11|||
130283748|NCT01962987|469002008|FG000|Overall Study|Adverse Event|4|||
130283749|NCT01962987|469002009|FG001|Overall Study|Adverse Event|4|||
130283750|NCT01962987|469002010|FG002|Overall Study|Adverse Event|0|||
130283751|NCT01962987|469002008|FG000|Overall Study|Lost to Follow-up|0|||
130283752|NCT01962987|469002009|FG001|Overall Study|Lost to Follow-up|0|||
130283753|NCT01962987|469002010|FG002|Overall Study|Lost to Follow-up|1|||
130283754|NCT01962987|469002008|FG000|Overall Study|Non compliance with dosing requirements|4|||
130283755|NCT01962987|469002009|FG001|Overall Study|Non compliance with dosing requirements|2|||
130283756|NCT01962987|469002010|FG002|Overall Study|Non compliance with dosing requirements|0|||
130283757|NCT01962987|469002008|FG000|Overall Study|Miscellaneous|1|||
130283758|NCT01962987|469002009|FG001|Overall Study|Miscellaneous|9|||
130283759|NCT01962987|469002010|FG002|Overall Study|Miscellaneous|2|||
130283760|NCT01962987|469002008|FG000|Overall Study|Restricted medication|5|||
130283761|NCT01962987|469002009|FG001|Overall Study|Restricted medication|1|||
130283762|NCT01962987|469002010|FG002|Overall Study|Restricted medication|1|||
130283763|NCT01962987|469002008|FG000|Overall Study|Serious Adverse Event|1|||
130283764|NCT01962987|469002009|FG001|Overall Study|Serious Adverse Event|0|||
130283765|NCT01962987|469002010|FG002|Overall Study|Serious Adverse Event|0|||
130283766|NCT01962987|469002008|FG000|Overall Study|Withdrawal by Subject|11|||
130283767|NCT01962987|469002009|FG001|Overall Study|Withdrawal by Subject|10|||
130283768|NCT01962987|469002010|FG002|Overall Study|Withdrawal by Subject|6|||
130283769|NCT01962987|469002008|FG000|Overall Study|Randomized in Error|4|||
130283770|NCT01962987|469002009|FG001|Overall Study|Randomized in Error|2|||
130283771|NCT01962987|469002010|FG002|Overall Study|Randomized in Error|2|||
130283772|NCT00347438|469002013|FG000|Overall Study|Withdrawal by Subject|1|||
130283773|NCT00347438|469002013|FG000|Overall Study|Physician Decision|1|||
130283774|NCT00322023|469002014|FG000|Overall Study|various|0|||
130283775|NCT00322023|469002015|FG001|Overall Study|various|2|||
130283776|NCT00322023|469002016|FG002|Overall Study|various|6|||
130283777|NCT00523705|469002017|FG000|Overall Study|No time for study.|0|||
130283778|NCT00523705|469002018|FG001|Overall Study|No time for study.|1|||
130283779|NCT00693017|469002019|FG000|Overall Study|Sponsor Decision|2|||
130283780|NCT00693017|469002020|FG001|Overall Study|Sponsor Decision|1|||
130283781|NCT00693017|469002019|FG000|Overall Study|Death|0|||
130283782|NCT00693017|469002020|FG001|Overall Study|Death|1|||
130283783|NCT00113399|469002032|FG000|Overall Study|Death|1|||
130283784|NCT00113399|469002033|FG001|Overall Study|Death|1|||
130283785|NCT00113399|469002032|FG000|Overall Study|Withdrawal by Subject|1|||
130283786|NCT00113399|469002033|FG001|Overall Study|Withdrawal by Subject|2|||
130283787|NCT00113399|469002032|FG000|Overall Study|Complete Response|0|||
130283788|NCT00113399|469002033|FG001|Overall Study|Complete Response|1|||
130283789|NCT00113399|469002032|FG000|Overall Study|Other|0|||
130283790|NCT00113399|469002033|FG001|Overall Study|Other|1|||
130283791|NCT01779856|469002035|FG000|Overall Study|Withdrawal by Subject|15|||
130283792|NCT01779856|469002035|FG000|Overall Study|Death|3|||
130283793|NCT01779856|469002035|FG000|Overall Study|Physician Decision|1|||
130283794|NCT01779856|469002035|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
130283795|NCT01779856|469002035|FG000|Overall Study|Delays in scheduling implant|1|||
130283796|NCT01779856|469002035|FG000|Overall Study|Subject ineligible for Implant|2|||
130283797|NCT01535599|469002036|FG000|Overall Study|Adverse Event|6|||
130283798|NCT01535599|469002037|FG001|Overall Study|Adverse Event|15|||
130283799|NCT01535599|469002036|FG000|Overall Study|Lost to Follow-up|3|||
130283800|NCT01535599|469002037|FG001|Overall Study|Lost to Follow-up|4|||
130283801|NCT01535599|469002036|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
130283802|NCT01535599|469002037|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
130283803|NCT01535599|469002036|FG000|Overall Study|Treatment Failure|33|||
130283804|NCT01535599|469002037|FG001|Overall Study|Treatment Failure|66|||
130283805|NCT01535599|469002036|FG000|Overall Study|BL Culture + for Group A Strep|0|||
130283806|NCT01535599|469002037|FG001|Overall Study|BL Culture + for Group A Strep|1|||
130283807|NCT01535599|469002036|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
130283808|NCT01535599|469002037|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
130283809|NCT01535599|469002036|FG000|Overall Study|Randomized in Error|2|||
130283810|NCT01535599|469002037|FG001|Overall Study|Randomized in Error|4|||
130283811|NCT01535599|469002036|FG000|Overall Study|Did not use product|1|||
130283812|NCT01535599|469002037|FG001|Overall Study|Did not use product|0|||
130283813|NCT01535599|469002036|FG000|Overall Study|Other|1|||
130283814|NCT01535599|469002037|FG001|Overall Study|Other|0|||
130283815|NCT01535599|469002036|FG000|Overall Study|Stopped medication|0|||
130283816|NCT01535599|469002037|FG001|Overall Study|Stopped medication|1|||
130283817|NCT01535599|469002036|FG000|Overall Study|Noncompliance|0|||
130283818|NCT01535599|469002037|FG001|Overall Study|Noncompliance|1|||
130283819|NCT04043234|469002038|FG000|Overall Study|Lost to Follow-up|1|||
130283820|NCT04043234|469002038|FG000|Overall Study|Withdrawal by Subject|1|||
130283821|NCT01165320|469002039|FG000|Overall Study|Clinical adverse experience|2|||
130283822|NCT01165320|469002040|FG001|Overall Study|Clinical adverse experience|1|||
130283823|NCT01165320|469002041|FG002|Overall Study|Clinical adverse experience|0|||
130283824|NCT01165320|469002039|FG000|Overall Study|Laboratory adverse experience|1|||
130283825|NCT01165320|469002040|FG001|Overall Study|Laboratory adverse experience|0|||
130283826|NCT01165320|469002041|FG002|Overall Study|Laboratory adverse experience|0|||
130283827|NCT01165320|469002039|FG000|Overall Study|Lack of Efficacy|0|||
130283828|NCT01165320|469002040|FG001|Overall Study|Lack of Efficacy|2|||
130283829|NCT01165320|469002041|FG002|Overall Study|Lack of Efficacy|0|||
130283830|NCT01165320|469002039|FG000|Overall Study|Reason unknown|0|||
130283831|NCT01165320|469002040|FG001|Overall Study|Reason unknown|1|||
130283832|NCT01165320|469002041|FG002|Overall Study|Reason unknown|0|||
130283833|NCT00385944|469002045|FG000|1st Maintenance Dose Period|Physician Decision|1|||
130283834|NCT00385944|469002046|FG001|1st Maintenance Dose Period|Physician Decision|0|||
130283835|NCT00385944|469002047|FG002|1st Maintenance Dose Period|Physician Decision|0|||
130283836|NCT00385944|469002045|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
130283837|NCT00385944|469002046|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
130283838|NCT00385944|469002047|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
130283839|NCT00385944|469002045|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
130283840|NCT00385944|469002046|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
130283841|NCT00385944|469002047|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
130283842|NCT00385944|469002045|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
130283843|NCT00385944|469002046|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
130283844|NCT00385944|469002047|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
130283845|NCT01155466|469002048|FG000|Overall Study|Adverse Event|13|||
130283846|NCT01155466|469002049|FG001|Overall Study|Adverse Event|15|||
130283847|NCT01155466|469002050|FG002|Overall Study|Adverse Event|6|||
130283848|NCT01155466|469002051|FG003|Overall Study|Adverse Event|17|||
130283849|NCT01155466|469002052|FG004|Overall Study|Adverse Event|18|||
130283850|NCT01155466|469002048|FG000|Overall Study|Lost to Follow-up|0|||
130283851|NCT01155466|469002049|FG001|Overall Study|Lost to Follow-up|0|||
130283852|NCT01155466|469002050|FG002|Overall Study|Lost to Follow-up|0|||
130283853|NCT01155466|469002051|FG003|Overall Study|Lost to Follow-up|0|||
130283854|NCT01155466|469002052|FG004|Overall Study|Lost to Follow-up|2|||
130042790|NCT02975349|468114425|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130042791|NCT02975349|468114426|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130042792|NCT02975349|468114427|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130042793|NCT02975349|468114421|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
130042794|NCT02975349|468114422|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
130042795|NCT02975349|468114423|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
130042796|NCT02975349|468114424|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
130283855|NCT01155466|469002048|FG000|Overall Study|Withdrawal by Subject|7|||
130283856|NCT01155466|469002049|FG001|Overall Study|Withdrawal by Subject|5|||
130283857|NCT01155466|469002050|FG002|Overall Study|Withdrawal by Subject|9|||
130283858|NCT01155466|469002051|FG003|Overall Study|Withdrawal by Subject|4|||
130283859|NCT01155466|469002052|FG004|Overall Study|Withdrawal by Subject|4|||
130283860|NCT01155466|469002048|FG000|Overall Study|Protocol Violation|0|||
130283861|NCT01155466|469002049|FG001|Overall Study|Protocol Violation|0|||
130042797|NCT02975349|468114425|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
130283862|NCT01155466|469002050|FG002|Overall Study|Protocol Violation|2|||
130283863|NCT01155466|469002051|FG003|Overall Study|Protocol Violation|0|||
130283864|NCT01155466|469002052|FG004|Overall Study|Protocol Violation|1|||
130283865|NCT01155466|469002048|FG000|Overall Study|Administrative|0|||
130283866|NCT01155466|469002049|FG001|Overall Study|Administrative|3|||
130283867|NCT01155466|469002050|FG002|Overall Study|Administrative|0|||
130283868|NCT01155466|469002051|FG003|Overall Study|Administrative|0|||
130283869|NCT01155466|469002052|FG004|Overall Study|Administrative|0|||
130283870|NCT01155466|469002048|FG000|Overall Study|Randomized not treated|2|||
130283871|NCT01155466|469002049|FG001|Overall Study|Randomized not treated|2|||
130283872|NCT01155466|469002050|FG002|Overall Study|Randomized not treated|3|||
130283873|NCT01155466|469002051|FG003|Overall Study|Randomized not treated|0|||
130283874|NCT01155466|469002052|FG004|Overall Study|Randomized not treated|2|||
130283875|NCT00590824|469002053|FG000|Overall Study|Disease could not be resected|0|||
130283876|NCT00590824|469002054|FG001|Overall Study|Disease could not be resected|2|||
130283877|NCT00590824|469002055|FG002|Overall Study|Disease could not be resected|1|||
130283878|NCT00590824|469002056|FG003|Overall Study|Disease could not be resected|0|||
130283879|NCT00590824|469002053|FG000|Overall Study|Adverse Event|0|||
130283880|NCT00590824|469002054|FG001|Overall Study|Adverse Event|0|||
130283881|NCT00590824|469002055|FG002|Overall Study|Adverse Event|0|||
130283882|NCT00590824|469002056|FG003|Overall Study|Adverse Event|1|||
130283883|NCT00791479|469002062|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283884|NCT00791479|469002063|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283885|NCT00791479|469002064|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283886|NCT00791479|469002065|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283887|NCT00791479|469002066|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
130283888|NCT00791479|469002067|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
130283889|NCT00791479|469002062|FG000|Overall Study|Adverse Event|0|||
130283890|NCT00791479|469002063|FG001|Overall Study|Adverse Event|1|||
130283891|NCT00791479|469002064|FG002|Overall Study|Adverse Event|0|||
130283892|NCT00791479|469002065|FG003|Overall Study|Adverse Event|2|||
130283893|NCT00791479|469002066|FG004|Overall Study|Adverse Event|0|||
130283894|NCT00791479|469002067|FG005|Overall Study|Adverse Event|1|||
130283895|NCT00791479|469002062|FG000|Overall Study|Lost to Follow-up|0|||
130283896|NCT00791479|469002063|FG001|Overall Study|Lost to Follow-up|1|||
130283897|NCT00791479|469002064|FG002|Overall Study|Lost to Follow-up|0|||
130283898|NCT00791479|469002065|FG003|Overall Study|Lost to Follow-up|0|||
130283899|NCT00791479|469002066|FG004|Overall Study|Lost to Follow-up|0|||
130283900|NCT00791479|469002067|FG005|Overall Study|Lost to Follow-up|1|||
130283901|NCT00791479|469002062|FG000|Overall Study|Protocol Violation|2|||
130283902|NCT00791479|469002063|FG001|Overall Study|Protocol Violation|1|||
130283903|NCT00791479|469002064|FG002|Overall Study|Protocol Violation|0|||
130283904|NCT00791479|469002065|FG003|Overall Study|Protocol Violation|1|||
130283905|NCT00791479|469002066|FG004|Overall Study|Protocol Violation|0|||
130283906|NCT00791479|469002067|FG005|Overall Study|Protocol Violation|0|||
130283907|NCT00791479|469002062|FG000|Overall Study|Withdrawal by Subject|0|||
130283908|NCT00791479|469002063|FG001|Overall Study|Withdrawal by Subject|0|||
130283909|NCT00791479|469002064|FG002|Overall Study|Withdrawal by Subject|0|||
130283910|NCT00791479|469002065|FG003|Overall Study|Withdrawal by Subject|1|||
130283911|NCT00791479|469002066|FG004|Overall Study|Withdrawal by Subject|0|||
130283912|NCT00791479|469002067|FG005|Overall Study|Withdrawal by Subject|1|||
130283913|NCT01778049|469002068|FG000|Open Label Treatment Period|Adverse Event|5|||
130283914|NCT01778049|469002069|FG001|Open Label Treatment Period|Adverse Event|15|||
130283915|NCT01778049|469002070|FG002|Open Label Treatment Period|Adverse Event|0|||
130042798|NCT02975349|468114426|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
130042799|NCT02975349|468114427|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
130042800|NCT02975349|468114421|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
130042801|NCT02975349|468114422|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130283916|NCT01778049|469002071|FG003|Open Label Treatment Period|Adverse Event|0|||
130283917|NCT01778049|469002072|FG004|Open Label Treatment Period|Adverse Event|0|||
130283918|NCT01778049|469002073|FG005|Open Label Treatment Period|Adverse Event|0|||
130283919|NCT01778049|469002068|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
130283920|NCT01778049|469002069|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
130283921|NCT01778049|469002070|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
130283922|NCT01778049|469002071|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
130283923|NCT01778049|469002072|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
130283924|NCT01778049|469002073|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
130042802|NCT02975349|468114423|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
130042803|NCT02975349|468114424|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130283925|NCT01778049|469002068|FG000|Open Label Treatment Period|Protocol Violation|5|||
130283926|NCT01778049|469002069|FG001|Open Label Treatment Period|Protocol Violation|5|||
130283927|NCT01778049|469002070|FG002|Open Label Treatment Period|Protocol Violation|0|||
130283928|NCT01778049|469002071|FG003|Open Label Treatment Period|Protocol Violation|0|||
130283929|NCT01778049|469002072|FG004|Open Label Treatment Period|Protocol Violation|0|||
130283930|NCT01778049|469002073|FG005|Open Label Treatment Period|Protocol Violation|0|||
130283931|NCT01778049|469002068|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
130283932|NCT01778049|469002069|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
130283933|NCT01778049|469002070|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
130283934|NCT01778049|469002071|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
130283935|NCT01778049|469002072|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
130283936|NCT01778049|469002073|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
130283937|NCT01778049|469002068|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
130283938|NCT01778049|469002069|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
130283939|NCT01778049|469002070|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
130283940|NCT01778049|469002071|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
130283941|NCT01778049|469002072|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
130283942|NCT01778049|469002073|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
130283943|NCT01778049|469002068|FG000|Open Label Treatment Period|Not treated|2|||
130283944|NCT01778049|469002069|FG001|Open Label Treatment Period|Not treated|1|||
130283945|NCT01778049|469002070|FG002|Open Label Treatment Period|Not treated|0|||
130283946|NCT01778049|469002071|FG003|Open Label Treatment Period|Not treated|0|||
130283947|NCT01778049|469002072|FG004|Open Label Treatment Period|Not treated|0|||
130283948|NCT01778049|469002073|FG005|Open Label Treatment Period|Not treated|0|||
130283949|NCT01778049|469002068|FG000|Open Label Treatment Period|Other reason not defined above|77|||
130283950|NCT01778049|469002069|FG001|Open Label Treatment Period|Other reason not defined above|94|||
130283951|NCT01778049|469002070|FG002|Open Label Treatment Period|Other reason not defined above|0|||
130283952|NCT01778049|469002071|FG003|Open Label Treatment Period|Other reason not defined above|0|||
130283953|NCT01778049|469002072|FG004|Open Label Treatment Period|Other reason not defined above|0|||
130283954|NCT01778049|469002073|FG005|Open Label Treatment Period|Other reason not defined above|0|||
130283955|NCT01778049|469002068|FG000|Double Blind Treatment Period|Adverse Event|0|||
130283956|NCT01778049|469002069|FG001|Double Blind Treatment Period|Adverse Event|0|||
130283957|NCT01778049|469002070|FG002|Double Blind Treatment Period|Adverse Event|4|||
130283958|NCT01778049|469002071|FG003|Double Blind Treatment Period|Adverse Event|5|||
130283959|NCT01778049|469002072|FG004|Double Blind Treatment Period|Adverse Event|3|||
130283960|NCT01778049|469002073|FG005|Double Blind Treatment Period|Adverse Event|2|||
130283961|NCT01778049|469002068|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
130283962|NCT01778049|469002069|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130283963|NCT01778049|469002070|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
130283964|NCT01778049|469002071|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
130283965|NCT01778049|469002072|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
130283966|NCT01778049|469002073|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
130283967|NCT01778049|469002068|FG000|Double Blind Treatment Period|Protocol Violation|0|||
130283968|NCT01778049|469002069|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130283969|NCT01778049|469002070|FG002|Double Blind Treatment Period|Protocol Violation|2|||
130283970|NCT01778049|469002071|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130283971|NCT01778049|469002072|FG004|Double Blind Treatment Period|Protocol Violation|0|||
130283972|NCT01778049|469002073|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130283973|NCT01778049|469002068|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130283974|NCT01778049|469002069|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130283975|NCT01778049|469002070|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
130283976|NCT01778049|469002071|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
130283977|NCT01778049|469002072|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
130283978|NCT01778049|469002073|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
130283979|NCT01778049|469002068|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
130283980|NCT01778049|469002069|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130283981|NCT01778049|469002070|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
130283982|NCT01778049|469002071|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
130283983|NCT01778049|469002072|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130283984|NCT01778049|469002073|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
130283985|NCT01778049|469002068|FG000|Double Blind Treatment Period|Not treated|0|||
130283986|NCT01778049|469002069|FG001|Double Blind Treatment Period|Not treated|0|||
130283987|NCT01778049|469002070|FG002|Double Blind Treatment Period|Not treated|0|||
130283988|NCT01778049|469002071|FG003|Double Blind Treatment Period|Not treated|2|||
130283989|NCT01778049|469002072|FG004|Double Blind Treatment Period|Not treated|2|||
130283990|NCT01778049|469002073|FG005|Double Blind Treatment Period|Not treated|0|||
130283991|NCT01778049|469002068|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
130283992|NCT01778049|469002069|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
130283993|NCT01778049|469002070|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
130283994|NCT01778049|469002071|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
130283995|NCT01778049|469002072|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
130283996|NCT01778049|469002073|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
130042804|NCT02975349|468114425|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
130042805|NCT02975349|468114426|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
130283997|NCT03773133|469002074|FG000|Overall Study|Screen Failure|8|||
130283998|NCT00107315|469002078|FG000|Overall Study|Disease Progression|9|||
130283999|NCT00107315|469002078|FG000|Overall Study|Adverse Event|4|||
130284000|NCT00107315|469002078|FG000|Overall Study|Withdrawal by Subject|2|||
130284001|NCT02509039|469002081|FG000|Overall Study|Adverse Event|0|||
130284002|NCT02509039|469002082|FG001|Overall Study|Adverse Event|1|||
130284003|NCT02509039|469002083|FG002|Overall Study|Adverse Event|1|||
130284004|NCT02509039|469002084|FG003|Overall Study|Adverse Event|1|||
130284005|NCT02509039|469002081|FG000|Overall Study|Withdrawal by Subject|0|||
130284006|NCT02509039|469002082|FG001|Overall Study|Withdrawal by Subject|0|||
130284007|NCT02509039|469002083|FG002|Overall Study|Withdrawal by Subject|1|||
130284008|NCT02509039|469002084|FG003|Overall Study|Withdrawal by Subject|0|||
130284009|NCT02509039|469002081|FG000|Overall Study|Progressive disease|2|||
130284010|NCT02509039|469002082|FG001|Overall Study|Progressive disease|2|||
130284011|NCT02509039|469002083|FG002|Overall Study|Progressive disease|1|||
130284012|NCT02509039|469002084|FG003|Overall Study|Progressive disease|5|||
130284013|NCT02509039|469002081|FG000|Overall Study|Study terminated by Sponsor|1|||
129887018|NCT03095599|467547217|FG001|Overall Study|Withdrawal prior to vaccination|0|||
130284014|NCT02509039|469002082|FG001|Overall Study|Study terminated by Sponsor|0|||
130284015|NCT02509039|469002083|FG002|Overall Study|Study terminated by Sponsor|0|||
130284016|NCT02509039|469002084|FG003|Overall Study|Study terminated by Sponsor|0|||
129887019|NCT00513019|467547219|FG000|Overall Study|Adverse Event|1|||
130042806|NCT02975349|468114427|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
130042807|NCT02975349|468114421|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
130042808|NCT02975349|468114422|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
130042809|NCT02975349|468114423|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
130042810|NCT02975349|468114424|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
130042811|NCT02975349|468114425|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
130042812|NCT02975349|468114426|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
130042813|NCT02975349|468114427|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
130042814|NCT02975349|468114421|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130284017|NCT03136497|469002085|FG000|Overall Study|Screen Failure|1|||
130284018|NCT03136497|469002086|FG001|Overall Study|Screen Failure|0|||
130284019|NCT03136497|469002087|FG002|Overall Study|Screen Failure|0|||
130284020|NCT00543296|469002088|FG000|Overall Study|Physician Decision|7|||
130284021|NCT00557310|469002089|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
130284022|NCT00557310|469002089|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
129887020|NCT00513019|467547220|FG001|Overall Study|Adverse Event|0|||
130042815|NCT02975349|468114422|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130042816|NCT02975349|468114423|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130042817|NCT02975349|468114424|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
130284023|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
130042818|NCT02975349|468114425|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130284024|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
130284025|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
130284026|NCT00557310|469002089|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
130284027|NCT03276026|469002092|FG000|Overall Study|Protocol Violation|1|||
130284028|NCT03276026|469002093|FG001|Overall Study|Protocol Violation|0|||
130042819|NCT02975349|468114426|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130042820|NCT02975349|468114427|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
130042821|NCT02975349|468114421|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130042822|NCT02975349|468114422|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
130284029|NCT04049266|469002097|FG000|Overall Study|Adverse Event|16|||
130284030|NCT04049266|469002098|FG001|Overall Study|Adverse Event|9|||
130284031|NCT04049266|469002097|FG000|Overall Study|Non-compliance with study drug|0|||
130284032|NCT04049266|469002098|FG001|Overall Study|Non-compliance with study drug|3|||
130284033|NCT04049266|469002097|FG000|Overall Study|Withdrawal by Subject|6|||
130284034|NCT04049266|469002098|FG001|Overall Study|Withdrawal by Subject|10|||
130284035|NCT04049266|469002097|FG000|Overall Study|Lost to Follow-up|2|||
130284036|NCT04049266|469002098|FG001|Overall Study|Lost to Follow-up|2|||
130284037|NCT04049266|469002097|FG000|Overall Study|Progressive disease|11|||
130284038|NCT04049266|469002098|FG001|Overall Study|Progressive disease|2|||
130284039|NCT04049266|469002097|FG000|Overall Study|Physician Decision|1|||
130284040|NCT04049266|469002098|FG001|Overall Study|Physician Decision|0|||
130284041|NCT04049266|469002097|FG000|Overall Study|Patient moved out of state|1|||
130284042|NCT04049266|469002098|FG001|Overall Study|Patient moved out of state|0|||
130284043|NCT01703208|469002099|FG000|Overall Study|Death|61|||
130284044|NCT01703208|469002100|FG001|Overall Study|Death|48|||
130284045|NCT01703208|469002099|FG000|Overall Study|Lack of Efficacy|1|||
130284046|NCT01703208|469002100|FG001|Overall Study|Lack of Efficacy|2|||
130284047|NCT01703208|469002099|FG000|Overall Study|Lost to Follow-up|68|||
130284048|NCT01703208|469002100|FG001|Overall Study|Lost to Follow-up|62|||
130284049|NCT01703208|469002099|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130284050|NCT01703208|469002100|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130284051|NCT01703208|469002099|FG000|Overall Study|Excluded Medication|1|||
130284052|NCT01703208|469002100|FG001|Overall Study|Excluded Medication|2|||
130284053|NCT01703208|469002099|FG000|Overall Study|Site Discontinued Study Participation|23|||
130284054|NCT01703208|469002100|FG001|Overall Study|Site Discontinued Study Participation|27|||
130284055|NCT01703208|469002099|FG000|Overall Study|Physician Decision|11|||
130284056|NCT01703208|469002100|FG001|Overall Study|Physician Decision|13|||
130284057|NCT01703208|469002099|FG000|Overall Study|Progressive disease|2|||
130284058|NCT01703208|469002100|FG001|Overall Study|Progressive disease|2|||
130284059|NCT01703208|469002099|FG000|Overall Study|Protocol Violation|1|||
130284060|NCT01703208|469002100|FG001|Overall Study|Protocol Violation|1|||
130284061|NCT01703208|469002099|FG000|Overall Study|Study Terminated by Sponsor|1710|||
130284062|NCT01703208|469002100|FG001|Overall Study|Study Terminated by Sponsor|1716|||
130284063|NCT01703208|469002099|FG000|Overall Study|Withdrawal by Subject|205|||
130284064|NCT01703208|469002100|FG001|Overall Study|Withdrawal by Subject|209|||
130284065|NCT01703208|469002099|FG000|Overall Study|Adverse Event|14|||
130284066|NCT01703208|469002100|FG001|Overall Study|Adverse Event|19|||
130284067|NCT01703208|469002099|FG000|Overall Study|Technical Problems|0|||
130284068|NCT01703208|469002100|FG001|Overall Study|Technical Problems|1|||
130284069|NCT01703208|469002099|FG000|Overall Study|Protocol Deviation|2|||
130284070|NCT01703208|469002100|FG001|Overall Study|Protocol Deviation|0|||
130284071|NCT00367744|469002104|FG000|Overall Study|Lost to Follow-up|4|||
130284072|NCT00367744|469002105|FG001|Overall Study|Lost to Follow-up|5|||
130284073|NCT04003207|469002112|FG000|Overall Study|Protocol Violation|1|||
130284074|NCT03941964|469002119|FG000|Overall Study|Adverse Event|1|||
130284075|NCT03941964|469002120|FG001|Overall Study|Adverse Event|8|||
130284076|NCT03941964|469002119|FG000|Overall Study|Progressive disease|7|||
130284077|NCT03941964|469002120|FG001|Overall Study|Progressive disease|3|||
130284078|NCT03941964|469002119|FG000|Overall Study|Lack of Efficacy|0|||
130284079|NCT03941964|469002120|FG001|Overall Study|Lack of Efficacy|1|||
130284080|NCT03941964|469002119|FG000|Overall Study|Death|3|||
130284081|NCT03941964|469002120|FG001|Overall Study|Death|1|||
130042823|NCT02975349|468114423|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130042824|NCT02975349|468114424|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130284082|NCT03941964|469002119|FG000|Overall Study|Withdrew consent|1|||
130284083|NCT03941964|469002120|FG001|Overall Study|Withdrew consent|3|||
130284084|NCT03941964|469002119|FG000|Overall Study|Physician Decision|9|||
130284085|NCT03941964|469002120|FG001|Overall Study|Physician Decision|2|||
130284086|NCT03941964|469002119|FG000|Overall Study|Other, not specified|2|||
130284087|NCT03941964|469002120|FG001|Overall Study|Other, not specified|1|||
130284088|NCT02298179|469002121|FG000|Overall Study|Lost to Follow-up|0|||
130284089|NCT02298179|469002122|FG001|Overall Study|Lost to Follow-up|0|||
130284090|NCT02298179|469002123|FG002|Overall Study|Lost to Follow-up|1|||
130284091|NCT02298179|469002124|FG003|Overall Study|Lost to Follow-up|0|||
130284092|NCT02298179|469002125|FG004|Overall Study|Lost to Follow-up|0|||
130284093|NCT02298179|469002126|FG005|Overall Study|Lost to Follow-up|0|||
130284094|NCT02298179|469002127|FG006|Overall Study|Lost to Follow-up|0|||
130284095|NCT02298179|469002128|FG007|Overall Study|Lost to Follow-up|1|||
130284096|NCT02298179|469002129|FG008|Overall Study|Lost to Follow-up|0|||
130284097|NCT02298179|469002130|FG009|Overall Study|Lost to Follow-up|0|||
130284098|NCT02298179|469002131|FG010|Overall Study|Lost to Follow-up|0|||
130284099|NCT02298179|469002132|FG011|Overall Study|Lost to Follow-up|0|||
130284100|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
130284101|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
130284102|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Death|0|||
130284103|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Death|0|||
130284104|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130284105|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
130284106|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
130284107|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
130284108|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
130284109|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
130284110|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
130284111|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
130284112|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
130284113|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
130284114|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
130284115|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
130284116|NCT00433160|469002139|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
130284117|NCT00433160|469002140|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
130284118|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
130284119|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
130284120|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
130284121|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
130284122|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
130284123|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
130284124|NCT00433160|469002139|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
130284125|NCT00433160|469002140|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
130284126|NCT00433160|469002139|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
130284127|NCT00433160|469002140|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
130284128|NCT00433160|469002139|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
130284129|NCT00433160|469002140|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
130284130|NCT00433160|469002139|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
130284131|NCT00433160|469002140|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
130284132|NCT02226198|469003980|FG000|Lead-in Phase|Protocol Violation|1|||
130284133|NCT02226198|469003981|FG001|Lead-in Phase|Protocol Violation|0|||
130284134|NCT02226198|469003982|FG002|Lead-in Phase|Protocol Violation|0|||
130284135|NCT02226198|469003980|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
130284136|NCT02226198|469003981|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
130284137|NCT02226198|469003982|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
130284138|NCT01440517|469003984|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
130284139|NCT01288612|469003986|FG000|Overall Study|Unable to contact|11|||
130284140|NCT01288612|469003987|FG001|Overall Study|Unable to contact|16|||
130284141|NCT01288612|469003988|FG002|Overall Study|Unable to contact|20|||
130284142|NCT01288612|469003986|FG000|Overall Study|Declined|78|||
130284143|NCT01288612|469003987|FG001|Overall Study|Declined|63|||
130284144|NCT01288612|469003988|FG002|Overall Study|Declined|62|||
130284145|NCT01288612|469003986|FG000|Overall Study|Unable to intubate|0|||
130284146|NCT01288612|469003987|FG001|Overall Study|Unable to intubate|3|||
130284147|NCT01288612|469003988|FG002|Overall Study|Unable to intubate|0|||
130284148|NCT05599451|469003989|FG000|Overall Study|Not randomized|11|||
130284149|NCT05599451|469003990|FG001|Overall Study|Not randomized|0|||
130284150|NCT05599451|469003991|FG002|Overall Study|Not randomized|0|||
130284151|NCT05599451|469003992|FG003|Overall Study|Not randomized|0|||
130284152|NCT05599451|469003993|FG004|Overall Study|Not randomized|0|||
130284153|NCT05599451|469003989|FG000|Overall Study|Physician Decision|0|||
130284154|NCT05599451|469003990|FG001|Overall Study|Physician Decision|0|||
130042825|NCT02975349|468114425|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130042826|NCT02975349|468114426|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130284155|NCT05599451|469003991|FG002|Overall Study|Physician Decision|0|||
130284156|NCT05599451|469003992|FG003|Overall Study|Physician Decision|1|||
130042827|NCT02975349|468114427|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
130284157|NCT05599451|469003993|FG004|Overall Study|Physician Decision|0|||
130284158|NCT00496483|469003994|FG000|Overall Study|Not dosed|9|||
130284159|NCT00496483|469003994|FG000|Overall Study|Adverse Event|2|||
130284160|NCT00496483|469003994|FG000|Overall Study|Lack of Efficacy|1|||
130284161|NCT00983515|469003996|FG000|Ritonavir Alone|liver panel out of range|6|||
130284162|NCT00983515|469003996|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
130284163|NCT01145352|469004007|FG000|Overall Study|Found to have been registered twice|6|||
129887021|NCT00513019|467547219|FG000|Overall Study|Withdrawal by Subject|4|||
129887022|NCT00513019|467547220|FG001|Overall Study|Withdrawal by Subject|5|||
129887023|NCT00742885|467547223|FG000|Overall Study|Lost to Follow-up|1|||
129887024|NCT00742885|467547224|FG001|Overall Study|Lost to Follow-up|0|||
129887025|NCT04781647|467547225|FG000|Overall Study|Study terminated by Sponsor|11|||
129887026|NCT04781647|467547226|FG001|Overall Study|Study terminated by Sponsor|9|||
129887027|NCT04781647|467547227|FG002|Overall Study|Study terminated by Sponsor|9|||
129887028|NCT04781647|467547225|FG000|Overall Study|Withdrawal by Subject|1|||
129887029|NCT04781647|467547226|FG001|Overall Study|Withdrawal by Subject|2|||
129887030|NCT04781647|467547227|FG002|Overall Study|Withdrawal by Subject|0|||
130284164|NCT01145352|469004007|FG000|Overall Study|Treated before marketing approval|4|||
130284165|NCT01145352|469004007|FG000|Overall Study|Syringe formulation was used|1|||
130284166|NCT01967823|469004008|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
130284167|NCT05289271|469004014|FG000|Overall Study|Mistakenly allocated, untreated|1|||
130284168|NCT05289271|469004015|FG001|Overall Study|Mistakenly allocated, untreated|0|||
130284169|NCT01257568|469004017|FG000|Overall Study|Lost to Follow-up|2|||
130284170|NCT01257568|469004017|FG000|Overall Study|Withdrawal by Subject|6|||
130284171|NCT01257568|469004017|FG000|Overall Study|Terminated|1|||
130284172|NCT01257568|469004017|FG000|Overall Study|Component Revision|24|||
129887031|NCT04781647|467547225|FG000|Overall Study|Adverse Event|0|||
129887032|NCT04781647|467547226|FG001|Overall Study|Adverse Event|1|||
129887033|NCT04781647|467547227|FG002|Overall Study|Adverse Event|1|||
129887034|NCT04781647|467547225|FG000|Overall Study|Protocol Violation|1|||
130284173|NCT03392883|469004018|FG000|Overall Study|Lost to Follow-up|122|||
130284174|NCT03392883|469004019|FG001|Overall Study|Lost to Follow-up|13|||
129887035|NCT04781647|467547226|FG001|Overall Study|Protocol Violation|0|||
129887036|NCT04781647|467547227|FG002|Overall Study|Protocol Violation|0|||
129887037|NCT04781647|467547225|FG000|Overall Study|Pregnancy|0|||
129887038|NCT04781647|467547226|FG001|Overall Study|Pregnancy|0|||
129887039|NCT04781647|467547227|FG002|Overall Study|Pregnancy|1|||
129887040|NCT04781647|467547225|FG000|Overall Study|Virology rebounded|1|||
129887041|NCT04781647|467547226|FG001|Overall Study|Virology rebounded|0|||
129887042|NCT04781647|467547227|FG002|Overall Study|Virology rebounded|0|||
129887043|NCT01755689|467547228|FG000|Overall Study|Withdrawal by Subject|1|||
129887044|NCT01755689|467547229|FG001|Overall Study|Withdrawal by Subject|3|||
129887045|NCT01755689|467547230|FG002|Overall Study|Withdrawal by Subject|2|||
129887046|NCT01755689|467547231|FG003|Overall Study|Withdrawal by Subject|1|||
130284175|NCT03392883|469004020|FG002|Overall Study|Lost to Follow-up|9|||
130284176|NCT03392883|469004018|FG000|Overall Study|Death|4|||
130284177|NCT03392883|469004019|FG001|Overall Study|Death|0|||
130284178|NCT03392883|469004020|FG002|Overall Study|Death|0|||
130284179|NCT03392883|469004018|FG000|Overall Study|Lack of Efficacy|29|||
130284180|NCT03392883|469004019|FG001|Overall Study|Lack of Efficacy|0|||
130284181|NCT03392883|469004020|FG002|Overall Study|Lack of Efficacy|0|||
130284182|NCT03392883|469004018|FG000|Overall Study|Withdrawal by Subject|180|||
130284183|NCT03392883|469004019|FG001|Overall Study|Withdrawal by Subject|0|||
130284184|NCT03392883|469004020|FG002|Overall Study|Withdrawal by Subject|0|||
130284185|NCT03392883|469004018|FG000|Overall Study|Adverse Event|1|||
130284186|NCT03392883|469004019|FG001|Overall Study|Adverse Event|0|||
130284187|NCT03392883|469004020|FG002|Overall Study|Adverse Event|0|||
130284188|NCT00132691|469004030|FG000|Overall Study|Lost to Follow-up|5|||
130284189|NCT00132691|469004031|FG001|Overall Study|Lost to Follow-up|8|||
130284190|NCT00132691|469004030|FG000|Overall Study|Missed 2-year visit|4|||
130284191|NCT00132691|469004031|FG001|Overall Study|Missed 2-year visit|4|||
130284192|NCT00132691|469004030|FG000|Overall Study|Death|2|||
130284193|NCT00132691|469004031|FG001|Overall Study|Death|0|||
130284194|NCT01739933|469004032|FG000|Overall Study|Death|89|||
130284195|NCT01739933|469004033|FG001|Overall Study|Death|86|||
130284196|NCT01739933|469004032|FG000|Overall Study|Withdrawal by Subject|10|||
130284197|NCT01739933|469004033|FG001|Overall Study|Withdrawal by Subject|8|||
130284198|NCT01739933|469004032|FG000|Overall Study|Lost to Follow-up|3|||
130284199|NCT01739933|469004033|FG001|Overall Study|Lost to Follow-up|10|||
130284200|NCT01739933|469004032|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
130284201|NCT01739933|469004033|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
130284202|NCT04098367|469004034|FG000|Overall Study|Adverse Event|0|||
130284203|NCT04098367|469004035|FG001|Overall Study|Adverse Event|0|||
130284204|NCT04098367|469004036|FG002|Overall Study|Adverse Event|1|||
130284205|NCT04098367|469004034|FG000|Overall Study|Lost to Follow-up|1|||
130284206|NCT04098367|469004035|FG001|Overall Study|Lost to Follow-up|5|||
130284207|NCT04098367|469004036|FG002|Overall Study|Lost to Follow-up|2|||
129887047|NCT01755689|467547232|FG004|Overall Study|Withdrawal by Subject|1|||
129887048|NCT01755689|467547228|FG000|Overall Study|Migrated/moved from study area|0|||
129887049|NCT01755689|467547229|FG001|Overall Study|Migrated/moved from study area|1|||
129887050|NCT01755689|467547230|FG002|Overall Study|Migrated/moved from study area|1|||
129887051|NCT01755689|467547231|FG003|Overall Study|Migrated/moved from study area|1|||
130284208|NCT04098367|469004034|FG000|Overall Study|Withdrawal by Subject|0|||
130284209|NCT04098367|469004035|FG001|Overall Study|Withdrawal by Subject|0|||
130284210|NCT04098367|469004036|FG002|Overall Study|Withdrawal by Subject|1|||
129887052|NCT01755689|467547232|FG004|Overall Study|Migrated/moved from study area|1|||
129887053|NCT01755689|467547228|FG000|Overall Study|Lost to Follow-up|1|||
129887054|NCT01755689|467547229|FG001|Overall Study|Lost to Follow-up|0|||
130284211|NCT04098367|469004034|FG000|Overall Study|Sick . Could not attend visit|1|||
130284212|NCT04098367|469004035|FG001|Overall Study|Sick . Could not attend visit|0|||
130284213|NCT04098367|469004036|FG002|Overall Study|Sick . Could not attend visit|0|||
130284214|NCT01231321|469004042|FG000|Overall Study|Adverse Event|3|||
130284215|NCT01231321|469004042|FG000|Overall Study|Lack of Efficacy|2|||
130284216|NCT00908115|469004043|FG000|Overall Study|Other|14|||
130284217|NCT01728077|469004044|FG000|Overall Study|Lack of Efficacy|3|||
130284218|NCT01728077|469004045|FG001|Overall Study|Lack of Efficacy|1|||
130284219|NCT01728077|469004044|FG000|Overall Study|Lost to Follow-up|1|||
130284220|NCT01728077|469004045|FG001|Overall Study|Lost to Follow-up|0|||
130284221|NCT01728077|469004044|FG000|Overall Study|Subject choice|2|||
130284222|NCT01728077|469004045|FG001|Overall Study|Subject choice|3|||
130284223|NCT01728077|469004044|FG000|Overall Study|Death|0|||
130284224|NCT01728077|469004045|FG001|Overall Study|Death|1|||
130284225|NCT01728077|469004044|FG000|Overall Study|Patient moving|1|||
130284226|NCT01728077|469004045|FG001|Overall Study|Patient moving|0|||
130284227|NCT01728077|469004044|FG000|Overall Study|Non compliance|1|||
130284228|NCT01728077|469004045|FG001|Overall Study|Non compliance|0|||
130284229|NCT00396136|469004051|FG000|Overall Study|Death|43|||
130284230|NCT00396136|469004051|FG000|Overall Study|Withdrawal by Subject|59|||
130284231|NCT00396136|469004051|FG000|Overall Study|Lost to Follow-up|15|||
130284232|NCT00396136|469004051|FG000|Overall Study|Study device explanted|8|||
130284233|NCT03960580|469004052|FG000|Overall Study|Adverse Event|2|||
130284234|NCT03960580|469004053|FG001|Overall Study|Adverse Event|1|||
130284235|NCT03960580|469004054|FG002|Overall Study|Adverse Event|1|||
130284236|NCT03960580|469004052|FG000|Overall Study|Lost to Follow-up|1|||
130284237|NCT03960580|469004053|FG001|Overall Study|Lost to Follow-up|0|||
130284238|NCT03960580|469004054|FG002|Overall Study|Lost to Follow-up|0|||
130284239|NCT03960580|469004052|FG000|Overall Study|Lack of Efficacy|2|||
130284240|NCT03960580|469004053|FG001|Overall Study|Lack of Efficacy|1|||
130284241|NCT03960580|469004054|FG002|Overall Study|Lack of Efficacy|0|||
130284242|NCT03960580|469004052|FG000|Overall Study|Protocol Violation|0|||
130284243|NCT03960580|469004053|FG001|Overall Study|Protocol Violation|0|||
130284244|NCT03960580|469004054|FG002|Overall Study|Protocol Violation|1|||
130284245|NCT03960580|469004052|FG000|Overall Study|Withdrawal by Subject|1|||
130284246|NCT03960580|469004053|FG001|Overall Study|Withdrawal by Subject|1|||
130106244|NCT03372369|468349955|FG001|Qualification Period|Withdrawal by Subject|13|||
130284247|NCT03960580|469004054|FG002|Overall Study|Withdrawal by Subject|1|||
130284248|NCT03960580|469004052|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
130284249|NCT03960580|469004053|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
130284250|NCT03960580|469004054|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
130284251|NCT02359045|469004059|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
130284252|NCT02359045|469004060|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130284253|NCT02359045|469004059|FG000|Overall Study|Lost to Follow-up|1|||
130284254|NCT02359045|469004060|FG001|Overall Study|Lost to Follow-up|1|||
130284255|NCT02359045|469004059|FG000|Overall Study|Adverse Event|0|||
130284256|NCT02359045|469004060|FG001|Overall Study|Adverse Event|1|||
130284257|NCT01271712|469004066|FG000|Double Blind Treatment|Death|2|||
130284258|NCT01271712|469004067|FG001|Double Blind Treatment|Death|0|||
130284259|NCT01271712|469004066|FG000|Double Blind Treatment|Lack of Efficacy|1|||
130284260|NCT01271712|469004067|FG001|Double Blind Treatment|Lack of Efficacy|0|||
130284261|NCT01271712|469004066|FG000|Double Blind Treatment|Adverse Event|9|||
130284262|NCT01271712|469004067|FG001|Double Blind Treatment|Adverse Event|4|||
130284263|NCT01271712|469004066|FG000|Double Blind Treatment|Progressive disease|23|||
130284264|NCT01271712|469004067|FG001|Double Blind Treatment|Progressive disease|3|||
130284265|NCT01271712|469004066|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
130284266|NCT01271712|469004067|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
130284267|NCT01271712|469004066|FG000|Double Blind Treatment|Non compliance with study drug|2|||
130284268|NCT01271712|469004067|FG001|Double Blind Treatment|Non compliance with study drug|0|||
130284269|NCT01271712|469004066|FG000|Double Blind Treatment|receive no study drug|1|||
130284270|NCT01271712|469004067|FG001|Double Blind Treatment|receive no study drug|0|||
130284271|NCT01271712|469004066|FG000|Open Label Treatment|Death|6|||
130284272|NCT01271712|469004067|FG001|Open Label Treatment|Death|5|||
130284273|NCT01271712|469004066|FG000|Open Label Treatment|Withdrawal by Subject|6|||
130284274|NCT01271712|469004067|FG001|Open Label Treatment|Withdrawal by Subject|11|||
130284275|NCT01271712|469004066|FG000|Open Label Treatment|Physician Decision|2|||
130284276|NCT01271712|469004067|FG001|Open Label Treatment|Physician Decision|0|||
130284277|NCT01271712|469004066|FG000|Open Label Treatment|Adverse Event|14|||
130284278|NCT01271712|469004067|FG001|Open Label Treatment|Adverse Event|8|||
130284279|NCT01271712|469004066|FG000|Open Label Treatment|Progressive disease|59|||
130284280|NCT01271712|469004067|FG001|Open Label Treatment|Progressive disease|32|||
130284281|NCT01271712|469004066|FG000|Open Label Treatment|transferred to rollover study|1|||
130284282|NCT01271712|469004067|FG001|Open Label Treatment|transferred to rollover study|0|||
130284283|NCT01271712|469004066|FG000|Open Label Treatment|Non-compliance with study drug|1|||
130284284|NCT01271712|469004067|FG001|Open Label Treatment|Non-compliance with study drug|0|||
130284285|NCT01271712|469004066|FG000|Open Label Treatment|Protocol Violation|0|||
130284286|NCT01271712|469004067|FG001|Open Label Treatment|Protocol Violation|1|||
130284287|NCT01271712|469004066|FG000|Open Label Treatment|Switching to other therapy|2|||
130284288|NCT01271712|469004067|FG001|Open Label Treatment|Switching to other therapy|1|||
130284289|NCT01271712|469004066|FG000|Safety Follow-up|Death|11|||
130284290|NCT01271712|469004067|FG001|Safety Follow-up|Death|7|||
130284291|NCT01271712|469004066|FG000|Safety Follow-up|Withdrawal by Subject|4|||
129887055|NCT01755689|467547230|FG002|Overall Study|Lost to Follow-up|1|||
129887056|NCT01755689|467547231|FG003|Overall Study|Lost to Follow-up|0|||
129887057|NCT01755689|467547232|FG004|Overall Study|Lost to Follow-up|2|||
130284292|NCT01271712|469004067|FG001|Safety Follow-up|Withdrawal by Subject|2|||
130284293|NCT01271712|469004066|FG000|Safety Follow-up|Protocol Violation|1|||
130284294|NCT01271712|469004067|FG001|Safety Follow-up|Protocol Violation|1|||
130284295|NCT01271712|469004066|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
130284296|NCT01271712|469004067|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
130284297|NCT01271712|469004066|FG000|Safety Follow-up|No follow-up|1|||
130284298|NCT01271712|469004067|FG001|Safety Follow-up|No follow-up|1|||
130284299|NCT01271712|469004066|FG000|Safety Follow-up|Progressive disease|1|||
130284300|NCT01271712|469004067|FG001|Safety Follow-up|Progressive disease|0|||
130284301|NCT01271712|469004066|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
130284302|NCT01271712|469004067|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
130284303|NCT00096226|469004070|FG000|Overall Study|Ineligible|2|||
130284304|NCT00096226|469004070|FG000|Overall Study|Protocol treatment not started|1|||
130106245|NCT03372369|468349954|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
130284305|NCT01666119|469004071|FG000|Overall Study|Adverse Event|6|||
130284306|NCT01666119|469004071|FG000|Overall Study|Withdrawal by Subject|16|||
130284307|NCT01666119|469004071|FG000|Overall Study|Lost to Follow-up|7|||
130284308|NCT01666119|469004071|FG000|Overall Study|non compliance with study medication, pa|18|||
130284309|NCT01666119|469004071|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
130284310|NCT05479097|469004074|FG000|Overall Study|Withdrawal by Subject|2|||
129887058|NCT01755689|467547228|FG000|Overall Study|Pregnancy|1|||
129887059|NCT01755689|467547229|FG001|Overall Study|Pregnancy|1|||
129887060|NCT01755689|467547230|FG002|Overall Study|Pregnancy|2|||
129887061|NCT01755689|467547231|FG003|Overall Study|Pregnancy|4|||
129887062|NCT01755689|467547232|FG004|Overall Study|Pregnancy|2|||
129887063|NCT01995357|467547233|FG000|Period 5|Lack of Efficacy|1|||
129887064|NCT01995357|467547234|FG001|Period 5|Lack of Efficacy|0|||
129887065|NCT01995357|467547235|FG002|Period 5|Lack of Efficacy|0|||
129887066|NCT01995357|467547236|FG003|Period 5|Lack of Efficacy|0|||
129887067|NCT01995357|467547237|FG004|Period 5|Lack of Efficacy|0|||
129887068|NCT01995357|467547238|FG005|Period 5|Lack of Efficacy|0|||
129887069|NCT01995357|467547233|FG000|Period 5|Adverse Event|1|||
129887070|NCT01995357|467547234|FG001|Period 5|Adverse Event|0|||
129887071|NCT01995357|467547235|FG002|Period 5|Adverse Event|1|||
129887072|NCT01995357|467547236|FG003|Period 5|Adverse Event|0|||
129887073|NCT01995357|467547237|FG004|Period 5|Adverse Event|0|||
130284311|NCT03894969|469004080|FG000|Overall Study|Adverse Event|0|||
129887074|NCT01995357|467547238|FG005|Period 5|Adverse Event|0|||
129887075|NCT03615482|467547239|FG000|Overall Study|Death|1|||
129887076|NCT03615482|467547240|FG001|Overall Study|Death|0|||
129887077|NCT03615482|467547239|FG000|Overall Study|Lost to Follow-up|7|||
129887078|NCT03615482|467547240|FG001|Overall Study|Lost to Follow-up|7|||
129887079|NCT03615482|467547239|FG000|Overall Study|Physician Decision|2|||
130284312|NCT03894969|469004081|FG001|Overall Study|Adverse Event|2|||
130284313|NCT03894969|469004082|FG002|Overall Study|Adverse Event|0|||
130284314|NCT03894969|469004083|FG003|Overall Study|Adverse Event|1|||
130284315|NCT03894969|469004084|FG004|Overall Study|Adverse Event|2|||
130284316|NCT03894969|469004080|FG000|Overall Study|Lost to Follow-up|3|||
130284317|NCT03894969|469004081|FG001|Overall Study|Lost to Follow-up|1|||
130284318|NCT03894969|469004082|FG002|Overall Study|Lost to Follow-up|1|||
130284319|NCT03894969|469004083|FG003|Overall Study|Lost to Follow-up|0|||
130284320|NCT03894969|469004084|FG004|Overall Study|Lost to Follow-up|0|||
130284321|NCT03894969|469004080|FG000|Overall Study|Withdrawal by Subject|2|||
130284322|NCT03894969|469004081|FG001|Overall Study|Withdrawal by Subject|1|||
130284323|NCT03894969|469004082|FG002|Overall Study|Withdrawal by Subject|3|||
130284324|NCT03894969|469004083|FG003|Overall Study|Withdrawal by Subject|4|||
130284325|NCT03894969|469004084|FG004|Overall Study|Withdrawal by Subject|8|||
130284326|NCT03894969|469004080|FG000|Overall Study|Other|0|||
130284327|NCT03894969|469004081|FG001|Overall Study|Other|0|||
130284328|NCT03894969|469004082|FG002|Overall Study|Other|0|||
130284329|NCT03894969|469004083|FG003|Overall Study|Other|0|||
130284330|NCT03894969|469004084|FG004|Overall Study|Other|3|||
130284331|NCT03894969|469004080|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130284332|NCT03894969|469004081|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130284333|NCT03894969|469004082|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
130284334|NCT03894969|469004083|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
130284335|NCT03894969|469004084|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
130284336|NCT03894969|469004080|FG000|Overall Study|Solicited Adverse Event|0|||
129887080|NCT03615482|467547240|FG001|Overall Study|Physician Decision|3|||
129887081|NCT03615482|467547239|FG000|Overall Study|Withdrawal by Subject|7|||
129887082|NCT03615482|467547240|FG001|Overall Study|Withdrawal by Subject|7|||
130284337|NCT03894969|469004081|FG001|Overall Study|Solicited Adverse Event|1|||
130284338|NCT03894969|469004082|FG002|Overall Study|Solicited Adverse Event|0|||
129887083|NCT01500226|467547243|FG000|Overall Study|Adverse Event|31|||
129887084|NCT01500226|467547244|FG001|Overall Study|Adverse Event|38|||
130284339|NCT03894969|469004083|FG003|Overall Study|Solicited Adverse Event|0|||
129887085|NCT01500226|467547243|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
129887086|NCT01500226|467547244|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
130284340|NCT03894969|469004084|FG004|Overall Study|Solicited Adverse Event|0|||
130042828|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
130042829|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
130042830|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
130042831|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
130042832|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
130042833|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
130042834|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
130042835|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130042836|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130042837|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130042838|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130042839|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
130042840|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130042841|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
130042842|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130042843|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130042844|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130042845|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130042846|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
130042847|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
130042848|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
130042849|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
130042850|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
130042851|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
130042852|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
130042853|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
130042854|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
130042855|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
130042856|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
130042857|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
130042858|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
130042859|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
130042860|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
130042861|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
130042862|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
130042863|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130284341|NCT00468676|469004085|FG000|Overall Study|Lost to Follow-up|14|||
130284342|NCT00468676|469004086|FG001|Overall Study|Lost to Follow-up|11|||
130284343|NCT00468676|469004085|FG000|Overall Study|Death|2|||
130284344|NCT00468676|469004086|FG001|Overall Study|Death|1|||
130284345|NCT00118846|469004090|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
130284346|NCT00118846|469004091|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
130284347|NCT00118846|469004090|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
130284348|NCT00118846|469004091|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
130284349|NCT00118846|469004090|FG000|Overall Study|Physician Decision|1|||
130284350|NCT00118846|469004091|FG001|Overall Study|Physician Decision|0|||
130284351|NCT00118846|469004090|FG000|Overall Study|Medical condition|2|||
130284352|NCT00118846|469004091|FG001|Overall Study|Medical condition|2|||
130284353|NCT00118846|469004090|FG000|Overall Study|Lost to Follow-up|0|||
130284354|NCT00118846|469004091|FG001|Overall Study|Lost to Follow-up|2|||
130284355|NCT00118846|469004090|FG000|Overall Study|Personal reason|4|||
130284356|NCT00118846|469004091|FG001|Overall Study|Personal reason|5|||
130284357|NCT00443053|469004092|FG000|Overall Study|Adverse Event|2|||
130284358|NCT00443053|469004093|FG001|Overall Study|Adverse Event|1|||
130284359|NCT00443053|469004092|FG000|Overall Study|Withdrawal by Subject|9|||
130284360|NCT00443053|469004093|FG001|Overall Study|Withdrawal by Subject|18|||
130284361|NCT00443053|469004092|FG000|Overall Study|Lost to Follow-up|4|||
130284362|NCT00443053|469004093|FG001|Overall Study|Lost to Follow-up|5|||
130284363|NCT00443053|469004092|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
130284364|NCT00443053|469004093|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
130284365|NCT00443053|469004092|FG000|Overall Study|Noncompliance|2|||
130284366|NCT00443053|469004093|FG001|Overall Study|Noncompliance|1|||
130284367|NCT00443053|469004092|FG000|Overall Study|Other|3|||
130284368|NCT00443053|469004093|FG001|Overall Study|Other|4|||
130284369|NCT00443053|469004092|FG000|Overall Study|Physician Decision|0|||
130284370|NCT00443053|469004093|FG001|Overall Study|Physician Decision|4|||
130284371|NCT00541866|469004094|FG000|Overall Study|Adverse Event|3|||
130284372|NCT00541866|469004095|FG001|Overall Study|Adverse Event|0|||
130284373|NCT00541866|469004096|FG002|Overall Study|Adverse Event|0|||
130284374|NCT00541866|469004097|FG003|Overall Study|Adverse Event|0|||
130284375|NCT00541866|469004098|FG004|Overall Study|Adverse Event|0|||
130284376|NCT00541866|469004094|FG000|Overall Study|Death|1|||
130284377|NCT00541866|469004095|FG001|Overall Study|Death|0|||
130284378|NCT00541866|469004096|FG002|Overall Study|Death|0|||
130284379|NCT00541866|469004097|FG003|Overall Study|Death|0|||
130284380|NCT00541866|469004098|FG004|Overall Study|Death|0|||
130284381|NCT00541866|469004094|FG000|Overall Study|Lack of Efficacy|19|||
130284382|NCT00541866|469004095|FG001|Overall Study|Lack of Efficacy|15|||
130284383|NCT00541866|469004096|FG002|Overall Study|Lack of Efficacy|10|||
130284384|NCT00541866|469004097|FG003|Overall Study|Lack of Efficacy|12|||
130284385|NCT00541866|469004098|FG004|Overall Study|Lack of Efficacy|14|||
130284386|NCT00541866|469004094|FG000|Overall Study|Not Reported or Other|11|||
130284387|NCT00541866|469004095|FG001|Overall Study|Not Reported or Other|3|||
130284388|NCT00541866|469004096|FG002|Overall Study|Not Reported or Other|3|||
130284389|NCT00541866|469004097|FG003|Overall Study|Not Reported or Other|3|||
130284390|NCT00541866|469004098|FG004|Overall Study|Not Reported or Other|1|||
130284391|NCT00541866|469004094|FG000|Overall Study|Physician Decision|0|||
130284392|NCT00541866|469004095|FG001|Overall Study|Physician Decision|0|||
130284393|NCT00541866|469004096|FG002|Overall Study|Physician Decision|2|||
130284394|NCT00541866|469004097|FG003|Overall Study|Physician Decision|1|||
130284395|NCT00541866|469004098|FG004|Overall Study|Physician Decision|0|||
130284396|NCT01327053|469004099|FG000|Overall Study|Adverse Event|23|||
130284397|NCT01327053|469004100|FG001|Overall Study|Adverse Event|57|||
130284398|NCT01327053|469004099|FG000|Overall Study|Patient/guardian decision|11|||
130284399|NCT01327053|469004100|FG001|Overall Study|Patient/guardian decision|35|||
130284400|NCT01327053|469004099|FG000|Overall Study|Physician Decision|10|||
130284401|NCT01327053|469004100|FG001|Overall Study|Physician Decision|14|||
130284402|NCT01327053|469004099|FG000|Overall Study|Death|1|||
130284403|NCT01327053|469004100|FG001|Overall Study|Death|5|||
130284404|NCT01327053|469004099|FG000|Overall Study|Lost to Follow-up|2|||
130284405|NCT01327053|469004100|FG001|Overall Study|Lost to Follow-up|4|||
130284406|NCT01327053|469004099|FG000|Overall Study|Non-compliance with study treatment|0|||
130284407|NCT01327053|469004100|FG001|Overall Study|Non-compliance with study treatment|5|||
130284408|NCT01327053|469004099|FG000|Overall Study|Study terminated by Sponsor|1|||
130284409|NCT01327053|469004100|FG001|Overall Study|Study terminated by Sponsor|3|||
130284410|NCT01327053|469004099|FG000|Overall Study|Progressive disease|31|||
130284411|NCT01327053|469004100|FG001|Overall Study|Progressive disease|26|||
130284412|NCT01327053|469004099|FG000|Overall Study|Protocol Violation|0|||
130284413|NCT01327053|469004100|FG001|Overall Study|Protocol Violation|1|||
130284414|NCT01327053|469004099|FG000|Overall Study|Untreated|0|||
130284415|NCT01327053|469004100|FG001|Overall Study|Untreated|1|||
130284416|NCT01574157|469004101|FG000|Overall Study|Withdrawal by Subject|4|||
130284417|NCT01574157|469004102|FG001|Overall Study|Withdrawal by Subject|5|||
130284418|NCT01574157|469004101|FG000|Overall Study|Lost to Follow-up|0|||
130042864|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130042865|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
130042866|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130042867|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130042868|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
130042869|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
130042870|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
130042871|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
130042872|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
130042873|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
130042874|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
130042875|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
130042876|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
130042877|NCT02975349|468114421|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
130042878|NCT02975349|468114422|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
130042879|NCT02975349|468114423|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
130042880|NCT02975349|468114424|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
130042881|NCT02975349|468114425|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
130042882|NCT02975349|468114426|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
130042883|NCT02975349|468114427|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
130042884|NCT03567187|468114430|FG000|Overall Study|Lost to Follow-up|18|||
130042885|NCT02032875|468114433|FG000|Treatment Period|Adverse Event|1|||
130042886|NCT02032875|468114434|FG001|Treatment Period|Adverse Event|0|||
130042887|NCT02032875|468114433|FG000|Treatment Period|Liver transplant, No extension needed|0|||
130042888|NCT02032875|468114434|FG001|Treatment Period|Liver transplant, No extension needed|1|||
130042889|NCT02032875|468114433|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
129887087|NCT01500226|467547243|FG000|Overall Study|Withdrawal by Subject|93|||
129887088|NCT01500226|467547244|FG001|Overall Study|Withdrawal by Subject|96|||
129887089|NCT01500226|467547243|FG000|Overall Study|Death|12|||
129887090|NCT01500226|467547244|FG001|Overall Study|Death|4|||
130042890|NCT02032875|468114434|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
130042891|NCT02032875|468114433|FG000|Follow-up Period|Death|0|||
130042892|NCT02032875|468114434|FG001|Follow-up Period|Death|1|||
130106246|NCT03372369|468349955|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
130106247|NCT03372369|468349954|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
130106248|NCT03372369|468349955|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
130106249|NCT02239601|468349956|FG000|Overall Study|Withdrawal by Subject|3|||
130106250|NCT02239601|468349957|FG001|Overall Study|Withdrawal by Subject|4|||
130106251|NCT02239601|468349956|FG000|Overall Study|Protocol Violation|4|||
130106252|NCT02239601|468349957|FG001|Overall Study|Protocol Violation|2|||
130106253|NCT01508325|468349958|FG000|Overall Study|Withdrawal by Subject|8|||
130106254|NCT01508325|468349959|FG001|Overall Study|Withdrawal by Subject|9|||
130106255|NCT01508325|468349958|FG000|Overall Study|Protocol Violation|0|||
130106256|NCT01508325|468349959|FG001|Overall Study|Protocol Violation|3|||
130106257|NCT01508325|468349958|FG000|Overall Study|Physician Decision|2|||
130106258|NCT01508325|468349959|FG001|Overall Study|Physician Decision|1|||
130106259|NCT01508325|468349958|FG000|Overall Study|Adverse Event|1|||
130284419|NCT01574157|469004102|FG001|Overall Study|Lost to Follow-up|3|||
130284420|NCT00721578|469004103|FG000|Overall Study|Death|1|||
130284421|NCT00721578|469004104|FG001|Overall Study|Death|1|||
130284422|NCT00721578|469004103|FG000|Overall Study|Withdrawal by Subject|1|||
130284423|NCT00721578|469004104|FG001|Overall Study|Withdrawal by Subject|1|||
130284424|NCT01944098|469004105|FG000|Overall Study|Physician Decision|1|||
129887091|NCT01500226|467547243|FG000|Overall Study|Disease Progression|16|||
129887092|NCT01500226|467547244|FG001|Overall Study|Disease Progression|14|||
130106260|NCT01508325|468349959|FG001|Overall Study|Adverse Event|0|||
130106261|NCT01508325|468349958|FG000|Overall Study|Lost to Follow-up|5|||
130284425|NCT01944098|469004106|FG001|Overall Study|Physician Decision|0|||
130284426|NCT05032690|469004107|FG000|Period 1|Adverse Event|0|||
129887093|NCT01500226|467547243|FG000|Overall Study|Protocol Violation|53|||
129887094|NCT01500226|467547244|FG001|Overall Study|Protocol Violation|39|||
129887095|NCT01500226|467547243|FG000|Overall Study|Physician Decision|17|||
129887096|NCT01500226|467547244|FG001|Overall Study|Physician Decision|15|||
129887097|NCT01500226|467547243|FG000|Overall Study|Lack of Efficacy|14|||
129887098|NCT01500226|467547244|FG001|Overall Study|Lack of Efficacy|30|||
129887099|NCT01500226|467547243|FG000|Overall Study|Lost to Follow-up|9|||
129887100|NCT01500226|467547244|FG001|Overall Study|Lost to Follow-up|5|||
129887101|NCT01500226|467547243|FG000|Overall Study|Other Reasons|19|||
129887102|NCT01500226|467547244|FG001|Overall Study|Other Reasons|16|||
129887103|NCT02955277|467547245|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
129887104|NCT02955277|467547246|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
129887105|NCT02955277|467547245|FG000|Post to Follow-up|Lost to Follow-up|8|||
129887106|NCT02955277|467547246|FG001|Post to Follow-up|Lost to Follow-up|11|||
129887107|NCT01668147|467547257|FG000|Overall Study|Withdrawal by Subject|6|||
129887108|NCT01809210|467547258|FG000|Overall Study|Withdrawal by Subject|0|||
129887109|NCT01809210|467547259|FG001|Overall Study|Withdrawal by Subject|0|||
129887110|NCT01809210|467547260|FG002|Overall Study|Withdrawal by Subject|1|||
129887111|NCT01809210|467547261|FG003|Overall Study|Withdrawal by Subject|1|||
129887112|NCT01809210|467547262|FG004|Overall Study|Withdrawal by Subject|1|||
129887113|NCT01809210|467547263|FG005|Overall Study|Withdrawal by Subject|0|||
129887114|NCT01809210|467547264|FG006|Overall Study|Withdrawal by Subject|4|||
129887115|NCT01809210|467547258|FG000|Overall Study|Death|1|||
129887116|NCT01809210|467547259|FG001|Overall Study|Death|1|||
129887117|NCT01809210|467547260|FG002|Overall Study|Death|2|||
130284427|NCT05032690|469004108|FG001|Period 1|Adverse Event|1|||
130284428|NCT05032690|469004109|FG002|Period 1|Adverse Event|0|||
130284429|NCT05032690|469004110|FG003|Period 1|Adverse Event|0|||
130284430|NCT05032690|469004107|FG000|Period 1|Withdrawal by Subject|1|||
130284431|NCT05032690|469004108|FG001|Period 1|Withdrawal by Subject|0|||
130284432|NCT05032690|469004109|FG002|Period 1|Withdrawal by Subject|0|||
130284433|NCT05032690|469004110|FG003|Period 1|Withdrawal by Subject|0|||
130284434|NCT05032690|469004107|FG000|Period 1|No longer meets eligibility criteria|0|||
130284435|NCT05032690|469004108|FG001|Period 1|No longer meets eligibility criteria|1|||
130284436|NCT05032690|469004109|FG002|Period 1|No longer meets eligibility criteria|0|||
130284437|NCT05032690|469004110|FG003|Period 1|No longer meets eligibility criteria|0|||
130284438|NCT05032690|469004107|FG000|Period 2|Adverse Event|1|||
130284439|NCT05032690|469004108|FG001|Period 2|Adverse Event|0|||
130284440|NCT05032690|469004109|FG002|Period 2|Adverse Event|0|||
130284441|NCT05032690|469004110|FG003|Period 2|Adverse Event|0|||
130284442|NCT05032690|469004107|FG000|Period 2|Withdrawal by Subject|0|||
130284443|NCT05032690|469004108|FG001|Period 2|Withdrawal by Subject|1|||
130284444|NCT05032690|469004109|FG002|Period 2|Withdrawal by Subject|0|||
130284445|NCT05032690|469004110|FG003|Period 2|Withdrawal by Subject|0|||
130284446|NCT05032690|469004107|FG000|Period 2|No longer meets eligibility criteria|0|||
130284447|NCT05032690|469004108|FG001|Period 2|No longer meets eligibility criteria|1|||
130284448|NCT05032690|469004109|FG002|Period 2|No longer meets eligibility criteria|0|||
129887118|NCT01809210|467547261|FG003|Overall Study|Death|0|||
129887119|NCT01809210|467547262|FG004|Overall Study|Death|1|||
130284449|NCT05032690|469004110|FG003|Period 2|No longer meets eligibility criteria|0|||
130284450|NCT05032690|469004107|FG000|Period 3|Adverse Event|0|||
129887120|NCT01809210|467547263|FG005|Overall Study|Death|3|||
129887121|NCT01809210|467547264|FG006|Overall Study|Death|1|||
129887122|NCT00590980|467547265|FG000|Overall Study|Did not meet all inclusion criteria|10|||
130284451|NCT05032690|469004108|FG001|Period 3|Adverse Event|1|||
129887123|NCT03699124|467547269|FG000|Overall Study|Adverse Event|6|||
129887124|NCT03699124|467547270|FG001|Overall Study|Adverse Event|5|||
129887125|NCT03699124|467547271|FG002|Overall Study|Adverse Event|2|||
129887126|NCT03699124|467547269|FG000|Overall Study|Death|0|||
129887127|NCT03699124|467547270|FG001|Overall Study|Death|2|||
129887128|NCT03699124|467547271|FG002|Overall Study|Death|0|||
129887129|NCT03699124|467547269|FG000|Overall Study|Lost to Follow-up|20|||
129887130|NCT03699124|467547270|FG001|Overall Study|Lost to Follow-up|16|||
129887131|NCT03699124|467547271|FG002|Overall Study|Lost to Follow-up|15|||
129887132|NCT03699124|467547269|FG000|Overall Study|Protocol Violation|1|||
129887133|NCT03699124|467547270|FG001|Overall Study|Protocol Violation|0|||
129887134|NCT03699124|467547271|FG002|Overall Study|Protocol Violation|0|||
129887135|NCT03699124|467547269|FG000|Overall Study|Withdrawal by Subject|13|||
129887136|NCT03699124|467547270|FG001|Overall Study|Withdrawal by Subject|14|||
129887137|NCT03699124|467547271|FG002|Overall Study|Withdrawal by Subject|13|||
129887138|NCT03699124|467547269|FG000|Overall Study|Other reasons|5|||
129887139|NCT03699124|467547270|FG001|Overall Study|Other reasons|3|||
129887140|NCT03699124|467547271|FG002|Overall Study|Other reasons|10|||
129887141|NCT01474512|467547272|FG000|Induction Period|Adverse Event|6|||
129887142|NCT01474512|467547273|FG001|Induction Period|Adverse Event|10|||
129887143|NCT01474512|467547274|FG002|Induction Period|Adverse Event|10|||
129887144|NCT01474512|467547275|FG003|Induction Period|Adverse Event|0|||
129887145|NCT01474512|467547276|FG004|Induction Period|Adverse Event|0|||
129887146|NCT01474512|467547277|FG005|Induction Period|Adverse Event|0|||
129887147|NCT01474512|467547278|FG006|Induction Period|Adverse Event|0|||
129887148|NCT01474512|467547279|FG007|Induction Period|Adverse Event|0|||
129887149|NCT01474512|467547280|FG008|Induction Period|Adverse Event|0|||
129887150|NCT01474512|467547281|FG009|Induction Period|Adverse Event|0|||
129887151|NCT01474512|467547282|FG010|Induction Period|Adverse Event|0|||
130106262|NCT01508325|468349959|FG001|Overall Study|Lost to Follow-up|6|||
130106263|NCT01508325|468349958|FG000|Overall Study|Other|2|||
130106264|NCT01508325|468349959|FG001|Overall Study|Other|2|||
130284452|NCT05032690|469004109|FG002|Period 3|Adverse Event|0|||
130284453|NCT05032690|469004110|FG003|Period 3|Adverse Event|0|||
130284454|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
130284455|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
130284456|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Death|1|||
130284457|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Death|0|||
130284458|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
130284459|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
130284460|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
130284461|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
130284462|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
130284463|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
130284464|NCT00350272|469004111|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
130284465|NCT00350272|469004112|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
130284466|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
130284467|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
130284468|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
130284469|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
130284470|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
130284471|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
130284472|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
130284473|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
129887152|NCT01474512|467547283|FG011|Induction Period|Adverse Event|0|||
129887153|NCT01474512|467547284|FG012|Induction Period|Adverse Event|0|||
130284474|NCT00350272|469004111|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
129887154|NCT01474512|467547285|FG013|Induction Period|Adverse Event|0|||
129887155|NCT01474512|467547286|FG014|Induction Period|Adverse Event|0|||
129887156|NCT01474512|467547287|FG015|Induction Period|Adverse Event|0|||
130284475|NCT00350272|469004112|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
129887157|NCT01474512|467547288|FG016|Induction Period|Adverse Event|0|||
129887158|NCT01474512|467547289|FG017|Induction Period|Adverse Event|0|||
130284476|NCT02910401|469004113|FG000|Overall Study|Study closure Study closure|0|||
130284477|NCT02910401|469004114|FG001|Overall Study|Study closure Study closure|0|||
130284478|NCT02910401|469004115|FG002|Overall Study|Study closure Study closure|2|||
130284479|NCT02910401|469004113|FG000|Overall Study|Physician Decision|1|||
130284480|NCT02910401|469004114|FG001|Overall Study|Physician Decision|0|||
130284481|NCT02910401|469004115|FG002|Overall Study|Physician Decision|0|||
130284482|NCT03300024|469004116|FG000|Overall Study|Physician Decision|4|||
130284483|NCT03300024|469004117|FG001|Overall Study|Physician Decision|6|||
130284484|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
130284485|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130284486|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130284487|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
130284488|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
130284489|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
130284490|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
130284491|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
130284492|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
130284493|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
130284494|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
130284495|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
130284496|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
130284497|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
130284498|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
130284499|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
130284500|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130284501|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
130284502|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130284503|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
130284504|NCT03222973|469004118|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
130284505|NCT03222973|469004119|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
130284506|NCT03222973|469004120|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
130284507|NCT03222973|469004121|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
130284508|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130284509|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130284510|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
130284511|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
130284512|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
130284513|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
130284514|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
130284515|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
130284516|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
130284517|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
130284518|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
130284519|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
130284520|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
130284521|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
130284522|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
130284523|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
130284524|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
130284525|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
130284526|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
130284527|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
130284528|NCT03222973|469004118|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130284529|NCT03222973|469004119|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130284530|NCT03222973|469004120|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
130284531|NCT03222973|469004121|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
130284532|NCT02080481|469004122|FG000|Overall Study|Never received a block.|1|||
130284533|NCT02080481|469004123|FG001|Overall Study|Never received a block.|0|||
130284534|NCT00840060|469005818|FG000|Overall Study|Withdrawal by Subject|1|||
130284535|NCT00840060|469005819|FG001|Overall Study|Withdrawal by Subject|0|||
130284536|NCT00840060|469005818|FG000|Overall Study|Change in emotional/behavioral status|0|||
130284537|NCT00840060|469005819|FG001|Overall Study|Change in emotional/behavioral status|1|||
130284538|NCT00871923|469005820|FG000|Overall Study|Death|1|||
130284539|NCT00871923|469005820|FG000|Overall Study|Withdrawal by Subject|1|||
130284540|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
130284541|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
130284542|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
130284543|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
130284544|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
130284545|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
130284546|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
130284547|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
130284548|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
130284549|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
130284550|NCT01263015|469005825|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
130284551|NCT01263015|469005826|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
130284552|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
130284553|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
130284554|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
130284555|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
130284556|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
130284557|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
130284558|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
130284559|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
130284560|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
130284561|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
130284562|NCT01263015|469005825|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
130284563|NCT01263015|469005826|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
130284564|NCT02723006|469005827|FG000|Overall Study|Withdrawal by Subject|0|||
130284565|NCT02723006|469005828|FG001|Overall Study|Withdrawal by Subject|1|||
130284566|NCT02723006|469005829|FG002|Overall Study|Withdrawal by Subject|1|||
130284567|NCT02723006|469005827|FG000|Overall Study|Study Terminated by Sponsor|1|||
130284568|NCT02723006|469005828|FG001|Overall Study|Study Terminated by Sponsor|6|||
130284569|NCT02723006|469005829|FG002|Overall Study|Study Terminated by Sponsor|6|||
130284570|NCT00303446|469005830|FG000|Overall Study|Withdrawal by Subject|2|||
130284571|NCT00303446|469005831|FG001|Overall Study|Withdrawal by Subject|2|||
130284572|NCT00303446|469005830|FG000|Overall Study|Death|0|||
130284573|NCT00303446|469005831|FG001|Overall Study|Death|1|||
130284574|NCT00303446|469005830|FG000|Overall Study|Physician Decision|0|||
130284575|NCT00303446|469005831|FG001|Overall Study|Physician Decision|1|||
130284576|NCT04258995|469005832|FG000|Overall Study|Lost to Follow-up|1|||
130284577|NCT04258995|469005833|FG001|Overall Study|Lost to Follow-up|1|||
130284578|NCT00642174|469005835|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
130284579|NCT00642174|469005836|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
130284580|NCT00896363|469005837|FG000|Overall Study|Adverse Event|3|||
130284581|NCT00896363|469005838|FG001|Overall Study|Adverse Event|4|||
130284582|NCT00896363|469005839|FG002|Overall Study|Adverse Event|2|||
130284583|NCT00896363|469005837|FG000|Overall Study|Lack of Efficacy|0|||
130284584|NCT00896363|469005838|FG001|Overall Study|Lack of Efficacy|2|||
130284585|NCT00896363|469005839|FG002|Overall Study|Lack of Efficacy|1|||
130284586|NCT00896363|469005837|FG000|Overall Study|Withdrawal by Subject|3|||
130284587|NCT00896363|469005838|FG001|Overall Study|Withdrawal by Subject|5|||
130284588|NCT00896363|469005839|FG002|Overall Study|Withdrawal by Subject|5|||
130284589|NCT00316693|469005842|FG000|Overall Study|Adverse Event|6|||
130284590|NCT00316693|469005843|FG001|Overall Study|Adverse Event|1|||
129887159|NCT01474512|467547272|FG000|Induction Period|Lack of Efficacy|7|||
129887160|NCT01474512|467547273|FG001|Induction Period|Lack of Efficacy|1|||
129887161|NCT01474512|467547274|FG002|Induction Period|Lack of Efficacy|0|||
129887162|NCT01474512|467547275|FG003|Induction Period|Lack of Efficacy|0|||
129887163|NCT01474512|467547276|FG004|Induction Period|Lack of Efficacy|0|||
129887164|NCT01474512|467547277|FG005|Induction Period|Lack of Efficacy|0|||
129887165|NCT01474512|467547278|FG006|Induction Period|Lack of Efficacy|0|||
129887166|NCT01474512|467547279|FG007|Induction Period|Lack of Efficacy|0|||
129887167|NCT01474512|467547280|FG008|Induction Period|Lack of Efficacy|0|||
129887168|NCT01474512|467547281|FG009|Induction Period|Lack of Efficacy|0|||
129887169|NCT01474512|467547282|FG010|Induction Period|Lack of Efficacy|0|||
129887170|NCT01474512|467547283|FG011|Induction Period|Lack of Efficacy|0|||
129887171|NCT01474512|467547284|FG012|Induction Period|Lack of Efficacy|0|||
129887172|NCT01474512|467547285|FG013|Induction Period|Lack of Efficacy|0|||
129887173|NCT01474512|467547286|FG014|Induction Period|Lack of Efficacy|0|||
129887174|NCT01474512|467547287|FG015|Induction Period|Lack of Efficacy|0|||
129887175|NCT01474512|467547288|FG016|Induction Period|Lack of Efficacy|0|||
129887176|NCT01474512|467547289|FG017|Induction Period|Lack of Efficacy|0|||
129887177|NCT01474512|467547272|FG000|Induction Period|Withdrawal by Subject|6|||
129887178|NCT01474512|467547273|FG001|Induction Period|Withdrawal by Subject|6|||
129887179|NCT01474512|467547274|FG002|Induction Period|Withdrawal by Subject|5|||
129887180|NCT01474512|467547275|FG003|Induction Period|Withdrawal by Subject|0|||
129887181|NCT01474512|467547276|FG004|Induction Period|Withdrawal by Subject|0|||
129887182|NCT01474512|467547277|FG005|Induction Period|Withdrawal by Subject|0|||
129887183|NCT01474512|467547278|FG006|Induction Period|Withdrawal by Subject|0|||
129887184|NCT01474512|467547279|FG007|Induction Period|Withdrawal by Subject|0|||
129887185|NCT01474512|467547280|FG008|Induction Period|Withdrawal by Subject|0|||
130284591|NCT00316693|469005842|FG000|Overall Study|Protocol Violation|1|||
130284592|NCT00316693|469005843|FG001|Overall Study|Protocol Violation|0|||
130284593|NCT00316693|469005842|FG000|Overall Study|Withdrawal by Subject|6|||
130284594|NCT00316693|469005843|FG001|Overall Study|Withdrawal by Subject|6|||
130284595|NCT00316693|469005842|FG000|Overall Study|Lost to Follow-up|26|||
130284596|NCT00316693|469005843|FG001|Overall Study|Lost to Follow-up|34|||
130284597|NCT00316693|469005842|FG000|Overall Study|Other|38|||
130284598|NCT00316693|469005843|FG001|Overall Study|Other|44|||
130284599|NCT03002818|469005847|FG000|Overall Study|Decision of the investigator|1|||
130284600|NCT00711113|469005848|FG000|Overall Study|Lost to Follow-up|9|||
130284601|NCT00711113|469005848|FG000|Overall Study|Implant lost|2|||
130284602|NCT01606787|469005856|FG000|Overall Study|Withdrawal by Subject|4|||
130284603|NCT01606787|469005857|FG001|Overall Study|Withdrawal by Subject|5|||
130284604|NCT01606787|469005856|FG000|Overall Study|Surgery canceled|0|||
130284605|NCT01606787|469005857|FG001|Overall Study|Surgery canceled|2|||
130284606|NCT04225676|469005858|FG000|Overall Study|Physician Decision|1|||
130284607|NCT04225676|469005858|FG000|Overall Study|Lack of Efficacy|1|||
130284608|NCT04225676|469005858|FG000|Overall Study|Study terminated by sponsor|3|||
130284609|NCT03245736|469005859|FG000|Overall Study|Adverse Event|1|||
130284610|NCT03245736|469005859|FG000|Overall Study|Progressive Disease|4|||
130284611|NCT00354107|469005865|FG000|Overall Study|Adverse Event|2|||
130284612|NCT00354107|469005865|FG000|Overall Study|Physician Decision|2|||
130284613|NCT00354107|469005865|FG000|Overall Study|Withdrawal by Subject|1|||
130284614|NCT01685801|469005868|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130284615|NCT01685801|469005869|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130284616|NCT01685801|469005870|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
130284617|NCT01685801|469005871|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
130284618|NCT01685801|469005868|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
130284619|NCT01685801|469005869|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
130284620|NCT01685801|469005870|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
130284621|NCT01685801|469005871|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
129887186|NCT01474512|467547281|FG009|Induction Period|Withdrawal by Subject|0|||
129887187|NCT01474512|467547282|FG010|Induction Period|Withdrawal by Subject|0|||
129887188|NCT01474512|467547283|FG011|Induction Period|Withdrawal by Subject|0|||
129887189|NCT01474512|467547284|FG012|Induction Period|Withdrawal by Subject|0|||
129887190|NCT01474512|467547285|FG013|Induction Period|Withdrawal by Subject|0|||
129887191|NCT01474512|467547286|FG014|Induction Period|Withdrawal by Subject|0|||
130284622|NCT04686084|469005872|FG000|Overall Study|Lost to Follow-up|1|||
129887192|NCT01474512|467547287|FG015|Induction Period|Withdrawal by Subject|0|||
129887193|NCT01474512|467547288|FG016|Induction Period|Withdrawal by Subject|0|||
129887194|NCT01474512|467547289|FG017|Induction Period|Withdrawal by Subject|0|||
129887195|NCT01474512|467547272|FG000|Induction Period|Protocol Violation|3|||
130284623|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
130284624|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
130284625|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130284626|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
130284627|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
129887196|NCT01474512|467547273|FG001|Induction Period|Protocol Violation|6|||
129887197|NCT01474512|467547274|FG002|Induction Period|Protocol Violation|0|||
129887198|NCT01474512|467547275|FG003|Induction Period|Protocol Violation|0|||
130284628|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130284629|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
130284630|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284631|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284632|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284633|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
130284634|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
130284635|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284636|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284637|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130042893|NCT02032875|468114433|FG000|Follow-up Period|Virologic Relapse|3|||
130042894|NCT02032875|468114434|FG001|Follow-up Period|Virologic Relapse|10|||
130284638|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284639|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284640|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
130284641|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284642|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284643|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284644|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284645|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284646|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284647|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
130284648|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284649|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284650|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284651|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284652|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284653|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284654|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284655|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284656|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284657|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284658|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
130284659|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284660|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284661|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
130284662|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284663|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284664|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284665|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284666|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284667|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284668|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284669|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130042895|NCT04358458|468114435|FG000|Overall Study|Death|1|||
130042896|NCT04358458|468114436|FG001|Overall Study|Death|1|||
130042897|NCT04358458|468114437|FG002|Overall Study|Death|3|||
130042898|NCT04358458|468114438|FG003|Overall Study|Death|8|||
130042899|NCT04358458|468114439|FG004|Overall Study|Death|1|||
130042900|NCT04358458|468114440|FG005|Overall Study|Death|6|||
130042901|NCT04358458|468114441|FG006|Overall Study|Death|2|||
130042902|NCT04358458|468114442|FG007|Overall Study|Death|3|||
130042903|NCT04358458|468114435|FG000|Overall Study|Lost to Follow-up|0|||
130042904|NCT04358458|468114436|FG001|Overall Study|Lost to Follow-up|0|||
130042905|NCT04358458|468114437|FG002|Overall Study|Lost to Follow-up|0|||
130042906|NCT04358458|468114438|FG003|Overall Study|Lost to Follow-up|0|||
130042907|NCT04358458|468114439|FG004|Overall Study|Lost to Follow-up|0|||
130042908|NCT04358458|468114440|FG005|Overall Study|Lost to Follow-up|0|||
130284670|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284671|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284672|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284673|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284674|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284675|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284676|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
130284677|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284678|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284679|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
130284680|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284681|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284682|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284683|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284684|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284685|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284686|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284687|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284688|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284689|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284690|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284691|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284692|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284693|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284694|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
130284695|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284696|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284697|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284698|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284699|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130316226|NCT04319198|469124334|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
130106265|NCT04682639|468349960|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
130284700|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284701|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284702|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284703|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284704|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284705|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
130284706|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284707|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284708|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284709|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284710|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284711|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284712|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
130284713|NCT03447314|469005876|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284714|NCT03447314|469005877|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284715|NCT03447314|469005878|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284716|NCT03447314|469005879|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
130284717|NCT03447314|469005880|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284718|NCT03447314|469005881|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
130284719|NCT03447314|469005882|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284720|NCT03447314|469005883|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284721|NCT03447314|469005884|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284722|NCT03447314|469005885|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284723|NCT03447314|469005886|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129887199|NCT01474512|467547276|FG004|Induction Period|Protocol Violation|0|||
129887200|NCT01474512|467547277|FG005|Induction Period|Protocol Violation|0|||
129887201|NCT01474512|467547278|FG006|Induction Period|Protocol Violation|0|||
129887202|NCT01474512|467547279|FG007|Induction Period|Protocol Violation|0|||
129887203|NCT01474512|467547280|FG008|Induction Period|Protocol Violation|0|||
129887204|NCT01474512|467547281|FG009|Induction Period|Protocol Violation|0|||
129887205|NCT01474512|467547282|FG010|Induction Period|Protocol Violation|0|||
129887206|NCT01474512|467547283|FG011|Induction Period|Protocol Violation|0|||
129887207|NCT01474512|467547284|FG012|Induction Period|Protocol Violation|0|||
129887208|NCT01474512|467547285|FG013|Induction Period|Protocol Violation|0|||
130042909|NCT04358458|468114441|FG006|Overall Study|Lost to Follow-up|0|||
130042910|NCT04358458|468114442|FG007|Overall Study|Lost to Follow-up|1|||
130042911|NCT04358458|468114435|FG000|Overall Study|Site is closing study participation|0|||
130042912|NCT04358458|468114436|FG001|Overall Study|Site is closing study participation|0|||
130284724|NCT03447314|469005887|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284725|NCT03447314|469005888|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284726|NCT03447314|469005889|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284727|NCT03447314|469005890|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284728|NCT03447314|469005891|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284729|NCT03447314|469005892|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284730|NCT03447314|469005893|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
130284731|NCT04600076|469005894|FG000|Overall Study|Lost to Follow-up|3|||
130284732|NCT02891681|469005895|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
130284733|NCT02891681|469005896|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
130284734|NCT02891681|469005897|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
130284735|NCT02891681|469005895|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
130284736|NCT02891681|469005896|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
130284737|NCT02891681|469005897|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
130284738|NCT02891681|469005895|FG000|Overall Study|Taken off study after first imaging appointment|1|||
130284739|NCT02891681|469005896|FG001|Overall Study|Taken off study after first imaging appointment|0|||
130284740|NCT02891681|469005897|FG002|Overall Study|Taken off study after first imaging appointment|0|||
130284741|NCT00957944|469005901|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
130284742|NCT00957944|469005902|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
130284743|NCT01482169|469005903|FG000|Overall Study|Physician Decision|2|||
130284744|NCT00522418|469005904|FG000|Overall Study|Local IRB Consent Violation|5|||
130284745|NCT00522418|469005905|FG001|Overall Study|Local IRB Consent Violation|5|||
130284746|NCT00522418|469005904|FG000|Overall Study|Early Study Termination|46|||
130284747|NCT00522418|469005905|FG001|Overall Study|Early Study Termination|47|||
130284748|NCT00522418|469005904|FG000|Overall Study|Noncompliance|2|||
130284749|NCT00522418|469005905|FG001|Overall Study|Noncompliance|2|||
130284750|NCT00522418|469005904|FG000|Overall Study|Reason Not Specified|3|||
130284751|NCT00522418|469005905|FG001|Overall Study|Reason Not Specified|1|||
130284752|NCT00522418|469005904|FG000|Overall Study|Consent Withdraw|1|||
130284753|NCT00522418|469005905|FG001|Overall Study|Consent Withdraw|2|||
130284754|NCT00522418|469005904|FG000|Overall Study|Lack of Efficacy|0|||
130284755|NCT00522418|469005905|FG001|Overall Study|Lack of Efficacy|1|||
130284756|NCT00578877|469005908|FG000|Overall Study|Lost to Follow-up|8|||
130284757|NCT00578877|469005909|FG001|Overall Study|Lost to Follow-up|10|||
130284758|NCT00578877|469005908|FG000|Overall Study|early discontinue|61|||
130284759|NCT00578877|469005909|FG001|Overall Study|early discontinue|101|||
130284760|NCT00578877|469005908|FG000|Overall Study|did not provide follow-up data|12|||
130284761|NCT00578877|469005909|FG001|Overall Study|did not provide follow-up data|17|||
130284762|NCT02437409|469005914|FG000|Overall Study|Withdrawal by Subject|3|||
130284763|NCT02437409|469005914|FG000|Overall Study|Screening failure|12|||
130284764|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
130284765|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
130284766|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
130284767|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
130284768|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
130284769|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
130284770|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
130284771|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
130284772|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
130042913|NCT04358458|468114437|FG002|Overall Study|Site is closing study participation|0|||
130042914|NCT04358458|468114438|FG003|Overall Study|Site is closing study participation|1|||
130284773|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
130284774|NCT00737568|469005917|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
129887209|NCT01474512|467547286|FG014|Induction Period|Protocol Violation|0|||
129887210|NCT01474512|467547287|FG015|Induction Period|Protocol Violation|0|||
129887211|NCT01474512|467547288|FG016|Induction Period|Protocol Violation|0|||
130106266|NCT04682639|468349961|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
130106267|NCT04682639|468349962|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
130106268|NCT04682639|468349963|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
130106269|NCT04682639|468349964|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
130106270|NCT04682639|468349960|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130106271|NCT04682639|468349961|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130106272|NCT04682639|468349962|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130106273|NCT04682639|468349963|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130106274|NCT04682639|468349964|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129887212|NCT01474512|467547289|FG017|Induction Period|Protocol Violation|0|||
129887213|NCT01474512|467547272|FG000|Induction Period|Sponsor Decision|1|||
129887214|NCT01474512|467547273|FG001|Induction Period|Sponsor Decision|1|||
129887215|NCT01474512|467547274|FG002|Induction Period|Sponsor Decision|1|||
129887216|NCT01474512|467547275|FG003|Induction Period|Sponsor Decision|0|||
129887217|NCT01474512|467547276|FG004|Induction Period|Sponsor Decision|0|||
129887218|NCT01474512|467547277|FG005|Induction Period|Sponsor Decision|0|||
129887219|NCT01474512|467547278|FG006|Induction Period|Sponsor Decision|0|||
129887220|NCT01474512|467547279|FG007|Induction Period|Sponsor Decision|0|||
129887221|NCT01474512|467547280|FG008|Induction Period|Sponsor Decision|0|||
129887222|NCT01474512|467547281|FG009|Induction Period|Sponsor Decision|0|||
129887223|NCT01474512|467547282|FG010|Induction Period|Sponsor Decision|0|||
129887224|NCT01474512|467547283|FG011|Induction Period|Sponsor Decision|0|||
129887225|NCT01474512|467547284|FG012|Induction Period|Sponsor Decision|0|||
129887226|NCT01474512|467547285|FG013|Induction Period|Sponsor Decision|0|||
129887227|NCT01474512|467547286|FG014|Induction Period|Sponsor Decision|0|||
129887228|NCT01474512|467547287|FG015|Induction Period|Sponsor Decision|0|||
129887229|NCT01474512|467547288|FG016|Induction Period|Sponsor Decision|0|||
129887230|NCT01474512|467547289|FG017|Induction Period|Sponsor Decision|0|||
129887231|NCT01474512|467547272|FG000|Induction Period|Lost to Follow-up|1|||
129887232|NCT01474512|467547273|FG001|Induction Period|Lost to Follow-up|0|||
129887233|NCT01474512|467547274|FG002|Induction Period|Lost to Follow-up|2|||
129887234|NCT01474512|467547275|FG003|Induction Period|Lost to Follow-up|0|||
129887235|NCT01474512|467547276|FG004|Induction Period|Lost to Follow-up|0|||
129887236|NCT01474512|467547277|FG005|Induction Period|Lost to Follow-up|0|||
129887237|NCT01474512|467547278|FG006|Induction Period|Lost to Follow-up|0|||
129887238|NCT01474512|467547279|FG007|Induction Period|Lost to Follow-up|0|||
130284775|NCT00737568|469005918|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
130284776|NCT00737568|469005917|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
130284777|NCT00737568|469005918|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
130284778|NCT00737568|469005917|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
130284779|NCT00737568|469005918|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
130284780|NCT00737568|469005917|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
130284781|NCT00737568|469005918|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
130284782|NCT00855933|469005919|FG000|Overall Study|Withdrawal by Subject|0|||
130284783|NCT00855933|469005920|FG001|Overall Study|Withdrawal by Subject|1|||
130284784|NCT00951080|469005921|FG000|Overall Study|Adverse Event|3|||
130284785|NCT00951080|469005922|FG001|Overall Study|Adverse Event|3|||
130284786|NCT00951080|469005921|FG000|Overall Study|Lost to Follow-up|0|||
130284787|NCT00951080|469005922|FG001|Overall Study|Lost to Follow-up|1|||
130284788|NCT00951080|469005921|FG000|Overall Study|Physician Decision|4|||
130284789|NCT00951080|469005922|FG001|Overall Study|Physician Decision|1|||
130284790|NCT00951080|469005921|FG000|Overall Study|Other|19|||
130284791|NCT00951080|469005922|FG001|Overall Study|Other|22|||
130284792|NCT01960998|469005923|FG000|Overall Study|Lost to Follow-up|3|||
130284793|NCT01960998|469005924|FG001|Overall Study|Lost to Follow-up|7|||
130284794|NCT01960998|469005923|FG000|Overall Study|Death|0|||
130284795|NCT01960998|469005924|FG001|Overall Study|Death|1|||
130284796|NCT01960998|469005923|FG000|Overall Study|Withdrawal by Subject|8|||
130284797|NCT01960998|469005924|FG001|Overall Study|Withdrawal by Subject|2|||
130284798|NCT01960998|469005923|FG000|Overall Study|lost computer access|0|||
130284799|NCT01960998|469005924|FG001|Overall Study|lost computer access|1|||
130284800|NCT00759356|469005925|FG000|Overall Study|Adverse Event|0|||
130284801|NCT00759356|469005926|FG001|Overall Study|Adverse Event|1|||
130284802|NCT00759356|469005925|FG000|Overall Study|Withdrawal by Subject|0|||
130284803|NCT00759356|469005926|FG001|Overall Study|Withdrawal by Subject|2|||
130284804|NCT00759356|469005925|FG000|Overall Study|Subject was unable to return|1|||
130284805|NCT00759356|469005926|FG001|Overall Study|Subject was unable to return|0|||
130284806|NCT01713283|469005930|FG000|Overall Study|Lack of Efficacy|10|||
130284807|NCT01713283|469005931|FG001|Overall Study|Lack of Efficacy|2|||
130284808|NCT01713283|469005930|FG000|Overall Study|Lost to Follow-up|1|||
130284809|NCT01713283|469005931|FG001|Overall Study|Lost to Follow-up|1|||
130284810|NCT01904149|469005937|FG000|Overall Study|Adverse Event|3|||
130284811|NCT01904149|469005938|FG001|Overall Study|Adverse Event|4|||
130284812|NCT01904149|469005939|FG002|Overall Study|Adverse Event|0|||
130284813|NCT01904149|469005940|FG003|Overall Study|Adverse Event|1|||
130284814|NCT01904149|469005941|FG004|Overall Study|Adverse Event|1|||
130284815|NCT01904149|469005942|FG005|Overall Study|Adverse Event|2|||
130284816|NCT01904149|469005937|FG000|Overall Study|Lack of Efficacy|0|||
130284817|NCT01904149|469005938|FG001|Overall Study|Lack of Efficacy|3|||
130284818|NCT01904149|469005939|FG002|Overall Study|Lack of Efficacy|1|||
130284819|NCT01904149|469005940|FG003|Overall Study|Lack of Efficacy|3|||
130284820|NCT01904149|469005941|FG004|Overall Study|Lack of Efficacy|3|||
130284821|NCT01904149|469005942|FG005|Overall Study|Lack of Efficacy|1|||
130284822|NCT01904149|469005937|FG000|Overall Study|Withdrawal by Subject|1|||
130284823|NCT01904149|469005938|FG001|Overall Study|Withdrawal by Subject|3|||
130284824|NCT01904149|469005939|FG002|Overall Study|Withdrawal by Subject|1|||
130284825|NCT01904149|469005940|FG003|Overall Study|Withdrawal by Subject|0|||
130284826|NCT01904149|469005941|FG004|Overall Study|Withdrawal by Subject|1|||
130284827|NCT01904149|469005942|FG005|Overall Study|Withdrawal by Subject|0|||
130284828|NCT01904149|469005937|FG000|Overall Study|Protocol Violation|0|||
130284829|NCT01904149|469005938|FG001|Overall Study|Protocol Violation|1|||
130284830|NCT01904149|469005939|FG002|Overall Study|Protocol Violation|0|||
130284831|NCT01904149|469005940|FG003|Overall Study|Protocol Violation|0|||
130284832|NCT01904149|469005941|FG004|Overall Study|Protocol Violation|0|||
130284833|NCT01904149|469005942|FG005|Overall Study|Protocol Violation|0|||
130284834|NCT01904149|469005937|FG000|Overall Study|non compliance with study drug|1|||
130284835|NCT01904149|469005938|FG001|Overall Study|non compliance with study drug|0|||
130284836|NCT01904149|469005939|FG002|Overall Study|non compliance with study drug|0|||
130284837|NCT01904149|469005940|FG003|Overall Study|non compliance with study drug|0|||
130284838|NCT01904149|469005941|FG004|Overall Study|non compliance with study drug|0|||
130284839|NCT01904149|469005942|FG005|Overall Study|non compliance with study drug|0|||
130284840|NCT00812006|469005943|FG000|Overall Study|Lost to Follow-up|0|||
129887239|NCT01474512|467547280|FG008|Induction Period|Lost to Follow-up|0|||
129887240|NCT01474512|467547281|FG009|Induction Period|Lost to Follow-up|0|||
129887241|NCT01474512|467547282|FG010|Induction Period|Lost to Follow-up|0|||
130042915|NCT04358458|468114439|FG004|Overall Study|Site is closing study participation|0|||
130284841|NCT00812006|469005944|FG001|Overall Study|Lost to Follow-up|0|||
130284842|NCT00812006|469005945|FG002|Overall Study|Lost to Follow-up|2|||
130284843|NCT00812006|469005943|FG000|Overall Study|Physician Decision|0|||
130284844|NCT00812006|469005944|FG001|Overall Study|Physician Decision|0|||
130284845|NCT00812006|469005945|FG002|Overall Study|Physician Decision|1|||
130284846|NCT00812006|469005943|FG000|Overall Study|Withdrawal by Subject|2|||
130284847|NCT00812006|469005944|FG001|Overall Study|Withdrawal by Subject|1|||
130284848|NCT00812006|469005945|FG002|Overall Study|Withdrawal by Subject|1|||
130284849|NCT00812006|469005943|FG000|Overall Study|Lack of Qualifying Event|4|||
130284850|NCT00812006|469005944|FG001|Overall Study|Lack of Qualifying Event|2|||
130284851|NCT00812006|469005945|FG002|Overall Study|Lack of Qualifying Event|2|||
130042916|NCT04358458|468114440|FG005|Overall Study|Site is closing study participation|0|||
130042917|NCT04358458|468114441|FG006|Overall Study|Site is closing study participation|0|||
130042918|NCT04358458|468114442|FG007|Overall Study|Site is closing study participation|0|||
130042919|NCT04358458|468114435|FG000|Overall Study|Sponsor request|2|||
130042920|NCT04358458|468114436|FG001|Overall Study|Sponsor request|3|||
130042921|NCT04358458|468114437|FG002|Overall Study|Sponsor request|3|||
130042922|NCT04358458|468114438|FG003|Overall Study|Sponsor request|0|||
130042923|NCT04358458|468114439|FG004|Overall Study|Sponsor request|2|||
130042924|NCT04358458|468114440|FG005|Overall Study|Sponsor request|3|||
130042925|NCT04358458|468114441|FG006|Overall Study|Sponsor request|1|||
130042926|NCT04358458|468114442|FG007|Overall Study|Sponsor request|1|||
130042927|NCT04358458|468114435|FG000|Overall Study|Withdrawal by Subject|0|||
130042928|NCT04358458|468114436|FG001|Overall Study|Withdrawal by Subject|0|||
130042929|NCT04358458|468114437|FG002|Overall Study|Withdrawal by Subject|1|||
129887242|NCT01474512|467547283|FG011|Induction Period|Lost to Follow-up|0|||
129887243|NCT01474512|467547284|FG012|Induction Period|Lost to Follow-up|0|||
129887244|NCT01474512|467547285|FG013|Induction Period|Lost to Follow-up|0|||
129887245|NCT01474512|467547286|FG014|Induction Period|Lost to Follow-up|0|||
130042930|NCT04358458|468114438|FG003|Overall Study|Withdrawal by Subject|1|||
130042931|NCT04358458|468114439|FG004|Overall Study|Withdrawal by Subject|0|||
130042932|NCT04358458|468114440|FG005|Overall Study|Withdrawal by Subject|1|||
130042933|NCT04358458|468114441|FG006|Overall Study|Withdrawal by Subject|0|||
130042934|NCT04358458|468114442|FG007|Overall Study|Withdrawal by Subject|1|||
130042935|NCT00151411|468115728|FG000|Overall Study|Lost to Follow-up|15|||
130042936|NCT00151411|468115729|FG001|Overall Study|Lost to Follow-up|19|||
130042937|NCT00151411|468115728|FG000|Overall Study|Withdrawal by Subject|12|||
130042938|NCT00151411|468115729|FG001|Overall Study|Withdrawal by Subject|20|||
130042939|NCT00151411|468115728|FG000|Overall Study|Adverse Event|6|||
130042940|NCT00151411|468115729|FG001|Overall Study|Adverse Event|0|||
130042941|NCT00151411|468115728|FG000|Overall Study|Pregnancy|0|||
130042942|NCT00151411|468115729|FG001|Overall Study|Pregnancy|4|||
130042943|NCT01712438|468115730|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
130042944|NCT01712438|468115730|FG000|Overall Study|Ongoing ITI treatment|6|||
130042945|NCT01712438|468115730|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
130042946|NCT01712438|468115730|FG000|Overall Study|Prematurely Discontinued|25|||
130042947|NCT04426630|468115731|FG000|Overall Study|Death|4|||
130042948|NCT04426630|468115731|FG000|Overall Study|Lost to Follow-up|2|||
130042949|NCT01157169|468115734|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
130042950|NCT01157169|468115735|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
130042951|NCT01157169|468115734|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
130042952|NCT01157169|468115735|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
130284852|NCT00235391|469005946|FG000|Overall Study|Adverse Event|4|||
130284853|NCT00235391|469005947|FG001|Overall Study|Adverse Event|5|||
130284854|NCT00235391|469005948|FG002|Overall Study|Adverse Event|10|||
130284855|NCT00235391|469005949|FG003|Overall Study|Adverse Event|72|||
130284856|NCT00235391|469005950|FG004|Overall Study|Adverse Event|5|||
130284857|NCT00235391|469005951|FG005|Overall Study|Adverse Event|2|||
130284858|NCT00235391|469005946|FG000|Overall Study|Abnormal laboratory value(s)|3|||
130284859|NCT00235391|469005947|FG001|Overall Study|Abnormal laboratory value(s)|5|||
130284860|NCT00235391|469005948|FG002|Overall Study|Abnormal laboratory value(s)|4|||
130284861|NCT00235391|469005949|FG003|Overall Study|Abnormal laboratory value(s)|27|||
130284862|NCT00235391|469005950|FG004|Overall Study|Abnormal laboratory value(s)|1|||
130284863|NCT00235391|469005951|FG005|Overall Study|Abnormal laboratory value(s)|2|||
130284864|NCT00235391|469005946|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130284865|NCT00235391|469005947|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130284866|NCT00235391|469005948|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
130284867|NCT00235391|469005949|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
130284868|NCT00235391|469005950|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
130284869|NCT00235391|469005951|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
130284870|NCT00235391|469005946|FG000|Overall Study|Condition no longer requires treatment|3|||
130284871|NCT00235391|469005947|FG001|Overall Study|Condition no longer requires treatment|0|||
130284872|NCT00235391|469005948|FG002|Overall Study|Condition no longer requires treatment|0|||
130284873|NCT00235391|469005949|FG003|Overall Study|Condition no longer requires treatment|11|||
130284874|NCT00235391|469005950|FG004|Overall Study|Condition no longer requires treatment|1|||
130284875|NCT00235391|469005951|FG005|Overall Study|Condition no longer requires treatment|0|||
130284876|NCT00235391|469005946|FG000|Overall Study|Protocol deviation|0|||
130284877|NCT00235391|469005947|FG001|Overall Study|Protocol deviation|0|||
130284878|NCT00235391|469005948|FG002|Overall Study|Protocol deviation|1|||
130284879|NCT00235391|469005949|FG003|Overall Study|Protocol deviation|11|||
130284880|NCT00235391|469005950|FG004|Overall Study|Protocol deviation|0|||
130284881|NCT00235391|469005951|FG005|Overall Study|Protocol deviation|0|||
130284882|NCT00235391|469005946|FG000|Overall Study|Withdrawal by Subject|2|||
130284883|NCT00235391|469005947|FG001|Overall Study|Withdrawal by Subject|3|||
130284884|NCT00235391|469005948|FG002|Overall Study|Withdrawal by Subject|3|||
130284885|NCT00235391|469005949|FG003|Overall Study|Withdrawal by Subject|61|||
130284886|NCT00235391|469005950|FG004|Overall Study|Withdrawal by Subject|5|||
130284887|NCT00235391|469005951|FG005|Overall Study|Withdrawal by Subject|0|||
130042953|NCT01123889|468115736|FG000|Overall Study|Lost to Follow-up|3|||
130284888|NCT00235391|469005946|FG000|Overall Study|Lost to Follow-up|0|||
130284889|NCT00235391|469005947|FG001|Overall Study|Lost to Follow-up|3|||
130284890|NCT00235391|469005948|FG002|Overall Study|Lost to Follow-up|3|||
130284891|NCT00235391|469005949|FG003|Overall Study|Lost to Follow-up|16|||
130284892|NCT00235391|469005950|FG004|Overall Study|Lost to Follow-up|0|||
130284893|NCT00235391|469005951|FG005|Overall Study|Lost to Follow-up|0|||
130284894|NCT00235391|469005946|FG000|Overall Study|Administrative problems|0|||
130284895|NCT00235391|469005947|FG001|Overall Study|Administrative problems|0|||
130284896|NCT00235391|469005948|FG002|Overall Study|Administrative problems|0|||
130284897|NCT00235391|469005949|FG003|Overall Study|Administrative problems|1|||
130284898|NCT00235391|469005950|FG004|Overall Study|Administrative problems|0|||
130042954|NCT01123889|468115737|FG001|Overall Study|Lost to Follow-up|1|||
130042955|NCT03846947|468115740|FG000|Overall Study|technical issues with imaging sequence|2|||
130042956|NCT04328623|468115743|FG000|Overall Study|Protocol Violation|0|||
130042957|NCT04328623|468115744|FG001|Overall Study|Protocol Violation|1|||
130042958|NCT00849693|468115745|FG000|Acute Treatment Phase|Adverse Event|12|||
130042959|NCT00849693|468115746|FG001|Acute Treatment Phase|Adverse Event|7|||
130284899|NCT00235391|469005951|FG005|Overall Study|Administrative problems|0|||
130284900|NCT00235391|469005946|FG000|Overall Study|Death|0|||
130284901|NCT00235391|469005947|FG001|Overall Study|Death|0|||
130284902|NCT00235391|469005948|FG002|Overall Study|Death|1|||
130284903|NCT00235391|469005949|FG003|Overall Study|Death|4|||
130284904|NCT00235391|469005950|FG004|Overall Study|Death|0|||
130284905|NCT00235391|469005951|FG005|Overall Study|Death|0|||
130284906|NCT00098748|469005955|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
130284907|NCT00098748|469005956|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
130284908|NCT00098748|469005957|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
130284909|NCT00098748|469005955|FG000|Received Study Treatment|Death|2|||
130284910|NCT00098748|469005956|FG001|Received Study Treatment|Death|1|||
130284911|NCT00098748|469005957|FG002|Received Study Treatment|Death|2|||
130284912|NCT00098748|469005955|FG000|Received Study Treatment|Adverse Event|1|||
130284913|NCT00098748|469005956|FG001|Received Study Treatment|Adverse Event|2|||
130284914|NCT00098748|469005957|FG002|Received Study Treatment|Adverse Event|5|||
130284915|NCT00098748|469005955|FG000|Received Study Treatment|Lack of Efficacy|40|||
130284916|NCT00098748|469005956|FG001|Received Study Treatment|Lack of Efficacy|27|||
130284917|NCT00098748|469005957|FG002|Received Study Treatment|Lack of Efficacy|27|||
130284918|NCT00098748|469005955|FG000|Received Study Treatment|Other|2|||
130284919|NCT00098748|469005956|FG001|Received Study Treatment|Other|2|||
130284920|NCT00098748|469005957|FG002|Received Study Treatment|Other|6|||
130284921|NCT00098748|469005955|FG000|Received Study Treatment|Subject defaulted|3|||
130284922|NCT00098748|469005956|FG001|Received Study Treatment|Subject defaulted|4|||
130284923|NCT00098748|469005957|FG002|Received Study Treatment|Subject defaulted|4|||
130284924|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
130284925|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
130284926|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
130284927|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
130284928|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
130284929|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
130284930|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
130284931|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
130284932|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
130284933|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
130284934|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
130284935|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
130284936|NCT00098748|469005955|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
130284937|NCT00098748|469005956|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
130284938|NCT00098748|469005957|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
130284939|NCT00570037|469005958|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
130284940|NCT00570037|469005959|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
130284941|NCT01081301|469005962|FG000|Overall Study|Bereaved|3|||
130284942|NCT01081301|469005962|FG000|Overall Study|Too busy|5|||
130284943|NCT01081301|469005962|FG000|Overall Study|Patient too ill|2|||
130284944|NCT01081301|469005962|FG000|Overall Study|Lost to Follow-up|4|||
130284945|NCT03551665|469005963|FG000|Overall Study|Lost to Follow-up|11|||
130284946|NCT03551665|469005964|FG001|Overall Study|Lost to Follow-up|2|||
130284947|NCT00413894|469007950|FG000|Overall Study|Withdrawal by Subject|10|||
130284948|NCT00413894|469007950|FG000|Overall Study|Administrative Reasons|1|||
130284949|NCT00413894|469007950|FG000|Overall Study|Hb <10 grams/deciliter|12|||
130284950|NCT00413894|469007950|FG000|Overall Study|Adverse Event|28|||
130284951|NCT00413894|469007950|FG000|Overall Study|Protocol Violation|11|||
130284952|NCT00413894|469007950|FG000|Overall Study|Other|18|||
130284953|NCT01942161|469007951|FG000|Overall Study|Adverse Event|1|||
130284954|NCT01942161|469007952|FG001|Overall Study|Adverse Event|2|||
130284955|NCT01942161|469007953|FG002|Overall Study|Adverse Event|5|||
130284956|NCT01942161|469007951|FG000|Overall Study|Physician Decision|3|||
130284957|NCT01942161|469007952|FG001|Overall Study|Physician Decision|1|||
130284958|NCT01942161|469007953|FG002|Overall Study|Physician Decision|0|||
130284959|NCT01942161|469007951|FG000|Overall Study|Protocol Violation|1|||
130284960|NCT01942161|469007952|FG001|Overall Study|Protocol Violation|0|||
130284961|NCT01942161|469007953|FG002|Overall Study|Protocol Violation|0|||
130284962|NCT01942161|469007951|FG000|Overall Study|Withdrawal by Subject|3|||
130284963|NCT01942161|469007952|FG001|Overall Study|Withdrawal by Subject|3|||
130284964|NCT01942161|469007953|FG002|Overall Study|Withdrawal by Subject|1|||
130284965|NCT02251717|469007957|FG000|Overall Study|Adverse Event|0|||
130284966|NCT02251717|469007958|FG001|Overall Study|Adverse Event|1|||
130284967|NCT02251717|469007957|FG000|Overall Study|Withdrew Consent|1|||
130284968|NCT02251717|469007958|FG001|Overall Study|Withdrew Consent|0|||
130284969|NCT03356977|469007959|FG000|Overall Study|Lost to Follow-up|3|||
130284970|NCT03356977|469007959|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130284971|NCT00445939|469007963|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
130284972|NCT00445939|469007964|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
130284973|NCT00445939|469007965|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
130284974|NCT00445939|469007966|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
130284975|NCT00445939|469007963|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
130284976|NCT00445939|469007964|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
130284977|NCT00445939|469007965|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
130284978|NCT00445939|469007966|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
130284979|NCT00378599|469007970|FG000|Overall Study|Adverse Event|38|||
130284980|NCT00378599|469007970|FG000|Overall Study|Protocol Violation|2|||
130284981|NCT00378599|469007970|FG000|Overall Study|Treatment failure|7|||
130284982|NCT00378599|469007970|FG000|Overall Study|Withdrawal by Subject|5|||
130284983|NCT00489736|469007971|FG000|Overall Study|Lack of Efficacy|53|||
129887246|NCT01474512|467547287|FG015|Induction Period|Lost to Follow-up|0|||
130106275|NCT04682639|468349960|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
130284984|NCT00489736|469007972|FG001|Overall Study|Lack of Efficacy|14|||
130284985|NCT00489736|469007971|FG000|Overall Study|Adverse Event|32|||
130284986|NCT00489736|469007972|FG001|Overall Study|Adverse Event|45|||
130284987|NCT00489736|469007971|FG000|Overall Study|Poor compliance|6|||
130042960|NCT00849693|468115747|FG002|Acute Treatment Phase|Adverse Event|6|||
130042961|NCT00849693|468115748|FG003|Acute Treatment Phase|Adverse Event|4|||
130042962|NCT00849693|468115745|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
130042963|NCT00849693|468115746|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
130042964|NCT00849693|468115747|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
130042965|NCT00849693|468115748|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
130042966|NCT00849693|468115745|FG000|Acute Treatment Phase|Protocol Violation|1|||
130042967|NCT00849693|468115746|FG001|Acute Treatment Phase|Protocol Violation|5|||
130042968|NCT00849693|468115747|FG002|Acute Treatment Phase|Protocol Violation|2|||
130042969|NCT00849693|468115748|FG003|Acute Treatment Phase|Protocol Violation|6|||
130042970|NCT00849693|468115745|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
130042971|NCT00849693|468115746|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
130042972|NCT00849693|468115747|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
130042973|NCT00849693|468115748|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
130042974|NCT00849693|468115745|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
130042975|NCT00849693|468115746|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
130042976|NCT00849693|468115747|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
130042977|NCT00849693|468115748|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
130042978|NCT00849693|468115745|FG000|Acute Treatment Phase|Physician Decision|2|||
130042979|NCT00849693|468115746|FG001|Acute Treatment Phase|Physician Decision|1|||
130042980|NCT00849693|468115747|FG002|Acute Treatment Phase|Physician Decision|2|||
130042981|NCT00849693|468115748|FG003|Acute Treatment Phase|Physician Decision|1|||
130042982|NCT00849693|468115745|FG000|Acute Treatment Phase|Sponsor decision|0|||
130042983|NCT00849693|468115746|FG001|Acute Treatment Phase|Sponsor decision|0|||
130042984|NCT00849693|468115747|FG002|Acute Treatment Phase|Sponsor decision|1|||
130042985|NCT00849693|468115748|FG003|Acute Treatment Phase|Sponsor decision|0|||
130042986|NCT00849693|468115745|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
130042987|NCT00849693|468115746|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
130042988|NCT00849693|468115747|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
130042989|NCT00849693|468115748|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
130284988|NCT00489736|469007972|FG001|Overall Study|Poor compliance|2|||
130284989|NCT00489736|469007971|FG000|Overall Study|Not coded/ Not pre-specified|5|||
130284990|NCT00489736|469007972|FG001|Overall Study|Not coded/ Not pre-specified|8|||
130284991|NCT03812185|469007976|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
130284992|NCT02576535|469007979|FG000|Overall Study|Withdrawal by Subject|2|||
130284993|NCT01529515|469007982|FG000|TRANSITION PHASE|Adverse Event|16|||
130284994|NCT01529515|469007983|FG001|TRANSITION PHASE|Adverse Event|0|||
130284995|NCT01529515|469007984|FG002|TRANSITION PHASE|Adverse Event|0|||
130284996|NCT01529515|469007985|FG003|TRANSITION PHASE|Adverse Event|0|||
130284997|NCT01529515|469007982|FG000|TRANSITION PHASE|Death|1|||
130284998|NCT01529515|469007983|FG001|TRANSITION PHASE|Death|0|||
130284999|NCT01529515|469007984|FG002|TRANSITION PHASE|Death|0|||
130285000|NCT01529515|469007985|FG003|TRANSITION PHASE|Death|0|||
130285001|NCT01529515|469007982|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
130285002|NCT01529515|469007983|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
130285003|NCT01529515|469007984|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
130285004|NCT01529515|469007985|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
130285005|NCT01529515|469007982|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
130285006|NCT01529515|469007983|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
130285007|NCT01529515|469007984|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
130285008|NCT01529515|469007985|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
130285009|NCT01529515|469007982|FG000|TRANSITION PHASE|Protocol Violation|4|||
130285010|NCT01529515|469007983|FG001|TRANSITION PHASE|Protocol Violation|0|||
130285011|NCT01529515|469007984|FG002|TRANSITION PHASE|Protocol Violation|0|||
130285012|NCT01529515|469007985|FG003|TRANSITION PHASE|Protocol Violation|0|||
130285013|NCT01529515|469007982|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
130285014|NCT01529515|469007983|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
130285015|NCT01529515|469007984|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
130285016|NCT01529515|469007985|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
130285017|NCT01529515|469007982|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
130042990|NCT00849693|468115745|FG000|Extension Phase|Adverse Event|4|||
130042991|NCT00849693|468115746|FG001|Extension Phase|Adverse Event|6|||
130042992|NCT00849693|468115747|FG002|Extension Phase|Adverse Event|3|||
130042993|NCT00849693|468115748|FG003|Extension Phase|Adverse Event|7|||
130042994|NCT00849693|468115745|FG000|Extension Phase|Lost to Follow-up|7|||
130042995|NCT00849693|468115746|FG001|Extension Phase|Lost to Follow-up|5|||
130042996|NCT00849693|468115747|FG002|Extension Phase|Lost to Follow-up|6|||
130285018|NCT01529515|469007983|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130285019|NCT01529515|469007984|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130285020|NCT01529515|469007985|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
130285021|NCT01529515|469007982|FG000|TRANSITION PHASE|Other|9|||
130285022|NCT01529515|469007983|FG001|TRANSITION PHASE|Other|0|||
130285023|NCT01529515|469007984|FG002|TRANSITION PHASE|Other|0|||
130285024|NCT01529515|469007985|FG003|TRANSITION PHASE|Other|0|||
130285025|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Adverse Event|0|||
130285026|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Adverse Event|10|||
130285027|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Adverse Event|0|||
130285028|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Adverse Event|0|||
130285029|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
130285030|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
130285031|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
130285032|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
130285033|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
130285034|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
130285035|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
130285036|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
130285037|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
130285038|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
130285039|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
130285040|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
130285041|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130285042|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
130285043|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130285044|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
130285045|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130285046|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
130285047|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130285048|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
130285049|NCT01529515|469007982|FG000|MAINTENANCE PHASE|Other|0|||
130285050|NCT01529515|469007983|FG001|MAINTENANCE PHASE|Other|10|||
130285051|NCT01529515|469007984|FG002|MAINTENANCE PHASE|Other|0|||
130285052|NCT01529515|469007985|FG003|MAINTENANCE PHASE|Other|0|||
130285053|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
130285054|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
130285055|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
130285056|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
130285057|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
130285058|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
130285059|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
130285060|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
130285061|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
130106276|NCT04682639|468349961|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130106277|NCT04682639|468349962|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130285062|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
130285063|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
130285064|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
130285065|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
130285066|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
130285067|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
130285068|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
130285069|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
130285070|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
130285071|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
130285072|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
130285073|NCT01529515|469007982|FG000|DOUBLE BLIND PHASE|Other|0|||
130285074|NCT01529515|469007983|FG001|DOUBLE BLIND PHASE|Other|0|||
130285075|NCT01529515|469007984|FG002|DOUBLE BLIND PHASE|Other|9|||
130285076|NCT01529515|469007985|FG003|DOUBLE BLIND PHASE|Other|2|||
130285077|NCT03334851|469007987|FG000|Overall Study|Other|0|||
130285078|NCT03334851|469007988|FG001|Overall Study|Other|0|||
130285079|NCT03334851|469007989|FG002|Overall Study|Other|0|||
130285080|NCT03334851|469007990|FG003|Overall Study|Other|0|||
130285081|NCT03334851|469007991|FG004|Overall Study|Other|0|||
130285082|NCT03334851|469007992|FG005|Overall Study|Other|0|||
130285083|NCT03334851|469007993|FG006|Overall Study|Other|0|||
130285084|NCT03334851|469007994|FG007|Overall Study|Other|1|||
130285085|NCT03334851|469007995|FG008|Overall Study|Other|0|||
130285086|NCT03334851|469007996|FG009|Overall Study|Other|0|||
130285087|NCT03334851|469007997|FG010|Overall Study|Other|0|||
130285088|NCT03334851|469007998|FG011|Overall Study|Other|0|||
130285089|NCT03334851|469007999|FG012|Overall Study|Other|0|||
130285090|NCT03334851|469007987|FG000|Overall Study|Adverse Event|0|||
130285091|NCT03334851|469007988|FG001|Overall Study|Adverse Event|0|||
130285092|NCT03334851|469007989|FG002|Overall Study|Adverse Event|0|||
130285093|NCT03334851|469007990|FG003|Overall Study|Adverse Event|0|||
130285094|NCT03334851|469007991|FG004|Overall Study|Adverse Event|0|||
130285095|NCT03334851|469007992|FG005|Overall Study|Adverse Event|0|||
130285096|NCT03334851|469007993|FG006|Overall Study|Adverse Event|0|||
130285097|NCT03334851|469007994|FG007|Overall Study|Adverse Event|1|||
130285098|NCT03334851|469007995|FG008|Overall Study|Adverse Event|0|||
130285099|NCT03334851|469007996|FG009|Overall Study|Adverse Event|0|||
130285100|NCT03334851|469007997|FG010|Overall Study|Adverse Event|0|||
130285101|NCT03334851|469007998|FG011|Overall Study|Adverse Event|0|||
130285102|NCT03334851|469007999|FG012|Overall Study|Adverse Event|0|||
130285103|NCT03334851|469007987|FG000|Overall Study|Withdrawal by Subject|0|||
130285104|NCT03334851|469007988|FG001|Overall Study|Withdrawal by Subject|0|||
130285105|NCT03334851|469007989|FG002|Overall Study|Withdrawal by Subject|0|||
130285106|NCT03334851|469007990|FG003|Overall Study|Withdrawal by Subject|0|||
130285107|NCT03334851|469007991|FG004|Overall Study|Withdrawal by Subject|0|||
130285108|NCT03334851|469007992|FG005|Overall Study|Withdrawal by Subject|0|||
130285109|NCT03334851|469007993|FG006|Overall Study|Withdrawal by Subject|0|||
130285110|NCT03334851|469007994|FG007|Overall Study|Withdrawal by Subject|0|||
130285111|NCT03334851|469007995|FG008|Overall Study|Withdrawal by Subject|0|||
130285112|NCT03334851|469007996|FG009|Overall Study|Withdrawal by Subject|0|||
130285113|NCT03334851|469007997|FG010|Overall Study|Withdrawal by Subject|1|||
130285114|NCT03334851|469007998|FG011|Overall Study|Withdrawal by Subject|0|||
130285115|NCT03334851|469007999|FG012|Overall Study|Withdrawal by Subject|1|||
130285116|NCT03334851|469007987|FG000|Overall Study|Lost to Follow-up|0|||
130285117|NCT03334851|469007988|FG001|Overall Study|Lost to Follow-up|0|||
130285118|NCT03334851|469007989|FG002|Overall Study|Lost to Follow-up|0|||
130285119|NCT03334851|469007990|FG003|Overall Study|Lost to Follow-up|0|||
130285120|NCT03334851|469007991|FG004|Overall Study|Lost to Follow-up|0|||
130285121|NCT03334851|469007992|FG005|Overall Study|Lost to Follow-up|0|||
130285122|NCT03334851|469007993|FG006|Overall Study|Lost to Follow-up|0|||
130285123|NCT03334851|469007994|FG007|Overall Study|Lost to Follow-up|0|||
130285124|NCT03334851|469007995|FG008|Overall Study|Lost to Follow-up|0|||
130285125|NCT03334851|469007996|FG009|Overall Study|Lost to Follow-up|0|||
130285126|NCT03334851|469007997|FG010|Overall Study|Lost to Follow-up|2|||
130285127|NCT03334851|469007998|FG011|Overall Study|Lost to Follow-up|1|||
130285128|NCT03334851|469007999|FG012|Overall Study|Lost to Follow-up|0|||
130285129|NCT03920293|469008000|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
130285130|NCT03920293|469008001|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
130285131|NCT03920293|469008000|FG000|Randomized-Controlled Period|Physician Decision|1|||
130285132|NCT03920293|469008001|FG001|Randomized-Controlled Period|Physician Decision|2|||
130285133|NCT03920293|469008000|FG000|Randomized-Controlled Period|Adverse Event|0|||
130285134|NCT03920293|469008001|FG001|Randomized-Controlled Period|Adverse Event|2|||
130285135|NCT03920293|469008000|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
130285136|NCT03920293|469008001|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
130285137|NCT03920293|469008000|FG000|Randomized-Controlled Period|Death|2|||
130285138|NCT03920293|469008001|FG001|Randomized-Controlled Period|Death|0|||
130285139|NCT03920293|469008000|FG000|Randomized-Controlled Period|Protocol Violation|1|||
130285140|NCT03920293|469008001|FG001|Randomized-Controlled Period|Protocol Violation|0|||
130285141|NCT03920293|469008000|FG000|Randomized-Controlled Period|Noncompliance|1|||
130285142|NCT03920293|469008001|FG001|Randomized-Controlled Period|Noncompliance|0|||
130285143|NCT03920293|469008000|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
130285144|NCT03920293|469008001|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
130285145|NCT03920293|469008000|FG000|Open- Label Extension Period|Death|3|||
130285146|NCT03920293|469008001|FG001|Open- Label Extension Period|Death|3|||
130285147|NCT03920293|469008000|FG000|Open- Label Extension Period|Physician Decision|5|||
130285148|NCT03920293|469008001|FG001|Open- Label Extension Period|Physician Decision|3|||
130285149|NCT03920293|469008000|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
130285150|NCT03920293|469008001|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
130285151|NCT01691885|469008003|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
130285152|NCT01691885|469008004|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
130285153|NCT01691885|469008003|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
130285154|NCT01691885|469008004|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
130285155|NCT03555981|469008005|FG000|Overall Study|Lost to Follow-up|0|||
130285156|NCT03555981|469008006|FG001|Overall Study|Lost to Follow-up|2|||
130285157|NCT03272828|469008009|FG000|Overall Study|Lost to Follow-up|7|||
130285158|NCT03272828|469008010|FG001|Overall Study|Lost to Follow-up|7|||
130285159|NCT03272828|469008009|FG000|Overall Study|Withdrawal by Subject|2|||
130285160|NCT03272828|469008010|FG001|Overall Study|Withdrawal by Subject|0|||
129887247|NCT01474512|467547288|FG016|Induction Period|Lost to Follow-up|0|||
129887248|NCT01474512|467547289|FG017|Induction Period|Lost to Follow-up|0|||
130285161|NCT03272828|469008009|FG000|Overall Study|Deceased|1|||
130285162|NCT03272828|469008010|FG001|Overall Study|Deceased|1|||
130285163|NCT03272828|469008009|FG000|Overall Study|Failed implant|1|||
130285164|NCT03272828|469008010|FG001|Overall Study|Failed implant|2|||
130285165|NCT03575065|469008014|FG000|Overall Study|Death|31|||
130285166|NCT03575065|469008015|FG001|Overall Study|Death|12|||
130285167|NCT03575065|469008014|FG000|Overall Study|Sponsor's Decision|28|||
130285168|NCT03575065|469008015|FG001|Overall Study|Sponsor's Decision|13|||
130285169|NCT03575065|469008014|FG000|Overall Study|Withdrawal by Subject|2|||
130285170|NCT03575065|469008015|FG001|Overall Study|Withdrawal by Subject|1|||
130285171|NCT03575065|469008014|FG000|Overall Study|Lost to Follow-up|1|||
130285172|NCT03575065|469008015|FG001|Overall Study|Lost to Follow-up|0|||
130285173|NCT02323126|469008020|FG000|Overall Study|Patient / guardian decision|0|||
130285174|NCT02323126|469008021|FG001|Overall Study|Patient / guardian decision|1|||
130285175|NCT02323126|469008022|FG002|Overall Study|Patient / guardian decision|2|||
130285176|NCT02323126|469008020|FG000|Overall Study|Progressive disease|14|||
130285177|NCT02323126|469008021|FG001|Overall Study|Progressive disease|8|||
130285178|NCT02323126|469008022|FG002|Overall Study|Progressive disease|14|||
130042997|NCT00849693|468115748|FG003|Extension Phase|Lost to Follow-up|6|||
130285179|NCT02323126|469008020|FG000|Overall Study|Physician Decision|0|||
130285180|NCT02323126|469008021|FG001|Overall Study|Physician Decision|1|||
130285181|NCT02323126|469008022|FG002|Overall Study|Physician Decision|3|||
130042998|NCT00849693|468115745|FG000|Extension Phase|Protocol Violation|0|||
130042999|NCT00849693|468115746|FG001|Extension Phase|Protocol Violation|3|||
130043000|NCT00849693|468115747|FG002|Extension Phase|Protocol Violation|2|||
130043001|NCT00849693|468115748|FG003|Extension Phase|Protocol Violation|3|||
130043002|NCT00849693|468115745|FG000|Extension Phase|Withdrawal by Subject|6|||
130043003|NCT00849693|468115746|FG001|Extension Phase|Withdrawal by Subject|9|||
130043004|NCT00849693|468115747|FG002|Extension Phase|Withdrawal by Subject|10|||
130285182|NCT02323126|469008020|FG000|Overall Study|Death|1|||
130285183|NCT02323126|469008021|FG001|Overall Study|Death|1|||
130285184|NCT02323126|469008022|FG002|Overall Study|Death|4|||
130285185|NCT02323126|469008020|FG000|Overall Study|Adverse Event|3|||
130285186|NCT02323126|469008021|FG001|Overall Study|Adverse Event|5|||
130285187|NCT02323126|469008022|FG002|Overall Study|Adverse Event|7|||
130285188|NCT03350256|469008023|FG000|Overall Study|Inclusion/exclusion violation|4|||
130285189|NCT03350256|469008023|FG000|Overall Study|Recommended for other therapies|2|||
130285190|NCT03350256|469008023|FG000|Overall Study|Protocol Violation|3|||
130285191|NCT03350256|469008023|FG000|Overall Study|Non compliance|2|||
130285192|NCT03350256|469008023|FG000|Overall Study|Denial by insurance|1|||
130285193|NCT03350256|469008023|FG000|Overall Study|Adverse Event|2|||
130285194|NCT03350256|469008023|FG000|Overall Study|Trial failure|12|||
130285195|NCT03350256|469008023|FG000|Overall Study|Did not proceed to permanent implant|3|||
130285196|NCT03350256|469008023|FG000|Overall Study|Withdrawal by Subject|3|||
130285197|NCT03350256|469008023|FG000|Overall Study|Subject moving out of state|1|||
130285198|NCT03350256|469008023|FG000|Overall Study|Lost to Follow-up|1|||
130285199|NCT03350256|469008023|FG000|Overall Study|Lack of Efficacy|2|||
130285200|NCT02324205|469008024|FG000|Overall Study|Withdrawal by Subject|37|||
130285201|NCT03664674|469008032|FG000|Overall Study|Adverse Event|1|||
130285202|NCT03664674|469008033|FG001|Overall Study|Adverse Event|1|||
130285203|NCT03664674|469008032|FG000|Overall Study|Physician Decision|0|||
130285204|NCT03664674|469008033|FG001|Overall Study|Physician Decision|1|||
130285205|NCT03664674|469008032|FG000|Overall Study|Withdrawal by Subject|2|||
130285206|NCT03664674|469008033|FG001|Overall Study|Withdrawal by Subject|0|||
130285207|NCT02174523|469008034|FG000|Overall Study|Withdrawal by Subject|1|||
130285208|NCT02174523|469008035|FG001|Overall Study|Withdrawal by Subject|0|||
130285209|NCT00856206|469008036|FG000|Overall Study|Protocol Violation|6|||
130285210|NCT00856206|469008037|FG001|Overall Study|Protocol Violation|18|||
130285211|NCT00856206|469008036|FG000|Overall Study|Adverse Event|10|||
130285212|NCT00856206|469008037|FG001|Overall Study|Adverse Event|46|||
130285213|NCT00856206|469008036|FG000|Overall Study|Lack of Efficacy|1|||
130285214|NCT00856206|469008037|FG001|Overall Study|Lack of Efficacy|2|||
130285215|NCT00856206|469008036|FG000|Overall Study|Withdrawal by Subject|15|||
130285216|NCT00856206|469008037|FG001|Overall Study|Withdrawal by Subject|36|||
130285217|NCT00856206|469008036|FG000|Overall Study|Lost to Follow-up|13|||
130285218|NCT00856206|469008037|FG001|Overall Study|Lost to Follow-up|39|||
130285219|NCT00856206|469008036|FG000|Overall Study|Death|2|||
130285220|NCT00856206|469008037|FG001|Overall Study|Death|2|||
130285221|NCT00856206|469008036|FG000|Overall Study|Decision by the Sponsor|4|||
130285222|NCT00856206|469008037|FG001|Overall Study|Decision by the Sponsor|8|||
130285223|NCT00856206|469008036|FG000|Overall Study|Other than specified above|3|||
130285224|NCT00856206|469008037|FG001|Overall Study|Other than specified above|10|||
130285225|NCT02780856|469008042|FG000|Overall Study|Lost to Follow-up|1|||
130285226|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
130285227|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
130285228|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
130285229|NCT00230282|469008044|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
130285230|NCT03006458|469008047|FG000|First Intervention|Unsatisfied Vision|0|||
130285231|NCT03006458|469008048|FG001|First Intervention|Unsatisfied Vision|3|||
130285232|NCT01468233|469008054|FG000|Treatment Period 1|Adverse Event|5|||
130285233|NCT01468233|469008055|FG001|Treatment Period 1|Adverse Event|3|||
130285234|NCT01468233|469008056|FG002|Treatment Period 1|Adverse Event|0|||
130285235|NCT01468233|469008057|FG003|Treatment Period 1|Adverse Event|0|||
130285236|NCT01468233|469008058|FG004|Treatment Period 1|Adverse Event|0|||
130285237|NCT01468233|469008059|FG005|Treatment Period 1|Adverse Event|0|||
130285238|NCT01468233|469008054|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130285239|NCT01468233|469008055|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130285240|NCT01468233|469008056|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130285241|NCT01468233|469008057|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130043005|NCT00849693|468115748|FG003|Extension Phase|Withdrawal by Subject|15|||
130043006|NCT00849693|468115745|FG000|Extension Phase|Parent or caregiver decision|9|||
130043007|NCT00849693|468115746|FG001|Extension Phase|Parent or caregiver decision|4|||
130043008|NCT00849693|468115747|FG002|Extension Phase|Parent or caregiver decision|10|||
130043009|NCT00849693|468115748|FG003|Extension Phase|Parent or caregiver decision|5|||
130043010|NCT00849693|468115745|FG000|Extension Phase|Physician Decision|1|||
130043011|NCT00849693|468115746|FG001|Extension Phase|Physician Decision|1|||
130043012|NCT00849693|468115747|FG002|Extension Phase|Physician Decision|2|||
130043013|NCT00849693|468115748|FG003|Extension Phase|Physician Decision|0|||
130043014|NCT00849693|468115745|FG000|Extension Phase|Sponsor decision|1|||
130043015|NCT00849693|468115746|FG001|Extension Phase|Sponsor decision|0|||
130285242|NCT01468233|469008058|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130285243|NCT01468233|469008059|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130285244|NCT01468233|469008054|FG000|Treatment Period 1|Lost to Follow-up|3|||
130285245|NCT01468233|469008055|FG001|Treatment Period 1|Lost to Follow-up|0|||
130285246|NCT01468233|469008056|FG002|Treatment Period 1|Lost to Follow-up|0|||
130285247|NCT01468233|469008057|FG003|Treatment Period 1|Lost to Follow-up|0|||
130285248|NCT01468233|469008058|FG004|Treatment Period 1|Lost to Follow-up|0|||
130285249|NCT01468233|469008059|FG005|Treatment Period 1|Lost to Follow-up|0|||
130285250|NCT01468233|469008054|FG000|Treatment Period 1|Other|1|||
130285251|NCT01468233|469008055|FG001|Treatment Period 1|Other|1|||
130106278|NCT04682639|468349963|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130285252|NCT01468233|469008056|FG002|Treatment Period 1|Other|0|||
130285253|NCT01468233|469008057|FG003|Treatment Period 1|Other|0|||
130285254|NCT01468233|469008058|FG004|Treatment Period 1|Other|0|||
130285255|NCT01468233|469008059|FG005|Treatment Period 1|Other|0|||
130285256|NCT01468233|469008054|FG000|Treatment Period 2|Adverse Event|0|||
130285257|NCT01468233|469008055|FG001|Treatment Period 2|Adverse Event|0|||
130285258|NCT01468233|469008056|FG002|Treatment Period 2|Adverse Event|3|||
130285259|NCT01468233|469008057|FG003|Treatment Period 2|Adverse Event|0|||
130285260|NCT01468233|469008058|FG004|Treatment Period 2|Adverse Event|2|||
130285261|NCT01468233|469008059|FG005|Treatment Period 2|Adverse Event|1|||
130285262|NCT01468233|469008054|FG000|Treatment Period 2|Lack of Efficacy|0|||
130285263|NCT01468233|469008055|FG001|Treatment Period 2|Lack of Efficacy|0|||
130285264|NCT01468233|469008056|FG002|Treatment Period 2|Lack of Efficacy|9|||
130285265|NCT01468233|469008057|FG003|Treatment Period 2|Lack of Efficacy|2|||
130285266|NCT01468233|469008058|FG004|Treatment Period 2|Lack of Efficacy|0|||
130285267|NCT01468233|469008059|FG005|Treatment Period 2|Lack of Efficacy|1|||
130285268|NCT01468233|469008054|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130285269|NCT01468233|469008055|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130285270|NCT01468233|469008056|FG002|Treatment Period 2|Withdrawal by Subject|9|||
130285271|NCT01468233|469008057|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130285272|NCT01468233|469008058|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130285273|NCT01468233|469008059|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130285274|NCT01468233|469008054|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
130285275|NCT01468233|469008055|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
130285276|NCT01468233|469008056|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
130285277|NCT01468233|469008057|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
130043016|NCT00849693|468115747|FG002|Extension Phase|Sponsor decision|0|||
130043017|NCT00849693|468115748|FG003|Extension Phase|Sponsor decision|1|||
130043018|NCT00849693|468115745|FG000|Extension Phase|Lack of Efficacy|2|||
130043019|NCT00849693|468115746|FG001|Extension Phase|Lack of Efficacy|2|||
130285278|NCT01468233|469008058|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
130285279|NCT01468233|469008059|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
130285280|NCT01468233|469008054|FG000|Treatment Period 2|Lost to Follow-up|0|||
130285281|NCT01468233|469008055|FG001|Treatment Period 2|Lost to Follow-up|0|||
130285282|NCT01468233|469008056|FG002|Treatment Period 2|Lost to Follow-up|3|||
130285283|NCT01468233|469008057|FG003|Treatment Period 2|Lost to Follow-up|0|||
130285284|NCT01468233|469008058|FG004|Treatment Period 2|Lost to Follow-up|2|||
130285285|NCT01468233|469008059|FG005|Treatment Period 2|Lost to Follow-up|0|||
130285286|NCT01468233|469008054|FG000|Treatment Period 2|Other|0|||
130285287|NCT01468233|469008055|FG001|Treatment Period 2|Other|0|||
130285288|NCT01468233|469008056|FG002|Treatment Period 2|Other|3|||
130285289|NCT01468233|469008057|FG003|Treatment Period 2|Other|0|||
130285290|NCT01468233|469008058|FG004|Treatment Period 2|Other|1|||
130285291|NCT01468233|469008059|FG005|Treatment Period 2|Other|0|||
130285292|NCT00457821|469008067|FG000|Part 2|Withdrawal by Subject|0|||
130285293|NCT00457821|469008068|FG001|Part 2|Withdrawal by Subject|0|||
130285294|NCT00457821|469008069|FG002|Part 2|Withdrawal by Subject|0|||
130285295|NCT00457821|469008070|FG003|Part 2|Withdrawal by Subject|0|||
130285296|NCT00457821|469008071|FG004|Part 2|Withdrawal by Subject|0|||
130285297|NCT00457821|469008072|FG005|Part 2|Withdrawal by Subject|0|||
130285298|NCT00457821|469008073|FG006|Part 2|Withdrawal by Subject|0|||
130285299|NCT00457821|469008074|FG007|Part 2|Withdrawal by Subject|1|||
130285300|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
130285301|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
130285302|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
130285303|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
130285304|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
130285305|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
130285306|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
130285307|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
130285308|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
130285309|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
130285310|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
130285311|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
130285312|NCT01632241|469008075|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
130285313|NCT01632241|469008076|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
130285314|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
130285315|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
130285316|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
130285317|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
130285318|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
130285319|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
130285320|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
130285321|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
130285322|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
130285323|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
130285324|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
130285325|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
130285326|NCT01632241|469008075|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
130285327|NCT01632241|469008076|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
130285328|NCT02851407|469008086|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130285329|NCT02851407|469008087|FG001|Overall Study|Withdrawal by parent/guardian|7|||
130285330|NCT02851407|469008086|FG000|Overall Study|Protocol deviation|0|||
130285331|NCT02851407|469008087|FG001|Overall Study|Protocol deviation|1|||
130285332|NCT02851407|469008086|FG000|Overall Study|Transferred to another hospital to continue|1|||
130285333|NCT02851407|469008087|FG001|Overall Study|Transferred to another hospital to continue|0|||
130043020|NCT00849693|468115747|FG002|Extension Phase|Lack of Efficacy|2|||
130043021|NCT00849693|468115748|FG003|Extension Phase|Lack of Efficacy|1|||
130043022|NCT00685178|468115749|FG000|Overall Study|Adverse Event|1|||
130285334|NCT02851407|469008086|FG000|Overall Study|Other Death|30|||
130285335|NCT02851407|469008087|FG001|Overall Study|Other Death|20|||
130285336|NCT02851407|469008086|FG000|Overall Study|Adverse event, serious fatal|6|||
130285337|NCT02851407|469008087|FG001|Overall Study|Adverse event, serious fatal|8|||
130285338|NCT02851407|469008086|FG000|Overall Study|Consent withdrawn by participant|5|||
130285339|NCT02851407|469008087|FG001|Overall Study|Consent withdrawn by participant|3|||
130285340|NCT02851407|469008086|FG000|Overall Study|Screen failure|2|||
130285341|NCT02851407|469008087|FG001|Overall Study|Screen failure|1|||
130285342|NCT02851407|469008086|FG000|Overall Study|Disease relapse|9|||
130043023|NCT00685178|468115750|FG001|Overall Study|Adverse Event|5|||
130285343|NCT02851407|469008087|FG001|Overall Study|Disease relapse|6|||
130285344|NCT02851407|469008086|FG000|Overall Study|Physician Decision|7|||
130285345|NCT02851407|469008087|FG001|Overall Study|Physician Decision|6|||
130285346|NCT02851407|469008086|FG000|Overall Study|Transferred to hospital closer to home|0|||
130285347|NCT02851407|469008087|FG001|Overall Study|Transferred to hospital closer to home|1|||
130285348|NCT02851407|469008086|FG000|Overall Study|Enrolled in an investigational study|0|||
130285349|NCT02851407|469008087|FG001|Overall Study|Enrolled in an investigational study|1|||
130285350|NCT02851407|469008086|FG000|Overall Study|Early recovery|1|||
130285351|NCT02851407|469008087|FG001|Overall Study|Early recovery|0|||
130285352|NCT02851407|469008086|FG000|Overall Study|Adverse event, non-fatal|7|||
130285353|NCT02851407|469008087|FG001|Overall Study|Adverse event, non-fatal|5|||
130285354|NCT02851407|469008086|FG000|Overall Study|Lost to Follow-up|0|||
130285355|NCT02851407|469008087|FG001|Overall Study|Lost to Follow-up|2|||
130285356|NCT02403635|469008088|FG000|Overall Study|Not eligible|9|||
130285357|NCT00835640|469008089|FG000|Second Intervention|Protocol Violation|1|||
130285358|NCT00835640|469008090|FG001|Second Intervention|Protocol Violation|0|||
130285359|NCT00068250|469008091|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
130285360|NCT00068250|469008092|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
130285361|NCT00068250|469008093|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
130043024|NCT00685178|468115751|FG002|Overall Study|Adverse Event|2|||
130043025|NCT00685178|468115752|FG003|Overall Study|Adverse Event|4|||
130043026|NCT00685178|468115749|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
130043027|NCT00685178|468115750|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
130043028|NCT00685178|468115751|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
130043029|NCT00685178|468115752|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
130043030|NCT00685178|468115749|FG000|Overall Study|voluntary study discharge|4|||
130043031|NCT00685178|468115750|FG001|Overall Study|voluntary study discharge|5|||
130043032|NCT00685178|468115751|FG002|Overall Study|voluntary study discharge|1|||
130043033|NCT00685178|468115752|FG003|Overall Study|voluntary study discharge|1|||
130043034|NCT00685178|468115749|FG000|Overall Study|incarcerated|1|||
130043035|NCT00685178|468115750|FG001|Overall Study|incarcerated|3|||
130043036|NCT00685178|468115751|FG002|Overall Study|incarcerated|7|||
130043037|NCT00685178|468115752|FG003|Overall Study|incarcerated|0|||
130043038|NCT00685178|468115749|FG000|Overall Study|administrative (disciplinary) discharge|0|||
130043039|NCT00685178|468115750|FG001|Overall Study|administrative (disciplinary) discharge|1|||
130043040|NCT00685178|468115751|FG002|Overall Study|administrative (disciplinary) discharge|0|||
130043041|NCT00685178|468115752|FG003|Overall Study|administrative (disciplinary) discharge|2|||
130043042|NCT00685178|468115749|FG000|Overall Study|Pregnancy|0|||
130043043|NCT00685178|468115750|FG001|Overall Study|Pregnancy|0|||
130043044|NCT00685178|468115751|FG002|Overall Study|Pregnancy|0|||
130043045|NCT00685178|468115752|FG003|Overall Study|Pregnancy|1|||
130043046|NCT00077623|468115753|FG000|Overall Study|Adverse Event|1|||
130043047|NCT00077623|468115754|FG001|Overall Study|Adverse Event|0|||
130043048|NCT00077623|468115755|FG002|Overall Study|Adverse Event|1|||
130043049|NCT00077623|468115753|FG000|Overall Study|Withdrawal by Subject|2|||
130106279|NCT04682639|468349964|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130285362|NCT00068250|469008094|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
130285363|NCT03349645|469008095|FG000|Overall Study|Sponsor Terminated Study|75|||
130285364|NCT03349645|469008095|FG000|Overall Study|Withdrawal by Subject|4|||
130285365|NCT03349645|469008095|FG000|Overall Study|Protocol Violation|1|||
130285366|NCT03349645|469008095|FG000|Overall Study|Other|2|||
130285367|NCT00580034|469008098|FG000|Overall Study|Toxicity|10|||
130285368|NCT00580034|469008099|FG001|Overall Study|Toxicity|0|||
130285369|NCT01939002|469008100|FG000|Overall Study|Adverse Event|13|||
130285370|NCT01939002|469008101|FG001|Overall Study|Adverse Event|13|||
130285371|NCT01939002|469008100|FG000|Overall Study|Withdrawal by Subject|5|||
130285372|NCT01939002|469008101|FG001|Overall Study|Withdrawal by Subject|3|||
130106280|NCT04682639|468349960|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130106281|NCT04682639|468349961|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
130285373|NCT01939002|469008100|FG000|Overall Study|Other|1|||
130285374|NCT01939002|469008101|FG001|Overall Study|Other|2|||
130285375|NCT03372460|469008105|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
130285376|NCT03372460|469008106|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
130043050|NCT00077623|468115754|FG001|Overall Study|Withdrawal by Subject|10|||
130043051|NCT00077623|468115755|FG002|Overall Study|Withdrawal by Subject|1|||
130043052|NCT00077623|468115753|FG000|Overall Study|Other-Non safety reason|18|||
130043053|NCT00077623|468115754|FG001|Overall Study|Other-Non safety reason|15|||
129887249|NCT01474512|467547272|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887250|NCT01474512|467547273|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887251|NCT01474512|467547274|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887252|NCT01474512|467547275|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
129887253|NCT01474512|467547276|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
129887254|NCT01474512|467547277|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
129887255|NCT01474512|467547278|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
129887256|NCT01474512|467547279|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887257|NCT01474512|467547280|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887258|NCT01474512|467547281|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887259|NCT01474512|467547282|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887260|NCT01474512|467547283|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887261|NCT01474512|467547284|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887262|NCT01474512|467547285|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887263|NCT01474512|467547286|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887264|NCT01474512|467547287|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887265|NCT01474512|467547288|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887266|NCT01474512|467547289|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887267|NCT01474512|467547272|FG000|Maintenance Period|Adverse Event|0|||
129887268|NCT01474512|467547273|FG001|Maintenance Period|Adverse Event|0|||
129887269|NCT01474512|467547274|FG002|Maintenance Period|Adverse Event|0|||
129887270|NCT01474512|467547275|FG003|Maintenance Period|Adverse Event|4|||
129887271|NCT01474512|467547276|FG004|Maintenance Period|Adverse Event|2|||
129887272|NCT01474512|467547277|FG005|Maintenance Period|Adverse Event|7|||
129887273|NCT01474512|467547278|FG006|Maintenance Period|Adverse Event|0|||
129887274|NCT01474512|467547279|FG007|Maintenance Period|Adverse Event|19|||
129887275|NCT01474512|467547280|FG008|Maintenance Period|Adverse Event|1|||
129887276|NCT01474512|467547281|FG009|Maintenance Period|Adverse Event|3|||
129887277|NCT01474512|467547282|FG010|Maintenance Period|Adverse Event|0|||
129887278|NCT01474512|467547283|FG011|Maintenance Period|Adverse Event|0|||
129887279|NCT01474512|467547284|FG012|Maintenance Period|Adverse Event|0|||
129887280|NCT01474512|467547285|FG013|Maintenance Period|Adverse Event|0|||
129887281|NCT01474512|467547286|FG014|Maintenance Period|Adverse Event|0|||
129887282|NCT01474512|467547287|FG015|Maintenance Period|Adverse Event|0|||
129887283|NCT01474512|467547288|FG016|Maintenance Period|Adverse Event|0|||
129887284|NCT01474512|467547289|FG017|Maintenance Period|Adverse Event|0|||
129887285|NCT01474512|467547272|FG000|Maintenance Period|Withdrawal by Subject|0|||
129887286|NCT01474512|467547273|FG001|Maintenance Period|Withdrawal by Subject|0|||
129887287|NCT01474512|467547274|FG002|Maintenance Period|Withdrawal by Subject|0|||
129887288|NCT01474512|467547275|FG003|Maintenance Period|Withdrawal by Subject|6|||
129887289|NCT01474512|467547276|FG004|Maintenance Period|Withdrawal by Subject|2|||
129887290|NCT01474512|467547277|FG005|Maintenance Period|Withdrawal by Subject|3|||
129887291|NCT01474512|467547278|FG006|Maintenance Period|Withdrawal by Subject|1|||
129887292|NCT01474512|467547279|FG007|Maintenance Period|Withdrawal by Subject|6|||
129887293|NCT01474512|467547280|FG008|Maintenance Period|Withdrawal by Subject|3|||
129887294|NCT01474512|467547281|FG009|Maintenance Period|Withdrawal by Subject|1|||
129887295|NCT01474512|467547282|FG010|Maintenance Period|Withdrawal by Subject|0|||
129887296|NCT01474512|467547283|FG011|Maintenance Period|Withdrawal by Subject|0|||
129887297|NCT01474512|467547284|FG012|Maintenance Period|Withdrawal by Subject|0|||
129887298|NCT01474512|467547285|FG013|Maintenance Period|Withdrawal by Subject|0|||
129887299|NCT01474512|467547286|FG014|Maintenance Period|Withdrawal by Subject|0|||
129887300|NCT01474512|467547287|FG015|Maintenance Period|Withdrawal by Subject|0|||
129887301|NCT01474512|467547288|FG016|Maintenance Period|Withdrawal by Subject|0|||
129887302|NCT01474512|467547289|FG017|Maintenance Period|Withdrawal by Subject|0|||
129887303|NCT01474512|467547272|FG000|Maintenance Period|Lost to Follow-up|0|||
129887304|NCT01474512|467547273|FG001|Maintenance Period|Lost to Follow-up|0|||
130043054|NCT00077623|468115755|FG002|Overall Study|Other-Non safety reason|19|||
129887305|NCT01474512|467547274|FG002|Maintenance Period|Lost to Follow-up|0|||
129887306|NCT01474512|467547275|FG003|Maintenance Period|Lost to Follow-up|3|||
130043055|NCT00077623|468115753|FG000|Overall Study|Insufficient therapeutic response|2|||
130043056|NCT00077623|468115754|FG001|Overall Study|Insufficient therapeutic response|0|||
129887307|NCT01474512|467547276|FG004|Maintenance Period|Lost to Follow-up|3|||
129887308|NCT01474512|467547277|FG005|Maintenance Period|Lost to Follow-up|0|||
129887309|NCT01474512|467547278|FG006|Maintenance Period|Lost to Follow-up|0|||
129887310|NCT01474512|467547279|FG007|Maintenance Period|Lost to Follow-up|2|||
130285377|NCT02499900|469008107|FG000|Core Study Period|Other|1|||
130285378|NCT02499900|469008108|FG001|Core Study Period|Other|4|||
130285379|NCT02499900|469008107|FG000|Core Study Period|Lost to Follow-up|1|||
130285380|NCT02499900|469008108|FG001|Core Study Period|Lost to Follow-up|2|||
130285381|NCT02499900|469008107|FG000|Core Study Period|Per sponsor request|0|||
130285382|NCT02499900|469008108|FG001|Core Study Period|Per sponsor request|1|||
130285383|NCT02499900|469008107|FG000|Core Study Period|Pregnancy|1|||
130285384|NCT02499900|469008108|FG001|Core Study Period|Pregnancy|0|||
129887311|NCT01474512|467547280|FG008|Maintenance Period|Lost to Follow-up|1|||
129887312|NCT01474512|467547281|FG009|Maintenance Period|Lost to Follow-up|1|||
129887313|NCT01474512|467547282|FG010|Maintenance Period|Lost to Follow-up|0|||
129887314|NCT01474512|467547283|FG011|Maintenance Period|Lost to Follow-up|0|||
129887315|NCT01474512|467547284|FG012|Maintenance Period|Lost to Follow-up|0|||
129887316|NCT01474512|467547285|FG013|Maintenance Period|Lost to Follow-up|0|||
129887317|NCT01474512|467547286|FG014|Maintenance Period|Lost to Follow-up|0|||
129887318|NCT01474512|467547287|FG015|Maintenance Period|Lost to Follow-up|0|||
129887319|NCT01474512|467547288|FG016|Maintenance Period|Lost to Follow-up|0|||
129887320|NCT01474512|467547289|FG017|Maintenance Period|Lost to Follow-up|0|||
129887321|NCT01474512|467547272|FG000|Maintenance Period|Death|0|||
129887322|NCT01474512|467547273|FG001|Maintenance Period|Death|0|||
129887323|NCT01474512|467547274|FG002|Maintenance Period|Death|0|||
129887324|NCT01474512|467547275|FG003|Maintenance Period|Death|0|||
129887325|NCT01474512|467547276|FG004|Maintenance Period|Death|0|||
129887326|NCT01474512|467547277|FG005|Maintenance Period|Death|2|||
129887327|NCT01474512|467547278|FG006|Maintenance Period|Death|0|||
129887328|NCT01474512|467547279|FG007|Maintenance Period|Death|0|||
129887329|NCT01474512|467547280|FG008|Maintenance Period|Death|0|||
129887330|NCT01474512|467547281|FG009|Maintenance Period|Death|0|||
129887331|NCT01474512|467547282|FG010|Maintenance Period|Death|0|||
129887332|NCT01474512|467547283|FG011|Maintenance Period|Death|0|||
129887333|NCT01474512|467547284|FG012|Maintenance Period|Death|0|||
129887334|NCT01474512|467547285|FG013|Maintenance Period|Death|0|||
129887335|NCT01474512|467547286|FG014|Maintenance Period|Death|0|||
129887336|NCT01474512|467547287|FG015|Maintenance Period|Death|0|||
129887337|NCT01474512|467547288|FG016|Maintenance Period|Death|0|||
129887338|NCT01474512|467547289|FG017|Maintenance Period|Death|0|||
129887339|NCT01474512|467547272|FG000|Maintenance Period|Physician Decision|0|||
130285385|NCT02499900|469008107|FG000|Core Study Period|Protocol Violation|3|||
130285386|NCT02499900|469008108|FG001|Core Study Period|Protocol Violation|0|||
130285387|NCT02499900|469008107|FG000|Core Study Period|Withdrawal by Subject|11|||
130285388|NCT02499900|469008108|FG001|Core Study Period|Withdrawal by Subject|10|||
130285389|NCT02499900|469008107|FG000|Core Study Period|Adverse Event|18|||
130285390|NCT02499900|469008108|FG001|Core Study Period|Adverse Event|14|||
130285391|NCT02499900|469008107|FG000|Core Study Period|Death|0|||
130285392|NCT02499900|469008108|FG001|Core Study Period|Death|1|||
130285393|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
130285394|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
130285395|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
130285396|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
130285397|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
130285398|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
130285399|NCT02499900|469008107|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
130285400|NCT02499900|469008108|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
130285401|NCT02499900|469008107|FG000|Extension Study Period|Adverse Event|2|||
130285402|NCT02499900|469008108|FG001|Extension Study Period|Adverse Event|4|||
130285403|NCT02499900|469008107|FG000|Extension Study Period|Withdrawal by Subject|5|||
130285404|NCT02499900|469008108|FG001|Extension Study Period|Withdrawal by Subject|2|||
130285405|NCT02499900|469008107|FG000|Extension Study Period|Physician Decision|2|||
129887340|NCT01474512|467547273|FG001|Maintenance Period|Physician Decision|0|||
129887341|NCT01474512|467547274|FG002|Maintenance Period|Physician Decision|0|||
129887342|NCT01474512|467547275|FG003|Maintenance Period|Physician Decision|0|||
129887343|NCT01474512|467547276|FG004|Maintenance Period|Physician Decision|0|||
129887344|NCT01474512|467547277|FG005|Maintenance Period|Physician Decision|1|||
129887345|NCT01474512|467547278|FG006|Maintenance Period|Physician Decision|0|||
130285406|NCT02499900|469008108|FG001|Extension Study Period|Physician Decision|5|||
130285407|NCT02499900|469008107|FG000|Extension Study Period|Pregnancy|1|||
130285408|NCT02499900|469008108|FG001|Extension Study Period|Pregnancy|2|||
130285409|NCT02499900|469008107|FG000|Extension Study Period|Lost to Follow-up|2|||
130316227|NCT04319198|469124332|FG000|Overall Study|Death|0|||
130043057|NCT00077623|468115755|FG002|Overall Study|Insufficient therapeutic response|0|||
130043058|NCT00077623|468115753|FG000|Overall Study|Death|12|||
130043059|NCT00077623|468115754|FG001|Overall Study|Death|18|||
130043060|NCT00077623|468115755|FG002|Overall Study|Death|11|||
130285410|NCT02499900|469008108|FG001|Extension Study Period|Lost to Follow-up|5|||
130285411|NCT02499900|469008107|FG000|Extension Study Period|Other|0|||
130285412|NCT02499900|469008108|FG001|Extension Study Period|Other|2|||
130285413|NCT03385265|469008109|FG000|Overall Study|Withdrawal by Subject|5|||
130285414|NCT03385265|469008110|FG001|Overall Study|Withdrawal by Subject|2|||
130043061|NCT00077623|468115753|FG000|Overall Study|Failure to return|1|||
130043062|NCT00077623|468115754|FG001|Overall Study|Failure to return|0|||
130043063|NCT00077623|468115755|FG002|Overall Study|Failure to return|0|||
130043064|NCT02138110|468115759|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
130043065|NCT02138110|468115759|FG000|Overall Scaffold Implantation|Death|3|||
130043066|NCT00882713|468115762|FG000|Overall Study|Adverse Event|2|||
130043067|NCT00882713|468115762|FG000|Overall Study|Death|3|||
130043068|NCT00882713|468115762|FG000|Overall Study|Administrative reasons|4|||
130043069|NCT00882713|468115762|FG000|Overall Study|refused treatment/withdrew consent|4|||
130043070|NCT00882713|468115762|FG000|Overall Study|Blood transfusion|2|||
130043071|NCT00882713|468115762|FG000|Overall Study|Insufficient therapeutic response|3|||
130043072|NCT00882713|468115762|FG000|Overall Study|Failure to return|2|||
130043073|NCT00882713|468115762|FG000|Overall Study|Other - Reasons|2|||
130043074|NCT01408537|468115765|FG000|Overall Study|Withdrawal by Subject|2|||
130285415|NCT03385265|469008111|FG002|Overall Study|Withdrawal by Subject|5|||
130285416|NCT03385265|469008112|FG003|Overall Study|Withdrawal by Subject|2|||
130285417|NCT02439450|469008114|FG000|Overall Study|Adverse Event|4|||
130285418|NCT02439450|469008115|FG001|Overall Study|Adverse Event|1|||
130285419|NCT02439450|469008116|FG002|Overall Study|Adverse Event|0|||
130285420|NCT02439450|469008117|FG003|Overall Study|Adverse Event|0|||
130285421|NCT02439450|469008114|FG000|Overall Study|Withdrawal by Subject|1|||
130285422|NCT02439450|469008115|FG001|Overall Study|Withdrawal by Subject|2|||
130285423|NCT02439450|469008116|FG002|Overall Study|Withdrawal by Subject|0|||
130285424|NCT02439450|469008117|FG003|Overall Study|Withdrawal by Subject|0|||
130285425|NCT02439450|469008114|FG000|Overall Study|Death|3|||
130285426|NCT02439450|469008115|FG001|Overall Study|Death|0|||
130285427|NCT02439450|469008116|FG002|Overall Study|Death|0|||
130285428|NCT02439450|469008117|FG003|Overall Study|Death|1|||
130285429|NCT02439450|469008114|FG000|Overall Study|Progressive Disease|18|||
130285430|NCT02439450|469008115|FG001|Overall Study|Progressive Disease|41|||
130285431|NCT02439450|469008116|FG002|Overall Study|Progressive Disease|2|||
130285432|NCT02439450|469008117|FG003|Overall Study|Progressive Disease|3|||
130285433|NCT01170065|469008120|FG000|Overall Study|Adverse Event|17|||
130285434|NCT01170065|469008121|FG001|Overall Study|Adverse Event|50|||
130285435|NCT01170065|469008122|FG002|Overall Study|Adverse Event|10|||
130285436|NCT01170065|469008120|FG000|Overall Study|Lost to Follow-up|1|||
130285437|NCT01170065|469008121|FG001|Overall Study|Lost to Follow-up|4|||
130285438|NCT01170065|469008122|FG002|Overall Study|Lost to Follow-up|1|||
130285439|NCT01170065|469008120|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
130285440|NCT01170065|469008121|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
130285441|NCT01170065|469008122|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
130285442|NCT01170065|469008120|FG000|Overall Study|Reason other than specified|3|||
130285443|NCT01170065|469008121|FG001|Overall Study|Reason other than specified|8|||
130285444|NCT01170065|469008122|FG002|Overall Study|Reason other than specified|3|||
130285445|NCT01170065|469008120|FG000|Overall Study|Ongoing after planned observation time|5|||
130285446|NCT01170065|469008121|FG001|Overall Study|Ongoing after planned observation time|26|||
130285447|NCT01170065|469008122|FG002|Overall Study|Ongoing after planned observation time|10|||
130285448|NCT00853125|469008129|FG000|Overall Study|Study participant's donor was CMV +|1|||
130285449|NCT03023826|469008131|FG000|Period 1|Withdrawal by Subject|0|||
130285450|NCT03023826|469008132|FG001|Period 1|Withdrawal by Subject|0|||
130285451|NCT03023826|469008133|FG002|Period 1|Withdrawal by Subject|0|||
130285452|NCT03023826|469008134|FG003|Period 1|Withdrawal by Subject|0|||
130285453|NCT03023826|469008135|FG004|Period 1|Withdrawal by Subject|1|||
130285454|NCT03023826|469008136|FG005|Period 1|Withdrawal by Subject|0|||
130285455|NCT00428220|469010121|FG000|Overall Study|Participant died|8|||
130285456|NCT00428220|469010121|FG000|Overall Study|Global deterioration of health status|7|||
130043075|NCT01408537|468115765|FG000|Overall Study|Protocol Violation|3|||
130043076|NCT01408537|468115765|FG000|Overall Study|Lost to Follow-up|3|||
130106282|NCT04682639|468349962|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130106283|NCT04682639|468349963|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130285457|NCT00428220|469010121|FG000|Overall Study|Lost to Follow-up|4|||
130285458|NCT00428220|469010121|FG000|Overall Study|Objective progression or relapse|123|||
130285459|NCT00428220|469010121|FG000|Overall Study|Participant refused continued treatment|7|||
130285460|NCT00428220|469010121|FG000|Overall Study|Adverse Event|51|||
130285461|NCT00428220|469010121|FG000|Overall Study|Other|23|||
130285462|NCT00549900|469010123|FG000|Overall Study|Adverse Event|1|||
130043077|NCT02760602|468115768|FG000|Overall Study|Withdrawal by Subject|1|||
130043078|NCT02760602|468115769|FG001|Overall Study|Withdrawal by Subject|0|||
130043079|NCT02760602|468115768|FG000|Overall Study|Terminated by sponsor|12|||
130043080|NCT02760602|468115769|FG001|Overall Study|Terminated by sponsor|13|||
130043081|NCT01260181|468115778|FG000|Overall Study|Decision of Investigator|1|||
130043082|NCT01844076|468115781|FG000|Overall Study|Adverse Event|1|||
130043083|NCT01844076|468115782|FG001|Overall Study|Adverse Event|0|||
130043084|NCT01844076|468115783|FG002|Overall Study|Adverse Event|0|||
130043085|NCT01844076|468115784|FG003|Overall Study|Adverse Event|0|||
130043086|NCT01844076|468115781|FG000|Overall Study|Withdrawal by Subject|1|||
130043087|NCT01844076|468115782|FG001|Overall Study|Withdrawal by Subject|0|||
130043088|NCT01844076|468115783|FG002|Overall Study|Withdrawal by Subject|0|||
130043089|NCT01844076|468115784|FG003|Overall Study|Withdrawal by Subject|0|||
130043090|NCT00635102|468115787|FG000|Overall Study|Withdrawal by Subject|7|||
130043091|NCT00635102|468115788|FG001|Overall Study|Withdrawal by Subject|8|||
130043092|NCT01938625|468115790|FG000|Overall Study|Withdrawal by Subject|0|||
130043093|NCT01938625|468115791|FG001|Overall Study|Withdrawal by Subject|1|||
130043094|NCT01938625|468115790|FG000|Overall Study|Adverse Event|0|||
130043095|NCT01938625|468115791|FG001|Overall Study|Adverse Event|1|||
130043096|NCT02088034|468115792|FG000|Overall Study|Lost to Follow-up|1|||
130043097|NCT02088034|468115793|FG001|Overall Study|Lost to Follow-up|1|||
130043098|NCT02088034|468115794|FG002|Overall Study|Lost to Follow-up|0|||
130043099|NCT02088034|468115792|FG000|Overall Study|Pregnancy|2|||
130043100|NCT02088034|468115793|FG001|Overall Study|Pregnancy|1|||
130043101|NCT02088034|468115794|FG002|Overall Study|Pregnancy|2|||
130043102|NCT01937312|468115795|FG000|Overall Study|Adverse Event|10|||
130285463|NCT02982018|469010124|FG000|Overall Study|Incorrect Lens Dispensed|1|||
130285464|NCT02982018|469010125|FG001|Overall Study|Incorrect Lens Dispensed|0|||
130285465|NCT02982018|469010124|FG000|Overall Study|Protocol Violation|1|||
130285466|NCT02982018|469010125|FG001|Overall Study|Protocol Violation|1|||
130285467|NCT02982018|469010124|FG000|Overall Study|Adverse Event|1|||
130285468|NCT02982018|469010125|FG001|Overall Study|Adverse Event|1|||
130285469|NCT02982018|469010124|FG000|Overall Study|Lens Discomfort|2|||
130285470|NCT02982018|469010125|FG001|Overall Study|Lens Discomfort|0|||
130285471|NCT02982018|469010124|FG000|Overall Study|Withdrawal by Subject|0|||
130285472|NCT02982018|469010125|FG001|Overall Study|Withdrawal by Subject|1|||
130285473|NCT03283098|469010126|FG000|Overall Study|Withdrawal by Subject|0|||
130285474|NCT03283098|469010127|FG001|Overall Study|Withdrawal by Subject|1|||
130285475|NCT00798317|469010128|FG000|Overall Study|Physician Decision|0|||
130285476|NCT00798317|469010129|FG001|Overall Study|Physician Decision|1|||
130285477|NCT00798317|469010128|FG000|Overall Study|Withdrawal by Subject|5|||
130285478|NCT00798317|469010129|FG001|Overall Study|Withdrawal by Subject|4|||
130285479|NCT00798317|469010128|FG000|Overall Study|Lost to Follow-up|2|||
130285480|NCT00798317|469010129|FG001|Overall Study|Lost to Follow-up|2|||
130285481|NCT00798317|469010128|FG000|Overall Study|Adverse Event|2|||
130285482|NCT00798317|469010129|FG001|Overall Study|Adverse Event|0|||
130285483|NCT00798317|469010128|FG000|Overall Study|Death|1|||
130285484|NCT00798317|469010129|FG001|Overall Study|Death|0|||
130285485|NCT00416715|469010130|FG000|Overall Study|Not evaluable for joint aches|7|||
130285486|NCT00416715|469010130|FG000|Overall Study|Vitamin D levels not evaluable|8|||
130285487|NCT02545517|469010141|FG000|Overall Study|Death|2|||
130285488|NCT02545517|469010142|FG001|Overall Study|Death|2|||
130285489|NCT02545517|469010143|FG002|Overall Study|Death|1|||
130043103|NCT01937312|468115796|FG001|Overall Study|Adverse Event|1|||
130043104|NCT01937312|468115795|FG000|Overall Study|Lack of Efficacy|0|||
130043105|NCT01937312|468115796|FG001|Overall Study|Lack of Efficacy|1|||
130285490|NCT02545517|469010141|FG000|Overall Study|Lost to Follow-up|14|||
130285491|NCT02545517|469010142|FG001|Overall Study|Lost to Follow-up|13|||
130285492|NCT02545517|469010143|FG002|Overall Study|Lost to Follow-up|17|||
130285493|NCT02545517|469010141|FG000|Overall Study|Protocol Violation|0|||
130043106|NCT01937312|468115795|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
130043107|NCT01937312|468115796|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
130043108|NCT01025336|468115799|FG000|Overall Study|Protocol Violation|0|||
130043109|NCT01025336|468115800|FG001|Overall Study|Protocol Violation|0|||
130043110|NCT01025336|468115801|FG002|Overall Study|Protocol Violation|0|||
130043111|NCT01025336|468115802|FG003|Overall Study|Protocol Violation|2|||
130285494|NCT02545517|469010142|FG001|Overall Study|Protocol Violation|1|||
130285495|NCT02545517|469010143|FG002|Overall Study|Protocol Violation|1|||
130285496|NCT02545517|469010141|FG000|Overall Study|Withdrawal by Subject|5|||
130285497|NCT02545517|469010142|FG001|Overall Study|Withdrawal by Subject|8|||
130285498|NCT02545517|469010143|FG002|Overall Study|Withdrawal by Subject|9|||
130285499|NCT02545517|469010141|FG000|Overall Study|Administrative reason|5|||
130043112|NCT01025336|468115803|FG004|Overall Study|Protocol Violation|0|||
130043113|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Adverse Event|12|||
130043114|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Adverse Event|3|||
130043115|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Adverse Event|4|||
130043116|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Adverse Event|2|||
130043117|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
130043118|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
130043119|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
130043120|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
130043121|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
130043122|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
130285500|NCT02545517|469010142|FG001|Overall Study|Administrative reason|6|||
130285501|NCT02545517|469010143|FG002|Overall Study|Administrative reason|10|||
130285502|NCT02545517|469010141|FG000|Overall Study|Other|2|||
130285503|NCT02545517|469010142|FG001|Overall Study|Other|4|||
130285504|NCT02545517|469010143|FG002|Overall Study|Other|3|||
130285505|NCT01069861|469010144|FG000|Overall Study|Death|1|||
130285506|NCT01069861|469010144|FG000|Overall Study|Adverse Event|1|||
130285507|NCT01069861|469010144|FG000|Overall Study|Did not meet entrance criteria|1|||
130285508|NCT04035564|469010145|FG000|Overall Study|Protocol Violation|1|||
130285509|NCT04035564|469010146|FG001|Overall Study|Protocol Violation|2|||
130285510|NCT04035564|469010145|FG000|Overall Study|No laboratory available|2|||
130285511|NCT04035564|469010146|FG001|Overall Study|No laboratory available|2|||
130285512|NCT04035564|469010145|FG000|Overall Study|Guardian declined consent|1|||
130285513|NCT04035564|469010146|FG001|Overall Study|Guardian declined consent|2|||
130285514|NCT00996281|469010148|FG000|Overall Study|Adverse Event|75|||
130285515|NCT00996281|469010149|FG001|Overall Study|Adverse Event|37|||
130285516|NCT00996281|469010148|FG000|Overall Study|Major Protocol Deviation|6|||
130285517|NCT00996281|469010149|FG001|Overall Study|Major Protocol Deviation|7|||
130285518|NCT00996281|469010148|FG000|Overall Study|Lost to Follow-up|14|||
130285519|NCT00996281|469010149|FG001|Overall Study|Lost to Follow-up|16|||
130285520|NCT00996281|469010148|FG000|Overall Study|Withdrawal by Subject|31|||
130285521|NCT00996281|469010149|FG001|Overall Study|Withdrawal by Subject|20|||
130285522|NCT00996281|469010148|FG000|Overall Study|Lack of Efficacy|0|||
130285523|NCT00996281|469010149|FG001|Overall Study|Lack of Efficacy|2|||
130285524|NCT00996281|469010148|FG000|Overall Study|Other|5|||
130285525|NCT00996281|469010149|FG001|Overall Study|Other|7|||
130285526|NCT02754141|469010150|FG000|Overall Study|Disease progression|11|||
130285527|NCT02754141|469010151|FG001|Overall Study|Disease progression|7|||
130285528|NCT02754141|469010152|FG002|Overall Study|Disease progression|8|||
130285529|NCT02754141|469010153|FG003|Overall Study|Disease progression|5|||
130043123|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
130043124|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
130285530|NCT02754141|469010154|FG004|Overall Study|Disease progression|7|||
130285531|NCT02754141|469010155|FG005|Overall Study|Disease progression|7|||
130285532|NCT02754141|469010156|FG006|Overall Study|Disease progression|7|||
130285533|NCT02754141|469010157|FG007|Overall Study|Disease progression|6|||
130285534|NCT02754141|469010158|FG008|Overall Study|Disease progression|11|||
130285535|NCT02754141|469010159|FG009|Overall Study|Disease progression|16|||
130285536|NCT02754141|469010160|FG010|Overall Study|Disease progression|18|||
130285537|NCT02754141|469010161|FG011|Overall Study|Disease progression|13|||
130285538|NCT02754141|469010162|FG012|Overall Study|Disease progression|10|||
130285539|NCT02754141|469010163|FG013|Overall Study|Disease progression|12|||
130285540|NCT02754141|469010164|FG014|Overall Study|Disease progression|12|||
130285541|NCT02754141|469010165|FG015|Overall Study|Disease progression|14|||
130285542|NCT02754141|469010166|FG016|Overall Study|Disease progression|0|||
130285543|NCT02754141|469010167|FG017|Overall Study|Disease progression|1|||
130285544|NCT02754141|469010150|FG000|Overall Study|Study drug toxicity|1|||
130285545|NCT02754141|469010151|FG001|Overall Study|Study drug toxicity|1|||
130285546|NCT02754141|469010152|FG002|Overall Study|Study drug toxicity|0|||
130285547|NCT02754141|469010153|FG003|Overall Study|Study drug toxicity|0|||
130285548|NCT02754141|469010154|FG004|Overall Study|Study drug toxicity|0|||
130285549|NCT02754141|469010155|FG005|Overall Study|Study drug toxicity|0|||
130285550|NCT02754141|469010156|FG006|Overall Study|Study drug toxicity|0|||
130285551|NCT02754141|469010157|FG007|Overall Study|Study drug toxicity|0|||
130285552|NCT02754141|469010158|FG008|Overall Study|Study drug toxicity|0|||
130285553|NCT02754141|469010159|FG009|Overall Study|Study drug toxicity|0|||
130285554|NCT02754141|469010160|FG010|Overall Study|Study drug toxicity|2|||
130285555|NCT02754141|469010161|FG011|Overall Study|Study drug toxicity|1|||
130285556|NCT02754141|469010162|FG012|Overall Study|Study drug toxicity|1|||
130285557|NCT02754141|469010163|FG013|Overall Study|Study drug toxicity|0|||
130285558|NCT02754141|469010164|FG014|Overall Study|Study drug toxicity|0|||
130285559|NCT02754141|469010165|FG015|Overall Study|Study drug toxicity|0|||
130285560|NCT02754141|469010166|FG016|Overall Study|Study drug toxicity|0|||
130285561|NCT02754141|469010167|FG017|Overall Study|Study drug toxicity|0|||
130285562|NCT02754141|469010150|FG000|Overall Study|AE unrelated to study drug|1|||
130285563|NCT02754141|469010151|FG001|Overall Study|AE unrelated to study drug|1|||
130285564|NCT02754141|469010152|FG002|Overall Study|AE unrelated to study drug|0|||
130285565|NCT02754141|469010153|FG003|Overall Study|AE unrelated to study drug|1|||
130285566|NCT02754141|469010154|FG004|Overall Study|AE unrelated to study drug|3|||
130285567|NCT02754141|469010155|FG005|Overall Study|AE unrelated to study drug|2|||
130285568|NCT02754141|469010156|FG006|Overall Study|AE unrelated to study drug|1|||
130285569|NCT02754141|469010157|FG007|Overall Study|AE unrelated to study drug|0|||
130285570|NCT02754141|469010158|FG008|Overall Study|AE unrelated to study drug|0|||
130285571|NCT02754141|469010159|FG009|Overall Study|AE unrelated to study drug|0|||
130285572|NCT02754141|469010160|FG010|Overall Study|AE unrelated to study drug|0|||
130285573|NCT02754141|469010161|FG011|Overall Study|AE unrelated to study drug|0|||
129887346|NCT01474512|467547279|FG007|Maintenance Period|Physician Decision|2|||
129887347|NCT01474512|467547280|FG008|Maintenance Period|Physician Decision|0|||
130285574|NCT02754141|469010162|FG012|Overall Study|AE unrelated to study drug|0|||
130285575|NCT02754141|469010163|FG013|Overall Study|AE unrelated to study drug|0|||
130285576|NCT02754141|469010164|FG014|Overall Study|AE unrelated to study drug|0|||
130285577|NCT02754141|469010165|FG015|Overall Study|AE unrelated to study drug|0|||
130285578|NCT02754141|469010166|FG016|Overall Study|AE unrelated to study drug|0|||
130285579|NCT02754141|469010167|FG017|Overall Study|AE unrelated to study drug|0|||
130285580|NCT02754141|469010150|FG000|Overall Study|Request to discontinue|0|||
130285581|NCT02754141|469010151|FG001|Overall Study|Request to discontinue|0|||
130285582|NCT02754141|469010152|FG002|Overall Study|Request to discontinue|0|||
130285583|NCT02754141|469010153|FG003|Overall Study|Request to discontinue|0|||
130285584|NCT02754141|469010154|FG004|Overall Study|Request to discontinue|0|||
130285585|NCT02754141|469010155|FG005|Overall Study|Request to discontinue|0|||
130285586|NCT02754141|469010156|FG006|Overall Study|Request to discontinue|0|||
130285587|NCT02754141|469010157|FG007|Overall Study|Request to discontinue|0|||
130285588|NCT02754141|469010158|FG008|Overall Study|Request to discontinue|1|||
130285589|NCT02754141|469010159|FG009|Overall Study|Request to discontinue|0|||
130285590|NCT02754141|469010160|FG010|Overall Study|Request to discontinue|0|||
130285591|NCT02754141|469010161|FG011|Overall Study|Request to discontinue|0|||
130043125|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
130043126|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
130043127|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
130043128|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
130043129|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
130043130|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
130043131|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
130043132|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
130043133|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
130043134|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
130043135|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
130043136|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
130043137|NCT02436239|468115806|FG000|Open-Lable Treatment Period|Other Reason|1|||
130043138|NCT02436239|468115807|FG001|Open-Lable Treatment Period|Other Reason|1|||
130043139|NCT02436239|468115808|FG002|Open-Lable Treatment Period|Other Reason|0|||
130043140|NCT02436239|468115809|FG003|Open-Lable Treatment Period|Other Reason|0|||
130043141|NCT02436239|468115806|FG000|Down-Taper Period|Withdrawal by Subject|4|||
130043142|NCT02436239|468115807|FG001|Down-Taper Period|Withdrawal by Subject|4|||
130043143|NCT02436239|468115808|FG002|Down-Taper Period|Withdrawal by Subject|1|||
130043144|NCT02436239|468115809|FG003|Down-Taper Period|Withdrawal by Subject|2|||
130043145|NCT02782715|468115813|FG000|Overall Study|Withdrawal by Subject|1|||
130285592|NCT02754141|469010162|FG012|Overall Study|Request to discontinue|0|||
129887348|NCT01474512|467547281|FG009|Maintenance Period|Physician Decision|0|||
129887349|NCT01474512|467547282|FG010|Maintenance Period|Physician Decision|0|||
129887350|NCT01474512|467547283|FG011|Maintenance Period|Physician Decision|0|||
130043146|NCT03368404|468115821|FG000|Overall Study|Adverse Event|2|||
130043147|NCT03368404|468115822|FG001|Overall Study|Adverse Event|1|||
130043148|NCT03368404|468115821|FG000|Overall Study|Withdrawal by Subject|1|||
130043149|NCT03368404|468115822|FG001|Overall Study|Withdrawal by Subject|1|||
130043150|NCT00995371|468115823|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
130043151|NCT00995371|468115824|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
130043152|NCT02983292|468115825|FG000|Overall Study|Participant unwell & cannot travel|2|||
130043153|NCT02983292|468115825|FG000|Overall Study|Lost to Follow-up|3|||
130043154|NCT02983292|468115825|FG000|Overall Study|Participant withdrew consent|2|||
130043155|NCT02983292|468115825|FG000|Overall Study|Revision|7|||
130043156|NCT02983292|468115825|FG000|Overall Study|Death|1|||
130043157|NCT02983292|468115825|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
130043158|NCT02983292|468115825|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
130043159|NCT02983292|468115825|FG000|Overall Study|Participant relocation|1|||
130043160|NCT04725682|468115826|FG000|Overall Study|Withdrawal by Subject|7|||
130043161|NCT04725682|468115827|FG001|Overall Study|Withdrawal by Subject|5|||
130043162|NCT04725682|468115826|FG000|Overall Study|Failed to comply with the requirements|2|||
130043163|NCT04725682|468115827|FG001|Overall Study|Failed to comply with the requirements|1|||
130043164|NCT04725682|468115826|FG000|Overall Study|Adverse Event|1|||
130043165|NCT04725682|468115827|FG001|Overall Study|Adverse Event|1|||
130043166|NCT04725682|468115826|FG000|Overall Study|Death|0|||
130043167|NCT04725682|468115827|FG001|Overall Study|Death|1|||
130043168|NCT01607892|468115829|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
130043169|NCT01607892|468115830|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
130043170|NCT01607892|468115831|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
130043171|NCT01607892|468115832|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
130043172|NCT01607892|468115833|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
130285593|NCT02754141|469010163|FG013|Overall Study|Request to discontinue|1|||
129887351|NCT01474512|467547284|FG012|Maintenance Period|Physician Decision|0|||
130043173|NCT01607892|468115829|FG000|Overall Study|Death|4|||
130043174|NCT01607892|468115830|FG001|Overall Study|Death|2|||
130043175|NCT01607892|468115831|FG002|Overall Study|Death|8|||
130043176|NCT01607892|468115832|FG003|Overall Study|Death|10|||
130043177|NCT01607892|468115833|FG004|Overall Study|Death|3|||
130043178|NCT01607892|468115829|FG000|Overall Study|Investigator discretion|2|||
130316228|NCT04319198|469124333|FG001|Overall Study|Death|3|||
130043179|NCT01607892|468115830|FG001|Overall Study|Investigator discretion|4|||
130043180|NCT01607892|468115831|FG002|Overall Study|Investigator discretion|4|||
130285594|NCT02754141|469010164|FG014|Overall Study|Request to discontinue|1|||
130285595|NCT02754141|469010165|FG015|Overall Study|Request to discontinue|0|||
130285596|NCT02754141|469010166|FG016|Overall Study|Request to discontinue|0|||
130285597|NCT02754141|469010167|FG017|Overall Study|Request to discontinue|0|||
130285598|NCT02754141|469010150|FG000|Overall Study|Withdrew consent|0|||
130285599|NCT02754141|469010151|FG001|Overall Study|Withdrew consent|0|||
130285600|NCT02754141|469010152|FG002|Overall Study|Withdrew consent|0|||
130285601|NCT02754141|469010153|FG003|Overall Study|Withdrew consent|0|||
130285602|NCT02754141|469010154|FG004|Overall Study|Withdrew consent|0|||
130285603|NCT02754141|469010155|FG005|Overall Study|Withdrew consent|0|||
130285604|NCT02754141|469010156|FG006|Overall Study|Withdrew consent|0|||
130285605|NCT02754141|469010157|FG007|Overall Study|Withdrew consent|0|||
130285606|NCT02754141|469010158|FG008|Overall Study|Withdrew consent|0|||
130285607|NCT02754141|469010159|FG009|Overall Study|Withdrew consent|1|||
130285608|NCT02754141|469010160|FG010|Overall Study|Withdrew consent|0|||
130285609|NCT02754141|469010161|FG011|Overall Study|Withdrew consent|0|||
130285610|NCT02754141|469010162|FG012|Overall Study|Withdrew consent|0|||
130285611|NCT02754141|469010163|FG013|Overall Study|Withdrew consent|0|||
130285612|NCT02754141|469010164|FG014|Overall Study|Withdrew consent|0|||
130285613|NCT02754141|469010165|FG015|Overall Study|Withdrew consent|0|||
130285614|NCT02754141|469010166|FG016|Overall Study|Withdrew consent|0|||
130285615|NCT02754141|469010167|FG017|Overall Study|Withdrew consent|0|||
130285616|NCT02754141|469010150|FG000|Overall Study|Maximum clinical benefit|0|||
130285617|NCT02754141|469010151|FG001|Overall Study|Maximum clinical benefit|0|||
130285618|NCT02754141|469010152|FG002|Overall Study|Maximum clinical benefit|0|||
130285619|NCT02754141|469010153|FG003|Overall Study|Maximum clinical benefit|1|||
130285620|NCT02754141|469010154|FG004|Overall Study|Maximum clinical benefit|0|||
130285621|NCT02754141|469010155|FG005|Overall Study|Maximum clinical benefit|0|||
130285622|NCT02754141|469010156|FG006|Overall Study|Maximum clinical benefit|0|||
130285623|NCT02754141|469010157|FG007|Overall Study|Maximum clinical benefit|0|||
130285624|NCT02754141|469010158|FG008|Overall Study|Maximum clinical benefit|0|||
130285625|NCT02754141|469010159|FG009|Overall Study|Maximum clinical benefit|0|||
130285626|NCT02754141|469010160|FG010|Overall Study|Maximum clinical benefit|0|||
130285627|NCT02754141|469010161|FG011|Overall Study|Maximum clinical benefit|0|||
130285628|NCT02754141|469010162|FG012|Overall Study|Maximum clinical benefit|0|||
130285629|NCT02754141|469010163|FG013|Overall Study|Maximum clinical benefit|0|||
130285630|NCT02754141|469010164|FG014|Overall Study|Maximum clinical benefit|0|||
130285631|NCT02754141|469010165|FG015|Overall Study|Maximum clinical benefit|0|||
130285632|NCT02754141|469010166|FG016|Overall Study|Maximum clinical benefit|0|||
130285633|NCT02754141|469010167|FG017|Overall Study|Maximum clinical benefit|0|||
130285634|NCT02754141|469010150|FG000|Overall Study|No longer meets study criteria|0|||
130285635|NCT02754141|469010151|FG001|Overall Study|No longer meets study criteria|0|||
130285636|NCT02754141|469010152|FG002|Overall Study|No longer meets study criteria|0|||
130285637|NCT02754141|469010153|FG003|Overall Study|No longer meets study criteria|1|||
130285638|NCT02754141|469010154|FG004|Overall Study|No longer meets study criteria|0|||
130285639|NCT02754141|469010155|FG005|Overall Study|No longer meets study criteria|0|||
130285640|NCT02754141|469010156|FG006|Overall Study|No longer meets study criteria|0|||
130285641|NCT02754141|469010157|FG007|Overall Study|No longer meets study criteria|0|||
130285642|NCT02754141|469010158|FG008|Overall Study|No longer meets study criteria|0|||
130285643|NCT02754141|469010159|FG009|Overall Study|No longer meets study criteria|0|||
130285644|NCT02754141|469010160|FG010|Overall Study|No longer meets study criteria|0|||
130285645|NCT02754141|469010161|FG011|Overall Study|No longer meets study criteria|0|||
130285646|NCT02754141|469010162|FG012|Overall Study|No longer meets study criteria|0|||
130043181|NCT01607892|468115832|FG003|Overall Study|Investigator discretion|8|||
130043182|NCT01607892|468115833|FG004|Overall Study|Investigator discretion|0|||
130043183|NCT01607892|468115829|FG000|Overall Study|Other treatments became available|1|||
130285647|NCT02754141|469010163|FG013|Overall Study|No longer meets study criteria|0|||
130285648|NCT02754141|469010164|FG014|Overall Study|No longer meets study criteria|0|||
130285649|NCT02754141|469010165|FG015|Overall Study|No longer meets study criteria|0|||
130043184|NCT01607892|468115830|FG001|Overall Study|Other treatments became available|1|||
130285650|NCT02754141|469010166|FG016|Overall Study|No longer meets study criteria|0|||
130043185|NCT01607892|468115831|FG002|Overall Study|Other treatments became available|0|||
130043186|NCT01607892|468115832|FG003|Overall Study|Other treatments became available|0|||
130043187|NCT01607892|468115833|FG004|Overall Study|Other treatments became available|2|||
130043188|NCT01607892|468115829|FG000|Overall Study|Intercurrent illness|1|||
130285651|NCT02754141|469010167|FG017|Overall Study|No longer meets study criteria|0|||
130285652|NCT02754141|469010150|FG000|Overall Study|Other reasons|0|||
130285653|NCT02754141|469010151|FG001|Overall Study|Other reasons|0|||
130285654|NCT02754141|469010152|FG002|Overall Study|Other reasons|0|||
130285655|NCT02754141|469010153|FG003|Overall Study|Other reasons|0|||
130285656|NCT02754141|469010154|FG004|Overall Study|Other reasons|0|||
130285657|NCT02754141|469010155|FG005|Overall Study|Other reasons|0|||
130285658|NCT02754141|469010156|FG006|Overall Study|Other reasons|0|||
130285659|NCT02754141|469010157|FG007|Overall Study|Other reasons|1|||
130285660|NCT02754141|469010158|FG008|Overall Study|Other reasons|0|||
130285661|NCT02754141|469010159|FG009|Overall Study|Other reasons|0|||
130285662|NCT02754141|469010160|FG010|Overall Study|Other reasons|0|||
130285663|NCT02754141|469010161|FG011|Overall Study|Other reasons|0|||
130285664|NCT02754141|469010162|FG012|Overall Study|Other reasons|2|||
130285665|NCT02754141|469010163|FG013|Overall Study|Other reasons|0|||
130285666|NCT02754141|469010164|FG014|Overall Study|Other reasons|0|||
130285667|NCT02754141|469010165|FG015|Overall Study|Other reasons|0|||
130285668|NCT02754141|469010166|FG016|Overall Study|Other reasons|0|||
130285669|NCT02754141|469010167|FG017|Overall Study|Other reasons|0|||
130285670|NCT02754141|469010150|FG000|Overall Study|Completed treatment as per protocol|0|||
130285671|NCT02754141|469010151|FG001|Overall Study|Completed treatment as per protocol|1|||
130285672|NCT02754141|469010152|FG002|Overall Study|Completed treatment as per protocol|0|||
130285673|NCT02754141|469010153|FG003|Overall Study|Completed treatment as per protocol|0|||
130285674|NCT02754141|469010154|FG004|Overall Study|Completed treatment as per protocol|0|||
130285675|NCT02754141|469010155|FG005|Overall Study|Completed treatment as per protocol|0|||
130285676|NCT02754141|469010156|FG006|Overall Study|Completed treatment as per protocol|0|||
130285677|NCT02754141|469010157|FG007|Overall Study|Completed treatment as per protocol|0|||
130043189|NCT01607892|468115830|FG001|Overall Study|Intercurrent illness|0|||
130285678|NCT02754141|469010158|FG008|Overall Study|Completed treatment as per protocol|0|||
130285679|NCT02754141|469010159|FG009|Overall Study|Completed treatment as per protocol|0|||
130285680|NCT02754141|469010160|FG010|Overall Study|Completed treatment as per protocol|0|||
130285681|NCT02754141|469010161|FG011|Overall Study|Completed treatment as per protocol|0|||
129887352|NCT01474512|467547285|FG013|Maintenance Period|Physician Decision|0|||
130043190|NCT01607892|468115831|FG002|Overall Study|Intercurrent illness|0|||
130285682|NCT02754141|469010162|FG012|Overall Study|Completed treatment as per protocol|1|||
130285683|NCT02754141|469010163|FG013|Overall Study|Completed treatment as per protocol|0|||
130285684|NCT02754141|469010164|FG014|Overall Study|Completed treatment as per protocol|0|||
130285685|NCT02754141|469010165|FG015|Overall Study|Completed treatment as per protocol|0|||
130285686|NCT02754141|469010166|FG016|Overall Study|Completed treatment as per protocol|0|||
130285687|NCT02754141|469010167|FG017|Overall Study|Completed treatment as per protocol|0|||
130285688|NCT02754141|469010150|FG000|Overall Study|Not completing monotherapy|0|||
130285689|NCT02754141|469010151|FG001|Overall Study|Not completing monotherapy|0|||
130285690|NCT02754141|469010152|FG002|Overall Study|Not completing monotherapy|0|||
130285691|NCT02754141|469010153|FG003|Overall Study|Not completing monotherapy|0|||
130285692|NCT02754141|469010154|FG004|Overall Study|Not completing monotherapy|0|||
130285693|NCT02754141|469010155|FG005|Overall Study|Not completing monotherapy|0|||
130285694|NCT02754141|469010156|FG006|Overall Study|Not completing monotherapy|0|||
130285695|NCT02754141|469010157|FG007|Overall Study|Not completing monotherapy|0|||
130285696|NCT02754141|469010158|FG008|Overall Study|Not completing monotherapy|0|||
130285697|NCT02754141|469010159|FG009|Overall Study|Not completing monotherapy|0|||
130285698|NCT02754141|469010160|FG010|Overall Study|Not completing monotherapy|0|||
130285699|NCT02754141|469010161|FG011|Overall Study|Not completing monotherapy|0|||
130285700|NCT02754141|469010162|FG012|Overall Study|Not completing monotherapy|0|||
130285701|NCT02754141|469010163|FG013|Overall Study|Not completing monotherapy|1|||
130285702|NCT02754141|469010164|FG014|Overall Study|Not completing monotherapy|0|||
130285703|NCT02754141|469010165|FG015|Overall Study|Not completing monotherapy|0|||
130285704|NCT02754141|469010166|FG016|Overall Study|Not completing monotherapy|0|||
130285705|NCT02754141|469010167|FG017|Overall Study|Not completing monotherapy|0|||
130285706|NCT03361189|469010168|FG000|Overall Study|Received heart transplant|1|||
130285707|NCT03361189|469010169|FG001|Overall Study|Received heart transplant|0|||
130285708|NCT03361189|469010168|FG000|Overall Study|Pacemake replacement|0|||
130285709|NCT03361189|469010169|FG001|Overall Study|Pacemake replacement|1|||
130285710|NCT03505788|469010170|FG000|Overall Study|Lost to Follow-up|2|||
130285711|NCT03505788|469010171|FG001|Overall Study|Lost to Follow-up|1|||
130285712|NCT03505788|469010170|FG000|Overall Study|Withdrawal by Subject|1|||
130285713|NCT03505788|469010171|FG001|Overall Study|Withdrawal by Subject|3|||
130285714|NCT03505788|469010170|FG000|Overall Study|Physician Decision|0|||
130285715|NCT03505788|469010171|FG001|Overall Study|Physician Decision|1|||
130285716|NCT03344549|469010172|FG000|Overall Study|Withdrawal by Subject|3|||
130285717|NCT03344549|469010173|FG001|Overall Study|Withdrawal by Subject|2|||
130285718|NCT03344549|469010172|FG000|Overall Study|Dialysis|2|||
130285719|NCT03344549|469010173|FG001|Overall Study|Dialysis|0|||
130285720|NCT03344549|469010172|FG000|Overall Study|Cancer|1|||
130285721|NCT03344549|469010173|FG001|Overall Study|Cancer|0|||
130285722|NCT03344549|469010172|FG000|Overall Study|Lack of electronic device|1|||
130285723|NCT03344549|469010173|FG001|Overall Study|Lack of electronic device|0|||
130285724|NCT03344549|469010172|FG000|Overall Study|Transportation difficulty|0|||
130285725|NCT03344549|469010173|FG001|Overall Study|Transportation difficulty|13|||
130285726|NCT03333252|469010174|FG000|Overall Study|Adverse Event|10|||
130285727|NCT03333252|469010175|FG001|Overall Study|Adverse Event|6|||
130285728|NCT03333252|469010176|FG002|Overall Study|Adverse Event|5|||
130285729|NCT03333252|469010177|FG003|Overall Study|Adverse Event|2|||
130285730|NCT03333252|469010174|FG000|Overall Study|Death|1|||
130285731|NCT03333252|469010175|FG001|Overall Study|Death|3|||
130285732|NCT03333252|469010176|FG002|Overall Study|Death|0|||
130285733|NCT03333252|469010177|FG003|Overall Study|Death|0|||
130285734|NCT03333252|469010174|FG000|Overall Study|Lack of Efficacy|8|||
130285735|NCT03333252|469010175|FG001|Overall Study|Lack of Efficacy|4|||
130285736|NCT03333252|469010176|FG002|Overall Study|Lack of Efficacy|0|||
130285737|NCT03333252|469010177|FG003|Overall Study|Lack of Efficacy|7|||
130285738|NCT03333252|469010174|FG000|Overall Study|Lost to Follow-up|0|||
130285739|NCT03333252|469010175|FG001|Overall Study|Lost to Follow-up|5|||
130285740|NCT03333252|469010176|FG002|Overall Study|Lost to Follow-up|9|||
130285741|NCT03333252|469010177|FG003|Overall Study|Lost to Follow-up|3|||
130285742|NCT03333252|469010174|FG000|Overall Study|Withdrawal by Subject|14|||
130285743|NCT03333252|469010175|FG001|Overall Study|Withdrawal by Subject|24|||
130285744|NCT03333252|469010176|FG002|Overall Study|Withdrawal by Subject|11|||
130285745|NCT03333252|469010177|FG003|Overall Study|Withdrawal by Subject|17|||
130285746|NCT00666588|469010181|FG000|Overall Study|ineligible|2|||
130285747|NCT00666588|469010182|FG001|Overall Study|ineligible|0|||
130285748|NCT00666588|469010183|FG002|Overall Study|ineligible|0|||
130285749|NCT00666588|469010184|FG003|Overall Study|ineligible|2|||
130285750|NCT00666588|469010181|FG000|Overall Study|inevaluable|2|||
130285751|NCT00666588|469010182|FG001|Overall Study|inevaluable|0|||
130285752|NCT00666588|469010183|FG002|Overall Study|inevaluable|0|||
130285753|NCT00666588|469010184|FG003|Overall Study|inevaluable|0|||
130285754|NCT01007123|469010189|FG000|Overall Study|Adverse Event|3|||
130285755|NCT01007123|469010190|FG001|Overall Study|Adverse Event|4|||
130285756|NCT01007123|469010191|FG002|Overall Study|Adverse Event|7|||
130285757|NCT01007123|469010192|FG003|Overall Study|Adverse Event|1|||
130285758|NCT01007123|469010189|FG000|Overall Study|Lack of Efficacy|1|||
130285759|NCT01007123|469010190|FG001|Overall Study|Lack of Efficacy|0|||
130285760|NCT01007123|469010191|FG002|Overall Study|Lack of Efficacy|1|||
130285761|NCT01007123|469010192|FG003|Overall Study|Lack of Efficacy|4|||
130285762|NCT01007123|469010189|FG000|Overall Study|Protocol Violation|1|||
130285763|NCT01007123|469010190|FG001|Overall Study|Protocol Violation|1|||
130043191|NCT01607892|468115832|FG003|Overall Study|Intercurrent illness|3|||
130285764|NCT01007123|469010191|FG002|Overall Study|Protocol Violation|2|||
130285765|NCT01007123|469010192|FG003|Overall Study|Protocol Violation|1|||
130043192|NCT01607892|468115833|FG004|Overall Study|Intercurrent illness|0|||
130043193|NCT01607892|468115829|FG000|Overall Study|Non-Compliance with study procedures|0|||
130285766|NCT01007123|469010189|FG000|Overall Study|Withdrawal by Subject|1|||
130285767|NCT01007123|469010190|FG001|Overall Study|Withdrawal by Subject|0|||
130285768|NCT01007123|469010191|FG002|Overall Study|Withdrawal by Subject|1|||
130285769|NCT01007123|469010192|FG003|Overall Study|Withdrawal by Subject|0|||
130285770|NCT01007123|469010189|FG000|Overall Study|Lost to Follow-up|0|||
130285771|NCT01007123|469010190|FG001|Overall Study|Lost to Follow-up|1|||
130285772|NCT01007123|469010191|FG002|Overall Study|Lost to Follow-up|0|||
130285773|NCT01007123|469010192|FG003|Overall Study|Lost to Follow-up|0|||
130285774|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
130043194|NCT01607892|468115830|FG001|Overall Study|Non-Compliance with study procedures|0|||
130043195|NCT01607892|468115831|FG002|Overall Study|Non-Compliance with study procedures|1|||
130043196|NCT01607892|468115832|FG003|Overall Study|Non-Compliance with study procedures|0|||
130043197|NCT01607892|468115833|FG004|Overall Study|Non-Compliance with study procedures|0|||
130043198|NCT01607892|468115829|FG000|Overall Study|Consent withdrawn by participant|9|||
130043199|NCT01607892|468115830|FG001|Overall Study|Consent withdrawn by participant|4|||
130285775|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
130285776|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
130285777|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
130285778|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
130285779|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
130285780|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
130285781|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
130285782|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
130285783|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
130285784|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Other|1|||
130285785|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Other|1|||
130285786|NCT02075047|469010193|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
130285787|NCT02075047|469010194|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
130285788|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
130285789|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
130285790|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
130285791|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
130285792|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
130285793|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
130285794|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
130285795|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
130285796|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
130285797|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
130285798|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Other|1|||
130285799|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Other|2|||
130285800|NCT02075047|469010193|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
130285801|NCT02075047|469010194|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
130285802|NCT04195438|469010201|FG000|Overall Study|Withdrawal by Subject|1|||
130285803|NCT01774097|469010202|FG000|Overall Study|Withdrawal by Subject|1|||
130285804|NCT01774097|469010203|FG001|Overall Study|Withdrawal by Subject|1|||
130285805|NCT01774097|469010202|FG000|Overall Study|Adverse Event|1|||
130285806|NCT01774097|469010203|FG001|Overall Study|Adverse Event|1|||
130285807|NCT00613925|469010204|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
130285808|NCT00613925|469010205|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
130285809|NCT01920568|469010212|FG000|Overall Study|Adverse Event|27|||
130285810|NCT01920568|469010213|FG001|Overall Study|Adverse Event|8|||
130285811|NCT01920568|469010212|FG000|Overall Study|Protocol Violation|5|||
130285812|NCT01920568|469010213|FG001|Overall Study|Protocol Violation|3|||
130285813|NCT01920568|469010212|FG000|Overall Study|Lost to Follow-up|2|||
130285814|NCT01920568|469010213|FG001|Overall Study|Lost to Follow-up|2|||
130285815|NCT01920568|469010212|FG000|Overall Study|Physician Decision|13|||
130285816|NCT01920568|469010213|FG001|Overall Study|Physician Decision|4|||
130285817|NCT01920568|469010212|FG000|Overall Study|Withdrawal by Subject|79|||
130285818|NCT01920568|469010213|FG001|Overall Study|Withdrawal by Subject|55|||
130285819|NCT01920568|469010212|FG000|Overall Study|Death due to disease progression|25|||
130285820|NCT01920568|469010213|FG001|Overall Study|Death due to disease progression|12|||
130285821|NCT00252694|469010215|FG000|Overall Study|Withdrawal by Subject|83|||
130285822|NCT00252694|469010216|FG001|Overall Study|Withdrawal by Subject|91|||
130285823|NCT00252694|469010215|FG000|Overall Study|Death|36|||
130285824|NCT00252694|469010216|FG001|Overall Study|Death|34|||
130285825|NCT00252694|469010215|FG000|Overall Study|Mostly Lost to Follow Up|8|||
130285826|NCT00252694|469010216|FG001|Overall Study|Mostly Lost to Follow Up|13|||
130285827|NCT00252694|469010215|FG000|Overall Study|Patient Moving|17|||
130285828|NCT00252694|469010216|FG001|Overall Study|Patient Moving|16|||
130285829|NCT00794365|469010217|FG000|Overall Study|Lost to Follow-up|38|||
130285830|NCT00794365|469010217|FG000|Overall Study|Other|17|||
130285831|NCT00794365|469010217|FG000|Overall Study|Poor Compliance|11|||
130285832|NCT00794365|469010217|FG000|Overall Study|Adverse Event|10|||
130285833|NCT00794365|469010217|FG000|Overall Study|Lack of Efficacy|3|||
130285834|NCT04584346|469010218|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
130285835|NCT04584346|469010219|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
130285836|NCT04239222|469010220|FG000|Baseline|Withdrawal by Subject|0|||
130285837|NCT04239222|469010221|FG001|Baseline|Withdrawal by Subject|0|||
130285838|NCT04239222|469010222|FG002|Baseline|Withdrawal by Subject|1|||
130285839|NCT04239222|469010223|FG003|Baseline|Withdrawal by Subject|1|||
130285840|NCT04239222|469010220|FG000|First Foot Assignment|Withdrawal by Subject|0|||
130285841|NCT04239222|469010221|FG001|First Foot Assignment|Withdrawal by Subject|0|||
130285842|NCT04239222|469010222|FG002|First Foot Assignment|Withdrawal by Subject|1|||
130285843|NCT04239222|469010223|FG003|First Foot Assignment|Withdrawal by Subject|0|||
130285844|NCT04239222|469010220|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130285845|NCT04239222|469010221|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130285846|NCT04239222|469010222|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
130285847|NCT04239222|469010223|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
130285848|NCT02701777|469010227|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
130285849|NCT02701777|469010228|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
130285850|NCT02701777|469010229|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
130285851|NCT02701777|469010230|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
130285852|NCT02701777|469010227|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
130285853|NCT02701777|469010228|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
130285854|NCT02701777|469010229|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
129887353|NCT01474512|467547286|FG014|Maintenance Period|Physician Decision|0|||
129887354|NCT01474512|467547287|FG015|Maintenance Period|Physician Decision|0|||
129887355|NCT01474512|467547288|FG016|Maintenance Period|Physician Decision|0|||
129887356|NCT01474512|467547289|FG017|Maintenance Period|Physician Decision|0|||
129887357|NCT01474512|467547272|FG000|Maintenance Period|Clinical Relapse|0|||
129887358|NCT01474512|467547273|FG001|Maintenance Period|Clinical Relapse|0|||
129887359|NCT01474512|467547274|FG002|Maintenance Period|Clinical Relapse|0|||
129887360|NCT01474512|467547275|FG003|Maintenance Period|Clinical Relapse|1|||
129887361|NCT01474512|467547276|FG004|Maintenance Period|Clinical Relapse|0|||
129887362|NCT01474512|467547277|FG005|Maintenance Period|Clinical Relapse|0|||
129887363|NCT01474512|467547278|FG006|Maintenance Period|Clinical Relapse|0|||
129887364|NCT01474512|467547279|FG007|Maintenance Period|Clinical Relapse|0|||
129887365|NCT01474512|467547280|FG008|Maintenance Period|Clinical Relapse|0|||
129887366|NCT01474512|467547281|FG009|Maintenance Period|Clinical Relapse|0|||
129887367|NCT01474512|467547282|FG010|Maintenance Period|Clinical Relapse|0|||
129887368|NCT01474512|467547283|FG011|Maintenance Period|Clinical Relapse|0|||
129887369|NCT01474512|467547284|FG012|Maintenance Period|Clinical Relapse|0|||
129887370|NCT01474512|467547285|FG013|Maintenance Period|Clinical Relapse|0|||
129887371|NCT01474512|467547286|FG014|Maintenance Period|Clinical Relapse|0|||
129887372|NCT01474512|467547287|FG015|Maintenance Period|Clinical Relapse|0|||
129887373|NCT01474512|467547288|FG016|Maintenance Period|Clinical Relapse|0|||
129887374|NCT01474512|467547289|FG017|Maintenance Period|Clinical Relapse|0|||
129887375|NCT01474512|467547272|FG000|Maintenance Period|Lack of Efficacy|0|||
129887376|NCT01474512|467547273|FG001|Maintenance Period|Lack of Efficacy|0|||
129887377|NCT01474512|467547274|FG002|Maintenance Period|Lack of Efficacy|0|||
129887378|NCT01474512|467547275|FG003|Maintenance Period|Lack of Efficacy|1|||
129887379|NCT01474512|467547276|FG004|Maintenance Period|Lack of Efficacy|0|||
129887380|NCT01474512|467547277|FG005|Maintenance Period|Lack of Efficacy|0|||
129887381|NCT01474512|467547278|FG006|Maintenance Period|Lack of Efficacy|0|||
130043200|NCT01607892|468115831|FG002|Overall Study|Consent withdrawn by participant|24|||
130043201|NCT01607892|468115832|FG003|Overall Study|Consent withdrawn by participant|14|||
130285855|NCT02701777|469010230|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
130285856|NCT00075725|469010231|FG000|Overall Study|Adverse Event|6|||
130285857|NCT00075725|469010232|FG001|Overall Study|Adverse Event|6|||
129887382|NCT01474512|467547279|FG007|Maintenance Period|Lack of Efficacy|11|||
129887383|NCT01474512|467547280|FG008|Maintenance Period|Lack of Efficacy|11|||
129887384|NCT01474512|467547281|FG009|Maintenance Period|Lack of Efficacy|12|||
129887385|NCT01474512|467547282|FG010|Maintenance Period|Lack of Efficacy|0|||
129887386|NCT01474512|467547283|FG011|Maintenance Period|Lack of Efficacy|0|||
129887387|NCT01474512|467547284|FG012|Maintenance Period|Lack of Efficacy|0|||
130285858|NCT00075725|469010233|FG002|Overall Study|Adverse Event|20|||
129887388|NCT01474512|467547285|FG013|Maintenance Period|Lack of Efficacy|0|||
129887389|NCT01474512|467547286|FG014|Maintenance Period|Lack of Efficacy|0|||
130043202|NCT01607892|468115833|FG004|Overall Study|Consent withdrawn by participant|4|||
130043203|NCT01607892|468115829|FG000|Overall Study|Disease progression|38|||
130043204|NCT01607892|468115830|FG001|Overall Study|Disease progression|13|||
130043205|NCT01607892|468115831|FG002|Overall Study|Disease progression|37|||
130043206|NCT01607892|468115832|FG003|Overall Study|Disease progression|57|||
130043207|NCT01607892|468115833|FG004|Overall Study|Disease progression|9|||
130043208|NCT01607892|468115829|FG000|Overall Study|Incidence or severity of Adverse events|3|||
130043209|NCT01607892|468115830|FG001|Overall Study|Incidence or severity of Adverse events|3|||
130043210|NCT01607892|468115831|FG002|Overall Study|Incidence or severity of Adverse events|7|||
130043211|NCT01607892|468115832|FG003|Overall Study|Incidence or severity of Adverse events|2|||
130285859|NCT00075725|469010234|FG003|Overall Study|Adverse Event|8|||
130285860|NCT00075725|469010235|FG004|Overall Study|Adverse Event|4|||
130285861|NCT00075725|469010236|FG005|Overall Study|Adverse Event|38|||
130285862|NCT00075725|469010237|FG006|Overall Study|Adverse Event|3|||
130285863|NCT00075725|469010238|FG007|Overall Study|Adverse Event|51|||
130285864|NCT00075725|469010239|FG008|Overall Study|Adverse Event|15|||
130285865|NCT00075725|469010240|FG009|Overall Study|Adverse Event|4|||
130285866|NCT00075725|469010241|FG010|Overall Study|Adverse Event|2|||
130285867|NCT00075725|469010242|FG011|Overall Study|Adverse Event|2|||
130285868|NCT00075725|469010231|FG000|Overall Study|Death|3|||
130285869|NCT00075725|469010232|FG001|Overall Study|Death|5|||
130285870|NCT00075725|469010233|FG002|Overall Study|Death|10|||
130285871|NCT00075725|469010234|FG003|Overall Study|Death|2|||
130285872|NCT00075725|469010235|FG004|Overall Study|Death|3|||
130285873|NCT00075725|469010236|FG005|Overall Study|Death|25|||
130285874|NCT00075725|469010237|FG006|Overall Study|Death|4|||
130285875|NCT00075725|469010238|FG007|Overall Study|Death|22|||
130285876|NCT00075725|469010239|FG008|Overall Study|Death|14|||
130285877|NCT00075725|469010240|FG009|Overall Study|Death|4|||
130285878|NCT00075725|469010241|FG010|Overall Study|Death|3|||
130285879|NCT00075725|469010242|FG011|Overall Study|Death|0|||
130285880|NCT00075725|469010231|FG000|Overall Study|Lost to Follow-up|1|||
130285881|NCT00075725|469010232|FG001|Overall Study|Lost to Follow-up|1|||
130285882|NCT00075725|469010233|FG002|Overall Study|Lost to Follow-up|4|||
130285883|NCT00075725|469010234|FG003|Overall Study|Lost to Follow-up|1|||
130285884|NCT00075725|469010235|FG004|Overall Study|Lost to Follow-up|0|||
130285885|NCT00075725|469010236|FG005|Overall Study|Lost to Follow-up|13|||
130285886|NCT00075725|469010237|FG006|Overall Study|Lost to Follow-up|2|||
130285887|NCT00075725|469010238|FG007|Overall Study|Lost to Follow-up|4|||
130285888|NCT00075725|469010239|FG008|Overall Study|Lost to Follow-up|1|||
130285889|NCT00075725|469010240|FG009|Overall Study|Lost to Follow-up|0|||
130285890|NCT00075725|469010241|FG010|Overall Study|Lost to Follow-up|0|||
130285891|NCT00075725|469010242|FG011|Overall Study|Lost to Follow-up|0|||
130285892|NCT00075725|469010231|FG000|Overall Study|Physician Decision|2|||
130285893|NCT00075725|469010232|FG001|Overall Study|Physician Decision|6|||
130285894|NCT00075725|469010233|FG002|Overall Study|Physician Decision|5|||
130285895|NCT00075725|469010234|FG003|Overall Study|Physician Decision|8|||
130285896|NCT00075725|469010235|FG004|Overall Study|Physician Decision|4|||
130285897|NCT00075725|469010236|FG005|Overall Study|Physician Decision|19|||
130285898|NCT00075725|469010237|FG006|Overall Study|Physician Decision|3|||
130285899|NCT00075725|469010238|FG007|Overall Study|Physician Decision|17|||
130285900|NCT00075725|469010239|FG008|Overall Study|Physician Decision|5|||
130285901|NCT00075725|469010240|FG009|Overall Study|Physician Decision|0|||
130285902|NCT00075725|469010241|FG010|Overall Study|Physician Decision|1|||
130285903|NCT00075725|469010242|FG011|Overall Study|Physician Decision|0|||
130285904|NCT00075725|469010231|FG000|Overall Study|Pregnancy|0|||
130285905|NCT00075725|469010232|FG001|Overall Study|Pregnancy|0|||
130285906|NCT00075725|469010233|FG002|Overall Study|Pregnancy|0|||
130285907|NCT00075725|469010234|FG003|Overall Study|Pregnancy|0|||
130285908|NCT00075725|469010235|FG004|Overall Study|Pregnancy|0|||
130285909|NCT00075725|469010236|FG005|Overall Study|Pregnancy|1|||
130285910|NCT00075725|469010237|FG006|Overall Study|Pregnancy|0|||
130285911|NCT00075725|469010238|FG007|Overall Study|Pregnancy|1|||
130285912|NCT00075725|469010239|FG008|Overall Study|Pregnancy|0|||
130285913|NCT00075725|469010240|FG009|Overall Study|Pregnancy|0|||
130285914|NCT00075725|469010241|FG010|Overall Study|Pregnancy|0|||
130285915|NCT00075725|469010242|FG011|Overall Study|Pregnancy|0|||
130285916|NCT00075725|469010231|FG000|Overall Study|Protocol Violation|1|||
130285917|NCT00075725|469010232|FG001|Overall Study|Protocol Violation|1|||
130285918|NCT00075725|469010233|FG002|Overall Study|Protocol Violation|0|||
130285919|NCT00075725|469010234|FG003|Overall Study|Protocol Violation|3|||
130043212|NCT01607892|468115833|FG004|Overall Study|Incidence or severity of Adverse events|6|||
130043213|NCT03022422|468115835|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
130285920|NCT00075725|469010235|FG004|Overall Study|Protocol Violation|3|||
130285921|NCT00075725|469010236|FG005|Overall Study|Protocol Violation|2|||
130285922|NCT00075725|469010237|FG006|Overall Study|Protocol Violation|1|||
130285923|NCT00075725|469010238|FG007|Overall Study|Protocol Violation|2|||
130285924|NCT00075725|469010239|FG008|Overall Study|Protocol Violation|3|||
130285925|NCT00075725|469010240|FG009|Overall Study|Protocol Violation|0|||
130285926|NCT00075725|469010241|FG010|Overall Study|Protocol Violation|0|||
130285927|NCT00075725|469010242|FG011|Overall Study|Protocol Violation|1|||
130316229|NCT04319198|469124334|FG002|Overall Study|Death|3|||
130285928|NCT00075725|469010231|FG000|Overall Study|Withdrawal by Subject|12|||
130285929|NCT00075725|469010232|FG001|Overall Study|Withdrawal by Subject|3|||
130285930|NCT00075725|469010233|FG002|Overall Study|Withdrawal by Subject|6|||
130285931|NCT00075725|469010234|FG003|Overall Study|Withdrawal by Subject|10|||
130285932|NCT00075725|469010235|FG004|Overall Study|Withdrawal by Subject|6|||
130285933|NCT00075725|469010236|FG005|Overall Study|Withdrawal by Subject|27|||
130285934|NCT00075725|469010237|FG006|Overall Study|Withdrawal by Subject|7|||
130285935|NCT00075725|469010238|FG007|Overall Study|Withdrawal by Subject|31|||
130285936|NCT00075725|469010239|FG008|Overall Study|Withdrawal by Subject|10|||
130285937|NCT00075725|469010240|FG009|Overall Study|Withdrawal by Subject|2|||
130285938|NCT00075725|469010241|FG010|Overall Study|Withdrawal by Subject|0|||
130285939|NCT00075725|469010242|FG011|Overall Study|Withdrawal by Subject|0|||
130285940|NCT00075725|469010231|FG000|Overall Study|Disease Progression, all other reasons|17|||
130285941|NCT00075725|469010232|FG001|Overall Study|Disease Progression, all other reasons|5|||
130285942|NCT00075725|469010233|FG002|Overall Study|Disease Progression, all other reasons|33|||
130285943|NCT00075725|469010234|FG003|Overall Study|Disease Progression, all other reasons|6|||
130285944|NCT00075725|469010235|FG004|Overall Study|Disease Progression, all other reasons|21|||
130285945|NCT00075725|469010236|FG005|Overall Study|Disease Progression, all other reasons|59|||
130285946|NCT00075725|469010237|FG006|Overall Study|Disease Progression, all other reasons|20|||
130285947|NCT00075725|469010238|FG007|Overall Study|Disease Progression, all other reasons|46|||
130285948|NCT00075725|469010239|FG008|Overall Study|Disease Progression, all other reasons|21|||
130285949|NCT00075725|469010240|FG009|Overall Study|Disease Progression, all other reasons|4|||
130285950|NCT00075725|469010241|FG010|Overall Study|Disease Progression, all other reasons|0|||
130285951|NCT00075725|469010242|FG011|Overall Study|Disease Progression, all other reasons|5|||
130285952|NCT00075725|469010231|FG000|Overall Study|Patient off treatment|0|||
130285953|NCT00075725|469010232|FG001|Overall Study|Patient off treatment|0|||
130285954|NCT00075725|469010233|FG002|Overall Study|Patient off treatment|1|||
130285955|NCT00075725|469010234|FG003|Overall Study|Patient off treatment|2|||
130285956|NCT00075725|469010235|FG004|Overall Study|Patient off treatment|1|||
130285957|NCT00075725|469010236|FG005|Overall Study|Patient off treatment|0|||
130285958|NCT00075725|469010237|FG006|Overall Study|Patient off treatment|0|||
130285959|NCT00075725|469010238|FG007|Overall Study|Patient off treatment|2|||
130285960|NCT00075725|469010239|FG008|Overall Study|Patient off treatment|1|||
130285961|NCT00075725|469010240|FG009|Overall Study|Patient off treatment|0|||
130285962|NCT00075725|469010241|FG010|Overall Study|Patient off treatment|0|||
130285963|NCT00075725|469010242|FG011|Overall Study|Patient off treatment|0|||
130285964|NCT00075725|469010231|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
130285965|NCT00075725|469010232|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
130285966|NCT00075725|469010233|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
130285967|NCT00075725|469010234|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
130285968|NCT00075725|469010235|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
130285969|NCT00075725|469010236|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
130285970|NCT00075725|469010237|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
130285971|NCT00075725|469010238|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
129887390|NCT01474512|467547287|FG015|Maintenance Period|Lack of Efficacy|0|||
129887391|NCT01474512|467547288|FG016|Maintenance Period|Lack of Efficacy|0|||
129887392|NCT01474512|467547289|FG017|Maintenance Period|Lack of Efficacy|0|||
130285972|NCT00075725|469010239|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
130285973|NCT00075725|469010240|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
130285974|NCT00075725|469010241|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
130285975|NCT00075725|469010242|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
130285976|NCT00075725|469010231|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
130285977|NCT00075725|469010232|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
130285978|NCT00075725|469010233|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
130285979|NCT00075725|469010234|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
130043214|NCT03022422|468115836|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
130285980|NCT00075725|469010235|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
130285981|NCT00075725|469010236|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
130285982|NCT00075725|469010237|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
130285983|NCT00075725|469010238|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
130285984|NCT00075725|469010239|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
130285985|NCT00075725|469010240|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
130285986|NCT00075725|469010241|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
130285987|NCT00075725|469010242|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
130285988|NCT00075725|469010231|FG000|Overall Study|Pt non compliant with therapy|2|||
130285989|NCT00075725|469010232|FG001|Overall Study|Pt non compliant with therapy|1|||
130285990|NCT00075725|469010233|FG002|Overall Study|Pt non compliant with therapy|1|||
130285991|NCT00075725|469010234|FG003|Overall Study|Pt non compliant with therapy|0|||
130285992|NCT00075725|469010235|FG004|Overall Study|Pt non compliant with therapy|2|||
130285993|NCT00075725|469010236|FG005|Overall Study|Pt non compliant with therapy|14|||
130285994|NCT00075725|469010237|FG006|Overall Study|Pt non compliant with therapy|2|||
130285995|NCT00075725|469010238|FG007|Overall Study|Pt non compliant with therapy|5|||
130285996|NCT00075725|469010239|FG008|Overall Study|Pt non compliant with therapy|3|||
130285997|NCT00075725|469010240|FG009|Overall Study|Pt non compliant with therapy|0|||
130285998|NCT00075725|469010241|FG010|Overall Study|Pt non compliant with therapy|0|||
130285999|NCT00075725|469010242|FG011|Overall Study|Pt non compliant with therapy|0|||
130286000|NCT00075725|469010231|FG000|Overall Study|Pt age out of range for treatment|0|||
130286001|NCT00075725|469010232|FG001|Overall Study|Pt age out of range for treatment|1|||
130286002|NCT00075725|469010233|FG002|Overall Study|Pt age out of range for treatment|0|||
130286003|NCT00075725|469010234|FG003|Overall Study|Pt age out of range for treatment|0|||
130286004|NCT00075725|469010235|FG004|Overall Study|Pt age out of range for treatment|0|||
130286005|NCT00075725|469010236|FG005|Overall Study|Pt age out of range for treatment|1|||
130286006|NCT00075725|469010237|FG006|Overall Study|Pt age out of range for treatment|0|||
130286007|NCT00075725|469010238|FG007|Overall Study|Pt age out of range for treatment|1|||
130286008|NCT00075725|469010239|FG008|Overall Study|Pt age out of range for treatment|0|||
130286009|NCT00075725|469010240|FG009|Overall Study|Pt age out of range for treatment|0|||
130286010|NCT00075725|469010241|FG010|Overall Study|Pt age out of range for treatment|0|||
130286011|NCT00075725|469010242|FG011|Overall Study|Pt age out of range for treatment|0|||
130286012|NCT00075725|469010231|FG000|Overall Study|Insurance issues|0|||
130286013|NCT00075725|469010232|FG001|Overall Study|Insurance issues|1|||
130286014|NCT00075725|469010233|FG002|Overall Study|Insurance issues|0|||
130286015|NCT00075725|469010234|FG003|Overall Study|Insurance issues|1|||
130286016|NCT00075725|469010235|FG004|Overall Study|Insurance issues|1|||
130286017|NCT00075725|469010236|FG005|Overall Study|Insurance issues|1|||
130286018|NCT00075725|469010237|FG006|Overall Study|Insurance issues|0|||
130286019|NCT00075725|469010238|FG007|Overall Study|Insurance issues|1|||
130286020|NCT00075725|469010239|FG008|Overall Study|Insurance issues|0|||
130286021|NCT00075725|469010240|FG009|Overall Study|Insurance issues|0|||
130286022|NCT00075725|469010241|FG010|Overall Study|Insurance issues|0|||
130286023|NCT00075725|469010242|FG011|Overall Study|Insurance issues|0|||
130286024|NCT00075725|469010231|FG000|Overall Study|MRD positive after extended ind|0|||
130286025|NCT00075725|469010232|FG001|Overall Study|MRD positive after extended ind|1|||
130286026|NCT00075725|469010233|FG002|Overall Study|MRD positive after extended ind|1|||
130286027|NCT00075725|469010234|FG003|Overall Study|MRD positive after extended ind|0|||
130286028|NCT00075725|469010235|FG004|Overall Study|MRD positive after extended ind|1|||
130286029|NCT00075725|469010236|FG005|Overall Study|MRD positive after extended ind|2|||
130043215|NCT03022422|468115837|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
130043216|NCT03022422|468115838|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
130286030|NCT00075725|469010237|FG006|Overall Study|MRD positive after extended ind|0|||
130286031|NCT00075725|469010238|FG007|Overall Study|MRD positive after extended ind|1|||
130286032|NCT00075725|469010239|FG008|Overall Study|MRD positive after extended ind|0|||
130286033|NCT00075725|469010240|FG009|Overall Study|MRD positive after extended ind|0|||
130286034|NCT00075725|469010241|FG010|Overall Study|MRD positive after extended ind|0|||
130043217|NCT03022422|468115839|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
130286035|NCT00075725|469010242|FG011|Overall Study|MRD positive after extended ind|0|||
130043218|NCT03022422|468115840|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
130043219|NCT01444391|468115841|FG000|Overall Study|Death|1|||
130043220|NCT02704429|468115842|FG000|Part A: 24 Weeks|Adverse Event|3|||
130043221|NCT02704429|468115843|FG001|Part A: 24 Weeks|Adverse Event|0|||
130043222|NCT02704429|468115842|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
130043223|NCT02704429|468115843|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
130043224|NCT02209597|468115846|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
130043225|NCT02209597|468115846|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
130286036|NCT00075725|469010231|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
130286037|NCT00075725|469010232|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
130286038|NCT00075725|469010233|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
130286039|NCT00075725|469010234|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
130286040|NCT00075725|469010235|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
130286041|NCT00075725|469010236|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
130286042|NCT00075725|469010237|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
130286043|NCT00075725|469010238|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
130286044|NCT00075725|469010239|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
130286045|NCT00075725|469010240|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
130286046|NCT00075725|469010241|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
130286047|NCT00075725|469010242|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
130286048|NCT00075725|469010231|FG000|Overall Study|Inevaluable|1|||
130286049|NCT00075725|469010232|FG001|Overall Study|Inevaluable|1|||
130286050|NCT00075725|469010233|FG002|Overall Study|Inevaluable|4|||
130286051|NCT00075725|469010234|FG003|Overall Study|Inevaluable|2|||
130286052|NCT00075725|469010235|FG004|Overall Study|Inevaluable|2|||
130286053|NCT00075725|469010236|FG005|Overall Study|Inevaluable|9|||
130286054|NCT00075725|469010237|FG006|Overall Study|Inevaluable|1|||
130286055|NCT00075725|469010238|FG007|Overall Study|Inevaluable|11|||
130286056|NCT00075725|469010239|FG008|Overall Study|Inevaluable|2|||
130286057|NCT00075725|469010240|FG009|Overall Study|Inevaluable|0|||
130286058|NCT00075725|469010241|FG010|Overall Study|Inevaluable|1|||
130286059|NCT00075725|469010242|FG011|Overall Study|Inevaluable|0|||
130286060|NCT00075725|469010231|FG000|Overall Study|Other|4|||
130286061|NCT00075725|469010232|FG001|Overall Study|Other|2|||
130286062|NCT00075725|469010233|FG002|Overall Study|Other|1|||
130286063|NCT00075725|469010234|FG003|Overall Study|Other|1|||
130286064|NCT00075725|469010235|FG004|Overall Study|Other|1|||
130286065|NCT00075725|469010236|FG005|Overall Study|Other|4|||
130286066|NCT00075725|469010237|FG006|Overall Study|Other|2|||
130286067|NCT00075725|469010238|FG007|Overall Study|Other|9|||
130286068|NCT00075725|469010239|FG008|Overall Study|Other|2|||
130286069|NCT00075725|469010240|FG009|Overall Study|Other|1|||
130286070|NCT00075725|469010241|FG010|Overall Study|Other|0|||
130286071|NCT00075725|469010242|FG011|Overall Study|Other|3|||
130043226|NCT02209597|468115846|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
130286072|NCT00075725|469010231|FG000|Overall Study|Pt trying to find a BM donor|0|||
130286073|NCT00075725|469010232|FG001|Overall Study|Pt trying to find a BM donor|1|||
130286074|NCT00075725|469010233|FG002|Overall Study|Pt trying to find a BM donor|0|||
130286075|NCT00075725|469010234|FG003|Overall Study|Pt trying to find a BM donor|0|||
130286076|NCT00075725|469010235|FG004|Overall Study|Pt trying to find a BM donor|0|||
130286077|NCT00075725|469010236|FG005|Overall Study|Pt trying to find a BM donor|0|||
130043227|NCT02209597|468115846|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
130043228|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Adverse Event|37|||
130043229|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Adverse Event|0|||
130043230|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Adverse Event|0|||
130043231|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Adverse Event|0|||
130043232|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Death|2|||
130043233|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Death|0|||
130043234|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Death|0|||
130043235|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Death|0|||
130043236|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
130043237|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
130043238|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
130043239|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
130043240|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
130043241|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
130043242|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
130043243|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
130043244|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
130043245|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
130043246|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
130043247|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
130043248|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
130043249|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
130043250|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
130043251|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
130043252|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Physician Decision|4|||
130043253|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Physician Decision|0|||
130043254|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Physician Decision|0|||
130043255|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Physician Decision|0|||
130043256|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Pregnancy|1|||
130043257|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Pregnancy|0|||
130043258|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Pregnancy|0|||
130043259|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Pregnancy|0|||
130043260|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
130043261|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
130043262|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
130043263|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
130043264|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
130043265|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
130043266|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
130043267|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
130043268|NCT01855789|468115848|FG000|1) Baseline up to Week 24|Other|4|||
130043269|NCT01855789|468115849|FG001|1) Baseline up to Week 24|Other|0|||
130043270|NCT01855789|468115850|FG002|1) Baseline up to Week 24|Other|0|||
130043271|NCT01855789|468115851|FG003|1) Baseline up to Week 24|Other|0|||
130043272|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
130043273|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
130043274|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
130043275|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
130286078|NCT00075725|469010237|FG006|Overall Study|Pt trying to find a BM donor|0|||
130286079|NCT00075725|469010238|FG007|Overall Study|Pt trying to find a BM donor|0|||
130286080|NCT00075725|469010239|FG008|Overall Study|Pt trying to find a BM donor|0|||
130286081|NCT00075725|469010240|FG009|Overall Study|Pt trying to find a BM donor|0|||
130286082|NCT00075725|469010241|FG010|Overall Study|Pt trying to find a BM donor|0|||
130286083|NCT00075725|469010242|FG011|Overall Study|Pt trying to find a BM donor|0|||
130286084|NCT00075725|469010231|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
130286085|NCT00075725|469010232|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
130286086|NCT00075725|469010233|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
130286087|NCT00075725|469010234|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
130286088|NCT00075725|469010235|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
130286089|NCT00075725|469010236|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
130043276|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
130043277|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
130043278|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
130043279|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
130043280|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
130043281|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
130043282|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
130043283|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
130043284|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
130043285|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
130286090|NCT00075725|469010237|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
130043286|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
130043287|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
130043288|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
130043289|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
130043290|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
130043291|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
130043292|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
130043293|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
130043294|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
130043295|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
130043296|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
130043297|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
130043298|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
130043299|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
130043300|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
130043301|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
130043302|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
130043303|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
130043304|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
130043305|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
130043306|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
130043307|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
130286091|NCT00075725|469010238|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
130286092|NCT00075725|469010239|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
130286093|NCT00075725|469010240|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
130286094|NCT00075725|469010241|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
130286095|NCT00075725|469010242|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
130286096|NCT00075725|469010231|FG000|Overall Study|Unsuccessful institutional transfer|0|||
130286097|NCT00075725|469010232|FG001|Overall Study|Unsuccessful institutional transfer|0|||
130286098|NCT00075725|469010233|FG002|Overall Study|Unsuccessful institutional transfer|2|||
130286099|NCT00075725|469010234|FG003|Overall Study|Unsuccessful institutional transfer|0|||
130286100|NCT00075725|469010235|FG004|Overall Study|Unsuccessful institutional transfer|0|||
130286101|NCT00075725|469010236|FG005|Overall Study|Unsuccessful institutional transfer|0|||
130286102|NCT00075725|469010237|FG006|Overall Study|Unsuccessful institutional transfer|0|||
130286103|NCT00075725|469010238|FG007|Overall Study|Unsuccessful institutional transfer|0|||
130286104|NCT00075725|469010239|FG008|Overall Study|Unsuccessful institutional transfer|0|||
130286105|NCT00075725|469010240|FG009|Overall Study|Unsuccessful institutional transfer|1|||
130286106|NCT00075725|469010241|FG010|Overall Study|Unsuccessful institutional transfer|0|||
130286107|NCT00075725|469010242|FG011|Overall Study|Unsuccessful institutional transfer|0|||
130286108|NCT00075725|469010231|FG000|Overall Study|specimen(s) not submitted|0|||
130286109|NCT00075725|469010232|FG001|Overall Study|specimen(s) not submitted|0|||
130286110|NCT00075725|469010233|FG002|Overall Study|specimen(s) not submitted|2|||
130286111|NCT00075725|469010234|FG003|Overall Study|specimen(s) not submitted|0|||
130286112|NCT00075725|469010235|FG004|Overall Study|specimen(s) not submitted|0|||
130286113|NCT00075725|469010236|FG005|Overall Study|specimen(s) not submitted|0|||
130286114|NCT00075725|469010237|FG006|Overall Study|specimen(s) not submitted|0|||
130286115|NCT00075725|469010238|FG007|Overall Study|specimen(s) not submitted|0|||
130286116|NCT00075725|469010239|FG008|Overall Study|specimen(s) not submitted|0|||
130286117|NCT00075725|469010240|FG009|Overall Study|specimen(s) not submitted|0|||
130286118|NCT00075725|469010241|FG010|Overall Study|specimen(s) not submitted|0|||
130286119|NCT00075725|469010242|FG011|Overall Study|specimen(s) not submitted|0|||
130286120|NCT00075725|469010231|FG000|Overall Study|Pt went to transplant|0|||
130286121|NCT00075725|469010232|FG001|Overall Study|Pt went to transplant|0|||
130286122|NCT00075725|469010233|FG002|Overall Study|Pt went to transplant|0|||
130286123|NCT00075725|469010234|FG003|Overall Study|Pt went to transplant|1|||
130286124|NCT00075725|469010235|FG004|Overall Study|Pt went to transplant|0|||
130286125|NCT00075725|469010236|FG005|Overall Study|Pt went to transplant|1|||
130286126|NCT00075725|469010237|FG006|Overall Study|Pt went to transplant|0|||
130043308|NCT01855789|468115848|FG000|2) Week 24 up to End of Study|Other|0|||
130286127|NCT00075725|469010238|FG007|Overall Study|Pt went to transplant|0|||
130286128|NCT00075725|469010239|FG008|Overall Study|Pt went to transplant|0|||
130286129|NCT00075725|469010240|FG009|Overall Study|Pt went to transplant|0|||
130286130|NCT00075725|469010241|FG010|Overall Study|Pt went to transplant|0|||
130286131|NCT00075725|469010242|FG011|Overall Study|Pt went to transplant|0|||
130286132|NCT00075725|469010231|FG000|Overall Study|Pt received additional steroids|0|||
130286133|NCT00075725|469010232|FG001|Overall Study|Pt received additional steroids|0|||
130286134|NCT00075725|469010233|FG002|Overall Study|Pt received additional steroids|0|||
130286135|NCT00075725|469010234|FG003|Overall Study|Pt received additional steroids|1|||
130286136|NCT00075725|469010235|FG004|Overall Study|Pt received additional steroids|0|||
130286137|NCT00075725|469010236|FG005|Overall Study|Pt received additional steroids|0|||
130286138|NCT00075725|469010237|FG006|Overall Study|Pt received additional steroids|0|||
130286139|NCT00075725|469010238|FG007|Overall Study|Pt received additional steroids|0|||
130286140|NCT00075725|469010239|FG008|Overall Study|Pt received additional steroids|0|||
130286141|NCT00075725|469010240|FG009|Overall Study|Pt received additional steroids|0|||
130286142|NCT00075725|469010241|FG010|Overall Study|Pt received additional steroids|0|||
130286143|NCT00075725|469010242|FG011|Overall Study|Pt received additional steroids|0|||
130286144|NCT00075725|469010231|FG000|Overall Study|Pt relocated|0|||
130286145|NCT00075725|469010232|FG001|Overall Study|Pt relocated|0|||
130286146|NCT00075725|469010233|FG002|Overall Study|Pt relocated|0|||
130286147|NCT00075725|469010234|FG003|Overall Study|Pt relocated|2|||
130286148|NCT00075725|469010235|FG004|Overall Study|Pt relocated|0|||
130286149|NCT00075725|469010236|FG005|Overall Study|Pt relocated|1|||
130286150|NCT00075725|469010237|FG006|Overall Study|Pt relocated|1|||
130286151|NCT00075725|469010238|FG007|Overall Study|Pt relocated|2|||
130286152|NCT00075725|469010239|FG008|Overall Study|Pt relocated|1|||
130286153|NCT00075725|469010240|FG009|Overall Study|Pt relocated|0|||
130286154|NCT00075725|469010241|FG010|Overall Study|Pt relocated|0|||
130286155|NCT00075725|469010242|FG011|Overall Study|Pt relocated|0|||
130286156|NCT00075725|469010231|FG000|Overall Study|Institution Terminated|0|||
130286157|NCT00075725|469010232|FG001|Overall Study|Institution Terminated|0|||
130286158|NCT00075725|469010233|FG002|Overall Study|Institution Terminated|0|||
130286159|NCT00075725|469010234|FG003|Overall Study|Institution Terminated|0|||
130286160|NCT00075725|469010235|FG004|Overall Study|Institution Terminated|1|||
130286161|NCT00075725|469010236|FG005|Overall Study|Institution Terminated|0|||
130286162|NCT00075725|469010237|FG006|Overall Study|Institution Terminated|0|||
130286163|NCT00075725|469010238|FG007|Overall Study|Institution Terminated|3|||
130286164|NCT00075725|469010239|FG008|Overall Study|Institution Terminated|0|||
130286165|NCT00075725|469010240|FG009|Overall Study|Institution Terminated|0|||
130286166|NCT00075725|469010241|FG010|Overall Study|Institution Terminated|0|||
130286167|NCT00075725|469010242|FG011|Overall Study|Institution Terminated|0|||
130286168|NCT00075725|469010231|FG000|Overall Study|Study Closure|1|||
130286169|NCT00075725|469010232|FG001|Overall Study|Study Closure|0|||
130286170|NCT00075725|469010233|FG002|Overall Study|Study Closure|0|||
130286171|NCT00075725|469010234|FG003|Overall Study|Study Closure|0|||
130286172|NCT00075725|469010235|FG004|Overall Study|Study Closure|1|||
130286173|NCT00075725|469010236|FG005|Overall Study|Study Closure|3|||
130286174|NCT00075725|469010237|FG006|Overall Study|Study Closure|0|||
130286175|NCT00075725|469010238|FG007|Overall Study|Study Closure|1|||
130286176|NCT00075725|469010239|FG008|Overall Study|Study Closure|0|||
130286177|NCT00075725|469010240|FG009|Overall Study|Study Closure|0|||
130286178|NCT00075725|469010241|FG010|Overall Study|Study Closure|0|||
130286179|NCT00075725|469010242|FG011|Overall Study|Study Closure|0|||
130286180|NCT00075725|469010231|FG000|Overall Study|Other complications|0|||
130286181|NCT00075725|469010232|FG001|Overall Study|Other complications|0|||
130286182|NCT00075725|469010233|FG002|Overall Study|Other complications|0|||
130286183|NCT00075725|469010234|FG003|Overall Study|Other complications|0|||
130286184|NCT00075725|469010235|FG004|Overall Study|Other complications|0|||
130286185|NCT00075725|469010236|FG005|Overall Study|Other complications|1|||
130286186|NCT00075725|469010237|FG006|Overall Study|Other complications|0|||
130286187|NCT00075725|469010238|FG007|Overall Study|Other complications|0|||
130286188|NCT00075725|469010239|FG008|Overall Study|Other complications|0|||
130286189|NCT00075725|469010240|FG009|Overall Study|Other complications|0|||
130286190|NCT00075725|469010241|FG010|Overall Study|Other complications|0|||
130286191|NCT00075725|469010242|FG011|Overall Study|Other complications|0|||
130286192|NCT00075725|469010231|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
130286193|NCT00075725|469010232|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
130286194|NCT00075725|469010233|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
130286195|NCT00075725|469010234|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
130286196|NCT00075725|469010235|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
130286197|NCT00075725|469010236|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
130286198|NCT00075725|469010237|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
130286199|NCT00075725|469010238|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
130286200|NCT00075725|469010239|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
130286201|NCT00075725|469010240|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
130286202|NCT00075725|469010241|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
130286203|NCT00075725|469010242|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
130286204|NCT00075725|469010231|FG000|Overall Study|Pt incarcerated|0|||
130286205|NCT00075725|469010232|FG001|Overall Study|Pt incarcerated|0|||
130286206|NCT00075725|469010233|FG002|Overall Study|Pt incarcerated|0|||
130286207|NCT00075725|469010234|FG003|Overall Study|Pt incarcerated|0|||
130286208|NCT00075725|469010235|FG004|Overall Study|Pt incarcerated|0|||
130286209|NCT00075725|469010236|FG005|Overall Study|Pt incarcerated|0|||
130286210|NCT00075725|469010237|FG006|Overall Study|Pt incarcerated|0|||
130286211|NCT00075725|469010238|FG007|Overall Study|Pt incarcerated|1|||
130286212|NCT00075725|469010239|FG008|Overall Study|Pt incarcerated|0|||
130286213|NCT00075725|469010240|FG009|Overall Study|Pt incarcerated|0|||
130286214|NCT00075725|469010241|FG010|Overall Study|Pt incarcerated|0|||
130286215|NCT00075725|469010242|FG011|Overall Study|Pt incarcerated|0|||
130286216|NCT02240368|469010243|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
130286217|NCT02240368|469010244|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
130286218|NCT02240368|469010245|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
130286219|NCT02240368|469010243|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
130286220|NCT02240368|469010244|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
130286221|NCT02240368|469010245|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
130286222|NCT02752958|469010251|FG000|Overall Study|Adverse Event|3|||
130286223|NCT02752958|469010251|FG000|Overall Study|Lost to Follow-up|1|||
130286224|NCT02752958|469010251|FG000|Overall Study|Protocol Violation|1|||
130286225|NCT02752958|469010251|FG000|Overall Study|Withdrawal by Subject|2|||
130286226|NCT02752958|469010251|FG000|Overall Study|Other (Reason not specified)|2|||
130286227|NCT03746600|469010252|FG000|Overall Study|Withdrawal by Subject|3|||
130286228|NCT03746600|469010253|FG001|Overall Study|Withdrawal by Subject|3|||
130286229|NCT03746600|469010252|FG000|Overall Study|dismissed from study|1|||
130286230|NCT03746600|469010253|FG001|Overall Study|dismissed from study|0|||
130286231|NCT03746600|469010252|FG000|Overall Study|Lost to Follow-up|1|||
130286232|NCT03746600|469010253|FG001|Overall Study|Lost to Follow-up|0|||
130286233|NCT00717522|469010254|FG000|Overall Study|Disease Progression|5|||
130286234|NCT00717522|469010254|FG000|Overall Study|Adverse Event|1|||
130286235|NCT00717522|469010254|FG000|Overall Study|Death|1|||
130286236|NCT02182440|469010255|FG000|Overall Study|Adverse Event|0|||
130286237|NCT02182440|469010256|FG001|Overall Study|Adverse Event|1|||
130286238|NCT02182440|469010257|FG002|Overall Study|Adverse Event|0|||
130286239|NCT02182440|469010258|FG003|Overall Study|Adverse Event|0|||
130286240|NCT02182440|469010255|FG000|Overall Study|Death|31|||
130286241|NCT02182440|469010256|FG001|Overall Study|Death|8|||
130286242|NCT02182440|469010257|FG002|Overall Study|Death|5|||
130286243|NCT02182440|469010258|FG003|Overall Study|Death|16|||
130286244|NCT02182440|469010255|FG000|Overall Study|Protocol Violation|0|||
130286245|NCT02182440|469010256|FG001|Overall Study|Protocol Violation|1|||
130286246|NCT02182440|469010257|FG002|Overall Study|Protocol Violation|0|||
130286247|NCT02182440|469010258|FG003|Overall Study|Protocol Violation|0|||
130286248|NCT02182440|469010255|FG000|Overall Study|Physician Decision|1|||
130286249|NCT02182440|469010256|FG001|Overall Study|Physician Decision|0|||
130286250|NCT02182440|469010257|FG002|Overall Study|Physician Decision|0|||
130286251|NCT02182440|469010258|FG003|Overall Study|Physician Decision|0|||
130043309|NCT01855789|468115849|FG001|2) Week 24 up to End of Study|Other|0|||
130043310|NCT01855789|468115850|FG002|2) Week 24 up to End of Study|Other|0|||
130043311|NCT01855789|468115851|FG003|2) Week 24 up to End of Study|Other|1|||
130286252|NCT02182440|469010255|FG000|Overall Study|Withdrawal by Subject|1|||
130286253|NCT02182440|469010256|FG001|Overall Study|Withdrawal by Subject|1|||
130286254|NCT02182440|469010257|FG002|Overall Study|Withdrawal by Subject|3|||
130286255|NCT02182440|469010258|FG003|Overall Study|Withdrawal by Subject|4|||
130286256|NCT02182440|469010255|FG000|Overall Study|different, e.g adm other hospital|12|||
130286257|NCT02182440|469010256|FG001|Overall Study|different, e.g adm other hospital|3|||
130286258|NCT02182440|469010257|FG002|Overall Study|different, e.g adm other hospital|3|||
130286259|NCT02182440|469010258|FG003|Overall Study|different, e.g adm other hospital|10|||
130286260|NCT00072293|469010259|FG000|Overall Study|Lost to Follow-up|1|||
130286261|NCT00072293|469010260|FG001|Overall Study|Lost to Follow-up|1|||
130286262|NCT00072293|469010259|FG000|Overall Study|Withdrawal by Subject|0|||
130286263|NCT00072293|469010260|FG001|Overall Study|Withdrawal by Subject|1|||
130286264|NCT01166958|469010261|FG000|Overall Study|Withdrawal by Subject|1|||
130286265|NCT01166958|469010262|FG001|Overall Study|Withdrawal by Subject|0|||
130286266|NCT04209114|469010263|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
130286267|NCT04209114|469010264|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
130286268|NCT04209114|469010265|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
130286269|NCT04209114|469010263|FG000|Pre-Treatment Phase|Other reasons|0|||
130286270|NCT04209114|469010264|FG001|Pre-Treatment Phase|Other reasons|0|||
130286271|NCT04209114|469010265|FG002|Pre-Treatment Phase|Other reasons|1|||
130286272|NCT04209114|469010263|FG000|Pre-Treatment Phase|Death|0|||
130286273|NCT04209114|469010264|FG001|Pre-Treatment Phase|Death|0|||
130286274|NCT04209114|469010265|FG002|Pre-Treatment Phase|Death|1|||
130286275|NCT04209114|469010263|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
130286276|NCT04209114|469010264|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
130286277|NCT04209114|469010265|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
130286278|NCT04209114|469010263|FG000|Treatment Phase|Other reasons|5|||
130286279|NCT04209114|469010264|FG001|Treatment Phase|Other reasons|3|||
130286280|NCT04209114|469010265|FG002|Treatment Phase|Other reasons|0|||
130286281|NCT04209114|469010263|FG000|Treatment Phase|Lost to Follow-up|1|||
130286282|NCT04209114|469010264|FG001|Treatment Phase|Lost to Follow-up|0|||
130286283|NCT04209114|469010265|FG002|Treatment Phase|Lost to Follow-up|0|||
130286284|NCT04209114|469010263|FG000|Treatment Phase|Participant withdrew consent|1|||
130286285|NCT04209114|469010264|FG001|Treatment Phase|Participant withdrew consent|0|||
130286286|NCT04209114|469010265|FG002|Treatment Phase|Participant withdrew consent|0|||
130043312|NCT03067311|468115852|FG000|Overall Study|Lost to Follow-up|1|||
130043313|NCT03067311|468115853|FG001|Overall Study|Lost to Follow-up|1|||
130043314|NCT03067311|468115852|FG000|Overall Study|Moved away|1|||
130286287|NCT04209114|469010263|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
130286288|NCT04209114|469010264|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
130043315|NCT03067311|468115853|FG001|Overall Study|Moved away|1|||
130286289|NCT04209114|469010265|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
130286290|NCT04209114|469010263|FG000|Treatment Phase|Death|4|||
130286291|NCT04209114|469010264|FG001|Treatment Phase|Death|1|||
130286292|NCT04209114|469010265|FG002|Treatment Phase|Death|0|||
130286293|NCT04209114|469010263|FG000|Treatment Phase|Study drug toxicity|4|||
130043316|NCT00907738|468115854|FG000|Overall Study|Adverse Event|2|||
130043317|NCT00907738|468115855|FG001|Overall Study|Adverse Event|0|||
130043318|NCT00907738|468115856|FG002|Overall Study|Adverse Event|1|||
130286294|NCT04209114|469010264|FG001|Treatment Phase|Study drug toxicity|6|||
130286295|NCT04209114|469010265|FG002|Treatment Phase|Study drug toxicity|0|||
130286296|NCT04209114|469010263|FG000|Treatment Phase|Disease progression|6|||
130286297|NCT04209114|469010264|FG001|Treatment Phase|Disease progression|9|||
130286298|NCT04209114|469010265|FG002|Treatment Phase|Disease progression|0|||
130286299|NCT01444027|469010273|FG000|Overall Study|Withdrawal by Subject|4|||
130286300|NCT01444027|469010274|FG001|Overall Study|Withdrawal by Subject|10|||
130286301|NCT01444027|469010275|FG002|Overall Study|Withdrawal by Subject|24|||
130286302|NCT01444027|469010273|FG000|Overall Study|Lost to Follow-up|26|||
130286303|NCT01444027|469010274|FG001|Overall Study|Lost to Follow-up|20|||
130286304|NCT01444027|469010275|FG002|Overall Study|Lost to Follow-up|14|||
130286305|NCT01416441|469010277|FG000|Overall Study|Lost to Follow-up|5|||
130286306|NCT01416441|469010277|FG000|Overall Study|Adverse Event|6|||
130286307|NCT01416441|469010277|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
130286308|NCT01416441|469010277|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
130286309|NCT01416441|469010277|FG000|Overall Study|Investigator Withdrew Subject|2|||
130286310|NCT01416441|469010277|FG000|Overall Study|Subject Withdrew Consent|12|||
130286311|NCT01416441|469010277|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
130286312|NCT02653495|469010282|FG000|Overall Study|Lost to Follow-up|2|||
130286313|NCT02653495|469010283|FG001|Overall Study|Lost to Follow-up|0|||
130286314|NCT02653495|469010282|FG000|Overall Study|Screening Failure|10|||
130286315|NCT02653495|469010283|FG001|Overall Study|Screening Failure|0|||
130286316|NCT00953680|469010284|FG000|Period 1|Withdrawal by Subject|0|||
130286317|NCT00953680|469010285|FG001|Period 1|Withdrawal by Subject|1|||
130286318|NCT01360398|469010286|FG000|Overall Study|Withdrawal by Subject|14|||
130286319|NCT01360398|469010286|FG000|Overall Study|Other|7|||
130286320|NCT01360398|469010286|FG000|Overall Study|Migrated/moved from study area|1|||
130286321|NCT00737711|469010287|FG000|Overall Study|Adverse Event|2|||
130286322|NCT00737711|469010287|FG000|Overall Study|Death|8|||
130286323|NCT00737711|469010287|FG000|Overall Study|Failure to return|4|||
130286324|NCT00737711|469010287|FG000|Overall Study|Protocol Violation|1|||
130286325|NCT00737711|469010287|FG000|Overall Study|Withdrawal by Subject|5|||
130286326|NCT00737711|469010287|FG000|Overall Study|Blood transfusion|6|||
130286327|NCT00737711|469010287|FG000|Overall Study|Other|5|||
130286328|NCT01514240|469012106|FG000|Overall Study|Adverse Event|4|||
130286329|NCT01514240|469012107|FG001|Overall Study|Adverse Event|4|||
130286330|NCT01514240|469012106|FG000|Overall Study|Subject Decision|2|||
130286331|NCT01514240|469012107|FG001|Overall Study|Subject Decision|7|||
130286332|NCT01103063|469012108|FG000|Overall Study|Adverse Event|3|||
130286333|NCT01103063|469012109|FG001|Overall Study|Adverse Event|1|||
130286334|NCT01103063|469012108|FG000|Overall Study|Lost to Follow-up|68|||
130286335|NCT01103063|469012109|FG001|Overall Study|Lost to Follow-up|51|||
130286336|NCT01103063|469012108|FG000|Overall Study|Withdrawal by Subject|60|||
130286337|NCT01103063|469012109|FG001|Overall Study|Withdrawal by Subject|15|||
130286338|NCT01103063|469012108|FG000|Overall Study|Other|16|||
130286339|NCT01103063|469012109|FG001|Overall Study|Other|11|||
130286340|NCT01103063|469012108|FG000|Overall Study|Protocol Violation|1|||
130286341|NCT01103063|469012109|FG001|Overall Study|Protocol Violation|0|||
130286342|NCT01103063|469012108|FG000|Overall Study|Study terminated by Sponsor|326|||
130286343|NCT01103063|469012109|FG001|Overall Study|Study terminated by Sponsor|342|||
130286344|NCT01103063|469012108|FG000|Overall Study|Death|3|||
130286345|NCT01103063|469012109|FG001|Overall Study|Death|1|||
130286346|NCT01187446|469012112|FG000|Overall Study|Patient started non-protocol therapy|0|||
130286347|NCT01187446|469012113|FG001|Overall Study|Patient started non-protocol therapy|1|||
130286348|NCT00149994|469012114|FG000|Overall Study|Administrative problems:|1|||
130286349|NCT00149994|469012115|FG001|Overall Study|Administrative problems:|0|||
130286350|NCT00149994|469012114|FG000|Overall Study|Protocol Violation|0|||
130286351|NCT00149994|469012115|FG001|Overall Study|Protocol Violation|1|||
130286352|NCT01342965|469012116|FG000|Overall Study|Death|58|||
130286353|NCT01342965|469012117|FG001|Overall Study|Death|57|||
129887393|NCT01474512|467547272|FG000|Maintenance Period|Protocol Violation|0|||
130043319|NCT00907738|468115857|FG003|Overall Study|Adverse Event|0|||
130286354|NCT01342965|469012116|FG000|Overall Study|Lost to Follow-up|5|||
130286355|NCT01342965|469012117|FG001|Overall Study|Lost to Follow-up|3|||
130286356|NCT01342965|469012116|FG000|Overall Study|Other Reasons- Unspecified|44|||
130286357|NCT01342965|469012117|FG001|Overall Study|Other Reasons- Unspecified|38|||
130286358|NCT01342965|469012116|FG000|Overall Study|Withdrawal by Subject|2|||
130286359|NCT01342965|469012117|FG001|Overall Study|Withdrawal by Subject|9|||
130286360|NCT03538444|469012128|FG000|Overall Study|opioid withdrawal|1|||
130286361|NCT03538444|469012129|FG001|Overall Study|opioid withdrawal|0|||
130286362|NCT03640052|469012132|FG000|Overall Study|Lost to Follow-up|0|||
130286363|NCT03640052|469012133|FG001|Overall Study|Lost to Follow-up|1|||
130286364|NCT03640052|469012134|FG002|Overall Study|Lost to Follow-up|0|||
130286365|NCT03640052|469012135|FG003|Overall Study|Lost to Follow-up|0|||
130286366|NCT03640052|469012136|FG004|Overall Study|Lost to Follow-up|0|||
130286367|NCT04422561|469012137|FG000|Overall Study|Lost to Follow-up|25|||
130286368|NCT04422561|469012138|FG001|Overall Study|Lost to Follow-up|11|||
130286369|NCT00790647|469012145|FG000|Overall Study|Adverse Event|1|||
130286370|NCT04926831|469012146|FG000|Overall Study|Withdrawal by Subject|2|||
130286371|NCT04926831|469012146|FG000|Overall Study|Adverse Event|2|||
130286372|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
130286373|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
130286374|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
130286375|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
130286376|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
130286377|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
130286378|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
130286379|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
130286380|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
130286381|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
130286382|NCT03549871|469012151|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
130286383|NCT03549871|469012152|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
130286384|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
130286385|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
130286386|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
130286387|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
130286388|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
130286389|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
130286390|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
130286391|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
130286392|NCT03549871|469012151|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
130286393|NCT03549871|469012152|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
130286394|NCT01133626|469012154|FG000|Overall Study|Adverse Event|0|||
130286395|NCT01133626|469012155|FG001|Overall Study|Adverse Event|1|||
130286396|NCT01133626|469012156|FG002|Overall Study|Adverse Event|0|||
130286397|NCT01133626|469012154|FG000|Overall Study|Withdrawal by Subject|1|||
130286398|NCT01133626|469012155|FG001|Overall Study|Withdrawal by Subject|2|||
130286399|NCT01133626|469012156|FG002|Overall Study|Withdrawal by Subject|2|||
130286400|NCT01133626|469012154|FG000|Overall Study|Other|0|||
130286401|NCT01133626|469012155|FG001|Overall Study|Other|2|||
130286402|NCT01133626|469012156|FG002|Overall Study|Other|0|||
130286403|NCT03298984|469012159|FG000|Overall Study|Physician Decision|1|||
130286404|NCT03298984|469012160|FG001|Overall Study|Physician Decision|0|||
130286405|NCT03298984|469012161|FG002|Overall Study|Physician Decision|0|||
130286406|NCT03298984|469012162|FG003|Overall Study|Physician Decision|6|||
130286407|NCT03298984|469012159|FG000|Overall Study|Lack of Efficacy|0|||
130286408|NCT03298984|469012160|FG001|Overall Study|Lack of Efficacy|1|||
130286409|NCT03298984|469012161|FG002|Overall Study|Lack of Efficacy|1|||
130286410|NCT03298984|469012162|FG003|Overall Study|Lack of Efficacy|4|||
130286411|NCT03298984|469012159|FG000|Overall Study|Relapsed disease (following remission)|0|||
130286412|NCT03298984|469012160|FG001|Overall Study|Relapsed disease (following remission)|0|||
130286413|NCT03298984|469012161|FG002|Overall Study|Relapsed disease (following remission)|1|||
130286414|NCT03298984|469012162|FG003|Overall Study|Relapsed disease (following remission)|1|||
130286415|NCT03298984|469012159|FG000|Overall Study|Adverse Event|0|||
130286416|NCT03298984|469012160|FG001|Overall Study|Adverse Event|0|||
130286417|NCT03298984|469012161|FG002|Overall Study|Adverse Event|0|||
130043320|NCT00907738|468115858|FG004|Overall Study|Adverse Event|0|||
130286418|NCT03298984|469012162|FG003|Overall Study|Adverse Event|1|||
130286419|NCT03298984|469012159|FG000|Overall Study|Death|0|||
130286420|NCT03298984|469012160|FG001|Overall Study|Death|0|||
130286421|NCT03298984|469012161|FG002|Overall Study|Death|0|||
130286422|NCT03298984|469012162|FG003|Overall Study|Death|2|||
130286423|NCT03298984|469012159|FG000|Overall Study|Insurance Company Decision|0|||
130286424|NCT03298984|469012160|FG001|Overall Study|Insurance Company Decision|0|||
130286425|NCT03298984|469012161|FG002|Overall Study|Insurance Company Decision|0|||
130286426|NCT03298984|469012162|FG003|Overall Study|Insurance Company Decision|1|||
130286427|NCT00294645|469012163|FG000|Overall Study|Death|10|||
130286428|NCT00294645|469012164|FG001|Overall Study|Death|18|||
130286429|NCT00294645|469012163|FG000|Overall Study|Lost to Follow-up|1|||
130286430|NCT00294645|469012164|FG001|Overall Study|Lost to Follow-up|10|||
130286431|NCT00294645|469012163|FG000|Overall Study|Withdrawal by Subject|18|||
130286432|NCT00294645|469012164|FG001|Overall Study|Withdrawal by Subject|34|||
130286433|NCT00294645|469012163|FG000|Overall Study|Physician Decision|15|||
130286434|NCT00294645|469012164|FG001|Overall Study|Physician Decision|20|||
130286435|NCT00294645|469012163|FG000|Overall Study|Other|4|||
130106284|NCT04682639|468349964|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
130286436|NCT00294645|469012164|FG001|Overall Study|Other|10|||
130286437|NCT03263923|469012165|FG000|Overall Study|Withdrawal by Subject|10|||
130286438|NCT03263923|469012166|FG001|Overall Study|Withdrawal by Subject|8|||
130286439|NCT03263923|469012165|FG000|Overall Study|Lost to Follow-up|15|||
130286440|NCT03263923|469012166|FG001|Overall Study|Lost to Follow-up|13|||
130286441|NCT03305081|469012179|FG000|Overall Study|Lost to Follow-up|10|||
130286442|NCT03305081|469012180|FG001|Overall Study|Lost to Follow-up|15|||
130286443|NCT00772369|469012181|FG000|Overall Study|Did not return record release form|1|||
130286444|NCT01774253|469012182|FG000|Overall Study|Lack of Efficacy|4|||
130286445|NCT01774253|469012182|FG000|Overall Study|Physician Decision|2|||
130286446|NCT01774253|469012182|FG000|Overall Study|Withdrawal by Subject|2|||
130286447|NCT01774253|469012182|FG000|Overall Study|Death|1|||
130286448|NCT00554619|469012183|FG000|Overall Study|Adverse Event|1|||
130286449|NCT00554619|469012183|FG000|Overall Study|Physician Decision|1|||
130286450|NCT00554619|469012183|FG000|Overall Study|Liver Function Test Abnormality|1|||
130286451|NCT01571284|469012186|FG000|Overall Study|Participant's decision|84|||
130286452|NCT01571284|469012186|FG000|Overall Study|Lost to Follow-up|3|||
130286453|NCT01571284|469012186|FG000|Overall Study|Enrolled but not treated|2|||
130286454|NCT01571284|469012186|FG000|Overall Study|Other than specified above|80|||
130286455|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Death|1|||
130286456|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Death|1|||
130286457|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Death|0|||
130286458|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Death|0|||
130286459|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Death|1|||
130286460|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Death|0|||
130286461|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Death|0|||
130286462|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Death|0|||
130286463|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Death|0|||
130286464|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Death|0|||
130286465|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
130286466|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
130286467|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
130286468|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286469|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
130286470|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286471|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286472|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286473|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286474|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
130286475|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286476|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286477|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286478|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286479|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
130286480|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286481|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286482|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286483|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286484|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
130286485|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
130286486|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286487|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286488|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286489|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286490|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286491|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286492|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286493|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286494|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
130286495|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
130286496|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286497|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286498|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
130286499|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
130286500|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286501|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286502|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286503|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286504|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
130286505|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
130286506|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286507|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286508|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
130286509|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130043321|NCT00907738|468115854|FG000|Overall Study|not specified or withdrew consent|3|||
130286510|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286511|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286512|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286513|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286514|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
130286515|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
130286516|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130286517|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130286518|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
130286519|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
130286520|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286521|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286522|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286523|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286524|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
130286525|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
130286526|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130286527|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130286528|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286529|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
130286530|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286531|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286532|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130043322|NCT00907738|468115855|FG001|Overall Study|not specified or withdrew consent|0|||
130286533|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286534|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286535|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
130286536|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286537|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286538|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
130286539|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
130286540|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286541|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286542|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286543|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286544|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
130286545|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286546|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286547|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286548|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286549|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286550|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286551|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286552|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286553|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286554|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286555|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286556|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286557|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286558|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286559|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286560|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286561|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286562|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286563|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286564|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286565|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
129791985|NCT00130442|467207381|FG000|Overall Study|Withdrawal by Subject|0|||
129791986|NCT00130442|467207382|FG001|Overall Study|Withdrawal by Subject|1|||
129791987|NCT00130442|467207381|FG000|Overall Study|did not meet criteria|1|||
129791988|NCT00130442|467207382|FG001|Overall Study|did not meet criteria|1|||
129791989|NCT00814333|467207383|FG000|Enrollment|Lost to Follow-up|1|||
130286566|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
130286567|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
130286568|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
130286569|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
130286570|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286571|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286572|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286573|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286574|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
130286575|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286576|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286577|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286578|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
130286579|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
130286580|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286581|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286582|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286583|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286584|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286585|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286586|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286587|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286588|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286589|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286590|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286591|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286592|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286593|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286594|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286595|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286596|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286597|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286598|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286599|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
130286600|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286601|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286602|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286603|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286604|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
130286605|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286606|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286607|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286608|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286609|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
130286610|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286611|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286612|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286613|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129791990|NCT00814333|467207384|FG001|Enrollment|Lost to Follow-up|0|||
129791991|NCT02233946|467207385|FG000|Baseline|Withdrawal by Subject|2|||
129791992|NCT02233946|467207386|FG001|Baseline|Withdrawal by Subject|0|||
129791993|NCT02233946|467207385|FG000|3-months Follow-up|Lost to Follow-up|53|||
129791994|NCT02233946|467207386|FG001|3-months Follow-up|Lost to Follow-up|29|||
129791995|NCT02233946|467207385|FG000|6-months Follow-up|Lost to Follow-up|21|||
129791996|NCT02233946|467207386|FG001|6-months Follow-up|Lost to Follow-up|2|||
130043323|NCT00907738|468115856|FG002|Overall Study|not specified or withdrew consent|0|||
130043324|NCT00907738|468115857|FG003|Overall Study|not specified or withdrew consent|0|||
130043325|NCT00907738|468115858|FG004|Overall Study|not specified or withdrew consent|0|||
130043326|NCT00907738|468115854|FG000|Overall Study|Disease progression|8|||
130043327|NCT00907738|468115855|FG001|Overall Study|Disease progression|1|||
130043328|NCT00907738|468115856|FG002|Overall Study|Disease progression|6|||
130043329|NCT00907738|468115857|FG003|Overall Study|Disease progression|4|||
130043330|NCT00907738|468115858|FG004|Overall Study|Disease progression|2|||
130043331|NCT02031146|468117365|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
130043332|NCT02031146|468117366|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
130043333|NCT02031146|468117367|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
130043334|NCT02031146|468117368|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
130043335|NCT02031146|468117369|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
130043336|NCT02031146|468117370|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
130043337|NCT02031146|468117371|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
130043338|NCT01582282|468117374|FG000|Overall Study|Adverse Event|1|||
130043339|NCT01582282|468117375|FG001|Overall Study|Adverse Event|1|||
130043340|NCT01582282|468117376|FG002|Overall Study|Adverse Event|0|||
130043341|NCT01582282|468117374|FG000|Overall Study|Lost to Follow-up|1|||
130043342|NCT01582282|468117375|FG001|Overall Study|Lost to Follow-up|0|||
130043343|NCT01582282|468117376|FG002|Overall Study|Lost to Follow-up|0|||
130043344|NCT01582282|468117374|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
130043345|NCT01582282|468117375|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
130043346|NCT01582282|468117376|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
130043347|NCT01486316|468117377|FG000|Overall Study|Device explanted with/without re-implant|3|||
130043348|NCT01486316|468117378|FG001|Overall Study|Device explanted with/without re-implant|2|||
130043349|NCT01486316|468117379|FG002|Overall Study|Device explanted with/without re-implant|0|||
130043350|NCT01486316|468117380|FG003|Overall Study|Device explanted with/without re-implant|2|||
130043351|NCT01486316|468117377|FG000|Overall Study|Not meeting eligibility criteria|0|||
130043352|NCT01486316|468117378|FG001|Overall Study|Not meeting eligibility criteria|0|||
130043353|NCT01486316|468117379|FG002|Overall Study|Not meeting eligibility criteria|1|||
130043354|NCT01486316|468117380|FG003|Overall Study|Not meeting eligibility criteria|0|||
130043355|NCT01486316|468117377|FG000|Overall Study|Withdrawal by Subject|1|||
130043356|NCT01486316|468117378|FG001|Overall Study|Withdrawal by Subject|0|||
130043357|NCT01486316|468117379|FG002|Overall Study|Withdrawal by Subject|3|||
130286614|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286615|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286616|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
130286617|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286618|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286619|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
130286620|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286621|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286622|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286623|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286624|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
130286625|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
130286626|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286627|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286628|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286629|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
130286630|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286631|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130043358|NCT01486316|468117380|FG003|Overall Study|Withdrawal by Subject|0|||
130043359|NCT01486316|468117377|FG000|Overall Study|Physician Decision|0|||
130043360|NCT01486316|468117378|FG001|Overall Study|Physician Decision|0|||
130286632|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286633|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286634|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
130286635|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
130286636|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286637|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
130286638|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286639|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
130286640|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286641|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286642|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286643|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286644|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
130286645|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Other|5|||
130286646|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Other|1|||
130286647|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Other|0|||
130286648|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Other|3|||
130286649|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Other|0|||
130286650|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Other|0|||
130286651|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Other|0|||
130286652|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Other|0|||
130286653|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Other|0|||
130286654|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Other|0|||
130286655|NCT03352557|469012187|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286656|NCT03352557|469012188|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286657|NCT03352557|469012189|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286658|NCT03352557|469012190|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286659|NCT03352557|469012191|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
130286660|NCT03352557|469012192|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286661|NCT03352557|469012193|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286662|NCT03352557|469012194|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286663|NCT03352557|469012195|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286664|NCT03352557|469012196|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
130286665|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Death|0|||
130286666|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Death|0|||
130286667|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Death|0|||
130286668|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Death|0|||
130286669|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Death|0|||
130286670|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Death|1|||
130286671|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Death|0|||
130286672|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Death|1|||
130286673|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Death|1|||
130286674|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Death|1|||
130286675|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286676|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286677|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286678|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286679|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286680|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
130286681|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286682|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286683|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286684|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
130286685|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286686|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286687|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286688|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286689|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286690|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286691|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286692|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286693|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
130286694|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
130286695|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286696|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286697|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286698|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286699|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
130286700|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
130286701|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
130286702|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
130286703|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
130286704|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
130286705|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286706|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286707|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286708|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286709|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286710|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
130286711|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
130286712|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
130286713|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
130286714|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
130286715|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286716|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286717|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286718|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286719|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286720|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286721|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286722|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286723|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
130286724|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
130286725|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286726|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286727|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286728|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286729|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286730|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130286731|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
130286732|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130286733|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
130286734|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
130286735|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286736|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286737|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286738|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286739|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129791997|NCT02233946|467207385|FG000|9-month Follow-up|Lost to Follow-up|20|||
129791998|NCT02233946|467207386|FG001|9-month Follow-up|Lost to Follow-up|11|||
129791999|NCT02233946|467207385|FG000|12-month Follow-up|Lost to Follow-up|28|||
129792000|NCT02233946|467207386|FG001|12-month Follow-up|Lost to Follow-up|11|||
129792001|NCT00773383|467207387|FG000|Overall Study|Adverse Event|4|||
129792002|NCT00773383|467207387|FG000|Overall Study|Death|1|||
129792003|NCT00773383|467207387|FG000|Overall Study|Progression of Disease|23|||
129792004|NCT00773383|467207387|FG000|Overall Study|Other|2|||
129792005|NCT00773383|467207387|FG000|Overall Study|No study dose received|1|||
129792006|NCT03384693|467207388|FG000|Overall Study|Adverse Event|3|||
129792007|NCT02919969|467207391|FG000|Overall Study|Lack of Efficacy|22|||
129792008|NCT02919969|467207391|FG000|Overall Study|Death|4|||
129792009|NCT02919969|467207391|FG000|Overall Study|Physician Decision|3|||
129887394|NCT01474512|467547273|FG001|Maintenance Period|Protocol Violation|0|||
129887395|NCT01474512|467547274|FG002|Maintenance Period|Protocol Violation|0|||
129887396|NCT01474512|467547275|FG003|Maintenance Period|Protocol Violation|1|||
129887397|NCT01474512|467547276|FG004|Maintenance Period|Protocol Violation|0|||
129887398|NCT01474512|467547277|FG005|Maintenance Period|Protocol Violation|0|||
129887399|NCT01474512|467547278|FG006|Maintenance Period|Protocol Violation|0|||
129792010|NCT02919969|467207391|FG000|Overall Study|Withdrawal by Subject|2|||
129792011|NCT01842633|467207392|FG000|Overall Study|Screen Failure|1|||
129792012|NCT01842633|467207393|FG001|Overall Study|Screen Failure|0|||
130286740|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286741|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286742|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
130286743|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
130286744|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
130286745|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286746|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286747|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286748|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286749|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286750|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286751|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286752|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
130286753|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286754|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
130286755|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286756|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286757|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286758|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286759|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286760|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286761|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286762|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
130286763|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286764|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
130286765|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286766|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286767|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286768|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129792013|NCT01842633|467207394|FG002|Overall Study|Screen Failure|0|||
129792014|NCT01842633|467207392|FG000|Overall Study|Adverse Event|1|||
129792015|NCT01842633|467207393|FG001|Overall Study|Adverse Event|1|||
129792016|NCT01842633|467207394|FG002|Overall Study|Adverse Event|0|||
129792017|NCT01842633|467207392|FG000|Overall Study|Withdrawal by Subject|0|||
129792018|NCT01842633|467207393|FG001|Overall Study|Withdrawal by Subject|1|||
130043361|NCT01486316|468117379|FG002|Overall Study|Physician Decision|1|||
130043362|NCT01486316|468117380|FG003|Overall Study|Physician Decision|0|||
130043363|NCT01486316|468117377|FG000|Overall Study|Death|0|||
130043364|NCT01486316|468117378|FG001|Overall Study|Death|1|||
130043365|NCT01486316|468117379|FG002|Overall Study|Death|0|||
130043366|NCT01486316|468117380|FG003|Overall Study|Death|0|||
130043367|NCT02495077|468117389|FG000|Overall Study|Adverse Event|0|||
130043368|NCT02495077|468117390|FG001|Overall Study|Adverse Event|1|||
130043369|NCT02495077|468117391|FG002|Overall Study|Adverse Event|1|||
130043370|NCT02495077|468117392|FG003|Overall Study|Adverse Event|0|||
130043371|NCT02495077|468117389|FG000|Overall Study|Death|3|||
130043372|NCT02495077|468117390|FG001|Overall Study|Death|5|||
130043373|NCT02495077|468117391|FG002|Overall Study|Death|0|||
130043374|NCT02495077|468117392|FG003|Overall Study|Death|0|||
130043375|NCT02495077|468117389|FG000|Overall Study|Lost to Follow-up|6|||
130043376|NCT02495077|468117390|FG001|Overall Study|Lost to Follow-up|4|||
130043377|NCT02495077|468117391|FG002|Overall Study|Lost to Follow-up|0|||
130043378|NCT02495077|468117392|FG003|Overall Study|Lost to Follow-up|0|||
130043379|NCT02495077|468117389|FG000|Overall Study|Physician Decision|2|||
130043380|NCT02495077|468117390|FG001|Overall Study|Physician Decision|1|||
130043381|NCT02495077|468117391|FG002|Overall Study|Physician Decision|4|||
130043382|NCT02495077|468117392|FG003|Overall Study|Physician Decision|0|||
130043383|NCT02495077|468117389|FG000|Overall Study|Protocol Violation|0|||
130043384|NCT02495077|468117390|FG001|Overall Study|Protocol Violation|1|||
130043385|NCT02495077|468117391|FG002|Overall Study|Protocol Violation|0|||
130043386|NCT02495077|468117392|FG003|Overall Study|Protocol Violation|0|||
130043387|NCT02495077|468117389|FG000|Overall Study|Screen Failure|0|||
130043388|NCT02495077|468117390|FG001|Overall Study|Screen Failure|0|||
130043389|NCT02495077|468117391|FG002|Overall Study|Screen Failure|0|||
130043390|NCT02495077|468117392|FG003|Overall Study|Screen Failure|48|||
130043391|NCT02495077|468117389|FG000|Overall Study|Withdrawal by Subject|7|||
130043392|NCT02495077|468117390|FG001|Overall Study|Withdrawal by Subject|7|||
130043393|NCT02495077|468117391|FG002|Overall Study|Withdrawal by Subject|7|||
130043394|NCT02495077|468117392|FG003|Overall Study|Withdrawal by Subject|0|||
130043395|NCT02495077|468117389|FG000|Overall Study|Covid-19 research restrictions|1|||
130043396|NCT02495077|468117390|FG001|Overall Study|Covid-19 research restrictions|0|||
130043397|NCT02495077|468117391|FG002|Overall Study|Covid-19 research restrictions|0|||
130043398|NCT02495077|468117392|FG003|Overall Study|Covid-19 research restrictions|0|||
130043399|NCT02495077|468117389|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
130043400|NCT02495077|468117390|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
130043401|NCT02495077|468117391|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
130043402|NCT02495077|468117392|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
130043403|NCT02495077|468117389|FG000|Overall Study|Incarcerated|0|||
130043404|NCT02495077|468117390|FG001|Overall Study|Incarcerated|1|||
130043405|NCT02495077|468117391|FG002|Overall Study|Incarcerated|0|||
130043406|NCT02495077|468117392|FG003|Overall Study|Incarcerated|0|||
130043407|NCT02495077|468117389|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
130043408|NCT02495077|468117390|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
130043409|NCT02495077|468117391|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
130106285|NCT04682639|468349960|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
130286769|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286770|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286771|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286772|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
130286773|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
130286774|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
130286775|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130106286|NCT04682639|468349961|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130043410|NCT02495077|468117392|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
130043411|NCT02495077|468117389|FG000|Overall Study|Timing of transplant and randomization|0|||
130043412|NCT02495077|468117390|FG001|Overall Study|Timing of transplant and randomization|0|||
130106287|NCT04682639|468349962|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130043413|NCT02495077|468117391|FG002|Overall Study|Timing of transplant and randomization|5|||
130043414|NCT02495077|468117392|FG003|Overall Study|Timing of transplant and randomization|0|||
129792019|NCT01842633|467207394|FG002|Overall Study|Withdrawal by Subject|0|||
129792020|NCT01842633|467207392|FG000|Overall Study|Technical issues|1|||
130043415|NCT02742649|468117399|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
130043416|NCT02742649|468117400|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130043417|NCT02742649|468117401|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130043418|NCT02742649|468117402|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130043419|NCT02742649|468117403|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
130043420|NCT02742649|468117399|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130043421|NCT02742649|468117400|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130043422|NCT02742649|468117401|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130043423|NCT02742649|468117402|FG003|Double-Blind Treatment Period|Adverse Event|0|||
130043424|NCT02742649|468117403|FG004|Double-Blind Treatment Period|Adverse Event|0|||
130043425|NCT02742649|468117399|FG000|Open-Label Period|Lost to Follow-up|0|||
130286776|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286777|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286778|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286779|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286780|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
130286781|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286782|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286783|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
130286784|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
130286785|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286786|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286787|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286788|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286789|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286790|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130043426|NCT02742649|468117400|FG001|Open-Label Period|Lost to Follow-up|0|||
130043427|NCT02742649|468117401|FG002|Open-Label Period|Lost to Follow-up|0|||
130286791|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286792|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
130286793|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129792021|NCT01842633|467207393|FG001|Overall Study|Technical issues|0|||
130043428|NCT02742649|468117402|FG003|Open-Label Period|Lost to Follow-up|0|||
130286794|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
130286795|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286796|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286797|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286798|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286799|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129792022|NCT01842633|467207394|FG002|Overall Study|Technical issues|0|||
129792023|NCT02093351|467207395|FG000|Part A|Adverse Event|0|||
129792024|NCT02093351|467207396|FG001|Part A|Adverse Event|1|||
129792025|NCT02093351|467207397|FG002|Part A|Adverse Event|1|||
129792026|NCT02093351|467207398|FG003|Part A|Adverse Event|0|||
129792027|NCT02093351|467207395|FG000|Part A|Condition under investigation worsened|2|||
129792028|NCT02093351|467207396|FG001|Part A|Condition under investigation worsened|0|||
129792029|NCT02093351|467207397|FG002|Part A|Condition under investigation worsened|2|||
129792030|NCT02093351|467207398|FG003|Part A|Condition under investigation worsened|0|||
129792031|NCT02093351|467207395|FG000|Part A|Death|0|||
129792032|NCT02093351|467207396|FG001|Part A|Death|1|||
129792033|NCT02093351|467207397|FG002|Part A|Death|0|||
129792034|NCT02093351|467207398|FG003|Part A|Death|0|||
129792035|NCT02093351|467207395|FG000|Part B|Patient decision|0|||
129792036|NCT02093351|467207396|FG001|Part B|Patient decision|0|||
129792037|NCT02093351|467207397|FG002|Part B|Patient decision|0|||
129792038|NCT02093351|467207398|FG003|Part B|Patient decision|3|||
129792039|NCT02093351|467207395|FG000|Part B|Disease progression|0|||
129792040|NCT02093351|467207396|FG001|Part B|Disease progression|0|||
129792041|NCT02093351|467207397|FG002|Part B|Disease progression|0|||
129792042|NCT02093351|467207398|FG003|Part B|Disease progression|4|||
129792043|NCT02093351|467207395|FG000|Part B|Complete response|0|||
129792044|NCT02093351|467207396|FG001|Part B|Complete response|0|||
129792045|NCT02093351|467207397|FG002|Part B|Complete response|0|||
129792046|NCT02093351|467207398|FG003|Part B|Complete response|1|||
129792047|NCT02093351|467207395|FG000|Part B|Adverse event + disease progression|0|||
129792048|NCT02093351|467207396|FG001|Part B|Adverse event + disease progression|0|||
129792049|NCT02093351|467207397|FG002|Part B|Adverse event + disease progression|0|||
129792050|NCT02093351|467207398|FG003|Part B|Adverse event + disease progression|1|||
129792051|NCT02093351|467207395|FG000|Part B|Lack of therapeutic response|0|||
129792052|NCT02093351|467207396|FG001|Part B|Lack of therapeutic response|0|||
129792053|NCT02093351|467207397|FG002|Part B|Lack of therapeutic response|0|||
129792054|NCT02093351|467207398|FG003|Part B|Lack of therapeutic response|12|||
129792055|NCT02093351|467207395|FG000|Part B|Condition under investigation worsened|0|||
129792056|NCT02093351|467207396|FG001|Part B|Condition under investigation worsened|0|||
129792057|NCT02093351|467207397|FG002|Part B|Condition under investigation worsened|0|||
129792058|NCT02093351|467207398|FG003|Part B|Condition under investigation worsened|39|||
129792059|NCT02093351|467207395|FG000|Part B|Adverse Event|0|||
129792060|NCT02093351|467207396|FG001|Part B|Adverse Event|0|||
129792061|NCT02093351|467207397|FG002|Part B|Adverse Event|0|||
129792062|NCT02093351|467207398|FG003|Part B|Adverse Event|2|||
129792063|NCT02093351|467207395|FG000|Part B|Death|0|||
129792064|NCT02093351|467207396|FG001|Part B|Death|0|||
129792065|NCT02093351|467207397|FG002|Part B|Death|0|||
129792066|NCT02093351|467207398|FG003|Part B|Death|1|||
129792067|NCT01099709|467207399|FG000|Period 1|Withdrawal by Subject|0|||
129792068|NCT01099709|467207400|FG001|Period 1|Withdrawal by Subject|1|||
129792069|NCT01099709|467207399|FG000|Period 1|Positive cotinine test|0|||
129792070|NCT01099709|467207400|FG001|Period 1|Positive cotinine test|1|||
129792071|NCT01099709|467207399|FG000|Period 1|Adverse Event|1|||
129792072|NCT01099709|467207400|FG001|Period 1|Adverse Event|0|||
129792073|NCT00718081|467207404|FG000|Overall Study|Adverse Event|0|||
129792074|NCT00718081|467207405|FG001|Overall Study|Adverse Event|1|||
129792075|NCT00718081|467207406|FG002|Overall Study|Adverse Event|0|||
129792076|NCT00718081|467207404|FG000|Overall Study|Lack of Efficacy|7|||
129792077|NCT00718081|467207405|FG001|Overall Study|Lack of Efficacy|3|||
129792078|NCT00718081|467207406|FG002|Overall Study|Lack of Efficacy|21|||
129792079|NCT01397825|467207409|FG000|Overall Study|Progressive Disease|10|||
129792080|NCT01397825|467207410|FG001|Overall Study|Progressive Disease|3|||
129792081|NCT01397825|467207411|FG002|Overall Study|Progressive Disease|11|||
130286800|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
130286801|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129792082|NCT01397825|467207412|FG003|Overall Study|Progressive Disease|1|||
129792083|NCT01397825|467207413|FG004|Overall Study|Progressive Disease|0|||
129792084|NCT01397825|467207409|FG000|Overall Study|Symptomatic Deterioration|2|||
129792085|NCT01397825|467207410|FG001|Overall Study|Symptomatic Deterioration|0|||
129792086|NCT01397825|467207411|FG002|Overall Study|Symptomatic Deterioration|4|||
129792087|NCT01397825|467207412|FG003|Overall Study|Symptomatic Deterioration|0|||
129792088|NCT01397825|467207413|FG004|Overall Study|Symptomatic Deterioration|0|||
129792089|NCT01397825|467207409|FG000|Overall Study|Adverse Event|0|||
130286802|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129792090|NCT01397825|467207410|FG001|Overall Study|Adverse Event|1|||
129792091|NCT01397825|467207411|FG002|Overall Study|Adverse Event|5|||
129792092|NCT01397825|467207412|FG003|Overall Study|Adverse Event|1|||
129887400|NCT01474512|467547279|FG007|Maintenance Period|Protocol Violation|1|||
129887401|NCT01474512|467547280|FG008|Maintenance Period|Protocol Violation|0|||
129887402|NCT01474512|467547281|FG009|Maintenance Period|Protocol Violation|1|||
129887403|NCT01474512|467547282|FG010|Maintenance Period|Protocol Violation|0|||
129887404|NCT01474512|467547283|FG011|Maintenance Period|Protocol Violation|0|||
129887405|NCT01474512|467547284|FG012|Maintenance Period|Protocol Violation|0|||
129887406|NCT01474512|467547285|FG013|Maintenance Period|Protocol Violation|0|||
129887407|NCT01474512|467547286|FG014|Maintenance Period|Protocol Violation|0|||
129887408|NCT01474512|467547287|FG015|Maintenance Period|Protocol Violation|0|||
129887409|NCT01474512|467547288|FG016|Maintenance Period|Protocol Violation|0|||
129887410|NCT01474512|467547289|FG017|Maintenance Period|Protocol Violation|0|||
129887411|NCT01474512|467547272|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
129887412|NCT01474512|467547273|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
129887413|NCT01474512|467547274|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
129887414|NCT01474512|467547275|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
129887415|NCT01474512|467547276|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
129887416|NCT01474512|467547277|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
129887417|NCT01474512|467547278|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
129887418|NCT01474512|467547279|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
129887419|NCT01474512|467547280|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
129887420|NCT01474512|467547281|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
129887421|NCT01474512|467547282|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
129887422|NCT01474512|467547283|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
129887423|NCT01474512|467547284|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
129887424|NCT01474512|467547285|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
129887425|NCT01474512|467547286|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
129887426|NCT01474512|467547287|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
129887427|NCT01474512|467547288|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
129887428|NCT01474512|467547289|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
129887429|NCT01474512|467547272|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
129887430|NCT01474512|467547273|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
129887431|NCT01474512|467547274|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
129887432|NCT01474512|467547275|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
129887433|NCT01474512|467547276|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
129887434|NCT01474512|467547277|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
129887435|NCT01474512|467547278|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
129887436|NCT01474512|467547279|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
129887437|NCT01474512|467547280|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
129887438|NCT01474512|467547281|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
129887439|NCT01474512|467547282|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
129887440|NCT01474512|467547283|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
129887441|NCT01474512|467547284|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
129887442|NCT01474512|467547285|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
129887443|NCT01474512|467547286|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
129887444|NCT01474512|467547287|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
129887445|NCT01474512|467547288|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
129887446|NCT01474512|467547289|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
129887447|NCT01474512|467547272|FG000|Long-Term Extension Period|Adverse Event|0|||
129887448|NCT01474512|467547273|FG001|Long-Term Extension Period|Adverse Event|0|||
129887449|NCT01474512|467547274|FG002|Long-Term Extension Period|Adverse Event|0|||
129887450|NCT01474512|467547275|FG003|Long-Term Extension Period|Adverse Event|0|||
129887451|NCT01474512|467547276|FG004|Long-Term Extension Period|Adverse Event|0|||
129887452|NCT01474512|467547277|FG005|Long-Term Extension Period|Adverse Event|0|||
129887453|NCT01474512|467547278|FG006|Long-Term Extension Period|Adverse Event|0|||
129887454|NCT01474512|467547279|FG007|Long-Term Extension Period|Adverse Event|0|||
129887455|NCT01474512|467547280|FG008|Long-Term Extension Period|Adverse Event|0|||
129887456|NCT01474512|467547281|FG009|Long-Term Extension Period|Adverse Event|0|||
129887457|NCT01474512|467547282|FG010|Long-Term Extension Period|Adverse Event|0|||
129887458|NCT01474512|467547283|FG011|Long-Term Extension Period|Adverse Event|1|||
129887459|NCT01474512|467547284|FG012|Long-Term Extension Period|Adverse Event|57|||
129887460|NCT01474512|467547285|FG013|Long-Term Extension Period|Adverse Event|58|||
129887461|NCT01474512|467547286|FG014|Long-Term Extension Period|Adverse Event|0|||
130286803|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
130286804|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
129887462|NCT01474512|467547287|FG015|Long-Term Extension Period|Adverse Event|0|||
129887463|NCT01474512|467547288|FG016|Long-Term Extension Period|Adverse Event|0|||
129887464|NCT01474512|467547289|FG017|Long-Term Extension Period|Adverse Event|0|||
130286805|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129887465|NCT01474512|467547272|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
130106288|NCT04682639|468349963|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130043429|NCT02742649|468117403|FG004|Open-Label Period|Lost to Follow-up|1|||
129887466|NCT01474512|467547273|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
129887467|NCT01474512|467547274|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
129887468|NCT01474512|467547275|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
129887469|NCT01474512|467547276|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
129887470|NCT01474512|467547277|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
129887471|NCT01474512|467547278|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
129887472|NCT01474512|467547279|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
129887473|NCT01474512|467547280|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
129887474|NCT01474512|467547281|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
130043430|NCT03937986|468117406|FG000|Overall Study|COVID-19 Pandemic|1|||
130043431|NCT02114203|468117419|FG000|Overall Study|Adverse Event|0|||
130043432|NCT02114203|468117420|FG001|Overall Study|Adverse Event|1|||
130043433|NCT02114203|468117421|FG002|Overall Study|Adverse Event|0|||
130043434|NCT02114203|468117419|FG000|Overall Study|Withdrawal by Subject|0|||
130043435|NCT02114203|468117420|FG001|Overall Study|Withdrawal by Subject|1|||
130043436|NCT02114203|468117421|FG002|Overall Study|Withdrawal by Subject|0|||
130043437|NCT01518699|468117423|FG000|Period 2|Protocol Violation|1|||
130043438|NCT01518699|468117424|FG001|Period 2|Protocol Violation|1|||
130043439|NCT01518699|468117425|FG002|Period 2|Protocol Violation|0|||
130043440|NCT01518699|468117426|FG003|Period 2|Protocol Violation|0|||
130043441|NCT01518699|468117427|FG004|Period 2|Protocol Violation|0|||
130043442|NCT01518699|468117428|FG005|Period 2|Protocol Violation|0|||
130043443|NCT01518699|468117423|FG000|Period 2|Lost to Follow-up|0|||
130043444|NCT01518699|468117424|FG001|Period 2|Lost to Follow-up|1|||
130043445|NCT01518699|468117425|FG002|Period 2|Lost to Follow-up|0|||
130043446|NCT01518699|468117426|FG003|Period 2|Lost to Follow-up|0|||
130043447|NCT01518699|468117427|FG004|Period 2|Lost to Follow-up|0|||
130043448|NCT01518699|468117428|FG005|Period 2|Lost to Follow-up|0|||
130043449|NCT01518699|468117423|FG000|Period 2|Adverse Event|1|||
130043450|NCT01518699|468117424|FG001|Period 2|Adverse Event|0|||
130043451|NCT01518699|468117425|FG002|Period 2|Adverse Event|0|||
130043452|NCT01518699|468117426|FG003|Period 2|Adverse Event|0|||
130043453|NCT01518699|468117427|FG004|Period 2|Adverse Event|0|||
130043454|NCT01518699|468117428|FG005|Period 2|Adverse Event|0|||
130043455|NCT02839746|468117430|FG000|Overall Study|Not met selection criteria|12|||
130043456|NCT00744055|468117431|FG000|Overall Study|Withdrawal by Subject|6|||
130043457|NCT00744055|468117432|FG001|Overall Study|Withdrawal by Subject|9|||
130043458|NCT00744055|468117431|FG000|Overall Study|Lack of Efficacy|0|||
130043459|NCT00744055|468117432|FG001|Overall Study|Lack of Efficacy|1|||
130043460|NCT00744055|468117431|FG000|Overall Study|Physician Decision|0|||
130043461|NCT00744055|468117432|FG001|Overall Study|Physician Decision|2|||
130043462|NCT00744055|468117431|FG000|Overall Study|Protocol Violation|1|||
130043463|NCT00744055|468117432|FG001|Overall Study|Protocol Violation|1|||
130043464|NCT00744055|468117431|FG000|Overall Study|Lost to Follow-up|0|||
130043465|NCT00744055|468117432|FG001|Overall Study|Lost to Follow-up|1|||
130043466|NCT02767570|468117435|FG000|Overall Study|Lost to Follow-up|3|||
130043467|NCT02767570|468117436|FG001|Overall Study|Lost to Follow-up|0|||
130043468|NCT02767570|468117435|FG000|Overall Study|COVID shutdown|2|||
130043469|NCT02767570|468117436|FG001|Overall Study|COVID shutdown|5|||
130043470|NCT02767570|468117435|FG000|Overall Study|Increased pain|2|||
130043471|NCT02767570|468117436|FG001|Overall Study|Increased pain|0|||
130043472|NCT02767570|468117435|FG000|Overall Study|Withdrawal by Subject|1|||
130043473|NCT02767570|468117436|FG001|Overall Study|Withdrawal by Subject|3|||
130043474|NCT02767570|468117435|FG000|Overall Study|Unrelated medical issue|1|||
130043475|NCT02767570|468117436|FG001|Overall Study|Unrelated medical issue|1|||
130043476|NCT02767570|468117435|FG000|Overall Study|Received intra-articular injection|0|||
130043477|NCT02767570|468117436|FG001|Overall Study|Received intra-articular injection|1|||
130286806|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286807|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286808|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286809|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129887475|NCT01474512|467547282|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
129887476|NCT01474512|467547283|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
130043478|NCT00417612|468117437|FG000|Overall Study|Errant diagnosis|0|||
130043479|NCT00417612|468117438|FG001|Overall Study|Errant diagnosis|1|||
130106289|NCT04682639|468349964|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
130043480|NCT00417612|468117437|FG000|Overall Study|Adverse Event|2|||
130043481|NCT00417612|468117438|FG001|Overall Study|Adverse Event|0|||
130043482|NCT00417612|468117437|FG000|Overall Study|Protocol Violation|0|||
130043483|NCT00417612|468117438|FG001|Overall Study|Protocol Violation|2|||
130043484|NCT00417612|468117437|FG000|Overall Study|Lost to Follow-up|1|||
130043485|NCT00417612|468117438|FG001|Overall Study|Lost to Follow-up|0|||
130043486|NCT01330381|468117441|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
130043487|NCT01330381|468117442|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
130043488|NCT01330381|468117443|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
130286810|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286811|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286812|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
130286813|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
130286814|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
130286815|NCT03352557|469012187|FG000|LTE Period: Week 80 to Week 173|Other|0|||
130286816|NCT03352557|469012188|FG001|LTE Period: Week 80 to Week 173|Other|0|||
130286817|NCT03352557|469012189|FG002|LTE Period: Week 80 to Week 173|Other|0|||
130286818|NCT03352557|469012190|FG003|LTE Period: Week 80 to Week 173|Other|0|||
130286819|NCT03352557|469012191|FG004|LTE Period: Week 80 to Week 173|Other|0|||
130286820|NCT03352557|469012192|FG005|LTE Period: Week 80 to Week 173|Other|0|||
130286821|NCT03352557|469012193|FG006|LTE Period: Week 80 to Week 173|Other|0|||
130286822|NCT03352557|469012194|FG007|LTE Period: Week 80 to Week 173|Other|1|||
130286823|NCT03352557|469012195|FG008|LTE Period: Week 80 to Week 173|Other|0|||
130286824|NCT03352557|469012196|FG009|LTE Period: Week 80 to Week 173|Other|0|||
130286825|NCT04065074|469012197|FG000|Overall Study|Adverse Event|1|||
130286826|NCT04065074|469012197|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
130286827|NCT00916058|469012198|FG000|Phase 1|Screen Failure|0|||
130286828|NCT00916058|469012199|FG001|Phase 1|Screen Failure|0|||
130286829|NCT00916058|469012200|FG002|Phase 1|Screen Failure|0|||
129792093|NCT01397825|467207413|FG004|Overall Study|Adverse Event|0|||
129792094|NCT01397825|467207409|FG000|Overall Study|Withdrawal by Subject|1|||
129792095|NCT01397825|467207410|FG001|Overall Study|Withdrawal by Subject|0|||
129792096|NCT01397825|467207411|FG002|Overall Study|Withdrawal by Subject|5|||
129792097|NCT01397825|467207412|FG003|Overall Study|Withdrawal by Subject|1|||
129792098|NCT01397825|467207413|FG004|Overall Study|Withdrawal by Subject|0|||
129792099|NCT00815516|467207414|FG000|Overall Study|Death|3|||
129792100|NCT00815516|467207415|FG001|Overall Study|Death|1|||
129792101|NCT00815516|467207414|FG000|Overall Study|Physician Decision|1|||
129792102|NCT00815516|467207415|FG001|Overall Study|Physician Decision|0|||
129792103|NCT01741012|467207421|FG000|Overall Study|Lost to Follow-up|1|||
129792104|NCT01741012|467207421|FG000|Overall Study|Withdrawal by Subject|2|||
129792105|NCT00470158|467207422|FG000|Overall Study|Death|0|||
129792106|NCT00470158|467207423|FG001|Overall Study|Death|0|||
129792107|NCT00470158|467207424|FG002|Overall Study|Death|0|||
129792108|NCT00470158|467207425|FG003|Overall Study|Death|0|||
129792109|NCT00470158|467207426|FG004|Overall Study|Death|2|||
129792110|NCT00470158|467207422|FG000|Overall Study|Lost to Follow-up|7|||
129792111|NCT00470158|467207423|FG001|Overall Study|Lost to Follow-up|8|||
129792112|NCT00470158|467207424|FG002|Overall Study|Lost to Follow-up|8|||
129792113|NCT00470158|467207425|FG003|Overall Study|Lost to Follow-up|5|||
129792114|NCT00470158|467207426|FG004|Overall Study|Lost to Follow-up|4|||
129792115|NCT00470158|467207422|FG000|Overall Study|Protocol Violation|1|||
129792116|NCT00470158|467207423|FG001|Overall Study|Protocol Violation|0|||
129792117|NCT00470158|467207424|FG002|Overall Study|Protocol Violation|0|||
129792118|NCT00470158|467207425|FG003|Overall Study|Protocol Violation|0|||
129792119|NCT00470158|467207426|FG004|Overall Study|Protocol Violation|0|||
129792120|NCT01236118|467207427|FG000|Overall Study|Adverse Event|2|||
129792121|NCT01236118|467207428|FG001|Overall Study|Adverse Event|0|||
129792122|NCT01236118|467207429|FG002|Overall Study|Adverse Event|2|||
129792123|NCT01236118|467207427|FG000|Overall Study|Physician Decision|0|||
129792124|NCT01236118|467207428|FG001|Overall Study|Physician Decision|1|||
129792125|NCT01236118|467207429|FG002|Overall Study|Physician Decision|0|||
129792126|NCT01236118|467207427|FG000|Overall Study|Withdrawal by Subject|0|||
129792127|NCT01236118|467207428|FG001|Overall Study|Withdrawal by Subject|0|||
129792128|NCT01236118|467207429|FG002|Overall Study|Withdrawal by Subject|1|||
129792129|NCT01129024|467207434|FG000|Overall Study|Physician Decision|5|||
129792130|NCT01129024|467207434|FG000|Overall Study|Study Terminated by Sponsor|8|||
129792131|NCT01129024|467207434|FG000|Overall Study|Withdrawal by Subject|2|||
129792132|NCT01129024|467207434|FG000|Overall Study|Lack of Efficacy|3|||
129792133|NCT01129024|467207434|FG000|Overall Study|Needed a Platelet Transfusion|1|||
129792134|NCT01993836|467207435|FG000|Overall Study|Surgery Cancelled|3|||
129792135|NCT01993836|467207436|FG001|Overall Study|Surgery Cancelled|0|||
130286830|NCT00916058|469012201|FG003|Phase 1|Screen Failure|0|||
130286831|NCT00916058|469012202|FG004|Phase 1|Screen Failure|0|||
129792136|NCT01993836|467207437|FG002|Overall Study|Surgery Cancelled|0|||
129792137|NCT01993836|467207435|FG000|Overall Study|Physician Decision|2|||
129792138|NCT01993836|467207436|FG001|Overall Study|Physician Decision|1|||
129792139|NCT01993836|467207437|FG002|Overall Study|Physician Decision|0|||
129792140|NCT01993836|467207435|FG000|Overall Study|Death|0|||
129792141|NCT01993836|467207436|FG001|Overall Study|Death|2|||
129792142|NCT01993836|467207437|FG002|Overall Study|Death|0|||
129792143|NCT01993836|467207435|FG000|Overall Study|Withdrawal by Subject|12|||
130286832|NCT00916058|469012203|FG005|Phase 1|Screen Failure|1|||
130286833|NCT00916058|469012204|FG006|Phase 1|Screen Failure|0|||
129792144|NCT01993836|467207436|FG001|Overall Study|Withdrawal by Subject|10|||
129792145|NCT01993836|467207437|FG002|Overall Study|Withdrawal by Subject|5|||
129792146|NCT02195687|467207439|FG000|Overall Study|Personal Reasons|1|||
129792147|NCT02195687|467207440|FG001|Overall Study|Personal Reasons|1|||
129792148|NCT02195687|467207439|FG000|Overall Study|Lost to Follow-up|4|||
129887477|NCT01474512|467547284|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
129887478|NCT01474512|467547285|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
129887479|NCT01474512|467547286|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
129887480|NCT01474512|467547287|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
129887481|NCT01474512|467547288|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
129887482|NCT01474512|467547289|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
129887483|NCT01474512|467547272|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
129887484|NCT01474512|467547273|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
129887485|NCT01474512|467547274|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
129887486|NCT01474512|467547275|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
129887487|NCT01474512|467547276|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
129887488|NCT01474512|467547277|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
129887489|NCT01474512|467547278|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
129887490|NCT01474512|467547279|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
129887491|NCT01474512|467547280|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
129887492|NCT01474512|467547281|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
129887493|NCT01474512|467547282|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
129887494|NCT01474512|467547283|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
129887495|NCT01474512|467547284|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
129887496|NCT01474512|467547285|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
129887497|NCT01474512|467547286|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
129887498|NCT01474512|467547287|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
129887499|NCT01474512|467547288|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
129887500|NCT01474512|467547289|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
129887501|NCT01474512|467547272|FG000|Long-Term Extension Period|Physician Decision|0|||
129887502|NCT01474512|467547273|FG001|Long-Term Extension Period|Physician Decision|0|||
129887503|NCT01474512|467547274|FG002|Long-Term Extension Period|Physician Decision|0|||
129887504|NCT01474512|467547275|FG003|Long-Term Extension Period|Physician Decision|0|||
129887505|NCT01474512|467547276|FG004|Long-Term Extension Period|Physician Decision|0|||
129887506|NCT01474512|467547277|FG005|Long-Term Extension Period|Physician Decision|0|||
129887507|NCT01474512|467547278|FG006|Long-Term Extension Period|Physician Decision|0|||
129887508|NCT01474512|467547279|FG007|Long-Term Extension Period|Physician Decision|0|||
129887509|NCT01474512|467547280|FG008|Long-Term Extension Period|Physician Decision|0|||
129887510|NCT01474512|467547281|FG009|Long-Term Extension Period|Physician Decision|0|||
129887511|NCT01474512|467547282|FG010|Long-Term Extension Period|Physician Decision|0|||
129887512|NCT01474512|467547283|FG011|Long-Term Extension Period|Physician Decision|0|||
129887513|NCT01474512|467547284|FG012|Long-Term Extension Period|Physician Decision|21|||
129887514|NCT01474512|467547285|FG013|Long-Term Extension Period|Physician Decision|21|||
129887515|NCT01474512|467547286|FG014|Long-Term Extension Period|Physician Decision|0|||
129887516|NCT01474512|467547287|FG015|Long-Term Extension Period|Physician Decision|0|||
129887517|NCT01474512|467547288|FG016|Long-Term Extension Period|Physician Decision|0|||
129887518|NCT01474512|467547289|FG017|Long-Term Extension Period|Physician Decision|0|||
130043489|NCT01330381|468117441|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
130043490|NCT01330381|468117442|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
130043491|NCT01330381|468117443|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
130043492|NCT01330381|468117441|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
129887519|NCT01474512|467547272|FG000|Long-Term Extension Period|Clinical Relapse|0|||
130043493|NCT01330381|468117442|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
130043494|NCT01330381|468117443|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
129887520|NCT01474512|467547273|FG001|Long-Term Extension Period|Clinical Relapse|0|||
129887521|NCT01474512|467547274|FG002|Long-Term Extension Period|Clinical Relapse|0|||
129887522|NCT01474512|467547275|FG003|Long-Term Extension Period|Clinical Relapse|0|||
129887523|NCT01474512|467547276|FG004|Long-Term Extension Period|Clinical Relapse|0|||
130043495|NCT01330381|468117441|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
130043496|NCT01330381|468117442|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
130043497|NCT01330381|468117443|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
130043498|NCT01330381|468117441|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
130043499|NCT01330381|468117442|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
130043500|NCT01330381|468117443|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
130043501|NCT01330381|468117441|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
130043502|NCT01330381|468117442|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
130043503|NCT01330381|468117443|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
130043504|NCT01330381|468117441|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
130043505|NCT01330381|468117442|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
130043506|NCT01330381|468117443|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
130043507|NCT01330381|468117441|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
130043508|NCT01330381|468117442|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
130043509|NCT01330381|468117443|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
130043510|NCT01330381|468117441|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
130043511|NCT01330381|468117442|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
130043512|NCT01330381|468117443|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
130043513|NCT01330381|468117441|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
130043514|NCT01330381|468117442|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
130043515|NCT01330381|468117443|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
130043516|NCT00224107|468117444|FG000|Overall Study|Adverse Event|20|||
130043517|NCT00224107|468117445|FG001|Overall Study|Adverse Event|6|||
130043518|NCT00224107|468117444|FG000|Overall Study|Protocol Violation|2|||
130043519|NCT00224107|468117445|FG001|Overall Study|Protocol Violation|3|||
130043520|NCT00224107|468117444|FG000|Overall Study|Withdrawal by Subject|1|||
130043521|NCT00224107|468117445|FG001|Overall Study|Withdrawal by Subject|4|||
130043522|NCT00224107|468117444|FG000|Overall Study|Lack of Efficacy|2|||
130043523|NCT00224107|468117445|FG001|Overall Study|Lack of Efficacy|0|||
130043524|NCT00224107|468117444|FG000|Overall Study|Lost to Follow-up|4|||
130043525|NCT00224107|468117445|FG001|Overall Study|Lost to Follow-up|0|||
130043526|NCT00224107|468117444|FG000|Overall Study|Physician Decision|1|||
130043527|NCT00224107|468117445|FG001|Overall Study|Physician Decision|0|||
130043528|NCT00224107|468117444|FG000|Overall Study|Other|1|||
130043529|NCT00224107|468117445|FG001|Overall Study|Other|1|||
130043530|NCT02046564|468117447|FG000|Overall Study|Adverse Event|6|||
130043531|NCT02046564|468117448|FG001|Overall Study|Adverse Event|3|||
130043532|NCT02046564|468117447|FG000|Overall Study|Physician Decision|0|||
130043533|NCT02046564|468117448|FG001|Overall Study|Physician Decision|1|||
130043534|NCT02046564|468117447|FG000|Overall Study|Protocol Violation|3|||
130043535|NCT02046564|468117448|FG001|Overall Study|Protocol Violation|1|||
130043536|NCT02046564|468117447|FG000|Overall Study|Withdrawal by Subject|4|||
130043537|NCT02046564|468117448|FG001|Overall Study|Withdrawal by Subject|10|||
130043538|NCT02046564|468117447|FG000|Overall Study|Subject met withdrawal criteria|2|||
130043539|NCT02046564|468117448|FG001|Overall Study|Subject met withdrawal criteria|5|||
130043540|NCT00984659|468117449|FG000|2-week Run-in Period|Adverse Event|8|||
130043541|NCT00984659|468117450|FG001|2-week Run-in Period|Adverse Event|0|||
130043542|NCT00984659|468117451|FG002|2-week Run-in Period|Adverse Event|0|||
130043543|NCT00984659|468117452|FG003|2-week Run-in Period|Adverse Event|0|||
130043544|NCT00984659|468117449|FG000|2-week Run-in Period|Protocol Violation|5|||
130043545|NCT00984659|468117450|FG001|2-week Run-in Period|Protocol Violation|0|||
130043546|NCT00984659|468117451|FG002|2-week Run-in Period|Protocol Violation|0|||
130043547|NCT00984659|468117452|FG003|2-week Run-in Period|Protocol Violation|0|||
130043548|NCT00984659|468117449|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
130043549|NCT00984659|468117450|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
130043550|NCT00984659|468117451|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
130043551|NCT00984659|468117452|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
130286834|NCT00916058|469012198|FG000|Phase 2|Screen Failure|0|||
130286835|NCT00916058|469012199|FG001|Phase 2|Screen Failure|0|||
130286836|NCT00916058|469012200|FG002|Phase 2|Screen Failure|0|||
130286837|NCT00916058|469012201|FG003|Phase 2|Screen Failure|0|||
130286838|NCT00916058|469012202|FG004|Phase 2|Screen Failure|0|||
130286839|NCT00916058|469012203|FG005|Phase 2|Screen Failure|0|||
130286840|NCT00916058|469012204|FG006|Phase 2|Screen Failure|3|||
129887524|NCT01474512|467547277|FG005|Long-Term Extension Period|Clinical Relapse|0|||
130043552|NCT00984659|468117449|FG000|2-week Run-in Period|Lost to Follow-up|3|||
130043553|NCT00984659|468117450|FG001|2-week Run-in Period|Lost to Follow-up|0|||
130043554|NCT00984659|468117451|FG002|2-week Run-in Period|Lost to Follow-up|0|||
130043555|NCT00984659|468117452|FG003|2-week Run-in Period|Lost to Follow-up|0|||
130043556|NCT00984659|468117449|FG000|2-week Run-in Period|Physician Decision|10|||
130043557|NCT00984659|468117450|FG001|2-week Run-in Period|Physician Decision|0|||
130043558|NCT00984659|468117451|FG002|2-week Run-in Period|Physician Decision|0|||
130286841|NCT00871117|469012205|FG000|Overall Study|Lost to Follow-up|5|||
130286842|NCT00871117|469012206|FG001|Overall Study|Lost to Follow-up|6|||
130286843|NCT00871117|469012205|FG000|Overall Study|Other|0|||
130286844|NCT00871117|469012206|FG001|Overall Study|Other|4|||
130286845|NCT03444766|469012207|FG000|Overall Study|Other Reasons|2|||
130286846|NCT03444766|469012207|FG000|Overall Study|Participant Withdrew Consent|5|||
130286847|NCT03444766|469012207|FG000|Overall Study|Lost to Follow-up|2|||
130286848|NCT03444766|469012207|FG000|Overall Study|Death|2|||
130286849|NCT03444766|469012207|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
130286850|NCT03444766|469012207|FG000|Overall Study|Disease Progression|49|||
130286851|NCT01767493|469012208|FG000|Overall Study|screen failures|3|||
130286852|NCT02275117|469012209|FG000|Overall Study|Adverse Event|0|||
130286853|NCT02275117|469012210|FG001|Overall Study|Adverse Event|0|||
130286854|NCT02275117|469012211|FG002|Overall Study|Adverse Event|0|||
130286855|NCT02275117|469012212|FG003|Overall Study|Adverse Event|0|||
130286856|NCT02275117|469012213|FG004|Overall Study|Adverse Event|1|||
130286857|NCT02275117|469012209|FG000|Overall Study|Lack of Efficacy|6|||
130286858|NCT02275117|469012210|FG001|Overall Study|Lack of Efficacy|7|||
130286859|NCT02275117|469012211|FG002|Overall Study|Lack of Efficacy|5|||
130286860|NCT02275117|469012212|FG003|Overall Study|Lack of Efficacy|2|||
130286861|NCT02275117|469012213|FG004|Overall Study|Lack of Efficacy|10|||
130286862|NCT02275117|469012209|FG000|Overall Study|Lost to Follow-up|11|||
130286863|NCT02275117|469012210|FG001|Overall Study|Lost to Follow-up|16|||
130286864|NCT02275117|469012211|FG002|Overall Study|Lost to Follow-up|15|||
130286865|NCT02275117|469012212|FG003|Overall Study|Lost to Follow-up|16|||
130286866|NCT02275117|469012213|FG004|Overall Study|Lost to Follow-up|8|||
130286867|NCT02275117|469012209|FG000|Overall Study|Physician Decision|0|||
130286868|NCT02275117|469012210|FG001|Overall Study|Physician Decision|1|||
130286869|NCT02275117|469012211|FG002|Overall Study|Physician Decision|1|||
130286870|NCT02275117|469012212|FG003|Overall Study|Physician Decision|0|||
130286871|NCT02275117|469012213|FG004|Overall Study|Physician Decision|1|||
130286872|NCT02275117|469012209|FG000|Overall Study|Protocol Violation|1|||
130286873|NCT02275117|469012210|FG001|Overall Study|Protocol Violation|0|||
130286874|NCT02275117|469012211|FG002|Overall Study|Protocol Violation|1|||
130286875|NCT02275117|469012212|FG003|Overall Study|Protocol Violation|1|||
130286876|NCT02275117|469012213|FG004|Overall Study|Protocol Violation|0|||
130286877|NCT02275117|469012209|FG000|Overall Study|Withdrawal by Subject|6|||
130286878|NCT02275117|469012210|FG001|Overall Study|Withdrawal by Subject|4|||
130286879|NCT02275117|469012211|FG002|Overall Study|Withdrawal by Subject|7|||
130286880|NCT02275117|469012212|FG003|Overall Study|Withdrawal by Subject|3|||
130286881|NCT02275117|469012213|FG004|Overall Study|Withdrawal by Subject|3|||
130286882|NCT02275117|469012209|FG000|Overall Study|Terminated by Sponsor|4|||
130286883|NCT02275117|469012210|FG001|Overall Study|Terminated by Sponsor|4|||
130286884|NCT02275117|469012211|FG002|Overall Study|Terminated by Sponsor|4|||
130286885|NCT02275117|469012212|FG003|Overall Study|Terminated by Sponsor|6|||
130286886|NCT02275117|469012213|FG004|Overall Study|Terminated by Sponsor|4|||
130286887|NCT02275117|469012209|FG000|Overall Study|Worsening of Study Indication|0|||
130286888|NCT02275117|469012210|FG001|Overall Study|Worsening of Study Indication|1|||
129792149|NCT02195687|467207440|FG001|Overall Study|Lost to Follow-up|1|||
129792150|NCT04369924|467207443|FG000|Overall Study|Lost to Follow-up|302|||
129792151|NCT04369924|467207444|FG001|Overall Study|Lost to Follow-up|339|||
129792152|NCT02677324|467207445|FG000|Overall Study|Disease Progression|6|||
129792153|NCT02677324|467207445|FG000|Overall Study|Inability to Swallow pills|1|||
129792154|NCT02677324|467207445|FG000|Overall Study|Non-compliance|1|||
129792155|NCT02677324|467207445|FG000|Overall Study|Lack of Efficacy|1|||
129792156|NCT02677324|467207445|FG000|Overall Study|Medical insurance coverage|1|||
129792157|NCT02677324|467207445|FG000|Overall Study|Adverse Event|1|||
129792158|NCT02677324|467207445|FG000|Overall Study|IgM Myeloma diagnosis|1|||
129792159|NCT02106923|467207450|FG000|Overall Study|Protocol Violation|0|||
129792160|NCT02106923|467207451|FG001|Overall Study|Protocol Violation|0|||
129792161|NCT02106923|467207452|FG002|Overall Study|Protocol Violation|0|||
129792162|NCT02106923|467207453|FG003|Overall Study|Protocol Violation|0|||
129792163|NCT02106923|467207454|FG004|Overall Study|Protocol Violation|0|||
129792164|NCT02106923|467207455|FG005|Overall Study|Protocol Violation|1|||
129792165|NCT03485495|467207456|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
129792166|NCT03485495|467207457|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
129792167|NCT01056380|467207460|FG000|Overall Study|Lost to Follow-up|2|||
129792168|NCT01056380|467207461|FG001|Overall Study|Lost to Follow-up|3|||
129792169|NCT03901456|467207462|FG000|Overall Study|Withdrawal by Subject|0|||
129792170|NCT03901456|467207463|FG001|Overall Study|Withdrawal by Subject|0|||
129792171|NCT03901456|467207464|FG002|Overall Study|Withdrawal by Subject|1|||
129792172|NCT03901456|467207462|FG000|Overall Study|Lost to Follow-up|0|||
129792173|NCT03901456|467207463|FG001|Overall Study|Lost to Follow-up|1|||
129792174|NCT03901456|467207464|FG002|Overall Study|Lost to Follow-up|0|||
129792175|NCT01261780|467207466|FG000|Overall Study|Withdrawal by Subject|1|||
129792176|NCT01261780|467207467|FG001|Overall Study|Withdrawal by Subject|0|||
129792177|NCT01261780|467207466|FG000|Overall Study|Event not related to subject|1|||
129792178|NCT01261780|467207467|FG001|Overall Study|Event not related to subject|2|||
129792179|NCT00732940|467207468|FG000|Overall Study|Withdrawal by Subject|1|||
129792180|NCT00732940|467207469|FG001|Overall Study|Withdrawal by Subject|2|||
129792181|NCT00732940|467207468|FG000|Overall Study|Adverse Event|0|||
129792182|NCT00732940|467207469|FG001|Overall Study|Adverse Event|1|||
129792183|NCT00732940|467207468|FG000|Overall Study|Lost to Follow-up|1|||
129792184|NCT00732940|467207469|FG001|Overall Study|Lost to Follow-up|0|||
129792185|NCT00773838|467207470|FG000|Overall Study|Adverse Event|29|||
129792186|NCT00773838|467207470|FG000|Overall Study|Lost to Follow-up|1|||
129792187|NCT00773838|467207470|FG000|Overall Study|Physician Decision|8|||
129792188|NCT00773838|467207470|FG000|Overall Study|Progressive Disease|82|||
130286889|NCT02275117|469012211|FG002|Overall Study|Worsening of Study Indication|2|||
130286890|NCT02275117|469012212|FG003|Overall Study|Worsening of Study Indication|0|||
130286891|NCT02275117|469012213|FG004|Overall Study|Worsening of Study Indication|0|||
130286892|NCT02275117|469012209|FG000|Overall Study|Study Burden|5|||
129792189|NCT00773838|467207470|FG000|Overall Study|Protocol Violation|2|||
129792190|NCT00773838|467207470|FG000|Overall Study|Withdrawal by Subject|21|||
129792191|NCT03562767|467207476|FG000|Overall Study|Physician Decision|2|||
129792192|NCT03562767|467207477|FG001|Overall Study|Physician Decision|0|||
129792193|NCT03562767|467207478|FG002|Overall Study|Physician Decision|0|||
129792194|NCT03562767|467207476|FG000|Overall Study|Logistic Reason|1|||
129792195|NCT03562767|467207477|FG001|Overall Study|Logistic Reason|3|||
129792196|NCT03562767|467207478|FG002|Overall Study|Logistic Reason|0|||
130286893|NCT02275117|469012210|FG001|Overall Study|Study Burden|4|||
130286894|NCT02275117|469012211|FG002|Overall Study|Study Burden|7|||
129887525|NCT01474512|467547278|FG006|Long-Term Extension Period|Clinical Relapse|0|||
130286895|NCT02275117|469012212|FG003|Overall Study|Study Burden|5|||
130286896|NCT02275117|469012213|FG004|Overall Study|Study Burden|7|||
130286897|NCT02275117|469012209|FG000|Overall Study|Other|1|||
130286898|NCT02275117|469012210|FG001|Overall Study|Other|0|||
130286899|NCT02275117|469012211|FG002|Overall Study|Other|0|||
130286900|NCT02275117|469012212|FG003|Overall Study|Other|0|||
130286901|NCT02275117|469012213|FG004|Overall Study|Other|2|||
130286902|NCT00977938|469012220|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
130286903|NCT00977938|469012221|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
130286904|NCT00977938|469012222|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
130286905|NCT00977938|469012223|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
130286906|NCT00977938|469012220|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
130286907|NCT00977938|469012221|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
130286908|NCT00977938|469012222|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
130286909|NCT00977938|469012223|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
130286910|NCT00977938|469012220|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
130286911|NCT00977938|469012221|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
130286912|NCT00977938|469012222|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
130286913|NCT00977938|469012223|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
130286914|NCT00977938|469012220|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
130286915|NCT00977938|469012221|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
130286916|NCT00977938|469012222|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
130286917|NCT00977938|469012223|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
130286918|NCT00977938|469012220|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
130286919|NCT00977938|469012221|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
130286920|NCT00977938|469012222|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
130286921|NCT00977938|469012223|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
130286922|NCT00977938|469012220|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
130286923|NCT00977938|469012221|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
130286924|NCT00977938|469012222|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
130286925|NCT00977938|469012223|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
129887526|NCT01474512|467547279|FG007|Long-Term Extension Period|Clinical Relapse|0|||
129887527|NCT01474512|467547280|FG008|Long-Term Extension Period|Clinical Relapse|0|||
129887528|NCT01474512|467547281|FG009|Long-Term Extension Period|Clinical Relapse|0|||
129887529|NCT01474512|467547282|FG010|Long-Term Extension Period|Clinical Relapse|0|||
129887530|NCT01474512|467547283|FG011|Long-Term Extension Period|Clinical Relapse|0|||
129887531|NCT01474512|467547284|FG012|Long-Term Extension Period|Clinical Relapse|9|||
130286926|NCT02142283|469012224|FG000|Overall Study|Death|20|||
130286927|NCT02142283|469012225|FG001|Overall Study|Death|18|||
130286928|NCT02142283|469012224|FG000|Overall Study|Withdrawal by Subject|1|||
130286929|NCT02142283|469012225|FG001|Overall Study|Withdrawal by Subject|3|||
130286930|NCT02460783|469012228|FG000|Overall Study|Withdrawal by Subject|1|||
129887532|NCT01474512|467547285|FG013|Long-Term Extension Period|Clinical Relapse|9|||
129887533|NCT01474512|467547286|FG014|Long-Term Extension Period|Clinical Relapse|0|||
129887534|NCT01474512|467547287|FG015|Long-Term Extension Period|Clinical Relapse|0|||
129887535|NCT01474512|467547288|FG016|Long-Term Extension Period|Clinical Relapse|0|||
129887536|NCT01474512|467547289|FG017|Long-Term Extension Period|Clinical Relapse|0|||
129887537|NCT01474512|467547272|FG000|Long-Term Extension Period|Death|0|||
129887538|NCT01474512|467547273|FG001|Long-Term Extension Period|Death|0|||
129887539|NCT01474512|467547274|FG002|Long-Term Extension Period|Death|0|||
130286931|NCT02460783|469012229|FG001|Overall Study|Withdrawal by Subject|3|||
130286932|NCT02460783|469012228|FG000|Overall Study|Lost to Follow-up|1|||
130286933|NCT02460783|469012229|FG001|Overall Study|Lost to Follow-up|1|||
130286934|NCT01646645|469012230|FG000|Overall Study|No Treated|1|||
130286935|NCT01646645|469012230|FG000|Overall Study|Inevaluable Donor|29|||
130286936|NCT02374814|469012236|FG000|Overall Study|Lost to Follow-up|1|||
130286937|NCT02374814|469012237|FG001|Overall Study|Lost to Follow-up|1|||
130286938|NCT02374814|469012238|FG002|Overall Study|Lost to Follow-up|0|||
130286939|NCT02374814|469012239|FG003|Overall Study|Lost to Follow-up|1|||
130286940|NCT02374814|469012240|FG004|Overall Study|Lost to Follow-up|0|||
130106290|NCT04682639|468349960|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
130286941|NCT02374814|469012241|FG005|Overall Study|Lost to Follow-up|0|||
130286942|NCT02374814|469012236|FG000|Overall Study|Withdrawal by Subject|0|||
130286943|NCT02374814|469012237|FG001|Overall Study|Withdrawal by Subject|0|||
130286944|NCT02374814|469012238|FG002|Overall Study|Withdrawal by Subject|1|||
130286945|NCT02374814|469012239|FG003|Overall Study|Withdrawal by Subject|1|||
129887540|NCT01474512|467547275|FG003|Long-Term Extension Period|Death|0|||
129887541|NCT01474512|467547276|FG004|Long-Term Extension Period|Death|0|||
129887542|NCT01474512|467547277|FG005|Long-Term Extension Period|Death|0|||
130286946|NCT02374814|469012240|FG004|Overall Study|Withdrawal by Subject|0|||
130286947|NCT02374814|469012241|FG005|Overall Study|Withdrawal by Subject|0|||
130286948|NCT00884039|469012245|FG000|Overall Study|Withdrawal by Subject|0|||
129887543|NCT01474512|467547278|FG006|Long-Term Extension Period|Death|0|||
129887544|NCT01474512|467547279|FG007|Long-Term Extension Period|Death|0|||
129887545|NCT01474512|467547280|FG008|Long-Term Extension Period|Death|0|||
129887546|NCT01474512|467547281|FG009|Long-Term Extension Period|Death|0|||
129887547|NCT01474512|467547282|FG010|Long-Term Extension Period|Death|0|||
129887548|NCT01474512|467547283|FG011|Long-Term Extension Period|Death|0|||
129887549|NCT01474512|467547284|FG012|Long-Term Extension Period|Death|9|||
129887550|NCT01474512|467547285|FG013|Long-Term Extension Period|Death|9|||
129887551|NCT01474512|467547286|FG014|Long-Term Extension Period|Death|0|||
129887552|NCT01474512|467547287|FG015|Long-Term Extension Period|Death|0|||
129887553|NCT01474512|467547288|FG016|Long-Term Extension Period|Death|0|||
129887554|NCT01474512|467547289|FG017|Long-Term Extension Period|Death|0|||
129887555|NCT01474512|467547272|FG000|Long-Term Extension Period|Sponsor Decision|0|||
129887556|NCT01474512|467547273|FG001|Long-Term Extension Period|Sponsor Decision|0|||
129887557|NCT01474512|467547274|FG002|Long-Term Extension Period|Sponsor Decision|0|||
129887558|NCT01474512|467547275|FG003|Long-Term Extension Period|Sponsor Decision|0|||
129887559|NCT01474512|467547276|FG004|Long-Term Extension Period|Sponsor Decision|0|||
129887560|NCT01474512|467547277|FG005|Long-Term Extension Period|Sponsor Decision|0|||
129887561|NCT01474512|467547278|FG006|Long-Term Extension Period|Sponsor Decision|0|||
129887562|NCT01474512|467547279|FG007|Long-Term Extension Period|Sponsor Decision|0|||
129887563|NCT01474512|467547280|FG008|Long-Term Extension Period|Sponsor Decision|0|||
129887564|NCT01474512|467547281|FG009|Long-Term Extension Period|Sponsor Decision|0|||
129887565|NCT01474512|467547282|FG010|Long-Term Extension Period|Sponsor Decision|0|||
129887566|NCT01474512|467547283|FG011|Long-Term Extension Period|Sponsor Decision|0|||
129887567|NCT01474512|467547284|FG012|Long-Term Extension Period|Sponsor Decision|6|||
129887568|NCT01474512|467547285|FG013|Long-Term Extension Period|Sponsor Decision|6|||
129887569|NCT01474512|467547286|FG014|Long-Term Extension Period|Sponsor Decision|0|||
129887570|NCT01474512|467547287|FG015|Long-Term Extension Period|Sponsor Decision|0|||
129887571|NCT01474512|467547288|FG016|Long-Term Extension Period|Sponsor Decision|0|||
129887572|NCT01474512|467547289|FG017|Long-Term Extension Period|Sponsor Decision|0|||
129887573|NCT01474512|467547272|FG000|Long-Term Extension Period|Protocol Violation|0|||
129887574|NCT01474512|467547273|FG001|Long-Term Extension Period|Protocol Violation|0|||
129887575|NCT01474512|467547274|FG002|Long-Term Extension Period|Protocol Violation|0|||
129887576|NCT01474512|467547275|FG003|Long-Term Extension Period|Protocol Violation|0|||
129887577|NCT01474512|467547276|FG004|Long-Term Extension Period|Protocol Violation|0|||
129887578|NCT01474512|467547277|FG005|Long-Term Extension Period|Protocol Violation|0|||
129887579|NCT01474512|467547278|FG006|Long-Term Extension Period|Protocol Violation|0|||
129887580|NCT01474512|467547279|FG007|Long-Term Extension Period|Protocol Violation|0|||
129887581|NCT01474512|467547280|FG008|Long-Term Extension Period|Protocol Violation|0|||
129887582|NCT01474512|467547281|FG009|Long-Term Extension Period|Protocol Violation|0|||
129887583|NCT01474512|467547282|FG010|Long-Term Extension Period|Protocol Violation|0|||
129887584|NCT01474512|467547283|FG011|Long-Term Extension Period|Protocol Violation|0|||
129887585|NCT01474512|467547284|FG012|Long-Term Extension Period|Protocol Violation|5|||
129887586|NCT01474512|467547285|FG013|Long-Term Extension Period|Protocol Violation|5|||
129887587|NCT01474512|467547286|FG014|Long-Term Extension Period|Protocol Violation|0|||
129887588|NCT01474512|467547287|FG015|Long-Term Extension Period|Protocol Violation|0|||
129887589|NCT01474512|467547288|FG016|Long-Term Extension Period|Protocol Violation|0|||
129887590|NCT01474512|467547289|FG017|Long-Term Extension Period|Protocol Violation|0|||
129887591|NCT01474512|467547272|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887592|NCT01474512|467547273|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887593|NCT01474512|467547274|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887594|NCT01474512|467547275|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887595|NCT01474512|467547276|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887596|NCT01474512|467547277|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887597|NCT01474512|467547278|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887598|NCT01474512|467547279|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887599|NCT01474512|467547280|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887600|NCT01474512|467547281|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887601|NCT01474512|467547282|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887602|NCT01474512|467547283|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887603|NCT01474512|467547284|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
129887604|NCT01474512|467547285|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
129887605|NCT01474512|467547286|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887606|NCT01474512|467547287|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
130043559|NCT00984659|468117452|FG003|2-week Run-in Period|Physician Decision|0|||
129887607|NCT01474512|467547288|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887608|NCT01474512|467547289|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887609|NCT01474512|467547272|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887610|NCT01474512|467547273|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887611|NCT01474512|467547274|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130286949|NCT00884039|469012246|FG001|Overall Study|Withdrawal by Subject|1|||
130286950|NCT00884039|469012245|FG000|Overall Study|Lack of Efficacy|2|||
130286951|NCT00884039|469012246|FG001|Overall Study|Lack of Efficacy|0|||
130286952|NCT00624819|469012249|FG000|Follow-up Period: Year 4|Parents decision|0|||
130286953|NCT00624819|469012250|FG001|Follow-up Period: Year 4|Parents decision|0|||
130286954|NCT00624819|469012251|FG002|Follow-up Period: Year 4|Parents decision|1|||
130286955|NCT00624819|469012252|FG003|Follow-up Period: Year 4|Parents decision|0|||
130286956|NCT00624819|469012249|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
130286957|NCT00624819|469012250|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
130286958|NCT00624819|469012251|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
130286959|NCT00624819|469012252|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
130106291|NCT04682639|468349961|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
130286960|NCT00405964|469012257|FG000|Overall Study|Treatment Failure|17|||
129792197|NCT00509262|467207479|FG000|Overall Study|Adverse Event|16|||
129792198|NCT00509262|467207480|FG001|Overall Study|Adverse Event|18|||
129792199|NCT00509262|467207479|FG000|Overall Study|Other|2|||
129792200|NCT00509262|467207480|FG001|Overall Study|Other|2|||
129792201|NCT00509262|467207479|FG000|Overall Study|Lack of Efficacy|1|||
129792202|NCT00509262|467207480|FG001|Overall Study|Lack of Efficacy|0|||
129792203|NCT00509262|467207479|FG000|Overall Study|Lost to Follow-up|1|||
129792204|NCT00509262|467207480|FG001|Overall Study|Lost to Follow-up|6|||
129792205|NCT00509262|467207479|FG000|Overall Study|Physician Decision|1|||
129792206|NCT00509262|467207480|FG001|Overall Study|Physician Decision|3|||
129792207|NCT00509262|467207479|FG000|Overall Study|Protocol Violation|2|||
129792208|NCT00509262|467207480|FG001|Overall Study|Protocol Violation|2|||
129792209|NCT00509262|467207479|FG000|Overall Study|Withdrawal by Subject|24|||
129792210|NCT00509262|467207480|FG001|Overall Study|Withdrawal by Subject|11|||
129792211|NCT01589770|467207481|FG000|Overall Study|EGFR <60ml/min|6|||
129792212|NCT01589770|467207482|FG001|Overall Study|EGFR <60ml/min|4|||
129792213|NCT01589770|467207481|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
129792214|NCT01589770|467207482|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
129792215|NCT01658813|467207487|FG000|Overall Study|Disease progression|3|||
129792216|NCT00938886|467207488|FG000|Overall Study|Death|0|||
129792217|NCT00938886|467207489|FG001|Overall Study|Death|1|||
129792218|NCT00938886|467207488|FG000|Overall Study|Withdrawal by Subject|4|||
129792219|NCT00938886|467207489|FG001|Overall Study|Withdrawal by Subject|7|||
129792220|NCT00938886|467207488|FG000|Overall Study|Lost to Follow-up|3|||
129792221|NCT00938886|467207489|FG001|Overall Study|Lost to Follow-up|2|||
129792222|NCT02674854|467207494|FG000|Overall Study|Adverse Event|17|||
129792223|NCT02674854|467207495|FG001|Overall Study|Adverse Event|15|||
129792224|NCT02674854|467207496|FG002|Overall Study|Adverse Event|5|||
129792225|NCT02674854|467207494|FG000|Overall Study|Withdrawal by Subject|1|||
129792226|NCT02674854|467207495|FG001|Overall Study|Withdrawal by Subject|5|||
129792227|NCT02674854|467207496|FG002|Overall Study|Withdrawal by Subject|4|||
129792228|NCT02674854|467207494|FG000|Overall Study|No-compliant subject|1|||
129792229|NCT02674854|467207495|FG001|Overall Study|No-compliant subject|0|||
129792230|NCT02674854|467207496|FG002|Overall Study|No-compliant subject|1|||
129792231|NCT02674854|467207494|FG000|Overall Study|Lost to Follow-up|1|||
129792232|NCT02674854|467207495|FG001|Overall Study|Lost to Follow-up|0|||
129792233|NCT02674854|467207496|FG002|Overall Study|Lost to Follow-up|2|||
129792234|NCT02674854|467207494|FG000|Overall Study|Lack of Efficacy|0|||
129792235|NCT02674854|467207495|FG001|Overall Study|Lack of Efficacy|3|||
129792236|NCT02674854|467207496|FG002|Overall Study|Lack of Efficacy|0|||
129792237|NCT02674854|467207494|FG000|Overall Study|Disallowed Concurrent Medication|2|||
129792238|NCT02674854|467207495|FG001|Overall Study|Disallowed Concurrent Medication|2|||
129792239|NCT02674854|467207496|FG002|Overall Study|Disallowed Concurrent Medication|0|||
129792240|NCT02674854|467207494|FG000|Overall Study|Protocol Violation|1|||
129792241|NCT02674854|467207495|FG001|Overall Study|Protocol Violation|1|||
129792242|NCT02674854|467207496|FG002|Overall Study|Protocol Violation|2|||
129792243|NCT02674854|467207494|FG000|Overall Study|Death|0|||
129792244|NCT02674854|467207495|FG001|Overall Study|Death|1|||
129792245|NCT02674854|467207496|FG002|Overall Study|Death|0|||
129792246|NCT02674854|467207494|FG000|Overall Study|Subject missed V6.2|1|||
129792247|NCT02674854|467207495|FG001|Overall Study|Subject missed V6.2|0|||
129792248|NCT02674854|467207496|FG002|Overall Study|Subject missed V6.2|0|||
129792249|NCT00913692|467207497|FG000|Screening (4 Months)|Physician Decision|3|||
129792250|NCT00913692|467207497|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
129792251|NCT00913692|467207497|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
129792252|NCT04738318|467207498|FG000|Overall Study|Protocol Violation|1|||
129792253|NCT04738318|467207499|FG001|Overall Study|Protocol Violation|0|||
129792254|NCT04231981|467207500|FG000|Overall Study|Adverse Event|1|||
129792255|NCT04231981|467207500|FG000|Overall Study|Death|16|||
129792256|NCT04231981|467207500|FG000|Overall Study|Lost to Follow-up|1|||
129792257|NCT02889562|467207501|FG000|Overall Study|Physician Decision|0|||
129792258|NCT02889562|467207502|FG001|Overall Study|Physician Decision|1|||
129792259|NCT02889562|467207501|FG000|Overall Study|Withdrawal by Subject|0|||
129792260|NCT02889562|467207502|FG001|Overall Study|Withdrawal by Subject|1|||
129792261|NCT01470989|467207505|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
129792262|NCT01470989|467207506|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
129792263|NCT01470989|467207505|FG000|Overall Study|Adverse Event|2|||
129792264|NCT01470989|467207506|FG001|Overall Study|Adverse Event|5|||
129792265|NCT01470989|467207505|FG000|Overall Study|Abnormal laboratory value|1|||
129792266|NCT01470989|467207506|FG001|Overall Study|Abnormal laboratory value|1|||
129792267|NCT01470989|467207505|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129792268|NCT01470989|467207506|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129792269|NCT01470989|467207505|FG000|Overall Study|Withdrawal by Subject|19|||
129792270|NCT01470989|467207506|FG001|Overall Study|Withdrawal by Subject|17|||
129792271|NCT01470989|467207505|FG000|Overall Study|Lost to Follow-up|18|||
129792272|NCT01470989|467207506|FG001|Overall Study|Lost to Follow-up|13|||
129792273|NCT01470989|467207505|FG000|Overall Study|Administrative problems|2|||
129792274|NCT01470989|467207506|FG001|Overall Study|Administrative problems|4|||
129792275|NCT01470989|467207505|FG000|Overall Study|Death|2|||
129792276|NCT01470989|467207506|FG001|Overall Study|Death|2|||
129792277|NCT01470989|467207505|FG000|Overall Study|Protocol deviation|1|||
129792278|NCT01470989|467207506|FG001|Overall Study|Protocol deviation|2|||
129792279|NCT00969280|467207507|FG000|Overall Study|Protocol Violation|2|||
129792280|NCT00969280|467207508|FG001|Overall Study|Protocol Violation|1|||
129792281|NCT00969280|467207507|FG000|Overall Study|Withdrawal by Subject|0|||
129792282|NCT00969280|467207508|FG001|Overall Study|Withdrawal by Subject|1|||
129792283|NCT00969280|467207507|FG000|Overall Study|infection of influenza A(H1N1)|0|||
129792284|NCT00969280|467207508|FG001|Overall Study|infection of influenza A(H1N1)|1|||
129792285|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792286|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792287|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792288|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792289|NCT04085367|467209060|FG000|Overall Study|Adverse Event|1|||
129792290|NCT04085367|467209061|FG001|Overall Study|Adverse Event|1|||
129792291|NCT04085367|467209060|FG000|Overall Study|Withdrawal by Subject|13|||
129792292|NCT04085367|467209061|FG001|Overall Study|Withdrawal by Subject|4|||
129792293|NCT04085367|467209060|FG000|Overall Study|Lost to Follow-up|3|||
129792294|NCT04085367|467209061|FG001|Overall Study|Lost to Follow-up|1|||
129792295|NCT04085367|467209060|FG000|Overall Study|Other unspecified|2|||
129792296|NCT04085367|467209061|FG001|Overall Study|Other unspecified|1|||
129792297|NCT04085367|467209060|FG000|Overall Study|Status Unknown|1|||
130106292|NCT04682639|468349962|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
130106293|NCT04682639|468349963|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130106294|NCT04682639|468349964|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130106295|NCT04682639|468349960|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
130106296|NCT04682639|468349961|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
130106297|NCT04682639|468349962|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
129792298|NCT04085367|467209061|FG001|Overall Study|Status Unknown|1|||
129792299|NCT03621475|467209064|FG000|Overall Study|No longer required restraints at initiation|0|||
129792300|NCT03621475|467209065|FG001|Overall Study|No longer required restraints at initiation|1|||
129792301|NCT00706849|467209072|FG000|Treatment Period|Adverse Event|0|||
129792302|NCT00706849|467209073|FG001|Treatment Period|Adverse Event|9|||
129792303|NCT00706849|467209072|FG000|Treatment Period|Other|0|||
130043560|NCT00984659|468117449|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
130043561|NCT00984659|468117450|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130043562|NCT00984659|468117451|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129792304|NCT00706849|467209073|FG001|Treatment Period|Other|1|||
130043563|NCT00984659|468117452|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
130043564|NCT00984659|468117449|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
130286961|NCT00405964|469012258|FG001|Overall Study|Treatment Failure|45|||
130286962|NCT00405964|469012257|FG000|Overall Study|Adverse Event|7|||
130286963|NCT00405964|469012258|FG001|Overall Study|Adverse Event|16|||
130286964|NCT00405964|469012257|FG000|Overall Study|Lost to Follow-up|5|||
130286965|NCT00405964|469012258|FG001|Overall Study|Lost to Follow-up|5|||
130286966|NCT00405964|469012257|FG000|Overall Study|Withdrawal by Subject|19|||
130286967|NCT00405964|469012258|FG001|Overall Study|Withdrawal by Subject|23|||
130286968|NCT00405964|469012257|FG000|Overall Study|Protocol Violation|11|||
130286969|NCT00405964|469012258|FG001|Overall Study|Protocol Violation|6|||
130286970|NCT02981407|469012264|FG000|Overall Study|Withdrawal by Subject|2|||
130286971|NCT02981407|469012265|FG001|Overall Study|Withdrawal by Subject|0|||
130043565|NCT00984659|468117450|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130043566|NCT00984659|468117451|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130286972|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
130286973|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
130286974|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
130286975|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
129792305|NCT00706849|467209072|FG000|Follow-up Period|Withdrawal by Subject|0|||
130043567|NCT00984659|468117452|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
130043568|NCT00984659|468117449|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
130043569|NCT00984659|468117450|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
130043570|NCT00984659|468117451|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
130043571|NCT00984659|468117452|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
130043572|NCT00984659|468117449|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
130043573|NCT00984659|468117450|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
130043574|NCT00984659|468117451|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
130043575|NCT00984659|468117452|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
130043576|NCT00984659|468117449|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
130043577|NCT00984659|468117450|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
130043578|NCT00984659|468117451|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
130043579|NCT00984659|468117452|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
130043580|NCT00984659|468117449|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
130043581|NCT00984659|468117450|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
130043582|NCT00984659|468117451|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
130043583|NCT00984659|468117452|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
130043584|NCT00984659|468117449|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130043585|NCT00984659|468117450|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
130043586|NCT00984659|468117451|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
130286976|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
130286977|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
130286978|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
130286979|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
130286980|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
130286981|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
130286982|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
130286983|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
130286984|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
130286985|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
130286986|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
130286987|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
130286988|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
130286989|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
130286990|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
130286991|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
130286992|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
130286993|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
130286994|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
130286995|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
130286996|NCT00624780|469012269|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
130286997|NCT00624780|469012270|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
130286998|NCT00624780|469012271|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
130286999|NCT00624780|469012272|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
130287000|NCT00624780|469012273|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
130287001|NCT00624780|469012274|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
130287002|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
130043587|NCT00984659|468117452|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
130043588|NCT00308620|468117453|FG000|Overall Study|Death|1|||
130043589|NCT00308620|468117454|FG001|Overall Study|Death|1|||
130043590|NCT00308620|468117455|FG002|Overall Study|Death|0|||
130043591|NCT00308620|468117453|FG000|Overall Study|Lost to Follow-up|0|||
130043592|NCT00308620|468117454|FG001|Overall Study|Lost to Follow-up|0|||
130043593|NCT00308620|468117455|FG002|Overall Study|Lost to Follow-up|1|||
129792306|NCT00706849|467209073|FG001|Follow-up Period|Withdrawal by Subject|2|||
129792307|NCT00706849|467209072|FG000|Follow-up Period|Protocol non-compliance|0|||
129792308|NCT00706849|467209073|FG001|Follow-up Period|Protocol non-compliance|1|||
129792309|NCT01611454|467209074|FG000|Overall Study|Lack of Efficacy|18|||
129792310|NCT01611454|467209075|FG001|Overall Study|Lack of Efficacy|10|||
129792311|NCT03269552|467209077|FG000|Overall Study|Adverse Event|2|||
129792312|NCT00920907|467209078|FG000|Induction Period|Adverse Event|0|||
129792313|NCT00920907|467209079|FG001|Induction Period|Adverse Event|2|||
129792314|NCT00920907|467209078|FG000|Induction Period|Death|1|||
129792315|NCT00920907|467209079|FG001|Induction Period|Death|1|||
129792316|NCT00920907|467209078|FG000|Induction Period|Disease Progression|12|||
129792317|NCT00920907|467209079|FG001|Induction Period|Disease Progression|11|||
129792318|NCT00920907|467209078|FG000|Induction Period|Study Drug Toxicity|8|||
129792319|NCT00920907|467209079|FG001|Induction Period|Study Drug Toxicity|6|||
129792320|NCT00920907|467209078|FG000|Induction Period|No longer meets study criteria|0|||
129792321|NCT00920907|467209079|FG001|Induction Period|No longer meets study criteria|1|||
129792322|NCT00920907|467209078|FG000|Induction Period|Withdrawal by Subject|1|||
129792323|NCT00920907|467209079|FG001|Induction Period|Withdrawal by Subject|1|||
129792324|NCT00920907|467209078|FG000|Maintenance Period|Disease Progression|3|||
129792325|NCT00920907|467209079|FG001|Maintenance Period|Disease Progression|7|||
129792326|NCT00920907|467209078|FG000|Maintenance Period|Administrative (study closure)|7|||
129792327|NCT00920907|467209079|FG001|Maintenance Period|Administrative (study closure)|2|||
129792328|NCT00920907|467209078|FG000|Maintenance Period|Study Drug Toxicity|0|||
129792329|NCT00920907|467209079|FG001|Maintenance Period|Study Drug Toxicity|2|||
129792330|NCT00920907|467209078|FG000|Maintenance Period|Death|1|||
129792331|NCT00920907|467209079|FG001|Maintenance Period|Death|1|||
129792332|NCT00920907|467209078|FG000|Maintenance Period|Withdrawal by Subject|1|||
129792333|NCT00920907|467209079|FG001|Maintenance Period|Withdrawal by Subject|0|||
129792334|NCT00920907|467209078|FG000|Maintenance Period|Adverse Event|0|||
129792335|NCT00920907|467209079|FG001|Maintenance Period|Adverse Event|1|||
129792336|NCT02616601|467209080|FG000|Overall Study|Withdrawal by Subject|4|||
129792337|NCT02616601|467209081|FG001|Overall Study|Withdrawal by Subject|4|||
129792338|NCT02616601|467209082|FG002|Overall Study|Withdrawal by Subject|3|||
129792339|NCT02616601|467209080|FG000|Overall Study|Adverse Event|2|||
129792340|NCT02616601|467209081|FG001|Overall Study|Adverse Event|0|||
129792341|NCT02616601|467209082|FG002|Overall Study|Adverse Event|2|||
129792342|NCT02616601|467209080|FG000|Overall Study|Death|1|||
129792343|NCT02616601|467209081|FG001|Overall Study|Death|0|||
129792344|NCT02616601|467209082|FG002|Overall Study|Death|0|||
130043594|NCT03894540|468117459|FG000|Overall Study|Adverse Event|0|||
130043595|NCT03894540|468117460|FG001|Overall Study|Adverse Event|0|||
129792345|NCT02616601|467209080|FG000|Overall Study|Lost to Follow-up|1|||
129792346|NCT02616601|467209081|FG001|Overall Study|Lost to Follow-up|0|||
129792347|NCT02616601|467209082|FG002|Overall Study|Lost to Follow-up|1|||
129792348|NCT02616601|467209080|FG000|Overall Study|Non-Compliance with Test Article|1|||
129792349|NCT02616601|467209081|FG001|Overall Study|Non-Compliance with Test Article|0|||
129792350|NCT02616601|467209082|FG002|Overall Study|Non-Compliance with Test Article|1|||
129792351|NCT00039871|467209083|FG000|Overall Study|Adverse Event|165|||
129792352|NCT00039871|467209083|FG000|Overall Study|Lost to Follow-up|18|||
129792353|NCT00039871|467209083|FG000|Overall Study|Protocol Violation|24|||
129792354|NCT00039871|467209083|FG000|Overall Study|Withdrawal by Subject|97|||
129792355|NCT00039871|467209083|FG000|Overall Study|Did not meet eligibility criteria|11|||
129792356|NCT00039871|467209083|FG000|Overall Study|Administrative|1|||
129792357|NCT00039871|467209083|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
129792358|NCT00039871|467209083|FG000|Overall Study|Never entered follow-up|7|||
129887612|NCT01474512|467547275|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887613|NCT01474512|467547276|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887614|NCT01474512|467547277|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130043596|NCT03894540|468117461|FG002|Overall Study|Adverse Event|0|||
130043597|NCT03894540|468117462|FG003|Overall Study|Adverse Event|0|||
130043598|NCT03894540|468117463|FG004|Overall Study|Adverse Event|1|||
130043599|NCT03894540|468117464|FG005|Overall Study|Adverse Event|0|||
129792359|NCT02186301|467209084|FG000|Overall Study|Progressive Disease|7|||
129792360|NCT02186301|467209085|FG001|Overall Study|Progressive Disease|22|||
129792361|NCT02186301|467209086|FG002|Overall Study|Progressive Disease|27|||
129792362|NCT02186301|467209084|FG000|Overall Study|Adverse Event|5|||
129792363|NCT02186301|467209085|FG001|Overall Study|Adverse Event|5|||
129887615|NCT01474512|467547278|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130043600|NCT03894540|468117459|FG000|Overall Study|Withdrawal by Subject|0|||
130043601|NCT03894540|468117460|FG001|Overall Study|Withdrawal by Subject|0|||
130043602|NCT03894540|468117461|FG002|Overall Study|Withdrawal by Subject|0|||
130043603|NCT03894540|468117462|FG003|Overall Study|Withdrawal by Subject|0|||
130043604|NCT03894540|468117463|FG004|Overall Study|Withdrawal by Subject|1|||
130043605|NCT03894540|468117464|FG005|Overall Study|Withdrawal by Subject|0|||
130043606|NCT03894540|468117459|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
130043607|NCT03894540|468117460|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
130043608|NCT03894540|468117461|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
130043609|NCT03894540|468117462|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
130043610|NCT03894540|468117463|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
130043611|NCT03894540|468117464|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
130043612|NCT03894540|468117459|FG000|Overall Study|Progressive Disease Clinical|1|||
130043613|NCT03894540|468117460|FG001|Overall Study|Progressive Disease Clinical|1|||
130043614|NCT03894540|468117461|FG002|Overall Study|Progressive Disease Clinical|0|||
130043615|NCT03894540|468117462|FG003|Overall Study|Progressive Disease Clinical|1|||
130043616|NCT03894540|468117463|FG004|Overall Study|Progressive Disease Clinical|5|||
130043617|NCT03894540|468117464|FG005|Overall Study|Progressive Disease Clinical|1|||
130043618|NCT03894540|468117459|FG000|Overall Study|Study termination by sponsor|0|||
130043619|NCT03894540|468117460|FG001|Overall Study|Study termination by sponsor|0|||
130043620|NCT03894540|468117461|FG002|Overall Study|Study termination by sponsor|0|||
130043621|NCT03894540|468117462|FG003|Overall Study|Study termination by sponsor|0|||
130043622|NCT03894540|468117463|FG004|Overall Study|Study termination by sponsor|2|||
130043623|NCT03894540|468117464|FG005|Overall Study|Study termination by sponsor|0|||
130043624|NCT03043365|468117465|FG000|Weeks 0 to Week 8|Adverse Event|1|||
130043625|NCT03043365|468117466|FG001|Weeks 0 to Week 8|Adverse Event|3|||
130043626|NCT03043365|468117465|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
130043627|NCT03043365|468117466|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
130043628|NCT03043365|468117465|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
130043629|NCT03043365|468117466|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
129887616|NCT01474512|467547279|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887617|NCT01474512|467547280|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887618|NCT01474512|467547281|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
130106298|NCT04682639|468349963|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
130043630|NCT02873221|468117467|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130043631|NCT02873221|468117468|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
129887619|NCT01474512|467547282|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887620|NCT01474512|467547283|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
129887621|NCT01474512|467547284|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887622|NCT01474512|467547285|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887623|NCT01474512|467547286|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887624|NCT01474512|467547287|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887625|NCT01474512|467547288|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887626|NCT01474512|467547289|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887627|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
129887628|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
129887629|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
129887630|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
129887631|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
129887632|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
129887633|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
129887634|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
129887635|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
129887636|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
129887637|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
129887638|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
129887639|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
129887640|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
129887641|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
129887642|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
129887643|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
129887644|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
130106299|NCT04682639|468349964|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
130043632|NCT02873221|468117469|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
129887645|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130043633|NCT02873221|468117467|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
130106300|NCT04682639|468349960|FG000|OLE Period (28 Weeks)|Other|1|||
129887646|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887647|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887648|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887649|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130043634|NCT02873221|468117468|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
130043635|NCT02873221|468117469|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
130043636|NCT02873221|468117467|FG000|Treatment Period|Protocol Violation|2|||
130043637|NCT02873221|468117468|FG001|Treatment Period|Protocol Violation|5|||
130043638|NCT02873221|468117469|FG002|Treatment Period|Protocol Violation|8|||
130043639|NCT02873221|468117467|FG000|Treatment Period|Pregnancy|4|||
130043640|NCT02873221|468117468|FG001|Treatment Period|Pregnancy|6|||
130043641|NCT02873221|468117469|FG002|Treatment Period|Pregnancy|3|||
130043642|NCT02873221|468117467|FG000|Treatment Period|Lack of Qualifying Event|0|||
130043643|NCT02873221|468117468|FG001|Treatment Period|Lack of Qualifying Event|3|||
130043644|NCT02873221|468117469|FG002|Treatment Period|Lack of Qualifying Event|1|||
130043645|NCT02873221|468117467|FG000|Treatment Period|Withdrawal of Consent|52|||
130043646|NCT02873221|468117468|FG001|Treatment Period|Withdrawal of Consent|51|||
130043647|NCT02873221|468117469|FG002|Treatment Period|Withdrawal of Consent|41|||
130043648|NCT02873221|468117467|FG000|Treatment Period|Lack of Efficacy|0|||
130043649|NCT02873221|468117468|FG001|Treatment Period|Lack of Efficacy|17|||
130043650|NCT02873221|468117469|FG002|Treatment Period|Lack of Efficacy|12|||
130043651|NCT02873221|468117467|FG000|Treatment Period|Adverse Event|4|||
130043652|NCT02873221|468117468|FG001|Treatment Period|Adverse Event|9|||
130043653|NCT02873221|468117469|FG002|Treatment Period|Adverse Event|11|||
130043654|NCT02873221|468117467|FG000|Treatment Period|Lost to Follow-up|26|||
130043655|NCT02873221|468117468|FG001|Treatment Period|Lost to Follow-up|30|||
130043656|NCT02873221|468117469|FG002|Treatment Period|Lost to Follow-up|26|||
130043657|NCT02873221|468117467|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130043658|NCT02873221|468117468|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
130043659|NCT02873221|468117469|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130043660|NCT02873221|468117467|FG000|Safety Follow-up Period|Protocol Violation|0|||
130043661|NCT02873221|468117468|FG001|Safety Follow-up Period|Protocol Violation|0|||
130043662|NCT02873221|468117469|FG002|Safety Follow-up Period|Protocol Violation|1|||
130043663|NCT02873221|468117467|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
130043664|NCT02873221|468117468|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
130106301|NCT04682639|468349961|FG001|OLE Period (28 Weeks)|Other|2|||
129792364|NCT02186301|467209086|FG002|Overall Study|Adverse Event|5|||
129792365|NCT02186301|467209084|FG000|Overall Study|Death|1|||
129792366|NCT02186301|467209085|FG001|Overall Study|Death|0|||
129792367|NCT02186301|467209086|FG002|Overall Study|Death|0|||
129792368|NCT02186301|467209084|FG000|Overall Study|Withdrawal by Subject|5|||
129792369|NCT02186301|467209085|FG001|Overall Study|Withdrawal by Subject|1|||
129792370|NCT02186301|467209086|FG002|Overall Study|Withdrawal by Subject|3|||
129792371|NCT02186301|467209084|FG000|Overall Study|Physician Decision|1|||
129792372|NCT02186301|467209085|FG001|Overall Study|Physician Decision|0|||
129792373|NCT02186301|467209086|FG002|Overall Study|Physician Decision|1|||
129792374|NCT02186301|467209084|FG000|Overall Study|Study Terminated by Sponsor|1|||
129792375|NCT02186301|467209085|FG001|Overall Study|Study Terminated by Sponsor|0|||
129792376|NCT02186301|467209086|FG002|Overall Study|Study Terminated by Sponsor|11|||
129792377|NCT02186301|467209084|FG000|Overall Study|Protocol Deviation|0|||
129792378|NCT02186301|467209085|FG001|Overall Study|Protocol Deviation|2|||
129792379|NCT02186301|467209086|FG002|Overall Study|Protocol Deviation|0|||
129792380|NCT02186301|467209084|FG000|Overall Study|Missing|0|||
129792381|NCT02186301|467209085|FG001|Overall Study|Missing|0|||
129792382|NCT02186301|467209086|FG002|Overall Study|Missing|2|||
129792383|NCT02186301|467209084|FG000|Overall Study|Other|0|||
129792384|NCT02186301|467209085|FG001|Overall Study|Other|0|||
129792385|NCT02186301|467209086|FG002|Overall Study|Other|1|||
129792386|NCT01275339|467209088|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
129792387|NCT01275339|467209089|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
129792388|NCT01275339|467209090|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
129792389|NCT01275339|467209091|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
129792390|NCT01275339|467209088|FG000|Overall Study|Withdrawal by Subject|0|||
129792391|NCT01275339|467209089|FG001|Overall Study|Withdrawal by Subject|0|||
129792392|NCT01275339|467209090|FG002|Overall Study|Withdrawal by Subject|1|||
129792393|NCT01275339|467209091|FG003|Overall Study|Withdrawal by Subject|0|||
129792394|NCT03560739|467209092|FG000|Overall Study|Adverse Event|0|||
129792395|NCT03560739|467209093|FG001|Overall Study|Adverse Event|1|||
129792396|NCT03560739|467209094|FG002|Overall Study|Adverse Event|0|||
129792397|NCT03560739|467209095|FG003|Overall Study|Adverse Event|0|||
129792398|NCT02478398|467209096|FG000|Overall Study|Adverse Event|20|||
129792399|NCT02478398|467209097|FG001|Overall Study|Adverse Event|5|||
129792400|NCT02478398|467209096|FG000|Overall Study|Lost to Follow-up|5|||
129792401|NCT02478398|467209097|FG001|Overall Study|Lost to Follow-up|4|||
129792402|NCT02478398|467209096|FG000|Overall Study|Non-Compliance With Study Drug|5|||
130043665|NCT02873221|468117469|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
130043666|NCT02873221|468117467|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
130043667|NCT02873221|468117468|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
130043668|NCT02873221|468117469|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
130043669|NCT01325493|468117472|FG000|Overall Study|Protocol Violation|0|||
130043670|NCT01325493|468117473|FG001|Overall Study|Protocol Violation|1|||
130043671|NCT01325493|468117472|FG000|Overall Study|loss of neuromonitoring signals|0|||
130043672|NCT01325493|468117473|FG001|Overall Study|loss of neuromonitoring signals|2|||
130287003|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
130287004|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
130287005|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
130287006|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
130287007|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
130287008|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130287009|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
130287010|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130287011|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
130287012|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
130287013|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
130287014|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130287015|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
130287016|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130287017|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
129792403|NCT02478398|467209097|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129792404|NCT02478398|467209096|FG000|Overall Study|Protocol Violation|3|||
130043673|NCT01325493|468117472|FG000|Overall Study|Allergy|1|||
130043674|NCT01325493|468117473|FG001|Overall Study|Allergy|0|||
130043675|NCT05372315|468117476|FG000|Overall Study|Withdrawal by Subject|1|||
130043676|NCT05372315|468117477|FG001|Overall Study|Withdrawal by Subject|0|||
130043677|NCT01508676|468117480|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
130043678|NCT01508676|468117481|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
130043679|NCT01508676|468117480|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
130043680|NCT01508676|468117481|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
130043681|NCT01508676|468117480|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
130043682|NCT01508676|468117481|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
130043683|NCT01508676|468117480|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
130043684|NCT01508676|468117481|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
130043685|NCT01508676|468117480|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
130043686|NCT01508676|468117481|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
130043687|NCT00650585|468117482|FG000|Overall Study|Lost to Follow-up|505|||
130043688|NCT00650585|468117483|FG001|Overall Study|Lost to Follow-up|482|||
130043689|NCT00650585|468117482|FG000|Overall Study|No parental consent|935|||
130043690|NCT00650585|468117483|FG001|Overall Study|No parental consent|866|||
130043691|NCT00650585|468117482|FG000|Overall Study|Excluded/ruled ineligible|357|||
130043692|NCT00650585|468117483|FG001|Overall Study|Excluded/ruled ineligible|129|||
130043693|NCT02532543|468117485|FG000|Overall Study|Lost to Follow-up|0|||
129792405|NCT02478398|467209097|FG001|Overall Study|Protocol Violation|1|||
129792406|NCT02478398|467209096|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
129792407|NCT02478398|467209097|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129792408|NCT02478398|467209096|FG000|Overall Study|Withdrawal By Participant|10|||
129792409|NCT02478398|467209097|FG001|Overall Study|Withdrawal By Participant|4|||
129792410|NCT03123185|467209098|FG000|Overall Study|Withdrawal by Subject|0|||
129792411|NCT03123185|467209099|FG001|Overall Study|Withdrawal by Subject|0|||
129792412|NCT03123185|467209100|FG002|Overall Study|Withdrawal by Subject|0|||
129792413|NCT03123185|467209101|FG003|Overall Study|Withdrawal by Subject|0|||
129792414|NCT03123185|467209102|FG004|Overall Study|Withdrawal by Subject|0|||
129792415|NCT03123185|467209103|FG005|Overall Study|Withdrawal by Subject|0|||
129792416|NCT03123185|467209104|FG006|Overall Study|Withdrawal by Subject|0|||
129792417|NCT03123185|467209105|FG007|Overall Study|Withdrawal by Subject|0|||
129792418|NCT03123185|467209106|FG008|Overall Study|Withdrawal by Subject|0|||
129792419|NCT03123185|467209107|FG009|Overall Study|Withdrawal by Subject|0|||
129792420|NCT03123185|467209108|FG010|Overall Study|Withdrawal by Subject|0|||
129792421|NCT03123185|467209109|FG011|Overall Study|Withdrawal by Subject|0|||
129792422|NCT03123185|467209110|FG012|Overall Study|Withdrawal by Subject|1|||
129792423|NCT03123185|467209111|FG013|Overall Study|Withdrawal by Subject|0|||
129792424|NCT00880685|467209115|FG000|Memantine 10mg|Lost to Follow-up|2|||
129792425|NCT00880685|467209115|FG000|Memantine 20mg|Withdrawal by Subject|1|||
129792426|NCT01249118|467209116|FG000|First Washout Period|Physician Decision|0|||
129887650|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
130043694|NCT02532543|468117486|FG001|Overall Study|Lost to Follow-up|0|||
130043695|NCT02532543|468117487|FG002|Overall Study|Lost to Follow-up|1|||
130043696|NCT02532543|468117488|FG003|Overall Study|Lost to Follow-up|0|||
130287018|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
130287019|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129792427|NCT01249118|467209117|FG001|First Washout Period|Physician Decision|1|||
129792428|NCT01249118|467209118|FG002|First Washout Period|Physician Decision|0|||
130043697|NCT00923091|468117494|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
130043698|NCT00923091|468117495|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
130043699|NCT00923091|468117496|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
130043700|NCT00923091|468117497|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
130043701|NCT00923091|468117498|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
130043702|NCT00923091|468117499|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
130043703|NCT00923091|468117500|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
130043704|NCT00923091|468117501|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
130043705|NCT00923091|468117502|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130043706|NCT00923091|468117503|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130043707|NCT00923091|468117504|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130043708|NCT00923091|468117505|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130043709|NCT00923091|468117506|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
130043710|NCT00923091|468117494|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
130043711|NCT00923091|468117495|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
130043712|NCT00923091|468117496|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
130043713|NCT00923091|468117497|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
130043714|NCT00923091|468117498|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
130043715|NCT00923091|468117499|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
130043716|NCT00923091|468117500|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
130043717|NCT00923091|468117501|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
130043718|NCT00923091|468117502|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130043719|NCT00923091|468117503|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130043720|NCT00923091|468117504|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130043721|NCT00923091|468117505|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130043722|NCT00923091|468117506|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
130043723|NCT00923091|468117494|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
130043724|NCT00923091|468117495|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
130043725|NCT00923091|468117496|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
130043726|NCT00923091|468117497|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
130043727|NCT00923091|468117498|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
130043728|NCT00923091|468117499|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
130043729|NCT00923091|468117500|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
130043730|NCT00923091|468117501|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
130043731|NCT00923091|468117502|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130043732|NCT00923091|468117503|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130287020|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
130287021|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
130287022|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
130287023|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
130287024|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
130287025|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
130287026|NCT00624780|469012269|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
130287027|NCT00624780|469012270|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
130287028|NCT00624780|469012271|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
130287029|NCT00624780|469012272|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
130287030|NCT00624780|469012273|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
130287031|NCT00624780|469012274|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
130287032|NCT00624780|469012269|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130287033|NCT00624780|469012270|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
130287034|NCT00624780|469012271|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
130287035|NCT00624780|469012272|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130287036|NCT00624780|469012273|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
130287037|NCT00624780|469012274|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
130287038|NCT00624780|469012269|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
130287039|NCT00624780|469012270|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287040|NCT00624780|469012271|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287041|NCT00624780|469012272|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287042|NCT00624780|469012273|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287043|NCT00624780|469012274|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
130287044|NCT00624780|469012269|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287045|NCT00624780|469012270|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287046|NCT00624780|469012271|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
130287047|NCT00624780|469012272|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287048|NCT00624780|469012273|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287049|NCT00624780|469012274|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
130287050|NCT00624780|469012269|FG000|Follow-up (Week 26)|Death|0|||
130287051|NCT00624780|469012270|FG001|Follow-up (Week 26)|Death|0|||
130287052|NCT00624780|469012271|FG002|Follow-up (Week 26)|Death|1|||
130287053|NCT00624780|469012272|FG003|Follow-up (Week 26)|Death|0|||
130043733|NCT00923091|468117504|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130043734|NCT00923091|468117505|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129792429|NCT04179890|467209119|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
129792430|NCT04179890|467209120|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
130043735|NCT00923091|468117506|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
130043736|NCT00923091|468117494|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129792431|NCT04179890|467209119|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
129792432|NCT04179890|467209120|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
129792433|NCT04179890|467209119|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
129792434|NCT04179890|467209120|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
129792435|NCT04179890|467209119|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
129792436|NCT04179890|467209120|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
130043737|NCT00923091|468117495|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043738|NCT00923091|468117496|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043739|NCT00923091|468117497|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043740|NCT00923091|468117498|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043741|NCT00923091|468117499|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
130043742|NCT00923091|468117500|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043743|NCT00923091|468117501|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043744|NCT00923091|468117502|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043745|NCT00923091|468117503|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043746|NCT00923091|468117504|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043747|NCT00923091|468117505|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043748|NCT00923091|468117506|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
130043749|NCT00923091|468117494|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043750|NCT00923091|468117495|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
130043751|NCT00923091|468117496|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043752|NCT00923091|468117497|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
130043753|NCT00923091|468117498|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043754|NCT00923091|468117499|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
130043755|NCT00923091|468117500|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043756|NCT00923091|468117501|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043757|NCT00923091|468117502|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043758|NCT00923091|468117503|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043759|NCT00923091|468117504|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043760|NCT00923091|468117505|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043761|NCT00923091|468117506|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
130043762|NCT00923091|468117494|FG000|Period III (Single-Blind)|Adverse Event|5|||
130043763|NCT00923091|468117495|FG001|Period III (Single-Blind)|Adverse Event|0|||
130043764|NCT00923091|468117496|FG002|Period III (Single-Blind)|Adverse Event|0|||
130043765|NCT00923091|468117497|FG003|Period III (Single-Blind)|Adverse Event|0|||
130043766|NCT00923091|468117498|FG004|Period III (Single-Blind)|Adverse Event|0|||
130043767|NCT00923091|468117499|FG005|Period III (Single-Blind)|Adverse Event|0|||
130043768|NCT00923091|468117500|FG006|Period III (Single-Blind)|Adverse Event|0|||
130043769|NCT00923091|468117501|FG007|Period III (Single-Blind)|Adverse Event|0|||
130043770|NCT00923091|468117502|FG008|Period III (Single-Blind)|Adverse Event|0|||
130043771|NCT00923091|468117503|FG009|Period III (Single-Blind)|Adverse Event|0|||
130043772|NCT00923091|468117504|FG010|Period III (Single-Blind)|Adverse Event|0|||
130043773|NCT00923091|468117505|FG011|Period III (Single-Blind)|Adverse Event|0|||
130043774|NCT00923091|468117506|FG012|Period III (Single-Blind)|Adverse Event|0|||
130043775|NCT00923091|468117494|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
130043776|NCT00923091|468117495|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
130287054|NCT00624780|469012273|FG004|Follow-up (Week 26)|Death|0|||
130287055|NCT00624780|469012274|FG005|Follow-up (Week 26)|Death|0|||
130287056|NCT00624780|469012269|FG000|Follow-up (Week 26)|Adverse Event|0|||
130287057|NCT00624780|469012270|FG001|Follow-up (Week 26)|Adverse Event|0|||
130287058|NCT00624780|469012271|FG002|Follow-up (Week 26)|Adverse Event|0|||
130287059|NCT00624780|469012272|FG003|Follow-up (Week 26)|Adverse Event|0|||
130287060|NCT00624780|469012273|FG004|Follow-up (Week 26)|Adverse Event|1|||
130287061|NCT00624780|469012274|FG005|Follow-up (Week 26)|Adverse Event|0|||
130043777|NCT00923091|468117496|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043778|NCT00923091|468117497|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043779|NCT00923091|468117498|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043780|NCT00923091|468117499|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043781|NCT00923091|468117500|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
130106302|NCT04682639|468349962|FG002|OLE Period (28 Weeks)|Other|0|||
130106303|NCT04682639|468349963|FG003|OLE Period (28 Weeks)|Other|0|||
130106304|NCT04682639|468349964|FG004|OLE Period (28 Weeks)|Other|1|||
130287062|NCT00624780|469012269|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
130287063|NCT00624780|469012270|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
130043782|NCT00923091|468117501|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043783|NCT00923091|468117502|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043784|NCT00923091|468117503|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043785|NCT00923091|468117504|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043786|NCT00923091|468117505|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043787|NCT00923091|468117506|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
130043788|NCT00923091|468117494|FG000|Period III (Single-Blind)|Protocol Violation|3|||
130043789|NCT00923091|468117495|FG001|Period III (Single-Blind)|Protocol Violation|0|||
130043790|NCT00923091|468117496|FG002|Period III (Single-Blind)|Protocol Violation|0|||
130043791|NCT00923091|468117497|FG003|Period III (Single-Blind)|Protocol Violation|0|||
130043792|NCT00923091|468117498|FG004|Period III (Single-Blind)|Protocol Violation|0|||
130043793|NCT00923091|468117499|FG005|Period III (Single-Blind)|Protocol Violation|0|||
130043794|NCT00923091|468117500|FG006|Period III (Single-Blind)|Protocol Violation|0|||
130043795|NCT00923091|468117501|FG007|Period III (Single-Blind)|Protocol Violation|0|||
130043796|NCT00923091|468117502|FG008|Period III (Single-Blind)|Protocol Violation|0|||
130043797|NCT00923091|468117503|FG009|Period III (Single-Blind)|Protocol Violation|0|||
130043798|NCT00923091|468117504|FG010|Period III (Single-Blind)|Protocol Violation|0|||
130043799|NCT00923091|468117505|FG011|Period III (Single-Blind)|Protocol Violation|0|||
130043800|NCT00923091|468117506|FG012|Period III (Single-Blind)|Protocol Violation|0|||
130043801|NCT00923091|468117494|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
130043802|NCT00923091|468117495|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
130043803|NCT00923091|468117496|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
130043804|NCT00923091|468117497|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
130043805|NCT00923091|468117498|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
130043806|NCT00923091|468117499|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
130043807|NCT00923091|468117500|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
130043808|NCT00923091|468117501|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
130043809|NCT00923091|468117502|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
130043810|NCT00923091|468117503|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
130043811|NCT00923091|468117504|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
130043812|NCT00923091|468117505|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
130043813|NCT00923091|468117506|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
130043814|NCT00923091|468117494|FG000|Period IV (Double-Blind)|Adverse Event|2|||
130043815|NCT00923091|468117495|FG001|Period IV (Double-Blind)|Adverse Event|0|||
130043816|NCT00923091|468117496|FG002|Period IV (Double-Blind)|Adverse Event|0|||
130043817|NCT00923091|468117497|FG003|Period IV (Double-Blind)|Adverse Event|0|||
130043818|NCT00923091|468117498|FG004|Period IV (Double-Blind)|Adverse Event|0|||
130043819|NCT00923091|468117499|FG005|Period IV (Double-Blind)|Adverse Event|0|||
130043820|NCT00923091|468117500|FG006|Period IV (Double-Blind)|Adverse Event|0|||
130043821|NCT00923091|468117501|FG007|Period IV (Double-Blind)|Adverse Event|0|||
130043822|NCT00923091|468117502|FG008|Period IV (Double-Blind)|Adverse Event|0|||
130043823|NCT00923091|468117503|FG009|Period IV (Double-Blind)|Adverse Event|0|||
130043824|NCT00923091|468117504|FG010|Period IV (Double-Blind)|Adverse Event|0|||
130043825|NCT00923091|468117505|FG011|Period IV (Double-Blind)|Adverse Event|0|||
130043826|NCT00923091|468117506|FG012|Period IV (Double-Blind)|Adverse Event|0|||
130043827|NCT00923091|468117494|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043828|NCT00923091|468117495|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
130043829|NCT00923091|468117496|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043830|NCT00923091|468117497|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043831|NCT00923091|468117498|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043832|NCT00923091|468117499|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043833|NCT00923091|468117500|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043834|NCT00923091|468117501|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043835|NCT00923091|468117502|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043836|NCT00923091|468117503|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043837|NCT00923091|468117504|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043838|NCT00923091|468117505|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043839|NCT00923091|468117506|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
130043840|NCT00923091|468117494|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
130043841|NCT00923091|468117495|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
130043842|NCT00923091|468117496|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
130043843|NCT00923091|468117497|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
130043844|NCT00923091|468117498|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
130043845|NCT00923091|468117499|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
130043846|NCT00923091|468117500|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
130043847|NCT00923091|468117501|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
130043848|NCT00923091|468117502|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
130043849|NCT00923091|468117503|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
130043850|NCT00923091|468117504|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
130043851|NCT00923091|468117505|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
130043852|NCT00923091|468117506|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
130043853|NCT00923091|468117494|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043854|NCT00923091|468117495|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043855|NCT00923091|468117496|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043856|NCT00923091|468117497|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043857|NCT00923091|468117498|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043858|NCT00923091|468117499|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043859|NCT00923091|468117500|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043860|NCT00923091|468117501|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043861|NCT00923091|468117502|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
130043862|NCT00923091|468117503|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043863|NCT00923091|468117504|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043864|NCT00923091|468117505|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
130043865|NCT00923091|468117506|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
130043866|NCT00923091|468117494|FG000|Period V (Double -Blind)|Protocol Violation|0|||
130043867|NCT00923091|468117495|FG001|Period V (Double -Blind)|Protocol Violation|0|||
130043868|NCT00923091|468117496|FG002|Period V (Double -Blind)|Protocol Violation|0|||
130043869|NCT00923091|468117497|FG003|Period V (Double -Blind)|Protocol Violation|0|||
130043870|NCT00923091|468117498|FG004|Period V (Double -Blind)|Protocol Violation|0|||
130043871|NCT00923091|468117499|FG005|Period V (Double -Blind)|Protocol Violation|0|||
130043872|NCT00923091|468117500|FG006|Period V (Double -Blind)|Protocol Violation|0|||
130043873|NCT00923091|468117501|FG007|Period V (Double -Blind)|Protocol Violation|0|||
130043874|NCT00923091|468117502|FG008|Period V (Double -Blind)|Protocol Violation|0|||
130043875|NCT00923091|468117503|FG009|Period V (Double -Blind)|Protocol Violation|0|||
130043876|NCT00923091|468117504|FG010|Period V (Double -Blind)|Protocol Violation|0|||
130043877|NCT00923091|468117505|FG011|Period V (Double -Blind)|Protocol Violation|0|||
130043878|NCT00923091|468117506|FG012|Period V (Double -Blind)|Protocol Violation|1|||
130043879|NCT00923091|468117494|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
130043880|NCT00923091|468117495|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
130043881|NCT00923091|468117496|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
130043882|NCT00923091|468117497|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
130043883|NCT00923091|468117498|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
130043884|NCT00923091|468117499|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
130043885|NCT00923091|468117500|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
130043886|NCT00923091|468117501|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
130043887|NCT00923091|468117502|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
130043888|NCT00923091|468117503|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
130043889|NCT00923091|468117504|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
130043890|NCT00923091|468117505|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
130043891|NCT00923091|468117506|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
130287064|NCT00624780|469012271|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
130287065|NCT00624780|469012272|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
130287066|NCT00624780|469012273|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
130287067|NCT00624780|469012274|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
130287068|NCT00624780|469012269|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
130043892|NCT00923091|468117494|FG000|Period VI (Open-Label)|Adverse Event|17|||
130043893|NCT00923091|468117495|FG001|Period VI (Open-Label)|Adverse Event|0|||
130043894|NCT00923091|468117496|FG002|Period VI (Open-Label)|Adverse Event|4|||
130043895|NCT00923091|468117497|FG003|Period VI (Open-Label)|Adverse Event|1|||
130043896|NCT00923091|468117498|FG004|Period VI (Open-Label)|Adverse Event|1|||
130043897|NCT00923091|468117499|FG005|Period VI (Open-Label)|Adverse Event|0|||
130043898|NCT00923091|468117500|FG006|Period VI (Open-Label)|Adverse Event|0|||
130043899|NCT00923091|468117501|FG007|Period VI (Open-Label)|Adverse Event|0|||
130043900|NCT00923091|468117502|FG008|Period VI (Open-Label)|Adverse Event|0|||
130043901|NCT00923091|468117503|FG009|Period VI (Open-Label)|Adverse Event|0|||
130043902|NCT00923091|468117504|FG010|Period VI (Open-Label)|Adverse Event|0|||
130043903|NCT00923091|468117505|FG011|Period VI (Open-Label)|Adverse Event|0|||
130043904|NCT00923091|468117506|FG012|Period VI (Open-Label)|Adverse Event|0|||
130043905|NCT00923091|468117494|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
130043906|NCT00923091|468117495|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
130043907|NCT00923091|468117496|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
130043908|NCT00923091|468117497|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
130287069|NCT00624780|469012270|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287070|NCT00624780|469012271|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
130043909|NCT00923091|468117498|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
130043910|NCT00923091|468117499|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043911|NCT00923091|468117500|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043912|NCT00923091|468117501|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043913|NCT00923091|468117502|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043914|NCT00923091|468117503|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043915|NCT00923091|468117504|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043916|NCT00923091|468117505|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043917|NCT00923091|468117506|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
130043918|NCT00923091|468117494|FG000|Period VI (Open-Label)|Protocol Violation|6|||
130043919|NCT00923091|468117495|FG001|Period VI (Open-Label)|Protocol Violation|1|||
130287071|NCT00624780|469012272|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287072|NCT00624780|469012273|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287073|NCT00624780|469012274|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
130287074|NCT00624780|469012269|FG000|Follow-up (Week 26)|Other|1|||
130287075|NCT00624780|469012270|FG001|Follow-up (Week 26)|Other|1|||
130287076|NCT00624780|469012271|FG002|Follow-up (Week 26)|Other|0|||
130287077|NCT00624780|469012272|FG003|Follow-up (Week 26)|Other|0|||
130287078|NCT00624780|469012273|FG004|Follow-up (Week 26)|Other|0|||
130287079|NCT00624780|469012274|FG005|Follow-up (Week 26)|Other|0|||
130287080|NCT00496197|469014620|FG000|Overall Study|Discontinued study due to death|43|||
130287081|NCT00496197|469014620|FG000|Overall Study|Adverse Event|13|||
130287082|NCT00496197|469014620|FG000|Overall Study|Does not meet entrance criteria|5|||
130287083|NCT00496197|469014620|FG000|Overall Study|Insufficient clinical response|3|||
130287084|NCT00496197|469014620|FG000|Overall Study|Insufficient bacteriological response|10|||
130287085|NCT00496197|469014620|FG000|Overall Study|Lost to Follow-up|11|||
130287086|NCT00496197|469014620|FG000|Overall Study|Withdrawal by Subject|11|||
130287087|NCT00496197|469014620|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
130287088|NCT00496197|469014620|FG000|Overall Study|Other|14|||
130287089|NCT00496197|469014620|FG000|Overall Study|Protocol Violation|8|||
130287090|NCT00683917|469014624|FG000|Overall Study|Study prematurely terminated|10|||
130287091|NCT01170598|469014631|FG000|Overall Study|Withdrawal by Subject|1|||
130043920|NCT00923091|468117496|FG002|Period VI (Open-Label)|Protocol Violation|3|||
130287092|NCT01170598|469014631|FG000|Overall Study|Death|3|||
130287093|NCT01170598|469014631|FG000|Overall Study|Lost to Follow-up|1|||
130287094|NCT01170598|469014631|FG000|Overall Study|Refused|1|||
130287095|NCT01779869|469014632|FG000|Overall Study|Physician Decision|2|||
130043921|NCT00923091|468117497|FG003|Period VI (Open-Label)|Protocol Violation|1|||
130043922|NCT00923091|468117498|FG004|Period VI (Open-Label)|Protocol Violation|4|||
130043923|NCT00923091|468117499|FG005|Period VI (Open-Label)|Protocol Violation|0|||
130043924|NCT00923091|468117500|FG006|Period VI (Open-Label)|Protocol Violation|0|||
130043925|NCT00923091|468117501|FG007|Period VI (Open-Label)|Protocol Violation|0|||
130043926|NCT00923091|468117502|FG008|Period VI (Open-Label)|Protocol Violation|0|||
130043927|NCT00923091|468117503|FG009|Period VI (Open-Label)|Protocol Violation|0|||
130043928|NCT00923091|468117504|FG010|Period VI (Open-Label)|Protocol Violation|0|||
130287096|NCT00027378|469014633|FG000|Overall Study|Physician Decision|0|||
130287097|NCT00027378|469014634|FG001|Overall Study|Physician Decision|3|||
130287098|NCT05605691|469014635|FG000|Overall Study|Lost to Follow-up|1|||
130287099|NCT02098369|469014636|FG000|Overall Study|Withdrawal by Subject|1|||
130287100|NCT02098369|469014637|FG001|Overall Study|Withdrawal by Subject|5|||
130287101|NCT02098369|469014638|FG002|Overall Study|Withdrawal by Subject|0|||
130287102|NCT02098369|469014636|FG000|Overall Study|Lost to Follow-up|5|||
130287103|NCT02098369|469014637|FG001|Overall Study|Lost to Follow-up|1|||
130287104|NCT02098369|469014638|FG002|Overall Study|Lost to Follow-up|3|||
129887651|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887652|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887653|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887654|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887655|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887656|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887657|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887658|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887659|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
129887660|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
129887661|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
129887662|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
129887663|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887664|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887665|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887666|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887667|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887668|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887669|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887670|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887671|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887672|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887673|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887674|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887675|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887676|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887677|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
129887678|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
129887679|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
129887680|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
129887681|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887682|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887683|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887684|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887685|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887686|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887687|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130287105|NCT02098369|469014636|FG000|Overall Study|Death|1|||
130287106|NCT02098369|469014637|FG001|Overall Study|Death|1|||
130287107|NCT02098369|469014638|FG002|Overall Study|Death|1|||
130287108|NCT02098369|469014636|FG000|Overall Study|Other|0|||
130287109|NCT02098369|469014637|FG001|Overall Study|Other|2|||
130106305|NCT04682639|468349960|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
130106306|NCT04682639|468349961|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
130106307|NCT04682639|468349962|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
130287110|NCT02098369|469014638|FG002|Overall Study|Other|1|||
130287111|NCT02927925|469014646|FG000|Overall Study|Death|16|||
129887688|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887689|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130043929|NCT00923091|468117505|FG011|Period VI (Open-Label)|Protocol Violation|0|||
130043930|NCT00923091|468117506|FG012|Period VI (Open-Label)|Protocol Violation|0|||
130287112|NCT02927925|469014646|FG000|Overall Study|Physician Decision|1|||
129887690|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130043931|NCT00923091|468117494|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
129887691|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130287113|NCT02927925|469014646|FG000|Overall Study|Withdrawal by Subject|11|||
129887692|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887693|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130043932|NCT00923091|468117495|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
130106308|NCT04682639|468349963|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
130106309|NCT04682639|468349964|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
130106310|NCT04682639|468349960|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
130106311|NCT04682639|468349961|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
130287114|NCT02927925|469014646|FG000|Overall Study|Other|3|||
130287115|NCT02927925|469014646|FG000|Overall Study|Disease progression at clinical cutoff|1|||
130287116|NCT02229214|469014653|FG000|Overall Study|Adverse Event|2|||
130287117|NCT02229214|469014654|FG001|Overall Study|Adverse Event|0|||
130043933|NCT00923091|468117496|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
130043934|NCT00923091|468117497|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
130043935|NCT00923091|468117498|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
130043936|NCT00923091|468117499|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
130043937|NCT00923091|468117500|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
130043938|NCT00923091|468117501|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
130043939|NCT00923091|468117502|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
130043940|NCT00923091|468117503|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
130043941|NCT00923091|468117504|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
130043942|NCT00923091|468117505|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
130043943|NCT00923091|468117506|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
130043944|NCT00923091|468117494|FG000|Period VI (Open-Label)|Other Reason|0|||
130043945|NCT00923091|468117495|FG001|Period VI (Open-Label)|Other Reason|0|||
130287118|NCT02229214|469014653|FG000|Overall Study|Withdrawal by Subject|4|||
130287119|NCT02229214|469014654|FG001|Overall Study|Withdrawal by Subject|0|||
130287120|NCT00246025|469014655|FG000|Overall Study|Adverse Event|7|||
130287121|NCT00246025|469014656|FG001|Overall Study|Adverse Event|9|||
130287122|NCT00246025|469014657|FG002|Overall Study|Adverse Event|9|||
130287123|NCT00246025|469014658|FG003|Overall Study|Adverse Event|10|||
130287124|NCT00246025|469014655|FG000|Overall Study|Withdrawal by Subject|3|||
130287125|NCT00246025|469014656|FG001|Overall Study|Withdrawal by Subject|0|||
130287126|NCT00246025|469014657|FG002|Overall Study|Withdrawal by Subject|1|||
130287127|NCT00246025|469014658|FG003|Overall Study|Withdrawal by Subject|2|||
130287128|NCT00246025|469014655|FG000|Overall Study|unsuitable medical history was found|0|||
130287129|NCT00246025|469014656|FG001|Overall Study|unsuitable medical history was found|0|||
130287130|NCT00246025|469014657|FG002|Overall Study|unsuitable medical history was found|0|||
130287131|NCT00246025|469014658|FG003|Overall Study|unsuitable medical history was found|1|||
130287132|NCT01238835|469014661|FG000|Overall Study|Death|124|||
130287133|NCT01238835|469014661|FG000|Overall Study|Withdrawal by Subject|9|||
130287134|NCT01238835|469014661|FG000|Overall Study|Lost to Follow-up|1|||
130287135|NCT01238835|469014661|FG000|Overall Study|Site early discontinuation|2|||
130287136|NCT00907803|469014663|FG000|Overall Study|Withdrawal of consent - long commute|1|||
130287137|NCT00907803|469014664|FG001|Overall Study|Withdrawal of consent - long commute|0|||
130287138|NCT00907803|469014665|FG002|Overall Study|Withdrawal of consent - long commute|0|||
130287139|NCT00907803|469014663|FG000|Overall Study|Adverse Event|2|||
130287140|NCT00907803|469014664|FG001|Overall Study|Adverse Event|0|||
130287141|NCT00907803|469014665|FG002|Overall Study|Adverse Event|0|||
130287142|NCT00907803|469014663|FG000|Overall Study|Withdrawal by Subject|0|||
130287143|NCT00907803|469014664|FG001|Overall Study|Withdrawal by Subject|1|||
130287144|NCT00907803|469014665|FG002|Overall Study|Withdrawal by Subject|0|||
130287145|NCT00907803|469014663|FG000|Overall Study|Lost to Follow-up|0|||
130287146|NCT00907803|469014664|FG001|Overall Study|Lost to Follow-up|1|||
130287147|NCT00907803|469014665|FG002|Overall Study|Lost to Follow-up|0|||
130287148|NCT00907803|469014663|FG000|Overall Study|Protocol Violation|0|||
130287149|NCT00907803|469014664|FG001|Overall Study|Protocol Violation|1|||
130287150|NCT00907803|469014665|FG002|Overall Study|Protocol Violation|0|||
130287151|NCT03510468|469014666|FG000|Overall Study|Lost to Follow-up|1|||
130287152|NCT03510468|469014666|FG000|Overall Study|Adverse Event|5|||
130287153|NCT03510468|469014666|FG000|Overall Study|Physician Decision|1|||
130287154|NCT03510468|469014666|FG000|Overall Study|non-compliant with treatment|2|||
130287155|NCT03510468|469014666|FG000|Overall Study|Missed visit|1|||
130287156|NCT04612842|469014667|FG000|Overall Study|Lost to Follow-up|20|||
130287157|NCT04612842|469014668|FG001|Overall Study|Lost to Follow-up|11|||
130287158|NCT04612842|469014667|FG000|Overall Study|Withdrawal by Subject|26|||
130287159|NCT04612842|469014668|FG001|Overall Study|Withdrawal by Subject|15|||
130287160|NCT04612842|469014667|FG000|Overall Study|Death|2|||
130287161|NCT04612842|469014668|FG001|Overall Study|Death|2|||
130287162|NCT02419131|469014669|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
130287163|NCT02419131|469014670|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
130287164|NCT02419131|469014671|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
130287165|NCT02419131|469014669|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
129887694|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130287166|NCT02419131|469014670|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
130043946|NCT00923091|468117496|FG002|Period VI (Open-Label)|Other Reason|0|||
130043947|NCT00923091|468117497|FG003|Period VI (Open-Label)|Other Reason|1|||
130043948|NCT00923091|468117498|FG004|Period VI (Open-Label)|Other Reason|1|||
130043949|NCT00923091|468117499|FG005|Period VI (Open-Label)|Other Reason|0|||
130043950|NCT00923091|468117500|FG006|Period VI (Open-Label)|Other Reason|0|||
130043951|NCT00923091|468117501|FG007|Period VI (Open-Label)|Other Reason|0|||
130043952|NCT00923091|468117502|FG008|Period VI (Open-Label)|Other Reason|0|||
130043953|NCT00923091|468117503|FG009|Period VI (Open-Label)|Other Reason|0|||
130043954|NCT00923091|468117504|FG010|Period VI (Open-Label)|Other Reason|0|||
130043955|NCT00923091|468117505|FG011|Period VI (Open-Label)|Other Reason|0|||
130043956|NCT00923091|468117506|FG012|Period VI (Open-Label)|Other Reason|0|||
130043957|NCT00467649|468117507|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
130043958|NCT00467649|468117508|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
130043959|NCT00467649|468117509|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
130043960|NCT00467649|468117510|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
130043961|NCT00467649|468117511|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
130043962|NCT00467649|468117512|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
130043963|NCT00467649|468117507|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
130043964|NCT00467649|468117508|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
130043965|NCT00467649|468117509|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
130043966|NCT00467649|468117510|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
130043967|NCT00467649|468117511|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
130043968|NCT00467649|468117512|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
130043969|NCT00467649|468117507|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
130043970|NCT00467649|468117508|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
130043971|NCT00467649|468117509|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130043972|NCT00467649|468117510|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130043973|NCT00467649|468117511|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130043974|NCT00467649|468117512|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
130043975|NCT00467649|468117507|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
130043976|NCT00467649|468117508|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
130043977|NCT00467649|468117509|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130043978|NCT00467649|468117510|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130043979|NCT00467649|468117511|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130043980|NCT00467649|468117512|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
130043981|NCT00467649|468117507|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
129792437|NCT04179890|467209119|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
129792438|NCT04179890|467209120|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
130043982|NCT00467649|468117508|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130043983|NCT00467649|468117509|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130043984|NCT00467649|468117510|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
130043985|NCT00467649|468117511|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130043986|NCT00467649|468117512|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
130043987|NCT00467649|468117507|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130043988|NCT00467649|468117508|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130043989|NCT00467649|468117509|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130043990|NCT00467649|468117510|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
130043991|NCT00467649|468117511|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130043992|NCT00467649|468117512|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
130043993|NCT00467649|468117507|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130043994|NCT00467649|468117508|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130043995|NCT00467649|468117509|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130043996|NCT00467649|468117510|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130043997|NCT00467649|468117511|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
130043998|NCT00467649|468117512|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
130043999|NCT03633331|468117515|FG000|Overall Study|Withdrawal by Subject|1|||
129792439|NCT04179890|467209119|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
129792440|NCT04179890|467209120|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
129792441|NCT04179890|467209119|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
129792442|NCT04179890|467209120|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
129887695|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
130044000|NCT03233048|468117516|FG000|Overall Study|Withdrawal by Subject|1|||
130044001|NCT00450866|468117521|FG000|Overall Study|Adverse Event|0|||
130044002|NCT00450866|468117522|FG001|Overall Study|Adverse Event|1|||
130044003|NCT00450866|468117521|FG000|Overall Study|Withdrawal by Subject|5|||
130044004|NCT00450866|468117522|FG001|Overall Study|Withdrawal by Subject|2|||
129887696|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887697|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
129887698|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
129887699|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
129887700|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
129887701|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
129887702|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
129887703|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
129887704|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
129887705|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
129887706|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
129887707|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
129887708|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
129887709|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
129887710|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
129887711|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
129887712|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
129887713|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
129887714|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
129887715|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
129887716|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
129887717|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887718|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887719|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887720|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887721|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887722|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887723|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887724|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887725|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887726|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887727|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887728|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887729|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887730|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887731|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887732|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887733|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
129887734|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
129887735|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
129887736|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
129887737|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
129887738|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
129887739|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
129887740|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
129887741|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
129887742|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
129887743|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
129887744|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
129887745|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
129887746|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
129887747|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
129887748|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
129887749|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
129887750|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
129887751|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
130044005|NCT00450866|468117521|FG000|Overall Study|Death|1|||
130044006|NCT00450866|468117522|FG001|Overall Study|Death|0|||
130044007|NCT00450866|468117521|FG000|Overall Study|Physician Decision|1|||
130044008|NCT00450866|468117522|FG001|Overall Study|Physician Decision|0|||
130044009|NCT01743027|468117523|FG000|Overall Study|Adverse Event|2|||
130044010|NCT01743027|468117524|FG001|Overall Study|Adverse Event|0|||
130044011|NCT01743027|468117525|FG002|Overall Study|Adverse Event|0|||
130044012|NCT01743027|468117526|FG003|Overall Study|Adverse Event|0|||
130044013|NCT01743027|468117523|FG000|Overall Study|Lost to Follow-up|0|||
130044014|NCT01743027|468117524|FG001|Overall Study|Lost to Follow-up|0|||
130287167|NCT02419131|469014671|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
130287168|NCT05426031|469014672|FG000|Overall Study|Circulatory Arrest|3|||
130287169|NCT05426031|469014673|FG001|Overall Study|Circulatory Arrest|2|||
130287170|NCT04677660|469014674|FG000|Overall Study|Lost to Follow-up|0|||
130287171|NCT04677660|469014675|FG001|Overall Study|Lost to Follow-up|2|||
130287172|NCT04677660|469014674|FG000|Overall Study|Withdrawal by Subject|0|||
130287173|NCT04677660|469014675|FG001|Overall Study|Withdrawal by Subject|1|||
130044015|NCT01743027|468117525|FG002|Overall Study|Lost to Follow-up|2|||
130044016|NCT01743027|468117526|FG003|Overall Study|Lost to Follow-up|0|||
130044017|NCT01743027|468117523|FG000|Overall Study|Progressive Disease|1|||
130044018|NCT01743027|468117524|FG001|Overall Study|Progressive Disease|4|||
130044019|NCT01743027|468117525|FG002|Overall Study|Progressive Disease|3|||
130044020|NCT01743027|468117526|FG003|Overall Study|Progressive Disease|0|||
130044021|NCT01743027|468117523|FG000|Overall Study|Protocol Violation|1|||
130044022|NCT01743027|468117524|FG001|Overall Study|Protocol Violation|1|||
130044023|NCT01743027|468117525|FG002|Overall Study|Protocol Violation|1|||
130044024|NCT01743027|468117526|FG003|Overall Study|Protocol Violation|0|||
130287174|NCT04677660|469014674|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
130287175|NCT04677660|469014675|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
130044025|NCT01743027|468117523|FG000|Overall Study|Withdrawal by Subject|1|||
130044026|NCT01743027|468117524|FG001|Overall Study|Withdrawal by Subject|0|||
130044027|NCT01743027|468117525|FG002|Overall Study|Withdrawal by Subject|3|||
130044028|NCT01743027|468117526|FG003|Overall Study|Withdrawal by Subject|1|||
130044029|NCT00964795|468117529|FG000|Overall Study|Withdrawal by Subject|79|||
130044030|NCT00964795|468117529|FG000|Overall Study|Adverse Event|12|||
130044031|NCT00964795|468117529|FG000|Overall Study|Death|14|||
130044032|NCT00964795|468117529|FG000|Overall Study|Lost to Follow-up|7|||
130044033|NCT00964795|468117529|FG000|Overall Study|Termination of Study by Sponsor|169|||
130044034|NCT00964795|468117529|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
130044035|NCT00964795|468117529|FG000|Overall Study|Other|23|||
130044036|NCT00586690|468117534|FG000|Overall Study|Death|2|||
130044037|NCT00586690|468117535|FG001|Overall Study|Death|0|||
130044038|NCT00586690|468117534|FG000|Overall Study|Disease Progression|10|||
130044039|NCT00586690|468117535|FG001|Overall Study|Disease Progression|0|||
130044040|NCT00586690|468117534|FG000|Overall Study|Adverse Event|1|||
130287176|NCT02437305|469014679|FG000|Overall Study|Lost to Follow-up|18|||
130287177|NCT02437305|469014680|FG001|Overall Study|Lost to Follow-up|12|||
130287178|NCT01560637|469014697|FG000|Overall Study|Adverse Event|63|||
130287179|NCT01560637|469014697|FG000|Overall Study|Death|69|||
130287180|NCT01560637|469014697|FG000|Overall Study|Lost to Follow-up|8|||
130287181|NCT01560637|469014697|FG000|Overall Study|Protocol Violation|8|||
130287182|NCT01560637|469014697|FG000|Overall Study|Withdrawal by Subject|24|||
130287183|NCT01560637|469014697|FG000|Overall Study|Progressive Disease|20|||
130287184|NCT01560637|469014697|FG000|Overall Study|Other Reason Not Specified|6|||
130287185|NCT01071200|469014698|FG000|Overall Study|Lack of ovarian response|1|||
130287186|NCT01071200|469014699|FG001|Overall Study|Lack of ovarian response|1|||
130287187|NCT01071200|469014698|FG000|Overall Study|No fertilization|4|||
130287188|NCT01071200|469014699|FG001|Overall Study|No fertilization|0|||
130287189|NCT01071200|469014698|FG000|Overall Study|No oocytes retrieved|1|||
130287190|NCT01071200|469014699|FG001|Overall Study|No oocytes retrieved|1|||
130287191|NCT01071200|469014698|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
130044041|NCT00586690|468117535|FG001|Overall Study|Adverse Event|0|||
130044042|NCT00586690|468117534|FG000|Overall Study|Lack of Efficacy|2|||
130044043|NCT00586690|468117535|FG001|Overall Study|Lack of Efficacy|0|||
130044044|NCT00586690|468117534|FG000|Overall Study|Lab can't accommodate|1|||
130044045|NCT00586690|468117535|FG001|Overall Study|Lab can't accommodate|0|||
130044046|NCT00857246|468117536|FG000|Induction Regimen|Adverse Event|1|||
130044047|NCT00857246|468117536|FG000|Induction Regimen|disease-related complications|1|||
130044048|NCT00857246|468117536|FG000|Induction Regimen|Withdrawal by Subject|1|||
130044049|NCT00857246|468117536|FG000|Surgery (Curative)|disease progression|6|||
130044050|NCT00857246|468117536|FG000|ChemoRT|Withdrawal by Subject|1|||
130044051|NCT00857246|468117536|FG000|ChemoRT|Adverse Event|2|||
130044052|NCT02104180|468117549|FG000|Overall Study|Protocol Violation|1|||
130044053|NCT02104180|468117550|FG001|Overall Study|Protocol Violation|0|||
130287192|NCT01071200|469014699|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
130287193|NCT01071200|469014698|FG000|Overall Study|No viable embryos|0|||
130287194|NCT01071200|469014699|FG001|Overall Study|No viable embryos|1|||
130287195|NCT00413920|469014700|FG000|Overall Study|Adverse Event|9|||
130287196|NCT00413920|469014701|FG001|Overall Study|Adverse Event|11|||
129887752|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
129887753|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887754|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887755|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887756|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887757|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887758|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887759|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887760|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887761|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887762|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887763|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887764|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887765|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887766|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887767|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
129887768|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887769|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
129887770|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
130044054|NCT01524289|468117551|FG000|Overall Study|Lost to Follow-up|0|||
130044055|NCT01524289|468117552|FG001|Overall Study|Lost to Follow-up|1|||
130044056|NCT01524289|468117551|FG000|Overall Study|Physician Decision|1|||
130287197|NCT00413920|469014700|FG000|Overall Study|Lack of Efficacy|11|||
130287198|NCT00413920|469014701|FG001|Overall Study|Lack of Efficacy|9|||
130287199|NCT00413920|469014700|FG000|Overall Study|Death|3|||
130287200|NCT00413920|469014701|FG001|Overall Study|Death|5|||
130287201|NCT00413920|469014700|FG000|Overall Study|Graft Loss|5|||
130044057|NCT01524289|468117552|FG001|Overall Study|Physician Decision|0|||
130044058|NCT01524289|468117551|FG000|Overall Study|Protocol Violation|5|||
130287202|NCT00413920|469014701|FG001|Overall Study|Graft Loss|3|||
130287203|NCT03730961|469014702|FG000|Overall Study|Adverse Event|0|||
130287204|NCT03730961|469014703|FG001|Overall Study|Adverse Event|1|||
130287205|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
130287206|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
130287207|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
130287208|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
130044059|NCT01524289|468117552|FG001|Overall Study|Protocol Violation|1|||
130044060|NCT01524289|468117551|FG000|Overall Study|Withdrawal by Subject|11|||
130044061|NCT01524289|468117552|FG001|Overall Study|Withdrawal by Subject|7|||
130044062|NCT01524289|468117551|FG000|Overall Study|Adverse Event|12|||
130044063|NCT01524289|468117552|FG001|Overall Study|Adverse Event|5|||
130044064|NCT01524289|468117551|FG000|Overall Study|Did not take study medication|1|||
130044065|NCT01524289|468117552|FG001|Overall Study|Did not take study medication|0|||
130044066|NCT01089725|468117553|FG000|Overall Study|Adverse Event|1|||
130044067|NCT01089725|468117554|FG001|Overall Study|Adverse Event|1|||
130044068|NCT01089725|468117555|FG002|Overall Study|Adverse Event|0|||
130044069|NCT01089725|468117556|FG003|Overall Study|Adverse Event|0|||
130044070|NCT01089725|468117557|FG004|Overall Study|Adverse Event|2|||
130044071|NCT01089725|468117553|FG000|Overall Study|Lack of Efficacy|4|||
130044072|NCT01089725|468117554|FG001|Overall Study|Lack of Efficacy|3|||
130044073|NCT01089725|468117555|FG002|Overall Study|Lack of Efficacy|1|||
130044074|NCT01089725|468117556|FG003|Overall Study|Lack of Efficacy|0|||
130044075|NCT01089725|468117557|FG004|Overall Study|Lack of Efficacy|4|||
130044076|NCT01089725|468117553|FG000|Overall Study|Lost to Follow-up|2|||
130044077|NCT01089725|468117554|FG001|Overall Study|Lost to Follow-up|2|||
130044078|NCT01089725|468117555|FG002|Overall Study|Lost to Follow-up|0|||
130044079|NCT01089725|468117556|FG003|Overall Study|Lost to Follow-up|3|||
130044080|NCT01089725|468117557|FG004|Overall Study|Lost to Follow-up|0|||
130044081|NCT01089725|468117553|FG000|Overall Study|Protocol Violation|0|||
130044082|NCT01089725|468117554|FG001|Overall Study|Protocol Violation|0|||
129887771|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130044083|NCT01089725|468117555|FG002|Overall Study|Protocol Violation|1|||
130044084|NCT01089725|468117556|FG003|Overall Study|Protocol Violation|1|||
130044085|NCT01089725|468117557|FG004|Overall Study|Protocol Violation|0|||
130044086|NCT01089725|468117553|FG000|Overall Study|Withdrawal by Subject|5|||
130287209|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
129887772|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887773|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887774|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130044087|NCT01089725|468117554|FG001|Overall Study|Withdrawal by Subject|5|||
130044088|NCT01089725|468117555|FG002|Overall Study|Withdrawal by Subject|4|||
130044089|NCT01089725|468117556|FG003|Overall Study|Withdrawal by Subject|5|||
130044090|NCT01089725|468117557|FG004|Overall Study|Withdrawal by Subject|4|||
130287210|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
130044091|NCT01089725|468117553|FG000|Overall Study|Study Terminated by Sponsor|51|||
130044092|NCT01089725|468117554|FG001|Overall Study|Study Terminated by Sponsor|56|||
130044093|NCT01089725|468117555|FG002|Overall Study|Study Terminated by Sponsor|53|||
130044094|NCT01089725|468117556|FG003|Overall Study|Study Terminated by Sponsor|68|||
130044095|NCT01089725|468117557|FG004|Overall Study|Study Terminated by Sponsor|68|||
130044096|NCT01089725|468117553|FG000|Overall Study|Randomized, but not treated|0|||
130044097|NCT01089725|468117554|FG001|Overall Study|Randomized, but not treated|1|||
130044098|NCT01089725|468117555|FG002|Overall Study|Randomized, but not treated|2|||
130044099|NCT01089725|468117556|FG003|Overall Study|Randomized, but not treated|1|||
130044100|NCT01089725|468117557|FG004|Overall Study|Randomized, but not treated|2|||
130044101|NCT01089725|468117553|FG000|Overall Study|Other|3|||
130044102|NCT01089725|468117554|FG001|Overall Study|Other|0|||
130044103|NCT01089725|468117555|FG002|Overall Study|Other|0|||
130044104|NCT01089725|468117556|FG003|Overall Study|Other|1|||
130044105|NCT01089725|468117557|FG004|Overall Study|Other|0|||
130044106|NCT01539837|468119075|FG000|Overall Study|reduce neutrophil level|0|||
130044107|NCT01539837|468119076|FG001|Overall Study|reduce neutrophil level|1|||
130044108|NCT01539837|468119077|FG002|Overall Study|reduce neutrophil level|1|||
130044109|NCT01539837|468119075|FG000|Overall Study|bad compliance|0|||
130044110|NCT01539837|468119076|FG001|Overall Study|bad compliance|0|||
130044111|NCT01539837|468119077|FG002|Overall Study|bad compliance|1|||
130044112|NCT01978912|468119079|FG000|Overall Study|Adverse Event|0|||
130044113|NCT01978912|468119080|FG001|Overall Study|Adverse Event|1|||
130044114|NCT01978912|468119081|FG002|Overall Study|Adverse Event|0|||
130044115|NCT01978912|468119082|FG003|Overall Study|Adverse Event|0|||
130044116|NCT01978912|468119079|FG000|Overall Study|Lost to Follow-up|1|||
130044117|NCT01978912|468119080|FG001|Overall Study|Lost to Follow-up|1|||
130044118|NCT01978912|468119081|FG002|Overall Study|Lost to Follow-up|0|||
130044119|NCT01978912|468119082|FG003|Overall Study|Lost to Follow-up|1|||
129792443|NCT04179890|467209119|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
129792444|NCT04179890|467209120|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
129792445|NCT04179890|467209119|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
129792446|NCT04179890|467209120|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
129792447|NCT00095238|467209121|FG000|Overall Study|Lack of Efficacy|9|||
129792448|NCT00095238|467209122|FG001|Overall Study|Lack of Efficacy|9|||
129792449|NCT00095238|467209121|FG000|Overall Study|Adverse Event|331|||
129792450|NCT00095238|467209122|FG001|Overall Study|Adverse Event|287|||
129792451|NCT00095238|467209121|FG000|Overall Study|Subject Withdrew Consent|208|||
129792452|NCT00095238|467209122|FG001|Overall Study|Subject Withdrew Consent|223|||
129792453|NCT00095238|467209121|FG000|Overall Study|Death|154|||
129792454|NCT00095238|467209122|FG001|Overall Study|Death|170|||
129792455|NCT00095238|467209121|FG000|Overall Study|Lost to Follow-up|19|||
130044120|NCT01978912|468119079|FG000|Overall Study|Withdrawal by Subject|1|||
129792456|NCT00095238|467209122|FG001|Overall Study|Lost to Follow-up|24|||
129792457|NCT00095238|467209121|FG000|Overall Study|Noncompliance|44|||
129792458|NCT00095238|467209122|FG001|Overall Study|Noncompliance|45|||
129792459|NCT00095238|467209121|FG000|Overall Study|No longer met study criteria|4|||
129792460|NCT00095238|467209122|FG001|Overall Study|No longer met study criteria|5|||
129792461|NCT00095238|467209121|FG000|Overall Study|Study terminated by sponsor|0|||
129792462|NCT00095238|467209122|FG001|Overall Study|Study terminated by sponsor|1|||
129792463|NCT00095238|467209121|FG000|Overall Study|Missing|1|||
129792464|NCT00095238|467209122|FG001|Overall Study|Missing|0|||
129792465|NCT00095238|467209121|FG000|Overall Study|Other Reasons|87|||
129792466|NCT00095238|467209122|FG001|Overall Study|Other Reasons|88|||
129792467|NCT04393298|467209125|FG000|Overall Study|Adverse Event|0|||
129792468|NCT04393298|467209126|FG001|Overall Study|Adverse Event|0|||
129792469|NCT04393298|467209127|FG002|Overall Study|Adverse Event|0|||
129792470|NCT04393298|467209128|FG003|Overall Study|Adverse Event|0|||
129792471|NCT04393298|467209129|FG004|Overall Study|Adverse Event|1|||
129792472|NCT04393298|467209130|FG005|Overall Study|Adverse Event|0|||
129792473|NCT04393298|467209131|FG006|Overall Study|Adverse Event|0|||
129792474|NCT04393298|467209132|FG007|Overall Study|Adverse Event|0|||
129792475|NCT04393298|467209133|FG008|Overall Study|Adverse Event|2|||
129792476|NCT04393298|467209134|FG009|Overall Study|Adverse Event|0|||
129792477|NCT04393298|467209135|FG010|Overall Study|Adverse Event|0|||
129792478|NCT04393298|467209136|FG011|Overall Study|Adverse Event|0|||
129792479|NCT04393298|467209137|FG012|Overall Study|Adverse Event|1|||
129792480|NCT04393298|467209138|FG013|Overall Study|Adverse Event|1|||
129792481|NCT04393298|467209139|FG014|Overall Study|Adverse Event|0|||
129792482|NCT04393298|467209125|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792483|NCT04393298|467209126|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129887775|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
130044121|NCT01978912|468119080|FG001|Overall Study|Withdrawal by Subject|0|||
130044122|NCT01978912|468119081|FG002|Overall Study|Withdrawal by Subject|2|||
130044123|NCT01978912|468119082|FG003|Overall Study|Withdrawal by Subject|2|||
130044124|NCT01978912|468119079|FG000|Overall Study|Lumbar Surgery|1|||
130044125|NCT01978912|468119080|FG001|Overall Study|Lumbar Surgery|0|||
130044126|NCT01978912|468119081|FG002|Overall Study|Lumbar Surgery|1|||
130044127|NCT01978912|468119082|FG003|Overall Study|Lumbar Surgery|0|||
130044128|NCT01978912|468119079|FG000|Overall Study|Intradiscal Steroid Injection|0|||
130044129|NCT01978912|468119080|FG001|Overall Study|Intradiscal Steroid Injection|1|||
130044130|NCT01978912|468119081|FG002|Overall Study|Intradiscal Steroid Injection|0|||
130044131|NCT01978912|468119082|FG003|Overall Study|Intradiscal Steroid Injection|0|||
130044132|NCT04220866|468119083|FG000|Overall Study|Death|4|||
130044133|NCT04220866|468119084|FG001|Overall Study|Death|5|||
130044134|NCT04220866|468119083|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
129792484|NCT04393298|467209127|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
129792485|NCT04393298|467209128|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792486|NCT04393298|467209129|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792487|NCT04393298|467209130|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792488|NCT04393298|467209131|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792489|NCT04393298|467209132|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792490|NCT04393298|467209133|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792491|NCT04393298|467209134|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792492|NCT04393298|467209135|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130044135|NCT04220866|468119084|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
130044136|NCT04220866|468119083|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
130044137|NCT04220866|468119084|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
129792493|NCT04393298|467209136|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792494|NCT04393298|467209137|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
130044138|NCT04220866|468119083|FG000|Overall Study|Withdrawal by Subject|0|||
130044139|NCT04220866|468119084|FG001|Overall Study|Withdrawal by Subject|1|||
130044140|NCT03515538|468119085|FG000|Overall Study|Lack of Efficacy|2|||
130044141|NCT03515538|468119086|FG001|Overall Study|Lack of Efficacy|0|||
130044142|NCT03515538|468119087|FG002|Overall Study|Lack of Efficacy|2|||
130044143|NCT03515538|468119088|FG003|Overall Study|Lack of Efficacy|0|||
130044144|NCT03515538|468119085|FG000|Overall Study|Death|0|||
130044145|NCT03515538|468119086|FG001|Overall Study|Death|0|||
130044146|NCT03515538|468119087|FG002|Overall Study|Death|1|||
130044147|NCT03515538|468119088|FG003|Overall Study|Death|0|||
130044148|NCT03515538|468119085|FG000|Overall Study|Protocol Violation|0|||
130044149|NCT03515538|468119086|FG001|Overall Study|Protocol Violation|0|||
130044150|NCT03515538|468119087|FG002|Overall Study|Protocol Violation|0|||
130044151|NCT03515538|468119088|FG003|Overall Study|Protocol Violation|1|||
130044152|NCT03515538|468119085|FG000|Overall Study|Screen failure (baseline dropout)|0|||
130044153|NCT03515538|468119086|FG001|Overall Study|Screen failure (baseline dropout)|1|||
130044154|NCT03515538|468119087|FG002|Overall Study|Screen failure (baseline dropout)|0|||
130044155|NCT03515538|468119088|FG003|Overall Study|Screen failure (baseline dropout)|0|||
130044156|NCT03515538|468119085|FG000|Overall Study|Withdrawal by Subject|2|||
130044157|NCT03515538|468119086|FG001|Overall Study|Withdrawal by Subject|2|||
130044158|NCT03515538|468119087|FG002|Overall Study|Withdrawal by Subject|1|||
130044159|NCT03515538|468119088|FG003|Overall Study|Withdrawal by Subject|3|||
130044160|NCT03515538|468119085|FG000|Overall Study|Physician Decision|1|||
130044161|NCT03515538|468119086|FG001|Overall Study|Physician Decision|0|||
130044162|NCT03515538|468119087|FG002|Overall Study|Physician Decision|0|||
130044163|NCT03515538|468119088|FG003|Overall Study|Physician Decision|1|||
130044164|NCT00546351|468119093|FG000|Overall Study|Adverse Event|76|||
130044165|NCT00546351|468119093|FG000|Overall Study|Lack of Efficacy|15|||
130044166|NCT00546351|468119093|FG000|Overall Study|Withdrawal by Subject|109|||
130044167|NCT00546351|468119093|FG000|Overall Study|Lost to Follow-up|9|||
130044168|NCT00546351|468119093|FG000|Overall Study|Protocol Deviation|1|||
130044169|NCT00546351|468119093|FG000|Overall Study|Unsatisfactory compliance|9|||
130044170|NCT00546351|468119093|FG000|Overall Study|Other reasons for premature termination|17|||
130044171|NCT03952650|468119094|FG000|Overall Study|TRAVEL|0|||
130044172|NCT03952650|468119095|FG001|Overall Study|TRAVEL|4|||
130044173|NCT03952650|468119096|FG002|Overall Study|TRAVEL|0|||
130044174|NCT03952650|468119097|FG003|Overall Study|TRAVEL|4|||
130044175|NCT03952650|468119098|FG004|Overall Study|TRAVEL|0|||
130044176|NCT03952650|468119099|FG005|Overall Study|TRAVEL|3|||
130044177|NCT03952650|468119100|FG006|Overall Study|TRAVEL|2|||
130044178|NCT03952650|468119094|FG000|Overall Study|Withdrawal by Subject|0|||
130044179|NCT03952650|468119095|FG001|Overall Study|Withdrawal by Subject|2|||
130044180|NCT03952650|468119096|FG002|Overall Study|Withdrawal by Subject|0|||
130044181|NCT03952650|468119097|FG003|Overall Study|Withdrawal by Subject|3|||
130044182|NCT03952650|468119098|FG004|Overall Study|Withdrawal by Subject|0|||
130044183|NCT03952650|468119099|FG005|Overall Study|Withdrawal by Subject|1|||
130044184|NCT03952650|468119100|FG006|Overall Study|Withdrawal by Subject|1|||
130044185|NCT03952650|468119094|FG000|Overall Study|Lost to Follow-up|0|||
130044186|NCT03952650|468119095|FG001|Overall Study|Lost to Follow-up|1|||
130044187|NCT03952650|468119096|FG002|Overall Study|Lost to Follow-up|0|||
130044188|NCT03952650|468119097|FG003|Overall Study|Lost to Follow-up|0|||
130044189|NCT03952650|468119098|FG004|Overall Study|Lost to Follow-up|0|||
130044190|NCT03952650|468119099|FG005|Overall Study|Lost to Follow-up|1|||
130044191|NCT03952650|468119100|FG006|Overall Study|Lost to Follow-up|1|||
130044192|NCT03952650|468119094|FG000|Overall Study|Received wrong vaccine and travelled|0|||
130044193|NCT03952650|468119095|FG001|Overall Study|Received wrong vaccine and travelled|0|||
130044194|NCT03952650|468119096|FG002|Overall Study|Received wrong vaccine and travelled|0|||
130044195|NCT03952650|468119097|FG003|Overall Study|Received wrong vaccine and travelled|0|||
130044196|NCT03952650|468119098|FG004|Overall Study|Received wrong vaccine and travelled|0|||
130044197|NCT03952650|468119099|FG005|Overall Study|Received wrong vaccine and travelled|1|||
130044198|NCT03952650|468119100|FG006|Overall Study|Received wrong vaccine and travelled|0|||
130287211|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
130287212|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
130287213|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130287214|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130287215|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
130287216|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
130287217|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Adverse Event|1|||
130287218|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Adverse Event|0|||
130044199|NCT03952650|468119094|FG000|Overall Study|Unable to make study visit|0|||
130044200|NCT03952650|468119095|FG001|Overall Study|Unable to make study visit|0|||
130044201|NCT03952650|468119096|FG002|Overall Study|Unable to make study visit|0|||
130044202|NCT03952650|468119097|FG003|Overall Study|Unable to make study visit|0|||
130044203|NCT03952650|468119098|FG004|Overall Study|Unable to make study visit|0|||
130044204|NCT03952650|468119099|FG005|Overall Study|Unable to make study visit|1|||
130044205|NCT03952650|468119100|FG006|Overall Study|Unable to make study visit|0|||
130044206|NCT02424149|468119101|FG000|Overall Study|surgery cancelled|2|||
129887776|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887777|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887778|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887779|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887780|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887781|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887782|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887783|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887784|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887785|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
129887786|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887787|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887788|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
129887789|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Death|0|||
129887790|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Death|0|||
129887791|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Death|0|||
129887792|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Death|0|||
129887793|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Death|0|||
129887794|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Death|0|||
129887795|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Death|0|||
129887796|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Death|0|||
129887797|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Death|0|||
129887798|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Death|0|||
129887799|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Death|0|||
129887800|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Death|0|||
129887801|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Death|0|||
129887802|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Death|0|||
129887803|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Death|0|||
129887804|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Death|0|||
129887805|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Death|1|||
129887806|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Death|0|||
129887807|NCT01118962|467547292|FG000|Overall Study|Adverse Event|2|||
129887808|NCT01118962|467547292|FG000|Overall Study|Lack of Efficacy|1|||
129887809|NCT01118962|467547292|FG000|Overall Study|Protocol Violation|1|||
129887810|NCT01118962|467547292|FG000|Overall Study|Withdrawal by Subject|4|||
129887811|NCT01118962|467547292|FG000|Overall Study|Pregnancy|1|||
129887812|NCT01118962|467547292|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
129887813|NCT01023308|467547295|FG000|Overall Study|Abnormal test proceedure results|3|||
129887814|NCT01023308|467547296|FG001|Overall Study|Abnormal test proceedure results|8|||
129887815|NCT01023308|467547295|FG000|Overall Study|Administrative problems|2|||
129887816|NCT01023308|467547296|FG001|Overall Study|Administrative problems|1|||
129887817|NCT01023308|467547295|FG000|Overall Study|Adverse Event|130|||
129887818|NCT01023308|467547296|FG001|Overall Study|Adverse Event|66|||
129887819|NCT01023308|467547295|FG000|Overall Study|Death|21|||
129887820|NCT01023308|467547296|FG001|Overall Study|Death|17|||
129887821|NCT01023308|467547295|FG000|Overall Study|Disease progression|82|||
129887822|NCT01023308|467547296|FG001|Overall Study|Disease progression|153|||
129887823|NCT01023308|467547295|FG000|Overall Study|New Cancer therapy|4|||
129887824|NCT01023308|467547296|FG001|Overall Study|New Cancer therapy|7|||
129887825|NCT01023308|467547295|FG000|Overall Study|Protocol Violation|3|||
129887826|NCT01023308|467547296|FG001|Overall Study|Protocol Violation|4|||
129887827|NCT01023308|467547295|FG000|Overall Study|Untreated|5|||
129887828|NCT01023308|467547296|FG001|Overall Study|Untreated|5|||
129887829|NCT01023308|467547295|FG000|Overall Study|Lost to Follow-up|1|||
129887830|NCT01023308|467547296|FG001|Overall Study|Lost to Follow-up|0|||
129887831|NCT01023308|467547295|FG000|Overall Study|Withdrawal by Subject|34|||
129887832|NCT01023308|467547296|FG001|Overall Study|Withdrawal by Subject|18|||
129887833|NCT00262743|467547299|FG000|Overall Study|Adverse Event|0|||
129887834|NCT00262743|467547300|FG001|Overall Study|Adverse Event|9|||
129887835|NCT00262743|467547299|FG000|Overall Study|Disease progression|0|||
130044207|NCT02424149|468119102|FG001|Overall Study|surgery cancelled|0|||
130044208|NCT02424149|468119101|FG000|Overall Study|Withdrawal by Subject|0|||
130044209|NCT02424149|468119102|FG001|Overall Study|Withdrawal by Subject|1|||
129887836|NCT00262743|467547300|FG001|Overall Study|Disease progression|3|||
129887837|NCT04430335|467547307|FG000|Overall Study|Withdrawal by Subject|1|||
129887838|NCT03249376|467547308|FG000|Overall Study|Adverse Event|11|||
129887839|NCT03249376|467547309|FG001|Overall Study|Adverse Event|5|||
129887840|NCT03249376|467547308|FG000|Overall Study|Lack of Efficacy|2|||
129887841|NCT03249376|467547309|FG001|Overall Study|Lack of Efficacy|4|||
129887842|NCT03249376|467547308|FG000|Overall Study|Protocol Violation|3|||
129887843|NCT03249376|467547309|FG001|Overall Study|Protocol Violation|2|||
129887844|NCT03249376|467547308|FG000|Overall Study|Physician Decision|0|||
129887845|NCT03249376|467547309|FG001|Overall Study|Physician Decision|2|||
129887846|NCT03249376|467547308|FG000|Overall Study|Withdrawal by Subject|3|||
129887847|NCT03249376|467547309|FG001|Overall Study|Withdrawal by Subject|9|||
129887848|NCT03249376|467547308|FG000|Overall Study|LTFU|2|||
130044210|NCT00592683|468119103|FG000|Overall Study|Found ineligible|0|||
129792495|NCT04393298|467209138|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792496|NCT04393298|467209139|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
129792497|NCT04393298|467209125|FG000|Overall Study|Lack of Efficacy|0|||
129792498|NCT04393298|467209126|FG001|Overall Study|Lack of Efficacy|0|||
129792499|NCT04393298|467209127|FG002|Overall Study|Lack of Efficacy|0|||
129792500|NCT04393298|467209128|FG003|Overall Study|Lack of Efficacy|0|||
129792501|NCT04393298|467209129|FG004|Overall Study|Lack of Efficacy|0|||
129792502|NCT04393298|467209130|FG005|Overall Study|Lack of Efficacy|0|||
129792503|NCT04393298|467209131|FG006|Overall Study|Lack of Efficacy|0|||
129792504|NCT04393298|467209132|FG007|Overall Study|Lack of Efficacy|0|||
129792505|NCT04393298|467209133|FG008|Overall Study|Lack of Efficacy|0|||
129792506|NCT04393298|467209134|FG009|Overall Study|Lack of Efficacy|0|||
129792507|NCT04393298|467209135|FG010|Overall Study|Lack of Efficacy|0|||
129792508|NCT04393298|467209136|FG011|Overall Study|Lack of Efficacy|0|||
129792509|NCT04393298|467209137|FG012|Overall Study|Lack of Efficacy|0|||
129792510|NCT04393298|467209138|FG013|Overall Study|Lack of Efficacy|0|||
129792511|NCT04393298|467209139|FG014|Overall Study|Lack of Efficacy|1|||
129792512|NCT04393298|467209125|FG000|Overall Study|Progression|1|||
129792513|NCT04393298|467209126|FG001|Overall Study|Progression|0|||
129792514|NCT04393298|467209127|FG002|Overall Study|Progression|0|||
129792515|NCT04393298|467209128|FG003|Overall Study|Progression|0|||
129792516|NCT04393298|467209129|FG004|Overall Study|Progression|0|||
129792517|NCT04393298|467209130|FG005|Overall Study|Progression|0|||
129792518|NCT04393298|467209131|FG006|Overall Study|Progression|0|||
129792519|NCT04393298|467209132|FG007|Overall Study|Progression|0|||
129792520|NCT04393298|467209133|FG008|Overall Study|Progression|0|||
129792521|NCT04393298|467209134|FG009|Overall Study|Progression|0|||
129792522|NCT04393298|467209135|FG010|Overall Study|Progression|1|||
129792523|NCT04393298|467209136|FG011|Overall Study|Progression|1|||
129792524|NCT04393298|467209137|FG012|Overall Study|Progression|0|||
129792525|NCT04393298|467209138|FG013|Overall Study|Progression|0|||
129792526|NCT04393298|467209139|FG014|Overall Study|Progression|0|||
129792527|NCT04393298|467209125|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
129792528|NCT04393298|467209126|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792529|NCT04393298|467209127|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792530|NCT04393298|467209128|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792531|NCT04393298|467209129|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792532|NCT04393298|467209130|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792533|NCT04393298|467209131|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792534|NCT04393298|467209132|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792535|NCT04393298|467209133|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792536|NCT04393298|467209134|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792537|NCT04393298|467209135|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792538|NCT04393298|467209136|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792539|NCT04393298|467209137|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792540|NCT04393298|467209138|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792541|NCT04393298|467209139|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792542|NCT04393298|467209125|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792543|NCT04393298|467209126|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
129792544|NCT04393298|467209127|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792545|NCT04393298|467209128|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792546|NCT04393298|467209129|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792547|NCT04393298|467209130|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792548|NCT04393298|467209131|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792549|NCT04393298|467209132|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792550|NCT04393298|467209133|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792551|NCT04393298|467209134|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792552|NCT04393298|467209135|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792553|NCT04393298|467209136|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792554|NCT04393298|467209137|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792555|NCT04393298|467209138|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792556|NCT04393298|467209139|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792557|NCT04393298|467209125|FG000|Overall Study|Clinical Progression|0|||
129792558|NCT04393298|467209126|FG001|Overall Study|Clinical Progression|2|||
129792559|NCT04393298|467209127|FG002|Overall Study|Clinical Progression|0|||
129792560|NCT04393298|467209128|FG003|Overall Study|Clinical Progression|0|||
129792561|NCT04393298|467209129|FG004|Overall Study|Clinical Progression|0|||
129792562|NCT04393298|467209130|FG005|Overall Study|Clinical Progression|0|||
129792563|NCT04393298|467209131|FG006|Overall Study|Clinical Progression|0|||
129792564|NCT04393298|467209132|FG007|Overall Study|Clinical Progression|0|||
129792565|NCT04393298|467209133|FG008|Overall Study|Clinical Progression|0|||
129792566|NCT04393298|467209134|FG009|Overall Study|Clinical Progression|0|||
129792567|NCT04393298|467209135|FG010|Overall Study|Clinical Progression|0|||
129792568|NCT04393298|467209136|FG011|Overall Study|Clinical Progression|0|||
129792569|NCT04393298|467209137|FG012|Overall Study|Clinical Progression|0|||
129792570|NCT04393298|467209138|FG013|Overall Study|Clinical Progression|0|||
129792571|NCT04393298|467209139|FG014|Overall Study|Clinical Progression|0|||
129792572|NCT04393298|467209125|FG000|Overall Study|Disease Progression|0|||
129792573|NCT04393298|467209126|FG001|Overall Study|Disease Progression|1|||
129792574|NCT04393298|467209127|FG002|Overall Study|Disease Progression|0|||
129792575|NCT04393298|467209128|FG003|Overall Study|Disease Progression|0|||
129792576|NCT04393298|467209129|FG004|Overall Study|Disease Progression|0|||
129792577|NCT04393298|467209130|FG005|Overall Study|Disease Progression|3|||
129792578|NCT04393298|467209131|FG006|Overall Study|Disease Progression|2|||
129792579|NCT04393298|467209132|FG007|Overall Study|Disease Progression|1|||
129792580|NCT04393298|467209133|FG008|Overall Study|Disease Progression|2|||
129792581|NCT04393298|467209134|FG009|Overall Study|Disease Progression|1|||
129792582|NCT04393298|467209135|FG010|Overall Study|Disease Progression|0|||
129792583|NCT04393298|467209136|FG011|Overall Study|Disease Progression|3|||
129792584|NCT04393298|467209137|FG012|Overall Study|Disease Progression|0|||
129792585|NCT04393298|467209138|FG013|Overall Study|Disease Progression|0|||
129792586|NCT04393298|467209139|FG014|Overall Study|Disease Progression|1|||
129792587|NCT04393298|467209125|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792588|NCT04393298|467209126|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792589|NCT04393298|467209127|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
129792590|NCT04393298|467209128|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792591|NCT04393298|467209129|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792592|NCT04393298|467209130|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792593|NCT04393298|467209131|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792594|NCT04393298|467209132|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792595|NCT04393298|467209133|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792596|NCT04393298|467209134|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792597|NCT04393298|467209135|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792598|NCT04393298|467209136|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792599|NCT04393298|467209137|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792600|NCT04393298|467209138|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792601|NCT04393298|467209139|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792602|NCT04393298|467209125|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792603|NCT04393298|467209126|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792604|NCT04393298|467209127|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
129792605|NCT04393298|467209128|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792606|NCT04393298|467209129|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
130287219|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Adverse Event|2|||
130287220|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Adverse Event|0|||
130287221|NCT01185964|469014709|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
130287222|NCT01185964|469014710|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
130287223|NCT01185964|469014711|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
130287224|NCT01185964|469014712|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
130287225|NCT01185964|469014709|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130287226|NCT01185964|469014710|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130287227|NCT01185964|469014711|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
130287228|NCT01185964|469014712|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
130287229|NCT01185964|469014709|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130287230|NCT01185964|469014710|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130287231|NCT01185964|469014711|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
130287232|NCT01185964|469014712|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
130287233|NCT01185964|469014709|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130287234|NCT01185964|469014710|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130287235|NCT01185964|469014711|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
130287236|NCT01185964|469014712|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
130287237|NCT01920893|469014713|FG000|Overall Study|Adverse Event|5|||
130287238|NCT01920893|469014714|FG001|Overall Study|Adverse Event|2|||
130287239|NCT01920893|469014713|FG000|Overall Study|Lack of Efficacy|2|||
130287240|NCT01920893|469014714|FG001|Overall Study|Lack of Efficacy|0|||
130287241|NCT03762616|469014715|FG000|Overall Study|Protocol Violation|2|||
130287242|NCT04465877|469014716|FG000|Overall Study|Noncompliant with study requirements|0|||
130287243|NCT04465877|469014717|FG001|Overall Study|Noncompliant with study requirements|0|||
130287244|NCT04465877|469014718|FG002|Overall Study|Noncompliant with study requirements|1|||
130287245|NCT04465877|469014719|FG003|Overall Study|Noncompliant with study requirements|0|||
130287246|NCT02323204|469014723|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
130287247|NCT02323204|469014724|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
130287248|NCT02323204|469014725|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
130287249|NCT02323204|469014726|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
129792607|NCT04393298|467209130|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792608|NCT04393298|467209131|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792609|NCT04393298|467209132|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792610|NCT04393298|467209133|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792611|NCT04393298|467209134|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792612|NCT04393298|467209135|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792613|NCT04393298|467209136|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792614|NCT04393298|467209137|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792615|NCT04393298|467209138|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792616|NCT04393298|467209139|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792617|NCT04393298|467209125|FG000|Overall Study|Progressive Disease (PD)|0|||
129792618|NCT04393298|467209126|FG001|Overall Study|Progressive Disease (PD)|0|||
129792619|NCT04393298|467209127|FG002|Overall Study|Progressive Disease (PD)|0|||
129792620|NCT04393298|467209128|FG003|Overall Study|Progressive Disease (PD)|3|||
129792621|NCT04393298|467209129|FG004|Overall Study|Progressive Disease (PD)|0|||
129792622|NCT04393298|467209130|FG005|Overall Study|Progressive Disease (PD)|0|||
129792623|NCT04393298|467209131|FG006|Overall Study|Progressive Disease (PD)|0|||
129792624|NCT04393298|467209132|FG007|Overall Study|Progressive Disease (PD)|0|||
129792625|NCT04393298|467209133|FG008|Overall Study|Progressive Disease (PD)|0|||
129792626|NCT04393298|467209134|FG009|Overall Study|Progressive Disease (PD)|0|||
129792627|NCT04393298|467209135|FG010|Overall Study|Progressive Disease (PD)|0|||
129792628|NCT04393298|467209136|FG011|Overall Study|Progressive Disease (PD)|0|||
129792629|NCT04393298|467209137|FG012|Overall Study|Progressive Disease (PD)|0|||
129792630|NCT04393298|467209138|FG013|Overall Study|Progressive Disease (PD)|0|||
129792631|NCT04393298|467209139|FG014|Overall Study|Progressive Disease (PD)|0|||
129792632|NCT04393298|467209125|FG000|Overall Study|Started a New Cancer Treatment|0|||
129792633|NCT04393298|467209126|FG001|Overall Study|Started a New Cancer Treatment|0|||
129792634|NCT04393298|467209127|FG002|Overall Study|Started a New Cancer Treatment|0|||
129792635|NCT04393298|467209128|FG003|Overall Study|Started a New Cancer Treatment|0|||
129792636|NCT04393298|467209129|FG004|Overall Study|Started a New Cancer Treatment|1|||
129792637|NCT04393298|467209130|FG005|Overall Study|Started a New Cancer Treatment|0|||
129792638|NCT04393298|467209131|FG006|Overall Study|Started a New Cancer Treatment|0|||
129792639|NCT04393298|467209132|FG007|Overall Study|Started a New Cancer Treatment|0|||
129792640|NCT04393298|467209133|FG008|Overall Study|Started a New Cancer Treatment|0|||
129792641|NCT04393298|467209134|FG009|Overall Study|Started a New Cancer Treatment|0|||
129792642|NCT04393298|467209135|FG010|Overall Study|Started a New Cancer Treatment|0|||
129792643|NCT04393298|467209136|FG011|Overall Study|Started a New Cancer Treatment|0|||
129792644|NCT04393298|467209137|FG012|Overall Study|Started a New Cancer Treatment|0|||
129792645|NCT04393298|467209138|FG013|Overall Study|Started a New Cancer Treatment|0|||
129792646|NCT04393298|467209139|FG014|Overall Study|Started a New Cancer Treatment|0|||
129792647|NCT04393298|467209125|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792648|NCT04393298|467209126|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792649|NCT04393298|467209127|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792650|NCT04393298|467209128|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792651|NCT04393298|467209129|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
129887849|NCT03249376|467547309|FG001|Overall Study|LTFU|1|||
129887850|NCT01154036|467547310|FG000|Phase I|Physician Decision|0|||
129887851|NCT01154036|467547311|FG001|Phase I|Physician Decision|1|||
129887852|NCT01154036|467547312|FG002|Phase I|Physician Decision|0|||
129887853|NCT01154036|467547313|FG003|Phase I|Physician Decision|0|||
129887854|NCT01154036|467547314|FG004|Phase I|Physician Decision|0|||
129887855|NCT01154036|467547315|FG005|Phase I|Physician Decision|0|||
129887856|NCT01154036|467547316|FG006|Phase I|Physician Decision|0|||
129887857|NCT01154036|467547317|FG007|Phase I|Physician Decision|0|||
129887858|NCT01154036|467547310|FG000|Phase I|Lost to Follow-up|0|||
129887859|NCT01154036|467547311|FG001|Phase I|Lost to Follow-up|3|||
129887860|NCT01154036|467547312|FG002|Phase I|Lost to Follow-up|6|||
129887861|NCT01154036|467547313|FG003|Phase I|Lost to Follow-up|0|||
129887862|NCT01154036|467547314|FG004|Phase I|Lost to Follow-up|0|||
129887863|NCT01154036|467547315|FG005|Phase I|Lost to Follow-up|0|||
129887864|NCT01154036|467547316|FG006|Phase I|Lost to Follow-up|0|||
129887865|NCT01154036|467547317|FG007|Phase I|Lost to Follow-up|0|||
129887866|NCT01154036|467547310|FG000|Phase I|Protocol Violation|0|||
129887867|NCT01154036|467547311|FG001|Phase I|Protocol Violation|3|||
129887868|NCT01154036|467547312|FG002|Phase I|Protocol Violation|9|||
129887869|NCT01154036|467547313|FG003|Phase I|Protocol Violation|0|||
129887870|NCT01154036|467547314|FG004|Phase I|Protocol Violation|0|||
129887871|NCT01154036|467547315|FG005|Phase I|Protocol Violation|0|||
129887872|NCT01154036|467547316|FG006|Phase I|Protocol Violation|0|||
129887873|NCT01154036|467547317|FG007|Phase I|Protocol Violation|0|||
129887874|NCT01154036|467547310|FG000|Phase I|Withdrawal by Subject|2|||
129887875|NCT01154036|467547311|FG001|Phase I|Withdrawal by Subject|10|||
129887876|NCT01154036|467547312|FG002|Phase I|Withdrawal by Subject|29|||
129887877|NCT01154036|467547313|FG003|Phase I|Withdrawal by Subject|0|||
129887878|NCT01154036|467547314|FG004|Phase I|Withdrawal by Subject|0|||
129887879|NCT01154036|467547315|FG005|Phase I|Withdrawal by Subject|0|||
129887880|NCT01154036|467547316|FG006|Phase I|Withdrawal by Subject|0|||
129887881|NCT01154036|467547317|FG007|Phase I|Withdrawal by Subject|0|||
129887882|NCT01154036|467547310|FG000|Phase I|Adverse Event|1|||
129887883|NCT01154036|467547311|FG001|Phase I|Adverse Event|11|||
129887884|NCT01154036|467547312|FG002|Phase I|Adverse Event|12|||
129887885|NCT01154036|467547313|FG003|Phase I|Adverse Event|0|||
129887886|NCT01154036|467547314|FG004|Phase I|Adverse Event|0|||
129887887|NCT01154036|467547315|FG005|Phase I|Adverse Event|0|||
129887888|NCT01154036|467547316|FG006|Phase I|Adverse Event|0|||
129887889|NCT01154036|467547317|FG007|Phase I|Adverse Event|0|||
129887890|NCT01154036|467547310|FG000|Phase II|Adverse Event|0|||
129887891|NCT01154036|467547311|FG001|Phase II|Adverse Event|0|||
129887892|NCT01154036|467547312|FG002|Phase II|Adverse Event|0|||
129887893|NCT01154036|467547313|FG003|Phase II|Adverse Event|0|||
129887894|NCT01154036|467547314|FG004|Phase II|Adverse Event|1|||
129887895|NCT01154036|467547315|FG005|Phase II|Adverse Event|1|||
129887896|NCT01154036|467547316|FG006|Phase II|Adverse Event|1|||
129887897|NCT01154036|467547317|FG007|Phase II|Adverse Event|1|||
129887898|NCT01154036|467547310|FG000|Phase II|Physician Decision|0|||
129887899|NCT01154036|467547311|FG001|Phase II|Physician Decision|0|||
129887900|NCT01154036|467547312|FG002|Phase II|Physician Decision|0|||
129887901|NCT01154036|467547313|FG003|Phase II|Physician Decision|0|||
129887902|NCT01154036|467547314|FG004|Phase II|Physician Decision|0|||
129887903|NCT01154036|467547315|FG005|Phase II|Physician Decision|0|||
129887904|NCT01154036|467547316|FG006|Phase II|Physician Decision|1|||
129887905|NCT01154036|467547317|FG007|Phase II|Physician Decision|0|||
130044211|NCT00592683|468119104|FG001|Overall Study|Found ineligible|1|||
130044212|NCT00592683|468119103|FG000|Overall Study|Withdrawal by Subject|1|||
130044213|NCT00592683|468119104|FG001|Overall Study|Withdrawal by Subject|0|||
130044214|NCT00592683|468119103|FG000|Overall Study|Adverse Event|0|||
130287250|NCT02323204|469014723|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
130287251|NCT02323204|469014724|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
130287252|NCT02323204|469014725|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
130287253|NCT02323204|469014726|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
130287254|NCT02323204|469014723|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
130287255|NCT02323204|469014724|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
130287256|NCT02323204|469014725|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
129887906|NCT01154036|467547310|FG000|Phase II|Lost to Follow-up|0|||
129887907|NCT01154036|467547311|FG001|Phase II|Lost to Follow-up|0|||
129887908|NCT01154036|467547312|FG002|Phase II|Lost to Follow-up|0|||
129887909|NCT01154036|467547313|FG003|Phase II|Lost to Follow-up|1|||
129887910|NCT01154036|467547314|FG004|Phase II|Lost to Follow-up|2|||
129887911|NCT01154036|467547315|FG005|Phase II|Lost to Follow-up|0|||
129887912|NCT01154036|467547316|FG006|Phase II|Lost to Follow-up|2|||
129887913|NCT01154036|467547317|FG007|Phase II|Lost to Follow-up|1|||
129887914|NCT01154036|467547310|FG000|Phase II|Protocol Violation|0|||
129887915|NCT01154036|467547311|FG001|Phase II|Protocol Violation|0|||
129887916|NCT01154036|467547312|FG002|Phase II|Protocol Violation|0|||
129887917|NCT01154036|467547313|FG003|Phase II|Protocol Violation|0|||
130044215|NCT00592683|468119104|FG001|Overall Study|Adverse Event|2|||
130044216|NCT00592683|468119103|FG000|Overall Study|Protocol Violation|1|||
130044217|NCT00592683|468119104|FG001|Overall Study|Protocol Violation|0|||
130044218|NCT00592683|468119103|FG000|Overall Study|Study drug expired|1|||
130044219|NCT00592683|468119104|FG001|Overall Study|Study drug expired|0|||
130044220|NCT00592683|468119103|FG000|Overall Study|Other|1|||
130044221|NCT00592683|468119104|FG001|Overall Study|Other|0|||
130044222|NCT00592683|468119103|FG000|Overall Study|Lost to Follow-up|0|||
130044223|NCT00592683|468119104|FG001|Overall Study|Lost to Follow-up|1|||
130044224|NCT01357239|468119107|FG000|Stratum: All Patients|Adverse Event|0|||
130044225|NCT01357239|468119108|FG001|Stratum: All Patients|Adverse Event|0|||
130044226|NCT01357239|468119109|FG002|Stratum: All Patients|Adverse Event|1|||
130044227|NCT01357239|468119110|FG003|Stratum: All Patients|Adverse Event|1|||
130044228|NCT01357239|468119107|FG000|Stratum: All Patients|Subject withdrew consent|0|||
130044229|NCT01357239|468119108|FG001|Stratum: All Patients|Subject withdrew consent|0|||
130044230|NCT01357239|468119109|FG002|Stratum: All Patients|Subject withdrew consent|1|||
130044231|NCT01357239|468119110|FG003|Stratum: All Patients|Subject withdrew consent|1|||
130044232|NCT01357239|468119107|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
130044233|NCT01357239|468119108|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
130044234|NCT01357239|468119109|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
130044235|NCT01357239|468119110|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
130044236|NCT01357239|468119107|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
130044237|NCT01357239|468119108|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
130044238|NCT01357239|468119109|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
130044239|NCT01357239|468119110|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
130044240|NCT01357239|468119107|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
130044241|NCT01357239|468119108|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
130044242|NCT01357239|468119109|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
130044243|NCT01357239|468119110|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
130044244|NCT00545818|468119119|FG000|Overall Study|Protocol Violation|1|||
130044245|NCT00545818|468119120|FG001|Overall Study|Protocol Violation|0|||
130044246|NCT00545818|468119119|FG000|Overall Study|Adverse Event|1|||
130044247|NCT00545818|468119120|FG001|Overall Study|Adverse Event|1|||
130044248|NCT00545818|468119119|FG000|Overall Study|Lost to Follow-up|1|||
130044249|NCT00545818|468119120|FG001|Overall Study|Lost to Follow-up|6|||
130044250|NCT00609609|468119121|FG000|Overall Study|Withdrawal by Subject|2|||
130044251|NCT00609609|468119122|FG001|Overall Study|Withdrawal by Subject|0|||
130044252|NCT00609609|468119121|FG000|Overall Study|Progression|4|||
130044253|NCT00609609|468119122|FG001|Overall Study|Progression|2|||
130044254|NCT01050062|468119123|FG000|Overall Study|Adverse Event|75|||
130044255|NCT01050062|468119124|FG001|Overall Study|Adverse Event|22|||
130044256|NCT01050062|468119123|FG000|Overall Study|Lost to Follow-up|83|||
130044257|NCT01050062|468119124|FG001|Overall Study|Lost to Follow-up|35|||
130287257|NCT02323204|469014726|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
130287258|NCT02323204|469014723|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
130287259|NCT02323204|469014724|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
130287260|NCT02323204|469014725|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
130287261|NCT02323204|469014726|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
130287262|NCT02323204|469014723|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
130287263|NCT02323204|469014724|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
130044258|NCT01050062|468119123|FG000|Overall Study|Lack of Efficacy|22|||
130287264|NCT02323204|469014725|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
130044259|NCT01050062|468119124|FG001|Overall Study|Lack of Efficacy|35|||
130044260|NCT01050062|468119123|FG000|Overall Study|Physician Decision|74|||
130044261|NCT01050062|468119124|FG001|Overall Study|Physician Decision|9|||
130044262|NCT01050062|468119123|FG000|Overall Study|Others|17|||
130044263|NCT01050062|468119124|FG001|Overall Study|Others|11|||
130044264|NCT00670111|468119127|FG000|Enrollment to One Month|Testing Failure|0|||
130044265|NCT00670111|468119128|FG001|Enrollment to One Month|Testing Failure|0|||
130044266|NCT00670111|468119129|FG002|Enrollment to One Month|Testing Failure|13|||
130044267|NCT00670111|468119127|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
130044268|NCT00670111|468119128|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
130044269|NCT00670111|468119129|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
130044270|NCT00670111|468119127|FG000|Enrollment to One Month|Physician Decision|1|||
130287265|NCT02323204|469014726|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
130287266|NCT02323204|469014723|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
130287267|NCT02323204|469014724|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
130287268|NCT02323204|469014725|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
130287269|NCT02323204|469014726|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
130287270|NCT02323204|469014723|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287271|NCT02323204|469014724|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
130287272|NCT02323204|469014725|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287273|NCT02323204|469014726|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
130287274|NCT02323204|469014723|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
130287275|NCT02323204|469014724|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
130287276|NCT02323204|469014725|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
130287277|NCT02323204|469014726|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
130287278|NCT02323204|469014723|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287279|NCT02323204|469014724|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
130287280|NCT02323204|469014725|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
130287281|NCT02323204|469014726|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
130287282|NCT03440918|469014732|FG000|Overall Study|Protocol Violation|0|||
130287283|NCT03440918|469014733|FG001|Overall Study|Protocol Violation|16|||
130287284|NCT03576755|469014745|FG000|Overall Study|Withdrawal by Subject|1|||
130044271|NCT00670111|468119128|FG001|Enrollment to One Month|Physician Decision|0|||
130044272|NCT00670111|468119129|FG002|Enrollment to One Month|Physician Decision|0|||
130044273|NCT03988751|468119130|FG000|Overall Study|Withdrawal by Subject|1|||
130044274|NCT03988751|468119131|FG001|Overall Study|Withdrawal by Subject|0|||
129792652|NCT04393298|467209130|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
130044275|NCT03988751|468119130|FG000|Overall Study|Protocol Violation|0|||
129792653|NCT04393298|467209131|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792654|NCT04393298|467209132|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792655|NCT04393298|467209133|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792656|NCT04393298|467209134|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792657|NCT04393298|467209135|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792658|NCT04393298|467209136|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792659|NCT04393298|467209137|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792660|NCT04393298|467209138|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792661|NCT04393298|467209139|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792662|NCT04393298|467209125|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792663|NCT04393298|467209126|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792664|NCT04393298|467209127|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792665|NCT04393298|467209128|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792666|NCT04393298|467209129|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792667|NCT04393298|467209130|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
129792668|NCT04393298|467209131|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792669|NCT04393298|467209132|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792670|NCT04393298|467209133|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792671|NCT04393298|467209134|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792672|NCT04393298|467209135|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792673|NCT04393298|467209136|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792674|NCT04393298|467209137|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792675|NCT04393298|467209138|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792676|NCT04393298|467209139|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792677|NCT04393298|467209125|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792678|NCT04393298|467209126|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792679|NCT04393298|467209127|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129887918|NCT01154036|467547314|FG004|Phase II|Protocol Violation|1|||
129887919|NCT01154036|467547315|FG005|Phase II|Protocol Violation|2|||
130044276|NCT03988751|468119131|FG001|Overall Study|Protocol Violation|1|||
130044277|NCT00844883|468119134|FG000|Overall Study|Bridged to liver transplant|3|||
130044278|NCT00844883|468119134|FG000|Overall Study|Bridged to resection|1|||
130044279|NCT02623361|468119135|FG000|Overall Study|Protocol Violation|0|||
129792680|NCT04393298|467209128|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792681|NCT04393298|467209129|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792682|NCT04393298|467209130|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
130044280|NCT02623361|468119136|FG001|Overall Study|Protocol Violation|1|||
130044281|NCT02623361|468119135|FG000|Overall Study|Withdrawal by Subject|0|||
130044282|NCT02623361|468119136|FG001|Overall Study|Withdrawal by Subject|1|||
130044283|NCT03000452|468119139|FG000|Treatment Period|Death|1|||
130044284|NCT03000452|468119139|FG000|Treatment Period|Progressive Disease (PD)|14|||
130044285|NCT03000452|468119139|FG000|Treatment Period|Physician Decision|1|||
130287285|NCT03576755|469014746|FG001|Overall Study|Withdrawal by Subject|0|||
130287286|NCT03576755|469014747|FG002|Overall Study|Withdrawal by Subject|0|||
130287287|NCT03576755|469014748|FG003|Overall Study|Withdrawal by Subject|0|||
130287288|NCT04962230|469014749|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
130287289|NCT04962230|469014749|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
130287290|NCT01396265|469014750|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
130287291|NCT03958656|469014753|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130287292|NCT03958656|469014754|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
130287293|NCT03958656|469014755|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130287294|NCT03958656|469014756|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
130287295|NCT03958656|469014753|FG000|Overall Study|No longer meets eligibility criteria|0|||
130287296|NCT03958656|469014754|FG001|Overall Study|No longer meets eligibility criteria|0|||
130287297|NCT03958656|469014755|FG002|Overall Study|No longer meets eligibility criteria|1|||
130287298|NCT03958656|469014756|FG003|Overall Study|No longer meets eligibility criteria|0|||
130287299|NCT03958656|469014753|FG000|Overall Study|Started anti-cancer treatment|0|||
130287300|NCT03958656|469014754|FG001|Overall Study|Started anti-cancer treatment|0|||
130287301|NCT03958656|469014755|FG002|Overall Study|Started anti-cancer treatment|1|||
130287302|NCT03958656|469014756|FG003|Overall Study|Started anti-cancer treatment|0|||
130287303|NCT03831880|469014757|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
130287304|NCT03831880|469014758|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
130287305|NCT03831880|469014757|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
130287306|NCT03831880|469014758|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
130287307|NCT04346108|469014761|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
130287308|NCT04346108|469014762|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
130287309|NCT04346108|469014763|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
130287310|NCT04346108|469014761|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
130287311|NCT04346108|469014762|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
130287312|NCT04346108|469014763|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
130287313|NCT03158012|469014764|FG000|Overall Study|Withdrawal by Subject|0|||
130287314|NCT03158012|469014765|FG001|Overall Study|Withdrawal by Subject|1|||
130287315|NCT01598753|469014766|FG000|Overall Study|Adverse Event|1|||
130287316|NCT01598753|469014767|FG001|Overall Study|Adverse Event|9|||
130287317|NCT01598753|469014768|FG002|Overall Study|Adverse Event|1|||
130287318|NCT01598753|469014769|FG003|Overall Study|Adverse Event|7|||
130287319|NCT01598753|469014766|FG000|Overall Study|Lost to Follow-up|4|||
130287320|NCT01598753|469014767|FG001|Overall Study|Lost to Follow-up|3|||
130287321|NCT01598753|469014768|FG002|Overall Study|Lost to Follow-up|7|||
130287322|NCT01598753|469014769|FG003|Overall Study|Lost to Follow-up|5|||
130287323|NCT01598753|469014766|FG000|Overall Study|Physician Decision|0|||
130287324|NCT01598753|469014767|FG001|Overall Study|Physician Decision|1|||
130287325|NCT01598753|469014768|FG002|Overall Study|Physician Decision|0|||
130287326|NCT01598753|469014769|FG003|Overall Study|Physician Decision|2|||
130287327|NCT01598753|469014766|FG000|Overall Study|Withdrawal by Subject|7|||
130287328|NCT01598753|469014767|FG001|Overall Study|Withdrawal by Subject|2|||
130287329|NCT01598753|469014768|FG002|Overall Study|Withdrawal by Subject|0|||
130287330|NCT01598753|469014769|FG003|Overall Study|Withdrawal by Subject|1|||
130287331|NCT02788201|469014770|FG000|Overall Study|Death|1|||
130287332|NCT02788201|469014771|FG001|Overall Study|Death|1|||
130287333|NCT02788201|469014772|FG002|Overall Study|Death|1|||
130287334|NCT02788201|469014773|FG003|Overall Study|Death|1|||
130287335|NCT02788201|469014774|FG004|Overall Study|Death|0|||
130287336|NCT02788201|469014775|FG005|Overall Study|Death|1|||
130287337|NCT02788201|469014770|FG000|Overall Study|Ineligible|0|||
130287338|NCT02788201|469014771|FG001|Overall Study|Ineligible|0|||
130287339|NCT02788201|469014772|FG002|Overall Study|Ineligible|0|||
130287340|NCT02788201|469014773|FG003|Overall Study|Ineligible|0|||
130287341|NCT02788201|469014774|FG004|Overall Study|Ineligible|0|||
130287342|NCT02788201|469014775|FG005|Overall Study|Ineligible|1|||
130287343|NCT02788201|469014770|FG000|Overall Study|Withdrawal by Subject|0|||
130287344|NCT02788201|469014771|FG001|Overall Study|Withdrawal by Subject|0|||
130287345|NCT02788201|469014772|FG002|Overall Study|Withdrawal by Subject|0|||
130287346|NCT02788201|469014773|FG003|Overall Study|Withdrawal by Subject|0|||
130287347|NCT02788201|469014774|FG004|Overall Study|Withdrawal by Subject|0|||
130287348|NCT02788201|469014775|FG005|Overall Study|Withdrawal by Subject|1|||
130044286|NCT03000452|468119139|FG000|Treatment Period|Miscellaneous|2|||
130287349|NCT01852825|469014776|FG000|Overall Study|Withdrawal by Subject|2|||
130287350|NCT01852825|469014777|FG001|Overall Study|Withdrawal by Subject|0|||
130287351|NCT01852825|469014778|FG002|Overall Study|Withdrawal by Subject|0|||
130287352|NCT04508751|469014782|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
130287353|NCT04508751|469014783|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
130287354|NCT04508751|469014784|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
130287355|NCT00724854|469014785|FG000|Overall Study|Lack of Efficacy|187|||
130287356|NCT00724854|469014786|FG001|Overall Study|Lack of Efficacy|13|||
130287357|NCT00724854|469014785|FG000|Overall Study|Lost to Follow-up|87|||
130044287|NCT03000452|468119139|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
130044288|NCT03000452|468119139|FG000|Follow-Up Period|Death|3|||
130044289|NCT03000452|468119139|FG000|Follow-Up Period|Withdrawal by Subject|3|||
130044290|NCT00537823|468119142|FG000|Overall Study|Adverse Event|2|||
130044291|NCT00537823|468119143|FG001|Overall Study|Adverse Event|0|||
130044292|NCT03065530|468119144|FG000|Overall Study|Lack of Efficacy|1|||
130044293|NCT03065530|468119145|FG001|Overall Study|Lack of Efficacy|1|||
130044294|NCT03065530|468119146|FG002|Overall Study|Lack of Efficacy|0|||
130287358|NCT00724854|469014786|FG001|Overall Study|Lost to Follow-up|10|||
130287359|NCT00724854|469014785|FG000|Overall Study|Adverse Event|62|||
130287360|NCT00724854|469014786|FG001|Overall Study|Adverse Event|4|||
130287361|NCT00724854|469014785|FG000|Overall Study|Other|42|||
130287362|NCT00724854|469014786|FG001|Overall Study|Other|3|||
130287363|NCT00724854|469014785|FG000|Overall Study|Death|11|||
130287364|NCT00724854|469014786|FG001|Overall Study|Death|0|||
130287365|NCT00724854|469014785|FG000|Overall Study|Change of treatment|7|||
130287366|NCT00724854|469014786|FG001|Overall Study|Change of treatment|0|||
130287367|NCT00724854|469014785|FG000|Overall Study|Withdrawal by Subject|5|||
130287368|NCT00724854|469014786|FG001|Overall Study|Withdrawal by Subject|0|||
130287369|NCT00724854|469014785|FG000|Overall Study|Adverse event + lack of efficacy|2|||
130287370|NCT00724854|469014786|FG001|Overall Study|Adverse event + lack of efficacy|1|||
129792683|NCT04393298|467209131|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130044295|NCT03065530|468119147|FG003|Overall Study|Lack of Efficacy|1|||
130044296|NCT03065530|468119144|FG000|Overall Study|Protocol Violation|1|||
130044297|NCT03065530|468119145|FG001|Overall Study|Protocol Violation|0|||
130287371|NCT01865812|469014787|FG000|Primary Treatment Phase|Adverse Event|2|||
130287372|NCT01865812|469014788|FG001|Primary Treatment Phase|Adverse Event|0|||
130287373|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
130287374|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
130287375|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Pruritus|0|||
130287376|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Pruritus|3|||
130287377|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
130287378|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
130287379|NCT01865812|469014787|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
130287380|NCT01865812|469014788|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
130287381|NCT01338610|469014789|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
130287382|NCT01338610|469014790|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
130287383|NCT01338610|469014791|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
130287384|NCT01338610|469014789|FG000|Overall Study|Protocol Violation|1|||
130287385|NCT01338610|469014790|FG001|Overall Study|Protocol Violation|0|||
130287386|NCT01338610|469014791|FG002|Overall Study|Protocol Violation|1|||
130287387|NCT01338610|469014789|FG000|Overall Study|Adverse Event|3|||
130287388|NCT01338610|469014790|FG001|Overall Study|Adverse Event|0|||
130287389|NCT01338610|469014791|FG002|Overall Study|Adverse Event|0|||
130287390|NCT01095653|469014792|FG000|Overall Study|Lack of Efficacy|3|||
130287391|NCT01095653|469014793|FG001|Overall Study|Lack of Efficacy|0|||
130287392|NCT01095653|469014794|FG002|Overall Study|Lack of Efficacy|0|||
130287393|NCT01095653|469014792|FG000|Overall Study|Adverse Event|1|||
130287394|NCT01095653|469014793|FG001|Overall Study|Adverse Event|4|||
130287395|NCT01095653|469014794|FG002|Overall Study|Adverse Event|4|||
130287396|NCT01095653|469014792|FG000|Overall Study|Lost to Follow-up|1|||
130287397|NCT01095653|469014793|FG001|Overall Study|Lost to Follow-up|0|||
130287398|NCT01095653|469014794|FG002|Overall Study|Lost to Follow-up|4|||
130287399|NCT01095653|469014792|FG000|Overall Study|Withdrawal by Subject|4|||
130287400|NCT01095653|469014793|FG001|Overall Study|Withdrawal by Subject|5|||
130287401|NCT01095653|469014794|FG002|Overall Study|Withdrawal by Subject|3|||
130287402|NCT01095653|469014792|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
130287403|NCT01095653|469014793|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
130287404|NCT01095653|469014794|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
130287405|NCT02046226|469014795|FG000|Overall Study|Lost to Follow-up|7|||
130287406|NCT00171925|469014796|FG000|Overall Study|Adverse Event|10|||
130287407|NCT00171925|469014797|FG001|Overall Study|Adverse Event|6|||
130287408|NCT00171925|469014796|FG000|Overall Study|Protocol Violation|1|||
130287409|NCT00171925|469014797|FG001|Overall Study|Protocol Violation|1|||
130287410|NCT00171925|469014796|FG000|Overall Study|Withdrawal by Subject|6|||
130287411|NCT00171925|469014797|FG001|Overall Study|Withdrawal by Subject|9|||
130287412|NCT00171925|469014796|FG000|Overall Study|Lost to Follow-up|2|||
130287413|NCT00171925|469014797|FG001|Overall Study|Lost to Follow-up|2|||
130287414|NCT00171925|469014796|FG000|Overall Study|Administrative problems|10|||
130044298|NCT03065530|468119146|FG002|Overall Study|Protocol Violation|1|||
130044299|NCT03065530|468119147|FG003|Overall Study|Protocol Violation|1|||
130044300|NCT03455543|468119148|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
130044301|NCT03455543|468119149|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
130044302|NCT03455543|468119150|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
130044303|NCT03455543|468119148|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
130044304|NCT03455543|468119149|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
130044305|NCT03455543|468119150|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
130044306|NCT03455543|468119148|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
130044307|NCT03455543|468119149|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
130044308|NCT03455543|468119150|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
130044309|NCT03455543|468119148|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
130044310|NCT03455543|468119149|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
130044311|NCT03455543|468119150|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
130044312|NCT03455543|468119148|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
130044313|NCT03455543|468119149|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
130044314|NCT03455543|468119150|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
130044315|NCT03455543|468119148|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
130044316|NCT03455543|468119149|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
130044317|NCT03455543|468119150|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
130044318|NCT03455543|468119148|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
130044319|NCT03455543|468119149|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
130287415|NCT00171925|469014797|FG001|Overall Study|Administrative problems|11|||
130287416|NCT00171925|469014796|FG000|Overall Study|Death|1|||
129887920|NCT01154036|467547316|FG006|Phase II|Protocol Violation|0|||
130044320|NCT03455543|468119150|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
130287417|NCT00171925|469014797|FG001|Overall Study|Death|2|||
130287418|NCT02692040|469014798|FG000|Overall Study|Protocol Violation|0|||
130044321|NCT03455543|468119148|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
130044322|NCT03455543|468119149|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
130044323|NCT03455543|468119150|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
130044324|NCT03455543|468119148|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
130044325|NCT03455543|468119149|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
130044326|NCT03455543|468119150|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
130044327|NCT00852930|468119151|FG000|Overall Study|Withdrawal by Subject|1|||
130287419|NCT02692040|469014799|FG001|Overall Study|Protocol Violation|0|||
130287420|NCT02692040|469014800|FG002|Overall Study|Protocol Violation|0|||
130287421|NCT02692040|469014801|FG003|Overall Study|Protocol Violation|0|||
130287422|NCT02692040|469014802|FG004|Overall Study|Protocol Violation|0|||
130287423|NCT02692040|469014803|FG005|Overall Study|Protocol Violation|0|||
130287424|NCT02692040|469014804|FG006|Overall Study|Protocol Violation|0|||
130287425|NCT02692040|469014805|FG007|Overall Study|Protocol Violation|0|||
130287426|NCT02692040|469014806|FG008|Overall Study|Protocol Violation|0|||
130287427|NCT02692040|469014807|FG009|Overall Study|Protocol Violation|0|||
130287428|NCT02692040|469014808|FG010|Overall Study|Protocol Violation|0|||
130287429|NCT02692040|469014809|FG011|Overall Study|Protocol Violation|0|||
130044328|NCT00852930|468119152|FG001|Overall Study|Withdrawal by Subject|1|||
130044329|NCT00852930|468119153|FG002|Overall Study|Withdrawal by Subject|1|||
130044330|NCT00852930|468119151|FG000|Overall Study|Physician Decision|0|||
130044331|NCT00852930|468119152|FG001|Overall Study|Physician Decision|0|||
130044332|NCT00852930|468119153|FG002|Overall Study|Physician Decision|1|||
130044333|NCT00479466|468119154|FG000|Overall Study|Adverse Event|5|||
130044334|NCT00479466|468119155|FG001|Overall Study|Adverse Event|1|||
130044335|NCT00479466|468119156|FG002|Overall Study|Adverse Event|0|||
130287430|NCT02692040|469014810|FG012|Overall Study|Protocol Violation|1|||
130287431|NCT02692040|469014811|FG013|Overall Study|Protocol Violation|0|||
130287432|NCT02692040|469014812|FG014|Overall Study|Protocol Violation|0|||
130287433|NCT02692040|469014813|FG015|Overall Study|Protocol Violation|0|||
130287434|NCT02692040|469014814|FG016|Overall Study|Protocol Violation|0|||
130287435|NCT02692040|469014798|FG000|Overall Study|Adverse Event|0|||
130287436|NCT02692040|469014799|FG001|Overall Study|Adverse Event|0|||
130044336|NCT00479466|468119157|FG003|Overall Study|Adverse Event|1|||
130044337|NCT00479466|468119158|FG004|Overall Study|Adverse Event|2|||
130044338|NCT00479466|468119159|FG005|Overall Study|Adverse Event|0|||
130044339|NCT00479466|468119154|FG000|Overall Study|Hyperglycemia|0|||
130044340|NCT00479466|468119155|FG001|Overall Study|Hyperglycemia|0|||
130044341|NCT00479466|468119156|FG002|Overall Study|Hyperglycemia|0|||
130044342|NCT00479466|468119157|FG003|Overall Study|Hyperglycemia|0|||
130044343|NCT00479466|468119158|FG004|Overall Study|Hyperglycemia|0|||
130044344|NCT00479466|468119159|FG005|Overall Study|Hyperglycemia|1|||
130044345|NCT00479466|468119154|FG000|Overall Study|Lack of Efficacy|2|||
130044346|NCT00479466|468119155|FG001|Overall Study|Lack of Efficacy|0|||
130044347|NCT00479466|468119156|FG002|Overall Study|Lack of Efficacy|1|||
130044348|NCT00479466|468119157|FG003|Overall Study|Lack of Efficacy|0|||
130044349|NCT00479466|468119158|FG004|Overall Study|Lack of Efficacy|0|||
130044350|NCT00479466|468119159|FG005|Overall Study|Lack of Efficacy|0|||
130044351|NCT00479466|468119154|FG000|Overall Study|Lost to Follow-up|0|||
130044352|NCT00479466|468119155|FG001|Overall Study|Lost to Follow-up|1|||
130287437|NCT02692040|469014800|FG002|Overall Study|Adverse Event|0|||
130287438|NCT02692040|469014801|FG003|Overall Study|Adverse Event|0|||
130287439|NCT02692040|469014802|FG004|Overall Study|Adverse Event|0|||
129792684|NCT04393298|467209132|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792685|NCT04393298|467209133|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792686|NCT04393298|467209134|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792687|NCT04393298|467209135|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792688|NCT04393298|467209136|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792689|NCT04393298|467209137|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
130044353|NCT00479466|468119156|FG002|Overall Study|Lost to Follow-up|1|||
130044354|NCT00479466|468119157|FG003|Overall Study|Lost to Follow-up|0|||
130287440|NCT02692040|469014803|FG005|Overall Study|Adverse Event|0|||
130287441|NCT02692040|469014804|FG006|Overall Study|Adverse Event|0|||
130287442|NCT02692040|469014805|FG007|Overall Study|Adverse Event|0|||
130287443|NCT02692040|469014806|FG008|Overall Study|Adverse Event|0|||
130287444|NCT02692040|469014807|FG009|Overall Study|Adverse Event|0|||
130287445|NCT02692040|469014808|FG010|Overall Study|Adverse Event|0|||
130287446|NCT02692040|469014809|FG011|Overall Study|Adverse Event|0|||
130287447|NCT02692040|469014810|FG012|Overall Study|Adverse Event|0|||
130287448|NCT02692040|469014811|FG013|Overall Study|Adverse Event|3|||
130287449|NCT02692040|469014812|FG014|Overall Study|Adverse Event|1|||
130287450|NCT02692040|469014813|FG015|Overall Study|Adverse Event|1|||
130287451|NCT02692040|469014814|FG016|Overall Study|Adverse Event|0|||
130287452|NCT02826421|469014822|FG000|Overall Study|Adverse Event|1|||
130287453|NCT02826421|469014823|FG001|Overall Study|Adverse Event|0|||
130287454|NCT02826421|469014824|FG002|Overall Study|Adverse Event|0|||
130287455|NCT02826421|469014825|FG003|Overall Study|Adverse Event|1|||
130287456|NCT02826421|469014822|FG000|Overall Study|Withdrawal by Subject|1|||
130287457|NCT02826421|469014823|FG001|Overall Study|Withdrawal by Subject|3|||
130287458|NCT02826421|469014824|FG002|Overall Study|Withdrawal by Subject|1|||
130287459|NCT02826421|469014825|FG003|Overall Study|Withdrawal by Subject|1|||
130287460|NCT02826421|469014822|FG000|Overall Study|Reason not given|1|||
130287461|NCT02826421|469014823|FG001|Overall Study|Reason not given|0|||
129792690|NCT04393298|467209138|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792691|NCT04393298|467209139|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
129792692|NCT04393298|467209125|FG000|Overall Study|Death|0|||
129792693|NCT04393298|467209126|FG001|Overall Study|Death|0|||
129792694|NCT04393298|467209127|FG002|Overall Study|Death|0|||
129792695|NCT04393298|467209128|FG003|Overall Study|Death|0|||
129792696|NCT04393298|467209129|FG004|Overall Study|Death|0|||
129792697|NCT04393298|467209130|FG005|Overall Study|Death|1|||
129792698|NCT04393298|467209131|FG006|Overall Study|Death|1|||
129792699|NCT04393298|467209132|FG007|Overall Study|Death|0|||
130106312|NCT04682639|468349962|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130106313|NCT04682639|468349963|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130287462|NCT02826421|469014824|FG002|Overall Study|Reason not given|1|||
130287463|NCT02826421|469014825|FG003|Overall Study|Reason not given|0|||
130287464|NCT02210221|469014828|FG000|Overall Study|Lack of Efficacy|7|||
130287465|NCT02210221|469014828|FG000|Overall Study|Withdrawal by Subject|43|||
130287466|NCT02141490|469014831|FG000|Overall Study|Screening failures|4|||
130287467|NCT02141490|469014832|FG001|Overall Study|Screening failures|0|||
130287468|NCT02141490|469014833|FG002|Overall Study|Screening failures|0|||
130287469|NCT00355342|469014838|FG000|Overall Study|Adverse Event|13|||
130287470|NCT00355342|469014839|FG001|Overall Study|Adverse Event|15|||
130287471|NCT00355342|469014838|FG000|Overall Study|Lost to Follow-up|4|||
130287472|NCT00355342|469014839|FG001|Overall Study|Lost to Follow-up|2|||
130287473|NCT00355342|469014838|FG000|Overall Study|Withdrawal by Subject|14|||
130287474|NCT00355342|469014839|FG001|Overall Study|Withdrawal by Subject|11|||
130287475|NCT00355342|469014838|FG000|Overall Study|Sponsor terminated study|2|||
130287476|NCT00355342|469014839|FG001|Overall Study|Sponsor terminated study|2|||
130287477|NCT00355342|469014838|FG000|Overall Study|Overcompliant-PI discretion|1|||
130287478|NCT00355342|469014839|FG001|Overall Study|Overcompliant-PI discretion|0|||
130287479|NCT00355342|469014838|FG000|Overall Study|Use of prohibited medication|1|||
130287480|NCT00355342|469014839|FG001|Overall Study|Use of prohibited medication|0|||
130287481|NCT00355342|469014838|FG000|Overall Study|COPD exacerbation|1|||
130287482|NCT00355342|469014839|FG001|Overall Study|COPD exacerbation|1|||
130287483|NCT00355342|469014838|FG000|Overall Study|Dispensed wrong study drug kit|1|||
130287484|NCT00355342|469014839|FG001|Overall Study|Dispensed wrong study drug kit|0|||
130287485|NCT00355342|469014838|FG000|Overall Study|Non-compliance with Dexa scans|1|||
130287486|NCT00355342|469014839|FG001|Overall Study|Non-compliance with Dexa scans|0|||
130287487|NCT00355342|469014838|FG000|Overall Study|Withdrawal by participant and physician|1|||
130287488|NCT00355342|469014839|FG001|Overall Study|Withdrawal by participant and physician|0|||
130287489|NCT00355342|469014838|FG000|Overall Study|Participant relocated|0|||
130287490|NCT00355342|469014839|FG001|Overall Study|Participant relocated|1|||
130287491|NCT00355342|469014838|FG000|Overall Study|Participant discontinued study drug|0|||
130287492|NCT00355342|469014839|FG001|Overall Study|Participant discontinued study drug|1|||
130287493|NCT00355342|469014838|FG000|Overall Study|Study management|0|||
130287494|NCT00355342|469014839|FG001|Overall Study|Study management|1|||
130287495|NCT00355342|469014838|FG000|Overall Study|Protocol Violation|0|||
130287496|NCT00355342|469014839|FG001|Overall Study|Protocol Violation|1|||
130287497|NCT00355342|469014838|FG000|Overall Study|Use of protocol excluded medication|0|||
130287498|NCT00355342|469014839|FG001|Overall Study|Use of protocol excluded medication|1|||
129792700|NCT04393298|467209133|FG008|Overall Study|Death|1|||
129792701|NCT04393298|467209134|FG009|Overall Study|Death|1|||
129792702|NCT04393298|467209135|FG010|Overall Study|Death|0|||
129792703|NCT04393298|467209136|FG011|Overall Study|Death|1|||
129792704|NCT04393298|467209137|FG012|Overall Study|Death|1|||
129792705|NCT04393298|467209138|FG013|Overall Study|Death|0|||
129792706|NCT04393298|467209139|FG014|Overall Study|Death|1|||
129792707|NCT04393298|467209125|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130287499|NCT00434759|469014840|FG000|Overall Study|Lack of Efficacy|5|||
130287500|NCT00434759|469014841|FG001|Overall Study|Lack of Efficacy|4|||
130287501|NCT00434759|469014840|FG000|Overall Study|Withdrawal by Subject|17|||
130287502|NCT00434759|469014841|FG001|Overall Study|Withdrawal by Subject|1|||
130287503|NCT00434759|469014840|FG000|Overall Study|family affairs|2|||
130287504|NCT00434759|469014841|FG001|Overall Study|family affairs|0|||
130044355|NCT00479466|468119158|FG004|Overall Study|Lost to Follow-up|2|||
130044356|NCT00479466|468119159|FG005|Overall Study|Lost to Follow-up|2|||
130044357|NCT00479466|468119154|FG000|Overall Study|Physician Decision|2|||
130044358|NCT00479466|468119155|FG001|Overall Study|Physician Decision|1|||
130044359|NCT00479466|468119156|FG002|Overall Study|Physician Decision|1|||
130044360|NCT00479466|468119157|FG003|Overall Study|Physician Decision|0|||
130106314|NCT04682639|468349964|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130106315|NCT04682639|468349960|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130106316|NCT04682639|468349961|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
130106317|NCT04682639|468349962|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130106318|NCT04682639|468349963|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130106319|NCT04682639|468349964|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130044361|NCT00479466|468119158|FG004|Overall Study|Physician Decision|0|||
130044362|NCT00479466|468119159|FG005|Overall Study|Physician Decision|0|||
130044363|NCT00479466|468119154|FG000|Overall Study|Pregnancy|0|||
130044364|NCT00479466|468119155|FG001|Overall Study|Pregnancy|0|||
130044365|NCT00479466|468119156|FG002|Overall Study|Pregnancy|0|||
130044366|NCT00479466|468119157|FG003|Overall Study|Pregnancy|0|||
130044367|NCT00479466|468119158|FG004|Overall Study|Pregnancy|1|||
130106320|NCT04682639|468349960|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
130106321|NCT04682639|468349961|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
130106322|NCT04682639|468349962|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
130044368|NCT00479466|468119159|FG005|Overall Study|Pregnancy|0|||
130044369|NCT00479466|468119154|FG000|Overall Study|Protocol Violation|1|||
130044370|NCT00479466|468119155|FG001|Overall Study|Protocol Violation|0|||
130044371|NCT00479466|468119156|FG002|Overall Study|Protocol Violation|0|||
130044372|NCT00479466|468119157|FG003|Overall Study|Protocol Violation|0|||
130044373|NCT00479466|468119158|FG004|Overall Study|Protocol Violation|0|||
130044374|NCT00479466|468119159|FG005|Overall Study|Protocol Violation|0|||
130044375|NCT00479466|468119154|FG000|Overall Study|Withdrawal by Subject|3|||
130106323|NCT04682639|468349963|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
130106324|NCT04682639|468349964|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
130106325|NCT01392170|468349965|FG000|Overall Study|Withdrawal by Subject|1|||
130106326|NCT01392170|468349965|FG000|Overall Study|Ineligible|1|||
130106327|NCT03174925|468349976|FG000|Overall Study|Elastographic images not retrievable|2|||
130106328|NCT03174925|468349976|FG000|Overall Study|Elastography image not interpretable|1|||
130106329|NCT01791127|468349977|FG000|Overall Study|Death|356|||
130106330|NCT01791127|468349977|FG000|Overall Study|Patient has withdrawn from study|293|||
130044376|NCT00479466|468119155|FG001|Overall Study|Withdrawal by Subject|5|||
130044377|NCT00479466|468119156|FG002|Overall Study|Withdrawal by Subject|0|||
130044378|NCT00479466|468119157|FG003|Overall Study|Withdrawal by Subject|2|||
130044379|NCT00479466|468119158|FG004|Overall Study|Withdrawal by Subject|3|||
130044380|NCT00479466|468119159|FG005|Overall Study|Withdrawal by Subject|1|||
130044381|NCT02614794|468119166|FG000|Overall Study|Death|258|||
130044382|NCT02614794|468119167|FG001|Overall Study|Death|151|||
130044383|NCT02614794|468119166|FG000|Overall Study|Study closure by Sponsor|119|||
130044384|NCT02614794|468119167|FG001|Overall Study|Study closure by Sponsor|45|||
130044385|NCT02614794|468119166|FG000|Overall Study|Withdrawal by Subject|24|||
130044386|NCT02614794|468119167|FG001|Overall Study|Withdrawal by Subject|5|||
130044387|NCT02614794|468119166|FG000|Overall Study|Lost to Follow-up|7|||
130044388|NCT02614794|468119167|FG001|Overall Study|Lost to Follow-up|0|||
130044389|NCT02614794|468119166|FG000|Overall Study|Physician Decision|1|||
130044390|NCT02614794|468119167|FG001|Overall Study|Physician Decision|1|||
130044391|NCT02614794|468119166|FG000|Overall Study|Hospital closure|1|||
130106331|NCT01791127|468349977|FG000|Overall Study|Lost to Follow-up|42|||
130106332|NCT01791127|468349977|FG000|Overall Study|All Siello leads are explanted|31|||
130106333|NCT01791127|468349977|FG000|Overall Study|Completion of 30 day safety registry|1|||
130106334|NCT01791127|468349977|FG000|Overall Study|Study terminated for EP Passion|749|||
130106335|NCT04247594|468349980|FG000|Overall Study|Withdrawal by Subject|4|||
130287505|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130044392|NCT02614794|468119167|FG001|Overall Study|Hospital closure|0|||
130044393|NCT02052960|468119172|FG000|Overall Study|Adverse Event|19|||
130044394|NCT02052960|468119173|FG001|Overall Study|Adverse Event|17|||
130044395|NCT02052960|468119172|FG000|Overall Study|Protocol Violation|4|||
130044396|NCT02052960|468119173|FG001|Overall Study|Protocol Violation|3|||
130044397|NCT02052960|468119172|FG000|Overall Study|Withdrawal by Subject|6|||
130044398|NCT02052960|468119173|FG001|Overall Study|Withdrawal by Subject|11|||
130044399|NCT02052960|468119172|FG000|Overall Study|Other|25|||
130044400|NCT02052960|468119173|FG001|Overall Study|Other|15|||
130044401|NCT01396525|468119176|FG000|Overall Study|Withdrawal by Subject|8|||
130044402|NCT01396525|468119176|FG000|Overall Study|Death|14|||
130044403|NCT01396525|468119176|FG000|Overall Study|Lost to Follow-up|4|||
130044404|NCT03114969|468119177|FG000|Overall Study|Lost to Follow-up|0|||
130044405|NCT03114969|468119178|FG001|Overall Study|Lost to Follow-up|0|||
130044406|NCT03114969|468119179|FG002|Overall Study|Lost to Follow-up|3|||
130044407|NCT03114969|468119180|FG003|Overall Study|Lost to Follow-up|2|||
130044408|NCT03114969|468119181|FG004|Overall Study|Lost to Follow-up|0|||
130044409|NCT03114969|468119182|FG005|Overall Study|Lost to Follow-up|0|||
130044410|NCT03114969|468119183|FG006|Overall Study|Lost to Follow-up|0|||
130044411|NCT03114969|468119184|FG007|Overall Study|Lost to Follow-up|0|||
130044412|NCT03114969|468119185|FG008|Overall Study|Lost to Follow-up|0|||
130044413|NCT03114969|468119177|FG000|Overall Study|Adverse Event|0|||
130044414|NCT03114969|468119178|FG001|Overall Study|Adverse Event|0|||
130044415|NCT03114969|468119179|FG002|Overall Study|Adverse Event|1|||
130044416|NCT03114969|468119180|FG003|Overall Study|Adverse Event|0|||
130044417|NCT03114969|468119181|FG004|Overall Study|Adverse Event|0|||
130044418|NCT03114969|468119182|FG005|Overall Study|Adverse Event|1|||
130044419|NCT03114969|468119183|FG006|Overall Study|Adverse Event|1|||
130044420|NCT03114969|468119184|FG007|Overall Study|Adverse Event|0|||
130044421|NCT03114969|468119185|FG008|Overall Study|Adverse Event|2|||
130044422|NCT00949650|468119186|FG000|Overall Study|Progressive disease|188|||
130044423|NCT00949650|468119187|FG001|Overall Study|Progressive disease|19|||
130044424|NCT00949650|468119186|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
130044425|NCT00949650|468119187|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
130044426|NCT00949650|468119186|FG000|Overall Study|Other Adverse Event (AE)|28|||
130044427|NCT00949650|468119187|FG001|Overall Study|Other Adverse Event (AE)|17|||
130106336|NCT02748616|468349986|FG000|Overall Study|Lost to Follow-up|1|||
130106337|NCT02748616|468349986|FG000|Overall Study|Withdrawal by Subject|2|||
130287506|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287507|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129792708|NCT04393298|467209126|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
130044428|NCT00949650|468119186|FG000|Overall Study|Protocol Violation|1|||
130106338|NCT02748616|468349986|FG000|Overall Study|Physician Decision|2|||
130106339|NCT02748616|468349986|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
130106340|NCT00589693|468349988|FG000|Overall Study|randomized in error|12|||
130106341|NCT00589693|468349989|FG001|Overall Study|randomized in error|6|||
130106342|NCT00589693|468349988|FG000|Overall Study|Adverse Event|4|||
130106343|NCT00589693|468349989|FG001|Overall Study|Adverse Event|4|||
130106344|NCT00589693|468349988|FG000|Overall Study|Death|26|||
130106345|NCT00589693|468349989|FG001|Overall Study|Death|16|||
130106346|NCT00589693|468349988|FG000|Overall Study|Lack of Efficacy|0|||
130106347|NCT00589693|468349989|FG001|Overall Study|Lack of Efficacy|1|||
130106348|NCT00589693|468349988|FG000|Overall Study|Lost to Follow-up|1|||
130106349|NCT00589693|468349989|FG001|Overall Study|Lost to Follow-up|0|||
130106350|NCT00589693|468349988|FG000|Overall Study|Physician Decision|0|||
130106351|NCT00589693|468349989|FG001|Overall Study|Physician Decision|1|||
130106352|NCT00589693|468349988|FG000|Overall Study|Protocol Violation|1|||
130106353|NCT00589693|468349989|FG001|Overall Study|Protocol Violation|1|||
130106354|NCT03231709|468349990|FG000|Treatment Period 1|Reason not Specified|0|||
130106355|NCT03231709|468349991|FG001|Treatment Period 1|Reason not Specified|1|||
130106356|NCT03231709|468349990|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
130106357|NCT03231709|468349991|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
130106358|NCT02609178|468349992|FG000|First Crown|Withdrawal by Subject|0|||
130106359|NCT02609178|468349993|FG001|First Crown|Withdrawal by Subject|0|||
130106360|NCT02609178|468349994|FG002|First Crown|Withdrawal by Subject|1|||
130106361|NCT02609178|468349995|FG003|First Crown|Withdrawal by Subject|1|||
130106362|NCT02609178|468349996|FG004|First Crown|Withdrawal by Subject|0|||
130106363|NCT02609178|468349997|FG005|First Crown|Withdrawal by Subject|0|||
130106364|NCT02419469|468349998|FG000|Overall Study|Withdrawal by Subject|1|||
130106365|NCT04057118|468350001|FG000|Overall Study|Adverse Event|1|||
130106366|NCT04057118|468350002|FG001|Overall Study|Adverse Event|0|||
130106367|NCT04057118|468350003|FG002|Overall Study|Adverse Event|1|||
130106368|NCT04057118|468350004|FG003|Overall Study|Adverse Event|1|||
130106369|NCT04057118|468350001|FG000|Overall Study|Physician Decision|0|||
130106370|NCT04057118|468350002|FG001|Overall Study|Physician Decision|0|||
130106371|NCT04057118|468350003|FG002|Overall Study|Physician Decision|1|||
130287508|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130287509|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287510|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287511|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287512|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130044429|NCT00949650|468119187|FG001|Overall Study|Protocol Violation|4|||
130044430|NCT00949650|468119186|FG000|Overall Study|Refusal to continue medication|7|||
130106372|NCT04057118|468350004|FG003|Overall Study|Physician Decision|1|||
130106373|NCT04057118|468350001|FG000|Overall Study|Withdrawal by Subject|2|||
130106374|NCT04057118|468350002|FG001|Overall Study|Withdrawal by Subject|2|||
130044431|NCT00949650|468119187|FG001|Overall Study|Refusal to continue medication|11|||
130106375|NCT04057118|468350003|FG002|Overall Study|Withdrawal by Subject|0|||
130287513|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130287514|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
130287515|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287516|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
130287517|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287518|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287519|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
130287520|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287521|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287522|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287523|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287524|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287525|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287526|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287527|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287528|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
130287529|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287530|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287531|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
130287532|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287533|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287534|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287535|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287536|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287537|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287538|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287539|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287540|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
130287541|NCT00969761|469014845|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129792709|NCT04393298|467209127|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792710|NCT04393298|467209128|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792711|NCT04393298|467209129|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792712|NCT04393298|467209130|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
129792713|NCT04393298|467209131|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792714|NCT04393298|467209132|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792715|NCT04393298|467209133|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792716|NCT04393298|467209134|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792717|NCT04393298|467209135|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792718|NCT04393298|467209136|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792719|NCT04393298|467209137|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792720|NCT04393298|467209138|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792721|NCT04393298|467209139|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792722|NCT04393298|467209125|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
129792723|NCT04393298|467209126|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
129792724|NCT04393298|467209127|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
129792725|NCT04393298|467209128|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
129792726|NCT04393298|467209129|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
129792727|NCT04393298|467209130|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
129792728|NCT04393298|467209131|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
129792729|NCT04393298|467209132|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
129792730|NCT04393298|467209133|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
129792731|NCT04393298|467209134|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
129792732|NCT04393298|467209135|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
129792733|NCT04393298|467209136|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
129792734|NCT04393298|467209137|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
129792735|NCT04393298|467209138|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
129792736|NCT04393298|467209139|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
129792737|NCT04393298|467209125|FG000|Overall Study|Patient Passed Away|0|||
129792738|NCT04393298|467209126|FG001|Overall Study|Patient Passed Away|0|||
129792739|NCT04393298|467209127|FG002|Overall Study|Patient Passed Away|0|||
129792740|NCT04393298|467209128|FG003|Overall Study|Patient Passed Away|0|||
129792741|NCT04393298|467209129|FG004|Overall Study|Patient Passed Away|0|||
129792742|NCT04393298|467209130|FG005|Overall Study|Patient Passed Away|0|||
130287542|NCT00969761|469014846|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287543|NCT00969761|469014847|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287544|NCT00969761|469014848|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287545|NCT00969761|469014849|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287546|NCT00969761|469014850|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287547|NCT00969761|469014851|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287548|NCT00969761|469014852|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287549|NCT00969761|469014853|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
130106376|NCT04057118|468350004|FG003|Overall Study|Withdrawal by Subject|2|||
130106377|NCT04057118|468350001|FG000|Overall Study|Not Specific|0|||
130106378|NCT04057118|468350002|FG001|Overall Study|Not Specific|0|||
130106379|NCT04057118|468350003|FG002|Overall Study|Not Specific|1|||
130106380|NCT04057118|468350004|FG003|Overall Study|Not Specific|1|||
130106381|NCT04736576|468350005|FG000|Overall Study|Progressive disease|3|||
130106382|NCT04736576|468350006|FG001|Overall Study|Progressive disease|1|||
130106383|NCT04736576|468350005|FG000|Overall Study|Death|1|||
130106384|NCT04736576|468350006|FG001|Overall Study|Death|0|||
130106385|NCT03273712|468350007|FG000|Overall Study|Death|5|||
130106386|NCT03273712|468350007|FG000|Overall Study|Adverse Event|1|||
130106387|NCT03273712|468350007|FG000|Overall Study|Disease Progression|1|||
130106388|NCT03959137|468350010|FG000|Overall Study|Protocol Violation|6|||
130106389|NCT00190684|468350011|FG000|Overall Study|Adverse Event|86|||
130106390|NCT00190684|468350011|FG000|Overall Study|Satisfactory response|80|||
130106391|NCT00190684|468350011|FG000|Overall Study|Lack of efficacy|204|||
130106392|NCT00190684|468350011|FG000|Overall Study|Lost to Follow-up|232|||
130106393|NCT00190684|468350011|FG000|Overall Study|Patient moved|60|||
130106394|NCT00190684|468350011|FG000|Overall Study|Patient Decision|432|||
130106395|NCT00190684|468350011|FG000|Overall Study|Clinical relapse|67|||
130106396|NCT00190684|468350011|FG000|Overall Study|Sponsor's decision|17|||
130106397|NCT00190684|468350011|FG000|Overall Study|Physician Decision|84|||
130106398|NCT00190684|468350011|FG000|Overall Study|Protocol Violation|123|||
130287550|NCT00969761|469014854|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287551|NCT00969761|469014855|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287552|NCT00969761|469014856|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
130287553|NCT00969761|469014845|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130287554|NCT00969761|469014846|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287555|NCT00969761|469014847|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
130287556|NCT00969761|469014848|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287557|NCT00969761|469014849|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130287558|NCT00969761|469014850|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287559|NCT00969761|469014851|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287560|NCT00969761|469014852|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
130287561|NCT00969761|469014853|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
130287562|NCT00969761|469014854|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
130287563|NCT00969761|469014855|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287564|NCT00969761|469014856|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
130287565|NCT00969761|469014845|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287566|NCT00969761|469014846|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287567|NCT00969761|469014847|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287568|NCT00969761|469014848|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
130287569|NCT00969761|469014849|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
130287570|NCT00969761|469014850|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287571|NCT00969761|469014851|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287572|NCT00969761|469014852|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287573|NCT00969761|469014853|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
130287574|NCT00969761|469014854|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287575|NCT00969761|469014855|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287576|NCT00969761|469014856|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
130287577|NCT04030247|469017450|FG000|Overall Study|Withdrawal by Subject|4|||
130287578|NCT04030247|469017450|FG000|Overall Study|Lost to Follow-up|13|||
130287579|NCT00509093|469017451|FG000|Overall Study|Adverse Event|10|||
130287580|NCT00509093|469017451|FG000|Overall Study|Disease Progression|9|||
130287581|NCT00509093|469017451|FG000|Overall Study|Transformed into MDS|1|||
130106399|NCT00190684|468350011|FG000|Overall Study|Study Period III Completed|103|||
130106400|NCT00190684|468350011|FG000|Overall Study|Study Period V Completed|1|||
130106401|NCT00829439|468350017|FG000|Overall Study|Adverse Event|0|||
129792743|NCT04393298|467209131|FG006|Overall Study|Patient Passed Away|0|||
130106402|NCT00829439|468350018|FG001|Overall Study|Adverse Event|0|||
129792744|NCT04393298|467209132|FG007|Overall Study|Patient Passed Away|1|||
129792745|NCT04393298|467209133|FG008|Overall Study|Patient Passed Away|0|||
130106403|NCT00829439|468350019|FG002|Overall Study|Adverse Event|1|||
129887921|NCT01154036|467547317|FG007|Phase II|Protocol Violation|0|||
129887922|NCT01154036|467547310|FG000|Phase II|Withdrawal by Subject|0|||
129887923|NCT01154036|467547311|FG001|Phase II|Withdrawal by Subject|0|||
129887924|NCT01154036|467547312|FG002|Phase II|Withdrawal by Subject|0|||
129887925|NCT01154036|467547313|FG003|Phase II|Withdrawal by Subject|0|||
129887926|NCT01154036|467547314|FG004|Phase II|Withdrawal by Subject|4|||
129887927|NCT01154036|467547315|FG005|Phase II|Withdrawal by Subject|2|||
129887928|NCT01154036|467547316|FG006|Phase II|Withdrawal by Subject|5|||
129887929|NCT01154036|467547317|FG007|Phase II|Withdrawal by Subject|4|||
129887930|NCT01555021|467547323|FG000|Overall Study|Lost to Follow-up|1|||
129887931|NCT01555021|467547324|FG001|Overall Study|Lost to Follow-up|2|||
129887932|NCT00322374|467547325|FG000|Starting Dose|Physician Decision|2|||
129887933|NCT00322374|467547326|FG001|Starting Dose|Physician Decision|0|||
129887934|NCT00322374|467547327|FG002|Starting Dose|Physician Decision|0|||
129887935|NCT00322374|467547328|FG003|Starting Dose|Physician Decision|0|||
129887936|NCT00322374|467547325|FG000|Starting Dose|Study Drug Toxicity|4|||
129887937|NCT00322374|467547326|FG001|Starting Dose|Study Drug Toxicity|0|||
129887938|NCT00322374|467547327|FG002|Starting Dose|Study Drug Toxicity|0|||
130287582|NCT00509093|469017451|FG000|Overall Study|Withdrawal by Subject|3|||
130287583|NCT00509093|469017451|FG000|Overall Study|Physician Decision|1|||
130287584|NCT03187834|469017452|FG000|Overall Study|Lost to Follow-up|0|||
130287585|NCT03187834|469017453|FG001|Overall Study|Lost to Follow-up|1|||
130287586|NCT03187834|469017454|FG002|Overall Study|Lost to Follow-up|2|||
130287587|NCT03187834|469017455|FG003|Overall Study|Lost to Follow-up|2|||
130287588|NCT03187834|469017452|FG000|Overall Study|Had invalid anthropometric measurements|5|||
130287589|NCT03187834|469017453|FG001|Overall Study|Had invalid anthropometric measurements|3|||
130287590|NCT03187834|469017454|FG002|Overall Study|Had invalid anthropometric measurements|4|||
130287591|NCT03187834|469017455|FG003|Overall Study|Had invalid anthropometric measurements|2|||
130287592|NCT00823212|469017456|FG000|Overall Study|Death|8|||
130287593|NCT00823212|469017457|FG001|Overall Study|Death|10|||
130287594|NCT00823212|469017456|FG000|Overall Study|Withdrawal by Subject|6|||
130287595|NCT00823212|469017457|FG001|Overall Study|Withdrawal by Subject|1|||
130287596|NCT00823212|469017456|FG000|Overall Study|Incarcerated|0|||
130287597|NCT00823212|469017457|FG001|Overall Study|Incarcerated|1|||
130287598|NCT00823212|469017456|FG000|Overall Study|Missed 12-month visit|21|||
130287599|NCT00823212|469017457|FG001|Overall Study|Missed 12-month visit|21|||
130287600|NCT01344538|469017458|FG000|Overall Study|Adverse Event|1|||
130287601|NCT01344538|469017459|FG001|Overall Study|Adverse Event|1|||
130287602|NCT01344538|469017458|FG000|Overall Study|Lost to Follow-up|1|||
130287603|NCT01344538|469017459|FG001|Overall Study|Lost to Follow-up|0|||
130287604|NCT01655381|469017460|FG000|Overall Study|Investigator Decision|1|||
130287605|NCT01655381|469017460|FG000|Overall Study|Moved to Another City|1|||
130287606|NCT01655381|469017460|FG000|Overall Study|Insufficient Treatment Response|1|||
130287607|NCT00320255|469017461|FG000|Overall Study|Lack of Efficacy|1|||
130287608|NCT00320255|469017462|FG001|Overall Study|Lack of Efficacy|0|||
130287609|NCT00320255|469017463|FG002|Overall Study|Lack of Efficacy|0|||
130287610|NCT00320255|469017464|FG003|Overall Study|Lack of Efficacy|0|||
130287611|NCT00320255|469017465|FG004|Overall Study|Lack of Efficacy|0|||
130287612|NCT00320255|469017466|FG005|Overall Study|Lack of Efficacy|0|||
130287613|NCT00320255|469017461|FG000|Overall Study|Adverse Event|5|||
130287614|NCT00320255|469017462|FG001|Overall Study|Adverse Event|2|||
130287615|NCT00320255|469017463|FG002|Overall Study|Adverse Event|3|||
129887939|NCT00322374|467547328|FG003|Starting Dose|Study Drug Toxicity|0|||
130044432|NCT00949650|468119186|FG000|Overall Study|Not treated|1|||
130044433|NCT00949650|468119187|FG001|Overall Study|Not treated|4|||
130044434|NCT00949650|468119186|FG000|Overall Study|Other not specified above|5|||
130044435|NCT00949650|468119187|FG001|Overall Study|Other not specified above|0|||
130044436|NCT02168946|468119188|FG000|Overall Study|Adverse Event|8|||
130044437|NCT02168946|468119189|FG001|Overall Study|Adverse Event|5|||
130044438|NCT02168946|468119188|FG000|Overall Study|Lost to Follow-up|3|||
130044439|NCT02168946|468119189|FG001|Overall Study|Lost to Follow-up|0|||
130044440|NCT02168946|468119188|FG000|Overall Study|Subject unable to come back for visits|1|||
130044441|NCT02168946|468119189|FG001|Overall Study|Subject unable to come back for visits|0|||
130044442|NCT00553787|468119197|FG000|Overall Study|Adverse Event|34|||
130044443|NCT00553787|468119198|FG001|Overall Study|Adverse Event|21|||
130044444|NCT00553787|468119199|FG002|Overall Study|Adverse Event|67|||
130044445|NCT00553787|468119197|FG000|Overall Study|Lost to Follow-up|132|||
130044446|NCT00553787|468119198|FG001|Overall Study|Lost to Follow-up|44|||
130044447|NCT00553787|468119199|FG002|Overall Study|Lost to Follow-up|78|||
130044448|NCT00553787|468119197|FG000|Overall Study|Withdrawal by Subject|151|||
130044449|NCT00553787|468119198|FG001|Overall Study|Withdrawal by Subject|40|||
130044450|NCT00553787|468119199|FG002|Overall Study|Withdrawal by Subject|83|||
130044451|NCT00553787|468119197|FG000|Overall Study|Lack of Efficacy|31|||
130044452|NCT00553787|468119198|FG001|Overall Study|Lack of Efficacy|1|||
130044453|NCT00553787|468119199|FG002|Overall Study|Lack of Efficacy|3|||
130044454|NCT00553787|468119197|FG000|Overall Study|Pregnancy|0|||
130044455|NCT00553787|468119198|FG001|Overall Study|Pregnancy|1|||
130044456|NCT00553787|468119199|FG002|Overall Study|Pregnancy|2|||
130044457|NCT00553787|468119197|FG000|Overall Study|non compliance|4|||
130106404|NCT00829439|468350020|FG003|Overall Study|Adverse Event|0|||
130287616|NCT00320255|469017464|FG003|Overall Study|Adverse Event|2|||
130287617|NCT00320255|469017465|FG004|Overall Study|Adverse Event|0|||
130287618|NCT00320255|469017466|FG005|Overall Study|Adverse Event|0|||
130287619|NCT00320255|469017461|FG000|Overall Study|Withdrawal by Subject|1|||
130287620|NCT00320255|469017462|FG001|Overall Study|Withdrawal by Subject|2|||
130287621|NCT00320255|469017463|FG002|Overall Study|Withdrawal by Subject|2|||
130287622|NCT00320255|469017464|FG003|Overall Study|Withdrawal by Subject|4|||
130287623|NCT00320255|469017465|FG004|Overall Study|Withdrawal by Subject|0|||
130287624|NCT00320255|469017466|FG005|Overall Study|Withdrawal by Subject|0|||
130287625|NCT00320255|469017461|FG000|Overall Study|Poor compliance/noncompliance|1|||
130287626|NCT00320255|469017462|FG001|Overall Study|Poor compliance/noncompliance|1|||
130287627|NCT00320255|469017463|FG002|Overall Study|Poor compliance/noncompliance|0|||
130287628|NCT00320255|469017464|FG003|Overall Study|Poor compliance/noncompliance|1|||
130287629|NCT00320255|469017465|FG004|Overall Study|Poor compliance/noncompliance|0|||
130287630|NCT00320255|469017466|FG005|Overall Study|Poor compliance/noncompliance|0|||
130287631|NCT00320255|469017461|FG000|Overall Study|No longer meets study criteria|0|||
130287632|NCT00320255|469017462|FG001|Overall Study|No longer meets study criteria|0|||
130287633|NCT00320255|469017463|FG002|Overall Study|No longer meets study criteria|0|||
130287634|NCT00320255|469017464|FG003|Overall Study|No longer meets study criteria|1|||
130287635|NCT00320255|469017465|FG004|Overall Study|No longer meets study criteria|0|||
130287636|NCT00320255|469017466|FG005|Overall Study|No longer meets study criteria|0|||
130287637|NCT00320255|469017461|FG000|Overall Study|Other|3|||
130287638|NCT00320255|469017462|FG001|Overall Study|Other|2|||
130287639|NCT00320255|469017463|FG002|Overall Study|Other|1|||
130287640|NCT00320255|469017464|FG003|Overall Study|Other|0|||
130044458|NCT00553787|468119198|FG001|Overall Study|non compliance|0|||
130044459|NCT00553787|468119199|FG002|Overall Study|non compliance|11|||
130044460|NCT00553787|468119197|FG000|Overall Study|Requirement for restricted medication|8|||
130044461|NCT00553787|468119198|FG001|Overall Study|Requirement for restricted medication|7|||
130044462|NCT00553787|468119199|FG002|Overall Study|Requirement for restricted medication|5|||
130044463|NCT00553787|468119197|FG000|Overall Study|Other|18|||
130044464|NCT00553787|468119198|FG001|Overall Study|Other|10|||
130044465|NCT00553787|468119199|FG002|Overall Study|Other|13|||
130044466|NCT02111811|468119200|FG000|Treatment Phase|Lost to Follow-up|22|||
130044467|NCT02111811|468119201|FG001|Treatment Phase|Lost to Follow-up|18|||
130287641|NCT00320255|469017465|FG004|Overall Study|Other|0|||
130287642|NCT00320255|469017466|FG005|Overall Study|Other|0|||
130287643|NCT03405935|469017468|FG000|Overall Study|Adverse Event|3|||
130287644|NCT03405935|469017468|FG000|Overall Study|Death|2|||
130287645|NCT03405935|469017468|FG000|Overall Study|Withdrawal by Subject|1|||
130044468|NCT02111811|468119200|FG000|Treatment Phase|Death|2|||
130044469|NCT02111811|468119201|FG001|Treatment Phase|Death|0|||
130106405|NCT00995488|468350021|FG000|Overall Study|Withdrawal by Subject|1|||
130106406|NCT02702271|468350022|FG000|Overall Study|Death|36|||
130044470|NCT02111811|468119200|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
130044471|NCT02111811|468119201|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
130044472|NCT02111811|468119200|FG000|Follow up Period (Aim 2)|Death|2|||
130044473|NCT02111811|468119201|FG001|Follow up Period (Aim 2)|Death|0|||
130287646|NCT03405935|469017468|FG000|Overall Study|Lost to Follow-up|2|||
130287647|NCT04979897|469017469|FG000|Overall Study|Death|1|||
129887940|NCT00322374|467547325|FG000|First Escalation|Documented Disease Progression|0|||
129887941|NCT00322374|467547326|FG001|First Escalation|Documented Disease Progression|6|||
129887942|NCT00322374|467547327|FG002|First Escalation|Documented Disease Progression|0|||
129887943|NCT00322374|467547328|FG003|First Escalation|Documented Disease Progression|0|||
129887944|NCT00322374|467547325|FG000|First Escalation|Physician Decision|0|||
129887945|NCT00322374|467547326|FG001|First Escalation|Physician Decision|12|||
129887946|NCT00322374|467547327|FG002|First Escalation|Physician Decision|0|||
129887947|NCT00322374|467547328|FG003|First Escalation|Physician Decision|0|||
129887948|NCT00322374|467547325|FG000|First Escalation|Study Drug Toxicity|0|||
129887949|NCT00322374|467547326|FG001|First Escalation|Study Drug Toxicity|11|||
129887950|NCT00322374|467547327|FG002|First Escalation|Study Drug Toxicity|0|||
129887951|NCT00322374|467547328|FG003|First Escalation|Study Drug Toxicity|0|||
129887952|NCT00322374|467547325|FG000|First Escalation|Participant Request|0|||
129887953|NCT00322374|467547326|FG001|First Escalation|Participant Request|1|||
129887954|NCT00322374|467547327|FG002|First Escalation|Participant Request|0|||
129887955|NCT00322374|467547328|FG003|First Escalation|Participant Request|0|||
129887956|NCT00322374|467547325|FG000|Second Escalation|Physician Decision|0|||
129887957|NCT00322374|467547326|FG001|Second Escalation|Physician Decision|0|||
129887958|NCT00322374|467547327|FG002|Second Escalation|Physician Decision|5|||
129887959|NCT00322374|467547328|FG003|Second Escalation|Physician Decision|0|||
129887960|NCT00322374|467547325|FG000|Second Escalation|Study Drug Toxicity|0|||
129887961|NCT00322374|467547326|FG001|Second Escalation|Study Drug Toxicity|0|||
129887962|NCT00322374|467547327|FG002|Second Escalation|Study Drug Toxicity|1|||
129887963|NCT00322374|467547328|FG003|Second Escalation|Study Drug Toxicity|0|||
129887964|NCT03653416|467547329|FG000|Overall Study|Protocol Violation|6|||
129887965|NCT03653416|467547330|FG001|Overall Study|Protocol Violation|1|||
129887966|NCT02388074|467547331|FG000|Overall Study|Lost in Transit|2|||
129887967|NCT02388074|467547331|FG000|Overall Study|Sample Not Returned|1|||
129887968|NCT00003458|467547334|FG000|Overall Study|Not evaluable|4|||
129887969|NCT02133924|467547335|FG000|Overall Study|Death|38|||
129887970|NCT02133924|467547335|FG000|Overall Study|Physician Decision|1|||
129887971|NCT02133924|467547335|FG000|Overall Study|Withdrawal by Subject|3|||
129887972|NCT01254890|467547336|FG000|Overall Study|Ineligible|0|||
129887973|NCT01254890|467547337|FG001|Overall Study|Ineligible|3|||
129887974|NCT01254890|467547336|FG000|Overall Study|Withdrawal by Subject|1|||
129887975|NCT01254890|467547337|FG001|Overall Study|Withdrawal by Subject|2|||
129887976|NCT01254890|467547336|FG000|Overall Study|Disease Progression|0|||
129887977|NCT01254890|467547337|FG001|Overall Study|Disease Progression|5|||
129887978|NCT04039503|467547342|FG000|Overall Study|Adverse Event|3|||
129887979|NCT04039503|467547343|FG001|Overall Study|Adverse Event|0|||
129887980|NCT04039503|467547344|FG002|Overall Study|Adverse Event|2|||
129887981|NCT04039503|467547345|FG003|Overall Study|Adverse Event|0|||
129887982|NCT04039503|467547342|FG000|Overall Study|Lost to Follow-up|0|||
129887983|NCT04039503|467547343|FG001|Overall Study|Lost to Follow-up|0|||
129887984|NCT04039503|467547344|FG002|Overall Study|Lost to Follow-up|1|||
129887985|NCT04039503|467547345|FG003|Overall Study|Lost to Follow-up|0|||
129887986|NCT04039503|467547342|FG000|Overall Study|Protocol Violation|0|||
129887987|NCT04039503|467547343|FG001|Overall Study|Protocol Violation|1|||
129887988|NCT04039503|467547344|FG002|Overall Study|Protocol Violation|2|||
129887989|NCT04039503|467547345|FG003|Overall Study|Protocol Violation|1|||
129887990|NCT04039503|467547342|FG000|Overall Study|Withdrawal by Subject|4|||
129887991|NCT04039503|467547343|FG001|Overall Study|Withdrawal by Subject|3|||
129887992|NCT04039503|467547344|FG002|Overall Study|Withdrawal by Subject|5|||
129887993|NCT04039503|467547345|FG003|Overall Study|Withdrawal by Subject|2|||
129887994|NCT04157686|467547347|FG000|Overall Study|Adverse Event|1|||
129887995|NCT04157686|467547348|FG001|Overall Study|Adverse Event|0|||
129887996|NCT04157686|467547349|FG002|Overall Study|Adverse Event|1|||
129887997|NCT04157686|467547350|FG003|Overall Study|Adverse Event|0|||
129887998|NCT04157686|467547351|FG004|Overall Study|Adverse Event|1|||
129887999|NCT04157686|467547352|FG005|Overall Study|Adverse Event|0|||
129888000|NCT04157686|467547353|FG006|Overall Study|Adverse Event|0|||
129888001|NCT04157686|467547354|FG007|Overall Study|Adverse Event|0|||
129888002|NCT04157686|467547347|FG000|Overall Study|Pregnancy|0|||
129888003|NCT04157686|467547348|FG001|Overall Study|Pregnancy|1|||
129888004|NCT04157686|467547349|FG002|Overall Study|Pregnancy|3|||
129888005|NCT04157686|467547350|FG003|Overall Study|Pregnancy|0|||
130287648|NCT04979897|469017470|FG001|Overall Study|Death|8|||
129888006|NCT04157686|467547351|FG004|Overall Study|Pregnancy|0|||
129888007|NCT04157686|467547352|FG005|Overall Study|Pregnancy|0|||
129888008|NCT04157686|467547353|FG006|Overall Study|Pregnancy|3|||
129888009|NCT04157686|467547354|FG007|Overall Study|Pregnancy|0|||
129888010|NCT04157686|467547347|FG000|Overall Study|Lost to Follow-up|1|||
129888011|NCT04157686|467547348|FG001|Overall Study|Lost to Follow-up|2|||
129888012|NCT04157686|467547349|FG002|Overall Study|Lost to Follow-up|8|||
129888013|NCT04157686|467547350|FG003|Overall Study|Lost to Follow-up|6|||
129888014|NCT04157686|467547351|FG004|Overall Study|Lost to Follow-up|6|||
129888015|NCT04157686|467547352|FG005|Overall Study|Lost to Follow-up|3|||
129888016|NCT04157686|467547353|FG006|Overall Study|Lost to Follow-up|7|||
129888017|NCT04157686|467547354|FG007|Overall Study|Lost to Follow-up|9|||
130287649|NCT04979897|469017469|FG000|Overall Study|Lost to Follow-up|111|||
130287650|NCT04979897|469017470|FG001|Overall Study|Lost to Follow-up|56|||
130287651|NCT04979897|469017469|FG000|Overall Study|Withdrawal by Subject|7|||
130287652|NCT04979897|469017470|FG001|Overall Study|Withdrawal by Subject|2|||
130287653|NCT02781792|469017477|FG000|Overall Study|Adverse Event|1|||
130287654|NCT02781792|469017478|FG001|Overall Study|Adverse Event|2|||
130287655|NCT02781792|469017477|FG000|Overall Study|Withdrawal by Subject|3|||
130287656|NCT02781792|469017478|FG001|Overall Study|Withdrawal by Subject|1|||
130287657|NCT02781792|469017477|FG000|Overall Study|Lack of Efficacy|1|||
130287658|NCT02781792|469017478|FG001|Overall Study|Lack of Efficacy|1|||
130287659|NCT02781792|469017477|FG000|Overall Study|Hospice|0|||
130287660|NCT02781792|469017478|FG001|Overall Study|Hospice|1|||
130287661|NCT01703117|469017479|FG000|Overall Study|Adverse Event|4|||
130287662|NCT01703117|469017480|FG001|Overall Study|Adverse Event|3|||
130287663|NCT01703117|469017479|FG000|Overall Study|Withdrawal by Subject|0|||
130287664|NCT01703117|469017480|FG001|Overall Study|Withdrawal by Subject|1|||
130287665|NCT00937404|469017492|FG000|Overall Study|Protocol Violation|1|||
130287666|NCT00937404|469017492|FG000|Overall Study|Withdrawal by Subject|1|||
130287667|NCT04644237|469017493|FG000|Overall Study|Death|3|||
130287668|NCT04644237|469017494|FG001|Overall Study|Death|2|||
130287669|NCT04644237|469017493|FG000|Overall Study|Adverse Event|15|||
130287670|NCT04644237|469017494|FG001|Overall Study|Adverse Event|12|||
130287671|NCT04644237|469017493|FG000|Overall Study|Progressive Disease|47|||
130287672|NCT04644237|469017494|FG001|Overall Study|Progressive Disease|19|||
129888018|NCT04157686|467547347|FG000|Overall Study|Lack of Efficacy|0|||
129888019|NCT04157686|467547348|FG001|Overall Study|Lack of Efficacy|0|||
129888020|NCT04157686|467547349|FG002|Overall Study|Lack of Efficacy|0|||
129888021|NCT04157686|467547350|FG003|Overall Study|Lack of Efficacy|0|||
129888022|NCT04157686|467547351|FG004|Overall Study|Lack of Efficacy|0|||
129888023|NCT04157686|467547352|FG005|Overall Study|Lack of Efficacy|2|||
129888024|NCT04157686|467547353|FG006|Overall Study|Lack of Efficacy|0|||
129888025|NCT04157686|467547354|FG007|Overall Study|Lack of Efficacy|1|||
129888026|NCT04157686|467547347|FG000|Overall Study|Withdrawal by Subject|10|||
129888027|NCT04157686|467547348|FG001|Overall Study|Withdrawal by Subject|10|||
129888028|NCT04157686|467547349|FG002|Overall Study|Withdrawal by Subject|12|||
129888029|NCT04157686|467547350|FG003|Overall Study|Withdrawal by Subject|20|||
129888030|NCT04157686|467547351|FG004|Overall Study|Withdrawal by Subject|12|||
129888031|NCT04157686|467547352|FG005|Overall Study|Withdrawal by Subject|11|||
129888032|NCT04157686|467547353|FG006|Overall Study|Withdrawal by Subject|18|||
130287673|NCT04644237|469017493|FG000|Overall Study|Clinical Progression|4|||
129888033|NCT04157686|467547354|FG007|Overall Study|Withdrawal by Subject|24|||
130287674|NCT04644237|469017494|FG001|Overall Study|Clinical Progression|1|||
130287675|NCT04644237|469017493|FG000|Overall Study|Withdrawal by Subject|1|||
130287676|NCT04644237|469017494|FG001|Overall Study|Withdrawal by Subject|2|||
130287677|NCT04644237|469017493|FG000|Overall Study|Physician Decision|3|||
130287678|NCT04644237|469017494|FG001|Overall Study|Physician Decision|0|||
130287679|NCT04644237|469017493|FG000|Overall Study|Other|1|||
130287680|NCT04644237|469017494|FG001|Overall Study|Other|0|||
130287681|NCT04644237|469017493|FG000|Overall Study|Randomized but not Treated|1|||
130287682|NCT04644237|469017494|FG001|Overall Study|Randomized but not Treated|0|||
130287683|NCT00090233|469017495|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
130287684|NCT00090233|469017496|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
130287685|NCT00090233|469017495|FG000|Overall Study|Adverse Event|214|||
130287686|NCT00090233|469017496|FG001|Overall Study|Adverse Event|198|||
130287687|NCT00090233|469017495|FG000|Overall Study|Lost to Follow-up|68|||
130287688|NCT00090233|469017496|FG001|Overall Study|Lost to Follow-up|95|||
130287689|NCT00090233|469017495|FG000|Overall Study|Protocol Violation|960|||
130287690|NCT00090233|469017496|FG001|Overall Study|Protocol Violation|1022|||
130287691|NCT00090233|469017495|FG000|Overall Study|Withdrawal by Subject|182|||
130287692|NCT00090233|469017496|FG001|Overall Study|Withdrawal by Subject|211|||
129888034|NCT04157686|467547347|FG000|Overall Study|Physician Decision|0|||
129888035|NCT04157686|467547348|FG001|Overall Study|Physician Decision|0|||
129888036|NCT04157686|467547349|FG002|Overall Study|Physician Decision|1|||
129888037|NCT04157686|467547350|FG003|Overall Study|Physician Decision|0|||
129888038|NCT04157686|467547351|FG004|Overall Study|Physician Decision|1|||
130287693|NCT00090233|469017495|FG000|Overall Study|Moved|203|||
130287694|NCT00090233|469017496|FG001|Overall Study|Moved|189|||
130287695|NCT00090233|469017495|FG000|Overall Study|Other|1211|||
130287696|NCT00090233|469017496|FG001|Overall Study|Other|1160|||
130287697|NCT00090233|469017495|FG000|Overall Study|Data not available at data cut-off point|1552|||
130287698|NCT00090233|469017496|FG001|Overall Study|Data not available at data cut-off point|1563|||
130287699|NCT04863248|469017497|FG000|Overall Study|Sponsor Terminated|4|||
130287700|NCT04863248|469017498|FG001|Overall Study|Sponsor Terminated|1|||
130287701|NCT04863248|469017497|FG000|Overall Study|Death|0|||
130287702|NCT04863248|469017498|FG001|Overall Study|Death|1|||
130287703|NCT04863248|469017497|FG000|Overall Study|Withdrawal by Subject|0|||
130287704|NCT04863248|469017498|FG001|Overall Study|Withdrawal by Subject|1|||
130287705|NCT02536300|469017499|FG000|Overall Study|Investigator's Discretion|17|||
130287706|NCT02536300|469017500|FG001|Overall Study|Investigator's Discretion|11|||
130287707|NCT02536300|469017501|FG002|Overall Study|Investigator's Discretion|2|||
130287708|NCT02536300|469017499|FG000|Overall Study|Progressive Disease|11|||
130287709|NCT02536300|469017500|FG001|Overall Study|Progressive Disease|7|||
130287710|NCT02536300|469017501|FG002|Overall Study|Progressive Disease|6|||
130287711|NCT02536300|469017499|FG000|Overall Study|Study Terminated by Sponsor|6|||
130287712|NCT02536300|469017500|FG001|Overall Study|Study Terminated by Sponsor|4|||
130287713|NCT02536300|469017501|FG002|Overall Study|Study Terminated by Sponsor|7|||
130287714|NCT02536300|469017499|FG000|Overall Study|Death|7|||
130287715|NCT02536300|469017500|FG001|Overall Study|Death|0|||
130287716|NCT02536300|469017501|FG002|Overall Study|Death|5|||
130287717|NCT02536300|469017499|FG000|Overall Study|Withdrew Consent|4|||
130287718|NCT02536300|469017500|FG001|Overall Study|Withdrew Consent|2|||
130287719|NCT02536300|469017501|FG002|Overall Study|Withdrew Consent|0|||
130287720|NCT02536300|469017499|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
130287721|NCT02536300|469017500|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
130287722|NCT02536300|469017501|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
130287723|NCT02536300|469017499|FG000|Overall Study|Enrolled but Never Treated|0|||
130287724|NCT02536300|469017500|FG001|Overall Study|Enrolled but Never Treated|0|||
130287725|NCT02536300|469017501|FG002|Overall Study|Enrolled but Never Treated|1|||
130287726|NCT02536300|469017499|FG000|Overall Study|Non-compliance With Study Drug|1|||
130287727|NCT02536300|469017500|FG001|Overall Study|Non-compliance With Study Drug|0|||
130287728|NCT02536300|469017501|FG002|Overall Study|Non-compliance With Study Drug|0|||
130287729|NCT02536300|469017499|FG000|Overall Study|Protocol Violation|0|||
130287730|NCT02536300|469017500|FG001|Overall Study|Protocol Violation|1|||
130287731|NCT02536300|469017501|FG002|Overall Study|Protocol Violation|0|||
130287732|NCT01691105|469017508|FG000|1 Month Follow-up|Lost to Follow-up|41|||
130287733|NCT01691105|469017509|FG001|1 Month Follow-up|Lost to Follow-up|38|||
130287734|NCT01691105|469017508|FG000|1 Month Follow-up|Death|2|||
130287735|NCT01691105|469017509|FG001|1 Month Follow-up|Death|3|||
130287736|NCT01691105|469017508|FG000|6 Month Follow-up|Lost to Follow-up|39|||
130287737|NCT01691105|469017509|FG001|6 Month Follow-up|Lost to Follow-up|58|||
130287738|NCT01691105|469017508|FG000|6 Month Follow-up|Death|13|||
130287739|NCT01691105|469017509|FG001|6 Month Follow-up|Death|13|||
130287740|NCT01691105|469017508|FG000|12 Month Follow-up|Lost to Follow-up|50|||
130287741|NCT01691105|469017509|FG001|12 Month Follow-up|Lost to Follow-up|71|||
130287742|NCT01691105|469017508|FG000|12 Month Follow-up|Death|22|||
130287743|NCT01691105|469017509|FG001|12 Month Follow-up|Death|30|||
130287744|NCT01691105|469017508|FG000|12 Month Biochemical Verification|Death|22|||
130287745|NCT01691105|469017509|FG001|12 Month Biochemical Verification|Death|30|||
130287746|NCT01691105|469017508|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
130287747|NCT01691105|469017509|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
130287748|NCT01691105|469017508|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
130287749|NCT01691105|469017509|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
130287750|NCT02233738|469017510|FG000|Overall Study|Lost to Follow-up|5|||
130287751|NCT02233738|469017511|FG001|Overall Study|Lost to Follow-up|12|||
130287752|NCT02233738|469017510|FG000|Overall Study|Death|0|||
130287753|NCT02233738|469017511|FG001|Overall Study|Death|1|||
130287754|NCT02233738|469017510|FG000|Overall Study|Withdrawal by Subject|0|||
130287755|NCT02233738|469017511|FG001|Overall Study|Withdrawal by Subject|1|||
130287756|NCT02233738|469017510|FG000|Overall Study|Did not return after Baseline|3|||
130287757|NCT02233738|469017511|FG001|Overall Study|Did not return after Baseline|2|||
130287758|NCT00096174|469017512|FG000|Overall Study|Lack of Efficacy|9|||
130287759|NCT00096174|469017512|FG000|Overall Study|Adverse Event|15|||
130287760|NCT00096174|469017512|FG000|Overall Study|Death|6|||
130287761|NCT00096174|469017512|FG000|Overall Study|Withdrawal by Subject|15|||
130287762|NCT00096174|469017512|FG000|Overall Study|Not started protocol therapy|3|||
130287763|NCT00096174|469017512|FG000|Overall Study|Ineligible|6|||
130287764|NCT00096174|469017512|FG000|Overall Study|other reason|8|||
130287765|NCT00445848|469017516|FG000|Overall Study|Adverse Event|14|||
130287766|NCT00445848|469017516|FG000|Overall Study|Withdrawal by Subject|4|||
130287767|NCT00445848|469017516|FG000|Overall Study|Progression|62|||
130287768|NCT00445848|469017516|FG000|Overall Study|Other-Not protocol specified|5|||
130287769|NCT04706273|469017517|FG000|Overall Study|Withdrawal by Subject|27|||
130287770|NCT04706273|469017517|FG000|Overall Study|Physician Decision|1|||
130287771|NCT04706273|469017517|FG000|Overall Study|Lost to Follow-up|42|||
130287772|NCT04706273|469017517|FG000|Overall Study|Death|85|||
129888039|NCT04157686|467547352|FG005|Overall Study|Physician Decision|0|||
130287773|NCT04706273|469017517|FG000|Overall Study|Amputation that removes study device|2|||
130287774|NCT04706273|469017517|FG000|Overall Study|Surgical bypass|3|||
130287775|NCT04706273|469017517|FG000|Overall Study|Changing hospital|23|||
130287776|NCT04706273|469017517|FG000|Overall Study|Unable to attend hospital|2|||
130287777|NCT03199053|469017520|FG000|ST Period|Withdrawal by Subject|2|||
130287778|NCT03199053|469017521|FG001|ST Period|Withdrawal by Subject|4|||
129888040|NCT04157686|467547353|FG006|Overall Study|Physician Decision|3|||
130044474|NCT00069121|468119206|FG000|Overall Study|Death|286|||
130044475|NCT00069121|468119207|FG001|Overall Study|Death|242|||
130044476|NCT00069121|468119206|FG000|Overall Study|Withdrawal by Subject|18|||
130044477|NCT00069121|468119207|FG001|Overall Study|Withdrawal by Subject|20|||
130044478|NCT00069121|468119206|FG000|Overall Study|Lost to Follow-up|63|||
130044479|NCT00069121|468119207|FG001|Overall Study|Lost to Follow-up|63|||
130044480|NCT00231478|468119210|FG000|Overall Study|Protocol Violation|3|||
130044481|NCT00231478|468119211|FG001|Overall Study|Protocol Violation|2|||
130044482|NCT00231478|468119210|FG000|Overall Study|Refused Treatment|1|||
130044483|NCT00231478|468119211|FG001|Overall Study|Refused Treatment|1|||
130044484|NCT00231478|468119210|FG000|Overall Study|Withdrawal by Subject|1|||
130044485|NCT00231478|468119211|FG001|Overall Study|Withdrawal by Subject|0|||
130044486|NCT00231478|468119210|FG000|Overall Study|Adverse Event|0|||
130044487|NCT00231478|468119211|FG001|Overall Study|Adverse Event|1|||
130287779|NCT03199053|469017522|FG002|ST Period|Withdrawal by Subject|6|||
130287780|NCT03199053|469017520|FG000|ST Period|Withdrawal by parent/guardian|1|||
130287781|NCT03199053|469017521|FG001|ST Period|Withdrawal by parent/guardian|1|||
130287782|NCT03199053|469017522|FG002|ST Period|Withdrawal by parent/guardian|1|||
130287783|NCT03199053|469017520|FG000|ST Period|Lost to Follow-up|2|||
130287784|NCT03199053|469017521|FG001|ST Period|Lost to Follow-up|0|||
130287785|NCT03199053|469017522|FG002|ST Period|Lost to Follow-up|1|||
130287786|NCT03199053|469017520|FG000|LT Period|Withdrawal by Subject|1|||
130287787|NCT03199053|469017521|FG001|LT Period|Withdrawal by Subject|3|||
130287788|NCT03199053|469017522|FG002|LT Period|Withdrawal by Subject|3|||
130287789|NCT03199053|469017520|FG000|LT Period|Withdrawal by parent/guardian|0|||
130287790|NCT03199053|469017521|FG001|LT Period|Withdrawal by parent/guardian|0|||
130287791|NCT03199053|469017522|FG002|LT Period|Withdrawal by parent/guardian|1|||
130287792|NCT03199053|469017520|FG000|LT Period|Lost to Follow-up|0|||
130287793|NCT03199053|469017521|FG001|LT Period|Lost to Follow-up|1|||
130287794|NCT03199053|469017522|FG002|LT Period|Lost to Follow-up|1|||
130287795|NCT03199053|469017520|FG000|LT Period|Miscellaneous|0|||
130287796|NCT03199053|469017521|FG001|LT Period|Miscellaneous|0|||
130287797|NCT03199053|469017522|FG002|LT Period|Miscellaneous|2|||
130287798|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
130287799|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
130287800|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
130287801|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
130287802|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
130287803|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
130287804|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
130287805|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
130287806|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
130287807|NCT03199053|469017520|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
130287808|NCT03199053|469017521|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
130287809|NCT03199053|469017522|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
130287810|NCT02509052|469017525|FG000|Overall Study|Non compliance|0|||
130287811|NCT02509052|469017526|FG001|Overall Study|Non compliance|0|||
130287812|NCT02509052|469017527|FG002|Overall Study|Non compliance|1|||
130287813|NCT01824823|469017528|FG000|Overall Study|Lack of Efficacy|1|||
130287814|NCT01824823|469017529|FG001|Overall Study|Lack of Efficacy|1|||
130287815|NCT01824823|469017528|FG000|Overall Study|Off-treatment reason not submitted|1|||
130287816|NCT01824823|469017529|FG001|Overall Study|Off-treatment reason not submitted|0|||
130287817|NCT03362931|469017532|FG000|Overall Study|Adverse Event|1|||
130287818|NCT03362931|469017532|FG000|Overall Study|Death|2|||
130287819|NCT01323270|469017533|FG000|Overall Study|Withdrawal by Subject|19|||
130287820|NCT01323270|469017534|FG001|Overall Study|Withdrawal by Subject|10|||
130044488|NCT00231478|468119210|FG000|Overall Study|Administrative|3|||
130044489|NCT00231478|468119211|FG001|Overall Study|Administrative|2|||
130044490|NCT04579393|468119220|FG000|Overall Study|Withdrawal by Subject|2|||
130287821|NCT01323270|469017533|FG000|Overall Study|Protocol Violation|9|||
130287822|NCT01323270|469017534|FG001|Overall Study|Protocol Violation|7|||
130287823|NCT01323270|469017533|FG000|Overall Study|Lost to Follow-up|4|||
130287824|NCT01323270|469017534|FG001|Overall Study|Lost to Follow-up|6|||
130287825|NCT01323270|469017533|FG000|Overall Study|Adverse Event|8|||
130287826|NCT01323270|469017534|FG001|Overall Study|Adverse Event|0|||
130287827|NCT01323270|469017533|FG000|Overall Study|Other|0|||
130287828|NCT01323270|469017534|FG001|Overall Study|Other|3|||
130287829|NCT01323270|469017533|FG000|Overall Study|Physician Decision|0|||
129888041|NCT04157686|467547354|FG007|Overall Study|Physician Decision|0|||
130044491|NCT04579393|468119221|FG001|Overall Study|Withdrawal by Subject|2|||
130287830|NCT01323270|469017534|FG001|Overall Study|Physician Decision|2|||
130287831|NCT01323270|469017533|FG000|Overall Study|Not eligible|1|||
130287832|NCT01323270|469017534|FG001|Overall Study|Not eligible|1|||
130287833|NCT01323270|469017533|FG000|Overall Study|Death|1|||
130287834|NCT01323270|469017534|FG001|Overall Study|Death|0|||
130044492|NCT04579393|468119220|FG000|Overall Study|Death|1|||
130044493|NCT04579393|468119221|FG001|Overall Study|Death|3|||
130044494|NCT00393458|468119222|FG000|Overall Study|Adverse Event|35|||
130044495|NCT00393458|468119223|FG001|Overall Study|Adverse Event|24|||
130044496|NCT00393458|468119224|FG002|Overall Study|Adverse Event|40|||
130044497|NCT00393458|468119225|FG003|Overall Study|Adverse Event|35|||
130044498|NCT00393458|468119222|FG000|Overall Study|Subject withdrew consent|27|||
130044499|NCT00393458|468119223|FG001|Overall Study|Subject withdrew consent|40|||
130044500|NCT00393458|468119224|FG002|Overall Study|Subject withdrew consent|33|||
130044501|NCT00393458|468119225|FG003|Overall Study|Subject withdrew consent|50|||
130044502|NCT00393458|468119222|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
130044503|NCT00393458|468119223|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
130044504|NCT00393458|468119224|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
130044505|NCT00393458|468119225|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
130044506|NCT00393458|468119222|FG000|Overall Study|Protocol deviation|11|||
130044507|NCT00393458|468119223|FG001|Overall Study|Protocol deviation|11|||
130044508|NCT00393458|468119224|FG002|Overall Study|Protocol deviation|11|||
130106407|NCT02702271|468350023|FG001|Overall Study|Death|7|||
130287835|NCT01323270|469017533|FG000|Overall Study|Randomized, but not vaccinated|1|||
130287836|NCT01323270|469017534|FG001|Overall Study|Randomized, but not vaccinated|0|||
130287837|NCT03761394|469017536|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
130287838|NCT03761394|469017537|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
130287839|NCT03761394|469017538|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
130287840|NCT03761394|469017539|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
130287841|NCT03761394|469017536|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
130287842|NCT03761394|469017537|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
130287843|NCT03761394|469017538|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
130106408|NCT02702271|468350022|FG000|Overall Study|Lost to Follow-up|12|||
130106409|NCT02702271|468350023|FG001|Overall Study|Lost to Follow-up|0|||
130287844|NCT03761394|469017539|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
130287845|NCT03761394|469017536|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130287846|NCT03761394|469017537|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130287847|NCT03761394|469017538|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
130287848|NCT03761394|469017539|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
130287849|NCT03761394|469017536|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130106410|NCT02702271|468350022|FG000|Overall Study|Withdrawal by Subject|8|||
130106411|NCT02702271|468350023|FG001|Overall Study|Withdrawal by Subject|1|||
130106412|NCT02702271|468350022|FG000|Overall Study|Physician Decision|2|||
130287850|NCT03761394|469017537|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130287851|NCT03761394|469017538|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
130287852|NCT03761394|469017539|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
130287853|NCT01080768|469017548|FG000|Overall Study|Protocol Deviation|2|||
130287854|NCT01080768|469017549|FG001|Overall Study|Protocol Deviation|1|||
130106413|NCT02702271|468350023|FG001|Overall Study|Physician Decision|0|||
130106414|NCT02702271|468350022|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
130106415|NCT02702271|468350023|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
130106416|NCT01494649|468350024|FG000|Overall Study|Lost to Follow-up|0|||
130106417|NCT01494649|468350025|FG001|Overall Study|Lost to Follow-up|1|||
130106418|NCT01174368|468350026|FG000|Overall Study|Withdrawal by Subject|1|||
130106419|NCT05166512|468350029|FG000|Randomized|Lost to Follow-up|2|||
130106420|NCT05166512|468350030|FG001|Randomized|Lost to Follow-up|0|||
130106421|NCT05166512|468350029|FG000|Randomized|Withdrawal by Subject|1|||
130106422|NCT05166512|468350030|FG001|Randomized|Withdrawal by Subject|0|||
130106423|NCT05166512|468350029|FG000|Baseline Data Collection|Lost to Follow-up|0|||
130106424|NCT05166512|468350030|FG001|Baseline Data Collection|Lost to Follow-up|3|||
130106425|NCT05166512|468350029|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
130106426|NCT05166512|468350030|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
130106427|NCT05166512|468350029|FG000|Baseline Data Collection|Protocol Violation|2|||
130106428|NCT05166512|468350030|FG001|Baseline Data Collection|Protocol Violation|0|||
130287855|NCT00931723|469017554|FG000|Overall Study|Withdrawal by Subject|11|||
129792746|NCT04393298|467209134|FG009|Overall Study|Patient Passed Away|0|||
130044509|NCT00393458|468119225|FG003|Overall Study|Protocol deviation|10|||
130044510|NCT00393458|468119222|FG000|Overall Study|Administrative problems|7|||
130106429|NCT05166512|468350029|FG000|4 Month Data Collection|Lost to Follow-up|1|||
130106430|NCT05166512|468350030|FG001|4 Month Data Collection|Lost to Follow-up|0|||
130106431|NCT05166512|468350029|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
129792747|NCT04393298|467209135|FG010|Overall Study|Patient Passed Away|0|||
130106432|NCT05166512|468350030|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
130106433|NCT05166512|468350029|FG000|12 Month Data Collection|Lost to Follow-up|3|||
130106434|NCT05166512|468350030|FG001|12 Month Data Collection|Lost to Follow-up|1|||
130106435|NCT05166512|468350029|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
130044511|NCT00393458|468119223|FG001|Overall Study|Administrative problems|8|||
130044512|NCT00393458|468119224|FG002|Overall Study|Administrative problems|5|||
130044513|NCT00393458|468119225|FG003|Overall Study|Administrative problems|2|||
129792748|NCT04393298|467209136|FG011|Overall Study|Patient Passed Away|0|||
130044514|NCT00393458|468119222|FG000|Overall Study|Lost to Follow-up|5|||
130287856|NCT00931723|469017555|FG001|Overall Study|Withdrawal by Subject|13|||
130287857|NCT00931723|469017554|FG000|Overall Study|Adverse Event|6|||
130287858|NCT00931723|469017555|FG001|Overall Study|Adverse Event|13|||
130287859|NCT00931723|469017554|FG000|Overall Study|Lithium found in blood|0|||
130287860|NCT00931723|469017555|FG001|Overall Study|Lithium found in blood|1|||
130287861|NCT00931723|469017554|FG000|Overall Study|Condition under investigation worsened|1|||
130287862|NCT00931723|469017555|FG001|Overall Study|Condition under investigation worsened|2|||
130287863|NCT00931723|469017554|FG000|Overall Study|Lost to Follow-up|1|||
130287864|NCT00931723|469017555|FG001|Overall Study|Lost to Follow-up|2|||
130287865|NCT00931723|469017554|FG000|Overall Study|Study-specific discontinuation criteria|1|||
130287866|NCT00931723|469017555|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130287867|NCT00931723|469017554|FG000|Overall Study|Severe non-compliance to protocol|2|||
130287868|NCT00931723|469017555|FG001|Overall Study|Severe non-compliance to protocol|0|||
130287869|NCT00931723|469017554|FG000|Overall Study|Safety reasons|0|||
130287870|NCT00931723|469017555|FG001|Overall Study|Safety reasons|1|||
130287871|NCT00931723|469017554|FG000|Overall Study|Took prohibited concomitant medication|0|||
130287872|NCT00931723|469017555|FG001|Overall Study|Took prohibited concomitant medication|1|||
130287873|NCT00931723|469017554|FG000|Overall Study|Lack or insufficient theraputic response|2|||
130287874|NCT00931723|469017555|FG001|Overall Study|Lack or insufficient theraputic response|5|||
130287875|NCT00931723|469017554|FG000|Overall Study|Sponsor decision|1|||
130287876|NCT00931723|469017555|FG001|Overall Study|Sponsor decision|0|||
130287877|NCT00931723|469017554|FG000|Overall Study|Late hospital discharge|1|||
130287878|NCT00931723|469017555|FG001|Overall Study|Late hospital discharge|0|||
130287879|NCT01643850|469017559|FG000|Overall Study|Withdrawal by Subject|0|||
130287880|NCT01643850|469017560|FG001|Overall Study|Withdrawal by Subject|0|||
130287881|NCT01643850|469017561|FG002|Overall Study|Withdrawal by Subject|0|||
130287882|NCT01643850|469017562|FG003|Overall Study|Withdrawal by Subject|0|||
130287883|NCT01643850|469017563|FG004|Overall Study|Withdrawal by Subject|1|||
130287884|NCT01643850|469017564|FG005|Overall Study|Withdrawal by Subject|0|||
130287885|NCT01643850|469017565|FG006|Overall Study|Withdrawal by Subject|0|||
130287886|NCT01643850|469017566|FG007|Overall Study|Withdrawal by Subject|0|||
130287887|NCT01643850|469017567|FG008|Overall Study|Withdrawal by Subject|0|||
130287888|NCT01643850|469017559|FG000|Overall Study|Lost to Follow-up|0|||
130287889|NCT01643850|469017560|FG001|Overall Study|Lost to Follow-up|0|||
130287890|NCT01643850|469017561|FG002|Overall Study|Lost to Follow-up|0|||
130287891|NCT01643850|469017562|FG003|Overall Study|Lost to Follow-up|0|||
130287892|NCT01643850|469017563|FG004|Overall Study|Lost to Follow-up|0|||
130287893|NCT01643850|469017564|FG005|Overall Study|Lost to Follow-up|0|||
130287894|NCT01643850|469017565|FG006|Overall Study|Lost to Follow-up|1|||
130287895|NCT01643850|469017566|FG007|Overall Study|Lost to Follow-up|0|||
130287896|NCT01643850|469017567|FG008|Overall Study|Lost to Follow-up|1|||
130287897|NCT01643850|469017559|FG000|Overall Study|Adverse Event|0|||
130287898|NCT01643850|469017560|FG001|Overall Study|Adverse Event|0|||
130287899|NCT01643850|469017561|FG002|Overall Study|Adverse Event|0|||
130287900|NCT01643850|469017562|FG003|Overall Study|Adverse Event|0|||
130287901|NCT01643850|469017563|FG004|Overall Study|Adverse Event|1|||
130287902|NCT01643850|469017564|FG005|Overall Study|Adverse Event|0|||
130287903|NCT01643850|469017565|FG006|Overall Study|Adverse Event|0|||
130287904|NCT01643850|469017566|FG007|Overall Study|Adverse Event|0|||
130287905|NCT01643850|469017567|FG008|Overall Study|Adverse Event|0|||
130287906|NCT01643850|469017559|FG000|Overall Study|Administrative Problems|0|||
130287907|NCT01643850|469017560|FG001|Overall Study|Administrative Problems|0|||
130287908|NCT01643850|469017561|FG002|Overall Study|Administrative Problems|1|||
130287909|NCT01643850|469017562|FG003|Overall Study|Administrative Problems|0|||
130287910|NCT01643850|469017563|FG004|Overall Study|Administrative Problems|1|||
130287911|NCT01643850|469017564|FG005|Overall Study|Administrative Problems|0|||
130287912|NCT01643850|469017565|FG006|Overall Study|Administrative Problems|0|||
130287913|NCT01643850|469017566|FG007|Overall Study|Administrative Problems|0|||
130287914|NCT01643850|469017567|FG008|Overall Study|Administrative Problems|0|||
130287915|NCT03054350|469017568|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
130287916|NCT03054350|469017569|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
130287917|NCT03054350|469017570|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
130287918|NCT03054350|469017571|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
130287919|NCT03054350|469017572|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
130287920|NCT03054350|469017573|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
130287921|NCT03054350|469017568|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129792749|NCT04393298|467209137|FG012|Overall Study|Patient Passed Away|0|||
130287922|NCT03054350|469017569|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129888042|NCT04157686|467547347|FG000|Overall Study|Death|0|||
129888043|NCT04157686|467547348|FG001|Overall Study|Death|0|||
129888044|NCT04157686|467547349|FG002|Overall Study|Death|0|||
129888045|NCT04157686|467547350|FG003|Overall Study|Death|2|||
129888046|NCT04157686|467547351|FG004|Overall Study|Death|0|||
129888047|NCT04157686|467547352|FG005|Overall Study|Death|0|||
129888048|NCT04157686|467547353|FG006|Overall Study|Death|0|||
129888049|NCT04157686|467547354|FG007|Overall Study|Death|0|||
129888050|NCT04157686|467547347|FG000|Overall Study|Protocol Violation|0|||
129888051|NCT04157686|467547348|FG001|Overall Study|Protocol Violation|0|||
129888052|NCT04157686|467547349|FG002|Overall Study|Protocol Violation|0|||
129888053|NCT04157686|467547350|FG003|Overall Study|Protocol Violation|0|||
129888054|NCT04157686|467547351|FG004|Overall Study|Protocol Violation|1|||
129888055|NCT04157686|467547352|FG005|Overall Study|Protocol Violation|0|||
129888056|NCT04157686|467547353|FG006|Overall Study|Protocol Violation|0|||
129888057|NCT04157686|467547354|FG007|Overall Study|Protocol Violation|0|||
130287923|NCT03054350|469017570|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
130287924|NCT03054350|469017571|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130287925|NCT03054350|469017572|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130287926|NCT03054350|469017573|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
130287927|NCT03054350|469017568|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
130287928|NCT03054350|469017569|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287929|NCT03054350|469017570|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287930|NCT03054350|469017571|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
130287931|NCT03054350|469017572|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287932|NCT03054350|469017573|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
130287933|NCT03054350|469017568|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287934|NCT03054350|469017569|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287935|NCT03054350|469017570|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
130044515|NCT00393458|468119223|FG001|Overall Study|Lost to Follow-up|6|||
130044516|NCT00393458|468119224|FG002|Overall Study|Lost to Follow-up|5|||
130044517|NCT00393458|468119225|FG003|Overall Study|Lost to Follow-up|3|||
130044518|NCT00393458|468119222|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130044519|NCT00393458|468119223|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130044520|NCT00393458|468119224|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130044521|NCT00393458|468119225|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130044522|NCT00393458|468119222|FG000|Overall Study|Death|1|||
130044523|NCT00393458|468119223|FG001|Overall Study|Death|1|||
130044524|NCT00393458|468119224|FG002|Overall Study|Death|5|||
130044525|NCT00393458|468119225|FG003|Overall Study|Death|5|||
130044526|NCT00393458|468119222|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130044527|NCT00393458|468119223|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130044528|NCT00393458|468119224|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130044529|NCT00393458|468119225|FG003|Overall Study|Abnormal test procedure result(s)|2|||
130044530|NCT00393458|468119222|FG000|Overall Study|Subject no longer requires study drug|0|||
130044531|NCT00393458|468119223|FG001|Overall Study|Subject no longer requires study drug|1|||
130044532|NCT00393458|468119224|FG002|Overall Study|Subject no longer requires study drug|0|||
130044533|NCT00393458|468119225|FG003|Overall Study|Subject no longer requires study drug|0|||
130044534|NCT00104104|468119234|FG000|Overall Study|Adverse Event|8|||
130044535|NCT00104104|468119235|FG001|Overall Study|Adverse Event|8|||
130044536|NCT00104104|468119234|FG000|Overall Study|Abnormal laboratory value(s)|20|||
130044537|NCT00104104|468119235|FG001|Overall Study|Abnormal laboratory value(s)|14|||
130044538|NCT00104104|468119234|FG000|Overall Study|Lack of Efficacy|0|||
130044539|NCT00104104|468119235|FG001|Overall Study|Lack of Efficacy|3|||
130044540|NCT00104104|468119234|FG000|Overall Study|Condition no longer requires study drug|7|||
130044541|NCT00104104|468119235|FG001|Overall Study|Condition no longer requires study drug|4|||
130044542|NCT00104104|468119234|FG000|Overall Study|Protocol Violation|5|||
130044543|NCT00104104|468119235|FG001|Overall Study|Protocol Violation|2|||
130044544|NCT00104104|468119234|FG000|Overall Study|Withdrawal by Subject|11|||
130044545|NCT00104104|468119235|FG001|Overall Study|Withdrawal by Subject|15|||
130044546|NCT00104104|468119234|FG000|Overall Study|Lost to Follow-up|3|||
130287936|NCT03054350|469017571|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287937|NCT03054350|469017572|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129888058|NCT04157686|467547347|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
129888059|NCT04157686|467547348|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
129888060|NCT04157686|467547349|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
130044547|NCT00104104|468119235|FG001|Overall Study|Lost to Follow-up|7|||
129888061|NCT04157686|467547350|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
129888062|NCT04157686|467547351|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
130044548|NCT00104104|468119234|FG000|Overall Study|Administrative problems|12|||
130044549|NCT00104104|468119235|FG001|Overall Study|Administrative problems|13|||
130044550|NCT00104104|468119234|FG000|Overall Study|Death|9|||
130044551|NCT00104104|468119235|FG001|Overall Study|Death|6|||
130044552|NCT01821677|468119238|FG000|Overall Study|Adverse Event|4|||
130044553|NCT01821677|468119239|FG001|Overall Study|Adverse Event|6|||
130044554|NCT01821677|468119240|FG002|Overall Study|Adverse Event|5|||
130044555|NCT01821677|468119238|FG000|Overall Study|Physician Decision|1|||
130044556|NCT01821677|468119239|FG001|Overall Study|Physician Decision|4|||
130044557|NCT01821677|468119240|FG002|Overall Study|Physician Decision|1|||
130044558|NCT01821677|468119238|FG000|Overall Study|Non-compliance|0|||
130044559|NCT01821677|468119239|FG001|Overall Study|Non-compliance|1|||
130044560|NCT01821677|468119240|FG002|Overall Study|Non-compliance|2|||
130044561|NCT01821677|468119238|FG000|Overall Study|Lost to Follow-up|2|||
130044562|NCT01821677|468119239|FG001|Overall Study|Lost to Follow-up|1|||
130044563|NCT01821677|468119240|FG002|Overall Study|Lost to Follow-up|3|||
130044564|NCT01821677|468119238|FG000|Overall Study|Protocol Violation|0|||
130044565|NCT01821677|468119239|FG001|Overall Study|Protocol Violation|0|||
130044566|NCT01821677|468119240|FG002|Overall Study|Protocol Violation|2|||
130044567|NCT01821677|468119238|FG000|Overall Study|Withdrawal by Subject|7|||
130044568|NCT01821677|468119239|FG001|Overall Study|Withdrawal by Subject|3|||
130044569|NCT01821677|468119240|FG002|Overall Study|Withdrawal by Subject|2|||
130044570|NCT01821677|468119238|FG000|Overall Study|Other|9|||
130044571|NCT01821677|468119239|FG001|Overall Study|Other|0|||
130044572|NCT01821677|468119240|FG002|Overall Study|Other|0|||
130044573|NCT00035815|468119242|FG000|Overall Study|Withdrawal by Subject|17|||
130044574|NCT00035815|468119243|FG001|Overall Study|Withdrawal by Subject|11|||
130044575|NCT01894516|468121149|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
130044576|NCT01894516|468121150|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
130044577|NCT01894516|468121151|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
130044578|NCT01894516|468121152|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
130044579|NCT01894516|468121149|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
130044580|NCT01894516|468121150|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130044581|NCT01894516|468121151|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130044582|NCT01894516|468121152|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
130044583|NCT01894516|468121149|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
130044584|NCT01894516|468121150|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
130044585|NCT01894516|468121151|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
130044586|NCT01894516|468121152|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
130044587|NCT01894516|468121149|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
130044588|NCT01894516|468121150|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
130044589|NCT01894516|468121151|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
130044590|NCT01894516|468121152|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
130044591|NCT01894516|468121149|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
130044592|NCT01894516|468121150|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
130044593|NCT01894516|468121151|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
130044594|NCT01894516|468121152|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
130044595|NCT01894516|468121149|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
130044596|NCT01894516|468121150|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
130044597|NCT01894516|468121151|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
130044598|NCT01894516|468121152|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
130044599|NCT01894516|468121149|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
130044600|NCT01894516|468121150|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
130044601|NCT01894516|468121151|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
130044602|NCT01894516|468121152|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
130044603|NCT01894516|468121149|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130044604|NCT01894516|468121150|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130044605|NCT01894516|468121151|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
130044606|NCT01894516|468121152|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
130044607|NCT03191396|468121154|FG000|Overall Study|Lost to Follow-up|0|||
130044608|NCT03191396|468121155|FG001|Overall Study|Lost to Follow-up|3|||
130044609|NCT03191396|468121154|FG000|Overall Study|Withdrawal by Subject|3|||
130044610|NCT03191396|468121155|FG001|Overall Study|Withdrawal by Subject|2|||
130044611|NCT03635190|468121156|FG000|Overall Study|Lost to Follow-up|4|||
130044612|NCT03635190|468121156|FG000|Overall Study|Death|3|||
130044613|NCT03635190|468121156|FG000|Overall Study|Withdrawal by Subject|1|||
130044614|NCT03635190|468121156|FG000|Overall Study|Patient moved and did not return for follow up|1|||
130044615|NCT03692910|468121157|FG000|Overall Study|Lost to Follow-up|4|||
130106436|NCT05166512|468350030|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
130044616|NCT03692910|468121158|FG001|Overall Study|Lost to Follow-up|0|||
130044617|NCT03692910|468121159|FG002|Overall Study|Lost to Follow-up|0|||
130044618|NCT03692910|468121157|FG000|Overall Study|Withdrawal by Subject|2|||
130106437|NCT02139306|468350031|FG000|Overall Study|Withdrawal by Subject|4|||
130287938|NCT03054350|469017573|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
130287939|NCT01133405|469017574|FG000|Period 1|Withdrawal by Subject|0|||
130287940|NCT01133405|469017575|FG001|Period 1|Withdrawal by Subject|1|||
130287941|NCT01133405|469017576|FG002|Period 1|Withdrawal by Subject|0|||
130287942|NCT01133405|469017577|FG003|Period 1|Withdrawal by Subject|1|||
130287943|NCT01133405|469017578|FG004|Period 1|Withdrawal by Subject|0|||
130287944|NCT01133405|469017579|FG005|Period 1|Withdrawal by Subject|1|||
130287945|NCT01133405|469017580|FG006|Period 1|Withdrawal by Subject|0|||
130287946|NCT01133405|469017581|FG007|Period 1|Withdrawal by Subject|0|||
130287947|NCT01133405|469017582|FG008|Period 1|Withdrawal by Subject|0|||
130287948|NCT01133405|469017583|FG009|Period 1|Withdrawal by Subject|0|||
130287949|NCT01133405|469017574|FG000|Period 1|Physician Decision|0|||
130287950|NCT01133405|469017575|FG001|Period 1|Physician Decision|0|||
130287951|NCT01133405|469017576|FG002|Period 1|Physician Decision|0|||
130287952|NCT01133405|469017577|FG003|Period 1|Physician Decision|1|||
130287953|NCT01133405|469017578|FG004|Period 1|Physician Decision|0|||
130287954|NCT01133405|469017579|FG005|Period 1|Physician Decision|0|||
130287955|NCT01133405|469017580|FG006|Period 1|Physician Decision|0|||
130287956|NCT01133405|469017581|FG007|Period 1|Physician Decision|0|||
130287957|NCT01133405|469017582|FG008|Period 1|Physician Decision|0|||
130287958|NCT01133405|469017583|FG009|Period 1|Physician Decision|0|||
130287959|NCT01133405|469017574|FG000|Period 1|Discontinued after randomization|1|||
130287960|NCT01133405|469017575|FG001|Period 1|Discontinued after randomization|0|||
130287961|NCT01133405|469017576|FG002|Period 1|Discontinued after randomization|0|||
130287962|NCT01133405|469017577|FG003|Period 1|Discontinued after randomization|0|||
130287963|NCT01133405|469017578|FG004|Period 1|Discontinued after randomization|0|||
130287964|NCT01133405|469017579|FG005|Period 1|Discontinued after randomization|0|||
130287965|NCT01133405|469017580|FG006|Period 1|Discontinued after randomization|1|||
130287966|NCT01133405|469017581|FG007|Period 1|Discontinued after randomization|0|||
130287967|NCT01133405|469017582|FG008|Period 1|Discontinued after randomization|0|||
130287968|NCT01133405|469017583|FG009|Period 1|Discontinued after randomization|0|||
130287969|NCT01133405|469017574|FG000|Period 1|Received drug only in period 2|0|||
130287970|NCT01133405|469017575|FG001|Period 1|Received drug only in period 2|1|||
130287971|NCT01133405|469017576|FG002|Period 1|Received drug only in period 2|0|||
130287972|NCT01133405|469017577|FG003|Period 1|Received drug only in period 2|2|||
130287973|NCT01133405|469017578|FG004|Period 1|Received drug only in period 2|0|||
130287974|NCT01133405|469017579|FG005|Period 1|Received drug only in period 2|1|||
130287975|NCT01133405|469017580|FG006|Period 1|Received drug only in period 2|0|||
130287976|NCT01133405|469017581|FG007|Period 1|Received drug only in period 2|0|||
130287977|NCT01133405|469017582|FG008|Period 1|Received drug only in period 2|0|||
130287978|NCT01133405|469017583|FG009|Period 1|Received drug only in period 2|0|||
130287979|NCT01133405|469017574|FG000|Period 1|Received drug only in period 3|0|||
130287980|NCT01133405|469017575|FG001|Period 1|Received drug only in period 3|1|||
130287981|NCT01133405|469017576|FG002|Period 1|Received drug only in period 3|1|||
130287982|NCT01133405|469017577|FG003|Period 1|Received drug only in period 3|0|||
130287983|NCT01133405|469017578|FG004|Period 1|Received drug only in period 3|0|||
130287984|NCT01133405|469017579|FG005|Period 1|Received drug only in period 3|0|||
130287985|NCT01133405|469017580|FG006|Period 1|Received drug only in period 3|0|||
130287986|NCT01133405|469017581|FG007|Period 1|Received drug only in period 3|0|||
130287987|NCT01133405|469017582|FG008|Period 1|Received drug only in period 3|0|||
130287988|NCT01133405|469017583|FG009|Period 1|Received drug only in period 3|0|||
130287989|NCT01133405|469017574|FG000|Period 2|Adverse Event|0|||
130287990|NCT01133405|469017575|FG001|Period 2|Adverse Event|0|||
130287991|NCT01133405|469017576|FG002|Period 2|Adverse Event|1|||
130287992|NCT01133405|469017577|FG003|Period 2|Adverse Event|0|||
130287993|NCT01133405|469017578|FG004|Period 2|Adverse Event|0|||
130287994|NCT01133405|469017579|FG005|Period 2|Adverse Event|0|||
130287995|NCT01133405|469017580|FG006|Period 2|Adverse Event|0|||
130287996|NCT01133405|469017581|FG007|Period 2|Adverse Event|0|||
130287997|NCT01133405|469017582|FG008|Period 2|Adverse Event|0|||
130287998|NCT01133405|469017583|FG009|Period 2|Adverse Event|0|||
130287999|NCT01133405|469017574|FG000|Period 2|Withdrawal by Subject|0|||
130288000|NCT01133405|469017575|FG001|Period 2|Withdrawal by Subject|0|||
130288001|NCT01133405|469017576|FG002|Period 2|Withdrawal by Subject|0|||
130288002|NCT01133405|469017577|FG003|Period 2|Withdrawal by Subject|1|||
129792750|NCT04393298|467209138|FG013|Overall Study|Patient Passed Away|0|||
130288003|NCT01133405|469017578|FG004|Period 2|Withdrawal by Subject|0|||
130288004|NCT01133405|469017579|FG005|Period 2|Withdrawal by Subject|1|||
130288005|NCT01133405|469017580|FG006|Period 2|Withdrawal by Subject|0|||
130288006|NCT01133405|469017581|FG007|Period 2|Withdrawal by Subject|0|||
130288007|NCT01133405|469017582|FG008|Period 2|Withdrawal by Subject|0|||
130288008|NCT01133405|469017583|FG009|Period 2|Withdrawal by Subject|0|||
130288009|NCT01133405|469017574|FG000|Period 2|Entry Criteria Not Met|0|||
129792751|NCT04393298|467209139|FG014|Overall Study|Patient Passed Away|0|||
129792752|NCT04393298|467209125|FG000|Overall Study|Patient Deceased|0|||
129792753|NCT04393298|467209126|FG001|Overall Study|Patient Deceased|0|||
129792754|NCT04393298|467209127|FG002|Overall Study|Patient Deceased|0|||
129792755|NCT04393298|467209128|FG003|Overall Study|Patient Deceased|0|||
129792756|NCT04393298|467209129|FG004|Overall Study|Patient Deceased|0|||
130044619|NCT03692910|468121158|FG001|Overall Study|Withdrawal by Subject|0|||
130044620|NCT03692910|468121159|FG002|Overall Study|Withdrawal by Subject|0|||
130044621|NCT01981122|468121162|FG000|Overall Study|Withdrawal by Subject|0|||
130044622|NCT01981122|468121163|FG001|Overall Study|Withdrawal by Subject|2|||
130288010|NCT01133405|469017575|FG001|Period 2|Entry Criteria Not Met|1|||
130288011|NCT01133405|469017576|FG002|Period 2|Entry Criteria Not Met|0|||
130288012|NCT01133405|469017577|FG003|Period 2|Entry Criteria Not Met|0|||
130288013|NCT01133405|469017578|FG004|Period 2|Entry Criteria Not Met|0|||
130288014|NCT01133405|469017579|FG005|Period 2|Entry Criteria Not Met|0|||
130288015|NCT01133405|469017580|FG006|Period 2|Entry Criteria Not Met|0|||
130288016|NCT01133405|469017581|FG007|Period 2|Entry Criteria Not Met|0|||
130288017|NCT01133405|469017582|FG008|Period 2|Entry Criteria Not Met|0|||
130288018|NCT01133405|469017583|FG009|Period 2|Entry Criteria Not Met|0|||
130288019|NCT01133405|469017574|FG000|Period 2|Physician Decision|0|||
130288020|NCT01133405|469017575|FG001|Period 2|Physician Decision|0|||
130288021|NCT01133405|469017576|FG002|Period 2|Physician Decision|0|||
130288022|NCT01133405|469017577|FG003|Period 2|Physician Decision|0|||
130288023|NCT01133405|469017578|FG004|Period 2|Physician Decision|0|||
130288024|NCT01133405|469017579|FG005|Period 2|Physician Decision|1|||
130288025|NCT01133405|469017580|FG006|Period 2|Physician Decision|0|||
130288026|NCT01133405|469017581|FG007|Period 2|Physician Decision|0|||
130288027|NCT01133405|469017582|FG008|Period 2|Physician Decision|0|||
130288028|NCT01133405|469017583|FG009|Period 2|Physician Decision|0|||
130288029|NCT03242772|469017584|FG000|Overall Study|Lost to Follow-up|2|||
130288030|NCT03242772|469017585|FG001|Overall Study|Lost to Follow-up|0|||
130288031|NCT03242772|469017584|FG000|Overall Study|Physician Decision|0|||
130288032|NCT03242772|469017585|FG001|Overall Study|Physician Decision|1|||
130288033|NCT03242772|469017584|FG000|Overall Study|Withdrawal by Subject|1|||
130288034|NCT03242772|469017585|FG001|Overall Study|Withdrawal by Subject|0|||
130288035|NCT00089986|469017586|FG000|Overall Study|Adverse Event|6|||
130288036|NCT00089986|469017587|FG001|Overall Study|Adverse Event|9|||
130288037|NCT00089986|469017588|FG002|Overall Study|Adverse Event|6|||
130288038|NCT00089986|469017586|FG000|Overall Study|Lost to Follow-up|3|||
130288039|NCT00089986|469017587|FG001|Overall Study|Lost to Follow-up|1|||
130288040|NCT00089986|469017588|FG002|Overall Study|Lost to Follow-up|1|||
130288041|NCT00089986|469017586|FG000|Overall Study|Protocol Violation|0|||
130288042|NCT00089986|469017587|FG001|Overall Study|Protocol Violation|1|||
130288043|NCT00089986|469017588|FG002|Overall Study|Protocol Violation|0|||
130288044|NCT00089986|469017586|FG000|Overall Study|Patient transferred to another hospital|2|||
130288045|NCT00089986|469017587|FG001|Overall Study|Patient transferred to another hospital|1|||
130288046|NCT00089986|469017588|FG002|Overall Study|Patient transferred to another hospital|0|||
130288047|NCT00089986|469017586|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
130288048|NCT00089986|469017587|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
130288049|NCT00089986|469017588|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
130288050|NCT00089986|469017586|FG000|Overall Study|Hemohlobin stopping rule|0|||
130288051|NCT00089986|469017587|FG001|Overall Study|Hemohlobin stopping rule|1|||
130288052|NCT00089986|469017588|FG002|Overall Study|Hemohlobin stopping rule|0|||
130288053|NCT00089986|469017586|FG000|Overall Study|Investigator decision to withdrew|0|||
130288054|NCT00089986|469017587|FG001|Overall Study|Investigator decision to withdrew|1|||
130288055|NCT00089986|469017588|FG002|Overall Study|Investigator decision to withdrew|0|||
130288056|NCT00089986|469017586|FG000|Overall Study|Enrollment in another study|0|||
130288057|NCT00089986|469017587|FG001|Overall Study|Enrollment in another study|1|||
130288058|NCT00089986|469017588|FG002|Overall Study|Enrollment in another study|0|||
130288059|NCT00089986|469017586|FG000|Overall Study|Family decision|0|||
130288060|NCT00089986|469017587|FG001|Overall Study|Family decision|1|||
130288061|NCT00089986|469017588|FG002|Overall Study|Family decision|0|||
130288062|NCT00089986|469017586|FG000|Overall Study|Do not resuscitate (DNR)|0|||
130288063|NCT00089986|469017587|FG001|Overall Study|Do not resuscitate (DNR)|0|||
130288064|NCT00089986|469017588|FG002|Overall Study|Do not resuscitate (DNR)|1|||
130044623|NCT01981122|468121162|FG000|Overall Study|Protocol Violation|0|||
130044624|NCT01981122|468121163|FG001|Overall Study|Protocol Violation|1|||
130288065|NCT00089986|469017586|FG000|Overall Study|Withdrawal by Subject|3|||
130288066|NCT00089986|469017587|FG001|Overall Study|Withdrawal by Subject|6|||
130288067|NCT00089986|469017588|FG002|Overall Study|Withdrawal by Subject|2|||
130288068|NCT02334683|469017595|FG000|First 12 Week Period|Lost to Follow-up|1|||
130288069|NCT02334683|469017596|FG001|First 12 Week Period|Lost to Follow-up|0|||
130288070|NCT02334683|469017595|FG000|Second 12 Week Period|Adverse Event|0|||
130288071|NCT02334683|469017596|FG001|Second 12 Week Period|Adverse Event|1|||
130288072|NCT01062841|469017597|FG000|Overall Study|Indwelling Device Removed|41|||
130288073|NCT01062841|469017598|FG001|Overall Study|Indwelling Device Removed|48|||
130288074|NCT01062841|469017597|FG000|Overall Study|Death|3|||
130288075|NCT01062841|469017598|FG001|Overall Study|Death|5|||
130288076|NCT01062841|469017597|FG000|Overall Study|Withdrawal by Subject|2|||
130288077|NCT01062841|469017598|FG001|Overall Study|Withdrawal by Subject|0|||
130288078|NCT01062841|469017597|FG000|Overall Study|Withdrawal by Study|3|||
130288079|NCT01062841|469017598|FG001|Overall Study|Withdrawal by Study|0|||
130288080|NCT01218100|469017599|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
130288081|NCT01218100|469017600|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
130288082|NCT01218100|469017601|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
130288083|NCT01218100|469017602|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
130288084|NCT01218100|469017599|FG000|Overall Study|Adverse Event|4|||
130288085|NCT01218100|469017600|FG001|Overall Study|Adverse Event|6|||
130288086|NCT01218100|469017601|FG002|Overall Study|Adverse Event|6|||
130288087|NCT01218100|469017602|FG003|Overall Study|Adverse Event|7|||
130288088|NCT01218100|469017599|FG000|Overall Study|Lack of Efficacy|9|||
130288089|NCT01218100|469017600|FG001|Overall Study|Lack of Efficacy|6|||
130288090|NCT01218100|469017601|FG002|Overall Study|Lack of Efficacy|5|||
130288091|NCT01218100|469017602|FG003|Overall Study|Lack of Efficacy|12|||
130288092|NCT01218100|469017599|FG000|Overall Study|Protocol Violation|0|||
129888063|NCT04157686|467547352|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
129888064|NCT04157686|467547353|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
129888065|NCT04157686|467547354|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
129888066|NCT01216293|467547355|FG000|Main Study|Adverse Event|1|||
129888067|NCT01216293|467547356|FG001|Main Study|Adverse Event|4|||
129888068|NCT01216293|467547357|FG002|Main Study|Adverse Event|2|||
129888069|NCT01216293|467547355|FG000|Main Study|Major Protocol Deviation|1|||
129888070|NCT01216293|467547356|FG001|Main Study|Major Protocol Deviation|0|||
129888071|NCT01216293|467547357|FG002|Main Study|Major Protocol Deviation|1|||
129888072|NCT01216293|467547355|FG000|Main Study|Lost to Follow-up|3|||
129888073|NCT01216293|467547356|FG001|Main Study|Lost to Follow-up|1|||
129888074|NCT01216293|467547357|FG002|Main Study|Lost to Follow-up|0|||
129888075|NCT01216293|467547355|FG000|Main Study|Voluntary Withdrawal|2|||
129888076|NCT01216293|467547356|FG001|Main Study|Voluntary Withdrawal|2|||
129888077|NCT01216293|467547357|FG002|Main Study|Voluntary Withdrawal|2|||
129888078|NCT01216293|467547355|FG000|Main Study|Other Reason Not Specified|0|||
129888079|NCT01216293|467547356|FG001|Main Study|Other Reason Not Specified|1|||
129888080|NCT01216293|467547357|FG002|Main Study|Other Reason Not Specified|1|||
129888081|NCT01216293|467547355|FG000|Main Study|Randomized, Not Treated|1|||
129888082|NCT01216293|467547356|FG001|Main Study|Randomized, Not Treated|0|||
129888083|NCT01216293|467547357|FG002|Main Study|Randomized, Not Treated|0|||
129888084|NCT01216293|467547355|FG000|Calcium Absorption Substudy|Adverse Event|0|||
129888085|NCT01216293|467547356|FG001|Calcium Absorption Substudy|Adverse Event|2|||
129888086|NCT01216293|467547357|FG002|Calcium Absorption Substudy|Adverse Event|0|||
129888087|NCT01216293|467547355|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
129888088|NCT01216293|467547356|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
129888089|NCT01216293|467547357|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
129888090|NCT01216293|467547355|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
129888091|NCT01216293|467547356|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
129888092|NCT01216293|467547357|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
129888093|NCT01671748|467547358|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
129888094|NCT01671748|467547359|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
129888095|NCT01671748|467547358|FG000|4 Week run-in Phase|Adverse Event|1|||
129888096|NCT01671748|467547359|FG001|4 Week run-in Phase|Adverse Event|0|||
129888097|NCT01671748|467547358|FG000|4 Week run-in Phase|Not eligible|9|||
129888098|NCT01671748|467547359|FG001|4 Week run-in Phase|Not eligible|0|||
129888099|NCT04212169|467549114|FG000|Overall Study|Adverse Event|0|||
129888100|NCT04212169|467549115|FG001|Overall Study|Adverse Event|0|||
129888101|NCT04212169|467549116|FG002|Overall Study|Adverse Event|0|||
129888102|NCT04212169|467549117|FG003|Overall Study|Adverse Event|2|||
129888103|NCT04212169|467549114|FG000|Overall Study|Lost to Follow-up|1|||
129888104|NCT04212169|467549115|FG001|Overall Study|Lost to Follow-up|0|||
129888105|NCT04212169|467549116|FG002|Overall Study|Lost to Follow-up|0|||
129888106|NCT04212169|467549117|FG003|Overall Study|Lost to Follow-up|2|||
129888107|NCT04212169|467549114|FG000|Overall Study|Withdrawal by Subject|10|||
129888108|NCT04212169|467549115|FG001|Overall Study|Withdrawal by Subject|2|||
129888109|NCT04212169|467549116|FG002|Overall Study|Withdrawal by Subject|5|||
129888110|NCT04212169|467549117|FG003|Overall Study|Withdrawal by Subject|7|||
129888111|NCT04212169|467549114|FG000|Overall Study|Other reason, unspecified|3|||
129888112|NCT04212169|467549115|FG001|Overall Study|Other reason, unspecified|1|||
130106438|NCT02139306|468350032|FG001|Overall Study|Withdrawal by Subject|6|||
130288093|NCT01218100|469017600|FG001|Overall Study|Protocol Violation|0|||
130288094|NCT01218100|469017601|FG002|Overall Study|Protocol Violation|1|||
130288095|NCT01218100|469017602|FG003|Overall Study|Protocol Violation|1|||
130288096|NCT01218100|469017599|FG000|Overall Study|Withdrawal by Subject|5|||
130288097|NCT01218100|469017600|FG001|Overall Study|Withdrawal by Subject|2|||
130288098|NCT01218100|469017601|FG002|Overall Study|Withdrawal by Subject|6|||
129888113|NCT04212169|467549116|FG002|Overall Study|Other reason, unspecified|0|||
129888114|NCT04212169|467549117|FG003|Overall Study|Other reason, unspecified|2|||
129888115|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888116|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
129888117|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
130044625|NCT01981122|468121162|FG000|Overall Study|Lost to Follow-up|0|||
130044626|NCT01981122|468121163|FG001|Overall Study|Lost to Follow-up|1|||
130288099|NCT01218100|469017602|FG003|Overall Study|Withdrawal by Subject|7|||
130288100|NCT01218100|469017599|FG000|Overall Study|Lost to Follow-up|3|||
130288101|NCT01218100|469017600|FG001|Overall Study|Lost to Follow-up|8|||
130288102|NCT01218100|469017601|FG002|Overall Study|Lost to Follow-up|2|||
130288103|NCT01218100|469017602|FG003|Overall Study|Lost to Follow-up|1|||
130288104|NCT01218100|469017599|FG000|Overall Study|Other Reason|2|||
130288105|NCT01218100|469017600|FG001|Overall Study|Other Reason|2|||
130288106|NCT01218100|469017601|FG002|Overall Study|Other Reason|6|||
130288107|NCT01218100|469017602|FG003|Overall Study|Other Reason|4|||
130288108|NCT02434354|469017609|FG000|Overall Study|screen fail|3|||
130288109|NCT02446418|469017610|FG000|Overall Study|Adverse Event|4|||
130288110|NCT02446418|469017611|FG001|Overall Study|Adverse Event|8|||
130288111|NCT02446418|469017610|FG000|Overall Study|Physician Decision|5|||
130288112|NCT02446418|469017611|FG001|Overall Study|Physician Decision|1|||
130288113|NCT02446418|469017610|FG000|Overall Study|Withdrawal by Subject|3|||
130288114|NCT02446418|469017611|FG001|Overall Study|Withdrawal by Subject|3|||
130288115|NCT02446418|469017610|FG000|Overall Study|Lost to Follow-up|2|||
130288116|NCT02446418|469017611|FG001|Overall Study|Lost to Follow-up|2|||
130288117|NCT02446418|469017610|FG000|Overall Study|Protocol Violation|1|||
130288118|NCT02446418|469017611|FG001|Overall Study|Protocol Violation|2|||
130288119|NCT02446418|469017610|FG000|Overall Study|Lack of Efficacy|2|||
130288120|NCT02446418|469017611|FG001|Overall Study|Lack of Efficacy|0|||
130288121|NCT02446418|469017610|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
130288122|NCT02446418|469017611|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
130288123|NCT02014480|469017614|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288124|NCT02014480|469017615|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288125|NCT02014480|469017616|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
130288126|NCT02014480|469017617|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288127|NCT02014480|469017618|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288128|NCT02014480|469017619|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
130288129|NCT02014480|469017614|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130288130|NCT02014480|469017615|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130288131|NCT02014480|469017616|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130288132|NCT02014480|469017617|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
130288133|NCT02014480|469017618|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
130288134|NCT02014480|469017619|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
130288135|NCT02014480|469017614|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288136|NCT02014480|469017615|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288137|NCT02014480|469017616|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
130288138|NCT02014480|469017617|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288139|NCT02014480|469017618|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288140|NCT02014480|469017619|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
130288141|NCT02014480|469017614|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130288142|NCT02014480|469017615|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130288143|NCT02014480|469017616|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
130288144|NCT02014480|469017617|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130288145|NCT02014480|469017618|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130288146|NCT02014480|469017619|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130044627|NCT01981122|468121162|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
130044628|NCT01981122|468121163|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
130044629|NCT01981122|468121162|FG000|Overall Study|Death|14|||
130044630|NCT01981122|468121163|FG001|Overall Study|Death|15|||
130044631|NCT03060577|468121164|FG000|Overall Study|Withdrawal by Subject|25|||
130044632|NCT03060577|468121165|FG001|Overall Study|Withdrawal by Subject|5|||
130044633|NCT03060577|468121164|FG000|Overall Study|Physician Decision|4|||
130044634|NCT03060577|468121165|FG001|Overall Study|Physician Decision|3|||
130044635|NCT03060577|468121164|FG000|Overall Study|Lost to Follow-up|3|||
130106439|NCT02139306|468350031|FG000|Overall Study|Adverse Event|3|||
130106440|NCT02139306|468350032|FG001|Overall Study|Adverse Event|4|||
130288147|NCT02014480|469017614|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130288148|NCT02014480|469017615|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
130288149|NCT02014480|469017616|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129792757|NCT04393298|467209130|FG005|Overall Study|Patient Deceased|0|||
130288150|NCT02014480|469017617|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130288151|NCT02014480|469017618|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
130288152|NCT02014480|469017619|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129792758|NCT04393298|467209131|FG006|Overall Study|Patient Deceased|0|||
129792759|NCT04393298|467209132|FG007|Overall Study|Patient Deceased|1|||
130044636|NCT03060577|468121165|FG001|Overall Study|Lost to Follow-up|0|||
130044637|NCT03060577|468121164|FG000|Overall Study|Death|7|||
130106441|NCT02139306|468350031|FG000|Overall Study|Physician Decision|0|||
130044638|NCT03060577|468121165|FG001|Overall Study|Death|1|||
130106442|NCT02139306|468350032|FG001|Overall Study|Physician Decision|1|||
130288153|NCT02014480|469017614|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288154|NCT02014480|469017615|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288155|NCT02014480|469017616|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
130288156|NCT02014480|469017617|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288157|NCT02014480|469017618|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
130288158|NCT02014480|469017619|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
130288159|NCT02014480|469017614|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288160|NCT02014480|469017615|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288161|NCT02014480|469017616|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288162|NCT02014480|469017617|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288163|NCT02014480|469017618|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
130288164|NCT02014480|469017619|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
130288165|NCT01414205|469017622|FG000|Overall Study|Death|5|||
130288166|NCT01414205|469017623|FG001|Overall Study|Death|1|||
130288167|NCT01414205|469017622|FG000|Overall Study|Lost to Follow-up|1|||
130288168|NCT01414205|469017623|FG001|Overall Study|Lost to Follow-up|4|||
130288169|NCT01414205|469017622|FG000|Overall Study|Physician Decision|0|||
130288170|NCT01414205|469017623|FG001|Overall Study|Physician Decision|1|||
130288171|NCT01414205|469017622|FG000|Overall Study|Randomized but not Treated|1|||
130288172|NCT01414205|469017623|FG001|Overall Study|Randomized but not Treated|1|||
130288173|NCT02305849|469017627|FG000|Overall Study|Adverse Event|10|||
130288174|NCT02305849|469017628|FG001|Overall Study|Adverse Event|12|||
130288175|NCT02305849|469017629|FG002|Overall Study|Adverse Event|7|||
130288176|NCT02305849|469017630|FG003|Overall Study|Adverse Event|3|||
130288177|NCT02305849|469017627|FG000|Overall Study|Lack of Efficacy|10|||
130288178|NCT02305849|469017628|FG001|Overall Study|Lack of Efficacy|6|||
130288179|NCT02305849|469017629|FG002|Overall Study|Lack of Efficacy|3|||
130288180|NCT02305849|469017630|FG003|Overall Study|Lack of Efficacy|9|||
130288181|NCT02305849|469017627|FG000|Overall Study|Withdrawal by Subject|2|||
130288182|NCT02305849|469017628|FG001|Overall Study|Withdrawal by Subject|2|||
130288183|NCT02305849|469017629|FG002|Overall Study|Withdrawal by Subject|1|||
130288184|NCT02305849|469017630|FG003|Overall Study|Withdrawal by Subject|4|||
130288185|NCT02305849|469017627|FG000|Overall Study|Lost to Follow-up|0|||
130288186|NCT02305849|469017628|FG001|Overall Study|Lost to Follow-up|2|||
129888118|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
129888119|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
130106443|NCT02139306|468350031|FG000|Overall Study|Other Unspecified|2|||
130106444|NCT02139306|468350032|FG001|Overall Study|Other Unspecified|3|||
130106445|NCT02139306|468350031|FG000|Overall Study|Protocol Violation|4|||
130106446|NCT02139306|468350032|FG001|Overall Study|Protocol Violation|0|||
130106447|NCT04449354|468350033|FG000|Overall Study|Withdrawal by Subject|1|||
130288187|NCT02305849|469017629|FG002|Overall Study|Lost to Follow-up|0|||
130288188|NCT02305849|469017630|FG003|Overall Study|Lost to Follow-up|0|||
130288189|NCT02305849|469017627|FG000|Overall Study|Protocol Violation|3|||
130288190|NCT02305849|469017628|FG001|Overall Study|Protocol Violation|2|||
130288191|NCT02305849|469017629|FG002|Overall Study|Protocol Violation|1|||
130288192|NCT02305849|469017630|FG003|Overall Study|Protocol Violation|1|||
130288193|NCT02305849|469017627|FG000|Overall Study|Lab data met discontinuation criteria|0|||
130288194|NCT02305849|469017628|FG001|Overall Study|Lab data met discontinuation criteria|1|||
130288195|NCT02305849|469017629|FG002|Overall Study|Lab data met discontinuation criteria|2|||
130288196|NCT02305849|469017630|FG003|Overall Study|Lab data met discontinuation criteria|1|||
130288197|NCT02305849|469017627|FG000|Overall Study|Miscellaneous|1|||
130288198|NCT02305849|469017628|FG001|Overall Study|Miscellaneous|2|||
130288199|NCT02305849|469017629|FG002|Overall Study|Miscellaneous|4|||
130288200|NCT02305849|469017630|FG003|Overall Study|Miscellaneous|1|||
130288201|NCT02305849|469017627|FG000|Overall Study|Not fulfill eligibility criteria|1|||
130288202|NCT02305849|469017628|FG001|Overall Study|Not fulfill eligibility criteria|1|||
130288203|NCT02305849|469017629|FG002|Overall Study|Not fulfill eligibility criteria|0|||
130288204|NCT02305849|469017630|FG003|Overall Study|Not fulfill eligibility criteria|0|||
130288205|NCT00495521|469017636|FG000|Overall Study|Physician Decision|0|||
130288206|NCT00495521|469017637|FG001|Overall Study|Physician Decision|1|||
130288207|NCT01300819|469017638|FG000|Overall Study|Adverse Event|9|||
130288208|NCT01300819|469017639|FG001|Overall Study|Adverse Event|27|||
129888120|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
129888121|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
130106448|NCT02913261|468350034|FG000|Overall Study|Technical problems|0|||
130288209|NCT01300819|469017638|FG000|Overall Study|Lack of Efficacy|2|||
130288210|NCT01300819|469017639|FG001|Overall Study|Lack of Efficacy|1|||
130288211|NCT01300819|469017638|FG000|Overall Study|Withdrawal by Subject|10|||
130288212|NCT01300819|469017639|FG001|Overall Study|Withdrawal by Subject|12|||
130288213|NCT01300819|469017638|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
130288214|NCT01300819|469017639|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
130288215|NCT01300819|469017638|FG000|Overall Study|Refusal to down titrate study drug|0|||
129888122|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888123|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888124|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888125|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888126|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888127|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888128|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
129888129|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
129888130|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888131|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888132|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888133|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888134|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888135|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888136|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
129888137|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
129888138|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
130106449|NCT02913261|468350035|FG001|Overall Study|Technical problems|1|||
130106450|NCT02913261|468350034|FG000|Overall Study|Lack of Efficacy|32|||
130288216|NCT01300819|469017639|FG001|Overall Study|Refusal to down titrate study drug|1|||
130288217|NCT01300819|469017638|FG000|Overall Study|Administrative reason|0|||
130288218|NCT01300819|469017639|FG001|Overall Study|Administrative reason|1|||
130288219|NCT01300819|469017638|FG000|Overall Study|Safety follow up not done by mistake|0|||
130288220|NCT01300819|469017639|FG001|Overall Study|Safety follow up not done by mistake|1|||
130288221|NCT01300819|469017638|FG000|Overall Study|Follow up call was not done|1|||
130288222|NCT01300819|469017639|FG001|Overall Study|Follow up call was not done|0|||
130288223|NCT00432744|469017640|FG000|Months 0-6|Withdrawal by Subject|4|||
130288224|NCT00432744|469017641|FG001|Months 0-6|Withdrawal by Subject|4|||
130288225|NCT00432744|469017640|FG000|Months 0-6|Too disabled to score|1|||
130288226|NCT00432744|469017641|FG001|Months 0-6|Too disabled to score|0|||
130288227|NCT00432744|469017640|FG000|Months 7 - 12|Withdrawal by Subject|1|||
130288228|NCT00432744|469017641|FG001|Months 7 - 12|Withdrawal by Subject|0|||
130288229|NCT00432744|469017640|FG000|Months 7 - 12|Too disabled to score|0|||
130288230|NCT00432744|469017641|FG001|Months 7 - 12|Too disabled to score|1|||
130288231|NCT01319721|469017642|FG000|Overall Study|Lost to Follow-up|1|||
130288232|NCT01319721|469017643|FG001|Overall Study|Lost to Follow-up|6|||
130288233|NCT00461305|469017645|FG000|Treatment|Adverse Event|26|||
130288234|NCT00461305|469017646|FG001|Treatment|Adverse Event|3|||
130288235|NCT00461305|469017645|FG000|Treatment|Lost to Follow-up|4|||
130288236|NCT00461305|469017646|FG001|Treatment|Lost to Follow-up|2|||
130288237|NCT00461305|469017645|FG000|Treatment|Protocol Violation|13|||
130288238|NCT00461305|469017646|FG001|Treatment|Protocol Violation|2|||
130288239|NCT00461305|469017645|FG000|Treatment|Withdrawal by Subject|48|||
130288240|NCT00461305|469017646|FG001|Treatment|Withdrawal by Subject|2|||
130288241|NCT00461305|469017645|FG000|Treatment|Never dispensed|5|||
130288242|NCT00461305|469017646|FG001|Treatment|Never dispensed|0|||
130288243|NCT00461305|469017645|FG000|Treatment|Study drug not taken|1|||
130288244|NCT00461305|469017646|FG001|Treatment|Study drug not taken|0|||
130288245|NCT00461305|469017645|FG000|Treatment|Partially missing diary|2|||
130288246|NCT00461305|469017646|FG001|Treatment|Partially missing diary|0|||
130288247|NCT00461305|469017645|FG000|Treatment|Other (missing drug etc)|2|||
130288248|NCT00461305|469017646|FG001|Treatment|Other (missing drug etc)|0|||
129888139|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
130106451|NCT02913261|468350035|FG001|Overall Study|Lack of Efficacy|69|||
130106452|NCT02913261|468350034|FG000|Overall Study|Adverse Event|27|||
130106453|NCT02913261|468350035|FG001|Overall Study|Adverse Event|5|||
130106454|NCT02913261|468350034|FG000|Overall Study|Death|25|||
130288249|NCT00461305|469017645|FG000|Continued Treatment|Adverse Event|26|||
129888140|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
129888141|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
130106455|NCT02913261|468350035|FG001|Overall Study|Death|22|||
130106456|NCT02913261|468350034|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
130288250|NCT00461305|469017646|FG001|Continued Treatment|Adverse Event|0|||
130288251|NCT00461305|469017645|FG000|Continued Treatment|Lost to Follow-up|4|||
130288252|NCT00461305|469017646|FG001|Continued Treatment|Lost to Follow-up|0|||
130288253|NCT00461305|469017645|FG000|Continued Treatment|Protocol Violation|13|||
130288254|NCT00461305|469017646|FG001|Continued Treatment|Protocol Violation|0|||
130288255|NCT00461305|469017645|FG000|Continued Treatment|Withdrawal by Subject|48|||
130288256|NCT00461305|469017646|FG001|Continued Treatment|Withdrawal by Subject|0|||
130288257|NCT00461305|469017645|FG000|Continued Treatment|Partially missing diary|2|||
130288258|NCT00461305|469017646|FG001|Continued Treatment|Partially missing diary|0|||
130288259|NCT00461305|469017645|FG000|Continued Treatment|Other (missing drug etc)|2|||
130288260|NCT00461305|469017646|FG001|Continued Treatment|Other (missing drug etc)|0|||
130044639|NCT03060577|468121164|FG000|Overall Study|Adverse Event|9|||
130044640|NCT03060577|468121165|FG001|Overall Study|Adverse Event|1|||
130044641|NCT03060577|468121164|FG000|Overall Study|Inclusion/Exclusion|1|||
130044642|NCT03060577|468121165|FG001|Overall Study|Inclusion/Exclusion|0|||
130044643|NCT03060577|468121164|FG000|Overall Study|Other|8|||
130044644|NCT03060577|468121165|FG001|Overall Study|Other|2|||
130044645|NCT03216265|468121169|FG000|Overall Study|Adverse Event|2|||
130044646|NCT03216265|468121170|FG001|Overall Study|Adverse Event|0|||
130044647|NCT03216265|468121171|FG002|Overall Study|Adverse Event|2|||
130044648|NCT03216265|468121169|FG000|Overall Study|Lost to Follow-up|0|||
130044649|NCT03216265|468121170|FG001|Overall Study|Lost to Follow-up|1|||
130044650|NCT03216265|468121171|FG002|Overall Study|Lost to Follow-up|0|||
130044651|NCT03216265|468121169|FG000|Overall Study|Withdrawal by Subject|0|||
130044652|NCT03216265|468121170|FG001|Overall Study|Withdrawal by Subject|0|||
130044653|NCT03216265|468121171|FG002|Overall Study|Withdrawal by Subject|1|||
130044654|NCT01277289|468121173|FG000|Overall Study|fragile vein|1|||
130044655|NCT01277289|468121174|FG001|Overall Study|fragile vein|0|||
130044656|NCT01277289|468121173|FG000|Overall Study|Physician Decision|1|||
130044657|NCT01277289|468121174|FG001|Overall Study|Physician Decision|0|||
130044658|NCT01277289|468121173|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
130044659|NCT01277289|468121174|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
130044660|NCT01277289|468121173|FG000|Overall Study|Protocol Violation|1|||
130044661|NCT01277289|468121174|FG001|Overall Study|Protocol Violation|1|||
130288261|NCT00787930|469017651|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
130288262|NCT01896271|469017652|FG000|Overall Study|Physician Decision|10|||
130288263|NCT02091284|469019800|FG000|Overall Study|Withdrawal by Subject|2|||
130288264|NCT02091284|469019801|FG001|Overall Study|Withdrawal by Subject|1|||
130288265|NCT02091284|469019800|FG000|Overall Study|unreliable data|1|||
130288266|NCT02091284|469019801|FG001|Overall Study|unreliable data|0|||
130288267|NCT03383783|469019802|FG000|Overall Study|Withdrawal by Subject|2|||
130288268|NCT01340937|469019803|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
130288269|NCT01340937|469019804|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
130288270|NCT01340937|469019805|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
130288271|NCT01340937|469019806|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
130288272|NCT01340937|469019803|FG000|Period 1: Infant Series|Adverse Event|0|||
130288273|NCT01340937|469019804|FG001|Period 1: Infant Series|Adverse Event|1|||
130288274|NCT01340937|469019805|FG002|Period 1: Infant Series|Adverse Event|4|||
130288275|NCT01340937|469019806|FG003|Period 1: Infant Series|Adverse Event|0|||
130288276|NCT01340937|469019803|FG000|Period 1: Infant Series|Death|2|||
130288277|NCT01340937|469019804|FG001|Period 1: Infant Series|Death|0|||
130288278|NCT01340937|469019805|FG002|Period 1: Infant Series|Death|2|||
130288279|NCT01340937|469019806|FG003|Period 1: Infant Series|Death|0|||
130288280|NCT01340937|469019803|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
130288281|NCT01340937|469019804|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
130288282|NCT01340937|469019805|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
130288283|NCT01340937|469019806|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
130288284|NCT01340937|469019803|FG000|Period 1: Infant Series|Physician Decision|2|||
130288285|NCT01340937|469019804|FG001|Period 1: Infant Series|Physician Decision|3|||
130288286|NCT01340937|469019805|FG002|Period 1: Infant Series|Physician Decision|1|||
130288287|NCT01340937|469019806|FG003|Period 1: Infant Series|Physician Decision|0|||
130288288|NCT01340937|469019803|FG000|Period 1: Infant Series|Protocol Violation|1|||
130288289|NCT01340937|469019804|FG001|Period 1: Infant Series|Protocol Violation|4|||
130288290|NCT01340937|469019805|FG002|Period 1: Infant Series|Protocol Violation|4|||
130044662|NCT01277289|468121173|FG000|Overall Study|Adverse Event|2|||
130044663|NCT01277289|468121174|FG001|Overall Study|Adverse Event|1|||
130044664|NCT01277289|468121173|FG000|Overall Study|consent withdrawn|1|||
130288291|NCT01340937|469019806|FG003|Period 1: Infant Series|Protocol Violation|3|||
130288292|NCT01340937|469019803|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
130044665|NCT01277289|468121174|FG001|Overall Study|consent withdrawn|1|||
130044666|NCT01277289|468121173|FG000|Overall Study|premature closure of the study|4|||
130106457|NCT02913261|468350035|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
130288293|NCT01340937|469019804|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
130288294|NCT01340937|469019805|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
130288295|NCT01340937|469019806|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
130288296|NCT01340937|469019803|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
130288297|NCT01340937|469019804|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
129792760|NCT04393298|467209133|FG008|Overall Study|Patient Deceased|0|||
130044667|NCT01277289|468121174|FG001|Overall Study|premature closure of the study|2|||
130044668|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
130044669|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
130288298|NCT01340937|469019805|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
130288299|NCT01340937|469019806|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
130044670|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
130044671|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
130288300|NCT01340937|469019803|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
130288301|NCT01340937|469019804|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
130288302|NCT01340937|469019805|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
130288303|NCT01340937|469019806|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
130288304|NCT01340937|469019803|FG000|Period 2: Interim Period|Adverse Event|1|||
130288305|NCT01340937|469019804|FG001|Period 2: Interim Period|Adverse Event|0|||
130288306|NCT01340937|469019805|FG002|Period 2: Interim Period|Adverse Event|1|||
130288307|NCT01340937|469019806|FG003|Period 2: Interim Period|Adverse Event|0|||
130288308|NCT01340937|469019803|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
130288309|NCT01340937|469019804|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
130288310|NCT01340937|469019805|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
130288311|NCT01340937|469019806|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
130288312|NCT01340937|469019803|FG000|Period 2: Interim Period|Physician Decision|0|||
130288313|NCT01340937|469019804|FG001|Period 2: Interim Period|Physician Decision|1|||
130288314|NCT01340937|469019805|FG002|Period 2: Interim Period|Physician Decision|1|||
130288315|NCT01340937|469019806|FG003|Period 2: Interim Period|Physician Decision|0|||
130288316|NCT01340937|469019803|FG000|Period 2: Interim Period|Protocol Violation|5|||
130288317|NCT01340937|469019804|FG001|Period 2: Interim Period|Protocol Violation|3|||
130288318|NCT01340937|469019805|FG002|Period 2: Interim Period|Protocol Violation|6|||
130288319|NCT01340937|469019806|FG003|Period 2: Interim Period|Protocol Violation|3|||
130044672|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
130044673|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
130044674|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
130044675|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
130044676|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
130044677|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
130044678|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
130044679|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
130044680|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
130044681|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
130044682|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
130044683|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
130044684|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
130044685|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
130044686|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
130044687|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
130044688|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
130044689|NCT00092547|468121175|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
130044690|NCT00092547|468121176|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
130044691|NCT00092547|468121177|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
130044692|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
130044693|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
130044694|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
130044695|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
130288320|NCT01340937|469019803|FG000|Period 2: Interim Period|Technical problems|4|||
129792761|NCT04393298|467209134|FG009|Overall Study|Patient Deceased|0|||
130044696|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
130044697|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
130288321|NCT01340937|469019804|FG001|Period 2: Interim Period|Technical problems|4|||
130288322|NCT01340937|469019805|FG002|Period 2: Interim Period|Technical problems|6|||
130288323|NCT01340937|469019806|FG003|Period 2: Interim Period|Technical problems|3|||
130044698|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
130044699|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
130044700|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
130288324|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
130288325|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
130288326|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
130288327|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
130288328|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
130288329|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
130288330|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
130288331|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
130288332|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
130288333|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129792762|NCT04393298|467209135|FG010|Overall Study|Patient Deceased|0|||
129792763|NCT04393298|467209136|FG011|Overall Study|Patient Deceased|0|||
129792764|NCT04393298|467209137|FG012|Overall Study|Patient Deceased|0|||
129792765|NCT04393298|467209138|FG013|Overall Study|Patient Deceased|0|||
129792766|NCT04393298|467209139|FG014|Overall Study|Patient Deceased|0|||
129792767|NCT04393298|467209125|FG000|Overall Study|Patient Discharged to Hospice|0|||
129792768|NCT04393298|467209126|FG001|Overall Study|Patient Discharged to Hospice|0|||
129792769|NCT04393298|467209127|FG002|Overall Study|Patient Discharged to Hospice|0|||
129792770|NCT04393298|467209128|FG003|Overall Study|Patient Discharged to Hospice|0|||
129792771|NCT04393298|467209129|FG004|Overall Study|Patient Discharged to Hospice|0|||
129792772|NCT04393298|467209130|FG005|Overall Study|Patient Discharged to Hospice|0|||
129792773|NCT04393298|467209131|FG006|Overall Study|Patient Discharged to Hospice|0|||
129792774|NCT04393298|467209132|FG007|Overall Study|Patient Discharged to Hospice|0|||
129792775|NCT04393298|467209133|FG008|Overall Study|Patient Discharged to Hospice|1|||
129792776|NCT04393298|467209134|FG009|Overall Study|Patient Discharged to Hospice|0|||
129792777|NCT04393298|467209135|FG010|Overall Study|Patient Discharged to Hospice|0|||
129792778|NCT04393298|467209136|FG011|Overall Study|Patient Discharged to Hospice|0|||
129792779|NCT04393298|467209137|FG012|Overall Study|Patient Discharged to Hospice|0|||
129792780|NCT04393298|467209138|FG013|Overall Study|Patient Discharged to Hospice|0|||
129792781|NCT04393298|467209139|FG014|Overall Study|Patient Discharged to Hospice|0|||
129792782|NCT04393298|467209125|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792783|NCT04393298|467209126|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792784|NCT04393298|467209127|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792785|NCT04393298|467209128|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792786|NCT04393298|467209129|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792787|NCT04393298|467209130|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792788|NCT04393298|467209131|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792789|NCT04393298|467209132|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792790|NCT04393298|467209133|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792791|NCT04393298|467209134|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
129792792|NCT04393298|467209135|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792793|NCT04393298|467209136|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792794|NCT04393298|467209137|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792795|NCT04393298|467209138|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792796|NCT04393298|467209139|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792797|NCT04393298|467209125|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
129792798|NCT04393298|467209126|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
129792799|NCT04393298|467209127|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
129792800|NCT04393298|467209128|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
129792801|NCT04393298|467209129|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
129792802|NCT04393298|467209130|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
129792803|NCT04393298|467209131|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
129792804|NCT04393298|467209132|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
129792805|NCT04393298|467209133|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
130044701|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
130044702|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
130288334|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129792806|NCT04393298|467209134|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
129792807|NCT04393298|467209135|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
129792808|NCT04393298|467209136|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
129792809|NCT04393298|467209137|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
129792810|NCT04393298|467209138|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
130044703|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
130288335|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
130288336|NCT01340937|469019803|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
130288337|NCT01340937|469019804|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
130288338|NCT01340937|469019805|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
130288339|NCT01340937|469019806|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
130288340|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
130288341|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
130288342|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
130288343|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
130288344|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
130288345|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
130288346|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
130288347|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
130288348|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
130288349|NCT02119156|469019807|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
130288350|NCT02119156|469019808|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
130288351|NCT02119156|469019809|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
130288352|NCT02119156|469019807|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
130288353|NCT02119156|469019808|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
130288354|NCT02119156|469019809|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
130288355|NCT02469415|469019810|FG000|Overall Study|Withdrawal by Subject|1|||
130288356|NCT02469415|469019810|FG000|Overall Study|Investigational agent placed on hold|2|||
130288357|NCT00350623|469019813|FG000|Overall Study|Lost to Follow-up|8|||
130288358|NCT00350623|469019814|FG001|Overall Study|Lost to Follow-up|3|||
130288359|NCT00350623|469019815|FG002|Overall Study|Lost to Follow-up|4|||
130288360|NCT00350623|469019813|FG000|Overall Study|Withdrawal by Subject|0|||
130288361|NCT00350623|469019814|FG001|Overall Study|Withdrawal by Subject|1|||
130288362|NCT00350623|469019815|FG002|Overall Study|Withdrawal by Subject|1|||
130288363|NCT00350623|469019813|FG000|Overall Study|patient traveling outside the country|0|||
130288364|NCT00350623|469019814|FG001|Overall Study|patient traveling outside the country|0|||
130288365|NCT00350623|469019815|FG002|Overall Study|patient traveling outside the country|1|||
130288366|NCT02685748|469019816|FG000|Overall Study|Withdrawal by Subject|3|||
130288367|NCT02685748|469019817|FG001|Overall Study|Withdrawal by Subject|2|||
130288368|NCT04126564|469019818|FG000|Overall Study|Withdrawal by Subject|0|||
130288369|NCT04126564|469019819|FG001|Overall Study|Withdrawal by Subject|2|||
130288370|NCT04126564|469019818|FG000|Overall Study|Lost to Follow-up|0|||
130288371|NCT04126564|469019819|FG001|Overall Study|Lost to Follow-up|1|||
130288372|NCT03500172|469019820|FG000|Period 1: Baseline Randomization|Death|0|||
130288373|NCT03500172|469019821|FG001|Period 1: Baseline Randomization|Death|0|||
130288374|NCT03500172|469019822|FG002|Period 1: Baseline Randomization|Death|0|||
130288375|NCT03500172|469019823|FG003|Period 1: Baseline Randomization|Death|0|||
130288376|NCT03500172|469019824|FG004|Period 1: Baseline Randomization|Death|0|||
130288377|NCT03500172|469019825|FG005|Period 1: Baseline Randomization|Death|0|||
130288378|NCT03500172|469019826|FG006|Period 1: Baseline Randomization|Death|0|||
130288379|NCT03500172|469019827|FG007|Period 1: Baseline Randomization|Death|0|||
130288380|NCT03500172|469019828|FG008|Period 1: Baseline Randomization|Death|0|||
130288381|NCT03500172|469019829|FG009|Period 1: Baseline Randomization|Death|2|||
130288382|NCT03500172|469019830|FG010|Period 1: Baseline Randomization|Death|0|||
130288383|NCT03500172|469019820|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
130288384|NCT03500172|469019821|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
130288385|NCT03500172|469019822|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
130288386|NCT03500172|469019823|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
130288387|NCT03500172|469019824|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
130288388|NCT03500172|469019825|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
130288389|NCT03500172|469019826|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
130288390|NCT03500172|469019827|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
130288391|NCT03500172|469019828|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
130288392|NCT03500172|469019829|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
130288393|NCT03500172|469019830|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
130288394|NCT03500172|469019820|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
130288395|NCT03500172|469019821|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
130288396|NCT03500172|469019822|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
130288397|NCT03500172|469019823|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
130288398|NCT03500172|469019824|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
130288399|NCT03500172|469019825|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
130288400|NCT03500172|469019826|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
130288401|NCT03500172|469019827|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
130288402|NCT03500172|469019828|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
130044704|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
130044705|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
130044706|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
130044707|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
130044708|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
130044709|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
130044710|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
130044711|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
130044712|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
130044713|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
130044714|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
130044715|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
130044716|NCT00092547|468121175|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
130044717|NCT00092547|468121176|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
130044718|NCT00092547|468121177|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
130044719|NCT00092547|468121175|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
130044720|NCT00092547|468121176|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
130044721|NCT00092547|468121177|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
130044722|NCT00092547|468121175|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
130044723|NCT00092547|468121176|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
130044724|NCT00092547|468121177|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
130044725|NCT00092547|468121175|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
130044726|NCT00092547|468121176|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
130044727|NCT00092547|468121177|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
130044728|NCT00092547|468121175|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
130044729|NCT00092547|468121176|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
130044730|NCT00092547|468121177|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
130044731|NCT01334125|468121187|FG000|Overall Study|Lost to Follow-up|3|||
130044732|NCT01334125|468121188|FG001|Overall Study|Lost to Follow-up|3|||
130044733|NCT00401973|468121191|FG000|Overall Study|Adverse Event|2|||
130044734|NCT00401973|468121192|FG001|Overall Study|Adverse Event|8|||
130044735|NCT00401973|468121193|FG002|Overall Study|Adverse Event|4|||
130044736|NCT00401973|468121191|FG000|Overall Study|Clinical Relapse|0|||
130044737|NCT00401973|468121192|FG001|Overall Study|Clinical Relapse|1|||
130044738|NCT00401973|468121193|FG002|Overall Study|Clinical Relapse|1|||
130044739|NCT00401973|468121191|FG000|Overall Study|Lack of Efficacy|0|||
130044740|NCT00401973|468121192|FG001|Overall Study|Lack of Efficacy|0|||
130044741|NCT00401973|468121193|FG002|Overall Study|Lack of Efficacy|3|||
130044742|NCT00401973|468121191|FG000|Overall Study|Lost to Follow-up|2|||
130044743|NCT00401973|468121192|FG001|Overall Study|Lost to Follow-up|2|||
130044744|NCT00401973|468121193|FG002|Overall Study|Lost to Follow-up|2|||
130044745|NCT00401973|468121191|FG000|Overall Study|Physician Decision|2|||
130044746|NCT00401973|468121192|FG001|Overall Study|Physician Decision|0|||
130044747|NCT00401973|468121193|FG002|Overall Study|Physician Decision|1|||
130044748|NCT00401973|468121191|FG000|Overall Study|Protocol Violation|1|||
130044749|NCT00401973|468121192|FG001|Overall Study|Protocol Violation|2|||
130044750|NCT00401973|468121193|FG002|Overall Study|Protocol Violation|3|||
130044751|NCT00401973|468121191|FG000|Overall Study|Sponsor Decision|0|||
130044752|NCT00401973|468121192|FG001|Overall Study|Sponsor Decision|1|||
130044753|NCT00401973|468121193|FG002|Overall Study|Sponsor Decision|0|||
130044754|NCT00401973|468121191|FG000|Overall Study|Withdrawal by Subject|4|||
130044755|NCT00401973|468121192|FG001|Overall Study|Withdrawal by Subject|12|||
130044756|NCT00401973|468121193|FG002|Overall Study|Withdrawal by Subject|9|||
130044757|NCT05523362|468121194|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
130044758|NCT05523362|468121194|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
130044759|NCT05523362|468121194|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
130044760|NCT05523362|468121194|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
130044761|NCT04075604|468121195|FG000|Overall Study|Adverse Event|0|||
130044762|NCT04075604|468121196|FG001|Overall Study|Adverse Event|0|||
130044763|NCT04075604|468121197|FG002|Overall Study|Adverse Event|3|||
130044764|NCT04075604|468121195|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130044765|NCT04075604|468121196|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130044766|NCT04075604|468121197|FG002|Overall Study|Participant request to discontinue study treatment|1|||
130044767|NCT04075604|468121195|FG000|Overall Study|Participant withdrew consent|0|||
130044768|NCT04075604|468121196|FG001|Overall Study|Participant withdrew consent|0|||
130044769|NCT04075604|468121197|FG002|Overall Study|Participant withdrew consent|1|||
130044770|NCT04075604|468121195|FG000|Overall Study|Other reasons|1|||
130044771|NCT04075604|468121196|FG001|Overall Study|Other reasons|0|||
130044772|NCT04075604|468121197|FG002|Overall Study|Other reasons|0|||
130044773|NCT04075604|468121195|FG000|Overall Study|Disease progression|0|||
130044774|NCT04075604|468121196|FG001|Overall Study|Disease progression|1|||
130288403|NCT03500172|469019829|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
130288404|NCT03500172|469019830|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
130288405|NCT03500172|469019820|FG000|Period 2: Re-Randomization|Death|0|||
130288406|NCT03500172|469019821|FG001|Period 2: Re-Randomization|Death|0|||
130288407|NCT03500172|469019822|FG002|Period 2: Re-Randomization|Death|0|||
130288408|NCT03500172|469019823|FG003|Period 2: Re-Randomization|Death|4|||
130288409|NCT03500172|469019824|FG004|Period 2: Re-Randomization|Death|2|||
130288410|NCT03500172|469019825|FG005|Period 2: Re-Randomization|Death|0|||
130288411|NCT03500172|469019826|FG006|Period 2: Re-Randomization|Death|5|||
130288412|NCT03500172|469019827|FG007|Period 2: Re-Randomization|Death|2|||
130288413|NCT03500172|469019828|FG008|Period 2: Re-Randomization|Death|0|||
130288414|NCT03500172|469019829|FG009|Period 2: Re-Randomization|Death|0|||
130288415|NCT03500172|469019830|FG010|Period 2: Re-Randomization|Death|0|||
130288416|NCT01974752|469019833|FG000|Overall Study|Death|33|||
130288417|NCT01974752|469019834|FG001|Overall Study|Death|11|||
130288418|NCT01974752|469019833|FG000|Overall Study|Lost to Follow-up|2|||
130288419|NCT01974752|469019834|FG001|Overall Study|Lost to Follow-up|0|||
130288420|NCT01974752|469019833|FG000|Overall Study|Withdrawal by Subject|2|||
130288421|NCT01974752|469019834|FG001|Overall Study|Withdrawal by Subject|3|||
130288422|NCT01974752|469019833|FG000|Overall Study|Other Eligibility Criteria|0|||
130288423|NCT01974752|469019834|FG001|Overall Study|Other Eligibility Criteria|1|||
130288424|NCT02435680|469019836|FG000|Overall Study|Physician Decision|3|||
130288425|NCT02435680|469019837|FG001|Overall Study|Physician Decision|0|||
130288426|NCT02435680|469019838|FG002|Overall Study|Physician Decision|0|||
130288427|NCT02435680|469019836|FG000|Overall Study|subject / guardian decision|0|||
130288428|NCT02435680|469019837|FG001|Overall Study|subject / guardian decision|3|||
130288429|NCT02435680|469019838|FG002|Overall Study|subject / guardian decision|2|||
130288430|NCT02435680|469019836|FG000|Overall Study|Adverse Event|8|||
130288431|NCT02435680|469019837|FG001|Overall Study|Adverse Event|3|||
130288432|NCT02435680|469019838|FG002|Overall Study|Adverse Event|2|||
130288433|NCT02435680|469019836|FG000|Overall Study|progressive disease|10|||
130288434|NCT02435680|469019837|FG001|Overall Study|progressive disease|7|||
130288435|NCT02435680|469019838|FG002|Overall Study|progressive disease|11|||
130288436|NCT02435680|469019836|FG000|Overall Study|not treated|0|||
130288437|NCT02435680|469019837|FG001|Overall Study|not treated|0|||
130288438|NCT02435680|469019838|FG002|Overall Study|not treated|1|||
130288439|NCT00330928|469019839|FG000|Overall Study|Lost to Follow-up|6|||
129792811|NCT04393298|467209139|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
129792812|NCT03754972|467209140|FG000|Overall Study|Protocol Violation|25|||
129792813|NCT02311582|467209141|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129792814|NCT02311582|467209142|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129792815|NCT02311582|467209143|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129792816|NCT02311582|467209144|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
129792817|NCT02311582|467209145|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
129792818|NCT03422627|467209146|FG000|Overall Study|Protocol-specified Criteria|1|||
129792819|NCT03422627|467209147|FG001|Overall Study|Protocol-specified Criteria|1|||
129792820|NCT03422627|467209148|FG002|Overall Study|Protocol-specified Criteria|0|||
129792821|NCT03422627|467209149|FG003|Overall Study|Protocol-specified Criteria|0|||
129792822|NCT03422627|467209150|FG004|Overall Study|Protocol-specified Criteria|2|||
129792823|NCT03422627|467209146|FG000|Overall Study|Requirement for Alternative Therapy|1|||
129792824|NCT03422627|467209147|FG001|Overall Study|Requirement for Alternative Therapy|1|||
129792825|NCT03422627|467209148|FG002|Overall Study|Requirement for Alternative Therapy|2|||
129792826|NCT03422627|467209149|FG003|Overall Study|Requirement for Alternative Therapy|0|||
129792827|NCT03422627|467209150|FG004|Overall Study|Requirement for Alternative Therapy|0|||
129792828|NCT03422627|467209146|FG000|Overall Study|Disease Progression|1|||
129792829|NCT03422627|467209147|FG001|Overall Study|Disease Progression|0|||
129792830|NCT03422627|467209148|FG002|Overall Study|Disease Progression|1|||
129792831|NCT03422627|467209149|FG003|Overall Study|Disease Progression|2|||
129792832|NCT03422627|467209150|FG004|Overall Study|Disease Progression|0|||
129792833|NCT03422627|467209146|FG000|Overall Study|Adverse Event|2|||
129792834|NCT03422627|467209147|FG001|Overall Study|Adverse Event|1|||
129792835|NCT03422627|467209148|FG002|Overall Study|Adverse Event|0|||
129792836|NCT03422627|467209149|FG003|Overall Study|Adverse Event|0|||
129792837|NCT03422627|467209150|FG004|Overall Study|Adverse Event|2|||
129792838|NCT03422627|467209146|FG000|Overall Study|Ineligibility Determined|0|||
129792839|NCT03422627|467209147|FG001|Overall Study|Ineligibility Determined|1|||
130288440|NCT00330928|469019839|FG000|Overall Study|Physician Decision|9|||
130288441|NCT00330928|469019839|FG000|Overall Study|Death|1|||
130288442|NCT00330928|469019839|FG000|Overall Study|IVUS could not be performed.|1|||
130288443|NCT03028480|469019842|FG000|Overall Study|No revisit after the first prescription date|2|||
129792840|NCT03422627|467209148|FG002|Overall Study|Ineligibility Determined|0|||
129792841|NCT03422627|467209149|FG003|Overall Study|Ineligibility Determined|0|||
129792842|NCT03422627|467209150|FG004|Overall Study|Ineligibility Determined|0|||
129792843|NCT03422627|467209146|FG000|Overall Study|Death|0|||
129792844|NCT03422627|467209147|FG001|Overall Study|Death|1|||
129792845|NCT03422627|467209148|FG002|Overall Study|Death|1|||
129792846|NCT03422627|467209149|FG003|Overall Study|Death|0|||
129792847|NCT03422627|467209150|FG004|Overall Study|Death|0|||
129792848|NCT03422627|467209146|FG000|Overall Study|Withdrawal by Subject|0|||
129792849|NCT03422627|467209147|FG001|Overall Study|Withdrawal by Subject|0|||
129792850|NCT03422627|467209148|FG002|Overall Study|Withdrawal by Subject|0|||
129792851|NCT03422627|467209149|FG003|Overall Study|Withdrawal by Subject|1|||
130288444|NCT03028480|469019842|FG000|Overall Study|Did not use the drug|1|||
130288445|NCT03028480|469019842|FG000|Overall Study|Violation of the enrollment deadline|10|||
130288446|NCT03028480|469019842|FG000|Overall Study|Case report forms were not collected|21|||
130288447|NCT02279719|469019845|FG000|Overall Study|Patients randomized but never treated|0|||
130288448|NCT02279719|469019846|FG001|Overall Study|Patients randomized but never treated|0|||
130288449|NCT02279719|469019847|FG002|Overall Study|Patients randomized but never treated|0|||
130288450|NCT02279719|469019848|FG003|Overall Study|Patients randomized but never treated|0|||
130288451|NCT02279719|469019849|FG004|Overall Study|Patients randomized but never treated|3|||
130288452|NCT02279719|469019850|FG005|Overall Study|Patients randomized but never treated|0|||
130288453|NCT02279719|469019851|FG006|Overall Study|Patients randomized but never treated|3|||
130288454|NCT03541187|469019852|FG000|Overall Study|Lost to Follow-up|2|||
130288455|NCT03541187|469019853|FG001|Overall Study|Lost to Follow-up|6|||
130288456|NCT03541187|469019852|FG000|Overall Study|Pregnancy|0|||
130288457|NCT03541187|469019853|FG001|Overall Study|Pregnancy|1|||
130288458|NCT03541187|469019852|FG000|Overall Study|Withdrawal by Subject|6|||
130288459|NCT03541187|469019853|FG001|Overall Study|Withdrawal by Subject|2|||
130288460|NCT03541187|469019852|FG000|Overall Study|Moved out of town|1|||
130288461|NCT03541187|469019853|FG001|Overall Study|Moved out of town|0|||
130288462|NCT03541187|469019852|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
130288463|NCT03541187|469019853|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
130288464|NCT03541187|469019852|FG000|Overall Study|Did not meet randomization criteria|1|||
130288465|NCT03541187|469019853|FG001|Overall Study|Did not meet randomization criteria|1|||
130288466|NCT03541187|469019852|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
130288467|NCT03541187|469019853|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
130288468|NCT03541187|469019852|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
130288469|NCT03541187|469019853|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
130288470|NCT01369680|469019854|FG000|Overall Study|Lost to Follow-up|0|||
130288471|NCT01369680|469019855|FG001|Overall Study|Lost to Follow-up|0|||
130288472|NCT01369680|469019856|FG002|Overall Study|Lost to Follow-up|1|||
130288473|NCT01369680|469019857|FG003|Overall Study|Lost to Follow-up|2|||
130288474|NCT00585221|469019860|FG000|Overall Study|Protocol Violation|8|||
130288475|NCT01118520|469019865|FG000|Overall Study|AAA repair|9|||
130288476|NCT01118520|469019866|FG001|Overall Study|AAA repair|7|||
130288477|NCT01118520|469019867|FG002|Overall Study|AAA repair|9|||
130288478|NCT01118520|469019865|FG000|Overall Study|Adverse Event|3|||
130288479|NCT01118520|469019866|FG001|Overall Study|Adverse Event|3|||
130288480|NCT01118520|469019867|FG002|Overall Study|Adverse Event|3|||
130288481|NCT01118520|469019865|FG000|Overall Study|Withdrawal by Subject|8|||
130288482|NCT01118520|469019866|FG001|Overall Study|Withdrawal by Subject|13|||
130288483|NCT01118520|469019867|FG002|Overall Study|Withdrawal by Subject|8|||
130288484|NCT01089023|469019870|FG000|Overall Study|Lost to Follow-up|3|||
130288485|NCT01089023|469019870|FG000|Overall Study|Adverse Event|1|||
130288486|NCT01089023|469019870|FG000|Overall Study|Withdrawal by Subject|1|||
130288487|NCT01089023|469019870|FG000|Overall Study|Protocol Violation|1|||
130288488|NCT01089023|469019870|FG000|Overall Study|Lack of Efficacy|1|||
130288489|NCT03421743|469019871|FG000|Overall Study|Lack of Efficacy|1|||
130288490|NCT03421743|469019872|FG001|Overall Study|Lack of Efficacy|0|||
130288491|NCT03421743|469019871|FG000|Overall Study|Adverse Event|2|||
130288492|NCT03421743|469019872|FG001|Overall Study|Adverse Event|1|||
130288493|NCT03421743|469019871|FG000|Overall Study|Withdrawal by Subject|0|||
130288494|NCT03421743|469019872|FG001|Overall Study|Withdrawal by Subject|1|||
130288495|NCT01166373|469019873|FG000|Overall Study|Lost to Follow-up|3|||
130288496|NCT01166373|469019874|FG001|Overall Study|Lost to Follow-up|2|||
130288497|NCT01166373|469019875|FG002|Overall Study|Lost to Follow-up|2|||
130288498|NCT01166373|469019876|FG003|Overall Study|Lost to Follow-up|2|||
130288499|NCT01166373|469019873|FG000|Overall Study|Withdrawal by Subject|1|||
130288500|NCT01166373|469019874|FG001|Overall Study|Withdrawal by Subject|2|||
130288501|NCT01166373|469019875|FG002|Overall Study|Withdrawal by Subject|2|||
130288502|NCT01166373|469019876|FG003|Overall Study|Withdrawal by Subject|3|||
130288503|NCT01166373|469019873|FG000|Overall Study|Physician Decision|1|||
130288504|NCT01166373|469019874|FG001|Overall Study|Physician Decision|0|||
130288505|NCT01166373|469019875|FG002|Overall Study|Physician Decision|0|||
130288506|NCT01166373|469019876|FG003|Overall Study|Physician Decision|0|||
130288507|NCT01819129|469019877|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
130288508|NCT01819129|469019878|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
130288509|NCT01819129|469019877|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
130288510|NCT01819129|469019878|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
130288511|NCT01819129|469019877|FG000|Overall Study|Other, Subject moved out of the country|0|||
129792852|NCT03422627|467209150|FG004|Overall Study|Withdrawal by Subject|0|||
130044775|NCT04075604|468121197|FG002|Overall Study|Disease progression|0|||
130044776|NCT04075604|468121195|FG000|Overall Study|Study drug toxicity|0|||
130044777|NCT04075604|468121196|FG001|Overall Study|Study drug toxicity|5|||
130044778|NCT04075604|468121197|FG002|Overall Study|Study drug toxicity|1|||
130044779|NCT01650779|468121200|FG000|Overall Study|Withdrawal by Subject|1|||
130044780|NCT03666143|468121201|FG000|Overall Study|Death|158|||
130044781|NCT03666143|468121201|FG000|Overall Study|Sponsor Decision|31|||
130044782|NCT03666143|468121201|FG000|Overall Study|Withdrawal by Subject|11|||
130044783|NCT03666143|468121201|FG000|Overall Study|Lost to Follow-up|5|||
130044784|NCT03666143|468121201|FG000|Overall Study|Physician Decision|1|||
130044785|NCT03666143|468121201|FG000|Overall Study|Rolled into extension study|9|||
130044786|NCT03666143|468121201|FG000|Overall Study|Progressive Disease|1|||
130044787|NCT04329923|468121202|FG000|Overall Study|Withdrawal by Subject|1|||
130044788|NCT04329923|468121203|FG001|Overall Study|Withdrawal by Subject|4|||
130044789|NCT04329923|468121204|FG002|Overall Study|Withdrawal by Subject|1|||
130044790|NCT04329923|468121205|FG003|Overall Study|Withdrawal by Subject|1|||
130044791|NCT04329923|468121206|FG004|Overall Study|Withdrawal by Subject|1|||
130044792|NCT04329923|468121207|FG005|Overall Study|Withdrawal by Subject|1|||
130044793|NCT04329923|468121202|FG000|Overall Study|early termination of study|0|||
130044794|NCT04329923|468121203|FG001|Overall Study|early termination of study|0|||
130044795|NCT04329923|468121204|FG002|Overall Study|early termination of study|0|||
130044796|NCT04329923|468121205|FG003|Overall Study|early termination of study|0|||
130044797|NCT04329923|468121206|FG004|Overall Study|early termination of study|1|||
130044798|NCT04329923|468121207|FG005|Overall Study|early termination of study|2|||
130044799|NCT04329923|468121202|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130044800|NCT04329923|468121203|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130044801|NCT04329923|468121204|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130044802|NCT04329923|468121205|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130044803|NCT04329923|468121206|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
130044804|NCT04329923|468121207|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
130044805|NCT01272180|468121208|FG000|Overall Study|Adverse Event|0|||
130044806|NCT01272180|468121209|FG001|Overall Study|Adverse Event|0|||
130044807|NCT01272180|468121210|FG002|Overall Study|Adverse Event|1|||
130044808|NCT01272180|468121211|FG003|Overall Study|Adverse Event|0|||
130044809|NCT01272180|468121208|FG000|Overall Study|Withdrawal by Subject|2|||
130044810|NCT01272180|468121209|FG001|Overall Study|Withdrawal by Subject|6|||
130044811|NCT01272180|468121210|FG002|Overall Study|Withdrawal by Subject|3|||
130288512|NCT01819129|469019878|FG001|Overall Study|Other, Subject moved out of the country|1|||
130288513|NCT01819129|469019877|FG000|Overall Study|Withdrawal by Subject|15|||
130288514|NCT01819129|469019878|FG001|Overall Study|Withdrawal by Subject|15|||
130288515|NCT01819129|469019877|FG000|Overall Study|Lost to Follow-up|5|||
130288516|NCT01819129|469019878|FG001|Overall Study|Lost to Follow-up|2|||
130288517|NCT01819129|469019877|FG000|Overall Study|Lack of Efficacy|0|||
130288518|NCT01819129|469019878|FG001|Overall Study|Lack of Efficacy|1|||
130288519|NCT01819129|469019877|FG000|Overall Study|Adverse Event|1|||
130288520|NCT01819129|469019878|FG001|Overall Study|Adverse Event|4|||
130288521|NCT01819129|469019877|FG000|Overall Study|Death|1|||
130288522|NCT01819129|469019878|FG001|Overall Study|Death|1|||
130288523|NCT01819129|469019877|FG000|Overall Study|Withdrawal Criteria|20|||
130288524|NCT01819129|469019878|FG001|Overall Study|Withdrawal Criteria|15|||
130288525|NCT02836873|469019888|FG000|Overall Study|Protocol Violation|0|||
130288526|NCT02836873|469019889|FG001|Overall Study|Protocol Violation|1|||
130288527|NCT02836873|469019888|FG000|Overall Study|Adverse Event|1|||
130288528|NCT02836873|469019889|FG001|Overall Study|Adverse Event|4|||
130288529|NCT02836873|469019888|FG000|Overall Study|Withdrawal by Subject|2|||
130288530|NCT02836873|469019889|FG001|Overall Study|Withdrawal by Subject|2|||
130288531|NCT02836873|469019888|FG000|Overall Study|Lost to Follow-up|1|||
130044812|NCT01272180|468121211|FG003|Overall Study|Withdrawal by Subject|2|||
130044813|NCT01272180|468121208|FG000|Overall Study|Lost to Follow-up|15|||
130288532|NCT02836873|469019889|FG001|Overall Study|Lost to Follow-up|3|||
130044814|NCT01272180|468121209|FG001|Overall Study|Lost to Follow-up|14|||
130044815|NCT01272180|468121210|FG002|Overall Study|Lost to Follow-up|8|||
130044816|NCT01272180|468121211|FG003|Overall Study|Lost to Follow-up|10|||
130044817|NCT01272180|468121208|FG000|Overall Study|Inappropriate enrollment|0|||
130044818|NCT01272180|468121209|FG001|Overall Study|Inappropriate enrollment|0|||
130044819|NCT01272180|468121210|FG002|Overall Study|Inappropriate enrollment|1|||
130044820|NCT01272180|468121211|FG003|Overall Study|Inappropriate enrollment|1|||
130288533|NCT02836873|469019888|FG000|Overall Study|Physician Decision|0|||
130288534|NCT02836873|469019889|FG001|Overall Study|Physician Decision|1|||
130288535|NCT02836873|469019888|FG000|Overall Study|Other|1|||
130288536|NCT02836873|469019889|FG001|Overall Study|Other|0|||
130288537|NCT00694096|469019890|FG000|Overall Study|Withdrawal by Subject|5|||
130044821|NCT01272180|468121208|FG000|Overall Study|Protocol Violation|0|||
130044822|NCT01272180|468121209|FG001|Overall Study|Protocol Violation|1|||
130044823|NCT01272180|468121210|FG002|Overall Study|Protocol Violation|0|||
130288538|NCT02914548|469019893|FG000|Overall Study|Adverse Event|15|||
129792853|NCT04656275|467209153|FG000|Overall Study|Study terminated by sponsor|2|||
129792854|NCT04656275|467209154|FG001|Overall Study|Study terminated by sponsor|4|||
129792855|NCT00934648|467209157|FG000|Overall Study|Failure to return|8|||
129792856|NCT00934648|467209157|FG000|Overall Study|Withdrawal by Subject|1|||
130288539|NCT02914548|469019894|FG001|Overall Study|Adverse Event|7|||
129792857|NCT03828370|467209158|FG000|3 Month Follow-up|Lost to Follow-up|4|||
130288540|NCT02914548|469019895|FG002|Overall Study|Adverse Event|15|||
130288541|NCT02914548|469019893|FG000|Overall Study|Physician Decision|2|||
130288542|NCT02914548|469019894|FG001|Overall Study|Physician Decision|2|||
130288543|NCT02914548|469019895|FG002|Overall Study|Physician Decision|0|||
130288544|NCT02914548|469019893|FG000|Overall Study|Protocol Violation|1|||
130288545|NCT02914548|469019894|FG001|Overall Study|Protocol Violation|0|||
130288546|NCT02914548|469019895|FG002|Overall Study|Protocol Violation|0|||
130288547|NCT02914548|469019893|FG000|Overall Study|Withdrawal by Subject|3|||
130288548|NCT02914548|469019894|FG001|Overall Study|Withdrawal by Subject|4|||
130288549|NCT02914548|469019895|FG002|Overall Study|Withdrawal by Subject|4|||
130288550|NCT02914548|469019893|FG000|Overall Study|>40% of body surface area|0|||
130288551|NCT02914548|469019894|FG001|Overall Study|>40% of body surface area|1|||
130288552|NCT02914548|469019895|FG002|Overall Study|>40% of body surface area|1|||
130288553|NCT02214225|469019896|FG000|Overall Study|Lost to Follow-up|46|||
130288554|NCT02214225|469019897|FG001|Overall Study|Lost to Follow-up|18|||
130288555|NCT02214225|469019898|FG002|Overall Study|Lost to Follow-up|18|||
130288556|NCT02214225|469019896|FG000|Overall Study|Withdrawal by Subject|2|||
130288557|NCT02214225|469019897|FG001|Overall Study|Withdrawal by Subject|0|||
130288558|NCT02214225|469019898|FG002|Overall Study|Withdrawal by Subject|2|||
130288559|NCT02214225|469019896|FG000|Overall Study|Death|5|||
130288560|NCT02214225|469019897|FG001|Overall Study|Death|0|||
130288561|NCT02214225|469019898|FG002|Overall Study|Death|1|||
130288562|NCT02214225|469019896|FG000|Overall Study|randomized in error, not vaccinated|2|||
130288563|NCT02214225|469019897|FG001|Overall Study|randomized in error, not vaccinated|1|||
130288564|NCT02214225|469019898|FG002|Overall Study|randomized in error, not vaccinated|1|||
130288565|NCT03754582|469019899|FG000|Treatment Phase|Adverse Event|0|||
130288566|NCT03754582|469019900|FG001|Treatment Phase|Adverse Event|1|||
130288567|NCT03754582|469019901|FG002|Treatment Phase|Adverse Event|0|||
130288568|NCT03754582|469019899|FG000|Follow-up Phase|Other|0|||
130288569|NCT03754582|469019900|FG001|Follow-up Phase|Other|0|||
130288570|NCT03754582|469019901|FG002|Follow-up Phase|Other|1|||
130288571|NCT02680574|469019902|FG000|Overall Study|Death|137|||
129792858|NCT03828370|467209159|FG001|3 Month Follow-up|Lost to Follow-up|12|||
129792859|NCT03828370|467209158|FG000|9 Month Follow up|Lost to Follow-up|12|||
129792860|NCT03828370|467209159|FG001|9 Month Follow up|Lost to Follow-up|20|||
129792861|NCT02554279|467209162|FG000|Overall Study|Adverse Event|2|||
129792862|NCT02554279|467209163|FG001|Overall Study|Adverse Event|5|||
129792863|NCT02554279|467209162|FG000|Overall Study|Lost to Follow-up|3|||
129792864|NCT02554279|467209163|FG001|Overall Study|Lost to Follow-up|2|||
129792865|NCT02554279|467209162|FG000|Overall Study|Withdrawal by Subject|6|||
129792866|NCT02554279|467209163|FG001|Overall Study|Withdrawal by Subject|4|||
129792867|NCT02554279|467209162|FG000|Overall Study|Protocol Violation|2|||
129792868|NCT02554279|467209163|FG001|Overall Study|Protocol Violation|1|||
129792869|NCT02554279|467209162|FG000|Overall Study|Other reason|19|||
129792870|NCT02554279|467209163|FG001|Overall Study|Other reason|6|||
129792871|NCT00812487|467209164|FG000|Overall Study|Lost to Follow-up|2|||
129792872|NCT00812487|467209165|FG001|Overall Study|Lost to Follow-up|0|||
129792873|NCT00812487|467209164|FG000|Overall Study|Withdrawal by Subject|3|||
129792874|NCT00812487|467209165|FG001|Overall Study|Withdrawal by Subject|2|||
129792875|NCT00812487|467209164|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
129792876|NCT00812487|467209165|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
129792877|NCT00812487|467209164|FG000|Overall Study|Protocol Violation|0|||
129792878|NCT00812487|467209165|FG001|Overall Study|Protocol Violation|1|||
129792879|NCT02360605|467209166|FG000|Overall Study|Withdrawal by Subject|4|||
130044824|NCT01272180|468121211|FG003|Overall Study|Protocol Violation|1|||
130044825|NCT01183858|468121212|FG000|Overall Study|Death not related to Progressive Disease|5|||
130288572|NCT02680574|469019903|FG001|Overall Study|Death|137|||
130288573|NCT02680574|469019902|FG000|Overall Study|Withdrawal by Subject|17|||
130288574|NCT02680574|469019903|FG001|Overall Study|Withdrawal by Subject|9|||
130288575|NCT02680574|469019902|FG000|Overall Study|Lost to Follow-up|4|||
130288576|NCT02680574|469019903|FG001|Overall Study|Lost to Follow-up|6|||
130288577|NCT02847858|469019904|FG000|Overall Study|Lost to Follow-up|401|||
129792880|NCT02360605|467209167|FG001|Overall Study|Withdrawal by Subject|9|||
129792881|NCT02360605|467209166|FG000|Overall Study|Lost to Follow-up|7|||
129792882|NCT02360605|467209167|FG001|Overall Study|Lost to Follow-up|8|||
129792883|NCT02360605|467209166|FG000|Overall Study|Death|0|||
129792884|NCT02360605|467209167|FG001|Overall Study|Death|1|||
129792885|NCT00290407|467209170|FG000|Overall Study|Physician Decision|2|||
129792886|NCT00723203|467209171|FG000|Overall Study|Withdrawal by Subject|3|||
129792887|NCT00740051|467209172|FG000|Overall Study|Lack of Efficacy|2|||
129792888|NCT00740051|467209173|FG001|Overall Study|Lack of Efficacy|5|||
130288578|NCT02847858|469019905|FG001|Overall Study|Lost to Follow-up|269|||
130288579|NCT00681564|469019906|FG000|Overall Study|Lost to Follow-up|6|||
130288580|NCT00681564|469019907|FG001|Overall Study|Lost to Follow-up|6|||
130288581|NCT00681564|469019906|FG000|Overall Study|Withdrawal by Subject|0|||
130288582|NCT00681564|469019907|FG001|Overall Study|Withdrawal by Subject|1|||
130288583|NCT00681564|469019906|FG000|Overall Study|Death|0|||
130288584|NCT00681564|469019907|FG001|Overall Study|Death|1|||
130288585|NCT01009346|469019912|FG000|Overall Study|Adverse Event|4|||
130288586|NCT01253265|469019914|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
130288587|NCT01253265|469019915|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288588|NCT01253265|469019916|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288589|NCT01253265|469019917|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288590|NCT01253265|469019918|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
130288591|NCT01253265|469019914|FG000|Overall Study|Withdrawal by Subject|0|||
130288592|NCT01253265|469019915|FG001|Overall Study|Withdrawal by Subject|0|||
130288593|NCT01253265|469019916|FG002|Overall Study|Withdrawal by Subject|0|||
130288594|NCT01253265|469019917|FG003|Overall Study|Withdrawal by Subject|0|||
130288595|NCT01253265|469019918|FG004|Overall Study|Withdrawal by Subject|1|||
130288596|NCT00541099|469019919|FG000|Overall Study|Ineligible|3|||
130288597|NCT00066469|469019921|FG000|Overall Study|Death|3|||
130288598|NCT00066469|469019921|FG000|Overall Study|Lack of Efficacy|9|||
130288599|NCT00066469|469019921|FG000|Overall Study|Lost to Follow-up|1|||
130288600|NCT00066469|469019921|FG000|Overall Study|Physician Decision|1|||
130288601|NCT00066469|469019921|FG000|Overall Study|Withdrawal by Subject|1|||
130288602|NCT00066469|469019921|FG000|Overall Study|ineligible|1|||
130288603|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Death|8|||
130288604|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Death|8|||
130288605|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Death|0|||
130288606|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Death|0|||
130288607|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
130288608|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130288609|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130288610|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
130288611|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130288612|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
130288613|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130288614|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
130288615|NCT03271047|469019922|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
130288616|NCT03271047|469019923|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
130288617|NCT03271047|469019924|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
130044826|NCT01183858|468121213|FG001|Overall Study|Death not related to Progressive Disease|6|||
130044827|NCT01183858|468121212|FG000|Overall Study|Adverse Event|14|||
130044828|NCT01183858|468121213|FG001|Overall Study|Adverse Event|11|||
130044829|NCT01183858|468121212|FG000|Overall Study|Investigator's Decision|0|||
130044830|NCT01183858|468121213|FG001|Overall Study|Investigator's Decision|3|||
130288618|NCT03271047|469019925|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
130288619|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Other|0|||
130288620|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Other|0|||
130288621|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Other|0|||
130288622|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Other|1|||
130288623|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Death|0|||
130288624|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Death|0|||
130288625|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Death|20|||
130288626|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Death|21|||
130288627|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
130288628|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
130288629|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
130288630|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
130288631|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130288632|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130044831|NCT01183858|468121212|FG000|Overall Study|Insufficient Therapeutic Response|2|||
130044832|NCT01183858|468121213|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130044833|NCT01183858|468121212|FG000|Overall Study|Refused Treatment|1|||
130044834|NCT01183858|468121213|FG001|Overall Study|Refused Treatment|4|||
130288633|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
130288634|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
130288635|NCT03271047|469019922|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130288636|NCT03271047|469019923|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130288637|NCT03271047|469019924|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
130288638|NCT03271047|469019925|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
130044835|NCT01183858|468121212|FG000|Overall Study|Withdrew Consent|4|||
130044836|NCT01183858|468121213|FG001|Overall Study|Withdrew Consent|4|||
130044837|NCT01183858|468121212|FG000|Overall Study|Discontinued Smoking|3|||
130044838|NCT01183858|468121213|FG001|Overall Study|Discontinued Smoking|1|||
130044839|NCT01183858|468121212|FG000|Overall Study|Protocol Violation|1|||
130044840|NCT01183858|468121213|FG001|Overall Study|Protocol Violation|0|||
130044841|NCT01183858|468121212|FG000|Overall Study|Administrative/Other|6|||
130044842|NCT01183858|468121213|FG001|Overall Study|Administrative/Other|6|||
130044843|NCT01183858|468121212|FG000|Overall Study|Progressive Disease|112|||
130044844|NCT01183858|468121213|FG001|Overall Study|Progressive Disease|115|||
130044845|NCT01183858|468121212|FG000|Overall Study|Death related to Progressive Disease|4|||
130044846|NCT01183858|468121213|FG001|Overall Study|Death related to Progressive Disease|5|||
130044847|NCT01183858|468121212|FG000|Overall Study|Lost to Follow-up|1|||
130044848|NCT01183858|468121213|FG001|Overall Study|Lost to Follow-up|1|||
130044849|NCT02747043|468121216|FG000|Overall Study|Other|1|||
130044850|NCT02747043|468121217|FG001|Overall Study|Other|1|||
130044851|NCT02747043|468121216|FG000|Overall Study|Adverse Event|3|||
130044852|NCT02747043|468121217|FG001|Overall Study|Adverse Event|1|||
130044853|NCT02747043|468121216|FG000|Overall Study|Withdrawal by Subject|1|||
130044854|NCT02747043|468121217|FG001|Overall Study|Withdrawal by Subject|1|||
130044855|NCT02747043|468121216|FG000|Overall Study|Physician Decision|1|||
130044856|NCT02747043|468121217|FG001|Overall Study|Physician Decision|1|||
130044857|NCT02747043|468121216|FG000|Overall Study|Protocol Violation|0|||
130044858|NCT02747043|468121217|FG001|Overall Study|Protocol Violation|1|||
130044859|NCT02747043|468121216|FG000|Overall Study|Disease progression|4|||
130044860|NCT02747043|468121217|FG001|Overall Study|Disease progression|0|||
130044861|NCT01295905|468121224|FG000|Overall Study|Did not meet inclusion criteria|1|||
130044862|NCT01295905|468121225|FG001|Overall Study|Did not meet inclusion criteria|0|||
130044863|NCT01295905|468121224|FG000|Overall Study|Met exclusion criteria|1|||
130044864|NCT01295905|468121225|FG001|Overall Study|Met exclusion criteria|0|||
130044865|NCT03842709|468121227|FG000|Overall Study|Withdrawal by Subject|3|||
130044866|NCT03842709|468121228|FG001|Overall Study|Withdrawal by Subject|3|||
130044867|NCT03842709|468121227|FG000|Overall Study|Lost to Follow-up|1|||
130044868|NCT03842709|468121228|FG001|Overall Study|Lost to Follow-up|0|||
130044869|NCT00641147|468121229|FG000|Completed 4 Months.|Physician Decision|1|||
130044870|NCT00641147|468121230|FG001|Completed 4 Months.|Physician Decision|0|||
130044871|NCT00641147|468121229|FG000|Completed 4 Months.|Adverse Event|1|||
130044872|NCT00641147|468121230|FG001|Completed 4 Months.|Adverse Event|0|||
130044873|NCT00641147|468121229|FG000|Completed 8 Months.|Physician Decision|2|||
130044874|NCT00641147|468121230|FG001|Completed 8 Months.|Physician Decision|1|||
130044875|NCT00641147|468121229|FG000|Completed 8 Months.|non compliance|1|||
130044876|NCT00641147|468121230|FG001|Completed 8 Months.|non compliance|0|||
130044877|NCT00641147|468121229|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
130044878|NCT00641147|468121230|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
130044879|NCT00641147|468121229|FG000|Completed 12 Months.|Physician Decision|1|||
130044880|NCT00641147|468121230|FG001|Completed 12 Months.|Physician Decision|1|||
130044881|NCT00641147|468121229|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
130044882|NCT00641147|468121230|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
130044883|NCT00641147|468121229|FG000|Completed 16 Months.|Physician Decision|1|||
130044884|NCT00641147|468121230|FG001|Completed 16 Months.|Physician Decision|0|||
130044885|NCT00641147|468121229|FG000|Completed 16 Months.|Lost to Follow-up|1|||
130288639|NCT00711802|469019926|FG000|Overall Study|Not treated (no further detail)|2|||
130288640|NCT00711802|469019927|FG001|Overall Study|Not treated (no further detail)|1|||
130288641|NCT00711802|469019928|FG002|Overall Study|Not treated (no further detail)|2|||
130044886|NCT00641147|468121230|FG001|Completed 16 Months.|Lost to Follow-up|0|||
130044887|NCT00791128|468121231|FG000|Overall Study|Adverse Event|4|||
130044888|NCT00791128|468121231|FG000|Overall Study|Device migration|2|||
130044889|NCT00791128|468121231|FG000|Overall Study|non-compliance by subject|2|||
130044890|NCT00791128|468121231|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
130044891|NCT01629667|468121232|FG000|Overall Study|Lost to Follow-up|0|||
130044892|NCT01629667|468121233|FG001|Overall Study|Lost to Follow-up|1|||
130044893|NCT01629667|468121234|FG002|Overall Study|Lost to Follow-up|1|||
130044894|NCT01629667|468121232|FG000|Overall Study|Withdrawal by Subject|31|||
130044895|NCT01629667|468121233|FG001|Overall Study|Withdrawal by Subject|20|||
130044896|NCT01629667|468121234|FG002|Overall Study|Withdrawal by Subject|28|||
130288642|NCT00711802|469019929|FG003|Overall Study|Not treated (no further detail)|0|||
130288643|NCT00711802|469019930|FG004|Overall Study|Not treated (no further detail)|2|||
130288644|NCT00711802|469019931|FG005|Overall Study|Not treated (no further detail)|0|||
130288645|NCT00711802|469019932|FG006|Overall Study|Not treated (no further detail)|0|||
130288646|NCT00711802|469019933|FG007|Overall Study|Not treated (no further detail)|0|||
130044897|NCT01629667|468121232|FG000|Overall Study|Death|1|||
130044898|NCT01629667|468121233|FG001|Overall Study|Death|5|||
130044899|NCT01629667|468121234|FG002|Overall Study|Death|3|||
130044900|NCT01629667|468121232|FG000|Overall Study|Randomized, not treated|2|||
130044901|NCT01629667|468121233|FG001|Overall Study|Randomized, not treated|1|||
130044902|NCT01629667|468121234|FG002|Overall Study|Randomized, not treated|0|||
130044903|NCT01629667|468121232|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
130044904|NCT01629667|468121233|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
130044905|NCT01629667|468121234|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
130044906|NCT01629667|468121232|FG000|Overall Study|Requiring lung transplant|2|||
130044907|NCT01629667|468121233|FG001|Overall Study|Requiring lung transplant|1|||
130044908|NCT01629667|468121234|FG002|Overall Study|Requiring lung transplant|3|||
130044909|NCT01629667|468121232|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
130044910|NCT01629667|468121233|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
130044911|NCT01629667|468121234|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
130044912|NCT01629667|468121232|FG000|Overall Study|Started other medicine|1|||
130044913|NCT01629667|468121233|FG001|Overall Study|Started other medicine|0|||
130044914|NCT01629667|468121234|FG002|Overall Study|Started other medicine|1|||
130044915|NCT01629667|468121232|FG000|Overall Study|Site error in safety follow-up|0|||
130044916|NCT01629667|468121233|FG001|Overall Study|Site error in safety follow-up|0|||
130044917|NCT01629667|468121234|FG002|Overall Study|Site error in safety follow-up|1|||
130044918|NCT01629667|468121232|FG000|Overall Study|Enrolled in another clinical study|0|||
130044919|NCT01629667|468121233|FG001|Overall Study|Enrolled in another clinical study|1|||
130044920|NCT01629667|468121234|FG002|Overall Study|Enrolled in another clinical study|0|||
130044921|NCT01629667|468121232|FG000|Overall Study|Code break|1|||
130044922|NCT01629667|468121233|FG001|Overall Study|Code break|0|||
130044923|NCT01629667|468121234|FG002|Overall Study|Code break|0|||
130044924|NCT02441803|468121235|FG000|Overall Study|Physician Decision|0|||
130044925|NCT02441803|468121236|FG001|Overall Study|Physician Decision|2|||
130044926|NCT02441803|468121237|FG002|Overall Study|Physician Decision|2|||
130044927|NCT01512368|468121243|FG000|Overall Study|Protocol Violation|3|||
130044928|NCT00328198|468121244|FG000|Treatment|Adverse Event|21|||
130044929|NCT00328198|468121244|FG000|Treatment|Death|1|||
130044930|NCT00328198|468121244|FG000|Treatment|Physician Decision|5|||
130044931|NCT00328198|468121244|FG000|Treatment|Withdrawal by Subject|5|||
130044932|NCT00328198|468121244|FG000|Treatment|Evidence of disease progression|2|||
130044933|NCT00328198|468121244|FG000|Treatment|Non-compliance|1|||
130044934|NCT00328198|468121244|FG000|Treatment|Confirmed complete response, MRD -|3|||
130044935|NCT00328198|468121244|FG000|Follow-up|Lost to Follow-up|4|||
130044936|NCT00328198|468121244|FG000|Follow-up|Death|31|||
130044937|NCT02717546|468121246|FG000|Overall Study|Lost to Follow-up|12|||
130044938|NCT03396471|468121252|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
130044939|NCT03396471|468121252|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
130044940|NCT03396471|468121252|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
130044941|NCT03396471|468121252|FG000|Study Treatment - Up to 22 Months|Death|2|||
130044942|NCT03396471|468121252|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
130044943|NCT03396471|468121252|FG000|Follow up - Up to 2 Years|Death|9|||
130044944|NCT03396471|468121252|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
130044945|NCT03396471|468121252|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
130044946|NCT03396471|468121252|FG000|Follow up - Up to 2 Years|study terminated|1|||
130044947|NCT03396471|468121252|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
130044948|NCT03396471|468121252|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
130044949|NCT03237845|468121253|FG000|Overall Study|Adverse Event|0|||
130044950|NCT03237845|468121254|FG001|Overall Study|Adverse Event|1|||
130044951|NCT03237845|468121253|FG000|Overall Study|Lost to Follow-up|13|||
130044952|NCT03237845|468121254|FG001|Overall Study|Lost to Follow-up|10|||
130044953|NCT03237845|468121253|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
130288647|NCT00711802|469019926|FG000|Overall Study|Adverse Event|0|||
130044954|NCT03237845|468121254|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
130044955|NCT03237845|468121253|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
130044956|NCT03237845|468121254|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
130044957|NCT03237845|468121253|FG000|Overall Study|Physician Decision|1|||
130044958|NCT03237845|468121254|FG001|Overall Study|Physician Decision|2|||
130044959|NCT03237845|468121253|FG000|Overall Study|Pregnancy|1|||
130044960|NCT03237845|468121254|FG001|Overall Study|Pregnancy|0|||
130044961|NCT03237845|468121253|FG000|Overall Study|Protocol Deviation|0|||
130044962|NCT03237845|468121254|FG001|Overall Study|Protocol Deviation|1|||
130044963|NCT03237845|468121253|FG000|Overall Study|Technical Problems|8|||
130044964|NCT03237845|468121254|FG001|Overall Study|Technical Problems|1|||
130044965|NCT03237845|468121253|FG000|Overall Study|Withdrawal by Subject|3|||
130288648|NCT00711802|469019927|FG001|Overall Study|Adverse Event|0|||
130288649|NCT00711802|469019928|FG002|Overall Study|Adverse Event|0|||
130288650|NCT00711802|469019929|FG003|Overall Study|Adverse Event|0|||
130288651|NCT00711802|469019930|FG004|Overall Study|Adverse Event|1|||
130288652|NCT00711802|469019931|FG005|Overall Study|Adverse Event|1|||
130288653|NCT00711802|469019932|FG006|Overall Study|Adverse Event|0|||
130288654|NCT00711802|469019933|FG007|Overall Study|Adverse Event|0|||
130288655|NCT00711802|469019926|FG000|Overall Study|Microbiological failure|0|||
130288656|NCT00711802|469019927|FG001|Overall Study|Microbiological failure|1|||
130288657|NCT00711802|469019928|FG002|Overall Study|Microbiological failure|0|||
130288658|NCT00711802|469019929|FG003|Overall Study|Microbiological failure|0|||
130288659|NCT00711802|469019930|FG004|Overall Study|Microbiological failure|0|||
130288660|NCT00711802|469019931|FG005|Overall Study|Microbiological failure|1|||
130288661|NCT00711802|469019932|FG006|Overall Study|Microbiological failure|0|||
130288662|NCT00711802|469019933|FG007|Overall Study|Microbiological failure|0|||
130288663|NCT00711802|469019926|FG000|Overall Study|Protocol Violation|0|||
130288664|NCT00711802|469019927|FG001|Overall Study|Protocol Violation|0|||
130288665|NCT00711802|469019928|FG002|Overall Study|Protocol Violation|0|||
130288666|NCT00711802|469019929|FG003|Overall Study|Protocol Violation|1|||
130288667|NCT00711802|469019930|FG004|Overall Study|Protocol Violation|0|||
130288668|NCT00711802|469019931|FG005|Overall Study|Protocol Violation|0|||
130044966|NCT03237845|468121254|FG001|Overall Study|Withdrawal by Subject|3|||
130044967|NCT03237845|468121253|FG000|Overall Study|Other Reasons|4|||
130044968|NCT03237845|468121254|FG001|Overall Study|Other Reasons|0|||
130044969|NCT01645280|468121257|FG000|Overall Study|Death|0|||
130044970|NCT01645280|468121258|FG001|Overall Study|Death|1|||
130044971|NCT01645280|468121259|FG002|Overall Study|Death|0|||
130044972|NCT01645280|468121260|FG003|Overall Study|Death|0|||
130044973|NCT01645280|468121261|FG004|Overall Study|Death|0|||
130044974|NCT01645280|468121257|FG000|Overall Study|Withdrawal by Subject|4|||
130044975|NCT01645280|468121258|FG001|Overall Study|Withdrawal by Subject|0|||
130044976|NCT01645280|468121259|FG002|Overall Study|Withdrawal by Subject|2|||
130044977|NCT01645280|468121260|FG003|Overall Study|Withdrawal by Subject|4|||
130044978|NCT01645280|468121261|FG004|Overall Study|Withdrawal by Subject|5|||
130044979|NCT01645280|468121257|FG000|Overall Study|Lost to Follow-up|0|||
130044980|NCT01645280|468121258|FG001|Overall Study|Lost to Follow-up|0|||
130044981|NCT01645280|468121259|FG002|Overall Study|Lost to Follow-up|0|||
130044982|NCT01645280|468121260|FG003|Overall Study|Lost to Follow-up|2|||
130044983|NCT01645280|468121261|FG004|Overall Study|Lost to Follow-up|1|||
130044984|NCT01645280|468121257|FG000|Overall Study|Other|1|||
130044985|NCT01645280|468121258|FG001|Overall Study|Other|1|||
130044986|NCT01645280|468121259|FG002|Overall Study|Other|2|||
130044987|NCT01645280|468121260|FG003|Overall Study|Other|0|||
130044988|NCT01645280|468121261|FG004|Overall Study|Other|0|||
130044989|NCT01645280|468121257|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
130044990|NCT01645280|468121258|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
130044991|NCT01645280|468121259|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
130044992|NCT01645280|468121260|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
130044993|NCT01645280|468121261|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
130044994|NCT00234104|468121266|FG000|Overall Study|Adverse Event|4|||
130044995|NCT00234104|468121267|FG001|Overall Study|Adverse Event|0|||
130044996|NCT00234104|468121268|FG002|Overall Study|Adverse Event|3|||
130044997|NCT00234104|468121269|FG003|Overall Study|Adverse Event|5|||
130044998|NCT00234104|468121266|FG000|Overall Study|Protocol Violation|0|||
130044999|NCT00234104|468121267|FG001|Overall Study|Protocol Violation|0|||
130288669|NCT00711802|469019932|FG006|Overall Study|Protocol Violation|0|||
130288670|NCT00711802|469019933|FG007|Overall Study|Protocol Violation|0|||
130288671|NCT00711802|469019926|FG000|Overall Study|Physician Decision|0|||
130288672|NCT00711802|469019927|FG001|Overall Study|Physician Decision|2|||
130288673|NCT00711802|469019928|FG002|Overall Study|Physician Decision|0|||
130288674|NCT00711802|469019929|FG003|Overall Study|Physician Decision|0|||
130288675|NCT00711802|469019930|FG004|Overall Study|Physician Decision|0|||
130288676|NCT00711802|469019931|FG005|Overall Study|Physician Decision|0|||
130045000|NCT00234104|468121268|FG002|Overall Study|Protocol Violation|0|||
130045001|NCT00234104|468121269|FG003|Overall Study|Protocol Violation|1|||
130045002|NCT00234104|468121266|FG000|Overall Study|Physician Decision|0|||
130045003|NCT00234104|468121267|FG001|Overall Study|Physician Decision|1|||
130288677|NCT00711802|469019932|FG006|Overall Study|Physician Decision|0|||
130288678|NCT00711802|469019933|FG007|Overall Study|Physician Decision|0|||
130288679|NCT00711802|469019926|FG000|Overall Study|Withdrawal by Subject|0|||
130288680|NCT00711802|469019927|FG001|Overall Study|Withdrawal by Subject|1|||
130288681|NCT00711802|469019928|FG002|Overall Study|Withdrawal by Subject|0|||
130045004|NCT00234104|468121268|FG002|Overall Study|Physician Decision|2|||
130045005|NCT00234104|468121269|FG003|Overall Study|Physician Decision|2|||
130045006|NCT02460822|468121270|FG000|Overall Study|Withdrawal by Subject|1|||
130288682|NCT00711802|469019929|FG003|Overall Study|Withdrawal by Subject|1|||
130288683|NCT00711802|469019930|FG004|Overall Study|Withdrawal by Subject|0|||
130288684|NCT00711802|469019931|FG005|Overall Study|Withdrawal by Subject|0|||
130288685|NCT00711802|469019932|FG006|Overall Study|Withdrawal by Subject|0|||
130288686|NCT00711802|469019933|FG007|Overall Study|Withdrawal by Subject|0|||
130288687|NCT00711802|469019926|FG000|Overall Study|Lost to Follow-up|0|||
130045007|NCT03849560|468121271|FG000|Overall Study|Withdrawal by Subject|1|||
130045008|NCT03849560|468121272|FG001|Overall Study|Withdrawal by Subject|0|||
130045009|NCT03849560|468121273|FG002|Overall Study|Withdrawal by Subject|0|||
130045010|NCT04045613|468121274|FG000|Overall Study|Adverse Event|2|||
130045011|NCT04045613|468121275|FG001|Overall Study|Adverse Event|2|||
130045012|NCT04045613|468121276|FG002|Overall Study|Adverse Event|1|||
130045013|NCT04045613|468121277|FG003|Overall Study|Adverse Event|1|||
130045014|NCT04045613|468121278|FG004|Overall Study|Adverse Event|0|||
130045015|NCT04045613|468121279|FG005|Overall Study|Adverse Event|0|||
130045016|NCT04045613|468121280|FG006|Overall Study|Adverse Event|1|||
130045017|NCT04045613|468121274|FG000|Overall Study|Withdrawal by Subject|0|||
130045018|NCT04045613|468121275|FG001|Overall Study|Withdrawal by Subject|5|||
130045019|NCT04045613|468121276|FG002|Overall Study|Withdrawal by Subject|0|||
130045020|NCT04045613|468121277|FG003|Overall Study|Withdrawal by Subject|0|||
130045021|NCT04045613|468121278|FG004|Overall Study|Withdrawal by Subject|0|||
130045022|NCT04045613|468121279|FG005|Overall Study|Withdrawal by Subject|1|||
130045023|NCT04045613|468121280|FG006|Overall Study|Withdrawal by Subject|0|||
130045024|NCT04045613|468121274|FG000|Overall Study|Physician Decision|2|||
130045025|NCT04045613|468121275|FG001|Overall Study|Physician Decision|0|||
130045026|NCT04045613|468121276|FG002|Overall Study|Physician Decision|0|||
130045027|NCT04045613|468121277|FG003|Overall Study|Physician Decision|0|||
130045028|NCT04045613|468121278|FG004|Overall Study|Physician Decision|1|||
130045029|NCT04045613|468121279|FG005|Overall Study|Physician Decision|0|||
130045030|NCT04045613|468121280|FG006|Overall Study|Physician Decision|0|||
130045031|NCT04045613|468121274|FG000|Overall Study|Death|3|||
130045032|NCT04045613|468121275|FG001|Overall Study|Death|0|||
130045033|NCT04045613|468121276|FG002|Overall Study|Death|0|||
130045034|NCT04045613|468121277|FG003|Overall Study|Death|0|||
130045035|NCT04045613|468121278|FG004|Overall Study|Death|0|||
130045036|NCT04045613|468121279|FG005|Overall Study|Death|0|||
130045037|NCT04045613|468121280|FG006|Overall Study|Death|1|||
130045038|NCT04045613|468121274|FG000|Overall Study|Other reasons|0|||
130045039|NCT04045613|468121275|FG001|Overall Study|Other reasons|1|||
130045040|NCT04045613|468121276|FG002|Overall Study|Other reasons|0|||
130045041|NCT04045613|468121277|FG003|Overall Study|Other reasons|0|||
130045042|NCT04045613|468121278|FG004|Overall Study|Other reasons|0|||
130045043|NCT04045613|468121279|FG005|Overall Study|Other reasons|0|||
130045044|NCT04045613|468121280|FG006|Overall Study|Other reasons|1|||
130045045|NCT04045613|468121274|FG000|Overall Study|Progressive disease: Clinical progression|1|||
130045046|NCT04045613|468121275|FG001|Overall Study|Progressive disease: Clinical progression|0|||
130045047|NCT04045613|468121276|FG002|Overall Study|Progressive disease: Clinical progression|3|||
130045048|NCT04045613|468121277|FG003|Overall Study|Progressive disease: Clinical progression|1|||
130045049|NCT04045613|468121278|FG004|Overall Study|Progressive disease: Clinical progression|1|||
130045050|NCT04045613|468121279|FG005|Overall Study|Progressive disease: Clinical progression|3|||
130045051|NCT04045613|468121280|FG006|Overall Study|Progressive disease: Clinical progression|3|||
130045052|NCT04045613|468121274|FG000|Overall Study|Progressive disease: Radiological progression|24|||
130045053|NCT04045613|468121275|FG001|Overall Study|Progressive disease: Radiological progression|6|||
130045054|NCT04045613|468121276|FG002|Overall Study|Progressive disease: Radiological progression|8|||
130045055|NCT04045613|468121277|FG003|Overall Study|Progressive disease: Radiological progression|0|||
130045056|NCT04045613|468121278|FG004|Overall Study|Progressive disease: Radiological progression|6|||
130045057|NCT04045613|468121279|FG005|Overall Study|Progressive disease: Radiological progression|6|||
130045058|NCT04045613|468121280|FG006|Overall Study|Progressive disease: Radiological progression|11|||
130045059|NCT01633060|468121283|FG000|Randomization Phase|Protocol deviation|1|||
130045060|NCT01633060|468121284|FG001|Randomization Phase|Protocol deviation|2|||
130045061|NCT01633060|468121283|FG000|Randomization Phase|Technical problem|0|||
130045062|NCT01633060|468121284|FG001|Randomization Phase|Technical problem|1|||
130045063|NCT01633060|468121283|FG000|Treatment Phase|Adverse Event|24|||
130288688|NCT00711802|469019927|FG001|Overall Study|Lost to Follow-up|0|||
130045064|NCT01633060|468121284|FG001|Treatment Phase|Adverse Event|3|||
130045065|NCT01633060|468121283|FG000|Treatment Phase|Lost to Follow-up|1|||
130045066|NCT01633060|468121284|FG001|Treatment Phase|Lost to Follow-up|0|||
130045067|NCT01633060|468121283|FG000|Treatment Phase|Physician Decision|16|||
130045068|NCT01633060|468121284|FG001|Treatment Phase|Physician Decision|7|||
130045069|NCT01633060|468121283|FG000|Treatment Phase|Progressive Disease|210|||
130045070|NCT01633060|468121284|FG001|Treatment Phase|Progressive Disease|120|||
130045071|NCT01633060|468121283|FG000|Treatment Phase|Protocol Deviation|1|||
130045072|NCT01633060|468121284|FG001|Treatment Phase|Protocol Deviation|0|||
130045073|NCT01633060|468121283|FG000|Treatment Phase|Study Terminated by sponsor|7|||
130288689|NCT00711802|469019928|FG002|Overall Study|Lost to Follow-up|3|||
130288690|NCT00711802|469019929|FG003|Overall Study|Lost to Follow-up|1|||
130288691|NCT00711802|469019930|FG004|Overall Study|Lost to Follow-up|10|||
130045074|NCT01633060|468121284|FG001|Treatment Phase|Study Terminated by sponsor|3|||
130045075|NCT01633060|468121283|FG000|Treatment Phase|Subject/guardian decision|25|||
130045076|NCT01633060|468121284|FG001|Treatment Phase|Subject/guardian decision|4|||
130045077|NCT01633060|468121283|FG000|Treatment Phase|Death|4|||
130045078|NCT01633060|468121284|FG001|Treatment Phase|Death|3|||
130045079|NCT01633060|468121283|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
130045080|NCT01633060|468121284|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
130045081|NCT01633060|468121283|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
130045082|NCT01633060|468121284|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
130045083|NCT01633060|468121283|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
130045084|NCT01633060|468121284|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
130045085|NCT01633060|468121283|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
130045086|NCT01633060|468121284|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
130045087|NCT01633060|468121283|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
130045088|NCT01633060|468121284|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
130045089|NCT01633060|468121283|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
130045090|NCT01633060|468121284|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
130045091|NCT00491530|468121290|FG000|Overall Study|Adverse Event|6|||
130045092|NCT00491530|468121291|FG001|Overall Study|Adverse Event|1|||
130045093|NCT00491530|468121292|FG002|Overall Study|Adverse Event|2|||
130045094|NCT00491530|468121290|FG000|Overall Study|Withdrawal by Subject|3|||
130045095|NCT00491530|468121291|FG001|Overall Study|Withdrawal by Subject|0|||
130045096|NCT00491530|468121292|FG002|Overall Study|Withdrawal by Subject|0|||
130045097|NCT00491530|468121290|FG000|Overall Study|Lost to Follow-up|3|||
130045098|NCT00491530|468121291|FG001|Overall Study|Lost to Follow-up|2|||
130045099|NCT00491530|468121292|FG002|Overall Study|Lost to Follow-up|2|||
130045100|NCT00491530|468121290|FG000|Overall Study|Lack of Efficacy|0|||
130045101|NCT00491530|468121291|FG001|Overall Study|Lack of Efficacy|1|||
130288692|NCT00711802|469019931|FG005|Overall Study|Lost to Follow-up|6|||
130288693|NCT00711802|469019932|FG006|Overall Study|Lost to Follow-up|4|||
130288694|NCT00711802|469019933|FG007|Overall Study|Lost to Follow-up|2|||
130288695|NCT00711802|469019926|FG000|Overall Study|Reason not reported|0|||
130288696|NCT00711802|469019927|FG001|Overall Study|Reason not reported|1|||
130288697|NCT00711802|469019928|FG002|Overall Study|Reason not reported|1|||
130288698|NCT00711802|469019929|FG003|Overall Study|Reason not reported|0|||
130288699|NCT00711802|469019930|FG004|Overall Study|Reason not reported|1|||
130288700|NCT00711802|469019931|FG005|Overall Study|Reason not reported|0|||
130288701|NCT00711802|469019932|FG006|Overall Study|Reason not reported|1|||
130288702|NCT00711802|469019933|FG007|Overall Study|Reason not reported|0|||
130288703|NCT02410824|469019934|FG000|First Intervention (One Week)|Headache|0|||
130288704|NCT02410824|469019935|FG001|First Intervention (One Week)|Headache|1|||
130288705|NCT02436408|469019936|FG000|Overall Study|Death|1|||
130288706|NCT00392808|469019937|FG000|Overall Study|Lost to Follow-up|3|||
130288707|NCT00392808|469019938|FG001|Overall Study|Lost to Follow-up|2|||
130288708|NCT00392808|469019939|FG002|Overall Study|Lost to Follow-up|1|||
130288709|NCT00392808|469019940|FG003|Overall Study|Lost to Follow-up|2|||
130288710|NCT00392808|469019937|FG000|Overall Study|Unable to withdraw blood|3|||
130288711|NCT00392808|469019938|FG001|Overall Study|Unable to withdraw blood|1|||
130288712|NCT00392808|469019939|FG002|Overall Study|Unable to withdraw blood|1|||
130288713|NCT00392808|469019940|FG003|Overall Study|Unable to withdraw blood|2|||
130288714|NCT02649855|469019941|FG000|Overall Study|Refused further treatment|2|||
130288715|NCT02649855|469019942|FG001|Overall Study|Refused further treatment|1|||
130288716|NCT02649855|469019943|FG002|Overall Study|Refused further treatment|1|||
130288717|NCT02649855|469019941|FG000|Overall Study|Withdrew consent|0|||
130288718|NCT02649855|469019942|FG001|Overall Study|Withdrew consent|1|||
130288719|NCT02649855|469019943|FG002|Overall Study|Withdrew consent|0|||
130288720|NCT02649855|469019941|FG000|Overall Study|Switched to alternative treatment|0|||
130288721|NCT02649855|469019942|FG001|Overall Study|Switched to alternative treatment|1|||
130288722|NCT02649855|469019943|FG002|Overall Study|Switched to alternative treatment|1|||
130288723|NCT02649855|469019941|FG000|Overall Study|Principal investigator discretion|0|||
130288724|NCT02649855|469019942|FG001|Overall Study|Principal investigator discretion|1|||
130045102|NCT00491530|468121292|FG002|Overall Study|Lack of Efficacy|0|||
130288725|NCT02649855|469019943|FG002|Overall Study|Principal investigator discretion|1|||
130288726|NCT02649855|469019941|FG000|Overall Study|No treatment, per protocol|1|||
130288727|NCT02649855|469019942|FG001|Overall Study|No treatment, per protocol|0|||
130288728|NCT02649855|469019943|FG002|Overall Study|No treatment, per protocol|0|||
130288729|NCT02649855|469019941|FG000|Overall Study|Initiate new treatment|1|||
130288730|NCT02649855|469019942|FG001|Overall Study|Initiate new treatment|0|||
130288731|NCT02649855|469019943|FG002|Overall Study|Initiate new treatment|0|||
130288732|NCT02782325|469019944|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
130288733|NCT02782325|469019945|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
130288734|NCT02782325|469019946|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
130288735|NCT02782325|469019944|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
130288736|NCT02782325|469019945|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
130288737|NCT02782325|469019946|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
130288738|NCT02818036|469019950|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
130288739|NCT02818036|469019951|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
130288740|NCT02818036|469019950|FG000|Overall Study|Withdrawal by Subject|1|||
130288741|NCT02818036|469019951|FG001|Overall Study|Withdrawal by Subject|0|||
130288742|NCT01038713|469019952|FG000|Overall Study|Patient to hospice|1|||
130288743|NCT01038713|469019953|FG001|Overall Study|Patient to hospice|1|||
130288744|NCT01038713|469019954|FG002|Overall Study|Patient to hospice|1|||
130288745|NCT01038713|469019952|FG000|Overall Study|Lost to Follow-up|3|||
130288746|NCT01038713|469019953|FG001|Overall Study|Lost to Follow-up|0|||
130288747|NCT01038713|469019954|FG002|Overall Study|Lost to Follow-up|0|||
130288748|NCT01038713|469019952|FG000|Overall Study|Neuroendocrine Tumor|0|||
130288749|NCT01038713|469019953|FG001|Overall Study|Neuroendocrine Tumor|1|||
130288750|NCT01038713|469019954|FG002|Overall Study|Neuroendocrine Tumor|0|||
130288751|NCT01038713|469019952|FG000|Overall Study|died from PEP|0|||
129792889|NCT00740051|467209172|FG000|Overall Study|Adverse Event|1|||
129792890|NCT00740051|467209173|FG001|Overall Study|Adverse Event|4|||
129792891|NCT00740051|467209172|FG000|Overall Study|Protocol Violation|2|||
129792892|NCT00740051|467209173|FG001|Overall Study|Protocol Violation|6|||
129792893|NCT00740051|467209172|FG000|Overall Study|Lost to Follow-up|3|||
129792894|NCT00740051|467209173|FG001|Overall Study|Lost to Follow-up|8|||
129792895|NCT00740051|467209172|FG000|Overall Study|Withdrawal by Subject|6|||
129792896|NCT00740051|467209173|FG001|Overall Study|Withdrawal by Subject|8|||
129792897|NCT00740051|467209172|FG000|Overall Study|Other reason (not specified)|4|||
130288752|NCT01038713|469019953|FG001|Overall Study|died from PEP|1|||
130288753|NCT01038713|469019954|FG002|Overall Study|died from PEP|0|||
130288754|NCT01038713|469019952|FG000|Overall Study|Autoimmune Pancreatitis|1|||
130288755|NCT01038713|469019953|FG001|Overall Study|Autoimmune Pancreatitis|0|||
130288756|NCT01038713|469019954|FG002|Overall Study|Autoimmune Pancreatitis|0|||
130288757|NCT03777917|469019957|FG000|Overall Study|Withdrawal by Subject|1|||
130288758|NCT03777917|469019958|FG001|Overall Study|Withdrawal by Subject|0|||
130288759|NCT03777917|469019957|FG000|Overall Study|Physician Decision|1|||
130288760|NCT03777917|469019958|FG001|Overall Study|Physician Decision|0|||
130288761|NCT03777917|469019957|FG000|Overall Study|Lost to Follow-up|6|||
130288762|NCT03777917|469019958|FG001|Overall Study|Lost to Follow-up|2|||
130288763|NCT03777917|469019957|FG000|Overall Study|Other|1|||
130288764|NCT03777917|469019958|FG001|Overall Study|Other|0|||
130288765|NCT01154283|469019959|FG000|0-6 Weeks|Withdrawal by Subject|7|||
130288766|NCT01154283|469019960|FG001|0-6 Weeks|Withdrawal by Subject|2|||
130288767|NCT01154283|469019959|FG000|0-6 Weeks|Death|0|||
130288768|NCT01154283|469019960|FG001|0-6 Weeks|Death|1|||
130288769|NCT01154283|469019959|FG000|7-12 Weeks|Death|1|||
130288770|NCT01154283|469019960|FG001|7-12 Weeks|Death|0|||
130288771|NCT01154283|469019959|FG000|7-12 Weeks|Withdrawal by Subject|0|||
130288772|NCT01154283|469019960|FG001|7-12 Weeks|Withdrawal by Subject|1|||
130288773|NCT00042432|469019961|FG000|Overall Study|Adverse Event|4|||
130288774|NCT00042432|469019962|FG001|Overall Study|Adverse Event|1|||
130288775|NCT00042432|469019961|FG000|Overall Study|Withdrawal by Subject|1|||
130288776|NCT00042432|469019962|FG001|Overall Study|Withdrawal by Subject|3|||
130288777|NCT00042432|469019961|FG000|Overall Study|Death|0|||
130288778|NCT00042432|469019962|FG001|Overall Study|Death|2|||
130288779|NCT00042432|469019961|FG000|Overall Study|Ineligibility determined|1|||
130288780|NCT00042432|469019962|FG001|Overall Study|Ineligibility determined|0|||
130288781|NCT00042432|469019961|FG000|Overall Study|Initiation of maintenance dialysis|1|||
130288782|NCT00042432|469019962|FG001|Overall Study|Initiation of maintenance dialysis|1|||
130288783|NCT00042432|469019961|FG000|Overall Study|Other|2|||
130288784|NCT00042432|469019962|FG001|Overall Study|Other|0|||
130288785|NCT00657150|469019963|FG000|Overall Study|Adverse Event|19|||
130288786|NCT00657150|469019964|FG001|Overall Study|Adverse Event|10|||
130288787|NCT00657150|469019963|FG000|Overall Study|Non-compliant with protocol|5|||
130288788|NCT00657150|469019964|FG001|Overall Study|Non-compliant with protocol|9|||
130288789|NCT00657150|469019963|FG000|Overall Study|Lost to Follow-up|2|||
130288790|NCT00657150|469019964|FG001|Overall Study|Lost to Follow-up|0|||
130288791|NCT00657150|469019963|FG000|Overall Study|Withdrawal by Subject|51|||
130288792|NCT00657150|469019964|FG001|Overall Study|Withdrawal by Subject|36|||
130288793|NCT00657150|469019963|FG000|Overall Study|Other|38|||
130288794|NCT00657150|469019964|FG001|Overall Study|Other|38|||
130288795|NCT00657150|469019963|FG000|Treatment|Adverse Event|60|||
130288796|NCT00657150|469019964|FG001|Treatment|Adverse Event|53|||
129792898|NCT00740051|467209173|FG001|Overall Study|Other reason (not specified)|1|||
130288797|NCT00657150|469019963|FG000|Treatment|Non-compliant with protocol|10|||
130288798|NCT00657150|469019964|FG001|Treatment|Non-compliant with protocol|9|||
130288799|NCT00657150|469019963|FG000|Treatment|Lost to Follow-up|1|||
130288800|NCT00657150|469019964|FG001|Treatment|Lost to Follow-up|0|||
130288801|NCT00657150|469019963|FG000|Treatment|Withdrawal by Subject|23|||
129792899|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
129792900|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
129792901|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
130288802|NCT00657150|469019964|FG001|Treatment|Withdrawal by Subject|20|||
130045103|NCT00491530|468121290|FG000|Overall Study|Investigator Discretion|0|||
130045104|NCT00491530|468121291|FG001|Overall Study|Investigator Discretion|1|||
130288803|NCT00657150|469019963|FG000|Treatment|Other|13|||
130288804|NCT00657150|469019964|FG001|Treatment|Other|15|||
130288805|NCT02966795|469019965|FG000|Overall Study|Patient Left the Country|0|||
130288806|NCT02966795|469019966|FG001|Overall Study|Patient Left the Country|1|||
130288807|NCT00468845|469019978|FG000|Overall Study|Adverse Event|9|||
130288808|NCT00468845|469019979|FG001|Overall Study|Adverse Event|14|||
130288809|NCT00468845|469019980|FG002|Overall Study|Adverse Event|11|||
130288810|NCT00468845|469019978|FG000|Overall Study|Lost to Follow-up|2|||
130288811|NCT00468845|469019979|FG001|Overall Study|Lost to Follow-up|1|||
130288812|NCT00468845|469019980|FG002|Overall Study|Lost to Follow-up|2|||
130288813|NCT00468845|469019978|FG000|Overall Study|Other|4|||
130288814|NCT00468845|469019979|FG001|Overall Study|Other|9|||
130288815|NCT00468845|469019980|FG002|Overall Study|Other|5|||
130288816|NCT00468845|469019978|FG000|Overall Study|No longer willing to participate|5|||
130288817|NCT00468845|469019979|FG001|Overall Study|No longer willing to participate|6|||
130288818|NCT00468845|469019980|FG002|Overall Study|No longer willing to participate|10|||
130288819|NCT00468845|469019978|FG000|Overall Study|Randomized, not treated|1|||
130288820|NCT00468845|469019979|FG001|Overall Study|Randomized, not treated|4|||
130288821|NCT00468845|469019980|FG002|Overall Study|Randomized, not treated|2|||
130288822|NCT02761694|469019985|FG000|Overall Study|Lack of Efficacy|0|||
130288823|NCT02761694|469019986|FG001|Overall Study|Lack of Efficacy|0|||
130288824|NCT02761694|469019987|FG002|Overall Study|Lack of Efficacy|0|||
129792902|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
129792903|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
129792904|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
129792905|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
129792906|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
129792907|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
129792908|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
129792909|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
129792910|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
129792911|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
129792912|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
129792913|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
129792914|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
129792915|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
129792916|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
129792917|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
129792918|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
129792919|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
129792920|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
129792921|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
129792922|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
130045105|NCT00491530|468121292|FG002|Overall Study|Investigator Discretion|0|||
130045106|NCT00491530|468121290|FG000|Overall Study|Patient Request|0|||
130288825|NCT02761694|469019988|FG003|Overall Study|Lack of Efficacy|0|||
130288826|NCT02761694|469019989|FG004|Overall Study|Lack of Efficacy|0|||
130288827|NCT02761694|469019990|FG005|Overall Study|Lack of Efficacy|0|||
130288828|NCT02761694|469019991|FG006|Overall Study|Lack of Efficacy|6|||
130288829|NCT02761694|469019992|FG007|Overall Study|Lack of Efficacy|0|||
130288830|NCT02761694|469019993|FG008|Overall Study|Lack of Efficacy|0|||
130288831|NCT02761694|469019994|FG009|Overall Study|Lack of Efficacy|1|||
130288832|NCT02761694|469019995|FG010|Overall Study|Lack of Efficacy|1|||
130288833|NCT02761694|469019996|FG011|Overall Study|Lack of Efficacy|4|||
130288834|NCT02761694|469019985|FG000|Overall Study|Death|0|||
130288835|NCT02761694|469019986|FG001|Overall Study|Death|0|||
130288836|NCT02761694|469019987|FG002|Overall Study|Death|0|||
130288837|NCT02761694|469019988|FG003|Overall Study|Death|0|||
130288838|NCT02761694|469019989|FG004|Overall Study|Death|0|||
130288839|NCT02761694|469019990|FG005|Overall Study|Death|0|||
130288840|NCT02761694|469019991|FG006|Overall Study|Death|2|||
130288841|NCT02761694|469019992|FG007|Overall Study|Death|0|||
130288842|NCT02761694|469019993|FG008|Overall Study|Death|2|||
130045107|NCT00491530|468121291|FG001|Overall Study|Patient Request|1|||
130288843|NCT02761694|469019994|FG009|Overall Study|Death|2|||
130288844|NCT02761694|469019995|FG010|Overall Study|Death|1|||
130288845|NCT02761694|469019996|FG011|Overall Study|Death|0|||
130288846|NCT02761694|469019985|FG000|Overall Study|Physician Decision|0|||
130288847|NCT02761694|469019986|FG001|Overall Study|Physician Decision|0|||
129792923|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
130288848|NCT02761694|469019987|FG002|Overall Study|Physician Decision|0|||
130288849|NCT02761694|469019988|FG003|Overall Study|Physician Decision|0|||
130288850|NCT02761694|469019989|FG004|Overall Study|Physician Decision|0|||
130288851|NCT02761694|469019990|FG005|Overall Study|Physician Decision|0|||
130288852|NCT02761694|469019991|FG006|Overall Study|Physician Decision|1|||
129792924|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
129792925|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
129792926|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
129792927|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
129792928|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
129792929|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
129792930|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
129792931|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
129792932|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
129792933|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
129792934|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
129792935|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
129792936|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
129792937|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
129792938|NCT01055496|467209178|FG000|Overall Study|Withdrawal by Subject|2|||
129792939|NCT01055496|467209179|FG001|Overall Study|Withdrawal by Subject|4|||
129792940|NCT01055496|467209178|FG000|Overall Study|Death|13|||
129792941|NCT01055496|467209179|FG001|Overall Study|Death|23|||
129792942|NCT01055496|467209178|FG000|Overall Study|Lost to Follow-up|0|||
129792943|NCT01055496|467209179|FG001|Overall Study|Lost to Follow-up|2|||
129792944|NCT01055496|467209178|FG000|Overall Study|Other - Unspecified|0|||
129792945|NCT01055496|467209179|FG001|Overall Study|Other - Unspecified|1|||
129792946|NCT01673282|467209181|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
129792947|NCT01673282|467209182|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
129792948|NCT01673282|467209181|FG000|Overall Study|Lack of Efficacy|9|||
129792949|NCT01673282|467209182|FG001|Overall Study|Lack of Efficacy|2|||
129792950|NCT01673282|467209181|FG000|Overall Study|Lost to Follow-up|11|||
129792951|NCT01673282|467209182|FG001|Overall Study|Lost to Follow-up|10|||
129792952|NCT01673282|467209181|FG000|Overall Study|Withdrawal by Subject|3|||
129792953|NCT01673282|467209182|FG001|Overall Study|Withdrawal by Subject|3|||
129792954|NCT01673282|467209181|FG000|Overall Study|Other|1|||
129792955|NCT01673282|467209182|FG001|Overall Study|Other|6|||
129792956|NCT01323920|467209188|FG000|Overall Study|Death|5|||
129792957|NCT01323920|467209188|FG000|Overall Study|Withdrawal by Subject|1|||
129792958|NCT02915874|467209189|FG000|Overall Study|Lost to Follow-up|5|||
129792959|NCT02915874|467209190|FG001|Overall Study|Lost to Follow-up|4|||
129792960|NCT02915874|467209189|FG000|Overall Study|Withdrawal by Subject|1|||
129792961|NCT02915874|467209190|FG001|Overall Study|Withdrawal by Subject|1|||
129792962|NCT02915874|467209189|FG000|Overall Study|Started New Anxiety Medication|0|||
129792963|NCT02915874|467209190|FG001|Overall Study|Started New Anxiety Medication|1|||
129792964|NCT02290431|467209191|FG000|Overall Study|Adverse Event|20|||
129792965|NCT02290431|467209191|FG000|Overall Study|Progressive disease|4|||
129792966|NCT02290431|467209191|FG000|Overall Study|Study terminated by Sponsor|1|||
129792967|NCT02290431|467209191|FG000|Overall Study|Physician Decision|2|||
129792968|NCT00821327|467209192|FG000|Overall Study|Adverse Event|13|||
129792969|NCT00821327|467209192|FG000|Overall Study|Patient Request|1|||
129792970|NCT00821327|467209192|FG000|Overall Study|Investigator Request|2|||
129792971|NCT00821327|467209192|FG000|Overall Study|Sponsor Request|1|||
129792972|NCT00821327|467209192|FG000|Overall Study|Disease Progression|13|||
129792973|NCT00821327|467209192|FG000|Overall Study|Other/Unknown|5|||
129792974|NCT02119676|467209193|FG000|Overall Study|Adverse Event|9|||
129792975|NCT02119676|467209194|FG001|Overall Study|Adverse Event|17|||
129792976|NCT02119676|467209195|FG002|Overall Study|Adverse Event|10|||
129792977|NCT02119676|467209196|FG003|Overall Study|Adverse Event|10|||
129792978|NCT02119676|467209193|FG000|Overall Study|Disease progression|53|||
129792979|NCT02119676|467209194|FG001|Overall Study|Disease progression|55|||
129792980|NCT02119676|467209195|FG002|Overall Study|Disease progression|68|||
129792981|NCT02119676|467209196|FG003|Overall Study|Disease progression|73|||
129792982|NCT02119676|467209193|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
129792983|NCT02119676|467209194|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
129792984|NCT02119676|467209195|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
129792985|NCT02119676|467209196|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
129792986|NCT02119676|467209193|FG000|Overall Study|Physician Decision|4|||
129792987|NCT02119676|467209194|FG001|Overall Study|Physician Decision|2|||
129792988|NCT02119676|467209195|FG002|Overall Study|Physician Decision|3|||
130045108|NCT00491530|468121292|FG002|Overall Study|Patient Request|0|||
129792989|NCT02119676|467209196|FG003|Overall Study|Physician Decision|2|||
129792990|NCT02119676|467209193|FG000|Overall Study|Death|9|||
129792991|NCT02119676|467209194|FG001|Overall Study|Death|3|||
129792992|NCT02119676|467209195|FG002|Overall Study|Death|2|||
129792993|NCT02119676|467209196|FG003|Overall Study|Death|1|||
129792994|NCT02119676|467209193|FG000|Overall Study|Noncompliance|0|||
129792995|NCT02119676|467209194|FG001|Overall Study|Noncompliance|1|||
129792996|NCT02119676|467209195|FG002|Overall Study|Noncompliance|0|||
129792997|NCT02119676|467209196|FG003|Overall Study|Noncompliance|0|||
129792998|NCT02119676|467209193|FG000|Overall Study|Lost to Follow-up|0|||
130288853|NCT02761694|469019992|FG007|Overall Study|Physician Decision|0|||
129888142|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888143|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888144|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888145|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
130288854|NCT02761694|469019993|FG008|Overall Study|Physician Decision|0|||
130288855|NCT02761694|469019994|FG009|Overall Study|Physician Decision|0|||
130288856|NCT02761694|469019995|FG010|Overall Study|Physician Decision|0|||
130288857|NCT02761694|469019996|FG011|Overall Study|Physician Decision|0|||
129888146|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888147|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888148|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
129888149|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
129888150|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888151|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888152|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888153|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888154|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888155|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
130045109|NCT00491530|468121290|FG000|Overall Study|Use of Prohibited Medication|0|||
130045110|NCT00491530|468121291|FG001|Overall Study|Use of Prohibited Medication|0|||
130045111|NCT00491530|468121292|FG002|Overall Study|Use of Prohibited Medication|1|||
130045112|NCT01174784|468121293|FG000|Overall Study|Screen fails|4|||
130045113|NCT04601272|468121295|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
130045114|NCT04601272|468121296|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
130045115|NCT04601272|468121297|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
130045116|NCT00414440|468121300|FG000|Core Period|Withdrawal by Subject|70|||
130045117|NCT00414440|468121301|FG001|Core Period|Withdrawal by Subject|32|||
130045118|NCT00414440|468121300|FG000|Extension Period|Lost to Follow-up|44|||
130045119|NCT00414440|468121301|FG001|Extension Period|Lost to Follow-up|52|||
130045120|NCT00414440|468121300|FG000|Extension Period|Did not consent to continue follow up|61|||
130045121|NCT00414440|468121301|FG001|Extension Period|Did not consent to continue follow up|54|||
130045122|NCT00414440|468121300|FG000|Extension Period|Other|1|||
130045123|NCT00414440|468121301|FG001|Extension Period|Other|1|||
130045124|NCT00414440|468121300|FG000|Extension Period|Administrative|16|||
130045125|NCT00414440|468121301|FG001|Extension Period|Administrative|16|||
130045126|NCT00414440|468121300|FG000|Extension Period|Death|1|||
130045127|NCT00414440|468121301|FG001|Extension Period|Death|2|||
130045128|NCT00414440|468121300|FG000|Extension Period|Withdrawal by Subject|9|||
130045129|NCT00414440|468121301|FG001|Extension Period|Withdrawal by Subject|7|||
130045130|NCT00414440|468121300|FG000|Extension Period|Not included in follow up period|18|||
130045131|NCT00414440|468121301|FG001|Extension Period|Not included in follow up period|8|||
130045132|NCT02498821|468121302|FG000|Overall Study|Screen failure|3|||
130045133|NCT02498821|468121303|FG001|Overall Study|Screen failure|5|||
130045134|NCT01716169|468121304|FG000|Overall Study|Adverse Event|1|||
130045135|NCT01716169|468121304|FG000|Overall Study|Lost to Follow-up|1|||
130045136|NCT01716169|468121304|FG000|Overall Study|Withdrawal by Subject|1|||
130045137|NCT01716169|468121304|FG000|Overall Study|inconsistent dressing application|1|||
130045138|NCT02285010|468121305|FG000|Overall Study|not abdominal hysterectomy|2|||
130045139|NCT02285010|468121306|FG001|Overall Study|not abdominal hysterectomy|0|||
130045140|NCT02285010|468121305|FG000|Overall Study|Not spinal anesthesia|3|||
130045141|NCT02285010|468121306|FG001|Overall Study|Not spinal anesthesia|1|||
130045142|NCT05258058|468121322|FG000|Overall Study|Withdrawal by Subject|2|||
130045143|NCT02725177|468121328|FG000|Overall Study|Physician Decision|4|||
130045144|NCT02725177|468121328|FG000|Overall Study|Adverse Event|1|||
130045145|NCT00793585|468121329|FG000|Overall Study|Adverse Event|1|||
130045146|NCT00793585|468121330|FG001|Overall Study|Adverse Event|1|||
130045147|NCT00793585|468121329|FG000|Overall Study|Protocol Violation|1|||
130045148|NCT00793585|468121330|FG001|Overall Study|Protocol Violation|2|||
130045149|NCT00377299|468121331|FG000|Overall Study|Lost to Follow-up|14|||
130045150|NCT00377299|468121332|FG001|Overall Study|Lost to Follow-up|19|||
130045151|NCT00377299|468121331|FG000|Overall Study|Adverse Event|0|||
130045152|NCT00377299|468121332|FG001|Overall Study|Adverse Event|1|||
130045153|NCT00377299|468121331|FG000|Overall Study|Withdrawal by Subject|5|||
130045154|NCT00377299|468121332|FG001|Overall Study|Withdrawal by Subject|4|||
130045155|NCT02369510|468121337|FG000|Overall Study|Spilled Medication|1|||
130045156|NCT02369510|468121338|FG001|Overall Study|Spilled Medication|2|||
130045157|NCT02369510|468121339|FG002|Overall Study|Spilled Medication|1|||
130045158|NCT02369510|468121337|FG000|Overall Study|Epidural Activation|1|||
130288858|NCT02761694|469019985|FG000|Overall Study|Withdrawal by Subject|0|||
130045159|NCT02369510|468121338|FG001|Overall Study|Epidural Activation|1|||
130045160|NCT02369510|468121339|FG002|Overall Study|Epidural Activation|5|||
130045161|NCT04952389|468121340|FG000|Overall Study|Withdrawal by Subject|8|||
130288859|NCT02761694|469019986|FG001|Overall Study|Withdrawal by Subject|0|||
130045162|NCT04952389|468121341|FG001|Overall Study|Withdrawal by Subject|4|||
130045163|NCT02050048|468121342|FG000|Overall Study|Lost to Follow-up|0|||
130045164|NCT02050048|468121343|FG001|Overall Study|Lost to Follow-up|1|||
130045165|NCT02050048|468121342|FG000|Overall Study|Death|1|||
130045166|NCT02050048|468121343|FG001|Overall Study|Death|0|||
130045167|NCT02050048|468121342|FG000|Overall Study|Ineligible after ERCP|4|||
130045168|NCT02050048|468121343|FG001|Overall Study|Ineligible after ERCP|1|||
130045169|NCT01507246|468121346|FG000|Overall Study|Required different surgical procedures|2|||
130045170|NCT01507246|468121347|FG001|Overall Study|Required different surgical procedures|1|||
130045171|NCT02903511|468121348|FG000|Overall Study|Withdrawal by Subject|1|||
130045172|NCT02903511|468121349|FG001|Overall Study|Withdrawal by Subject|0|||
130045173|NCT02903511|468121348|FG000|Overall Study|Lost to Follow-up|3|||
130045174|NCT02903511|468121349|FG001|Overall Study|Lost to Follow-up|2|||
130045175|NCT02699515|468123094|FG000|Overall Study|Death|3|||
130045176|NCT02699515|468123095|FG001|Overall Study|Death|3|||
130045177|NCT02699515|468123096|FG002|Overall Study|Death|3|||
130045178|NCT02699515|468123097|FG003|Overall Study|Death|23|||
130045179|NCT02699515|468123098|FG004|Overall Study|Death|22|||
130045180|NCT02699515|468123099|FG005|Overall Study|Death|23|||
130045181|NCT02699515|468123100|FG006|Overall Study|Death|3|||
130045182|NCT02699515|468123101|FG007|Overall Study|Death|5|||
130045183|NCT02699515|468123094|FG000|Overall Study|Withdrawal by Subject|0|||
130045184|NCT02699515|468123095|FG001|Overall Study|Withdrawal by Subject|0|||
130045185|NCT02699515|468123096|FG002|Overall Study|Withdrawal by Subject|3|||
130045186|NCT02699515|468123097|FG003|Overall Study|Withdrawal by Subject|1|||
130045187|NCT02699515|468123098|FG004|Overall Study|Withdrawal by Subject|5|||
130045188|NCT02699515|468123099|FG005|Overall Study|Withdrawal by Subject|3|||
130045189|NCT02699515|468123100|FG006|Overall Study|Withdrawal by Subject|0|||
130045190|NCT02699515|468123101|FG007|Overall Study|Withdrawal by Subject|1|||
130045191|NCT02699515|468123094|FG000|Overall Study|Other|1|||
130045192|NCT02699515|468123095|FG001|Overall Study|Other|0|||
130045193|NCT02699515|468123096|FG002|Overall Study|Other|1|||
130045194|NCT02699515|468123097|FG003|Overall Study|Other|6|||
130045195|NCT02699515|468123098|FG004|Overall Study|Other|4|||
130045196|NCT02699515|468123099|FG005|Overall Study|Other|3|||
130045197|NCT02699515|468123100|FG006|Overall Study|Other|0|||
130045198|NCT02699515|468123101|FG007|Overall Study|Other|0|||
130045199|NCT00375934|468123102|FG000|Overall Study|Adverse Event|1|||
130045200|NCT00375934|468123103|FG001|Overall Study|Adverse Event|1|||
130045201|NCT00375934|468123102|FG000|Overall Study|Withdrawal by Subject|2|||
130045202|NCT00375934|468123103|FG001|Overall Study|Withdrawal by Subject|2|||
130045203|NCT00375934|468123102|FG000|Overall Study|Lack of Efficacy|0|||
130045204|NCT00375934|468123103|FG001|Overall Study|Lack of Efficacy|2|||
130045205|NCT00375934|468123102|FG000|Overall Study|Physician Decision|0|||
130045206|NCT00375934|468123103|FG001|Overall Study|Physician Decision|1|||
130045207|NCT01300286|468123104|FG000|Overall Study|did not get dosed|1|||
130045208|NCT02584634|468123109|FG000|Overall Study|Adverse Event|3|||
130045209|NCT02584634|468123110|FG001|Overall Study|Adverse Event|5|||
130045210|NCT02584634|468123109|FG000|Overall Study|Death|0|||
130288860|NCT02761694|469019987|FG002|Overall Study|Withdrawal by Subject|0|||
130288861|NCT02761694|469019988|FG003|Overall Study|Withdrawal by Subject|1|||
130288862|NCT02761694|469019989|FG004|Overall Study|Withdrawal by Subject|0|||
130288863|NCT02761694|469019990|FG005|Overall Study|Withdrawal by Subject|0|||
130288864|NCT02761694|469019991|FG006|Overall Study|Withdrawal by Subject|4|||
130288865|NCT02761694|469019992|FG007|Overall Study|Withdrawal by Subject|0|||
130288866|NCT02761694|469019993|FG008|Overall Study|Withdrawal by Subject|2|||
130045211|NCT02584634|468123110|FG001|Overall Study|Death|1|||
130045212|NCT02584634|468123109|FG000|Overall Study|Lost to Follow-up|0|||
130045213|NCT02584634|468123110|FG001|Overall Study|Lost to Follow-up|1|||
130288867|NCT02761694|469019994|FG009|Overall Study|Withdrawal by Subject|1|||
130288868|NCT02761694|469019995|FG010|Overall Study|Withdrawal by Subject|0|||
130288869|NCT02761694|469019996|FG011|Overall Study|Withdrawal by Subject|0|||
130288870|NCT02761694|469019985|FG000|Overall Study|Lost to Follow-up|0|||
130288871|NCT02761694|469019986|FG001|Overall Study|Lost to Follow-up|0|||
130288872|NCT02761694|469019987|FG002|Overall Study|Lost to Follow-up|0|||
130288873|NCT02761694|469019988|FG003|Overall Study|Lost to Follow-up|0|||
130288874|NCT02761694|469019989|FG004|Overall Study|Lost to Follow-up|0|||
130288875|NCT02761694|469019990|FG005|Overall Study|Lost to Follow-up|0|||
130045214|NCT02584634|468123109|FG000|Overall Study|Physician Decision|1|||
130045215|NCT02584634|468123110|FG001|Overall Study|Physician Decision|2|||
130045216|NCT02584634|468123109|FG000|Overall Study|Progressive disease|7|||
130045217|NCT02584634|468123110|FG001|Overall Study|Progressive disease|15|||
130045218|NCT02584634|468123109|FG000|Overall Study|Withdrawal by Subject|1|||
130045219|NCT02584634|468123110|FG001|Overall Study|Withdrawal by Subject|1|||
130288876|NCT02761694|469019991|FG006|Overall Study|Lost to Follow-up|1|||
130288877|NCT02761694|469019992|FG007|Overall Study|Lost to Follow-up|0|||
130045220|NCT02584634|468123109|FG000|Overall Study|Other|0|||
130045221|NCT02584634|468123110|FG001|Overall Study|Other|6|||
130045222|NCT00283712|468123111|FG000|Overall Study|Death|0|||
130045223|NCT00283712|468123112|FG001|Overall Study|Death|1|||
130288878|NCT02761694|469019993|FG008|Overall Study|Lost to Follow-up|0|||
130288879|NCT02761694|469019994|FG009|Overall Study|Lost to Follow-up|0|||
130288880|NCT02761694|469019995|FG010|Overall Study|Lost to Follow-up|0|||
130288881|NCT02761694|469019996|FG011|Overall Study|Lost to Follow-up|1|||
130288882|NCT02761694|469019985|FG000|Overall Study|Adverse Event|0|||
130288883|NCT02761694|469019986|FG001|Overall Study|Adverse Event|0|||
130288884|NCT02761694|469019987|FG002|Overall Study|Adverse Event|0|||
130288885|NCT02761694|469019988|FG003|Overall Study|Adverse Event|0|||
130288886|NCT02761694|469019989|FG004|Overall Study|Adverse Event|0|||
130288887|NCT02761694|469019990|FG005|Overall Study|Adverse Event|0|||
130288888|NCT02761694|469019991|FG006|Overall Study|Adverse Event|1|||
130288889|NCT02761694|469019992|FG007|Overall Study|Adverse Event|0|||
130288890|NCT02761694|469019993|FG008|Overall Study|Adverse Event|1|||
130288891|NCT02761694|469019994|FG009|Overall Study|Adverse Event|0|||
130288892|NCT02761694|469019995|FG010|Overall Study|Adverse Event|0|||
130288893|NCT02761694|469019996|FG011|Overall Study|Adverse Event|1|||
130288894|NCT02761694|469019985|FG000|Overall Study|Other|4|||
130288895|NCT02761694|469019986|FG001|Overall Study|Other|4|||
130288896|NCT02761694|469019987|FG002|Overall Study|Other|1|||
130288897|NCT02761694|469019988|FG003|Overall Study|Other|2|||
130288898|NCT02761694|469019989|FG004|Overall Study|Other|3|||
130288899|NCT02761694|469019990|FG005|Overall Study|Other|3|||
130288900|NCT02761694|469019991|FG006|Overall Study|Other|18|||
130288901|NCT02761694|469019992|FG007|Overall Study|Other|8|||
130288902|NCT02761694|469019993|FG008|Overall Study|Other|0|||
130288903|NCT02761694|469019994|FG009|Overall Study|Other|1|||
130288904|NCT02761694|469019995|FG010|Overall Study|Other|1|||
130288905|NCT02761694|469019996|FG011|Overall Study|Other|0|||
130288906|NCT02395055|469019997|FG000|Overall Study|Withdrawal by Subject|7|||
130288907|NCT02395055|469019998|FG001|Overall Study|Withdrawal by Subject|3|||
130288908|NCT04070326|469020002|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
130288909|NCT04070326|469020003|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
130288910|NCT00526110|469020007|FG000|Overall Study|Adverse Event|2|||
130288911|NCT00526110|469020008|FG001|Overall Study|Adverse Event|9|||
130288912|NCT00526110|469020007|FG000|Overall Study|Disease Progression|0|||
130288913|NCT00526110|469020008|FG001|Overall Study|Disease Progression|19|||
130288914|NCT00526110|469020007|FG000|Overall Study|Maximal Response|0|||
130288915|NCT00526110|469020008|FG001|Overall Study|Maximal Response|6|||
130288916|NCT00526110|469020007|FG000|Overall Study|Withdrawal by Subject|0|||
130288917|NCT00526110|469020008|FG001|Overall Study|Withdrawal by Subject|2|||
130288918|NCT00526110|469020007|FG000|Overall Study|Poor Tolerance|0|||
130288919|NCT00526110|469020008|FG001|Overall Study|Poor Tolerance|5|||
130288920|NCT03959982|469022008|FG000|Overall Study|Withdrawal by Subject|1|||
130288921|NCT03959982|469022009|FG001|Overall Study|Withdrawal by Subject|0|||
130288922|NCT03959982|469022008|FG000|Overall Study|Physician Decision|2|||
130288923|NCT03959982|469022009|FG001|Overall Study|Physician Decision|0|||
130288924|NCT03959982|469022008|FG000|Overall Study|Lost to Follow-up|1|||
130288925|NCT03959982|469022009|FG001|Overall Study|Lost to Follow-up|0|||
130288926|NCT00758589|469022010|FG000|Overall Study|Adverse Event|3|||
130288927|NCT00758589|469022011|FG001|Overall Study|Adverse Event|2|||
130288928|NCT00758589|469022012|FG002|Overall Study|Adverse Event|5|||
130288929|NCT00758589|469022013|FG003|Overall Study|Adverse Event|4|||
130288930|NCT00758589|469022010|FG000|Overall Study|Withdrawal by Subject|0|||
130288931|NCT00758589|469022011|FG001|Overall Study|Withdrawal by Subject|1|||
130288932|NCT00758589|469022012|FG002|Overall Study|Withdrawal by Subject|1|||
130288933|NCT00758589|469022013|FG003|Overall Study|Withdrawal by Subject|1|||
130288934|NCT00758589|469022010|FG000|Overall Study|Palm stopped to work|0|||
130288935|NCT00758589|469022011|FG001|Overall Study|Palm stopped to work|0|||
130288936|NCT00758589|469022012|FG002|Overall Study|Palm stopped to work|0|||
130288937|NCT00758589|469022013|FG003|Overall Study|Palm stopped to work|1|||
130288938|NCT05320393|469022014|FG000|Overall Study|Withdrawal by Subject|1|||
130288939|NCT05320393|469022015|FG001|Overall Study|Withdrawal by Subject|0|||
130288940|NCT05320393|469022016|FG002|Overall Study|Withdrawal by Subject|2|||
130288941|NCT05320393|469022014|FG000|Overall Study|Lost to Follow-up|1|||
130288942|NCT05320393|469022015|FG001|Overall Study|Lost to Follow-up|2|||
130288943|NCT05320393|469022016|FG002|Overall Study|Lost to Follow-up|1|||
130045224|NCT00098345|468123114|FG000|Overall Study|Adverse Event|7|||
130045225|NCT00098345|468123114|FG000|Overall Study|Withdrawal by Subject|2|||
130288944|NCT05320393|469022014|FG000|Overall Study|Moved; too much driving|0|||
130288945|NCT05320393|469022015|FG001|Overall Study|Moved; too much driving|0|||
130045226|NCT00098345|468123114|FG000|Overall Study|progression|4|||
130106458|NCT02913261|468350034|FG000|Overall Study|Disease relapse|8|||
130288946|NCT05320393|469022016|FG002|Overall Study|Moved; too much driving|2|||
130288947|NCT05320393|469022014|FG000|Overall Study|Did not receive treatment|0|||
130288948|NCT05320393|469022015|FG001|Overall Study|Did not receive treatment|0|||
130288949|NCT05320393|469022016|FG002|Overall Study|Did not receive treatment|1|||
130288950|NCT03559699|469022020|FG000|Overall Study|Withdrawal by Subject|6|||
130288951|NCT03559699|469022020|FG000|Overall Study|Lost to Follow-up|1|||
130288952|NCT05438602|469022025|FG000|Treatment (15 Days)|Adverse Event|2|||
130288953|NCT05438602|469022026|FG001|Treatment (15 Days)|Adverse Event|1|||
130288954|NCT05438602|469022027|FG002|Treatment (15 Days)|Adverse Event|3|||
130288955|NCT05438602|469022025|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
130288956|NCT05438602|469022026|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
130288957|NCT05438602|469022027|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
130288958|NCT05438602|469022025|FG000|Treatment (15 Days)|Other|0|||
130288959|NCT05438602|469022026|FG001|Treatment (15 Days)|Other|0|||
130288960|NCT05438602|469022027|FG002|Treatment (15 Days)|Other|1|||
130288961|NCT05438602|469022025|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
130288962|NCT05438602|469022026|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
130288963|NCT05438602|469022027|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
130288964|NCT05438602|469022025|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
130288965|NCT05438602|469022026|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
130288966|NCT05438602|469022027|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
130288967|NCT05438602|469022025|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
130288968|NCT05438602|469022026|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
130288969|NCT05438602|469022027|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
130288970|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
130288971|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
130288972|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
130288973|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
130288974|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
130288975|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
130288976|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
130288977|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
130288978|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
130288979|NCT05438602|469022025|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
130288980|NCT05438602|469022026|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
130288981|NCT05438602|469022027|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
130288982|NCT01930890|469022028|FG000|Overall Study|Study Termination|14|||
130288983|NCT01930890|469022029|FG001|Overall Study|Study Termination|28|||
130288984|NCT01930890|469022030|FG002|Overall Study|Study Termination|13|||
130288985|NCT01930890|469022031|FG003|Overall Study|Study Termination|25|||
130288986|NCT01930890|469022028|FG000|Overall Study|Death|0|||
130288987|NCT01930890|469022029|FG001|Overall Study|Death|0|||
130288988|NCT01930890|469022030|FG002|Overall Study|Death|0|||
130288989|NCT01930890|469022031|FG003|Overall Study|Death|1|||
130288990|NCT01930890|469022028|FG000|Overall Study|Investigator Decision|0|||
130288991|NCT01930890|469022029|FG001|Overall Study|Investigator Decision|1|||
130288992|NCT01930890|469022030|FG002|Overall Study|Investigator Decision|0|||
129792999|NCT02119676|467209194|FG001|Overall Study|Lost to Follow-up|0|||
129793000|NCT02119676|467209195|FG002|Overall Study|Lost to Follow-up|1|||
129793001|NCT02119676|467209196|FG003|Overall Study|Lost to Follow-up|0|||
129793002|NCT02119676|467209193|FG000|Overall Study|Protocol deviation|0|||
129793003|NCT02119676|467209194|FG001|Overall Study|Protocol deviation|0|||
129793004|NCT02119676|467209195|FG002|Overall Study|Protocol deviation|1|||
129793005|NCT02119676|467209196|FG003|Overall Study|Protocol deviation|0|||
130106459|NCT02913261|468350035|FG001|Overall Study|Disease relapse|13|||
130106460|NCT02913261|468350034|FG000|Overall Study|Physician Decision|8|||
130106461|NCT02913261|468350035|FG001|Overall Study|Physician Decision|9|||
130106462|NCT02913261|468350034|FG000|Overall Study|Subject/guardian decision|4|||
130106463|NCT02913261|468350035|FG001|Overall Study|Subject/guardian decision|6|||
130106464|NCT02913261|468350034|FG000|Overall Study|Graft loss|2|||
130106465|NCT02913261|468350035|FG001|Overall Study|Graft loss|0|||
130106466|NCT03022799|468350036|FG000|Overall Study|Adverse Event|0|||
130106467|NCT03022799|468350037|FG001|Overall Study|Adverse Event|0|||
130288993|NCT01930890|469022031|FG003|Overall Study|Investigator Decision|0|||
130288994|NCT01930890|469022028|FG000|Overall Study|Consent Withdrawn|0|||
130288995|NCT01930890|469022029|FG001|Overall Study|Consent Withdrawn|3|||
130106468|NCT03022799|468350038|FG002|Overall Study|Adverse Event|0|||
130288996|NCT01930890|469022030|FG002|Overall Study|Consent Withdrawn|0|||
130288997|NCT01930890|469022031|FG003|Overall Study|Consent Withdrawn|1|||
130288998|NCT01930890|469022028|FG000|Overall Study|Adverse Event|0|||
130288999|NCT01930890|469022029|FG001|Overall Study|Adverse Event|1|||
129793006|NCT02119676|467209193|FG000|Overall Study|Other, unspecified|2|||
129793007|NCT02119676|467209194|FG001|Overall Study|Other, unspecified|1|||
129793008|NCT02119676|467209195|FG002|Overall Study|Other, unspecified|3|||
129793009|NCT02119676|467209196|FG003|Overall Study|Other, unspecified|4|||
130106469|NCT03022799|468350039|FG003|Overall Study|Adverse Event|0|||
130289000|NCT01930890|469022030|FG002|Overall Study|Adverse Event|0|||
129793010|NCT02119676|467209193|FG000|Overall Study|Did not receive study med|2|||
129793011|NCT02119676|467209194|FG001|Overall Study|Did not receive study med|2|||
129793012|NCT02119676|467209195|FG002|Overall Study|Did not receive study med|4|||
129793013|NCT02119676|467209196|FG003|Overall Study|Did not receive study med|5|||
130106470|NCT03022799|468350040|FG004|Overall Study|Adverse Event|0|||
130289001|NCT01930890|469022031|FG003|Overall Study|Adverse Event|0|||
130289002|NCT01278407|469022032|FG000|Confirmatory Phase|Adverse Event|5|||
130045227|NCT03707977|468123117|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
130045228|NCT03707977|468123118|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
130045229|NCT03707977|468123119|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
130045230|NCT03707977|468123117|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
130045231|NCT03707977|468123118|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
130045232|NCT03707977|468123119|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
130045233|NCT02564120|468123120|FG000|Overall Study|Did not return release forms|160|||
130045234|NCT02564120|468123120|FG000|Overall Study|Death|58|||
130045235|NCT02564120|468123120|FG000|Overall Study|Withdrawal by Subject|204|||
130045236|NCT02564120|468123120|FG000|Overall Study|Other medical condition|24|||
130045237|NCT01966731|468123123|FG000|Overall Study|Death|2|||
130045238|NCT01966731|468123123|FG000|Overall Study|Lost to Follow-up|1|||
130045239|NCT01966731|468123123|FG000|Overall Study|Physician Decision|2|||
130289003|NCT01278407|469022033|FG001|Confirmatory Phase|Adverse Event|10|||
130289004|NCT01278407|469022034|FG002|Confirmatory Phase|Adverse Event|1|||
130045240|NCT01966731|468123123|FG000|Overall Study|Follow up is not complete|600|||
130045241|NCT01966731|468123123|FG000|Overall Study|Screening Failure|29|||
130045242|NCT01966731|468123123|FG000|Overall Study|Found to be ineligible|1|||
130045243|NCT01380093|468123125|FG000|Naloxone Challenge Phase|Screen failures|21|||
130045244|NCT01380093|468123126|FG001|Naloxone Challenge Phase|Screen failures|0|||
130045245|NCT01380093|468123127|FG002|Naloxone Challenge Phase|Screen failures|0|||
130045246|NCT01380093|468123128|FG003|Naloxone Challenge Phase|Screen failures|0|||
130045247|NCT01380093|468123129|FG004|Naloxone Challenge Phase|Screen failures|0|||
130045248|NCT01380093|468123130|FG005|Naloxone Challenge Phase|Screen failures|0|||
130045249|NCT01380093|468123131|FG006|Naloxone Challenge Phase|Screen failures|0|||
130045250|NCT01380093|468123132|FG007|Naloxone Challenge Phase|Screen failures|0|||
130045251|NCT01380093|468123133|FG008|Naloxone Challenge Phase|Screen failures|0|||
130045252|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045253|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
130045254|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045255|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045256|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045257|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045258|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130106471|NCT03022799|468350041|FG005|Overall Study|Adverse Event|0|||
130289005|NCT01278407|469022035|FG003|Confirmatory Phase|Adverse Event|0|||
130289006|NCT01278407|469022036|FG004|Confirmatory Phase|Adverse Event|0|||
130289007|NCT01278407|469022032|FG000|Confirmatory Phase|Participant's Choice|3|||
130289008|NCT01278407|469022033|FG001|Confirmatory Phase|Participant's Choice|5|||
130289009|NCT01278407|469022034|FG002|Confirmatory Phase|Participant's Choice|3|||
130289010|NCT01278407|469022035|FG003|Confirmatory Phase|Participant's Choice|0|||
130289011|NCT01278407|469022036|FG004|Confirmatory Phase|Participant's Choice|0|||
129793014|NCT00219544|467209197|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
129793015|NCT00219544|467209198|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
129793016|NCT00219544|467209197|FG000|Single Blind Treatment Period|Adverse Event|9|||
129793017|NCT00219544|467209198|FG001|Single Blind Treatment Period|Adverse Event|0|||
129793018|NCT00219544|467209197|FG000|Single Blind Treatment Period|Protocol Violation|4|||
129793019|NCT00219544|467209198|FG001|Single Blind Treatment Period|Protocol Violation|0|||
129793020|NCT00219544|467209197|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
130289012|NCT01278407|469022032|FG000|Confirmatory Phase|Other|1|||
130289013|NCT01278407|469022033|FG001|Confirmatory Phase|Other|1|||
130289014|NCT01278407|469022034|FG002|Confirmatory Phase|Other|2|||
130289015|NCT01278407|469022035|FG003|Confirmatory Phase|Other|0|||
130289016|NCT01278407|469022036|FG004|Confirmatory Phase|Other|0|||
130289017|NCT01278407|469022032|FG000|Extension Phase|Adverse Event|0|||
130289018|NCT01278407|469022033|FG001|Extension Phase|Adverse Event|0|||
130289019|NCT01278407|469022034|FG002|Extension Phase|Adverse Event|0|||
130289020|NCT01278407|469022035|FG003|Extension Phase|Adverse Event|7|||
130289021|NCT01278407|469022036|FG004|Extension Phase|Adverse Event|16|||
130289022|NCT01278407|469022032|FG000|Extension Phase|Participant's Choice|0|||
130289023|NCT01278407|469022033|FG001|Extension Phase|Participant's Choice|0|||
130289024|NCT01278407|469022034|FG002|Extension Phase|Participant's Choice|0|||
130289025|NCT01278407|469022035|FG003|Extension Phase|Participant's Choice|4|||
130289026|NCT01278407|469022036|FG004|Extension Phase|Participant's Choice|11|||
130045259|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045260|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
130045261|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130106472|NCT03022799|468350042|FG006|Overall Study|Adverse Event|0|||
130289027|NCT01278407|469022032|FG000|Extension Phase|Other|0|||
130289028|NCT01278407|469022033|FG001|Extension Phase|Other|0|||
130289029|NCT01278407|469022034|FG002|Extension Phase|Other|0|||
130289030|NCT01278407|469022035|FG003|Extension Phase|Other|1|||
130289031|NCT01278407|469022036|FG004|Extension Phase|Other|3|||
130289032|NCT02534935|469022037|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
130289033|NCT02534935|469022038|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
130289034|NCT02534935|469022039|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
130289035|NCT02534935|469022037|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
130289036|NCT02534935|469022038|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
130289037|NCT02534935|469022039|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
130289038|NCT02534935|469022037|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
130289039|NCT02534935|469022038|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
130289040|NCT02534935|469022039|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
130289041|NCT02534935|469022037|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
130289042|NCT02534935|469022038|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
130289043|NCT02534935|469022039|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
130289044|NCT02534935|469022037|FG000|Stage 1: 24 Months|Adverse Event|0|||
130289045|NCT02534935|469022038|FG001|Stage 1: 24 Months|Adverse Event|2|||
130289046|NCT02534935|469022039|FG002|Stage 1: 24 Months|Adverse Event|0|||
130289047|NCT02534935|469022037|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
130289048|NCT02534935|469022038|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
130289049|NCT02534935|469022039|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
130289050|NCT02534935|469022037|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
130289051|NCT02534935|469022038|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
130289052|NCT02534935|469022039|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
130289053|NCT01460719|469022040|FG000|Overall Study|Adverse Event|1|||
130289054|NCT01460719|469022040|FG000|Overall Study|Withdrawal by Subject|1|||
130289055|NCT00076336|469022044|FG000|Overall Study|Death|13|||
130289056|NCT00076336|469022045|FG001|Overall Study|Death|17|||
130289057|NCT00076336|469022044|FG000|Overall Study|Adverse Event|4|||
130289058|NCT00076336|469022045|FG001|Overall Study|Adverse Event|4|||
130289059|NCT00076336|469022044|FG000|Overall Study|Lost to Follow-up|4|||
130289060|NCT00076336|469022045|FG001|Overall Study|Lost to Follow-up|4|||
130289061|NCT00076336|469022044|FG000|Overall Study|Non-Compliance|2|||
130289062|NCT00076336|469022045|FG001|Overall Study|Non-Compliance|0|||
130289063|NCT00076336|469022044|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
130289064|NCT00076336|469022045|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
130289065|NCT00076336|469022044|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
130289066|NCT00076336|469022045|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
130289067|NCT00076336|469022044|FG000|Overall Study|Liver Transplantation|3|||
130289068|NCT00076336|469022045|FG001|Overall Study|Liver Transplantation|3|||
130289069|NCT00076336|469022044|FG000|Overall Study|Virologic Breakthrough|14|||
130289070|NCT00076336|469022045|FG001|Overall Study|Virologic Breakthrough|16|||
130289071|NCT00076336|469022044|FG000|Overall Study|Treatment failure|4|||
130289072|NCT00076336|469022045|FG001|Overall Study|Treatment failure|5|||
130289073|NCT02838901|469022046|FG000|Overall Study|Withdrawal by Subject|1|||
130289074|NCT02838901|469022047|FG001|Overall Study|Withdrawal by Subject|1|||
130289075|NCT02838901|469022046|FG000|Overall Study|Lost to Follow-up|1|||
130289076|NCT02838901|469022047|FG001|Overall Study|Lost to Follow-up|1|||
130289077|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
130289078|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
130289079|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
130289080|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
130289081|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
130289082|NCT01224821|469022052|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
130289083|NCT01224821|469022052|FG000|Long-Term Follow-Up|Death|2|||
129793021|NCT00219544|467209198|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
129793022|NCT00219544|467209197|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
129793023|NCT00219544|467209198|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
129793024|NCT00219544|467209197|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
129793025|NCT00219544|467209198|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
129793026|NCT01007253|467209201|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
129793027|NCT01007253|467209202|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
129793028|NCT01007253|467209203|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
129793029|NCT01007253|467209204|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
130289084|NCT01224821|469022052|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
130289085|NCT00623545|469022053|FG000|Overall Study|Adverse Event|6|||
130289086|NCT00623545|469022053|FG000|Overall Study|Withdrawal by Subject|4|||
130289087|NCT02585830|469022060|FG000|Overall Study|Withdrawal by Subject|3|||
130289088|NCT03276052|469022064|FG000|Overall Study|Withdrawal by Subject|5|||
130289089|NCT03276052|469022064|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
130289090|NCT03220581|469022066|FG000|Overall Study|Withdrawal by Subject|0|||
130289091|NCT03220581|469022067|FG001|Overall Study|Withdrawal by Subject|1|||
130289092|NCT03220581|469022066|FG000|Overall Study|Lost to Follow-up|3|||
130289093|NCT03220581|469022067|FG001|Overall Study|Lost to Follow-up|6|||
130289094|NCT00919867|469022068|FG000|First Intervention|Withdrawal by Subject|0|||
130289095|NCT00919867|469022069|FG001|First Intervention|Withdrawal by Subject|0|||
130289096|NCT00919867|469022070|FG002|First Intervention|Withdrawal by Subject|1|||
130289097|NCT00919867|469022071|FG003|First Intervention|Withdrawal by Subject|0|||
130289098|NCT00919867|469022072|FG004|First Intervention|Withdrawal by Subject|0|||
130289099|NCT00919867|469022073|FG005|First Intervention|Withdrawal by Subject|0|||
130289100|NCT00919867|469022068|FG000|First Intervention|Physician Decision|0|||
130289101|NCT00919867|469022069|FG001|First Intervention|Physician Decision|0|||
130289102|NCT00919867|469022070|FG002|First Intervention|Physician Decision|0|||
130289103|NCT00919867|469022071|FG003|First Intervention|Physician Decision|0|||
129793030|NCT00814801|467209205|FG000|Overall Study|Adverse Event|15|||
130289104|NCT00919867|469022072|FG004|First Intervention|Physician Decision|0|||
130289105|NCT00919867|469022073|FG005|First Intervention|Physician Decision|1|||
130289106|NCT00435162|469022074|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
130289107|NCT00435162|469022075|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
130289108|NCT00435162|469022076|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
130289109|NCT00435162|469022077|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
130289110|NCT00435162|469022078|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
130289111|NCT00435162|469022079|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
130289112|NCT01765426|469022082|FG000|Overall Study|Lost to Follow-up|0|||
130289113|NCT01765426|469022083|FG001|Overall Study|Lost to Follow-up|1|||
130289114|NCT01765426|469022084|FG002|Overall Study|Lost to Follow-up|0|||
130289115|NCT01765426|469022085|FG003|Overall Study|Lost to Follow-up|0|||
130289116|NCT01510184|469022086|FG000|Overall Study|Sponsor discretion|28|||
130289117|NCT01510184|469022087|FG001|Overall Study|Sponsor discretion|28|||
130289118|NCT01510184|469022086|FG000|Overall Study|Death|1|||
130289119|NCT01510184|469022087|FG001|Overall Study|Death|2|||
130289120|NCT01510184|469022086|FG000|Overall Study|Withdrawal by Subject|1|||
130289121|NCT01510184|469022087|FG001|Overall Study|Withdrawal by Subject|4|||
130289122|NCT01510184|469022086|FG000|Overall Study|Other|0|||
130289123|NCT01510184|469022087|FG001|Overall Study|Other|1|||
130289124|NCT01484834|469022098|FG000|Overall Study|Lost to Follow-up|5|||
130289125|NCT01484834|469022099|FG001|Overall Study|Lost to Follow-up|8|||
130289126|NCT01484834|469022100|FG002|Overall Study|Lost to Follow-up|1|||
130289127|NCT01484834|469022101|FG003|Overall Study|Lost to Follow-up|4|||
130289128|NCT00747344|469022102|FG000|Controlled Period|Adverse Event|3|||
130289129|NCT00747344|469022103|FG001|Controlled Period|Adverse Event|0|||
130289130|NCT00747344|469022104|FG002|Controlled Period|Adverse Event|0|||
130289131|NCT00747344|469022105|FG003|Controlled Period|Adverse Event|0|||
130289132|NCT00747344|469022102|FG000|Controlled Period|Lack of Efficacy|2|||
130289133|NCT00747344|469022103|FG001|Controlled Period|Lack of Efficacy|1|||
130289134|NCT00747344|469022104|FG002|Controlled Period|Lack of Efficacy|0|||
130289135|NCT00747344|469022105|FG003|Controlled Period|Lack of Efficacy|0|||
130289136|NCT00747344|469022102|FG000|Controlled Period|Other|0|||
130289137|NCT00747344|469022103|FG001|Controlled Period|Other|3|||
130289138|NCT00747344|469022104|FG002|Controlled Period|Other|0|||
130289139|NCT00747344|469022105|FG003|Controlled Period|Other|0|||
130289140|NCT00747344|469022102|FG000|After Controlled Period|Adverse Event|0|||
130289141|NCT00747344|469022103|FG001|After Controlled Period|Adverse Event|0|||
130289142|NCT00747344|469022104|FG002|After Controlled Period|Adverse Event|0|||
130289143|NCT00747344|469022105|FG003|After Controlled Period|Adverse Event|1|||
130289144|NCT00765882|469022106|FG000|Overall Study|Adverse Event|10|||
130289145|NCT00765882|469022107|FG001|Overall Study|Adverse Event|21|||
130289146|NCT00765882|469022108|FG002|Overall Study|Adverse Event|20|||
130289147|NCT00765882|469022106|FG000|Overall Study|Lack of Efficacy|4|||
130289148|NCT00765882|469022107|FG001|Overall Study|Lack of Efficacy|0|||
130289149|NCT00765882|469022108|FG002|Overall Study|Lack of Efficacy|1|||
130289150|NCT00765882|469022106|FG000|Overall Study|Protocol Violation|4|||
129793031|NCT00814801|467209206|FG001|Overall Study|Adverse Event|16|||
129793032|NCT00814801|467209207|FG002|Overall Study|Adverse Event|19|||
129793033|NCT00814801|467209205|FG000|Overall Study|Withdrawal by Subject|9|||
130289151|NCT00765882|469022107|FG001|Overall Study|Protocol Violation|3|||
130289152|NCT00765882|469022108|FG002|Overall Study|Protocol Violation|1|||
130289153|NCT00765882|469022106|FG000|Overall Study|Withdrawal by Subject|2|||
130289154|NCT00765882|469022107|FG001|Overall Study|Withdrawal by Subject|6|||
130289155|NCT00765882|469022108|FG002|Overall Study|Withdrawal by Subject|6|||
130289156|NCT00765882|469022106|FG000|Overall Study|Lost to Follow-up|1|||
130289157|NCT00765882|469022107|FG001|Overall Study|Lost to Follow-up|9|||
130289158|NCT00765882|469022108|FG002|Overall Study|Lost to Follow-up|6|||
130289159|NCT00765882|469022106|FG000|Overall Study|Other Reason|3|||
130289160|NCT00765882|469022107|FG001|Overall Study|Other Reason|1|||
130289161|NCT00765882|469022108|FG002|Overall Study|Other Reason|2|||
130289162|NCT02231762|469022109|FG000|Combination Phase|Adverse Event|10|||
130289163|NCT02231762|469022110|FG001|Combination Phase|Adverse Event|0|||
130289164|NCT02231762|469022111|FG002|Combination Phase|Adverse Event|0|||
130289165|NCT02231762|469022112|FG003|Combination Phase|Adverse Event|0|||
130289166|NCT02231762|469022109|FG000|Combination Phase|Withdrawal by Subject|2|||
130289167|NCT02231762|469022110|FG001|Combination Phase|Withdrawal by Subject|0|||
130289168|NCT02231762|469022111|FG002|Combination Phase|Withdrawal by Subject|0|||
130289169|NCT02231762|469022112|FG003|Combination Phase|Withdrawal by Subject|0|||
130289170|NCT02231762|469022109|FG000|Combination Phase|Disease Progression|6|||
130289171|NCT02231762|469022110|FG001|Combination Phase|Disease Progression|0|||
130289172|NCT02231762|469022111|FG002|Combination Phase|Disease Progression|0|||
130289173|NCT02231762|469022112|FG003|Combination Phase|Disease Progression|0|||
130289174|NCT02231762|469022109|FG000|Combination Phase|Did not meet inclusion criteria|1|||
130289175|NCT02231762|469022110|FG001|Combination Phase|Did not meet inclusion criteria|0|||
130289176|NCT02231762|469022111|FG002|Combination Phase|Did not meet inclusion criteria|0|||
130289177|NCT02231762|469022112|FG003|Combination Phase|Did not meet inclusion criteria|0|||
130289178|NCT02231762|469022109|FG000|Combination Phase|Protocol Violation|1|||
130289179|NCT02231762|469022110|FG001|Combination Phase|Protocol Violation|0|||
130289180|NCT02231762|469022111|FG002|Combination Phase|Protocol Violation|0|||
130289181|NCT02231762|469022112|FG003|Combination Phase|Protocol Violation|0|||
130289182|NCT02231762|469022109|FG000|Maintenance Phase|Disease progression|0|||
130289183|NCT02231762|469022110|FG001|Maintenance Phase|Disease progression|3|||
130289184|NCT02231762|469022111|FG002|Maintenance Phase|Disease progression|4|||
130289185|NCT02231762|469022112|FG003|Maintenance Phase|Disease progression|3|||
130289186|NCT02231762|469022109|FG000|Maintenance Phase|Adverse Event|0|||
130289187|NCT02231762|469022110|FG001|Maintenance Phase|Adverse Event|0|||
130289188|NCT02231762|469022111|FG002|Maintenance Phase|Adverse Event|1|||
130289189|NCT02231762|469022112|FG003|Maintenance Phase|Adverse Event|2|||
130289190|NCT01799239|469022113|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
130289191|NCT01799239|469022114|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
130289192|NCT01799239|469022113|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
130289193|NCT01799239|469022114|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
130289194|NCT01799239|469022113|FG000|Period 1 (7 Days)|Protocol Violation|0|||
130289195|NCT01799239|469022114|FG001|Period 1 (7 Days)|Protocol Violation|1|||
129888156|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888157|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
129888158|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
129888159|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888160|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888161|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888162|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888163|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888164|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888165|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888166|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888167|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888168|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888169|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
129888170|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888171|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888172|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888173|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888174|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888175|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888176|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888177|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888178|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
129888179|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
129888180|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
129888181|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888182|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
130045262|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
130045263|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
130045264|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130106473|NCT03022799|468350043|FG007|Overall Study|Adverse Event|0|||
130289196|NCT01799239|469022113|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
130289197|NCT01799239|469022114|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
130289198|NCT01799239|469022113|FG000|Period 2 (7 Days)|Protocol Violation|1|||
130289199|NCT01799239|469022114|FG001|Period 2 (7 Days)|Protocol Violation|0|||
130289200|NCT01286987|469022118|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
130289201|NCT01286987|469022119|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
130289202|NCT01286987|469022120|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
130289203|NCT01286987|469022121|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
130289204|NCT01286987|469022122|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
129888183|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888184|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888185|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888186|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888187|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888188|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
129888189|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
129888190|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888191|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888192|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888193|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888194|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888195|NCT02018861|467549120|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888196|NCT02018861|467549121|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888197|NCT02018861|467549122|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888198|NCT02018861|467549123|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888199|NCT02018861|467549124|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888200|NCT02018861|467549125|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888201|NCT02018861|467549126|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
129888202|NCT02018861|467549127|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
129888203|NCT02018861|467549128|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888204|NCT02018861|467549129|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888205|NCT02018861|467549120|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888206|NCT02018861|467549121|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888207|NCT02018861|467549122|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888208|NCT02018861|467549123|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888209|NCT02018861|467549124|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888210|NCT02018861|467549125|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888211|NCT02018861|467549126|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
129888212|NCT02018861|467549127|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
129888213|NCT02018861|467549128|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
130045265|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130045266|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130045267|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129793034|NCT00814801|467209206|FG001|Overall Study|Withdrawal by Subject|11|||
129793035|NCT00814801|467209207|FG002|Overall Study|Withdrawal by Subject|14|||
129793036|NCT00814801|467209205|FG000|Overall Study|Inappropriate as a subject|1|||
129793037|NCT00814801|467209206|FG001|Overall Study|Inappropriate as a subject|1|||
129793038|NCT00814801|467209207|FG002|Overall Study|Inappropriate as a subject|1|||
129793039|NCT00814801|467209205|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
129793040|NCT00814801|467209206|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
129793041|NCT00814801|467209207|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
129793042|NCT00814801|467209205|FG000|Overall Study|Missing or change of caregiver|6|||
129793043|NCT00814801|467209206|FG001|Overall Study|Missing or change of caregiver|2|||
129793044|NCT00814801|467209207|FG002|Overall Study|Missing or change of caregiver|4|||
129793045|NCT00814801|467209205|FG000|Overall Study|Non-compliance|0|||
129793046|NCT00814801|467209206|FG001|Overall Study|Non-compliance|1|||
129793047|NCT00814801|467209207|FG002|Overall Study|Non-compliance|1|||
129793048|NCT00814801|467209205|FG000|Overall Study|Other|2|||
129793049|NCT00814801|467209206|FG001|Overall Study|Other|6|||
129793050|NCT00814801|467209207|FG002|Overall Study|Other|4|||
129793051|NCT00586664|467209208|FG000|Overall Study|Withdrawal by Subject|3|||
129793052|NCT00586664|467209209|FG001|Overall Study|Withdrawal by Subject|7|||
129793053|NCT00586664|467209210|FG002|Overall Study|Withdrawal by Subject|1|||
129793054|NCT00586664|467209208|FG000|Overall Study|Exclusion criteria met|2|||
129793055|NCT00586664|467209209|FG001|Overall Study|Exclusion criteria met|0|||
129793056|NCT00586664|467209210|FG002|Overall Study|Exclusion criteria met|0|||
129793057|NCT02751931|467209211|FG000|Overall Study|Adverse Event|3|||
129793058|NCT02751931|467209212|FG001|Overall Study|Adverse Event|0|||
129793059|NCT02751931|467209211|FG000|Overall Study|Other: Miscelleneous|10|||
129793060|NCT02751931|467209212|FG001|Overall Study|Other: Miscelleneous|8|||
129793061|NCT01037088|467209213|FG000|Overall Study|Withdrawal by Subject|3|||
129793062|NCT01585584|467209214|FG000|Overall Study|Lack of Efficacy|1|||
129793063|NCT01585584|467209214|FG000|Overall Study|Withdrawal by Subject|1|||
129793064|NCT01585584|467209214|FG000|Overall Study|Physician Decision|2|||
129793065|NCT00266864|467209215|FG000|Overall Study|Lost to Follow-up|4|||
129793066|NCT00266864|467209216|FG001|Overall Study|Lost to Follow-up|1|||
129793067|NCT00266864|467209215|FG000|Overall Study|Withdrawal by Subject|1|||
130289205|NCT01286987|469022123|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
130289206|NCT01286987|469022124|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
130289207|NCT01286987|469022125|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
130289208|NCT01286987|469022126|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
130289209|NCT01286987|469022127|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
130289210|NCT01286987|469022128|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
130289211|NCT01286987|469022129|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
130289212|NCT01286987|469022130|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
130289213|NCT01286987|469022131|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
130289214|NCT01286987|469022132|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
130289215|NCT01286987|469022118|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
130289216|NCT01286987|469022119|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
130289217|NCT01286987|469022120|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
130289218|NCT01286987|469022121|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
130289219|NCT01286987|469022122|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
130289220|NCT01286987|469022123|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
130289221|NCT01286987|469022124|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
130289222|NCT01286987|469022125|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
130289223|NCT01286987|469022126|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
130289224|NCT01286987|469022127|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
130289225|NCT01286987|469022128|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
130289226|NCT01286987|469022129|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
130289227|NCT01286987|469022130|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
130289228|NCT01286987|469022131|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
130289229|NCT01286987|469022132|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
130289230|NCT01286987|469022118|FG000|Part 1: Dose Escalation|Physician Decision|0|||
130289231|NCT01286987|469022119|FG001|Part 1: Dose Escalation|Physician Decision|0|||
130289232|NCT01286987|469022120|FG002|Part 1: Dose Escalation|Physician Decision|0|||
130289233|NCT01286987|469022121|FG003|Part 1: Dose Escalation|Physician Decision|0|||
130289234|NCT01286987|469022122|FG004|Part 1: Dose Escalation|Physician Decision|1|||
130289235|NCT01286987|469022123|FG005|Part 1: Dose Escalation|Physician Decision|0|||
129793068|NCT00266864|467209216|FG001|Overall Study|Withdrawal by Subject|1|||
129793069|NCT03036800|467209217|FG000|Overall Study|Protocol Violation|1|||
130289236|NCT01286987|469022124|FG006|Part 1: Dose Escalation|Physician Decision|0|||
130289237|NCT01286987|469022125|FG007|Part 1: Dose Escalation|Physician Decision|0|||
130289238|NCT01286987|469022126|FG008|Part 1: Dose Escalation|Physician Decision|0|||
130289239|NCT01286987|469022127|FG009|Part 1: Dose Escalation|Physician Decision|0|||
130289240|NCT01286987|469022128|FG010|Part 1: Dose Escalation|Physician Decision|0|||
130289241|NCT01286987|469022129|FG011|Part 1: Dose Escalation|Physician Decision|0|||
130289242|NCT01286987|469022130|FG012|Part 1: Dose Escalation|Physician Decision|0|||
130289243|NCT01286987|469022131|FG013|Part 1: Dose Escalation|Physician Decision|0|||
130289244|NCT01286987|469022132|FG014|Part 1: Dose Escalation|Physician Decision|0|||
130289245|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Death|0|||
130289246|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Death|0|||
130289247|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Death|0|||
130289248|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Death|0|||
130289249|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Death|0|||
130289250|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Death|0|||
130289251|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Death|0|||
130289252|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Death|0|||
130289253|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Death|0|||
130289254|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Death|0|||
130289255|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Death|0|||
130289256|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Death|0|||
130289257|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Death|1|||
130289258|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Death|1|||
130289259|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Death|0|||
130289260|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Physician Decision|0|||
130289261|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Physician Decision|0|||
130289262|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Physician Decision|0|||
129793070|NCT03036800|467209218|FG001|Overall Study|Protocol Violation|0|||
129793071|NCT03036800|467209217|FG000|Overall Study|Non-compliance|1|||
129793072|NCT03036800|467209218|FG001|Overall Study|Non-compliance|0|||
129793073|NCT03036800|467209217|FG000|Overall Study|Lost to Follow-up|1|||
129793074|NCT03036800|467209218|FG001|Overall Study|Lost to Follow-up|0|||
129793075|NCT03036800|467209217|FG000|Overall Study|Death|1|||
130045268|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130289263|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Physician Decision|0|||
130289264|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Physician Decision|0|||
130289265|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Physician Decision|0|||
130289266|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Physician Decision|0|||
130289267|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Physician Decision|0|||
130289268|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Physician Decision|0|||
130289269|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Physician Decision|0|||
130045269|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
130045270|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045271|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
130045272|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045273|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045274|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045275|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045276|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045277|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130289270|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Physician Decision|1|||
130289271|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Physician Decision|1|||
130289272|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Physician Decision|0|||
130289273|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Physician Decision|1|||
130045278|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
130045279|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045280|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
130045281|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
130045282|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045283|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045284|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045285|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045286|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045287|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
130045288|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045289|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
130045290|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
130045291|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045292|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045293|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045294|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045295|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045296|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
130045297|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045298|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045299|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
130106474|NCT03022799|468350044|FG008|Overall Study|Adverse Event|0|||
130106475|NCT03022799|468350045|FG009|Overall Study|Adverse Event|1|||
130289274|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Physician Decision|0|||
130289275|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Other|0|||
130289276|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Other|0|||
130289277|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Other|0|||
130289278|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Other|0|||
130289279|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Other|0|||
130289280|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Other|0|||
130289281|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Other|0|||
130289282|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Other|0|||
130289283|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Other|0|||
130289284|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Other|0|||
130289285|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Other|0|||
130289286|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Other|0|||
130289287|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Other|0|||
130289288|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Other|1|||
130289289|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Other|0|||
130289290|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
130289291|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
130289292|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
130289293|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
130289294|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
130289295|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
130289296|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
130289297|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
130289298|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
130289299|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
130289300|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
130289301|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
130289302|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
130289303|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
130289304|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
130289305|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
130289306|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
130289307|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
129793076|NCT03036800|467209218|FG001|Overall Study|Death|0|||
129793077|NCT03036800|467209217|FG000|Overall Study|Tolerance|5|||
129793078|NCT03036800|467209218|FG001|Overall Study|Tolerance|0|||
129793079|NCT03036800|467209217|FG000|Overall Study|Unknown/no reason given|50|||
129793080|NCT03036800|467209218|FG001|Overall Study|Unknown/no reason given|39|||
129793081|NCT01077154|467209219|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
129793082|NCT01077154|467209220|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
129793083|NCT01077154|467209219|FG000|Overall Study|Withdrawal by Subject|369|||
129793084|NCT01077154|467209220|FG001|Overall Study|Withdrawal by Subject|385|||
129793085|NCT01077154|467209219|FG000|Overall Study|Death|215|||
129793086|NCT01077154|467209220|FG001|Overall Study|Death|214|||
129793087|NCT01077154|467209219|FG000|Overall Study|Lost to Follow-up|43|||
129793088|NCT01077154|467209220|FG001|Overall Study|Lost to Follow-up|35|||
129793089|NCT01077154|467209219|FG000|Overall Study|Noncompliance|22|||
129793090|NCT01077154|467209220|FG001|Overall Study|Noncompliance|20|||
129793091|NCT01077154|467209219|FG000|Overall Study|Disease Progression|18|||
129793092|NCT01077154|467209220|FG001|Overall Study|Disease Progression|20|||
129793093|NCT01077154|467209219|FG000|Overall Study|Ineligibility Determined|10|||
129793094|NCT01077154|467209220|FG001|Overall Study|Ineligibility Determined|14|||
129793095|NCT01077154|467209219|FG000|Overall Study|Other|14|||
129793096|NCT01077154|467209220|FG001|Overall Study|Other|11|||
129793097|NCT01077154|467209219|FG000|Overall Study|Adverse Event|9|||
129793098|NCT01077154|467209220|FG001|Overall Study|Adverse Event|9|||
129793099|NCT01077154|467209219|FG000|Overall Study|Administrative Decision|1|||
129793100|NCT01077154|467209220|FG001|Overall Study|Administrative Decision|6|||
129793101|NCT01077154|467209219|FG000|Overall Study|Protocol Deviation|1|||
129793102|NCT01077154|467209220|FG001|Overall Study|Protocol Deviation|0|||
129793103|NCT00686998|467209221|FG000|Overall Study|Adverse Event|3|||
129793104|NCT00686998|467209222|FG001|Overall Study|Adverse Event|2|||
129793105|NCT00686998|467209223|FG002|Overall Study|Adverse Event|1|||
129793106|NCT00686998|467209221|FG000|Overall Study|Withdrawal by Subject|2|||
129793107|NCT00686998|467209222|FG001|Overall Study|Withdrawal by Subject|1|||
129793108|NCT00686998|467209223|FG002|Overall Study|Withdrawal by Subject|2|||
129793109|NCT00686998|467209221|FG000|Overall Study|Lack of Efficacy|7|||
129793110|NCT00686998|467209222|FG001|Overall Study|Lack of Efficacy|5|||
129793111|NCT00686998|467209223|FG002|Overall Study|Lack of Efficacy|0|||
129793112|NCT00686998|467209221|FG000|Overall Study|Other|0|||
129793113|NCT00686998|467209222|FG001|Overall Study|Other|0|||
129793114|NCT00686998|467209223|FG002|Overall Study|Other|1|||
129793115|NCT00686998|467209221|FG000|Overall Study|Safety Reasons|1|||
129793116|NCT00686998|467209222|FG001|Overall Study|Safety Reasons|0|||
129793117|NCT00686998|467209223|FG002|Overall Study|Safety Reasons|0|||
129793118|NCT00371761|467210681|FG000|Overall Study|Adverse Event|1|||
129793119|NCT00371761|467210682|FG001|Overall Study|Adverse Event|1|||
129793120|NCT00371761|467210681|FG000|Overall Study|Withdrawal by Subject|1|||
129793121|NCT00371761|467210682|FG001|Overall Study|Withdrawal by Subject|3|||
129793122|NCT00371761|467210681|FG000|Overall Study|Investigator Judgment|2|||
129793123|NCT00371761|467210682|FG001|Overall Study|Investigator Judgment|3|||
129793124|NCT00371761|467210681|FG000|Overall Study|Study termination|4|||
130289308|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
130289309|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
130289310|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
129793125|NCT00371761|467210682|FG001|Overall Study|Study termination|3|||
129793126|NCT01736657|467210689|FG000|Overall Study|insufficient vascular access|1|||
129793127|NCT00997438|467210700|FG000|Overall Study|Blood draw difficulty|2|||
129793128|NCT00997438|467210701|FG001|Overall Study|Blood draw difficulty|0|||
129793129|NCT00997438|467210702|FG002|Overall Study|Blood draw difficulty|1|||
130045300|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045301|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045302|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045303|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045304|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045305|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
130045306|NCT01380093|468123125|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045307|NCT01380093|468123126|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045308|NCT01380093|468123127|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
130045309|NCT01380093|468123128|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045310|NCT01380093|468123129|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045311|NCT01380093|468123130|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045312|NCT01380093|468123131|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045313|NCT01380093|468123132|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045314|NCT01380093|468123133|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
130045315|NCT01380093|468123125|FG000|Treatment Phase: Second Intervention|Other|0|||
130045316|NCT01380093|468123126|FG001|Treatment Phase: Second Intervention|Other|0|||
130045317|NCT01380093|468123127|FG002|Treatment Phase: Second Intervention|Other|0|||
130045318|NCT01380093|468123128|FG003|Treatment Phase: Second Intervention|Other|1|||
130045319|NCT01380093|468123129|FG004|Treatment Phase: Second Intervention|Other|0|||
130045320|NCT01380093|468123130|FG005|Treatment Phase: Second Intervention|Other|0|||
130045321|NCT01380093|468123131|FG006|Treatment Phase: Second Intervention|Other|0|||
130045322|NCT01380093|468123132|FG007|Treatment Phase: Second Intervention|Other|0|||
130045323|NCT01380093|468123133|FG008|Treatment Phase: Second Intervention|Other|0|||
130045324|NCT01380093|468123125|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
130045325|NCT01380093|468123126|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
130045326|NCT01380093|468123127|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
130045327|NCT01380093|468123128|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
130045328|NCT01380093|468123129|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
130045329|NCT01380093|468123130|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
130045330|NCT01380093|468123131|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
130045331|NCT01380093|468123132|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
130045332|NCT01380093|468123133|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
130045333|NCT01380093|468123125|FG000|Treatment Phase: Third Intervention|Other|0|||
130045334|NCT01380093|468123126|FG001|Treatment Phase: Third Intervention|Other|0|||
130045335|NCT01380093|468123127|FG002|Treatment Phase: Third Intervention|Other|0|||
130045336|NCT01380093|468123128|FG003|Treatment Phase: Third Intervention|Other|0|||
130045337|NCT01380093|468123129|FG004|Treatment Phase: Third Intervention|Other|0|||
130045338|NCT01380093|468123130|FG005|Treatment Phase: Third Intervention|Other|0|||
130045339|NCT01380093|468123131|FG006|Treatment Phase: Third Intervention|Other|0|||
130045340|NCT01380093|468123132|FG007|Treatment Phase: Third Intervention|Other|0|||
130045341|NCT01380093|468123133|FG008|Treatment Phase: Third Intervention|Other|1|||
130045342|NCT04734873|468123134|FG000|Overall Study|Lost to Follow-up|1|||
130045343|NCT04734873|468123135|FG001|Overall Study|Lost to Follow-up|3|||
130045344|NCT04734873|468123136|FG002|Overall Study|Lost to Follow-up|2|||
130045345|NCT04734873|468123134|FG000|Overall Study|Randomized but not dosed|1|||
130045346|NCT04734873|468123135|FG001|Overall Study|Randomized but not dosed|0|||
130289311|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
130289312|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
130289313|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
130289314|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
130289315|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
130289316|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
130289317|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
130289318|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
130289319|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
130289320|NCT01286987|469022118|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289321|NCT01286987|469022119|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289322|NCT01286987|469022120|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289323|NCT01286987|469022121|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289324|NCT01286987|469022122|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130045347|NCT04734873|468123136|FG002|Overall Study|Randomized but not dosed|1|||
130045348|NCT00201201|468123137|FG000|Overall Study|Death|0|||
130045349|NCT00201201|468123138|FG001|Overall Study|Death|2|||
130106476|NCT03022799|468350046|FG010|Overall Study|Adverse Event|1|||
130289325|NCT01286987|469022123|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289326|NCT01286987|469022124|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130045350|NCT00201201|468123137|FG000|Overall Study|Withdrawal by Subject|5|||
129888214|NCT02018861|467549129|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888215|NCT02018861|467549120|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888216|NCT02018861|467549121|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888217|NCT02018861|467549122|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888218|NCT02018861|467549123|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888219|NCT02018861|467549124|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888220|NCT02018861|467549125|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888221|NCT02018861|467549126|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888222|NCT02018861|467549127|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888223|NCT02018861|467549128|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
129888224|NCT02018861|467549129|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888225|NCT02018861|467549120|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888226|NCT02018861|467549121|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888227|NCT02018861|467549122|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888228|NCT02018861|467549123|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888229|NCT02018861|467549124|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888230|NCT02018861|467549125|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888231|NCT02018861|467549126|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888232|NCT02018861|467549127|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888233|NCT02018861|467549128|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
129888234|NCT02018861|467549129|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888235|NCT02018861|467549120|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888236|NCT02018861|467549121|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888237|NCT02018861|467549122|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888238|NCT02018861|467549123|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888239|NCT02018861|467549124|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888240|NCT02018861|467549125|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888241|NCT02018861|467549126|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888242|NCT02018861|467549127|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888243|NCT02018861|467549128|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
129888244|NCT02018861|467549129|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888245|NCT00504348|467549130|FG000|Overall Study|Adverse Event|3|||
129888246|NCT00504348|467549130|FG000|Overall Study|Lack of Efficacy|4|||
129888247|NCT00504348|467549130|FG000|Overall Study|Physician Decision|1|||
129888248|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
129888249|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
129888250|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
129888251|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
129888252|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
129888253|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
130045351|NCT00201201|468123138|FG001|Overall Study|Withdrawal by Subject|5|||
130045352|NCT01342640|468123140|FG000|Overall Study|Adverse Event|3|||
130045353|NCT01342640|468123140|FG000|Overall Study|Protocol Violation|16|||
130045354|NCT01342640|468123140|FG000|Overall Study|Lost to Follow-up|21|||
130289327|NCT01286987|469022125|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289328|NCT01286987|469022126|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289329|NCT01286987|469022127|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289330|NCT01286987|469022128|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
130289331|NCT01286987|469022129|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289332|NCT01286987|469022130|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289333|NCT01286987|469022131|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289334|NCT01286987|469022132|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
130289335|NCT02594098|469022133|FG000|Overall Study|Lack of Efficacy|17|||
130289336|NCT02594098|469022134|FG001|Overall Study|Lack of Efficacy|6|||
130289337|NCT02594098|469022133|FG000|Overall Study|Withdrawal by Subject|1|||
130289338|NCT02594098|469022134|FG001|Overall Study|Withdrawal by Subject|3|||
130289339|NCT02594098|469022133|FG000|Overall Study|Terminated participation|6|||
130289340|NCT02594098|469022134|FG001|Overall Study|Terminated participation|2|||
130289341|NCT02594098|469022133|FG000|Overall Study|Seek alternative treatment|2|||
130289342|NCT02594098|469022134|FG001|Overall Study|Seek alternative treatment|1|||
130289343|NCT02594098|469022133|FG000|Overall Study|Other|0|||
130289344|NCT02594098|469022134|FG001|Overall Study|Other|1|||
130289345|NCT00033540|469022135|FG000|Overall Study|Adverse Event|14|||
130289346|NCT00033540|469022135|FG000|Overall Study|Death|1|||
130289347|NCT00033540|469022135|FG000|Overall Study|Progression|26|||
130289348|NCT00033540|469022135|FG000|Overall Study|Withdrawal by Subject|6|||
130289349|NCT00033540|469022135|FG000|Overall Study|Other|5|||
130045355|NCT01342640|468123140|FG000|Overall Study|Other|1|||
130045356|NCT02640612|468123142|FG000|Overall Study|Adverse Event|6|||
130289350|NCT00033540|469022135|FG000|Overall Study|Ineligible|3|||
130289351|NCT00033540|469022135|FG000|Overall Study|Never received treatment|2|||
130289352|NCT03366103|469022136|FG000|Overall Study|Disease Progression|3|||
130289353|NCT03366103|469022137|FG001|Overall Study|Disease Progression|1|||
130289354|NCT03366103|469022138|FG002|Overall Study|Disease Progression|0|||
130289355|NCT03366103|469022136|FG000|Overall Study|Adverse Event|0|||
130289356|NCT03366103|469022137|FG001|Overall Study|Adverse Event|1|||
130289357|NCT03366103|469022138|FG002|Overall Study|Adverse Event|0|||
130289358|NCT01036529|469022139|FG000|Overall Study|Adverse Event|0|||
130289359|NCT01036529|469022140|FG001|Overall Study|Adverse Event|1|||
130289360|NCT01036529|469022139|FG000|Overall Study|Lost to Follow-up|0|||
130289361|NCT01036529|469022140|FG001|Overall Study|Lost to Follow-up|1|||
130289362|NCT01036529|469022139|FG000|Overall Study|Physician Decision|1|||
130289363|NCT01036529|469022140|FG001|Overall Study|Physician Decision|0|||
130289364|NCT01036529|469022139|FG000|Overall Study|Withdrawal by Subject|1|||
130289365|NCT01036529|469022140|FG001|Overall Study|Withdrawal by Subject|1|||
130045357|NCT02640612|468123143|FG001|Overall Study|Adverse Event|7|||
130045358|NCT02640612|468123144|FG002|Overall Study|Adverse Event|2|||
130045359|NCT02640612|468123142|FG000|Overall Study|Death|1|||
130045360|NCT02640612|468123143|FG001|Overall Study|Death|0|||
130106477|NCT03022799|468350047|FG011|Overall Study|Adverse Event|0|||
130106478|NCT03022799|468350048|FG012|Overall Study|Adverse Event|0|||
130106479|NCT00883129|468350049|FG000|Overall Study|Adverse Event|7|||
130106480|NCT00883129|468350050|FG001|Overall Study|Adverse Event|15|||
130045361|NCT02640612|468123144|FG002|Overall Study|Death|0|||
130045362|NCT02640612|468123142|FG000|Overall Study|Withdrawal by Subject|10|||
130045363|NCT02640612|468123143|FG001|Overall Study|Withdrawal by Subject|3|||
130045364|NCT02640612|468123144|FG002|Overall Study|Withdrawal by Subject|3|||
130045365|NCT02640612|468123142|FG000|Overall Study|Lost to Follow-up|4|||
130045366|NCT02640612|468123143|FG001|Overall Study|Lost to Follow-up|1|||
130045367|NCT02640612|468123144|FG002|Overall Study|Lost to Follow-up|1|||
130045368|NCT02640612|468123142|FG000|Overall Study|Protocol Violation|0|||
130045369|NCT02640612|468123143|FG001|Overall Study|Protocol Violation|2|||
130045370|NCT02640612|468123144|FG002|Overall Study|Protocol Violation|0|||
130045371|NCT02640612|468123142|FG000|Overall Study|Lack of Efficacy|1|||
130045372|NCT02640612|468123143|FG001|Overall Study|Lack of Efficacy|1|||
130045373|NCT02640612|468123144|FG002|Overall Study|Lack of Efficacy|0|||
130045374|NCT01720667|468123145|FG000|Overall Study|Adverse Event|1|||
130045375|NCT01720667|468123146|FG001|Overall Study|Adverse Event|1|||
130045376|NCT01720667|468123145|FG000|Overall Study|Withdrawal by Subject|3|||
130045377|NCT01720667|468123146|FG001|Overall Study|Withdrawal by Subject|0|||
130045378|NCT03472534|468123147|FG000|Overall Study|Withdrawal by Subject|9|||
130045379|NCT03472534|468123147|FG000|Overall Study|Adverse Event|2|||
130045380|NCT01319929|468123151|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
130045381|NCT01319929|468123152|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
130045382|NCT01319929|468123151|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
130045383|NCT01319929|468123152|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
130045384|NCT01319929|468123151|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
130045385|NCT01319929|468123152|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
130045386|NCT01319929|468123151|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
130045387|NCT01319929|468123152|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
130045388|NCT01319929|468123151|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
130045389|NCT01319929|468123152|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
130045390|NCT01221233|468123153|FG000|Overall Study|Withdrawal by Subject|3|||
130045391|NCT01221233|468123154|FG001|Overall Study|Withdrawal by Subject|1|||
130045392|NCT03865407|468123156|FG000|Overall Study|Adverse Event|1|||
130045393|NCT03865407|468123157|FG001|Overall Study|Adverse Event|0|||
130045394|NCT03865407|468123156|FG000|Overall Study|Withdrawal by Subject|1|||
130045395|NCT03865407|468123157|FG001|Overall Study|Withdrawal by Subject|0|||
130045396|NCT03865407|468123156|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
130045397|NCT03865407|468123157|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
130045398|NCT02117050|468123158|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
130045399|NCT00546819|468123161|FG000|Overall Study|Adverse Event|2|||
130045400|NCT00546819|468123162|FG001|Overall Study|Adverse Event|3|||
130045401|NCT00546819|468123161|FG000|Overall Study|Lost to Follow-up|2|||
130045402|NCT00546819|468123162|FG001|Overall Study|Lost to Follow-up|1|||
130045403|NCT00546819|468123161|FG000|Overall Study|Withdrawal by Subject|4|||
130045404|NCT00546819|468123162|FG001|Overall Study|Withdrawal by Subject|2|||
130045405|NCT02859415|468123164|FG000|Overall Study|Physician Decision|1|||
130045406|NCT02859415|468123165|FG001|Overall Study|Physician Decision|0|||
130045407|NCT02859415|468123164|FG000|Overall Study|Off treatment due to cardiac event|0|||
130045408|NCT02859415|468123165|FG001|Overall Study|Off treatment due to cardiac event|1|||
130045409|NCT01478347|468123170|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
130045410|NCT01478347|468123170|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
130106481|NCT00883129|468350049|FG000|Overall Study|Withdrawal by Subject|8|||
130106482|NCT00883129|468350050|FG001|Overall Study|Withdrawal by Subject|9|||
130106483|NCT00883129|468350049|FG000|Overall Study|Non-compliance|3|||
130106484|NCT00883129|468350050|FG001|Overall Study|Non-compliance|6|||
130106485|NCT00883129|468350049|FG000|Overall Study|Lost to Follow-up|1|||
130106486|NCT00883129|468350050|FG001|Overall Study|Lost to Follow-up|2|||
130289366|NCT01036529|469022139|FG000|Overall Study|Sponsor study termination|11|||
130289367|NCT01036529|469022140|FG001|Overall Study|Sponsor study termination|12|||
130289368|NCT01853072|469022141|FG000|Overall Study|Adverse event prior to treatment|0|||
130045411|NCT01478347|468123170|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
130045412|NCT00196937|468123171|FG000|Overall Study|Serious Adverse Event|1|||
130045413|NCT00196937|468123172|FG001|Overall Study|Serious Adverse Event|0|||
130106487|NCT00883129|468350049|FG000|Overall Study|Death|1|||
130106488|NCT00883129|468350050|FG001|Overall Study|Death|2|||
130106489|NCT00883129|468350049|FG000|Overall Study|Defined Treatment Failure|0|||
130289369|NCT01853072|469022142|FG001|Overall Study|Adverse event prior to treatment|1|||
130289370|NCT01853072|469022141|FG000|Overall Study|Adverse Event|0|||
130045414|NCT00196937|468123173|FG002|Overall Study|Serious Adverse Event|0|||
130045415|NCT00196937|468123171|FG000|Overall Study|Non-serious adverse event|1|||
130045416|NCT00196937|468123172|FG001|Overall Study|Non-serious adverse event|1|||
130045417|NCT00196937|468123173|FG002|Overall Study|Non-serious adverse event|1|||
130045418|NCT00196937|468123171|FG000|Overall Study|Withdrawal by Subject|0|||
130045419|NCT00196937|468123172|FG001|Overall Study|Withdrawal by Subject|0|||
130045420|NCT00196937|468123173|FG002|Overall Study|Withdrawal by Subject|2|||
130045421|NCT00196937|468123171|FG000|Overall Study|Lost to Follow-up|4|||
130045422|NCT00196937|468123172|FG001|Overall Study|Lost to Follow-up|3|||
130045423|NCT00196937|468123173|FG002|Overall Study|Lost to Follow-up|3|||
130045424|NCT00196937|468123171|FG000|Overall Study|Other|3|||
130045425|NCT00196937|468123172|FG001|Overall Study|Other|1|||
130045426|NCT00196937|468123173|FG002|Overall Study|Other|1|||
130045427|NCT02335450|468123176|FG000|Overall Study|Pregnancy|1|||
130045428|NCT02973815|468123177|FG000|Post Intervention|Death|1|||
130045429|NCT02973815|468123178|FG001|Post Intervention|Death|0|||
130045430|NCT02973815|468123177|FG000|Post Intervention|Lost to Follow-up|7|||
130045431|NCT02973815|468123178|FG001|Post Intervention|Lost to Follow-up|24|||
130045432|NCT02973815|468123177|FG000|Follow-up|Lost to Follow-up|2|||
130045433|NCT02973815|468123178|FG001|Follow-up|Lost to Follow-up|0|||
130045434|NCT02613572|468123179|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
129793130|NCT00997438|467210700|FG000|Overall Study|Withdrawal by Subject|1|||
129793131|NCT00997438|467210701|FG001|Overall Study|Withdrawal by Subject|1|||
129793132|NCT00997438|467210702|FG002|Overall Study|Withdrawal by Subject|0|||
129793133|NCT00997438|467210700|FG000|Overall Study|Exclusion criteria at visit 1|2|||
129793134|NCT00997438|467210701|FG001|Overall Study|Exclusion criteria at visit 1|2|||
129793135|NCT00997438|467210702|FG002|Overall Study|Exclusion criteria at visit 1|3|||
129793136|NCT03505671|467210703|FG000|Overall Study|Withdrawal by Subject|2|||
129793137|NCT03505671|467210704|FG001|Overall Study|Withdrawal by Subject|1|||
129793138|NCT03505671|467210703|FG000|Overall Study|Lost to Follow-up|1|||
129793139|NCT03505671|467210704|FG001|Overall Study|Lost to Follow-up|0|||
129793140|NCT02038829|467210707|FG000|Washout Period 1|Death|0|||
130045435|NCT02613572|468123180|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
130289371|NCT01853072|469022142|FG001|Overall Study|Adverse Event|3|||
129793141|NCT02038829|467210708|FG001|Washout Period 1|Death|0|||
129793142|NCT02038829|467210709|FG002|Washout Period 1|Death|0|||
130289372|NCT01853072|469022141|FG000|Overall Study|Death|1|||
130289373|NCT01853072|469022142|FG001|Overall Study|Death|4|||
130289374|NCT01853072|469022141|FG000|Overall Study|Lost to Follow-up|0|||
130289375|NCT01853072|469022142|FG001|Overall Study|Lost to Follow-up|3|||
130289376|NCT01853072|469022141|FG000|Overall Study|Non-compliance with study drug|0|||
130289377|NCT01853072|469022142|FG001|Overall Study|Non-compliance with study drug|1|||
130289378|NCT01853072|469022141|FG000|Overall Study|Physician Decision|1|||
130289379|NCT01853072|469022142|FG001|Overall Study|Physician Decision|1|||
130289380|NCT01853072|469022141|FG000|Overall Study|Withdrawal by Subject|1|||
130289381|NCT01853072|469022142|FG001|Overall Study|Withdrawal by Subject|2|||
130289382|NCT01853072|469022141|FG000|Overall Study|Reason not specified|9|||
130289383|NCT01853072|469022142|FG001|Overall Study|Reason not specified|6|||
130289384|NCT01816906|469022143|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
130289385|NCT01816906|469022144|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
130289386|NCT01816906|469022143|FG000|Six Months|Lost to Follow-up|14|||
130289387|NCT01816906|469022144|FG001|Six Months|Lost to Follow-up|16|||
130289388|NCT01816906|469022143|FG000|12 Months|Adverse Event|2|||
130289389|NCT01816906|469022144|FG001|12 Months|Adverse Event|2|||
130289390|NCT01816906|469022143|FG000|12 Months|Death|0|||
130289391|NCT01816906|469022144|FG001|12 Months|Death|2|||
130289392|NCT01816906|469022143|FG000|12 Months|Lost to Follow-up|2|||
130289393|NCT01816906|469022144|FG001|12 Months|Lost to Follow-up|1|||
130289394|NCT00746733|469022145|FG000|Second Intervention|Adverse Event|1|||
130289395|NCT00746733|469022146|FG001|Second Intervention|Adverse Event|0|||
130289396|NCT00746733|469022145|FG000|Third Intervention|Withdrawal by Subject|1|||
130289397|NCT00746733|469022146|FG001|Third Intervention|Withdrawal by Subject|1|||
130289398|NCT01527383|469022147|FG000|Overall Study|Adverse Event|5|||
130289399|NCT01527383|469022148|FG001|Overall Study|Adverse Event|0|||
130289400|NCT01527383|469022147|FG000|Overall Study|Lost to Follow-up|3|||
130289401|NCT01527383|469022148|FG001|Overall Study|Lost to Follow-up|0|||
130289402|NCT01527383|469022147|FG000|Overall Study|Physician Decision|2|||
130289403|NCT01527383|469022148|FG001|Overall Study|Physician Decision|0|||
130289404|NCT01527383|469022147|FG000|Overall Study|Pregnancy|1|||
130289405|NCT01527383|469022148|FG001|Overall Study|Pregnancy|0|||
130289406|NCT01527383|469022147|FG000|Overall Study|Protocol Violation|1|||
130289407|NCT01527383|469022148|FG001|Overall Study|Protocol Violation|0|||
130289408|NCT01527383|469022147|FG000|Overall Study|Screen failure|1|||
130289409|NCT01527383|469022148|FG001|Overall Study|Screen failure|0|||
130289410|NCT01527383|469022147|FG000|Overall Study|Participant moved|0|||
130289411|NCT01527383|469022148|FG001|Overall Study|Participant moved|1|||
130289412|NCT01527383|469022147|FG000|Overall Study|Withdrawal by Subject|2|||
130289413|NCT01527383|469022148|FG001|Overall Study|Withdrawal by Subject|3|||
130289414|NCT03412604|469022149|FG000|Overall Study|Withdrawal by Subject|1|||
130289415|NCT00930969|469022151|FG000|Overall Study|Death|5|||
130289416|NCT00930969|469022151|FG000|Overall Study|Lost to Follow-up|1|||
130289417|NCT00930969|469022151|FG000|Overall Study|Physician Decision|13|||
130289418|NCT00930969|469022151|FG000|Overall Study|Withdrawal by Subject|19|||
130289419|NCT01287221|469022152|FG000|Overall Study|Lack of Perceived Benefit|1|||
130289420|NCT01287221|469022153|FG001|Overall Study|Lack of Perceived Benefit|1|||
130289421|NCT01287221|469022152|FG000|Overall Study|Adverse Event|3|||
130289422|NCT01287221|469022153|FG001|Overall Study|Adverse Event|3|||
130045436|NCT02613572|468123181|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
130045437|NCT02613572|468123179|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
130289423|NCT01287221|469022152|FG000|Overall Study|Withdrawal by Subject|0|||
130289424|NCT01287221|469022153|FG001|Overall Study|Withdrawal by Subject|1|||
130289425|NCT00787137|469022155|FG000|Overall Study|Study Termination|0|||
130289426|NCT00787137|469022156|FG001|Overall Study|Study Termination|0|||
130289427|NCT00787137|469022157|FG002|Overall Study|Study Termination|1|||
130289428|NCT02513823|469022159|FG000|Overall Study|Lost to Follow-up|4|||
130289429|NCT02513823|469022159|FG000|Overall Study|Physician Decision|1|||
130289430|NCT02743780|469022164|FG000|Part 3 (7 Days)|Adverse Event|0|||
130289431|NCT02743780|469022165|FG001|Part 3 (7 Days)|Adverse Event|0|||
130289432|NCT02743780|469022166|FG002|Part 3 (7 Days)|Adverse Event|1|||
130289433|NCT02743780|469022167|FG003|Part 3 (7 Days)|Adverse Event|0|||
130289434|NCT02743780|469022168|FG004|Part 3 (7 Days)|Adverse Event|0|||
130289435|NCT01294462|469022169|FG000|Overall Study|Lost to Follow-up|1|||
130289436|NCT01294462|469022170|FG001|Overall Study|Lost to Follow-up|0|||
130289437|NCT01294462|469022169|FG000|Overall Study|Withdrawal by Subject|65|||
130289438|NCT01294462|469022170|FG001|Overall Study|Withdrawal by Subject|63|||
130289439|NCT04342689|469022178|FG000|Overall Study|Withdrawal by Subject|32|||
130289440|NCT04342689|469022179|FG001|Overall Study|Withdrawal by Subject|33|||
130289441|NCT04342689|469022178|FG000|Overall Study|Lost to Follow-up|10|||
130289442|NCT04342689|469022179|FG001|Overall Study|Lost to Follow-up|12|||
130289443|NCT01460407|469022182|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
130289444|NCT01460407|469022183|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
130289445|NCT01367704|469022184|FG000|Overall Study|Lost to Follow-up|47|||
130289446|NCT01367704|469022185|FG001|Overall Study|Lost to Follow-up|161|||
130289447|NCT01400243|469022187|FG000|Overall Study|Protocol Violation|8|||
130289448|NCT01400243|469022188|FG001|Overall Study|Protocol Violation|11|||
130289449|NCT02193087|469022189|FG000|Overall Study|Adverse Event|2|||
130289450|NCT02193087|469022190|FG001|Overall Study|Adverse Event|0|||
130289451|NCT02193087|469022191|FG002|Overall Study|Adverse Event|0|||
130289452|NCT02193087|469022192|FG003|Overall Study|Adverse Event|11|||
130289453|NCT02193087|469022189|FG000|Overall Study|Lost to Follow-up|14|||
130289454|NCT02193087|469022190|FG001|Overall Study|Lost to Follow-up|6|||
130289455|NCT02193087|469022191|FG002|Overall Study|Lost to Follow-up|4|||
130289456|NCT02193087|469022192|FG003|Overall Study|Lost to Follow-up|37|||
130289457|NCT02193087|469022189|FG000|Overall Study|Protocol Violation|2|||
130289458|NCT02193087|469022190|FG001|Overall Study|Protocol Violation|0|||
130289459|NCT02193087|469022191|FG002|Overall Study|Protocol Violation|1|||
130289460|NCT02193087|469022192|FG003|Overall Study|Protocol Violation|2|||
130289461|NCT02193087|469022189|FG000|Overall Study|Withdrawal by Subject|10|||
130289462|NCT02193087|469022190|FG001|Overall Study|Withdrawal by Subject|3|||
130289463|NCT02193087|469022191|FG002|Overall Study|Withdrawal by Subject|1|||
130289464|NCT02193087|469022192|FG003|Overall Study|Withdrawal by Subject|19|||
130289465|NCT02193087|469022189|FG000|Overall Study|Other Reason Not Specified|7|||
130289466|NCT02193087|469022190|FG001|Overall Study|Other Reason Not Specified|2|||
130289467|NCT02193087|469022191|FG002|Overall Study|Other Reason Not Specified|1|||
130289468|NCT02193087|469022192|FG003|Overall Study|Other Reason Not Specified|9|||
130289469|NCT02193087|469022189|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
130289470|NCT02193087|469022190|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
130289471|NCT02193087|469022191|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
130289472|NCT02193087|469022192|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
130289473|NCT04096820|469022193|FG000|Overall Study|Did not return for intervention|2|||
130289474|NCT04096820|469022193|FG000|Overall Study|Death|1|||
130289475|NCT00475865|469022194|FG000|Overall Study|Adverse Event|0|||
130289476|NCT00475865|469022195|FG001|Overall Study|Adverse Event|3|||
130289477|NCT00475865|469022196|FG002|Overall Study|Adverse Event|4|||
130289478|NCT00475865|469022194|FG000|Overall Study|Lack of Efficacy|1|||
130289479|NCT00475865|469022195|FG001|Overall Study|Lack of Efficacy|0|||
130289480|NCT00475865|469022196|FG002|Overall Study|Lack of Efficacy|0|||
130289481|NCT00475865|469022194|FG000|Overall Study|Progressive disease|0|||
130289482|NCT00475865|469022195|FG001|Overall Study|Progressive disease|1|||
130289483|NCT00475865|469022196|FG002|Overall Study|Progressive disease|2|||
130289484|NCT00475865|469022194|FG000|Overall Study|Participant did not wish to continue|1|||
130289485|NCT00475865|469022195|FG001|Overall Study|Participant did not wish to continue|0|||
130289486|NCT00475865|469022196|FG002|Overall Study|Participant did not wish to continue|0|||
130289487|NCT00475865|469022194|FG000|Overall Study|Other than above|0|||
130289488|NCT00475865|469022195|FG001|Overall Study|Other than above|1|||
130289489|NCT00475865|469022196|FG002|Overall Study|Other than above|0|||
130289490|NCT00946322|469022198|FG000|Pre-treatment|participant failure to follow up|1|||
130289491|NCT00946322|469022198|FG000|Post-treatment|participant failure to follow up|2|||
130289492|NCT01453946|469022200|FG000|Overall Study|Did not receive drug for the taper phase|1|||
130045438|NCT02613572|468123180|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
130045439|NCT02613572|468123181|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
130045440|NCT04542291|468123182|FG000|Overall Study|Adverse Event|1|||
130045441|NCT04542291|468123182|FG000|Overall Study|Physician Decision|2|||
130045442|NCT00853905|468123187|FG000|Overall Study|Lost to Follow-up|1|||
130045443|NCT00853905|468123188|FG001|Overall Study|Lost to Follow-up|3|||
130045444|NCT00853905|468123187|FG000|Overall Study|Withdrawal by Subject|0|||
130045445|NCT00853905|468123188|FG001|Overall Study|Withdrawal by Subject|1|||
130045446|NCT00853905|468123187|FG000|Overall Study|never had surgery|1|||
130289493|NCT01453946|469022200|FG000|Overall Study|Protocol Violation|2|||
130289494|NCT01453946|469022200|FG000|Overall Study|Lack of Efficacy|3|||
130289495|NCT01453946|469022200|FG000|Overall Study|Adverse Event|3|||
130289496|NCT00846040|469022201|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
130289497|NCT00846040|469022202|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
130289498|NCT00846040|469022203|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
130289499|NCT00846040|469022201|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
130289500|NCT00846040|469022202|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
130289501|NCT00846040|469022203|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
130289502|NCT01822535|469022206|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
130289503|NCT01822535|469022207|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
130289504|NCT01822535|469022206|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
130289505|NCT01822535|469022207|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
130289506|NCT01822535|469022206|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
130289507|NCT01822535|469022207|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
130289508|NCT02278614|469022208|FG000|Overall Study|Withdrawal by Subject|3|||
130289509|NCT02278614|469022209|FG001|Overall Study|Withdrawal by Subject|5|||
130289510|NCT02278614|469022208|FG000|Overall Study|Adverse Event|1|||
130289511|NCT02278614|469022209|FG001|Overall Study|Adverse Event|0|||
130289512|NCT02278614|469022208|FG000|Overall Study|left eye was not eligible|1|||
130289513|NCT02278614|469022209|FG001|Overall Study|left eye was not eligible|0|||
130289514|NCT02279498|469022212|FG000|Overall Study|Adverse Event|3|||
130289515|NCT02279498|469022213|FG001|Overall Study|Adverse Event|0|||
130289516|NCT02279498|469022212|FG000|Overall Study|Lack of Efficacy|4|||
130289517|NCT02279498|469022213|FG001|Overall Study|Lack of Efficacy|0|||
130289518|NCT02279498|469022212|FG000|Overall Study|Lost to Follow-up|0|||
130289519|NCT02279498|469022213|FG001|Overall Study|Lost to Follow-up|1|||
130289520|NCT02279498|469022212|FG000|Overall Study|Withdrawal by Subject|9|||
130289521|NCT02279498|469022213|FG001|Overall Study|Withdrawal by Subject|2|||
130289522|NCT02279498|469022212|FG000|Overall Study|Undefined|2|||
129888254|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
130289523|NCT02279498|469022213|FG001|Overall Study|Undefined|1|||
130045447|NCT00853905|468123188|FG001|Overall Study|never had surgery|0|||
130045448|NCT01787591|468123190|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
130045449|NCT01787591|468123191|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
130289524|NCT01048866|469022214|FG000|Overall Study|Adverse Event|1|||
130045450|NCT01787591|468123192|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
130289525|NCT01048866|469022215|FG001|Overall Study|Adverse Event|0|||
130289526|NCT01048866|469022214|FG000|Overall Study|Protocol Violation|1|||
130289527|NCT01048866|469022215|FG001|Overall Study|Protocol Violation|0|||
130289528|NCT01048866|469022214|FG000|Overall Study|Physician Decision|1|||
130289529|NCT01048866|469022215|FG001|Overall Study|Physician Decision|0|||
130289530|NCT01048866|469022214|FG000|Overall Study|Withdrawal by Subject|0|||
130289531|NCT01048866|469022215|FG001|Overall Study|Withdrawal by Subject|2|||
130289532|NCT01048866|469022214|FG000|Overall Study|Lost to Follow-up|0|||
130289533|NCT01048866|469022215|FG001|Overall Study|Lost to Follow-up|2|||
130289534|NCT01048866|469022214|FG000|Overall Study|Other|1|||
130289535|NCT01048866|469022215|FG001|Overall Study|Other|1|||
130289536|NCT03582813|469022216|FG000|Overall Study|Lost to Follow-up|18|||
130289537|NCT03582813|469022217|FG001|Overall Study|Lost to Follow-up|21|||
130289538|NCT03582813|469022216|FG000|Overall Study|Withdrawal by Subject|1|||
130289539|NCT03582813|469022217|FG001|Overall Study|Withdrawal by Subject|0|||
130289540|NCT02230683|469022220|FG000|Overall Study|Adverse Event|1|||
130289541|NCT00260065|469022221|FG000|Overall Study|Progressive Disease|22|||
130289542|NCT00260065|469022221|FG000|Overall Study|Adverse Event|17|||
130289543|NCT00260065|469022221|FG000|Overall Study|Death|13|||
130289544|NCT00260065|469022221|FG000|Overall Study|Withdrawal by Subject|13|||
130289545|NCT00260065|469022221|FG000|Overall Study|Physician Decision|19|||
130289546|NCT00260065|469022221|FG000|Overall Study|Not otherwise specified|8|||
130289547|NCT00260065|469022221|FG000|Overall Study|Medication Noncompliance|1|||
130289548|NCT04068519|469022222|FG000|Dose Verification|Death|15|||
130289549|NCT04068519|469022222|FG000|Dose Verification|Withdrawal by Subject|1|||
130289550|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Death|35|||
130289551|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
130289552|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
130289553|NCT04068519|469022222|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
130289554|NCT04068519|469022222|FG000|Indication Expansion|Death|152|||
130289555|NCT04068519|469022222|FG000|Indication Expansion|Withdrawal by Subject|10|||
130289556|NCT04068519|469022222|FG000|Indication Expansion|Lost to Follow-up|7|||
130289557|NCT04431713|469023659|FG000|Overall Study|Withdrawal by Subject|2|||
130289558|NCT04431713|469023660|FG001|Overall Study|Withdrawal by Subject|0|||
130289559|NCT04431713|469023659|FG000|Overall Study|Death|2|||
130289560|NCT04431713|469023660|FG001|Overall Study|Death|2|||
130289561|NCT02285114|469023662|FG000|Main Phase|Investigator's Discretion|0|||
130289562|NCT02285114|469023663|FG001|Main Phase|Investigator's Discretion|2|||
130289563|NCT02285114|469023664|FG002|Main Phase|Investigator's Discretion|0|||
130289564|NCT02285114|469023665|FG003|Main Phase|Investigator's Discretion|0|||
130289565|NCT02285114|469023666|FG004|Main Phase|Investigator's Discretion|0|||
130289566|NCT02285114|469023667|FG005|Main Phase|Investigator's Discretion|0|||
130289567|NCT02285114|469023662|FG000|Main Phase|Enrolled but Never Treated|1|||
130289568|NCT02285114|469023663|FG001|Main Phase|Enrolled but Never Treated|0|||
130289569|NCT02285114|469023664|FG002|Main Phase|Enrolled but Never Treated|0|||
130289570|NCT02285114|469023665|FG003|Main Phase|Enrolled but Never Treated|0|||
130289571|NCT02285114|469023666|FG004|Main Phase|Enrolled but Never Treated|0|||
130289572|NCT02285114|469023667|FG005|Main Phase|Enrolled but Never Treated|0|||
130289573|NCT02285114|469023662|FG000|Main Phase|Withdrew Consent|0|||
130289574|NCT02285114|469023663|FG001|Main Phase|Withdrew Consent|0|||
130289575|NCT02285114|469023664|FG002|Main Phase|Withdrew Consent|1|||
130289576|NCT02285114|469023665|FG003|Main Phase|Withdrew Consent|0|||
130289577|NCT02285114|469023666|FG004|Main Phase|Withdrew Consent|0|||
130289578|NCT02285114|469023667|FG005|Main Phase|Withdrew Consent|0|||
130289579|NCT02285114|469023662|FG000|Extension Phase|Investigator's Discretion|0|||
130289580|NCT02285114|469023663|FG001|Extension Phase|Investigator's Discretion|0|||
130289581|NCT02285114|469023664|FG002|Extension Phase|Investigator's Discretion|0|||
130289582|NCT02285114|469023665|FG003|Extension Phase|Investigator's Discretion|14|||
130289583|NCT02285114|469023666|FG004|Extension Phase|Investigator's Discretion|1|||
130289584|NCT02285114|469023667|FG005|Extension Phase|Investigator's Discretion|0|||
130289585|NCT02285114|469023662|FG000|Extension Phase|Lost to Follow-up|0|||
129793143|NCT02038829|467210710|FG003|Washout Period 1|Death|0|||
129793144|NCT02038829|467210711|FG004|Washout Period 1|Death|1|||
129793145|NCT02038829|467210712|FG005|Washout Period 1|Death|0|||
129793146|NCT02038829|467210713|FG006|Washout Period 1|Death|0|||
129793147|NCT02038829|467210714|FG007|Washout Period 1|Death|0|||
129793148|NCT02038829|467210715|FG008|Washout Period 1|Death|0|||
130106490|NCT00883129|468350050|FG001|Overall Study|Defined Treatment Failure|2|||
129793149|NCT02038829|467210716|FG009|Washout Period 1|Death|0|||
129793150|NCT02038829|467210717|FG010|Washout Period 1|Death|0|||
130289586|NCT02285114|469023663|FG001|Extension Phase|Lost to Follow-up|0|||
130289587|NCT02285114|469023664|FG002|Extension Phase|Lost to Follow-up|0|||
130289588|NCT02285114|469023665|FG003|Extension Phase|Lost to Follow-up|1|||
130289589|NCT02285114|469023666|FG004|Extension Phase|Lost to Follow-up|1|||
130289590|NCT02285114|469023667|FG005|Extension Phase|Lost to Follow-up|0|||
130289591|NCT02285114|469023662|FG000|Extension Phase|Non-compliance with Study Drug|0|||
129793151|NCT02038829|467210718|FG011|Washout Period 1|Death|0|||
130289592|NCT02285114|469023663|FG001|Extension Phase|Non-compliance with Study Drug|0|||
130289593|NCT02285114|469023664|FG002|Extension Phase|Non-compliance with Study Drug|0|||
130289594|NCT02285114|469023665|FG003|Extension Phase|Non-compliance with Study Drug|2|||
130289595|NCT02285114|469023666|FG004|Extension Phase|Non-compliance with Study Drug|0|||
130289596|NCT02285114|469023667|FG005|Extension Phase|Non-compliance with Study Drug|0|||
130289597|NCT02285114|469023662|FG000|Extension Phase|Pregnancy|0|||
130289598|NCT02285114|469023663|FG001|Extension Phase|Pregnancy|0|||
130289599|NCT02285114|469023664|FG002|Extension Phase|Pregnancy|0|||
130289600|NCT02285114|469023665|FG003|Extension Phase|Pregnancy|1|||
129888255|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
129888256|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
129888257|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
129888258|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
129888259|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
129888260|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
130289601|NCT02285114|469023666|FG004|Extension Phase|Pregnancy|0|||
130289602|NCT02285114|469023667|FG005|Extension Phase|Pregnancy|0|||
130289603|NCT01156389|469023673|FG000|Overall Study|Elevated liver enzymes|4|||
130289604|NCT01156389|469023674|FG001|Overall Study|Elevated liver enzymes|0|||
130289605|NCT01156389|469023673|FG000|Overall Study|Vomiting|0|||
129888261|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
129888262|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
129888263|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
129888264|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
130289606|NCT01156389|469023674|FG001|Overall Study|Vomiting|1|||
130289607|NCT04599166|469023682|FG000|Overall Study|Technological failure connecting to study app|80|||
130289608|NCT01777542|469023683|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
130289609|NCT01777542|469023684|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
129888265|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
130289610|NCT00953524|469023686|FG000|Overall Study|Adverse Event|2|||
130289611|NCT00953524|469023687|FG001|Overall Study|Adverse Event|0|||
130289612|NCT00953524|469023688|FG002|Overall Study|Adverse Event|1|||
130289613|NCT00953524|469023689|FG003|Overall Study|Adverse Event|2|||
130289614|NCT00953524|469023686|FG000|Overall Study|Protocol Violation|18|||
130289615|NCT00953524|469023687|FG001|Overall Study|Protocol Violation|10|||
130289616|NCT00953524|469023688|FG002|Overall Study|Protocol Violation|11|||
130289617|NCT00953524|469023689|FG003|Overall Study|Protocol Violation|6|||
130289618|NCT00953524|469023686|FG000|Overall Study|Lost to Follow-up|0|||
130289619|NCT00953524|469023687|FG001|Overall Study|Lost to Follow-up|1|||
130289620|NCT00953524|469023688|FG002|Overall Study|Lost to Follow-up|1|||
130289621|NCT00953524|469023689|FG003|Overall Study|Lost to Follow-up|0|||
130289622|NCT00953524|469023686|FG000|Overall Study|Withdrawal by Subject|2|||
130289623|NCT00953524|469023687|FG001|Overall Study|Withdrawal by Subject|4|||
130289624|NCT00953524|469023688|FG002|Overall Study|Withdrawal by Subject|1|||
130289625|NCT00953524|469023689|FG003|Overall Study|Withdrawal by Subject|0|||
130289626|NCT00869050|469023697|FG000|Overall Study|Screen Failure|3|||
130289627|NCT03554772|469023701|FG000|Overall Study|Lost to Follow-up|0|||
130289628|NCT03554772|469023702|FG001|Overall Study|Lost to Follow-up|0|||
130289629|NCT03554772|469023703|FG002|Overall Study|Lost to Follow-up|0|||
130289630|NCT03554772|469023704|FG003|Overall Study|Lost to Follow-up|2|||
130289631|NCT01994863|469023706|FG000|Period 1|Adverse Event|4|||
130289632|NCT01994863|469023707|FG001|Period 1|Adverse Event|0|||
130289633|NCT01994863|469023706|FG000|Period 1|Withdrawal by Subject|1|||
130289634|NCT01994863|469023707|FG001|Period 1|Withdrawal by Subject|0|||
130289635|NCT01994863|469023706|FG000|Period 1|Trial stopped by sponsor|1|||
130289636|NCT01994863|469023707|FG001|Period 1|Trial stopped by sponsor|3|||
130289637|NCT01994863|469023706|FG000|Period 1|Lack of Efficacy|1|||
130289638|NCT01994863|469023707|FG001|Period 1|Lack of Efficacy|0|||
130289639|NCT01994863|469023706|FG000|Period 2|Adverse Event|0|||
130289640|NCT01994863|469023707|FG001|Period 2|Adverse Event|1|||
130289641|NCT01994863|469023706|FG000|Period 2|Lack of Efficacy|0|||
130289642|NCT01994863|469023707|FG001|Period 2|Lack of Efficacy|2|||
130289643|NCT01994863|469023706|FG000|Period 2|Withdrawal by Subject|1|||
130289644|NCT01994863|469023707|FG001|Period 2|Withdrawal by Subject|1|||
130289645|NCT01145053|469023708|FG000|Overall Study|Adverse Event|22|||
130289646|NCT01145053|469023708|FG000|Overall Study|Lost to Follow-up|28|||
130289647|NCT01145053|469023708|FG000|Overall Study|Withdrawal by Subject|25|||
130289648|NCT01145053|469023708|FG000|Overall Study|Other|18|||
130289649|NCT05136898|469023709|FG000|Overall Study|Adverse Event|2|||
130289650|NCT03060512|469023710|FG000|Overall Study|Adverse Event|4|||
130289651|NCT03060512|469023711|FG001|Overall Study|Adverse Event|6|||
130289652|NCT03060512|469023710|FG000|Overall Study|Lost to Follow-up|1|||
130289653|NCT03060512|469023711|FG001|Overall Study|Lost to Follow-up|1|||
130289654|NCT03060512|469023710|FG000|Overall Study|Withdrawal by Subject|1|||
130289655|NCT03060512|469023711|FG001|Overall Study|Withdrawal by Subject|0|||
130289656|NCT03060512|469023710|FG000|Overall Study|Non-compliance with study medication|1|||
130289657|NCT03060512|469023711|FG001|Overall Study|Non-compliance with study medication|2|||
130289658|NCT03946124|469023712|FG000|Overall Study|Withdrawal by Subject|19|||
130289659|NCT00241631|469023714|FG000|Run in (2 Weeks)|Physician Decision|3|||
130289660|NCT00241631|469023715|FG001|Run in (2 Weeks)|Physician Decision|3|||
130289661|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|sore throat|1|||
130289662|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|sore throat|0|||
130289663|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
130289664|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
130289665|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
130289666|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
130289667|NCT00241631|469023714|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
130289668|NCT00241631|469023715|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
130289669|NCT01561755|469023722|FG000|Overall Study|Lost to Follow-up|0|||
130289670|NCT01561755|469023723|FG001|Overall Study|Lost to Follow-up|1|||
130289671|NCT02813668|469023725|FG000|Overall Study|Death|4|||
130289672|NCT02813668|469023725|FG000|Overall Study|Lost to Follow-up|509|||
130289673|NCT02813668|469023725|FG000|Overall Study|Withdrawal by Subject|148|||
130289674|NCT02813668|469023725|FG000|Overall Study|No longer at worksite|85|||
130289675|NCT02813668|469023725|FG000|Overall Study|Medical reasons not related to the study|4|||
130289676|NCT04662073|469023726|FG000|Overall Study|Withdrawal by Subject|1|||
130289677|NCT04662073|469023727|FG001|Overall Study|Withdrawal by Subject|0|||
130289678|NCT02185014|469023728|FG000|Overall Study|Adverse Event|18|||
130289679|NCT02185014|469023728|FG000|Overall Study|Withdrew Consent|8|||
130289680|NCT02185014|469023728|FG000|Overall Study|Lost to Follow-up|4|||
130289681|NCT02185014|469023728|FG000|Overall Study|Lack of Efficacy|14|||
130289682|NCT02185014|469023728|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
130289683|NCT02185014|469023728|FG000|Overall Study|Subject Noncompliance|1|||
130289684|NCT02185014|469023728|FG000|Overall Study|Other|4|||
130289685|NCT02370641|469023733|FG000|Overall Study|dropped study|4|||
130289686|NCT02370641|469023734|FG001|Overall Study|dropped study|2|||
130289687|NCT02133664|469023738|FG000|Overall Study|Lost to Follow-up|2|||
130289688|NCT02133664|469023739|FG001|Overall Study|Lost to Follow-up|1|||
130289689|NCT02133664|469023738|FG000|Overall Study|Adverse Event|3|||
130289690|NCT02133664|469023739|FG001|Overall Study|Adverse Event|6|||
130289691|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
130289692|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
130289693|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
130289694|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
130289695|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
130289696|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
130289697|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
130289698|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
130289699|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
130289700|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
130289701|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
130289702|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
130289703|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
130289704|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
130289705|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
130289706|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
130289707|NCT03906656|469023742|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
130045451|NCT01787591|468123193|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
130045452|NCT02489630|468123194|FG000|Overall Study|Oversedation|1|||
130045453|NCT02489630|468123195|FG001|Overall Study|Oversedation|1|||
130045454|NCT02489630|468123194|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
130289708|NCT03906656|469023743|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
130289709|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
130289710|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
130289711|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
130289712|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
130289713|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
130289714|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
130289715|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
130289716|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
130289717|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
130289718|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
130045455|NCT02489630|468123195|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
130045456|NCT01326962|468123196|FG000|Overall Study|Adverse Event|1|||
130045457|NCT01326962|468123196|FG000|Overall Study|Withdrawal by Subject|1|||
130045458|NCT01326962|468123196|FG000|Overall Study|Lost to Follow-up|3|||
130045459|NCT01326962|468123196|FG000|Overall Study|Other|2|||
130045460|NCT01056523|468123197|FG000|Overall Study|Death|1|||
130045461|NCT01056523|468123198|FG001|Overall Study|Death|0|||
130045462|NCT01056523|468123199|FG002|Overall Study|Death|2|||
130045463|NCT01056523|468123200|FG003|Overall Study|Death|3|||
130045464|NCT01056523|468123201|FG004|Overall Study|Death|0|||
130045465|NCT01056523|468123202|FG005|Overall Study|Death|0|||
130045466|NCT01056523|468123203|FG006|Overall Study|Death|1|||
130045467|NCT03429556|468123206|FG000|Overall Study|Lost to Follow-up|0|||
130045468|NCT03429556|468123207|FG001|Overall Study|Lost to Follow-up|1|||
130045469|NCT03429556|468123208|FG002|Overall Study|Lost to Follow-up|0|||
130045470|NCT03429556|468123209|FG003|Overall Study|Lost to Follow-up|0|||
130045471|NCT01863758|468123210|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
130045472|NCT01863758|468123210|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
130045473|NCT04285723|468123220|FG000|Overall Study|Subject decision|1|||
130045474|NCT04285723|468123221|FG001|Overall Study|Subject decision|2|||
130045475|NCT04285723|468123220|FG000|Overall Study|Physician Decision|1|||
130045476|NCT04285723|468123221|FG001|Overall Study|Physician Decision|0|||
130045477|NCT04285723|468123220|FG000|Overall Study|No efficiency|1|||
130045478|NCT04285723|468123221|FG001|Overall Study|No efficiency|0|||
130045479|NCT00969618|468123227|FG000|Overall Study|Adverse Event|29|||
130045480|NCT00969618|468123227|FG000|Overall Study|Entry Criteria Not Met|3|||
130045481|NCT00969618|468123227|FG000|Overall Study|Lack of Efficacy|2|||
130045482|NCT00969618|468123227|FG000|Overall Study|Lost to Follow-up|7|||
130045483|NCT00969618|468123227|FG000|Overall Study|Physician Decision|1|||
130045484|NCT00969618|468123227|FG000|Overall Study|Protocol Violation|9|||
130045485|NCT00969618|468123227|FG000|Overall Study|Withdrawal by Subject|27|||
130045486|NCT05363293|468123232|FG000|Overall Study|Withdrawal by Subject|1|||
130045487|NCT05363293|468123233|FG001|Overall Study|Withdrawal by Subject|0|||
130045488|NCT05363293|468123234|FG002|Overall Study|Withdrawal by Subject|0|||
130045489|NCT05363293|468123235|FG003|Overall Study|Withdrawal by Subject|0|||
130045490|NCT05363293|468123236|FG004|Overall Study|Withdrawal by Subject|0|||
130045491|NCT05363293|468123237|FG005|Overall Study|Withdrawal by Subject|0|||
130045492|NCT05363293|468123238|FG006|Overall Study|Withdrawal by Subject|0|||
130045493|NCT05363293|468123239|FG007|Overall Study|Withdrawal by Subject|0|||
130045494|NCT05363293|468123240|FG008|Overall Study|Withdrawal by Subject|0|||
130045495|NCT05363293|468123241|FG009|Overall Study|Withdrawal by Subject|0|||
130045496|NCT01318902|468123242|FG000|Overall Study|Symptomatic Deterioration|0|||
130045497|NCT01318902|468123243|FG001|Overall Study|Symptomatic Deterioration|1|||
130045498|NCT01318902|468123244|FG002|Overall Study|Symptomatic Deterioration|1|||
130045499|NCT01318902|468123245|FG003|Overall Study|Symptomatic Deterioration|2|||
130045500|NCT01318902|468123242|FG000|Overall Study|Withdrawal by Patient|0|||
130045501|NCT01318902|468123243|FG001|Overall Study|Withdrawal by Patient|1|||
130045502|NCT01318902|468123244|FG002|Overall Study|Withdrawal by Patient|0|||
130045503|NCT01318902|468123245|FG003|Overall Study|Withdrawal by Patient|3|||
130045504|NCT01318902|468123242|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130045505|NCT01318902|468123243|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
130045506|NCT01318902|468123244|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130045507|NCT01318902|468123245|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
130045508|NCT01318902|468123242|FG000|Overall Study|Adverse Event|0|||
130045509|NCT01318902|468123243|FG001|Overall Study|Adverse Event|1|||
130045510|NCT01318902|468123244|FG002|Overall Study|Adverse Event|0|||
130045511|NCT01318902|468123245|FG003|Overall Study|Adverse Event|0|||
130045512|NCT01318902|468123242|FG000|Overall Study|Terminated by Sponsor|0|||
130045513|NCT01318902|468123243|FG001|Overall Study|Terminated by Sponsor|0|||
130045514|NCT01318902|468123244|FG002|Overall Study|Terminated by Sponsor|1|||
130045515|NCT01318902|468123245|FG003|Overall Study|Terminated by Sponsor|0|||
130045516|NCT02452970|468125515|FG000|Overall Study|Adverse Event|1|||
130045517|NCT02400346|468125516|FG000|Overall Study|Adverse Event|24|||
130045518|NCT02400346|468125516|FG000|Overall Study|Lack of Efficacy|9|||
130289719|NCT03906656|469023742|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
130289720|NCT03906656|469023743|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
130289721|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
130289722|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
130289723|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
130289724|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
130289725|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Death|2|||
130289726|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Death|0|||
130289727|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
130289728|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
130289729|NCT03906656|469023742|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
130289730|NCT03906656|469023743|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
130289731|NCT01945775|469023744|FG000|Overall Study|Death|214|||
130289732|NCT01945775|469023745|FG001|Overall Study|Death|98|||
130289733|NCT01945775|469023744|FG000|Overall Study|Lost to Follow-up|12|||
130289734|NCT01945775|469023745|FG001|Overall Study|Lost to Follow-up|7|||
130289735|NCT01945775|469023744|FG000|Overall Study|Withdrawal by Subject|11|||
130289736|NCT01945775|469023745|FG001|Overall Study|Withdrawal by Subject|21|||
130289737|NCT01945775|469023744|FG000|Overall Study|Other|50|||
130289738|NCT01945775|469023745|FG001|Overall Study|Other|18|||
130289739|NCT02876328|469023746|FG000|Overall Study|Death|2|||
130289740|NCT02876328|469023747|FG001|Overall Study|Death|1|||
130289741|NCT02876328|469023748|FG002|Overall Study|Death|3|||
130289742|NCT02876328|469023749|FG003|Overall Study|Death|0|||
130289743|NCT02876328|469023750|FG004|Overall Study|Death|0|||
130289744|NCT02876328|469023751|FG005|Overall Study|Death|0|||
130289745|NCT02876328|469023752|FG006|Overall Study|Death|1|||
130289746|NCT02876328|469023753|FG007|Overall Study|Death|3|||
130289747|NCT02876328|469023754|FG008|Overall Study|Death|0|||
130289748|NCT02876328|469023755|FG009|Overall Study|Death|1|||
130289749|NCT02876328|469023756|FG010|Overall Study|Death|1|||
130289750|NCT02876328|469023757|FG011|Overall Study|Death|0|||
130289751|NCT02876328|469023758|FG012|Overall Study|Death|0|||
130289752|NCT02876328|469023759|FG013|Overall Study|Death|0|||
130289753|NCT02876328|469023760|FG014|Overall Study|Death|0|||
130045519|NCT02400346|468125516|FG000|Overall Study|Non-compliance with IMP|1|||
130289754|NCT02876328|469023761|FG015|Overall Study|Death|0|||
130289755|NCT02876328|469023762|FG016|Overall Study|Death|1|||
130289756|NCT02876328|469023763|FG017|Overall Study|Death|1|||
130289757|NCT02876328|469023764|FG018|Overall Study|Death|0|||
130289758|NCT02876328|469023765|FG019|Overall Study|Death|0|||
130289759|NCT02876328|469023766|FG020|Overall Study|Death|0|||
130289760|NCT02876328|469023767|FG021|Overall Study|Death|1|||
130289761|NCT02876328|469023768|FG022|Overall Study|Death|0|||
130045520|NCT02400346|468125516|FG000|Overall Study|Withdrawal by Subject|7|||
130045521|NCT02400346|468125516|FG000|Overall Study|Administrative or other reason(s)|2|||
130045522|NCT02400346|468125516|FG000|Overall Study|Lost to Follow-up|1|||
130045523|NCT01283581|468125517|FG000|Overall Study|Lost to Follow-up|8|||
130045524|NCT01283581|468125518|FG001|Overall Study|Lost to Follow-up|6|||
130045525|NCT01283581|468125519|FG002|Overall Study|Lost to Follow-up|8|||
130045526|NCT01283581|468125517|FG000|Overall Study|Withdrawal by Subject|2|||
130045527|NCT01283581|468125518|FG001|Overall Study|Withdrawal by Subject|5|||
130045528|NCT01283581|468125519|FG002|Overall Study|Withdrawal by Subject|2|||
130045529|NCT01283581|468125517|FG000|Overall Study|Adverse Event|1|||
130045530|NCT01283581|468125518|FG001|Overall Study|Adverse Event|1|||
130045531|NCT01283581|468125519|FG002|Overall Study|Adverse Event|4|||
130045532|NCT01283581|468125517|FG000|Overall Study|Physician Decision|0|||
130045533|NCT01283581|468125518|FG001|Overall Study|Physician Decision|1|||
130045534|NCT01283581|468125519|FG002|Overall Study|Physician Decision|2|||
130045535|NCT01283581|468125517|FG000|Overall Study|Protocol Violation|0|||
130045536|NCT01283581|468125518|FG001|Overall Study|Protocol Violation|1|||
130106491|NCT03273257|468350051|FG000|Overall Study|Death|0|||
130106492|NCT03273257|468350052|FG001|Overall Study|Death|1|||
130289762|NCT02876328|469023769|FG023|Overall Study|Death|0|||
130289763|NCT02876328|469023746|FG000|Overall Study|Withdrawal by Subject|0|||
130289764|NCT02876328|469023747|FG001|Overall Study|Withdrawal by Subject|2|||
130289765|NCT02876328|469023748|FG002|Overall Study|Withdrawal by Subject|3|||
130289766|NCT02876328|469023749|FG003|Overall Study|Withdrawal by Subject|3|||
130289767|NCT02876328|469023750|FG004|Overall Study|Withdrawal by Subject|0|||
130289768|NCT02876328|469023751|FG005|Overall Study|Withdrawal by Subject|1|||
130289769|NCT02876328|469023752|FG006|Overall Study|Withdrawal by Subject|0|||
130289770|NCT02876328|469023753|FG007|Overall Study|Withdrawal by Subject|1|||
130289771|NCT02876328|469023754|FG008|Overall Study|Withdrawal by Subject|1|||
130289772|NCT02876328|469023755|FG009|Overall Study|Withdrawal by Subject|2|||
130289773|NCT02876328|469023756|FG010|Overall Study|Withdrawal by Subject|0|||
130289774|NCT02876328|469023757|FG011|Overall Study|Withdrawal by Subject|0|||
130289775|NCT02876328|469023758|FG012|Overall Study|Withdrawal by Subject|0|||
130289776|NCT02876328|469023759|FG013|Overall Study|Withdrawal by Subject|0|||
130289777|NCT02876328|469023760|FG014|Overall Study|Withdrawal by Subject|0|||
130289778|NCT02876328|469023761|FG015|Overall Study|Withdrawal by Subject|0|||
130289779|NCT02876328|469023762|FG016|Overall Study|Withdrawal by Subject|1|||
130289780|NCT02876328|469023763|FG017|Overall Study|Withdrawal by Subject|3|||
130289781|NCT02876328|469023764|FG018|Overall Study|Withdrawal by Subject|0|||
130289782|NCT02876328|469023765|FG019|Overall Study|Withdrawal by Subject|0|||
130289783|NCT02876328|469023766|FG020|Overall Study|Withdrawal by Subject|1|||
130289784|NCT02876328|469023767|FG021|Overall Study|Withdrawal by Subject|0|||
130289785|NCT02876328|469023768|FG022|Overall Study|Withdrawal by Subject|0|||
130289786|NCT02876328|469023769|FG023|Overall Study|Withdrawal by Subject|0|||
130289787|NCT02876328|469023746|FG000|Overall Study|Missed 12 Month Visit|15|||
130289788|NCT02876328|469023747|FG001|Overall Study|Missed 12 Month Visit|10|||
130289789|NCT02876328|469023748|FG002|Overall Study|Missed 12 Month Visit|11|||
130289790|NCT02876328|469023749|FG003|Overall Study|Missed 12 Month Visit|6|||
130289791|NCT02876328|469023750|FG004|Overall Study|Missed 12 Month Visit|10|||
130289792|NCT02876328|469023751|FG005|Overall Study|Missed 12 Month Visit|14|||
130045537|NCT01283581|468125519|FG002|Overall Study|Protocol Violation|2|||
130289793|NCT02876328|469023752|FG006|Overall Study|Missed 12 Month Visit|3|||
130289794|NCT02876328|469023753|FG007|Overall Study|Missed 12 Month Visit|8|||
130289795|NCT02876328|469023754|FG008|Overall Study|Missed 12 Month Visit|9|||
130045538|NCT01283581|468125517|FG000|Overall Study|Noncompliance|1|||
130045539|NCT01283581|468125518|FG001|Overall Study|Noncompliance|0|||
130045540|NCT01283581|468125519|FG002|Overall Study|Noncompliance|0|||
130045541|NCT01283581|468125517|FG000|Overall Study|Investigator unblinded|0|||
130289796|NCT02876328|469023755|FG009|Overall Study|Missed 12 Month Visit|5|||
130289797|NCT02876328|469023756|FG010|Overall Study|Missed 12 Month Visit|4|||
130289798|NCT02876328|469023757|FG011|Overall Study|Missed 12 Month Visit|1|||
130289799|NCT02876328|469023758|FG012|Overall Study|Missed 12 Month Visit|5|||
130289800|NCT02876328|469023759|FG013|Overall Study|Missed 12 Month Visit|4|||
130289801|NCT02876328|469023760|FG014|Overall Study|Missed 12 Month Visit|4|||
130289802|NCT02876328|469023761|FG015|Overall Study|Missed 12 Month Visit|4|||
130289803|NCT02876328|469023762|FG016|Overall Study|Missed 12 Month Visit|3|||
130289804|NCT02876328|469023763|FG017|Overall Study|Missed 12 Month Visit|6|||
130289805|NCT02876328|469023764|FG018|Overall Study|Missed 12 Month Visit|2|||
130289806|NCT02876328|469023765|FG019|Overall Study|Missed 12 Month Visit|2|||
130289807|NCT02876328|469023766|FG020|Overall Study|Missed 12 Month Visit|11|||
130289808|NCT02876328|469023767|FG021|Overall Study|Missed 12 Month Visit|7|||
130289809|NCT02876328|469023768|FG022|Overall Study|Missed 12 Month Visit|1|||
130289810|NCT02876328|469023769|FG023|Overall Study|Missed 12 Month Visit|0|||
130289811|NCT03515941|469023774|FG000|Overall Study|Adverse Event|1|||
130289812|NCT03515941|469023775|FG001|Overall Study|Adverse Event|0|||
130289813|NCT00334282|469023776|FG000|Overall Study|Lost to Follow-up|11|||
130289814|NCT00334282|469023777|FG001|Overall Study|Lost to Follow-up|5|||
130289815|NCT00334282|469023776|FG000|Overall Study|Withdrawal by Subject|17|||
130289816|NCT00334282|469023777|FG001|Overall Study|Withdrawal by Subject|3|||
129888266|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
129888267|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
129888268|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
129888269|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Other|2|||
129888270|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Other|0|||
129888271|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Other|1|||
129888272|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Adverse Event|21|||
129888273|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Adverse Event|26|||
129888274|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Adverse Event|0|||
129888275|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
129888276|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
129888277|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
130289817|NCT00334282|469023776|FG000|Overall Study|Death|194|||
130289818|NCT00334282|469023777|FG001|Overall Study|Death|100|||
130289819|NCT02759315|469023778|FG000|Overall Study|Adverse Event|0|||
130289820|NCT02759315|469023779|FG001|Overall Study|Adverse Event|0|||
130289821|NCT02759315|469023780|FG002|Overall Study|Adverse Event|0|||
130289822|NCT02759315|469023781|FG003|Overall Study|Adverse Event|1|||
130289823|NCT02759315|469023782|FG004|Overall Study|Adverse Event|0|||
130289824|NCT02759315|469023778|FG000|Overall Study|Death|0|||
130289825|NCT02759315|469023779|FG001|Overall Study|Death|0|||
130289826|NCT02759315|469023780|FG002|Overall Study|Death|1|||
130289827|NCT02759315|469023781|FG003|Overall Study|Death|0|||
130289828|NCT02759315|469023782|FG004|Overall Study|Death|0|||
130289829|NCT02759315|469023778|FG000|Overall Study|Lost to Follow-up|2|||
130289830|NCT02759315|469023779|FG001|Overall Study|Lost to Follow-up|0|||
130289831|NCT02759315|469023780|FG002|Overall Study|Lost to Follow-up|4|||
130289832|NCT02759315|469023781|FG003|Overall Study|Lost to Follow-up|0|||
130289833|NCT02759315|469023782|FG004|Overall Study|Lost to Follow-up|0|||
130289834|NCT02759315|469023778|FG000|Overall Study|Protocol Violation|0|||
130289835|NCT02759315|469023779|FG001|Overall Study|Protocol Violation|1|||
130289836|NCT02759315|469023780|FG002|Overall Study|Protocol Violation|0|||
130289837|NCT02759315|469023781|FG003|Overall Study|Protocol Violation|0|||
130289838|NCT02759315|469023782|FG004|Overall Study|Protocol Violation|0|||
130289839|NCT02759315|469023778|FG000|Overall Study|Study terminated prior to completion|2|||
130289840|NCT02759315|469023779|FG001|Overall Study|Study terminated prior to completion|0|||
130289841|NCT02759315|469023780|FG002|Overall Study|Study terminated prior to completion|5|||
130289842|NCT02759315|469023781|FG003|Overall Study|Study terminated prior to completion|0|||
130289843|NCT02759315|469023782|FG004|Overall Study|Study terminated prior to completion|1|||
130289844|NCT03464422|469023789|FG000|Overall Study|Lost to Follow-up|2|||
130289845|NCT03464422|469023789|FG000|Overall Study|Withdrawal by Subject|2|||
130289846|NCT01628367|469023795|FG000|Overall Study|Adverse Event|1|||
130289847|NCT01628367|469023796|FG001|Overall Study|Adverse Event|0|||
130289848|NCT03353922|469023799|FG000|Overall Study|Withdrawal by Subject|1|||
130289849|NCT03353922|469023800|FG001|Overall Study|Withdrawal by Subject|0|||
130289850|NCT03353922|469023801|FG002|Overall Study|Withdrawal by Subject|1|||
130289851|NCT03353922|469023802|FG003|Overall Study|Withdrawal by Subject|1|||
130289852|NCT03353922|469023803|FG004|Overall Study|Withdrawal by Subject|0|||
130289853|NCT03353922|469023804|FG005|Overall Study|Withdrawal by Subject|0|||
130289854|NCT03353922|469023799|FG000|Overall Study|Adverse Event|0|||
130289855|NCT03353922|469023800|FG001|Overall Study|Adverse Event|1|||
130289856|NCT03353922|469023801|FG002|Overall Study|Adverse Event|0|||
130289857|NCT03353922|469023802|FG003|Overall Study|Adverse Event|0|||
130289858|NCT03353922|469023803|FG004|Overall Study|Adverse Event|0|||
130289859|NCT03353922|469023804|FG005|Overall Study|Adverse Event|0|||
130289860|NCT00740714|469023805|FG000|Overall Study|Withdrawal by Subject|17|||
130289861|NCT00740714|469023806|FG001|Overall Study|Withdrawal by Subject|19|||
130289862|NCT00740714|469023807|FG002|Overall Study|Withdrawal by Subject|29|||
129888278|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
130289863|NCT03688555|469023808|FG000|Treatment Period|Adverse Event|0|||
129888279|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
129888280|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
130289864|NCT03688555|469023809|FG001|Treatment Period|Adverse Event|0|||
129793152|NCT02038829|467210707|FG000|Treatment Period 2|Adverse Event|0|||
129793153|NCT02038829|467210708|FG001|Treatment Period 2|Adverse Event|0|||
130289865|NCT03688555|469023810|FG002|Treatment Period|Adverse Event|1|||
130289866|NCT00886119|469023811|FG000|Period 1|Did not meet inclusion criteria|1|||
130289867|NCT00886119|469023812|FG001|Period 1|Did not meet inclusion criteria|0|||
130289868|NCT00259298|469023817|FG000|Overall Study|Withdrawal by Subject|1|||
130289869|NCT00259298|469023817|FG000|Overall Study|Physician Decision|2|||
130289870|NCT00645528|469023818|FG000|Overall Study|Did not show up for Visit 2|7|||
130289871|NCT01140568|469023819|FG000|Overall Study|disease progression|31|||
130289872|NCT01140568|469023819|FG000|Overall Study|Withdrawal by Subject|1|||
130289873|NCT01140568|469023819|FG000|Overall Study|Screen Fail|4|||
130289874|NCT03618628|469023820|FG000|Overall Study|Death|1|||
130289875|NCT03618628|469023820|FG000|Overall Study|Lost to Follow-up|1|||
130289876|NCT01741532|469023822|FG000|Overall Study|Adverse Event|4|||
130289877|NCT01741532|469023823|FG001|Overall Study|Adverse Event|0|||
130289878|NCT01741532|469023822|FG000|Overall Study|Withdrawal by Subject|1|||
130289879|NCT01741532|469023823|FG001|Overall Study|Withdrawal by Subject|1|||
130289880|NCT01741532|469023822|FG000|Overall Study|Protocol Violation|0|||
130289881|NCT01741532|469023823|FG001|Overall Study|Protocol Violation|1|||
130289882|NCT01741532|469023822|FG000|Overall Study|Worsening of the disease|3|||
130289883|NCT01741532|469023823|FG001|Overall Study|Worsening of the disease|1|||
130289884|NCT01741532|469023822|FG000|Overall Study|Sponsor decision|1|||
130289885|NCT01741532|469023823|FG001|Overall Study|Sponsor decision|0|||
130289886|NCT01741532|469023822|FG000|Overall Study|Medical event|1|||
130289887|NCT01741532|469023823|FG001|Overall Study|Medical event|0|||
130289888|NCT02153346|469023826|FG000|Overall Study|Lost to Follow-up|11|||
130289889|NCT03158272|469023828|FG000|Overall Study|Disease progression|3|||
129793154|NCT02038829|467210709|FG002|Treatment Period 2|Adverse Event|0|||
129793155|NCT02038829|467210710|FG003|Treatment Period 2|Adverse Event|0|||
129793156|NCT02038829|467210711|FG004|Treatment Period 2|Adverse Event|0|||
129793157|NCT02038829|467210712|FG005|Treatment Period 2|Adverse Event|0|||
129793158|NCT02038829|467210713|FG006|Treatment Period 2|Adverse Event|0|||
129793159|NCT02038829|467210714|FG007|Treatment Period 2|Adverse Event|0|||
129793160|NCT02038829|467210715|FG008|Treatment Period 2|Adverse Event|0|||
129793161|NCT02038829|467210716|FG009|Treatment Period 2|Adverse Event|0|||
129793162|NCT02038829|467210717|FG010|Treatment Period 2|Adverse Event|1|||
129793163|NCT02038829|467210718|FG011|Treatment Period 2|Adverse Event|0|||
129793164|NCT02038829|467210707|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129793165|NCT02038829|467210708|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129793166|NCT02038829|467210709|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129793167|NCT02038829|467210710|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129793168|NCT02038829|467210711|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129793169|NCT02038829|467210712|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129793170|NCT02038829|467210713|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129793171|NCT02038829|467210714|FG007|Treatment Period 2|Withdrawal by Subject|0|||
129793172|NCT02038829|467210715|FG008|Treatment Period 2|Withdrawal by Subject|0|||
129793173|NCT02038829|467210716|FG009|Treatment Period 2|Withdrawal by Subject|0|||
129793174|NCT02038829|467210717|FG010|Treatment Period 2|Withdrawal by Subject|0|||
129793175|NCT02038829|467210718|FG011|Treatment Period 2|Withdrawal by Subject|0|||
129793176|NCT02038829|467210707|FG000|Washout Period 2|Adverse Event|0|||
129793177|NCT02038829|467210708|FG001|Washout Period 2|Adverse Event|0|||
129793178|NCT02038829|467210709|FG002|Washout Period 2|Adverse Event|0|||
129793179|NCT02038829|467210710|FG003|Washout Period 2|Adverse Event|0|||
129793180|NCT02038829|467210711|FG004|Washout Period 2|Adverse Event|0|||
129793181|NCT02038829|467210712|FG005|Washout Period 2|Adverse Event|0|||
129793182|NCT02038829|467210713|FG006|Washout Period 2|Adverse Event|0|||
129793183|NCT02038829|467210714|FG007|Washout Period 2|Adverse Event|0|||
129793184|NCT02038829|467210715|FG008|Washout Period 2|Adverse Event|1|||
129793185|NCT02038829|467210716|FG009|Washout Period 2|Adverse Event|0|||
130045542|NCT01283581|468125518|FG001|Overall Study|Investigator unblinded|0|||
130045543|NCT01283581|468125519|FG002|Overall Study|Investigator unblinded|1|||
130045544|NCT01283581|468125517|FG000|Overall Study|"Early termination"|0|||
130289890|NCT03158272|469023829|FG001|Overall Study|Disease progression|3|||
130289891|NCT03158272|469023830|FG002|Overall Study|Disease progression|4|||
130289892|NCT03158272|469023831|FG003|Overall Study|Disease progression|6|||
130289893|NCT03158272|469023828|FG000|Overall Study|Death|0|||
130289894|NCT03158272|469023829|FG001|Overall Study|Death|0|||
130289895|NCT03158272|469023830|FG002|Overall Study|Death|1|||
130289896|NCT03158272|469023831|FG003|Overall Study|Death|0|||
130289897|NCT03158272|469023828|FG000|Overall Study|Other reasons|0|||
130289898|NCT03158272|469023829|FG001|Overall Study|Other reasons|0|||
130289899|NCT03158272|469023830|FG002|Overall Study|Other reasons|1|||
130289900|NCT03158272|469023831|FG003|Overall Study|Other reasons|0|||
130289901|NCT03158272|469023828|FG000|Overall Study|Adverse event unrelated to the drug|0|||
130289902|NCT03158272|469023829|FG001|Overall Study|Adverse event unrelated to the drug|1|||
130289903|NCT03158272|469023830|FG002|Overall Study|Adverse event unrelated to the drug|0|||
130289904|NCT03158272|469023831|FG003|Overall Study|Adverse event unrelated to the drug|0|||
130289905|NCT02366767|469023834|FG000|Overall Study|left for home after 1 day at camp|1|||
129793186|NCT02038829|467210717|FG010|Washout Period 2|Adverse Event|0|||
130045545|NCT01283581|468125518|FG001|Overall Study|"Early termination"|0|||
130045546|NCT01283581|468125519|FG002|Overall Study|"Early termination"|1|||
130045547|NCT00486226|468125520|FG000|Overall Study|Death|3|||
130045548|NCT00486226|468125520|FG000|Overall Study|Adverse Event|1|||
130289906|NCT02366767|469023835|FG001|Overall Study|left for home after 1 day at camp|0|||
130289907|NCT02558400|469023838|FG000|Overall Study|Adverse Event|47|||
130289908|NCT02558400|469023839|FG001|Overall Study|Adverse Event|53|||
130289909|NCT02558400|469023840|FG002|Overall Study|Adverse Event|4|||
130289910|NCT02558400|469023838|FG000|Overall Study|Withdrawal by Subject|13|||
130289911|NCT02558400|469023839|FG001|Overall Study|Withdrawal by Subject|9|||
130289912|NCT02558400|469023840|FG002|Overall Study|Withdrawal by Subject|8|||
130289913|NCT02558400|469023838|FG000|Overall Study|Non-Compliant|0|||
130289914|NCT02558400|469023839|FG001|Overall Study|Non-Compliant|1|||
130289915|NCT02558400|469023840|FG002|Overall Study|Non-Compliant|3|||
130289916|NCT02558400|469023838|FG000|Overall Study|Lost to Follow-up|5|||
130289917|NCT02558400|469023839|FG001|Overall Study|Lost to Follow-up|5|||
130289918|NCT02558400|469023840|FG002|Overall Study|Lost to Follow-up|4|||
130289919|NCT02558400|469023838|FG000|Overall Study|Lack of Efficacy|0|||
130289920|NCT02558400|469023839|FG001|Overall Study|Lack of Efficacy|13|||
130289921|NCT02558400|469023840|FG002|Overall Study|Lack of Efficacy|1|||
130289922|NCT02558400|469023838|FG000|Overall Study|Disallowed Concurrent Medication|6|||
130289923|NCT02558400|469023839|FG001|Overall Study|Disallowed Concurrent Medication|7|||
130289924|NCT02558400|469023840|FG002|Overall Study|Disallowed Concurrent Medication|5|||
130289925|NCT02558400|469023838|FG000|Overall Study|Physician Decision|2|||
130289926|NCT02558400|469023839|FG001|Overall Study|Physician Decision|2|||
130289927|NCT02558400|469023840|FG002|Overall Study|Physician Decision|0|||
130289928|NCT02558400|469023838|FG000|Overall Study|Protocol Violation|6|||
130289929|NCT02558400|469023839|FG001|Overall Study|Protocol Violation|3|||
130289930|NCT02558400|469023840|FG002|Overall Study|Protocol Violation|8|||
130289931|NCT02558400|469023838|FG000|Overall Study|Death|0|||
130289932|NCT02558400|469023839|FG001|Overall Study|Death|1|||
130289933|NCT02558400|469023840|FG002|Overall Study|Death|0|||
130289934|NCT02558400|469023838|FG000|Overall Study|Ineligible for the study|0|||
130289935|NCT02558400|469023839|FG001|Overall Study|Ineligible for the study|2|||
130289936|NCT02558400|469023840|FG002|Overall Study|Ineligible for the study|0|||
130289937|NCT03654885|469025314|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
130289938|NCT03654885|469025315|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
130289939|NCT03654885|469025314|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
130289940|NCT03654885|469025315|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
130289941|NCT03654885|469025314|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
130289942|NCT03654885|469025315|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
130289943|NCT03654885|469025314|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
130289944|NCT03654885|469025315|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
130289945|NCT03654885|469025314|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
130289946|NCT03654885|469025315|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
130289947|NCT03654885|469025314|FG000|Overall Study|Adverse Event in Study Eye|3|||
130289948|NCT03654885|469025315|FG001|Overall Study|Adverse Event in Study Eye|0|||
130289949|NCT03654885|469025314|FG000|Overall Study|Consent Withdrawn|1|||
129793187|NCT02038829|467210718|FG011|Washout Period 2|Adverse Event|0|||
129793188|NCT02038829|467210707|FG000|Washout Period 2|Withdrawal by Subject|0|||
129793189|NCT02038829|467210708|FG001|Washout Period 2|Withdrawal by Subject|0|||
129793190|NCT02038829|467210709|FG002|Washout Period 2|Withdrawal by Subject|0|||
129793191|NCT02038829|467210710|FG003|Washout Period 2|Withdrawal by Subject|0|||
129793192|NCT02038829|467210711|FG004|Washout Period 2|Withdrawal by Subject|0|||
129793193|NCT02038829|467210712|FG005|Washout Period 2|Withdrawal by Subject|1|||
129793194|NCT02038829|467210713|FG006|Washout Period 2|Withdrawal by Subject|0|||
129793195|NCT02038829|467210714|FG007|Washout Period 2|Withdrawal by Subject|0|||
129793196|NCT02038829|467210715|FG008|Washout Period 2|Withdrawal by Subject|0|||
129793197|NCT02038829|467210716|FG009|Washout Period 2|Withdrawal by Subject|0|||
129793198|NCT02038829|467210717|FG010|Washout Period 2|Withdrawal by Subject|0|||
129793199|NCT02038829|467210718|FG011|Washout Period 2|Withdrawal by Subject|0|||
129793200|NCT02038829|467210707|FG000|Treatment Period 4|Adverse Event|0|||
129793201|NCT02038829|467210708|FG001|Treatment Period 4|Adverse Event|1|||
129793202|NCT02038829|467210709|FG002|Treatment Period 4|Adverse Event|0|||
129793203|NCT02038829|467210710|FG003|Treatment Period 4|Adverse Event|0|||
129793204|NCT02038829|467210711|FG004|Treatment Period 4|Adverse Event|0|||
130289950|NCT03654885|469025315|FG001|Overall Study|Consent Withdrawn|0|||
130289951|NCT03654885|469025314|FG000|Overall Study|Death|3|||
129793205|NCT02038829|467210712|FG005|Treatment Period 4|Adverse Event|0|||
129793206|NCT02038829|467210713|FG006|Treatment Period 4|Adverse Event|0|||
129793207|NCT02038829|467210714|FG007|Treatment Period 4|Adverse Event|0|||
129793208|NCT02038829|467210715|FG008|Treatment Period 4|Adverse Event|0|||
130289952|NCT03654885|469025315|FG001|Overall Study|Death|1|||
130289953|NCT03654885|469025314|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
130289954|NCT03654885|469025315|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
130289955|NCT03654885|469025314|FG000|Overall Study|Lost to Follow-up|3|||
130289956|NCT03654885|469025315|FG001|Overall Study|Lost to Follow-up|3|||
130289957|NCT05275582|469025316|FG000|Overall Study|Lost to Follow-up|1|||
130289958|NCT05275582|469025317|FG001|Overall Study|Lost to Follow-up|0|||
130289959|NCT05275582|469025316|FG000|Overall Study|Withdrawal by Subject|0|||
130289960|NCT05275582|469025317|FG001|Overall Study|Withdrawal by Subject|2|||
130289961|NCT05275582|469025316|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
130289962|NCT05275582|469025317|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
130289963|NCT05275582|469025316|FG000|Overall Study|Death|1|||
130289964|NCT05275582|469025317|FG001|Overall Study|Death|0|||
130289965|NCT05275582|469025316|FG000|Overall Study|Protocol Violation|1|||
130289966|NCT05275582|469025317|FG001|Overall Study|Protocol Violation|0|||
130289967|NCT00031460|469025320|FG000|Overall Study|Lost to Follow-up|0|||
130289968|NCT00031460|469025321|FG001|Overall Study|Lost to Follow-up|1|||
130289969|NCT00031460|469025320|FG000|Overall Study|Withdrawal by Subject|1|||
130289970|NCT00031460|469025321|FG001|Overall Study|Withdrawal by Subject|1|||
130289971|NCT00031460|469025320|FG000|Overall Study|Non-Compliant|1|||
129793209|NCT02038829|467210716|FG009|Treatment Period 4|Adverse Event|0|||
129793210|NCT02038829|467210717|FG010|Treatment Period 4|Adverse Event|0|||
129793211|NCT02038829|467210718|FG011|Treatment Period 4|Adverse Event|0|||
129793212|NCT02038829|467210707|FG000|Washout Period 4|Adverse Event|0|||
129793213|NCT02038829|467210708|FG001|Washout Period 4|Adverse Event|0|||
129793214|NCT02038829|467210709|FG002|Washout Period 4|Adverse Event|0|||
130289972|NCT00031460|469025321|FG001|Overall Study|Non-Compliant|1|||
130289973|NCT00031460|469025320|FG000|Overall Study|Death|0|||
130289974|NCT00031460|469025321|FG001|Overall Study|Death|1|||
130289975|NCT00031460|469025320|FG000|Overall Study|Reactivation of Disease|5|||
130289976|NCT00031460|469025321|FG001|Overall Study|Reactivation of Disease|9|||
130289977|NCT00031460|469025320|FG000|Overall Study|Disruption of blinded drug supply|2|||
130289978|NCT00031460|469025321|FG001|Overall Study|Disruption of blinded drug supply|0|||
130289979|NCT00031460|469025320|FG000|Overall Study|Confirmed unevaluable|0|||
130289980|NCT00031460|469025321|FG001|Overall Study|Confirmed unevaluable|1|||
130289981|NCT02210832|469025322|FG000|Overall Study|Pregnancy termination .|3|||
130289982|NCT02210832|469025323|FG001|Overall Study|Pregnancy termination .|4|||
130289983|NCT02210832|469025324|FG002|Overall Study|Pregnancy termination .|1|||
130289984|NCT02210832|469025322|FG000|Overall Study|Lost to Follow-up|26|||
130289985|NCT02210832|469025323|FG001|Overall Study|Lost to Follow-up|32|||
130289986|NCT02210832|469025324|FG002|Overall Study|Lost to Follow-up|17|||
130289987|NCT02080260|469025329|FG000|Overall Study|Death|18|||
130289988|NCT02080260|469025329|FG000|Overall Study|Withdrawal by Subject|1|||
130289989|NCT00471887|469025332|FG000|Overall Study|Adverse Event|9|||
130289990|NCT01030874|469025336|FG000|Overall Study|Withdrawal by Subject|1|||
130289991|NCT01030874|469025337|FG001|Overall Study|Withdrawal by Subject|0|||
130289992|NCT01030874|469025336|FG000|Overall Study|Discharged in first 2 weeks|17|||
130289993|NCT01030874|469025337|FG001|Overall Study|Discharged in first 2 weeks|16|||
130289994|NCT04639219|469025338|FG000|Overall Study|Withdrawal by Subject|8|||
130289995|NCT04639219|469025338|FG000|Overall Study|Lost to Follow-up|6|||
130289996|NCT04639219|469025338|FG000|Overall Study|Death|55|||
130289997|NCT01998893|469025339|FG000|Overall Study|Adverse Event|2|||
130289998|NCT01998893|469025339|FG000|Overall Study|Death|1|||
130289999|NCT01998893|469025339|FG000|Overall Study|Lost to Follow-up|8|||
130290000|NCT01998893|469025339|FG000|Overall Study|Physician Decision|2|||
130290001|NCT01998893|469025339|FG000|Overall Study|Protocol Violation|2|||
130290002|NCT01998893|469025339|FG000|Overall Study|Withdrawal by Subject|1|||
130290003|NCT01998893|469025339|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
130290004|NCT03784846|469025340|FG000|Pre-COVID Study|Lost to Follow-up|3|||
130290005|NCT03784846|469025341|FG001|Pre-COVID Study|Lost to Follow-up|3|||
130290006|NCT03784846|469025342|FG002|Pre-COVID Study|Lost to Follow-up|2|||
130290007|NCT03784846|469025340|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
130290008|NCT03784846|469025341|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
130290009|NCT03784846|469025342|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
130290010|NCT03784846|469025340|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
130290011|NCT03784846|469025341|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
130290012|NCT03784846|469025342|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
130290013|NCT03784846|469025340|FG000|Post-COVID Study|Lost to Follow-up|3|||
130290014|NCT03784846|469025341|FG001|Post-COVID Study|Lost to Follow-up|5|||
130290015|NCT03784846|469025342|FG002|Post-COVID Study|Lost to Follow-up|1|||
130290016|NCT03784846|469025340|FG000|Post-COVID Study|Withdrawal by Subject|1|||
130290017|NCT03784846|469025341|FG001|Post-COVID Study|Withdrawal by Subject|2|||
130290018|NCT03784846|469025342|FG002|Post-COVID Study|Withdrawal by Subject|0|||
130290019|NCT00867087|469025343|FG000|Overall Study|Other|1|||
130290020|NCT00867087|469025343|FG000|Overall Study|Withdrawal by Subject|4|||
130290021|NCT00867087|469025343|FG000|Overall Study|Death|37|||
130290022|NCT03883113|469025345|FG000|Overall Study|Physician Decision|4|||
130290023|NCT03883113|469025346|FG001|Overall Study|Physician Decision|2|||
130290024|NCT03883113|469025345|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
130290025|NCT03883113|469025346|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
130290026|NCT03883113|469025345|FG000|Overall Study|Pregnancy|1|||
130290027|NCT03883113|469025346|FG001|Overall Study|Pregnancy|0|||
130290028|NCT03883113|469025345|FG000|Overall Study|Adverse Event|0|||
130290029|NCT03883113|469025346|FG001|Overall Study|Adverse Event|1|||
130290030|NCT03883113|469025345|FG000|Overall Study|Withdrawal by Subject|1|||
130290031|NCT03883113|469025346|FG001|Overall Study|Withdrawal by Subject|2|||
130290032|NCT03883113|469025345|FG000|Overall Study|Lost to Follow-up|1|||
130290033|NCT03883113|469025346|FG001|Overall Study|Lost to Follow-up|0|||
130290034|NCT01457950|469025347|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
130290035|NCT01457950|469025348|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
130290036|NCT01457950|469025349|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
130290037|NCT01457950|469025350|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
130290038|NCT01457950|469025347|FG000|Double-Blind Phase|Protocol Violation|2|||
130290039|NCT01457950|469025348|FG001|Double-Blind Phase|Protocol Violation|1|||
130290040|NCT01457950|469025349|FG002|Double-Blind Phase|Protocol Violation|0|||
130290041|NCT01457950|469025350|FG003|Double-Blind Phase|Protocol Violation|0|||
130290042|NCT01457950|469025347|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
130290043|NCT01457950|469025348|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130290044|NCT01457950|469025349|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130290045|NCT01457950|469025350|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130290046|NCT01457950|469025347|FG000|Open-Label Phase|Adverse Event|0|||
130290047|NCT01457950|469025348|FG001|Open-Label Phase|Adverse Event|0|||
130290048|NCT01457950|469025349|FG002|Open-Label Phase|Adverse Event|0|||
130045549|NCT00486226|468125520|FG000|Overall Study|Withdrawal by Subject|1|||
130045550|NCT00486226|468125520|FG000|Overall Study|Lost to Follow-up|8|||
130045551|NCT01259492|468125521|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
130045552|NCT01259492|468125522|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
130045553|NCT01259492|468125523|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
130290049|NCT01457950|469025350|FG003|Open-Label Phase|Adverse Event|1|||
130290050|NCT01457950|469025347|FG000|Open-Label Phase|Protocol Violation|0|||
130290051|NCT01457950|469025348|FG001|Open-Label Phase|Protocol Violation|0|||
130290052|NCT01457950|469025349|FG002|Open-Label Phase|Protocol Violation|0|||
130290053|NCT01457950|469025350|FG003|Open-Label Phase|Protocol Violation|1|||
130290054|NCT01457950|469025347|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130290055|NCT01457950|469025348|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130290056|NCT01457950|469025349|FG002|Open-Label Phase|Withdrawal by Subject|2|||
130290057|NCT01457950|469025350|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130290058|NCT00054691|469025351|FG000|Overall Study|Unmeasurable Disease|2|||
130290059|NCT00054691|469025351|FG000|Overall Study|Noncompliant|1|||
130290060|NCT02498067|469025352|FG000|Overall Study|Lost to Follow-up|22|||
130290061|NCT02498067|469025352|FG000|Overall Study|Did not meet inclusion criteria|11|||
130290062|NCT03351114|469025356|FG000|Overall Study|Withdrawal by Subject|1|||
130290063|NCT01371643|469025361|FG000|Overall Study|Withdrawal by Subject|3|||
130290064|NCT01371643|469025362|FG001|Overall Study|Withdrawal by Subject|0|||
130290065|NCT03249935|469025363|FG000|Overall Study|Discharged from facility early|36|||
130290066|NCT03249935|469025363|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
130290067|NCT03249935|469025363|FG000|Overall Study|Protocol Violation|5|||
130290068|NCT03593681|469025364|FG000|Overall Study|Inadequate sample collected|12|||
130290069|NCT03593681|469025364|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
130290070|NCT03593681|469025364|FG000|Overall Study|Protocol Violation|3|||
130290071|NCT03593681|469025364|FG000|Overall Study|Withdrawal by Subject|3|||
130290072|NCT03593681|469025364|FG000|Overall Study|Procedure not attempted|3|||
130290073|NCT03593681|469025364|FG000|Overall Study|Adverse Event|2|||
130290074|NCT03593681|469025364|FG000|Overall Study|Physician Decision|1|||
130290075|NCT03987932|469025371|FG000|Overall Study|Lost to Follow-up|2|||
130290076|NCT03987932|469025372|FG001|Overall Study|Lost to Follow-up|1|||
130290077|NCT03987932|469025373|FG002|Overall Study|Lost to Follow-up|1|||
130290078|NCT03987932|469025371|FG000|Overall Study|Non-study related elective surgery|0|||
130290079|NCT03987932|469025372|FG001|Overall Study|Non-study related elective surgery|0|||
130290080|NCT03987932|469025373|FG002|Overall Study|Non-study related elective surgery|1|||
130290081|NCT01669421|469025374|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
130290082|NCT01669421|469025374|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
130290083|NCT00810901|469025378|FG000|Overall Study|Lost to Follow-up|88|||
130290084|NCT00810901|469025379|FG001|Overall Study|Lost to Follow-up|58|||
130290085|NCT00343915|469025386|FG000|Primary Study|Withdrawal by Subject|1|||
130290086|NCT00343915|469025387|FG001|Primary Study|Withdrawal by Subject|0|||
130290087|NCT00343915|469025386|FG000|Primary Study|Lost to Follow-up|2|||
130290088|NCT00343915|469025387|FG001|Primary Study|Lost to Follow-up|3|||
130290089|NCT00343915|469025386|FG000|Primary Study|Other|1|||
130290090|NCT00343915|469025387|FG001|Primary Study|Other|0|||
130290091|NCT00882908|469025388|FG000|Overall Study|Adverse Event|0|||
130290092|NCT00882908|469025389|FG001|Overall Study|Adverse Event|0|||
130290093|NCT00882908|469025390|FG002|Overall Study|Adverse Event|1|||
130290094|NCT00882908|469025391|FG003|Overall Study|Adverse Event|0|||
130290095|NCT00882908|469025392|FG004|Overall Study|Adverse Event|1|||
130290096|NCT00882908|469025388|FG000|Overall Study|Lost to Follow-up|3|||
130290097|NCT00882908|469025389|FG001|Overall Study|Lost to Follow-up|5|||
130290098|NCT00882908|469025390|FG002|Overall Study|Lost to Follow-up|3|||
130290099|NCT00882908|469025391|FG003|Overall Study|Lost to Follow-up|1|||
130290100|NCT00882908|469025392|FG004|Overall Study|Lost to Follow-up|2|||
130290101|NCT00882908|469025388|FG000|Overall Study|Protocol Violation|0|||
130290102|NCT00882908|469025389|FG001|Overall Study|Protocol Violation|1|||
130290103|NCT00882908|469025390|FG002|Overall Study|Protocol Violation|0|||
130290104|NCT00882908|469025391|FG003|Overall Study|Protocol Violation|0|||
130290105|NCT00882908|469025392|FG004|Overall Study|Protocol Violation|0|||
130290106|NCT00882908|469025388|FG000|Overall Study|Withdrawal by Subject|0|||
130290107|NCT00882908|469025389|FG001|Overall Study|Withdrawal by Subject|0|||
130045554|NCT01259492|468125524|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
130290108|NCT00882908|469025390|FG002|Overall Study|Withdrawal by Subject|3|||
130290109|NCT00882908|469025391|FG003|Overall Study|Withdrawal by Subject|5|||
130290110|NCT00882908|469025392|FG004|Overall Study|Withdrawal by Subject|2|||
130290111|NCT00882908|469025388|FG000|Overall Study|Subject reached a virologic endpoint|0|||
130290112|NCT00882908|469025389|FG001|Overall Study|Subject reached a virologic endpoint|0|||
130290113|NCT00882908|469025390|FG002|Overall Study|Subject reached a virologic endpoint|0|||
130290114|NCT00882908|469025391|FG003|Overall Study|Subject reached a virologic endpoint|0|||
130290115|NCT00882908|469025392|FG004|Overall Study|Subject reached a virologic endpoint|1|||
130290116|NCT00882908|469025388|FG000|Overall Study|Study terminated in error|0|||
130290117|NCT00882908|469025389|FG001|Overall Study|Study terminated in error|0|||
130290118|NCT00882908|469025390|FG002|Overall Study|Study terminated in error|0|||
130290119|NCT00882908|469025391|FG003|Overall Study|Study terminated in error|1|||
130290120|NCT00882908|469025392|FG004|Overall Study|Study terminated in error|0|||
130290121|NCT05291936|469025393|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
130290122|NCT05291936|469025394|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
130290123|NCT05291936|469025393|FG000|Period 1|Withdrew Consent during study|1|||
130290124|NCT05291936|469025394|FG001|Period 1|Withdrew Consent during study|0|||
130290125|NCT05291936|469025393|FG000|Period 2|Adverse Event|0|||
130290126|NCT05291936|469025394|FG001|Period 2|Adverse Event|1|||
130290127|NCT05291936|469025393|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130290128|NCT05291936|469025394|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130290129|NCT00581828|469025395|FG000|Overall Study|Protocol Violation|1|||
130290130|NCT02370095|469025396|FG000|Overall Study|Withdrawal by Subject|0|||
130290131|NCT02370095|469025397|FG001|Overall Study|Withdrawal by Subject|1|||
130290132|NCT01667562|469025398|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
130290133|NCT01667562|469025399|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
130290134|NCT01667562|469025398|FG000|Erlotinib Phase|Lost to Follow-up|0|||
130290135|NCT01667562|469025399|FG001|Erlotinib Phase|Lost to Follow-up|1|||
130290136|NCT01667562|469025398|FG000|Erlotinib Phase|Adverse Event|0|||
130290137|NCT01667562|469025399|FG001|Erlotinib Phase|Adverse Event|1|||
130290138|NCT01667562|469025398|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
130290139|NCT01667562|469025399|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
130290140|NCT02130986|469025403|FG000|Overall Study|Withdrawal by Subject|4|||
130290141|NCT02130986|469025404|FG001|Overall Study|Withdrawal by Subject|4|||
130290142|NCT02130986|469025403|FG000|Overall Study|Lost to Follow-up|151|||
130290143|NCT02130986|469025404|FG001|Overall Study|Lost to Follow-up|160|||
130290144|NCT01129882|469025405|FG000|Overall Study|Adverse Event|39|||
130290145|NCT01129882|469025405|FG000|Overall Study|Death|6|||
130290146|NCT01129882|469025405|FG000|Overall Study|Lack of Efficacy|5|||
130290147|NCT01129882|469025405|FG000|Overall Study|Lost to Follow-up|13|||
130290148|NCT01129882|469025405|FG000|Overall Study|Physician Decision|27|||
130290149|NCT01129882|469025405|FG000|Overall Study|Protocol Deviation|3|||
130290150|NCT01129882|469025405|FG000|Overall Study|Withdrawal Criteria Met|19|||
130290151|NCT01129882|469025405|FG000|Overall Study|Trial Termination by Sponsor|6|||
130290152|NCT01129882|469025405|FG000|Overall Study|Withdrawal by Subject|160|||
130290153|NCT05590000|469025406|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
130290154|NCT00536874|469025407|FG000|Overall Study|Adverse Event|1|||
130290155|NCT00536874|469025407|FG000|Overall Study|Death|2|||
130290156|NCT00536874|469025407|FG000|Overall Study|Withdrawal by Subject|1|||
130290157|NCT00762996|469025408|FG000|Period One|Protocol Violation|0|||
130290158|NCT00762996|469025409|FG001|Period One|Protocol Violation|0|||
130290159|NCT00762996|469025410|FG002|Period One|Protocol Violation|1|||
130290160|NCT00762996|469025411|FG003|Period One|Protocol Violation|0|||
130290161|NCT00762996|469025408|FG000|Period One|ineligible|0|||
130290162|NCT00762996|469025409|FG001|Period One|ineligible|0|||
130290163|NCT00762996|469025410|FG002|Period One|ineligible|1|||
130290164|NCT00762996|469025411|FG003|Period One|ineligible|1|||
130290165|NCT00762996|469025408|FG000|Period One|Adverse Event|0|||
130290166|NCT00762996|469025409|FG001|Period One|Adverse Event|0|||
130290167|NCT00762996|469025410|FG002|Period One|Adverse Event|1|||
130290168|NCT00762996|469025411|FG003|Period One|Adverse Event|0|||
130290169|NCT00762996|469025408|FG000|Period One|Withdrawal by Subject|0|||
130290170|NCT00762996|469025409|FG001|Period One|Withdrawal by Subject|0|||
130290171|NCT00762996|469025410|FG002|Period One|Withdrawal by Subject|1|||
130290172|NCT00762996|469025411|FG003|Period One|Withdrawal by Subject|0|||
130290173|NCT02689076|469025413|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
130290174|NCT02689076|469025414|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
130290175|NCT02689076|469025415|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
130290176|NCT02689076|469025413|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
130290177|NCT02689076|469025414|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
130290178|NCT02689076|469025415|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
130110726|NCT03705169|468365853|FG008|Overall Study|Did not receive study treatment|0|||
130290179|NCT02689076|469025413|FG000|Overall Study|Did not have an HIE match|2|||
130290180|NCT02689076|469025414|FG001|Overall Study|Did not have an HIE match|0|||
130290181|NCT02689076|469025415|FG002|Overall Study|Did not have an HIE match|0|||
130290182|NCT02689076|469025413|FG000|Overall Study|Death during non-VA encounter|2|||
130290183|NCT02689076|469025414|FG001|Overall Study|Death during non-VA encounter|5|||
130290184|NCT02689076|469025415|FG002|Overall Study|Death during non-VA encounter|0|||
130290185|NCT02689076|469025413|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
130290186|NCT02689076|469025414|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
130290187|NCT02689076|469025415|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
130290188|NCT02689076|469025413|FG000|Overall Study|Participant no longer active in VA system|1|||
130290189|NCT02689076|469025414|FG001|Overall Study|Participant no longer active in VA system|0|||
130290190|NCT02689076|469025415|FG002|Overall Study|Participant no longer active in VA system|0|||
130290191|NCT02689076|469025413|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
130290192|NCT02689076|469025414|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
130290193|NCT02689076|469025415|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
130290194|NCT02084238|469025416|FG000|Overall Study|Lost to Follow-up|2|||
130290195|NCT01304329|469025417|FG000|Third Intervention (3 Days)|Adverse Event|0|||
130290196|NCT01304329|469025418|FG001|Third Intervention (3 Days)|Adverse Event|1|||
130290197|NCT01304329|469025419|FG002|Third Intervention (3 Days)|Adverse Event|0|||
130290198|NCT01304329|469025420|FG003|Third Intervention (3 Days)|Adverse Event|0|||
130290199|NCT01304329|469025421|FG004|Third Intervention (3 Days)|Adverse Event|0|||
130290200|NCT01304329|469025422|FG005|Third Intervention (3 Days)|Adverse Event|0|||
130290201|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Adverse Event|0|||
130290202|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Adverse Event|1|||
130290203|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Adverse Event|0|||
130290204|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Adverse Event|0|||
130290205|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Adverse Event|0|||
130290206|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Adverse Event|0|||
130290207|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
130290208|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290209|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290210|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290211|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290212|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
130290213|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
130290214|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
130290215|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
130290216|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
130290217|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
130290218|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
130290219|NCT00993499|469025429|FG000|Run-in Period (8 Days)|Progressive disease|0|||
130290220|NCT00993499|469025430|FG001|Run-in Period (8 Days)|Progressive disease|1|||
130290221|NCT00993499|469025431|FG002|Run-in Period (8 Days)|Progressive disease|1|||
130290222|NCT00993499|469025432|FG003|Run-in Period (8 Days)|Progressive disease|0|||
130290223|NCT00993499|469025433|FG004|Run-in Period (8 Days)|Progressive disease|0|||
130290224|NCT00993499|469025434|FG005|Run-in Period (8 Days)|Progressive disease|0|||
130290225|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
130290226|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
130290227|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290228|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290229|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290230|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
130290231|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
130290232|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
130290233|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290234|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290235|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290236|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
130290237|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290238|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290239|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
130290240|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
130290241|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290242|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
130290243|NCT00993499|469025429|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290244|NCT00993499|469025430|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290245|NCT00993499|469025431|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
130290246|NCT00993499|469025432|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290247|NCT00993499|469025433|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290248|NCT00993499|469025434|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
130290249|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290250|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
130290251|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129888281|NCT02718417|467549132|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
129888282|NCT02718417|467549133|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
129888283|NCT02718417|467549134|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
129888284|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Physician's decision|6|||
129888285|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Physician's decision|7|||
129888286|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Physician's decision|0|||
130045555|NCT01259492|468125521|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
130045556|NCT01259492|468125522|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
130045557|NCT01259492|468125523|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
130045558|NCT01259492|468125524|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
130045559|NCT01259492|468125521|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
130045560|NCT01259492|468125522|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
130045561|NCT01259492|468125523|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
130045562|NCT01259492|468125524|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
130045563|NCT01259492|468125521|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
130045564|NCT01259492|468125522|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
130045565|NCT01259492|468125523|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
130045566|NCT01259492|468125524|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
130045567|NCT01259492|468125521|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
130045568|NCT01259492|468125522|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
130290252|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290253|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290254|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
130290255|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
130290256|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
130290257|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
130290258|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
130290259|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
130290260|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
130290261|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|DLT|1|||
130290262|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|DLT|0|||
130290263|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|DLT|2|||
130290264|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|DLT|1|||
130290265|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|DLT|0|||
130290266|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|DLT|0|||
130290267|NCT00993499|469025429|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
130290268|NCT00993499|469025430|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
130290269|NCT00993499|469025431|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
130290270|NCT00993499|469025432|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
130290271|NCT00993499|469025433|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
130290272|NCT00993499|469025434|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
130290273|NCT01406015|469025443|FG000|Overall Study|Withdrawal by Subject|3|||
130290274|NCT01406015|469025444|FG001|Overall Study|Withdrawal by Subject|3|||
130290275|NCT00844805|469025445|FG000|Treatment Phase|Adverse Event|5|||
130290276|NCT00844805|469025446|FG001|Treatment Phase|Adverse Event|1|||
130290277|NCT00844805|469025447|FG002|Treatment Phase|Adverse Event|0|||
130290278|NCT00844805|469025448|FG003|Treatment Phase|Adverse Event|0|||
130290279|NCT00844805|469025445|FG000|Treatment Phase|Withdrawal by Subject|3|||
130290280|NCT00844805|469025446|FG001|Treatment Phase|Withdrawal by Subject|4|||
130290281|NCT00844805|469025447|FG002|Treatment Phase|Withdrawal by Subject|0|||
130290282|NCT00844805|469025448|FG003|Treatment Phase|Withdrawal by Subject|0|||
130290283|NCT00844805|469025445|FG000|Treatment Phase|Noncompliance With Protocol|1|||
130290284|NCT00844805|469025446|FG001|Treatment Phase|Noncompliance With Protocol|0|||
130290285|NCT00844805|469025447|FG002|Treatment Phase|Noncompliance With Protocol|0|||
130290286|NCT00844805|469025448|FG003|Treatment Phase|Noncompliance With Protocol|0|||
130290287|NCT00844805|469025445|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
130045569|NCT01259492|468125523|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
130045570|NCT01259492|468125524|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
130045571|NCT01259492|468125521|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
129888287|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Progressive disease|100|||
130290288|NCT00844805|469025446|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
130290289|NCT00844805|469025447|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
130290290|NCT00844805|469025448|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
130290291|NCT00844805|469025445|FG000|Follow-Up Phase|Adverse Event|0|||
130290292|NCT00844805|469025446|FG001|Follow-Up Phase|Adverse Event|0|||
130290293|NCT00844805|469025447|FG002|Follow-Up Phase|Adverse Event|1|||
130290294|NCT00844805|469025448|FG003|Follow-Up Phase|Adverse Event|0|||
130290295|NCT00844805|469025445|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130290296|NCT00844805|469025446|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130290297|NCT00844805|469025447|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
130290298|NCT00844805|469025448|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
130290299|NCT00844805|469025445|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
130290300|NCT00844805|469025446|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
130290301|NCT00844805|469025447|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
130290302|NCT00844805|469025448|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
130290303|NCT00844805|469025445|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
129793215|NCT02038829|467210710|FG003|Washout Period 4|Adverse Event|0|||
129793216|NCT02038829|467210711|FG004|Washout Period 4|Adverse Event|0|||
129793217|NCT02038829|467210712|FG005|Washout Period 4|Adverse Event|0|||
129793218|NCT02038829|467210713|FG006|Washout Period 4|Adverse Event|1|||
129793219|NCT02038829|467210714|FG007|Washout Period 4|Adverse Event|0|||
129793220|NCT02038829|467210715|FG008|Washout Period 4|Adverse Event|0|||
129793221|NCT02038829|467210716|FG009|Washout Period 4|Adverse Event|0|||
129793222|NCT02038829|467210717|FG010|Washout Period 4|Adverse Event|0|||
129793223|NCT02038829|467210718|FG011|Washout Period 4|Adverse Event|0|||
129793224|NCT02038829|467210707|FG000|Treatment Period 6|Adverse Event|0|||
129793225|NCT02038829|467210708|FG001|Treatment Period 6|Adverse Event|0|||
129793226|NCT02038829|467210709|FG002|Treatment Period 6|Adverse Event|1|||
129793227|NCT02038829|467210710|FG003|Treatment Period 6|Adverse Event|0|||
129793228|NCT02038829|467210711|FG004|Treatment Period 6|Adverse Event|0|||
129793229|NCT02038829|467210712|FG005|Treatment Period 6|Adverse Event|0|||
129793230|NCT02038829|467210713|FG006|Treatment Period 6|Adverse Event|0|||
129793231|NCT02038829|467210714|FG007|Treatment Period 6|Adverse Event|0|||
129793232|NCT02038829|467210715|FG008|Treatment Period 6|Adverse Event|0|||
129793233|NCT02038829|467210716|FG009|Treatment Period 6|Adverse Event|0|||
129793234|NCT02038829|467210717|FG010|Treatment Period 6|Adverse Event|0|||
129793235|NCT02038829|467210718|FG011|Treatment Period 6|Adverse Event|0|||
129793236|NCT02579928|467210719|FG000|Overall Study|Withdrawal by Subject|1|||
129793237|NCT02579928|467210720|FG001|Overall Study|Withdrawal by Subject|0|||
129793238|NCT01933789|467210729|FG000|Overall Study|Death|0|||
129793239|NCT01933789|467210730|FG001|Overall Study|Death|0|||
129793240|NCT01933789|467210731|FG002|Overall Study|Death|0|||
129793241|NCT01933789|467210732|FG003|Overall Study|Death|0|||
129793242|NCT01933789|467210733|FG004|Overall Study|Death|21|||
129793243|NCT01933789|467210734|FG005|Overall Study|Death|32|||
129793244|NCT01933789|467210735|FG006|Overall Study|Death|0|||
129793245|NCT01933789|467210736|FG007|Overall Study|Death|0|||
129793246|NCT01933789|467210737|FG008|Overall Study|Death|0|||
129793247|NCT01933789|467210729|FG000|Overall Study|Lost to Follow-up|0|||
129793248|NCT01933789|467210730|FG001|Overall Study|Lost to Follow-up|0|||
129793249|NCT01933789|467210731|FG002|Overall Study|Lost to Follow-up|0|||
129793250|NCT01933789|467210732|FG003|Overall Study|Lost to Follow-up|1|||
129793251|NCT01933789|467210733|FG004|Overall Study|Lost to Follow-up|8|||
129793252|NCT01933789|467210734|FG005|Overall Study|Lost to Follow-up|9|||
129793253|NCT01933789|467210735|FG006|Overall Study|Lost to Follow-up|1|||
129793254|NCT01933789|467210736|FG007|Overall Study|Lost to Follow-up|4|||
129793255|NCT01933789|467210737|FG008|Overall Study|Lost to Follow-up|0|||
129793256|NCT01933789|467210729|FG000|Overall Study|Withdrawal by Subject|2|||
129793257|NCT01933789|467210730|FG001|Overall Study|Withdrawal by Subject|1|||
129793258|NCT01933789|467210731|FG002|Overall Study|Withdrawal by Subject|0|||
129793259|NCT01933789|467210732|FG003|Overall Study|Withdrawal by Subject|0|||
129793260|NCT01933789|467210733|FG004|Overall Study|Withdrawal by Subject|17|||
130110727|NCT03705169|468365854|FG009|Overall Study|Did not receive study treatment|0|||
129793261|NCT01933789|467210734|FG005|Overall Study|Withdrawal by Subject|16|||
129793262|NCT01933789|467210735|FG006|Overall Study|Withdrawal by Subject|1|||
129793263|NCT01933789|467210736|FG007|Overall Study|Withdrawal by Subject|4|||
130290304|NCT00844805|469025446|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
130290305|NCT00844805|469025447|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
130045572|NCT01259492|468125522|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
130045573|NCT01259492|468125523|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
130045574|NCT01259492|468125524|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
130045575|NCT01259492|468125521|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
130045576|NCT01259492|468125522|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
130290306|NCT00844805|469025448|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
130290307|NCT00844805|469025445|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130290308|NCT00844805|469025446|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130290309|NCT00844805|469025447|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
130290310|NCT00844805|469025448|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
130290311|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
130290312|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
130290313|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
130290314|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
130290315|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
130290316|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
130290317|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
130290318|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
130290319|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
130290320|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
130290321|NCT01352741|469025449|FG000|Open-label Tapentadol Titration Period|Other|4|||
130290322|NCT01352741|469025450|FG001|Open-label Tapentadol Titration Period|Other|0|||
130290323|NCT01352741|469025449|FG000|Double-blind Comparative Period|Protocol Violation|2|||
130290324|NCT01352741|469025450|FG001|Double-blind Comparative Period|Protocol Violation|0|||
130290325|NCT01352741|469025449|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
130290326|NCT01352741|469025450|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
130290327|NCT01352741|469025449|FG000|Double-blind Comparative Period|Adverse Event|16|||
130290328|NCT01352741|469025450|FG001|Double-blind Comparative Period|Adverse Event|17|||
130290329|NCT01352741|469025449|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
130290330|NCT01352741|469025450|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
130290331|NCT01352741|469025449|FG000|Double-blind Comparative Period|Death|0|||
130290332|NCT01352741|469025450|FG001|Double-blind Comparative Period|Death|1|||
130290333|NCT01352741|469025449|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
130290334|NCT01352741|469025450|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
130290335|NCT01352741|469025449|FG000|Double-blind Comparative Period|Other|1|||
130290336|NCT01352741|469025450|FG001|Double-blind Comparative Period|Other|2|||
130290337|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
130290338|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
130290339|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
130290340|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
130290341|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
130290342|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
130290343|NCT01352741|469025449|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
130290344|NCT01352741|469025450|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
130290345|NCT01886690|469025452|FG000|Overall Study|Protocol Violation|0|||
130290346|NCT01886690|469025453|FG001|Overall Study|Protocol Violation|1|||
130290347|NCT01886690|469025452|FG000|Overall Study|Personal Reasons|0|||
130290348|NCT01886690|469025453|FG001|Overall Study|Personal Reasons|1|||
130290349|NCT01510145|469025454|FG000|Overall Study|Adverse Event|6|||
130290350|NCT01510145|469025454|FG000|Overall Study|Lost to Follow-up|5|||
130290351|NCT01510145|469025454|FG000|Overall Study|Withdrawal by Subject|6|||
130290352|NCT01510145|469025454|FG000|Overall Study|Relative reported subject withdrew|1|||
130290353|NCT03081858|469027325|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
130290354|NCT03081858|469027326|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130290355|NCT03081858|469027327|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130290356|NCT03081858|469027328|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
130290357|NCT00262847|469027331|FG000|Overall Study|Disease Progression|309|||
130290358|NCT00262847|469027332|FG001|Overall Study|Disease Progression|274|||
130290359|NCT00262847|469027333|FG002|Overall Study|Disease Progression|195|||
130290360|NCT00262847|469027331|FG000|Overall Study|Patient Refusal|41|||
130290361|NCT00262847|469027332|FG001|Overall Study|Patient Refusal|52|||
130290362|NCT00262847|469027333|FG002|Overall Study|Patient Refusal|47|||
130290363|NCT00262847|469027331|FG000|Overall Study|Adverse Event|74|||
130290364|NCT00262847|469027332|FG001|Overall Study|Adverse Event|88|||
130290365|NCT00262847|469027333|FG002|Overall Study|Adverse Event|108|||
129888288|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Progressive disease|88|||
130045577|NCT01259492|468125523|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
130290366|NCT00262847|469027331|FG000|Overall Study|Death|8|||
130290367|NCT00262847|469027332|FG001|Overall Study|Death|8|||
130290368|NCT00262847|469027333|FG002|Overall Study|Death|11|||
130290369|NCT00262847|469027331|FG000|Overall Study|Concomitant disease|3|||
130290370|NCT00262847|469027332|FG001|Overall Study|Concomitant disease|2|||
130290371|NCT00262847|469027333|FG002|Overall Study|Concomitant disease|4|||
130290372|NCT00262847|469027331|FG000|Overall Study|Other Reasons|79|||
130290373|NCT00262847|469027332|FG001|Overall Study|Other Reasons|88|||
130290374|NCT00262847|469027333|FG002|Overall Study|Other Reasons|27|||
130290375|NCT00262847|469027331|FG000|Overall Study|Did not receive study treatment|4|||
130290376|NCT00262847|469027332|FG001|Overall Study|Did not receive study treatment|1|||
130290377|NCT00262847|469027333|FG002|Overall Study|Did not receive study treatment|4|||
129888289|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Progressive disease|0|||
129888290|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Other|2|||
129888291|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Other|1|||
129888292|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Other|0|||
130290378|NCT03966885|469027334|FG000|Overall Study|Death|1|||
130290379|NCT03966885|469027335|FG001|Overall Study|Death|0|||
130290380|NCT03966885|469027334|FG000|Overall Study|Lost to Follow-up|1|||
130290381|NCT03966885|469027335|FG001|Overall Study|Lost to Follow-up|2|||
130290382|NCT03966885|469027334|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
130290383|NCT03966885|469027335|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
130290384|NCT03966885|469027334|FG000|Overall Study|Moved from study area.|0|||
130290385|NCT03966885|469027335|FG001|Overall Study|Moved from study area.|2|||
130290386|NCT05013424|469027352|FG000|Overall Study|Lost to Follow-up|1|||
130290387|NCT05013424|469027353|FG001|Overall Study|Lost to Follow-up|1|||
130290388|NCT05013424|469027354|FG002|Overall Study|Lost to Follow-up|1|||
130290389|NCT05013424|469027352|FG000|Overall Study|Withdrawal by Subject|0|||
130290390|NCT05013424|469027353|FG001|Overall Study|Withdrawal by Subject|1|||
130290391|NCT05013424|469027354|FG002|Overall Study|Withdrawal by Subject|0|||
130290392|NCT03899064|469027355|FG000|Overall Study|Lost to Follow-up|1|||
130290393|NCT03899064|469027355|FG000|Overall Study|Protocol Violation|2|||
130290394|NCT03899064|469027355|FG000|Overall Study|Withdrawal by Subject|2|||
130290395|NCT03899064|469027355|FG000|Overall Study|Other|2|||
130290396|NCT03710876|469027356|FG000|Overall Study|Death|0|||
130290397|NCT03710876|469027357|FG001|Overall Study|Death|2|||
130290398|NCT03710876|469027356|FG000|Overall Study|Withdrawal by Subject|0|||
130290399|NCT03710876|469027357|FG001|Overall Study|Withdrawal by Subject|2|||
130290400|NCT00289198|469027366|FG000|Overall Study|Adverse Event|0|||
130290401|NCT00289198|469027367|FG001|Overall Study|Adverse Event|2|||
130290402|NCT00289198|469027366|FG000|Overall Study|Protocol Violation|2|||
130290403|NCT00289198|469027367|FG001|Overall Study|Protocol Violation|1|||
130290404|NCT00289198|469027366|FG000|Overall Study|Withdrawal by Subject|4|||
130290405|NCT00289198|469027367|FG001|Overall Study|Withdrawal by Subject|1|||
130290406|NCT00289198|469027366|FG000|Overall Study|Lack of Efficacy|2|||
130290407|NCT00289198|469027367|FG001|Overall Study|Lack of Efficacy|0|||
130290408|NCT00289198|469027366|FG000|Overall Study|Other: Low compliance|0|||
130045578|NCT01259492|468125524|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
130045579|NCT01259492|468125521|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
130045580|NCT01259492|468125522|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
130045581|NCT01259492|468125523|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
130045582|NCT01259492|468125524|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
130045583|NCT01259492|468125521|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
130045584|NCT01259492|468125522|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
130045585|NCT01259492|468125523|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
130045586|NCT01259492|468125524|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
130045587|NCT01259492|468125521|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
130045588|NCT01259492|468125522|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
130045589|NCT01259492|468125523|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
130045590|NCT01259492|468125524|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
130045591|NCT01259492|468125521|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
130045592|NCT01259492|468125522|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
130045593|NCT01259492|468125523|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
130045594|NCT01259492|468125524|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
130045595|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
130045596|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
130045597|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
130045598|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
130045599|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
130045600|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
130045601|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
130045602|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
130045603|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
130045604|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
130045605|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
130045606|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
130045607|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
130045608|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
130045609|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
130290409|NCT00289198|469027367|FG001|Overall Study|Other: Low compliance|1|||
130290410|NCT00289198|469027366|FG000|Overall Study|Other: Physician's decision|0|||
130290411|NCT00289198|469027367|FG001|Overall Study|Other: Physician's decision|1|||
130290412|NCT00289198|469027366|FG000|Overall Study|Other: Unable to attend on schedule|2|||
130290413|NCT00289198|469027367|FG001|Overall Study|Other: Unable to attend on schedule|1|||
130290414|NCT00289198|469027366|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
130290415|NCT00289198|469027367|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
130290416|NCT00289198|469027366|FG000|Overall Study|Other: Impossible to come on visit|0|||
130290417|NCT00289198|469027367|FG001|Overall Study|Other: Impossible to come on visit|1|||
130290418|NCT01176565|469027368|FG000|Overall Study|Lost to Follow-up|12|||
130290419|NCT01176565|469027369|FG001|Overall Study|Lost to Follow-up|16|||
130290420|NCT01176565|469027368|FG000|Overall Study|Withdrawal by Subject|7|||
130290421|NCT01176565|469027369|FG001|Overall Study|Withdrawal by Subject|1|||
130290422|NCT01176565|469027368|FG000|Overall Study|Not Analyzed (any other reason)|1|||
130290423|NCT01176565|469027369|FG001|Overall Study|Not Analyzed (any other reason)|2|||
130290424|NCT03602885|469027370|FG000|Overall Study|Lost to Follow-up|3|||
130290425|NCT03602885|469027371|FG001|Overall Study|Lost to Follow-up|0|||
130290426|NCT03106415|469027377|FG000|Phase 1|Withdrawal by Subject|1|||
130290427|NCT03106415|469027378|FG001|Phase 1|Withdrawal by Subject|0|||
130290428|NCT03106415|469027379|FG002|Phase 1|Withdrawal by Subject|0|||
130290429|NCT03106415|469027377|FG000|Phase 1|Adverse Event|1|||
130290430|NCT03106415|469027378|FG001|Phase 1|Adverse Event|1|||
130290431|NCT03106415|469027379|FG002|Phase 1|Adverse Event|0|||
130290432|NCT03106415|469027377|FG000|Phase 1|Protocol Violation|0|||
130290433|NCT03106415|469027378|FG001|Phase 1|Protocol Violation|1|||
130045610|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
130290434|NCT03106415|469027379|FG002|Phase 1|Protocol Violation|0|||
130290435|NCT00293709|469027380|FG000|Overall Study|Other|47|||
130290436|NCT02088073|469027381|FG000|Acute Phase|Withdrawal by Subject|5|||
130045611|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
130045612|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
130290437|NCT02088073|469027382|FG001|Acute Phase|Withdrawal by Subject|0|||
130290438|NCT02088073|469027383|FG002|Acute Phase|Withdrawal by Subject|0|||
130290439|NCT02088073|469027384|FG003|Acute Phase|Withdrawal by Subject|0|||
130290440|NCT02088073|469027385|FG004|Acute Phase|Withdrawal by Subject|0|||
130290441|NCT02088073|469027381|FG000|Acute Phase|Hyperkalemia|2|||
130290442|NCT02088073|469027382|FG001|Acute Phase|Hyperkalemia|0|||
130290443|NCT02088073|469027383|FG002|Acute Phase|Hyperkalemia|0|||
130290444|NCT02088073|469027384|FG003|Acute Phase|Hyperkalemia|0|||
130290445|NCT02088073|469027385|FG004|Acute Phase|Hyperkalemia|0|||
130290446|NCT02088073|469027381|FG000|Maintanance Phase|Withdrawal by Subject|0|||
130290447|NCT02088073|469027382|FG001|Maintanance Phase|Withdrawal by Subject|2|||
130290448|NCT02088073|469027383|FG002|Maintanance Phase|Withdrawal by Subject|0|||
130290449|NCT02088073|469027384|FG003|Maintanance Phase|Withdrawal by Subject|0|||
130290450|NCT02088073|469027385|FG004|Maintanance Phase|Withdrawal by Subject|0|||
130290451|NCT02088073|469027381|FG000|Maintanance Phase|Adverse Event|0|||
130290452|NCT02088073|469027382|FG001|Maintanance Phase|Adverse Event|0|||
130290453|NCT02088073|469027383|FG002|Maintanance Phase|Adverse Event|3|||
130290454|NCT02088073|469027384|FG003|Maintanance Phase|Adverse Event|0|||
130290455|NCT02088073|469027385|FG004|Maintanance Phase|Adverse Event|1|||
130290456|NCT02088073|469027381|FG000|Maintanance Phase|Physician Decision|0|||
130290457|NCT02088073|469027382|FG001|Maintanance Phase|Physician Decision|0|||
130290458|NCT02088073|469027383|FG002|Maintanance Phase|Physician Decision|0|||
130290459|NCT02088073|469027384|FG003|Maintanance Phase|Physician Decision|0|||
130290460|NCT02088073|469027385|FG004|Maintanance Phase|Physician Decision|1|||
130290461|NCT02088073|469027381|FG000|Maintanance Phase|Sponsor's decision|0|||
130290462|NCT02088073|469027382|FG001|Maintanance Phase|Sponsor's decision|2|||
130290463|NCT02088073|469027383|FG002|Maintanance Phase|Sponsor's decision|0|||
130290464|NCT02088073|469027384|FG003|Maintanance Phase|Sponsor's decision|2|||
130290465|NCT02088073|469027385|FG004|Maintanance Phase|Sponsor's decision|1|||
130290466|NCT02088073|469027381|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
130290467|NCT02088073|469027382|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
130290468|NCT02088073|469027383|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
130290469|NCT02088073|469027384|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
130290470|NCT02088073|469027385|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
130290471|NCT02088073|469027381|FG000|Maintanance Phase|Miscellaneous|0|||
130290472|NCT02088073|469027382|FG001|Maintanance Phase|Miscellaneous|2|||
130290473|NCT02088073|469027383|FG002|Maintanance Phase|Miscellaneous|1|||
130290474|NCT02088073|469027384|FG003|Maintanance Phase|Miscellaneous|2|||
130290475|NCT02088073|469027385|FG004|Maintanance Phase|Miscellaneous|1|||
130290476|NCT02088073|469027381|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
130290477|NCT02088073|469027382|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
130290478|NCT02088073|469027383|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
130290479|NCT02088073|469027384|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
130290480|NCT02088073|469027385|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
130290481|NCT02088073|469027381|FG000|Maintanance Phase|Subject compliance|0|||
130290482|NCT02088073|469027382|FG001|Maintanance Phase|Subject compliance|1|||
130290483|NCT02088073|469027383|FG002|Maintanance Phase|Subject compliance|0|||
130290484|NCT02088073|469027384|FG003|Maintanance Phase|Subject compliance|0|||
130290485|NCT02088073|469027385|FG004|Maintanance Phase|Subject compliance|0|||
130290486|NCT01804582|469027386|FG000|Overall Study|Lost to Follow-up|47|||
130290487|NCT01804582|469027387|FG001|Overall Study|Lost to Follow-up|56|||
130290488|NCT01804582|469027386|FG000|Overall Study|Physician Decision|2|||
130290489|NCT01804582|469027387|FG001|Overall Study|Physician Decision|0|||
130290490|NCT02046174|469027388|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
130290491|NCT02046174|469027389|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
130290492|NCT02118597|469027390|FG000|Overall Study|Sponsor terminated the study|14|||
130290493|NCT02118597|469027390|FG000|Overall Study|Serious Adverse Event|1|||
130290494|NCT02118597|469027390|FG000|Overall Study|Investigator's decision|1|||
130290495|NCT01891344|469027391|FG000|Overall Study|Ongoing|6|||
130290496|NCT01891344|469027392|FG001|Overall Study|Ongoing|2|||
130290497|NCT01891344|469027393|FG002|Overall Study|Ongoing|0|||
130290498|NCT01891344|469027394|FG003|Overall Study|Ongoing|1|||
130290499|NCT01891344|469027395|FG004|Overall Study|Ongoing|4|||
130290500|NCT01891344|469027396|FG005|Overall Study|Ongoing|1|||
130290501|NCT01891344|469027397|FG006|Overall Study|Ongoing|0|||
130290502|NCT01891344|469027398|FG007|Overall Study|Ongoing|0|||
130290503|NCT00186537|469027402|FG000|Overall Study|Withdrawal by Subject|4|||
130290504|NCT00186537|469027403|FG001|Overall Study|Withdrawal by Subject|0|||
130290505|NCT00186537|469027404|FG002|Overall Study|Withdrawal by Subject|3|||
130290506|NCT00186537|469027402|FG000|Overall Study|ALT > 1.5 x ULN|3|||
130290507|NCT00186537|469027403|FG001|Overall Study|ALT > 1.5 x ULN|0|||
130290508|NCT00186537|469027404|FG002|Overall Study|ALT > 1.5 x ULN|0|||
129793264|NCT01933789|467210737|FG008|Overall Study|Withdrawal by Subject|0|||
130290509|NCT03294135|469027405|FG000|Overall Study|Serious Adverse Event|1|||
130290510|NCT03294135|469027406|FG001|Overall Study|Serious Adverse Event|0|||
130290511|NCT03294135|469027407|FG002|Overall Study|Serious Adverse Event|0|||
130290512|NCT03294135|469027405|FG000|Overall Study|Lost to Follow-up|1|||
129793265|NCT01933789|467210729|FG000|Overall Study|Became Ineligible|4|||
130290513|NCT03294135|469027406|FG001|Overall Study|Lost to Follow-up|0|||
130290514|NCT03294135|469027407|FG002|Overall Study|Lost to Follow-up|1|||
130290515|NCT03294135|469027405|FG000|Overall Study|Withdrawal by Subject|0|||
130290516|NCT03294135|469027406|FG001|Overall Study|Withdrawal by Subject|0|||
129793266|NCT01933789|467210730|FG001|Overall Study|Became Ineligible|0|||
130290517|NCT03294135|469027407|FG002|Overall Study|Withdrawal by Subject|1|||
130290518|NCT03294135|469027405|FG000|Overall Study|Other|2|||
130290519|NCT03294135|469027406|FG001|Overall Study|Other|0|||
130290520|NCT03294135|469027407|FG002|Overall Study|Other|0|||
130290521|NCT02763254|469027408|FG000|Overall Study|Adverse Event|1|||
130290522|NCT03684304|469027409|FG000|Overall Study|Lost to Follow-up|19|||
130290523|NCT03684304|469027410|FG001|Overall Study|Lost to Follow-up|17|||
130290524|NCT01143051|469027411|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
130290525|NCT01143051|469027412|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
130290526|NCT01143051|469027413|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
130290527|NCT01143051|469027414|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
130290528|NCT01143051|469027415|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
130290529|NCT01143051|469027416|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
130290530|NCT01143051|469027411|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
130290531|NCT01143051|469027412|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
130290532|NCT01143051|469027413|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
130290533|NCT01143051|469027414|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
130290534|NCT01143051|469027415|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
130290535|NCT01143051|469027416|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
130290536|NCT01665430|469027417|FG000|Overall Study|Adverse Event|1|||
130290537|NCT01665430|469027417|FG000|Overall Study|Withdrawal by Subject|6|||
130290538|NCT01665430|469027417|FG000|Overall Study|Other Unspecified|2|||
130290539|NCT02310230|469027418|FG000|Overall Study|Physician Decision|1|||
130290540|NCT02310230|469027419|FG001|Overall Study|Physician Decision|3|||
130290541|NCT02310230|469027418|FG000|Overall Study|monitor baseline taken after induction|2|||
130290542|NCT02310230|469027419|FG001|Overall Study|monitor baseline taken after induction|7|||
130290543|NCT02310230|469027418|FG000|Overall Study|Poor signal quality|5|||
130290544|NCT02310230|469027419|FG001|Overall Study|Poor signal quality|8|||
130290545|NCT02310230|469027418|FG000|Overall Study|Case cancelled|1|||
130290546|NCT02310230|469027419|FG001|Overall Study|Case cancelled|0|||
130290547|NCT01605227|469027420|FG000|Overall Study|Did not receive study treatment|2|||
130290548|NCT01605227|469027421|FG001|Overall Study|Did not receive study treatment|3|||
130290549|NCT01605227|469027420|FG000|Overall Study|Adverse Event|228|||
130290550|NCT01605227|469027421|FG001|Overall Study|Adverse Event|42|||
130290551|NCT01605227|469027420|FG000|Overall Study|Progressive Disease|132|||
130290552|NCT01605227|469027421|FG001|Overall Study|Progressive Disease|128|||
130290553|NCT01605227|469027420|FG000|Overall Study|Clinical Deterioration|227|||
130290554|NCT01605227|469027421|FG001|Overall Study|Clinical Deterioration|133|||
130290555|NCT01605227|469027420|FG000|Overall Study|Lost to Follow-up|1|||
130290556|NCT01605227|469027421|FG001|Overall Study|Lost to Follow-up|0|||
130290557|NCT01605227|469027420|FG000|Overall Study|Protocol Violation|1|||
130290558|NCT01605227|469027421|FG001|Overall Study|Protocol Violation|0|||
130290559|NCT01605227|469027420|FG000|Overall Study|Physician Decision|9|||
130290560|NCT01605227|469027421|FG001|Overall Study|Physician Decision|7|||
130290561|NCT01605227|469027420|FG000|Overall Study|Withdrawal by Subject|18|||
130290562|NCT01605227|469027421|FG001|Overall Study|Withdrawal by Subject|14|||
130290563|NCT01605227|469027420|FG000|Overall Study|Sponsor Decision|2|||
130290564|NCT01605227|469027421|FG001|Overall Study|Sponsor Decision|0|||
130290565|NCT01605227|469027420|FG000|Overall Study|Started New Therapy|1|||
130290566|NCT01605227|469027421|FG001|Overall Study|Started New Therapy|0|||
130290567|NCT01605227|469027420|FG000|Overall Study|Subject Decision|0|||
130290568|NCT01605227|469027421|FG001|Overall Study|Subject Decision|1|||
130290569|NCT01605227|469027420|FG000|Overall Study|Dose Held >6 weeks|0|||
130290570|NCT01605227|469027421|FG001|Overall Study|Dose Held >6 weeks|1|||
130290571|NCT02961790|469027422|FG000|Overall Study|Canceled|4|||
130290572|NCT02961790|469027423|FG001|Overall Study|Canceled|5|||
130290573|NCT02961790|469027424|FG002|Overall Study|Canceled|1|||
130045613|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
130052152|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
130290574|NCT02961790|469027425|FG003|Overall Study|Canceled|4|||
130290575|NCT02961790|469027422|FG000|Overall Study|without baseline data|4|||
130290576|NCT02961790|469027423|FG001|Overall Study|without baseline data|0|||
130290577|NCT02961790|469027424|FG002|Overall Study|without baseline data|1|||
130290578|NCT02961790|469027425|FG003|Overall Study|without baseline data|0|||
130290579|NCT02961790|469027422|FG000|Overall Study|without post baseline data|7|||
130290580|NCT02961790|469027423|FG001|Overall Study|without post baseline data|6|||
130290581|NCT02961790|469027424|FG002|Overall Study|without post baseline data|4|||
130290582|NCT02961790|469027425|FG003|Overall Study|without post baseline data|1|||
130290583|NCT02078102|469027426|FG000|Overall Study|Adverse Event|1|||
130290584|NCT02078102|469027427|FG001|Overall Study|Adverse Event|0|||
130290585|NCT02078102|469027426|FG000|Overall Study|Withdrawal by Subject|1|||
130290586|NCT02078102|469027427|FG001|Overall Study|Withdrawal by Subject|0|||
130290587|NCT02078102|469027426|FG000|Overall Study|Physician Decision|0|||
130290588|NCT02078102|469027427|FG001|Overall Study|Physician Decision|1|||
130290589|NCT03093974|469027430|FG000|Overall Study|Withdrawal by Subject|32|||
130290590|NCT03093974|469027431|FG001|Overall Study|Withdrawal by Subject|27|||
130290591|NCT03093974|469027430|FG000|Overall Study|Adverse Event|17|||
130290592|NCT03093974|469027431|FG001|Overall Study|Adverse Event|24|||
130290593|NCT03093974|469027430|FG000|Overall Study|Death|0|||
130290594|NCT03093974|469027431|FG001|Overall Study|Death|1|||
130290595|NCT03093974|469027430|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130290596|NCT03093974|469027431|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130290597|NCT03093974|469027430|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
130290598|NCT03093974|469027431|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
130290599|NCT03093974|469027430|FG000|Overall Study|Lost to Follow-up|0|||
130290600|NCT03093974|469027431|FG001|Overall Study|Lost to Follow-up|1|||
130290601|NCT03093974|469027430|FG000|Overall Study|Other|1|||
130290602|NCT03093974|469027431|FG001|Overall Study|Other|2|||
130290603|NCT01866423|469027434|FG000|Overall Study|Lack of Efficacy|3|||
130290604|NCT01866423|469027434|FG000|Overall Study|Sponsor Decision|1|||
130290605|NCT01813721|469027435|FG000|Overall Study|Ineligibility determined|63|||
130290606|NCT01813721|469027435|FG000|Overall Study|Withdrawal by Subject|1|||
130290607|NCT02387164|469027436|FG000|Overall Study|Lost to Follow-up|2|||
130290608|NCT02387164|469027437|FG001|Overall Study|Lost to Follow-up|0|||
130290609|NCT02387164|469027436|FG000|Overall Study|Diagnosed|1|||
130290610|NCT02387164|469027437|FG001|Overall Study|Diagnosed|2|||
130290611|NCT01479595|469027440|FG000|Overall Study|Protocol deviation|0|||
130290612|NCT01479595|469027441|FG001|Overall Study|Protocol deviation|1|||
130290613|NCT01479595|469027440|FG000|Overall Study|Adverse Event|2|||
130290614|NCT01479595|469027441|FG001|Overall Study|Adverse Event|1|||
130290615|NCT02255565|469027443|FG000|Overall Study|Withdrawal by Subject|0|||
130052153|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
130290616|NCT02255565|469027444|FG001|Overall Study|Withdrawal by Subject|1|||
130290617|NCT02255565|469027445|FG002|Overall Study|Withdrawal by Subject|0|||
130290618|NCT02120365|469027446|FG000|Overall Study|Withdrawal by Subject|0|||
130290619|NCT02120365|469027447|FG001|Overall Study|Withdrawal by Subject|0|||
130290620|NCT02120365|469027448|FG002|Overall Study|Withdrawal by Subject|2|||
130290621|NCT02120365|469027449|FG003|Overall Study|Withdrawal by Subject|4|||
130290622|NCT02120365|469027450|FG004|Overall Study|Withdrawal by Subject|0|||
130290623|NCT02120365|469027451|FG005|Overall Study|Withdrawal by Subject|2|||
130290624|NCT01719003|469027454|FG000|Overall Study|Non compliant with protocol|1|||
130290625|NCT01719003|469027455|FG001|Overall Study|Non compliant with protocol|1|||
130290626|NCT01719003|469027456|FG002|Overall Study|Non compliant with protocol|0|||
130290627|NCT01719003|469027457|FG003|Overall Study|Non compliant with protocol|1|||
130290628|NCT01719003|469027458|FG004|Overall Study|Non compliant with protocol|2|||
130290629|NCT01719003|469027459|FG005|Overall Study|Non compliant with protocol|1|||
130290630|NCT01719003|469027460|FG006|Overall Study|Non compliant with protocol|2|||
130290631|NCT01719003|469027461|FG007|Overall Study|Non compliant with protocol|3|||
130290632|NCT01719003|469027462|FG008|Overall Study|Non compliant with protocol|0|||
130290633|NCT01719003|469027454|FG000|Overall Study|Adverse Event|6|||
130290634|NCT01719003|469027455|FG001|Overall Study|Adverse Event|5|||
130290635|NCT01719003|469027456|FG002|Overall Study|Adverse Event|4|||
130290636|NCT01719003|469027457|FG003|Overall Study|Adverse Event|3|||
130290637|NCT01719003|469027458|FG004|Overall Study|Adverse Event|4|||
130290638|NCT01719003|469027459|FG005|Overall Study|Adverse Event|3|||
130290639|NCT01719003|469027460|FG006|Overall Study|Adverse Event|6|||
130290640|NCT01719003|469027461|FG007|Overall Study|Adverse Event|5|||
130290641|NCT01719003|469027462|FG008|Overall Study|Adverse Event|0|||
130290642|NCT01719003|469027454|FG000|Overall Study|Lost to Follow-up|0|||
130290643|NCT01719003|469027455|FG001|Overall Study|Lost to Follow-up|6|||
130290644|NCT01719003|469027456|FG002|Overall Study|Lost to Follow-up|7|||
130290645|NCT01719003|469027457|FG003|Overall Study|Lost to Follow-up|2|||
130290646|NCT01719003|469027458|FG004|Overall Study|Lost to Follow-up|3|||
130290647|NCT01719003|469027459|FG005|Overall Study|Lost to Follow-up|4|||
130290648|NCT01719003|469027460|FG006|Overall Study|Lost to Follow-up|3|||
130290649|NCT01719003|469027461|FG007|Overall Study|Lost to Follow-up|2|||
130290650|NCT01719003|469027462|FG008|Overall Study|Lost to Follow-up|2|||
130290651|NCT01719003|469027454|FG000|Overall Study|Refusal to continue, not due to AE|2|||
130290652|NCT01719003|469027455|FG001|Overall Study|Refusal to continue, not due to AE|5|||
130290653|NCT01719003|469027456|FG002|Overall Study|Refusal to continue, not due to AE|4|||
130290654|NCT01719003|469027457|FG003|Overall Study|Refusal to continue, not due to AE|4|||
130290655|NCT01719003|469027458|FG004|Overall Study|Refusal to continue, not due to AE|4|||
130290656|NCT01719003|469027459|FG005|Overall Study|Refusal to continue, not due to AE|3|||
130290657|NCT01719003|469027460|FG006|Overall Study|Refusal to continue, not due to AE|8|||
130290658|NCT01719003|469027461|FG007|Overall Study|Refusal to continue, not due to AE|7|||
130290659|NCT01719003|469027462|FG008|Overall Study|Refusal to continue, not due to AE|1|||
130290660|NCT01719003|469027454|FG000|Overall Study|Reason other than those specified|0|||
130290661|NCT01719003|469027455|FG001|Overall Study|Reason other than those specified|0|||
130290662|NCT01719003|469027456|FG002|Overall Study|Reason other than those specified|2|||
130290663|NCT01719003|469027457|FG003|Overall Study|Reason other than those specified|3|||
130290664|NCT01719003|469027458|FG004|Overall Study|Reason other than those specified|4|||
130290665|NCT01719003|469027459|FG005|Overall Study|Reason other than those specified|1|||
130290666|NCT01719003|469027460|FG006|Overall Study|Reason other than those specified|0|||
130290667|NCT01719003|469027461|FG007|Overall Study|Reason other than those specified|3|||
130290668|NCT01719003|469027462|FG008|Overall Study|Reason other than those specified|1|||
130290669|NCT01719003|469027454|FG000|Overall Study|Lack of Efficacy|0|||
130290670|NCT01719003|469027455|FG001|Overall Study|Lack of Efficacy|0|||
130290671|NCT01719003|469027456|FG002|Overall Study|Lack of Efficacy|0|||
130290672|NCT01719003|469027457|FG003|Overall Study|Lack of Efficacy|0|||
130290673|NCT01719003|469027458|FG004|Overall Study|Lack of Efficacy|0|||
130290674|NCT01719003|469027459|FG005|Overall Study|Lack of Efficacy|0|||
130290675|NCT01719003|469027460|FG006|Overall Study|Lack of Efficacy|1|||
130290676|NCT01719003|469027461|FG007|Overall Study|Lack of Efficacy|0|||
130290677|NCT01719003|469027462|FG008|Overall Study|Lack of Efficacy|0|||
130290678|NCT00900146|469027463|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
130290679|NCT00900146|469027464|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
130290680|NCT00900146|469027465|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
130290681|NCT00900146|469027466|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
130290682|NCT00900146|469027467|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
130290683|NCT00900146|469027463|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
130290684|NCT00900146|469027464|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
130290685|NCT00900146|469027465|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
130290686|NCT00900146|469027466|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
130290687|NCT00900146|469027467|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
130290688|NCT00900146|469027463|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
130290689|NCT00900146|469027464|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290690|NCT00900146|469027465|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290691|NCT00900146|469027466|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290692|NCT00900146|469027467|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
130290693|NCT00900146|469027463|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
130290694|NCT00900146|469027464|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
130290695|NCT00900146|469027465|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
130290696|NCT00900146|469027466|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
130290697|NCT00900146|469027467|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
130290698|NCT00900146|469027463|FG000|Intermediate: Period III|Lost to Follow-up|2|||
130290699|NCT00900146|469027464|FG001|Intermediate: Period III|Lost to Follow-up|0|||
130290700|NCT00900146|469027465|FG002|Intermediate: Period III|Lost to Follow-up|0|||
130290701|NCT00900146|469027466|FG003|Intermediate: Period III|Lost to Follow-up|0|||
130290702|NCT00900146|469027467|FG004|Intermediate: Period III|Lost to Follow-up|1|||
130290703|NCT00900146|469027463|FG000|Intermediate: Period III|Administrative problems|85|||
130290704|NCT00900146|469027464|FG001|Intermediate: Period III|Administrative problems|92|||
130290705|NCT00900146|469027465|FG002|Intermediate: Period III|Administrative problems|84|||
130290706|NCT00900146|469027466|FG003|Intermediate: Period III|Administrative problems|90|||
130290707|NCT00900146|469027467|FG004|Intermediate: Period III|Administrative problems|163|||
130290708|NCT01028716|469027472|FG000|Overall Study|Physician Decision|1|||
130290709|NCT01143896|469027477|FG000|Overall Study|Did not complete Baseline Interview|5|||
130290710|NCT01143896|469027478|FG001|Overall Study|Did not complete Baseline Interview|4|||
130290711|NCT01143896|469027477|FG000|Overall Study|Lost to Follow-up|18|||
130290712|NCT01143896|469027478|FG001|Overall Study|Lost to Follow-up|13|||
130290713|NCT01143896|469027477|FG000|Overall Study|Withdrawal by Subject|13|||
130290714|NCT01143896|469027478|FG001|Overall Study|Withdrawal by Subject|5|||
130290715|NCT01143896|469027477|FG000|Overall Study|Death|6|||
130290716|NCT01143896|469027478|FG001|Overall Study|Death|3|||
130290717|NCT00320372|469027479|FG000|Overall Study|Physician Decision|4|||
130290718|NCT00320372|469027480|FG001|Overall Study|Physician Decision|7|||
130290719|NCT00320372|469027479|FG000|Overall Study|Death|7|||
130290720|NCT00320372|469027480|FG001|Overall Study|Death|8|||
130290721|NCT00320372|469027479|FG000|Overall Study|Withdrawal by Subject|55|||
130290722|NCT00320372|469027480|FG001|Overall Study|Withdrawal by Subject|37|||
130290723|NCT00320372|469027479|FG000|Overall Study|Non-Compliance|40|||
130290724|NCT00320372|469027480|FG001|Overall Study|Non-Compliance|39|||
130290725|NCT00320372|469027479|FG000|Overall Study|Did not Meet (I/E)|3|||
130290726|NCT00320372|469027480|FG001|Overall Study|Did not Meet (I/E)|1|||
130290727|NCT00320372|469027479|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
130290728|NCT00320372|469027480|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
130290729|NCT02068118|469027482|FG000|18-month Comparative Study Period|Death|90|||
130290730|NCT02068118|469027483|FG001|18-month Comparative Study Period|Death|97|||
130290731|NCT02068118|469027482|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
130290732|NCT02068118|469027483|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
130290733|NCT02068118|469027482|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
130290734|NCT02068118|469027483|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
130290735|NCT02068118|469027482|FG000|18-month Comparative Study Period|Heart transplant|9|||
130290736|NCT02068118|469027483|FG001|18-month Comparative Study Period|Heart transplant|15|||
130290737|NCT02068118|469027482|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
130290738|NCT02068118|469027483|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
130290739|NCT02068118|469027482|FG000|18-month Comparative Study Period|Hemiplegia|0|||
130290740|NCT02068118|469027483|FG001|18-month Comparative Study Period|Hemiplegia|1|||
130290741|NCT02068118|469027482|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
130290742|NCT02068118|469027483|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
130290743|NCT02068118|469027482|FG000|18-month Comparative Study Period|Move|0|||
130290744|NCT02068118|469027483|FG001|18-month Comparative Study Period|Move|1|||
130290745|NCT02068118|469027482|FG000|18-month Comparative Study Period|Hearing loss|0|||
130290746|NCT02068118|469027483|FG001|18-month Comparative Study Period|Hearing loss|1|||
130290747|NCT02068118|469027482|FG000|Extension Period|Death|0|||
130290748|NCT02068118|469027483|FG001|Extension Period|Death|2|||
130290749|NCT02068118|469027482|FG000|Extension Period|Withdrawal by Subject|1|||
130290750|NCT02068118|469027483|FG001|Extension Period|Withdrawal by Subject|0|||
130290751|NCT02068118|469027482|FG000|Extension Period|Heart transplant|1|||
130290752|NCT02068118|469027483|FG001|Extension Period|Heart transplant|0|||
130290753|NCT02068118|469027482|FG000|Extension Period|Wrong device use|0|||
130290754|NCT02068118|469027483|FG001|Extension Period|Wrong device use|1|||
130290755|NCT00283868|469027484|FG000|Overall Study|Lost to Follow-up|7|||
130290756|NCT00283868|469027485|FG001|Overall Study|Lost to Follow-up|8|||
130052154|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
130045614|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
130045615|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
130045616|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
130045617|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
130045618|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
130045619|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
130290757|NCT01996592|469027487|FG000|Overall Study|no response to text/no diary entry|32|||
130290758|NCT01996592|469027487|FG000|Overall Study|change in surgical date|4|||
130290759|NCT01996592|469027487|FG000|Overall Study|Withdrawal by Subject|5|||
130290760|NCT01996592|469027487|FG000|Overall Study|change in mode of delivery|4|||
130290761|NCT00394901|469027488|FG000|Baseline Phase|Protocol Violation|0|||
129793267|NCT01933789|467210731|FG002|Overall Study|Became Ineligible|0|||
129793268|NCT01933789|467210732|FG003|Overall Study|Became Ineligible|0|||
129793269|NCT01933789|467210733|FG004|Overall Study|Became Ineligible|13|||
129793270|NCT01933789|467210734|FG005|Overall Study|Became Ineligible|10|||
129793271|NCT01933789|467210735|FG006|Overall Study|Became Ineligible|13|||
129793272|NCT01933789|467210736|FG007|Overall Study|Became Ineligible|6|||
129793273|NCT01933789|467210737|FG008|Overall Study|Became Ineligible|0|||
129793274|NCT01117792|467210743|FG000|Overall Study|Death|1|||
129793275|NCT01117792|467210743|FG000|Overall Study|Adverse Event|3|||
129793276|NCT01721577|467210744|FG000|Overall Study|Lack of Efficacy|1|||
129793277|NCT01721577|467210745|FG001|Overall Study|Lack of Efficacy|0|||
129793278|NCT01721577|467210744|FG000|Overall Study|Death|1|||
129793279|NCT01721577|467210745|FG001|Overall Study|Death|0|||
129793280|NCT01721577|467210744|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
129793281|NCT01721577|467210745|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
129793282|NCT01721577|467210744|FG000|Overall Study|Adverse Event|0|||
129793283|NCT01721577|467210745|FG001|Overall Study|Adverse Event|2|||
129793284|NCT02497976|467210748|FG000|Overall Study|Withdrawal by Subject|2|||
129793285|NCT02497976|467210749|FG001|Overall Study|Withdrawal by Subject|0|||
129793286|NCT02497976|467210748|FG000|Overall Study|Moved out of area|0|||
129793287|NCT02497976|467210749|FG001|Overall Study|Moved out of area|1|||
129793288|NCT01966432|467210752|FG000|Overall Study|Lost to Follow-up|3|||
129793289|NCT01966432|467210753|FG001|Overall Study|Lost to Follow-up|2|||
129793290|NCT01966432|467210754|FG002|Overall Study|Lost to Follow-up|5|||
129793291|NCT01966432|467210752|FG000|Overall Study|Withdrawal by Subject|1|||
129793292|NCT01966432|467210753|FG001|Overall Study|Withdrawal by Subject|3|||
129793293|NCT01966432|467210754|FG002|Overall Study|Withdrawal by Subject|0|||
129793294|NCT01966432|467210752|FG000|Overall Study|Subject Incarcerated|0|||
129793295|NCT01966432|467210753|FG001|Overall Study|Subject Incarcerated|0|||
129793296|NCT01966432|467210754|FG002|Overall Study|Subject Incarcerated|1|||
129793297|NCT01966432|467210752|FG000|Overall Study|SBIRT program ended|1|||
129793298|NCT01966432|467210753|FG001|Overall Study|SBIRT program ended|8|||
129793299|NCT01966432|467210754|FG002|Overall Study|SBIRT program ended|20|||
129793300|NCT00584740|467210757|FG000|Overall Study|Adverse Event|1|||
129793301|NCT00584740|467210758|FG001|Overall Study|Adverse Event|1|||
129793302|NCT00584740|467210757|FG000|Overall Study|Lack of Efficacy|8|||
129793303|NCT00584740|467210758|FG001|Overall Study|Lack of Efficacy|2|||
129793304|NCT00584740|467210757|FG000|Overall Study|Withdrawal by Subject|3|||
129793305|NCT00584740|467210758|FG001|Overall Study|Withdrawal by Subject|2|||
129793306|NCT00584740|467210757|FG000|Overall Study|Lost to Follow-up|0|||
129793307|NCT00584740|467210758|FG001|Overall Study|Lost to Follow-up|1|||
129793308|NCT01903525|467210759|FG000|Overall Study|Lost to Follow-up|5|||
129793309|NCT01903525|467210760|FG001|Overall Study|Lost to Follow-up|9|||
129793310|NCT01903525|467210759|FG000|Overall Study|Adverse Event|0|||
129793311|NCT01903525|467210760|FG001|Overall Study|Adverse Event|1|||
129793312|NCT00930982|467210761|FG000|Overall Study|Adverse Event|19|||
129793313|NCT00930982|467210762|FG001|Overall Study|Adverse Event|23|||
129793314|NCT00930982|467210761|FG000|Overall Study|Protocol Violation|1|||
129793315|NCT00930982|467210762|FG001|Overall Study|Protocol Violation|5|||
129793316|NCT00930982|467210761|FG000|Overall Study|Withdrawal by Subject|1|||
129793317|NCT00930982|467210762|FG001|Overall Study|Withdrawal by Subject|1|||
129793318|NCT03915860|467210763|FG000|Overall Study|Adverse Event|3|||
129793319|NCT03915860|467210763|FG000|Overall Study|Withdrawal by Subject|6|||
129793320|NCT03915860|467210763|FG000|Overall Study|Lost to Follow-up|2|||
129793321|NCT03915860|467210763|FG000|Overall Study|Other than specified|3|||
129793322|NCT02195011|467210764|FG000|Overall Study|Adverse Event|4|||
129793323|NCT02195011|467210765|FG001|Overall Study|Adverse Event|0|||
129793324|NCT02195011|467210764|FG000|Overall Study|Progressive Disease|18|||
129793325|NCT02195011|467210765|FG001|Overall Study|Progressive Disease|1|||
129793326|NCT02195011|467210764|FG000|Overall Study|Withdrawal by Subject|3|||
130106493|NCT03273257|468350051|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
130290762|NCT00394901|469027489|FG001|Baseline Phase|Protocol Violation|0|||
129793327|NCT02195011|467210765|FG001|Overall Study|Withdrawal by Subject|0|||
129793328|NCT01853618|467210766|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
129793329|NCT01853618|467210767|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
130290763|NCT00394901|469027490|FG002|Baseline Phase|Protocol Violation|1|||
130290764|NCT00394901|469027491|FG003|Baseline Phase|Protocol Violation|0|||
130290765|NCT00394901|469027488|FG000|Double-blind Phase|Adverse Event|5|||
130290766|NCT00394901|469027489|FG001|Double-blind Phase|Adverse Event|7|||
130290767|NCT00394901|469027490|FG002|Double-blind Phase|Adverse Event|16|||
130290768|NCT00394901|469027491|FG003|Double-blind Phase|Adverse Event|20|||
130290769|NCT00394901|469027488|FG000|Double-blind Phase|Lack of Efficacy|6|||
130290770|NCT00394901|469027489|FG001|Double-blind Phase|Lack of Efficacy|4|||
130290771|NCT00394901|469027490|FG002|Double-blind Phase|Lack of Efficacy|1|||
130290772|NCT00394901|469027491|FG003|Double-blind Phase|Lack of Efficacy|3|||
130290773|NCT00394901|469027488|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130290774|NCT00394901|469027489|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130290775|NCT00394901|469027490|FG002|Double-blind Phase|Withdrawal by Subject|0|||
130290776|NCT00394901|469027491|FG003|Double-blind Phase|Withdrawal by Subject|0|||
130290777|NCT00394901|469027488|FG000|Double-blind Phase|Lost to Follow-up|0|||
130290778|NCT00394901|469027489|FG001|Double-blind Phase|Lost to Follow-up|0|||
130290779|NCT00394901|469027490|FG002|Double-blind Phase|Lost to Follow-up|0|||
130290780|NCT00394901|469027491|FG003|Double-blind Phase|Lost to Follow-up|1|||
130290781|NCT00394901|469027488|FG000|Double-blind Phase|Protocol Violation|0|||
130290782|NCT00394901|469027489|FG001|Double-blind Phase|Protocol Violation|0|||
130290783|NCT00394901|469027490|FG002|Double-blind Phase|Protocol Violation|0|||
130290784|NCT00394901|469027491|FG003|Double-blind Phase|Protocol Violation|1|||
129793330|NCT01853618|467210768|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
129793331|NCT01853618|467210769|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
129793332|NCT01853618|467210770|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
129793333|NCT01853618|467210766|FG000|Overall Study|Progressive disease|1|||
129793334|NCT01853618|467210767|FG001|Overall Study|Progressive disease|1|||
129793335|NCT01853618|467210768|FG002|Overall Study|Progressive disease|1|||
129793336|NCT01853618|467210769|FG003|Overall Study|Progressive disease|1|||
129793337|NCT01853618|467210770|FG004|Overall Study|Progressive disease|2|||
129793338|NCT01853618|467210766|FG000|Overall Study|Physician Decision|0|||
129793339|NCT01853618|467210767|FG001|Overall Study|Physician Decision|1|||
129793340|NCT01853618|467210768|FG002|Overall Study|Physician Decision|1|||
129793341|NCT01853618|467210769|FG003|Overall Study|Physician Decision|0|||
129793342|NCT01853618|467210770|FG004|Overall Study|Physician Decision|0|||
129793343|NCT01853618|467210766|FG000|Overall Study|Refused further treatment|0|||
129793344|NCT01853618|467210767|FG001|Overall Study|Refused further treatment|0|||
129793345|NCT01853618|467210768|FG002|Overall Study|Refused further treatment|0|||
130290785|NCT00394901|469027488|FG000|Double-blind Phase|Death|1|||
130290786|NCT00394901|469027489|FG001|Double-blind Phase|Death|0|||
130290787|NCT00394901|469027490|FG002|Double-blind Phase|Death|0|||
130290788|NCT00394901|469027491|FG003|Double-blind Phase|Death|0|||
130290789|NCT00394901|469027488|FG000|Double-blind Phase|Subject's Personal Reason|1|||
130290790|NCT00394901|469027489|FG001|Double-blind Phase|Subject's Personal Reason|0|||
130290791|NCT00394901|469027490|FG002|Double-blind Phase|Subject's Personal Reason|0|||
130290792|NCT00394901|469027491|FG003|Double-blind Phase|Subject's Personal Reason|1|||
130290793|NCT00394901|469027488|FG000|Double-blind Phase|Lack of Compliance|0|||
130290794|NCT00394901|469027489|FG001|Double-blind Phase|Lack of Compliance|3|||
130290795|NCT00394901|469027490|FG002|Double-blind Phase|Lack of Compliance|0|||
130290796|NCT00394901|469027491|FG003|Double-blind Phase|Lack of Compliance|0|||
130290797|NCT00394901|469027488|FG000|Double-blind Phase|Entry into another study was found|0|||
130290798|NCT00394901|469027489|FG001|Double-blind Phase|Entry into another study was found|0|||
130290799|NCT00394901|469027490|FG002|Double-blind Phase|Entry into another study was found|1|||
130290800|NCT00394901|469027491|FG003|Double-blind Phase|Entry into another study was found|0|||
130290801|NCT00394901|469027488|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
130290802|NCT00394901|469027489|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
130290803|NCT00394901|469027490|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
130290804|NCT00394901|469027491|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
130290805|NCT05028517|469027492|FG000|Overall Study|Lost to Follow-up|13|||
130290806|NCT05028517|469027493|FG001|Overall Study|Lost to Follow-up|20|||
130290807|NCT05028517|469027494|FG002|Overall Study|Lost to Follow-up|12|||
130290808|NCT05028517|469027492|FG000|Overall Study|Withdrawal by Subject|0|||
130290809|NCT05028517|469027493|FG001|Overall Study|Withdrawal by Subject|0|||
130290810|NCT05028517|469027494|FG002|Overall Study|Withdrawal by Subject|1|||
129793346|NCT01853618|467210769|FG003|Overall Study|Refused further treatment|0|||
129793347|NCT01853618|467210770|FG004|Overall Study|Refused further treatment|1|||
129793348|NCT01146860|467210773|FG000|Overall Study|Withdrawal by Subject|0|||
129793349|NCT01146860|467210774|FG001|Overall Study|Withdrawal by Subject|1|||
129793350|NCT01075191|467210775|FG000|Overall Study|Death|1|||
130290811|NCT02256267|469027495|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
130290812|NCT02256267|469027495|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
130290813|NCT01066780|469027499|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
130290814|NCT01066780|469027500|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
130290815|NCT02360293|469027501|FG000|Overall Study|Lost to Follow-up|73|||
130290816|NCT02360293|469027502|FG001|Overall Study|Lost to Follow-up|95|||
130045620|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
130045621|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
130045622|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
130045623|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
130045624|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
130045625|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
130045626|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
130290817|NCT02360293|469027501|FG000|Overall Study|Withdrawal by Subject|2|||
130045627|NCT01259492|468125521|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
130045628|NCT01259492|468125522|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
130045629|NCT01259492|468125523|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
130290818|NCT02360293|469027502|FG001|Overall Study|Withdrawal by Subject|1|||
130290819|NCT02360293|469027501|FG000|Overall Study|Excluded|1|||
130290820|NCT02360293|469027502|FG001|Overall Study|Excluded|0|||
130290821|NCT04316741|469027503|FG000|Baseline Enrollment|Lost to Follow-up|1|||
130290822|NCT04316741|469027504|FG001|Baseline Enrollment|Lost to Follow-up|1|||
130290823|NCT04316741|469027503|FG000|Immediate Post-Test|Lost to Follow-up|5|||
130290824|NCT04316741|469027504|FG001|Immediate Post-Test|Lost to Follow-up|1|||
130290825|NCT04316741|469027503|FG000|1-month Post-test|Lost to Follow-up|7|||
130290826|NCT04316741|469027504|FG001|1-month Post-test|Lost to Follow-up|2|||
130290827|NCT04316741|469027503|FG000|3-month Follow-up|Lost to Follow-up|10|||
130290828|NCT04316741|469027504|FG001|3-month Follow-up|Lost to Follow-up|2|||
130290829|NCT01498185|469027506|FG000|Overall Study|Adverse Event|0|||
130290830|NCT01498185|469027507|FG001|Overall Study|Adverse Event|0|||
130290831|NCT01498185|469027508|FG002|Overall Study|Adverse Event|0|||
130290832|NCT01498185|469027509|FG003|Overall Study|Adverse Event|1|||
130290833|NCT01498185|469027510|FG004|Overall Study|Adverse Event|0|||
130290834|NCT01498185|469027506|FG000|Overall Study|Withdrawal by Subject|1|||
130290835|NCT01498185|469027507|FG001|Overall Study|Withdrawal by Subject|1|||
130290836|NCT01498185|469027508|FG002|Overall Study|Withdrawal by Subject|0|||
130290837|NCT01498185|469027509|FG003|Overall Study|Withdrawal by Subject|2|||
130290838|NCT01498185|469027510|FG004|Overall Study|Withdrawal by Subject|1|||
130290839|NCT01498185|469027506|FG000|Overall Study|No longer met criteria, etc|0|||
130290840|NCT01498185|469027507|FG001|Overall Study|No longer met criteria, etc|0|||
130290841|NCT01498185|469027508|FG002|Overall Study|No longer met criteria, etc|0|||
130290842|NCT01498185|469027509|FG003|Overall Study|No longer met criteria, etc|0|||
130290843|NCT01498185|469027510|FG004|Overall Study|No longer met criteria, etc|2|||
130290844|NCT01827332|469027511|FG000|Overall Study|Lost to Follow-up|2|||
130290845|NCT01827332|469027512|FG001|Overall Study|Lost to Follow-up|1|||
130290846|NCT02725593|469027513|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
130290847|NCT02725593|469027514|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
130290848|NCT02725593|469027513|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
130290849|NCT02725593|469027514|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
130290850|NCT02725593|469027513|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
130290851|NCT02725593|469027514|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
130290852|NCT02725593|469027513|FG000|Long Term Extension|Withdrawal by Subject|1|||
129888293|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
129888294|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
129888295|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
129888296|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
129888297|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
129888298|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
129888299|NCT02718417|467549132|FG000|Observation Phase (OP)|Adverse Event|0|||
129888300|NCT02718417|467549133|FG001|Observation Phase (OP)|Adverse Event|0|||
129888301|NCT02718417|467549134|FG002|Observation Phase (OP)|Adverse Event|1|||
129888302|NCT02718417|467549132|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
129888303|NCT02718417|467549133|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
129888304|NCT02718417|467549134|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
129888305|NCT02718417|467549132|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
129888306|NCT02718417|467549133|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
129888307|NCT02718417|467549134|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
129888308|NCT02718417|467549132|FG000|Observation Phase (OP)|Physician Decision|0|||
129888309|NCT02718417|467549133|FG001|Observation Phase (OP)|Physician Decision|0|||
129888310|NCT02718417|467549134|FG002|Observation Phase (OP)|Physician Decision|9|||
129888311|NCT02718417|467549132|FG000|Observation Phase (OP)|Progressive disease|0|||
129888312|NCT02718417|467549133|FG001|Observation Phase (OP)|Progressive disease|0|||
129888313|NCT02718417|467549134|FG002|Observation Phase (OP)|Progressive disease|92|||
129888314|NCT02718417|467549132|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
129888315|NCT02718417|467549133|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
129888316|NCT02718417|467549134|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
129888317|NCT02718417|467549132|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
129888318|NCT02718417|467549133|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
129888319|NCT02718417|467549134|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
129888320|NCT02718417|467549132|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
129888321|NCT02718417|467549133|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
129888322|NCT02718417|467549134|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
129888323|NCT02718417|467549132|FG000|Observation Phase (OP)|Other|0|||
129888324|NCT02718417|467549133|FG001|Observation Phase (OP)|Other|0|||
130045630|NCT01259492|468125524|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
130045631|NCT01058369|468125532|FG000|Overall Study|Adverse Event|1|||
130045632|NCT01058369|468125532|FG000|Overall Study|Early termination study|1|||
130045633|NCT00663858|468125533|FG000|Overall Study|Adverse Event|9|||
130045634|NCT00663858|468125534|FG001|Overall Study|Adverse Event|1|||
130045635|NCT00663858|468125535|FG002|Overall Study|Adverse Event|6|||
130045636|NCT00663858|468125533|FG000|Overall Study|Lack of Efficacy|5|||
130045637|NCT00663858|468125534|FG001|Overall Study|Lack of Efficacy|1|||
130045638|NCT00663858|468125535|FG002|Overall Study|Lack of Efficacy|3|||
130045639|NCT00663858|468125533|FG000|Overall Study|Withdrawal by Subject|7|||
130045640|NCT00663858|468125534|FG001|Overall Study|Withdrawal by Subject|3|||
129888325|NCT02718417|467549134|FG002|Observation Phase (OP)|Other|7|||
130045641|NCT00663858|468125535|FG002|Overall Study|Withdrawal by Subject|3|||
130045642|NCT00663858|468125533|FG000|Overall Study|Protocol Violation|5|||
130045643|NCT00663858|468125534|FG001|Overall Study|Protocol Violation|3|||
130290853|NCT02725593|469027514|FG001|Long Term Extension|Withdrawal by Subject|3|||
130290854|NCT00387647|469029121|FG000|Overall Study|Death|18|||
130290855|NCT01309269|469029124|FG000|Overall Study|Adverse Event|56|||
130290856|NCT01309269|469029124|FG000|Overall Study|Withdrawal by Subject|25|||
130290857|NCT01309269|469029124|FG000|Overall Study|Lack of Acceptance|15|||
130290858|NCT01309269|469029124|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
130290859|NCT01309269|469029124|FG000|Overall Study|Kidney Transplant|25|||
130290860|NCT01309269|469029124|FG000|Overall Study|Administrative Problems|141|||
130290861|NCT01309269|469029124|FG000|Overall Study|Other|256|||
130290862|NCT01309269|469029124|FG000|Overall Study|Other|1|||
130290863|NCT01309269|469029124|FG000|Overall Study|Study Completion Data Not Recorded|95|||
130290864|NCT01309269|469029124|FG000|Overall Study|Enrolled but not Treated|107|||
130290865|NCT03131596|469029127|FG000|Overall Study|Protocol Violation|3|||
130290866|NCT03131596|469029128|FG001|Overall Study|Protocol Violation|3|||
130290867|NCT03131596|469029127|FG000|Overall Study|Lost to Follow-up|3|||
130290868|NCT03131596|469029128|FG001|Overall Study|Lost to Follow-up|0|||
130290869|NCT04411420|469029129|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
130290870|NCT04411420|469029130|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
130290871|NCT04411420|469029129|FG000|Survey Subset|Lost to Follow-up|134|||
130290872|NCT04411420|469029130|FG001|Survey Subset|Lost to Follow-up|120|||
130290873|NCT03769311|469029133|FG000|Overall Study|Withdrawal by Subject|1|||
130290874|NCT01596335|469029134|FG000|Overall Study|exacerbation of primary disease|5|||
130290875|NCT01596335|469029135|FG001|Overall Study|exacerbation of primary disease|9|||
130290876|NCT03627065|469029136|FG000|Overall Study|Study Terminated by sponsor|1|||
130290877|NCT03627065|469029136|FG000|Overall Study|Withdrawal by Subject|2|||
130290878|NCT04524455|469029137|FG000|Overall Study|Death|3|||
130290879|NCT04524455|469029138|FG001|Overall Study|Death|3|||
130290880|NCT04524455|469029137|FG000|Overall Study|Decision by Sponsor|0|||
130290881|NCT04524455|469029138|FG001|Overall Study|Decision by Sponsor|2|||
130290882|NCT04524455|469029137|FG000|Overall Study|Withdrawal of Consent From Study|1|||
130290883|NCT04524455|469029138|FG001|Overall Study|Withdrawal of Consent From Study|0|||
130290884|NCT04524455|469029137|FG000|Overall Study|Lost to Follow-up|0|||
130290885|NCT04524455|469029138|FG001|Overall Study|Lost to Follow-up|1|||
130290886|NCT01062061|469029143|FG000|Overall Study|Enrolled more than once|2|||
130290887|NCT01062061|469029143|FG000|Overall Study|Investigated before study start|13|||
130290888|NCT01062061|469029143|FG000|Overall Study|Outside chief indications|10|||
130290889|NCT01062061|469029143|FG000|Overall Study|Failed to meet inclusion criteria|2|||
130045644|NCT00663858|468125535|FG002|Overall Study|Protocol Violation|4|||
130045645|NCT00663858|468125533|FG000|Overall Study|Other|8|||
130045646|NCT00663858|468125534|FG001|Overall Study|Other|2|||
130290890|NCT00524589|469029144|FG000|Overall Study|Withdrawal by Subject|2|||
130290891|NCT00524589|469029144|FG000|Overall Study|Disease Progression|16|||
130290892|NCT00098722|469029145|FG000|Double Blind Phase|Adverse Event|7|||
130290893|NCT00098722|469029146|FG001|Double Blind Phase|Adverse Event|7|||
130290894|NCT00098722|469029147|FG002|Double Blind Phase|Adverse Event|3|||
130290895|NCT00098722|469029148|FG003|Double Blind Phase|Adverse Event|0|||
130045647|NCT00663858|468125535|FG002|Overall Study|Other|4|||
129793351|NCT01075191|467210775|FG000|Overall Study|Intensification|3|||
129793352|NCT01075191|467210775|FG000|Overall Study|Co-morbidities|1|||
130290896|NCT00098722|469029149|FG004|Double Blind Phase|Adverse Event|0|||
130290897|NCT00098722|469029150|FG005|Double Blind Phase|Adverse Event|0|||
130290898|NCT00098722|469029151|FG006|Double Blind Phase|Adverse Event|0|||
130290899|NCT00098722|469029145|FG000|Double Blind Phase|Death|2|||
130290900|NCT00098722|469029146|FG001|Double Blind Phase|Death|5|||
130290901|NCT00098722|469029147|FG002|Double Blind Phase|Death|0|||
130290902|NCT00098722|469029148|FG003|Double Blind Phase|Death|0|||
130290903|NCT00098722|469029149|FG004|Double Blind Phase|Death|0|||
130290904|NCT00098722|469029150|FG005|Double Blind Phase|Death|0|||
130290905|NCT00098722|469029151|FG006|Double Blind Phase|Death|0|||
130290906|NCT00098722|469029145|FG000|Double Blind Phase|Lack of Efficacy|21|||
130290907|NCT00098722|469029146|FG001|Double Blind Phase|Lack of Efficacy|23|||
130290908|NCT00098722|469029147|FG002|Double Blind Phase|Lack of Efficacy|15|||
130290909|NCT00098722|469029148|FG003|Double Blind Phase|Lack of Efficacy|0|||
130290910|NCT00098722|469029149|FG004|Double Blind Phase|Lack of Efficacy|0|||
130290911|NCT00098722|469029150|FG005|Double Blind Phase|Lack of Efficacy|0|||
130290912|NCT00098722|469029151|FG006|Double Blind Phase|Lack of Efficacy|0|||
130290913|NCT00098722|469029145|FG000|Double Blind Phase|Participant defaulted|16|||
130290914|NCT00098722|469029146|FG001|Double Blind Phase|Participant defaulted|11|||
130290915|NCT00098722|469029147|FG002|Double Blind Phase|Participant defaulted|9|||
130290916|NCT00098722|469029148|FG003|Double Blind Phase|Participant defaulted|0|||
130290917|NCT00098722|469029149|FG004|Double Blind Phase|Participant defaulted|0|||
130290918|NCT00098722|469029150|FG005|Double Blind Phase|Participant defaulted|0|||
130290919|NCT00098722|469029151|FG006|Double Blind Phase|Participant defaulted|0|||
130290920|NCT00098722|469029145|FG000|Double Blind Phase|Pregnancy|1|||
130290921|NCT00098722|469029146|FG001|Double Blind Phase|Pregnancy|0|||
130290922|NCT00098722|469029147|FG002|Double Blind Phase|Pregnancy|0|||
130290923|NCT00098722|469029148|FG003|Double Blind Phase|Pregnancy|0|||
130290924|NCT00098722|469029149|FG004|Double Blind Phase|Pregnancy|0|||
130290925|NCT00098722|469029150|FG005|Double Blind Phase|Pregnancy|0|||
130290926|NCT00098722|469029151|FG006|Double Blind Phase|Pregnancy|0|||
130290927|NCT00098722|469029145|FG000|Double Blind Phase|Randomized, not treated|4|||
130290928|NCT00098722|469029146|FG001|Double Blind Phase|Randomized, not treated|3|||
130290929|NCT00098722|469029147|FG002|Double Blind Phase|Randomized, not treated|3|||
130290930|NCT00098722|469029148|FG003|Double Blind Phase|Randomized, not treated|0|||
130290931|NCT00098722|469029149|FG004|Double Blind Phase|Randomized, not treated|0|||
130290932|NCT00098722|469029150|FG005|Double Blind Phase|Randomized, not treated|0|||
130290933|NCT00098722|469029151|FG006|Double Blind Phase|Randomized, not treated|0|||
130290934|NCT00098722|469029145|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
130290935|NCT00098722|469029146|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
130290936|NCT00098722|469029147|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
130290937|NCT00098722|469029148|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
130290938|NCT00098722|469029149|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
130290939|NCT00098722|469029150|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
130045648|NCT02940886|468125536|FG000|Overall Study|Adverse Event|7|||
130045649|NCT02940886|468125537|FG001|Overall Study|Adverse Event|3|||
130290940|NCT00098722|469029151|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
130290941|NCT00098722|469029145|FG000|Double Blind Phase|Other|7|||
130290942|NCT00098722|469029146|FG001|Double Blind Phase|Other|8|||
130290943|NCT00098722|469029147|FG002|Double Blind Phase|Other|7|||
130290944|NCT00098722|469029148|FG003|Double Blind Phase|Other|0|||
130290945|NCT00098722|469029149|FG004|Double Blind Phase|Other|0|||
130290946|NCT00098722|469029150|FG005|Double Blind Phase|Other|0|||
130290947|NCT00098722|469029151|FG006|Double Blind Phase|Other|0|||
130290948|NCT00098722|469029145|FG000|Open Label Phase|Adverse Event|0|||
130290949|NCT00098722|469029146|FG001|Open Label Phase|Adverse Event|0|||
130290950|NCT00098722|469029147|FG002|Open Label Phase|Adverse Event|0|||
130290951|NCT00098722|469029148|FG003|Open Label Phase|Adverse Event|5|||
130290952|NCT00098722|469029149|FG004|Open Label Phase|Adverse Event|0|||
130290953|NCT00098722|469029150|FG005|Open Label Phase|Adverse Event|0|||
130290954|NCT00098722|469029151|FG006|Open Label Phase|Adverse Event|0|||
130290955|NCT00098722|469029145|FG000|Open Label Phase|Death|0|||
130290956|NCT00098722|469029146|FG001|Open Label Phase|Death|0|||
130290957|NCT00098722|469029147|FG002|Open Label Phase|Death|0|||
130290958|NCT00098722|469029148|FG003|Open Label Phase|Death|2|||
130290959|NCT00098722|469029149|FG004|Open Label Phase|Death|0|||
130290960|NCT00098722|469029150|FG005|Open Label Phase|Death|0|||
130290961|NCT00098722|469029151|FG006|Open Label Phase|Death|0|||
130290962|NCT00098722|469029145|FG000|Open Label Phase|Lack of Efficacy|0|||
130290963|NCT00098722|469029146|FG001|Open Label Phase|Lack of Efficacy|0|||
130290964|NCT00098722|469029147|FG002|Open Label Phase|Lack of Efficacy|0|||
130290965|NCT00098722|469029148|FG003|Open Label Phase|Lack of Efficacy|8|||
130290966|NCT00098722|469029149|FG004|Open Label Phase|Lack of Efficacy|0|||
130290967|NCT00098722|469029150|FG005|Open Label Phase|Lack of Efficacy|0|||
130290968|NCT00098722|469029151|FG006|Open Label Phase|Lack of Efficacy|0|||
130290969|NCT00098722|469029145|FG000|Open Label Phase|Pregnancy|0|||
130290970|NCT00098722|469029146|FG001|Open Label Phase|Pregnancy|0|||
130290971|NCT00098722|469029147|FG002|Open Label Phase|Pregnancy|0|||
130290972|NCT00098722|469029148|FG003|Open Label Phase|Pregnancy|1|||
130290973|NCT00098722|469029149|FG004|Open Label Phase|Pregnancy|0|||
129793353|NCT01075191|467210775|FG000|Overall Study|Adverse Event|4|||
129793354|NCT01075191|467210775|FG000|Overall Study|Noncompliance|3|||
129793355|NCT01075191|467210775|FG000|Overall Study|Therapy Break|3|||
129793356|NCT01075191|467210775|FG000|Overall Study|Patient's Wish|2|||
129793357|NCT01075191|467210775|FG000|Overall Study|Unknown Reasons|1|||
129793358|NCT02635646|467210781|FG000|Overall Study|Lost to Follow-up|24|||
129793359|NCT02635646|467210782|FG001|Overall Study|Lost to Follow-up|25|||
129793360|NCT02635646|467210781|FG000|Overall Study|Pregnancy|1|||
129793361|NCT02635646|467210782|FG001|Overall Study|Pregnancy|1|||
129793362|NCT00645788|467210783|FG000|Overall Study|Did not receive study drug|1|||
129793363|NCT00645788|467210784|FG001|Overall Study|Did not receive study drug|1|||
129793364|NCT00645788|467210785|FG002|Overall Study|Did not receive study drug|0|||
129793365|NCT00645788|467210786|FG003|Overall Study|Did not receive study drug|0|||
129793366|NCT00645788|467210783|FG000|Overall Study|Adverse Event|4|||
129793367|NCT00645788|467210784|FG001|Overall Study|Adverse Event|9|||
130290974|NCT00098722|469029150|FG005|Open Label Phase|Pregnancy|0|||
130290975|NCT00098722|469029151|FG006|Open Label Phase|Pregnancy|0|||
130290976|NCT00098722|469029145|FG000|Open Label Phase|Participant defaulted|0|||
130290977|NCT00098722|469029146|FG001|Open Label Phase|Participant defaulted|0|||
130290978|NCT00098722|469029147|FG002|Open Label Phase|Participant defaulted|0|||
130290979|NCT00098722|469029148|FG003|Open Label Phase|Participant defaulted|18|||
129793368|NCT00645788|467210785|FG002|Overall Study|Adverse Event|5|||
129793369|NCT00645788|467210786|FG003|Overall Study|Adverse Event|3|||
129793370|NCT00645788|467210783|FG000|Overall Study|Lost to Follow-up|1|||
129793371|NCT00645788|467210784|FG001|Overall Study|Lost to Follow-up|0|||
129793372|NCT00645788|467210785|FG002|Overall Study|Lost to Follow-up|0|||
129793373|NCT00645788|467210786|FG003|Overall Study|Lost to Follow-up|0|||
130290980|NCT00098722|469029149|FG004|Open Label Phase|Participant defaulted|0|||
130290981|NCT00098722|469029150|FG005|Open Label Phase|Participant defaulted|0|||
130290982|NCT00098722|469029151|FG006|Open Label Phase|Participant defaulted|0|||
130290983|NCT00098722|469029145|FG000|Open Label Phase|Ongoing at cut-off date|0|||
130290984|NCT00098722|469029146|FG001|Open Label Phase|Ongoing at cut-off date|0|||
130290985|NCT00098722|469029147|FG002|Open Label Phase|Ongoing at cut-off date|0|||
130290986|NCT00098722|469029148|FG003|Open Label Phase|Ongoing at cut-off date|220|||
130290987|NCT00098722|469029149|FG004|Open Label Phase|Ongoing at cut-off date|50|||
130290988|NCT00098722|469029150|FG005|Open Label Phase|Ongoing at cut-off date|0|||
130290989|NCT00098722|469029151|FG006|Open Label Phase|Ongoing at cut-off date|0|||
130290990|NCT00098722|469029145|FG000|Open Label Phase|Other|0|||
130290991|NCT00098722|469029146|FG001|Open Label Phase|Other|0|||
130290992|NCT00098722|469029147|FG002|Open Label Phase|Other|0|||
130290993|NCT00098722|469029148|FG003|Open Label Phase|Other|18|||
130290994|NCT00098722|469029149|FG004|Open Label Phase|Other|0|||
129793374|NCT00645788|467210783|FG000|Overall Study|Protocol Violation|1|||
129793375|NCT00645788|467210784|FG001|Overall Study|Protocol Violation|0|||
129793376|NCT00645788|467210785|FG002|Overall Study|Protocol Violation|2|||
129793377|NCT00645788|467210786|FG003|Overall Study|Protocol Violation|0|||
130290995|NCT00098722|469029150|FG005|Open Label Phase|Other|0|||
130290996|NCT00098722|469029151|FG006|Open Label Phase|Other|0|||
130290997|NCT00098722|469029145|FG000|Observation Phase|Death|0|||
130290998|NCT00098722|469029146|FG001|Observation Phase|Death|0|||
130290999|NCT00098722|469029147|FG002|Observation Phase|Death|0|||
130291000|NCT00098722|469029148|FG003|Observation Phase|Death|0|||
129793378|NCT00645788|467210783|FG000|Overall Study|Withdrawal by Subject|0|||
130291001|NCT00098722|469029149|FG004|Observation Phase|Death|0|||
130291002|NCT00098722|469029150|FG005|Observation Phase|Death|5|||
130291003|NCT00098722|469029151|FG006|Observation Phase|Death|3|||
130291004|NCT00098722|469029145|FG000|Observation Phase|Lack of Efficacy|0|||
130291005|NCT00098722|469029146|FG001|Observation Phase|Lack of Efficacy|0|||
130291006|NCT00098722|469029147|FG002|Observation Phase|Lack of Efficacy|0|||
130291007|NCT00098722|469029148|FG003|Observation Phase|Lack of Efficacy|0|||
130291008|NCT00098722|469029149|FG004|Observation Phase|Lack of Efficacy|0|||
130291009|NCT00098722|469029150|FG005|Observation Phase|Lack of Efficacy|2|||
130291010|NCT00098722|469029151|FG006|Observation Phase|Lack of Efficacy|0|||
130291011|NCT00098722|469029145|FG000|Observation Phase|Participant defaulted|0|||
130291012|NCT00098722|469029146|FG001|Observation Phase|Participant defaulted|0|||
130291013|NCT00098722|469029147|FG002|Observation Phase|Participant defaulted|0|||
130291014|NCT00098722|469029148|FG003|Observation Phase|Participant defaulted|0|||
130291015|NCT00098722|469029149|FG004|Observation Phase|Participant defaulted|0|||
130291016|NCT00098722|469029150|FG005|Observation Phase|Participant defaulted|17|||
130291017|NCT00098722|469029151|FG006|Observation Phase|Participant defaulted|4|||
130291018|NCT00098722|469029145|FG000|Observation Phase|Other|0|||
130291019|NCT00098722|469029146|FG001|Observation Phase|Other|0|||
130291020|NCT00098722|469029147|FG002|Observation Phase|Other|0|||
130291021|NCT00098722|469029148|FG003|Observation Phase|Other|0|||
130291022|NCT00098722|469029149|FG004|Observation Phase|Other|0|||
130291023|NCT00098722|469029150|FG005|Observation Phase|Other|21|||
130291024|NCT00098722|469029151|FG006|Observation Phase|Other|10|||
130291025|NCT02351349|469029152|FG000|Overall Study|Withdrawal by Subject|2|||
130291026|NCT02351349|469029153|FG001|Overall Study|Withdrawal by Subject|3|||
130291027|NCT00440310|469029154|FG000|Overall Study|Lost to Follow-up|4|||
130291028|NCT00440310|469029155|FG001|Overall Study|Lost to Follow-up|5|||
130291029|NCT00440310|469029154|FG000|Overall Study|Protocol Violation|0|||
130291030|NCT00440310|469029155|FG001|Overall Study|Protocol Violation|1|||
130291031|NCT00440310|469029154|FG000|Overall Study|Withdrawal by Subject|15|||
130291032|NCT00440310|469029155|FG001|Overall Study|Withdrawal by Subject|14|||
130291033|NCT00440310|469029154|FG000|Overall Study|No Reply at EOS|7|||
130291034|NCT00440310|469029155|FG001|Overall Study|No Reply at EOS|7|||
130291035|NCT00440310|469029154|FG000|Overall Study|Other|1|||
130291036|NCT00440310|469029155|FG001|Overall Study|Other|0|||
130291037|NCT00440310|469029154|FG000|Overall Study|Status Unknown|1|||
130291038|NCT00440310|469029155|FG001|Overall Study|Status Unknown|3|||
130291039|NCT01610596|469029162|FG000|Overall Study|Lost to Follow-up|0|||
130291040|NCT01610596|469029163|FG001|Overall Study|Lost to Follow-up|1|||
130291041|NCT01519674|469029164|FG000|Overall Study|Adverse Event|3|||
130291042|NCT01519674|469029165|FG001|Overall Study|Adverse Event|3|||
130291043|NCT01519674|469029166|FG002|Overall Study|Adverse Event|0|||
130291044|NCT01519674|469029164|FG000|Overall Study|Lack of Efficacy|1|||
130291045|NCT01519674|469029165|FG001|Overall Study|Lack of Efficacy|1|||
130291046|NCT01519674|469029166|FG002|Overall Study|Lack of Efficacy|1|||
130291047|NCT01519674|469029164|FG000|Overall Study|Protocol Violation|0|||
130291048|NCT01519674|469029165|FG001|Overall Study|Protocol Violation|3|||
130291049|NCT01519674|469029166|FG002|Overall Study|Protocol Violation|1|||
130291050|NCT01519674|469029164|FG000|Overall Study|Withdrawal Criteria|7|||
130291051|NCT01519674|469029165|FG001|Overall Study|Withdrawal Criteria|2|||
130291052|NCT01519674|469029166|FG002|Overall Study|Withdrawal Criteria|7|||
130291053|NCT01519674|469029164|FG000|Overall Study|Unsclassified|10|||
130291054|NCT01519674|469029165|FG001|Overall Study|Unsclassified|4|||
130291055|NCT01519674|469029166|FG002|Overall Study|Unsclassified|3|||
130291056|NCT00799591|469029167|FG000|Overall Study|De-escalation of doses|20|||
130291057|NCT00799591|469029167|FG000|Overall Study|Death|14|||
130291058|NCT00799591|469029167|FG000|Overall Study|Technical failure|12|||
130291059|NCT00799591|469029167|FG000|Overall Study|Resistant germ|11|||
130291060|NCT00799591|469029167|FG000|Overall Study|New infection|4|||
130291061|NCT00799591|469029167|FG000|Overall Study|Resistance germ and technical failure|2|||
130291062|NCT00799591|469029167|FG000|Overall Study|Persistance of fever undetermined origin|1|||
130291063|NCT00799591|469029167|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
130291064|NCT00799591|469029167|FG000|Overall Study|Infectious origin not probable|1|||
130291065|NCT02317809|469029168|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
130291066|NCT02317809|469029169|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
130291067|NCT02317809|469029168|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
130291068|NCT02317809|469029169|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
130291069|NCT02969590|469029172|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
130291070|NCT02969590|469029173|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
130291071|NCT02969590|469029174|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
130291072|NCT02590562|469029179|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
130291073|NCT00598078|469029185|FG000|Period 2 (Day 2)|Adverse Event|1|||
130291074|NCT00598078|469029186|FG001|Period 2 (Day 2)|Adverse Event|0|||
130291075|NCT02699450|469029191|FG000|Overall Study|Death|2|||
130291076|NCT02699450|469029192|FG001|Overall Study|Death|1|||
130291077|NCT02699450|469029193|FG002|Overall Study|Death|2|||
130291078|NCT02699450|469029191|FG000|Overall Study|Met Criteria for Study Exit|0|||
130291079|NCT02699450|469029192|FG001|Overall Study|Met Criteria for Study Exit|0|||
130291080|NCT02699450|469029193|FG002|Overall Study|Met Criteria for Study Exit|1|||
130291081|NCT02699450|469029191|FG000|Overall Study|Protocol Violation|4|||
130291082|NCT02699450|469029192|FG001|Overall Study|Protocol Violation|3|||
130291083|NCT02699450|469029193|FG002|Overall Study|Protocol Violation|5|||
130291084|NCT02699450|469029191|FG000|Overall Study|Lost to Follow-up|3|||
130291085|NCT02699450|469029192|FG001|Overall Study|Lost to Follow-up|0|||
130291086|NCT02699450|469029193|FG002|Overall Study|Lost to Follow-up|5|||
130291087|NCT02699450|469029191|FG000|Overall Study|Physician Decision|2|||
130291088|NCT02699450|469029192|FG001|Overall Study|Physician Decision|0|||
129793379|NCT00645788|467210784|FG001|Overall Study|Withdrawal by Subject|1|||
130291089|NCT02699450|469029193|FG002|Overall Study|Physician Decision|0|||
130291090|NCT02699450|469029191|FG000|Overall Study|Withdrawal by Subject|3|||
130291091|NCT02699450|469029192|FG001|Overall Study|Withdrawal by Subject|1|||
130291092|NCT02699450|469029193|FG002|Overall Study|Withdrawal by Subject|2|||
130291093|NCT02699450|469029191|FG000|Overall Study|Adverse Event|1|||
130291094|NCT02699450|469029192|FG001|Overall Study|Adverse Event|0|||
130291095|NCT02699450|469029193|FG002|Overall Study|Adverse Event|0|||
130291096|NCT01133275|469029196|FG000|Overall Study|Withdrawal by Subject|1|||
130291097|NCT01133275|469029196|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
130291098|NCT00700102|469029197|FG000|Overall Study|Died|394|||
130291099|NCT00700102|469029198|FG001|Overall Study|Died|385|||
130291100|NCT00700102|469029197|FG000|Overall Study|Lost to Follow-up|8|||
130291101|NCT00700102|469029198|FG001|Overall Study|Lost to Follow-up|10|||
130291102|NCT02525939|469029199|FG000|Overall Study|Lost to Follow-up|27|||
130291103|NCT02525939|469029200|FG001|Overall Study|Lost to Follow-up|24|||
130291104|NCT02525939|469029199|FG000|Overall Study|Physician Decision|0|||
130291105|NCT02525939|469029200|FG001|Overall Study|Physician Decision|1|||
130291106|NCT02525939|469029199|FG000|Overall Study|Withdrawal by Subject|24|||
130291107|NCT02525939|469029200|FG001|Overall Study|Withdrawal by Subject|39|||
130291108|NCT02525939|469029199|FG000|Overall Study|Death|180|||
130291109|NCT02525939|469029200|FG001|Overall Study|Death|179|||
130291110|NCT01635764|469029201|FG000|Overall Study|Adverse Event|46|||
130291111|NCT01635764|469029201|FG000|Overall Study|Lack of Efficacy|76|||
130291112|NCT01635764|469029201|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
130291113|NCT01635764|469029201|FG000|Overall Study|Protocol Deviation|1|||
130291114|NCT01635764|469029201|FG000|Overall Study|Withdrew Consent|67|||
130291115|NCT01635764|469029201|FG000|Overall Study|Lost to Follow-up|53|||
130291116|NCT01635764|469029201|FG000|Overall Study|Other|28|||
130291117|NCT01174004|469029202|FG000|Overall Study|Adverse Event|2|||
130291118|NCT01174004|469029203|FG001|Overall Study|Adverse Event|10|||
130291119|NCT01174004|469029202|FG000|Overall Study|Withdrawal by Subject|2|||
130291120|NCT01174004|469029203|FG001|Overall Study|Withdrawal by Subject|3|||
130291121|NCT01174004|469029202|FG000|Overall Study|At Discretion of Sponsor|2|||
130291122|NCT01174004|469029203|FG001|Overall Study|At Discretion of Sponsor|2|||
130291123|NCT01174004|469029202|FG000|Overall Study|Protocol Violation|0|||
130291124|NCT01174004|469029203|FG001|Overall Study|Protocol Violation|1|||
130291125|NCT01174004|469029202|FG000|Overall Study|Physician Decision|1|||
130291126|NCT01174004|469029203|FG001|Overall Study|Physician Decision|0|||
130291127|NCT00693472|469029204|FG000|Part 1|Adverse Event|1|||
130291128|NCT00693472|469029205|FG001|Part 1|Adverse Event|1|||
130291129|NCT00693472|469029206|FG002|Part 1|Adverse Event|0|||
130291130|NCT00693472|469029207|FG003|Part 1|Adverse Event|0|||
130291131|NCT00693472|469029204|FG000|Part 1|Lost to Follow-up|0|||
130291132|NCT00693472|469029205|FG001|Part 1|Lost to Follow-up|1|||
130291133|NCT00693472|469029206|FG002|Part 1|Lost to Follow-up|0|||
130291134|NCT00693472|469029207|FG003|Part 1|Lost to Follow-up|0|||
130291135|NCT00693472|469029204|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
130291136|NCT00693472|469029205|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
130291137|NCT00693472|469029206|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
130291138|NCT00693472|469029207|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
130291139|NCT00693472|469029204|FG000|Part 2|Adverse Event|0|||
130291140|NCT00693472|469029205|FG001|Part 2|Adverse Event|0|||
130291141|NCT00693472|469029206|FG002|Part 2|Adverse Event|1|||
130291142|NCT00693472|469029207|FG003|Part 2|Adverse Event|0|||
130291143|NCT00693472|469029204|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
130291144|NCT00693472|469029205|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
130291145|NCT00693472|469029206|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
130291146|NCT00693472|469029207|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
130291147|NCT00849875|469029210|FG000|Overall Study|Death|28|||
130291148|NCT00849875|469029210|FG000|Overall Study|Ongoing (unknown completion status)|11|||
130291149|NCT00849875|469029210|FG000|Overall Study|Others|6|||
130291150|NCT00849875|469029210|FG000|Overall Study|Lost to Follow-up|2|||
130291151|NCT00086502|469029211|FG000|Overall Study|Adverse Event|11|||
130291152|NCT00086502|469029212|FG001|Overall Study|Adverse Event|2|||
130291153|NCT00086502|469029211|FG000|Overall Study|Lack of Efficacy|0|||
130291154|NCT00086502|469029212|FG001|Overall Study|Lack of Efficacy|2|||
130291155|NCT00086502|469029211|FG000|Overall Study|Lost to Follow-up|3|||
130291156|NCT00086502|469029212|FG001|Overall Study|Lost to Follow-up|1|||
130291157|NCT00086502|469029211|FG000|Overall Study|Physician Decision|1|||
130291158|NCT00086502|469029212|FG001|Overall Study|Physician Decision|1|||
130291159|NCT00086502|469029211|FG000|Overall Study|Pregnancy|0|||
130291160|NCT00086502|469029212|FG001|Overall Study|Pregnancy|1|||
130291161|NCT00086502|469029211|FG000|Overall Study|Protocol Violation|3|||
130291162|NCT00086502|469029212|FG001|Overall Study|Protocol Violation|3|||
130291163|NCT00086502|469029211|FG000|Overall Study|Withdrawal by Subject|5|||
130291164|NCT00086502|469029212|FG001|Overall Study|Withdrawal by Subject|6|||
130291165|NCT00086502|469029211|FG000|Overall Study|Patient Moved|1|||
130291166|NCT00086502|469029212|FG001|Overall Study|Patient Moved|1|||
130291167|NCT00086502|469029211|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
130291168|NCT00086502|469029212|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
130291169|NCT00086502|469029211|FG000|Overall Study|Patient Accidentally Unblinded|1|||
130291170|NCT00086502|469029212|FG001|Overall Study|Patient Accidentally Unblinded|0|||
130291171|NCT01515475|469029218|FG000|Overall Study|Lost to Follow-up|20|||
130291172|NCT01515475|469029219|FG001|Overall Study|Lost to Follow-up|15|||
130291173|NCT01515475|469029220|FG002|Overall Study|Lost to Follow-up|12|||
129888326|NCT02718417|467549132|FG000|Follow-up Phase|Adverse Event|3|||
129888327|NCT02718417|467549133|FG001|Follow-up Phase|Adverse Event|1|||
129888328|NCT02718417|467549134|FG002|Follow-up Phase|Adverse Event|1|||
129888329|NCT02718417|467549132|FG000|Follow-up Phase|Other|4|||
129888330|NCT02718417|467549133|FG001|Follow-up Phase|Other|6|||
129888331|NCT02718417|467549134|FG002|Follow-up Phase|Other|4|||
130291174|NCT01515475|469029221|FG003|Overall Study|Lost to Follow-up|12|||
130291175|NCT01420627|469029222|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
130291176|NCT00837876|469029223|FG000|Overall Study|Death|2|||
130291177|NCT00837876|469029223|FG000|Overall Study|Adverse Event|7|||
130291178|NCT00837876|469029223|FG000|Overall Study|Physician Decision|1|||
130291179|NCT00837876|469029223|FG000|Overall Study|Withdrawal by Subject|3|||
130291180|NCT00837876|469029223|FG000|Overall Study|disease progression|24|||
130291181|NCT00453973|469029224|FG000|Overall Study|Adverse Event|4|||
130291182|NCT00453973|469029225|FG001|Overall Study|Adverse Event|9|||
130291183|NCT00453973|469029224|FG000|Overall Study|Withdrawal by Subject|7|||
130291184|NCT00453973|469029225|FG001|Overall Study|Withdrawal by Subject|6|||
130291185|NCT00453973|469029224|FG000|Overall Study|PI Decision|0|||
130291186|NCT00453973|469029225|FG001|Overall Study|PI Decision|2|||
130291187|NCT00453973|469029224|FG000|Overall Study|Relocation|1|||
130291188|NCT00453973|469029225|FG001|Overall Study|Relocation|0|||
130291189|NCT00453973|469029224|FG000|Overall Study|Renal transplant|1|||
130291190|NCT00453973|469029225|FG001|Overall Study|Renal transplant|1|||
130291191|NCT00453973|469029224|FG000|Overall Study|Site closed by sponsor|3|||
130291192|NCT00453973|469029225|FG001|Overall Study|Site closed by sponsor|0|||
130291193|NCT00453973|469029224|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
130291194|NCT00453973|469029225|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
130291195|NCT00276094|469029226|FG000|Overall Study|Adverse Event|15|||
130291196|NCT00276094|469029227|FG001|Overall Study|Adverse Event|13|||
130291197|NCT00276094|469029228|FG002|Overall Study|Adverse Event|11|||
130291198|NCT00276094|469029226|FG000|Overall Study|Withdrawal by Subject|14|||
130291199|NCT00276094|469029227|FG001|Overall Study|Withdrawal by Subject|14|||
130291200|NCT00276094|469029228|FG002|Overall Study|Withdrawal by Subject|12|||
130291201|NCT00276094|469029226|FG000|Overall Study|Protocol Violation|16|||
130291202|NCT00276094|469029227|FG001|Overall Study|Protocol Violation|7|||
130291203|NCT00276094|469029228|FG002|Overall Study|Protocol Violation|10|||
130291204|NCT00276094|469029226|FG000|Overall Study|Lost to Follow-up|8|||
130291205|NCT00276094|469029227|FG001|Overall Study|Lost to Follow-up|6|||
130291206|NCT00276094|469029228|FG002|Overall Study|Lost to Follow-up|4|||
130291207|NCT00276094|469029226|FG000|Overall Study|Other-Subject moved out of country|1|||
130291208|NCT00276094|469029227|FG001|Overall Study|Other-Subject moved out of country|0|||
130291209|NCT00276094|469029228|FG002|Overall Study|Other-Subject moved out of country|0|||
130291210|NCT00276094|469029226|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
130291211|NCT00276094|469029227|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
130291212|NCT00276094|469029228|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
130291213|NCT00276094|469029226|FG000|Overall Study|Other-Lack of efficacy|1|||
130291214|NCT00276094|469029227|FG001|Overall Study|Other-Lack of efficacy|0|||
130291215|NCT00276094|469029228|FG002|Overall Study|Other-Lack of efficacy|0|||
130291216|NCT00276094|469029226|FG000|Overall Study|Other-Refused follow-up visit|1|||
130291217|NCT00276094|469029227|FG001|Overall Study|Other-Refused follow-up visit|0|||
130291218|NCT00276094|469029228|FG002|Overall Study|Other-Refused follow-up visit|0|||
130291219|NCT00276094|469029226|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
130291220|NCT00276094|469029227|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
130291221|NCT00276094|469029228|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
130291222|NCT00276094|469029226|FG000|Overall Study|Other-Relocation|0|||
130291223|NCT00276094|469029227|FG001|Overall Study|Other-Relocation|1|||
130291224|NCT00276094|469029228|FG002|Overall Study|Other-Relocation|0|||
130291225|NCT00276094|469029226|FG000|Overall Study|Other-Study medication lost|0|||
130291226|NCT00276094|469029227|FG001|Overall Study|Other-Study medication lost|0|||
130291227|NCT00276094|469029228|FG002|Overall Study|Other-Study medication lost|1|||
130291228|NCT02075632|469029233|FG000|Overall Study|Adverse Event|1|||
130291229|NCT02075632|469029234|FG001|Overall Study|Adverse Event|1|||
130291230|NCT02075632|469029233|FG000|Overall Study|Lost to Follow-up|0|||
130291231|NCT02075632|469029234|FG001|Overall Study|Lost to Follow-up|3|||
130291232|NCT02075632|469029233|FG000|Overall Study|Withdrawal by Subject|0|||
130291233|NCT02075632|469029234|FG001|Overall Study|Withdrawal by Subject|1|||
130291234|NCT01969500|469029243|FG000|Overall Study|Death|0|||
130291235|NCT01969500|469029244|FG001|Overall Study|Death|1|||
130291236|NCT01969500|469029243|FG000|Overall Study|extended hospitalization|1|||
130291237|NCT01969500|469029244|FG001|Overall Study|extended hospitalization|1|||
130291238|NCT01873729|469029245|FG000|Overall Study|Withdrawal by Subject|1|||
130291239|NCT02463032|469029246|FG000|Overall Study|Lack of Efficacy|61|||
130291240|NCT02463032|469029247|FG001|Overall Study|Lack of Efficacy|50|||
130291241|NCT02463032|469029246|FG000|Overall Study|Death|8|||
130291242|NCT02463032|469029247|FG001|Overall Study|Death|8|||
130291243|NCT02463032|469029246|FG000|Overall Study|Adverse Event|2|||
130291244|NCT02463032|469029247|FG001|Overall Study|Adverse Event|6|||
130291245|NCT00613080|469029248|FG000|Overall Study|Ineligible / no protocol treatment|11|||
129888332|NCT02718417|467549132|FG000|Follow-up Phase|Withdrawal by Subject|19|||
130291246|NCT03757130|469029249|FG000|Overall Study|Lost to Follow-up|0|||
130291247|NCT03757130|469029250|FG001|Overall Study|Lost to Follow-up|0|||
130291248|NCT03757130|469029251|FG002|Overall Study|Lost to Follow-up|0|||
130291249|NCT03757130|469029252|FG003|Overall Study|Lost to Follow-up|1|||
130291250|NCT03757130|469029253|FG004|Overall Study|Lost to Follow-up|0|||
130291251|NCT03757130|469029254|FG005|Overall Study|Lost to Follow-up|0|||
130291252|NCT03757130|469029255|FG006|Overall Study|Lost to Follow-up|0|||
130291253|NCT03757130|469029256|FG007|Overall Study|Lost to Follow-up|1|||
130291254|NCT03757130|469029249|FG000|Overall Study|Withdrawal by Subject|0|||
130291255|NCT03757130|469029250|FG001|Overall Study|Withdrawal by Subject|0|||
130291256|NCT03757130|469029251|FG002|Overall Study|Withdrawal by Subject|0|||
130291257|NCT03757130|469029252|FG003|Overall Study|Withdrawal by Subject|0|||
130291258|NCT03757130|469029253|FG004|Overall Study|Withdrawal by Subject|0|||
130291259|NCT03757130|469029254|FG005|Overall Study|Withdrawal by Subject|0|||
130291260|NCT03757130|469029255|FG006|Overall Study|Withdrawal by Subject|1|||
130291261|NCT03757130|469029256|FG007|Overall Study|Withdrawal by Subject|0|||
130291262|NCT02226549|469029257|FG000|Overall Study|Randomized but Never Treated|1|||
130291263|NCT02226549|469029258|FG001|Overall Study|Randomized but Never Treated|0|||
130291264|NCT02226549|469029257|FG000|Overall Study|Lost to Follow-up|0|||
130291265|NCT02226549|469029258|FG001|Overall Study|Lost to Follow-up|1|||
130291266|NCT02726880|469029260|FG000|Overall Study|Withdrawal by Subject|2|||
130291267|NCT02726880|469029261|FG001|Overall Study|Withdrawal by Subject|0|||
130291268|NCT02726880|469029260|FG000|Overall Study|Lost to Follow-up|1|||
130291269|NCT02726880|469029261|FG001|Overall Study|Lost to Follow-up|3|||
130291270|NCT02312219|469029262|FG000|Overall Study|Withdrawal by Subject|1|||
130291271|NCT02312219|469029263|FG001|Overall Study|Withdrawal by Subject|2|||
130291272|NCT02312219|469029262|FG000|Overall Study|could not schedule imaging in time|0|||
130291273|NCT02312219|469029263|FG001|Overall Study|could not schedule imaging in time|2|||
130291274|NCT02312219|469029262|FG000|Overall Study|Other|0|||
130291275|NCT02312219|469029263|FG001|Overall Study|Other|1|||
130291276|NCT02312219|469029262|FG000|Overall Study|Not randomized. Ineligible|0|||
129888333|NCT02718417|467549133|FG001|Follow-up Phase|Withdrawal by Subject|17|||
129888334|NCT02718417|467549134|FG002|Follow-up Phase|Withdrawal by Subject|5|||
129888335|NCT02718417|467549132|FG000|Follow-up Phase|Study terminated by sponsor|100|||
129888336|NCT02718417|467549133|FG001|Follow-up Phase|Study terminated by sponsor|138|||
129888337|NCT02718417|467549134|FG002|Follow-up Phase|Study terminated by sponsor|6|||
129888338|NCT02718417|467549132|FG000|Follow-up Phase|Lost to Follow-up|2|||
129888339|NCT02718417|467549133|FG001|Follow-up Phase|Lost to Follow-up|3|||
129888340|NCT02718417|467549134|FG002|Follow-up Phase|Lost to Follow-up|0|||
129888341|NCT02718417|467549132|FG000|Follow-up Phase|Death leading to discontinuation|7|||
129888342|NCT02718417|467549133|FG001|Follow-up Phase|Death leading to discontinuation|7|||
129888343|NCT02718417|467549134|FG002|Follow-up Phase|Death leading to discontinuation|3|||
129888344|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
129888345|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
129888346|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
129888347|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
130291277|NCT02312219|469029263|FG001|Overall Study|Not randomized. Ineligible|1|||
130291278|NCT01269385|469029264|FG000|Overall Study|Adverse Event|1|||
130291279|NCT01269385|469029265|FG001|Overall Study|Adverse Event|1|||
130291280|NCT01269385|469029266|FG002|Overall Study|Adverse Event|0|||
130291281|NCT01269385|469029267|FG003|Overall Study|Adverse Event|0|||
130291282|NCT00546260|469029268|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
130291283|NCT00546260|469029269|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
130291284|NCT03759041|469029270|FG000|Overall Study|Withdrawal by Subject|4|||
130291285|NCT03759041|469029271|FG001|Overall Study|Withdrawal by Subject|10|||
130291286|NCT03759041|469029272|FG002|Overall Study|Withdrawal by Subject|10|||
130291287|NCT03759041|469029270|FG000|Overall Study|Adverse Event|1|||
130291288|NCT03759041|469029271|FG001|Overall Study|Adverse Event|3|||
130291289|NCT03759041|469029272|FG002|Overall Study|Adverse Event|4|||
130291290|NCT03759041|469029270|FG000|Overall Study|Lack of Efficacy|0|||
130291291|NCT03759041|469029271|FG001|Overall Study|Lack of Efficacy|0|||
130291292|NCT03759041|469029272|FG002|Overall Study|Lack of Efficacy|1|||
130291293|NCT03759041|469029270|FG000|Overall Study|Study Terminated by Sponsor|15|||
130291294|NCT03759041|469029271|FG001|Overall Study|Study Terminated by Sponsor|16|||
130291295|NCT03759041|469029272|FG002|Overall Study|Study Terminated by Sponsor|10|||
130291296|NCT03759041|469029270|FG000|Overall Study|Other reason for discontinuation|0|||
130291297|NCT03759041|469029271|FG001|Overall Study|Other reason for discontinuation|2|||
130291298|NCT03759041|469029272|FG002|Overall Study|Other reason for discontinuation|1|||
130291299|NCT03759041|469029270|FG000|Overall Study|Lost to Follow-up|7|||
130291300|NCT03759041|469029271|FG001|Overall Study|Lost to Follow-up|2|||
130291301|NCT03759041|469029272|FG002|Overall Study|Lost to Follow-up|2|||
130291302|NCT03759041|469029270|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
130291303|NCT03759041|469029271|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
130291304|NCT03759041|469029272|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
130291305|NCT04384107|469029273|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
130291306|NCT04384107|469029274|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
130291307|NCT04384107|469029273|FG000|Overall Study|Lost to Follow-up|1|||
130291308|NCT04384107|469029274|FG001|Overall Study|Lost to Follow-up|0|||
130291309|NCT00276614|469029275|FG000|Overall Study|Progression of disease under study|3|||
130291310|NCT01522404|469029278|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
130291311|NCT01522404|469029279|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
130291312|NCT01522404|469029278|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
130291313|NCT01522404|469029279|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
130291314|NCT01522404|469029278|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
130291315|NCT01522404|469029279|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
130291316|NCT01591863|469029284|FG000|Overall Study|Adverse Event|3|||
130291317|NCT01591863|469029284|FG000|Overall Study|Withdrawal by Subject|1|||
130291318|NCT01591863|469029284|FG000|Overall Study|recurrence|9|||
130291319|NCT01591863|469029284|FG000|Overall Study|Lack of Efficacy|1|||
130291320|NCT00664326|469030648|FG000|Overall Study|Adverse Event|14|||
130291321|NCT00664326|469030648|FG000|Overall Study|Noncompliance with study medication|3|||
130291322|NCT00664326|469030648|FG000|Overall Study|Withdrawal by Subject|1|||
130291323|NCT00664326|469030648|FG000|Overall Study|Physician Decision|1|||
130291324|NCT00664326|469030648|FG000|Overall Study|Other Reasons|3|||
130291325|NCT00664326|469030648|FG000|Overall Study|Death|2|||
130291326|NCT00664326|469030648|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
130291327|NCT01266317|469030649|FG000|Overall Study|Withdrawal by Subject|2|||
130291328|NCT00490776|469030650|FG000|Overall Study|Withdrawal by Subject|1|||
130291329|NCT00490776|469030650|FG000|Overall Study|Administrative Problems|1|||
130291330|NCT00490776|469030650|FG000|Overall Study|Death|1|||
130291331|NCT00490776|469030650|FG000|Overall Study|New Cancer Therapy|1|||
130291332|NCT00490776|469030650|FG000|Overall Study|Disease Progression|5|||
130291333|NCT00046930|469030658|FG000|Overall Study|Ineligible|12|||
130291334|NCT00046930|469030659|FG001|Overall Study|Ineligible|4|||
130291335|NCT04912895|469030660|FG000|Overall Study|Unable to provide specimen|2|||
130291336|NCT04912895|469030661|FG001|Overall Study|Unable to provide specimen|0|||
130291337|NCT04912895|469030662|FG002|Overall Study|Unable to provide specimen|0|||
130291338|NCT00520013|469030663|FG000|Overall Study|Withdrawal by Subject|0|||
130291339|NCT00520013|469030664|FG001|Overall Study|Withdrawal by Subject|0|||
130291340|NCT00520013|469030665|FG002|Overall Study|Withdrawal by Subject|1|||
130291341|NCT00520013|469030663|FG000|Overall Study|Adverse Event|2|||
130291342|NCT00520013|469030664|FG001|Overall Study|Adverse Event|10|||
130291343|NCT00520013|469030665|FG002|Overall Study|Adverse Event|7|||
130291344|NCT00520013|469030663|FG000|Overall Study|Progressive Disease|7|||
130291345|NCT00520013|469030664|FG001|Overall Study|Progressive Disease|3|||
130291346|NCT00520013|469030665|FG002|Overall Study|Progressive Disease|0|||
130291347|NCT00520013|469030663|FG000|Overall Study|Clinical Progression|3|||
130291348|NCT00520013|469030664|FG001|Overall Study|Clinical Progression|1|||
130291349|NCT00520013|469030665|FG002|Overall Study|Clinical Progression|0|||
130291350|NCT00520013|469030663|FG000|Overall Study|Death|0|||
130291351|NCT00520013|469030664|FG001|Overall Study|Death|1|||
130291352|NCT00520013|469030665|FG002|Overall Study|Death|0|||
130291353|NCT00520013|469030663|FG000|Overall Study|Physician Decision|0|||
130291354|NCT00520013|469030664|FG001|Overall Study|Physician Decision|0|||
130291355|NCT00520013|469030665|FG002|Overall Study|Physician Decision|3|||
130291356|NCT02677844|469030666|FG000|Period 3|Withdrawal by Subject|0|||
130291357|NCT02677844|469030667|FG001|Period 3|Withdrawal by Subject|0|||
130291358|NCT02677844|469030668|FG002|Period 3|Withdrawal by Subject|0|||
130291359|NCT02677844|469030669|FG003|Period 3|Withdrawal by Subject|1|||
130291360|NCT02677844|469030670|FG004|Period 3|Withdrawal by Subject|0|||
130291361|NCT02677844|469030671|FG005|Period 3|Withdrawal by Subject|0|||
130291362|NCT02677844|469030672|FG006|Period 3|Withdrawal by Subject|0|||
130291363|NCT01149486|469030673|FG000|First Intervention|Adverse Event|0|||
130291364|NCT01149486|469030674|FG001|First Intervention|Adverse Event|1|||
130291365|NCT01135914|469030677|FG000|Overall Study|Withdrawal by Subject|1|||
130291366|NCT01135914|469030678|FG001|Overall Study|Withdrawal by Subject|3|||
130291367|NCT01135914|469030679|FG002|Overall Study|Withdrawal by Subject|6|||
130291368|NCT01135914|469030677|FG000|Overall Study|Lost to Follow-up|1|||
130291369|NCT01135914|469030678|FG001|Overall Study|Lost to Follow-up|0|||
130045650|NCT02940886|468125536|FG000|Overall Study|Protocol Violation|0|||
130291370|NCT01135914|469030679|FG002|Overall Study|Lost to Follow-up|1|||
130291371|NCT01135914|469030677|FG000|Overall Study|Protocol Violation|0|||
130291372|NCT01135914|469030678|FG001|Overall Study|Protocol Violation|0|||
130291373|NCT01135914|469030679|FG002|Overall Study|Protocol Violation|3|||
130291374|NCT01135914|469030677|FG000|Overall Study|Lack of Efficacy|2|||
130291375|NCT01135914|469030678|FG001|Overall Study|Lack of Efficacy|1|||
130291376|NCT01135914|469030679|FG002|Overall Study|Lack of Efficacy|10|||
130291377|NCT01135914|469030677|FG000|Overall Study|Adverse Event|0|||
130291378|NCT01135914|469030678|FG001|Overall Study|Adverse Event|1|||
130291379|NCT01135914|469030679|FG002|Overall Study|Adverse Event|2|||
130291380|NCT03532932|469030680|FG000|Overall Study|Protocol Deviation|33|||
130291381|NCT03532932|469030681|FG001|Overall Study|Protocol Deviation|31|||
130291382|NCT03532932|469030680|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
130291383|NCT03532932|469030681|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
130291384|NCT03532932|469030680|FG000|Overall Study|Withdrawal by Subject|2|||
130291385|NCT03532932|469030681|FG001|Overall Study|Withdrawal by Subject|0|||
130291386|NCT03532932|469030680|FG000|Overall Study|Lost to Follow-up|15|||
130291387|NCT03532932|469030681|FG001|Overall Study|Lost to Follow-up|9|||
130291388|NCT03532932|469030680|FG000|Overall Study|Adverse Event|4|||
130291389|NCT03532932|469030681|FG001|Overall Study|Adverse Event|3|||
130291390|NCT03532932|469030680|FG000|Overall Study|Death|0|||
130291391|NCT03532932|469030681|FG001|Overall Study|Death|2|||
130291392|NCT03532932|469030680|FG000|Overall Study|Other|11|||
130291393|NCT03532932|469030681|FG001|Overall Study|Other|16|||
130291394|NCT01344629|469030686|FG000|Crossover Period 2|Withdrawal by Subject|0|||
130291395|NCT01344629|469030687|FG001|Crossover Period 2|Withdrawal by Subject|1|||
129793380|NCT00645788|467210785|FG002|Overall Study|Withdrawal by Subject|0|||
130291396|NCT00391391|469030689|FG000|Overall Study|Adverse Event|0|||
130291397|NCT00391391|469030690|FG001|Overall Study|Adverse Event|0|||
130291398|NCT00391391|469030691|FG002|Overall Study|Adverse Event|0|||
130291399|NCT00391391|469030692|FG003|Overall Study|Adverse Event|1|||
130291400|NCT00391391|469030689|FG000|Overall Study|Lost to Follow-up|1|||
130291401|NCT00391391|469030690|FG001|Overall Study|Lost to Follow-up|3|||
130291402|NCT00391391|469030691|FG002|Overall Study|Lost to Follow-up|7|||
130291403|NCT00391391|469030692|FG003|Overall Study|Lost to Follow-up|4|||
130291404|NCT00391391|469030689|FG000|Overall Study|Protocol Violation|2|||
130291405|NCT00391391|469030690|FG001|Overall Study|Protocol Violation|3|||
130291406|NCT00391391|469030691|FG002|Overall Study|Protocol Violation|6|||
130291407|NCT00391391|469030692|FG003|Overall Study|Protocol Violation|7|||
130291408|NCT00391391|469030689|FG000|Overall Study|Withdrawal by Subject|6|||
130291409|NCT00391391|469030690|FG001|Overall Study|Withdrawal by Subject|4|||
130291410|NCT00391391|469030691|FG002|Overall Study|Withdrawal by Subject|10|||
130291411|NCT00391391|469030692|FG003|Overall Study|Withdrawal by Subject|7|||
130291412|NCT04063787|469030693|FG000|Overall Study|Inadequate Doppler data|4|||
130291413|NCT04063787|469030693|FG000|Overall Study|Lost to Follow-up|2|||
130291414|NCT04063787|469030693|FG000|Overall Study|Death|3|||
130291415|NCT05545644|469030694|FG000|Overall Study|Lost to Follow-up|4|||
130291416|NCT05545644|469030695|FG001|Overall Study|Lost to Follow-up|3|||
130291417|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
130291418|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
130291419|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
130291420|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
130291421|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
130291422|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
129793381|NCT00645788|467210786|FG003|Overall Study|Withdrawal by Subject|2|||
129793382|NCT00645788|467210783|FG000|Overall Study|Pulmonary exacerbation|13|||
129793383|NCT00645788|467210784|FG001|Overall Study|Pulmonary exacerbation|16|||
129793384|NCT00645788|467210785|FG002|Overall Study|Pulmonary exacerbation|11|||
129793385|NCT00645788|467210786|FG003|Overall Study|Pulmonary exacerbation|9|||
129793386|NCT00459979|467210788|FG000|Overall Study|Withdrawal by Subject|1|||
129793387|NCT00459979|467210788|FG000|Overall Study|Protocol Violation|1|||
129793388|NCT00570232|467210789|FG000|Overall Study|Adverse Event|10|||
129793389|NCT00570232|467210789|FG000|Overall Study|discontinued due to medical condition|3|||
129793390|NCT00570232|467210789|FG000|Overall Study|discontinued due to recurrence|8|||
129793391|NCT00570232|467210789|FG000|Overall Study|discontinued due to noncompliance|2|||
129793392|NCT02207946|467210793|FG000|Overall Study|Lost to Follow-up|1|||
129793393|NCT02207946|467210794|FG001|Overall Study|Lost to Follow-up|0|||
129793394|NCT02207946|467210793|FG000|Overall Study|Adverse Event|0|||
129793395|NCT02207946|467210794|FG001|Overall Study|Adverse Event|1|||
129793396|NCT02361346|467210806|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
130291423|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
130291424|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
130291425|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
130291426|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
130291427|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
130291428|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
130291429|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
130291430|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
130291431|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
129793397|NCT02361346|467210807|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793398|NCT02361346|467210808|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793399|NCT02361346|467210809|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
129793400|NCT02361346|467210810|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
130291432|NCT00554099|469030698|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130291433|NCT00554099|469030699|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130291434|NCT00554099|469030700|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
130291435|NCT00554099|469030698|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
130045651|NCT02940886|468125537|FG001|Overall Study|Protocol Violation|2|||
130045652|NCT02940886|468125536|FG000|Overall Study|Withdrawal by Subject|28|||
130045653|NCT02940886|468125537|FG001|Overall Study|Withdrawal by Subject|20|||
130045654|NCT02940886|468125536|FG000|Overall Study|Death|1|||
130291436|NCT00554099|469030699|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
130291437|NCT00554099|469030700|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
130291438|NCT00554099|469030698|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
130291439|NCT00554099|469030699|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
130291440|NCT00554099|469030700|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
130291441|NCT00554099|469030698|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
130291442|NCT00554099|469030699|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
130291443|NCT00554099|469030700|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
130291444|NCT03002623|469030701|FG000|Overall Study|Lost to Follow-up|1|||
130291445|NCT03002623|469030702|FG001|Overall Study|Lost to Follow-up|0|||
130291446|NCT03002623|469030701|FG000|Overall Study|Physician Decision|1|||
130291447|NCT03002623|469030702|FG001|Overall Study|Physician Decision|1|||
130291448|NCT00493636|469030704|FG000|Overall Study|Withdrawal by Subject|1|||
130291449|NCT00493636|469030705|FG001|Overall Study|Withdrawal by Subject|0|||
130291450|NCT00493636|469030704|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
130291451|NCT00493636|469030705|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
130291452|NCT00493636|469030704|FG000|Overall Study|Mis-randomization|1|||
130291453|NCT00493636|469030705|FG001|Overall Study|Mis-randomization|1|||
130291454|NCT02012686|469030712|FG000|Overall Study|muscle contraction|0|||
130291455|NCT02012686|469030713|FG001|Overall Study|muscle contraction|1|||
130291456|NCT02012686|469030712|FG000|Overall Study|electrocardiography monitoring noise|0|||
130291457|NCT02012686|469030713|FG001|Overall Study|electrocardiography monitoring noise|1|||
130291458|NCT00612508|469030714|FG000|Overall Study|Withdrawal by Subject|3|||
130291459|NCT00612508|469030715|FG001|Overall Study|Withdrawal by Subject|4|||
130291460|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
130291461|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
130291462|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
130291463|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
130291464|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
130291465|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
130045655|NCT02940886|468125537|FG001|Overall Study|Death|0|||
130291466|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
130291467|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
130291468|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
130291469|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
130291470|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
130291471|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
130291472|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
130291473|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
130291474|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
130291475|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
130291476|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
130291477|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
130291478|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
130291479|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
130291480|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
130291481|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
130291482|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
130291483|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
130291484|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
130291485|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
130291486|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
130291487|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
130291488|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
130291489|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
130291490|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
130291491|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
130291492|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
130291493|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
130291494|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
130291495|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
130045656|NCT02940886|468125536|FG000|Overall Study|Lack of Efficacy|1|||
130045657|NCT02940886|468125537|FG001|Overall Study|Lack of Efficacy|0|||
130045658|NCT02940886|468125536|FG000|Overall Study|Lost to Follow-up|49|||
130045659|NCT02940886|468125537|FG001|Overall Study|Lost to Follow-up|21|||
130045660|NCT02940886|468125536|FG000|Overall Study|Physician Decision|9|||
130045661|NCT02940886|468125537|FG001|Overall Study|Physician Decision|4|||
130045662|NCT02940886|468125536|FG000|Overall Study|Sponsor decision|0|||
130045663|NCT02940886|468125537|FG001|Overall Study|Sponsor decision|1|||
130045664|NCT02940886|468125536|FG000|Overall Study|No treatment|7|||
130045665|NCT02940886|468125537|FG001|Overall Study|No treatment|2|||
130045666|NCT02940886|468125536|FG000|Overall Study|Enrolment error|0|||
130045667|NCT02940886|468125537|FG001|Overall Study|Enrolment error|1|||
130045668|NCT01306058|468125541|FG000|Overall Study|Death|1|||
130045669|NCT01306058|468125541|FG000|Overall Study|Enrolled but did not get treatment|1|||
130045670|NCT01666444|468125542|FG000|Overall Study|Did not initiate treatment|2|||
130045671|NCT01666444|468125543|FG001|Overall Study|Did not initiate treatment|1|||
130045672|NCT00592358|468125550|FG000|Overall Study|Withdrawal by Subject|2|||
130045673|NCT00592358|468125550|FG000|Overall Study|Adverse Event|1|||
130045674|NCT00592358|468125550|FG000|Overall Study|Lack of Efficacy|2|||
130045675|NCT00592358|468125550|FG000|Overall Study|Inability to swallow pills|1|||
130045676|NCT00084682|468125551|FG000|Overall Study|Withdrawal by Subject|1|||
130045677|NCT01166659|468125552|FG000|Overall Study|Subject Decision|8|||
130045678|NCT01166659|468125552|FG000|Overall Study|Investigator Decision|2|||
130045679|NCT01166659|468125552|FG000|Overall Study|Death|1|||
130045680|NCT01166659|468125552|FG000|Overall Study|Lost to Follow-up|1|||
130045681|NCT01166659|468125552|FG000|Overall Study|Study Closed at Site|1|||
130045682|NCT01371838|468125568|FG000|Overall Study|Withdrawal by Subject|27|||
130045683|NCT01371838|468125569|FG001|Overall Study|Withdrawal by Subject|33|||
130045684|NCT01371838|468125568|FG000|Overall Study|Lost to Follow-up|10|||
130045685|NCT01371838|468125569|FG001|Overall Study|Lost to Follow-up|20|||
130045686|NCT01371838|468125568|FG000|Overall Study|Death|3|||
130045687|NCT01371838|468125569|FG001|Overall Study|Death|4|||
130045688|NCT01371838|468125568|FG000|Overall Study|Protocol Violation|3|||
130045689|NCT01371838|468125569|FG001|Overall Study|Protocol Violation|0|||
130045690|NCT01371838|468125568|FG000|Overall Study|Investigator Decision|3|||
130045691|NCT01371838|468125569|FG001|Overall Study|Investigator Decision|8|||
130045692|NCT01371838|468125568|FG000|Overall Study|Last follow-up visit not conducted|2|||
130045693|NCT01371838|468125569|FG001|Overall Study|Last follow-up visit not conducted|0|||
130045694|NCT01371838|468125568|FG000|Overall Study|Lack of therapeutic response|0|||
130045695|NCT01371838|468125569|FG001|Overall Study|Lack of therapeutic response|1|||
130045696|NCT01371838|468125568|FG000|Overall Study|Surgery|1|||
130045697|NCT01371838|468125569|FG001|Overall Study|Surgery|0|||
130045698|NCT02241512|468125570|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
130045699|NCT02241512|468125571|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
130045700|NCT00641043|468125574|FG000|Overall Study|Adverse Event|6|||
130045701|NCT00641043|468125575|FG001|Overall Study|Adverse Event|4|||
130045702|NCT00641043|468125574|FG000|Overall Study|Protocol Violation|2|||
130045703|NCT00641043|468125575|FG001|Overall Study|Protocol Violation|3|||
130045704|NCT00641043|468125574|FG000|Overall Study|Lost to Follow-up|3|||
130045705|NCT00641043|468125575|FG001|Overall Study|Lost to Follow-up|2|||
130045706|NCT00641043|468125574|FG000|Overall Study|Withdrawal by Subject|4|||
130045707|NCT00641043|468125575|FG001|Overall Study|Withdrawal by Subject|4|||
130045708|NCT00641043|468125574|FG000|Overall Study|Other incl. lack of efficacy|4|||
130291496|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
130291497|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
130291498|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
130291499|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
130291500|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
130291501|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
130291502|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
130045709|NCT00641043|468125575|FG001|Overall Study|Other incl. lack of efficacy|2|||
130291503|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
130045710|NCT04275310|468125576|FG000|Overall Study|Non-randomized due to running out of funding|4|||
130045711|NCT04275310|468125577|FG001|Overall Study|Non-randomized due to running out of funding|0|||
130045712|NCT04101422|468125580|FG000|Overall Study|Ineligible|1|||
130045713|NCT04101422|468125581|FG001|Overall Study|Ineligible|0|||
130045714|NCT04101422|468125582|FG002|Overall Study|Ineligible|9|||
130045715|NCT04101422|468125583|FG003|Overall Study|Ineligible|0|||
130045716|NCT04101422|468125580|FG000|Overall Study|Withdrawal by Subject|0|||
130045717|NCT04101422|468125581|FG001|Overall Study|Withdrawal by Subject|0|||
130106494|NCT03273257|468350052|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
130045718|NCT04101422|468125582|FG002|Overall Study|Withdrawal by Subject|1|||
130045719|NCT04101422|468125583|FG003|Overall Study|Withdrawal by Subject|0|||
130045720|NCT04101422|468125580|FG000|Overall Study|Not attending to the stimuli|0|||
130045721|NCT04101422|468125581|FG001|Overall Study|Not attending to the stimuli|0|||
130045722|NCT04101422|468125582|FG002|Overall Study|Not attending to the stimuli|4|||
130045723|NCT04101422|468125583|FG003|Overall Study|Not attending to the stimuli|0|||
130045724|NCT04101422|468125580|FG000|Overall Study|Did not download app|0|||
130045725|NCT04101422|468125581|FG001|Overall Study|Did not download app|0|||
130045726|NCT04101422|468125582|FG002|Overall Study|Did not download app|0|||
130045727|NCT04101422|468125583|FG003|Overall Study|Did not download app|17|||
130045728|NCT04101422|468125580|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
130045729|NCT04101422|468125581|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
130045730|NCT04101422|468125582|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
130045731|NCT04101422|468125583|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
130045732|NCT00718861|468125586|FG000|Overall Study|Withdrawal by Subject|15|||
130045733|NCT00718861|468125587|FG001|Overall Study|Withdrawal by Subject|10|||
130045734|NCT00718861|468125586|FG000|Overall Study|Adverse Event|2|||
130045735|NCT00718861|468125587|FG001|Overall Study|Adverse Event|1|||
130045736|NCT00718861|468125586|FG000|Overall Study|Lost to Follow-up|2|||
130045737|NCT00718861|468125587|FG001|Overall Study|Lost to Follow-up|1|||
130045738|NCT00718861|468125586|FG000|Overall Study|Administrative Problems|1|||
130045739|NCT00718861|468125587|FG001|Overall Study|Administrative Problems|1|||
130045740|NCT00718861|468125586|FG000|Overall Study|Death|1|||
130291504|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
130291505|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
130291506|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
130291507|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
130291508|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
130291509|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
130291510|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
130291511|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
130291512|NCT02008357|469030716|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
130291513|NCT02008357|469030717|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
130291514|NCT02008357|469030716|FG000|Open-label Extension Period|Adverse Event|8|||
130291515|NCT02008357|469030717|FG001|Open-label Extension Period|Adverse Event|7|||
130291516|NCT02008357|469030716|FG000|Open-label Extension Period|Death|7|||
130291517|NCT02008357|469030717|FG001|Open-label Extension Period|Death|4|||
130291518|NCT02008357|469030716|FG000|Open-label Extension Period|Lack of Efficacy|9|||
130291519|NCT02008357|469030717|FG001|Open-label Extension Period|Lack of Efficacy|5|||
130291520|NCT02008357|469030716|FG000|Open-label Extension Period|Lost to Follow-up|2|||
130291521|NCT02008357|469030717|FG001|Open-label Extension Period|Lost to Follow-up|2|||
130291522|NCT02008357|469030716|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
130291523|NCT02008357|469030717|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
130291524|NCT02008357|469030716|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
130291525|NCT02008357|469030717|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
130291526|NCT02008357|469030716|FG000|Open-label Extension Period|Safety Risk|2|||
130291527|NCT02008357|469030717|FG001|Open-label Extension Period|Safety Risk|1|||
130291528|NCT02008357|469030716|FG000|Open-label Extension Period|Non-Compliance|0|||
130291529|NCT02008357|469030717|FG001|Open-label Extension Period|Non-Compliance|1|||
130291530|NCT02008357|469030716|FG000|Open-label Extension Period|Investigator Recommendation|0|||
130291531|NCT02008357|469030717|FG001|Open-label Extension Period|Investigator Recommendation|1|||
130291532|NCT02008357|469030716|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
130291533|NCT02008357|469030717|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
130291534|NCT02008357|469030716|FG000|Open-label Extension Period|Coordinating Center Request|2|||
130291535|NCT02008357|469030717|FG001|Open-label Extension Period|Coordinating Center Request|4|||
130291536|NCT02008357|469030716|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
130291537|NCT02008357|469030717|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
130291538|NCT02008357|469030716|FG000|Open-label Extension Period|Study Ended|20|||
130291539|NCT02008357|469030717|FG001|Open-label Extension Period|Study Ended|25|||
130291540|NCT02008357|469030716|FG000|Open-label Extension Period|Personal Reasons|0|||
130291541|NCT02008357|469030717|FG001|Open-label Extension Period|Personal Reasons|1|||
130291542|NCT02008357|469030716|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
130045741|NCT00718861|468125587|FG001|Overall Study|Death|5|||
130045742|NCT01749735|468125589|FG000|Overall Study|Withdrawal by Subject|1|||
130291543|NCT02008357|469030717|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
130045743|NCT01749735|468125590|FG001|Overall Study|Withdrawal by Subject|0|||
130045744|NCT00611455|468125593|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
130106495|NCT03273257|468350051|FG000|Overall Study|Study terminated|3|||
130291544|NCT02008357|469030716|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
130291545|NCT02008357|469030717|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
130291546|NCT02008357|469030716|FG000|Open-label Extension Period|Other|2|||
130291547|NCT02008357|469030717|FG001|Open-label Extension Period|Other|0|||
130291548|NCT01442064|469030718|FG000|Overall Study|Adverse Event|2|||
130291549|NCT01442064|469030719|FG001|Overall Study|Adverse Event|2|||
130291550|NCT01442064|469030720|FG002|Overall Study|Adverse Event|2|||
130291551|NCT01442064|469030721|FG003|Overall Study|Adverse Event|1|||
130291552|NCT01442064|469030722|FG004|Overall Study|Adverse Event|2|||
130291553|NCT01442064|469030723|FG005|Overall Study|Adverse Event|0|||
130291554|NCT01442064|469030718|FG000|Overall Study|Death|0|||
130291555|NCT01442064|469030719|FG001|Overall Study|Death|1|||
130291556|NCT01442064|469030720|FG002|Overall Study|Death|3|||
130291557|NCT01442064|469030721|FG003|Overall Study|Death|3|||
130291558|NCT01442064|469030722|FG004|Overall Study|Death|1|||
130291559|NCT01442064|469030723|FG005|Overall Study|Death|3|||
130291560|NCT01442064|469030718|FG000|Overall Study|Lost to Follow-up|5|||
130291561|NCT01442064|469030719|FG001|Overall Study|Lost to Follow-up|5|||
130291562|NCT01442064|469030720|FG002|Overall Study|Lost to Follow-up|1|||
130291563|NCT01442064|469030721|FG003|Overall Study|Lost to Follow-up|1|||
130291564|NCT01442064|469030722|FG004|Overall Study|Lost to Follow-up|3|||
130291565|NCT01442064|469030723|FG005|Overall Study|Lost to Follow-up|3|||
130291566|NCT01442064|469030718|FG000|Overall Study|Physician Decision|1|||
130291567|NCT01442064|469030719|FG001|Overall Study|Physician Decision|1|||
130291568|NCT01442064|469030720|FG002|Overall Study|Physician Decision|2|||
130291569|NCT01442064|469030721|FG003|Overall Study|Physician Decision|3|||
130291570|NCT01442064|469030722|FG004|Overall Study|Physician Decision|3|||
130291571|NCT01442064|469030723|FG005|Overall Study|Physician Decision|1|||
130291572|NCT01442064|469030718|FG000|Overall Study|Withdrawal by Subject|6|||
130291573|NCT01442064|469030719|FG001|Overall Study|Withdrawal by Subject|3|||
130291574|NCT01442064|469030720|FG002|Overall Study|Withdrawal by Subject|2|||
130291575|NCT01442064|469030721|FG003|Overall Study|Withdrawal by Subject|2|||
130291576|NCT01442064|469030722|FG004|Overall Study|Withdrawal by Subject|2|||
130291577|NCT01442064|469030723|FG005|Overall Study|Withdrawal by Subject|1|||
130291578|NCT01442064|469030718|FG000|Overall Study|Sponsor decision|82|||
130291579|NCT01442064|469030719|FG001|Overall Study|Sponsor decision|88|||
130291580|NCT01442064|469030720|FG002|Overall Study|Sponsor decision|92|||
130291581|NCT01442064|469030721|FG003|Overall Study|Sponsor decision|88|||
130291582|NCT01442064|469030722|FG004|Overall Study|Sponsor decision|95|||
130291583|NCT01442064|469030723|FG005|Overall Study|Sponsor decision|87|||
130291584|NCT01442064|469030718|FG000|Overall Study|Subject non-compliance|0|||
130291585|NCT01442064|469030719|FG001|Overall Study|Subject non-compliance|0|||
130291586|NCT01442064|469030720|FG002|Overall Study|Subject non-compliance|0|||
129888348|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
130291587|NCT01442064|469030721|FG003|Overall Study|Subject non-compliance|0|||
130291588|NCT01442064|469030722|FG004|Overall Study|Subject non-compliance|0|||
130291589|NCT01442064|469030723|FG005|Overall Study|Subject non-compliance|2|||
130291590|NCT01442064|469030718|FG000|Overall Study|Condition mandated other intervention|1|||
130291591|NCT01442064|469030719|FG001|Overall Study|Condition mandated other intervention|1|||
130291592|NCT01442064|469030720|FG002|Overall Study|Condition mandated other intervention|2|||
130291593|NCT01442064|469030721|FG003|Overall Study|Condition mandated other intervention|0|||
130291594|NCT01442064|469030722|FG004|Overall Study|Condition mandated other intervention|0|||
130291595|NCT01442064|469030723|FG005|Overall Study|Condition mandated other intervention|2|||
130291596|NCT03553498|469030726|FG000|Overall Study|Missing primary outcome|1|||
130291597|NCT03553498|469030727|FG001|Overall Study|Missing primary outcome|2|||
130291598|NCT04941807|469030728|FG000|Overall Study|Lost to Follow-up|1|||
130291599|NCT04941807|469030729|FG001|Overall Study|Lost to Follow-up|1|||
130291600|NCT02741570|469030730|FG000|Pre-Treatment Period|Other reasons|0|||
130291601|NCT02741570|469030731|FG001|Pre-Treatment Period|Other reasons|3|||
130291602|NCT02741570|469030730|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
130291603|NCT02741570|469030731|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
130291604|NCT02741570|469030730|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
130291605|NCT02741570|469030731|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
130291606|NCT02741570|469030730|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
130291607|NCT02741570|469030731|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
130291608|NCT02741570|469030730|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
130291609|NCT02741570|469030731|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
130291610|NCT02741570|469030730|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130291611|NCT02741570|469030731|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
130291612|NCT02741570|469030730|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
130291613|NCT02741570|469030731|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130291614|NCT02741570|469030730|FG000|Pre-Treatment Period|Death|0|||
129888349|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
130291615|NCT02741570|469030731|FG001|Pre-Treatment Period|Death|1|||
129888350|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
130291616|NCT02741570|469030730|FG000|Pre-Treatment Period|Disease progression|0|||
130291617|NCT02741570|469030731|FG001|Pre-Treatment Period|Disease progression|1|||
130291618|NCT02741570|469030730|FG000|Treatment Period|Other reasons|47|||
129793401|NCT02361346|467210811|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793402|NCT02361346|467210812|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793403|NCT02361346|467210813|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
130045745|NCT00611455|468125594|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
130045746|NCT00611455|468125595|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130045747|NCT00611455|468125593|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
130045748|NCT00611455|468125594|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130045749|NCT00611455|468125595|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
130045750|NCT00611455|468125593|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
130291619|NCT02741570|469030731|FG001|Treatment Period|Other reasons|12|||
130291620|NCT02741570|469030730|FG000|Treatment Period|Poor/non-compliance|0|||
130291621|NCT02741570|469030731|FG001|Treatment Period|Poor/non-compliance|2|||
130291622|NCT02741570|469030730|FG000|Treatment Period|Maximum clinical benefit|4|||
130291623|NCT02741570|469030731|FG001|Treatment Period|Maximum clinical benefit|6|||
130291624|NCT02741570|469030730|FG000|Treatment Period|Lost to Follow-up|1|||
130291625|NCT02741570|469030731|FG001|Treatment Period|Lost to Follow-up|3|||
130291626|NCT02741570|469030730|FG000|Treatment Period|Participant withdrew consent|9|||
130291627|NCT02741570|469030731|FG001|Treatment Period|Participant withdrew consent|13|||
130291628|NCT02741570|469030730|FG000|Treatment Period|Participant request to discontinue treatment|8|||
130291629|NCT02741570|469030731|FG001|Treatment Period|Participant request to discontinue treatment|23|||
130291630|NCT02741570|469030730|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
130291631|NCT02741570|469030731|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
130291632|NCT02741570|469030730|FG000|Treatment Period|Death|9|||
130291633|NCT02741570|469030731|FG001|Treatment Period|Death|7|||
130291634|NCT02741570|469030730|FG000|Treatment Period|Study drug toxicity|55|||
130291635|NCT02741570|469030731|FG001|Treatment Period|Study drug toxicity|47|||
130291636|NCT02741570|469030730|FG000|Treatment Period|Disease progression|294|||
130291637|NCT02741570|469030731|FG001|Treatment Period|Disease progression|301|||
130291638|NCT02741570|469030730|FG000|Treatment Period|Administrative reason by sponsor|0|||
130291639|NCT02741570|469030731|FG001|Treatment Period|Administrative reason by sponsor|1|||
130291640|NCT01100567|469030732|FG000|Overall Study|Withdrawal by Subject|5|||
130291641|NCT01100567|469030733|FG001|Overall Study|Withdrawal by Subject|8|||
130291642|NCT01100567|469030732|FG000|Overall Study|Early Hospital Discharge|6|||
130291643|NCT01100567|469030733|FG001|Overall Study|Early Hospital Discharge|4|||
130291644|NCT01100567|469030732|FG000|Overall Study|Lost to Follow-up|1|||
130291645|NCT01100567|469030733|FG001|Overall Study|Lost to Follow-up|2|||
130291646|NCT01100567|469030732|FG000|Overall Study|Physician Decision|0|||
130291647|NCT01100567|469030733|FG001|Overall Study|Physician Decision|1|||
130291648|NCT01100567|469030732|FG000|Overall Study|Deemed ineligible after consent|0|||
130291649|NCT01100567|469030733|FG001|Overall Study|Deemed ineligible after consent|1|||
130291650|NCT00160199|469030736|FG000|Overall Study|Adverse Event|5|||
130291651|NCT00160199|469030737|FG001|Overall Study|Adverse Event|14|||
130291652|NCT00160199|469030736|FG000|Overall Study|Lack of Efficacy|0|||
130291653|NCT00160199|469030737|FG001|Overall Study|Lack of Efficacy|1|||
130291654|NCT00160199|469030736|FG000|Overall Study|Lost to Follow-up|7|||
130291655|NCT00160199|469030737|FG001|Overall Study|Lost to Follow-up|7|||
130291656|NCT00160199|469030736|FG000|Overall Study|Withdrawal by Subject|4|||
130291657|NCT00160199|469030737|FG001|Overall Study|Withdrawal by Subject|6|||
130291658|NCT00160199|469030736|FG000|Overall Study|Administrative|0|||
130291659|NCT00160199|469030737|FG001|Overall Study|Administrative|1|||
130291660|NCT00160199|469030736|FG000|Overall Study|Protocol Violation|8|||
130291661|NCT00160199|469030737|FG001|Overall Study|Protocol Violation|8|||
130291662|NCT03352453|469030738|FG000|Overall Study|Miscellaneous Reasons|1|||
130291663|NCT03352453|469030739|FG001|Overall Study|Miscellaneous Reasons|2|||
130291664|NCT03352453|469030738|FG000|Overall Study|Lack of Efficacy|1|||
130291665|NCT03352453|469030739|FG001|Overall Study|Lack of Efficacy|0|||
130291666|NCT03352453|469030738|FG000|Overall Study|Withdrawal by Subject|8|||
130291667|NCT03352453|469030739|FG001|Overall Study|Withdrawal by Subject|14|||
129793404|NCT02361346|467210814|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793405|NCT02361346|467210806|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793406|NCT02361346|467210807|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793407|NCT02361346|467210808|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793408|NCT02361346|467210809|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793409|NCT02361346|467210810|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
130045751|NCT00611455|468125594|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
130291668|NCT03352453|469030738|FG000|Overall Study|Study Terminated by Sponsor|2|||
130291669|NCT03352453|469030739|FG001|Overall Study|Study Terminated by Sponsor|1|||
130291670|NCT03352453|469030738|FG000|Overall Study|Protocol Deviation|1|||
130291671|NCT03352453|469030739|FG001|Overall Study|Protocol Deviation|0|||
130291672|NCT03352453|469030738|FG000|Overall Study|Lost to Follow-up|7|||
130291673|NCT03352453|469030739|FG001|Overall Study|Lost to Follow-up|6|||
130291674|NCT03352453|469030738|FG000|Overall Study|Adverse Event|2|||
130291675|NCT03352453|469030739|FG001|Overall Study|Adverse Event|9|||
130291676|NCT01241760|469030744|FG000|Overall Study|Adverse Event|1|||
130291677|NCT01241760|469030745|FG001|Overall Study|Adverse Event|0|||
130291678|NCT01241760|469030744|FG000|Overall Study|Lost to Follow-up|18|||
130291679|NCT01241760|469030745|FG001|Overall Study|Lost to Follow-up|22|||
130291680|NCT01241760|469030744|FG000|Overall Study|Withdrawal by Subject|13|||
130291681|NCT01241760|469030745|FG001|Overall Study|Withdrawal by Subject|13|||
130291682|NCT01241760|469030744|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
130291683|NCT01241760|469030745|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
130291684|NCT01241760|469030744|FG000|Overall Study|Other|1|||
130291685|NCT01241760|469030745|FG001|Overall Study|Other|1|||
130291686|NCT00514020|469030746|FG000|Overall Study|Adverse Event|6|||
130291687|NCT00514020|469030746|FG000|Overall Study|Withdrawal by Subject|3|||
130291688|NCT00514020|469030746|FG000|Overall Study|Physician Decision|1|||
130291689|NCT00514020|469030746|FG000|Overall Study|disease progression|9|||
130291690|NCT00514020|469030746|FG000|Overall Study|other complicating disease|2|||
130291691|NCT00514020|469030746|FG000|Overall Study|patient went to radiation treatment|1|||
130291692|NCT00514020|469030746|FG000|Overall Study|"patients moved to the no tx group"|6|||
130291693|NCT03089944|469030747|FG000|Overall Study|Lost to Follow-up|8|||
130291694|NCT03089944|469030747|FG000|Overall Study|Withdrew Consent|2|||
130291695|NCT03089944|469030747|FG000|Overall Study|Adverse Event|1|||
130291696|NCT03089944|469030747|FG000|Overall Study|Other|1|||
130291697|NCT01636713|469030748|FG000|Overall Study|Adverse Event|16|||
130291698|NCT01636713|469030749|FG001|Overall Study|Adverse Event|16|||
130291699|NCT01636713|469030750|FG002|Overall Study|Adverse Event|7|||
130291700|NCT01636713|469030748|FG000|Overall Study|Lack of Efficacy|6|||
130291701|NCT01636713|469030749|FG001|Overall Study|Lack of Efficacy|6|||
130291702|NCT01636713|469030750|FG002|Overall Study|Lack of Efficacy|2|||
130291703|NCT01636713|469030748|FG000|Overall Study|Protocol Violation|3|||
130291704|NCT01636713|469030749|FG001|Overall Study|Protocol Violation|0|||
130291705|NCT01636713|469030750|FG002|Overall Study|Protocol Violation|1|||
130291706|NCT01636713|469030748|FG000|Overall Study|Lost to Follow-up|0|||
130291707|NCT01636713|469030749|FG001|Overall Study|Lost to Follow-up|0|||
130291708|NCT01636713|469030750|FG002|Overall Study|Lost to Follow-up|1|||
130291709|NCT01636713|469030748|FG000|Overall Study|Withdrawal by Subject|5|||
130291710|NCT01636713|469030749|FG001|Overall Study|Withdrawal by Subject|4|||
130291711|NCT01636713|469030750|FG002|Overall Study|Withdrawal by Subject|8|||
130291712|NCT01636713|469030748|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130291713|NCT01636713|469030749|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
130291714|NCT01636713|469030750|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
130291715|NCT03780959|469030751|FG000|Part 1|Adverse Event|1|||
130291716|NCT03780959|469030752|FG001|Part 1|Adverse Event|0|||
130291717|NCT03780959|469030753|FG002|Part 1|Adverse Event|0|||
130291718|NCT03780959|469030751|FG000|Part 1|Withdrawal by Subject|1|||
130291719|NCT03780959|469030752|FG001|Part 1|Withdrawal by Subject|0|||
130291720|NCT03780959|469030753|FG002|Part 1|Withdrawal by Subject|0|||
130291721|NCT03780959|469030751|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
130291722|NCT03780959|469030752|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
130291723|NCT03780959|469030753|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
130291724|NCT03780959|469030751|FG000|Part 1|Response Status|2|||
130291725|NCT03780959|469030752|FG001|Part 1|Response Status|0|||
130291726|NCT03780959|469030753|FG002|Part 1|Response Status|0|||
130291727|NCT03780959|469030751|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
130291728|NCT03780959|469030752|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
130291729|NCT03780959|469030753|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
130291730|NCT03780959|469030751|FG000|Part 2|Response Status|0|||
130291731|NCT03780959|469030752|FG001|Part 2|Response Status|18|||
130291732|NCT03780959|469030753|FG002|Part 2|Response Status|6|||
129793410|NCT02361346|467210811|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793411|NCT02361346|467210812|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793412|NCT02361346|467210813|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793413|NCT02361346|467210814|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793414|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
129793415|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
129793416|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
130291733|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
130291734|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
130291735|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
130291736|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
130291737|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
130291738|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
130291739|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
129793417|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
129793418|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
130291740|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
130291741|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
130291742|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
130291743|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
130291744|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
130291745|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
130291746|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
130291747|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
130291748|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
130291749|NCT03689244|469030758|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
130291750|NCT03689244|469030759|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
130291751|NCT03689244|469030760|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
130291752|NCT03689244|469030761|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
130291753|NCT03689244|469030758|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130291754|NCT03689244|469030759|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130291755|NCT03689244|469030760|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
130291756|NCT03689244|469030761|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
130291757|NCT03689244|469030758|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130291758|NCT03689244|469030759|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130291759|NCT03689244|469030760|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
130291760|NCT03689244|469030761|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
130291761|NCT03689244|469030758|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
130291762|NCT03689244|469030759|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
130291763|NCT03689244|469030760|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
130291764|NCT03689244|469030761|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
130291765|NCT03697993|469030772|FG000|Overall Study|Became Ineligible after Enrollment|1|||
130291766|NCT03697993|469030773|FG001|Overall Study|Became Ineligible after Enrollment|3|||
130291767|NCT03697993|469030772|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
130291768|NCT03697993|469030773|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
130291769|NCT03697993|469030772|FG000|Overall Study|Lost to Follow-up|3|||
130291770|NCT03697993|469030773|FG001|Overall Study|Lost to Follow-up|0|||
130291771|NCT03697993|469030772|FG000|Overall Study|Physician Decision|4|||
130291772|NCT03697993|469030773|FG001|Overall Study|Physician Decision|0|||
130291773|NCT03697993|469030772|FG000|Overall Study|Initial Urine Culture Negative|0|||
130291774|NCT03697993|469030773|FG001|Overall Study|Initial Urine Culture Negative|1|||
130291775|NCT01565564|469030774|FG000|Overall Study|Lost to Follow-up|5|||
130291776|NCT01565564|469030775|FG001|Overall Study|Lost to Follow-up|1|||
130291777|NCT02698371|469030776|FG000|All Participants Flow|Lost to Follow-up|3|||
130291778|NCT02698371|469030776|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
130291779|NCT02698371|469030776|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
130291780|NCT02698371|469030776|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
130291781|NCT02698371|469030776|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
130291782|NCT02698371|469030776|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
130291783|NCT02698371|469030776|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
130291784|NCT00459537|469030781|FG000|Overall Study|Adverse Event|1|||
130291785|NCT00459537|469030782|FG001|Overall Study|Adverse Event|6|||
130291786|NCT00459537|469030781|FG000|Overall Study|Lack of Efficacy|10|||
130291787|NCT00459537|469030782|FG001|Overall Study|Lack of Efficacy|11|||
130291788|NCT00459537|469030781|FG000|Overall Study|Withdrawal by Subject|20|||
130291789|NCT00459537|469030782|FG001|Overall Study|Withdrawal by Subject|26|||
130291790|NCT00459537|469030781|FG000|Overall Study|Lost to Follow-up|27|||
130291791|NCT00459537|469030782|FG001|Overall Study|Lost to Follow-up|30|||
130291792|NCT00459537|469030781|FG000|Overall Study|Administrative problems|3|||
130291793|NCT00459537|469030782|FG001|Overall Study|Administrative problems|0|||
130291794|NCT00459537|469030781|FG000|Overall Study|Protocol Violation|4|||
130291795|NCT00459537|469030782|FG001|Overall Study|Protocol Violation|3|||
130291796|NCT00459537|469030781|FG000|Overall Study|Missing|1|||
130291797|NCT00459537|469030782|FG001|Overall Study|Missing|0|||
130291798|NCT01999218|469030783|FG000|Overall Study|Hyperglycemia|18|||
130291799|NCT01999218|469030784|FG001|Overall Study|Hyperglycemia|17|||
130291800|NCT01999218|469030785|FG002|Overall Study|Hyperglycemia|17|||
130291801|NCT01999218|469030783|FG000|Overall Study|Lack of Efficacy|1|||
130106496|NCT03273257|468350052|FG001|Overall Study|Study terminated|2|||
130106497|NCT01185639|468350054|FG000|Overall Study|Progressed and didn't receive therapy|2|||
130106498|NCT01898884|468350055|FG000|Multiple Dose Period|Adverse Event|0|||
130106499|NCT01898884|468350056|FG001|Multiple Dose Period|Adverse Event|0|||
130291802|NCT01999218|469030784|FG001|Overall Study|Lack of Efficacy|0|||
130291803|NCT01999218|469030785|FG002|Overall Study|Lack of Efficacy|1|||
130291804|NCT01999218|469030783|FG000|Overall Study|Lost to Follow-up|22|||
130106500|NCT01898884|468350057|FG002|Multiple Dose Period|Adverse Event|0|||
130106501|NCT01898884|468350058|FG003|Multiple Dose Period|Adverse Event|0|||
130291805|NCT01999218|469030784|FG001|Overall Study|Lost to Follow-up|17|||
130291806|NCT01999218|469030785|FG002|Overall Study|Lost to Follow-up|18|||
130291807|NCT01999218|469030783|FG000|Overall Study|Non-Compliance With Study Drug|6|||
130291808|NCT01999218|469030784|FG001|Overall Study|Non-Compliance With Study Drug|4|||
130291809|NCT01999218|469030785|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130291810|NCT01999218|469030783|FG000|Overall Study|Physician Decision|1|||
130291811|NCT01999218|469030784|FG001|Overall Study|Physician Decision|4|||
130291812|NCT01999218|469030785|FG002|Overall Study|Physician Decision|6|||
130291813|NCT01999218|469030783|FG000|Overall Study|Protocol Violation|4|||
130291814|NCT01999218|469030784|FG001|Overall Study|Protocol Violation|5|||
130291815|NCT01999218|469030785|FG002|Overall Study|Protocol Violation|4|||
130291816|NCT01999218|469030783|FG000|Overall Study|Screen failure|0|||
130291817|NCT01999218|469030784|FG001|Overall Study|Screen failure|1|||
130291818|NCT01999218|469030785|FG002|Overall Study|Screen failure|0|||
130291819|NCT01999218|469030783|FG000|Overall Study|Study Terminated By Sponsor|7|||
130291820|NCT01999218|469030784|FG001|Overall Study|Study Terminated By Sponsor|5|||
130291821|NCT01999218|469030785|FG002|Overall Study|Study Terminated By Sponsor|12|||
130291822|NCT01999218|469030783|FG000|Overall Study|Participant moves|2|||
130291823|NCT01999218|469030784|FG001|Overall Study|Participant moves|5|||
130291824|NCT01999218|469030785|FG002|Overall Study|Participant moves|3|||
130291825|NCT01999218|469030783|FG000|Overall Study|Withdrawal by Subject|28|||
130291826|NCT01999218|469030784|FG001|Overall Study|Withdrawal by Subject|29|||
130291827|NCT01999218|469030785|FG002|Overall Study|Withdrawal by Subject|34|||
130291828|NCT01999218|469030783|FG000|Overall Study|Creatinine/eGFR|0|||
130291829|NCT01999218|469030784|FG001|Overall Study|Creatinine/eGFR|0|||
130291830|NCT01999218|469030785|FG002|Overall Study|Creatinine/eGFR|1|||
130291831|NCT01999218|469030783|FG000|Overall Study|Death|7|||
130291832|NCT01999218|469030784|FG001|Overall Study|Death|1|||
130291833|NCT01999218|469030785|FG002|Overall Study|Death|2|||
130291834|NCT01999218|469030783|FG000|Overall Study|Excluded Medication|1|||
130291835|NCT01999218|469030784|FG001|Overall Study|Excluded Medication|1|||
130291836|NCT01999218|469030785|FG002|Overall Study|Excluded Medication|2|||
130291837|NCT01999218|469030783|FG000|Overall Study|Adverse Event|9|||
130291838|NCT01999218|469030784|FG001|Overall Study|Adverse Event|7|||
130291839|NCT01999218|469030785|FG002|Overall Study|Adverse Event|7|||
130291840|NCT01999218|469030783|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
130291841|NCT01999218|469030784|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
130291842|NCT01999218|469030785|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
130316230|NCT04319198|469124332|FG000|Overall Study|Reason Not Specified|0|||
130316231|NCT04319198|469124333|FG001|Overall Study|Reason Not Specified|2|||
130316232|NCT04319198|469124334|FG002|Overall Study|Reason Not Specified|4|||
130316233|NCT04319198|469124332|FG000|Overall Study|Withdrawal of Consent|0|||
130316234|NCT04319198|469124333|FG001|Overall Study|Withdrawal of Consent|0|||
130316235|NCT04319198|469124334|FG002|Overall Study|Withdrawal of Consent|5|||
130316236|NCT04319198|469124332|FG000|Overall Study|Site Terminated by Sponsor|0|||
130316237|NCT04319198|469124333|FG001|Overall Study|Site Terminated by Sponsor|1|||
130316238|NCT04319198|469124334|FG002|Overall Study|Site Terminated by Sponsor|0|||
130316239|NCT04073186|469124340|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
130316240|NCT04073186|469124340|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
130316241|NCT04073186|469124340|FG000|First Wearing Cycle|Protocol Violation|1|||
130316242|NCT04073186|469124340|FG000|First Wearing Cycle|Lens Discomfort|2|||
130316243|NCT04073186|469124340|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
130316244|NCT04073186|469124340|FG000|Second Wearing Cycle|Adverse Event|1|||
130316245|NCT00473434|469124341|FG000|Overall Study|Physician Decision|3|||
130316246|NCT00473434|469124341|FG000|Overall Study|Withdrawal by Subject|9|||
130316247|NCT00473434|469124341|FG000|Overall Study|Compliance|3|||
130316248|NCT00473434|469124341|FG000|Overall Study|Lack of Efficacy|3|||
130316249|NCT00473434|469124341|FG000|Overall Study|Adverse Event|3|||
130316250|NCT00473434|469124341|FG000|Overall Study|Patient was selling medication to others|1|||
130316251|NCT00473434|469124341|FG000|Overall Study|Safety evaluation|1|||
130316252|NCT00473434|469124341|FG000|Overall Study|Reason not specified|6|||
130316253|NCT00473434|469124341|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
130316254|NCT00473434|469124341|FG000|Overall Study|Switching to trial medication|1|||
130316255|NCT00473434|469124341|FG000|Overall Study|No longer required|1|||
130316256|NCT01453140|469124344|FG000|Overall Study|Adverse Event|3|||
130316257|NCT00743249|469124345|FG000|Overall Study|Adverse Event|0|||
130316258|NCT00743249|469124346|FG001|Overall Study|Adverse Event|4|||
130316259|NCT00743249|469124345|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
130316260|NCT00743249|469124346|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
130316261|NCT00743249|469124345|FG000|Overall Study|Unsuccessful insertion of stent|2|||
130316262|NCT00743249|469124346|FG001|Overall Study|Unsuccessful insertion of stent|1|||
130316263|NCT02653326|469124347|FG000|Overall Study|Lost to Follow-up|10|||
130316264|NCT02653326|469124348|FG001|Overall Study|Lost to Follow-up|7|||
130316265|NCT05767021|469124351|FG000|Overall Study|Adverse Event|2|||
130316266|NCT05767021|469124351|FG000|Overall Study|Protocol Deviation|1|||
130316267|NCT05767021|469124351|FG000|Overall Study|Withdrawal by Subject|1|||
130316268|NCT05767021|469124351|FG000|Overall Study|Physician Decision|1|||
130291843|NCT02032407|469032314|FG000|Overall Study|Lost to Follow-up|2|||
130291844|NCT02032407|469032314|FG000|Overall Study|Pregnancy|1|||
130291845|NCT02032407|469032314|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130291846|NCT02191605|469032315|FG000|Overall Study|Lost to Follow-up|9|||
130291847|NCT02191605|469032316|FG001|Overall Study|Lost to Follow-up|4|||
130291848|NCT02191605|469032317|FG002|Overall Study|Lost to Follow-up|7|||
130291849|NCT02191605|469032318|FG003|Overall Study|Lost to Follow-up|3|||
130291850|NCT02191605|469032319|FG004|Overall Study|Lost to Follow-up|4|||
130291851|NCT03647267|469032323|FG000|Overall Study|Lost to Follow-up|1|||
130291852|NCT03647267|469032324|FG001|Overall Study|Lost to Follow-up|0|||
130291853|NCT01350115|469032325|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
130291854|NCT01350115|469032326|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
130291855|NCT01350115|469032325|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
130291856|NCT01350115|469032326|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
130291857|NCT01350115|469032325|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
130291858|NCT01350115|469032326|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
130291859|NCT05079477|469032327|FG000|Overall Study|Lost to Follow-up|2|||
130291860|NCT05079477|469032328|FG001|Overall Study|Lost to Follow-up|0|||
130291861|NCT05079477|469032327|FG000|Overall Study|Withdrawal by Subject|1|||
130291862|NCT05079477|469032328|FG001|Overall Study|Withdrawal by Subject|0|||
130291863|NCT05079477|469032327|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
130291864|NCT05079477|469032328|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
130291865|NCT05079477|469032327|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
130291866|NCT05079477|469032328|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
130291867|NCT00734071|469032329|FG000|Overall Study|Adverse Event|4|||
130291868|NCT00734071|469032330|FG001|Overall Study|Adverse Event|3|||
130291869|NCT00734071|469032329|FG000|Overall Study|Lack of Efficacy|3|||
130291870|NCT00734071|469032330|FG001|Overall Study|Lack of Efficacy|1|||
130291871|NCT00734071|469032329|FG000|Overall Study|Noncompliance|2|||
130291872|NCT00734071|469032330|FG001|Overall Study|Noncompliance|2|||
130291873|NCT00734071|469032329|FG000|Overall Study|Protocol Deviations|3|||
130291874|NCT00734071|469032330|FG001|Overall Study|Protocol Deviations|4|||
130291875|NCT00734071|469032329|FG000|Overall Study|Voluntary Withdrawal|9|||
130291876|NCT00734071|469032330|FG001|Overall Study|Voluntary Withdrawal|7|||
130291877|NCT00734071|469032329|FG000|Overall Study|Lost to Follow-up|16|||
130291878|NCT00734071|469032330|FG001|Overall Study|Lost to Follow-up|8|||
130291879|NCT00734071|469032329|FG000|Overall Study|Other|1|||
130291880|NCT00734071|469032330|FG001|Overall Study|Other|2|||
130291881|NCT00240110|469032334|FG000|Overall Study|Lost to Follow-up|6|||
130291882|NCT00240110|469032335|FG001|Overall Study|Lost to Follow-up|7|||
130291883|NCT00583791|469032336|FG000|Overall Study|Other|67|||
130291884|NCT00583791|469032336|FG000|Overall Study|Death|6|||
130291885|NCT03323736|469032337|FG000|Overall Study|Screen Failure|14|||
130291886|NCT03323736|469032338|FG001|Overall Study|Screen Failure|9|||
130291887|NCT03323736|469032339|FG002|Overall Study|Screen Failure|1|||
130291888|NCT03323736|469032337|FG000|Overall Study|Withdrawal Before Treatment|3|||
130291889|NCT03323736|469032338|FG001|Overall Study|Withdrawal Before Treatment|1|||
130291890|NCT03323736|469032339|FG002|Overall Study|Withdrawal Before Treatment|1|||
130291891|NCT03323736|469032337|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
130291892|NCT03323736|469032338|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
130291893|NCT03323736|469032339|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
130291894|NCT02654236|469032343|FG000|Overall Study|Withdrawal by Subject|0|||
130291895|NCT02654236|469032344|FG001|Overall Study|Withdrawal by Subject|0|||
130291896|NCT02654236|469032345|FG002|Overall Study|Withdrawal by Subject|2|||
130291897|NCT03204890|469032346|FG000|Overall Study|Withdrawal by Subject|1|||
130291898|NCT01549873|469032347|FG000|Overall Study|Physician Decision|0|||
130291899|NCT01549873|469032348|FG001|Overall Study|Physician Decision|1|||
130291900|NCT01688739|469032352|FG000|Overall Study|Administrative Decision|1|||
130291901|NCT01688739|469032353|FG001|Overall Study|Administrative Decision|0|||
130291902|NCT01688739|469032354|FG002|Overall Study|Administrative Decision|0|||
130291903|NCT01688739|469032355|FG003|Overall Study|Administrative Decision|0|||
130291904|NCT01688739|469032356|FG004|Overall Study|Administrative Decision|0|||
129793419|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
130291905|NCT01688739|469032357|FG005|Overall Study|Administrative Decision|0|||
130291906|NCT01688739|469032358|FG006|Overall Study|Administrative Decision|0|||
130291907|NCT01688739|469032359|FG007|Overall Study|Administrative Decision|0|||
130291908|NCT01688739|469032360|FG008|Overall Study|Administrative Decision|0|||
130291909|NCT01688739|469032361|FG009|Overall Study|Administrative Decision|0|||
130291910|NCT02559414|469032363|FG000|Overall Study|Lost to Follow-up|0|||
130291911|NCT02559414|469032364|FG001|Overall Study|Lost to Follow-up|1|||
130291912|NCT02559414|469032365|FG002|Overall Study|Lost to Follow-up|0|||
130291913|NCT02559414|469032363|FG000|Overall Study|Withdrawal by Subject|1|||
130291914|NCT02559414|469032364|FG001|Overall Study|Withdrawal by Subject|0|||
130291915|NCT02559414|469032365|FG002|Overall Study|Withdrawal by Subject|1|||
129793420|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
130291916|NCT02559414|469032363|FG000|Overall Study|Other|0|||
130291917|NCT02559414|469032364|FG001|Overall Study|Other|1|||
130291918|NCT02559414|469032365|FG002|Overall Study|Other|1|||
130291919|NCT03369431|469032366|FG000|Overall Study|Lost to Follow-up|1|||
130291920|NCT03369431|469032367|FG001|Overall Study|Lost to Follow-up|3|||
130291921|NCT03369431|469032366|FG000|Overall Study|Withdrawal by Subject|2|||
130291922|NCT03369431|469032367|FG001|Overall Study|Withdrawal by Subject|3|||
130291923|NCT03369431|469032366|FG000|Overall Study|Protocol Violation|1|||
130291924|NCT03369431|469032367|FG001|Overall Study|Protocol Violation|1|||
130291925|NCT01113580|469032372|FG000|Overall Study|Protocol Violation|1|||
130291926|NCT01113580|469032373|FG001|Overall Study|Protocol Violation|0|||
130291927|NCT02785458|469032381|FG000|1 Month|Withdrawal by Subject|2|||
130291928|NCT02785458|469032382|FG001|1 Month|Withdrawal by Subject|1|||
130291929|NCT02785458|469032381|FG000|1 Month|Lost to Follow-up|38|||
130291930|NCT02785458|469032382|FG001|1 Month|Lost to Follow-up|31|||
130291931|NCT02785458|469032381|FG000|1 Month|Deemed Ineligible|1|||
130291932|NCT02785458|469032382|FG001|1 Month|Deemed Ineligible|0|||
130291933|NCT02785458|469032381|FG000|1 Month|Completed Evaluation by Baseline|42|||
130291934|NCT02785458|469032382|FG001|1 Month|Completed Evaluation by Baseline|39|||
130291935|NCT02785458|469032381|FG000|1 Month|Partial Interview|0|||
130291936|NCT02785458|469032382|FG001|1 Month|Partial Interview|4|||
130291937|NCT02785458|469032381|FG000|3 Months|Withdrawal by Subject|3|||
130291938|NCT02785458|469032382|FG001|3 Months|Withdrawal by Subject|1|||
130291939|NCT02785458|469032381|FG000|3 Months|Lost to Follow-up|25|||
130291940|NCT02785458|469032382|FG001|3 Months|Lost to Follow-up|21|||
130291941|NCT02785458|469032381|FG000|3 Months|Completed Evaluation at 1 Month|100|||
130291942|NCT02785458|469032382|FG001|3 Months|Completed Evaluation at 1 Month|89|||
130291943|NCT00824005|469032384|FG000|Overall Study|Death|0|||
130291944|NCT00824005|469032385|FG001|Overall Study|Death|1|||
130291945|NCT00824005|469032384|FG000|Overall Study|Lost to Follow-up|0|||
130291946|NCT00824005|469032385|FG001|Overall Study|Lost to Follow-up|1|||
130291947|NCT03458702|469032386|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
130291948|NCT03458702|469032387|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
130291949|NCT03458702|469032386|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
130291950|NCT03458702|469032387|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
130291951|NCT01390779|469032388|FG000|Overall Study|Physician Decision|1|||
130291952|NCT01874275|469032389|FG000|Overall Study|Lost to Follow-up|1|||
130291953|NCT01874275|469032390|FG001|Overall Study|Lost to Follow-up|0|||
130291954|NCT01697462|469032391|FG000|Overall Study|Disease Progression|1|||
130291955|NCT01697462|469032391|FG000|Overall Study|Adverse Event|6|||
130291956|NCT01697462|469032391|FG000|Overall Study|Lost to Follow-up|21|||
130291957|NCT01697462|469032391|FG000|Overall Study|Withdrawal by Subject|12|||
130291958|NCT01697462|469032391|FG000|Overall Study|Investigator Decision|21|||
130291959|NCT01697462|469032391|FG000|Overall Study|Death|1|||
130291960|NCT01697462|469032391|FG000|Overall Study|Other|10|||
130291961|NCT01697462|469032391|FG000|Overall Study|Missing|5|||
130291962|NCT00168103|469032392|FG000|Overall Study|Withdrawal by Subject|1|||
130291963|NCT00168103|469032393|FG001|Overall Study|Withdrawal by Subject|2|||
130291964|NCT00168103|469032394|FG002|Overall Study|Withdrawal by Subject|1|||
130291965|NCT00168103|469032395|FG003|Overall Study|Withdrawal by Subject|0|||
130291966|NCT00168103|469032392|FG000|Overall Study|Lost to Follow-up|1|||
130291967|NCT00168103|469032393|FG001|Overall Study|Lost to Follow-up|3|||
130291968|NCT00168103|469032394|FG002|Overall Study|Lost to Follow-up|0|||
130291969|NCT00168103|469032395|FG003|Overall Study|Lost to Follow-up|0|||
130291970|NCT00989235|469032396|FG000|Overall Study|Death|0|||
130291971|NCT00989235|469032397|FG001|Overall Study|Death|1|||
130291972|NCT00989235|469032396|FG000|Overall Study|Adverse Event|0|||
130291973|NCT00989235|469032397|FG001|Overall Study|Adverse Event|1|||
130291974|NCT00989235|469032396|FG000|Overall Study|Lack of Efficacy|1|||
130291975|NCT00989235|469032397|FG001|Overall Study|Lack of Efficacy|0|||
130291976|NCT00989235|469032396|FG000|Overall Study|Withdrawal of Consent|1|||
130291977|NCT00989235|469032397|FG001|Overall Study|Withdrawal of Consent|1|||
130291978|NCT00989235|469032396|FG000|Overall Study|Desire to Become Pregnant|1|||
130291979|NCT00989235|469032397|FG001|Overall Study|Desire to Become Pregnant|0|||
130291980|NCT00989235|469032396|FG000|Overall Study|Randomized by Mistake|0|||
130291981|NCT00989235|469032397|FG001|Overall Study|Randomized by Mistake|2|||
130291982|NCT00989235|469032396|FG000|Overall Study|Lost to Follow-up|0|||
130291983|NCT00989235|469032397|FG001|Overall Study|Lost to Follow-up|1|||
130291984|NCT00545532|469032398|FG000|Overall Study|Withdrawal by Subject|1|||
130291985|NCT00545532|469032399|FG001|Overall Study|Withdrawal by Subject|3|||
129793421|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
130291986|NCT00545532|469032398|FG000|Overall Study|Lost to Follow-up|5|||
130291987|NCT00545532|469032399|FG001|Overall Study|Lost to Follow-up|6|||
129793422|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
130291988|NCT00545532|469032398|FG000|Overall Study|Death|0|||
130291989|NCT00545532|469032399|FG001|Overall Study|Death|1|||
130291990|NCT03630302|469032400|FG000|Surgery|hardware issue prevented LFP recordings|1|||
130291991|NCT03630302|469032400|FG000|3 Month Visit|Adverse Event|2|||
130291992|NCT03630302|469032400|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
129888351|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
129888352|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
129888353|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
129888354|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
129888355|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
129888356|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Other|0|||
129888357|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Other|2|||
129888358|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Other|0|||
129888359|NCT00551213|467549139|FG000|Overall Study|Adverse Event|6|||
129888360|NCT00551213|467549140|FG001|Overall Study|Adverse Event|3|||
129888361|NCT00551213|467549139|FG000|Overall Study|Progressive Disease|41|||
129888362|NCT00551213|467549140|FG001|Overall Study|Progressive Disease|12|||
129888363|NCT00551213|467549139|FG000|Overall Study|Withdrawal by Subject|2|||
129888364|NCT00551213|467549140|FG001|Overall Study|Withdrawal by Subject|0|||
129888365|NCT00551213|467549139|FG000|Overall Study|Not Treated|1|||
129888366|NCT00551213|467549140|FG001|Overall Study|Not Treated|2|||
129888367|NCT01890967|467549141|FG000|Overall Study|Adverse Event|3|||
129888368|NCT01890967|467549142|FG001|Overall Study|Adverse Event|3|||
129888369|NCT01890967|467549143|FG002|Overall Study|Adverse Event|3|||
129888370|NCT01890967|467549144|FG003|Overall Study|Adverse Event|2|||
129888371|NCT01890967|467549145|FG004|Overall Study|Adverse Event|1|||
129888372|NCT01890967|467549146|FG005|Overall Study|Adverse Event|7|||
129888373|NCT01890967|467549141|FG000|Overall Study|Death|1|||
129888374|NCT01890967|467549142|FG001|Overall Study|Death|0|||
129888375|NCT01890967|467549143|FG002|Overall Study|Death|0|||
129888376|NCT01890967|467549144|FG003|Overall Study|Death|0|||
130045752|NCT00611455|468125595|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130045753|NCT00611455|468125593|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130045754|NCT00611455|468125594|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
130291993|NCT00931801|469032403|FG000|Overall Study|Adverse Event|0|||
130291994|NCT00931801|469032404|FG001|Overall Study|Adverse Event|0|||
130291995|NCT00931801|469032405|FG002|Overall Study|Adverse Event|1|||
130291996|NCT00931801|469032403|FG000|Overall Study|Lost to Follow-up|0|||
130291997|NCT00931801|469032404|FG001|Overall Study|Lost to Follow-up|1|||
130291998|NCT00931801|469032405|FG002|Overall Study|Lost to Follow-up|0|||
130291999|NCT00931801|469032403|FG000|Overall Study|Withdrawal by Subject|1|||
130292000|NCT00931801|469032404|FG001|Overall Study|Withdrawal by Subject|0|||
130292001|NCT00931801|469032405|FG002|Overall Study|Withdrawal by Subject|0|||
130292002|NCT00931801|469032403|FG000|Overall Study|Confirmed Virologic Failure|0|||
130292003|NCT00931801|469032404|FG001|Overall Study|Confirmed Virologic Failure|0|||
130292004|NCT00931801|469032405|FG002|Overall Study|Confirmed Virologic Failure|3|||
130292005|NCT00933244|469032406|FG000|Overall Study|Withdrawal by Subject|5|||
130292006|NCT00933244|469032407|FG001|Overall Study|Withdrawal by Subject|1|||
130292007|NCT00933244|469032408|FG002|Overall Study|Withdrawal by Subject|3|||
130292008|NCT02266875|469032409|FG000|Overall Study|Withdrawal by Subject|9|||
130292009|NCT02266875|469032410|FG001|Overall Study|Withdrawal by Subject|0|||
130292010|NCT02266875|469032409|FG000|Overall Study|Lost to Follow-up|2|||
130292011|NCT02266875|469032410|FG001|Overall Study|Lost to Follow-up|0|||
130292012|NCT00875056|469032412|FG000|Overall Study|Adverse Event|6|||
130292013|NCT00875056|469032413|FG001|Overall Study|Adverse Event|1|||
130292014|NCT00875056|469032414|FG002|Overall Study|Adverse Event|2|||
130292015|NCT00875056|469032412|FG000|Overall Study|Progressive Disease|14|||
130292016|NCT00875056|469032413|FG001|Overall Study|Progressive Disease|8|||
130292017|NCT00875056|469032414|FG002|Overall Study|Progressive Disease|3|||
130292018|NCT00875056|469032412|FG000|Overall Study|Withdrawal by Subject|3|||
130292019|NCT00875056|469032413|FG001|Overall Study|Withdrawal by Subject|0|||
130292020|NCT00875056|469032414|FG002|Overall Study|Withdrawal by Subject|1|||
130292021|NCT01920152|469032421|FG000|Overall Study|Withdrawal by Subject|1|||
130292022|NCT01920152|469032422|FG001|Overall Study|Withdrawal by Subject|2|||
130292023|NCT04375397|469032423|FG000|Overall Study|Death|1|||
130292024|NCT04375397|469032424|FG001|Overall Study|Death|1|||
130292025|NCT04375397|469032423|FG000|Overall Study|Withdrew consent|2|||
130292026|NCT04375397|469032424|FG001|Overall Study|Withdrew consent|0|||
130292027|NCT04375397|469032423|FG000|Overall Study|Lost to Follow-up|6|||
130292028|NCT04375397|469032424|FG001|Overall Study|Lost to Follow-up|4|||
130292029|NCT04375397|469032423|FG000|Overall Study|Other, not specified|0|||
130292030|NCT04375397|469032424|FG001|Overall Study|Other, not specified|1|||
129888377|NCT01890967|467549145|FG004|Overall Study|Death|0|||
129888378|NCT01890967|467549146|FG005|Overall Study|Death|0|||
130292031|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130292032|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130292033|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
130292034|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
130292035|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129888379|NCT01890967|467549141|FG000|Overall Study|Lost to Follow-up|1|||
129888380|NCT01890967|467549142|FG001|Overall Study|Lost to Follow-up|1|||
130292036|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130292037|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
130045755|NCT00611455|468125595|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130045756|NCT00611455|468125593|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
130045757|NCT00611455|468125594|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
130045758|NCT00611455|468125595|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
130045759|NCT00611455|468125593|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
130045760|NCT00611455|468125594|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
130045761|NCT00611455|468125595|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
130045762|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
130045763|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
130045764|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
130045765|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
130045766|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
130045767|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
130045768|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
130045769|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
130045770|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
130045771|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
130045772|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
130045773|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
130045774|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
130045775|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
130045776|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
130045777|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
130045778|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
130045779|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
130045780|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
130045781|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
130045782|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
130045783|NCT00611455|468125593|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
130045784|NCT00611455|468125594|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
130045785|NCT00611455|468125595|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
130045786|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
130045787|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
130045788|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
130045789|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
130045790|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
130045791|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
130045792|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
130045793|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
130045794|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
130045795|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
130045796|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
130045797|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
130045798|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
130045799|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
130045800|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
130292038|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
130292039|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130292040|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130292041|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
130292042|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
130292043|NCT00610441|469032428|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130292044|NCT00610441|469032429|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
130292045|NCT00610441|469032430|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130292046|NCT00610441|469032431|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
130292047|NCT00610441|469032428|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130292048|NCT00610441|469032429|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130292049|NCT00610441|469032430|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
130292050|NCT00610441|469032431|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
130292051|NCT00610441|469032428|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130292052|NCT00610441|469032429|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
130292053|NCT00610441|469032430|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130292054|NCT00610441|469032431|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
130292055|NCT00610441|469032428|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
129888381|NCT01890967|467549143|FG002|Overall Study|Lost to Follow-up|1|||
130292056|NCT00610441|469032429|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
130292057|NCT00610441|469032430|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
130292058|NCT00610441|469032431|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
130292059|NCT00610441|469032428|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130292060|NCT00610441|469032429|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130292061|NCT00610441|469032430|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
130292062|NCT00610441|469032431|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
130292063|NCT00610441|469032428|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
130292064|NCT00610441|469032429|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130292065|NCT00610441|469032430|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130292066|NCT00610441|469032431|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
130292067|NCT01995552|469032432|FG000|Overall Study|Protocol Violation|1|||
130292068|NCT01995552|469032432|FG000|Overall Study|Lack of Efficacy|15|||
130292069|NCT01995552|469032432|FG000|Overall Study|Death|1|||
129793423|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793424|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793425|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793426|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793427|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793428|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793429|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793430|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
129793431|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793432|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793433|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793434|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793435|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793436|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793437|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
130292070|NCT01011933|469032434|FG000|Overall Study|Wrong cell type|1|||
130292071|NCT01011933|469032434|FG000|Overall Study|Improper pre-protocol Rx|1|||
130292072|NCT01011933|469032434|FG000|Overall Study|Inadequate pathology|1|||
130292073|NCT01011933|469032434|FG000|Overall Study|Never treated|1|||
130292074|NCT01439074|469032435|FG000|Overall Study|Lost to Follow-up|3|||
130292075|NCT01439074|469032436|FG001|Overall Study|Lost to Follow-up|4|||
130292076|NCT01439074|469032435|FG000|Overall Study|Subject shedding|1|||
130292077|NCT01439074|469032436|FG001|Overall Study|Subject shedding|0|||
130292078|NCT01439074|469032435|FG000|Overall Study|Withdrawal by Subject|1|||
130292079|NCT01439074|469032436|FG001|Overall Study|Withdrawal by Subject|5|||
130292080|NCT01439074|469032435|FG000|Overall Study|Other|4|||
130292081|NCT01439074|469032436|FG001|Overall Study|Other|4|||
130292082|NCT02639338|469032437|FG000|Overall Study|Lost to Follow-up|2|||
130292083|NCT02639338|469032438|FG001|Overall Study|Lost to Follow-up|2|||
130292084|NCT02639338|469032437|FG000|Overall Study|Withdrew Consent|1|||
130292085|NCT02639338|469032438|FG001|Overall Study|Withdrew Consent|2|||
130292086|NCT02639338|469032437|FG000|Overall Study|Death|1|||
130292087|NCT02639338|469032438|FG001|Overall Study|Death|0|||
130292088|NCT02639338|469032437|FG000|Overall Study|Randomized but Not Treated|0|||
130292089|NCT02639338|469032438|FG001|Overall Study|Randomized but Not Treated|1|||
130292090|NCT00787202|469032439|FG000|Overall Study|Adverse Event|3|||
130292091|NCT00787202|469032440|FG001|Overall Study|Adverse Event|2|||
130292092|NCT00787202|469032441|FG002|Overall Study|Adverse Event|0|||
130292093|NCT00787202|469032442|FG003|Overall Study|Adverse Event|0|||
130292094|NCT00787202|469032443|FG004|Overall Study|Adverse Event|2|||
130292095|NCT00787202|469032439|FG000|Overall Study|Lack of Efficacy|5|||
130292096|NCT00787202|469032440|FG001|Overall Study|Lack of Efficacy|6|||
130292097|NCT00787202|469032441|FG002|Overall Study|Lack of Efficacy|5|||
130292098|NCT00787202|469032442|FG003|Overall Study|Lack of Efficacy|2|||
130292099|NCT00787202|469032443|FG004|Overall Study|Lack of Efficacy|1|||
130292100|NCT00787202|469032439|FG000|Overall Study|Lost to Follow-up|1|||
130292101|NCT00787202|469032440|FG001|Overall Study|Lost to Follow-up|0|||
130292102|NCT00787202|469032441|FG002|Overall Study|Lost to Follow-up|0|||
129793438|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793439|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
129793440|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793441|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129888382|NCT01890967|467549144|FG003|Overall Study|Lost to Follow-up|1|||
130292103|NCT00787202|469032442|FG003|Overall Study|Lost to Follow-up|0|||
130292104|NCT00787202|469032443|FG004|Overall Study|Lost to Follow-up|0|||
130292105|NCT00787202|469032439|FG000|Overall Study|Withdrawal by Subject|2|||
130292106|NCT00787202|469032440|FG001|Overall Study|Withdrawal by Subject|2|||
130292107|NCT00787202|469032441|FG002|Overall Study|Withdrawal by Subject|2|||
130292108|NCT00787202|469032442|FG003|Overall Study|Withdrawal by Subject|0|||
130292109|NCT00787202|469032443|FG004|Overall Study|Withdrawal by Subject|0|||
130292110|NCT00787202|469032439|FG000|Overall Study|Protocol Violation|2|||
130292111|NCT00787202|469032440|FG001|Overall Study|Protocol Violation|1|||
130292112|NCT00787202|469032441|FG002|Overall Study|Protocol Violation|0|||
130292113|NCT00787202|469032442|FG003|Overall Study|Protocol Violation|0|||
130292114|NCT00787202|469032443|FG004|Overall Study|Protocol Violation|1|||
130292115|NCT00787202|469032439|FG000|Overall Study|Randomized, not treated|1|||
130292116|NCT00787202|469032440|FG001|Overall Study|Randomized, not treated|0|||
130292117|NCT00787202|469032441|FG002|Overall Study|Randomized, not treated|0|||
130292118|NCT00787202|469032442|FG003|Overall Study|Randomized, not treated|0|||
130292119|NCT00787202|469032443|FG004|Overall Study|Randomized, not treated|0|||
130292120|NCT02525094|469032450|FG000|Overall Study|Lost to Follow-up|2|||
130292121|NCT02525094|469032451|FG001|Overall Study|Lost to Follow-up|1|||
130292122|NCT02525094|469032450|FG000|Overall Study|Withdrawal by Subject|5|||
130292123|NCT02525094|469032451|FG001|Overall Study|Withdrawal by Subject|6|||
130292124|NCT02525094|469032450|FG000|Overall Study|Not Treated|1|||
130292125|NCT02525094|469032451|FG001|Overall Study|Not Treated|1|||
130292126|NCT01751776|469032456|FG000|Overall Study|Adverse Event|0|||
130292127|NCT01751776|469032457|FG001|Overall Study|Adverse Event|0|||
130292128|NCT01751776|469032458|FG002|Overall Study|Adverse Event|0|||
130292129|NCT01751776|469032459|FG003|Overall Study|Adverse Event|0|||
130292130|NCT01751776|469032460|FG004|Overall Study|Adverse Event|0|||
130292131|NCT01751776|469032461|FG005|Overall Study|Adverse Event|0|||
130292132|NCT01751776|469032462|FG006|Overall Study|Adverse Event|4|||
130292133|NCT01751776|469032463|FG007|Overall Study|Adverse Event|2|||
130292134|NCT01751776|469032456|FG000|Overall Study|Consent withdrawn|0|||
130292135|NCT01751776|469032457|FG001|Overall Study|Consent withdrawn|0|||
129793442|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793443|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793444|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793445|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793446|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793447|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793448|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
129793449|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793450|NCT01163318|467210815|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
129793451|NCT01163318|467210815|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
129793452|NCT01163318|467210815|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
129793453|NCT01163318|467210815|FG000|Overall Study|Participants Without Case Report Form|7|||
129793454|NCT01163318|467210815|FG000|Overall Study|Multiple Reasons Per Participant|224|||
129793455|NCT01006603|467210816|FG000|Overall Study|Withdrawal by Subject|17|||
129793456|NCT01006603|467210817|FG001|Overall Study|Withdrawal by Subject|19|||
129793457|NCT01006603|467210816|FG000|Overall Study|Lost to Follow-up|0|||
129888383|NCT01890967|467549145|FG004|Overall Study|Lost to Follow-up|0|||
130292136|NCT01751776|469032458|FG002|Overall Study|Consent withdrawn|0|||
130292137|NCT01751776|469032459|FG003|Overall Study|Consent withdrawn|0|||
129888384|NCT01890967|467549146|FG005|Overall Study|Lost to Follow-up|1|||
130292138|NCT01751776|469032460|FG004|Overall Study|Consent withdrawn|0|||
130292139|NCT01751776|469032461|FG005|Overall Study|Consent withdrawn|0|||
130292140|NCT01751776|469032462|FG006|Overall Study|Consent withdrawn|0|||
129793458|NCT01006603|467210817|FG001|Overall Study|Lost to Follow-up|1|||
129793459|NCT01006603|467210816|FG000|Overall Study|Safety reason|1|||
129793460|NCT01006603|467210817|FG001|Overall Study|Safety reason|1|||
129793461|NCT01006603|467210816|FG000|Overall Study|Protocol Violation|1|||
129793462|NCT01006603|467210817|FG001|Overall Study|Protocol Violation|3|||
129793463|NCT01006603|467210816|FG000|Overall Study|Incorrect enrolment|0|||
129793464|NCT01006603|467210817|FG001|Overall Study|Incorrect enrolment|2|||
129793465|NCT01006603|467210816|FG000|Overall Study|Adverse Event|15|||
130292141|NCT01751776|469032463|FG007|Overall Study|Consent withdrawn|1|||
130292142|NCT01751776|469032456|FG000|Overall Study|Other reason not specified above|0|||
130292143|NCT01751776|469032457|FG001|Overall Study|Other reason not specified above|0|||
130292144|NCT01751776|469032458|FG002|Overall Study|Other reason not specified above|0|||
130292145|NCT01751776|469032459|FG003|Overall Study|Other reason not specified above|0|||
130292146|NCT01751776|469032460|FG004|Overall Study|Other reason not specified above|0|||
130292147|NCT01751776|469032461|FG005|Overall Study|Other reason not specified above|0|||
130292148|NCT01751776|469032462|FG006|Overall Study|Other reason not specified above|0|||
130292149|NCT01751776|469032463|FG007|Overall Study|Other reason not specified above|1|||
130292150|NCT00831701|469032468|FG000|Overall Study|Withdrawal by Subject|2|||
130292151|NCT00831701|469032469|FG001|Overall Study|Withdrawal by Subject|0|||
130292152|NCT00831701|469032468|FG000|Overall Study|Stone expulsion before first medication|2|||
130292153|NCT00831701|469032469|FG001|Overall Study|Stone expulsion before first medication|2|||
129793466|NCT01006603|467210817|FG001|Overall Study|Adverse Event|7|||
129793467|NCT01006603|467210816|FG000|Overall Study|Death|1|||
129793468|NCT01006603|467210817|FG001|Overall Study|Death|1|||
129793469|NCT01006603|467210816|FG000|Overall Study|Study specific discontinuation criteria|33|||
129793470|NCT01006603|467210817|FG001|Overall Study|Study specific discontinuation criteria|34|||
129888385|NCT01890967|467549141|FG000|Overall Study|Protocol Violation|0|||
130292154|NCT00831701|469032468|FG000|Overall Study|Lost to Follow-up|1|||
130292155|NCT00831701|469032469|FG001|Overall Study|Lost to Follow-up|3|||
130292156|NCT02210091|469032470|FG000|Overall Study|Physician Decision|0|||
130292157|NCT02210091|469032471|FG001|Overall Study|Physician Decision|1|||
130292158|NCT02210091|469032470|FG000|Overall Study|Withdrawal by Sponsor|0|||
130292159|NCT02210091|469032471|FG001|Overall Study|Withdrawal by Sponsor|1|||
130292160|NCT02290938|469032472|FG000|Overall Study|Lost to Follow-up|14|||
130292161|NCT02290938|469032473|FG001|Overall Study|Lost to Follow-up|43|||
130292162|NCT03159104|469032474|FG000|Overall Study|Violation of inclusion criteria|1|||
130292163|NCT03159104|469032475|FG001|Overall Study|Violation of inclusion criteria|2|||
130292164|NCT00456599|469032476|FG000|Overall Study|Non-compliance|1|||
130292165|NCT00456599|469032476|FG000|Overall Study|Withdrawal by Subject|2|||
130292166|NCT00151372|469033947|FG000|Overall Study|Death|12|||
130292167|NCT00151372|469033948|FG001|Overall Study|Death|11|||
130292168|NCT00151372|469033947|FG000|Overall Study|Lost to Follow-up|5|||
130292169|NCT00151372|469033948|FG001|Overall Study|Lost to Follow-up|5|||
130292170|NCT00151372|469033947|FG000|Overall Study|Too sick medically to continue|5|||
130292171|NCT00151372|469033948|FG001|Overall Study|Too sick medically to continue|6|||
130292172|NCT00151372|469033947|FG000|Overall Study|Withdrawal by Subject|7|||
130292173|NCT00151372|469033948|FG001|Overall Study|Withdrawal by Subject|7|||
130292174|NCT04732949|469033949|FG000|Overall Study|Withdrawal by Subject|23|||
130292175|NCT04732949|469033950|FG001|Overall Study|Withdrawal by Subject|27|||
129793471|NCT01006603|467210816|FG000|Overall Study|Other|3|||
129793472|NCT01006603|467210817|FG001|Overall Study|Other|7|||
129793473|NCT05772702|467210825|FG000|Overall Study|Adverse Event|1|||
129793474|NCT00884377|467212666|FG000|Overall Study|Withdrawal by Subject|1|||
130292176|NCT04732949|469033949|FG000|Overall Study|Protocol Violation|0|||
130292177|NCT04732949|469033950|FG001|Overall Study|Protocol Violation|1|||
130292178|NCT04732949|469033949|FG000|Overall Study|Non-compliance|0|||
130292179|NCT04732949|469033950|FG001|Overall Study|Non-compliance|2|||
130292180|NCT04732949|469033949|FG000|Overall Study|Physician Decision|2|||
130292181|NCT04732949|469033950|FG001|Overall Study|Physician Decision|1|||
130292182|NCT04732949|469033949|FG000|Overall Study|Serious adverse event (Fatal)|16|||
130292183|NCT04732949|469033950|FG001|Overall Study|Serious adverse event (Fatal)|18|||
130292184|NCT04732949|469033949|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
130292185|NCT04732949|469033950|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
130292186|NCT04732949|469033949|FG000|Overall Study|Non-serious adverse event|1|||
130292187|NCT04732949|469033950|FG001|Overall Study|Non-serious adverse event|3|||
130292188|NCT04732949|469033949|FG000|Overall Study|Lost to Follow-up|26|||
130292189|NCT04732949|469033950|FG001|Overall Study|Lost to Follow-up|27|||
130292190|NCT04732949|469033949|FG000|Overall Study|Other|6|||
130292191|NCT04732949|469033950|FG001|Overall Study|Other|3|||
130292192|NCT03747120|469033951|FG000|Overall Study|treatment related toxicity|3|||
130292193|NCT03747120|469033952|FG001|Overall Study|treatment related toxicity|0|||
130292194|NCT03747120|469033953|FG002|Overall Study|treatment related toxicity|0|||
130292195|NCT03747120|469033951|FG000|Overall Study|Withdrawal by Subject|0|||
130292196|NCT03747120|469033952|FG001|Overall Study|Withdrawal by Subject|1|||
130292197|NCT03747120|469033953|FG002|Overall Study|Withdrawal by Subject|2|||
130292198|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Death|1|||
130292199|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Death|0|||
130292200|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Death|0|||
130292201|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Death|0|||
130292202|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
130292203|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
130292204|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
130292205|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
130292206|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
130292207|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
130292208|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
130292209|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
130292210|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
130292211|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
130292212|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
130292213|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
130292214|NCT04271475|469033959|FG000|DB Period: Day 1 up to EODBT|Other|8|||
130292215|NCT04271475|469033960|FG001|DB Period: Day 1 up to EODBT|Other|5|||
130292216|NCT04271475|469033961|FG002|DB Period: Day 1 up to EODBT|Other|0|||
130292217|NCT04271475|469033962|FG003|DB Period: Day 1 up to EODBT|Other|0|||
130292218|NCT04271475|469033959|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
130292219|NCT04271475|469033960|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
130292220|NCT04271475|469033961|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
130292221|NCT04271475|469033962|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
130292222|NCT04271475|469033959|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130292223|NCT04271475|469033960|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130292224|NCT04271475|469033961|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
130292225|NCT04271475|469033962|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
130292226|NCT00159913|469033964|FG000|Overall Study|Adverse Event|1|||
130292227|NCT00159913|469033965|FG001|Overall Study|Adverse Event|0|||
130292228|NCT00159913|469033966|FG002|Overall Study|Adverse Event|1|||
130292229|NCT00159913|469033967|FG003|Overall Study|Adverse Event|0|||
130292230|NCT00159913|469033964|FG000|Overall Study|Withdrawal by Subject|0|||
130292231|NCT00159913|469033965|FG001|Overall Study|Withdrawal by Subject|0|||
130292232|NCT00159913|469033966|FG002|Overall Study|Withdrawal by Subject|0|||
130292233|NCT00159913|469033967|FG003|Overall Study|Withdrawal by Subject|1|||
130292234|NCT00159913|469033964|FG000|Overall Study|Lost to Follow-up|0|||
130292235|NCT00159913|469033965|FG001|Overall Study|Lost to Follow-up|0|||
130292236|NCT00159913|469033966|FG002|Overall Study|Lost to Follow-up|0|||
130292237|NCT00159913|469033967|FG003|Overall Study|Lost to Follow-up|1|||
130292238|NCT00159913|469033964|FG000|Overall Study|Protocol Violation|1|||
130292239|NCT00159913|469033965|FG001|Overall Study|Protocol Violation|0|||
130292240|NCT00159913|469033966|FG002|Overall Study|Protocol Violation|1|||
130292241|NCT00159913|469033967|FG003|Overall Study|Protocol Violation|0|||
130292242|NCT01318070|469033972|FG000|Overall Study|Adverse Event|1|||
130292243|NCT01318070|469033973|FG001|Overall Study|Adverse Event|1|||
130292244|NCT01318070|469033974|FG002|Overall Study|Adverse Event|5|||
130292245|NCT01318070|469033972|FG000|Overall Study|Withdrawal by Subject|0|||
130292246|NCT01318070|469033973|FG001|Overall Study|Withdrawal by Subject|1|||
130292247|NCT01318070|469033974|FG002|Overall Study|Withdrawal by Subject|1|||
130292248|NCT01318070|469033972|FG000|Overall Study|Lack of Efficacy|0|||
130292249|NCT01318070|469033973|FG001|Overall Study|Lack of Efficacy|0|||
130292250|NCT01318070|469033974|FG002|Overall Study|Lack of Efficacy|1|||
130292251|NCT01318070|469033972|FG000|Overall Study|Principal Investigator Discretion|1|||
130292252|NCT01318070|469033973|FG001|Overall Study|Principal Investigator Discretion|0|||
130292253|NCT01318070|469033974|FG002|Overall Study|Principal Investigator Discretion|0|||
130292254|NCT02956850|469033975|FG000|Overall Study|Withdrawal by Subject|0|||
130292255|NCT02956850|469033976|FG001|Overall Study|Withdrawal by Subject|0|||
130292256|NCT02956850|469033977|FG002|Overall Study|Withdrawal by Subject|0|||
130292257|NCT02956850|469033978|FG003|Overall Study|Withdrawal by Subject|0|||
130292258|NCT02956850|469033979|FG004|Overall Study|Withdrawal by Subject|0|||
130292259|NCT02956850|469033980|FG005|Overall Study|Withdrawal by Subject|0|||
130292260|NCT02956850|469033981|FG006|Overall Study|Withdrawal by Subject|0|||
130292261|NCT02956850|469033982|FG007|Overall Study|Withdrawal by Subject|0|||
130292262|NCT02956850|469033983|FG008|Overall Study|Withdrawal by Subject|0|||
130292263|NCT02956850|469033984|FG009|Overall Study|Withdrawal by Subject|0|||
130292264|NCT02956850|469033985|FG010|Overall Study|Withdrawal by Subject|0|||
130045801|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
130045802|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
130045803|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
130045804|NCT00611455|468125593|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
130045805|NCT00611455|468125594|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
130045806|NCT00611455|468125595|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
130045807|NCT04983901|468125596|FG000|Overall Study|Death|1|||
130045808|NCT04983901|468125597|FG001|Overall Study|Death|4|||
130045809|NCT04983901|468125596|FG000|Overall Study|Lost to Follow-up|3|||
130045810|NCT04983901|468125597|FG001|Overall Study|Lost to Follow-up|0|||
130045811|NCT04983901|468125596|FG000|Overall Study|Protocol Violation|1|||
130045812|NCT04983901|468125597|FG001|Overall Study|Protocol Violation|0|||
130045813|NCT04983901|468125596|FG000|Overall Study|Withdrawal by Subject|1|||
130045814|NCT04983901|468125597|FG001|Overall Study|Withdrawal by Subject|2|||
130045815|NCT03671369|468125602|FG000|Overall Study|Other|1|||
130045816|NCT03671369|468125602|FG000|Overall Study|Withdrawal by Subject|289|||
130045817|NCT03671369|468125602|FG000|Overall Study|Not willing to be vaccinated|1|||
130045818|NCT04382651|468125603|FG000|Overall Study|Death|26|||
130045819|NCT04382651|468125604|FG001|Overall Study|Death|23|||
130045820|NCT04382651|468125603|FG000|Overall Study|Lost to Follow-up|3|||
130045821|NCT04382651|468125604|FG001|Overall Study|Lost to Follow-up|4|||
130045822|NCT04382651|468125603|FG000|Overall Study|Withdrawal by Subject|2|||
130045823|NCT04382651|468125604|FG001|Overall Study|Withdrawal by Subject|0|||
130045824|NCT04382651|468125603|FG000|Overall Study|Physician Decision|0|||
130045825|NCT04382651|468125604|FG001|Overall Study|Physician Decision|1|||
130045826|NCT02732912|468125605|FG000|Overall Study|Discharged before night|2|||
130045827|NCT02732912|468125606|FG001|Overall Study|Discharged before night|6|||
130045828|NCT02732912|468125605|FG000|Overall Study|Incomplete completion of questionnaire|2|||
130045829|NCT02732912|468125606|FG001|Overall Study|Incomplete completion of questionnaire|3|||
130045830|NCT02732912|468125605|FG000|Overall Study|No outcome; discharged or refused|6|||
130045831|NCT02732912|468125606|FG001|Overall Study|No outcome; discharged or refused|9|||
130045832|NCT01507545|468125607|FG000|Overall Study|Withdrawal by Subject|6|||
130045833|NCT01507545|468125608|FG001|Overall Study|Withdrawal by Subject|2|||
130045834|NCT01507545|468125607|FG000|Overall Study|Lost to Follow-up|1|||
130045835|NCT01507545|468125608|FG001|Overall Study|Lost to Follow-up|0|||
130045836|NCT01507545|468125607|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
130045837|NCT01507545|468125608|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
130045838|NCT01507545|468125607|FG000|Overall Study|Progressive disease|60|||
130045839|NCT01507545|468125608|FG001|Overall Study|Progressive disease|27|||
130045840|NCT01507545|468125607|FG000|Overall Study|Other|6|||
130045841|NCT01507545|468125608|FG001|Overall Study|Other|4|||
130292265|NCT02956850|469033986|FG011|Overall Study|Withdrawal by Subject|0|||
130292266|NCT02956850|469033987|FG012|Overall Study|Withdrawal by Subject|0|||
130292267|NCT02956850|469033988|FG013|Overall Study|Withdrawal by Subject|0|||
130292268|NCT02956850|469033989|FG014|Overall Study|Withdrawal by Subject|0|||
130292269|NCT02956850|469033990|FG015|Overall Study|Withdrawal by Subject|0|||
130292270|NCT02956850|469033991|FG016|Overall Study|Withdrawal by Subject|0|||
130292271|NCT02956850|469033992|FG017|Overall Study|Withdrawal by Subject|1|||
130292272|NCT01287195|469033997|FG000|Overall Study|Withdrawal by Subject|2|||
130292273|NCT00870194|469034001|FG000|Overall Study|Adverse Event|10|||
130292274|NCT00870194|469034002|FG001|Overall Study|Adverse Event|5|||
130292275|NCT00870194|469034001|FG000|Overall Study|Lack of Efficacy|0|||
130292276|NCT00870194|469034002|FG001|Overall Study|Lack of Efficacy|1|||
130292277|NCT00870194|469034001|FG000|Overall Study|Lost to Follow-up|2|||
129793475|NCT00884377|467212667|FG001|Overall Study|Withdrawal by Subject|0|||
129793476|NCT00884377|467212666|FG000|Overall Study|Could not confirm diagnosis|1|||
129793477|NCT00884377|467212667|FG001|Overall Study|Could not confirm diagnosis|0|||
129793478|NCT00884377|467212666|FG000|Overall Study|Physician Decision|0|||
129793479|NCT00884377|467212667|FG001|Overall Study|Physician Decision|1|||
129793480|NCT02003365|467212668|FG000|Overall Study|Lost to Follow-up|0|||
130045842|NCT01873742|468125609|FG000|Overall Study|Lost to Follow-up|68|||
130292278|NCT00870194|469034002|FG001|Overall Study|Lost to Follow-up|0|||
130292279|NCT00870194|469034001|FG000|Overall Study|Physician Decision|3|||
130292280|NCT00870194|469034002|FG001|Overall Study|Physician Decision|1|||
130292281|NCT00870194|469034001|FG000|Overall Study|Protocol Violation|3|||
130292282|NCT00870194|469034002|FG001|Overall Study|Protocol Violation|3|||
130045843|NCT01873742|468125610|FG001|Overall Study|Lost to Follow-up|76|||
130045844|NCT00790296|468125612|FG000|Overall Study|Did not meet study eligibility criteria|1|||
130045845|NCT00790296|468125613|FG001|Overall Study|Did not meet study eligibility criteria|1|||
130045846|NCT00790296|468125612|FG000|Overall Study|Adverse Event|0|||
130045847|NCT00790296|468125613|FG001|Overall Study|Adverse Event|1|||
130292283|NCT00870194|469034001|FG000|Overall Study|Entry Criteria Not Met|1|||
129793481|NCT02003365|467212669|FG001|Overall Study|Lost to Follow-up|0|||
129793482|NCT02003365|467212670|FG002|Overall Study|Lost to Follow-up|1|||
129793483|NCT00622739|467212671|FG000|Overall Study|Physician Decision|1|||
130292284|NCT00870194|469034002|FG001|Overall Study|Entry Criteria Not Met|2|||
129793484|NCT00622739|467212672|FG001|Overall Study|Physician Decision|0|||
129793485|NCT00622739|467212671|FG000|Overall Study|Adverse Event|1|||
129793486|NCT00622739|467212672|FG001|Overall Study|Adverse Event|2|||
129793487|NCT00622739|467212671|FG000|Overall Study|Lack of Efficacy|0|||
129793488|NCT00622739|467212672|FG001|Overall Study|Lack of Efficacy|2|||
129793489|NCT00622739|467212671|FG000|Overall Study|Withdrawal by Subject|0|||
129793490|NCT00622739|467212672|FG001|Overall Study|Withdrawal by Subject|1|||
129793491|NCT00622739|467212671|FG000|Overall Study|Lost to Follow-up|0|||
129793492|NCT00622739|467212672|FG001|Overall Study|Lost to Follow-up|1|||
129793493|NCT03387150|467212673|FG000|Overall Study|Withdrawal by Subject|3|||
129793494|NCT03387150|467212674|FG001|Overall Study|Withdrawal by Subject|0|||
129793495|NCT03387150|467212675|FG002|Overall Study|Withdrawal by Subject|3|||
129793496|NCT03387150|467212676|FG003|Overall Study|Withdrawal by Subject|4|||
129793497|NCT03387150|467212677|FG004|Overall Study|Withdrawal by Subject|1|||
129793498|NCT03387150|467212678|FG005|Overall Study|Withdrawal by Subject|2|||
129793499|NCT03387150|467212679|FG006|Overall Study|Withdrawal by Subject|0|||
129793500|NCT03387150|467212673|FG000|Overall Study|Lost to Follow-up|3|||
129793501|NCT03387150|467212674|FG001|Overall Study|Lost to Follow-up|2|||
129793502|NCT03387150|467212675|FG002|Overall Study|Lost to Follow-up|2|||
129793503|NCT03387150|467212676|FG003|Overall Study|Lost to Follow-up|3|||
129793504|NCT03387150|467212677|FG004|Overall Study|Lost to Follow-up|3|||
129793505|NCT03387150|467212678|FG005|Overall Study|Lost to Follow-up|3|||
129793506|NCT03387150|467212679|FG006|Overall Study|Lost to Follow-up|0|||
129793507|NCT03387150|467212673|FG000|Overall Study|Participant unable to adhere to visit|0|||
130292285|NCT00870194|469034001|FG000|Overall Study|Subject Decision|7|||
130292286|NCT00870194|469034002|FG001|Overall Study|Subject Decision|2|||
130292287|NCT02322190|469034003|FG000|Overall Study|Death on study|1|||
130292288|NCT02322190|469034004|FG001|Overall Study|Death on study|0|||
130045848|NCT01671488|468125614|FG000|Overall Study|Withdrawal by Subject|1|||
130292289|NCT01685983|469034008|FG000|Overall Study|Adverse Event|7|||
130292290|NCT01685983|469034008|FG000|Overall Study|Death|1|||
130292291|NCT01685983|469034008|FG000|Overall Study|Withdrawal by Subject|19|||
130292292|NCT01685983|469034008|FG000|Overall Study|Protocol Violation|2|||
130292293|NCT01685983|469034008|FG000|Overall Study|Physician Decision|13|||
129888386|NCT01890967|467549142|FG001|Overall Study|Protocol Violation|3|||
130045849|NCT02612077|468125615|FG000|Overall Study|Adverse Event|3|||
130292294|NCT01685983|469034008|FG000|Overall Study|Other|7|||
130292295|NCT01685983|469034008|FG000|Overall Study|Progressive Disease|32|||
130292296|NCT01685983|469034008|FG000|Overall Study|Noncompliance with Study Drug|1|||
130292297|NCT01443130|469034010|FG000|Overall Study|Lost to Follow-up|44|||
130292298|NCT01443130|469034011|FG001|Overall Study|Lost to Follow-up|42|||
130292299|NCT01443130|469034012|FG002|Overall Study|Lost to Follow-up|50|||
130292300|NCT01443130|469034013|FG003|Overall Study|Lost to Follow-up|23|||
130292301|NCT01443130|469034014|FG004|Overall Study|Lost to Follow-up|25|||
130292302|NCT01443130|469034015|FG005|Overall Study|Lost to Follow-up|21|||
130292303|NCT01443130|469034010|FG000|Overall Study|Death|0|||
130292304|NCT01443130|469034011|FG001|Overall Study|Death|1|||
130292305|NCT01443130|469034012|FG002|Overall Study|Death|0|||
130292306|NCT01443130|469034013|FG003|Overall Study|Death|7|||
130292307|NCT01443130|469034014|FG004|Overall Study|Death|10|||
130292308|NCT01443130|469034015|FG005|Overall Study|Death|8|||
130292309|NCT01443130|469034010|FG000|Overall Study|Adverse Event|2|||
130292310|NCT01443130|469034011|FG001|Overall Study|Adverse Event|1|||
130292311|NCT01443130|469034012|FG002|Overall Study|Adverse Event|1|||
129793508|NCT03387150|467212674|FG001|Overall Study|Participant unable to adhere to visit|1|||
130292312|NCT01443130|469034013|FG003|Overall Study|Adverse Event|0|||
129793509|NCT03387150|467212675|FG002|Overall Study|Participant unable to adhere to visit|0|||
129793510|NCT03387150|467212676|FG003|Overall Study|Participant unable to adhere to visit|0|||
129793511|NCT03387150|467212677|FG004|Overall Study|Participant unable to adhere to visit|2|||
129793512|NCT03387150|467212678|FG005|Overall Study|Participant unable to adhere to visit|2|||
129793513|NCT03387150|467212679|FG006|Overall Study|Participant unable to adhere to visit|0|||
129793514|NCT02448680|467212681|FG000|Overall Study|Physician Decision|1|||
130292313|NCT01443130|469034014|FG004|Overall Study|Adverse Event|0|||
130292314|NCT01443130|469034015|FG005|Overall Study|Adverse Event|0|||
130292315|NCT01443130|469034010|FG000|Overall Study|Protocol Violation|2|||
130292316|NCT01443130|469034011|FG001|Overall Study|Protocol Violation|1|||
130292317|NCT01443130|469034012|FG002|Overall Study|Protocol Violation|3|||
130292318|NCT01443130|469034013|FG003|Overall Study|Protocol Violation|2|||
130292319|NCT01443130|469034014|FG004|Overall Study|Protocol Violation|2|||
130292320|NCT01443130|469034015|FG005|Overall Study|Protocol Violation|3|||
130292321|NCT01443130|469034010|FG000|Overall Study|Withdrawal by Subject|15|||
130292322|NCT01443130|469034011|FG001|Overall Study|Withdrawal by Subject|14|||
130292323|NCT01443130|469034012|FG002|Overall Study|Withdrawal by Subject|12|||
130292324|NCT01443130|469034013|FG003|Overall Study|Withdrawal by Subject|7|||
130292325|NCT01443130|469034014|FG004|Overall Study|Withdrawal by Subject|7|||
130292326|NCT01443130|469034015|FG005|Overall Study|Withdrawal by Subject|2|||
130292327|NCT01443130|469034010|FG000|Overall Study|Death of Subject's Infant|5|||
130292328|NCT01443130|469034011|FG001|Overall Study|Death of Subject's Infant|10|||
130292329|NCT01443130|469034012|FG002|Overall Study|Death of Subject's Infant|11|||
130292330|NCT01443130|469034013|FG003|Overall Study|Death of Subject's Infant|0|||
130292331|NCT01443130|469034014|FG004|Overall Study|Death of Subject's Infant|0|||
130292332|NCT01443130|469034015|FG005|Overall Study|Death of Subject's Infant|0|||
130292333|NCT01167907|469034017|FG000|Overall Study|Protocol Violation|1|||
130292334|NCT01167907|469034018|FG001|Overall Study|Protocol Violation|0|||
130292335|NCT01167907|469034017|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
130292336|NCT01167907|469034018|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
130292337|NCT03077698|469034021|FG000|Progestin Monotherapy|Stable Disease|8|||
130292338|NCT03077698|469034022|FG001|Progestin Monotherapy|Stable Disease|0|||
130292339|NCT03077698|469034021|FG000|Progestin Monotherapy|Adverse Event|1|||
130292340|NCT03077698|469034022|FG001|Progestin Monotherapy|Adverse Event|0|||
130292341|NCT03077698|469034021|FG000|Progestin Monotherapy|Death|1|||
130292342|NCT03077698|469034022|FG001|Progestin Monotherapy|Death|0|||
130292343|NCT03077698|469034021|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
130292344|NCT03077698|469034022|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
130292345|NCT03077698|469034021|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
130292346|NCT03077698|469034022|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
130292347|NCT03077698|469034021|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
130292348|NCT03077698|469034022|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
129793515|NCT02448680|467212682|FG001|Overall Study|Physician Decision|1|||
130292349|NCT03077698|469034021|FG000|Safety Follow Up|Withdrawal by Subject|2|||
130292350|NCT03077698|469034022|FG001|Safety Follow Up|Withdrawal by Subject|1|||
129793516|NCT02448680|467212681|FG000|Overall Study|Withdrawal by Subject|0|||
129793517|NCT02448680|467212682|FG001|Overall Study|Withdrawal by Subject|2|||
130292351|NCT03077698|469034021|FG000|Safety Follow Up|Transfer of care to hospice|1|||
130292352|NCT03077698|469034022|FG001|Safety Follow Up|Transfer of care to hospice|0|||
130292353|NCT03461406|469034023|FG000|Overall Study|Death|1|||
130292354|NCT03461406|469034024|FG001|Overall Study|Death|2|||
130292355|NCT03461406|469034023|FG000|Overall Study|Consent Withdrawn by Participant|0|||
130292356|NCT03461406|469034024|FG001|Overall Study|Consent Withdrawn by Participant|1|||
130292357|NCT03461406|469034023|FG000|Overall Study|Screen Failure|3|||
130292358|NCT03461406|469034024|FG001|Overall Study|Screen Failure|1|||
130292359|NCT03461406|469034023|FG000|Overall Study|Reason not Specified|1|||
130045850|NCT02612077|468125615|FG000|Overall Study|Withdrawal by Subject|9|||
130045851|NCT02612077|468125615|FG000|Overall Study|Protocol Violation|28|||
130045852|NCT02612077|468125615|FG000|Overall Study|Lost to Follow-up|20|||
130045853|NCT02612077|468125615|FG000|Overall Study|Death|377|||
130045854|NCT02612077|468125615|FG000|Overall Study|Moved or Changed Medical Team|23|||
130045855|NCT02612077|468125615|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
130045856|NCT02612077|468125615|FG000|Overall Study|Disease Progression|3|||
130045857|NCT02612077|468125615|FG000|Overall Study|Unknown reason|2|||
130045858|NCT01022853|468125616|FG000|Overall Study|Progressive disease|2|||
130045859|NCT01022853|468125617|FG001|Overall Study|Progressive disease|3|||
130045860|NCT01022853|468125618|FG002|Overall Study|Progressive disease|11|||
130045861|NCT01022853|468125619|FG003|Overall Study|Progressive disease|7|||
130045862|NCT01022853|468125620|FG004|Overall Study|Progressive disease|1|||
130045863|NCT01022853|468125616|FG000|Overall Study|Dose-limiting toxicity|0|||
130292360|NCT03461406|469034024|FG001|Overall Study|Reason not Specified|3|||
130045864|NCT01022853|468125617|FG001|Overall Study|Dose-limiting toxicity|0|||
130045865|NCT01022853|468125618|FG002|Overall Study|Dose-limiting toxicity|0|||
130045866|NCT01022853|468125619|FG003|Overall Study|Dose-limiting toxicity|0|||
130045867|NCT01022853|468125620|FG004|Overall Study|Dose-limiting toxicity|1|||
130045868|NCT01022853|468125616|FG000|Overall Study|Withdrawal by Subject|0|||
130045869|NCT01022853|468125617|FG001|Overall Study|Withdrawal by Subject|1|||
130045870|NCT01022853|468125618|FG002|Overall Study|Withdrawal by Subject|1|||
130045871|NCT01022853|468125619|FG003|Overall Study|Withdrawal by Subject|1|||
130045872|NCT01022853|468125620|FG004|Overall Study|Withdrawal by Subject|0|||
130045873|NCT01022853|468125616|FG000|Overall Study|Other not stated above|1|||
130045874|NCT01022853|468125617|FG001|Overall Study|Other not stated above|0|||
130045875|NCT01022853|468125618|FG002|Overall Study|Other not stated above|1|||
130045876|NCT01022853|468125619|FG003|Overall Study|Other not stated above|0|||
130045877|NCT01022853|468125620|FG004|Overall Study|Other not stated above|0|||
130045878|NCT01753518|468125621|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
130292361|NCT03461406|469034023|FG000|Overall Study|Lost to Follow-up|3|||
130292362|NCT03461406|469034024|FG001|Overall Study|Lost to Follow-up|0|||
130292363|NCT00973102|469034027|FG000|Overall Study|Protocol Violation|1|||
130292364|NCT00973102|469034028|FG001|Overall Study|Protocol Violation|0|||
129888387|NCT01890967|467549143|FG002|Overall Study|Protocol Violation|3|||
129888388|NCT01890967|467549144|FG003|Overall Study|Protocol Violation|2|||
129888389|NCT01890967|467549145|FG004|Overall Study|Protocol Violation|4|||
129888390|NCT01890967|467549146|FG005|Overall Study|Protocol Violation|1|||
129888391|NCT01890967|467549141|FG000|Overall Study|Sponsor Decision|2|||
129888392|NCT01890967|467549142|FG001|Overall Study|Sponsor Decision|0|||
129888393|NCT01890967|467549143|FG002|Overall Study|Sponsor Decision|1|||
129888394|NCT01890967|467549144|FG003|Overall Study|Sponsor Decision|3|||
129888395|NCT01890967|467549145|FG004|Overall Study|Sponsor Decision|2|||
129888396|NCT01890967|467549146|FG005|Overall Study|Sponsor Decision|3|||
129888397|NCT01890967|467549141|FG000|Overall Study|Withdrawal by Subject|3|||
129888398|NCT01890967|467549142|FG001|Overall Study|Withdrawal by Subject|4|||
129888399|NCT01890967|467549143|FG002|Overall Study|Withdrawal by Subject|2|||
129888400|NCT01890967|467549144|FG003|Overall Study|Withdrawal by Subject|3|||
129888401|NCT01890967|467549145|FG004|Overall Study|Withdrawal by Subject|3|||
129888402|NCT01890967|467549146|FG005|Overall Study|Withdrawal by Subject|1|||
129888403|NCT01383993|467549148|FG000|Overall Study|Adverse Event|1|||
130045879|NCT01753518|468125622|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
130045880|NCT01753518|468125621|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
130045881|NCT01753518|468125622|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
130045882|NCT01753518|468125621|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
130045883|NCT01753518|468125622|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
130045884|NCT01753518|468125621|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
130045885|NCT01753518|468125622|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
130045886|NCT01971476|468125623|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
130045887|NCT01971476|468125624|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
130045888|NCT01971476|468125625|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
130045889|NCT01971476|468125623|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
130045890|NCT01971476|468125624|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
130292365|NCT00973102|469034027|FG000|Overall Study|Prisoner|0|||
129888404|NCT01383993|467549149|FG001|Overall Study|Adverse Event|1|||
129888405|NCT01383993|467549150|FG002|Overall Study|Adverse Event|0|||
129888406|NCT01383993|467549148|FG000|Overall Study|Withdrawal by Subject|0|||
129888407|NCT01383993|467549149|FG001|Overall Study|Withdrawal by Subject|0|||
129888408|NCT01383993|467549150|FG002|Overall Study|Withdrawal by Subject|1|||
130292366|NCT00973102|469034028|FG001|Overall Study|Prisoner|1|||
130045891|NCT01971476|468125625|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
130045892|NCT01971476|468125623|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
130045893|NCT01971476|468125624|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
130045894|NCT01971476|468125625|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
130292367|NCT00966719|469034031|FG000|Overall Study|Lost to Follow-up|6|||
130292368|NCT00966719|469034032|FG001|Overall Study|Lost to Follow-up|11|||
130316269|NCT05767021|469124351|FG000|Overall Study|Lack of Efficacy|11|||
130292369|NCT01710527|469034033|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
130292370|NCT01710527|469034034|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
130292371|NCT02635347|469034037|FG000|Overall Study|Failed screening|20|||
130292372|NCT02635347|469034038|FG001|Overall Study|Failed screening|7|||
130292373|NCT02124772|469034040|FG000|Overall Study|Lack of Efficacy|2|||
130292374|NCT02124772|469034041|FG001|Overall Study|Lack of Efficacy|0|||
130292375|NCT02124772|469034042|FG002|Overall Study|Lack of Efficacy|0|||
130292376|NCT02124772|469034043|FG003|Overall Study|Lack of Efficacy|1|||
130292377|NCT02124772|469034044|FG004|Overall Study|Lack of Efficacy|2|||
130292378|NCT02124772|469034045|FG005|Overall Study|Lack of Efficacy|3|||
130292379|NCT02124772|469034046|FG006|Overall Study|Lack of Efficacy|0|||
130292380|NCT02124772|469034047|FG007|Overall Study|Lack of Efficacy|2|||
130292381|NCT02124772|469034048|FG008|Overall Study|Lack of Efficacy|0|||
130292382|NCT02124772|469034049|FG009|Overall Study|Lack of Efficacy|1|||
130292383|NCT02124772|469034050|FG010|Overall Study|Lack of Efficacy|0|||
130292384|NCT02124772|469034051|FG011|Overall Study|Lack of Efficacy|0|||
130292385|NCT02124772|469034052|FG012|Overall Study|Lack of Efficacy|1|||
130292386|NCT02124772|469034040|FG000|Overall Study|Adverse Event|1|||
130292387|NCT02124772|469034041|FG001|Overall Study|Adverse Event|4|||
130292388|NCT02124772|469034042|FG002|Overall Study|Adverse Event|1|||
130292389|NCT02124772|469034043|FG003|Overall Study|Adverse Event|5|||
130292390|NCT02124772|469034044|FG004|Overall Study|Adverse Event|2|||
130292391|NCT02124772|469034045|FG005|Overall Study|Adverse Event|1|||
130292392|NCT02124772|469034046|FG006|Overall Study|Adverse Event|1|||
130292393|NCT02124772|469034047|FG007|Overall Study|Adverse Event|5|||
130292394|NCT02124772|469034048|FG008|Overall Study|Adverse Event|0|||
130292395|NCT02124772|469034049|FG009|Overall Study|Adverse Event|3|||
130292396|NCT02124772|469034050|FG010|Overall Study|Adverse Event|1|||
130292397|NCT02124772|469034051|FG011|Overall Study|Adverse Event|3|||
130292398|NCT02124772|469034052|FG012|Overall Study|Adverse Event|1|||
130292399|NCT02124772|469034040|FG000|Overall Study|Withdrawal consent|0|||
130292400|NCT02124772|469034041|FG001|Overall Study|Withdrawal consent|1|||
130292401|NCT02124772|469034042|FG002|Overall Study|Withdrawal consent|1|||
130292402|NCT02124772|469034043|FG003|Overall Study|Withdrawal consent|1|||
130292403|NCT02124772|469034044|FG004|Overall Study|Withdrawal consent|0|||
130292404|NCT02124772|469034045|FG005|Overall Study|Withdrawal consent|1|||
130292405|NCT02124772|469034046|FG006|Overall Study|Withdrawal consent|1|||
130292406|NCT02124772|469034047|FG007|Overall Study|Withdrawal consent|0|||
130292407|NCT02124772|469034048|FG008|Overall Study|Withdrawal consent|0|||
130292408|NCT02124772|469034049|FG009|Overall Study|Withdrawal consent|1|||
130292409|NCT02124772|469034050|FG010|Overall Study|Withdrawal consent|0|||
130292410|NCT02124772|469034051|FG011|Overall Study|Withdrawal consent|1|||
130292411|NCT02124772|469034052|FG012|Overall Study|Withdrawal consent|0|||
130292412|NCT02124772|469034040|FG000|Overall Study|Investigator discretion|0|||
130292413|NCT02124772|469034041|FG001|Overall Study|Investigator discretion|2|||
130292414|NCT02124772|469034042|FG002|Overall Study|Investigator discretion|2|||
130292415|NCT02124772|469034043|FG003|Overall Study|Investigator discretion|1|||
130292416|NCT02124772|469034044|FG004|Overall Study|Investigator discretion|1|||
130292417|NCT02124772|469034045|FG005|Overall Study|Investigator discretion|0|||
130292418|NCT02124772|469034046|FG006|Overall Study|Investigator discretion|1|||
130292419|NCT02124772|469034047|FG007|Overall Study|Investigator discretion|0|||
130292420|NCT02124772|469034048|FG008|Overall Study|Investigator discretion|0|||
130292421|NCT02124772|469034049|FG009|Overall Study|Investigator discretion|1|||
130292422|NCT02124772|469034050|FG010|Overall Study|Investigator discretion|0|||
130292423|NCT02124772|469034051|FG011|Overall Study|Investigator discretion|1|||
130292424|NCT02124772|469034052|FG012|Overall Study|Investigator discretion|0|||
130292425|NCT02124772|469034040|FG000|Overall Study|Progressive disease|0|||
130292426|NCT02124772|469034041|FG001|Overall Study|Progressive disease|0|||
130292427|NCT02124772|469034042|FG002|Overall Study|Progressive disease|0|||
130292428|NCT02124772|469034043|FG003|Overall Study|Progressive disease|0|||
130292429|NCT02124772|469034044|FG004|Overall Study|Progressive disease|0|||
130292430|NCT02124772|469034045|FG005|Overall Study|Progressive disease|0|||
130292431|NCT02124772|469034046|FG006|Overall Study|Progressive disease|1|||
130292432|NCT02124772|469034047|FG007|Overall Study|Progressive disease|1|||
130292433|NCT02124772|469034048|FG008|Overall Study|Progressive disease|0|||
130292434|NCT02124772|469034049|FG009|Overall Study|Progressive disease|0|||
130292435|NCT02124772|469034050|FG010|Overall Study|Progressive disease|0|||
130292436|NCT02124772|469034051|FG011|Overall Study|Progressive disease|0|||
130292437|NCT02124772|469034052|FG012|Overall Study|Progressive disease|0|||
130292438|NCT02124772|469034040|FG000|Overall Study|Other|0|||
130292439|NCT02124772|469034041|FG001|Overall Study|Other|7|||
130292440|NCT02124772|469034042|FG002|Overall Study|Other|2|||
130292441|NCT02124772|469034043|FG003|Overall Study|Other|5|||
130292442|NCT02124772|469034044|FG004|Overall Study|Other|4|||
130292443|NCT02124772|469034045|FG005|Overall Study|Other|3|||
130292444|NCT02124772|469034046|FG006|Overall Study|Other|4|||
130292445|NCT02124772|469034047|FG007|Overall Study|Other|1|||
130292446|NCT02124772|469034048|FG008|Overall Study|Other|1|||
130045895|NCT02075255|468125626|FG000|Overall Study|Study specific withdrawal criteria|0|||
130045896|NCT02075255|468125627|FG001|Overall Study|Study specific withdrawal criteria|1|||
130045897|NCT02075255|468125628|FG002|Overall Study|Study specific withdrawal criteria|1|||
130292447|NCT02124772|469034049|FG009|Overall Study|Other|1|||
130292448|NCT02124772|469034050|FG010|Overall Study|Other|1|||
130292449|NCT02124772|469034051|FG011|Overall Study|Other|1|||
130292450|NCT02124772|469034052|FG012|Overall Study|Other|0|||
130292451|NCT00780273|469034053|FG000|Overall Study|Death|1|||
130292452|NCT00780273|469034053|FG000|Overall Study|Lost to Follow-up|1|||
130292453|NCT01688921|469034054|FG000|Overall Study|Lost to Follow-up|7|||
130292454|NCT01688921|469034055|FG001|Overall Study|Lost to Follow-up|13|||
130292455|NCT01688921|469034054|FG000|Overall Study|Physician Decision|6|||
130292456|NCT01688921|469034055|FG001|Overall Study|Physician Decision|1|||
130292457|NCT01688921|469034054|FG000|Overall Study|Protocol Violation|0|||
130292458|NCT01688921|469034055|FG001|Overall Study|Protocol Violation|1|||
130292459|NCT01688921|469034054|FG000|Overall Study|informed consent|3|||
130292460|NCT01688921|469034055|FG001|Overall Study|informed consent|0|||
130292461|NCT02358044|469034056|FG000|Overall Study|Adverse Event|0|||
130292462|NCT02358044|469034057|FG001|Overall Study|Adverse Event|1|||
130292463|NCT02358044|469034056|FG000|Overall Study|Lost to Follow-up|2|||
130292464|NCT02358044|469034057|FG001|Overall Study|Lost to Follow-up|1|||
130292465|NCT02358044|469034056|FG000|Overall Study|Physician Decision|0|||
130292466|NCT02358044|469034057|FG001|Overall Study|Physician Decision|1|||
130292467|NCT02358044|469034056|FG000|Overall Study|Withdrawal by Subject|0|||
130292468|NCT02358044|469034057|FG001|Overall Study|Withdrawal by Subject|4|||
130292469|NCT01739803|469034060|FG000|Overall Study|Lost to Follow-up|9|||
130292470|NCT01739803|469034061|FG001|Overall Study|Lost to Follow-up|6|||
130292471|NCT00969436|469034063|FG000|Overall Study|Protocol Violation|1|||
130292472|NCT00969436|469034064|FG001|Overall Study|Protocol Violation|3|||
130292473|NCT00969436|469034065|FG002|Overall Study|Protocol Violation|0|||
130292474|NCT00969436|469034063|FG000|Overall Study|Migrated/moved from study area|12|||
130292475|NCT00969436|469034064|FG001|Overall Study|Migrated/moved from study area|10|||
130292476|NCT00969436|469034065|FG002|Overall Study|Migrated/moved from study area|2|||
130292477|NCT00969436|469034063|FG000|Overall Study|Father - serious health problem|0|||
130292478|NCT00969436|469034064|FG001|Overall Study|Father - serious health problem|0|||
130292479|NCT00969436|469034065|FG002|Overall Study|Father - serious health problem|1|||
130292480|NCT00969436|469034063|FG000|Overall Study|Parents personal problem|0|||
130292481|NCT00969436|469034064|FG001|Overall Study|Parents personal problem|0|||
130292482|NCT00969436|469034065|FG002|Overall Study|Parents personal problem|1|||
130292483|NCT00969436|469034063|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
130292484|NCT00969436|469034064|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
130292485|NCT00969436|469034065|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
130292486|NCT00969436|469034063|FG000|Overall Study|Withdrawal by Subject|3|||
130292487|NCT00969436|469034064|FG001|Overall Study|Withdrawal by Subject|0|||
130292488|NCT00969436|469034065|FG002|Overall Study|Withdrawal by Subject|2|||
130292489|NCT00969436|469034063|FG000|Overall Study|Lost to Follow-up|8|||
130292490|NCT00969436|469034064|FG001|Overall Study|Lost to Follow-up|8|||
130292491|NCT00969436|469034065|FG002|Overall Study|Lost to Follow-up|5|||
130292492|NCT03474081|469034070|FG000|Overall Study|Adverse Event|6|||
130292493|NCT03474081|469034071|FG001|Overall Study|Adverse Event|3|||
130292494|NCT03474081|469034070|FG000|Overall Study|Lost to Follow-up|2|||
130292495|NCT03474081|469034071|FG001|Overall Study|Lost to Follow-up|1|||
130292496|NCT03474081|469034070|FG000|Overall Study|Physician Decision|3|||
130292497|NCT03474081|469034071|FG001|Overall Study|Physician Decision|2|||
130292498|NCT03474081|469034070|FG000|Overall Study|Withdrawal by Subject|5|||
130292499|NCT03474081|469034071|FG001|Overall Study|Withdrawal by Subject|7|||
130292500|NCT03474081|469034070|FG000|Overall Study|Investigator site closed|1|||
130292501|NCT03474081|469034071|FG001|Overall Study|Investigator site closed|0|||
130292502|NCT01831817|469034072|FG000|Overall Study|Lost to Follow-up|1|||
130292503|NCT01831817|469034073|FG001|Overall Study|Lost to Follow-up|0|||
130292504|NCT01831817|469034074|FG002|Overall Study|Lost to Follow-up|0|||
130292505|NCT01831817|469034075|FG003|Overall Study|Lost to Follow-up|0|||
130292506|NCT01831817|469034072|FG000|Overall Study|Withdrawl of Consent|3|||
130292507|NCT01831817|469034073|FG001|Overall Study|Withdrawl of Consent|0|||
130292508|NCT01831817|469034074|FG002|Overall Study|Withdrawl of Consent|0|||
130292509|NCT01831817|469034075|FG003|Overall Study|Withdrawl of Consent|0|||
130292510|NCT02198235|469034077|FG000|Overall Study|Lost to Follow-up|3|||
129793518|NCT01857310|467212683|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
129793519|NCT01857310|467212684|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
129793520|NCT00998764|467212685|FG000|Overall Study|Lack of Efficacy|3|||
129793521|NCT00998764|467212686|FG001|Overall Study|Lack of Efficacy|6|||
129793522|NCT00998764|467212685|FG000|Overall Study|Adverse Event|17|||
129793523|NCT00998764|467212686|FG001|Overall Study|Adverse Event|12|||
129793524|NCT00998764|467212685|FG000|Overall Study|Withdrawal by Subject|19|||
129793525|NCT00998764|467212686|FG001|Overall Study|Withdrawal by Subject|25|||
129793526|NCT00998764|467212685|FG000|Overall Study|Physician Decision|3|||
130292511|NCT02198235|469034078|FG001|Overall Study|Lost to Follow-up|2|||
130292512|NCT02198235|469034079|FG002|Overall Study|Lost to Follow-up|2|||
130292513|NCT04573881|469034082|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
130292514|NCT00541346|469035749|FG000|Follow-up|Adverse Event|1|||
130292515|NCT05160766|469035752|FG000|Overall Study|Adverse Event|0|||
130292516|NCT05160766|469035753|FG001|Overall Study|Adverse Event|1|||
130292517|NCT05160766|469035754|FG002|Overall Study|Adverse Event|0|||
130292518|NCT05160766|469035755|FG003|Overall Study|Adverse Event|0|||
130292519|NCT05160766|469035752|FG000|Overall Study|COVID-19 infection|0|||
130292520|NCT05160766|469035753|FG001|Overall Study|COVID-19 infection|1|||
130292521|NCT05160766|469035754|FG002|Overall Study|COVID-19 infection|0|||
130292522|NCT05160766|469035755|FG003|Overall Study|COVID-19 infection|0|||
130292523|NCT05160766|469035752|FG000|Overall Study|travel time|1|||
130292524|NCT05160766|469035753|FG001|Overall Study|travel time|0|||
130292525|NCT05160766|469035754|FG002|Overall Study|travel time|0|||
130292526|NCT05160766|469035755|FG003|Overall Study|travel time|1|||
130292527|NCT05160766|469035752|FG000|Overall Study|Withdrawal by Subject|3|||
130292528|NCT05160766|469035753|FG001|Overall Study|Withdrawal by Subject|5|||
130292529|NCT05160766|469035754|FG002|Overall Study|Withdrawal by Subject|4|||
130292530|NCT05160766|469035755|FG003|Overall Study|Withdrawal by Subject|2|||
130292531|NCT05160766|469035752|FG000|Overall Study|Death|0|||
130292532|NCT05160766|469035753|FG001|Overall Study|Death|0|||
130292533|NCT05160766|469035754|FG002|Overall Study|Death|2|||
130292534|NCT05160766|469035755|FG003|Overall Study|Death|5|||
130292535|NCT05160766|469035752|FG000|Overall Study|Lost to Follow-up|0|||
130292536|NCT05160766|469035753|FG001|Overall Study|Lost to Follow-up|0|||
130292537|NCT05160766|469035754|FG002|Overall Study|Lost to Follow-up|1|||
130292538|NCT05160766|469035755|FG003|Overall Study|Lost to Follow-up|2|||
130292539|NCT05160766|469035752|FG000|Overall Study|No show|0|||
130292540|NCT05160766|469035753|FG001|Overall Study|No show|0|||
130292541|NCT05160766|469035754|FG002|Overall Study|No show|1|||
130292542|NCT05160766|469035755|FG003|Overall Study|No show|1|||
130292543|NCT05160766|469035752|FG000|Overall Study|Physician Decision|0|||
130292544|NCT05160766|469035753|FG001|Overall Study|Physician Decision|0|||
130292545|NCT05160766|469035754|FG002|Overall Study|Physician Decision|0|||
130292546|NCT05160766|469035755|FG003|Overall Study|Physician Decision|1|||
129888409|NCT01383993|467549148|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
130292547|NCT05160766|469035752|FG000|Overall Study|Protocol Violation|0|||
130292548|NCT05160766|469035753|FG001|Overall Study|Protocol Violation|0|||
130292549|NCT05160766|469035754|FG002|Overall Study|Protocol Violation|1|||
130292550|NCT05160766|469035755|FG003|Overall Study|Protocol Violation|0|||
130292551|NCT02853435|469035756|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292552|NCT02853435|469035757|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292553|NCT02853435|469035758|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292554|NCT02853435|469035759|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292555|NCT02853435|469035760|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
130292556|NCT02853435|469035761|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
130292557|NCT00996801|469035762|FG000|Overall Study|Adverse Event|6|||
130292558|NCT00996801|469035763|FG001|Overall Study|Adverse Event|4|||
130292559|NCT00996801|469035764|FG002|Overall Study|Adverse Event|12|||
130292560|NCT00996801|469035765|FG003|Overall Study|Adverse Event|17|||
130292561|NCT00996801|469035766|FG004|Overall Study|Adverse Event|31|||
130292562|NCT00996801|469035767|FG005|Overall Study|Adverse Event|3|||
130292563|NCT00996801|469035762|FG000|Overall Study|Lack of Efficacy|3|||
130292564|NCT00996801|469035763|FG001|Overall Study|Lack of Efficacy|0|||
130292565|NCT00996801|469035764|FG002|Overall Study|Lack of Efficacy|1|||
130292566|NCT00996801|469035765|FG003|Overall Study|Lack of Efficacy|3|||
130292567|NCT00996801|469035766|FG004|Overall Study|Lack of Efficacy|0|||
130292568|NCT00996801|469035767|FG005|Overall Study|Lack of Efficacy|1|||
130292569|NCT00996801|469035762|FG000|Overall Study|Lost to Follow-up|0|||
130292570|NCT00996801|469035763|FG001|Overall Study|Lost to Follow-up|0|||
130292571|NCT00996801|469035764|FG002|Overall Study|Lost to Follow-up|0|||
130292572|NCT00996801|469035765|FG003|Overall Study|Lost to Follow-up|3|||
130292573|NCT00996801|469035766|FG004|Overall Study|Lost to Follow-up|3|||
130292574|NCT00996801|469035767|FG005|Overall Study|Lost to Follow-up|2|||
130292575|NCT00996801|469035762|FG000|Overall Study|Physician Decision|0|||
129888410|NCT01383993|467549149|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
130292576|NCT00996801|469035763|FG001|Overall Study|Physician Decision|0|||
130292577|NCT00996801|469035764|FG002|Overall Study|Physician Decision|0|||
130292578|NCT00996801|469035765|FG003|Overall Study|Physician Decision|1|||
130292579|NCT00996801|469035766|FG004|Overall Study|Physician Decision|0|||
130292580|NCT00996801|469035767|FG005|Overall Study|Physician Decision|0|||
130292581|NCT00996801|469035762|FG000|Overall Study|Progressive Disease|0|||
129793527|NCT00998764|467212686|FG001|Overall Study|Physician Decision|3|||
129793528|NCT00998764|467212685|FG000|Overall Study|Death|3|||
129793529|NCT00998764|467212686|FG001|Overall Study|Death|1|||
129793530|NCT00998764|467212685|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
129793531|NCT00998764|467212686|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
129793532|NCT00998764|467212685|FG000|Overall Study|Protocol Violation|0|||
129793533|NCT00998764|467212686|FG001|Overall Study|Protocol Violation|1|||
130045898|NCT02075255|468125626|FG000|Overall Study|Withdrawal by Subject|4|||
130045899|NCT02075255|468125627|FG001|Overall Study|Withdrawal by Subject|1|||
130045900|NCT02075255|468125628|FG002|Overall Study|Withdrawal by Subject|0|||
130045901|NCT02075255|468125626|FG000|Overall Study|Lost to Follow-up|0|||
130045902|NCT02075255|468125627|FG001|Overall Study|Lost to Follow-up|0|||
130045903|NCT02075255|468125628|FG002|Overall Study|Lost to Follow-up|1|||
129793534|NCT00998764|467212685|FG000|Overall Study|Failed to Return|1|||
129793535|NCT00998764|467212686|FG001|Overall Study|Failed to Return|1|||
129793536|NCT00998764|467212685|FG000|Overall Study|Lost to Follow-up|1|||
129793537|NCT00998764|467212686|FG001|Overall Study|Lost to Follow-up|1|||
129793538|NCT00998764|467212685|FG000|Overall Study|Loss of Caregiver|0|||
129793539|NCT00998764|467212686|FG001|Overall Study|Loss of Caregiver|3|||
129793540|NCT00998764|467212685|FG000|Overall Study|Other|4|||
129793541|NCT00998764|467212686|FG001|Overall Study|Other|4|||
129793542|NCT00998764|467212685|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
129793543|NCT00998764|467212686|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
129793544|NCT04761627|467212687|FG000|Run-in Period|Death|1|||
129793545|NCT04761627|467212688|FG001|Run-in Period|Death|0|||
129793546|NCT04761627|467212689|FG002|Run-in Period|Death|0|||
129793547|NCT04761627|467212687|FG000|Run-in Period|Required alternative therapy|2|||
129793548|NCT04761627|467212688|FG001|Run-in Period|Required alternative therapy|0|||
129793549|NCT04761627|467212689|FG002|Run-in Period|Required alternative therapy|0|||
129793550|NCT04761627|467212687|FG000|Run-in Period|Lost to Follow-up|2|||
129793551|NCT04761627|467212688|FG001|Run-in Period|Lost to Follow-up|0|||
129793552|NCT04761627|467212689|FG002|Run-in Period|Lost to Follow-up|0|||
129793553|NCT04761627|467212687|FG000|Run-in Period|Protocol Violation|3|||
129793554|NCT04761627|467212688|FG001|Run-in Period|Protocol Violation|0|||
129793555|NCT04761627|467212689|FG002|Run-in Period|Protocol Violation|0|||
129793556|NCT04761627|467212687|FG000|Run-in Period|Abnormal liver function|1|||
129793557|NCT04761627|467212688|FG001|Run-in Period|Abnormal liver function|0|||
129793558|NCT04761627|467212689|FG002|Run-in Period|Abnormal liver function|0|||
129793559|NCT04761627|467212687|FG000|Run-in Period|Adverse Event|6|||
129793560|NCT04761627|467212688|FG001|Run-in Period|Adverse Event|0|||
129793561|NCT04761627|467212689|FG002|Run-in Period|Adverse Event|0|||
130045904|NCT02075255|468125626|FG000|Overall Study|Adverse Event|0|||
130045905|NCT02075255|468125627|FG001|Overall Study|Adverse Event|0|||
130292582|NCT00996801|469035763|FG001|Overall Study|Progressive Disease|1|||
130292583|NCT00996801|469035764|FG002|Overall Study|Progressive Disease|0|||
130292584|NCT00996801|469035765|FG003|Overall Study|Progressive Disease|0|||
130292585|NCT00996801|469035766|FG004|Overall Study|Progressive Disease|0|||
130292586|NCT00996801|469035767|FG005|Overall Study|Progressive Disease|0|||
130292587|NCT00996801|469035762|FG000|Overall Study|Protocol Violation|3|||
130292588|NCT00996801|469035763|FG001|Overall Study|Protocol Violation|4|||
130292589|NCT00996801|469035764|FG002|Overall Study|Protocol Violation|1|||
130292590|NCT00996801|469035765|FG003|Overall Study|Protocol Violation|2|||
130292591|NCT00996801|469035766|FG004|Overall Study|Protocol Violation|3|||
130292592|NCT00996801|469035767|FG005|Overall Study|Protocol Violation|4|||
130292593|NCT00996801|469035762|FG000|Overall Study|Study Terminated by Sponsor|0|||
130292594|NCT00996801|469035763|FG001|Overall Study|Study Terminated by Sponsor|1|||
130292595|NCT00996801|469035764|FG002|Overall Study|Study Terminated by Sponsor|0|||
130292596|NCT00996801|469035765|FG003|Overall Study|Study Terminated by Sponsor|0|||
130292597|NCT00996801|469035766|FG004|Overall Study|Study Terminated by Sponsor|46|||
130292598|NCT00996801|469035767|FG005|Overall Study|Study Terminated by Sponsor|0|||
130292599|NCT00996801|469035762|FG000|Overall Study|Withdrawal by Subject|8|||
130292600|NCT00996801|469035763|FG001|Overall Study|Withdrawal by Subject|6|||
130292601|NCT00996801|469035764|FG002|Overall Study|Withdrawal by Subject|9|||
130292602|NCT00996801|469035765|FG003|Overall Study|Withdrawal by Subject|5|||
130292603|NCT00996801|469035766|FG004|Overall Study|Withdrawal by Subject|5|||
130292604|NCT00996801|469035767|FG005|Overall Study|Withdrawal by Subject|9|||
130292605|NCT02804750|469035768|FG000|Period 1|Adverse Event|0|||
130292606|NCT02804750|469035769|FG001|Period 1|Adverse Event|2|||
130292607|NCT02804750|469035768|FG000|Period 1|Withdrawal by Subject|0|||
130292608|NCT02804750|469035769|FG001|Period 1|Withdrawal by Subject|1|||
130292609|NCT02804750|469035768|FG000|Period 2|Adverse Event|1|||
130292610|NCT02804750|469035769|FG001|Period 2|Adverse Event|0|||
130292611|NCT02804750|469035768|FG000|Period 3|Adverse Event|0|||
130292612|NCT02804750|469035769|FG001|Period 3|Adverse Event|2|||
130292613|NCT02804750|469035768|FG000|Period 4|Adverse Event|0|||
130292614|NCT02804750|469035769|FG001|Period 4|Adverse Event|5|||
130292615|NCT01657760|469035773|FG000|Overall Study|Withdrawal by Subject|0|||
130292616|NCT01657760|469035774|FG001|Overall Study|Withdrawal by Subject|0|||
130292617|NCT01657760|469035775|FG002|Overall Study|Withdrawal by Subject|0|||
130292618|NCT01657760|469035776|FG003|Overall Study|Withdrawal by Subject|1|||
130292619|NCT01657760|469035773|FG000|Overall Study|Physician Decision|1|||
130292620|NCT01657760|469035774|FG001|Overall Study|Physician Decision|1|||
130292621|NCT01657760|469035775|FG002|Overall Study|Physician Decision|1|||
130292622|NCT01657760|469035776|FG003|Overall Study|Physician Decision|2|||
130292623|NCT00940485|469035781|FG000|Overall Study|HBeAb positive at Baseline|3|||
130292624|NCT00940485|469035782|FG001|Overall Study|HBeAb positive at Baseline|2|||
130292625|NCT00940485|469035781|FG000|Overall Study|Lost to Follow-up|2|||
130292626|NCT00940485|469035782|FG001|Overall Study|Lost to Follow-up|3|||
130292627|NCT00940485|469035781|FG000|Overall Study|Adverse Event|8|||
130292628|NCT00940485|469035782|FG001|Overall Study|Adverse Event|0|||
130292629|NCT00940485|469035781|FG000|Overall Study|Withdrawal by Subject|1|||
130292630|NCT00940485|469035782|FG001|Overall Study|Withdrawal by Subject|1|||
130292631|NCT00940485|469035781|FG000|Overall Study|Others|1|||
130292632|NCT00940485|469035782|FG001|Overall Study|Others|1|||
130292633|NCT06250738|469035788|FG000|Overall Study|Lost to Follow-up|1|||
130292634|NCT02936284|469035790|FG000|Overall Study|Withdrawal by Subject|3|||
130292635|NCT02936284|469035791|FG001|Overall Study|Withdrawal by Subject|1|||
130292636|NCT02936284|469035790|FG000|Overall Study|Lost to Follow-up|7|||
130292637|NCT02936284|469035791|FG001|Overall Study|Lost to Follow-up|8|||
130292638|NCT01068249|469035794|FG000|Overall Study|Death|1|||
130292639|NCT01068249|469035794|FG000|Overall Study|Withdrawal by Subject|3|||
130292640|NCT03921554|469035797|FG000|Overall Study|Adverse Event|2|||
130292641|NCT03921554|469035797|FG000|Overall Study|Withdrawal by Subject|1|||
130292642|NCT03921554|469035797|FG000|Overall Study|Death|3|||
130292643|NCT01146652|469035802|FG000|Overall Study|Adverse Event|506|||
130292644|NCT01146652|469035803|FG001|Overall Study|Adverse Event|15|||
130292645|NCT01146652|469035802|FG000|Overall Study|Lack of Efficacy|91|||
130292646|NCT01146652|469035803|FG001|Overall Study|Lack of Efficacy|7|||
130292647|NCT01146652|469035802|FG000|Overall Study|Poor compliance to protocol|38|||
130292648|NCT01146652|469035803|FG001|Overall Study|Poor compliance to protocol|1|||
130292649|NCT01146652|469035802|FG000|Overall Study|Other unspecified reasons|314|||
130292650|NCT01146652|469035803|FG001|Overall Study|Other unspecified reasons|22|||
130292651|NCT01146652|469035802|FG000|Overall Study|Enrolled but not treated|2|||
130292652|NCT01146652|469035803|FG001|Overall Study|Enrolled but not treated|0|||
130292653|NCT03455829|469035807|FG000|Overall Study|Death|2|||
130292654|NCT03455829|469035808|FG001|Overall Study|Death|3|||
130292655|NCT03455829|469035809|FG002|Overall Study|Death|2|||
130292656|NCT03455829|469035810|FG003|Overall Study|Death|4|||
130292657|NCT03455829|469035811|FG004|Overall Study|Death|2|||
130292658|NCT03455829|469035807|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
130292659|NCT03455829|469035808|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
130292660|NCT03455829|469035809|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
130292661|NCT03455829|469035810|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
130292662|NCT03455829|469035811|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
130292663|NCT03455829|469035807|FG000|Overall Study|Disease progression|0|||
130292664|NCT03455829|469035808|FG001|Overall Study|Disease progression|0|||
130292665|NCT03455829|469035809|FG002|Overall Study|Disease progression|0|||
130292666|NCT03455829|469035810|FG003|Overall Study|Disease progression|1|||
130292667|NCT03455829|469035811|FG004|Overall Study|Disease progression|1|||
130292668|NCT00096018|469035819|FG000|Overall Study|Became Ineligible (not treated)|0|||
130292669|NCT00096018|469035820|FG001|Overall Study|Became Ineligible (not treated)|3|||
130292670|NCT00096018|469035819|FG000|Overall Study|Miscellaneous (not treated)|0|||
130292671|NCT00096018|469035820|FG001|Overall Study|Miscellaneous (not treated)|2|||
129888411|NCT01383993|467549150|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
129888412|NCT00795132|467549154|FG000|Overall Study|Death|1|||
129888413|NCT00795132|467549154|FG000|Overall Study|Relapse|2|||
129888414|NCT02561455|467549155|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
129888415|NCT02561455|467549156|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
129888416|NCT02561455|467549157|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
129888417|NCT02561455|467549158|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
129888418|NCT02561455|467549155|FG000|Overall Study|Withdrawal by Subject|1|||
129888419|NCT02561455|467549156|FG001|Overall Study|Withdrawal by Subject|0|||
129888420|NCT02561455|467549157|FG002|Overall Study|Withdrawal by Subject|1|||
129888421|NCT02561455|467549158|FG003|Overall Study|Withdrawal by Subject|0|||
129888422|NCT02561455|467549155|FG000|Overall Study|Disease Progression|0|||
129888423|NCT02561455|467549156|FG001|Overall Study|Disease Progression|1|||
129888424|NCT02561455|467549157|FG002|Overall Study|Disease Progression|0|||
129888425|NCT02561455|467549158|FG003|Overall Study|Disease Progression|0|||
129888426|NCT02451930|467549159|FG000|Overall Study|Death|0|||
129888427|NCT02451930|467549160|FG001|Overall Study|Death|15|||
129888428|NCT02451930|467549159|FG000|Overall Study|Lost to Follow-up|0|||
129888429|NCT02451930|467549160|FG001|Overall Study|Lost to Follow-up|3|||
129888430|NCT02451930|467549159|FG000|Overall Study|Sponsor Decision|2|||
129888431|NCT02451930|467549160|FG001|Overall Study|Sponsor Decision|10|||
129888432|NCT02451930|467549159|FG000|Overall Study|Withdrawal by Subject|0|||
129888433|NCT02451930|467549160|FG001|Overall Study|Withdrawal by Subject|1|||
129888434|NCT02451930|467549159|FG000|Overall Study|Other|0|||
129888435|NCT02451930|467549160|FG001|Overall Study|Other|1|||
129888436|NCT03685708|467549167|FG000|Overall Study|Withdrawal by Subject|0|||
129888437|NCT03685708|467549168|FG001|Overall Study|Withdrawal by Subject|0|||
129888438|NCT03685708|467549169|FG002|Overall Study|Withdrawal by Subject|1|||
129888439|NCT03685708|467549167|FG000|Overall Study|Screen Fail|0|||
129888440|NCT03685708|467549168|FG001|Overall Study|Screen Fail|1|||
129888441|NCT03685708|467549169|FG002|Overall Study|Screen Fail|1|||
129888442|NCT03685708|467549167|FG000|Overall Study|COVID 19 Pandemic|1|||
129888443|NCT03685708|467549168|FG001|Overall Study|COVID 19 Pandemic|1|||
129888444|NCT03685708|467549169|FG002|Overall Study|COVID 19 Pandemic|6|||
129888445|NCT03685708|467549167|FG000|Overall Study|Disease Progression|0|||
129888446|NCT03685708|467549168|FG001|Overall Study|Disease Progression|0|||
129888447|NCT03685708|467549169|FG002|Overall Study|Disease Progression|1|||
129888448|NCT04006366|467549170|FG000|Overall Study|Withdrawal by Subject|1|||
129888449|NCT00627042|467549177|FG000|Overall Study|Withdrawal by Subject|2|||
129888450|NCT02268552|467549178|FG000|Part 1|Death|1|||
129888451|NCT02268552|467549179|FG001|Part 1|Death|1|||
129888452|NCT02268552|467549180|FG002|Part 1|Death|1|||
129888453|NCT02268552|467549181|FG003|Part 1|Death|2|||
130045906|NCT02075255|468125628|FG002|Overall Study|Adverse Event|1|||
130292672|NCT00096018|469035819|FG000|Overall Study|Adverse Event|0|||
130292673|NCT00096018|469035820|FG001|Overall Study|Adverse Event|5|||
130292674|NCT00096018|469035819|FG000|Overall Study|Death|0|||
130292675|NCT00096018|469035820|FG001|Overall Study|Death|1|||
130292676|NCT00096018|469035819|FG000|Overall Study|Withdrawal by Subject|0|||
130292677|NCT00096018|469035820|FG001|Overall Study|Withdrawal by Subject|2|||
130292678|NCT00096018|469035819|FG000|Overall Study|Miscellaneous|2|||
130292679|NCT00096018|469035820|FG001|Overall Study|Miscellaneous|1|||
130292680|NCT03689712|469035821|FG000|Overall Study|Adverse Event|1|||
130292681|NCT03689712|469035822|FG001|Overall Study|Adverse Event|0|||
130292682|NCT03689712|469035821|FG000|Overall Study|Death|20|||
130292683|NCT03689712|469035822|FG001|Overall Study|Death|10|||
129888454|NCT02268552|467549182|FG004|Part 1|Death|0|||
129888455|NCT02268552|467549183|FG005|Part 1|Death|0|||
129888456|NCT02268552|467549184|FG006|Part 1|Death|0|||
130292684|NCT03689712|469035821|FG000|Overall Study|Lost to Follow-up|6|||
130292685|NCT03689712|469035822|FG001|Overall Study|Lost to Follow-up|6|||
129888457|NCT02268552|467549178|FG000|Part 1|Subject/guardian decision|0|||
129888458|NCT02268552|467549179|FG001|Part 1|Subject/guardian decision|0|||
130045907|NCT02075255|468125626|FG000|Overall Study|Death|0|||
129888459|NCT02268552|467549180|FG002|Part 1|Subject/guardian decision|0|||
129888460|NCT02268552|467549181|FG003|Part 1|Subject/guardian decision|1|||
130045908|NCT02075255|468125627|FG001|Overall Study|Death|2|||
130292686|NCT03689712|469035821|FG000|Overall Study|Other|1|||
130292687|NCT03689712|469035822|FG001|Overall Study|Other|0|||
130292688|NCT03689712|469035821|FG000|Overall Study|Patient Non-Compliance|0|||
130292689|NCT03689712|469035822|FG001|Overall Study|Patient Non-Compliance|1|||
130292690|NCT03689712|469035821|FG000|Overall Study|Withdrawal by Subject|20|||
130292691|NCT03689712|469035822|FG001|Overall Study|Withdrawal by Subject|4|||
130292692|NCT03689712|469035821|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
130292693|NCT03689712|469035822|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
130292694|NCT03689712|469035821|FG000|Overall Study|Randomized but not Treated|13|||
130292695|NCT03689712|469035822|FG001|Overall Study|Randomized but not Treated|7|||
130292696|NCT03689712|469035821|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
130292697|NCT03689712|469035822|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
130292698|NCT00689793|469035823|FG000|Overall Study|Lost to Follow-up|4|||
130292699|NCT00689793|469035824|FG001|Overall Study|Lost to Follow-up|5|||
130292700|NCT03968159|469035825|FG000|Overall Study|Adverse Event|4|||
130292701|NCT03968159|469035826|FG001|Overall Study|Adverse Event|4|||
130292702|NCT03968159|469035825|FG000|Overall Study|Lost to Follow-up|1|||
130292703|NCT03968159|469035826|FG001|Overall Study|Lost to Follow-up|1|||
130292704|NCT03968159|469035825|FG000|Overall Study|Use of prohibited medication|0|||
130292705|NCT03968159|469035826|FG001|Overall Study|Use of prohibited medication|1|||
130292706|NCT03968159|469035825|FG000|Overall Study|Protocol Violation|2|||
130292707|NCT03968159|469035826|FG001|Overall Study|Protocol Violation|2|||
130292708|NCT03968159|469035825|FG000|Overall Study|Withdrawal by Subject|4|||
130292709|NCT03968159|469035826|FG001|Overall Study|Withdrawal by Subject|6|||
130292710|NCT03968159|469035825|FG000|Overall Study|Lack of Efficacy|0|||
130292711|NCT03968159|469035826|FG001|Overall Study|Lack of Efficacy|1|||
130292712|NCT03968159|469035825|FG000|Overall Study|Not further specified|2|||
130292713|NCT03968159|469035826|FG001|Overall Study|Not further specified|0|||
130292714|NCT03283150|469035827|FG000|Overall Study|Withdrawal by Subject|6|||
130292715|NCT03283150|469035828|FG001|Overall Study|Withdrawal by Subject|0|||
130292716|NCT03283150|469035829|FG002|Overall Study|Withdrawal by Subject|0|||
130292717|NCT00864851|469035830|FG000|Overall Study|Withdrawal by Subject|0|||
130292718|NCT00864851|469035831|FG001|Overall Study|Withdrawal by Subject|1|||
130292719|NCT00864851|469035832|FG002|Overall Study|Withdrawal by Subject|0|||
130292720|NCT00864851|469035830|FG000|Overall Study|Physician Decision|1|||
130292721|NCT00864851|469035831|FG001|Overall Study|Physician Decision|0|||
130292722|NCT00864851|469035832|FG002|Overall Study|Physician Decision|0|||
130292723|NCT00864851|469035830|FG000|Overall Study|Death|1|||
130292724|NCT00864851|469035831|FG001|Overall Study|Death|0|||
130292725|NCT00864851|469035832|FG002|Overall Study|Death|0|||
130292726|NCT00864851|469035830|FG000|Overall Study|Patient uncooperative|1|||
130292727|NCT00864851|469035831|FG001|Overall Study|Patient uncooperative|0|||
130292728|NCT00864851|469035832|FG002|Overall Study|Patient uncooperative|0|||
130292729|NCT01842581|469035836|FG000|Overall Study|Adverse Event|6|||
130292730|NCT01842581|469035837|FG001|Overall Study|Adverse Event|4|||
130292731|NCT01842581|469035836|FG000|Overall Study|HE breakthrough|26|||
130292732|NCT01842581|469035837|FG001|Overall Study|HE breakthrough|13|||
130045909|NCT02075255|468125628|FG002|Overall Study|Death|0|||
130292733|NCT01842581|469035836|FG000|Overall Study|Liver transplant|2|||
130292734|NCT01842581|469035837|FG001|Overall Study|Liver transplant|0|||
130292735|NCT01842581|469035836|FG000|Overall Study|Lost to Follow-up|2|||
130292736|NCT01842581|469035837|FG001|Overall Study|Lost to Follow-up|5|||
130292737|NCT01842581|469035836|FG000|Overall Study|Withdrawal by Subject|5|||
130292738|NCT01842581|469035837|FG001|Overall Study|Withdrawal by Subject|7|||
130292739|NCT01842581|469035836|FG000|Overall Study|Other than specified|3|||
130292740|NCT01842581|469035837|FG001|Overall Study|Other than specified|1|||
130292741|NCT00353873|469035838|FG000|Overall Study|Protocol Violation|1|||
130292742|NCT00353873|469035839|FG001|Overall Study|Protocol Violation|2|||
130292743|NCT00353873|469035838|FG000|Overall Study|Exacerbation|1|||
130292744|NCT00353873|469035839|FG001|Overall Study|Exacerbation|0|||
130292745|NCT00353873|469035838|FG000|Overall Study|Adverse Event|1|||
130292746|NCT00353873|469035839|FG001|Overall Study|Adverse Event|0|||
130292747|NCT00353873|469035838|FG000|Overall Study|Physician Decision|2|||
130292748|NCT00353873|469035839|FG001|Overall Study|Physician Decision|0|||
130292749|NCT00353873|469035838|FG000|Overall Study|Withdrawal by Subject|1|||
130292750|NCT00353873|469035839|FG001|Overall Study|Withdrawal by Subject|1|||
130292751|NCT02717130|469035840|FG000|Overall Study|Withdrawal by Subject|1|||
130292752|NCT02717130|469035840|FG000|Overall Study|Adverse Event|1|||
130292753|NCT02717130|469035840|FG000|Overall Study|Physician Decision|1|||
130292754|NCT02717130|469035840|FG000|Overall Study|Study Closure|4|||
130292755|NCT00106691|469035841|FG000|Overall Study|Adverse Event|60|||
130292756|NCT00106691|469035842|FG001|Overall Study|Adverse Event|64|||
130292757|NCT00106691|469035841|FG000|Overall Study|Lost to Follow-up|23|||
130292758|NCT00106691|469035842|FG001|Overall Study|Lost to Follow-up|18|||
130292759|NCT00106691|469035841|FG000|Overall Study|Physician Decision|18|||
130292760|NCT00106691|469035842|FG001|Overall Study|Physician Decision|21|||
130292761|NCT00106691|469035841|FG000|Overall Study|Protocol Violation|13|||
130292762|NCT00106691|469035842|FG001|Overall Study|Protocol Violation|18|||
130292763|NCT00106691|469035841|FG000|Overall Study|Withdrawal by Subject|75|||
130292764|NCT00106691|469035842|FG001|Overall Study|Withdrawal by Subject|70|||
130292765|NCT00106691|469035841|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
130292766|NCT00106691|469035842|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
130292767|NCT00106691|469035841|FG000|Overall Study|QTc>480|3|||
130292768|NCT00106691|469035842|FG001|Overall Study|QTc>480|1|||
130292769|NCT00106691|469035841|FG000|Overall Study|mililtary deployment|2|||
130292770|NCT00106691|469035842|FG001|Overall Study|mililtary deployment|0|||
129793562|NCT04761627|467212687|FG000|Run-in Period|Withdrawal by Subject|7|||
129793563|NCT04761627|467212688|FG001|Run-in Period|Withdrawal by Subject|0|||
129793564|NCT04761627|467212689|FG002|Run-in Period|Withdrawal by Subject|0|||
129793565|NCT04761627|467212687|FG000|Run-in Period|Did not meet PASI 50|15|||
129793566|NCT04761627|467212688|FG001|Run-in Period|Did not meet PASI 50|0|||
129793567|NCT04761627|467212689|FG002|Run-in Period|Did not meet PASI 50|0|||
129793568|NCT04761627|467212687|FG000|Run-in Period|Study site closure|2|||
129793569|NCT04761627|467212688|FG001|Run-in Period|Study site closure|0|||
129793570|NCT04761627|467212689|FG002|Run-in Period|Study site closure|0|||
129793571|NCT04761627|467212687|FG000|Run-in Period|Pregnancy|2|||
129793572|NCT04761627|467212688|FG001|Run-in Period|Pregnancy|0|||
129793573|NCT04761627|467212689|FG002|Run-in Period|Pregnancy|0|||
129793574|NCT04761627|467212687|FG000|Post-randomization Period|Military service|0|||
129793575|NCT04761627|467212688|FG001|Post-randomization Period|Military service|1|||
129793576|NCT04761627|467212689|FG002|Post-randomization Period|Military service|0|||
129793577|NCT04761627|467212687|FG000|Post-randomization Period|Adverse Event|0|||
129793578|NCT04761627|467212688|FG001|Post-randomization Period|Adverse Event|4|||
129793579|NCT04761627|467212689|FG002|Post-randomization Period|Adverse Event|2|||
129793580|NCT04761627|467212687|FG000|Post-randomization Period|Lost to Follow-up|0|||
129793581|NCT04761627|467212688|FG001|Post-randomization Period|Lost to Follow-up|6|||
129793582|NCT04761627|467212689|FG002|Post-randomization Period|Lost to Follow-up|6|||
129793583|NCT04761627|467212687|FG000|Post-randomization Period|Withdrawal by Subject|0|||
130292771|NCT00106691|469035841|FG000|Overall Study|Study Site Closing/PI Moved|1|||
130292772|NCT00106691|469035842|FG001|Overall Study|Study Site Closing/PI Moved|2|||
130292773|NCT00106691|469035841|FG000|Overall Study|Cardiologist recommendation|1|||
130292774|NCT00106691|469035842|FG001|Overall Study|Cardiologist recommendation|0|||
130292775|NCT00106691|469035841|FG000|Overall Study|Pt. moved to another state|1|||
130292776|NCT00106691|469035842|FG001|Overall Study|Pt. moved to another state|0|||
130292777|NCT00106691|469035841|FG000|Overall Study|Taking exclusionary avodart|1|||
130292778|NCT00106691|469035842|FG001|Overall Study|Taking exclusionary avodart|0|||
130292779|NCT00106691|469035841|FG000|Overall Study|Not able to discontinue plavix|0|||
130292780|NCT00106691|469035842|FG001|Overall Study|Not able to discontinue plavix|1|||
130292781|NCT00530920|469035843|FG000|Overall Study|Randomized but not treated|0|||
130292782|NCT00530920|469035844|FG001|Overall Study|Randomized but not treated|2|||
130292783|NCT00530920|469035845|FG002|Overall Study|Randomized but not treated|0|||
130292784|NCT00530920|469035843|FG000|Overall Study|Adverse Event|0|||
130292785|NCT00530920|469035844|FG001|Overall Study|Adverse Event|0|||
130292786|NCT00530920|469035845|FG002|Overall Study|Adverse Event|3|||
130292787|NCT00530920|469035843|FG000|Overall Study|Withdrawal by Subject|0|||
130292788|NCT00530920|469035844|FG001|Overall Study|Withdrawal by Subject|0|||
130292789|NCT00530920|469035845|FG002|Overall Study|Withdrawal by Subject|1|||
130292790|NCT04957758|469035847|FG000|Overall Study|Adverse Event|1|||
130292791|NCT04957758|469035848|FG001|Overall Study|Adverse Event|0|||
130292792|NCT04957758|469035847|FG000|Overall Study|Lost to Follow-up|0|||
130292793|NCT04957758|469035848|FG001|Overall Study|Lost to Follow-up|2|||
130292794|NCT04957758|469035847|FG000|Overall Study|Withdrawal by Subject|4|||
130292795|NCT04957758|469035848|FG001|Overall Study|Withdrawal by Subject|2|||
130292796|NCT04957758|469035847|FG000|Overall Study|Protocol Violation|0|||
130292797|NCT04957758|469035848|FG001|Overall Study|Protocol Violation|1|||
130292798|NCT00707746|469035849|FG000|Treatment Period|Adverse Event|2|||
130292799|NCT00707746|469035850|FG001|Treatment Period|Adverse Event|4|||
130292800|NCT00707746|469035849|FG000|Treatment Period|Ineligibility|0|||
130292801|NCT00707746|469035850|FG001|Treatment Period|Ineligibility|1|||
130292802|NCT00685373|469035853|FG000|Overall Study|Adverse Event|3|||
130292803|NCT00685373|469035853|FG000|Overall Study|Withdrawal by Subject|5|||
130292804|NCT00685373|469035853|FG000|Overall Study|Lack of Efficacy|3|||
129793584|NCT04761627|467212688|FG001|Post-randomization Period|Withdrawal by Subject|7|||
129793585|NCT04761627|467212689|FG002|Post-randomization Period|Withdrawal by Subject|6|||
129793586|NCT04761627|467212687|FG000|Post-randomization Period|Pregnancy|0|||
130292805|NCT00685373|469035853|FG000|Overall Study|Condition no longer requires study drug|1|||
130292806|NCT00685373|469035853|FG000|Overall Study|Lost to Follow-up|2|||
129793587|NCT04761627|467212688|FG001|Post-randomization Period|Pregnancy|0|||
129793588|NCT04761627|467212689|FG002|Post-randomization Period|Pregnancy|1|||
129793589|NCT04761627|467212687|FG000|Post-randomization Period|Study site closure|0|||
130292807|NCT00685373|469035853|FG000|Overall Study|Protocol Violation|1|||
130292808|NCT02642965|469035855|FG000|Overall Study|Lack of Efficacy|4|||
130292809|NCT02642965|469035855|FG000|Overall Study|Physician Decision|9|||
130292810|NCT03099148|469035858|FG000|Wash-out|scheduling conflict|0|||
130292811|NCT03099148|469035859|FG001|Wash-out|scheduling conflict|1|||
130292812|NCT03099148|469035860|FG002|Wash-out|scheduling conflict|0|||
130292813|NCT03099148|469035861|FG003|Wash-out|scheduling conflict|0|||
130292814|NCT03099148|469035858|FG000|Wash-out|Adverse Event|0|||
129888461|NCT02268552|467549182|FG004|Part 1|Subject/guardian decision|0|||
129888462|NCT02268552|467549183|FG005|Part 1|Subject/guardian decision|0|||
129888463|NCT02268552|467549184|FG006|Part 1|Subject/guardian decision|0|||
129888464|NCT02268552|467549178|FG000|Part 2|Death|0|||
129888465|NCT02268552|467549179|FG001|Part 2|Death|0|||
129888466|NCT02268552|467549180|FG002|Part 2|Death|0|||
129888467|NCT02268552|467549181|FG003|Part 2|Death|0|||
129888468|NCT02268552|467549182|FG004|Part 2|Death|0|||
129888469|NCT02268552|467549183|FG005|Part 2|Death|0|||
129888470|NCT02268552|467549184|FG006|Part 2|Death|2|||
129888471|NCT02268552|467549178|FG000|Part 2|Subject/guardian decision|0|||
129888472|NCT02268552|467549179|FG001|Part 2|Subject/guardian decision|0|||
129888473|NCT02268552|467549180|FG002|Part 2|Subject/guardian decision|0|||
129888474|NCT02268552|467549181|FG003|Part 2|Subject/guardian decision|0|||
129888475|NCT02268552|467549182|FG004|Part 2|Subject/guardian decision|0|||
129888476|NCT02268552|467549183|FG005|Part 2|Subject/guardian decision|0|||
129888477|NCT02268552|467549184|FG006|Part 2|Subject/guardian decision|1|||
129888478|NCT02268552|467549178|FG000|Part 3 Extension|Death|0|||
129888479|NCT02268552|467549179|FG001|Part 3 Extension|Death|1|||
130292815|NCT03099148|469035859|FG001|Wash-out|Adverse Event|1|||
130292816|NCT03099148|469035860|FG002|Wash-out|Adverse Event|0|||
129888480|NCT02268552|467549180|FG002|Part 3 Extension|Death|1|||
129888481|NCT02268552|467549181|FG003|Part 3 Extension|Death|1|||
129888482|NCT02268552|467549182|FG004|Part 3 Extension|Death|1|||
129888483|NCT02268552|467549183|FG005|Part 3 Extension|Death|1|||
129888484|NCT02268552|467549184|FG006|Part 3 Extension|Death|0|||
129888485|NCT02268552|467549178|FG000|Part 3 Extension|Early termination of trial|1|||
129888486|NCT02268552|467549179|FG001|Part 3 Extension|Early termination of trial|0|||
129888487|NCT02268552|467549180|FG002|Part 3 Extension|Early termination of trial|0|||
129888488|NCT02268552|467549181|FG003|Part 3 Extension|Early termination of trial|0|||
129888489|NCT02268552|467549182|FG004|Part 3 Extension|Early termination of trial|2|||
129888490|NCT02268552|467549183|FG005|Part 3 Extension|Early termination of trial|9|||
129888491|NCT02268552|467549184|FG006|Part 3 Extension|Early termination of trial|11|||
129888492|NCT02268552|467549178|FG000|Part 3 Extension|Subject/guardian decision|0|||
129888493|NCT02268552|467549179|FG001|Part 3 Extension|Subject/guardian decision|0|||
129888494|NCT02268552|467549180|FG002|Part 3 Extension|Subject/guardian decision|0|||
129888495|NCT02268552|467549181|FG003|Part 3 Extension|Subject/guardian decision|0|||
129888496|NCT02268552|467549182|FG004|Part 3 Extension|Subject/guardian decision|0|||
129888497|NCT02268552|467549183|FG005|Part 3 Extension|Subject/guardian decision|0|||
129888498|NCT02268552|467549184|FG006|Part 3 Extension|Subject/guardian decision|1|||
129888499|NCT00997243|467549185|FG000|Overall Study|Early termination of study by sponsor|7|||
129888500|NCT01349907|467549190|FG000|Overall Study|Adverse Event|37|||
129888501|NCT01349907|467549191|FG001|Overall Study|Adverse Event|11|||
129888502|NCT01349907|467549190|FG000|Overall Study|Treatment failure|13|||
129888503|NCT01349907|467549191|FG001|Overall Study|Treatment failure|4|||
129888504|NCT01349907|467549190|FG000|Overall Study|Lost to Follow-up|25|||
129888505|NCT01349907|467549191|FG001|Overall Study|Lost to Follow-up|6|||
129888506|NCT01349907|467549190|FG000|Overall Study|Withdrawal by Subject|30|||
129888507|NCT01349907|467549191|FG001|Overall Study|Withdrawal by Subject|8|||
129888508|NCT01349907|467549190|FG000|Overall Study|Protocol Violation|33|||
129888509|NCT01349907|467549191|FG001|Overall Study|Protocol Violation|13|||
129888510|NCT01349907|467549190|FG000|Overall Study|Administrative|1|||
129888511|NCT01349907|467549191|FG001|Overall Study|Administrative|1|||
129888512|NCT04011384|467549207|FG000|Overall Study|Withdrawal by Subject|2|||
129888513|NCT04011384|467549208|FG001|Overall Study|Withdrawal by Subject|0|||
129888514|NCT01686932|467549209|FG000|Period 1|Adverse Event|1|||
130292817|NCT03099148|469035861|FG003|Wash-out|Adverse Event|0|||
130292818|NCT01703065|469035862|FG000|Overall Study|Lack of Efficacy|1|||
129888515|NCT01686932|467549210|FG001|Period 1|Adverse Event|1|||
129888516|NCT01364727|467549213|FG000|Overall Study|Not Eligible|2|||
129888517|NCT04716881|467549214|FG000|Overall Study|Adverse Event|1|||
129888518|NCT04716881|467549214|FG000|Overall Study|Lost to Follow-up|1|||
129888519|NCT01558674|467549215|FG000|Part 1|Study Terminated by Sponsor|10|||
129888520|NCT01558674|467549216|FG001|Part 1|Study Terminated by Sponsor|0|||
129888521|NCT01558674|467549215|FG000|Part 1|Withdrawal by Subject|1|||
129888522|NCT01558674|467549216|FG001|Part 1|Withdrawal by Subject|0|||
129888523|NCT04147260|467549217|FG000|Overall Study|Adverse Event|1|||
129888524|NCT04147260|467549218|FG001|Overall Study|Adverse Event|0|||
129888525|NCT04147260|467549219|FG002|Overall Study|Adverse Event|1|||
129888526|NCT04147260|467549220|FG003|Overall Study|Adverse Event|2|||
129888527|NCT04147260|467549221|FG004|Overall Study|Adverse Event|0|||
130292819|NCT01703065|469035863|FG001|Overall Study|Lack of Efficacy|0|||
130292820|NCT01439126|469035864|FG000|Overall Study|Adverse Event|2|||
130292821|NCT01439126|469035865|FG001|Overall Study|Adverse Event|0|||
130292822|NCT01439126|469035864|FG000|Overall Study|Withdrawal by Subject|5|||
130292823|NCT01439126|469035865|FG001|Overall Study|Withdrawal by Subject|21|||
130292824|NCT01439126|469035864|FG000|Overall Study|Protocol Violation|6|||
130292825|NCT01439126|469035865|FG001|Overall Study|Protocol Violation|4|||
130292826|NCT01439126|469035864|FG000|Overall Study|Lost to Follow-up|6|||
130292827|NCT01439126|469035865|FG001|Overall Study|Lost to Follow-up|3|||
130292828|NCT01439126|469035864|FG000|Overall Study|Other-Use of prohibited treatment|0|||
130292829|NCT01439126|469035865|FG001|Overall Study|Other-Use of prohibited treatment|2|||
130292830|NCT01439126|469035864|FG000|Overall Study|Other-Miscellaneous|12|||
130292831|NCT01439126|469035865|FG001|Overall Study|Other-Miscellaneous|12|||
130292832|NCT01617447|469035866|FG000|Overall Study|Adverse Event|0|||
130292833|NCT01617447|469035867|FG001|Overall Study|Adverse Event|1|||
130292834|NCT01617447|469035866|FG000|Overall Study|Physician Decision|0|||
130292835|NCT01617447|469035867|FG001|Overall Study|Physician Decision|2|||
130292836|NCT02713529|469035869|FG000|Overall Study|Withdrawal by Subject|3|||
130292837|NCT02713529|469035870|FG001|Overall Study|Withdrawal by Subject|1|||
130292838|NCT02713529|469035871|FG002|Overall Study|Withdrawal by Subject|4|||
130292839|NCT02713529|469035872|FG003|Overall Study|Withdrawal by Subject|2|||
130292840|NCT02713529|469035873|FG004|Overall Study|Withdrawal by Subject|0|||
130292841|NCT02713529|469035874|FG005|Overall Study|Withdrawal by Subject|1|||
130292842|NCT02713529|469035875|FG006|Overall Study|Withdrawal by Subject|1|||
130292843|NCT02713529|469035869|FG000|Overall Study|Lost to Follow-up|1|||
130292844|NCT02713529|469035870|FG001|Overall Study|Lost to Follow-up|0|||
130292845|NCT02713529|469035871|FG002|Overall Study|Lost to Follow-up|1|||
130292846|NCT02713529|469035872|FG003|Overall Study|Lost to Follow-up|0|||
130292847|NCT02713529|469035873|FG004|Overall Study|Lost to Follow-up|0|||
130292848|NCT02713529|469035874|FG005|Overall Study|Lost to Follow-up|0|||
130292849|NCT02713529|469035875|FG006|Overall Study|Lost to Follow-up|0|||
130292850|NCT02713529|469035869|FG000|Overall Study|Death|3|||
130292851|NCT02713529|469035870|FG001|Overall Study|Death|3|||
130292852|NCT02713529|469035871|FG002|Overall Study|Death|26|||
130292853|NCT02713529|469035872|FG003|Overall Study|Death|27|||
130292854|NCT02713529|469035873|FG004|Overall Study|Death|3|||
130292855|NCT02713529|469035874|FG005|Overall Study|Death|13|||
130292856|NCT02713529|469035875|FG006|Overall Study|Death|3|||
130292857|NCT02827500|469035876|FG000|Overall Study|Death|7|||
130292858|NCT02827500|469035877|FG001|Overall Study|Death|3|||
130292859|NCT02827500|469035876|FG000|Overall Study|Lost to Follow-up|1|||
130292860|NCT02827500|469035877|FG001|Overall Study|Lost to Follow-up|1|||
130292861|NCT02827500|469035876|FG000|Overall Study|Withdrawal by Subject|3|||
130292862|NCT02827500|469035877|FG001|Overall Study|Withdrawal by Subject|1|||
130292863|NCT02827500|469035876|FG000|Overall Study|Missing primary endpoint data|3|||
130292864|NCT02827500|469035877|FG001|Overall Study|Missing primary endpoint data|1|||
129793590|NCT04761627|467212688|FG001|Post-randomization Period|Study site closure|0|||
129793591|NCT04761627|467212689|FG002|Post-randomization Period|Study site closure|1|||
129793592|NCT04761627|467212687|FG000|Post-randomization Period|Family planning|0|||
129793593|NCT04761627|467212688|FG001|Post-randomization Period|Family planning|1|||
129793594|NCT04761627|467212689|FG002|Post-randomization Period|Family planning|0|||
129793595|NCT01214174|467212690|FG000|Overall Study|Withdrawal by Subject|0|||
129793596|NCT01214174|467212691|FG001|Overall Study|Withdrawal by Subject|0|||
129793597|NCT01214174|467212692|FG002|Overall Study|Withdrawal by Subject|1|||
129793598|NCT01634178|467212695|FG000|Treatment Period 1|Adverse Event|0|||
129793599|NCT01634178|467212696|FG001|Treatment Period 1|Adverse Event|1|||
129793600|NCT01634178|467212695|FG000|Treatment Period 2|Adverse Event|1|||
129793601|NCT01634178|467212696|FG001|Treatment Period 2|Adverse Event|0|||
129793602|NCT05867342|467212697|FG000|Overall Study|Investigator Decision|3|||
129793603|NCT05867342|467212698|FG001|Overall Study|Investigator Decision|3|||
129793604|NCT00991952|467212700|FG000|Overall Study|Adverse Event|0|||
129793605|NCT00991952|467212701|FG001|Overall Study|Adverse Event|1|||
129793606|NCT00582816|467212702|FG000|Overall Study|Engraftment Failure|3|||
129793607|NCT01609478|467212705|FG000|Overall Study|Adverse Event|3|||
130292865|NCT02827500|469035876|FG000|Overall Study|Other|5|||
130292866|NCT02827500|469035877|FG001|Overall Study|Other|1|||
130292867|NCT02308488|469035878|FG000|Overall Study|Withdrawal by Subject|2|||
130292868|NCT02242981|469035879|FG000|Overall Study|Withdrawal by Subject|1|||
130292869|NCT02644356|469035885|FG000|Overall Study|Withdrawal by Subject|2|||
130292870|NCT00897390|469035887|FG000|Overall Study|Adverse Event|2|||
130292871|NCT00897390|469035887|FG000|Overall Study|No Longer Met Study Criteria|1|||
130292872|NCT00897390|469035887|FG000|Overall Study|Personal Reasons|1|||
129793608|NCT01609478|467212706|FG001|Overall Study|Adverse Event|1|||
129793609|NCT01609478|467212707|FG002|Overall Study|Adverse Event|5|||
129793610|NCT01609478|467212705|FG000|Overall Study|Protocol Deviation|0|||
129793611|NCT01609478|467212706|FG001|Overall Study|Protocol Deviation|1|||
129793612|NCT01609478|467212707|FG002|Overall Study|Protocol Deviation|1|||
129793613|NCT01609478|467212705|FG000|Overall Study|Non-Compliance with study treatment|1|||
130292873|NCT00897390|469035887|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
130292874|NCT02564978|469035889|FG000|Overall Study|Adverse Event|8|||
130292875|NCT02564978|469035889|FG000|Overall Study|Death|1|||
130292876|NCT02564978|469035889|FG000|Overall Study|Lost to Follow-up|1|||
130292877|NCT02564978|469035889|FG000|Overall Study|Withdrawal by Subject|15|||
130045910|NCT01088412|468125629|FG000|Overall Study|Adverse Event|38|||
130045911|NCT01088412|468125630|FG001|Overall Study|Adverse Event|0|||
130045912|NCT01088412|468125631|FG002|Overall Study|Adverse Event|0|||
130045913|NCT01088412|468125629|FG000|Overall Study|Death|42|||
130045914|NCT01088412|468125630|FG001|Overall Study|Death|6|||
130045915|NCT01088412|468125631|FG002|Overall Study|Death|0|||
130045916|NCT01088412|468125629|FG000|Overall Study|Other Reason per Case Report Form|2089|||
130045917|NCT01088412|468125630|FG001|Overall Study|Other Reason per Case Report Form|103|||
130045918|NCT01088412|468125631|FG002|Overall Study|Other Reason per Case Report Form|9|||
130045919|NCT01088412|468125629|FG000|Overall Study|Withdrawal by Subject|1761|||
130045920|NCT01088412|468125630|FG001|Overall Study|Withdrawal by Subject|25|||
130045921|NCT01088412|468125631|FG002|Overall Study|Withdrawal by Subject|1|||
130045922|NCT01088412|468125629|FG000|Overall Study|Received Another GH Product|79|||
130045923|NCT01088412|468125630|FG001|Overall Study|Received Another GH Product|0|||
130045924|NCT01088412|468125631|FG002|Overall Study|Received Another GH Product|0|||
130045925|NCT01088412|468125629|FG000|Overall Study|Participant Moved|601|||
130045926|NCT01088412|468125630|FG001|Overall Study|Participant Moved|21|||
130045927|NCT01088412|468125631|FG002|Overall Study|Participant Moved|2|||
129888528|NCT04147260|467549217|FG000|Overall Study|Withdrawal by Subject|0|||
129888529|NCT04147260|467549218|FG001|Overall Study|Withdrawal by Subject|0|||
129888530|NCT04147260|467549219|FG002|Overall Study|Withdrawal by Subject|1|||
129888531|NCT04147260|467549220|FG003|Overall Study|Withdrawal by Subject|1|||
129888532|NCT04147260|467549221|FG004|Overall Study|Withdrawal by Subject|0|||
129888533|NCT01734850|467549226|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
129888534|NCT01734850|467549227|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
129888535|NCT01734850|467549228|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
129888536|NCT01734850|467549226|FG000|Overall Study|Not infused due to manufacturing failure|0|||
129888537|NCT01734850|467549227|FG001|Overall Study|Not infused due to manufacturing failure|0|||
129888538|NCT01734850|467549228|FG002|Overall Study|Not infused due to manufacturing failure|1|||
129888539|NCT02204293|467549229|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
129888540|NCT02204293|467549230|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
129888541|NCT02204293|467549231|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
129888542|NCT02204293|467549232|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
129888543|NCT02204293|467549233|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
129888544|NCT02204293|467549234|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
129888545|NCT02204293|467549229|FG000|Core Study Part I|Adverse Event|1|||
129888546|NCT02204293|467549230|FG001|Core Study Part I|Adverse Event|0|||
130045928|NCT01088412|468125629|FG000|Overall Study|Physician Decision|1041|||
130292878|NCT02564978|469035889|FG000|Overall Study|Early Study Closure|2|||
129793614|NCT01609478|467212706|FG001|Overall Study|Non-Compliance with study treatment|0|||
129793615|NCT01609478|467212707|FG002|Overall Study|Non-Compliance with study treatment|0|||
129793616|NCT01609478|467212705|FG000|Overall Study|Physician Decision|1|||
129793617|NCT01609478|467212706|FG001|Overall Study|Physician Decision|0|||
129793618|NCT01609478|467212707|FG002|Overall Study|Physician Decision|1|||
129793619|NCT01609478|467212705|FG000|Overall Study|Withdrawal by Subject|2|||
129793620|NCT01609478|467212706|FG001|Overall Study|Withdrawal by Subject|0|||
129793621|NCT01609478|467212707|FG002|Overall Study|Withdrawal by Subject|2|||
129793622|NCT04966741|467212708|FG000|Overall Study|Lost to Follow-up|1|||
129793623|NCT04966741|467212709|FG001|Overall Study|Lost to Follow-up|0|||
129793624|NCT02522871|467212717|FG000|Overall Study|Protocol Violation|1|||
129793625|NCT02522871|467212718|FG001|Overall Study|Protocol Violation|4|||
129793626|NCT02522871|467212717|FG000|Overall Study|Treated without randomization|1|||
129793627|NCT02522871|467212718|FG001|Overall Study|Treated without randomization|0|||
129793628|NCT02522871|467212717|FG000|Overall Study|Death|9|||
129793629|NCT02522871|467212718|FG001|Overall Study|Death|9|||
129793630|NCT02522871|467212717|FG000|Overall Study|Died in operating room prior to transplant|0|||
129793631|NCT02522871|467212718|FG001|Overall Study|Died in operating room prior to transplant|1|||
129793632|NCT00725842|467212719|FG000|Overall Study|Lost to Follow-up|19|||
129793633|NCT00725842|467212719|FG000|Overall Study|Death|1|||
129793634|NCT00725842|467212719|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
129793635|NCT00725842|467212719|FG000|Overall Study|Consent date prior to study start date|5|||
129793636|NCT00725842|467212719|FG000|Overall Study|Inclusion criterion not met|1|||
129793637|NCT00725842|467212719|FG000|Overall Study|No Visit 1 data|1|||
129793638|NCT01715129|467212720|FG000|Overall Study|Adverse Event, fatal|1|||
129793639|NCT01715129|467212720|FG000|Overall Study|Lack of Efficacy|3|||
129793640|NCT01715129|467212720|FG000|Overall Study|Protocol Violation|1|||
129793641|NCT01715129|467212720|FG000|Overall Study|Consent Withdrawn|2|||
129793642|NCT01715129|467212720|FG000|Overall Study|Lost to Follow-up|1|||
129793643|NCT01715129|467212720|FG000|Overall Study|Other|1|||
129793644|NCT02793622|467212721|FG000|Overall Study|Lost to Follow-up|31|||
130045929|NCT01088412|468125630|FG001|Overall Study|Physician Decision|8|||
130045930|NCT01088412|468125631|FG002|Overall Study|Physician Decision|4|||
130045931|NCT01088412|468125629|FG000|Overall Study|Sponsor Decision|4467|||
130045932|NCT01088412|468125630|FG001|Overall Study|Sponsor Decision|79|||
130045933|NCT01088412|468125631|FG002|Overall Study|Sponsor Decision|23|||
130292879|NCT02564978|469035889|FG000|Overall Study|Other Reason|5|||
130292880|NCT01825941|469037451|FG000|Overall Study|Lost to Follow-up|4|||
130292881|NCT01825941|469037452|FG001|Overall Study|Lost to Follow-up|1|||
130292882|NCT00203021|469037453|FG000|Overall Study|Death|4|||
130292883|NCT00203021|469037454|FG001|Overall Study|Death|1|||
130292884|NCT00203021|469037453|FG000|Overall Study|Adverse Event|10|||
130292885|NCT00203021|469037454|FG001|Overall Study|Adverse Event|5|||
130292886|NCT00203021|469037453|FG000|Overall Study|Withdrawal by Subject|45|||
130292887|NCT00203021|469037454|FG001|Overall Study|Withdrawal by Subject|48|||
130292888|NCT00203021|469037453|FG000|Overall Study|Lost to Follow-up|9|||
129793645|NCT02793622|467212722|FG001|Overall Study|Lost to Follow-up|19|||
129793646|NCT02793622|467212721|FG000|Overall Study|Withdrawal by Subject|21|||
129793647|NCT02793622|467212722|FG001|Overall Study|Withdrawal by Subject|17|||
129793648|NCT02793622|467212721|FG000|Overall Study|Adverse Event|0|||
129793649|NCT02793622|467212722|FG001|Overall Study|Adverse Event|1|||
129793650|NCT02793622|467212721|FG000|Overall Study|Protocol Violation|1|||
129793651|NCT02793622|467212722|FG001|Overall Study|Protocol Violation|5|||
129793652|NCT00722371|467212723|FG000|Overall Study|Adverse Event|6|||
129793653|NCT00722371|467212724|FG001|Overall Study|Adverse Event|13|||
129793654|NCT00722371|467212725|FG002|Overall Study|Adverse Event|9|||
129793655|NCT00722371|467212726|FG003|Overall Study|Adverse Event|10|||
129793656|NCT00722371|467212727|FG004|Overall Study|Adverse Event|6|||
129793657|NCT00722371|467212728|FG005|Overall Study|Adverse Event|8|||
129793658|NCT00722371|467212729|FG006|Overall Study|Adverse Event|4|||
129793659|NCT00722371|467212723|FG000|Overall Study|Contraindication|0|||
129793660|NCT00722371|467212724|FG001|Overall Study|Contraindication|0|||
130292889|NCT00203021|469037454|FG001|Overall Study|Lost to Follow-up|7|||
130292890|NCT00203021|469037453|FG000|Overall Study|Other than specified|11|||
130292891|NCT00203021|469037454|FG001|Overall Study|Other than specified|16|||
130292892|NCT04284813|469037464|FG000|Overall Study|Withdrawal by Subject|1|||
130292893|NCT00431951|469037465|FG000|Overall Study|Inability to follow study procedures|1|||
130292894|NCT00431951|469037466|FG001|Overall Study|Inability to follow study procedures|0|||
130292895|NCT00431951|469037467|FG002|Overall Study|Inability to follow study procedures|1|||
130292896|NCT00431951|469037468|FG003|Overall Study|Inability to follow study procedures|2|||
130292897|NCT00431951|469037465|FG000|Overall Study|Lost to Follow-up|0|||
130292898|NCT00431951|469037466|FG001|Overall Study|Lost to Follow-up|1|||
130292899|NCT00431951|469037467|FG002|Overall Study|Lost to Follow-up|0|||
130292900|NCT00431951|469037468|FG003|Overall Study|Lost to Follow-up|0|||
130292901|NCT00431951|469037465|FG000|Overall Study|Withdrawal by Subject|0|||
130292902|NCT00431951|469037466|FG001|Overall Study|Withdrawal by Subject|1|||
130292903|NCT00431951|469037467|FG002|Overall Study|Withdrawal by Subject|0|||
129793661|NCT00722371|467212725|FG002|Overall Study|Contraindication|1|||
129793662|NCT00722371|467212726|FG003|Overall Study|Contraindication|0|||
129793663|NCT00722371|467212727|FG004|Overall Study|Contraindication|0|||
129793664|NCT00722371|467212728|FG005|Overall Study|Contraindication|0|||
129793665|NCT00722371|467212729|FG006|Overall Study|Contraindication|0|||
129793666|NCT00722371|467212723|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
129793667|NCT00722371|467212724|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
129793668|NCT00722371|467212725|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
129793669|NCT00722371|467212726|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
129888547|NCT02204293|467549231|FG002|Core Study Part I|Adverse Event|0|||
129888548|NCT02204293|467549232|FG003|Core Study Part I|Adverse Event|0|||
130106502|NCT01898884|468350059|FG004|Multiple Dose Period|Adverse Event|0|||
130106503|NCT01898884|468350060|FG005|Multiple Dose Period|Adverse Event|0|||
130106504|NCT01898884|468350061|FG006|Multiple Dose Period|Adverse Event|1|||
130106505|NCT01898884|468350062|FG007|Multiple Dose Period|Adverse Event|0|||
130292904|NCT00431951|469037468|FG003|Overall Study|Withdrawal by Subject|0|||
130292905|NCT00431951|469037465|FG000|Overall Study|Adverse Event|0|||
130292906|NCT00431951|469037466|FG001|Overall Study|Adverse Event|0|||
130292907|NCT00431951|469037467|FG002|Overall Study|Adverse Event|1|||
130292908|NCT00431951|469037468|FG003|Overall Study|Adverse Event|0|||
129793670|NCT00722371|467212727|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
129793671|NCT00722371|467212728|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
129793672|NCT00722371|467212729|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
129793673|NCT00722371|467212723|FG000|Overall Study|Excluded medication|0|||
129793674|NCT00722371|467212724|FG001|Overall Study|Excluded medication|1|||
129793675|NCT00722371|467212725|FG002|Overall Study|Excluded medication|1|||
129793676|NCT00722371|467212726|FG003|Overall Study|Excluded medication|0|||
130292909|NCT01146288|469037469|FG000|First Intervention(1 Day)|Adverse Event|0|||
130045934|NCT01088412|468125629|FG000|Overall Study|Third Party Required to Change Brand|487|||
130045935|NCT01088412|468125630|FG001|Overall Study|Third Party Required to Change Brand|0|||
130045936|NCT01088412|468125631|FG002|Overall Study|Third Party Required to Change Brand|0|||
130045937|NCT01088412|468125629|FG000|Overall Study|Lost to Follow-up|3052|||
130045938|NCT01088412|468125630|FG001|Overall Study|Lost to Follow-up|130|||
130045939|NCT01088412|468125631|FG002|Overall Study|Lost to Follow-up|11|||
130045940|NCT01088412|468125629|FG000|Overall Study|Study Summary Not Completed|4360|||
130292910|NCT01146288|469037470|FG001|First Intervention(1 Day)|Adverse Event|1|||
130292911|NCT00385723|469037471|FG000|Overall Study|Lost to Follow-up|1|||
130292912|NCT00385723|469037472|FG001|Overall Study|Lost to Follow-up|1|||
130292913|NCT00385723|469037473|FG002|Overall Study|Lost to Follow-up|0|||
130292914|NCT00385723|469037471|FG000|Overall Study|Withdrawal by Subject|1|||
130292915|NCT00385723|469037472|FG001|Overall Study|Withdrawal by Subject|0|||
130045941|NCT01088412|468125630|FG001|Overall Study|Study Summary Not Completed|64|||
130045942|NCT01088412|468125631|FG002|Overall Study|Study Summary Not Completed|22|||
130045943|NCT00301067|468125632|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
130045944|NCT00301067|468125633|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
130045945|NCT00301067|468125634|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
130045946|NCT00301067|468125635|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
130045947|NCT00301067|468125632|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
130045948|NCT00301067|468125633|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130045949|NCT00301067|468125634|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
130045950|NCT00301067|468125635|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
130045951|NCT00301067|468125632|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
130045952|NCT00301067|468125633|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
130292916|NCT00385723|469037473|FG002|Overall Study|Withdrawal by Subject|2|||
130292917|NCT01100528|469037476|FG000|Overall Study|Death|1|||
130292918|NCT01100528|469037476|FG000|Overall Study|Withdrawal by Subject|2|||
130292919|NCT01299571|469037481|FG000|Overall Study|Protocol Violation|107|||
130292920|NCT00708734|469037484|FG000|Overall Study|scheduling conflict|2|||
130292921|NCT00708734|469037484|FG000|Overall Study|moved|1|||
130292922|NCT00708734|469037484|FG000|Overall Study|leg injury|1|||
130292923|NCT00708734|469037484|FG000|Overall Study|knee replacement|1|||
130292924|NCT00708734|469037484|FG000|Overall Study|vertigo|1|||
129793677|NCT00722371|467212727|FG004|Overall Study|Excluded medication|0|||
129793678|NCT00722371|467212728|FG005|Overall Study|Excluded medication|0|||
129793679|NCT00722371|467212729|FG006|Overall Study|Excluded medication|1|||
129793680|NCT00722371|467212723|FG000|Overall Study|Hyperglycemia|2|||
129793681|NCT00722371|467212724|FG001|Overall Study|Hyperglycemia|6|||
129793682|NCT00722371|467212725|FG002|Overall Study|Hyperglycemia|4|||
129793683|NCT00722371|467212726|FG003|Overall Study|Hyperglycemia|2|||
129793684|NCT00722371|467212727|FG004|Overall Study|Hyperglycemia|5|||
129793685|NCT00722371|467212728|FG005|Overall Study|Hyperglycemia|1|||
129793686|NCT00722371|467212729|FG006|Overall Study|Hyperglycemia|1|||
129793687|NCT00722371|467212723|FG000|Overall Study|Hypoglycemia|1|||
129888549|NCT02204293|467549233|FG004|Core Study Part I|Adverse Event|0|||
130045953|NCT00301067|468125634|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
130045954|NCT00301067|468125635|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
130045955|NCT00301067|468125632|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
130292925|NCT00708734|469037484|FG000|Overall Study|leg fracture|1|||
130292926|NCT02006069|469037486|FG000|Overall Study|MPP other programming|239|||
130292927|NCT02006069|469037487|FG001|Overall Study|MPP other programming|0|||
130292928|NCT02006069|469037486|FG000|Overall Study|RV only pacing|0|||
130292929|NCT02006069|469037487|FG001|Overall Study|RV only pacing|3|||
130292930|NCT02066129|469037488|FG000|Overall Study|Lost to Follow-up|13|||
130292931|NCT02066129|469037489|FG001|Overall Study|Lost to Follow-up|12|||
130292932|NCT02066129|469037488|FG000|Overall Study|Withdrawal by Subject|7|||
130045956|NCT00301067|468125633|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
130045957|NCT00301067|468125634|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
130045958|NCT00301067|468125635|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
130292933|NCT02066129|469037489|FG001|Overall Study|Withdrawal by Subject|10|||
130292934|NCT02066129|469037488|FG000|Overall Study|Lack of Efficacy|8|||
130292935|NCT02066129|469037489|FG001|Overall Study|Lack of Efficacy|10|||
130292936|NCT02066129|469037488|FG000|Overall Study|Physician Decision|1|||
130292937|NCT02066129|469037489|FG001|Overall Study|Physician Decision|1|||
130292938|NCT00316888|469037493|FG000|Overall Study|Adverse Event|4|||
130292939|NCT00316888|469037494|FG001|Overall Study|Adverse Event|5|||
130292940|NCT00316888|469037493|FG000|Overall Study|Withdrawal by Subject|2|||
130292941|NCT00316888|469037494|FG001|Overall Study|Withdrawal by Subject|2|||
130292942|NCT00316888|469037493|FG000|Overall Study|Not start protocol therapy|0|||
129793688|NCT00722371|467212724|FG001|Overall Study|Hypoglycemia|0|||
129793689|NCT00722371|467212725|FG002|Overall Study|Hypoglycemia|0|||
129888550|NCT02204293|467549234|FG005|Core Study Part I|Adverse Event|0|||
130292943|NCT00316888|469037494|FG001|Overall Study|Not start protocol therapy|1|||
130292944|NCT00857948|469037495|FG000|Overall Study|Withdrawal by Subject|2|||
129793690|NCT00722371|467212726|FG003|Overall Study|Hypoglycemia|0|||
130292945|NCT00857948|469037496|FG001|Overall Study|Withdrawal by Subject|0|||
130292946|NCT00857948|469037497|FG002|Overall Study|Withdrawal by Subject|0|||
130292947|NCT00857948|469037498|FG003|Overall Study|Withdrawal by Subject|0|||
130292948|NCT00857948|469037495|FG000|Overall Study|Protocol Violation|1|||
130292949|NCT00857948|469037496|FG001|Overall Study|Protocol Violation|0|||
130292950|NCT00857948|469037497|FG002|Overall Study|Protocol Violation|1|||
130292951|NCT00857948|469037498|FG003|Overall Study|Protocol Violation|0|||
130292952|NCT00815191|469037499|FG000|Overall Study|Protocol Violation|1|||
130292953|NCT00815191|469037500|FG001|Overall Study|Protocol Violation|1|||
130292954|NCT01814670|469037503|FG000|Overall Study|Protocol Violation|12|||
130292955|NCT03443427|469037504|FG000|Overall Study|Adverse Event|2|||
130292956|NCT03443427|469037505|FG001|Overall Study|Adverse Event|3|||
130292957|NCT03443427|469037504|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
130292958|NCT03443427|469037505|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
130292959|NCT03443427|469037504|FG000|Overall Study|Other|4|||
130292960|NCT03443427|469037505|FG001|Overall Study|Other|6|||
130292961|NCT02576860|469037506|FG000|Overall Study|Adverse Event|6|||
130292962|NCT02576860|469037507|FG001|Overall Study|Adverse Event|6|||
130292963|NCT02576860|469037506|FG000|Overall Study|Lost to Follow-up|5|||
130292964|NCT02576860|469037507|FG001|Overall Study|Lost to Follow-up|7|||
130292965|NCT02576860|469037506|FG000|Overall Study|Physician Decision|0|||
130292966|NCT02576860|469037507|FG001|Overall Study|Physician Decision|1|||
130292967|NCT02576860|469037506|FG000|Overall Study|Protocol Violation|0|||
130292968|NCT02576860|469037507|FG001|Overall Study|Protocol Violation|2|||
130292969|NCT02576860|469037506|FG000|Overall Study|Withdrawal by Subject|13|||
130292970|NCT02576860|469037507|FG001|Overall Study|Withdrawal by Subject|8|||
130292971|NCT02576860|469037506|FG000|Overall Study|Disallowed medication|1|||
130292972|NCT02576860|469037507|FG001|Overall Study|Disallowed medication|0|||
130292973|NCT01541917|469037508|FG000|Overall Study|Lost to Follow-up|2|||
130292974|NCT01541917|469037509|FG001|Overall Study|Lost to Follow-up|2|||
130292975|NCT01541917|469037508|FG000|Overall Study|Withdrawal by Subject|13|||
130292976|NCT01541917|469037509|FG001|Overall Study|Withdrawal by Subject|7|||
130292977|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
130292978|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
130292979|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
130292980|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
130292981|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
130292982|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
130292983|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
130292984|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
130292985|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
130106506|NCT01898884|468350063|FG008|Multiple Dose Period|Adverse Event|0|||
130292986|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
130292987|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
130292988|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
130292989|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
130292990|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
130292991|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
130292992|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
130292993|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
130292994|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
130292995|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
130292996|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
130292997|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
130292998|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
130292999|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
130293000|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
130293001|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
130293002|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130293003|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130293004|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
130293005|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
130293006|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
130293007|NCT00121641|469037510|FG000|24-week Short-term Treatment Period|Other Reason|1|||
130293008|NCT00121641|469037511|FG001|24-week Short-term Treatment Period|Other Reason|0|||
130293009|NCT00121641|469037512|FG002|24-week Short-term Treatment Period|Other Reason|0|||
130293010|NCT00121641|469037513|FG003|24-week Short-term Treatment Period|Other Reason|0|||
130293011|NCT00121641|469037514|FG004|24-week Short-term Treatment Period|Other Reason|0|||
130293012|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
130293013|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
130293014|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
130293015|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
130293016|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
130293017|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
130293018|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
130293019|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
130293020|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
130293021|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
130293022|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
129793691|NCT00722371|467212727|FG004|Overall Study|Hypoglycemia|0|||
129793692|NCT00722371|467212728|FG005|Overall Study|Hypoglycemia|0|||
129793693|NCT00722371|467212729|FG006|Overall Study|Hypoglycemia|0|||
129793694|NCT00722371|467212723|FG000|Overall Study|Lack of Efficacy|4|||
129793695|NCT00722371|467212724|FG001|Overall Study|Lack of Efficacy|6|||
129793696|NCT00722371|467212725|FG002|Overall Study|Lack of Efficacy|6|||
129793697|NCT00722371|467212726|FG003|Overall Study|Lack of Efficacy|6|||
129793698|NCT00722371|467212727|FG004|Overall Study|Lack of Efficacy|2|||
129793699|NCT00722371|467212728|FG005|Overall Study|Lack of Efficacy|3|||
129793700|NCT00722371|467212729|FG006|Overall Study|Lack of Efficacy|0|||
129793701|NCT00722371|467212723|FG000|Overall Study|Lost to Follow-up|11|||
129793702|NCT00722371|467212724|FG001|Overall Study|Lost to Follow-up|14|||
129793703|NCT00722371|467212725|FG002|Overall Study|Lost to Follow-up|21|||
129793704|NCT00722371|467212726|FG003|Overall Study|Lost to Follow-up|13|||
129793705|NCT00722371|467212727|FG004|Overall Study|Lost to Follow-up|8|||
129793706|NCT00722371|467212728|FG005|Overall Study|Lost to Follow-up|16|||
129793707|NCT00722371|467212729|FG006|Overall Study|Lost to Follow-up|13|||
129793708|NCT00722371|467212723|FG000|Overall Study|Physician Decision|5|||
130293023|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
130293024|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
130293025|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
130293026|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
130293027|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
130293028|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
130293029|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
130293030|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
130293031|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
130293032|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
130293033|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
130293034|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
130293035|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
130293036|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
129793709|NCT00722371|467212724|FG001|Overall Study|Physician Decision|2|||
129793710|NCT00722371|467212725|FG002|Overall Study|Physician Decision|2|||
129793711|NCT00722371|467212726|FG003|Overall Study|Physician Decision|5|||
129793712|NCT00722371|467212727|FG004|Overall Study|Physician Decision|2|||
129793713|NCT00722371|467212728|FG005|Overall Study|Physician Decision|3|||
129793714|NCT00722371|467212729|FG006|Overall Study|Physician Decision|4|||
130045959|NCT00301067|468125632|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
130293037|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
130293038|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
130293039|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
130293040|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
130293041|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
130293042|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
130293043|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
130293044|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
130293045|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
130293046|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
130293047|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
130293048|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
130293049|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
130293050|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
130293051|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
130293052|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Death|0|||
130293053|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Death|0|||
130293054|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Death|0|||
130293055|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Death|1|||
130293056|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Death|0|||
130293057|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Missing|0|||
130293058|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Missing|0|||
130293059|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Missing|1|||
130293060|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Missing|0|||
130293061|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Missing|0|||
130293062|NCT00121641|469037510|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
130293063|NCT00121641|469037511|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
130293064|NCT00121641|469037512|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
130293065|NCT00121641|469037513|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
130293066|NCT00121641|469037514|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
130293067|NCT00094107|469037525|FG000|Overall Study|Lack of Efficacy|23|||
130293068|NCT00094107|469037525|FG000|Overall Study|Death|5|||
130293069|NCT00094107|469037525|FG000|Overall Study|Adverse Event|3|||
130293070|NCT00094107|469037525|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
130293071|NCT00525824|469037528|FG000|Overall Study|Adverse Event|7|||
130293072|NCT00525824|469037529|FG001|Overall Study|Adverse Event|11|||
130293073|NCT00525824|469037530|FG002|Overall Study|Adverse Event|6|||
130293074|NCT00525824|469037531|FG003|Overall Study|Adverse Event|7|||
130293075|NCT00525824|469037528|FG000|Overall Study|Withdrawal by Subject|5|||
130293076|NCT00525824|469037529|FG001|Overall Study|Withdrawal by Subject|9|||
130293077|NCT00525824|469037530|FG002|Overall Study|Withdrawal by Subject|3|||
130293078|NCT00525824|469037531|FG003|Overall Study|Withdrawal by Subject|4|||
130293079|NCT00525824|469037528|FG000|Overall Study|Lost to Follow-up|4|||
130293080|NCT00525824|469037529|FG001|Overall Study|Lost to Follow-up|2|||
130293081|NCT00525824|469037530|FG002|Overall Study|Lost to Follow-up|4|||
130293082|NCT00525824|469037531|FG003|Overall Study|Lost to Follow-up|0|||
130293083|NCT00525824|469037528|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
130293084|NCT00525824|469037529|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
130293085|NCT00525824|469037530|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
130293086|NCT00525824|469037531|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
130293087|NCT00525824|469037528|FG000|Overall Study|Severe non-compliance|0|||
130293088|NCT00525824|469037529|FG001|Overall Study|Severe non-compliance|1|||
130293089|NCT00525824|469037530|FG002|Overall Study|Severe non-compliance|1|||
130293090|NCT00525824|469037531|FG003|Overall Study|Severe non-compliance|1|||
130293091|NCT00525824|469037528|FG000|Overall Study|Safety reasons|1|||
130293092|NCT00525824|469037529|FG001|Overall Study|Safety reasons|0|||
130293093|NCT00525824|469037530|FG002|Overall Study|Safety reasons|1|||
130293094|NCT00525824|469037531|FG003|Overall Study|Safety reasons|0|||
130293095|NCT00525824|469037528|FG000|Overall Study|Other|1|||
130293096|NCT00525824|469037529|FG001|Overall Study|Other|3|||
130045960|NCT00301067|468125633|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
130293097|NCT00525824|469037530|FG002|Overall Study|Other|3|||
130293098|NCT00525824|469037531|FG003|Overall Study|Other|1|||
130293099|NCT00806442|469037535|FG000|Overall Study|Lost to Follow-up|3|||
130293100|NCT00806442|469037536|FG001|Overall Study|Lost to Follow-up|2|||
130293101|NCT00806442|469037535|FG000|Overall Study|Withdrawal by Subject|1|||
130293102|NCT00806442|469037536|FG001|Overall Study|Withdrawal by Subject|5|||
130293103|NCT01264770|469037552|FG000|Overall Study|Not reported|0|||
130293104|NCT01264770|469037553|FG001|Overall Study|Not reported|0|||
130293105|NCT01264770|469037554|FG002|Overall Study|Not reported|1|||
129888551|NCT02204293|467549229|FG000|Core Study Part I|Physician Decision|0|||
129888552|NCT02204293|467549230|FG001|Core Study Part I|Physician Decision|3|||
129888553|NCT02204293|467549231|FG002|Core Study Part I|Physician Decision|0|||
129888554|NCT02204293|467549232|FG003|Core Study Part I|Physician Decision|0|||
129888555|NCT02204293|467549233|FG004|Core Study Part I|Physician Decision|0|||
129888556|NCT02204293|467549234|FG005|Core Study Part I|Physician Decision|0|||
129888557|NCT02204293|467549229|FG000|LTE Phase|Study Suspended|0|||
129888558|NCT02204293|467549230|FG001|LTE Phase|Study Suspended|0|||
130045961|NCT00301067|468125634|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
130045962|NCT00301067|468125635|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
129888559|NCT02204293|467549231|FG002|LTE Phase|Study Suspended|0|||
129888560|NCT02204293|467549232|FG003|LTE Phase|Study Suspended|0|||
130045963|NCT00301067|468125632|FG000|Follow up Until Death|Alive at last data cut point|1|||
130045964|NCT00301067|468125633|FG001|Follow up Until Death|Alive at last data cut point|0|||
130045965|NCT00301067|468125634|FG002|Follow up Until Death|Alive at last data cut point|0|||
130045966|NCT00301067|468125635|FG003|Follow up Until Death|Alive at last data cut point|1|||
130045967|NCT01208181|468125637|FG000|Part 1|Withdrawal by Subject|11|||
130045968|NCT01208181|468125638|FG001|Part 1|Withdrawal by Subject|10|||
130045969|NCT01208181|468125639|FG002|Part 1|Withdrawal by Subject|0|||
130045970|NCT01208181|468125640|FG003|Part 1|Withdrawal by Subject|0|||
130045971|NCT01208181|468125641|FG004|Part 1|Withdrawal by Subject|0|||
130045972|NCT01208181|468125637|FG000|Part 1|Technical problem|5|||
130045973|NCT01208181|468125638|FG001|Part 1|Technical problem|0|||
130045974|NCT01208181|468125639|FG002|Part 1|Technical problem|0|||
130045975|NCT01208181|468125640|FG003|Part 1|Technical problem|0|||
130045976|NCT01208181|468125641|FG004|Part 1|Technical problem|0|||
130045977|NCT01208181|468125637|FG000|Part 1|Protocol Violation|10|||
130293106|NCT01264770|469037555|FG003|Overall Study|Not reported|0|||
130293107|NCT01264770|469037556|FG004|Overall Study|Not reported|0|||
130293108|NCT01264770|469037557|FG005|Overall Study|Not reported|0|||
130293109|NCT01264770|469037552|FG000|Overall Study|e.g., change in circumstances|8|||
130293110|NCT01264770|469037553|FG001|Overall Study|e.g., change in circumstances|3|||
130293111|NCT01264770|469037554|FG002|Overall Study|e.g., change in circumstances|3|||
130293112|NCT01264770|469037555|FG003|Overall Study|e.g., change in circumstances|3|||
130293113|NCT01264770|469037556|FG004|Overall Study|e.g., change in circumstances|4|||
130293114|NCT01264770|469037557|FG005|Overall Study|e.g., change in circumstances|4|||
130293115|NCT01264770|469037552|FG000|Overall Study|Severe non-compliance to protocol|0|||
130293116|NCT01264770|469037553|FG001|Overall Study|Severe non-compliance to protocol|0|||
130293117|NCT01264770|469037554|FG002|Overall Study|Severe non-compliance to protocol|1|||
130293118|NCT01264770|469037555|FG003|Overall Study|Severe non-compliance to protocol|1|||
130293119|NCT01264770|469037556|FG004|Overall Study|Severe non-compliance to protocol|0|||
130293120|NCT01264770|469037557|FG005|Overall Study|Severe non-compliance to protocol|0|||
130293121|NCT01264770|469037552|FG000|Overall Study|Lack of therapeutic response|1|||
130293122|NCT01264770|469037553|FG001|Overall Study|Lack of therapeutic response|0|||
130293123|NCT01264770|469037554|FG002|Overall Study|Lack of therapeutic response|2|||
130293124|NCT01264770|469037555|FG003|Overall Study|Lack of therapeutic response|1|||
130293125|NCT01264770|469037556|FG004|Overall Study|Lack of therapeutic response|1|||
130293126|NCT01264770|469037557|FG005|Overall Study|Lack of therapeutic response|0|||
130293127|NCT01264770|469037552|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
130293128|NCT01264770|469037553|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
130293129|NCT01264770|469037554|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
130293130|NCT01264770|469037555|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
130293131|NCT01264770|469037556|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
130293132|NCT01264770|469037557|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
130293133|NCT01264770|469037552|FG000|Overall Study|Lost to Follow-up|0|||
130293134|NCT01264770|469037553|FG001|Overall Study|Lost to Follow-up|0|||
130293135|NCT01264770|469037554|FG002|Overall Study|Lost to Follow-up|1|||
130293136|NCT01264770|469037555|FG003|Overall Study|Lost to Follow-up|1|||
130293137|NCT01264770|469037556|FG004|Overall Study|Lost to Follow-up|0|||
130045978|NCT01208181|468125638|FG001|Part 1|Protocol Violation|5|||
130045979|NCT01208181|468125639|FG002|Part 1|Protocol Violation|0|||
130045980|NCT01208181|468125640|FG003|Part 1|Protocol Violation|0|||
130045981|NCT01208181|468125641|FG004|Part 1|Protocol Violation|0|||
130293138|NCT01264770|469037557|FG005|Overall Study|Lost to Follow-up|0|||
130293139|NCT01264770|469037552|FG000|Overall Study|Adverse Event|7|||
130293140|NCT01264770|469037553|FG001|Overall Study|Adverse Event|7|||
129888561|NCT02204293|467549233|FG004|LTE Phase|Study Suspended|0|||
129888562|NCT02204293|467549234|FG005|LTE Phase|Study Suspended|7|||
130045982|NCT01208181|468125637|FG000|Part 1|Physician Decision|4|||
130045983|NCT01208181|468125638|FG001|Part 1|Physician Decision|0|||
130045984|NCT01208181|468125639|FG002|Part 1|Physician Decision|0|||
130045985|NCT01208181|468125640|FG003|Part 1|Physician Decision|0|||
130045986|NCT01208181|468125641|FG004|Part 1|Physician Decision|0|||
130045987|NCT01208181|468125637|FG000|Part 1|Non-compliance with study drug|1|||
129888563|NCT02019602|467549235|FG000|Screening Period|Ineligibility|4|||
129888564|NCT02019602|467549236|FG001|Screening Period|Ineligibility|0|||
130045988|NCT01208181|468125638|FG001|Part 1|Non-compliance with study drug|1|||
130045989|NCT01208181|468125639|FG002|Part 1|Non-compliance with study drug|0|||
130045990|NCT01208181|468125640|FG003|Part 1|Non-compliance with study drug|0|||
130045991|NCT01208181|468125641|FG004|Part 1|Non-compliance with study drug|0|||
130045992|NCT01208181|468125637|FG000|Part 1|Lost to Follow-up|5|||
130045993|NCT01208181|468125638|FG001|Part 1|Lost to Follow-up|3|||
130293141|NCT01264770|469037554|FG002|Overall Study|Adverse Event|8|||
130293142|NCT01264770|469037555|FG003|Overall Study|Adverse Event|0|||
130293143|NCT01264770|469037556|FG004|Overall Study|Adverse Event|2|||
130293144|NCT01264770|469037557|FG005|Overall Study|Adverse Event|1|||
130293145|NCT02356887|469037561|FG000|Overall Study|poor compliance|2|||
130293146|NCT01490294|469037562|FG000|Overall Study|Prematurely discontinuation|4|||
130293147|NCT01490294|469037563|FG001|Overall Study|Prematurely discontinuation|0|||
130293148|NCT01490294|469037564|FG002|Overall Study|Prematurely discontinuation|1|||
130293149|NCT01490294|469037565|FG003|Overall Study|Prematurely discontinuation|1|||
130293150|NCT01490294|469037562|FG000|Overall Study|Adverse Event|1|||
130293151|NCT01490294|469037563|FG001|Overall Study|Adverse Event|0|||
130293152|NCT01490294|469037564|FG002|Overall Study|Adverse Event|0|||
130293153|NCT01490294|469037565|FG003|Overall Study|Adverse Event|0|||
130293154|NCT00160654|469037572|FG000|Overall Study|Adverse Event|14|||
130293155|NCT00160654|469037572|FG000|Overall Study|Lack of Efficacy|4|||
130293156|NCT00160654|469037572|FG000|Overall Study|Lost to Follow-up|2|||
130293157|NCT00160654|469037572|FG000|Overall Study|Intake of expired drug|7|||
130293158|NCT00160654|469037572|FG000|Overall Study|Psychological trauma|1|||
130293159|NCT00160654|469037572|FG000|Overall Study|Sponsor decision|1|||
130293160|NCT00160654|469037572|FG000|Overall Study|Patient met exclusion criteria|1|||
130293161|NCT00160654|469037572|FG000|Overall Study|Patient decision|1|||
130293162|NCT00160654|469037572|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
130293163|NCT00160654|469037572|FG000|Overall Study|Met exclusion criteria|1|||
130293164|NCT02404649|469037573|FG000|Overall Study|Adverse Event|1|||
130293165|NCT02404649|469037574|FG001|Overall Study|Adverse Event|2|||
130293166|NCT00330668|469037578|FG000|BID Dosing Period|Adverse Event|1|||
130293167|NCT00330668|469037578|FG000|BID Dosing Period|Lost to Follow-up|7|||
130293168|NCT00330668|469037578|FG000|BID Dosing Period|Non-Compliance|5|||
130293169|NCT00330668|469037578|FG000|BID Dosing Period|Withdrawal by Subject|19|||
130293170|NCT00330668|469037578|FG000|BID Dosing Period|Sponsor's decision|1|||
130293171|NCT00330668|469037578|FG000|BID Dosing Period|Other|3|||
130293172|NCT00330668|469037578|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
130293173|NCT00330668|469037578|FG000|QD Dosing Period|Other|1|||
130293174|NCT00330668|469037578|FG000|QD Dosing Period|Withdrawal by Subject|1|||
130293175|NCT00330668|469037578|FG000|QD Dosing Period|Lost to Follow-up|2|||
130293176|NCT01839656|469037579|FG000|Overall Study|Withdrawal by Subject|1|||
130293177|NCT01839656|469037580|FG001|Overall Study|Withdrawal by Subject|1|||
130293178|NCT01839656|469037579|FG000|Overall Study|Adverse event, serious fatal|1|||
130293179|NCT01839656|469037580|FG001|Overall Study|Adverse event, serious fatal|4|||
130293180|NCT01839656|469037579|FG000|Overall Study|Early study closure|0|||
130293181|NCT01839656|469037580|FG001|Overall Study|Early study closure|11|||
130293182|NCT01839656|469037579|FG000|Overall Study|Adverse Event|1|||
130293183|NCT01839656|469037580|FG001|Overall Study|Adverse Event|0|||
130293184|NCT01595581|469037581|FG000|Overall Study|Withdrawal by Subject|1|||
130293185|NCT01595581|469037582|FG001|Overall Study|Withdrawal by Subject|0|||
130293186|NCT02535416|469037592|FG000|Overall Study|Family bereavement overseas|1|||
130293187|NCT02535416|469037593|FG001|Overall Study|Family bereavement overseas|0|||
130293188|NCT02535416|469037594|FG002|Overall Study|Family bereavement overseas|0|||
130293189|NCT02535416|469037595|FG003|Overall Study|Family bereavement overseas|0|||
130293190|NCT02535416|469037596|FG004|Overall Study|Family bereavement overseas|0|||
130293191|NCT02535416|469037597|FG005|Overall Study|Family bereavement overseas|0|||
130293192|NCT02535416|469037598|FG006|Overall Study|Family bereavement overseas|0|||
130293193|NCT02535416|469037599|FG007|Overall Study|Family bereavement overseas|0|||
130293194|NCT02535416|469037600|FG008|Overall Study|Family bereavement overseas|0|||
130293195|NCT02739321|469037603|FG000|Overall Study|Lack of Efficacy|1|||
130293196|NCT02739321|469037604|FG001|Overall Study|Lack of Efficacy|1|||
130045994|NCT01208181|468125639|FG002|Part 1|Lost to Follow-up|0|||
130293197|NCT02739321|469037603|FG000|Overall Study|Lost to Follow-up|1|||
130293198|NCT02739321|469037604|FG001|Overall Study|Lost to Follow-up|1|||
130293199|NCT02739321|469037603|FG000|Overall Study|Withdrawal by Subject|1|||
130045995|NCT01208181|468125640|FG003|Part 1|Lost to Follow-up|0|||
130045996|NCT01208181|468125641|FG004|Part 1|Lost to Follow-up|1|||
130045997|NCT01208181|468125637|FG000|Part 1|Lack of Efficacy|37|||
130045998|NCT01208181|468125638|FG001|Part 1|Lack of Efficacy|12|||
130293200|NCT02739321|469037604|FG001|Overall Study|Withdrawal by Subject|2|||
130293201|NCT01711866|469037605|FG000|Overall Study|Noncompliant|3|||
130293202|NCT01711866|469037605|FG000|Overall Study|Withdrawal by Subject|3|||
130293203|NCT01711866|469037605|FG000|Overall Study|Adverse Event|2|||
130293204|NCT00958217|469037609|FG000|Overall Study|Death|2|||
130293205|NCT00958217|469037610|FG001|Overall Study|Death|1|||
130293206|NCT00958217|469037609|FG000|Overall Study|Withdrawal by Subject|4|||
130293207|NCT00958217|469037610|FG001|Overall Study|Withdrawal by Subject|3|||
130293208|NCT00958217|469037609|FG000|Overall Study|Lost to Follow-up|17|||
130293209|NCT00958217|469037610|FG001|Overall Study|Lost to Follow-up|19|||
130293210|NCT00958217|469037609|FG000|Overall Study|Moved out of area|1|||
130293211|NCT00958217|469037610|FG001|Overall Study|Moved out of area|1|||
130293212|NCT00958217|469037609|FG000|Overall Study|Inpatient hospitalization|0|||
130293213|NCT00958217|469037610|FG001|Overall Study|Inpatient hospitalization|1|||
130293214|NCT00528996|469039257|FG000|Overall Study|Other reasons than listing|6|||
129888565|NCT02019602|467549235|FG000|Screening Period|Adverse Event|1|||
129888566|NCT02019602|467549236|FG001|Screening Period|Adverse Event|0|||
129888567|NCT01058863|467549237|FG000|Overall Study|Lost to Follow-up|1|||
129888568|NCT01058863|467549237|FG000|Overall Study|Withdrawal by Subject|1|||
129888569|NCT01058863|467549237|FG000|Overall Study|Sponsor requested withdrawal|1|||
129888570|NCT01058863|467549237|FG000|Overall Study|Randomized in error|1|||
129888571|NCT00681187|467549238|FG000|Overall Study|Withdrawal by Subject|1|||
129888572|NCT00681187|467549239|FG001|Overall Study|Withdrawal by Subject|0|||
129888573|NCT00681187|467549238|FG000|Overall Study|Death|0|||
129888574|NCT00681187|467549239|FG001|Overall Study|Death|1|||
130293215|NCT00528996|469039258|FG001|Overall Study|Other reasons than listing|7|||
130293216|NCT00528996|469039259|FG002|Overall Study|Other reasons than listing|14|||
129888575|NCT00681187|467549238|FG000|Overall Study|Adverse Event|0|||
130293217|NCT00528996|469039260|FG003|Overall Study|Other reasons than listing|11|||
130293218|NCT00528996|469039261|FG004|Overall Study|Other reasons than listing|5|||
130293219|NCT00528996|469039257|FG000|Overall Study|Refused continue medication|16|||
130293220|NCT00528996|469039258|FG001|Overall Study|Refused continue medication|0|||
130293221|NCT00528996|469039259|FG002|Overall Study|Refused continue medication|3|||
130293222|NCT00528996|469039260|FG003|Overall Study|Refused continue medication|3|||
130293223|NCT00528996|469039261|FG004|Overall Study|Refused continue medication|6|||
130293224|NCT00528996|469039257|FG000|Overall Study|Lost to Follow-up|2|||
130293225|NCT00528996|469039258|FG001|Overall Study|Lost to Follow-up|0|||
130293226|NCT00528996|469039259|FG002|Overall Study|Lost to Follow-up|4|||
130293227|NCT00528996|469039260|FG003|Overall Study|Lost to Follow-up|1|||
130293228|NCT00528996|469039261|FG004|Overall Study|Lost to Follow-up|3|||
130293229|NCT00528996|469039257|FG000|Overall Study|Protocol Violation|1|||
130293230|NCT00528996|469039258|FG001|Overall Study|Protocol Violation|2|||
130293231|NCT00528996|469039259|FG002|Overall Study|Protocol Violation|3|||
130293232|NCT00528996|469039260|FG003|Overall Study|Protocol Violation|3|||
130293233|NCT00528996|469039261|FG004|Overall Study|Protocol Violation|2|||
130293234|NCT00528996|469039257|FG000|Overall Study|Lack of Efficacy|7|||
130293235|NCT00528996|469039258|FG001|Overall Study|Lack of Efficacy|2|||
130293236|NCT00528996|469039259|FG002|Overall Study|Lack of Efficacy|1|||
129888576|NCT00681187|467549239|FG001|Overall Study|Adverse Event|1|||
129888577|NCT02788006|467549241|FG000|Overall Study|Patient not treated|1|||
129888578|NCT02269943|467549244|FG000|Treatment Period|Death|0|||
129888579|NCT02269943|467549245|FG001|Treatment Period|Death|1|||
130045999|NCT01208181|468125639|FG002|Part 1|Lack of Efficacy|0|||
130046000|NCT01208181|468125640|FG003|Part 1|Lack of Efficacy|0|||
130046001|NCT01208181|468125641|FG004|Part 1|Lack of Efficacy|17|||
130293237|NCT00528996|469039260|FG003|Overall Study|Lack of Efficacy|3|||
130293238|NCT00528996|469039261|FG004|Overall Study|Lack of Efficacy|3|||
130293239|NCT00528996|469039257|FG000|Overall Study|Adverse Event|32|||
130293240|NCT00528996|469039258|FG001|Overall Study|Adverse Event|13|||
130293241|NCT00528996|469039259|FG002|Overall Study|Adverse Event|18|||
130293242|NCT00528996|469039260|FG003|Overall Study|Adverse Event|29|||
130293243|NCT00528996|469039261|FG004|Overall Study|Adverse Event|18|||
130293244|NCT05565937|469039263|FG000|Overall Study|Adverse Event|0|||
130293245|NCT05565937|469039264|FG001|Overall Study|Adverse Event|1|||
130293246|NCT05565937|469039263|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
130293247|NCT05565937|469039264|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
130293248|NCT05565937|469039263|FG000|Overall Study|Lost to Follow-up|2|||
130293249|NCT05565937|469039264|FG001|Overall Study|Lost to Follow-up|0|||
129888580|NCT02269943|467549244|FG000|Treatment Period|Adverse Event|1|||
129888581|NCT02269943|467549245|FG001|Treatment Period|Adverse Event|10|||
130293250|NCT05565937|469039263|FG000|Overall Study|Pregnancy|0|||
129888582|NCT02269943|467549244|FG000|Treatment Period|Progressive Disease|5|||
129888583|NCT02269943|467549245|FG001|Treatment Period|Progressive Disease|17|||
129888584|NCT02269943|467549244|FG000|Treatment Period|Symptomatic Deterioration|0|||
130293251|NCT05565937|469039264|FG001|Overall Study|Pregnancy|2|||
130293252|NCT05565937|469039263|FG000|Overall Study|Anisometropia|0|||
130293253|NCT05565937|469039264|FG001|Overall Study|Anisometropia|1|||
130293254|NCT04544683|469039265|FG000|Overall Study|Lost to Follow-up|2|||
129888585|NCT02269943|467549245|FG001|Treatment Period|Symptomatic Deterioration|2|||
129888586|NCT02269943|467549244|FG000|Follow-Up Survival Period|Death|3|||
130046002|NCT01208181|468125637|FG000|Part 1|Adverse Event|26|||
129888587|NCT02269943|467549245|FG001|Follow-Up Survival Period|Death|16|||
130046003|NCT01208181|468125638|FG001|Part 1|Adverse Event|24|||
130293255|NCT04544683|469039265|FG000|Overall Study|Underwent cervical spine surgery|6|||
130293256|NCT04938037|469039268|FG000|Overall Study|Lost to Follow-up|4|||
130293257|NCT04938037|469039269|FG001|Overall Study|Lost to Follow-up|3|||
130293258|NCT01806064|469039270|FG000|Overall Study|Randomized Not Enrolled|0|||
130293259|NCT01806064|469039271|FG001|Overall Study|Randomized Not Enrolled|0|||
130293260|NCT01806064|469039272|FG002|Overall Study|Randomized Not Enrolled|0|||
130293261|NCT01806064|469039273|FG003|Overall Study|Randomized Not Enrolled|1|||
130293262|NCT01806064|469039274|FG004|Overall Study|Randomized Not Enrolled|2|||
130293263|NCT01282294|469039278|FG000|Overall Study|Lost to Follow-up|14|||
130293264|NCT01282294|469039278|FG000|Overall Study|Screening failure|1|||
130293265|NCT01282294|469039278|FG000|Overall Study|Adverse Event|1|||
130293266|NCT01282294|469039278|FG000|Overall Study|Patient non-compliance|2|||
130293267|NCT01282294|469039278|FG000|Overall Study|Physician Decision|1|||
130293268|NCT02943915|469039279|FG000|Overall Study|Withdrawal by Subject|2|||
130293269|NCT02943915|469039280|FG001|Overall Study|Withdrawal by Subject|1|||
130293270|NCT02943915|469039281|FG002|Overall Study|Withdrawal by Subject|0|||
130293271|NCT02943915|469039282|FG003|Overall Study|Withdrawal by Subject|0|||
130293272|NCT02943915|469039279|FG000|Overall Study|Lost to Follow-up|3|||
130293273|NCT02943915|469039280|FG001|Overall Study|Lost to Follow-up|1|||
130293274|NCT02943915|469039281|FG002|Overall Study|Lost to Follow-up|0|||
130293275|NCT02943915|469039282|FG003|Overall Study|Lost to Follow-up|0|||
130293276|NCT02943915|469039279|FG000|Overall Study|excluded|0|||
130293277|NCT02943915|469039280|FG001|Overall Study|excluded|1|||
130293278|NCT02943915|469039281|FG002|Overall Study|excluded|0|||
130293279|NCT02943915|469039282|FG003|Overall Study|excluded|0|||
130293280|NCT00004445|469039285|FG000|Overall Study|Physician Decision|2|||
130293281|NCT00004445|469039285|FG000|Overall Study|Withdrawal by Subject|1|||
130293282|NCT02753127|469039295|FG000|Overall Study|Lost to Follow-up|13|||
130293283|NCT02753127|469039296|FG001|Overall Study|Lost to Follow-up|11|||
130293284|NCT02753127|469039295|FG000|Overall Study|Withdrawal by Subject|37|||
130293285|NCT02753127|469039296|FG001|Overall Study|Withdrawal by Subject|47|||
130293286|NCT02753127|469039295|FG000|Overall Study|Other|3|||
130293287|NCT02753127|469039296|FG001|Overall Study|Other|8|||
130293288|NCT02753127|469039295|FG000|Overall Study|Hospice|0|||
130293289|NCT02753127|469039296|FG001|Overall Study|Hospice|2|||
130293290|NCT01818284|469039300|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
130293291|NCT01818284|469039301|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
130293292|NCT01818284|469039300|FG000|Overall Study|Death|0|||
130293293|NCT01818284|469039301|FG001|Overall Study|Death|2|||
130293294|NCT03681678|469039302|FG000|Overall Study|Lost to Follow-up|20|||
130293295|NCT04619004|469039303|FG000|Overall Study|Death|114|||
130293296|NCT04619004|469039304|FG001|Overall Study|Death|28|||
130293297|NCT04619004|469039303|FG000|Overall Study|Lost to Follow-up|1|||
130293298|NCT04619004|469039304|FG001|Overall Study|Lost to Follow-up|1|||
130293299|NCT04619004|469039303|FG000|Overall Study|Withdrawal by Subject|24|||
130293300|NCT04619004|469039304|FG001|Overall Study|Withdrawal by Subject|7|||
130293301|NCT04619004|469039303|FG000|Overall Study|Other - Not specified|0|||
130293302|NCT04619004|469039304|FG001|Overall Study|Other - Not specified|1|||
130293303|NCT01114360|469039306|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
130293304|NCT01114360|469039307|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
130293305|NCT03007745|469039308|FG000|Overall Study|Sleep test negative for OSA|53|||
130293306|NCT03007745|469039309|FG001|Overall Study|Sleep test negative for OSA|49|||
130293307|NCT03007745|469039308|FG000|Overall Study|Physician Decision|6|||
130293308|NCT03007745|469039309|FG001|Overall Study|Physician Decision|9|||
130293309|NCT03007745|469039308|FG000|Overall Study|Withdrawal by Subject|38|||
130293310|NCT03007745|469039309|FG001|Overall Study|Withdrawal by Subject|16|||
130293311|NCT03007745|469039308|FG000|Overall Study|Lost to Follow-up|19|||
130293312|NCT03007745|469039309|FG001|Overall Study|Lost to Follow-up|25|||
130293313|NCT03007745|469039308|FG000|Overall Study|Unable to login to website|17|||
130293314|NCT03007745|469039309|FG001|Overall Study|Unable to login to website|4|||
130293315|NCT01300351|469039310|FG000|Overall Study|Did not receive treatment|2|||
130293316|NCT01300351|469039311|FG001|Overall Study|Did not receive treatment|0|||
130293317|NCT01300351|469039310|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
130293318|NCT01300351|469039311|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
130293319|NCT01300351|469039310|FG000|Overall Study|Lost to Follow-up|0|||
130293320|NCT01300351|469039311|FG001|Overall Study|Lost to Follow-up|1|||
130293321|NCT01300351|469039310|FG000|Overall Study|Adverse Event|0|||
130293322|NCT01300351|469039311|FG001|Overall Study|Adverse Event|4|||
130293323|NCT01300351|469039310|FG000|Overall Study|Withdrawal by Subject|7|||
130293324|NCT01300351|469039311|FG001|Overall Study|Withdrawal by Subject|10|||
130293325|NCT05824936|469039315|FG000|Overall Study|Lost to Follow-up|1|||
130293326|NCT00673881|469039316|FG000|Overall Study|Withdrawal by Subject|1|||
130293327|NCT00413010|469039317|FG000|Overall Study|Adverse Event|8|||
130293328|NCT00413010|469039318|FG001|Overall Study|Adverse Event|4|||
130293329|NCT00413010|469039317|FG000|Overall Study|Laboratory abnormality|0|||
130293330|NCT00413010|469039318|FG001|Overall Study|Laboratory abnormality|2|||
130293331|NCT00413010|469039317|FG000|Overall Study|Lack of Efficacy|0|||
130293332|NCT00413010|469039318|FG001|Overall Study|Lack of Efficacy|3|||
130293333|NCT00413010|469039317|FG000|Overall Study|Lost to Follow-up|3|||
130293334|NCT00413010|469039318|FG001|Overall Study|Lost to Follow-up|0|||
130293335|NCT00413010|469039317|FG000|Overall Study|Withdrawal by Subject|7|||
130293336|NCT00413010|469039318|FG001|Overall Study|Withdrawal by Subject|2|||
130293337|NCT00413010|469039317|FG000|Overall Study|Due to termination of the study|54|||
130293338|NCT00413010|469039318|FG001|Overall Study|Due to termination of the study|52|||
130293339|NCT01533922|469039319|FG000|Overall Study|Adverse Event|5|||
130293340|NCT01533922|469039320|FG001|Overall Study|Adverse Event|8|||
130293341|NCT01533922|469039321|FG002|Overall Study|Adverse Event|6|||
130293342|NCT01533922|469039322|FG003|Overall Study|Adverse Event|3|||
130293343|NCT01533922|469039323|FG004|Overall Study|Adverse Event|4|||
130293344|NCT01533922|469039319|FG000|Overall Study|Lack of Efficacy|0|||
130293345|NCT01533922|469039320|FG001|Overall Study|Lack of Efficacy|0|||
130293346|NCT01533922|469039321|FG002|Overall Study|Lack of Efficacy|1|||
130293347|NCT01533922|469039322|FG003|Overall Study|Lack of Efficacy|0|||
130293348|NCT01533922|469039323|FG004|Overall Study|Lack of Efficacy|0|||
130293349|NCT01533922|469039319|FG000|Overall Study|Protocol Violation|0|||
130293350|NCT01533922|469039320|FG001|Overall Study|Protocol Violation|3|||
130293351|NCT01533922|469039321|FG002|Overall Study|Protocol Violation|0|||
130293352|NCT01533922|469039322|FG003|Overall Study|Protocol Violation|0|||
130293353|NCT01533922|469039323|FG004|Overall Study|Protocol Violation|1|||
130293354|NCT01533922|469039319|FG000|Overall Study|Withdrawal by Subject|3|||
130293355|NCT01533922|469039320|FG001|Overall Study|Withdrawal by Subject|1|||
130293356|NCT01533922|469039321|FG002|Overall Study|Withdrawal by Subject|2|||
130293357|NCT01533922|469039322|FG003|Overall Study|Withdrawal by Subject|2|||
130293358|NCT01533922|469039323|FG004|Overall Study|Withdrawal by Subject|1|||
130293359|NCT01533922|469039319|FG000|Overall Study|Other reason not defined above|2|||
130293360|NCT01533922|469039320|FG001|Overall Study|Other reason not defined above|0|||
130293361|NCT01533922|469039321|FG002|Overall Study|Other reason not defined above|1|||
130293362|NCT01533922|469039322|FG003|Overall Study|Other reason not defined above|0|||
130293363|NCT01533922|469039323|FG004|Overall Study|Other reason not defined above|0|||
130293364|NCT02634606|469039326|FG000|Overall Study|unable to obtain the drug at start|13|||
130293365|NCT01267175|469039327|FG000|Overall Study|Withdrawal by Subject|1|||
130293366|NCT01267175|469039327|FG000|Overall Study|Lost to Follow-up|1|||
130293367|NCT00286221|469039330|FG000|Overall Study|Protocol Violation|2|||
130293368|NCT00286221|469039331|FG001|Overall Study|Protocol Violation|1|||
130293369|NCT00286221|469039332|FG002|Overall Study|Protocol Violation|6|||
130293370|NCT00286221|469039333|FG003|Overall Study|Protocol Violation|4|||
130293371|NCT00286221|469039330|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
130293372|NCT00286221|469039331|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
130293373|NCT00286221|469039332|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
130293374|NCT00286221|469039333|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
130293375|NCT00286221|469039330|FG000|Overall Study|Inability to trigger PCA|2|||
130293376|NCT00286221|469039331|FG001|Overall Study|Inability to trigger PCA|0|||
130293377|NCT00286221|469039332|FG002|Overall Study|Inability to trigger PCA|0|||
130293378|NCT00286221|469039333|FG003|Overall Study|Inability to trigger PCA|0|||
130293379|NCT00286221|469039330|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
130293380|NCT00286221|469039331|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
130293381|NCT00286221|469039332|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
130293382|NCT00286221|469039333|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
130293383|NCT02553538|469039335|FG000|Overall Study|Could Not Reach by Telephone|133|||
130293384|NCT02553538|469039336|FG001|Overall Study|Could Not Reach by Telephone|0|||
130293385|NCT02553538|469039335|FG000|Overall Study|Died or Left Network|54|||
130293386|NCT02553538|469039336|FG001|Overall Study|Died or Left Network|56|||
130293387|NCT02690649|469039337|FG000|Overall Study|Withdrawal by Subject|1|||
130293388|NCT02690649|469039338|FG001|Overall Study|Withdrawal by Subject|1|||
130293389|NCT02690649|469039337|FG000|Overall Study|Protocol Violation|0|||
130293390|NCT02690649|469039338|FG001|Overall Study|Protocol Violation|3|||
130293391|NCT02276547|469039339|FG000|Overall Study|Death|2|||
130293392|NCT02276547|469039339|FG000|Overall Study|Explant|2|||
130293393|NCT01754194|469039340|FG000|Overall Study|Lost to Follow-up|39|||
130293394|NCT01754194|469039341|FG001|Overall Study|Lost to Follow-up|14|||
130293395|NCT01754194|469039340|FG000|Overall Study|Withdrawal by Subject|4|||
130293396|NCT01754194|469039341|FG001|Overall Study|Withdrawal by Subject|5|||
130293397|NCT01754194|469039340|FG000|Overall Study|Other|9|||
130293398|NCT01754194|469039341|FG001|Overall Study|Other|8|||
130293399|NCT00907296|469039342|FG000|Overall Study|Ineligibility Determined|1|||
130293400|NCT00907296|469039343|FG001|Overall Study|Ineligibility Determined|0|||
130293401|NCT00907296|469039344|FG002|Overall Study|Ineligibility Determined|0|||
130293402|NCT00907296|469039345|FG003|Overall Study|Ineligibility Determined|1|||
130293403|NCT00907296|469039346|FG004|Overall Study|Ineligibility Determined|0|||
130293404|NCT00907296|469039347|FG005|Overall Study|Ineligibility Determined|0|||
130293405|NCT00907296|469039348|FG006|Overall Study|Ineligibility Determined|0|||
130293406|NCT00907296|469039349|FG007|Overall Study|Ineligibility Determined|1|||
130293407|NCT00907296|469039350|FG008|Overall Study|Ineligibility Determined|0|||
130293408|NCT00907296|469039351|FG009|Overall Study|Ineligibility Determined|0|||
130293409|NCT00907296|469039342|FG000|Overall Study|Protocol Deviation|0|||
130293410|NCT00907296|469039343|FG001|Overall Study|Protocol Deviation|1|||
130046004|NCT01208181|468125639|FG002|Part 1|Adverse Event|0|||
130293411|NCT00907296|469039344|FG002|Overall Study|Protocol Deviation|0|||
130293412|NCT00907296|469039345|FG003|Overall Study|Protocol Deviation|0|||
130293413|NCT00907296|469039346|FG004|Overall Study|Protocol Deviation|0|||
130293414|NCT00907296|469039347|FG005|Overall Study|Protocol Deviation|0|||
130293415|NCT00907296|469039348|FG006|Overall Study|Protocol Deviation|0|||
130293416|NCT00907296|469039349|FG007|Overall Study|Protocol Deviation|0|||
130293417|NCT00907296|469039350|FG008|Overall Study|Protocol Deviation|0|||
130293418|NCT00907296|469039351|FG009|Overall Study|Protocol Deviation|0|||
130293419|NCT00907296|469039342|FG000|Overall Study|Noncompliance|1|||
130293420|NCT00907296|469039343|FG001|Overall Study|Noncompliance|1|||
130293421|NCT00907296|469039344|FG002|Overall Study|Noncompliance|1|||
130293422|NCT00907296|469039345|FG003|Overall Study|Noncompliance|0|||
130293423|NCT00907296|469039346|FG004|Overall Study|Noncompliance|0|||
130293424|NCT00907296|469039347|FG005|Overall Study|Noncompliance|1|||
130293425|NCT00907296|469039348|FG006|Overall Study|Noncompliance|0|||
130293426|NCT00907296|469039349|FG007|Overall Study|Noncompliance|2|||
130293427|NCT00907296|469039350|FG008|Overall Study|Noncompliance|0|||
130293428|NCT00907296|469039351|FG009|Overall Study|Noncompliance|0|||
130293429|NCT00907296|469039342|FG000|Overall Study|Adverse Event|2|||
130293430|NCT00907296|469039343|FG001|Overall Study|Adverse Event|0|||
130293431|NCT00907296|469039344|FG002|Overall Study|Adverse Event|0|||
130293432|NCT00907296|469039345|FG003|Overall Study|Adverse Event|0|||
130293433|NCT00907296|469039346|FG004|Overall Study|Adverse Event|0|||
130293434|NCT00907296|469039347|FG005|Overall Study|Adverse Event|0|||
130293435|NCT00907296|469039348|FG006|Overall Study|Adverse Event|1|||
130293436|NCT00907296|469039349|FG007|Overall Study|Adverse Event|0|||
130293437|NCT00907296|469039350|FG008|Overall Study|Adverse Event|0|||
130293438|NCT00907296|469039351|FG009|Overall Study|Adverse Event|1|||
130293439|NCT00907296|469039342|FG000|Overall Study|Withdrawal by Subject|7|||
130293440|NCT00907296|469039343|FG001|Overall Study|Withdrawal by Subject|2|||
130293441|NCT00907296|469039344|FG002|Overall Study|Withdrawal by Subject|1|||
130293442|NCT00907296|469039345|FG003|Overall Study|Withdrawal by Subject|1|||
130293443|NCT00907296|469039346|FG004|Overall Study|Withdrawal by Subject|1|||
130293444|NCT00907296|469039347|FG005|Overall Study|Withdrawal by Subject|5|||
130293445|NCT00907296|469039348|FG006|Overall Study|Withdrawal by Subject|3|||
130293446|NCT00907296|469039349|FG007|Overall Study|Withdrawal by Subject|2|||
130293447|NCT00907296|469039350|FG008|Overall Study|Withdrawal by Subject|4|||
130293448|NCT00907296|469039351|FG009|Overall Study|Withdrawal by Subject|2|||
130293449|NCT00907296|469039342|FG000|Overall Study|Lost to Follow-up|9|||
130293450|NCT00907296|469039343|FG001|Overall Study|Lost to Follow-up|1|||
130293451|NCT00907296|469039344|FG002|Overall Study|Lost to Follow-up|0|||
130293452|NCT00907296|469039345|FG003|Overall Study|Lost to Follow-up|2|||
130293453|NCT00907296|469039346|FG004|Overall Study|Lost to Follow-up|0|||
130293454|NCT00907296|469039347|FG005|Overall Study|Lost to Follow-up|3|||
130293455|NCT00907296|469039348|FG006|Overall Study|Lost to Follow-up|2|||
130293456|NCT00907296|469039349|FG007|Overall Study|Lost to Follow-up|2|||
130293457|NCT00907296|469039350|FG008|Overall Study|Lost to Follow-up|0|||
129793715|NCT00722371|467212723|FG000|Overall Study|Pregnancy|1|||
129793716|NCT00722371|467212724|FG001|Overall Study|Pregnancy|1|||
129793717|NCT00722371|467212725|FG002|Overall Study|Pregnancy|0|||
129793718|NCT00722371|467212726|FG003|Overall Study|Pregnancy|0|||
129793719|NCT00722371|467212727|FG004|Overall Study|Pregnancy|0|||
129793720|NCT00722371|467212728|FG005|Overall Study|Pregnancy|1|||
129793721|NCT00722371|467212729|FG006|Overall Study|Pregnancy|0|||
129793722|NCT00722371|467212723|FG000|Overall Study|Protocol Violation|6|||
129793723|NCT00722371|467212724|FG001|Overall Study|Protocol Violation|1|||
129793724|NCT00722371|467212725|FG002|Overall Study|Protocol Violation|0|||
129793725|NCT00722371|467212726|FG003|Overall Study|Protocol Violation|1|||
129793726|NCT00722371|467212727|FG004|Overall Study|Protocol Violation|4|||
129793727|NCT00722371|467212728|FG005|Overall Study|Protocol Violation|2|||
129793728|NCT00722371|467212729|FG006|Overall Study|Protocol Violation|1|||
129793729|NCT00722371|467212723|FG000|Overall Study|Withdrawal by Subject|18|||
129793730|NCT00722371|467212724|FG001|Overall Study|Withdrawal by Subject|27|||
130293458|NCT00907296|469039351|FG009|Overall Study|Lost to Follow-up|4|||
130293459|NCT00357656|469039355|FG000|Overall Study|Other, No surgery performed|0|||
130293460|NCT00357656|469039356|FG001|Overall Study|Other, No surgery performed|3|||
129793731|NCT00722371|467212725|FG002|Overall Study|Withdrawal by Subject|19|||
130293461|NCT02573246|469039357|FG000|Overall Study|Lost to Follow-up|2|||
130293462|NCT02573246|469039358|FG001|Overall Study|Lost to Follow-up|0|||
130293463|NCT02573246|469039359|FG002|Overall Study|Lost to Follow-up|0|||
130293464|NCT02573246|469039360|FG003|Overall Study|Lost to Follow-up|0|||
129793732|NCT00722371|467212726|FG003|Overall Study|Withdrawal by Subject|23|||
130293465|NCT02573246|469039361|FG004|Overall Study|Lost to Follow-up|1|||
130293466|NCT02573246|469039357|FG000|Overall Study|Withdrawal by Subject|0|||
130293467|NCT02573246|469039358|FG001|Overall Study|Withdrawal by Subject|0|||
130293468|NCT02573246|469039359|FG002|Overall Study|Withdrawal by Subject|0|||
129793733|NCT00722371|467212727|FG004|Overall Study|Withdrawal by Subject|19|||
129793734|NCT00722371|467212728|FG005|Overall Study|Withdrawal by Subject|18|||
129793735|NCT00722371|467212729|FG006|Overall Study|Withdrawal by Subject|26|||
130293469|NCT02573246|469039360|FG003|Overall Study|Withdrawal by Subject|0|||
130293470|NCT02573246|469039361|FG004|Overall Study|Withdrawal by Subject|1|||
130293471|NCT02573246|469039357|FG000|Overall Study|Physician Decision|1|||
130293472|NCT02573246|469039358|FG001|Overall Study|Physician Decision|1|||
130293473|NCT02573246|469039359|FG002|Overall Study|Physician Decision|3|||
130293474|NCT02573246|469039360|FG003|Overall Study|Physician Decision|2|||
130293475|NCT02573246|469039361|FG004|Overall Study|Physician Decision|2|||
130293476|NCT01219933|469039362|FG000|Overall Study|Adverse Event|8|||
130293477|NCT01219933|469039362|FG000|Overall Study|No LDA reached|5|||
130293478|NCT01219933|469039362|FG000|Overall Study|No LDA maintained|7|||
130293479|NCT01219933|469039362|FG000|Overall Study|Lost to Follow-up|3|||
130293480|NCT01219933|469039362|FG000|Overall Study|GC free|1|||
130293481|NCT01219933|469039362|FG000|Overall Study|Withdrawal by Subject|5|||
130293482|NCT01219933|469039362|FG000|Overall Study|Protocol Violation|8|||
130293483|NCT01219933|469039362|FG000|Overall Study|Lack of Efficacy|1|||
130293484|NCT03149003|469039363|FG000|Overall Study|Randomized but not treated|0|||
130293485|NCT03149003|469039364|FG001|Overall Study|Randomized but not treated|1|||
130293486|NCT03149003|469039365|FG002|Overall Study|Randomized but not treated|18|||
130293487|NCT02900170|469039367|FG000|Overall Study|Lost to Follow-up|8|||
130293488|NCT01565941|469039368|FG000|Overall Study|Withdrawn by parent/guardian|3|||
130293489|NCT01565941|469039369|FG001|Overall Study|Withdrawn by parent/guardian|2|||
130293490|NCT01565941|469039368|FG000|Overall Study|Randomized; did not receive intevention|8|||
130293491|NCT01565941|469039369|FG001|Overall Study|Randomized; did not receive intevention|2|||
130293492|NCT03262116|469039370|FG000|Overall Study|Physician Decision|0|||
130293493|NCT03262116|469039371|FG001|Overall Study|Physician Decision|2|||
130293494|NCT03262116|469039372|FG002|Overall Study|Physician Decision|1|||
130293495|NCT03262116|469039373|FG003|Overall Study|Physician Decision|1|||
130293496|NCT03262116|469039374|FG004|Overall Study|Physician Decision|1|||
130293497|NCT03262116|469039375|FG005|Overall Study|Physician Decision|2|||
130293498|NCT02365285|469039376|FG000|Overall Study|Physician Decision|0|||
130293499|NCT02365285|469039377|FG001|Overall Study|Physician Decision|1|||
130293500|NCT02365285|469039378|FG002|Overall Study|Physician Decision|1|||
130293501|NCT02365285|469039379|FG003|Overall Study|Physician Decision|0|||
130293502|NCT02365285|469039376|FG000|Overall Study|Adverse Event|0|||
130293503|NCT02365285|469039377|FG001|Overall Study|Adverse Event|0|||
130293504|NCT02365285|469039378|FG002|Overall Study|Adverse Event|0|||
130293505|NCT02365285|469039379|FG003|Overall Study|Adverse Event|2|||
130293506|NCT02608450|469039382|FG000|Overall Study|Lost to Follow-up|39|||
130293507|NCT02608450|469039383|FG001|Overall Study|Lost to Follow-up|32|||
130293508|NCT02608450|469039382|FG000|Overall Study|Withdrawal by Subject|21|||
130293509|NCT02608450|469039383|FG001|Overall Study|Withdrawal by Subject|15|||
130293510|NCT02608450|469039382|FG000|Overall Study|Adverse Event|3|||
130293511|NCT02608450|469039383|FG001|Overall Study|Adverse Event|6|||
130293512|NCT02608450|469039382|FG000|Overall Study|Withdrawal by parent|2|||
130293513|NCT02608450|469039383|FG001|Overall Study|Withdrawal by parent|3|||
130293514|NCT02608450|469039382|FG000|Overall Study|Lack of Efficacy|0|||
130293515|NCT02608450|469039383|FG001|Overall Study|Lack of Efficacy|3|||
130293516|NCT02608450|469039382|FG000|Overall Study|Noncompliance with study drug|0|||
130293517|NCT02608450|469039383|FG001|Overall Study|Noncompliance with study drug|2|||
130293518|NCT02608450|469039382|FG000|Overall Study|Physician Decision|0|||
130293519|NCT02608450|469039383|FG001|Overall Study|Physician Decision|1|||
130293520|NCT02608450|469039382|FG000|Overall Study|Pregnancy|0|||
130293521|NCT02608450|469039383|FG001|Overall Study|Pregnancy|1|||
130293522|NCT02608450|469039382|FG000|Overall Study|Progressive disease|1|||
130293523|NCT02608450|469039383|FG001|Overall Study|Progressive disease|0|||
130293524|NCT02608450|469039382|FG000|Overall Study|Multiple reasons|0|||
130293525|NCT02608450|469039383|FG001|Overall Study|Multiple reasons|2|||
130293526|NCT00249613|469039386|FG000|12 Month Follow-up|Death|1|||
130293527|NCT00249613|469039387|FG001|12 Month Follow-up|Death|1|||
130293528|NCT00249613|469039386|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
130293529|NCT00249613|469039387|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
130293530|NCT00249613|469039386|FG000|12 Month Follow-up|Lost to Follow-up|10|||
130293531|NCT00249613|469039387|FG001|12 Month Follow-up|Lost to Follow-up|8|||
130293532|NCT00424190|469039388|FG000|Overall Study|Withdrew consent|3|||
130293533|NCT00424190|469039389|FG001|Overall Study|Withdrew consent|4|||
130293534|NCT00424190|469039388|FG000|Overall Study|Death|3|||
130293535|NCT00424190|469039389|FG001|Overall Study|Death|0|||
130293536|NCT00424190|469039388|FG000|Overall Study|Noncompliance|1|||
130293537|NCT00424190|469039389|FG001|Overall Study|Noncompliance|2|||
130293538|NCT00424190|469039388|FG000|Overall Study|Request of sponsor or investigator|0|||
130293539|NCT00424190|469039389|FG001|Overall Study|Request of sponsor or investigator|2|||
129793736|NCT01092832|467212730|FG000|Overall Study|Other|1|||
129793737|NCT01092832|467212731|FG001|Overall Study|Other|0|||
130293540|NCT00424190|469039388|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
130293541|NCT00424190|469039389|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
130293542|NCT00424190|469039388|FG000|Overall Study|Other|15|||
130293543|NCT00424190|469039389|FG001|Overall Study|Other|21|||
130293544|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
130293545|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
130293546|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
130293547|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
130293548|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
130293549|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
130293550|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
130293551|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
130293552|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
130293553|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130293554|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130293555|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
130293556|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
130293557|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
130293558|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
130293559|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
130293560|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
130293561|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
130293562|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
130293563|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
130293564|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
130293565|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
130293566|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
130293567|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
130293568|NCT01672866|469039390|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
130293569|NCT01672866|469039391|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
130293570|NCT01672866|469039392|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
130293571|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
130293572|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
130293573|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
130293574|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
130293575|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
130293576|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
130293577|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
130293578|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
130293579|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
130293580|NCT01672866|469039390|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
130293581|NCT01672866|469039391|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
130293582|NCT01672866|469039392|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
130293583|NCT01378429|469039395|FG000|Overall Study|Noncompliance with study drug|1|||
130293584|NCT01378429|469039396|FG001|Overall Study|Noncompliance with study drug|0|||
130293585|NCT02241187|469039397|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
130293586|NCT00199888|469039398|FG000|Overall Study|Lost to Follow-up|1|||
130293587|NCT05219669|469039399|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293588|NCT05219669|469039400|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293589|NCT05219669|469039401|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
130293590|NCT05219669|469039402|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293591|NCT05219669|469039403|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293592|NCT05219669|469039404|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
130293593|NCT02544373|469039406|FG000|Overall Study|Lost to Follow-up|5|||
130293594|NCT02544373|469039407|FG001|Overall Study|Lost to Follow-up|3|||
130293595|NCT02544373|469039406|FG000|Overall Study|Withdrawal by Subject|8|||
130293596|NCT02544373|469039407|FG001|Overall Study|Withdrawal by Subject|2|||
130293597|NCT02621073|469039408|FG000|Overall Study|Lost to Follow-up|0|||
130293598|NCT02621073|469039409|FG001|Overall Study|Lost to Follow-up|1|||
130293599|NCT02621073|469039408|FG000|Overall Study|Physician Decision|3|||
130293600|NCT02621073|469039409|FG001|Overall Study|Physician Decision|2|||
130293601|NCT01440881|469039410|FG000|Overall Study|Death|0|||
130293602|NCT01440881|469039411|FG001|Overall Study|Death|1|||
129888588|NCT02269943|467549244|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
129888589|NCT02269943|467549245|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
130293603|NCT02383433|469039414|FG000|Overall Study|Disease progression|2|||
130293604|NCT02920957|469039415|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
130293605|NCT02920957|469039416|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
130293606|NCT02920957|469039415|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
130293607|NCT02920957|469039416|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
130293608|NCT02920957|469039415|FG000|First Intervention : 1 Month|Adverse Event|1|||
130293609|NCT02920957|469039416|FG001|First Intervention : 1 Month|Adverse Event|0|||
130293610|NCT02920957|469039415|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
130293611|NCT02920957|469039416|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
130293612|NCT01345682|469039422|FG000|Overall Study|Progressive disease per RECIST|226|||
130293613|NCT01345682|469039423|FG001|Overall Study|Progressive disease per RECIST|93|||
130293614|NCT01345682|469039422|FG000|Overall Study|Worsening of underlying cancer disease|23|||
130293615|NCT01345682|469039423|FG001|Overall Study|Worsening of underlying cancer disease|12|||
130293616|NCT01345682|469039422|FG000|Overall Study|Adverse Event|51|||
130293617|NCT01345682|469039423|FG001|Overall Study|Adverse Event|41|||
130293618|NCT01345682|469039422|FG000|Overall Study|Non-compliance with protocol|0|||
130293619|NCT01345682|469039423|FG001|Overall Study|Non-compliance with protocol|1|||
130293620|NCT01345682|469039422|FG000|Overall Study|Lost to Follow-up|0|||
130293621|NCT01345682|469039423|FG001|Overall Study|Lost to Follow-up|1|||
130293622|NCT01345682|469039422|FG000|Overall Study|Refused to continue trial medication|16|||
130293623|NCT01345682|469039423|FG001|Overall Study|Refused to continue trial medication|9|||
130293624|NCT01345682|469039422|FG000|Overall Study|Not treated|2|||
130293625|NCT01345682|469039423|FG001|Overall Study|Not treated|1|||
130293626|NCT01345682|469039422|FG000|Overall Study|Reason other than those specified above|4|||
130293627|NCT01345682|469039423|FG001|Overall Study|Reason other than those specified above|3|||
130293628|NCT01075984|469039428|FG000|Treatment Phase|Adverse Event|0|||
130293629|NCT01075984|469039429|FG001|Treatment Phase|Adverse Event|1|||
130293630|NCT01075984|469039430|FG002|Treatment Phase|Adverse Event|3|||
130293631|NCT01075984|469039431|FG003|Treatment Phase|Adverse Event|7|||
130293632|NCT01075984|469039432|FG004|Treatment Phase|Adverse Event|35|||
130293633|NCT01075984|469039428|FG000|Treatment Phase|Protocol Violation|0|||
130293634|NCT01075984|469039429|FG001|Treatment Phase|Protocol Violation|0|||
130293635|NCT01075984|469039430|FG002|Treatment Phase|Protocol Violation|1|||
130293636|NCT01075984|469039431|FG003|Treatment Phase|Protocol Violation|0|||
130293637|NCT01075984|469039432|FG004|Treatment Phase|Protocol Violation|3|||
130293638|NCT01075984|469039428|FG000|Treatment Phase|Withdrawal by Subject|0|||
130293639|NCT01075984|469039429|FG001|Treatment Phase|Withdrawal by Subject|0|||
130293640|NCT01075984|469039430|FG002|Treatment Phase|Withdrawal by Subject|2|||
130293641|NCT01075984|469039431|FG003|Treatment Phase|Withdrawal by Subject|0|||
130293642|NCT01075984|469039432|FG004|Treatment Phase|Withdrawal by Subject|15|||
130293643|NCT01075984|469039428|FG000|Treatment Phase|Treatment Failure|0|||
130293644|NCT01075984|469039429|FG001|Treatment Phase|Treatment Failure|0|||
130293645|NCT01075984|469039430|FG002|Treatment Phase|Treatment Failure|1|||
130293646|NCT01075984|469039431|FG003|Treatment Phase|Treatment Failure|0|||
130293647|NCT01075984|469039432|FG004|Treatment Phase|Treatment Failure|5|||
130293648|NCT01075984|469039428|FG000|Treatment Phase|Progression of disease|0|||
130293649|NCT01075984|469039429|FG001|Treatment Phase|Progression of disease|0|||
130293650|NCT01075984|469039430|FG002|Treatment Phase|Progression of disease|0|||
130293651|NCT01075984|469039431|FG003|Treatment Phase|Progression of disease|0|||
130293652|NCT01075984|469039432|FG004|Treatment Phase|Progression of disease|2|||
130293653|NCT01075984|469039428|FG000|Follow-up Phase|Protocol Violation|0|||
130293654|NCT01075984|469039429|FG001|Follow-up Phase|Protocol Violation|0|||
130293655|NCT01075984|469039430|FG002|Follow-up Phase|Protocol Violation|1|||
129793738|NCT02068768|467212732|FG000|Overall Study|Lost to Follow-up|5|||
130293656|NCT01075984|469039431|FG003|Follow-up Phase|Protocol Violation|0|||
130293657|NCT01075984|469039432|FG004|Follow-up Phase|Protocol Violation|3|||
130293658|NCT01075984|469039428|FG000|Follow-up Phase|Adverse Event|0|||
130293659|NCT01075984|469039429|FG001|Follow-up Phase|Adverse Event|0|||
130293660|NCT01075984|469039430|FG002|Follow-up Phase|Adverse Event|0|||
130293661|NCT01075984|469039431|FG003|Follow-up Phase|Adverse Event|2|||
130293662|NCT01075984|469039432|FG004|Follow-up Phase|Adverse Event|27|||
130293663|NCT01075984|469039428|FG000|Follow-up Phase|Administrative|0|||
129793739|NCT02068768|467212732|FG000|Overall Study|Early Termination by Sponsor|2|||
130293664|NCT01075984|469039429|FG001|Follow-up Phase|Administrative|0|||
129793740|NCT00555425|467212733|FG000|Overall Study|Missed Medication > 1 wk|34|||
129793741|NCT00555425|467212734|FG001|Overall Study|Missed Medication > 1 wk|15|||
130293665|NCT01075984|469039430|FG002|Follow-up Phase|Administrative|0|||
130293666|NCT01075984|469039431|FG003|Follow-up Phase|Administrative|0|||
130293667|NCT01075984|469039432|FG004|Follow-up Phase|Administrative|1|||
130293668|NCT01075984|469039428|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130293669|NCT01075984|469039429|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130293670|NCT01075984|469039430|FG002|Follow-up Phase|Withdrawal by Subject|0|||
130293671|NCT01075984|469039431|FG003|Follow-up Phase|Withdrawal by Subject|0|||
130293672|NCT01075984|469039432|FG004|Follow-up Phase|Withdrawal by Subject|10|||
130293673|NCT01075984|469039428|FG000|Follow-up Phase|Progression of disease|0|||
130293674|NCT01075984|469039429|FG001|Follow-up Phase|Progression of disease|0|||
130293675|NCT01075984|469039430|FG002|Follow-up Phase|Progression of disease|0|||
130293676|NCT01075984|469039431|FG003|Follow-up Phase|Progression of disease|0|||
130293677|NCT01075984|469039432|FG004|Follow-up Phase|Progression of disease|2|||
130046005|NCT01208181|468125640|FG003|Part 1|Adverse Event|0|||
130046006|NCT01208181|468125641|FG004|Part 1|Adverse Event|4|||
130293678|NCT01075984|469039428|FG000|Follow-up Phase|Treatment failure|0|||
130293679|NCT01075984|469039429|FG001|Follow-up Phase|Treatment failure|0|||
130293680|NCT01075984|469039430|FG002|Follow-up Phase|Treatment failure|0|||
130293681|NCT01075984|469039431|FG003|Follow-up Phase|Treatment failure|0|||
130293682|NCT01075984|469039432|FG004|Follow-up Phase|Treatment failure|4|||
130293683|NCT02440789|469039433|FG000|Overall Study|Withdrawal by Subject|3|||
130293684|NCT02440789|469039433|FG000|Overall Study|Not willing to adhere to reqs|1|||
130293685|NCT03684694|469039436|FG000|Phase 1|Withdrawal by Subject|1|||
130293686|NCT03684694|469039437|FG001|Phase 1|Withdrawal by Subject|0|||
130293687|NCT03684694|469039438|FG002|Phase 1|Withdrawal by Subject|0|||
130293688|NCT03684694|469039439|FG003|Phase 1|Withdrawal by Subject|0|||
130293689|NCT03684694|469039440|FG004|Phase 1|Withdrawal by Subject|0|||
130293690|NCT03684694|469039441|FG005|Phase 1|Withdrawal by Subject|0|||
130293691|NCT03684694|469039436|FG000|Phase 1|Investigator/Sponsor Decision|12|||
130293692|NCT03684694|469039437|FG001|Phase 1|Investigator/Sponsor Decision|2|||
130293693|NCT03684694|469039438|FG002|Phase 1|Investigator/Sponsor Decision|1|||
130293694|NCT03684694|469039439|FG003|Phase 1|Investigator/Sponsor Decision|0|||
130293695|NCT03684694|469039440|FG004|Phase 1|Investigator/Sponsor Decision|0|||
130293696|NCT03684694|469039441|FG005|Phase 1|Investigator/Sponsor Decision|0|||
130293697|NCT03684694|469039436|FG000|Phase 1|Death|24|||
130293698|NCT03684694|469039437|FG001|Phase 1|Death|0|||
130293699|NCT03684694|469039438|FG002|Phase 1|Death|3|||
130293700|NCT03684694|469039439|FG003|Phase 1|Death|0|||
130293701|NCT03684694|469039440|FG004|Phase 1|Death|0|||
130293702|NCT03684694|469039441|FG005|Phase 1|Death|0|||
130293703|NCT03684694|469039436|FG000|Phase 1|Lost to Follow-up|0|||
130293704|NCT03684694|469039437|FG001|Phase 1|Lost to Follow-up|0|||
130293705|NCT03684694|469039438|FG002|Phase 1|Lost to Follow-up|1|||
130293706|NCT03684694|469039439|FG003|Phase 1|Lost to Follow-up|0|||
130293707|NCT03684694|469039440|FG004|Phase 1|Lost to Follow-up|0|||
130293708|NCT03684694|469039441|FG005|Phase 1|Lost to Follow-up|0|||
130293709|NCT03684694|469039436|FG000|Phase 1|Miscellaneous|0|||
130293710|NCT03684694|469039437|FG001|Phase 1|Miscellaneous|1|||
130293711|NCT03684694|469039438|FG002|Phase 1|Miscellaneous|0|||
130293712|NCT03684694|469039439|FG003|Phase 1|Miscellaneous|0|||
130293713|NCT03684694|469039440|FG004|Phase 1|Miscellaneous|0|||
130293714|NCT03684694|469039441|FG005|Phase 1|Miscellaneous|0|||
130293715|NCT03684694|469039436|FG000|Phase 2|Withdrawal by Subject|0|||
130293716|NCT03684694|469039437|FG001|Phase 2|Withdrawal by Subject|0|||
130293717|NCT03684694|469039438|FG002|Phase 2|Withdrawal by Subject|0|||
130293718|NCT03684694|469039439|FG003|Phase 2|Withdrawal by Subject|0|||
130293719|NCT03684694|469039440|FG004|Phase 2|Withdrawal by Subject|0|||
130293720|NCT03684694|469039441|FG005|Phase 2|Withdrawal by Subject|1|||
130293721|NCT03684694|469039436|FG000|Phase 2|Investigator/Sponsor Decision|0|||
130293722|NCT03684694|469039437|FG001|Phase 2|Investigator/Sponsor Decision|0|||
130293723|NCT03684694|469039438|FG002|Phase 2|Investigator/Sponsor Decision|0|||
130293724|NCT03684694|469039439|FG003|Phase 2|Investigator/Sponsor Decision|17|||
130293725|NCT03684694|469039440|FG004|Phase 2|Investigator/Sponsor Decision|16|||
130293726|NCT03684694|469039441|FG005|Phase 2|Investigator/Sponsor Decision|6|||
130293727|NCT03684694|469039436|FG000|Phase 2|Death|0|||
130293728|NCT03684694|469039437|FG001|Phase 2|Death|0|||
130293729|NCT03684694|469039438|FG002|Phase 2|Death|0|||
130293730|NCT03684694|469039439|FG003|Phase 2|Death|28|||
130293731|NCT03684694|469039440|FG004|Phase 2|Death|14|||
130293732|NCT03684694|469039441|FG005|Phase 2|Death|3|||
130293733|NCT03684694|469039436|FG000|Phase 2|Lost to Follow-up|0|||
130293734|NCT03684694|469039437|FG001|Phase 2|Lost to Follow-up|0|||
130293735|NCT03684694|469039438|FG002|Phase 2|Lost to Follow-up|0|||
130293736|NCT03684694|469039439|FG003|Phase 2|Lost to Follow-up|1|||
130293737|NCT03684694|469039440|FG004|Phase 2|Lost to Follow-up|0|||
129888590|NCT02269943|467549244|FG000|Follow-Up Survival Period|Alive|2|||
130046007|NCT01208181|468125637|FG000|Part 2|Adverse Event|0|||
130293738|NCT03684694|469039441|FG005|Phase 2|Lost to Follow-up|0|||
130293739|NCT03684694|469039436|FG000|Phase 2|Miscellaneous|0|||
130293740|NCT03684694|469039437|FG001|Phase 2|Miscellaneous|0|||
130293741|NCT03684694|469039438|FG002|Phase 2|Miscellaneous|0|||
130046008|NCT01208181|468125638|FG001|Part 2|Adverse Event|0|||
130293742|NCT03684694|469039439|FG003|Phase 2|Miscellaneous|3|||
130293743|NCT03684694|469039440|FG004|Phase 2|Miscellaneous|0|||
130293744|NCT03684694|469039441|FG005|Phase 2|Miscellaneous|0|||
130293745|NCT03172130|469040854|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
130293746|NCT03172130|469040855|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
130293747|NCT02831933|469040859|FG000|Overall Study|Physician Decision|11|||
130293748|NCT05065190|469040865|FG000|Overall Study|Other than listed|2|||
130293749|NCT05065190|469040866|FG001|Overall Study|Other than listed|12|||
130046009|NCT01208181|468125639|FG002|Part 2|Adverse Event|6|||
130293750|NCT05065190|469040865|FG000|Overall Study|Lack of Efficacy|4|||
130293751|NCT05065190|469040866|FG001|Overall Study|Lack of Efficacy|0|||
130293752|NCT05065190|469040865|FG000|Overall Study|Adverse Event|1|||
130293753|NCT05065190|469040866|FG001|Overall Study|Adverse Event|10|||
130293754|NCT02769962|469040873|FG000|Overall Study|Physician Decision|0|||
130293755|NCT02769962|469040874|FG001|Overall Study|Physician Decision|0|||
130293756|NCT02769962|469040875|FG002|Overall Study|Physician Decision|0|||
130293757|NCT02769962|469040876|FG003|Overall Study|Physician Decision|0|||
130293758|NCT02769962|469040877|FG004|Overall Study|Physician Decision|0|||
130293759|NCT02769962|469040878|FG005|Overall Study|Physician Decision|1|||
130293760|NCT02769962|469040879|FG006|Overall Study|Physician Decision|0|||
130293761|NCT02769962|469040880|FG007|Overall Study|Physician Decision|1|||
130293762|NCT02769962|469040873|FG000|Overall Study|Refused further treatment|0|||
130293763|NCT02769962|469040874|FG001|Overall Study|Refused further treatment|0|||
130293764|NCT02769962|469040875|FG002|Overall Study|Refused further treatment|0|||
130293765|NCT02769962|469040876|FG003|Overall Study|Refused further treatment|0|||
130293766|NCT02769962|469040877|FG004|Overall Study|Refused further treatment|0|||
130293767|NCT02769962|469040878|FG005|Overall Study|Refused further treatment|1|||
130293768|NCT02769962|469040879|FG006|Overall Study|Refused further treatment|1|||
130293769|NCT02769962|469040880|FG007|Overall Study|Refused further treatment|0|||
130293770|NCT01073930|469040882|FG000|Overall Study|Withdrawal by Subject|3|||
130293771|NCT01073930|469040883|FG001|Overall Study|Withdrawal by Subject|2|||
130293772|NCT01073930|469040882|FG000|Overall Study|Lost to Follow-up|0|||
130293773|NCT01073930|469040883|FG001|Overall Study|Lost to Follow-up|1|||
130293774|NCT01073930|469040882|FG000|Overall Study|Adverse Event|0|||
130293775|NCT01073930|469040883|FG001|Overall Study|Adverse Event|1|||
130293776|NCT01073930|469040882|FG000|Overall Study|Noncompliance with study drug|0|||
130293777|NCT01073930|469040883|FG001|Overall Study|Noncompliance with study drug|1|||
130293778|NCT01073930|469040882|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
130293779|NCT01073930|469040883|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
130293780|NCT01022424|469040884|FG000|Overall Study|Adverse Event|1|||
130293781|NCT01022424|469040884|FG000|Overall Study|Physician Decision|1|||
130293782|NCT01022424|469040884|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
130293783|NCT01266590|469040885|FG000|Overall Study|Adverse Event|3|||
130293784|NCT01266590|469040885|FG000|Overall Study|Lost to Follow-up|1|||
130293785|NCT01266590|469040885|FG000|Overall Study|Withdrawal by Subject|1|||
130293786|NCT01266590|469040885|FG000|Overall Study|Physician Decision|1|||
130293787|NCT02783170|469040888|FG000|Overall Study|Randomized but not Vaccinated|1|||
130293788|NCT02783170|469040889|FG001|Overall Study|Randomized but not Vaccinated|0|||
130293789|NCT03320330|469040890|FG000|Overall Study|Lack of Efficacy|5|||
130293790|NCT03320330|469040891|FG001|Overall Study|Lack of Efficacy|5|||
130293791|NCT03320330|469040892|FG002|Overall Study|Lack of Efficacy|14|||
130293792|NCT03320330|469040890|FG000|Overall Study|Physician Decision|1|||
130293793|NCT03320330|469040891|FG001|Overall Study|Physician Decision|0|||
130293794|NCT03320330|469040892|FG002|Overall Study|Physician Decision|0|||
130293795|NCT04692077|469040894|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
130293796|NCT03826342|469040895|FG000|Overall Study|Withdrawal by Subject|8|||
130293797|NCT03826342|469040896|FG001|Overall Study|Withdrawal by Subject|1|||
130293798|NCT03826342|469040895|FG000|Overall Study|Lost to Follow-up|7|||
130293799|NCT03826342|469040896|FG001|Overall Study|Lost to Follow-up|7|||
130293800|NCT03826342|469040895|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
130293801|NCT03826342|469040896|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
130293802|NCT02046070|469040900|FG000|Overall Study|Progressive Disease|18|||
130293803|NCT02046070|469040901|FG001|Overall Study|Progressive Disease|11|||
130293804|NCT02046070|469040902|FG002|Overall Study|Progressive Disease|40|||
130293805|NCT02046070|469040900|FG000|Overall Study|Adverse Event|8|||
130293806|NCT02046070|469040901|FG001|Overall Study|Adverse Event|10|||
130293807|NCT02046070|469040902|FG002|Overall Study|Adverse Event|17|||
130293808|NCT02046070|469040900|FG000|Overall Study|Withdrawal by Subject|1|||
130293809|NCT02046070|469040901|FG001|Overall Study|Withdrawal by Subject|2|||
130293810|NCT02046070|469040902|FG002|Overall Study|Withdrawal by Subject|6|||
130293811|NCT02046070|469040900|FG000|Overall Study|Study Terminated by Sponsor|1|||
130293812|NCT02046070|469040901|FG001|Overall Study|Study Terminated by Sponsor|1|||
130293813|NCT02046070|469040902|FG002|Overall Study|Study Terminated by Sponsor|1|||
129793742|NCT00555425|467212733|FG000|Overall Study|Missed 3 physician management visits|1|||
129793743|NCT00555425|467212734|FG001|Overall Study|Missed 3 physician management visits|0|||
129793744|NCT00555425|467212733|FG000|Overall Study|Met criteria for protective transfer|16|||
129793745|NCT00555425|467212734|FG001|Overall Study|Met criteria for protective transfer|3|||
129793746|NCT00555425|467212733|FG000|Overall Study|Became pregnant and transferred care|0|||
129793747|NCT00555425|467212734|FG001|Overall Study|Became pregnant and transferred care|1|||
129888591|NCT02269943|467549245|FG001|Follow-Up Survival Period|Alive|8|||
130293814|NCT02046070|469040900|FG000|Overall Study|Reason not Specified|4|||
130293815|NCT02046070|469040901|FG001|Overall Study|Reason not Specified|4|||
130293816|NCT02046070|469040902|FG002|Overall Study|Reason not Specified|6|||
130293817|NCT04030962|469040903|FG000|Stage 2|Adverse Event|0|||
130293818|NCT04030962|469040904|FG001|Stage 2|Adverse Event|0|||
130293819|NCT04030962|469040905|FG002|Stage 2|Adverse Event|0|||
130293820|NCT04030962|469040906|FG003|Stage 2|Adverse Event|0|||
130293821|NCT04030962|469040907|FG004|Stage 2|Adverse Event|0|||
130293822|NCT04030962|469040908|FG005|Stage 2|Adverse Event|0|||
130293823|NCT04030962|469040909|FG006|Stage 2|Adverse Event|0|||
130293824|NCT04030962|469040910|FG007|Stage 2|Adverse Event|0|||
130293825|NCT04030962|469040911|FG008|Stage 2|Adverse Event|1|||
130293826|NCT04030962|469040912|FG009|Stage 2|Adverse Event|0|||
130293827|NCT04030962|469040913|FG010|Stage 2|Adverse Event|1|||
130293828|NCT04030962|469040914|FG011|Stage 2|Adverse Event|1|||
130293829|NCT04030962|469040915|FG012|Stage 2|Adverse Event|1|||
130293830|NCT04030962|469040903|FG000|Stage 2|Withdrawal by Subject|0|||
130293831|NCT04030962|469040904|FG001|Stage 2|Withdrawal by Subject|0|||
130293832|NCT04030962|469040905|FG002|Stage 2|Withdrawal by Subject|0|||
130293833|NCT04030962|469040906|FG003|Stage 2|Withdrawal by Subject|0|||
130293834|NCT04030962|469040907|FG004|Stage 2|Withdrawal by Subject|0|||
130293835|NCT04030962|469040908|FG005|Stage 2|Withdrawal by Subject|0|||
130293836|NCT04030962|469040909|FG006|Stage 2|Withdrawal by Subject|0|||
130293837|NCT04030962|469040910|FG007|Stage 2|Withdrawal by Subject|0|||
130293838|NCT04030962|469040911|FG008|Stage 2|Withdrawal by Subject|1|||
130293839|NCT04030962|469040912|FG009|Stage 2|Withdrawal by Subject|0|||
130293840|NCT04030962|469040913|FG010|Stage 2|Withdrawal by Subject|0|||
130293841|NCT04030962|469040914|FG011|Stage 2|Withdrawal by Subject|2|||
130293842|NCT04030962|469040915|FG012|Stage 2|Withdrawal by Subject|1|||
130293843|NCT04030962|469040903|FG000|Stage 2|Lost to Follow-up|0|||
130293844|NCT04030962|469040904|FG001|Stage 2|Lost to Follow-up|0|||
130293845|NCT04030962|469040905|FG002|Stage 2|Lost to Follow-up|0|||
130293846|NCT04030962|469040906|FG003|Stage 2|Lost to Follow-up|0|||
130293847|NCT04030962|469040907|FG004|Stage 2|Lost to Follow-up|0|||
130293848|NCT04030962|469040908|FG005|Stage 2|Lost to Follow-up|0|||
130293849|NCT04030962|469040909|FG006|Stage 2|Lost to Follow-up|0|||
130293850|NCT04030962|469040910|FG007|Stage 2|Lost to Follow-up|0|||
130293851|NCT04030962|469040911|FG008|Stage 2|Lost to Follow-up|1|||
130293852|NCT04030962|469040912|FG009|Stage 2|Lost to Follow-up|0|||
130293853|NCT04030962|469040913|FG010|Stage 2|Lost to Follow-up|0|||
130293854|NCT04030962|469040914|FG011|Stage 2|Lost to Follow-up|0|||
130293855|NCT04030962|469040915|FG012|Stage 2|Lost to Follow-up|0|||
130293856|NCT04030962|469040903|FG000|Stage 2|Technical Problems|0|||
130293857|NCT04030962|469040904|FG001|Stage 2|Technical Problems|0|||
130293858|NCT04030962|469040905|FG002|Stage 2|Technical Problems|0|||
130293859|NCT04030962|469040906|FG003|Stage 2|Technical Problems|0|||
130293860|NCT04030962|469040907|FG004|Stage 2|Technical Problems|0|||
130293861|NCT04030962|469040908|FG005|Stage 2|Technical Problems|0|||
130293862|NCT04030962|469040909|FG006|Stage 2|Technical Problems|0|||
130293863|NCT04030962|469040910|FG007|Stage 2|Technical Problems|0|||
130293864|NCT04030962|469040911|FG008|Stage 2|Technical Problems|0|||
130293865|NCT04030962|469040912|FG009|Stage 2|Technical Problems|0|||
130293866|NCT04030962|469040913|FG010|Stage 2|Technical Problems|0|||
130293867|NCT04030962|469040914|FG011|Stage 2|Technical Problems|1|||
130293868|NCT04030962|469040915|FG012|Stage 2|Technical Problems|0|||
130293869|NCT05601102|469040918|FG000|Overall Study|Death|1|||
130293870|NCT05601102|469040919|FG001|Overall Study|Death|2|||
130293871|NCT05601102|469040918|FG000|Overall Study|Withdrawal by Subject|1|||
130293872|NCT05601102|469040919|FG001|Overall Study|Withdrawal by Subject|1|||
130293873|NCT05601102|469040918|FG000|Overall Study|Lost to Follow-up|0|||
130293874|NCT05601102|469040919|FG001|Overall Study|Lost to Follow-up|2|||
130293875|NCT05288166|469040920|FG000|Overall Study|Adverse Event|1|||
130293876|NCT05288166|469040921|FG001|Overall Study|Adverse Event|0|||
130293877|NCT05288166|469040920|FG000|Overall Study|Lost to Follow-up|2|||
130293878|NCT05288166|469040921|FG001|Overall Study|Lost to Follow-up|0|||
130293879|NCT05288166|469040920|FG000|Overall Study|Physician Decision|0|||
130293880|NCT05288166|469040921|FG001|Overall Study|Physician Decision|2|||
130293881|NCT05288166|469040920|FG000|Overall Study|Screen Failure|1|||
130293882|NCT05288166|469040921|FG001|Overall Study|Screen Failure|1|||
130293883|NCT05288166|469040920|FG000|Overall Study|Withdrawal by Subject|4|||
130293884|NCT05288166|469040921|FG001|Overall Study|Withdrawal by Subject|2|||
130293885|NCT05288166|469040920|FG000|Overall Study|On Study Treatment|408|||
130293886|NCT05288166|469040921|FG001|Overall Study|On Study Treatment|418|||
130293887|NCT02981524|469040923|FG000|Overall Study|Progressive Disease|14|||
130293888|NCT02981524|469040923|FG000|Overall Study|Death (unrelated)|1|||
130293889|NCT02981524|469040923|FG000|Overall Study|Treatment Related Toxicity|1|||
130293890|NCT02981524|469040923|FG000|Overall Study|Withdrawal by Subject|1|||
130293891|NCT00895661|469040927|FG000|Overall Study|Death|1|||
130293892|NCT00895661|469040927|FG000|Overall Study|reason unknown|2|||
130293893|NCT04094584|469040928|FG000|Overall Study|No interest in study|88|||
130293894|NCT04094584|469040928|FG000|Overall Study|Unwilling to undergo screening tests|36|||
130293895|NCT04094584|469040928|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
130293896|NCT04094584|469040928|FG000|Overall Study|Opioid use|7|||
130293897|NCT04094584|469040928|FG000|Overall Study|Need for major surgery in study period|4|||
130293898|NCT04094584|469040928|FG000|Overall Study|eligible but declined enrollment|4|||
130293899|NCT04094584|469040928|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
130293900|NCT04094584|469040928|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
130293901|NCT04094584|469040928|FG000|Overall Study|Lost to Follow-up|3|||
130293902|NCT04094584|469040928|FG000|Overall Study|Withdrawal by Subject|2|||
130293903|NCT00791557|469040929|FG000|Overall Study|Adverse Event|1|||
130293904|NCT03344640|469040930|FG000|Overall Study|Adverse Event|1|||
130293905|NCT03344640|469040931|FG001|Overall Study|Adverse Event|0|||
130293906|NCT03344640|469040930|FG000|Overall Study|Physician Decision|1|||
130293907|NCT03344640|469040931|FG001|Overall Study|Physician Decision|1|||
130293908|NCT03344640|469040930|FG000|Overall Study|Withdrawal by Subject|1|||
130293909|NCT03344640|469040931|FG001|Overall Study|Withdrawal by Subject|2|||
130293910|NCT03344640|469040930|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
130293911|NCT03344640|469040931|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
130293912|NCT01902888|469040932|FG000|Overall Study|Study Terminated|3|||
130293913|NCT00582738|469040933|FG000|Overall Study|Administrative Problems|7|||
130293914|NCT00582738|469040934|FG001|Overall Study|Administrative Problems|8|||
130293915|NCT00582738|469040933|FG000|Overall Study|Adverse Event|0|||
130293916|NCT00582738|469040934|FG001|Overall Study|Adverse Event|5|||
130293917|NCT00582738|469040933|FG000|Overall Study|Graft Lost|0|||
130293918|NCT00582738|469040934|FG001|Overall Study|Graft Lost|1|||
130293919|NCT00582738|469040933|FG000|Overall Study|Other|1|||
130293920|NCT00582738|469040934|FG001|Overall Study|Other|0|||
130293921|NCT00582738|469040933|FG000|Overall Study|Protocol Violation|1|||
130293922|NCT00582738|469040934|FG001|Overall Study|Protocol Violation|1|||
130293923|NCT00582738|469040933|FG000|Overall Study|Withdrawal by Subject|0|||
130293924|NCT00582738|469040934|FG001|Overall Study|Withdrawal by Subject|3|||
130293925|NCT00652899|469040935|FG000|Overall Study|Death|1|||
130293926|NCT00652899|469040935|FG000|Overall Study|Treating physician decision|1|||
130293927|NCT04135859|469040937|FG000|Overall Study|Withdrawal by Subject|1|||
130293928|NCT04135859|469040938|FG001|Overall Study|Withdrawal by Subject|0|||
130293929|NCT04135859|469040937|FG000|Overall Study|Withdrawal due to screening failure|1|||
130293930|NCT04135859|469040938|FG001|Overall Study|Withdrawal due to screening failure|2|||
130293931|NCT04135859|469040937|FG000|Overall Study|Did not complete stress test|3|||
130293932|NCT04135859|469040938|FG001|Overall Study|Did not complete stress test|3|||
130293933|NCT04135859|469040937|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
130293934|NCT04135859|469040938|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
130293935|NCT00551291|469040939|FG000|Overall Study|Physician Decision|1|||
130293936|NCT01943552|469040940|FG000|Overall Study|Adverse Event|3|||
130293937|NCT01943552|469040941|FG001|Overall Study|Adverse Event|2|||
130293938|NCT01943552|469040940|FG000|Overall Study|Withdrawal by Subject|6|||
130293939|NCT01943552|469040941|FG001|Overall Study|Withdrawal by Subject|6|||
130293940|NCT01943552|469040940|FG000|Overall Study|Other Reasons|16|||
130293941|NCT01943552|469040941|FG001|Overall Study|Other Reasons|17|||
130293942|NCT01600053|469040942|FG000|Overall Study|Adverse Event|2|||
130293943|NCT01600053|469040942|FG000|Overall Study|trial will not meet the interim endpoint|9|||
130293944|NCT04047420|469040943|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
130293945|NCT04047420|469040943|FG000|Washout Period|Refused Participation|2|||
130293946|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
130293947|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
130293948|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
130293949|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130293950|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
130293951|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
130293952|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
130293953|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
130293954|NCT02636946|469040945|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
130293955|NCT02636946|469040946|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
130293956|NCT02636946|469040945|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
130293957|NCT02636946|469040946|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
130293958|NCT00477269|469040947|FG000|Core Study|Adverse Event|6|||
130293959|NCT00477269|469040948|FG001|Core Study|Adverse Event|4|||
129888592|NCT03050398|467549246|FG000|Overall Study|Study terminated by sponsor|8|||
129888593|NCT00598481|467549247|FG000|Treatment|Physician Decision|1|||
130293960|NCT00477269|469040949|FG002|Core Study|Adverse Event|0|||
130293961|NCT00477269|469040947|FG000|Core Study|Death|3|||
130293962|NCT00477269|469040948|FG001|Core Study|Death|3|||
130293963|NCT00477269|469040949|FG002|Core Study|Death|0|||
130293964|NCT00477269|469040947|FG000|Core Study|Withdrawn Consent|0|||
130293965|NCT00477269|469040948|FG001|Core Study|Withdrawn Consent|1|||
130293966|NCT00477269|469040949|FG002|Core Study|Withdrawn Consent|0|||
130293967|NCT00477269|469040947|FG000|Open Label Extension|Adverse Event|0|||
130293968|NCT00477269|469040948|FG001|Open Label Extension|Adverse Event|0|||
130293969|NCT00477269|469040949|FG002|Open Label Extension|Adverse Event|4|||
129793748|NCT03149848|467212741|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
129793749|NCT03149848|467212741|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
129793750|NCT01244490|467212742|FG000|Overall Study|Lack of Efficacy|14|||
129793751|NCT01244490|467212743|FG001|Overall Study|Lack of Efficacy|5|||
129793752|NCT01244490|467212744|FG002|Overall Study|Lack of Efficacy|5|||
129793753|NCT01244490|467212742|FG000|Overall Study|Withdrawal by Subject|4|||
129793754|NCT01244490|467212743|FG001|Overall Study|Withdrawal by Subject|4|||
129793755|NCT01244490|467212744|FG002|Overall Study|Withdrawal by Subject|9|||
129793756|NCT01244490|467212742|FG000|Overall Study|Adverse Event|1|||
129793757|NCT01244490|467212743|FG001|Overall Study|Adverse Event|9|||
129793758|NCT01244490|467212744|FG002|Overall Study|Adverse Event|5|||
129793759|NCT01244490|467212742|FG000|Overall Study|Lost to Follow-up|0|||
129793760|NCT01244490|467212743|FG001|Overall Study|Lost to Follow-up|6|||
129793761|NCT01244490|467212744|FG002|Overall Study|Lost to Follow-up|3|||
129793762|NCT01244490|467212742|FG000|Overall Study|Other|0|||
129793763|NCT01244490|467212743|FG001|Overall Study|Other|0|||
129793764|NCT01244490|467212744|FG002|Overall Study|Other|1|||
129793765|NCT00400153|467212748|FG000|Overall Study|AE due to study disease worsening|14|||
129793766|NCT00400153|467212749|FG001|Overall Study|AE due to study disease worsening|19|||
129793767|NCT00400153|467212750|FG002|Overall Study|AE due to study disease worsening|20|||
129793768|NCT00400153|467212748|FG000|Overall Study|AE due to other disease worsening|2|||
129888594|NCT01991197|467549248|FG000|Overall Study|Lost to Follow-up|1|||
129888595|NCT01991197|467549249|FG001|Overall Study|Lost to Follow-up|1|||
129888596|NCT01991197|467549248|FG000|Overall Study|Physician Decision|0|||
130293970|NCT00477269|469040947|FG000|Open Label Extension|Abnormal laboratory values|0|||
130293971|NCT00477269|469040948|FG001|Open Label Extension|Abnormal laboratory values|0|||
130293972|NCT00477269|469040949|FG002|Open Label Extension|Abnormal laboratory values|1|||
130293973|NCT00477269|469040947|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
130293974|NCT00477269|469040948|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
130293975|NCT00477269|469040949|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
130293976|NCT00477269|469040947|FG000|Open Label Extension|Adminiatrative problems|0|||
130293977|NCT00477269|469040948|FG001|Open Label Extension|Adminiatrative problems|0|||
130293978|NCT00477269|469040949|FG002|Open Label Extension|Adminiatrative problems|2|||
130293979|NCT00477269|469040947|FG000|Open Label Extension|Death|0|||
130293980|NCT00477269|469040948|FG001|Open Label Extension|Death|0|||
130293981|NCT00477269|469040949|FG002|Open Label Extension|Death|4|||
130293982|NCT01792518|469040952|FG000|Overall Study|Adverse Event|3|||
130293983|NCT01792518|469040953|FG001|Overall Study|Adverse Event|4|||
130293984|NCT01792518|469040952|FG000|Overall Study|Protocol Violation|0|||
130293985|NCT01792518|469040953|FG001|Overall Study|Protocol Violation|1|||
130293986|NCT01792518|469040952|FG000|Overall Study|Lost to Follow-up|3|||
130293987|NCT01792518|469040953|FG001|Overall Study|Lost to Follow-up|1|||
129793769|NCT00400153|467212749|FG001|Overall Study|AE due to other disease worsening|1|||
129888597|NCT01991197|467549249|FG001|Overall Study|Physician Decision|2|||
129888598|NCT01991197|467549248|FG000|Overall Study|Withdrawal by Subject|2|||
130293988|NCT01792518|469040952|FG000|Overall Study|Withdrawal by Subject|2|||
130293989|NCT01792518|469040953|FG001|Overall Study|Withdrawal by Subject|0|||
130106507|NCT01898884|468350055|FG000|Multiple Dose Period|Randomized Not Treated|0|||
130293990|NCT01792518|469040952|FG000|Overall Study|Other Reason|0|||
130293991|NCT01792518|469040953|FG001|Overall Study|Other Reason|1|||
130293992|NCT00351273|469040987|FG000|Overall Study|Lost to Follow-up|1|||
129793770|NCT00400153|467212750|FG002|Overall Study|AE due to other disease worsening|0|||
130293993|NCT00351273|469040988|FG001|Overall Study|Lost to Follow-up|2|||
130293994|NCT00351273|469040989|FG002|Overall Study|Lost to Follow-up|5|||
129793771|NCT00400153|467212748|FG000|Overall Study|AE due to other condition|3|||
129793772|NCT00400153|467212749|FG001|Overall Study|AE due to other condition|14|||
130046010|NCT01208181|468125640|FG003|Part 2|Adverse Event|7|||
130046011|NCT01208181|468125641|FG004|Part 2|Adverse Event|0|||
130046012|NCT01208181|468125637|FG000|Part 2|Withdrawal by Subject|0|||
130046013|NCT01208181|468125638|FG001|Part 2|Withdrawal by Subject|0|||
130046014|NCT01208181|468125639|FG002|Part 2|Withdrawal by Subject|1|||
130046015|NCT01208181|468125640|FG003|Part 2|Withdrawal by Subject|1|||
130046016|NCT01208181|468125641|FG004|Part 2|Withdrawal by Subject|0|||
130046017|NCT01208181|468125637|FG000|Part 2|Protocol Violation|0|||
130046018|NCT01208181|468125638|FG001|Part 2|Protocol Violation|0|||
130046019|NCT01208181|468125639|FG002|Part 2|Protocol Violation|1|||
130046020|NCT01208181|468125640|FG003|Part 2|Protocol Violation|0|||
130046021|NCT01208181|468125641|FG004|Part 2|Protocol Violation|0|||
130046022|NCT01208181|468125637|FG000|Part 2|Physician Decision|0|||
130046023|NCT01208181|468125638|FG001|Part 2|Physician Decision|0|||
130046024|NCT01208181|468125639|FG002|Part 2|Physician Decision|1|||
130046025|NCT01208181|468125640|FG003|Part 2|Physician Decision|2|||
130046026|NCT01208181|468125641|FG004|Part 2|Physician Decision|0|||
130046027|NCT01208181|468125637|FG000|Part 2|Non-compliance with study drug|0|||
130046028|NCT01208181|468125638|FG001|Part 2|Non-compliance with study drug|0|||
130046029|NCT01208181|468125639|FG002|Part 2|Non-compliance with study drug|1|||
130293995|NCT01977690|469040990|FG000|Overall Study|Withdrawal by Subject|0|||
130293996|NCT01977690|469040991|FG001|Overall Study|Withdrawal by Subject|4|||
130046030|NCT01208181|468125640|FG003|Part 2|Non-compliance with study drug|1|||
130293997|NCT03442296|469040997|FG000|3 Month Follow-up|Death|3|||
130293998|NCT03442296|469040998|FG001|3 Month Follow-up|Death|1|||
130293999|NCT03442296|469040997|FG000|3 Month Follow-up|Lost to Follow-up|1|||
130294000|NCT03442296|469040998|FG001|3 Month Follow-up|Lost to Follow-up|1|||
130294001|NCT03442296|469040997|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
130294002|NCT03442296|469040998|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
130294003|NCT03442296|469040997|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
130294004|NCT03442296|469040998|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
130294005|NCT03442296|469040997|FG000|12 Month Follow-up|Incomplete measurement|1|||
130294006|NCT03442296|469040998|FG001|12 Month Follow-up|Incomplete measurement|1|||
130294007|NCT00447122|469041000|FG000|Overall Study|worsening medical condition -came off|0|||
130294008|NCT00447122|469041001|FG001|Overall Study|worsening medical condition -came off|1|||
130046031|NCT01208181|468125641|FG004|Part 2|Non-compliance with study drug|0|||
130294009|NCT00447122|469041002|FG002|Overall Study|worsening medical condition -came off|0|||
130294010|NCT00447122|469041003|FG003|Overall Study|worsening medical condition -came off|0|||
130294011|NCT01174173|469041006|FG000|Overall Study|drug-drug interaction|1|||
130294012|NCT00720343|469042157|FG000|Overall Study|Lost to Follow-up|1|||
130294013|NCT00720343|469042158|FG001|Overall Study|Lost to Follow-up|0|||
130294014|NCT00720343|469042157|FG000|Overall Study|Protocol Violation|0|||
130294015|NCT00720343|469042158|FG001|Overall Study|Protocol Violation|2|||
130294016|NCT02008773|469042159|FG000|Overall Study|Adverse Event|3|||
130294017|NCT02008773|469042160|FG001|Overall Study|Adverse Event|3|||
130046032|NCT01208181|468125637|FG000|Part 2|Lost to Follow-up|0|||
130046033|NCT01208181|468125638|FG001|Part 2|Lost to Follow-up|0|||
130046034|NCT01208181|468125639|FG002|Part 2|Lost to Follow-up|1|||
130046035|NCT01208181|468125640|FG003|Part 2|Lost to Follow-up|2|||
130046036|NCT01208181|468125641|FG004|Part 2|Lost to Follow-up|0|||
130046037|NCT01208181|468125637|FG000|Part 2|Lack of Efficacy|0|||
130046038|NCT01208181|468125638|FG001|Part 2|Lack of Efficacy|0|||
130046039|NCT01208181|468125639|FG002|Part 2|Lack of Efficacy|5|||
130046040|NCT01208181|468125640|FG003|Part 2|Lack of Efficacy|7|||
130046041|NCT01208181|468125641|FG004|Part 2|Lack of Efficacy|0|||
130046042|NCT00942708|468125642|FG000|Overall Study|Withdrawal by Subject|1|||
130046043|NCT01426386|468125647|FG000|Overall Study|Adverse Event|0|||
130046044|NCT01426386|468125648|FG001|Overall Study|Adverse Event|1|||
130046045|NCT01426386|468125649|FG002|Overall Study|Adverse Event|0|||
130046046|NCT01426386|468125650|FG003|Overall Study|Adverse Event|0|||
130046047|NCT01426386|468125651|FG004|Overall Study|Adverse Event|0|||
130046048|NCT01426386|468125652|FG005|Overall Study|Adverse Event|0|||
130046049|NCT01426386|468125647|FG000|Overall Study|Did not attend scheduled visit|1|||
130046050|NCT01426386|468125648|FG001|Overall Study|Did not attend scheduled visit|4|||
130046051|NCT01426386|468125649|FG002|Overall Study|Did not attend scheduled visit|0|||
130046052|NCT01426386|468125650|FG003|Overall Study|Did not attend scheduled visit|0|||
130046053|NCT01426386|468125651|FG004|Overall Study|Did not attend scheduled visit|2|||
130046054|NCT01426386|468125652|FG005|Overall Study|Did not attend scheduled visit|1|||
130046055|NCT01426386|468125647|FG000|Overall Study|Poor response|2|||
130046056|NCT01426386|468125648|FG001|Overall Study|Poor response|1|||
130046057|NCT01426386|468125649|FG002|Overall Study|Poor response|2|||
130046058|NCT01426386|468125650|FG003|Overall Study|Poor response|0|||
130046059|NCT01426386|468125651|FG004|Overall Study|Poor response|1|||
130294018|NCT02008773|469042161|FG002|Overall Study|Adverse Event|1|||
130294019|NCT02008773|469042162|FG003|Overall Study|Adverse Event|2|||
130294020|NCT02008773|469042159|FG000|Overall Study|Medication Non-compliance|2|||
130294021|NCT02008773|469042160|FG001|Overall Study|Medication Non-compliance|1|||
130046060|NCT01426386|468125652|FG005|Overall Study|Poor response|0|||
130046061|NCT01426386|468125647|FG000|Overall Study|Personal reasons|0|||
130046062|NCT01426386|468125648|FG001|Overall Study|Personal reasons|0|||
129888599|NCT01991197|467549249|FG001|Overall Study|Withdrawal by Subject|0|||
129888600|NCT01010217|467549250|FG000|Overall Study|Lost to Follow-up|4|||
130294022|NCT02008773|469042161|FG002|Overall Study|Medication Non-compliance|3|||
130294023|NCT02008773|469042162|FG003|Overall Study|Medication Non-compliance|2|||
130294024|NCT02008773|469042159|FG000|Overall Study|Withdrawal by Subject|8|||
130294025|NCT02008773|469042160|FG001|Overall Study|Withdrawal by Subject|4|||
130294026|NCT02008773|469042161|FG002|Overall Study|Withdrawal by Subject|7|||
130294027|NCT02008773|469042162|FG003|Overall Study|Withdrawal by Subject|6|||
130294028|NCT02008773|469042159|FG000|Overall Study|Lost to Follow-up|0|||
130294029|NCT02008773|469042160|FG001|Overall Study|Lost to Follow-up|1|||
130294030|NCT02008773|469042161|FG002|Overall Study|Lost to Follow-up|3|||
130294031|NCT02008773|469042162|FG003|Overall Study|Lost to Follow-up|2|||
130294032|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
130294033|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130294034|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130294035|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
130294036|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
130294037|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130294038|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130294039|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
130294040|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
130294041|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130294042|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130294043|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
130294044|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
130294045|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130294046|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130294047|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
130294048|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
130294049|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
130294050|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
130294051|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
130294052|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
130294053|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130294054|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130294055|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
130294056|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
130294057|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130294058|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130294059|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
130294060|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
130294061|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130294062|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
130294063|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129888601|NCT01010217|467549251|FG001|Overall Study|Lost to Follow-up|5|||
129888602|NCT01010217|467549252|FG002|Overall Study|Lost to Follow-up|1|||
129888603|NCT01010217|467549253|FG003|Overall Study|Lost to Follow-up|0|||
130294064|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
130294065|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130294066|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130294067|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
130294068|NCT02198794|469042163|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
130294069|NCT02198794|469042164|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130294070|NCT02198794|469042165|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130294071|NCT02198794|469042166|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
130294072|NCT02198794|469042163|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
130294073|NCT02198794|469042164|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
130294074|NCT02198794|469042165|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
130294075|NCT02198794|469042166|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
129888604|NCT01010217|467549254|FG004|Overall Study|Lost to Follow-up|0|||
130294076|NCT02198794|469042163|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
130294077|NCT02198794|469042164|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
129888605|NCT01010217|467549250|FG000|Overall Study|Withdrawal by Subject|1|||
129888606|NCT01010217|467549251|FG001|Overall Study|Withdrawal by Subject|0|||
129888607|NCT01010217|467549252|FG002|Overall Study|Withdrawal by Subject|0|||
129888608|NCT01010217|467549253|FG003|Overall Study|Withdrawal by Subject|0|||
129888609|NCT01010217|467549254|FG004|Overall Study|Withdrawal by Subject|0|||
129888610|NCT01010217|467549250|FG000|Overall Study|Physician Decision|0|||
129888611|NCT01010217|467549251|FG001|Overall Study|Physician Decision|0|||
129888612|NCT01010217|467549252|FG002|Overall Study|Physician Decision|0|||
129888613|NCT01010217|467549253|FG003|Overall Study|Physician Decision|6|||
129888614|NCT01010217|467549254|FG004|Overall Study|Physician Decision|3|||
129888615|NCT01439711|467549255|FG000|Overall Study|Ineligible|13|||
129888616|NCT01439711|467549255|FG000|Overall Study|Cancel|3|||
129888617|NCT01439711|467549255|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
129888618|NCT01439711|467549255|FG000|Overall Study|Adverse Event|5|||
129888619|NCT01439711|467549255|FG000|Overall Study|Withdrawal by Subject|3|||
129888620|NCT01439711|467549255|FG000|Overall Study|Progression During Active Tx|3|||
129888621|NCT01439711|467549255|FG000|Overall Study|Noncompliance|3|||
129888622|NCT01439711|467549255|FG000|Overall Study|No MRI|9|||
129888623|NCT04242875|467549256|FG000|Overall Study|Adverse Event|2|||
129888624|NCT02397460|467549257|FG000|Treatment Period 2|Adverse Event|0|||
129888625|NCT02397460|467549258|FG001|Treatment Period 2|Adverse Event|0|||
129888626|NCT02397460|467549259|FG002|Treatment Period 2|Adverse Event|0|||
129888627|NCT02397460|467549260|FG003|Treatment Period 2|Adverse Event|0|||
129888628|NCT02397460|467549261|FG004|Treatment Period 2|Adverse Event|0|||
129888629|NCT02397460|467549262|FG005|Treatment Period 2|Adverse Event|0|||
130294078|NCT02198794|469042165|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
130294079|NCT02198794|469042166|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
130294080|NCT02198794|469042163|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129888630|NCT02397460|467549263|FG006|Treatment Period 2|Adverse Event|0|||
129888631|NCT02397460|467549264|FG007|Treatment Period 2|Adverse Event|1|||
129888632|NCT02397460|467549257|FG000|Treatment Period 4|Adverse Event|0|||
129888633|NCT02397460|467549258|FG001|Treatment Period 4|Adverse Event|1|||
130294081|NCT02198794|469042164|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130294082|NCT02198794|469042165|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
130294083|NCT02198794|469042166|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
130294084|NCT02198794|469042163|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130294085|NCT02198794|469042164|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130294086|NCT02198794|469042165|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
130294087|NCT02198794|469042166|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
130294088|NCT02198794|469042163|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
130294089|NCT02198794|469042164|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
130294090|NCT02198794|469042165|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
130294091|NCT02198794|469042166|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
130294092|NCT01918332|469042167|FG000|Overall Study|Adverse Event|0|||
130294093|NCT01918332|469042168|FG001|Overall Study|Adverse Event|0|||
130294094|NCT01918332|469042169|FG002|Overall Study|Adverse Event|0|||
130294095|NCT01918332|469042170|FG003|Overall Study|Adverse Event|1|||
130294096|NCT01918332|469042167|FG000|Overall Study|Withdrawal by Subject|2|||
130294097|NCT01918332|469042168|FG001|Overall Study|Withdrawal by Subject|3|||
130294098|NCT01918332|469042169|FG002|Overall Study|Withdrawal by Subject|2|||
130294099|NCT01918332|469042170|FG003|Overall Study|Withdrawal by Subject|3|||
130294100|NCT01918332|469042167|FG000|Overall Study|Protocol Violation|6|||
130294101|NCT01918332|469042168|FG001|Overall Study|Protocol Violation|2|||
130294102|NCT01918332|469042169|FG002|Overall Study|Protocol Violation|6|||
130294103|NCT01918332|469042170|FG003|Overall Study|Protocol Violation|3|||
130294104|NCT01918332|469042167|FG000|Overall Study|lipid result by central lab did not meet|0|||
130294105|NCT01918332|469042168|FG001|Overall Study|lipid result by central lab did not meet|0|||
130294106|NCT01918332|469042169|FG002|Overall Study|lipid result by central lab did not meet|1|||
130294107|NCT01918332|469042170|FG003|Overall Study|lipid result by central lab did not meet|0|||
130294108|NCT02408523|469042171|FG000|Overall Study|Adverse Event|4|||
130294109|NCT02408523|469042172|FG001|Overall Study|Adverse Event|10|||
129888634|NCT02397460|467549259|FG002|Treatment Period 4|Adverse Event|0|||
129888635|NCT02397460|467549260|FG003|Treatment Period 4|Adverse Event|0|||
129888636|NCT02397460|467549261|FG004|Treatment Period 4|Adverse Event|0|||
129888637|NCT02397460|467549262|FG005|Treatment Period 4|Adverse Event|0|||
129888638|NCT02397460|467549263|FG006|Treatment Period 4|Adverse Event|0|||
130294110|NCT02408523|469042171|FG000|Overall Study|Lack of Efficacy|0|||
130294111|NCT02408523|469042172|FG001|Overall Study|Lack of Efficacy|1|||
129888639|NCT02397460|467549264|FG007|Treatment Period 4|Adverse Event|0|||
130294112|NCT02408523|469042171|FG000|Overall Study|Protocol Violation|1|||
130294113|NCT02408523|469042172|FG001|Overall Study|Protocol Violation|2|||
129888640|NCT02397460|467549257|FG000|Treatment Period 4|Physician Decision|0|||
129888641|NCT02397460|467549258|FG001|Treatment Period 4|Physician Decision|0|||
129888642|NCT02397460|467549259|FG002|Treatment Period 4|Physician Decision|0|||
129888643|NCT02397460|467549260|FG003|Treatment Period 4|Physician Decision|0|||
129888644|NCT02397460|467549261|FG004|Treatment Period 4|Physician Decision|1|||
129888645|NCT02397460|467549262|FG005|Treatment Period 4|Physician Decision|0|||
129888646|NCT02397460|467549263|FG006|Treatment Period 4|Physician Decision|0|||
129888647|NCT02397460|467549264|FG007|Treatment Period 4|Physician Decision|0|||
129888648|NCT01406717|467549265|FG000|Overall Study|Subject non-compliance|4|||
129888649|NCT01406717|467549266|FG001|Overall Study|Subject non-compliance|3|||
129888650|NCT01406717|467549265|FG000|Overall Study|Protocol Violation|5|||
129888651|NCT01406717|467549266|FG001|Overall Study|Protocol Violation|1|||
129888652|NCT01406717|467549265|FG000|Overall Study|Lost to Follow-up|14|||
129888653|NCT01406717|467549266|FG001|Overall Study|Lost to Follow-up|8|||
130046063|NCT01426386|468125649|FG002|Overall Study|Personal reasons|0|||
130046064|NCT01426386|468125650|FG003|Overall Study|Personal reasons|0|||
130046065|NCT01426386|468125651|FG004|Overall Study|Personal reasons|1|||
130046066|NCT01426386|468125652|FG005|Overall Study|Personal reasons|0|||
130046067|NCT01457339|468125653|FG000|Period 3 (100 mg)|Adverse Event|0|||
130046068|NCT01457339|468125654|FG001|Period 3 (100 mg)|Adverse Event|1|||
130046069|NCT01457339|468125653|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
130294114|NCT02408523|469042171|FG000|Overall Study|Lost to Follow-up|2|||
130294115|NCT02408523|469042172|FG001|Overall Study|Lost to Follow-up|3|||
130294116|NCT02408523|469042171|FG000|Overall Study|Withdrawal by Subject|3|||
130294117|NCT02408523|469042172|FG001|Overall Study|Withdrawal by Subject|1|||
130294118|NCT02408523|469042171|FG000|Overall Study|Sponsor request|1|||
130294119|NCT02408523|469042172|FG001|Overall Study|Sponsor request|0|||
130294120|NCT02408523|469042171|FG000|Overall Study|Did not satisfy extension conditions|0|||
130294121|NCT02408523|469042172|FG001|Overall Study|Did not satisfy extension conditions|1|||
130294122|NCT00701805|469042173|FG000|Overall Study|Withdrawal by Subject|3|||
130294123|NCT00701805|469042174|FG001|Overall Study|Withdrawal by Subject|1|||
130294124|NCT00701805|469042175|FG002|Overall Study|Withdrawal by Subject|4|||
130294125|NCT00701805|469042176|FG003|Overall Study|Withdrawal by Subject|3|||
130294126|NCT00701805|469042173|FG000|Overall Study|Adverse Event|0|||
130294127|NCT00701805|469042174|FG001|Overall Study|Adverse Event|1|||
130294128|NCT00701805|469042175|FG002|Overall Study|Adverse Event|1|||
130294129|NCT00701805|469042176|FG003|Overall Study|Adverse Event|0|||
130294130|NCT00701805|469042173|FG000|Overall Study|Missed 7 consecutive doses|0|||
130294131|NCT00701805|469042174|FG001|Overall Study|Missed 7 consecutive doses|1|||
130294132|NCT00701805|469042175|FG002|Overall Study|Missed 7 consecutive doses|0|||
130294133|NCT00701805|469042176|FG003|Overall Study|Missed 7 consecutive doses|0|||
130294134|NCT00701805|469042173|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
130294135|NCT00701805|469042174|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
130294136|NCT00701805|469042175|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
130294137|NCT00701805|469042176|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
130294138|NCT00701805|469042173|FG000|Overall Study|Physician decision, change of therapy|0|||
130294139|NCT00701805|469042174|FG001|Overall Study|Physician decision, change of therapy|0|||
130294140|NCT00701805|469042175|FG002|Overall Study|Physician decision, change of therapy|0|||
130294141|NCT00701805|469042176|FG003|Overall Study|Physician decision, change of therapy|1|||
130294142|NCT00701805|469042173|FG000|Overall Study|Difficult to travel to dialysis site|0|||
130294143|NCT00701805|469042174|FG001|Overall Study|Difficult to travel to dialysis site|0|||
130294144|NCT00701805|469042175|FG002|Overall Study|Difficult to travel to dialysis site|1|||
130294145|NCT00701805|469042176|FG003|Overall Study|Difficult to travel to dialysis site|0|||
130294146|NCT00701805|469042173|FG000|Overall Study|Resumption criteria were not met|0|||
130294147|NCT00701805|469042174|FG001|Overall Study|Resumption criteria were not met|1|||
130294148|NCT00701805|469042175|FG002|Overall Study|Resumption criteria were not met|0|||
130294149|NCT00701805|469042176|FG003|Overall Study|Resumption criteria were not met|0|||
130294150|NCT02252965|469042180|FG000|Overall Study|Adverse Event|9|||
130294151|NCT02252965|469042181|FG001|Overall Study|Adverse Event|14|||
130294152|NCT02252965|469042180|FG000|Overall Study|Lost to Follow-up|16|||
130294153|NCT02252965|469042181|FG001|Overall Study|Lost to Follow-up|8|||
130294154|NCT02252965|469042180|FG000|Overall Study|Protocol Violation|4|||
130294155|NCT02252965|469042181|FG001|Overall Study|Protocol Violation|5|||
130294156|NCT02252965|469042180|FG000|Overall Study|Lack of Efficacy|0|||
130294157|NCT02252965|469042181|FG001|Overall Study|Lack of Efficacy|2|||
130294158|NCT02252965|469042180|FG000|Overall Study|Withdrawal by Subject|7|||
130294159|NCT02252965|469042181|FG001|Overall Study|Withdrawal by Subject|9|||
130294160|NCT02252965|469042180|FG000|Overall Study|Other|4|||
130294161|NCT02252965|469042181|FG001|Overall Study|Other|5|||
130294162|NCT04256512|469042182|FG000|Overall Study|Withdrawal by Subject|1|||
130294163|NCT04435600|469042190|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294164|NCT04435600|469042191|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294165|NCT04435600|469042192|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
130294166|NCT04435600|469042193|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294167|NCT04435600|469042194|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294168|NCT04435600|469042195|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294169|NCT04435600|469042196|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294170|NCT04435600|469042197|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294171|NCT04435600|469042198|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294172|NCT04435600|469042199|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
130294173|NCT04435600|469042190|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294174|NCT04435600|469042191|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294175|NCT04435600|469042192|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294176|NCT04435600|469042193|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294177|NCT04435600|469042194|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294178|NCT04435600|469042195|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294179|NCT04435600|469042196|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294180|NCT04435600|469042197|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294181|NCT04435600|469042198|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
130294182|NCT04435600|469042199|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
130294183|NCT04435600|469042190|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294184|NCT04435600|469042191|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294185|NCT04435600|469042192|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294186|NCT04435600|469042193|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294187|NCT04435600|469042194|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294188|NCT04435600|469042195|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294189|NCT04435600|469042196|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294190|NCT04435600|469042197|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294191|NCT04435600|469042198|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
130294192|NCT04435600|469042199|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
130294193|NCT04435600|469042190|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294194|NCT04435600|469042191|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294195|NCT04435600|469042192|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294196|NCT04435600|469042193|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294197|NCT04435600|469042194|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294198|NCT04435600|469042195|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294199|NCT04435600|469042196|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294200|NCT04435600|469042197|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294201|NCT04435600|469042198|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
130294202|NCT04435600|469042199|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
130294203|NCT02797184|469042201|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
130294204|NCT02797184|469042202|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
130294205|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
130294206|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
130294207|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
130294208|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
130294209|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
130294210|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
130294211|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
130294212|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
130294213|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
130294214|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130294215|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130294216|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
130294217|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
130294218|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
130294219|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
130294220|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
130294221|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
130294222|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130294223|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130294224|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
130294225|NCT05149313|469042203|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
130294226|NCT05149313|469042204|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
130294227|NCT05149313|469042205|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
130294228|NCT05149313|469042206|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
130294229|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
130294230|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
130294231|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
130294232|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
130294233|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130294234|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
130294235|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
130294236|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
130294237|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130294238|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
130294239|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
130294240|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
130294241|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130294242|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130294243|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
130294244|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130294245|NCT05149313|469042203|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130294246|NCT05149313|469042204|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130294247|NCT05149313|469042205|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
130294248|NCT05149313|469042206|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
130294249|NCT03199391|469042211|FG000|Overall Study|Death|1|||
130294250|NCT03199391|469042211|FG000|Overall Study|Lost to Follow-up|3|||
130294251|NCT03199391|469042211|FG000|Overall Study|Adverse Event|2|||
130294252|NCT03199391|469042211|FG000|Overall Study|Withdrawal by Subject|10|||
130294253|NCT01867086|469042212|FG000|Overall Study|Disease Progression|1|||
130294254|NCT00483041|469042214|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
130294255|NCT00483041|469042215|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
130294256|NCT02258529|469042217|FG000|Overall Study|Study Terminated by Sponsor|9|||
130294257|NCT02258529|469042217|FG000|Overall Study|Adverse Event|1|||
130294258|NCT00443781|469042218|FG000|Overall Study|Lost to Follow-up|10|||
130294259|NCT00443781|469042218|FG000|Overall Study|Physician Decision|2|||
130294260|NCT00443781|469042218|FG000|Overall Study|Protocol Violation|1|||
130294261|NCT00443781|469042218|FG000|Overall Study|Withdrawal by Subject|6|||
130294262|NCT00443781|469042218|FG000|Overall Study|Unable to comply with study follow up|2|||
130294263|NCT00443781|469042218|FG000|Overall Study|Investigator terminated participation|1|||
130294264|NCT00443781|469042218|FG000|Overall Study|Insurance not covered|2|||
130294265|NCT00443781|469042218|FG000|Overall Study|PD/FAD not done|1|||
130294266|NCT02066415|469042219|FG000|Overall Study|Decision by Sponsor|5|||
130294267|NCT02066415|469042220|FG001|Overall Study|Decision by Sponsor|4|||
130294268|NCT02066415|469042221|FG002|Overall Study|Decision by Sponsor|2|||
130294269|NCT02066415|469042219|FG000|Overall Study|Withdrawal by Subject|9|||
130294270|NCT02066415|469042220|FG001|Overall Study|Withdrawal by Subject|1|||
130294271|NCT02066415|469042221|FG002|Overall Study|Withdrawal by Subject|4|||
130294272|NCT02066415|469042219|FG000|Overall Study|Lost to Follow-up|7|||
130294273|NCT02066415|469042220|FG001|Overall Study|Lost to Follow-up|2|||
130294274|NCT02066415|469042221|FG002|Overall Study|Lost to Follow-up|2|||
130294275|NCT05432167|469042225|FG000|Overall Study|Adverse Event|0|||
130294276|NCT05432167|469042226|FG001|Overall Study|Adverse Event|2|||
130294277|NCT05432167|469042227|FG002|Overall Study|Adverse Event|1|||
130294278|NCT05432167|469042225|FG000|Overall Study|Lost to Follow-up|3|||
130294279|NCT05432167|469042226|FG001|Overall Study|Lost to Follow-up|3|||
130294280|NCT05432167|469042227|FG002|Overall Study|Lost to Follow-up|2|||
130294281|NCT05432167|469042225|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130294282|NCT05432167|469042226|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130294283|NCT05432167|469042227|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
130294284|NCT05432167|469042225|FG000|Overall Study|Physician Decision|1|||
130294285|NCT05432167|469042226|FG001|Overall Study|Physician Decision|0|||
130294286|NCT05432167|469042227|FG002|Overall Study|Physician Decision|0|||
130294287|NCT05432167|469042225|FG000|Overall Study|Withdrawal by Subject|7|||
130294288|NCT05432167|469042226|FG001|Overall Study|Withdrawal by Subject|4|||
130294289|NCT05432167|469042227|FG002|Overall Study|Withdrawal by Subject|11|||
130294290|NCT05432167|469042225|FG000|Overall Study|Other|0|||
130294291|NCT05432167|469042226|FG001|Overall Study|Other|0|||
130294292|NCT05432167|469042227|FG002|Overall Study|Other|1|||
130294293|NCT02616393|469042235|FG000|Overall Study|Death|5|||
130294294|NCT02616393|469042236|FG001|Overall Study|Death|12|||
130294295|NCT02616393|469042237|FG002|Overall Study|Death|1|||
130294296|NCT02616393|469042235|FG000|Overall Study|Termination by Sponsor|4|||
130294297|NCT02616393|469042236|FG001|Overall Study|Termination by Sponsor|5|||
130294298|NCT02616393|469042237|FG002|Overall Study|Termination by Sponsor|2|||
130294299|NCT02616393|469042235|FG000|Overall Study|Other|3|||
130294300|NCT02616393|469042236|FG001|Overall Study|Other|0|||
130294301|NCT02616393|469042237|FG002|Overall Study|Other|0|||
130294302|NCT02616393|469042235|FG000|Overall Study|Withdrawal by Subject|1|||
130294303|NCT02616393|469042236|FG001|Overall Study|Withdrawal by Subject|1|||
130294304|NCT02616393|469042237|FG002|Overall Study|Withdrawal by Subject|0|||
130294305|NCT02616393|469042235|FG000|Overall Study|Lost to Follow-up|0|||
130294306|NCT02616393|469042236|FG001|Overall Study|Lost to Follow-up|2|||
130294307|NCT02616393|469042237|FG002|Overall Study|Lost to Follow-up|0|||
130294308|NCT00364533|469042239|FG000|Overall Study|Adverse Event|8|||
130294309|NCT00364533|469042240|FG001|Overall Study|Adverse Event|7|||
130294310|NCT00364533|469042241|FG002|Overall Study|Adverse Event|15|||
130294311|NCT00364533|469042242|FG003|Overall Study|Adverse Event|5|||
130294312|NCT00364533|469042243|FG004|Overall Study|Adverse Event|2|||
129888654|NCT01406717|467549265|FG000|Overall Study|Withdrawal by Subject|19|||
129888655|NCT01406717|467549266|FG001|Overall Study|Withdrawal by Subject|15|||
129888656|NCT01406717|467549265|FG000|Overall Study|Adverse Event|1|||
129888657|NCT01406717|467549266|FG001|Overall Study|Adverse Event|2|||
129888658|NCT01406717|467549265|FG000|Overall Study|Lack of Efficacy|0|||
129888659|NCT01406717|467549266|FG001|Overall Study|Lack of Efficacy|1|||
129888660|NCT01406717|467549265|FG000|Overall Study|Non-completion of visit activity|0|||
129888661|NCT01406717|467549266|FG001|Overall Study|Non-completion of visit activity|1|||
129888662|NCT02584855|467549270|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
129888663|NCT02584855|467549271|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129888664|NCT02584855|467549272|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129888665|NCT02584855|467549273|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
129888666|NCT02584855|467549274|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
129888667|NCT02584855|467549275|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
129888668|NCT02584855|467549270|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
129888669|NCT02584855|467549271|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130294313|NCT00364533|469042239|FG000|Overall Study|Withdrawal by Subject|4|||
130294314|NCT00364533|469042240|FG001|Overall Study|Withdrawal by Subject|8|||
130294315|NCT00364533|469042241|FG002|Overall Study|Withdrawal by Subject|6|||
130294316|NCT00364533|469042242|FG003|Overall Study|Withdrawal by Subject|6|||
130294317|NCT00364533|469042243|FG004|Overall Study|Withdrawal by Subject|6|||
130294318|NCT00364533|469042239|FG000|Overall Study|Lack of Efficacy|22|||
130294319|NCT00364533|469042240|FG001|Overall Study|Lack of Efficacy|22|||
130294320|NCT00364533|469042241|FG002|Overall Study|Lack of Efficacy|21|||
130294321|NCT00364533|469042242|FG003|Overall Study|Lack of Efficacy|17|||
130294322|NCT00364533|469042243|FG004|Overall Study|Lack of Efficacy|42|||
130294323|NCT00364533|469042239|FG000|Overall Study|Subject discharged from hospital|4|||
130294324|NCT00364533|469042240|FG001|Overall Study|Subject discharged from hospital|1|||
130294325|NCT00364533|469042241|FG002|Overall Study|Subject discharged from hospital|2|||
130294326|NCT00364533|469042242|FG003|Overall Study|Subject discharged from hospital|3|||
130294327|NCT00364533|469042243|FG004|Overall Study|Subject discharged from hospital|1|||
130294328|NCT00364533|469042239|FG000|Overall Study|Variations in drug compliance|2|||
130294329|NCT00364533|469042240|FG001|Overall Study|Variations in drug compliance|1|||
130294330|NCT00364533|469042241|FG002|Overall Study|Variations in drug compliance|1|||
130294331|NCT00364533|469042242|FG003|Overall Study|Variations in drug compliance|0|||
130294332|NCT00364533|469042243|FG004|Overall Study|Variations in drug compliance|0|||
130294333|NCT00364533|469042239|FG000|Overall Study|Non-compliance|1|||
130294334|NCT00364533|469042240|FG001|Overall Study|Non-compliance|0|||
130294335|NCT00364533|469042241|FG002|Overall Study|Non-compliance|0|||
130294336|NCT00364533|469042242|FG003|Overall Study|Non-compliance|0|||
130294337|NCT00364533|469042243|FG004|Overall Study|Non-compliance|0|||
130294338|NCT00364533|469042239|FG000|Overall Study|Protocol Violation|1|||
130294339|NCT00364533|469042240|FG001|Overall Study|Protocol Violation|1|||
130294340|NCT00364533|469042241|FG002|Overall Study|Protocol Violation|0|||
130294341|NCT00364533|469042242|FG003|Overall Study|Protocol Violation|0|||
130294342|NCT00364533|469042243|FG004|Overall Study|Protocol Violation|0|||
130294343|NCT02758301|469042244|FG000|Overall Study|Death|12|||
130294344|NCT02758301|469042245|FG001|Overall Study|Death|0|||
130294345|NCT02758301|469042244|FG000|Overall Study|Physician Decision|10|||
130294346|NCT02758301|469042245|FG001|Overall Study|Physician Decision|1|||
130294347|NCT02758301|469042244|FG000|Overall Study|Withdrawal by Subject|5|||
130294348|NCT02758301|469042245|FG001|Overall Study|Withdrawal by Subject|6|||
130294349|NCT02758301|469042244|FG000|Overall Study|Lost to Follow-up|7|||
130294350|NCT02758301|469042245|FG001|Overall Study|Lost to Follow-up|0|||
130294351|NCT02758301|469042244|FG000|Overall Study|Protocol Violation|0|||
130294352|NCT02758301|469042245|FG001|Overall Study|Protocol Violation|1|||
130294353|NCT02445573|469042246|FG000|Overall Study|Withdrawal by Subject|1|||
130294354|NCT02445573|469042247|FG001|Overall Study|Withdrawal by Subject|1|||
130294355|NCT02445573|469042246|FG000|Overall Study|Lost to Follow-up|0|||
130294356|NCT02445573|469042247|FG001|Overall Study|Lost to Follow-up|1|||
130294357|NCT02855944|469042248|FG000|Period 1: Treatment|Ongoing|14|||
130294358|NCT02855944|469042249|FG001|Period 1: Treatment|Ongoing|0|||
130294359|NCT02855944|469042248|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
130294360|NCT02855944|469042249|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
130294361|NCT02855944|469042248|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
130046070|NCT01457339|468125654|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
130294362|NCT02855944|469042249|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
130294363|NCT03242018|469042258|FG000|Overall Study|Adverse Event|7|||
130046071|NCT01457339|468125653|FG000|Period 6 (250 mg)|Family Emergency|1|||
129888670|NCT02584855|467549272|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
129888671|NCT02584855|467549273|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
129888672|NCT02584855|467549274|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
130046072|NCT01457339|468125654|FG001|Period 6 (250 mg)|Family Emergency|0|||
130294364|NCT03242018|469042259|FG001|Overall Study|Adverse Event|7|||
130294365|NCT03242018|469042260|FG002|Overall Study|Adverse Event|6|||
130294366|NCT03242018|469042258|FG000|Overall Study|Lost to Follow-up|2|||
130294367|NCT03242018|469042259|FG001|Overall Study|Lost to Follow-up|2|||
130294368|NCT03242018|469042260|FG002|Overall Study|Lost to Follow-up|2|||
130294369|NCT03242018|469042258|FG000|Overall Study|At the Participant's Own Request|5|||
130294370|NCT03242018|469042259|FG001|Overall Study|At the Participant's Own Request|1|||
130294371|NCT03242018|469042260|FG002|Overall Study|At the Participant's Own Request|4|||
130294372|NCT03242018|469042258|FG000|Overall Study|Reason Not Specified|3|||
130294373|NCT03242018|469042259|FG001|Overall Study|Reason Not Specified|4|||
130294374|NCT03242018|469042260|FG002|Overall Study|Reason Not Specified|1|||
130294375|NCT03242018|469042258|FG000|Overall Study|Study Terminated by Sponsor|1|||
130294376|NCT03242018|469042259|FG001|Overall Study|Study Terminated by Sponsor|0|||
130294377|NCT03242018|469042260|FG002|Overall Study|Study Terminated by Sponsor|1|||
130294378|NCT01283542|469042262|FG000|Main Phase|Acute or progressive vision loss|1|||
130294379|NCT01283542|469042262|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
130294380|NCT01283542|469042262|FG000|Main Phase|abnormal laboratory values|5|||
130294381|NCT01283542|469042262|FG000|Extension Phase|Physician Decision|1|||
130294382|NCT01283542|469042262|FG000|Extension Phase|Adverse Event|1|||
130294383|NCT01283542|469042262|FG000|Extension Phase|Administrative problems|1|||
130294384|NCT00903331|469042263|FG000|Overall Study|Death|4|||
130294385|NCT00903331|469042264|FG001|Overall Study|Death|8|||
130294386|NCT00903331|469042263|FG000|Overall Study|Withdrawal of consent|1|||
130294387|NCT00903331|469042264|FG001|Overall Study|Withdrawal of consent|8|||
130294388|NCT00903331|469042263|FG000|Overall Study|Lung transplant|0|||
130294389|NCT00903331|469042264|FG001|Overall Study|Lung transplant|2|||
130294390|NCT00257660|469042265|FG000|Overall Study|Lack of Efficacy|5|||
130294391|NCT00257660|469042266|FG001|Overall Study|Lack of Efficacy|23|||
130294392|NCT00257660|469042265|FG000|Overall Study|Withdrawal by Subject|2|||
130294393|NCT00257660|469042266|FG001|Overall Study|Withdrawal by Subject|0|||
130294394|NCT00257660|469042265|FG000|Overall Study|Lost to Follow-up|1|||
130294395|NCT00257660|469042266|FG001|Overall Study|Lost to Follow-up|0|||
130294396|NCT00257660|469042265|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
130294397|NCT00257660|469042266|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
130294398|NCT00257660|469042265|FG000|Overall Study|No longer wanted to do blood draws|1|||
130294399|NCT00257660|469042266|FG001|Overall Study|No longer wanted to do blood draws|0|||
130294400|NCT02449018|469042271|FG000|Overall Study|Abnormal laboratory value|0|||
130294401|NCT02449018|469042272|FG001|Overall Study|Abnormal laboratory value|1|||
130294402|NCT02449018|469042271|FG000|Overall Study|Administrative problems|1|||
130294403|NCT02449018|469042272|FG001|Overall Study|Administrative problems|0|||
130294404|NCT02449018|469042271|FG000|Overall Study|Adverse Event|5|||
130294405|NCT02449018|469042272|FG001|Overall Study|Adverse Event|1|||
130294406|NCT02449018|469042271|FG000|Overall Study|Protocol deviation|4|||
130294407|NCT02449018|469042272|FG001|Overall Study|Protocol deviation|0|||
130294408|NCT02449018|469042271|FG000|Overall Study|Patient decision|2|||
130294409|NCT02449018|469042272|FG001|Overall Study|Patient decision|0|||
130294410|NCT03995355|469042273|FG000|Overall Study|Adverse Event|1|||
130294411|NCT03995355|469042274|FG001|Overall Study|Adverse Event|0|||
129793773|NCT00400153|467212750|FG002|Overall Study|AE due to other condition|15|||
129793774|NCT00400153|467212748|FG000|Overall Study|Protocol Violation|7|||
129793775|NCT00400153|467212749|FG001|Overall Study|Protocol Violation|4|||
129793776|NCT00400153|467212750|FG002|Overall Study|Protocol Violation|9|||
129793777|NCT00400153|467212748|FG000|Overall Study|Lost to Follow-up|2|||
129793778|NCT00400153|467212749|FG001|Overall Study|Lost to Follow-up|1|||
129793779|NCT00400153|467212750|FG002|Overall Study|Lost to Follow-up|4|||
129793780|NCT00400153|467212748|FG000|Overall Study|Withdrawal by Subject|12|||
129793781|NCT00400153|467212749|FG001|Overall Study|Withdrawal by Subject|11|||
129793782|NCT00400153|467212750|FG002|Overall Study|Withdrawal by Subject|10|||
129793783|NCT00400153|467212748|FG000|Overall Study|Other reasons - not mentioned above|8|||
129793784|NCT00400153|467212749|FG001|Overall Study|Other reasons - not mentioned above|5|||
129793785|NCT00400153|467212750|FG002|Overall Study|Other reasons - not mentioned above|3|||
129793786|NCT00393042|467212751|FG000|First Intervention|Withdrawal by Subject|1|||
129793787|NCT00393042|467212752|FG001|First Intervention|Withdrawal by Subject|2|||
129793788|NCT00393042|467212751|FG000|First Intervention|Lost to Follow-up|3|||
129793789|NCT00393042|467212752|FG001|First Intervention|Lost to Follow-up|3|||
129793790|NCT00393042|467212751|FG000|First Intervention|Protocol Violation|1|||
129793791|NCT00393042|467212752|FG001|First Intervention|Protocol Violation|0|||
129793792|NCT00393042|467212751|FG000|First Intervention|Adverse Event|0|||
129793793|NCT00393042|467212752|FG001|First Intervention|Adverse Event|1|||
129793794|NCT00393042|467212751|FG000|Second Intervetion|Adverse Event|0|||
129793795|NCT00393042|467212752|FG001|Second Intervetion|Adverse Event|3|||
130294412|NCT03995355|469042273|FG000|Overall Study|Withdrawal by Subject|1|||
130294413|NCT03995355|469042274|FG001|Overall Study|Withdrawal by Subject|0|||
130294414|NCT03995355|469042273|FG000|Overall Study|Scheduling Issues|0|||
130294415|NCT03995355|469042274|FG001|Overall Study|Scheduling Issues|1|||
130294416|NCT03426631|469042275|FG000|Overall Study|Lost to Follow-up|0|||
130294417|NCT03426631|469042276|FG001|Overall Study|Lost to Follow-up|1|||
130294418|NCT00654004|469042277|FG000|Overall Study|Lost to Follow-up|1|||
130294419|NCT00654004|469042278|FG001|Overall Study|Lost to Follow-up|0|||
129793796|NCT00393042|467212751|FG000|Second Intervetion|Withdrawal by Subject|0|||
130046073|NCT01457339|468125653|FG000|Period 6 (250 mg)|Personal appointment|0|||
130046074|NCT01457339|468125654|FG001|Period 6 (250 mg)|Personal appointment|1|||
130046075|NCT01096667|468125655|FG000|Overall Study|Lost to Follow-up|1|||
130046076|NCT01096667|468125656|FG001|Overall Study|Lost to Follow-up|1|||
130046077|NCT01096667|468125657|FG002|Overall Study|Lost to Follow-up|1|||
130046078|NCT01096667|468125658|FG003|Overall Study|Lost to Follow-up|0|||
130046079|NCT01096667|468125659|FG004|Overall Study|Lost to Follow-up|0|||
130046080|NCT01096667|468125655|FG000|Overall Study|Withdrawal by Subject|1|||
130046081|NCT01096667|468125656|FG001|Overall Study|Withdrawal by Subject|0|||
130046082|NCT01096667|468125657|FG002|Overall Study|Withdrawal by Subject|0|||
130046083|NCT01096667|468125658|FG003|Overall Study|Withdrawal by Subject|1|||
130046084|NCT01096667|468125659|FG004|Overall Study|Withdrawal by Subject|0|||
130046085|NCT01096667|468125655|FG000|Overall Study|Reason not available|0|||
130046086|NCT01096667|468125656|FG001|Overall Study|Reason not available|1|||
130046087|NCT01096667|468125657|FG002|Overall Study|Reason not available|1|||
130046088|NCT01096667|468125658|FG003|Overall Study|Reason not available|1|||
130046089|NCT01096667|468125659|FG004|Overall Study|Reason not available|0|||
130046090|NCT01096667|468125655|FG000|Overall Study|Protocol Violation|0|||
130046091|NCT01096667|468125656|FG001|Overall Study|Protocol Violation|0|||
130046092|NCT01096667|468125657|FG002|Overall Study|Protocol Violation|0|||
130046093|NCT01096667|468125658|FG003|Overall Study|Protocol Violation|1|||
130046094|NCT01096667|468125659|FG004|Overall Study|Protocol Violation|0|||
130046095|NCT01096667|468125655|FG000|Overall Study|Not treated|1|||
130046096|NCT01096667|468125656|FG001|Overall Study|Not treated|0|||
130046097|NCT01096667|468125657|FG002|Overall Study|Not treated|0|||
130046098|NCT01096667|468125658|FG003|Overall Study|Not treated|0|||
130046099|NCT01096667|468125659|FG004|Overall Study|Not treated|0|||
130046100|NCT00306891|468125660|FG000|Part A|Withdrawal by Subject|1|||
130046101|NCT00306891|468125661|FG001|Part A|Withdrawal by Subject|1|||
130046102|NCT00306891|468125662|FG002|Part A|Withdrawal by Subject|0|||
130046103|NCT00306891|468125663|FG003|Part A|Withdrawal by Subject|0|||
130046104|NCT00306891|468125660|FG000|Part A|Condition under investigation worsened|2|||
130046105|NCT00306891|468125661|FG001|Part A|Condition under investigation worsened|2|||
130046106|NCT00306891|468125662|FG002|Part A|Condition under investigation worsened|0|||
130046107|NCT00306891|468125663|FG003|Part A|Condition under investigation worsened|0|||
130046108|NCT00306891|468125660|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
130046109|NCT00306891|468125661|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
130046110|NCT00306891|468125662|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
130046111|NCT00306891|468125663|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
130294420|NCT00267150|469042285|FG000|Overall Study|Adverse Event|1|||
130294421|NCT03134183|469042286|FG000|Overall Study|Withdrawal by Subject|1|||
130294422|NCT03134183|469042287|FG001|Overall Study|Withdrawal by Subject|1|||
130294423|NCT01969721|469042288|FG000|Overall Study|Adverse Event|3|||
130294424|NCT01969721|469042289|FG001|Overall Study|Adverse Event|8|||
130294425|NCT01969721|469042290|FG002|Overall Study|Adverse Event|3|||
130294426|NCT01969721|469042291|FG003|Overall Study|Adverse Event|2|||
130294427|NCT01969721|469042288|FG000|Overall Study|Lack of Efficacy|0|||
130294428|NCT01969721|469042289|FG001|Overall Study|Lack of Efficacy|0|||
130294429|NCT01969721|469042290|FG002|Overall Study|Lack of Efficacy|1|||
130294430|NCT01969721|469042291|FG003|Overall Study|Lack of Efficacy|0|||
130294431|NCT01969721|469042288|FG000|Overall Study|Non compliant with protocol|1|||
130294432|NCT01969721|469042289|FG001|Overall Study|Non compliant with protocol|1|||
130294433|NCT01969721|469042290|FG002|Overall Study|Non compliant with protocol|0|||
130294434|NCT01969721|469042291|FG003|Overall Study|Non compliant with protocol|2|||
130294435|NCT01969721|469042288|FG000|Overall Study|Other not defined above|0|||
130294436|NCT01969721|469042289|FG001|Overall Study|Other not defined above|2|||
130294437|NCT01969721|469042290|FG002|Overall Study|Other not defined above|0|||
130294438|NCT01969721|469042291|FG003|Overall Study|Other not defined above|0|||
130294439|NCT01969721|469042288|FG000|Overall Study|Discontinued during washout periods.|0|||
130294440|NCT01969721|469042289|FG001|Overall Study|Discontinued during washout periods.|1|||
130294441|NCT01969721|469042290|FG002|Overall Study|Discontinued during washout periods.|1|||
130294442|NCT01969721|469042291|FG003|Overall Study|Discontinued during washout periods.|2|||
130294443|NCT01012323|469042292|FG000|Overall Study|Investigator Judgment|1|||
130294444|NCT02117349|469042293|FG000|Overall Study|Withdrawal by Subject|1|||
130046112|NCT00306891|468125660|FG000|Part A|Partial bowel obstruction|1|||
130046113|NCT00306891|468125661|FG001|Part A|Partial bowel obstruction|0|||
130046114|NCT00306891|468125662|FG002|Part A|Partial bowel obstruction|0|||
130046115|NCT00306891|468125663|FG003|Part A|Partial bowel obstruction|0|||
130046116|NCT00306891|468125660|FG000|Part A|Reaccumul. of ascites following drainage|0|||
130046117|NCT00306891|468125661|FG001|Part A|Reaccumul. of ascites following drainage|1|||
130294445|NCT02117349|469042294|FG001|Overall Study|Withdrawal by Subject|0|||
130294446|NCT02117349|469042293|FG000|Overall Study|Lost to Follow-up|1|||
130294447|NCT02117349|469042294|FG001|Overall Study|Lost to Follow-up|1|||
130294448|NCT02117349|469042293|FG000|Overall Study|Death|1|||
130046118|NCT00306891|468125662|FG002|Part A|Reaccumul. of ascites following drainage|0|||
130046119|NCT00306891|468125663|FG003|Part A|Reaccumul. of ascites following drainage|0|||
130046120|NCT00306891|468125660|FG000|Part A|Suspicion of second malignancy|0|||
130294449|NCT02117349|469042294|FG001|Overall Study|Death|0|||
130294450|NCT00495755|469042295|FG000|Overall Study|Adverse Event|3|||
130294451|NCT02265796|469042296|FG000|Overall Study|Death|1|||
130294452|NCT02265796|469042297|FG001|Overall Study|Death|0|||
130294453|NCT02265796|469042296|FG000|Overall Study|started on excluded medication|1|||
130294454|NCT02265796|469042297|FG001|Overall Study|started on excluded medication|0|||
130294455|NCT02265796|469042296|FG000|Overall Study|Withdrawal by Subject|1|||
130294456|NCT02265796|469042297|FG001|Overall Study|Withdrawal by Subject|1|||
130294457|NCT03938324|469043706|FG000|Overall Study|Lost to Follow-up|42|||
130294458|NCT03938324|469043707|FG001|Overall Study|Lost to Follow-up|21|||
130294459|NCT03938324|469043706|FG000|Overall Study|Withdrawal by Subject|6|||
130294460|NCT03938324|469043707|FG001|Overall Study|Withdrawal by Subject|1|||
130294461|NCT00837759|469043708|FG000|Overall Study|Protocol Violation|3|||
130294462|NCT00837759|469043708|FG000|Overall Study|Lost to Follow-up|1|||
130294463|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Adverse Event|3|||
130294464|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Adverse Event|0|||
130294465|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
130294466|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
130294467|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Physician Decision|1|||
130294468|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Physician Decision|0|||
130294469|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
130294470|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
130294471|NCT02081599|469043709|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
130294472|NCT02081599|469043710|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
130294473|NCT02081599|469043709|FG000|Period 1：Double-blind Period|stopping criteria|1|||
130294474|NCT02081599|469043710|FG001|Period 1：Double-blind Period|stopping criteria|0|||
130294475|NCT02081599|469043709|FG000|Period 2：Open-label Period|Adverse Event|1|||
130294476|NCT02081599|469043710|FG001|Period 2：Open-label Period|Adverse Event|0|||
130294477|NCT02081599|469043709|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
130294478|NCT02081599|469043710|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
130294479|NCT02081599|469043709|FG000|Period 2：Open-label Period|Physician Decision|1|||
130294480|NCT02081599|469043710|FG001|Period 2：Open-label Period|Physician Decision|0|||
130294481|NCT02081599|469043709|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
130294482|NCT02081599|469043710|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
130294483|NCT01286077|469043711|FG000|Overall Study|Adverse Event|2|||
130294484|NCT01286077|469043712|FG001|Overall Study|Adverse Event|0|||
130294485|NCT01286077|469043711|FG000|Overall Study|Death|1|||
130294486|NCT01286077|469043712|FG001|Overall Study|Death|0|||
130294487|NCT01286077|469043711|FG000|Overall Study|Protocol Violation|1|||
130294488|NCT01286077|469043712|FG001|Overall Study|Protocol Violation|1|||
130294489|NCT01286077|469043711|FG000|Overall Study|Withdrawal by Subject|0|||
130294490|NCT01286077|469043712|FG001|Overall Study|Withdrawal by Subject|2|||
130294491|NCT01286077|469043711|FG000|Overall Study|Intercurrent illness|1|||
130294492|NCT01286077|469043712|FG001|Overall Study|Intercurrent illness|0|||
130294493|NCT01286077|469043711|FG000|Overall Study|Non-compliance|1|||
130294494|NCT01286077|469043712|FG001|Overall Study|Non-compliance|0|||
130294495|NCT01286077|469043711|FG000|Overall Study|The subject starts with alternative MMY|0|||
130294496|NCT01286077|469043712|FG001|Overall Study|The subject starts with alternative MMY|3|||
130294497|NCT01286077|469043711|FG000|Overall Study|Patient's decision to stop treatment|3|||
130294498|NCT01286077|469043712|FG001|Overall Study|Patient's decision to stop treatment|0|||
130294499|NCT01286077|469043711|FG000|Overall Study|Progression of disease|0|||
130294500|NCT01286077|469043712|FG001|Overall Study|Progression of disease|1|||
130294501|NCT01286077|469043711|FG000|Overall Study|refill medication not received in time|1|||
130294502|NCT01286077|469043712|FG001|Overall Study|refill medication not received in time|0|||
130294503|NCT05063539|469043713|FG000|Overall Study|Adverse Event|1|||
130294504|NCT05063539|469043714|FG001|Overall Study|Adverse Event|2|||
130294505|NCT05063539|469043715|FG002|Overall Study|Adverse Event|1|||
130046121|NCT00306891|468125661|FG001|Part A|Suspicion of second malignancy|1|||
130294506|NCT05063539|469043713|FG000|Overall Study|Death|0|||
130294507|NCT05063539|469043714|FG001|Overall Study|Death|1|||
130294508|NCT05063539|469043715|FG002|Overall Study|Death|1|||
130294509|NCT05063539|469043713|FG000|Overall Study|Lost to Follow-up|0|||
130294510|NCT05063539|469043714|FG001|Overall Study|Lost to Follow-up|1|||
130046122|NCT00306891|468125662|FG002|Part A|Suspicion of second malignancy|0|||
130294511|NCT05063539|469043715|FG002|Overall Study|Lost to Follow-up|0|||
130294512|NCT05063539|469043713|FG000|Overall Study|Physician Decision|4|||
130294513|NCT05063539|469043714|FG001|Overall Study|Physician Decision|3|||
130294514|NCT05063539|469043715|FG002|Overall Study|Physician Decision|1|||
130294515|NCT05063539|469043713|FG000|Overall Study|Progressive Disease|0|||
130294516|NCT05063539|469043714|FG001|Overall Study|Progressive Disease|2|||
130294517|NCT05063539|469043715|FG002|Overall Study|Progressive Disease|0|||
130294518|NCT05063539|469043713|FG000|Overall Study|Withdrawal by Subject|17|||
130294519|NCT05063539|469043714|FG001|Overall Study|Withdrawal by Subject|26|||
130294520|NCT05063539|469043715|FG002|Overall Study|Withdrawal by Subject|14|||
130294521|NCT05063539|469043713|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130294522|NCT05063539|469043714|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
130294523|NCT05063539|469043715|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
130294524|NCT05063539|469043713|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
130294525|NCT05063539|469043714|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
130294526|NCT05063539|469043715|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
130294527|NCT05063539|469043713|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
130294528|NCT05063539|469043714|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
130294529|NCT05063539|469043715|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
130294530|NCT05063539|469043713|FG000|Overall Study|Discontinued due to Common Close Design|0|||
130294531|NCT05063539|469043714|FG001|Overall Study|Discontinued due to Common Close Design|1|||
130294532|NCT05063539|469043715|FG002|Overall Study|Discontinued due to Common Close Design|0|||
130294533|NCT05063539|469043713|FG000|Overall Study|Participant not co-operative|0|||
130294534|NCT05063539|469043714|FG001|Overall Study|Participant not co-operative|1|||
130294535|NCT05063539|469043715|FG002|Overall Study|Participant not co-operative|0|||
130294536|NCT05063539|469043713|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
130294537|NCT05063539|469043714|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
130294538|NCT05063539|469043715|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
130294539|NCT05063539|469043713|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
130294540|NCT05063539|469043714|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
130294541|NCT05063539|469043715|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
130294542|NCT01751139|469043716|FG000|Overall Study|Other|135|||
130294543|NCT01751139|469043716|FG000|Overall Study|Sponsor study termination|1609|||
130294544|NCT01751139|469043716|FG000|Overall Study|Lost to Follow-up|240|||
130294545|NCT01751139|469043716|FG000|Overall Study|Withdrawal by Subject|251|||
130294546|NCT01751139|469043716|FG000|Overall Study|Adverse Event|1|||
130294547|NCT01751139|469043716|FG000|Overall Study|Death|31|||
130294548|NCT04736628|469043717|FG000|Overall Study|Not treated|0|||
130294549|NCT04736628|469043718|FG001|Overall Study|Not treated|0|||
130294550|NCT04736628|469043719|FG002|Overall Study|Not treated|0|||
130294551|NCT04736628|469043720|FG003|Overall Study|Not treated|2|||
130294552|NCT04736628|469043717|FG000|Overall Study|Other reason than listed|1|||
130294553|NCT04736628|469043718|FG001|Overall Study|Other reason than listed|2|||
130294554|NCT04736628|469043719|FG002|Overall Study|Other reason than listed|2|||
130294555|NCT04736628|469043720|FG003|Overall Study|Other reason than listed|3|||
130294556|NCT04736628|469043717|FG000|Overall Study|Protocol deviation|0|||
130294557|NCT04736628|469043718|FG001|Overall Study|Protocol deviation|0|||
130294558|NCT04736628|469043719|FG002|Overall Study|Protocol deviation|0|||
130294559|NCT04736628|469043720|FG003|Overall Study|Protocol deviation|1|||
130294560|NCT04736628|469043717|FG000|Overall Study|Burden of study procedures|1|||
130294561|NCT04736628|469043718|FG001|Overall Study|Burden of study procedures|0|||
130294562|NCT04736628|469043719|FG002|Overall Study|Burden of study procedures|0|||
130294563|NCT04736628|469043720|FG003|Overall Study|Burden of study procedures|1|||
130294564|NCT04736628|469043717|FG000|Overall Study|Change of residence|0|||
130294565|NCT04736628|469043718|FG001|Overall Study|Change of residence|1|||
130294566|NCT04736628|469043719|FG002|Overall Study|Change of residence|0|||
130294567|NCT04736628|469043720|FG003|Overall Study|Change of residence|0|||
130294568|NCT04736628|469043717|FG000|Overall Study|Perceived lack of efficacy|1|||
130294569|NCT04736628|469043718|FG001|Overall Study|Perceived lack of efficacy|0|||
130294570|NCT04736628|469043719|FG002|Overall Study|Perceived lack of efficacy|0|||
130294571|NCT04736628|469043720|FG003|Overall Study|Perceived lack of efficacy|1|||
130294572|NCT04736628|469043717|FG000|Overall Study|Adverse Event|3|||
130294573|NCT04736628|469043718|FG001|Overall Study|Adverse Event|2|||
130294574|NCT04736628|469043719|FG002|Overall Study|Adverse Event|4|||
130294575|NCT04736628|469043720|FG003|Overall Study|Adverse Event|3|||
130294576|NCT04279613|469043721|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294577|NCT04279613|469043722|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294578|NCT04279613|469043723|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294579|NCT04279613|469043724|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
130294580|NCT04279613|469043725|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
130294581|NCT04279613|469043721|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294582|NCT04279613|469043722|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
130294583|NCT04279613|469043723|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294584|NCT04279613|469043724|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294585|NCT04279613|469043725|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
130294586|NCT04279613|469043721|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294587|NCT04279613|469043722|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294588|NCT04279613|469043723|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
130294589|NCT04279613|469043724|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294590|NCT04279613|469043725|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
130294591|NCT04279613|469043721|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294592|NCT04279613|469043722|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294593|NCT04279613|469043723|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294594|NCT04279613|469043724|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
130294595|NCT04279613|469043725|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
130294596|NCT04279613|469043721|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294597|NCT04279613|469043722|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294598|NCT04279613|469043723|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294599|NCT04279613|469043724|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
130294600|NCT04279613|469043725|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
130294613|NCT02704689|469043729|FG000|Overall Study|Physician Decision|1|||
130294614|NCT02704689|469043729|FG000|Overall Study|Study device not implanted|2|||
130294615|NCT02212678|469043732|FG000|Overall Study|Adverse Event|1|||
130294616|NCT02337634|469043733|FG000|Overall Study|Protocol Violation|3|||
130294617|NCT02337634|469043734|FG001|Overall Study|Protocol Violation|1|||
130294618|NCT02337634|469043733|FG000|Overall Study|Lost to Follow-up|1|||
130294619|NCT02337634|469043734|FG001|Overall Study|Lost to Follow-up|0|||
130294620|NCT04068610|469043735|FG000|Overall Study|Death|4|||
130294621|NCT04068610|469043736|FG001|Overall Study|Death|8|||
130294622|NCT04068610|469043737|FG002|Overall Study|Death|13|||
130294623|NCT04068610|469043735|FG000|Overall Study|Lost to Follow-up|0|||
130294624|NCT04068610|469043736|FG001|Overall Study|Lost to Follow-up|2|||
130294625|NCT04068610|469043737|FG002|Overall Study|Lost to Follow-up|0|||
130294626|NCT04068610|469043735|FG000|Overall Study|Withdrawal by Subject|0|||
130294627|NCT04068610|469043736|FG001|Overall Study|Withdrawal by Subject|4|||
130294628|NCT04068610|469043737|FG002|Overall Study|Withdrawal by Subject|2|||
130294629|NCT04068610|469043735|FG000|Overall Study|Other|3|||
130294630|NCT04068610|469043736|FG001|Overall Study|Other|12|||
130294631|NCT04068610|469043737|FG002|Overall Study|Other|11|||
130294632|NCT02428205|469043738|FG000|Overall Study|Lack of Efficacy|1|||
130294633|NCT02428205|469043739|FG001|Overall Study|Lack of Efficacy|0|||
130294634|NCT02428205|469043738|FG000|Overall Study|Lost to Follow-up|1|||
130294635|NCT02428205|469043739|FG001|Overall Study|Lost to Follow-up|1|||
130294636|NCT02428205|469043738|FG000|Overall Study|Worse behavior|0|||
130294637|NCT02428205|469043739|FG001|Overall Study|Worse behavior|1|||
130294638|NCT00527319|469043740|FG000|Overall Study|Withdrawal by Subject|5|||
130294639|NCT00527319|469043741|FG001|Overall Study|Withdrawal by Subject|0|||
130294640|NCT00527319|469043742|FG002|Overall Study|Withdrawal by Subject|1|||
130294641|NCT00527319|469043740|FG000|Overall Study|Lost to Follow-up|1|||
130294642|NCT00527319|469043741|FG001|Overall Study|Lost to Follow-up|0|||
130294643|NCT00527319|469043742|FG002|Overall Study|Lost to Follow-up|0|||
130294644|NCT00527319|469043740|FG000|Overall Study|Death|0|||
130294645|NCT00527319|469043741|FG001|Overall Study|Death|3|||
130294646|NCT00527319|469043742|FG002|Overall Study|Death|1|||
130294647|NCT00527319|469043740|FG000|Overall Study|Intercurrent Medical Illness|0|||
130294648|NCT00527319|469043741|FG001|Overall Study|Intercurrent Medical Illness|1|||
130294649|NCT00527319|469043742|FG002|Overall Study|Intercurrent Medical Illness|3|||
130294650|NCT00527319|469043740|FG000|Overall Study|Adverse Event|0|||
130294651|NCT00527319|469043741|FG001|Overall Study|Adverse Event|0|||
130294652|NCT00527319|469043742|FG002|Overall Study|Adverse Event|1|||
130294653|NCT03344172|469043745|FG000|Overall Study|Received <1 dose of treatment|1|||
130294654|NCT03344172|469043746|FG001|Overall Study|Received <1 dose of treatment|0|||
130294655|NCT00680368|469043749|FG000|Overall Study|not supervised, not eligible|15|||
130294656|NCT00430937|469043753|FG000|Overall Study|Adverse Event|3|||
130294657|NCT00430937|469043754|FG001|Overall Study|Adverse Event|8|||
130294658|NCT00430937|469043753|FG000|Overall Study|Death|0|||
130294659|NCT00430937|469043754|FG001|Overall Study|Death|1|||
130294660|NCT00430937|469043753|FG000|Overall Study|Lost to Follow-up|6|||
130294661|NCT00430937|469043754|FG001|Overall Study|Lost to Follow-up|6|||
130294662|NCT00430937|469043753|FG000|Overall Study|Withdrawal by Subject|5|||
130294663|NCT00430937|469043754|FG001|Overall Study|Withdrawal by Subject|2|||
130294664|NCT00430937|469043753|FG000|Overall Study|Protocol Violation|3|||
130294665|NCT00430937|469043754|FG001|Overall Study|Protocol Violation|2|||
130294666|NCT00430937|469043753|FG000|Overall Study|Lack of Efficacy|6|||
130294667|NCT00430937|469043754|FG001|Overall Study|Lack of Efficacy|5|||
130294668|NCT00430937|469043753|FG000|Overall Study|Inappropriate enrollment|2|||
130294669|NCT00430937|469043754|FG001|Overall Study|Inappropriate enrollment|1|||
130294670|NCT00430937|469043753|FG000|Overall Study|Administrative reasons|1|||
130294671|NCT00430937|469043754|FG001|Overall Study|Administrative reasons|0|||
130294672|NCT00430937|469043753|FG000|Overall Study|Protocol discontinuation criteria met|1|||
130294673|NCT00430937|469043754|FG001|Overall Study|Protocol discontinuation criteria met|2|||
130294674|NCT00430937|469043753|FG000|Overall Study|Unable to classify|0|||
130294675|NCT00430937|469043754|FG001|Overall Study|Unable to classify|1|||
130294676|NCT02392403|469043757|FG000|Overall Study|Adverse Event|1|||
130294677|NCT02392403|469043757|FG000|Overall Study|Death|1|||
130294678|NCT02392403|469043757|FG000|Overall Study|Withdrawal by Subject|1|||
130294679|NCT00657371|469043761|FG000|Overall Study|Poor bowel preparation|15|||
130294680|NCT00657371|469043761|FG000|Overall Study|Unable to intubate the cecum|5|||
130294681|NCT00657371|469043761|FG000|Overall Study|Protocol Violation|2|||
130294682|NCT00657371|469043761|FG000|Overall Study|Device- related reasons|13|||
130294683|NCT00657371|469043761|FG000|Overall Study|Pre-existing medical condition|4|||
130294684|NCT01639755|469043762|FG000|Overall Study|Study Ongoing|15|||
130294685|NCT01639755|469043762|FG000|Overall Study|Patient had device explantation|4|||
130294686|NCT03629912|469043763|FG000|Overall Study|Lost to Follow-up|19|||
130294687|NCT03629912|469043764|FG001|Overall Study|Lost to Follow-up|7|||
130294688|NCT03629912|469043765|FG002|Overall Study|Lost to Follow-up|5|||
130294689|NCT03629912|469043766|FG003|Overall Study|Lost to Follow-up|1|||
130294690|NCT03629912|469043763|FG000|Overall Study|Withdrawal by Subject|6|||
130294691|NCT03629912|469043764|FG001|Overall Study|Withdrawal by Subject|0|||
130294692|NCT03629912|469043765|FG002|Overall Study|Withdrawal by Subject|1|||
130294693|NCT03629912|469043766|FG003|Overall Study|Withdrawal by Subject|2|||
130294694|NCT03629912|469043763|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
130294695|NCT03629912|469043764|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
130294696|NCT03629912|469043765|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
130294697|NCT03629912|469043766|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
130294698|NCT03629912|469043763|FG000|Overall Study|Death|1|||
130294699|NCT03629912|469043764|FG001|Overall Study|Death|0|||
130294700|NCT03629912|469043765|FG002|Overall Study|Death|0|||
130294701|NCT03629912|469043766|FG003|Overall Study|Death|0|||
130294702|NCT01475162|469043767|FG000|Overall Study|Physician Decision|1|||
130294703|NCT01475162|469043767|FG000|Overall Study|Death|10|||
130294704|NCT01475162|469043767|FG000|Overall Study|Study closed for safety|3|||
129793797|NCT00393042|467212752|FG001|Second Intervetion|Withdrawal by Subject|2|||
129793798|NCT00393042|467212751|FG000|Second Intervetion|Lack of Efficacy|1|||
129793799|NCT00393042|467212752|FG001|Second Intervetion|Lack of Efficacy|0|||
129793800|NCT00393042|467212751|FG000|Second Intervetion|Lost to Follow-up|0|||
129793801|NCT00393042|467212752|FG001|Second Intervetion|Lost to Follow-up|2|||
129793802|NCT00393042|467212751|FG000|Second Intervetion|Protocol Violation|1|||
129793803|NCT00393042|467212752|FG001|Second Intervetion|Protocol Violation|1|||
129793804|NCT01150474|467212757|FG000|Overall Study|Withdrawal by Subject|5|||
129793805|NCT01150474|467212758|FG001|Overall Study|Withdrawal by Subject|2|||
129793806|NCT01150474|467212757|FG000|Overall Study|Cancer found|1|||
129793807|NCT01150474|467212758|FG001|Overall Study|Cancer found|0|||
129793808|NCT01150474|467212757|FG000|Overall Study|Multiple Studies|0|||
129793809|NCT01150474|467212758|FG001|Overall Study|Multiple Studies|1|||
129793810|NCT01150474|467212757|FG000|Overall Study|Rectotomy|1|||
129888673|NCT02584855|467549275|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
130294705|NCT00490022|469043768|FG000|Overall Study|Adverse Event|0|||
130294706|NCT00490022|469043769|FG001|Overall Study|Adverse Event|2|||
129793811|NCT01150474|467212758|FG001|Overall Study|Rectotomy|0|||
130294707|NCT00490022|469043768|FG000|Overall Study|Withdrawal by Subject|1|||
130294708|NCT00490022|469043769|FG001|Overall Study|Withdrawal by Subject|0|||
130294709|NCT00490022|469043768|FG000|Overall Study|Subject failed to disclose concommitant|0|||
130294710|NCT00490022|469043769|FG001|Overall Study|Subject failed to disclose concommitant|1|||
130294711|NCT05059977|469043771|FG000|Overall Study|Withdrawal by Subject|0|||
130294712|NCT05059977|469043772|FG001|Overall Study|Withdrawal by Subject|0|||
130294713|NCT05059977|469043773|FG002|Overall Study|Withdrawal by Subject|1|||
130294714|NCT00576472|469043776|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294715|NCT00576472|469043777|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
129888674|NCT02584855|467549270|FG000|Open-Label Treatment Period|Adverse Event|14|||
129888675|NCT02584855|467549271|FG001|Open-Label Treatment Period|Adverse Event|0|||
129888676|NCT02584855|467549272|FG002|Open-Label Treatment Period|Adverse Event|0|||
129888677|NCT02584855|467549273|FG003|Open-Label Treatment Period|Adverse Event|0|||
129888678|NCT02584855|467549274|FG004|Open-Label Treatment Period|Adverse Event|0|||
129888679|NCT02584855|467549275|FG005|Open-Label Treatment Period|Adverse Event|0|||
129888680|NCT02584855|467549270|FG000|Open-Label Treatment Period|Death|2|||
129888681|NCT02584855|467549271|FG001|Open-Label Treatment Period|Death|0|||
129888682|NCT02584855|467549272|FG002|Open-Label Treatment Period|Death|0|||
129888683|NCT02584855|467549273|FG003|Open-Label Treatment Period|Death|0|||
129888684|NCT02584855|467549274|FG004|Open-Label Treatment Period|Death|0|||
129888685|NCT02584855|467549275|FG005|Open-Label Treatment Period|Death|0|||
129888686|NCT02584855|467549270|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
129888687|NCT02584855|467549271|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
129888688|NCT02584855|467549272|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
129888689|NCT02584855|467549273|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
129888690|NCT02584855|467549274|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
129888691|NCT02584855|467549275|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
129888692|NCT02584855|467549270|FG000|Open-Label Treatment Period|Protocol Violation|1|||
129888693|NCT02584855|467549271|FG001|Open-Label Treatment Period|Protocol Violation|0|||
129888694|NCT02584855|467549272|FG002|Open-Label Treatment Period|Protocol Violation|0|||
129888695|NCT02584855|467549273|FG003|Open-Label Treatment Period|Protocol Violation|0|||
129888696|NCT02584855|467549274|FG004|Open-Label Treatment Period|Protocol Violation|0|||
129888697|NCT02584855|467549275|FG005|Open-Label Treatment Period|Protocol Violation|0|||
129888698|NCT02584855|467549270|FG000|Open-Label Treatment Period|No PI Available|2|||
129888699|NCT02584855|467549271|FG001|Open-Label Treatment Period|No PI Available|0|||
129888700|NCT02584855|467549272|FG002|Open-Label Treatment Period|No PI Available|0|||
129888701|NCT02584855|467549273|FG003|Open-Label Treatment Period|No PI Available|0|||
129888702|NCT02584855|467549274|FG004|Open-Label Treatment Period|No PI Available|0|||
129888703|NCT02584855|467549275|FG005|Open-Label Treatment Period|No PI Available|0|||
129888704|NCT02584855|467549270|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
129888705|NCT02584855|467549271|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
129888706|NCT02584855|467549272|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
129888707|NCT02584855|467549273|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
129888708|NCT02584855|467549274|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
129888709|NCT02584855|467549275|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
129888710|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888711|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888712|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
129888713|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888714|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888715|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888716|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
130294716|NCT00576472|469043778|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294717|NCT00576472|469043779|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
130294718|NCT00576472|469043780|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294719|NCT00576472|469043781|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294720|NCT00576472|469043782|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294721|NCT00576472|469043783|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294722|NCT00576472|469043784|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294723|NCT00576472|469043785|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294724|NCT00576472|469043786|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294725|NCT00576472|469043787|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294726|NCT00576472|469043788|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294727|NCT00576472|469043789|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294728|NCT00576472|469043790|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
130294729|NCT00576472|469043776|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
130294730|NCT00576472|469043777|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
130294731|NCT00576472|469043778|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
130294732|NCT00576472|469043779|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
130294733|NCT00576472|469043780|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
130294734|NCT00576472|469043781|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
129888717|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
129888718|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
129888719|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
129888720|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
130106508|NCT01898884|468350056|FG001|Multiple Dose Period|Randomized Not Treated|0|||
130294735|NCT00576472|469043782|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
130294736|NCT00576472|469043783|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
130294737|NCT00576472|469043784|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
130294738|NCT00576472|469043785|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
130046123|NCT00306891|468125663|FG003|Part A|Suspicion of second malignancy|0|||
130294739|NCT00576472|469043786|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
130294740|NCT00576472|469043787|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
130294741|NCT00576472|469043788|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
130294742|NCT00576472|469043789|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
130294743|NCT00576472|469043790|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
130294744|NCT00576472|469043776|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294745|NCT00576472|469043777|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294746|NCT00576472|469043778|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294747|NCT00576472|469043779|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
130294748|NCT00576472|469043780|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294749|NCT00576472|469043781|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294750|NCT00576472|469043782|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294751|NCT00576472|469043783|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294752|NCT00576472|469043784|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294753|NCT00576472|469043785|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294754|NCT00576472|469043786|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294755|NCT00576472|469043787|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294756|NCT00576472|469043788|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294757|NCT00576472|469043789|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294758|NCT00576472|469043790|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
130294759|NCT00576472|469043776|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
130294760|NCT00576472|469043777|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
130294761|NCT00576472|469043778|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
130294762|NCT00576472|469043779|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
130294763|NCT00576472|469043780|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
130294764|NCT00576472|469043781|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
130294765|NCT00576472|469043782|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
130294766|NCT00576472|469043783|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
130294767|NCT00576472|469043784|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
130294768|NCT00576472|469043785|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
130294769|NCT00576472|469043786|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
130294770|NCT00576472|469043787|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
130294771|NCT00576472|469043788|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
130294772|NCT00576472|469043789|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
130294773|NCT00576472|469043790|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
130294774|NCT00576472|469043776|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294775|NCT00576472|469043777|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294776|NCT00576472|469043778|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294777|NCT00576472|469043779|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
130294778|NCT00576472|469043780|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294779|NCT00576472|469043781|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294780|NCT00576472|469043782|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294781|NCT00576472|469043783|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294782|NCT00576472|469043784|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294783|NCT00576472|469043785|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294784|NCT00576472|469043786|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294785|NCT00576472|469043787|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294786|NCT00576472|469043788|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294787|NCT00576472|469043789|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294788|NCT00576472|469043790|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
130294789|NCT00576472|469043776|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294790|NCT00576472|469043777|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294791|NCT00576472|469043778|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294792|NCT00576472|469043779|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294793|NCT00576472|469043780|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294794|NCT00576472|469043781|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294795|NCT00576472|469043782|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
130294796|NCT00576472|469043783|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294797|NCT00576472|469043784|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294798|NCT00576472|469043785|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294799|NCT00576472|469043786|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294800|NCT00576472|469043787|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294801|NCT00576472|469043788|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294802|NCT00576472|469043789|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294803|NCT00576472|469043790|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
130294804|NCT00576472|469043776|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
130294805|NCT00576472|469043777|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
130294806|NCT00576472|469043778|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
130294807|NCT00576472|469043779|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
130294808|NCT00576472|469043780|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
129888721|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
129888722|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888723|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
129888724|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888725|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888726|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888727|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888728|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888729|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
129888730|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888731|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888732|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888733|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888734|NCT02584855|467549270|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
130294809|NCT00576472|469043781|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
130294810|NCT00576472|469043782|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
130294811|NCT00576472|469043783|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
130294812|NCT00576472|469043784|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
130294813|NCT00576472|469043785|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
130294814|NCT00576472|469043786|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
130294815|NCT00576472|469043787|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
130294816|NCT00576472|469043788|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
130294817|NCT00576472|469043789|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
130294818|NCT00576472|469043790|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
130294819|NCT00576472|469043776|FG000|MPH Cross Over Phase|Physician Decision|0|||
130294820|NCT00576472|469043777|FG001|MPH Cross Over Phase|Physician Decision|0|||
130294821|NCT00576472|469043778|FG002|MPH Cross Over Phase|Physician Decision|0|||
130294822|NCT00576472|469043779|FG003|MPH Cross Over Phase|Physician Decision|0|||
129888735|NCT02584855|467549271|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888736|NCT02584855|467549272|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888737|NCT02584855|467549273|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888738|NCT02584855|467549274|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
130046124|NCT00306891|468125660|FG000|Part A|QTC interval outwith elig. criteria|1|||
130046125|NCT00306891|468125661|FG001|Part A|QTC interval outwith elig. criteria|0|||
130046126|NCT00306891|468125662|FG002|Part A|QTC interval outwith elig. criteria|0|||
130046127|NCT00306891|468125663|FG003|Part A|QTC interval outwith elig. criteria|0|||
130046128|NCT00306891|468125660|FG000|Part B|Death|0|||
130046129|NCT00306891|468125661|FG001|Part B|Death|0|||
130046130|NCT00306891|468125662|FG002|Part B|Death|1|||
130046131|NCT00306891|468125663|FG003|Part B|Death|2|||
130046132|NCT00306891|468125660|FG000|Part B|Adverse Event|0|||
130046133|NCT00306891|468125661|FG001|Part B|Adverse Event|0|||
130046134|NCT00306891|468125662|FG002|Part B|Adverse Event|5|||
130046135|NCT00306891|468125663|FG003|Part B|Adverse Event|5|||
130046136|NCT00306891|468125660|FG000|Part B|Withdrawal by Subject|0|||
130046137|NCT00306891|468125661|FG001|Part B|Withdrawal by Subject|0|||
130046138|NCT00306891|468125662|FG002|Part B|Withdrawal by Subject|3|||
130046139|NCT00306891|468125663|FG003|Part B|Withdrawal by Subject|1|||
130046140|NCT00306891|468125660|FG000|Part B|Condition under investigation worsened|0|||
130046141|NCT00306891|468125661|FG001|Part B|Condition under investigation worsened|0|||
130046142|NCT00306891|468125662|FG002|Part B|Condition under investigation worsened|2|||
130046143|NCT00306891|468125663|FG003|Part B|Condition under investigation worsened|8|||
130046144|NCT00306891|468125660|FG000|Part B|Development of study specific disc crit.|0|||
130046145|NCT00306891|468125661|FG001|Part B|Development of study specific disc crit.|0|||
130046146|NCT00306891|468125662|FG002|Part B|Development of study specific disc crit.|0|||
130046147|NCT00306891|468125663|FG003|Part B|Development of study specific disc crit.|1|||
130046148|NCT00673673|468125664|FG000|Overall Study|Progressive disease|27|||
130046149|NCT00673673|468125664|FG000|Overall Study|Adverse Event|4|||
130046150|NCT00673673|468125664|FG000|Overall Study|Withdrawal by Subject|3|||
130046151|NCT00673673|468125664|FG000|Overall Study|Investigators' discretion|2|||
130046152|NCT01751646|468125665|FG000|Overall Study|Lost to Follow-up|5|||
130046153|NCT01751646|468125666|FG001|Overall Study|Lost to Follow-up|1|||
130046154|NCT01751646|468125665|FG000|Overall Study|Withdrawal by Subject|0|||
130046155|NCT01751646|468125666|FG001|Overall Study|Withdrawal by Subject|4|||
130046156|NCT01751646|468125665|FG000|Overall Study|Starting hormone therapy|1|||
130046157|NCT01751646|468125666|FG001|Overall Study|Starting hormone therapy|0|||
130046158|NCT01751646|468125665|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
130294823|NCT00576472|469043780|FG004|MPH Cross Over Phase|Physician Decision|0|||
130294824|NCT00576472|469043781|FG005|MPH Cross Over Phase|Physician Decision|0|||
130294825|NCT00576472|469043782|FG006|MPH Cross Over Phase|Physician Decision|4|||
130046159|NCT01751646|468125666|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
129888739|NCT02584855|467549275|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888740|NCT02584855|467549270|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
129888741|NCT02584855|467549271|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
129888742|NCT02584855|467549272|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
129888743|NCT02584855|467549273|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
129888744|NCT02584855|467549274|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
130046160|NCT01751646|468125665|FG000|Overall Study|Inadvertent enrollment|1|||
130046161|NCT01751646|468125666|FG001|Overall Study|Inadvertent enrollment|1|||
130294826|NCT00576472|469043783|FG007|MPH Cross Over Phase|Physician Decision|0|||
130294827|NCT00576472|469043784|FG008|MPH Cross Over Phase|Physician Decision|0|||
130294828|NCT00576472|469043785|FG009|MPH Cross Over Phase|Physician Decision|0|||
130294829|NCT00576472|469043786|FG010|MPH Cross Over Phase|Physician Decision|0|||
130294830|NCT00576472|469043787|FG011|MPH Cross Over Phase|Physician Decision|0|||
130294831|NCT00576472|469043788|FG012|MPH Cross Over Phase|Physician Decision|0|||
130294832|NCT00576472|469043789|FG013|MPH Cross Over Phase|Physician Decision|0|||
130294833|NCT00576472|469043790|FG014|MPH Cross Over Phase|Physician Decision|0|||
130294834|NCT00576472|469043776|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294835|NCT00576472|469043777|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294836|NCT00576472|469043778|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294837|NCT00576472|469043779|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294838|NCT00576472|469043780|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294839|NCT00576472|469043781|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294840|NCT00576472|469043782|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294841|NCT00576472|469043783|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294842|NCT00576472|469043784|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
130294843|NCT00576472|469043785|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294844|NCT00576472|469043786|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
130294845|NCT00576472|469043787|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
130294846|NCT00576472|469043788|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294847|NCT00576472|469043789|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294848|NCT00576472|469043790|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
130294849|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294850|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294851|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294852|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294853|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294854|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294855|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294856|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129793812|NCT01150474|467212757|FG000|Overall Study|Drug did not arrive in time|1|||
129793813|NCT01150474|467212758|FG001|Overall Study|Drug did not arrive in time|0|||
129793814|NCT01150474|467212757|FG000|Overall Study|Drug not administered|1|||
129793815|NCT01150474|467212758|FG001|Overall Study|Drug not administered|0|||
129793816|NCT01150474|467212757|FG000|Overall Study|Surgery Changed|1|||
129793817|NCT01150474|467212758|FG001|Overall Study|Surgery Changed|0|||
129793818|NCT01423604|467212759|FG000|Safety Run-In|Adverse Event|3|||
129793819|NCT01423604|467212760|FG001|Safety Run-In|Adverse Event|0|||
129793820|NCT01423604|467212759|FG000|Safety Run-In|Death|1|||
129793821|NCT01423604|467212760|FG001|Safety Run-In|Death|0|||
129888745|NCT02584855|467549275|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
130046162|NCT01751646|468125665|FG000|Overall Study|Moved out of the area|1|||
130046163|NCT01751646|468125666|FG001|Overall Study|Moved out of the area|5|||
130046164|NCT01751646|468125665|FG000|Overall Study|Inability to attend required visits|0|||
130046165|NCT01751646|468125666|FG001|Overall Study|Inability to attend required visits|1|||
130046166|NCT01751646|468125665|FG000|Overall Study|Off study due to multiple obligations|0|||
130046167|NCT01751646|468125666|FG001|Overall Study|Off study due to multiple obligations|1|||
130046168|NCT01751646|468125665|FG000|Overall Study|Fails to comply with study requirements|0|||
130046169|NCT01751646|468125666|FG001|Overall Study|Fails to comply with study requirements|1|||
130046170|NCT01751646|468125665|FG000|Overall Study|Childcare issues|1|||
130046171|NCT01751646|468125666|FG001|Overall Study|Childcare issues|1|||
130046172|NCT04538950|468125667|FG000|Overall Study|Pulmonary Issues|2|||
130046173|NCT04538950|468125667|FG000|Overall Study|illness|2|||
130046174|NCT00970294|468125670|FG000|Overall Study|Physician Decision|4|||
130294857|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294858|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294859|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294860|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294861|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129793822|NCT01423604|467212759|FG000|Safety Run-In|Physician Decision|1|||
130046175|NCT00970294|468125670|FG000|Overall Study|Withdrawal by Subject|1|||
130046176|NCT00847561|468125671|FG000|Overall Study|Withdrawal by Subject|4|||
130294862|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
130294863|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
130294864|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
130294865|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
130294866|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
130294867|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
130294868|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
130106509|NCT01898884|468350057|FG002|Multiple Dose Period|Randomized Not Treated|0|||
130106510|NCT01898884|468350058|FG003|Multiple Dose Period|Randomized Not Treated|0|||
130106511|NCT01898884|468350059|FG004|Multiple Dose Period|Randomized Not Treated|0|||
130106512|NCT01898884|468350060|FG005|Multiple Dose Period|Randomized Not Treated|0|||
130106513|NCT01898884|468350061|FG006|Multiple Dose Period|Randomized Not Treated|0|||
130106514|NCT01898884|468350062|FG007|Multiple Dose Period|Randomized Not Treated|0|||
130106515|NCT01898884|468350063|FG008|Multiple Dose Period|Randomized Not Treated|1|||
130106516|NCT00759759|468350064|FG000|Overall Study|didn't return for period 2|1|||
130106517|NCT00759759|468350065|FG001|Overall Study|didn't return for period 2|0|||
130106518|NCT00759759|468350064|FG000|Overall Study|Didn't receive drug in period 2|1|||
130106519|NCT00759759|468350065|FG001|Overall Study|Didn't receive drug in period 2|0|||
130106520|NCT00759759|468350064|FG000|Overall Study|Withdrawal by Subject|2|||
130106521|NCT00759759|468350065|FG001|Overall Study|Withdrawal by Subject|1|||
130106522|NCT01211613|468351577|FG000|Overall Study|Lost to Follow-up|2|||
130106523|NCT01211613|468351578|FG001|Overall Study|Lost to Follow-up|2|||
130106524|NCT01211613|468351579|FG002|Overall Study|Lost to Follow-up|2|||
130106525|NCT01211613|468351577|FG000|Overall Study|Withdrawal by Subject|1|||
130106526|NCT01211613|468351578|FG001|Overall Study|Withdrawal by Subject|0|||
130106527|NCT01211613|468351579|FG002|Overall Study|Withdrawal by Subject|0|||
130106528|NCT03853213|468351580|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
130106529|NCT03853213|468351581|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
130106530|NCT03853213|468351580|FG000|Overall Study|Other (e.g., too busy)|0|||
130106531|NCT03853213|468351581|FG001|Overall Study|Other (e.g., too busy)|2|||
130106532|NCT01458132|468351582|FG000|Overall Study|Other|15|||
130106533|NCT01458132|468351583|FG001|Overall Study|Other|3|||
130106534|NCT00833976|468351588|FG000|Overall Study|Withdrawal by Subject|5|||
130106535|NCT00833976|468351588|FG000|Overall Study|Lost to Follow-up|4|||
130106536|NCT00833976|468351588|FG000|Overall Study|Did not meet eligibility criteria|41|||
130106537|NCT00833976|468351588|FG000|Overall Study|Physician Decision|1|||
130106538|NCT03911960|468351589|FG000|Overall Study|Lost to Follow-up|5|||
130106539|NCT03911960|468351590|FG001|Overall Study|Lost to Follow-up|3|||
130106540|NCT00297492|468351591|FG000|Set Quit Date|Lost to Follow-up|7|||
130106541|NCT00297492|468351592|FG001|Set Quit Date|Lost to Follow-up|13|||
130106542|NCT00297492|468351593|FG002|Set Quit Date|Lost to Follow-up|5|||
130106543|NCT00297492|468351591|FG000|6 Month Follow-up|Lost to Follow-up|63|||
130106544|NCT00297492|468351592|FG001|6 Month Follow-up|Lost to Follow-up|49|||
130106545|NCT00297492|468351593|FG002|6 Month Follow-up|Lost to Follow-up|27|||
130106546|NCT02437890|468351596|FG000|Overall Study|Non-compliance to study drug|0|||
130106547|NCT02437890|468351597|FG001|Overall Study|Non-compliance to study drug|1|||
130106548|NCT02437890|468351598|FG002|Overall Study|Non-compliance to study drug|0|||
130106549|NCT02437890|468351599|FG003|Overall Study|Non-compliance to study drug|0|||
130106550|NCT02437890|468351600|FG004|Overall Study|Non-compliance to study drug|1|||
130106551|NCT02437890|468351596|FG000|Overall Study|Sponsor's decision|1|||
130106552|NCT02437890|468351597|FG001|Overall Study|Sponsor's decision|1|||
130106553|NCT02437890|468351598|FG002|Overall Study|Sponsor's decision|4|||
130106554|NCT02437890|468351599|FG003|Overall Study|Sponsor's decision|0|||
130106555|NCT02437890|468351600|FG004|Overall Study|Sponsor's decision|2|||
130046177|NCT00847561|468125672|FG001|Overall Study|Withdrawal by Subject|3|||
130046178|NCT00847561|468125671|FG000|Overall Study|Unable to schedule|9|||
130046179|NCT00847561|468125672|FG001|Overall Study|Unable to schedule|1|||
130046180|NCT01333189|468125673|FG000|Overall Study|Time constraints|1|||
130046181|NCT01333189|468125674|FG001|Overall Study|Time constraints|0|||
130046182|NCT01333189|468125673|FG000|Overall Study|Adverse Event|1|||
130106556|NCT02437890|468351596|FG000|Overall Study|Physician Decision|0|||
129793823|NCT01423604|467212760|FG001|Safety Run-In|Physician Decision|0|||
129793824|NCT01423604|467212759|FG000|Safety Run-In|Disease progression|3|||
129793825|NCT01423604|467212760|FG001|Safety Run-In|Disease progression|0|||
130106557|NCT02437890|468351597|FG001|Overall Study|Physician Decision|0|||
130106558|NCT02437890|468351598|FG002|Overall Study|Physician Decision|0|||
129793826|NCT01423604|467212759|FG000|Safety Run-In|Patient decision|1|||
129793827|NCT01423604|467212760|FG001|Safety Run-In|Patient decision|0|||
129793828|NCT01423604|467212759|FG000|Randomized|Adverse Event|4|||
130046183|NCT01333189|468125674|FG001|Overall Study|Adverse Event|0|||
130046184|NCT01333189|468125673|FG000|Overall Study|Transportation difficulties|0|||
130106559|NCT02437890|468351599|FG003|Overall Study|Physician Decision|1|||
130106560|NCT02437890|468351600|FG004|Overall Study|Physician Decision|0|||
130106561|NCT02437890|468351596|FG000|Overall Study|Unable to attend visit(s)|1|||
130294869|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
130294870|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
130294871|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
130294872|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
130294873|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
130294874|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
130294875|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
130294876|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
130294877|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
129888746|NCT02337478|467549276|FG000|Overall Study|Lack of Efficacy|5|||
129888747|NCT03583541|467550882|FG000|Overall Study|Lost to Follow-up|31|||
129888748|NCT03583541|467550883|FG001|Overall Study|Lost to Follow-up|65|||
129888749|NCT04102540|467550884|FG000|Overall Study|Withdrawn by PI|2|||
129888750|NCT04102540|467550884|FG000|Overall Study|Lost to Follow-up|6|||
129888751|NCT00280293|467550887|FG000|Overall Study|Protocol Violation|3|||
129888752|NCT00280293|467550888|FG001|Overall Study|Protocol Violation|0|||
129888753|NCT00280293|467550887|FG000|Overall Study|Physician Decision|5|||
129888754|NCT00280293|467550888|FG001|Overall Study|Physician Decision|4|||
129888755|NCT00280293|467550887|FG000|Overall Study|Lost to Follow-up|14|||
129888756|NCT00280293|467550888|FG001|Overall Study|Lost to Follow-up|12|||
129888757|NCT00280293|467550887|FG000|Overall Study|Withdrawal by Subject|3|||
129888758|NCT00280293|467550888|FG001|Overall Study|Withdrawal by Subject|5|||
129888759|NCT00280293|467550887|FG000|Overall Study|Incarceration/Legal Reasons|1|||
129888760|NCT00280293|467550888|FG001|Overall Study|Incarceration/Legal Reasons|1|||
129888761|NCT00280293|467550887|FG000|Overall Study|Adverse Event|0|||
129888762|NCT00280293|467550888|FG001|Overall Study|Adverse Event|1|||
129888763|NCT01458249|467550889|FG000|Overall Study|Not treated|1|||
129888764|NCT01458249|467550889|FG000|Overall Study|Adverse Event|4|||
129888765|NCT01458249|467550889|FG000|Overall Study|Other|2|||
129888766|NCT01458249|467550889|FG000|Overall Study|Ongoing|1|||
129888767|NCT01348854|467550890|FG000|Overall Study|Lost to Follow-up|2|||
129888768|NCT01348854|467550891|FG001|Overall Study|Lost to Follow-up|1|||
129888769|NCT01348854|467550890|FG000|Overall Study|Withdrawal by Subject|1|||
129888770|NCT01348854|467550891|FG001|Overall Study|Withdrawal by Subject|0|||
129888771|NCT00594932|467550894|FG000|First 3 Months|Withdrawal by Subject|1|||
129888772|NCT00594932|467550895|FG001|First 3 Months|Withdrawal by Subject|3|||
129888773|NCT00594932|467550894|FG000|Final 3 Months|Withdrawal by Subject|4|||
129888774|NCT00594932|467550895|FG001|Final 3 Months|Withdrawal by Subject|3|||
129888775|NCT01094171|467550896|FG000|Overall Study|Lost to Follow-up|2|||
129888776|NCT01094171|467550896|FG000|Overall Study|Informed consent withdrawal|4|||
129888777|NCT01094171|467550896|FG000|Overall Study|Migration from the study area|3|||
129888778|NCT01094171|467550896|FG000|Overall Study|Other|1|||
129888779|NCT01009047|467550898|FG000|Overall Study|Adverse Event|5|||
129888780|NCT01009047|467550899|FG001|Overall Study|Adverse Event|0|||
129888781|NCT01009047|467550898|FG000|Overall Study|Lost to Follow-up|0|||
129888782|NCT01009047|467550899|FG001|Overall Study|Lost to Follow-up|2|||
129888783|NCT01009047|467550898|FG000|Overall Study|Lack of Efficacy|4|||
130046185|NCT01333189|468125674|FG001|Overall Study|Transportation difficulties|1|||
130046186|NCT01333189|468125673|FG000|Overall Study|Moved from region|0|||
130046187|NCT01333189|468125674|FG001|Overall Study|Moved from region|1|||
130046188|NCT00465738|468125676|FG000|Overall Study|Lost to Follow-up|2|||
130046189|NCT00465738|468125677|FG001|Overall Study|Lost to Follow-up|0|||
130046190|NCT00465738|468125676|FG000|Overall Study|Adverse Event|0|||
130046191|NCT00465738|468125677|FG001|Overall Study|Adverse Event|1|||
130046192|NCT00465738|468125676|FG000|Overall Study|Withdrawal by Subject|2|||
130046193|NCT00465738|468125677|FG001|Overall Study|Withdrawal by Subject|0|||
130046194|NCT00465738|468125676|FG000|Overall Study|Other|2|||
130046195|NCT00465738|468125677|FG001|Overall Study|Other|5|||
130046196|NCT02792777|468125678|FG000|Overall Study|Withdrawal by Subject|2|||
130046197|NCT02792777|468125679|FG001|Overall Study|Withdrawal by Subject|0|||
130046198|NCT02792777|468125678|FG000|Overall Study|Recording malfunction|2|||
130046199|NCT02792777|468125679|FG001|Overall Study|Recording malfunction|0|||
130046200|NCT02792777|468125678|FG000|Overall Study|Later determined to be ineligible|2|||
130046201|NCT02792777|468125679|FG001|Overall Study|Later determined to be ineligible|0|||
130046202|NCT02792777|468125678|FG000|Overall Study|Participant interviewed twice|1|||
130046203|NCT02792777|468125679|FG001|Overall Study|Participant interviewed twice|0|||
130046204|NCT04799782|468125682|FG000|Washout|Physician Decision|2|||
130046205|NCT04799782|468125683|FG001|Washout|Physician Decision|0|||
130046206|NCT04799782|468125682|FG000|Washout|Withdrawal by Subject|0|||
130106562|NCT02437890|468351597|FG001|Overall Study|Unable to attend visit(s)|0|||
130294878|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
129888784|NCT01009047|467550899|FG001|Overall Study|Lack of Efficacy|11|||
130046207|NCT04799782|468125683|FG001|Washout|Withdrawal by Subject|2|||
130046208|NCT04799782|468125682|FG000|Washout|Lost to Follow-up|0|||
130046209|NCT04799782|468125683|FG001|Washout|Lost to Follow-up|1|||
130046210|NCT02606877|468125684|FG000|Overall Study|Adverse Event|3|||
130294879|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
130294880|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
130294881|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
130294882|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
130294883|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
130294884|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
130294885|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
130294886|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
130294887|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
130294888|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
130294889|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
130294890|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
130294891|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
130294892|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
130294893|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
130294894|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Side effects|0|||
130294895|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Side effects|0|||
130294896|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Side effects|0|||
130294897|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Side effects|0|||
130294898|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Side effects|0|||
130294899|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Side effects|0|||
130294900|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Side effects|0|||
130294901|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Side effects|0|||
130294902|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Side effects|0|||
130294903|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Side effects|0|||
130294904|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Side effects|0|||
130294905|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Side effects|0|||
130294906|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Side effects|0|||
130294907|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Side effects|0|||
130294908|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Side effects|8|||
130294909|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294910|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294911|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294912|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294913|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294914|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294915|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294916|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294917|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294918|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294919|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294920|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294921|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294922|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
130294923|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
130294924|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
130294925|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
130294926|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
130294927|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
130294928|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
130294929|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
130294930|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
129793829|NCT01423604|467212760|FG001|Randomized|Adverse Event|10|||
129793830|NCT01423604|467212759|FG000|Randomized|Death|1|||
129793831|NCT01423604|467212760|FG001|Randomized|Death|0|||
129793832|NCT01423604|467212759|FG000|Randomized|Physician Decision|16|||
129793833|NCT01423604|467212760|FG001|Randomized|Physician Decision|13|||
129793834|NCT01423604|467212759|FG000|Randomized|Other - unspecified|37|||
129793835|NCT01423604|467212760|FG001|Randomized|Other - unspecified|31|||
129793836|NCT01423604|467212759|FG000|Randomized|Patient decision|5|||
129793837|NCT01423604|467212760|FG001|Randomized|Patient decision|9|||
129793838|NCT00424255|467212761|FG000|Overall Study|Death|115|||
130294931|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
130294932|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
130294933|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
130294934|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
130294935|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
130294936|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
130294937|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
130294938|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
130294939|NCT00576472|469043776|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129793839|NCT00424255|467212762|FG001|Overall Study|Death|111|||
129793840|NCT00424255|467212761|FG000|Overall Study|Lost to Follow-up|26|||
130294940|NCT00576472|469043777|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294941|NCT00576472|469043778|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294942|NCT00576472|469043779|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294943|NCT00576472|469043780|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294944|NCT00576472|469043781|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294945|NCT00576472|469043782|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294946|NCT00576472|469043783|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294947|NCT00576472|469043784|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294948|NCT00576472|469043785|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294949|NCT00576472|469043786|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294950|NCT00576472|469043787|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294951|NCT00576472|469043788|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294952|NCT00576472|469043789|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
130294953|NCT00576472|469043790|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
130294954|NCT04405245|469043792|FG000|Overall Study|Adverse Event|0|||
130294955|NCT04405245|469043793|FG001|Overall Study|Adverse Event|1|||
130294956|NCT04405245|469043794|FG002|Overall Study|Adverse Event|0|||
130294957|NCT02391961|469043797|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
130294958|NCT02391961|469043798|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
130294959|NCT02391961|469043797|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130294960|NCT02391961|469043798|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
130294961|NCT02391961|469043797|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130294962|NCT02391961|469043798|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130294963|NCT03263780|469043801|FG000|Overall Study|Withdrawal by Subject|3|||
130294964|NCT03263780|469043801|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
130294965|NCT01504204|469043802|FG000|Overall Study|Lost to Follow-up|1|||
130294966|NCT01504204|469043803|FG001|Overall Study|Lost to Follow-up|1|||
129793841|NCT00424255|467212762|FG001|Overall Study|Lost to Follow-up|20|||
129793842|NCT00424255|467212761|FG000|Overall Study|Protocol Violation|0|||
129793843|NCT00424255|467212762|FG001|Overall Study|Protocol Violation|1|||
130046211|NCT02606877|468125685|FG001|Overall Study|Adverse Event|0|||
130294967|NCT02723175|469043804|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
130294968|NCT02723175|469043805|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
130294969|NCT02723175|469043804|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
130294970|NCT02723175|469043805|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
130294971|NCT03691779|469043809|FG000|Part B (24 Weeks)|Adverse Event|0|||
130294972|NCT03691779|469043810|FG001|Part B (24 Weeks)|Adverse Event|1|||
130294973|NCT03691779|469043809|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
130294974|NCT03691779|469043810|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
130294975|NCT01561963|469043811|FG000|Overall Study|Adverse Event|1|||
130294976|NCT00162266|469043814|FG000|Double-Blind Period|Adverse Event|5|||
130294977|NCT00162266|469043815|FG001|Double-Blind Period|Adverse Event|9|||
130294978|NCT00162266|469043816|FG002|Double-Blind Period|Adverse Event|11|||
130294979|NCT00162266|469043817|FG003|Double-Blind Period|Adverse Event|0|||
130294980|NCT00162266|469043814|FG000|Double-Blind Period|Death|0|||
130294981|NCT00162266|469043815|FG001|Double-Blind Period|Death|1|||
130294982|NCT00162266|469043816|FG002|Double-Blind Period|Death|0|||
130294983|NCT00162266|469043817|FG003|Double-Blind Period|Death|0|||
130294984|NCT00162266|469043814|FG000|Double-Blind Period|Lost to Follow-up|1|||
130294985|NCT00162266|469043815|FG001|Double-Blind Period|Lost to Follow-up|2|||
130294986|NCT00162266|469043816|FG002|Double-Blind Period|Lost to Follow-up|0|||
130294987|NCT00162266|469043817|FG003|Double-Blind Period|Lost to Follow-up|0|||
130294988|NCT00162266|469043814|FG000|Double-Blind Period|Other Reason|1|||
130294989|NCT00162266|469043815|FG001|Double-Blind Period|Other Reason|0|||
130294990|NCT00162266|469043816|FG002|Double-Blind Period|Other Reason|1|||
130294991|NCT00162266|469043817|FG003|Double-Blind Period|Other Reason|0|||
130294992|NCT00162266|469043814|FG000|Double-Blind Period|Lack of Efficacy|13|||
130294993|NCT00162266|469043815|FG001|Double-Blind Period|Lack of Efficacy|17|||
130294994|NCT00162266|469043816|FG002|Double-Blind Period|Lack of Efficacy|30|||
130294995|NCT00162266|469043817|FG003|Double-Blind Period|Lack of Efficacy|0|||
130294996|NCT00162266|469043814|FG000|Double-Blind Period|Withdrawal by Subject|5|||
130294997|NCT00162266|469043815|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129793844|NCT00424255|467212761|FG000|Overall Study|Withdrawal by Subject|34|||
130294998|NCT00162266|469043816|FG002|Double-Blind Period|Withdrawal by Subject|6|||
130294999|NCT00162266|469043817|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129793845|NCT00424255|467212762|FG001|Overall Study|Withdrawal by Subject|38|||
129793846|NCT00424255|467212761|FG000|Overall Study|Physician Decision|3|||
129793847|NCT00424255|467212762|FG001|Overall Study|Physician Decision|7|||
130295000|NCT00162266|469043814|FG000|Open-Label Period|Death|0|||
130295001|NCT00162266|469043815|FG001|Open-Label Period|Death|0|||
130295002|NCT00162266|469043816|FG002|Open-Label Period|Death|0|||
130295003|NCT00162266|469043817|FG003|Open-Label Period|Death|7|||
130295004|NCT00162266|469043814|FG000|Open-Label Period|Adverse Event|0|||
130295005|NCT00162266|469043815|FG001|Open-Label Period|Adverse Event|0|||
130295006|NCT00162266|469043816|FG002|Open-Label Period|Adverse Event|0|||
130295007|NCT00162266|469043817|FG003|Open-Label Period|Adverse Event|46|||
130295008|NCT00162266|469043814|FG000|Open-Label Period|Lack of Efficacy|0|||
130295009|NCT00162266|469043815|FG001|Open-Label Period|Lack of Efficacy|0|||
130295010|NCT00162266|469043816|FG002|Open-Label Period|Lack of Efficacy|0|||
130295011|NCT00162266|469043817|FG003|Open-Label Period|Lack of Efficacy|26|||
130295012|NCT00162266|469043814|FG000|Open-Label Period|Lost to Follow-up|0|||
130295013|NCT00162266|469043815|FG001|Open-Label Period|Lost to Follow-up|0|||
130046212|NCT02606877|468125684|FG000|Overall Study|Non-compliance with protocol|0|||
130046213|NCT02606877|468125685|FG001|Overall Study|Non-compliance with protocol|1|||
130046214|NCT02606877|468125684|FG000|Overall Study|Other than listed above|1|||
130046215|NCT02606877|468125685|FG001|Overall Study|Other than listed above|0|||
130046216|NCT05243550|468126894|FG000|Overall Study|Ongoing in the Study|171|||
130295014|NCT00162266|469043816|FG002|Open-Label Period|Lost to Follow-up|0|||
130295015|NCT00162266|469043817|FG003|Open-Label Period|Lost to Follow-up|3|||
130295016|NCT00162266|469043814|FG000|Open-Label Period|Withdrawal by Subject|0|||
130295017|NCT00162266|469043815|FG001|Open-Label Period|Withdrawal by Subject|0|||
130295018|NCT00162266|469043816|FG002|Open-Label Period|Withdrawal by Subject|0|||
130295019|NCT00162266|469043817|FG003|Open-Label Period|Withdrawal by Subject|31|||
130295020|NCT00162266|469043814|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
130295021|NCT00162266|469043815|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
130295022|NCT00162266|469043816|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
130295023|NCT00162266|469043817|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
130295024|NCT00162266|469043814|FG000|Open-Label Period|Other Reasons|0|||
130295025|NCT00162266|469043815|FG001|Open-Label Period|Other Reasons|0|||
130295026|NCT00162266|469043816|FG002|Open-Label Period|Other Reasons|0|||
130295027|NCT00162266|469043817|FG003|Open-Label Period|Other Reasons|15|||
130295028|NCT02299076|469043818|FG000|Overall Study|Fraudulent Entries|20|||
130295029|NCT02299076|469043819|FG001|Overall Study|Fraudulent Entries|14|||
130295030|NCT04208087|469043820|FG000|Overall Study|Adverse Event|1|||
130295031|NCT04208087|469043821|FG001|Overall Study|Adverse Event|0|||
130295032|NCT04208087|469043822|FG002|Overall Study|Adverse Event|0|||
130295033|NCT04208087|469043823|FG003|Overall Study|Adverse Event|0|||
130295034|NCT04208087|469043824|FG004|Overall Study|Adverse Event|0|||
130295035|NCT04208087|469043820|FG000|Overall Study|Withdrawal by Subject|0|||
130295036|NCT04208087|469043821|FG001|Overall Study|Withdrawal by Subject|0|||
130295037|NCT04208087|469043822|FG002|Overall Study|Withdrawal by Subject|1|||
130295038|NCT04208087|469043823|FG003|Overall Study|Withdrawal by Subject|0|||
130295039|NCT04208087|469043824|FG004|Overall Study|Withdrawal by Subject|0|||
130295040|NCT04208087|469043820|FG000|Overall Study|Other|0|||
130295041|NCT04208087|469043821|FG001|Overall Study|Other|0|||
130295042|NCT04208087|469043822|FG002|Overall Study|Other|0|||
130295043|NCT04208087|469043823|FG003|Overall Study|Other|0|||
130295044|NCT04208087|469043824|FG004|Overall Study|Other|1|||
130295045|NCT02477553|469043826|FG000|Overall Study|Screening up-to-date|12|||
130295046|NCT02477553|469043827|FG001|Overall Study|Screening up-to-date|13|||
130295047|NCT02477553|469043826|FG000|Overall Study|No MD visit|1|||
130295048|NCT02477553|469043827|FG001|Overall Study|No MD visit|1|||
130295049|NCT02477553|469043826|FG000|Overall Study|Workup consistent w/CRC|1|||
130295050|NCT02477553|469043827|FG001|Overall Study|Workup consistent w/CRC|1|||
130295051|NCT02477553|469043826|FG000|Overall Study|Technical issues with intervention|2|||
130295052|NCT02477553|469043827|FG001|Overall Study|Technical issues with intervention|0|||
130295053|NCT02477553|469043826|FG000|Overall Study|Elevated risk for CRC|2|||
130295054|NCT02477553|469043827|FG001|Overall Study|Elevated risk for CRC|2|||
130295055|NCT02477553|469043826|FG000|Overall Study|MD advised against screening|1|||
130295056|NCT02477553|469043827|FG001|Overall Study|MD advised against screening|3|||
130295057|NCT02477553|469043826|FG000|Overall Study|patient deceased|1|||
130295058|NCT02477553|469043827|FG001|Overall Study|patient deceased|0|||
130295059|NCT00637572|469043829|FG000|Overall Study|Adverse Event|1|||
130295060|NCT00637572|469043830|FG001|Overall Study|Adverse Event|2|||
130295061|NCT00637572|469043829|FG000|Overall Study|Death|0|||
130295062|NCT00637572|469043830|FG001|Overall Study|Death|1|||
130295063|NCT00637572|469043829|FG000|Overall Study|Lost to Follow-up|0|||
130295064|NCT00637572|469043830|FG001|Overall Study|Lost to Follow-up|1|||
130295065|NCT00637572|469043829|FG000|Overall Study|Physician Decision|1|||
130295066|NCT00637572|469043830|FG001|Overall Study|Physician Decision|1|||
130295067|NCT00637572|469043829|FG000|Overall Study|Withdrawal by Subject|0|||
130295068|NCT00637572|469043830|FG001|Overall Study|Withdrawal by Subject|2|||
130295069|NCT00637572|469043829|FG000|Overall Study|Illicit Drug Use|1|||
130295070|NCT00637572|469043830|FG001|Overall Study|Illicit Drug Use|0|||
130295071|NCT00896649|469043831|FG000|Overall Study|Physician Decision|1|||
130046217|NCT05243550|468126894|FG000|Overall Study|Withdrawal by Subject|10|||
130046218|NCT05243550|468126894|FG000|Overall Study|Lost to Follow-up|7|||
130046219|NCT05243550|468126894|FG000|Overall Study|Adverse Event|3|||
130295072|NCT00896649|469043831|FG000|Overall Study|Pregnancy|1|||
130295073|NCT00896649|469043831|FG000|Overall Study|missing documentation|1|||
130295074|NCT00896649|469043831|FG000|Overall Study|technical difficulties|2|||
130295075|NCT03652675|469043834|FG000|Overall Study|Lost to Follow-up|4|||
130295076|NCT03652675|469043835|FG001|Overall Study|Lost to Follow-up|4|||
130295077|NCT01638559|469043836|FG000|Overall Study|Lost to Follow-up|1|||
129793848|NCT00424255|467212761|FG000|Overall Study|Cognitive Disturbance|1|||
129793849|NCT00424255|467212762|FG001|Overall Study|Cognitive Disturbance|0|||
129793850|NCT00424255|467212761|FG000|Overall Study|Non-compliance by Participants|1|||
129793851|NCT00424255|467212762|FG001|Overall Study|Non-compliance by Participants|0|||
129793852|NCT00424255|467212761|FG000|Overall Study|Fatigue|1|||
129793853|NCT00424255|467212762|FG001|Overall Study|Fatigue|0|||
129793854|NCT00424255|467212761|FG000|Overall Study|Disease Progression|0|||
129793855|NCT00424255|467212762|FG001|Overall Study|Disease Progression|2|||
129793856|NCT00424255|467212761|FG000|Overall Study|Sponsor Terminated Study|161|||
129793857|NCT00424255|467212762|FG001|Overall Study|Sponsor Terminated Study|167|||
129793858|NCT00327470|467212763|FG000|Overall Study|Randomized, but not treated|0|||
129793859|NCT00327470|467212764|FG001|Overall Study|Randomized, but not treated|2|||
129793860|NCT00327470|467212763|FG000|Overall Study|Adverse Event|9|||
129793861|NCT00327470|467212764|FG001|Overall Study|Adverse Event|14|||
129793862|NCT00327470|467212763|FG000|Overall Study|Lack of Efficacy|7|||
129793863|NCT00327470|467212764|FG001|Overall Study|Lack of Efficacy|19|||
129793864|NCT00327470|467212763|FG000|Overall Study|Other|5|||
129793865|NCT00327470|467212764|FG001|Overall Study|Other|9|||
129793866|NCT00327470|467212763|FG000|Overall Study|Lost to Follow-up|1|||
129793867|NCT00327470|467212764|FG001|Overall Study|Lost to Follow-up|3|||
129793868|NCT00327470|467212763|FG000|Overall Study|Withdrawal by Subject|6|||
129793869|NCT00327470|467212764|FG001|Overall Study|Withdrawal by Subject|12|||
129793870|NCT00327470|467212763|FG000|Overall Study|Death|1|||
129793871|NCT00327470|467212764|FG001|Overall Study|Death|4|||
129793872|NCT01226121|467212765|FG000|Overall Study|Lost to Follow-up|2|||
129793873|NCT01226121|467212766|FG001|Overall Study|Lost to Follow-up|0|||
129793874|NCT01226121|467212767|FG002|Overall Study|Lost to Follow-up|1|||
129793875|NCT02581943|467212768|FG000|Overall Study|Death|5|||
129793876|NCT02581943|467212769|FG001|Overall Study|Death|2|||
129793877|NCT02581943|467212768|FG000|Overall Study|Disease Progression|12|||
129793878|NCT02581943|467212769|FG001|Overall Study|Disease Progression|15|||
129793879|NCT02581943|467212768|FG000|Overall Study|Withdrawal by Subject|1|||
129793880|NCT02581943|467212769|FG001|Overall Study|Withdrawal by Subject|2|||
129793881|NCT03021564|467212770|FG000|Overall Study|Death|84|||
129793882|NCT03021564|467212771|FG001|Overall Study|Death|466|||
129793883|NCT03021564|467212770|FG000|Overall Study|Lost to Follow-up|0|||
129793884|NCT03021564|467212771|FG001|Overall Study|Lost to Follow-up|2|||
129793885|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
129793886|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
129793887|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
129793888|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
129793889|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
129793890|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
129793891|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793892|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
129793893|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793894|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793895|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793896|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793897|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
129793898|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
129793899|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
129793900|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
129793901|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
129793902|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
129793903|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793904|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
129793905|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793906|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
130046220|NCT05243550|468126894|FG000|Overall Study|Noncompliance|1|||
130046221|NCT05243550|468126894|FG000|Overall Study|Physician Decision|1|||
130046222|NCT05243550|468126894|FG000|Overall Study|Other Reason|4|||
130046223|NCT00893113|468126899|FG000|Overall Study|Lost to Follow-up|4|||
130046224|NCT00893113|468126900|FG001|Overall Study|Lost to Follow-up|8|||
130046225|NCT00893113|468126899|FG000|Overall Study|Early Termination|1|||
130046226|NCT00893113|468126900|FG001|Overall Study|Early Termination|1|||
130046227|NCT00893113|468126899|FG000|Overall Study|Withdrew Consent|8|||
130295078|NCT01638559|469043836|FG000|Overall Study|Withdrawal by Subject|1|||
130295079|NCT01638559|469043836|FG000|Overall Study|Subject declined to travel for biopsy|1|||
130295080|NCT00483002|469043839|FG000|Overall Study|Adverse Event|68|||
130295081|NCT00483002|469043839|FG000|Overall Study|Lack of Efficacy|555|||
130295082|NCT00483002|469043839|FG000|Overall Study|Lost to Follow-up|962|||
130295083|NCT00483002|469043839|FG000|Overall Study|Other|2|||
130295084|NCT00483002|469043839|FG000|Overall Study|Other|967|||
130295085|NCT01403116|469043840|FG000|Overall Study|Adverse Event|7|||
130295086|NCT01403116|469043841|FG001|Overall Study|Adverse Event|4|||
130295087|NCT01403116|469043840|FG000|Overall Study|Lost to Follow-up|7|||
130295088|NCT01403116|469043841|FG001|Overall Study|Lost to Follow-up|5|||
130295089|NCT01403116|469043840|FG000|Overall Study|Withdrawal by Subject|12|||
130295090|NCT01403116|469043841|FG001|Overall Study|Withdrawal by Subject|15|||
130295091|NCT01403116|469043840|FG000|Overall Study|Non-compliance of study drug|3|||
130295092|NCT01403116|469043841|FG001|Overall Study|Non-compliance of study drug|0|||
130295093|NCT01403116|469043840|FG000|Overall Study|Protocol Violation|0|||
130295094|NCT01403116|469043841|FG001|Overall Study|Protocol Violation|1|||
130295095|NCT01403116|469043840|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
130295096|NCT01403116|469043841|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
130295097|NCT01403116|469043840|FG000|Overall Study|Hct >54%|2|||
130295098|NCT01403116|469043841|FG001|Overall Study|Hct >54%|0|||
130295099|NCT01403116|469043840|FG000|Overall Study|unable to keep appointments|0|||
130295100|NCT01403116|469043841|FG001|Overall Study|unable to keep appointments|2|||
130046228|NCT00893113|468126900|FG001|Overall Study|Withdrew Consent|7|||
130046229|NCT00128206|468126909|FG000|Overall Study|Lost to Follow-up|137|||
130046230|NCT00128206|468126910|FG001|Overall Study|Lost to Follow-up|118|||
130046231|NCT00128206|468126909|FG000|Overall Study|Adverse Event|0|||
130046232|NCT00128206|468126910|FG001|Overall Study|Adverse Event|2|||
130046233|NCT03270085|468126911|FG000|Overall Study|Withdrawal by Subject|1|||
130046234|NCT03270085|468126912|FG001|Overall Study|Withdrawal by Subject|0|||
130046235|NCT01269125|468126913|FG000|Overall Study|Adverse Event|3|||
130046236|NCT01269125|468126914|FG001|Overall Study|Adverse Event|5|||
130046237|NCT01269125|468126915|FG002|Overall Study|Adverse Event|0|||
130046238|NCT01269125|468126913|FG000|Overall Study|Lost to Follow-up|4|||
130046239|NCT01269125|468126914|FG001|Overall Study|Lost to Follow-up|0|||
130046240|NCT01269125|468126915|FG002|Overall Study|Lost to Follow-up|0|||
130046241|NCT01040832|468126917|FG000|Overall Study|Adverse Event|4|||
130046242|NCT01040832|468126918|FG001|Overall Study|Adverse Event|5|||
130046243|NCT01040832|468126917|FG000|Overall Study|Death|4|||
130046244|NCT01040832|468126918|FG001|Overall Study|Death|6|||
130046245|NCT01040832|468126917|FG000|Overall Study|Withdrawal by Subject|2|||
130046246|NCT01040832|468126918|FG001|Overall Study|Withdrawal by Subject|3|||
130046247|NCT01040832|468126917|FG000|Overall Study|Progressive disease|32|||
130046248|NCT01040832|468126918|FG001|Overall Study|Progressive disease|17|||
130046249|NCT01040832|468126917|FG000|Overall Study|Symptomatic deterioration|2|||
130046250|NCT01040832|468126918|FG001|Overall Study|Symptomatic deterioration|5|||
130046251|NCT01040832|468126917|FG000|Overall Study|Other|2|||
130046252|NCT01040832|468126918|FG001|Overall Study|Other|1|||
130046253|NCT03238248|468126920|FG000|Overall Study|Death|5|||
130046254|NCT03238248|468126920|FG000|Overall Study|Withdrawal by Subject|7|||
130046255|NCT03238248|468126920|FG000|Overall Study|Participant proceeding to transplant|10|||
130046256|NCT03238248|468126920|FG000|Overall Study|Lack of Efficacy|4|||
130295101|NCT01895309|469043842|FG000|Overall Study|Adverse Event|13|||
130295102|NCT01895309|469043843|FG001|Overall Study|Adverse Event|17|||
130295103|NCT01895309|469043842|FG000|Overall Study|Protocol Violation|1|||
130295104|NCT01895309|469043843|FG001|Overall Study|Protocol Violation|0|||
130295105|NCT01895309|469043842|FG000|Overall Study|Lack of Efficacy|1|||
130295106|NCT01895309|469043843|FG001|Overall Study|Lack of Efficacy|3|||
130295107|NCT01895309|469043842|FG000|Overall Study|Lost to Follow-up|1|||
130295108|NCT01895309|469043843|FG001|Overall Study|Lost to Follow-up|3|||
130295109|NCT01895309|469043842|FG000|Overall Study|Physician Decision|15|||
130295110|NCT01895309|469043843|FG001|Overall Study|Physician Decision|10|||
130295111|NCT01895309|469043842|FG000|Overall Study|Withdrawal by Subject|9|||
130295112|NCT01895309|469043843|FG001|Overall Study|Withdrawal by Subject|18|||
130295113|NCT04268745|469043844|FG000|Overall Study|Lost to Follow-up|2|||
130295114|NCT04268745|469043845|FG001|Overall Study|Lost to Follow-up|3|||
130295115|NCT04268745|469043844|FG000|Overall Study|Withdrawal by Subject|4|||
130046257|NCT03238248|468126920|FG000|Overall Study|Physician Decision|3|||
130046258|NCT03238248|468126920|FG000|Overall Study|Transitioning to another study|1|||
130046259|NCT03238248|468126920|FG000|Overall Study|No longer benefiting|1|||
130046260|NCT03238248|468126920|FG000|Overall Study|Other complicating disease|1|||
130046261|NCT03238248|468126920|FG000|Overall Study|Adverse Event|5|||
130106563|NCT02437890|468351598|FG002|Overall Study|Unable to attend visit(s)|0|||
130106564|NCT02437890|468351599|FG003|Overall Study|Unable to attend visit(s)|0|||
130106565|NCT02437890|468351600|FG004|Overall Study|Unable to attend visit(s)|0|||
130106566|NCT02437890|468351596|FG000|Overall Study|Lack of Efficacy|1|||
130106567|NCT02437890|468351597|FG001|Overall Study|Lack of Efficacy|3|||
130106568|NCT02437890|468351598|FG002|Overall Study|Lack of Efficacy|0|||
130106569|NCT02437890|468351599|FG003|Overall Study|Lack of Efficacy|3|||
130106570|NCT02437890|468351600|FG004|Overall Study|Lack of Efficacy|1|||
130106571|NCT02437890|468351596|FG000|Overall Study|Adverse Event|4|||
130106572|NCT02437890|468351597|FG001|Overall Study|Adverse Event|9|||
130106573|NCT02437890|468351598|FG002|Overall Study|Adverse Event|5|||
130106574|NCT02437890|468351599|FG003|Overall Study|Adverse Event|11|||
130106575|NCT02437890|468351600|FG004|Overall Study|Adverse Event|7|||
130106576|NCT02437890|468351596|FG000|Overall Study|Withdrawal by Subject|1|||
130106577|NCT02437890|468351597|FG001|Overall Study|Withdrawal by Subject|2|||
130106578|NCT02437890|468351598|FG002|Overall Study|Withdrawal by Subject|6|||
130106579|NCT02437890|468351599|FG003|Overall Study|Withdrawal by Subject|5|||
130106580|NCT02437890|468351600|FG004|Overall Study|Withdrawal by Subject|5|||
130106581|NCT02437890|468351596|FG000|Overall Study|Death|0|||
130106582|NCT02437890|468351597|FG001|Overall Study|Death|0|||
130106583|NCT02437890|468351598|FG002|Overall Study|Death|0|||
130106584|NCT02437890|468351599|FG003|Overall Study|Death|2|||
130106585|NCT02437890|468351600|FG004|Overall Study|Death|0|||
130106586|NCT02414854|468351601|FG000|Overall Study|Adverse Event|9|||
130106587|NCT02414854|468351602|FG001|Overall Study|Adverse Event|7|||
130106588|NCT02414854|468351603|FG002|Overall Study|Adverse Event|1|||
130106589|NCT02414854|468351604|FG003|Overall Study|Adverse Event|12|||
130106590|NCT02414854|468351601|FG000|Overall Study|Poor compliance to protocol|1|||
130106591|NCT02414854|468351602|FG001|Overall Study|Poor compliance to protocol|1|||
130106592|NCT02414854|468351603|FG002|Overall Study|Poor compliance to protocol|2|||
130106593|NCT02414854|468351604|FG003|Overall Study|Poor compliance to protocol|2|||
130106594|NCT02414854|468351601|FG000|Overall Study|Other than specified above|12|||
130106595|NCT02414854|468351602|FG001|Overall Study|Other than specified above|37|||
130106596|NCT02414854|468351603|FG002|Overall Study|Other than specified above|17|||
130106597|NCT02414854|468351604|FG003|Overall Study|Other than specified above|37|||
130106598|NCT04723173|468351605|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
130106599|NCT01422720|468351606|FG000|Overall Study|Adverse Event|16|||
130106600|NCT01422720|468351606|FG000|Overall Study|Lack of Efficacy|1|||
130106601|NCT01422720|468351606|FG000|Overall Study|Withdrawal by Subject|4|||
130106602|NCT01422720|468351606|FG000|Overall Study|Ineligibility|1|||
130106603|NCT02082262|468351607|FG000|Overall Study|Withdrawal by Subject|3|||
130106604|NCT02082262|468351607|FG000|Overall Study|Adverse Event|48|||
130106605|NCT01074307|468351609|FG000|Overall Study|No primary endpoint evaluation|14|||
130106606|NCT01074307|468351610|FG001|Overall Study|No primary endpoint evaluation|6|||
130106607|NCT01074307|468351609|FG000|Overall Study|Exclusion criterion|0|||
130106608|NCT01074307|468351610|FG001|Overall Study|Exclusion criterion|1|||
130106609|NCT01074307|468351609|FG000|Overall Study|Protocol Violation|8|||
130106610|NCT01074307|468351610|FG001|Overall Study|Protocol Violation|5|||
130106611|NCT02162511|468351615|FG000|Overall Study|Lack of Efficacy|0|||
130106612|NCT02162511|468351616|FG001|Overall Study|Lack of Efficacy|0|||
130106613|NCT02162511|468351617|FG002|Overall Study|Lack of Efficacy|2|||
130106614|NCT01408576|468351618|FG000|Overall Study|Lack of Efficacy|17|||
130106615|NCT01408576|468351619|FG001|Overall Study|Lack of Efficacy|30|||
130106616|NCT01408576|468351620|FG002|Overall Study|Lack of Efficacy|48|||
130106617|NCT01408576|468351618|FG000|Overall Study|Protocol Violation|1|||
130106618|NCT01408576|468351619|FG001|Overall Study|Protocol Violation|2|||
129793907|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793908|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793909|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129793910|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
130106619|NCT01408576|468351620|FG002|Overall Study|Protocol Violation|2|||
129793911|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130106620|NCT01408576|468351618|FG000|Overall Study|Lost to Follow-up|10|||
130106621|NCT01408576|468351619|FG001|Overall Study|Lost to Follow-up|9|||
130295116|NCT04268745|469043845|FG001|Overall Study|Withdrawal by Subject|2|||
130295117|NCT04268745|469043844|FG000|Overall Study|Death in the family|1|||
130295118|NCT04268745|469043845|FG001|Overall Study|Death in the family|0|||
130295119|NCT04046250|469043848|FG000|Overall Study|Death|0|||
129793912|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
130106622|NCT01408576|468351620|FG002|Overall Study|Lost to Follow-up|17|||
130106623|NCT01408576|468351618|FG000|Overall Study|Withdrawal by Subject|34|||
130106624|NCT01408576|468351619|FG001|Overall Study|Withdrawal by Subject|60|||
130106625|NCT01408576|468351620|FG002|Overall Study|Withdrawal by Subject|66|||
130106626|NCT01408576|468351618|FG000|Overall Study|Sponsor terminated study|89|||
130106627|NCT01408576|468351619|FG001|Overall Study|Sponsor terminated study|333|||
130106628|NCT01408576|468351620|FG002|Overall Study|Sponsor terminated study|330|||
130106629|NCT01408576|468351618|FG000|Overall Study|AE, serious fatal|4|||
130046262|NCT03238248|468126920|FG000|Overall Study|Disease progression|26|||
130295120|NCT04046250|469043849|FG001|Overall Study|Death|1|||
130295121|NCT04046250|469043848|FG000|Overall Study|Withdrawal by Subject|3|||
130295122|NCT04046250|469043849|FG001|Overall Study|Withdrawal by Subject|3|||
130295123|NCT04576897|469043850|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
130295124|NCT00527332|469043853|FG000|Overall Study|Protocol Violation|4|||
130295125|NCT00527332|469043854|FG001|Overall Study|Protocol Violation|8|||
130295126|NCT00527332|469043853|FG000|Overall Study|Withdrew consent|5|||
130046263|NCT03238248|468126920|FG000|Overall Study|N/A participant is still on treatment|1|||
130046264|NCT03238248|468126920|FG000|Overall Study|Decline in condition|1|||
130046265|NCT03238248|468126920|FG000|Overall Study|Alternative therapy|2|||
130046266|NCT01013883|468126921|FG000|Overall Study|Lost to Follow-up|2|||
130046267|NCT01013883|468126922|FG001|Overall Study|Lost to Follow-up|2|||
130046268|NCT00474630|468126923|FG000|Overall Study|Adverse Event|98|||
130046269|NCT00474630|468126924|FG001|Overall Study|Adverse Event|26|||
130046270|NCT00474630|468126923|FG000|Overall Study|Lost to Follow-up|22|||
130046271|NCT00474630|468126924|FG001|Overall Study|Lost to Follow-up|15|||
130046272|NCT00474630|468126923|FG000|Overall Study|Withdrawal by Subject|21|||
130046273|NCT00474630|468126924|FG001|Overall Study|Withdrawal by Subject|15|||
130046274|NCT00474630|468126923|FG000|Overall Study|Protocol Violation|3|||
130046275|NCT00474630|468126924|FG001|Overall Study|Protocol Violation|4|||
130046276|NCT00474630|468126923|FG000|Overall Study|Lack of Efficacy|5|||
130046277|NCT00474630|468126924|FG001|Overall Study|Lack of Efficacy|6|||
130046278|NCT00474630|468126923|FG000|Overall Study|Drug noncompliance, other|11|||
130046279|NCT00474630|468126924|FG001|Overall Study|Drug noncompliance, other|4|||
130046280|NCT03088605|468126925|FG000|Overall Study|Withdrawal by Subject|1|||
130046281|NCT03088605|468126926|FG001|Overall Study|Withdrawal by Subject|0|||
130046282|NCT02225223|468126927|FG000|Overall Study|Death|10|||
130046283|NCT02225223|468126928|FG001|Overall Study|Death|1|||
130046284|NCT02225223|468126927|FG000|Overall Study|Lost to Follow-up|5|||
130046285|NCT02225223|468126928|FG001|Overall Study|Lost to Follow-up|0|||
130046286|NCT02225223|468126927|FG000|Overall Study|Other|1|||
130046287|NCT02225223|468126928|FG001|Overall Study|Other|2|||
130046288|NCT02225223|468126927|FG000|Overall Study|Physician Decision|1|||
130046289|NCT02225223|468126928|FG001|Overall Study|Physician Decision|0|||
130046290|NCT02225223|468126927|FG000|Overall Study|Withdrawal by Subject|2|||
130046291|NCT02225223|468126928|FG001|Overall Study|Withdrawal by Subject|2|||
130046292|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
130046293|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
130046294|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
130046295|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
130046296|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
130046297|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
130046298|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
130046299|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
130046300|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
130046301|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
130046302|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
130046303|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
130046304|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
130046305|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
130046306|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
130046307|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
130046308|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
130046309|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
130046310|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
130046311|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
130046312|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
130046313|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
130046314|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
130295127|NCT00527332|469043854|FG001|Overall Study|Withdrew consent|1|||
130295128|NCT02666105|469043855|FG000|Overall Study|Death|1|||
130295129|NCT02100969|469045251|FG000|Overall Study|Did not pass screening phase|1|||
130295130|NCT01629953|469045252|FG000|Overall Study|Death|3|||
130295131|NCT01629953|469045253|FG001|Overall Study|Death|1|||
130295132|NCT01629953|469045252|FG000|Overall Study|Lost to Follow-up|10|||
130295133|NCT01629953|469045253|FG001|Overall Study|Lost to Follow-up|14|||
130295134|NCT01646203|469045254|FG000|Overall Study|Adverse Event|2|||
130295135|NCT01646203|469045255|FG001|Overall Study|Adverse Event|0|||
130295136|NCT01646203|469045256|FG002|Overall Study|Adverse Event|1|||
130295137|NCT01646203|469045254|FG000|Overall Study|Withdrawal by Subject|0|||
130295138|NCT01646203|469045255|FG001|Overall Study|Withdrawal by Subject|1|||
130295139|NCT01646203|469045256|FG002|Overall Study|Withdrawal by Subject|0|||
130295140|NCT01646203|469045254|FG000|Overall Study|Physician's Decision|0|||
130106630|NCT01408576|468351619|FG001|Overall Study|AE, serious fatal|4|||
130106631|NCT01408576|468351620|FG002|Overall Study|AE, serious fatal|1|||
130106632|NCT01408576|468351618|FG000|Overall Study|SAE, non-fatal|11|||
130106633|NCT01408576|468351619|FG001|Overall Study|SAE, non-fatal|23|||
130106634|NCT01408576|468351620|FG002|Overall Study|SAE, non-fatal|14|||
130106635|NCT01408576|468351618|FG000|Overall Study|AE, non-serious non-fatal|12|||
130106636|NCT01408576|468351619|FG001|Overall Study|AE, non-serious non-fatal|19|||
130106637|NCT01408576|468351620|FG002|Overall Study|AE, non-serious non-fatal|11|||
130106638|NCT01408576|468351618|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130106639|NCT01408576|468351619|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130106640|NCT01408576|468351620|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130106641|NCT01408576|468351618|FG000|Overall Study|AE, unknown type|0|||
130106642|NCT01408576|468351619|FG001|Overall Study|AE, unknown type|1|||
130106643|NCT01408576|468351620|FG002|Overall Study|AE, unknown type|0|||
130106644|NCT01408576|468351618|FG000|Overall Study|Other|10|||
130106645|NCT01408576|468351619|FG001|Overall Study|Other|16|||
130106646|NCT01408576|468351620|FG002|Overall Study|Other|18|||
130106647|NCT00802529|468351621|FG000|Overall Study|Lost to Follow-up|0|||
130106648|NCT00802529|468351622|FG001|Overall Study|Lost to Follow-up|1|||
130106649|NCT00552617|468351624|FG000|Overall Study|Not Treated|0|||
130106650|NCT00552617|468351625|FG001|Overall Study|Not Treated|0|||
130106651|NCT00552617|468351626|FG002|Overall Study|Not Treated|1|||
130106652|NCT00552617|468351627|FG003|Overall Study|Not Treated|0|||
130106653|NCT00552617|468351628|FG004|Overall Study|Not Treated|0|||
130106654|NCT00552617|468351629|FG005|Overall Study|Not Treated|0|||
130106655|NCT00552617|468351630|FG006|Overall Study|Not Treated|0|||
130106656|NCT00552617|468351631|FG007|Overall Study|Not Treated|0|||
130106657|NCT00552617|468351632|FG008|Overall Study|Not Treated|0|||
130106658|NCT00552617|468351633|FG009|Overall Study|Not Treated|1|||
130106659|NCT00552617|468351624|FG000|Overall Study|Lost to Follow-up|0|||
130106660|NCT00552617|468351625|FG001|Overall Study|Lost to Follow-up|0|||
130106661|NCT00552617|468351626|FG002|Overall Study|Lost to Follow-up|0|||
130106662|NCT00552617|468351627|FG003|Overall Study|Lost to Follow-up|1|||
130106663|NCT00552617|468351628|FG004|Overall Study|Lost to Follow-up|0|||
130106664|NCT00552617|468351629|FG005|Overall Study|Lost to Follow-up|2|||
130106665|NCT00552617|468351630|FG006|Overall Study|Lost to Follow-up|0|||
130106666|NCT00552617|468351631|FG007|Overall Study|Lost to Follow-up|0|||
130106667|NCT00552617|468351632|FG008|Overall Study|Lost to Follow-up|2|||
130106668|NCT00552617|468351633|FG009|Overall Study|Lost to Follow-up|0|||
130106669|NCT00337129|468351641|FG000|Overall Study|Adverse Event|4|||
130106670|NCT00337129|468351641|FG000|Overall Study|Withdrawal by Subject|1|||
130106671|NCT00337129|468351641|FG000|Overall Study|Lack of Efficacy|32|||
130106672|NCT00337129|468351641|FG000|Overall Study|Death|2|||
130106673|NCT00337129|468351641|FG000|Overall Study|not protocol specified|1|||
130106674|NCT00563524|468351644|FG000|Overall Study|Adverse Event|0|||
130106675|NCT00563524|468351645|FG001|Overall Study|Adverse Event|1|||
130106676|NCT00563524|468351646|FG002|Overall Study|Adverse Event|0|||
129888785|NCT01009047|467550898|FG000|Overall Study|Withdrawal by consent|16|||
129888786|NCT01009047|467550899|FG001|Overall Study|Withdrawal by consent|11|||
130106677|NCT00563524|468351647|FG003|Overall Study|Adverse Event|0|||
129888787|NCT01009047|467550898|FG000|Overall Study|Other|3|||
130106678|NCT00563524|468351648|FG004|Overall Study|Adverse Event|2|||
130106679|NCT00563524|468351649|FG005|Overall Study|Adverse Event|0|||
130106680|NCT00563524|468351644|FG000|Overall Study|Lost to Follow-up|1|||
130106681|NCT00563524|468351645|FG001|Overall Study|Lost to Follow-up|0|||
130106682|NCT00563524|468351646|FG002|Overall Study|Lost to Follow-up|0|||
130106683|NCT00563524|468351647|FG003|Overall Study|Lost to Follow-up|0|||
130106684|NCT00563524|468351648|FG004|Overall Study|Lost to Follow-up|0|||
130106685|NCT00563524|468351649|FG005|Overall Study|Lost to Follow-up|0|||
130106686|NCT00563524|468351644|FG000|Overall Study|Protocol Violation|0|||
130106687|NCT00563524|468351645|FG001|Overall Study|Protocol Violation|1|||
130106688|NCT00563524|468351646|FG002|Overall Study|Protocol Violation|0|||
130046315|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
130046316|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
130046317|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
130046318|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
130046319|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
130046320|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
130046321|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
130046322|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
130046323|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
130046324|NCT00958568|468126930|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
130046325|NCT00958568|468126931|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
130046326|NCT00958568|468126932|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
130106689|NCT00563524|468351647|FG003|Overall Study|Protocol Violation|0|||
130106690|NCT00563524|468351648|FG004|Overall Study|Protocol Violation|0|||
130106691|NCT00563524|468351649|FG005|Overall Study|Protocol Violation|0|||
130106692|NCT00563524|468351644|FG000|Overall Study|Withdrawal by Subject|1|||
130106693|NCT00563524|468351645|FG001|Overall Study|Withdrawal by Subject|1|||
130106694|NCT00563524|468351646|FG002|Overall Study|Withdrawal by Subject|3|||
130106695|NCT00563524|468351647|FG003|Overall Study|Withdrawal by Subject|0|||
130106696|NCT00563524|468351648|FG004|Overall Study|Withdrawal by Subject|0|||
130106697|NCT00563524|468351649|FG005|Overall Study|Withdrawal by Subject|1|||
130106698|NCT02360397|468351653|FG000|Overall Study|Incomplete screening|3|||
130106699|NCT02360397|468351653|FG000|Overall Study|Adverse Event|1|||
130106700|NCT01537549|468351654|FG000|Overall Study|Lost to Follow-up|1|||
130106701|NCT01537549|468351654|FG000|Overall Study|Withdrawal by Subject|2|||
130106702|NCT01286207|468351657|FG000|Overall Study|Adverse Event|27|||
130106703|NCT01286207|468351658|FG001|Overall Study|Adverse Event|41|||
130106704|NCT01286207|468351659|FG002|Overall Study|Adverse Event|8|||
130106705|NCT01286207|468351657|FG000|Overall Study|Lost to Follow-up|49|||
130106706|NCT01286207|468351658|FG001|Overall Study|Lost to Follow-up|43|||
130106707|NCT01286207|468351659|FG002|Overall Study|Lost to Follow-up|20|||
130106708|NCT01286207|468351657|FG000|Overall Study|Withdrawal by Subject|93|||
130106709|NCT01286207|468351658|FG001|Overall Study|Withdrawal by Subject|79|||
130106710|NCT01286207|468351659|FG002|Overall Study|Withdrawal by Subject|41|||
130106711|NCT01286207|468351657|FG000|Overall Study|Lack of Response|92|||
130106712|NCT01286207|468351658|FG001|Overall Study|Lack of Response|38|||
130106713|NCT01286207|468351659|FG002|Overall Study|Lack of Response|8|||
130106714|NCT01286207|468351657|FG000|Overall Study|Other|37|||
130106715|NCT01286207|468351658|FG001|Overall Study|Other|47|||
130106716|NCT01286207|468351659|FG002|Overall Study|Other|13|||
130106717|NCT01383954|468351660|FG000|Overall Study|Lack of Efficacy|2|||
130106718|NCT01383954|468351660|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
130106719|NCT01383954|468351660|FG000|Overall Study|Adverse Event|1|||
130106720|NCT01383954|468351660|FG000|Overall Study|Reason Not Specified|9|||
130106721|NCT00450177|468351661|FG000|Overall Study|Adverse Event|7|||
130106722|NCT00450177|468351662|FG001|Overall Study|Adverse Event|4|||
130106723|NCT00450177|468351661|FG000|Overall Study|Withdrawal by Subject|1|||
130106724|NCT00450177|468351662|FG001|Overall Study|Withdrawal by Subject|6|||
130106725|NCT00450177|468351661|FG000|Overall Study|Withdrawal by Primary Team|1|||
130106726|NCT00450177|468351662|FG001|Overall Study|Withdrawal by Primary Team|1|||
130046327|NCT00958568|468126933|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
130106727|NCT00763269|468351666|FG000|Overall Study|Lost to Follow-up|12|||
130106728|NCT00763269|468351667|FG001|Overall Study|Lost to Follow-up|13|||
130106729|NCT01128153|468351669|FG000|Overall Study|Adverse Event|1|||
130106730|NCT01128153|468351670|FG001|Overall Study|Adverse Event|3|||
130106731|NCT01128153|468351669|FG000|Overall Study|Condition under investigation worsened|8|||
130106732|NCT01128153|468351670|FG001|Overall Study|Condition under investigation worsened|7|||
130106733|NCT01128153|468351669|FG000|Overall Study|Withdrawal by Subject|2|||
130106734|NCT01128153|468351670|FG001|Overall Study|Withdrawal by Subject|3|||
130106735|NCT01128153|468351669|FG000|Overall Study|Incorrect enrolment to study|2|||
130106736|NCT01128153|468351670|FG001|Overall Study|Incorrect enrolment to study|1|||
130106737|NCT01128153|468351669|FG000|Overall Study|Protocol Violation|2|||
130106738|NCT01128153|468351670|FG001|Overall Study|Protocol Violation|0|||
130106739|NCT01128153|468351669|FG000|Overall Study|Developed discontinuation criteria|1|||
130106740|NCT01128153|468351670|FG001|Overall Study|Developed discontinuation criteria|1|||
130106741|NCT01682512|468351671|FG000|Overall Study|Adverse Event|6|||
130106742|NCT01682512|468351672|FG001|Overall Study|Adverse Event|5|||
130106743|NCT01682512|468351673|FG002|Overall Study|Adverse Event|2|||
130106744|NCT01682512|468351671|FG000|Overall Study|Withdrawal by Subject|2|||
130106745|NCT01682512|468351672|FG001|Overall Study|Withdrawal by Subject|6|||
130106746|NCT01682512|468351673|FG002|Overall Study|Withdrawal by Subject|3|||
130106747|NCT01682512|468351671|FG000|Overall Study|Physician Decision|0|||
130106748|NCT01682512|468351672|FG001|Overall Study|Physician Decision|2|||
130106749|NCT01682512|468351673|FG002|Overall Study|Physician Decision|0|||
130106750|NCT01682512|468351671|FG000|Overall Study|Study terminated by sponsor|46|||
130106751|NCT01682512|468351672|FG001|Overall Study|Study terminated by sponsor|43|||
130106752|NCT01682512|468351673|FG002|Overall Study|Study terminated by sponsor|0|||
130106753|NCT01682512|468351671|FG000|Overall Study|Lost to Follow-up|3|||
130106754|NCT01682512|468351672|FG001|Overall Study|Lost to Follow-up|0|||
130106755|NCT01682512|468351673|FG002|Overall Study|Lost to Follow-up|2|||
130106756|NCT01682512|468351671|FG000|Overall Study|Protocol Violation|2|||
130106757|NCT01682512|468351672|FG001|Overall Study|Protocol Violation|3|||
130106758|NCT01682512|468351673|FG002|Overall Study|Protocol Violation|2|||
130106759|NCT01682512|468351671|FG000|Overall Study|Primary lack of efficacy|10|||
130106760|NCT01682512|468351672|FG001|Overall Study|Primary lack of efficacy|7|||
130106761|NCT01682512|468351673|FG002|Overall Study|Primary lack of efficacy|7|||
130106762|NCT01682512|468351671|FG000|Overall Study|Secondary lack of efficacy|1|||
130106763|NCT01682512|468351672|FG001|Overall Study|Secondary lack of efficacy|1|||
130106764|NCT01682512|468351673|FG002|Overall Study|Secondary lack of efficacy|0|||
130106765|NCT01682512|468351671|FG000|Overall Study|Other than stated above|2|||
130295141|NCT01646203|469045255|FG001|Overall Study|Physician's Decision|1|||
130106766|NCT01682512|468351672|FG001|Overall Study|Other than stated above|4|||
130106767|NCT01682512|468351673|FG002|Overall Study|Other than stated above|2|||
130106768|NCT00054275|468351676|FG000|Overall Study|Withdrawal by Subject|4|||
130106769|NCT00054275|468351676|FG000|Overall Study|Adverse Event|5|||
130106770|NCT00054275|468351676|FG000|Overall Study|Progressive disease in cycle 1|1|||
130106771|NCT00054275|468351676|FG000|Overall Study|Physician Decision|1|||
130106772|NCT02030834|468351684|FG000|Overall Study|Death|4|||
130106773|NCT02030834|468351685|FG001|Overall Study|Death|0|||
130106774|NCT02030834|468351686|FG002|Overall Study|Death|0|||
130106775|NCT02030834|468351684|FG000|Overall Study|Manufacturing failure|2|||
130106776|NCT02030834|468351685|FG001|Overall Study|Manufacturing failure|0|||
130106777|NCT02030834|468351686|FG002|Overall Study|Manufacturing failure|1|||
130106778|NCT02030834|468351684|FG000|Overall Study|Disease progression|2|||
130106779|NCT02030834|468351685|FG001|Overall Study|Disease progression|0|||
130106780|NCT02030834|468351686|FG002|Overall Study|Disease progression|2|||
130295142|NCT01646203|469045256|FG002|Overall Study|Physician's Decision|0|||
130295143|NCT03242252|469045258|FG000|Overall Study|At the Participant's own Request|18|||
130295144|NCT03242252|469045259|FG001|Overall Study|At the Participant's own Request|10|||
130295145|NCT03242252|469045260|FG002|Overall Study|At the Participant's own Request|15|||
130295146|NCT03242252|469045258|FG000|Overall Study|Adverse Event|8|||
130295147|NCT03242252|469045259|FG001|Overall Study|Adverse Event|6|||
130295148|NCT03242252|469045260|FG002|Overall Study|Adverse Event|9|||
130295149|NCT03242252|469045258|FG000|Overall Study|Poor Compliance to Protocol|0|||
130295150|NCT03242252|469045259|FG001|Overall Study|Poor Compliance to Protocol|2|||
130295151|NCT03242252|469045260|FG002|Overall Study|Poor Compliance to Protocol|3|||
130295152|NCT03242252|469045258|FG000|Overall Study|Study Terminated by Sponsor|1|||
130295153|NCT03242252|469045259|FG001|Overall Study|Study Terminated by Sponsor|0|||
130106781|NCT02030834|468351684|FG000|Overall Study|Lost to Follow-up|1|||
130106782|NCT02030834|468351685|FG001|Overall Study|Lost to Follow-up|0|||
130106783|NCT02030834|468351686|FG002|Overall Study|Lost to Follow-up|0|||
130106784|NCT02030834|468351684|FG000|Overall Study|Withdrawal by Subject|1|||
130106785|NCT02030834|468351685|FG001|Overall Study|Withdrawal by Subject|0|||
130106786|NCT02030834|468351686|FG002|Overall Study|Withdrawal by Subject|0|||
130106787|NCT02030834|468351684|FG000|Overall Study|Lack of funding|1|||
130106788|NCT02030834|468351685|FG001|Overall Study|Lack of funding|0|||
130106789|NCT02030834|468351686|FG002|Overall Study|Lack of funding|0|||
130106790|NCT00996918|468351689|FG000|Overall Study|Lack of Efficacy|1|||
130106791|NCT00996918|468351690|FG001|Overall Study|Lack of Efficacy|1|||
130106792|NCT00996918|468351691|FG002|Overall Study|Lack of Efficacy|2|||
130295154|NCT03242252|469045260|FG002|Overall Study|Study Terminated by Sponsor|0|||
130295155|NCT03242252|469045258|FG000|Overall Study|Reason not Specified|4|||
130106793|NCT00996918|468351692|FG003|Overall Study|Lack of Efficacy|2|||
130106794|NCT00996918|468351693|FG004|Overall Study|Lack of Efficacy|0|||
130106795|NCT00996918|468351689|FG000|Overall Study|Adverse Event|2|||
130106796|NCT00996918|468351690|FG001|Overall Study|Adverse Event|5|||
130106797|NCT00996918|468351691|FG002|Overall Study|Adverse Event|2|||
130106798|NCT00996918|468351692|FG003|Overall Study|Adverse Event|6|||
130106799|NCT00996918|468351693|FG004|Overall Study|Adverse Event|0|||
130106800|NCT00996918|468351689|FG000|Overall Study|Withdrawal by Subject|1|||
130106801|NCT00996918|468351690|FG001|Overall Study|Withdrawal by Subject|4|||
130106802|NCT00996918|468351691|FG002|Overall Study|Withdrawal by Subject|3|||
130106803|NCT00996918|468351692|FG003|Overall Study|Withdrawal by Subject|3|||
130106804|NCT00996918|468351693|FG004|Overall Study|Withdrawal by Subject|2|||
129793913|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129793914|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129793915|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793916|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793917|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793918|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793919|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
129793920|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
129793921|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793922|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793923|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793924|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793925|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
129793926|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
129793927|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793928|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793929|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793930|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793931|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
129793932|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
129793933|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793934|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793935|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793936|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793937|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
129793938|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
129793939|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793940|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793941|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793942|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793943|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
129793944|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
129793945|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793946|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793947|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793948|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793949|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
129793950|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
129793951|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793952|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793953|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793954|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793955|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793956|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
129793957|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793958|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
130106805|NCT00996918|468351689|FG000|Overall Study|Physician Decision|1|||
130106806|NCT00996918|468351690|FG001|Overall Study|Physician Decision|0|||
129793959|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793960|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793961|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793962|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
129793963|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129888788|NCT01009047|467550899|FG001|Overall Study|Other|2|||
130106807|NCT00996918|468351691|FG002|Overall Study|Physician Decision|0|||
130106808|NCT00996918|468351692|FG003|Overall Study|Physician Decision|0|||
130106809|NCT00996918|468351693|FG004|Overall Study|Physician Decision|0|||
130295156|NCT03242252|469045259|FG001|Overall Study|Reason not Specified|4|||
129793964|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129793965|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129793966|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129793967|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
129793968|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
129793969|NCT01163032|467212791|FG000|Randomization Phase|Withdrawal by Subject|2|||
129793970|NCT01163032|467212792|FG001|Randomization Phase|Withdrawal by Subject|3|||
129793971|NCT01163032|467212793|FG002|Randomization Phase|Withdrawal by Subject|0|||
129793972|NCT01163032|467212791|FG000|Randomization Phase|Adverse Event|3|||
129793973|NCT01163032|467212792|FG001|Randomization Phase|Adverse Event|3|||
129793974|NCT01163032|467212793|FG002|Randomization Phase|Adverse Event|0|||
129793975|NCT01163032|467212791|FG000|Randomization Phase|Protocol Violation|0|||
129793976|NCT01163032|467212792|FG001|Randomization Phase|Protocol Violation|1|||
129793977|NCT01163032|467212793|FG002|Randomization Phase|Protocol Violation|0|||
129793978|NCT01163032|467212791|FG000|Randomization Phase|Various*|5|||
129793979|NCT01163032|467212792|FG001|Randomization Phase|Various*|4|||
129793980|NCT01163032|467212793|FG002|Randomization Phase|Various*|0|||
129793981|NCT01163032|467212791|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
129793982|NCT01163032|467212792|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
129793983|NCT01163032|467212793|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
129793984|NCT01163032|467212791|FG000|Open Label Extension Phase|Adverse Event|0|||
129793985|NCT01163032|467212792|FG001|Open Label Extension Phase|Adverse Event|0|||
129793986|NCT01163032|467212793|FG002|Open Label Extension Phase|Adverse Event|3|||
130046328|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130046329|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
130046330|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130046331|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
130046332|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130046333|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
130046334|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130046335|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
130046336|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
130046337|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
130046338|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
130046339|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
130046340|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
130046341|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
130046342|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
130046343|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
130046344|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130046345|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
130046346|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130046347|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
130046348|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130046349|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
130046350|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130046351|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
130046352|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
130046353|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
130046354|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
130046355|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
130046356|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
130046357|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
130046358|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
130046359|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
130046360|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
130046361|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
130046362|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
130046363|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
130106810|NCT00996918|468351689|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
130106811|NCT00996918|468351690|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
129793987|NCT01163032|467212791|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
129793988|NCT01163032|467212792|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
129793989|NCT01163032|467212793|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
129793990|NCT01163032|467212791|FG000|Open Label Extension Phase|Protocol Violation|0|||
129793991|NCT01163032|467212792|FG001|Open Label Extension Phase|Protocol Violation|0|||
129793992|NCT01163032|467212793|FG002|Open Label Extension Phase|Protocol Violation|1|||
129793993|NCT01163032|467212791|FG000|Open Label Extension Phase|Study Termination|0|||
129793994|NCT01163032|467212792|FG001|Open Label Extension Phase|Study Termination|0|||
129793995|NCT01163032|467212793|FG002|Open Label Extension Phase|Study Termination|7|||
129793996|NCT01163032|467212791|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
129793997|NCT01163032|467212792|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
129793998|NCT01163032|467212793|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
129793999|NCT01307020|467212796|FG000|Overall Study|Lost to Follow-up|0|||
129794000|NCT01307020|467212797|FG001|Overall Study|Lost to Follow-up|0|||
129794001|NCT01307020|467212798|FG002|Overall Study|Lost to Follow-up|1|||
129794002|NCT01307020|467212799|FG003|Overall Study|Lost to Follow-up|1|||
129794003|NCT01307020|467212800|FG004|Overall Study|Lost to Follow-up|0|||
129794004|NCT01307020|467212801|FG005|Overall Study|Lost to Follow-up|0|||
129794005|NCT01307020|467212802|FG006|Overall Study|Lost to Follow-up|1|||
129794006|NCT01307020|467212803|FG007|Overall Study|Lost to Follow-up|0|||
129794007|NCT01307020|467212804|FG008|Overall Study|Lost to Follow-up|0|||
129794008|NCT01307020|467212805|FG009|Overall Study|Lost to Follow-up|0|||
129794009|NCT01307020|467212796|FG000|Overall Study|Electronic data capture failure|0|||
129794010|NCT01307020|467212797|FG001|Overall Study|Electronic data capture failure|1|||
129794011|NCT01307020|467212798|FG002|Overall Study|Electronic data capture failure|0|||
129794012|NCT01307020|467212799|FG003|Overall Study|Electronic data capture failure|0|||
129794013|NCT01307020|467212800|FG004|Overall Study|Electronic data capture failure|0|||
129794014|NCT01307020|467212801|FG005|Overall Study|Electronic data capture failure|0|||
130046364|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
130046365|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
130046366|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
130046367|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
130046368|NCT00958568|468126930|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
130046369|NCT00958568|468126931|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
130046370|NCT00958568|468126932|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
130046371|NCT00958568|468126933|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
130046372|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
130046373|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
130046374|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
130046375|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
130046376|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
130046377|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
130046378|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
130046379|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
130046380|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
130046381|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
130046382|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
130046383|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
130046384|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
130046385|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
130046386|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
130046387|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
130046388|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
130046389|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
130046390|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
130046391|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
130046392|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
130046393|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
130046394|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
130046395|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
130046396|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
130046397|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
130046398|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
130046399|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
130295157|NCT03242252|469045260|FG002|Overall Study|Reason not Specified|1|||
130295158|NCT03242252|469045258|FG000|Overall Study|Lost to Follow-up|5|||
130295159|NCT03242252|469045259|FG001|Overall Study|Lost to Follow-up|1|||
129794015|NCT01307020|467212802|FG006|Overall Study|Electronic data capture failure|0|||
129794016|NCT01307020|467212803|FG007|Overall Study|Electronic data capture failure|0|||
129794017|NCT01307020|467212804|FG008|Overall Study|Electronic data capture failure|0|||
129794018|NCT01307020|467212805|FG009|Overall Study|Electronic data capture failure|0|||
130106812|NCT00996918|468351691|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
130106813|NCT00996918|468351692|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
130106814|NCT00996918|468351693|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
130106815|NCT00996918|468351689|FG000|Overall Study|Loss of Caregiver|0|||
130106816|NCT00996918|468351690|FG001|Overall Study|Loss of Caregiver|1|||
130106817|NCT00996918|468351691|FG002|Overall Study|Loss of Caregiver|0|||
130106818|NCT00996918|468351692|FG003|Overall Study|Loss of Caregiver|0|||
130106819|NCT00996918|468351693|FG004|Overall Study|Loss of Caregiver|0|||
130106820|NCT00996918|468351689|FG000|Overall Study|Other|3|||
130106821|NCT00996918|468351690|FG001|Overall Study|Other|1|||
130106822|NCT00996918|468351691|FG002|Overall Study|Other|0|||
130106823|NCT00996918|468351692|FG003|Overall Study|Other|0|||
130295160|NCT03242252|469045260|FG002|Overall Study|Lost to Follow-up|4|||
130295161|NCT01659255|469045261|FG000|Overall Study|Adverse Event|0|||
130295162|NCT01659255|469045262|FG001|Overall Study|Adverse Event|0|||
130295163|NCT01659255|469045263|FG002|Overall Study|Adverse Event|0|||
130295164|NCT01659255|469045264|FG003|Overall Study|Adverse Event|0|||
130295165|NCT01659255|469045265|FG004|Overall Study|Adverse Event|0|||
130295166|NCT01659255|469045266|FG005|Overall Study|Adverse Event|1|||
130295167|NCT01659255|469045267|FG006|Overall Study|Adverse Event|1|||
130295168|NCT01659255|469045268|FG007|Overall Study|Adverse Event|0|||
130295169|NCT01659255|469045269|FG008|Overall Study|Adverse Event|0|||
130295170|NCT01659255|469045270|FG009|Overall Study|Adverse Event|1|||
130295171|NCT01659255|469045271|FG010|Overall Study|Adverse Event|0|||
130295172|NCT01659255|469045272|FG011|Overall Study|Adverse Event|1|||
130295173|NCT01659255|469045273|FG012|Overall Study|Adverse Event|0|||
130295174|NCT01659255|469045274|FG013|Overall Study|Adverse Event|2|||
130295175|NCT01659255|469045275|FG014|Overall Study|Adverse Event|0|||
130295176|NCT01659255|469045276|FG015|Overall Study|Adverse Event|1|||
130295177|NCT01659255|469045277|FG016|Overall Study|Adverse Event|0|||
130295178|NCT01659255|469045261|FG000|Overall Study|Death|0|||
130295179|NCT01659255|469045262|FG001|Overall Study|Death|1|||
130295180|NCT01659255|469045263|FG002|Overall Study|Death|0|||
130295181|NCT01659255|469045264|FG003|Overall Study|Death|0|||
130295182|NCT01659255|469045265|FG004|Overall Study|Death|0|||
130295183|NCT01659255|469045266|FG005|Overall Study|Death|0|||
130295184|NCT01659255|469045267|FG006|Overall Study|Death|0|||
130295185|NCT01659255|469045268|FG007|Overall Study|Death|1|||
130295186|NCT01659255|469045269|FG008|Overall Study|Death|1|||
130295187|NCT01659255|469045270|FG009|Overall Study|Death|0|||
130295188|NCT01659255|469045271|FG010|Overall Study|Death|0|||
130295189|NCT01659255|469045272|FG011|Overall Study|Death|0|||
130295190|NCT01659255|469045273|FG012|Overall Study|Death|1|||
130295191|NCT01659255|469045274|FG013|Overall Study|Death|1|||
130295192|NCT01659255|469045275|FG014|Overall Study|Death|2|||
130295193|NCT01659255|469045276|FG015|Overall Study|Death|1|||
130295194|NCT01659255|469045277|FG016|Overall Study|Death|0|||
130295195|NCT01659255|469045261|FG000|Overall Study|Progressive Disease|2|||
130295196|NCT01659255|469045262|FG001|Overall Study|Progressive Disease|0|||
130295197|NCT01659255|469045263|FG002|Overall Study|Progressive Disease|0|||
130295198|NCT01659255|469045264|FG003|Overall Study|Progressive Disease|0|||
130295199|NCT01659255|469045265|FG004|Overall Study|Progressive Disease|0|||
130295200|NCT01659255|469045266|FG005|Overall Study|Progressive Disease|0|||
130295201|NCT01659255|469045267|FG006|Overall Study|Progressive Disease|0|||
130295202|NCT01659255|469045268|FG007|Overall Study|Progressive Disease|1|||
130295203|NCT01659255|469045269|FG008|Overall Study|Progressive Disease|0|||
130295204|NCT01659255|469045270|FG009|Overall Study|Progressive Disease|2|||
130295205|NCT01659255|469045271|FG010|Overall Study|Progressive Disease|2|||
130295206|NCT01659255|469045272|FG011|Overall Study|Progressive Disease|3|||
130295207|NCT01659255|469045273|FG012|Overall Study|Progressive Disease|5|||
130295208|NCT01659255|469045274|FG013|Overall Study|Progressive Disease|13|||
130106824|NCT00996918|468351693|FG004|Overall Study|Other|0|||
130295209|NCT01659255|469045275|FG014|Overall Study|Progressive Disease|6|||
130295210|NCT01659255|469045276|FG015|Overall Study|Progressive Disease|2|||
130295211|NCT01659255|469045277|FG016|Overall Study|Progressive Disease|3|||
130295212|NCT01659255|469045261|FG000|Overall Study|Withdrew Consent|0|||
130295213|NCT01659255|469045262|FG001|Overall Study|Withdrew Consent|0|||
130295214|NCT01659255|469045263|FG002|Overall Study|Withdrew Consent|0|||
130295215|NCT01659255|469045264|FG003|Overall Study|Withdrew Consent|0|||
130295216|NCT01659255|469045265|FG004|Overall Study|Withdrew Consent|0|||
130295217|NCT01659255|469045266|FG005|Overall Study|Withdrew Consent|0|||
130295218|NCT01659255|469045267|FG006|Overall Study|Withdrew Consent|0|||
130295219|NCT01659255|469045268|FG007|Overall Study|Withdrew Consent|0|||
130295220|NCT01659255|469045269|FG008|Overall Study|Withdrew Consent|0|||
130295221|NCT01659255|469045270|FG009|Overall Study|Withdrew Consent|0|||
130295222|NCT01659255|469045271|FG010|Overall Study|Withdrew Consent|1|||
130295223|NCT01659255|469045272|FG011|Overall Study|Withdrew Consent|0|||
130106825|NCT04440007|468351696|FG000|Overall Study|Adverse Event|0|||
130106826|NCT04440007|468351697|FG001|Overall Study|Adverse Event|1|||
130046400|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
130046401|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
130046402|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
130046403|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
130046404|NCT00958568|468126930|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
130046405|NCT00958568|468126931|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
130046406|NCT00958568|468126932|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
130046407|NCT00958568|468126933|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
130046408|NCT01936649|468126944|FG000|Overall Study|Withdrawal by Subject|4|||
130046409|NCT01936649|468126944|FG000|Overall Study|Physician Decision|2|||
130046410|NCT01936649|468126944|FG000|Overall Study|Protocol Violation|2|||
130046411|NCT01936649|468126944|FG000|Overall Study|Other than specified above|5|||
130046412|NCT04655586|468126951|FG000|Overall Study|Physician Decision|1|||
130046413|NCT04655586|468126952|FG001|Overall Study|Physician Decision|3|||
130046414|NCT04655586|468126953|FG002|Overall Study|Physician Decision|4|||
130046415|NCT04655586|468126951|FG000|Overall Study|Withdrawal by Subject|1|||
130046416|NCT04655586|468126952|FG001|Overall Study|Withdrawal by Subject|3|||
130046417|NCT04655586|468126953|FG002|Overall Study|Withdrawal by Subject|1|||
130046418|NCT02927171|468126960|FG000|Overall Study|Lost to Follow-up|0|||
130046419|NCT02927171|468126961|FG001|Overall Study|Lost to Follow-up|1|||
130046420|NCT04530825|468126966|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
130046421|NCT04530825|468126967|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
130046422|NCT04530825|468126968|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
130046423|NCT04530825|468126969|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
130046424|NCT04530825|468126966|FG000|Overall Study|Did not complete follow-up|3|||
130046425|NCT04530825|468126967|FG001|Overall Study|Did not complete follow-up|0|||
130046426|NCT04530825|468126968|FG002|Overall Study|Did not complete follow-up|0|||
130046427|NCT04530825|468126969|FG003|Overall Study|Did not complete follow-up|0|||
130046428|NCT00850499|468126971|FG000|Overall Study|Adverse Event|3|||
130046429|NCT00850499|468126972|FG001|Overall Study|Adverse Event|1|||
130046430|NCT00850499|468126971|FG000|Overall Study|Lack of Efficacy|0|||
130046431|NCT00850499|468126972|FG001|Overall Study|Lack of Efficacy|1|||
130046432|NCT00552305|468126973|FG000|Overall Study|Adverse Event|43|||
130046433|NCT00552305|468126973|FG000|Overall Study|Lack of Efficacy|120|||
130046434|NCT00552305|468126973|FG000|Overall Study|Lost to Follow-up|4|||
130046435|NCT00552305|468126973|FG000|Overall Study|Protocol Violation|3|||
130046436|NCT00552305|468126973|FG000|Overall Study|Withdrawal by Subject|44|||
130046437|NCT00552305|468126973|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
130046438|NCT00552305|468126973|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
130046439|NCT00552305|468126973|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
130046440|NCT00552305|468126973|FG000|Overall Study|Unsatisfactory compliance|11|||
130106827|NCT04440007|468351696|FG000|Overall Study|Lost to Follow-up|1|||
130106828|NCT04440007|468351697|FG001|Overall Study|Lost to Follow-up|3|||
130106829|NCT04440007|468351696|FG000|Overall Study|Death|7|||
130106830|NCT04440007|468351697|FG001|Overall Study|Death|2|||
130106831|NCT04440007|468351696|FG000|Overall Study|Physician Decision|1|||
130106832|NCT04440007|468351697|FG001|Overall Study|Physician Decision|1|||
130106833|NCT04440007|468351696|FG000|Overall Study|Withdrawal by Subject|2|||
130106834|NCT04440007|468351697|FG001|Overall Study|Withdrawal by Subject|1|||
130106835|NCT04440007|468351696|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
130106836|NCT04440007|468351697|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
130106837|NCT04440007|468351696|FG000|Overall Study|Discontinued prior to dosing|0|||
130106838|NCT04440007|468351697|FG001|Overall Study|Discontinued prior to dosing|2|||
130106839|NCT01466673|468351698|FG000|Overall Study|Non-compliance with study treatment|2|||
130106840|NCT01466673|468351699|FG001|Overall Study|Non-compliance with study treatment|0|||
130106841|NCT01466673|468351698|FG000|Overall Study|Lost to Follow-up|3|||
130106842|NCT01466673|468351699|FG001|Overall Study|Lost to Follow-up|5|||
130106843|NCT01466673|468351698|FG000|Overall Study|Adverse Event|2|||
130106844|NCT01466673|468351699|FG001|Overall Study|Adverse Event|1|||
130106845|NCT00854607|468351700|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
130106846|NCT02623426|468351704|FG000|Overall Study|Lost to Follow-up|0|||
130046441|NCT00552305|468126973|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
130046442|NCT00552305|468126973|FG000|Overall Study|AE/Other: prohibited drug required|1|||
130046443|NCT00552305|468126973|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
130046444|NCT00552305|468126973|FG000|Overall Study|Other: Site closed|4|||
130046445|NCT00552305|468126973|FG000|Overall Study|Other: Personal problems|1|||
130046446|NCT00552305|468126973|FG000|Overall Study|Other: Unable to attend visits|1|||
130046447|NCT00552305|468126973|FG000|Overall Study|Other: Subject underwent surgery|4|||
130046448|NCT00552305|468126973|FG000|Overall Study|Other: Subject became pregnant|1|||
130106847|NCT02623426|468351705|FG001|Overall Study|Lost to Follow-up|0|||
130106848|NCT02623426|468351706|FG002|Overall Study|Lost to Follow-up|1|||
130106849|NCT02623426|468351704|FG000|Overall Study|Withdrawal by Subject|1|||
130106850|NCT02623426|468351705|FG001|Overall Study|Withdrawal by Subject|2|||
130046449|NCT00552305|468126973|FG000|Overall Study|Other: Health problems, not drug related|1|||
130046450|NCT00552305|468126973|FG000|Overall Study|Other: Subject moved from area|2|||
130046451|NCT00552305|468126973|FG000|Overall Study|Other: Subject incarcerated|1|||
130046452|NCT00552305|468126973|FG000|Overall Study|Other: Subject went to rehab|1|||
130046453|NCT04498910|468126974|FG000|Overall Study|Lost to Follow-up|0|||
130046454|NCT04498910|468126975|FG001|Overall Study|Lost to Follow-up|1|||
130046455|NCT04498910|468126974|FG000|Overall Study|Withdrawal by Subject|2|||
130046456|NCT04498910|468126975|FG001|Overall Study|Withdrawal by Subject|1|||
130046457|NCT04498910|468126974|FG000|Overall Study|Adverse Event|1|||
130046458|NCT04498910|468126975|FG001|Overall Study|Adverse Event|0|||
130046459|NCT01849848|468126976|FG000|Overall Study|Physician Decision|1|||
130046460|NCT01849848|468126976|FG000|Overall Study|Progression of the primary disease|3|||
130046461|NCT00909090|468126977|FG000|Overall Study|Lost to Follow-up|17|||
130046462|NCT00909090|468126978|FG001|Overall Study|Lost to Follow-up|17|||
130046463|NCT01214434|468126984|FG000|Overall Study|Withdrawal by Subject|1|||
130046464|NCT01214434|468126985|FG001|Overall Study|Withdrawal by Subject|0|||
130046465|NCT01214434|468126984|FG000|Overall Study|Lost to Follow-up|2|||
130046466|NCT01214434|468126985|FG001|Overall Study|Lost to Follow-up|2|||
130046467|NCT01214434|468126984|FG000|Overall Study|Site error|1|||
130046468|NCT01214434|468126985|FG001|Overall Study|Site error|0|||
130046469|NCT00138151|468126986|FG000|Overall Study|Withdrawal by Subject|3|||
130046470|NCT00138151|468126986|FG000|Overall Study|Physician Decision|1|||
130046471|NCT03503773|468126987|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
130046472|NCT03503773|468126988|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
130046473|NCT03503773|468126987|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
130046474|NCT03503773|468126988|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
130046475|NCT03503773|468126987|FG000|Overall Study|Not completing the primary ABPM|3|||
130046476|NCT03503773|468126988|FG001|Overall Study|Not completing the primary ABPM|1|||
130046477|NCT03503773|468126987|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130046478|NCT03503773|468126988|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130046479|NCT02675517|468126994|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
130046480|NCT02675517|468126994|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
130046481|NCT00425438|468126995|FG000|Overall Study|Termination by Sponsor|25|||
130046482|NCT00425438|468126996|FG001|Overall Study|Termination by Sponsor|27|||
130046483|NCT02619253|468126997|FG000|Overall Study|Adverse Event|0|||
130046484|NCT02619253|468126998|FG001|Overall Study|Adverse Event|0|||
130046485|NCT02619253|468126999|FG002|Overall Study|Adverse Event|1|||
130046486|NCT02619253|468127000|FG003|Overall Study|Adverse Event|1|||
130046487|NCT02619253|468127001|FG004|Overall Study|Adverse Event|3|||
130046488|NCT02619253|468126997|FG000|Overall Study|Alternative Therapy|0|||
130046489|NCT02619253|468126998|FG001|Overall Study|Alternative Therapy|0|||
130046490|NCT02619253|468126999|FG002|Overall Study|Alternative Therapy|1|||
130046491|NCT02619253|468127000|FG003|Overall Study|Alternative Therapy|0|||
130046492|NCT02619253|468127001|FG004|Overall Study|Alternative Therapy|0|||
130046493|NCT02619253|468126997|FG000|Overall Study|Death|0|||
130046494|NCT02619253|468126998|FG001|Overall Study|Death|0|||
130046495|NCT02619253|468126999|FG002|Overall Study|Death|0|||
130046496|NCT02619253|468127000|FG003|Overall Study|Death|1|||
130046497|NCT02619253|468127001|FG004|Overall Study|Death|0|||
130046498|NCT02619253|468126997|FG000|Overall Study|Disease Progression|4|||
130046499|NCT02619253|468126998|FG001|Overall Study|Disease Progression|2|||
130046500|NCT02619253|468126999|FG002|Overall Study|Disease Progression|8|||
130046501|NCT02619253|468127000|FG003|Overall Study|Disease Progression|9|||
130046502|NCT02619253|468127001|FG004|Overall Study|Disease Progression|10|||
130046503|NCT02619253|468126997|FG000|Overall Study|Needed a disqualifying therapy|0|||
130046504|NCT02619253|468126998|FG001|Overall Study|Needed a disqualifying therapy|0|||
130046505|NCT02619253|468126999|FG002|Overall Study|Needed a disqualifying therapy|1|||
130046506|NCT02619253|468127000|FG003|Overall Study|Needed a disqualifying therapy|0|||
130046507|NCT02619253|468127001|FG004|Overall Study|Needed a disqualifying therapy|0|||
130046508|NCT02619253|468126997|FG000|Overall Study|Transferred to hospice|0|||
130046509|NCT02619253|468126998|FG001|Overall Study|Transferred to hospice|0|||
130046510|NCT02619253|468126999|FG002|Overall Study|Transferred to hospice|1|||
130046511|NCT02619253|468127000|FG003|Overall Study|Transferred to hospice|0|||
130046512|NCT02619253|468127001|FG004|Overall Study|Transferred to hospice|0|||
130046513|NCT02619253|468126997|FG000|Overall Study|Physician Decision|0|||
130046514|NCT02619253|468126998|FG001|Overall Study|Physician Decision|1|||
130046515|NCT02619253|468126999|FG002|Overall Study|Physician Decision|2|||
130046516|NCT02619253|468127000|FG003|Overall Study|Physician Decision|3|||
130046517|NCT02619253|468127001|FG004|Overall Study|Physician Decision|0|||
130046518|NCT02619253|468126997|FG000|Overall Study|Withdrawal by Subject|0|||
130046519|NCT02619253|468126998|FG001|Overall Study|Withdrawal by Subject|1|||
130046520|NCT02619253|468126999|FG002|Overall Study|Withdrawal by Subject|0|||
130046521|NCT02619253|468127000|FG003|Overall Study|Withdrawal by Subject|0|||
130046522|NCT02619253|468127001|FG004|Overall Study|Withdrawal by Subject|2|||
130046523|NCT00514449|468127002|FG000|Overall Study|Withdrawal by Subject|1|||
130046524|NCT00514449|468127003|FG001|Overall Study|Withdrawal by Subject|2|||
130046525|NCT00514449|468127002|FG000|Overall Study|Protocol Violation|1|||
130046526|NCT00514449|468127003|FG001|Overall Study|Protocol Violation|2|||
130046527|NCT00514449|468127002|FG000|Overall Study|Lost to Follow-up|1|||
130046528|NCT00514449|468127003|FG001|Overall Study|Lost to Follow-up|0|||
130046529|NCT00149825|468127007|FG000|Overall Study|Intolerance to medication side effects|1|||
130046530|NCT00149825|468127008|FG001|Overall Study|Intolerance to medication side effects|2|||
130046531|NCT00149825|468127007|FG000|Overall Study|Time commitments|2|||
130046532|NCT00149825|468127008|FG001|Overall Study|Time commitments|1|||
130046533|NCT00149825|468127007|FG000|Overall Study|Not liking insomnia therapy|1|||
130046534|NCT00149825|468127008|FG001|Overall Study|Not liking insomnia therapy|0|||
130046535|NCT00149825|468127007|FG000|Overall Study|Other|1|||
130046536|NCT00149825|468127008|FG001|Overall Study|Other|0|||
130046537|NCT01359982|468127009|FG000|Overall Study|Adverse Event|2|||
130046538|NCT01359982|468127010|FG001|Overall Study|Adverse Event|0|||
130046539|NCT01359982|468127011|FG002|Overall Study|Adverse Event|0|||
130046540|NCT01359982|468127012|FG003|Overall Study|Adverse Event|1|||
130046541|NCT01359982|468127013|FG004|Overall Study|Adverse Event|0|||
130046542|NCT01359982|468127014|FG005|Overall Study|Adverse Event|0|||
130046543|NCT01359982|468127009|FG000|Overall Study|Death|1|||
130046544|NCT01359982|468127010|FG001|Overall Study|Death|0|||
130046545|NCT01359982|468127011|FG002|Overall Study|Death|0|||
130046546|NCT01359982|468127012|FG003|Overall Study|Death|0|||
130046547|NCT01359982|468127013|FG004|Overall Study|Death|0|||
130046548|NCT01359982|468127014|FG005|Overall Study|Death|0|||
130046549|NCT03694522|468127016|FG000|Overall Study|Withdrawal by Subject|8|||
130046550|NCT03694522|468127017|FG001|Overall Study|Withdrawal by Subject|10|||
130046551|NCT03694522|468127016|FG000|Overall Study|Physician Decision|53|||
129794019|NCT02380690|467212806|FG000|Overall Study|Lost to Follow-up|14|||
130046552|NCT03694522|468127017|FG001|Overall Study|Physician Decision|54|||
130046553|NCT03694522|468127016|FG000|Overall Study|Other|1|||
130046554|NCT03694522|468127017|FG001|Overall Study|Other|1|||
130046555|NCT03694522|468127016|FG000|Overall Study|Lost to Follow-up|0|||
130046556|NCT03694522|468127017|FG001|Overall Study|Lost to Follow-up|1|||
130046557|NCT02760407|468127018|FG000|Overall Study|Death|2|||
130046558|NCT02760407|468127019|FG001|Overall Study|Death|3|||
130046559|NCT02760407|468127020|FG002|Overall Study|Death|1|||
130046560|NCT02760407|468127021|FG003|Overall Study|Death|1|||
130046561|NCT02760407|468127018|FG000|Overall Study|Lost to Follow-up|1|||
130046562|NCT02760407|468127019|FG001|Overall Study|Lost to Follow-up|7|||
130046563|NCT02760407|468127020|FG002|Overall Study|Lost to Follow-up|4|||
130046564|NCT02760407|468127021|FG003|Overall Study|Lost to Follow-up|6|||
130046565|NCT02760407|468127018|FG000|Overall Study|Withdrawal by Subject|25|||
130046566|NCT02760407|468127019|FG001|Overall Study|Withdrawal by Subject|31|||
130046567|NCT02760407|468127020|FG002|Overall Study|Withdrawal by Subject|37|||
130046568|NCT02760407|468127021|FG003|Overall Study|Withdrawal by Subject|25|||
130046569|NCT02760407|468127018|FG000|Overall Study|Violation of Eligibility criteria|0|||
130046570|NCT02760407|468127019|FG001|Overall Study|Violation of Eligibility criteria|0|||
130046571|NCT02760407|468127020|FG002|Overall Study|Violation of Eligibility criteria|1|||
130046572|NCT02760407|468127021|FG003|Overall Study|Violation of Eligibility criteria|1|||
130046573|NCT02760407|468127018|FG000|Overall Study|Personal reasons|0|||
130046574|NCT02760407|468127019|FG001|Overall Study|Personal reasons|0|||
130046575|NCT02760407|468127020|FG002|Overall Study|Personal reasons|0|||
130046576|NCT02760407|468127021|FG003|Overall Study|Personal reasons|1|||
130046577|NCT02760407|468127018|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
130046578|NCT02760407|468127019|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
130046579|NCT02760407|468127020|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
130046580|NCT02760407|468127021|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
130046581|NCT02760407|468127018|FG000|Overall Study|Use of prohibited Medication|0|||
130046582|NCT02760407|468127019|FG001|Overall Study|Use of prohibited Medication|0|||
130046583|NCT02760407|468127020|FG002|Overall Study|Use of prohibited Medication|1|||
130046584|NCT02760407|468127021|FG003|Overall Study|Use of prohibited Medication|0|||
130046585|NCT02760407|468127018|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
130046586|NCT02760407|468127019|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
130046587|NCT02760407|468127020|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
130046588|NCT02760407|468127021|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
130046589|NCT02760407|468127018|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
130046590|NCT02760407|468127019|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
130046591|NCT02760407|468127020|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
130046592|NCT02760407|468127021|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
130046593|NCT02760407|468127018|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
130046594|NCT02760407|468127019|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
130046595|NCT02760407|468127020|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
130046596|NCT02760407|468127021|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
130046597|NCT02760407|468127018|FG000|Overall Study|Inadequately Enrolled|0|||
130046598|NCT02760407|468127019|FG001|Overall Study|Inadequately Enrolled|0|||
130046599|NCT02760407|468127020|FG002|Overall Study|Inadequately Enrolled|0|||
130046600|NCT02760407|468127021|FG003|Overall Study|Inadequately Enrolled|1|||
130046601|NCT02760407|468127018|FG000|Overall Study|Withdrawal By PI's Decision|0|||
130046602|NCT02760407|468127019|FG001|Overall Study|Withdrawal By PI's Decision|1|||
130046603|NCT02760407|468127020|FG002|Overall Study|Withdrawal By PI's Decision|0|||
130046604|NCT02760407|468127021|FG003|Overall Study|Withdrawal By PI's Decision|0|||
130046605|NCT02760407|468127018|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
130046606|NCT02760407|468127019|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
130046607|NCT02760407|468127020|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
130046608|NCT02760407|468127021|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
130046609|NCT02760407|468127018|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
130046610|NCT02760407|468127019|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
130046611|NCT02760407|468127020|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
130046612|NCT02760407|468127021|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
130046613|NCT02760407|468127018|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
130046614|NCT02760407|468127019|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
130046615|NCT02760407|468127020|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
130046616|NCT02760407|468127021|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
130046617|NCT02760407|468127018|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
130295224|NCT01659255|469045273|FG012|Overall Study|Withdrew Consent|0|||
130295225|NCT01659255|469045274|FG013|Overall Study|Withdrew Consent|1|||
130046618|NCT02760407|468127019|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
130046619|NCT02760407|468127020|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
130046620|NCT02760407|468127021|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
130046621|NCT02760407|468127018|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
129794020|NCT02380690|467212807|FG001|Overall Study|Lost to Follow-up|4|||
129794021|NCT02380690|467212806|FG000|Overall Study|Withdrawal by Subject|20|||
129794022|NCT02380690|467212807|FG001|Overall Study|Withdrawal by Subject|8|||
129794023|NCT00727532|467212808|FG000|Overall Study|Adverse Event|1|||
129794024|NCT00727532|467212808|FG000|Overall Study|Withdrawal by Subject|1|||
129794025|NCT00829933|467212809|FG000|Overall Study|Adverse Event|2|||
129794026|NCT00829933|467212810|FG001|Overall Study|Adverse Event|3|||
129794027|NCT00829933|467212811|FG002|Overall Study|Adverse Event|2|||
129794028|NCT00829933|467212812|FG003|Overall Study|Adverse Event|1|||
129794029|NCT00829933|467212809|FG000|Overall Study|Death|0|||
129794030|NCT00829933|467212810|FG001|Overall Study|Death|0|||
129794031|NCT00829933|467212811|FG002|Overall Study|Death|1|||
129794032|NCT00829933|467212812|FG003|Overall Study|Death|1|||
129794033|NCT00829933|467212809|FG000|Overall Study|Lack of Efficacy|0|||
129794034|NCT00829933|467212810|FG001|Overall Study|Lack of Efficacy|1|||
129794035|NCT00829933|467212811|FG002|Overall Study|Lack of Efficacy|0|||
129794036|NCT00829933|467212812|FG003|Overall Study|Lack of Efficacy|0|||
129794037|NCT00829933|467212809|FG000|Overall Study|Physician Decision|5|||
129794038|NCT00829933|467212810|FG001|Overall Study|Physician Decision|7|||
129794039|NCT00829933|467212811|FG002|Overall Study|Physician Decision|8|||
129794040|NCT00829933|467212812|FG003|Overall Study|Physician Decision|1|||
129794041|NCT00829933|467212809|FG000|Overall Study|Pregnancy|0|||
129794042|NCT00829933|467212810|FG001|Overall Study|Pregnancy|0|||
129794043|NCT00829933|467212811|FG002|Overall Study|Pregnancy|0|||
129794044|NCT00829933|467212812|FG003|Overall Study|Pregnancy|2|||
129794045|NCT00829933|467212809|FG000|Overall Study|Protocol Violation|2|||
129794046|NCT00829933|467212810|FG001|Overall Study|Protocol Violation|1|||
129794047|NCT00829933|467212811|FG002|Overall Study|Protocol Violation|0|||
129794048|NCT00829933|467212812|FG003|Overall Study|Protocol Violation|0|||
129794049|NCT00829933|467212809|FG000|Overall Study|withdrew before treatment started|5|||
129794050|NCT00829933|467212810|FG001|Overall Study|withdrew before treatment started|1|||
129794051|NCT00829933|467212811|FG002|Overall Study|withdrew before treatment started|2|||
129794052|NCT00829933|467212812|FG003|Overall Study|withdrew before treatment started|9|||
129794053|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
129794054|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
129794055|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
129794056|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
129794057|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
129794058|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
129794059|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
129794060|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
129794061|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
129794062|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
129794063|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
129794064|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
130046622|NCT02760407|468127019|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
130046623|NCT02760407|468127020|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
130046624|NCT02760407|468127021|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
130046625|NCT02760407|468127018|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
130046626|NCT02760407|468127019|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
130046627|NCT02760407|468127020|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
130046628|NCT02760407|468127021|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
130046629|NCT02760407|468127018|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
130046630|NCT02760407|468127019|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
130046631|NCT02760407|468127020|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
130046632|NCT02760407|468127021|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
130046633|NCT02760407|468127018|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
130046634|NCT02760407|468127019|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
130046635|NCT02760407|468127020|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
130046636|NCT02760407|468127021|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
130046637|NCT02760407|468127018|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
129794065|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
129794066|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
129794067|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
129794068|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
129794069|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
129794070|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130106851|NCT02623426|468351706|FG002|Overall Study|Withdrawal by Subject|2|||
130106852|NCT05458895|468351711|FG000|Overall Study|Withdrawal by Subject|8|||
130106853|NCT05458895|468351711|FG000|Overall Study|Lost to Follow-up|17|||
130106854|NCT05458895|468351711|FG000|Overall Study|Pregnancy|2|||
130106855|NCT05458895|468351711|FG000|Overall Study|Withdrawal by Study Team|1|||
130106856|NCT04639310|468351712|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
130106857|NCT04639310|468351713|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
130106858|NCT00817778|468353303|FG000|Overall Study|Adverse Event|1|||
130106859|NCT00817778|468353304|FG001|Overall Study|Adverse Event|0|||
130106860|NCT00817778|468353303|FG000|Overall Study|Withdrawal by Subject|1|||
130106861|NCT00817778|468353304|FG001|Overall Study|Withdrawal by Subject|1|||
130106862|NCT00817778|468353303|FG000|Overall Study|Protocol Violation|0|||
130106863|NCT00817778|468353304|FG001|Overall Study|Protocol Violation|1|||
130106864|NCT00817778|468353303|FG000|Overall Study|Study-specific discontinuation criteria|0|||
130106865|NCT00817778|468353304|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130106866|NCT00817778|468353303|FG000|Overall Study|Poor venous access|1|||
130106867|NCT00817778|468353304|FG001|Overall Study|Poor venous access|0|||
130106868|NCT02923115|468353309|FG000|Overall Study|Lost to Follow-up|0|||
130106869|NCT02923115|468353310|FG001|Overall Study|Lost to Follow-up|0|||
130106870|NCT02923115|468353311|FG002|Overall Study|Lost to Follow-up|0|||
130106871|NCT02923115|468353312|FG003|Overall Study|Lost to Follow-up|1|||
130106872|NCT02923115|468353313|FG004|Overall Study|Lost to Follow-up|0|||
130106873|NCT02923115|468353314|FG005|Overall Study|Lost to Follow-up|0|||
130106874|NCT02923115|468353309|FG000|Overall Study|Withdrawal by Subject|0|||
130106875|NCT02923115|468353310|FG001|Overall Study|Withdrawal by Subject|1|||
130106876|NCT02923115|468353311|FG002|Overall Study|Withdrawal by Subject|0|||
130106877|NCT02923115|468353312|FG003|Overall Study|Withdrawal by Subject|0|||
130106878|NCT02923115|468353313|FG004|Overall Study|Withdrawal by Subject|0|||
130106879|NCT02923115|468353314|FG005|Overall Study|Withdrawal by Subject|0|||
130106880|NCT02923115|468353309|FG000|Overall Study|Randomized, but not dosed|0|||
130106881|NCT02923115|468353310|FG001|Overall Study|Randomized, but not dosed|0|||
130106882|NCT02923115|468353311|FG002|Overall Study|Randomized, but not dosed|3|||
130106883|NCT02923115|468353312|FG003|Overall Study|Randomized, but not dosed|1|||
130106884|NCT02923115|468353313|FG004|Overall Study|Randomized, but not dosed|5|||
130106885|NCT02923115|468353314|FG005|Overall Study|Randomized, but not dosed|0|||
130106886|NCT00520494|468353315|FG000|Overall Study|Withdrawal by Subject|1|||
130106887|NCT03471182|468353318|FG000|Overall Study|Withdrawal by Subject|1|||
130106888|NCT03471182|468353319|FG001|Overall Study|Withdrawal by Subject|1|||
130106889|NCT03471182|468353320|FG002|Overall Study|Withdrawal by Subject|0|||
129794071|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
129794072|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
130106890|NCT03471182|468353318|FG000|Overall Study|Technical failure|2|||
130106891|NCT03471182|468353319|FG001|Overall Study|Technical failure|0|||
130106892|NCT03471182|468353320|FG002|Overall Study|Technical failure|0|||
130295226|NCT01659255|469045275|FG014|Overall Study|Withdrew Consent|0|||
130295227|NCT01659255|469045276|FG015|Overall Study|Withdrew Consent|0|||
130295228|NCT01659255|469045277|FG016|Overall Study|Withdrew Consent|0|||
130295229|NCT01659255|469045261|FG000|Overall Study|Investigator Decision|0|||
130295230|NCT01659255|469045262|FG001|Overall Study|Investigator Decision|0|||
130295231|NCT01659255|469045263|FG002|Overall Study|Investigator Decision|0|||
130295232|NCT01659255|469045264|FG003|Overall Study|Investigator Decision|0|||
130295233|NCT01659255|469045265|FG004|Overall Study|Investigator Decision|0|||
130295234|NCT01659255|469045266|FG005|Overall Study|Investigator Decision|0|||
130295235|NCT01659255|469045267|FG006|Overall Study|Investigator Decision|0|||
130295236|NCT01659255|469045268|FG007|Overall Study|Investigator Decision|0|||
130295237|NCT01659255|469045269|FG008|Overall Study|Investigator Decision|0|||
130295238|NCT01659255|469045270|FG009|Overall Study|Investigator Decision|0|||
130295239|NCT01659255|469045271|FG010|Overall Study|Investigator Decision|0|||
130295240|NCT01659255|469045272|FG011|Overall Study|Investigator Decision|0|||
130295241|NCT01659255|469045273|FG012|Overall Study|Investigator Decision|1|||
130295242|NCT01659255|469045274|FG013|Overall Study|Investigator Decision|1|||
130295243|NCT01659255|469045275|FG014|Overall Study|Investigator Decision|0|||
130295244|NCT01659255|469045276|FG015|Overall Study|Investigator Decision|0|||
130295245|NCT01659255|469045277|FG016|Overall Study|Investigator Decision|0|||
130295246|NCT01659255|469045261|FG000|Overall Study|Sponsor's Decision|0|||
130106893|NCT00068406|468353321|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
130106894|NCT00068406|468353321|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
130106895|NCT03451331|468353322|FG000|Overall Study|Withdrawal by Subject|1|||
130295247|NCT01659255|469045262|FG001|Overall Study|Sponsor's Decision|0|||
130295248|NCT01659255|469045263|FG002|Overall Study|Sponsor's Decision|0|||
130295249|NCT01659255|469045264|FG003|Overall Study|Sponsor's Decision|0|||
130295250|NCT01659255|469045265|FG004|Overall Study|Sponsor's Decision|0|||
130295251|NCT01659255|469045266|FG005|Overall Study|Sponsor's Decision|0|||
130106896|NCT03451331|468353323|FG001|Overall Study|Withdrawal by Subject|0|||
130295252|NCT01659255|469045267|FG006|Overall Study|Sponsor's Decision|1|||
130106897|NCT03451331|468353322|FG000|Overall Study|Unable to start treatment.|1|||
130106898|NCT03451331|468353323|FG001|Overall Study|Unable to start treatment.|1|||
130106899|NCT01875991|468353324|FG000|Overall Study|Withdrawal by Subject|6|||
130106900|NCT01875991|468353325|FG001|Overall Study|Withdrawal by Subject|6|||
130106901|NCT01875991|468353324|FG000|Overall Study|Sponsor Decision|1|||
130106902|NCT01875991|468353325|FG001|Overall Study|Sponsor Decision|0|||
130106903|NCT02454972|468353326|FG000|Overall Study|Progressive disease|17|||
130106904|NCT02454972|468353327|FG001|Overall Study|Progressive disease|16|||
130106905|NCT02454972|468353328|FG002|Overall Study|Progressive disease|59|||
130106906|NCT02454972|468353329|FG003|Overall Study|Progressive disease|23|||
130106907|NCT02454972|468353330|FG004|Overall Study|Progressive disease|16|||
130295253|NCT01659255|469045268|FG007|Overall Study|Sponsor's Decision|0|||
130295254|NCT01659255|469045269|FG008|Overall Study|Sponsor's Decision|0|||
130295255|NCT01659255|469045270|FG009|Overall Study|Sponsor's Decision|0|||
130295256|NCT01659255|469045271|FG010|Overall Study|Sponsor's Decision|0|||
130295257|NCT01659255|469045272|FG011|Overall Study|Sponsor's Decision|0|||
130295258|NCT01659255|469045273|FG012|Overall Study|Sponsor's Decision|0|||
130295259|NCT01659255|469045274|FG013|Overall Study|Sponsor's Decision|0|||
130295260|NCT01659255|469045275|FG014|Overall Study|Sponsor's Decision|0|||
130295261|NCT01659255|469045276|FG015|Overall Study|Sponsor's Decision|0|||
130295262|NCT01659255|469045277|FG016|Overall Study|Sponsor's Decision|0|||
130295263|NCT01659255|469045261|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295264|NCT01659255|469045262|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295265|NCT01659255|469045263|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295266|NCT01659255|469045264|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295267|NCT01659255|469045265|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295268|NCT01659255|469045266|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295269|NCT01659255|469045267|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295270|NCT01659255|469045268|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295271|NCT01659255|469045269|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295272|NCT01659255|469045270|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295273|NCT01659255|469045271|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295274|NCT01659255|469045272|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295275|NCT01659255|469045273|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295276|NCT01659255|469045274|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295277|NCT01659255|469045275|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295278|NCT01659255|469045276|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
130295279|NCT01659255|469045277|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
130295280|NCT01659255|469045261|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
130295281|NCT01659255|469045262|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
130295282|NCT01659255|469045263|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
130295283|NCT01659255|469045264|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
130295284|NCT01659255|469045265|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
130295285|NCT01659255|469045266|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
130106908|NCT02454972|468353331|FG005|Overall Study|Progressive disease|12|||
130106909|NCT02454972|468353332|FG006|Overall Study|Progressive disease|19|||
130106910|NCT02454972|468353333|FG007|Overall Study|Progressive disease|27|||
130106911|NCT02454972|468353334|FG008|Overall Study|Progressive disease|0|||
130106912|NCT02454972|468353326|FG000|Overall Study|Death|0|||
130106913|NCT02454972|468353327|FG001|Overall Study|Death|0|||
130106914|NCT02454972|468353328|FG002|Overall Study|Death|5|||
130106915|NCT02454972|468353329|FG003|Overall Study|Death|1|||
130106916|NCT02454972|468353330|FG004|Overall Study|Death|0|||
130106917|NCT02454972|468353331|FG005|Overall Study|Death|0|||
130106918|NCT02454972|468353332|FG006|Overall Study|Death|0|||
130106919|NCT02454972|468353333|FG007|Overall Study|Death|0|||
130106920|NCT02454972|468353334|FG008|Overall Study|Death|95|||
130106921|NCT02454972|468353326|FG000|Overall Study|Physician Decision|0|||
130106922|NCT02454972|468353327|FG001|Overall Study|Physician Decision|1|||
130106923|NCT02454972|468353328|FG002|Overall Study|Physician Decision|2|||
130295286|NCT01659255|469045267|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
130295287|NCT01659255|469045268|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
130295288|NCT01659255|469045269|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
130295289|NCT01659255|469045270|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
130295290|NCT01659255|469045271|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
130295291|NCT01659255|469045272|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
130295292|NCT01659255|469045273|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
130106924|NCT02454972|468353329|FG003|Overall Study|Physician Decision|1|||
130106925|NCT02454972|468353330|FG004|Overall Study|Physician Decision|2|||
130295293|NCT01659255|469045274|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
130106926|NCT02454972|468353331|FG005|Overall Study|Physician Decision|0|||
130106927|NCT02454972|468353332|FG006|Overall Study|Physician Decision|0|||
130106928|NCT02454972|468353333|FG007|Overall Study|Physician Decision|1|||
130295294|NCT01659255|469045275|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
130295295|NCT01659255|469045276|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
130295296|NCT01659255|469045277|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
130295297|NCT01116427|469045278|FG000|Core Phase|Adverse Event|0|||
130295298|NCT01116427|469045279|FG001|Core Phase|Adverse Event|1|||
130295299|NCT01116427|469045278|FG000|Core Phase|Lost to Follow-up|1|||
129794073|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794074|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794075|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794076|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794077|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
129794078|NCT01986933|467212817|FG000|Active-to-active (Part B)|Adverse Event|0|||
129794079|NCT01986933|467212818|FG001|Active-to-active (Part B)|Adverse Event|2|||
129794080|NCT01986933|467212819|FG002|Active-to-active (Part B)|Adverse Event|0|||
129794081|NCT01986933|467212820|FG003|Active-to-active (Part B)|Adverse Event|1|||
129794082|NCT01986933|467212821|FG004|Active-to-active (Part B)|Adverse Event|3|||
129794083|NCT01986933|467212817|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
129794084|NCT01986933|467212818|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
129794085|NCT01986933|467212819|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
129794086|NCT01986933|467212820|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
130046638|NCT02760407|468127019|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
130046639|NCT02760407|468127020|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
130046640|NCT02760407|468127021|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
130046641|NCT01748760|468127022|FG000|Overall Study|Withdrawal by Subject|1|||
130046642|NCT01748760|468127023|FG001|Overall Study|Withdrawal by Subject|1|||
130046643|NCT01748760|468127022|FG000|Overall Study|Lost to Follow-up|5|||
130046644|NCT01748760|468127023|FG001|Overall Study|Lost to Follow-up|1|||
130046645|NCT01164501|468127024|FG000|Overall Study|Not treated|2|||
130046646|NCT01164501|468127025|FG001|Overall Study|Not treated|0|||
130046647|NCT01164501|468127026|FG002|Overall Study|Not treated|1|||
130046648|NCT01164501|468127024|FG000|Overall Study|Adverse Event|18|||
130046649|NCT01164501|468127025|FG001|Overall Study|Adverse Event|4|||
130046650|NCT01164501|468127026|FG002|Overall Study|Adverse Event|21|||
130046651|NCT01164501|468127024|FG000|Overall Study|Lack of Efficacy|0|||
130046652|NCT01164501|468127025|FG001|Overall Study|Lack of Efficacy|0|||
130046653|NCT01164501|468127026|FG002|Overall Study|Lack of Efficacy|1|||
130046654|NCT01164501|468127024|FG000|Overall Study|Non compliant with protocol|1|||
130046655|NCT01164501|468127025|FG001|Overall Study|Non compliant with protocol|1|||
130046656|NCT01164501|468127026|FG002|Overall Study|Non compliant with protocol|4|||
130046657|NCT01164501|468127024|FG000|Overall Study|Lost to Follow-up|3|||
130046658|NCT01164501|468127025|FG001|Overall Study|Lost to Follow-up|0|||
130046659|NCT01164501|468127026|FG002|Overall Study|Lost to Follow-up|3|||
130046660|NCT01164501|468127024|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
130046661|NCT01164501|468127025|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
130046662|NCT01164501|468127026|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
130046663|NCT01164501|468127024|FG000|Overall Study|Other reason not defined above|9|||
130046664|NCT01164501|468127025|FG001|Overall Study|Other reason not defined above|1|||
130046665|NCT01164501|468127026|FG002|Overall Study|Other reason not defined above|4|||
130046666|NCT00206518|468127027|FG000|Overall Study|Lack of Efficacy|6|||
130046667|NCT00206518|468127028|FG001|Overall Study|Lack of Efficacy|4|||
130046668|NCT00206518|468127027|FG000|Overall Study|Adverse Event|2|||
130046669|NCT00206518|468127028|FG001|Overall Study|Adverse Event|1|||
130046670|NCT00206518|468127027|FG000|Overall Study|Physician Decision|1|||
130046671|NCT00206518|468127028|FG001|Overall Study|Physician Decision|0|||
130046672|NCT00206518|468127027|FG000|Overall Study|Protocol Violation|1|||
130046673|NCT00206518|468127028|FG001|Overall Study|Protocol Violation|1|||
130046674|NCT00515463|468127031|FG000|Overall Study|Physician Decision|4|||
130046675|NCT00515463|468127032|FG001|Overall Study|Physician Decision|2|||
130046676|NCT00515463|468127031|FG000|Overall Study|Adverse Event|1|||
130046677|NCT00515463|468127032|FG001|Overall Study|Adverse Event|2|||
130046678|NCT00515463|468127031|FG000|Overall Study|Withdrawal by Subject|3|||
130295300|NCT01116427|469045279|FG001|Core Phase|Lost to Follow-up|0|||
130046679|NCT00515463|468127032|FG001|Overall Study|Withdrawal by Subject|4|||
130046680|NCT00515463|468127031|FG000|Overall Study|Lost to Follow-up|6|||
130046681|NCT00515463|468127032|FG001|Overall Study|Lost to Follow-up|5|||
130046682|NCT00515463|468127031|FG000|Overall Study|Other|0|||
130046683|NCT00515463|468127032|FG001|Overall Study|Other|1|||
130046684|NCT02269319|468127033|FG000|Overall Study|Lost to Follow-up|4|||
130046685|NCT02269319|468127034|FG001|Overall Study|Lost to Follow-up|3|||
130046686|NCT02269319|468127033|FG000|Overall Study|Adverse Event|0|||
130046687|NCT02269319|468127034|FG001|Overall Study|Adverse Event|1|||
130046688|NCT02269319|468127033|FG000|Overall Study|Instructions not followed|1|||
130046689|NCT02269319|468127034|FG001|Overall Study|Instructions not followed|0|||
130046690|NCT03268746|468128505|FG000|Overall Study|Withdrawal by Subject|1|||
130295301|NCT01116427|469045278|FG000|Core Phase|Withdrawal by Subject|3|||
130295302|NCT01116427|469045279|FG001|Core Phase|Withdrawal by Subject|0|||
130046691|NCT00891657|468128508|FG000|Overall Study|Withdrawal by Subject|1|||
130046692|NCT00891657|468128509|FG001|Overall Study|Withdrawal by Subject|1|||
130295303|NCT01116427|469045278|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
130295304|NCT01116427|469045279|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
130295305|NCT01116427|469045278|FG000|Extension Phase|Adverse Event|1|||
130295306|NCT01116427|469045279|FG001|Extension Phase|Adverse Event|1|||
130295307|NCT01116427|469045278|FG000|Extension Phase|Lost to Follow-up|2|||
130295308|NCT01116427|469045279|FG001|Extension Phase|Lost to Follow-up|0|||
130295309|NCT01116427|469045278|FG000|Extension Phase|Withdrawal by Subject|5|||
130295310|NCT01116427|469045279|FG001|Extension Phase|Withdrawal by Subject|1|||
130295311|NCT01116427|469045278|FG000|Extension Phase|Not using appropriate birth control|1|||
130295312|NCT01116427|469045279|FG001|Extension Phase|Not using appropriate birth control|0|||
130295313|NCT02989805|469045282|FG000|Overall Study|invalid consent|6|||
130295314|NCT02989805|469045283|FG001|Overall Study|invalid consent|4|||
130046693|NCT02926573|468128510|FG000|Overall Study|Nausea|1|||
130046694|NCT02926573|468128511|FG001|Overall Study|Nausea|0|||
130046695|NCT02926573|468128510|FG000|Overall Study|Remain intubated|2|||
130046696|NCT02926573|468128511|FG001|Overall Study|Remain intubated|2|||
130046697|NCT02926573|468128510|FG000|Overall Study|Change in surgery plan|3|||
130046698|NCT02926573|468128511|FG001|Overall Study|Change in surgery plan|1|||
130046699|NCT02926573|468128510|FG000|Overall Study|Change to outpatient status|5|||
130046700|NCT02926573|468128511|FG001|Overall Study|Change to outpatient status|1|||
130046701|NCT02926573|468128510|FG000|Overall Study|Withdrawal by Subject|0|||
130046702|NCT02926573|468128511|FG001|Overall Study|Withdrawal by Subject|2|||
130046703|NCT02926573|468128510|FG000|Overall Study|Return to operating room|0|||
130046704|NCT02926573|468128511|FG001|Overall Study|Return to operating room|2|||
130046705|NCT02926573|468128510|FG000|Overall Study|Delirium|0|||
130046706|NCT02926573|468128511|FG001|Overall Study|Delirium|1|||
130046707|NCT00858702|468128514|FG000|Overall Study|Lack of Efficacy|1|||
130046708|NCT00858702|468128515|FG001|Overall Study|Lack of Efficacy|0|||
130046709|NCT00858702|468128514|FG000|Overall Study|Protocol Violation|1|||
130046710|NCT00858702|468128515|FG001|Overall Study|Protocol Violation|1|||
130046711|NCT00858702|468128514|FG000|Overall Study|Other|2|||
130046712|NCT00858702|468128515|FG001|Overall Study|Other|1|||
130046713|NCT00858702|468128514|FG000|Overall Study|Withdrawal by Subject|1|||
130046714|NCT00858702|468128515|FG001|Overall Study|Withdrawal by Subject|0|||
130046715|NCT01839188|468128516|FG000|Overall Study|Withdrawal by Subject|1|||
130046716|NCT02902809|468128521|FG000|Overall Study|Discontinuation of asthma program|28|||
130046717|NCT00532259|468128522|FG000|Overall Study|Withdrawal by Subject|2|||
130046718|NCT00532259|468128522|FG000|Overall Study|Adverse Event|1|||
130295315|NCT02211313|469045284|FG000|Overall Study|Treatment Failure|5|||
130046719|NCT00532259|468128522|FG000|Overall Study|Death|1|||
130046720|NCT00532259|468128522|FG000|Overall Study|Lack of Efficacy|21|||
130046721|NCT00532259|468128522|FG000|Overall Study|Lost to Follow-up|3|||
130046722|NCT00532259|468128522|FG000|Overall Study|Physician Decision|3|||
130046723|NCT00532259|468128522|FG000|Overall Study|Protocol Violation|1|||
130046724|NCT00793104|468128523|FG000|Overall Study|Lost to Follow-up|1|||
130295316|NCT02211313|469045285|FG001|Overall Study|Treatment Failure|2|||
130106929|NCT02454972|468353334|FG008|Overall Study|Physician Decision|0|||
130106930|NCT02454972|468353326|FG000|Overall Study|Non treatment-related adverse event|2|||
130106931|NCT02454972|468353327|FG001|Overall Study|Non treatment-related adverse event|0|||
130106932|NCT02454972|468353328|FG002|Overall Study|Non treatment-related adverse event|1|||
130106933|NCT02454972|468353329|FG003|Overall Study|Non treatment-related adverse event|0|||
130106934|NCT02454972|468353330|FG004|Overall Study|Non treatment-related adverse event|0|||
130106935|NCT02454972|468353331|FG005|Overall Study|Non treatment-related adverse event|1|||
130295317|NCT02211313|469045284|FG000|Overall Study|No Follow up Questionnaires|1|||
130295318|NCT02211313|469045285|FG001|Overall Study|No Follow up Questionnaires|1|||
130295319|NCT03743064|469045286|FG000|Overall Study|Adverse Event|7|||
130295320|NCT03743064|469045287|FG001|Overall Study|Adverse Event|9|||
130295321|NCT03743064|469045286|FG000|Overall Study|Death|25|||
130295322|NCT03743064|469045287|FG001|Overall Study|Death|28|||
130295323|NCT03743064|469045286|FG000|Overall Study|Lost to Follow-up|3|||
130295324|NCT03743064|469045287|FG001|Overall Study|Lost to Follow-up|6|||
130295325|NCT03743064|469045286|FG000|Overall Study|Withdrawal by Subject|28|||
130295326|NCT03743064|469045287|FG001|Overall Study|Withdrawal by Subject|25|||
130295327|NCT03743064|469045286|FG000|Overall Study|Physician Decision|2|||
130295328|NCT03743064|469045287|FG001|Overall Study|Physician Decision|4|||
130295329|NCT03743064|469045286|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
130046725|NCT01302769|468128524|FG000|Overall Study|Lost to Follow-up|1|||
130046726|NCT01302769|468128525|FG001|Overall Study|Lost to Follow-up|1|||
130046727|NCT03494725|468128526|FG000|Overall Study|Withdrawal by Subject|0|||
130046728|NCT03494725|468128527|FG001|Overall Study|Withdrawal by Subject|2|||
130046729|NCT03494725|468128526|FG000|Overall Study|Antibiotic use|1|||
130046730|NCT03494725|468128527|FG001|Overall Study|Antibiotic use|0|||
130046731|NCT04983940|468128528|FG000|Overall Study|Lost to Follow-up|14|||
130046732|NCT04983940|468128528|FG000|Overall Study|Lack of Efficacy|2|||
130295330|NCT03743064|469045287|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
130295331|NCT02771626|469045288|FG000|Overall Study|Adverse Event|1|||
130295332|NCT02771626|469045289|FG001|Overall Study|Adverse Event|5|||
130295333|NCT02771626|469045290|FG002|Overall Study|Adverse Event|3|||
130295334|NCT02771626|469045291|FG003|Overall Study|Adverse Event|0|||
130295335|NCT02771626|469045292|FG004|Overall Study|Adverse Event|1|||
130046733|NCT03245814|468128531|FG000|Overall Study|Lost to Follow-up|5|||
130295336|NCT02771626|469045293|FG005|Overall Study|Adverse Event|1|||
130295337|NCT02771626|469045288|FG000|Overall Study|Radiologic Disease Progression|6|||
130295338|NCT02771626|469045289|FG001|Overall Study|Radiologic Disease Progression|13|||
130295339|NCT02771626|469045290|FG002|Overall Study|Radiologic Disease Progression|10|||
130295340|NCT02771626|469045291|FG003|Overall Study|Radiologic Disease Progression|7|||
130295341|NCT02771626|469045292|FG004|Overall Study|Radiologic Disease Progression|28|||
130295342|NCT02771626|469045293|FG005|Overall Study|Radiologic Disease Progression|15|||
130295343|NCT02771626|469045288|FG000|Overall Study|Symptomatic Deterioration|0|||
130295344|NCT02771626|469045289|FG001|Overall Study|Symptomatic Deterioration|4|||
130295345|NCT02771626|469045290|FG002|Overall Study|Symptomatic Deterioration|2|||
130295346|NCT02771626|469045291|FG003|Overall Study|Symptomatic Deterioration|0|||
130295347|NCT02771626|469045292|FG004|Overall Study|Symptomatic Deterioration|5|||
130295348|NCT02771626|469045293|FG005|Overall Study|Symptomatic Deterioration|2|||
130295349|NCT02771626|469045288|FG000|Overall Study|Participant Request|0|||
130295350|NCT02771626|469045289|FG001|Overall Study|Participant Request|1|||
130295351|NCT02771626|469045290|FG002|Overall Study|Participant Request|0|||
130295352|NCT02771626|469045291|FG003|Overall Study|Participant Request|2|||
130295353|NCT02771626|469045292|FG004|Overall Study|Participant Request|0|||
130295354|NCT02771626|469045293|FG005|Overall Study|Participant Request|1|||
130295355|NCT02771626|469045288|FG000|Overall Study|Investigator Decision|0|||
130295356|NCT02771626|469045289|FG001|Overall Study|Investigator Decision|1|||
130295357|NCT02771626|469045290|FG002|Overall Study|Investigator Decision|0|||
130295358|NCT02771626|469045291|FG003|Overall Study|Investigator Decision|0|||
130295359|NCT02771626|469045292|FG004|Overall Study|Investigator Decision|1|||
130295360|NCT02771626|469045293|FG005|Overall Study|Investigator Decision|0|||
130295361|NCT02771626|469045288|FG000|Overall Study|Study Termination by Sponsor|0|||
130295362|NCT02771626|469045289|FG001|Overall Study|Study Termination by Sponsor|2|||
130295363|NCT02771626|469045290|FG002|Overall Study|Study Termination by Sponsor|1|||
130295364|NCT02771626|469045291|FG003|Overall Study|Study Termination by Sponsor|0|||
130295365|NCT02771626|469045292|FG004|Overall Study|Study Termination by Sponsor|1|||
130295366|NCT02771626|469045293|FG005|Overall Study|Study Termination by Sponsor|0|||
130295367|NCT02771626|469045288|FG000|Overall Study|Informed Consent Withdrawn|0|||
130295368|NCT02771626|469045289|FG001|Overall Study|Informed Consent Withdrawn|0|||
130295369|NCT02771626|469045290|FG002|Overall Study|Informed Consent Withdrawn|1|||
130295370|NCT02771626|469045291|FG003|Overall Study|Informed Consent Withdrawn|0|||
130295371|NCT02771626|469045292|FG004|Overall Study|Informed Consent Withdrawn|1|||
130046734|NCT03245814|468128532|FG001|Overall Study|Lost to Follow-up|8|||
130295372|NCT02771626|469045293|FG005|Overall Study|Informed Consent Withdrawn|1|||
130295373|NCT02771626|469045288|FG000|Overall Study|Other, Not Specified|1|||
130295374|NCT02771626|469045289|FG001|Overall Study|Other, Not Specified|0|||
130295375|NCT02771626|469045290|FG002|Overall Study|Other, Not Specified|0|||
130106936|NCT02454972|468353332|FG006|Overall Study|Non treatment-related adverse event|0|||
130106937|NCT02454972|468353333|FG007|Overall Study|Non treatment-related adverse event|1|||
130106938|NCT02454972|468353334|FG008|Overall Study|Non treatment-related adverse event|0|||
130106939|NCT02454972|468353326|FG000|Overall Study|Treatment-related adverse events|0|||
130106940|NCT02454972|468353327|FG001|Overall Study|Treatment-related adverse events|1|||
130106941|NCT02454972|468353328|FG002|Overall Study|Treatment-related adverse events|1|||
130106942|NCT02454972|468353329|FG003|Overall Study|Treatment-related adverse events|0|||
130106943|NCT02454972|468353330|FG004|Overall Study|Treatment-related adverse events|2|||
130106944|NCT02454972|468353331|FG005|Overall Study|Treatment-related adverse events|0|||
130106945|NCT02454972|468353332|FG006|Overall Study|Treatment-related adverse events|0|||
130106946|NCT02454972|468353333|FG007|Overall Study|Treatment-related adverse events|2|||
130106947|NCT02454972|468353334|FG008|Overall Study|Treatment-related adverse events|0|||
130106948|NCT02454972|468353326|FG000|Overall Study|Patient moves to compassionate use|0|||
130106949|NCT02454972|468353327|FG001|Overall Study|Patient moves to compassionate use|0|||
130106950|NCT02454972|468353328|FG002|Overall Study|Patient moves to compassionate use|0|||
130106951|NCT02454972|468353329|FG003|Overall Study|Patient moves to compassionate use|0|||
130106952|NCT02454972|468353330|FG004|Overall Study|Patient moves to compassionate use|0|||
130106953|NCT02454972|468353331|FG005|Overall Study|Patient moves to compassionate use|0|||
130106954|NCT02454972|468353332|FG006|Overall Study|Patient moves to compassionate use|2|||
130106955|NCT02454972|468353333|FG007|Overall Study|Patient moves to compassionate use|0|||
130106956|NCT02454972|468353334|FG008|Overall Study|Patient moves to compassionate use|0|||
130106957|NCT02454972|468353326|FG000|Overall Study|Withdrawal by Subject|0|||
130106958|NCT02454972|468353327|FG001|Overall Study|Withdrawal by Subject|1|||
130106959|NCT02454972|468353328|FG002|Overall Study|Withdrawal by Subject|5|||
130106960|NCT02454972|468353329|FG003|Overall Study|Withdrawal by Subject|2|||
130106961|NCT02454972|468353330|FG004|Overall Study|Withdrawal by Subject|3|||
130106962|NCT02454972|468353331|FG005|Overall Study|Withdrawal by Subject|2|||
130295376|NCT02771626|469045291|FG003|Overall Study|Other, Not Specified|0|||
130295377|NCT02771626|469045292|FG004|Overall Study|Other, Not Specified|0|||
130295378|NCT02771626|469045293|FG005|Overall Study|Other, Not Specified|1|||
130295379|NCT02648217|469045294|FG000|Overall Study|Adverse Event|0|||
130106963|NCT02454972|468353332|FG006|Overall Study|Withdrawal by Subject|0|||
130106964|NCT02454972|468353333|FG007|Overall Study|Withdrawal by Subject|1|||
130106965|NCT02454972|468353334|FG008|Overall Study|Withdrawal by Subject|2|||
130106966|NCT02454972|468353326|FG000|Overall Study|Multiple delay/holds on treatment|0|||
130106967|NCT02454972|468353327|FG001|Overall Study|Multiple delay/holds on treatment|0|||
130106968|NCT02454972|468353328|FG002|Overall Study|Multiple delay/holds on treatment|0|||
130295380|NCT02648217|469045295|FG001|Overall Study|Adverse Event|1|||
130295381|NCT02648217|469045294|FG000|Overall Study|Lost to Follow-up|1|||
130295382|NCT02648217|469045295|FG001|Overall Study|Lost to Follow-up|1|||
130295383|NCT02648217|469045294|FG000|Overall Study|Withdrawal by Subject|4|||
130295384|NCT02648217|469045295|FG001|Overall Study|Withdrawal by Subject|3|||
130295385|NCT02648217|469045294|FG000|Overall Study|Unclassified|5|||
130295386|NCT02648217|469045295|FG001|Overall Study|Unclassified|0|||
130295387|NCT03316950|469045296|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
130295388|NCT03316950|469045297|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
130295389|NCT03316950|469045298|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
130295390|NCT03316950|469045299|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
130295391|NCT03316950|469045296|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
130295392|NCT03316950|469045297|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
130295393|NCT03316950|469045298|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
130295394|NCT03316950|469045299|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
130295395|NCT03316950|469045296|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
130295396|NCT03316950|469045297|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
129888789|NCT01676220|467550900|FG000|Overall Study|Randomized But Not Treated|4|||
129888790|NCT01676220|467550901|FG001|Overall Study|Randomized But Not Treated|1|||
129888791|NCT01676220|467550900|FG000|Overall Study|Adverse Event|10|||
130106969|NCT02454972|468353329|FG003|Overall Study|Multiple delay/holds on treatment|1|||
130106970|NCT02454972|468353330|FG004|Overall Study|Multiple delay/holds on treatment|0|||
130106971|NCT02454972|468353331|FG005|Overall Study|Multiple delay/holds on treatment|0|||
130106972|NCT02454972|468353332|FG006|Overall Study|Multiple delay/holds on treatment|0|||
130106973|NCT02454972|468353333|FG007|Overall Study|Multiple delay/holds on treatment|0|||
130106974|NCT02454972|468353334|FG008|Overall Study|Multiple delay/holds on treatment|0|||
130106975|NCT02454972|468353326|FG000|Overall Study|Never treated|0|||
130295397|NCT03316950|469045298|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
130295398|NCT03316950|469045299|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
130295399|NCT02335424|469045300|FG000|Overall Study|Withdrawal by Subject|19|||
129888792|NCT01676220|467550901|FG001|Overall Study|Adverse Event|8|||
129888793|NCT01676220|467550900|FG000|Overall Study|Lack of Efficacy|2|||
129888794|NCT01676220|467550901|FG001|Overall Study|Lack of Efficacy|5|||
129888795|NCT01676220|467550900|FG000|Overall Study|Protocol Violation|11|||
129888796|NCT01676220|467550901|FG001|Overall Study|Protocol Violation|12|||
129888797|NCT01676220|467550900|FG000|Overall Study|Received Rescue Therapy|14|||
129888798|NCT01676220|467550901|FG001|Overall Study|Received Rescue Therapy|22|||
129888799|NCT01676220|467550900|FG000|Overall Study|Personal Reason|34|||
129888800|NCT01676220|467550901|FG001|Overall Study|Personal Reason|45|||
129888801|NCT01676220|467550900|FG000|Overall Study|Lost to Follow-up|11|||
129888802|NCT01676220|467550901|FG001|Overall Study|Lost to Follow-up|18|||
129888803|NCT01676220|467550900|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
129888804|NCT01676220|467550901|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
129888805|NCT01676220|467550900|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
129888806|NCT01676220|467550901|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
129888807|NCT01676220|467550900|FG000|Overall Study|Perceived Lack of Efficacy|3|||
129888808|NCT01676220|467550901|FG001|Overall Study|Perceived Lack of Efficacy|1|||
129888809|NCT01676220|467550900|FG000|Overall Study|Non Serious Hypoglycemia|2|||
129888810|NCT01676220|467550901|FG001|Overall Study|Non Serious Hypoglycemia|0|||
129888811|NCT01676220|467550900|FG000|Overall Study|No More Need of Insulin|1|||
129888812|NCT01676220|467550901|FG001|Overall Study|No More Need of Insulin|0|||
129888813|NCT03875911|467550904|FG000|Overall Study|Lost to Follow-up|3|||
129888814|NCT03875911|467550905|FG001|Overall Study|Lost to Follow-up|6|||
129888815|NCT03875911|467550906|FG002|Overall Study|Lost to Follow-up|2|||
129888816|NCT03875911|467550904|FG000|Overall Study|Surgery cancelled|1|||
129888817|NCT03875911|467550905|FG001|Overall Study|Surgery cancelled|0|||
129888818|NCT03875911|467550906|FG002|Overall Study|Surgery cancelled|1|||
129888819|NCT03875911|467550904|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
129888820|NCT03875911|467550905|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
129888821|NCT03875911|467550906|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
129888822|NCT03824938|467550907|FG000|Overall Study|Withdrawal by Subject|2|||
129888823|NCT03824938|467550908|FG001|Overall Study|Withdrawal by Subject|1|||
129888824|NCT03824938|467550909|FG002|Overall Study|Withdrawal by Subject|0|||
129888825|NCT03824938|467550910|FG003|Overall Study|Withdrawal by Subject|2|||
129888826|NCT03824938|467550911|FG004|Overall Study|Withdrawal by Subject|0|||
129888827|NCT03824938|467550912|FG005|Overall Study|Withdrawal by Subject|1|||
129888828|NCT03824938|467550907|FG000|Overall Study|Lost to Follow-up|0|||
129888829|NCT03824938|467550908|FG001|Overall Study|Lost to Follow-up|1|||
129888830|NCT03824938|467550909|FG002|Overall Study|Lost to Follow-up|0|||
129888831|NCT03824938|467550910|FG003|Overall Study|Lost to Follow-up|0|||
129888832|NCT03824938|467550911|FG004|Overall Study|Lost to Follow-up|1|||
130046735|NCT03245814|468128531|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
130046736|NCT03245814|468128532|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
130046737|NCT02263365|468128536|FG000|Overall Study|Physician Decision|22|||
130046738|NCT02263365|468128537|FG001|Overall Study|Physician Decision|18|||
130046739|NCT00945191|468128538|FG000|Overall Study|Did not achieve a complete response|18|||
130046740|NCT00945191|468128538|FG000|Overall Study|Participant relocated to another state|1|||
130046741|NCT00945191|468128538|FG000|Overall Study|Disease progression|3|||
130046742|NCT00945191|468128538|FG000|Overall Study|Serious adverse event or adverse event|1|||
130046743|NCT00945191|468128538|FG000|Overall Study|Investigator's discretion|1|||
130046744|NCT00394914|468128541|FG000|Treatment Period|Adverse Event|0|||
130046745|NCT00394914|468128542|FG001|Treatment Period|Adverse Event|3|||
130046746|NCT00394914|468128543|FG002|Treatment Period|Adverse Event|1|||
130046747|NCT00394914|468128541|FG000|Treatment Period|Lost to Follow-up|0|||
130046748|NCT00394914|468128542|FG001|Treatment Period|Lost to Follow-up|1|||
130046749|NCT00394914|468128543|FG002|Treatment Period|Lost to Follow-up|0|||
130046750|NCT00394914|468128541|FG000|Treatment Period|Withdrawal by Subject|0|||
130046751|NCT00394914|468128542|FG001|Treatment Period|Withdrawal by Subject|2|||
130046752|NCT00394914|468128543|FG002|Treatment Period|Withdrawal by Subject|2|||
130046753|NCT00394914|468128541|FG000|Treatment Period|Noncompliance with protocol|0|||
130046754|NCT00394914|468128542|FG001|Treatment Period|Noncompliance with protocol|3|||
130046755|NCT00394914|468128543|FG002|Treatment Period|Noncompliance with protocol|2|||
130046756|NCT00394914|468128541|FG000|Treatment Period|Did not meet protocol eligibility|0|||
130046757|NCT00394914|468128542|FG001|Treatment Period|Did not meet protocol eligibility|1|||
130046758|NCT00394914|468128543|FG002|Treatment Period|Did not meet protocol eligibility|1|||
130046759|NCT00312377|468128548|FG000|Overall Study|Death|403|||
130046760|NCT00312377|468128549|FG001|Overall Study|Death|418|||
130046761|NCT00312377|468128548|FG000|Overall Study|Withdrawal by Subject|23|||
130046762|NCT00312377|468128549|FG001|Overall Study|Withdrawal by Subject|30|||
129888833|NCT03824938|467550912|FG005|Overall Study|Lost to Follow-up|0|||
129888834|NCT01990300|467550916|FG000|Overall Study|Case Report Forms Uncollected|89|||
129888835|NCT01990300|467550916|FG000|Overall Study|Protocol Deviation|53|||
129888836|NCT04496167|467550919|FG000|Overall Study|Adverse Event|6|||
129888837|NCT04496167|467550920|FG001|Overall Study|Adverse Event|2|||
129888838|NCT04496167|467550919|FG000|Overall Study|Withdrawal by Subject|7|||
129888839|NCT04496167|467550920|FG001|Overall Study|Withdrawal by Subject|6|||
130046763|NCT00312377|468128548|FG000|Overall Study|Lost to Follow-up|9|||
130106976|NCT02454972|468353327|FG001|Overall Study|Never treated|0|||
130106977|NCT02454972|468353328|FG002|Overall Study|Never treated|3|||
130106978|NCT02454972|468353329|FG003|Overall Study|Never treated|1|||
130106979|NCT02454972|468353330|FG004|Overall Study|Never treated|1|||
130106980|NCT02454972|468353331|FG005|Overall Study|Never treated|0|||
130106981|NCT02454972|468353332|FG006|Overall Study|Never treated|0|||
130106982|NCT02454972|468353333|FG007|Overall Study|Never treated|0|||
130106983|NCT02454972|468353334|FG008|Overall Study|Never treated|5|||
130106984|NCT02454972|468353326|FG000|Overall Study|Lost to Follow-up|0|||
130106985|NCT02454972|468353327|FG001|Overall Study|Lost to Follow-up|0|||
130106986|NCT02454972|468353328|FG002|Overall Study|Lost to Follow-up|0|||
130106987|NCT02454972|468353329|FG003|Overall Study|Lost to Follow-up|0|||
130106988|NCT02454972|468353330|FG004|Overall Study|Lost to Follow-up|0|||
130295400|NCT02335424|469045300|FG000|Overall Study|Adverse Event|25|||
130295401|NCT02335424|469045300|FG000|Overall Study|Death|273|||
130295402|NCT02335424|469045300|FG000|Overall Study|Lost to Follow-up|3|||
130295403|NCT02335424|469045300|FG000|Overall Study|Physician Decision|13|||
130295404|NCT02335424|469045300|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
130295405|NCT02335424|469045300|FG000|Overall Study|Protocol Violation|1|||
129888840|NCT04496167|467550919|FG000|Overall Study|Lost to Follow-up|3|||
130046764|NCT00312377|468128549|FG001|Overall Study|Lost to Follow-up|12|||
130046765|NCT00312377|468128548|FG000|Overall Study|Non-compliance|0|||
130046766|NCT00312377|468128549|FG001|Overall Study|Non-compliance|2|||
130046767|NCT00312377|468128548|FG000|Overall Study|Randomised but never received treatment|6|||
130046768|NCT00312377|468128549|FG001|Overall Study|Randomised but never received treatment|6|||
130046769|NCT00312377|468128548|FG000|Overall Study|Discontinue treatment survival follow up|202|||
130046770|NCT00312377|468128549|FG001|Overall Study|Discontinue treatment survival follow up|200|||
130046771|NCT00312377|468128548|FG000|Overall Study|Site ended participation in study|1|||
130046772|NCT00312377|468128549|FG001|Overall Study|Site ended participation in study|0|||
130046773|NCT00872898|468128550|FG000|Part Two - Double Blind|Adverse Event|4|||
130046774|NCT00872898|468128551|FG001|Part Two - Double Blind|Adverse Event|3|||
130046775|NCT00872898|468128550|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
130046776|NCT00872898|468128551|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
130046777|NCT00872898|468128550|FG000|Part Two - Double Blind|Protocol Violation|1|||
130046778|NCT00872898|468128551|FG001|Part Two - Double Blind|Protocol Violation|0|||
130046779|NCT00872898|468128550|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
130046780|NCT00872898|468128551|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
130046781|NCT00872898|468128550|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
130046782|NCT00872898|468128551|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
130046783|NCT00872898|468128550|FG000|Part Two - Double Blind|Other reasons|2|||
130046784|NCT00872898|468128551|FG001|Part Two - Double Blind|Other reasons|0|||
130046785|NCT01004146|468128557|FG000|Overall Study|Withdrawal by Subject|4|||
130046786|NCT01004146|468128558|FG001|Overall Study|Withdrawal by Subject|5|||
130046787|NCT01001494|468128565|FG000|Overall Study|Adverse Event|8|||
130046788|NCT01001494|468128566|FG001|Overall Study|Adverse Event|4|||
130046789|NCT01001494|468128567|FG002|Overall Study|Adverse Event|6|||
130046790|NCT01001494|468128565|FG000|Overall Study|Protocol Violation|0|||
130046791|NCT01001494|468128566|FG001|Overall Study|Protocol Violation|1|||
130046792|NCT01001494|468128567|FG002|Overall Study|Protocol Violation|1|||
130046793|NCT01001494|468128565|FG000|Overall Study|Lost to Follow-up|2|||
130046794|NCT01001494|468128566|FG001|Overall Study|Lost to Follow-up|0|||
130046795|NCT01001494|468128567|FG002|Overall Study|Lost to Follow-up|1|||
130046796|NCT01001494|468128565|FG000|Overall Study|Withdrawal by Subject|9|||
130046797|NCT01001494|468128566|FG001|Overall Study|Withdrawal by Subject|7|||
130046798|NCT01001494|468128567|FG002|Overall Study|Withdrawal by Subject|17|||
130046799|NCT01001494|468128565|FG000|Overall Study|COPD exacerbation|3|||
130046800|NCT01001494|468128566|FG001|Overall Study|COPD exacerbation|4|||
130046801|NCT01001494|468128567|FG002|Overall Study|COPD exacerbation|5|||
130046802|NCT01001494|468128565|FG000|Overall Study|Lack of Efficacy|2|||
130046803|NCT01001494|468128566|FG001|Overall Study|Lack of Efficacy|0|||
130046804|NCT01001494|468128567|FG002|Overall Study|Lack of Efficacy|8|||
130046805|NCT01001494|468128565|FG000|Overall Study|Other|0|||
130046806|NCT01001494|468128566|FG001|Overall Study|Other|1|||
130046807|NCT01001494|468128567|FG002|Overall Study|Other|3|||
130106989|NCT02454972|468353331|FG005|Overall Study|Lost to Follow-up|0|||
129888841|NCT04496167|467550920|FG001|Overall Study|Lost to Follow-up|5|||
130046808|NCT02179398|468128568|FG000|Overall Study|Lack of obligatory data|3|||
130046809|NCT02179398|468128569|FG001|Overall Study|Lack of obligatory data|3|||
130046810|NCT02179398|468128568|FG000|Overall Study|Lost to Follow-up|0|||
130046811|NCT02179398|468128569|FG001|Overall Study|Lost to Follow-up|1|||
130046812|NCT00408681|468128576|FG000|Overall Study|Lack of Efficacy|2|||
130046813|NCT00408681|468128576|FG000|Overall Study|Adverse Event|7|||
130046814|NCT02519231|468128579|FG000|Overall Study|Lost to Follow-up|2|||
130295406|NCT02335424|469045300|FG000|Overall Study|Screen failure|1|||
130106990|NCT02454972|468353332|FG006|Overall Study|Lost to Follow-up|0|||
130106991|NCT02454972|468353333|FG007|Overall Study|Lost to Follow-up|0|||
130295407|NCT02776033|469045303|FG000|Overall Study|Withdrawal by Subject|0|||
130106992|NCT02454972|468353334|FG008|Overall Study|Lost to Follow-up|2|||
130106993|NCT02454972|468353326|FG000|Overall Study|Study termination|0|||
130106994|NCT02454972|468353327|FG001|Overall Study|Study termination|0|||
130295408|NCT02776033|469045304|FG001|Overall Study|Withdrawal by Subject|0|||
130295409|NCT02776033|469045305|FG002|Overall Study|Withdrawal by Subject|2|||
130106995|NCT02454972|468353328|FG002|Overall Study|Study termination|0|||
130106996|NCT02454972|468353329|FG003|Overall Study|Study termination|0|||
130295410|NCT02776033|469045303|FG000|Overall Study|Physician Decision|2|||
130295411|NCT02776033|469045304|FG001|Overall Study|Physician Decision|0|||
130295412|NCT02776033|469045305|FG002|Overall Study|Physician Decision|0|||
130295413|NCT02776033|469045303|FG000|Overall Study|Lost to Follow-up|1|||
130295414|NCT02776033|469045304|FG001|Overall Study|Lost to Follow-up|0|||
130295415|NCT02776033|469045305|FG002|Overall Study|Lost to Follow-up|0|||
130106997|NCT02454972|468353330|FG004|Overall Study|Study termination|0|||
130106998|NCT02454972|468353331|FG005|Overall Study|Study termination|0|||
130106999|NCT02454972|468353332|FG006|Overall Study|Study termination|0|||
130107000|NCT02454972|468353333|FG007|Overall Study|Study termination|0|||
130107001|NCT02454972|468353334|FG008|Overall Study|Study termination|6|||
130107002|NCT01377233|468353337|FG000|Open-label|Adverse Event|1|||
130107003|NCT01377233|468353338|FG001|Open-label|Adverse Event|0|||
130107004|NCT01377233|468353339|FG002|Open-label|Adverse Event|0|||
130107005|NCT01377233|468353340|FG003|Open-label|Adverse Event|0|||
130107006|NCT01377233|468353341|FG004|Open-label|Adverse Event|0|||
130107007|NCT01377233|468353337|FG000|Open-label|Withdrawal by Subject|3|||
130295416|NCT02776033|469045303|FG000|Overall Study|Adverse Event|1|||
130295417|NCT02776033|469045304|FG001|Overall Study|Adverse Event|2|||
130107008|NCT01377233|468353338|FG001|Open-label|Withdrawal by Subject|0|||
130107009|NCT01377233|468353339|FG002|Open-label|Withdrawal by Subject|0|||
130107010|NCT01377233|468353340|FG003|Open-label|Withdrawal by Subject|0|||
130107011|NCT01377233|468353341|FG004|Open-label|Withdrawal by Subject|0|||
130107012|NCT01377233|468353337|FG000|Double-blind|Adverse Event|0|||
130107013|NCT01377233|468353338|FG001|Double-blind|Adverse Event|1|||
130107014|NCT01377233|468353339|FG002|Double-blind|Adverse Event|2|||
130107015|NCT01377233|468353340|FG003|Double-blind|Adverse Event|2|||
130107016|NCT01377233|468353341|FG004|Double-blind|Adverse Event|0|||
130107017|NCT01377233|468353337|FG000|Double-blind|Protocol Violation|0|||
130107018|NCT01377233|468353338|FG001|Double-blind|Protocol Violation|0|||
130107019|NCT01377233|468353339|FG002|Double-blind|Protocol Violation|0|||
130107020|NCT01377233|468353340|FG003|Double-blind|Protocol Violation|0|||
130107021|NCT01377233|468353341|FG004|Double-blind|Protocol Violation|1|||
130295418|NCT02776033|469045305|FG002|Overall Study|Adverse Event|0|||
130295419|NCT02712424|469045306|FG000|Overall Study|Lost to Follow-up|34|||
130295420|NCT02712424|469045307|FG001|Overall Study|Lost to Follow-up|32|||
130295421|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
130295422|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
130295423|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
130295424|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
130295425|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
130295426|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
130295427|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
130295428|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
130295429|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
130295430|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
130295431|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
130295432|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
130295433|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
130295434|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
130295435|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
130295436|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
129888842|NCT04496167|467550919|FG000|Overall Study|Not Treated|1|||
130107022|NCT01377233|468353337|FG000|Double-blind|Withdrawal by Subject|0|||
130295437|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
130295438|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
130295439|NCT01302054|469045313|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
130295440|NCT01302054|469045314|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
130295441|NCT01302054|469045315|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
130295442|NCT01302054|469045313|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
130295443|NCT01302054|469045314|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
130295444|NCT01302054|469045315|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
130295445|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130295446|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
130107023|NCT01377233|468353338|FG001|Double-blind|Withdrawal by Subject|0|||
130107024|NCT01377233|468353339|FG002|Double-blind|Withdrawal by Subject|0|||
130107025|NCT01377233|468353340|FG003|Double-blind|Withdrawal by Subject|1|||
130046815|NCT02519231|468128580|FG001|Overall Study|Lost to Follow-up|5|||
130046816|NCT02519231|468128579|FG000|Overall Study|Withdrawal by Subject|0|||
130046817|NCT02519231|468128580|FG001|Overall Study|Withdrawal by Subject|1|||
130295447|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
130295448|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130295449|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130295450|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130295451|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130295452|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
130295453|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
130295454|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130295455|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
130295456|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
130295457|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130295458|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
130295459|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
130295460|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
130295461|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
130295462|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
130295463|NCT01302054|469045313|FG000|Double-Blind Treatment Phase|Other|0|||
130295464|NCT01302054|469045314|FG001|Double-Blind Treatment Phase|Other|4|||
130295465|NCT01302054|469045315|FG002|Double-Blind Treatment Phase|Other|9|||
130295466|NCT02713867|469045316|FG000|Randomization|Other Reason|2|||
130295467|NCT02713867|469045317|FG001|Randomization|Other Reason|1|||
130295468|NCT02713867|469045316|FG000|Randomization|Participant Withdrew consent|0|||
130295469|NCT02713867|469045317|FG001|Randomization|Participant Withdrew consent|2|||
130295470|NCT02713867|469045316|FG000|Treatment Period|Other Reasons|22|||
130295471|NCT02713867|469045317|FG001|Treatment Period|Other Reasons|28|||
130295472|NCT02713867|469045316|FG000|Treatment Period|Administrative reason by sponsor|21|||
130295473|NCT02713867|469045317|FG001|Treatment Period|Administrative reason by sponsor|16|||
130295474|NCT02713867|469045316|FG000|Treatment Period|No longer meets study criteria|2|||
130295475|NCT02713867|469045317|FG001|Treatment Period|No longer meets study criteria|1|||
130295476|NCT02713867|469045316|FG000|Treatment Period|Poor/Non Compliance|1|||
130295477|NCT02713867|469045317|FG001|Treatment Period|Poor/Non Compliance|0|||
130295478|NCT02713867|469045316|FG000|Treatment Period|Maximum Clinical Benefit|5|||
130295479|NCT02713867|469045317|FG001|Treatment Period|Maximum Clinical Benefit|6|||
130295480|NCT02713867|469045316|FG000|Treatment Period|Withdrew consent|3|||
129794087|NCT01986933|467212821|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
129794088|NCT01986933|467212817|FG000|Active-to-active (Part B)|Pregnancy|0|||
129794089|NCT01986933|467212818|FG001|Active-to-active (Part B)|Pregnancy|0|||
129794090|NCT01986933|467212819|FG002|Active-to-active (Part B)|Pregnancy|0|||
129794091|NCT01986933|467212820|FG003|Active-to-active (Part B)|Pregnancy|0|||
129794092|NCT01986933|467212821|FG004|Active-to-active (Part B)|Pregnancy|1|||
129794093|NCT01986933|467212817|FG000|Active-to-active (Part B)|Physician Decision|0|||
129794094|NCT01986933|467212818|FG001|Active-to-active (Part B)|Physician Decision|0|||
129794095|NCT01986933|467212819|FG002|Active-to-active (Part B)|Physician Decision|1|||
129794096|NCT01986933|467212820|FG003|Active-to-active (Part B)|Physician Decision|1|||
129794097|NCT01986933|467212821|FG004|Active-to-active (Part B)|Physician Decision|0|||
129794098|NCT01986933|467212817|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
129794099|NCT01986933|467212818|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
129794100|NCT01986933|467212819|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
129794101|NCT01986933|467212820|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
129794102|NCT01986933|467212821|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
129794103|NCT01986933|467212817|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
129794104|NCT01986933|467212818|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
129794105|NCT01986933|467212819|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
129794106|NCT01986933|467212820|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
129794107|NCT01986933|467212821|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
129888843|NCT04496167|467550920|FG001|Overall Study|Not Treated|2|||
130046818|NCT00447421|468128581|FG000|Overall Study|Lack of Efficacy|1|||
130046819|NCT00447421|468128581|FG000|Overall Study|Adverse Event|3|||
130046820|NCT00447421|468128581|FG000|Overall Study|Sponsor Decision|2|||
130295481|NCT02713867|469045317|FG001|Treatment Period|Withdrew consent|6|||
130295482|NCT02713867|469045316|FG000|Treatment Period|Requested to Discontinue|8|||
130295483|NCT02713867|469045317|FG001|Treatment Period|Requested to Discontinue|8|||
130295484|NCT02713867|469045316|FG000|Treatment Period|AE unrelated to Study Drug|11|||
130295485|NCT02713867|469045317|FG001|Treatment Period|AE unrelated to Study Drug|10|||
130295486|NCT02713867|469045316|FG000|Treatment Period|Death|7|||
130295487|NCT02713867|469045317|FG001|Treatment Period|Death|3|||
130295488|NCT02713867|469045316|FG000|Treatment Period|Study Drug Toxicity|16|||
130295489|NCT02713867|469045317|FG001|Treatment Period|Study Drug Toxicity|19|||
130295490|NCT02713867|469045316|FG000|Treatment Period|Disease Progression|82|||
130295491|NCT02713867|469045317|FG001|Treatment Period|Disease Progression|83|||
130295492|NCT02715726|469045321|FG000|Overall Study|Adverse Event|2|||
130295493|NCT02715726|469045322|FG001|Overall Study|Adverse Event|6|||
130295494|NCT02715726|469045321|FG000|Overall Study|Protocol Violation|1|||
130295495|NCT02715726|469045322|FG001|Overall Study|Protocol Violation|0|||
130295496|NCT02715726|469045321|FG000|Overall Study|Death|2|||
130295497|NCT02715726|469045322|FG001|Overall Study|Death|1|||
130295498|NCT02715726|469045321|FG000|Overall Study|Participant moved|1|||
130295499|NCT02715726|469045322|FG001|Overall Study|Participant moved|3|||
130295500|NCT02715726|469045321|FG000|Overall Study|Other than specified above|11|||
130295501|NCT02715726|469045322|FG001|Overall Study|Other than specified above|15|||
130295502|NCT02715726|469045321|FG000|Overall Study|Randomized but not treated|1|||
130295503|NCT02715726|469045322|FG001|Overall Study|Randomized but not treated|2|||
130295504|NCT01177969|469045323|FG000|Overall Study|Protocol Violation|2|||
130295505|NCT01177969|469045324|FG001|Overall Study|Protocol Violation|1|||
130295506|NCT01177969|469045323|FG000|Overall Study|Withdrawal by Subject|1|||
130295507|NCT01177969|469045324|FG001|Overall Study|Withdrawal by Subject|2|||
130295508|NCT03230292|469045325|FG000|Overall Study|Adverse Event|1|||
130295509|NCT03230292|469045325|FG000|Overall Study|Protocol Violation|1|||
130295510|NCT03230292|469045325|FG000|Overall Study|Lost to Follow-up|1|||
130295511|NCT03230292|469045325|FG000|Overall Study|Withdrawal by Subject|3|||
130295512|NCT00635089|469045327|FG000|Overall Study|Adverse Event|7|||
130295513|NCT00635089|469045327|FG000|Overall Study|Lack of Efficacy|28|||
130295514|NCT00635089|469045327|FG000|Overall Study|Protocol Deviation|4|||
130295515|NCT00635089|469045327|FG000|Overall Study|Lost to Follow-up|8|||
130295516|NCT00635089|469045327|FG000|Overall Study|Other|31|||
130295517|NCT02565810|469045328|FG000|Overall Study|Withdrawal by Subject|1|||
130295518|NCT00491608|469045331|FG000|Overall Study|Death|2|||
130295519|NCT00491608|469045331|FG000|Overall Study|Withdrawal by Subject|1|||
130295520|NCT04109976|469045332|FG000|Overall Study|Withdrawal by Subject|1|||
130295521|NCT04109976|469045333|FG001|Overall Study|Withdrawal by Subject|0|||
130295522|NCT00413374|469045334|FG000|Overall Study|Ineligible due to screening criteria.|3|||
130295523|NCT00413374|469045335|FG001|Overall Study|Ineligible due to screening criteria.|0|||
130295524|NCT00413374|469045334|FG000|Overall Study|Adverse Event|1|||
130295525|NCT00413374|469045335|FG001|Overall Study|Adverse Event|0|||
130295526|NCT00413374|469045334|FG000|Overall Study|Lost to Follow-up|1|||
130295527|NCT00413374|469045335|FG001|Overall Study|Lost to Follow-up|0|||
130295528|NCT00413374|469045334|FG000|Overall Study|Surgery|1|||
130295529|NCT00413374|469045335|FG001|Overall Study|Surgery|0|||
130295530|NCT02613169|469045337|FG000|Overall Study|Withdrawal by Subject|4|||
130295531|NCT02613169|469045338|FG001|Overall Study|Withdrawal by Subject|1|||
130295532|NCT02613169|469045337|FG000|Overall Study|Lost to Follow-up|0|||
130295533|NCT02613169|469045338|FG001|Overall Study|Lost to Follow-up|5|||
130295534|NCT02613169|469045337|FG000|Overall Study|HIV|0|||
130295535|NCT02613169|469045338|FG001|Overall Study|HIV|2|||
130295536|NCT02613169|469045337|FG000|Overall Study|No TB infection endpoint|14|||
130295537|NCT02613169|469045338|FG001|Overall Study|No TB infection endpoint|9|||
130295538|NCT00343382|469045339|FG000|Overall Study|Adverse Event|2|||
130295539|NCT00343382|469045340|FG001|Overall Study|Adverse Event|10|||
130295540|NCT00343382|469045341|FG002|Overall Study|Adverse Event|7|||
130295541|NCT00343382|469045339|FG000|Overall Study|Withdrawal by Subject|1|||
130295542|NCT00343382|469045340|FG001|Overall Study|Withdrawal by Subject|2|||
130295543|NCT00343382|469045341|FG002|Overall Study|Withdrawal by Subject|6|||
130295544|NCT00343382|469045339|FG000|Overall Study|Other Reason Not Specified|1|||
130295545|NCT00343382|469045340|FG001|Overall Study|Other Reason Not Specified|2|||
130295546|NCT00343382|469045341|FG002|Overall Study|Other Reason Not Specified|4|||
130295547|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
130295548|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
130295549|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
130295550|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
130295551|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
130295552|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
130295553|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295554|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295555|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295556|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295557|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
130295558|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
130295559|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
130295560|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
130107026|NCT01377233|468353341|FG004|Double-blind|Withdrawal by Subject|0|||
130107027|NCT01377233|468353337|FG000|Double-blind|Administrative or other|0|||
130107028|NCT01377233|468353338|FG001|Double-blind|Administrative or other|0|||
130107029|NCT01377233|468353339|FG002|Double-blind|Administrative or other|0|||
130107030|NCT01377233|468353340|FG003|Double-blind|Administrative or other|1|||
130107031|NCT01377233|468353341|FG004|Double-blind|Administrative or other|1|||
130107032|NCT01785875|468353342|FG000|Overall Study|Withdrawal by Subject|41|||
130107033|NCT01785875|468353343|FG001|Overall Study|Withdrawal by Subject|34|||
130107034|NCT01785875|468353344|FG002|Overall Study|Withdrawal by Subject|36|||
130107035|NCT01785875|468353342|FG000|Overall Study|Lost to Follow-up|19|||
130107036|NCT01785875|468353343|FG001|Overall Study|Lost to Follow-up|22|||
130107037|NCT01785875|468353344|FG002|Overall Study|Lost to Follow-up|6|||
130107038|NCT01785875|468353342|FG000|Overall Study|Death|27|||
130107039|NCT01785875|468353343|FG001|Overall Study|Death|16|||
130107040|NCT01785875|468353344|FG002|Overall Study|Death|7|||
130107041|NCT01785875|468353342|FG000|Overall Study|Sponsor Decision|0|||
130107042|NCT01785875|468353343|FG001|Overall Study|Sponsor Decision|2|||
130107043|NCT01785875|468353344|FG002|Overall Study|Sponsor Decision|0|||
130107044|NCT01785875|468353342|FG000|Overall Study|Protocol Specified Criteria|207|||
130107045|NCT01785875|468353343|FG001|Overall Study|Protocol Specified Criteria|214|||
130107046|NCT01785875|468353344|FG002|Overall Study|Protocol Specified Criteria|55|||
130107047|NCT01785875|468353342|FG000|Overall Study|Missing|0|||
130107048|NCT01785875|468353343|FG001|Overall Study|Missing|1|||
130107049|NCT01785875|468353344|FG002|Overall Study|Missing|3|||
130107050|NCT00417027|468353345|FG000|Overall Study|Protocol Violation|0|||
130107051|NCT00417027|468353346|FG001|Overall Study|Protocol Violation|5|||
130107052|NCT00417027|468353347|FG002|Overall Study|Protocol Violation|5|||
130107053|NCT00707174|468353348|FG000|Overall Study|Adverse Event|1|||
130107054|NCT00707174|468353349|FG001|Overall Study|Adverse Event|6|||
130107055|NCT00707174|468353348|FG000|Overall Study|Withdrawal by Subject|4|||
130107056|NCT00707174|468353349|FG001|Overall Study|Withdrawal by Subject|1|||
130107057|NCT04991311|468353350|FG000|Overall Study|Adverse Event|1|||
130107058|NCT00755937|468353351|FG000|Recruitment|Unknown if infliximab received|164|||
130107059|NCT00755937|468353351|FG000|Observational Follow-up|Lost to Follow-up|148|||
130107060|NCT00572156|468353354|FG000|Overall Study|Adverse Event|3|||
130107061|NCT00572156|468353355|FG001|Overall Study|Adverse Event|1|||
130107062|NCT00572156|468353356|FG002|Overall Study|Adverse Event|5|||
130107063|NCT00572156|468353357|FG003|Overall Study|Adverse Event|1|||
130107064|NCT00572156|468353354|FG000|Overall Study|Lost to Follow-up|1|||
130107065|NCT00572156|468353355|FG001|Overall Study|Lost to Follow-up|1|||
130107066|NCT00572156|468353356|FG002|Overall Study|Lost to Follow-up|1|||
130107067|NCT00572156|468353357|FG003|Overall Study|Lost to Follow-up|0|||
130107068|NCT00572156|468353354|FG000|Overall Study|Protocol Violation|1|||
130107069|NCT00572156|468353355|FG001|Overall Study|Protocol Violation|2|||
130107070|NCT00572156|468353356|FG002|Overall Study|Protocol Violation|0|||
130107071|NCT00572156|468353357|FG003|Overall Study|Protocol Violation|2|||
129888844|NCT04496167|467550919|FG000|Overall Study|Other Than Specified|1|||
130107072|NCT00572156|468353354|FG000|Overall Study|Patient/Parent Decision|1|||
130107073|NCT00572156|468353355|FG001|Overall Study|Patient/Parent Decision|6|||
130107074|NCT00572156|468353356|FG002|Overall Study|Patient/Parent Decision|4|||
130107075|NCT00572156|468353357|FG003|Overall Study|Patient/Parent Decision|3|||
130295561|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295562|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
130295563|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
130295564|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295565|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295566|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295567|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295568|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
130295569|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295570|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
130295571|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130295572|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130295573|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
130295574|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
130295575|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130107076|NCT00572156|468353354|FG000|Overall Study|Sponsor Decision|20|||
130107077|NCT00572156|468353355|FG001|Overall Study|Sponsor Decision|16|||
130107078|NCT00572156|468353356|FG002|Overall Study|Sponsor Decision|17|||
130107079|NCT00572156|468353357|FG003|Overall Study|Sponsor Decision|19|||
130107080|NCT01440595|468353358|FG000|Overall Study|Lost to Follow-up|0|||
130107081|NCT01440595|468353359|FG001|Overall Study|Lost to Follow-up|1|||
130107082|NCT01440595|468353360|FG002|Overall Study|Lost to Follow-up|0|||
130107083|NCT01440595|468353358|FG000|Overall Study|Study terminated by sponsor.|1|||
130107084|NCT01440595|468353359|FG001|Overall Study|Study terminated by sponsor.|2|||
130107085|NCT01440595|468353360|FG002|Overall Study|Study terminated by sponsor.|1|||
130107086|NCT01347879|468353361|FG000|Overall Study|Adverse Event|0|||
130107087|NCT01347879|468353362|FG001|Overall Study|Adverse Event|12|||
130107088|NCT01347879|468353361|FG000|Overall Study|Lost to Follow-up|2|||
130107089|NCT01347879|468353362|FG001|Overall Study|Lost to Follow-up|0|||
130107090|NCT01347879|468353361|FG000|Overall Study|Withdrawal by Subject|3|||
130107091|NCT01347879|468353362|FG001|Overall Study|Withdrawal by Subject|2|||
130107092|NCT01347879|468353361|FG000|Overall Study|Other|2|||
130107093|NCT01347879|468353362|FG001|Overall Study|Other|3|||
130107094|NCT01223196|468353363|FG000|Overall Study|Lost to Follow-up|2|||
130107095|NCT01223196|468353364|FG001|Overall Study|Lost to Follow-up|0|||
130107096|NCT01223196|468353363|FG000|Overall Study|Physician Decision|1|||
130107097|NCT01223196|468353364|FG001|Overall Study|Physician Decision|0|||
130107098|NCT01223196|468353363|FG000|Overall Study|Withdrawal by Subject|1|||
130107099|NCT01223196|468353364|FG001|Overall Study|Withdrawal by Subject|0|||
130107100|NCT01238822|468353369|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
130107101|NCT02725671|468353383|FG000|Overall Study|Lost to Follow-up|1|||
130107102|NCT00965263|468353384|FG000|Overall Study|Physician Decision|2|||
130107103|NCT00965263|468353385|FG001|Overall Study|Physician Decision|0|||
130107104|NCT00965263|468353384|FG000|Overall Study|Family emergency|0|||
130107105|NCT00965263|468353385|FG001|Overall Study|Family emergency|1|||
130107106|NCT00965263|468353384|FG000|Overall Study|Protocol Violation|0|||
130107107|NCT00965263|468353385|FG001|Overall Study|Protocol Violation|2|||
130107108|NCT03496207|468353386|FG000|Base Study|Adverse Event|0|||
130107109|NCT03496207|468353387|FG001|Base Study|Adverse Event|0|||
130107110|NCT03496207|468353388|FG002|Base Study|Adverse Event|1|||
130107111|NCT03496207|468353389|FG003|Base Study|Adverse Event|1|||
130107112|NCT03496207|468353390|FG004|Base Study|Adverse Event|4|||
130107113|NCT03496207|468353386|FG000|Base Study|Death|0|||
130107114|NCT03496207|468353387|FG001|Base Study|Death|0|||
130107115|NCT03496207|468353388|FG002|Base Study|Death|0|||
130107116|NCT03496207|468353389|FG003|Base Study|Death|0|||
130107117|NCT03496207|468353390|FG004|Base Study|Death|1|||
130107118|NCT03496207|468353386|FG000|Base Study|Withdrawal by Subject|0|||
129794108|NCT01986933|467212817|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
129794109|NCT01986933|467212818|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129794110|NCT01986933|467212819|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
129794111|NCT01986933|467212820|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129794112|NCT01986933|467212821|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129794113|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
129794114|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
129794115|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
129794116|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
129794117|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
129794118|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794119|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794120|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794121|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
129794122|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794123|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
129794124|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
129794125|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
129794126|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
129794127|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
129794128|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
129794129|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
129794130|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
129794131|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
129794132|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
129794133|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794134|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
130107119|NCT03496207|468353387|FG001|Base Study|Withdrawal by Subject|0|||
130107120|NCT03496207|468353388|FG002|Base Study|Withdrawal by Subject|1|||
130107121|NCT03496207|468353389|FG003|Base Study|Withdrawal by Subject|0|||
130107122|NCT03496207|468353390|FG004|Base Study|Withdrawal by Subject|1|||
130107123|NCT03496207|468353386|FG000|Extension Period|Adverse Event|0|||
130107124|NCT03496207|468353387|FG001|Extension Period|Adverse Event|0|||
130107125|NCT03496207|468353388|FG002|Extension Period|Adverse Event|0|||
130107126|NCT03496207|468353389|FG003|Extension Period|Adverse Event|1|||
130107127|NCT03496207|468353390|FG004|Extension Period|Adverse Event|1|||
130107128|NCT03496207|468353386|FG000|Extension Period|Death|1|||
130107129|NCT03496207|468353387|FG001|Extension Period|Death|0|||
130107130|NCT03496207|468353388|FG002|Extension Period|Death|0|||
130046821|NCT02124798|468128583|FG000|Overall Study|Adverse Event|3|||
130046822|NCT02124798|468128583|FG000|Overall Study|Lost to Follow-up|1|||
130046823|NCT01707147|468128586|FG000|Overall Study|Administered Trajenta prior to contract|5|||
130046824|NCT01707147|468128586|FG000|Overall Study|Patients who have not taken Trajenta|1|||
130046825|NCT01707147|468128586|FG000|Overall Study|Follow-up failure|17|||
130046826|NCT01707147|468128586|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
130046827|NCT02053246|468128587|FG000|Overall Study|Withdrawal by Subject|3|||
130046828|NCT02053246|468128587|FG000|Overall Study|Physician Decision|1|||
130107131|NCT03496207|468353389|FG003|Extension Period|Death|1|||
130107132|NCT03496207|468353390|FG004|Extension Period|Death|2|||
130107133|NCT03496207|468353386|FG000|Extension Period|Withdrawal by Subject|1|||
130107134|NCT03496207|468353387|FG001|Extension Period|Withdrawal by Subject|0|||
130107135|NCT03496207|468353388|FG002|Extension Period|Withdrawal by Subject|0|||
130107136|NCT03496207|468353389|FG003|Extension Period|Withdrawal by Subject|1|||
130107137|NCT03496207|468353390|FG004|Extension Period|Withdrawal by Subject|1|||
130107138|NCT03496207|468353386|FG000|Extension Period|Elevated hemoglobin levels|0|||
130107139|NCT03496207|468353387|FG001|Extension Period|Elevated hemoglobin levels|0|||
130107140|NCT03496207|468353388|FG002|Extension Period|Elevated hemoglobin levels|0|||
130107141|NCT03496207|468353389|FG003|Extension Period|Elevated hemoglobin levels|0|||
130107142|NCT03496207|468353390|FG004|Extension Period|Elevated hemoglobin levels|1|||
130107143|NCT02567266|468353392|FG000|Overall Study|Withdrawal by Subject|10|||
130107144|NCT02567266|468353393|FG001|Overall Study|Withdrawal by Subject|7|||
130107145|NCT02567266|468353394|FG002|Overall Study|Withdrawal by Subject|6|||
130107146|NCT02567266|468353392|FG000|Overall Study|Lost to Follow-up|13|||
130107147|NCT02567266|468353393|FG001|Overall Study|Lost to Follow-up|8|||
130107148|NCT02567266|468353394|FG002|Overall Study|Lost to Follow-up|10|||
130107149|NCT00123487|468353395|FG000|Randomized|Death prior to starting treatment|0|||
130107150|NCT00123487|468353396|FG001|Randomized|Death prior to starting treatment|1|||
130107151|NCT00123487|468353395|FG000|Randomized|SAE prior to starting treatment|1|||
130107152|NCT00123487|468353396|FG001|Randomized|SAE prior to starting treatment|0|||
130107153|NCT00123487|468353395|FG000|Treated With Study Drug|Adverse Event|23|||
130107154|NCT00123487|468353396|FG001|Treated With Study Drug|Adverse Event|22|||
130107155|NCT00123487|468353395|FG000|Treated With Study Drug|Disease Progression|141|||
130107156|NCT00123487|468353396|FG001|Treated With Study Drug|Disease Progression|122|||
130107157|NCT00123487|468353395|FG000|Treated With Study Drug|Physician Decision|8|||
130107158|NCT00123487|468353396|FG001|Treated With Study Drug|Physician Decision|9|||
130107159|NCT00123487|468353395|FG000|Treated With Study Drug|Other|59|||
130107160|NCT00123487|468353396|FG001|Treated With Study Drug|Other|58|||
130107161|NCT00123487|468353395|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
130107162|NCT00123487|468353396|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
130107163|NCT00123487|468353395|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
130107164|NCT00123487|468353396|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
130107165|NCT00123487|468353395|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
130107166|NCT00123487|468353396|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
130107167|NCT02643966|468353397|FG000|First Screening Round|ineligible|1|||
130107168|NCT02643966|468353397|FG000|First Screening Round|excluded from analysis|2|||
130107169|NCT02643966|468353397|FG000|First Screening Round|Lost to Follow-up|56|||
130107170|NCT02643966|468353397|FG000|First Screening Round|Withdrawal by Subject|28|||
130107171|NCT02643966|468353397|FG000|First Screening Round|Death|1|||
130107172|NCT02643966|468353397|FG000|Between First and Second Screening|Lost to Follow-up|65|||
130107173|NCT02643966|468353397|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
130107174|NCT02643966|468353397|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
130107175|NCT02643966|468353397|FG000|Second Screening Round|Withdrawal by Subject|20|||
130295576|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295577|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295578|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295579|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
130295580|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
130295581|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
130295582|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
130295583|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130107176|NCT02643966|468353397|FG000|Second Screening Round|Lost to Follow-up|57|||
130107177|NCT02643966|468353397|FG000|Second Screening Round|Physician Decision|2|||
130107178|NCT02643966|468353397|FG000|Second Screening Round|Death|4|||
130107179|NCT02643966|468353397|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
130295584|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
130046829|NCT02795156|468128588|FG000|Overall Study|Progressive Disease|22|||
130107180|NCT02643966|468353397|FG000|Between Second and Third Screening|Death|1|||
130107181|NCT02643966|468353397|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
130107182|NCT02643966|468353397|FG000|Third Screening Round|PI excluded|2|||
130107183|NCT02643966|468353397|FG000|Third Screening Round|Lost to Follow-up|241|||
130107184|NCT03835975|468353398|FG000|Overall Study|Lost to Follow-up|1|||
130046830|NCT02795156|468128589|FG001|Overall Study|Progressive Disease|7|||
130295585|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
130295586|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295587|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295588|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295589|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295590|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
130295591|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295592|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295593|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
130295594|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295595|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295596|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
130295597|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295598|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295599|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295600|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295601|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
130295602|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
130295603|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295604|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295605|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295606|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295607|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130107185|NCT03835975|468353399|FG001|Overall Study|Lost to Follow-up|1|||
130295608|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295609|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295610|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295611|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295612|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
130295613|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295614|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295615|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
130295616|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130046831|NCT02795156|468128590|FG002|Overall Study|Progressive Disease|34|||
130046832|NCT02795156|468128591|FG003|Overall Study|Progressive Disease|7|||
130046833|NCT02795156|468128588|FG000|Overall Study|Adverse Event|13|||
130046834|NCT02795156|468128589|FG001|Overall Study|Adverse Event|2|||
130046835|NCT02795156|468128590|FG002|Overall Study|Adverse Event|3|||
130046836|NCT02795156|468128591|FG003|Overall Study|Adverse Event|2|||
130046837|NCT02795156|468128588|FG000|Overall Study|Death|1|||
130046838|NCT02795156|468128589|FG001|Overall Study|Death|1|||
130046839|NCT02795156|468128590|FG002|Overall Study|Death|1|||
130046840|NCT02795156|468128591|FG003|Overall Study|Death|0|||
130046841|NCT02795156|468128588|FG000|Overall Study|Physician Decision|1|||
130046842|NCT02795156|468128589|FG001|Overall Study|Physician Decision|0|||
130046843|NCT02795156|468128590|FG002|Overall Study|Physician Decision|1|||
130046844|NCT02795156|468128591|FG003|Overall Study|Physician Decision|0|||
130046845|NCT02795156|468128588|FG000|Overall Study|Withdrawal by Subject|2|||
130046846|NCT02795156|468128589|FG001|Overall Study|Withdrawal by Subject|0|||
130046847|NCT02795156|468128590|FG002|Overall Study|Withdrawal by Subject|3|||
130046848|NCT02795156|468128591|FG003|Overall Study|Withdrawal by Subject|0|||
130046849|NCT00815308|468128592|FG000|Overall Study|Adverse Event|4|||
130046850|NCT00815308|468128592|FG000|Overall Study|Withdrawal by Subject|0|||
130046851|NCT00815308|468128592|FG000|Overall Study|Protocol Violation|6|||
130046852|NCT00638846|468128596|FG000|Overall Study|Adverse Event|0|||
130046853|NCT00638846|468128597|FG001|Overall Study|Adverse Event|1|||
130046854|NCT00638846|468128596|FG000|Overall Study|Lost to Follow-up|3|||
130046855|NCT00638846|468128597|FG001|Overall Study|Lost to Follow-up|2|||
130046856|NCT00638846|468128596|FG000|Overall Study|lens issue|1|||
130046857|NCT00638846|468128597|FG001|Overall Study|lens issue|3|||
130046858|NCT01171521|468128600|FG000|Overall Study|Lost to Follow-up|5|||
130107186|NCT03835975|468353400|FG002|Overall Study|Lost to Follow-up|0|||
130295617|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295618|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295619|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295620|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295621|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295622|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130046859|NCT01171521|468128600|FG000|Overall Study|screen failure|1|||
130046860|NCT00652093|468128605|FG000|Overall Study|Withdrawal by Subject|0|||
130046861|NCT00652093|468128606|FG001|Overall Study|Withdrawal by Subject|0|||
130107187|NCT03835975|468353401|FG003|Overall Study|Lost to Follow-up|0|||
130107188|NCT03835975|468353402|FG004|Overall Study|Lost to Follow-up|0|||
130107189|NCT03835975|468353398|FG000|Overall Study|No longer met eligibility criteria|0|||
130107190|NCT03835975|468353399|FG001|Overall Study|No longer met eligibility criteria|1|||
130107191|NCT03835975|468353400|FG002|Overall Study|No longer met eligibility criteria|0|||
130107192|NCT03835975|468353401|FG003|Overall Study|No longer met eligibility criteria|0|||
130107193|NCT03835975|468353402|FG004|Overall Study|No longer met eligibility criteria|0|||
130107194|NCT03835975|468353398|FG000|Overall Study|Protocol Violation|1|||
130107195|NCT03835975|468353399|FG001|Overall Study|Protocol Violation|1|||
130107196|NCT03835975|468353400|FG002|Overall Study|Protocol Violation|2|||
130107197|NCT03835975|468353401|FG003|Overall Study|Protocol Violation|0|||
130107198|NCT03835975|468353402|FG004|Overall Study|Protocol Violation|0|||
130107199|NCT03835975|468353398|FG000|Overall Study|Withdrawal by Subject|1|||
130107200|NCT03835975|468353399|FG001|Overall Study|Withdrawal by Subject|0|||
130107201|NCT03835975|468353400|FG002|Overall Study|Withdrawal by Subject|1|||
130107202|NCT03835975|468353401|FG003|Overall Study|Withdrawal by Subject|1|||
130107203|NCT03835975|468353402|FG004|Overall Study|Withdrawal by Subject|0|||
130107204|NCT00061945|468353403|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
130107205|NCT00061945|468353404|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
130107206|NCT00061945|468353403|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
130107207|NCT00061945|468353404|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
130107208|NCT00061945|468353403|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
130107209|NCT00061945|468353404|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
130107210|NCT00061945|468353403|FG000|Course IV: Alemtuzumab|Early exits|6|||
130295623|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
130295624|NCT02914561|469045346|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
130295625|NCT02914561|469045347|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295626|NCT02914561|469045348|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295627|NCT02914561|469045349|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295628|NCT02914561|469045350|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295629|NCT02914561|469045351|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
130295630|NCT02914561|469045352|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295631|NCT02914561|469045353|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295632|NCT02914561|469045354|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295633|NCT02914561|469045355|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295634|NCT02914561|469045356|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
130295635|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295636|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130107211|NCT00061945|468353404|FG001|Course IV: Alemtuzumab|Early exits|15|||
130107212|NCT01039584|468353405|FG000|Overall Study|Withdrawal by Subject|4|||
130107213|NCT01039584|468353406|FG001|Overall Study|Withdrawal by Subject|2|||
130107214|NCT01039584|468353407|FG002|Overall Study|Withdrawal by Subject|1|||
130107215|NCT01039584|468353405|FG000|Overall Study|Protocol Violation|10|||
130107216|NCT01039584|468353406|FG001|Overall Study|Protocol Violation|4|||
130107217|NCT01039584|468353407|FG002|Overall Study|Protocol Violation|6|||
130107218|NCT01039584|468353405|FG000|Overall Study|Lost to Follow-up|5|||
130107219|NCT01039584|468353406|FG001|Overall Study|Lost to Follow-up|3|||
130107220|NCT01039584|468353407|FG002|Overall Study|Lost to Follow-up|4|||
130107221|NCT01039584|468353405|FG000|Overall Study|Negative Baseline culture for Candida|59|||
130107222|NCT01039584|468353406|FG001|Overall Study|Negative Baseline culture for Candida|59|||
130107223|NCT01039584|468353407|FG002|Overall Study|Negative Baseline culture for Candida|24|||
130107224|NCT01039584|468353405|FG000|Overall Study|Lack of Efficacy|7|||
130107225|NCT01039584|468353406|FG001|Overall Study|Lack of Efficacy|6|||
130107226|NCT01039584|468353407|FG002|Overall Study|Lack of Efficacy|10|||
130107227|NCT01039584|468353405|FG000|Overall Study|other|1|||
130107228|NCT01039584|468353406|FG001|Overall Study|other|3|||
130107229|NCT01039584|468353407|FG002|Overall Study|other|1|||
130295637|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295638|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295639|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295640|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
130295641|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
129794135|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794136|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794137|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794138|NCT03119701|467212822|FG000|6-day Dosing|Death|4|||
130107230|NCT01039584|468353405|FG000|Overall Study|Pap smear with significant pathology|10|||
130107231|NCT01039584|468353406|FG001|Overall Study|Pap smear with significant pathology|10|||
130107232|NCT01039584|468353407|FG002|Overall Study|Pap smear with significant pathology|3|||
129794139|NCT03119701|467212823|FG001|6-day Dosing|Death|1|||
130107233|NCT01039584|468353405|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
130107234|NCT01039584|468353406|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
130107235|NCT01039584|468353407|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
130107236|NCT03672396|468353410|FG000|Overall Study|Withdrawal by Subject|4|||
130107237|NCT03672396|468353410|FG000|Overall Study|Physician Decision|1|||
129794140|NCT03119701|467212822|FG000|6-day Dosing|Adverse Event|3|||
129794141|NCT03119701|467212823|FG001|6-day Dosing|Adverse Event|0|||
129794142|NCT03119701|467212822|FG000|6-day Dosing|Physician Decision|0|||
129794143|NCT03119701|467212823|FG001|6-day Dosing|Physician Decision|1|||
129794144|NCT03119701|467212822|FG000|6-day Dosing|Withdrawal by Subject|0|||
129794145|NCT03119701|467212823|FG001|6-day Dosing|Withdrawal by Subject|1|||
129794146|NCT03119701|467212822|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
129794147|NCT03119701|467212823|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
130107238|NCT03672396|468353410|FG000|Overall Study|Adverse Event|1|||
130107239|NCT02441179|468353412|FG000|Overall Study|Withdrawal by Subject|1|||
130107240|NCT02441179|468353413|FG001|Overall Study|Withdrawal by Subject|1|||
130107241|NCT00975884|468353414|FG000|Overall Study|Adverse Event|1|||
130107242|NCT00975884|468353415|FG001|Overall Study|Adverse Event|0|||
130107243|NCT00975884|468353414|FG000|Overall Study|Lost to Follow-up|5|||
130107244|NCT00975884|468353415|FG001|Overall Study|Lost to Follow-up|3|||
130107245|NCT00975884|468353414|FG000|Overall Study|Withdrawal by Subject|9|||
130107246|NCT00975884|468353415|FG001|Overall Study|Withdrawal by Subject|9|||
130107247|NCT00975884|468353414|FG000|Overall Study|Other|1|||
130107248|NCT00975884|468353415|FG001|Overall Study|Other|3|||
130107249|NCT01656967|468353416|FG000|Overall Study|faulty monitor|1|||
130107250|NCT01656967|468353417|FG001|Overall Study|faulty monitor|0|||
130046862|NCT00652093|468128607|FG002|Overall Study|Withdrawal by Subject|1|||
130046863|NCT00652093|468128608|FG003|Overall Study|Withdrawal by Subject|0|||
130046864|NCT00652093|468128609|FG004|Overall Study|Withdrawal by Subject|1|||
130046865|NCT00652093|468128610|FG005|Overall Study|Withdrawal by Subject|0|||
130046866|NCT00652093|468128605|FG000|Overall Study|Physician Decision|0|||
130046867|NCT00652093|468128606|FG001|Overall Study|Physician Decision|0|||
130046868|NCT00652093|468128607|FG002|Overall Study|Physician Decision|0|||
130046869|NCT00652093|468128608|FG003|Overall Study|Physician Decision|0|||
130046870|NCT00652093|468128609|FG004|Overall Study|Physician Decision|1|||
130046871|NCT00652093|468128610|FG005|Overall Study|Physician Decision|0|||
130107251|NCT01656967|468353416|FG000|Overall Study|unsuccessful ETT insertion|3|||
130107252|NCT01656967|468353417|FG001|Overall Study|unsuccessful ETT insertion|2|||
130107253|NCT00051636|468353418|FG000|Period 1 - Core|Adverse Event|2|||
130107254|NCT00051636|468353419|FG001|Period 1 - Core|Adverse Event|2|||
130107255|NCT00051636|468353418|FG000|Period 1 - Core|Protocol Violation|1|||
130107256|NCT00051636|468353419|FG001|Period 1 - Core|Protocol Violation|0|||
130107257|NCT00051636|468353418|FG000|Period 1 - Core|Withdrawal by Subject|1|||
130295642|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
130295643|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
130295644|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
130295645|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
130295646|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295647|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295648|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295649|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295650|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295651|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
130295652|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
130295653|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
130295654|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
130295655|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
130295656|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
129794148|NCT00811642|467212832|FG000|Overall Study|Adverse Event|3|||
129794149|NCT00811642|467212832|FG000|Overall Study|Protocol Violation|1|||
130046872|NCT00734929|468128611|FG000|Overall Study|Lost to Follow-up|1|||
130107258|NCT00051636|468353419|FG001|Period 1 - Core|Withdrawal by Subject|2|||
129794150|NCT00811642|467212832|FG000|Overall Study|Death|2|||
130107259|NCT00051636|468353418|FG000|Period 1 - Core|Lost to Follow-up|0|||
130107260|NCT00051636|468353419|FG001|Period 1 - Core|Lost to Follow-up|2|||
130107261|NCT00051636|468353418|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
129794151|NCT00811642|467212832|FG000|Overall Study|Withdrawal by Subject|7|||
129794152|NCT00811642|467212832|FG000|Overall Study|Cumulative use of antifungal agent|2|||
129794153|NCT00782795|467212833|FG000|Overall Study|Withdrawal by Subject|1|||
129794154|NCT00782795|467212834|FG001|Overall Study|Withdrawal by Subject|2|||
129794155|NCT00562627|467214272|FG000|Overall Study|Protocol Violation|1|||
129794156|NCT00562627|467214273|FG001|Overall Study|Protocol Violation|1|||
130107262|NCT00051636|468353419|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
130107263|NCT00051636|468353418|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
129794157|NCT00562627|467214274|FG002|Overall Study|Protocol Violation|1|||
129794158|NCT00625742|467214275|FG000|Overall Study|Disease Progression|2|||
129794159|NCT00625742|467214275|FG000|Overall Study|Withdrawal by Subject|1|||
129794160|NCT00625742|467214275|FG000|Overall Study|Adverse Event|4|||
129794161|NCT00625742|467214275|FG000|Overall Study|Lost to Follow-up|4|||
129794162|NCT00625742|467214275|FG000|Overall Study|Ineligible|1|||
130107264|NCT00051636|468353419|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
130107265|NCT00051636|468353418|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
130295657|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295658|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295659|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295660|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295661|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295662|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
130295663|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
130295664|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
129794163|NCT01709578|467214276|FG000|Overall Study|Rescued and entered in long term safety|63|||
129794164|NCT01709578|467214277|FG001|Overall Study|Rescued and entered in long term safety|25|||
129794165|NCT01709578|467214278|FG002|Overall Study|Rescued and entered in long term safety|26|||
129794166|NCT01709578|467214276|FG000|Overall Study|Adverse Event|9|||
129794167|NCT01709578|467214277|FG001|Overall Study|Adverse Event|18|||
129794168|NCT01709578|467214278|FG002|Overall Study|Adverse Event|17|||
130295665|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
130295666|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
130295667|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
130295668|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295669|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129794169|NCT01709578|467214276|FG000|Overall Study|Lack of Efficacy|5|||
129794170|NCT01709578|467214277|FG001|Overall Study|Lack of Efficacy|4|||
129794171|NCT01709578|467214278|FG002|Overall Study|Lack of Efficacy|2|||
129888845|NCT04496167|467550920|FG001|Overall Study|Other Than Specified|1|||
129888846|NCT03018106|467550921|FG000|Overall Study|Lost to Follow-up|0|||
130295670|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295671|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295672|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295673|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295674|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
130295675|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295676|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
130295677|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
130295678|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
130295679|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295680|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295681|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295682|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295683|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129794172|NCT01709578|467214276|FG000|Overall Study|Poor compliance to protocol|1|||
129888847|NCT03018106|467550922|FG001|Overall Study|Lost to Follow-up|1|||
129888848|NCT03055832|467550923|FG000|Week 2|Withdrawal by Subject|1|||
129888849|NCT03055832|467550924|FG001|Week 2|Withdrawal by Subject|0|||
130046873|NCT00734929|468128612|FG001|Overall Study|Lost to Follow-up|2|||
130046874|NCT00734929|468128611|FG000|Overall Study|No intervention/ screen fail|5|||
130046875|NCT00734929|468128612|FG001|Overall Study|No intervention/ screen fail|3|||
130046876|NCT03176966|468128616|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
130046877|NCT03176966|468128617|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
130046878|NCT03176966|468128616|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
130046879|NCT03176966|468128617|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
130046880|NCT03176966|468128616|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
130046881|NCT03176966|468128617|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
130107266|NCT00051636|468353419|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
129794173|NCT01709578|467214277|FG001|Overall Study|Poor compliance to protocol|2|||
130046882|NCT03176966|468128616|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
130046883|NCT03176966|468128617|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
130046884|NCT03176966|468128616|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
130046885|NCT03176966|468128617|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
130046886|NCT03176966|468128616|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
130046887|NCT03176966|468128617|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
130046888|NCT03176966|468128616|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
130046889|NCT03176966|468128617|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
130046890|NCT01696877|468128620|FG000|Overall Study|Adverse Event|0|||
130107267|NCT00051636|468353418|FG000|Period 2- Extended Observation Period|Death|4|||
130107268|NCT00051636|468353419|FG001|Period 2- Extended Observation Period|Death|5|||
130107269|NCT00051636|468353418|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
130107270|NCT00051636|468353419|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
130107271|NCT00479765|468353420|FG000|Overall Study|study terminated|4|||
130107272|NCT00420849|468353421|FG000|Overall Study|Lack of Efficacy|154|||
130107273|NCT00420849|468353421|FG000|Overall Study|Adverse Event|107|||
130107274|NCT00420849|468353421|FG000|Overall Study|Withdrawal by Subject|28|||
130107275|NCT00420849|468353421|FG000|Overall Study|Death|18|||
130107276|NCT00420849|468353421|FG000|Overall Study|Other|14|||
130107277|NCT00420849|468353421|FG000|Overall Study|Transplant|8|||
130107278|NCT00420849|468353421|FG000|Overall Study|Protocol Violation|1|||
130107279|NCT00420849|468353421|FG000|Overall Study|Lost to Follow-up|1|||
130295684|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295685|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
130295686|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
130295687|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
130295688|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
130295689|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
129794174|NCT01709578|467214278|FG002|Overall Study|Poor compliance to protocol|1|||
129794175|NCT01709578|467214276|FG000|Overall Study|Other, not related to safety or efficacy|2|||
129794176|NCT01709578|467214277|FG001|Overall Study|Other, not related to safety or efficacy|7|||
129794177|NCT01709578|467214278|FG002|Overall Study|Other, not related to safety or efficacy|5|||
129794178|NCT04050371|467214279|FG000|Overall Study|Withdrawal by Subject|1|||
129794179|NCT04050371|467214280|FG001|Overall Study|Withdrawal by Subject|0|||
129794180|NCT00597701|467214281|FG000|Overall Study|Withdrawal by Subject|5|||
129794181|NCT00597701|467214282|FG001|Overall Study|Withdrawal by Subject|5|||
129794182|NCT00597701|467214281|FG000|Overall Study|Death|0|||
129794183|NCT00597701|467214282|FG001|Overall Study|Death|1|||
129794184|NCT00597701|467214281|FG000|Overall Study|Physician Decision|2|||
129794185|NCT00597701|467214282|FG001|Overall Study|Physician Decision|0|||
129794186|NCT00597701|467214281|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
129794187|NCT00597701|467214282|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
129794188|NCT01107418|467214283|FG000|Overall Study|Disease Progression|45|||
129794189|NCT01107418|467214283|FG000|Overall Study|Adverse Event|3|||
129794190|NCT01107418|467214283|FG000|Overall Study|Withdrawal by Subject|1|||
129794191|NCT01107418|467214283|FG000|Overall Study|Study Closing|1|||
129794192|NCT01107418|467214283|FG000|Overall Study|Started Other Therapy|1|||
129794193|NCT01107418|467214283|FG000|Overall Study|Entered Extension Study|1|||
129794194|NCT00301821|467214290|FG000|Overall Study|Ineligible|25|||
129794195|NCT00301821|467214290|FG000|Overall Study|Cancel|1|||
129794196|NCT03150485|467214293|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129794197|NCT03150485|467214294|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129794198|NCT03150485|467214295|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
129794199|NCT03150485|467214296|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
130295690|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295691|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295692|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295693|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295694|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295695|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295696|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
130295697|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130295698|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
130295699|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130046891|NCT01696877|468128621|FG001|Overall Study|Adverse Event|1|||
130046892|NCT02961764|468128622|FG000|Overall Study|Protocol Violation|0|||
130107280|NCT00944125|468353422|FG000|3 to 6 Months|Withdrawal by Subject|0|||
129794200|NCT03150485|467214297|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
129794201|NCT03150485|467214298|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
129794202|NCT01394718|467214301|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
129794203|NCT01394718|467214302|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
130107281|NCT00944125|468353423|FG001|3 to 6 Months|Withdrawal by Subject|2|||
129794204|NCT01362595|467214309|FG000|Overall Study|Screen failure|10|||
129794205|NCT01362595|467214309|FG000|Overall Study|Withdrawal by Subject|2|||
129794206|NCT02469038|467214310|FG000|Overall Study|Physician Decision|4|||
129794207|NCT02469038|467214311|FG001|Overall Study|Physician Decision|5|||
129794208|NCT00636987|467214312|FG000|Overall Study|Death|44|||
129794209|NCT00636987|467214312|FG000|Overall Study|Explanted|13|||
129794210|NCT00636987|467214312|FG000|Overall Study|Lost to Follow-up|63|||
129794211|NCT00636987|467214312|FG000|Overall Study|5 year visit window not complete|69|||
129794212|NCT01251146|467214313|FG000|Overall Study|Lost to Follow-up|3|||
129794213|NCT01251146|467214314|FG001|Overall Study|Lost to Follow-up|10|||
129794214|NCT01739400|467214315|FG000|Overall Study|Physician Decision|3|||
129794215|NCT01739400|467214316|FG001|Overall Study|Physician Decision|0|||
129794216|NCT01739400|467214315|FG000|Overall Study|Lost to Follow-up|2|||
130046893|NCT02961764|468128623|FG001|Overall Study|Protocol Violation|1|||
130046894|NCT02961764|468128622|FG000|Overall Study|Death|2|||
130046895|NCT02961764|468128623|FG001|Overall Study|Death|0|||
129794217|NCT01739400|467214316|FG001|Overall Study|Lost to Follow-up|0|||
129794218|NCT01739400|467214315|FG000|Overall Study|Death|5|||
129794219|NCT01739400|467214316|FG001|Overall Study|Death|2|||
129794220|NCT01739400|467214315|FG000|Overall Study|Withdrawal by Subject|7|||
130046896|NCT02961764|468128622|FG000|Overall Study|Lost to Follow-up|35|||
130046897|NCT02961764|468128623|FG001|Overall Study|Lost to Follow-up|24|||
130046898|NCT02961764|468128622|FG000|Overall Study|Withdrawal by Subject|2|||
130046899|NCT02961764|468128623|FG001|Overall Study|Withdrawal by Subject|0|||
130046900|NCT01422304|468128624|FG000|Overall Study|Adverse Event|0|||
130046901|NCT01422304|468128625|FG001|Overall Study|Adverse Event|1|||
130046902|NCT01422304|468128624|FG000|Overall Study|Lost to Follow-up|14|||
130046903|NCT01422304|468128625|FG001|Overall Study|Lost to Follow-up|20|||
130046904|NCT01422304|468128624|FG000|Overall Study|Never Entered Follow-up|2|||
130046905|NCT01422304|468128625|FG001|Overall Study|Never Entered Follow-up|1|||
130046906|NCT01422304|468128624|FG000|Overall Study|Protocol Violation|1|||
130046907|NCT01422304|468128625|FG001|Overall Study|Protocol Violation|0|||
130046908|NCT01422304|468128624|FG000|Overall Study|Withdrawal by Subject|4|||
130046909|NCT01422304|468128625|FG001|Overall Study|Withdrawal by Subject|2|||
130046910|NCT01422304|468128624|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
129794221|NCT01739400|467214316|FG001|Overall Study|Withdrawal by Subject|7|||
129794222|NCT01083173|467214323|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
129794223|NCT01083173|467214324|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
129794224|NCT01083173|467214323|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
129794225|NCT01083173|467214324|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
129794226|NCT01083173|467214323|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
129794227|NCT01083173|467214324|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
129794228|NCT01083173|467214323|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
129794229|NCT01083173|467214324|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
129794230|NCT01083173|467214323|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
129794231|NCT01083173|467214324|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
129794232|NCT01083173|467214323|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
129794233|NCT01083173|467214324|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
129794234|NCT01083173|467214323|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
129794235|NCT01083173|467214324|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
129794236|NCT01083173|467214323|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
129794237|NCT01083173|467214324|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
129794238|NCT01083173|467214323|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
129794239|NCT01083173|467214324|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
129794240|NCT01083173|467214323|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
129800267|NCT02445391|467236291|FG001|Overall Study|Complicating disease|2|||
130046911|NCT01422304|468128625|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
130046912|NCT01422304|468128624|FG000|Overall Study|Not Treated|3|||
130046913|NCT01422304|468128625|FG001|Overall Study|Not Treated|11|||
129800268|NCT02445391|467236292|FG002|Overall Study|Complicating disease|1|||
130046914|NCT00469014|468128626|FG000|Initial Phase Randomization|Disease Progression|0|||
130046915|NCT00469014|468128627|FG001|Initial Phase Randomization|Disease Progression|1|||
130046916|NCT00469014|468128628|FG002|Initial Phase Randomization|Disease Progression|1|||
130046917|NCT00469014|468128629|FG003|Initial Phase Randomization|Disease Progression|0|||
130046918|NCT00469014|468128626|FG000|Initial Phase Randomization|No Response|1|||
130046919|NCT00469014|468128627|FG001|Initial Phase Randomization|No Response|0|||
130046920|NCT00469014|468128628|FG002|Initial Phase Randomization|No Response|0|||
130046921|NCT00469014|468128629|FG003|Initial Phase Randomization|No Response|1|||
130046922|NCT00469014|468128626|FG000|Adaptive Randomization|Not Evaluable|1|||
130046923|NCT00469014|468128627|FG001|Adaptive Randomization|Not Evaluable|0|||
130046924|NCT00469014|468128628|FG002|Adaptive Randomization|Not Evaluable|0|||
130046925|NCT00469014|468128629|FG003|Adaptive Randomization|Not Evaluable|1|||
130046926|NCT00469014|468128626|FG000|Adaptive Randomization|No Response|0|||
130046927|NCT00469014|468128627|FG001|Adaptive Randomization|No Response|1|||
130046928|NCT00469014|468128628|FG002|Adaptive Randomization|No Response|0|||
130046929|NCT00469014|468128629|FG003|Adaptive Randomization|No Response|0|||
130046930|NCT00469014|468128626|FG000|Adaptive Randomization|Death|0|||
130046931|NCT00469014|468128627|FG001|Adaptive Randomization|Death|0|||
130046932|NCT00469014|468128628|FG002|Adaptive Randomization|Death|1|||
130046933|NCT00469014|468128629|FG003|Adaptive Randomization|Death|0|||
130046934|NCT00866294|468128630|FG000|Overall Study|Adverse Event|12|||
130046935|NCT00866294|468128631|FG001|Overall Study|Adverse Event|13|||
130046936|NCT00866294|468128632|FG002|Overall Study|Adverse Event|9|||
130046937|NCT00866294|468128630|FG000|Overall Study|Lack of Efficacy|7|||
130046938|NCT00866294|468128631|FG001|Overall Study|Lack of Efficacy|1|||
130046939|NCT00866294|468128632|FG002|Overall Study|Lack of Efficacy|0|||
130046940|NCT00866294|468128630|FG000|Overall Study|Protocol Violation|2|||
130046941|NCT00866294|468128631|FG001|Overall Study|Protocol Violation|0|||
130046942|NCT00866294|468128632|FG002|Overall Study|Protocol Violation|0|||
130046943|NCT00866294|468128630|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
130295700|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
130046944|NCT00866294|468128631|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130046945|NCT00866294|468128632|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
130046946|NCT00866294|468128630|FG000|Overall Study|Lost to Follow-up|1|||
130046947|NCT00866294|468128631|FG001|Overall Study|Lost to Follow-up|3|||
130046948|NCT00866294|468128632|FG002|Overall Study|Lost to Follow-up|0|||
130046949|NCT00866294|468128630|FG000|Overall Study|Physician Decision|6|||
130046950|NCT00866294|468128631|FG001|Overall Study|Physician Decision|2|||
130046951|NCT00866294|468128632|FG002|Overall Study|Physician Decision|1|||
130046952|NCT00916721|468128633|FG000|Overall Study|Lost to Follow-up|0|||
130046953|NCT00916721|468128634|FG001|Overall Study|Lost to Follow-up|1|||
130046954|NCT00916721|468128633|FG000|Overall Study|Adverse Event|6|||
130046955|NCT00916721|468128634|FG001|Overall Study|Adverse Event|3|||
130046956|NCT00916721|468128633|FG000|Overall Study|Withdrawal by Subject|2|||
130046957|NCT00916721|468128634|FG001|Overall Study|Withdrawal by Subject|2|||
130107282|NCT00944125|468353422|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
130107283|NCT00944125|468353423|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
130107284|NCT00446134|468353424|FG000|Overall Study|Adverse Event|7|||
130107285|NCT00446134|468353425|FG001|Overall Study|Adverse Event|17|||
130107286|NCT00446134|468353426|FG002|Overall Study|Adverse Event|13|||
130107287|NCT00446134|468353427|FG003|Overall Study|Adverse Event|18|||
130107288|NCT00446134|468353424|FG000|Overall Study|Lack of Efficacy|19|||
130107289|NCT00446134|468353425|FG001|Overall Study|Lack of Efficacy|19|||
130107290|NCT00446134|468353426|FG002|Overall Study|Lack of Efficacy|24|||
130107291|NCT00446134|468353427|FG003|Overall Study|Lack of Efficacy|19|||
130107292|NCT00446134|468353424|FG000|Overall Study|Protocol Violation|0|||
130107293|NCT00446134|468353425|FG001|Overall Study|Protocol Violation|2|||
130107294|NCT00446134|468353426|FG002|Overall Study|Protocol Violation|1|||
130107295|NCT00446134|468353427|FG003|Overall Study|Protocol Violation|0|||
130107296|NCT00446134|468353424|FG000|Overall Study|Lost to Follow-up|1|||
130107297|NCT00446134|468353425|FG001|Overall Study|Lost to Follow-up|3|||
130107298|NCT00446134|468353426|FG002|Overall Study|Lost to Follow-up|1|||
130107299|NCT00446134|468353427|FG003|Overall Study|Lost to Follow-up|1|||
130107300|NCT00446134|468353424|FG000|Overall Study|Withdrawal by Subject|3|||
130295701|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295702|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295703|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295704|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295705|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295706|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295707|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295708|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295709|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
130295710|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295711|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
130295712|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295713|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295714|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295715|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295716|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130046958|NCT00916721|468128633|FG000|Overall Study|Protocol Violation|2|||
130107301|NCT00446134|468353425|FG001|Overall Study|Withdrawal by Subject|3|||
130107302|NCT00446134|468353426|FG002|Overall Study|Withdrawal by Subject|1|||
130107303|NCT00446134|468353427|FG003|Overall Study|Withdrawal by Subject|3|||
130107304|NCT00446134|468353424|FG000|Overall Study|Physician Decision|0|||
130107305|NCT00446134|468353425|FG001|Overall Study|Physician Decision|0|||
130107306|NCT00446134|468353426|FG002|Overall Study|Physician Decision|0|||
130107307|NCT00446134|468353427|FG003|Overall Study|Physician Decision|2|||
130046959|NCT00916721|468128634|FG001|Overall Study|Protocol Violation|4|||
130046960|NCT01903434|468128638|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
130046961|NCT01903434|468128639|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
130107308|NCT00446134|468353424|FG000|Overall Study|Adverse Event-Diarrhea|1|||
130107309|NCT00446134|468353425|FG001|Overall Study|Adverse Event-Diarrhea|1|||
130107310|NCT00446134|468353426|FG002|Overall Study|Adverse Event-Diarrhea|2|||
130107311|NCT00446134|468353427|FG003|Overall Study|Adverse Event-Diarrhea|0|||
130107312|NCT00446134|468353424|FG000|Overall Study|Reason Not Completed|3|||
130046962|NCT01903434|468128638|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
130046963|NCT01903434|468128639|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
130107313|NCT00446134|468353425|FG001|Overall Study|Reason Not Completed|0|||
130107314|NCT00446134|468353426|FG002|Overall Study|Reason Not Completed|1|||
130107315|NCT00446134|468353427|FG003|Overall Study|Reason Not Completed|2|||
130107316|NCT04816877|468353428|FG000|Overall Study|Withdrawal by Subject|1|||
130107317|NCT04816877|468353429|FG001|Overall Study|Withdrawal by Subject|0|||
130107318|NCT00928135|468353430|FG000|Overall Study|Withdrawal by Subject|1|||
130107319|NCT00928135|468353431|FG001|Overall Study|Withdrawal by Subject|0|||
129794241|NCT01083173|467214324|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
129794242|NCT01083173|467214323|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
129794243|NCT01083173|467214324|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
129794244|NCT03410823|467214325|FG000|Overall Study|Death|1|||
129794245|NCT03410823|467214325|FG000|Overall Study|Withdrawal by Subject|2|||
129794246|NCT03410823|467214325|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
129794247|NCT03569293|467214326|FG000|Overall Study|Adverse Event|4|||
129794248|NCT03569293|467214327|FG001|Overall Study|Adverse Event|1|||
129794249|NCT03569293|467214328|FG002|Overall Study|Adverse Event|5|||
129794250|NCT03569293|467214329|FG003|Overall Study|Adverse Event|1|||
129794251|NCT03569293|467214330|FG004|Overall Study|Adverse Event|0|||
129794252|NCT03569293|467214331|FG005|Overall Study|Adverse Event|0|||
130107320|NCT03338673|468353434|FG000|Overall Study|Lost to Follow-up|1|||
130107321|NCT03338673|468353435|FG001|Overall Study|Lost to Follow-up|1|||
130107322|NCT00434148|468353438|FG000|Overall Study|Adverse Event|18|||
130107323|NCT00434148|468353439|FG001|Overall Study|Adverse Event|18|||
130107324|NCT00434148|468353438|FG000|Overall Study|Lack of Efficacy|25|||
130107325|NCT00434148|468353439|FG001|Overall Study|Lack of Efficacy|28|||
130107326|NCT00434148|468353438|FG000|Overall Study|Withdrawal by Subject|15|||
130107327|NCT00434148|468353439|FG001|Overall Study|Withdrawal by Subject|15|||
130107328|NCT00434148|468353438|FG000|Overall Study|Protocol Violation|4|||
130107329|NCT00434148|468353439|FG001|Overall Study|Protocol Violation|0|||
130107330|NCT00434148|468353438|FG000|Overall Study|Administrative problems|6|||
130107331|NCT00434148|468353439|FG001|Overall Study|Administrative problems|10|||
130107332|NCT00434148|468353438|FG000|Overall Study|Lost to Follow-up|0|||
130107333|NCT00434148|468353439|FG001|Overall Study|Lost to Follow-up|1|||
130107334|NCT00434148|468353438|FG000|Overall Study|Condition no longer requires study drug|1|||
130107335|NCT00434148|468353439|FG001|Overall Study|Condition no longer requires study drug|0|||
130107336|NCT00434148|468353438|FG000|Overall Study|Abnormal test procedure result|0|||
130107337|NCT00434148|468353439|FG001|Overall Study|Abnormal test procedure result|1|||
130295717|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129794253|NCT03569293|467214326|FG000|Overall Study|Withdrawal by Subject|16|||
130107338|NCT01861717|468353446|FG000|Overall Study|Lost to Follow-up|1|||
130107339|NCT01861717|468353446|FG000|Overall Study|Withdrawal by Subject|1|||
130107340|NCT03033069|468353447|FG000|Overall Study|Adverse Event|6|||
129794254|NCT03569293|467214327|FG001|Overall Study|Withdrawal by Subject|2|||
129794255|NCT03569293|467214328|FG002|Overall Study|Withdrawal by Subject|4|||
129794256|NCT03569293|467214329|FG003|Overall Study|Withdrawal by Subject|1|||
129794257|NCT03569293|467214330|FG004|Overall Study|Withdrawal by Subject|0|||
129794258|NCT03569293|467214331|FG005|Overall Study|Withdrawal by Subject|0|||
129794259|NCT03569293|467214326|FG000|Overall Study|Lost to Follow-up|1|||
129794260|NCT03569293|467214327|FG001|Overall Study|Lost to Follow-up|3|||
129794261|NCT03569293|467214328|FG002|Overall Study|Lost to Follow-up|1|||
129794262|NCT03569293|467214329|FG003|Overall Study|Lost to Follow-up|1|||
129794263|NCT03569293|467214330|FG004|Overall Study|Lost to Follow-up|0|||
129794264|NCT03569293|467214331|FG005|Overall Study|Lost to Follow-up|0|||
129794265|NCT03569293|467214326|FG000|Overall Study|Other|8|||
129794266|NCT03569293|467214327|FG001|Overall Study|Other|2|||
129794267|NCT03569293|467214328|FG002|Overall Study|Other|1|||
129888850|NCT03619174|467550925|FG000|Overall Study|Lost to Follow-up|3|||
130107341|NCT03033069|468353448|FG001|Overall Study|Adverse Event|7|||
130107342|NCT03033069|468353449|FG002|Overall Study|Adverse Event|4|||
130107343|NCT03033069|468353450|FG003|Overall Study|Adverse Event|6|||
130107344|NCT03033069|468353447|FG000|Overall Study|Lack of Efficacy|0|||
130107345|NCT03033069|468353448|FG001|Overall Study|Lack of Efficacy|0|||
130107346|NCT03033069|468353449|FG002|Overall Study|Lack of Efficacy|1|||
130107347|NCT03033069|468353450|FG003|Overall Study|Lack of Efficacy|0|||
130107348|NCT03033069|468353447|FG000|Overall Study|Lost to Follow-up|6|||
130107349|NCT03033069|468353448|FG001|Overall Study|Lost to Follow-up|5|||
130107350|NCT03033069|468353449|FG002|Overall Study|Lost to Follow-up|5|||
130107351|NCT03033069|468353450|FG003|Overall Study|Lost to Follow-up|6|||
130107352|NCT03033069|468353447|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130295718|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
130295719|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129794268|NCT03569293|467214329|FG003|Overall Study|Other|1|||
129794269|NCT03569293|467214330|FG004|Overall Study|Other|0|||
129794270|NCT03569293|467214331|FG005|Overall Study|Other|0|||
129794271|NCT03569293|467214326|FG000|Overall Study|Ongoing at Time of Analysis|8|||
129794272|NCT03569293|467214327|FG001|Overall Study|Ongoing at Time of Analysis|1|||
129794273|NCT03569293|467214328|FG002|Overall Study|Ongoing at Time of Analysis|3|||
130107353|NCT03033069|468353448|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130107354|NCT03033069|468353449|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130107355|NCT03033069|468353450|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130107356|NCT03033069|468353447|FG000|Overall Study|Protocol Deviation|0|||
130107357|NCT03033069|468353448|FG001|Overall Study|Protocol Deviation|1|||
130107358|NCT03033069|468353449|FG002|Overall Study|Protocol Deviation|0|||
130107359|NCT03033069|468353450|FG003|Overall Study|Protocol Deviation|0|||
130046964|NCT01469052|468128642|FG000|Overall Study|Adverse Event|2|||
130046965|NCT01469052|468128643|FG001|Overall Study|Adverse Event|3|||
130046966|NCT01469052|468128644|FG002|Overall Study|Adverse Event|0|||
130046967|NCT01469052|468128645|FG003|Overall Study|Adverse Event|2|||
130046968|NCT01469052|468128646|FG004|Overall Study|Adverse Event|0|||
130046969|NCT01469052|468128647|FG005|Overall Study|Adverse Event|1|||
130046970|NCT01469052|468128642|FG000|Overall Study|Progressive disease|3|||
130046971|NCT01469052|468128643|FG001|Overall Study|Progressive disease|0|||
130046972|NCT01469052|468128644|FG002|Overall Study|Progressive disease|5|||
130046973|NCT01469052|468128645|FG003|Overall Study|Progressive disease|3|||
130046974|NCT01469052|468128646|FG004|Overall Study|Progressive disease|7|||
130046975|NCT01469052|468128647|FG005|Overall Study|Progressive disease|2|||
130046976|NCT01469052|468128642|FG000|Overall Study|Lack of Efficacy|0|||
130046977|NCT01469052|468128643|FG001|Overall Study|Lack of Efficacy|0|||
130046978|NCT01469052|468128644|FG002|Overall Study|Lack of Efficacy|0|||
130046979|NCT01469052|468128645|FG003|Overall Study|Lack of Efficacy|0|||
130046980|NCT01469052|468128646|FG004|Overall Study|Lack of Efficacy|0|||
130046981|NCT01469052|468128647|FG005|Overall Study|Lack of Efficacy|2|||
130046982|NCT01469052|468128642|FG000|Overall Study|Moved to rollover protocol|1|||
130046983|NCT01469052|468128643|FG001|Overall Study|Moved to rollover protocol|0|||
130046984|NCT01469052|468128644|FG002|Overall Study|Moved to rollover protocol|1|||
130046985|NCT01469052|468128645|FG003|Overall Study|Moved to rollover protocol|0|||
130046986|NCT01469052|468128646|FG004|Overall Study|Moved to rollover protocol|0|||
130046987|NCT01469052|468128647|FG005|Overall Study|Moved to rollover protocol|1|||
130046988|NCT01469052|468128642|FG000|Overall Study|Other|0|||
130046989|NCT01469052|468128643|FG001|Overall Study|Other|1|||
130046990|NCT01469052|468128644|FG002|Overall Study|Other|0|||
130046991|NCT01469052|468128645|FG003|Overall Study|Other|0|||
130046992|NCT01469052|468128646|FG004|Overall Study|Other|1|||
130046993|NCT01469052|468128647|FG005|Overall Study|Other|0|||
130046994|NCT01519427|468128652|FG000|Overall Study|disease progression|2|||
130046995|NCT03894904|468128653|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
130046996|NCT03894904|468128654|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
130046997|NCT03894904|468128653|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
130046998|NCT03894904|468128654|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
130046999|NCT02190435|468128655|FG000|Overall Study|First 12 patients were lead-ins|12|||
130047000|NCT02190435|468128656|FG001|Overall Study|First 12 patients were lead-ins|0|||
130047001|NCT02190435|468128655|FG000|Overall Study|3 consented screen fails|3|||
130047002|NCT02190435|468128656|FG001|Overall Study|3 consented screen fails|0|||
130047003|NCT01781026|468128657|FG000|Overall Study|Lack of Efficacy|2|||
130047004|NCT01589094|468128658|FG000|Overall Study|Did not receive treatment|2|||
130047005|NCT03575468|468128659|FG000|Overall Study|Withdrawal by Subject|3|||
130047006|NCT03575468|468128660|FG001|Overall Study|Withdrawal by Subject|0|||
130047007|NCT03575468|468128659|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
130047008|NCT03575468|468128660|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
130047009|NCT03575468|468128659|FG000|Overall Study|Lost to Follow-up|13|||
130047010|NCT03575468|468128660|FG001|Overall Study|Lost to Follow-up|17|||
130047011|NCT05270694|468130045|FG000|Overall Study|Death|1|||
130047012|NCT05270694|468130045|FG000|Overall Study|Medical issues impacted ability to participate|2|||
130047013|NCT05270694|468130045|FG000|Overall Study|Lost to Follow-up|3|||
130047014|NCT05270694|468130045|FG000|Overall Study|Withdrawal by Subject|3|||
130047015|NCT01991977|468130046|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
130047016|NCT01991977|468130046|FG000|Overall Study|Withdrew after start of treatment|5|||
130047017|NCT05094154|468130047|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
130047018|NCT05094154|468130048|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
130047019|NCT05094154|468130047|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
130047020|NCT05094154|468130048|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
130047021|NCT02531035|468130057|FG000|Overall Study|Death|0|||
130047022|NCT02531035|468130058|FG001|Overall Study|Death|1|||
130047023|NCT02531035|468130057|FG000|Overall Study|Protocol Violation|1|||
130047024|NCT02531035|468130058|FG001|Overall Study|Protocol Violation|1|||
130047025|NCT02531035|468130057|FG000|Overall Study|Noncompliance with study drug|8|||
130047026|NCT02531035|468130058|FG001|Overall Study|Noncompliance with study drug|3|||
130047027|NCT02531035|468130057|FG000|Overall Study|Physician Decision|1|||
130047028|NCT02531035|468130058|FG001|Overall Study|Physician Decision|0|||
130047029|NCT02531035|468130057|FG000|Overall Study|Adverse Event|16|||
130047030|NCT02531035|468130058|FG001|Overall Study|Adverse Event|45|||
130047031|NCT02531035|468130057|FG000|Overall Study|Other|3|||
130047032|NCT02531035|468130058|FG001|Overall Study|Other|2|||
130107360|NCT03033069|468353447|FG000|Overall Study|Withdrawal by Subject|10|||
130107361|NCT03033069|468353448|FG001|Overall Study|Withdrawal by Subject|10|||
130107362|NCT03033069|468353449|FG002|Overall Study|Withdrawal by Subject|11|||
130107363|NCT03033069|468353450|FG003|Overall Study|Withdrawal by Subject|6|||
130107364|NCT03033069|468353447|FG000|Overall Study|Withdrawal By Caregiver|1|||
130107365|NCT03033069|468353448|FG001|Overall Study|Withdrawal By Caregiver|0|||
130107366|NCT03033069|468353449|FG002|Overall Study|Withdrawal By Caregiver|0|||
130107367|NCT03033069|468353450|FG003|Overall Study|Withdrawal By Caregiver|0|||
130107368|NCT03033069|468353447|FG000|Overall Study|Reason not Specified|0|||
130107369|NCT03033069|468353448|FG001|Overall Study|Reason not Specified|1|||
130107370|NCT03033069|468353449|FG002|Overall Study|Reason not Specified|0|||
130107371|NCT03033069|468353450|FG003|Overall Study|Reason not Specified|1|||
130107372|NCT03724968|468355094|FG000|Overall Study|Insurance issues|0|||
130295720|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295721|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295722|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
130295723|NCT02914561|469045346|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295724|NCT02914561|469045347|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295725|NCT02914561|469045348|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295726|NCT02914561|469045349|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295727|NCT02914561|469045350|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295728|NCT02914561|469045351|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295729|NCT02914561|469045352|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295730|NCT02914561|469045353|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
130295731|NCT02914561|469045354|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130295732|NCT02914561|469045355|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130295733|NCT02914561|469045356|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
130295734|NCT01455220|469045359|FG000|Overall Study|screen fail|30|||
130295735|NCT00521222|469045361|FG000|Overall Study|Lost to Follow-up|0|||
130295736|NCT00521222|469045362|FG001|Overall Study|Lost to Follow-up|0|||
130295737|NCT00521222|469045363|FG002|Overall Study|Lost to Follow-up|1|||
130295738|NCT00521222|469045364|FG003|Overall Study|Lost to Follow-up|1|||
130295739|NCT00521222|469045361|FG000|Overall Study|Withdrawal by Subject|0|||
130295740|NCT00521222|469045362|FG001|Overall Study|Withdrawal by Subject|0|||
130295741|NCT00521222|469045363|FG002|Overall Study|Withdrawal by Subject|2|||
130295742|NCT00521222|469045364|FG003|Overall Study|Withdrawal by Subject|0|||
130295743|NCT00521222|469045361|FG000|Overall Study|Physician Decision|0|||
130107373|NCT03724968|468355095|FG001|Overall Study|Insurance issues|1|||
130107374|NCT03724968|468355094|FG000|Overall Study|Study closed|0|||
130107375|NCT03724968|468355095|FG001|Overall Study|Study closed|1|||
130107376|NCT01858558|468355096|FG000|Overall Study|Death|1|||
130107377|NCT01858558|468355097|FG001|Overall Study|Death|1|||
130107378|NCT01858558|468355096|FG000|Overall Study|Lost to Follow-up|1|||
130107379|NCT01858558|468355097|FG001|Overall Study|Lost to Follow-up|0|||
130107380|NCT01858558|468355096|FG000|Overall Study|Disease progression|3|||
130295744|NCT00521222|469045362|FG001|Overall Study|Physician Decision|1|||
130295745|NCT00521222|469045363|FG002|Overall Study|Physician Decision|0|||
129888851|NCT03619174|467550926|FG001|Overall Study|Lost to Follow-up|0|||
130107381|NCT01858558|468355097|FG001|Overall Study|Disease progression|1|||
130107382|NCT01858558|468355096|FG000|Overall Study|Product contamination|2|||
130107383|NCT01858558|468355097|FG001|Overall Study|Product contamination|0|||
130295746|NCT00521222|469045364|FG003|Overall Study|Physician Decision|1|||
130295747|NCT03332160|469045365|FG000|Overall Study|Withdrawal by Subject|1|||
130295748|NCT03332160|469045366|FG001|Overall Study|Withdrawal by Subject|1|||
130295749|NCT03332160|469045365|FG000|Overall Study|Adverse Event|0|||
130295750|NCT03332160|469045366|FG001|Overall Study|Adverse Event|1|||
130295751|NCT03332160|469045365|FG000|Overall Study|Developed Exclusion Criteria|0|||
130295752|NCT03332160|469045366|FG001|Overall Study|Developed Exclusion Criteria|1|||
130295753|NCT03332160|469045365|FG000|Overall Study|Non-adherence to treatment|0|||
130295754|NCT03332160|469045366|FG001|Overall Study|Non-adherence to treatment|2|||
130295755|NCT03869333|469045367|FG000|Overall Study|Lost to Follow-up|1|||
130295756|NCT03869333|469045368|FG001|Overall Study|Lost to Follow-up|0|||
130295757|NCT03869333|469045369|FG002|Overall Study|Lost to Follow-up|0|||
130295758|NCT03869333|469045370|FG003|Overall Study|Lost to Follow-up|0|||
130295759|NCT03869333|469045367|FG000|Overall Study|Pregnancy|1|||
130295760|NCT03869333|469045368|FG001|Overall Study|Pregnancy|0|||
130295761|NCT03869333|469045369|FG002|Overall Study|Pregnancy|0|||
130295762|NCT03869333|469045370|FG003|Overall Study|Pregnancy|0|||
130295763|NCT03869333|469045367|FG000|Overall Study|Physician Decision|0|||
130295764|NCT03869333|469045368|FG001|Overall Study|Physician Decision|1|||
130295765|NCT03869333|469045369|FG002|Overall Study|Physician Decision|0|||
130295766|NCT03869333|469045370|FG003|Overall Study|Physician Decision|0|||
130295767|NCT01927055|469045371|FG000|Open-label|Adverse Event|6|||
130295768|NCT01927055|469045372|FG001|Open-label|Adverse Event|0|||
130295769|NCT01927055|469045373|FG002|Open-label|Adverse Event|0|||
130295770|NCT01927055|469045371|FG000|Open-label|Withdrawal by Subject|1|||
130295771|NCT01927055|469045372|FG001|Open-label|Withdrawal by Subject|0|||
130295772|NCT01927055|469045373|FG002|Open-label|Withdrawal by Subject|0|||
130295773|NCT01927055|469045371|FG000|Open-label|Study Stopped|4|||
130295774|NCT01927055|469045372|FG001|Open-label|Study Stopped|0|||
130295775|NCT01927055|469045373|FG002|Open-label|Study Stopped|0|||
130295776|NCT01927055|469045371|FG000|Open-label|Supine Hypertension|4|||
130295777|NCT01927055|469045372|FG001|Open-label|Supine Hypertension|0|||
130295778|NCT01927055|469045373|FG002|Open-label|Supine Hypertension|0|||
130295779|NCT01927055|469045371|FG000|Open-label|Difficulty attending study visits|1|||
130295780|NCT01927055|469045372|FG001|Open-label|Difficulty attending study visits|0|||
130295781|NCT01927055|469045373|FG002|Open-label|Difficulty attending study visits|0|||
130047033|NCT02531035|468130057|FG000|Overall Study|Withdrawal by Subject|42|||
130047034|NCT02531035|468130058|FG001|Overall Study|Withdrawal by Subject|32|||
130047035|NCT02531035|468130057|FG000|Overall Study|Lost to Follow-up|8|||
130047036|NCT02531035|468130058|FG001|Overall Study|Lost to Follow-up|10|||
130047037|NCT02531035|468130057|FG000|Overall Study|Randomized, not treated|2|||
130047038|NCT02531035|468130058|FG001|Overall Study|Randomized, not treated|1|||
130047039|NCT03032068|468130068|FG000|Overall Study|Adverse Event|1|||
130047040|NCT01597622|468130069|FG000|Overall Study|Adverse Event|7|||
130047041|NCT01597622|468130069|FG000|Overall Study|Lack of Efficacy|3|||
130047042|NCT01597622|468130069|FG000|Overall Study|Protocol Violation|1|||
130047043|NCT01597622|468130069|FG000|Overall Study|Lost to Follow-up|1|||
130047044|NCT01597622|468130069|FG000|Overall Study|Investigator Discretion|5|||
130047045|NCT01597622|468130069|FG000|Overall Study|Withdrawal by Subject|20|||
130047046|NCT01597622|468130069|FG000|Overall Study|Death|1|||
130047047|NCT03918642|468130071|FG000|Overall Study|Lost to Follow-up|12|||
130047048|NCT03918642|468130072|FG001|Overall Study|Lost to Follow-up|10|||
130047049|NCT03825042|468130073|FG000|Overall Study|Adverse Event|1|||
130047050|NCT03825042|468130074|FG001|Overall Study|Adverse Event|0|||
130047051|NCT03825042|468130073|FG000|Overall Study|Withdrawal by Subject|1|||
130047052|NCT03825042|468130074|FG001|Overall Study|Withdrawal by Subject|0|||
130047053|NCT00500149|468130082|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
130047054|NCT00500149|468130083|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
130047055|NCT00500149|468130082|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
130047056|NCT00500149|468130083|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
130047057|NCT00500149|468130082|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
130047058|NCT00500149|468130083|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
130047059|NCT00500149|468130082|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
130047060|NCT00500149|468130083|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
130047061|NCT00500149|468130082|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
130047062|NCT00500149|468130083|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
130295782|NCT01927055|469045371|FG000|Double-Blind|Adverse Event|0|||
130295783|NCT01927055|469045372|FG001|Double-Blind|Adverse Event|1|||
130295784|NCT01927055|469045373|FG002|Double-Blind|Adverse Event|1|||
130295785|NCT01927055|469045371|FG000|Double-Blind|Protocol Violation|0|||
130295786|NCT01927055|469045372|FG001|Double-Blind|Protocol Violation|0|||
130295787|NCT01927055|469045373|FG002|Double-Blind|Protocol Violation|1|||
130295788|NCT01927055|469045371|FG000|Double-Blind|Withdrawal by Subject|0|||
130295789|NCT01927055|469045372|FG001|Double-Blind|Withdrawal by Subject|2|||
130295790|NCT01927055|469045373|FG002|Double-Blind|Withdrawal by Subject|3|||
130295791|NCT01927055|469045371|FG000|Double-Blind|Study Stopped|0|||
130295792|NCT01927055|469045372|FG001|Double-Blind|Study Stopped|7|||
130295793|NCT01927055|469045373|FG002|Double-Blind|Study Stopped|7|||
130295794|NCT01927055|469045371|FG000|Double-Blind|Supine Hypertension|0|||
130295795|NCT01927055|469045372|FG001|Double-Blind|Supine Hypertension|0|||
130295796|NCT01927055|469045373|FG002|Double-Blind|Supine Hypertension|1|||
130295797|NCT01927055|469045371|FG000|Double-Blind|Extended Vacation|0|||
130295798|NCT01927055|469045372|FG001|Double-Blind|Extended Vacation|1|||
130295799|NCT01927055|469045373|FG002|Double-Blind|Extended Vacation|0|||
130295800|NCT00952614|469045379|FG000|Overall Study|Death|3|||
130295801|NCT00952614|469045379|FG000|Overall Study|Lost to Follow-up|3|||
130295802|NCT00952614|469045379|FG000|Overall Study|other reason|1|||
130295803|NCT04023682|469045380|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
130295804|NCT01291277|469045381|FG000|Overall Study|Death|2|||
130295805|NCT01291277|469045382|FG001|Overall Study|Death|2|||
130295806|NCT01291277|469045381|FG000|Overall Study|Lost to Follow-up|3|||
130295807|NCT01291277|469045382|FG001|Overall Study|Lost to Follow-up|1|||
130295808|NCT02963701|469045383|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
130295809|NCT02963701|469045384|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
130295810|NCT03480009|469045387|FG000|Overall Study|Lost to Follow-up|4|||
130295811|NCT03480009|469045388|FG001|Overall Study|Lost to Follow-up|5|||
129888852|NCT03619174|467550925|FG000|Overall Study|Withdrawal by Subject|4|||
129888853|NCT03619174|467550926|FG001|Overall Study|Withdrawal by Subject|3|||
129888854|NCT03619174|467550925|FG000|Overall Study|Pregnancy|1|||
129888855|NCT03619174|467550926|FG001|Overall Study|Pregnancy|1|||
129888856|NCT03619174|467550925|FG000|Overall Study|Discomfort during treatment|1|||
129888857|NCT03619174|467550926|FG001|Overall Study|Discomfort during treatment|0|||
129888858|NCT01012973|467550927|FG000|Overall Study|Adverse Event|5|||
129888859|NCT01012973|467550928|FG001|Overall Study|Adverse Event|5|||
129888860|NCT01012973|467550927|FG000|Overall Study|Lack of Efficacy|0|||
130295812|NCT03480009|469045389|FG002|Overall Study|Lost to Follow-up|4|||
130295813|NCT03480009|469045390|FG003|Overall Study|Lost to Follow-up|0|||
129888861|NCT01012973|467550928|FG001|Overall Study|Lack of Efficacy|5|||
130047063|NCT00500149|468130082|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
130047064|NCT00500149|468130083|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
130047065|NCT00500149|468130082|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
130047066|NCT00500149|468130083|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
130047067|NCT00521339|468130084|FG000|Treatment Phase|Adverse Event|2|||
130047068|NCT00521339|468130085|FG001|Treatment Phase|Adverse Event|0|||
130047069|NCT00521339|468130086|FG002|Treatment Phase|Adverse Event|0|||
130047070|NCT00521339|468130084|FG000|Treatment Phase|Intolerability to study drug|2|||
130047071|NCT00521339|468130085|FG001|Treatment Phase|Intolerability to study drug|0|||
130047072|NCT00521339|468130086|FG002|Treatment Phase|Intolerability to study drug|0|||
130047073|NCT00521339|468130084|FG000|Treatment Phase|Lack of Efficacy|3|||
130047074|NCT00521339|468130085|FG001|Treatment Phase|Lack of Efficacy|0|||
130047075|NCT00521339|468130086|FG002|Treatment Phase|Lack of Efficacy|0|||
130047076|NCT00521339|468130084|FG000|Treatment Phase|Withdrawal by Subject|3|||
130047077|NCT00521339|468130085|FG001|Treatment Phase|Withdrawal by Subject|0|||
130047078|NCT00521339|468130086|FG002|Treatment Phase|Withdrawal by Subject|0|||
130047079|NCT00521339|468130084|FG000|Treatment Phase|Lost to Follow-up|1|||
130047080|NCT00521339|468130085|FG001|Treatment Phase|Lost to Follow-up|0|||
130047081|NCT00521339|468130086|FG002|Treatment Phase|Lost to Follow-up|0|||
130047082|NCT00521339|468130084|FG000|Treatment Phase|Protocol Violation|1|||
130047083|NCT00521339|468130085|FG001|Treatment Phase|Protocol Violation|0|||
130047084|NCT00521339|468130086|FG002|Treatment Phase|Protocol Violation|0|||
130047085|NCT00521339|468130084|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
130047086|NCT00521339|468130085|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
130047087|NCT00521339|468130086|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
130047088|NCT00521339|468130084|FG000|Treatment Extension Phase|Death|0|||
130047089|NCT00521339|468130085|FG001|Treatment Extension Phase|Death|0|||
130047090|NCT00521339|468130086|FG002|Treatment Extension Phase|Death|1|||
130047091|NCT00089843|468130087|FG000|Overall Study|Withdrawal by Subject|1|||
130047092|NCT00089843|468130088|FG001|Overall Study|Withdrawal by Subject|4|||
130047093|NCT00089843|468130089|FG002|Overall Study|Withdrawal by Subject|5|||
130047094|NCT00089843|468130090|FG003|Overall Study|Withdrawal by Subject|6|||
130047095|NCT00089843|468130087|FG000|Overall Study|Physician Decision|1|||
130295814|NCT01105377|469045391|FG000|Overall Study|Withdrawal by Subject|0|||
130047096|NCT00089843|468130088|FG001|Overall Study|Physician Decision|0|||
130047097|NCT00089843|468130089|FG002|Overall Study|Physician Decision|0|||
130047098|NCT00089843|468130090|FG003|Overall Study|Physician Decision|1|||
130047099|NCT03314519|468130091|FG000|Overall Study|Protocol Violation|3|||
130295815|NCT01105377|469045392|FG001|Overall Study|Withdrawal by Subject|1|||
129888862|NCT01012973|467550927|FG000|Overall Study|Lost to Follow-up|1|||
129888863|NCT01012973|467550928|FG001|Overall Study|Lost to Follow-up|0|||
130047100|NCT03314519|468130092|FG001|Overall Study|Protocol Violation|2|||
130295816|NCT02540291|469045398|FG000|Overall Study|Death|7|||
130295817|NCT02540291|469045399|FG001|Overall Study|Death|7|||
130295818|NCT02540291|469045400|FG002|Overall Study|Death|5|||
130295819|NCT02540291|469045401|FG003|Overall Study|Death|7|||
130047101|NCT03042611|468130093|FG000|Core Phase|Withdrawal by Subject|13|||
130047102|NCT03042611|468130094|FG001|Core Phase|Withdrawal by Subject|4|||
130295820|NCT02540291|469045398|FG000|Overall Study|Lost to Follow-up|0|||
130295821|NCT02540291|469045399|FG001|Overall Study|Lost to Follow-up|0|||
130295822|NCT02540291|469045400|FG002|Overall Study|Lost to Follow-up|1|||
130295823|NCT02540291|469045401|FG003|Overall Study|Lost to Follow-up|0|||
130295824|NCT02540291|469045398|FG000|Overall Study|Withdrawal Of Consent|0|||
130295825|NCT02540291|469045399|FG001|Overall Study|Withdrawal Of Consent|1|||
130295826|NCT02540291|469045400|FG002|Overall Study|Withdrawal Of Consent|0|||
130295827|NCT02540291|469045401|FG003|Overall Study|Withdrawal Of Consent|0|||
129794274|NCT03569293|467214329|FG003|Overall Study|Ongoing at Time of Analysis|0|||
129794275|NCT03569293|467214330|FG004|Overall Study|Ongoing at Time of Analysis|0|||
129794276|NCT03569293|467214331|FG005|Overall Study|Ongoing at Time of Analysis|0|||
129794277|NCT05128929|467214333|FG000|Overall Study|Adverse Event|0|||
129794278|NCT05128929|467214334|FG001|Overall Study|Adverse Event|1|||
129794279|NCT02742246|467214335|FG000|Overall Study|Never initiated treatment|5|||
129794280|NCT02742246|467214336|FG001|Overall Study|Never initiated treatment|3|||
129794281|NCT02742246|467214337|FG002|Overall Study|Never initiated treatment|1|||
129794282|NCT02742246|467214335|FG000|Overall Study|dropped out during treatment|7|||
129794283|NCT02742246|467214336|FG001|Overall Study|dropped out during treatment|13|||
129794284|NCT02742246|467214337|FG002|Overall Study|dropped out during treatment|10|||
129794285|NCT02742246|467214335|FG000|Overall Study|Death|1|||
129794286|NCT02742246|467214336|FG001|Overall Study|Death|0|||
129794287|NCT02742246|467214337|FG002|Overall Study|Death|0|||
129794288|NCT03553836|467214339|FG000|Overall Study|Ongoing in Study|460|||
129794289|NCT03553836|467214340|FG001|Overall Study|Ongoing in Study|459|||
130047103|NCT03042611|468130095|FG002|Core Phase|Withdrawal by Subject|0|||
130047104|NCT03042611|468130096|FG003|Core Phase|Withdrawal by Subject|0|||
130047105|NCT03042611|468130093|FG000|Core Phase|Death|232|||
130047106|NCT03042611|468130094|FG001|Core Phase|Death|110|||
130047107|NCT03042611|468130095|FG002|Core Phase|Death|0|||
130047108|NCT03042611|468130096|FG003|Core Phase|Death|0|||
130047109|NCT03042611|468130093|FG000|Core Phase|Lost to Follow-up|4|||
130047110|NCT03042611|468130094|FG001|Core Phase|Lost to Follow-up|7|||
130047111|NCT03042611|468130095|FG002|Core Phase|Lost to Follow-up|0|||
130047112|NCT03042611|468130096|FG003|Core Phase|Lost to Follow-up|0|||
130047113|NCT03042611|468130093|FG000|Core Phase|Physician Decision|7|||
130047114|NCT03042611|468130094|FG001|Core Phase|Physician Decision|2|||
130047115|NCT03042611|468130095|FG002|Core Phase|Physician Decision|0|||
130047116|NCT03042611|468130096|FG003|Core Phase|Physician Decision|0|||
130047117|NCT03042611|468130093|FG000|Core Phase|Study Closed|0|||
130047118|NCT03042611|468130094|FG001|Core Phase|Study Closed|1|||
130047119|NCT03042611|468130095|FG002|Core Phase|Study Closed|0|||
130047120|NCT03042611|468130096|FG003|Core Phase|Study Closed|0|||
130047121|NCT03042611|468130093|FG000|Extension Phase|Death|0|||
130047122|NCT03042611|468130094|FG001|Extension Phase|Death|0|||
130047123|NCT03042611|468130095|FG002|Extension Phase|Death|34|||
130047124|NCT03042611|468130096|FG003|Extension Phase|Death|16|||
130047125|NCT03042611|468130093|FG000|Extension Phase|Lost to Follow-up|0|||
130047126|NCT03042611|468130094|FG001|Extension Phase|Lost to Follow-up|0|||
130047127|NCT03042611|468130095|FG002|Extension Phase|Lost to Follow-up|1|||
130047128|NCT03042611|468130096|FG003|Extension Phase|Lost to Follow-up|1|||
130047129|NCT03042611|468130093|FG000|Extension Phase|Study Closed|0|||
130047130|NCT03042611|468130094|FG001|Extension Phase|Study Closed|0|||
130047131|NCT03042611|468130095|FG002|Extension Phase|Study Closed|17|||
130047132|NCT03042611|468130096|FG003|Extension Phase|Study Closed|11|||
130047133|NCT00950690|468130099|FG000|Overall Study|Death|4|||
130047134|NCT00950690|468130099|FG000|Overall Study|Adverse Event|15|||
130047135|NCT00950690|468130099|FG000|Overall Study|Lack of Efficacy|22|||
130047136|NCT00950690|468130099|FG000|Overall Study|Lost to Follow-up|40|||
130047137|NCT00950690|468130099|FG000|Overall Study|Other|163|||
130047138|NCT01713036|468130100|FG000|Overall Study|Death|1|||
130047139|NCT03567291|468130103|FG000|Period I|Adverse Event|14|||
130047140|NCT03567291|468130104|FG001|Period I|Adverse Event|0|||
130047141|NCT03567291|468130105|FG002|Period I|Adverse Event|0|||
130047142|NCT03567291|468130106|FG003|Period I|Adverse Event|0|||
130047143|NCT03567291|468130103|FG000|Period I|Protocol Violation|1|||
130047144|NCT03567291|468130104|FG001|Period I|Protocol Violation|0|||
130295828|NCT02540291|469045398|FG000|Overall Study|Study Terminated By Sponsor|1|||
129794290|NCT03553836|467214339|FG000|Overall Study|Withdrawal by Subject|9|||
129794291|NCT03553836|467214340|FG001|Overall Study|Withdrawal by Subject|10|||
129794292|NCT03553836|467214339|FG000|Overall Study|Lost to Follow-up|1|||
130047145|NCT03567291|468130105|FG002|Period I|Protocol Violation|0|||
130047146|NCT03567291|468130106|FG003|Period I|Protocol Violation|0|||
130047147|NCT03567291|468130103|FG000|Period I|Withdrawal by Subject|23|||
130295829|NCT02540291|469045399|FG001|Overall Study|Study Terminated By Sponsor|0|||
130295830|NCT02540291|469045400|FG002|Overall Study|Study Terminated By Sponsor|0|||
130047148|NCT03567291|468130104|FG001|Period I|Withdrawal by Subject|0|||
130047149|NCT03567291|468130105|FG002|Period I|Withdrawal by Subject|0|||
130047150|NCT03567291|468130106|FG003|Period I|Withdrawal by Subject|0|||
130047151|NCT03567291|468130103|FG000|Period I|Lost to Follow-up|2|||
130047152|NCT03567291|468130104|FG001|Period I|Lost to Follow-up|0|||
130295831|NCT02540291|469045401|FG003|Overall Study|Study Terminated By Sponsor|0|||
130295832|NCT02540291|469045398|FG000|Overall Study|Other|0|||
130295833|NCT02540291|469045399|FG001|Overall Study|Other|0|||
130295834|NCT02540291|469045400|FG002|Overall Study|Other|1|||
130295835|NCT02540291|469045401|FG003|Overall Study|Other|0|||
130295836|NCT00707954|469047197|FG000|Overall Study|Physician Decision|0|||
130295837|NCT00707954|469047198|FG001|Overall Study|Physician Decision|0|||
130295838|NCT00707954|469047199|FG002|Overall Study|Physician Decision|0|||
130047153|NCT03567291|468130105|FG002|Period I|Lost to Follow-up|0|||
130047154|NCT03567291|468130106|FG003|Period I|Lost to Follow-up|0|||
130047155|NCT03567291|468130103|FG000|Period I|Terminated by sponsor|44|||
130047156|NCT03567291|468130104|FG001|Period I|Terminated by sponsor|0|||
130047157|NCT03567291|468130105|FG002|Period I|Terminated by sponsor|0|||
130047158|NCT03567291|468130106|FG003|Period I|Terminated by sponsor|0|||
130047159|NCT03567291|468130103|FG000|Period I|Missing or unknown|7|||
130047160|NCT03567291|468130104|FG001|Period I|Missing or unknown|0|||
130047161|NCT03567291|468130105|FG002|Period I|Missing or unknown|0|||
130047162|NCT03567291|468130106|FG003|Period I|Missing or unknown|0|||
130047163|NCT03567291|468130103|FG000|Period II|Adverse Event|0|||
130047164|NCT03567291|468130104|FG001|Period II|Adverse Event|1|||
130047165|NCT03567291|468130105|FG002|Period II|Adverse Event|0|||
130047166|NCT03567291|468130106|FG003|Period II|Adverse Event|0|||
130047167|NCT03567291|468130103|FG000|Period II|Missing or unknown|0|||
130047168|NCT03567291|468130104|FG001|Period II|Missing or unknown|2|||
130047169|NCT03567291|468130105|FG002|Period II|Missing or unknown|1|||
130047170|NCT03567291|468130106|FG003|Period II|Missing or unknown|0|||
130047171|NCT03567291|468130103|FG000|Period III|Adverse Event|0|||
130047172|NCT03567291|468130104|FG001|Period III|Adverse Event|0|||
130047173|NCT03567291|468130105|FG002|Period III|Adverse Event|0|||
130047174|NCT03567291|468130106|FG003|Period III|Adverse Event|4|||
130047175|NCT03567291|468130103|FG000|Period III|Withdrawal by Subject|0|||
130047176|NCT03567291|468130104|FG001|Period III|Withdrawal by Subject|0|||
130047177|NCT03567291|468130105|FG002|Period III|Withdrawal by Subject|0|||
130047178|NCT03567291|468130106|FG003|Period III|Withdrawal by Subject|4|||
130047179|NCT03567291|468130103|FG000|Period III|Lost to Follow-up|0|||
130047180|NCT03567291|468130104|FG001|Period III|Lost to Follow-up|0|||
130047181|NCT03567291|468130105|FG002|Period III|Lost to Follow-up|0|||
130047182|NCT03567291|468130106|FG003|Period III|Lost to Follow-up|1|||
130047183|NCT03567291|468130103|FG000|Period III|Terminated by sponsor|0|||
130047184|NCT03567291|468130104|FG001|Period III|Terminated by sponsor|0|||
130047185|NCT03567291|468130105|FG002|Period III|Terminated by sponsor|0|||
130047186|NCT03567291|468130106|FG003|Period III|Terminated by sponsor|68|||
130047187|NCT03567291|468130103|FG000|Period III|Missing or unknown|0|||
130047188|NCT03567291|468130104|FG001|Period III|Missing or unknown|0|||
130047189|NCT03567291|468130105|FG002|Period III|Missing or unknown|0|||
130047190|NCT03567291|468130106|FG003|Period III|Missing or unknown|8|||
130047191|NCT01103349|468130107|FG000|Overall Study|Adverse Event|8|||
130047192|NCT01103349|468130108|FG001|Overall Study|Adverse Event|5|||
130047193|NCT01103349|468130109|FG002|Overall Study|Adverse Event|3|||
130047194|NCT01103349|468130107|FG000|Overall Study|Consent withdrawn|1|||
130047195|NCT01103349|468130108|FG001|Overall Study|Consent withdrawn|0|||
130047196|NCT01103349|468130109|FG002|Overall Study|Consent withdrawn|0|||
130047197|NCT01103349|468130107|FG000|Overall Study|Incorrectly included in the trial|1|||
130047198|NCT01103349|468130108|FG001|Overall Study|Incorrectly included in the trial|0|||
130047199|NCT01103349|468130109|FG002|Overall Study|Incorrectly included in the trial|0|||
130047200|NCT01103349|468130107|FG000|Overall Study|Withdrawal by Subject|1|||
130047201|NCT01103349|468130108|FG001|Overall Study|Withdrawal by Subject|1|||
130047202|NCT01103349|468130109|FG002|Overall Study|Withdrawal by Subject|0|||
130047203|NCT01103349|468130107|FG000|Overall Study|did not want to take trial medication|0|||
130295839|NCT00707954|469047200|FG003|Overall Study|Physician Decision|0|||
130295840|NCT00707954|469047201|FG004|Overall Study|Physician Decision|1|||
130295841|NCT04037254|469047202|FG000|Overall Study|Protocol Violation|1|||
130295842|NCT04037254|469047203|FG001|Overall Study|Protocol Violation|0|||
130295843|NCT04037254|469047204|FG002|Overall Study|Protocol Violation|0|||
130295844|NCT04037254|469047205|FG003|Overall Study|Protocol Violation|0|||
130295845|NCT04037254|469047206|FG004|Overall Study|Protocol Violation|0|||
130295846|NCT04037254|469047202|FG000|Overall Study|Withdrawal by Subject|0|||
130295847|NCT04037254|469047203|FG001|Overall Study|Withdrawal by Subject|0|||
130295848|NCT04037254|469047204|FG002|Overall Study|Withdrawal by Subject|1|||
130295849|NCT04037254|469047205|FG003|Overall Study|Withdrawal by Subject|0|||
130295850|NCT04037254|469047206|FG004|Overall Study|Withdrawal by Subject|0|||
130295851|NCT04037254|469047202|FG000|Overall Study|Delayed or incomplete treatment|0|||
130295852|NCT04037254|469047203|FG001|Overall Study|Delayed or incomplete treatment|2|||
130295853|NCT04037254|469047204|FG002|Overall Study|Delayed or incomplete treatment|1|||
130295854|NCT04037254|469047205|FG003|Overall Study|Delayed or incomplete treatment|0|||
130295855|NCT04037254|469047206|FG004|Overall Study|Delayed or incomplete treatment|0|||
130295856|NCT01306656|469047207|FG000|Overall Study|Lost to Follow-up|1|||
130295857|NCT01306656|469047208|FG001|Overall Study|Lost to Follow-up|0|||
130295858|NCT02504580|469047209|FG000|Overall Study|Other|1|||
130295859|NCT02504580|469047210|FG001|Overall Study|Other|0|||
130295860|NCT02504580|469047211|FG002|Overall Study|Other|0|||
130295861|NCT02504580|469047212|FG003|Overall Study|Other|2|||
130295862|NCT02504580|469047213|FG004|Overall Study|Other|1|||
130295863|NCT02504580|469047214|FG005|Overall Study|Other|1|||
130295864|NCT02504580|469047215|FG006|Overall Study|Other|1|||
130295865|NCT02504580|469047216|FG007|Overall Study|Other|2|||
130295866|NCT02504580|469047217|FG008|Overall Study|Other|0|||
130295867|NCT02504580|469047218|FG009|Overall Study|Other|0|||
130295868|NCT02504580|469047219|FG010|Overall Study|Other|0|||
130295869|NCT02504580|469047220|FG011|Overall Study|Other|2|||
130295870|NCT02504580|469047209|FG000|Overall Study|Subject refusal to continue|0|||
130295871|NCT02504580|469047210|FG001|Overall Study|Subject refusal to continue|1|||
130295872|NCT02504580|469047211|FG002|Overall Study|Subject refusal to continue|0|||
130295873|NCT02504580|469047212|FG003|Overall Study|Subject refusal to continue|0|||
130295874|NCT02504580|469047213|FG004|Overall Study|Subject refusal to continue|0|||
130295875|NCT02504580|469047214|FG005|Overall Study|Subject refusal to continue|0|||
130295876|NCT02504580|469047215|FG006|Overall Study|Subject refusal to continue|0|||
130295877|NCT02504580|469047216|FG007|Overall Study|Subject refusal to continue|0|||
130295878|NCT02504580|469047217|FG008|Overall Study|Subject refusal to continue|0|||
130295879|NCT02504580|469047218|FG009|Overall Study|Subject refusal to continue|0|||
130295880|NCT02504580|469047219|FG010|Overall Study|Subject refusal to continue|0|||
130295881|NCT02504580|469047220|FG011|Overall Study|Subject refusal to continue|0|||
130295882|NCT00448747|469047222|FG000|Overall Study|collapsed veins|1|||
130295883|NCT00448747|469047223|FG001|Overall Study|collapsed veins|0|||
130295884|NCT04051827|469047229|FG000|Overall Study|Death|1|||
130295885|NCT04051827|469047229|FG000|Overall Study|Withdrawal by Subject|4|||
130295886|NCT04051827|469047229|FG000|Overall Study|Progressive disease|16|||
130295887|NCT04051827|469047229|FG000|Overall Study|Physician Decision|1|||
130295888|NCT04051827|469047229|FG000|Overall Study|Other|4|||
130295889|NCT01424566|469047230|FG000|Single-blind Treatment|Adverse Event|71|||
130295890|NCT01424566|469047231|FG001|Single-blind Treatment|Adverse Event|0|||
130295891|NCT01424566|469047232|FG002|Single-blind Treatment|Adverse Event|0|||
130295892|NCT01424566|469047230|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
130295893|NCT01424566|469047231|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
130295894|NCT01424566|469047232|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
130295895|NCT01424566|469047230|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
130295896|NCT01424566|469047231|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
130295897|NCT01424566|469047232|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
130295898|NCT01424566|469047230|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
130295899|NCT01424566|469047231|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
130295900|NCT01424566|469047232|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
130295901|NCT01424566|469047230|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
130295902|NCT01424566|469047231|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
130295903|NCT01424566|469047232|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
130295904|NCT01424566|469047230|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
130295905|NCT01424566|469047231|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
130295906|NCT01424566|469047232|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
130295907|NCT01424566|469047230|FG000|Double-blind Treatment|Adverse Event|0|||
130295908|NCT01424566|469047231|FG001|Double-blind Treatment|Adverse Event|21|||
129794293|NCT03553836|467214340|FG001|Overall Study|Lost to Follow-up|3|||
129794294|NCT03553836|467214339|FG000|Overall Study|Death|17|||
129794295|NCT03553836|467214340|FG001|Overall Study|Death|17|||
130295909|NCT01424566|469047232|FG002|Double-blind Treatment|Adverse Event|13|||
130295910|NCT01424566|469047230|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
130295911|NCT01424566|469047231|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
130295912|NCT01424566|469047232|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
130295913|NCT01424566|469047230|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
130295914|NCT01424566|469047231|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
130295915|NCT01424566|469047232|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
129794296|NCT03220438|467214341|FG000|Overall Study|Lost to Follow-up|0|||
130295916|NCT01424566|469047230|FG000|Double-blind Treatment|Lack of Efficacy|0|||
130295917|NCT01424566|469047231|FG001|Double-blind Treatment|Lack of Efficacy|1|||
130295918|NCT01424566|469047232|FG002|Double-blind Treatment|Lack of Efficacy|1|||
130295919|NCT03779503|469047237|FG000|First Intervention|Adverse Event|0|||
130295920|NCT03779503|469047238|FG001|First Intervention|Adverse Event|1|||
130295921|NCT03779503|469047237|FG000|First Intervention|Withdrawal by Subject|1|||
130295922|NCT03779503|469047238|FG001|First Intervention|Withdrawal by Subject|0|||
130295923|NCT00687609|469047239|FG000|Overall Study|Physician Decision|1|||
130295924|NCT00687609|469047239|FG000|Overall Study|Withdrawal by Subject|2|||
130295925|NCT00908037|469047240|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295926|NCT00908037|469047241|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295927|NCT00908037|469047242|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295928|NCT00908037|469047243|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295929|NCT00908037|469047244|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
130295930|NCT00908037|469047245|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295931|NCT00908037|469047246|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
130295932|NCT00908037|469047247|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295933|NCT00908037|469047248|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
130295934|NCT00908037|469047249|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295935|NCT00908037|469047250|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295936|NCT00908037|469047251|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
130295937|NCT00908037|469047240|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295938|NCT00908037|469047241|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295939|NCT00908037|469047242|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295940|NCT00908037|469047243|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295941|NCT00908037|469047244|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
130295942|NCT00908037|469047245|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295943|NCT00908037|469047246|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295944|NCT00908037|469047247|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295945|NCT00908037|469047248|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
130295946|NCT00908037|469047249|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295947|NCT00908037|469047250|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295948|NCT00908037|469047251|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
130295949|NCT00908037|469047240|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295950|NCT00908037|469047241|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295951|NCT00908037|469047242|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295952|NCT00908037|469047243|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
130295953|NCT00908037|469047244|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295954|NCT00908037|469047245|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295955|NCT00908037|469047246|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
130295956|NCT00908037|469047247|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295957|NCT00908037|469047248|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295958|NCT00908037|469047249|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295959|NCT00908037|469047250|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295960|NCT00908037|469047251|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
130295961|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295962|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295963|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295964|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295965|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295966|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295967|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295968|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295969|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295970|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295971|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
130295972|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
129794297|NCT03220438|467214342|FG001|Overall Study|Lost to Follow-up|0|||
129794298|NCT03220438|467214343|FG002|Overall Study|Lost to Follow-up|1|||
129794299|NCT03220438|467214344|FG003|Overall Study|Lost to Follow-up|0|||
129794300|NCT04062123|467214345|FG000|Overall Study|Withdrawal by Subject|0|||
129794301|NCT04062123|467214346|FG001|Overall Study|Withdrawal by Subject|1|||
130295973|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295974|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295975|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129794302|NCT04062123|467214347|FG002|Overall Study|Withdrawal by Subject|0|||
129794303|NCT01479985|467214350|FG000|Overall Study|Tablet malfunction, no data saved|1|||
130295976|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295977|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295978|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295979|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295980|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295981|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295982|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
130295983|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
130295984|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
130295985|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295986|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295987|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295988|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295989|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295990|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295991|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295992|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295993|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295994|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
130295995|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295996|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
130295997|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130295998|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130295999|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296000|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296001|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296002|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296003|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296004|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296005|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296006|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296007|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
130296008|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
130296009|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296010|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296011|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296012|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296013|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296014|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296015|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296016|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296017|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296018|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
130296019|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296020|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
130296021|NCT00908037|469047240|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296022|NCT00908037|469047241|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296023|NCT00908037|469047242|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296024|NCT00908037|469047243|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296025|NCT00908037|469047244|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296026|NCT00908037|469047245|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296027|NCT00908037|469047246|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296028|NCT00908037|469047247|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296029|NCT00908037|469047248|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296030|NCT00908037|469047249|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129888864|NCT01012973|467550927|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
129888865|NCT01012973|467550928|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
129888866|NCT01012973|467550927|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
130296031|NCT00908037|469047250|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
130296032|NCT00908037|469047251|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
130296033|NCT00581360|469047257|FG000|Overall Study|Withdrawal by Subject|1|||
130296034|NCT00552760|469047258|FG000|Overall Study|Adverse Event|3|||
130296035|NCT00552760|469047259|FG001|Overall Study|Adverse Event|5|||
130296036|NCT00552760|469047258|FG000|Overall Study|Relapsed- Depressed Event|10|||
130296037|NCT00552760|469047259|FG001|Overall Study|Relapsed- Depressed Event|16|||
130296038|NCT00552760|469047258|FG000|Overall Study|Relapse- Manic Event|3|||
130296039|NCT00552760|469047259|FG001|Overall Study|Relapse- Manic Event|3|||
130296040|NCT00552760|469047258|FG000|Overall Study|Relapsed- Mixed Event|3|||
130296041|NCT00552760|469047259|FG001|Overall Study|Relapsed- Mixed Event|5|||
130296042|NCT00552760|469047258|FG000|Overall Study|Protocol Violation|0|||
130296043|NCT00552760|469047259|FG001|Overall Study|Protocol Violation|1|||
130296044|NCT00552760|469047258|FG000|Overall Study|Lost to Follow-up|1|||
130296045|NCT00552760|469047259|FG001|Overall Study|Lost to Follow-up|1|||
130296046|NCT00552760|469047258|FG000|Overall Study|Non-compliance|1|||
130296047|NCT00552760|469047259|FG001|Overall Study|Non-compliance|1|||
130296048|NCT00552760|469047258|FG000|Overall Study|Medical Condition|1|||
130296049|NCT00552760|469047259|FG001|Overall Study|Medical Condition|1|||
130296050|NCT00552760|469047258|FG000|Overall Study|Withdrawal by Subject|3|||
130296051|NCT00552760|469047259|FG001|Overall Study|Withdrawal by Subject|0|||
130296052|NCT00552760|469047258|FG000|Overall Study|Medication Change|1|||
130296053|NCT00552760|469047259|FG001|Overall Study|Medication Change|0|||
130296054|NCT00924404|469047262|FG000|Overall Study|Lost to Follow-up|6|||
130296055|NCT00924404|469047263|FG001|Overall Study|Lost to Follow-up|4|||
130296056|NCT03831945|469047264|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
130296057|NCT03831945|469047265|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
130296058|NCT03831945|469047264|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
130296059|NCT03831945|469047265|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
130296060|NCT03831945|469047264|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
130296061|NCT03831945|469047265|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
130296062|NCT00710385|469047267|FG000|Overall Study|Did not qualify|1|||
130296063|NCT00710385|469047267|FG000|Overall Study|Withdrawal by Subject|1|||
130296064|NCT00710385|469047267|FG000|Overall Study|Undisclosed back pain|1|||
130296065|NCT00710385|469047267|FG000|Overall Study|Physician Decision|1|||
130296066|NCT00710385|469047267|FG000|Overall Study|Undisclosed excessive methadone use|1|||
130296067|NCT02976103|469047268|FG000|Overall Study|Withdrawal by Subject|1|||
130296068|NCT02976103|469047269|FG001|Overall Study|Withdrawal by Subject|0|||
130296069|NCT02976103|469047268|FG000|Overall Study|Lost to Follow-up|12|||
130296070|NCT02976103|469047269|FG001|Overall Study|Lost to Follow-up|8|||
130296071|NCT01985360|469047270|FG000|Overall Study|Withdrawal by Subject|4|||
130296072|NCT01985360|469047271|FG001|Overall Study|Withdrawal by Subject|0|||
129888867|NCT01012973|467550928|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
129888868|NCT01012973|467550927|FG000|Overall Study|Protocol Violation|5|||
129888869|NCT01012973|467550928|FG001|Overall Study|Protocol Violation|2|||
129888870|NCT01012973|467550927|FG000|Overall Study|Withdrawal by Subject|4|||
129888871|NCT01012973|467550928|FG001|Overall Study|Withdrawal by Subject|6|||
129888872|NCT02213055|467550930|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
129888873|NCT02213055|467550931|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
129888874|NCT02213055|467550930|FG000|Overall Study|Protocol was not Followed during Study|1|||
129888875|NCT02213055|467550931|FG001|Overall Study|Protocol was not Followed during Study|0|||
129888876|NCT02213055|467550930|FG000|Overall Study|Documentation Issue at Enrollment|1|||
130296073|NCT01985360|469047270|FG000|Overall Study|Lost to Follow-up|5|||
130296074|NCT01985360|469047271|FG001|Overall Study|Lost to Follow-up|3|||
130296075|NCT04881747|469047274|FG000|Period 2 Washout|Adverse Event|1|||
130296076|NCT04881747|469047275|FG001|Period 2 Washout|Adverse Event|0|||
130296077|NCT04881747|469047276|FG002|Period 2 Washout|Adverse Event|0|||
130296078|NCT04881747|469047277|FG003|Period 2 Washout|Adverse Event|0|||
129888877|NCT02213055|467550931|FG001|Overall Study|Documentation Issue at Enrollment|0|||
129888878|NCT02213055|467550930|FG000|Overall Study|Documentation Issue during Study|10|||
130047204|NCT01103349|468130108|FG001|Overall Study|did not want to take trial medication|1|||
130047205|NCT01103349|468130109|FG002|Overall Study|did not want to take trial medication|0|||
130296079|NCT04881747|469047278|FG004|Period 2 Washout|Adverse Event|1|||
130296080|NCT04881747|469047279|FG005|Period 2 Washout|Adverse Event|0|||
130296081|NCT04881747|469047274|FG000|Period 2 Washout|Withdrawal by Subject|1|||
130296082|NCT04881747|469047275|FG001|Period 2 Washout|Withdrawal by Subject|0|||
130296083|NCT04881747|469047276|FG002|Period 2 Washout|Withdrawal by Subject|0|||
130296084|NCT04881747|469047277|FG003|Period 2 Washout|Withdrawal by Subject|1|||
130296085|NCT04881747|469047278|FG004|Period 2 Washout|Withdrawal by Subject|0|||
130296086|NCT04881747|469047279|FG005|Period 2 Washout|Withdrawal by Subject|0|||
130296087|NCT04598269|469047282|FG000|Overall Study|Adverse Event|0|||
130296088|NCT04598269|469047283|FG001|Overall Study|Adverse Event|3|||
130296089|NCT04598269|469047282|FG000|Overall Study|Withdrawal by Subject|1|||
130296090|NCT04598269|469047283|FG001|Overall Study|Withdrawal by Subject|4|||
130296091|NCT04598269|469047282|FG000|Overall Study|Lost to Follow-up|1|||
130296092|NCT04598269|469047283|FG001|Overall Study|Lost to Follow-up|0|||
130296093|NCT04598269|469047282|FG000|Overall Study|Not Treated|2|||
130296094|NCT04598269|469047283|FG001|Overall Study|Not Treated|0|||
130296095|NCT02598128|469047288|FG000|Period A: Days -7 to -1|Adverse Event|1|||
130296096|NCT02598128|469047289|FG001|Period A: Days -7 to -1|Adverse Event|0|||
130296097|NCT02598128|469047290|FG002|Period A: Days -7 to -1|Adverse Event|0|||
130296098|NCT02598128|469047291|FG003|Period A: Days -7 to -1|Adverse Event|0|||
130296099|NCT01459913|469047292|FG000|Overall Study|Adverse Event|0|||
130296100|NCT01459913|469047293|FG001|Overall Study|Adverse Event|0|||
130296101|NCT01459913|469047294|FG002|Overall Study|Adverse Event|0|||
130296102|NCT01459913|469047295|FG003|Overall Study|Adverse Event|3|||
130296103|NCT01459913|469047292|FG000|Overall Study|Withdrawal by Subject|4|||
130296104|NCT01459913|469047293|FG001|Overall Study|Withdrawal by Subject|0|||
130296105|NCT01459913|469047294|FG002|Overall Study|Withdrawal by Subject|0|||
130296106|NCT01459913|469047295|FG003|Overall Study|Withdrawal by Subject|5|||
130296107|NCT01459913|469047292|FG000|Overall Study|Lost to Follow-up|7|||
130296108|NCT01459913|469047293|FG001|Overall Study|Lost to Follow-up|4|||
130296109|NCT01459913|469047294|FG002|Overall Study|Lost to Follow-up|1|||
130296110|NCT01459913|469047295|FG003|Overall Study|Lost to Follow-up|8|||
130296111|NCT01459913|469047292|FG000|Overall Study|Death|0|||
130296112|NCT01459913|469047293|FG001|Overall Study|Death|0|||
130296113|NCT01459913|469047294|FG002|Overall Study|Death|0|||
130296114|NCT01459913|469047295|FG003|Overall Study|Death|1|||
130296115|NCT01459913|469047292|FG000|Overall Study|Non- Compliance|0|||
130296116|NCT01459913|469047293|FG001|Overall Study|Non- Compliance|0|||
130296117|NCT01459913|469047294|FG002|Overall Study|Non- Compliance|0|||
130296118|NCT01459913|469047295|FG003|Overall Study|Non- Compliance|3|||
130296119|NCT01459913|469047292|FG000|Overall Study|Physician Decision|0|||
130296120|NCT01459913|469047293|FG001|Overall Study|Physician Decision|1|||
130296121|NCT01459913|469047294|FG002|Overall Study|Physician Decision|0|||
130296122|NCT01459913|469047295|FG003|Overall Study|Physician Decision|0|||
130296123|NCT01459913|469047292|FG000|Overall Study|Study Terminated by Sponsor|30|||
130296124|NCT01459913|469047293|FG001|Overall Study|Study Terminated by Sponsor|15|||
130296125|NCT01459913|469047294|FG002|Overall Study|Study Terminated by Sponsor|9|||
130296126|NCT01459913|469047295|FG003|Overall Study|Study Terminated by Sponsor|11|||
130296127|NCT01459913|469047292|FG000|Overall Study|Other|0|||
130296128|NCT01459913|469047293|FG001|Overall Study|Other|0|||
130296129|NCT01459913|469047294|FG002|Overall Study|Other|3|||
130296130|NCT01459913|469047295|FG003|Overall Study|Other|1|||
130296131|NCT01459913|469047292|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
130296132|NCT01459913|469047293|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
130296133|NCT01459913|469047294|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
130296134|NCT01459913|469047295|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
130296135|NCT01064687|469047297|FG000|Overall Study|Adverse Event|9|||
130296136|NCT01064687|469047298|FG001|Overall Study|Adverse Event|4|||
130296137|NCT01064687|469047299|FG002|Overall Study|Adverse Event|10|||
130296138|NCT01064687|469047300|FG003|Overall Study|Adverse Event|3|||
130296139|NCT01064687|469047297|FG000|Overall Study|Death|1|||
130296140|NCT01064687|469047298|FG001|Overall Study|Death|1|||
130296141|NCT01064687|469047299|FG002|Overall Study|Death|0|||
130296142|NCT01064687|469047300|FG003|Overall Study|Death|0|||
129888879|NCT02213055|467550931|FG001|Overall Study|Documentation Issue during Study|0|||
130296143|NCT01064687|469047297|FG000|Overall Study|Entry Criteria Not Met|3|||
130296144|NCT01064687|469047298|FG001|Overall Study|Entry Criteria Not Met|0|||
130296145|NCT01064687|469047299|FG002|Overall Study|Entry Criteria Not Met|0|||
130296146|NCT01064687|469047300|FG003|Overall Study|Entry Criteria Not Met|0|||
130296147|NCT01064687|469047297|FG000|Overall Study|Lack of Efficacy|1|||
130296148|NCT01064687|469047298|FG001|Overall Study|Lack of Efficacy|0|||
130296149|NCT01064687|469047299|FG002|Overall Study|Lack of Efficacy|2|||
130296150|NCT01064687|469047300|FG003|Overall Study|Lack of Efficacy|3|||
130296151|NCT01064687|469047297|FG000|Overall Study|Lost to Follow-up|7|||
130296152|NCT01064687|469047298|FG001|Overall Study|Lost to Follow-up|10|||
130296153|NCT01064687|469047299|FG002|Overall Study|Lost to Follow-up|13|||
130296154|NCT01064687|469047300|FG003|Overall Study|Lost to Follow-up|5|||
130296155|NCT01064687|469047297|FG000|Overall Study|Physician Decision|2|||
130296156|NCT01064687|469047298|FG001|Overall Study|Physician Decision|2|||
130296157|NCT01064687|469047299|FG002|Overall Study|Physician Decision|0|||
130296158|NCT01064687|469047300|FG003|Overall Study|Physician Decision|0|||
130296159|NCT01064687|469047297|FG000|Overall Study|Protocol Violation|1|||
130296160|NCT01064687|469047298|FG001|Overall Study|Protocol Violation|1|||
130296161|NCT01064687|469047299|FG002|Overall Study|Protocol Violation|0|||
130296162|NCT01064687|469047300|FG003|Overall Study|Protocol Violation|1|||
130296163|NCT01064687|469047297|FG000|Overall Study|Sponsor Decision|0|||
130296164|NCT01064687|469047298|FG001|Overall Study|Sponsor Decision|0|||
130296165|NCT01064687|469047299|FG002|Overall Study|Sponsor Decision|3|||
130296166|NCT01064687|469047300|FG003|Overall Study|Sponsor Decision|0|||
130296167|NCT01064687|469047297|FG000|Overall Study|Withdrawal by Subject|9|||
130296168|NCT01064687|469047298|FG001|Overall Study|Withdrawal by Subject|7|||
130296169|NCT01064687|469047299|FG002|Overall Study|Withdrawal by Subject|12|||
130296170|NCT01064687|469047300|FG003|Overall Study|Withdrawal by Subject|5|||
130296171|NCT01064687|469047297|FG000|Overall Study|Treatment Noncompliance|1|||
130296172|NCT01064687|469047298|FG001|Overall Study|Treatment Noncompliance|1|||
130296173|NCT01064687|469047299|FG002|Overall Study|Treatment Noncompliance|1|||
130296174|NCT01064687|469047300|FG003|Overall Study|Treatment Noncompliance|0|||
130296175|NCT00619489|469047301|FG000|Overall Study|Adverse Event|0|||
130296176|NCT00619489|469047302|FG001|Overall Study|Adverse Event|7|||
130296177|NCT00619489|469047301|FG000|Overall Study|Withdrawal by Subject|1|||
130296178|NCT00619489|469047302|FG001|Overall Study|Withdrawal by Subject|1|||
130296179|NCT00619489|469047301|FG000|Overall Study|Lack of Efficacy|0|||
130296180|NCT00619489|469047302|FG001|Overall Study|Lack of Efficacy|11|||
130296181|NCT00619489|469047301|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
130296182|NCT00619489|469047302|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
130296183|NCT02966015|469047303|FG000|Inclusion Visit|did not answer questionnaire|8|||
130296184|NCT02966015|469047304|FG001|Inclusion Visit|did not answer questionnaire|3|||
130296185|NCT03040986|469047309|FG000|Overall Study|Hospice|1|||
130296186|NCT03040986|469047310|FG001|Overall Study|Hospice|0|||
130296187|NCT03040986|469047309|FG000|Overall Study|Adverse Event|2|||
130296188|NCT03040986|469047310|FG001|Overall Study|Adverse Event|1|||
130296189|NCT03040986|469047309|FG000|Overall Study|Disease progression on study|3|||
130296190|NCT03040986|469047310|FG001|Overall Study|Disease progression on study|1|||
130296191|NCT01183468|469047315|FG000|Overall Study|Lost to Follow-up|2|||
130296192|NCT01183468|469047316|FG001|Overall Study|Lost to Follow-up|1|||
130296193|NCT01183468|469047317|FG002|Overall Study|Lost to Follow-up|0|||
130296194|NCT01183468|469047318|FG003|Overall Study|Lost to Follow-up|0|||
130296195|NCT01183468|469047315|FG000|Overall Study|Physician Decision|1|||
130296196|NCT01183468|469047316|FG001|Overall Study|Physician Decision|0|||
130296197|NCT01183468|469047317|FG002|Overall Study|Physician Decision|0|||
130296198|NCT01183468|469047318|FG003|Overall Study|Physician Decision|0|||
130296199|NCT01183468|469047315|FG000|Overall Study|Withdrawal by Subject|0|||
130296200|NCT01183468|469047316|FG001|Overall Study|Withdrawal by Subject|1|||
130296201|NCT01183468|469047317|FG002|Overall Study|Withdrawal by Subject|0|||
130296202|NCT01183468|469047318|FG003|Overall Study|Withdrawal by Subject|0|||
130296203|NCT00845065|469047319|FG000|Overall Study|Adverse Event|3|||
130296204|NCT00845065|469047320|FG001|Overall Study|Adverse Event|23|||
130296205|NCT00845065|469047319|FG000|Overall Study|Lack of Efficacy|43|||
130296206|NCT00845065|469047320|FG001|Overall Study|Lack of Efficacy|21|||
130296207|NCT00845065|469047319|FG000|Overall Study|Non-Medical Reasons|1|||
130296208|NCT00845065|469047320|FG001|Overall Study|Non-Medical Reasons|11|||
130296209|NCT01198509|469047321|FG000|Overall Study|Withdrawal by Subject|1|||
130296210|NCT01198509|469047322|FG001|Overall Study|Withdrawal by Subject|0|||
130296211|NCT01198509|469047323|FG002|Overall Study|Withdrawal by Subject|0|||
130296212|NCT01198509|469047324|FG003|Overall Study|Withdrawal by Subject|0|||
130296213|NCT01198509|469047325|FG004|Overall Study|Withdrawal by Subject|0|||
130296214|NCT01198509|469047326|FG005|Overall Study|Withdrawal by Subject|0|||
130296215|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
130296216|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
130296217|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
130296218|NCT00499746|469047327|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
130296219|NCT02273960|469047328|FG000|Short Term Period|Lost to Follow-up|1|||
130296220|NCT02273960|469047329|FG001|Short Term Period|Lost to Follow-up|0|||
130296221|NCT02273960|469047330|FG002|Short Term Period|Lost to Follow-up|0|||
130296222|NCT02273960|469047331|FG003|Short Term Period|Lost to Follow-up|0|||
130296223|NCT02273960|469047328|FG000|Short Term Period|Lack of Efficacy|0|||
130296224|NCT02273960|469047329|FG001|Short Term Period|Lack of Efficacy|0|||
130296225|NCT02273960|469047330|FG002|Short Term Period|Lack of Efficacy|0|||
130296226|NCT02273960|469047331|FG003|Short Term Period|Lack of Efficacy|1|||
130296227|NCT02273960|469047328|FG000|Short Term Period|ST complete, not entering LTE|4|||
130296228|NCT02273960|469047329|FG001|Short Term Period|ST complete, not entering LTE|6|||
130296229|NCT02273960|469047330|FG002|Short Term Period|ST complete, not entering LTE|4|||
130296230|NCT02273960|469047331|FG003|Short Term Period|ST complete, not entering LTE|5|||
130296231|NCT02273960|469047328|FG000|Long Term Extension|Death|0|||
130296232|NCT02273960|469047329|FG001|Long Term Extension|Death|0|||
130296233|NCT02273960|469047330|FG002|Long Term Extension|Death|0|||
130296234|NCT02273960|469047331|FG003|Long Term Extension|Death|1|||
130296235|NCT00558272|469047332|FG000|Overall Study|Adverse Event|10|||
130296236|NCT00558272|469047333|FG001|Overall Study|Adverse Event|0|||
130296237|NCT00558272|469047332|FG000|Overall Study|Death|1|||
130296238|NCT00558272|469047333|FG001|Overall Study|Death|0|||
130296239|NCT00558272|469047332|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
130296240|NCT00558272|469047333|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
130296241|NCT00558272|469047332|FG000|Overall Study|AZ study team decision|0|||
130296242|NCT00558272|469047333|FG001|Overall Study|AZ study team decision|1|||
130296243|NCT00558272|469047332|FG000|Overall Study|Incorrectly enrolled|1|||
130296244|NCT00558272|469047333|FG001|Overall Study|Incorrectly enrolled|0|||
130296245|NCT00558272|469047332|FG000|Overall Study|Withdrawal by Subject|0|||
130296246|NCT00558272|469047333|FG001|Overall Study|Withdrawal by Subject|1|||
130296247|NCT02745535|469047335|FG000|Overall Study|Death|1|||
130296248|NCT02745535|469047335|FG000|Overall Study|Adverse Event|3|||
130296249|NCT02745535|469047335|FG000|Overall Study|Lost to Follow-up|2|||
130296250|NCT00849108|469047336|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
130296251|NCT00849108|469047337|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
130296252|NCT00849108|469047336|FG000|Cohort 2 Efficacy|Adverse Event|0|||
130296253|NCT00849108|469047337|FG001|Cohort 2 Efficacy|Adverse Event|1|||
130296254|NCT00849108|469047336|FG000|Cohort 2 Efficacy|Other|0|||
130296255|NCT00849108|469047337|FG001|Cohort 2 Efficacy|Other|9|||
130296256|NCT01563172|469047338|FG000|Overall Study|Adverse Event|5|||
130296257|NCT01563172|469047338|FG000|Overall Study|Lost to Follow-up|2|||
130296258|NCT01563172|469047338|FG000|Overall Study|Other (Protocol deviation)|5|||
130296259|NCT01563172|469047338|FG000|Overall Study|Other (Not specified)|1|||
130296260|NCT02014584|469047341|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296261|NCT02014584|469047342|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
130296262|NCT02014584|469047343|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296263|NCT02014584|469047344|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296264|NCT02014584|469047345|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296265|NCT02014584|469047346|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
130296266|NCT02014584|469047341|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
130296267|NCT02014584|469047342|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
130296268|NCT02014584|469047343|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296269|NCT02014584|469047344|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296270|NCT02014584|469047345|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296271|NCT02014584|469047346|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
130296272|NCT02014584|469047341|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296273|NCT02014584|469047342|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296274|NCT02014584|469047343|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
130296275|NCT02014584|469047344|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296276|NCT02014584|469047345|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296277|NCT02014584|469047346|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
130296278|NCT02014584|469047341|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296279|NCT02014584|469047342|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296280|NCT02014584|469047343|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
130296281|NCT02014584|469047344|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
130296282|NCT02014584|469047345|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296283|NCT02014584|469047346|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
130296284|NCT02014584|469047341|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296285|NCT02014584|469047342|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296286|NCT02014584|469047343|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296287|NCT02014584|469047344|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296288|NCT02014584|469047345|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
130296289|NCT02014584|469047346|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
130296290|NCT00772109|469047347|FG000|Overall Study|Serious adverse event|1|||
130296291|NCT00772109|469047348|FG001|Overall Study|Serious adverse event|0|||
130296292|NCT00772109|469047349|FG002|Overall Study|Serious adverse event|1|||
130296293|NCT00772109|469047350|FG003|Overall Study|Serious adverse event|0|||
130296294|NCT00772109|469047347|FG000|Overall Study|Protocol Violation|5|||
130296295|NCT00772109|469047348|FG001|Overall Study|Protocol Violation|8|||
130296296|NCT00772109|469047349|FG002|Overall Study|Protocol Violation|7|||
130296297|NCT00772109|469047350|FG003|Overall Study|Protocol Violation|6|||
130296298|NCT00772109|469047347|FG000|Overall Study|Lost to Follow-up|7|||
130296299|NCT00772109|469047348|FG001|Overall Study|Lost to Follow-up|3|||
130296300|NCT00772109|469047349|FG002|Overall Study|Lost to Follow-up|5|||
130296301|NCT00772109|469047350|FG003|Overall Study|Lost to Follow-up|9|||
130296302|NCT00772109|469047347|FG000|Overall Study|Withdrawal by Subject|8|||
130296303|NCT00772109|469047348|FG001|Overall Study|Withdrawal by Subject|8|||
130296304|NCT00772109|469047349|FG002|Overall Study|Withdrawal by Subject|6|||
130296305|NCT00772109|469047350|FG003|Overall Study|Withdrawal by Subject|16|||
130296306|NCT01624090|469047351|FG000|Overall Study|DLT, taken off therapy|0|||
130296307|NCT01624090|469047352|FG001|Overall Study|DLT, taken off therapy|1|||
130296308|NCT01624090|469047353|FG002|Overall Study|DLT, taken off therapy|0|||
130296309|NCT01624090|469047354|FG003|Overall Study|DLT, taken off therapy|0|||
130296310|NCT01624090|469047351|FG000|Overall Study|Withdrew prior to treatment|0|||
130296311|NCT01624090|469047352|FG001|Overall Study|Withdrew prior to treatment|1|||
130296312|NCT01624090|469047353|FG002|Overall Study|Withdrew prior to treatment|0|||
130296313|NCT01624090|469047354|FG003|Overall Study|Withdrew prior to treatment|0|||
130296314|NCT01624090|469047351|FG000|Overall Study|Died on study|0|||
130296315|NCT01624090|469047352|FG001|Overall Study|Died on study|0|||
130296316|NCT01624090|469047353|FG002|Overall Study|Died on study|2|||
130296317|NCT01624090|469047354|FG003|Overall Study|Died on study|0|||
130296318|NCT01624090|469047351|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
130296319|NCT01624090|469047352|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
130296320|NCT01624090|469047353|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
130296321|NCT01624090|469047354|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
130296322|NCT01624090|469047351|FG000|Overall Study|Dose escalated|0|||
130296323|NCT01624090|469047352|FG001|Overall Study|Dose escalated|0|||
130296324|NCT01624090|469047353|FG002|Overall Study|Dose escalated|3|||
130296325|NCT01624090|469047354|FG003|Overall Study|Dose escalated|0|||
130296326|NCT00752726|469047355|FG000|Overall Study|Lost to Follow-up|2|||
130296327|NCT00752726|469047356|FG001|Overall Study|Lost to Follow-up|1|||
130296328|NCT00752726|469047355|FG000|Overall Study|Adverse Event|3|||
130296329|NCT00752726|469047356|FG001|Overall Study|Adverse Event|0|||
130296330|NCT00752726|469047355|FG000|Overall Study|Withdrawal by Subject|5|||
130296331|NCT00752726|469047356|FG001|Overall Study|Withdrawal by Subject|10|||
129794304|NCT01479985|467214351|FG001|Overall Study|Tablet malfunction, no data saved|1|||
129794305|NCT01479985|467214350|FG000|Overall Study|No decisional conflict scale responses|0|||
129794306|NCT01479985|467214351|FG001|Overall Study|No decisional conflict scale responses|2|||
129794307|NCT01479985|467214350|FG000|Overall Study|No post-visit survey|5|||
129794308|NCT01479985|467214351|FG001|Overall Study|No post-visit survey|3|||
129794309|NCT00662532|467214357|FG000|Overall Study|Adverse Event|0|||
129794310|NCT00662532|467214358|FG001|Overall Study|Adverse Event|1|||
129794311|NCT00662532|467214357|FG000|Overall Study|Lost to Follow-up|0|||
129794312|NCT00662532|467214358|FG001|Overall Study|Lost to Follow-up|1|||
129794313|NCT01850602|467214359|FG000|Overall Study|Adverse Event|7|||
129794314|NCT01850602|467214360|FG001|Overall Study|Adverse Event|10|||
129794315|NCT01850602|467214359|FG000|Overall Study|Physician Decision|2|||
129794316|NCT01850602|467214360|FG001|Overall Study|Physician Decision|1|||
129794317|NCT01850602|467214359|FG000|Overall Study|Withdrawal by Subject|2|||
129794318|NCT01850602|467214360|FG001|Overall Study|Withdrawal by Subject|4|||
129794319|NCT01850602|467214359|FG000|Overall Study|Decrease in serum calcium|2|||
129794320|NCT01850602|467214360|FG001|Overall Study|Decrease in serum calcium|3|||
129794321|NCT01850602|467214359|FG000|Overall Study|Increase in serum ferritin|1|||
129794322|NCT01850602|467214360|FG001|Overall Study|Increase in serum ferritin|0|||
129794323|NCT00367770|467214361|FG000|Overall Study|Adverse Event|1|||
130296332|NCT00752726|469047355|FG000|Overall Study|Other Reason|1|||
129794324|NCT00367770|467214361|FG000|Overall Study|Withdrawal by Subject|1|||
130296333|NCT00752726|469047356|FG001|Overall Study|Other Reason|2|||
130296334|NCT00042666|469047357|FG000|Overall Study|Adverse Event|2|||
130296335|NCT00042666|469047357|FG000|Overall Study|Death|4|||
130296336|NCT00042666|469047357|FG000|Overall Study|Protocol Violation|1|||
130296337|NCT00042666|469047357|FG000|Overall Study|Participant/Physician Perception|1|||
129794325|NCT01155479|467214362|FG000|Part I|Adverse Event|13|||
129794326|NCT01155479|467214363|FG001|Part I|Adverse Event|8|||
129794327|NCT01155479|467214364|FG002|Part I|Adverse Event|18|||
129794328|NCT01155479|467214365|FG003|Part I|Adverse Event|7|||
130296338|NCT00042666|469047357|FG000|Overall Study|Progressive Disease|41|||
129794329|NCT01155479|467214366|FG004|Part I|Adverse Event|6|||
129794330|NCT01155479|467214362|FG000|Part I|Administrative|2|||
130296339|NCT00042666|469047357|FG000|Overall Study|Other|1|||
130296340|NCT00042666|469047357|FG000|Overall Study|Other|4|||
130296341|NCT04232215|469047358|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
130296342|NCT04232215|469047359|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130296343|NCT01555125|469047362|FG000|Induction Period|Lost to Follow-up|0|||
130296344|NCT01555125|469047363|FG001|Induction Period|Lost to Follow-up|2|||
130296345|NCT01555125|469047364|FG002|Induction Period|Lost to Follow-up|0|||
130296346|NCT01555125|469047365|FG003|Induction Period|Lost to Follow-up|0|||
130296347|NCT01555125|469047366|FG004|Induction Period|Lost to Follow-up|0|||
130296348|NCT01555125|469047362|FG000|Induction Period|Adverse Event|0|||
130296349|NCT01555125|469047363|FG001|Induction Period|Adverse Event|1|||
130296350|NCT01555125|469047364|FG002|Induction Period|Adverse Event|0|||
130296351|NCT01555125|469047365|FG003|Induction Period|Adverse Event|0|||
130296352|NCT01555125|469047366|FG004|Induction Period|Adverse Event|1|||
130296353|NCT01555125|469047362|FG000|Induction Period|Subject / guardian decision|0|||
130296354|NCT01555125|469047363|FG001|Induction Period|Subject / guardian decision|0|||
130296355|NCT01555125|469047364|FG002|Induction Period|Subject / guardian decision|0|||
130296356|NCT01555125|469047365|FG003|Induction Period|Subject / guardian decision|0|||
130296357|NCT01555125|469047366|FG004|Induction Period|Subject / guardian decision|2|||
130296358|NCT01555125|469047362|FG000|Induction Period|Death|1|||
130296359|NCT01555125|469047363|FG001|Induction Period|Death|0|||
130296360|NCT01555125|469047364|FG002|Induction Period|Death|0|||
130296361|NCT01555125|469047365|FG003|Induction Period|Death|0|||
130296362|NCT01555125|469047366|FG004|Induction Period|Death|0|||
130296363|NCT01555125|469047362|FG000|Maintenance Period|Adverse Event|1|||
130296364|NCT01555125|469047363|FG001|Maintenance Period|Adverse Event|1|||
130296365|NCT01555125|469047364|FG002|Maintenance Period|Adverse Event|0|||
130296366|NCT01555125|469047365|FG003|Maintenance Period|Adverse Event|0|||
130296367|NCT01555125|469047366|FG004|Maintenance Period|Adverse Event|0|||
130296368|NCT01555125|469047362|FG000|Maintenance Period|Subject / guardian decision|1|||
130296369|NCT01555125|469047363|FG001|Maintenance Period|Subject / guardian decision|2|||
130296370|NCT01555125|469047364|FG002|Maintenance Period|Subject / guardian decision|0|||
130296371|NCT01555125|469047365|FG003|Maintenance Period|Subject / guardian decision|0|||
130296372|NCT01555125|469047366|FG004|Maintenance Period|Subject / guardian decision|0|||
130296373|NCT01555125|469047362|FG000|Maintenance Period|Lost to Follow-up|2|||
130296374|NCT01555125|469047363|FG001|Maintenance Period|Lost to Follow-up|0|||
130296375|NCT01555125|469047364|FG002|Maintenance Period|Lost to Follow-up|0|||
130296376|NCT01555125|469047365|FG003|Maintenance Period|Lost to Follow-up|1|||
130296377|NCT01555125|469047366|FG004|Maintenance Period|Lost to Follow-up|0|||
130296378|NCT01555125|469047362|FG000|Maintenance Period|Lack of Efficacy|6|||
130296379|NCT01555125|469047363|FG001|Maintenance Period|Lack of Efficacy|1|||
130296380|NCT01555125|469047364|FG002|Maintenance Period|Lack of Efficacy|3|||
130296381|NCT01555125|469047365|FG003|Maintenance Period|Lack of Efficacy|0|||
130296382|NCT01555125|469047366|FG004|Maintenance Period|Lack of Efficacy|0|||
130296383|NCT01555125|469047362|FG000|Maintenance Period|Physician Decision|0|||
130296384|NCT01555125|469047363|FG001|Maintenance Period|Physician Decision|0|||
130296385|NCT01555125|469047364|FG002|Maintenance Period|Physician Decision|1|||
130296386|NCT01555125|469047365|FG003|Maintenance Period|Physician Decision|0|||
130296387|NCT01555125|469047366|FG004|Maintenance Period|Physician Decision|0|||
130296388|NCT01555125|469047362|FG000|Maintenance Period|Death|0|||
130296389|NCT01555125|469047363|FG001|Maintenance Period|Death|0|||
130296390|NCT01555125|469047364|FG002|Maintenance Period|Death|0|||
130296391|NCT01555125|469047365|FG003|Maintenance Period|Death|1|||
130296392|NCT01555125|469047366|FG004|Maintenance Period|Death|0|||
130296393|NCT01555125|469047362|FG000|Extension|Adverse Event|1|||
130296394|NCT01555125|469047363|FG001|Extension|Adverse Event|2|||
130296395|NCT01555125|469047364|FG002|Extension|Adverse Event|1|||
130296396|NCT01555125|469047365|FG003|Extension|Adverse Event|1|||
130296397|NCT01555125|469047366|FG004|Extension|Adverse Event|0|||
130296398|NCT01555125|469047362|FG000|Extension|Protocol deviation|1|||
130296399|NCT01555125|469047363|FG001|Extension|Protocol deviation|0|||
130296400|NCT01555125|469047364|FG002|Extension|Protocol deviation|0|||
130296401|NCT01555125|469047365|FG003|Extension|Protocol deviation|0|||
130296402|NCT01555125|469047366|FG004|Extension|Protocol deviation|0|||
130296403|NCT01555125|469047362|FG000|Extension|Lack of Efficacy|7|||
130296404|NCT01555125|469047363|FG001|Extension|Lack of Efficacy|6|||
130296405|NCT01555125|469047364|FG002|Extension|Lack of Efficacy|3|||
130296406|NCT01555125|469047365|FG003|Extension|Lack of Efficacy|0|||
130296407|NCT01555125|469047366|FG004|Extension|Lack of Efficacy|0|||
130296408|NCT01555125|469047362|FG000|Extension|Lost to Follow-up|2|||
130296409|NCT01555125|469047363|FG001|Extension|Lost to Follow-up|1|||
130296410|NCT01555125|469047364|FG002|Extension|Lost to Follow-up|2|||
130296411|NCT01555125|469047365|FG003|Extension|Lost to Follow-up|0|||
130296412|NCT01555125|469047366|FG004|Extension|Lost to Follow-up|0|||
130296413|NCT01555125|469047362|FG000|Extension|Study terminated by sponsor|32|||
130296414|NCT01555125|469047363|FG001|Extension|Study terminated by sponsor|33|||
130296415|NCT01555125|469047364|FG002|Extension|Study terminated by sponsor|16|||
130296416|NCT01555125|469047365|FG003|Extension|Study terminated by sponsor|20|||
130296417|NCT01555125|469047366|FG004|Extension|Study terminated by sponsor|0|||
130296418|NCT01555125|469047362|FG000|Extension|Subject/guardian decision|1|||
129888880|NCT02213055|467550930|FG000|Overall Study|Did not have Live Lice|8|||
130047206|NCT01103349|468130107|FG000|Overall Study|forgot to take medication|0|||
130047207|NCT01103349|468130108|FG001|Overall Study|forgot to take medication|0|||
130047208|NCT01103349|468130109|FG002|Overall Study|forgot to take medication|1|||
130047209|NCT00090285|468130110|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
130296419|NCT01555125|469047363|FG001|Extension|Subject/guardian decision|9|||
130296420|NCT01555125|469047364|FG002|Extension|Subject/guardian decision|1|||
130296421|NCT01555125|469047365|FG003|Extension|Subject/guardian decision|0|||
130296422|NCT01555125|469047366|FG004|Extension|Subject/guardian decision|0|||
130296423|NCT01555125|469047362|FG000|Extension|Technical Problems|1|||
130296424|NCT01555125|469047363|FG001|Extension|Technical Problems|0|||
130296425|NCT01555125|469047364|FG002|Extension|Technical Problems|0|||
130296426|NCT01555125|469047365|FG003|Extension|Technical Problems|1|||
130296427|NCT01555125|469047366|FG004|Extension|Technical Problems|0|||
130296428|NCT01555125|469047362|FG000|Follow-Up Period|Lost to Follow-up|1|||
130296429|NCT01555125|469047363|FG001|Follow-Up Period|Lost to Follow-up|0|||
130296430|NCT01555125|469047364|FG002|Follow-Up Period|Lost to Follow-up|0|||
130296431|NCT01555125|469047365|FG003|Follow-Up Period|Lost to Follow-up|0|||
130296432|NCT01555125|469047366|FG004|Follow-Up Period|Lost to Follow-up|0|||
130296433|NCT01555125|469047362|FG000|Follow-Up Period|Subject / guardian decision|3|||
130296434|NCT01555125|469047363|FG001|Follow-Up Period|Subject / guardian decision|1|||
130296435|NCT01555125|469047364|FG002|Follow-Up Period|Subject / guardian decision|1|||
130296436|NCT01555125|469047365|FG003|Follow-Up Period|Subject / guardian decision|1|||
130296437|NCT01555125|469047366|FG004|Follow-Up Period|Subject / guardian decision|0|||
130296438|NCT02651220|469047367|FG000|Overall Study|Adverse Event|1|||
130296439|NCT02651220|469047368|FG001|Overall Study|Adverse Event|5|||
130296440|NCT02651220|469047369|FG002|Overall Study|Adverse Event|1|||
130296441|NCT02651220|469047367|FG000|Overall Study|Lost to Follow-up|8|||
130296442|NCT02651220|469047368|FG001|Overall Study|Lost to Follow-up|14|||
129794331|NCT01155479|467214363|FG001|Part I|Administrative|2|||
129794332|NCT01155479|467214364|FG002|Part I|Administrative|2|||
129794333|NCT01155479|467214365|FG003|Part I|Administrative|0|||
129794334|NCT01155479|467214366|FG004|Part I|Administrative|0|||
129794335|NCT01155479|467214362|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
129794336|NCT01155479|467214363|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
129794337|NCT01155479|467214364|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
129794338|NCT01155479|467214365|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
129794339|NCT01155479|467214366|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
129794340|NCT01155479|467214362|FG000|Part I|Withdrawal by Subject|11|||
129794341|NCT01155479|467214363|FG001|Part I|Withdrawal by Subject|13|||
129794342|NCT01155479|467214364|FG002|Part I|Withdrawal by Subject|8|||
129794343|NCT01155479|467214365|FG003|Part I|Withdrawal by Subject|8|||
129794344|NCT01155479|467214366|FG004|Part I|Withdrawal by Subject|9|||
129794345|NCT01155479|467214362|FG000|Part I|Lost to Follow-up|0|||
129794346|NCT01155479|467214363|FG001|Part I|Lost to Follow-up|0|||
129794347|NCT01155479|467214364|FG002|Part I|Lost to Follow-up|1|||
129794348|NCT01155479|467214365|FG003|Part I|Lost to Follow-up|1|||
129794349|NCT01155479|467214366|FG004|Part I|Lost to Follow-up|0|||
129794350|NCT01155479|467214362|FG000|Part I|Treatment Failure|3|||
129794351|NCT01155479|467214363|FG001|Part I|Treatment Failure|0|||
129794352|NCT01155479|467214364|FG002|Part I|Treatment Failure|3|||
129794353|NCT01155479|467214365|FG003|Part I|Treatment Failure|1|||
129794354|NCT01155479|467214366|FG004|Part I|Treatment Failure|2|||
129794355|NCT01155479|467214362|FG000|Part I|Did Not Receive Treatment|4|||
129794356|NCT01155479|467214363|FG001|Part I|Did Not Receive Treatment|2|||
129794357|NCT01155479|467214364|FG002|Part I|Did Not Receive Treatment|2|||
129794358|NCT01155479|467214365|FG003|Part I|Did Not Receive Treatment|6|||
129794359|NCT01155479|467214366|FG004|Part I|Did Not Receive Treatment|1|||
129794360|NCT01155479|467214362|FG000|Part I|Non-Compliance with Protocol|2|||
129794361|NCT01155479|467214363|FG001|Part I|Non-Compliance with Protocol|1|||
129794362|NCT01155479|467214364|FG002|Part I|Non-Compliance with Protocol|3|||
129794363|NCT01155479|467214365|FG003|Part I|Non-Compliance with Protocol|3|||
129794364|NCT01155479|467214366|FG004|Part I|Non-Compliance with Protocol|2|||
129794365|NCT01155479|467214362|FG000|Part II|Adverse Event|7|||
129794366|NCT01155479|467214363|FG001|Part II|Adverse Event|6|||
129794367|NCT01155479|467214364|FG002|Part II|Adverse Event|8|||
129888881|NCT02213055|467550931|FG001|Overall Study|Did not have Live Lice|0|||
130296443|NCT02651220|469047369|FG002|Overall Study|Lost to Follow-up|14|||
130296444|NCT02651220|469047367|FG000|Overall Study|Non-Compliance with Study Drug|4|||
130296445|NCT02651220|469047368|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130296446|NCT02651220|469047369|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129794368|NCT01155479|467214365|FG003|Part II|Adverse Event|3|||
129794369|NCT01155479|467214366|FG004|Part II|Adverse Event|4|||
129794370|NCT01155479|467214362|FG000|Part II|Administrative|43|||
129794371|NCT01155479|467214363|FG001|Part II|Administrative|49|||
129794372|NCT01155479|467214364|FG002|Part II|Administrative|36|||
129794373|NCT01155479|467214365|FG003|Part II|Administrative|38|||
129794374|NCT01155479|467214366|FG004|Part II|Administrative|46|||
129794375|NCT01155479|467214362|FG000|Part II|Withdrawal by Subject|8|||
130296447|NCT02651220|469047367|FG000|Overall Study|Pregnancy|1|||
130296448|NCT02651220|469047368|FG001|Overall Study|Pregnancy|0|||
130296449|NCT02651220|469047369|FG002|Overall Study|Pregnancy|1|||
130296450|NCT02651220|469047367|FG000|Overall Study|Protocol Violation|0|||
130296451|NCT02651220|469047368|FG001|Overall Study|Protocol Violation|0|||
130296452|NCT02651220|469047369|FG002|Overall Study|Protocol Violation|1|||
130296453|NCT02651220|469047367|FG000|Overall Study|Withdrawal by Subject|5|||
130296454|NCT02651220|469047368|FG001|Overall Study|Withdrawal by Subject|6|||
130296455|NCT02651220|469047369|FG002|Overall Study|Withdrawal by Subject|8|||
130296456|NCT02651220|469047367|FG000|Overall Study|Miscellaneous|4|||
130296457|NCT02651220|469047368|FG001|Overall Study|Miscellaneous|1|||
130296458|NCT02651220|469047369|FG002|Overall Study|Miscellaneous|2|||
130296459|NCT02651220|469047367|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130296460|NCT02651220|469047368|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130296461|NCT02651220|469047369|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
130296462|NCT05327361|469047377|FG000|Overall Study|Lost to Follow-up|4|||
130296463|NCT01439373|469047378|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
130296464|NCT01439373|469047379|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
130296465|NCT01439373|469047378|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
130296466|NCT01439373|469047379|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
130296467|NCT01078168|469047384|FG000|Overall Study|Physician Decision|0|||
130296468|NCT01078168|469047385|FG001|Overall Study|Physician Decision|1|||
130296469|NCT01264419|469047387|FG000|Overall Study|Lost to Follow-up|3|||
130296470|NCT00477152|469049878|FG000|Overall Study|Parent withdrew consent|2|||
130296471|NCT00477152|469049878|FG000|Overall Study|Adverse Event|1|||
130296472|NCT02905006|469049879|FG000|Overall Study|Adverse Event|1|||
130296473|NCT02905006|469049880|FG001|Overall Study|Adverse Event|1|||
130296474|NCT02905006|469049881|FG002|Overall Study|Adverse Event|1|||
130296475|NCT02905006|469049882|FG003|Overall Study|Adverse Event|1|||
130296476|NCT02905006|469049883|FG004|Overall Study|Adverse Event|0|||
130296477|NCT02905006|469049884|FG005|Overall Study|Adverse Event|1|||
130296478|NCT02905006|469049879|FG000|Overall Study|Lack of Efficacy|1|||
130296479|NCT02905006|469049880|FG001|Overall Study|Lack of Efficacy|0|||
130296480|NCT02905006|469049881|FG002|Overall Study|Lack of Efficacy|0|||
130296481|NCT02905006|469049882|FG003|Overall Study|Lack of Efficacy|0|||
130296482|NCT02905006|469049883|FG004|Overall Study|Lack of Efficacy|0|||
130296483|NCT02905006|469049884|FG005|Overall Study|Lack of Efficacy|0|||
130296484|NCT02905006|469049879|FG000|Overall Study|Protocol Violation|2|||
130296485|NCT02905006|469049880|FG001|Overall Study|Protocol Violation|0|||
130296486|NCT02905006|469049881|FG002|Overall Study|Protocol Violation|0|||
130296487|NCT02905006|469049882|FG003|Overall Study|Protocol Violation|0|||
130296488|NCT02905006|469049883|FG004|Overall Study|Protocol Violation|0|||
130296489|NCT02905006|469049884|FG005|Overall Study|Protocol Violation|0|||
130296490|NCT02905006|469049879|FG000|Overall Study|Lost to Follow-up|0|||
130296491|NCT02905006|469049880|FG001|Overall Study|Lost to Follow-up|0|||
130296492|NCT02905006|469049881|FG002|Overall Study|Lost to Follow-up|0|||
130296493|NCT02905006|469049882|FG003|Overall Study|Lost to Follow-up|1|||
130296494|NCT02905006|469049883|FG004|Overall Study|Lost to Follow-up|1|||
130296495|NCT02905006|469049884|FG005|Overall Study|Lost to Follow-up|0|||
130296496|NCT02905006|469049879|FG000|Overall Study|Withdrawal by Subject|0|||
130296497|NCT02905006|469049880|FG001|Overall Study|Withdrawal by Subject|0|||
130296498|NCT02905006|469049881|FG002|Overall Study|Withdrawal by Subject|1|||
130296499|NCT02905006|469049882|FG003|Overall Study|Withdrawal by Subject|1|||
130296500|NCT02905006|469049883|FG004|Overall Study|Withdrawal by Subject|0|||
130296501|NCT02905006|469049884|FG005|Overall Study|Withdrawal by Subject|1|||
130296502|NCT02905006|469049879|FG000|Overall Study|Screening exclusion criteria met|1|||
130296503|NCT02905006|469049880|FG001|Overall Study|Screening exclusion criteria met|0|||
130296504|NCT02905006|469049881|FG002|Overall Study|Screening exclusion criteria met|0|||
130296505|NCT02905006|469049882|FG003|Overall Study|Screening exclusion criteria met|0|||
130296506|NCT02905006|469049883|FG004|Overall Study|Screening exclusion criteria met|0|||
130296507|NCT02905006|469049884|FG005|Overall Study|Screening exclusion criteria met|0|||
130296508|NCT02905006|469049879|FG000|Overall Study|Lab withdrawal criterion met|0|||
130296509|NCT02905006|469049880|FG001|Overall Study|Lab withdrawal criterion met|1|||
130296510|NCT02905006|469049881|FG002|Overall Study|Lab withdrawal criterion met|2|||
130296511|NCT02905006|469049882|FG003|Overall Study|Lab withdrawal criterion met|2|||
130296512|NCT02905006|469049883|FG004|Overall Study|Lab withdrawal criterion met|2|||
130296513|NCT02905006|469049884|FG005|Overall Study|Lab withdrawal criterion met|1|||
130296514|NCT02905006|469049879|FG000|Overall Study|Positive for Tuberculosis|0|||
130296515|NCT02905006|469049880|FG001|Overall Study|Positive for Tuberculosis|1|||
130296516|NCT02905006|469049881|FG002|Overall Study|Positive for Tuberculosis|0|||
130296517|NCT02905006|469049882|FG003|Overall Study|Positive for Tuberculosis|0|||
130296518|NCT02905006|469049883|FG004|Overall Study|Positive for Tuberculosis|0|||
130296519|NCT02905006|469049884|FG005|Overall Study|Positive for Tuberculosis|0|||
130296520|NCT02905006|469049879|FG000|Overall Study|Subject positive for Hep B|0|||
130296521|NCT02905006|469049880|FG001|Overall Study|Subject positive for Hep B|0|||
130296522|NCT02905006|469049881|FG002|Overall Study|Subject positive for Hep B|1|||
130296523|NCT02905006|469049882|FG003|Overall Study|Subject positive for Hep B|0|||
130296524|NCT02905006|469049883|FG004|Overall Study|Subject positive for Hep B|0|||
130296525|NCT02905006|469049884|FG005|Overall Study|Subject positive for Hep B|0|||
130296526|NCT02905006|469049879|FG000|Overall Study|Patient moved abroad|0|||
130296527|NCT02905006|469049880|FG001|Overall Study|Patient moved abroad|0|||
130296528|NCT02905006|469049881|FG002|Overall Study|Patient moved abroad|0|||
130296529|NCT02905006|469049882|FG003|Overall Study|Patient moved abroad|1|||
130296530|NCT02905006|469049883|FG004|Overall Study|Patient moved abroad|0|||
130296531|NCT02905006|469049884|FG005|Overall Study|Patient moved abroad|0|||
130296532|NCT02905006|469049879|FG000|Overall Study|Patient randomized by mistake|0|||
130296533|NCT02905006|469049880|FG001|Overall Study|Patient randomized by mistake|0|||
130296534|NCT02905006|469049881|FG002|Overall Study|Patient randomized by mistake|0|||
130296535|NCT02905006|469049882|FG003|Overall Study|Patient randomized by mistake|0|||
130296536|NCT02905006|469049883|FG004|Overall Study|Patient randomized by mistake|0|||
130296537|NCT02905006|469049884|FG005|Overall Study|Patient randomized by mistake|1|||
130296538|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
130296539|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
129794376|NCT01155479|467214363|FG001|Part II|Withdrawal by Subject|4|||
129794377|NCT01155479|467214364|FG002|Part II|Withdrawal by Subject|12|||
129794378|NCT01155479|467214365|FG003|Part II|Withdrawal by Subject|7|||
129888882|NCT02213055|467550930|FG000|Overall Study|Had another Treatment during the Study|3|||
129888883|NCT02213055|467550931|FG001|Overall Study|Had another Treatment during the Study|0|||
129888884|NCT02213055|467550930|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
129888885|NCT02213055|467550931|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
129888886|NCT02213055|467550930|FG000|Overall Study|Did not Return to School|5|||
129888887|NCT02213055|467550931|FG001|Overall Study|Did not Return to School|0|||
129888888|NCT00231894|467550932|FG000|Overall Study|Withdrawal by Subject|1|||
129888889|NCT00231894|467550933|FG001|Overall Study|Withdrawal by Subject|1|||
129888890|NCT02025205|467550935|FG000|Overall Study|Withdrawal by Subject|1|||
129888891|NCT02025205|467550936|FG001|Overall Study|Withdrawal by Subject|1|||
129888892|NCT02025205|467550935|FG000|Overall Study|Protocol Violation|2|||
129888893|NCT02025205|467550936|FG001|Overall Study|Protocol Violation|1|||
129888894|NCT02025205|467550935|FG000|Overall Study|Death|0|||
129888895|NCT02025205|467550936|FG001|Overall Study|Death|1|||
129888896|NCT01782326|467550937|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
129888897|NCT01782326|467550938|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
129888898|NCT01782326|467550937|FG000|Planned Treatment Epoch|Death|29|||
129888899|NCT01782326|467550938|FG001|Planned Treatment Epoch|Death|30|||
129888900|NCT01782326|467550937|FG000|Planned Treatment Epoch|Physician Decision|18|||
129888901|NCT01782326|467550938|FG001|Planned Treatment Epoch|Physician Decision|16|||
129888902|NCT01782326|467550937|FG000|Planned Treatment Epoch|Protocol deviation|2|||
129888903|NCT01782326|467550938|FG001|Planned Treatment Epoch|Protocol deviation|3|||
129888904|NCT01782326|467550937|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
129888905|NCT01782326|467550938|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
129888906|NCT01782326|467550937|FG000|Planned Treatment Epoch|Technical problems|0|||
129888907|NCT01782326|467550938|FG001|Planned Treatment Epoch|Technical problems|4|||
129888908|NCT01782326|467550937|FG000|Double-blind Treatment|Adverse Event|129|||
129888909|NCT01782326|467550938|FG001|Double-blind Treatment|Adverse Event|145|||
129888910|NCT01782326|467550937|FG000|Double-blind Treatment|Subject/guardian decision|111|||
130296540|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
130296541|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
130296542|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
130296543|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
130296544|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130296545|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
130296546|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
130296547|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
130296548|NCT02429791|469049885|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
130296549|NCT02429791|469049886|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
130296550|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
130296551|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
130296552|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
130296553|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
130296554|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
130296555|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
130296556|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
130296557|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
130296558|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130296559|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130296560|NCT02429791|469049885|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
130296561|NCT02429791|469049886|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
130296562|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
130296563|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
130296564|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
130296565|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
130296566|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
130296567|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
130296568|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
130296569|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
130296570|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
129888911|NCT01782326|467550938|FG001|Double-blind Treatment|Subject/guardian decision|125|||
130047210|NCT00090285|468130111|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
130047211|NCT00090285|468130112|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129888912|NCT01782326|467550937|FG000|Double-blind Treatment|Lack of Efficacy|17|||
129888913|NCT01782326|467550938|FG001|Double-blind Treatment|Lack of Efficacy|22|||
130047212|NCT00090285|468130113|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129888914|NCT01782326|467550937|FG000|Double-blind Treatment|Physician Decision|13|||
129888915|NCT01782326|467550938|FG001|Double-blind Treatment|Physician Decision|16|||
130047213|NCT00090285|468130114|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130047214|NCT00090285|468130115|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
130047215|NCT00090285|468130110|FG000|Base Study Vaccination Period|Adverse Event|2|||
130047216|NCT00090285|468130111|FG001|Base Study Vaccination Period|Adverse Event|4|||
130047217|NCT00090285|468130112|FG002|Base Study Vaccination Period|Adverse Event|0|||
130047218|NCT00090285|468130113|FG003|Base Study Vaccination Period|Adverse Event|0|||
130047219|NCT00090285|468130114|FG004|Base Study Vaccination Period|Adverse Event|0|||
130047220|NCT00090285|468130115|FG005|Base Study Vaccination Period|Adverse Event|0|||
130296571|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
130296572|NCT02429791|469049885|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
130296573|NCT02429791|469049886|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
130296574|NCT04201093|469049887|FG000|Overall Study|Adverse Event|6|||
130296575|NCT04201093|469049888|FG001|Overall Study|Adverse Event|29|||
130296576|NCT04201093|469049889|FG002|Overall Study|Adverse Event|35|||
130296577|NCT04201093|469049887|FG000|Overall Study|Death|2|||
130296578|NCT04201093|469049888|FG001|Overall Study|Death|1|||
130296579|NCT04201093|469049889|FG002|Overall Study|Death|0|||
130296580|NCT04201093|469049887|FG000|Overall Study|Lack of Efficacy|5|||
130296581|NCT04201093|469049888|FG001|Overall Study|Lack of Efficacy|1|||
130296582|NCT04201093|469049889|FG002|Overall Study|Lack of Efficacy|2|||
130296583|NCT04201093|469049887|FG000|Overall Study|Lost to Follow-up|0|||
130296584|NCT04201093|469049888|FG001|Overall Study|Lost to Follow-up|0|||
130296585|NCT04201093|469049889|FG002|Overall Study|Lost to Follow-up|1|||
130296586|NCT04201093|469049887|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130296587|NCT04201093|469049888|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130296588|NCT04201093|469049889|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
130296589|NCT04201093|469049887|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130296590|NCT04201093|469049888|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130296591|NCT04201093|469049889|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
130296592|NCT04201093|469049887|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
130296593|NCT04201093|469049888|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
130296594|NCT04201093|469049889|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
130296595|NCT04201093|469049887|FG000|Overall Study|Physician Decision|1|||
130296596|NCT04201093|469049888|FG001|Overall Study|Physician Decision|0|||
130296597|NCT04201093|469049889|FG002|Overall Study|Physician Decision|0|||
130296598|NCT04201093|469049887|FG000|Overall Study|Protocol Deviation|1|||
130296599|NCT04201093|469049888|FG001|Overall Study|Protocol Deviation|0|||
130296600|NCT04201093|469049889|FG002|Overall Study|Protocol Deviation|0|||
130296601|NCT04201093|469049887|FG000|Overall Study|Site Terminated by Sponsor|5|||
130047221|NCT00090285|468130110|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
130047222|NCT00090285|468130111|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
130047223|NCT00090285|468130112|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
130047224|NCT00090285|468130113|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
130047225|NCT00090285|468130114|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130047226|NCT00090285|468130115|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
130047227|NCT00090285|468130110|FG000|Base Study Vaccination Period|Protocol Violation|2|||
130047228|NCT00090285|468130111|FG001|Base Study Vaccination Period|Protocol Violation|3|||
130296602|NCT04201093|469049888|FG001|Overall Study|Site Terminated by Sponsor|3|||
130296603|NCT04201093|469049889|FG002|Overall Study|Site Terminated by Sponsor|1|||
130296604|NCT04201093|469049887|FG000|Overall Study|Withdrawal by Subject|7|||
130296605|NCT04201093|469049888|FG001|Overall Study|Withdrawal by Subject|8|||
130296606|NCT04201093|469049889|FG002|Overall Study|Withdrawal by Subject|15|||
130296607|NCT04201093|469049887|FG000|Overall Study|Other|0|||
130296608|NCT04201093|469049888|FG001|Overall Study|Other|1|||
130296609|NCT04201093|469049889|FG002|Overall Study|Other|2|||
130296610|NCT00007020|469049890|FG000|Overall Study|Death|16|||
130296611|NCT00007020|469049890|FG000|Overall Study|Lost to Follow-up|13|||
130296612|NCT00007020|469049890|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
130296613|NCT00007020|469049890|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
130296614|NCT00007020|469049890|FG000|Overall Study|Pt cared for by outside physician|4|||
130296615|NCT00007020|469049890|FG000|Overall Study|No evidence of treatment|6|||
130296616|NCT00881504|469049891|FG000|Overall Study|Withdrawal by Subject|1|||
129794379|NCT01155479|467214366|FG004|Part II|Withdrawal by Subject|3|||
129794380|NCT01155479|467214362|FG000|Part II|Lost to Follow-up|1|||
129794381|NCT01155479|467214363|FG001|Part II|Lost to Follow-up|0|||
129794382|NCT01155479|467214364|FG002|Part II|Lost to Follow-up|0|||
129794383|NCT01155479|467214365|FG003|Part II|Lost to Follow-up|0|||
129794384|NCT01155479|467214366|FG004|Part II|Lost to Follow-up|1|||
129794385|NCT01155479|467214362|FG000|Part II|Treatment Failure|0|||
129794386|NCT01155479|467214363|FG001|Part II|Treatment Failure|1|||
129794387|NCT01155479|467214364|FG002|Part II|Treatment Failure|2|||
129794388|NCT01155479|467214365|FG003|Part II|Treatment Failure|0|||
129794389|NCT01155479|467214366|FG004|Part II|Treatment Failure|1|||
129794390|NCT01155479|467214362|FG000|Part II|Non-Compliance with Protocol|0|||
129794391|NCT01155479|467214363|FG001|Part II|Non-Compliance with Protocol|1|||
130296617|NCT01276223|469049892|FG000|Overall Study|Adverse Event|7|||
130296618|NCT01276223|469049893|FG001|Overall Study|Adverse Event|4|||
130296619|NCT01276223|469049894|FG002|Overall Study|Adverse Event|1|||
130296620|NCT01276223|469049892|FG000|Overall Study|Lost to Follow-up|0|||
130296621|NCT01276223|469049893|FG001|Overall Study|Lost to Follow-up|0|||
130296622|NCT01276223|469049894|FG002|Overall Study|Lost to Follow-up|1|||
130296623|NCT01276223|469049892|FG000|Overall Study|Other|0|||
130296624|NCT01276223|469049893|FG001|Overall Study|Other|0|||
130296625|NCT01276223|469049894|FG002|Overall Study|Other|1|||
130296626|NCT01276223|469049892|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
130296627|NCT01276223|469049893|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
130296628|NCT01276223|469049894|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
130296629|NCT01276223|469049892|FG000|Overall Study|Protocol Violation|1|||
130296630|NCT01276223|469049893|FG001|Overall Study|Protocol Violation|0|||
130296631|NCT01276223|469049894|FG002|Overall Study|Protocol Violation|0|||
130296632|NCT05856227|469049895|FG000|Overall Study|Adverse Event|0|||
130296633|NCT05856227|469049896|FG001|Overall Study|Adverse Event|1|||
130296634|NCT05856227|469049895|FG000|Overall Study|Due to Investigator absence|1|||
130296635|NCT05856227|469049896|FG001|Overall Study|Due to Investigator absence|0|||
130296636|NCT05856227|469049895|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
130296637|NCT05856227|469049896|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
130296638|NCT01571232|469049898|FG000|Overall Study|Lost to Follow-up|0|||
130296639|NCT01571232|469049899|FG001|Overall Study|Lost to Follow-up|1|||
130296640|NCT01571232|469049898|FG000|Overall Study|Withdrawal by Subject|1|||
130296641|NCT01571232|469049899|FG001|Overall Study|Withdrawal by Subject|0|||
130296642|NCT00771615|469049900|FG000|Overall Study|Withdrawal by Subject|0|||
130296643|NCT00771615|469049901|FG001|Overall Study|Withdrawal by Subject|1|||
130296644|NCT00771615|469049902|FG002|Overall Study|Withdrawal by Subject|0|||
130296645|NCT00771615|469049903|FG003|Overall Study|Withdrawal by Subject|0|||
130296646|NCT00771615|469049904|FG004|Overall Study|Withdrawal by Subject|0|||
130296647|NCT00771615|469049905|FG005|Overall Study|Withdrawal by Subject|0|||
130296648|NCT00771615|469049906|FG006|Overall Study|Withdrawal by Subject|0|||
130296649|NCT00771615|469049907|FG007|Overall Study|Withdrawal by Subject|1|||
130296650|NCT00771615|469049908|FG008|Overall Study|Withdrawal by Subject|0|||
130296651|NCT00771615|469049900|FG000|Overall Study|Lost to Follow-up|1|||
130296652|NCT00771615|469049901|FG001|Overall Study|Lost to Follow-up|1|||
130296653|NCT00771615|469049902|FG002|Overall Study|Lost to Follow-up|1|||
130296654|NCT00771615|469049903|FG003|Overall Study|Lost to Follow-up|1|||
130296655|NCT00771615|469049904|FG004|Overall Study|Lost to Follow-up|0|||
130296656|NCT00771615|469049905|FG005|Overall Study|Lost to Follow-up|1|||
130296657|NCT00771615|469049906|FG006|Overall Study|Lost to Follow-up|1|||
130296658|NCT00771615|469049907|FG007|Overall Study|Lost to Follow-up|0|||
130296659|NCT00771615|469049908|FG008|Overall Study|Lost to Follow-up|0|||
130296660|NCT02455076|469049909|FG000|Inpatient|Withdrawal by Subject|1|||
130296661|NCT02455076|469049910|FG001|Inpatient|Withdrawal by Subject|0|||
130296662|NCT02455076|469049911|FG002|Inpatient|Withdrawal by Subject|0|||
130296663|NCT02455076|469049912|FG003|Inpatient|Withdrawal by Subject|0|||
130296664|NCT02455076|469049913|FG004|Inpatient|Withdrawal by Subject|0|||
130296665|NCT02455076|469049909|FG000|Inpatient|Discharged <24 h after admission|0|||
130296666|NCT02455076|469049910|FG001|Inpatient|Discharged <24 h after admission|1|||
130296667|NCT02455076|469049911|FG002|Inpatient|Discharged <24 h after admission|0|||
130296668|NCT02455076|469049912|FG003|Inpatient|Discharged <24 h after admission|0|||
130296669|NCT02455076|469049913|FG004|Inpatient|Discharged <24 h after admission|0|||
130296670|NCT02455076|469049909|FG000|Inpatient|Adverse Event|3|||
130296671|NCT02455076|469049910|FG001|Inpatient|Adverse Event|0|||
130296672|NCT02455076|469049911|FG002|Inpatient|Adverse Event|0|||
130296673|NCT02455076|469049912|FG003|Inpatient|Adverse Event|0|||
130296674|NCT02455076|469049913|FG004|Inpatient|Adverse Event|0|||
130296675|NCT02455076|469049909|FG000|Outpatient|Adverse Event|0|||
130296676|NCT02455076|469049910|FG001|Outpatient|Adverse Event|0|||
130296677|NCT02455076|469049911|FG002|Outpatient|Adverse Event|0|||
130296678|NCT02455076|469049912|FG003|Outpatient|Adverse Event|5|||
130296679|NCT02455076|469049913|FG004|Outpatient|Adverse Event|0|||
130296680|NCT02455076|469049909|FG000|Outpatient|Lost to Follow-up|0|||
130296681|NCT02455076|469049910|FG001|Outpatient|Lost to Follow-up|0|||
130296682|NCT02455076|469049911|FG002|Outpatient|Lost to Follow-up|0|||
130296683|NCT02455076|469049912|FG003|Outpatient|Lost to Follow-up|1|||
130296684|NCT02455076|469049913|FG004|Outpatient|Lost to Follow-up|12|||
130296685|NCT03517969|469049914|FG000|Overall Study|Never started protocol treatment|3|||
130296686|NCT03517969|469049915|FG001|Overall Study|Never started protocol treatment|5|||
130296687|NCT03517969|469049914|FG000|Overall Study|Disease progression|11|||
130296688|NCT03517969|469049915|FG001|Overall Study|Disease progression|16|||
130296689|NCT03517969|469049914|FG000|Overall Study|PSA progression|8|||
130296690|NCT03517969|469049915|FG001|Overall Study|PSA progression|1|||
130296691|NCT03517969|469049914|FG000|Overall Study|Clinical progression|4|||
130296692|NCT03517969|469049915|FG001|Overall Study|Clinical progression|2|||
130296693|NCT03517969|469049914|FG000|Overall Study|Adverse Event|5|||
130296694|NCT03517969|469049915|FG001|Overall Study|Adverse Event|4|||
130296695|NCT03517969|469049914|FG000|Overall Study|Intercurrent illness|1|||
130296696|NCT03517969|469049915|FG001|Overall Study|Intercurrent illness|2|||
130296697|NCT03517969|469049914|FG000|Overall Study|Death|1|||
130296698|NCT03517969|469049915|FG001|Overall Study|Death|1|||
130296699|NCT03517969|469049914|FG000|Overall Study|Withdrawal by Subject|1|||
130296700|NCT03517969|469049915|FG001|Overall Study|Withdrawal by Subject|2|||
130296701|NCT03517969|469049914|FG000|Overall Study|Physician Decision|1|||
130296702|NCT03517969|469049915|FG001|Overall Study|Physician Decision|1|||
130296703|NCT03517969|469049914|FG000|Overall Study|No clinical benefit|1|||
130296704|NCT03517969|469049915|FG001|Overall Study|No clinical benefit|0|||
130296705|NCT03517969|469049914|FG000|Overall Study|Delayed treatment for dental treatment|1|||
130296706|NCT03517969|469049915|FG001|Overall Study|Delayed treatment for dental treatment|0|||
129794392|NCT01155479|467214364|FG002|Part II|Non-Compliance with Protocol|0|||
129794393|NCT01155479|467214365|FG003|Part II|Non-Compliance with Protocol|2|||
129794394|NCT01155479|467214366|FG004|Part II|Non-Compliance with Protocol|0|||
129794395|NCT00470184|467214367|FG000|Overall Study|Not Treated(became ineligible)|4|||
129794396|NCT00470184|467214367|FG000|Overall Study|Not treated (other)|1|||
129794397|NCT00470184|467214367|FG000|Overall Study|disease Progression|4|||
130107384|NCT01858558|468355096|FG000|Overall Study|Failed expansion of cell product|2|||
130107385|NCT01858558|468355097|FG001|Overall Study|Failed expansion of cell product|0|||
130107386|NCT01142466|468355098|FG000|Overall Study|Adverse Event|2|||
130296707|NCT03517969|469049914|FG000|Overall Study|Difficult to maintain appointment|0|||
130296708|NCT03517969|469049915|FG001|Overall Study|Difficult to maintain appointment|1|||
130296709|NCT03517969|469049914|FG000|Overall Study|Protocol Violation|0|||
130296710|NCT03517969|469049915|FG001|Overall Study|Protocol Violation|1|||
130296711|NCT05779007|469049920|FG000|Overall Study|not meeting eligibility criteria|3517|||
130296712|NCT05779007|469049921|FG001|Overall Study|not meeting eligibility criteria|2009|||
130296713|NCT01638546|469049932|FG000|Overall Study|Adverse Event|1|||
130296714|NCT01638546|469049933|FG001|Overall Study|Adverse Event|3|||
130296715|NCT05147662|469049936|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130296716|NCT05147662|469049936|FG000|Overall Study|Assigned to treatment but never treated|1|||
130296717|NCT04676867|469049937|FG000|Overall Study|Screen failure|0|||
129794398|NCT00470184|467214367|FG000|Overall Study|Adverse Event|3|||
129794399|NCT00470184|467214367|FG000|Overall Study|Withdrawal by Subject|4|||
129794400|NCT00470184|467214367|FG000|Overall Study|other|5|||
130296718|NCT04676867|469049938|FG001|Overall Study|Screen failure|0|||
130296719|NCT04676867|469049939|FG002|Overall Study|Screen failure|6|||
130296720|NCT04676867|469049940|FG003|Overall Study|Screen failure|2|||
130296721|NCT04676867|469049937|FG000|Overall Study|Death|0|||
130296722|NCT04676867|469049938|FG001|Overall Study|Death|0|||
130296723|NCT04676867|469049939|FG002|Overall Study|Death|1|||
130296724|NCT04676867|469049940|FG003|Overall Study|Death|0|||
130296725|NCT04676867|469049937|FG000|Overall Study|Withdrawal by Subject|2|||
130296726|NCT04676867|469049938|FG001|Overall Study|Withdrawal by Subject|2|||
130296727|NCT04676867|469049939|FG002|Overall Study|Withdrawal by Subject|4|||
130296728|NCT04676867|469049940|FG003|Overall Study|Withdrawal by Subject|4|||
130296729|NCT04676867|469049937|FG000|Overall Study|Lost to Follow-up|1|||
130296730|NCT04676867|469049938|FG001|Overall Study|Lost to Follow-up|0|||
130296731|NCT04676867|469049939|FG002|Overall Study|Lost to Follow-up|0|||
130296732|NCT04676867|469049940|FG003|Overall Study|Lost to Follow-up|0|||
130296733|NCT00549770|469049945|FG000|Overall Study|Protocol deviation|1|||
130296734|NCT00549770|469049946|FG001|Overall Study|Protocol deviation|1|||
130047229|NCT00090285|468130112|FG002|Base Study Vaccination Period|Protocol Violation|0|||
130047230|NCT00090285|468130113|FG003|Base Study Vaccination Period|Protocol Violation|0|||
130296735|NCT00549770|469049947|FG002|Overall Study|Protocol deviation|1|||
130296736|NCT00549770|469049948|FG003|Overall Study|Protocol deviation|2|||
130296737|NCT00549770|469049949|FG004|Overall Study|Protocol deviation|2|||
130296738|NCT00549770|469049950|FG005|Overall Study|Protocol deviation|2|||
130296739|NCT00549770|469049951|FG006|Overall Study|Protocol deviation|1|||
130296740|NCT00549770|469049952|FG007|Overall Study|Protocol deviation|2|||
130296741|NCT00549770|469049945|FG000|Overall Study|Administrative problems|0|||
130296742|NCT00549770|469049946|FG001|Overall Study|Administrative problems|1|||
130296743|NCT00549770|469049947|FG002|Overall Study|Administrative problems|0|||
130296744|NCT00549770|469049948|FG003|Overall Study|Administrative problems|0|||
130296745|NCT00549770|469049949|FG004|Overall Study|Administrative problems|0|||
130296746|NCT00549770|469049950|FG005|Overall Study|Administrative problems|0|||
130296747|NCT00549770|469049951|FG006|Overall Study|Administrative problems|0|||
130296748|NCT00549770|469049952|FG007|Overall Study|Administrative problems|1|||
130296749|NCT00549770|469049945|FG000|Overall Study|Lost to Follow-up|0|||
130296750|NCT00549770|469049946|FG001|Overall Study|Lost to Follow-up|0|||
130296751|NCT00549770|469049947|FG002|Overall Study|Lost to Follow-up|2|||
130296752|NCT00549770|469049948|FG003|Overall Study|Lost to Follow-up|2|||
130296753|NCT00549770|469049949|FG004|Overall Study|Lost to Follow-up|3|||
130296754|NCT00549770|469049950|FG005|Overall Study|Lost to Follow-up|2|||
130296755|NCT00549770|469049951|FG006|Overall Study|Lost to Follow-up|0|||
130296756|NCT00549770|469049952|FG007|Overall Study|Lost to Follow-up|0|||
130296757|NCT00549770|469049945|FG000|Overall Study|Withdrawal by Subject|4|||
130296758|NCT00549770|469049946|FG001|Overall Study|Withdrawal by Subject|6|||
130296759|NCT00549770|469049947|FG002|Overall Study|Withdrawal by Subject|4|||
130296760|NCT00549770|469049948|FG003|Overall Study|Withdrawal by Subject|5|||
130296761|NCT00549770|469049949|FG004|Overall Study|Withdrawal by Subject|6|||
130296762|NCT00549770|469049950|FG005|Overall Study|Withdrawal by Subject|6|||
130296763|NCT00549770|469049951|FG006|Overall Study|Withdrawal by Subject|4|||
130296764|NCT00549770|469049952|FG007|Overall Study|Withdrawal by Subject|9|||
130296765|NCT00549770|469049945|FG000|Overall Study|Lack of Efficacy|1|||
130296766|NCT00549770|469049946|FG001|Overall Study|Lack of Efficacy|0|||
130296767|NCT00549770|469049947|FG002|Overall Study|Lack of Efficacy|2|||
130296768|NCT00549770|469049948|FG003|Overall Study|Lack of Efficacy|3|||
130296769|NCT00549770|469049949|FG004|Overall Study|Lack of Efficacy|5|||
130296770|NCT00549770|469049950|FG005|Overall Study|Lack of Efficacy|1|||
129794401|NCT00470184|467214367|FG000|Overall Study|recurrence|1|||
129794402|NCT02483533|467214369|FG000|Overall Study|Lack of Efficacy|50|||
129794403|NCT02483533|467214370|FG001|Overall Study|Lack of Efficacy|50|||
129794404|NCT00768469|467214372|FG000|Overall Study|Adverse Event|0|||
129794405|NCT00768469|467214373|FG001|Overall Study|Adverse Event|2|||
129794406|NCT00768469|467214372|FG000|Overall Study|Disease Progression|3|||
129794407|NCT00768469|467214373|FG001|Overall Study|Disease Progression|4|||
129794408|NCT00768469|467214372|FG000|Overall Study|Withdrawal by Subject|0|||
129794409|NCT00768469|467214373|FG001|Overall Study|Withdrawal by Subject|1|||
129794410|NCT02953509|467214376|FG000|Overall Study|Death|1|||
129794411|NCT02953509|467214377|FG001|Overall Study|Death|3|||
129794412|NCT02953509|467214378|FG002|Overall Study|Death|3|||
129888916|NCT01782326|467550937|FG000|Double-blind Treatment|Protocol deviation|8|||
129888917|NCT01782326|467550938|FG001|Double-blind Treatment|Protocol deviation|7|||
130107387|NCT01142466|468355099|FG001|Overall Study|Adverse Event|1|||
130296771|NCT00549770|469049951|FG006|Overall Study|Lack of Efficacy|3|||
130296772|NCT00549770|469049952|FG007|Overall Study|Lack of Efficacy|8|||
130296773|NCT00549770|469049945|FG000|Overall Study|Abnormal test procedure results|0|||
130296774|NCT00549770|469049946|FG001|Overall Study|Abnormal test procedure results|0|||
130296775|NCT00549770|469049947|FG002|Overall Study|Abnormal test procedure results|0|||
130296776|NCT00549770|469049948|FG003|Overall Study|Abnormal test procedure results|2|||
129888918|NCT01782326|467550937|FG000|Double-blind Treatment|Technical problems|0|||
129794413|NCT02953509|467214379|FG003|Overall Study|Death|4|||
129794414|NCT02953509|467214380|FG004|Overall Study|Death|12|||
129888919|NCT01782326|467550938|FG001|Double-blind Treatment|Technical problems|5|||
130296777|NCT00549770|469049949|FG004|Overall Study|Abnormal test procedure results|0|||
130296778|NCT00549770|469049950|FG005|Overall Study|Abnormal test procedure results|1|||
130296779|NCT00549770|469049951|FG006|Overall Study|Abnormal test procedure results|1|||
130296780|NCT00549770|469049952|FG007|Overall Study|Abnormal test procedure results|1|||
129888920|NCT01767129|467550939|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
129888921|NCT01767129|467550940|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129888922|NCT03389893|467550941|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
129888923|NCT03389893|467550942|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
129888924|NCT03389893|467550943|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
129888925|NCT03389893|467550944|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
129888926|NCT03389893|467550941|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
129888927|NCT03389893|467550942|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
129888928|NCT03389893|467550943|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
130296781|NCT00549770|469049945|FG000|Overall Study|Abnormal laboratory values|0|||
130296782|NCT00549770|469049946|FG001|Overall Study|Abnormal laboratory values|0|||
130296783|NCT00549770|469049947|FG002|Overall Study|Abnormal laboratory values|0|||
130296784|NCT00549770|469049948|FG003|Overall Study|Abnormal laboratory values|0|||
130296785|NCT00549770|469049949|FG004|Overall Study|Abnormal laboratory values|0|||
130296786|NCT00549770|469049950|FG005|Overall Study|Abnormal laboratory values|1|||
130296787|NCT00549770|469049951|FG006|Overall Study|Abnormal laboratory values|0|||
130296788|NCT00549770|469049952|FG007|Overall Study|Abnormal laboratory values|0|||
130296789|NCT00549770|469049945|FG000|Overall Study|Adverse Event|1|||
130296790|NCT00549770|469049946|FG001|Overall Study|Adverse Event|3|||
130296791|NCT00549770|469049947|FG002|Overall Study|Adverse Event|1|||
130296792|NCT00549770|469049948|FG003|Overall Study|Adverse Event|2|||
130296793|NCT00549770|469049949|FG004|Overall Study|Adverse Event|1|||
130296794|NCT00549770|469049950|FG005|Overall Study|Adverse Event|0|||
130296795|NCT00549770|469049951|FG006|Overall Study|Adverse Event|5|||
130296796|NCT00549770|469049952|FG007|Overall Study|Adverse Event|4|||
130296797|NCT01079936|469049953|FG000|Phase I: MTD|First Remission Status|2|||
130296798|NCT01079936|469049954|FG001|Phase I: MTD|First Remission Status|0|||
130296799|NCT01079936|469049955|FG002|Phase I: MTD|First Remission Status|0|||
130296800|NCT01079936|469049956|FG003|Phase I: MTD|First Remission Status|0|||
130296801|NCT01079936|469049957|FG004|Phase I: MTD|First Remission Status|0|||
130296802|NCT01079936|469049953|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
130296803|NCT01079936|469049954|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
130296804|NCT01079936|469049955|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
130296805|NCT01079936|469049956|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
130296806|NCT01079936|469049957|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
130296807|NCT01079936|469049953|FG000|Phase II|Adverse Event|0|||
130296808|NCT01079936|469049954|FG001|Phase II|Adverse Event|0|||
130296809|NCT01079936|469049955|FG002|Phase II|Adverse Event|1|||
130296810|NCT01079936|469049956|FG003|Phase II|Adverse Event|0|||
130296811|NCT01079936|469049957|FG004|Phase II|Adverse Event|0|||
130296812|NCT01079936|469049953|FG000|Phase II|Insurance Issue|0|||
130296813|NCT01079936|469049954|FG001|Phase II|Insurance Issue|0|||
130296814|NCT01079936|469049955|FG002|Phase II|Insurance Issue|0|||
130296815|NCT01079936|469049956|FG003|Phase II|Insurance Issue|0|||
130296816|NCT01079936|469049957|FG004|Phase II|Insurance Issue|1|||
130296817|NCT00548717|469049958|FG000|Overall Study|Death|5|||
130296818|NCT00548717|469049959|FG001|Overall Study|Death|2|||
130296819|NCT00548717|469049958|FG000|Overall Study|Relapse|3|||
130296820|NCT00548717|469049959|FG001|Overall Study|Relapse|0|||
130296821|NCT00548717|469049958|FG000|Overall Study|Alternative treatment for GVHD|1|||
130296822|NCT00548717|469049959|FG001|Overall Study|Alternative treatment for GVHD|0|||
130296823|NCT02809053|469049961|FG000|Overall Study|Death|0|||
129888929|NCT03389893|467550944|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
130047231|NCT00090285|468130114|FG004|Base Study Vaccination Period|Protocol Violation|0|||
130296824|NCT02809053|469049962|FG001|Overall Study|Death|1|||
130296825|NCT02809053|469049961|FG000|Overall Study|Lost to Follow-up|3|||
130296826|NCT02809053|469049962|FG001|Overall Study|Lost to Follow-up|1|||
130296827|NCT02809053|469049961|FG000|Overall Study|Withdrawal by Subject|2|||
130296828|NCT02809053|469049962|FG001|Overall Study|Withdrawal by Subject|3|||
130296829|NCT02809053|469049961|FG000|Overall Study|Disease Progression|2|||
130296830|NCT02809053|469049962|FG001|Overall Study|Disease Progression|1|||
130296831|NCT00869401|469049965|FG000|Overall Study|Withdrawal by Subject|0|||
130296832|NCT00869401|469049966|FG001|Overall Study|Withdrawal by Subject|0|||
130296833|NCT00869401|469049967|FG002|Overall Study|Withdrawal by Subject|0|||
130296834|NCT00869401|469049968|FG003|Overall Study|Withdrawal by Subject|5|||
130296835|NCT00869401|469049969|FG004|Overall Study|Withdrawal by Subject|3|||
130296836|NCT01147900|469049970|FG000|At Year 10|Lost to Follow-up|0|||
130296837|NCT01147900|469049971|FG001|At Year 10|Lost to Follow-up|1|||
130296838|NCT01147900|469049972|FG002|At Year 10|Lost to Follow-up|0|||
130296839|NCT01953913|469049973|FG000|Overall Study|Disease Progression|349|||
130296840|NCT01953913|469049973|FG000|Overall Study|Worsening of underlying cancer|22|||
130296841|NCT01953913|469049973|FG000|Overall Study|Adverse Event|20|||
130296842|NCT01953913|469049973|FG000|Overall Study|Protocol Violation|6|||
130296843|NCT01953913|469049973|FG000|Overall Study|Lost to Follow-up|4|||
130296844|NCT01953913|469049973|FG000|Overall Study|Withdrawal by Subject|32|||
130296845|NCT01953913|469049973|FG000|Overall Study|Other than listed|108|||
130047232|NCT00090285|468130115|FG005|Base Study Vaccination Period|Protocol Violation|0|||
130047233|NCT00090285|468130110|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
130047234|NCT00090285|468130111|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
130047235|NCT00090285|468130112|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
130296846|NCT01953913|469049973|FG000|Overall Study|Not Treated|1|||
130296847|NCT01732913|469049974|FG000|Overall Study|Study Terminated by Sponsor|105|||
130296848|NCT01732913|469049975|FG001|Overall Study|Study Terminated by Sponsor|55|||
130296849|NCT01732913|469049974|FG000|Overall Study|Withdrawal by Subject|27|||
130296850|NCT01732913|469049975|FG001|Overall Study|Withdrawal by Subject|4|||
130296851|NCT01732913|469049974|FG000|Overall Study|Physician Decision|14|||
130296852|NCT01732913|469049975|FG001|Overall Study|Physician Decision|7|||
130296853|NCT01732913|469049974|FG000|Overall Study|Other|7|||
130296854|NCT01732913|469049975|FG001|Overall Study|Other|1|||
130296855|NCT01732913|469049974|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
130296856|NCT01732913|469049975|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
130296857|NCT00082381|469049976|FG000|Overall Study|Adverse Event|27|||
129794415|NCT02953509|467214381|FG005|Overall Study|Death|3|||
129794416|NCT02953509|467214382|FG006|Overall Study|Death|25|||
129794417|NCT02953509|467214383|FG007|Overall Study|Death|10|||
129794418|NCT02953509|467214384|FG008|Overall Study|Death|21|||
129794419|NCT02953509|467214385|FG009|Overall Study|Death|20|||
129794420|NCT02953509|467214376|FG000|Overall Study|Reason Not Specified|0|||
129794421|NCT02953509|467214377|FG001|Overall Study|Reason Not Specified|2|||
129794422|NCT02953509|467214378|FG002|Overall Study|Reason Not Specified|8|||
129794423|NCT02953509|467214379|FG003|Overall Study|Reason Not Specified|2|||
129794424|NCT02953509|467214380|FG004|Overall Study|Reason Not Specified|11|||
129794425|NCT02953509|467214381|FG005|Overall Study|Reason Not Specified|4|||
129794426|NCT02953509|467214382|FG006|Overall Study|Reason Not Specified|12|||
129794427|NCT02953509|467214383|FG007|Overall Study|Reason Not Specified|2|||
129794428|NCT02953509|467214384|FG008|Overall Study|Reason Not Specified|7|||
129794429|NCT02953509|467214385|FG009|Overall Study|Reason Not Specified|2|||
129794430|NCT02953509|467214376|FG000|Overall Study|Consent Withdrawn|1|||
129794431|NCT02953509|467214377|FG001|Overall Study|Consent Withdrawn|1|||
129794432|NCT02953509|467214378|FG002|Overall Study|Consent Withdrawn|2|||
129794433|NCT02953509|467214379|FG003|Overall Study|Consent Withdrawn|1|||
129794434|NCT02953509|467214380|FG004|Overall Study|Consent Withdrawn|3|||
129794435|NCT02953509|467214381|FG005|Overall Study|Consent Withdrawn|0|||
129794436|NCT02953509|467214382|FG006|Overall Study|Consent Withdrawn|4|||
129794437|NCT02953509|467214383|FG007|Overall Study|Consent Withdrawn|1|||
129794438|NCT02953509|467214384|FG008|Overall Study|Consent Withdrawn|1|||
129794439|NCT02953509|467214385|FG009|Overall Study|Consent Withdrawn|4|||
129794440|NCT02953509|467214376|FG000|Overall Study|Lost to Follow-up|0|||
129794441|NCT02953509|467214377|FG001|Overall Study|Lost to Follow-up|0|||
129794442|NCT02953509|467214378|FG002|Overall Study|Lost to Follow-up|0|||
129794443|NCT02953509|467214379|FG003|Overall Study|Lost to Follow-up|0|||
129794444|NCT02953509|467214380|FG004|Overall Study|Lost to Follow-up|0|||
129794445|NCT02953509|467214381|FG005|Overall Study|Lost to Follow-up|0|||
129794446|NCT02953509|467214382|FG006|Overall Study|Lost to Follow-up|1|||
129794447|NCT02953509|467214383|FG007|Overall Study|Lost to Follow-up|1|||
129794448|NCT02953509|467214384|FG008|Overall Study|Lost to Follow-up|1|||
129794449|NCT02953509|467214385|FG009|Overall Study|Lost to Follow-up|1|||
129794450|NCT02953509|467214376|FG000|Overall Study|Study terminated by sponsor|1|||
129794451|NCT02953509|467214377|FG001|Overall Study|Study terminated by sponsor|0|||
129794452|NCT02953509|467214378|FG002|Overall Study|Study terminated by sponsor|0|||
129794453|NCT02953509|467214379|FG003|Overall Study|Study terminated by sponsor|0|||
129794454|NCT02953509|467214380|FG004|Overall Study|Study terminated by sponsor|0|||
129794455|NCT02953509|467214381|FG005|Overall Study|Study terminated by sponsor|0|||
129794456|NCT02953509|467214382|FG006|Overall Study|Study terminated by sponsor|1|||
129794457|NCT02953509|467214383|FG007|Overall Study|Study terminated by sponsor|0|||
129794458|NCT02953509|467214384|FG008|Overall Study|Study terminated by sponsor|1|||
130047236|NCT00090285|468130113|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
130047237|NCT00090285|468130114|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130047238|NCT00090285|468130115|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
130047239|NCT00090285|468130110|FG000|Base Study Vaccination Period|Uncooperative|2|||
130047240|NCT00090285|468130111|FG001|Base Study Vaccination Period|Uncooperative|2|||
130296858|NCT00082381|469049977|FG001|Overall Study|Adverse Event|2|||
130296859|NCT00082381|469049976|FG000|Overall Study|Lost to Follow-up|5|||
129794459|NCT02953509|467214385|FG009|Overall Study|Study terminated by sponsor|1|||
129794460|NCT00484185|467214386|FG000|Overall Study|Lost to Follow-up|44|||
129794461|NCT00484185|467214386|FG000|Overall Study|Other|20|||
129794462|NCT00484185|467214386|FG000|Overall Study|Randomized but not treated|5|||
129794463|NCT00484185|467214386|FG000|Overall Study|Death|2|||
129794464|NCT00459056|467214387|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
129794465|NCT00459056|467214388|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
129794466|NCT02283177|467214389|FG000|Overall Study|Withdrawal by Subject|1|||
129794467|NCT02283177|467214390|FG001|Overall Study|Withdrawal by Subject|1|||
129794468|NCT01101191|467214391|FG000|Period 1|Withdrawal by Subject|1|||
130296860|NCT00082381|469049977|FG001|Overall Study|Lost to Follow-up|7|||
130296861|NCT00082381|469049976|FG000|Overall Study|Patient Decision|8|||
130296862|NCT00082381|469049977|FG001|Overall Study|Patient Decision|4|||
130296863|NCT00082381|469049976|FG000|Overall Study|Physician Decision|1|||
130296864|NCT00082381|469049977|FG001|Overall Study|Physician Decision|2|||
130296865|NCT00082381|469049976|FG000|Overall Study|Protocol Violation|10|||
130296866|NCT00082381|469049977|FG001|Overall Study|Protocol Violation|11|||
130296867|NCT00082381|469049976|FG000|Overall Study|Loss of Glucose Control|4|||
130296868|NCT00082381|469049977|FG001|Overall Study|Loss of Glucose Control|0|||
130296869|NCT00025155|469049978|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
130296870|NCT00025155|469049978|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
130296871|NCT03022981|469049979|FG000|Overall Study|Adverse Event|0|||
130296872|NCT03022981|469049980|FG001|Overall Study|Adverse Event|1|||
130296873|NCT03022981|469049981|FG002|Overall Study|Adverse Event|0|||
130296874|NCT03022981|469049979|FG000|Overall Study|Investigator's Discretion|0|||
130296875|NCT03022981|469049980|FG001|Overall Study|Investigator's Discretion|1|||
130296876|NCT03022981|469049981|FG002|Overall Study|Investigator's Discretion|2|||
130296877|NCT03022981|469049979|FG000|Overall Study|Lost to Follow-up|6|||
130296878|NCT03022981|469049980|FG001|Overall Study|Lost to Follow-up|2|||
130296879|NCT03022981|469049981|FG002|Overall Study|Lost to Follow-up|1|||
130296880|NCT03022981|469049979|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130296881|NCT03022981|469049980|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130296882|NCT03022981|469049981|FG002|Overall Study|Non-Compliance With Study Drug|2|||
130296883|NCT03022981|469049979|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
130296884|NCT03022981|469049980|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
130296885|NCT03022981|469049981|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
129794469|NCT01101191|467214392|FG001|Period 1|Withdrawal by Subject|0|||
129794470|NCT01101191|467214391|FG000|Period 1|Adverse Event|1|||
129794471|NCT01101191|467214392|FG001|Period 1|Adverse Event|2|||
129794472|NCT03761797|467214393|FG000|Overall Study|Changing hospital|11|||
129794473|NCT03761797|467214393|FG000|Overall Study|Improvement/remission|6|||
129794474|NCT03761797|467214393|FG000|Overall Study|Withdrawal by Subject|19|||
129794475|NCT03761797|467214393|FG000|Overall Study|Lost to Follow-up|33|||
129794476|NCT03761797|467214393|FG000|Overall Study|Adverse Event|37|||
129794477|NCT03761797|467214393|FG000|Overall Study|Case report form (CRF) not collected|5|||
129794478|NCT03761797|467214393|FG000|Overall Study|No patient visit after entry|13|||
129794479|NCT03761797|467214393|FG000|Overall Study|Switch to other diabetes medication|10|||
129794480|NCT03761797|467214393|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
129794481|NCT03761797|467214393|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
129794482|NCT03761797|467214393|FG000|Overall Study|Insufficient effectives|2|||
129794483|NCT03761797|467214393|FG000|Overall Study|Excessive alcohol intake|1|||
129794484|NCT00879879|467214394|FG000|Overall Study|Death|1|||
129794485|NCT00879879|467214394|FG000|Overall Study|Withdrawal by Subject|1|||
129794486|NCT00879879|467214394|FG000|Overall Study|Physician Decision|1|||
129888930|NCT03389893|467550941|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
129888931|NCT03389893|467550942|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
130296886|NCT00444067|469049982|FG000|Overall Study|Lost to Follow-up|0|||
130296887|NCT00444067|469049983|FG001|Overall Study|Lost to Follow-up|1|||
130296888|NCT03178669|469049984|FG000|Overall Study|Adverse Event|4|||
130296889|NCT03178669|469049985|FG001|Overall Study|Adverse Event|1|||
130296890|NCT03178669|469049986|FG002|Overall Study|Adverse Event|4|||
130296891|NCT03178669|469049987|FG003|Overall Study|Adverse Event|2|||
130296892|NCT03178669|469049988|FG004|Overall Study|Adverse Event|2|||
130296893|NCT03178669|469049984|FG000|Overall Study|Lack of Efficacy|0|||
129794487|NCT00989573|467214398|FG000|Overall Study|Adverse Event|8|||
129794488|NCT00989573|467214399|FG001|Overall Study|Adverse Event|12|||
129794489|NCT00989573|467214400|FG002|Overall Study|Adverse Event|4|||
129794490|NCT00989573|467214398|FG000|Overall Study|Physician Decision|0|||
130296894|NCT03178669|469049985|FG001|Overall Study|Lack of Efficacy|0|||
130296895|NCT03178669|469049986|FG002|Overall Study|Lack of Efficacy|2|||
130296896|NCT03178669|469049987|FG003|Overall Study|Lack of Efficacy|0|||
130296897|NCT03178669|469049988|FG004|Overall Study|Lack of Efficacy|1|||
130296898|NCT03178669|469049984|FG000|Overall Study|Physician Decision|0|||
130296899|NCT03178669|469049985|FG001|Overall Study|Physician Decision|0|||
130296900|NCT03178669|469049986|FG002|Overall Study|Physician Decision|0|||
130296901|NCT03178669|469049987|FG003|Overall Study|Physician Decision|0|||
130296902|NCT03178669|469049988|FG004|Overall Study|Physician Decision|1|||
130296903|NCT03178669|469049984|FG000|Overall Study|Withdrawal by Subject|1|||
130296904|NCT03178669|469049985|FG001|Overall Study|Withdrawal by Subject|0|||
130296905|NCT03178669|469049986|FG002|Overall Study|Withdrawal by Subject|1|||
130296906|NCT03178669|469049987|FG003|Overall Study|Withdrawal by Subject|1|||
130296907|NCT03178669|469049988|FG004|Overall Study|Withdrawal by Subject|0|||
130296908|NCT03178669|469049984|FG000|Overall Study|Lost to Follow-up|0|||
130296909|NCT03178669|469049985|FG001|Overall Study|Lost to Follow-up|0|||
130296910|NCT03178669|469049986|FG002|Overall Study|Lost to Follow-up|0|||
130296911|NCT03178669|469049987|FG003|Overall Study|Lost to Follow-up|1|||
130296912|NCT03178669|469049988|FG004|Overall Study|Lost to Follow-up|0|||
130296913|NCT01600092|469049989|FG000|Overall Study|Adverse Event|2|||
130296914|NCT01600092|469049990|FG001|Overall Study|Adverse Event|0|||
130296915|NCT01600092|469049989|FG000|Overall Study|Lost to Follow-up|4|||
130296916|NCT01600092|469049990|FG001|Overall Study|Lost to Follow-up|6|||
130296917|NCT01600092|469049989|FG000|Overall Study|Withdrawal by parent/guardian|8|||
130296918|NCT01600092|469049990|FG001|Overall Study|Withdrawal by parent/guardian|6|||
130296919|NCT01600092|469049989|FG000|Overall Study|Physician Decision|1|||
130296920|NCT01600092|469049990|FG001|Overall Study|Physician Decision|1|||
130296921|NCT01600092|469049989|FG000|Overall Study|Randomized but not vaccinated|3|||
130296922|NCT01600092|469049990|FG001|Overall Study|Randomized but not vaccinated|3|||
130296923|NCT00079677|469049991|FG000|Overall Study|Adverse Event|5|||
130296924|NCT00079677|469049992|FG001|Overall Study|Adverse Event|6|||
130296925|NCT00079677|469049991|FG000|Overall Study|Lack of Efficacy|1|||
130296926|NCT00079677|469049992|FG001|Overall Study|Lack of Efficacy|0|||
130296927|NCT00079677|469049991|FG000|Overall Study|Lost to Follow-up|2|||
130296928|NCT00079677|469049992|FG001|Overall Study|Lost to Follow-up|2|||
130296929|NCT00079677|469049991|FG000|Overall Study|Physician Decision|3|||
130296930|NCT00079677|469049992|FG001|Overall Study|Physician Decision|0|||
130296931|NCT00079677|469049991|FG000|Overall Study|Protocol Violation|2|||
130296932|NCT00079677|469049992|FG001|Overall Study|Protocol Violation|3|||
130296933|NCT00079677|469049991|FG000|Overall Study|Withdrawal by Subject|5|||
130296934|NCT00079677|469049992|FG001|Overall Study|Withdrawal by Subject|3|||
130296935|NCT00079677|469049991|FG000|Overall Study|Miscellaneous|2|||
130296936|NCT00079677|469049992|FG001|Overall Study|Miscellaneous|0|||
130296937|NCT01300455|469049993|FG000|Washout|Withdrawal by Subject|1|||
130296938|NCT01300455|469049994|FG001|Washout|Withdrawal by Subject|0|||
130296939|NCT00084487|469049995|FG000|Overall Study|Death|1|||
130296940|NCT00565136|469049996|FG000|Overall Study|Lost to Follow-up|1|||
130296941|NCT00565136|469049996|FG000|Overall Study|Withdrawal by Subject|1|||
130296942|NCT00565136|469049996|FG000|Overall Study|Protocol Violation|1|||
130296943|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296944|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
130296945|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296946|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296947|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296948|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296949|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296950|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296951|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296952|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296953|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296954|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296955|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296956|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296957|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296958|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296959|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296960|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296961|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
130296962|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296963|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296964|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296965|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
130296966|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296967|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
130296968|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296969|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
130296970|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296971|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296972|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296973|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296974|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296975|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296976|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296977|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296978|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296979|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296980|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
130296981|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296982|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296983|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
130296984|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296985|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
130296986|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296987|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
130296988|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
130296989|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296990|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296991|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296992|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296993|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296994|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296995|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296996|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296997|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130047241|NCT00090285|468130112|FG002|Base Study Vaccination Period|Uncooperative|0|||
130047242|NCT00090285|468130113|FG003|Base Study Vaccination Period|Uncooperative|0|||
130047243|NCT00090285|468130114|FG004|Base Study Vaccination Period|Uncooperative|0|||
130047244|NCT00090285|468130115|FG005|Base Study Vaccination Period|Uncooperative|0|||
130047245|NCT00090285|468130110|FG000|Base Study Vaccination Period|Moved|20|||
130047246|NCT00090285|468130111|FG001|Base Study Vaccination Period|Moved|21|||
130047247|NCT00090285|468130112|FG002|Base Study Vaccination Period|Moved|0|||
130047248|NCT00090285|468130113|FG003|Base Study Vaccination Period|Moved|0|||
130047249|NCT00090285|468130114|FG004|Base Study Vaccination Period|Moved|0|||
130047250|NCT00090285|468130115|FG005|Base Study Vaccination Period|Moved|0|||
130047251|NCT00090285|468130110|FG000|Base Study Vaccination Period|Site Terminated|1|||
130047252|NCT00090285|468130111|FG001|Base Study Vaccination Period|Site Terminated|0|||
130047253|NCT00090285|468130112|FG002|Base Study Vaccination Period|Site Terminated|0|||
130047254|NCT00090285|468130113|FG003|Base Study Vaccination Period|Site Terminated|0|||
130047255|NCT00090285|468130114|FG004|Base Study Vaccination Period|Site Terminated|0|||
130047256|NCT00090285|468130115|FG005|Base Study Vaccination Period|Site Terminated|0|||
130047257|NCT00090285|468130110|FG000|Base Study Vaccination Period|Other|2|||
130047258|NCT00090285|468130111|FG001|Base Study Vaccination Period|Other|2|||
130047259|NCT00090285|468130112|FG002|Base Study Vaccination Period|Other|0|||
130047260|NCT00090285|468130113|FG003|Base Study Vaccination Period|Other|0|||
130047261|NCT00090285|468130114|FG004|Base Study Vaccination Period|Other|0|||
130047262|NCT00090285|468130115|FG005|Base Study Vaccination Period|Other|0|||
130047263|NCT00090285|468130110|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
129794491|NCT00989573|467214399|FG001|Overall Study|Physician Decision|2|||
129794492|NCT00989573|467214400|FG002|Overall Study|Physician Decision|0|||
129794493|NCT00989573|467214398|FG000|Overall Study|Protocol Violation|1|||
129794494|NCT00989573|467214399|FG001|Overall Study|Protocol Violation|1|||
129794495|NCT00989573|467214400|FG002|Overall Study|Protocol Violation|1|||
129794496|NCT00989573|467214398|FG000|Overall Study|Withdrawal by Subject|4|||
129794497|NCT00989573|467214399|FG001|Overall Study|Withdrawal by Subject|7|||
130047264|NCT00090285|468130111|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
129794498|NCT00989573|467214400|FG002|Overall Study|Withdrawal by Subject|3|||
129794499|NCT03687970|467214401|FG000|Overall Study|visit scheduling conflicts|2|||
129794500|NCT03687970|467214402|FG001|Overall Study|visit scheduling conflicts|0|||
130047265|NCT00090285|468130112|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
130047266|NCT00090285|468130113|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
130296998|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130296999|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
130297000|NCT02528357|469049997|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297001|NCT02528357|469049998|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297002|NCT02528357|469049999|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297003|NCT02528357|469050000|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297004|NCT02528357|469050001|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297005|NCT02528357|469050002|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297006|NCT02528357|469050003|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297007|NCT02528357|469050004|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297008|NCT02528357|469050005|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297009|NCT02528357|469050006|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297010|NCT02528357|469050007|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297011|NCT02528357|469050008|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297012|NCT02528357|469050009|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297013|NCT02528357|469050010|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297014|NCT02528357|469050011|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297015|NCT02528357|469050012|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297016|NCT02528357|469050013|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297017|NCT02528357|469050014|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297018|NCT02528357|469050015|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297019|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297020|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297021|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297022|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297023|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297024|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297025|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297026|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297027|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297028|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297029|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297030|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297031|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297032|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
130297033|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
130297034|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297035|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297036|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297037|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
130297038|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297039|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297040|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297041|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297042|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297043|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297044|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297045|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297046|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297047|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297048|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297049|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297050|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297051|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
130107388|NCT01142466|468355098|FG000|Overall Study|Withdrawal by Subject|1|||
130107389|NCT01142466|468355099|FG001|Overall Study|Withdrawal by Subject|1|||
130107390|NCT00569231|468355104|FG000|Overall Study|Study unrelated surgery|1|||
130297052|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297053|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297054|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297055|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297056|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
130297057|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297058|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297059|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297060|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297061|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297062|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297063|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297064|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297065|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297066|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297067|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
130297068|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297069|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
130297070|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
130297071|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
130297072|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297073|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297074|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297075|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
130297076|NCT02528357|469049997|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297077|NCT02528357|469049998|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297078|NCT02528357|469049999|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297079|NCT02528357|469050000|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297080|NCT02528357|469050001|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297081|NCT02528357|469050002|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297082|NCT02528357|469050003|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297083|NCT02528357|469050004|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297084|NCT02528357|469050005|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297085|NCT02528357|469050006|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297086|NCT02528357|469050007|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297087|NCT02528357|469050008|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
130297088|NCT02528357|469050009|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
130297089|NCT02528357|469050010|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297090|NCT02528357|469050011|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297091|NCT02528357|469050012|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297092|NCT02528357|469050013|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297093|NCT02528357|469050014|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297094|NCT02528357|469050015|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297095|NCT02528357|469049997|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297096|NCT02528357|469049998|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297097|NCT02528357|469049999|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297098|NCT02528357|469050000|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129888932|NCT03389893|467550943|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
129888933|NCT03389893|467550944|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
129888934|NCT03389893|467550941|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
129888935|NCT03389893|467550942|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
129888936|NCT03389893|467550943|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
130047267|NCT00090285|468130114|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
129888937|NCT03389893|467550944|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
130297099|NCT02528357|469050001|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297100|NCT02528357|469050002|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297101|NCT02528357|469050003|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297102|NCT02528357|469050004|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297103|NCT02528357|469050005|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297104|NCT02528357|469050006|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297105|NCT02528357|469050007|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297106|NCT02528357|469050008|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130047268|NCT00090285|468130115|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
130047269|NCT00090285|468130110|FG000|Base Study Vaccination Period|HIV positive|1|||
130047270|NCT00090285|468130111|FG001|Base Study Vaccination Period|HIV positive|1|||
130047271|NCT00090285|468130112|FG002|Base Study Vaccination Period|HIV positive|0|||
130047272|NCT00090285|468130113|FG003|Base Study Vaccination Period|HIV positive|0|||
130047273|NCT00090285|468130114|FG004|Base Study Vaccination Period|HIV positive|0|||
130047274|NCT00090285|468130115|FG005|Base Study Vaccination Period|HIV positive|0|||
130047275|NCT00090285|468130110|FG000|Base Study Follow-up Period|Adverse Event|3|||
130047276|NCT00090285|468130111|FG001|Base Study Follow-up Period|Adverse Event|10|||
130047277|NCT00090285|468130112|FG002|Base Study Follow-up Period|Adverse Event|0|||
130047278|NCT00090285|468130113|FG003|Base Study Follow-up Period|Adverse Event|0|||
130047279|NCT00090285|468130114|FG004|Base Study Follow-up Period|Adverse Event|0|||
130047280|NCT00090285|468130115|FG005|Base Study Follow-up Period|Adverse Event|0|||
130047281|NCT00090285|468130110|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
130047282|NCT00090285|468130111|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
130047283|NCT00090285|468130112|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
130047284|NCT00090285|468130113|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
130047285|NCT00090285|468130114|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
130047286|NCT00090285|468130115|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
130047287|NCT00090285|468130110|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
129794501|NCT00817479|467214403|FG000|Overall Study|Physician Decision|1|||
129794502|NCT00817479|467214404|FG001|Overall Study|Physician Decision|1|||
129794503|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
129794504|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
129794505|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
129794506|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
129794507|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
129794508|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
129794509|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
129794510|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
129794511|NCT04030026|467214406|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
129794512|NCT04030026|467214407|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
129794513|NCT04030026|467214406|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
129794514|NCT04030026|467214407|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
129794515|NCT04030026|467214406|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
130047288|NCT00090285|468130111|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
130047289|NCT00090285|468130112|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
130047290|NCT00090285|468130113|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
130047291|NCT00090285|468130114|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
130297107|NCT02528357|469050009|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297108|NCT02528357|469050010|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297109|NCT02528357|469050011|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297110|NCT02528357|469050012|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129794516|NCT04030026|467214407|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
129794517|NCT00523367|467214408|FG000|Overall Study|19 screen failures|19|||
129794518|NCT00523367|467214408|FG000|Overall Study|4 Withdrawn by PI|4|||
129794519|NCT04480424|467214409|FG000|Overall Study|Withdrawal by Subject|0|||
129794520|NCT04480424|467214410|FG001|Overall Study|Withdrawal by Subject|2|||
129794521|NCT04480424|467214409|FG000|Overall Study|Lost to Follow-up|3|||
129794522|NCT04480424|467214410|FG001|Overall Study|Lost to Follow-up|3|||
129794523|NCT04480424|467214409|FG000|Overall Study|Death|14|||
129794524|NCT04480424|467214410|FG001|Overall Study|Death|16|||
129794525|NCT04480424|467214409|FG000|Overall Study|Reason not Specified|5|||
129794526|NCT04480424|467214410|FG001|Overall Study|Reason not Specified|5|||
130047292|NCT00090285|468130115|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
130047293|NCT00090285|468130110|FG000|Base Study Follow-up Period|Moved|41|||
130047294|NCT00090285|468130111|FG001|Base Study Follow-up Period|Moved|36|||
130047295|NCT00090285|468130112|FG002|Base Study Follow-up Period|Moved|0|||
130047296|NCT00090285|468130113|FG003|Base Study Follow-up Period|Moved|0|||
130047297|NCT00090285|468130114|FG004|Base Study Follow-up Period|Moved|0|||
130047298|NCT00090285|468130115|FG005|Base Study Follow-up Period|Moved|0|||
130047299|NCT00090285|468130110|FG000|Base Study Follow-up Period|Other|2|||
130297111|NCT02528357|469050013|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
130297112|NCT02528357|469050014|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297113|NCT02528357|469050015|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
130297114|NCT02528357|469049997|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297115|NCT02528357|469049998|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297116|NCT02528357|469049999|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297117|NCT02528357|469050000|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297118|NCT02528357|469050001|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297119|NCT02528357|469050002|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297120|NCT02528357|469050003|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297121|NCT02528357|469050004|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297122|NCT02528357|469050005|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297123|NCT02528357|469050006|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297124|NCT02528357|469050007|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297125|NCT02528357|469050008|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297126|NCT02528357|469050009|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297127|NCT02528357|469050010|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297128|NCT02528357|469050011|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297129|NCT02528357|469050012|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
130297130|NCT02528357|469050013|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
130297131|NCT02528357|469050014|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
130297132|NCT02528357|469050015|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
130297133|NCT02438813|469050021|FG000|Overall Study|Patient Decision|59|||
130297134|NCT02438813|469050021|FG000|Overall Study|Patient Lost to Follow-Up|137|||
130297135|NCT02438813|469050021|FG000|Overall Study|Study Ended by Sponsor|80|||
130297136|NCT02438813|469050021|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
130297137|NCT02228096|469050032|FG000|Overall Study|Study terminated by Sponsor|24|||
130297138|NCT02228096|469050032|FG000|Overall Study|Lack of Efficacy|18|||
130297139|NCT02228096|469050032|FG000|Overall Study|Death|12|||
130297140|NCT02228096|469050032|FG000|Overall Study|Physician Decision|3|||
130297141|NCT02228096|469050032|FG000|Overall Study|Subject/guardian decision|2|||
130297142|NCT02228096|469050032|FG000|Overall Study|New therapy for study indication|1|||
130297143|NCT02228096|469050032|FG000|Overall Study|Enrolled, not infused|11|||
130297144|NCT00454649|469050033|FG000|Overall Study|Lack of Efficacy|2|||
130297145|NCT00454649|469050034|FG001|Overall Study|Lack of Efficacy|2|||
130297146|NCT00454649|469050035|FG002|Overall Study|Lack of Efficacy|10|||
130297147|NCT00454649|469050036|FG003|Overall Study|Lack of Efficacy|3|||
130297148|NCT00454649|469050037|FG004|Overall Study|Lack of Efficacy|0|||
130297149|NCT00454649|469050038|FG005|Overall Study|Lack of Efficacy|4|||
130297150|NCT00454649|469050039|FG006|Overall Study|Lack of Efficacy|5|||
130297151|NCT00454649|469050040|FG007|Overall Study|Lack of Efficacy|13|||
130297152|NCT00454649|469050041|FG008|Overall Study|Lack of Efficacy|10|||
130297153|NCT00454649|469050042|FG009|Overall Study|Lack of Efficacy|2|||
130297154|NCT00454649|469050033|FG000|Overall Study|Adverse Event|0|||
130297155|NCT00454649|469050034|FG001|Overall Study|Adverse Event|1|||
130297156|NCT00454649|469050035|FG002|Overall Study|Adverse Event|3|||
130297157|NCT00454649|469050036|FG003|Overall Study|Adverse Event|0|||
130297158|NCT00454649|469050037|FG004|Overall Study|Adverse Event|1|||
130297159|NCT00454649|469050038|FG005|Overall Study|Adverse Event|2|||
130297160|NCT00454649|469050039|FG006|Overall Study|Adverse Event|3|||
130297161|NCT00454649|469050040|FG007|Overall Study|Adverse Event|4|||
130297162|NCT00454649|469050041|FG008|Overall Study|Adverse Event|6|||
130297163|NCT00454649|469050042|FG009|Overall Study|Adverse Event|2|||
130297164|NCT00454649|469050033|FG000|Overall Study|Lost to Follow-up|0|||
130297165|NCT00454649|469050034|FG001|Overall Study|Lost to Follow-up|0|||
130297166|NCT00454649|469050035|FG002|Overall Study|Lost to Follow-up|1|||
130297167|NCT00454649|469050036|FG003|Overall Study|Lost to Follow-up|0|||
130297168|NCT00454649|469050037|FG004|Overall Study|Lost to Follow-up|0|||
130297169|NCT00454649|469050038|FG005|Overall Study|Lost to Follow-up|0|||
130297170|NCT00454649|469050039|FG006|Overall Study|Lost to Follow-up|1|||
130047300|NCT00090285|468130111|FG001|Base Study Follow-up Period|Other|0|||
130047301|NCT00090285|468130112|FG002|Base Study Follow-up Period|Other|0|||
130297171|NCT00454649|469050040|FG007|Overall Study|Lost to Follow-up|0|||
130297172|NCT00454649|469050041|FG008|Overall Study|Lost to Follow-up|0|||
130297173|NCT00454649|469050042|FG009|Overall Study|Lost to Follow-up|0|||
130297174|NCT00454649|469050033|FG000|Overall Study|Other|1|||
130297175|NCT00454649|469050034|FG001|Overall Study|Other|1|||
130297176|NCT00454649|469050035|FG002|Overall Study|Other|5|||
130297177|NCT00454649|469050036|FG003|Overall Study|Other|3|||
130297178|NCT00454649|469050037|FG004|Overall Study|Other|0|||
130297179|NCT00454649|469050038|FG005|Overall Study|Other|0|||
130297180|NCT00454649|469050039|FG006|Overall Study|Other|0|||
130297181|NCT00454649|469050040|FG007|Overall Study|Other|0|||
130297182|NCT00454649|469050041|FG008|Overall Study|Other|3|||
130297183|NCT00454649|469050042|FG009|Overall Study|Other|1|||
130297184|NCT00454649|469050033|FG000|Overall Study|Withdrawal by Subject|0|||
130297185|NCT00454649|469050034|FG001|Overall Study|Withdrawal by Subject|0|||
130297186|NCT00454649|469050035|FG002|Overall Study|Withdrawal by Subject|0|||
130297187|NCT00454649|469050036|FG003|Overall Study|Withdrawal by Subject|0|||
130297188|NCT00454649|469050037|FG004|Overall Study|Withdrawal by Subject|0|||
130297189|NCT00454649|469050038|FG005|Overall Study|Withdrawal by Subject|1|||
130297190|NCT00454649|469050039|FG006|Overall Study|Withdrawal by Subject|0|||
130297191|NCT00454649|469050040|FG007|Overall Study|Withdrawal by Subject|2|||
130297192|NCT00454649|469050041|FG008|Overall Study|Withdrawal by Subject|1|||
130297193|NCT00454649|469050042|FG009|Overall Study|Withdrawal by Subject|0|||
130297194|NCT01789606|469050043|FG000|Overall Study|Participant not Purchased the Product|0|||
130297195|NCT01789606|469050044|FG001|Overall Study|Participant not Purchased the Product|20|||
130297196|NCT01789606|469050043|FG000|Overall Study|Withdrawal by Subject|0|||
130297197|NCT01789606|469050044|FG001|Overall Study|Withdrawal by Subject|1|||
130297198|NCT01789606|469050043|FG000|Overall Study|Ineligible|6|||
130297199|NCT01789606|469050044|FG001|Overall Study|Ineligible|2|||
130297200|NCT01789606|469050043|FG000|Overall Study|Administrative Reasons|17|||
130297201|NCT01789606|469050044|FG001|Overall Study|Administrative Reasons|6|||
130297202|NCT01789606|469050043|FG000|Overall Study|No Study Medication Taken|0|||
130297203|NCT01789606|469050044|FG001|Overall Study|No Study Medication Taken|1|||
130297204|NCT01789606|469050043|FG000|Overall Study|Protocol Violation|0|||
130297205|NCT01789606|469050044|FG001|Overall Study|Protocol Violation|55|||
130297206|NCT01789606|469050043|FG000|Overall Study|Adverse Event|0|||
130297207|NCT01789606|469050044|FG001|Overall Study|Adverse Event|3|||
130297208|NCT01789606|469050043|FG000|Overall Study|Lost to Follow-up|0|||
130297209|NCT01789606|469050044|FG001|Overall Study|Lost to Follow-up|14|||
130297210|NCT01789606|469050043|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
130297211|NCT01789606|469050044|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
130297212|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
130297213|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
130297214|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
130297215|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
130297216|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
130297217|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
130297218|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
130297219|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
130297220|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Death|0|||
130297221|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Death|1|||
130297222|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
130297223|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
130297224|NCT03281304|469050060|FG000|Treatment Phase (up to 42 Months)|Other|0|||
130297225|NCT03281304|469050061|FG001|Treatment Phase (up to 42 Months)|Other|2|||
130297226|NCT03281304|469050060|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
130297227|NCT03281304|469050061|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
130297228|NCT00626405|469050062|FG000|Overall Study|Deemed Ineligible|1|||
130297229|NCT00626405|469050063|FG001|Overall Study|Deemed Ineligible|0|||
130297230|NCT00626405|469050062|FG000|Overall Study|Withdrawal by Subject|0|||
130297231|NCT00626405|469050063|FG001|Overall Study|Withdrawal by Subject|1|||
130297232|NCT03834220|469050064|FG000|Overall Study|Adverse Event|1|||
130297233|NCT03834220|469050065|FG001|Overall Study|Adverse Event|0|||
130297234|NCT03834220|469050066|FG002|Overall Study|Adverse Event|0|||
130297235|NCT03834220|469050064|FG000|Overall Study|Death|8|||
130297236|NCT03834220|469050065|FG001|Overall Study|Death|1|||
130297237|NCT03834220|469050066|FG002|Overall Study|Death|17|||
130297238|NCT03834220|469050064|FG000|Overall Study|Reason not Specified|9|||
130297239|NCT03834220|469050065|FG001|Overall Study|Reason not Specified|0|||
130297240|NCT03834220|469050066|FG002|Overall Study|Reason not Specified|6|||
130297241|NCT03834220|469050064|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
130297242|NCT03834220|469050065|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
130297243|NCT03834220|469050066|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
130297244|NCT03834220|469050064|FG000|Overall Study|Withdrawal of Consent|2|||
130297245|NCT03834220|469050065|FG001|Overall Study|Withdrawal of Consent|2|||
130297246|NCT03834220|469050066|FG002|Overall Study|Withdrawal of Consent|2|||
130297247|NCT02593318|469050067|FG000|Overall Study|Withdrawal by Subject|1|||
130297248|NCT02593318|469050068|FG001|Overall Study|Withdrawal by Subject|1|||
130297249|NCT02720692|469052143|FG000|Overall Study|Withdrawal by Subject|3|||
130297250|NCT02720692|469052144|FG001|Overall Study|Withdrawal by Subject|0|||
130297251|NCT02720692|469052143|FG000|Overall Study|Physician Decision|1|||
130297252|NCT02720692|469052144|FG001|Overall Study|Physician Decision|0|||
130297253|NCT02720692|469052143|FG000|Overall Study|Lost to Follow-up|8|||
130297254|NCT02720692|469052144|FG001|Overall Study|Lost to Follow-up|3|||
130297255|NCT02720692|469052143|FG000|Overall Study|Subject unable to return for visit|1|||
130297256|NCT02720692|469052144|FG001|Overall Study|Subject unable to return for visit|0|||
130297257|NCT05011513|469052145|FG000|Overall Study|Death|0|||
130297258|NCT05011513|469052146|FG001|Overall Study|Death|1|||
130297259|NCT05011513|469052145|FG000|Overall Study|Lost to Follow-up|4|||
130297260|NCT05011513|469052146|FG001|Overall Study|Lost to Follow-up|0|||
130297261|NCT05011513|469052145|FG000|Overall Study|Withdrawal by Subject|18|||
130297262|NCT05011513|469052146|FG001|Overall Study|Withdrawal by Subject|17|||
130297263|NCT05011513|469052145|FG000|Overall Study|Other|4|||
130297264|NCT05011513|469052146|FG001|Overall Study|Other|2|||
130297265|NCT03878758|469052147|FG000|Overall Study|Withdrawal by Subject|1|||
130297266|NCT03878758|469052147|FG000|Overall Study|Protocol defined|2|||
130297267|NCT03878758|469052147|FG000|Overall Study|Improper consent documentation|1|||
130297268|NCT02315560|469052148|FG000|Overall Study|noncompliance by subjects|3|||
130297269|NCT00358436|469052150|FG000|Overall Study|Adverse Event|29|||
130297270|NCT00358436|469052151|FG001|Overall Study|Adverse Event|13|||
130297271|NCT00358436|469052150|FG000|Overall Study|Lack of Efficacy|34|||
130297272|NCT00358436|469052151|FG001|Overall Study|Lack of Efficacy|36|||
130297273|NCT00358436|469052150|FG000|Overall Study|Lost to Follow-up|11|||
130297274|NCT00358436|469052151|FG001|Overall Study|Lost to Follow-up|6|||
130297275|NCT00358436|469052150|FG000|Overall Study|Protocol Violation|8|||
130297276|NCT00358436|469052151|FG001|Overall Study|Protocol Violation|3|||
130297277|NCT00358436|469052150|FG000|Overall Study|Withdrawal by Subject|40|||
130297278|NCT00358436|469052151|FG001|Overall Study|Withdrawal by Subject|17|||
130297279|NCT00358436|469052150|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
130297280|NCT00358436|469052151|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
130297281|NCT00358436|469052150|FG000|Overall Study|COPD exacerbation|22|||
130297282|NCT00358436|469052151|FG001|Overall Study|COPD exacerbation|10|||
130297283|NCT00358436|469052150|FG000|Overall Study|Other|6|||
130297284|NCT00358436|469052151|FG001|Overall Study|Other|1|||
130297285|NCT00321464|469052152|FG000|Overall Study|Death|169|||
130297286|NCT00321464|469052153|FG001|Overall Study|Death|174|||
130297287|NCT00321464|469052152|FG000|Overall Study|Disease progression|124|||
130297288|NCT00321464|469052153|FG001|Overall Study|Disease progression|124|||
130297289|NCT00321464|469052152|FG000|Overall Study|Withdrawal by Subject|117|||
130297290|NCT00321464|469052153|FG001|Overall Study|Withdrawal by Subject|118|||
130297291|NCT00321464|469052152|FG000|Overall Study|Participant request|57|||
130297292|NCT00321464|469052153|FG001|Overall Study|Participant request|61|||
130297293|NCT00321464|469052152|FG000|Overall Study|Adverse Event|43|||
130297294|NCT00321464|469052153|FG001|Overall Study|Adverse Event|28|||
130297295|NCT00321464|469052152|FG000|Overall Study|Physician Decision|15|||
130297296|NCT00321464|469052153|FG001|Overall Study|Physician Decision|14|||
130297297|NCT00321464|469052152|FG000|Overall Study|Noncompliance|4|||
130297298|NCT00321464|469052153|FG001|Overall Study|Noncompliance|10|||
130297299|NCT00321464|469052152|FG000|Overall Study|Lost to Follow-up|7|||
130297300|NCT00321464|469052153|FG001|Overall Study|Lost to Follow-up|8|||
130297301|NCT00321464|469052152|FG000|Overall Study|Protocol deviation|0|||
130297302|NCT00321464|469052153|FG001|Overall Study|Protocol deviation|2|||
130297303|NCT00321464|469052152|FG000|Overall Study|Ineligibility determined|2|||
130297304|NCT00321464|469052153|FG001|Overall Study|Ineligibility determined|1|||
130297305|NCT00321464|469052152|FG000|Overall Study|Other|21|||
130297306|NCT00321464|469052153|FG001|Overall Study|Other|18|||
130297307|NCT00652951|469052156|FG000|Booster Phase|Adverse event, non-fatal|0|||
130297308|NCT00652951|469052157|FG001|Booster Phase|Adverse event, non-fatal|1|||
130297309|NCT00652951|469052158|FG002|Booster Phase|Adverse event, non-fatal|0|||
130297310|NCT00652951|469052156|FG000|Booster Phase|Other|1|||
130107391|NCT00569231|468355104|FG000|Overall Study|Airfare expense|2|||
130107392|NCT00569231|468355104|FG000|Overall Study|Withdrawal by Subject|1|||
130107393|NCT00569231|468355104|FG000|Overall Study|Car accident injury|1|||
130107394|NCT00569231|468355104|FG000|Overall Study|Non-compliance|2|||
130297311|NCT00652951|469052157|FG001|Booster Phase|Other|0|||
130297312|NCT00652951|469052158|FG002|Booster Phase|Other|0|||
130297313|NCT01206582|469052159|FG000|Overall Study|Withdrew prior to study|1|||
130107395|NCT00700310|468355107|FG000|Overall Study|Adverse Event|6|||
130297314|NCT01206582|469052160|FG001|Overall Study|Withdrew prior to study|0|||
130297315|NCT01206582|469052159|FG000|Overall Study|Discontinued intervention before week 8|1|||
130297316|NCT01206582|469052160|FG001|Overall Study|Discontinued intervention before week 8|2|||
130297317|NCT06359080|469052163|FG000|Overall Study|Withdrawal by Subject|3|||
130297318|NCT00306527|469052166|FG000|Overall Study|Lost to Follow-up|3|||
130297319|NCT00306527|469052167|FG001|Overall Study|Lost to Follow-up|4|||
130297320|NCT00306527|469052168|FG002|Overall Study|Lost to Follow-up|3|||
130297321|NCT00306527|469052169|FG003|Overall Study|Lost to Follow-up|0|||
130297322|NCT00306527|469052166|FG000|Overall Study|Withdrawal by Subject|2|||
130297323|NCT00306527|469052167|FG001|Overall Study|Withdrawal by Subject|3|||
129794527|NCT02782923|467214411|FG000|Overall Study|Lost to Follow-up|15|||
130297324|NCT00306527|469052168|FG002|Overall Study|Withdrawal by Subject|0|||
130107396|NCT00700310|468355108|FG001|Overall Study|Adverse Event|10|||
130107397|NCT00700310|468355109|FG002|Overall Study|Adverse Event|5|||
130107398|NCT00700310|468355110|FG003|Overall Study|Adverse Event|11|||
130107399|NCT00700310|468355107|FG000|Overall Study|Lost to Follow-up|4|||
130107400|NCT00700310|468355108|FG001|Overall Study|Lost to Follow-up|1|||
130107401|NCT00700310|468355109|FG002|Overall Study|Lost to Follow-up|0|||
130107402|NCT00700310|468355110|FG003|Overall Study|Lost to Follow-up|1|||
130107403|NCT00700310|468355107|FG000|Overall Study|Withdrawal by Subject|8|||
130107404|NCT00700310|468355108|FG001|Overall Study|Withdrawal by Subject|9|||
130107405|NCT00700310|468355109|FG002|Overall Study|Withdrawal by Subject|8|||
130107406|NCT00700310|468355110|FG003|Overall Study|Withdrawal by Subject|8|||
130107407|NCT00700310|468355107|FG000|Overall Study|Lack of Efficacy|0|||
130107408|NCT00700310|468355108|FG001|Overall Study|Lack of Efficacy|3|||
130107409|NCT00700310|468355109|FG002|Overall Study|Lack of Efficacy|0|||
130107410|NCT00700310|468355110|FG003|Overall Study|Lack of Efficacy|1|||
130107411|NCT00700310|468355107|FG000|Overall Study|Administrative/Other|1|||
130107412|NCT00700310|468355108|FG001|Overall Study|Administrative/Other|3|||
130107413|NCT00700310|468355109|FG002|Overall Study|Administrative/Other|1|||
130107414|NCT00700310|468355110|FG003|Overall Study|Administrative/Other|3|||
130107415|NCT00700310|468355107|FG000|Overall Study|Randomized, Not Treated|2|||
130297325|NCT00306527|469052169|FG003|Overall Study|Withdrawal by Subject|3|||
130297326|NCT00306527|469052166|FG000|Overall Study|Adverse Event|0|||
130297327|NCT00306527|469052167|FG001|Overall Study|Adverse Event|0|||
130297328|NCT00306527|469052168|FG002|Overall Study|Adverse Event|1|||
130297329|NCT00306527|469052169|FG003|Overall Study|Adverse Event|1|||
130297330|NCT00306527|469052166|FG000|Overall Study|Death|1|||
130297331|NCT00306527|469052167|FG001|Overall Study|Death|0|||
130297332|NCT00306527|469052168|FG002|Overall Study|Death|1|||
130297333|NCT00306527|469052169|FG003|Overall Study|Death|2|||
130297334|NCT00417963|469052185|FG000|Overall Study|Lost to Follow-up|3|||
130297335|NCT00417963|469052185|FG000|Overall Study|Withdrawal by Subject|18|||
130297336|NCT00417963|469052185|FG000|Overall Study|Death|17|||
130297337|NCT00417963|469052185|FG000|Overall Study|Study device could not be deployed|3|||
130297338|NCT01023672|469052186|FG000|Overall Study|Worsening disease|2|||
130297339|NCT01023672|469052186|FG000|Overall Study|Death|1|||
130297340|NCT00387725|469052187|FG000|Overall Study|Adverse Event|0|||
130297341|NCT00387725|469052188|FG001|Overall Study|Adverse Event|0|||
130297342|NCT00387725|469052189|FG002|Overall Study|Adverse Event|0|||
130297343|NCT00387725|469052190|FG003|Overall Study|Adverse Event|1|||
130297344|NCT00387725|469052187|FG000|Overall Study|Protocol Violation|0|||
130297345|NCT00387725|469052188|FG001|Overall Study|Protocol Violation|1|||
130297346|NCT00387725|469052189|FG002|Overall Study|Protocol Violation|0|||
130297347|NCT00387725|469052190|FG003|Overall Study|Protocol Violation|0|||
130297348|NCT00387725|469052187|FG000|Overall Study|Withdrawal by Subject|1|||
130297349|NCT00387725|469052188|FG001|Overall Study|Withdrawal by Subject|0|||
130297350|NCT00387725|469052189|FG002|Overall Study|Withdrawal by Subject|1|||
130297351|NCT00387725|469052190|FG003|Overall Study|Withdrawal by Subject|0|||
130297352|NCT00387725|469052187|FG000|Overall Study|Parent/legal guardian request|0|||
130297353|NCT00387725|469052188|FG001|Overall Study|Parent/legal guardian request|0|||
130297354|NCT00387725|469052189|FG002|Overall Study|Parent/legal guardian request|1|||
130297355|NCT00387725|469052190|FG003|Overall Study|Parent/legal guardian request|1|||
130297356|NCT02017522|469052193|FG000|Overall Study|Withdrawal by Subject|1|||
130297357|NCT02166463|469052194|FG000|Overall Study|Lost to Follow-up|0|||
130297358|NCT02166463|469052195|FG001|Overall Study|Lost to Follow-up|1|||
130297359|NCT02166463|469052194|FG000|Overall Study|Physician Decision|10|||
130297360|NCT02166463|469052195|FG001|Overall Study|Physician Decision|10|||
130297361|NCT02166463|469052194|FG000|Overall Study|Ineligible|11|||
130297362|NCT02166463|469052195|FG001|Overall Study|Ineligible|2|||
130297363|NCT02166463|469052194|FG000|Overall Study|Progressive Disease|9|||
130297364|NCT02166463|469052195|FG001|Overall Study|Progressive Disease|6|||
130297365|NCT02166463|469052194|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
129794528|NCT02418156|467214412|FG000|Overall Study|Lost to Follow-up|12|||
129794529|NCT02418156|467214412|FG000|Overall Study|Death|2|||
129794530|NCT02418156|467214412|FG000|Overall Study|Physician Decision|1|||
129794531|NCT02418156|467214412|FG000|Overall Study|Withdrawal by Subject|1|||
130107416|NCT00700310|468355108|FG001|Overall Study|Randomized, Not Treated|0|||
130107417|NCT00700310|468355109|FG002|Overall Study|Randomized, Not Treated|2|||
130107418|NCT00700310|468355110|FG003|Overall Study|Randomized, Not Treated|2|||
130107419|NCT00681824|468355115|FG000|Overall Study|withdrawn by investigator|0|||
130297366|NCT02166463|469052195|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
130297367|NCT02166463|469052194|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
130297368|NCT02166463|469052195|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
130297369|NCT02166463|469052194|FG000|Overall Study|Refusal of further protocol therapy|5|||
129794532|NCT02418156|467214412|FG000|Overall Study|Subject refused to return|1|||
130297370|NCT02166463|469052195|FG001|Overall Study|Refusal of further protocol therapy|6|||
130297371|NCT00859937|469052196|FG000|Overall Study|Protocol Violation|1|||
130297372|NCT00859937|469052197|FG001|Overall Study|Protocol Violation|0|||
130297373|NCT02478164|469052198|FG000|Overall Study|Lack of Efficacy|13|||
130297374|NCT02478164|469052198|FG000|Overall Study|Adverse Event|1|||
130297375|NCT02478164|469052198|FG000|Overall Study|Withdrawal by Subject|1|||
130297376|NCT05194267|469052199|FG000|Overall Study|Withdrawal by Subject|2|||
130297377|NCT00802893|469052200|FG000|Overall Study|study terminated|3|||
130297378|NCT06151288|469052201|FG000|Overall Study|Lost to Follow-up|4|||
130297379|NCT06151288|469052202|FG001|Overall Study|Lost to Follow-up|2|||
130297380|NCT06151288|469052203|FG002|Overall Study|Lost to Follow-up|4|||
130297381|NCT06151288|469052204|FG003|Overall Study|Lost to Follow-up|3|||
130297382|NCT06151288|469052201|FG000|Overall Study|Withdrawal by Subject|4|||
130297383|NCT06151288|469052202|FG001|Overall Study|Withdrawal by Subject|5|||
130297384|NCT06151288|469052203|FG002|Overall Study|Withdrawal by Subject|1|||
130297385|NCT06151288|469052204|FG003|Overall Study|Withdrawal by Subject|1|||
130297386|NCT04588389|469052205|FG000|Overall Study|Issues with anesthesia during surgery|2|||
130297387|NCT04588389|469052206|FG001|Overall Study|Issues with anesthesia during surgery|0|||
130297388|NCT04588389|469052207|FG002|Overall Study|Issues with anesthesia during surgery|0|||
130297389|NCT02911142|469052208|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
130297390|NCT02911142|469052208|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
130297391|NCT02911142|469052208|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
130297392|NCT02911142|469052208|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
130297393|NCT00026312|469052209|FG000|Overall Study|Adverse Event|0|||
130297394|NCT00026312|469052210|FG001|Overall Study|Adverse Event|32|||
130297395|NCT00026312|469052209|FG000|Overall Study|Death|1|||
130297396|NCT00026312|469052210|FG001|Overall Study|Death|7|||
130297397|NCT00026312|469052209|FG000|Overall Study|Lack of Efficacy|19|||
130297398|NCT00026312|469052210|FG001|Overall Study|Lack of Efficacy|114|||
130297399|NCT00026312|469052209|FG000|Overall Study|Lost to Follow-up|0|||
130297400|NCT00026312|469052210|FG001|Overall Study|Lost to Follow-up|5|||
130297401|NCT00026312|469052209|FG000|Overall Study|Physician Decision|1|||
130297402|NCT00026312|469052210|FG001|Overall Study|Physician Decision|37|||
130297403|NCT00026312|469052209|FG000|Overall Study|Protocol Violation|0|||
130297404|NCT00026312|469052210|FG001|Overall Study|Protocol Violation|3|||
130297405|NCT00026312|469052209|FG000|Overall Study|Withdrawal by Subject|1|||
130297406|NCT00026312|469052210|FG001|Overall Study|Withdrawal by Subject|6|||
130297407|NCT00026312|469052209|FG000|Overall Study|Ineligible|4|||
130297408|NCT00026312|469052210|FG001|Overall Study|Ineligible|5|||
130297409|NCT00026312|469052209|FG000|Overall Study|Entry onto another COG study|0|||
130297410|NCT00026312|469052210|FG001|Overall Study|Entry onto another COG study|1|||
130297411|NCT00026312|469052209|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
130297412|NCT00026312|469052210|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
130297413|NCT00231413|469052213|FG000|Overall Study|Non-serious AE|0|||
130297414|NCT00231413|469052214|FG001|Overall Study|Non-serious AE|0|||
130297415|NCT00231413|469052215|FG002|Overall Study|Non-serious AE|1|||
130297416|NCT00231413|469052216|FG003|Overall Study|Non-serious AE|0|||
130297417|NCT00231413|469052217|FG004|Overall Study|Non-serious AE|0|||
130297418|NCT00231413|469052218|FG005|Overall Study|Non-serious AE|0|||
130297419|NCT00231413|469052219|FG006|Overall Study|Non-serious AE|1|||
130297420|NCT00231413|469052213|FG000|Overall Study|Withdrawal by Subject|3|||
130297421|NCT00231413|469052214|FG001|Overall Study|Withdrawal by Subject|1|||
130297422|NCT00231413|469052215|FG002|Overall Study|Withdrawal by Subject|4|||
130297423|NCT00231413|469052216|FG003|Overall Study|Withdrawal by Subject|2|||
130297424|NCT00231413|469052217|FG004|Overall Study|Withdrawal by Subject|2|||
130297425|NCT00231413|469052218|FG005|Overall Study|Withdrawal by Subject|0|||
130297426|NCT00231413|469052219|FG006|Overall Study|Withdrawal by Subject|3|||
130297427|NCT00231413|469052213|FG000|Overall Study|Migrated/moved from study area|0|||
130297428|NCT00231413|469052214|FG001|Overall Study|Migrated/moved from study area|0|||
129794533|NCT04854642|467216323|FG000|Overall Study|Adverse Event|1|||
130297429|NCT00231413|469052215|FG002|Overall Study|Migrated/moved from study area|1|||
130297430|NCT00231413|469052216|FG003|Overall Study|Migrated/moved from study area|0|||
130297431|NCT00231413|469052217|FG004|Overall Study|Migrated/moved from study area|0|||
130297432|NCT00231413|469052218|FG005|Overall Study|Migrated/moved from study area|1|||
130297433|NCT00231413|469052219|FG006|Overall Study|Migrated/moved from study area|0|||
130297434|NCT00231413|469052213|FG000|Overall Study|Lost to Follow-up|4|||
130297435|NCT00231413|469052214|FG001|Overall Study|Lost to Follow-up|4|||
130297436|NCT00231413|469052215|FG002|Overall Study|Lost to Follow-up|1|||
129888938|NCT01024751|467550948|FG000|Enrolled Participants|Ineligible at baseline|3|||
129888939|NCT01024751|467550949|FG001|Enrolled Participants|Ineligible at baseline|4|||
129888940|NCT01024751|467550948|FG000|Eligible Participants|Withdrawal by Subject|0|||
129888941|NCT01024751|467550949|FG001|Eligible Participants|Withdrawal by Subject|1|||
129888942|NCT01024751|467550948|FG000|Eligible Participants|Lost to Follow-up|0|||
129888943|NCT01024751|467550949|FG001|Eligible Participants|Lost to Follow-up|1|||
129888944|NCT01024751|467550948|FG000|Eligible Participants|Ineligible|0|||
130047302|NCT00090285|468130113|FG003|Base Study Follow-up Period|Other|0|||
130047303|NCT00090285|468130114|FG004|Base Study Follow-up Period|Other|0|||
130047304|NCT00090285|468130115|FG005|Base Study Follow-up Period|Other|0|||
130047305|NCT00090285|468130110|FG000|Base Study Follow-up Period|Protocol Violation|1|||
130297437|NCT00231413|469052216|FG003|Overall Study|Lost to Follow-up|1|||
130297438|NCT00231413|469052217|FG004|Overall Study|Lost to Follow-up|1|||
130297439|NCT00231413|469052218|FG005|Overall Study|Lost to Follow-up|4|||
130297440|NCT00231413|469052219|FG006|Overall Study|Lost to Follow-up|0|||
130297441|NCT00231413|469052213|FG000|Overall Study|Pregnancy|1|||
130297442|NCT00231413|469052214|FG001|Overall Study|Pregnancy|0|||
130297443|NCT00231413|469052215|FG002|Overall Study|Pregnancy|0|||
130297444|NCT00231413|469052216|FG003|Overall Study|Pregnancy|0|||
130297445|NCT00231413|469052217|FG004|Overall Study|Pregnancy|0|||
130297446|NCT00231413|469052218|FG005|Overall Study|Pregnancy|0|||
130297447|NCT00231413|469052219|FG006|Overall Study|Pregnancy|0|||
130297448|NCT02294734|469052220|FG000|Overall Study|Adverse Event|5|||
130297449|NCT02294734|469052221|FG001|Overall Study|Adverse Event|5|||
130297450|NCT02294734|469052220|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
130297451|NCT02294734|469052221|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
130297452|NCT02294734|469052220|FG000|Overall Study|Lost to Follow-up|2|||
130297453|NCT02294734|469052221|FG001|Overall Study|Lost to Follow-up|0|||
130297454|NCT02294734|469052220|FG000|Overall Study|Physician Decision|2|||
130297455|NCT02294734|469052221|FG001|Overall Study|Physician Decision|1|||
130297456|NCT02294734|469052220|FG000|Overall Study|Withdrawal by Subject|4|||
130297457|NCT02294734|469052221|FG001|Overall Study|Withdrawal by Subject|2|||
130297458|NCT03157583|469052222|FG000|Overall Study|Other (did not meet study criteria)|1|||
130297459|NCT00847015|469052225|FG000|Overall Study|Withdrawal by Subject|1|||
130297460|NCT00847015|469052225|FG000|Overall Study|declined any surgery|1|||
130297461|NCT00847015|469052225|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
130297462|NCT01141478|469052226|FG000|Overall Study|Withdrawal by Subject|1|||
129794534|NCT04854642|467216324|FG001|Overall Study|Adverse Event|2|||
130047306|NCT00090285|468130111|FG001|Base Study Follow-up Period|Protocol Violation|0|||
130047307|NCT00090285|468130112|FG002|Base Study Follow-up Period|Protocol Violation|0|||
130047308|NCT00090285|468130113|FG003|Base Study Follow-up Period|Protocol Violation|0|||
130047309|NCT00090285|468130114|FG004|Base Study Follow-up Period|Protocol Violation|0|||
130047310|NCT00090285|468130115|FG005|Base Study Follow-up Period|Protocol Violation|0|||
130107420|NCT00681824|468355116|FG001|Overall Study|withdrawn by investigator|0|||
130107421|NCT00681824|468355117|FG002|Overall Study|withdrawn by investigator|1|||
130297463|NCT01141478|469052227|FG001|Overall Study|Withdrawal by Subject|1|||
130297464|NCT03847909|469052237|FG000|Overall Study|Withdrawal by Subject|1|||
129794535|NCT04854642|467216323|FG000|Overall Study|Withdrawal by Subject|0|||
129794536|NCT04854642|467216324|FG001|Overall Study|Withdrawal by Subject|1|||
129794537|NCT01314911|467216325|FG000|Overall Study|Lost to Follow-up|3|||
129794538|NCT01314911|467216326|FG001|Overall Study|Lost to Follow-up|2|||
130107422|NCT00681824|468355115|FG000|Overall Study|scheduling conflict|1|||
129794539|NCT01314911|467216325|FG000|Overall Study|Withdrawal by Subject|1|||
129794540|NCT01314911|467216326|FG001|Overall Study|Withdrawal by Subject|3|||
129794541|NCT01314911|467216325|FG000|Overall Study|Received Non-randomized Study Drug|0|||
129794542|NCT01314911|467216326|FG001|Overall Study|Received Non-randomized Study Drug|1|||
129794543|NCT01314911|467216325|FG000|Overall Study|Never Started Treatment|1|||
129794544|NCT01314911|467216326|FG001|Overall Study|Never Started Treatment|0|||
129794545|NCT04078178|467216334|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
129794546|NCT04078178|467216335|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
130047311|NCT00090285|468130110|FG000|Base Study Follow-up Period|Uncooperative|3|||
130297465|NCT03847909|469052238|FG001|Overall Study|Withdrawal by Subject|1|||
130297466|NCT00975143|469052239|FG000|Overall Study|Adverse Event|19|||
130297467|NCT00975143|469052240|FG001|Overall Study|Adverse Event|15|||
130297468|NCT00975143|469052239|FG000|Overall Study|Withdrawal by Subject|15|||
130297469|NCT00975143|469052240|FG001|Overall Study|Withdrawal by Subject|15|||
129888945|NCT01024751|467550949|FG001|Eligible Participants|Ineligible|1|||
129888946|NCT02448719|467550950|FG000|Overall Study|Withdrawal by Subject|0|||
130107423|NCT00681824|468355116|FG001|Overall Study|scheduling conflict|0|||
130297470|NCT00975143|469052239|FG000|Overall Study|Lost to Follow-up|20|||
130297471|NCT00975143|469052240|FG001|Overall Study|Lost to Follow-up|16|||
130297472|NCT00975143|469052239|FG000|Overall Study|Non-compliance|5|||
130297473|NCT00975143|469052240|FG001|Overall Study|Non-compliance|8|||
130297474|NCT00975143|469052239|FG000|Overall Study|Physician Decision|1|||
130297475|NCT00975143|469052240|FG001|Overall Study|Physician Decision|2|||
130297476|NCT00975143|469052239|FG000|Overall Study|Details not available|10|||
130297477|NCT00975143|469052240|FG001|Overall Study|Details not available|4|||
130297478|NCT01375608|469052241|FG000|Overall Study|Withdrawal by Subject|2|||
130297479|NCT02049138|469052244|FG000|Overall Study|Adverse Event|46|||
130297480|NCT02049138|469052245|FG001|Overall Study|Adverse Event|25|||
130297481|NCT02049138|469052246|FG002|Overall Study|Adverse Event|1|||
130297482|NCT02049138|469052244|FG000|Overall Study|Withdrawal by Subject|57|||
130297483|NCT02049138|469052245|FG001|Overall Study|Withdrawal by Subject|21|||
130297484|NCT02049138|469052246|FG002|Overall Study|Withdrawal by Subject|5|||
130297485|NCT02049138|469052244|FG000|Overall Study|Lost to Follow-up|18|||
130297486|NCT02049138|469052245|FG001|Overall Study|Lost to Follow-up|5|||
130297487|NCT02049138|469052246|FG002|Overall Study|Lost to Follow-up|1|||
130297488|NCT02049138|469052244|FG000|Overall Study|Lack of Efficacy|10|||
130297489|NCT02049138|469052245|FG001|Overall Study|Lack of Efficacy|26|||
130297490|NCT02049138|469052246|FG002|Overall Study|Lack of Efficacy|1|||
130297491|NCT02049138|469052244|FG000|Overall Study|Non-Compliance|15|||
130297492|NCT02049138|469052245|FG001|Overall Study|Non-Compliance|6|||
129794547|NCT04078178|467216334|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
130297493|NCT02049138|469052246|FG002|Overall Study|Non-Compliance|0|||
130297494|NCT02049138|469052244|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
129794548|NCT04078178|467216335|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
129794549|NCT04078178|467216334|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
129794550|NCT04078178|467216335|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
129794551|NCT04078178|467216334|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
129794552|NCT04078178|467216335|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
129794553|NCT04078178|467216334|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
129794554|NCT04078178|467216335|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
129794555|NCT04006119|467216336|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
129794556|NCT04006119|467216336|FG000|End of Treatment Veledimex|Adverse Event|2|||
129794557|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
129794558|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
129794559|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
129794560|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
129794561|NCT04617795|467216337|FG000|Main Study|Lost to Follow-up|1|||
129794562|NCT04617795|467216338|FG001|Main Study|Lost to Follow-up|0|||
129794563|NCT00472459|467216339|FG000|Overall Study|Adverse Event|13|||
129794564|NCT00472459|467216340|FG001|Overall Study|Adverse Event|13|||
129794565|NCT00472459|467216339|FG000|Overall Study|Withdrawal by Subject|5|||
129794566|NCT00472459|467216340|FG001|Overall Study|Withdrawal by Subject|5|||
129794567|NCT00472459|467216339|FG000|Overall Study|Protocol Violation|3|||
129794568|NCT00472459|467216340|FG001|Overall Study|Protocol Violation|3|||
129794569|NCT00472459|467216339|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
129794570|NCT00472459|467216340|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
129794571|NCT00472459|467216339|FG000|Overall Study|Lost to Follow-up|1|||
129794572|NCT00472459|467216340|FG001|Overall Study|Lost to Follow-up|1|||
129794573|NCT03442764|467216341|FG000|Overall Study|Adverse Event|1|||
129794574|NCT03442764|467216342|FG001|Overall Study|Adverse Event|0|||
129794575|NCT03442764|467216343|FG002|Overall Study|Adverse Event|0|||
129794576|NCT04850313|467216344|FG000|Overall Study|Withdrawal by Subject|0|||
129794577|NCT04850313|467216345|FG001|Overall Study|Withdrawal by Subject|1|||
129794578|NCT02395016|467216346|FG000|Overall Study|Adverse Event|4|||
129794579|NCT02395016|467216347|FG001|Overall Study|Adverse Event|3|||
129794580|NCT02395016|467216346|FG000|Overall Study|Withdrawal by Subject|9|||
130107424|NCT00681824|468355117|FG002|Overall Study|scheduling conflict|0|||
130297495|NCT02049138|469052245|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
130297496|NCT02049138|469052246|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
130297497|NCT02049138|469052244|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
130297498|NCT02049138|469052245|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130297499|NCT02049138|469052246|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130297500|NCT02049138|469052244|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129794581|NCT02395016|467216347|FG001|Overall Study|Withdrawal by Subject|6|||
129794582|NCT02395016|467216346|FG000|Overall Study|Protocol Violation|2|||
129794583|NCT02395016|467216347|FG001|Overall Study|Protocol Violation|3|||
129794584|NCT01547780|467216348|FG000|Baseline PET Scan|Physician Decision|1|||
129794585|NCT01547780|467216349|FG001|Baseline PET Scan|Physician Decision|0|||
129794586|NCT01547780|467216350|FG002|Baseline PET Scan|Physician Decision|1|||
130297501|NCT02049138|469052245|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
130297502|NCT02049138|469052246|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
129794587|NCT01547780|467216351|FG003|Baseline PET Scan|Physician Decision|0|||
129794588|NCT01547780|467216348|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
129794589|NCT01547780|467216349|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
129888947|NCT02448719|467550951|FG001|Overall Study|Withdrawal by Subject|0|||
129888948|NCT02448719|467550952|FG002|Overall Study|Withdrawal by Subject|0|||
129888949|NCT02448719|467550953|FG003|Overall Study|Withdrawal by Subject|0|||
129888950|NCT02448719|467550954|FG004|Overall Study|Withdrawal by Subject|1|||
129888951|NCT02448719|467550955|FG005|Overall Study|Withdrawal by Subject|0|||
129888952|NCT02448719|467550956|FG006|Overall Study|Withdrawal by Subject|0|||
129888953|NCT02448719|467550957|FG007|Overall Study|Withdrawal by Subject|0|||
129888954|NCT02448719|467550958|FG008|Overall Study|Withdrawal by Subject|0|||
129888955|NCT02448719|467550959|FG009|Overall Study|Withdrawal by Subject|0|||
129888956|NCT02448719|467550960|FG010|Overall Study|Withdrawal by Subject|0|||
129888957|NCT01232556|467550961|FG000|Overall Study|Withdrawal by Subject|21|||
129888958|NCT01232556|467550962|FG001|Overall Study|Withdrawal by Subject|17|||
129794590|NCT01547780|467216350|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
129794591|NCT01547780|467216351|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
129794592|NCT00814879|467216353|FG000|By Week 24|Cancer Diagnosis|1|||
129794593|NCT00814879|467216354|FG001|By Week 24|Cancer Diagnosis|0|||
129794594|NCT00814879|467216353|FG000|By Week 24|Incarceration|0|||
129794595|NCT00814879|467216354|FG001|By Week 24|Incarceration|1|||
129794596|NCT00814879|467216353|FG000|By Week 48|Lost to Follow-up|2|||
129794597|NCT00814879|467216354|FG001|By Week 48|Lost to Follow-up|2|||
129794598|NCT00814879|467216353|FG000|By Week 48|Death|0|||
129888959|NCT01232556|467550961|FG000|Overall Study|Death|97|||
130047312|NCT00090285|468130111|FG001|Base Study Follow-up Period|Uncooperative|4|||
130107425|NCT00681824|468355115|FG000|Overall Study|Death|0|||
130297503|NCT02049138|469052244|FG000|Overall Study|Other|15|||
130297504|NCT02049138|469052245|FG001|Overall Study|Other|13|||
130297505|NCT02049138|469052246|FG002|Overall Study|Other|0|||
130297506|NCT02049138|469052244|FG000|Overall Study|Missing|0|||
130297507|NCT02049138|469052245|FG001|Overall Study|Missing|1|||
130297508|NCT02049138|469052246|FG002|Overall Study|Missing|0|||
130297509|NCT02925741|469052247|FG000|Overall Study|Withdrawal by Subject|11|||
130297510|NCT02925741|469052248|FG001|Overall Study|Withdrawal by Subject|0|||
130297511|NCT05086510|469052249|FG000|Overall Study|Lost to Follow-up|0|||
130297512|NCT05086510|469052250|FG001|Overall Study|Lost to Follow-up|2|||
130297513|NCT05086510|469052249|FG000|Overall Study|Death|0|||
130297514|NCT05086510|469052250|FG001|Overall Study|Death|2|||
130297515|NCT00295932|469052251|FG000|Overall Study|Not Treated|0|||
130297516|NCT00295932|469052252|FG001|Overall Study|Not Treated|0|||
130297517|NCT00295932|469052253|FG002|Overall Study|Not Treated|0|||
130297518|NCT00295932|469052254|FG003|Overall Study|Not Treated|0|||
130297519|NCT00295932|469052255|FG004|Overall Study|Not Treated|0|||
130297520|NCT00295932|469052256|FG005|Overall Study|Not Treated|0|||
130297521|NCT00295932|469052257|FG006|Overall Study|Not Treated|0|||
130297522|NCT00295932|469052258|FG007|Overall Study|Not Treated|0|||
130297523|NCT00295932|469052259|FG008|Overall Study|Not Treated|0|||
130297524|NCT00295932|469052260|FG009|Overall Study|Not Treated|0|||
130297525|NCT00295932|469052261|FG010|Overall Study|Not Treated|1|||
130297526|NCT00109577|469052262|FG000|Overall Study|Withdrawal by Subject|3|||
130297527|NCT00109577|469052263|FG001|Overall Study|Withdrawal by Subject|3|||
130297528|NCT00884832|469052264|FG000|Overall Study|Withdrawal by Subject|0|||
130297529|NCT00884832|469052265|FG001|Overall Study|Withdrawal by Subject|1|||
130297530|NCT02337725|469052266|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
130297531|NCT02337725|469052267|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
130297532|NCT02337725|469052266|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
130297533|NCT02337725|469052267|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
130297534|NCT02337725|469052266|FG000|Overall Study|Major Protocol Deviation|0|||
130297535|NCT02337725|469052267|FG001|Overall Study|Major Protocol Deviation|1|||
130297536|NCT02337725|469052266|FG000|Overall Study|Voluntary Withdrawal|14|||
130297537|NCT02337725|469052267|FG001|Overall Study|Voluntary Withdrawal|3|||
130297538|NCT02337725|469052266|FG000|Overall Study|Lack of Efficacy|4|||
130297539|NCT02337725|469052267|FG001|Overall Study|Lack of Efficacy|0|||
130297540|NCT02096263|469052268|FG000|Overall Study|Adverse Event|1|||
130297541|NCT02096263|469052269|FG001|Overall Study|Adverse Event|0|||
130297542|NCT02096263|469052270|FG002|Overall Study|Adverse Event|1|||
130297543|NCT02096263|469052268|FG000|Overall Study|Lost to Follow-up|14|||
130297544|NCT02096263|469052269|FG001|Overall Study|Lost to Follow-up|18|||
130297545|NCT02096263|469052270|FG002|Overall Study|Lost to Follow-up|15|||
129794599|NCT00814879|467216354|FG001|By Week 48|Death|1|||
129794600|NCT00588952|467216355|FG000|Overall Study|Adverse Event|0|||
129794601|NCT00588952|467216356|FG001|Overall Study|Adverse Event|2|||
129794602|NCT00588952|467216355|FG000|Overall Study|Withdrawal by Subject|3|||
129888960|NCT01232556|467550962|FG001|Overall Study|Death|97|||
129888961|NCT01232556|467550961|FG000|Overall Study|Lost to Follow-up|0|||
129888962|NCT01232556|467550962|FG001|Overall Study|Lost to Follow-up|2|||
130297546|NCT02096263|469052268|FG000|Overall Study|Other|7|||
130297547|NCT02096263|469052269|FG001|Overall Study|Other|9|||
130297548|NCT02096263|469052270|FG002|Overall Study|Other|6|||
130297549|NCT02096263|469052268|FG000|Overall Study|Sponsor study termination|0|||
130297550|NCT02096263|469052269|FG001|Overall Study|Sponsor study termination|0|||
130297551|NCT02096263|469052270|FG002|Overall Study|Sponsor study termination|1|||
130297552|NCT02096263|469052268|FG000|Overall Study|Protocol Violation|7|||
129888963|NCT01232556|467550961|FG000|Overall Study|Terminated by Sponsor|35|||
129888964|NCT01232556|467550962|FG001|Overall Study|Terminated by Sponsor|51|||
129888965|NCT01232556|467550961|FG000|Overall Study|Other|6|||
129888966|NCT01232556|467550962|FG001|Overall Study|Other|4|||
129888967|NCT01473420|467550964|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
129888968|NCT01473420|467550965|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
129888969|NCT01473420|467550964|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
129888970|NCT01473420|467550965|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
129888971|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
129888972|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
129888973|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
129888974|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
129888975|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
129888976|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
129888977|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
129888978|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
129888979|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
129888980|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
129888981|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
129888982|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
129888983|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
129888984|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
129888985|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
129888986|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
129888987|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
129888988|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
129888989|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
129888990|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
129888991|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
130297553|NCT02096263|469052269|FG001|Overall Study|Protocol Violation|2|||
130297554|NCT02096263|469052270|FG002|Overall Study|Protocol Violation|8|||
130297555|NCT02096263|469052268|FG000|Overall Study|Withdrawal by Subject|5|||
130297556|NCT02096263|469052269|FG001|Overall Study|Withdrawal by Subject|7|||
130297557|NCT02096263|469052270|FG002|Overall Study|Withdrawal by Subject|8|||
130297558|NCT03322423|469052271|FG000|Period 1|Subject no longer eligible|0|||
130297559|NCT03322423|469052272|FG001|Period 1|Subject no longer eligible|1|||
130297560|NCT03322423|469052271|FG000|Period 1|Withdrawal by Subject|0|||
130297561|NCT03322423|469052272|FG001|Period 1|Withdrawal by Subject|1|||
130297562|NCT03322423|469052271|FG000|Period 1|Incorrect Lens Dispensed|1|||
130297563|NCT03322423|469052272|FG001|Period 1|Incorrect Lens Dispensed|0|||
130297564|NCT03322423|469052271|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
130297565|NCT03322423|469052272|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
130297566|NCT03322423|469052271|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
130297567|NCT03322423|469052272|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
130297568|NCT03322423|469052271|FG000|Period 2|Protocol Violation|1|||
130297569|NCT03322423|469052272|FG001|Period 2|Protocol Violation|0|||
130297570|NCT03322423|469052271|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
130297571|NCT03322423|469052272|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
130297572|NCT00500760|469052279|FG000|Overall Study|Death|32|||
130297573|NCT00500760|469052280|FG001|Overall Study|Death|15|||
130297574|NCT00500760|469052279|FG000|Overall Study|Withdrawal by Subject|5|||
130297575|NCT00500760|469052280|FG001|Overall Study|Withdrawal by Subject|7|||
130297576|NCT00500760|469052279|FG000|Overall Study|Administrative decision|2|||
130297577|NCT00500760|469052280|FG001|Overall Study|Administrative decision|0|||
130297578|NCT00500760|469052279|FG000|Overall Study|Lost to Follow-up|3|||
130297579|NCT00500760|469052280|FG001|Overall Study|Lost to Follow-up|0|||
130297580|NCT00500760|469052279|FG000|Overall Study|Other|1|||
130297581|NCT00500760|469052280|FG001|Overall Study|Other|2|||
130297582|NCT02925728|469052286|FG000|Overall Study|Death|3|||
130297583|NCT02925728|469052287|FG001|Overall Study|Death|5|||
130297584|NCT02925728|469052286|FG000|Overall Study|Physician Decision|1|||
130297585|NCT02925728|469052287|FG001|Overall Study|Physician Decision|0|||
130297586|NCT02925728|469052286|FG000|Overall Study|Withdrawal by Subject|1|||
129888992|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
129888993|NCT04172987|467550966|FG000|Lead In Period|Adverse Event|1|||
129888994|NCT04172987|467550966|FG000|Lead In Period|Protocol Violation|1|||
129888995|NCT04172987|467550966|FG000|Period 1|Physician Decision|1|||
129888996|NCT04172987|467550966|FG000|Period 2|Adverse Event|5|||
129888997|NCT04172987|467550966|FG000|Period 2|Dosing Termination by Sponsor|4|||
130297587|NCT02925728|469052287|FG001|Overall Study|Withdrawal by Subject|0|||
130297588|NCT05098509|469052288|FG000|Overall Study|Withdrawal by Subject|0|||
130297589|NCT05098509|469052289|FG001|Overall Study|Withdrawal by Subject|0|||
130297590|NCT05098509|469052290|FG002|Overall Study|Withdrawal by Subject|1|||
130297591|NCT05098509|469052291|FG003|Overall Study|Withdrawal by Subject|0|||
130297592|NCT05098509|469052288|FG000|Overall Study|Early study termination|1|||
130297593|NCT05098509|469052289|FG001|Overall Study|Early study termination|1|||
130297594|NCT05098509|469052290|FG002|Overall Study|Early study termination|1|||
130297595|NCT05098509|469052291|FG003|Overall Study|Early study termination|0|||
130297596|NCT04033068|469052292|FG000|Overall Study|Withdrawal by Subject|0|||
130297597|NCT04033068|469052293|FG001|Overall Study|Withdrawal by Subject|0|||
130297598|NCT04033068|469052294|FG002|Overall Study|Withdrawal by Subject|1|||
130297599|NCT04033068|469052295|FG003|Overall Study|Withdrawal by Subject|0|||
130297600|NCT04033068|469052292|FG000|Overall Study|Lost to Follow-up|0|||
130297601|NCT04033068|469052293|FG001|Overall Study|Lost to Follow-up|1|||
130297602|NCT04033068|469052294|FG002|Overall Study|Lost to Follow-up|0|||
130297603|NCT04033068|469052295|FG003|Overall Study|Lost to Follow-up|0|||
130297604|NCT04033068|469052292|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130297605|NCT04033068|469052293|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130297606|NCT04033068|469052294|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
130297607|NCT04033068|469052295|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
130297608|NCT02986854|469052297|FG000|Overall Study|Withdrawal by Subject|0|||
130297609|NCT02986854|469052298|FG001|Overall Study|Withdrawal by Subject|1|||
130297610|NCT02986854|469052299|FG002|Overall Study|Withdrawal by Subject|1|||
130297611|NCT02986854|469052297|FG000|Overall Study|Lost to Follow-up|3|||
130297612|NCT02986854|469052298|FG001|Overall Study|Lost to Follow-up|11|||
130297613|NCT02986854|469052299|FG002|Overall Study|Lost to Follow-up|2|||
130297614|NCT00324233|469052300|FG000|First Period|unable to insert catheter|1|||
130297615|NCT00324233|469052301|FG001|First Period|unable to insert catheter|0|||
130297616|NCT00324233|469052300|FG000|Second Period|unable to insert catheter|1|||
130297617|NCT00324233|469052301|FG001|Second Period|unable to insert catheter|1|||
130297618|NCT00324233|469052300|FG000|Second Period|Protocol Violation|4|||
130297619|NCT00324233|469052301|FG001|Second Period|Protocol Violation|6|||
130297620|NCT01972789|469052306|FG000|Overall Study|Adverse Event|11|||
130297621|NCT01972789|469052307|FG001|Overall Study|Adverse Event|4|||
130297622|NCT01972789|469052306|FG000|Overall Study|Subject withdrew consent|14|||
130297623|NCT01972789|469052307|FG001|Overall Study|Subject withdrew consent|12|||
130297624|NCT01972789|469052306|FG000|Overall Study|Lost to Follow-up|4|||
130297625|NCT01972789|469052307|FG001|Overall Study|Lost to Follow-up|7|||
130297626|NCT01972789|469052306|FG000|Overall Study|Death|7|||
130107426|NCT00681824|468355116|FG001|Overall Study|Death|1|||
130107427|NCT00681824|468355117|FG002|Overall Study|Death|0|||
130297627|NCT01972789|469052307|FG001|Overall Study|Death|5|||
130297628|NCT01972789|469052306|FG000|Overall Study|Protocol deviation|1|||
130297629|NCT01972789|469052307|FG001|Overall Study|Protocol deviation|0|||
130297630|NCT01972789|469052306|FG000|Overall Study|Physician Decision|3|||
130297631|NCT01972789|469052307|FG001|Overall Study|Physician Decision|2|||
130297632|NCT00086411|469052315|FG000|Overall Study|Lost to Follow-up|11|||
130297633|NCT00086411|469052316|FG001|Overall Study|Lost to Follow-up|11|||
130297634|NCT00086411|469052317|FG002|Overall Study|Lost to Follow-up|13|||
130297635|NCT00086411|469052318|FG003|Overall Study|Lost to Follow-up|12|||
130297636|NCT00279812|469052319|FG000|Overall Study|Protocol Violation|1|||
130297637|NCT00279812|469052320|FG001|Overall Study|Protocol Violation|1|||
130297638|NCT00279812|469052321|FG002|Overall Study|Protocol Violation|0|||
130297639|NCT00279812|469052322|FG003|Overall Study|Protocol Violation|0|||
130297640|NCT00279812|469052323|FG004|Overall Study|Protocol Violation|1|||
130297641|NCT00279812|469052324|FG005|Overall Study|Protocol Violation|0|||
130297642|NCT00279812|469052319|FG000|Overall Study|Withdrawal by Subject|0|||
130297643|NCT00279812|469052320|FG001|Overall Study|Withdrawal by Subject|4|||
130297644|NCT00279812|469052321|FG002|Overall Study|Withdrawal by Subject|2|||
130297645|NCT00279812|469052322|FG003|Overall Study|Withdrawal by Subject|0|||
130297646|NCT00279812|469052323|FG004|Overall Study|Withdrawal by Subject|0|||
130297647|NCT00279812|469052324|FG005|Overall Study|Withdrawal by Subject|0|||
130297648|NCT00279812|469052319|FG000|Overall Study|Adverse Event|0|||
130297649|NCT00279812|469052320|FG001|Overall Study|Adverse Event|1|||
130297650|NCT00279812|469052321|FG002|Overall Study|Adverse Event|1|||
130297651|NCT00279812|469052322|FG003|Overall Study|Adverse Event|0|||
130297652|NCT00279812|469052323|FG004|Overall Study|Adverse Event|2|||
130297653|NCT00279812|469052324|FG005|Overall Study|Adverse Event|1|||
130297654|NCT01879072|469052325|FG000|Overall Study|Withdrawal by Subject|121|||
130297655|NCT01879072|469052325|FG000|Overall Study|Not Transplanted|30|||
130107428|NCT03724916|468355118|FG000|Overall Study|Withdrawal by Subject|0|||
130107429|NCT03724916|468355119|FG001|Overall Study|Withdrawal by Subject|1|||
130297656|NCT02503501|469054097|FG000|Overall Study|Physician Decision|1|||
130297657|NCT02503501|469054098|FG001|Overall Study|Physician Decision|0|||
130297658|NCT02503501|469054097|FG000|Overall Study|Protocol Violation|0|||
130297659|NCT02503501|469054098|FG001|Overall Study|Protocol Violation|1|||
130297660|NCT02503501|469054097|FG000|Overall Study|Withdrawal by Subject|0|||
130297661|NCT02503501|469054098|FG001|Overall Study|Withdrawal by Subject|2|||
130297662|NCT01740401|469054099|FG000|Overall Study|Progression of disease|6|||
130297663|NCT01740401|469054099|FG000|Overall Study|Adverse Event|2|||
130297664|NCT01740401|469054099|FG000|Overall Study|Did not reach primary endpoint|2|||
130297665|NCT02806960|469054100|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297666|NCT02806960|469054101|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297667|NCT02806960|469054102|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297668|NCT02806960|469054103|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
130297669|NCT03667690|469054104|FG000|Overall Study|Adverse Event|0|||
130297670|NCT03667690|469054105|FG001|Overall Study|Adverse Event|3|||
130297671|NCT03667690|469054104|FG000|Overall Study|Death|22|||
130297672|NCT03667690|469054105|FG001|Overall Study|Death|21|||
130297673|NCT03667690|469054104|FG000|Overall Study|Lost to Follow-up|4|||
130297674|NCT03667690|469054105|FG001|Overall Study|Lost to Follow-up|5|||
130297675|NCT03667690|469054104|FG000|Overall Study|Withdrawal by Subject|7|||
130297676|NCT03667690|469054105|FG001|Overall Study|Withdrawal by Subject|8|||
130297677|NCT03667690|469054104|FG000|Overall Study|Subject could not return for additional investigational product|1|||
130297678|NCT03667690|469054105|FG001|Overall Study|Subject could not return for additional investigational product|0|||
130297679|NCT03667690|469054104|FG000|Overall Study|Subject discharged to hospice care|2|||
130297680|NCT03667690|469054105|FG001|Overall Study|Subject discharged to hospice care|0|||
130297681|NCT03667690|469054104|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
130297682|NCT03667690|469054105|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
130297683|NCT03667690|469054104|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
130297684|NCT03667690|469054105|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
130297685|NCT03667690|469054104|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
130297686|NCT03667690|469054105|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
130297687|NCT03667690|469054104|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
130297688|NCT03667690|469054105|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
130297689|NCT03667690|469054104|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
130297690|NCT03667690|469054105|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
130297691|NCT03495102|469054106|FG000|Overall Study|Adverse Event|5|||
130297692|NCT03495102|469054107|FG001|Overall Study|Adverse Event|7|||
130297693|NCT03495102|469054108|FG002|Overall Study|Adverse Event|10|||
130297694|NCT03495102|469054106|FG000|Overall Study|Death|3|||
130297695|NCT03495102|469054107|FG001|Overall Study|Death|4|||
130297696|NCT03495102|469054108|FG002|Overall Study|Death|4|||
130297697|NCT03495102|469054106|FG000|Overall Study|Lost to Follow-up|15|||
130297698|NCT03495102|469054107|FG001|Overall Study|Lost to Follow-up|16|||
130297699|NCT03495102|469054108|FG002|Overall Study|Lost to Follow-up|17|||
130297700|NCT03495102|469054106|FG000|Overall Study|Physician Decision|2|||
130297701|NCT03495102|469054107|FG001|Overall Study|Physician Decision|0|||
129794603|NCT00588952|467216356|FG001|Overall Study|Withdrawal by Subject|5|||
129794604|NCT01277042|467216357|FG000|Overall Study|Adverse Event|4|||
129794605|NCT01277042|467216358|FG001|Overall Study|Adverse Event|3|||
129794606|NCT01277042|467216357|FG000|Overall Study|Lost to Follow-up|2|||
129794607|NCT01277042|467216358|FG001|Overall Study|Lost to Follow-up|2|||
129794608|NCT01277042|467216357|FG000|Overall Study|Withdrawal by Subject|2|||
129794609|NCT01277042|467216358|FG001|Overall Study|Withdrawal by Subject|0|||
129794610|NCT01461057|467216359|FG000|Overall Study|Death|10|||
129794611|NCT01461057|467216360|FG001|Overall Study|Death|9|||
129794612|NCT01461057|467216359|FG000|Overall Study|Withdrawal by Subject|2|||
129794613|NCT01461057|467216360|FG001|Overall Study|Withdrawal by Subject|3|||
129794614|NCT01461057|467216359|FG000|Overall Study|Physician Decision|0|||
129794615|NCT01461057|467216360|FG001|Overall Study|Physician Decision|2|||
129794616|NCT01461057|467216359|FG000|Overall Study|Adverse Event|0|||
129794617|NCT01461057|467216360|FG001|Overall Study|Adverse Event|1|||
129794618|NCT01461057|467216359|FG000|Overall Study|Progression of Disease|1|||
129794619|NCT01461057|467216360|FG001|Overall Study|Progression of Disease|0|||
129794620|NCT01461057|467216359|FG000|Overall Study|Study Terminated by Sponsor|2|||
129794621|NCT01461057|467216360|FG001|Overall Study|Study Terminated by Sponsor|0|||
129794622|NCT01288976|467216361|FG000|Overall Study|Withdrawal by Subject|58|||
129794623|NCT01288976|467216362|FG001|Overall Study|Withdrawal by Subject|12|||
129794624|NCT01288976|467216363|FG002|Overall Study|Withdrawal by Subject|9|||
129794625|NCT01288976|467216361|FG000|Overall Study|Death|98|||
129794626|NCT01288976|467216362|FG001|Overall Study|Death|6|||
129794627|NCT01288976|467216363|FG002|Overall Study|Death|4|||
129794628|NCT01288976|467216361|FG000|Overall Study|Data unavailable|22|||
130297702|NCT03495102|469054108|FG002|Overall Study|Physician Decision|2|||
129794629|NCT01288976|467216362|FG001|Overall Study|Data unavailable|9|||
129794630|NCT01288976|467216363|FG002|Overall Study|Data unavailable|7|||
129794631|NCT00959374|467216366|FG000|Overall Study|Withdrawal by Subject|2|||
129794632|NCT00959374|467216366|FG000|Overall Study|Lost to Follow-up|14|||
129794633|NCT00959374|467216366|FG000|Overall Study|Death|1|||
130297703|NCT03495102|469054106|FG000|Overall Study|Withdrawal by Subject|25|||
129794634|NCT00959374|467216366|FG000|Overall Study|Protocol Violation|1|||
129794635|NCT00959374|467216366|FG000|Overall Study|Implant Removed/Not Replaced|4|||
129794636|NCT00959374|467216366|FG000|Overall Study|Physician Decision|1|||
130047313|NCT00090285|468130112|FG002|Base Study Follow-up Period|Uncooperative|0|||
130047314|NCT00090285|468130113|FG003|Base Study Follow-up Period|Uncooperative|0|||
130047315|NCT00090285|468130114|FG004|Base Study Follow-up Period|Uncooperative|0|||
130047316|NCT00090285|468130115|FG005|Base Study Follow-up Period|Uncooperative|0|||
130297704|NCT03495102|469054107|FG001|Overall Study|Withdrawal by Subject|36|||
130297705|NCT03495102|469054108|FG002|Overall Study|Withdrawal by Subject|18|||
130297706|NCT03495102|469054106|FG000|Overall Study|Protocol Violation|1|||
130297707|NCT03495102|469054107|FG001|Overall Study|Protocol Violation|1|||
130297708|NCT03495102|469054108|FG002|Overall Study|Protocol Violation|0|||
130297709|NCT03495102|469054106|FG000|Overall Study|Site Closure|3|||
130297710|NCT03495102|469054107|FG001|Overall Study|Site Closure|1|||
130297711|NCT03495102|469054108|FG002|Overall Study|Site Closure|2|||
130297712|NCT03495102|469054106|FG000|Overall Study|Non-compliance|1|||
130297713|NCT03495102|469054107|FG001|Overall Study|Non-compliance|0|||
130297714|NCT03495102|469054108|FG002|Overall Study|Non-compliance|0|||
130297715|NCT03495102|469054106|FG000|Overall Study|Participant Duplicated at Another Site|0|||
130297716|NCT03495102|469054107|FG001|Overall Study|Participant Duplicated at Another Site|0|||
130297717|NCT03495102|469054108|FG002|Overall Study|Participant Duplicated at Another Site|1|||
130297718|NCT03495102|469054106|FG000|Overall Study|Primary Care Physician Recommendation|0|||
130297719|NCT03495102|469054107|FG001|Overall Study|Primary Care Physician Recommendation|1|||
130297720|NCT03495102|469054108|FG002|Overall Study|Primary Care Physician Recommendation|0|||
130297721|NCT03495102|469054106|FG000|Overall Study|Relocated to Another Country|0|||
130297722|NCT03495102|469054107|FG001|Overall Study|Relocated to Another Country|1|||
130297723|NCT03495102|469054108|FG002|Overall Study|Relocated to Another Country|0|||
130297724|NCT03495102|469054106|FG000|Overall Study|Participant was in Rehabilitation|1|||
130297725|NCT03495102|469054107|FG001|Overall Study|Participant was in Rehabilitation|0|||
130297726|NCT03495102|469054108|FG002|Overall Study|Participant was in Rehabilitation|0|||
130297727|NCT01161537|469054110|FG000|Part B|Withdrawal by Subject|2|||
130297728|NCT04327024|469054113|FG000|Overall Study|Death|1|||
130297729|NCT04327024|469054114|FG001|Overall Study|Death|2|||
130297730|NCT04327024|469054115|FG002|Overall Study|Death|1|||
130297731|NCT04327024|469054113|FG000|Overall Study|Non-compliance with study drug|0|||
130047317|NCT00090285|468130110|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
130047318|NCT00090285|468130111|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
130297732|NCT04327024|469054114|FG001|Overall Study|Non-compliance with study drug|1|||
130047319|NCT00090285|468130112|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
130107430|NCT03724916|468355120|FG002|Overall Study|Withdrawal by Subject|1|||
130297733|NCT04327024|469054115|FG002|Overall Study|Non-compliance with study drug|0|||
130297734|NCT04327024|469054113|FG000|Overall Study|Withdrawal by Subject|1|||
130107431|NCT03724916|468355121|FG003|Overall Study|Withdrawal by Subject|2|||
129794637|NCT02284178|467216367|FG000|Overall Study|Met exclusion criteria|49|||
129794638|NCT02284178|467216368|FG001|Overall Study|Met exclusion criteria|54|||
129794639|NCT01483690|467216372|FG000|Overall Study|Adverse Event|1|||
129794640|NCT01483690|467216373|FG001|Overall Study|Adverse Event|2|||
129794641|NCT01483690|467216372|FG000|Overall Study|clinical deterioration|1|||
129794642|NCT01483690|467216373|FG001|Overall Study|clinical deterioration|0|||
129794643|NCT01483690|467216372|FG000|Overall Study|Physician Decision|0|||
129794644|NCT01483690|467216373|FG001|Overall Study|Physician Decision|2|||
129794645|NCT01483690|467216372|FG000|Overall Study|exclusionary procedure|0|||
130047320|NCT00090285|468130113|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
130047321|NCT00090285|468130114|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
130297735|NCT04327024|469054114|FG001|Overall Study|Withdrawal by Subject|1|||
130297736|NCT04327024|469054115|FG002|Overall Study|Withdrawal by Subject|2|||
130297737|NCT01192568|469054117|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
130297738|NCT01192568|469054118|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
130297739|NCT01192568|469054119|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
130297740|NCT01192568|469054120|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
130297741|NCT01192568|469054117|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
130297742|NCT01192568|469054118|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
130297743|NCT01192568|469054119|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
130297744|NCT01192568|469054120|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
130297745|NCT02593825|469054121|FG000|Intervention|Lost to Follow-up|10|||
130297746|NCT02593825|469054122|FG001|Intervention|Lost to Follow-up|12|||
130297747|NCT02522325|469054123|FG000|Overall Study|Adverse Event|0|||
130297748|NCT02522325|469054124|FG001|Overall Study|Adverse Event|1|||
130297749|NCT01209078|469054125|FG000|Overall Study|Adverse Event|5|||
130297750|NCT01209078|469054126|FG001|Overall Study|Adverse Event|0|||
130297751|NCT01209078|469054125|FG000|Overall Study|Lost to Follow-up|4|||
130297752|NCT01209078|469054126|FG001|Overall Study|Lost to Follow-up|0|||
130297753|NCT01209078|469054125|FG000|Overall Study|Physician Decision|5|||
130297754|NCT01209078|469054126|FG001|Overall Study|Physician Decision|2|||
130297755|NCT01209078|469054125|FG000|Overall Study|Withdrawal by Subject|2|||
130297756|NCT01209078|469054126|FG001|Overall Study|Withdrawal by Subject|1|||
130297757|NCT00924508|469054127|FG000|Overall Study|Withdrawal by Subject|3|||
130297758|NCT00511134|469054129|FG000|Overall Study|Withdrawal by Subject|0|||
130297759|NCT00511134|469054130|FG001|Overall Study|Withdrawal by Subject|2|||
130297760|NCT01949090|469054131|FG000|Overall Study|Serious Adverse Event|0|||
130297761|NCT01949090|469054132|FG001|Overall Study|Serious Adverse Event|1|||
130297762|NCT01949090|469054133|FG002|Overall Study|Serious Adverse Event|2|||
130297763|NCT01949090|469054134|FG003|Overall Study|Serious Adverse Event|0|||
130297764|NCT01949090|469054135|FG004|Overall Study|Serious Adverse Event|1|||
130297765|NCT01949090|469054131|FG000|Overall Study|Withdrawal by Subject|2|||
130297766|NCT01949090|469054132|FG001|Overall Study|Withdrawal by Subject|0|||
130297767|NCT01949090|469054133|FG002|Overall Study|Withdrawal by Subject|0|||
130297768|NCT01949090|469054134|FG003|Overall Study|Withdrawal by Subject|0|||
130297769|NCT01949090|469054135|FG004|Overall Study|Withdrawal by Subject|1|||
130297770|NCT01949090|469054131|FG000|Overall Study|Protocol non-compliance|0|||
130297771|NCT01949090|469054132|FG001|Overall Study|Protocol non-compliance|0|||
130297772|NCT01949090|469054133|FG002|Overall Study|Protocol non-compliance|0|||
130297773|NCT01949090|469054134|FG003|Overall Study|Protocol non-compliance|0|||
130297774|NCT01949090|469054135|FG004|Overall Study|Protocol non-compliance|1|||
130297775|NCT01949090|469054131|FG000|Overall Study|Lost to Follow-up|2|||
130297776|NCT01949090|469054132|FG001|Overall Study|Lost to Follow-up|1|||
130297777|NCT01949090|469054133|FG002|Overall Study|Lost to Follow-up|0|||
130297778|NCT01949090|469054134|FG003|Overall Study|Lost to Follow-up|1|||
130297779|NCT01949090|469054135|FG004|Overall Study|Lost to Follow-up|1|||
130297780|NCT03459365|469054136|FG000|Overall Study|Withdrawal by Subject|6|||
130297781|NCT03459365|469054136|FG000|Overall Study|Protocol Violation|8|||
130297782|NCT00785980|469054140|FG000|7 Day Washout Period|Protocol Violation|3|||
130297783|NCT03055013|469054141|FG000|Overall Study|Adverse Event|78|||
130297784|NCT03055013|469054142|FG001|Overall Study|Adverse Event|0|||
130297785|NCT03055013|469054141|FG000|Overall Study|Death|6|||
130297786|NCT03055013|469054142|FG001|Overall Study|Death|0|||
130297787|NCT03055013|469054141|FG000|Overall Study|Disease relapse|33|||
129888998|NCT00738530|467550976|FG000|Overall Study|Death|220|||
130297788|NCT03055013|469054142|FG001|Overall Study|Disease relapse|0|||
130297789|NCT03055013|469054141|FG000|Overall Study|Withdrawal by Subject|28|||
130297790|NCT03055013|469054142|FG001|Overall Study|Withdrawal by Subject|0|||
130297791|NCT03055013|469054141|FG000|Overall Study|Other complicating disease|5|||
129794646|NCT01483690|467216373|FG001|Overall Study|exclusionary procedure|1|||
129888999|NCT00738530|467550977|FG001|Overall Study|Death|224|||
130297792|NCT03055013|469054142|FG001|Overall Study|Other complicating disease|0|||
130297793|NCT03055013|469054141|FG000|Overall Study|Physician Decision|1|||
129794647|NCT00478881|467216379|FG000|Overall Study|Adverse Event|31|||
129794648|NCT00478881|467216380|FG001|Overall Study|Adverse Event|12|||
130297794|NCT03055013|469054142|FG001|Overall Study|Physician Decision|0|||
130297795|NCT03055013|469054141|FG000|Overall Study|Benign mass/non-RCC|4|||
130297796|NCT03055013|469054142|FG001|Overall Study|Benign mass/non-RCC|0|||
129794649|NCT00478881|467216379|FG000|Overall Study|Lack of Efficacy|0|||
129794650|NCT00478881|467216380|FG001|Overall Study|Lack of Efficacy|3|||
129794651|NCT00478881|467216379|FG000|Overall Study|Lost to Follow-up|0|||
130297797|NCT03055013|469054141|FG000|Overall Study|Enrolled in another trial|1|||
130297798|NCT03055013|469054142|FG001|Overall Study|Enrolled in another trial|0|||
130297799|NCT03055013|469054141|FG000|Overall Study|Non-protocol therapy|1|||
130297800|NCT03055013|469054142|FG001|Overall Study|Non-protocol therapy|0|||
130297801|NCT03055013|469054141|FG000|Overall Study|Incompliance|1|||
130297802|NCT03055013|469054142|FG001|Overall Study|Incompliance|0|||
130297803|NCT03055013|469054141|FG000|Overall Study|Insurance issues|1|||
130297804|NCT03055013|469054142|FG001|Overall Study|Insurance issues|0|||
130297805|NCT03055013|469054141|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
130297806|NCT03055013|469054142|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
130297807|NCT03055013|469054141|FG000|Overall Study|Did not receive nivolumab|10|||
130297808|NCT03055013|469054142|FG001|Overall Study|Did not receive nivolumab|0|||
130297809|NCT03055013|469054141|FG000|Overall Study|Did not receive surgery|0|||
130297810|NCT03055013|469054142|FG001|Overall Study|Did not receive surgery|28|||
130297811|NCT00528801|469054143|FG000|Overall Study|Withdrawal by Subject|1|||
130297812|NCT00528801|469054144|FG001|Overall Study|Withdrawal by Subject|1|||
130297813|NCT00528801|469054143|FG000|Overall Study|Protocol Violation|11|||
130297814|NCT00528801|469054144|FG001|Overall Study|Protocol Violation|5|||
130297815|NCT00528801|469054143|FG000|Overall Study|Lost to Follow-up|15|||
130297816|NCT00528801|469054144|FG001|Overall Study|Lost to Follow-up|4|||
130297817|NCT00528801|469054143|FG000|Overall Study|Administrative Reasons|0|||
130297818|NCT00528801|469054144|FG001|Overall Study|Administrative Reasons|1|||
130297819|NCT00344500|469054145|FG000|Overall Study|Adverse Event|6|||
130297820|NCT00344500|469054146|FG001|Overall Study|Adverse Event|2|||
130297821|NCT00344500|469054147|FG002|Overall Study|Adverse Event|0|||
130297822|NCT00344500|469054145|FG000|Overall Study|Lost to Follow-up|5|||
130297823|NCT00344500|469054146|FG001|Overall Study|Lost to Follow-up|13|||
130297824|NCT00344500|469054147|FG002|Overall Study|Lost to Follow-up|1|||
130297825|NCT00344500|469054145|FG000|Overall Study|Withdrawal by Subject|7|||
130297826|NCT00344500|469054146|FG001|Overall Study|Withdrawal by Subject|10|||
130297827|NCT00344500|469054147|FG002|Overall Study|Withdrawal by Subject|0|||
130297828|NCT00344500|469054145|FG000|Overall Study|Protocol Violation|4|||
130297829|NCT00344500|469054146|FG001|Overall Study|Protocol Violation|7|||
130297830|NCT00344500|469054147|FG002|Overall Study|Protocol Violation|1|||
130297831|NCT00344500|469054145|FG000|Overall Study|Not Noted|1|||
130297832|NCT00344500|469054146|FG001|Overall Study|Not Noted|3|||
130297833|NCT00344500|469054147|FG002|Overall Study|Not Noted|0|||
130297834|NCT02207491|469054148|FG000|Overall Study|Adverse Event|20|||
130297835|NCT02207491|469054149|FG001|Overall Study|Adverse Event|4|||
130297836|NCT02207491|469054148|FG000|Overall Study|Withdrawal by Subject|3|||
129794652|NCT00478881|467216380|FG001|Overall Study|Lost to Follow-up|1|||
129794653|NCT00478881|467216379|FG000|Overall Study|Protocol Violation|2|||
129794654|NCT00478881|467216380|FG001|Overall Study|Protocol Violation|2|||
129794655|NCT00478881|467216379|FG000|Overall Study|Withdrawal by Subject|6|||
129794656|NCT00478881|467216380|FG001|Overall Study|Withdrawal by Subject|2|||
129794657|NCT00478881|467216379|FG000|Overall Study|Non-Compliance with Study Medication|0|||
129794658|NCT00478881|467216380|FG001|Overall Study|Non-Compliance with Study Medication|2|||
129794659|NCT00737464|467216381|FG000|Overall Study|Adverse Event|1|||
129794660|NCT00737464|467216381|FG000|Overall Study|Death|6|||
129794661|NCT00737464|467216381|FG000|Overall Study|Other - Failure to Return|1|||
129794662|NCT00737464|467216381|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
129794663|NCT00737464|467216381|FG000|Overall Study|Other reasons|4|||
129794664|NCT01041495|467216387|FG000|Overall Study|Withdrawal by Subject|2|||
129794665|NCT01041495|467216388|FG001|Overall Study|Withdrawal by Subject|5|||
129794666|NCT01041495|467216387|FG000|Overall Study|Adverse Event|2|||
130297837|NCT02207491|469054149|FG001|Overall Study|Withdrawal by Subject|2|||
130297838|NCT02207491|469054148|FG000|Overall Study|Non-compliant|0|||
129794667|NCT01041495|467216388|FG001|Overall Study|Adverse Event|1|||
129794668|NCT01041495|467216387|FG000|Overall Study|Lost to Follow-up|0|||
129794669|NCT01041495|467216388|FG001|Overall Study|Lost to Follow-up|1|||
130297839|NCT02207491|469054149|FG001|Overall Study|Non-compliant|1|||
130297840|NCT02207491|469054148|FG000|Overall Study|Lost to Follow-up|0|||
130297841|NCT02207491|469054149|FG001|Overall Study|Lost to Follow-up|1|||
130297842|NCT02207491|469054148|FG000|Overall Study|Lack of Efficacy|3|||
130297843|NCT02207491|469054149|FG001|Overall Study|Lack of Efficacy|0|||
130297844|NCT02207491|469054148|FG000|Overall Study|Physician Decision|2|||
129794670|NCT03584373|467216389|FG000|Overall Study|Lost to Follow-up|7|||
130297845|NCT02207491|469054149|FG001|Overall Study|Physician Decision|0|||
130297846|NCT02207491|469054148|FG000|Overall Study|Protocol Violation|3|||
130297847|NCT02207491|469054149|FG001|Overall Study|Protocol Violation|5|||
129794671|NCT03584373|467216390|FG001|Overall Study|Lost to Follow-up|8|||
129794672|NCT01487577|467216391|FG000|Overall Study|Became ineligible after signing consent|1|||
129794673|NCT03780400|467216393|FG000|Overall Study|Lost to Follow-up|5|||
129794674|NCT03780400|467216393|FG000|Overall Study|Withdrawal by Subject|2|||
130297848|NCT00599755|469054150|FG000|Overall Study|Adverse Event|11|||
130297849|NCT00599755|469054150|FG000|Overall Study|Withdrawal by Subject|2|||
130297850|NCT00599755|469054150|FG000|Overall Study|Progression of Disease|3|||
130297851|NCT00599755|469054150|FG000|Overall Study|Other Reason|2|||
130297852|NCT00599755|469054150|FG000|Overall Study|No data available|1|||
130297853|NCT04680975|469054152|FG000|Overall Study|Adverse Event|3|||
130297854|NCT04680975|469054152|FG000|Overall Study|Death|1|||
130297855|NCT04680975|469054152|FG000|Overall Study|Progressive Disease|1|||
130297856|NCT04680975|469054152|FG000|Overall Study|Withdrawal by Subject|1|||
130297857|NCT03909152|469054153|FG000|Overall Study|Adverse Event|14|||
130297858|NCT03909152|469054154|FG001|Overall Study|Adverse Event|5|||
130297859|NCT03909152|469054155|FG002|Overall Study|Adverse Event|1|||
130297860|NCT03909152|469054156|FG003|Overall Study|Adverse Event|14|||
129889000|NCT00738530|467550976|FG000|Overall Study|Lost to Follow-up|8|||
129889001|NCT00738530|467550977|FG001|Overall Study|Lost to Follow-up|6|||
129889002|NCT00738530|467550976|FG000|Overall Study|Withdrawal by Subject|6|||
129889003|NCT00738530|467550977|FG001|Overall Study|Withdrawal by Subject|8|||
129889004|NCT01628510|467550978|FG000|Overall Study|Withdrawal by Subject|0|||
129889005|NCT01628510|467550979|FG001|Overall Study|Withdrawal by Subject|4|||
129889006|NCT01628510|467550978|FG000|Overall Study|Death|3|||
129889007|NCT01628510|467550979|FG001|Overall Study|Death|1|||
129889008|NCT04179461|467550980|FG000|Overall Study|Lost to Follow-up|4|||
129889009|NCT01653847|467550981|FG000|Overall Study|Withdrawal by Subject|1|||
129889010|NCT01653847|467550982|FG001|Overall Study|Withdrawal by Subject|0|||
130297861|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
130297862|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
130297863|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
130297864|NCT02615691|469054157|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
130297865|NCT02702414|469054158|FG000|Overall Study|Death|96|||
130297866|NCT02702414|469054159|FG001|Overall Study|Death|42|||
130297867|NCT02702414|469054158|FG000|Overall Study|Lost to Follow-up|0|||
130297868|NCT02702414|469054159|FG001|Overall Study|Lost to Follow-up|1|||
130297869|NCT02702414|469054158|FG000|Overall Study|Withdrawal by Subject|0|||
130297870|NCT02702414|469054159|FG001|Overall Study|Withdrawal by Subject|1|||
130297871|NCT02702414|469054158|FG000|Overall Study|Protocol Violation|1|||
130297872|NCT02702414|469054159|FG001|Overall Study|Protocol Violation|0|||
130297873|NCT02702414|469054158|FG000|Overall Study|Sponsor Decision|8|||
130297874|NCT02702414|469054159|FG001|Overall Study|Sponsor Decision|7|||
130297875|NCT02596230|469054160|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
130297876|NCT02596230|469054161|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
129889011|NCT04707391|467550983|FG000|Overall Study|Adverse Event|5|||
129889012|NCT04707391|467550984|FG001|Overall Study|Adverse Event|8|||
129889013|NCT04707391|467550983|FG000|Overall Study|Lost to Follow-up|44|||
129889014|NCT04707391|467550984|FG001|Overall Study|Lost to Follow-up|31|||
129889015|NCT04707391|467550983|FG000|Overall Study|Protocol Violation|1|||
129889016|NCT04707391|467550984|FG001|Overall Study|Protocol Violation|5|||
129889017|NCT04707391|467550983|FG000|Overall Study|Withdrawal by Subject|27|||
129889018|NCT04707391|467550984|FG001|Overall Study|Withdrawal by Subject|25|||
129889019|NCT04707391|467550983|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
129889020|NCT04707391|467550984|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
129889021|NCT04707391|467550983|FG000|Overall Study|Other|0|||
129889022|NCT04707391|467550984|FG001|Overall Study|Other|2|||
130047322|NCT00090285|468130115|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
130047323|NCT00090285|468130110|FG000|Extension 1|Adverse Event|0|||
130047324|NCT00090285|468130111|FG001|Extension 1|Adverse Event|0|||
130047325|NCT00090285|468130112|FG002|Extension 1|Adverse Event|2|||
130047326|NCT00090285|468130113|FG003|Extension 1|Adverse Event|0|||
130047327|NCT00090285|468130114|FG004|Extension 1|Adverse Event|0|||
130047328|NCT00090285|468130115|FG005|Extension 1|Adverse Event|0|||
130047329|NCT00090285|468130110|FG000|Extension 1|Lost to Follow-up|0|||
130047330|NCT00090285|468130111|FG001|Extension 1|Lost to Follow-up|0|||
130047331|NCT00090285|468130112|FG002|Extension 1|Lost to Follow-up|35|||
130047332|NCT00090285|468130113|FG003|Extension 1|Lost to Follow-up|0|||
130047333|NCT00090285|468130114|FG004|Extension 1|Lost to Follow-up|0|||
130297877|NCT02596230|469054162|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
130297878|NCT02596230|469054163|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
130297879|NCT02596230|469054164|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
130297880|NCT02596230|469054160|FG000|Objective 2, One Year|Lost to Follow-up|0|||
130297881|NCT02596230|469054161|FG001|Objective 2, One Year|Lost to Follow-up|41|||
130297882|NCT02596230|469054162|FG002|Objective 2, One Year|Lost to Follow-up|41|||
129889023|NCT03246672|467550985|FG000|Overall Study|Lost to Follow-up|2|||
129889024|NCT01347645|467550986|FG000|Overall Study|Death|1|||
129889025|NCT01347645|467550987|FG001|Overall Study|Death|5|||
129889026|NCT01347645|467550988|FG002|Overall Study|Death|2|||
129889027|NCT01347645|467550989|FG003|Overall Study|Death|7|||
129889028|NCT01347645|467550990|FG004|Overall Study|Death|7|||
129889029|NCT01347645|467550986|FG000|Overall Study|Lost to Follow-up|1|||
130047334|NCT00090285|468130115|FG005|Extension 1|Lost to Follow-up|0|||
130047335|NCT00090285|468130110|FG000|Extension 1|Withdrawal by Subject|0|||
130047336|NCT00090285|468130111|FG001|Extension 1|Withdrawal by Subject|0|||
130047337|NCT00090285|468130112|FG002|Extension 1|Withdrawal by Subject|13|||
130047338|NCT00090285|468130113|FG003|Extension 1|Withdrawal by Subject|1|||
130297883|NCT02596230|469054163|FG003|Objective 2, One Year|Lost to Follow-up|32|||
130297884|NCT02596230|469054164|FG004|Objective 2, One Year|Lost to Follow-up|46|||
130297885|NCT02596230|469054160|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
130297886|NCT02596230|469054161|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
130297887|NCT02596230|469054162|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
130297888|NCT02596230|469054163|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
130297889|NCT02596230|469054164|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
130297890|NCT02596230|469054160|FG000|Objective 2, One Year|Adverse drug reaction|0|||
130297891|NCT02596230|469054161|FG001|Objective 2, One Year|Adverse drug reaction|1|||
130297892|NCT02596230|469054162|FG002|Objective 2, One Year|Adverse drug reaction|0|||
130297893|NCT02596230|469054163|FG003|Objective 2, One Year|Adverse drug reaction|0|||
130297894|NCT02596230|469054164|FG004|Objective 2, One Year|Adverse drug reaction|0|||
130297895|NCT02596230|469054160|FG000|Objective 2, One Year|Death|0|||
130297896|NCT02596230|469054161|FG001|Objective 2, One Year|Death|12|||
130297897|NCT02596230|469054162|FG002|Objective 2, One Year|Death|41|||
130297898|NCT02596230|469054163|FG003|Objective 2, One Year|Death|21|||
130297899|NCT02596230|469054164|FG004|Objective 2, One Year|Death|30|||
130297900|NCT02596230|469054160|FG000|Objective 2, One Year|Other|0|||
130297901|NCT02596230|469054161|FG001|Objective 2, One Year|Other|3|||
130297902|NCT02596230|469054162|FG002|Objective 2, One Year|Other|2|||
130297903|NCT02596230|469054163|FG003|Objective 2, One Year|Other|0|||
130297904|NCT02596230|469054164|FG004|Objective 2, One Year|Other|0|||
130297905|NCT01272869|469054165|FG000|Period 2 (14 Days)|Adverse Event|1|||
130297906|NCT01272869|469054166|FG001|Period 2 (14 Days)|Adverse Event|0|||
130297907|NCT03908476|469054168|FG000|Overall Study|Death|3|||
130297908|NCT03908476|469054169|FG001|Overall Study|Death|0|||
130297909|NCT03908476|469054168|FG000|Overall Study|Lost to Follow-up|3|||
130297910|NCT03908476|469054169|FG001|Overall Study|Lost to Follow-up|1|||
130297911|NCT03908476|469054168|FG000|Overall Study|Withdrawal by Subject|7|||
130297912|NCT03908476|469054169|FG001|Overall Study|Withdrawal by Subject|1|||
130297913|NCT03908476|469054168|FG000|Overall Study|Physician Decision|2|||
130297914|NCT03908476|469054169|FG001|Overall Study|Physician Decision|0|||
130297915|NCT03908476|469054168|FG000|Overall Study|System Explanted and not Replaced|4|||
130297916|NCT03908476|469054169|FG001|Overall Study|System Explanted and not Replaced|0|||
130297917|NCT03908476|469054168|FG000|Overall Study|Intrathecal Pump|1|||
130297918|NCT03908476|469054169|FG001|Overall Study|Intrathecal Pump|0|||
130297919|NCT03908476|469054168|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
130297920|NCT03908476|469054169|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
130297921|NCT02868229|469054170|FG000|Overall Study|Adverse Event|1|||
130297922|NCT02868229|469054171|FG001|Overall Study|Adverse Event|0|||
130297923|NCT02868229|469054172|FG002|Overall Study|Adverse Event|0|||
130297924|NCT02868229|469054173|FG003|Overall Study|Adverse Event|1|||
130297925|NCT02868229|469054170|FG000|Overall Study|Death|0|||
129794675|NCT03823378|467216394|FG000|Overall Study|Adverse Event|2|||
129794676|NCT03823378|467216395|FG001|Overall Study|Adverse Event|2|||
129794677|NCT03823378|467216396|FG002|Overall Study|Adverse Event|0|||
129794678|NCT03823378|467216397|FG003|Overall Study|Adverse Event|0|||
129794679|NCT03823378|467216398|FG004|Overall Study|Adverse Event|0|||
129794680|NCT03823378|467216399|FG005|Overall Study|Adverse Event|0|||
129794681|NCT03823378|467216394|FG000|Overall Study|Lost to Follow-up|0|||
129794682|NCT03823378|467216395|FG001|Overall Study|Lost to Follow-up|1|||
129794683|NCT03823378|467216396|FG002|Overall Study|Lost to Follow-up|0|||
129794684|NCT03823378|467216397|FG003|Overall Study|Lost to Follow-up|0|||
129794685|NCT03823378|467216398|FG004|Overall Study|Lost to Follow-up|1|||
129794686|NCT03823378|467216399|FG005|Overall Study|Lost to Follow-up|0|||
129794687|NCT03823378|467216394|FG000|Overall Study|Withdrawal by Subject|0|||
129794688|NCT03823378|467216395|FG001|Overall Study|Withdrawal by Subject|1|||
129794689|NCT03823378|467216396|FG002|Overall Study|Withdrawal by Subject|4|||
130297926|NCT02868229|469054171|FG001|Overall Study|Death|0|||
130297927|NCT02868229|469054172|FG002|Overall Study|Death|1|||
130297928|NCT02868229|469054173|FG003|Overall Study|Death|1|||
130297929|NCT02868229|469054170|FG000|Overall Study|Missed dose|0|||
129794690|NCT03823378|467216397|FG003|Overall Study|Withdrawal by Subject|2|||
130297930|NCT02868229|469054171|FG001|Overall Study|Missed dose|0|||
130297931|NCT02868229|469054172|FG002|Overall Study|Missed dose|0|||
129794691|NCT03823378|467216398|FG004|Overall Study|Withdrawal by Subject|0|||
129889030|NCT01347645|467550987|FG001|Overall Study|Lost to Follow-up|1|||
130297932|NCT02868229|469054173|FG003|Overall Study|Missed dose|3|||
130297933|NCT03194438|469054174|FG000|Overall Study|Withdrawal by Subject|2|||
129794692|NCT03823378|467216399|FG005|Overall Study|Withdrawal by Subject|1|||
129794693|NCT03823378|467216394|FG000|Overall Study|Other, not specified|19|||
129794694|NCT03823378|467216395|FG001|Overall Study|Other, not specified|12|||
130297934|NCT02250664|469054175|FG000|Overall Study|Lost to Follow-up|18|||
130297935|NCT02250664|469054176|FG001|Overall Study|Lost to Follow-up|28|||
130297936|NCT02250664|469054177|FG002|Overall Study|Lost to Follow-up|33|||
129889031|NCT01347645|467550988|FG002|Overall Study|Lost to Follow-up|0|||
129889032|NCT01347645|467550989|FG003|Overall Study|Lost to Follow-up|1|||
129889033|NCT01347645|467550990|FG004|Overall Study|Lost to Follow-up|1|||
129889034|NCT01347645|467550986|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
129889035|NCT01347645|467550987|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
130047339|NCT00090285|468130114|FG004|Extension 1|Withdrawal by Subject|0|||
130047340|NCT00090285|468130115|FG005|Extension 1|Withdrawal by Subject|0|||
129889036|NCT01347645|467550988|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
130047341|NCT00090285|468130110|FG000|Extension 1|Other|0|||
129794695|NCT03823378|467216396|FG002|Overall Study|Other, not specified|6|||
129794696|NCT03823378|467216397|FG003|Overall Study|Other, not specified|8|||
129794697|NCT03823378|467216398|FG004|Overall Study|Other, not specified|17|||
129794698|NCT03823378|467216399|FG005|Overall Study|Other, not specified|7|||
129794699|NCT01282203|467216400|FG000|Overall Study|Adverse Event|1|||
129794700|NCT00058539|467216403|FG000|Overall Study|Disease progression|24|||
129794701|NCT00058539|467216403|FG000|Overall Study|Adverse Event|3|||
129794702|NCT00058539|467216403|FG000|Overall Study|Withdrawal by Subject|5|||
130297937|NCT02250664|469054175|FG000|Overall Study|Personal Reasons|7|||
130297938|NCT02250664|469054176|FG001|Overall Study|Personal Reasons|8|||
130297939|NCT02250664|469054177|FG002|Overall Study|Personal Reasons|14|||
130297940|NCT02250664|469054175|FG000|Overall Study|Adverse Event|6|||
130297941|NCT02250664|469054176|FG001|Overall Study|Adverse Event|3|||
130297942|NCT02250664|469054177|FG002|Overall Study|Adverse Event|8|||
130297943|NCT02250664|469054175|FG000|Overall Study|Incarcerated|2|||
130297944|NCT02250664|469054176|FG001|Overall Study|Incarcerated|1|||
130297945|NCT02250664|469054177|FG002|Overall Study|Incarcerated|2|||
130297946|NCT02250664|469054175|FG000|Overall Study|Withdrawal by Subject|0|||
130297947|NCT02250664|469054176|FG001|Overall Study|Withdrawal by Subject|1|||
130297948|NCT02250664|469054177|FG002|Overall Study|Withdrawal by Subject|2|||
130297949|NCT02250664|469054175|FG000|Overall Study|Death|0|||
130297950|NCT02250664|469054176|FG001|Overall Study|Death|1|||
130297951|NCT02250664|469054177|FG002|Overall Study|Death|1|||
130297952|NCT02250664|469054175|FG000|Overall Study|Physician Decision|1|||
130297953|NCT02250664|469054176|FG001|Overall Study|Physician Decision|3|||
130297954|NCT02250664|469054177|FG002|Overall Study|Physician Decision|1|||
130297955|NCT02250664|469054175|FG000|Overall Study|Protocol Violation|1|||
130297956|NCT02250664|469054176|FG001|Overall Study|Protocol Violation|0|||
130297957|NCT02250664|469054177|FG002|Overall Study|Protocol Violation|1|||
130297958|NCT02250664|469054175|FG000|Overall Study|Reason unknown|1|||
130297959|NCT02250664|469054176|FG001|Overall Study|Reason unknown|0|||
130297960|NCT02250664|469054177|FG002|Overall Study|Reason unknown|0|||
129794703|NCT00058539|467216403|FG000|Overall Study|Physician Decision|9|||
129794704|NCT00058539|467216403|FG000|Overall Study|Death|1|||
129794705|NCT02963831|467216404|FG000|Overall Study|Progressive Disease|3|||
129794706|NCT02963831|467216405|FG001|Overall Study|Progressive Disease|3|||
129794707|NCT02963831|467216406|FG002|Overall Study|Progressive Disease|16|||
129794708|NCT02963831|467216407|FG003|Overall Study|Progressive Disease|27|||
129794709|NCT02963831|467216404|FG000|Overall Study|Withdrawal by Subject|1|||
129794710|NCT02963831|467216405|FG001|Overall Study|Withdrawal by Subject|0|||
129794711|NCT02963831|467216406|FG002|Overall Study|Withdrawal by Subject|2|||
129794712|NCT02963831|467216407|FG003|Overall Study|Withdrawal by Subject|4|||
129794713|NCT02963831|467216404|FG000|Overall Study|Adverse Event|0|||
129794714|NCT02963831|467216405|FG001|Overall Study|Adverse Event|1|||
129794715|NCT02963831|467216406|FG002|Overall Study|Adverse Event|1|||
129794716|NCT02963831|467216407|FG003|Overall Study|Adverse Event|2|||
129794717|NCT02963831|467216404|FG000|Overall Study|Death|0|||
129794718|NCT02963831|467216405|FG001|Overall Study|Death|0|||
129794719|NCT02963831|467216406|FG002|Overall Study|Death|0|||
129794720|NCT02963831|467216407|FG003|Overall Study|Death|2|||
129794721|NCT03977454|467216408|FG000|Overall Study|immediate postoperative revision|2|||
129794722|NCT03977454|467216409|FG001|Overall Study|immediate postoperative revision|2|||
129794723|NCT04365257|467216410|FG000|Overall Study|Physician Decision|1|||
129794724|NCT04365257|467216411|FG001|Overall Study|Physician Decision|0|||
130107432|NCT03724916|468355118|FG000|Overall Study|Randomized but not Treated|1|||
130297961|NCT00117793|469054178|FG000|Overall Study|Withdrawal by Subject|12|||
130297962|NCT04268173|469054179|FG000|Overall Study|Lost to Follow-up|75|||
130297963|NCT04268173|469054180|FG001|Overall Study|Lost to Follow-up|108|||
130297964|NCT00545103|469054181|FG000|Overall Study|Lack of Efficacy|48|||
130297965|NCT00545103|469054182|FG001|Overall Study|Lack of Efficacy|45|||
130297966|NCT00545103|469054183|FG002|Overall Study|Lack of Efficacy|31|||
130297967|NCT00545103|469054184|FG003|Overall Study|Lack of Efficacy|27|||
130297968|NCT00545103|469054181|FG000|Overall Study|Withdrawal by Subject|6|||
130297969|NCT00545103|469054182|FG001|Overall Study|Withdrawal by Subject|10|||
130297970|NCT00545103|469054183|FG002|Overall Study|Withdrawal by Subject|18|||
130297971|NCT00545103|469054184|FG003|Overall Study|Withdrawal by Subject|22|||
130297972|NCT00545103|469054181|FG000|Overall Study|Adverse Event|11|||
130297973|NCT00545103|469054182|FG001|Overall Study|Adverse Event|12|||
129794725|NCT04365257|467216410|FG000|Overall Study|Patient Noncompliance|1|||
129794726|NCT04365257|467216411|FG001|Overall Study|Patient Noncompliance|0|||
129794727|NCT04365257|467216410|FG000|Overall Study|Withdrawal by Subject|0|||
130297974|NCT00545103|469054183|FG002|Overall Study|Adverse Event|17|||
130297975|NCT00545103|469054184|FG003|Overall Study|Adverse Event|10|||
130297976|NCT00545103|469054181|FG000|Overall Study|Lost to Follow-up|4|||
129794728|NCT04365257|467216411|FG001|Overall Study|Withdrawal by Subject|1|||
129794729|NCT03452527|467216412|FG000|Overall Study|Withdrawal by Subject|1|||
129794730|NCT03452527|467216413|FG001|Overall Study|Withdrawal by Subject|1|||
130297977|NCT00545103|469054182|FG001|Overall Study|Lost to Follow-up|6|||
130297978|NCT00545103|469054183|FG002|Overall Study|Lost to Follow-up|3|||
130297979|NCT00545103|469054184|FG003|Overall Study|Lost to Follow-up|4|||
129794731|NCT03452527|467216412|FG000|Overall Study|Study Terminated|2|||
129794732|NCT03452527|467216413|FG001|Overall Study|Study Terminated|3|||
129794733|NCT02129777|467216414|FG000|Double-Blind Period|Adverse Event|0|||
129794734|NCT02129777|467216415|FG001|Double-Blind Period|Adverse Event|0|||
129794735|NCT02129777|467216416|FG002|Double-Blind Period|Adverse Event|0|||
130047342|NCT00090285|468130111|FG001|Extension 1|Other|0|||
130297980|NCT00545103|469054181|FG000|Overall Study|Protocol Violation|1|||
130297981|NCT00545103|469054182|FG001|Overall Study|Protocol Violation|2|||
130297982|NCT00545103|469054183|FG002|Overall Study|Protocol Violation|3|||
130297983|NCT00545103|469054184|FG003|Overall Study|Protocol Violation|0|||
130297984|NCT00545103|469054181|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
130297985|NCT00545103|469054182|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
130297986|NCT00545103|469054183|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
130297987|NCT00545103|469054184|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
130297988|NCT00545103|469054181|FG000|Overall Study|Difficult to open package|0|||
130297989|NCT00545103|469054182|FG001|Overall Study|Difficult to open package|0|||
130297990|NCT00545103|469054183|FG002|Overall Study|Difficult to open package|0|||
130297991|NCT00545103|469054184|FG003|Overall Study|Difficult to open package|1|||
130297992|NCT00545103|469054181|FG000|Overall Study|Investigational product not taken|1|||
130297993|NCT00545103|469054182|FG001|Overall Study|Investigational product not taken|0|||
130297994|NCT00545103|469054183|FG002|Overall Study|Investigational product not taken|0|||
130297995|NCT00545103|469054184|FG003|Overall Study|Investigational product not taken|1|||
130297996|NCT00545103|469054181|FG000|Overall Study|Wish to start a family|0|||
130297997|NCT00545103|469054182|FG001|Overall Study|Wish to start a family|0|||
130297998|NCT00545103|469054183|FG002|Overall Study|Wish to start a family|0|||
130297999|NCT00545103|469054184|FG003|Overall Study|Wish to start a family|1|||
130298000|NCT00545103|469054181|FG000|Overall Study|Diverticulitis crisis|0|||
130298001|NCT00545103|469054182|FG001|Overall Study|Diverticulitis crisis|0|||
130298002|NCT00545103|469054183|FG002|Overall Study|Diverticulitis crisis|0|||
130298003|NCT00545103|469054184|FG003|Overall Study|Diverticulitis crisis|1|||
130298004|NCT00545103|469054181|FG000|Overall Study|Personal reasons|1|||
130298005|NCT00545103|469054182|FG001|Overall Study|Personal reasons|0|||
130298006|NCT00545103|469054183|FG002|Overall Study|Personal reasons|0|||
130298007|NCT00545103|469054184|FG003|Overall Study|Personal reasons|0|||
130298008|NCT00545103|469054181|FG000|Overall Study|Subject's decision|1|||
130298009|NCT00545103|469054182|FG001|Overall Study|Subject's decision|0|||
130298010|NCT00545103|469054183|FG002|Overall Study|Subject's decision|0|||
130298011|NCT00545103|469054184|FG003|Overall Study|Subject's decision|0|||
130298012|NCT00545103|469054181|FG000|Overall Study|Noncompliance|0|||
130298013|NCT00545103|469054182|FG001|Overall Study|Noncompliance|1|||
130298014|NCT00545103|469054183|FG002|Overall Study|Noncompliance|0|||
130298015|NCT00545103|469054184|FG003|Overall Study|Noncompliance|0|||
130298016|NCT00545103|469054181|FG000|Overall Study|Investigator decision|0|||
130298017|NCT00545103|469054182|FG001|Overall Study|Investigator decision|0|||
130298018|NCT00545103|469054183|FG002|Overall Study|Investigator decision|1|||
130298019|NCT00545103|469054184|FG003|Overall Study|Investigator decision|0|||
130298020|NCT00545103|469054181|FG000|Overall Study|Subject moved|0|||
130298021|NCT00545103|469054182|FG001|Overall Study|Subject moved|1|||
130298022|NCT00545103|469054183|FG002|Overall Study|Subject moved|0|||
130298023|NCT00545103|469054184|FG003|Overall Study|Subject moved|0|||
130298024|NCT00545103|469054181|FG000|Overall Study|Use of prohibited medication|0|||
130298025|NCT00545103|469054182|FG001|Overall Study|Use of prohibited medication|0|||
130298026|NCT00545103|469054183|FG002|Overall Study|Use of prohibited medication|1|||
130298027|NCT00545103|469054184|FG003|Overall Study|Use of prohibited medication|0|||
130298028|NCT00545103|469054181|FG000|Overall Study|Does not want to take study drug anymore|1|||
130298029|NCT00545103|469054182|FG001|Overall Study|Does not want to take study drug anymore|0|||
130298030|NCT00545103|469054183|FG002|Overall Study|Does not want to take study drug anymore|1|||
130298031|NCT00545103|469054184|FG003|Overall Study|Does not want to take study drug anymore|0|||
130298032|NCT00545103|469054181|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
130298033|NCT00545103|469054182|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
130298034|NCT00545103|469054183|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
130298035|NCT00545103|469054184|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
130298036|NCT00545103|469054181|FG000|Overall Study|Death|0|||
130298037|NCT00545103|469054182|FG001|Overall Study|Death|1|||
130298038|NCT00545103|469054183|FG002|Overall Study|Death|0|||
130298039|NCT00545103|469054184|FG003|Overall Study|Death|0|||
130298040|NCT04891107|469054185|FG000|Overall Study|Physician Decision|1|||
129794736|NCT02129777|467216417|FG003|Double-Blind Period|Adverse Event|0|||
130298041|NCT04891107|469054185|FG000|Overall Study|Withdrawal by Subject|1|||
130298042|NCT04891107|469054185|FG000|Overall Study|Screen failure after consent|1|||
130298043|NCT01571453|469054186|FG000|Overall Study|Adverse Event|14|||
130298044|NCT01571453|469054187|FG001|Overall Study|Adverse Event|32|||
130298045|NCT01571453|469054186|FG000|Overall Study|Lack of Efficacy|8|||
130298046|NCT01571453|469054187|FG001|Overall Study|Lack of Efficacy|3|||
130298047|NCT01571453|469054186|FG000|Overall Study|Non-compliance|2|||
129794737|NCT02129777|467216418|FG004|Double-Blind Period|Adverse Event|1|||
130298048|NCT01571453|469054187|FG001|Overall Study|Non-compliance|4|||
130298049|NCT01571453|469054186|FG000|Overall Study|Protocol Violation|1|||
130298050|NCT01571453|469054187|FG001|Overall Study|Protocol Violation|5|||
130298051|NCT01571453|469054186|FG000|Overall Study|Withdrawal of consent|5|||
130298052|NCT01571453|469054187|FG001|Overall Study|Withdrawal of consent|13|||
130298053|NCT01571453|469054186|FG000|Overall Study|Lost to Follow-up|4|||
130298054|NCT01571453|469054187|FG001|Overall Study|Lost to Follow-up|2|||
130298055|NCT01571453|469054186|FG000|Overall Study|Administrative or other reason(s)|4|||
130298056|NCT01571453|469054187|FG001|Overall Study|Administrative or other reason(s)|3|||
130298057|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
130298058|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
130298059|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
130298060|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
130298061|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
130298062|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
130298063|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
130298064|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298065|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298066|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298067|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298068|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
130298069|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
130298070|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
130298071|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298072|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298073|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298074|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
130298075|NCT02453555|469054188|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
130298076|NCT02453555|469054189|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
130298077|NCT02453555|469054190|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
130298078|NCT02453555|469054191|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
130298079|NCT02453555|469054192|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
130298080|NCT02453555|469054193|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
130298081|NCT02453555|469054188|FG000|Extension Period|Adverse Event|0|||
130298082|NCT02453555|469054189|FG001|Extension Period|Adverse Event|0|||
130298083|NCT02453555|469054190|FG002|Extension Period|Adverse Event|1|||
130298084|NCT02453555|469054191|FG003|Extension Period|Adverse Event|2|||
130298085|NCT02453555|469054192|FG004|Extension Period|Adverse Event|1|||
130298086|NCT02453555|469054193|FG005|Extension Period|Adverse Event|1|||
130298087|NCT02453555|469054188|FG000|Extension Period|Protocol Violation|0|||
129794738|NCT02129777|467216419|FG005|Double-Blind Period|Adverse Event|0|||
129794739|NCT02129777|467216420|FG006|Double-Blind Period|Adverse Event|0|||
129794740|NCT02129777|467216414|FG000|Double-Blind Period|Lost to Follow-up|1|||
129794741|NCT02129777|467216415|FG001|Double-Blind Period|Lost to Follow-up|1|||
129794742|NCT02129777|467216416|FG002|Double-Blind Period|Lost to Follow-up|1|||
129794743|NCT02129777|467216417|FG003|Double-Blind Period|Lost to Follow-up|2|||
129794744|NCT02129777|467216418|FG004|Double-Blind Period|Lost to Follow-up|0|||
129794745|NCT02129777|467216419|FG005|Double-Blind Period|Lost to Follow-up|0|||
129794746|NCT02129777|467216420|FG006|Double-Blind Period|Lost to Follow-up|0|||
129794747|NCT02129777|467216414|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129794748|NCT02129777|467216415|FG001|Double-Blind Period|Withdrawal by Subject|4|||
129794749|NCT02129777|467216416|FG002|Double-Blind Period|Withdrawal by Subject|3|||
129794750|NCT02129777|467216417|FG003|Double-Blind Period|Withdrawal by Subject|2|||
129794751|NCT02129777|467216418|FG004|Double-Blind Period|Withdrawal by Subject|3|||
129794752|NCT02129777|467216419|FG005|Double-Blind Period|Withdrawal by Subject|0|||
129794753|NCT02129777|467216420|FG006|Double-Blind Period|Withdrawal by Subject|0|||
129794754|NCT02129777|467216414|FG000|Double-Blind Period|Pregnancy|0|||
129794755|NCT02129777|467216415|FG001|Double-Blind Period|Pregnancy|0|||
129794756|NCT02129777|467216416|FG002|Double-Blind Period|Pregnancy|0|||
129794757|NCT02129777|467216417|FG003|Double-Blind Period|Pregnancy|0|||
129794758|NCT02129777|467216418|FG004|Double-Blind Period|Pregnancy|1|||
129794759|NCT02129777|467216419|FG005|Double-Blind Period|Pregnancy|0|||
129794760|NCT02129777|467216420|FG006|Double-Blind Period|Pregnancy|0|||
129794761|NCT02129777|467216414|FG000|Double-Blind Period|Lack of Efficacy|3|||
129794762|NCT02129777|467216415|FG001|Double-Blind Period|Lack of Efficacy|1|||
129794763|NCT02129777|467216416|FG002|Double-Blind Period|Lack of Efficacy|0|||
129794764|NCT02129777|467216417|FG003|Double-Blind Period|Lack of Efficacy|3|||
129794765|NCT02129777|467216418|FG004|Double-Blind Period|Lack of Efficacy|2|||
129794766|NCT02129777|467216419|FG005|Double-Blind Period|Lack of Efficacy|0|||
129794767|NCT02129777|467216420|FG006|Double-Blind Period|Lack of Efficacy|0|||
129794768|NCT02129777|467216414|FG000|Double-Blind Period|Other|1|||
129794769|NCT02129777|467216415|FG001|Double-Blind Period|Other|2|||
130047343|NCT00090285|468130112|FG002|Extension 1|Other|4|||
130298088|NCT02453555|469054189|FG001|Extension Period|Protocol Violation|0|||
130298089|NCT02453555|469054190|FG002|Extension Period|Protocol Violation|1|||
130298090|NCT02453555|469054191|FG003|Extension Period|Protocol Violation|0|||
130298091|NCT02453555|469054192|FG004|Extension Period|Protocol Violation|0|||
130298092|NCT02453555|469054193|FG005|Extension Period|Protocol Violation|0|||
130298093|NCT02453555|469054188|FG000|Extension Period|Withdrawal by Subject|0|||
130298094|NCT02453555|469054189|FG001|Extension Period|Withdrawal by Subject|0|||
130298095|NCT02453555|469054190|FG002|Extension Period|Withdrawal by Subject|1|||
130298096|NCT02453555|469054191|FG003|Extension Period|Withdrawal by Subject|0|||
130298097|NCT02453555|469054192|FG004|Extension Period|Withdrawal by Subject|0|||
130298098|NCT02453555|469054193|FG005|Extension Period|Withdrawal by Subject|0|||
130298099|NCT04284774|469054194|FG000|Overall Study|Progressive disease|5|||
130298100|NCT02879578|469054195|FG000|Overall Study|Adverse Event|1|||
130298101|NCT02879578|469054196|FG001|Overall Study|Adverse Event|2|||
130298102|NCT02879578|469054197|FG002|Overall Study|Adverse Event|14|||
130298103|NCT02879578|469054195|FG000|Overall Study|Protocol Violation|0|||
130298104|NCT02879578|469054196|FG001|Overall Study|Protocol Violation|1|||
130298105|NCT02879578|469054197|FG002|Overall Study|Protocol Violation|1|||
130298106|NCT02879578|469054195|FG000|Overall Study|Withdrawal by Subject|8|||
130298107|NCT02879578|469054196|FG001|Overall Study|Withdrawal by Subject|6|||
130298108|NCT02879578|469054197|FG002|Overall Study|Withdrawal by Subject|9|||
130298109|NCT02879578|469054195|FG000|Overall Study|Lost to Follow-up|1|||
130298110|NCT02879578|469054196|FG001|Overall Study|Lost to Follow-up|0|||
130298111|NCT02879578|469054197|FG002|Overall Study|Lost to Follow-up|4|||
130298112|NCT02879578|469054195|FG000|Overall Study|Physician Decision|0|||
130298113|NCT02879578|469054196|FG001|Overall Study|Physician Decision|0|||
130298114|NCT02879578|469054197|FG002|Overall Study|Physician Decision|4|||
130298115|NCT03203291|469054203|FG000|Overall Study|Withdrawal by Subject|1|||
130298116|NCT02039856|469054204|FG000|Overall Study|Death|5|||
130298117|NCT02039856|469054205|FG001|Overall Study|Death|3|||
130298118|NCT02039856|469054204|FG000|Overall Study|Partial survey completion|61|||
130298119|NCT02039856|469054205|FG001|Overall Study|Partial survey completion|26|||
130298120|NCT02039856|469054204|FG000|Overall Study|Lost to Follow-up|388|||
130298121|NCT02039856|469054205|FG001|Overall Study|Lost to Follow-up|206|||
130298122|NCT02039856|469054204|FG000|Overall Study|Withdrawal by Subject|1573|||
130298123|NCT02039856|469054205|FG001|Overall Study|Withdrawal by Subject|618|||
130298124|NCT02409342|469054206|FG000|Overall Study|Death|211|||
130298125|NCT02409342|469054207|FG001|Overall Study|Death|201|||
130298126|NCT02409342|469054206|FG000|Overall Study|Withdrawal by Subject|24|||
130298127|NCT02409342|469054207|FG001|Overall Study|Withdrawal by Subject|17|||
130298128|NCT02409342|469054206|FG000|Overall Study|Study Terminated By Sponsor|48|||
130298129|NCT02409342|469054207|FG001|Overall Study|Study Terminated By Sponsor|59|||
130298130|NCT02409342|469054206|FG000|Overall Study|Lost to Follow-up|3|||
130298131|NCT02409342|469054207|FG001|Overall Study|Lost to Follow-up|5|||
130298132|NCT02409342|469054206|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
130298133|NCT02409342|469054207|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
130298134|NCT02409342|469054206|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
130298135|NCT02409342|469054207|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
130298136|NCT02409342|469054206|FG000|Overall Study|Sponsor Decision|1|||
130298137|NCT02409342|469054207|FG001|Overall Study|Sponsor Decision|0|||
130298138|NCT03908970|469054208|FG000|Overall Study|Adverse Event|7|||
130298139|NCT03908970|469054209|FG001|Overall Study|Adverse Event|21|||
130298140|NCT03908970|469054208|FG000|Overall Study|Physician Decision|1|||
130298141|NCT03908970|469054209|FG001|Overall Study|Physician Decision|4|||
130298142|NCT03908970|469054208|FG000|Overall Study|Withdrawal by Subject|9|||
130298143|NCT03908970|469054209|FG001|Overall Study|Withdrawal by Subject|22|||
130298144|NCT01274429|469054215|FG000|Overall Study|Study closed do to lack of funding|5|||
130298145|NCT03268941|469055991|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298146|NCT03268941|469055992|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298147|NCT03268941|469055993|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298148|NCT03268941|469055994|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
130298149|NCT03268941|469055995|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298150|NCT03268941|469055996|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298151|NCT03268941|469055997|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
130298152|NCT03268941|469055991|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298153|NCT03268941|469055992|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298154|NCT03268941|469055993|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298155|NCT03268941|469055994|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
130298156|NCT03268941|469055995|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298157|NCT03268941|469055996|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298158|NCT03268941|469055997|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
130298159|NCT03268941|469055991|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
130298160|NCT03268941|469055992|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298161|NCT03268941|469055993|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298162|NCT03268941|469055994|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130047344|NCT00090285|468130113|FG003|Extension 1|Other|0|||
130047345|NCT00090285|468130114|FG004|Extension 1|Other|0|||
130047346|NCT00090285|468130115|FG005|Extension 1|Other|0|||
130298163|NCT03268941|469055995|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298164|NCT03268941|469055996|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298165|NCT03268941|469055997|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
130298166|NCT03268941|469055991|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
130298167|NCT03268941|469055992|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
130298168|NCT03268941|469055993|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
130298169|NCT03268941|469055994|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
130298170|NCT03268941|469055995|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
130298171|NCT03268941|469055996|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
130298172|NCT03268941|469055997|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
130298173|NCT03268941|469055991|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298174|NCT03268941|469055992|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298175|NCT03268941|469055993|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298176|NCT03268941|469055994|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298177|NCT03268941|469055995|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298178|NCT03268941|469055996|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
130298179|NCT03268941|469055997|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
130298180|NCT01216683|469055998|FG000|Induction|Never started treatment|0|||
130298181|NCT01216683|469055999|FG001|Induction|Never started treatment|6|||
130298182|NCT01216683|469056000|FG002|Induction|Never started treatment|3|||
130298183|NCT01216683|469055998|FG000|Induction|Lack of Efficacy|4|||
129794770|NCT02129777|467216416|FG002|Double-Blind Period|Other|0|||
130298184|NCT01216683|469055999|FG001|Induction|Lack of Efficacy|3|||
130298185|NCT01216683|469056000|FG002|Induction|Lack of Efficacy|7|||
130298186|NCT01216683|469055998|FG000|Induction|Adverse Event|0|||
130298187|NCT01216683|469055999|FG001|Induction|Adverse Event|5|||
129794771|NCT02129777|467216417|FG003|Double-Blind Period|Other|0|||
130298188|NCT01216683|469056000|FG002|Induction|Adverse Event|5|||
130298189|NCT01216683|469055998|FG000|Induction|Death|0|||
130298190|NCT01216683|469055999|FG001|Induction|Death|0|||
130298191|NCT01216683|469056000|FG002|Induction|Death|2|||
130298192|NCT01216683|469055998|FG000|Induction|Withdrawal by Subject|0|||
130298193|NCT01216683|469055999|FG001|Induction|Withdrawal by Subject|4|||
130298194|NCT01216683|469056000|FG002|Induction|Withdrawal by Subject|2|||
130298195|NCT01216683|469055998|FG000|Induction|Other disease|0|||
130298196|NCT01216683|469055999|FG001|Induction|Other disease|1|||
130298197|NCT01216683|469056000|FG002|Induction|Other disease|2|||
130298198|NCT01216683|469055998|FG000|Continuation|Lack of Efficacy|3|||
129794772|NCT02129777|467216418|FG004|Double-Blind Period|Other|0|||
129794773|NCT02129777|467216419|FG005|Double-Blind Period|Other|0|||
129794774|NCT02129777|467216420|FG006|Double-Blind Period|Other|0|||
129794775|NCT02129777|467216414|FG000|Open-Label Period|Lack of Efficacy|0|||
129794776|NCT02129777|467216415|FG001|Open-Label Period|Lack of Efficacy|0|||
129794777|NCT02129777|467216416|FG002|Open-Label Period|Lack of Efficacy|0|||
129794778|NCT02129777|467216417|FG003|Open-Label Period|Lack of Efficacy|0|||
129794779|NCT02129777|467216418|FG004|Open-Label Period|Lack of Efficacy|0|||
129794780|NCT02129777|467216419|FG005|Open-Label Period|Lack of Efficacy|0|||
129794781|NCT02129777|467216420|FG006|Open-Label Period|Lack of Efficacy|5|||
129794782|NCT02129777|467216414|FG000|Open-Label Period|Lost to Follow-up|0|||
129794783|NCT02129777|467216415|FG001|Open-Label Period|Lost to Follow-up|0|||
129794784|NCT02129777|467216416|FG002|Open-Label Period|Lost to Follow-up|0|||
129794785|NCT02129777|467216417|FG003|Open-Label Period|Lost to Follow-up|0|||
129794786|NCT02129777|467216418|FG004|Open-Label Period|Lost to Follow-up|0|||
129794787|NCT02129777|467216419|FG005|Open-Label Period|Lost to Follow-up|1|||
130047347|NCT00090285|468130110|FG000|Extension 1|Moved|0|||
130298199|NCT01216683|469055999|FG001|Continuation|Lack of Efficacy|2|||
130298200|NCT01216683|469056000|FG002|Continuation|Lack of Efficacy|7|||
129794788|NCT02129777|467216420|FG006|Open-Label Period|Lost to Follow-up|1|||
129794789|NCT02129777|467216414|FG000|Open-Label Period|Withdrawal by Subject|0|||
129794790|NCT02129777|467216415|FG001|Open-Label Period|Withdrawal by Subject|0|||
130047348|NCT00090285|468130111|FG001|Extension 1|Moved|0|||
129794791|NCT02129777|467216416|FG002|Open-Label Period|Withdrawal by Subject|0|||
129794792|NCT02129777|467216417|FG003|Open-Label Period|Withdrawal by Subject|0|||
130298201|NCT01216683|469055998|FG000|Continuation|Adverse Event|5|||
130298202|NCT01216683|469055999|FG001|Continuation|Adverse Event|3|||
130298203|NCT01216683|469056000|FG002|Continuation|Adverse Event|16|||
130298204|NCT01216683|469055998|FG000|Continuation|Death|1|||
130298205|NCT01216683|469055999|FG001|Continuation|Death|0|||
130298206|NCT01216683|469056000|FG002|Continuation|Death|2|||
129794793|NCT02129777|467216418|FG004|Open-Label Period|Withdrawal by Subject|0|||
130047349|NCT00090285|468130112|FG002|Extension 1|Moved|3|||
130298207|NCT01216683|469055998|FG000|Continuation|Withdrawal by Subject|4|||
130298208|NCT01216683|469055999|FG001|Continuation|Withdrawal by Subject|5|||
129794794|NCT02129777|467216419|FG005|Open-Label Period|Withdrawal by Subject|1|||
129794795|NCT02129777|467216420|FG006|Open-Label Period|Withdrawal by Subject|3|||
130047350|NCT00090285|468130113|FG003|Extension 1|Moved|0|||
130298209|NCT01216683|469056000|FG002|Continuation|Withdrawal by Subject|9|||
130298210|NCT01216683|469055998|FG000|Continuation|Other diseases|0|||
130298211|NCT01216683|469055999|FG001|Continuation|Other diseases|2|||
130298212|NCT01216683|469056000|FG002|Continuation|Other diseases|1|||
130298213|NCT01216683|469055998|FG000|Continuation|Physician Decision|1|||
130298214|NCT01216683|469055999|FG001|Continuation|Physician Decision|0|||
130298215|NCT01216683|469056000|FG002|Continuation|Physician Decision|1|||
130298216|NCT01216683|469055998|FG000|Continuation|Non-compliance|1|||
130298217|NCT01216683|469055999|FG001|Continuation|Non-compliance|0|||
130298218|NCT01216683|469056000|FG002|Continuation|Non-compliance|1|||
130298219|NCT01216683|469055998|FG000|Continuation|Insurance change|0|||
130298220|NCT01216683|469055999|FG001|Continuation|Insurance change|1|||
130298221|NCT01216683|469056000|FG002|Continuation|Insurance change|0|||
130298222|NCT01216683|469055998|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
130298223|NCT01216683|469055999|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
130298224|NCT01216683|469056000|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
130298225|NCT01216683|469055998|FG000|Continuation|Not reported|0|||
130298226|NCT01216683|469055999|FG001|Continuation|Not reported|0|||
130298227|NCT01216683|469056000|FG002|Continuation|Not reported|1|||
130298228|NCT01216683|469055998|FG000|Continuation|Never started treatment|0|||
130298229|NCT01216683|469055999|FG001|Continuation|Never started treatment|1|||
130298230|NCT01216683|469056000|FG002|Continuation|Never started treatment|5|||
130298231|NCT00765063|469056006|FG000|Overall Study|Lack of Efficacy|5|||
130298232|NCT00765063|469056006|FG000|Overall Study|Withdrawal by Subject|1|||
130298233|NCT00765063|469056006|FG000|Overall Study|Other|16|||
130298234|NCT00765063|469056006|FG000|Overall Study|Protocol Violation|6|||
130298235|NCT00765063|469056006|FG000|Overall Study|Adverse Event|4|||
130298236|NCT03614325|469056009|FG000|Overall Study|Withdrawal by Subject|0|||
130298237|NCT03614325|469056010|FG001|Overall Study|Withdrawal by Subject|2|||
130298238|NCT03614325|469056009|FG000|Overall Study|Surgery Cancelled|2|||
130298239|NCT03614325|469056010|FG001|Overall Study|Surgery Cancelled|1|||
130298240|NCT03614325|469056009|FG000|Overall Study|Lost to Follow-up|2|||
130298241|NCT03614325|469056010|FG001|Overall Study|Lost to Follow-up|1|||
130298242|NCT03614325|469056009|FG000|Overall Study|Surgery never scheduled|1|||
130298243|NCT03614325|469056010|FG001|Overall Study|Surgery never scheduled|0|||
130298244|NCT01041287|469056011|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
130298245|NCT01041287|469056012|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
130298246|NCT01041287|469056011|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
130298247|NCT01041287|469056012|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
130298248|NCT02814175|469056013|FG000|Part 1|Adverse Event|2|||
130298249|NCT02814175|469056014|FG001|Part 1|Adverse Event|3|||
130298250|NCT02814175|469056015|FG002|Part 1|Adverse Event|0|||
130298251|NCT02814175|469056016|FG003|Part 1|Adverse Event|0|||
130298252|NCT02814175|469056017|FG004|Part 1|Adverse Event|0|||
130298253|NCT02814175|469056018|FG005|Part 1|Adverse Event|0|||
130298254|NCT02814175|469056013|FG000|Part 1|Withdrawal Consent|8|||
130298255|NCT02814175|469056014|FG001|Part 1|Withdrawal Consent|1|||
130298256|NCT02814175|469056015|FG002|Part 1|Withdrawal Consent|0|||
130298257|NCT02814175|469056016|FG003|Part 1|Withdrawal Consent|0|||
130298258|NCT02814175|469056017|FG004|Part 1|Withdrawal Consent|0|||
130298259|NCT02814175|469056018|FG005|Part 1|Withdrawal Consent|0|||
130298260|NCT02814175|469056013|FG000|Part 1|Lost to Follow-up|1|||
130298261|NCT02814175|469056014|FG001|Part 1|Lost to Follow-up|0|||
130298262|NCT02814175|469056015|FG002|Part 1|Lost to Follow-up|0|||
130298263|NCT02814175|469056016|FG003|Part 1|Lost to Follow-up|0|||
130298264|NCT02814175|469056017|FG004|Part 1|Lost to Follow-up|0|||
130298265|NCT02814175|469056018|FG005|Part 1|Lost to Follow-up|0|||
130298266|NCT02814175|469056013|FG000|Part 1|Lack of Efficacy|1|||
130298267|NCT02814175|469056014|FG001|Part 1|Lack of Efficacy|2|||
130298268|NCT02814175|469056015|FG002|Part 1|Lack of Efficacy|0|||
130298269|NCT02814175|469056016|FG003|Part 1|Lack of Efficacy|0|||
130298270|NCT02814175|469056017|FG004|Part 1|Lack of Efficacy|0|||
130298271|NCT02814175|469056018|FG005|Part 1|Lack of Efficacy|0|||
130298272|NCT02814175|469056013|FG000|Part 2|Adverse Event|0|||
130298273|NCT02814175|469056014|FG001|Part 2|Adverse Event|0|||
130298274|NCT02814175|469056015|FG002|Part 2|Adverse Event|0|||
130298275|NCT02814175|469056016|FG003|Part 2|Adverse Event|1|||
130298276|NCT02814175|469056017|FG004|Part 2|Adverse Event|1|||
130298277|NCT02814175|469056018|FG005|Part 2|Adverse Event|2|||
130298278|NCT02814175|469056013|FG000|Part 2|Withdrawal Consent|0|||
130298279|NCT02814175|469056014|FG001|Part 2|Withdrawal Consent|0|||
130298280|NCT02814175|469056015|FG002|Part 2|Withdrawal Consent|0|||
130298281|NCT02814175|469056016|FG003|Part 2|Withdrawal Consent|2|||
130298282|NCT02814175|469056017|FG004|Part 2|Withdrawal Consent|1|||
130298283|NCT02814175|469056018|FG005|Part 2|Withdrawal Consent|1|||
130298284|NCT02814175|469056013|FG000|Part 2|Lost to Follow-up|0|||
130298285|NCT02814175|469056014|FG001|Part 2|Lost to Follow-up|0|||
130298286|NCT02814175|469056015|FG002|Part 2|Lost to Follow-up|0|||
130298287|NCT02814175|469056016|FG003|Part 2|Lost to Follow-up|1|||
130298288|NCT02814175|469056017|FG004|Part 2|Lost to Follow-up|0|||
130298289|NCT02814175|469056018|FG005|Part 2|Lost to Follow-up|0|||
130298290|NCT02814175|469056013|FG000|Part 2|Lack of Efficacy|0|||
130298291|NCT02814175|469056014|FG001|Part 2|Lack of Efficacy|0|||
130298292|NCT02814175|469056015|FG002|Part 2|Lack of Efficacy|0|||
130298293|NCT02814175|469056016|FG003|Part 2|Lack of Efficacy|0|||
130298294|NCT02814175|469056017|FG004|Part 2|Lack of Efficacy|0|||
130298295|NCT02814175|469056018|FG005|Part 2|Lack of Efficacy|3|||
130298296|NCT01673620|469056024|FG000|Overall Study|Adverse Event|1|||
130298297|NCT01673620|469056025|FG001|Overall Study|Adverse Event|0|||
130298298|NCT01597635|469056026|FG000|Part A|Adverse Event|3|||
130298299|NCT01597635|469056027|FG001|Part A|Adverse Event|0|||
130298300|NCT01597635|469056028|FG002|Part A|Adverse Event|0|||
130298301|NCT01597635|469056026|FG000|Part B|Adverse Event|0|||
130298302|NCT01597635|469056027|FG001|Part B|Adverse Event|0|||
130298303|NCT01597635|469056028|FG002|Part B|Adverse Event|1|||
130298304|NCT01597635|469056026|FG000|Part B|Protocol Violation|0|||
130298305|NCT01597635|469056027|FG001|Part B|Protocol Violation|1|||
130298306|NCT01597635|469056028|FG002|Part B|Protocol Violation|0|||
130298307|NCT01597635|469056026|FG000|Part B|Protocol-defined stopping criteria|0|||
130298308|NCT01597635|469056027|FG001|Part B|Protocol-defined stopping criteria|4|||
130298309|NCT01597635|469056028|FG002|Part B|Protocol-defined stopping criteria|3|||
130298310|NCT01597635|469056026|FG000|Part B|Withdrawal by Subject|0|||
130298311|NCT01597635|469056027|FG001|Part B|Withdrawal by Subject|1|||
130298312|NCT01597635|469056028|FG002|Part B|Withdrawal by Subject|0|||
130298313|NCT00495625|469056029|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
130298314|NCT01912339|469056030|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
130298315|NCT01912339|469056031|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
130298316|NCT01912339|469056032|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
130298317|NCT01912339|469056030|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
130298318|NCT01912339|469056031|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
130298319|NCT01912339|469056032|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
130298320|NCT01912339|469056030|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
130298321|NCT01912339|469056031|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
130298322|NCT01912339|469056032|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
130298323|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
130298324|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
130298325|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
130298326|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
130298327|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
130298328|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
130298329|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
130298330|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
130047351|NCT00090285|468130114|FG004|Extension 1|Moved|0|||
130047352|NCT00090285|468130115|FG005|Extension 1|Moved|0|||
130047353|NCT00090285|468130110|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
130298331|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
130298332|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
130298333|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
130298334|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
130298335|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
130298336|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
130298337|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
130298338|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
130298339|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
130298340|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
130298341|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
130298342|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
130298343|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
130047354|NCT00090285|468130111|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
130298344|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
130298345|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
130298346|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
130298347|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
130298348|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
130298349|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
130298350|NCT01912339|469056030|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
130298351|NCT01912339|469056031|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
130298352|NCT01912339|469056032|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
130298353|NCT03464019|469056033|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
130298354|NCT03464019|469056034|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
130298355|NCT03464019|469056035|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
130298356|NCT03464019|469056033|FG000|NODE-301 Part 1|Ablation|0|||
130298357|NCT03464019|469056034|FG001|NODE-301 Part 1|Ablation|0|||
130298358|NCT03464019|469056035|FG002|NODE-301 Part 1|Ablation|16|||
130298359|NCT03464019|469056033|FG000|NODE-301 Part 1|Test Dose Failure|0|||
130298360|NCT03464019|469056034|FG001|NODE-301 Part 1|Test Dose Failure|0|||
130298361|NCT03464019|469056035|FG002|NODE-301 Part 1|Test Dose Failure|8|||
130298362|NCT03464019|469056033|FG000|NODE-301 Part 1|Adverse Event|0|||
130298363|NCT03464019|469056034|FG001|NODE-301 Part 1|Adverse Event|0|||
130298364|NCT03464019|469056035|FG002|NODE-301 Part 1|Adverse Event|5|||
130298365|NCT03464019|469056033|FG000|NODE-301 Part 1|Physician Decision|0|||
130298366|NCT03464019|469056034|FG001|NODE-301 Part 1|Physician Decision|0|||
130298367|NCT03464019|469056035|FG002|NODE-301 Part 1|Physician Decision|4|||
130298368|NCT03464019|469056033|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
130298369|NCT03464019|469056034|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
130298370|NCT03464019|469056035|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
130298371|NCT03464019|469056033|FG000|NODE-301 Part 1|Protocol Violation|0|||
130298372|NCT03464019|469056034|FG001|NODE-301 Part 1|Protocol Violation|0|||
130298373|NCT03464019|469056035|FG002|NODE-301 Part 1|Protocol Violation|2|||
130298374|NCT03464019|469056033|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
130298375|NCT03464019|469056034|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
130298376|NCT03464019|469056035|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
130298377|NCT03464019|469056033|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
130298378|NCT03464019|469056034|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
130298379|NCT03464019|469056035|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
130298380|NCT03464019|469056033|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
130298381|NCT03464019|469056034|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
130298382|NCT03464019|469056035|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
130298383|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
130298384|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
130298385|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
130298386|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
130298387|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
130298388|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
130298389|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
130298390|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
130298391|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
130298392|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
130298393|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
130298394|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
130298395|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
130298396|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
130298397|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
130298398|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
130298399|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
130298400|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
130298401|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
130298402|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
130298403|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
130298404|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
130298405|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
130298406|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
130298407|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
130298408|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
130298409|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
130298410|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
130298411|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
130298412|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
130298413|NCT03464019|469056033|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
130298414|NCT03464019|469056034|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
130298415|NCT03464019|469056035|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
130298416|NCT00126776|469056036|FG000|Overall Study|follow up complete on all patients|0|||
130298417|NCT00126776|469056037|FG001|Overall Study|follow up complete on all patients|0|||
130298418|NCT03626545|469056041|FG000|Overall Study|Progressive disease|3|||
130298419|NCT03626545|469056042|FG001|Overall Study|Progressive disease|82|||
130298420|NCT03626545|469056043|FG002|Overall Study|Progressive disease|85|||
129889037|NCT01347645|467550989|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
129889038|NCT01347645|467550990|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
129889039|NCT01347645|467550986|FG000|Overall Study|Other|1|||
129889040|NCT01347645|467550987|FG001|Overall Study|Other|0|||
129889041|NCT01347645|467550988|FG002|Overall Study|Other|0|||
129889042|NCT01347645|467550989|FG003|Overall Study|Other|0|||
129889043|NCT01347645|467550990|FG004|Overall Study|Other|1|||
129889044|NCT01347645|467550986|FG000|Overall Study|Withdrawal by Subject|0|||
129889045|NCT01347645|467550987|FG001|Overall Study|Withdrawal by Subject|0|||
129889046|NCT01347645|467550988|FG002|Overall Study|Withdrawal by Subject|0|||
129889047|NCT01347645|467550989|FG003|Overall Study|Withdrawal by Subject|3|||
130047355|NCT00090285|468130112|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
130047356|NCT00090285|468130113|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
130047357|NCT00090285|468130114|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
130047358|NCT00090285|468130115|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
130047359|NCT00090285|468130110|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130047360|NCT00090285|468130111|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130047361|NCT00090285|468130112|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130047362|NCT00090285|468130113|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130047363|NCT00090285|468130114|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
130047364|NCT00090285|468130115|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
130047365|NCT00090285|468130110|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130047366|NCT00090285|468130111|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130047367|NCT00090285|468130112|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130047368|NCT00090285|468130113|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130047369|NCT00090285|468130114|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
130047370|NCT00090285|468130115|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
130047371|NCT00090285|468130110|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
130047372|NCT00090285|468130111|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
130047373|NCT00090285|468130112|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
130047374|NCT00090285|468130113|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
130047375|NCT00090285|468130114|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
130047376|NCT00090285|468130115|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
130047377|NCT00907478|468130116|FG000|Overall Study|Ineligibility determined|0|||
130047378|NCT00907478|468130117|FG001|Overall Study|Ineligibility determined|0|||
130047379|NCT00907478|468130118|FG002|Overall Study|Ineligibility determined|1|||
130047380|NCT00907478|468130116|FG000|Overall Study|Noncompliance|0|||
130298421|NCT03626545|469056041|FG000|Overall Study|Adverse Event|3|||
130298422|NCT03626545|469056042|FG001|Overall Study|Adverse Event|13|||
130298423|NCT03626545|469056043|FG002|Overall Study|Adverse Event|10|||
130298424|NCT03626545|469056041|FG000|Overall Study|Physician Decision|1|||
130298425|NCT03626545|469056042|FG001|Overall Study|Physician Decision|18|||
130298426|NCT03626545|469056043|FG002|Overall Study|Physician Decision|14|||
130298427|NCT03626545|469056041|FG000|Overall Study|Subject Decision|0|||
130298428|NCT03626545|469056042|FG001|Overall Study|Subject Decision|5|||
130298429|NCT03626545|469056043|FG002|Overall Study|Subject Decision|5|||
130298430|NCT03626545|469056041|FG000|Overall Study|Death|1|||
130298431|NCT03626545|469056042|FG001|Overall Study|Death|1|||
130298432|NCT03626545|469056043|FG002|Overall Study|Death|1|||
130298433|NCT03626545|469056041|FG000|Overall Study|Protocol Deviation|0|||
130298434|NCT03626545|469056042|FG001|Overall Study|Protocol Deviation|1|||
130298435|NCT03626545|469056043|FG002|Overall Study|Protocol Deviation|1|||
130298436|NCT03626545|469056041|FG000|Overall Study|Guardian Decision|0|||
130298437|NCT03626545|469056042|FG001|Overall Study|Guardian Decision|0|||
130298438|NCT03626545|469056043|FG002|Overall Study|Guardian Decision|1|||
130298439|NCT01939366|469056046|FG000|Overall Study|Adverse Event|8|||
130047381|NCT00907478|468130117|FG001|Overall Study|Noncompliance|0|||
130047382|NCT00907478|468130118|FG002|Overall Study|Noncompliance|1|||
130298440|NCT01939366|469056047|FG001|Overall Study|Adverse Event|17|||
130298441|NCT01939366|469056048|FG002|Overall Study|Adverse Event|30|||
130298442|NCT01939366|469056049|FG003|Overall Study|Adverse Event|8|||
130298443|NCT01939366|469056050|FG004|Overall Study|Adverse Event|5|||
129889048|NCT01347645|467550990|FG004|Overall Study|Withdrawal by Subject|3|||
129889049|NCT01347645|467550986|FG000|Overall Study|Physician Decision|0|||
129889050|NCT01347645|467550987|FG001|Overall Study|Physician Decision|0|||
129889051|NCT01347645|467550988|FG002|Overall Study|Physician Decision|0|||
129889052|NCT01347645|467550989|FG003|Overall Study|Physician Decision|0|||
130047383|NCT00907478|468130116|FG000|Overall Study|Adverse Event|3|||
130047384|NCT00907478|468130117|FG001|Overall Study|Adverse Event|1|||
130298444|NCT01939366|469056046|FG000|Overall Study|Lack of Efficacy|2|||
130298445|NCT01939366|469056047|FG001|Overall Study|Lack of Efficacy|1|||
130298446|NCT01939366|469056048|FG002|Overall Study|Lack of Efficacy|1|||
130298447|NCT01939366|469056049|FG003|Overall Study|Lack of Efficacy|1|||
130298448|NCT01939366|469056050|FG004|Overall Study|Lack of Efficacy|3|||
130298449|NCT01939366|469056046|FG000|Overall Study|Lost to Follow-up|1|||
130298450|NCT01939366|469056047|FG001|Overall Study|Lost to Follow-up|1|||
130047385|NCT00907478|468130118|FG002|Overall Study|Adverse Event|2|||
130298451|NCT01939366|469056048|FG002|Overall Study|Lost to Follow-up|0|||
130298452|NCT01939366|469056049|FG003|Overall Study|Lost to Follow-up|0|||
130298453|NCT01939366|469056050|FG004|Overall Study|Lost to Follow-up|0|||
130298454|NCT01939366|469056046|FG000|Overall Study|Withdrawal by Subject|1|||
130298455|NCT01939366|469056047|FG001|Overall Study|Withdrawal by Subject|0|||
130298456|NCT01939366|469056048|FG002|Overall Study|Withdrawal by Subject|2|||
130298457|NCT01939366|469056049|FG003|Overall Study|Withdrawal by Subject|2|||
130298458|NCT01939366|469056050|FG004|Overall Study|Withdrawal by Subject|3|||
130298459|NCT01939366|469056046|FG000|Overall Study|Inclusion criteria not met|0|||
130298460|NCT01939366|469056047|FG001|Overall Study|Inclusion criteria not met|1|||
130298461|NCT01939366|469056048|FG002|Overall Study|Inclusion criteria not met|1|||
130298462|NCT01939366|469056049|FG003|Overall Study|Inclusion criteria not met|0|||
130298463|NCT01939366|469056050|FG004|Overall Study|Inclusion criteria not met|1|||
130298464|NCT01939366|469056046|FG000|Overall Study|Other|0|||
130298465|NCT01939366|469056047|FG001|Overall Study|Other|0|||
130298466|NCT01939366|469056048|FG002|Overall Study|Other|2|||
130298467|NCT01939366|469056049|FG003|Overall Study|Other|2|||
130298468|NCT01939366|469056050|FG004|Overall Study|Other|1|||
130298469|NCT01939366|469056046|FG000|Overall Study|Protocol Violation|0|||
130298470|NCT01939366|469056047|FG001|Overall Study|Protocol Violation|0|||
130298471|NCT01939366|469056048|FG002|Overall Study|Protocol Violation|0|||
130298472|NCT01939366|469056049|FG003|Overall Study|Protocol Violation|1|||
130298473|NCT01939366|469056050|FG004|Overall Study|Protocol Violation|0|||
130298474|NCT01939366|469056046|FG000|Overall Study|Sponsor decision|0|||
130298475|NCT01939366|469056047|FG001|Overall Study|Sponsor decision|0|||
130298476|NCT01939366|469056048|FG002|Overall Study|Sponsor decision|0|||
130298477|NCT01939366|469056049|FG003|Overall Study|Sponsor decision|0|||
130298478|NCT01939366|469056050|FG004|Overall Study|Sponsor decision|2|||
130298479|NCT01939366|469056046|FG000|Overall Study|GCP non-compliance at site|2|||
130298480|NCT01939366|469056047|FG001|Overall Study|GCP non-compliance at site|3|||
130298481|NCT01939366|469056048|FG002|Overall Study|GCP non-compliance at site|2|||
130298482|NCT01939366|469056049|FG003|Overall Study|GCP non-compliance at site|3|||
130298483|NCT01939366|469056050|FG004|Overall Study|GCP non-compliance at site|3|||
130298484|NCT02271945|469056055|FG000|Overall Study|Death|3|||
130298485|NCT02271945|469056056|FG001|Overall Study|Death|3|||
130298486|NCT02271945|469056055|FG000|Overall Study|Withdrawal by Subject|1|||
130298487|NCT02271945|469056056|FG001|Overall Study|Withdrawal by Subject|1|||
130298488|NCT02271945|469056055|FG000|Overall Study|Other|1|||
130298489|NCT02271945|469056056|FG001|Overall Study|Other|1|||
130298490|NCT00615030|469056057|FG000|Period I|Administrative problem|0|||
130298491|NCT00615030|469056058|FG001|Period I|Administrative problem|0|||
130298492|NCT00615030|469056059|FG002|Period I|Administrative problem|0|||
130298493|NCT00615030|469056060|FG003|Period I|Administrative problem|0|||
130298494|NCT00615030|469056061|FG004|Period I|Administrative problem|1|||
130298495|NCT00615030|469056062|FG005|Period I|Administrative problem|0|||
130298496|NCT00615030|469056063|FG006|Period I|Administrative problem|0|||
130298497|NCT00615030|469056064|FG007|Period I|Administrative problem|0|||
130298498|NCT00615030|469056065|FG008|Period I|Administrative problem|0|||
130298499|NCT00615030|469056066|FG009|Period I|Administrative problem|0|||
130298500|NCT00615030|469056067|FG010|Period I|Administrative problem|0|||
130298501|NCT00615030|469056068|FG011|Period I|Administrative problem|0|||
130298502|NCT00615030|469056057|FG000|Period I|Protocol deviation|1|||
130298503|NCT00615030|469056058|FG001|Period I|Protocol deviation|0|||
130298504|NCT00615030|469056059|FG002|Period I|Protocol deviation|0|||
130298505|NCT00615030|469056060|FG003|Period I|Protocol deviation|0|||
130298506|NCT00615030|469056061|FG004|Period I|Protocol deviation|0|||
130298507|NCT00615030|469056062|FG005|Period I|Protocol deviation|0|||
130298508|NCT00615030|469056063|FG006|Period I|Protocol deviation|0|||
130298509|NCT00615030|469056064|FG007|Period I|Protocol deviation|0|||
130298510|NCT00615030|469056065|FG008|Period I|Protocol deviation|0|||
130047386|NCT00907478|468130116|FG000|Overall Study|Withdrawal by Subject|8|||
130047387|NCT00907478|468130117|FG001|Overall Study|Withdrawal by Subject|9|||
130047388|NCT00907478|468130118|FG002|Overall Study|Withdrawal by Subject|6|||
130047389|NCT00907478|468130116|FG000|Overall Study|Requirement for alternative therapy|1|||
130298511|NCT00615030|469056066|FG009|Period I|Protocol deviation|0|||
130047390|NCT00907478|468130117|FG001|Overall Study|Requirement for alternative therapy|2|||
130047391|NCT00907478|468130118|FG002|Overall Study|Requirement for alternative therapy|3|||
130298512|NCT00615030|469056067|FG010|Period I|Protocol deviation|0|||
130298513|NCT00615030|469056068|FG011|Period I|Protocol deviation|0|||
130047392|NCT00907478|468130116|FG000|Overall Study|Physician Decision|2|||
130298514|NCT00615030|469056057|FG000|Period I|Subject withdrew consent|0|||
130298515|NCT00615030|469056058|FG001|Period I|Subject withdrew consent|0|||
130298516|NCT00615030|469056059|FG002|Period I|Subject withdrew consent|0|||
130298517|NCT00615030|469056060|FG003|Period I|Subject withdrew consent|0|||
130298518|NCT00615030|469056061|FG004|Period I|Subject withdrew consent|0|||
130047393|NCT00907478|468130117|FG001|Overall Study|Physician Decision|0|||
130298519|NCT00615030|469056062|FG005|Period I|Subject withdrew consent|0|||
130298520|NCT00615030|469056063|FG006|Period I|Subject withdrew consent|0|||
130298521|NCT00615030|469056064|FG007|Period I|Subject withdrew consent|0|||
130298522|NCT00615030|469056065|FG008|Period I|Subject withdrew consent|1|||
130298523|NCT00615030|469056066|FG009|Period I|Subject withdrew consent|0|||
130298524|NCT00615030|469056067|FG010|Period I|Subject withdrew consent|1|||
130298525|NCT00615030|469056068|FG011|Period I|Subject withdrew consent|1|||
130298526|NCT00615030|469056057|FG000|Period I|Abnormal laboratory value(s)|0|||
130298527|NCT00615030|469056058|FG001|Period I|Abnormal laboratory value(s)|0|||
130298528|NCT00615030|469056059|FG002|Period I|Abnormal laboratory value(s)|0|||
130298529|NCT00615030|469056060|FG003|Period I|Abnormal laboratory value(s)|0|||
130298530|NCT00615030|469056061|FG004|Period I|Abnormal laboratory value(s)|0|||
130298531|NCT00615030|469056062|FG005|Period I|Abnormal laboratory value(s)|1|||
130298532|NCT00615030|469056063|FG006|Period I|Abnormal laboratory value(s)|0|||
130298533|NCT00615030|469056064|FG007|Period I|Abnormal laboratory value(s)|0|||
130298534|NCT00615030|469056065|FG008|Period I|Abnormal laboratory value(s)|0|||
130298535|NCT00615030|469056066|FG009|Period I|Abnormal laboratory value(s)|0|||
130298536|NCT00615030|469056067|FG010|Period I|Abnormal laboratory value(s)|0|||
130298537|NCT00615030|469056068|FG011|Period I|Abnormal laboratory value(s)|0|||
130298538|NCT00615030|469056057|FG000|Period II|Adverse Event|0|||
130298539|NCT00615030|469056058|FG001|Period II|Adverse Event|0|||
130298540|NCT00615030|469056059|FG002|Period II|Adverse Event|1|||
130298541|NCT00615030|469056060|FG003|Period II|Adverse Event|0|||
130298542|NCT00615030|469056061|FG004|Period II|Adverse Event|0|||
130298543|NCT00615030|469056062|FG005|Period II|Adverse Event|0|||
130298544|NCT00615030|469056063|FG006|Period II|Adverse Event|0|||
130298545|NCT00615030|469056064|FG007|Period II|Adverse Event|0|||
130298546|NCT00615030|469056065|FG008|Period II|Adverse Event|1|||
130298547|NCT00615030|469056066|FG009|Period II|Adverse Event|0|||
130298548|NCT00615030|469056067|FG010|Period II|Adverse Event|0|||
130298549|NCT00615030|469056068|FG011|Period II|Adverse Event|0|||
130298550|NCT00615030|469056057|FG000|Period II|Subject withdrew consent|0|||
130298551|NCT00615030|469056058|FG001|Period II|Subject withdrew consent|0|||
130298552|NCT00615030|469056059|FG002|Period II|Subject withdrew consent|0|||
130298553|NCT00615030|469056060|FG003|Period II|Subject withdrew consent|1|||
130298554|NCT00615030|469056061|FG004|Period II|Subject withdrew consent|0|||
130298555|NCT00615030|469056062|FG005|Period II|Subject withdrew consent|0|||
129794796|NCT02129777|467216414|FG000|Open-Label Period|Study Termination|0|||
129794797|NCT02129777|467216415|FG001|Open-Label Period|Study Termination|0|||
129794798|NCT02129777|467216416|FG002|Open-Label Period|Study Termination|0|||
129794799|NCT02129777|467216417|FG003|Open-Label Period|Study Termination|0|||
129794800|NCT02129777|467216418|FG004|Open-Label Period|Study Termination|0|||
129794801|NCT02129777|467216419|FG005|Open-Label Period|Study Termination|10|||
129794802|NCT02129777|467216420|FG006|Open-Label Period|Study Termination|39|||
129794803|NCT01001299|467216421|FG000|Overall Study|Insufficient Therapeutic Response|20|||
129794804|NCT01001299|467216421|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
129794805|NCT01001299|467216421|FG000|Overall Study|Death|1|||
129794806|NCT01001299|467216421|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
129794807|NCT01001299|467216421|FG000|Overall Study|Withdrew Consent|1|||
129794808|NCT01565499|467216422|FG000|Overall Study|Physician Decision|1|||
129794809|NCT01565499|467216422|FG000|Overall Study|Adverse Event|5|||
129794810|NCT01565499|467216422|FG000|Overall Study|Withdrawal by Subject|2|||
129794811|NCT03116347|467216423|FG000|Overall Study|Withdrawal by Subject|1|||
129794812|NCT03116347|467216424|FG001|Overall Study|Withdrawal by Subject|2|||
129794813|NCT01255787|467216425|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
129794814|NCT01255787|467216426|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
129794815|NCT01255787|467216427|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
129794816|NCT01255787|467216428|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
129794817|NCT01255787|467216425|FG000|Overall Study|Major Protocol Deviation|1|||
129794818|NCT01255787|467216426|FG001|Overall Study|Major Protocol Deviation|1|||
129794819|NCT01255787|467216427|FG002|Overall Study|Major Protocol Deviation|0|||
129794820|NCT01255787|467216428|FG003|Overall Study|Major Protocol Deviation|4|||
129794821|NCT01255787|467216425|FG000|Overall Study|Lost to Follow-up|1|||
129794822|NCT01255787|467216426|FG001|Overall Study|Lost to Follow-up|2|||
130298556|NCT00615030|469056063|FG006|Period II|Subject withdrew consent|1|||
130298557|NCT00615030|469056064|FG007|Period II|Subject withdrew consent|0|||
130298558|NCT00615030|469056065|FG008|Period II|Subject withdrew consent|0|||
130298559|NCT00615030|469056066|FG009|Period II|Subject withdrew consent|0|||
130298560|NCT00615030|469056067|FG010|Period II|Subject withdrew consent|0|||
130298561|NCT00615030|469056068|FG011|Period II|Subject withdrew consent|0|||
130298562|NCT00615030|469056057|FG000|Period III|Administrative problems|1|||
130298563|NCT00615030|469056058|FG001|Period III|Administrative problems|0|||
130298564|NCT00615030|469056059|FG002|Period III|Administrative problems|0|||
130298565|NCT00615030|469056060|FG003|Period III|Administrative problems|1|||
130298566|NCT00615030|469056061|FG004|Period III|Administrative problems|0|||
130298567|NCT00615030|469056062|FG005|Period III|Administrative problems|0|||
130298568|NCT00615030|469056063|FG006|Period III|Administrative problems|0|||
130298569|NCT00615030|469056064|FG007|Period III|Administrative problems|0|||
130298570|NCT00615030|469056065|FG008|Period III|Administrative problems|0|||
130298571|NCT00615030|469056066|FG009|Period III|Administrative problems|0|||
129794823|NCT01255787|467216427|FG002|Overall Study|Lost to Follow-up|4|||
129794824|NCT01255787|467216428|FG003|Overall Study|Lost to Follow-up|2|||
129794825|NCT01255787|467216425|FG000|Overall Study|Withdrawal of Consent|3|||
129794826|NCT01255787|467216426|FG001|Overall Study|Withdrawal of Consent|9|||
129794827|NCT01255787|467216427|FG002|Overall Study|Withdrawal of Consent|3|||
129794828|NCT01255787|467216428|FG003|Overall Study|Withdrawal of Consent|4|||
129794829|NCT01255787|467216425|FG000|Overall Study|Pregnancy|0|||
129794830|NCT01255787|467216426|FG001|Overall Study|Pregnancy|0|||
129794831|NCT01255787|467216427|FG002|Overall Study|Pregnancy|0|||
129794832|NCT01255787|467216428|FG003|Overall Study|Pregnancy|1|||
129794833|NCT01255787|467216425|FG000|Overall Study|Lack of Efficacy|2|||
129794834|NCT01255787|467216426|FG001|Overall Study|Lack of Efficacy|2|||
129794835|NCT01255787|467216427|FG002|Overall Study|Lack of Efficacy|2|||
129794836|NCT01255787|467216428|FG003|Overall Study|Lack of Efficacy|2|||
129794837|NCT01255787|467216425|FG000|Overall Study|Noncompliance with Study Drug|3|||
129794838|NCT01255787|467216426|FG001|Overall Study|Noncompliance with Study Drug|1|||
129794839|NCT01255787|467216427|FG002|Overall Study|Noncompliance with Study Drug|0|||
129794840|NCT01255787|467216428|FG003|Overall Study|Noncompliance with Study Drug|0|||
129794841|NCT00476047|467216429|FG000|Overall Study|Lost to Follow-up|1|||
129794842|NCT03170232|467216430|FG000|Overall Study|Adverse Event|0|||
129794843|NCT03170232|467216431|FG001|Overall Study|Adverse Event|1|||
129794844|NCT03170232|467216430|FG000|Overall Study|Protocol Violation|0|||
129794845|NCT03170232|467216431|FG001|Overall Study|Protocol Violation|1|||
129794846|NCT03170232|467216430|FG000|Overall Study|Lack of Efficacy|0|||
129794847|NCT03170232|467216431|FG001|Overall Study|Lack of Efficacy|1|||
129794848|NCT03170232|467216430|FG000|Overall Study|Study closed/terminated|26|||
129794849|NCT03170232|467216431|FG001|Overall Study|Study closed/terminated|23|||
129794850|NCT03170232|467216430|FG000|Overall Study|Lost to Follow-up|1|||
129794851|NCT03170232|467216431|FG001|Overall Study|Lost to Follow-up|0|||
129794852|NCT03170232|467216430|FG000|Overall Study|Withdrawal by Subject|0|||
129794853|NCT03170232|467216431|FG001|Overall Study|Withdrawal by Subject|1|||
129794854|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
129794855|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
129794856|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
129794857|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
130298572|NCT00615030|469056067|FG010|Period III|Administrative problems|0|||
130298573|NCT00615030|469056068|FG011|Period III|Administrative problems|0|||
130298574|NCT00151476|469056069|FG000|FAP Identified Subjects|Protocol Violation|0|||
130298575|NCT00151476|469056070|FG001|FAP Identified Subjects|Protocol Violation|1|||
130298576|NCT00151476|469056069|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
130298577|NCT00151476|469056070|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
130298578|NCT00151476|469056069|FG000|FAP Analyzed Subjects|Other study participation|0|||
130298579|NCT00151476|469056070|FG001|FAP Analyzed Subjects|Other study participation|1|||
130298580|NCT03446456|469056071|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
130298581|NCT03446456|469056072|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
130298582|NCT03446456|469056071|FG000|Overall Study|Lost to Follow-up|1|||
130298583|NCT03446456|469056072|FG001|Overall Study|Lost to Follow-up|3|||
130298584|NCT03446456|469056071|FG000|Overall Study|Participant failed the toxicology test|1|||
130298585|NCT03446456|469056072|FG001|Overall Study|Participant failed the toxicology test|0|||
130298586|NCT03446456|469056071|FG000|Overall Study|Break down of the experimental equipment|1|||
130298587|NCT03446456|469056072|FG001|Overall Study|Break down of the experimental equipment|0|||
130298588|NCT04099511|469056079|FG000|Overall Study|Lost to Follow-up|2|||
130298589|NCT04099511|469056080|FG001|Overall Study|Lost to Follow-up|2|||
130298590|NCT04099511|469056079|FG000|Overall Study|Withdrawal by Subject|8|||
130298591|NCT04099511|469056080|FG001|Overall Study|Withdrawal by Subject|4|||
130298592|NCT03002311|469056085|FG000|Overall Study|Lost to Follow-up|13|||
130298593|NCT03002311|469056086|FG001|Overall Study|Lost to Follow-up|26|||
130298594|NCT03002311|469056085|FG000|Overall Study|Referral provider called to schedule app|3|||
130298595|NCT03002311|469056086|FG001|Overall Study|Referral provider called to schedule app|3|||
130298596|NCT03002311|469056085|FG000|Overall Study|Physician Decision|3|||
130298597|NCT03002311|469056086|FG001|Overall Study|Physician Decision|1|||
129794858|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
129794859|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
129794860|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
129794861|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
129794862|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
129794863|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
129794864|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
129794865|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
129794866|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
129794867|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
130298598|NCT00320424|469056087|FG000|Overall Study|Adverse Event|3|||
130298599|NCT00320424|469056087|FG000|Overall Study|Other|3|||
130298600|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
130298601|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
130298602|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
130298603|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
130298604|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
130298605|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
130298606|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Death|1|||
130298607|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Death|4|||
130298608|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
130298609|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
130298610|NCT00658814|469056088|FG000|Remission Induction Chemotherapy|Not eligible|1|||
130298611|NCT00658814|469056089|FG001|Remission Induction Chemotherapy|Not eligible|2|||
130298612|NCT00658814|469056088|FG000|Consolidation Therapy|Not protocol specified|0|||
130298613|NCT00658814|469056089|FG001|Consolidation Therapy|Not protocol specified|1|||
130298614|NCT00658814|469056088|FG000|Consolidation Therapy|Not eligible|2|||
130298615|NCT00658814|469056089|FG001|Consolidation Therapy|Not eligible|2|||
130298616|NCT00658814|469056088|FG000|Maintenance Therapy|Adverse Event|1|||
130298617|NCT00658814|469056089|FG001|Maintenance Therapy|Adverse Event|1|||
130298618|NCT00658814|469056088|FG000|Maintenance Therapy|Not protocol specified|1|||
130298619|NCT00658814|469056089|FG001|Maintenance Therapy|Not protocol specified|0|||
130298620|NCT00658814|469056088|FG000|Maintenance Therapy|Not eligible|1|||
130298621|NCT00658814|469056089|FG001|Maintenance Therapy|Not eligible|0|||
130298622|NCT03270891|469056090|FG000|Overall Study|Lost to Follow-up|3|||
130298623|NCT03270891|469056091|FG001|Overall Study|Lost to Follow-up|6|||
130298624|NCT03270891|469056092|FG002|Overall Study|Lost to Follow-up|0|||
130298625|NCT03270891|469056090|FG000|Overall Study|Withdrawal by Subject|1|||
130298626|NCT03270891|469056091|FG001|Overall Study|Withdrawal by Subject|0|||
130298627|NCT03270891|469056092|FG002|Overall Study|Withdrawal by Subject|0|||
130298628|NCT03270891|469056090|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
130298629|NCT03270891|469056091|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
130298630|NCT03270891|469056092|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
130298631|NCT02540668|469056093|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
130298632|NCT02540668|469056094|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
130298633|NCT02883062|469056096|FG000|Overall Study|Withdrawal by Subject|6|||
130298634|NCT02883062|469056097|FG001|Overall Study|Withdrawal by Subject|0|||
130298635|NCT02888743|469056098|FG000|Overall Study|Withdrawal by Subject|1|||
130298636|NCT02888743|469056099|FG001|Overall Study|Withdrawal by Subject|2|||
130298637|NCT02888743|469056100|FG002|Overall Study|Withdrawal by Subject|2|||
130298638|NCT02888743|469056101|FG003|Overall Study|Withdrawal by Subject|0|||
130298639|NCT02888743|469056102|FG004|Overall Study|Withdrawal by Subject|1|||
130298640|NCT02888743|469056098|FG000|Overall Study|Disease progression before treatment|2|||
130298641|NCT02888743|469056099|FG001|Overall Study|Disease progression before treatment|0|||
129794868|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
129794869|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
129794870|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
129794871|NCT03882008|467216433|FG000|Overall Study|Withdrawal by Subject|1|||
129794872|NCT03882008|467216433|FG000|Overall Study|Lost to Follow-up|1|||
129794873|NCT02009384|467216434|FG000|Overall Study|Death|2|||
129794874|NCT00718237|467216436|FG000|Overall Study|Adverse Event|1|||
129794875|NCT00718237|467216437|FG001|Overall Study|Adverse Event|3|||
129794876|NCT00718237|467216436|FG000|Overall Study|Lost to Follow-up|2|||
129794877|NCT00718237|467216437|FG001|Overall Study|Lost to Follow-up|2|||
129794878|NCT00718237|467216436|FG000|Overall Study|Physician Decision|1|||
129794879|NCT00718237|467216437|FG001|Overall Study|Physician Decision|0|||
129794880|NCT00718237|467216436|FG000|Overall Study|Withdrawal by Subject|9|||
129794881|NCT00718237|467216437|FG001|Overall Study|Withdrawal by Subject|10|||
129794882|NCT03189381|467216438|FG000|Overall Study|Death|1|||
129794883|NCT03189381|467216439|FG001|Overall Study|Death|0|||
130047394|NCT00907478|468130118|FG002|Overall Study|Physician Decision|3|||
130047395|NCT00907478|468130116|FG000|Overall Study|Death|4|||
130298642|NCT02888743|469056100|FG002|Overall Study|Disease progression before treatment|2|||
130047396|NCT00907478|468130117|FG001|Overall Study|Death|2|||
130298643|NCT02888743|469056101|FG003|Overall Study|Disease progression before treatment|0|||
130298644|NCT02888743|469056102|FG004|Overall Study|Disease progression before treatment|0|||
130047397|NCT00907478|468130118|FG002|Overall Study|Death|1|||
130298645|NCT02888743|469056098|FG000|Overall Study|Patient ineligible|1|||
130298646|NCT02888743|469056099|FG001|Overall Study|Patient ineligible|2|||
129794884|NCT00251004|467216440|FG000|Overall Study|Withdrawal by Subject|23|||
129794885|NCT00251004|467216441|FG001|Overall Study|Withdrawal by Subject|16|||
130298647|NCT02888743|469056100|FG002|Overall Study|Patient ineligible|0|||
130298648|NCT02888743|469056101|FG003|Overall Study|Patient ineligible|0|||
130298649|NCT02888743|469056102|FG004|Overall Study|Patient ineligible|0|||
130298650|NCT04816721|469056107|FG000|Overall Study|Withdrawal by Subject|0|||
130298651|NCT04816721|469056108|FG001|Overall Study|Withdrawal by Subject|2|||
130298652|NCT04816721|469056109|FG002|Overall Study|Withdrawal by Subject|0|||
130298653|NCT04816721|469056110|FG003|Overall Study|Withdrawal by Subject|1|||
130298654|NCT04816721|469056111|FG004|Overall Study|Withdrawal by Subject|1|||
130298655|NCT04816721|469056112|FG005|Overall Study|Withdrawal by Subject|0|||
130298656|NCT04816721|469056113|FG006|Overall Study|Withdrawal by Subject|0|||
130298657|NCT04816721|469056114|FG007|Overall Study|Withdrawal by Subject|0|||
130298658|NCT04816721|469056107|FG000|Overall Study|Miscellaneous|0|||
130298659|NCT04816721|469056108|FG001|Overall Study|Miscellaneous|0|||
130298660|NCT04816721|469056109|FG002|Overall Study|Miscellaneous|0|||
130298661|NCT04816721|469056110|FG003|Overall Study|Miscellaneous|0|||
130298662|NCT04816721|469056111|FG004|Overall Study|Miscellaneous|0|||
130298663|NCT04816721|469056112|FG005|Overall Study|Miscellaneous|1|||
130298664|NCT04816721|469056113|FG006|Overall Study|Miscellaneous|0|||
130298665|NCT04816721|469056114|FG007|Overall Study|Miscellaneous|0|||
130298666|NCT04816721|469056107|FG000|Overall Study|Lost to Follow-up|0|||
130298667|NCT04816721|469056108|FG001|Overall Study|Lost to Follow-up|0|||
130298668|NCT04816721|469056109|FG002|Overall Study|Lost to Follow-up|0|||
130298669|NCT04816721|469056110|FG003|Overall Study|Lost to Follow-up|1|||
130298670|NCT04816721|469056111|FG004|Overall Study|Lost to Follow-up|0|||
130298671|NCT04816721|469056112|FG005|Overall Study|Lost to Follow-up|0|||
130298672|NCT04816721|469056113|FG006|Overall Study|Lost to Follow-up|0|||
130298673|NCT04816721|469056114|FG007|Overall Study|Lost to Follow-up|0|||
130298674|NCT02708485|469056115|FG000|Overall Study|Withdrawal by Subject|3|||
130298675|NCT02708485|469056116|FG001|Overall Study|Withdrawal by Subject|2|||
130298676|NCT03266172|469056117|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
130298677|NCT03266172|469056118|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
130298678|NCT03266172|469056119|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
130298679|NCT03266172|469056117|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
130298680|NCT03266172|469056118|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
130298681|NCT03266172|469056119|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
130298682|NCT03266172|469056117|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
130298683|NCT03266172|469056118|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
130298684|NCT03266172|469056119|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
130298685|NCT03266172|469056117|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
130298686|NCT03266172|469056118|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
130298687|NCT03266172|469056119|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
129794886|NCT00251004|467216442|FG002|Overall Study|Withdrawal by Subject|14|||
129794887|NCT00251004|467216440|FG000|Overall Study|Death|9|||
129794888|NCT00251004|467216441|FG001|Overall Study|Death|10|||
129794889|NCT00251004|467216442|FG002|Overall Study|Death|8|||
129794890|NCT00251004|467216440|FG000|Overall Study|Lost to Follow-up|1|||
129794891|NCT00251004|467216441|FG001|Overall Study|Lost to Follow-up|2|||
129794892|NCT00251004|467216442|FG002|Overall Study|Lost to Follow-up|1|||
129794893|NCT00251004|467216440|FG000|Overall Study|Graft Loss|12|||
129794894|NCT00251004|467216441|FG001|Overall Study|Graft Loss|13|||
129794895|NCT00251004|467216442|FG002|Overall Study|Graft Loss|8|||
129794896|NCT03455764|467216443|FG000|Overall Study|Adverse Event|1|||
129794897|NCT03455764|467216444|FG001|Overall Study|Adverse Event|0|||
129794898|NCT03455764|467216445|FG002|Overall Study|Adverse Event|0|||
129794899|NCT03455764|467216446|FG003|Overall Study|Adverse Event|0|||
129794900|NCT03455764|467216447|FG004|Overall Study|Adverse Event|0|||
129794901|NCT03455764|467216443|FG000|Overall Study|Disease Progression|4|||
129794902|NCT03455764|467216444|FG001|Overall Study|Disease Progression|0|||
129794903|NCT03455764|467216445|FG002|Overall Study|Disease Progression|0|||
129794904|NCT03455764|467216446|FG003|Overall Study|Disease Progression|0|||
129794905|NCT03455764|467216447|FG004|Overall Study|Disease Progression|0|||
129794906|NCT03455764|467216443|FG000|Overall Study|On Treatment|1|||
129794907|NCT03455764|467216444|FG001|Overall Study|On Treatment|0|||
129794908|NCT03455764|467216445|FG002|Overall Study|On Treatment|0|||
129794909|NCT03455764|467216446|FG003|Overall Study|On Treatment|0|||
129794910|NCT03455764|467216447|FG004|Overall Study|On Treatment|0|||
129794911|NCT04221230|467216458|FG000|Overall Study|Lost to Follow-up|12|||
129794912|NCT04221230|467216459|FG001|Overall Study|Lost to Follow-up|12|||
129794913|NCT04221230|467216458|FG000|Overall Study|Protocol Violation|2|||
129794914|NCT04221230|467216459|FG001|Overall Study|Protocol Violation|2|||
129794915|NCT04221230|467216458|FG000|Overall Study|Adverse Event|0|||
129794916|NCT04221230|467216459|FG001|Overall Study|Adverse Event|8|||
129794917|NCT04221230|467216458|FG000|Overall Study|Physician Decision|1|||
129794918|NCT04221230|467216459|FG001|Overall Study|Physician Decision|0|||
129794919|NCT04221230|467216458|FG000|Overall Study|Withdrawal by Subject|13|||
129889053|NCT01347645|467550990|FG004|Overall Study|Physician Decision|1|||
130298688|NCT03266172|469056117|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130298689|NCT03266172|469056118|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130298690|NCT03266172|469056119|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
130298691|NCT03266172|469056117|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
130298692|NCT03266172|469056118|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129889054|NCT01347645|467550986|FG000|Overall Study|Adverse Event|0|||
129889055|NCT01347645|467550987|FG001|Overall Study|Adverse Event|0|||
129889056|NCT01347645|467550988|FG002|Overall Study|Adverse Event|0|||
129889057|NCT01347645|467550989|FG003|Overall Study|Adverse Event|1|||
129889058|NCT01347645|467550990|FG004|Overall Study|Adverse Event|1|||
129889059|NCT00388362|467550991|FG000|Enrolled|Ineligible|1|||
129889060|NCT00388362|467550991|FG000|Enrolled|Adverse Event|9|||
129889061|NCT00388362|467550991|FG000|Enrolled|Death|1|||
129889062|NCT00388362|467550991|FG000|Enrolled|Loss insurance|1|||
129889063|NCT00388362|467550991|FG000|Enrolled|Withdrawal by Subject|1|||
129889064|NCT00388362|467550991|FG000|Remained on Study Median of 514 Days|Death|2|||
129889065|NCT01141660|467550992|FG000|Overall Study|Physician Decision|0|||
129889066|NCT01141660|467550993|FG001|Overall Study|Physician Decision|12|||
130047398|NCT00907478|468130116|FG000|Overall Study|Protocol-specified criteria|5|||
130047399|NCT00907478|468130117|FG001|Overall Study|Protocol-specified criteria|2|||
130047400|NCT00907478|468130118|FG002|Overall Study|Protocol-specified criteria|3|||
130047401|NCT00907478|468130116|FG000|Overall Study|Pregnancy|0|||
130047402|NCT00907478|468130117|FG001|Overall Study|Pregnancy|1|||
130047403|NCT00907478|468130118|FG002|Overall Study|Pregnancy|1|||
130047404|NCT00907478|468130116|FG000|Overall Study|Lost to Follow-up|1|||
130047405|NCT00907478|468130117|FG001|Overall Study|Lost to Follow-up|0|||
130047406|NCT00907478|468130118|FG002|Overall Study|Lost to Follow-up|0|||
130047407|NCT00907478|468130116|FG000|Overall Study|Other|3|||
130047408|NCT00907478|468130117|FG001|Overall Study|Other|0|||
130047409|NCT00907478|468130118|FG002|Overall Study|Other|1|||
130047410|NCT02639182|468130119|FG000|Overall Study|Disease Progression|50|||
130047411|NCT02639182|468130120|FG001|Overall Study|Disease Progression|49|||
130047412|NCT02639182|468130119|FG000|Overall Study|Adverse Event|7|||
130047413|NCT02639182|468130120|FG001|Overall Study|Adverse Event|5|||
130047414|NCT02639182|468130119|FG000|Overall Study|Physician Decision|3|||
130047415|NCT02639182|468130120|FG001|Overall Study|Physician Decision|3|||
130047416|NCT02639182|468130119|FG000|Overall Study|Withdrew Consent|5|||
130047417|NCT02639182|468130120|FG001|Overall Study|Withdrew Consent|4|||
130047418|NCT02639182|468130119|FG000|Overall Study|Lost to Follow-up|0|||
130047419|NCT02639182|468130120|FG001|Overall Study|Lost to Follow-up|1|||
130047420|NCT02639182|468130119|FG000|Overall Study|Study Closure|1|||
130047421|NCT02639182|468130120|FG001|Overall Study|Study Closure|2|||
130107433|NCT03724916|468355119|FG001|Overall Study|Randomized but not Treated|0|||
130298693|NCT03266172|469056119|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
130298694|NCT01554514|469056122|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
130298695|NCT01554514|469056122|FG000|Overall Study|Physician Decision|1|||
130298696|NCT00300365|469056123|FG000|Overall Study|Lost to Follow-up|1|||
130298697|NCT00300365|469056124|FG001|Overall Study|Lost to Follow-up|0|||
130298698|NCT00300365|469056123|FG000|Overall Study|Physician Decision|2|||
130298699|NCT00300365|469056124|FG001|Overall Study|Physician Decision|0|||
130298700|NCT00300365|469056123|FG000|Overall Study|Withdrawal by Subject|1|||
130298701|NCT00300365|469056124|FG001|Overall Study|Withdrawal by Subject|0|||
130298702|NCT00300365|469056123|FG000|Overall Study|Adverse Event|0|||
130298703|NCT00300365|469056124|FG001|Overall Study|Adverse Event|2|||
130298704|NCT00290498|469056125|FG000|Overall Study|Death|2|||
130298705|NCT00290498|469056126|FG001|Overall Study|Death|0|||
130298706|NCT00290498|469056125|FG000|Overall Study|Physician Decision|1|||
130298707|NCT00290498|469056126|FG001|Overall Study|Physician Decision|0|||
130298708|NCT00290498|469056125|FG000|Overall Study|Withdrawal by Subject|1|||
130298709|NCT00290498|469056126|FG001|Overall Study|Withdrawal by Subject|0|||
130298710|NCT00290498|469056125|FG000|Overall Study|Ineligible|3|||
130298711|NCT00290498|469056126|FG001|Overall Study|Ineligible|0|||
130298712|NCT00290498|469056125|FG000|Overall Study|Non-Compliance|1|||
130298713|NCT00290498|469056126|FG001|Overall Study|Non-Compliance|0|||
130298714|NCT01716104|469056128|FG000|Overall Study|Do not meet inclusion criteria|6|||
130298715|NCT01716104|469056129|FG001|Overall Study|Do not meet inclusion criteria|7|||
130298716|NCT01753401|469056130|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
130298717|NCT01753401|469056131|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
130298718|NCT01753401|469056132|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
130298719|NCT01753401|469056133|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
130298720|NCT01753401|469056130|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
129889067|NCT00209027|467550995|FG000|Overall Study|study terminated|10|||
129889068|NCT00209027|467550996|FG001|Overall Study|study terminated|0|||
129889069|NCT01163149|467550997|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
129889070|NCT01163149|467550998|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130047422|NCT02639182|468130119|FG000|Overall Study|Sponsor Ended Study|0|||
130047423|NCT02639182|468130120|FG001|Overall Study|Sponsor Ended Study|1|||
130047424|NCT02639182|468130119|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
130298721|NCT01753401|469056131|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
130298722|NCT01753401|469056132|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
130298723|NCT01753401|469056133|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
130298724|NCT01753401|469056130|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130298725|NCT01753401|469056131|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
130298726|NCT01753401|469056132|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130298727|NCT01753401|469056133|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
130298728|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
130298729|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
130298730|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
130298731|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
130298732|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130298733|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130298734|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
130298735|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
130298736|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
130298737|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
130298738|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
130298739|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
130298740|NCT01753401|469056130|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
130298741|NCT01753401|469056131|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
130298742|NCT01753401|469056132|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
130298743|NCT01753401|469056133|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
130298744|NCT05026853|469056134|FG000|Overall Study|Cancelled appointment|1|||
130298745|NCT05026853|469056135|FG001|Overall Study|Cancelled appointment|0|||
130298746|NCT05026853|469056134|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
130298747|NCT05026853|469056135|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
130298748|NCT05026853|469056134|FG000|Overall Study|Did not complete 12-week survey|16|||
130298749|NCT05026853|469056135|FG001|Overall Study|Did not complete 12-week survey|16|||
130298750|NCT03615066|469056136|FG000|Main Study|Withdrew Consent|0|||
130298751|NCT03615066|469056137|FG001|Main Study|Withdrew Consent|1|||
130298752|NCT03615066|469056138|FG002|Main Study|Withdrew Consent|1|||
130298753|NCT03615066|469056136|FG000|Main Study|Lost to Follow-up|0|||
130298754|NCT03615066|469056137|FG001|Main Study|Lost to Follow-up|0|||
130298755|NCT03615066|469056138|FG002|Main Study|Lost to Follow-up|1|||
130298756|NCT03615066|469056136|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
130298757|NCT03615066|469056137|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
130298758|NCT03615066|469056138|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
130298759|NCT03615066|469056136|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
130298760|NCT03615066|469056137|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
130298761|NCT03615066|469056138|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
130298762|NCT03615066|469056136|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
130298763|NCT03615066|469056137|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
130298764|NCT03615066|469056138|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
130298765|NCT00129961|469056139|FG000|Overall Study|Adverse Event|1|||
130298766|NCT00129961|469056140|FG001|Overall Study|Adverse Event|0|||
130298767|NCT00129961|469056139|FG000|Overall Study|Death|1|||
130298768|NCT00129961|469056140|FG001|Overall Study|Death|1|||
130298769|NCT00129961|469056139|FG000|Overall Study|Withdrawal by Sponsor|14|||
130298770|NCT00129961|469056140|FG001|Overall Study|Withdrawal by Sponsor|20|||
130298771|NCT00129961|469056139|FG000|Overall Study|Physician Decision|1|||
130298772|NCT00129961|469056140|FG001|Overall Study|Physician Decision|0|||
130298773|NCT00129961|469056139|FG000|Overall Study|Withdrawal by Subject|2|||
130298774|NCT00129961|469056140|FG001|Overall Study|Withdrawal by Subject|1|||
130298775|NCT00129961|469056139|FG000|Overall Study|Missing Record|0|||
130298776|NCT00129961|469056140|FG001|Overall Study|Missing Record|1|||
129794920|NCT04221230|467216459|FG001|Overall Study|Withdrawal by Subject|11|||
129794921|NCT04221230|467216458|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129794922|NCT04221230|467216459|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129794923|NCT04221230|467216458|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129794924|NCT04221230|467216459|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129794925|NCT04221230|467216458|FG000|Overall Study|Pregnancy|0|||
129794926|NCT04221230|467216459|FG001|Overall Study|Pregnancy|1|||
129794927|NCT04221230|467216458|FG000|Overall Study|Other|1|||
129794928|NCT04221230|467216459|FG001|Overall Study|Other|2|||
129794929|NCT02021656|467216461|FG000|Overall Study|Adverse Event|1|||
129794930|NCT02021656|467216461|FG000|Overall Study|Lack of Efficacy|2|||
129794931|NCT02021656|467216461|FG000|Overall Study|Lost to Follow-up|1|||
129794932|NCT02021656|467216461|FG000|Overall Study|Withdrew Consent|2|||
129889071|NCT01163149|467550999|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
129889072|NCT01163149|467550997|FG000|Extension Treatment Period|Adverse Event|0|||
130298777|NCT00694304|469056144|FG000|Overall Study|Adverse Event|42|||
130298778|NCT00694304|469056144|FG000|Overall Study|Lack of Efficacy|35|||
130298779|NCT00694304|469056144|FG000|Overall Study|Non-compliance With Study Product|16|||
130298780|NCT00694304|469056144|FG000|Overall Study|Protocol Violation|6|||
130298781|NCT00694304|469056144|FG000|Overall Study|Withdrawal of Consent|61|||
130298782|NCT00694304|469056144|FG000|Overall Study|Lost to Follow-up|15|||
130298783|NCT00694304|469056144|FG000|Overall Study|Administrative or Other Reasons|32|||
130298784|NCT01270256|469056145|FG000|Overall Study|Withdrawal by Subject|1|||
130298785|NCT01270256|469056146|FG001|Overall Study|Withdrawal by Subject|0|||
130298786|NCT04407234|469056155|FG000|Overall Study|Adverse Event|3|||
130298787|NCT04407234|469056156|FG001|Overall Study|Adverse Event|3|||
130298788|NCT00727558|469056157|FG000|Overall Study|Lens issue|0|||
130298789|NCT00727558|469056158|FG001|Overall Study|Lens issue|1|||
130298790|NCT00727558|469056157|FG000|Overall Study|Adverse Event|0|||
130298791|NCT00727558|469056158|FG001|Overall Study|Adverse Event|1|||
130298792|NCT00727558|469056157|FG000|Overall Study|Subject unable to return for follow-up|1|||
130298793|NCT00727558|469056158|FG001|Overall Study|Subject unable to return for follow-up|1|||
130298794|NCT00727558|469056157|FG000|Overall Study|Lost to Follow-up|1|||
130298795|NCT00727558|469056158|FG001|Overall Study|Lost to Follow-up|0|||
130298796|NCT01754493|469057806|FG000|Overall Study|Adverse Event|1|||
130298797|NCT01754493|469057806|FG000|Overall Study|Lost to Follow-up|3|||
130298798|NCT01754493|469057806|FG000|Overall Study|Withdrawal by Subject|1|||
130298799|NCT01754493|469057806|FG000|Overall Study|Moved out of town|1|||
130298800|NCT01754493|469057806|FG000|Overall Study|Scheduling conflict|1|||
130298801|NCT01543776|469057807|FG000|Overall Study|Withdrawal by Subject|2|||
130298802|NCT01543776|469057808|FG001|Overall Study|Withdrawal by Subject|2|||
130298803|NCT00568126|469057809|FG000|Overall Study|Adverse Event|3|||
130298804|NCT00568126|469057810|FG001|Overall Study|Adverse Event|0|||
130298805|NCT00568126|469057809|FG000|Overall Study|Withdrawal by Subject|2|||
130298806|NCT00568126|469057810|FG001|Overall Study|Withdrawal by Subject|3|||
130298807|NCT00568126|469057809|FG000|Overall Study|Lost to Follow-up|4|||
130298808|NCT00568126|469057810|FG001|Overall Study|Lost to Follow-up|3|||
130298809|NCT00568126|469057809|FG000|Overall Study|Lack of Efficacy|0|||
130298810|NCT00568126|469057810|FG001|Overall Study|Lack of Efficacy|1|||
130298811|NCT00568126|469057809|FG000|Overall Study|Physician Decision|2|||
130298812|NCT00568126|469057810|FG001|Overall Study|Physician Decision|2|||
130298813|NCT04395690|469057811|FG000|Overall Study|Lost to Follow-up|1|||
130298814|NCT04395690|469057812|FG001|Overall Study|Lost to Follow-up|1|||
130298815|NCT02421588|469057813|FG000|Overall Study|Non-treatment-related AE|8|||
130298816|NCT02421588|469057814|FG001|Overall Study|Non-treatment-related AE|8|||
130298817|NCT02421588|469057813|FG000|Overall Study|Progressive disease|152|||
130298818|NCT02421588|469057814|FG001|Overall Study|Progressive disease|135|||
130298819|NCT02421588|469057813|FG000|Overall Study|Death|11|||
130298820|NCT02421588|469057814|FG001|Overall Study|Death|3|||
130298821|NCT02421588|469057813|FG000|Overall Study|Physician Decision|8|||
130298822|NCT02421588|469057814|FG001|Overall Study|Physician Decision|17|||
130298823|NCT02421588|469057813|FG000|Overall Study|Other reason not specified|3|||
130298824|NCT02421588|469057814|FG001|Overall Study|Other reason not specified|1|||
130298825|NCT02421588|469057813|FG000|Overall Study|Symptomatic deterioration|13|||
130298826|NCT02421588|469057814|FG001|Overall Study|Symptomatic deterioration|19|||
130298827|NCT02421588|469057813|FG000|Overall Study|Treatment-related AE|10|||
130298828|NCT02421588|469057814|FG001|Overall Study|Treatment-related AE|14|||
130298829|NCT02421588|469057813|FG000|Overall Study|Withdrawal by Subject|14|||
130298830|NCT02421588|469057814|FG001|Overall Study|Withdrawal by Subject|16|||
130298831|NCT02421588|469057813|FG000|Overall Study|Not treated|2|||
130298832|NCT02421588|469057814|FG001|Overall Study|Not treated|8|||
130298833|NCT02649894|469057820|FG000|Overall Study|Adverse Event|1|||
130298834|NCT02649894|469057821|FG001|Overall Study|Adverse Event|0|||
130298835|NCT02649894|469057820|FG000|Overall Study|Physician Decision|0|||
130298836|NCT02649894|469057821|FG001|Overall Study|Physician Decision|1|||
130298837|NCT02649894|469057820|FG000|Overall Study|Withdrawal by Subject|5|||
130298838|NCT02649894|469057821|FG001|Overall Study|Withdrawal by Subject|2|||
130298839|NCT02649894|469057820|FG000|Overall Study|Lost to Follow-up|2|||
130298840|NCT02649894|469057821|FG001|Overall Study|Lost to Follow-up|1|||
130298841|NCT02649894|469057820|FG000|Overall Study|Death|30|||
130298842|NCT02649894|469057821|FG001|Overall Study|Death|7|||
130298843|NCT02649894|469057820|FG000|Overall Study|Other, not specified|6|||
130298844|NCT02649894|469057821|FG001|Overall Study|Other, not specified|0|||
130298845|NCT00719680|469057822|FG000|Overall Study|Adverse Event|1|||
130298846|NCT00719680|469057822|FG000|Overall Study|Lost to Follow-up|1|||
130298847|NCT00719680|469057822|FG000|Overall Study|Withdrawal by Subject|3|||
130298848|NCT04071158|469057823|FG000|Overall Study|Lost to Follow-up|1|||
130298849|NCT04071158|469057824|FG001|Overall Study|Lost to Follow-up|2|||
130298850|NCT04071158|469057825|FG002|Overall Study|Lost to Follow-up|3|||
130298851|NCT04071158|469057826|FG003|Overall Study|Lost to Follow-up|3|||
130298852|NCT04071158|469057827|FG004|Overall Study|Lost to Follow-up|5|||
130298853|NCT04071158|469057823|FG000|Overall Study|Randomized but not treated|2|||
130298854|NCT04071158|469057824|FG001|Overall Study|Randomized but not treated|2|||
130298855|NCT04071158|469057825|FG002|Overall Study|Randomized but not treated|0|||
130298856|NCT04071158|469057826|FG003|Overall Study|Randomized but not treated|0|||
130298857|NCT04071158|469057827|FG004|Overall Study|Randomized but not treated|0|||
130298858|NCT01286740|469057828|FG000|Overall Study|Enrolled but not treated|1|||
130298859|NCT01286740|469057828|FG000|Overall Study|Protocol Violation|1|||
130298860|NCT01110382|469057830|FG000|Overall Study|Withdrawal by Subject|0|||
130298861|NCT01110382|469057831|FG001|Overall Study|Withdrawal by Subject|1|||
130298862|NCT01110382|469057830|FG000|Overall Study|Protocol Violation|0|||
130298863|NCT01110382|469057831|FG001|Overall Study|Protocol Violation|1|||
130298864|NCT05222555|469057832|FG000|Overall Study|Ongoing|2|||
130298865|NCT05222555|469057833|FG001|Overall Study|Ongoing|18|||
130298866|NCT05222555|469057832|FG000|Overall Study|Adverse Event|1|||
130298867|NCT05222555|469057833|FG001|Overall Study|Adverse Event|1|||
130298868|NCT05222555|469057832|FG000|Overall Study|Death|0|||
130298869|NCT05222555|469057833|FG001|Overall Study|Death|6|||
130298870|NCT05222555|469057832|FG000|Overall Study|Withdrawal by Subject|0|||
130298871|NCT05222555|469057833|FG001|Overall Study|Withdrawal by Subject|11|||
130298872|NCT01422824|469057834|FG000|Overall Study|Case record form not evaluated|1|||
130298873|NCT01422824|469057834|FG000|Overall Study|Lost to Follow-up|37|||
130298874|NCT00902174|469057835|FG000|Overall Study|Adverse Event|27|||
130298875|NCT00902174|469057836|FG001|Overall Study|Adverse Event|7|||
130298876|NCT00902174|469057835|FG000|Overall Study|Lack of Efficacy|1|||
130298877|NCT00902174|469057836|FG001|Overall Study|Lack of Efficacy|5|||
130298878|NCT00902174|469057835|FG000|Overall Study|Death|2|||
130298879|NCT00902174|469057836|FG001|Overall Study|Death|2|||
130298880|NCT00902174|469057835|FG000|Overall Study|Withdrawal by Subject|2|||
130298881|NCT00902174|469057836|FG001|Overall Study|Withdrawal by Subject|1|||
130298882|NCT00902174|469057835|FG000|Overall Study|Abnormal labs|1|||
130298883|NCT00902174|469057836|FG001|Overall Study|Abnormal labs|1|||
130298884|NCT00902174|469057835|FG000|Overall Study|Protocol Violation|1|||
130298885|NCT00902174|469057836|FG001|Overall Study|Protocol Violation|1|||
130298886|NCT00902174|469057835|FG000|Overall Study|Administration problem|0|||
130298887|NCT00902174|469057836|FG001|Overall Study|Administration problem|1|||
130298888|NCT01581619|469057837|FG000|Overall Study|Withdrawal by Subject|1|||
130298889|NCT01581619|469057837|FG000|Overall Study|Lost to Follow-up|1|||
130298890|NCT03129360|469057840|FG000|Overall Study|Did not meet entry criteria|0|||
130298891|NCT03129360|469057841|FG001|Overall Study|Did not meet entry criteria|2|||
130298892|NCT03129360|469057842|FG002|Overall Study|Did not meet entry criteria|1|||
130298893|NCT03129360|469057840|FG000|Overall Study|Excluded due to motion in scanner|1|||
130298894|NCT03129360|469057841|FG001|Overall Study|Excluded due to motion in scanner|0|||
130298895|NCT03129360|469057842|FG002|Overall Study|Excluded due to motion in scanner|0|||
130298896|NCT03006887|469057843|FG000|Overall Study|Adverse Event|1|||
130298897|NCT03836677|469057844|FG000|Period 1|Adverse Event|0|||
130298898|NCT03836677|469057845|FG001|Period 1|Adverse Event|1|||
130298899|NCT03836677|469057844|FG000|Period 2|Severe non-compliance to protocol|1|||
130298900|NCT03836677|469057845|FG001|Period 2|Severe non-compliance to protocol|0|||
130298901|NCT01353911|469057846|FG000|Overall Study|Lost to Follow-up|2|||
130298902|NCT01353911|469057847|FG001|Overall Study|Lost to Follow-up|6|||
130298903|NCT01353911|469057848|FG002|Overall Study|Lost to Follow-up|4|||
130298904|NCT01353911|469057849|FG003|Overall Study|Lost to Follow-up|0|||
130298905|NCT01353911|469057850|FG004|Overall Study|Lost to Follow-up|4|||
130298906|NCT01353911|469057851|FG005|Overall Study|Lost to Follow-up|4|||
130298907|NCT01353911|469057852|FG006|Overall Study|Lost to Follow-up|3|||
130298908|NCT01353911|469057853|FG007|Overall Study|Lost to Follow-up|6|||
130298909|NCT01353911|469057846|FG000|Overall Study|Withdrawal by Subject|2|||
130298910|NCT01353911|469057847|FG001|Overall Study|Withdrawal by Subject|3|||
130298911|NCT01353911|469057848|FG002|Overall Study|Withdrawal by Subject|4|||
130298912|NCT01353911|469057849|FG003|Overall Study|Withdrawal by Subject|2|||
130298913|NCT01353911|469057850|FG004|Overall Study|Withdrawal by Subject|2|||
130298914|NCT01353911|469057851|FG005|Overall Study|Withdrawal by Subject|3|||
130298915|NCT01353911|469057852|FG006|Overall Study|Withdrawal by Subject|3|||
130298916|NCT01353911|469057853|FG007|Overall Study|Withdrawal by Subject|9|||
130298917|NCT01353911|469057846|FG000|Overall Study|Status Not Recorded|4|||
130298918|NCT01353911|469057847|FG001|Overall Study|Status Not Recorded|0|||
130298919|NCT01353911|469057848|FG002|Overall Study|Status Not Recorded|1|||
130298920|NCT01353911|469057849|FG003|Overall Study|Status Not Recorded|0|||
130298921|NCT01353911|469057850|FG004|Overall Study|Status Not Recorded|0|||
130298922|NCT01353911|469057851|FG005|Overall Study|Status Not Recorded|0|||
130298923|NCT01353911|469057852|FG006|Overall Study|Status Not Recorded|0|||
129794933|NCT00596362|467216462|FG000|Overall Study|Progressive Disease|1|||
129794934|NCT00282347|467216465|FG000|Treatment Period|Death|2|||
130298924|NCT01353911|469057853|FG007|Overall Study|Status Not Recorded|0|||
130298925|NCT00462748|469057858|FG000|Overall Study|Adverse Event|7|||
130298926|NCT00462748|469057859|FG001|Overall Study|Adverse Event|5|||
130298927|NCT00462748|469057860|FG002|Overall Study|Adverse Event|9|||
130298928|NCT00462748|469057858|FG000|Overall Study|Protocol Violation|0|||
130298929|NCT00462748|469057859|FG001|Overall Study|Protocol Violation|2|||
130298930|NCT00462748|469057860|FG002|Overall Study|Protocol Violation|1|||
130298931|NCT00462748|469057858|FG000|Overall Study|Withdrew consent|3|||
130298932|NCT00462748|469057859|FG001|Overall Study|Withdrew consent|3|||
130298933|NCT00462748|469057860|FG002|Overall Study|Withdrew consent|0|||
130298934|NCT00462748|469057858|FG000|Overall Study|Lost to Follow-up|1|||
130298935|NCT00462748|469057859|FG001|Overall Study|Lost to Follow-up|1|||
130298936|NCT00462748|469057860|FG002|Overall Study|Lost to Follow-up|1|||
130298937|NCT00462748|469057858|FG000|Overall Study|Discontinued after 41 days Rx|1|||
130298938|NCT00462748|469057859|FG001|Overall Study|Discontinued after 41 days Rx|0|||
130298939|NCT00462748|469057860|FG002|Overall Study|Discontinued after 41 days Rx|0|||
130298940|NCT03233438|469057861|FG000|Overall Study|Lost to Follow-up|4|||
130298941|NCT03233438|469057862|FG001|Overall Study|Lost to Follow-up|9|||
130298942|NCT03233438|469057861|FG000|Overall Study|Withdrawal by Subject|2|||
130298943|NCT03233438|469057862|FG001|Overall Study|Withdrawal by Subject|1|||
130298944|NCT03233438|469057861|FG000|Overall Study|No recording of dalbavancin|0|||
130298945|NCT03233438|469057862|FG001|Overall Study|No recording of dalbavancin|1|||
130298946|NCT03429543|469057863|FG000|Overall Study|Adverse Event|1|||
130298947|NCT03429543|469057864|FG001|Overall Study|Adverse Event|1|||
130298948|NCT03429543|469057865|FG002|Overall Study|Adverse Event|0|||
130298949|NCT03429543|469057866|FG003|Overall Study|Adverse Event|0|||
130298950|NCT03429543|469057867|FG004|Overall Study|Adverse Event|0|||
130298951|NCT03429543|469057868|FG005|Overall Study|Adverse Event|2|||
130298952|NCT03429543|469057869|FG006|Overall Study|Adverse Event|0|||
130298953|NCT03429543|469057863|FG000|Overall Study|Lost to Follow-up|1|||
130298954|NCT03429543|469057864|FG001|Overall Study|Lost to Follow-up|0|||
130298955|NCT03429543|469057865|FG002|Overall Study|Lost to Follow-up|0|||
130298956|NCT03429543|469057866|FG003|Overall Study|Lost to Follow-up|0|||
130298957|NCT03429543|469057867|FG004|Overall Study|Lost to Follow-up|1|||
130298958|NCT03429543|469057868|FG005|Overall Study|Lost to Follow-up|0|||
130298959|NCT03429543|469057869|FG006|Overall Study|Lost to Follow-up|0|||
130298960|NCT03429543|469057863|FG000|Overall Study|Withdrawal by Subject|5|||
130298961|NCT03429543|469057864|FG001|Overall Study|Withdrawal by Subject|0|||
130298962|NCT03429543|469057865|FG002|Overall Study|Withdrawal by Subject|1|||
130298963|NCT03429543|469057866|FG003|Overall Study|Withdrawal by Subject|2|||
130298964|NCT03429543|469057867|FG004|Overall Study|Withdrawal by Subject|6|||
130298965|NCT03429543|469057868|FG005|Overall Study|Withdrawal by Subject|3|||
130298966|NCT03429543|469057869|FG006|Overall Study|Withdrawal by Subject|1|||
130298967|NCT03429543|469057863|FG000|Overall Study|Other reason than listed|0|||
130298968|NCT03429543|469057864|FG001|Overall Study|Other reason than listed|1|||
130298969|NCT03429543|469057865|FG002|Overall Study|Other reason than listed|0|||
130298970|NCT03429543|469057866|FG003|Overall Study|Other reason than listed|0|||
129794935|NCT00282347|467216466|FG001|Treatment Period|Death|0|||
129794936|NCT00282347|467216465|FG000|Treatment Period|Lost to Follow-up|2|||
129794937|NCT00282347|467216466|FG001|Treatment Period|Lost to Follow-up|5|||
129794938|NCT00282347|467216465|FG000|Treatment Period|Withdrawal by Subject|1|||
129794939|NCT00282347|467216466|FG001|Treatment Period|Withdrawal by Subject|3|||
129794940|NCT00282347|467216465|FG000|Treatment Period|Physician Decision|0|||
129794941|NCT00282347|467216466|FG001|Treatment Period|Physician Decision|1|||
129794942|NCT00282347|467216465|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
129794943|NCT00282347|467216466|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
129794944|NCT00282347|467216465|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
129794945|NCT00282347|467216466|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
129794946|NCT00282347|467216465|FG000|Safety Follow-up Period|Physician Decision|1|||
129794947|NCT00282347|467216466|FG001|Safety Follow-up Period|Physician Decision|1|||
129794948|NCT00282347|467216465|FG000|Safety Follow-up Period|Protocol Deviation|0|||
129794949|NCT00282347|467216466|FG001|Safety Follow-up Period|Protocol Deviation|2|||
129794950|NCT00282347|467216465|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
130298971|NCT03429543|469057867|FG004|Overall Study|Other reason than listed|4|||
130298972|NCT03429543|469057868|FG005|Overall Study|Other reason than listed|4|||
129794951|NCT00282347|467216466|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
129794952|NCT00282347|467216465|FG000|B Cell Follow-up Period|Physician Decision|1|||
129794953|NCT00282347|467216466|FG001|B Cell Follow-up Period|Physician Decision|0|||
130047425|NCT02639182|468130120|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
130298973|NCT03429543|469057869|FG006|Overall Study|Other reason than listed|0|||
130298974|NCT03429543|469057863|FG000|Overall Study|Not treated|0|||
130298975|NCT03429543|469057864|FG001|Overall Study|Not treated|0|||
130298976|NCT03429543|469057865|FG002|Overall Study|Not treated|0|||
130298977|NCT03429543|469057866|FG003|Overall Study|Not treated|0|||
130298978|NCT03429543|469057867|FG004|Overall Study|Not treated|1|||
130298979|NCT03429543|469057868|FG005|Overall Study|Not treated|0|||
130298980|NCT03429543|469057869|FG006|Overall Study|Not treated|0|||
130298981|NCT01818492|469057870|FG000|Overall Study|Adverse Event|2|||
130298982|NCT01818492|469057870|FG000|Overall Study|Death|3|||
130298983|NCT01818492|469057870|FG000|Overall Study|Withdrawal by Subject|1|||
130298984|NCT01818492|469057870|FG000|Overall Study|Additional therapy when not allowed PP|4|||
130298985|NCT01729208|469057871|FG000|Baseline|Physician Decision|5|||
130298986|NCT01729208|469057872|FG001|Baseline|Physician Decision|4|||
130298987|NCT01729208|469057871|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
130298988|NCT01729208|469057872|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
130298989|NCT01729208|469057871|FG000|12 Months Follow-up|Lost to Follow-up|3|||
130298990|NCT01729208|469057872|FG001|12 Months Follow-up|Lost to Follow-up|3|||
130298991|NCT01729208|469057871|FG000|24 Months Follow-up|Lost to Follow-up|3|||
130298992|NCT01729208|469057872|FG001|24 Months Follow-up|Lost to Follow-up|0|||
130298993|NCT01729208|469057871|FG000|36 Months Follow-up|Physician Decision|1|||
130298994|NCT01729208|469057872|FG001|36 Months Follow-up|Physician Decision|0|||
130298995|NCT01729208|469057871|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
130298996|NCT01729208|469057872|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
130298997|NCT02428413|469057874|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
130298998|NCT02428413|469057875|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
130298999|NCT02428413|469057874|FG000|Overall Study|Protocol Violation|1|||
130299000|NCT02428413|469057875|FG001|Overall Study|Protocol Violation|2|||
130299001|NCT02428413|469057874|FG000|Overall Study|Case Cancelled|2|||
130299002|NCT02428413|469057875|FG001|Overall Study|Case Cancelled|0|||
130299003|NCT02428413|469057874|FG000|Overall Study|Missed Cases|1|||
130299004|NCT02428413|469057875|FG001|Overall Study|Missed Cases|2|||
130299005|NCT02428413|469057874|FG000|Overall Study|Nurse Refusal|1|||
130299006|NCT02428413|469057875|FG001|Overall Study|Nurse Refusal|0|||
130299007|NCT03688100|469057878|FG000|Overall Study|Lost to Follow-up|21|||
130299008|NCT03688100|469057879|FG001|Overall Study|Lost to Follow-up|15|||
130299009|NCT03688100|469057880|FG002|Overall Study|Lost to Follow-up|15|||
130299010|NCT03688100|469057881|FG003|Overall Study|Lost to Follow-up|18|||
130299011|NCT03688100|469057878|FG000|Overall Study|Withdrawal by Subject|19|||
130299012|NCT03688100|469057879|FG001|Overall Study|Withdrawal by Subject|16|||
130299013|NCT03688100|469057880|FG002|Overall Study|Withdrawal by Subject|0|||
130299014|NCT03688100|469057881|FG003|Overall Study|Withdrawal by Subject|0|||
130299015|NCT03688100|469057878|FG000|Overall Study|Death|36|||
130299016|NCT03688100|469057879|FG001|Overall Study|Death|27|||
130299017|NCT03688100|469057880|FG002|Overall Study|Death|0|||
130299018|NCT03688100|469057881|FG003|Overall Study|Death|0|||
130299019|NCT02345330|469057884|FG000|Overall Study|Death|1|||
130299020|NCT02345330|469057884|FG000|Overall Study|Progressive Disease|2|||
130299021|NCT00494507|469057885|FG000|Double-Blind Phase|Adverse Event|2|||
130299022|NCT00494507|469057886|FG001|Double-Blind Phase|Adverse Event|0|||
130299023|NCT00494507|469057887|FG002|Double-Blind Phase|Adverse Event|1|||
130299024|NCT00494507|469057888|FG003|Double-Blind Phase|Adverse Event|0|||
130299025|NCT00494507|469057885|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
130299026|NCT00494507|469057886|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
130299027|NCT00494507|469057887|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130299028|NCT00494507|469057888|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130299029|NCT00494507|469057885|FG000|Double-Blind Phase|Subject Non-compliance|0|||
130299030|NCT00494507|469057886|FG001|Double-Blind Phase|Subject Non-compliance|0|||
130047426|NCT03069690|468130121|FG000|Pregnancy Intervention|Pregnancy loss|9|||
130299031|NCT00494507|469057887|FG002|Double-Blind Phase|Subject Non-compliance|1|||
130299032|NCT00494507|469057888|FG003|Double-Blind Phase|Subject Non-compliance|0|||
130299033|NCT00494507|469057885|FG000|Double-Blind Phase|Negative DNA test|0|||
130299034|NCT00494507|469057886|FG001|Double-Blind Phase|Negative DNA test|0|||
129794954|NCT00282347|467216465|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
130299035|NCT00494507|469057887|FG002|Double-Blind Phase|Negative DNA test|0|||
129794955|NCT00282347|467216466|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
130299036|NCT00494507|469057888|FG003|Double-Blind Phase|Negative DNA test|1|||
130299037|NCT00494507|469057885|FG000|Open-Label Phase|Adverse Event|0|||
130299038|NCT00494507|469057886|FG001|Open-Label Phase|Adverse Event|1|||
130299039|NCT00494507|469057887|FG002|Open-Label Phase|Adverse Event|5|||
130299040|NCT00494507|469057888|FG003|Open-Label Phase|Adverse Event|3|||
130299041|NCT00494507|469057885|FG000|Open-Label Phase|Worsening Disease|0|||
130299042|NCT00494507|469057886|FG001|Open-Label Phase|Worsening Disease|0|||
130299043|NCT00494507|469057887|FG002|Open-Label Phase|Worsening Disease|0|||
130047427|NCT03069690|468130122|FG001|Pregnancy Intervention|Pregnancy loss|4|||
130047428|NCT03069690|468130123|FG002|Pregnancy Intervention|Pregnancy loss|0|||
130047429|NCT03069690|468130124|FG003|Pregnancy Intervention|Pregnancy loss|0|||
130047430|NCT03069690|468130125|FG004|Pregnancy Intervention|Pregnancy loss|0|||
130299044|NCT00494507|469057888|FG003|Open-Label Phase|Worsening Disease|2|||
130299045|NCT02437084|469057890|FG000|Overall Study|Withdrawal by Subject|2|||
130299046|NCT02437084|469057890|FG000|Overall Study|Physician Decision|1|||
130299047|NCT00587847|469057891|FG000|Overall Study|Lack of Efficacy|5|||
130299048|NCT00587847|469057891|FG000|Overall Study|Adverse Event|2|||
130299049|NCT03729245|469057892|FG000|Overall Study|Lost to Follow-up|5|||
130299050|NCT03729245|469057893|FG001|Overall Study|Lost to Follow-up|6|||
130299051|NCT03729245|469057892|FG000|Overall Study|Withdrawal by Subject|16|||
130047431|NCT03069690|468130126|FG005|Pregnancy Intervention|Pregnancy loss|0|||
130047432|NCT03069690|468130121|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
130047433|NCT03069690|468130122|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
130047434|NCT03069690|468130123|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
130299052|NCT03729245|469057893|FG001|Overall Study|Withdrawal by Subject|19|||
130299053|NCT03729245|469057892|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
130299054|NCT03729245|469057893|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
130299055|NCT04032080|469057894|FG000|Overall Study|Death|6|||
130299056|NCT00989781|469057901|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
130299057|NCT00989781|469057902|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
130299058|NCT00576576|469057905|FG000|Overall Study|Lost to Follow-up|6|||
130299059|NCT00576576|469057905|FG000|Overall Study|Protocol Violation|1|||
130299060|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
130047435|NCT03069690|468130124|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
130047436|NCT03069690|468130125|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
130047437|NCT03069690|468130126|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
130047438|NCT03069690|468130121|FG000|Postpartum Intervention|Lost to Follow-up|0|||
130299061|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
130299062|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
130299063|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
130299064|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
130299065|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
130299066|NCT01805037|469057911|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
130299067|NCT01805037|469057912|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
130299068|NCT01805037|469057911|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
130299069|NCT01805037|469057912|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
130299070|NCT01805037|469057911|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
130299071|NCT01805037|469057912|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
130299072|NCT01805037|469057911|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
130299073|NCT01805037|469057912|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
130299074|NCT01805037|469057911|FG000|Follow Up (up to 3 Years)|Death|0|||
130299075|NCT01805037|469057912|FG001|Follow Up (up to 3 Years)|Death|2|||
130299076|NCT01805037|469057911|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
130299077|NCT01805037|469057912|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
130299078|NCT01805037|469057911|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
130299079|NCT01805037|469057912|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
130299080|NCT02177838|469057915|FG000|Overall Study|Withdrawal by Subject|1|||
130299081|NCT02177838|469057915|FG000|Overall Study|Physician Decision|1|||
130299082|NCT02177838|469057915|FG000|Overall Study|Death|1|||
130299083|NCT03517566|469057917|FG000|Overall Study|Adverse Event|5|||
130299084|NCT03517566|469057918|FG001|Overall Study|Adverse Event|2|||
130299085|NCT03517566|469057919|FG002|Overall Study|Adverse Event|2|||
130299086|NCT03517566|469057920|FG003|Overall Study|Adverse Event|8|||
130299087|NCT03517566|469057921|FG004|Overall Study|Adverse Event|7|||
130299088|NCT03517566|469057917|FG000|Overall Study|Lack of Efficacy|3|||
130299089|NCT03517566|469057918|FG001|Overall Study|Lack of Efficacy|2|||
130299090|NCT03517566|469057919|FG002|Overall Study|Lack of Efficacy|1|||
130299091|NCT03517566|469057920|FG003|Overall Study|Lack of Efficacy|1|||
130299092|NCT03517566|469057921|FG004|Overall Study|Lack of Efficacy|4|||
130299093|NCT03517566|469057917|FG000|Overall Study|Lost to Follow-up|3|||
130299094|NCT03517566|469057918|FG001|Overall Study|Lost to Follow-up|1|||
130299095|NCT03517566|469057919|FG002|Overall Study|Lost to Follow-up|1|||
130299096|NCT03517566|469057920|FG003|Overall Study|Lost to Follow-up|1|||
130299097|NCT03517566|469057921|FG004|Overall Study|Lost to Follow-up|0|||
130299098|NCT03517566|469057917|FG000|Overall Study|Physician Decision|1|||
130299099|NCT03517566|469057918|FG001|Overall Study|Physician Decision|1|||
130299100|NCT03517566|469057919|FG002|Overall Study|Physician Decision|0|||
130299101|NCT03517566|469057920|FG003|Overall Study|Physician Decision|1|||
130299102|NCT03517566|469057921|FG004|Overall Study|Physician Decision|0|||
130299103|NCT03517566|469057917|FG000|Overall Study|Pregnancy|0|||
130299104|NCT03517566|469057918|FG001|Overall Study|Pregnancy|1|||
130299105|NCT03517566|469057919|FG002|Overall Study|Pregnancy|0|||
130299106|NCT03517566|469057920|FG003|Overall Study|Pregnancy|0|||
130299107|NCT03517566|469057921|FG004|Overall Study|Pregnancy|0|||
130299108|NCT03517566|469057917|FG000|Overall Study|Protocol Deviation|0|||
130299109|NCT03517566|469057918|FG001|Overall Study|Protocol Deviation|1|||
130299110|NCT03517566|469057919|FG002|Overall Study|Protocol Deviation|0|||
130047439|NCT03069690|468130122|FG001|Postpartum Intervention|Lost to Follow-up|0|||
130047440|NCT03069690|468130123|FG002|Postpartum Intervention|Lost to Follow-up|5|||
130047441|NCT03069690|468130124|FG003|Postpartum Intervention|Lost to Follow-up|5|||
130047442|NCT03069690|468130125|FG004|Postpartum Intervention|Lost to Follow-up|2|||
130047443|NCT03069690|468130126|FG005|Postpartum Intervention|Lost to Follow-up|4|||
130047444|NCT01372878|468130129|FG000|Overall Study|Withdrawal by Subject|63|||
130047445|NCT01372878|468130129|FG000|Overall Study|Protocol Violation|17|||
130047446|NCT01372878|468130129|FG000|Overall Study|incomplete study procedure|104|||
130047447|NCT00117338|468130130|FG000|Overall Study|Adverse Event|0|||
130047448|NCT00117338|468130131|FG001|Overall Study|Adverse Event|1|||
130047449|NCT00117338|468130130|FG000|Overall Study|Protocol Violation|3|||
130047450|NCT00117338|468130131|FG001|Overall Study|Protocol Violation|2|||
130047451|NCT00117338|468130130|FG000|Overall Study|Withdrawal by Subject|1|||
130047452|NCT00117338|468130131|FG001|Overall Study|Withdrawal by Subject|0|||
130047453|NCT00117338|468130130|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
130047454|NCT00117338|468130131|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
130047455|NCT00117338|468130130|FG000|Overall Study|Lack of Efficacy|0|||
130299111|NCT03517566|469057920|FG003|Overall Study|Protocol Deviation|1|||
130299112|NCT03517566|469057921|FG004|Overall Study|Protocol Deviation|1|||
130299113|NCT03517566|469057917|FG000|Overall Study|Study terminated by Sponsor|11|||
130299114|NCT03517566|469057918|FG001|Overall Study|Study terminated by Sponsor|5|||
130299115|NCT03517566|469057919|FG002|Overall Study|Study terminated by Sponsor|6|||
130299116|NCT03517566|469057920|FG003|Overall Study|Study terminated by Sponsor|14|||
130299117|NCT03517566|469057921|FG004|Overall Study|Study terminated by Sponsor|12|||
130299118|NCT03517566|469057917|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
130299119|NCT03517566|469057918|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
130299120|NCT03517566|469057919|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
130299121|NCT03517566|469057920|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
130299122|NCT03517566|469057921|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
130299123|NCT04566692|469057923|FG000|Overall Study|Adverse Event|2|||
130299124|NCT04566692|469057924|FG001|Overall Study|Adverse Event|0|||
130299125|NCT04566692|469057923|FG000|Overall Study|Withdrawal by Subject|1|||
130299126|NCT04566692|469057924|FG001|Overall Study|Withdrawal by Subject|1|||
130299127|NCT04311463|469057927|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
130299128|NCT04311463|469057928|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
130299129|NCT04311463|469057927|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
130299130|NCT04311463|469057928|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
130299131|NCT04311463|469057927|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
130299132|NCT04311463|469057928|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
130299133|NCT00737633|469057930|FG000|Overall Study|Study terminated by sponsor|44|||
130299134|NCT00737633|469057931|FG001|Overall Study|Study terminated by sponsor|55|||
130299135|NCT00737633|469057930|FG000|Overall Study|Lost to Follow-up|0|||
130299136|NCT00737633|469057931|FG001|Overall Study|Lost to Follow-up|1|||
130299137|NCT00737633|469057930|FG000|Overall Study|protocol non-compliance|0|||
130299138|NCT00737633|469057931|FG001|Overall Study|protocol non-compliance|1|||
130299139|NCT01300260|469057936|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
130299140|NCT01300260|469057937|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
130299141|NCT01300260|469057936|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
130299142|NCT01300260|469057937|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
130299143|NCT01300260|469057936|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
130299144|NCT01300260|469057937|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
130299145|NCT00293020|469057943|FG000|Overall Study|Withdrawal by Subject|34|||
130299146|NCT00293020|469057943|FG000|Overall Study|Adverse Event|30|||
130299147|NCT00293020|469057943|FG000|Overall Study|Death|32|||
130299148|NCT00293020|469057943|FG000|Overall Study|Lack of Efficacy|12|||
130299149|NCT00293020|469057943|FG000|Overall Study|Lost to Follow-up|4|||
130299150|NCT00293020|469057943|FG000|Overall Study|Protocol Violation|6|||
130299151|NCT00293020|469057943|FG000|Overall Study|Physician Decision|21|||
130299152|NCT00293020|469057943|FG000|Overall Study|Other Reason|22|||
130299153|NCT00293020|469057943|FG000|Overall Study|No dose taken|1|||
130299154|NCT01147848|469057944|FG000|Run-in Period|Screen Failure|623|||
130299155|NCT01147848|469057945|FG001|Run-in Period|Screen Failure|0|||
130299156|NCT01147848|469057946|FG002|Run-in Period|Screen Failure|0|||
130299157|NCT01147848|469057944|FG000|Run-in Period|Run-in Failure|135|||
130299158|NCT01147848|469057945|FG001|Run-in Period|Run-in Failure|0|||
130299159|NCT01147848|469057946|FG002|Run-in Period|Run-in Failure|0|||
130299160|NCT01147848|469057944|FG000|Randomized Phase|Adverse Event|0|||
130299161|NCT01147848|469057945|FG001|Randomized Phase|Adverse Event|6|||
130299162|NCT01147848|469057946|FG002|Randomized Phase|Adverse Event|8|||
129794956|NCT00356122|467216467|FG000|TREATMENT|Lack of Efficacy|26|||
130047456|NCT00117338|468130131|FG001|Overall Study|Lack of Efficacy|1|||
130047457|NCT02240628|468130132|FG000|Overall Study|Physician Decision|6|||
130047458|NCT02240628|468130133|FG001|Overall Study|Physician Decision|5|||
130052155|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
130299163|NCT01147848|469057944|FG000|Randomized Phase|Lack of Efficacy|0|||
130299164|NCT01147848|469057945|FG001|Randomized Phase|Lack of Efficacy|20|||
130299165|NCT01147848|469057946|FG002|Randomized Phase|Lack of Efficacy|11|||
130299166|NCT01147848|469057944|FG000|Randomized Phase|Protocol Violation|0|||
130299167|NCT01147848|469057945|FG001|Randomized Phase|Protocol Violation|7|||
130299168|NCT01147848|469057946|FG002|Randomized Phase|Protocol Violation|10|||
130299169|NCT01147848|469057944|FG000|Randomized Phase|Lost to Follow-up|0|||
130299170|NCT01147848|469057945|FG001|Randomized Phase|Lost to Follow-up|5|||
130299171|NCT01147848|469057946|FG002|Randomized Phase|Lost to Follow-up|7|||
130299172|NCT01147848|469057944|FG000|Randomized Phase|Physician Decision|0|||
130299173|NCT01147848|469057945|FG001|Randomized Phase|Physician Decision|0|||
130299174|NCT01147848|469057946|FG002|Randomized Phase|Physician Decision|1|||
130299175|NCT01147848|469057944|FG000|Randomized Phase|Withdrawal by Subject|0|||
130299176|NCT01147848|469057945|FG001|Randomized Phase|Withdrawal by Subject|7|||
130047459|NCT02385123|468130134|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
130047460|NCT01070303|468130138|FG000|Overall Study|Adverse Event|39|||
130299177|NCT01147848|469057946|FG002|Randomized Phase|Withdrawal by Subject|9|||
130299178|NCT02540265|469057948|FG000|Overall Study|Lost to Follow-up|0|||
130299179|NCT02540265|469057949|FG001|Overall Study|Lost to Follow-up|0|||
130299180|NCT02540265|469057950|FG002|Overall Study|Lost to Follow-up|1|||
130299181|NCT03157037|469057953|FG000|Overall Study|Death|1|||
130299182|NCT02102399|469057957|FG000|Overall Study|Withdrawal by Subject|6|||
130299183|NCT02102399|469057958|FG001|Overall Study|Withdrawal by Subject|4|||
130299184|NCT03101085|469057959|FG000|Overall Study|Lost to Follow-up|0|||
130299185|NCT03101085|469057960|FG001|Overall Study|Lost to Follow-up|1|||
130299186|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299187|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299188|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299189|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299190|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299191|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299192|NCT00718770|469057961|FG000|Overall Study|Lack of Efficacy|1|||
130299193|NCT00718770|469057961|FG000|Overall Study|Adverse Event|1|||
130299194|NCT00695864|469057962|FG000|Placebo|Withdrawal by Subject|1|||
130299195|NCT00695864|469057962|FG000|Placebo|Physician Decision|4|||
130299196|NCT01704456|469057963|FG000|Overall Study|Lost to Follow-up|8|||
130299197|NCT01704456|469057964|FG001|Overall Study|Lost to Follow-up|14|||
130299198|NCT00498355|469057965|FG000|Overall Study|Lost to Follow-up|1|||
130299199|NCT04583956|469057966|FG000|Overall Study|Death|9|||
130299200|NCT04583956|469057967|FG001|Overall Study|Death|11|||
130299201|NCT04583956|469057966|FG000|Overall Study|Lost to Follow-up|7|||
130299202|NCT04583956|469057967|FG001|Overall Study|Lost to Follow-up|9|||
130047461|NCT01070303|468130138|FG000|Overall Study|Withdrawal by Subject|20|||
130047462|NCT01070303|468130138|FG000|Overall Study|Lost to Follow-up|9|||
130047463|NCT01070303|468130138|FG000|Overall Study|Protocol Violation|0|||
130047464|NCT01070303|468130138|FG000|Overall Study|Lack of Efficacy|2|||
130047465|NCT01070303|468130138|FG000|Overall Study|Administrative Reason|1|||
130047466|NCT01070303|468130138|FG000|Overall Study|Other|18|||
130047467|NCT02345434|468130139|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
130047468|NCT02345434|468130140|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
130047469|NCT00859898|468130142|FG000|Overall Study|Lack of Efficacy|0|||
130047470|NCT00859898|468130143|FG001|Overall Study|Lack of Efficacy|1|||
130047471|NCT00859898|468130144|FG002|Overall Study|Lack of Efficacy|1|||
130047472|NCT00859898|468130142|FG000|Overall Study|Adverse Event|4|||
130047473|NCT00859898|468130143|FG001|Overall Study|Adverse Event|9|||
130047474|NCT00859898|468130144|FG002|Overall Study|Adverse Event|8|||
130299203|NCT04583956|469057966|FG000|Overall Study|Protocol Violation|2|||
130299204|NCT04583956|469057967|FG001|Overall Study|Protocol Violation|0|||
130047475|NCT00859898|468130142|FG000|Overall Study|Withdrawal by Subject|11|||
130107434|NCT03724916|468355120|FG002|Overall Study|Randomized but not Treated|0|||
130107435|NCT03724916|468355121|FG003|Overall Study|Randomized but not Treated|0|||
130107436|NCT04575038|468355122|FG000|Overall Study|Withdrawal by Subject|1|||
130299205|NCT04583956|469057966|FG000|Overall Study|Withdrawal by Subject|0|||
130299206|NCT04583956|469057967|FG001|Overall Study|Withdrawal by Subject|2|||
130299207|NCT04583956|469057966|FG000|Overall Study|Randomized but not dosed|2|||
130299208|NCT04583956|469057967|FG001|Overall Study|Randomized but not dosed|3|||
130299209|NCT04583956|469057966|FG000|Overall Study|Withdrawal of consent before product administration|1|||
130299210|NCT04583956|469057967|FG001|Overall Study|Withdrawal of consent before product administration|0|||
130299211|NCT04599465|469059704|FG000|Overall Study|Physician Decision|1|||
130299212|NCT04599465|469059704|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
130299213|NCT03416127|469059705|FG000|Overall Study|Withdrawal by Subject|0|||
130299214|NCT03416127|469059706|FG001|Overall Study|Withdrawal by Subject|1|||
130299215|NCT03416127|469059707|FG002|Overall Study|Withdrawal by Subject|1|||
130299216|NCT01971008|469059708|FG000|Overall Study|Protocol Violation|2|||
130299217|NCT01971008|469059709|FG001|Overall Study|Protocol Violation|1|||
130299218|NCT02489942|469059712|FG000|Overall Study|Request by patient|602|||
130299219|NCT02489942|469059712|FG000|Overall Study|Improvement/remission|157|||
130299220|NCT02489942|469059712|FG000|Overall Study|No change/Progressive disease|263|||
130299221|NCT02489942|469059712|FG000|Overall Study|Adverse Event|522|||
130299222|NCT02489942|469059712|FG000|Overall Study|Other personal reasons|1218|||
130299223|NCT02489942|469059712|FG000|Overall Study|Lost to Follow-up|456|||
130299224|NCT02489942|469059712|FG000|Overall Study|Not continuously investigated|7|||
130299225|NCT02489942|469059712|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
130299226|NCT02489942|469059712|FG000|Overall Study|Multiple registration|1|||
130299227|NCT02489942|469059712|FG000|Overall Study|No patient visit after entry|100|||
130299228|NCT02489942|469059712|FG000|Overall Study|No treatment with Jardiance|2|||
130299229|NCT02489942|469059712|FG000|Overall Study|Patient received Jardiance before registration|1|||
130299230|NCT02489942|469059712|FG000|Overall Study|No CRF collected|86|||
130299231|NCT00858208|469059713|FG000|Overall Study|Adverse Event|3|||
130299232|NCT00858208|469059713|FG000|Overall Study|Lost to Follow-up|26|||
130299233|NCT00858208|469059713|FG000|Overall Study|Participant refused|40|||
130299234|NCT00858208|469059713|FG000|Overall Study|Other|10|||
130299235|NCT02702180|469059714|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130299236|NCT02702180|469059715|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
130299237|NCT02702180|469059716|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130299238|NCT02702180|469059714|FG000|Double-blind Treatment Period|Adverse Event|0|||
130299239|NCT02702180|469059715|FG001|Double-blind Treatment Period|Adverse Event|0|||
130299240|NCT02702180|469059716|FG002|Double-blind Treatment Period|Adverse Event|1|||
130299241|NCT02702180|469059714|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130299242|NCT02702180|469059715|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129794957|NCT00356122|467216467|FG000|TREATMENT|Adverse Event|10|||
129794958|NCT00356122|467216467|FG000|TREATMENT|Subject's request|4|||
129794959|NCT00356122|467216467|FG000|TREATMENT|Other|4|||
129794960|NCT00356122|467216467|FG000|TREATMENT|Did not receive study medication|1|||
129794961|NCT00356122|467216467|FG000|FOLLOW-UP|Death|37|||
129794962|NCT00356122|467216467|FG000|FOLLOW-UP|Lost to Follow-up|2|||
129794963|NCT00356122|467216467|FG000|FOLLOW-UP|Other|2|||
129794964|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
129794965|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
129794966|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
129794967|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
130299243|NCT02702180|469059716|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130299244|NCT02702180|469059714|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130299245|NCT02702180|469059715|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130299246|NCT02702180|469059716|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130299247|NCT02702180|469059714|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129794968|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
129794969|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
129794970|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
129794971|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
130047476|NCT00859898|468130143|FG001|Overall Study|Withdrawal by Subject|8|||
130047477|NCT00859898|468130144|FG002|Overall Study|Withdrawal by Subject|11|||
130299248|NCT02702180|469059715|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
130299249|NCT02702180|469059716|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
130299250|NCT02702180|469059714|FG000|Open-label Treatment Period|Withdrawn in error|0|||
130299251|NCT02702180|469059715|FG001|Open-label Treatment Period|Withdrawn in error|0|||
130299252|NCT02702180|469059716|FG002|Open-label Treatment Period|Withdrawn in error|1|||
130299253|NCT00567359|469059717|FG000|Overall Study|Withdrawal by Subject|1|||
130299254|NCT00679172|469059718|FG000|Overall Study|Non-compliance|1|||
130299255|NCT00679172|469059719|FG001|Overall Study|Non-compliance|1|||
130299256|NCT00679172|469059720|FG002|Overall Study|Non-compliance|0|||
130299257|NCT00679172|469059721|FG003|Overall Study|Non-compliance|1|||
130299258|NCT00679172|469059722|FG004|Overall Study|Non-compliance|0|||
130299259|NCT00679172|469059718|FG000|Overall Study|Other not specified|0|||
130299260|NCT00679172|469059719|FG001|Overall Study|Other not specified|0|||
130299261|NCT00679172|469059720|FG002|Overall Study|Other not specified|1|||
130299262|NCT00679172|469059721|FG003|Overall Study|Other not specified|0|||
130299263|NCT00679172|469059722|FG004|Overall Study|Other not specified|0|||
130299264|NCT00793325|469059723|FG000|Overall Study|Protocol Violation|18|||
130299265|NCT00793325|469059723|FG000|Overall Study|Lost to Follow-up|1|||
130299266|NCT00372697|469059724|FG000|Overall Study|Protocol Violation|1|||
130299267|NCT00372697|469059725|FG001|Overall Study|Protocol Violation|1|||
130299268|NCT01815840|469059726|FG000|Overall Study|Missing|1|||
130299269|NCT01815840|469059727|FG001|Overall Study|Missing|0|||
130299270|NCT01815840|469059726|FG000|Overall Study|Withdrew Consent|31|||
130299271|NCT01815840|469059727|FG001|Overall Study|Withdrew Consent|30|||
130299272|NCT01815840|469059726|FG000|Overall Study|Administrative/Other|1|||
130299273|NCT01815840|469059727|FG001|Overall Study|Administrative/Other|3|||
130299274|NCT01815840|469059726|FG000|Overall Study|Adverse Event|10|||
130299275|NCT01815840|469059727|FG001|Overall Study|Adverse Event|16|||
130299276|NCT01815840|469059726|FG000|Overall Study|Death|2|||
130299277|NCT01815840|469059727|FG001|Overall Study|Death|2|||
130299278|NCT01815840|469059726|FG000|Overall Study|Disease progression|3|||
130299279|NCT01815840|469059727|FG001|Overall Study|Disease progression|2|||
130299280|NCT01815840|469059726|FG000|Overall Study|Investigators Decision|2|||
130299281|NCT01815840|469059727|FG001|Overall Study|Investigators Decision|3|||
130299282|NCT01815840|469059726|FG000|Overall Study|Lost to Follow-up|3|||
130299283|NCT01815840|469059727|FG001|Overall Study|Lost to Follow-up|6|||
130299284|NCT01815840|469059726|FG000|Overall Study|Refused Treatment|5|||
130299285|NCT01815840|469059727|FG001|Overall Study|Refused Treatment|1|||
130047478|NCT00859898|468130142|FG000|Overall Study|Death|0|||
130047479|NCT00859898|468130143|FG001|Overall Study|Death|0|||
130299286|NCT01815840|469059726|FG000|Overall Study|Sponsor Termination Treatment|1|||
130299287|NCT01815840|469059727|FG001|Overall Study|Sponsor Termination Treatment|0|||
130299288|NCT03221842|469059728|FG000|Period 1 (Open-label)|Adverse Event|4|||
130299289|NCT03221842|469059729|FG001|Period 1 (Open-label)|Adverse Event|0|||
130299290|NCT03221842|469059728|FG000|Period 1 (Open-label)|Physician Decision|2|||
130299291|NCT03221842|469059729|FG001|Period 1 (Open-label)|Physician Decision|0|||
130299292|NCT03221842|469059728|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
130299293|NCT03221842|469059729|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
130299294|NCT03221842|469059728|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
130299295|NCT03221842|469059729|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
130299296|NCT03221842|469059728|FG000|Period 1 (Open-label)|Other|2|||
130299297|NCT03221842|469059729|FG001|Period 1 (Open-label)|Other|0|||
130299298|NCT03221842|469059728|FG000|Period 2 (Randomized, Blinded)|Death|0|||
130299299|NCT03221842|469059729|FG001|Period 2 (Randomized, Blinded)|Death|1|||
130299300|NCT03221842|469059728|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
130299301|NCT03221842|469059729|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
130299302|NCT00704288|469059731|FG000|Overall Treatment Period|Adverse Event|11|||
130299303|NCT00704288|469059732|FG001|Overall Treatment Period|Adverse Event|8|||
130299304|NCT00704288|469059733|FG002|Overall Treatment Period|Adverse Event|22|||
130299305|NCT00704288|469059731|FG000|Overall Treatment Period|Death|0|||
130299306|NCT00704288|469059732|FG001|Overall Treatment Period|Death|0|||
130299307|NCT00704288|469059733|FG002|Overall Treatment Period|Death|1|||
130299308|NCT00704288|469059731|FG000|Overall Treatment Period|Physician Decision|0|||
130299309|NCT00704288|469059732|FG001|Overall Treatment Period|Physician Decision|2|||
130299310|NCT00704288|469059733|FG002|Overall Treatment Period|Physician Decision|0|||
130299311|NCT00704288|469059731|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
130299312|NCT00704288|469059732|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
130299313|NCT00704288|469059733|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
130299314|NCT00704288|469059731|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
130299315|NCT00704288|469059732|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
130299316|NCT00704288|469059733|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
130299317|NCT00704288|469059731|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
130299318|NCT00704288|469059732|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
130299319|NCT00704288|469059733|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
130299320|NCT00704288|469059731|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
130299321|NCT00704288|469059732|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
130299322|NCT00704288|469059733|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
130299323|NCT00704288|469059731|FG000|Overall Treatment Period|Roll-over to another study|1|||
130299324|NCT00704288|469059732|FG001|Overall Treatment Period|Roll-over to another study|0|||
130299325|NCT00704288|469059733|FG002|Overall Treatment Period|Roll-over to another study|4|||
130299326|NCT00704288|469059731|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
130299327|NCT00704288|469059732|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
130299328|NCT00704288|469059733|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
130299329|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Death|41|||
130299330|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Death|50|||
130299331|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Death|93|||
130299332|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
130299333|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
130299334|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
130299335|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
130299336|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
130299337|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
130299338|NCT00704288|469059731|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
130299339|NCT00704288|469059732|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
130299340|NCT00704288|469059733|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
130299341|NCT03387020|469059735|FG000|Overall Study|Adverse Event|0|||
130299342|NCT03387020|469059736|FG001|Overall Study|Adverse Event|2|||
130299343|NCT03387020|469059737|FG002|Overall Study|Adverse Event|0|||
130299344|NCT03387020|469059735|FG000|Overall Study|Withdrawal by Subject|2|||
130299345|NCT03387020|469059736|FG001|Overall Study|Withdrawal by Subject|0|||
130299346|NCT03387020|469059737|FG002|Overall Study|Withdrawal by Subject|0|||
130299347|NCT00434642|469059738|FG000|Blinded Treatment Phase|Adverse Event|12|||
130299348|NCT00434642|469059739|FG001|Blinded Treatment Phase|Adverse Event|58|||
130299349|NCT00434642|469059738|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
130299350|NCT00434642|469059739|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
130299351|NCT00434642|469059738|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
130299352|NCT00434642|469059739|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
130299353|NCT00434642|469059738|FG000|Blinded Treatment Phase|Physician Decision|19|||
130299354|NCT00434642|469059739|FG001|Blinded Treatment Phase|Physician Decision|27|||
130299355|NCT00434642|469059738|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
130299356|NCT00434642|469059739|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
130299357|NCT00434642|469059738|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
130299358|NCT00434642|469059739|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
130299359|NCT00434642|469059738|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
130299360|NCT00434642|469059739|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
130299361|NCT00434642|469059738|FG000|Open-label Treatment Phase|Adverse Event|0|||
130299362|NCT00434642|469059739|FG001|Open-label Treatment Phase|Adverse Event|5|||
130299363|NCT00434642|469059738|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
130299364|NCT00434642|469059739|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
130299365|NCT04512976|469059744|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299366|NCT04512976|469059745|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299367|NCT04512976|469059746|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299368|NCT04512976|469059747|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299369|NCT04512976|469059748|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
130299370|NCT04512976|469059749|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
130299371|NCT00527982|469059750|FG000|Overall Study|Physician Decision|1|||
130299372|NCT00527982|469059751|FG001|Overall Study|Physician Decision|0|||
130299373|NCT00753454|469059758|FG000|Overall Study|Adverse Event|4|||
130299374|NCT00753454|469059758|FG000|Overall Study|Lack of Efficacy|1|||
130299375|NCT00753454|469059758|FG000|Overall Study|Lost to Follow-up|3|||
130299376|NCT00753454|469059758|FG000|Overall Study|Withdrawal by Subject|5|||
130299377|NCT00753454|469059758|FG000|Overall Study|Investigator Decision|1|||
130299378|NCT03927144|469059759|FG000|Core Phase|Adverse Event|9|||
130299379|NCT03927144|469059760|FG001|Core Phase|Adverse Event|5|||
130299380|NCT03927144|469059759|FG000|Core Phase|Lost to Follow-up|3|||
130299381|NCT03927144|469059760|FG001|Core Phase|Lost to Follow-up|2|||
130299382|NCT03927144|469059759|FG000|Core Phase|New Therapy for Study Indication|0|||
130299383|NCT03927144|469059760|FG001|Core Phase|New Therapy for Study Indication|1|||
130299384|NCT03927144|469059759|FG000|Core Phase|No Longer Clinically Benefiting|4|||
130299385|NCT03927144|469059760|FG001|Core Phase|No Longer Clinically Benefiting|4|||
130299386|NCT03927144|469059759|FG000|Core Phase|Physician Decision|2|||
130299387|NCT03927144|469059760|FG001|Core Phase|Physician Decision|8|||
130299388|NCT03927144|469059759|FG000|Core Phase|Protocol Violation|2|||
130299389|NCT03927144|469059760|FG001|Core Phase|Protocol Violation|2|||
130299390|NCT03927144|469059759|FG000|Core Phase|Withdrawal by Subject|16|||
130299391|NCT03927144|469059760|FG001|Core Phase|Withdrawal by Subject|40|||
130299392|NCT03927144|469059759|FG000|Extension Phase|Adverse Event|2|||
130299393|NCT03927144|469059760|FG001|Extension Phase|Adverse Event|1|||
130299394|NCT03927144|469059759|FG000|Extension Phase|No longer clinically benefiting|4|||
130299395|NCT03927144|469059760|FG001|Extension Phase|No longer clinically benefiting|5|||
130299396|NCT03927144|469059759|FG000|Extension Phase|Pregnancy|1|||
130299397|NCT03927144|469059760|FG001|Extension Phase|Pregnancy|0|||
130299398|NCT03927144|469059759|FG000|Extension Phase|Protocol Violation|0|||
130299399|NCT03927144|469059760|FG001|Extension Phase|Protocol Violation|1|||
130299400|NCT03927144|469059759|FG000|Extension Phase|Withdrawal by Subject|8|||
130299401|NCT03927144|469059760|FG001|Extension Phase|Withdrawal by Subject|3|||
130299402|NCT04541628|469059763|FG000|Overall Study|Study Terminated|1|||
130299403|NCT04541628|469059764|FG001|Overall Study|Study Terminated|1|||
130299404|NCT04541628|469059765|FG002|Overall Study|Study Terminated|1|||
130299405|NCT05011058|469059769|FG000|Overall Study|Sponsor Decision|2|||
130299406|NCT05011058|469059770|FG001|Overall Study|Sponsor Decision|0|||
130299407|NCT05011058|469059771|FG002|Overall Study|Sponsor Decision|14|||
130299408|NCT05011058|469059772|FG003|Overall Study|Sponsor Decision|0|||
130299409|NCT05011058|469059773|FG004|Overall Study|Sponsor Decision|0|||
130299410|NCT05011058|469059774|FG005|Overall Study|Sponsor Decision|1|||
130299411|NCT05011058|469059775|FG006|Overall Study|Sponsor Decision|0|||
130299412|NCT05011058|469059776|FG007|Overall Study|Sponsor Decision|5|||
130299413|NCT01452919|469059777|FG000|Open-Label Treatment|Adverse Event|5|||
130299414|NCT01452919|469059778|FG001|Open-Label Treatment|Adverse Event|0|||
130299415|NCT01452919|469059779|FG002|Open-Label Treatment|Adverse Event|0|||
130299416|NCT01452919|469059777|FG000|Open-Label Treatment|Lost to Follow-up|4|||
130299417|NCT01452919|469059778|FG001|Open-Label Treatment|Lost to Follow-up|0|||
130299418|NCT01452919|469059779|FG002|Open-Label Treatment|Lost to Follow-up|0|||
130299419|NCT01452919|469059777|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
130299420|NCT01452919|469059778|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
130299421|NCT01452919|469059779|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
130299422|NCT01452919|469059777|FG000|Open-Label Treatment|Protocol Violation|4|||
130299423|NCT01452919|469059778|FG001|Open-Label Treatment|Protocol Violation|0|||
130299424|NCT01452919|469059779|FG002|Open-Label Treatment|Protocol Violation|0|||
130299425|NCT01452919|469059777|FG000|Open-Label Treatment|Sponsor Decision|1|||
130299426|NCT01452919|469059778|FG001|Open-Label Treatment|Sponsor Decision|0|||
130299427|NCT01452919|469059779|FG002|Open-Label Treatment|Sponsor Decision|0|||
130299428|NCT01452919|469059777|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
130299429|NCT01452919|469059778|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
130299430|NCT01452919|469059779|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
130299431|NCT01452919|469059777|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
130299432|NCT01452919|469059778|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
130299433|NCT01452919|469059779|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
130299434|NCT01452919|469059777|FG000|Randomization Treatment|Adverse Event|0|||
130299435|NCT01452919|469059778|FG001|Randomization Treatment|Adverse Event|0|||
130299436|NCT01452919|469059779|FG002|Randomization Treatment|Adverse Event|2|||
130299437|NCT01452919|469059777|FG000|Randomization Treatment|Sponsor Decision|0|||
130299438|NCT01452919|469059778|FG001|Randomization Treatment|Sponsor Decision|1|||
130299439|NCT01452919|469059779|FG002|Randomization Treatment|Sponsor Decision|0|||
129889073|NCT01163149|467550998|FG001|Extension Treatment Period|Adverse Event|1|||
130299440|NCT01452919|469059777|FG000|Randomization Treatment|Withdrawal by Subject|0|||
130299441|NCT01452919|469059778|FG001|Randomization Treatment|Withdrawal by Subject|1|||
130299442|NCT01452919|469059779|FG002|Randomization Treatment|Withdrawal by Subject|0|||
130299443|NCT01452919|469059777|FG000|Randomization Treatment|Subject is moving or has moved|0|||
130299444|NCT01452919|469059778|FG001|Randomization Treatment|Subject is moving or has moved|1|||
130299445|NCT01452919|469059779|FG002|Randomization Treatment|Subject is moving or has moved|0|||
129794972|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
129794973|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
129794974|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
129794975|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
129794976|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
129794977|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
129794978|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
129794979|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
129794980|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
129794981|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
129794982|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
129794983|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
129794984|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
129794985|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
129889074|NCT01163149|467550999|FG002|Extension Treatment Period|Adverse Event|0|||
129889075|NCT01163149|467550997|FG000|Extension Treatment Period|Noncompliance|0|||
130047480|NCT00859898|468130144|FG002|Overall Study|Death|1|||
130299446|NCT01192412|469059780|FG000|Overall Study|Lost to Follow-up|2|||
130299447|NCT01192412|469059781|FG001|Overall Study|Lost to Follow-up|1|||
130299448|NCT01192412|469059780|FG000|Overall Study|Withdrawal by Subject|2|||
130299449|NCT01192412|469059781|FG001|Overall Study|Withdrawal by Subject|1|||
130299450|NCT01359943|469059784|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
130299451|NCT01359943|469059785|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
130299452|NCT01359943|469059786|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
130299453|NCT01359943|469059784|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
130299454|NCT01359943|469059785|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
130299455|NCT01359943|469059786|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
130299456|NCT01359943|469059784|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
130299457|NCT01359943|469059785|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
130299458|NCT01359943|469059786|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
130299459|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
130299460|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
130299461|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
130299462|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
130299463|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
130299464|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
130299465|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
130299466|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
130299467|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
130299468|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130299469|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130299470|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
130299471|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
130299472|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
130299473|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
130299474|NCT01359943|469059784|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
130299475|NCT01359943|469059785|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
130299476|NCT01359943|469059786|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
130299477|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
130299478|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
130299479|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
130299480|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
130299481|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
130299482|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
130299483|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
130299484|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
130299485|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
130299486|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130299487|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130299488|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
130299489|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
130299490|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
130299491|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
130299492|NCT01359943|469059784|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
130299493|NCT01359943|469059785|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
130299494|NCT01359943|469059786|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
130299495|NCT00308074|469059790|FG000|Overall Study|Withdrawal by Subject|1|||
130299496|NCT01529034|469059797|FG000|Overall Study|Discontinued prior to study treatment|14|||
130299497|NCT01529034|469059797|FG000|Overall Study|Site closure|62|||
130299498|NCT01529034|469059797|FG000|Overall Study|Study termination|29|||
130299499|NCT01529034|469059797|FG000|Overall Study|Withdrawal by Subject|25|||
130299500|NCT01529034|469059797|FG000|Overall Study|No treated SCs within protocol window|13|||
130299501|NCT01529034|469059797|FG000|Overall Study|Noncompliance|8|||
130299502|NCT01529034|469059797|FG000|Overall Study|Caregiver no longer available|7|||
130299503|NCT01529034|469059797|FG000|Overall Study|Adverse Event|4|||
130299504|NCT01529034|469059797|FG000|Overall Study|Protocol Violation|4|||
130299505|NCT01529034|469059797|FG000|Overall Study|Lack of Efficacy|4|||
130299506|NCT01529034|469059797|FG000|Overall Study|Investigator no longer available|2|||
130299507|NCT01529034|469059797|FG000|Overall Study|Study drug not available|2|||
130299508|NCT03194646|469059800|FG000|Overall Study|Adverse Event|24|||
130299509|NCT03194646|469059801|FG001|Overall Study|Adverse Event|25|||
130299510|NCT03194646|469059802|FG002|Overall Study|Adverse Event|14|||
130299511|NCT03194646|469059803|FG003|Overall Study|Adverse Event|17|||
130299512|NCT03194646|469059800|FG000|Overall Study|Lack of Efficacy|4|||
130299513|NCT03194646|469059801|FG001|Overall Study|Lack of Efficacy|2|||
130299514|NCT03194646|469059802|FG002|Overall Study|Lack of Efficacy|2|||
130299515|NCT03194646|469059803|FG003|Overall Study|Lack of Efficacy|12|||
130299516|NCT03194646|469059800|FG000|Overall Study|Lost to Follow-up|30|||
130299517|NCT03194646|469059801|FG001|Overall Study|Lost to Follow-up|22|||
130299518|NCT03194646|469059802|FG002|Overall Study|Lost to Follow-up|12|||
130299519|NCT03194646|469059803|FG003|Overall Study|Lost to Follow-up|35|||
130299520|NCT03194646|469059800|FG000|Overall Study|Non-compliance with study drug|4|||
130299521|NCT03194646|469059801|FG001|Overall Study|Non-compliance with study drug|0|||
130299522|NCT03194646|469059802|FG002|Overall Study|Non-compliance with study drug|1|||
130299523|NCT03194646|469059803|FG003|Overall Study|Non-compliance with study drug|1|||
130299524|NCT03194646|469059800|FG000|Overall Study|Other|89|||
130299525|NCT03194646|469059801|FG001|Overall Study|Other|68|||
130299526|NCT03194646|469059802|FG002|Overall Study|Other|34|||
130299527|NCT03194646|469059803|FG003|Overall Study|Other|31|||
130299528|NCT03194646|469059800|FG000|Overall Study|Physician Decision|7|||
130299529|NCT03194646|469059801|FG001|Overall Study|Physician Decision|9|||
130299530|NCT03194646|469059802|FG002|Overall Study|Physician Decision|5|||
130299531|NCT03194646|469059803|FG003|Overall Study|Physician Decision|4|||
130299532|NCT03194646|469059800|FG000|Overall Study|Pregnancy|4|||
130299533|NCT03194646|469059801|FG001|Overall Study|Pregnancy|5|||
130299534|NCT03194646|469059802|FG002|Overall Study|Pregnancy|1|||
130299535|NCT03194646|469059803|FG003|Overall Study|Pregnancy|2|||
130299536|NCT03194646|469059800|FG000|Overall Study|Protocol Violation|4|||
130299537|NCT03194646|469059801|FG001|Overall Study|Protocol Violation|2|||
130299538|NCT03194646|469059802|FG002|Overall Study|Protocol Violation|1|||
130299539|NCT03194646|469059803|FG003|Overall Study|Protocol Violation|1|||
130299540|NCT03194646|469059800|FG000|Overall Study|Site terminated by sponsor|0|||
130299541|NCT03194646|469059801|FG001|Overall Study|Site terminated by sponsor|0|||
130299542|NCT03194646|469059802|FG002|Overall Study|Site terminated by sponsor|2|||
130299543|NCT03194646|469059803|FG003|Overall Study|Site terminated by sponsor|0|||
130299544|NCT03194646|469059800|FG000|Overall Study|Study terminated by sponsor|62|||
130299545|NCT03194646|469059801|FG001|Overall Study|Study terminated by sponsor|61|||
130299546|NCT03194646|469059802|FG002|Overall Study|Study terminated by sponsor|30|||
130299547|NCT03194646|469059803|FG003|Overall Study|Study terminated by sponsor|34|||
130299548|NCT03194646|469059800|FG000|Overall Study|Withdrawal by Subject|75|||
130299549|NCT03194646|469059801|FG001|Overall Study|Withdrawal by Subject|74|||
130299550|NCT03194646|469059802|FG002|Overall Study|Withdrawal by Subject|36|||
130299551|NCT03194646|469059803|FG003|Overall Study|Withdrawal by Subject|131|||
130299552|NCT03194646|469059800|FG000|Overall Study|Missing|1|||
130299553|NCT03194646|469059801|FG001|Overall Study|Missing|0|||
130299554|NCT03194646|469059802|FG002|Overall Study|Missing|1|||
130299555|NCT03194646|469059803|FG003|Overall Study|Missing|12|||
130299556|NCT02141360|469059805|FG000|Overall Study|Withdrawal by Subject|6|||
130299557|NCT02141360|469059806|FG001|Overall Study|Withdrawal by Subject|0|||
130299558|NCT02141360|469059807|FG002|Overall Study|Withdrawal by Subject|0|||
130299559|NCT02141360|469059805|FG000|Overall Study|Study Terminated before Visit|1|||
130299560|NCT02141360|469059806|FG001|Overall Study|Study Terminated before Visit|0|||
130299561|NCT02141360|469059807|FG002|Overall Study|Study Terminated before Visit|0|||
130299562|NCT01178099|469059808|FG000|Overall Study|Physician Decision|0|||
130299563|NCT01178099|469059809|FG001|Overall Study|Physician Decision|1|||
130299564|NCT02516592|469059812|FG000|Overall Study|Patient withdrew consent|5|||
130047481|NCT00859898|468130142|FG000|Overall Study|Lost to Follow-up|10|||
130299565|NCT02516592|469059813|FG001|Overall Study|Patient withdrew consent|2|||
130299566|NCT02516592|469059812|FG000|Overall Study|Protocol deviation|4|||
130299567|NCT02516592|469059813|FG001|Overall Study|Protocol deviation|4|||
130299568|NCT02516592|469059812|FG000|Overall Study|Lost to Follow-up|2|||
130299569|NCT02516592|469059813|FG001|Overall Study|Lost to Follow-up|3|||
130299570|NCT02516592|469059812|FG000|Overall Study|Patient/guardian decision|2|||
130299571|NCT02516592|469059813|FG001|Overall Study|Patient/guardian decision|1|||
130299572|NCT02516592|469059812|FG000|Overall Study|Adverse Event|1|||
130299573|NCT02516592|469059813|FG001|Overall Study|Adverse Event|2|||
130299574|NCT02516592|469059812|FG000|Overall Study|Abnormal test procedure result|1|||
130299575|NCT02516592|469059813|FG001|Overall Study|Abnormal test procedure result|0|||
130299576|NCT02516592|469059812|FG000|Overall Study|Death|1|||
130299577|NCT02516592|469059813|FG001|Overall Study|Death|1|||
130299578|NCT02473367|469059814|FG000|Wait 1|Withdrawal by Subject|1|||
130299579|NCT02473367|469059814|FG000|Period 4|Lost to Follow-up|1|||
130299580|NCT00454584|469059816|FG000|Controlled Period|Adverse Event|5|||
130299581|NCT00454584|469059817|FG001|Controlled Period|Adverse Event|2|||
130299582|NCT00454584|469059818|FG002|Controlled Period|Adverse Event|1|||
130299583|NCT00454584|469059819|FG003|Controlled Period|Adverse Event|0|||
130299584|NCT00454584|469059820|FG004|Controlled Period|Adverse Event|0|||
130299585|NCT00454584|469059821|FG005|Controlled Period|Adverse Event|0|||
130299586|NCT00454584|469059816|FG000|Controlled Period|Lost to Follow-up|1|||
130299587|NCT00454584|469059817|FG001|Controlled Period|Lost to Follow-up|2|||
130299588|NCT00454584|469059818|FG002|Controlled Period|Lost to Follow-up|2|||
130299589|NCT00454584|469059819|FG003|Controlled Period|Lost to Follow-up|0|||
130299590|NCT00454584|469059820|FG004|Controlled Period|Lost to Follow-up|0|||
130299591|NCT00454584|469059821|FG005|Controlled Period|Lost to Follow-up|0|||
130299592|NCT00454584|469059816|FG000|Controlled Period|Other|5|||
130299593|NCT00454584|469059817|FG001|Controlled Period|Other|4|||
130299594|NCT00454584|469059818|FG002|Controlled Period|Other|2|||
130299595|NCT00454584|469059819|FG003|Controlled Period|Other|0|||
130299596|NCT00454584|469059820|FG004|Controlled Period|Other|0|||
130299597|NCT00454584|469059821|FG005|Controlled Period|Other|0|||
130299598|NCT00454584|469059816|FG000|After Controlled Period|Adverse Event|0|||
130299599|NCT00454584|469059817|FG001|After Controlled Period|Adverse Event|0|||
129794986|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
129794987|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
130299600|NCT00454584|469059818|FG002|After Controlled Period|Adverse Event|0|||
130299601|NCT00454584|469059819|FG003|After Controlled Period|Adverse Event|9|||
130299602|NCT00454584|469059820|FG004|After Controlled Period|Adverse Event|3|||
130299603|NCT00454584|469059821|FG005|After Controlled Period|Adverse Event|9|||
130299604|NCT00454584|469059816|FG000|After Controlled Period|Lack of Efficacy|0|||
130299605|NCT00454584|469059817|FG001|After Controlled Period|Lack of Efficacy|0|||
130299606|NCT00454584|469059818|FG002|After Controlled Period|Lack of Efficacy|0|||
130299607|NCT00454584|469059819|FG003|After Controlled Period|Lack of Efficacy|1|||
130299608|NCT00454584|469059820|FG004|After Controlled Period|Lack of Efficacy|0|||
130299609|NCT00454584|469059821|FG005|After Controlled Period|Lack of Efficacy|0|||
130299610|NCT00454584|469059816|FG000|After Controlled Period|Lost to Follow-up|0|||
130299611|NCT00454584|469059817|FG001|After Controlled Period|Lost to Follow-up|0|||
130299612|NCT00454584|469059818|FG002|After Controlled Period|Lost to Follow-up|0|||
130299613|NCT00454584|469059819|FG003|After Controlled Period|Lost to Follow-up|2|||
130299614|NCT00454584|469059820|FG004|After Controlled Period|Lost to Follow-up|4|||
130299615|NCT00454584|469059821|FG005|After Controlled Period|Lost to Follow-up|6|||
130299616|NCT00454584|469059816|FG000|After Controlled Period|Other|0|||
130299617|NCT00454584|469059817|FG001|After Controlled Period|Other|0|||
130299618|NCT00454584|469059818|FG002|After Controlled Period|Other|0|||
130299619|NCT00454584|469059819|FG003|After Controlled Period|Other|1|||
130299620|NCT00454584|469059820|FG004|After Controlled Period|Other|0|||
130299621|NCT00454584|469059821|FG005|After Controlled Period|Other|0|||
130299622|NCT00454584|469059816|FG000|After Controlled Period|Other|0|||
130299623|NCT00454584|469059817|FG001|After Controlled Period|Other|0|||
130299624|NCT00454584|469059818|FG002|After Controlled Period|Other|0|||
130299625|NCT00454584|469059819|FG003|After Controlled Period|Other|13|||
130299626|NCT00454584|469059820|FG004|After Controlled Period|Other|5|||
130299627|NCT00454584|469059821|FG005|After Controlled Period|Other|17|||
130299628|NCT00454181|469059823|FG000|Overall Study|Adverse Event|1|||
130299629|NCT00454181|469059824|FG001|Overall Study|Adverse Event|1|||
130299630|NCT00454181|469059823|FG000|Overall Study|Lost to Follow-up|11|||
130299631|NCT00454181|469059824|FG001|Overall Study|Lost to Follow-up|1|||
130299632|NCT00454181|469059823|FG000|Overall Study|Protocol Violation|1|||
130299633|NCT00454181|469059824|FG001|Overall Study|Protocol Violation|1|||
130299634|NCT00454181|469059823|FG000|Overall Study|Withdrawal by Subject|2|||
130299635|NCT00454181|469059824|FG001|Overall Study|Withdrawal by Subject|0|||
130299636|NCT03689855|469059836|FG000|Overall Study|Adverse Event|3|||
130299637|NCT03689855|469059836|FG000|Overall Study|Withdrawal by Subject|1|||
130299638|NCT02409719|469059837|FG000|Overall Study|Lost to Follow-up|3|||
130299639|NCT02409719|469059838|FG001|Overall Study|Lost to Follow-up|3|||
130299640|NCT00764673|469059839|FG000|Overall Study|Death|1|||
130299641|NCT00764673|469059839|FG000|Overall Study|Lost to Follow-up|3|||
130299642|NCT00764673|469059839|FG000|Overall Study|Withdrawal by Subject|6|||
130047482|NCT00859898|468130143|FG001|Overall Study|Lost to Follow-up|11|||
130299643|NCT00764673|469059839|FG000|Overall Study|Revision of Device|2|||
130299644|NCT01438177|469059840|FG000|Overall Study|Withdrawal by Subject|1|||
130299645|NCT01438177|469059840|FG000|Overall Study|Initiation of new therapy|1|||
130299646|NCT01727336|469059843|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130299647|NCT01727336|469059844|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
130299648|NCT01727336|469059845|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
129794988|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
129794989|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
129794990|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
129794991|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
129794992|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
129794993|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
129794994|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
129794995|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
129794996|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
129794997|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
129794998|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
129794999|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
129795000|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
129795001|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
129795002|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
129795003|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
129795004|NCT00993044|467216471|FG000|Irinotecan 50 mg|Physician Decision|1|||
129795005|NCT00734747|467216472|FG000|SRS Procedure|No staples placed|3|||
129795006|NCT00734747|467216472|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
129795007|NCT01909453|467216476|FG000|Overall Study|Ongoing|118|||
129795008|NCT01909453|467216477|FG001|Overall Study|Ongoing|103|||
129795009|NCT01909453|467216478|FG002|Overall Study|Ongoing|83|||
129795010|NCT01909453|467216479|FG003|Overall Study|Ongoing|164|||
129795011|NCT01909453|467216480|FG004|Overall Study|Ongoing|50|||
129795012|NCT01909453|467216476|FG000|Overall Study|Death|69|||
129795013|NCT01909453|467216477|FG001|Overall Study|Death|74|||
129795014|NCT01909453|467216478|FG002|Overall Study|Death|88|||
129795015|NCT01909453|467216479|FG003|Overall Study|Death|86|||
129795016|NCT01909453|467216480|FG004|Overall Study|Death|29|||
129795017|NCT01909453|467216476|FG000|Overall Study|Lost to Follow-up|3|||
129795018|NCT01909453|467216477|FG001|Overall Study|Lost to Follow-up|4|||
129795019|NCT01909453|467216478|FG002|Overall Study|Lost to Follow-up|4|||
129795020|NCT01909453|467216479|FG003|Overall Study|Lost to Follow-up|3|||
129795021|NCT01909453|467216480|FG004|Overall Study|Lost to Follow-up|3|||
129795022|NCT01909453|467216476|FG000|Overall Study|Withdrawal by Subject|2|||
129795023|NCT01909453|467216477|FG001|Overall Study|Withdrawal by Subject|13|||
129795024|NCT01909453|467216478|FG002|Overall Study|Withdrawal by Subject|16|||
129795025|NCT01909453|467216479|FG003|Overall Study|Withdrawal by Subject|5|||
129795026|NCT01909453|467216480|FG004|Overall Study|Withdrawal by Subject|4|||
129795027|NCT03350984|467217879|FG000|Overall Study|Death|1|||
129795028|NCT03350984|467217880|FG001|Overall Study|Death|0|||
129795029|NCT03350984|467217879|FG000|Overall Study|Lost to Follow-up|5|||
129795030|NCT03350984|467217880|FG001|Overall Study|Lost to Follow-up|6|||
129795031|NCT03350984|467217879|FG000|Overall Study|Protocol Violation|1|||
129795032|NCT03350984|467217880|FG001|Overall Study|Protocol Violation|2|||
129795033|NCT03350984|467217879|FG000|Overall Study|Physician Decision|1|||
129795034|NCT03350984|467217880|FG001|Overall Study|Physician Decision|0|||
129795035|NCT00642473|467217881|FG000|Overall Study|Withdrawal by Subject|0|||
129795036|NCT00642473|467217882|FG001|Overall Study|Withdrawal by Subject|5|||
129795037|NCT00642473|467217881|FG000|Overall Study|Progression or death|2|||
129795038|NCT00642473|467217882|FG001|Overall Study|Progression or death|4|||
129795039|NCT00642473|467217881|FG000|Overall Study|Other|2|||
129795040|NCT00642473|467217882|FG001|Overall Study|Other|2|||
129795041|NCT03981822|467217888|FG000|Overall Study|Lost to Follow-up|0|||
129795042|NCT03981822|467217889|FG001|Overall Study|Lost to Follow-up|1|||
129795043|NCT03981822|467217890|FG002|Overall Study|Lost to Follow-up|1|||
129795044|NCT03981822|467217891|FG003|Overall Study|Lost to Follow-up|0|||
129795045|NCT03981822|467217892|FG004|Overall Study|Lost to Follow-up|6|||
129795046|NCT03981822|467217893|FG005|Overall Study|Lost to Follow-up|4|||
129795047|NCT03981822|467217894|FG006|Overall Study|Lost to Follow-up|4|||
130299649|NCT01727336|469059846|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130299650|NCT01727336|469059847|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129795048|NCT03981822|467217895|FG007|Overall Study|Lost to Follow-up|2|||
129795049|NCT03981822|467217888|FG000|Overall Study|Withdrawal by Subject|0|||
129795050|NCT03981822|467217889|FG001|Overall Study|Withdrawal by Subject|1|||
129795051|NCT03981822|467217890|FG002|Overall Study|Withdrawal by Subject|0|||
129795052|NCT03981822|467217891|FG003|Overall Study|Withdrawal by Subject|0|||
129795053|NCT03981822|467217892|FG004|Overall Study|Withdrawal by Subject|0|||
129795054|NCT03981822|467217893|FG005|Overall Study|Withdrawal by Subject|1|||
129795055|NCT03981822|467217894|FG006|Overall Study|Withdrawal by Subject|0|||
130047483|NCT00859898|468130144|FG002|Overall Study|Lost to Follow-up|5|||
129795056|NCT03981822|467217895|FG007|Overall Study|Withdrawal by Subject|2|||
129795057|NCT03981822|467217888|FG000|Overall Study|COVID-19 Related|0|||
129795058|NCT03981822|467217889|FG001|Overall Study|COVID-19 Related|0|||
129795059|NCT03981822|467217890|FG002|Overall Study|COVID-19 Related|0|||
130047484|NCT00859898|468130142|FG000|Overall Study|poor/non-compliance|2|||
130047485|NCT00859898|468130143|FG001|Overall Study|poor/non-compliance|0|||
129795060|NCT03981822|467217891|FG003|Overall Study|COVID-19 Related|0|||
129795061|NCT03981822|467217892|FG004|Overall Study|COVID-19 Related|2|||
129795062|NCT03981822|467217893|FG005|Overall Study|COVID-19 Related|1|||
129795063|NCT03981822|467217894|FG006|Overall Study|COVID-19 Related|2|||
129795064|NCT03981822|467217895|FG007|Overall Study|COVID-19 Related|1|||
129795065|NCT06460493|467217896|FG000|Overall Study|Withdrawal by Subject|2|||
129795066|NCT02987660|467217901|FG000|Overall Study|Study terminated by sponsor|10|||
129795067|NCT02987660|467217902|FG001|Overall Study|Study terminated by sponsor|10|||
129795068|NCT03707184|467217903|FG000|Overall Study|Withdrawal by Subject|2|||
129795069|NCT04704154|467217904|FG000|Overall Study|Adverse Event|3|||
129795070|NCT04704154|467217905|FG001|Overall Study|Adverse Event|2|||
129795071|NCT04704154|467217906|FG002|Overall Study|Adverse Event|4|||
129795072|NCT04704154|467217907|FG003|Overall Study|Adverse Event|2|||
129795073|NCT04704154|467217908|FG004|Overall Study|Adverse Event|3|||
129795074|NCT04704154|467217909|FG005|Overall Study|Adverse Event|0|||
129795075|NCT04704154|467217904|FG000|Overall Study|Death|3|||
129795076|NCT04704154|467217905|FG001|Overall Study|Death|0|||
129795077|NCT04704154|467217906|FG002|Overall Study|Death|0|||
129795078|NCT04704154|467217907|FG003|Overall Study|Death|0|||
129795079|NCT04704154|467217908|FG004|Overall Study|Death|3|||
129795080|NCT04704154|467217909|FG005|Overall Study|Death|0|||
129795081|NCT04704154|467217904|FG000|Overall Study|Physician Decision|1|||
129795082|NCT04704154|467217905|FG001|Overall Study|Physician Decision|0|||
129795083|NCT04704154|467217906|FG002|Overall Study|Physician Decision|1|||
129795084|NCT04704154|467217907|FG003|Overall Study|Physician Decision|0|||
129795085|NCT04704154|467217908|FG004|Overall Study|Physician Decision|2|||
129795086|NCT04704154|467217909|FG005|Overall Study|Physician Decision|0|||
129795087|NCT04704154|467217904|FG000|Overall Study|Participant Decision|1|||
129795088|NCT04704154|467217905|FG001|Overall Study|Participant Decision|1|||
129795089|NCT04704154|467217906|FG002|Overall Study|Participant Decision|0|||
129795090|NCT04704154|467217907|FG003|Overall Study|Participant Decision|0|||
129795091|NCT04704154|467217908|FG004|Overall Study|Participant Decision|0|||
129795092|NCT04704154|467217909|FG005|Overall Study|Participant Decision|0|||
129795093|NCT04704154|467217904|FG000|Overall Study|Progressive Disease|19|||
129795094|NCT04704154|467217905|FG001|Overall Study|Progressive Disease|17|||
129795095|NCT04704154|467217906|FG002|Overall Study|Progressive Disease|20|||
129795096|NCT04704154|467217907|FG003|Overall Study|Progressive Disease|18|||
129795097|NCT04704154|467217908|FG004|Overall Study|Progressive Disease|36|||
129795098|NCT04704154|467217909|FG005|Overall Study|Progressive Disease|30|||
129795099|NCT04704154|467217904|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
129795100|NCT04704154|467217905|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
129795101|NCT04704154|467217906|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
129795102|NCT04704154|467217907|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
129795103|NCT04704154|467217908|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
129795104|NCT04704154|467217909|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
129795105|NCT04704154|467217904|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
129795106|NCT04704154|467217905|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795107|NCT04704154|467217906|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
129795108|NCT04704154|467217907|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795109|NCT04704154|467217908|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795110|NCT04704154|467217909|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795111|NCT01653782|467217912|FG000|Overall Study|Withdrawal by Subject|9|||
129795112|NCT01653782|467217913|FG001|Overall Study|Withdrawal by Subject|15|||
129795113|NCT01653782|467217914|FG002|Overall Study|Withdrawal by Subject|4|||
129795114|NCT01653782|467217912|FG000|Overall Study|Lost to Follow-up|7|||
129795115|NCT01653782|467217913|FG001|Overall Study|Lost to Follow-up|3|||
129795116|NCT01653782|467217914|FG002|Overall Study|Lost to Follow-up|2|||
130047486|NCT00859898|468130144|FG002|Overall Study|poor/non-compliance|0|||
130047487|NCT00859898|468130142|FG000|Overall Study|No longer meets criteria|0|||
130047488|NCT00859898|468130143|FG001|Overall Study|No longer meets criteria|1|||
130047489|NCT00859898|468130144|FG002|Overall Study|No longer meets criteria|0|||
130047490|NCT00859898|468130142|FG000|Overall Study|non-specified|1|||
129795117|NCT01142128|467217915|FG000|Overall Study|Physician Decision|1|||
129795118|NCT01142128|467217915|FG000|Overall Study|Lost to Follow-up|1|||
129795119|NCT01142128|467217915|FG000|Overall Study|Withdrawal by Subject|2|||
129795120|NCT05442775|467217918|FG000|Overall Study|Trial terminated|61|||
129795121|NCT05442775|467217918|FG000|Overall Study|Lack of Efficacy|4|||
129795122|NCT05442775|467217918|FG000|Overall Study|Withdrawal by Subject|4|||
129795123|NCT05442775|467217918|FG000|Overall Study|Death|1|||
129795124|NCT05442775|467217918|FG000|Overall Study|Participant removed at Sponsor request|1|||
129795125|NCT01606254|467217919|FG000|Overall Study|Withdrawal by Subject|1|||
129795126|NCT01606254|467217920|FG001|Overall Study|Withdrawal by Subject|3|||
129795127|NCT01606254|467217921|FG002|Overall Study|Withdrawal by Subject|0|||
130047491|NCT00859898|468130143|FG001|Overall Study|non-specified|1|||
130047492|NCT00859898|468130144|FG002|Overall Study|non-specified|1|||
130047493|NCT01302041|468130145|FG000|Overall Study|Death|5|||
130047494|NCT01302041|468130145|FG000|Overall Study|Withdrawal by Subject|4|||
130047495|NCT01302041|468130145|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
130047496|NCT01302041|468130145|FG000|Overall Study|Other-Miscellaneous Reason|2|||
130047497|NCT04504032|468130146|FG000|Overall Study|Adverse Event|1|||
130047498|NCT04504032|468130147|FG001|Overall Study|Adverse Event|2|||
130047499|NCT04504032|468130146|FG000|Overall Study|Lost to Follow-up|6|||
130047500|NCT04504032|468130147|FG001|Overall Study|Lost to Follow-up|9|||
130299651|NCT01727336|469059848|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
130299652|NCT01727336|469059843|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
130299653|NCT01727336|469059844|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
130299654|NCT01727336|469059845|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
130299655|NCT01727336|469059846|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130299656|NCT01727336|469059847|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130299657|NCT01727336|469059848|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
130299658|NCT01727336|469059843|FG000|Part 2 Blinded|Death|0|||
130299659|NCT01727336|469059844|FG001|Part 2 Blinded|Death|0|||
130299660|NCT01727336|469059845|FG002|Part 2 Blinded|Death|0|||
130299661|NCT01727336|469059846|FG003|Part 2 Blinded|Death|0|||
130299662|NCT01727336|469059847|FG004|Part 2 Blinded|Death|20|||
130299663|NCT01727336|469059848|FG005|Part 2 Blinded|Death|16|||
130299664|NCT01727336|469059843|FG000|Part 2 Blinded|Lack of Efficacy|0|||
130299665|NCT01727336|469059844|FG001|Part 2 Blinded|Lack of Efficacy|0|||
130299666|NCT01727336|469059845|FG002|Part 2 Blinded|Lack of Efficacy|0|||
130299667|NCT01727336|469059846|FG003|Part 2 Blinded|Lack of Efficacy|0|||
130299668|NCT01727336|469059847|FG004|Part 2 Blinded|Lack of Efficacy|42|||
130299669|NCT01727336|469059848|FG005|Part 2 Blinded|Lack of Efficacy|44|||
130299670|NCT01727336|469059843|FG000|Part 2 Blinded|Lost to Follow-up|0|||
130299671|NCT01727336|469059844|FG001|Part 2 Blinded|Lost to Follow-up|0|||
130299672|NCT01727336|469059845|FG002|Part 2 Blinded|Lost to Follow-up|0|||
130299673|NCT01727336|469059846|FG003|Part 2 Blinded|Lost to Follow-up|0|||
130299674|NCT01727336|469059847|FG004|Part 2 Blinded|Lost to Follow-up|0|||
130299675|NCT01727336|469059848|FG005|Part 2 Blinded|Lost to Follow-up|1|||
130299676|NCT01727336|469059843|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
130299677|NCT01727336|469059844|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
130299678|NCT01727336|469059845|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
130299679|NCT01727336|469059846|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
130299680|NCT01727336|469059847|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
130299681|NCT01727336|469059848|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
130299682|NCT01727336|469059843|FG000|Part 2 Blinded|use of prohibited medications|0|||
130299683|NCT01727336|469059844|FG001|Part 2 Blinded|use of prohibited medications|0|||
130299684|NCT01727336|469059845|FG002|Part 2 Blinded|use of prohibited medications|0|||
130299685|NCT01727336|469059846|FG003|Part 2 Blinded|use of prohibited medications|0|||
130299686|NCT01727336|469059847|FG004|Part 2 Blinded|use of prohibited medications|1|||
130299687|NCT01727336|469059848|FG005|Part 2 Blinded|use of prohibited medications|3|||
130299688|NCT00619099|469059849|FG000|Overall Study|Progressive Disease|7|||
130299689|NCT00619099|469059850|FG001|Overall Study|Progressive Disease|5|||
130299690|NCT00619099|469059849|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
130299691|NCT00619099|469059850|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
130299692|NCT00619099|469059849|FG000|Overall Study|Adverse Event|4|||
130299693|NCT00619099|469059850|FG001|Overall Study|Adverse Event|3|||
130299694|NCT00619099|469059849|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
130299695|NCT00619099|469059850|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
130299696|NCT00619099|469059849|FG000|Overall Study|Withdrawal by Subject|10|||
130299697|NCT00619099|469059850|FG001|Overall Study|Withdrawal by Subject|2|||
130299698|NCT00619099|469059849|FG000|Overall Study|Physician Decision|9|||
130299699|NCT00619099|469059850|FG001|Overall Study|Physician Decision|6|||
130299700|NCT00129467|469059851|FG000|Received Intervention|Death|1|||
130299701|NCT00129467|469059852|FG001|Received Intervention|Death|1|||
130299702|NCT00129467|469059851|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
129795128|NCT01606254|467217922|FG003|Overall Study|Withdrawal by Subject|2|||
130047501|NCT04504032|468130146|FG000|Overall Study|Protocol Violation|2|||
130047502|NCT04504032|468130147|FG001|Overall Study|Protocol Violation|0|||
130047503|NCT04504032|468130146|FG000|Overall Study|Study terminated by sponsor|1|||
129795129|NCT01606254|467217919|FG000|Overall Study|Adverse Event|1|||
129795130|NCT01606254|467217920|FG001|Overall Study|Adverse Event|1|||
130047504|NCT04504032|468130147|FG001|Overall Study|Study terminated by sponsor|2|||
130047505|NCT04504032|468130146|FG000|Overall Study|Withdrawal by Subject|9|||
130047506|NCT04504032|468130147|FG001|Overall Study|Withdrawal by Subject|11|||
130047507|NCT04504032|468130146|FG000|Overall Study|Disease progression prior to dosing|15|||
130299703|NCT00129467|469059852|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
130299704|NCT00129467|469059851|FG000|Received Intervention|Delirium|2|||
130299705|NCT00129467|469059852|FG001|Received Intervention|Delirium|0|||
129795131|NCT01606254|467217921|FG002|Overall Study|Adverse Event|0|||
130299706|NCT00129467|469059851|FG000|Received Intervention|Withdrawal by Subject|1|||
130299707|NCT00129467|469059852|FG001|Received Intervention|Withdrawal by Subject|0|||
130299708|NCT00129467|469059851|FG000|Received Intervention|Nausea|1|||
130299709|NCT00129467|469059852|FG001|Received Intervention|Nausea|0|||
130299710|NCT00129467|469059851|FG000|Received Intervention|Intolerance to citalopram|0|||
130299711|NCT00129467|469059852|FG001|Received Intervention|Intolerance to citalopram|1|||
130299712|NCT00129467|469059851|FG000|Received Intervention|Dizzyness, fatigue|0|||
130299713|NCT00129467|469059852|FG001|Received Intervention|Dizzyness, fatigue|1|||
130299714|NCT00129467|469059851|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
130299715|NCT00129467|469059852|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
130299716|NCT00129467|469059851|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
130299717|NCT00129467|469059852|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
130299718|NCT01424228|469059858|FG000|Overall Study|Withdrawal by Subject|27|||
130299719|NCT01424228|469059859|FG001|Overall Study|Withdrawal by Subject|11|||
130299720|NCT01424228|469059858|FG000|Overall Study|Adverse Event|10|||
130299721|NCT01424228|469059859|FG001|Overall Study|Adverse Event|14|||
130299722|NCT01424228|469059858|FG000|Overall Study|Sponsor's decision|9|||
130299723|NCT01424228|469059859|FG001|Overall Study|Sponsor's decision|12|||
130299724|NCT01424228|469059858|FG000|Overall Study|Lack of Efficacy|5|||
130299725|NCT01424228|469059859|FG001|Overall Study|Lack of Efficacy|7|||
130299726|NCT01424228|469059858|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
130299727|NCT01424228|469059859|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
130299728|NCT01424228|469059858|FG000|Overall Study|Non-compliance|2|||
130299729|NCT01424228|469059859|FG001|Overall Study|Non-compliance|0|||
130299730|NCT01424228|469059858|FG000|Overall Study|Worsening of symptoms|1|||
130299731|NCT01424228|469059859|FG001|Overall Study|Worsening of symptoms|0|||
130299732|NCT01424228|469059858|FG000|Overall Study|Unplanned journey|0|||
130299733|NCT01424228|469059859|FG001|Overall Study|Unplanned journey|1|||
130299734|NCT00671437|469059862|FG000|Overall Study|Progressive disease before C1 week 8|8|||
130299735|NCT00671437|469059862|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
129795132|NCT01606254|467217922|FG003|Overall Study|Adverse Event|1|||
129795133|NCT04543409|467217923|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130299736|NCT00671437|469059862|FG000|Overall Study|Adverse Event|3|||
130299737|NCT00671437|469059862|FG000|Overall Study|Ineligible post-hoc|1|||
130299738|NCT03927404|469059864|FG000|Overall Study|Withdrawal by Subject|1|||
130299739|NCT01229449|469059865|FG000|Overall Study|Withdrawal by Subject|0|||
130299740|NCT01229449|469059866|FG001|Overall Study|Withdrawal by Subject|3|||
130299741|NCT01229449|469059867|FG002|Overall Study|Withdrawal by Subject|0|||
130299742|NCT01229449|469059868|FG003|Overall Study|Withdrawal by Subject|1|||
130299743|NCT01229449|469059869|FG004|Overall Study|Withdrawal by Subject|1|||
130299744|NCT01229449|469059865|FG000|Overall Study|Lost to Follow-up|1|||
130299745|NCT01229449|469059866|FG001|Overall Study|Lost to Follow-up|1|||
130299746|NCT01229449|469059867|FG002|Overall Study|Lost to Follow-up|1|||
130299747|NCT01229449|469059868|FG003|Overall Study|Lost to Follow-up|0|||
130299748|NCT01229449|469059869|FG004|Overall Study|Lost to Follow-up|0|||
130299749|NCT01229449|469059865|FG000|Overall Study|Physician Decision|0|||
130299750|NCT01229449|469059866|FG001|Overall Study|Physician Decision|0|||
129795134|NCT04543409|467217924|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129795135|NCT04543409|467217923|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
129795136|NCT04543409|467217924|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
129795137|NCT04543409|467217923|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
129795138|NCT04543409|467217924|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
129795139|NCT04543409|467217923|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
129795140|NCT04543409|467217924|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
129795141|NCT04543409|467217923|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
129795142|NCT04543409|467217924|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
129795143|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
129795144|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
129795145|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
129889076|NCT01163149|467550998|FG001|Extension Treatment Period|Noncompliance|0|||
129889077|NCT01163149|467550999|FG002|Extension Treatment Period|Noncompliance|1|||
130299751|NCT01229449|469059867|FG002|Overall Study|Physician Decision|1|||
130299752|NCT01229449|469059868|FG003|Overall Study|Physician Decision|0|||
130299753|NCT01229449|469059869|FG004|Overall Study|Physician Decision|0|||
130299754|NCT00377364|469059870|FG000|Overall Study|Lost to Follow-up|1|||
130299755|NCT00377364|469059871|FG001|Overall Study|Lost to Follow-up|0|||
130299756|NCT00377364|469059870|FG000|Overall Study|Withdrawal by Subject|1|||
130299757|NCT00377364|469059871|FG001|Overall Study|Withdrawal by Subject|0|||
130299758|NCT03180307|469059875|FG000|Overall Study|Lost to Follow-up|2|||
130299759|NCT03180307|469059876|FG001|Overall Study|Lost to Follow-up|0|||
130299760|NCT03180307|469059875|FG000|Overall Study|Death|1|||
130299761|NCT03180307|469059876|FG001|Overall Study|Death|0|||
129795146|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
129795147|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
130299762|NCT03180307|469059875|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
130299763|NCT03180307|469059876|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
130299764|NCT03596450|469059877|FG000|Overall Study|Death|9|||
130299765|NCT03596450|469059878|FG001|Overall Study|Death|9|||
130299766|NCT03596450|469059877|FG000|Overall Study|Protocol Violation|18|||
130299767|NCT03596450|469059878|FG001|Overall Study|Protocol Violation|26|||
130299768|NCT03596450|469059877|FG000|Overall Study|Lost to Follow-up|50|||
130299769|NCT03596450|469059878|FG001|Overall Study|Lost to Follow-up|56|||
130299770|NCT03596450|469059877|FG000|Overall Study|Adverse Event|14|||
130299771|NCT03596450|469059878|FG001|Overall Study|Adverse Event|7|||
130299772|NCT03596450|469059877|FG000|Overall Study|Withdrawal by Subject|38|||
130299773|NCT03596450|469059878|FG001|Overall Study|Withdrawal by Subject|36|||
130299774|NCT03596450|469059877|FG000|Overall Study|Accidentally Randomized|2|||
130299775|NCT03596450|469059878|FG001|Overall Study|Accidentally Randomized|0|||
130299776|NCT03596450|469059877|FG000|Overall Study|Other reasons|48|||
130299777|NCT03596450|469059878|FG001|Overall Study|Other reasons|53|||
130299778|NCT03596450|469059877|FG000|Overall Study|Pregnancy|2|||
130299779|NCT03596450|469059878|FG001|Overall Study|Pregnancy|0|||
130299780|NCT00410605|469059882|FG000|Overall Study|Adverse Event|12|||
130299781|NCT00410605|469059882|FG000|Overall Study|Physician Decision|3|||
130299782|NCT00410605|469059882|FG000|Overall Study|Withdrawal by Subject|5|||
130299783|NCT00410605|469059882|FG000|Overall Study|Started Non-Protocol Therapy|3|||
130299784|NCT00410605|469059882|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
130299785|NCT00410605|469059882|FG000|Overall Study|Transferred to another Institution|1|||
130299786|NCT02100475|469062233|FG000|Overall Study|Unclassified|1|||
130299787|NCT02100475|469062234|FG001|Overall Study|Unclassified|2|||
130299788|NCT02100475|469062233|FG000|Overall Study|Withdrawal criteria|1|||
130299789|NCT02100475|469062234|FG001|Overall Study|Withdrawal criteria|0|||
130299790|NCT00649428|469062235|FG000|Overall Study|Adverse Event|2|||
130299791|NCT00649428|469062236|FG001|Overall Study|Adverse Event|2|||
130299792|NCT00649428|469062235|FG000|Overall Study|Withdrawal by Subject|6|||
130299793|NCT00649428|469062236|FG001|Overall Study|Withdrawal by Subject|6|||
130299794|NCT00649428|469062235|FG000|Overall Study|Lost to Follow-up|1|||
130299795|NCT00649428|469062236|FG001|Overall Study|Lost to Follow-up|3|||
130299796|NCT00649428|469062235|FG000|Overall Study|Insufficient manufacturing yield|5|||
130299797|NCT00649428|469062236|FG001|Overall Study|Insufficient manufacturing yield|1|||
130299798|NCT00649428|469062235|FG000|Overall Study|Protocol Violation|6|||
130299799|NCT00649428|469062236|FG001|Overall Study|Protocol Violation|2|||
130299800|NCT00649428|469062235|FG000|Overall Study|Physician Decision|0|||
130299801|NCT00649428|469062236|FG001|Overall Study|Physician Decision|1|||
130299802|NCT00742417|469062237|FG000|Randomized|Withdrawal by legal representative|0|||
130299803|NCT00742417|469062238|FG001|Randomized|Withdrawal by legal representative|1|||
130299804|NCT00742417|469062237|FG000|Randomized|Withdrawal by Subject|1|||
130299805|NCT00742417|469062238|FG001|Randomized|Withdrawal by Subject|0|||
130299806|NCT00742417|469062237|FG000|Randomized|Physician Decision|1|||
130299807|NCT00742417|469062238|FG001|Randomized|Physician Decision|0|||
130299808|NCT00742417|469062237|FG000|Intensive Period|Withdrawal by Subject|1|||
130299809|NCT00742417|469062238|FG001|Intensive Period|Withdrawal by Subject|1|||
130299810|NCT00742417|469062237|FG000|Intensive Period|Adverse Event|2|||
130299811|NCT00742417|469062238|FG001|Intensive Period|Adverse Event|0|||
130299812|NCT04566601|469062239|FG000|Overall Study|Other than listed|13|||
130299813|NCT04566601|469062240|FG001|Overall Study|Other than listed|4|||
130299814|NCT04566601|469062241|FG002|Overall Study|Other than listed|2|||
130299815|NCT04566601|469062242|FG003|Overall Study|Other than listed|1|||
130299816|NCT04566601|469062243|FG004|Overall Study|Other than listed|4|||
130299817|NCT04566601|469062239|FG000|Overall Study|Protocol deviation|3|||
130299818|NCT04566601|469062240|FG001|Overall Study|Protocol deviation|0|||
130299819|NCT04566601|469062241|FG002|Overall Study|Protocol deviation|1|||
130299820|NCT04566601|469062242|FG003|Overall Study|Protocol deviation|1|||
130299821|NCT04566601|469062243|FG004|Overall Study|Protocol deviation|1|||
130299822|NCT04566601|469062239|FG000|Overall Study|Technical problems|0|||
130299823|NCT04566601|469062240|FG001|Overall Study|Technical problems|0|||
130299824|NCT04566601|469062241|FG002|Overall Study|Technical problems|1|||
130299825|NCT04566601|469062242|FG003|Overall Study|Technical problems|0|||
130299826|NCT04566601|469062243|FG004|Overall Study|Technical problems|0|||
130299827|NCT04566601|469062239|FG000|Overall Study|No reason available|3|||
130299828|NCT04566601|469062240|FG001|Overall Study|No reason available|2|||
130299829|NCT04566601|469062241|FG002|Overall Study|No reason available|7|||
130299830|NCT04566601|469062242|FG003|Overall Study|No reason available|1|||
130299831|NCT04566601|469062243|FG004|Overall Study|No reason available|5|||
130299832|NCT04566601|469062239|FG000|Overall Study|Burden of study procedures|3|||
130299833|NCT04566601|469062240|FG001|Overall Study|Burden of study procedures|0|||
130299834|NCT04566601|469062241|FG002|Overall Study|Burden of study procedures|0|||
130299835|NCT04566601|469062242|FG003|Overall Study|Burden of study procedures|3|||
130299836|NCT04566601|469062243|FG004|Overall Study|Burden of study procedures|1|||
130299837|NCT04566601|469062239|FG000|Overall Study|Change of residence|2|||
130047508|NCT04504032|468130147|FG001|Overall Study|Disease progression prior to dosing|3|||
130047509|NCT04504032|468130146|FG000|Overall Study|Drug supply issues|1|||
130047510|NCT04504032|468130147|FG001|Overall Study|Drug supply issues|1|||
130047511|NCT04504032|468130146|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
130047512|NCT04504032|468130147|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
130047513|NCT02416908|468130150|FG000|Dose Escalation Phase|Adverse Event|0|||
130047514|NCT02416908|468130151|FG001|Dose Escalation Phase|Adverse Event|0|||
130047515|NCT02416908|468130152|FG002|Dose Escalation Phase|Adverse Event|3|||
130047516|NCT02416908|468130153|FG003|Dose Escalation Phase|Adverse Event|0|||
130047517|NCT02416908|468130150|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130047518|NCT02416908|468130151|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130047519|NCT02416908|468130152|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
130047520|NCT02416908|468130153|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130047521|NCT00940342|468130156|FG000|Overall Study|Adverse Event|0|||
130047522|NCT00940342|468130157|FG001|Overall Study|Adverse Event|2|||
130299838|NCT04566601|469062240|FG001|Overall Study|Change of residence|2|||
130299839|NCT04566601|469062241|FG002|Overall Study|Change of residence|0|||
130299840|NCT04566601|469062242|FG003|Overall Study|Change of residence|1|||
130299841|NCT04566601|469062243|FG004|Overall Study|Change of residence|2|||
130299842|NCT04566601|469062239|FG000|Overall Study|Perceived lack of efficacy|2|||
130299843|NCT04566601|469062240|FG001|Overall Study|Perceived lack of efficacy|0|||
130299844|NCT04566601|469062241|FG002|Overall Study|Perceived lack of efficacy|1|||
130299845|NCT04566601|469062242|FG003|Overall Study|Perceived lack of efficacy|1|||
130299846|NCT04566601|469062243|FG004|Overall Study|Perceived lack of efficacy|2|||
130299847|NCT04566601|469062239|FG000|Overall Study|Adverse Event|7|||
130299848|NCT04566601|469062240|FG001|Overall Study|Adverse Event|4|||
130299849|NCT04566601|469062241|FG002|Overall Study|Adverse Event|6|||
130299850|NCT04566601|469062242|FG003|Overall Study|Adverse Event|5|||
130299851|NCT04566601|469062243|FG004|Overall Study|Adverse Event|12|||
130299852|NCT01363661|469062245|FG000|Overall Study|Adverse Event|9|||
130299853|NCT01363661|469062246|FG001|Overall Study|Adverse Event|2|||
130299854|NCT01363661|469062245|FG000|Overall Study|Withdrawal by Subject|1|||
130299855|NCT01363661|469062246|FG001|Overall Study|Withdrawal by Subject|1|||
130299856|NCT01363661|469062245|FG000|Overall Study|Protocol Violation|1|||
130299857|NCT01363661|469062246|FG001|Overall Study|Protocol Violation|0|||
130299858|NCT01363661|469062245|FG000|Overall Study|Lost to Follow-up|3|||
130299859|NCT01363661|469062246|FG001|Overall Study|Lost to Follow-up|1|||
130299860|NCT03775512|469062247|FG000|Overall Study|Death|1|||
130299861|NCT03775512|469062248|FG001|Overall Study|Death|1|||
130299862|NCT03775512|469062247|FG000|Overall Study|Withdrawal by Subject|7|||
130299863|NCT03775512|469062248|FG001|Overall Study|Withdrawal by Subject|4|||
130299864|NCT03775512|469062247|FG000|Overall Study|Lost to Follow-up|5|||
130299865|NCT03775512|469062248|FG001|Overall Study|Lost to Follow-up|5|||
130299866|NCT03775512|469062247|FG000|Overall Study|Excluded before Catheter insertion|14|||
130299867|NCT03775512|469062248|FG001|Overall Study|Excluded before Catheter insertion|5|||
130299868|NCT03775512|469062247|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
130299869|NCT03775512|469062248|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
130299870|NCT03775512|469062247|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
130299871|NCT03775512|469062248|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
130299872|NCT01378325|469062251|FG000|Overall Study|Protocol Violation|0|||
130299873|NCT01378325|469062252|FG001|Overall Study|Protocol Violation|1|||
130299874|NCT00767806|469062253|FG000|Overall Study|Adverse Event|30|||
130299875|NCT00767806|469062254|FG001|Overall Study|Adverse Event|11|||
130299876|NCT00767806|469062253|FG000|Overall Study|Withdrawal by Subject|8|||
130299877|NCT00767806|469062254|FG001|Overall Study|Withdrawal by Subject|13|||
129889078|NCT01932996|467551000|FG000|Overall Study|Protocol Violation|2|||
129889079|NCT01932996|467551001|FG001|Overall Study|Protocol Violation|0|||
130047523|NCT00940342|468130158|FG002|Overall Study|Adverse Event|1|||
130047524|NCT03792750|468130160|FG000|Overall Study|Death|3|||
130047525|NCT00700752|468130165|FG000|First Intervention|Withdrawal by Subject|0|||
130047526|NCT00700752|468130166|FG001|First Intervention|Withdrawal by Subject|2|||
130047527|NCT01645930|468130167|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
130047528|NCT01645930|468130167|FG000|Overall Study|Progressive Disease|12|||
130047529|NCT01645930|468130167|FG000|Overall Study|Adverse Event|4|||
130299878|NCT00767806|469062253|FG000|Overall Study|Protocol Violation|6|||
130299879|NCT00767806|469062254|FG001|Overall Study|Protocol Violation|5|||
130299880|NCT00767806|469062253|FG000|Overall Study|Lack of Efficacy|1|||
130299881|NCT00767806|469062254|FG001|Overall Study|Lack of Efficacy|9|||
130299882|NCT00767806|469062253|FG000|Overall Study|Physician Decision|4|||
130299883|NCT00767806|469062254|FG001|Overall Study|Physician Decision|3|||
130299884|NCT00767806|469062253|FG000|Overall Study|Lost to Follow-up|1|||
130299885|NCT00767806|469062254|FG001|Overall Study|Lost to Follow-up|4|||
130299886|NCT00767806|469062253|FG000|Overall Study|Entry Criteria Not Met|1|||
130299887|NCT00767806|469062254|FG001|Overall Study|Entry Criteria Not Met|1|||
130299888|NCT00767806|469062253|FG000|Overall Study|Sponsor Decision|0|||
130299889|NCT00767806|469062254|FG001|Overall Study|Sponsor Decision|1|||
130299890|NCT01272635|469062255|FG000|Overall Study|Lost to Follow-up|31|||
130047530|NCT01645930|468130167|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
130047531|NCT01645930|468130167|FG000|Overall Study|Withdrawal by Participant|2|||
130047532|NCT01645930|468130167|FG000|Overall Study|Reason not Defined|1|||
130299891|NCT01272635|469062256|FG001|Overall Study|Lost to Follow-up|20|||
130299892|NCT01272635|469062257|FG002|Overall Study|Lost to Follow-up|31|||
130299893|NCT01272635|469062258|FG003|Overall Study|Lost to Follow-up|23|||
130299894|NCT02397057|469062261|FG000|Overall Study|Withdrawal by Subject|6|||
130299895|NCT02397057|469062262|FG001|Overall Study|Withdrawal by Subject|7|||
130299896|NCT02397057|469062261|FG000|Overall Study|Lost to Follow-up|4|||
130299897|NCT02397057|469062262|FG001|Overall Study|Lost to Follow-up|3|||
130299898|NCT02397057|469062261|FG000|Overall Study|Death|1|||
130299899|NCT02397057|469062262|FG001|Overall Study|Death|0|||
130299900|NCT02397057|469062261|FG000|Overall Study|Adverse Event|0|||
130299901|NCT02397057|469062262|FG001|Overall Study|Adverse Event|1|||
130299902|NCT02397057|469062261|FG000|Overall Study|Physician Decision|0|||
130299903|NCT02397057|469062262|FG001|Overall Study|Physician Decision|1|||
130299904|NCT02397057|469062261|FG000|Overall Study|Subject did not receive study drug|0|||
130299905|NCT02397057|469062262|FG001|Overall Study|Subject did not receive study drug|1|||
130299906|NCT01393639|469062263|FG000|Overall Study|Protocol Violation|0|||
130299907|NCT01393639|469062264|FG001|Overall Study|Protocol Violation|0|||
130299908|NCT01393639|469062265|FG002|Overall Study|Protocol Violation|0|||
130299909|NCT01393639|469062266|FG003|Overall Study|Protocol Violation|1|||
130299910|NCT01393639|469062267|FG004|Overall Study|Protocol Violation|0|||
130299911|NCT01393639|469062268|FG005|Overall Study|Protocol Violation|0|||
130299912|NCT01393639|469062269|FG006|Overall Study|Protocol Violation|0|||
130299913|NCT01393639|469062263|FG000|Overall Study|Other|0|||
130299914|NCT01393639|469062264|FG001|Overall Study|Other|2|||
130299915|NCT01393639|469062265|FG002|Overall Study|Other|0|||
130299916|NCT01393639|469062266|FG003|Overall Study|Other|2|||
130299917|NCT01393639|469062267|FG004|Overall Study|Other|1|||
130299918|NCT01393639|469062268|FG005|Overall Study|Other|0|||
130299919|NCT01393639|469062269|FG006|Overall Study|Other|1|||
130299920|NCT01393639|469062263|FG000|Overall Study|Withdrawal by Subject|1|||
130299921|NCT01393639|469062264|FG001|Overall Study|Withdrawal by Subject|1|||
130299922|NCT01393639|469062265|FG002|Overall Study|Withdrawal by Subject|0|||
130299923|NCT01393639|469062266|FG003|Overall Study|Withdrawal by Subject|0|||
130299924|NCT01393639|469062267|FG004|Overall Study|Withdrawal by Subject|0|||
130299925|NCT01393639|469062268|FG005|Overall Study|Withdrawal by Subject|0|||
130299926|NCT01393639|469062269|FG006|Overall Study|Withdrawal by Subject|1|||
130299927|NCT01393639|469062263|FG000|Overall Study|Medication error without associated AE|0|||
130299928|NCT01393639|469062264|FG001|Overall Study|Medication error without associated AE|0|||
130299929|NCT01393639|469062265|FG002|Overall Study|Medication error without associated AE|0|||
130299930|NCT01393639|469062266|FG003|Overall Study|Medication error without associated AE|0|||
130299931|NCT01393639|469062267|FG004|Overall Study|Medication error without associated AE|0|||
130299932|NCT01393639|469062268|FG005|Overall Study|Medication error without associated AE|0|||
130299933|NCT01393639|469062269|FG006|Overall Study|Medication error without associated AE|1|||
130299934|NCT01393639|469062263|FG000|Overall Study|Lost to Follow-up|0|||
130299935|NCT01393639|469062264|FG001|Overall Study|Lost to Follow-up|1|||
130299936|NCT01393639|469062265|FG002|Overall Study|Lost to Follow-up|0|||
130299937|NCT01393639|469062266|FG003|Overall Study|Lost to Follow-up|0|||
130299938|NCT01393639|469062267|FG004|Overall Study|Lost to Follow-up|0|||
130047533|NCT02522377|468130168|FG000|Overall Study|Withdrawal by Subject|1|||
130047534|NCT02522377|468130169|FG001|Overall Study|Withdrawal by Subject|0|||
130047535|NCT02522377|468130168|FG000|Overall Study|Remission Achieved|3|||
130047536|NCT02522377|468130169|FG001|Overall Study|Remission Achieved|0|||
130047537|NCT01158950|468130170|FG000|1st Intervention (1 Day)|Physician Decision|1|||
130107437|NCT04575038|468355123|FG001|Overall Study|Withdrawal by Subject|1|||
130107438|NCT03591107|468355126|FG000|Overall Study|Same patient in both arms|1|||
130107439|NCT03591107|468355127|FG001|Overall Study|Same patient in both arms|1|||
130299939|NCT01393639|469062268|FG005|Overall Study|Lost to Follow-up|0|||
130299940|NCT01393639|469062269|FG006|Overall Study|Lost to Follow-up|1|||
130299941|NCT01393639|469062263|FG000|Overall Study|Lack of Efficacy|0|||
130299942|NCT01393639|469062264|FG001|Overall Study|Lack of Efficacy|0|||
130299943|NCT01393639|469062265|FG002|Overall Study|Lack of Efficacy|0|||
130299944|NCT01393639|469062266|FG003|Overall Study|Lack of Efficacy|0|||
130299945|NCT01393639|469062267|FG004|Overall Study|Lack of Efficacy|0|||
130299946|NCT01393639|469062268|FG005|Overall Study|Lack of Efficacy|0|||
130299947|NCT01393639|469062269|FG006|Overall Study|Lack of Efficacy|1|||
130299948|NCT01393639|469062263|FG000|Overall Study|Adverse Event|2|||
130299949|NCT01393639|469062264|FG001|Overall Study|Adverse Event|3|||
130299950|NCT01393639|469062265|FG002|Overall Study|Adverse Event|1|||
130299951|NCT01393639|469062266|FG003|Overall Study|Adverse Event|2|||
130299952|NCT01393639|469062267|FG004|Overall Study|Adverse Event|0|||
130299953|NCT01393639|469062268|FG005|Overall Study|Adverse Event|2|||
130299954|NCT01393639|469062269|FG006|Overall Study|Adverse Event|3|||
130299955|NCT02241343|469062272|FG000|Overall Study|Adverse Event|1|||
130299956|NCT01329939|469062275|FG000|Overall Study|Lost to Follow-up|3|||
130299957|NCT01329939|469062276|FG001|Overall Study|Lost to Follow-up|0|||
130299958|NCT01329939|469062277|FG002|Overall Study|Lost to Follow-up|1|||
130299959|NCT01329939|469062278|FG003|Overall Study|Lost to Follow-up|2|||
130299960|NCT01329939|469062275|FG000|Overall Study|Withdrawal by Subject|0|||
130299961|NCT01329939|469062276|FG001|Overall Study|Withdrawal by Subject|1|||
130299962|NCT01329939|469062277|FG002|Overall Study|Withdrawal by Subject|0|||
130299963|NCT01329939|469062278|FG003|Overall Study|Withdrawal by Subject|0|||
130299964|NCT01329939|469062275|FG000|Overall Study|Adverse Event|0|||
130299965|NCT01329939|469062276|FG001|Overall Study|Adverse Event|0|||
130299966|NCT01329939|469062277|FG002|Overall Study|Adverse Event|0|||
130299967|NCT01329939|469062278|FG003|Overall Study|Adverse Event|3|||
130299968|NCT03722524|469062279|FG000|Overall Study|Protocol Violation|86|||
130299969|NCT03722524|469062279|FG000|Overall Study|Adverse Event|7|||
130299970|NCT03722524|469062279|FG000|Overall Study|Lost to Follow-up|1|||
130299971|NCT03722524|469062279|FG000|Overall Study|Reason is not stated|1|||
130299972|NCT03722524|469062279|FG000|Overall Study|Physician Decision|1|||
130299973|NCT03722524|469062279|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
130299974|NCT02942485|469062280|FG000|Overall Study|Lost to Follow-up|1|||
130299975|NCT02942485|469062281|FG001|Overall Study|Lost to Follow-up|0|||
130299976|NCT04369950|469062283|FG000|Overall Study|Protocol Violation|2|||
130299977|NCT04369950|469062284|FG001|Overall Study|Protocol Violation|2|||
130299978|NCT00989963|469062285|FG000|Overall Study|Adverse Event|1|||
130299979|NCT00989963|469062286|FG001|Overall Study|Adverse Event|1|||
130299980|NCT00989963|469062287|FG002|Overall Study|Adverse Event|1|||
130299981|NCT01240200|469062288|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
130299982|NCT01240200|469062289|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
130299983|NCT00646399|469062292|FG000|Overall Study|Death|63|||
130299984|NCT00646399|469062293|FG001|Overall Study|Death|53|||
130299985|NCT00646399|469062292|FG000|Overall Study|Withdrawal by Subject|9|||
130299986|NCT00646399|469062293|FG001|Overall Study|Withdrawal by Subject|10|||
130299987|NCT00646399|469062292|FG000|Overall Study|Other Reason|11|||
130299988|NCT00646399|469062293|FG001|Overall Study|Other Reason|11|||
130299989|NCT00455143|469062297|FG000|Overall Study|Physician Decision|1|||
130299990|NCT00455143|469062297|FG000|Overall Study|Withdrawal by Subject|1|||
130299991|NCT00455143|469062297|FG000|Overall Study|Staff was not avail to follow patient|2|||
130299992|NCT00455143|469062297|FG000|Overall Study|No longer met Inclusion Criteria|1|||
130299993|NCT00455143|469062297|FG000|Overall Study|Surgical time, staff not available|1|||
130299994|NCT00470418|469062298|FG000|Overall Study|Withdrawal by Subject|1|||
130299995|NCT00470418|469062299|FG001|Overall Study|Withdrawal by Subject|0|||
130299996|NCT02479139|469062300|FG000|Overall Study|Lost to Follow-up|2|||
130299997|NCT02479139|469062301|FG001|Overall Study|Lost to Follow-up|4|||
130299998|NCT02479139|469062302|FG002|Overall Study|Lost to Follow-up|4|||
130047538|NCT01158950|468130171|FG001|1st Intervention (1 Day)|Physician Decision|2|||
130047539|NCT02707757|468130179|FG000|Overall Study|Protocol Violation|3|||
130047540|NCT02707757|468130180|FG001|Overall Study|Protocol Violation|2|||
130299999|NCT02479139|469062303|FG003|Overall Study|Lost to Follow-up|2|||
130300000|NCT02479139|469062304|FG004|Overall Study|Lost to Follow-up|3|||
130300001|NCT02479139|469062305|FG005|Overall Study|Lost to Follow-up|5|||
130300002|NCT02479139|469062300|FG000|Overall Study|Withdrew Consent|5|||
129795148|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
129795149|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
129795150|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
129795151|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
129795152|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
129795153|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
130047541|NCT02707757|468130179|FG000|Overall Study|Withdrawal by Subject|2|||
130047542|NCT02707757|468130180|FG001|Overall Study|Withdrawal by Subject|0|||
130047543|NCT02707757|468130179|FG000|Overall Study|Death|0|||
130047544|NCT02707757|468130180|FG001|Overall Study|Death|1|||
130300003|NCT02479139|469062301|FG001|Overall Study|Withdrew Consent|6|||
130300004|NCT02479139|469062302|FG002|Overall Study|Withdrew Consent|1|||
130300005|NCT02479139|469062303|FG003|Overall Study|Withdrew Consent|4|||
130300006|NCT02479139|469062304|FG004|Overall Study|Withdrew Consent|1|||
130300007|NCT02479139|469062305|FG005|Overall Study|Withdrew Consent|1|||
130300008|NCT02479139|469062300|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300009|NCT02479139|469062301|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300010|NCT02479139|469062302|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
130300011|NCT02479139|469062303|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300012|NCT02479139|469062304|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300013|NCT02479139|469062305|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
130300014|NCT02479139|469062300|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130300015|NCT02479139|469062301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130300016|NCT02479139|469062302|FG002|Overall Study|Other Miscellaneous Reasons|1|||
130300017|NCT02479139|469062303|FG003|Overall Study|Other Miscellaneous Reasons|1|||
130300018|NCT02479139|469062304|FG004|Overall Study|Other Miscellaneous Reasons|1|||
130300019|NCT02479139|469062305|FG005|Overall Study|Other Miscellaneous Reasons|0|||
130047545|NCT02707757|468130179|FG000|Overall Study|Adverse Event|6|||
130047546|NCT02707757|468130180|FG001|Overall Study|Adverse Event|4|||
130047547|NCT02707757|468130179|FG000|Overall Study|Renal transplant/elective operation|1|||
130300020|NCT00885482|469062306|FG000|Overall Study|Pregnancy|1|||
130300021|NCT00885482|469062306|FG000|Overall Study|Lack of Efficacy|1|||
130300022|NCT00885482|469062306|FG000|Overall Study|Death|1|||
130300023|NCT00885482|469062306|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
130300024|NCT00084656|469062307|FG000|Overall Study|Other reasons|0|||
130300025|NCT00084656|469062308|FG001|Overall Study|Other reasons|12|||
130300026|NCT00084656|469062309|FG002|Overall Study|Other reasons|11|||
130300027|NCT00084656|469062307|FG000|Overall Study|Withdrawal by Subject|15|||
130300028|NCT00084656|469062308|FG001|Overall Study|Withdrawal by Subject|4|||
130300029|NCT00084656|469062309|FG002|Overall Study|Withdrawal by Subject|4|||
130300030|NCT00084656|469062307|FG000|Overall Study|Disease relapse|0|||
130300031|NCT00084656|469062308|FG001|Overall Study|Disease relapse|9|||
130300032|NCT00084656|469062309|FG002|Overall Study|Disease relapse|10|||
130300033|NCT00084656|469062307|FG000|Overall Study|Disease progression|9|||
130300034|NCT00084656|469062308|FG001|Overall Study|Disease progression|0|||
130300035|NCT00084656|469062309|FG002|Overall Study|Disease progression|0|||
130300036|NCT00084656|469062307|FG000|Overall Study|Lost to Follow-up|1|||
130300037|NCT00084656|469062308|FG001|Overall Study|Lost to Follow-up|0|||
130300038|NCT00084656|469062309|FG002|Overall Study|Lost to Follow-up|1|||
130300039|NCT02772978|469062310|FG000|Overall Study|Withdrawal by Subject|1|||
130300040|NCT02772978|469062311|FG001|Overall Study|Withdrawal by Subject|1|||
130300041|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
130300042|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
130300043|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
130300044|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
130300045|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
130300046|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
130300047|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
130300048|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
130300049|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
130300050|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
130300051|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
130300052|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
130300053|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
130300054|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
130300055|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
130300056|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
130300057|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
130300058|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
130300059|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
130300060|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
130300061|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
130300062|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
130300063|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
130300064|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
130300065|NCT01532869|469062312|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
130300066|NCT01532869|469062313|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
130300067|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
130300068|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
130300069|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
130300070|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
130300071|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
130300072|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
130300073|NCT01532869|469062312|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
130300074|NCT01532869|469062313|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
130047548|NCT02707757|468130180|FG001|Overall Study|Renal transplant/elective operation|5|||
130047549|NCT02955186|468130181|FG000|Overall Study|Withdrawal by Subject|6|||
129795154|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
129795155|NCT02093026|467217925|FG000|Overall Study|Adverse Event|26|||
129795156|NCT02093026|467217925|FG000|Overall Study|Death|10|||
129795157|NCT02093026|467217925|FG000|Overall Study|Other|157|||
129795158|NCT00518973|467217926|FG000|Overall Study|Withdrawal by Subject|3|||
129795159|NCT00518973|467217927|FG001|Overall Study|Withdrawal by Subject|2|||
129795160|NCT00174291|467217944|FG000|Overall Study|Lost to Follow-up|1|||
129795161|NCT00174291|467217945|FG001|Overall Study|Lost to Follow-up|1|||
129795162|NCT00174291|467217944|FG000|Overall Study|Protocol Violation|0|||
130300075|NCT01331291|469062314|FG000|Overall Study|Lack of Efficacy|2|||
130300076|NCT01331291|469062315|FG001|Overall Study|Lack of Efficacy|8|||
130300077|NCT01331291|469062314|FG000|Overall Study|Death|0|||
130300078|NCT01331291|469062315|FG001|Overall Study|Death|1|||
130300079|NCT00778895|469062316|FG000|Active Phase|Adverse Event|3|||
130300080|NCT00778895|469062317|FG001|Active Phase|Adverse Event|1|||
130300081|NCT00778895|469062318|FG002|Active Phase|Adverse Event|0|||
130300082|NCT00778895|469062316|FG000|Active Phase|Withdrawal by Subject|1|||
130300083|NCT00778895|469062317|FG001|Active Phase|Withdrawal by Subject|4|||
130300084|NCT00778895|469062318|FG002|Active Phase|Withdrawal by Subject|0|||
130300085|NCT00778895|469062316|FG000|Active Phase|Lost to Follow-up|1|||
130300086|NCT00778895|469062317|FG001|Active Phase|Lost to Follow-up|1|||
130300087|NCT00778895|469062318|FG002|Active Phase|Lost to Follow-up|0|||
130300088|NCT00778895|469062316|FG000|Active Phase|Other|2|||
130300089|NCT00778895|469062317|FG001|Active Phase|Other|0|||
130300090|NCT00778895|469062318|FG002|Active Phase|Other|0|||
130300091|NCT00778895|469062316|FG000|ESFU Phase|Adverse Event|2|||
130300092|NCT00778895|469062317|FG001|ESFU Phase|Adverse Event|1|||
130300093|NCT00778895|469062318|FG002|ESFU Phase|Adverse Event|0|||
130300094|NCT00778895|469062316|FG000|ESFU Phase|Withdrawal by Subject|1|||
130300095|NCT00778895|469062317|FG001|ESFU Phase|Withdrawal by Subject|4|||
130300096|NCT00778895|469062318|FG002|ESFU Phase|Withdrawal by Subject|0|||
130300097|NCT00778895|469062316|FG000|ESFU Phase|Lost to Follow-up|6|||
130300098|NCT00778895|469062317|FG001|ESFU Phase|Lost to Follow-up|7|||
130300099|NCT00778895|469062318|FG002|ESFU Phase|Lost to Follow-up|2|||
130300100|NCT00778895|469062316|FG000|ESFU Phase|Other|2|||
130300101|NCT00778895|469062317|FG001|ESFU Phase|Other|0|||
130300102|NCT00778895|469062318|FG002|ESFU Phase|Other|0|||
130300103|NCT02540993|469062320|FG000|Overall Study|Lost to Follow-up|5|||
129795163|NCT00174291|467217945|FG001|Overall Study|Protocol Violation|2|||
129795164|NCT00174291|467217944|FG000|Overall Study|Study terminated by sponsor|1|||
130300104|NCT02540993|469062321|FG001|Overall Study|Lost to Follow-up|3|||
130300105|NCT02540993|469062320|FG000|Overall Study|Withdrawal by Subject|4|||
130300106|NCT02540993|469062321|FG001|Overall Study|Withdrawal by Subject|6|||
130300107|NCT02540993|469062320|FG000|Overall Study|GCP violations|33|||
130300108|NCT02540993|469062321|FG001|Overall Study|GCP violations|27|||
130300109|NCT00409344|469062322|FG000|Overall Study|no enrollment|0|||
130300110|NCT00409344|469062323|FG001|Overall Study|no enrollment|0|||
130300111|NCT01009086|469062324|FG000|Overall Study|Lack of Efficacy|16|||
130300112|NCT01009086|469062325|FG001|Overall Study|Lack of Efficacy|15|||
130300113|NCT01009086|469062326|FG002|Overall Study|Lack of Efficacy|9|||
130300114|NCT01009086|469062324|FG000|Overall Study|Lost to Follow-up|4|||
130047550|NCT02955186|468130182|FG001|Overall Study|Withdrawal by Subject|2|||
130047551|NCT02955186|468130181|FG000|Overall Study|Protocol Violation|1|||
130047552|NCT02955186|468130182|FG001|Overall Study|Protocol Violation|0|||
130300115|NCT01009086|469062325|FG001|Overall Study|Lost to Follow-up|5|||
130300116|NCT01009086|469062326|FG002|Overall Study|Lost to Follow-up|3|||
130300117|NCT01009086|469062324|FG000|Overall Study|Adverse Event|12|||
130300118|NCT01009086|469062325|FG001|Overall Study|Adverse Event|11|||
130300119|NCT01009086|469062326|FG002|Overall Study|Adverse Event|8|||
130300120|NCT01009086|469062324|FG000|Overall Study|Withdrawal by Subject|9|||
130300121|NCT01009086|469062325|FG001|Overall Study|Withdrawal by Subject|11|||
130300122|NCT01009086|469062326|FG002|Overall Study|Withdrawal by Subject|13|||
130300123|NCT01009086|469062324|FG000|Overall Study|Other|3|||
130300124|NCT01009086|469062325|FG001|Overall Study|Other|5|||
130300125|NCT01009086|469062326|FG002|Overall Study|Other|1|||
130300126|NCT03135210|469062327|FG000|Overall Study|Death|0|||
130300127|NCT03135210|469062328|FG001|Overall Study|Death|1|||
130300128|NCT00590577|469062330|FG000|Overall Study|Lack of Efficacy|31|||
130300129|NCT00590577|469062331|FG001|Overall Study|Lack of Efficacy|28|||
130300130|NCT00590577|469062332|FG002|Overall Study|Lack of Efficacy|23|||
130300131|NCT00590577|469062333|FG003|Overall Study|Lack of Efficacy|45|||
130300132|NCT00590577|469062330|FG000|Overall Study|Withdrawal by Subject|23|||
130300133|NCT00590577|469062331|FG001|Overall Study|Withdrawal by Subject|28|||
130300134|NCT00590577|469062332|FG002|Overall Study|Withdrawal by Subject|30|||
130300135|NCT00590577|469062333|FG003|Overall Study|Withdrawal by Subject|26|||
130300136|NCT00590577|469062330|FG000|Overall Study|Adverse Event|10|||
130300137|NCT00590577|469062331|FG001|Overall Study|Adverse Event|10|||
130300138|NCT00590577|469062332|FG002|Overall Study|Adverse Event|13|||
130300139|NCT00590577|469062333|FG003|Overall Study|Adverse Event|11|||
130300140|NCT00590577|469062330|FG000|Overall Study|Lost to Follow-up|12|||
130300141|NCT00590577|469062331|FG001|Overall Study|Lost to Follow-up|6|||
130300142|NCT00590577|469062332|FG002|Overall Study|Lost to Follow-up|6|||
130300143|NCT00590577|469062333|FG003|Overall Study|Lost to Follow-up|9|||
130300144|NCT00590577|469062330|FG000|Overall Study|Pregnancy|0|||
130300145|NCT00590577|469062331|FG001|Overall Study|Pregnancy|1|||
130300146|NCT00590577|469062332|FG002|Overall Study|Pregnancy|0|||
130300147|NCT00590577|469062333|FG003|Overall Study|Pregnancy|0|||
130300148|NCT00590577|469062330|FG000|Overall Study|Various reasons|1|||
130300149|NCT00590577|469062331|FG001|Overall Study|Various reasons|3|||
130300150|NCT00590577|469062332|FG002|Overall Study|Various reasons|1|||
130300151|NCT00590577|469062333|FG003|Overall Study|Various reasons|2|||
130300152|NCT04349033|469062334|FG000|Overall Study|Lost to Follow-up|3|||
130300153|NCT04349033|469062335|FG001|Overall Study|Lost to Follow-up|1|||
130300154|NCT04349033|469062336|FG002|Overall Study|Lost to Follow-up|1|||
130300155|NCT04058886|469062340|FG000|Overall Study|Withdrawal by Subject|4|||
130300156|NCT04058886|469062340|FG000|Overall Study|Inadequate deafness interpreter service|1|||
130300157|NCT02332291|469062341|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
130300158|NCT02332291|469062342|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
130300159|NCT02332291|469062341|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
130300160|NCT02332291|469062342|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
130300161|NCT02332291|469062341|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
130300162|NCT02332291|469062342|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
130300163|NCT02332291|469062341|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
130300164|NCT02332291|469062342|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
130300165|NCT02332291|469062341|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
130300166|NCT02332291|469062342|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
130300167|NCT02332291|469062341|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
130300168|NCT02332291|469062342|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
130300169|NCT02220712|469062346|FG000|Overall Study|Adverse Event|1|||
130300170|NCT02220712|469062346|FG000|Overall Study|Withdrawal by Subject|2|||
130300171|NCT02220712|469062346|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
130047553|NCT01632878|468130183|FG000|Screening|Physician Decision|268|||
130047554|NCT01632878|468130183|FG000|Treatment|Lost to Follow-up|41|||
130047555|NCT01632878|468130183|FG000|Treatment|Withdrawal by Subject|36|||
130047556|NCT01632878|468130183|FG000|Treatment|Physician Decision|34|||
130300172|NCT00760838|469062347|FG000|Overall Study|Adverse Event|1|||
130300173|NCT00760838|469062348|FG001|Overall Study|Adverse Event|1|||
130300174|NCT00760838|469062347|FG000|Overall Study|Lack of Efficacy|1|||
130300175|NCT00760838|469062348|FG001|Overall Study|Lack of Efficacy|0|||
130300176|NCT00760838|469062347|FG000|Overall Study|Lost to Follow-up|2|||
130300177|NCT00760838|469062348|FG001|Overall Study|Lost to Follow-up|0|||
130300178|NCT00760838|469062347|FG000|Overall Study|Withdrawal by Subject|1|||
130047557|NCT01632878|468130183|FG000|Treatment|missing information|4|||
130047558|NCT01632878|468130183|FG000|Treatment|no information on study completion|43|||
130300179|NCT00760838|469062348|FG001|Overall Study|Withdrawal by Subject|1|||
130300180|NCT03624127|469062349|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
130300181|NCT03624127|469062350|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
129795165|NCT00174291|467217945|FG001|Overall Study|Study terminated by sponsor|0|||
130300182|NCT03624127|469062351|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
130300183|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
130300184|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
130300185|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
130300186|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Death|0|||
130300187|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Death|1|||
130300188|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Death|0|||
130300189|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
130300190|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
130300191|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
130300192|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
130300193|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
130300194|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
130300195|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
130300196|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
130300197|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
130300198|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
130300199|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
130300200|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
130300201|NCT03624127|469062349|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
130300202|NCT03624127|469062350|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
130300203|NCT03624127|469062351|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
130300204|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
130300205|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
130300206|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
130300207|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
130300208|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130300209|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
130300210|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130300211|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
130300212|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
130300213|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
130300214|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
130300215|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
130300216|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
130300217|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
130300218|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
130300219|NCT03624127|469062349|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
130300220|NCT03624127|469062350|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
130300221|NCT03624127|469062351|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
130300222|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
130300223|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
130300224|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
130300225|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
130300226|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130300227|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
130300228|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
130300229|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
130300230|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
130300231|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
130300232|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
130300233|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
130300234|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
130300235|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
130300236|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
130300237|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
130300238|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130300239|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
130300240|NCT03624127|469062349|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
130300241|NCT03624127|469062350|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
130300242|NCT03624127|469062351|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
130300243|NCT02607228|469062352|FG000|Overall Study|Progressive Disease|4|||
129795166|NCT00174291|467217944|FG000|Overall Study|Withdrawal by Subject|3|||
130300244|NCT02607228|469062353|FG001|Overall Study|Progressive Disease|3|||
130300245|NCT02607228|469062354|FG002|Overall Study|Progressive Disease|1|||
130300246|NCT02607228|469062355|FG003|Overall Study|Progressive Disease|5|||
130300247|NCT02607228|469062356|FG004|Overall Study|Progressive Disease|4|||
130300248|NCT02607228|469062357|FG005|Overall Study|Progressive Disease|3|||
130300249|NCT02607228|469062358|FG006|Overall Study|Progressive Disease|1|||
130300250|NCT02607228|469062352|FG000|Overall Study|Adverse Event|1|||
130300251|NCT02607228|469062353|FG001|Overall Study|Adverse Event|0|||
130107440|NCT03591107|468355126|FG000|Overall Study|Sought care at other clinics|0|||
130300252|NCT02607228|469062354|FG002|Overall Study|Adverse Event|1|||
130300253|NCT02607228|469062355|FG003|Overall Study|Adverse Event|0|||
130300254|NCT02607228|469062356|FG004|Overall Study|Adverse Event|1|||
130300255|NCT02607228|469062357|FG005|Overall Study|Adverse Event|1|||
130300256|NCT02607228|469062358|FG006|Overall Study|Adverse Event|1|||
130300257|NCT02607228|469062352|FG000|Overall Study|Investigator's Discretion|0|||
130300258|NCT02607228|469062353|FG001|Overall Study|Investigator's Discretion|0|||
130300259|NCT02607228|469062354|FG002|Overall Study|Investigator's Discretion|1|||
130300260|NCT02607228|469062355|FG003|Overall Study|Investigator's Discretion|0|||
130300261|NCT02607228|469062356|FG004|Overall Study|Investigator's Discretion|0|||
130300262|NCT02607228|469062357|FG005|Overall Study|Investigator's Discretion|1|||
130300263|NCT02607228|469062358|FG006|Overall Study|Investigator's Discretion|0|||
130300264|NCT02607228|469062352|FG000|Overall Study|Withdrew Consent|0|||
130300265|NCT02607228|469062353|FG001|Overall Study|Withdrew Consent|1|||
130300266|NCT02607228|469062354|FG002|Overall Study|Withdrew Consent|0|||
130300267|NCT02607228|469062355|FG003|Overall Study|Withdrew Consent|0|||
130300268|NCT02607228|469062356|FG004|Overall Study|Withdrew Consent|0|||
130300269|NCT02607228|469062357|FG005|Overall Study|Withdrew Consent|1|||
130300270|NCT02607228|469062358|FG006|Overall Study|Withdrew Consent|0|||
130300271|NCT02607228|469062352|FG000|Overall Study|Study Terminated by Sponsor|0|||
130300272|NCT02607228|469062353|FG001|Overall Study|Study Terminated by Sponsor|0|||
130300273|NCT02607228|469062354|FG002|Overall Study|Study Terminated by Sponsor|0|||
130300274|NCT02607228|469062355|FG003|Overall Study|Study Terminated by Sponsor|1|||
130300275|NCT02607228|469062356|FG004|Overall Study|Study Terminated by Sponsor|0|||
130300276|NCT02607228|469062357|FG005|Overall Study|Study Terminated by Sponsor|0|||
130300277|NCT02607228|469062358|FG006|Overall Study|Study Terminated by Sponsor|0|||
130300278|NCT03576716|469062361|FG000|Overall Study|Withdrawal by Subject|0|||
130300279|NCT03576716|469062362|FG001|Overall Study|Withdrawal by Subject|1|||
130300280|NCT00559988|469062363|FG000|Overall Study|Death|147|||
130300281|NCT00559988|469062364|FG001|Overall Study|Death|140|||
130300282|NCT00559988|469062363|FG000|Overall Study|Withdrawal by Subject|152|||
130300283|NCT00559988|469062364|FG001|Overall Study|Withdrawal by Subject|139|||
130300284|NCT00559988|469062363|FG000|Overall Study|Lost to Follow-up|42|||
130300285|NCT00559988|469062364|FG001|Overall Study|Lost to Follow-up|56|||
130300286|NCT00559988|469062363|FG000|Overall Study|ICD device explanted|10|||
130300287|NCT00559988|469062364|FG001|Overall Study|ICD device explanted|17|||
130300288|NCT01455194|469062365|FG000|Overall Study|Screen Failure|20|||
130300289|NCT01455194|469062366|FG001|Overall Study|Screen Failure|0|||
130300290|NCT01455194|469062367|FG002|Overall Study|Screen Failure|0|||
130300291|NCT01455194|469062368|FG003|Overall Study|Screen Failure|0|||
130300292|NCT01455194|469062365|FG000|Overall Study|Randomisation Failure|90|||
130300293|NCT01455194|469062366|FG001|Overall Study|Randomisation Failure|0|||
130300294|NCT01455194|469062367|FG002|Overall Study|Randomisation Failure|0|||
130300295|NCT01455194|469062368|FG003|Overall Study|Randomisation Failure|0|||
130300296|NCT01455194|469062365|FG000|Overall Study|Deterioration in asthma|12|||
130300297|NCT01455194|469062366|FG001|Overall Study|Deterioration in asthma|6|||
130300298|NCT01455194|469062367|FG002|Overall Study|Deterioration in asthma|14|||
130300299|NCT01455194|469062368|FG003|Overall Study|Deterioration in asthma|9|||
130300300|NCT01455194|469062365|FG000|Overall Study|Adverse Event|1|||
130300301|NCT01455194|469062366|FG001|Overall Study|Adverse Event|1|||
130300302|NCT01455194|469062367|FG002|Overall Study|Adverse Event|1|||
130300303|NCT01455194|469062368|FG003|Overall Study|Adverse Event|3|||
130300304|NCT01455194|469062365|FG000|Overall Study|Withdrawal by Subject|21|||
130300305|NCT01455194|469062366|FG001|Overall Study|Withdrawal by Subject|16|||
130300306|NCT01455194|469062367|FG002|Overall Study|Withdrawal by Subject|12|||
130300307|NCT01455194|469062368|FG003|Overall Study|Withdrawal by Subject|9|||
130300308|NCT01455194|469062365|FG000|Overall Study|Lost to Follow-up|2|||
130300309|NCT01455194|469062366|FG001|Overall Study|Lost to Follow-up|0|||
130300310|NCT01455194|469062367|FG002|Overall Study|Lost to Follow-up|1|||
130300311|NCT01455194|469062368|FG003|Overall Study|Lost to Follow-up|1|||
130300312|NCT01455194|469062365|FG000|Overall Study|Pregnancy|0|||
130300313|NCT01455194|469062366|FG001|Overall Study|Pregnancy|1|||
130300314|NCT01455194|469062367|FG002|Overall Study|Pregnancy|1|||
130300315|NCT01455194|469062368|FG003|Overall Study|Pregnancy|0|||
130300316|NCT01455194|469062365|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
130300317|NCT01455194|469062366|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
130300318|NCT01455194|469062367|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
130300319|NCT01455194|469062368|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
130300320|NCT01455194|469062365|FG000|Overall Study|Miscellaneous|4|||
130300321|NCT01455194|469062366|FG001|Overall Study|Miscellaneous|5|||
130300322|NCT01455194|469062367|FG002|Overall Study|Miscellaneous|1|||
130300323|NCT01455194|469062368|FG003|Overall Study|Miscellaneous|4|||
130300324|NCT02249182|469062369|FG000|Treatment Phase|Lost to Follow-up|4|||
130300325|NCT02249182|469062370|FG001|Treatment Phase|Lost to Follow-up|0|||
130300326|NCT02249182|469062371|FG002|Treatment Phase|Lost to Follow-up|0|||
130300327|NCT02249182|469062372|FG003|Treatment Phase|Lost to Follow-up|0|||
130300328|NCT02249182|469062373|FG004|Treatment Phase|Lost to Follow-up|0|||
130300329|NCT04356040|469062376|FG000|Overall Study|Death|2|||
130300330|NCT04356040|469062377|FG001|Overall Study|Death|0|||
129795167|NCT00174291|467217945|FG001|Overall Study|Withdrawal by Subject|3|||
129795168|NCT01923168|467217948|FG000|Overall Study|Protocol Violation|1|||
129795169|NCT01923168|467217949|FG001|Overall Study|Protocol Violation|1|||
129795170|NCT01923168|467217950|FG002|Overall Study|Protocol Violation|0|||
129795171|NCT01923168|467217948|FG000|Overall Study|Subject/guardian decision|14|||
129795172|NCT01923168|467217949|FG001|Overall Study|Subject/guardian decision|14|||
130300331|NCT04356040|469062376|FG000|Overall Study|Lost to Follow-up|1|||
130300332|NCT04356040|469062377|FG001|Overall Study|Lost to Follow-up|0|||
130300333|NCT04356040|469062376|FG000|Overall Study|Physician Decision|0|||
130300334|NCT04356040|469062377|FG001|Overall Study|Physician Decision|1|||
130300335|NCT04356040|469062376|FG000|Overall Study|Withdrawal by Subject|13|||
130300336|NCT04356040|469062377|FG001|Overall Study|Withdrawal by Subject|1|||
130300337|NCT04356040|469062376|FG000|Overall Study|Enrollment Pause|10|||
130300338|NCT04356040|469062377|FG001|Overall Study|Enrollment Pause|0|||
130300339|NCT04356040|469062376|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
130300340|NCT04356040|469062377|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
130300341|NCT04356040|469062376|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
130300342|NCT04356040|469062377|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
130300343|NCT04356040|469062376|FG000|Overall Study|PI left institution|3|||
130300344|NCT04356040|469062377|FG001|Overall Study|PI left institution|0|||
130300345|NCT00788710|469062378|FG000|Overall Study|Adverse Event|1|||
130300346|NCT00788710|469062379|FG001|Overall Study|Adverse Event|3|||
130300347|NCT00788710|469062380|FG002|Overall Study|Adverse Event|4|||
130300348|NCT00788710|469062378|FG000|Overall Study|Lack of Efficacy|0|||
130300349|NCT00788710|469062379|FG001|Overall Study|Lack of Efficacy|0|||
130300350|NCT00788710|469062380|FG002|Overall Study|Lack of Efficacy|1|||
130300351|NCT00788710|469062378|FG000|Overall Study|Lost to Follow-up|0|||
130300352|NCT00788710|469062379|FG001|Overall Study|Lost to Follow-up|1|||
130300353|NCT00788710|469062380|FG002|Overall Study|Lost to Follow-up|0|||
130300354|NCT00788710|469062378|FG000|Overall Study|Physician Decision|2|||
130300355|NCT00788710|469062379|FG001|Overall Study|Physician Decision|1|||
130300356|NCT00788710|469062380|FG002|Overall Study|Physician Decision|0|||
130300357|NCT00788710|469062378|FG000|Overall Study|Protocol Violation|0|||
130300358|NCT00788710|469062379|FG001|Overall Study|Protocol Violation|1|||
130300359|NCT00788710|469062380|FG002|Overall Study|Protocol Violation|1|||
130300360|NCT00788710|469062378|FG000|Overall Study|Withdrawal by Subject|2|||
130300361|NCT00788710|469062379|FG001|Overall Study|Withdrawal by Subject|2|||
130300362|NCT00788710|469062380|FG002|Overall Study|Withdrawal by Subject|0|||
130300363|NCT01990859|469062381|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
130300364|NCT01990859|469062381|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
130300365|NCT01717326|469062382|FG000|Overall Study|Death|0|||
130300366|NCT01717326|469062383|FG001|Overall Study|Death|0|||
130300367|NCT01717326|469062384|FG002|Overall Study|Death|0|||
130300368|NCT01717326|469062385|FG003|Overall Study|Death|0|||
130300369|NCT01717326|469062386|FG004|Overall Study|Death|0|||
130300370|NCT01717326|469062387|FG005|Overall Study|Death|0|||
130300371|NCT01717326|469062388|FG006|Overall Study|Death|0|||
130300372|NCT01717326|469062389|FG007|Overall Study|Death|0|||
130300373|NCT01717326|469062390|FG008|Overall Study|Death|0|||
130300374|NCT01717326|469062391|FG009|Overall Study|Death|0|||
130300375|NCT01717326|469062392|FG010|Overall Study|Death|1|||
130300376|NCT01717326|469062393|FG011|Overall Study|Death|0|||
130300377|NCT01717326|469062394|FG012|Overall Study|Death|0|||
130300378|NCT01717326|469062395|FG013|Overall Study|Death|0|||
130300379|NCT01717326|469062396|FG014|Overall Study|Death|0|||
130300380|NCT01717326|469062397|FG015|Overall Study|Death|0|||
130300381|NCT01717326|469062398|FG016|Overall Study|Death|0|||
130300382|NCT01717326|469062399|FG017|Overall Study|Death|0|||
130300383|NCT01717326|469062400|FG018|Overall Study|Death|0|||
129795173|NCT01923168|467217950|FG002|Overall Study|Subject/guardian decision|4|||
129795174|NCT01923168|467217948|FG000|Overall Study|Adverse Event|12|||
129795175|NCT01923168|467217949|FG001|Overall Study|Adverse Event|12|||
129795176|NCT01923168|467217950|FG002|Overall Study|Adverse Event|0|||
129795177|NCT01923168|467217948|FG000|Overall Study|Physician Decision|6|||
130300384|NCT01717326|469062401|FG019|Overall Study|Death|0|||
130300385|NCT01717326|469062382|FG000|Overall Study|Lost to Follow-up|3|||
130300386|NCT01717326|469062383|FG001|Overall Study|Lost to Follow-up|0|||
130300387|NCT01717326|469062384|FG002|Overall Study|Lost to Follow-up|0|||
130300388|NCT01717326|469062385|FG003|Overall Study|Lost to Follow-up|2|||
130300389|NCT01717326|469062386|FG004|Overall Study|Lost to Follow-up|1|||
129795178|NCT01923168|467217949|FG001|Overall Study|Physician Decision|9|||
129795179|NCT01923168|467217950|FG002|Overall Study|Physician Decision|5|||
129795180|NCT01923168|467217948|FG000|Overall Study|Progressive disease|4|||
129795181|NCT01923168|467217949|FG001|Overall Study|Progressive disease|3|||
129795182|NCT01923168|467217950|FG002|Overall Study|Progressive disease|7|||
130300390|NCT01717326|469062387|FG005|Overall Study|Lost to Follow-up|0|||
130300391|NCT01717326|469062388|FG006|Overall Study|Lost to Follow-up|1|||
130300392|NCT01717326|469062389|FG007|Overall Study|Lost to Follow-up|0|||
130300393|NCT01717326|469062390|FG008|Overall Study|Lost to Follow-up|0|||
130300394|NCT01717326|469062391|FG009|Overall Study|Lost to Follow-up|0|||
130300395|NCT01717326|469062392|FG010|Overall Study|Lost to Follow-up|1|||
130300396|NCT01717326|469062393|FG011|Overall Study|Lost to Follow-up|0|||
130300397|NCT01717326|469062394|FG012|Overall Study|Lost to Follow-up|0|||
130300398|NCT01717326|469062395|FG013|Overall Study|Lost to Follow-up|0|||
130300399|NCT01717326|469062396|FG014|Overall Study|Lost to Follow-up|0|||
130300400|NCT01717326|469062397|FG015|Overall Study|Lost to Follow-up|2|||
130300401|NCT01717326|469062398|FG016|Overall Study|Lost to Follow-up|1|||
130300402|NCT01717326|469062399|FG017|Overall Study|Lost to Follow-up|0|||
130300403|NCT01717326|469062400|FG018|Overall Study|Lost to Follow-up|2|||
130300404|NCT01717326|469062401|FG019|Overall Study|Lost to Follow-up|3|||
130300405|NCT01717326|469062382|FG000|Overall Study|Physician Decision|0|||
130300406|NCT01717326|469062383|FG001|Overall Study|Physician Decision|0|||
130300407|NCT01717326|469062384|FG002|Overall Study|Physician Decision|0|||
130300408|NCT01717326|469062385|FG003|Overall Study|Physician Decision|0|||
130300409|NCT01717326|469062386|FG004|Overall Study|Physician Decision|0|||
130300410|NCT01717326|469062387|FG005|Overall Study|Physician Decision|0|||
130300411|NCT01717326|469062388|FG006|Overall Study|Physician Decision|0|||
130300412|NCT01717326|469062389|FG007|Overall Study|Physician Decision|0|||
130300413|NCT01717326|469062390|FG008|Overall Study|Physician Decision|0|||
130300414|NCT01717326|469062391|FG009|Overall Study|Physician Decision|1|||
130300415|NCT01717326|469062392|FG010|Overall Study|Physician Decision|0|||
130300416|NCT01717326|469062393|FG011|Overall Study|Physician Decision|0|||
130300417|NCT01717326|469062394|FG012|Overall Study|Physician Decision|0|||
130300418|NCT01717326|469062395|FG013|Overall Study|Physician Decision|0|||
130300419|NCT01717326|469062396|FG014|Overall Study|Physician Decision|0|||
130300420|NCT01717326|469062397|FG015|Overall Study|Physician Decision|0|||
130300421|NCT01717326|469062398|FG016|Overall Study|Physician Decision|0|||
130300422|NCT01717326|469062399|FG017|Overall Study|Physician Decision|0|||
130300423|NCT01717326|469062400|FG018|Overall Study|Physician Decision|0|||
130300424|NCT01717326|469062401|FG019|Overall Study|Physician Decision|0|||
130300425|NCT01717326|469062382|FG000|Overall Study|Protocol Violation|0|||
130300426|NCT01717326|469062383|FG001|Overall Study|Protocol Violation|0|||
130300427|NCT01717326|469062384|FG002|Overall Study|Protocol Violation|0|||
130300428|NCT01717326|469062385|FG003|Overall Study|Protocol Violation|0|||
130300429|NCT01717326|469062386|FG004|Overall Study|Protocol Violation|1|||
130300430|NCT01717326|469062387|FG005|Overall Study|Protocol Violation|0|||
130300431|NCT01717326|469062388|FG006|Overall Study|Protocol Violation|0|||
130300432|NCT01717326|469062389|FG007|Overall Study|Protocol Violation|0|||
130300433|NCT01717326|469062390|FG008|Overall Study|Protocol Violation|0|||
130300434|NCT01717326|469062391|FG009|Overall Study|Protocol Violation|0|||
130300435|NCT01717326|469062392|FG010|Overall Study|Protocol Violation|0|||
130300436|NCT01717326|469062393|FG011|Overall Study|Protocol Violation|0|||
130300437|NCT01717326|469062394|FG012|Overall Study|Protocol Violation|0|||
130300438|NCT01717326|469062395|FG013|Overall Study|Protocol Violation|0|||
130300439|NCT01717326|469062396|FG014|Overall Study|Protocol Violation|0|||
130300440|NCT01717326|469062397|FG015|Overall Study|Protocol Violation|0|||
130300441|NCT01717326|469062398|FG016|Overall Study|Protocol Violation|0|||
130300442|NCT01717326|469062399|FG017|Overall Study|Protocol Violation|0|||
130300443|NCT01717326|469062400|FG018|Overall Study|Protocol Violation|0|||
130300444|NCT01717326|469062401|FG019|Overall Study|Protocol Violation|0|||
130300445|NCT01717326|469062382|FG000|Overall Study|Withdrawal by Subject|0|||
130047559|NCT00081289|468130184|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
130047560|NCT00081289|468130185|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
130047561|NCT00081289|468130184|FG000|Overall Study|Ineligible / no protocol treatment|3|||
130047562|NCT00081289|468130185|FG001|Overall Study|Ineligible / no protocol treatment|4|||
130300446|NCT01717326|469062383|FG001|Overall Study|Withdrawal by Subject|1|||
130300447|NCT01717326|469062384|FG002|Overall Study|Withdrawal by Subject|0|||
130300448|NCT01717326|469062385|FG003|Overall Study|Withdrawal by Subject|0|||
130300449|NCT01717326|469062386|FG004|Overall Study|Withdrawal by Subject|0|||
130300450|NCT01717326|469062387|FG005|Overall Study|Withdrawal by Subject|0|||
130300451|NCT01717326|469062388|FG006|Overall Study|Withdrawal by Subject|0|||
130047563|NCT02749370|468130186|FG000|Overall Study|Withdrawal by Subject|11|||
130047564|NCT02749370|468130186|FG000|Overall Study|Lost to Follow-up|3|||
130300452|NCT01717326|469062389|FG007|Overall Study|Withdrawal by Subject|0|||
130300453|NCT01717326|469062390|FG008|Overall Study|Withdrawal by Subject|0|||
130300454|NCT01717326|469062391|FG009|Overall Study|Withdrawal by Subject|1|||
130300455|NCT01717326|469062392|FG010|Overall Study|Withdrawal by Subject|0|||
130300456|NCT01717326|469062393|FG011|Overall Study|Withdrawal by Subject|0|||
130300457|NCT01717326|469062394|FG012|Overall Study|Withdrawal by Subject|1|||
130300458|NCT01717326|469062395|FG013|Overall Study|Withdrawal by Subject|0|||
130300459|NCT01717326|469062396|FG014|Overall Study|Withdrawal by Subject|0|||
130300460|NCT01717326|469062397|FG015|Overall Study|Withdrawal by Subject|1|||
130300461|NCT01717326|469062398|FG016|Overall Study|Withdrawal by Subject|0|||
130300462|NCT01717326|469062399|FG017|Overall Study|Withdrawal by Subject|0|||
130300463|NCT01717326|469062400|FG018|Overall Study|Withdrawal by Subject|2|||
130300464|NCT01717326|469062401|FG019|Overall Study|Withdrawal by Subject|3|||
130300465|NCT02262754|469062403|FG000|Overall Study|Adverse Event|3|||
130300466|NCT02262754|469062404|FG001|Overall Study|Adverse Event|4|||
130300467|NCT02262754|469062405|FG002|Overall Study|Adverse Event|0|||
130300468|NCT02262754|469062403|FG000|Overall Study|Lack of Efficacy|2|||
130300469|NCT02262754|469062404|FG001|Overall Study|Lack of Efficacy|0|||
130300470|NCT02262754|469062405|FG002|Overall Study|Lack of Efficacy|1|||
130300471|NCT02262754|469062403|FG000|Overall Study|Lost to Follow-up|0|||
130300472|NCT02262754|469062404|FG001|Overall Study|Lost to Follow-up|0|||
130300473|NCT02262754|469062405|FG002|Overall Study|Lost to Follow-up|1|||
130300474|NCT02262754|469062403|FG000|Overall Study|No longer meets eligibility criteria|0|||
130300475|NCT02262754|469062404|FG001|Overall Study|No longer meets eligibility criteria|1|||
130300476|NCT02262754|469062405|FG002|Overall Study|No longer meets eligibility criteria|0|||
130300477|NCT02262754|469062403|FG000|Overall Study|Study terminated by sponsor|5|||
130300478|NCT02262754|469062404|FG001|Overall Study|Study terminated by sponsor|4|||
130300479|NCT02262754|469062405|FG002|Overall Study|Study terminated by sponsor|4|||
130300480|NCT02262754|469062403|FG000|Overall Study|Protocol Violation|1|||
130300481|NCT02262754|469062404|FG001|Overall Study|Protocol Violation|0|||
130300482|NCT02262754|469062405|FG002|Overall Study|Protocol Violation|0|||
130300483|NCT02262754|469062403|FG000|Overall Study|Withdrawal by Subject|1|||
130300484|NCT02262754|469062404|FG001|Overall Study|Withdrawal by Subject|0|||
130300485|NCT02262754|469062405|FG002|Overall Study|Withdrawal by Subject|1|||
130300486|NCT02262754|469062403|FG000|Overall Study|Other|4|||
130300487|NCT02262754|469062404|FG001|Overall Study|Other|0|||
130300488|NCT02262754|469062405|FG002|Overall Study|Other|2|||
130300489|NCT03208088|469062410|FG000|Period 2|Withdrawal by Subject|0|||
130300490|NCT03208088|469062411|FG001|Period 2|Withdrawal by Subject|0|||
130300491|NCT03208088|469062412|FG002|Period 2|Withdrawal by Subject|0|||
130300492|NCT03208088|469062413|FG003|Period 2|Withdrawal by Subject|0|||
130300493|NCT03208088|469062414|FG004|Period 2|Withdrawal by Subject|0|||
130300494|NCT03208088|469062415|FG005|Period 2|Withdrawal by Subject|0|||
130300495|NCT03208088|469062416|FG006|Period 2|Withdrawal by Subject|0|||
130300496|NCT03208088|469062417|FG007|Period 2|Withdrawal by Subject|0|||
130300497|NCT03208088|469062418|FG008|Period 2|Withdrawal by Subject|1|||
130300498|NCT03208088|469062419|FG009|Period 2|Withdrawal by Subject|0|||
130300499|NCT03208088|469062410|FG000|Period 3|Unsatisfactory Test Article|0|||
130300500|NCT03208088|469062411|FG001|Period 3|Unsatisfactory Test Article|0|||
130300501|NCT03208088|469062412|FG002|Period 3|Unsatisfactory Test Article|0|||
130300502|NCT03208088|469062413|FG003|Period 3|Unsatisfactory Test Article|1|||
130300503|NCT03208088|469062414|FG004|Period 3|Unsatisfactory Test Article|0|||
130300504|NCT03208088|469062415|FG005|Period 3|Unsatisfactory Test Article|0|||
130300505|NCT03208088|469062416|FG006|Period 3|Unsatisfactory Test Article|0|||
130300506|NCT03208088|469062417|FG007|Period 3|Unsatisfactory Test Article|0|||
130300507|NCT03208088|469062418|FG008|Period 3|Unsatisfactory Test Article|0|||
130300508|NCT03208088|469062419|FG009|Period 3|Unsatisfactory Test Article|0|||
130300509|NCT03208088|469062410|FG000|Period 4|Unsatisfactory Test Article|0|||
130300510|NCT03208088|469062411|FG001|Period 4|Unsatisfactory Test Article|0|||
130300511|NCT03208088|469062412|FG002|Period 4|Unsatisfactory Test Article|0|||
130300512|NCT03208088|469062413|FG003|Period 4|Unsatisfactory Test Article|1|||
130300513|NCT03208088|469062414|FG004|Period 4|Unsatisfactory Test Article|0|||
130300514|NCT03208088|469062415|FG005|Period 4|Unsatisfactory Test Article|0|||
130300515|NCT03208088|469062416|FG006|Period 4|Unsatisfactory Test Article|0|||
130300516|NCT03208088|469062417|FG007|Period 4|Unsatisfactory Test Article|0|||
130300517|NCT03208088|469062418|FG008|Period 4|Unsatisfactory Test Article|0|||
130300518|NCT03208088|469062419|FG009|Period 4|Unsatisfactory Test Article|0|||
130300519|NCT02577016|469062420|FG000|Overall Study|Adverse Event|2|||
130300520|NCT02577016|469062421|FG001|Overall Study|Adverse Event|1|||
130300521|NCT02577016|469062420|FG000|Overall Study|Physician Decision|0|||
130300522|NCT02577016|469062421|FG001|Overall Study|Physician Decision|1|||
130300523|NCT02126839|469062422|FG000|Overall Study|Adverse Event|0|||
130300524|NCT02126839|469062423|FG001|Overall Study|Adverse Event|1|||
130300525|NCT02126839|469062422|FG000|Overall Study|Withdrawal by Subject|1|||
130300526|NCT02126839|469062423|FG001|Overall Study|Withdrawal by Subject|0|||
130300527|NCT02126839|469062422|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130300528|NCT02126839|469062423|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130300529|NCT02126839|469062422|FG000|Overall Study|Protocol Violation|2|||
130107441|NCT03591107|468355127|FG001|Overall Study|Sought care at other clinics|2|||
130107442|NCT03591107|468355126|FG000|Overall Study|Discharged from clinic|0|||
130107443|NCT03591107|468355127|FG001|Overall Study|Discharged from clinic|1|||
130107444|NCT03591107|468355126|FG000|Overall Study|Withdrawal by Subject|0|||
130107445|NCT03591107|468355127|FG001|Overall Study|Withdrawal by Subject|1|||
130107446|NCT01902134|468355130|FG000|Overall Study|Adverse Event|3|||
130107447|NCT01902134|468355131|FG001|Overall Study|Adverse Event|1|||
130107448|NCT01902134|468355132|FG002|Overall Study|Adverse Event|2|||
130107449|NCT01902134|468355133|FG003|Overall Study|Adverse Event|1|||
130107450|NCT01902134|468355134|FG004|Overall Study|Adverse Event|1|||
130107451|NCT01902134|468355135|FG005|Overall Study|Adverse Event|3|||
130107452|NCT01902134|468355130|FG000|Overall Study|Lack of Efficacy|0|||
130107453|NCT01902134|468355131|FG001|Overall Study|Lack of Efficacy|0|||
130107454|NCT01902134|468355132|FG002|Overall Study|Lack of Efficacy|2|||
130107455|NCT01902134|468355133|FG003|Overall Study|Lack of Efficacy|0|||
130107456|NCT01902134|468355134|FG004|Overall Study|Lack of Efficacy|0|||
130107457|NCT01902134|468355135|FG005|Overall Study|Lack of Efficacy|1|||
130107458|NCT01902134|468355130|FG000|Overall Study|Physician Decision|0|||
130107459|NCT01902134|468355131|FG001|Overall Study|Physician Decision|1|||
130107460|NCT01902134|468355132|FG002|Overall Study|Physician Decision|0|||
130107461|NCT01902134|468355133|FG003|Overall Study|Physician Decision|0|||
130107462|NCT01902134|468355134|FG004|Overall Study|Physician Decision|0|||
130107463|NCT01902134|468355135|FG005|Overall Study|Physician Decision|0|||
130300530|NCT02126839|469062423|FG001|Overall Study|Protocol Violation|3|||
130300531|NCT02126839|469062422|FG000|Overall Study|Sponsor request|0|||
130300532|NCT02126839|469062423|FG001|Overall Study|Sponsor request|1|||
130300533|NCT02126839|469062422|FG000|Overall Study|Lost to Follow-up|1|||
130300534|NCT02126839|469062423|FG001|Overall Study|Lost to Follow-up|4|||
130300535|NCT02126839|469062422|FG000|Overall Study|Other|5|||
130300536|NCT02126839|469062423|FG001|Overall Study|Other|5|||
130300537|NCT00812565|469062424|FG000|Overall Study|Did Not Receive Study Medication|1|||
130300538|NCT00812565|469062425|FG001|Overall Study|Did Not Receive Study Medication|1|||
130300539|NCT00812565|469062426|FG002|Overall Study|Did Not Receive Study Medication|0|||
130300540|NCT00812565|469062427|FG003|Overall Study|Did Not Receive Study Medication|0|||
130300541|NCT00812565|469062428|FG004|Overall Study|Did Not Receive Study Medication|0|||
130300542|NCT00812565|469062429|FG005|Overall Study|Did Not Receive Study Medication|0|||
130300543|NCT00812565|469062430|FG006|Overall Study|Did Not Receive Study Medication|0|||
130300544|NCT00812565|469062431|FG007|Overall Study|Did Not Receive Study Medication|0|||
130300545|NCT00812565|469062424|FG000|Overall Study|Adverse Event|0|||
130300546|NCT00812565|469062425|FG001|Overall Study|Adverse Event|0|||
130300547|NCT00812565|469062426|FG002|Overall Study|Adverse Event|0|||
130300548|NCT00812565|469062427|FG003|Overall Study|Adverse Event|2|||
130300549|NCT00812565|469062428|FG004|Overall Study|Adverse Event|0|||
130300550|NCT00812565|469062429|FG005|Overall Study|Adverse Event|0|||
130300551|NCT00812565|469062430|FG006|Overall Study|Adverse Event|0|||
130300552|NCT00812565|469062431|FG007|Overall Study|Adverse Event|1|||
130300553|NCT00812565|469062424|FG000|Overall Study|Did Not Come to Study Visit|1|||
130300554|NCT00812565|469062425|FG001|Overall Study|Did Not Come to Study Visit|0|||
130300555|NCT00812565|469062426|FG002|Overall Study|Did Not Come to Study Visit|0|||
130300556|NCT00812565|469062427|FG003|Overall Study|Did Not Come to Study Visit|0|||
130300557|NCT00812565|469062428|FG004|Overall Study|Did Not Come to Study Visit|0|||
130300558|NCT00812565|469062429|FG005|Overall Study|Did Not Come to Study Visit|0|||
130300559|NCT00812565|469062430|FG006|Overall Study|Did Not Come to Study Visit|0|||
130300560|NCT00812565|469062431|FG007|Overall Study|Did Not Come to Study Visit|0|||
130300561|NCT00812565|469062424|FG000|Overall Study|Withdrawal of Consent|1|||
130300562|NCT00812565|469062425|FG001|Overall Study|Withdrawal of Consent|0|||
130300563|NCT00812565|469062426|FG002|Overall Study|Withdrawal of Consent|0|||
130300564|NCT00812565|469062427|FG003|Overall Study|Withdrawal of Consent|0|||
130300565|NCT00812565|469062428|FG004|Overall Study|Withdrawal of Consent|1|||
130300566|NCT00812565|469062429|FG005|Overall Study|Withdrawal of Consent|0|||
130300567|NCT00812565|469062430|FG006|Overall Study|Withdrawal of Consent|0|||
130300568|NCT00812565|469062431|FG007|Overall Study|Withdrawal of Consent|0|||
130300569|NCT00812565|469062424|FG000|Overall Study|Reason Not Specified|0|||
130107464|NCT01902134|468355130|FG000|Overall Study|Protocol Violation|0|||
130107465|NCT01902134|468355131|FG001|Overall Study|Protocol Violation|0|||
130300570|NCT00812565|469062425|FG001|Overall Study|Reason Not Specified|0|||
130300571|NCT00812565|469062426|FG002|Overall Study|Reason Not Specified|0|||
130300572|NCT00812565|469062427|FG003|Overall Study|Reason Not Specified|0|||
130300573|NCT00812565|469062428|FG004|Overall Study|Reason Not Specified|0|||
130300574|NCT00812565|469062429|FG005|Overall Study|Reason Not Specified|1|||
130300575|NCT00812565|469062430|FG006|Overall Study|Reason Not Specified|0|||
130107466|NCT01902134|468355132|FG002|Overall Study|Protocol Violation|0|||
130300576|NCT00812565|469062431|FG007|Overall Study|Reason Not Specified|0|||
130300577|NCT02596945|469062434|FG000|Overall Study|No documentation of study drug dosing|3|||
130300578|NCT02596945|469062434|FG000|Overall Study|Other|32|||
130107467|NCT01902134|468355133|FG003|Overall Study|Protocol Violation|0|||
130107468|NCT01902134|468355134|FG004|Overall Study|Protocol Violation|0|||
130300579|NCT02596945|469062434|FG000|Overall Study|Change to hemodialysis|15|||
130300580|NCT02596945|469062434|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
130300581|NCT02596945|469062434|FG000|Overall Study|Withdrawal by Subject|1|||
130300582|NCT02596945|469062434|FG000|Overall Study|Missing|1|||
130300583|NCT00422383|469062435|FG000|Overall Study|Adverse Event|5|||
130300584|NCT00422383|469062436|FG001|Overall Study|Adverse Event|3|||
130300585|NCT00422383|469062437|FG002|Overall Study|Adverse Event|1|||
130300586|NCT00422383|469062438|FG003|Overall Study|Adverse Event|1|||
130300587|NCT00422383|469062439|FG004|Overall Study|Adverse Event|0|||
130300588|NCT00422383|469062435|FG000|Overall Study|Lack of Efficacy|4|||
130300589|NCT00422383|469062436|FG001|Overall Study|Lack of Efficacy|4|||
130300590|NCT00422383|469062437|FG002|Overall Study|Lack of Efficacy|2|||
130300591|NCT00422383|469062438|FG003|Overall Study|Lack of Efficacy|1|||
130300592|NCT00422383|469062439|FG004|Overall Study|Lack of Efficacy|1|||
130300593|NCT00422383|469062435|FG000|Overall Study|Lost to Follow-up|0|||
130300594|NCT00422383|469062436|FG001|Overall Study|Lost to Follow-up|1|||
130300595|NCT00422383|469062437|FG002|Overall Study|Lost to Follow-up|0|||
130300596|NCT00422383|469062438|FG003|Overall Study|Lost to Follow-up|0|||
130300597|NCT00422383|469062439|FG004|Overall Study|Lost to Follow-up|1|||
130300598|NCT00422383|469062435|FG000|Overall Study|Protocol Violation|1|||
130300599|NCT00422383|469062436|FG001|Overall Study|Protocol Violation|1|||
130300600|NCT00422383|469062437|FG002|Overall Study|Protocol Violation|1|||
130300601|NCT00422383|469062438|FG003|Overall Study|Protocol Violation|0|||
130300602|NCT00422383|469062439|FG004|Overall Study|Protocol Violation|0|||
130300603|NCT00422383|469062435|FG000|Overall Study|Withdrawal by Subject|5|||
130300604|NCT00422383|469062436|FG001|Overall Study|Withdrawal by Subject|5|||
130300605|NCT00422383|469062437|FG002|Overall Study|Withdrawal by Subject|0|||
130300606|NCT00422383|469062438|FG003|Overall Study|Withdrawal by Subject|0|||
130300607|NCT00422383|469062439|FG004|Overall Study|Withdrawal by Subject|1|||
130300608|NCT05066165|469064081|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
130300609|NCT05066165|469064082|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
130300610|NCT05066165|469064081|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
130300611|NCT05066165|469064082|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
130300612|NCT03738618|469064083|FG000|Overall Study|Protocol deviation|23|||
130300613|NCT03738618|469064084|FG001|Overall Study|Protocol deviation|0|||
130300614|NCT03738618|469064083|FG000|Overall Study|Adverse Event|4|||
130300615|NCT03738618|469064084|FG001|Overall Study|Adverse Event|0|||
130300616|NCT03738618|469064083|FG000|Overall Study|Lost to Follow-up|2|||
130300617|NCT03738618|469064084|FG001|Overall Study|Lost to Follow-up|0|||
130300618|NCT03738618|469064083|FG000|Overall Study|Randomization failure|1|||
130300619|NCT03738618|469064084|FG001|Overall Study|Randomization failure|0|||
130300620|NCT03738618|469064083|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
130300621|NCT03738618|469064084|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
130300622|NCT03738618|469064083|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
130300623|NCT03738618|469064084|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
130300624|NCT01769196|469064085|FG000|Overall Study|Adverse Event|24|||
130300625|NCT01769196|469064086|FG001|Overall Study|Adverse Event|20|||
130300626|NCT01769196|469064085|FG000|Overall Study|Death|21|||
130300627|NCT01769196|469064086|FG001|Overall Study|Death|26|||
130300628|NCT01769196|469064085|FG000|Overall Study|Investigator Discretion|7|||
130300629|NCT01769196|469064086|FG001|Overall Study|Investigator Discretion|3|||
130300630|NCT01769196|469064085|FG000|Overall Study|Lack of Efficacy|3|||
130300631|NCT01769196|469064086|FG001|Overall Study|Lack of Efficacy|2|||
130300632|NCT01769196|469064085|FG000|Overall Study|Progressive disease|11|||
130300633|NCT01769196|469064086|FG001|Overall Study|Progressive disease|6|||
130300634|NCT01769196|469064085|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
130300635|NCT01769196|469064086|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
130300636|NCT01769196|469064085|FG000|Overall Study|Protocol Violation|0|||
130300637|NCT01769196|469064086|FG001|Overall Study|Protocol Violation|3|||
130300638|NCT01769196|469064085|FG000|Overall Study|Study terminated by sponsor|160|||
130300639|NCT01769196|469064086|FG001|Overall Study|Study terminated by sponsor|161|||
130300640|NCT01769196|469064085|FG000|Overall Study|Participant never dosed with study drug|1|||
130300641|NCT01769196|469064086|FG001|Overall Study|Participant never dosed with study drug|0|||
130300642|NCT01769196|469064085|FG000|Overall Study|Withdrew consent|36|||
130300643|NCT01769196|469064086|FG001|Overall Study|Withdrew consent|40|||
130300644|NCT01450098|469064093|FG000|Period 3|Protocol Violation|0|||
130300645|NCT01450098|469064094|FG001|Period 3|Protocol Violation|1|||
130300646|NCT01450098|469064093|FG000|Period 3|Withdrawal by Subject|0|||
130300647|NCT01450098|469064094|FG001|Period 3|Withdrawal by Subject|2|||
130300648|NCT00655629|469064095|FG000|Overall Study|Adverse Event|4|||
130300649|NCT00655629|469064096|FG001|Overall Study|Adverse Event|1|||
130300650|NCT00655629|469064095|FG000|Overall Study|Lack of Efficacy|2|||
130300651|NCT00655629|469064096|FG001|Overall Study|Lack of Efficacy|12|||
130300652|NCT00655629|469064095|FG000|Overall Study|Lost to Follow-up|4|||
130300653|NCT00655629|469064096|FG001|Overall Study|Lost to Follow-up|3|||
130300654|NCT00655629|469064095|FG000|Overall Study|Protocol Violation|5|||
130300655|NCT00655629|469064096|FG001|Overall Study|Protocol Violation|3|||
130300656|NCT00655629|469064095|FG000|Overall Study|consent withdrawn|6|||
130300657|NCT00655629|469064096|FG001|Overall Study|consent withdrawn|4|||
130300658|NCT00705367|469064097|FG000|Long-term Extension Period|Adverse Event|2|||
130300659|NCT00705367|469064098|FG001|Long-term Extension Period|Adverse Event|0|||
130300660|NCT00705367|469064097|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
130300661|NCT00705367|469064098|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
130300662|NCT00705367|469064097|FG000|Long-term Extension Period|Lack of Efficacy|1|||
130300663|NCT00705367|469064098|FG001|Long-term Extension Period|Lack of Efficacy|0|||
130300664|NCT00705367|469064097|FG000|Long-term Extension Period|No longer met study criteria|1|||
130300665|NCT00705367|469064098|FG001|Long-term Extension Period|No longer met study criteria|0|||
130300666|NCT00705367|469064097|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
130300667|NCT00705367|469064098|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
130300668|NCT01832155|469064099|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
130300669|NCT01832155|469064100|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
130300670|NCT01832155|469064099|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
130300671|NCT01832155|469064100|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
130300672|NCT01055314|469064101|FG000|Overall Study|Adverse Event|7|||
130300673|NCT01055314|469064102|FG001|Overall Study|Adverse Event|4|||
130300674|NCT01055314|469064101|FG000|Overall Study|Death|2|||
130300675|NCT01055314|469064102|FG001|Overall Study|Death|1|||
130300676|NCT01055314|469064101|FG000|Overall Study|Lack of Efficacy|11|||
130300677|NCT01055314|469064102|FG001|Overall Study|Lack of Efficacy|19|||
130300678|NCT01055314|469064101|FG000|Overall Study|Physician Decision|10|||
130300679|NCT01055314|469064102|FG001|Overall Study|Physician Decision|5|||
130300680|NCT01055314|469064101|FG000|Overall Study|Withdrawal by Subject|1|||
130300681|NCT01055314|469064102|FG001|Overall Study|Withdrawal by Subject|0|||
130300682|NCT01055314|469064101|FG000|Overall Study|Ineligible|3|||
130300683|NCT01055314|469064102|FG001|Overall Study|Ineligible|5|||
130300684|NCT01055314|469064101|FG000|Overall Study|Refusal of further protocol therapy|10|||
130300685|NCT01055314|469064102|FG001|Overall Study|Refusal of further protocol therapy|4|||
130300686|NCT01055314|469064101|FG000|Overall Study|No treatment|1|||
130300687|NCT01055314|469064102|FG001|Overall Study|No treatment|0|||
130300688|NCT01279616|469064103|FG000|Overall Study|donor could not be located|5|||
130300689|NCT01279616|469064103|FG000|Overall Study|no signs of sickle cell disease|2|||
130300690|NCT02462720|469064104|FG000|Part 2|Withdrawal by Subject|1|||
130300691|NCT02462720|469064105|FG001|Part 2|Withdrawal by Subject|0|||
130300692|NCT02462720|469064104|FG000|Part 2|Protocol Violation|0|||
130300693|NCT02462720|469064105|FG001|Part 2|Protocol Violation|1|||
130300694|NCT00183625|469064108|FG000|Overall Study|Withdrawal by Subject|18|||
130300695|NCT00183625|469064109|FG001|Overall Study|Withdrawal by Subject|18|||
130300696|NCT00183625|469064110|FG002|Overall Study|Withdrawal by Subject|19|||
130300697|NCT00183625|469064111|FG003|Overall Study|Withdrawal by Subject|14|||
130107469|NCT01902134|468355135|FG005|Overall Study|Protocol Violation|1|||
130300698|NCT05249569|469064114|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
130300699|NCT02678923|469064115|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
130300700|NCT02678923|469064116|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
130300701|NCT02678923|469064115|FG000|Overall Study|Withdrawal by Subject|3|||
130300702|NCT02678923|469064116|FG001|Overall Study|Withdrawal by Subject|2|||
130300703|NCT02678923|469064115|FG000|Overall Study|Lost to Follow-up|1|||
130300704|NCT02678923|469064116|FG001|Overall Study|Lost to Follow-up|0|||
130300705|NCT02678923|469064115|FG000|Overall Study|Did Not Return for Study Visits|1|||
130300706|NCT02678923|469064116|FG001|Overall Study|Did Not Return for Study Visits|0|||
130300707|NCT00098306|469064119|FG000|Double Blind|Randomized, not treated|9|||
130300708|NCT00098306|469064120|FG001|Double Blind|Randomized, not treated|5|||
130300709|NCT00098306|469064121|FG002|Double Blind|Randomized, not treated|2|||
130300710|NCT00098306|469064122|FG003|Double Blind|Randomized, not treated|0|||
130300711|NCT00098306|469064123|FG004|Double Blind|Randomized, not treated|0|||
130300712|NCT00098306|469064124|FG005|Double Blind|Randomized, not treated|0|||
130300713|NCT00098306|469064125|FG006|Double Blind|Randomized, not treated|0|||
130300714|NCT00098306|469064119|FG000|Double Blind|Ongoing at cut-off date|151|||
130300715|NCT00098306|469064120|FG001|Double Blind|Ongoing at cut-off date|166|||
130300716|NCT00098306|469064121|FG002|Double Blind|Ongoing at cut-off date|72|||
130300717|NCT00098306|469064122|FG003|Double Blind|Ongoing at cut-off date|0|||
130300718|NCT00098306|469064123|FG004|Double Blind|Ongoing at cut-off date|0|||
130300719|NCT00098306|469064124|FG005|Double Blind|Ongoing at cut-off date|0|||
130300720|NCT00098306|469064125|FG006|Double Blind|Ongoing at cut-off date|0|||
130300721|NCT00098306|469064119|FG000|Double Blind|Adverse Event|11|||
130300722|NCT00098306|469064120|FG001|Double Blind|Adverse Event|10|||
130300723|NCT00098306|469064121|FG002|Double Blind|Adverse Event|6|||
130300724|NCT00098306|469064122|FG003|Double Blind|Adverse Event|0|||
130300725|NCT00098306|469064123|FG004|Double Blind|Adverse Event|0|||
130300726|NCT00098306|469064124|FG005|Double Blind|Adverse Event|0|||
130300727|NCT00098306|469064125|FG006|Double Blind|Adverse Event|0|||
130300728|NCT00098306|469064119|FG000|Double Blind|Lack of Efficacy|43|||
130300729|NCT00098306|469064120|FG001|Double Blind|Lack of Efficacy|34|||
130300730|NCT00098306|469064121|FG002|Double Blind|Lack of Efficacy|17|||
130300731|NCT00098306|469064122|FG003|Double Blind|Lack of Efficacy|0|||
130300732|NCT00098306|469064123|FG004|Double Blind|Lack of Efficacy|0|||
130300733|NCT00098306|469064124|FG005|Double Blind|Lack of Efficacy|0|||
130300734|NCT00098306|469064125|FG006|Double Blind|Lack of Efficacy|0|||
130300735|NCT00098306|469064119|FG000|Double Blind|Death|1|||
130300736|NCT00098306|469064120|FG001|Double Blind|Death|4|||
130300737|NCT00098306|469064121|FG002|Double Blind|Death|1|||
130300738|NCT00098306|469064122|FG003|Double Blind|Death|0|||
130300739|NCT00098306|469064123|FG004|Double Blind|Death|0|||
130300740|NCT00098306|469064124|FG005|Double Blind|Death|0|||
130300741|NCT00098306|469064125|FG006|Double Blind|Death|0|||
130300742|NCT00098306|469064119|FG000|Double Blind|Participant defaulted|19|||
130300743|NCT00098306|469064120|FG001|Double Blind|Participant defaulted|18|||
130300744|NCT00098306|469064121|FG002|Double Blind|Participant defaulted|11|||
130300745|NCT00098306|469064122|FG003|Double Blind|Participant defaulted|0|||
130300746|NCT00098306|469064123|FG004|Double Blind|Participant defaulted|0|||
130300747|NCT00098306|469064124|FG005|Double Blind|Participant defaulted|0|||
130300748|NCT00098306|469064125|FG006|Double Blind|Participant defaulted|0|||
130300749|NCT00098306|469064119|FG000|Double Blind|Un-specified|7|||
130300750|NCT00098306|469064120|FG001|Double Blind|Un-specified|3|||
130300751|NCT00098306|469064121|FG002|Double Blind|Un-specified|11|||
130300752|NCT00098306|469064122|FG003|Double Blind|Un-specified|0|||
130300753|NCT00098306|469064123|FG004|Double Blind|Un-specified|0|||
130300754|NCT00098306|469064124|FG005|Double Blind|Un-specified|0|||
130300755|NCT00098306|469064125|FG006|Double Blind|Un-specified|0|||
130300756|NCT00098306|469064119|FG000|Open Label|Lack of Efficacy|0|||
130300757|NCT00098306|469064120|FG001|Open Label|Lack of Efficacy|0|||
130300758|NCT00098306|469064121|FG002|Open Label|Lack of Efficacy|0|||
130300759|NCT00098306|469064122|FG003|Open Label|Lack of Efficacy|13|||
130300760|NCT00098306|469064123|FG004|Open Label|Lack of Efficacy|0|||
130300761|NCT00098306|469064124|FG005|Open Label|Lack of Efficacy|0|||
130300762|NCT00098306|469064125|FG006|Open Label|Lack of Efficacy|0|||
130300763|NCT00098306|469064119|FG000|Open Label|Adverse Event|0|||
130300764|NCT00098306|469064120|FG001|Open Label|Adverse Event|0|||
130300765|NCT00098306|469064121|FG002|Open Label|Adverse Event|0|||
130300766|NCT00098306|469064122|FG003|Open Label|Adverse Event|2|||
130300767|NCT00098306|469064123|FG004|Open Label|Adverse Event|0|||
130300768|NCT00098306|469064124|FG005|Open Label|Adverse Event|0|||
130300769|NCT00098306|469064125|FG006|Open Label|Adverse Event|0|||
130300770|NCT00098306|469064119|FG000|Open Label|Death|0|||
130300771|NCT00098306|469064120|FG001|Open Label|Death|0|||
130300772|NCT00098306|469064121|FG002|Open Label|Death|0|||
130300773|NCT00098306|469064122|FG003|Open Label|Death|4|||
130300774|NCT00098306|469064123|FG004|Open Label|Death|0|||
130300775|NCT00098306|469064124|FG005|Open Label|Death|0|||
130300776|NCT00098306|469064125|FG006|Open Label|Death|0|||
130300777|NCT00098306|469064119|FG000|Open Label|Participant defaulted|0|||
130300778|NCT00098306|469064120|FG001|Open Label|Participant defaulted|0|||
130300779|NCT00098306|469064121|FG002|Open Label|Participant defaulted|0|||
130300780|NCT00098306|469064122|FG003|Open Label|Participant defaulted|24|||
130300781|NCT00098306|469064123|FG004|Open Label|Participant defaulted|0|||
130300782|NCT00098306|469064124|FG005|Open Label|Participant defaulted|0|||
130300783|NCT00098306|469064125|FG006|Open Label|Participant defaulted|0|||
130300784|NCT00098306|469064119|FG000|Open Label|Un-specified|0|||
130300785|NCT00098306|469064120|FG001|Open Label|Un-specified|0|||
130300786|NCT00098306|469064121|FG002|Open Label|Un-specified|0|||
130300787|NCT00098306|469064122|FG003|Open Label|Un-specified|15|||
130300788|NCT00098306|469064123|FG004|Open Label|Un-specified|0|||
130300789|NCT00098306|469064124|FG005|Open Label|Un-specified|0|||
130300790|NCT00098306|469064125|FG006|Open Label|Un-specified|0|||
130300791|NCT00098306|469064119|FG000|Open Label|Ongoing at cut-off date|0|||
130300792|NCT00098306|469064120|FG001|Open Label|Ongoing at cut-off date|0|||
130300793|NCT00098306|469064121|FG002|Open Label|Ongoing at cut-off date|0|||
130300794|NCT00098306|469064122|FG003|Open Label|Ongoing at cut-off date|269|||
130300795|NCT00098306|469064123|FG004|Open Label|Ongoing at cut-off date|62|||
130300796|NCT00098306|469064124|FG005|Open Label|Ongoing at cut-off date|0|||
130300797|NCT00098306|469064125|FG006|Open Label|Ongoing at cut-off date|0|||
130300798|NCT00098306|469064119|FG000|Observational Phase|Death|0|||
130300799|NCT00098306|469064120|FG001|Observational Phase|Death|0|||
130300800|NCT00098306|469064121|FG002|Observational Phase|Death|0|||
130300801|NCT00098306|469064122|FG003|Observational Phase|Death|0|||
130300802|NCT00098306|469064123|FG004|Observational Phase|Death|0|||
130300803|NCT00098306|469064124|FG005|Observational Phase|Death|5|||
130300804|NCT00098306|469064125|FG006|Observational Phase|Death|4|||
130300805|NCT00098306|469064119|FG000|Observational Phase|Participant defaulted|0|||
130300806|NCT00098306|469064120|FG001|Observational Phase|Participant defaulted|0|||
130300807|NCT00098306|469064121|FG002|Observational Phase|Participant defaulted|0|||
130300808|NCT00098306|469064122|FG003|Observational Phase|Participant defaulted|0|||
130300809|NCT00098306|469064123|FG004|Observational Phase|Participant defaulted|0|||
130300810|NCT00098306|469064124|FG005|Observational Phase|Participant defaulted|34|||
130300811|NCT00098306|469064125|FG006|Observational Phase|Participant defaulted|18|||
130300812|NCT00098306|469064119|FG000|Observational Phase|Un-specified|0|||
130300813|NCT00098306|469064120|FG001|Observational Phase|Un-specified|0|||
130300814|NCT00098306|469064121|FG002|Observational Phase|Un-specified|0|||
130300815|NCT00098306|469064122|FG003|Observational Phase|Un-specified|0|||
130300816|NCT00098306|469064123|FG004|Observational Phase|Un-specified|0|||
130300817|NCT00098306|469064124|FG005|Observational Phase|Un-specified|7|||
130300818|NCT00098306|469064125|FG006|Observational Phase|Un-specified|4|||
130300819|NCT01423916|469064126|FG000|Overall Study|Adverse Event|5|||
130300820|NCT01423916|469064127|FG001|Overall Study|Adverse Event|9|||
130300821|NCT01423916|469064128|FG002|Overall Study|Adverse Event|2|||
130300822|NCT01423916|469064126|FG000|Overall Study|Met Withdrawal Criteria|1|||
130300823|NCT01423916|469064127|FG001|Overall Study|Met Withdrawal Criteria|1|||
130300824|NCT01423916|469064128|FG002|Overall Study|Met Withdrawal Criteria|1|||
130300825|NCT01423916|469064126|FG000|Overall Study|Physician Decision|1|||
130300826|NCT01423916|469064127|FG001|Overall Study|Physician Decision|0|||
130300827|NCT01423916|469064128|FG002|Overall Study|Physician Decision|1|||
130300828|NCT01423916|469064126|FG000|Overall Study|Withdrawal by Subject|3|||
130300829|NCT01423916|469064127|FG001|Overall Study|Withdrawal by Subject|10|||
130300830|NCT01423916|469064128|FG002|Overall Study|Withdrawal by Subject|3|||
130300831|NCT01423916|469064126|FG000|Overall Study|Protocol Deviation|1|||
130300832|NCT01423916|469064127|FG001|Overall Study|Protocol Deviation|0|||
130300833|NCT01423916|469064128|FG002|Overall Study|Protocol Deviation|0|||
130300834|NCT01966445|469064131|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300835|NCT01966445|469064132|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300836|NCT01966445|469064133|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300837|NCT01966445|469064134|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
130300838|NCT01966445|469064135|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
130300839|NCT01966445|469064136|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
130300840|NCT01966445|469064137|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129889080|NCT01349660|467551007|FG000|Overall Study|Still Receiving Study Treatment|0|||
129889081|NCT01349660|467551008|FG001|Overall Study|Still Receiving Study Treatment|0|||
130300841|NCT01966445|469064131|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300842|NCT01966445|469064132|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130300843|NCT01966445|469064133|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300844|NCT01966445|469064134|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130300845|NCT01966445|469064135|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
130300846|NCT01966445|469064136|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300847|NCT01966445|469064137|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
130300848|NCT01966445|469064131|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300849|NCT01966445|469064132|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
130300850|NCT01966445|469064133|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
130300851|NCT01966445|469064134|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300852|NCT01966445|469064135|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
130300853|NCT01966445|469064136|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300854|NCT01966445|469064137|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
130300855|NCT01966445|469064131|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300856|NCT01966445|469064132|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300857|NCT01966445|469064133|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300858|NCT01966445|469064134|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300859|NCT01966445|469064135|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300860|NCT01966445|469064136|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
130300861|NCT01966445|469064137|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
130300862|NCT01966445|469064131|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300863|NCT01966445|469064132|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300864|NCT01966445|469064133|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300865|NCT01966445|469064134|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300866|NCT01966445|469064135|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300867|NCT01966445|469064136|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
130300868|NCT01966445|469064137|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
130300869|NCT01374178|469064140|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
130300870|NCT01374178|469064141|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
130300871|NCT01374178|469064140|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
130300872|NCT01374178|469064141|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
130300873|NCT04856904|469064144|FG000|Overall Study|Physician Decision|1|||
130300874|NCT04856904|469064145|FG001|Overall Study|Physician Decision|1|||
130300875|NCT04856904|469064144|FG000|Overall Study|Withdrawal by Subject|13|||
130300876|NCT04856904|469064145|FG001|Overall Study|Withdrawal by Subject|13|||
130300877|NCT04856904|469064144|FG000|Overall Study|Adverse Event|1|||
130300878|NCT04856904|469064145|FG001|Overall Study|Adverse Event|1|||
130300879|NCT04856904|469064144|FG000|Overall Study|Non-compliance with study drug|1|||
130300880|NCT04856904|469064145|FG001|Overall Study|Non-compliance with study drug|1|||
130300881|NCT04856904|469064144|FG000|Overall Study|Lost to Follow-up|4|||
130300882|NCT04856904|469064145|FG001|Overall Study|Lost to Follow-up|4|||
130300883|NCT04856904|469064144|FG000|Overall Study|Withdrawal by Subject|1|||
130300884|NCT04856904|469064145|FG001|Overall Study|Withdrawal by Subject|1|||
130300885|NCT04856904|469064144|FG000|Overall Study|Protocol Violation|1|||
130300886|NCT04856904|469064145|FG001|Overall Study|Protocol Violation|1|||
130300887|NCT00077649|469064146|FG000|Overall Study|Adverse Event|5|||
130300888|NCT00077649|469064147|FG001|Overall Study|Adverse Event|1|||
130300889|NCT00077649|469064148|FG002|Overall Study|Adverse Event|7|||
130300890|NCT00077649|469064149|FG003|Overall Study|Adverse Event|9|||
130300891|NCT00077649|469064146|FG000|Overall Study|Lack of Efficacy|5|||
130300892|NCT00077649|469064147|FG001|Overall Study|Lack of Efficacy|3|||
130300893|NCT00077649|469064148|FG002|Overall Study|Lack of Efficacy|3|||
130300894|NCT00077649|469064149|FG003|Overall Study|Lack of Efficacy|2|||
130300895|NCT00077649|469064146|FG000|Overall Study|Withdrawal by Subject|0|||
130300896|NCT00077649|469064147|FG001|Overall Study|Withdrawal by Subject|1|||
130300897|NCT00077649|469064148|FG002|Overall Study|Withdrawal by Subject|1|||
130300898|NCT00077649|469064149|FG003|Overall Study|Withdrawal by Subject|2|||
130300899|NCT00077649|469064146|FG000|Overall Study|Lost to Follow-up|2|||
130300900|NCT00077649|469064147|FG001|Overall Study|Lost to Follow-up|2|||
130300901|NCT00077649|469064148|FG002|Overall Study|Lost to Follow-up|3|||
130300902|NCT00077649|469064149|FG003|Overall Study|Lost to Follow-up|2|||
130300903|NCT00077649|469064146|FG000|Overall Study|Abnormality of Laboratory Test|1|||
130300904|NCT00077649|469064147|FG001|Overall Study|Abnormality of Laboratory Test|2|||
130300905|NCT00077649|469064148|FG002|Overall Study|Abnormality of Laboratory Test|1|||
130300906|NCT00077649|469064149|FG003|Overall Study|Abnormality of Laboratory Test|2|||
130300907|NCT00077649|469064146|FG000|Overall Study|Randomized but never dosed|1|||
130300908|NCT00077649|469064147|FG001|Overall Study|Randomized but never dosed|0|||
130300909|NCT00077649|469064148|FG002|Overall Study|Randomized but never dosed|0|||
130300910|NCT00077649|469064149|FG003|Overall Study|Randomized but never dosed|0|||
130300911|NCT01641822|469064150|FG000|Run-in Phase|Noncompliance with study drug|1|||
130300912|NCT01641822|469064151|FG001|Run-in Phase|Noncompliance with study drug|0|||
130300913|NCT01641822|469064152|FG002|Run-in Phase|Noncompliance with study drug|0|||
130300914|NCT01641822|469064150|FG000|Run-in Phase|Adverse Event|3|||
130300915|NCT01641822|469064151|FG001|Run-in Phase|Adverse Event|0|||
130300916|NCT01641822|469064152|FG002|Run-in Phase|Adverse Event|0|||
130300917|NCT01641822|469064150|FG000|Run-in Phase|Withdrew consent|1|||
130300918|NCT01641822|469064151|FG001|Run-in Phase|Withdrew consent|0|||
130300919|NCT01641822|469064152|FG002|Run-in Phase|Withdrew consent|0|||
130300920|NCT01641822|469064150|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
130300921|NCT01641822|469064151|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
129889082|NCT01349660|467551009|FG002|Overall Study|Still Receiving Study Treatment|1|||
129889083|NCT01349660|467551007|FG000|Overall Study|Disease Progression|2|||
129889084|NCT01349660|467551008|FG001|Overall Study|Disease Progression|4|||
130047565|NCT03242759|468130187|FG000|Overall Study|Adverse Event|5|||
130047566|NCT03242759|468130188|FG001|Overall Study|Adverse Event|1|||
130300922|NCT01641822|469064152|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
130300923|NCT01641822|469064150|FG000|Comparative Phase|Noncompliance with study drug|0|||
130300924|NCT01641822|469064151|FG001|Comparative Phase|Noncompliance with study drug|1|||
130300925|NCT01641822|469064152|FG002|Comparative Phase|Noncompliance with study drug|0|||
130300926|NCT01641822|469064150|FG000|Comparative Phase|Investigator's discretion|0|||
130300927|NCT01641822|469064151|FG001|Comparative Phase|Investigator's discretion|0|||
130300928|NCT01641822|469064152|FG002|Comparative Phase|Investigator's discretion|1|||
130300929|NCT01641822|469064150|FG000|Comparative Phase|Pregnancy|0|||
130300930|NCT01641822|469064151|FG001|Comparative Phase|Pregnancy|0|||
130300931|NCT01641822|469064152|FG002|Comparative Phase|Pregnancy|1|||
130300932|NCT01641822|469064150|FG000|Comparative Phase|Adverse event, serious fatal|0|||
130300933|NCT01641822|469064151|FG001|Comparative Phase|Adverse event, serious fatal|1|||
130300934|NCT01641822|469064152|FG002|Comparative Phase|Adverse event, serious fatal|0|||
130300935|NCT01641822|469064150|FG000|Comparative Phase|Withdrew consent|0|||
130300936|NCT01641822|469064151|FG001|Comparative Phase|Withdrew consent|3|||
130300937|NCT01641822|469064152|FG002|Comparative Phase|Withdrew consent|7|||
130300938|NCT01641822|469064150|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
130300939|NCT01641822|469064151|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
130300940|NCT01641822|469064152|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
130300941|NCT02421601|469064153|FG000|Overall Study|Adverse Event|4|||
130300942|NCT02421601|469064153|FG000|Overall Study|Lack of Efficacy|5|||
130300943|NCT02421601|469064153|FG000|Overall Study|Physician Decision|1|||
130300944|NCT02421601|469064153|FG000|Overall Study|Withdrawal by Subject|31|||
130300945|NCT02421601|469064153|FG000|Overall Study|Others|41|||
130300946|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
130300947|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
130300948|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
130300949|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
130300950|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
130300951|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
130300952|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
130300953|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
130300954|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
130300955|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
130300956|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
130300957|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
130300958|NCT00599638|469064154|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
130300959|NCT00599638|469064155|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
130300960|NCT00599638|469064156|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
130300961|NCT00599638|469064157|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
130300962|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130300963|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
130300964|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
130300965|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130300966|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
130300967|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
130300968|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
130300969|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
130300970|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130300971|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130300972|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
130300973|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
130300974|NCT00599638|469064154|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
130300975|NCT00599638|469064155|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
130300976|NCT00599638|469064156|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
130300977|NCT00599638|469064157|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
130300978|NCT00599638|469064154|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
130300979|NCT00599638|469064155|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130300980|NCT00599638|469064156|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130300981|NCT00599638|469064157|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
130300982|NCT02895945|469064160|FG000|Overall Study|Physician Decision|2|||
130300983|NCT02895945|469064161|FG001|Overall Study|Physician Decision|1|||
130300984|NCT01026220|469064165|FG000|Induction|Death|1|||
130047567|NCT03242759|468130187|FG000|Overall Study|Withdrawal by Subject|4|||
130300985|NCT01026220|469064166|FG001|Induction|Death|0|||
130300986|NCT01026220|469064167|FG002|Induction|Death|0|||
130300987|NCT01026220|469064165|FG000|Induction|Lack of Efficacy|2|||
130300988|NCT01026220|469064166|FG001|Induction|Lack of Efficacy|0|||
130300989|NCT01026220|469064167|FG002|Induction|Lack of Efficacy|0|||
130300990|NCT01026220|469064165|FG000|Induction|Physician Decision|12|||
130300991|NCT01026220|469064166|FG001|Induction|Physician Decision|0|||
130300992|NCT01026220|469064167|FG002|Induction|Physician Decision|0|||
130300993|NCT01026220|469064165|FG000|Induction|Withdrawal by Subject|9|||
130300994|NCT01026220|469064166|FG001|Induction|Withdrawal by Subject|0|||
130300995|NCT01026220|469064167|FG002|Induction|Withdrawal by Subject|0|||
130300996|NCT01026220|469064165|FG000|Induction|Ineligible|1|||
130300997|NCT01026220|469064166|FG001|Induction|Ineligible|0|||
130300998|NCT01026220|469064167|FG002|Induction|Ineligible|0|||
130300999|NCT01026220|469064165|FG000|Consolidation Maintenance|Death|0|||
130301000|NCT01026220|469064166|FG001|Consolidation Maintenance|Death|1|||
130301001|NCT01026220|469064167|FG002|Consolidation Maintenance|Death|0|||
130301002|NCT01026220|469064165|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
130301003|NCT01026220|469064166|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
130301004|NCT01026220|469064167|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
130301005|NCT01026220|469064165|FG000|Consolidation Maintenance|Physician Decision|0|||
130301006|NCT01026220|469064166|FG001|Consolidation Maintenance|Physician Decision|2|||
130301007|NCT01026220|469064167|FG002|Consolidation Maintenance|Physician Decision|7|||
130301008|NCT01026220|469064165|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
130301009|NCT01026220|469064166|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
130301010|NCT01026220|469064167|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
130301011|NCT03550404|469064168|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
130301012|NCT03550404|469064169|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
130301013|NCT03550404|469064170|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
130301014|NCT03550404|469064168|FG000|Phase 2|Vacated position|1|||
130301015|NCT03550404|469064169|FG001|Phase 2|Vacated position|0|||
130301016|NCT03550404|469064170|FG002|Phase 2|Vacated position|0|||
130301017|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
130301018|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
130301019|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
130301020|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
130301021|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
130301022|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
130301023|NCT01389323|469064172|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
130301024|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
130301025|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
130301026|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
130301027|NCT01389323|469064172|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
130301028|NCT05096312|469064173|FG000|Overall Study|Lost to Follow-up|2|||
130301029|NCT05096312|469064174|FG001|Overall Study|Lost to Follow-up|4|||
130301030|NCT05096312|469064173|FG000|Overall Study|Adverse Event|1|||
130301031|NCT05096312|469064174|FG001|Overall Study|Adverse Event|0|||
130301032|NCT00844558|469064176|FG000|Overall Study|Withdrawal by Subject|9|||
130301033|NCT00844558|469064177|FG001|Overall Study|Withdrawal by Subject|2|||
130301034|NCT00844558|469064176|FG000|Overall Study|Death|1|||
130301035|NCT00844558|469064177|FG001|Overall Study|Death|0|||
130301036|NCT00844558|469064176|FG000|Overall Study|Protocol Violation|1|||
130301037|NCT00844558|469064177|FG001|Overall Study|Protocol Violation|1|||
130301038|NCT00844558|469064176|FG000|Overall Study|Lost to Follow-up|0|||
130301039|NCT00844558|469064177|FG001|Overall Study|Lost to Follow-up|1|||
130301040|NCT00844558|469064176|FG000|Overall Study|Physician Decision|1|||
130301041|NCT00844558|469064177|FG001|Overall Study|Physician Decision|0|||
130301042|NCT01894022|469064193|FG000|Overall Study|Death|1|||
130301043|NCT01894022|469064194|FG001|Overall Study|Death|0|||
130301044|NCT01894022|469064193|FG000|Overall Study|Adverse Event, non-fatal|1|||
130301045|NCT01894022|469064194|FG001|Overall Study|Adverse Event, non-fatal|0|||
130301046|NCT01894022|469064193|FG000|Overall Study|Study Closed/terminated|7|||
130301047|NCT01894022|469064194|FG001|Overall Study|Study Closed/terminated|10|||
130301048|NCT04294147|469064203|FG000|Overall Study|Protocol Violation|2|||
130301049|NCT04294147|469064204|FG001|Overall Study|Protocol Violation|0|||
130301050|NCT05392803|469064205|FG000|Overall Study|Lost to Follow-up|0|||
130301051|NCT05392803|469064206|FG001|Overall Study|Lost to Follow-up|2|||
130301052|NCT01887353|469064209|FG000|Overall Study|Study stopped early|4|||
130301053|NCT01887353|469064210|FG001|Overall Study|Study stopped early|3|||
130301054|NCT00699335|469064211|FG000|Overall Study|Combination of multiple reasons|176|||
130301055|NCT00699335|469064211|FG000|Overall Study|Missing data|52|||
130047568|NCT03242759|468130188|FG001|Overall Study|Withdrawal by Subject|3|||
130301056|NCT01069705|469064212|FG000|Overall Study|Adverse Event|1|||
130301057|NCT01069705|469064212|FG000|Overall Study|Withdrawal by Subject|2|||
130301058|NCT02999633|469064213|FG000|Overall Study|Adverse Event|2|||
130047569|NCT03242759|468130187|FG000|Overall Study|Lost to Follow-up|3|||
130301059|NCT02999633|469064213|FG000|Overall Study|Progressive disease|12|||
130047570|NCT03242759|468130188|FG001|Overall Study|Lost to Follow-up|1|||
130301060|NCT03262441|469064214|FG000|Overall Study|Withdrawal by Subject|1|||
130301061|NCT01545050|469064215|FG000|Overall Study|Lack of Efficacy|0|||
130301062|NCT01545050|469064216|FG001|Overall Study|Lack of Efficacy|0|||
130301063|NCT01545050|469064217|FG002|Overall Study|Lack of Efficacy|0|||
130301064|NCT01545050|469064218|FG003|Overall Study|Lack of Efficacy|3|||
130301065|NCT01545050|469064219|FG004|Overall Study|Lack of Efficacy|2|||
130301066|NCT01545050|469064215|FG000|Overall Study|Adverse Event|1|||
130301067|NCT01545050|469064216|FG001|Overall Study|Adverse Event|1|||
130301068|NCT01545050|469064217|FG002|Overall Study|Adverse Event|2|||
130301069|NCT01545050|469064218|FG003|Overall Study|Adverse Event|2|||
130301070|NCT01545050|469064219|FG004|Overall Study|Adverse Event|0|||
130301071|NCT01545050|469064215|FG000|Overall Study|Discontinued study treatment|1|||
130301072|NCT01545050|469064216|FG001|Overall Study|Discontinued study treatment|0|||
130301073|NCT01545050|469064217|FG002|Overall Study|Discontinued study treatment|0|||
130301074|NCT01545050|469064218|FG003|Overall Study|Discontinued study treatment|0|||
130301075|NCT01545050|469064219|FG004|Overall Study|Discontinued study treatment|0|||
130301076|NCT01545050|469064215|FG000|Overall Study|Withdrawal by Subject|1|||
130301077|NCT01545050|469064216|FG001|Overall Study|Withdrawal by Subject|0|||
130301078|NCT01545050|469064217|FG002|Overall Study|Withdrawal by Subject|0|||
130301079|NCT01545050|469064218|FG003|Overall Study|Withdrawal by Subject|2|||
130301080|NCT01545050|469064219|FG004|Overall Study|Withdrawal by Subject|1|||
130301081|NCT01545050|469064215|FG000|Overall Study|Participant no longer meets study criteria|0|||
130301082|NCT01545050|469064216|FG001|Overall Study|Participant no longer meets study criteria|2|||
130301083|NCT01545050|469064217|FG002|Overall Study|Participant no longer meets study criteria|0|||
130301084|NCT01545050|469064218|FG003|Overall Study|Participant no longer meets study criteria|0|||
130301085|NCT01545050|469064219|FG004|Overall Study|Participant no longer meets study criteria|1|||
130301086|NCT01545050|469064215|FG000|Overall Study|Administrative reason by sponsor|4|||
130301087|NCT01545050|469064216|FG001|Overall Study|Administrative reason by sponsor|2|||
130301088|NCT01545050|469064217|FG002|Overall Study|Administrative reason by sponsor|3|||
130301089|NCT01545050|469064218|FG003|Overall Study|Administrative reason by sponsor|5|||
130301090|NCT01545050|469064219|FG004|Overall Study|Administrative reason by sponsor|5|||
130301091|NCT03235089|469064220|FG000|Overall Study|Lost to Follow-up|1|||
130301092|NCT03235089|469064221|FG001|Overall Study|Lost to Follow-up|1|||
130301093|NCT03235089|469064220|FG000|Overall Study|Physician Decision|2|||
130301094|NCT03235089|469064221|FG001|Overall Study|Physician Decision|2|||
130301095|NCT03238924|469064222|FG000|Overall Study|Withdrawal by Subject|2|||
130301096|NCT03238924|469064223|FG001|Overall Study|Withdrawal by Subject|2|||
130301097|NCT04667104|469064226|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
130301098|NCT04667104|469064227|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
130301099|NCT04667104|469064228|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
130301100|NCT02188849|469064229|FG000|Overall Study|Lost to Follow-up|3|||
130301101|NCT02188849|469064230|FG001|Overall Study|Lost to Follow-up|8|||
130301102|NCT01630889|469064231|FG000|Overall Study|Death|2|||
130301103|NCT01630889|469064231|FG000|Overall Study|Withdrawal by Subject|1|||
130301104|NCT01630889|469064231|FG000|Overall Study|Other than Specified|2|||
130301105|NCT01630889|469064231|FG000|Overall Study|Lost to Follow-up|4|||
130301106|NCT01630889|469064231|FG000|Overall Study|Other|1|||
130301107|NCT00605345|469064232|FG000|Overall Study|Withdrawal by Subject|1|||
130301108|NCT00605345|469064233|FG001|Overall Study|Withdrawal by Subject|0|||
130301109|NCT00605345|469064232|FG000|Overall Study|Adverse Event|0|||
130301110|NCT00605345|469064233|FG001|Overall Study|Adverse Event|1|||
130301111|NCT00605345|469064232|FG000|Overall Study|Protocol Violation|0|||
130301112|NCT00605345|469064233|FG001|Overall Study|Protocol Violation|2|||
130301113|NCT00566254|469064234|FG000|Overall Study|Adverse Event|3|||
130301114|NCT00566254|469064235|FG001|Overall Study|Adverse Event|1|||
130301115|NCT00566254|469064234|FG000|Overall Study|Protocol Violation|1|||
130301116|NCT00566254|469064235|FG001|Overall Study|Protocol Violation|3|||
130301117|NCT00566254|469064234|FG000|Overall Study|Withdrawal by Subject|1|||
130301118|NCT00566254|469064235|FG001|Overall Study|Withdrawal by Subject|2|||
130301119|NCT00566254|469064234|FG000|Overall Study|Lack of Efficacy|5|||
130301120|NCT00566254|469064235|FG001|Overall Study|Lack of Efficacy|6|||
130301121|NCT00566254|469064234|FG000|Overall Study|Other|0|||
130301122|NCT00566254|469064235|FG001|Overall Study|Other|2|||
130301123|NCT00238238|469064236|FG000|Overall Study|Withdrawal by Subject|0|||
130301124|NCT00238238|469064237|FG001|Overall Study|Withdrawal by Subject|3|||
130301125|NCT00238238|469064238|FG002|Overall Study|Withdrawal by Subject|0|||
130301126|NCT01345669|469064239|FG000|Overall Study|Primary tumour recurrence|53|||
130301127|NCT01345669|469064240|FG001|Overall Study|Primary tumour recurrence|32|||
130301128|NCT01345669|469064239|FG000|Overall Study|Second primary tumour|4|||
130301129|NCT01345669|469064240|FG001|Overall Study|Second primary tumour|3|||
130301130|NCT01345669|469064239|FG000|Overall Study|Adverse Event|63|||
130301131|NCT01345669|469064240|FG001|Overall Study|Adverse Event|9|||
130301132|NCT01345669|469064239|FG000|Overall Study|Protocol Violation|3|||
130301133|NCT01345669|469064240|FG001|Overall Study|Protocol Violation|1|||
130301134|NCT01345669|469064239|FG000|Overall Study|Lost to Follow-up|1|||
130301135|NCT01345669|469064240|FG001|Overall Study|Lost to Follow-up|1|||
130301136|NCT01345669|469064239|FG000|Overall Study|Withdrawal by Subject|52|||
130301137|NCT01345669|469064240|FG001|Overall Study|Withdrawal by Subject|13|||
130301138|NCT01345669|469064239|FG000|Overall Study|Other Reasons|111|||
130301139|NCT01345669|469064240|FG001|Overall Study|Other Reasons|60|||
130301140|NCT01793883|469064241|FG000|Overall Study|Withdrawal by Subject|3|||
130301141|NCT01793883|469064242|FG001|Overall Study|Withdrawal by Subject|7|||
130301142|NCT01793883|469064243|FG002|Overall Study|Withdrawal by Subject|3|||
130301143|NCT01793883|469064241|FG000|Overall Study|Subject noncompliance|0|||
130301144|NCT01793883|469064242|FG001|Overall Study|Subject noncompliance|1|||
130301145|NCT01793883|469064243|FG002|Overall Study|Subject noncompliance|1|||
130301146|NCT01793883|469064241|FG000|Overall Study|Lost to Follow-up|5|||
130301147|NCT01793883|469064242|FG001|Overall Study|Lost to Follow-up|1|||
130301148|NCT01793883|469064243|FG002|Overall Study|Lost to Follow-up|3|||
130301149|NCT01793883|469064241|FG000|Overall Study|Randomized in error|1|||
130301150|NCT01793883|469064242|FG001|Overall Study|Randomized in error|0|||
130301151|NCT01793883|469064243|FG002|Overall Study|Randomized in error|0|||
130301152|NCT01793883|469064241|FG000|Overall Study|Unable to complete spriometry|1|||
130301153|NCT01793883|469064242|FG001|Overall Study|Unable to complete spriometry|0|||
130301154|NCT01793883|469064243|FG002|Overall Study|Unable to complete spriometry|0|||
130301155|NCT01793883|469064241|FG000|Overall Study|Unable to complete measurements|1|||
130301156|NCT01793883|469064242|FG001|Overall Study|Unable to complete measurements|0|||
130301157|NCT01793883|469064243|FG002|Overall Study|Unable to complete measurements|0|||
130301158|NCT01793883|469064241|FG000|Overall Study|Met exclusion criteria|1|||
130301159|NCT01793883|469064242|FG001|Overall Study|Met exclusion criteria|0|||
130301160|NCT01793883|469064243|FG002|Overall Study|Met exclusion criteria|0|||
130301161|NCT01793883|469064241|FG000|Overall Study|Dosing error|0|||
130301162|NCT01793883|469064242|FG001|Overall Study|Dosing error|1|||
130301163|NCT01793883|469064243|FG002|Overall Study|Dosing error|0|||
130301164|NCT01793883|469064241|FG000|Overall Study|Respiratory distress during spirometry|0|||
130301165|NCT01793883|469064242|FG001|Overall Study|Respiratory distress during spirometry|0|||
130301166|NCT01793883|469064243|FG002|Overall Study|Respiratory distress during spirometry|1|||
130301167|NCT02478255|469064244|FG000|Overall Study|Physician Decision|6|||
130301168|NCT02478255|469064245|FG001|Overall Study|Physician Decision|0|||
130301169|NCT02478255|469064244|FG000|Overall Study|Withdrawal by Subject|2|||
130301170|NCT02478255|469064245|FG001|Overall Study|Withdrawal by Subject|0|||
130301171|NCT01730586|469064246|FG000|Overall Study|Progressive Disease|2|||
130301172|NCT01730586|469064246|FG000|Overall Study|Inadequate Trial|8|||
130301173|NCT01730586|469064246|FG000|Overall Study|Adverse Event|2|||
130301174|NCT01730586|469064246|FG000|Overall Study|Hospice|1|||
130301175|NCT00061633|469064247|FG000|Overall Study|Adverse Event|1|||
130301176|NCT00061633|469064248|FG001|Overall Study|Adverse Event|2|||
130301177|NCT00061633|469064247|FG000|Overall Study|Withdrawal by Subject|2|||
130301178|NCT00061633|469064248|FG001|Overall Study|Withdrawal by Subject|2|||
130301179|NCT00061633|469064247|FG000|Overall Study|Lost to Follow-up|1|||
130301180|NCT00061633|469064248|FG001|Overall Study|Lost to Follow-up|4|||
130301181|NCT00061633|469064247|FG000|Overall Study|Other|1|||
130301182|NCT00061633|469064248|FG001|Overall Study|Other|1|||
130301183|NCT00061633|469064247|FG000|Overall Study|Never received study treatment|0|||
130301184|NCT00061633|469064248|FG001|Overall Study|Never received study treatment|2|||
130301185|NCT00842543|469066562|FG000|Overall Study|Withdrawal by Subject|2|||
130301186|NCT00842543|469066563|FG001|Overall Study|Withdrawal by Subject|0|||
130301187|NCT00842543|469066564|FG002|Overall Study|Withdrawal by Subject|3|||
130301188|NCT00842543|469066565|FG003|Overall Study|Withdrawal by Subject|4|||
130301189|NCT01483183|469066570|FG000|Overall Study|Physician Decision|0|||
130301190|NCT01483183|469066571|FG001|Overall Study|Physician Decision|0|||
130301191|NCT01483183|469066572|FG002|Overall Study|Physician Decision|0|||
130301192|NCT01483183|469066573|FG003|Overall Study|Physician Decision|0|||
130301193|NCT01483183|469066574|FG004|Overall Study|Physician Decision|0|||
130301194|NCT01483183|469066575|FG005|Overall Study|Physician Decision|0|||
130301195|NCT01483183|469066576|FG006|Overall Study|Physician Decision|2|||
130301196|NCT01483183|469066577|FG007|Overall Study|Physician Decision|0|||
130301197|NCT01483183|469066578|FG008|Overall Study|Physician Decision|0|||
130301198|NCT01483183|469066579|FG009|Overall Study|Physician Decision|0|||
130301199|NCT01483183|469066570|FG000|Overall Study|Withdrawal by Subject|0|||
130301200|NCT01483183|469066571|FG001|Overall Study|Withdrawal by Subject|0|||
130301201|NCT01483183|469066572|FG002|Overall Study|Withdrawal by Subject|0|||
130301202|NCT01483183|469066573|FG003|Overall Study|Withdrawal by Subject|0|||
130301203|NCT01483183|469066574|FG004|Overall Study|Withdrawal by Subject|0|||
130301204|NCT01483183|469066575|FG005|Overall Study|Withdrawal by Subject|0|||
130301205|NCT01483183|469066576|FG006|Overall Study|Withdrawal by Subject|0|||
130301206|NCT01483183|469066577|FG007|Overall Study|Withdrawal by Subject|0|||
130301207|NCT01483183|469066578|FG008|Overall Study|Withdrawal by Subject|0|||
130301208|NCT01483183|469066579|FG009|Overall Study|Withdrawal by Subject|1|||
130301209|NCT00239928|469066580|FG000|Overall Study|Lack of Efficacy|1|||
130301210|NCT00239928|469066580|FG000|Overall Study|Adverse Event|4|||
130301211|NCT00239928|469066580|FG000|Overall Study|Not need to continue study|3|||
130301212|NCT00239928|469066580|FG000|Overall Study|Withdrawal by Subject|2|||
130301213|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301214|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301215|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
130301216|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
130301217|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
130301218|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301219|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
130301220|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
130301221|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
130301222|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301223|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301224|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301225|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
130301226|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
130301227|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130301228|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
130301229|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130301230|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130301231|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130301232|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
130301233|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
130301234|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
130301235|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301236|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301237|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301238|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
130301239|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301240|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301241|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301242|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301243|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301244|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301245|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
130301246|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301247|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301248|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301249|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301250|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301251|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
130301252|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301253|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301254|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301255|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301256|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301257|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301258|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301259|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301260|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
130301261|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301262|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301263|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301264|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
130301265|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301266|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301267|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301268|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
130301269|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301270|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301271|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301272|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
130301273|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301274|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301275|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130047571|NCT03242759|468130187|FG000|Overall Study|Administrative problems|1|||
130301276|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301277|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
130301278|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301279|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301280|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301281|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
130301282|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301283|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301284|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
130301285|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301286|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301287|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301288|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301289|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301290|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
130301291|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301292|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
130047572|NCT03242759|468130188|FG001|Overall Study|Administrative problems|1|||
130047573|NCT03242759|468130187|FG000|Overall Study|Death|22|||
130047574|NCT03242759|468130188|FG001|Overall Study|Death|0|||
130047575|NCT03242759|468130187|FG000|Overall Study|Change visit schedule|0|||
130047576|NCT03242759|468130188|FG001|Overall Study|Change visit schedule|1|||
130047577|NCT01240811|468131496|FG000|Overall Study|Physician Decision|0|||
130047578|NCT01240811|468131497|FG001|Overall Study|Physician Decision|1|||
130301293|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301294|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301295|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301296|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301297|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301298|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301299|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301300|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301301|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301302|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301303|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
130301304|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
130301305|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301306|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301307|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301308|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301309|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301310|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301311|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301312|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301313|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301314|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301315|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301316|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
130301317|NCT03100058|469066582|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301318|NCT03100058|469066583|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301319|NCT03100058|469066584|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301320|NCT03100058|469066585|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301321|NCT03100058|469066586|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301322|NCT03100058|469066587|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301323|NCT03100058|469066588|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
130301324|NCT03100058|469066589|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301325|NCT03100058|469066590|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301326|NCT03100058|469066591|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130047579|NCT01240811|468131498|FG002|Overall Study|Physician Decision|0|||
130301327|NCT03100058|469066592|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301328|NCT03100058|469066593|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301329|NCT03100058|469066594|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
130301330|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301331|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301332|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301333|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130047580|NCT01240811|468131496|FG000|Overall Study|Withdrawal by Subject|0|||
130301334|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301335|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301336|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301337|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301338|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301339|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
130301340|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
130301341|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
130301342|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
130301343|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301344|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301345|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301346|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301347|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301348|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301349|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301350|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301351|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301352|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301353|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
130301354|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
130301355|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
130301356|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301357|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301358|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301359|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301360|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301361|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301362|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301363|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301364|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301365|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
130301366|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
130301367|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
130301368|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
130301369|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301370|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301371|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301372|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301373|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301374|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129795183|NCT01923168|467217948|FG000|Overall Study|Death|0|||
129795184|NCT01923168|467217949|FG001|Overall Study|Death|0|||
130301375|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301376|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301377|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301378|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301379|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
130301380|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301381|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
130301382|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301383|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301384|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301385|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301386|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301387|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301388|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301389|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301390|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301391|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301392|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301393|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
130301394|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
130301395|NCT03100058|469066582|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301396|NCT03100058|469066583|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301397|NCT03100058|469066584|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301398|NCT03100058|469066585|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301399|NCT03100058|469066586|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301400|NCT03100058|469066587|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301401|NCT03100058|469066588|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301402|NCT03100058|469066589|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301403|NCT03100058|469066590|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301404|NCT03100058|469066591|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
130301405|NCT03100058|469066592|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301406|NCT03100058|469066593|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301407|NCT03100058|469066594|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
130301408|NCT00774800|469066596|FG000|Intervention 4|Withdrawal by Subject|1|||
130301409|NCT01331109|469066597|FG000|Overall Study|Adverse Event|6|||
130301410|NCT01331109|469066597|FG000|Overall Study|Lack of Efficacy|2|||
130301411|NCT01331109|469066597|FG000|Overall Study|Protocol Violation|3|||
130301412|NCT01331109|469066597|FG000|Overall Study|Withdrawal by Subject|7|||
130301413|NCT01331109|469066597|FG000|Overall Study|Lost to Follow-up|1|||
130301414|NCT01331109|469066597|FG000|Overall Study|Study Terminated by Sponsor|38|||
130301415|NCT00479856|469066598|FG000|Overall Study|Adverse Event|1|||
130301416|NCT00479856|469066598|FG000|Overall Study|Withdrawal by Subject|1|||
130301417|NCT00479856|469066598|FG000|Overall Study|Physician Decision|1|||
130301418|NCT00661622|469066601|FG000|Overall Study|Protocol Violation|1|||
130301419|NCT00661622|469066602|FG001|Overall Study|Protocol Violation|0|||
130301420|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
130301421|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
130301422|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
130301423|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
130301424|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Death|2|||
130301425|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Death|2|||
130301426|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Death|0|||
130301427|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Death|0|||
130301428|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
130301429|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
130301430|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
130301431|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
130301432|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
130301433|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130301434|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130301435|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
130301436|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
130301437|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
130301438|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
130301439|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
130301440|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
130301441|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130301442|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130301443|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
130301444|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130301445|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
129795185|NCT01923168|467217950|FG002|Overall Study|Death|1|||
130301446|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130301447|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
130301448|NCT03068754|469066605|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
130301449|NCT03068754|469066606|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
130301450|NCT03068754|469066607|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
130301451|NCT03068754|469066608|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
130301452|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
130301453|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
130301454|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
130301455|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
130047581|NCT01240811|468131497|FG001|Overall Study|Withdrawal by Subject|0|||
130301456|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Death|0|||
130301457|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Death|0|||
129795186|NCT03418571|467217953|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
129795187|NCT03418571|467217954|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
129795188|NCT02376829|467217955|FG000|Overall Study|Withdrawal by Subject|27|||
130301458|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Death|0|||
130301459|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Death|1|||
130301460|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
130301461|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
130301462|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
130301463|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
130301464|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130301465|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130301466|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
130301467|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
130301468|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130301469|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130301470|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
130301471|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
130301472|NCT03068754|469066605|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
130301473|NCT03068754|469066606|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
130301474|NCT03068754|469066607|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
130301475|NCT03068754|469066608|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
130301476|NCT04496453|469066616|FG000|Overall Study|Lost to Follow-up|6|||
130301477|NCT03997825|469066617|FG000|Overall Study|Death|3|||
130301478|NCT03997825|469066617|FG000|Overall Study|Lost to Follow-up|10|||
130301479|NCT03997825|469066617|FG000|Overall Study|Withdrawal by Subject|3|||
130301480|NCT03997825|469066617|FG000|Overall Study|Refused participation|1|||
130301481|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
130301482|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
130301483|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
130301484|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
130301485|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
130301486|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
130301487|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
130301488|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
130301489|NCT00383162|469066618|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
130301490|NCT00383162|469066619|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
130301491|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
130301492|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
130301493|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
130301494|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
130301495|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
130301496|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
130301497|NCT00383162|469066618|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
130301498|NCT00383162|469066619|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
130301499|NCT00767819|469066620|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130301500|NCT00767819|469066621|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
130301501|NCT00767819|469066622|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130301502|NCT00767819|469066620|FG000|Overall Study|Withdrawal by Subject|1|||
130301503|NCT00767819|469066621|FG001|Overall Study|Withdrawal by Subject|1|||
130301504|NCT00767819|469066622|FG002|Overall Study|Withdrawal by Subject|0|||
130301505|NCT00767819|469066620|FG000|Overall Study|Administrative problems|0|||
130301506|NCT00767819|469066621|FG001|Overall Study|Administrative problems|1|||
130301507|NCT00767819|469066622|FG002|Overall Study|Administrative problems|0|||
130301508|NCT00767819|469066620|FG000|Overall Study|Death|2|||
130301509|NCT00767819|469066621|FG001|Overall Study|Death|3|||
130301510|NCT00767819|469066622|FG002|Overall Study|Death|0|||
130301511|NCT00767819|469066620|FG000|Overall Study|Adverse Event|2|||
130301512|NCT00767819|469066621|FG001|Overall Study|Adverse Event|0|||
130301513|NCT00767819|469066622|FG002|Overall Study|Adverse Event|0|||
130301514|NCT00767819|469066620|FG000|Overall Study|Abnormal lab values|1|||
130301515|NCT00767819|469066621|FG001|Overall Study|Abnormal lab values|0|||
130301516|NCT00767819|469066622|FG002|Overall Study|Abnormal lab values|0|||
130301517|NCT00767819|469066620|FG000|Overall Study|Lost to Follow-up|1|||
130301518|NCT00767819|469066621|FG001|Overall Study|Lost to Follow-up|0|||
130301519|NCT00767819|469066622|FG002|Overall Study|Lost to Follow-up|0|||
130301520|NCT02726022|469066624|FG000|Overall Study|Adverse Event|14|||
130301521|NCT02726022|469066624|FG000|Overall Study|Treatment Failure|8|||
130301522|NCT02726022|469066624|FG000|Overall Study|Poor Compliance|13|||
130301523|NCT02726022|469066624|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
130301524|NCT00915551|469066625|FG000|Overall Study|Withdrawal by Subject|0|||
130301525|NCT00915551|469066626|FG001|Overall Study|Withdrawal by Subject|1|||
130301526|NCT00235716|469066627|FG000|Overall Study|Death|26|||
130301527|NCT00235716|469066628|FG001|Overall Study|Death|39|||
130301528|NCT00235716|469066629|FG002|Overall Study|Death|32|||
130301529|NCT00235716|469066630|FG003|Overall Study|Death|31|||
129889085|NCT01349660|467551009|FG002|Overall Study|Disease Progression|50|||
129889086|NCT01349660|467551007|FG000|Overall Study|Adverse Event|1|||
129889087|NCT01349660|467551008|FG001|Overall Study|Adverse Event|1|||
129889088|NCT01349660|467551009|FG002|Overall Study|Adverse Event|12|||
129889089|NCT01349660|467551007|FG000|Overall Study|Withdrawal by Subject|2|||
130107470|NCT01902134|468355130|FG000|Overall Study|Withdrawal by Subject|4|||
130107471|NCT01902134|468355131|FG001|Overall Study|Withdrawal by Subject|8|||
130301530|NCT00235716|469066627|FG000|Overall Study|Withdrawal by Subject|23|||
130301531|NCT00235716|469066628|FG001|Overall Study|Withdrawal by Subject|19|||
130301532|NCT00235716|469066629|FG002|Overall Study|Withdrawal by Subject|17|||
130301533|NCT00235716|469066630|FG003|Overall Study|Withdrawal by Subject|18|||
130301534|NCT00235716|469066627|FG000|Overall Study|Lost to Follow-up|12|||
130301535|NCT00235716|469066628|FG001|Overall Study|Lost to Follow-up|7|||
130301536|NCT00235716|469066629|FG002|Overall Study|Lost to Follow-up|14|||
130301537|NCT00235716|469066630|FG003|Overall Study|Lost to Follow-up|10|||
130301538|NCT00235716|469066627|FG000|Overall Study|Adverse Event|1|||
130301539|NCT00235716|469066628|FG001|Overall Study|Adverse Event|1|||
130301540|NCT00235716|469066629|FG002|Overall Study|Adverse Event|1|||
130301541|NCT00235716|469066630|FG003|Overall Study|Adverse Event|0|||
130301542|NCT00235716|469066627|FG000|Overall Study|Physician Decision|0|||
130301543|NCT00235716|469066628|FG001|Overall Study|Physician Decision|1|||
130301544|NCT00235716|469066629|FG002|Overall Study|Physician Decision|1|||
130301545|NCT00235716|469066630|FG003|Overall Study|Physician Decision|3|||
130301546|NCT04390841|469066631|FG000|Overall Study|Withdrawal by Subject|2|||
130301547|NCT02891382|469066644|FG000|Overall Study|Lost to Follow-up|3|||
130301548|NCT02891382|469066645|FG001|Overall Study|Lost to Follow-up|4|||
130301549|NCT02891382|469066646|FG002|Overall Study|Lost to Follow-up|5|||
130301550|NCT02891382|469066647|FG003|Overall Study|Lost to Follow-up|3|||
130301551|NCT02891382|469066648|FG004|Overall Study|Lost to Follow-up|4|||
130301552|NCT02516228|469066651|FG000|Overall Study|Lost to Follow-up|1|||
130301553|NCT02516228|469066651|FG000|Overall Study|Withdrawal by Subject|1|||
130301554|NCT02516228|469066651|FG000|Overall Study|Physician Decision|1|||
130301555|NCT03916484|469066654|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130301556|NCT03916484|469066655|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
130301557|NCT03916484|469066656|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130301558|NCT03916484|469066657|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
130301559|NCT03916484|469066654|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
130301560|NCT03916484|469066655|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
130301561|NCT03916484|469066656|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
130301562|NCT03916484|469066657|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
130301563|NCT00504894|469066666|FG000|Overall Study|fMRI technical problems|1|||
130301564|NCT00504894|469066667|FG001|Overall Study|fMRI technical problems|1|||
130301565|NCT00504894|469066668|FG002|Overall Study|fMRI technical problems|0|||
130301566|NCT00504894|469066666|FG000|Overall Study|Withdrawal by Subject|0|||
130301567|NCT00504894|469066667|FG001|Overall Study|Withdrawal by Subject|1|||
130301568|NCT00504894|469066668|FG002|Overall Study|Withdrawal by Subject|0|||
130301569|NCT00504894|469066666|FG000|Overall Study|Infusion technical problems|0|||
130301570|NCT00504894|469066667|FG001|Overall Study|Infusion technical problems|1|||
130301571|NCT00504894|469066668|FG002|Overall Study|Infusion technical problems|0|||
130301572|NCT00504894|469066666|FG000|Overall Study|poor subject data|2|||
130301573|NCT00504894|469066667|FG001|Overall Study|poor subject data|0|||
130301574|NCT00504894|469066668|FG002|Overall Study|poor subject data|0|||
130301575|NCT05090852|469066669|FG000|Overall Study|Physician Decision|5|||
130301576|NCT01196416|469066670|FG000|Overall Study|Withdrawal by Subject|2|||
130301577|NCT00148941|469066672|FG000|Overall Study|Lost to Follow-up|17|||
130301578|NCT00148941|469066673|FG001|Overall Study|Lost to Follow-up|24|||
130301579|NCT00148941|469066674|FG002|Overall Study|Lost to Follow-up|18|||
129889090|NCT01349660|467551008|FG001|Overall Study|Withdrawal by Subject|0|||
129889091|NCT01349660|467551009|FG002|Overall Study|Withdrawal by Subject|9|||
130301580|NCT00148941|469066675|FG003|Overall Study|Lost to Follow-up|22|||
129795189|NCT02376829|467217956|FG001|Overall Study|Withdrawal by Subject|44|||
129795190|NCT01439347|467217957|FG000|Overall Study|Death|10|||
129795191|NCT01439347|467217958|FG001|Overall Study|Death|9|||
129795192|NCT01439347|467217957|FG000|Overall Study|Withdrawal by Subject|0|||
129795193|NCT01439347|467217958|FG001|Overall Study|Withdrawal by Subject|1|||
129795194|NCT01439347|467217957|FG000|Overall Study|Physician Decision|1|||
130301581|NCT00148941|469066672|FG000|Overall Study|Withdrawal by Subject|1|||
130301582|NCT00148941|469066673|FG001|Overall Study|Withdrawal by Subject|0|||
130301583|NCT00148941|469066674|FG002|Overall Study|Withdrawal by Subject|1|||
130301584|NCT00148941|469066675|FG003|Overall Study|Withdrawal by Subject|0|||
130301585|NCT00148941|469066672|FG000|Overall Study|Other|0|||
130301586|NCT00148941|469066673|FG001|Overall Study|Other|0|||
130301587|NCT00148941|469066674|FG002|Overall Study|Other|1|||
130301588|NCT00148941|469066675|FG003|Overall Study|Other|2|||
130301589|NCT02673684|469066676|FG000|Overall Study|Study not completed d/t loss of funding|9|||
130301590|NCT02673684|469066677|FG001|Overall Study|Study not completed d/t loss of funding|8|||
130301591|NCT01092663|469066678|FG000|Overall Study|Withdrawal by Subject|3|||
130301592|NCT01092663|469066679|FG001|Overall Study|Withdrawal by Subject|2|||
130301593|NCT01092663|469066678|FG000|Overall Study|Glucose >300mg/dL|1|||
130301594|NCT01092663|469066679|FG001|Overall Study|Glucose >300mg/dL|0|||
130301595|NCT01092663|469066678|FG000|Overall Study|High fasting triglyceride|2|||
130301596|NCT01092663|469066679|FG001|Overall Study|High fasting triglyceride|0|||
130301597|NCT01092663|469066678|FG000|Overall Study|Adverse Event|1|||
130301598|NCT01092663|469066679|FG001|Overall Study|Adverse Event|1|||
130301599|NCT01092663|469066678|FG000|Overall Study|Protocol Violation|0|||
130301600|NCT01092663|469066679|FG001|Overall Study|Protocol Violation|1|||
130301601|NCT03688620|469066680|FG000|Overall Study|Other|0|||
130301602|NCT03688620|469066681|FG001|Overall Study|Other|0|||
130301603|NCT03688620|469066682|FG002|Overall Study|Other|1|||
130301604|NCT03688620|469066680|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
130301605|NCT03688620|469066681|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
130301606|NCT03688620|469066682|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
130301607|NCT03688620|469066680|FG000|Overall Study|Lost to Follow-up|16|||
130301608|NCT03688620|469066681|FG001|Overall Study|Lost to Follow-up|0|||
130301609|NCT03688620|469066682|FG002|Overall Study|Lost to Follow-up|1|||
130301610|NCT03688620|469066680|FG000|Overall Study|Withdrawal by Subject|0|||
130301611|NCT03688620|469066681|FG001|Overall Study|Withdrawal by Subject|0|||
130301612|NCT03688620|469066682|FG002|Overall Study|Withdrawal by Subject|6|||
130301613|NCT01008904|469066683|FG000|Overall Study|Lost to Follow-up|1|||
130301614|NCT01008904|469066683|FG000|Overall Study|Adverse Event|2|||
130301615|NCT01008904|469066683|FG000|Overall Study|unexpected unrelated surgery|1|||
130301616|NCT01183065|469066684|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
130301617|NCT02456857|469066685|FG000|Overall Study|Disease Progression|4|||
130301618|NCT00781859|469066686|FG000|Overall Study|Adverse Event|2|||
130301619|NCT00781859|469066687|FG001|Overall Study|Adverse Event|2|||
130301620|NCT00781859|469066686|FG000|Overall Study|Withdrawal by Subject|8|||
130301621|NCT00781859|469066687|FG001|Overall Study|Withdrawal by Subject|4|||
130301622|NCT00781859|469066686|FG000|Overall Study|Lost to Follow-up|6|||
130301623|NCT00781859|469066687|FG001|Overall Study|Lost to Follow-up|3|||
130301624|NCT00781859|469066686|FG000|Overall Study|Death|3|||
130301625|NCT00781859|469066687|FG001|Overall Study|Death|0|||
130301626|NCT01983774|469066691|FG000|Overall Study|Lung Transplant|0|||
130301627|NCT01983774|469066692|FG001|Overall Study|Lung Transplant|1|||
130301628|NCT01983774|469066691|FG000|Overall Study|Lost to Follow-up|1|||
130301629|NCT01983774|469066692|FG001|Overall Study|Lost to Follow-up|0|||
130301630|NCT01008449|469066693|FG000|Overall Study|Lost to Follow-up|29|||
130301631|NCT01008449|469066694|FG001|Overall Study|Lost to Follow-up|19|||
130301632|NCT01220180|469066695|FG000|Overall Study|Lost to Follow-up|76|||
130301633|NCT01220180|469066695|FG000|Overall Study|Other|72|||
130301634|NCT01220180|469066695|FG000|Overall Study|Adverse Event|35|||
129795195|NCT01439347|467217958|FG001|Overall Study|Physician Decision|0|||
129795196|NCT01439347|467217957|FG000|Overall Study|Sponsor Terminated Study|2|||
129795197|NCT01439347|467217958|FG001|Overall Study|Sponsor Terminated Study|3|||
129889092|NCT01349660|467551007|FG000|Overall Study|Death|1|||
129889093|NCT01349660|467551008|FG001|Overall Study|Death|1|||
129889094|NCT01349660|467551009|FG002|Overall Study|Death|0|||
129889095|NCT01349660|467551007|FG000|Overall Study|Non-Permitted Interventions|0|||
130301635|NCT01220180|469066695|FG000|Overall Study|Lack of Efficacy|22|||
130301636|NCT01220180|469066695|FG000|Overall Study|Death|1|||
130301637|NCT01220180|469066695|FG000|Overall Study|Randomized but not treated|1|||
130301638|NCT01067469|469066700|FG000|Overall Study|Withdrawal by Subject|0|||
130301639|NCT01067469|469066701|FG001|Overall Study|Withdrawal by Subject|1|||
130301640|NCT01067469|469066700|FG000|Overall Study|Disease Progression|0|||
130301641|NCT01067469|469066701|FG001|Overall Study|Disease Progression|1|||
130301642|NCT01299116|469066704|FG000|Overall Study|Lost to Follow-up|65|||
130301643|NCT01299116|469066705|FG001|Overall Study|Lost to Follow-up|9|||
130301644|NCT01299116|469066706|FG002|Overall Study|Lost to Follow-up|11|||
130301645|NCT01620944|469066707|FG000|Overall Study|Early termination of Study|2|||
129889096|NCT01349660|467551008|FG001|Overall Study|Non-Permitted Interventions|0|||
129795198|NCT04068896|467217959|FG000|Overall Study|Adverse Event|2|||
129795199|NCT04068896|467217960|FG001|Overall Study|Adverse Event|0|||
130301646|NCT01620944|469066708|FG001|Overall Study|Early termination of Study|1|||
130301647|NCT01123707|469066710|FG000|Overall Study|Lost to Follow-up|3|||
130301648|NCT01123707|469066711|FG001|Overall Study|Lost to Follow-up|1|||
130301649|NCT01123707|469066712|FG002|Overall Study|Lost to Follow-up|3|||
130301650|NCT01123707|469066713|FG003|Overall Study|Lost to Follow-up|2|||
130301651|NCT01123707|469066710|FG000|Overall Study|Adverse Event|5|||
130301652|NCT01123707|469066711|FG001|Overall Study|Adverse Event|7|||
130301653|NCT01123707|469066712|FG002|Overall Study|Adverse Event|5|||
130301654|NCT01123707|469066713|FG003|Overall Study|Adverse Event|3|||
130301655|NCT01123707|469066710|FG000|Overall Study|Sponsor Discontinued Study|30|||
130301656|NCT01123707|469066711|FG001|Overall Study|Sponsor Discontinued Study|24|||
130301657|NCT01123707|469066712|FG002|Overall Study|Sponsor Discontinued Study|25|||
130301658|NCT01123707|469066713|FG003|Overall Study|Sponsor Discontinued Study|40|||
130301659|NCT01123707|469066710|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130301660|NCT01123707|469066711|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
130301661|NCT01123707|469066712|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
130301662|NCT01123707|469066713|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
130301663|NCT01123707|469066710|FG000|Overall Study|Investigator Withdrew Participant|0|||
130301664|NCT01123707|469066711|FG001|Overall Study|Investigator Withdrew Participant|1|||
130301665|NCT01123707|469066712|FG002|Overall Study|Investigator Withdrew Participant|1|||
130301666|NCT01123707|469066713|FG003|Overall Study|Investigator Withdrew Participant|1|||
130301667|NCT01123707|469066710|FG000|Overall Study|Subject Withdrew Consent|4|||
130301668|NCT01123707|469066711|FG001|Overall Study|Subject Withdrew Consent|5|||
130301669|NCT01123707|469066712|FG002|Overall Study|Subject Withdrew Consent|1|||
130301670|NCT01123707|469066713|FG003|Overall Study|Subject Withdrew Consent|2|||
130301671|NCT01123707|469066710|FG000|Overall Study|Lack of Efficacy|1|||
130301672|NCT01123707|469066711|FG001|Overall Study|Lack of Efficacy|2|||
130301673|NCT01123707|469066712|FG002|Overall Study|Lack of Efficacy|1|||
130301674|NCT01123707|469066713|FG003|Overall Study|Lack of Efficacy|0|||
130301675|NCT01123707|469066710|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
130301676|NCT01123707|469066711|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
130301677|NCT01123707|469066712|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
130301678|NCT01123707|469066713|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
130301679|NCT04378114|469066714|FG000|Overall Study|Withdrawal by Subject|5|||
130301680|NCT01959243|469066717|FG000|Overall Study|Investigator Decision|3|||
130301681|NCT01959243|469066718|FG001|Overall Study|Investigator Decision|0|||
130301682|NCT01959243|469066717|FG000|Overall Study|Adverse Event|5|||
130301683|NCT01959243|469066718|FG001|Overall Study|Adverse Event|2|||
130301684|NCT01959243|469066717|FG000|Overall Study|Administrative reasons|2|||
130301685|NCT01959243|469066718|FG001|Overall Study|Administrative reasons|1|||
130301686|NCT01959243|469066717|FG000|Overall Study|Lost to Follow-up|3|||
130301687|NCT01959243|469066718|FG001|Overall Study|Lost to Follow-up|1|||
130301688|NCT00629798|469066721|FG000|Overall Study|Not Treated|4|||
130301689|NCT02554981|469066722|FG000|Overall Study|Adverse Event|1|||
130301690|NCT02554981|469066722|FG000|Overall Study|Administrative Reasons|1|||
130301691|NCT02554981|469066722|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130301692|NCT01114438|469066723|FG000|Overall Study|Adverse Event|10|||
130301693|NCT01114438|469066723|FG000|Overall Study|concomitant medication|1|||
130301694|NCT01114438|469066723|FG000|Overall Study|Physician Decision|1|||
130301695|NCT01114438|469066723|FG000|Overall Study|Withdrawal by Subject|2|||
130301696|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Adverse Event|2|||
130301697|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Adverse Event|4|||
129795200|NCT04068896|467217961|FG002|Overall Study|Adverse Event|1|||
129795201|NCT04068896|467217962|FG003|Overall Study|Adverse Event|0|||
129795202|NCT04068896|467217963|FG004|Overall Study|Adverse Event|0|||
129795203|NCT04068896|467217964|FG005|Overall Study|Adverse Event|0|||
129795204|NCT04068896|467217959|FG000|Overall Study|Death|3|||
130301698|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Adverse Event|4|||
129795205|NCT04068896|467217960|FG001|Overall Study|Death|1|||
129795206|NCT04068896|467217961|FG002|Overall Study|Death|3|||
129795207|NCT04068896|467217962|FG003|Overall Study|Death|19|||
129795208|NCT04068896|467217963|FG004|Overall Study|Death|17|||
129795209|NCT04068896|467217964|FG005|Overall Study|Death|0|||
129795210|NCT04068896|467217959|FG000|Overall Study|Physician Decision|0|||
130301699|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
130301700|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
130301701|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
130301702|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
130301703|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
130301704|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
130301705|NCT00428844|469066726|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
130301706|NCT00428844|469066727|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
129795211|NCT04068896|467217960|FG001|Overall Study|Physician Decision|0|||
129795212|NCT04068896|467217961|FG002|Overall Study|Physician Decision|0|||
129795213|NCT04068896|467217962|FG003|Overall Study|Physician Decision|1|||
129795214|NCT04068896|467217963|FG004|Overall Study|Physician Decision|0|||
129795215|NCT04068896|467217964|FG005|Overall Study|Physician Decision|0|||
129795216|NCT04068896|467217959|FG000|Overall Study|progressive disease|3|||
129795217|NCT04068896|467217960|FG001|Overall Study|progressive disease|5|||
129795218|NCT04068896|467217961|FG002|Overall Study|progressive disease|3|||
129795219|NCT04068896|467217962|FG003|Overall Study|progressive disease|2|||
129795220|NCT04068896|467217963|FG004|Overall Study|progressive disease|1|||
129795221|NCT04068896|467217964|FG005|Overall Study|progressive disease|2|||
129795222|NCT04068896|467217959|FG000|Overall Study|Study terminated by sponsor|0|||
129795223|NCT04068896|467217960|FG001|Overall Study|Study terminated by sponsor|0|||
129795224|NCT04068896|467217961|FG002|Overall Study|Study terminated by sponsor|1|||
129795225|NCT04068896|467217962|FG003|Overall Study|Study terminated by sponsor|2|||
129795226|NCT04068896|467217963|FG004|Overall Study|Study terminated by sponsor|1|||
129795227|NCT04068896|467217964|FG005|Overall Study|Study terminated by sponsor|4|||
129795228|NCT04068896|467217959|FG000|Overall Study|Protocol Violation|0|||
129795229|NCT04068896|467217960|FG001|Overall Study|Protocol Violation|0|||
129795230|NCT04068896|467217961|FG002|Overall Study|Protocol Violation|0|||
129795231|NCT04068896|467217962|FG003|Overall Study|Protocol Violation|1|||
129795232|NCT04068896|467217963|FG004|Overall Study|Protocol Violation|0|||
130301707|NCT00428844|469066728|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
130301708|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
130301709|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
130301710|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
130301711|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
130301712|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
130301713|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
130301714|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
130301715|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
130301716|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
130301717|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
130301718|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
130301719|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
130301720|NCT00428844|469066726|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
130301721|NCT00428844|469066727|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
130301722|NCT00428844|469066728|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
130301723|NCT00488826|469066731|FG000|Overall Study|Withdrawal by Subject|40|||
130301724|NCT00488826|469066732|FG001|Overall Study|Withdrawal by Subject|35|||
130301725|NCT00488826|469066733|FG002|Overall Study|Withdrawal by Subject|19|||
130301726|NCT00488826|469066731|FG000|Overall Study|Protocol Violation|0|||
130301727|NCT00488826|469066732|FG001|Overall Study|Protocol Violation|0|||
130301728|NCT00488826|469066733|FG002|Overall Study|Protocol Violation|2|||
130301729|NCT00488826|469066731|FG000|Overall Study|Adverse Event|9|||
130301730|NCT00488826|469066732|FG001|Overall Study|Adverse Event|15|||
130301731|NCT00488826|469066733|FG002|Overall Study|Adverse Event|4|||
130301732|NCT00488826|469066731|FG000|Overall Study|Lost to Follow-up|5|||
130301733|NCT00488826|469066732|FG001|Overall Study|Lost to Follow-up|1|||
130301734|NCT00488826|469066733|FG002|Overall Study|Lost to Follow-up|0|||
130301735|NCT00488826|469066731|FG000|Overall Study|Protocol Deviations|2|||
130301736|NCT00488826|469066732|FG001|Overall Study|Protocol Deviations|1|||
130301737|NCT00488826|469066733|FG002|Overall Study|Protocol Deviations|1|||
130301738|NCT02292706|469066734|FG000|Overall Study|Lost to Follow-up|20|||
130301739|NCT02292706|469066735|FG001|Overall Study|Lost to Follow-up|44|||
130301740|NCT02292706|469066736|FG002|Overall Study|Lost to Follow-up|24|||
129795233|NCT04068896|467217964|FG005|Overall Study|Protocol Violation|0|||
129795234|NCT04068896|467217959|FG000|Overall Study|Withdrawal by Subject|0|||
129795235|NCT04068896|467217960|FG001|Overall Study|Withdrawal by Subject|3|||
129795236|NCT04068896|467217961|FG002|Overall Study|Withdrawal by Subject|0|||
130301741|NCT02292706|469066737|FG003|Overall Study|Lost to Follow-up|61|||
130301742|NCT02292706|469066738|FG004|Overall Study|Lost to Follow-up|21|||
130301743|NCT02292706|469066739|FG005|Overall Study|Lost to Follow-up|52|||
130301744|NCT02292706|469066740|FG006|Overall Study|Lost to Follow-up|25|||
130301745|NCT02292706|469066741|FG007|Overall Study|Lost to Follow-up|0|||
130301746|NCT02292706|469066734|FG000|Overall Study|Withdrew consent|15|||
130301747|NCT02292706|469066735|FG001|Overall Study|Withdrew consent|56|||
129795237|NCT04068896|467217962|FG003|Overall Study|Withdrawal by Subject|2|||
130301748|NCT02292706|469066736|FG002|Overall Study|Withdrew consent|43|||
129795238|NCT04068896|467217963|FG004|Overall Study|Withdrawal by Subject|1|||
130301749|NCT02292706|469066737|FG003|Overall Study|Withdrew consent|36|||
129795239|NCT04068896|467217964|FG005|Overall Study|Withdrawal by Subject|0|||
129795240|NCT04068896|467217959|FG000|Overall Study|Symptomatic deterioration|2|||
129795241|NCT04068896|467217960|FG001|Overall Study|Symptomatic deterioration|0|||
129795242|NCT04068896|467217961|FG002|Overall Study|Symptomatic deterioration|0|||
130301750|NCT02292706|469066738|FG004|Overall Study|Withdrew consent|13|||
130301751|NCT02292706|469066739|FG005|Overall Study|Withdrew consent|51|||
130301752|NCT02292706|469066740|FG006|Overall Study|Withdrew consent|20|||
130301753|NCT02292706|469066741|FG007|Overall Study|Withdrew consent|0|||
130301754|NCT02292706|469066734|FG000|Overall Study|Death|3|||
130301755|NCT02292706|469066735|FG001|Overall Study|Death|11|||
130301756|NCT02292706|469066736|FG002|Overall Study|Death|16|||
130301757|NCT02292706|469066737|FG003|Overall Study|Death|22|||
130301758|NCT02292706|469066738|FG004|Overall Study|Death|8|||
130301759|NCT02292706|469066739|FG005|Overall Study|Death|17|||
130301760|NCT02292706|469066740|FG006|Overall Study|Death|3|||
130301761|NCT02292706|469066741|FG007|Overall Study|Death|0|||
130301762|NCT02292706|469066734|FG000|Overall Study|Study terminated by sponsor|0|||
130301763|NCT02292706|469066735|FG001|Overall Study|Study terminated by sponsor|9|||
130301764|NCT02292706|469066736|FG002|Overall Study|Study terminated by sponsor|4|||
130301765|NCT02292706|469066737|FG003|Overall Study|Study terminated by sponsor|21|||
130301766|NCT02292706|469066738|FG004|Overall Study|Study terminated by sponsor|11|||
130301767|NCT02292706|469066739|FG005|Overall Study|Study terminated by sponsor|13|||
130301768|NCT02292706|469066740|FG006|Overall Study|Study terminated by sponsor|3|||
130301769|NCT02292706|469066741|FG007|Overall Study|Study terminated by sponsor|0|||
130301770|NCT02292706|469066734|FG000|Overall Study|Investigator's discretion|4|||
130301771|NCT02292706|469066735|FG001|Overall Study|Investigator's discretion|9|||
130301772|NCT02292706|469066736|FG002|Overall Study|Investigator's discretion|7|||
130301773|NCT02292706|469066737|FG003|Overall Study|Investigator's discretion|11|||
130301774|NCT02292706|469066738|FG004|Overall Study|Investigator's discretion|4|||
130301775|NCT02292706|469066739|FG005|Overall Study|Investigator's discretion|10|||
130301776|NCT02292706|469066740|FG006|Overall Study|Investigator's discretion|1|||
130301777|NCT02292706|469066741|FG007|Overall Study|Investigator's discretion|0|||
130301778|NCT02292706|469066734|FG000|Overall Study|Liver transplant|1|||
130301779|NCT02292706|469066735|FG001|Overall Study|Liver transplant|1|||
130301780|NCT02292706|469066736|FG002|Overall Study|Liver transplant|11|||
130301781|NCT02292706|469066737|FG003|Overall Study|Liver transplant|16|||
130301782|NCT02292706|469066738|FG004|Overall Study|Liver transplant|5|||
130301783|NCT02292706|469066739|FG005|Overall Study|Liver transplant|6|||
130301784|NCT02292706|469066740|FG006|Overall Study|Liver transplant|5|||
130301785|NCT02292706|469066741|FG007|Overall Study|Liver transplant|0|||
130301786|NCT02292706|469066734|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
130301787|NCT02292706|469066735|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
130301788|NCT02292706|469066736|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
130301789|NCT02292706|469066737|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
130301790|NCT02292706|469066738|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
130301791|NCT02292706|469066739|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
130301792|NCT02292706|469066740|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
130301793|NCT02292706|469066741|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
130301794|NCT02292706|469066734|FG000|Overall Study|Subject terminated by sponsor|1|||
130301795|NCT02292706|469066735|FG001|Overall Study|Subject terminated by sponsor|0|||
130301796|NCT02292706|469066736|FG002|Overall Study|Subject terminated by sponsor|0|||
130301797|NCT02292706|469066737|FG003|Overall Study|Subject terminated by sponsor|2|||
130301798|NCT02292706|469066738|FG004|Overall Study|Subject terminated by sponsor|1|||
130301799|NCT02292706|469066739|FG005|Overall Study|Subject terminated by sponsor|0|||
130301800|NCT02292706|469066740|FG006|Overall Study|Subject terminated by sponsor|0|||
130301801|NCT02292706|469066741|FG007|Overall Study|Subject terminated by sponsor|0|||
130301802|NCT02292706|469066734|FG000|Overall Study|Missing|0|||
130301803|NCT02292706|469066735|FG001|Overall Study|Missing|0|||
130301804|NCT02292706|469066736|FG002|Overall Study|Missing|1|||
130301805|NCT02292706|469066737|FG003|Overall Study|Missing|1|||
130301806|NCT02292706|469066738|FG004|Overall Study|Missing|0|||
130301807|NCT02292706|469066739|FG005|Overall Study|Missing|1|||
130301808|NCT02292706|469066740|FG006|Overall Study|Missing|0|||
130301809|NCT02292706|469066741|FG007|Overall Study|Missing|0|||
130301810|NCT02292706|469066734|FG000|Overall Study|Virologic relapse or reinfection|1|||
130301811|NCT02292706|469066735|FG001|Overall Study|Virologic relapse or reinfection|0|||
130301812|NCT02292706|469066736|FG002|Overall Study|Virologic relapse or reinfection|0|||
130301813|NCT02292706|469066737|FG003|Overall Study|Virologic relapse or reinfection|1|||
129795243|NCT04068896|467217962|FG003|Overall Study|Symptomatic deterioration|0|||
130301814|NCT02292706|469066738|FG004|Overall Study|Virologic relapse or reinfection|0|||
129795244|NCT04068896|467217963|FG004|Overall Study|Symptomatic deterioration|0|||
129795245|NCT04068896|467217964|FG005|Overall Study|Symptomatic deterioration|0|||
129795246|NCT02398227|467217965|FG000|Overall Study|Lost to Follow-up|21|||
130301815|NCT02292706|469066739|FG005|Overall Study|Virologic relapse or reinfection|1|||
130301816|NCT02292706|469066740|FG006|Overall Study|Virologic relapse or reinfection|0|||
130301817|NCT02292706|469066741|FG007|Overall Study|Virologic relapse or reinfection|0|||
130301818|NCT02725866|469066744|FG000|Overall Study|Failure to return|6|||
129795247|NCT02398227|467217966|FG001|Overall Study|Lost to Follow-up|12|||
130301819|NCT02725866|469066744|FG000|Overall Study|Withdrew consent|3|||
130301820|NCT02725866|469066744|FG000|Overall Study|Insufficient virological response|1|||
130301821|NCT02725866|469066744|FG000|Overall Study|Other, not specified|4|||
129795248|NCT02398227|467217965|FG000|Overall Study|Withdrawal by Subject|5|||
130301822|NCT03043651|469066750|FG000|Overall Study|Death|1|||
130301823|NCT03043651|469066750|FG000|Overall Study|Progressive Disease|2|||
130301824|NCT03043651|469066750|FG000|Overall Study|Adverse Event|2|||
130301825|NCT03043651|469066750|FG000|Overall Study|Withdrawal by Subject|4|||
130301826|NCT03043651|469066750|FG000|Overall Study|Study Terminated by Sponsor|39|||
130301827|NCT03597061|469066758|FG000|Overall Study|Lost to Follow-up|1|||
130301828|NCT03597061|469066759|FG001|Overall Study|Lost to Follow-up|0|||
130301829|NCT03597061|469066758|FG000|Overall Study|Protocol Violation|0|||
130301830|NCT03597061|469066759|FG001|Overall Study|Protocol Violation|1|||
130301831|NCT00411632|469066760|FG000|Overall Study|Death|1|||
130301832|NCT00761527|469066761|FG000|Overall Study|Adverse Event|3|||
130301833|NCT00761527|469066761|FG000|Overall Study|Poor Compliance|8|||
130301834|NCT00761527|469066761|FG000|Overall Study|Lost to Follow-up|9|||
130301835|NCT00761527|469066761|FG000|Overall Study|Unknown reason|2|||
130301836|NCT01431963|469066762|FG000|Overall Study|Adverse Event|18|||
130301837|NCT01431963|469066762|FG000|Overall Study|Lack of Efficacy|7|||
130301838|NCT01431963|469066762|FG000|Overall Study|Protocol Violation|1|||
130301839|NCT01431963|469066762|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
130301840|NCT01431963|469066762|FG000|Overall Study|Physician Decision|4|||
130301841|NCT01431963|469066762|FG000|Overall Study|Withdrawal by Subject|3|||
130301842|NCT02921087|469066765|FG000|Overall Study|Withdrawal by Subject|0|||
130301843|NCT02921087|469066766|FG001|Overall Study|Withdrawal by Subject|1|||
130301844|NCT00687531|469066767|FG000|Overall Study|Did not meet protocol eligibility|104|||
130301845|NCT00687531|469066767|FG000|Overall Study|Adverse Event|5|||
130301846|NCT00687531|469066767|FG000|Overall Study|Lost to Follow-up|26|||
130301847|NCT00619307|469066768|FG000|Overall Study|Adverse Event|0|||
130301848|NCT00619307|469066769|FG001|Overall Study|Adverse Event|1|||
130301849|NCT00619307|469066768|FG000|Overall Study|Lost to Follow-up|0|||
130301850|NCT00619307|469066769|FG001|Overall Study|Lost to Follow-up|1|||
130301851|NCT00619307|469066768|FG000|Overall Study|Protocol Violation|3|||
130301852|NCT00619307|469066769|FG001|Overall Study|Protocol Violation|0|||
130301853|NCT00619307|469066768|FG000|Overall Study|Withdrew consent|1|||
130301854|NCT00619307|469066769|FG001|Overall Study|Withdrew consent|0|||
130301855|NCT00619307|469066768|FG000|Overall Study|Severe migraine|0|||
130301856|NCT00619307|469066769|FG001|Overall Study|Severe migraine|1|||
130301857|NCT00619307|469066768|FG000|Overall Study|MS attack plus steroids|0|||
130301858|NCT00619307|469066769|FG001|Overall Study|MS attack plus steroids|1|||
130301859|NCT03210961|469068474|FG000|Overall Study|Adverse Event|0|||
130301860|NCT03210961|469068475|FG001|Overall Study|Adverse Event|0|||
130301861|NCT03210961|469068476|FG002|Overall Study|Adverse Event|0|||
130301862|NCT03210961|469068477|FG003|Overall Study|Adverse Event|0|||
130301863|NCT03210961|469068478|FG004|Overall Study|Adverse Event|0|||
130301864|NCT03210961|469068479|FG005|Overall Study|Adverse Event|0|||
130301865|NCT03210961|469068480|FG006|Overall Study|Adverse Event|0|||
130301866|NCT03210961|469068481|FG007|Overall Study|Adverse Event|0|||
130301867|NCT03210961|469068482|FG008|Overall Study|Adverse Event|0|||
130301868|NCT03210961|469068483|FG009|Overall Study|Adverse Event|0|||
130301869|NCT03210961|469068484|FG010|Overall Study|Adverse Event|0|||
130301870|NCT03210961|469068485|FG011|Overall Study|Adverse Event|0|||
130301871|NCT03210961|469068486|FG012|Overall Study|Adverse Event|0|||
130301872|NCT03210961|469068487|FG013|Overall Study|Adverse Event|1|||
130301873|NCT03210961|469068488|FG014|Overall Study|Adverse Event|0|||
130301874|NCT03210961|469068474|FG000|Overall Study|Lost to Follow-up|0|||
130301875|NCT03210961|469068475|FG001|Overall Study|Lost to Follow-up|0|||
130301876|NCT03210961|469068476|FG002|Overall Study|Lost to Follow-up|0|||
130301877|NCT03210961|469068477|FG003|Overall Study|Lost to Follow-up|0|||
130301878|NCT03210961|469068478|FG004|Overall Study|Lost to Follow-up|0|||
130301879|NCT03210961|469068479|FG005|Overall Study|Lost to Follow-up|0|||
130301880|NCT03210961|469068480|FG006|Overall Study|Lost to Follow-up|0|||
130301881|NCT03210961|469068481|FG007|Overall Study|Lost to Follow-up|0|||
130301882|NCT03210961|469068482|FG008|Overall Study|Lost to Follow-up|0|||
130301883|NCT03210961|469068483|FG009|Overall Study|Lost to Follow-up|0|||
130301884|NCT03210961|469068484|FG010|Overall Study|Lost to Follow-up|0|||
130301885|NCT03210961|469068485|FG011|Overall Study|Lost to Follow-up|0|||
130301886|NCT03210961|469068486|FG012|Overall Study|Lost to Follow-up|0|||
130301887|NCT03210961|469068487|FG013|Overall Study|Lost to Follow-up|0|||
130301888|NCT03210961|469068488|FG014|Overall Study|Lost to Follow-up|1|||
130301889|NCT03210961|469068474|FG000|Overall Study|Withdrawal by Subject|0|||
130301890|NCT03210961|469068475|FG001|Overall Study|Withdrawal by Subject|0|||
130301891|NCT03210961|469068476|FG002|Overall Study|Withdrawal by Subject|0|||
130301892|NCT03210961|469068477|FG003|Overall Study|Withdrawal by Subject|0|||
130301893|NCT03210961|469068478|FG004|Overall Study|Withdrawal by Subject|0|||
130301894|NCT03210961|469068479|FG005|Overall Study|Withdrawal by Subject|0|||
130301895|NCT03210961|469068480|FG006|Overall Study|Withdrawal by Subject|0|||
130301896|NCT03210961|469068481|FG007|Overall Study|Withdrawal by Subject|0|||
130301897|NCT03210961|469068482|FG008|Overall Study|Withdrawal by Subject|0|||
130301898|NCT03210961|469068483|FG009|Overall Study|Withdrawal by Subject|0|||
130301899|NCT03210961|469068484|FG010|Overall Study|Withdrawal by Subject|0|||
130301900|NCT03210961|469068485|FG011|Overall Study|Withdrawal by Subject|0|||
130301901|NCT03210961|469068486|FG012|Overall Study|Withdrawal by Subject|0|||
130301902|NCT03210961|469068487|FG013|Overall Study|Withdrawal by Subject|0|||
130301903|NCT03210961|469068488|FG014|Overall Study|Withdrawal by Subject|1|||
130301904|NCT03210961|469068474|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301905|NCT03210961|469068475|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301906|NCT03210961|469068476|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301907|NCT03210961|469068477|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301908|NCT03210961|469068478|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301909|NCT03210961|469068479|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301910|NCT03210961|469068480|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301911|NCT03210961|469068481|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301912|NCT03210961|469068482|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301913|NCT03210961|469068483|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301914|NCT03210961|469068484|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301915|NCT03210961|469068485|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301916|NCT03210961|469068486|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301917|NCT03210961|469068487|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
130301918|NCT03210961|469068488|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
130301919|NCT03210961|469068474|FG000|Overall Study|Other|0|||
130301920|NCT03210961|469068475|FG001|Overall Study|Other|0|||
130301921|NCT03210961|469068476|FG002|Overall Study|Other|0|||
130301922|NCT03210961|469068477|FG003|Overall Study|Other|1|||
130301923|NCT03210961|469068478|FG004|Overall Study|Other|0|||
130301924|NCT03210961|469068479|FG005|Overall Study|Other|0|||
130301925|NCT03210961|469068480|FG006|Overall Study|Other|1|||
130301926|NCT03210961|469068481|FG007|Overall Study|Other|0|||
130301927|NCT03210961|469068482|FG008|Overall Study|Other|0|||
130301928|NCT03210961|469068483|FG009|Overall Study|Other|0|||
130301929|NCT03210961|469068484|FG010|Overall Study|Other|1|||
130301930|NCT03210961|469068485|FG011|Overall Study|Other|0|||
130301931|NCT03210961|469068486|FG012|Overall Study|Other|2|||
130301932|NCT03210961|469068487|FG013|Overall Study|Other|2|||
130301933|NCT03210961|469068488|FG014|Overall Study|Other|0|||
130301934|NCT00602420|469068489|FG000|Overall Study|Death|1|||
130301935|NCT00602420|469068490|FG001|Overall Study|Death|4|||
130301936|NCT00602420|469068489|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
130301937|NCT00602420|469068490|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
130301938|NCT00602420|469068489|FG000|Overall Study|Withdrawal by Subject|18|||
130301939|NCT00602420|469068490|FG001|Overall Study|Withdrawal by Subject|17|||
130301940|NCT00602420|469068489|FG000|Overall Study|Adverse Event|1|||
130301941|NCT00602420|469068490|FG001|Overall Study|Adverse Event|0|||
130301942|NCT00703924|469068499|FG000|Overall Study|Withdrawal by Subject|1|||
130301943|NCT00703924|469068500|FG001|Overall Study|Withdrawal by Subject|1|||
130301944|NCT03077919|469068501|FG000|Overall Study|Lost to Follow-up|4|||
130301945|NCT03077919|469068502|FG001|Overall Study|Lost to Follow-up|1|||
130301946|NCT03592368|469068503|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130301947|NCT03592368|469068504|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
130301948|NCT03592368|469068505|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130301949|NCT03592368|469068506|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
130301950|NCT03592368|469068503|FG000|Overall Study|Adverse Event|0|||
130301951|NCT03592368|469068504|FG001|Overall Study|Adverse Event|0|||
130301952|NCT03592368|469068505|FG002|Overall Study|Adverse Event|0|||
130301953|NCT03592368|469068506|FG003|Overall Study|Adverse Event|1|||
130301954|NCT03592368|469068503|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
130301955|NCT03592368|469068504|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
130301956|NCT03592368|469068505|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
130301957|NCT03592368|469068506|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
130301958|NCT03499314|469068507|FG000|Overall Study|Time Commitment|1|||
129795249|NCT02398227|467217966|FG001|Overall Study|Withdrawal by Subject|6|||
129795250|NCT02398227|467217965|FG000|Overall Study|Removed from treatment and dropped out|1|||
130301959|NCT03499314|469068508|FG001|Overall Study|Time Commitment|2|||
130301960|NCT03499314|469068507|FG000|Overall Study|Medical issue unrelated to research study|1|||
130301961|NCT03499314|469068508|FG001|Overall Study|Medical issue unrelated to research study|1|||
130301962|NCT01618695|469068510|FG000|Core Phase|Adverse Event|4|||
130301963|NCT01618695|469068511|FG001|Core Phase|Adverse Event|5|||
130301964|NCT01618695|469068512|FG002|Core Phase|Adverse Event|15|||
130301965|NCT01618695|469068513|FG003|Core Phase|Adverse Event|20|||
130301966|NCT01618695|469068510|FG000|Core Phase|Lost to Follow-up|0|||
130301967|NCT01618695|469068511|FG001|Core Phase|Lost to Follow-up|0|||
130301968|NCT01618695|469068512|FG002|Core Phase|Lost to Follow-up|1|||
130301969|NCT01618695|469068513|FG003|Core Phase|Lost to Follow-up|0|||
130301970|NCT01618695|469068510|FG000|Core Phase|Withdrawal by Subject|16|||
130301971|NCT01618695|469068511|FG001|Core Phase|Withdrawal by Subject|11|||
130301972|NCT01618695|469068512|FG002|Core Phase|Withdrawal by Subject|9|||
130301973|NCT01618695|469068513|FG003|Core Phase|Withdrawal by Subject|13|||
130301974|NCT01618695|469068510|FG000|Core Phase|Pregnancy|2|||
130301975|NCT01618695|469068511|FG001|Core Phase|Pregnancy|0|||
130301976|NCT01618695|469068512|FG002|Core Phase|Pregnancy|0|||
130301977|NCT01618695|469068513|FG003|Core Phase|Pregnancy|0|||
130301978|NCT01618695|469068510|FG000|Core Phase|Lack of Efficacy|1|||
130301979|NCT01618695|469068511|FG001|Core Phase|Lack of Efficacy|2|||
130301980|NCT01618695|469068512|FG002|Core Phase|Lack of Efficacy|1|||
130301981|NCT01618695|469068513|FG003|Core Phase|Lack of Efficacy|1|||
130301982|NCT01618695|469068510|FG000|Core Phase|Other than specified|1|||
130301983|NCT01618695|469068511|FG001|Core Phase|Other than specified|2|||
130301984|NCT01618695|469068512|FG002|Core Phase|Other than specified|2|||
130301985|NCT01618695|469068513|FG003|Core Phase|Other than specified|2|||
130301986|NCT01618695|469068510|FG000|Core Phase|Not treated|1|||
130301987|NCT01618695|469068511|FG001|Core Phase|Not treated|0|||
130301988|NCT01618695|469068512|FG002|Core Phase|Not treated|2|||
130301989|NCT01618695|469068513|FG003|Core Phase|Not treated|0|||
130301990|NCT01618695|469068510|FG000|Extension Phase|Lack of Efficacy|17|||
130301991|NCT01618695|469068511|FG001|Extension Phase|Lack of Efficacy|33|||
130301992|NCT01618695|469068512|FG002|Extension Phase|Lack of Efficacy|26|||
130301993|NCT01618695|469068513|FG003|Extension Phase|Lack of Efficacy|24|||
130301994|NCT01618695|469068510|FG000|Extension Phase|Pregnancy|2|||
130301995|NCT01618695|469068511|FG001|Extension Phase|Pregnancy|0|||
130301996|NCT01618695|469068512|FG002|Extension Phase|Pregnancy|1|||
130301997|NCT01618695|469068513|FG003|Extension Phase|Pregnancy|1|||
130301998|NCT01618695|469068510|FG000|Extension Phase|Withdrawal by Subject|43|||
130301999|NCT01618695|469068511|FG001|Extension Phase|Withdrawal by Subject|48|||
130302000|NCT01618695|469068512|FG002|Extension Phase|Withdrawal by Subject|42|||
130302001|NCT01618695|469068513|FG003|Extension Phase|Withdrawal by Subject|33|||
130302002|NCT01618695|469068510|FG000|Extension Phase|Adverse Event|18|||
130302003|NCT01618695|469068511|FG001|Extension Phase|Adverse Event|16|||
130302004|NCT01618695|469068512|FG002|Extension Phase|Adverse Event|9|||
130302005|NCT01618695|469068513|FG003|Extension Phase|Adverse Event|20|||
130302006|NCT01618695|469068510|FG000|Extension Phase|Lost to Follow-up|2|||
130302007|NCT01618695|469068511|FG001|Extension Phase|Lost to Follow-up|1|||
130302008|NCT01618695|469068512|FG002|Extension Phase|Lost to Follow-up|1|||
130302009|NCT01618695|469068513|FG003|Extension Phase|Lost to Follow-up|1|||
130302010|NCT01618695|469068510|FG000|Extension Phase|Other than specified|13|||
130302011|NCT01618695|469068511|FG001|Extension Phase|Other than specified|18|||
130302012|NCT01618695|469068512|FG002|Extension Phase|Other than specified|13|||
130302013|NCT01618695|469068513|FG003|Extension Phase|Other than specified|18|||
130302014|NCT02454478|469068516|FG000|Overall Study|Incomplete DLT Evaluation|1|||
130302015|NCT02352753|469068520|FG000|6-Month Dosing Period|Decision by sponsor|2|||
130302016|NCT02352753|469068520|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
130302017|NCT02352753|469068520|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
130302018|NCT02352753|469068520|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
130302019|NCT02352753|469068520|FG000|3-Month Dosing Period|Decision by sponsor|14|||
130302020|NCT02352753|469068520|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
130302021|NCT00539305|469068521|FG000|Overall Study|Adverse Event|1|||
130302022|NCT00539305|469068522|FG001|Overall Study|Adverse Event|0|||
130302023|NCT00539305|469068521|FG000|Overall Study|Substance Use|0|||
130302024|NCT00539305|469068522|FG001|Overall Study|Substance Use|1|||
130302025|NCT00539305|469068521|FG000|Overall Study|Withdrawal by Subject|0|||
130302026|NCT00539305|469068522|FG001|Overall Study|Withdrawal by Subject|1|||
130302027|NCT00413036|469068528|FG000|Overall Study|Adverse Event|44|||
130302028|NCT00413036|469068528|FG000|Overall Study|Lack of Efficacy|129|||
130302029|NCT00413036|469068528|FG000|Overall Study|Withdrawal by Subject|7|||
130302030|NCT00413036|469068528|FG000|Overall Study|Death|9|||
130302031|NCT00413036|469068528|FG000|Overall Study|Other|26|||
130302032|NCT00413036|469068528|FG000|Overall Study|Missing|2|||
130302033|NCT01369641|469068529|FG000|Overall Study|Withdrawal by Subject|1|||
130302034|NCT02760810|469068537|FG000|Overall Study|Protocol Violation|1|||
130302035|NCT00820222|469068538|FG000|Overall Study|Lost to Follow-up|10|||
130302036|NCT00820222|469068539|FG001|Overall Study|Lost to Follow-up|9|||
130302037|NCT00820222|469068538|FG000|Overall Study|Withdrawal by Subject|19|||
130302038|NCT00820222|469068539|FG001|Overall Study|Withdrawal by Subject|21|||
130302039|NCT00820222|469068538|FG000|Overall Study|Physician Decision|93|||
130302040|NCT00820222|469068539|FG001|Overall Study|Physician Decision|88|||
130302041|NCT00820222|469068538|FG000|Overall Study|Sponsor Terminated Study|43|||
130302042|NCT00820222|469068539|FG001|Overall Study|Sponsor Terminated Study|65|||
130302043|NCT00820222|469068538|FG000|Overall Study|Unkown|11|||
130302044|NCT00820222|469068539|FG001|Overall Study|Unkown|7|||
130302045|NCT00932165|469068540|FG000|Overall Study|Lost to Follow-up|1|||
130302046|NCT00588094|469068541|FG000|Overall Study|Adverse Event|3|||
130302047|NCT00588094|469068541|FG000|Overall Study|Progression of Disease|2|||
130302048|NCT01336023|469068542|FG000|Week 0 to Week 26|Adverse Event|8|||
130302049|NCT01336023|469068543|FG001|Week 0 to Week 26|Adverse Event|10|||
130302050|NCT01336023|469068544|FG002|Week 0 to Week 26|Adverse Event|24|||
130302051|NCT01336023|469068542|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
130302052|NCT01336023|469068543|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
130302053|NCT01336023|469068544|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
130302054|NCT01336023|469068542|FG000|Week 0 to Week 26|Protocol Violation|1|||
130302055|NCT01336023|469068543|FG001|Week 0 to Week 26|Protocol Violation|2|||
130302056|NCT01336023|469068544|FG002|Week 0 to Week 26|Protocol Violation|0|||
130302057|NCT01336023|469068542|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
130302058|NCT01336023|469068543|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
130302059|NCT01336023|469068544|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
130302060|NCT01336023|469068542|FG000|Week 0 to Week 26|Unclassified|5|||
130302061|NCT01336023|469068543|FG001|Week 0 to Week 26|Unclassified|16|||
130302062|NCT01336023|469068544|FG002|Week 0 to Week 26|Unclassified|9|||
130302063|NCT01336023|469068542|FG000|Week 27 to 52|Adverse Event|1|||
130302064|NCT01336023|469068543|FG001|Week 27 to 52|Adverse Event|5|||
130302065|NCT01336023|469068544|FG002|Week 27 to 52|Adverse Event|2|||
130302066|NCT01336023|469068542|FG000|Week 27 to 52|Protocol Violation|0|||
130302067|NCT01336023|469068543|FG001|Week 27 to 52|Protocol Violation|2|||
130302068|NCT01336023|469068544|FG002|Week 27 to 52|Protocol Violation|1|||
130302069|NCT01336023|469068542|FG000|Week 27 to 52|Withdrawal Criteria|14|||
130302070|NCT01336023|469068543|FG001|Week 27 to 52|Withdrawal Criteria|19|||
130302071|NCT01336023|469068544|FG002|Week 27 to 52|Withdrawal Criteria|16|||
130302072|NCT01336023|469068542|FG000|Week 27 to 52|Unclassified|13|||
130302073|NCT01336023|469068543|FG001|Week 27 to 52|Unclassified|18|||
130302074|NCT01336023|469068544|FG002|Week 27 to 52|Unclassified|9|||
130302075|NCT00666965|469068547|FG000|Overall Study|Adverse Event|0|||
130302076|NCT00666965|469068548|FG001|Overall Study|Adverse Event|2|||
130302077|NCT00666965|469068549|FG002|Overall Study|Adverse Event|1|||
130302078|NCT00666965|469068550|FG003|Overall Study|Adverse Event|9|||
130302079|NCT00666965|469068547|FG000|Overall Study|Lack of Efficacy|1|||
130302080|NCT00666965|469068548|FG001|Overall Study|Lack of Efficacy|1|||
130302081|NCT00666965|469068549|FG002|Overall Study|Lack of Efficacy|0|||
130302082|NCT00666965|469068550|FG003|Overall Study|Lack of Efficacy|0|||
130302083|NCT00666965|469068547|FG000|Overall Study|Protocol Violation|0|||
130302084|NCT00666965|469068548|FG001|Overall Study|Protocol Violation|0|||
130302085|NCT00666965|469068549|FG002|Overall Study|Protocol Violation|0|||
130302086|NCT00666965|469068550|FG003|Overall Study|Protocol Violation|2|||
130302087|NCT00666965|469068547|FG000|Overall Study|Discontinuation criteria|2|||
130302088|NCT00666965|469068548|FG001|Overall Study|Discontinuation criteria|1|||
130302089|NCT00666965|469068549|FG002|Overall Study|Discontinuation criteria|1|||
130302090|NCT00666965|469068550|FG003|Overall Study|Discontinuation criteria|2|||
130302091|NCT00666965|469068547|FG000|Overall Study|Withdrawal by Subject|0|||
130302092|NCT00666965|469068548|FG001|Overall Study|Withdrawal by Subject|0|||
130302093|NCT00666965|469068549|FG002|Overall Study|Withdrawal by Subject|0|||
130302094|NCT00666965|469068550|FG003|Overall Study|Withdrawal by Subject|2|||
130302095|NCT01853878|469068554|FG000|Overall Study|Recurrence|2|||
130302096|NCT01853878|469068555|FG001|Overall Study|Recurrence|0|||
130302097|NCT01853878|469068554|FG000|Overall Study|Adverse Event|2|||
130302098|NCT01853878|469068555|FG001|Overall Study|Adverse Event|0|||
130302099|NCT01853878|469068554|FG000|Overall Study|Withdrawal by Subject|3|||
130302100|NCT01853878|469068555|FG001|Overall Study|Withdrawal by Subject|1|||
130302101|NCT01853878|469068554|FG000|Overall Study|Migrated/moved from the study area|1|||
130302102|NCT01853878|469068555|FG001|Overall Study|Migrated/moved from the study area|0|||
130302103|NCT01853878|469068554|FG000|Overall Study|Other|55|||
130302104|NCT01853878|469068555|FG001|Overall Study|Other|43|||
130302105|NCT01361178|469068556|FG000|Overall Study|Death|13|||
130302106|NCT01361178|469068557|FG001|Overall Study|Death|0|||
130302107|NCT00391625|469068558|FG000|Month 14|Withdrawal by Subject|1|||
130302108|NCT00391625|469068558|FG000|Month 50|Physician Decision|1|||
130302109|NCT03916081|469068561|FG000|Overall Study|Adverse Event|1|||
130302110|NCT03916081|469068562|FG001|Overall Study|Adverse Event|0|||
130302111|NCT03916081|469068563|FG002|Overall Study|Adverse Event|0|||
130302112|NCT03916081|469068561|FG000|Overall Study|Physician Decision|0|||
130302113|NCT03916081|469068562|FG001|Overall Study|Physician Decision|0|||
130302114|NCT03916081|469068563|FG002|Overall Study|Physician Decision|1|||
130302115|NCT03916081|469068561|FG000|Overall Study|Lost to Follow-up|0|||
130302116|NCT03916081|469068562|FG001|Overall Study|Lost to Follow-up|1|||
130302117|NCT03916081|469068563|FG002|Overall Study|Lost to Follow-up|0|||
130302118|NCT03916081|469068561|FG000|Overall Study|Withdrawal by Subject|3|||
130302119|NCT03916081|469068562|FG001|Overall Study|Withdrawal by Subject|0|||
130302120|NCT03916081|469068563|FG002|Overall Study|Withdrawal by Subject|1|||
130302121|NCT03916081|469068561|FG000|Overall Study|Worsening of AD|0|||
130302122|NCT03916081|469068562|FG001|Overall Study|Worsening of AD|0|||
130302123|NCT03916081|469068563|FG002|Overall Study|Worsening of AD|1|||
130302124|NCT03244826|469068564|FG000|Overall Study|Withdrawal by Subject|2|||
130302125|NCT03244826|469068565|FG001|Overall Study|Withdrawal by Subject|0|||
130302126|NCT03244826|469068564|FG000|Overall Study|Transplant delayed or withdrawn|12|||
130302127|NCT03244826|469068565|FG001|Overall Study|Transplant delayed or withdrawn|10|||
130302128|NCT00416455|469068569|FG000|Overall Study|PET / CT not done|3|||
130302129|NCT00416455|469068570|FG001|Overall Study|PET / CT not done|5|||
130302130|NCT00416455|469068569|FG000|Overall Study|PET / CT poor quality|2|||
130302131|NCT00416455|469068570|FG001|Overall Study|PET / CT poor quality|1|||
130302132|NCT00416455|469068569|FG000|Overall Study|Inadequate pathology|11|||
130302133|NCT00416455|469068570|FG001|Overall Study|Inadequate pathology|2|||
130302134|NCT00348309|469068572|FG000|Overall Study|Adverse Event|56|||
130302135|NCT00348309|469068573|FG001|Overall Study|Adverse Event|28|||
130302136|NCT00348309|469068574|FG002|Overall Study|Adverse Event|63|||
130302137|NCT00348309|469068572|FG000|Overall Study|Lost to Follow-up|6|||
130047582|NCT01240811|468131498|FG002|Overall Study|Withdrawal by Subject|1|||
130047583|NCT01543490|468131502|FG000|Overall Study|Adverse Event|4|||
130047584|NCT01543490|468131503|FG001|Overall Study|Adverse Event|0|||
130302138|NCT00348309|469068573|FG001|Overall Study|Lost to Follow-up|7|||
130302139|NCT00348309|469068574|FG002|Overall Study|Lost to Follow-up|4|||
130302140|NCT00348309|469068572|FG000|Overall Study|Protocol Violation|7|||
130302141|NCT00348309|469068573|FG001|Overall Study|Protocol Violation|12|||
130302142|NCT00348309|469068574|FG002|Overall Study|Protocol Violation|7|||
130302143|NCT00348309|469068572|FG000|Overall Study|Withdrawal by Subject|33|||
130302144|NCT00348309|469068573|FG001|Overall Study|Withdrawal by Subject|37|||
130302145|NCT00348309|469068574|FG002|Overall Study|Withdrawal by Subject|40|||
130302146|NCT00348309|469068572|FG000|Overall Study|Non-compliance|8|||
130302147|NCT00348309|469068573|FG001|Overall Study|Non-compliance|6|||
130302148|NCT00348309|469068574|FG002|Overall Study|Non-compliance|8|||
130302149|NCT00348309|469068572|FG000|Overall Study|Death of caregiver|1|||
130302150|NCT00348309|469068573|FG001|Overall Study|Death of caregiver|0|||
130302151|NCT00348309|469068574|FG002|Overall Study|Death of caregiver|1|||
130302152|NCT00348309|469068572|FG000|Overall Study|Lack of insight, dementia|1|||
130302153|NCT00348309|469068573|FG001|Overall Study|Lack of insight, dementia|0|||
130302154|NCT00348309|469068574|FG002|Overall Study|Lack of insight, dementia|0|||
130302155|NCT00348309|469068572|FG000|Overall Study|Wrong bottle allocated|1|||
130302156|NCT00348309|469068573|FG001|Overall Study|Wrong bottle allocated|0|||
130302157|NCT00348309|469068574|FG002|Overall Study|Wrong bottle allocated|0|||
130302158|NCT00348309|469068572|FG000|Overall Study|Caregiver sick|1|||
130302159|NCT00348309|469068573|FG001|Overall Study|Caregiver sick|0|||
130302160|NCT00348309|469068574|FG002|Overall Study|Caregiver sick|0|||
130302161|NCT00348309|469068572|FG000|Overall Study|Use of prohibited medication|5|||
130302162|NCT00348309|469068573|FG001|Overall Study|Use of prohibited medication|2|||
130302163|NCT00348309|469068574|FG002|Overall Study|Use of prohibited medication|2|||
130302164|NCT00348309|469068572|FG000|Overall Study|Caregiver withdrawal|3|||
130302165|NCT00348309|469068573|FG001|Overall Study|Caregiver withdrawal|0|||
130302166|NCT00348309|469068574|FG002|Overall Study|Caregiver withdrawal|7|||
130302167|NCT00348309|469068572|FG000|Overall Study|Unable to complete ET visit|1|||
130302168|NCT00348309|469068573|FG001|Overall Study|Unable to complete ET visit|0|||
130302169|NCT00348309|469068574|FG002|Overall Study|Unable to complete ET visit|0|||
130302170|NCT00348309|469068572|FG000|Overall Study|PI closing medical practice|1|||
130302171|NCT00348309|469068573|FG001|Overall Study|PI closing medical practice|0|||
130302172|NCT00348309|469068574|FG002|Overall Study|PI closing medical practice|0|||
130302173|NCT00348309|469068572|FG000|Overall Study|Principal investigator's decision|1|||
130302174|NCT00348309|469068573|FG001|Overall Study|Principal investigator's decision|0|||
130302175|NCT00348309|469068574|FG002|Overall Study|Principal investigator's decision|0|||
130302176|NCT00348309|469068572|FG000|Overall Study|No disponibility of medication|1|||
130302177|NCT00348309|469068573|FG001|Overall Study|No disponibility of medication|0|||
130302178|NCT00348309|469068574|FG002|Overall Study|No disponibility of medication|0|||
130302179|NCT00348309|469068572|FG000|Overall Study|Worsened neurodegenerative disease|1|||
130047585|NCT01543490|468131502|FG000|Overall Study|Physician Decision|1|||
130302180|NCT00348309|469068573|FG001|Overall Study|Worsened neurodegenerative disease|0|||
130302181|NCT00348309|469068574|FG002|Overall Study|Worsened neurodegenerative disease|0|||
130302182|NCT00348309|469068572|FG000|Overall Study|Cognitive and behaviour worsening|2|||
130302183|NCT00348309|469068573|FG001|Overall Study|Cognitive and behaviour worsening|0|||
130302184|NCT00348309|469068574|FG002|Overall Study|Cognitive and behaviour worsening|0|||
129889097|NCT01349660|467551009|FG002|Overall Study|Non-Permitted Interventions|2|||
129889098|NCT01349660|467551007|FG000|Overall Study|Study Compliance|0|||
130302185|NCT00348309|469068572|FG000|Overall Study|Worsening of alzheimer|1|||
130302186|NCT00348309|469068573|FG001|Overall Study|Worsening of alzheimer|0|||
130302187|NCT00348309|469068574|FG002|Overall Study|Worsening of alzheimer|1|||
130302188|NCT00348309|469068572|FG000|Overall Study|Did not appear in time for Visit 3|1|||
130302189|NCT00348309|469068573|FG001|Overall Study|Did not appear in time for Visit 3|0|||
130302190|NCT00348309|469068574|FG002|Overall Study|Did not appear in time for Visit 3|0|||
130302191|NCT00348309|469068572|FG000|Overall Study|Participant died|2|||
130302192|NCT00348309|469068573|FG001|Overall Study|Participant died|1|||
130302193|NCT00348309|469068574|FG002|Overall Study|Participant died|1|||
130302194|NCT00348309|469068572|FG000|Overall Study|Decision of sponsor|1|||
130302195|NCT00348309|469068573|FG001|Overall Study|Decision of sponsor|0|||
130302196|NCT00348309|469068574|FG002|Overall Study|Decision of sponsor|0|||
130302197|NCT00348309|469068572|FG000|Overall Study|Ineffectiveness of treatment|0|||
130302198|NCT00348309|469068573|FG001|Overall Study|Ineffectiveness of treatment|1|||
130302199|NCT00348309|469068574|FG002|Overall Study|Ineffectiveness of treatment|0|||
130302200|NCT00348309|469068572|FG000|Overall Study|A foul of exclusion criteria|0|||
130302201|NCT00348309|469068573|FG001|Overall Study|A foul of exclusion criteria|1|||
130302202|NCT00348309|469068574|FG002|Overall Study|A foul of exclusion criteria|0|||
130302203|NCT00348309|469068572|FG000|Overall Study|Participant was hospitalized|0|||
130302204|NCT00348309|469068573|FG001|Overall Study|Participant was hospitalized|1|||
130302205|NCT00348309|469068574|FG002|Overall Study|Participant was hospitalized|0|||
130302206|NCT00348309|469068572|FG000|Overall Study|Sponsor refuseal|0|||
130302207|NCT00348309|469068573|FG001|Overall Study|Sponsor refuseal|1|||
130302208|NCT00348309|469068574|FG002|Overall Study|Sponsor refuseal|1|||
130302209|NCT00348309|469068572|FG000|Overall Study|Forgot often medication|0|||
130302210|NCT00348309|469068573|FG001|Overall Study|Forgot often medication|1|||
130302211|NCT00348309|469068574|FG002|Overall Study|Forgot often medication|0|||
130302212|NCT00348309|469068572|FG000|Overall Study|Medical Monitor decision|0|||
130302213|NCT00348309|469068573|FG001|Overall Study|Medical Monitor decision|0|||
130302214|NCT00348309|469068574|FG002|Overall Study|Medical Monitor decision|1|||
130302215|NCT00348309|469068572|FG000|Overall Study|Increased dose of Aricept|0|||
130302216|NCT00348309|469068573|FG001|Overall Study|Increased dose of Aricept|0|||
130302217|NCT00348309|469068574|FG002|Overall Study|Increased dose of Aricept|1|||
130302218|NCT00348309|469068572|FG000|Overall Study|Site closure|0|||
130302219|NCT00348309|469068573|FG001|Overall Study|Site closure|0|||
130302220|NCT00348309|469068574|FG002|Overall Study|Site closure|1|||
130302221|NCT00348309|469068572|FG000|Overall Study|Adverse event not attended|0|||
130302222|NCT00348309|469068573|FG001|Overall Study|Adverse event not attended|0|||
130302223|NCT00348309|469068574|FG002|Overall Study|Adverse event not attended|1|||
130302224|NCT00348309|469068572|FG000|Overall Study|ECG abnormal|0|||
130302225|NCT00348309|469068573|FG001|Overall Study|ECG abnormal|0|||
130302226|NCT00348309|469068574|FG002|Overall Study|ECG abnormal|2|||
130302227|NCT00348309|469068572|FG000|Overall Study|Cardiologist recommendations|0|||
130302228|NCT00348309|469068573|FG001|Overall Study|Cardiologist recommendations|0|||
130302229|NCT00348309|469068574|FG002|Overall Study|Cardiologist recommendations|1|||
130302230|NCT00348309|469068572|FG000|Overall Study|HCV career|0|||
130302231|NCT00348309|469068573|FG001|Overall Study|HCV career|0|||
130302232|NCT00348309|469068574|FG002|Overall Study|HCV career|1|||
130302233|NCT00622388|469068575|FG000|Overall Study|Disease Progression|47|||
130302234|NCT00622388|469068575|FG000|Overall Study|Adverse Event|6|||
130302235|NCT00622388|469068575|FG000|Overall Study|Protocol Violation|3|||
130047586|NCT01543490|468131503|FG001|Overall Study|Physician Decision|0|||
130302236|NCT00622388|469068575|FG000|Overall Study|Participant Refusal|1|||
130302237|NCT00622388|469068575|FG000|Overall Study|Death|3|||
130302238|NCT00622388|469068575|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
130302239|NCT00622388|469068575|FG000|Overall Study|Took Prohibited Medication|2|||
130302240|NCT00622388|469068575|FG000|Overall Study|Withdrew Consent|1|||
130302241|NCT00622388|469068575|FG000|Overall Study|Insurance Expired|1|||
130302242|NCT00828750|469068576|FG000|Overall Study|Lack of Efficacy|3|||
130302243|NCT00828750|469068576|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
130302244|NCT04079114|469068577|FG000|Overall Study|Study prematuely terminated.|166|||
129889099|NCT01349660|467551008|FG001|Overall Study|Study Compliance|0|||
130302245|NCT01364389|469068578|FG000|Overall Study|Withdrawal by Subject|0|||
130302246|NCT01364389|469068579|FG001|Overall Study|Withdrawal by Subject|1|||
130302247|NCT01364389|469068580|FG002|Overall Study|Withdrawal by Subject|0|||
130302248|NCT01364389|469068578|FG000|Overall Study|Protocol deviation|0|||
130302249|NCT01364389|469068579|FG001|Overall Study|Protocol deviation|0|||
130302250|NCT01364389|469068580|FG002|Overall Study|Protocol deviation|1|||
130302251|NCT01364389|469068578|FG000|Overall Study|Administrative problems|1|||
130302252|NCT01364389|469068579|FG001|Overall Study|Administrative problems|0|||
130302253|NCT01364389|469068580|FG002|Overall Study|Administrative problems|0|||
130302254|NCT01364389|469068578|FG000|Overall Study|Adverse Event|1|||
130302255|NCT01364389|469068579|FG001|Overall Study|Adverse Event|0|||
130302256|NCT01364389|469068580|FG002|Overall Study|Adverse Event|0|||
130302257|NCT01068158|469068581|FG000|Overall Study|Withdrawal by Subject|1|||
130302258|NCT01068158|469068582|FG001|Overall Study|Withdrawal by Subject|2|||
130302259|NCT01068158|469068581|FG000|Overall Study|Lost to Follow-up|7|||
130302260|NCT01068158|469068582|FG001|Overall Study|Lost to Follow-up|0|||
130302261|NCT01068158|469068581|FG000|Overall Study|Protocol Violation|0|||
130302262|NCT01068158|469068582|FG001|Overall Study|Protocol Violation|2|||
130302263|NCT00991406|469068583|FG000|Overall Study|One participant did not respond to FES.|1|||
130302264|NCT01300572|469068584|FG000|Overall Study|HAMA + post dosimetry|1|||
130302265|NCT02160145|469068586|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
130302266|NCT02160145|469068587|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
130302267|NCT02160145|469068588|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
130302268|NCT02160145|469068586|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
130302269|NCT02160145|469068587|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
130302270|NCT02160145|469068588|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
130302271|NCT02160145|469068586|FG000|Randomized Double-blind Period|Subject decision|0|||
130302272|NCT02160145|469068587|FG001|Randomized Double-blind Period|Subject decision|21|||
130302273|NCT02160145|469068588|FG002|Randomized Double-blind Period|Subject decision|20|||
130302274|NCT02160145|469068586|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
130302275|NCT02160145|469068587|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
130302276|NCT02160145|469068588|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
130302277|NCT02160145|469068586|FG000|Randomized Double-blind Period|Physician Decision|0|||
130302278|NCT02160145|469068587|FG001|Randomized Double-blind Period|Physician Decision|7|||
130302279|NCT02160145|469068588|FG002|Randomized Double-blind Period|Physician Decision|5|||
130302280|NCT00375518|469068589|FG000|Overall Study|Withdrawal by Subject|2|||
130302281|NCT00375518|469068590|FG001|Overall Study|Withdrawal by Subject|10|||
130302282|NCT00375518|469068589|FG000|Overall Study|Patient Not Treated|6|||
130302283|NCT00375518|469068590|FG001|Overall Study|Patient Not Treated|6|||
130302284|NCT00375518|469068589|FG000|Overall Study|Death|0|||
130302285|NCT00375518|469068590|FG001|Overall Study|Death|1|||
130302286|NCT01108523|469068591|FG000|Overall Study|Protocol Violation|4|||
130302287|NCT03848949|469068601|FG000|Overall Study|Lost to Follow-up|5|||
130302288|NCT03848949|469068602|FG001|Overall Study|Lost to Follow-up|7|||
130302289|NCT02353728|469068605|FG000|Overall Study|Subject non-compliance|1|||
130302290|NCT02301624|469068606|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
130302291|NCT02301624|469068607|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
130302292|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
130302293|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
130302294|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Adverse Event|2|||
130302295|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Adverse Event|5|||
130302296|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Physician Decision|3|||
130302297|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Physician Decision|3|||
130302298|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Death|2|||
130302299|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Death|1|||
130302300|NCT02301624|469068606|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
130302301|NCT02301624|469068607|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
130302302|NCT00895310|469068608|FG000|Overall Study|Withdrawal by Subject|1|||
130302303|NCT00659230|469068609|FG000|Overall Study|Lost to Follow-up|2|||
130302304|NCT00659230|469068610|FG001|Overall Study|Lost to Follow-up|5|||
130302305|NCT00659230|469068609|FG000|Overall Study|Lost source documentation|5|||
130302306|NCT00659230|469068610|FG001|Overall Study|Lost source documentation|4|||
130302307|NCT00659230|469068609|FG000|Overall Study|Did not return post-randomization|2|||
130302308|NCT00659230|469068610|FG001|Overall Study|Did not return post-randomization|3|||
130302309|NCT00547521|469068611|FG000|Short Term Study (4 Months)|Adverse Event|1|||
130302310|NCT00547521|469068612|FG001|Short Term Study (4 Months)|Adverse Event|0|||
130302311|NCT00547521|469068611|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
130302312|NCT00547521|469068612|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
130302313|NCT00547521|469068611|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
130302314|NCT00547521|469068612|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
130302315|NCT00547521|469068611|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
130302316|NCT00547521|469068612|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
130302317|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
130302318|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
130302319|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
130302320|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
130302321|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
130302322|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
130302323|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
130302324|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
130302325|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Other|0|||
130302326|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Other|2|||
130302327|NCT00547521|469068611|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
130302328|NCT00547521|469068612|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
130302329|NCT03109184|469071144|FG000|Overall Study|Lost to Follow-up|6|||
130302330|NCT03109184|469071145|FG001|Overall Study|Lost to Follow-up|6|||
130302331|NCT03109184|469071144|FG000|Overall Study|Withdrawal by Subject|1|||
130302332|NCT03109184|469071145|FG001|Overall Study|Withdrawal by Subject|1|||
130302333|NCT01031979|469071148|FG000|Overall Study|Lost to Follow-up|5|||
130302334|NCT01031979|469071149|FG001|Overall Study|Lost to Follow-up|4|||
130302335|NCT03831100|469071151|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
130302336|NCT03831100|469071152|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
130302337|NCT02008227|469071156|FG000|Overall Study|Lost to Follow-up|7|||
130302338|NCT02008227|469071157|FG001|Overall Study|Lost to Follow-up|9|||
130302339|NCT02008227|469071156|FG000|Overall Study|Death|494|||
130302340|NCT02008227|469071157|FG001|Overall Study|Death|485|||
130302341|NCT02008227|469071156|FG000|Overall Study|Withdrawal by Subject|67|||
130302342|NCT02008227|469071157|FG001|Overall Study|Withdrawal by Subject|36|||
130302343|NCT02008227|469071156|FG000|Overall Study|Study Terminated By Sponsor|44|||
130302344|NCT02008227|469071157|FG001|Overall Study|Study Terminated By Sponsor|83|||
130302345|NCT01487265|469071160|FG000|Overall Study|Adverse Event|8|||
130302346|NCT01487265|469071160|FG000|Overall Study|Withdrawal by Subject|5|||
130302347|NCT01487265|469071160|FG000|Overall Study|Disease Progression|21|||
130302348|NCT01487265|469071160|FG000|Overall Study|Death|2|||
130302349|NCT01487265|469071160|FG000|Overall Study|Still on Treatment|1|||
130302350|NCT00965575|469071161|FG000|Overall Study|subject unwillingness to swallow study c|1|||
130302351|NCT00965575|469071162|FG001|Overall Study|subject unwillingness to swallow study c|0|||
130302352|NCT01959841|469071163|FG000|Overall Study|Adverse Event|1|||
130302353|NCT01959841|469071164|FG001|Overall Study|Adverse Event|3|||
130302354|NCT01959841|469071165|FG002|Overall Study|Adverse Event|2|||
130302355|NCT01959841|469071163|FG000|Overall Study|Lack of Efficacy|5|||
130302356|NCT01959841|469071164|FG001|Overall Study|Lack of Efficacy|0|||
130302357|NCT01959841|469071165|FG002|Overall Study|Lack of Efficacy|0|||
130302358|NCT01959841|469071163|FG000|Overall Study|Lost to Follow-up|1|||
130302359|NCT01959841|469071164|FG001|Overall Study|Lost to Follow-up|1|||
130302360|NCT01959841|469071165|FG002|Overall Study|Lost to Follow-up|0|||
130302361|NCT01959841|469071163|FG000|Overall Study|Physician Decision|0|||
130302362|NCT01959841|469071164|FG001|Overall Study|Physician Decision|2|||
130302363|NCT01959841|469071165|FG002|Overall Study|Physician Decision|3|||
130302364|NCT01959841|469071163|FG000|Overall Study|Protocol Violation|16|||
130302365|NCT01959841|469071164|FG001|Overall Study|Protocol Violation|23|||
130302366|NCT01959841|469071165|FG002|Overall Study|Protocol Violation|16|||
130302367|NCT01959841|469071163|FG000|Overall Study|Withdrawal by Subject|7|||
130302368|NCT01959841|469071164|FG001|Overall Study|Withdrawal by Subject|7|||
130302369|NCT01959841|469071165|FG002|Overall Study|Withdrawal by Subject|5|||
130302370|NCT01959841|469071163|FG000|Overall Study|Clinical laboratory value|2|||
130302371|NCT01959841|469071164|FG001|Overall Study|Clinical laboratory value|6|||
130302372|NCT01959841|469071165|FG002|Overall Study|Clinical laboratory value|6|||
130302373|NCT01959841|469071163|FG000|Overall Study|Platelet count below on day1 or 4|11|||
130302374|NCT01959841|469071164|FG001|Overall Study|Platelet count below on day1 or 4|15|||
130302375|NCT01959841|469071165|FG002|Overall Study|Platelet count below on day1 or 4|11|||
130302376|NCT00780416|469071166|FG000|Overall Study|Physician Decision|3|||
130302377|NCT00780416|469071167|FG001|Overall Study|Physician Decision|3|||
130302378|NCT00780416|469071166|FG000|Overall Study|Protocol Violation|1|||
130302379|NCT00780416|469071167|FG001|Overall Study|Protocol Violation|0|||
130302380|NCT00780416|469071166|FG000|Overall Study|Withdrawal by Subject|8|||
130302381|NCT00780416|469071167|FG001|Overall Study|Withdrawal by Subject|6|||
130302382|NCT00666224|469071168|FG000|Double-Blind|Adverse Event|15|||
130302383|NCT00666224|469071169|FG001|Double-Blind|Adverse Event|5|||
130302384|NCT00666224|469071168|FG000|Double-Blind|Lost to Follow-up|2|||
130302385|NCT00666224|469071169|FG001|Double-Blind|Lost to Follow-up|2|||
130302386|NCT00666224|469071168|FG000|Double-Blind|Withdrawal by Subject|18|||
130302387|NCT00666224|469071169|FG001|Double-Blind|Withdrawal by Subject|14|||
130302388|NCT00666224|469071168|FG000|Double-Blind|Physician Decision|0|||
130302389|NCT00666224|469071169|FG001|Double-Blind|Physician Decision|3|||
130302390|NCT00666224|469071168|FG000|Double-Blind|Sponsor decision|1|||
130302391|NCT00666224|469071169|FG001|Double-Blind|Sponsor decision|0|||
130302392|NCT00666224|469071168|FG000|Double-Blind|Pregnancy|3|||
130302393|NCT00666224|469071169|FG001|Double-Blind|Pregnancy|2|||
130302394|NCT00666224|469071168|FG000|Double-Blind|Noncompliance|1|||
130302395|NCT00666224|469071169|FG001|Double-Blind|Noncompliance|0|||
130302396|NCT00666224|469071168|FG000|Double-Blind|Death|1|||
130302397|NCT00666224|469071169|FG001|Double-Blind|Death|0|||
130302398|NCT00666224|469071168|FG000|Double-Blind|Undefined/Unknown|4|||
130302399|NCT00666224|469071169|FG001|Double-Blind|Undefined/Unknown|1|||
130302400|NCT00666224|469071168|FG000|Open-Label|Adverse Event|8|||
130302401|NCT00666224|469071169|FG001|Open-Label|Adverse Event|43|||
130302402|NCT00666224|469071168|FG000|Open-Label|Lost to Follow-up|4|||
130302403|NCT00666224|469071169|FG001|Open-Label|Lost to Follow-up|5|||
130302404|NCT00666224|469071168|FG000|Open-Label|Withdrawal by Subject|12|||
130302405|NCT00666224|469071169|FG001|Open-Label|Withdrawal by Subject|25|||
130302406|NCT00666224|469071168|FG000|Open-Label|Physician Decision|7|||
130302407|NCT00666224|469071169|FG001|Open-Label|Physician Decision|5|||
130302408|NCT00666224|469071168|FG000|Open-Label|Pregnancy|1|||
130302409|NCT00666224|469071169|FG001|Open-Label|Pregnancy|5|||
130302410|NCT00666224|469071168|FG000|Open-Label|Noncompliance|2|||
130302411|NCT00666224|469071169|FG001|Open-Label|Noncompliance|1|||
130302412|NCT00666224|469071168|FG000|Open-Label|Undefined/Unknown|1|||
130302413|NCT00666224|469071169|FG001|Open-Label|Undefined/Unknown|1|||
130302414|NCT03521141|469071173|FG000|Overall Study|Death|1|||
130302415|NCT03521141|469071174|FG001|Overall Study|Death|0|||
130302416|NCT03521141|469071175|FG002|Overall Study|Death|1|||
130302417|NCT01271725|469071182|FG000|Part A|Progressive disease according to RECIST|8|||
130302418|NCT01271725|469071183|FG001|Part A|Progressive disease according to RECIST|0|||
130302419|NCT01271725|469071182|FG000|Part A|Clinical signs/symptoms of progression|2|||
130302420|NCT01271725|469071183|FG001|Part A|Clinical signs/symptoms of progression|0|||
130302421|NCT01271725|469071182|FG000|Part A|Other Adverse Event|8|||
130302422|NCT01271725|469071183|FG001|Part A|Other Adverse Event|0|||
130302423|NCT01271725|469071182|FG000|Part A|Lost to Follow-up|1|||
130302424|NCT01271725|469071183|FG001|Part A|Lost to Follow-up|0|||
130302425|NCT01271725|469071182|FG000|Part A|Withdrawal by Subject|12|||
130302426|NCT01271725|469071183|FG001|Part A|Withdrawal by Subject|0|||
130302427|NCT01271725|469071182|FG000|Part A|Other than specified|3|||
130302428|NCT01271725|469071183|FG001|Part A|Other than specified|0|||
130302429|NCT01271725|469071182|FG000|Part A|Protocol Violation|1|||
130302430|NCT01271725|469071183|FG001|Part A|Protocol Violation|0|||
130302431|NCT01271725|469071182|FG000|Part B|Other than specified|0|||
130302432|NCT01271725|469071183|FG001|Part B|Other than specified|2|||
130302433|NCT01271725|469071182|FG000|Part B|Clinical signs/symptoms of progression|0|||
130302434|NCT01271725|469071183|FG001|Part B|Clinical signs/symptoms of progression|2|||
130302435|NCT01271725|469071182|FG000|Part B|Other Adverse Event|0|||
130302436|NCT01271725|469071183|FG001|Part B|Other Adverse Event|1|||
130302437|NCT01271725|469071182|FG000|Part B|Protocol Violation|0|||
130302438|NCT01271725|469071183|FG001|Part B|Protocol Violation|1|||
130302439|NCT01271725|469071182|FG000|Part B|Withdrawal by Subject|0|||
130302440|NCT01271725|469071183|FG001|Part B|Withdrawal by Subject|6|||
130302441|NCT01702025|469071184|FG000|Overall Study|Equipment failure|1|||
130302442|NCT01702025|469071185|FG001|Overall Study|Equipment failure|0|||
130302443|NCT01702025|469071186|FG002|Overall Study|Equipment failure|0|||
130302444|NCT01702025|469071187|FG003|Overall Study|Equipment failure|0|||
130302445|NCT01702025|469071184|FG000|Overall Study|Adverse Event|1|||
130302446|NCT01702025|469071185|FG001|Overall Study|Adverse Event|1|||
130302447|NCT01702025|469071186|FG002|Overall Study|Adverse Event|1|||
130302448|NCT01702025|469071187|FG003|Overall Study|Adverse Event|0|||
130302449|NCT03354273|469071188|FG000|Overall Study|Adverse Event|5|||
130302450|NCT03354273|469071188|FG000|Overall Study|Screen Failure|21|||
130302451|NCT03354273|469071188|FG000|Overall Study|Withdrawal by Subject|34|||
130302452|NCT03354273|469071188|FG000|Overall Study|Technical Problems|30|||
130302453|NCT03354273|469071188|FG000|Overall Study|Lost to Follow-up|4|||
130302454|NCT03354273|469071188|FG000|Overall Study|Investigator Decision|3|||
130302455|NCT03354273|469071188|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
130302456|NCT03354273|469071188|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
130302457|NCT03354273|469071188|FG000|Overall Study|COVID-19 Restrictions|9|||
130302458|NCT03354273|469071188|FG000|Overall Study|Other|5|||
130302459|NCT03229109|469071194|FG000|Overall Study|Withdrawal by Subject|0|||
130302460|NCT03229109|469071195|FG001|Overall Study|Withdrawal by Subject|0|||
130302461|NCT03229109|469071196|FG002|Overall Study|Withdrawal by Subject|0|||
130302462|NCT03229109|469071197|FG003|Overall Study|Withdrawal by Subject|1|||
130302463|NCT04207749|469071198|FG000|Overall Study|Lost to Follow-up|0|||
130302464|NCT04207749|469071199|FG001|Overall Study|Lost to Follow-up|2|||
130302465|NCT04207749|469071198|FG000|Overall Study|Protocol Violation|0|||
130302466|NCT04207749|469071199|FG001|Overall Study|Protocol Violation|1|||
130302467|NCT04207749|469071198|FG000|Overall Study|Withdrawal by Subject|3|||
130302468|NCT04207749|469071199|FG001|Overall Study|Withdrawal by Subject|0|||
130302469|NCT04207749|469071198|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
130302470|NCT04207749|469071199|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
130302471|NCT01835223|469071202|FG000|Overall Study|Adverse Event|1|||
130302472|NCT01835223|469071203|FG001|Overall Study|Adverse Event|0|||
130302473|NCT01835223|469071202|FG000|Overall Study|Withdrawal by Subject|2|||
130302474|NCT01835223|469071203|FG001|Overall Study|Withdrawal by Subject|0|||
130302475|NCT01835223|469071202|FG000|Overall Study|Disease progression|2|||
130302476|NCT01835223|469071203|FG001|Overall Study|Disease progression|1|||
130302477|NCT01835223|469071202|FG000|Overall Study|Became Inelligible|4|||
130302478|NCT01835223|469071203|FG001|Overall Study|Became Inelligible|0|||
130302479|NCT01504841|469071207|FG000|Overall Study|Withdrawal by Subject|1|||
130302480|NCT01504841|469071208|FG001|Overall Study|Withdrawal by Subject|1|||
130302481|NCT01504841|469071209|FG002|Overall Study|Withdrawal by Subject|0|||
130302482|NCT03149055|469071214|FG000|Overall Study|Not treated|4|||
130302483|NCT02629822|469071215|FG000|Base Study|Lost to Follow-up|2|||
130302484|NCT02629822|469071215|FG000|Base Study|Non-Compliance With Study Drug|1|||
130302485|NCT02629822|469071215|FG000|Extension Study|Adverse Event|1|||
130302486|NCT02629822|469071215|FG000|Extension Study|Lost to Follow-up|1|||
129795251|NCT02398227|467217966|FG001|Overall Study|Removed from treatment and dropped out|0|||
129795252|NCT02694718|467217968|FG000|Overall Study|Death|1|||
129795253|NCT02694718|467217968|FG000|Overall Study|Withdrawal by Subject|1|||
129795254|NCT02925793|467217969|FG000|Overall Study|Adverse Event|3|||
129795255|NCT02925793|467217970|FG001|Overall Study|Adverse Event|3|||
129795256|NCT02925793|467217971|FG002|Overall Study|Adverse Event|6|||
129795257|NCT02925793|467217969|FG000|Overall Study|Withdrawal by Subject|16|||
129795258|NCT02925793|467217970|FG001|Overall Study|Withdrawal by Subject|15|||
129795259|NCT02925793|467217971|FG002|Overall Study|Withdrawal by Subject|13|||
129795260|NCT02925793|467217969|FG000|Overall Study|Investigator Discretion|0|||
129795261|NCT02925793|467217970|FG001|Overall Study|Investigator Discretion|1|||
129795262|NCT02925793|467217971|FG002|Overall Study|Investigator Discretion|1|||
129795263|NCT02925793|467217969|FG000|Overall Study|Lost to Follow-up|2|||
129889100|NCT01349660|467551009|FG002|Overall Study|Study Compliance|1|||
129889101|NCT01349660|467551007|FG000|Overall Study|Declining Performance Status|0|||
129889102|NCT01349660|467551008|FG001|Overall Study|Declining Performance Status|0|||
129889103|NCT01349660|467551009|FG002|Overall Study|Declining Performance Status|1|||
129889104|NCT00519636|467551010|FG000|Treatment Period 1|Adverse Event|1|||
129889105|NCT00519636|467551011|FG001|Treatment Period 1|Adverse Event|0|||
129889106|NCT00519636|467551012|FG002|Treatment Period 1|Adverse Event|1|||
129889107|NCT00519636|467551013|FG003|Treatment Period 1|Adverse Event|0|||
129889108|NCT00519636|467551010|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
129889109|NCT00519636|467551011|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
129889110|NCT00519636|467551012|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
129889111|NCT00519636|467551013|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
130302487|NCT04440813|469071216|FG000|Overall Study|Lost to Follow-up|5|||
129889112|NCT00519636|467551010|FG000|Washout Period|Adverse Event|2|||
130302488|NCT04440813|469071217|FG001|Overall Study|Lost to Follow-up|5|||
130302489|NCT03679624|469071218|FG000|Overall Study|Adverse Event|1|||
129889113|NCT00519636|467551011|FG001|Washout Period|Adverse Event|1|||
130302490|NCT03679624|469071219|FG001|Overall Study|Adverse Event|0|||
130302491|NCT01610336|469071220|FG000|Overall Study|Progressive Disease|4|||
130302492|NCT01610336|469071221|FG001|Overall Study|Progressive Disease|6|||
130302493|NCT01610336|469071222|FG002|Overall Study|Progressive Disease|6|||
130302494|NCT01610336|469071223|FG003|Overall Study|Progressive Disease|5|||
130302495|NCT01610336|469071224|FG004|Overall Study|Progressive Disease|3|||
129795264|NCT02925793|467217970|FG001|Overall Study|Lost to Follow-up|3|||
129795265|NCT02925793|467217971|FG002|Overall Study|Lost to Follow-up|1|||
130047587|NCT01543490|468131502|FG000|Overall Study|Lack of Efficacy|3|||
130047588|NCT01543490|468131503|FG001|Overall Study|Lack of Efficacy|3|||
130047589|NCT01543490|468131502|FG000|Overall Study|Lost to Follow-up|5|||
130047590|NCT01543490|468131503|FG001|Overall Study|Lost to Follow-up|0|||
130047591|NCT01543490|468131502|FG000|Overall Study|Withdrawal by Subject|2|||
130047592|NCT01543490|468131503|FG001|Overall Study|Withdrawal by Subject|0|||
130047593|NCT01543490|468131502|FG000|Overall Study|Other-Various Administrative Reasons|1|||
130047594|NCT01543490|468131503|FG001|Overall Study|Other-Various Administrative Reasons|2|||
130302496|NCT01610336|469071225|FG005|Overall Study|Progressive Disease|10|||
130302497|NCT01610336|469071226|FG006|Overall Study|Progressive Disease|1|||
130302498|NCT01610336|469071227|FG007|Overall Study|Progressive Disease|6|||
130302499|NCT01610336|469071228|FG008|Overall Study|Progressive Disease|6|||
129889114|NCT00519636|467551012|FG002|Washout Period|Adverse Event|1|||
130047595|NCT04168645|468131505|FG000|Overall Study|Lost to Follow-up|23|||
130047596|NCT04168645|468131506|FG001|Overall Study|Lost to Follow-up|28|||
130047597|NCT04168645|468131507|FG002|Overall Study|Lost to Follow-up|15|||
130302500|NCT01610336|469071229|FG009|Overall Study|Progressive Disease|40|||
130302501|NCT01610336|469071230|FG010|Overall Study|Progressive Disease|36|||
130302502|NCT01610336|469071220|FG000|Overall Study|Adverse Event|0|||
130302503|NCT01610336|469071221|FG001|Overall Study|Adverse Event|0|||
130302504|NCT01610336|469071222|FG002|Overall Study|Adverse Event|0|||
130302505|NCT01610336|469071223|FG003|Overall Study|Adverse Event|1|||
130302506|NCT01610336|469071224|FG004|Overall Study|Adverse Event|1|||
130302507|NCT01610336|469071225|FG005|Overall Study|Adverse Event|1|||
130302508|NCT01610336|469071226|FG006|Overall Study|Adverse Event|0|||
130302509|NCT01610336|469071227|FG007|Overall Study|Adverse Event|0|||
130302510|NCT01610336|469071228|FG008|Overall Study|Adverse Event|2|||
130047598|NCT04168645|468131508|FG003|Overall Study|Lost to Follow-up|12|||
130302511|NCT01610336|469071229|FG009|Overall Study|Adverse Event|8|||
130302512|NCT01610336|469071230|FG010|Overall Study|Adverse Event|6|||
130302513|NCT01610336|469071220|FG000|Overall Study|Subject/Guardian decision|1|||
130302514|NCT01610336|469071221|FG001|Overall Study|Subject/Guardian decision|1|||
130302515|NCT01610336|469071222|FG002|Overall Study|Subject/Guardian decision|0|||
130302516|NCT01610336|469071223|FG003|Overall Study|Subject/Guardian decision|1|||
130302517|NCT01610336|469071224|FG004|Overall Study|Subject/Guardian decision|0|||
130302518|NCT01610336|469071225|FG005|Overall Study|Subject/Guardian decision|0|||
130302519|NCT01610336|469071226|FG006|Overall Study|Subject/Guardian decision|0|||
130302520|NCT01610336|469071227|FG007|Overall Study|Subject/Guardian decision|1|||
130302521|NCT01610336|469071228|FG008|Overall Study|Subject/Guardian decision|0|||
130302522|NCT01610336|469071229|FG009|Overall Study|Subject/Guardian decision|2|||
130302523|NCT01610336|469071230|FG010|Overall Study|Subject/Guardian decision|2|||
130302524|NCT01610336|469071220|FG000|Overall Study|Death|0|||
130302525|NCT01610336|469071221|FG001|Overall Study|Death|0|||
130047599|NCT04168645|468131505|FG000|Overall Study|Death|1|||
130047600|NCT04168645|468131506|FG001|Overall Study|Death|1|||
130047601|NCT04168645|468131507|FG002|Overall Study|Death|0|||
130047602|NCT04168645|468131508|FG003|Overall Study|Death|0|||
130302526|NCT01610336|469071222|FG002|Overall Study|Death|0|||
130302527|NCT01610336|469071223|FG003|Overall Study|Death|0|||
130302528|NCT01610336|469071224|FG004|Overall Study|Death|0|||
130302529|NCT01610336|469071225|FG005|Overall Study|Death|1|||
130302530|NCT01610336|469071226|FG006|Overall Study|Death|3|||
130302531|NCT01610336|469071227|FG007|Overall Study|Death|0|||
130302532|NCT01610336|469071228|FG008|Overall Study|Death|0|||
130302533|NCT01610336|469071229|FG009|Overall Study|Death|1|||
130302534|NCT01610336|469071230|FG010|Overall Study|Death|2|||
130302535|NCT01610336|469071220|FG000|Overall Study|Non-Compliance with study treatment|0|||
130047603|NCT04168645|468131505|FG000|Overall Study|Withdrawal by Subject|5|||
130302536|NCT01610336|469071221|FG001|Overall Study|Non-Compliance with study treatment|0|||
130302537|NCT01610336|469071222|FG002|Overall Study|Non-Compliance with study treatment|0|||
130302538|NCT01610336|469071223|FG003|Overall Study|Non-Compliance with study treatment|0|||
130302539|NCT01610336|469071224|FG004|Overall Study|Non-Compliance with study treatment|0|||
130302540|NCT01610336|469071225|FG005|Overall Study|Non-Compliance with study treatment|0|||
130302541|NCT01610336|469071226|FG006|Overall Study|Non-Compliance with study treatment|0|||
130302542|NCT01610336|469071227|FG007|Overall Study|Non-Compliance with study treatment|0|||
130302543|NCT01610336|469071228|FG008|Overall Study|Non-Compliance with study treatment|0|||
130302544|NCT01610336|469071229|FG009|Overall Study|Non-Compliance with study treatment|1|||
130302545|NCT01610336|469071230|FG010|Overall Study|Non-Compliance with study treatment|0|||
130302546|NCT01610336|469071220|FG000|Overall Study|Physician Decision|0|||
130302547|NCT01610336|469071221|FG001|Overall Study|Physician Decision|0|||
130302548|NCT01610336|469071222|FG002|Overall Study|Physician Decision|0|||
130302549|NCT01610336|469071223|FG003|Overall Study|Physician Decision|0|||
129889115|NCT00519636|467551013|FG003|Washout Period|Adverse Event|0|||
130047604|NCT04168645|468131506|FG001|Overall Study|Withdrawal by Subject|2|||
130047605|NCT04168645|468131507|FG002|Overall Study|Withdrawal by Subject|2|||
130047606|NCT04168645|468131508|FG003|Overall Study|Withdrawal by Subject|2|||
130302550|NCT01610336|469071224|FG004|Overall Study|Physician Decision|0|||
130302551|NCT01610336|469071225|FG005|Overall Study|Physician Decision|0|||
130302552|NCT01610336|469071226|FG006|Overall Study|Physician Decision|1|||
129889116|NCT00519636|467551010|FG000|Washout Period|Lost to Follow-up|1|||
129889117|NCT00519636|467551011|FG001|Washout Period|Lost to Follow-up|0|||
129889118|NCT00519636|467551012|FG002|Washout Period|Lost to Follow-up|0|||
129889119|NCT00519636|467551013|FG003|Washout Period|Lost to Follow-up|0|||
129889120|NCT00519636|467551010|FG000|Washout Period|Protocol Violation|0|||
129889121|NCT00519636|467551011|FG001|Washout Period|Protocol Violation|0|||
129889122|NCT00519636|467551012|FG002|Washout Period|Protocol Violation|1|||
129889123|NCT00519636|467551013|FG003|Washout Period|Protocol Violation|2|||
129889124|NCT00519636|467551010|FG000|Washout Period|Withdrawal by Subject|1|||
129889125|NCT00519636|467551011|FG001|Washout Period|Withdrawal by Subject|0|||
129889126|NCT00519636|467551012|FG002|Washout Period|Withdrawal by Subject|1|||
129889127|NCT00519636|467551013|FG003|Washout Period|Withdrawal by Subject|0|||
129889128|NCT00519636|467551010|FG000|Washout Period|Failed to meet continuation criteria|14|||
129889129|NCT00519636|467551011|FG001|Washout Period|Failed to meet continuation criteria|11|||
129889130|NCT00519636|467551012|FG002|Washout Period|Failed to meet continuation criteria|9|||
129889131|NCT00519636|467551013|FG003|Washout Period|Failed to meet continuation criteria|3|||
129889132|NCT00519636|467551010|FG000|Washout Period|Out of pollen area > 48 hours|1|||
129889133|NCT00519636|467551011|FG001|Washout Period|Out of pollen area > 48 hours|0|||
129889134|NCT00519636|467551012|FG002|Washout Period|Out of pollen area > 48 hours|0|||
129889135|NCT00519636|467551013|FG003|Washout Period|Out of pollen area > 48 hours|0|||
129889136|NCT00519636|467551010|FG000|Washout Period|Participating in study at another site|1|||
129889137|NCT00519636|467551011|FG001|Washout Period|Participating in study at another site|0|||
129889138|NCT00519636|467551012|FG002|Washout Period|Participating in study at another site|0|||
129889139|NCT00519636|467551013|FG003|Washout Period|Participating in study at another site|0|||
129889140|NCT00519636|467551010|FG000|Washout Period|Non-compliant|0|||
129889141|NCT00519636|467551011|FG001|Washout Period|Non-compliant|1|||
129889142|NCT00519636|467551012|FG002|Washout Period|Non-compliant|0|||
129889143|NCT00519636|467551013|FG003|Washout Period|Non-compliant|0|||
129889144|NCT00519636|467551010|FG000|Washout Period|Per doctors request|0|||
129889145|NCT00519636|467551011|FG001|Washout Period|Per doctors request|1|||
129889146|NCT00519636|467551012|FG002|Washout Period|Per doctors request|0|||
130302553|NCT01610336|469071227|FG007|Overall Study|Physician Decision|0|||
130302554|NCT01610336|469071228|FG008|Overall Study|Physician Decision|0|||
130302555|NCT01610336|469071229|FG009|Overall Study|Physician Decision|0|||
130302556|NCT01610336|469071230|FG010|Overall Study|Physician Decision|0|||
130302557|NCT01610336|469071220|FG000|Overall Study|Protocol Deviation|0|||
130302558|NCT01610336|469071221|FG001|Overall Study|Protocol Deviation|0|||
130302559|NCT01610336|469071222|FG002|Overall Study|Protocol Deviation|0|||
130302560|NCT01610336|469071223|FG003|Overall Study|Protocol Deviation|0|||
130302561|NCT01610336|469071224|FG004|Overall Study|Protocol Deviation|0|||
130302562|NCT01610336|469071225|FG005|Overall Study|Protocol Deviation|0|||
130302563|NCT01610336|469071226|FG006|Overall Study|Protocol Deviation|0|||
130302564|NCT01610336|469071227|FG007|Overall Study|Protocol Deviation|0|||
130302565|NCT01610336|469071228|FG008|Overall Study|Protocol Deviation|0|||
130302566|NCT01610336|469071229|FG009|Overall Study|Protocol Deviation|1|||
130302567|NCT01610336|469071230|FG010|Overall Study|Protocol Deviation|0|||
130302568|NCT01610336|469071220|FG000|Overall Study|Transfer to another trial|0|||
130302569|NCT01610336|469071221|FG001|Overall Study|Transfer to another trial|0|||
130302570|NCT01610336|469071222|FG002|Overall Study|Transfer to another trial|0|||
130302571|NCT01610336|469071223|FG003|Overall Study|Transfer to another trial|0|||
130302572|NCT01610336|469071224|FG004|Overall Study|Transfer to another trial|0|||
130302573|NCT01610336|469071225|FG005|Overall Study|Transfer to another trial|0|||
130302574|NCT01610336|469071226|FG006|Overall Study|Transfer to another trial|0|||
130302575|NCT01610336|469071227|FG007|Overall Study|Transfer to another trial|0|||
130302576|NCT01610336|469071228|FG008|Overall Study|Transfer to another trial|0|||
130302577|NCT01610336|469071229|FG009|Overall Study|Transfer to another trial|0|||
130302578|NCT01610336|469071230|FG010|Overall Study|Transfer to another trial|1|||
130302579|NCT00741013|469071231|FG000|Overall Study|Adverse Event|1|||
130302580|NCT00741013|469071232|FG001|Overall Study|Adverse Event|0|||
130302581|NCT00741013|469071233|FG002|Overall Study|Adverse Event|0|||
130302582|NCT00741013|469071231|FG000|Overall Study|Withdrawal by Subject|0|||
130302583|NCT00741013|469071232|FG001|Overall Study|Withdrawal by Subject|0|||
130302584|NCT00741013|469071233|FG002|Overall Study|Withdrawal by Subject|1|||
130302585|NCT00741013|469071231|FG000|Overall Study|Discovered failed screen after enrolled|0|||
130302586|NCT00741013|469071232|FG001|Overall Study|Discovered failed screen after enrolled|2|||
130302587|NCT00741013|469071233|FG002|Overall Study|Discovered failed screen after enrolled|0|||
130302588|NCT01559675|469071237|FG000|Overall Study|Protocol Violation|1|||
130302589|NCT01559675|469071238|FG001|Overall Study|Protocol Violation|2|||
130302590|NCT01559675|469071237|FG000|Overall Study|2nd operation on same patient excluded|14|||
130302591|NCT01559675|469071238|FG001|Overall Study|2nd operation on same patient excluded|12|||
130302592|NCT00291018|469071239|FG000|Overall Study|Not Consented or Declined PAS|12|||
130302593|NCT00291018|469071240|FG001|Overall Study|Not Consented or Declined PAS|15|||
130302594|NCT00291018|469071241|FG002|Overall Study|Not Consented or Declined PAS|15|||
130302595|NCT00291018|469071239|FG000|Overall Study|Death|3|||
130302596|NCT00291018|469071240|FG001|Overall Study|Death|3|||
130302597|NCT00291018|469071241|FG002|Overall Study|Death|4|||
130302598|NCT00291018|469071239|FG000|Overall Study|Withdrawal by Subject|2|||
130302599|NCT00291018|469071240|FG001|Overall Study|Withdrawal by Subject|8|||
130302600|NCT00291018|469071241|FG002|Overall Study|Withdrawal by Subject|1|||
130302601|NCT00291018|469071239|FG000|Overall Study|Failures|5|||
130302602|NCT00291018|469071240|FG001|Overall Study|Failures|12|||
130302603|NCT00291018|469071241|FG002|Overall Study|Failures|5|||
130302604|NCT00291018|469071239|FG000|Overall Study|Lost to Follow-up|3|||
130302605|NCT00291018|469071240|FG001|Overall Study|Lost to Follow-up|4|||
130302606|NCT00291018|469071241|FG002|Overall Study|Lost to Follow-up|18|||
130302607|NCT01496469|469071242|FG000|Overall Study|Adverse Event|1|||
130302608|NCT01496469|469071243|FG001|Overall Study|Adverse Event|0|||
130302609|NCT01496469|469071242|FG000|Overall Study|Protocol Violation|2|||
130302610|NCT01496469|469071243|FG001|Overall Study|Protocol Violation|0|||
130302611|NCT01496469|469071242|FG000|Overall Study|Lost to Follow-up|1|||
130302612|NCT01496469|469071243|FG001|Overall Study|Lost to Follow-up|1|||
130302613|NCT01496469|469071242|FG000|Overall Study|Withdrawal by Subject|4|||
130302614|NCT01496469|469071243|FG001|Overall Study|Withdrawal by Subject|4|||
130302615|NCT01496469|469071242|FG000|Overall Study|BP exceeds protocol limits|1|||
130302616|NCT01496469|469071243|FG001|Overall Study|BP exceeds protocol limits|2|||
130302617|NCT01496469|469071242|FG000|Overall Study|Other|1|||
130302618|NCT01496469|469071243|FG001|Overall Study|Other|1|||
130302619|NCT00193180|469071244|FG000|Overall Study|Lack of Efficacy|1|||
130302620|NCT00193180|469071244|FG000|Overall Study|Adverse Event|8|||
130302621|NCT00193180|469071244|FG000|Overall Study|Protocol Violation|1|||
130302622|NCT01357551|469071245|FG000|Overall Study|Withdrawal by Subject|6|||
130302623|NCT01357551|469071246|FG001|Overall Study|Withdrawal by Subject|4|||
130302624|NCT01357551|469071245|FG000|Overall Study|Death|0|||
130302625|NCT01357551|469071246|FG001|Overall Study|Death|1|||
130302626|NCT01357551|469071245|FG000|Overall Study|Lost to Follow-up|16|||
130302627|NCT01357551|469071246|FG001|Overall Study|Lost to Follow-up|6|||
130302628|NCT05362058|469071247|FG000|Treatment Period|Adverse Event|3|||
130302629|NCT05362058|469071248|FG001|Treatment Period|Adverse Event|3|||
130302630|NCT05362058|469071247|FG000|Treatment Period|Assigned treatment by mistake|3|||
130302631|NCT05362058|469071248|FG001|Treatment Period|Assigned treatment by mistake|4|||
130302632|NCT05362058|469071247|FG000|Treatment Period|Death|1|||
130302633|NCT05362058|469071248|FG001|Treatment Period|Death|1|||
130302634|NCT05362058|469071247|FG000|Treatment Period|Lost to Follow-up|6|||
130302635|NCT05362058|469071248|FG001|Treatment Period|Lost to Follow-up|3|||
130302636|NCT05362058|469071247|FG000|Treatment Period|Non-compliance with study drug|0|||
130302637|NCT05362058|469071248|FG001|Treatment Period|Non-compliance with study drug|1|||
130302638|NCT05362058|469071247|FG000|Treatment Period|Physician Decision|1|||
130302639|NCT05362058|469071248|FG001|Treatment Period|Physician Decision|0|||
130302640|NCT05362058|469071247|FG000|Treatment Period|Protocol deviation|1|||
130302641|NCT05362058|469071248|FG001|Treatment Period|Protocol deviation|0|||
130302642|NCT05362058|469071247|FG000|Treatment Period|Withdrawal by Subject|10|||
130302643|NCT05362058|469071248|FG001|Treatment Period|Withdrawal by Subject|11|||
129889147|NCT00519636|467551013|FG003|Washout Period|Per doctors request|0|||
130047607|NCT04168645|468131505|FG000|Overall Study|Administrative Withdrawal|3|||
130047608|NCT04168645|468131506|FG001|Overall Study|Administrative Withdrawal|1|||
130047609|NCT04168645|468131507|FG002|Overall Study|Administrative Withdrawal|1|||
130047610|NCT04168645|468131508|FG003|Overall Study|Administrative Withdrawal|3|||
130047611|NCT03132805|468131511|FG000|Overall Study|Lost to Follow-up|142|||
130047612|NCT03132805|468131512|FG001|Overall Study|Lost to Follow-up|141|||
130302644|NCT05362058|469071247|FG000|Follow-Up Period|Death|1|||
130302645|NCT05362058|469071248|FG001|Follow-Up Period|Death|0|||
130302646|NCT05362058|469071247|FG000|Follow-Up Period|Lost to Follow-up|2|||
130302647|NCT05362058|469071248|FG001|Follow-Up Period|Lost to Follow-up|1|||
130047613|NCT03132805|468131513|FG002|Overall Study|Lost to Follow-up|113|||
130047614|NCT01158534|468131515|FG000|Overall Study|Withdrawal by Subject|1|||
130302648|NCT05362058|469071247|FG000|Follow-Up Period|Protocol deviation|1|||
130302649|NCT05362058|469071248|FG001|Follow-Up Period|Protocol deviation|1|||
130302650|NCT05362058|469071247|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130302651|NCT05362058|469071248|FG001|Follow-Up Period|Withdrawal by Subject|3|||
130302652|NCT01235234|469071249|FG000|Overall Study|Adverse Event|2|||
130302653|NCT01235234|469071250|FG001|Overall Study|Adverse Event|2|||
130302654|NCT01235234|469071251|FG002|Overall Study|Adverse Event|1|||
130302655|NCT00286494|469071258|FG000|Overall Study|Hyperglycemic rescue|12|||
130302656|NCT00286494|469071259|FG001|Overall Study|Hyperglycemic rescue|19|||
130302657|NCT00286494|469071260|FG002|Overall Study|Hyperglycemic rescue|18|||
130302658|NCT00286494|469071258|FG000|Overall Study|Withdrawal by Subject|2|||
130302659|NCT00286494|469071259|FG001|Overall Study|Withdrawal by Subject|10|||
130302660|NCT00286494|469071260|FG002|Overall Study|Withdrawal by Subject|9|||
130302661|NCT00286494|469071258|FG000|Overall Study|Adverse Event|3|||
130302662|NCT00286494|469071259|FG001|Overall Study|Adverse Event|8|||
130302663|NCT00286494|469071260|FG002|Overall Study|Adverse Event|6|||
130302664|NCT00286494|469071258|FG000|Overall Study|Physician Decision|5|||
130302665|NCT00286494|469071259|FG001|Overall Study|Physician Decision|5|||
130302666|NCT00286494|469071260|FG002|Overall Study|Physician Decision|1|||
129795266|NCT02925793|467217969|FG000|Overall Study|Lack of Efficacy|2|||
129795267|NCT02925793|467217970|FG001|Overall Study|Lack of Efficacy|6|||
129795268|NCT02925793|467217971|FG002|Overall Study|Lack of Efficacy|4|||
130302667|NCT00286494|469071258|FG000|Overall Study|Lost to Follow-up|3|||
130302668|NCT00286494|469071259|FG001|Overall Study|Lost to Follow-up|1|||
130302669|NCT00286494|469071260|FG002|Overall Study|Lost to Follow-up|3|||
130302670|NCT00286494|469071258|FG000|Overall Study|Protocol Violation|1|||
130302671|NCT00286494|469071259|FG001|Overall Study|Protocol Violation|1|||
130302672|NCT00286494|469071260|FG002|Overall Study|Protocol Violation|2|||
130302673|NCT04776317|469071261|FG000|Overall Study|Physician Decision|0|||
130302674|NCT04776317|469071262|FG001|Overall Study|Physician Decision|1|||
130302675|NCT04776317|469071263|FG002|Overall Study|Physician Decision|0|||
130302676|NCT04776317|469071264|FG003|Overall Study|Physician Decision|0|||
130302677|NCT04776317|469071265|FG004|Overall Study|Physician Decision|0|||
130302678|NCT04776317|469071266|FG005|Overall Study|Physician Decision|0|||
130302679|NCT04776317|469071267|FG006|Overall Study|Physician Decision|0|||
130302680|NCT04776317|469071268|FG007|Overall Study|Physician Decision|0|||
130302681|NCT04776317|469071269|FG008|Overall Study|Physician Decision|0|||
130302682|NCT04776317|469071270|FG009|Overall Study|Physician Decision|0|||
130302683|NCT04776317|469071271|FG010|Overall Study|Physician Decision|0|||
130302684|NCT04776317|469071272|FG011|Overall Study|Physician Decision|0|||
130302685|NCT04776317|469071273|FG012|Overall Study|Physician Decision|0|||
130302686|NCT04776317|469071274|FG013|Overall Study|Physician Decision|0|||
130302687|NCT04776317|469071275|FG014|Overall Study|Physician Decision|0|||
130302688|NCT04776317|469071261|FG000|Overall Study|Protocol Violation|0|||
130302689|NCT04776317|469071262|FG001|Overall Study|Protocol Violation|0|||
130302690|NCT04776317|469071263|FG002|Overall Study|Protocol Violation|1|||
130302691|NCT04776317|469071264|FG003|Overall Study|Protocol Violation|0|||
130302692|NCT04776317|469071265|FG004|Overall Study|Protocol Violation|0|||
130302693|NCT04776317|469071266|FG005|Overall Study|Protocol Violation|0|||
130302694|NCT04776317|469071267|FG006|Overall Study|Protocol Violation|0|||
130302695|NCT04776317|469071268|FG007|Overall Study|Protocol Violation|0|||
130302696|NCT04776317|469071269|FG008|Overall Study|Protocol Violation|0|||
129795269|NCT02925793|467217969|FG000|Overall Study|Other:|2|||
129795270|NCT02925793|467217970|FG001|Overall Study|Other:|1|||
129795271|NCT02925793|467217971|FG002|Overall Study|Other:|3|||
129795272|NCT00256282|467217973|FG000|Overall Study|Disease progression, relapse during acti|12|||
129795273|NCT00256282|467217973|FG000|Overall Study|Adverse Event|3|||
129795274|NCT00256282|467217973|FG000|Overall Study|Physician Decision|1|||
129795275|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
129795276|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
129795277|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Other|2|||
129795278|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Other|2|||
129795279|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Personal reasons|2|||
129795280|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Personal reasons|2|||
129795281|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
129795282|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
129795283|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
130107472|NCT01902134|468355132|FG002|Overall Study|Withdrawal by Subject|9|||
130107473|NCT01902134|468355133|FG003|Overall Study|Withdrawal by Subject|1|||
130107474|NCT01902134|468355134|FG004|Overall Study|Withdrawal by Subject|5|||
130107475|NCT01902134|468355135|FG005|Overall Study|Withdrawal by Subject|4|||
130107476|NCT01902134|468355130|FG000|Overall Study|no compliance|1|||
130107477|NCT01902134|468355131|FG001|Overall Study|no compliance|0|||
130107478|NCT01902134|468355132|FG002|Overall Study|no compliance|0|||
130302697|NCT04776317|469071270|FG009|Overall Study|Protocol Violation|0|||
130302698|NCT04776317|469071271|FG010|Overall Study|Protocol Violation|0|||
130107479|NCT01902134|468355133|FG003|Overall Study|no compliance|0|||
130107480|NCT01902134|468355134|FG004|Overall Study|no compliance|0|||
130302699|NCT04776317|469071272|FG011|Overall Study|Protocol Violation|0|||
130302700|NCT04776317|469071273|FG012|Overall Study|Protocol Violation|0|||
130302701|NCT04776317|469071274|FG013|Overall Study|Protocol Violation|0|||
130302702|NCT04776317|469071275|FG014|Overall Study|Protocol Violation|0|||
130302703|NCT04776317|469071261|FG000|Overall Study|Withdrawal by Subject|0|||
129795284|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
130302704|NCT04776317|469071262|FG001|Overall Study|Withdrawal by Subject|0|||
130302705|NCT04776317|469071263|FG002|Overall Study|Withdrawal by Subject|0|||
130302706|NCT04776317|469071264|FG003|Overall Study|Withdrawal by Subject|0|||
130302707|NCT04776317|469071265|FG004|Overall Study|Withdrawal by Subject|1|||
130302708|NCT04776317|469071266|FG005|Overall Study|Withdrawal by Subject|0|||
129795285|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
129795286|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
129795287|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
129795288|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
129795289|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
129795290|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
130047615|NCT01158534|468131515|FG000|Overall Study|Death|1|||
130047616|NCT01158534|468131515|FG000|Overall Study|Other|1|||
130047617|NCT01988012|468131516|FG000|Overall Study|Adverse Event|5|||
130047618|NCT01988012|468131516|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130302709|NCT04776317|469071267|FG006|Overall Study|Withdrawal by Subject|0|||
130302710|NCT04776317|469071268|FG007|Overall Study|Withdrawal by Subject|0|||
130302711|NCT04776317|469071269|FG008|Overall Study|Withdrawal by Subject|0|||
130302712|NCT04776317|469071270|FG009|Overall Study|Withdrawal by Subject|0|||
130302713|NCT04776317|469071271|FG010|Overall Study|Withdrawal by Subject|0|||
130302714|NCT04776317|469071272|FG011|Overall Study|Withdrawal by Subject|0|||
130302715|NCT04776317|469071273|FG012|Overall Study|Withdrawal by Subject|0|||
130302716|NCT04776317|469071274|FG013|Overall Study|Withdrawal by Subject|0|||
130302717|NCT04776317|469071275|FG014|Overall Study|Withdrawal by Subject|0|||
130302718|NCT04207060|469071276|FG000|Overall Study|Lost to Follow-up|2|||
130302719|NCT04207060|469071277|FG001|Overall Study|Lost to Follow-up|0|||
130302720|NCT02524158|469071278|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
130302721|NCT02524158|469071279|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
130302722|NCT02524158|469071278|FG000|12-weeks Assessment|Lost to Follow-up|18|||
130302723|NCT02524158|469071279|FG001|12-weeks Assessment|Lost to Follow-up|12|||
130302724|NCT02524158|469071278|FG000|6-month Assessment|Withdrawal by Subject|1|||
130302725|NCT02524158|469071279|FG001|6-month Assessment|Withdrawal by Subject|1|||
130302726|NCT02524158|469071278|FG000|6-month Assessment|Lost to Follow-up|21|||
130302727|NCT02524158|469071279|FG001|6-month Assessment|Lost to Follow-up|20|||
130302728|NCT03671304|469071280|FG000|Overall Study|study terminated|7|||
130302729|NCT02718716|469071281|FG000|Overall Study|Lack of Efficacy|1|||
130302730|NCT02718716|469071282|FG001|Overall Study|Lack of Efficacy|0|||
130302731|NCT02718716|469071283|FG002|Overall Study|Lack of Efficacy|0|||
130302732|NCT02718716|469071284|FG003|Overall Study|Lack of Efficacy|0|||
130302733|NCT02718716|469071285|FG004|Overall Study|Lack of Efficacy|0|||
130302734|NCT04869358|469071289|FG000|Overall Study|Wish to have children.|1|||
130302735|NCT04869358|469071290|FG001|Overall Study|Wish to have children.|0|||
130302736|NCT04869358|469071291|FG002|Overall Study|Wish to have children.|0|||
130302737|NCT04869358|469071292|FG003|Overall Study|Wish to have children.|0|||
130302738|NCT04164732|469071293|FG000|Treatment run-in Period|Adverse Event|4|||
130302739|NCT04164732|469071294|FG001|Treatment run-in Period|Adverse Event|0|||
130302740|NCT04164732|469071295|FG002|Treatment run-in Period|Adverse Event|0|||
130302741|NCT04164732|469071293|FG000|Treatment run-in Period|Physician Decision|1|||
130302742|NCT04164732|469071294|FG001|Treatment run-in Period|Physician Decision|0|||
130302743|NCT04164732|469071295|FG002|Treatment run-in Period|Physician Decision|0|||
130302744|NCT04164732|469071293|FG000|Treatment run-in Period|Screen Failure|1|||
130302745|NCT04164732|469071294|FG001|Treatment run-in Period|Screen Failure|0|||
130302746|NCT04164732|469071295|FG002|Treatment run-in Period|Screen Failure|0|||
130302747|NCT04164732|469071293|FG000|Randomized Treatment Period|Adverse Event|0|||
130302748|NCT04164732|469071294|FG001|Randomized Treatment Period|Adverse Event|1|||
130302749|NCT04164732|469071295|FG002|Randomized Treatment Period|Adverse Event|0|||
130302750|NCT04164732|469071293|FG000|Randomized Treatment Period|Protocol Deviation|0|||
130302751|NCT04164732|469071294|FG001|Randomized Treatment Period|Protocol Deviation|1|||
130302752|NCT04164732|469071295|FG002|Randomized Treatment Period|Protocol Deviation|1|||
130302753|NCT04164732|469071293|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
129795291|NCT00667446|467217974|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
130047619|NCT01988012|468131516|FG000|Overall Study|Patient Withdrawal of Consent|4|||
130047620|NCT01988012|468131516|FG000|Overall Study|Lost to Follow-up|1|||
130047621|NCT01988012|468131516|FG000|Overall Study|Physician Decision|1|||
130047622|NCT01988012|468131516|FG000|Overall Study|Protocol Violation|1|||
130302754|NCT04164732|469071294|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
130302755|NCT04164732|469071295|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
130302756|NCT04302545|469071296|FG000|Overall Study|Lost to Follow-up|3|||
130302757|NCT04302545|469071297|FG001|Overall Study|Lost to Follow-up|4|||
130302758|NCT02690714|469071301|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
130302759|NCT02690714|469071301|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
130302760|NCT02202538|469071302|FG000|Overall Study|Withdrawal by Subject|5|||
130302761|NCT02202538|469071302|FG000|Overall Study|Did not meet all inclusion criteria|2|||
130302762|NCT02202538|469071302|FG000|Overall Study|Investigator Decision|1|||
130302763|NCT01457846|469071303|FG000|Overall Study|Death before treatment|1|||
130047623|NCT01228071|468131517|FG000|Overall Study|Protocol Violation|1|||
130047624|NCT01228071|468131517|FG000|Overall Study|Withdrawal by Subject|1|||
130047625|NCT00553059|468131518|FG000|Overall Study|Deemed ineligible|1|||
130047626|NCT00553059|468131519|FG001|Overall Study|Deemed ineligible|1|||
130047627|NCT00553059|468131518|FG000|Overall Study|Drug supply not available|0|||
130047628|NCT00553059|468131519|FG001|Overall Study|Drug supply not available|1|||
130047629|NCT00771030|468131524|FG000|Overall Study|Adverse Event|0|||
130047630|NCT00771030|468131525|FG001|Overall Study|Adverse Event|1|||
130047631|NCT00771030|468131526|FG002|Overall Study|Adverse Event|0|||
130047632|NCT00771030|468131527|FG003|Overall Study|Adverse Event|0|||
130047633|NCT00771030|468131528|FG004|Overall Study|Adverse Event|0|||
130047634|NCT00771030|468131529|FG005|Overall Study|Adverse Event|0|||
130047635|NCT00771030|468131530|FG006|Overall Study|Adverse Event|0|||
130047636|NCT05232097|468131540|FG000|Overall Study|Physician Decision|1|||
130047637|NCT01327339|468131541|FG000|Overall Study|Protocol Violation|8|||
130047638|NCT01172288|468131542|FG000|Overall Study|Adverse Event|1|||
130047639|NCT01172288|468131543|FG001|Overall Study|Adverse Event|0|||
130047640|NCT01172288|468131542|FG000|Overall Study|Protocol Violation|0|||
130047641|NCT01172288|468131543|FG001|Overall Study|Protocol Violation|1|||
130047642|NCT02795767|468131546|FG000|Overall Study|Received Commercial Emicizumab|1|||
130047643|NCT02795767|468131547|FG001|Overall Study|Received Commercial Emicizumab|0|||
130047644|NCT02795767|468131548|FG002|Overall Study|Received Commercial Emicizumab|0|||
130047645|NCT03662334|468131549|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
130047646|NCT03662334|468131550|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
130047647|NCT01097330|468131554|FG000|Overall Study|Study terminated early|7|||
130047648|NCT01097330|468131555|FG001|Overall Study|Study terminated early|5|||
130047649|NCT00510692|468131557|FG000|Overall Study|Adverse Event|1|||
130047650|NCT00510692|468131558|FG001|Overall Study|Adverse Event|3|||
130047651|NCT00510692|468131557|FG000|Overall Study|Withdrawal by Subject|1|||
130047652|NCT00510692|468131558|FG001|Overall Study|Withdrawal by Subject|0|||
130047653|NCT01845077|468131559|FG000|Washout Period|Lost to Follow-up|0|||
130047654|NCT01845077|468131560|FG001|Washout Period|Lost to Follow-up|1|||
130047655|NCT01845077|468131561|FG002|Washout Period|Lost to Follow-up|0|||
130047656|NCT01845077|468131562|FG003|Washout Period|Lost to Follow-up|1|||
130047657|NCT01845077|468131563|FG004|Washout Period|Lost to Follow-up|0|||
130047658|NCT01845077|468131564|FG005|Washout Period|Lost to Follow-up|1|||
130047659|NCT01845077|468131559|FG000|Washout Period|Adverse Event|1|||
130047660|NCT01845077|468131560|FG001|Washout Period|Adverse Event|0|||
130047661|NCT01845077|468131561|FG002|Washout Period|Adverse Event|0|||
130047662|NCT01845077|468131562|FG003|Washout Period|Adverse Event|0|||
130047663|NCT01845077|468131563|FG004|Washout Period|Adverse Event|0|||
130047664|NCT01845077|468131564|FG005|Washout Period|Adverse Event|0|||
130047665|NCT01845077|468131559|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
130047666|NCT01845077|468131560|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
130047667|NCT01845077|468131561|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
130047668|NCT01845077|468131562|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
130047669|NCT01845077|468131563|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
130047670|NCT01845077|468131564|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
130047671|NCT01845077|468131559|FG000|Washout Period|Protocol Violation|0|||
130047672|NCT01845077|468131560|FG001|Washout Period|Protocol Violation|0|||
130047673|NCT01845077|468131561|FG002|Washout Period|Protocol Violation|0|||
130047674|NCT01845077|468131562|FG003|Washout Period|Protocol Violation|1|||
130047675|NCT01845077|468131563|FG004|Washout Period|Protocol Violation|1|||
130047676|NCT01845077|468131564|FG005|Washout Period|Protocol Violation|0|||
130107481|NCT01902134|468355135|FG005|Overall Study|no compliance|0|||
130107482|NCT01902134|468355130|FG000|Overall Study|Other|0|||
130107483|NCT01902134|468355131|FG001|Overall Study|Other|1|||
130302764|NCT01457846|469071304|FG001|Overall Study|Death before treatment|2|||
130302765|NCT01457846|469071303|FG000|Overall Study|Did not receive treatment|0|||
130302766|NCT01457846|469071304|FG001|Overall Study|Did not receive treatment|1|||
130302767|NCT01457846|469071303|FG000|Overall Study|Death|27|||
130302768|NCT01457846|469071304|FG001|Overall Study|Death|16|||
130302769|NCT01457846|469071303|FG000|Overall Study|Unclassified reason for not completed|11|||
130302770|NCT01457846|469071304|FG001|Overall Study|Unclassified reason for not completed|10|||
129889148|NCT00519636|467551010|FG000|Washout Period|Subject randomized in error|0|||
130047677|NCT01797432|468131565|FG000|Overall Study|Lost to Follow-up|1|||
130047678|NCT01797432|468131565|FG000|Overall Study|Adverse Event|1|||
130047679|NCT01797432|468131565|FG000|Overall Study|Withdrawal by Subject|1|||
130047680|NCT01797432|468131565|FG000|Overall Study|lived too far from study site|1|||
130047681|NCT01137435|468131566|FG000|Overall Study|Lost to Follow-up|24|||
130047682|NCT01137435|468131566|FG000|Overall Study|Off label usage|4|||
130047683|NCT02746679|468131572|FG000|Overall Study|Lost to Follow-up|4|||
130047684|NCT02746679|468131573|FG001|Overall Study|Lost to Follow-up|6|||
130047685|NCT00501852|468131574|FG000|Overall Study|Adverse Event|3|||
130047686|NCT00501852|468131574|FG000|Overall Study|Withdrawal by Subject|2|||
130047687|NCT01416610|468131578|FG000|Overall Study|Adverse Event|4|||
130302771|NCT01457846|469071303|FG000|Overall Study|Withdrawal by Subject|1|||
129795292|NCT00667446|467217975|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
129795293|NCT00322153|467217976|FG000|Overall Study|Adverse Event|21|||
129795294|NCT00322153|467217977|FG001|Overall Study|Adverse Event|34|||
129795295|NCT00322153|467217976|FG000|Overall Study|Protocol Violation|6|||
129795296|NCT00322153|467217977|FG001|Overall Study|Protocol Violation|14|||
129795297|NCT00322153|467217976|FG000|Overall Study|Withdrawal by Subject|18|||
129795298|NCT00322153|467217977|FG001|Overall Study|Withdrawal by Subject|10|||
129795299|NCT00322153|467217976|FG000|Overall Study|Lack of Efficacy|8|||
129795300|NCT00322153|467217977|FG001|Overall Study|Lack of Efficacy|3|||
129795301|NCT00322153|467217976|FG000|Overall Study|Lost to Follow-up|5|||
129795302|NCT00322153|467217977|FG001|Overall Study|Lost to Follow-up|4|||
129795303|NCT00322153|467217976|FG000|Overall Study|Withdrawn for other reasons|5|||
129795304|NCT00322153|467217977|FG001|Overall Study|Withdrawn for other reasons|4|||
129795305|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
129795306|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
129795307|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
129795308|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
129795309|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
129795310|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
129795311|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
129795312|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
129795313|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
129795314|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
129795315|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
129795316|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
129795317|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
129795318|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
129795319|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
129795320|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
129795321|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
129795322|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
129795323|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Other|4|||
129795324|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Other|9|||
129795325|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Other|4|||
129795326|NCT00591578|467217981|FG000|Open-Label Extension Phase|Adverse Event|3|||
129795327|NCT00591578|467217982|FG001|Open-Label Extension Phase|Adverse Event|5|||
129795328|NCT00591578|467217983|FG002|Open-Label Extension Phase|Adverse Event|0|||
129795329|NCT00591578|467217981|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
129795330|NCT00591578|467217982|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
129795331|NCT00591578|467217983|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129795332|NCT00591578|467217981|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
129795333|NCT00591578|467217982|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
129795334|NCT00591578|467217983|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
129795335|NCT00591578|467217981|FG000|Open-Label Extension Phase|Other|1|||
129795336|NCT00591578|467217982|FG001|Open-Label Extension Phase|Other|0|||
129795337|NCT00591578|467217983|FG002|Open-Label Extension Phase|Other|0|||
129795338|NCT02632838|467217984|FG000|Overall Study|Withdrawal by Subject|3|||
129795339|NCT02632838|467217985|FG001|Overall Study|Withdrawal by Subject|0|||
129795340|NCT02632838|467217984|FG000|Overall Study|Lost to Follow-up|0|||
129795341|NCT02632838|467217985|FG001|Overall Study|Lost to Follow-up|2|||
129795342|NCT01343901|467217986|FG000|Overall Study|Death|85|||
129795343|NCT01343901|467217986|FG000|Overall Study|Physician Decision|4|||
129795344|NCT01343901|467217986|FG000|Overall Study|Lost to Follow-up|12|||
129795345|NCT01343901|467217986|FG000|Overall Study|Management by another medical team|11|||
129795346|NCT01343901|467217986|FG000|Overall Study|Participant decision|1|||
129795347|NCT02810340|467217987|FG000|Overall Study|Withdrawal by Subject|1|||
129795348|NCT02810340|467217988|FG001|Overall Study|Withdrawal by Subject|0|||
129795349|NCT02810340|467217989|FG002|Overall Study|Withdrawal by Subject|0|||
129795350|NCT02810340|467217987|FG000|Overall Study|Incarceration|0|||
129795351|NCT02810340|467217988|FG001|Overall Study|Incarceration|1|||
129795352|NCT02810340|467217989|FG002|Overall Study|Incarceration|0|||
129795353|NCT02810340|467217987|FG000|Overall Study|Lost to Follow-up|0|||
129795354|NCT02810340|467217988|FG001|Overall Study|Lost to Follow-up|0|||
129795355|NCT02810340|467217989|FG002|Overall Study|Lost to Follow-up|1|||
129795356|NCT03945175|467217992|FG000|Overall Study|Did not meet inclusion criteria|31|||
129795357|NCT03945175|467217992|FG000|Overall Study|Withdrew consent|2|||
129795358|NCT03945175|467217992|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
129795359|NCT03945175|467217992|FG000|Overall Study|Early termination during Mydayis treatment|1|||
129795360|NCT00870233|467217993|FG000|Overall Study|Withdrawal by Subject|18|||
129795361|NCT00870233|467217993|FG000|Overall Study|Did not undergo laparotomy|3|||
129795362|NCT00870233|467217993|FG000|Overall Study|Incompatible internet browser|2|||
129795363|NCT00870233|467217993|FG000|Overall Study|Death|1|||
129795364|NCT00378079|467217997|FG000|Overall Study|Lost to Follow-up|6|||
129795365|NCT00378079|467217998|FG001|Overall Study|Lost to Follow-up|1|||
129795366|NCT00378079|467217999|FG002|Overall Study|Lost to Follow-up|0|||
129795367|NCT01233687|467218000|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
129795368|NCT01233687|467218000|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
129795369|NCT01233687|467218000|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
129795370|NCT03324581|467218004|FG000|Overall Study|Adverse Event|18|||
129795371|NCT03324581|467218005|FG001|Overall Study|Adverse Event|11|||
129795372|NCT03324581|467218006|FG002|Overall Study|Adverse Event|7|||
129795373|NCT03324581|467218004|FG000|Overall Study|Lack of Efficacy|0|||
129795374|NCT03324581|467218005|FG001|Overall Study|Lack of Efficacy|1|||
129795375|NCT03324581|467218006|FG002|Overall Study|Lack of Efficacy|0|||
129795376|NCT03324581|467218004|FG000|Overall Study|Lost to Follow-up|5|||
130302772|NCT01457846|469071304|FG001|Overall Study|Withdrawal by Subject|1|||
130302773|NCT01457846|469071303|FG000|Overall Study|Lost to Follow-up|1|||
130302774|NCT01457846|469071304|FG001|Overall Study|Lost to Follow-up|0|||
130302775|NCT02161757|469071305|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
130302776|NCT02161757|469071306|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
130302777|NCT02161757|469071307|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
130302778|NCT02161757|469071305|FG000|Treatment Through Study Completion|Adverse Event|1|||
130302779|NCT02161757|469071306|FG001|Treatment Through Study Completion|Adverse Event|1|||
130302780|NCT02161757|469071307|FG002|Treatment Through Study Completion|Adverse Event|0|||
130302781|NCT02161757|469071305|FG000|Treatment Through Study Completion|Protocol Violation|0|||
130302782|NCT02161757|469071306|FG001|Treatment Through Study Completion|Protocol Violation|1|||
130302783|NCT02161757|469071307|FG002|Treatment Through Study Completion|Protocol Violation|2|||
130302784|NCT02161757|469071305|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
130302785|NCT02161757|469071306|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
130302786|NCT02161757|469071307|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
130302787|NCT02161757|469071305|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
130302788|NCT02161757|469071306|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
130302789|NCT02161757|469071307|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
130302790|NCT02161757|469071305|FG000|Treatment Through Study Completion|Other|20|||
130302791|NCT02161757|469071306|FG001|Treatment Through Study Completion|Other|19|||
130302792|NCT02161757|469071307|FG002|Treatment Through Study Completion|Other|12|||
130302793|NCT02161757|469071305|FG000|Treatment Through Study Completion|Death|2|||
130302794|NCT02161757|469071306|FG001|Treatment Through Study Completion|Death|1|||
130302795|NCT02161757|469071307|FG002|Treatment Through Study Completion|Death|1|||
130302796|NCT00465647|469071310|FG000|Overall Study|Administrative|2|||
130302797|NCT00465647|469071311|FG001|Overall Study|Administrative|2|||
130302798|NCT00465647|469071312|FG002|Overall Study|Administrative|3|||
130302799|NCT00465647|469071313|FG003|Overall Study|Administrative|2|||
130302800|NCT00465647|469071310|FG000|Overall Study|Adverse Event|2|||
130302801|NCT00465647|469071311|FG001|Overall Study|Adverse Event|0|||
130302802|NCT00465647|469071312|FG002|Overall Study|Adverse Event|3|||
130302803|NCT00465647|469071313|FG003|Overall Study|Adverse Event|2|||
130302804|NCT00465647|469071310|FG000|Overall Study|Withdrawal by Subject|1|||
130302805|NCT00465647|469071311|FG001|Overall Study|Withdrawal by Subject|2|||
130302806|NCT00465647|469071312|FG002|Overall Study|Withdrawal by Subject|2|||
130302807|NCT00465647|469071313|FG003|Overall Study|Withdrawal by Subject|7|||
130302808|NCT00465647|469071310|FG000|Overall Study|"The other reasons included loss of IV"|8|||
130302809|NCT00465647|469071311|FG001|Overall Study|"The other reasons included loss of IV"|4|||
130302810|NCT00465647|469071312|FG002|Overall Study|"The other reasons included loss of IV"|3|||
130302811|NCT00465647|469071313|FG003|Overall Study|"The other reasons included loss of IV"|2|||
130302812|NCT01240135|469071316|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
130302813|NCT01240135|469071317|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
130302814|NCT01240135|469071316|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
130302815|NCT01240135|469071317|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
130302816|NCT01371305|469071318|FG000|Overall Study|Adverse Event|0|||
130302817|NCT01371305|469071319|FG001|Overall Study|Adverse Event|0|||
130302818|NCT01371305|469071320|FG002|Overall Study|Adverse Event|0|||
130302819|NCT01371305|469071321|FG003|Overall Study|Adverse Event|2|||
130302820|NCT01371305|469071322|FG004|Overall Study|Adverse Event|1|||
130302821|NCT01371305|469071323|FG005|Overall Study|Adverse Event|0|||
129795377|NCT03324581|467218005|FG001|Overall Study|Lost to Follow-up|3|||
129889149|NCT00519636|467551011|FG001|Washout Period|Subject randomized in error|0|||
129889150|NCT00519636|467551012|FG002|Washout Period|Subject randomized in error|1|||
129889151|NCT00519636|467551013|FG003|Washout Period|Subject randomized in error|0|||
130302822|NCT01371305|469071318|FG000|Overall Study|Study terminated by sponsor|0|||
130302823|NCT01371305|469071319|FG001|Overall Study|Study terminated by sponsor|0|||
130302824|NCT01371305|469071320|FG002|Overall Study|Study terminated by sponsor|0|||
130302825|NCT01371305|469071321|FG003|Overall Study|Study terminated by sponsor|0|||
130302826|NCT01371305|469071322|FG004|Overall Study|Study terminated by sponsor|3|||
129795378|NCT03324581|467218006|FG002|Overall Study|Lost to Follow-up|6|||
129795379|NCT03324581|467218004|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
129795380|NCT03324581|467218005|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
129795381|NCT03324581|467218006|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
129795382|NCT03324581|467218004|FG000|Overall Study|Physician Decision|0|||
129795383|NCT03324581|467218005|FG001|Overall Study|Physician Decision|1|||
129795384|NCT03324581|467218006|FG002|Overall Study|Physician Decision|2|||
129795385|NCT03324581|467218004|FG000|Overall Study|Protocol Deviation|8|||
129795386|NCT03324581|467218005|FG001|Overall Study|Protocol Deviation|9|||
129795387|NCT03324581|467218006|FG002|Overall Study|Protocol Deviation|4|||
129795388|NCT03324581|467218004|FG000|Overall Study|Withdrawal by Subject|6|||
129795389|NCT03324581|467218005|FG001|Overall Study|Withdrawal by Subject|8|||
129795390|NCT03324581|467218006|FG002|Overall Study|Withdrawal by Subject|6|||
129795391|NCT03324581|467218004|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
129795392|NCT03324581|467218005|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
129795393|NCT03324581|467218006|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
129795394|NCT02274038|467218007|FG000|Overall Study|Death|1|||
129795395|NCT03783702|467218008|FG000|Overall Study|Lost to Follow-up|6|||
129795396|NCT03783702|467218009|FG001|Overall Study|Lost to Follow-up|8|||
130302827|NCT01371305|469071323|FG005|Overall Study|Study terminated by sponsor|1|||
130302828|NCT01371305|469071318|FG000|Overall Study|Subject request|0|||
130302829|NCT01371305|469071319|FG001|Overall Study|Subject request|0|||
130302830|NCT01371305|469071320|FG002|Overall Study|Subject request|0|||
130302831|NCT01371305|469071321|FG003|Overall Study|Subject request|0|||
130302832|NCT01371305|469071322|FG004|Overall Study|Subject request|0|||
130302833|NCT01371305|469071323|FG005|Overall Study|Subject request|1|||
130302834|NCT02828020|469071326|FG000|Treatment Period|Adverse Event|3|||
130302835|NCT02828020|469071327|FG001|Treatment Period|Adverse Event|1|||
130302836|NCT02828020|469071328|FG002|Treatment Period|Adverse Event|1|||
130302837|NCT02828020|469071326|FG000|Treatment Period|Withdrawal of Consent|10|||
130302838|NCT02828020|469071327|FG001|Treatment Period|Withdrawal of Consent|14|||
130302839|NCT02828020|469071328|FG002|Treatment Period|Withdrawal of Consent|9|||
130302840|NCT02828020|469071326|FG000|Treatment Period|Lost to Follow-up|21|||
130302841|NCT02828020|469071327|FG001|Treatment Period|Lost to Follow-up|24|||
130302842|NCT02828020|469071328|FG002|Treatment Period|Lost to Follow-up|18|||
130302843|NCT02828020|469071326|FG000|Treatment Period|Lack of Qualifying Event|44|||
130302844|NCT02828020|469071327|FG001|Treatment Period|Lack of Qualifying Event|53|||
130302845|NCT02828020|469071328|FG002|Treatment Period|Lack of Qualifying Event|43|||
130302846|NCT02828020|469071326|FG000|Treatment Period|Pregnancy|0|||
130302847|NCT02828020|469071327|FG001|Treatment Period|Pregnancy|2|||
130302848|NCT02828020|469071328|FG002|Treatment Period|Pregnancy|0|||
130302849|NCT02828020|469071326|FG000|Treatment Period|Protocol Violation|2|||
130302850|NCT02828020|469071327|FG001|Treatment Period|Protocol Violation|4|||
130302851|NCT02828020|469071328|FG002|Treatment Period|Protocol Violation|7|||
129795397|NCT03783702|467218008|FG000|Overall Study|Protocol Violation|1|||
129795398|NCT03783702|467218009|FG001|Overall Study|Protocol Violation|3|||
129795399|NCT04473482|467218010|FG000|Overall Study|Death|0|||
130302852|NCT02828020|469071326|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130302853|NCT02828020|469071327|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
129795400|NCT04473482|467218011|FG001|Overall Study|Death|3|||
129795401|NCT04473482|467218010|FG000|Overall Study|Lost to Follow-up|9|||
129795402|NCT04473482|467218011|FG001|Overall Study|Lost to Follow-up|7|||
129795403|NCT04473482|467218010|FG000|Overall Study|Withdrawal by Subject|2|||
129795404|NCT04473482|467218011|FG001|Overall Study|Withdrawal by Subject|1|||
129795405|NCT01306877|467218012|FG000|Overall Study|Lost to Follow-up|3|||
129795406|NCT01306877|467218013|FG001|Overall Study|Lost to Follow-up|3|||
129795407|NCT01306877|467218012|FG000|Overall Study|Physician Decision|0|||
129795408|NCT01306877|467218013|FG001|Overall Study|Physician Decision|1|||
129795409|NCT00006389|467218014|FG000|Overall Study|Adverse Event|1|||
129795410|NCT01076075|467218020|FG000|Overall Study|Adverse Event|3|||
129795411|NCT01076075|467218021|FG001|Overall Study|Adverse Event|9|||
129795412|NCT01076075|467218020|FG000|Overall Study|Lack of Efficacy|5|||
130302854|NCT02828020|469071328|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
130302855|NCT02828020|469071326|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
129795413|NCT01076075|467218021|FG001|Overall Study|Lack of Efficacy|4|||
129795414|NCT01076075|467218020|FG000|Overall Study|Lost to Follow-up|6|||
129795415|NCT01076075|467218021|FG001|Overall Study|Lost to Follow-up|5|||
129795416|NCT01076075|467218020|FG000|Overall Study|other|19|||
129795417|NCT01076075|467218021|FG001|Overall Study|other|9|||
130302856|NCT02828020|469071327|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
129795418|NCT01076075|467218020|FG000|Overall Study|Protocol Violation|0|||
129795419|NCT01076075|467218021|FG001|Overall Study|Protocol Violation|1|||
129795420|NCT01076075|467218020|FG000|Overall Study|Withdrawal by Subject|8|||
129795421|NCT01076075|467218021|FG001|Overall Study|Withdrawal by Subject|19|||
129795422|NCT01445886|467218024|FG000|Overall Study|Lost to Follow-up|2|||
129795423|NCT01445886|467218024|FG000|Overall Study|Protocol Violation|3|||
129795424|NCT00995865|467218027|FG000|Overall Study|Protocol Violation|2|||
129795425|NCT00995865|467218028|FG001|Overall Study|Protocol Violation|0|||
129795426|NCT00995865|467218029|FG002|Overall Study|Protocol Violation|0|||
130302857|NCT02828020|469071328|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
130302858|NCT02828020|469071326|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
130302859|NCT02828020|469071327|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
129889152|NCT00519636|467551010|FG000|Washout Period|Prohibited medications|0|||
129889153|NCT00519636|467551011|FG001|Washout Period|Prohibited medications|0|||
130047688|NCT01416610|468131578|FG000|Overall Study|Adverse Event -Patient decision|3|||
130047689|NCT01416610|468131578|FG000|Overall Study|Lack of Efficacy|4|||
130047690|NCT01416610|468131578|FG000|Overall Study|No reason given|5|||
130047691|NCT01416610|468131578|FG000|Overall Study|Withdrawal by Subject|13|||
130047692|NCT01416610|468131578|FG000|Overall Study|Lost to Follow-up|7|||
130047693|NCT01416610|468131578|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
130047694|NCT01927562|468131579|FG000|Overall Study|Lost to Follow-up|30|||
130047695|NCT01927562|468131579|FG000|Overall Study|Withdrawal by Subject|3|||
130047696|NCT01927562|468131579|FG000|Overall Study|Physician Decision|5|||
130047697|NCT00642616|468131580|FG000|Overall Study|Adverse Event|2|||
130047698|NCT00642616|468131581|FG001|Overall Study|Adverse Event|0|||
130047699|NCT00642616|468131582|FG002|Overall Study|Adverse Event|1|||
130047700|NCT00642616|468131583|FG003|Overall Study|Adverse Event|0|||
130047701|NCT00642616|468131580|FG000|Overall Study|Study Terminated by Sponsor|7|||
130047702|NCT00642616|468131581|FG001|Overall Study|Study Terminated by Sponsor|6|||
130047703|NCT00642616|468131582|FG002|Overall Study|Study Terminated by Sponsor|4|||
130047704|NCT00642616|468131583|FG003|Overall Study|Study Terminated by Sponsor|5|||
130047705|NCT00642616|468131580|FG000|Overall Study|Withdrawal by Subject|0|||
130047706|NCT00642616|468131581|FG001|Overall Study|Withdrawal by Subject|1|||
130047707|NCT00642616|468131582|FG002|Overall Study|Withdrawal by Subject|1|||
130302860|NCT02828020|469071328|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
130302861|NCT02828020|469071326|FG000|Safety Follow-up Period|Protocol Violation|0|||
130302862|NCT02828020|469071327|FG001|Safety Follow-up Period|Protocol Violation|2|||
130302863|NCT02828020|469071328|FG002|Safety Follow-up Period|Protocol Violation|1|||
130302864|NCT02828020|469071326|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
130302865|NCT02828020|469071327|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130302866|NCT02828020|469071328|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
130302867|NCT01339897|469071329|FG000|Overall Study|Adverse Event|1|||
130302868|NCT01339897|469071330|FG001|Overall Study|Adverse Event|0|||
130302869|NCT01339897|469071331|FG002|Overall Study|Adverse Event|0|||
130302870|NCT01339897|469071332|FG003|Overall Study|Adverse Event|1|||
130302871|NCT01138501|469071333|FG000|Overall Study|Protocol Violation|2|||
130302872|NCT01138501|469071333|FG000|Overall Study|Withdrawal by Subject|3|||
130302873|NCT00847197|469071337|FG000|Overall Study|Adverse Event|21|||
130302874|NCT00847197|469071338|FG001|Overall Study|Adverse Event|3|||
130302875|NCT00847197|469071337|FG000|Overall Study|Protocol Violation|0|||
130302876|NCT00847197|469071338|FG001|Overall Study|Protocol Violation|1|||
130302877|NCT00847197|469071337|FG000|Overall Study|Withdrawal by Subject|3|||
130302878|NCT00847197|469071338|FG001|Overall Study|Withdrawal by Subject|1|||
130302879|NCT01743040|469071339|FG000|Overall Study|Death|1|||
130302880|NCT01743040|469071339|FG000|Overall Study|Lost to Follow-up|66|||
130302881|NCT01743040|469071339|FG000|Overall Study|Physician Decision|40|||
130302882|NCT01743040|469071339|FG000|Overall Study|Protocol Violation|1|||
130302883|NCT01743040|469071339|FG000|Overall Study|Withdrawal by Subject|121|||
130302884|NCT01894243|469071340|FG000|Overall Study|Adverse Event|0|||
130302885|NCT01894243|469071341|FG001|Overall Study|Adverse Event|1|||
130302886|NCT01894243|469071342|FG002|Overall Study|Adverse Event|2|||
130302887|NCT01894243|469071340|FG000|Overall Study|Death|0|||
130302888|NCT01894243|469071341|FG001|Overall Study|Death|0|||
130302889|NCT01894243|469071342|FG002|Overall Study|Death|3|||
130302890|NCT01894243|469071340|FG000|Overall Study|Lack of Efficacy|3|||
130302891|NCT01894243|469071341|FG001|Overall Study|Lack of Efficacy|3|||
130302892|NCT01894243|469071342|FG002|Overall Study|Lack of Efficacy|1|||
130047708|NCT00642616|468131583|FG003|Overall Study|Withdrawal by Subject|1|||
130047709|NCT00642616|468131580|FG000|Overall Study|Protocol Violation|0|||
130047710|NCT00642616|468131581|FG001|Overall Study|Protocol Violation|0|||
130047711|NCT00642616|468131582|FG002|Overall Study|Protocol Violation|2|||
130047712|NCT00642616|468131583|FG003|Overall Study|Protocol Violation|0|||
130047713|NCT00642616|468131580|FG000|Overall Study|Physician Decision|0|||
130047714|NCT00642616|468131581|FG001|Overall Study|Physician Decision|0|||
130107484|NCT01902134|468355132|FG002|Overall Study|Other|2|||
130302893|NCT01894243|469071340|FG000|Overall Study|Condition under investigation worsened|8|||
130302894|NCT01894243|469071341|FG001|Overall Study|Condition under investigation worsened|6|||
130302895|NCT01894243|469071342|FG002|Overall Study|Condition under investigation worsened|2|||
130302896|NCT01894243|469071340|FG000|Overall Study|Subject decision|1|||
130302897|NCT01894243|469071341|FG001|Overall Study|Subject decision|0|||
130302898|NCT01894243|469071342|FG002|Overall Study|Subject decision|0|||
130302899|NCT01894243|469071340|FG000|Overall Study|Other|1|||
130302900|NCT01894243|469071341|FG001|Overall Study|Other|0|||
130302901|NCT01894243|469071342|FG002|Overall Study|Other|0|||
130302902|NCT00830180|469071346|FG000|Overall Study|Adverse Event|6|||
130302903|NCT00830180|469071346|FG000|Overall Study|Death|11|||
130302904|NCT00830180|469071346|FG000|Overall Study|Insufficient clinical response|1|||
130302905|NCT00830180|469071346|FG000|Overall Study|Withdrawal by Subject|5|||
130302906|NCT00830180|469071346|FG000|Overall Study|Progressive disease|2|||
130302907|NCT00830180|469071346|FG000|Overall Study|Other - Unspecified|1|||
130302908|NCT01832532|469071347|FG000|Overall Study|Withdrawal by Subject|5|||
130302909|NCT01832532|469071348|FG001|Overall Study|Withdrawal by Subject|2|||
130302910|NCT02687581|469071350|FG000|Overall Study|Withdrawal by Subject|1|||
130302911|NCT02687581|469071351|FG001|Overall Study|Withdrawal by Subject|0|||
130302912|NCT02687581|469071352|FG002|Overall Study|Withdrawal by Subject|0|||
130302913|NCT02687581|469071353|FG003|Overall Study|Withdrawal by Subject|1|||
130302914|NCT02687581|469071350|FG000|Overall Study|Lost to Follow-up|2|||
130302915|NCT02687581|469071351|FG001|Overall Study|Lost to Follow-up|2|||
130302916|NCT02687581|469071352|FG002|Overall Study|Lost to Follow-up|0|||
130302917|NCT02687581|469071353|FG003|Overall Study|Lost to Follow-up|0|||
130302918|NCT02687581|469071350|FG000|Overall Study|the device is too small for the patient.|1|||
130302919|NCT02687581|469071351|FG001|Overall Study|the device is too small for the patient.|0|||
130302920|NCT02687581|469071352|FG002|Overall Study|the device is too small for the patient.|0|||
130302921|NCT02687581|469071353|FG003|Overall Study|the device is too small for the patient.|0|||
130302922|NCT01990612|469071356|FG000|Overall Study|Lost to Follow-up|2|||
130302923|NCT01990612|469071357|FG001|Overall Study|Lost to Follow-up|1|||
130302924|NCT01990612|469071356|FG000|Overall Study|Withdrawal by Subject|5|||
130302925|NCT01990612|469071357|FG001|Overall Study|Withdrawal by Subject|2|||
130302926|NCT02974842|469071358|FG000|Overall Study|Withdrawal by Subject|4|||
130302927|NCT02974842|469071358|FG000|Overall Study|Screen failures|4|||
130302928|NCT02467582|469073357|FG000|Allocation|Withdrawal by Subject|1|||
130302929|NCT02467582|469073358|FG001|Allocation|Withdrawal by Subject|0|||
130302930|NCT02467582|469073357|FG000|Follow-up|Death|5|||
130302931|NCT02467582|469073358|FG001|Follow-up|Death|4|||
130302932|NCT02467582|469073357|FG000|Follow-up|Lost to Follow-up|6|||
130302933|NCT02467582|469073358|FG001|Follow-up|Lost to Follow-up|5|||
130302934|NCT02291419|469073359|FG000|Overall Study|Early study termination|1|||
130302935|NCT02291419|469073360|FG001|Overall Study|Early study termination|5|||
130302936|NCT03047031|469073372|FG000|Overall Study|Other than listed|1|||
130302937|NCT03047031|469073373|FG001|Overall Study|Other than listed|0|||
129795427|NCT00995865|467218027|FG000|Overall Study|Lost to Follow-up|0|||
129795428|NCT00995865|467218028|FG001|Overall Study|Lost to Follow-up|0|||
129795429|NCT00995865|467218029|FG002|Overall Study|Lost to Follow-up|1|||
129795430|NCT05080660|467218030|FG000|Overall Study|Adverse Event|4|||
129795431|NCT05080660|467218031|FG001|Overall Study|Adverse Event|0|||
129795432|NCT05080660|467218030|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
129795433|NCT05080660|467218031|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
129795434|NCT05080660|467218030|FG000|Overall Study|Physician Decision|1|||
129795435|NCT05080660|467218031|FG001|Overall Study|Physician Decision|0|||
129795436|NCT05080660|467218030|FG000|Overall Study|Protocol Deviation|2|||
129795437|NCT05080660|467218031|FG001|Overall Study|Protocol Deviation|0|||
129795438|NCT05080660|467218030|FG000|Overall Study|Withdrawal by Subject|5|||
129795439|NCT05080660|467218031|FG001|Overall Study|Withdrawal by Subject|2|||
129795440|NCT04285580|467219545|FG000|Overall Study|Protocol Violation|0|||
129795441|NCT04285580|467219546|FG001|Overall Study|Protocol Violation|1|||
129795442|NCT00076024|467219547|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
129795443|NCT00076024|467219548|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
129795444|NCT00076024|467219549|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
129795445|NCT00076024|467219550|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
129795446|NCT00076024|467219547|FG000|Phase 1, Lead-in|Adverse Event|1|||
129795447|NCT00076024|467219548|FG001|Phase 1, Lead-in|Adverse Event|0|||
129795448|NCT00076024|467219549|FG002|Phase 1, Lead-in|Adverse Event|0|||
130302938|NCT03047031|469073374|FG002|Overall Study|Other than listed|0|||
130302939|NCT03047031|469073372|FG000|Overall Study|Lost to Follow-up|4|||
130302940|NCT03047031|469073373|FG001|Overall Study|Lost to Follow-up|0|||
130302941|NCT03047031|469073374|FG002|Overall Study|Lost to Follow-up|0|||
130302942|NCT03047031|469073372|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
130302943|NCT03047031|469073373|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
130302944|NCT03047031|469073374|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
130302945|NCT03047031|469073372|FG000|Overall Study|Adverse Event|1|||
130302946|NCT03047031|469073373|FG001|Overall Study|Adverse Event|0|||
130302947|NCT03047031|469073374|FG002|Overall Study|Adverse Event|0|||
129795449|NCT00076024|467219550|FG003|Phase 1, Lead-in|Adverse Event|0|||
130047715|NCT00642616|468131582|FG002|Overall Study|Physician Decision|1|||
129795450|NCT00076024|467219547|FG000|Phase 1, Lead-in|Clinical progression|1|||
129795451|NCT00076024|467219548|FG001|Phase 1, Lead-in|Clinical progression|0|||
129795452|NCT00076024|467219549|FG002|Phase 1, Lead-in|Clinical progression|0|||
129795453|NCT00076024|467219550|FG003|Phase 1, Lead-in|Clinical progression|0|||
129795454|NCT00076024|467219547|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
129795455|NCT00076024|467219548|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
129795456|NCT00076024|467219549|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
129795457|NCT00076024|467219550|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
129795458|NCT00076024|467219547|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
129795459|NCT00076024|467219548|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
129795460|NCT00076024|467219549|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
129795461|NCT00076024|467219550|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
129795462|NCT00076024|467219547|FG000|Phase 2, Double-blind|Adverse Event|0|||
129795463|NCT00076024|467219548|FG001|Phase 2, Double-blind|Adverse Event|25|||
129795464|NCT00076024|467219549|FG002|Phase 2, Double-blind|Adverse Event|6|||
129795465|NCT00076024|467219550|FG003|Phase 2, Double-blind|Adverse Event|0|||
129795466|NCT00076024|467219547|FG000|Phase 2, Double-blind|Un-specified|0|||
129795467|NCT00076024|467219548|FG001|Phase 2, Double-blind|Un-specified|14|||
129795468|NCT00076024|467219549|FG002|Phase 2, Double-blind|Un-specified|6|||
129795469|NCT00076024|467219550|FG003|Phase 2, Double-blind|Un-specified|0|||
129795470|NCT00076024|467219547|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
129795471|NCT00076024|467219548|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
129795472|NCT00076024|467219549|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
129795473|NCT00076024|467219550|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
129795474|NCT00076024|467219547|FG000|Phase 2, Open-label|Adverse Event|0|||
129795475|NCT00076024|467219548|FG001|Phase 2, Open-label|Adverse Event|0|||
129795476|NCT00076024|467219549|FG002|Phase 2, Open-label|Adverse Event|0|||
129795477|NCT00076024|467219550|FG003|Phase 2, Open-label|Adverse Event|2|||
129795478|NCT00076024|467219547|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
129795479|NCT00076024|467219548|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
130047716|NCT00642616|468131583|FG003|Overall Study|Physician Decision|1|||
130047717|NCT00492921|468131584|FG000|Overall Study|Death|1|||
130047718|NCT00492921|468131585|FG001|Overall Study|Death|0|||
130047719|NCT00492921|468131586|FG002|Overall Study|Death|1|||
130047720|NCT00399802|468131587|FG000|Overall Study|Adverse Event|0|||
129795480|NCT00076024|467219549|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
130047721|NCT00399802|468131588|FG001|Overall Study|Adverse Event|2|||
130047722|NCT00399802|468131587|FG000|Overall Study|Participant discontinued by mistake|0|||
130047723|NCT00399802|468131588|FG001|Overall Study|Participant discontinued by mistake|1|||
130047724|NCT00542815|468131589|FG000|Overall Study|Adverse Event|19|||
130047725|NCT00542815|468131590|FG001|Overall Study|Adverse Event|6|||
130047726|NCT00542815|468131591|FG002|Overall Study|Adverse Event|9|||
130047727|NCT00542815|468131589|FG000|Overall Study|Death|10|||
130047728|NCT00542815|468131590|FG001|Overall Study|Death|7|||
130047729|NCT00542815|468131591|FG002|Overall Study|Death|3|||
130047730|NCT00542815|468131589|FG000|Overall Study|Lack of Efficacy|9|||
130047731|NCT00542815|468131590|FG001|Overall Study|Lack of Efficacy|2|||
130047732|NCT00542815|468131591|FG002|Overall Study|Lack of Efficacy|0|||
130047733|NCT00542815|468131589|FG000|Overall Study|Physician Decision|2|||
130047734|NCT00542815|468131590|FG001|Overall Study|Physician Decision|1|||
130047735|NCT00542815|468131591|FG002|Overall Study|Physician Decision|0|||
130047736|NCT00542815|468131589|FG000|Overall Study|Protocol Violation|1|||
130047737|NCT00542815|468131590|FG001|Overall Study|Protocol Violation|1|||
130302948|NCT03047031|469073372|FG000|Overall Study|Withdrawal by Subject|2|||
130302949|NCT03047031|469073373|FG001|Overall Study|Withdrawal by Subject|0|||
129795481|NCT00076024|467219550|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
129795482|NCT00076024|467219547|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
129795483|NCT00076024|467219548|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
129795484|NCT00076024|467219549|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
130047738|NCT00542815|468131591|FG002|Overall Study|Protocol Violation|2|||
130047739|NCT00542815|468131589|FG000|Overall Study|Withdrawal by Subject|41|||
130047740|NCT00542815|468131590|FG001|Overall Study|Withdrawal by Subject|5|||
130047741|NCT00542815|468131591|FG002|Overall Study|Withdrawal by Subject|8|||
130047742|NCT00542815|468131589|FG000|Overall Study|Other reasons|24|||
130302950|NCT03047031|469073374|FG002|Overall Study|Withdrawal by Subject|0|||
129795485|NCT00076024|467219550|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
129795486|NCT00076024|467219547|FG000|Phase 2, Open-label|Other|0|||
130047743|NCT00542815|468131590|FG001|Overall Study|Other reasons|10|||
130047744|NCT00542815|468131591|FG002|Overall Study|Other reasons|10|||
130047745|NCT01520922|468131592|FG000|Treatment Phase|Physician Decision|2|||
130047746|NCT01520922|468131593|FG001|Treatment Phase|Physician Decision|1|||
130047747|NCT01520922|468131592|FG000|Treatment Phase|Progression|0|||
130047748|NCT01520922|468131593|FG001|Treatment Phase|Progression|2|||
130047749|NCT01520922|468131592|FG000|Treatment Phase|Adverse Event|3|||
130047750|NCT01520922|468131593|FG001|Treatment Phase|Adverse Event|5|||
130302951|NCT03047031|469073372|FG000|Overall Study|Change to other medication|2|||
129795487|NCT00076024|467219548|FG001|Phase 2, Open-label|Other|0|||
129795488|NCT00076024|467219549|FG002|Phase 2, Open-label|Other|0|||
129795489|NCT00076024|467219550|FG003|Phase 2, Open-label|Other|2|||
129795490|NCT01155219|467219551|FG000|Overall Study|Adverse Event|3|||
129795491|NCT01155219|467219552|FG001|Overall Study|Adverse Event|1|||
129795492|NCT01155219|467219551|FG000|Overall Study|non-medical reason|1|||
129795493|NCT01155219|467219552|FG001|Overall Study|non-medical reason|2|||
129795494|NCT00719264|467219553|FG000|Overall Study|Adverse Event|41|||
129795495|NCT00719264|467219554|FG001|Overall Study|Adverse Event|49|||
129795496|NCT00719264|467219553|FG000|Overall Study|Death|13|||
129795497|NCT00719264|467219554|FG001|Overall Study|Death|10|||
129795498|NCT00719264|467219553|FG000|Overall Study|Administrative Problems|6|||
129889154|NCT00519636|467551012|FG002|Washout Period|Prohibited medications|1|||
129889155|NCT00519636|467551013|FG003|Washout Period|Prohibited medications|0|||
129889156|NCT00519636|467551010|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
129889157|NCT00519636|467551011|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
129889158|NCT00519636|467551012|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
129889159|NCT00519636|467551013|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
129889160|NCT00519636|467551010|FG000|Treatment Period 2|Subject randomized in error|0|||
129795499|NCT00719264|467219554|FG001|Overall Study|Administrative Problems|4|||
129795500|NCT00719264|467219553|FG000|Overall Study|Lost to Follow-up|1|||
129795501|NCT00719264|467219554|FG001|Overall Study|Lost to Follow-up|1|||
129795502|NCT00719264|467219553|FG000|Overall Study|Withdrawal by Subject|12|||
129795503|NCT00719264|467219554|FG001|Overall Study|Withdrawal by Subject|7|||
129795504|NCT00719264|467219553|FG000|Overall Study|Protocol Deviation|1|||
129795505|NCT00719264|467219554|FG001|Overall Study|Protocol Deviation|3|||
129795506|NCT00719264|467219553|FG000|Overall Study|New Cancer Therapy|4|||
129795507|NCT00719264|467219554|FG001|Overall Study|New Cancer Therapy|2|||
129795508|NCT00719264|467219553|FG000|Overall Study|Disease Progression|104|||
129795509|NCT00719264|467219554|FG001|Overall Study|Disease Progression|107|||
129795510|NCT02278341|467219556|FG000|Overall Study|Randomized but never received study drug|1|||
129795511|NCT02278341|467219557|FG001|Overall Study|Randomized but never received study drug|1|||
129795512|NCT02278341|467219556|FG000|Overall Study|Adverse Event|3|||
129795513|NCT02278341|467219557|FG001|Overall Study|Adverse Event|0|||
129795514|NCT02278341|467219556|FG000|Overall Study|Death|68|||
129795515|NCT02278341|467219557|FG001|Overall Study|Death|56|||
129795516|NCT02278341|467219556|FG000|Overall Study|Withdrawal by Subject|30|||
129795517|NCT02278341|467219557|FG001|Overall Study|Withdrawal by Subject|19|||
129795518|NCT02278341|467219556|FG000|Overall Study|Lost to Follow-up|0|||
129795519|NCT02278341|467219557|FG001|Overall Study|Lost to Follow-up|1|||
129795520|NCT02278341|467219556|FG000|Overall Study|Physician Decision|1|||
129795521|NCT02278341|467219557|FG001|Overall Study|Physician Decision|1|||
129795522|NCT02278341|467219556|FG000|Overall Study|Miscellaneous|15|||
129795523|NCT02278341|467219557|FG001|Overall Study|Miscellaneous|14|||
130302952|NCT03047031|469073373|FG001|Overall Study|Change to other medication|0|||
130302953|NCT03047031|469073374|FG002|Overall Study|Change to other medication|0|||
130302954|NCT03047031|469073372|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
130302955|NCT03047031|469073373|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
130302956|NCT03047031|469073374|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
130302957|NCT01959139|469073385|FG000|Phase II|Disease progression|0|||
130302958|NCT01959139|469073386|FG001|Phase II|Disease progression|0|||
130302959|NCT01959139|469073387|FG002|Phase II|Disease progression|26|||
130302960|NCT01959139|469073388|FG003|Phase II|Disease progression|34|||
130302961|NCT01959139|469073385|FG000|Phase II|Adverse Event|0|||
130302962|NCT01959139|469073386|FG001|Phase II|Adverse Event|0|||
130302963|NCT01959139|469073387|FG002|Phase II|Adverse Event|10|||
130302964|NCT01959139|469073388|FG003|Phase II|Adverse Event|11|||
130302965|NCT01959139|469073385|FG000|Phase II|Patient Refusal|0|||
130302966|NCT01959139|469073386|FG001|Phase II|Patient Refusal|0|||
130302967|NCT01959139|469073387|FG002|Phase II|Patient Refusal|5|||
130302968|NCT01959139|469073388|FG003|Phase II|Patient Refusal|4|||
129795524|NCT04902326|467219558|FG000|Overall Study|Withdrawal by Subject|1|||
129795525|NCT04902326|467219559|FG001|Overall Study|Withdrawal by Subject|3|||
129795526|NCT04902326|467219560|FG002|Overall Study|Withdrawal by Subject|0|||
129795527|NCT04902326|467219561|FG003|Overall Study|Withdrawal by Subject|1|||
129795528|NCT04902326|467219558|FG000|Overall Study|Lost to Follow-up|14|||
129889161|NCT00519636|467551011|FG001|Treatment Period 2|Subject randomized in error|1|||
129889162|NCT00519636|467551012|FG002|Treatment Period 2|Subject randomized in error|0|||
129889163|NCT00519636|467551013|FG003|Treatment Period 2|Subject randomized in error|0|||
130047751|NCT01520922|468131592|FG000|Follow up|Lost to Follow-up|0|||
129795529|NCT04902326|467219559|FG001|Overall Study|Lost to Follow-up|14|||
130302969|NCT01959139|469073385|FG000|Phase II|Death|0|||
130302970|NCT01959139|469073386|FG001|Phase II|Death|0|||
130302971|NCT01959139|469073387|FG002|Phase II|Death|3|||
130302972|NCT01959139|469073388|FG003|Phase II|Death|1|||
130302973|NCT01959139|469073385|FG000|Phase II|Other/Unknown|0|||
129795530|NCT04902326|467219560|FG002|Overall Study|Lost to Follow-up|14|||
129795531|NCT04902326|467219561|FG003|Overall Study|Lost to Follow-up|6|||
129795532|NCT02604017|467219562|FG000|Overall Study|Withdrew Consent|0|||
129889164|NCT00519636|467551010|FG000|Treatment Period 2|Per doctors request|0|||
130302974|NCT01959139|469073386|FG001|Phase II|Other/Unknown|0|||
130302975|NCT01959139|469073387|FG002|Phase II|Other/Unknown|8|||
129795533|NCT02604017|467219563|FG001|Overall Study|Withdrew Consent|2|||
129795534|NCT02604017|467219562|FG000|Overall Study|Lost to Follow-up|5|||
129795535|NCT02604017|467219563|FG001|Overall Study|Lost to Follow-up|6|||
129795536|NCT02604017|467219562|FG000|Overall Study|Other|1|||
129795537|NCT02604017|467219563|FG001|Overall Study|Other|0|||
129795538|NCT00740246|467219564|FG000|Overall Study|Received Blood Transfusion|0|||
129795539|NCT00740246|467219565|FG001|Overall Study|Received Blood Transfusion|1|||
129795540|NCT00740246|467219564|FG000|Overall Study|Adverse Event|1|||
129795541|NCT00740246|467219565|FG001|Overall Study|Adverse Event|2|||
129795542|NCT00740246|467219564|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
129795543|NCT00740246|467219565|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
129795544|NCT00740246|467219564|FG000|Overall Study|Lost to Follow-up|2|||
129795545|NCT00740246|467219565|FG001|Overall Study|Lost to Follow-up|2|||
129795546|NCT00740246|467219564|FG000|Overall Study|Withdrawal by Subject|4|||
129795547|NCT00740246|467219565|FG001|Overall Study|Withdrawal by Subject|3|||
129795548|NCT00740246|467219564|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
129795549|NCT00740246|467219565|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
129795550|NCT00740246|467219564|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
129795551|NCT00740246|467219565|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
129795552|NCT00740246|467219564|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
129795553|NCT00740246|467219565|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
129795554|NCT00740246|467219564|FG000|Overall Study|Unable To Comply With Study Visits|2|||
129795555|NCT00740246|467219565|FG001|Overall Study|Unable To Comply With Study Visits|0|||
129795556|NCT00740246|467219564|FG000|Overall Study|Unable to Access Vein|0|||
129795557|NCT00740246|467219565|FG001|Overall Study|Unable to Access Vein|2|||
129795558|NCT00740246|467219564|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
129795559|NCT00740246|467219565|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
129795560|NCT01117051|467219566|FG000|Overall Study|Withdrawal by Subject|5|||
129795561|NCT01117051|467219567|FG001|Overall Study|Withdrawal by Subject|3|||
129795562|NCT01117051|467219566|FG000|Overall Study|Adverse Event|4|||
129795563|NCT01117051|467219567|FG001|Overall Study|Adverse Event|3|||
129795564|NCT01117051|467219566|FG000|Overall Study|Lost to Follow-up|0|||
129795565|NCT01117051|467219567|FG001|Overall Study|Lost to Follow-up|1|||
129795566|NCT01117051|467219566|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
129795567|NCT01117051|467219567|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
129795568|NCT01117051|467219566|FG000|Overall Study|Sponsor's decision|3|||
129795569|NCT01117051|467219567|FG001|Overall Study|Sponsor's decision|1|||
129795570|NCT01117051|467219566|FG000|Overall Study|Surgical procedure|0|||
129795571|NCT01117051|467219567|FG001|Overall Study|Surgical procedure|1|||
129795572|NCT01117051|467219566|FG000|Overall Study|Randomized by mistake|0|||
129795573|NCT01117051|467219567|FG001|Overall Study|Randomized by mistake|1|||
129795574|NCT01117051|467219566|FG000|Overall Study|Convenience issue|1|||
129795575|NCT01117051|467219567|FG001|Overall Study|Convenience issue|0|||
129795576|NCT00366340|467219568|FG000|Infant Series|Protocol Violation|3|||
129795577|NCT00366340|467219569|FG001|Infant Series|Protocol Violation|4|||
129795578|NCT00366340|467219568|FG000|Infant Series|Withdrawal by Subject|3|||
129795579|NCT00366340|467219569|FG001|Infant Series|Withdrawal by Subject|3|||
129795580|NCT00366340|467219568|FG000|Infant Series|Adverse Event|0|||
130302976|NCT01959139|469073388|FG003|Phase II|Other/Unknown|5|||
130302977|NCT01959139|469073385|FG000|Phase II|On treatment|0|||
130302978|NCT01959139|469073386|FG001|Phase II|On treatment|0|||
130302979|NCT01959139|469073387|FG002|Phase II|On treatment|4|||
130302980|NCT01959139|469073388|FG003|Phase II|On treatment|0|||
130302981|NCT00630344|469073391|FG000|Overall Study|Adverse Event|5|||
130302982|NCT00630344|469073391|FG000|Overall Study|Progressive Disease|19|||
130302983|NCT00630344|469073391|FG000|Overall Study|Physician Decision|9|||
130302984|NCT00630344|469073391|FG000|Overall Study|Withdrawal by Subject|1|||
130302985|NCT00630344|469073391|FG000|Overall Study|Intercurrent Illness|1|||
129795581|NCT00366340|467219569|FG001|Infant Series|Adverse Event|2|||
129795582|NCT00366340|467219568|FG000|Infant Series|Lost to Follow-up|1|||
129795583|NCT00366340|467219569|FG001|Infant Series|Lost to Follow-up|1|||
129795584|NCT00366340|467219568|FG000|Infant Series|Failure to return|1|||
129795585|NCT00366340|467219569|FG001|Infant Series|Failure to return|0|||
129795586|NCT00366340|467219568|FG000|After the Infant Series|Parent/legal guardian request|1|||
130302986|NCT00630344|469073391|FG000|Overall Study|Other|1|||
129795587|NCT00366340|467219569|FG001|After the Infant Series|Parent/legal guardian request|1|||
130047752|NCT01520922|468131593|FG001|Follow up|Lost to Follow-up|1|||
130302987|NCT00930553|469073394|FG000|Overall Study|Adverse Event|1|||
130302988|NCT00930553|469073394|FG000|Overall Study|Lack of Efficacy|7|||
130302989|NCT00930553|469073394|FG000|Overall Study|Physician Decision|39|||
129795588|NCT00366340|467219568|FG000|After the Infant Series|Failed to return|0|||
129795589|NCT00366340|467219569|FG001|After the Infant Series|Failed to return|1|||
129795590|NCT00366340|467219568|FG000|After the Infant Series|Protocol Violation|2|||
129795591|NCT00366340|467219569|FG001|After the Infant Series|Protocol Violation|2|||
129795592|NCT00366340|467219568|FG000|After the Infant Series|Adverse Event|0|||
129795593|NCT00366340|467219569|FG001|After the Infant Series|Adverse Event|1|||
129795594|NCT00366340|467219568|FG000|After the Infant Series|Lost to Follow-up|0|||
129795595|NCT00366340|467219569|FG001|After the Infant Series|Lost to Follow-up|1|||
129795596|NCT00366340|467219568|FG000|Toddler Dose|Failed to return|1|||
129795597|NCT00366340|467219569|FG001|Toddler Dose|Failed to return|0|||
129795598|NCT00366340|467219568|FG000|Toddler Dose|Parent/legal guardian request|0|||
129795599|NCT00366340|467219569|FG001|Toddler Dose|Parent/legal guardian request|1|||
129795600|NCT01315236|467219573|FG000|Double-blind Phase|Death|1|||
129795601|NCT01315236|467219574|FG001|Double-blind Phase|Death|0|||
129795602|NCT01315236|467219573|FG000|Double-blind Phase|Adverse Event|1|||
129795603|NCT01315236|467219574|FG001|Double-blind Phase|Adverse Event|0|||
129795604|NCT01315236|467219573|FG000|Double-blind Phase|Withdrawal of Consent|1|||
129795605|NCT01315236|467219574|FG001|Double-blind Phase|Withdrawal of Consent|0|||
129795606|NCT01315236|467219573|FG000|Double-blind Phase|Lost to Follow-up|1|||
129795607|NCT01315236|467219574|FG001|Double-blind Phase|Lost to Follow-up|0|||
129795608|NCT01315236|467219573|FG000|Open-label Phase|Death|1|||
129795609|NCT01315236|467219574|FG001|Open-label Phase|Death|0|||
129795610|NCT01315236|467219573|FG000|Open-label Phase|Adverse Event|0|||
129795611|NCT01315236|467219574|FG001|Open-label Phase|Adverse Event|1|||
129795612|NCT01315236|467219573|FG000|Open-label Phase|Other|0|||
129795613|NCT01315236|467219574|FG001|Open-label Phase|Other|1|||
129795614|NCT01315236|467219573|FG000|12-Month Follow-up Period|Death|0|||
129795615|NCT01315236|467219574|FG001|12-Month Follow-up Period|Death|1|||
129795616|NCT01315236|467219573|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
129795617|NCT01315236|467219574|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
129795618|NCT00442468|467219575|FG000|Overall Study|Adverse Event|4|||
129795619|NCT00442468|467219575|FG000|Overall Study|Withdrawal by Subject|91|||
129795620|NCT00442468|467219575|FG000|Overall Study|Did not complete all study procedures|88|||
129795621|NCT00589784|467219578|FG000|Overall Study|Withdrawal by Subject|0|||
129795622|NCT00589784|467219579|FG001|Overall Study|Withdrawal by Subject|6|||
129795623|NCT00589784|467219578|FG000|Overall Study|Patient inevaluable|1|||
129795624|NCT00589784|467219579|FG001|Overall Study|Patient inevaluable|0|||
129795625|NCT00589784|467219578|FG000|Overall Study|Adverse Event|0|||
129795626|NCT00589784|467219579|FG001|Overall Study|Adverse Event|4|||
129795627|NCT00521001|467219581|FG000|Overall Study|Ineligible|1|||
129795628|NCT02821910|467219582|FG000|Overall Study|Withdrawal by Subject|0|||
129795629|NCT02821910|467219583|FG001|Overall Study|Withdrawal by Subject|0|||
129795630|NCT02821910|467219584|FG002|Overall Study|Withdrawal by Subject|1|||
129795631|NCT02821910|467219585|FG003|Overall Study|Withdrawal by Subject|0|||
129795632|NCT02821910|467219586|FG004|Overall Study|Withdrawal by Subject|0|||
129795633|NCT02821910|467219587|FG005|Overall Study|Withdrawal by Subject|1|||
129795634|NCT02821910|467219582|FG000|Overall Study|Other than specified|1|||
129795635|NCT02821910|467219583|FG001|Overall Study|Other than specified|0|||
129795636|NCT02821910|467219584|FG002|Overall Study|Other than specified|1|||
129795637|NCT02821910|467219585|FG003|Overall Study|Other than specified|0|||
129795638|NCT02821910|467219586|FG004|Overall Study|Other than specified|0|||
129795639|NCT02821910|467219587|FG005|Overall Study|Other than specified|0|||
129795640|NCT01289782|467219588|FG000|Overall Study|Lost to Follow-up|14|||
129795641|NCT01289782|467219589|FG001|Overall Study|Lost to Follow-up|7|||
129795642|NCT01289782|467219588|FG000|Overall Study|Protocol Violation|1|||
129795643|NCT01289782|467219589|FG001|Overall Study|Protocol Violation|1|||
129795644|NCT01289782|467219588|FG000|Overall Study|Withdrawal by Subject|8|||
129795645|NCT01289782|467219589|FG001|Overall Study|Withdrawal by Subject|2|||
129795646|NCT01289782|467219588|FG000|Overall Study|Sponsor's Decision|1|||
129795647|NCT01289782|467219589|FG001|Overall Study|Sponsor's Decision|0|||
130107485|NCT01902134|468355133|FG003|Overall Study|Other|0|||
130302990|NCT00930553|469073394|FG000|Overall Study|Protocol Violation|1|||
130302991|NCT00930553|469073394|FG000|Overall Study|Pregnancy|1|||
130302992|NCT00930553|469073394|FG000|Overall Study|Withdrawal by Subject|88|||
129795648|NCT01289782|467219588|FG000|Overall Study|Reason not specified|1|||
129795649|NCT01289782|467219589|FG001|Overall Study|Reason not specified|2|||
129795650|NCT01025154|467219593|FG000|Overall Study|Lost to Follow-up|1|||
129795651|NCT01025154|467219593|FG000|Overall Study|Withdrawal by Subject|1|||
130302993|NCT00930553|469073394|FG000|Overall Study|Lost to Follow-up|25|||
129795652|NCT00542451|467219598|FG000|Overall Study|Adverse Event|31|||
129795653|NCT00542451|467219598|FG000|Overall Study|Withdrawal by Subject|30|||
129795654|NCT00542451|467219598|FG000|Overall Study|Physician Decision|4|||
129795655|NCT00542451|467219598|FG000|Overall Study|Recurrent disease|1|||
129795656|NCT00542451|467219598|FG000|Overall Study|unknown reason|1|||
129795657|NCT00542451|467219598|FG000|Overall Study|Death|2|||
129795658|NCT00542451|467219598|FG000|Overall Study|Lost to Follow-up|10|||
129795659|NCT03519386|467219599|FG000|Overall Study|Withdrawal by Subject|4|||
129795660|NCT03519386|467219600|FG001|Overall Study|Withdrawal by Subject|1|||
129795661|NCT03519386|467219601|FG002|Overall Study|Withdrawal by Subject|2|||
129795662|NCT03519386|467219599|FG000|Overall Study|Physician Decision|1|||
129795663|NCT03519386|467219600|FG001|Overall Study|Physician Decision|1|||
130302994|NCT00930553|469073394|FG000|Overall Study|Death|9|||
130302995|NCT00930553|469073394|FG000|Overall Study|Study terminated by sponsor|24|||
130302996|NCT00930553|469073394|FG000|Overall Study|Other than specified above|28|||
130302997|NCT01964963|469073395|FG000|Overall Study|Case Report Forms Uncollected|888|||
130302998|NCT01964963|469073395|FG000|Overall Study|Protocol Deviation|50|||
130302999|NCT01964963|469073395|FG000|Overall Study|Data Reliability was not Assured|5|||
130303000|NCT00856544|469073404|FG000|Overall Study|Randomized but not treated|3|||
130303001|NCT00856544|469073405|FG001|Overall Study|Randomized but not treated|0|||
130107486|NCT01902134|468355134|FG004|Overall Study|Other|1|||
130303002|NCT00856544|469073406|FG002|Overall Study|Randomized but not treated|0|||
130303003|NCT00856544|469073407|FG003|Overall Study|Randomized but not treated|0|||
130303004|NCT00856544|469073404|FG000|Overall Study|Death|0|||
129795664|NCT03519386|467219601|FG002|Overall Study|Physician Decision|1|||
129795665|NCT03519386|467219599|FG000|Overall Study|Lost to Follow-up|0|||
129795666|NCT03519386|467219600|FG001|Overall Study|Lost to Follow-up|1|||
129795667|NCT03519386|467219601|FG002|Overall Study|Lost to Follow-up|1|||
129795668|NCT03519386|467219599|FG000|Overall Study|Death|1|||
129795669|NCT03519386|467219600|FG001|Overall Study|Death|0|||
129795670|NCT03519386|467219601|FG002|Overall Study|Death|4|||
129795671|NCT03519386|467219599|FG000|Overall Study|Adverse Event|2|||
129795672|NCT03519386|467219600|FG001|Overall Study|Adverse Event|1|||
129795673|NCT03519386|467219601|FG002|Overall Study|Adverse Event|2|||
129795674|NCT03519386|467219599|FG000|Overall Study|Explanted|2|||
129795675|NCT03519386|467219600|FG001|Overall Study|Explanted|1|||
129795676|NCT03519386|467219601|FG002|Overall Study|Explanted|0|||
129795677|NCT03519386|467219599|FG000|Overall Study|Ongoing in study|190|||
129795678|NCT03519386|467219600|FG001|Overall Study|Ongoing in study|192|||
129795679|NCT03519386|467219601|FG002|Overall Study|Ongoing in study|183|||
129795680|NCT04341662|467219603|FG000|Overall Study|Did not have source-verified blood loss data|423|||
129795681|NCT04341662|467219604|FG001|Overall Study|Did not have source-verified blood loss data|514|||
129795682|NCT01582854|467219605|FG000|Overall Study|Death|8|||
129795683|NCT01582854|467219606|FG001|Overall Study|Death|5|||
129795684|NCT01582854|467219605|FG000|Overall Study|Adverse Event|2|||
129795685|NCT01582854|467219606|FG001|Overall Study|Adverse Event|3|||
129795686|NCT01582854|467219605|FG000|Overall Study|Withdrawal by Participant|8|||
129795687|NCT01582854|467219606|FG001|Overall Study|Withdrawal by Participant|11|||
129795688|NCT01582854|467219605|FG000|Overall Study|Lost to Follow-up|1|||
129795689|NCT01582854|467219606|FG001|Overall Study|Lost to Follow-up|2|||
129795690|NCT01582854|467219605|FG000|Overall Study|Physician Decision|0|||
129795691|NCT01582854|467219606|FG001|Overall Study|Physician Decision|1|||
129795692|NCT01582854|467219605|FG000|Overall Study|Recurrent Stroke|13|||
129795693|NCT01582854|467219606|FG001|Overall Study|Recurrent Stroke|8|||
129795694|NCT01582854|467219605|FG000|Overall Study|Disallowed Concomitant Medication|3|||
129795695|NCT01582854|467219606|FG001|Overall Study|Disallowed Concomitant Medication|2|||
129795696|NCT01582854|467219605|FG000|Overall Study|Carotid or Neurosurgery|0|||
130303005|NCT00856544|469073405|FG001|Overall Study|Death|2|||
130303006|NCT00856544|469073406|FG002|Overall Study|Death|0|||
129795697|NCT01582854|467219606|FG001|Overall Study|Carotid or Neurosurgery|1|||
129795698|NCT01582854|467219605|FG000|Overall Study|General Anaesthesia|0|||
129795699|NCT01582854|467219606|FG001|Overall Study|General Anaesthesia|1|||
129795700|NCT01582854|467219605|FG000|Overall Study|Other Miscellaneous Reason|1|||
129795701|NCT01582854|467219606|FG001|Overall Study|Other Miscellaneous Reason|0|||
129795702|NCT03101267|467219607|FG000|Primary Study Period|Withdrawal by Subject|1|||
129795703|NCT03101267|467219608|FG001|Primary Study Period|Withdrawal by Subject|2|||
129795704|NCT03101267|467219609|FG002|Primary Study Period|Withdrawal by Subject|3|||
129795705|NCT03101267|467219607|FG000|Primary Study Period|Miscellaneous|2|||
129795706|NCT03101267|467219608|FG001|Primary Study Period|Miscellaneous|0|||
130303007|NCT00856544|469073407|FG003|Overall Study|Death|0|||
130303008|NCT00856544|469073404|FG000|Overall Study|Adverse Event|20|||
130303009|NCT00856544|469073405|FG001|Overall Study|Adverse Event|29|||
130303010|NCT00856544|469073406|FG002|Overall Study|Adverse Event|2|||
130303011|NCT00856544|469073407|FG003|Overall Study|Adverse Event|3|||
130303012|NCT00856544|469073404|FG000|Overall Study|Lack of Efficacy|16|||
130303013|NCT00856544|469073405|FG001|Overall Study|Lack of Efficacy|12|||
130303014|NCT00856544|469073406|FG002|Overall Study|Lack of Efficacy|3|||
130303015|NCT00856544|469073407|FG003|Overall Study|Lack of Efficacy|3|||
130303016|NCT00856544|469073404|FG000|Overall Study|Other|9|||
130303017|NCT00856544|469073405|FG001|Overall Study|Other|16|||
130303018|NCT00856544|469073406|FG002|Overall Study|Other|1|||
130303019|NCT00856544|469073407|FG003|Overall Study|Other|6|||
130303020|NCT00856544|469073404|FG000|Overall Study|Lost to Follow-up|1|||
130303021|NCT00856544|469073405|FG001|Overall Study|Lost to Follow-up|2|||
129795707|NCT03101267|467219609|FG002|Primary Study Period|Miscellaneous|0|||
129795708|NCT01222403|467219610|FG000|Overall Study|Inappropriate enrollment|0|||
129795709|NCT01222403|467219611|FG001|Overall Study|Inappropriate enrollment|2|||
130303022|NCT00856544|469073406|FG002|Overall Study|Lost to Follow-up|2|||
130303023|NCT00856544|469073407|FG003|Overall Study|Lost to Follow-up|0|||
130303024|NCT00856544|469073404|FG000|Overall Study|Withdrawal by Subject|8|||
130303025|NCT00856544|469073405|FG001|Overall Study|Withdrawal by Subject|5|||
130303026|NCT00856544|469073406|FG002|Overall Study|Withdrawal by Subject|0|||
130303027|NCT00856544|469073407|FG003|Overall Study|Withdrawal by Subject|1|||
130303028|NCT00787189|469073408|FG000|Overall Study|Lost to Follow-up|2|||
130303029|NCT00787189|469073409|FG001|Overall Study|Lost to Follow-up|2|||
130303030|NCT00296140|469073410|FG000|Overall Study|Lost to Follow-up|1|||
130303031|NCT00296140|469073411|FG001|Overall Study|Lost to Follow-up|0|||
130303032|NCT00296140|469073410|FG000|Overall Study|Withdrawal by Subject|1|||
130303033|NCT00296140|469073411|FG001|Overall Study|Withdrawal by Subject|0|||
130303034|NCT00296140|469073410|FG000|Overall Study|Discharge to Nursing Home|1|||
130303035|NCT00296140|469073411|FG001|Overall Study|Discharge to Nursing Home|0|||
130303036|NCT01856582|469073412|FG000|Overall Study|Died prior to Boost infusion|1|||
130303037|NCT00596830|469073413|FG000|Overall Study|Death|258|||
130303038|NCT00596830|469073414|FG001|Overall Study|Death|247|||
130303039|NCT00596830|469073413|FG000|Overall Study|Lost to Follow-up|7|||
130303040|NCT00596830|469073414|FG001|Overall Study|Lost to Follow-up|11|||
130303041|NCT00596830|469073413|FG000|Overall Study|Withdrawal by Subject|22|||
130303042|NCT00596830|469073414|FG001|Overall Study|Withdrawal by Subject|12|||
130303043|NCT00596830|469073413|FG000|Overall Study|Study terminated by sponsor|51|||
130303044|NCT00596830|469073414|FG001|Overall Study|Study terminated by sponsor|62|||
130303045|NCT00596830|469073413|FG000|Overall Study|Follow-up was discontinued|1|||
130303046|NCT00596830|469073414|FG001|Overall Study|Follow-up was discontinued|0|||
130303047|NCT00596830|469073413|FG000|Overall Study|Randomized but not treated|3|||
130303048|NCT00596830|469073414|FG001|Overall Study|Randomized but not treated|7|||
130303049|NCT00887926|469073415|FG000|Overall Study|Withdrawal by Subject|0|||
130047753|NCT01520922|468131592|FG000|Survival Follow-up|Withdrawal by Subject|1|||
129795710|NCT01028378|467219612|FG000|Overall Study|Lost to Follow-up|12|||
129795711|NCT01028378|467219612|FG000|Overall Study|Withdrawal by Subject|1|||
129795712|NCT01028378|467219612|FG000|Overall Study|Adminstrative Reasons|4|||
129795713|NCT01262352|467219613|FG000|Period 1|Illness after randomization|1|||
129795714|NCT01262352|467219614|FG001|Period 1|Illness after randomization|0|||
130047754|NCT01520922|468131593|FG001|Survival Follow-up|Withdrawal by Subject|0|||
129795715|NCT01262352|467219613|FG000|Washout|Adverse Event|1|||
129795716|NCT01262352|467219614|FG001|Washout|Adverse Event|1|||
130303050|NCT00887926|469073416|FG001|Overall Study|Withdrawal by Subject|1|||
130303051|NCT00887926|469073417|FG002|Overall Study|Withdrawal by Subject|0|||
130303052|NCT00887926|469073418|FG003|Overall Study|Withdrawal by Subject|0|||
130303053|NCT00880191|469073419|FG000|Overall Study|Refused further treatment|4|||
130052156|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
130303054|NCT00880191|469073420|FG001|Overall Study|Refused further treatment|1|||
130303055|NCT00880191|469073419|FG000|Overall Study|Adverse Event|8|||
129795717|NCT01262352|467219613|FG000|Washout|Extended Washout|0|||
130303056|NCT00880191|469073420|FG001|Overall Study|Adverse Event|6|||
130303057|NCT00880191|469073419|FG000|Overall Study|Hospitalization/efficacy|1|||
130303058|NCT00880191|469073420|FG001|Overall Study|Hospitalization/efficacy|1|||
130047755|NCT04770155|468131598|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047756|NCT04770155|468131599|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047757|NCT04770155|468131600|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047758|NCT04770155|468131601|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047759|NCT04770155|468131602|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047760|NCT04770155|468131603|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047761|NCT04770155|468131604|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047762|NCT04770155|468131605|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
130047763|NCT00864227|468131606|FG000|Overall Study|Withdrawal by Subject|1|||
130047764|NCT00864227|468131606|FG000|Overall Study|Disease Relapse/Progression|3|||
130047765|NCT03461289|468131607|FG000|Overall Study|Death|1|||
130047766|NCT01558089|468131610|FG000|Overall Study|Adverse Event|1|||
130047767|NCT01558089|468131610|FG000|Overall Study|Lack of Efficacy|1|||
130047768|NCT01558089|468131610|FG000|Overall Study|Lost to Follow-up|5|||
130047769|NCT01558089|468131610|FG000|Overall Study|Withdrawal by Subject|6|||
130047770|NCT00336492|468131611|FG000|Overall Study|Adverse Event|4|||
130047771|NCT00336492|468131612|FG001|Overall Study|Adverse Event|3|||
130047772|NCT00336492|468131613|FG002|Overall Study|Adverse Event|6|||
130047773|NCT00336492|468131611|FG000|Overall Study|Lack of Efficacy|6|||
130047774|NCT00336492|468131612|FG001|Overall Study|Lack of Efficacy|1|||
130047775|NCT00336492|468131613|FG002|Overall Study|Lack of Efficacy|4|||
130047776|NCT00336492|468131611|FG000|Overall Study|Other|5|||
130047777|NCT00336492|468131612|FG001|Overall Study|Other|0|||
130047778|NCT00336492|468131613|FG002|Overall Study|Other|1|||
130047779|NCT00227877|468131614|FG000|Pre-visit Assessment|Technical difficulties|7|||
130047780|NCT00227877|468131615|FG001|Pre-visit Assessment|Technical difficulties|3|||
130047781|NCT00227877|468131616|FG002|Pre-visit Assessment|Technical difficulties|0|||
130047782|NCT00227877|468131617|FG003|Pre-visit Assessment|Technical difficulties|0|||
130047783|NCT00227877|468131614|FG000|Post-visit Checklist|Lost to Follow-up|24|||
130047784|NCT00227877|468131615|FG001|Post-visit Checklist|Lost to Follow-up|13|||
130303059|NCT02097030|469073421|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
130303060|NCT02097030|469073422|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
130303061|NCT02097030|469073421|FG000|First Intervention (3 Days)|Visual Acuity|0|||
130303062|NCT02097030|469073422|FG001|First Intervention (3 Days)|Visual Acuity|1|||
130303063|NCT01919801|469073423|FG000|Overall Study|Withdrawal by Subject|1|||
130303064|NCT01919801|469073424|FG001|Overall Study|Withdrawal by Subject|0|||
130303065|NCT01919801|469073423|FG000|Overall Study|Physician Decision|0|||
130303066|NCT01919801|469073424|FG001|Overall Study|Physician Decision|1|||
130303067|NCT01919801|469073423|FG000|Overall Study|Lost to Follow-up|0|||
130303068|NCT01919801|469073424|FG001|Overall Study|Lost to Follow-up|1|||
130303069|NCT01919801|469073423|FG000|Overall Study|Other|0|||
130303070|NCT01919801|469073424|FG001|Overall Study|Other|1|||
130303071|NCT01843062|469073425|FG000|Overall Study|Protocol Violation|1|||
130303072|NCT01843062|469073426|FG001|Overall Study|Protocol Violation|0|||
130303073|NCT01843062|469073425|FG000|Overall Study|New treatment following progression|2|||
130303074|NCT01843062|469073426|FG001|Overall Study|New treatment following progression|0|||
130303075|NCT01843062|469073425|FG000|Overall Study|Pregnancy|1|||
130303076|NCT01843062|469073426|FG001|Overall Study|Pregnancy|0|||
129889165|NCT00519636|467551011|FG001|Treatment Period 2|Per doctors request|0|||
129889166|NCT00519636|467551012|FG002|Treatment Period 2|Per doctors request|1|||
129889167|NCT00519636|467551013|FG003|Treatment Period 2|Per doctors request|0|||
129889168|NCT00519636|467551010|FG000|Treatment Period 2|Subject misrandomized|0|||
129889169|NCT00519636|467551011|FG001|Treatment Period 2|Subject misrandomized|0|||
129889170|NCT00519636|467551012|FG002|Treatment Period 2|Subject misrandomized|0|||
129889171|NCT00519636|467551013|FG003|Treatment Period 2|Subject misrandomized|1|||
129889172|NCT00519636|467551010|FG000|Post Study Period|Subject randomized in error|0|||
129889173|NCT00519636|467551011|FG001|Post Study Period|Subject randomized in error|0|||
129889174|NCT00519636|467551012|FG002|Post Study Period|Subject randomized in error|0|||
129889175|NCT00519636|467551013|FG003|Post Study Period|Subject randomized in error|1|||
129889176|NCT02846558|467551018|FG000|Overall Study|Adverse Event|1|||
129889177|NCT02846558|467551019|FG001|Overall Study|Adverse Event|0|||
129889178|NCT02846558|467551020|FG002|Overall Study|Adverse Event|0|||
129889179|NCT02846558|467551021|FG003|Overall Study|Adverse Event|0|||
129889180|NCT02846558|467551018|FG000|Overall Study|Withdrawal by Subject|5|||
129889181|NCT02846558|467551019|FG001|Overall Study|Withdrawal by Subject|4|||
130047785|NCT00227877|468131616|FG002|Post-visit Checklist|Lost to Follow-up|1|||
130303077|NCT01843062|469073425|FG000|Overall Study|Adverse Event|2|||
130303078|NCT01843062|469073426|FG001|Overall Study|Adverse Event|0|||
130303079|NCT01843062|469073425|FG000|Overall Study|Incorrect randomisation|1|||
130303080|NCT01843062|469073426|FG001|Overall Study|Incorrect randomisation|0|||
129889182|NCT02846558|467551020|FG002|Overall Study|Withdrawal by Subject|2|||
129795718|NCT01262352|467219614|FG001|Washout|Extended Washout|1|||
129795719|NCT01185834|467219618|FG000|Overall Study|Lost to Follow-up|2|||
129795720|NCT01185834|467219618|FG000|Overall Study|Discomfort|4|||
129795721|NCT01185834|467219618|FG000|Overall Study|Biomicroscopy|4|||
129795722|NCT01185834|467219618|FG000|Overall Study|Time/Job Conflict|2|||
129795723|NCT01185834|467219618|FG000|Overall Study|Early exit - Site error|2|||
129795724|NCT00107952|467219627|FG000|Overall Study|Death|75|||
129795725|NCT00107952|467219628|FG001|Overall Study|Death|61|||
129795726|NCT00107952|467219627|FG000|Overall Study|Lost to Follow-up|0|||
129795727|NCT00107952|467219628|FG001|Overall Study|Lost to Follow-up|3|||
129795728|NCT00107952|467219627|FG000|Overall Study|Withdrawal by Subject|9|||
129795729|NCT00107952|467219628|FG001|Overall Study|Withdrawal by Subject|6|||
129795730|NCT00107952|467219627|FG000|Overall Study|Other|2|||
129795731|NCT00107952|467219628|FG001|Overall Study|Other|5|||
129795732|NCT00107952|467219627|FG000|Overall Study|Never received study treatment|9|||
129795733|NCT00107952|467219628|FG001|Overall Study|Never received study treatment|6|||
129795734|NCT01975831|467219629|FG000|Overall Study|Adverse Event|1|||
129795735|NCT01975831|467219630|FG001|Overall Study|Adverse Event|2|||
129795736|NCT01975831|467219631|FG002|Overall Study|Adverse Event|2|||
129795737|NCT01975831|467219632|FG003|Overall Study|Adverse Event|0|||
129795738|NCT01975831|467219633|FG004|Overall Study|Adverse Event|1|||
129795739|NCT01975831|467219634|FG005|Overall Study|Adverse Event|1|||
129795740|NCT01975831|467219635|FG006|Overall Study|Adverse Event|3|||
129795741|NCT01975831|467219636|FG007|Overall Study|Adverse Event|4|||
129795742|NCT01975831|467219637|FG008|Overall Study|Adverse Event|1|||
129795743|NCT01975831|467219629|FG000|Overall Study|Death|1|||
129795744|NCT01975831|467219630|FG001|Overall Study|Death|1|||
129795745|NCT01975831|467219631|FG002|Overall Study|Death|0|||
129795746|NCT01975831|467219632|FG003|Overall Study|Death|0|||
129795747|NCT01975831|467219633|FG004|Overall Study|Death|1|||
129795748|NCT01975831|467219634|FG005|Overall Study|Death|0|||
129795749|NCT01975831|467219635|FG006|Overall Study|Death|1|||
129795750|NCT01975831|467219636|FG007|Overall Study|Death|0|||
129795751|NCT01975831|467219637|FG008|Overall Study|Death|0|||
129795752|NCT01975831|467219629|FG000|Overall Study|Progressive Disease|1|||
129795753|NCT01975831|467219630|FG001|Overall Study|Progressive Disease|3|||
129795754|NCT01975831|467219631|FG002|Overall Study|Progressive Disease|2|||
129795755|NCT01975831|467219632|FG003|Overall Study|Progressive Disease|4|||
129795756|NCT01975831|467219633|FG004|Overall Study|Progressive Disease|13|||
129795757|NCT01975831|467219634|FG005|Overall Study|Progressive Disease|9|||
129795758|NCT01975831|467219635|FG006|Overall Study|Progressive Disease|10|||
129795759|NCT01975831|467219636|FG007|Overall Study|Progressive Disease|8|||
129795760|NCT01975831|467219637|FG008|Overall Study|Progressive Disease|10|||
129795761|NCT01975831|467219629|FG000|Overall Study|Withdrawal by Subject|0|||
129795762|NCT01975831|467219630|FG001|Overall Study|Withdrawal by Subject|3|||
129795763|NCT01975831|467219631|FG002|Overall Study|Withdrawal by Subject|0|||
129795764|NCT01975831|467219632|FG003|Overall Study|Withdrawal by Subject|0|||
129795765|NCT01975831|467219633|FG004|Overall Study|Withdrawal by Subject|3|||
129795766|NCT01975831|467219634|FG005|Overall Study|Withdrawal by Subject|1|||
129795767|NCT01975831|467219635|FG006|Overall Study|Withdrawal by Subject|1|||
129795768|NCT01975831|467219636|FG007|Overall Study|Withdrawal by Subject|0|||
129795769|NCT01975831|467219637|FG008|Overall Study|Withdrawal by Subject|0|||
129795770|NCT01975831|467219629|FG000|Overall Study|Physician Decision|0|||
129795771|NCT01975831|467219630|FG001|Overall Study|Physician Decision|0|||
129889183|NCT02846558|467551021|FG003|Overall Study|Withdrawal by Subject|2|||
130303081|NCT01843062|469073425|FG000|Overall Study|Withdrawal by Subject|12|||
130303082|NCT01843062|469073426|FG001|Overall Study|Withdrawal by Subject|3|||
130303083|NCT01843062|469073425|FG000|Overall Study|Death|1|||
130303084|NCT01843062|469073426|FG001|Overall Study|Death|2|||
130303085|NCT01843062|469073425|FG000|Overall Study|Lost to Follow-up|2|||
130303086|NCT01843062|469073426|FG001|Overall Study|Lost to Follow-up|4|||
130303087|NCT01677858|469073427|FG000|Overall Study|Adverse Event|0|||
130303088|NCT01677858|469073428|FG001|Overall Study|Adverse Event|0|||
130303089|NCT01677858|469073429|FG002|Overall Study|Adverse Event|2|||
130303090|NCT01677858|469073430|FG003|Overall Study|Adverse Event|3|||
130303091|NCT01677858|469073431|FG004|Overall Study|Adverse Event|13|||
129795772|NCT01975831|467219631|FG002|Overall Study|Physician Decision|0|||
129795773|NCT01975831|467219632|FG003|Overall Study|Physician Decision|0|||
129795774|NCT01975831|467219633|FG004|Overall Study|Physician Decision|0|||
129795775|NCT01975831|467219634|FG005|Overall Study|Physician Decision|1|||
129795776|NCT01975831|467219635|FG006|Overall Study|Physician Decision|0|||
129795777|NCT01975831|467219636|FG007|Overall Study|Physician Decision|1|||
129795778|NCT01975831|467219637|FG008|Overall Study|Physician Decision|0|||
130303092|NCT01677858|469073427|FG000|Overall Study|Death|0|||
130303093|NCT01677858|469073428|FG001|Overall Study|Death|0|||
129795779|NCT01975831|467219629|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
129795780|NCT01975831|467219630|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
129795781|NCT01975831|467219631|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
129795782|NCT01975831|467219632|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
129889184|NCT02846558|467551018|FG000|Overall Study|Lost to Follow-up|2|||
130303094|NCT01677858|469073429|FG002|Overall Study|Death|0|||
129795783|NCT01975831|467219633|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
129795784|NCT01975831|467219634|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
129795785|NCT01975831|467219635|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
129795786|NCT01975831|467219636|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
129795787|NCT01975831|467219637|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
129795788|NCT01975831|467219629|FG000|Overall Study|Entered Hospice|0|||
129795789|NCT01975831|467219630|FG001|Overall Study|Entered Hospice|0|||
129795790|NCT01975831|467219631|FG002|Overall Study|Entered Hospice|0|||
129795791|NCT01975831|467219632|FG003|Overall Study|Entered Hospice|0|||
129795792|NCT01975831|467219633|FG004|Overall Study|Entered Hospice|0|||
129795793|NCT01975831|467219634|FG005|Overall Study|Entered Hospice|1|||
129795794|NCT01975831|467219635|FG006|Overall Study|Entered Hospice|0|||
129795795|NCT01975831|467219636|FG007|Overall Study|Entered Hospice|0|||
129795796|NCT01975831|467219637|FG008|Overall Study|Entered Hospice|0|||
129795797|NCT01975831|467219629|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795798|NCT01975831|467219630|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795799|NCT01975831|467219631|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795800|NCT01975831|467219632|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795801|NCT01975831|467219633|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795802|NCT01975831|467219634|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795803|NCT01975831|467219635|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
129795804|NCT01975831|467219636|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795805|NCT01975831|467219637|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
129795806|NCT01401959|467219638|FG000|Enrolled|Withdrawal by Subject|1|||
129795807|NCT01401959|467219639|FG001|Enrolled|Withdrawal by Subject|0|||
129795808|NCT01401959|467219640|FG002|Enrolled|Withdrawal by Subject|0|||
129795809|NCT01401959|467219638|FG000|Treated|Disease Progression|2|||
129795810|NCT01401959|467219639|FG001|Treated|Disease Progression|2|||
129889185|NCT02846558|467551019|FG001|Overall Study|Lost to Follow-up|0|||
130107487|NCT01902134|468355135|FG005|Overall Study|Other|0|||
130107488|NCT00305110|468355136|FG000|Overall Study|Missing data|29|||
130107489|NCT00678379|468355137|FG000|Overall Study|Injection performed after tonsillectomy|2|||
130107490|NCT00678379|468355138|FG001|Overall Study|Injection performed after tonsillectomy|0|||
130107491|NCT00678379|468355139|FG002|Overall Study|Injection performed after tonsillectomy|1|||
130107492|NCT00678379|468355137|FG000|Overall Study|Incomplete Data|4|||
130107493|NCT00678379|468355138|FG001|Overall Study|Incomplete Data|3|||
130107494|NCT00678379|468355139|FG002|Overall Study|Incomplete Data|3|||
130303095|NCT01677858|469073430|FG003|Overall Study|Death|0|||
130303096|NCT01677858|469073431|FG004|Overall Study|Death|1|||
130303097|NCT01677858|469073427|FG000|Overall Study|Physician Decision|1|||
130303098|NCT01677858|469073428|FG001|Overall Study|Physician Decision|0|||
130107495|NCT01084603|468355144|FG000|Baseline|Withdrawal by Subject|2|||
130107496|NCT01084603|468355144|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
130107497|NCT01084603|468355144|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
130107498|NCT01084603|468355144|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
130107499|NCT01084603|468355144|FG000|Washout Period 4|Adverse Event|1|||
130107500|NCT04388527|468355146|FG000|Overall Study|Death|14|||
130107501|NCT04388527|468355146|FG000|Overall Study|Withdrawal by Subject|2|||
130107502|NCT04388527|468355146|FG000|Overall Study|Lost to Follow-up|1|||
130107503|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
130107504|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
130107505|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
130107506|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
130107507|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
130107508|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
130107509|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
130107510|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
130303099|NCT01677858|469073429|FG002|Overall Study|Physician Decision|2|||
130303100|NCT01677858|469073430|FG003|Overall Study|Physician Decision|0|||
130303101|NCT01677858|469073431|FG004|Overall Study|Physician Decision|12|||
130303102|NCT01677858|469073427|FG000|Overall Study|Progressive Disease|2|||
130303103|NCT01677858|469073428|FG001|Overall Study|Progressive Disease|1|||
130107511|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130107512|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130303104|NCT01677858|469073429|FG002|Overall Study|Progressive Disease|9|||
129795811|NCT01401959|467219640|FG002|Treated|Disease Progression|1|||
129795812|NCT01401959|467219638|FG000|Treated|Adverse Event|4|||
130303105|NCT01677858|469073430|FG003|Overall Study|Progressive Disease|3|||
130303106|NCT01677858|469073431|FG004|Overall Study|Progressive Disease|43|||
129795813|NCT01401959|467219639|FG001|Treated|Adverse Event|3|||
129795814|NCT01401959|467219640|FG002|Treated|Adverse Event|2|||
129795815|NCT01401959|467219638|FG000|Treated|Withdrawal by Subject|1|||
130303107|NCT01677858|469073427|FG000|Overall Study|Withdrawal by Subject|0|||
130303108|NCT01677858|469073428|FG001|Overall Study|Withdrawal by Subject|1|||
129795816|NCT01401959|467219639|FG001|Treated|Withdrawal by Subject|2|||
129795817|NCT01401959|467219640|FG002|Treated|Withdrawal by Subject|2|||
129795818|NCT01401959|467219638|FG000|Treated|Protocol Violation|0|||
129795819|NCT01401959|467219639|FG001|Treated|Protocol Violation|1|||
129795820|NCT01401959|467219640|FG002|Treated|Protocol Violation|0|||
129795821|NCT00887744|467219641|FG000|Overall Study|Adverse Event|3|||
129795822|NCT00887744|467219641|FG000|Overall Study|Death|1|||
129795823|NCT00887744|467219641|FG000|Overall Study|Lost to Follow-up|3|||
130303109|NCT01677858|469073429|FG002|Overall Study|Withdrawal by Subject|1|||
130303110|NCT01677858|469073430|FG003|Overall Study|Withdrawal by Subject|0|||
130303111|NCT01677858|469073431|FG004|Overall Study|Withdrawal by Subject|15|||
130303112|NCT01677858|469073427|FG000|Overall Study|Lost to Follow-up|0|||
130303113|NCT01677858|469073428|FG001|Overall Study|Lost to Follow-up|0|||
130303114|NCT01677858|469073429|FG002|Overall Study|Lost to Follow-up|0|||
130303115|NCT01677858|469073430|FG003|Overall Study|Lost to Follow-up|0|||
130303116|NCT01677858|469073431|FG004|Overall Study|Lost to Follow-up|1|||
130303117|NCT00773747|469073432|FG000|Overall Study|Lack of Efficacy|112|||
130303118|NCT00773747|469073433|FG001|Overall Study|Lack of Efficacy|144|||
130303119|NCT00773747|469073432|FG000|Overall Study|Physician Decision|26|||
130303120|NCT00773747|469073433|FG001|Overall Study|Physician Decision|18|||
130303121|NCT00773747|469073432|FG000|Overall Study|Lost to Follow-up|0|||
130303122|NCT00773747|469073433|FG001|Overall Study|Lost to Follow-up|1|||
130303123|NCT00773747|469073432|FG000|Overall Study|Protocol Violation|2|||
129795824|NCT00887744|467219641|FG000|Overall Study|Withdrawal by Subject|18|||
129795825|NCT00887744|467219641|FG000|Overall Study|Various reasons|9|||
129795826|NCT00450385|467219648|FG000|Overall Study|Death|3|||
129795827|NCT00450385|467219648|FG000|Overall Study|Protocol Violation|1|||
129795828|NCT00450385|467219648|FG000|Overall Study|Withdrawal by Subject|2|||
129795829|NCT00450385|467219648|FG000|Overall Study|Lack of Efficacy|2|||
129795830|NCT00450385|467219648|FG000|Overall Study|Adverse Event|1|||
129795831|NCT00450385|467219648|FG000|Overall Study|Physician Decision|1|||
129795832|NCT00450385|467219648|FG000|Overall Study|Other|3|||
129795833|NCT01390220|467219654|FG000|Test Dose Phase|Adverse Event|17|||
129795834|NCT01390220|467219655|FG001|Test Dose Phase|Adverse Event|0|||
129795835|NCT01390220|467219656|FG002|Test Dose Phase|Adverse Event|0|||
129795836|NCT01390220|467219654|FG000|Test Dose Phase|Withdrawal by Subject|8|||
129795837|NCT01390220|467219655|FG001|Test Dose Phase|Withdrawal by Subject|0|||
129795838|NCT01390220|467219656|FG002|Test Dose Phase|Withdrawal by Subject|0|||
129795839|NCT01390220|467219654|FG000|Test Dose Phase|Lost to Follow-up|2|||
129795840|NCT01390220|467219655|FG001|Test Dose Phase|Lost to Follow-up|0|||
130047786|NCT00227877|468131617|FG003|Post-visit Checklist|Lost to Follow-up|0|||
130047787|NCT00227877|468131614|FG000|3-months Follow-up|Completed late|135|||
130047788|NCT00227877|468131615|FG001|3-months Follow-up|Completed late|128|||
130047789|NCT00227877|468131616|FG002|3-months Follow-up|Completed late|34|||
130047790|NCT00227877|468131617|FG003|3-months Follow-up|Completed late|8|||
130047791|NCT00227877|468131614|FG000|3-months Follow-up|Lost to Follow-up|178|||
130047792|NCT00227877|468131615|FG001|3-months Follow-up|Lost to Follow-up|139|||
130047793|NCT00227877|468131616|FG002|3-months Follow-up|Lost to Follow-up|18|||
130047794|NCT00227877|468131617|FG003|3-months Follow-up|Lost to Follow-up|13|||
130047795|NCT00227877|468131614|FG000|12-months Follow-up|Completed late|78|||
130047796|NCT00227877|468131615|FG001|12-months Follow-up|Completed late|74|||
130047797|NCT00227877|468131616|FG002|12-months Follow-up|Completed late|1|||
130047798|NCT00227877|468131617|FG003|12-months Follow-up|Completed late|0|||
130047799|NCT00227877|468131614|FG000|12-months Follow-up|Lost to Follow-up|232|||
130047800|NCT00227877|468131615|FG001|12-months Follow-up|Lost to Follow-up|189|||
130047801|NCT00227877|468131616|FG002|12-months Follow-up|Lost to Follow-up|30|||
130047802|NCT00227877|468131617|FG003|12-months Follow-up|Lost to Follow-up|26|||
130047803|NCT02522481|468131622|FG000|Overall Study|discontinued|1|||
130047804|NCT02522481|468131622|FG000|Overall Study|Not dosed|2|||
130047805|NCT00404768|468131625|FG000|Part A and B|Withdrawn due to labor progression|1|||
130047806|NCT00404768|468131626|FG001|Part A and B|Withdrawn due to labor progression|0|||
130047807|NCT00404768|468131627|FG002|Part A and B|Withdrawn due to labor progression|0|||
130047808|NCT00404768|468131628|FG003|Part A and B|Withdrawn due to labor progression|0|||
130047809|NCT00404768|468131625|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
130047810|NCT00404768|468131626|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
129795841|NCT01390220|467219656|FG002|Test Dose Phase|Lost to Follow-up|0|||
130047811|NCT00404768|468131627|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
130047812|NCT00404768|468131628|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
130303124|NCT00773747|469073433|FG001|Overall Study|Protocol Violation|2|||
130303125|NCT00773747|469073432|FG000|Overall Study|Withdrawal by Subject|89|||
130303126|NCT00773747|469073433|FG001|Overall Study|Withdrawal by Subject|61|||
129795842|NCT01390220|467219654|FG000|Test Dose Phase|Protocol Violation|8|||
129795843|NCT01390220|467219655|FG001|Test Dose Phase|Protocol Violation|0|||
130047813|NCT00404768|468131625|FG000|Part C|Adverse Event|0|||
130047814|NCT00404768|468131626|FG001|Part C|Adverse Event|0|||
130303127|NCT00773747|469073432|FG000|Overall Study|Adverse Event|61|||
129795844|NCT01390220|467219656|FG002|Test Dose Phase|Protocol Violation|0|||
129795845|NCT01390220|467219654|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
130107513|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130107514|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
130107515|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
130107516|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130107517|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130107518|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
130107519|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
130107520|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
129795846|NCT01390220|467219655|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
129795847|NCT01390220|467219656|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
129795848|NCT01390220|467219654|FG000|Test Dose Phase|Study/Site closure|6|||
129795849|NCT01390220|467219655|FG001|Test Dose Phase|Study/Site closure|0|||
129795850|NCT01390220|467219656|FG002|Test Dose Phase|Study/Site closure|0|||
129795851|NCT01390220|467219654|FG000|Test Dose Phase|Caregiver no longer available|5|||
130107521|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
129795852|NCT01390220|467219655|FG001|Test Dose Phase|Caregiver no longer available|0|||
129795853|NCT01390220|467219656|FG002|Test Dose Phase|Caregiver no longer available|0|||
129795854|NCT01390220|467219654|FG000|Test Dose Phase|Noncompliance|2|||
129795855|NCT01390220|467219655|FG001|Test Dose Phase|Noncompliance|0|||
129795856|NCT01390220|467219656|FG002|Test Dose Phase|Noncompliance|0|||
129795857|NCT01390220|467219654|FG000|Test Dose Phase|Logistical|6|||
129795858|NCT01390220|467219655|FG001|Test Dose Phase|Logistical|0|||
129795859|NCT01390220|467219656|FG002|Test Dose Phase|Logistical|0|||
129795860|NCT01390220|467219654|FG000|Comparative Phase|Withdrawal by Subject|0|||
129795861|NCT01390220|467219655|FG001|Comparative Phase|Withdrawal by Subject|1|||
129795862|NCT01390220|467219656|FG002|Comparative Phase|Withdrawal by Subject|0|||
129795863|NCT03063203|467219657|FG000|Overall Study|Chose alternative therapy|3|||
129795864|NCT03063203|467219657|FG000|Overall Study|Death|2|||
129795865|NCT03063203|467219657|FG000|Overall Study|Disease progression|4|||
129795866|NCT03063203|467219657|FG000|Overall Study|Physician Decision|5|||
129795867|NCT02045303|467219658|FG000|Overall Study|Protocol Violation|2|||
129795868|NCT02045303|467219659|FG001|Overall Study|Protocol Violation|1|||
129795869|NCT02045303|467219660|FG002|Overall Study|Protocol Violation|0|||
129795870|NCT02045303|467219658|FG000|Overall Study|Withdrawal by Subject|0|||
129795871|NCT02045303|467219659|FG001|Overall Study|Withdrawal by Subject|2|||
129795872|NCT02045303|467219660|FG002|Overall Study|Withdrawal by Subject|0|||
129795873|NCT01856023|467219661|FG000|Overall Study|Death|1|||
129795874|NCT01856023|467219662|FG001|Overall Study|Death|2|||
129795875|NCT01856023|467219661|FG000|Overall Study|Adverse Event|2|||
129795876|NCT01856023|467219662|FG001|Overall Study|Adverse Event|1|||
129795877|NCT01856023|467219661|FG000|Overall Study|Lack of Efficacy|5|||
129795878|NCT01856023|467219662|FG001|Overall Study|Lack of Efficacy|5|||
129795879|NCT01856023|467219661|FG000|Overall Study|non compliance, study closure|1|||
129795880|NCT01856023|467219662|FG001|Overall Study|non compliance, study closure|3|||
129795881|NCT01856023|467219661|FG000|Overall Study|Withdrawal by Subject|1|||
129795882|NCT01856023|467219662|FG001|Overall Study|Withdrawal by Subject|1|||
129795883|NCT00829283|467219665|FG000|Overall Study|Lost to Follow-up|7|||
129795884|NCT00829283|467219666|FG001|Overall Study|Lost to Follow-up|25|||
129795885|NCT04718103|467219667|FG000|Overall Study|Adverse Event|1|||
129795886|NCT04718103|467219668|FG001|Overall Study|Adverse Event|1|||
129795887|NCT04718103|467219667|FG000|Overall Study|Lack of Efficacy|4|||
129795888|NCT04718103|467219668|FG001|Overall Study|Lack of Efficacy|1|||
129795889|NCT04718103|467219667|FG000|Overall Study|Lost to Follow-up|2|||
129795890|NCT04718103|467219668|FG001|Overall Study|Lost to Follow-up|2|||
129795891|NCT04718103|467219667|FG000|Overall Study|Physician Decision|2|||
129795892|NCT04718103|467219668|FG001|Overall Study|Physician Decision|0|||
129795893|NCT04718103|467219667|FG000|Overall Study|Pregnancy|0|||
129795894|NCT04718103|467219668|FG001|Overall Study|Pregnancy|1|||
129795895|NCT04718103|467219667|FG000|Overall Study|Withdrawal by Subject|10|||
129795896|NCT04718103|467219668|FG001|Overall Study|Withdrawal by Subject|6|||
129889186|NCT02846558|467551020|FG002|Overall Study|Lost to Follow-up|0|||
129889187|NCT02846558|467551021|FG003|Overall Study|Lost to Follow-up|0|||
129795897|NCT04718103|467219667|FG000|Overall Study|Randomized, not treated|4|||
129795898|NCT04718103|467219668|FG001|Overall Study|Randomized, not treated|1|||
129889188|NCT00904150|467551031|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
129889189|NCT00904150|467551032|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
130303128|NCT00773747|469073433|FG001|Overall Study|Adverse Event|62|||
129795899|NCT04718103|467219667|FG000|Overall Study|GCP violations|7|||
129795900|NCT04718103|467219668|FG001|Overall Study|GCP violations|5|||
129795901|NCT00136604|467219669|FG000|Overall Study|Lost to Follow-up|1|||
129795902|NCT00136604|467219670|FG001|Overall Study|Lost to Follow-up|0|||
129795903|NCT00136604|467219671|FG002|Overall Study|Lost to Follow-up|0|||
129795904|NCT00136604|467219672|FG003|Overall Study|Lost to Follow-up|0|||
129795905|NCT00136604|467219673|FG004|Overall Study|Lost to Follow-up|1|||
129795906|NCT00136604|467219669|FG000|Overall Study|Migrated/moved from study area|0|||
129795907|NCT00136604|467219670|FG001|Overall Study|Migrated/moved from study area|1|||
129795908|NCT00136604|467219671|FG002|Overall Study|Migrated/moved from study area|0|||
129795909|NCT00136604|467219672|FG003|Overall Study|Migrated/moved from study area|0|||
129795910|NCT00136604|467219673|FG004|Overall Study|Migrated/moved from study area|0|||
129795911|NCT01309893|467219675|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
129795912|NCT01309893|467219676|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
129795913|NCT01309893|467219675|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
129795914|NCT01309893|467219676|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
129795915|NCT00321893|467219678|FG000|Overall Study|Non-Compliance/Refusal|16|||
129795916|NCT00321893|467219679|FG001|Overall Study|Non-Compliance/Refusal|10|||
129795917|NCT00321893|467219678|FG000|Overall Study|Lost to Follow-up|2|||
129795918|NCT00321893|467219679|FG001|Overall Study|Lost to Follow-up|1|||
130303129|NCT00773747|469073432|FG000|Overall Study|Death|5|||
130303130|NCT00773747|469073433|FG001|Overall Study|Death|8|||
130303131|NCT00773747|469073432|FG000|Overall Study|Not Treated|2|||
130303132|NCT00773747|469073433|FG001|Overall Study|Not Treated|0|||
130303133|NCT02669212|469073436|FG000|Overall Study|Lost to Follow-up|1|||
130303134|NCT02669212|469073437|FG001|Overall Study|Lost to Follow-up|0|||
129795919|NCT00321893|467219678|FG000|Overall Study|Adverse Event|6|||
129795920|NCT00321893|467219679|FG001|Overall Study|Adverse Event|3|||
129795921|NCT00769483|467219680|FG000|Overall Study|Withdrawal by Subject|0|||
129795922|NCT00769483|467219681|FG001|Overall Study|Withdrawal by Subject|1|||
129795923|NCT00769483|467219682|FG002|Overall Study|Withdrawal by Subject|0|||
129795924|NCT00769483|467219683|FG003|Overall Study|Withdrawal by Subject|0|||
129795925|NCT00769483|467219684|FG004|Overall Study|Withdrawal by Subject|1|||
129795926|NCT00769483|467219685|FG005|Overall Study|Withdrawal by Subject|0|||
129795927|NCT00999921|467219689|FG000|Overall Study|Lost to Follow-up|10|||
129795928|NCT00999921|467219690|FG001|Overall Study|Lost to Follow-up|19|||
129795929|NCT03500679|467219697|FG000|Overall Study|Lost to Follow-up|6|||
129795930|NCT03500679|467219698|FG001|Overall Study|Lost to Follow-up|3|||
129795931|NCT03500679|467219697|FG000|Overall Study|Withdrawal by Subject|3|||
129795932|NCT03500679|467219698|FG001|Overall Study|Withdrawal by Subject|0|||
129795933|NCT01962922|467219699|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
129795934|NCT01962922|467219700|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
129795935|NCT01962922|467219699|FG000|PK Portion Day 7|non-compliance|1|||
129795936|NCT01962922|467219700|FG001|PK Portion Day 7|non-compliance|0|||
129795937|NCT01962922|467219699|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
129795938|NCT01962922|467219700|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
129795939|NCT01962922|467219699|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
129795940|NCT01962922|467219700|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
129795941|NCT03670836|467219701|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
129795942|NCT03670836|467219702|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
129795943|NCT03670836|467219701|FG000|Per Protocol Population (PP)|Physician Decision|9|||
129795944|NCT03670836|467219702|FG001|Per Protocol Population (PP)|Physician Decision|10|||
129795945|NCT03670836|467219701|FG000|Per Protocol Population (PP)|Physician Decision|4|||
129795946|NCT03670836|467219702|FG001|Per Protocol Population (PP)|Physician Decision|6|||
129795947|NCT03670836|467219701|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
129795948|NCT03670836|467219702|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
129795949|NCT02582255|467221539|FG000|Overall Study|Protocol Violation|0|||
129795950|NCT02582255|467221540|FG001|Overall Study|Protocol Violation|3|||
129795951|NCT03034200|467221545|FG000|Overall Study|Disease progression|8|||
129795952|NCT03034200|467221546|FG001|Overall Study|Disease progression|10|||
129795953|NCT03034200|467221547|FG002|Overall Study|Disease progression|4|||
129795954|NCT03034200|467221545|FG000|Overall Study|Physician Decision|2|||
129795955|NCT03034200|467221546|FG001|Overall Study|Physician Decision|0|||
129795956|NCT03034200|467221547|FG002|Overall Study|Physician Decision|3|||
129795957|NCT03034200|467221545|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
129795958|NCT03034200|467221546|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
129795959|NCT03034200|467221547|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
129795960|NCT03034200|467221545|FG000|Overall Study|Adjuvant Therapy|0|||
129795961|NCT03034200|467221546|FG001|Overall Study|Adjuvant Therapy|0|||
130107522|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
130303135|NCT02669212|469073436|FG000|Overall Study|Medical Condition|3|||
130303136|NCT02669212|469073437|FG001|Overall Study|Medical Condition|4|||
129795962|NCT03034200|467221547|FG002|Overall Study|Adjuvant Therapy|1|||
129795963|NCT01466179|467221548|FG000|Overall Study|Ongoing in core study|2|||
129795964|NCT01466179|467221548|FG000|Overall Study|Physician Decision|46|||
130303137|NCT02669212|469073436|FG000|Overall Study|Withdrawal by Subject|0|||
130303138|NCT02669212|469073437|FG001|Overall Study|Withdrawal by Subject|2|||
129795965|NCT01466179|467221548|FG000|Overall Study|Progressive disease|43|||
129795966|NCT01466179|467221548|FG000|Overall Study|Adverse Event|32|||
129795967|NCT01466179|467221548|FG000|Overall Study|Disease relapse|23|||
129795968|NCT01466179|467221548|FG000|Overall Study|Lack of Efficacy|14|||
129795969|NCT01466179|467221548|FG000|Overall Study|Death|7|||
129795970|NCT01466179|467221548|FG000|Overall Study|Withdrawal by Subject|7|||
129795971|NCT01466179|467221548|FG000|Overall Study|Protocol Violation|2|||
129795972|NCT01466179|467221548|FG000|Overall Study|Other|3|||
129795973|NCT00749580|467221549|FG000|Overall Study|Lost to Follow-up|4|||
129795974|NCT00749580|467221550|FG001|Overall Study|Lost to Follow-up|8|||
129795975|NCT00749580|467221549|FG000|Overall Study|Adverse Event|0|||
129795976|NCT00749580|467221550|FG001|Overall Study|Adverse Event|1|||
129795977|NCT03489551|467221554|FG000|Overall Study|Withdrawal by Subject|2|||
129795978|NCT00054717|467221555|FG000|Overall Study|Randomized but not treated|2|||
129795979|NCT00054717|467221556|FG001|Overall Study|Randomized but not treated|8|||
129795980|NCT00054717|467221555|FG000|Overall Study|Adverse Event|70|||
129795981|NCT00054717|467221556|FG001|Overall Study|Adverse Event|22|||
129795982|NCT00054717|467221555|FG000|Overall Study|Protocol Violation|18|||
129795983|NCT00054717|467221556|FG001|Overall Study|Protocol Violation|19|||
129795984|NCT00054717|467221555|FG000|Overall Study|Lost to Follow-up|23|||
129795985|NCT00054717|467221556|FG001|Overall Study|Lost to Follow-up|13|||
129795986|NCT00054717|467221555|FG000|Overall Study|Withdrawal by Subject|32|||
129795987|NCT00054717|467221556|FG001|Overall Study|Withdrawal by Subject|20|||
129795988|NCT00054717|467221555|FG000|Overall Study|Other reason not defined above|117|||
129795989|NCT00054717|467221556|FG001|Overall Study|Other reason not defined above|217|||
129795990|NCT04565236|467221557|FG000|Overall Study|Patient/Guardian Decision|0|||
129795991|NCT04565236|467221558|FG001|Overall Study|Patient/Guardian Decision|0|||
129795992|NCT04565236|467221559|FG002|Overall Study|Patient/Guardian Decision|1|||
129795993|NCT04565236|467221560|FG003|Overall Study|Patient/Guardian Decision|0|||
129795994|NCT04423939|467221561|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
129795995|NCT04423939|467221562|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
129795996|NCT04423939|467221561|FG000|Overall Study|Death|3|||
129795997|NCT04423939|467221562|FG001|Overall Study|Death|0|||
129795998|NCT04423939|467221561|FG000|Overall Study|Withdrawal by Subject|3|||
129795999|NCT04423939|467221562|FG001|Overall Study|Withdrawal by Subject|0|||
129796000|NCT04423939|467221561|FG000|Overall Study|Caregiver to patient who died|0|||
129796001|NCT04423939|467221562|FG001|Overall Study|Caregiver to patient who died|3|||
129796002|NCT04423939|467221561|FG000|Overall Study|Caregiver to patient who withdrew|0|||
129796003|NCT04423939|467221562|FG001|Overall Study|Caregiver to patient who withdrew|3|||
129796004|NCT04626310|467221565|FG000|Overall Study|4-miss from treatment|6|||
129796005|NCT04626310|467221566|FG001|Overall Study|4-miss from treatment|5|||
129796006|NCT04626310|467221567|FG002|Overall Study|4-miss from treatment|5|||
129796007|NCT04626310|467221565|FG000|Overall Study|Withdrawal by Subject|1|||
129796008|NCT04626310|467221566|FG001|Overall Study|Withdrawal by Subject|0|||
129796009|NCT04626310|467221567|FG002|Overall Study|Withdrawal by Subject|3|||
129796010|NCT00287079|467221569|FG000|Overall Study|Qualifying relapse|12|||
129796011|NCT00287079|467221570|FG001|Overall Study|Qualifying relapse|1|||
129796012|NCT00287079|467221569|FG000|Overall Study|Non-qualifying relapse|1|||
129796013|NCT00287079|467221570|FG001|Overall Study|Non-qualifying relapse|0|||
129796014|NCT00287079|467221569|FG000|Overall Study|Adverse Event|5|||
129796015|NCT00287079|467221570|FG001|Overall Study|Adverse Event|0|||
129796016|NCT00287079|467221569|FG000|Overall Study|Protocol Violation|1|||
129796017|NCT00287079|467221570|FG001|Overall Study|Protocol Violation|0|||
129796018|NCT00287079|467221569|FG000|Overall Study|Other|3|||
129796019|NCT00287079|467221570|FG001|Overall Study|Other|0|||
129796020|NCT00423670|467221573|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
129796021|NCT00423670|467221574|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796022|NCT00423670|467221575|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796023|NCT00423670|467221576|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796024|NCT00423670|467221577|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796025|NCT00423670|467221578|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796026|NCT00423670|467221579|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796027|NCT00423670|467221580|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796028|NCT00423670|467221573|FG000|Treatment Period|Adverse Event|8|||
129796029|NCT00423670|467221574|FG001|Treatment Period|Adverse Event|12|||
129796030|NCT00423670|467221575|FG002|Treatment Period|Adverse Event|15|||
129796031|NCT00423670|467221576|FG003|Treatment Period|Adverse Event|20|||
129796032|NCT00423670|467221577|FG004|Treatment Period|Adverse Event|9|||
130303139|NCT02669212|469073436|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
130303140|NCT02669212|469073437|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
130303141|NCT03549104|469073438|FG000|Overall Study|Withdrawal by Subject|5|||
129796033|NCT00423670|467221578|FG005|Treatment Period|Adverse Event|4|||
129796034|NCT00423670|467221579|FG006|Treatment Period|Adverse Event|7|||
129796035|NCT00423670|467221580|FG007|Treatment Period|Adverse Event|2|||
130303142|NCT03549104|469073439|FG001|Overall Study|Withdrawal by Subject|2|||
129796036|NCT00423670|467221573|FG000|Treatment Period|Protocol-defined clinical event|0|||
129796037|NCT00423670|467221574|FG001|Treatment Period|Protocol-defined clinical event|7|||
129796038|NCT00423670|467221575|FG002|Treatment Period|Protocol-defined clinical event|4|||
129796039|NCT00423670|467221576|FG003|Treatment Period|Protocol-defined clinical event|12|||
129796040|NCT00423670|467221577|FG004|Treatment Period|Protocol-defined clinical event|5|||
129796041|NCT00423670|467221578|FG005|Treatment Period|Protocol-defined clinical event|4|||
129796042|NCT00423670|467221579|FG006|Treatment Period|Protocol-defined clinical event|16|||
129796043|NCT00423670|467221580|FG007|Treatment Period|Protocol-defined clinical event|15|||
129796044|NCT00423670|467221573|FG000|Treatment Period|Lost to Follow-up|2|||
129796045|NCT00423670|467221574|FG001|Treatment Period|Lost to Follow-up|1|||
129796046|NCT00423670|467221575|FG002|Treatment Period|Lost to Follow-up|3|||
129889190|NCT00904150|467551031|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
129889191|NCT00904150|467551032|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
129889192|NCT04129580|467552520|FG000|Overall Study|Lost to Follow-up|14|||
129889193|NCT04129580|467552521|FG001|Overall Study|Lost to Follow-up|25|||
129889194|NCT00224133|467552524|FG000|Overall Study|Adverse Event|93|||
129889195|NCT00224133|467552524|FG000|Overall Study|Protocol Violation|6|||
129889196|NCT00224133|467552524|FG000|Overall Study|Withdrawal by Subject|33|||
129889197|NCT00224133|467552524|FG000|Overall Study|Lack of Efficacy|58|||
129889198|NCT00224133|467552524|FG000|Overall Study|Lost to Follow-up|21|||
129889199|NCT00224133|467552524|FG000|Overall Study|Physician Decision|1|||
129889200|NCT00224133|467552524|FG000|Overall Study|Other|14|||
129889201|NCT02056119|467552529|FG000|Overall Study|Death|1|||
129889202|NCT02056119|467552530|FG001|Overall Study|Death|2|||
129889203|NCT02056119|467552529|FG000|Overall Study|Intubated for less than 24 hrs|2|||
129889204|NCT02056119|467552530|FG001|Overall Study|Intubated for less than 24 hrs|7|||
129889205|NCT02056119|467552529|FG000|Overall Study|No aerosol treatments were given.|3|||
129889206|NCT02056119|467552530|FG001|Overall Study|No aerosol treatments were given.|2|||
129889207|NCT02056119|467552529|FG000|Overall Study|Received Metaneb treatment|0|||
129889208|NCT02056119|467552530|FG001|Overall Study|Received Metaneb treatment|2|||
129889209|NCT02056119|467552529|FG000|Overall Study|Protocol Violation|4|||
129889210|NCT02056119|467552530|FG001|Overall Study|Protocol Violation|7|||
129889211|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
129889212|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
129889213|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
129889214|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
129889215|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
129889216|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
129889217|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
129889218|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
130047815|NCT00404768|468131627|FG002|Part C|Adverse Event|0|||
129796047|NCT00423670|467221576|FG003|Treatment Period|Lost to Follow-up|1|||
130303143|NCT03549104|469073438|FG000|Overall Study|Covid shelter in place|1|||
130303144|NCT03549104|469073439|FG001|Overall Study|Covid shelter in place|2|||
130303145|NCT03078855|469073440|FG000|Overall Study|Lack of Efficacy|62|||
130303146|NCT03078855|469073441|FG001|Overall Study|Lack of Efficacy|31|||
130303147|NCT03078855|469073440|FG000|Overall Study|Death|1|||
130303148|NCT03078855|469073441|FG001|Overall Study|Death|0|||
130303149|NCT03078855|469073440|FG000|Overall Study|Withdrawal by Subject|12|||
130303150|NCT03078855|469073441|FG001|Overall Study|Withdrawal by Subject|6|||
130303151|NCT03078855|469073440|FG000|Overall Study|Physician Decision|3|||
129796048|NCT00423670|467221577|FG004|Treatment Period|Lost to Follow-up|6|||
129796049|NCT00423670|467221578|FG005|Treatment Period|Lost to Follow-up|0|||
129796050|NCT00423670|467221579|FG006|Treatment Period|Lost to Follow-up|3|||
129796051|NCT00423670|467221580|FG007|Treatment Period|Lost to Follow-up|1|||
129796052|NCT00423670|467221573|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
129796053|NCT00423670|467221574|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
130047816|NCT00404768|468131628|FG003|Part C|Adverse Event|3|||
130303152|NCT03078855|469073441|FG001|Overall Study|Physician Decision|2|||
130303153|NCT03078855|469073440|FG000|Overall Study|Second Malignancy|4|||
130303154|NCT03078855|469073441|FG001|Overall Study|Second Malignancy|0|||
130303155|NCT03078855|469073440|FG000|Overall Study|Ineligible|2|||
130303156|NCT03078855|469073441|FG001|Overall Study|Ineligible|0|||
130303157|NCT03078855|469073440|FG000|Overall Study|Withdrew before day 1 treatment|2|||
129796054|NCT00423670|467221575|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
129796055|NCT00423670|467221576|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
129796056|NCT00423670|467221577|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
130047817|NCT00404768|468131625|FG000|Part C|Lost to Follow-up|0|||
129796057|NCT00423670|467221578|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
130047818|NCT00404768|468131626|FG001|Part C|Lost to Follow-up|0|||
130047819|NCT00404768|468131627|FG002|Part C|Lost to Follow-up|3|||
130047820|NCT00404768|468131628|FG003|Part C|Lost to Follow-up|1|||
130303158|NCT03078855|469073441|FG001|Overall Study|Withdrew before day 1 treatment|1|||
130303159|NCT00391027|469073442|FG000|Overall Study|Adverse Event|8|||
130303160|NCT00391027|469073443|FG001|Overall Study|Adverse Event|8|||
130303161|NCT00391027|469073442|FG000|Overall Study|Lack of Efficacy|3|||
130303162|NCT00391027|469073443|FG001|Overall Study|Lack of Efficacy|0|||
129796058|NCT00423670|467221579|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
129889219|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
130047821|NCT00404768|468131625|FG000|Part C|Withdrawal by Subject|0|||
129796059|NCT00423670|467221580|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
129796060|NCT00423670|467221573|FG000|Treatment Period|Investigator decision|0|||
129796061|NCT00423670|467221574|FG001|Treatment Period|Investigator decision|0|||
129796062|NCT00423670|467221575|FG002|Treatment Period|Investigator decision|0|||
129796063|NCT00423670|467221576|FG003|Treatment Period|Investigator decision|0|||
129796064|NCT00423670|467221577|FG004|Treatment Period|Investigator decision|0|||
129796065|NCT00423670|467221578|FG005|Treatment Period|Investigator decision|0|||
129796066|NCT00423670|467221579|FG006|Treatment Period|Investigator decision|0|||
129796067|NCT00423670|467221580|FG007|Treatment Period|Investigator decision|1|||
129796068|NCT00423670|467221573|FG000|Treatment Period|Non-compliance with protocol|3|||
129796069|NCT00423670|467221574|FG001|Treatment Period|Non-compliance with protocol|1|||
129796070|NCT00423670|467221575|FG002|Treatment Period|Non-compliance with protocol|1|||
129796071|NCT00423670|467221576|FG003|Treatment Period|Non-compliance with protocol|3|||
129796072|NCT00423670|467221577|FG004|Treatment Period|Non-compliance with protocol|2|||
129796073|NCT00423670|467221578|FG005|Treatment Period|Non-compliance with protocol|0|||
129796074|NCT00423670|467221579|FG006|Treatment Period|Non-compliance with protocol|2|||
129796075|NCT00423670|467221580|FG007|Treatment Period|Non-compliance with protocol|2|||
129796076|NCT00423670|467221573|FG000|Follow-up Period|Lost to Follow-up|0|||
129796077|NCT00423670|467221574|FG001|Follow-up Period|Lost to Follow-up|12|||
129796078|NCT00423670|467221575|FG002|Follow-up Period|Lost to Follow-up|8|||
129796079|NCT00423670|467221576|FG003|Follow-up Period|Lost to Follow-up|3|||
129796080|NCT00423670|467221577|FG004|Follow-up Period|Lost to Follow-up|1|||
129796081|NCT00423670|467221578|FG005|Follow-up Period|Lost to Follow-up|0|||
129796082|NCT00423670|467221579|FG006|Follow-up Period|Lost to Follow-up|5|||
129796083|NCT00423670|467221580|FG007|Follow-up Period|Lost to Follow-up|0|||
129796084|NCT00423670|467221573|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796085|NCT00423670|467221574|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
129796086|NCT00423670|467221575|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
129796087|NCT00423670|467221576|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796088|NCT00423670|467221577|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796089|NCT00423670|467221578|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
129796090|NCT00423670|467221579|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796091|NCT00423670|467221580|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796092|NCT00423670|467221573|FG000|Follow-up Period|Non-compliance with protocol|2|||
129796093|NCT00423670|467221574|FG001|Follow-up Period|Non-compliance with protocol|0|||
129796094|NCT00423670|467221575|FG002|Follow-up Period|Non-compliance with protocol|1|||
129796095|NCT00423670|467221576|FG003|Follow-up Period|Non-compliance with protocol|1|||
129796096|NCT00423670|467221577|FG004|Follow-up Period|Non-compliance with protocol|0|||
129796097|NCT00423670|467221578|FG005|Follow-up Period|Non-compliance with protocol|0|||
129796098|NCT00423670|467221579|FG006|Follow-up Period|Non-compliance with protocol|3|||
129796099|NCT00423670|467221580|FG007|Follow-up Period|Non-compliance with protocol|2|||
129796100|NCT01082640|467221581|FG000|Overall Study|Adverse Event|9|||
129796101|NCT01082640|467221582|FG001|Overall Study|Adverse Event|5|||
129796102|NCT01082640|467221583|FG002|Overall Study|Adverse Event|3|||
129796103|NCT01082640|467221581|FG000|Overall Study|Withdrawal by Subject|3|||
129796104|NCT01082640|467221582|FG001|Overall Study|Withdrawal by Subject|3|||
129796105|NCT01082640|467221583|FG002|Overall Study|Withdrawal by Subject|2|||
129796106|NCT01082640|467221581|FG000|Overall Study|Major protocol deviation|3|||
129796107|NCT01082640|467221582|FG001|Overall Study|Major protocol deviation|3|||
129796108|NCT01082640|467221583|FG002|Overall Study|Major protocol deviation|0|||
129796109|NCT01082640|467221581|FG000|Overall Study|Lost to Follow-up|0|||
129796110|NCT01082640|467221582|FG001|Overall Study|Lost to Follow-up|3|||
129796111|NCT01082640|467221583|FG002|Overall Study|Lost to Follow-up|0|||
129796112|NCT01082640|467221581|FG000|Overall Study|Other|2|||
129796113|NCT01082640|467221582|FG001|Overall Study|Other|1|||
129796114|NCT01082640|467221583|FG002|Overall Study|Other|3|||
129796115|NCT03190369|467221588|FG000|Overall Study|Poor compliance to protocol|0|||
129796116|NCT03190369|467221589|FG001|Overall Study|Poor compliance to protocol|1|||
129796117|NCT03190369|467221588|FG000|Overall Study|Withdraw before treatment|1|||
129796118|NCT03190369|467221589|FG001|Overall Study|Withdraw before treatment|5|||
129796119|NCT03190369|467221588|FG000|Overall Study|Randomized but not treated|0|||
129796120|NCT03190369|467221589|FG001|Overall Study|Randomized but not treated|2|||
129796121|NCT02011893|467221590|FG000|Enrollment to Randomization|Adverse Event|2|||
129796122|NCT02011893|467221591|FG001|Enrollment to Randomization|Adverse Event|0|||
129796123|NCT02011893|467221592|FG002|Enrollment to Randomization|Adverse Event|0|||
129796124|NCT02011893|467221590|FG000|Enrollment to Randomization|Physician Decision|10|||
129796125|NCT02011893|467221591|FG001|Enrollment to Randomization|Physician Decision|0|||
129796126|NCT02011893|467221592|FG002|Enrollment to Randomization|Physician Decision|0|||
130047822|NCT00404768|468131626|FG001|Part C|Withdrawal by Subject|0|||
129796127|NCT02011893|467221590|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
129796128|NCT02011893|467221591|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
129796129|NCT02011893|467221592|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
129796130|NCT02011893|467221590|FG000|Enrollment to Randomization|Screening Failure|29|||
130110728|NCT03705169|468365845|FG000|Overall Study|Concerns about study visit compliance|0|||
129796131|NCT02011893|467221591|FG001|Enrollment to Randomization|Screening Failure|0|||
129796132|NCT02011893|467221592|FG002|Enrollment to Randomization|Screening Failure|0|||
129796133|NCT02011893|467221590|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
129796134|NCT02011893|467221591|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
129796135|NCT02011893|467221592|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
129796136|NCT02011893|467221590|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
129796137|NCT02011893|467221591|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
129796138|NCT02011893|467221592|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
130303163|NCT00391027|469073442|FG000|Overall Study|Withdrawal by Subject|10|||
130303164|NCT00391027|469073443|FG001|Overall Study|Withdrawal by Subject|1|||
130303165|NCT00391027|469073442|FG000|Overall Study|Other|4|||
130303166|NCT00391027|469073443|FG001|Overall Study|Other|3|||
130303167|NCT01846741|469073451|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
130303168|NCT01628965|469073452|FG000|Overall Study|Adverse Event|30|||
130303169|NCT01628965|469073452|FG000|Overall Study|Lack of Efficacy|7|||
130303170|NCT01628965|469073452|FG000|Overall Study|Withdrawal by Subject|3|||
130303171|NCT01628965|469073452|FG000|Overall Study|Lost to Follow-up|1|||
130303172|NCT01628965|469073452|FG000|Overall Study|Discontinuation criteria|8|||
130303173|NCT00360568|469073454|FG000|Overall Study|Adverse Event|1|||
130303174|NCT00360568|469073455|FG001|Overall Study|Adverse Event|2|||
130303175|NCT00360568|469073454|FG000|Overall Study|Lack of Efficacy|1|||
130303176|NCT00360568|469073455|FG001|Overall Study|Lack of Efficacy|0|||
130303177|NCT00360568|469073454|FG000|Overall Study|Withdrawal by Subject|0|||
130303178|NCT00360568|469073455|FG001|Overall Study|Withdrawal by Subject|3|||
130303179|NCT04006392|469073456|FG000|Overall Study|Lost to Follow-up|0|||
130303180|NCT04006392|469073457|FG001|Overall Study|Lost to Follow-up|1|||
130303181|NCT03824587|469073458|FG000|Run-in Period|Screen Failure|0|||
130303182|NCT03824587|469073459|FG001|Run-in Period|Screen Failure|275|||
130303183|NCT03824587|469073458|FG000|Treatment Period|Adverse Event|4|||
130303184|NCT03824587|469073459|FG001|Treatment Period|Adverse Event|1|||
130303185|NCT03824587|469073458|FG000|Treatment Period|Withdrawal by Subject|0|||
130303186|NCT03824587|469073459|FG001|Treatment Period|Withdrawal by Subject|1|||
129796139|NCT02011893|467221590|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
129796140|NCT02011893|467221591|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
129796141|NCT02011893|467221592|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
129796142|NCT02011893|467221590|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
129796143|NCT02011893|467221591|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
129796144|NCT02011893|467221592|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
129796145|NCT02011893|467221590|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
129796146|NCT02011893|467221591|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
129796147|NCT02011893|467221592|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
129796148|NCT01241240|467221593|FG000|Overall Study|Adverse Event|5|||
129796149|NCT01241240|467221594|FG001|Overall Study|Adverse Event|4|||
129796150|NCT01241240|467221593|FG000|Overall Study|Lost to Follow-up|2|||
129796151|NCT01241240|467221594|FG001|Overall Study|Lost to Follow-up|4|||
129796152|NCT01241240|467221593|FG000|Overall Study|Personal Reasons|1|||
129796153|NCT01241240|467221594|FG001|Overall Study|Personal Reasons|1|||
129796154|NCT00450112|467221595|FG000|Overall Study|Other Treatment Required|5|||
129796155|NCT00450112|467221596|FG001|Overall Study|Other Treatment Required|1|||
129796156|NCT00450112|467221595|FG000|Overall Study|Withdrawal by Subject|4|||
129796157|NCT00450112|467221596|FG001|Overall Study|Withdrawal by Subject|1|||
129796158|NCT00450112|467221595|FG000|Overall Study|Lost to Follow-up|2|||
129796159|NCT00450112|467221596|FG001|Overall Study|Lost to Follow-up|1|||
129796160|NCT00450112|467221595|FG000|Overall Study|Others|2|||
129796161|NCT00450112|467221596|FG001|Overall Study|Others|3|||
129796162|NCT05153473|467221597|FG000|Overall Study|Death|46|||
129796163|NCT05153473|467221597|FG000|Overall Study|Lost to Follow-up|3|||
130303187|NCT03824587|469073458|FG000|Treatment Period|Kidney Transplant|1|||
130303188|NCT03824587|469073459|FG001|Treatment Period|Kidney Transplant|1|||
130303189|NCT00986362|469073460|FG000|Overall Study|Death|2|||
130303190|NCT00986362|469073461|FG001|Overall Study|Death|0|||
130303191|NCT00986362|469073460|FG000|Overall Study|Lost to Follow-up|0|||
130303192|NCT00986362|469073461|FG001|Overall Study|Lost to Follow-up|1|||
130303193|NCT02006979|469073462|FG000|Overall Study|Withdrawal by Subject|1|||
130303194|NCT02006979|469073463|FG001|Overall Study|Withdrawal by Subject|1|||
129796164|NCT02962765|467221598|FG000|Overall Study|Protocol Violation|9|||
129796165|NCT02962765|467221598|FG000|Overall Study|Withdrawal by Subject|3|||
129796166|NCT02962765|467221598|FG000|Overall Study|Lost to Follow-up|1|||
129796167|NCT02962765|467221598|FG000|Overall Study|Death|1|||
129796168|NCT02962765|467221598|FG000|Overall Study|Limited access to study medication|3|||
130047823|NCT00404768|468131627|FG002|Part C|Withdrawal by Subject|2|||
130047824|NCT00404768|468131628|FG003|Part C|Withdrawal by Subject|1|||
130303195|NCT02006979|469073462|FG000|Overall Study|Protocol Violation|0|||
130303196|NCT02006979|469073463|FG001|Overall Study|Protocol Violation|1|||
130303197|NCT03170193|469073464|FG000|Overall Study|Withdrawal by Subject|0|||
130303198|NCT03170193|469073465|FG001|Overall Study|Withdrawal by Subject|0|||
129796169|NCT00064298|467221603|FG000|Overall Study|Withdrawal by Subject|2|||
129796170|NCT00064298|467221604|FG001|Overall Study|Withdrawal by Subject|1|||
129796171|NCT00064298|467221603|FG000|Overall Study|Lost to Follow-up|2|||
129796172|NCT00064298|467221604|FG001|Overall Study|Lost to Follow-up|2|||
129796173|NCT00064298|467221603|FG000|Overall Study|Death|0|||
129796174|NCT00064298|467221604|FG001|Overall Study|Death|1|||
129796175|NCT00064298|467221603|FG000|Overall Study|Disease Progression|2|||
129796176|NCT00064298|467221604|FG001|Overall Study|Disease Progression|1|||
129796177|NCT03614975|467221605|FG000|Overall Study|Physician Decision|7|||
129796178|NCT03614975|467221606|FG001|Overall Study|Physician Decision|5|||
129796179|NCT03614975|467221605|FG000|Overall Study|Withdrawal by Subject|2|||
129796180|NCT03614975|467221606|FG001|Overall Study|Withdrawal by Subject|2|||
129796181|NCT03614975|467221605|FG000|Overall Study|Specimens not in lab batch shipment|1|||
129796182|NCT03614975|467221606|FG001|Overall Study|Specimens not in lab batch shipment|1|||
129796183|NCT01569464|467221607|FG000|Overall Study|Adverse Event|4|||
129796184|NCT01569464|467221608|FG001|Overall Study|Adverse Event|0|||
129796185|NCT01569464|467221607|FG000|Overall Study|Lack of Efficacy|1|||
129796186|NCT01569464|467221608|FG001|Overall Study|Lack of Efficacy|0|||
129796187|NCT01569464|467221607|FG000|Overall Study|Protocol Violation|1|||
129796188|NCT01569464|467221608|FG001|Overall Study|Protocol Violation|0|||
129796189|NCT01569464|467221607|FG000|Overall Study|Lost to Follow-up|2|||
129796190|NCT01569464|467221608|FG001|Overall Study|Lost to Follow-up|3|||
129796191|NCT01569464|467221607|FG000|Overall Study|Withdrawal by Subject|1|||
129796192|NCT01569464|467221608|FG001|Overall Study|Withdrawal by Subject|1|||
129796193|NCT01569464|467221607|FG000|Overall Study|Other|1|||
129796194|NCT01569464|467221608|FG001|Overall Study|Other|1|||
129796195|NCT03533686|467221609|FG000|Overall Study|Withdrawal by Subject|1|||
129796196|NCT03533686|467221610|FG001|Overall Study|Withdrawal by Subject|0|||
129796197|NCT03533686|467221611|FG002|Overall Study|Withdrawal by Subject|0|||
129796198|NCT03533686|467221612|FG003|Overall Study|Withdrawal by Subject|3|||
129796199|NCT03533686|467221613|FG004|Overall Study|Withdrawal by Subject|5|||
129796200|NCT03533686|467221614|FG005|Overall Study|Withdrawal by Subject|1|||
129796201|NCT03533686|467221609|FG000|Overall Study|Lost to Follow-up|0|||
129796202|NCT03533686|467221610|FG001|Overall Study|Lost to Follow-up|1|||
129796203|NCT03533686|467221611|FG002|Overall Study|Lost to Follow-up|0|||
129796204|NCT03533686|467221612|FG003|Overall Study|Lost to Follow-up|0|||
129796205|NCT03533686|467221613|FG004|Overall Study|Lost to Follow-up|2|||
129796206|NCT03533686|467221614|FG005|Overall Study|Lost to Follow-up|0|||
129796207|NCT03533686|467221609|FG000|Overall Study|Screen Failure|0|||
129796208|NCT03533686|467221610|FG001|Overall Study|Screen Failure|0|||
129796209|NCT03533686|467221611|FG002|Overall Study|Screen Failure|0|||
129796210|NCT03533686|467221612|FG003|Overall Study|Screen Failure|2|||
129796211|NCT03533686|467221613|FG004|Overall Study|Screen Failure|0|||
129796212|NCT03533686|467221614|FG005|Overall Study|Screen Failure|0|||
130303199|NCT03170193|469073466|FG002|Overall Study|Withdrawal by Subject|0|||
130303200|NCT03170193|469073467|FG003|Overall Study|Withdrawal by Subject|1|||
130303201|NCT03170193|469073468|FG004|Overall Study|Withdrawal by Subject|0|||
130303202|NCT03170193|469073469|FG005|Overall Study|Withdrawal by Subject|0|||
130303203|NCT03170193|469073470|FG006|Overall Study|Withdrawal by Subject|0|||
130303204|NCT03170193|469073464|FG000|Overall Study|Lost to Follow-up|1|||
130303205|NCT03170193|469073465|FG001|Overall Study|Lost to Follow-up|1|||
130303206|NCT03170193|469073466|FG002|Overall Study|Lost to Follow-up|0|||
130303207|NCT03170193|469073467|FG003|Overall Study|Lost to Follow-up|0|||
130303208|NCT03170193|469073468|FG004|Overall Study|Lost to Follow-up|0|||
130303209|NCT03170193|469073469|FG005|Overall Study|Lost to Follow-up|0|||
130303210|NCT03170193|469073470|FG006|Overall Study|Lost to Follow-up|0|||
130303211|NCT01368081|469073471|FG000|Overall Study|Adverse Event|4|||
130303212|NCT01368081|469073472|FG001|Overall Study|Adverse Event|4|||
130303213|NCT01368081|469073473|FG002|Overall Study|Adverse Event|3|||
130303214|NCT01368081|469073474|FG003|Overall Study|Adverse Event|2|||
130303215|NCT01368081|469073475|FG004|Overall Study|Adverse Event|2|||
130303216|NCT01368081|469073476|FG005|Overall Study|Adverse Event|5|||
130303217|NCT01368081|469073477|FG006|Overall Study|Adverse Event|6|||
130303218|NCT01368081|469073478|FG007|Overall Study|Adverse Event|2|||
130303219|NCT01368081|469073479|FG008|Overall Study|Adverse Event|3|||
130303220|NCT01368081|469073480|FG009|Overall Study|Adverse Event|5|||
130303221|NCT01368081|469073481|FG010|Overall Study|Adverse Event|6|||
130303222|NCT01368081|469073482|FG011|Overall Study|Adverse Event|1|||
130303223|NCT01368081|469073483|FG012|Overall Study|Adverse Event|3|||
130303224|NCT01368081|469073471|FG000|Overall Study|Lack of Efficacy|0|||
130303225|NCT01368081|469073472|FG001|Overall Study|Lack of Efficacy|1|||
130303226|NCT01368081|469073473|FG002|Overall Study|Lack of Efficacy|0|||
130303227|NCT01368081|469073474|FG003|Overall Study|Lack of Efficacy|1|||
129796213|NCT00245583|467221615|FG000|Overall Study|Lost to Follow-up|1|||
129796214|NCT00245583|467221616|FG001|Overall Study|Lost to Follow-up|5|||
129796215|NCT00245583|467221615|FG000|Overall Study|Adverse Event|2|||
129796216|NCT00245583|467221616|FG001|Overall Study|Adverse Event|1|||
130303228|NCT01368081|469073475|FG004|Overall Study|Lack of Efficacy|0|||
130303229|NCT01368081|469073476|FG005|Overall Study|Lack of Efficacy|0|||
130303230|NCT01368081|469073477|FG006|Overall Study|Lack of Efficacy|0|||
129796217|NCT00245583|467221615|FG000|Overall Study|Lack of Efficacy|1|||
129796218|NCT00245583|467221616|FG001|Overall Study|Lack of Efficacy|0|||
129796219|NCT00245583|467221615|FG000|Overall Study|Withdrawal by Subject|2|||
129796220|NCT00245583|467221616|FG001|Overall Study|Withdrawal by Subject|3|||
129796221|NCT02414139|467221617|FG000|Treatment Period|Adverse Event|11|||
129796222|NCT02414139|467221618|FG001|Treatment Period|Adverse Event|6|||
129796223|NCT02414139|467221619|FG002|Treatment Period|Adverse Event|8|||
129796224|NCT02414139|467221620|FG003|Treatment Period|Adverse Event|5|||
129796225|NCT02414139|467221621|FG004|Treatment Period|Adverse Event|14|||
129796226|NCT02414139|467221622|FG005|Treatment Period|Adverse Event|3|||
129796227|NCT02414139|467221623|FG006|Treatment Period|Adverse Event|6|||
129796228|NCT02414139|467221624|FG007|Treatment Period|Adverse Event|1|||
129796229|NCT02414139|467221625|FG008|Treatment Period|Adverse Event|6|||
129796230|NCT02414139|467221626|FG009|Treatment Period|Adverse Event|8|||
129796231|NCT02414139|467221617|FG000|Treatment Period|Death|0|||
129796232|NCT02414139|467221618|FG001|Treatment Period|Death|0|||
129796233|NCT02414139|467221619|FG002|Treatment Period|Death|1|||
129796234|NCT02414139|467221620|FG003|Treatment Period|Death|1|||
129796235|NCT02414139|467221621|FG004|Treatment Period|Death|0|||
129796236|NCT02414139|467221622|FG005|Treatment Period|Death|0|||
129796237|NCT02414139|467221623|FG006|Treatment Period|Death|0|||
129796238|NCT02414139|467221624|FG007|Treatment Period|Death|0|||
129796239|NCT02414139|467221625|FG008|Treatment Period|Death|0|||
129796240|NCT02414139|467221626|FG009|Treatment Period|Death|1|||
129796241|NCT02414139|467221617|FG000|Treatment Period|Physician Decision|5|||
129796242|NCT02414139|467221618|FG001|Treatment Period|Physician Decision|4|||
129796243|NCT02414139|467221619|FG002|Treatment Period|Physician Decision|6|||
129796244|NCT02414139|467221620|FG003|Treatment Period|Physician Decision|1|||
129796245|NCT02414139|467221621|FG004|Treatment Period|Physician Decision|4|||
129796246|NCT02414139|467221622|FG005|Treatment Period|Physician Decision|0|||
129796247|NCT02414139|467221623|FG006|Treatment Period|Physician Decision|2|||
129796248|NCT02414139|467221624|FG007|Treatment Period|Physician Decision|0|||
129796249|NCT02414139|467221625|FG008|Treatment Period|Physician Decision|1|||
129796250|NCT02414139|467221626|FG009|Treatment Period|Physician Decision|4|||
129796251|NCT02414139|467221617|FG000|Treatment Period|Progressive disease|48|||
129796252|NCT02414139|467221618|FG001|Treatment Period|Progressive disease|31|||
129796253|NCT02414139|467221619|FG002|Treatment Period|Progressive disease|37|||
129796254|NCT02414139|467221620|FG003|Treatment Period|Progressive disease|21|||
129796255|NCT02414139|467221621|FG004|Treatment Period|Progressive disease|43|||
129796256|NCT02414139|467221622|FG005|Treatment Period|Progressive disease|12|||
129796257|NCT02414139|467221623|FG006|Treatment Period|Progressive disease|16|||
129796258|NCT02414139|467221624|FG007|Treatment Period|Progressive disease|2|||
129796259|NCT02414139|467221625|FG008|Treatment Period|Progressive disease|20|||
129796260|NCT02414139|467221626|FG009|Treatment Period|Progressive disease|14|||
129796261|NCT02414139|467221617|FG000|Treatment Period|Protocol deviation|0|||
129796262|NCT02414139|467221618|FG001|Treatment Period|Protocol deviation|0|||
129796263|NCT02414139|467221619|FG002|Treatment Period|Protocol deviation|1|||
129796264|NCT02414139|467221620|FG003|Treatment Period|Protocol deviation|0|||
129796265|NCT02414139|467221621|FG004|Treatment Period|Protocol deviation|0|||
129796266|NCT02414139|467221622|FG005|Treatment Period|Protocol deviation|0|||
129796267|NCT02414139|467221623|FG006|Treatment Period|Protocol deviation|0|||
129796268|NCT02414139|467221624|FG007|Treatment Period|Protocol deviation|0|||
129796269|NCT02414139|467221625|FG008|Treatment Period|Protocol deviation|0|||
129796270|NCT02414139|467221626|FG009|Treatment Period|Protocol deviation|0|||
129796271|NCT02414139|467221617|FG000|Treatment Period|Subject/Guardian decision|5|||
129796272|NCT02414139|467221618|FG001|Treatment Period|Subject/Guardian decision|1|||
129796273|NCT02414139|467221619|FG002|Treatment Period|Subject/Guardian decision|1|||
129796274|NCT02414139|467221620|FG003|Treatment Period|Subject/Guardian decision|2|||
129796275|NCT02414139|467221621|FG004|Treatment Period|Subject/Guardian decision|5|||
129796276|NCT02414139|467221622|FG005|Treatment Period|Subject/Guardian decision|0|||
129796277|NCT02414139|467221623|FG006|Treatment Period|Subject/Guardian decision|2|||
129796278|NCT02414139|467221624|FG007|Treatment Period|Subject/Guardian decision|0|||
129796279|NCT02414139|467221625|FG008|Treatment Period|Subject/Guardian decision|1|||
129796280|NCT02414139|467221626|FG009|Treatment Period|Subject/Guardian decision|1|||
129796281|NCT02414139|467221617|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796282|NCT02414139|467221618|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796283|NCT02414139|467221619|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796284|NCT02414139|467221620|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796285|NCT02414139|467221621|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
129796286|NCT02414139|467221622|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796287|NCT02414139|467221623|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
129796288|NCT02414139|467221624|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796289|NCT02414139|467221625|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
129796290|NCT02414139|467221626|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
130303231|NCT01368081|469073478|FG007|Overall Study|Lack of Efficacy|2|||
129796291|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129796292|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796293|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796294|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796295|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
129796296|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796297|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796298|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796299|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796300|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796301|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Death|0|||
129796302|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Death|1|||
129796303|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Death|0|||
129796304|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Death|0|||
129796305|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Death|1|||
129796306|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Death|0|||
129796307|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Death|0|||
129796308|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Death|0|||
129796309|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Death|0|||
129796310|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Death|1|||
129796311|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
129796312|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796313|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796314|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796315|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796316|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796317|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796318|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796319|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796320|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796321|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129796322|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129796323|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129796324|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129796325|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129796326|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129796327|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129796328|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129796329|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129796330|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129796331|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
129796332|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129796333|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
129796334|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129796335|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
129796336|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
129796337|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129796338|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
129796339|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129796340|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129796341|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796342|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
129796343|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796344|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796345|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130303232|NCT01368081|469073479|FG008|Overall Study|Lack of Efficacy|0|||
129796346|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796347|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796348|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
130047825|NCT00404768|468131625|FG000|Part C|Early withdrawal from study medication|0|||
130047826|NCT00404768|468131626|FG001|Part C|Early withdrawal from study medication|0|||
130047827|NCT00404768|468131627|FG002|Part C|Early withdrawal from study medication|1|||
130047828|NCT00404768|468131628|FG003|Part C|Early withdrawal from study medication|0|||
130047829|NCT00404768|468131625|FG000|Part C|Participant did not respond to therapy|0|||
130047830|NCT00404768|468131626|FG001|Part C|Participant did not respond to therapy|0|||
130047831|NCT00404768|468131627|FG002|Part C|Participant did not respond to therapy|1|||
130047832|NCT00404768|468131628|FG003|Part C|Participant did not respond to therapy|1|||
130303233|NCT01368081|469073480|FG009|Overall Study|Lack of Efficacy|0|||
129796349|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796350|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
129796351|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
129796352|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129796353|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
129796354|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129796355|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129796356|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129796357|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129796358|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129796359|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129796360|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129796361|NCT03631355|467221627|FG000|Overall Study|Lost to Follow-up|1|||
129796362|NCT03631355|467221628|FG001|Overall Study|Lost to Follow-up|2|||
129796363|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
129796364|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
129796365|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
129796366|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
129796367|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
129796368|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
129796369|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
129796370|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
129796371|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
129796372|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
129796373|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
129796374|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
129796375|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
129796376|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
129796377|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
129796378|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
129796379|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
129796380|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
129796381|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
129796382|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
129796383|NCT00495131|467221635|FG000|Overall Study|Adverse Event|6|||
129796384|NCT00495131|467221636|FG001|Overall Study|Adverse Event|2|||
129796385|NCT00495131|467221635|FG000|Overall Study|Lack of Efficacy|0|||
129796386|NCT00495131|467221636|FG001|Overall Study|Lack of Efficacy|2|||
129796387|NCT00495131|467221635|FG000|Overall Study|Lost to Follow-up|0|||
129796388|NCT00495131|467221636|FG001|Overall Study|Lost to Follow-up|2|||
129796389|NCT00495131|467221635|FG000|Overall Study|Withdrawal by Subject|1|||
129796390|NCT00495131|467221636|FG001|Overall Study|Withdrawal by Subject|0|||
129796391|NCT00744471|467221637|FG000|Overall Study|Randomized but not treated|1|||
129796392|NCT00744471|467221638|FG001|Overall Study|Randomized but not treated|1|||
129796393|NCT00744471|467221639|FG002|Overall Study|Randomized but not treated|4|||
129796394|NCT00744471|467221640|FG003|Overall Study|Randomized but not treated|0|||
129796395|NCT00744471|467221637|FG000|Overall Study|Death|0|||
129796396|NCT00744471|467221638|FG001|Overall Study|Death|0|||
129796397|NCT00744471|467221639|FG002|Overall Study|Death|0|||
129796398|NCT00744471|467221640|FG003|Overall Study|Death|1|||
129796399|NCT00744471|467221637|FG000|Overall Study|Adverse Event|6|||
129796400|NCT00744471|467221638|FG001|Overall Study|Adverse Event|7|||
129796401|NCT00744471|467221639|FG002|Overall Study|Adverse Event|5|||
129796402|NCT00744471|467221640|FG003|Overall Study|Adverse Event|9|||
129796403|NCT00744471|467221637|FG000|Overall Study|Withdrawal by Subject|9|||
129796404|NCT00744471|467221638|FG001|Overall Study|Withdrawal by Subject|9|||
129796405|NCT00744471|467221639|FG002|Overall Study|Withdrawal by Subject|15|||
130303234|NCT01368081|469073481|FG010|Overall Study|Lack of Efficacy|0|||
129796406|NCT00744471|467221640|FG003|Overall Study|Withdrawal by Subject|12|||
129796407|NCT00744471|467221637|FG000|Overall Study|Protocol Violation|1|||
129796408|NCT00744471|467221638|FG001|Overall Study|Protocol Violation|4|||
129796409|NCT00744471|467221639|FG002|Overall Study|Protocol Violation|1|||
129796410|NCT00744471|467221640|FG003|Overall Study|Protocol Violation|2|||
129796411|NCT00744471|467221637|FG000|Overall Study|Entered extension study|41|||
129796412|NCT00744471|467221638|FG001|Overall Study|Entered extension study|84|||
129796413|NCT00744471|467221639|FG002|Overall Study|Entered extension study|100|||
129796414|NCT00744471|467221640|FG003|Overall Study|Entered extension study|91|||
129796415|NCT00744471|467221637|FG000|Overall Study|Other|2|||
129796416|NCT00744471|467221638|FG001|Overall Study|Other|3|||
129796417|NCT00744471|467221639|FG002|Overall Study|Other|6|||
129796418|NCT00744471|467221640|FG003|Overall Study|Other|2|||
129796419|NCT00744471|467221637|FG000|Overall Study|Lack of Efficacy|83|||
129796420|NCT00744471|467221638|FG001|Overall Study|Lack of Efficacy|37|||
129796421|NCT00744471|467221639|FG002|Overall Study|Lack of Efficacy|19|||
129796422|NCT00744471|467221640|FG003|Overall Study|Lack of Efficacy|31|||
129796423|NCT00744471|467221637|FG000|Overall Study|Lost to Follow-up|0|||
129796424|NCT00744471|467221638|FG001|Overall Study|Lost to Follow-up|0|||
129796425|NCT00744471|467221639|FG002|Overall Study|Lost to Follow-up|2|||
129796426|NCT00744471|467221640|FG003|Overall Study|Lost to Follow-up|0|||
129796427|NCT03224546|467221641|FG000|Overall Study|Lost to Follow-up|9|||
129796428|NCT03224546|467221642|FG001|Overall Study|Lost to Follow-up|8|||
129796429|NCT03224546|467221643|FG002|Overall Study|Lost to Follow-up|3|||
129796430|NCT03224546|467221641|FG000|Overall Study|Withdrawal by Subject|7|||
129796431|NCT03224546|467221642|FG001|Overall Study|Withdrawal by Subject|14|||
129796432|NCT03224546|467221643|FG002|Overall Study|Withdrawal by Subject|12|||
129796433|NCT04706416|467221648|FG000|Overall Study|Lost to Follow-up|2|||
129796434|NCT04706416|467221649|FG001|Overall Study|Lost to Follow-up|0|||
129796435|NCT01539317|467221653|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
129796436|NCT01539317|467221654|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
129796437|NCT00976573|467221661|FG000|Overall Study|Ineligible|0|||
129796438|NCT00976573|467221662|FG001|Overall Study|Ineligible|1|||
129796439|NCT00976573|467221661|FG000|Overall Study|Cancel prior to receiving treatment|4|||
129796440|NCT00976573|467221662|FG001|Overall Study|Cancel prior to receiving treatment|2|||
129796441|NCT02117427|467221663|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
129796442|NCT02117427|467221664|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
129796443|NCT02117427|467221665|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
129796444|NCT02117427|467221663|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
129796445|NCT02117427|467221664|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
129796446|NCT02117427|467221665|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
129796447|NCT02117427|467221663|FG000|Overall Study|Physician Decision|0|||
129796448|NCT02117427|467221664|FG001|Overall Study|Physician Decision|2|||
129796449|NCT02117427|467221665|FG002|Overall Study|Physician Decision|0|||
129796450|NCT02117427|467221663|FG000|Overall Study|No longer meets inclusion criteria|0|||
129796451|NCT02117427|467221664|FG001|Overall Study|No longer meets inclusion criteria|1|||
129796452|NCT02117427|467221665|FG002|Overall Study|No longer meets inclusion criteria|0|||
129796453|NCT02117427|467221663|FG000|Overall Study|Death|0|||
129796454|NCT02117427|467221664|FG001|Overall Study|Death|1|||
130047833|NCT00404768|468131625|FG000|Part C|Physician withdrew the study medication|0|||
130047834|NCT00404768|468131626|FG001|Part C|Physician withdrew the study medication|0|||
129796455|NCT02117427|467221665|FG002|Overall Study|Death|0|||
129796456|NCT02730208|467221666|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129796457|NCT02730208|467221667|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
129796458|NCT00510952|467221673|FG000|Overall Study|Adverse Event|1|||
129796459|NCT00510952|467221674|FG001|Overall Study|Adverse Event|0|||
129796460|NCT00510952|467221673|FG000|Overall Study|Entry Criteria Not Met|3|||
129796461|NCT00510952|467221674|FG001|Overall Study|Entry Criteria Not Met|1|||
129796462|NCT00510952|467221673|FG000|Overall Study|Lost to Follow-up|5|||
129796463|NCT00510952|467221674|FG001|Overall Study|Lost to Follow-up|3|||
129796464|NCT00510952|467221673|FG000|Overall Study|Physician Decision|1|||
129796465|NCT00510952|467221674|FG001|Overall Study|Physician Decision|1|||
129796466|NCT00510952|467221673|FG000|Overall Study|Protocol Violation|7|||
129796467|NCT00510952|467221674|FG001|Overall Study|Protocol Violation|4|||
129796468|NCT00510952|467221673|FG000|Overall Study|Sponsor Decision|1|||
129796469|NCT00510952|467221674|FG001|Overall Study|Sponsor Decision|0|||
129796470|NCT00510952|467221673|FG000|Overall Study|Withdrawal by Subject|6|||
129796471|NCT00510952|467221674|FG001|Overall Study|Withdrawal by Subject|7|||
129796472|NCT00510952|467221673|FG000|Overall Study|Did Not Receive Study Drug|2|||
129796473|NCT00510952|467221674|FG001|Overall Study|Did Not Receive Study Drug|0|||
129796474|NCT02793128|467221684|FG000|Overall Study|Death|4|||
129796475|NCT02793128|467221684|FG000|Overall Study|Withdrawal by Subject|2|||
129796476|NCT02793128|467221684|FG000|Overall Study|Physician Decision|1|||
129796477|NCT02793128|467221684|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
129796478|NCT02793128|467221684|FG000|Overall Study|Patient elected nephroureterectomy|1|||
129796479|NCT02359851|467221685|FG000|Overall Study|Death|1|||
130047835|NCT00404768|468131627|FG002|Part C|Physician withdrew the study medication|1|||
129796480|NCT02359851|467221685|FG000|Overall Study|Disease progression|1|||
129796481|NCT01888003|467221686|FG000|Overall Study|Study Terminated|5|||
130047836|NCT00404768|468131628|FG003|Part C|Physician withdrew the study medication|0|||
129796482|NCT01888003|467221687|FG001|Overall Study|Study Terminated|6|||
129796483|NCT01888003|467221688|FG002|Overall Study|Study Terminated|40|||
129796484|NCT00055471|467221689|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
129889220|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
129796485|NCT00055471|467221690|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
129796486|NCT00055471|467221691|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
129796487|NCT00055471|467221689|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
129796488|NCT00055471|467221690|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
129796489|NCT00055471|467221691|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
129796490|NCT00055471|467221689|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
129796491|NCT00055471|467221690|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
129796492|NCT00055471|467221691|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
129796493|NCT01854944|467221692|FG000|Overall Study|Withdrawal by Subject|0|||
129796494|NCT01854944|467221693|FG001|Overall Study|Withdrawal by Subject|0|||
129796495|NCT01854944|467221694|FG002|Overall Study|Withdrawal by Subject|1|||
129796496|NCT02101112|467221695|FG000|Overall Study|Adverse Event|0|||
129796497|NCT02101112|467221696|FG001|Overall Study|Adverse Event|0|||
129796498|NCT02101112|467221697|FG002|Overall Study|Adverse Event|1|||
129796499|NCT02101112|467221698|FG003|Overall Study|Adverse Event|0|||
129796500|NCT02101112|467221699|FG004|Overall Study|Adverse Event|0|||
129796501|NCT02101112|467221700|FG005|Overall Study|Adverse Event|0|||
129796502|NCT02101112|467221695|FG000|Overall Study|Withdrawal by Subject|0|||
129796503|NCT02101112|467221696|FG001|Overall Study|Withdrawal by Subject|0|||
129796504|NCT02101112|467221697|FG002|Overall Study|Withdrawal by Subject|0|||
129796505|NCT02101112|467221698|FG003|Overall Study|Withdrawal by Subject|0|||
129796506|NCT02101112|467221699|FG004|Overall Study|Withdrawal by Subject|1|||
129796507|NCT02101112|467221700|FG005|Overall Study|Withdrawal by Subject|0|||
129796508|NCT02125604|467221701|FG000|Overall Study|Other|4|||
129796509|NCT02125604|467221701|FG000|Overall Study|Investigator Decision|1|||
129796510|NCT02125604|467221701|FG000|Overall Study|Lost to Follow-up|2|||
129796511|NCT02125604|467221701|FG000|Overall Study|Consent Withdrawn|4|||
129796512|NCT02125604|467221701|FG000|Overall Study|Adverse Event|20|||
129796513|NCT04340063|467221702|FG000|Overall Study|Withdrawal by Subject|1|||
129796514|NCT04340063|467221703|FG001|Overall Study|Withdrawal by Subject|2|||
129796515|NCT04340063|467221702|FG000|Overall Study|Lost to Follow-up|3|||
129796516|NCT04340063|467221703|FG001|Overall Study|Lost to Follow-up|1|||
129796517|NCT04340063|467221702|FG000|Overall Study|Protocol Violation|0|||
129796518|NCT04340063|467221703|FG001|Overall Study|Protocol Violation|1|||
129796519|NCT01876810|467221704|FG000|Overall Study|Physician Decision|0|||
129796520|NCT01876810|467221705|FG001|Overall Study|Physician Decision|1|||
129796521|NCT01683019|467223274|FG000|Overall Study|Withdrawal by Subject|2|||
129796522|NCT01683019|467223275|FG001|Overall Study|Withdrawal by Subject|1|||
129796523|NCT01683019|467223276|FG002|Overall Study|Withdrawal by Subject|4|||
129796524|NCT00543855|467223277|FG000|Overall Study|Adverse Event|3|||
129796525|NCT00543855|467223278|FG001|Overall Study|Adverse Event|1|||
129796526|NCT00543855|467223279|FG002|Overall Study|Adverse Event|3|||
129796527|NCT00543855|467223280|FG003|Overall Study|Adverse Event|4|||
129796528|NCT00543855|467223277|FG000|Overall Study|Lost to Follow-up|0|||
130303235|NCT01368081|469073482|FG011|Overall Study|Lack of Efficacy|0|||
130303236|NCT01368081|469073483|FG012|Overall Study|Lack of Efficacy|0|||
130303237|NCT01368081|469073471|FG000|Overall Study|Protocol Violation|0|||
129796529|NCT00543855|467223278|FG001|Overall Study|Lost to Follow-up|0|||
129796530|NCT00543855|467223279|FG002|Overall Study|Lost to Follow-up|1|||
129796531|NCT00543855|467223280|FG003|Overall Study|Lost to Follow-up|0|||
129796532|NCT00543855|467223277|FG000|Overall Study|Withdrawal by Subject|0|||
129796533|NCT00543855|467223278|FG001|Overall Study|Withdrawal by Subject|1|||
129796534|NCT00543855|467223279|FG002|Overall Study|Withdrawal by Subject|2|||
129796535|NCT00543855|467223280|FG003|Overall Study|Withdrawal by Subject|0|||
129796536|NCT00543855|467223277|FG000|Overall Study|Protocol Violation|1|||
129796537|NCT00543855|467223278|FG001|Overall Study|Protocol Violation|0|||
129796538|NCT00543855|467223279|FG002|Overall Study|Protocol Violation|0|||
129796539|NCT00543855|467223280|FG003|Overall Study|Protocol Violation|0|||
129796540|NCT05828095|467223282|FG000|Overall Study|Lost to Follow-up|1|||
129796541|NCT05828095|467223283|FG001|Overall Study|Lost to Follow-up|0|||
129796542|NCT05828095|467223282|FG000|Overall Study|Reactogenicity symptom|0|||
129796543|NCT05828095|467223283|FG001|Overall Study|Reactogenicity symptom|1|||
129796544|NCT03206073|467223284|FG000|Overall Study|Participant Noncompliance|0|||
129796545|NCT03206073|467223285|FG001|Overall Study|Participant Noncompliance|1|||
129796546|NCT03206073|467223286|FG002|Overall Study|Participant Noncompliance|0|||
129796547|NCT03206073|467223287|FG003|Overall Study|Participant Noncompliance|0|||
129796548|NCT03206073|467223284|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
129796549|NCT03206073|467223285|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
129796550|NCT03206073|467223286|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
129796551|NCT03206073|467223287|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
129796552|NCT03206073|467223284|FG000|Overall Study|Death|0|||
129796553|NCT03206073|467223285|FG001|Overall Study|Death|0|||
129796554|NCT03206073|467223286|FG002|Overall Study|Death|1|||
129796555|NCT03206073|467223287|FG003|Overall Study|Death|0|||
129796556|NCT03206073|467223284|FG000|Overall Study|Taken off active treatment|0|||
129796557|NCT03206073|467223285|FG001|Overall Study|Taken off active treatment|0|||
129796558|NCT03206073|467223286|FG002|Overall Study|Taken off active treatment|3|||
129796559|NCT03206073|467223287|FG003|Overall Study|Taken off active treatment|0|||
129796560|NCT03332771|467223288|FG000|Overall Study|Adverse Event|6|||
129796561|NCT03332771|467223289|FG001|Overall Study|Adverse Event|4|||
129796562|NCT03332771|467223290|FG002|Overall Study|Adverse Event|1|||
130303238|NCT01368081|469073472|FG001|Overall Study|Protocol Violation|0|||
129889221|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
129889222|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
129889223|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
129889224|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
129889225|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
129889226|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
129889227|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
129889228|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
129889229|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
129889230|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
129889231|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
129889232|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889233|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889234|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
129889235|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889236|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889237|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889238|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889239|NCT03220737|467552531|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889240|NCT03220737|467552532|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889241|NCT03220737|467552533|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889242|NCT03220737|467552534|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889243|NCT03220737|467552535|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
129889244|NCT03220737|467552536|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889245|NCT03220737|467552537|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889246|NCT03220737|467552531|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
129889247|NCT03220737|467552532|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889248|NCT03220737|467552533|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889249|NCT03220737|467552534|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889250|NCT03220737|467552535|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889251|NCT03220737|467552536|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889252|NCT03220737|467552537|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889253|NCT03220737|467552531|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
129889254|NCT03220737|467552532|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889255|NCT03220737|467552533|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889256|NCT03220737|467552534|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889257|NCT03220737|467552535|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889258|NCT03220737|467552536|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889259|NCT03220737|467552537|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889260|NCT03220737|467552531|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
129889261|NCT03220737|467552532|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129889262|NCT03220737|467552533|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130047837|NCT00404768|468131625|FG000|Part C|Participant delivered baby|0|||
130047838|NCT00404768|468131626|FG001|Part C|Participant delivered baby|0|||
130047839|NCT00404768|468131627|FG002|Part C|Participant delivered baby|0|||
130047840|NCT00404768|468131628|FG003|Part C|Participant delivered baby|1|||
130047841|NCT00404768|468131625|FG000|Part C|Unsatisfactory uterine response to IP|0|||
129889263|NCT03220737|467552534|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129796563|NCT03332771|467223291|FG003|Overall Study|Adverse Event|3|||
129796564|NCT03332771|467223288|FG000|Overall Study|Poor Compliance to Protocol|0|||
129796565|NCT03332771|467223289|FG001|Overall Study|Poor Compliance to Protocol|1|||
129796566|NCT03332771|467223290|FG002|Overall Study|Poor Compliance to Protocol|0|||
129796567|NCT03332771|467223291|FG003|Overall Study|Poor Compliance to Protocol|1|||
129796568|NCT03332771|467223288|FG000|Overall Study|Lost to Follow-up|2|||
129796569|NCT03332771|467223289|FG001|Overall Study|Lost to Follow-up|2|||
129796570|NCT03332771|467223290|FG002|Overall Study|Lost to Follow-up|1|||
129796571|NCT03332771|467223291|FG003|Overall Study|Lost to Follow-up|2|||
129796572|NCT03332771|467223288|FG000|Overall Study|At the Participant's own request|20|||
129796573|NCT03332771|467223289|FG001|Overall Study|At the Participant's own request|26|||
129796574|NCT03332771|467223290|FG002|Overall Study|At the Participant's own request|14|||
129796575|NCT03332771|467223291|FG003|Overall Study|At the Participant's own request|23|||
129796576|NCT03332771|467223288|FG000|Overall Study|Reason Not Specified|6|||
129796577|NCT03332771|467223289|FG001|Overall Study|Reason Not Specified|18|||
129796578|NCT03332771|467223290|FG002|Overall Study|Reason Not Specified|16|||
129796579|NCT03332771|467223291|FG003|Overall Study|Reason Not Specified|19|||
129796580|NCT00096954|467223292|FG000|Overall Study|Adverse Event|3|||
129796581|NCT00096954|467223293|FG001|Overall Study|Adverse Event|1|||
129796582|NCT00096954|467223292|FG000|Overall Study|Withdrawal by Subject|9|||
129796583|NCT00096954|467223293|FG001|Overall Study|Withdrawal by Subject|8|||
129796584|NCT00096954|467223292|FG000|Overall Study|Physician Decision|1|||
129796585|NCT00096954|467223293|FG001|Overall Study|Physician Decision|1|||
129796586|NCT00096954|467223292|FG000|Overall Study|Sponsors Decision|1|||
129796587|NCT00096954|467223293|FG001|Overall Study|Sponsors Decision|1|||
129796588|NCT00096954|467223292|FG000|Overall Study|Pregnancy|1|||
129796589|NCT00096954|467223293|FG001|Overall Study|Pregnancy|1|||
129796590|NCT00096954|467223292|FG000|Overall Study|Initiation of immunotherapy|1|||
129796591|NCT00096954|467223293|FG001|Overall Study|Initiation of immunotherapy|0|||
129796592|NCT00096954|467223292|FG000|Overall Study|Non-compliance|0|||
129796593|NCT00096954|467223293|FG001|Overall Study|Non-compliance|3|||
129796594|NCT00096954|467223292|FG000|Overall Study|Lost to Follow-up|8|||
130047842|NCT00404768|468131626|FG001|Part C|Unsatisfactory uterine response to IP|0|||
130047843|NCT00404768|468131627|FG002|Part C|Unsatisfactory uterine response to IP|0|||
129796595|NCT00096954|467223293|FG001|Overall Study|Lost to Follow-up|5|||
129796596|NCT04478123|467223295|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
129796597|NCT04478123|467223295|FG000|Overall Study|NE|1|||
129796598|NCT04444895|467223296|FG000|Overall Study|Adverse Event|2|||
129796599|NCT04444895|467223296|FG000|Overall Study|Lost to Follow-up|2|||
129796600|NCT04444895|467223296|FG000|Overall Study|Withdrawal by Subject|5|||
129796601|NCT03581786|467223299|FG000|Overall Study|Death|67|||
129796602|NCT03581786|467223300|FG001|Overall Study|Death|47|||
129796603|NCT03581786|467223299|FG000|Overall Study|Withdrawal by Subject|2|||
129796604|NCT03581786|467223300|FG001|Overall Study|Withdrawal by Subject|5|||
129796605|NCT03581786|467223299|FG000|Overall Study|Lost to Follow-up|7|||
129796606|NCT03581786|467223300|FG001|Overall Study|Lost to Follow-up|4|||
129796607|NCT03581786|467223299|FG000|Overall Study|reason other than specified above|0|||
129796608|NCT03581786|467223300|FG001|Overall Study|reason other than specified above|1|||
129796609|NCT05523323|467223301|FG000|Overall Study|Death|26|||
129796610|NCT05523323|467223302|FG001|Overall Study|Death|21|||
129796611|NCT05523323|467223301|FG000|Overall Study|Ongoing participants|35|||
129796612|NCT05523323|467223302|FG001|Overall Study|Ongoing participants|30|||
129796613|NCT03435640|467223303|FG000|Overall Study|Withdrawal by Subject|0|||
129796614|NCT03435640|467223304|FG001|Overall Study|Withdrawal by Subject|1|||
129796615|NCT03435640|467223305|FG002|Overall Study|Withdrawal by Subject|0|||
129796616|NCT03435640|467223306|FG003|Overall Study|Withdrawal by Subject|2|||
129796617|NCT03435640|467223307|FG004|Overall Study|Withdrawal by Subject|0|||
129796618|NCT03435640|467223308|FG005|Overall Study|Withdrawal by Subject|0|||
129796619|NCT03435640|467223309|FG006|Overall Study|Withdrawal by Subject|3|||
129889264|NCT03220737|467552535|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129889265|NCT03220737|467552536|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
130047844|NCT00404768|468131628|FG003|Part C|Unsatisfactory uterine response to IP|1|||
130047845|NCT00404768|468131625|FG000|Part C|Active labor|0|||
130047846|NCT00404768|468131626|FG001|Part C|Active labor|0|||
129796620|NCT03435640|467223310|FG007|Overall Study|Withdrawal by Subject|0|||
129796621|NCT03435640|467223311|FG008|Overall Study|Withdrawal by Subject|0|||
129796622|NCT03435640|467223312|FG009|Overall Study|Withdrawal by Subject|2|||
129796623|NCT03435640|467223313|FG010|Overall Study|Withdrawal by Subject|3|||
129796624|NCT03435640|467223303|FG000|Overall Study|Lost to Follow-up|0|||
129796625|NCT03435640|467223304|FG001|Overall Study|Lost to Follow-up|0|||
129796626|NCT03435640|467223305|FG002|Overall Study|Lost to Follow-up|1|||
130047847|NCT00404768|468131627|FG002|Part C|Active labor|0|||
130047848|NCT00404768|468131628|FG003|Part C|Active labor|1|||
129796627|NCT03435640|467223306|FG003|Overall Study|Lost to Follow-up|0|||
129796628|NCT03435640|467223307|FG004|Overall Study|Lost to Follow-up|0|||
129796629|NCT03435640|467223308|FG005|Overall Study|Lost to Follow-up|0|||
129796630|NCT03435640|467223309|FG006|Overall Study|Lost to Follow-up|0|||
130047849|NCT00404768|468131625|FG000|Part C|Lack of Efficacy|0|||
129796631|NCT03435640|467223310|FG007|Overall Study|Lost to Follow-up|0|||
129796632|NCT03435640|467223311|FG008|Overall Study|Lost to Follow-up|0|||
129796633|NCT03435640|467223312|FG009|Overall Study|Lost to Follow-up|0|||
129796634|NCT03435640|467223313|FG010|Overall Study|Lost to Follow-up|0|||
129796635|NCT01347307|467223316|FG000|Overall Study|Death|0|||
129796636|NCT01347307|467223317|FG001|Overall Study|Death|4|||
129796637|NCT01347307|467223316|FG000|Overall Study|Physician Decision|0|||
129796638|NCT01347307|467223317|FG001|Overall Study|Physician Decision|1|||
129796639|NCT00920829|467223325|FG000|Allocation|No post randomization data|3|||
129796640|NCT00920829|467223326|FG001|Allocation|No post randomization data|1|||
129796641|NCT00920829|467223327|FG002|Allocation|No post randomization data|0|||
129796642|NCT00920829|467223328|FG003|Allocation|No post randomization data|2|||
129796643|NCT00920829|467223325|FG000|Available for Analysis|Withdrawal by Subject|6|||
129796644|NCT00920829|467223326|FG001|Available for Analysis|Withdrawal by Subject|6|||
129796645|NCT00920829|467223327|FG002|Available for Analysis|Withdrawal by Subject|6|||
129796646|NCT00920829|467223328|FG003|Available for Analysis|Withdrawal by Subject|10|||
129796647|NCT00920829|467223325|FG000|Available for Analysis|Required Medical Treatment|0|||
129796648|NCT00920829|467223326|FG001|Available for Analysis|Required Medical Treatment|1|||
129796649|NCT00920829|467223327|FG002|Available for Analysis|Required Medical Treatment|2|||
129796650|NCT00920829|467223328|FG003|Available for Analysis|Required Medical Treatment|0|||
129796651|NCT00920829|467223325|FG000|Available for Analysis|Adverse Event|1|||
129796652|NCT00920829|467223326|FG001|Available for Analysis|Adverse Event|2|||
129796653|NCT00920829|467223327|FG002|Available for Analysis|Adverse Event|1|||
129796654|NCT00920829|467223328|FG003|Available for Analysis|Adverse Event|0|||
129796655|NCT00920829|467223325|FG000|Available for Analysis|Death|1|||
129796656|NCT00920829|467223326|FG001|Available for Analysis|Death|0|||
129796657|NCT00920829|467223327|FG002|Available for Analysis|Death|0|||
129796658|NCT00920829|467223328|FG003|Available for Analysis|Death|0|||
129796659|NCT00920829|467223325|FG000|Available for Analysis|Protocol Violation|0|||
129796660|NCT00920829|467223326|FG001|Available for Analysis|Protocol Violation|0|||
129796661|NCT00920829|467223327|FG002|Available for Analysis|Protocol Violation|1|||
129796662|NCT00920829|467223328|FG003|Available for Analysis|Protocol Violation|0|||
129796663|NCT00920829|467223325|FG000|Available for Analysis|Required more treatment|0|||
129796664|NCT00920829|467223326|FG001|Available for Analysis|Required more treatment|2|||
129796665|NCT00920829|467223327|FG002|Available for Analysis|Required more treatment|0|||
129796666|NCT00920829|467223328|FG003|Available for Analysis|Required more treatment|1|||
129796667|NCT04533880|467223329|FG000|Overall Study|Lost to Follow-up|0|||
129796668|NCT04533880|467223330|FG001|Overall Study|Lost to Follow-up|1|||
129796669|NCT04533880|467223331|FG002|Overall Study|Lost to Follow-up|1|||
129796670|NCT01711879|467223336|FG000|Overall Study|Death|1|||
129796671|NCT01711879|467223337|FG001|Overall Study|Death|0|||
129796672|NCT02239224|467223340|FG000|Overall Study|Administrative|0|||
129796673|NCT02239224|467223341|FG001|Overall Study|Administrative|0|||
129796674|NCT02239224|467223342|FG002|Overall Study|Administrative|3|||
129796675|NCT02239224|467223343|FG003|Overall Study|Administrative|1|||
129796676|NCT03183778|467223346|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
129796677|NCT00721123|467223348|FG000|Overall Study|Adverse Event|96|||
129796678|NCT00721123|467223348|FG000|Overall Study|Death|10|||
129796679|NCT00721123|467223348|FG000|Overall Study|Insufficient Therapeutic Response|21|||
129796680|NCT00721123|467223348|FG000|Overall Study|Protocol Violation|1|||
129796681|NCT00721123|467223348|FG000|Overall Study|Refused Treatment|41|||
129796682|NCT00721123|467223348|FG000|Overall Study|Failure to Return|9|||
129796683|NCT00721123|467223348|FG000|Overall Study|Withdrawal by Subject|5|||
129796684|NCT03954041|467223357|FG000|Overall Study|Lost to Follow-up|3|||
129796685|NCT03954041|467223358|FG001|Overall Study|Lost to Follow-up|3|||
129796686|NCT03954041|467223359|FG002|Overall Study|Lost to Follow-up|6|||
130047850|NCT00404768|468131626|FG001|Part C|Lack of Efficacy|0|||
130047851|NCT00404768|468131627|FG002|Part C|Lack of Efficacy|0|||
130047852|NCT00404768|468131628|FG003|Part C|Lack of Efficacy|2|||
130047853|NCT00404768|468131625|FG000|Part C|Treatment failure|0|||
130047854|NCT00404768|468131626|FG001|Part C|Treatment failure|0|||
129796687|NCT03954041|467223357|FG000|Overall Study|Death|4|||
130047855|NCT00404768|468131627|FG002|Part C|Treatment failure|0|||
130047856|NCT00404768|468131628|FG003|Part C|Treatment failure|1|||
129796688|NCT03954041|467223358|FG001|Overall Study|Death|0|||
129796689|NCT03954041|467223359|FG002|Overall Study|Death|1|||
130047857|NCT00404768|468131625|FG000|Part C|Investigator discretion|0|||
129796690|NCT03954041|467223357|FG000|Overall Study|Death by neurologic criteria|0|||
129796691|NCT03954041|467223358|FG001|Overall Study|Death by neurologic criteria|0|||
129796692|NCT03954041|467223359|FG002|Overall Study|Death by neurologic criteria|1|||
129796693|NCT03954041|467223357|FG000|Overall Study|Reason not specified|7|||
129796694|NCT03954041|467223358|FG001|Overall Study|Reason not specified|4|||
129796695|NCT03954041|467223359|FG002|Overall Study|Reason not specified|2|||
129796696|NCT03954041|467223357|FG000|Overall Study|Withdrew prior to dosing|4|||
129796697|NCT03954041|467223358|FG001|Overall Study|Withdrew prior to dosing|2|||
129796698|NCT03954041|467223359|FG002|Overall Study|Withdrew prior to dosing|0|||
130047858|NCT00404768|468131626|FG001|Part C|Investigator discretion|0|||
130047859|NCT00404768|468131627|FG002|Part C|Investigator discretion|0|||
130303239|NCT01368081|469073473|FG002|Overall Study|Protocol Violation|0|||
130303240|NCT01368081|469073474|FG003|Overall Study|Protocol Violation|0|||
130303241|NCT01368081|469073475|FG004|Overall Study|Protocol Violation|0|||
130303242|NCT01368081|469073476|FG005|Overall Study|Protocol Violation|1|||
130303243|NCT01368081|469073477|FG006|Overall Study|Protocol Violation|0|||
130303244|NCT01368081|469073478|FG007|Overall Study|Protocol Violation|1|||
130303245|NCT01368081|469073479|FG008|Overall Study|Protocol Violation|0|||
130303246|NCT01368081|469073480|FG009|Overall Study|Protocol Violation|0|||
130303247|NCT01368081|469073481|FG010|Overall Study|Protocol Violation|0|||
130303248|NCT01368081|469073482|FG011|Overall Study|Protocol Violation|0|||
130303249|NCT01368081|469073483|FG012|Overall Study|Protocol Violation|0|||
130303250|NCT01368081|469073471|FG000|Overall Study|Lost to Follow-up|0|||
130303251|NCT01368081|469073472|FG001|Overall Study|Lost to Follow-up|0|||
130303252|NCT01368081|469073473|FG002|Overall Study|Lost to Follow-up|0|||
130303253|NCT01368081|469073474|FG003|Overall Study|Lost to Follow-up|0|||
130303254|NCT01368081|469073475|FG004|Overall Study|Lost to Follow-up|0|||
130303255|NCT01368081|469073476|FG005|Overall Study|Lost to Follow-up|0|||
130303256|NCT01368081|469073477|FG006|Overall Study|Lost to Follow-up|0|||
130303257|NCT01368081|469073478|FG007|Overall Study|Lost to Follow-up|0|||
130303258|NCT01368081|469073479|FG008|Overall Study|Lost to Follow-up|0|||
130303259|NCT01368081|469073480|FG009|Overall Study|Lost to Follow-up|0|||
130303260|NCT01368081|469073481|FG010|Overall Study|Lost to Follow-up|0|||
130303261|NCT01368081|469073482|FG011|Overall Study|Lost to Follow-up|0|||
130303262|NCT01368081|469073483|FG012|Overall Study|Lost to Follow-up|1|||
130303263|NCT01368081|469073471|FG000|Overall Study|Withdrawal by Subject|4|||
130303264|NCT01368081|469073472|FG001|Overall Study|Withdrawal by Subject|4|||
130303265|NCT01368081|469073473|FG002|Overall Study|Withdrawal by Subject|1|||
130303266|NCT01368081|469073474|FG003|Overall Study|Withdrawal by Subject|1|||
130303267|NCT01368081|469073475|FG004|Overall Study|Withdrawal by Subject|0|||
130303268|NCT01368081|469073476|FG005|Overall Study|Withdrawal by Subject|3|||
130303269|NCT01368081|469073477|FG006|Overall Study|Withdrawal by Subject|4|||
130303270|NCT01368081|469073478|FG007|Overall Study|Withdrawal by Subject|2|||
130303271|NCT01368081|469073479|FG008|Overall Study|Withdrawal by Subject|5|||
130303272|NCT01368081|469073480|FG009|Overall Study|Withdrawal by Subject|4|||
129796699|NCT03868124|467223360|FG000|Overall Study|Withdrawal by Subject|4|||
130303273|NCT01368081|469073481|FG010|Overall Study|Withdrawal by Subject|3|||
130303274|NCT01368081|469073482|FG011|Overall Study|Withdrawal by Subject|2|||
129796700|NCT03868124|467223361|FG001|Overall Study|Withdrawal by Subject|0|||
129796701|NCT03868124|467223362|FG002|Overall Study|Withdrawal by Subject|1|||
129796702|NCT03868124|467223360|FG000|Overall Study|Physician Decision|1|||
129796703|NCT03868124|467223361|FG001|Overall Study|Physician Decision|0|||
129796704|NCT03868124|467223362|FG002|Overall Study|Physician Decision|1|||
129796705|NCT03868124|467223360|FG000|Overall Study|Lost to Follow-up|1|||
129796706|NCT03868124|467223361|FG001|Overall Study|Lost to Follow-up|1|||
129796707|NCT03868124|467223362|FG002|Overall Study|Lost to Follow-up|2|||
129796708|NCT03868124|467223360|FG000|Overall Study|Death|1|||
129796709|NCT03868124|467223361|FG001|Overall Study|Death|1|||
129796710|NCT03868124|467223362|FG002|Overall Study|Death|2|||
129796711|NCT03868124|467223360|FG000|Overall Study|Adverse Event|0|||
129796712|NCT03868124|467223361|FG001|Overall Study|Adverse Event|0|||
129796713|NCT03868124|467223362|FG002|Overall Study|Adverse Event|3|||
129796714|NCT03868124|467223360|FG000|Overall Study|Explanted|2|||
129796715|NCT03868124|467223361|FG001|Overall Study|Explanted|1|||
129796716|NCT03868124|467223362|FG002|Overall Study|Explanted|0|||
129796717|NCT03868124|467223360|FG000|Overall Study|Ongoing in study|176|||
129796718|NCT03868124|467223361|FG001|Overall Study|Ongoing in study|180|||
129796719|NCT03868124|467223362|FG002|Overall Study|Ongoing in study|183|||
129796720|NCT04177355|467223363|FG000|Overall Study|Lost to Follow-up|0|||
129796721|NCT04177355|467223364|FG001|Overall Study|Lost to Follow-up|2|||
129796722|NCT04177355|467223365|FG002|Overall Study|Lost to Follow-up|0|||
129796723|NCT04177355|467223366|FG003|Overall Study|Lost to Follow-up|1|||
129796724|NCT04177355|467223367|FG004|Overall Study|Lost to Follow-up|2|||
129796725|NCT04177355|467223368|FG005|Overall Study|Lost to Follow-up|0|||
130303275|NCT01368081|469073483|FG012|Overall Study|Withdrawal by Subject|0|||
130303276|NCT01368081|469073471|FG000|Overall Study|Other reason not defined above|2|||
130303277|NCT01368081|469073472|FG001|Overall Study|Other reason not defined above|0|||
130303278|NCT01368081|469073473|FG002|Overall Study|Other reason not defined above|0|||
130303279|NCT01368081|469073474|FG003|Overall Study|Other reason not defined above|1|||
130303280|NCT01368081|469073475|FG004|Overall Study|Other reason not defined above|0|||
130303281|NCT01368081|469073476|FG005|Overall Study|Other reason not defined above|1|||
130303282|NCT01368081|469073477|FG006|Overall Study|Other reason not defined above|2|||
130303283|NCT01368081|469073478|FG007|Overall Study|Other reason not defined above|0|||
130303284|NCT01368081|469073479|FG008|Overall Study|Other reason not defined above|0|||
130303285|NCT01368081|469073480|FG009|Overall Study|Other reason not defined above|1|||
130303286|NCT01368081|469073481|FG010|Overall Study|Other reason not defined above|0|||
130303287|NCT01368081|469073482|FG011|Overall Study|Other reason not defined above|0|||
130303288|NCT01368081|469073483|FG012|Overall Study|Other reason not defined above|3|||
130303289|NCT03755661|469073486|FG000|Overall Study|Lost to Follow-up|1|||
130303290|NCT03755661|469073487|FG001|Overall Study|Lost to Follow-up|0|||
130303291|NCT02277119|469073488|FG000|Overall Study|Lack of Efficacy|1|||
130303292|NCT02277119|469073489|FG001|Overall Study|Lack of Efficacy|1|||
130303293|NCT02277119|469073490|FG002|Overall Study|Lack of Efficacy|1|||
129796726|NCT04177355|467223369|FG006|Overall Study|Lost to Follow-up|1|||
129796727|NCT04177355|467223370|FG007|Overall Study|Lost to Follow-up|0|||
129796728|NCT04177355|467223371|FG008|Overall Study|Lost to Follow-up|0|||
129796729|NCT04177355|467223372|FG009|Overall Study|Lost to Follow-up|0|||
129796730|NCT04177355|467223373|FG010|Overall Study|Lost to Follow-up|0|||
129796731|NCT04177355|467223363|FG000|Overall Study|Withdrawal by Subject|0|||
129796732|NCT04177355|467223364|FG001|Overall Study|Withdrawal by Subject|0|||
130303294|NCT02277119|469073488|FG000|Overall Study|Protocol Violation|2|||
130303295|NCT02277119|469073489|FG001|Overall Study|Protocol Violation|3|||
130303296|NCT02277119|469073490|FG002|Overall Study|Protocol Violation|7|||
130303297|NCT04699461|469073491|FG000|Overall Study|Withdrawal by Subject|1|||
130303298|NCT04699461|469073492|FG001|Overall Study|Withdrawal by Subject|0|||
130303299|NCT04699461|469073491|FG000|Overall Study|Study termination by sponsor|2|||
129796733|NCT04177355|467223365|FG002|Overall Study|Withdrawal by Subject|0|||
129796734|NCT04177355|467223366|FG003|Overall Study|Withdrawal by Subject|1|||
129796735|NCT04177355|467223367|FG004|Overall Study|Withdrawal by Subject|1|||
129796736|NCT04177355|467223368|FG005|Overall Study|Withdrawal by Subject|0|||
129796737|NCT04177355|467223369|FG006|Overall Study|Withdrawal by Subject|0|||
129796738|NCT04177355|467223370|FG007|Overall Study|Withdrawal by Subject|0|||
129796739|NCT04177355|467223371|FG008|Overall Study|Withdrawal by Subject|1|||
129796740|NCT04177355|467223372|FG009|Overall Study|Withdrawal by Subject|0|||
129796741|NCT04177355|467223373|FG010|Overall Study|Withdrawal by Subject|0|||
129796742|NCT00433511|467223374|FG000|Step 1|Adverse Event|50|||
129796743|NCT00433511|467223375|FG001|Step 1|Adverse Event|157|||
129796744|NCT00433511|467223376|FG002|Step 1|Adverse Event|153|||
129796745|NCT00433511|467223374|FG000|Step 1|Withdrawal by Subject|45|||
129796746|NCT00433511|467223375|FG001|Step 1|Withdrawal by Subject|143|||
129796747|NCT00433511|467223376|FG002|Step 1|Withdrawal by Subject|154|||
129796748|NCT00433511|467223374|FG000|Step 1|Death|3|||
129796749|NCT00433511|467223375|FG001|Step 1|Death|1|||
129796750|NCT00433511|467223376|FG002|Step 1|Death|1|||
129796751|NCT00433511|467223374|FG000|Step 1|Physician Decision|1|||
129796752|NCT00433511|467223375|FG001|Step 1|Physician Decision|4|||
129796753|NCT00433511|467223376|FG002|Step 1|Physician Decision|3|||
130303300|NCT04699461|469073492|FG001|Overall Study|Study termination by sponsor|1|||
129796754|NCT00433511|467223374|FG000|Step 1|Never started protocol therapy|28|||
129796755|NCT00433511|467223375|FG001|Step 1|Never started protocol therapy|64|||
129796756|NCT00433511|467223376|FG002|Step 1|Never started protocol therapy|66|||
129796757|NCT00433511|467223374|FG000|Step 1|Alternative therapy|2|||
129796758|NCT00433511|467223375|FG001|Step 1|Alternative therapy|1|||
129796759|NCT00433511|467223376|FG002|Step 1|Alternative therapy|3|||
129796760|NCT00433511|467223374|FG000|Step 1|Disease progression, relapse|5|||
129796761|NCT00433511|467223375|FG001|Step 1|Disease progression, relapse|3|||
129796762|NCT00433511|467223376|FG002|Step 1|Disease progression, relapse|3|||
129796763|NCT00433511|467223374|FG000|Step 1|Other complicating disease|2|||
129796764|NCT00433511|467223375|FG001|Step 1|Other complicating disease|6|||
129796765|NCT00433511|467223376|FG002|Step 1|Other complicating disease|3|||
129796766|NCT00433511|467223374|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
129796767|NCT00433511|467223375|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
129796768|NCT00433511|467223376|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
129796769|NCT00433511|467223374|FG000|Step 1|Suspected recurrence|0|||
129796770|NCT00433511|467223375|FG001|Step 1|Suspected recurrence|1|||
129796771|NCT00433511|467223376|FG002|Step 1|Suspected recurrence|0|||
129796772|NCT00433511|467223374|FG000|Step 1|Insurance/drug distribution issues|0|||
129796773|NCT00433511|467223375|FG001|Step 1|Insurance/drug distribution issues|1|||
129796774|NCT00433511|467223376|FG002|Step 1|Insurance/drug distribution issues|2|||
129796775|NCT00433511|467223374|FG000|Step 1|Patient moved|0|||
129796776|NCT00433511|467223375|FG001|Step 1|Patient moved|0|||
129796777|NCT00433511|467223376|FG002|Step 1|Patient moved|1|||
129796778|NCT00433511|467223374|FG000|Step 2 (Arm D)|Adverse Event|0|||
130047860|NCT00404768|468131628|FG003|Part C|Investigator discretion|1|||
130303301|NCT04699461|469073491|FG000|Overall Study|Death|1|||
129796779|NCT00433511|467223375|FG001|Step 2 (Arm D)|Adverse Event|0|||
129796780|NCT00433511|467223376|FG002|Step 2 (Arm D)|Adverse Event|135|||
129796781|NCT00433511|467223374|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
129796782|NCT00433511|467223375|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
129796783|NCT00433511|467223376|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
129796784|NCT00433511|467223374|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
129796785|NCT00433511|467223375|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
129796786|NCT00433511|467223376|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
129796787|NCT00433511|467223374|FG000|Step 2 (Arm D)|Physician Decision|0|||
129796788|NCT00433511|467223375|FG001|Step 2 (Arm D)|Physician Decision|0|||
129796789|NCT00433511|467223376|FG002|Step 2 (Arm D)|Physician Decision|9|||
129796790|NCT00433511|467223374|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
129796791|NCT00433511|467223375|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
129796792|NCT00433511|467223376|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
129796793|NCT00433511|467223374|FG000|Step 2 (Arm D)|Other complicating disease|0|||
129796794|NCT00433511|467223375|FG001|Step 2 (Arm D)|Other complicating disease|0|||
129796795|NCT00433511|467223376|FG002|Step 2 (Arm D)|Other complicating disease|3|||
129796796|NCT00433511|467223374|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
129796797|NCT00433511|467223375|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
129796798|NCT00433511|467223376|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
129796799|NCT00433511|467223374|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
129796800|NCT00433511|467223375|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
129796801|NCT00433511|467223376|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
129796802|NCT00433511|467223374|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
129796803|NCT00433511|467223375|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
129796804|NCT00433511|467223376|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
130047861|NCT00404768|468131625|FG000|Part C|Researcher suspended study medication|0|||
129796805|NCT00433511|467223374|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
129796806|NCT00433511|467223375|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
129796807|NCT00433511|467223376|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
129796808|NCT02806973|467223378|FG000|Period 1|Withdrawal by Subject|0|||
129796809|NCT02806973|467223379|FG001|Period 1|Withdrawal by Subject|2|||
129796810|NCT02806973|467223380|FG002|Period 1|Withdrawal by Subject|1|||
130303302|NCT04699461|469073492|FG001|Overall Study|Death|0|||
130303303|NCT04699461|469073491|FG000|Overall Study|Radiographic progression|0|||
129796811|NCT02806973|467223381|FG003|Period 1|Withdrawal by Subject|1|||
129796812|NCT02806973|467223378|FG000|Period 1|Adverse Event|0|||
129796813|NCT02806973|467223379|FG001|Period 1|Adverse Event|0|||
129796814|NCT02806973|467223380|FG002|Period 1|Adverse Event|0|||
129796815|NCT02806973|467223381|FG003|Period 1|Adverse Event|1|||
129796816|NCT02806973|467223378|FG000|Period 3|Withdrawal by Subject|0|||
129796817|NCT02806973|467223379|FG001|Period 3|Withdrawal by Subject|0|||
129796818|NCT02806973|467223380|FG002|Period 3|Withdrawal by Subject|0|||
129796819|NCT02806973|467223381|FG003|Period 3|Withdrawal by Subject|3|||
130047862|NCT00404768|468131626|FG001|Part C|Researcher suspended study medication|0|||
130303304|NCT04699461|469073492|FG001|Overall Study|Radiographic progression|1|||
129796820|NCT02806973|467223378|FG000|Period 3|Adverse Event|0|||
129796821|NCT02806973|467223379|FG001|Period 3|Adverse Event|0|||
129796822|NCT02806973|467223380|FG002|Period 3|Adverse Event|1|||
129796823|NCT02806973|467223381|FG003|Period 3|Adverse Event|0|||
129796824|NCT04209426|467223387|FG000|Overall Study|Lost to Follow-up|3|||
129796825|NCT04209426|467223388|FG001|Overall Study|Lost to Follow-up|2|||
130303305|NCT03068767|469073493|FG000|Overall Study|Lost to Follow-up|7|||
130303306|NCT03068767|469073494|FG001|Overall Study|Lost to Follow-up|3|||
130303307|NCT03068767|469073493|FG000|Overall Study|Protocol Violation|3|||
130303308|NCT03068767|469073494|FG001|Overall Study|Protocol Violation|0|||
130303309|NCT04167137|469073497|FG000|Overall Study|Disease progression|1|||
130303310|NCT04167137|469073498|FG001|Overall Study|Disease progression|1|||
130303311|NCT04167137|469073499|FG002|Overall Study|Disease progression|3|||
130303312|NCT04167137|469073500|FG003|Overall Study|Disease progression|3|||
130303313|NCT04167137|469073501|FG004|Overall Study|Disease progression|2|||
130303314|NCT04167137|469073502|FG005|Overall Study|Disease progression|3|||
130303315|NCT04167137|469073503|FG006|Overall Study|Disease progression|2|||
130303316|NCT04167137|469073504|FG007|Overall Study|Disease progression|2|||
130303317|NCT04167137|469073497|FG000|Overall Study|Withdrawal by Subject|1|||
130303318|NCT04167137|469073498|FG001|Overall Study|Withdrawal by Subject|0|||
130303319|NCT04167137|469073499|FG002|Overall Study|Withdrawal by Subject|0|||
130303320|NCT04167137|469073500|FG003|Overall Study|Withdrawal by Subject|1|||
130303321|NCT04167137|469073501|FG004|Overall Study|Withdrawal by Subject|0|||
130303322|NCT04167137|469073502|FG005|Overall Study|Withdrawal by Subject|2|||
130303323|NCT04167137|469073503|FG006|Overall Study|Withdrawal by Subject|1|||
130303324|NCT04167137|469073504|FG007|Overall Study|Withdrawal by Subject|0|||
130303325|NCT04167137|469073497|FG000|Overall Study|Adverse Event|0|||
130303326|NCT04167137|469073498|FG001|Overall Study|Adverse Event|0|||
130303327|NCT04167137|469073499|FG002|Overall Study|Adverse Event|0|||
130303328|NCT04167137|469073500|FG003|Overall Study|Adverse Event|0|||
130303329|NCT04167137|469073501|FG004|Overall Study|Adverse Event|0|||
130303330|NCT04167137|469073502|FG005|Overall Study|Adverse Event|1|||
130303331|NCT04167137|469073503|FG006|Overall Study|Adverse Event|0|||
130303332|NCT04167137|469073504|FG007|Overall Study|Adverse Event|1|||
130303333|NCT04167137|469073497|FG000|Overall Study|Physician Decision|0|||
130303334|NCT04167137|469073498|FG001|Overall Study|Physician Decision|0|||
130303335|NCT04167137|469073499|FG002|Overall Study|Physician Decision|0|||
130303336|NCT04167137|469073500|FG003|Overall Study|Physician Decision|1|||
130303337|NCT04167137|469073501|FG004|Overall Study|Physician Decision|0|||
130303338|NCT04167137|469073502|FG005|Overall Study|Physician Decision|0|||
130303339|NCT04167137|469073503|FG006|Overall Study|Physician Decision|1|||
130303340|NCT04167137|469073504|FG007|Overall Study|Physician Decision|0|||
130303341|NCT04167137|469073497|FG000|Overall Study|Death|0|||
130303342|NCT04167137|469073498|FG001|Overall Study|Death|1|||
130303343|NCT04167137|469073499|FG002|Overall Study|Death|0|||
130303344|NCT04167137|469073500|FG003|Overall Study|Death|0|||
130303345|NCT04167137|469073501|FG004|Overall Study|Death|0|||
130303346|NCT04167137|469073502|FG005|Overall Study|Death|0|||
130303347|NCT04167137|469073503|FG006|Overall Study|Death|0|||
130303348|NCT04167137|469073504|FG007|Overall Study|Death|0|||
130303349|NCT04167137|469073497|FG000|Overall Study|Study terminated by Sponsor|0|||
130303350|NCT04167137|469073498|FG001|Overall Study|Study terminated by Sponsor|0|||
130303351|NCT04167137|469073499|FG002|Overall Study|Study terminated by Sponsor|0|||
130303352|NCT04167137|469073500|FG003|Overall Study|Study terminated by Sponsor|0|||
130303353|NCT04167137|469073501|FG004|Overall Study|Study terminated by Sponsor|0|||
130303354|NCT04167137|469073502|FG005|Overall Study|Study terminated by Sponsor|0|||
130303355|NCT04167137|469073503|FG006|Overall Study|Study terminated by Sponsor|0|||
130303356|NCT04167137|469073504|FG007|Overall Study|Study terminated by Sponsor|1|||
130303357|NCT01748825|469073507|FG000|Dose Escalation|Refused further treatment|2|||
130303358|NCT01748825|469073508|FG001|Dose Escalation|Refused further treatment|2|||
130303359|NCT01748825|469073509|FG002|Dose Escalation|Refused further treatment|0|||
130303360|NCT01748825|469073510|FG003|Dose Escalation|Refused further treatment|0|||
130303361|NCT01748825|469073511|FG004|Dose Escalation|Refused further treatment|1|||
130303362|NCT01748825|469073512|FG005|Dose Escalation|Refused further treatment|2|||
130303363|NCT01748825|469073513|FG006|Dose Escalation|Refused further treatment|0|||
129796826|NCT03355664|467223394|FG000|Overall Study|Adverse Event|1|||
130303364|NCT01748825|469073514|FG007|Dose Escalation|Refused further treatment|0|||
130303365|NCT01748825|469073515|FG008|Dose Escalation|Refused further treatment|0|||
130303366|NCT01748825|469073516|FG009|Dose Escalation|Refused further treatment|0|||
130303367|NCT01748825|469073507|FG000|Dose Escalation|Switched to alternative treatment|0|||
130303368|NCT01748825|469073508|FG001|Dose Escalation|Switched to alternative treatment|0|||
130303369|NCT01748825|469073509|FG002|Dose Escalation|Switched to alternative treatment|0|||
130303370|NCT01748825|469073510|FG003|Dose Escalation|Switched to alternative treatment|1|||
130303371|NCT01748825|469073511|FG004|Dose Escalation|Switched to alternative treatment|0|||
130303372|NCT01748825|469073512|FG005|Dose Escalation|Switched to alternative treatment|0|||
130303373|NCT01748825|469073513|FG006|Dose Escalation|Switched to alternative treatment|0|||
130303374|NCT01748825|469073514|FG007|Dose Escalation|Switched to alternative treatment|0|||
130303375|NCT01748825|469073515|FG008|Dose Escalation|Switched to alternative treatment|0|||
130303376|NCT01748825|469073516|FG009|Dose Escalation|Switched to alternative treatment|0|||
130303377|NCT01748825|469073507|FG000|Dose Escalation|Adverse Event|0|||
130303378|NCT01748825|469073508|FG001|Dose Escalation|Adverse Event|0|||
129796827|NCT03355664|467223395|FG001|Overall Study|Adverse Event|2|||
129796828|NCT03355664|467223394|FG000|Overall Study|Lost to Follow-up|11|||
129796829|NCT03355664|467223395|FG001|Overall Study|Lost to Follow-up|7|||
129796830|NCT03355664|467223394|FG000|Overall Study|Protocol Violation|1|||
129796831|NCT03355664|467223395|FG001|Overall Study|Protocol Violation|2|||
129796832|NCT03355664|467223394|FG000|Overall Study|Withdrawal by Subject|2|||
129796833|NCT03355664|467223395|FG001|Overall Study|Withdrawal by Subject|1|||
129796834|NCT01751802|467223398|FG000|Overall Study|Adverse Event|4|||
129796835|NCT01751802|467223399|FG001|Overall Study|Adverse Event|2|||
129796836|NCT01484938|467223400|FG000|Overall Study|Adverse Event|2|||
130303379|NCT01748825|469073509|FG002|Dose Escalation|Adverse Event|0|||
130303380|NCT01748825|469073510|FG003|Dose Escalation|Adverse Event|0|||
130303381|NCT01748825|469073511|FG004|Dose Escalation|Adverse Event|0|||
130303382|NCT01748825|469073512|FG005|Dose Escalation|Adverse Event|0|||
130303383|NCT01748825|469073513|FG006|Dose Escalation|Adverse Event|1|||
129796837|NCT01484938|467223400|FG000|Overall Study|Lost to Follow-up|1|||
129796838|NCT01484938|467223400|FG000|Overall Study|Noncompliance|1|||
129796839|NCT01858636|467223401|FG000|Overall Study|No Device Deployment Attempted|24|||
130303384|NCT01748825|469073514|FG007|Dose Escalation|Adverse Event|0|||
130303385|NCT01748825|469073515|FG008|Dose Escalation|Adverse Event|0|||
130303386|NCT01748825|469073516|FG009|Dose Escalation|Adverse Event|0|||
130303387|NCT01748825|469073507|FG000|Dose Expansion|Refused further treatment|0|||
130303388|NCT01748825|469073508|FG001|Dose Expansion|Refused further treatment|0|||
130303389|NCT01748825|469073509|FG002|Dose Expansion|Refused further treatment|0|||
130303390|NCT01748825|469073510|FG003|Dose Expansion|Refused further treatment|0|||
130303391|NCT01748825|469073511|FG004|Dose Expansion|Refused further treatment|0|||
130303392|NCT01748825|469073512|FG005|Dose Expansion|Refused further treatment|0|||
130303393|NCT01748825|469073513|FG006|Dose Expansion|Refused further treatment|0|||
130303394|NCT01748825|469073514|FG007|Dose Expansion|Refused further treatment|0|||
130303395|NCT01748825|469073515|FG008|Dose Expansion|Refused further treatment|1|||
130303396|NCT01748825|469073516|FG009|Dose Expansion|Refused further treatment|1|||
130303397|NCT01748825|469073507|FG000|Dose Expansion|Switched to alternative treatment|0|||
130303398|NCT01748825|469073508|FG001|Dose Expansion|Switched to alternative treatment|0|||
130303399|NCT01748825|469073509|FG002|Dose Expansion|Switched to alternative treatment|0|||
130303400|NCT01748825|469073510|FG003|Dose Expansion|Switched to alternative treatment|0|||
130303401|NCT01748825|469073511|FG004|Dose Expansion|Switched to alternative treatment|0|||
130303402|NCT01748825|469073512|FG005|Dose Expansion|Switched to alternative treatment|0|||
130303403|NCT01748825|469073513|FG006|Dose Expansion|Switched to alternative treatment|0|||
129796840|NCT01858636|467223401|FG000|Overall Study|Physician Decision|1|||
129796841|NCT01858636|467223401|FG000|Overall Study|Death|1|||
129796842|NCT01858636|467223401|FG000|Overall Study|Lost to Follow-up|1|||
129796843|NCT01858636|467223401|FG000|Overall Study|Withdrawal by Subject|1|||
129796844|NCT01227564|467223409|FG000|Overall Study|No Longer Willing to Participate|4|||
129796845|NCT01227564|467223410|FG001|Overall Study|No Longer Willing to Participate|2|||
129796846|NCT01227564|467223411|FG002|Overall Study|No Longer Willing to Participate|5|||
129796847|NCT01227564|467223409|FG000|Overall Study|Participant moved to another town|0|||
129796848|NCT01227564|467223410|FG001|Overall Study|Participant moved to another town|0|||
129796849|NCT01227564|467223411|FG002|Overall Study|Participant moved to another town|1|||
129796850|NCT02862600|467223420|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
129796851|NCT02862600|467223420|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
129796852|NCT02862600|467223420|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
129796853|NCT02862600|467223420|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
129796854|NCT00772070|467223436|FG000|Overall Study|Lost to Follow-up|0|||
129796855|NCT00772070|467223437|FG001|Overall Study|Lost to Follow-up|8|||
129796856|NCT00772070|467223436|FG000|Overall Study|Withdrawal by Subject|0|||
129796857|NCT00772070|467223437|FG001|Overall Study|Withdrawal by Subject|2|||
129796858|NCT00772070|467223436|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
129796859|NCT00772070|467223437|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
129796860|NCT01309308|467223438|FG000|Overall Study|Lost to Follow-up|6|||
129796861|NCT01309308|467223439|FG001|Overall Study|Lost to Follow-up|4|||
129796862|NCT01017575|467223440|FG000|Overall Study|Lack of Efficacy|0|||
129796863|NCT01017575|467223441|FG001|Overall Study|Lack of Efficacy|1|||
129796864|NCT01017575|467223442|FG002|Overall Study|Lack of Efficacy|0|||
129796865|NCT01017575|467223443|FG003|Overall Study|Lack of Efficacy|1|||
129796866|NCT01017575|467223444|FG004|Overall Study|Lack of Efficacy|1|||
129796867|NCT01017575|467223440|FG000|Overall Study|Adverse Event|0|||
129796868|NCT01017575|467223441|FG001|Overall Study|Adverse Event|1|||
129796869|NCT01017575|467223442|FG002|Overall Study|Adverse Event|0|||
129796870|NCT01017575|467223443|FG003|Overall Study|Adverse Event|0|||
130047863|NCT00404768|468131627|FG002|Part C|Researcher suspended study medication|0|||
130047864|NCT00404768|468131628|FG003|Part C|Researcher suspended study medication|1|||
130303404|NCT01748825|469073514|FG007|Dose Expansion|Switched to alternative treatment|0|||
130303405|NCT01748825|469073515|FG008|Dose Expansion|Switched to alternative treatment|0|||
130303406|NCT01748825|469073516|FG009|Dose Expansion|Switched to alternative treatment|1|||
130303407|NCT01748825|469073507|FG000|Dose Expansion|Adverse Event|0|||
130303408|NCT01748825|469073508|FG001|Dose Expansion|Adverse Event|0|||
130303409|NCT01748825|469073509|FG002|Dose Expansion|Adverse Event|0|||
130303410|NCT01748825|469073510|FG003|Dose Expansion|Adverse Event|0|||
130303411|NCT01748825|469073511|FG004|Dose Expansion|Adverse Event|0|||
130303412|NCT01748825|469073512|FG005|Dose Expansion|Adverse Event|0|||
130303413|NCT01748825|469073513|FG006|Dose Expansion|Adverse Event|0|||
130303414|NCT01748825|469073514|FG007|Dose Expansion|Adverse Event|0|||
130303415|NCT01748825|469073515|FG008|Dose Expansion|Adverse Event|0|||
130303416|NCT01748825|469073516|FG009|Dose Expansion|Adverse Event|3|||
130303417|NCT01748825|469073507|FG000|Dose Expansion|Physician Decision|0|||
130303418|NCT01748825|469073508|FG001|Dose Expansion|Physician Decision|0|||
130303419|NCT01748825|469073509|FG002|Dose Expansion|Physician Decision|0|||
130303420|NCT01748825|469073510|FG003|Dose Expansion|Physician Decision|0|||
130303421|NCT01748825|469073511|FG004|Dose Expansion|Physician Decision|0|||
130303422|NCT01748825|469073512|FG005|Dose Expansion|Physician Decision|0|||
130303423|NCT01748825|469073513|FG006|Dose Expansion|Physician Decision|0|||
130303424|NCT01748825|469073514|FG007|Dose Expansion|Physician Decision|0|||
130303425|NCT01748825|469073515|FG008|Dose Expansion|Physician Decision|1|||
130303426|NCT01748825|469073516|FG009|Dose Expansion|Physician Decision|0|||
130303427|NCT04412707|469073520|FG000|Cycle 1|Death|0|||
130303428|NCT04412707|469073521|FG001|Cycle 1|Death|3|||
130303429|NCT04412707|469073520|FG000|Cycle 1|Disease progression|1|||
130303430|NCT04412707|469073521|FG001|Cycle 1|Disease progression|2|||
130303431|NCT04412707|469073520|FG000|Cycle 2|Death|0|||
130303432|NCT04412707|469073521|FG001|Cycle 2|Death|1|||
130303433|NCT04412707|469073520|FG000|Cycle 2|Disease progression|3|||
130303434|NCT04412707|469073521|FG001|Cycle 2|Disease progression|0|||
130303435|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
130303436|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
130303437|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
130303438|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
130303439|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
130303440|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
130303441|NCT04412707|469073520|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
130303442|NCT04412707|469073521|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
130303443|NCT01370265|469074853|FG000|First Intervention|Adverse Event|1|||
130303444|NCT01370265|469074854|FG001|First Intervention|Adverse Event|1|||
130303445|NCT01732770|469074856|FG000|Overall Study|Lost to Follow-up|2|||
130303446|NCT01732770|469074857|FG001|Overall Study|Lost to Follow-up|3|||
130303447|NCT01732770|469074856|FG000|Overall Study|Withdrawal by Subject|5|||
130303448|NCT01732770|469074857|FG001|Overall Study|Withdrawal by Subject|3|||
130303449|NCT01732770|469074856|FG000|Overall Study|Decision by Sponsor|2|||
130303450|NCT01732770|469074857|FG001|Overall Study|Decision by Sponsor|2|||
130303451|NCT01732770|469074856|FG000|Overall Study|Death|1|||
130303452|NCT01732770|469074857|FG001|Overall Study|Death|0|||
130303453|NCT00871338|469074860|FG000|Prior to Booster|Withdrawal by Subject|1|||
130303454|NCT00871338|469074861|FG001|Prior to Booster|Withdrawal by Subject|3|||
130303455|NCT00871338|469074860|FG000|Prior to Booster|Lost to Follow-up|1|||
130303456|NCT00871338|469074861|FG001|Prior to Booster|Lost to Follow-up|0|||
130303457|NCT02391363|469074862|FG000|Overall Study|Lost to Follow-up|5|||
130303458|NCT02391363|469074863|FG001|Overall Study|Lost to Follow-up|5|||
130303459|NCT02391363|469074862|FG000|Overall Study|Withdrawal by Subject|6|||
130303460|NCT02391363|469074863|FG001|Overall Study|Withdrawal by Subject|3|||
130303461|NCT04794270|469074864|FG000|Period 1|Non Compliance|1|||
130303462|NCT04794270|469074865|FG001|Period 1|Non Compliance|0|||
130303463|NCT04794270|469074864|FG000|Period 1|Adverse Event|1|||
130303464|NCT04794270|469074865|FG001|Period 1|Adverse Event|0|||
130303465|NCT04794270|469074864|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
130303466|NCT04794270|469074865|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
130303467|NCT00265317|469074868|FG000|Lead-In|Objective progression or relapse|6|||
130303468|NCT00265317|469074869|FG001|Lead-In|Objective progression or relapse|11|||
130303469|NCT00265317|469074870|FG002|Lead-In|Objective progression or relapse|0|||
130303470|NCT00265317|469074871|FG003|Lead-In|Objective progression or relapse|0|||
130303471|NCT00265317|469074868|FG000|Lead-In|Adverse Event|2|||
130303472|NCT00265317|469074869|FG001|Lead-In|Adverse Event|1|||
130303473|NCT00265317|469074870|FG002|Lead-In|Adverse Event|0|||
130303474|NCT00265317|469074871|FG003|Lead-In|Adverse Event|0|||
130303475|NCT00265317|469074868|FG000|Lead-In|Death|3|||
130303476|NCT00265317|469074869|FG001|Lead-In|Death|5|||
130303477|NCT00265317|469074870|FG002|Lead-In|Death|0|||
130303478|NCT00265317|469074871|FG003|Lead-In|Death|0|||
130303479|NCT00265317|469074868|FG000|Lead-In|Withdrawal/other than adverse event|1|||
130303480|NCT00265317|469074869|FG001|Lead-In|Withdrawal/other than adverse event|0|||
130303481|NCT00265317|469074870|FG002|Lead-In|Withdrawal/other than adverse event|0|||
130303482|NCT00265317|469074871|FG003|Lead-In|Withdrawal/other than adverse event|0|||
130303483|NCT00265317|469074868|FG000|Phase 2|Objective progression or relapse|0|||
130303484|NCT00265317|469074869|FG001|Phase 2|Objective progression or relapse|0|||
130303485|NCT00265317|469074870|FG002|Phase 2|Objective progression or relapse|37|||
130303486|NCT00265317|469074871|FG003|Phase 2|Objective progression or relapse|38|||
130303487|NCT00265317|469074868|FG000|Phase 2|Global deterioration of health status|0|||
130303488|NCT00265317|469074869|FG001|Phase 2|Global deterioration of health status|0|||
130303489|NCT00265317|469074870|FG002|Phase 2|Global deterioration of health status|3|||
130303490|NCT00265317|469074871|FG003|Phase 2|Global deterioration of health status|0|||
130303491|NCT00265317|469074868|FG000|Phase 2|Adverse Event|0|||
130303492|NCT00265317|469074869|FG001|Phase 2|Adverse Event|0|||
130303493|NCT00265317|469074870|FG002|Phase 2|Adverse Event|7|||
130303494|NCT00265317|469074871|FG003|Phase 2|Adverse Event|5|||
130303495|NCT00265317|469074868|FG000|Phase 2|Death|0|||
130303496|NCT00265317|469074869|FG001|Phase 2|Death|0|||
130303497|NCT00265317|469074870|FG002|Phase 2|Death|12|||
130303498|NCT00265317|469074871|FG003|Phase 2|Death|15|||
130303499|NCT00265317|469074868|FG000|Phase 2|Protocol Violation|0|||
130303500|NCT00265317|469074869|FG001|Phase 2|Protocol Violation|0|||
130303501|NCT00265317|469074870|FG002|Phase 2|Protocol Violation|1|||
130303502|NCT00265317|469074871|FG003|Phase 2|Protocol Violation|4|||
130303503|NCT00265317|469074868|FG000|Phase 2|Lost to Follow-up|0|||
130303504|NCT00265317|469074869|FG001|Phase 2|Lost to Follow-up|0|||
130303505|NCT00265317|469074870|FG002|Phase 2|Lost to Follow-up|0|||
129796871|NCT01017575|467223444|FG004|Overall Study|Adverse Event|2|||
130303506|NCT00265317|469074871|FG003|Phase 2|Lost to Follow-up|1|||
130303507|NCT00265317|469074868|FG000|Phase 2|Withdrawal/other than adverse event|0|||
130303508|NCT00265317|469074869|FG001|Phase 2|Withdrawal/other than adverse event|0|||
130303509|NCT00265317|469074870|FG002|Phase 2|Withdrawal/other than adverse event|2|||
130303510|NCT00265317|469074871|FG003|Phase 2|Withdrawal/other than adverse event|1|||
130303511|NCT00265317|469074868|FG000|Phase 2|Study terminated by sponsor|0|||
130047865|NCT03123939|468131629|FG000|Overall Study|Lack of Efficacy|6|||
129796872|NCT01017575|467223440|FG000|Overall Study|Withdrawal by Subject|1|||
129796873|NCT01017575|467223441|FG001|Overall Study|Withdrawal by Subject|0|||
129796874|NCT01017575|467223442|FG002|Overall Study|Withdrawal by Subject|0|||
129796875|NCT01017575|467223443|FG003|Overall Study|Withdrawal by Subject|0|||
129796876|NCT01017575|467223444|FG004|Overall Study|Withdrawal by Subject|0|||
129796877|NCT04271280|467223445|FG000|Overall Study|Lost to Follow-up|300|||
129796878|NCT04271280|467223445|FG000|Overall Study|Death|153|||
129796879|NCT04271280|467223445|FG000|Overall Study|Withdrawal of consent by patient|59|||
129796880|NCT04271280|467223445|FG000|Overall Study|Other|51|||
129796881|NCT04271280|467223445|FG000|Overall Study|No end of study information|42|||
129796882|NCT01857583|467223448|FG000|Overall Study|Adverse Event|0|||
129796883|NCT01857583|467223449|FG001|Overall Study|Adverse Event|0|||
129796884|NCT01857583|467223450|FG002|Overall Study|Adverse Event|1|||
129796885|NCT01857583|467223451|FG003|Overall Study|Adverse Event|1|||
129796886|NCT01857583|467223448|FG000|Overall Study|Death|0|||
129796887|NCT01857583|467223449|FG001|Overall Study|Death|1|||
129796888|NCT01857583|467223450|FG002|Overall Study|Death|1|||
129796889|NCT01857583|467223451|FG003|Overall Study|Death|0|||
129796890|NCT01857583|467223448|FG000|Overall Study|Physician Decision|0|||
129796891|NCT01857583|467223449|FG001|Overall Study|Physician Decision|0|||
129796892|NCT01857583|467223450|FG002|Overall Study|Physician Decision|0|||
129796893|NCT01857583|467223451|FG003|Overall Study|Physician Decision|1|||
129796894|NCT01857583|467223448|FG000|Overall Study|Withdrawal by Subject|1|||
129796895|NCT01857583|467223449|FG001|Overall Study|Withdrawal by Subject|0|||
129796896|NCT01857583|467223450|FG002|Overall Study|Withdrawal by Subject|1|||
129796897|NCT01857583|467223451|FG003|Overall Study|Withdrawal by Subject|2|||
129796898|NCT00458536|467223454|FG000|Overall Study|Disease progression prior to treatment|7|||
129796899|NCT00458536|467223454|FG000|Overall Study|Unable to make vaccine|3|||
129796900|NCT00458536|467223454|FG000|Overall Study|No measurable disease after surgery|2|||
129796901|NCT00458536|467223454|FG000|Overall Study|Did not have renal cell carcinoma|2|||
129796902|NCT00458536|467223454|FG000|Overall Study|Patient did not have surgery|1|||
129796903|NCT00458536|467223454|FG000|Overall Study|Ineligible due to toxicity|1|||
129796904|NCT00458536|467223454|FG000|Overall Study|Withdrawal by Subject|1|||
129796905|NCT00458536|467223454|FG000|Overall Study|Progressive disease during treatment|2|||
129796906|NCT03287635|467223457|FG000|Overall Study|Lost to Follow-up|5|||
129796907|NCT03287635|467223457|FG000|Overall Study|Withdrawal by Subject|1|||
130303512|NCT00265317|469074869|FG001|Phase 2|Study terminated by sponsor|0|||
130303513|NCT00265317|469074870|FG002|Phase 2|Study terminated by sponsor|1|||
130303514|NCT00265317|469074871|FG003|Phase 2|Study terminated by sponsor|0|||
130303515|NCT00265317|469074868|FG000|Phase 2|Other|0|||
130303516|NCT00265317|469074869|FG001|Phase 2|Other|0|||
130303517|NCT00265317|469074870|FG002|Phase 2|Other|1|||
130303518|NCT00265317|469074871|FG003|Phase 2|Other|1|||
130303519|NCT02510001|469074872|FG000|Overall Study|Early disease progression|0|||
129796908|NCT03287635|467223457|FG000|Overall Study|Physician Decision|1|||
129796909|NCT00323869|467223458|FG000|Overall Study|Death|1|||
129796910|NCT00206076|467225100|FG000|Overall Study|Physician Decision|2|||
130303520|NCT02510001|469074873|FG001|Overall Study|Early disease progression|0|||
130303521|NCT02510001|469074874|FG002|Overall Study|Early disease progression|0|||
130303522|NCT02510001|469074875|FG003|Overall Study|Early disease progression|1|||
130303523|NCT02510001|469074876|FG004|Overall Study|Early disease progression|1|||
130303524|NCT02510001|469074877|FG005|Overall Study|Early disease progression|1|||
130303525|NCT02510001|469074878|FG006|Overall Study|Early disease progression|0|||
130303526|NCT02510001|469074879|FG007|Overall Study|Early disease progression|0|||
130303527|NCT02510001|469074872|FG000|Overall Study|Adverse Event|0|||
129796911|NCT00206076|467225101|FG001|Overall Study|Physician Decision|0|||
129796912|NCT00206076|467225100|FG000|Overall Study|Withdrawal by Subject|1|||
130303528|NCT02510001|469074873|FG001|Overall Study|Adverse Event|0|||
129796913|NCT00206076|467225101|FG001|Overall Study|Withdrawal by Subject|1|||
129796914|NCT00750880|467225104|FG000|Overall Study|Adverse Event|76|||
129796915|NCT00750880|467225104|FG000|Overall Study|Death|4|||
129796916|NCT00750880|467225104|FG000|Overall Study|Lack of Efficacy|46|||
129796917|NCT00750880|467225104|FG000|Overall Study|Lost to Follow-up|10|||
130303529|NCT02510001|469074874|FG002|Overall Study|Adverse Event|0|||
129796918|NCT00750880|467225104|FG000|Overall Study|Protocol Violation|15|||
129796919|NCT00750880|467225104|FG000|Overall Study|Withdrawal by Subject|33|||
129796920|NCT00750880|467225104|FG000|Overall Study|Physician Decision|20|||
129796921|NCT00750880|467225104|FG000|Overall Study|Administrative|11|||
129796922|NCT02964507|467225110|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796923|NCT02964507|467225111|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
129796924|NCT02964507|467225112|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
130303530|NCT02510001|469074875|FG003|Overall Study|Adverse Event|1|||
130303531|NCT02510001|469074876|FG004|Overall Study|Adverse Event|2|||
130303532|NCT02510001|469074877|FG005|Overall Study|Adverse Event|1|||
129796925|NCT02964507|467225113|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
130303533|NCT02510001|469074878|FG006|Overall Study|Adverse Event|2|||
129796926|NCT02964507|467225114|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
130303534|NCT02510001|469074879|FG007|Overall Study|Adverse Event|5|||
129796927|NCT02964507|467225115|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796928|NCT02964507|467225116|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796929|NCT02964507|467225117|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796930|NCT02964507|467225110|FG000|Overall Study|Study terminated by Sponsor|9|||
129796931|NCT02964507|467225111|FG001|Overall Study|Study terminated by Sponsor|1|||
129796932|NCT02964507|467225112|FG002|Overall Study|Study terminated by Sponsor|9|||
129796933|NCT02964507|467225113|FG003|Overall Study|Study terminated by Sponsor|3|||
129796934|NCT02964507|467225114|FG004|Overall Study|Study terminated by Sponsor|3|||
129796935|NCT02964507|467225115|FG005|Overall Study|Study terminated by Sponsor|2|||
129796936|NCT02964507|467225116|FG006|Overall Study|Study terminated by Sponsor|0|||
129796937|NCT02964507|467225117|FG007|Overall Study|Study terminated by Sponsor|0|||
129796938|NCT02964507|467225110|FG000|Overall Study|Other|3|||
129796939|NCT02964507|467225111|FG001|Overall Study|Other|0|||
129796940|NCT02964507|467225112|FG002|Overall Study|Other|0|||
129796941|NCT02964507|467225113|FG003|Overall Study|Other|0|||
129796942|NCT02964507|467225114|FG004|Overall Study|Other|1|||
129796943|NCT02964507|467225115|FG005|Overall Study|Other|0|||
129796944|NCT02964507|467225116|FG006|Overall Study|Other|0|||
129796945|NCT02964507|467225117|FG007|Overall Study|Other|0|||
129796946|NCT02964507|467225110|FG000|Overall Study|Death|11|||
130303535|NCT02510001|469074872|FG000|Overall Study|Physician Decision|0|||
130303536|NCT02510001|469074873|FG001|Overall Study|Physician Decision|0|||
130303537|NCT02510001|469074874|FG002|Overall Study|Physician Decision|0|||
130303538|NCT02510001|469074875|FG003|Overall Study|Physician Decision|0|||
130303539|NCT02510001|469074876|FG004|Overall Study|Physician Decision|1|||
130303540|NCT02510001|469074877|FG005|Overall Study|Physician Decision|0|||
130303541|NCT02510001|469074878|FG006|Overall Study|Physician Decision|0|||
130303542|NCT02510001|469074879|FG007|Overall Study|Physician Decision|0|||
130303543|NCT02510001|469074872|FG000|Overall Study|Withdrawal by Subject|0|||
130303544|NCT02510001|469074873|FG001|Overall Study|Withdrawal by Subject|0|||
130303545|NCT02510001|469074874|FG002|Overall Study|Withdrawal by Subject|0|||
130303546|NCT02510001|469074875|FG003|Overall Study|Withdrawal by Subject|0|||
130303547|NCT02510001|469074876|FG004|Overall Study|Withdrawal by Subject|0|||
130303548|NCT02510001|469074877|FG005|Overall Study|Withdrawal by Subject|0|||
130303549|NCT02510001|469074878|FG006|Overall Study|Withdrawal by Subject|0|||
130303550|NCT02510001|469074879|FG007|Overall Study|Withdrawal by Subject|2|||
130303551|NCT02950480|469074884|FG000|Overall Study|Withdrawal by Subject|1|||
130303552|NCT02950480|469074885|FG001|Overall Study|Withdrawal by Subject|0|||
130303553|NCT00711971|469074888|FG000|Overall Study|Lost to Follow-up|3|||
130303554|NCT00711971|469074889|FG001|Overall Study|Lost to Follow-up|4|||
130303555|NCT00711971|469074890|FG002|Overall Study|Lost to Follow-up|1|||
130303556|NCT02644343|469074891|FG000|Overall Study|Withdrawal by Subject|1|||
130303557|NCT03704688|469074894|FG000|Overall Study|Adverse Event|0|||
130303558|NCT03704688|469074895|FG001|Overall Study|Adverse Event|0|||
130303559|NCT03704688|469074896|FG002|Overall Study|Adverse Event|0|||
130303560|NCT03704688|469074897|FG003|Overall Study|Adverse Event|4|||
130303561|NCT03704688|469074898|FG004|Overall Study|Adverse Event|1|||
130303562|NCT03704688|469074899|FG005|Overall Study|Adverse Event|0|||
130303563|NCT03704688|469074894|FG000|Overall Study|Disease Progression|0|||
130303564|NCT03704688|469074895|FG001|Overall Study|Disease Progression|0|||
130303565|NCT03704688|469074896|FG002|Overall Study|Disease Progression|0|||
130303566|NCT03704688|469074897|FG003|Overall Study|Disease Progression|3|||
130303567|NCT03704688|469074898|FG004|Overall Study|Disease Progression|1|||
130303568|NCT03704688|469074899|FG005|Overall Study|Disease Progression|0|||
130303569|NCT03704688|469074894|FG000|Overall Study|Death|0|||
130303570|NCT03704688|469074895|FG001|Overall Study|Death|0|||
130303571|NCT03704688|469074896|FG002|Overall Study|Death|0|||
130303572|NCT03704688|469074897|FG003|Overall Study|Death|0|||
130303573|NCT03704688|469074898|FG004|Overall Study|Death|3|||
130303574|NCT03704688|469074899|FG005|Overall Study|Death|0|||
129796947|NCT02964507|467225111|FG001|Overall Study|Death|9|||
130303575|NCT01440816|469074903|FG000|Overall Study|Disease Progression|0|||
130303576|NCT01440816|469074904|FG001|Overall Study|Disease Progression|9|||
130303577|NCT01440816|469074903|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
129796948|NCT02964507|467225112|FG002|Overall Study|Death|12|||
129796949|NCT02964507|467225113|FG003|Overall Study|Death|2|||
129796950|NCT02964507|467225114|FG004|Overall Study|Death|10|||
130303578|NCT01440816|469074904|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
130303579|NCT00847886|469074905|FG000|Overall Study|Adverse Event|0|||
130303580|NCT00847886|469074906|FG001|Overall Study|Adverse Event|1|||
130303581|NCT01687101|469074907|FG000|Overall Study|Lost to Follow-up|7|||
130303582|NCT03920254|469074909|FG000|Overall Study|Adverse Event|1|||
130303583|NCT03920254|469074910|FG001|Overall Study|Adverse Event|0|||
130303584|NCT03920254|469074911|FG002|Overall Study|Adverse Event|0|||
130303585|NCT03920254|469074909|FG000|Overall Study|Physician Decision|0|||
129796951|NCT02964507|467225115|FG005|Overall Study|Death|5|||
129796952|NCT02964507|467225116|FG006|Overall Study|Death|0|||
129796953|NCT02964507|467225117|FG007|Overall Study|Death|0|||
130303586|NCT03920254|469074910|FG001|Overall Study|Physician Decision|1|||
130303587|NCT03920254|469074911|FG002|Overall Study|Physician Decision|2|||
130303588|NCT03920254|469074909|FG000|Overall Study|Study Terminated By Sponsor|12|||
130303589|NCT03920254|469074910|FG001|Overall Study|Study Terminated By Sponsor|17|||
130303590|NCT03920254|469074911|FG002|Overall Study|Study Terminated By Sponsor|12|||
130303591|NCT03920254|469074909|FG000|Overall Study|Withdrawal by Subject|0|||
129889266|NCT03220737|467552537|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129889267|NCT03486899|467552538|FG000|Overall Study|Lost to Follow-up|4|||
129889268|NCT03486899|467552539|FG001|Overall Study|Lost to Follow-up|1|||
129889269|NCT03486899|467552540|FG002|Overall Study|Lost to Follow-up|4|||
129889270|NCT03486899|467552541|FG003|Overall Study|Lost to Follow-up|3|||
129889271|NCT03486899|467552538|FG000|Overall Study|Death|1|||
129889272|NCT03486899|467552539|FG001|Overall Study|Death|0|||
130047866|NCT03123939|468131629|FG000|Overall Study|Death|5|||
130303592|NCT03920254|469074910|FG001|Overall Study|Withdrawal by Subject|0|||
130303593|NCT03920254|469074911|FG002|Overall Study|Withdrawal by Subject|1|||
130303594|NCT03250182|469074912|FG000|Overall Study|Withdrawal by Subject|1|||
130303595|NCT05274269|469074913|FG000|Overall Study|Adverse Event|0|||
130303596|NCT05274269|469074914|FG001|Overall Study|Adverse Event|3|||
130303597|NCT05274269|469074913|FG000|Overall Study|Death|0|||
130303598|NCT05274269|469074914|FG001|Overall Study|Death|1|||
130303599|NCT05274269|469074913|FG000|Overall Study|Other|0|||
130303600|NCT05274269|469074914|FG001|Overall Study|Other|2|||
130047867|NCT03123939|468131629|FG000|Overall Study|Physician Decision|2|||
130047868|NCT03123939|468131629|FG000|Overall Study|Subject/guardian decision|2|||
130047869|NCT03123939|468131629|FG000|Overall Study|Lost to Follow-up|1|||
130047870|NCT03123939|468131629|FG000|Overall Study|New therapy for study indication|1|||
130047871|NCT03123939|468131629|FG000|Overall Study|Protocol deviation|1|||
130047872|NCT03123939|468131629|FG000|Overall Study|Progressive disease|18|||
130047873|NCT03123939|468131629|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
130110729|NCT03705169|468365846|FG001|Overall Study|Concerns about study visit compliance|0|||
130303601|NCT05274269|469074913|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130303602|NCT05274269|469074914|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129889273|NCT03486899|467552540|FG002|Overall Study|Death|0|||
130047874|NCT03123939|468131629|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
130303603|NCT01858740|469074918|FG000|Overall Study|Death|4|||
129889274|NCT03486899|467552541|FG003|Overall Study|Death|1|||
129796954|NCT02964507|467225110|FG000|Overall Study|Withdrawal by Subject|1|||
129796955|NCT02964507|467225111|FG001|Overall Study|Withdrawal by Subject|0|||
129796956|NCT02964507|467225112|FG002|Overall Study|Withdrawal by Subject|1|||
129796957|NCT02964507|467225113|FG003|Overall Study|Withdrawal by Subject|1|||
129796958|NCT02964507|467225114|FG004|Overall Study|Withdrawal by Subject|0|||
129796959|NCT02964507|467225115|FG005|Overall Study|Withdrawal by Subject|1|||
129796960|NCT02964507|467225116|FG006|Overall Study|Withdrawal by Subject|0|||
129796961|NCT02964507|467225117|FG007|Overall Study|Withdrawal by Subject|0|||
129796962|NCT02964507|467225110|FG000|Overall Study|Physician Decision|2|||
129796963|NCT02964507|467225111|FG001|Overall Study|Physician Decision|0|||
129796964|NCT02964507|467225112|FG002|Overall Study|Physician Decision|3|||
129796965|NCT02964507|467225113|FG003|Overall Study|Physician Decision|0|||
129796966|NCT02964507|467225114|FG004|Overall Study|Physician Decision|1|||
129796967|NCT02964507|467225115|FG005|Overall Study|Physician Decision|0|||
129796968|NCT02964507|467225116|FG006|Overall Study|Physician Decision|0|||
129796969|NCT02964507|467225117|FG007|Overall Study|Physician Decision|0|||
129796970|NCT02495233|467225118|FG000|Overall Study|Miscellaneous|0|||
129796971|NCT02495233|467225119|FG001|Overall Study|Miscellaneous|1|||
129796972|NCT03880461|467225120|FG000|Overall Study|Determined ineligible after enrollment|45|||
129796973|NCT03880461|467225121|FG001|Overall Study|Determined ineligible after enrollment|44|||
129796974|NCT03880461|467225120|FG000|Overall Study|No weight measurement after enrollment|24|||
129796975|NCT03880461|467225121|FG001|Overall Study|No weight measurement after enrollment|17|||
129796976|NCT02652767|467225123|FG000|Overall Study|Death|2|||
129796977|NCT02652767|467225123|FG000|Overall Study|Lost to Follow-up|1|||
129796978|NCT02652767|467225123|FG000|Overall Study|Withdrawal by Subject|1|||
129796979|NCT01115803|467225125|FG000|Overall Study|Withdrawal by Subject|0|||
129796980|NCT01115803|467225126|FG001|Overall Study|Withdrawal by Subject|0|||
129796981|NCT01115803|467225127|FG002|Overall Study|Withdrawal by Subject|0|||
129796982|NCT01115803|467225128|FG003|Overall Study|Withdrawal by Subject|0|||
129796983|NCT01115803|467225129|FG004|Overall Study|Withdrawal by Subject|0|||
129796984|NCT01115803|467225130|FG005|Overall Study|Withdrawal by Subject|0|||
129796985|NCT01115803|467225131|FG006|Overall Study|Withdrawal by Subject|1|||
129796986|NCT01115803|467225125|FG000|Overall Study|Lost to Follow-up|0|||
129796987|NCT01115803|467225126|FG001|Overall Study|Lost to Follow-up|0|||
129796988|NCT01115803|467225127|FG002|Overall Study|Lost to Follow-up|1|||
129796989|NCT01115803|467225128|FG003|Overall Study|Lost to Follow-up|0|||
129796990|NCT01115803|467225129|FG004|Overall Study|Lost to Follow-up|0|||
129796991|NCT01115803|467225130|FG005|Overall Study|Lost to Follow-up|0|||
129796992|NCT01115803|467225131|FG006|Overall Study|Lost to Follow-up|0|||
129796993|NCT01115803|467225125|FG000|Overall Study|Progressive Disease during Cycle1|0|||
129796994|NCT01115803|467225126|FG001|Overall Study|Progressive Disease during Cycle1|0|||
129796995|NCT01115803|467225127|FG002|Overall Study|Progressive Disease during Cycle1|0|||
129796996|NCT01115803|467225128|FG003|Overall Study|Progressive Disease during Cycle1|0|||
129796997|NCT01115803|467225129|FG004|Overall Study|Progressive Disease during Cycle1|0|||
129796998|NCT01115803|467225130|FG005|Overall Study|Progressive Disease during Cycle1|0|||
129796999|NCT01115803|467225131|FG006|Overall Study|Progressive Disease during Cycle1|1|||
129797000|NCT03475875|467225132|FG000|Period 1|Lost to Follow-up|1|||
129797001|NCT03475875|467225133|FG001|Period 1|Lost to Follow-up|0|||
129797002|NCT03475875|467225132|FG000|Period 1|Adverse Event|2|||
129797003|NCT03475875|467225133|FG001|Period 1|Adverse Event|1|||
129797004|NCT03475875|467225132|FG000|Period 2|Adverse Event|3|||
129797005|NCT03475875|467225133|FG001|Period 2|Adverse Event|0|||
129797006|NCT03475875|467225132|FG000|Period 2|Protocol Violation|0|||
129797007|NCT03475875|467225133|FG001|Period 2|Protocol Violation|1|||
129797008|NCT01642407|467225134|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
129797009|NCT01642407|467225134|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
129797010|NCT01642407|467225134|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
129797011|NCT04025710|467225135|FG000|Overall Study|Death|3|||
129797012|NCT04025710|467225135|FG000|Overall Study|Lost to Follow-up|5|||
129889275|NCT03486899|467552538|FG000|Overall Study|Adverse Event|0|||
129889276|NCT03486899|467552539|FG001|Overall Study|Adverse Event|2|||
129889277|NCT03486899|467552540|FG002|Overall Study|Adverse Event|0|||
129797013|NCT04025710|467225135|FG000|Overall Study|Withdrawal by Subject|1|||
129797014|NCT04025710|467225135|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
129797015|NCT04025710|467225135|FG000|Overall Study|Drop-out according to protocol|34|||
129797016|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
129797017|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
129797018|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
129797019|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
129797020|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
129797021|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
129797022|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
129797023|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
129889278|NCT03486899|467552541|FG003|Overall Study|Adverse Event|2|||
129889279|NCT03486899|467552538|FG000|Overall Study|Withdrawal by Subject|3|||
130303604|NCT01068769|469074919|FG000|Overall Study|Ineligible|1|||
130303605|NCT00709618|469074920|FG000|Overall Study|Withdrawal by Subject|4|||
130303606|NCT00709618|469074920|FG000|Overall Study|Lost to Follow-up|1|||
130303607|NCT00709618|469074920|FG000|Overall Study|Study Closed/Terminated|25|||
130303608|NCT04042909|469074921|FG000|Overall Study|Withdrawal by Subject|1|||
130303609|NCT04042909|469074922|FG001|Overall Study|Withdrawal by Subject|0|||
130303610|NCT04042909|469074923|FG002|Overall Study|Withdrawal by Subject|0|||
130303611|NCT04042909|469074921|FG000|Overall Study|duplicate cases|2|||
130303612|NCT04042909|469074922|FG001|Overall Study|duplicate cases|0|||
130303613|NCT04042909|469074923|FG002|Overall Study|duplicate cases|0|||
130303614|NCT04042909|469074921|FG000|Overall Study|technical problem|0|||
130303615|NCT04042909|469074922|FG001|Overall Study|technical problem|1|||
130303616|NCT04042909|469074923|FG002|Overall Study|technical problem|0|||
130303617|NCT00894361|469074926|FG000|Overall Study|deaths and less than 2 years followup|24|||
130303618|NCT00894361|469074927|FG001|Overall Study|deaths and less than 2 years followup|64|||
130303619|NCT04124705|469074936|FG000|Titration Period|Adverse Event|9|||
130303620|NCT04124705|469074937|FG001|Titration Period|Adverse Event|5|||
130303621|NCT04124705|469074936|FG000|Titration Period|Withdrawal by Subject|6|||
129797024|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
129797025|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
129797026|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
129797027|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
129797028|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
129797029|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
129797030|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
129797031|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
129797032|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
129797033|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
129797034|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
129797035|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
129797036|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
129797037|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
129797038|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
129797039|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
129797040|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129797041|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129797042|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
129797043|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129797044|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129797045|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
129797046|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129797047|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129797048|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
129889280|NCT03486899|467552539|FG001|Overall Study|Withdrawal by Subject|7|||
129889281|NCT03486899|467552540|FG002|Overall Study|Withdrawal by Subject|4|||
129889282|NCT03486899|467552541|FG003|Overall Study|Withdrawal by Subject|3|||
129889283|NCT03486899|467552538|FG000|Overall Study|Other Reasons|0|||
129889284|NCT03486899|467552539|FG001|Overall Study|Other Reasons|1|||
129889285|NCT03486899|467552540|FG002|Overall Study|Other Reasons|0|||
129889286|NCT03486899|467552541|FG003|Overall Study|Other Reasons|1|||
129889287|NCT01848834|467552547|FG000|Overall Study|Adverse Event|3|||
129889288|NCT01848834|467552548|FG001|Overall Study|Adverse Event|11|||
129889289|NCT01848834|467552549|FG002|Overall Study|Adverse Event|3|||
129889290|NCT01848834|467552550|FG003|Overall Study|Adverse Event|5|||
129889291|NCT01848834|467552551|FG004|Overall Study|Adverse Event|9|||
129889292|NCT01848834|467552547|FG000|Overall Study|Death|2|||
129889293|NCT01848834|467552548|FG001|Overall Study|Death|11|||
129889294|NCT01848834|467552549|FG002|Overall Study|Death|1|||
129889295|NCT01848834|467552550|FG003|Overall Study|Death|8|||
129889296|NCT01848834|467552551|FG004|Overall Study|Death|27|||
129889297|NCT01848834|467552547|FG000|Overall Study|Excluded Medication|5|||
129889298|NCT01848834|467552548|FG001|Overall Study|Excluded Medication|4|||
129889299|NCT01848834|467552549|FG002|Overall Study|Excluded Medication|3|||
129889300|NCT01848834|467552550|FG003|Overall Study|Excluded Medication|6|||
129889301|NCT01848834|467552551|FG004|Overall Study|Excluded Medication|6|||
129889302|NCT01848834|467552547|FG000|Overall Study|Lost to Follow-up|5|||
129889303|NCT01848834|467552548|FG001|Overall Study|Lost to Follow-up|5|||
129889304|NCT01848834|467552549|FG002|Overall Study|Lost to Follow-up|3|||
129889305|NCT01848834|467552550|FG003|Overall Study|Lost to Follow-up|0|||
129889306|NCT01848834|467552551|FG004|Overall Study|Lost to Follow-up|3|||
129889307|NCT01848834|467552547|FG000|Overall Study|Physician Decision|1|||
129889308|NCT01848834|467552548|FG001|Overall Study|Physician Decision|3|||
129889309|NCT01848834|467552549|FG002|Overall Study|Physician Decision|4|||
129889310|NCT01848834|467552550|FG003|Overall Study|Physician Decision|0|||
129889311|NCT01848834|467552551|FG004|Overall Study|Physician Decision|11|||
129889312|NCT01848834|467552547|FG000|Overall Study|Protocol Violation|0|||
129889313|NCT01848834|467552548|FG001|Overall Study|Protocol Violation|0|||
129889314|NCT01848834|467552549|FG002|Overall Study|Protocol Violation|0|||
129797049|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129797050|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129797051|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
129797052|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129797053|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129797054|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
129797055|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129889315|NCT01848834|467552550|FG003|Overall Study|Protocol Violation|0|||
129889316|NCT01848834|467552551|FG004|Overall Study|Protocol Violation|1|||
129889317|NCT01848834|467552547|FG000|Overall Study|Sponsor Decision|1|||
129889318|NCT01848834|467552548|FG001|Overall Study|Sponsor Decision|1|||
129889319|NCT01848834|467552549|FG002|Overall Study|Sponsor Decision|0|||
129889320|NCT01848834|467552550|FG003|Overall Study|Sponsor Decision|1|||
129889321|NCT01848834|467552551|FG004|Overall Study|Sponsor Decision|1|||
129797056|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129797057|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
129797058|NCT01562873|467225139|FG000|Overall Study|Disease Progression per RECIST|10|||
129797059|NCT01562873|467225140|FG001|Overall Study|Disease Progression per RECIST|0|||
129797060|NCT01562873|467225139|FG000|Overall Study|Adverse Event|1|||
129797061|NCT01562873|467225140|FG001|Overall Study|Adverse Event|0|||
129797062|NCT01562873|467225139|FG000|Overall Study|Clinical Disease Progression|9|||
129797063|NCT01562873|467225140|FG001|Overall Study|Clinical Disease Progression|0|||
129797064|NCT01562873|467225139|FG000|Overall Study|Clinical PD and adverse event|1|||
129797065|NCT01562873|467225140|FG001|Overall Study|Clinical PD and adverse event|0|||
129797066|NCT02942576|467225142|FG000|Overall Study|Adverse Event|28|||
129797067|NCT02942576|467225143|FG001|Overall Study|Adverse Event|6|||
129797068|NCT02942576|467225142|FG000|Overall Study|Withdrawal by Subject|7|||
129797069|NCT02942576|467225143|FG001|Overall Study|Withdrawal by Subject|5|||
129797070|NCT02942576|467225142|FG000|Overall Study|Physician Decision|1|||
129797071|NCT02942576|467225143|FG001|Overall Study|Physician Decision|4|||
129797072|NCT02942576|467225142|FG000|Overall Study|Other|10|||
129797073|NCT02942576|467225143|FG001|Overall Study|Other|8|||
129797074|NCT00938964|467225144|FG000|Overall Study|Death|3|||
129797075|NCT00938964|467225145|FG001|Overall Study|Death|3|||
129797076|NCT00938964|467225144|FG000|Overall Study|Lost to Follow-up|2|||
129797077|NCT00938964|467225145|FG001|Overall Study|Lost to Follow-up|3|||
129797078|NCT00938964|467225144|FG000|Overall Study|Withdrawal by Subject|22|||
129797079|NCT00938964|467225145|FG001|Overall Study|Withdrawal by Subject|18|||
129797080|NCT00938964|467225144|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
129797081|NCT00938964|467225145|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
129797082|NCT03523000|467225147|FG000|Overall Study|Withdrawal by Subject|3|||
129797083|NCT03523000|467225148|FG001|Overall Study|Withdrawal by Subject|0|||
129797084|NCT03523000|467225147|FG000|Overall Study|Unsuccessful trial|2|||
129797085|NCT03523000|467225148|FG001|Overall Study|Unsuccessful trial|0|||
129797086|NCT00194675|467225152|FG000|Overall Study|Lost to Follow-up|1|||
129797087|NCT00194675|467225153|FG001|Overall Study|Lost to Follow-up|1|||
129797088|NCT00194675|467225152|FG000|Overall Study|lack of interest|1|||
129797089|NCT00194675|467225153|FG001|Overall Study|lack of interest|1|||
129797090|NCT00194675|467225152|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
129797091|NCT00194675|467225153|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
129797092|NCT00194675|467225152|FG000|Overall Study|Protocol Violation|1|||
129797093|NCT00194675|467225153|FG001|Overall Study|Protocol Violation|0|||
129797094|NCT00194675|467225152|FG000|Overall Study|Death|1|||
129797095|NCT00194675|467225153|FG001|Overall Study|Death|0|||
129797096|NCT00704808|467225154|FG000|Overall Study|Discontinued prior to starting treatment|14|||
129797097|NCT00704808|467225154|FG000|Overall Study|Death|7|||
129797098|NCT00704808|467225154|FG000|Overall Study|Tumor progression|80|||
129797099|NCT00704808|467225154|FG000|Overall Study|Patient's decision|11|||
129797100|NCT00704808|467225154|FG000|Overall Study|Early therapy discontinuation|16|||
129797101|NCT00704808|467225154|FG000|Overall Study|Adverse Event|1|||
129797102|NCT00704808|467225154|FG000|Overall Study|Lost to Follow-up|1|||
129797103|NCT00704808|467225154|FG000|Overall Study|Treatment change|1|||
129797104|NCT01285960|467225155|FG000|Overall Study|Withdrawal by Subject|2|||
129797105|NCT01285960|467225155|FG000|Overall Study|Lost to Follow-up|2|||
129797106|NCT01285960|467225155|FG000|Overall Study|2 subjects received less 10 sonications|2|||
129797107|NCT01476644|467225159|FG000|Overall Study|Death|5|||
129797108|NCT01476644|467225159|FG000|Overall Study|moved to another state|2|||
129797109|NCT01476644|467225159|FG000|Overall Study|Lost to Follow-up|19|||
129797110|NCT01476644|467225159|FG000|Overall Study|Withdrawal by Subject|13|||
130047875|NCT04773041|468131630|FG000|Overall Study|Unable to data match|1|||
130047876|NCT04773041|468131631|FG001|Overall Study|Unable to data match|0|||
130047877|NCT04773041|468131632|FG002|Overall Study|Unable to data match|0|||
130047878|NCT01118143|468131633|FG000|Overall Study|Withdrawal by Subject|2|||
130047879|NCT01118143|468131634|FG001|Overall Study|Withdrawal by Subject|5|||
129797111|NCT00095628|467225160|FG000|Overall Study|Disease progression prior to treatment|1|||
129797112|NCT02280473|467225161|FG000|Overall Study|Adverse Event|1|||
129797113|NCT02280473|467225162|FG001|Overall Study|Adverse Event|1|||
129797114|NCT02280473|467225161|FG000|Overall Study|Lack of Efficacy|0|||
129797115|NCT02280473|467225162|FG001|Overall Study|Lack of Efficacy|1|||
129797116|NCT02280473|467225161|FG000|Overall Study|Lost to Follow-up|0|||
129797117|NCT02280473|467225162|FG001|Overall Study|Lost to Follow-up|1|||
129797118|NCT01484054|467225163|FG000|Period 1|Withdrawal by Subject|0|||
129797119|NCT01484054|467225164|FG001|Period 1|Withdrawal by Subject|1|||
129797120|NCT00410202|467225173|FG000|On-Treatment|Continuing treatment|69|||
130047880|NCT02112448|468131635|FG000|Overall Study|lab values precluding use of ketorolac|2|||
129797121|NCT00410202|467225174|FG001|On-Treatment|Continuing treatment|71|||
129797122|NCT00410202|467225175|FG002|On-Treatment|Continuing treatment|66|||
129797123|NCT00410202|467225173|FG000|On-Treatment|Adverse Event|1|||
129797124|NCT00410202|467225174|FG001|On-Treatment|Adverse Event|3|||
129797125|NCT00410202|467225175|FG002|On-Treatment|Adverse Event|2|||
129797126|NCT00410202|467225173|FG000|On-Treatment|Death|1|||
129797127|NCT00410202|467225174|FG001|On-Treatment|Death|0|||
129797128|NCT00410202|467225175|FG002|On-Treatment|Death|0|||
129797129|NCT00410202|467225173|FG000|On-Treatment|Lost to Follow-up|1|||
129797130|NCT00410202|467225174|FG001|On-Treatment|Lost to Follow-up|0|||
129797131|NCT00410202|467225175|FG002|On-Treatment|Lost to Follow-up|1|||
129797132|NCT00410202|467225173|FG000|On-Treatment|Lack of Efficacy|1|||
129797133|NCT00410202|467225174|FG001|On-Treatment|Lack of Efficacy|4|||
129797134|NCT00410202|467225175|FG002|On-Treatment|Lack of Efficacy|0|||
129797135|NCT00410202|467225173|FG000|On-Treatment|Withdrawal by Subject|2|||
129797136|NCT00410202|467225174|FG001|On-Treatment|Withdrawal by Subject|1|||
129797137|NCT00410202|467225175|FG002|On-Treatment|Withdrawal by Subject|1|||
129797138|NCT00410202|467225173|FG000|On-Treatment|Other Reason|0|||
129797139|NCT00410202|467225174|FG001|On-Treatment|Other Reason|0|||
129797140|NCT00410202|467225175|FG002|On-Treatment|Other Reason|1|||
129797141|NCT00410202|467225173|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
129797142|NCT00410202|467225174|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
129797143|NCT00410202|467225175|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
129797144|NCT00410202|467225173|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
129797145|NCT00410202|467225174|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
129797146|NCT00410202|467225175|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
129797147|NCT00410202|467225173|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
129797148|NCT00410202|467225174|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
129797149|NCT00410202|467225175|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
129797150|NCT00937391|467225176|FG000|Stage 2|Withdrawal by Subject|1|||
129797151|NCT03194490|467225195|FG000|Overall Study|Lost to Follow-up|1|||
129797152|NCT03194490|467225196|FG001|Overall Study|Lost to Follow-up|3|||
129797153|NCT03194490|467225195|FG000|Overall Study|participant developed specific neck pain|1|||
129797154|NCT03194490|467225196|FG001|Overall Study|participant developed specific neck pain|0|||
129797155|NCT01758289|467225197|FG000|Overall Study|Premature Study Termination|44|||
129797156|NCT01758289|467225197|FG000|Overall Study|Adverse Event|9|||
129797157|NCT01574079|467225198|FG000|Overall Study|Physician Decision|0|||
129797158|NCT01574079|467225199|FG001|Overall Study|Physician Decision|2|||
129797159|NCT01574079|467225198|FG000|Overall Study|Lost to Follow-up|1|||
129797160|NCT01574079|467225199|FG001|Overall Study|Lost to Follow-up|0|||
129797161|NCT03640559|467225203|FG000|Overall Study|Physician Decision|1|||
129797162|NCT03640559|467225204|FG001|Overall Study|Physician Decision|1|||
129797163|NCT03640559|467225203|FG000|Overall Study|Withdrawal by Subject|1|||
129797164|NCT03640559|467225204|FG001|Overall Study|Withdrawal by Subject|0|||
129797165|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
129797166|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
129797167|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
129797168|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
129797169|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
129797170|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
129797171|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
129797172|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
129797173|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
129797174|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
129797175|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
129797176|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
129797177|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
129797178|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129797179|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129797180|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Other|107|||
129797181|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Other|0|||
129797182|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Other|0|||
129797183|NCT01436162|467225205|FG000|Randomized Phase|Adverse Event|1|||
129797184|NCT01436162|467225206|FG001|Randomized Phase|Adverse Event|5|||
129797185|NCT01436162|467225207|FG002|Randomized Phase|Adverse Event|6|||
129797186|NCT01436162|467225205|FG000|Randomized Phase|Protocol Violation|4|||
129797187|NCT01436162|467225206|FG001|Randomized Phase|Protocol Violation|4|||
129797188|NCT01436162|467225207|FG002|Randomized Phase|Protocol Violation|2|||
130303622|NCT04124705|469074937|FG001|Titration Period|Withdrawal by Subject|3|||
130303623|NCT04124705|469074936|FG000|Titration Period|Lost to Follow-up|0|||
130303624|NCT04124705|469074937|FG001|Titration Period|Lost to Follow-up|1|||
129797189|NCT01436162|467225205|FG000|Randomized Phase|Withdrawal by Subject|16|||
129797190|NCT01436162|467225206|FG001|Randomized Phase|Withdrawal by Subject|9|||
129797191|NCT01436162|467225207|FG002|Randomized Phase|Withdrawal by Subject|8|||
129797192|NCT01436162|467225205|FG000|Randomized Phase|Lost to Follow-up|17|||
129797193|NCT01436162|467225206|FG001|Randomized Phase|Lost to Follow-up|5|||
129797194|NCT01436162|467225207|FG002|Randomized Phase|Lost to Follow-up|4|||
129797195|NCT01436162|467225205|FG000|Randomized Phase|Lack of Efficacy|0|||
129797196|NCT01436162|467225206|FG001|Randomized Phase|Lack of Efficacy|1|||
129797197|NCT01436162|467225207|FG002|Randomized Phase|Lack of Efficacy|1|||
129797198|NCT01436162|467225205|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
130303625|NCT04124705|469074936|FG000|Titration Period|Death|1|||
130303626|NCT04124705|469074937|FG001|Titration Period|Death|1|||
130303627|NCT04124705|469074936|FG000|Titration Period|Lack of Efficacy|2|||
130303628|NCT04124705|469074937|FG001|Titration Period|Lack of Efficacy|0|||
129797199|NCT01436162|467225206|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
130303629|NCT04124705|469074936|FG000|Titration Period|Physician Decision|2|||
130303630|NCT04124705|469074937|FG001|Titration Period|Physician Decision|0|||
130303631|NCT04124705|469074936|FG000|Titration Period|Non-compliance with Study Drug|2|||
130303632|NCT04124705|469074937|FG001|Titration Period|Non-compliance with Study Drug|0|||
130303633|NCT04124705|469074936|FG000|Titration Period|Other|4|||
130303634|NCT04124705|469074937|FG001|Titration Period|Other|9|||
130303635|NCT04124705|469074936|FG000|Stabilization Period|Adverse Event|4|||
130303636|NCT04124705|469074937|FG001|Stabilization Period|Adverse Event|2|||
130303637|NCT04124705|469074936|FG000|Stabilization Period|Withdrawal by Subject|1|||
130303638|NCT04124705|469074937|FG001|Stabilization Period|Withdrawal by Subject|1|||
130303639|NCT04124705|469074936|FG000|Stabilization Period|Lost to Follow-up|0|||
130303640|NCT04124705|469074937|FG001|Stabilization Period|Lost to Follow-up|1|||
130303641|NCT04124705|469074936|FG000|Stabilization Period|Lack of Efficacy|4|||
129797200|NCT01436162|467225207|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
129797201|NCT01436162|467225205|FG000|Randomized Phase|Other|2|||
129797202|NCT01436162|467225206|FG001|Randomized Phase|Other|5|||
129797203|NCT01436162|467225207|FG002|Randomized Phase|Other|4|||
129797204|NCT01931202|467225211|FG000|Overall Study|Withdrawal by Subject|0|||
129797205|NCT01931202|467225212|FG001|Overall Study|Withdrawal by Subject|0|||
129797206|NCT01931202|467225213|FG002|Overall Study|Withdrawal by Subject|2|||
129797207|NCT01931202|467225211|FG000|Overall Study|Lost to Follow-up|0|||
129797208|NCT01931202|467225212|FG001|Overall Study|Lost to Follow-up|5|||
129797209|NCT01931202|467225213|FG002|Overall Study|Lost to Follow-up|2|||
129797210|NCT02211638|467225218|FG000|Overall Study|Case Report Forms Uncollected|291|||
129797211|NCT02211638|467225218|FG000|Overall Study|Protocol Violation|692|||
129797212|NCT02775903|467225219|FG000|Overall Study|Death|7|||
129797213|NCT02775903|467225220|FG001|Overall Study|Death|11|||
129797214|NCT02775903|467225221|FG002|Overall Study|Death|12|||
129797215|NCT02775903|467225222|FG003|Overall Study|Death|11|||
129797216|NCT02775903|467225219|FG000|Overall Study|Adverse Event|0|||
129797217|NCT02775903|467225220|FG001|Overall Study|Adverse Event|1|||
129797218|NCT02775903|467225221|FG002|Overall Study|Adverse Event|12|||
129797219|NCT02775903|467225222|FG003|Overall Study|Adverse Event|3|||
129797220|NCT02775903|467225219|FG000|Overall Study|Progressive disease|15|||
129797221|NCT02775903|467225220|FG001|Overall Study|Progressive disease|14|||
129797222|NCT02775903|467225221|FG002|Overall Study|Progressive disease|30|||
129797223|NCT02775903|467225222|FG003|Overall Study|Progressive disease|20|||
129797224|NCT02775903|467225219|FG000|Overall Study|Lack of Efficacy|2|||
129797225|NCT02775903|467225220|FG001|Overall Study|Lack of Efficacy|2|||
129797226|NCT02775903|467225221|FG002|Overall Study|Lack of Efficacy|2|||
129797227|NCT02775903|467225222|FG003|Overall Study|Lack of Efficacy|6|||
129797228|NCT02775903|467225219|FG000|Overall Study|Withdrawal by Subject|7|||
129797229|NCT02775903|467225220|FG001|Overall Study|Withdrawal by Subject|5|||
129797230|NCT02775903|467225221|FG002|Overall Study|Withdrawal by Subject|5|||
129797231|NCT02775903|467225222|FG003|Overall Study|Withdrawal by Subject|8|||
129797232|NCT02775903|467225219|FG000|Overall Study|Other reasons|7|||
129797233|NCT02775903|467225220|FG001|Overall Study|Other reasons|8|||
129797234|NCT02775903|467225221|FG002|Overall Study|Other reasons|2|||
129797235|NCT02775903|467225222|FG003|Overall Study|Other reasons|12|||
129797236|NCT04041700|467225223|FG000|Overall Study|Pregnancy|1|||
129797237|NCT04041700|467225223|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
129797238|NCT04571515|467225226|FG000|Overall Study|Physician Decision|0|||
129797239|NCT04571515|467225227|FG001|Overall Study|Physician Decision|0|||
129797240|NCT04571515|467225228|FG002|Overall Study|Physician Decision|0|||
130303642|NCT04124705|469074937|FG001|Stabilization Period|Lack of Efficacy|2|||
130303643|NCT04124705|469074936|FG000|Stabilization Period|Protocol Deviation|0|||
129797241|NCT04571515|467225229|FG003|Overall Study|Physician Decision|0|||
129797242|NCT04571515|467225230|FG004|Overall Study|Physician Decision|1|||
129797243|NCT04571515|467225226|FG000|Overall Study|Withdrawal by Subject|0|||
129797244|NCT04571515|467225227|FG001|Overall Study|Withdrawal by Subject|0|||
129797245|NCT04571515|467225228|FG002|Overall Study|Withdrawal by Subject|0|||
130303644|NCT04124705|469074937|FG001|Stabilization Period|Protocol Deviation|2|||
130303645|NCT04124705|469074936|FG000|Stabilization Period|Other|2|||
130303646|NCT04124705|469074937|FG001|Stabilization Period|Other|2|||
129797246|NCT04571515|467225229|FG003|Overall Study|Withdrawal by Subject|0|||
129797247|NCT04571515|467225230|FG004|Overall Study|Withdrawal by Subject|1|||
129797248|NCT04571515|467225226|FG000|Overall Study|insufficient pain|1|||
129797249|NCT04571515|467225227|FG001|Overall Study|insufficient pain|0|||
129797250|NCT04571515|467225228|FG002|Overall Study|insufficient pain|0|||
129797251|NCT04571515|467225229|FG003|Overall Study|insufficient pain|0|||
129797252|NCT04571515|467225230|FG004|Overall Study|insufficient pain|1|||
129797253|NCT05140382|467225231|FG000|Overall Study|Death|3|||
130303647|NCT01636986|469074938|FG000|Overall Study|Withdrawal by Subject|0|||
130303648|NCT01636986|469074939|FG001|Overall Study|Withdrawal by Subject|1|||
130303649|NCT01636986|469074938|FG000|Overall Study|Corneal Staining|0|||
130303650|NCT01636986|469074939|FG001|Overall Study|Corneal Staining|1|||
130047881|NCT02112448|468131636|FG001|Overall Study|lab values precluding use of ketorolac|2|||
130047882|NCT02112448|468131635|FG000|Overall Study|Protocol Violation|1|||
130047883|NCT02112448|468131636|FG001|Overall Study|Protocol Violation|2|||
130047884|NCT02112448|468131635|FG000|Overall Study|Physician Decision|4|||
130047885|NCT02112448|468131636|FG001|Overall Study|Physician Decision|6|||
130047886|NCT02112448|468131635|FG000|Overall Study|required heparin so could not use ketoro|1|||
130047887|NCT02112448|468131636|FG001|Overall Study|required heparin so could not use ketoro|0|||
130047888|NCT01937130|468133111|FG000|Overall Study|Withdrawal by Subject|0|||
130047889|NCT01937130|468133112|FG001|Overall Study|Withdrawal by Subject|0|||
130047890|NCT01937130|468133113|FG002|Overall Study|Withdrawal by Subject|0|||
130047891|NCT01937130|468133114|FG003|Overall Study|Withdrawal by Subject|1|||
130047892|NCT01937130|468133111|FG000|Overall Study|Adverse Event|0|||
130047893|NCT01937130|468133112|FG001|Overall Study|Adverse Event|1|||
130047894|NCT01937130|468133113|FG002|Overall Study|Adverse Event|0|||
130047895|NCT01937130|468133114|FG003|Overall Study|Adverse Event|1|||
130047896|NCT01937130|468133111|FG000|Overall Study|Death|1|||
130047897|NCT01937130|468133112|FG001|Overall Study|Death|1|||
130047898|NCT01937130|468133113|FG002|Overall Study|Death|1|||
130047899|NCT01937130|468133114|FG003|Overall Study|Death|0|||
130047900|NCT01937130|468133111|FG000|Overall Study|Lost to Follow-up|2|||
130047901|NCT01937130|468133112|FG001|Overall Study|Lost to Follow-up|0|||
130047902|NCT01937130|468133113|FG002|Overall Study|Lost to Follow-up|2|||
130047903|NCT01937130|468133114|FG003|Overall Study|Lost to Follow-up|0|||
130303651|NCT01844778|469074946|FG000|Overall Study|Protocol deviation|0|||
130303652|NCT01844778|469074947|FG001|Overall Study|Protocol deviation|1|||
130303653|NCT01844778|469074948|FG002|Overall Study|Protocol deviation|2|||
130303654|NCT01844778|469074946|FG000|Overall Study|Withdrawal by Subject|2|||
130303655|NCT01844778|469074947|FG001|Overall Study|Withdrawal by Subject|0|||
130303656|NCT01844778|469074948|FG002|Overall Study|Withdrawal by Subject|0|||
130303657|NCT01844778|469074946|FG000|Overall Study|Adverse Event|0|||
130303658|NCT01844778|469074947|FG001|Overall Study|Adverse Event|2|||
130303659|NCT01844778|469074948|FG002|Overall Study|Adverse Event|2|||
130303660|NCT01153698|469074950|FG000|Overall Study|Adverse Event|12|||
130303661|NCT01153698|469074950|FG000|Overall Study|Lost to Follow-up|4|||
130303662|NCT01153698|469074950|FG000|Overall Study|Withdrawal by Subject|2|||
130303663|NCT01153698|469074950|FG000|Overall Study|Switch to other anticoagulants|4|||
130303664|NCT01153698|469074950|FG000|Overall Study|Other|2|||
130303665|NCT01153698|469074950|FG000|Overall Study|Not treated with Pradaxa|5|||
130303666|NCT02106403|469074952|FG000|Follow-Up Visit 3|Other Reason|0|||
130303667|NCT02106403|469074953|FG001|Follow-Up Visit 3|Other Reason|0|||
130303668|NCT02106403|469074954|FG002|Follow-Up Visit 3|Other Reason|0|||
130303669|NCT02106403|469074955|FG003|Follow-Up Visit 3|Other Reason|0|||
130303670|NCT02106403|469074956|FG004|Follow-Up Visit 3|Other Reason|0|||
130303671|NCT02106403|469074957|FG005|Follow-Up Visit 3|Other Reason|1|||
130303672|NCT01496846|469074961|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
130303673|NCT01496846|469074962|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
130303674|NCT01496846|469074963|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303675|NCT01496846|469074964|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303676|NCT01496846|469074965|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303677|NCT01496846|469074966|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
130303678|NCT01772576|469074969|FG000|Overall Study|Death|15|||
130303679|NCT01772576|469074969|FG000|Overall Study|Protocol Violation|1|||
130303680|NCT01772576|469074969|FG000|Overall Study|Lost to Follow-up|3|||
130303681|NCT01772576|469074969|FG000|Overall Study|Study device not used|3|||
130303682|NCT01772576|469074969|FG000|Overall Study|Adverse Event|6|||
130303683|NCT01772576|469074969|FG000|Overall Study|Withdrawal by Subject|6|||
130303684|NCT04356352|469074976|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
130303685|NCT04356352|469074977|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
130303686|NCT04356352|469074978|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
129797254|NCT05140382|467225232|FG001|Overall Study|Death|0|||
129797255|NCT05140382|467225233|FG002|Overall Study|Death|0|||
129797256|NCT05140382|467225231|FG000|Overall Study|Investigator decision|1|||
130047904|NCT01937130|468133111|FG000|Overall Study|Physician Decision|0|||
130047905|NCT01937130|468133112|FG001|Overall Study|Physician Decision|1|||
130047906|NCT01937130|468133113|FG002|Overall Study|Physician Decision|0|||
130047907|NCT01937130|468133114|FG003|Overall Study|Physician Decision|0|||
130047908|NCT01937130|468133111|FG000|Overall Study|Patients unable to swallow|0|||
130047909|NCT01937130|468133112|FG001|Overall Study|Patients unable to swallow|1|||
130047910|NCT01937130|468133113|FG002|Overall Study|Patients unable to swallow|0|||
130303687|NCT04356352|469074976|FG000|Overall Study|Protocol Violation|0|||
130303688|NCT04356352|469074977|FG001|Overall Study|Protocol Violation|3|||
130303689|NCT04356352|469074978|FG002|Overall Study|Protocol Violation|1|||
130303690|NCT00379912|469074983|FG000|Overall Study|Lack of Efficacy|1|||
130303691|NCT00379912|469074984|FG001|Overall Study|Lack of Efficacy|0|||
129797257|NCT05140382|467225232|FG001|Overall Study|Investigator decision|0|||
129797258|NCT05140382|467225233|FG002|Overall Study|Investigator decision|0|||
129797259|NCT05140382|467225231|FG000|Overall Study|Other|4|||
129797260|NCT05140382|467225232|FG001|Overall Study|Other|0|||
129797261|NCT05140382|467225233|FG002|Overall Study|Other|1|||
129797262|NCT05140382|467225231|FG000|Overall Study|Progressive disease|20|||
129797263|NCT05140382|467225232|FG001|Overall Study|Progressive disease|1|||
129797264|NCT05140382|467225233|FG002|Overall Study|Progressive disease|12|||
129797265|NCT05140382|467225231|FG000|Overall Study|Subjective disease progression|2|||
129797266|NCT05140382|467225232|FG001|Overall Study|Subjective disease progression|1|||
129797267|NCT05140382|467225233|FG002|Overall Study|Subjective disease progression|0|||
129797268|NCT05140382|467225231|FG000|Overall Study|Unknown at data cut-off|0|||
129797269|NCT05140382|467225232|FG001|Overall Study|Unknown at data cut-off|0|||
129797270|NCT05140382|467225233|FG002|Overall Study|Unknown at data cut-off|1|||
129797271|NCT05140382|467225231|FG000|Overall Study|Withdrawal by Subject|1|||
129797272|NCT05140382|467225232|FG001|Overall Study|Withdrawal by Subject|0|||
129797273|NCT05140382|467225233|FG002|Overall Study|Withdrawal by Subject|4|||
129797274|NCT05140382|467225231|FG000|Overall Study|Withdrawal of consent|0|||
129797275|NCT05140382|467225232|FG001|Overall Study|Withdrawal of consent|0|||
129797276|NCT05140382|467225233|FG002|Overall Study|Withdrawal of consent|1|||
129797277|NCT02294773|467226592|FG000|Overall Study|Withdrawal by Subject|0|||
129797278|NCT02294773|467226593|FG001|Overall Study|Withdrawal by Subject|2|||
129797279|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Adverse Event|2|||
129797280|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Adverse Event|0|||
129797281|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
129797282|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
129797283|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
129797284|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
129797285|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
129797286|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129797287|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
129797288|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
129797289|NCT04123665|467226598|FG000|Overall Study|Withdrawal by Subject|7|||
129797290|NCT04123665|467226599|FG001|Overall Study|Withdrawal by Subject|0|||
129797291|NCT04123665|467226598|FG000|Overall Study|Lost to Follow-up|1|||
129797292|NCT04123665|467226599|FG001|Overall Study|Lost to Follow-up|0|||
129797293|NCT02237911|467226600|FG000|Overall Study|Withdrawal by Subject|4|||
129797294|NCT02237911|467226601|FG001|Overall Study|Withdrawal by Subject|7|||
129797295|NCT02237911|467226602|FG002|Overall Study|Withdrawal by Subject|2|||
129797296|NCT02237911|467226600|FG000|Overall Study|Lost to Follow-up|3|||
129797297|NCT02237911|467226601|FG001|Overall Study|Lost to Follow-up|1|||
129797298|NCT02237911|467226602|FG002|Overall Study|Lost to Follow-up|1|||
129797299|NCT00053365|467226603|FG000|Overall Study|Incorrect cell type|1|||
129797300|NCT00053365|467226603|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
129797301|NCT00053365|467226603|FG000|Overall Study|Never treated|4|||
129797302|NCT00958789|467226608|FG000|Overall Study|Death|5|||
129797303|NCT00958789|467226608|FG000|Overall Study|Lost to Follow-up|14|||
129797304|NCT00958789|467226608|FG000|Overall Study|Withdrawal by Subject|17|||
129797305|NCT00958789|467226608|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
129797306|NCT00958789|467226608|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
129797307|NCT00958789|467226608|FG000|Overall Study|Subject terminated|2|||
129797308|NCT00958789|467226608|FG000|Overall Study|Revision|7|||
129797309|NCT05007717|467226610|FG000|Overall Study|Death|3|||
129797310|NCT05007717|467226611|FG001|Overall Study|Death|2|||
129797311|NCT00427960|467226613|FG000|Overall Study|Adverse Event|2|||
129797312|NCT00427960|467226614|FG001|Overall Study|Adverse Event|0|||
130303692|NCT00621140|469074985|FG000|Overall Study|Adverse Event|4|||
130303693|NCT00621140|469074986|FG001|Overall Study|Adverse Event|5|||
130303694|NCT00621140|469074985|FG000|Overall Study|Lost to Follow-up|1|||
129797313|NCT00427960|467226613|FG000|Overall Study|Withdrawal by Subject|0|||
129797314|NCT00427960|467226614|FG001|Overall Study|Withdrawal by Subject|3|||
130303695|NCT00621140|469074986|FG001|Overall Study|Lost to Follow-up|2|||
130303696|NCT00621140|469074985|FG000|Overall Study|Withdrawal by Subject|4|||
130303697|NCT00621140|469074986|FG001|Overall Study|Withdrawal by Subject|6|||
129797315|NCT00427960|467226613|FG000|Overall Study|Other|0|||
129797316|NCT00427960|467226614|FG001|Overall Study|Other|1|||
129797317|NCT03282565|467226617|FG000|Overall Study|COVID-19 Research Shutdown|0|||
130303698|NCT00621140|469074985|FG000|Overall Study|Other incl. lack of efficacy|6|||
130303699|NCT00621140|469074986|FG001|Overall Study|Other incl. lack of efficacy|5|||
129797318|NCT03282565|467226618|FG001|Overall Study|COVID-19 Research Shutdown|2|||
129797319|NCT03282565|467226619|FG002|Overall Study|COVID-19 Research Shutdown|2|||
129797320|NCT01869725|467226620|FG000|Overall Study|ineligible after registration|1|||
129797321|NCT01869725|467226620|FG000|Overall Study|Death|1|||
129797322|NCT01869725|467226620|FG000|Overall Study|Lost to Follow-up|2|||
129797323|NCT01143207|467226621|FG000|Overall Study|Lost to Follow-up|2|||
130303700|NCT02873338|469074987|FG000|Overall Study|Adverse Event|0|||
129797324|NCT04163718|467226626|FG000|Overall Study|Study terminated|12|||
129797325|NCT03463031|467226635|FG000|Overall Study|Withdrawal by Subject|4|||
129797326|NCT03463031|467226636|FG001|Overall Study|Withdrawal by Subject|2|||
129797327|NCT03463031|467226635|FG000|Overall Study|Investigator/Sponsor Decision|0|||
129797328|NCT03463031|467226636|FG001|Overall Study|Investigator/Sponsor Decision|1|||
129797329|NCT03463031|467226635|FG000|Overall Study|Lost to Follow-up|1|||
129797330|NCT03463031|467226636|FG001|Overall Study|Lost to Follow-up|1|||
129797331|NCT03463031|467226635|FG000|Overall Study|Adverse Event|4|||
129797332|NCT03463031|467226636|FG001|Overall Study|Adverse Event|1|||
129797333|NCT03463031|467226635|FG000|Overall Study|Use of prohibited medication by subject|1|||
129797334|NCT03463031|467226636|FG001|Overall Study|Use of prohibited medication by subject|0|||
129797335|NCT02131532|467226637|FG000|Overall Study|Withdrawal by Subject|1|||
129797336|NCT02131532|467226637|FG000|Overall Study|Physician Decision|1|||
129797337|NCT02131532|467226637|FG000|Overall Study|Other health conditions|2|||
129797338|NCT01466595|467226643|FG000|Overall Study|Withdrawal by Subject|0|||
129797339|NCT01466595|467226644|FG001|Overall Study|Withdrawal by Subject|1|||
129797340|NCT00057954|467226645|FG000|Overall Study|Death|1|||
130107523|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
130107524|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
130107525|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
130107526|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
130107527|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
130107528|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130107529|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
130107530|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130107531|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
130107532|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130107533|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130107534|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
130107535|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
130107536|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130107537|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
130107538|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
130107539|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130107540|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130107541|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
130107542|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
130107543|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
130107544|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
130107545|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
130107546|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
130107547|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
130107548|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
130107549|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
130107550|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
130107551|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
130107552|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
130107553|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130107554|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
130107555|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130107556|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130107557|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130303701|NCT02873338|469074988|FG001|Overall Study|Adverse Event|2|||
130303702|NCT02873338|469074989|FG002|Overall Study|Adverse Event|1|||
130303703|NCT02873338|469074987|FG000|Overall Study|Death|2|||
129797341|NCT00057954|467226645|FG000|Overall Study|Disease progression|1|||
129797342|NCT01264016|467226646|FG000|Overall Study|Withdrawal by Subject|1|||
129797343|NCT01264016|467226646|FG000|Overall Study|Felt faint at sight of blood|1|||
129797344|NCT02147184|467226647|FG000|Overall Study|Lost to Follow-up|28|||
129797345|NCT02147184|467226648|FG001|Overall Study|Lost to Follow-up|15|||
129797346|NCT02147184|467226647|FG000|Overall Study|Study Burden|11|||
129797347|NCT02147184|467226648|FG001|Overall Study|Study Burden|7|||
129797348|NCT02147184|467226647|FG000|Overall Study|Pregnancy|6|||
129889322|NCT01848834|467552547|FG000|Overall Study|Withdrawal by Subject|2|||
129889323|NCT01848834|467552548|FG001|Overall Study|Withdrawal by Subject|13|||
130303704|NCT02873338|469074988|FG001|Overall Study|Death|1|||
130303705|NCT02873338|469074989|FG002|Overall Study|Death|1|||
130303706|NCT02873338|469074987|FG000|Overall Study|Withdrawal by Subject|2|||
129797349|NCT02147184|467226648|FG001|Overall Study|Pregnancy|0|||
129797350|NCT02147184|467226647|FG000|Overall Study|Moved out of state|3|||
129797351|NCT02147184|467226648|FG001|Overall Study|Moved out of state|3|||
129797352|NCT02147184|467226647|FG000|Overall Study|Physician Decision|0|||
130047911|NCT01937130|468133114|FG003|Overall Study|Patients unable to swallow|0|||
130047912|NCT01937130|468133111|FG000|Overall Study|Patient lost to FU due to death|2|||
130047913|NCT01937130|468133112|FG001|Overall Study|Patient lost to FU due to death|0|||
130047914|NCT01937130|468133113|FG002|Overall Study|Patient lost to FU due to death|0|||
130303707|NCT02873338|469074988|FG001|Overall Study|Withdrawal by Subject|1|||
130303708|NCT02873338|469074989|FG002|Overall Study|Withdrawal by Subject|3|||
130303709|NCT02873338|469074987|FG000|Overall Study|Lack of Efficacy|0|||
130303710|NCT02873338|469074988|FG001|Overall Study|Lack of Efficacy|2|||
130303711|NCT02873338|469074989|FG002|Overall Study|Lack of Efficacy|0|||
130303712|NCT02873338|469074987|FG000|Overall Study|Other or Missing|14|||
130303713|NCT02873338|469074988|FG001|Overall Study|Other or Missing|15|||
130303714|NCT02873338|469074989|FG002|Overall Study|Other or Missing|13|||
130303715|NCT03657095|469074990|FG000|Overall Study|Withdrawal by Subject|1|||
130047915|NCT01937130|468133114|FG003|Overall Study|Patient lost to FU due to death|0|||
130047916|NCT02100657|468133115|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
130047917|NCT02100657|468133116|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
130303716|NCT03657095|469074991|FG001|Overall Study|Withdrawal by Subject|1|||
130303717|NCT03657095|469074990|FG000|Overall Study|Adverse Event|0|||
130047918|NCT02100657|468133117|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
130047919|NCT02100657|468133115|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
130047920|NCT02100657|468133116|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
130047921|NCT02100657|468133117|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
130047922|NCT02100657|468133115|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
130047923|NCT02100657|468133116|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
130047924|NCT02100657|468133117|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
130047925|NCT02100657|468133115|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
130047926|NCT02100657|468133116|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
130047927|NCT02100657|468133117|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
130303718|NCT03657095|469074991|FG001|Overall Study|Adverse Event|3|||
130303719|NCT03657095|469074990|FG000|Overall Study|Study Terminated by Sponsor|58|||
130303720|NCT03657095|469074991|FG001|Overall Study|Study Terminated by Sponsor|49|||
130303721|NCT02980133|469074992|FG000|Overall Study|Other than specified|1|||
130303722|NCT02980133|469074993|FG001|Overall Study|Other than specified|1|||
130303723|NCT02980133|469074994|FG002|Overall Study|Other than specified|2|||
130303724|NCT02980133|469074995|FG003|Overall Study|Other than specified|2|||
130303725|NCT02980133|469074992|FG000|Overall Study|Lost to Follow-up|0|||
130303726|NCT02980133|469074993|FG001|Overall Study|Lost to Follow-up|0|||
130303727|NCT02980133|469074994|FG002|Overall Study|Lost to Follow-up|1|||
130303728|NCT02980133|469074995|FG003|Overall Study|Lost to Follow-up|3|||
130303729|NCT02980133|469074992|FG000|Overall Study|Protocol Violation|0|||
130303730|NCT02980133|469074993|FG001|Overall Study|Protocol Violation|1|||
130303731|NCT02980133|469074994|FG002|Overall Study|Protocol Violation|0|||
130303732|NCT02980133|469074995|FG003|Overall Study|Protocol Violation|0|||
130047928|NCT02100657|468133115|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
130303733|NCT02980133|469074992|FG000|Overall Study|Withdrawal by parent/guardian|6|||
130303734|NCT02980133|469074993|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130303735|NCT02980133|469074994|FG002|Overall Study|Withdrawal by parent/guardian|3|||
129889324|NCT01848834|467552549|FG002|Overall Study|Withdrawal by Subject|10|||
129889325|NCT01848834|467552550|FG003|Overall Study|Withdrawal by Subject|6|||
129889326|NCT01848834|467552551|FG004|Overall Study|Withdrawal by Subject|36|||
129889327|NCT02040090|467552552|FG000|Overall Study|Adverse Event|2|||
129889328|NCT02040090|467552553|FG001|Overall Study|Adverse Event|0|||
129889329|NCT02040090|467552552|FG000|Overall Study|Physician Decision|1|||
130047929|NCT02100657|468133116|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
130047930|NCT02100657|468133117|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
130047931|NCT02100657|468133115|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
130047932|NCT02100657|468133116|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
130047933|NCT02100657|468133117|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
130047934|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
130047935|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
130047936|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
130047937|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Death|0|||
130047938|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Death|0|||
130047939|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Death|1|||
130047940|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
130047941|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
130303736|NCT02980133|469074995|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130303737|NCT02980133|469074992|FG000|Overall Study|Withdrawal by Subject|0|||
130303738|NCT02980133|469074993|FG001|Overall Study|Withdrawal by Subject|0|||
130303739|NCT02980133|469074994|FG002|Overall Study|Withdrawal by Subject|1|||
130303740|NCT02980133|469074995|FG003|Overall Study|Withdrawal by Subject|0|||
130303741|NCT00384332|469074996|FG000|Overall Study|Lost to Follow-up|4|||
130303742|NCT00384332|469074997|FG001|Overall Study|Lost to Follow-up|0|||
130303743|NCT02560012|469074998|FG000|Overall Study|Study Terminated|2|||
130303744|NCT01007838|469074999|FG000|Overall Study|Withdrawal by Subject|1|||
130303745|NCT01007838|469075000|FG001|Overall Study|Withdrawal by Subject|0|||
130303746|NCT01007838|469075001|FG002|Overall Study|Withdrawal by Subject|0|||
130303747|NCT01007838|469075002|FG003|Overall Study|Withdrawal by Subject|0|||
130303748|NCT01007838|469074999|FG000|Overall Study|Physician Decision|1|||
130303749|NCT01007838|469075000|FG001|Overall Study|Physician Decision|0|||
130303750|NCT01007838|469075001|FG002|Overall Study|Physician Decision|0|||
130303751|NCT01007838|469075002|FG003|Overall Study|Physician Decision|0|||
130303752|NCT01007838|469074999|FG000|Overall Study|Started home haemodialysis|1|||
130303753|NCT01007838|469075000|FG001|Overall Study|Started home haemodialysis|0|||
130303754|NCT01007838|469075001|FG002|Overall Study|Started home haemodialysis|0|||
130303755|NCT01007838|469075002|FG003|Overall Study|Started home haemodialysis|0|||
130303756|NCT00852241|469075003|FG000|Overall Study|Physician Decision|18|||
130303757|NCT00118430|469075005|FG000|Overall Study|Withdrawal by Subject|6|||
130303758|NCT00118430|469075006|FG001|Overall Study|Withdrawal by Subject|2|||
130303759|NCT00118430|469075007|FG002|Overall Study|Withdrawal by Subject|0|||
130303760|NCT00118430|469075005|FG000|Overall Study|Lost to Follow-up|15|||
130303761|NCT00118430|469075006|FG001|Overall Study|Lost to Follow-up|22|||
130303762|NCT00118430|469075007|FG002|Overall Study|Lost to Follow-up|28|||
130303763|NCT02147288|469075008|FG000|Overall Study|post-operative hematoma|1|||
130303764|NCT02147288|469075009|FG001|Overall Study|post-operative hematoma|1|||
130303765|NCT02147288|469075010|FG002|Overall Study|post-operative hematoma|0|||
130303766|NCT02147288|469075011|FG003|Overall Study|post-operative hematoma|0|||
130303767|NCT02147288|469075012|FG004|Overall Study|post-operative hematoma|0|||
130303768|NCT02147288|469075013|FG005|Overall Study|post-operative hematoma|0|||
130303769|NCT02147288|469075014|FG006|Overall Study|post-operative hematoma|0|||
130303770|NCT02147288|469075015|FG007|Overall Study|post-operative hematoma|0|||
130303771|NCT02147288|469075016|FG008|Overall Study|post-operative hematoma|0|||
130303772|NCT02147288|469075017|FG009|Overall Study|post-operative hematoma|0|||
130303773|NCT02147288|469075008|FG000|Overall Study|complications from concurrent hernia rep|0|||
130303774|NCT02147288|469075009|FG001|Overall Study|complications from concurrent hernia rep|1|||
130303775|NCT02147288|469075010|FG002|Overall Study|complications from concurrent hernia rep|0|||
130303776|NCT02147288|469075011|FG003|Overall Study|complications from concurrent hernia rep|0|||
130303777|NCT02147288|469075012|FG004|Overall Study|complications from concurrent hernia rep|0|||
130303778|NCT02147288|469075013|FG005|Overall Study|complications from concurrent hernia rep|0|||
130303779|NCT02147288|469075014|FG006|Overall Study|complications from concurrent hernia rep|0|||
130303780|NCT02147288|469075015|FG007|Overall Study|complications from concurrent hernia rep|0|||
130303781|NCT02147288|469075016|FG008|Overall Study|complications from concurrent hernia rep|0|||
130303782|NCT02147288|469075017|FG009|Overall Study|complications from concurrent hernia rep|0|||
130303783|NCT02069392|469075020|FG000|Overall Study|Withdrawal by Subject|4|||
130303784|NCT02069392|469075021|FG001|Overall Study|Withdrawal by Subject|2|||
130303785|NCT00269633|469075022|FG000|Overall Study|Withdrawal by Subject|1|||
130303786|NCT00269633|469075023|FG001|Overall Study|Withdrawal by Subject|0|||
130303787|NCT02927938|469075024|FG000|Overall Study|Death|0|||
130303788|NCT02927938|469075025|FG001|Overall Study|Death|1|||
130303789|NCT02927938|469075026|FG002|Overall Study|Death|0|||
130303790|NCT02927938|469075027|FG003|Overall Study|Death|4|||
130303791|NCT02927938|469075024|FG000|Overall Study|Early Study Termination|1|||
130303792|NCT02927938|469075025|FG001|Overall Study|Early Study Termination|5|||
130303793|NCT02927938|469075026|FG002|Overall Study|Early Study Termination|4|||
130303794|NCT02927938|469075027|FG003|Overall Study|Early Study Termination|3|||
130303795|NCT02476006|469075028|FG000|Overall Study|Death|4|||
130303796|NCT02476006|469075028|FG000|Overall Study|Lack of treatment efficacy|2|||
130303797|NCT02476006|469075028|FG000|Overall Study|Pregnancy|1|||
130303798|NCT02476006|469075028|FG000|Overall Study|Participant did not wish to continue|39|||
130303799|NCT02476006|469075028|FG000|Overall Study|Adverse Event|41|||
130303800|NCT02476006|469075028|FG000|Overall Study|Poor compliance to study protocol|3|||
130303801|NCT02476006|469075028|FG000|Overall Study|Sponsor decision|6|||
130303802|NCT02476006|469075028|FG000|Overall Study|Lost to Follow-up|5|||
130303803|NCT02476006|469075028|FG000|Overall Study|Physician Decision|5|||
130303804|NCT02476006|469075028|FG000|Overall Study|Study ended treatment not available|4|||
130303805|NCT02476006|469075028|FG000|Overall Study|Switched to commercial drug|4|||
130303806|NCT02476006|469075028|FG000|Overall Study|Excluded from study|1|||
130303807|NCT02476006|469075028|FG000|Overall Study|Protocol Violation|1|||
130303808|NCT02476006|469075028|FG000|Overall Study|Enrolled but not treated|4|||
130303809|NCT02611817|469077312|FG000|Open-label Induction Phase|Reason not Specified|9|||
130303810|NCT02611817|469077313|FG001|Open-label Induction Phase|Reason not Specified|0|||
130303811|NCT02611817|469077314|FG002|Open-label Induction Phase|Reason not Specified|0|||
130303812|NCT02611817|469077312|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
130303813|NCT02611817|469077313|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
130303814|NCT02611817|469077314|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
130303815|NCT02611817|469077312|FG000|Open-label Induction Phase|Pregnancy|1|||
130303816|NCT02611817|469077313|FG001|Open-label Induction Phase|Pregnancy|0|||
130303817|NCT02611817|469077314|FG002|Open-label Induction Phase|Pregnancy|0|||
130303818|NCT02611817|469077312|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
130303819|NCT02611817|469077313|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
130303820|NCT02611817|469077314|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
130303821|NCT02611817|469077312|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
130303822|NCT02611817|469077313|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
130303823|NCT02611817|469077314|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
130303824|NCT02611817|469077312|FG000|Open-label Induction Phase|Protocol Violation|5|||
130047942|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
130047943|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
130047944|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
130047945|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
130047946|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
130303825|NCT02611817|469077313|FG001|Open-label Induction Phase|Protocol Violation|0|||
130303826|NCT02611817|469077314|FG002|Open-label Induction Phase|Protocol Violation|0|||
130303827|NCT02611817|469077312|FG000|Open-label Induction Phase|Adverse Event|16|||
130303828|NCT02611817|469077313|FG001|Open-label Induction Phase|Adverse Event|0|||
130303829|NCT02611817|469077314|FG002|Open-label Induction Phase|Adverse Event|0|||
130303830|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
130303831|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
130303832|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
130303833|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
130303834|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
130303835|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
130303836|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
130303837|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
130303838|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
130303839|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
130303840|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
130303841|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
130303842|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
130303843|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
130303844|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
130303845|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
130303846|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
130303847|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
130303848|NCT02611817|469077312|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
130303849|NCT02611817|469077313|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
130303850|NCT02611817|469077314|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
130303851|NCT00931606|469077315|FG000|Overall Study|Death|1|||
130303852|NCT00931606|469077316|FG001|Overall Study|Death|3|||
130303853|NCT00931606|469077317|FG002|Overall Study|Death|2|||
130303854|NCT00931606|469077318|FG003|Overall Study|Death|0|||
130303855|NCT00931606|469077315|FG000|Overall Study|Lost to Follow-up|0|||
130303856|NCT00931606|469077316|FG001|Overall Study|Lost to Follow-up|1|||
130303857|NCT00931606|469077317|FG002|Overall Study|Lost to Follow-up|0|||
130303858|NCT00931606|469077318|FG003|Overall Study|Lost to Follow-up|0|||
130303859|NCT00931606|469077315|FG000|Overall Study|Physician Decision|0|||
130303860|NCT00931606|469077316|FG001|Overall Study|Physician Decision|0|||
130303861|NCT00931606|469077317|FG002|Overall Study|Physician Decision|3|||
130303862|NCT00931606|469077318|FG003|Overall Study|Physician Decision|0|||
130303863|NCT00931606|469077315|FG000|Overall Study|Sponsor Decision|1|||
130303864|NCT00931606|469077316|FG001|Overall Study|Sponsor Decision|4|||
130303865|NCT00931606|469077317|FG002|Overall Study|Sponsor Decision|0|||
130303866|NCT00931606|469077318|FG003|Overall Study|Sponsor Decision|2|||
130303867|NCT00931606|469077315|FG000|Overall Study|Withdrawal by Subject|3|||
130303868|NCT00931606|469077316|FG001|Overall Study|Withdrawal by Subject|1|||
130303869|NCT00931606|469077317|FG002|Overall Study|Withdrawal by Subject|1|||
130303870|NCT00931606|469077318|FG003|Overall Study|Withdrawal by Subject|1|||
130303871|NCT03412812|469077326|FG000|Level 1|Death|3|||
130303872|NCT03412812|469077327|FG001|Level 1|Death|0|||
130303873|NCT03412812|469077326|FG000|Level 1|Adverse Event|0|||
130303874|NCT03412812|469077327|FG001|Level 1|Adverse Event|1|||
130303875|NCT03828617|469077331|FG000|Overall Study|Lost to Follow-up|22|||
130303876|NCT03828617|469077332|FG001|Overall Study|Lost to Follow-up|12|||
130303877|NCT03828617|469077333|FG002|Overall Study|Lost to Follow-up|23|||
130303878|NCT03828617|469077334|FG003|Overall Study|Lost to Follow-up|7|||
130303879|NCT03828617|469077331|FG000|Overall Study|No longer met eligibility criteria|0|||
130303880|NCT03828617|469077332|FG001|Overall Study|No longer met eligibility criteria|1|||
130303881|NCT03828617|469077333|FG002|Overall Study|No longer met eligibility criteria|1|||
130303882|NCT03828617|469077334|FG003|Overall Study|No longer met eligibility criteria|3|||
130303883|NCT03828617|469077331|FG000|Overall Study|Protocol Violation|0|||
130303884|NCT03828617|469077332|FG001|Overall Study|Protocol Violation|2|||
130303885|NCT03828617|469077333|FG002|Overall Study|Protocol Violation|0|||
130303886|NCT03828617|469077334|FG003|Overall Study|Protocol Violation|0|||
130303887|NCT03828617|469077331|FG000|Overall Study|Withdrawal by Subject|2|||
130303888|NCT03828617|469077332|FG001|Overall Study|Withdrawal by Subject|0|||
130303889|NCT03828617|469077333|FG002|Overall Study|Withdrawal by Subject|2|||
130303890|NCT03828617|469077334|FG003|Overall Study|Withdrawal by Subject|0|||
130303891|NCT03826186|469077335|FG000|Overall Study|Protocol Violation|2|||
130303892|NCT03826186|469077336|FG001|Overall Study|Protocol Violation|0|||
130303893|NCT03826186|469077335|FG000|Overall Study|Withdrawal by Subject|1|||
130303894|NCT03826186|469077336|FG001|Overall Study|Withdrawal by Subject|0|||
129797353|NCT02147184|467226648|FG001|Overall Study|Physician Decision|2|||
130303895|NCT00082407|469077339|FG000|Overall Study|Adverse Event|20|||
130303896|NCT00082407|469077340|FG001|Overall Study|Adverse Event|0|||
130303897|NCT00082407|469077339|FG000|Overall Study|Protocol Violation|14|||
130303898|NCT00082407|469077340|FG001|Overall Study|Protocol Violation|12|||
130303899|NCT00082407|469077339|FG000|Overall Study|Patient Decision|13|||
130303900|NCT00082407|469077340|FG001|Overall Study|Patient Decision|6|||
130303901|NCT00082407|469077339|FG000|Overall Study|Physician Decision|5|||
130303902|NCT00082407|469077340|FG001|Overall Study|Physician Decision|3|||
130303903|NCT00082407|469077339|FG000|Overall Study|Loss of Glucose Control|2|||
129797354|NCT02147184|467226647|FG000|Overall Study|Other|1|||
130303904|NCT00082407|469077340|FG001|Overall Study|Loss of Glucose Control|2|||
130303905|NCT00082407|469077339|FG000|Overall Study|Death|2|||
130303906|NCT00082407|469077340|FG001|Overall Study|Death|1|||
129797355|NCT02147184|467226648|FG001|Overall Study|Other|0|||
129797356|NCT02117414|467226649|FG000|Overall Study|Death|5|||
129797357|NCT02117414|467226650|FG001|Overall Study|Death|2|||
129797358|NCT02117414|467226649|FG000|Overall Study|Withdrawal by Subject|10|||
129797359|NCT02117414|467226650|FG001|Overall Study|Withdrawal by Subject|4|||
130107558|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
130303907|NCT00082407|469077339|FG000|Overall Study|Lost to Follow-up|0|||
130303908|NCT00082407|469077340|FG001|Overall Study|Lost to Follow-up|3|||
130303909|NCT00891228|469077342|FG000|Overall Study|Adverse Event|0|||
130303910|NCT00891228|469077343|FG001|Overall Study|Adverse Event|2|||
130303911|NCT00891228|469077344|FG002|Overall Study|Adverse Event|3|||
130303912|NCT00891228|469077342|FG000|Overall Study|Withdrawal by Subject|2|||
130303913|NCT00891228|469077343|FG001|Overall Study|Withdrawal by Subject|4|||
130303914|NCT00891228|469077344|FG002|Overall Study|Withdrawal by Subject|5|||
130303915|NCT00891228|469077342|FG000|Overall Study|Protocol Violation|3|||
130303916|NCT00891228|469077343|FG001|Overall Study|Protocol Violation|1|||
130303917|NCT00891228|469077344|FG002|Overall Study|Protocol Violation|2|||
130303918|NCT00891228|469077342|FG000|Overall Study|Physician Decision|2|||
130303919|NCT00891228|469077343|FG001|Overall Study|Physician Decision|1|||
130303920|NCT00891228|469077344|FG002|Overall Study|Physician Decision|0|||
130303921|NCT00891228|469077342|FG000|Overall Study|Lost to Follow-up|4|||
130303922|NCT00891228|469077343|FG001|Overall Study|Lost to Follow-up|4|||
130303923|NCT00891228|469077344|FG002|Overall Study|Lost to Follow-up|5|||
130303924|NCT00891228|469077342|FG000|Overall Study|Pregnancy|0|||
130303925|NCT00891228|469077343|FG001|Overall Study|Pregnancy|1|||
130303926|NCT00891228|469077344|FG002|Overall Study|Pregnancy|0|||
130303927|NCT02688985|469077347|FG000|Overall Study|Adverse Event|1|||
130303928|NCT02688985|469077348|FG001|Overall Study|Adverse Event|2|||
130303929|NCT02688985|469077349|FG002|Overall Study|Adverse Event|2|||
130303930|NCT02688985|469077350|FG003|Overall Study|Adverse Event|0|||
130303931|NCT02688985|469077351|FG004|Overall Study|Adverse Event|0|||
130303932|NCT02688985|469077347|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
130303933|NCT02688985|469077348|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
130303934|NCT02688985|469077349|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
130303935|NCT02688985|469077350|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
129797360|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
129797361|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
129797362|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
129797363|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
129797364|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
129797365|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
129797366|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
129797367|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
129797368|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
129797369|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Death|1|||
129797370|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Death|0|||
129797371|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Death|0|||
129797372|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
129797373|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
129797374|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
129797375|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
129797376|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
129797377|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
129797378|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
129797379|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
129797380|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
129797381|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Death|1|||
129797382|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Death|1|||
129797383|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Death|0|||
129797384|NCT06400979|467226656|FG000|Overall Study|Lost to Follow-up|29|||
129797385|NCT06400979|467226656|FG000|Overall Study|Withdrawal by Subject|1|||
129797386|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
129797387|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
129797388|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
129797389|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
129797390|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129797391|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
129797392|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129797393|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
129797394|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
129797395|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
129797396|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
129797397|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
129797398|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
129797399|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
129797400|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
129797401|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
130107559|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
130107560|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
130303936|NCT02688985|469077351|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
129797402|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Program Termination|3|||
129797403|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Program Termination|0|||
129797404|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Program Termination|1|||
129797405|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Program Termination|1|||
129797406|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
129797407|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
129797408|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
129797409|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
129797410|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
130303937|NCT02688985|469077347|FG000|Overall Study|Death|0|||
130303938|NCT02688985|469077348|FG001|Overall Study|Death|0|||
130303939|NCT02688985|469077349|FG002|Overall Study|Death|0|||
130303940|NCT02688985|469077350|FG003|Overall Study|Death|0|||
130303941|NCT02688985|469077351|FG004|Overall Study|Death|1|||
130303942|NCT02688985|469077347|FG000|Overall Study|Lack of Efficacy|0|||
130303943|NCT02688985|469077348|FG001|Overall Study|Lack of Efficacy|0|||
130303944|NCT02688985|469077349|FG002|Overall Study|Lack of Efficacy|0|||
130303945|NCT02688985|469077350|FG003|Overall Study|Lack of Efficacy|0|||
129797411|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
130303946|NCT02688985|469077351|FG004|Overall Study|Lack of Efficacy|1|||
130303947|NCT02688985|469077347|FG000|Overall Study|Lost to Follow-up|2|||
130303948|NCT02688985|469077348|FG001|Overall Study|Lost to Follow-up|0|||
129889330|NCT02040090|467552553|FG001|Overall Study|Physician Decision|0|||
130303949|NCT02688985|469077349|FG002|Overall Study|Lost to Follow-up|1|||
130303950|NCT02688985|469077350|FG003|Overall Study|Lost to Follow-up|1|||
129797412|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
130303951|NCT02688985|469077351|FG004|Overall Study|Lost to Follow-up|1|||
130303952|NCT02688985|469077347|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130303953|NCT02688985|469077348|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130303954|NCT02688985|469077349|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129797413|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
129797414|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
129797415|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
129797416|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
129797417|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
129797418|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
129797419|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
129797420|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
129797421|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
129797422|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
129797423|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
129797424|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
129797425|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
129797426|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
129797427|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
129797428|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
129797429|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
129797430|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
129797431|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
129797432|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
129797433|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
129797434|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
129797435|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
129797436|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
129797437|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
129797438|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
129797439|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
129797440|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
129797441|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
129797442|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
129797443|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
129797444|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
129797445|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
129797446|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
129797447|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
129797448|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
129797449|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
129797450|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
129797451|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
129797452|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
129797453|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
129797454|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
129797455|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
129797456|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
129797457|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
129797458|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
129797459|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
129797460|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
129797461|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
129797462|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
129797463|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
129797464|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
129797465|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
129797466|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
129797467|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
129797468|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
129797469|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
129797470|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
129797471|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
129797472|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
129797473|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
130303955|NCT02688985|469077350|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129797474|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
130303956|NCT02688985|469077351|FG004|Overall Study|Non-Compliance With Study Drug|1|||
130303957|NCT02688985|469077347|FG000|Overall Study|Other|3|||
130303958|NCT02688985|469077348|FG001|Overall Study|Other|4|||
130303959|NCT02688985|469077349|FG002|Overall Study|Other|1|||
130303960|NCT02688985|469077350|FG003|Overall Study|Other|0|||
130303961|NCT02688985|469077351|FG004|Overall Study|Other|0|||
130303962|NCT02688985|469077347|FG000|Overall Study|Physician Decision|2|||
129797475|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
129797476|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
129797477|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
129797478|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
130303963|NCT02688985|469077348|FG001|Overall Study|Physician Decision|2|||
130303964|NCT02688985|469077349|FG002|Overall Study|Physician Decision|0|||
130303965|NCT02688985|469077350|FG003|Overall Study|Physician Decision|0|||
130303966|NCT02688985|469077351|FG004|Overall Study|Physician Decision|1|||
130303967|NCT02688985|469077347|FG000|Overall Study|Pregnancy|0|||
130303968|NCT02688985|469077348|FG001|Overall Study|Pregnancy|0|||
130303969|NCT02688985|469077349|FG002|Overall Study|Pregnancy|2|||
130303970|NCT02688985|469077350|FG003|Overall Study|Pregnancy|1|||
129797479|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
129797480|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
129797481|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
129797482|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
130303971|NCT02688985|469077351|FG004|Overall Study|Pregnancy|0|||
130303972|NCT02688985|469077347|FG000|Overall Study|Study Terminated By Sponsor|0|||
130303973|NCT02688985|469077348|FG001|Overall Study|Study Terminated By Sponsor|0|||
130303974|NCT02688985|469077349|FG002|Overall Study|Study Terminated By Sponsor|0|||
130303975|NCT02688985|469077350|FG003|Overall Study|Study Terminated By Sponsor|1|||
130303976|NCT02688985|469077351|FG004|Overall Study|Study Terminated By Sponsor|0|||
130303977|NCT02688985|469077347|FG000|Overall Study|Withdrawal by Subject|2|||
130303978|NCT02688985|469077348|FG001|Overall Study|Withdrawal by Subject|8|||
130303979|NCT02688985|469077349|FG002|Overall Study|Withdrawal by Subject|7|||
130303980|NCT02688985|469077350|FG003|Overall Study|Withdrawal by Subject|1|||
130303981|NCT02688985|469077351|FG004|Overall Study|Withdrawal by Subject|4|||
130303982|NCT01726582|469077354|FG000|Overall Study|Physician Decision|99|||
129797483|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
129797484|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
129797485|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
129797486|NCT01058265|467226663|FG000|Overall Study|Lost to Follow-up|11|||
129797487|NCT01058265|467226664|FG001|Overall Study|Lost to Follow-up|12|||
130303983|NCT01726582|469077354|FG000|Overall Study|Death|85|||
130303984|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
130303985|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
130303986|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
130303987|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
129797488|NCT02869438|467226665|FG000|Overall Study|Lost to Follow-up|1|||
129797489|NCT02869438|467226666|FG001|Overall Study|Lost to Follow-up|0|||
129797490|NCT02869438|467226665|FG000|Overall Study|Adverse Event|1|||
129797491|NCT02869438|467226666|FG001|Overall Study|Adverse Event|0|||
129797492|NCT02869438|467226665|FG000|Overall Study|Withdrawal by Subject|1|||
129797493|NCT02869438|467226666|FG001|Overall Study|Withdrawal by Subject|2|||
129797494|NCT02169284|467226669|FG000|Overall Study|Physician Decision|0|||
129797495|NCT02169284|467226670|FG001|Overall Study|Physician Decision|1|||
129797496|NCT00984568|467226671|FG000|Overall Study|Withdrawal by Subject|1|||
129797497|NCT00984568|467226672|FG001|Overall Study|Withdrawal by Subject|2|||
129797498|NCT00984568|467226671|FG000|Overall Study|Lack of Efficacy|2|||
129797499|NCT00984568|467226672|FG001|Overall Study|Lack of Efficacy|0|||
129797500|NCT00984568|467226671|FG000|Overall Study|Adverse Event|2|||
129797501|NCT00984568|467226672|FG001|Overall Study|Adverse Event|0|||
130303988|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
129797502|NCT00984568|467226671|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
129797503|NCT00984568|467226672|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
129797504|NCT00984568|467226671|FG000|Overall Study|Lost to Follow-up|0|||
129797505|NCT00984568|467226672|FG001|Overall Study|Lost to Follow-up|1|||
129797506|NCT00984568|467226671|FG000|Overall Study|Opportunistic Infection|1|||
129797507|NCT00984568|467226672|FG001|Overall Study|Opportunistic Infection|0|||
129797508|NCT00984568|467226671|FG000|Overall Study|Unknown Reason|1|||
129797509|NCT00984568|467226672|FG001|Overall Study|Unknown Reason|3|||
129797510|NCT03583073|467226673|FG000|Overall Study|Lost to Follow-up|8|||
129797511|NCT03583073|467226674|FG001|Overall Study|Lost to Follow-up|12|||
129797512|NCT01367119|467226675|FG000|Overall Study|Adverse Event|1|||
130303989|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
130303990|NCT01363908|469077355|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
130303991|NCT01363908|469077356|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
130303992|NCT03437577|469077357|FG000|Pre-Randomization|Withdrawal by Subject|0|||
130303993|NCT03437577|469077358|FG001|Pre-Randomization|Withdrawal by Subject|0|||
130303994|NCT03437577|469077359|FG002|Pre-Randomization|Withdrawal by Subject|10|||
130303995|NCT03437577|469077357|FG000|Post-Randomization|Physician Decision|0|||
129797513|NCT01367119|467226676|FG001|Overall Study|Adverse Event|0|||
129797514|NCT01367119|467226675|FG000|Overall Study|Withdrawal by Subject|1|||
129797515|NCT01367119|467226676|FG001|Overall Study|Withdrawal by Subject|1|||
129797516|NCT03180684|467226677|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
129797517|NCT03180684|467226678|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
129797518|NCT03180684|467226677|FG000|Overall Study|Physician Decision|1|||
129797519|NCT03180684|467226678|FG001|Overall Study|Physician Decision|0|||
129797520|NCT03180684|467226677|FG000|Overall Study|Lost to Follow-up|1|||
129797521|NCT03180684|467226678|FG001|Overall Study|Lost to Follow-up|0|||
129797522|NCT03180684|467226677|FG000|Overall Study|Progressive Disease|1|||
129797523|NCT03180684|467226678|FG001|Overall Study|Progressive Disease|0|||
129797524|NCT02675231|467226679|FG000|Overall Study|Withdrawal by Subject|2|||
129797525|NCT02675231|467226680|FG001|Overall Study|Withdrawal by Subject|4|||
129797526|NCT02675231|467226681|FG002|Overall Study|Withdrawal by Subject|2|||
129797527|NCT02675231|467226679|FG000|Overall Study|Lost to Follow-up|3|||
129797528|NCT02675231|467226680|FG001|Overall Study|Lost to Follow-up|4|||
129797529|NCT02675231|467226681|FG002|Overall Study|Lost to Follow-up|3|||
129797530|NCT03370289|467226686|FG000|Overall Study|Screen Failure|1|||
129797531|NCT03370289|467226686|FG000|Overall Study|Sample Size Sufficient|4|||
129797532|NCT02220998|467226688|FG000|Overall Study|Randomized but Never Treated|1|||
129797533|NCT02220998|467226689|FG001|Overall Study|Randomized but Never Treated|2|||
129797534|NCT02220998|467226688|FG000|Overall Study|Death|2|||
129797535|NCT02220998|467226689|FG001|Overall Study|Death|0|||
129797536|NCT02220998|467226688|FG000|Overall Study|Lack of Efficacy|0|||
129797537|NCT02220998|467226689|FG001|Overall Study|Lack of Efficacy|5|||
129797538|NCT02220998|467226688|FG000|Overall Study|Lost to Follow-up|4|||
129797539|NCT02220998|467226689|FG001|Overall Study|Lost to Follow-up|4|||
129797540|NCT00873860|467226690|FG000|Overall Study|Lost to Follow-up|1|||
129797541|NCT00873860|467226691|FG001|Overall Study|Lost to Follow-up|0|||
129797542|NCT00873860|467226692|FG002|Overall Study|Lost to Follow-up|0|||
129797543|NCT00873860|467226693|FG003|Overall Study|Lost to Follow-up|1|||
129797544|NCT00873860|467226690|FG000|Overall Study|Withdrawal by Subject|1|||
129797545|NCT00873860|467226691|FG001|Overall Study|Withdrawal by Subject|0|||
129797546|NCT00873860|467226692|FG002|Overall Study|Withdrawal by Subject|2|||
129797547|NCT00873860|467226693|FG003|Overall Study|Withdrawal by Subject|0|||
129797548|NCT00873860|467226690|FG000|Overall Study|Death|1|||
129797549|NCT00873860|467226691|FG001|Overall Study|Death|0|||
129797550|NCT00873860|467226692|FG002|Overall Study|Death|0|||
129797551|NCT00873860|467226693|FG003|Overall Study|Death|0|||
129797552|NCT00873860|467226690|FG000|Overall Study|Other|1|||
129797553|NCT00873860|467226691|FG001|Overall Study|Other|0|||
129797554|NCT00873860|467226692|FG002|Overall Study|Other|1|||
130047947|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
130047948|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
130047949|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
130047950|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
130303996|NCT03437577|469077358|FG001|Post-Randomization|Physician Decision|2|||
130303997|NCT03437577|469077359|FG002|Post-Randomization|Physician Decision|0|||
129797555|NCT00873860|467226693|FG003|Overall Study|Other|0|||
129797556|NCT01610271|467226710|FG000|Overall Study|Surgery not complete|0|||
129797557|NCT01610271|467226711|FG001|Overall Study|Surgery not complete|1|||
129797558|NCT01610271|467226710|FG000|Overall Study|Prosthesis not implanted|2|||
129797559|NCT01610271|467226711|FG001|Overall Study|Prosthesis not implanted|3|||
129797560|NCT00364130|467226712|FG000|Intervention Period|Lost to Follow-up|4|||
129797561|NCT00364130|467226713|FG001|Intervention Period|Lost to Follow-up|3|||
129797562|NCT00364130|467226712|FG000|Intervention Period|Pregnancy|1|||
129797563|NCT00364130|467226713|FG001|Intervention Period|Pregnancy|0|||
129797564|NCT00364130|467226712|FG000|Intervention Period|Withdrawal by Subject|4|||
129797565|NCT00364130|467226713|FG001|Intervention Period|Withdrawal by Subject|5|||
129797566|NCT00364130|467226712|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
129797567|NCT00364130|467226713|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
129797568|NCT05281601|467226714|FG000|Overall Study|Physician Decision|2|||
129797569|NCT05281601|467226715|FG001|Overall Study|Physician Decision|0|||
129797570|NCT05281601|467226714|FG000|Overall Study|Lost to Follow-up|2|||
129797571|NCT05281601|467226715|FG001|Overall Study|Lost to Follow-up|0|||
129797572|NCT05281601|467226714|FG000|Overall Study|Death|1|||
129797573|NCT05281601|467226715|FG001|Overall Study|Death|0|||
129797574|NCT05281601|467226714|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130047951|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
129797575|NCT05281601|467226715|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129797576|NCT00586846|467226716|FG000|Overall Study|Physician Decision|1|||
129797577|NCT00586846|467226716|FG000|Overall Study|Death|1|||
129797578|NCT00586846|467226716|FG000|Overall Study|Evaluable for Toxicity Only|4|||
129797579|NCT00144027|467226718|FG000|Overall Study|Lost to Follow-up|1|||
130303998|NCT00536471|469077360|FG000|Overall Study|Lost to Follow-up|48|||
129797580|NCT00144027|467226719|FG001|Overall Study|Lost to Follow-up|3|||
129797581|NCT00144027|467226718|FG000|Overall Study|Withdrawal by Subject|2|||
129797582|NCT00144027|467226719|FG001|Overall Study|Withdrawal by Subject|2|||
130107561|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
130107562|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
130107563|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
130107564|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
130107565|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
130107566|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
130107567|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
130107568|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
130107569|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
130107570|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
130107571|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
130107572|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
130107573|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
130107574|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
130107575|NCT04440163|468355147|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
130107576|NCT04440163|468355148|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
130107577|NCT04440163|468355149|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
130107578|NCT04440163|468355150|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
130107579|NCT04440163|468355151|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
130107580|NCT04440163|468355152|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
130107581|NCT04440163|468355153|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
130107582|NCT04440163|468355154|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
130107583|NCT04440163|468355147|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
130107584|NCT04440163|468355148|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
130107585|NCT04440163|468355149|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
130107586|NCT04440163|468355150|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
130107587|NCT04440163|468355151|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
130107588|NCT04440163|468355152|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
129797583|NCT00144027|467226718|FG000|Overall Study|did not complete baseline assessment|0|||
129797584|NCT00144027|467226719|FG001|Overall Study|did not complete baseline assessment|6|||
129797585|NCT04597918|467226720|FG000|Overall Study|Withdrawal by Subject|6|||
129797586|NCT04597918|467226720|FG000|Overall Study|Lost to Follow-up|3|||
129797587|NCT04597918|467226720|FG000|Overall Study|Death|1|||
129797588|NCT00395538|467226721|FG000|Overall Study|Did not re-consent to revised protocol|1|||
129797589|NCT00395538|467226722|FG001|Overall Study|Did not re-consent to revised protocol|10|||
129797590|NCT00395538|467226723|FG002|Overall Study|Did not re-consent to revised protocol|0|||
129797591|NCT00395538|467226721|FG000|Overall Study|FDA partial hold on PTH|0|||
129797592|NCT00395538|467226722|FG001|Overall Study|FDA partial hold on PTH|0|||
129797593|NCT00395538|467226723|FG002|Overall Study|FDA partial hold on PTH|11|||
129797594|NCT00395538|467226721|FG000|Overall Study|Failed screening|0|||
129797595|NCT00395538|467226722|FG001|Overall Study|Failed screening|0|||
129797596|NCT00395538|467226723|FG002|Overall Study|Failed screening|4|||
129797597|NCT00395538|467226721|FG000|Overall Study|Switch to Natpara|0|||
129797598|NCT00395538|467226722|FG001|Overall Study|Switch to Natpara|0|||
129797599|NCT00395538|467226723|FG002|Overall Study|Switch to Natpara|3|||
129797600|NCT00395538|467226721|FG000|Overall Study|Adverse Event|1|||
129797601|NCT00395538|467226722|FG001|Overall Study|Adverse Event|0|||
129797602|NCT00395538|467226723|FG002|Overall Study|Adverse Event|2|||
129797603|NCT00395538|467226721|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
129797604|NCT00395538|467226722|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
129797605|NCT00395538|467226723|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
129797606|NCT00395538|467226721|FG000|Overall Study|Non-compliance with study protocol|0|||
129797607|NCT00395538|467226722|FG001|Overall Study|Non-compliance with study protocol|1|||
129797608|NCT00395538|467226723|FG002|Overall Study|Non-compliance with study protocol|0|||
129797609|NCT00395538|467226721|FG000|Overall Study|PTH resistance|0|||
129797610|NCT00395538|467226722|FG001|Overall Study|PTH resistance|0|||
129889331|NCT02040090|467552552|FG000|Overall Study|Withdrawal by Subject|0|||
129889332|NCT02040090|467552553|FG001|Overall Study|Withdrawal by Subject|1|||
129889333|NCT02040090|467552552|FG000|Overall Study|Lost to Follow-up|0|||
129889334|NCT02040090|467552553|FG001|Overall Study|Lost to Follow-up|1|||
129889335|NCT03259373|467552562|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
129889336|NCT03259373|467552563|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
129889337|NCT03259373|467552562|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
130107589|NCT04440163|468355153|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
129797611|NCT00395538|467226723|FG002|Overall Study|PTH resistance|1|||
129797612|NCT00395538|467226721|FG000|Overall Study|Pregnancy|1|||
129797613|NCT00395538|467226722|FG001|Overall Study|Pregnancy|0|||
129797614|NCT00395538|467226723|FG002|Overall Study|Pregnancy|0|||
129797615|NCT00395538|467226721|FG000|Overall Study|Partial recovery of parathyroid function|0|||
129797616|NCT00395538|467226722|FG001|Overall Study|Partial recovery of parathyroid function|0|||
129797617|NCT00395538|467226723|FG002|Overall Study|Partial recovery of parathyroid function|1|||
129797618|NCT00395538|467226721|FG000|Overall Study|Participant elected to discontinue|0|||
129797619|NCT00395538|467226722|FG001|Overall Study|Participant elected to discontinue|0|||
129797620|NCT00395538|467226723|FG002|Overall Study|Participant elected to discontinue|1|||
129797621|NCT00285207|467226726|FG000|Overall Study|Lost to Follow-up|3|||
129797622|NCT00285207|467226727|FG001|Overall Study|Lost to Follow-up|2|||
129797623|NCT00285207|467226726|FG000|Overall Study|Withdrawal by Subject|5|||
129797624|NCT00285207|467226727|FG001|Overall Study|Withdrawal by Subject|2|||
129797625|NCT00285207|467226726|FG000|Overall Study|Pregnancy|1|||
129797626|NCT00285207|467226727|FG001|Overall Study|Pregnancy|1|||
129797627|NCT00285207|467226726|FG000|Overall Study|non-compliance|0|||
129797628|NCT00285207|467226727|FG001|Overall Study|non-compliance|1|||
129797629|NCT05063318|467226728|FG000|Overall Study|Progressive disease|2|||
129797630|NCT05063318|467226729|FG001|Overall Study|Progressive disease|0|||
129797631|NCT05063318|467226730|FG002|Overall Study|Progressive disease|3|||
129797632|NCT05063318|467226728|FG000|Overall Study|Compassionate use|1|||
129797633|NCT05063318|467226729|FG001|Overall Study|Compassionate use|3|||
129797634|NCT05063318|467226730|FG002|Overall Study|Compassionate use|3|||
129797635|NCT05063318|467226728|FG000|Overall Study|Adverse Event|0|||
129797636|NCT05063318|467226729|FG001|Overall Study|Adverse Event|1|||
129797637|NCT05063318|467226730|FG002|Overall Study|Adverse Event|0|||
129797638|NCT05063318|467226728|FG000|Overall Study|Withdrawal by Subject|0|||
129797639|NCT05063318|467226729|FG001|Overall Study|Withdrawal by Subject|1|||
129797640|NCT05063318|467226730|FG002|Overall Study|Withdrawal by Subject|0|||
129797641|NCT01659658|467228176|FG000|Overall Study|Withdrawal by Patient|18|||
129797642|NCT01659658|467228177|FG001|Overall Study|Withdrawal by Patient|4|||
129797643|NCT01659658|467228178|FG002|Overall Study|Withdrawal by Patient|2|||
129797644|NCT01659658|467228179|FG003|Overall Study|Withdrawal by Patient|0|||
129797645|NCT01659658|467228180|FG004|Overall Study|Withdrawal by Patient|11|||
129797646|NCT01659658|467228176|FG000|Overall Study|Study Terminated by Sponsor|9|||
129797647|NCT01659658|467228177|FG001|Overall Study|Study Terminated by Sponsor|7|||
129797648|NCT01659658|467228178|FG002|Overall Study|Study Terminated by Sponsor|0|||
129797649|NCT01659658|467228179|FG003|Overall Study|Study Terminated by Sponsor|1|||
129797650|NCT01659658|467228180|FG004|Overall Study|Study Terminated by Sponsor|4|||
129797651|NCT01659658|467228176|FG000|Overall Study|Reason not Specified|61|||
129797652|NCT01659658|467228177|FG001|Overall Study|Reason not Specified|15|||
129797653|NCT01659658|467228178|FG002|Overall Study|Reason not Specified|8|||
129797654|NCT01659658|467228179|FG003|Overall Study|Reason not Specified|1|||
129797655|NCT01659658|467228180|FG004|Overall Study|Reason not Specified|34|||
129797656|NCT01659658|467228176|FG000|Overall Study|Lost to Follow-up|2|||
129797657|NCT01659658|467228177|FG001|Overall Study|Lost to Follow-up|0|||
129797658|NCT01659658|467228178|FG002|Overall Study|Lost to Follow-up|0|||
129797659|NCT01659658|467228179|FG003|Overall Study|Lost to Follow-up|0|||
129797660|NCT01659658|467228180|FG004|Overall Study|Lost to Follow-up|0|||
129797661|NCT00084838|467228181|FG000|Overall Study|Death|1|||
129797662|NCT00084838|467228181|FG000|Overall Study|Adverse Event|2|||
129797663|NCT00084838|467228181|FG000|Overall Study|Withdrawal by Subject|1|||
129797664|NCT00084838|467228181|FG000|Overall Study|Progressive Disease|4|||
130047952|NCT02100657|468133115|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
130047953|NCT02100657|468133116|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
130303999|NCT00536471|469077361|FG001|Overall Study|Lost to Follow-up|23|||
130304000|NCT00536471|469077362|FG002|Overall Study|Lost to Follow-up|48|||
130304001|NCT00536471|469077363|FG003|Overall Study|Lost to Follow-up|22|||
129797665|NCT00084838|467228181|FG000|Overall Study|Pt Non-Compliance|1|||
129797666|NCT00084838|467228181|FG000|Overall Study|Ineligible|4|||
129797667|NCT00122278|467228182|FG000|Overall Study|Lost to Follow-up|2|||
129797668|NCT00122278|467228183|FG001|Overall Study|Lost to Follow-up|0|||
129797669|NCT01994590|467228184|FG000|Overall Study|Adverse Event|1|||
129797670|NCT01994590|467228184|FG000|Overall Study|Trial Terminated|1|||
129797671|NCT03228420|467228191|FG000|Overall Study|Lost to Follow-up|5|||
129797672|NCT03228420|467228192|FG001|Overall Study|Lost to Follow-up|3|||
129797673|NCT03228420|467228191|FG000|Overall Study|Withdrawal by Subject|10|||
129797674|NCT03228420|467228192|FG001|Overall Study|Withdrawal by Subject|0|||
129797675|NCT03228420|467228191|FG000|Overall Study|Adverse Event|5|||
129797676|NCT03228420|467228192|FG001|Overall Study|Adverse Event|2|||
129797677|NCT02428608|467228193|FG000|Overall Study|Pregnancy|2|||
129797678|NCT02428608|467228193|FG000|Overall Study|Lost to Follow-up|37|||
129797679|NCT02428608|467228193|FG000|Overall Study|Withdrawal by Subject|2|||
129797680|NCT02428608|467228193|FG000|Overall Study|scheduling conflicts|15|||
129797681|NCT02428608|467228193|FG000|Overall Study|moved away|10|||
129797682|NCT02428608|467228193|FG000|Overall Study|Death|1|||
129797683|NCT02428608|467228193|FG000|Overall Study|various|16|||
129797684|NCT03468985|467228194|FG000|Overall Study|Adverse Event|0|||
129797685|NCT03468985|467228195|FG001|Overall Study|Adverse Event|2|||
129797686|NCT03468985|467228196|FG002|Overall Study|Adverse Event|0|||
130304002|NCT00536471|469077360|FG000|Overall Study|Adverse Event|32|||
130304003|NCT00536471|469077361|FG001|Overall Study|Adverse Event|16|||
130304004|NCT00536471|469077362|FG002|Overall Study|Adverse Event|28|||
130304005|NCT00536471|469077363|FG003|Overall Study|Adverse Event|13|||
130304006|NCT00536471|469077360|FG000|Overall Study|Withdrawal by Subject|40|||
130304007|NCT00536471|469077361|FG001|Overall Study|Withdrawal by Subject|24|||
129797687|NCT03468985|467228197|FG003|Overall Study|Adverse Event|0|||
129797688|NCT03468985|467228194|FG000|Overall Study|Withdrawal by Subject|0|||
129797689|NCT03468985|467228195|FG001|Overall Study|Withdrawal by Subject|0|||
129797690|NCT03468985|467228196|FG002|Overall Study|Withdrawal by Subject|0|||
129797691|NCT03468985|467228197|FG003|Overall Study|Withdrawal by Subject|1|||
129797692|NCT00085709|467228198|FG000|Overall Study|Adverse Event|8|||
129797693|NCT00085709|467228199|FG001|Overall Study|Adverse Event|0|||
129797694|NCT00085709|467228198|FG000|Overall Study|Death|8|||
129797695|NCT00085709|467228199|FG001|Overall Study|Death|2|||
129797696|NCT00085709|467228198|FG000|Overall Study|Refusal unrelated to adverse events|1|||
129797697|NCT00085709|467228199|FG001|Overall Study|Refusal unrelated to adverse events|2|||
129797698|NCT00085709|467228198|FG000|Overall Study|Progression|3|||
129797699|NCT00085709|467228199|FG001|Overall Study|Progression|4|||
129797700|NCT00085709|467228198|FG000|Overall Study|Not protocol specified|12|||
129797701|NCT00085709|467228199|FG001|Overall Study|Not protocol specified|22|||
129797702|NCT00085709|467228198|FG000|Overall Study|Not eligible|19|||
129797703|NCT00085709|467228199|FG001|Overall Study|Not eligible|19|||
129797704|NCT00085709|467228198|FG000|Overall Study|Withdrawal by Subject|2|||
129797705|NCT00085709|467228199|FG001|Overall Study|Withdrawal by Subject|1|||
129797706|NCT00397943|467228200|FG000|Overall Study|Unspecified reasons|12|||
129797707|NCT00397943|467228201|FG001|Overall Study|Unspecified reasons|9|||
129797708|NCT00397943|467228202|FG002|Overall Study|Unspecified reasons|0|||
129797709|NCT00397943|467228203|FG003|Overall Study|Unspecified reasons|0|||
129797710|NCT00397943|467228204|FG004|Overall Study|Unspecified reasons|0|||
129797711|NCT04521777|467228205|FG000|Overall Study|Death|2|||
129797712|NCT04521777|467228205|FG000|Overall Study|Withdrawal by Subject|2|||
129797713|NCT03139604|467228208|FG000|Overall Study|Other|7|||
129797714|NCT03139604|467228209|FG001|Overall Study|Other|3|||
129797715|NCT03139604|467228208|FG000|Overall Study|Withdrawal by Subject|16|||
129797716|NCT03139604|467228209|FG001|Overall Study|Withdrawal by Subject|17|||
129797717|NCT03139604|467228208|FG000|Overall Study|Physician Decision|1|||
129797718|NCT03139604|467228209|FG001|Overall Study|Physician Decision|2|||
129797719|NCT03139604|467228208|FG000|Overall Study|Lost to Follow-up|3|||
129797720|NCT03139604|467228209|FG001|Overall Study|Lost to Follow-up|1|||
129797721|NCT03139604|467228208|FG000|Overall Study|Death|65|||
129797722|NCT03139604|467228209|FG001|Overall Study|Death|67|||
129797723|NCT03139604|467228208|FG000|Overall Study|Study Terminated by Sponsor|122|||
129797724|NCT03139604|467228209|FG001|Overall Study|Study Terminated by Sponsor|127|||
129797725|NCT03139604|467228208|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
130304008|NCT00536471|469077362|FG002|Overall Study|Withdrawal by Subject|43|||
130304009|NCT00536471|469077363|FG003|Overall Study|Withdrawal by Subject|21|||
130304010|NCT00536471|469077360|FG000|Overall Study|Lack of Efficacy|17|||
130304011|NCT00536471|469077361|FG001|Overall Study|Lack of Efficacy|18|||
130304012|NCT00536471|469077362|FG002|Overall Study|Lack of Efficacy|11|||
130304013|NCT00536471|469077363|FG003|Overall Study|Lack of Efficacy|9|||
130304014|NCT00536471|469077360|FG000|Overall Study|Protocol Violation|8|||
130304015|NCT00536471|469077361|FG001|Overall Study|Protocol Violation|1|||
130304016|NCT00536471|469077362|FG002|Overall Study|Protocol Violation|2|||
130304017|NCT00536471|469077363|FG003|Overall Study|Protocol Violation|3|||
130304018|NCT00536471|469077360|FG000|Overall Study|Physician Decision|11|||
130304019|NCT00536471|469077361|FG001|Overall Study|Physician Decision|1|||
130304020|NCT00536471|469077362|FG002|Overall Study|Physician Decision|3|||
130304021|NCT00536471|469077363|FG003|Overall Study|Physician Decision|2|||
130304022|NCT00536471|469077360|FG000|Overall Study|Death|0|||
130304023|NCT00536471|469077361|FG001|Overall Study|Death|0|||
130304024|NCT00536471|469077362|FG002|Overall Study|Death|1|||
130304025|NCT00536471|469077363|FG003|Overall Study|Death|2|||
129797726|NCT03139604|467228209|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
130107590|NCT04440163|468355154|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
130107591|NCT04440163|468355147|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130304026|NCT00536471|469077360|FG000|Overall Study|Sponsor Decision|0|||
129797727|NCT04950608|467228210|FG000|Overall Study|Withdrawal by Subject|2|||
129797728|NCT04950608|467228210|FG000|Overall Study|Physician Decision|3|||
129797729|NCT02007512|467228211|FG000|Double Blind Treatment Period|Adverse Event|4|||
129797730|NCT02007512|467228212|FG001|Double Blind Treatment Period|Adverse Event|6|||
129797731|NCT02007512|467228213|FG002|Double Blind Treatment Period|Adverse Event|2|||
129797732|NCT02007512|467228214|FG003|Double Blind Treatment Period|Adverse Event|2|||
130304027|NCT00536471|469077361|FG001|Overall Study|Sponsor Decision|1|||
130304028|NCT00536471|469077362|FG002|Overall Study|Sponsor Decision|3|||
130304029|NCT00536471|469077363|FG003|Overall Study|Sponsor Decision|2|||
130304030|NCT00988091|469077373|FG000|Double-blind Period|Withdrawal by Subject|15|||
130304031|NCT00988091|469077374|FG001|Double-blind Period|Withdrawal by Subject|13|||
130304032|NCT00988091|469077373|FG000|Double-blind Period|Lost to Follow-up|12|||
130304033|NCT00988091|469077374|FG001|Double-blind Period|Lost to Follow-up|14|||
130304034|NCT00988091|469077373|FG000|Double-blind Period|Other|8|||
130304035|NCT00988091|469077374|FG001|Double-blind Period|Other|8|||
130304036|NCT00988091|469077373|FG000|Double-blind Period|Adverse Event|6|||
130304037|NCT00988091|469077374|FG001|Double-blind Period|Adverse Event|9|||
130304038|NCT00988091|469077373|FG000|Double-blind Period|Use of exclusionary medication|2|||
130304039|NCT00988091|469077374|FG001|Double-blind Period|Use of exclusionary medication|3|||
130304040|NCT00988091|469077373|FG000|Open-label Period|Adverse Event|4|||
130304041|NCT00988091|469077374|FG001|Open-label Period|Adverse Event|7|||
130304042|NCT00988091|469077373|FG000|Open-label Period|Use of exclusionary medication|1|||
130304043|NCT00988091|469077374|FG001|Open-label Period|Use of exclusionary medication|1|||
130304044|NCT00988091|469077373|FG000|Open-label Period|Protocol Violation|1|||
130304045|NCT00988091|469077374|FG001|Open-label Period|Protocol Violation|1|||
130304046|NCT00988091|469077373|FG000|Open-label Period|Withdrawal by Subject|10|||
130304047|NCT00988091|469077374|FG001|Open-label Period|Withdrawal by Subject|16|||
130304048|NCT00988091|469077373|FG000|Open-label Period|Lost to Follow-up|3|||
130304049|NCT00988091|469077374|FG001|Open-label Period|Lost to Follow-up|5|||
130304050|NCT00988091|469077373|FG000|Open-label Period|Other|2|||
130304051|NCT00988091|469077374|FG001|Open-label Period|Other|3|||
130304052|NCT00994422|469077375|FG000|Overall Study|Lost to Follow-up|7|||
130304053|NCT00994422|469077376|FG001|Overall Study|Lost to Follow-up|1|||
130304054|NCT00836186|469077381|FG000|Overall Study|Blood could not be drawn|1|||
130304055|NCT00532298|469077382|FG000|Overall Study|Adverse Event|1|||
130304056|NCT00532298|469077383|FG001|Overall Study|Adverse Event|0|||
130304057|NCT00532298|469077384|FG002|Overall Study|Adverse Event|0|||
130304058|NCT00532298|469077385|FG003|Overall Study|Adverse Event|0|||
130304059|NCT00532298|469077386|FG004|Overall Study|Adverse Event|1|||
130304060|NCT00532298|469077387|FG005|Overall Study|Adverse Event|1|||
130304061|NCT00532298|469077382|FG000|Overall Study|Lost to Follow-up|1|||
130304062|NCT00532298|469077383|FG001|Overall Study|Lost to Follow-up|1|||
130304063|NCT00532298|469077384|FG002|Overall Study|Lost to Follow-up|1|||
130304064|NCT00532298|469077385|FG003|Overall Study|Lost to Follow-up|0|||
130304065|NCT00532298|469077386|FG004|Overall Study|Lost to Follow-up|0|||
130304066|NCT00532298|469077387|FG005|Overall Study|Lost to Follow-up|1|||
130304067|NCT01973998|469077388|FG000|Overall Study|Death|2|||
130304068|NCT01973998|469077389|FG001|Overall Study|Death|2|||
130304069|NCT02951429|469077396|FG000|Overall Study|Adverse Event|3|||
130304070|NCT02951429|469077397|FG001|Overall Study|Adverse Event|7|||
130304071|NCT02951429|469077396|FG000|Overall Study|Death|28|||
130304072|NCT02951429|469077397|FG001|Overall Study|Death|36|||
130304073|NCT02951429|469077396|FG000|Overall Study|Lack of Efficacy|0|||
130304074|NCT02951429|469077397|FG001|Overall Study|Lack of Efficacy|1|||
130304075|NCT02951429|469077396|FG000|Overall Study|Lost to Follow-up|0|||
130304076|NCT02951429|469077397|FG001|Overall Study|Lost to Follow-up|1|||
130304077|NCT02951429|469077396|FG000|Overall Study|Lung Transplantation|9|||
130304078|NCT02951429|469077397|FG001|Overall Study|Lung Transplantation|6|||
130304079|NCT02951429|469077396|FG000|Overall Study|Other|1|||
130304080|NCT02951429|469077397|FG001|Overall Study|Other|3|||
130304081|NCT02951429|469077396|FG000|Overall Study|Progressive Disease|1|||
130304082|NCT02951429|469077397|FG001|Overall Study|Progressive Disease|1|||
130304083|NCT02951429|469077396|FG000|Overall Study|Withdrawal by Subject|7|||
130304084|NCT02951429|469077397|FG001|Overall Study|Withdrawal by Subject|11|||
130304085|NCT02951429|469077396|FG000|Overall Study|Participant ongoing in the study|23|||
130304086|NCT02951429|469077397|FG001|Overall Study|Participant ongoing in the study|17|||
130304087|NCT01620528|469077398|FG000|Treatment Period|Did Not Receive Study Drug|0|||
130304088|NCT01620528|469077399|FG001|Treatment Period|Did Not Receive Study Drug|0|||
130304089|NCT01620528|469077400|FG002|Treatment Period|Did Not Receive Study Drug|1|||
130304090|NCT01620528|469077398|FG000|Treatment Period|Withdrawal by Subject|35|||
130304091|NCT01620528|469077399|FG001|Treatment Period|Withdrawal by Subject|21|||
130304092|NCT01620528|469077400|FG002|Treatment Period|Withdrawal by Subject|16|||
130304093|NCT01620528|469077398|FG000|Treatment Period|Adverse Event|17|||
130304094|NCT01620528|469077399|FG001|Treatment Period|Adverse Event|13|||
130304095|NCT01620528|469077400|FG002|Treatment Period|Adverse Event|21|||
130304096|NCT01620528|469077398|FG000|Treatment Period|Lost to Follow-up|16|||
130304097|NCT01620528|469077399|FG001|Treatment Period|Lost to Follow-up|8|||
130304098|NCT01620528|469077400|FG002|Treatment Period|Lost to Follow-up|14|||
130304099|NCT01620528|469077398|FG000|Treatment Period|Other|9|||
130304100|NCT01620528|469077399|FG001|Treatment Period|Other|5|||
130304101|NCT01620528|469077400|FG002|Treatment Period|Other|7|||
130304102|NCT01620528|469077398|FG000|Treatment Period|Subject Noncompliant|11|||
130304103|NCT01620528|469077399|FG001|Treatment Period|Subject Noncompliant|2|||
130304104|NCT01620528|469077400|FG002|Treatment Period|Subject Noncompliant|2|||
130304105|NCT01620528|469077398|FG000|Treatment Period|Pregnancy|7|||
130304106|NCT01620528|469077399|FG001|Treatment Period|Pregnancy|2|||
130304107|NCT01620528|469077400|FG002|Treatment Period|Pregnancy|2|||
130304108|NCT01620528|469077398|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
130304109|NCT01620528|469077399|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
130304110|NCT01620528|469077400|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
130304111|NCT01620528|469077398|FG000|Treatment Period|Exclusionary Medication Received|0|||
130304112|NCT01620528|469077399|FG001|Treatment Period|Exclusionary Medication Received|1|||
130304113|NCT01620528|469077400|FG002|Treatment Period|Exclusionary Medication Received|0|||
130304114|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130304115|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
130304116|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130304117|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130304118|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
130304119|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
130304120|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
130304121|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
130304122|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
130304123|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
130304124|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
130304125|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
130304126|NCT01620528|469077398|FG000|Post-Treatment Follow-Up Period|Other|6|||
130304127|NCT01620528|469077399|FG001|Post-Treatment Follow-Up Period|Other|4|||
130304128|NCT01620528|469077400|FG002|Post-Treatment Follow-Up Period|Other|2|||
130304129|NCT03664765|469077401|FG000|Overall Study|Withdrawal by Subject|4|||
130304130|NCT03664765|469077402|FG001|Overall Study|Withdrawal by Subject|1|||
130304131|NCT03664765|469077401|FG000|Overall Study|Lost to Follow-up|0|||
130304132|NCT03664765|469077402|FG001|Overall Study|Lost to Follow-up|1|||
130304133|NCT01090063|469077403|FG000|Screen|Screen Failed|4|||
130304134|NCT01090063|469077403|FG000|Treatment|Withdrawal by Subject|4|||
130304135|NCT04038567|469077407|FG000|Overall Study|Lost to Follow-up|6|||
130304136|NCT04038567|469077408|FG001|Overall Study|Lost to Follow-up|4|||
130304137|NCT04038567|469077409|FG002|Overall Study|Lost to Follow-up|5|||
130304138|NCT04038567|469077410|FG003|Overall Study|Lost to Follow-up|4|||
130304139|NCT04038567|469077411|FG004|Overall Study|Lost to Follow-up|6|||
130304140|NCT04038567|469077412|FG005|Overall Study|Lost to Follow-up|4|||
130304141|NCT04038567|469077413|FG006|Overall Study|Lost to Follow-up|4|||
130304142|NCT04038567|469077414|FG007|Overall Study|Lost to Follow-up|1|||
130304143|NCT04038567|469077407|FG000|Overall Study|Withdrawal by Subject|2|||
130304144|NCT04038567|469077408|FG001|Overall Study|Withdrawal by Subject|1|||
130304145|NCT04038567|469077409|FG002|Overall Study|Withdrawal by Subject|1|||
130304146|NCT04038567|469077410|FG003|Overall Study|Withdrawal by Subject|1|||
130304147|NCT04038567|469077411|FG004|Overall Study|Withdrawal by Subject|4|||
130304148|NCT04038567|469077412|FG005|Overall Study|Withdrawal by Subject|1|||
130304149|NCT04038567|469077413|FG006|Overall Study|Withdrawal by Subject|1|||
130304150|NCT04038567|469077414|FG007|Overall Study|Withdrawal by Subject|1|||
130304151|NCT04038567|469077407|FG000|Overall Study|missed survey window|1|||
130304152|NCT04038567|469077408|FG001|Overall Study|missed survey window|2|||
130304153|NCT04038567|469077409|FG002|Overall Study|missed survey window|0|||
130304154|NCT04038567|469077410|FG003|Overall Study|missed survey window|0|||
130304155|NCT04038567|469077411|FG004|Overall Study|missed survey window|1|||
130304156|NCT04038567|469077412|FG005|Overall Study|missed survey window|1|||
130304157|NCT04038567|469077413|FG006|Overall Study|missed survey window|2|||
130304158|NCT04038567|469077414|FG007|Overall Study|missed survey window|2|||
130304159|NCT04038567|469077407|FG000|Overall Study|technical issues|0|||
130304160|NCT04038567|469077408|FG001|Overall Study|technical issues|0|||
130304161|NCT04038567|469077409|FG002|Overall Study|technical issues|0|||
130304162|NCT04038567|469077410|FG003|Overall Study|technical issues|0|||
130304163|NCT04038567|469077411|FG004|Overall Study|technical issues|0|||
130304164|NCT04038567|469077412|FG005|Overall Study|technical issues|0|||
130304165|NCT04038567|469077413|FG006|Overall Study|technical issues|1|||
130304166|NCT04038567|469077414|FG007|Overall Study|technical issues|0|||
130304167|NCT04038567|469077407|FG000|Overall Study|Medical issues (i.e., illness)|0|||
130304168|NCT04038567|469077408|FG001|Overall Study|Medical issues (i.e., illness)|1|||
130304169|NCT04038567|469077409|FG002|Overall Study|Medical issues (i.e., illness)|2|||
130304170|NCT04038567|469077410|FG003|Overall Study|Medical issues (i.e., illness)|1|||
130304171|NCT04038567|469077411|FG004|Overall Study|Medical issues (i.e., illness)|1|||
130304172|NCT04038567|469077412|FG005|Overall Study|Medical issues (i.e., illness)|1|||
130304173|NCT04038567|469077413|FG006|Overall Study|Medical issues (i.e., illness)|0|||
130304174|NCT04038567|469077414|FG007|Overall Study|Medical issues (i.e., illness)|0|||
130304175|NCT04038567|469077407|FG000|Overall Study|Death|0|||
130304176|NCT04038567|469077408|FG001|Overall Study|Death|0|||
130304177|NCT04038567|469077409|FG002|Overall Study|Death|0|||
130304178|NCT04038567|469077410|FG003|Overall Study|Death|1|||
130304179|NCT04038567|469077411|FG004|Overall Study|Death|1|||
129889338|NCT03259373|467552563|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
129889339|NCT03259373|467552562|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
130304180|NCT04038567|469077412|FG005|Overall Study|Death|0|||
130304181|NCT04038567|469077413|FG006|Overall Study|Death|0|||
130304182|NCT04038567|469077414|FG007|Overall Study|Death|1|||
130304183|NCT01817959|469077415|FG000|Overall Study|Graft loss|1|||
130304184|NCT01817959|469077416|FG001|Overall Study|Graft loss|1|||
130304185|NCT01817959|469077415|FG000|Overall Study|forbidden medication|1|||
130304186|NCT01817959|469077416|FG001|Overall Study|forbidden medication|1|||
130304187|NCT01817959|469077415|FG000|Overall Study|Adverse Event|1|||
130304188|NCT01817959|469077416|FG001|Overall Study|Adverse Event|0|||
130304189|NCT01817959|469077415|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
130304190|NCT01817959|469077416|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
130304191|NCT00923845|469077419|FG000|Induction Therapy|Poor performance status|0|||
130304192|NCT00923845|469077420|FG001|Induction Therapy|Poor performance status|2|||
130304193|NCT01128946|469077424|FG000|Period I|Protocol Violation|0|||
130304194|NCT01128946|469077425|FG001|Period I|Protocol Violation|1|||
130304195|NCT01128946|469077426|FG002|Period I|Protocol Violation|0|||
130304196|NCT01128946|469077427|FG003|Period I|Protocol Violation|0|||
130304197|NCT01128946|469077424|FG000|Period I|Withdrawal by Subject|0|||
130304198|NCT01128946|469077425|FG001|Period I|Withdrawal by Subject|0|||
130304199|NCT01128946|469077426|FG002|Period I|Withdrawal by Subject|1|||
130304200|NCT01128946|469077427|FG003|Period I|Withdrawal by Subject|1|||
130304201|NCT01128946|469077424|FG000|Period II|Protocol Violation|0|||
130304202|NCT01128946|469077425|FG001|Period II|Protocol Violation|1|||
130304203|NCT01128946|469077426|FG002|Period II|Protocol Violation|0|||
130304204|NCT01128946|469077427|FG003|Period II|Protocol Violation|0|||
130304205|NCT01128946|469077424|FG000|Period II|Withdrawal by Subject|0|||
130304206|NCT01128946|469077425|FG001|Period II|Withdrawal by Subject|0|||
130304207|NCT01128946|469077426|FG002|Period II|Withdrawal by Subject|0|||
130304208|NCT01128946|469077427|FG003|Period II|Withdrawal by Subject|1|||
130304209|NCT01128946|469077424|FG000|Period III|Protocol Violation|1|||
130304210|NCT01128946|469077425|FG001|Period III|Protocol Violation|0|||
130304211|NCT01128946|469077426|FG002|Period III|Protocol Violation|0|||
130304212|NCT01128946|469077427|FG003|Period III|Protocol Violation|0|||
130304213|NCT01371734|469077428|FG000|Overall Study|Other|2|||
130304214|NCT01371734|469077429|FG001|Overall Study|Other|1|||
130304215|NCT01371734|469077430|FG002|Overall Study|Other|2|||
130304216|NCT01371734|469077428|FG000|Overall Study|Withdrawal by Subject|3|||
130304217|NCT01371734|469077429|FG001|Overall Study|Withdrawal by Subject|4|||
130304218|NCT01371734|469077430|FG002|Overall Study|Withdrawal by Subject|9|||
130304219|NCT01371734|469077428|FG000|Overall Study|Lost to Follow-up|5|||
130304220|NCT01371734|469077429|FG001|Overall Study|Lost to Follow-up|3|||
130304221|NCT01371734|469077430|FG002|Overall Study|Lost to Follow-up|1|||
130304222|NCT01371734|469077428|FG000|Overall Study|Protocol Violation|3|||
130304223|NCT01371734|469077429|FG001|Overall Study|Protocol Violation|1|||
130304224|NCT01371734|469077430|FG002|Overall Study|Protocol Violation|2|||
130304225|NCT01371734|469077428|FG000|Overall Study|Adverse Event|8|||
130304226|NCT01371734|469077429|FG001|Overall Study|Adverse Event|8|||
130304227|NCT01371734|469077430|FG002|Overall Study|Adverse Event|3|||
130304228|NCT01371734|469077428|FG000|Overall Study|Lack of Efficacy|2|||
130304229|NCT01371734|469077429|FG001|Overall Study|Lack of Efficacy|2|||
130304230|NCT01371734|469077430|FG002|Overall Study|Lack of Efficacy|0|||
130304231|NCT03565237|469077431|FG000|Overall Study|Non-compliance of Investigational Product|1|||
130304232|NCT03565237|469077431|FG000|Overall Study|Physician Decision|1|||
130304233|NCT01140061|469077435|FG000|Part I|Adverse Event|1|||
130304234|NCT01140061|469077436|FG001|Part I|Adverse Event|0|||
130304235|NCT01140061|469077437|FG002|Part I|Adverse Event|0|||
130304236|NCT01140061|469077438|FG003|Part I|Adverse Event|0|||
130304237|NCT01140061|469077439|FG004|Part I|Adverse Event|0|||
130304238|NCT01140061|469077440|FG005|Part I|Adverse Event|0|||
130304239|NCT01140061|469077441|FG006|Part I|Adverse Event|0|||
130304240|NCT01140061|469077442|FG007|Part I|Adverse Event|0|||
130304241|NCT01140061|469077443|FG008|Part I|Adverse Event|0|||
130304242|NCT01140061|469077444|FG009|Part I|Adverse Event|0|||
130304243|NCT01140061|469077435|FG000|Extension|Laboratory Adverse Event|0|||
130304244|NCT01140061|469077436|FG001|Extension|Laboratory Adverse Event|0|||
130304245|NCT01140061|469077437|FG002|Extension|Laboratory Adverse Event|0|||
130304246|NCT01140061|469077438|FG003|Extension|Laboratory Adverse Event|0|||
130304247|NCT01140061|469077439|FG004|Extension|Laboratory Adverse Event|0|||
130304248|NCT01140061|469077440|FG005|Extension|Laboratory Adverse Event|0|||
130304249|NCT01140061|469077441|FG006|Extension|Laboratory Adverse Event|0|||
130304250|NCT01140061|469077442|FG007|Extension|Laboratory Adverse Event|0|||
130304251|NCT01140061|469077443|FG008|Extension|Laboratory Adverse Event|0|||
130304252|NCT01140061|469077444|FG009|Extension|Laboratory Adverse Event|1|||
130304253|NCT02708355|469077445|FG000|Overall Study|Adverse Event|1|||
130304254|NCT02708355|469077446|FG001|Overall Study|Adverse Event|0|||
129797733|NCT02007512|467228211|FG000|Double Blind Treatment Period|Death|1|||
130304255|NCT02708355|469077447|FG002|Overall Study|Adverse Event|0|||
130304256|NCT02669121|469077448|FG000|Overall Study|Adverse Event|4|||
130304257|NCT02669121|469077449|FG001|Overall Study|Adverse Event|5|||
130304258|NCT02669121|469077448|FG000|Overall Study|Lost to Follow-up|15|||
130304259|NCT02669121|469077449|FG001|Overall Study|Lost to Follow-up|27|||
130304260|NCT02669121|469077448|FG000|Overall Study|Withdrawal by Subject|132|||
130304261|NCT02669121|469077449|FG001|Overall Study|Withdrawal by Subject|140|||
130304262|NCT02669121|469077448|FG000|Overall Study|Pregnancy|0|||
130304263|NCT02669121|469077449|FG001|Overall Study|Pregnancy|1|||
130304264|NCT02669121|469077448|FG000|Overall Study|Discharged from US Military Active Service|117|||
130304265|NCT02669121|469077449|FG001|Overall Study|Discharged from US Military Active Service|91|||
130304266|NCT02669121|469077448|FG000|Overall Study|Reason not Specified|22|||
130304267|NCT02669121|469077449|FG001|Overall Study|Reason not Specified|18|||
130304268|NCT03216746|469077450|FG000|Overall Study|Lost to Follow-up|6|||
130304269|NCT03216746|469077451|FG001|Overall Study|Lost to Follow-up|8|||
130304270|NCT03216746|469077452|FG002|Overall Study|Lost to Follow-up|5|||
130304271|NCT03216746|469077453|FG003|Overall Study|Lost to Follow-up|6|||
130304272|NCT04384523|469077454|FG000|Overall Study|Lost to Follow-up|0|||
130304273|NCT04384523|469077455|FG001|Overall Study|Lost to Follow-up|0|||
130304274|NCT04384523|469077456|FG002|Overall Study|Lost to Follow-up|0|||
130304275|NCT04384523|469077457|FG003|Overall Study|Lost to Follow-up|0|||
130304276|NCT04384523|469077458|FG004|Overall Study|Lost to Follow-up|0|||
130304277|NCT04384523|469077459|FG005|Overall Study|Lost to Follow-up|1|||
130304278|NCT04384523|469077454|FG000|Overall Study|Protocol Violation|0|||
130304279|NCT04384523|469077455|FG001|Overall Study|Protocol Violation|1|||
130304280|NCT04384523|469077456|FG002|Overall Study|Protocol Violation|0|||
130304281|NCT04384523|469077457|FG003|Overall Study|Protocol Violation|0|||
130304282|NCT04384523|469077458|FG004|Overall Study|Protocol Violation|0|||
130304283|NCT04384523|469077459|FG005|Overall Study|Protocol Violation|0|||
130304284|NCT04384523|469077454|FG000|Overall Study|Withdrawal by Subject|1|||
130304285|NCT04384523|469077455|FG001|Overall Study|Withdrawal by Subject|0|||
130304286|NCT04384523|469077456|FG002|Overall Study|Withdrawal by Subject|0|||
130304287|NCT04384523|469077457|FG003|Overall Study|Withdrawal by Subject|0|||
130304288|NCT04384523|469077458|FG004|Overall Study|Withdrawal by Subject|0|||
130304289|NCT04384523|469077459|FG005|Overall Study|Withdrawal by Subject|0|||
130304290|NCT00835341|469077460|FG000|Overall Study|Lost to Follow-up|3|||
130304291|NCT00835341|469077461|FG001|Overall Study|Lost to Follow-up|12|||
130304292|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
130304293|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
130304294|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
130304295|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304296|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304297|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304298|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304299|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304300|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
130304301|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Physician Decision|1|||
130304302|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Physician Decision|2|||
130304303|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Physician Decision|0|||
130304304|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Physician Decision|0|||
130304305|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Physician Decision|0|||
130304306|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Physician Decision|0|||
130304307|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Physician Decision|0|||
130304308|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Physician Decision|0|||
130304309|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Physician Decision|0|||
130304310|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
130304311|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
130304312|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
130304313|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
130304314|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
130304315|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
130304316|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
130304317|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
130304318|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
130304319|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
130304320|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304321|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304322|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304323|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304324|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304325|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304326|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304327|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
130304328|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
130304329|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
130304330|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304331|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304332|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304333|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304334|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304335|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304336|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
130304337|NCT04405076|469077463|FG000|Part A (Blinded Phase)|Other than Specified|0|||
130304338|NCT04405076|469077464|FG001|Part A (Blinded Phase)|Other than Specified|0|||
130304339|NCT04405076|469077465|FG002|Part A (Blinded Phase)|Other than Specified|3|||
130304340|NCT04405076|469077466|FG003|Part A (Blinded Phase)|Other than Specified|0|||
130107592|NCT04440163|468355148|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130107593|NCT04440163|468355149|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130107594|NCT04440163|468355150|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
130107595|NCT04440163|468355151|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130107596|NCT04440163|468355152|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130107597|NCT04440163|468355153|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130107598|NCT04440163|468355154|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
130107599|NCT02018042|468355157|FG000|Overall Study|Withdrawal by Subject|1|||
130304341|NCT04405076|469077467|FG004|Part A (Blinded Phase)|Other than Specified|0|||
130304342|NCT04405076|469077468|FG005|Part A (Blinded Phase)|Other than Specified|0|||
130304343|NCT04405076|469077469|FG006|Part A (Blinded Phase)|Other than Specified|0|||
130304344|NCT04405076|469077470|FG007|Part A (Blinded Phase)|Other than Specified|0|||
130304345|NCT04405076|469077471|FG008|Part A (Blinded Phase)|Other than Specified|0|||
130304346|NCT04405076|469077463|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130107600|NCT01954082|468355158|FG000|Overall Study|Study Suspension|42|||
130107601|NCT01954082|468355159|FG001|Overall Study|Study Suspension|36|||
130107602|NCT01954082|468355158|FG000|Overall Study|Adverse Event|10|||
130107603|NCT01954082|468355159|FG001|Overall Study|Adverse Event|4|||
130107604|NCT01954082|468355158|FG000|Overall Study|Intolerance|0|||
130304347|NCT04405076|469077464|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304348|NCT04405076|469077465|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304349|NCT04405076|469077466|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
130304350|NCT04405076|469077467|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
130304351|NCT04405076|469077468|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
130304352|NCT04405076|469077469|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304353|NCT04405076|469077470|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304354|NCT04405076|469077471|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
130304355|NCT04405076|469077463|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304356|NCT04405076|469077464|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304357|NCT04405076|469077465|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304358|NCT04405076|469077466|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304359|NCT04405076|469077467|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
130304360|NCT04405076|469077468|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304361|NCT04405076|469077469|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304362|NCT04405076|469077470|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304363|NCT04405076|469077471|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
130304364|NCT04405076|469077463|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304365|NCT04405076|469077464|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304366|NCT04405076|469077465|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304367|NCT04405076|469077466|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
130304368|NCT04405076|469077467|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
130304369|NCT04405076|469077468|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
130304370|NCT04405076|469077469|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304371|NCT04405076|469077470|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304372|NCT04405076|469077471|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
130304373|NCT04405076|469077463|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304374|NCT04405076|469077464|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304375|NCT04405076|469077465|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304376|NCT04405076|469077466|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304377|NCT04405076|469077467|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304378|NCT04405076|469077468|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304379|NCT04405076|469077469|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
130304380|NCT04405076|469077470|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
130107605|NCT01954082|468355159|FG001|Overall Study|Intolerance|1|||
130107606|NCT01954082|468355158|FG000|Overall Study|Non-compliance|6|||
130107607|NCT01954082|468355159|FG001|Overall Study|Non-compliance|4|||
130107608|NCT01954082|468355158|FG000|Overall Study|Physician Decision|2|||
130107609|NCT01954082|468355159|FG001|Overall Study|Physician Decision|0|||
130304381|NCT04405076|469077471|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
130304382|NCT04405076|469077463|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304383|NCT04405076|469077464|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304384|NCT04405076|469077465|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304385|NCT04405076|469077466|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304386|NCT04405076|469077467|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304387|NCT04405076|469077468|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304388|NCT04405076|469077469|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
130304389|NCT04405076|469077470|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304390|NCT04405076|469077471|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
130304391|NCT00392990|469077474|FG000|Treatment on Study|Adverse Event|3|||
130304392|NCT00392990|469077475|FG001|Treatment on Study|Adverse Event|1|||
130304393|NCT00392990|469077474|FG000|Follow up for 2 Years|Death|4|||
130304394|NCT00392990|469077475|FG001|Follow up for 2 Years|Death|0|||
130304395|NCT03052816|469077478|FG000|Overall Study|Withdrawal by Subject|1|||
130304396|NCT03052816|469077479|FG001|Overall Study|Withdrawal by Subject|0|||
130304397|NCT03052816|469077478|FG000|Overall Study|Desired opioids|2|||
130304398|NCT03052816|469077479|FG001|Overall Study|Desired opioids|0|||
130304399|NCT00408434|469077480|FG000|Overall Study|Adverse Event|0|||
130304400|NCT00408434|469077481|FG001|Overall Study|Adverse Event|0|||
130304401|NCT00408434|469077482|FG002|Overall Study|Adverse Event|1|||
130304402|NCT00408434|469077483|FG003|Overall Study|Adverse Event|0|||
130304403|NCT00408434|469077484|FG004|Overall Study|Adverse Event|0|||
130304404|NCT00408434|469077485|FG005|Overall Study|Adverse Event|0|||
130304405|NCT00408434|469077486|FG006|Overall Study|Adverse Event|0|||
130304406|NCT00408434|469077480|FG000|Overall Study|Progressive disease|6|||
130304407|NCT00408434|469077481|FG001|Overall Study|Progressive disease|3|||
130304408|NCT00408434|469077482|FG002|Overall Study|Progressive disease|4|||
130304409|NCT00408434|469077483|FG003|Overall Study|Progressive disease|3|||
130304410|NCT00408434|469077484|FG004|Overall Study|Progressive disease|3|||
130304411|NCT00408434|469077485|FG005|Overall Study|Progressive disease|1|||
130304412|NCT00408434|469077486|FG006|Overall Study|Progressive disease|4|||
130304413|NCT00408434|469077480|FG000|Overall Study|Other|0|||
130304414|NCT00408434|469077481|FG001|Overall Study|Other|0|||
130304415|NCT00408434|469077482|FG002|Overall Study|Other|1|||
130304416|NCT00408434|469077483|FG003|Overall Study|Other|0|||
130304417|NCT00408434|469077484|FG004|Overall Study|Other|2|||
130304418|NCT00408434|469077485|FG005|Overall Study|Other|1|||
130304419|NCT00408434|469077486|FG006|Overall Study|Other|0|||
130304420|NCT00408434|469077480|FG000|Overall Study|Terminated by Investigator|0|||
130304421|NCT00408434|469077481|FG001|Overall Study|Terminated by Investigator|0|||
130304422|NCT00408434|469077482|FG002|Overall Study|Terminated by Investigator|0|||
130304423|NCT00408434|469077483|FG003|Overall Study|Terminated by Investigator|0|||
130304424|NCT00408434|469077484|FG004|Overall Study|Terminated by Investigator|1|||
130304425|NCT00408434|469077485|FG005|Overall Study|Terminated by Investigator|1|||
130304426|NCT00408434|469077486|FG006|Overall Study|Terminated by Investigator|0|||
130304427|NCT04000581|469077487|FG000|Overall Study|Withdrawal by Subject|0|||
130304428|NCT04000581|469077488|FG001|Overall Study|Withdrawal by Subject|1|||
130304429|NCT00588354|469077489|FG000|Baseline to 2 Weeks|Adverse Event|1|||
130304430|NCT00588354|469077490|FG001|Baseline to 2 Weeks|Adverse Event|0|||
130304431|NCT00588354|469077489|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
130304432|NCT00588354|469077490|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
130304433|NCT00588354|469077489|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
130304434|NCT00588354|469077490|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
130047954|NCT02100657|468133117|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
130304435|NCT00895453|469077491|FG000|Overall Study|Lost to Follow-up|25|||
130304436|NCT00895453|469077492|FG001|Overall Study|Lost to Follow-up|25|||
130304437|NCT00895453|469077493|FG002|Overall Study|Lost to Follow-up|23|||
130304438|NCT01736618|469077500|FG000|Overall Study|Death|294|||
130304439|NCT01736618|469077500|FG000|Overall Study|Lost to Follow-up|193|||
130304440|NCT01736618|469077500|FG000|Overall Study|Withdrawal by Subject|54|||
130304441|NCT01736618|469077500|FG000|Overall Study|Subject unable to be followed at study location|223|||
130304442|NCT01736618|469077500|FG000|Overall Study|Physician Decision|33|||
130304443|NCT01736618|469077500|FG000|Overall Study|Transplant or removal of target organ|19|||
130047955|NCT02115815|468133119|FG000|Overall Study|Withdrawal by Subject|2|||
130304444|NCT01736618|469077500|FG000|Overall Study|Change in indication or condition|78|||
130304445|NCT01736618|469077500|FG000|Overall Study|Study device explant|103|||
130047956|NCT02115815|468133120|FG001|Overall Study|Withdrawal by Subject|0|||
130304446|NCT01736618|469077500|FG000|Overall Study|Unable to complete implant|2|||
130304447|NCT00400569|469077505|FG000|Overall Study|Death|1|||
130304448|NCT00620113|469077508|FG000|Overall Study|Adverse Event|3|||
130304449|NCT00620113|469077509|FG001|Overall Study|Adverse Event|2|||
130304450|NCT00620113|469077510|FG002|Overall Study|Adverse Event|2|||
130304451|NCT00620113|469077511|FG003|Overall Study|Adverse Event|1|||
130304452|NCT00620113|469077508|FG000|Overall Study|Lack of Efficacy|2|||
130304453|NCT00620113|469077509|FG001|Overall Study|Lack of Efficacy|3|||
130047957|NCT02115815|468133121|FG002|Overall Study|Withdrawal by Subject|0|||
130047958|NCT02115815|468133122|FG003|Overall Study|Withdrawal by Subject|0|||
130047959|NCT02115815|468133123|FG004|Overall Study|Withdrawal by Subject|0|||
130047960|NCT02115815|468133124|FG005|Overall Study|Withdrawal by Subject|0|||
130304454|NCT00620113|469077510|FG002|Overall Study|Lack of Efficacy|0|||
130304455|NCT00620113|469077511|FG003|Overall Study|Lack of Efficacy|2|||
130304456|NCT00620113|469077508|FG000|Overall Study|Physician Decision|1|||
130304457|NCT00620113|469077509|FG001|Overall Study|Physician Decision|0|||
130304458|NCT00620113|469077510|FG002|Overall Study|Physician Decision|0|||
130304459|NCT00620113|469077511|FG003|Overall Study|Physician Decision|2|||
130304460|NCT00620113|469077508|FG000|Overall Study|Protocol Violation|2|||
130304461|NCT00620113|469077509|FG001|Overall Study|Protocol Violation|1|||
130304462|NCT00620113|469077510|FG002|Overall Study|Protocol Violation|0|||
130304463|NCT00620113|469077511|FG003|Overall Study|Protocol Violation|0|||
130304464|NCT00620113|469077508|FG000|Overall Study|Withdrawal by Subject|5|||
130304465|NCT00620113|469077509|FG001|Overall Study|Withdrawal by Subject|1|||
130304466|NCT00620113|469077510|FG002|Overall Study|Withdrawal by Subject|3|||
130304467|NCT00620113|469077511|FG003|Overall Study|Withdrawal by Subject|5|||
130047961|NCT02115815|468133125|FG006|Overall Study|Withdrawal by Subject|0|||
130047962|NCT02115815|468133119|FG000|Overall Study|Not enough drug to dose participant|0|||
130047963|NCT02115815|468133120|FG001|Overall Study|Not enough drug to dose participant|0|||
130047964|NCT02115815|468133121|FG002|Overall Study|Not enough drug to dose participant|0|||
130047965|NCT02115815|468133122|FG003|Overall Study|Not enough drug to dose participant|0|||
130047966|NCT02115815|468133123|FG004|Overall Study|Not enough drug to dose participant|0|||
130047967|NCT02115815|468133124|FG005|Overall Study|Not enough drug to dose participant|1|||
130047968|NCT02115815|468133125|FG006|Overall Study|Not enough drug to dose participant|0|||
130047969|NCT02115815|468133119|FG000|Overall Study|Missed appointment, randomized in error|0|||
130047970|NCT02115815|468133120|FG001|Overall Study|Missed appointment, randomized in error|0|||
130047971|NCT02115815|468133121|FG002|Overall Study|Missed appointment, randomized in error|0|||
130047972|NCT02115815|468133122|FG003|Overall Study|Missed appointment, randomized in error|0|||
130047973|NCT02115815|468133123|FG004|Overall Study|Missed appointment, randomized in error|0|||
130047974|NCT02115815|468133124|FG005|Overall Study|Missed appointment, randomized in error|1|||
130047975|NCT02115815|468133125|FG006|Overall Study|Missed appointment, randomized in error|0|||
130047976|NCT04003155|468133126|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
130047977|NCT04003155|468133127|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
130047978|NCT04003155|468133128|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
130107610|NCT01954082|468355158|FG000|Overall Study|Parent Decision|1|||
130107611|NCT01954082|468355159|FG001|Overall Study|Parent Decision|0|||
130107612|NCT01954082|468355158|FG000|Overall Study|Withdrawal by Subject|0|||
130107613|NCT01954082|468355159|FG001|Overall Study|Withdrawal by Subject|1|||
130047979|NCT04003155|468133129|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
130107614|NCT01954082|468355158|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
130107615|NCT01954082|468355159|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
130304468|NCT02461745|469077514|FG000|Overall Study|Lack of Efficacy|9|||
130304469|NCT02461745|469077515|FG001|Overall Study|Lack of Efficacy|1|||
129797734|NCT02007512|467228212|FG001|Double Blind Treatment Period|Death|0|||
129797735|NCT02007512|467228213|FG002|Double Blind Treatment Period|Death|0|||
130304470|NCT02461745|469077514|FG000|Overall Study|Lost to Follow-up|2|||
130304471|NCT02461745|469077515|FG001|Overall Study|Lost to Follow-up|2|||
130304472|NCT02461745|469077514|FG000|Overall Study|Withdrawal by Subject|3|||
130304473|NCT02461745|469077515|FG001|Overall Study|Withdrawal by Subject|1|||
130304474|NCT00211887|469077518|FG000|Overall Study|Adverse Event|8|||
130304475|NCT00211887|469077519|FG001|Overall Study|Adverse Event|4|||
130304476|NCT00211887|469077520|FG002|Overall Study|Adverse Event|6|||
130304477|NCT00211887|469077518|FG000|Overall Study|Death|1|||
130304478|NCT00211887|469077519|FG001|Overall Study|Death|1|||
130304479|NCT00211887|469077520|FG002|Overall Study|Death|1|||
130304480|NCT00211887|469077518|FG000|Overall Study|Lost to Follow-up|28|||
130304481|NCT00211887|469077519|FG001|Overall Study|Lost to Follow-up|13|||
130304482|NCT00211887|469077520|FG002|Overall Study|Lost to Follow-up|9|||
130304483|NCT00211887|469077518|FG000|Overall Study|Non-medical reason|31|||
130304484|NCT00211887|469077519|FG001|Overall Study|Non-medical reason|14|||
130304485|NCT00211887|469077520|FG002|Overall Study|Non-medical reason|8|||
130304486|NCT00211887|469077518|FG000|Overall Study|Other medical reason|15|||
129797736|NCT02007512|467228214|FG003|Double Blind Treatment Period|Death|0|||
130304487|NCT00211887|469077519|FG001|Overall Study|Other medical reason|11|||
130304488|NCT00211887|469077520|FG002|Overall Study|Other medical reason|7|||
130304489|NCT00211887|469077518|FG000|Overall Study|Side effects|19|||
130304490|NCT00211887|469077519|FG001|Overall Study|Side effects|13|||
130304491|NCT00211887|469077520|FG002|Overall Study|Side effects|5|||
130304492|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Adverse Event|33|||
130304493|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
130304494|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
130304495|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
130304496|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Physician Decision|6|||
130304497|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
130304498|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
130304499|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
130304500|NCT00965419|469077524|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
130304501|NCT00965419|469077524|FG000|Follow-up Phase|Adverse Event|9|||
130304502|NCT00965419|469077524|FG000|Follow-up Phase|Protocol Violation|4|||
130304503|NCT00965419|469077524|FG000|Follow-up Phase|Withdrawal by Subject|8|||
130304504|NCT00965419|469077524|FG000|Follow-up Phase|Physician Decision|4|||
130304505|NCT00965419|469077524|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
130304506|NCT00965419|469077524|FG000|Follow-up Phase|Lack of Efficacy|28|||
130304507|NCT00826618|469079025|FG000|Overall Study|Withdrawal by Subject|1|||
130304508|NCT03712787|469079026|FG000|Overall Study|Adverse Event|2|||
130047980|NCT04003155|468133130|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
130047981|NCT04003155|468133126|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
130304509|NCT03712787|469079027|FG001|Overall Study|Adverse Event|3|||
130304510|NCT03712787|469079028|FG002|Overall Study|Adverse Event|0|||
130304511|NCT03712787|469079029|FG003|Overall Study|Adverse Event|4|||
130304512|NCT03712787|469079026|FG000|Overall Study|Withdrawal by Subject|4|||
130304513|NCT03712787|469079027|FG001|Overall Study|Withdrawal by Subject|14|||
130304514|NCT03712787|469079028|FG002|Overall Study|Withdrawal by Subject|12|||
130304515|NCT03712787|469079029|FG003|Overall Study|Withdrawal by Subject|8|||
130304516|NCT03712787|469079026|FG000|Overall Study|Lost to Follow-up|1|||
130304517|NCT03712787|469079027|FG001|Overall Study|Lost to Follow-up|1|||
130304518|NCT03712787|469079028|FG002|Overall Study|Lost to Follow-up|2|||
130304519|NCT03712787|469079029|FG003|Overall Study|Lost to Follow-up|1|||
130304520|NCT03712787|469079026|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
130304521|NCT03712787|469079027|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
130304522|NCT03712787|469079028|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
130304523|NCT03712787|469079029|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
130304524|NCT03712787|469079026|FG000|Overall Study|COVID-19 Infection|0|||
130304525|NCT03712787|469079027|FG001|Overall Study|COVID-19 Infection|1|||
130304526|NCT03712787|469079028|FG002|Overall Study|COVID-19 Infection|0|||
130304527|NCT03712787|469079029|FG003|Overall Study|COVID-19 Infection|0|||
130304528|NCT03712787|469079026|FG000|Overall Study|Other, Not Specified|79|||
130304529|NCT03712787|469079027|FG001|Overall Study|Other, Not Specified|77|||
130304530|NCT03712787|469079028|FG002|Overall Study|Other, Not Specified|74|||
130304531|NCT03712787|469079029|FG003|Overall Study|Other, Not Specified|78|||
130304532|NCT00732875|469079030|FG000|Overall Study|Adverse Event|16|||
130304533|NCT00732875|469079030|FG000|Overall Study|Withdrawal by Subject|6|||
130304534|NCT00732875|469079030|FG000|Overall Study|Lack of Efficacy|13|||
130304535|NCT00303485|469079040|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
130304536|NCT00303485|469079041|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
130304537|NCT00303485|469079040|FG000|Overall Study|Failure to return|0|||
130304538|NCT00303485|469079041|FG001|Overall Study|Failure to return|1|||
130304539|NCT00303485|469079040|FG000|Overall Study|Withdrawal by Subject|1|||
130304540|NCT00303485|469079041|FG001|Overall Study|Withdrawal by Subject|0|||
130304541|NCT02219334|469079047|FG000|Overall Study|Withdrawal by Subject|1|||
130304542|NCT02219334|469079048|FG001|Overall Study|Withdrawal by Subject|0|||
130304543|NCT02219334|469079047|FG000|Overall Study|Protocol Violation|7|||
130304544|NCT02219334|469079048|FG001|Overall Study|Protocol Violation|3|||
130304545|NCT02630472|469079051|FG000|Overall Study|Physician Decision|10|||
130304546|NCT02630472|469079052|FG001|Overall Study|Physician Decision|0|||
130304547|NCT04878211|469079053|FG000|Overall Study|Lost to Follow-up|0|||
130304548|NCT04878211|469079054|FG001|Overall Study|Lost to Follow-up|0|||
130304549|NCT04878211|469079055|FG002|Overall Study|Lost to Follow-up|0|||
130304550|NCT04878211|469079056|FG003|Overall Study|Lost to Follow-up|1|||
130304551|NCT04878211|469079057|FG004|Overall Study|Lost to Follow-up|0|||
130304552|NCT04878211|469079058|FG005|Overall Study|Lost to Follow-up|1|||
130047982|NCT04003155|468133127|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
130047983|NCT04003155|468133128|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
130304553|NCT04878211|469079053|FG000|Overall Study|Protocol deviation|1|||
130304554|NCT04878211|469079054|FG001|Overall Study|Protocol deviation|0|||
130304555|NCT04878211|469079055|FG002|Overall Study|Protocol deviation|0|||
130304556|NCT04878211|469079056|FG003|Overall Study|Protocol deviation|0|||
130304557|NCT04878211|469079057|FG004|Overall Study|Protocol deviation|0|||
130304558|NCT04878211|469079058|FG005|Overall Study|Protocol deviation|0|||
130304559|NCT04878211|469079053|FG000|Overall Study|Study terminated by sponsor|0|||
130047984|NCT04003155|468133129|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
130304560|NCT04878211|469079054|FG001|Overall Study|Study terminated by sponsor|0|||
130304561|NCT04878211|469079055|FG002|Overall Study|Study terminated by sponsor|0|||
130304562|NCT04878211|469079056|FG003|Overall Study|Study terminated by sponsor|0|||
130304563|NCT04878211|469079057|FG004|Overall Study|Study terminated by sponsor|9|||
130304564|NCT04878211|469079058|FG005|Overall Study|Study terminated by sponsor|4|||
130304565|NCT04878211|469079053|FG000|Overall Study|Subject decision|0|||
130304566|NCT04878211|469079054|FG001|Overall Study|Subject decision|0|||
130304567|NCT04878211|469079055|FG002|Overall Study|Subject decision|0|||
130304568|NCT04878211|469079056|FG003|Overall Study|Subject decision|0|||
130304569|NCT04878211|469079057|FG004|Overall Study|Subject decision|1|||
130304570|NCT04878211|469079058|FG005|Overall Study|Subject decision|0|||
130304571|NCT04774926|469079059|FG000|Overall Study|Adverse Event|15|||
130304572|NCT04774926|469079059|FG000|Overall Study|Lost to Follow-up|3|||
130304573|NCT04774926|469079059|FG000|Overall Study|Physician Decision|6|||
130304574|NCT04774926|469079059|FG000|Overall Study|Withdrawal by Subject|3|||
130304575|NCT04774926|469079059|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
130304576|NCT02783599|469079060|FG000|Overall Study|Progressive disease|23|||
130304577|NCT02783599|469079060|FG000|Overall Study|Surgical Resection|10|||
130304578|NCT02783599|469079060|FG000|Overall Study|Adverse Event|4|||
130304579|NCT02783599|469079060|FG000|Overall Study|Physician Decision|2|||
130304580|NCT02783599|469079060|FG000|Overall Study|Death|1|||
130304581|NCT05173012|469079064|FG000|Overall Study|Adverse Event|2|||
130304582|NCT05173012|469079065|FG001|Overall Study|Adverse Event|3|||
130304583|NCT05173012|469079066|FG002|Overall Study|Adverse Event|4|||
130304584|NCT05173012|469079067|FG003|Overall Study|Adverse Event|13|||
130304585|NCT05173012|469079068|FG004|Overall Study|Adverse Event|0|||
130304586|NCT05173012|469079069|FG005|Overall Study|Adverse Event|0|||
130304587|NCT05173012|469079070|FG006|Overall Study|Adverse Event|2|||
130304588|NCT05173012|469079071|FG007|Overall Study|Adverse Event|4|||
130304589|NCT05173012|469079064|FG000|Overall Study|Lost to Follow-up|0|||
130304590|NCT05173012|469079065|FG001|Overall Study|Lost to Follow-up|0|||
130304591|NCT05173012|469079066|FG002|Overall Study|Lost to Follow-up|0|||
130304592|NCT05173012|469079067|FG003|Overall Study|Lost to Follow-up|1|||
130304593|NCT05173012|469079068|FG004|Overall Study|Lost to Follow-up|0|||
130304594|NCT05173012|469079069|FG005|Overall Study|Lost to Follow-up|0|||
130304595|NCT05173012|469079070|FG006|Overall Study|Lost to Follow-up|0|||
130304596|NCT05173012|469079071|FG007|Overall Study|Lost to Follow-up|0|||
130304597|NCT05173012|469079064|FG000|Overall Study|Withdrawal by Subject|1|||
130304598|NCT05173012|469079065|FG001|Overall Study|Withdrawal by Subject|0|||
130304599|NCT05173012|469079066|FG002|Overall Study|Withdrawal by Subject|1|||
130304600|NCT05173012|469079067|FG003|Overall Study|Withdrawal by Subject|3|||
130304601|NCT05173012|469079068|FG004|Overall Study|Withdrawal by Subject|1|||
130304602|NCT05173012|469079069|FG005|Overall Study|Withdrawal by Subject|0|||
130304603|NCT05173012|469079070|FG006|Overall Study|Withdrawal by Subject|1|||
130304604|NCT05173012|469079071|FG007|Overall Study|Withdrawal by Subject|0|||
130304605|NCT05173012|469079064|FG000|Overall Study|Protocol Deviation|0|||
130304606|NCT05173012|469079065|FG001|Overall Study|Protocol Deviation|0|||
130304607|NCT05173012|469079066|FG002|Overall Study|Protocol Deviation|0|||
130304608|NCT05173012|469079067|FG003|Overall Study|Protocol Deviation|1|||
130304609|NCT05173012|469079068|FG004|Overall Study|Protocol Deviation|0|||
130304610|NCT05173012|469079069|FG005|Overall Study|Protocol Deviation|0|||
130304611|NCT05173012|469079070|FG006|Overall Study|Protocol Deviation|0|||
130047985|NCT04003155|468133130|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
130047986|NCT04003155|468133126|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
130047987|NCT04003155|468133127|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
130047988|NCT04003155|468133128|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
130047989|NCT04003155|468133129|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
130047990|NCT04003155|468133130|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
130304612|NCT05173012|469079071|FG007|Overall Study|Protocol Deviation|0|||
130304613|NCT05173012|469079064|FG000|Overall Study|Other|0|||
130304614|NCT05173012|469079065|FG001|Overall Study|Other|0|||
130304615|NCT05173012|469079066|FG002|Overall Study|Other|0|||
130304616|NCT05173012|469079067|FG003|Overall Study|Other|2|||
130304617|NCT05173012|469079068|FG004|Overall Study|Other|0|||
130304618|NCT05173012|469079069|FG005|Overall Study|Other|0|||
130304619|NCT05173012|469079070|FG006|Overall Study|Other|0|||
130304620|NCT05173012|469079071|FG007|Overall Study|Other|0|||
130304621|NCT02936843|469079072|FG000|Overall Study|Lost to Follow-up|3|||
130304622|NCT02936843|469079073|FG001|Overall Study|Lost to Follow-up|1|||
130304623|NCT02936843|469079072|FG000|Overall Study|Withdrawal by Subject|1|||
130304624|NCT02936843|469079073|FG001|Overall Study|Withdrawal by Subject|1|||
130304625|NCT03668613|469079074|FG000|Overall Study|Adverse Event|1|||
130304626|NCT03668613|469079075|FG001|Overall Study|Adverse Event|2|||
130304627|NCT03668613|469079074|FG000|Overall Study|Lack of Efficacy|5|||
130304628|NCT03668613|469079075|FG001|Overall Study|Lack of Efficacy|1|||
130304629|NCT03668613|469079074|FG000|Overall Study|Pregnancy|0|||
130304630|NCT03668613|469079075|FG001|Overall Study|Pregnancy|2|||
130304631|NCT03668613|469079074|FG000|Overall Study|Protocol Violation|1|||
130304632|NCT03668613|469079075|FG001|Overall Study|Protocol Violation|0|||
130304633|NCT03668613|469079074|FG000|Overall Study|Physician Decision|1|||
130304634|NCT03668613|469079075|FG001|Overall Study|Physician Decision|0|||
130304635|NCT03668613|469079074|FG000|Overall Study|Withdrawal by Subject|2|||
130304636|NCT03668613|469079075|FG001|Overall Study|Withdrawal by Subject|1|||
130304637|NCT03668613|469079074|FG000|Overall Study|Guardian decision|1|||
130304638|NCT03668613|469079075|FG001|Overall Study|Guardian decision|0|||
130304639|NCT01393821|469079076|FG000|Overall Study|Cancel|1|||
130304640|NCT01393821|469079077|FG001|Overall Study|Cancel|1|||
130304641|NCT01393821|469079076|FG000|Overall Study|not evaluable for primary endpoint|4|||
130304642|NCT01393821|469079077|FG001|Overall Study|not evaluable for primary endpoint|2|||
130304643|NCT03386487|469079078|FG000|Overall Study|Lost to Follow-up|5|||
130304644|NCT03386487|469079079|FG001|Overall Study|Lost to Follow-up|6|||
130304645|NCT03386487|469079078|FG000|Overall Study|Withdrawal by Subject|11|||
130304646|NCT03386487|469079079|FG001|Overall Study|Withdrawal by Subject|7|||
130304647|NCT03386487|469079078|FG000|Overall Study|Physician Decision|11|||
130304648|NCT03386487|469079079|FG001|Overall Study|Physician Decision|8|||
130304649|NCT02703324|469079080|FG000|Period Two|Withdrawal by Subject|0|||
130304650|NCT02703324|469079081|FG001|Period Two|Withdrawal by Subject|0|||
130304651|NCT02703324|469079082|FG002|Period Two|Withdrawal by Subject|1|||
130304652|NCT02703324|469079083|FG003|Period Two|Withdrawal by Subject|0|||
130304653|NCT02703324|469079084|FG004|Period Two|Withdrawal by Subject|0|||
130304654|NCT02703324|469079085|FG005|Period Two|Withdrawal by Subject|0|||
130304655|NCT06312592|469079086|FG000|Overall Study|Lost to Follow-up|29|||
130304656|NCT06312592|469079087|FG001|Overall Study|Lost to Follow-up|13|||
130304657|NCT01948063|469079090|FG000|Overall Study|Boston MCI halted research protocol|0|||
130304658|NCT01948063|469079091|FG001|Overall Study|Boston MCI halted research protocol|1|||
130304659|NCT01948063|469079090|FG000|Overall Study|Discovered an enrollment in other study|0|||
130304660|NCT01948063|469079091|FG001|Overall Study|Discovered an enrollment in other study|1|||
130304661|NCT01948063|469079090|FG000|Overall Study|Blood samples were accidentally thawed|1|||
130304662|NCT01948063|469079091|FG001|Overall Study|Blood samples were accidentally thawed|0|||
130304663|NCT01858766|469079092|FG000|Overall Study|Randomized but Never Treated|0|||
130304664|NCT01858766|469079093|FG001|Overall Study|Randomized but Never Treated|0|||
130304665|NCT01858766|469079094|FG002|Overall Study|Randomized but Never Treated|0|||
130304666|NCT01858766|469079095|FG003|Overall Study|Randomized but Never Treated|0|||
130304667|NCT01858766|469079096|FG004|Overall Study|Randomized but Never Treated|0|||
130304668|NCT01858766|469079097|FG005|Overall Study|Randomized but Never Treated|1|||
130304669|NCT01858766|469079098|FG006|Overall Study|Randomized but Never Treated|0|||
130304670|NCT01858766|469079099|FG007|Overall Study|Randomized but Never Treated|0|||
130304671|NCT01858766|469079100|FG008|Overall Study|Randomized but Never Treated|0|||
130304672|NCT01858766|469079101|FG009|Overall Study|Randomized but Never Treated|0|||
130304673|NCT01858766|469079102|FG010|Overall Study|Randomized but Never Treated|0|||
130304674|NCT01858766|469079103|FG011|Overall Study|Randomized but Never Treated|0|||
130304675|NCT01858766|469079104|FG012|Overall Study|Randomized but Never Treated|0|||
130304676|NCT01858766|469079105|FG013|Overall Study|Randomized but Never Treated|0|||
130304677|NCT01858766|469079106|FG014|Overall Study|Randomized but Never Treated|0|||
130304678|NCT01858766|469079107|FG015|Overall Study|Randomized but Never Treated|0|||
130304679|NCT01858766|469079108|FG016|Overall Study|Randomized but Never Treated|0|||
130304680|NCT01858766|469079109|FG017|Overall Study|Randomized but Never Treated|1|||
130304681|NCT01858766|469079110|FG018|Overall Study|Randomized but Never Treated|0|||
130304682|NCT01858766|469079092|FG000|Overall Study|Death|0|||
130304683|NCT01858766|469079093|FG001|Overall Study|Death|0|||
130304684|NCT01858766|469079094|FG002|Overall Study|Death|1|||
130304685|NCT01858766|469079095|FG003|Overall Study|Death|0|||
130304686|NCT01858766|469079096|FG004|Overall Study|Death|0|||
130304687|NCT01858766|469079097|FG005|Overall Study|Death|0|||
130304688|NCT01858766|469079098|FG006|Overall Study|Death|0|||
130304689|NCT01858766|469079099|FG007|Overall Study|Death|0|||
130304690|NCT01858766|469079100|FG008|Overall Study|Death|0|||
130304691|NCT01858766|469079101|FG009|Overall Study|Death|0|||
130304692|NCT01858766|469079102|FG010|Overall Study|Death|0|||
130304693|NCT01858766|469079103|FG011|Overall Study|Death|0|||
130304694|NCT01858766|469079104|FG012|Overall Study|Death|0|||
130304695|NCT01858766|469079105|FG013|Overall Study|Death|0|||
130304696|NCT01858766|469079106|FG014|Overall Study|Death|0|||
130304697|NCT01858766|469079107|FG015|Overall Study|Death|0|||
130304698|NCT01858766|469079108|FG016|Overall Study|Death|0|||
130304699|NCT01858766|469079109|FG017|Overall Study|Death|0|||
130304700|NCT01858766|469079110|FG018|Overall Study|Death|0|||
130304701|NCT01858766|469079092|FG000|Overall Study|Lack of Efficacy|1|||
130304702|NCT01858766|469079093|FG001|Overall Study|Lack of Efficacy|0|||
130304703|NCT01858766|469079094|FG002|Overall Study|Lack of Efficacy|0|||
130304704|NCT01858766|469079095|FG003|Overall Study|Lack of Efficacy|0|||
130304705|NCT01858766|469079096|FG004|Overall Study|Lack of Efficacy|1|||
130304706|NCT01858766|469079097|FG005|Overall Study|Lack of Efficacy|2|||
130304707|NCT01858766|469079098|FG006|Overall Study|Lack of Efficacy|0|||
130304708|NCT01858766|469079099|FG007|Overall Study|Lack of Efficacy|0|||
130304709|NCT01858766|469079100|FG008|Overall Study|Lack of Efficacy|0|||
130304710|NCT01858766|469079101|FG009|Overall Study|Lack of Efficacy|0|||
130304711|NCT01858766|469079102|FG010|Overall Study|Lack of Efficacy|0|||
130304712|NCT01858766|469079103|FG011|Overall Study|Lack of Efficacy|3|||
130304713|NCT01858766|469079104|FG012|Overall Study|Lack of Efficacy|5|||
130304714|NCT01858766|469079105|FG013|Overall Study|Lack of Efficacy|3|||
130304715|NCT01858766|469079106|FG014|Overall Study|Lack of Efficacy|5|||
130304716|NCT01858766|469079107|FG015|Overall Study|Lack of Efficacy|5|||
130304717|NCT01858766|469079108|FG016|Overall Study|Lack of Efficacy|2|||
130304718|NCT01858766|469079109|FG017|Overall Study|Lack of Efficacy|3|||
130304719|NCT01858766|469079110|FG018|Overall Study|Lack of Efficacy|3|||
130304720|NCT01858766|469079092|FG000|Overall Study|Lost to Follow-up|0|||
130304721|NCT01858766|469079093|FG001|Overall Study|Lost to Follow-up|0|||
130304722|NCT01858766|469079094|FG002|Overall Study|Lost to Follow-up|0|||
130304723|NCT01858766|469079095|FG003|Overall Study|Lost to Follow-up|0|||
130304724|NCT01858766|469079096|FG004|Overall Study|Lost to Follow-up|0|||
130304725|NCT01858766|469079097|FG005|Overall Study|Lost to Follow-up|1|||
130304726|NCT01858766|469079098|FG006|Overall Study|Lost to Follow-up|0|||
130304727|NCT01858766|469079099|FG007|Overall Study|Lost to Follow-up|2|||
130304728|NCT01858766|469079100|FG008|Overall Study|Lost to Follow-up|0|||
130304729|NCT01858766|469079101|FG009|Overall Study|Lost to Follow-up|0|||
130304730|NCT01858766|469079102|FG010|Overall Study|Lost to Follow-up|0|||
130304731|NCT01858766|469079103|FG011|Overall Study|Lost to Follow-up|1|||
130304732|NCT01858766|469079104|FG012|Overall Study|Lost to Follow-up|0|||
130304733|NCT01858766|469079105|FG013|Overall Study|Lost to Follow-up|0|||
130304734|NCT01858766|469079106|FG014|Overall Study|Lost to Follow-up|3|||
130304735|NCT01858766|469079107|FG015|Overall Study|Lost to Follow-up|1|||
130304736|NCT01858766|469079108|FG016|Overall Study|Lost to Follow-up|1|||
130304737|NCT01858766|469079109|FG017|Overall Study|Lost to Follow-up|0|||
130304738|NCT01858766|469079110|FG018|Overall Study|Lost to Follow-up|1|||
130304739|NCT01858766|469079092|FG000|Overall Study|Withdrew Consent|0|||
130304740|NCT01858766|469079093|FG001|Overall Study|Withdrew Consent|0|||
130304741|NCT01858766|469079094|FG002|Overall Study|Withdrew Consent|0|||
130304742|NCT01858766|469079095|FG003|Overall Study|Withdrew Consent|0|||
130304743|NCT01858766|469079096|FG004|Overall Study|Withdrew Consent|0|||
130304744|NCT01858766|469079097|FG005|Overall Study|Withdrew Consent|0|||
130304745|NCT01858766|469079098|FG006|Overall Study|Withdrew Consent|0|||
130304746|NCT01858766|469079099|FG007|Overall Study|Withdrew Consent|0|||
130304747|NCT01858766|469079100|FG008|Overall Study|Withdrew Consent|0|||
130304748|NCT01858766|469079101|FG009|Overall Study|Withdrew Consent|0|||
130304749|NCT01858766|469079102|FG010|Overall Study|Withdrew Consent|0|||
130304750|NCT01858766|469079103|FG011|Overall Study|Withdrew Consent|1|||
130304751|NCT01858766|469079104|FG012|Overall Study|Withdrew Consent|0|||
130304752|NCT01858766|469079105|FG013|Overall Study|Withdrew Consent|0|||
130304753|NCT01858766|469079106|FG014|Overall Study|Withdrew Consent|0|||
130304754|NCT01858766|469079107|FG015|Overall Study|Withdrew Consent|0|||
130304755|NCT01858766|469079108|FG016|Overall Study|Withdrew Consent|0|||
130304756|NCT01858766|469079109|FG017|Overall Study|Withdrew Consent|0|||
130304757|NCT01858766|469079110|FG018|Overall Study|Withdrew Consent|0|||
130304758|NCT03517228|469079113|FG000|Overall Study|Withdrawal by Subject|2|||
130304759|NCT03517228|469079113|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
130304760|NCT03517228|469079113|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
130304761|NCT03517228|469079113|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
130304762|NCT03517228|469079113|FG000|Overall Study|Canceled due to device being updated|1|||
130304763|NCT03517228|469079113|FG000|Overall Study|No V Cares in stock|1|||
130304764|NCT03517228|469079113|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
130304765|NCT03781414|469079124|FG000|Overall Study|Study terminated by sponsor|39|||
130304766|NCT03781414|469079125|FG001|Overall Study|Study terminated by sponsor|34|||
130304767|NCT03781414|469079126|FG002|Overall Study|Study terminated by sponsor|25|||
130304768|NCT03781414|469079124|FG000|Overall Study|Adverse Event|3|||
130304769|NCT03781414|469079125|FG001|Overall Study|Adverse Event|6|||
130304770|NCT03781414|469079126|FG002|Overall Study|Adverse Event|3|||
130304771|NCT03781414|469079124|FG000|Overall Study|Physician Decision|2|||
130304772|NCT03781414|469079125|FG001|Overall Study|Physician Decision|0|||
130304773|NCT03781414|469079126|FG002|Overall Study|Physician Decision|1|||
130304774|NCT03781414|469079124|FG000|Overall Study|Withdrawal by Subject|2|||
130304775|NCT03781414|469079125|FG001|Overall Study|Withdrawal by Subject|3|||
130304776|NCT03781414|469079126|FG002|Overall Study|Withdrawal by Subject|3|||
130304777|NCT03781414|469079124|FG000|Overall Study|Death|1|||
130304778|NCT03781414|469079125|FG001|Overall Study|Death|4|||
130304779|NCT03781414|469079126|FG002|Overall Study|Death|0|||
130304780|NCT03781414|469079124|FG000|Overall Study|Lost to Follow-up|1|||
130304781|NCT03781414|469079125|FG001|Overall Study|Lost to Follow-up|1|||
130304782|NCT03781414|469079126|FG002|Overall Study|Lost to Follow-up|0|||
130304783|NCT04752358|469079130|FG000|Overall Study|Death|2|||
130304784|NCT04752358|469079131|FG001|Overall Study|Death|1|||
130304785|NCT00719355|469079134|FG000|Overall Study|Death|0|||
130304786|NCT00719355|469079135|FG001|Overall Study|Death|1|||
130304787|NCT00719355|469079134|FG000|Overall Study|Medical|14|||
130304788|NCT00719355|469079135|FG001|Overall Study|Medical|5|||
130304789|NCT00719355|469079134|FG000|Overall Study|Compliance|4|||
130304790|NCT00719355|469079135|FG001|Overall Study|Compliance|6|||
130304791|NCT00719355|469079134|FG000|Overall Study|Moved|0|||
130304792|NCT00719355|469079135|FG001|Overall Study|Moved|1|||
130304793|NCT01835158|469079136|FG000|Overall Study|Withdrawal by Subject|1|||
130304794|NCT01835158|469079137|FG001|Overall Study|Withdrawal by Subject|6|||
130304795|NCT03364738|469079139|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
130304796|NCT03364738|469079139|FG000|Overall Study|Withdrawal by Subject|1|||
130304797|NCT03364738|469079139|FG000|Overall Study|Adverse Event|1|||
130304798|NCT03245398|469079143|FG000|Overall Study|Travelled to another island|1|||
130304799|NCT03245398|469079144|FG001|Overall Study|Travelled to another island|0|||
130304800|NCT03422536|469079151|FG000|Randomized|Physician Decision|1|||
130304801|NCT03422536|469079152|FG001|Randomized|Physician Decision|1|||
130304802|NCT03422536|469079151|FG000|Allocation - Received Intervention|Disease progression|19|||
130304803|NCT03422536|469079152|FG001|Allocation - Received Intervention|Disease progression|25|||
130304804|NCT03422536|469079151|FG000|Allocation - Received Intervention|Death|1|||
130304805|NCT03422536|469079152|FG001|Allocation - Received Intervention|Death|3|||
130304806|NCT03422536|469079151|FG000|Allocation - Received Intervention|Adverse Event|1|||
130304807|NCT03422536|469079152|FG001|Allocation - Received Intervention|Adverse Event|0|||
130304808|NCT03422536|469079151|FG000|Allocation - Received Intervention|Physician Decision|1|||
130304809|NCT03422536|469079152|FG001|Allocation - Received Intervention|Physician Decision|1|||
130304810|NCT03422536|469079151|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
130304811|NCT03422536|469079152|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
130304812|NCT03422536|469079151|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
130304813|NCT03422536|469079152|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
130304814|NCT04531241|469079153|FG000|Period 1|Withdrawal by Subject|2|||
130304815|NCT04531241|469079154|FG001|Period 1|Withdrawal by Subject|0|||
130304816|NCT04531241|469079153|FG000|Period 1|Dispesed incorrect lens power|1|||
130304817|NCT04531241|469079154|FG001|Period 1|Dispesed incorrect lens power|0|||
130304818|NCT04531241|469079153|FG000|Period 1|Protocol Violation|1|||
130304819|NCT04531241|469079154|FG001|Period 1|Protocol Violation|0|||
130304820|NCT04531241|469079153|FG000|Period 1|No longer eligible|0|||
130304821|NCT04531241|469079154|FG001|Period 1|No longer eligible|1|||
130304822|NCT04531241|469079153|FG000|Period 1|Lens Discomfort|0|||
130304823|NCT04531241|469079154|FG001|Period 1|Lens Discomfort|1|||
130304824|NCT04531241|469079153|FG000|Period 2|Covid-19 Related|1|||
130304825|NCT04531241|469079154|FG001|Period 2|Covid-19 Related|1|||
130304826|NCT02023996|469079155|FG000|Overall Study|Protocol Violation|6|||
130304827|NCT00395850|469079162|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
130304828|NCT00395850|469079163|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130304829|NCT00395850|469079164|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130304830|NCT00395850|469079165|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
130304831|NCT00395850|469079162|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
130304832|NCT00395850|469079163|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130304833|NCT00395850|469079164|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130304834|NCT00395850|469079165|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
130304835|NCT00395850|469079162|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
130304836|NCT00395850|469079163|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130304837|NCT00395850|469079164|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130304838|NCT00395850|469079165|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
130304839|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
130304840|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
130304841|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
130304842|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
130304843|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
130304844|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130304845|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130304846|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
130304847|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
130304848|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130304849|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130304850|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
130304851|NCT00395850|469079162|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
130304852|NCT00395850|469079163|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130304853|NCT00395850|469079164|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130304854|NCT00395850|469079165|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
130304855|NCT01620762|469079168|FG000|Overall Study|Protocol Violation|1|||
130304856|NCT01620762|469079169|FG001|Overall Study|Protocol Violation|1|||
130304857|NCT01620762|469079170|FG002|Overall Study|Protocol Violation|1|||
130304858|NCT01620762|469079168|FG000|Overall Study|Adverse Event|9|||
130304859|NCT01620762|469079169|FG001|Overall Study|Adverse Event|5|||
130304860|NCT01620762|469079170|FG002|Overall Study|Adverse Event|2|||
130304861|NCT01620762|469079168|FG000|Overall Study|Withdrawal by Subject|23|||
130304862|NCT01620762|469079169|FG001|Overall Study|Withdrawal by Subject|26|||
130304863|NCT01620762|469079170|FG002|Overall Study|Withdrawal by Subject|27|||
130304864|NCT01620762|469079168|FG000|Overall Study|Lost to Follow-up|11|||
130304865|NCT01620762|469079169|FG001|Overall Study|Lost to Follow-up|17|||
130304866|NCT01620762|469079170|FG002|Overall Study|Lost to Follow-up|10|||
130304867|NCT01620762|469079168|FG000|Overall Study|Protocol deviation|1|||
130304868|NCT01620762|469079169|FG001|Overall Study|Protocol deviation|1|||
130304869|NCT01620762|469079170|FG002|Overall Study|Protocol deviation|6|||
130304870|NCT01620762|469079168|FG000|Overall Study|Subject deterioration|0|||
130304871|NCT01620762|469079169|FG001|Overall Study|Subject deterioration|1|||
130304872|NCT01620762|469079170|FG002|Overall Study|Subject deterioration|1|||
130304873|NCT01620762|469079168|FG000|Overall Study|Non-specified|3|||
130304874|NCT01620762|469079169|FG001|Overall Study|Non-specified|6|||
130304875|NCT01620762|469079170|FG002|Overall Study|Non-specified|5|||
130304876|NCT01620762|469079168|FG000|Overall Study|Use of prohibted therapies|0|||
130304877|NCT01620762|469079169|FG001|Overall Study|Use of prohibted therapies|1|||
130304878|NCT01620762|469079170|FG002|Overall Study|Use of prohibted therapies|1|||
130304879|NCT00705146|469079175|FG000|Overall Study|Lost to Follow-up|1|||
130304880|NCT00705146|469079176|FG001|Overall Study|Lost to Follow-up|1|||
130304881|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
130304882|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304883|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304884|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304885|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304886|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
130304887|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
130304888|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304889|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304890|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304891|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304892|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
130304893|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
130304894|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304895|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304896|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304897|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304898|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
130304899|NCT00095173|469079179|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
130304900|NCT00095173|469079180|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
130304901|NCT00095173|469079181|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
130304902|NCT00095173|469079182|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
130304903|NCT00095173|469079183|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
130304904|NCT00095173|469079184|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
130304905|NCT00095173|469079179|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304906|NCT00095173|469079180|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
130304907|NCT00095173|469079181|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
130304908|NCT00095173|469079182|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304909|NCT00095173|469079183|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304910|NCT00095173|469079184|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
130304911|NCT00095173|469079179|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304912|NCT00095173|469079180|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
130304913|NCT00095173|469079181|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304914|NCT00095173|469079182|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304915|NCT00095173|469079183|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304916|NCT00095173|469079184|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
130304917|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Death|0|||
130304918|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Death|0|||
130304919|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Death|0|||
130304920|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Death|0|||
130304921|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Death|0|||
130304922|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Death|1|||
130304923|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130304924|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130304925|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
130304926|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
130304927|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
130304928|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
130304929|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130304930|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130304931|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
130304932|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
130304933|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
130304934|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
130304935|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130304936|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130304937|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
130304938|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
130304939|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
130304940|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
130304941|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130304942|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130304943|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129889340|NCT03259373|467552563|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
129889341|NCT03259373|467552562|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
130047991|NCT04003155|468133126|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
130304944|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
130304945|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
130304946|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
130304947|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304948|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304949|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304950|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
130304951|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
130304952|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
130304953|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130304954|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130304955|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130047992|NCT04003155|468133127|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
130047993|NCT04003155|468133128|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
129891097|NCT02408549|467559616|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
130047994|NCT04003155|468133129|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
130304956|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
130304957|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
130304958|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
130304959|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130304960|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130304961|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
130304962|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
130304963|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
130304964|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
130304965|NCT00095173|469079179|FG000|Open-Label Extension Phase (Period C)|Other|0|||
130304966|NCT00095173|469079180|FG001|Open-Label Extension Phase (Period C)|Other|0|||
130304967|NCT00095173|469079181|FG002|Open-Label Extension Phase (Period C)|Other|0|||
130304968|NCT00095173|469079182|FG003|Open-Label Extension Phase (Period C)|Other|4|||
130304969|NCT00095173|469079183|FG004|Open-Label Extension Phase (Period C)|Other|6|||
130304970|NCT00095173|469079184|FG005|Open-Label Extension Phase (Period C)|Other|8|||
130304971|NCT00330681|469079188|FG000|Overall Study|Adverse Event|3|||
130304972|NCT00330681|469079189|FG001|Overall Study|Adverse Event|6|||
130304973|NCT00330681|469079188|FG000|Overall Study|Protocol Violation|0|||
130304974|NCT00330681|469079189|FG001|Overall Study|Protocol Violation|1|||
130304975|NCT00330681|469079188|FG000|Overall Study|Withdrawal by Subject|5|||
130304976|NCT00330681|469079189|FG001|Overall Study|Withdrawal by Subject|5|||
130304977|NCT00330681|469079188|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
130304978|NCT00330681|469079189|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
130304979|NCT04698993|469079190|FG000|Overall Study|PCR results not accessible|2|||
130304980|NCT04698993|469079191|FG001|Overall Study|PCR results not accessible|7|||
130304981|NCT04698993|469079190|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
130304982|NCT04698993|469079191|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
130304983|NCT02578186|469079192|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
130304984|NCT02578186|469079193|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
130304985|NCT02578186|469079192|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
130304986|NCT02578186|469079193|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
130304987|NCT00527904|469079194|FG000|Overall Study|Adverse Event|45|||
130304988|NCT00527904|469079194|FG000|Overall Study|Withdrawal by Subject|21|||
130304989|NCT00527904|469079194|FG000|Overall Study|Lost to Follow-up|8|||
130304990|NCT00527904|469079194|FG000|Overall Study|misc|22|||
130304991|NCT00428389|469079195|FG000|Core Phase|Adverse Event|6|||
130304992|NCT00428389|469079196|FG001|Core Phase|Adverse Event|4|||
130304993|NCT00428389|469079195|FG000|Core Phase|Lack of Efficacy|2|||
130304994|NCT00428389|469079196|FG001|Core Phase|Lack of Efficacy|0|||
130304995|NCT00428389|469079195|FG000|Core Phase|Abnormal test procedure result(s)|0|||
130304996|NCT00428389|469079196|FG001|Core Phase|Abnormal test procedure result(s)|1|||
130304997|NCT00428389|469079195|FG000|Core Phase|Withdrawal by Subject|3|||
130304998|NCT00428389|469079196|FG001|Core Phase|Withdrawal by Subject|4|||
130304999|NCT00428389|469079195|FG000|Core Phase|Protocol deviation|0|||
130305000|NCT00428389|469079196|FG001|Core Phase|Protocol deviation|2|||
130305001|NCT00428389|469079195|FG000|Extension Phase|Adverse Event|17|||
130305002|NCT00428389|469079196|FG001|Extension Phase|Adverse Event|11|||
130305003|NCT00428389|469079195|FG000|Extension Phase|Lack of Efficacy|4|||
130305004|NCT00428389|469079196|FG001|Extension Phase|Lack of Efficacy|3|||
130305005|NCT00428389|469079195|FG000|Extension Phase|Withdrawal by Subject|6|||
130305006|NCT00428389|469079196|FG001|Extension Phase|Withdrawal by Subject|6|||
130305007|NCT00428389|469079195|FG000|Extension Phase|Lost to Follow-up|0|||
130305008|NCT00428389|469079196|FG001|Extension Phase|Lost to Follow-up|3|||
130305009|NCT00428389|469079195|FG000|Extension Phase|Death|1|||
130305010|NCT00428389|469079196|FG001|Extension Phase|Death|0|||
130305011|NCT00428389|469079195|FG000|Extension Phase|Protocol Violation|3|||
130305012|NCT00428389|469079196|FG001|Extension Phase|Protocol Violation|2|||
130305013|NCT00428389|469079195|FG000|Extension Phase|Administrative problems|1|||
130305014|NCT00428389|469079196|FG001|Extension Phase|Administrative problems|1|||
130305015|NCT01534195|469079197|FG000|Overall Study|Withdrawal by Subject|1|||
130305016|NCT01534195|469079198|FG001|Overall Study|Withdrawal by Subject|1|||
130305017|NCT01320202|469079199|FG000|Overall Study|Adverse Event|5|||
130305018|NCT01320202|469079200|FG001|Overall Study|Adverse Event|5|||
130305019|NCT01320202|469079199|FG000|Overall Study|Death|5|||
130305020|NCT01320202|469079200|FG001|Overall Study|Death|3|||
130305021|NCT01320202|469079199|FG000|Overall Study|Lost to Follow-up|1|||
130305022|NCT01320202|469079200|FG001|Overall Study|Lost to Follow-up|0|||
130305023|NCT01320202|469079199|FG000|Overall Study|Physician Decision|3|||
130305024|NCT01320202|469079200|FG001|Overall Study|Physician Decision|1|||
130305025|NCT01320202|469079199|FG000|Overall Study|Protocol Violation|2|||
130305026|NCT01320202|469079200|FG001|Overall Study|Protocol Violation|1|||
130305027|NCT01320202|469079199|FG000|Overall Study|Withdrawal by Subject|10|||
130107616|NCT01954082|468355158|FG000|Overall Study|Redirection of Care|0|||
130107617|NCT01954082|468355159|FG001|Overall Study|Redirection of Care|2|||
130107618|NCT01954082|468355158|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
130305028|NCT01320202|469079200|FG001|Overall Study|Withdrawal by Subject|3|||
130305029|NCT01320202|469079199|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
130305030|NCT01320202|469079200|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
130305031|NCT01320202|469079199|FG000|Overall Study|kidney transplant|1|||
130305032|NCT01320202|469079200|FG001|Overall Study|kidney transplant|2|||
130305033|NCT01320202|469079199|FG000|Overall Study|blood transfusion|1|||
130305034|NCT01320202|469079200|FG001|Overall Study|blood transfusion|7|||
130305035|NCT01320202|469079199|FG000|Overall Study|moved/changed dialysis|5|||
130305036|NCT01320202|469079200|FG001|Overall Study|moved/changed dialysis|2|||
130305037|NCT01320202|469079199|FG000|Overall Study|sponsor request|2|||
130305038|NCT01320202|469079200|FG001|Overall Study|sponsor request|0|||
130305039|NCT01320202|469079199|FG000|Overall Study|ineligible|3|||
130305040|NCT01320202|469079200|FG001|Overall Study|ineligible|0|||
130305041|NCT01320202|469079199|FG000|Overall Study|regained renal function|1|||
130305042|NCT01320202|469079200|FG001|Overall Study|regained renal function|0|||
130305043|NCT00635882|469079201|FG000|Overall Study|Protocol Violation|1|||
130305044|NCT00635882|469079202|FG001|Overall Study|Protocol Violation|0|||
130305045|NCT00635882|469079203|FG002|Overall Study|Protocol Violation|0|||
130305046|NCT00635882|469079204|FG003|Overall Study|Protocol Violation|0|||
130305047|NCT00635882|469079205|FG004|Overall Study|Protocol Violation|0|||
130305048|NCT00635882|469079206|FG005|Overall Study|Protocol Violation|0|||
130305049|NCT00825812|469079207|FG000|Overall Study|Never entered follow up|0|||
130305050|NCT00825812|469079208|FG001|Overall Study|Never entered follow up|0|||
130305051|NCT00825812|469079209|FG002|Overall Study|Never entered follow up|0|||
130305052|NCT00825812|469079210|FG003|Overall Study|Never entered follow up|1|||
130305053|NCT00825812|469079207|FG000|Overall Study|Adverse Event|0|||
130305054|NCT00825812|469079208|FG001|Overall Study|Adverse Event|0|||
130305055|NCT00825812|469079209|FG002|Overall Study|Adverse Event|0|||
130305056|NCT00825812|469079210|FG003|Overall Study|Adverse Event|1|||
130305057|NCT00825812|469079207|FG000|Overall Study|Subject withdrew consent|0|||
130305058|NCT00825812|469079208|FG001|Overall Study|Subject withdrew consent|0|||
130305059|NCT00825812|469079209|FG002|Overall Study|Subject withdrew consent|3|||
130305060|NCT00825812|469079210|FG003|Overall Study|Subject withdrew consent|2|||
130305061|NCT00825812|469079207|FG000|Overall Study|Non-compliance with protocol|0|||
130305062|NCT00825812|469079208|FG001|Overall Study|Non-compliance with protocol|0|||
130305063|NCT00825812|469079209|FG002|Overall Study|Non-compliance with protocol|0|||
130305064|NCT00825812|469079210|FG003|Overall Study|Non-compliance with protocol|1|||
130305065|NCT00825812|469079207|FG000|Overall Study|Administrative|0|||
130305066|NCT00825812|469079208|FG001|Overall Study|Administrative|1|||
130305067|NCT00825812|469079209|FG002|Overall Study|Administrative|3|||
130305068|NCT00825812|469079210|FG003|Overall Study|Administrative|5|||
130305069|NCT01278797|469079213|FG000|Period 1|Adverse Event|0|||
130305070|NCT01278797|469079214|FG001|Period 1|Adverse Event|1|||
130305071|NCT01278797|469079213|FG000|Period 1|Protocol Violation|1|||
130305072|NCT01278797|469079214|FG001|Period 1|Protocol Violation|0|||
130305073|NCT03343626|469081599|FG000|Overall Study|Lost to Follow-up|4|||
130305074|NCT03343626|469081600|FG001|Overall Study|Lost to Follow-up|3|||
130305075|NCT03343626|469081601|FG002|Overall Study|Lost to Follow-up|2|||
130305076|NCT03343626|469081602|FG003|Overall Study|Lost to Follow-up|5|||
130305077|NCT03343626|469081603|FG004|Overall Study|Lost to Follow-up|4|||
130305078|NCT03343626|469081604|FG005|Overall Study|Lost to Follow-up|4|||
130305079|NCT03343626|469081605|FG006|Overall Study|Lost to Follow-up|4|||
130305080|NCT03343626|469081606|FG007|Overall Study|Lost to Follow-up|7|||
130305081|NCT03343626|469081599|FG000|Overall Study|Withdrawal of Consent|2|||
130305082|NCT03343626|469081600|FG001|Overall Study|Withdrawal of Consent|1|||
130305083|NCT03343626|469081601|FG002|Overall Study|Withdrawal of Consent|0|||
130305084|NCT03343626|469081602|FG003|Overall Study|Withdrawal of Consent|3|||
130305085|NCT03343626|469081603|FG004|Overall Study|Withdrawal of Consent|3|||
130305086|NCT03343626|469081604|FG005|Overall Study|Withdrawal of Consent|1|||
130305087|NCT03343626|469081605|FG006|Overall Study|Withdrawal of Consent|1|||
130305088|NCT03343626|469081606|FG007|Overall Study|Withdrawal of Consent|2|||
130305089|NCT03343626|469081599|FG000|Overall Study|Reason not Specified|0|||
130305090|NCT03343626|469081600|FG001|Overall Study|Reason not Specified|1|||
130305091|NCT03343626|469081601|FG002|Overall Study|Reason not Specified|0|||
130305092|NCT03343626|469081602|FG003|Overall Study|Reason not Specified|0|||
130305093|NCT03343626|469081603|FG004|Overall Study|Reason not Specified|0|||
130305094|NCT03343626|469081604|FG005|Overall Study|Reason not Specified|0|||
130305095|NCT03343626|469081605|FG006|Overall Study|Reason not Specified|0|||
130305096|NCT03343626|469081606|FG007|Overall Study|Reason not Specified|1|||
130107619|NCT01954082|468355159|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
130305097|NCT03343626|469081599|FG000|Overall Study|Data Entry Error|0|||
130305098|NCT03343626|469081600|FG001|Overall Study|Data Entry Error|0|||
130305099|NCT03343626|469081601|FG002|Overall Study|Data Entry Error|0|||
130305100|NCT03343626|469081602|FG003|Overall Study|Data Entry Error|0|||
130107620|NCT01954082|468355158|FG000|Overall Study|Comfort Care|0|||
130305101|NCT03343626|469081603|FG004|Overall Study|Data Entry Error|0|||
130305102|NCT03343626|469081604|FG005|Overall Study|Data Entry Error|0|||
130305103|NCT03343626|469081605|FG006|Overall Study|Data Entry Error|0|||
130305104|NCT03343626|469081606|FG007|Overall Study|Data Entry Error|1|||
130305105|NCT02475278|469081609|FG000|Overall Study|Lost to Follow-up|1|||
130305106|NCT02475278|469081609|FG000|Overall Study|Reason Not Specified|1|||
130305107|NCT01865448|469081610|FG000|Overall Study|Adverse Event|1|||
130305108|NCT01865448|469081611|FG001|Overall Study|Adverse Event|1|||
130305109|NCT01865448|469081610|FG000|Overall Study|Pregnancy|0|||
130305110|NCT01865448|469081611|FG001|Overall Study|Pregnancy|1|||
130305111|NCT01865448|469081610|FG000|Overall Study|dropout unrelated to study|1|||
130305112|NCT01865448|469081611|FG001|Overall Study|dropout unrelated to study|1|||
130305113|NCT05111249|469081615|FG000|Overall Study|Lost to Follow-up|0|||
130305114|NCT05111249|469081616|FG001|Overall Study|Lost to Follow-up|2|||
130305115|NCT05111249|469081615|FG000|Overall Study|Physician Decision|0|||
130305116|NCT05111249|469081616|FG001|Overall Study|Physician Decision|1|||
130305117|NCT05111249|469081615|FG000|Overall Study|Participant decision|1|||
130305118|NCT05111249|469081616|FG001|Overall Study|Participant decision|5|||
130305119|NCT05128578|469081617|FG000|Overall Study|Withdrawal by Subject|9|||
130305120|NCT05128578|469081617|FG000|Overall Study|Lost to Follow-up|5|||
130305121|NCT00872599|469081620|FG000|Second Washout Period|Adverse Event|1|||
130305122|NCT00872599|469081621|FG001|Second Washout Period|Adverse Event|1|||
130305123|NCT00801229|469081624|FG000|Signed Consent|Withdrawal by Subject|2|||
130305124|NCT00801229|469081625|FG001|Signed Consent|Withdrawal by Subject|2|||
130305125|NCT00801229|469081624|FG000|Signed Consent|Found Ineligible|1|||
130305126|NCT00801229|469081625|FG001|Signed Consent|Found Ineligible|1|||
130305127|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
130305128|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
130305129|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
130305130|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
130305131|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
130305132|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
130305133|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
130305134|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
130305135|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
130305136|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
130305137|NCT00801229|469081624|FG000|Received Study Drug/Placebo|Adverse Event|1|||
130305138|NCT00801229|469081625|FG001|Received Study Drug/Placebo|Adverse Event|1|||
130305139|NCT02610777|469081626|FG000|Overall Study|Lost to Follow-up|1|||
130305140|NCT02610777|469081627|FG001|Overall Study|Lost to Follow-up|0|||
130305141|NCT02610777|469081626|FG000|Overall Study|Site Terminated by Sponsor|9|||
130305142|NCT02610777|469081627|FG001|Overall Study|Site Terminated by Sponsor|8|||
130305143|NCT02610777|469081626|FG000|Overall Study|Withdrawal by Subject|2|||
130305144|NCT02610777|469081627|FG001|Overall Study|Withdrawal by Subject|2|||
130305145|NCT02610777|469081626|FG000|Overall Study|Reason not Specified|0|||
130305146|NCT02610777|469081627|FG001|Overall Study|Reason not Specified|1|||
130305147|NCT02610777|469081626|FG000|Overall Study|Death|50|||
130305148|NCT02610777|469081627|FG001|Overall Study|Death|47|||
130305149|NCT02300259|469081630|FG000|Period 1|Adverse Event|0|||
130305150|NCT02300259|469081631|FG001|Period 1|Adverse Event|0|||
130305151|NCT02300259|469081632|FG002|Period 1|Adverse Event|1|||
130305152|NCT02300259|469081630|FG000|Period 1|Withdrawal by Subject|0|||
130305153|NCT02300259|469081631|FG001|Period 1|Withdrawal by Subject|0|||
130305154|NCT02300259|469081632|FG002|Period 1|Withdrawal by Subject|1|||
130305155|NCT02300259|469081630|FG000|Period 2|Adverse Event|1|||
130305156|NCT02300259|469081631|FG001|Period 2|Adverse Event|0|||
130305157|NCT02300259|469081632|FG002|Period 2|Adverse Event|0|||
130305158|NCT02300259|469081630|FG000|Period 2|Withdrawal by Subject|0|||
130305159|NCT02300259|469081631|FG001|Period 2|Withdrawal by Subject|0|||
130305160|NCT02300259|469081632|FG002|Period 2|Withdrawal by Subject|1|||
130305161|NCT02737475|469081633|FG000|Overall Study|Other reasons|0|||
130305162|NCT02737475|469081634|FG001|Overall Study|Other reasons|0|||
130305163|NCT02737475|469081635|FG002|Overall Study|Other reasons|0|||
130305164|NCT02737475|469081636|FG003|Overall Study|Other reasons|0|||
130305165|NCT02737475|469081637|FG004|Overall Study|Other reasons|1|||
130305166|NCT02737475|469081638|FG005|Overall Study|Other reasons|1|||
130305167|NCT02737475|469081639|FG006|Overall Study|Other reasons|0|||
130305168|NCT02737475|469081640|FG007|Overall Study|Other reasons|0|||
130305169|NCT02737475|469081641|FG008|Overall Study|Other reasons|1|||
130305170|NCT02737475|469081642|FG009|Overall Study|Other reasons|0|||
130305171|NCT02737475|469081643|FG010|Overall Study|Other reasons|1|||
130305172|NCT02737475|469081644|FG011|Overall Study|Other reasons|0|||
130305173|NCT02737475|469081645|FG012|Overall Study|Other reasons|0|||
130305174|NCT02737475|469081646|FG013|Overall Study|Other reasons|0|||
130305175|NCT02737475|469081647|FG014|Overall Study|Other reasons|0|||
130305176|NCT02737475|469081648|FG015|Overall Study|Other reasons|0|||
130305177|NCT02737475|469081649|FG016|Overall Study|Other reasons|0|||
130305178|NCT02737475|469081650|FG017|Overall Study|Other reasons|0|||
130305179|NCT02737475|469081651|FG018|Overall Study|Other reasons|0|||
130305180|NCT02737475|469081652|FG019|Overall Study|Other reasons|0|||
130305181|NCT02737475|469081653|FG020|Overall Study|Other reasons|0|||
130305182|NCT02737475|469081654|FG021|Overall Study|Other reasons|1|||
130305183|NCT02737475|469081655|FG022|Overall Study|Other reasons|0|||
130305184|NCT02737475|469081656|FG023|Overall Study|Other reasons|1|||
130305185|NCT02737475|469081657|FG024|Overall Study|Other reasons|1|||
130305186|NCT02737475|469081658|FG025|Overall Study|Other reasons|1|||
130305187|NCT02737475|469081659|FG026|Overall Study|Other reasons|0|||
130305188|NCT02737475|469081633|FG000|Overall Study|Death|1|||
130305189|NCT02737475|469081634|FG001|Overall Study|Death|0|||
130305190|NCT02737475|469081635|FG002|Overall Study|Death|0|||
130305191|NCT02737475|469081636|FG003|Overall Study|Death|1|||
130305192|NCT02737475|469081637|FG004|Overall Study|Death|0|||
130305193|NCT02737475|469081638|FG005|Overall Study|Death|0|||
130305194|NCT02737475|469081639|FG006|Overall Study|Death|0|||
130305195|NCT02737475|469081640|FG007|Overall Study|Death|2|||
130305196|NCT02737475|469081641|FG008|Overall Study|Death|0|||
130305197|NCT02737475|469081642|FG009|Overall Study|Death|0|||
130305198|NCT02737475|469081643|FG010|Overall Study|Death|0|||
130305199|NCT02737475|469081644|FG011|Overall Study|Death|4|||
130305200|NCT02737475|469081645|FG012|Overall Study|Death|2|||
130305201|NCT02737475|469081646|FG013|Overall Study|Death|2|||
130305202|NCT02737475|469081647|FG014|Overall Study|Death|0|||
130305203|NCT02737475|469081648|FG015|Overall Study|Death|2|||
130305204|NCT02737475|469081649|FG016|Overall Study|Death|2|||
130305205|NCT02737475|469081650|FG017|Overall Study|Death|2|||
130305206|NCT02737475|469081651|FG018|Overall Study|Death|1|||
130305207|NCT02737475|469081652|FG019|Overall Study|Death|0|||
130305208|NCT02737475|469081653|FG020|Overall Study|Death|0|||
130305209|NCT02737475|469081654|FG021|Overall Study|Death|0|||
130305210|NCT02737475|469081655|FG022|Overall Study|Death|0|||
130305211|NCT02737475|469081656|FG023|Overall Study|Death|0|||
130305212|NCT02737475|469081657|FG024|Overall Study|Death|0|||
130305213|NCT02737475|469081658|FG025|Overall Study|Death|0|||
130305214|NCT02737475|469081659|FG026|Overall Study|Death|0|||
130305215|NCT02737475|469081633|FG000|Overall Study|Participant withdrew consent|0|||
130305216|NCT02737475|469081634|FG001|Overall Study|Participant withdrew consent|0|||
130305217|NCT02737475|469081635|FG002|Overall Study|Participant withdrew consent|0|||
130305218|NCT02737475|469081636|FG003|Overall Study|Participant withdrew consent|0|||
130305219|NCT02737475|469081637|FG004|Overall Study|Participant withdrew consent|0|||
130305220|NCT02737475|469081638|FG005|Overall Study|Participant withdrew consent|2|||
130305221|NCT02737475|469081639|FG006|Overall Study|Participant withdrew consent|0|||
130305222|NCT02737475|469081640|FG007|Overall Study|Participant withdrew consent|0|||
130305223|NCT02737475|469081641|FG008|Overall Study|Participant withdrew consent|0|||
130305224|NCT02737475|469081642|FG009|Overall Study|Participant withdrew consent|0|||
130305225|NCT02737475|469081643|FG010|Overall Study|Participant withdrew consent|0|||
130305226|NCT02737475|469081644|FG011|Overall Study|Participant withdrew consent|0|||
130305227|NCT02737475|469081645|FG012|Overall Study|Participant withdrew consent|0|||
130305228|NCT02737475|469081646|FG013|Overall Study|Participant withdrew consent|0|||
130305229|NCT02737475|469081647|FG014|Overall Study|Participant withdrew consent|1|||
130305230|NCT02737475|469081648|FG015|Overall Study|Participant withdrew consent|0|||
130305231|NCT02737475|469081649|FG016|Overall Study|Participant withdrew consent|0|||
130305232|NCT02737475|469081650|FG017|Overall Study|Participant withdrew consent|2|||
130305233|NCT02737475|469081651|FG018|Overall Study|Participant withdrew consent|1|||
130305234|NCT02737475|469081652|FG019|Overall Study|Participant withdrew consent|0|||
130305235|NCT02737475|469081653|FG020|Overall Study|Participant withdrew consent|2|||
130305236|NCT02737475|469081654|FG021|Overall Study|Participant withdrew consent|0|||
130305237|NCT02737475|469081655|FG022|Overall Study|Participant withdrew consent|0|||
130305238|NCT02737475|469081656|FG023|Overall Study|Participant withdrew consent|0|||
130305239|NCT02737475|469081657|FG024|Overall Study|Participant withdrew consent|0|||
130047995|NCT04003155|468133130|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
130047996|NCT04003155|468133126|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
130305240|NCT02737475|469081658|FG025|Overall Study|Participant withdrew consent|0|||
130305241|NCT02737475|469081659|FG026|Overall Study|Participant withdrew consent|0|||
130305242|NCT02737475|469081633|FG000|Overall Study|Lost to Follow-up|0|||
130305243|NCT02737475|469081634|FG001|Overall Study|Lost to Follow-up|0|||
130047997|NCT04003155|468133127|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
130047998|NCT04003155|468133128|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
130305244|NCT02737475|469081635|FG002|Overall Study|Lost to Follow-up|0|||
130305245|NCT02737475|469081636|FG003|Overall Study|Lost to Follow-up|0|||
130305246|NCT02737475|469081637|FG004|Overall Study|Lost to Follow-up|0|||
130305247|NCT02737475|469081638|FG005|Overall Study|Lost to Follow-up|0|||
130305248|NCT02737475|469081639|FG006|Overall Study|Lost to Follow-up|0|||
130305249|NCT02737475|469081640|FG007|Overall Study|Lost to Follow-up|0|||
130305250|NCT02737475|469081641|FG008|Overall Study|Lost to Follow-up|0|||
130305251|NCT02737475|469081642|FG009|Overall Study|Lost to Follow-up|0|||
130305252|NCT02737475|469081643|FG010|Overall Study|Lost to Follow-up|0|||
130305253|NCT02737475|469081644|FG011|Overall Study|Lost to Follow-up|0|||
130305254|NCT02737475|469081645|FG012|Overall Study|Lost to Follow-up|0|||
130305255|NCT02737475|469081646|FG013|Overall Study|Lost to Follow-up|0|||
130305256|NCT02737475|469081647|FG014|Overall Study|Lost to Follow-up|0|||
130305257|NCT02737475|469081648|FG015|Overall Study|Lost to Follow-up|1|||
130305258|NCT02737475|469081649|FG016|Overall Study|Lost to Follow-up|0|||
130305259|NCT02737475|469081650|FG017|Overall Study|Lost to Follow-up|0|||
130305260|NCT02737475|469081651|FG018|Overall Study|Lost to Follow-up|0|||
130305261|NCT02737475|469081652|FG019|Overall Study|Lost to Follow-up|0|||
130305262|NCT02737475|469081653|FG020|Overall Study|Lost to Follow-up|0|||
130305263|NCT02737475|469081654|FG021|Overall Study|Lost to Follow-up|0|||
129889342|NCT03259373|467552563|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
130305264|NCT02737475|469081655|FG022|Overall Study|Lost to Follow-up|0|||
130305265|NCT02737475|469081656|FG023|Overall Study|Lost to Follow-up|0|||
130305266|NCT02737475|469081657|FG024|Overall Study|Lost to Follow-up|0|||
130305267|NCT02737475|469081658|FG025|Overall Study|Lost to Follow-up|0|||
130305268|NCT02737475|469081659|FG026|Overall Study|Lost to Follow-up|0|||
130305269|NCT02737475|469081633|FG000|Overall Study|Disease Progression|0|||
130305270|NCT02737475|469081634|FG001|Overall Study|Disease Progression|0|||
130305271|NCT02737475|469081635|FG002|Overall Study|Disease Progression|0|||
130305272|NCT02737475|469081636|FG003|Overall Study|Disease Progression|0|||
130305273|NCT02737475|469081637|FG004|Overall Study|Disease Progression|0|||
130305274|NCT02737475|469081638|FG005|Overall Study|Disease Progression|0|||
130305275|NCT02737475|469081639|FG006|Overall Study|Disease Progression|0|||
130305276|NCT02737475|469081640|FG007|Overall Study|Disease Progression|0|||
130305277|NCT02737475|469081641|FG008|Overall Study|Disease Progression|0|||
130305278|NCT02737475|469081642|FG009|Overall Study|Disease Progression|0|||
130305279|NCT02737475|469081643|FG010|Overall Study|Disease Progression|0|||
130305280|NCT02737475|469081644|FG011|Overall Study|Disease Progression|0|||
130305281|NCT02737475|469081645|FG012|Overall Study|Disease Progression|0|||
130305282|NCT02737475|469081646|FG013|Overall Study|Disease Progression|0|||
130305283|NCT02737475|469081647|FG014|Overall Study|Disease Progression|0|||
130305284|NCT02737475|469081648|FG015|Overall Study|Disease Progression|0|||
130305285|NCT02737475|469081649|FG016|Overall Study|Disease Progression|0|||
130305286|NCT02737475|469081650|FG017|Overall Study|Disease Progression|0|||
130305287|NCT02737475|469081651|FG018|Overall Study|Disease Progression|0|||
130305288|NCT02737475|469081652|FG019|Overall Study|Disease Progression|0|||
130305289|NCT02737475|469081653|FG020|Overall Study|Disease Progression|0|||
130305290|NCT02737475|469081654|FG021|Overall Study|Disease Progression|0|||
130305291|NCT02737475|469081655|FG022|Overall Study|Disease Progression|0|||
130305292|NCT02737475|469081656|FG023|Overall Study|Disease Progression|0|||
130305293|NCT02737475|469081657|FG024|Overall Study|Disease Progression|0|||
130305294|NCT02737475|469081658|FG025|Overall Study|Disease Progression|0|||
130305295|NCT02737475|469081659|FG026|Overall Study|Disease Progression|1|||
130305296|NCT03688074|469081660|FG000|Overall Study|Adverse Event|0|||
130305297|NCT03688074|469081661|FG001|Overall Study|Adverse Event|1|||
130305298|NCT03688074|469081660|FG000|Overall Study|Other|1|||
130305299|NCT03688074|469081661|FG001|Overall Study|Other|0|||
130305300|NCT00660179|469081662|FG000|Overall Study|Death|44|||
130305301|NCT00660179|469081663|FG001|Overall Study|Death|47|||
130305302|NCT00660179|469081664|FG002|Overall Study|Death|34|||
130305303|NCT00660179|469081662|FG000|Overall Study|Withdrawal of consent|4|||
130305304|NCT00660179|469081663|FG001|Overall Study|Withdrawal of consent|6|||
130305305|NCT00660179|469081664|FG002|Overall Study|Withdrawal of consent|4|||
130047999|NCT04003155|468133129|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
130048000|NCT04003155|468133130|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
130305306|NCT00660179|469081662|FG000|Overall Study|Lost to Follow-up|7|||
130305307|NCT00660179|469081663|FG001|Overall Study|Lost to Follow-up|5|||
130305308|NCT00660179|469081664|FG002|Overall Study|Lost to Follow-up|2|||
130305309|NCT00660179|469081662|FG000|Overall Study|Administrative reason|0|||
130305310|NCT00660179|469081663|FG001|Overall Study|Administrative reason|0|||
130305311|NCT00660179|469081664|FG002|Overall Study|Administrative reason|1|||
130305312|NCT00660179|469081662|FG000|Overall Study|Incorrect randomization|1|||
130305313|NCT00660179|469081663|FG001|Overall Study|Incorrect randomization|0|||
130305314|NCT00660179|469081664|FG002|Overall Study|Incorrect randomization|0|||
130305315|NCT02255461|469081665|FG000|Overall Study|Adverse Event|0|||
129891098|NCT02408549|467559616|FG000|Overall Study|Subject moved to another place, far from site|1|||
130048001|NCT04003155|468133126|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
130305316|NCT02255461|469081666|FG001|Overall Study|Adverse Event|1|||
130305317|NCT02255461|469081667|FG002|Overall Study|Adverse Event|0|||
130305318|NCT02255461|469081668|FG003|Overall Study|Adverse Event|0|||
130048002|NCT04003155|468133127|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
130305319|NCT02255461|469081669|FG004|Overall Study|Adverse Event|1|||
130305320|NCT02255461|469081665|FG000|Overall Study|Withdrawal by Subject|0|||
130305321|NCT02255461|469081666|FG001|Overall Study|Withdrawal by Subject|0|||
130305322|NCT02255461|469081667|FG002|Overall Study|Withdrawal by Subject|1|||
130305323|NCT02255461|469081668|FG003|Overall Study|Withdrawal by Subject|0|||
130305324|NCT02255461|469081669|FG004|Overall Study|Withdrawal by Subject|1|||
130305325|NCT02255461|469081665|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
130305326|NCT02255461|469081666|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
130305327|NCT02255461|469081667|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
130305328|NCT02255461|469081668|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
130305329|NCT02255461|469081669|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
130305330|NCT03056339|469081674|FG000|Overall Study|Failed Requirements|0|||
130305331|NCT03056339|469081675|FG001|Overall Study|Failed Requirements|2|||
130305332|NCT03056339|469081676|FG002|Overall Study|Failed Requirements|7|||
130305333|NCT03056339|469081677|FG003|Overall Study|Failed Requirements|1|||
130305334|NCT01128244|469081682|FG000|Overall Study|Adverse Event|1|||
130305335|NCT01128244|469081682|FG000|Overall Study|Scheduling conflict|2|||
130305336|NCT04171219|469081685|FG000|Overall Study|Adverse Event|1|||
130305337|NCT04171219|469081686|FG001|Overall Study|Adverse Event|0|||
130305338|NCT04171219|469081685|FG000|Overall Study|Death|0|||
130305339|NCT04171219|469081686|FG001|Overall Study|Death|1|||
130305340|NCT04171219|469081685|FG000|Overall Study|Lack of Efficacy|9|||
130305341|NCT04171219|469081686|FG001|Overall Study|Lack of Efficacy|13|||
130305342|NCT04171219|469081685|FG000|Overall Study|Withdrawal by Subject|1|||
130305343|NCT04171219|469081686|FG001|Overall Study|Withdrawal by Subject|2|||
130305344|NCT04171219|469081685|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
130305345|NCT04171219|469081686|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
130305346|NCT04171219|469081685|FG000|Overall Study|Clinical PD/Patient choice|1|||
130305347|NCT04171219|469081686|FG001|Overall Study|Clinical PD/Patient choice|0|||
130305348|NCT04171219|469081685|FG000|Overall Study|Toxicity/ Patient choice|1|||
130305349|NCT04171219|469081686|FG001|Overall Study|Toxicity/ Patient choice|0|||
130305350|NCT04809285|469081687|FG000|Phase 1|Lost to Follow-up|6|||
130305351|NCT04809285|469081687|FG000|Phase 1|Protocol Violation|2|||
130305352|NCT04809285|469081687|FG000|Phase 1|Physician Decision|3|||
130305353|NCT04809285|469081687|FG000|Phase 1|Withdrawal by Subject|29|||
130107621|NCT01954082|468355159|FG001|Overall Study|Comfort Care|1|||
130107622|NCT01954082|468355158|FG000|Overall Study|Infant Moved|0|||
130305354|NCT04809285|469081687|FG000|Phase 2|Protocol Violation|3|||
130305355|NCT04809285|469081687|FG000|Phase 2|Withdrawal by Subject|4|||
130305356|NCT03040674|469081691|FG000|Overall Study|Lost to Follow-up|225|||
130305357|NCT03040674|469081691|FG000|Overall Study|Death|23|||
130305358|NCT02206035|469081692|FG000|Overall Study|Physician Decision|10|||
130305359|NCT02206035|469081693|FG001|Overall Study|Physician Decision|0|||
130305360|NCT02206035|469081694|FG002|Overall Study|Physician Decision|175|||
130305361|NCT01934010|469081695|FG000|Overall Study|Adverse Event|1|||
130305362|NCT01934010|469081696|FG001|Overall Study|Adverse Event|1|||
130305363|NCT01934010|469081697|FG002|Overall Study|Adverse Event|0|||
130305364|NCT01934010|469081695|FG000|Overall Study|Withdrawal by Subject|15|||
130305365|NCT01934010|469081696|FG001|Overall Study|Withdrawal by Subject|6|||
130305366|NCT01934010|469081697|FG002|Overall Study|Withdrawal by Subject|2|||
130305367|NCT01934010|469081695|FG000|Overall Study|Lost to Follow-up|7|||
130305368|NCT01934010|469081696|FG001|Overall Study|Lost to Follow-up|4|||
130305369|NCT01934010|469081697|FG002|Overall Study|Lost to Follow-up|0|||
130305370|NCT04303572|469081698|FG000|Overall Study|Study closed due to poor enrollment|1|||
130305371|NCT04929249|469081699|FG000|Overall Study|Adverse Event|2|||
130305372|NCT04929249|469081700|FG001|Overall Study|Adverse Event|1|||
130305373|NCT04929249|469081699|FG000|Overall Study|Death|2|||
130305374|NCT04929249|469081700|FG001|Overall Study|Death|1|||
130305375|NCT04929249|469081699|FG000|Overall Study|Lost to Follow-up|3|||
130305376|NCT04929249|469081700|FG001|Overall Study|Lost to Follow-up|11|||
130305377|NCT04929249|469081699|FG000|Overall Study|Technical problems|0|||
130305378|NCT04929249|469081700|FG001|Overall Study|Technical problems|1|||
130305379|NCT04929249|469081699|FG000|Overall Study|Subject decision|6|||
130305380|NCT04929249|469081700|FG001|Overall Study|Subject decision|8|||
130305381|NCT04929249|469081699|FG000|Overall Study|Withdrew consent|0|||
130305382|NCT04929249|469081700|FG001|Overall Study|Withdrew consent|8|||
130305383|NCT00172042|469081712|FG000|Overall Study|Adverse Event|27|||
130305384|NCT00172042|469081713|FG001|Overall Study|Adverse Event|13|||
130305385|NCT00172042|469081712|FG000|Overall Study|Abnormal laboratory value(s)|5|||
130305386|NCT00172042|469081713|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130305387|NCT00172042|469081712|FG000|Overall Study|Abnormal test procedure(s)|0|||
130305388|NCT00172042|469081713|FG001|Overall Study|Abnormal test procedure(s)|3|||
130305389|NCT00172042|469081712|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
130305390|NCT00172042|469081713|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
130305391|NCT00172042|469081712|FG000|Overall Study|Patient no longer requires study drug|10|||
130305392|NCT00172042|469081713|FG001|Overall Study|Patient no longer requires study drug|8|||
130305393|NCT00172042|469081712|FG000|Overall Study|Protocol Violation|8|||
130107623|NCT01954082|468355159|FG001|Overall Study|Infant Moved|1|||
130305394|NCT00172042|469081713|FG001|Overall Study|Protocol Violation|7|||
130305395|NCT00172042|469081712|FG000|Overall Study|Withdrawal by Subject|37|||
130305396|NCT00172042|469081713|FG001|Overall Study|Withdrawal by Subject|25|||
130305397|NCT00172042|469081712|FG000|Overall Study|Lost to Follow-up|3|||
130305398|NCT00172042|469081713|FG001|Overall Study|Lost to Follow-up|5|||
130305399|NCT00172042|469081712|FG000|Overall Study|Administrative problems|13|||
130305400|NCT00172042|469081713|FG001|Overall Study|Administrative problems|10|||
130305401|NCT00172042|469081712|FG000|Overall Study|Death|42|||
130305402|NCT00172042|469081713|FG001|Overall Study|Death|42|||
130305403|NCT01771250|469081714|FG000|Period 1|Met exclusion criteria|1|||
130305404|NCT01771250|469081715|FG001|Period 1|Met exclusion criteria|0|||
130305405|NCT00483938|469081716|FG000|Overall Study|Protocol Violation|0|||
130305406|NCT00483938|469081717|FG001|Overall Study|Protocol Violation|0|||
130305407|NCT00483938|469081718|FG002|Overall Study|Protocol Violation|0|||
130305408|NCT00483938|469081719|FG003|Overall Study|Protocol Violation|0|||
130305409|NCT00483938|469081720|FG004|Overall Study|Protocol Violation|0|||
130305410|NCT00483938|469081721|FG005|Overall Study|Protocol Violation|0|||
130305411|NCT00483938|469081722|FG006|Overall Study|Protocol Violation|3|||
130305412|NCT00483938|469081716|FG000|Overall Study|Withdrawal by Subject|1|||
130305413|NCT00483938|469081717|FG001|Overall Study|Withdrawal by Subject|6|||
130305414|NCT00483938|469081718|FG002|Overall Study|Withdrawal by Subject|0|||
130305415|NCT00483938|469081719|FG003|Overall Study|Withdrawal by Subject|0|||
130305416|NCT00483938|469081720|FG004|Overall Study|Withdrawal by Subject|1|||
130305417|NCT00483938|469081721|FG005|Overall Study|Withdrawal by Subject|3|||
130305418|NCT00483938|469081722|FG006|Overall Study|Withdrawal by Subject|2|||
130305419|NCT00483938|469081716|FG000|Overall Study|Lost to Follow-up|1|||
130305420|NCT00483938|469081717|FG001|Overall Study|Lost to Follow-up|2|||
130305421|NCT00483938|469081718|FG002|Overall Study|Lost to Follow-up|0|||
130305422|NCT00483938|469081719|FG003|Overall Study|Lost to Follow-up|2|||
130305423|NCT00483938|469081720|FG004|Overall Study|Lost to Follow-up|1|||
130305424|NCT00483938|469081721|FG005|Overall Study|Lost to Follow-up|1|||
130305425|NCT00483938|469081722|FG006|Overall Study|Lost to Follow-up|3|||
130305426|NCT00483938|469081716|FG000|Overall Study|Death|0|||
130305427|NCT00483938|469081717|FG001|Overall Study|Death|2|||
130305428|NCT00483938|469081718|FG002|Overall Study|Death|0|||
130305429|NCT00483938|469081719|FG003|Overall Study|Death|0|||
130305430|NCT00483938|469081720|FG004|Overall Study|Death|0|||
130305431|NCT00483938|469081721|FG005|Overall Study|Death|0|||
130305432|NCT00483938|469081722|FG006|Overall Study|Death|0|||
130305433|NCT00483938|469081716|FG000|Overall Study|Other|3|||
130305434|NCT00483938|469081717|FG001|Overall Study|Other|9|||
130305435|NCT00483938|469081718|FG002|Overall Study|Other|0|||
130305436|NCT00483938|469081719|FG003|Overall Study|Other|4|||
130305437|NCT00483938|469081720|FG004|Overall Study|Other|0|||
130305438|NCT00483938|469081721|FG005|Overall Study|Other|4|||
130305439|NCT00483938|469081722|FG006|Overall Study|Other|32|||
130305440|NCT02218008|469081723|FG000|Stage 1 (S1)|Adverse Event|6|||
130305441|NCT02218008|469081724|FG001|Stage 1 (S1)|Adverse Event|5|||
130305442|NCT02218008|469081725|FG002|Stage 1 (S1)|Adverse Event|11|||
130305443|NCT02218008|469081726|FG003|Stage 1 (S1)|Adverse Event|0|||
130305444|NCT02218008|469081727|FG004|Stage 1 (S1)|Adverse Event|0|||
130305445|NCT02218008|469081728|FG005|Stage 1 (S1)|Adverse Event|0|||
130305446|NCT02218008|469081723|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
130305447|NCT02218008|469081724|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
129889343|NCT03259373|467552562|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
130048003|NCT04003155|468133128|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
130305448|NCT02218008|469081725|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
130305449|NCT02218008|469081726|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
130048004|NCT04003155|468133129|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
130305450|NCT02218008|469081727|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
130305451|NCT02218008|469081728|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
130305452|NCT02218008|469081723|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
130305453|NCT02218008|469081724|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
130305454|NCT02218008|469081725|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
130305455|NCT02218008|469081726|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
130305456|NCT02218008|469081727|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
130305457|NCT02218008|469081728|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
130305458|NCT02218008|469081723|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
130107624|NCT01954082|468355158|FG000|Overall Study|Randomized not Treated|4|||
130107625|NCT01954082|468355159|FG001|Overall Study|Randomized not Treated|2|||
130107626|NCT00618774|468355162|FG000|Overall Study|Adverse Event|5|||
130107627|NCT00618774|468355163|FG001|Overall Study|Adverse Event|3|||
130107628|NCT00618774|468355162|FG000|Overall Study|Withdrawal by Subject|1|||
130107629|NCT00618774|468355163|FG001|Overall Study|Withdrawal by Subject|0|||
130107630|NCT02261974|468355164|FG000|Overall Study|Withdrawal by Subject|3|||
130107631|NCT02261974|468355165|FG001|Overall Study|Withdrawal by Subject|2|||
130107632|NCT02261974|468355164|FG000|Overall Study|Pregnancy|0|||
130107633|NCT02261974|468355165|FG001|Overall Study|Pregnancy|1|||
130107634|NCT02261974|468355164|FG000|Overall Study|Missed treatment cut-off date|6|||
130305459|NCT02218008|469081724|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
130305460|NCT02218008|469081725|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
130107635|NCT02261974|468355165|FG001|Overall Study|Missed treatment cut-off date|3|||
130107636|NCT02261974|468355164|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
130107637|NCT02261974|468355165|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
130107638|NCT02261974|468355164|FG000|Overall Study|Lost to Follow-up|2|||
130107639|NCT02261974|468355165|FG001|Overall Study|Lost to Follow-up|0|||
130305461|NCT02218008|469081726|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
130305462|NCT02218008|469081727|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
130305463|NCT02218008|469081728|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
130305464|NCT02218008|469081723|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
130305465|NCT02218008|469081724|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
130305466|NCT02218008|469081725|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305467|NCT02218008|469081726|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305468|NCT02218008|469081727|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130305469|NCT02218008|469081728|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
130107640|NCT02261974|468355164|FG000|Overall Study|Adverse Event|1|||
130107641|NCT02261974|468355165|FG001|Overall Study|Adverse Event|0|||
130107642|NCT05180630|468355166|FG000|First Intervention|Physician Decision|0|||
130107643|NCT05180630|468355167|FG001|First Intervention|Physician Decision|0|||
130107644|NCT05180630|468355168|FG002|First Intervention|Physician Decision|3|||
130107645|NCT00709735|468355171|FG000|Overall Study|Lost to Follow-up|1|||
130107646|NCT00709735|468355172|FG001|Overall Study|Lost to Follow-up|1|||
130107647|NCT00709735|468355171|FG000|Overall Study|Relapse into Opioid Abuse|0|||
130107648|NCT00709735|468355172|FG001|Overall Study|Relapse into Opioid Abuse|1|||
130107649|NCT00709735|468355171|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
130107650|NCT00709735|468355172|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
130107651|NCT00666718|468355173|FG000|Overall Study|Adverse Event|0|||
130107652|NCT00666718|468355174|FG001|Overall Study|Adverse Event|1|||
130107653|NCT00666718|468355173|FG000|Overall Study|Death|1|||
130107654|NCT00666718|468355174|FG001|Overall Study|Death|0|||
130107655|NCT00666718|468355173|FG000|Overall Study|Lost to Follow-up|1|||
130107656|NCT00666718|468355174|FG001|Overall Study|Lost to Follow-up|0|||
130107657|NCT00666718|468355173|FG000|Overall Study|Entry Criteria Not Met|2|||
130305470|NCT02218008|469081723|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
130305471|NCT02218008|469081724|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
130305472|NCT02218008|469081725|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
130305473|NCT02218008|469081726|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
130305474|NCT02218008|469081727|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
130305475|NCT02218008|469081728|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
130305476|NCT02218008|469081723|FG000|Stage 1 (S1)|Pregnancy|0|||
130305477|NCT02218008|469081724|FG001|Stage 1 (S1)|Pregnancy|0|||
130305478|NCT02218008|469081725|FG002|Stage 1 (S1)|Pregnancy|1|||
130305479|NCT02218008|469081726|FG003|Stage 1 (S1)|Pregnancy|0|||
130305480|NCT02218008|469081727|FG004|Stage 1 (S1)|Pregnancy|0|||
130305481|NCT02218008|469081728|FG005|Stage 1 (S1)|Pregnancy|0|||
130107658|NCT00666718|468355174|FG001|Overall Study|Entry Criteria Not Met|0|||
130107659|NCT00666718|468355173|FG000|Overall Study|Protocol Violation|1|||
130107660|NCT00666718|468355174|FG001|Overall Study|Protocol Violation|3|||
130107661|NCT00666718|468355173|FG000|Overall Study|Withdrawal by Subject|7|||
130107662|NCT00666718|468355174|FG001|Overall Study|Withdrawal by Subject|12|||
130107663|NCT00666718|468355173|FG000|Overall Study|Physician Decision|0|||
130107664|NCT00666718|468355174|FG001|Overall Study|Physician Decision|2|||
130305482|NCT02218008|469081723|FG000|Stage 1 (S1)|Protocol Violation|0|||
130305483|NCT02218008|469081724|FG001|Stage 1 (S1)|Protocol Violation|0|||
130305484|NCT02218008|469081725|FG002|Stage 1 (S1)|Protocol Violation|1|||
130107665|NCT00963599|468355175|FG000|Overall Study|Adverse Event|2|||
130107666|NCT00963599|468355176|FG001|Overall Study|Adverse Event|0|||
130107667|NCT00963599|468355177|FG002|Overall Study|Adverse Event|1|||
130107668|NCT00963599|468355178|FG003|Overall Study|Adverse Event|2|||
130107669|NCT00963599|468355175|FG000|Overall Study|Lack of Efficacy|0|||
130107670|NCT00963599|468355176|FG001|Overall Study|Lack of Efficacy|2|||
130107671|NCT00963599|468355177|FG002|Overall Study|Lack of Efficacy|1|||
130305485|NCT02218008|469081726|FG003|Stage 1 (S1)|Protocol Violation|0|||
130305486|NCT02218008|469081727|FG004|Stage 1 (S1)|Protocol Violation|0|||
130305487|NCT02218008|469081728|FG005|Stage 1 (S1)|Protocol Violation|0|||
130305488|NCT02218008|469081723|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
130305489|NCT02218008|469081724|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305490|NCT02218008|469081725|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305491|NCT02218008|469081726|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305492|NCT02218008|469081727|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305493|NCT02218008|469081728|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
130305494|NCT02218008|469081723|FG000|Stage 2 (S2)|Adverse Event|0|||
130305495|NCT02218008|469081724|FG001|Stage 2 (S2)|Adverse Event|0|||
130305496|NCT02218008|469081725|FG002|Stage 2 (S2)|Adverse Event|0|||
130305497|NCT02218008|469081726|FG003|Stage 2 (S2)|Adverse Event|2|||
130305498|NCT02218008|469081727|FG004|Stage 2 (S2)|Adverse Event|3|||
130305499|NCT02218008|469081728|FG005|Stage 2 (S2)|Adverse Event|3|||
130305500|NCT02218008|469081723|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
130305501|NCT02218008|469081724|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
130305502|NCT02218008|469081725|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
130305503|NCT02218008|469081726|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
130305504|NCT02218008|469081727|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
130305505|NCT02218008|469081728|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
130305506|NCT02218008|469081723|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
130305507|NCT02218008|469081724|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
130305508|NCT02218008|469081725|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
130305509|NCT02218008|469081726|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
130305510|NCT02218008|469081727|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
130305511|NCT02218008|469081728|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
130305512|NCT02218008|469081723|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305513|NCT02218008|469081724|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305514|NCT02218008|469081725|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305515|NCT02218008|469081726|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
130305516|NCT02218008|469081727|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305517|NCT02218008|469081728|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
130305518|NCT02218008|469081723|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
130305519|NCT02218008|469081724|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
130305520|NCT02218008|469081725|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
130305521|NCT02218008|469081726|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
130305522|NCT02218008|469081727|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
130305523|NCT02218008|469081728|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
130305524|NCT02038075|469081729|FG000|Overall Study|Withdrawal by Subject|3|||
130305525|NCT02038075|469081730|FG001|Overall Study|Withdrawal by Subject|0|||
130305526|NCT00106353|469081731|FG000|Part 1|Disease progression|3|||
130305527|NCT00106353|469081732|FG001|Part 1|Disease progression|4|||
130305528|NCT00106353|469081733|FG002|Part 1|Disease progression|1|||
130305529|NCT00106353|469081734|FG003|Part 1|Disease progression|3|||
130305530|NCT00106353|469081735|FG004|Part 1|Disease progression|0|||
130305531|NCT00106353|469081736|FG005|Part 1|Disease progression|0|||
130305532|NCT00106353|469081737|FG006|Part 1|Disease progression|0|||
130305533|NCT00106353|469081731|FG000|Part 1|Withdrawal by Subject|0|||
130048005|NCT04003155|468133130|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
130048006|NCT04003155|468133126|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
130048007|NCT04003155|468133127|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
130048008|NCT04003155|468133128|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
130107672|NCT00963599|468355178|FG003|Overall Study|Lack of Efficacy|4|||
130305534|NCT00106353|469081732|FG001|Part 1|Withdrawal by Subject|0|||
130305535|NCT00106353|469081733|FG002|Part 1|Withdrawal by Subject|1|||
130305536|NCT00106353|469081734|FG003|Part 1|Withdrawal by Subject|2|||
130305537|NCT00106353|469081735|FG004|Part 1|Withdrawal by Subject|0|||
130305538|NCT00106353|469081736|FG005|Part 1|Withdrawal by Subject|0|||
130305539|NCT00106353|469081737|FG006|Part 1|Withdrawal by Subject|0|||
130305540|NCT00106353|469081731|FG000|Part 1|Symptomatic deterioration|0|||
130305541|NCT00106353|469081732|FG001|Part 1|Symptomatic deterioration|0|||
130305542|NCT00106353|469081733|FG002|Part 1|Symptomatic deterioration|1|||
130305543|NCT00106353|469081734|FG003|Part 1|Symptomatic deterioration|0|||
130305544|NCT00106353|469081735|FG004|Part 1|Symptomatic deterioration|0|||
130305545|NCT00106353|469081736|FG005|Part 1|Symptomatic deterioration|0|||
130305546|NCT00106353|469081737|FG006|Part 1|Symptomatic deterioration|0|||
130305547|NCT00106353|469081731|FG000|Part 1|Entered follow-up phase|1|||
130305548|NCT00106353|469081732|FG001|Part 1|Entered follow-up phase|1|||
130305549|NCT00106353|469081733|FG002|Part 1|Entered follow-up phase|0|||
130305550|NCT00106353|469081734|FG003|Part 1|Entered follow-up phase|1|||
130305551|NCT00106353|469081735|FG004|Part 1|Entered follow-up phase|0|||
130305552|NCT00106353|469081736|FG005|Part 1|Entered follow-up phase|0|||
130305553|NCT00106353|469081737|FG006|Part 1|Entered follow-up phase|0|||
130305554|NCT00106353|469081731|FG000|Part 1|Adverse Event|0|||
130305555|NCT00106353|469081732|FG001|Part 1|Adverse Event|0|||
130305556|NCT00106353|469081733|FG002|Part 1|Adverse Event|0|||
130305557|NCT00106353|469081734|FG003|Part 1|Adverse Event|1|||
130305558|NCT00106353|469081735|FG004|Part 1|Adverse Event|0|||
130305559|NCT00106353|469081736|FG005|Part 1|Adverse Event|0|||
130305560|NCT00106353|469081737|FG006|Part 1|Adverse Event|0|||
130305561|NCT00106353|469081731|FG000|Part 2|Disease progression|0|||
130305562|NCT00106353|469081732|FG001|Part 2|Disease progression|0|||
130305563|NCT00106353|469081733|FG002|Part 2|Disease progression|0|||
130305564|NCT00106353|469081734|FG003|Part 2|Disease progression|0|||
130305565|NCT00106353|469081735|FG004|Part 2|Disease progression|8|||
130305566|NCT00106353|469081736|FG005|Part 2|Disease progression|14|||
130305567|NCT00106353|469081737|FG006|Part 2|Disease progression|13|||
130305568|NCT00106353|469081731|FG000|Part 2|Death|0|||
130305569|NCT00106353|469081732|FG001|Part 2|Death|0|||
130305570|NCT00106353|469081733|FG002|Part 2|Death|0|||
130305571|NCT00106353|469081734|FG003|Part 2|Death|0|||
130305572|NCT00106353|469081735|FG004|Part 2|Death|3|||
130305573|NCT00106353|469081736|FG005|Part 2|Death|0|||
130305574|NCT00106353|469081737|FG006|Part 2|Death|1|||
130305575|NCT00106353|469081731|FG000|Part 2|Symptomatic deterioration|0|||
130305576|NCT00106353|469081732|FG001|Part 2|Symptomatic deterioration|0|||
130305577|NCT00106353|469081733|FG002|Part 2|Symptomatic deterioration|0|||
130305578|NCT00106353|469081734|FG003|Part 2|Symptomatic deterioration|0|||
130305579|NCT00106353|469081735|FG004|Part 2|Symptomatic deterioration|3|||
130305580|NCT00106353|469081736|FG005|Part 2|Symptomatic deterioration|0|||
130305581|NCT00106353|469081737|FG006|Part 2|Symptomatic deterioration|0|||
130305582|NCT00106353|469081731|FG000|Part 2|Adverse Event|0|||
130305583|NCT00106353|469081732|FG001|Part 2|Adverse Event|0|||
130305584|NCT00106353|469081733|FG002|Part 2|Adverse Event|0|||
130305585|NCT00106353|469081734|FG003|Part 2|Adverse Event|0|||
130305586|NCT00106353|469081735|FG004|Part 2|Adverse Event|0|||
130305587|NCT00106353|469081736|FG005|Part 2|Adverse Event|2|||
130305588|NCT00106353|469081737|FG006|Part 2|Adverse Event|1|||
130305589|NCT00106353|469081731|FG000|Part 2|Other|0|||
130305590|NCT00106353|469081732|FG001|Part 2|Other|0|||
130305591|NCT00106353|469081733|FG002|Part 2|Other|0|||
130305592|NCT00106353|469081734|FG003|Part 2|Other|0|||
130305593|NCT00106353|469081735|FG004|Part 2|Other|1|||
130305594|NCT00106353|469081736|FG005|Part 2|Other|1|||
130305595|NCT00106353|469081737|FG006|Part 2|Other|1|||
130305596|NCT00106353|469081731|FG000|Part 2|Withdrawal by Subject|0|||
130305597|NCT00106353|469081732|FG001|Part 2|Withdrawal by Subject|0|||
130305598|NCT00106353|469081733|FG002|Part 2|Withdrawal by Subject|0|||
130305599|NCT00106353|469081734|FG003|Part 2|Withdrawal by Subject|0|||
130305600|NCT00106353|469081735|FG004|Part 2|Withdrawal by Subject|1|||
130305601|NCT00106353|469081736|FG005|Part 2|Withdrawal by Subject|0|||
130305602|NCT00106353|469081737|FG006|Part 2|Withdrawal by Subject|0|||
130305603|NCT00106353|469081731|FG000|Part 2|Physician Decision|0|||
130305604|NCT00106353|469081732|FG001|Part 2|Physician Decision|0|||
130305605|NCT00106353|469081733|FG002|Part 2|Physician Decision|0|||
130305606|NCT00106353|469081734|FG003|Part 2|Physician Decision|0|||
130305607|NCT00106353|469081735|FG004|Part 2|Physician Decision|0|||
130305608|NCT00106353|469081736|FG005|Part 2|Physician Decision|1|||
130305609|NCT00106353|469081737|FG006|Part 2|Physician Decision|0|||
130305610|NCT03477838|469081741|FG000|Overall Study|Lost to Follow-up|14|||
129889344|NCT03259373|467552563|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
130048009|NCT04003155|468133129|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
130305611|NCT02519595|469081742|FG000|Overall Study|Protocol Violation|8|||
130305612|NCT02519595|469081743|FG001|Overall Study|Protocol Violation|22|||
130305613|NCT02519595|469081744|FG002|Overall Study|Protocol Violation|16|||
130305614|NCT00850538|469081747|FG000|Overall Study|unable/unwilling to complete MRI|13|||
130305615|NCT00850538|469081747|FG000|Overall Study|specimen missed due to scheduling error|14|||
130305616|NCT00850538|469081747|FG000|Overall Study|specimen unusable|7|||
130305617|NCT00850538|469081747|FG000|Overall Study|Withdrawal by Subject|3|||
130305618|NCT00850538|469081747|FG000|Overall Study|radiology error|2|||
130305619|NCT00850538|469081747|FG000|Overall Study|Protocol Violation|2|||
130305620|NCT03188510|469081748|FG000|Overall Study|Inappropriate behavior with site staff|0|||
130305621|NCT03188510|469081749|FG001|Overall Study|Inappropriate behavior with site staff|1|||
130305622|NCT03188510|469081750|FG002|Overall Study|Inappropriate behavior with site staff|0|||
130305623|NCT03052049|469081757|FG000|Overall Study|Withdrawal by Subject|2|||
130305624|NCT00999518|469081761|FG000|Overall Study|Adverse Event|1|||
130305625|NCT00999518|469081762|FG001|Overall Study|Adverse Event|6|||
130305626|NCT00999518|469081763|FG002|Overall Study|Adverse Event|3|||
130305627|NCT00999518|469081764|FG003|Overall Study|Adverse Event|1|||
130305628|NCT00999518|469081765|FG004|Overall Study|Adverse Event|2|||
130305629|NCT00999518|469081761|FG000|Overall Study|Lack of Efficacy|2|||
130305630|NCT00999518|469081762|FG001|Overall Study|Lack of Efficacy|0|||
130305631|NCT00999518|469081763|FG002|Overall Study|Lack of Efficacy|0|||
130305632|NCT00999518|469081764|FG003|Overall Study|Lack of Efficacy|2|||
130305633|NCT00999518|469081765|FG004|Overall Study|Lack of Efficacy|2|||
130305634|NCT00999518|469081761|FG000|Overall Study|Lost to Follow-up|0|||
130305635|NCT00999518|469081762|FG001|Overall Study|Lost to Follow-up|0|||
130305636|NCT00999518|469081763|FG002|Overall Study|Lost to Follow-up|0|||
130305637|NCT00999518|469081764|FG003|Overall Study|Lost to Follow-up|4|||
130305638|NCT00999518|469081765|FG004|Overall Study|Lost to Follow-up|1|||
130305639|NCT00999518|469081761|FG000|Overall Study|Did not meet entrance criteria|0|||
130305640|NCT00999518|469081762|FG001|Overall Study|Did not meet entrance criteria|0|||
130305641|NCT00999518|469081763|FG002|Overall Study|Did not meet entrance criteria|0|||
130305642|NCT00999518|469081764|FG003|Overall Study|Did not meet entrance criteria|0|||
130305643|NCT00999518|469081765|FG004|Overall Study|Did not meet entrance criteria|1|||
130305644|NCT00999518|469081761|FG000|Overall Study|Study terminated by sponsor|10|||
130305645|NCT00999518|469081762|FG001|Overall Study|Study terminated by sponsor|6|||
130305646|NCT00999518|469081763|FG002|Overall Study|Study terminated by sponsor|5|||
130305647|NCT00999518|469081764|FG003|Overall Study|Study terminated by sponsor|5|||
130305648|NCT00999518|469081765|FG004|Overall Study|Study terminated by sponsor|9|||
130305649|NCT00999518|469081761|FG000|Overall Study|Pregnancy|0|||
130305650|NCT00999518|469081762|FG001|Overall Study|Pregnancy|0|||
130305651|NCT00999518|469081763|FG002|Overall Study|Pregnancy|1|||
130305652|NCT00999518|469081764|FG003|Overall Study|Pregnancy|0|||
130305653|NCT00999518|469081765|FG004|Overall Study|Pregnancy|0|||
130305654|NCT00999518|469081761|FG000|Overall Study|Protocol Violation|0|||
130305655|NCT00999518|469081762|FG001|Overall Study|Protocol Violation|1|||
130305656|NCT00999518|469081763|FG002|Overall Study|Protocol Violation|0|||
130305657|NCT00999518|469081764|FG003|Overall Study|Protocol Violation|0|||
130305658|NCT00999518|469081765|FG004|Overall Study|Protocol Violation|2|||
130305659|NCT00999518|469081761|FG000|Overall Study|Withdrawal by Subject|5|||
130305660|NCT00999518|469081762|FG001|Overall Study|Withdrawal by Subject|4|||
130305661|NCT00999518|469081763|FG002|Overall Study|Withdrawal by Subject|10|||
130305662|NCT00999518|469081764|FG003|Overall Study|Withdrawal by Subject|6|||
130305663|NCT00999518|469081765|FG004|Overall Study|Withdrawal by Subject|1|||
130305664|NCT00999518|469081761|FG000|Overall Study|Other|5|||
130305665|NCT00999518|469081762|FG001|Overall Study|Other|7|||
130305666|NCT00999518|469081763|FG002|Overall Study|Other|1|||
130305667|NCT00999518|469081764|FG003|Overall Study|Other|4|||
130305668|NCT00999518|469081765|FG004|Overall Study|Other|5|||
130305669|NCT00999518|469081761|FG000|Overall Study|Randomized but not Treated|1|||
130305670|NCT00999518|469081762|FG001|Overall Study|Randomized but not Treated|1|||
130305671|NCT00999518|469081763|FG002|Overall Study|Randomized but not Treated|2|||
130305672|NCT00999518|469081764|FG003|Overall Study|Randomized but not Treated|0|||
130305673|NCT00999518|469081765|FG004|Overall Study|Randomized but not Treated|1|||
130305674|NCT01088399|469081766|FG000|Overall Study|Adverse Event|211|||
130305675|NCT01088399|469081767|FG001|Overall Study|Adverse Event|16|||
130305676|NCT01088399|469081768|FG002|Overall Study|Adverse Event|0|||
130305677|NCT01088399|469081766|FG000|Overall Study|Death|204|||
130305678|NCT01088399|469081767|FG001|Overall Study|Death|45|||
130305679|NCT01088399|469081768|FG002|Overall Study|Death|0|||
130305680|NCT01088399|469081766|FG000|Overall Study|Lack of Efficacy|298|||
130305681|NCT01088399|469081767|FG001|Overall Study|Lack of Efficacy|7|||
130305682|NCT01088399|469081768|FG002|Overall Study|Lack of Efficacy|5|||
130305683|NCT01088399|469081766|FG000|Overall Study|Lost to Follow-up|1070|||
130305684|NCT01088399|469081767|FG001|Overall Study|Lost to Follow-up|278|||
130305685|NCT01088399|469081768|FG002|Overall Study|Lost to Follow-up|58|||
130048010|NCT04003155|468133130|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
130048011|NCT04003155|468133126|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
130048012|NCT04003155|468133127|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
130048013|NCT04003155|468133128|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
130048014|NCT04003155|468133129|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
130048015|NCT04003155|468133130|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
130305686|NCT01088399|469081766|FG000|Overall Study|Physician Decision|531|||
130305687|NCT01088399|469081767|FG001|Overall Study|Physician Decision|88|||
130305688|NCT01088399|469081768|FG002|Overall Study|Physician Decision|16|||
130305689|NCT01088399|469081766|FG000|Overall Study|Withdrawal by Subject|544|||
130305690|NCT01088399|469081767|FG001|Overall Study|Withdrawal by Subject|195|||
130305691|NCT01088399|469081768|FG002|Overall Study|Withdrawal by Subject|33|||
130305692|NCT01088399|469081766|FG000|Overall Study|Change to or start of somatropin therapy|234|||
130305693|NCT01088399|469081767|FG001|Overall Study|Change to or start of somatropin therapy|17|||
130305694|NCT01088399|469081768|FG002|Overall Study|Change to or start of somatropin therapy|12|||
130305695|NCT01088399|469081766|FG000|Overall Study|Sponsor decision|1573|||
130305696|NCT01088399|469081767|FG001|Overall Study|Sponsor decision|298|||
130305697|NCT01088399|469081768|FG002|Overall Study|Sponsor decision|7|||
130305698|NCT01088399|469081766|FG000|Overall Study|Protocol Violation|10|||
130305699|NCT01088399|469081767|FG001|Overall Study|Protocol Violation|1|||
130305700|NCT01088399|469081768|FG002|Overall Study|Protocol Violation|0|||
130305701|NCT01088399|469081766|FG000|Overall Study|Enrollment criteria not met|48|||
130305702|NCT01088399|469081767|FG001|Overall Study|Enrollment criteria not met|119|||
130305703|NCT01088399|469081768|FG002|Overall Study|Enrollment criteria not met|70|||
130305704|NCT01088399|469081766|FG000|Overall Study|Study summary visit not completed|2398|||
130305705|NCT01088399|469081767|FG001|Overall Study|Study summary visit not completed|283|||
130305706|NCT01088399|469081768|FG002|Overall Study|Study summary visit not completed|80|||
130305707|NCT00782483|469081769|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
130305708|NCT01946152|469083410|FG000|Overall Study|Adverse Event|1|||
130305709|NCT01946152|469083411|FG001|Overall Study|Adverse Event|0|||
130305710|NCT01946152|469083412|FG002|Overall Study|Adverse Event|0|||
130107673|NCT00963599|468355175|FG000|Overall Study|Lost to Follow-up|0|||
130107674|NCT00963599|468355176|FG001|Overall Study|Lost to Follow-up|1|||
130107675|NCT00963599|468355177|FG002|Overall Study|Lost to Follow-up|1|||
130107676|NCT00963599|468355178|FG003|Overall Study|Lost to Follow-up|1|||
130107677|NCT00963599|468355175|FG000|Overall Study|Protocol Violation|2|||
130107678|NCT00963599|468355176|FG001|Overall Study|Protocol Violation|2|||
130305711|NCT01946152|469083413|FG003|Overall Study|Adverse Event|0|||
130305712|NCT01946152|469083410|FG000|Overall Study|Withdrawal by Subject|0|||
130305713|NCT01946152|469083411|FG001|Overall Study|Withdrawal by Subject|2|||
130305714|NCT01946152|469083412|FG002|Overall Study|Withdrawal by Subject|0|||
130305715|NCT01946152|469083413|FG003|Overall Study|Withdrawal by Subject|0|||
130305716|NCT01946152|469083410|FG000|Overall Study|Progression|0|||
130305717|NCT01946152|469083411|FG001|Overall Study|Progression|1|||
130305718|NCT01946152|469083412|FG002|Overall Study|Progression|4|||
130305719|NCT01946152|469083413|FG003|Overall Study|Progression|7|||
130305720|NCT01946152|469083410|FG000|Overall Study|Physician Decision|0|||
130107679|NCT00963599|468355177|FG002|Overall Study|Protocol Violation|3|||
130107680|NCT00963599|468355178|FG003|Overall Study|Protocol Violation|4|||
130107681|NCT00963599|468355175|FG000|Overall Study|Withdrawal by Subject|2|||
130107682|NCT00963599|468355176|FG001|Overall Study|Withdrawal by Subject|1|||
130107683|NCT00963599|468355177|FG002|Overall Study|Withdrawal by Subject|3|||
130107684|NCT00963599|468355178|FG003|Overall Study|Withdrawal by Subject|3|||
130107685|NCT00810615|468355182|FG000|Overall Study|Withdrawal by Subject|1|||
130107686|NCT00810615|468355183|FG001|Overall Study|Withdrawal by Subject|1|||
130107687|NCT02525562|468355184|FG000|Overall Study|Death|9|||
130107688|NCT02525562|468355185|FG001|Overall Study|Death|0|||
130107689|NCT02525562|468355186|FG002|Overall Study|Death|0|||
130107690|NCT02525562|468355184|FG000|Overall Study|Lost to Follow-up|19|||
130107691|NCT02525562|468355185|FG001|Overall Study|Lost to Follow-up|0|||
130107692|NCT02525562|468355186|FG002|Overall Study|Lost to Follow-up|0|||
130107693|NCT02525562|468355184|FG000|Overall Study|Withdrawal by Subject|37|||
130107694|NCT02525562|468355185|FG001|Overall Study|Withdrawal by Subject|0|||
130107695|NCT02525562|468355186|FG002|Overall Study|Withdrawal by Subject|0|||
130107696|NCT02525562|468355184|FG000|Overall Study|Revision/Removal of Study Device|4|||
130107697|NCT02525562|468355185|FG001|Overall Study|Revision/Removal of Study Device|0|||
130107698|NCT02525562|468355186|FG002|Overall Study|Revision/Removal of Study Device|0|||
130107699|NCT02525562|468355184|FG000|Overall Study|Study Closed by Sponsor|154|||
130107700|NCT02525562|468355185|FG001|Overall Study|Study Closed by Sponsor|0|||
130107701|NCT02525562|468355186|FG002|Overall Study|Study Closed by Sponsor|0|||
130107702|NCT02164539|468355187|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
130107703|NCT02164539|468355188|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
130107704|NCT02164539|468355189|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
130107705|NCT02164539|468355190|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
130107706|NCT02164539|468355191|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
130107707|NCT02164539|468355192|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
130107708|NCT02164539|468355193|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
130107709|NCT02164539|468355187|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
130107710|NCT02164539|468355188|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
130107711|NCT02164539|468355189|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
130107712|NCT02164539|468355190|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
130107713|NCT02164539|468355191|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
130107714|NCT02164539|468355192|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
130107715|NCT02164539|468355193|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
130107716|NCT02164539|468355187|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
130107717|NCT02164539|468355188|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
130107718|NCT02164539|468355189|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
130107719|NCT02164539|468355190|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
130107720|NCT02164539|468355191|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
130107721|NCT02164539|468355192|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
130305721|NCT01946152|469083411|FG001|Overall Study|Physician Decision|0|||
130305722|NCT01946152|469083412|FG002|Overall Study|Physician Decision|1|||
130305723|NCT01946152|469083413|FG003|Overall Study|Physician Decision|0|||
130305724|NCT01946152|469083410|FG000|Overall Study|Second malignancy|0|||
130305725|NCT01946152|469083411|FG001|Overall Study|Second malignancy|0|||
130107722|NCT02164539|468355193|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
130305726|NCT01946152|469083412|FG002|Overall Study|Second malignancy|1|||
130305727|NCT01946152|469083413|FG003|Overall Study|Second malignancy|0|||
130305728|NCT01946152|469083410|FG000|Overall Study|Adverse Event|0|||
130305729|NCT01946152|469083411|FG001|Overall Study|Adverse Event|0|||
130305730|NCT01946152|469083412|FG002|Overall Study|Adverse Event|0|||
130305731|NCT01946152|469083413|FG003|Overall Study|Adverse Event|1|||
130305732|NCT01016600|469083419|FG000|Overall Study|Did not start treatment|1|||
130305733|NCT01016600|469083420|FG001|Overall Study|Did not start treatment|0|||
130305734|NCT01016600|469083421|FG002|Overall Study|Did not start treatment|0|||
130305735|NCT01016600|469083422|FG003|Overall Study|Did not start treatment|0|||
130305736|NCT02679755|469083423|FG000|Overall Study|Death|0|||
130305737|NCT02679755|469083424|FG001|Overall Study|Death|3|||
130305738|NCT02679755|469083423|FG000|Overall Study|Global deterioration of health status|1|||
130305739|NCT02679755|469083424|FG001|Overall Study|Global deterioration of health status|8|||
130305740|NCT02679755|469083423|FG000|Overall Study|Lost to Follow-up|1|||
130305741|NCT02679755|469083424|FG001|Overall Study|Lost to Follow-up|0|||
130305742|NCT02679755|469083423|FG000|Overall Study|Objective progression or relapse|24|||
130305743|NCT02679755|469083424|FG001|Overall Study|Objective progression or relapse|83|||
130305744|NCT02679755|469083423|FG000|Overall Study|Not defined|0|||
130305745|NCT02679755|469083424|FG001|Overall Study|Not defined|2|||
130305746|NCT02679755|469083423|FG000|Overall Study|Withdrawal by participant|6|||
130305747|NCT02679755|469083424|FG001|Overall Study|Withdrawal by participant|3|||
130305748|NCT02679755|469083423|FG000|Overall Study|Adverse Event|1|||
130305749|NCT02679755|469083424|FG001|Overall Study|Adverse Event|4|||
130305750|NCT02679755|469083423|FG000|Overall Study|Adverse events not related to study drug|1|||
130305751|NCT02679755|469083424|FG001|Overall Study|Adverse events not related to study drug|2|||
130305752|NCT02451917|469083427|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
130305753|NCT02451917|469083428|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
130305754|NCT02451917|469083427|FG000|First Intervention (24 Weeks)|Death|0|||
130305755|NCT02451917|469083428|FG001|First Intervention (24 Weeks)|Death|1|||
130305756|NCT02451917|469083427|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
130048016|NCT04003155|468133126|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
130048017|NCT04003155|468133127|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
130048018|NCT04003155|468133128|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
130048019|NCT04003155|468133129|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
130048020|NCT04003155|468133130|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
130048021|NCT01912872|468133131|FG000|Overall Study|Lost to Follow-up|2|||
130048022|NCT01912872|468133132|FG001|Overall Study|Lost to Follow-up|3|||
130048023|NCT01912872|468133133|FG002|Overall Study|Lost to Follow-up|5|||
130048024|NCT01912872|468133134|FG003|Overall Study|Lost to Follow-up|5|||
130048025|NCT01912872|468133131|FG000|Overall Study|Other unspecified|3|||
130048026|NCT01912872|468133132|FG001|Overall Study|Other unspecified|1|||
130048027|NCT01912872|468133133|FG002|Overall Study|Other unspecified|3|||
130048028|NCT01912872|468133134|FG003|Overall Study|Other unspecified|0|||
130048029|NCT01912872|468133131|FG000|Overall Study|Informed consent withdrawn|0|||
130048030|NCT01912872|468133132|FG001|Overall Study|Informed consent withdrawn|0|||
130048031|NCT01912872|468133133|FG002|Overall Study|Informed consent withdrawn|1|||
130048032|NCT01912872|468133134|FG003|Overall Study|Informed consent withdrawn|1|||
130048033|NCT01912872|468133131|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
130048034|NCT01912872|468133132|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
130048035|NCT01912872|468133133|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
130048036|NCT01912872|468133134|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
130048037|NCT01912872|468133131|FG000|Overall Study|Protocol Violation|0|||
130048038|NCT01912872|468133132|FG001|Overall Study|Protocol Violation|0|||
130048039|NCT01912872|468133133|FG002|Overall Study|Protocol Violation|1|||
130048040|NCT01912872|468133134|FG003|Overall Study|Protocol Violation|0|||
130048041|NCT01912872|468133131|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130048042|NCT01912872|468133132|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130048043|NCT01912872|468133133|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130048044|NCT01912872|468133134|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
130048045|NCT01912872|468133131|FG000|Overall Study|Withdrawal of study medication|0|||
130048046|NCT01912872|468133132|FG001|Overall Study|Withdrawal of study medication|0|||
130048047|NCT01912872|468133133|FG002|Overall Study|Withdrawal of study medication|0|||
130048048|NCT01912872|468133134|FG003|Overall Study|Withdrawal of study medication|2|||
130048049|NCT01912872|468133131|FG000|Overall Study|Missing|0|||
130048050|NCT01912872|468133132|FG001|Overall Study|Missing|0|||
130048051|NCT01912872|468133133|FG002|Overall Study|Missing|0|||
130048052|NCT01912872|468133134|FG003|Overall Study|Missing|1|||
130305757|NCT02451917|469083428|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
130305758|NCT04737278|469083431|FG000|Overall Study|Lost to Follow-up|1|||
130305759|NCT04737278|469083432|FG001|Overall Study|Lost to Follow-up|1|||
130305760|NCT04737278|469083431|FG000|Overall Study|Withdrawal by Subject|1|||
130305761|NCT04737278|469083432|FG001|Overall Study|Withdrawal by Subject|0|||
130305762|NCT04737278|469083431|FG000|Overall Study|Protocol Violation|1|||
130305763|NCT04737278|469083432|FG001|Overall Study|Protocol Violation|1|||
130305764|NCT04737278|469083431|FG000|Overall Study|failure to complete questionnaire|1|||
130305765|NCT04737278|469083432|FG001|Overall Study|failure to complete questionnaire|1|||
130305766|NCT00546000|469083433|FG000|Overall Study|Adverse Event|1|||
130305767|NCT00546000|469083433|FG000|Overall Study|Lost to Follow-up|1|||
130305768|NCT00546000|469083433|FG000|Overall Study|Baseline HPA Axis Supression|2|||
130305769|NCT01504412|469083435|FG000|Overall Study|Adverse Event|1|||
130305770|NCT01504412|469083436|FG001|Overall Study|Adverse Event|8|||
130305771|NCT01504412|469083437|FG002|Overall Study|Adverse Event|1|||
130305772|NCT01504412|469083438|FG003|Overall Study|Adverse Event|7|||
130305773|NCT01504412|469083439|FG004|Overall Study|Adverse Event|10|||
130305774|NCT01504412|469083435|FG000|Overall Study|Withdrawal by Subject|2|||
130305775|NCT01504412|469083436|FG001|Overall Study|Withdrawal by Subject|1|||
130305776|NCT01504412|469083437|FG002|Overall Study|Withdrawal by Subject|1|||
130048053|NCT02778867|468133135|FG000|Phase 1|Withdrawal by Subject|2|||
130048054|NCT02778867|468133136|FG001|Phase 1|Withdrawal by Subject|3|||
130048055|NCT02778867|468133137|FG002|Phase 1|Withdrawal by Subject|0|||
130048056|NCT02778867|468133138|FG003|Phase 1|Withdrawal by Subject|0|||
130048057|NCT02778867|468133135|FG000|Phase 2|Withdrawal by Subject|0|||
130048058|NCT02778867|468133136|FG001|Phase 2|Withdrawal by Subject|0|||
130048059|NCT02778867|468133137|FG002|Phase 2|Withdrawal by Subject|1|||
130048060|NCT02778867|468133138|FG003|Phase 2|Withdrawal by Subject|0|||
130048061|NCT02778867|468133135|FG000|Phase 2|Physician Decision|0|||
130048062|NCT02778867|468133136|FG001|Phase 2|Physician Decision|0|||
130048063|NCT02778867|468133137|FG002|Phase 2|Physician Decision|0|||
130048064|NCT02778867|468133138|FG003|Phase 2|Physician Decision|1|||
130048065|NCT02778867|468133135|FG000|Phase 2|Adverse Event|0|||
130048066|NCT02778867|468133136|FG001|Phase 2|Adverse Event|0|||
130048067|NCT02778867|468133137|FG002|Phase 2|Adverse Event|0|||
130048068|NCT02778867|468133138|FG003|Phase 2|Adverse Event|1|||
130048069|NCT02546856|468133144|FG000|4 Months Evaluation|Death|2|||
130048070|NCT02546856|468133145|FG001|4 Months Evaluation|Death|3|||
130048071|NCT02546856|468133144|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
130048072|NCT02546856|468133145|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
130048073|NCT02546856|468133144|FG000|4 Months Evaluation|Lost to Follow-up|3|||
130048074|NCT02546856|468133145|FG001|4 Months Evaluation|Lost to Follow-up|3|||
130048075|NCT02546856|468133144|FG000|4 Months Evaluation|Physician Decision|3|||
130048076|NCT02546856|468133145|FG001|4 Months Evaluation|Physician Decision|0|||
130048077|NCT02546856|468133144|FG000|4 Months Evaluation|Working or living abroad|5|||
130048078|NCT02546856|468133145|FG001|4 Months Evaluation|Working or living abroad|1|||
130048079|NCT02546856|468133144|FG000|4 Months Evaluation|reasons not due to titration|4|||
130048080|NCT02546856|468133145|FG001|4 Months Evaluation|reasons not due to titration|1|||
130048081|NCT02546856|468133144|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
130048082|NCT02546856|468133145|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
130048083|NCT02546856|468133144|FG000|6 Months Evaluation|Death|1|||
130048084|NCT02546856|468133145|FG001|6 Months Evaluation|Death|1|||
130048085|NCT02546856|468133144|FG000|6 Months Evaluation|Lost to Follow-up|1|||
130048086|NCT02546856|468133145|FG001|6 Months Evaluation|Lost to Follow-up|1|||
130048087|NCT02546856|468133144|FG000|6 Months Evaluation|Working or living abroad|6|||
130048088|NCT02546856|468133145|FG001|6 Months Evaluation|Working or living abroad|4|||
130048089|NCT02546856|468133144|FG000|6 Months Evaluation|reasons not due to titration|0|||
130048090|NCT02546856|468133145|FG001|6 Months Evaluation|reasons not due to titration|1|||
130048091|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
130048092|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
130048093|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
130048094|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130048095|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130048096|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130048097|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130048098|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
130048099|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
130048100|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
130305777|NCT01504412|469083438|FG003|Overall Study|Withdrawal by Subject|5|||
130048101|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
130048102|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130048103|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130048104|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130048105|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130048106|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
130048107|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
130048108|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
130048109|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
130305778|NCT01504412|469083439|FG004|Overall Study|Withdrawal by Subject|1|||
130305779|NCT01504412|469083435|FG000|Overall Study|Other|2|||
130305780|NCT01504412|469083436|FG001|Overall Study|Other|1|||
130305781|NCT01504412|469083437|FG002|Overall Study|Other|1|||
130305782|NCT01504412|469083438|FG003|Overall Study|Other|6|||
130305783|NCT01504412|469083439|FG004|Overall Study|Other|1|||
130305784|NCT01504412|469083435|FG000|Overall Study|Lost to Follow-up|0|||
130305785|NCT01504412|469083436|FG001|Overall Study|Lost to Follow-up|2|||
130305786|NCT01504412|469083437|FG002|Overall Study|Lost to Follow-up|0|||
130305787|NCT01504412|469083438|FG003|Overall Study|Lost to Follow-up|0|||
130305788|NCT01504412|469083439|FG004|Overall Study|Lost to Follow-up|0|||
130305789|NCT01504412|469083435|FG000|Overall Study|Lack of Efficacy|0|||
130305790|NCT01504412|469083436|FG001|Overall Study|Lack of Efficacy|0|||
130305791|NCT01504412|469083437|FG002|Overall Study|Lack of Efficacy|1|||
130305792|NCT01504412|469083438|FG003|Overall Study|Lack of Efficacy|0|||
130305793|NCT01504412|469083439|FG004|Overall Study|Lack of Efficacy|1|||
130305794|NCT01504412|469083435|FG000|Overall Study|Death|0|||
130305795|NCT01504412|469083436|FG001|Overall Study|Death|0|||
130305796|NCT01504412|469083437|FG002|Overall Study|Death|0|||
130305797|NCT01504412|469083438|FG003|Overall Study|Death|1|||
130048110|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130048111|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130048112|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130048113|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130048114|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
130048115|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
130048116|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
130048117|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130048118|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130048119|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130048120|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130048121|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130048122|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
130048123|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
130048124|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
130048125|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
130048126|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130048127|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130048128|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130048129|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130048130|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
130048131|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
130048132|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
130048133|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130048134|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130048135|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130048136|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130048137|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130048138|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
130048139|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
130048140|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
130048141|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130048142|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130048143|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130048144|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130048145|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130048146|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
130048147|NCT01097616|468133147|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048148|NCT01097616|468133148|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048149|NCT01097616|468133149|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
130048150|NCT01097616|468133150|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048151|NCT01097616|468133151|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048152|NCT01097616|468133152|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048153|NCT01097616|468133153|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048154|NCT01097616|468133154|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
130048155|NCT01097616|468133147|FG000|Optional DB EXT Phase|Adverse Event|0|||
130305798|NCT01504412|469083439|FG004|Overall Study|Death|0|||
130305799|NCT02974257|469083440|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
130305800|NCT02974257|469083441|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
130305801|NCT02974257|469083440|FG000|Overall Study|Clinical indication for thiamine|1|||
130305802|NCT02974257|469083441|FG001|Overall Study|Clinical indication for thiamine|0|||
130305803|NCT02974257|469083440|FG000|Overall Study|Already on thiamine|1|||
130305804|NCT02974257|469083441|FG001|Overall Study|Already on thiamine|0|||
130305805|NCT02974257|469083440|FG000|Overall Study|Extubated prior to study drug|0|||
130305806|NCT02974257|469083441|FG001|Overall Study|Extubated prior to study drug|1|||
130305807|NCT02974257|469083440|FG000|Overall Study|Death|0|||
130305808|NCT02974257|469083441|FG001|Overall Study|Death|1|||
130305809|NCT01449006|469083446|FG000|Overall Study|Lost to Follow-up|1|||
130305810|NCT01449006|469083447|FG001|Overall Study|Lost to Follow-up|0|||
130305811|NCT01449006|469083446|FG000|Overall Study|Withdrawal by Subject|1|||
130305812|NCT01449006|469083447|FG001|Overall Study|Withdrawal by Subject|0|||
130305813|NCT01449006|469083446|FG000|Overall Study|Protocol Violation|1|||
130305814|NCT01449006|469083447|FG001|Overall Study|Protocol Violation|0|||
130305815|NCT03350815|469083448|FG000|Period 1|Adverse Event|10|||
130305816|NCT03350815|469083449|FG001|Period 1|Adverse Event|0|||
130305817|NCT03350815|469083450|FG002|Period 1|Adverse Event|0|||
130305818|NCT03350815|469083451|FG003|Period 1|Adverse Event|0|||
130305819|NCT03350815|469083448|FG000|Period 1|Technical problems|1|||
130305820|NCT03350815|469083449|FG001|Period 1|Technical problems|0|||
130305821|NCT03350815|469083450|FG002|Period 1|Technical problems|0|||
130305822|NCT03350815|469083451|FG003|Period 1|Technical problems|0|||
130305823|NCT03350815|469083448|FG000|Period 1|Lost to Follow-up|3|||
130305824|NCT03350815|469083449|FG001|Period 1|Lost to Follow-up|0|||
130305825|NCT03350815|469083450|FG002|Period 1|Lost to Follow-up|0|||
130305826|NCT03350815|469083451|FG003|Period 1|Lost to Follow-up|0|||
130305827|NCT03350815|469083448|FG000|Period 1|Physician Decision|1|||
130305828|NCT03350815|469083449|FG001|Period 1|Physician Decision|0|||
130305829|NCT03350815|469083450|FG002|Period 1|Physician Decision|0|||
130305830|NCT03350815|469083451|FG003|Period 1|Physician Decision|0|||
130305831|NCT03350815|469083448|FG000|Period 1|Withdrawal by Subject|8|||
130305832|NCT03350815|469083449|FG001|Period 1|Withdrawal by Subject|0|||
130305833|NCT03350815|469083450|FG002|Period 1|Withdrawal by Subject|0|||
130305834|NCT03350815|469083451|FG003|Period 1|Withdrawal by Subject|0|||
130305835|NCT03350815|469083448|FG000|Period 1|Lack of Efficacy|15|||
130305836|NCT03350815|469083449|FG001|Period 1|Lack of Efficacy|0|||
130305837|NCT03350815|469083450|FG002|Period 1|Lack of Efficacy|0|||
130305838|NCT03350815|469083451|FG003|Period 1|Lack of Efficacy|0|||
130305839|NCT03350815|469083448|FG000|Period 1|Non-compliance with study treatment|2|||
130305840|NCT03350815|469083449|FG001|Period 1|Non-compliance with study treatment|0|||
130305841|NCT03350815|469083450|FG002|Period 1|Non-compliance with study treatment|0|||
130305842|NCT03350815|469083451|FG003|Period 1|Non-compliance with study treatment|0|||
130305843|NCT03350815|469083448|FG000|Period 1|Protocol Violation|3|||
130305844|NCT03350815|469083449|FG001|Period 1|Protocol Violation|0|||
130048156|NCT01097616|468133148|FG001|Optional DB EXT Phase|Adverse Event|7|||
130048157|NCT01097616|468133149|FG002|Optional DB EXT Phase|Adverse Event|2|||
130048158|NCT01097616|468133150|FG003|Optional DB EXT Phase|Adverse Event|0|||
130107723|NCT02164539|468355187|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
130107724|NCT02164539|468355188|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130048159|NCT01097616|468133151|FG004|Optional DB EXT Phase|Adverse Event|0|||
130048160|NCT01097616|468133152|FG005|Optional DB EXT Phase|Adverse Event|0|||
130048161|NCT01097616|468133153|FG006|Optional DB EXT Phase|Adverse Event|0|||
130048162|NCT01097616|468133154|FG007|Optional DB EXT Phase|Adverse Event|0|||
130048163|NCT01097616|468133147|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
130048164|NCT01097616|468133148|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
130048165|NCT01097616|468133149|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
130048166|NCT01097616|468133150|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
130048167|NCT01097616|468133151|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
130048168|NCT01097616|468133152|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
130048169|NCT01097616|468133153|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
130107725|NCT02164539|468355189|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130305845|NCT03350815|469083450|FG002|Period 1|Protocol Violation|0|||
130305846|NCT03350815|469083451|FG003|Period 1|Protocol Violation|0|||
130305847|NCT03350815|469083448|FG000|Period 2|Adverse Event|0|||
130305848|NCT03350815|469083449|FG001|Period 2|Adverse Event|3|||
130305849|NCT03350815|469083450|FG002|Period 2|Adverse Event|5|||
130305850|NCT03350815|469083451|FG003|Period 2|Adverse Event|0|||
130305851|NCT03350815|469083448|FG000|Period 2|Technical problem|0|||
130305852|NCT03350815|469083449|FG001|Period 2|Technical problem|1|||
130305853|NCT03350815|469083450|FG002|Period 2|Technical problem|0|||
130305854|NCT03350815|469083451|FG003|Period 2|Technical problem|0|||
130305855|NCT03350815|469083448|FG000|Period 2|Lost to Follow-up|0|||
130305856|NCT03350815|469083449|FG001|Period 2|Lost to Follow-up|3|||
130305857|NCT03350815|469083450|FG002|Period 2|Lost to Follow-up|3|||
130305858|NCT03350815|469083451|FG003|Period 2|Lost to Follow-up|0|||
130305859|NCT03350815|469083448|FG000|Period 2|Physician Decision|0|||
130305860|NCT03350815|469083449|FG001|Period 2|Physician Decision|0|||
130305861|NCT03350815|469083450|FG002|Period 2|Physician Decision|1|||
130305862|NCT03350815|469083451|FG003|Period 2|Physician Decision|0|||
130305863|NCT03350815|469083448|FG000|Period 2|Withdrawal by Subject|0|||
130305864|NCT03350815|469083449|FG001|Period 2|Withdrawal by Subject|3|||
130305865|NCT03350815|469083450|FG002|Period 2|Withdrawal by Subject|4|||
130305866|NCT03350815|469083451|FG003|Period 2|Withdrawal by Subject|0|||
130107726|NCT02164539|468355190|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130107727|NCT02164539|468355191|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130107728|NCT02164539|468355192|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130107729|NCT02164539|468355193|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
130107730|NCT02164539|468355187|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
130107731|NCT02164539|468355188|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
130107732|NCT02164539|468355189|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
130107733|NCT02164539|468355190|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
130107734|NCT02164539|468355191|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
130107735|NCT02164539|468355192|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
130107736|NCT02164539|468355193|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
130107737|NCT02164539|468355187|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
130107738|NCT02164539|468355188|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
130107739|NCT02164539|468355189|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
130107740|NCT02164539|468355190|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
130107741|NCT02164539|468355191|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
130107742|NCT02164539|468355192|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
130107743|NCT02164539|468355193|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
130107744|NCT01255722|468355194|FG000|Overall Study|Adverse Event|0|||
130107745|NCT01255722|468355195|FG001|Overall Study|Adverse Event|1|||
130107746|NCT01255722|468355196|FG002|Overall Study|Adverse Event|1|||
130107747|NCT01255722|468355194|FG000|Overall Study|asymptomatic patient|1|||
130107748|NCT01255722|468355195|FG001|Overall Study|asymptomatic patient|0|||
130107749|NCT01255722|468355196|FG002|Overall Study|asymptomatic patient|0|||
130107750|NCT01255722|468355194|FG000|Overall Study|beta-blocker contraindicated|2|||
130107751|NCT01255722|468355195|FG001|Overall Study|beta-blocker contraindicated|0|||
130107752|NCT01255722|468355196|FG002|Overall Study|beta-blocker contraindicated|0|||
130107753|NCT01612702|468355199|FG000|Overall Study|Protocol Violation|11|||
130107754|NCT01612702|468355200|FG001|Overall Study|Protocol Violation|11|||
130107755|NCT01542736|468355201|FG000|Overall Study|Death|1|||
130107756|NCT02400905|468355202|FG000|Overall Study|Death|24|||
130107757|NCT02400905|468355202|FG000|Overall Study|Lost to Follow-up|18|||
130107758|NCT02400905|468355202|FG000|Overall Study|Withdrawal by Subject|16|||
130107759|NCT02400905|468355202|FG000|Overall Study|Physician Decision|4|||
130107760|NCT02400905|468355202|FG000|Overall Study|Other|1|||
130107761|NCT03091400|468355207|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
130107762|NCT03091400|468355208|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
130107763|NCT00743119|468355213|FG000|Overall Study|unreliable|3|||
130107764|NCT00743119|468355213|FG000|Overall Study|Withdrawal by Subject|1|||
130107765|NCT02176642|468355215|FG000|Overall Study|Withdrawal by Subject|0|||
130107766|NCT02176642|468355216|FG001|Overall Study|Withdrawal by Subject|1|||
130107767|NCT01309828|468355217|FG000|Overall Study|Adverse Event|10|||
130107768|NCT01309828|468355218|FG001|Overall Study|Adverse Event|11|||
130107769|NCT01309828|468355217|FG000|Overall Study|Voluntary Withdrawal|5|||
130107770|NCT01309828|468355218|FG001|Overall Study|Voluntary Withdrawal|4|||
130107771|NCT01309828|468355217|FG000|Overall Study|Major Protocol Deviation|0|||
130107772|NCT01309828|468355218|FG001|Overall Study|Major Protocol Deviation|1|||
130107773|NCT01309828|468355217|FG000|Overall Study|Other|1|||
130107774|NCT01309828|468355218|FG001|Overall Study|Other|0|||
130107775|NCT00295620|468355219|FG000|Overall Study|Lost to Follow-up|9|||
130107776|NCT00295620|468355220|FG001|Overall Study|Lost to Follow-up|5|||
130107777|NCT00295620|468355219|FG000|Overall Study|Withdrawal by Subject|37|||
130107778|NCT00295620|468355220|FG001|Overall Study|Withdrawal by Subject|50|||
130107779|NCT00295620|468355219|FG000|Overall Study|Death|206|||
130107780|NCT00295620|468355220|FG001|Overall Study|Death|207|||
130107781|NCT00295620|468355219|FG000|Overall Study|Other reasons|10|||
130107782|NCT00295620|468355220|FG001|Overall Study|Other reasons|9|||
130107783|NCT00295620|468355219|FG000|Overall Study|Discontinuation by sponsor|580|||
130107784|NCT00295620|468355220|FG001|Overall Study|Discontinuation by sponsor|593|||
130305867|NCT03350815|469083448|FG000|Period 2|Lack of Efficacy|0|||
130305868|NCT03350815|469083449|FG001|Period 2|Lack of Efficacy|6|||
130107785|NCT00295620|468355219|FG000|Overall Study|Protocol Violation|30|||
130305869|NCT03350815|469083450|FG002|Period 2|Lack of Efficacy|2|||
130107786|NCT00295620|468355220|FG001|Overall Study|Protocol Violation|32|||
130107787|NCT00217971|468355221|FG000|Overall Study|Adverse Event|1|||
130107788|NCT00217971|468355222|FG001|Overall Study|Adverse Event|1|||
130305870|NCT03350815|469083451|FG003|Period 2|Lack of Efficacy|0|||
130305871|NCT03350815|469083448|FG000|Period 2|Protocol Violation|0|||
130107789|NCT00217971|468355221|FG000|Overall Study|Lost to Follow-up|15|||
130107790|NCT00217971|468355222|FG001|Overall Study|Lost to Follow-up|19|||
130107791|NCT00217971|468355221|FG000|Overall Study|Physician Decision|0|||
130107792|NCT00217971|468355222|FG001|Overall Study|Physician Decision|1|||
130107793|NCT00217971|468355221|FG000|Overall Study|Withdrawal by Subject|7|||
130107794|NCT00217971|468355222|FG001|Overall Study|Withdrawal by Subject|12|||
130107795|NCT00217971|468355221|FG000|Overall Study|non compliant|1|||
130107796|NCT00217971|468355222|FG001|Overall Study|non compliant|0|||
130107797|NCT02989610|468355223|FG000|Overall Study|Withdrawal by Subject|20|||
130107798|NCT02989610|468355223|FG000|Overall Study|Departure of PI from Site|8|||
130107799|NCT02989610|468355223|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
130107800|NCT02989610|468355223|FG000|Overall Study|Lost to Follow-up|3|||
130107801|NCT02989610|468355223|FG000|Overall Study|Death|3|||
130107802|NCT02989610|468355223|FG000|Overall Study|System Explant|3|||
130107803|NCT02989610|468355223|FG000|Overall Study|Subject Non-Compliance|2|||
130107804|NCT02989610|468355223|FG000|Overall Study|System Revision|2|||
130107805|NCT02989610|468355223|FG000|Overall Study|PI Left, Study Closing|1|||
130107806|NCT02989610|468355223|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
130107807|NCT02989610|468355223|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
130107808|NCT02556632|468355228|FG000|Overall Study|Lost to Follow-up|1|||
130107809|NCT02556632|468355229|FG001|Overall Study|Lost to Follow-up|0|||
130107810|NCT02556632|468355230|FG002|Overall Study|Lost to Follow-up|0|||
130107811|NCT02556632|468355228|FG000|Overall Study|Disliked Intervention|1|||
130107812|NCT02556632|468355229|FG001|Overall Study|Disliked Intervention|1|||
130107813|NCT02556632|468355230|FG002|Overall Study|Disliked Intervention|1|||
130107814|NCT02556632|468355228|FG000|Overall Study|No Reason|1|||
130107815|NCT02556632|468355229|FG001|Overall Study|No Reason|0|||
130107816|NCT02556632|468355230|FG002|Overall Study|No Reason|1|||
130107817|NCT02556632|468355228|FG000|Overall Study|Personal Issues|0|||
130107818|NCT02556632|468355229|FG001|Overall Study|Personal Issues|1|||
130107819|NCT02556632|468355230|FG002|Overall Study|Personal Issues|1|||
130107820|NCT02556632|468355228|FG000|Overall Study|Changed Mind|0|||
130107821|NCT02556632|468355229|FG001|Overall Study|Changed Mind|1|||
130107822|NCT02556632|468355230|FG002|Overall Study|Changed Mind|0|||
130107823|NCT02556632|468355228|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
130107824|NCT02556632|468355229|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
130107825|NCT02556632|468355230|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
130107826|NCT02556632|468355228|FG000|Overall Study|Unrelated Adverse Event|1|||
130107827|NCT02556632|468355229|FG001|Overall Study|Unrelated Adverse Event|0|||
130107828|NCT02556632|468355230|FG002|Overall Study|Unrelated Adverse Event|3|||
130107829|NCT02556632|468355228|FG000|Overall Study|Related Adverse Event|0|||
130107830|NCT02556632|468355229|FG001|Overall Study|Related Adverse Event|1|||
130107831|NCT02556632|468355230|FG002|Overall Study|Related Adverse Event|0|||
130107832|NCT02556632|468355228|FG000|Overall Study|Possibly Related Adverse Event|0|||
130107833|NCT02556632|468355229|FG001|Overall Study|Possibly Related Adverse Event|0|||
130107834|NCT02556632|468355230|FG002|Overall Study|Possibly Related Adverse Event|1|||
130107835|NCT02556632|468355228|FG000|Overall Study|Did Not Start RT|0|||
130107836|NCT02556632|468355229|FG001|Overall Study|Did Not Start RT|1|||
130107837|NCT02556632|468355230|FG002|Overall Study|Did Not Start RT|0|||
130107838|NCT02556632|468355228|FG000|Overall Study|Ineligible|0|||
130107839|NCT02556632|468355229|FG001|Overall Study|Ineligible|1|||
130107840|NCT02556632|468355230|FG002|Overall Study|Ineligible|0|||
130107841|NCT02556632|468355228|FG000|Overall Study|Disliked Study Procedures|0|||
130107842|NCT02556632|468355229|FG001|Overall Study|Disliked Study Procedures|0|||
130107843|NCT02556632|468355230|FG002|Overall Study|Disliked Study Procedures|1|||
130107844|NCT02556632|468355228|FG000|Overall Study|Treatment or Change Delay|0|||
130107845|NCT02556632|468355229|FG001|Overall Study|Treatment or Change Delay|0|||
130107846|NCT02556632|468355230|FG002|Overall Study|Treatment or Change Delay|1|||
130107847|NCT00808015|468355233|FG000|Overall Study|Death|1|||
130107848|NCT00808015|468355233|FG000|Overall Study|Lack of Efficacy|58|||
130107849|NCT00808015|468355233|FG000|Overall Study|Lost to Follow-up|76|||
130107850|NCT00808015|468355233|FG000|Overall Study|Participants not willing to participate|158|||
130107851|NCT00808015|468355233|FG000|Overall Study|Adverse Event|22|||
130107852|NCT00808015|468355233|FG000|Overall Study|Other|25|||
130107853|NCT00808015|468355233|FG000|Overall Study|Enrolled but not treated|4|||
130107854|NCT02574260|468355236|FG000|Overall Study|Disease Progression|1|||
130107855|NCT01066039|468355241|FG000|Overall Study|Adverse Event|6|||
130107856|NCT01066039|468355241|FG000|Overall Study|Withdrawal by Subject|17|||
130107857|NCT01066039|468355241|FG000|Overall Study|Protocol Violation|2|||
130107858|NCT01066039|468355241|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
130107859|NCT01066039|468355241|FG000|Overall Study|Investigator's Request|1|||
130107860|NCT01066039|468355241|FG000|Overall Study|Dropout due to Insulin Administration|1|||
130107861|NCT01066039|468355241|FG000|Overall Study|Additional Antihypertensive Required|4|||
130107862|NCT01066039|468355241|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
130107863|NCT01066039|468355241|FG000|Overall Study|Failure to Control Blood Pressure|1|||
130107864|NCT01066039|468355241|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
130107865|NCT04508621|468355242|FG000|Overall Study|Adverse Event|39|||
130107866|NCT04508621|468355243|FG001|Overall Study|Adverse Event|16|||
130107867|NCT04508621|468355242|FG000|Overall Study|Lack of Efficacy|2|||
130107868|NCT04508621|468355243|FG001|Overall Study|Lack of Efficacy|8|||
130107869|NCT04508621|468355242|FG000|Overall Study|Physician Decision|0|||
130107870|NCT04508621|468355243|FG001|Overall Study|Physician Decision|1|||
130107871|NCT04508621|468355242|FG000|Overall Study|Withdrawal by Subject|10|||
130107872|NCT04508621|468355243|FG001|Overall Study|Withdrawal by Subject|14|||
130107873|NCT04508621|468355242|FG000|Overall Study|Lost to Follow-up|12|||
130107874|NCT04508621|468355243|FG001|Overall Study|Lost to Follow-up|9|||
130107875|NCT04508621|468355242|FG000|Overall Study|COVID-19 related crisis|3|||
130107876|NCT04508621|468355243|FG001|Overall Study|COVID-19 related crisis|0|||
130107877|NCT04508621|468355242|FG000|Overall Study|Subject non-compliance|1|||
130107878|NCT04508621|468355243|FG001|Overall Study|Subject non-compliance|0|||
130107879|NCT00084617|468355253|FG000|Overall Study|Withdrawal by Subject|7|||
130107880|NCT00084617|468355253|FG000|Overall Study|Lack of Efficacy|1|||
130107881|NCT00084617|468355253|FG000|Overall Study|Protocol Violation|1|||
130107882|NCT01625286|468355254|FG000|Overall Study|Adverse Event|0|||
130107883|NCT01625286|468355255|FG001|Overall Study|Adverse Event|0|||
130107884|NCT01625286|468355256|FG002|Overall Study|Adverse Event|0|||
130107885|NCT01625286|468355257|FG003|Overall Study|Adverse Event|0|||
130107886|NCT01625286|468355258|FG004|Overall Study|Adverse Event|1|||
130107887|NCT01625286|468355259|FG005|Overall Study|Adverse Event|2|||
130107888|NCT01625286|468355260|FG006|Overall Study|Adverse Event|1|||
130107889|NCT01625286|468355254|FG000|Overall Study|Death|0|||
130107890|NCT01625286|468355255|FG001|Overall Study|Death|0|||
130107891|NCT01625286|468355256|FG002|Overall Study|Death|1|||
130107892|NCT01625286|468355257|FG003|Overall Study|Death|1|||
130107893|NCT01625286|468355258|FG004|Overall Study|Death|0|||
130107894|NCT01625286|468355259|FG005|Overall Study|Death|11|||
130107895|NCT01625286|468355260|FG006|Overall Study|Death|16|||
130107896|NCT01625286|468355254|FG000|Overall Study|Withdrawal by Subject|0|||
130107897|NCT01625286|468355255|FG001|Overall Study|Withdrawal by Subject|1|||
130107898|NCT01625286|468355256|FG002|Overall Study|Withdrawal by Subject|0|||
130107899|NCT01625286|468355257|FG003|Overall Study|Withdrawal by Subject|1|||
130107900|NCT01625286|468355258|FG004|Overall Study|Withdrawal by Subject|0|||
130107901|NCT01625286|468355259|FG005|Overall Study|Withdrawal by Subject|0|||
130107902|NCT01625286|468355260|FG006|Overall Study|Withdrawal by Subject|1|||
130107903|NCT01625286|468355254|FG000|Overall Study|Any reason not specifically recorded|0|||
130107904|NCT01625286|468355255|FG001|Overall Study|Any reason not specifically recorded|0|||
130107905|NCT01625286|468355256|FG002|Overall Study|Any reason not specifically recorded|0|||
130107906|NCT01625286|468355257|FG003|Overall Study|Any reason not specifically recorded|0|||
130107907|NCT01625286|468355258|FG004|Overall Study|Any reason not specifically recorded|0|||
130107908|NCT01625286|468355259|FG005|Overall Study|Any reason not specifically recorded|1|||
130107909|NCT01625286|468355260|FG006|Overall Study|Any reason not specifically recorded|0|||
130107910|NCT01625286|468355254|FG000|Overall Study|Progressive disease|6|||
130107911|NCT01625286|468355255|FG001|Overall Study|Progressive disease|3|||
130107912|NCT01625286|468355256|FG002|Overall Study|Progressive disease|4|||
130107913|NCT01625286|468355257|FG003|Overall Study|Progressive disease|5|||
130107914|NCT01625286|468355258|FG004|Overall Study|Progressive disease|5|||
130107915|NCT01625286|468355259|FG005|Overall Study|Progressive disease|0|||
130107916|NCT01625286|468355260|FG006|Overall Study|Progressive disease|0|||
130107917|NCT01625286|468355254|FG000|Overall Study|Lost to Follow-up|0|||
130107918|NCT01625286|468355255|FG001|Overall Study|Lost to Follow-up|0|||
130107919|NCT01625286|468355256|FG002|Overall Study|Lost to Follow-up|0|||
130107920|NCT01625286|468355257|FG003|Overall Study|Lost to Follow-up|0|||
130107921|NCT01625286|468355258|FG004|Overall Study|Lost to Follow-up|0|||
130107922|NCT01625286|468355259|FG005|Overall Study|Lost to Follow-up|0|||
130107923|NCT01625286|468355260|FG006|Overall Study|Lost to Follow-up|1|||
130107924|NCT00828516|468355261|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
130107925|NCT00350519|468357123|FG000|Overall Study|Death|0|||
130107926|NCT00350519|468357124|FG001|Overall Study|Death|1|||
130107927|NCT00350519|468357123|FG000|Overall Study|Physician Decision|0|||
130107928|NCT00350519|468357124|FG001|Overall Study|Physician Decision|1|||
130107929|NCT00350519|468357123|FG000|Overall Study|Protocol Violation|1|||
130107930|NCT00350519|468357124|FG001|Overall Study|Protocol Violation|2|||
130107931|NCT00350519|468357123|FG000|Overall Study|Withdrawal by Subject|3|||
130107932|NCT00350519|468357124|FG001|Overall Study|Withdrawal by Subject|2|||
130107933|NCT03836729|468357125|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
130107934|NCT01637961|468357126|FG000|Overall Study|Ineligible: wrong primary|1|||
130107935|NCT01637961|468357126|FG000|Overall Study|Ineligible: inadequate pathology|1|||
130107936|NCT03101293|468357130|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
130107937|NCT03101293|468357131|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
130107938|NCT03862625|468357138|FG000|Overall Study|Lost to Follow-up|0|||
130107939|NCT03862625|468357139|FG001|Overall Study|Lost to Follow-up|1|||
130048170|NCT01097616|468133154|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
130048171|NCT01097616|468133147|FG000|Optional DB EXT Phase|Protocol Violation|0|||
130048172|NCT01097616|468133148|FG001|Optional DB EXT Phase|Protocol Violation|2|||
130048173|NCT01097616|468133149|FG002|Optional DB EXT Phase|Protocol Violation|3|||
130048174|NCT01097616|468133150|FG003|Optional DB EXT Phase|Protocol Violation|0|||
130048175|NCT01097616|468133151|FG004|Optional DB EXT Phase|Protocol Violation|0|||
130048176|NCT01097616|468133152|FG005|Optional DB EXT Phase|Protocol Violation|0|||
130048177|NCT01097616|468133153|FG006|Optional DB EXT Phase|Protocol Violation|0|||
130048178|NCT01097616|468133154|FG007|Optional DB EXT Phase|Protocol Violation|0|||
130048179|NCT01097616|468133147|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
130048180|NCT01097616|468133148|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
130048181|NCT01097616|468133149|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
130048182|NCT01097616|468133150|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
130048183|NCT01097616|468133151|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
130048184|NCT01097616|468133152|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
130048185|NCT01097616|468133153|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
130048186|NCT01097616|468133154|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
130048187|NCT01097616|468133147|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
130048188|NCT01097616|468133148|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
130048189|NCT01097616|468133149|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
130048190|NCT01097616|468133150|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
130048191|NCT01097616|468133151|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
130048192|NCT01097616|468133152|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
130048193|NCT01097616|468133153|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
130048194|NCT01097616|468133154|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
130048195|NCT01097616|468133147|FG000|Optional DB EXT Phase|Physician Decision|1|||
130048196|NCT01097616|468133148|FG001|Optional DB EXT Phase|Physician Decision|0|||
130048197|NCT01097616|468133149|FG002|Optional DB EXT Phase|Physician Decision|0|||
130048198|NCT01097616|468133150|FG003|Optional DB EXT Phase|Physician Decision|0|||
130048199|NCT01097616|468133151|FG004|Optional DB EXT Phase|Physician Decision|0|||
130048200|NCT01097616|468133152|FG005|Optional DB EXT Phase|Physician Decision|0|||
130048201|NCT01097616|468133153|FG006|Optional DB EXT Phase|Physician Decision|0|||
130048202|NCT01097616|468133154|FG007|Optional DB EXT Phase|Physician Decision|0|||
130048203|NCT01097616|468133147|FG000|DB RO Phase|Adverse Event|0|||
130048204|NCT01097616|468133148|FG001|DB RO Phase|Adverse Event|0|||
130048205|NCT01097616|468133149|FG002|DB RO Phase|Adverse Event|0|||
130048206|NCT01097616|468133150|FG003|DB RO Phase|Adverse Event|0|||
130048207|NCT01097616|468133151|FG004|DB RO Phase|Adverse Event|0|||
130048208|NCT01097616|468133152|FG005|DB RO Phase|Adverse Event|0|||
130048209|NCT01097616|468133153|FG006|DB RO Phase|Adverse Event|1|||
130048210|NCT01097616|468133154|FG007|DB RO Phase|Adverse Event|0|||
130048211|NCT01097616|468133147|FG000|DB RO Phase|Withdrawal by Subject|0|||
130048212|NCT01097616|468133148|FG001|DB RO Phase|Withdrawal by Subject|0|||
130048213|NCT01097616|468133149|FG002|DB RO Phase|Withdrawal by Subject|0|||
130048214|NCT01097616|468133150|FG003|DB RO Phase|Withdrawal by Subject|0|||
130048215|NCT01097616|468133151|FG004|DB RO Phase|Withdrawal by Subject|0|||
130048216|NCT01097616|468133152|FG005|DB RO Phase|Withdrawal by Subject|1|||
130048217|NCT01097616|468133153|FG006|DB RO Phase|Withdrawal by Subject|0|||
130048218|NCT01097616|468133154|FG007|DB RO Phase|Withdrawal by Subject|0|||
130048219|NCT01097616|468133147|FG000|DB RO Phase|Lost to Follow-up|0|||
130048220|NCT01097616|468133148|FG001|DB RO Phase|Lost to Follow-up|0|||
130048221|NCT01097616|468133149|FG002|DB RO Phase|Lost to Follow-up|0|||
130048222|NCT01097616|468133150|FG003|DB RO Phase|Lost to Follow-up|1|||
130048223|NCT01097616|468133151|FG004|DB RO Phase|Lost to Follow-up|1|||
130048224|NCT01097616|468133152|FG005|DB RO Phase|Lost to Follow-up|0|||
130048225|NCT01097616|468133153|FG006|DB RO Phase|Lost to Follow-up|0|||
130048226|NCT01097616|468133154|FG007|DB RO Phase|Lost to Follow-up|1|||
130048227|NCT01097616|468133147|FG000|DB RO Phase|Not Treated in RO|0|||
130048228|NCT01097616|468133148|FG001|DB RO Phase|Not Treated in RO|0|||
130048229|NCT01097616|468133149|FG002|DB RO Phase|Not Treated in RO|0|||
130048230|NCT01097616|468133150|FG003|DB RO Phase|Not Treated in RO|0|||
130048231|NCT01097616|468133151|FG004|DB RO Phase|Not Treated in RO|0|||
130048232|NCT01097616|468133152|FG005|DB RO Phase|Not Treated in RO|1|||
130048233|NCT01097616|468133153|FG006|DB RO Phase|Not Treated in RO|0|||
130048234|NCT01097616|468133154|FG007|DB RO Phase|Not Treated in RO|0|||
130048235|NCT00130208|468133155|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
130048236|NCT00130208|468133156|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
130048237|NCT00130208|468133155|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
130305872|NCT03350815|469083449|FG001|Period 2|Protocol Violation|0|||
130305873|NCT03350815|469083450|FG002|Period 2|Protocol Violation|1|||
130048238|NCT00130208|468133156|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
130048239|NCT00130208|468133155|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
130048240|NCT00130208|468133156|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
130305874|NCT03350815|469083451|FG003|Period 2|Protocol Violation|0|||
130048241|NCT00130208|468133155|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
130048242|NCT00130208|468133156|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
130048243|NCT00130208|468133155|FG000|Maintenance Period (26 Weeks)|Other|1|||
130305875|NCT03350815|469083448|FG000|Period 2|New therapy for study indication|0|||
130107940|NCT01270841|468357140|FG000|Overall Study|Adverse Event|0|||
130107941|NCT01270841|468357141|FG001|Overall Study|Adverse Event|1|||
130107942|NCT01270841|468357142|FG002|Overall Study|Adverse Event|0|||
130107943|NCT01270841|468357143|FG003|Overall Study|Adverse Event|3|||
130107944|NCT01270841|468357140|FG000|Overall Study|Withdrawal by Subject|3|||
130107945|NCT01270841|468357141|FG001|Overall Study|Withdrawal by Subject|2|||
130107946|NCT01270841|468357142|FG002|Overall Study|Withdrawal by Subject|3|||
130305876|NCT03350815|469083449|FG001|Period 2|New therapy for study indication|0|||
130305877|NCT03350815|469083450|FG002|Period 2|New therapy for study indication|1|||
130305878|NCT03350815|469083451|FG003|Period 2|New therapy for study indication|0|||
130305879|NCT02837029|469083454|FG000|Screening|Failed to meet screening requirements.|7|||
130305880|NCT02837029|469083455|FG001|Screening|Failed to meet screening requirements.|3|||
130305881|NCT02837029|469083456|FG002|Screening|Failed to meet screening requirements.|0|||
130305882|NCT02837029|469083454|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
130305883|NCT02837029|469083455|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
130305884|NCT02837029|469083456|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
130305885|NCT02837029|469083454|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
130305886|NCT02837029|469083455|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
130107947|NCT01270841|468357143|FG003|Overall Study|Withdrawal by Subject|3|||
130107948|NCT01270841|468357140|FG000|Overall Study|Lost to Follow-up|3|||
130107949|NCT01270841|468357141|FG001|Overall Study|Lost to Follow-up|1|||
130107950|NCT01270841|468357142|FG002|Overall Study|Lost to Follow-up|4|||
130107951|NCT01270841|468357143|FG003|Overall Study|Lost to Follow-up|2|||
130107952|NCT01270841|468357140|FG000|Overall Study|Physician Decision|0|||
130107953|NCT01270841|468357141|FG001|Overall Study|Physician Decision|1|||
130107954|NCT01270841|468357142|FG002|Overall Study|Physician Decision|0|||
130107955|NCT01270841|468357143|FG003|Overall Study|Physician Decision|0|||
130107956|NCT01270841|468357140|FG000|Overall Study|Did not qualify|6|||
130107957|NCT01270841|468357141|FG001|Overall Study|Did not qualify|3|||
130107958|NCT01270841|468357142|FG002|Overall Study|Did not qualify|4|||
130107959|NCT01270841|468357143|FG003|Overall Study|Did not qualify|5|||
130107960|NCT01270841|468357140|FG000|Overall Study|Protocol Violation|1|||
130107961|NCT01270841|468357141|FG001|Overall Study|Protocol Violation|5|||
130107962|NCT01270841|468357142|FG002|Overall Study|Protocol Violation|0|||
130107963|NCT01270841|468357143|FG003|Overall Study|Protocol Violation|0|||
130107964|NCT01270841|468357140|FG000|Overall Study|Enrolled in error|0|||
130107965|NCT01270841|468357141|FG001|Overall Study|Enrolled in error|1|||
130107966|NCT01270841|468357142|FG002|Overall Study|Enrolled in error|0|||
130107967|NCT01270841|468357143|FG003|Overall Study|Enrolled in error|0|||
130107968|NCT02082912|468357144|FG000|Overall Study|Physician Decision|0|||
130107969|NCT02082912|468357145|FG001|Overall Study|Physician Decision|1|||
130107970|NCT03137082|468357153|FG000|Overall Study|Withdrawal by Subject|1|||
130107971|NCT03137082|468357154|FG001|Overall Study|Withdrawal by Subject|1|||
130107972|NCT03137082|468357153|FG000|Overall Study|Lost to Follow-up|1|||
130107973|NCT03137082|468357154|FG001|Overall Study|Lost to Follow-up|0|||
130107974|NCT00544557|468357155|FG000|Overall Study|Adverse Event|140|||
130107975|NCT00544557|468357155|FG000|Overall Study|Lack of Efficacy|196|||
130107976|NCT00544557|468357155|FG000|Overall Study|Other|98|||
130107977|NCT01020305|468357161|FG000|Overall Study|Adverse Event|2|||
130107978|NCT00467818|468357162|FG000|Overall Study|Adverse Event|1|||
130107979|NCT00467818|468357163|FG001|Overall Study|Adverse Event|0|||
130107980|NCT00467818|468357162|FG000|Overall Study|Lost to Follow-up|2|||
130107981|NCT00467818|468357163|FG001|Overall Study|Lost to Follow-up|2|||
130107982|NCT01017029|468357167|FG000|Overall Study|Lost to Follow-up|1|||
130107983|NCT01017029|468357168|FG001|Overall Study|Lost to Follow-up|0|||
130107984|NCT01017029|468357167|FG000|Overall Study|Administrative problem|0|||
130107985|NCT01017029|468357168|FG001|Overall Study|Administrative problem|1|||
130107986|NCT01017029|468357167|FG000|Overall Study|Death|3|||
130107987|NCT01017029|468357168|FG001|Overall Study|Death|1|||
130107988|NCT02753400|468357170|FG000|Overall Study|Adverse Event|3|||
130107989|NCT02753400|468357171|FG001|Overall Study|Adverse Event|0|||
130107990|NCT02753400|468357170|FG000|Overall Study|Withdrawal by Subject|2|||
130107991|NCT02753400|468357171|FG001|Overall Study|Withdrawal by Subject|1|||
130107992|NCT01415921|468357172|FG000|Overall Study|Adverse Event|0|||
130107993|NCT01415921|468357173|FG001|Overall Study|Adverse Event|1|||
130107994|NCT01415921|468357172|FG000|Overall Study|Physician Decision|1|||
130107995|NCT01415921|468357173|FG001|Overall Study|Physician Decision|1|||
130107996|NCT01415921|468357172|FG000|Overall Study|Withdrawal by Subject|0|||
130107997|NCT01415921|468357173|FG001|Overall Study|Withdrawal by Subject|1|||
130107998|NCT01415921|468357172|FG000|Overall Study|Other|2|||
130107999|NCT01415921|468357173|FG001|Overall Study|Other|0|||
130108000|NCT01830920|468357178|FG000|Overall Study|Adverse Event|1|||
130108001|NCT01830920|468357179|FG001|Overall Study|Adverse Event|0|||
130108002|NCT01830920|468357180|FG002|Overall Study|Adverse Event|1|||
130108003|NCT01830920|468357181|FG003|Overall Study|Adverse Event|0|||
130108004|NCT01830920|468357182|FG004|Overall Study|Adverse Event|0|||
130108005|NCT01830920|468357178|FG000|Overall Study|Withdrawal by Subject|2|||
130305887|NCT02837029|469083456|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
130108006|NCT01830920|468357179|FG001|Overall Study|Withdrawal by Subject|2|||
130108007|NCT01830920|468357180|FG002|Overall Study|Withdrawal by Subject|1|||
130108008|NCT01830920|468357181|FG003|Overall Study|Withdrawal by Subject|7|||
130108009|NCT01830920|468357182|FG004|Overall Study|Withdrawal by Subject|1|||
130108010|NCT01830920|468357178|FG000|Overall Study|Death|3|||
130108011|NCT01830920|468357179|FG001|Overall Study|Death|3|||
130108012|NCT01830920|468357180|FG002|Overall Study|Death|5|||
130108013|NCT01830920|468357181|FG003|Overall Study|Death|4|||
130108014|NCT01830920|468357182|FG004|Overall Study|Death|4|||
130108015|NCT01830920|468357178|FG000|Overall Study|Other|15|||
130108016|NCT01830920|468357179|FG001|Overall Study|Other|1|||
130108017|NCT01830920|468357180|FG002|Overall Study|Other|1|||
130108018|NCT01830920|468357181|FG003|Overall Study|Other|5|||
130108019|NCT01830920|468357182|FG004|Overall Study|Other|3|||
130108020|NCT01313728|468357183|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
130108021|NCT03876873|468357186|FG000|Overall Study|Physician Decision|0|||
130108022|NCT03876873|468357187|FG001|Overall Study|Physician Decision|1|||
130108023|NCT03547531|468357188|FG000|Overall Study|not coming in data collection : sick|2|||
130108024|NCT03547531|468357189|FG001|Overall Study|not coming in data collection : sick|2|||
130108025|NCT03547531|468357188|FG000|Overall Study|having family occasion|0|||
130108026|NCT03547531|468357189|FG001|Overall Study|having family occasion|2|||
130108027|NCT03402126|468357191|FG000|Overall Study|Lost to Follow-up|6|||
130108028|NCT03402126|468357191|FG000|Overall Study|Protocol Violation|10|||
130108029|NCT03402126|468357191|FG000|Overall Study|Sponsor request/Study termination|29|||
130108030|NCT03402126|468357191|FG000|Overall Study|Study product no longer in use|1|||
130108031|NCT03402126|468357191|FG000|Overall Study|Technical problems|1|||
130108032|NCT03402126|468357191|FG000|Overall Study|Withdrawal by Subject|6|||
130108033|NCT03402126|468357191|FG000|Overall Study|Physician Decision|2|||
130108034|NCT03402126|468357191|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
130108035|NCT03402126|468357191|FG000|Overall Study|Death|4|||
130108036|NCT02117479|468357192|FG000|Overall Study|Death|13|||
130108037|NCT02117479|468357193|FG001|Overall Study|Death|8|||
130108038|NCT02117479|468357192|FG000|Overall Study|Adverse Event|8|||
130108039|NCT02117479|468357193|FG001|Overall Study|Adverse Event|16|||
130108040|NCT02117479|468357192|FG000|Overall Study|Subject decision|8|||
130108041|NCT02117479|468357193|FG001|Overall Study|Subject decision|9|||
130108042|NCT02117479|468357192|FG000|Overall Study|Disease progression|104|||
130108043|NCT02117479|468357193|FG001|Overall Study|Disease progression|108|||
130108044|NCT02117479|468357192|FG000|Overall Study|Noncompliance with study treatment|1|||
130108045|NCT02117479|468357193|FG001|Overall Study|Noncompliance with study treatment|0|||
130108046|NCT02117479|468357192|FG000|Overall Study|Study terminated by the sponsor|4|||
130108047|NCT02117479|468357193|FG001|Overall Study|Study terminated by the sponsor|6|||
130108048|NCT02117479|468357192|FG000|Overall Study|Physician Decision|7|||
130108049|NCT02117479|468357193|FG001|Overall Study|Physician Decision|2|||
130108050|NCT02117479|468357192|FG000|Overall Study|Other unspecified|11|||
130108051|NCT02117479|468357193|FG001|Overall Study|Other unspecified|7|||
130108052|NCT01959230|468357194|FG000|Overall Study|Failure to follow study procedures|0|||
130108053|NCT01959230|468357195|FG001|Overall Study|Failure to follow study procedures|1|||
130108054|NCT01959230|468357194|FG000|Overall Study|Administrative reasons|2|||
130305888|NCT02837029|469083454|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
130305889|NCT02837029|469083455|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
130305890|NCT02837029|469083456|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
130305891|NCT02837029|469083454|FG000|Cycle 2 and Beyond|Adverse Event|1|||
130108055|NCT01959230|468357195|FG001|Overall Study|Administrative reasons|0|||
130108056|NCT01959230|468357194|FG000|Overall Study|Withdrawal by Subject|2|||
130108057|NCT01959230|468357195|FG001|Overall Study|Withdrawal by Subject|0|||
130108058|NCT01453374|468357196|FG000|Overall Study|Adverse Event|7|||
130108059|NCT01453374|468357196|FG000|Overall Study|Lack of Efficacy|1|||
130108060|NCT01453374|468357196|FG000|Overall Study|Lost to Follow-up|3|||
130108061|NCT01453374|468357196|FG000|Overall Study|Withdrawal by Subject|5|||
130108062|NCT01453374|468357196|FG000|Overall Study|Incarcerated|2|||
130108063|NCT00720304|468357197|FG000|Overall Study|Withdrawal by Subject|14|||
130108064|NCT00720304|468357198|FG001|Overall Study|Withdrawal by Subject|1|||
130108065|NCT00720304|468357197|FG000|Overall Study|Death|1|||
130108066|NCT00720304|468357198|FG001|Overall Study|Death|0|||
130108067|NCT00720304|468357197|FG000|Overall Study|Physician Decision|5|||
130108068|NCT00720304|468357198|FG001|Overall Study|Physician Decision|2|||
130108069|NCT00720304|468357197|FG000|Overall Study|Adverse Event|3|||
130305892|NCT02837029|469083455|FG001|Cycle 2 and Beyond|Adverse Event|0|||
130305893|NCT02837029|469083456|FG002|Cycle 2 and Beyond|Adverse Event|0|||
130108070|NCT00720304|468357198|FG001|Overall Study|Adverse Event|1|||
130108071|NCT00720304|468357197|FG000|Overall Study|Disease progression|6|||
130108072|NCT00720304|468357198|FG001|Overall Study|Disease progression|1|||
130108073|NCT01333475|468357199|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
130108074|NCT01333475|468357200|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
130108075|NCT01333475|468357199|FG000|Overall Study|Toxicity|1|||
130108076|NCT01333475|468357200|FG001|Overall Study|Toxicity|3|||
130305894|NCT02837029|469083454|FG000|2 Year Follow-up|Death|6|||
130048244|NCT00130208|468133156|FG001|Maintenance Period (26 Weeks)|Other|1|||
130048245|NCT00130208|468133155|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
130048246|NCT00130208|468133156|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
130048247|NCT00130208|468133155|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
130048248|NCT00130208|468133156|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
130048249|NCT00130208|468133155|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
130048250|NCT00130208|468133156|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
130048251|NCT00130208|468133155|FG000|Washout Period (8 Weeks)|Other|1|||
130048252|NCT00130208|468133156|FG001|Washout Period (8 Weeks)|Other|1|||
130048253|NCT00589472|468133158|FG000|Overall Study|Adverse Event|1|||
130048254|NCT01703819|468133161|FG000|Overall Study|Adverse Event|0|||
130048255|NCT01703819|468133162|FG001|Overall Study|Adverse Event|1|||
130048256|NCT01703819|468133161|FG000|Overall Study|Withdrawal by Subject|0|||
130048257|NCT01703819|468133162|FG001|Overall Study|Withdrawal by Subject|1|||
130048258|NCT02145156|468133163|FG000|Overall Study|No match to vaccination records|60|||
130048259|NCT02145156|468133164|FG001|Overall Study|No match to vaccination records|52|||
130048260|NCT02145156|468133165|FG002|Overall Study|No match to vaccination records|41|||
130048261|NCT00532883|468133166|FG000|Overall Study|Adverse Event|1|||
130048262|NCT00532883|468133167|FG001|Overall Study|Adverse Event|0|||
130048263|NCT00532883|468133168|FG002|Overall Study|Adverse Event|0|||
130048264|NCT00532883|468133169|FG003|Overall Study|Adverse Event|1|||
130048265|NCT00532883|468133166|FG000|Overall Study|Lost to Follow-up|1|||
130048266|NCT00532883|468133167|FG001|Overall Study|Lost to Follow-up|1|||
130048267|NCT00532883|468133168|FG002|Overall Study|Lost to Follow-up|1|||
130048268|NCT00532883|468133169|FG003|Overall Study|Lost to Follow-up|0|||
130048269|NCT00532883|468133166|FG000|Overall Study|Withdrawal by Subject|0|||
130048270|NCT00532883|468133167|FG001|Overall Study|Withdrawal by Subject|1|||
130048271|NCT00532883|468133168|FG002|Overall Study|Withdrawal by Subject|1|||
130048272|NCT00532883|468133169|FG003|Overall Study|Withdrawal by Subject|0|||
130048273|NCT00532883|468133166|FG000|Overall Study|Subject was Nonadherent|0|||
130048274|NCT00532883|468133167|FG001|Overall Study|Subject was Nonadherent|1|||
130048275|NCT00532883|468133168|FG002|Overall Study|Subject was Nonadherent|1|||
130048276|NCT00532883|468133169|FG003|Overall Study|Subject was Nonadherent|0|||
130048277|NCT00532883|468133166|FG000|Overall Study|Early Study Termination|4|||
130048278|NCT00532883|468133167|FG001|Overall Study|Early Study Termination|4|||
130048279|NCT00532883|468133168|FG002|Overall Study|Early Study Termination|1|||
130048280|NCT00532883|468133169|FG003|Overall Study|Early Study Termination|4|||
130048281|NCT01797783|468133170|FG000|Overall Study|Adverse Event|1|||
130048282|NCT01797783|468133171|FG001|Overall Study|Adverse Event|1|||
130048283|NCT01797783|468133170|FG000|Overall Study|Withdrawal by Subject|1|||
130048284|NCT01797783|468133171|FG001|Overall Study|Withdrawal by Subject|0|||
130048285|NCT01651052|468133174|FG000|Overall Study|Death|21|||
130048286|NCT01651052|468133174|FG000|Overall Study|Explant|1|||
130048287|NCT01651052|468133174|FG000|Overall Study|Withdrawal by Subject|1|||
130048288|NCT01651052|468133174|FG000|Overall Study|Lost to Follow-up|3|||
130048289|NCT00871858|468133177|FG000|Overall Study|Protocol Violation|3|||
130048290|NCT00871858|468133178|FG001|Overall Study|Protocol Violation|4|||
130048291|NCT00871858|468133177|FG000|Overall Study|Adverse Event|1|||
130048292|NCT00871858|468133178|FG001|Overall Study|Adverse Event|1|||
130048293|NCT00871858|468133177|FG000|Overall Study|Withdrawal by Subject|1|||
130048294|NCT00871858|468133178|FG001|Overall Study|Withdrawal by Subject|1|||
130048295|NCT00871858|468133177|FG000|Overall Study|Lost to Follow-up|0|||
130048296|NCT00871858|468133178|FG001|Overall Study|Lost to Follow-up|1|||
130048297|NCT01188798|468133179|FG000|Overall Study|Death|0|||
130048298|NCT01188798|468133180|FG001|Overall Study|Death|1|||
130048299|NCT01188798|468133179|FG000|Overall Study|Required additional transplant|1|||
130048300|NCT01188798|468133180|FG001|Overall Study|Required additional transplant|1|||
130048301|NCT01188798|468133179|FG000|Overall Study|Protocol closure|1|||
130048302|NCT01188798|468133180|FG001|Overall Study|Protocol closure|1|||
130048303|NCT01024465|468133194|FG000|Overall Study|Adverse Event|2|||
130048304|NCT01024465|468133194|FG000|Overall Study|Physician Decision|1|||
130048305|NCT03078608|468133195|FG000|Overall Study|Death|1|||
130048306|NCT03078608|468133196|FG001|Overall Study|Death|2|||
130048307|NCT03078608|468133197|FG002|Overall Study|Death|0|||
130048308|NCT03078608|468133198|FG003|Overall Study|Death|0|||
130048309|NCT03078608|468133195|FG000|Overall Study|Withdrawal by Subject|8|||
130048310|NCT03078608|468133196|FG001|Overall Study|Withdrawal by Subject|1|||
130048311|NCT03078608|468133197|FG002|Overall Study|Withdrawal by Subject|0|||
130048312|NCT03078608|468133198|FG003|Overall Study|Withdrawal by Subject|0|||
130048313|NCT03078608|468133195|FG000|Overall Study|Lost to Follow-up|5|||
130048314|NCT03078608|468133196|FG001|Overall Study|Lost to Follow-up|8|||
130048315|NCT03078608|468133197|FG002|Overall Study|Lost to Follow-up|4|||
130048316|NCT03078608|468133198|FG003|Overall Study|Lost to Follow-up|1|||
130048317|NCT00723840|468133199|FG000|Overall Study|Lost to Follow-up|2|||
130048318|NCT00723840|468133199|FG000|Overall Study|Failure to return|18|||
130048319|NCT00723840|468133199|FG000|Overall Study|Withdrawal by Subject|55|||
130048320|NCT00723840|468133199|FG000|Overall Study|Serious Adverse Events|3|||
130048321|NCT00723840|468133199|FG000|Overall Study|Other Medical Event|2|||
130108077|NCT02981602|468357201|FG000|Overall Study|Adverse Event|0|||
130108078|NCT02981602|468357202|FG001|Overall Study|Adverse Event|0|||
130108079|NCT02981602|468357203|FG002|Overall Study|Adverse Event|0|||
130108080|NCT02981602|468357204|FG003|Overall Study|Adverse Event|1|||
130108081|NCT02981602|468357205|FG004|Overall Study|Adverse Event|0|||
130108082|NCT00386100|468357206|FG000|Overall Study|Did not receive study medication|6|||
130108083|NCT00386100|468357207|FG001|Overall Study|Did not receive study medication|4|||
130108084|NCT00386100|468357206|FG000|Overall Study|Adverse Event|15|||
130108085|NCT00386100|468357207|FG001|Overall Study|Adverse Event|25|||
130108086|NCT00386100|468357206|FG000|Overall Study|Death|0|||
130108087|NCT00386100|468357207|FG001|Overall Study|Death|1|||
130108088|NCT00386100|468357206|FG000|Overall Study|Insufficient therapeutic effect|30|||
130108089|NCT00386100|468357207|FG001|Overall Study|Insufficient therapeutic effect|6|||
130108090|NCT00386100|468357206|FG000|Overall Study|Lost to Follow-up|29|||
130108091|NCT00386100|468357207|FG001|Overall Study|Lost to Follow-up|29|||
130108092|NCT00386100|468357206|FG000|Overall Study|Non-compliance|18|||
130108093|NCT00386100|468357207|FG001|Overall Study|Non-compliance|19|||
130108094|NCT00386100|468357206|FG000|Overall Study|Protocol Violation|5|||
130108095|NCT00386100|468357207|FG001|Overall Study|Protocol Violation|3|||
130108096|NCT00386100|468357206|FG000|Overall Study|Withdrawal by Subject|32|||
130108097|NCT00386100|468357207|FG001|Overall Study|Withdrawal by Subject|31|||
130108098|NCT00386100|468357206|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
130108099|NCT00386100|468357207|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
130108100|NCT00386100|468357206|FG000|Overall Study|BMD <2.5|1|||
130108101|NCT00386100|468357207|FG001|Overall Study|BMD <2.5|0|||
130108102|NCT00386100|468357206|FG000|Overall Study|Consecutive elevated Hba1C|1|||
130108103|NCT00386100|468357207|FG001|Overall Study|Consecutive elevated Hba1C|0|||
130108104|NCT00386100|468357206|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
130108105|NCT00386100|468357207|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
129797737|NCT02007512|467228211|FG000|Double Blind Treatment Period|Disease progression|51|||
130108106|NCT00386100|468357206|FG000|Overall Study|Laboratory findings|1|||
130108107|NCT00386100|468357207|FG001|Overall Study|Laboratory findings|0|||
130108108|NCT00386100|468357206|FG000|Overall Study|Participant's concern due to CPK levels|1|||
130108109|NCT00386100|468357207|FG001|Overall Study|Participant's concern due to CPK levels|0|||
130108110|NCT00386100|468357206|FG000|Overall Study|Participant moving out of state|2|||
129797738|NCT02007512|467228212|FG001|Double Blind Treatment Period|Disease progression|50|||
129797739|NCT02007512|467228213|FG002|Double Blind Treatment Period|Disease progression|57|||
129797740|NCT02007512|467228214|FG003|Double Blind Treatment Period|Disease progression|52|||
129797741|NCT02007512|467228211|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797742|NCT02007512|467228212|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797743|NCT02007512|467228213|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797744|NCT02007512|467228214|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797745|NCT02007512|467228211|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129797746|NCT02007512|467228212|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129797747|NCT02007512|467228213|FG002|Double Blind Treatment Period|Protocol Violation|0|||
129797748|NCT02007512|467228214|FG003|Double Blind Treatment Period|Protocol Violation|1|||
129797749|NCT02007512|467228211|FG000|Double Blind Treatment Period|Other|2|||
129797750|NCT02007512|467228212|FG001|Double Blind Treatment Period|Other|1|||
129797751|NCT02007512|467228213|FG002|Double Blind Treatment Period|Other|1|||
129797752|NCT02007512|467228214|FG003|Double Blind Treatment Period|Other|2|||
129797753|NCT02007512|467228211|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
129797754|NCT02007512|467228212|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
129797755|NCT02007512|467228213|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
129797756|NCT02007512|467228214|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
129797757|NCT02007512|467228211|FG000|Open Label Treatment Period|Adverse Event|1|||
129797758|NCT02007512|467228212|FG001|Open Label Treatment Period|Adverse Event|0|||
129797759|NCT02007512|467228213|FG002|Open Label Treatment Period|Adverse Event|0|||
129797760|NCT02007512|467228214|FG003|Open Label Treatment Period|Adverse Event|0|||
129797761|NCT02007512|467228211|FG000|Open Label Treatment Period|Other|1|||
129797762|NCT02007512|467228212|FG001|Open Label Treatment Period|Other|1|||
129797763|NCT02007512|467228213|FG002|Open Label Treatment Period|Other|0|||
129797764|NCT02007512|467228214|FG003|Open Label Treatment Period|Other|0|||
129797765|NCT02007512|467228211|FG000|Open Label Treatment Period|Disease progression|23|||
129797766|NCT02007512|467228212|FG001|Open Label Treatment Period|Disease progression|11|||
129797767|NCT02007512|467228213|FG002|Open Label Treatment Period|Disease progression|0|||
129797768|NCT02007512|467228214|FG003|Open Label Treatment Period|Disease progression|0|||
130305895|NCT02837029|469083455|FG001|2 Year Follow-up|Death|7|||
129797769|NCT00900601|467228219|FG000|Overall Study|Physician Decision|1|||
129797770|NCT00608543|467228220|FG000|Overall Study|Adverse Event|4|||
129797771|NCT03026088|467228221|FG000|Overall Study|Study termination|20|||
130108111|NCT00386100|468357207|FG001|Overall Study|Participant moving out of state|0|||
130108112|NCT00386100|468357206|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
130108113|NCT00386100|468357207|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
130108114|NCT00386100|468357206|FG000|Overall Study|Didn't meet entry criteria|1|||
130108115|NCT00386100|468357207|FG001|Overall Study|Didn't meet entry criteria|1|||
130108116|NCT00386100|468357206|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
130108117|NCT00386100|468357207|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
130108118|NCT00386100|468357206|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
130108119|NCT00386100|468357207|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
130108120|NCT00386100|468357206|FG000|Overall Study|Bad metabolic control & patient security|1|||
130108121|NCT00386100|468357207|FG001|Overall Study|Bad metabolic control & patient security|0|||
130108122|NCT00386100|468357206|FG000|Overall Study|Bone loss by DXA bone scan|1|||
130108123|NCT00386100|468357207|FG001|Overall Study|Bone loss by DXA bone scan|0|||
130108124|NCT00386100|468357206|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
130108125|NCT00386100|468357207|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
130108126|NCT00386100|468357206|FG000|Overall Study|7.6% bone loss|1|||
130108127|NCT00386100|468357207|FG001|Overall Study|7.6% bone loss|0|||
130108128|NCT00386100|468357206|FG000|Overall Study|Osteoporosis|0|||
130108129|NCT00386100|468357207|FG001|Overall Study|Osteoporosis|1|||
130108130|NCT00386100|468357206|FG000|Overall Study|Positive pregnancy test|1|||
130108131|NCT00386100|468357207|FG001|Overall Study|Positive pregnancy test|3|||
130108132|NCT00386100|468357206|FG000|Overall Study|Out of country for 5 months|1|||
130108133|NCT00386100|468357207|FG001|Overall Study|Out of country for 5 months|0|||
130108134|NCT00386100|468357206|FG000|Overall Study|Hb1Ac >8%|0|||
130108135|NCT00386100|468357207|FG001|Overall Study|Hb1Ac >8%|1|||
130108136|NCT00386100|468357206|FG000|Overall Study|Participant randomized in error|1|||
130108137|NCT00386100|468357207|FG001|Overall Study|Participant randomized in error|0|||
130108138|NCT01706770|468357208|FG000|Overall Study|Lost to Follow-up|1|||
130108139|NCT01706770|468357209|FG001|Overall Study|Lost to Follow-up|0|||
130108140|NCT01706770|468357208|FG000|Overall Study|Physician Decision|1|||
130108141|NCT01706770|468357209|FG001|Overall Study|Physician Decision|0|||
130108142|NCT03636542|468357212|FG000|Overall Study|Lost to Follow-up|1|||
130108143|NCT03636542|468357213|FG001|Overall Study|Lost to Follow-up|1|||
130108144|NCT03636542|468357212|FG000|Overall Study|Physician Decision|0|||
130108145|NCT03636542|468357213|FG001|Overall Study|Physician Decision|1|||
130108146|NCT03636542|468357212|FG000|Overall Study|Withdrawal by Subject|1|||
130108147|NCT03636542|468357213|FG001|Overall Study|Withdrawal by Subject|0|||
130108148|NCT03674827|468357216|FG000|Treatment Phase|Adverse Event|0|||
130108149|NCT03674827|468357217|FG001|Treatment Phase|Adverse Event|0|||
130108150|NCT03674827|468357218|FG002|Treatment Phase|Adverse Event|0|||
130108151|NCT03674827|468357219|FG003|Treatment Phase|Adverse Event|0|||
130108152|NCT03674827|468357220|FG004|Treatment Phase|Adverse Event|0|||
130108153|NCT03674827|468357221|FG005|Treatment Phase|Adverse Event|2|||
130108154|NCT03674827|468357216|FG000|Treatment Phase|Death|2|||
130108155|NCT03674827|468357217|FG001|Treatment Phase|Death|0|||
130108156|NCT03674827|468357218|FG002|Treatment Phase|Death|0|||
130108157|NCT03674827|468357219|FG003|Treatment Phase|Death|0|||
130108158|NCT03674827|468357220|FG004|Treatment Phase|Death|1|||
130108159|NCT03674827|468357221|FG005|Treatment Phase|Death|0|||
130108160|NCT03674827|468357216|FG000|Treatment Phase|Progressive Disease|0|||
130108161|NCT03674827|468357217|FG001|Treatment Phase|Progressive Disease|4|||
130108162|NCT03674827|468357218|FG002|Treatment Phase|Progressive Disease|3|||
130108163|NCT03674827|468357219|FG003|Treatment Phase|Progressive Disease|4|||
130108164|NCT03674827|468357220|FG004|Treatment Phase|Progressive Disease|4|||
130108165|NCT03674827|468357221|FG005|Treatment Phase|Progressive Disease|9|||
130108166|NCT03674827|468357216|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
130108167|NCT03674827|468357217|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
130108168|NCT03674827|468357218|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
130108169|NCT03674827|468357219|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
130108170|NCT03674827|468357220|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
130108171|NCT03674827|468357221|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
130108172|NCT03674827|468357216|FG000|Treatment Phase|Withdrawal by Subject|0|||
130108173|NCT03674827|468357217|FG001|Treatment Phase|Withdrawal by Subject|0|||
130108174|NCT03674827|468357218|FG002|Treatment Phase|Withdrawal by Subject|0|||
130108175|NCT03674827|468357219|FG003|Treatment Phase|Withdrawal by Subject|0|||
130108176|NCT03674827|468357220|FG004|Treatment Phase|Withdrawal by Subject|0|||
130108177|NCT03674827|468357221|FG005|Treatment Phase|Withdrawal by Subject|1|||
130108178|NCT03674827|468357216|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
130108179|NCT03674827|468357217|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
130108180|NCT03674827|468357218|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
130305896|NCT02837029|469083456|FG002|2 Year Follow-up|Death|0|||
130108181|NCT03674827|468357219|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
130108182|NCT03674827|468357220|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
130108183|NCT03674827|468357221|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
130108184|NCT03674827|468357216|FG000|Treatment Phase|Other|0|||
130108185|NCT03674827|468357217|FG001|Treatment Phase|Other|1|||
130108186|NCT03674827|468357218|FG002|Treatment Phase|Other|0|||
130108187|NCT03674827|468357219|FG003|Treatment Phase|Other|0|||
130108188|NCT03674827|468357220|FG004|Treatment Phase|Other|0|||
130108189|NCT03674827|468357221|FG005|Treatment Phase|Other|1|||
130108190|NCT03674827|468357216|FG000|Long-Term Follow-up Phase|Death|2|||
130108191|NCT03674827|468357217|FG001|Long-Term Follow-up Phase|Death|4|||
130108192|NCT03674827|468357218|FG002|Long-Term Follow-up Phase|Death|2|||
130108193|NCT03674827|468357219|FG003|Long-Term Follow-up Phase|Death|3|||
130108194|NCT03674827|468357220|FG004|Long-Term Follow-up Phase|Death|2|||
130108195|NCT03674827|468357221|FG005|Long-Term Follow-up Phase|Death|6|||
130108196|NCT03674827|468357216|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
130108197|NCT03674827|468357217|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
130108198|NCT03674827|468357218|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
130108199|NCT03674827|468357219|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
130108200|NCT03674827|468357220|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
130108201|NCT03674827|468357221|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
130108202|NCT03674827|468357216|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
130108203|NCT03674827|468357217|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
130108204|NCT03674827|468357218|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
130108205|NCT03674827|468357219|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
130108206|NCT03674827|468357220|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
130108207|NCT03674827|468357221|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
130108208|NCT00527397|468357222|FG000|Overall Study|Adverse Event|3|||
130108209|NCT00527397|468357222|FG000|Overall Study|Lack of Efficacy|1|||
130108210|NCT00527397|468357222|FG000|Overall Study|Protocol Violation|1|||
130108211|NCT00527397|468357222|FG000|Overall Study|Withdrawal by Subject|6|||
130108212|NCT00527397|468357222|FG000|Overall Study|Study terminated by sponsor|13|||
130108213|NCT01783483|468357223|FG000|Overall Study|Death|3|||
130108214|NCT01783483|468357224|FG001|Overall Study|Death|3|||
130108215|NCT01783483|468357223|FG000|Overall Study|Lost to Follow-up|14|||
130108216|NCT01783483|468357224|FG001|Overall Study|Lost to Follow-up|10|||
130108217|NCT01783483|468357223|FG000|Overall Study|Withdrawal by Subject|2|||
130108218|NCT01783483|468357224|FG001|Overall Study|Withdrawal by Subject|1|||
130108219|NCT01783483|468357223|FG000|Overall Study|Physician Decision|1|||
130108220|NCT01783483|468357224|FG001|Overall Study|Physician Decision|1|||
130108221|NCT04130919|468357227|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
130108222|NCT04130919|468357228|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
130305897|NCT00398567|469083457|FG000|Overall Study|Disease Progression|3|||
130305898|NCT00398567|469083458|FG001|Overall Study|Disease Progression|4|||
130305899|NCT00398567|469083459|FG002|Overall Study|Disease Progression|27|||
130305900|NCT00398567|469083457|FG000|Overall Study|Withdrawal by Subject|1|||
130305901|NCT00398567|469083458|FG001|Overall Study|Withdrawal by Subject|0|||
130305902|NCT00398567|469083459|FG002|Overall Study|Withdrawal by Subject|4|||
130305903|NCT00398567|469083457|FG000|Overall Study|Adverse Event|0|||
130305904|NCT00398567|469083458|FG001|Overall Study|Adverse Event|0|||
130305905|NCT00398567|469083459|FG002|Overall Study|Adverse Event|2|||
130305906|NCT00398567|469083457|FG000|Overall Study|Protocol Violation|0|||
130305907|NCT00398567|469083458|FG001|Overall Study|Protocol Violation|0|||
130305908|NCT00398567|469083459|FG002|Overall Study|Protocol Violation|1|||
130305909|NCT02034877|469083460|FG000|Overall Study|Lost to Follow-up|0|||
130305910|NCT02034877|469083461|FG001|Overall Study|Lost to Follow-up|3|||
130305911|NCT02034877|469083460|FG000|Overall Study|No Longer Willing to Participate|0|||
130305912|NCT02034877|469083461|FG001|Overall Study|No Longer Willing to Participate|3|||
130305913|NCT03906071|469083464|FG000|Overall Study|Death|180|||
130305914|NCT03906071|469083465|FG001|Overall Study|Death|185|||
130305915|NCT03906071|469083464|FG000|Overall Study|Lost to Follow-up|3|||
130305916|NCT03906071|469083465|FG001|Overall Study|Lost to Follow-up|3|||
130305917|NCT03906071|469083464|FG000|Overall Study|Withdrawal by Subject|15|||
130305918|NCT03906071|469083465|FG001|Overall Study|Withdrawal by Subject|27|||
130305919|NCT03906071|469083464|FG000|Overall Study|Other|2|||
130305920|NCT03906071|469083465|FG001|Overall Study|Other|1|||
130305921|NCT01564732|469083477|FG000|Overall Study|Early termination by the study sponsor|6|||
130305922|NCT01564732|469083478|FG001|Overall Study|Early termination by the study sponsor|5|||
130108223|NCT04130919|468357229|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
130108224|NCT04130919|468357230|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
130108225|NCT04130919|468357231|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
130108226|NCT04130919|468357232|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
130108227|NCT04130919|468357227|FG000|Blinded Treatment Phase|Adverse Event|0|||
130108228|NCT04130919|468357228|FG001|Blinded Treatment Phase|Adverse Event|0|||
130108229|NCT04130919|468357229|FG002|Blinded Treatment Phase|Adverse Event|1|||
130108230|NCT04130919|468357230|FG003|Blinded Treatment Phase|Adverse Event|0|||
130108231|NCT04130919|468357231|FG004|Blinded Treatment Phase|Adverse Event|0|||
130108232|NCT04130919|468357232|FG005|Blinded Treatment Phase|Adverse Event|0|||
130108233|NCT04130919|468357227|FG000|Blinded Treatment Phase|Disease worsening|0|||
130305923|NCT01979952|469083481|FG000|Overall Study|Adverse Event|4|||
130108234|NCT04130919|468357228|FG001|Blinded Treatment Phase|Disease worsening|0|||
130108235|NCT04130919|468357229|FG002|Blinded Treatment Phase|Disease worsening|1|||
130108236|NCT04130919|468357230|FG003|Blinded Treatment Phase|Disease worsening|0|||
130108237|NCT04130919|468357231|FG004|Blinded Treatment Phase|Disease worsening|0|||
130108238|NCT04130919|468357232|FG005|Blinded Treatment Phase|Disease worsening|0|||
130108239|NCT04130919|468357227|FG000|Blinded Treatment Phase|Investigator's decision|0|||
130108240|NCT04130919|468357228|FG001|Blinded Treatment Phase|Investigator's decision|1|||
130108241|NCT04130919|468357229|FG002|Blinded Treatment Phase|Investigator's decision|0|||
130108242|NCT04130919|468357230|FG003|Blinded Treatment Phase|Investigator's decision|0|||
130108243|NCT04130919|468357231|FG004|Blinded Treatment Phase|Investigator's decision|0|||
130108244|NCT04130919|468357232|FG005|Blinded Treatment Phase|Investigator's decision|0|||
130108245|NCT04130919|468357227|FG000|Blinded Treatment Phase|Withdrew consent|1|||
130108246|NCT04130919|468357228|FG001|Blinded Treatment Phase|Withdrew consent|0|||
130108247|NCT04130919|468357229|FG002|Blinded Treatment Phase|Withdrew consent|0|||
130108248|NCT04130919|468357230|FG003|Blinded Treatment Phase|Withdrew consent|0|||
130108249|NCT04130919|468357231|FG004|Blinded Treatment Phase|Withdrew consent|0|||
130108250|NCT04130919|468357232|FG005|Blinded Treatment Phase|Withdrew consent|0|||
130108251|NCT04130919|468357227|FG000|Open-label Treatment Phase|Withdrew consent|0|||
130108252|NCT04130919|468357228|FG001|Open-label Treatment Phase|Withdrew consent|0|||
130108253|NCT04130919|468357229|FG002|Open-label Treatment Phase|Withdrew consent|0|||
130108254|NCT04130919|468357230|FG003|Open-label Treatment Phase|Withdrew consent|1|||
130108255|NCT04130919|468357231|FG004|Open-label Treatment Phase|Withdrew consent|1|||
130108256|NCT04130919|468357232|FG005|Open-label Treatment Phase|Withdrew consent|1|||
130108257|NCT04130919|468357227|FG000|Open-label Treatment Phase|Disease worsening|0|||
130108258|NCT04130919|468357228|FG001|Open-label Treatment Phase|Disease worsening|0|||
130108259|NCT04130919|468357229|FG002|Open-label Treatment Phase|Disease worsening|0|||
130108260|NCT04130919|468357230|FG003|Open-label Treatment Phase|Disease worsening|1|||
130108261|NCT04130919|468357231|FG004|Open-label Treatment Phase|Disease worsening|0|||
130108262|NCT04130919|468357232|FG005|Open-label Treatment Phase|Disease worsening|1|||
130108263|NCT04130919|468357227|FG000|Open-label Treatment Phase|Investigator's decision|0|||
130108264|NCT04130919|468357228|FG001|Open-label Treatment Phase|Investigator's decision|0|||
130108265|NCT04130919|468357229|FG002|Open-label Treatment Phase|Investigator's decision|0|||
130108266|NCT04130919|468357230|FG003|Open-label Treatment Phase|Investigator's decision|1|||
130108267|NCT04130919|468357231|FG004|Open-label Treatment Phase|Investigator's decision|0|||
130108268|NCT04130919|468357232|FG005|Open-label Treatment Phase|Investigator's decision|0|||
130108269|NCT04130919|468357227|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130108270|NCT04130919|468357228|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130108271|NCT04130919|468357229|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
130108272|NCT04130919|468357230|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
130108273|NCT04130919|468357231|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
130108274|NCT04130919|468357232|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
130108275|NCT04130919|468357227|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130108276|NCT04130919|468357228|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130108277|NCT04130919|468357229|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130108278|NCT04130919|468357230|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130108279|NCT04130919|468357231|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
130305924|NCT01979952|469083482|FG001|Overall Study|Adverse Event|5|||
130305925|NCT01979952|469083481|FG000|Overall Study|Protocol Violation|1|||
130305926|NCT01979952|469083482|FG001|Overall Study|Protocol Violation|0|||
130305927|NCT01979952|469083481|FG000|Overall Study|Withdrawal by Subject|2|||
130305928|NCT01979952|469083482|FG001|Overall Study|Withdrawal by Subject|1|||
130305929|NCT01979952|469083481|FG000|Overall Study|Other than specified above|1|||
130305930|NCT01979952|469083482|FG001|Overall Study|Other than specified above|0|||
130305931|NCT05438576|469083483|FG000|Overall Study|Death|1|||
130305932|NCT05438576|469083484|FG001|Overall Study|Death|1|||
130305933|NCT05438576|469083483|FG000|Overall Study|Withdrawal by Subject|4|||
130305934|NCT05438576|469083484|FG001|Overall Study|Withdrawal by Subject|2|||
130305935|NCT05438576|469083483|FG000|Overall Study|Not Eligible|2|||
130305936|NCT05438576|469083484|FG001|Overall Study|Not Eligible|1|||
130305937|NCT05438576|469083483|FG000|Overall Study|Did not complete baseline testing|22|||
130305938|NCT05438576|469083484|FG001|Overall Study|Did not complete baseline testing|4|||
130305939|NCT01067144|469083490|FG000|Treatment|Did not receive allocated intervention|4|||
130305940|NCT01067144|469083491|FG001|Treatment|Did not receive allocated intervention|7|||
130305941|NCT01067144|469083490|FG000|Follow-up|Lost to Follow-up|22|||
130305942|NCT01067144|469083491|FG001|Follow-up|Lost to Follow-up|12|||
130305943|NCT01067144|469083490|FG000|Follow-up|Censored owing to second surgery|19|||
130305944|NCT01067144|469083491|FG001|Follow-up|Censored owing to second surgery|28|||
130305945|NCT01067144|469083490|FG000|Follow-up|Withdrawal by Subject|18|||
130305946|NCT01067144|469083491|FG001|Follow-up|Withdrawal by Subject|14|||
130305947|NCT01067144|469083490|FG000|Follow-up|Surgery cancelled|0|||
130305948|NCT01067144|469083491|FG001|Follow-up|Surgery cancelled|1|||
130305949|NCT01067144|469083490|FG000|Follow-up|Death|0|||
130305950|NCT01067144|469083491|FG001|Follow-up|Death|1|||
130305951|NCT00475709|469083492|FG000|Overall Study|Did not meet eligibility criteria|8|||
130305952|NCT00475709|469083492|FG000|Overall Study|Death|41|||
130305953|NCT00475709|469083492|FG000|Overall Study|Device Explant|6|||
130305954|NCT00475709|469083492|FG000|Overall Study|Lost to Follow-up|21|||
130305955|NCT00555672|469083493|FG000|Overall Study|Death|0|||
130305956|NCT00555672|469083494|FG001|Overall Study|Death|2|||
130305957|NCT00555672|469083493|FG000|Overall Study|Adverse Event|8|||
130305958|NCT00555672|469083494|FG001|Overall Study|Adverse Event|2|||
130305959|NCT00555672|469083493|FG000|Overall Study|Objective progression or relapse|11|||
130305960|NCT00555672|469083494|FG001|Overall Study|Objective progression or relapse|5|||
130305961|NCT00555672|469083493|FG000|Overall Study|Other|3|||
130305962|NCT00555672|469083494|FG001|Overall Study|Other|1|||
130305963|NCT00555672|469083493|FG000|Overall Study|Participant refused|2|||
130305964|NCT00555672|469083494|FG001|Overall Study|Participant refused|0|||
130305965|NCT01415401|469083499|FG000|Overall Study|Adverse Event|5|||
130305966|NCT01415401|469083499|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
130305967|NCT01415401|469083499|FG000|Overall Study|Terminated by Sponsor|1|||
130305968|NCT04765202|469083513|FG000|Overall Study|Lost to Follow-up|1|||
130305969|NCT04765202|469083514|FG001|Overall Study|Lost to Follow-up|1|||
130305970|NCT04765202|469083515|FG002|Overall Study|Lost to Follow-up|2|||
130305971|NCT04765202|469083516|FG003|Overall Study|Lost to Follow-up|2|||
130305972|NCT04765202|469083513|FG000|Overall Study|Physician Decision|0|||
130305973|NCT04765202|469083514|FG001|Overall Study|Physician Decision|0|||
130305974|NCT04765202|469083515|FG002|Overall Study|Physician Decision|1|||
130305975|NCT04765202|469083516|FG003|Overall Study|Physician Decision|1|||
130305976|NCT02305238|469083518|FG000|Overall Study|Death|2|||
130305977|NCT02305238|469083519|FG001|Overall Study|Death|1|||
129889345|NCT03259373|467552562|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
130108280|NCT04130919|468357232|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
130108281|NCT02624518|468357236|FG000|Overall Study|Physician Decision|1|||
130108282|NCT00370396|468357239|FG000|Overall Study|Withdrawal by Subject|0|||
130108283|NCT00370396|468357240|FG001|Overall Study|Withdrawal by Subject|0|||
130108284|NCT00370396|468357241|FG002|Overall Study|Withdrawal by Subject|1|||
130108285|NCT00370396|468357239|FG000|Overall Study|Lost to Follow-up|11|||
130108286|NCT00370396|468357240|FG001|Overall Study|Lost to Follow-up|1|||
130108287|NCT00370396|468357241|FG002|Overall Study|Lost to Follow-up|0|||
130108288|NCT01462695|468357242|FG000|Overall Study|Adverse Event|1|||
130108289|NCT01462695|468357243|FG001|Overall Study|Adverse Event|1|||
130108290|NCT01462695|468357242|FG000|Overall Study|Death|2|||
130108291|NCT01462695|468357243|FG001|Overall Study|Death|0|||
130108292|NCT01462695|468357242|FG000|Overall Study|Lack of Efficacy|6|||
130108293|NCT01462695|468357243|FG001|Overall Study|Lack of Efficacy|12|||
130108294|NCT01462695|468357242|FG000|Overall Study|Physician Decision|5|||
130108295|NCT01462695|468357243|FG001|Overall Study|Physician Decision|0|||
130108296|NCT01462695|468357242|FG000|Overall Study|Withdrawal by Subject|2|||
130108297|NCT01462695|468357243|FG001|Overall Study|Withdrawal by Subject|0|||
130108298|NCT01462695|468357242|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
130108299|NCT01462695|468357243|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
130108300|NCT01364298|468357245|FG000|Overall Study|Adverse Event|3|||
130108301|NCT01364298|468357246|FG001|Overall Study|Adverse Event|4|||
130108302|NCT01364298|468357245|FG000|Overall Study|Lack of adherence to treatment|1|||
130108303|NCT01364298|468357246|FG001|Overall Study|Lack of adherence to treatment|3|||
130108304|NCT01364298|468357245|FG000|Overall Study|Lack of Efficacy|1|||
130108305|NCT01364298|468357246|FG001|Overall Study|Lack of Efficacy|0|||
130108306|NCT01364298|468357245|FG000|Overall Study|Lost to Follow-up|5|||
130108307|NCT01364298|468357246|FG001|Overall Study|Lost to Follow-up|10|||
130108308|NCT01364298|468357245|FG000|Overall Study|Withdrawal by Subject|3|||
130108309|NCT01364298|468357246|FG001|Overall Study|Withdrawal by Subject|3|||
130108310|NCT01364298|468357245|FG000|Overall Study|Other|1|||
130108311|NCT01364298|468357246|FG001|Overall Study|Other|3|||
130108312|NCT03797222|468357249|FG000|Overall Study|Withdrawal by Subject|1|||
130108313|NCT00659581|468357252|FG000|Overall Study|Adverse Event|1006|||
130108314|NCT00659581|468357252|FG000|Overall Study|Lack of Efficacy|1183|||
130108315|NCT00659581|468357252|FG000|Overall Study|Other|6393|||
130108316|NCT00725725|468357253|FG000|Overall Study|Adverse Event|1|||
130108317|NCT00725725|468357254|FG001|Overall Study|Adverse Event|3|||
130108318|NCT00725725|468357255|FG002|Overall Study|Adverse Event|2|||
130108319|NCT00725725|468357253|FG000|Overall Study|Lost to Follow-up|2|||
130108320|NCT00725725|468357254|FG001|Overall Study|Lost to Follow-up|0|||
130108321|NCT00725725|468357255|FG002|Overall Study|Lost to Follow-up|2|||
130108322|NCT00725725|468357253|FG000|Overall Study|Withdrawal by Subject|1|||
130108323|NCT00725725|468357254|FG001|Overall Study|Withdrawal by Subject|0|||
130108324|NCT00725725|468357255|FG002|Overall Study|Withdrawal by Subject|1|||
130108325|NCT00725725|468357253|FG000|Overall Study|Protocol Violation|0|||
130108326|NCT00725725|468357254|FG001|Overall Study|Protocol Violation|1|||
130305978|NCT02305238|469083520|FG002|Overall Study|Death|0|||
130305979|NCT02305238|469083518|FG000|Overall Study|Progressive disease|4|||
130305980|NCT02305238|469083519|FG001|Overall Study|Progressive disease|4|||
130305981|NCT02305238|469083520|FG002|Overall Study|Progressive disease|0|||
130305982|NCT02305238|469083518|FG000|Overall Study|Logistical difficulties|1|||
130305983|NCT02305238|469083519|FG001|Overall Study|Logistical difficulties|3|||
130305984|NCT02305238|469083520|FG002|Overall Study|Logistical difficulties|0|||
130305985|NCT02305238|469083518|FG000|Overall Study|Protocol Violation|0|||
130305986|NCT02305238|469083519|FG001|Overall Study|Protocol Violation|3|||
130305987|NCT02305238|469083520|FG002|Overall Study|Protocol Violation|0|||
130305988|NCT02305238|469083518|FG000|Overall Study|Physician Decision|2|||
130305989|NCT02305238|469083519|FG001|Overall Study|Physician Decision|1|||
130305990|NCT02305238|469083520|FG002|Overall Study|Physician Decision|0|||
130305991|NCT02305238|469083518|FG000|Overall Study|Adverse Event|4|||
130305992|NCT02305238|469083519|FG001|Overall Study|Adverse Event|2|||
130305993|NCT02305238|469083520|FG002|Overall Study|Adverse Event|0|||
130108327|NCT00725725|468357255|FG002|Overall Study|Protocol Violation|0|||
130108328|NCT01619085|468357259|FG000|Overall Study|Adverse Event|231|||
130108329|NCT01619085|468357259|FG000|Overall Study|Protocol Violation|4|||
130108330|NCT01619085|468357259|FG000|Overall Study|Lost to Follow-up|3|||
130108331|NCT01619085|468357259|FG000|Overall Study|Withdrawal by Subject|45|||
130108332|NCT01619085|468357259|FG000|Overall Study|Other than specified|96|||
130108333|NCT01619085|468357259|FG000|Overall Study|Not treated|1|||
130108334|NCT01619085|468357259|FG000|Overall Study|Death|145|||
130108335|NCT03125629|468357260|FG000|Overall Study|Withdrawal by Subject|2|||
130108336|NCT03125629|468357260|FG000|Overall Study|Equipment malfunction|1|||
130108337|NCT03909971|468357261|FG000|Overall Study|Other Reasons Not Specified|0|||
130108338|NCT03909971|468357262|FG001|Overall Study|Other Reasons Not Specified|1|||
130108339|NCT03909971|468357261|FG000|Overall Study|Global Deterioration of Health Status|2|||
130108340|NCT03909971|468357262|FG001|Overall Study|Global Deterioration of Health Status|1|||
130108341|NCT03909971|468357261|FG000|Overall Study|Progressive Disease|6|||
130108342|NCT03909971|468357262|FG001|Overall Study|Progressive Disease|14|||
130108343|NCT03909971|468357261|FG000|Overall Study|Death|2|||
130108344|NCT03909971|468357262|FG001|Overall Study|Death|6|||
130108345|NCT04523831|468357268|FG000|Overall Study|Lost to Follow-up|15|||
130108346|NCT04523831|468357269|FG001|Overall Study|Lost to Follow-up|17|||
130108347|NCT04523831|468357268|FG000|Overall Study|Death|0|||
130305994|NCT02305238|469083518|FG000|Overall Study|Withdrawal by Subject|3|||
130305995|NCT02305238|469083519|FG001|Overall Study|Withdrawal by Subject|4|||
130305996|NCT02305238|469083520|FG002|Overall Study|Withdrawal by Subject|0|||
130108348|NCT04523831|468357269|FG001|Overall Study|Death|3|||
130108349|NCT04523831|468357268|FG000|Overall Study|Adverse Event|2|||
130108350|NCT04523831|468357269|FG001|Overall Study|Adverse Event|0|||
130108351|NCT00430638|468357274|FG000|Overall Study|Adverse Event|15|||
130108352|NCT00430638|468357275|FG001|Overall Study|Adverse Event|15|||
130108353|NCT00430638|468357274|FG000|Overall Study|Uncontrolled blood pressure|48|||
130108354|NCT00430638|468357275|FG001|Overall Study|Uncontrolled blood pressure|13|||
130108355|NCT00430638|468357274|FG000|Overall Study|Lost to Follow-up|1|||
130108356|NCT00430638|468357275|FG001|Overall Study|Lost to Follow-up|7|||
130108357|NCT00430638|468357274|FG000|Overall Study|Protocol Violation|6|||
130108358|NCT00430638|468357275|FG001|Overall Study|Protocol Violation|4|||
130108359|NCT00430638|468357274|FG000|Overall Study|Withdrawal by Subject|4|||
130108360|NCT00430638|468357275|FG001|Overall Study|Withdrawal by Subject|6|||
130108361|NCT00430638|468357274|FG000|Overall Study|Non-compliant|2|||
130108362|NCT00430638|468357275|FG001|Overall Study|Non-compliant|1|||
130108363|NCT00430638|468357274|FG000|Overall Study|Other|2|||
130108364|NCT00430638|468357275|FG001|Overall Study|Other|2|||
130108365|NCT03185949|468357276|FG000|ITT Analysis|Withdrawal by Subject|4|||
130108366|NCT03185949|468357277|FG001|ITT Analysis|Withdrawal by Subject|3|||
130108367|NCT03185949|468357276|FG000|PP Analysis|Protocol Violation|2|||
130108368|NCT03185949|468357277|FG001|PP Analysis|Protocol Violation|2|||
130108369|NCT03185949|468357276|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
130108370|NCT03185949|468357277|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
130108371|NCT05166421|468357286|FG000|Overall Study|Other|3|||
130108372|NCT05166421|468357287|FG001|Overall Study|Other|1|||
130108373|NCT05166421|468357288|FG002|Overall Study|Other|1|||
130108374|NCT05166421|468357286|FG000|Overall Study|Withdrawal by Subject|5|||
130108375|NCT05166421|468357287|FG001|Overall Study|Withdrawal by Subject|3|||
130108376|NCT05166421|468357288|FG002|Overall Study|Withdrawal by Subject|6|||
130108377|NCT05166421|468357286|FG000|Overall Study|Lost to Follow-up|4|||
130108378|NCT05166421|468357287|FG001|Overall Study|Lost to Follow-up|1|||
130108379|NCT05166421|468357288|FG002|Overall Study|Lost to Follow-up|7|||
130108380|NCT03053622|468358860|FG000|Overall Study|Lost to Follow-up|0|||
130108381|NCT03053622|468358861|FG001|Overall Study|Lost to Follow-up|0|||
130108382|NCT03053622|468358862|FG002|Overall Study|Lost to Follow-up|0|||
130108383|NCT03053622|468358863|FG003|Overall Study|Lost to Follow-up|1|||
130108384|NCT02598622|468358864|FG000|Overall Study|Withdrawal by Subject|3|||
130108385|NCT02598622|468358865|FG001|Overall Study|Withdrawal by Subject|0|||
130108386|NCT02598622|468358864|FG000|Overall Study|Physician Decision|3|||
130108387|NCT02598622|468358865|FG001|Overall Study|Physician Decision|0|||
130108388|NCT01355523|468358869|FG000|Overall Study|Withdrawal by Subject|1|||
130108389|NCT01355523|468358870|FG001|Overall Study|Withdrawal by Subject|4|||
130305997|NCT02305238|469083518|FG000|Overall Study|Randomized failure|0|||
130305998|NCT02305238|469083519|FG001|Overall Study|Randomized failure|0|||
130108390|NCT01355523|468358869|FG000|Overall Study|Lost to Follow-up|0|||
130108391|NCT01355523|468358870|FG001|Overall Study|Lost to Follow-up|2|||
130305999|NCT02305238|469083520|FG002|Overall Study|Randomized failure|8|||
130108392|NCT01355523|468358869|FG000|Overall Study|Protocol Violation|0|||
130108393|NCT01355523|468358870|FG001|Overall Study|Protocol Violation|2|||
130108394|NCT01355523|468358869|FG000|Overall Study|Adverse Event|0|||
130108395|NCT01355523|468358870|FG001|Overall Study|Adverse Event|2|||
130108396|NCT01835470|468358871|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
130108397|NCT01835470|468358871|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
130108398|NCT01272193|468358872|FG000|Overall Study|Adverse Event|1|||
130108399|NCT01272193|468358873|FG001|Overall Study|Adverse Event|1|||
130108400|NCT01272193|468358872|FG000|Overall Study|Lack of Efficacy|0|||
130108401|NCT01272193|468358873|FG001|Overall Study|Lack of Efficacy|3|||
130108402|NCT01272193|468358872|FG000|Overall Study|Withdrawal Criteria|1|||
130108403|NCT01272193|468358873|FG001|Overall Study|Withdrawal Criteria|1|||
130108404|NCT01272193|468358872|FG000|Overall Study|Unclassified|8|||
130108405|NCT01272193|468358873|FG001|Overall Study|Unclassified|7|||
130306000|NCT02305238|469083518|FG000|Overall Study|Required procedure failed|0|||
130306001|NCT02305238|469083519|FG001|Overall Study|Required procedure failed|1|||
130306002|NCT02305238|469083520|FG002|Overall Study|Required procedure failed|0|||
130306003|NCT01019369|469083521|FG000|Overall Study|Lost to Follow-up|10|||
130306004|NCT01019369|469083522|FG001|Overall Study|Lost to Follow-up|6|||
130306005|NCT01019369|469083521|FG000|Overall Study|Withdrawal by Subject|0|||
130306006|NCT01019369|469083522|FG001|Overall Study|Withdrawal by Subject|1|||
130306007|NCT02513472|469083523|FG000|Overall Study|Radiological Disease Progression|45|||
130306008|NCT02513472|469083524|FG001|Overall Study|Radiological Disease Progression|57|||
130306009|NCT02513472|469083523|FG000|Overall Study|Clinical Disease Progression|5|||
130306010|NCT02513472|469083524|FG001|Overall Study|Clinical Disease Progression|13|||
130306011|NCT02513472|469083523|FG000|Overall Study|Adverse Event|8|||
130306012|NCT02513472|469083524|FG001|Overall Study|Adverse Event|11|||
130306013|NCT02513472|469083523|FG000|Overall Study|Withdrawal by Subject|0|||
130306014|NCT02513472|469083524|FG001|Overall Study|Withdrawal by Subject|4|||
130306015|NCT02513472|469083523|FG000|Overall Study|Subject Choice|2|||
130306016|NCT02513472|469083524|FG001|Overall Study|Subject Choice|7|||
130306017|NCT02513472|469083523|FG000|Overall Study|Treatment Completed as per Protocol|3|||
130306018|NCT02513472|469083524|FG001|Overall Study|Treatment Completed as per Protocol|3|||
130306019|NCT02513472|469083523|FG000|Overall Study|Other|3|||
130306020|NCT02513472|469083524|FG001|Overall Study|Other|6|||
129797772|NCT03416374|467228223|FG000|Between Treatment Period I and II|Other|0|||
129797773|NCT03416374|467228224|FG001|Between Treatment Period I and II|Other|9|||
129797774|NCT03416374|467228223|FG000|Treatment Period II|Lack of Efficacy|3|||
129797775|NCT03416374|467228224|FG001|Treatment Period II|Lack of Efficacy|11|||
129797776|NCT03416374|467228223|FG000|Treatment Period II|Adverse Event|1|||
129797777|NCT03416374|467228224|FG001|Treatment Period II|Adverse Event|4|||
129797778|NCT03416374|467228223|FG000|Treatment Period II|Death|0|||
129797779|NCT03416374|467228224|FG001|Treatment Period II|Death|1|||
129797780|NCT03416374|467228223|FG000|Treatment Period II|Other|0|||
129797781|NCT03416374|467228224|FG001|Treatment Period II|Other|2|||
129797782|NCT03583164|467228225|FG000|Overall Study|Death in Main Phase|35|||
129797783|NCT03583164|467228225|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
129797784|NCT03583164|467228225|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
129797785|NCT03583164|467228225|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
129797786|NCT03583164|467228225|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
129797787|NCT03583164|467228225|FG000|Overall Study|Physician decision in Main Phase|1|||
129797788|NCT03583164|467228225|FG000|Overall Study|Physician decision in Extended Phase|2|||
129797789|NCT03583164|467228225|FG000|Overall Study|Death in Extended Phase|13|||
129797790|NCT03583164|467228225|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
129797791|NCT03583164|467228225|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
129797792|NCT03583164|467228225|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
129797793|NCT03583164|467228225|FG000|Overall Study|Treatment failure in Main Phase|2|||
129797794|NCT03583164|467228225|FG000|Overall Study|Treatment failure in Extended Phase|4|||
129797795|NCT03583164|467228225|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
129797796|NCT03583164|467228225|FG000|Overall Study|Other not specified reason in Main Phase|2|||
129797797|NCT00559754|467228226|FG000|Overall Study|Disease progression|1|||
129797798|NCT00559754|467228226|FG000|Overall Study|Adverse Event|5|||
129797799|NCT00559754|467228226|FG000|Overall Study|Protocol Violation|1|||
130306021|NCT01380834|469083525|FG000|Overall Study|Physician Decision|1|||
130306022|NCT01380834|469083526|FG001|Overall Study|Physician Decision|0|||
130306023|NCT04310566|469083527|FG000|Period 1|Study Termination due to COVID-19|15|||
129797800|NCT00559754|467228226|FG000|Overall Study|Investigator criteria|2|||
129797801|NCT00559754|467228226|FG000|Overall Study|Withdrawal by Subject|2|||
129797802|NCT00214500|467228231|FG000|Treatment Period|Adverse Event|1|||
129797803|NCT00214500|467228231|FG000|Extension Period|Withdrawal by Subject|2|||
129797804|NCT02537574|467228233|FG000|Overall Study|Adverse Event|1|||
129797805|NCT02537574|467228234|FG001|Overall Study|Adverse Event|3|||
130108406|NCT01440647|468358874|FG000|Overall Study|Death|2|||
130108407|NCT01440647|468358875|FG001|Overall Study|Death|3|||
130108408|NCT04335110|468358893|FG000|Overall Study|Withdrawal by Subject|1|||
130108409|NCT04335110|468358894|FG001|Overall Study|Withdrawal by Subject|1|||
130306024|NCT04310566|469083528|FG001|Period 1|Study Termination due to COVID-19|17|||
130306025|NCT04310566|469083527|FG000|Period 1|Protocol Violation|0|||
130306026|NCT04310566|469083528|FG001|Period 1|Protocol Violation|1|||
130306027|NCT04310566|469083527|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
130306028|NCT04310566|469083528|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
130306029|NCT04310566|469083527|FG000|Period 1|Lost to Follow-up|1|||
130306030|NCT04310566|469083528|FG001|Period 1|Lost to Follow-up|0|||
130306031|NCT04310566|469083527|FG000|Period 1|Withdrawal by Subject|0|||
130306032|NCT04310566|469083528|FG001|Period 1|Withdrawal by Subject|1|||
130306033|NCT04310566|469083527|FG000|Period 2|Study Termination|7|||
130306034|NCT04310566|469083528|FG001|Period 2|Study Termination|5|||
130306035|NCT04565951|469083529|FG000|Overall Study|Lost to Follow-up|66|||
130306036|NCT04565951|469083530|FG001|Overall Study|Lost to Follow-up|38|||
130306037|NCT04565951|469083529|FG000|Overall Study|Withdrawal by Subject|14|||
130108410|NCT04335110|468358893|FG000|Overall Study|Death|0|||
130108411|NCT04335110|468358894|FG001|Overall Study|Death|1|||
130108412|NCT02595528|468358895|FG000|Overall Study|Withdrawal by Subject|1|||
130108413|NCT02595528|468358896|FG001|Overall Study|Withdrawal by Subject|2|||
130108414|NCT02595528|468358897|FG002|Overall Study|Withdrawal by Subject|1|||
130108415|NCT02595528|468358898|FG003|Overall Study|Withdrawal by Subject|3|||
130108416|NCT02595528|468358895|FG000|Overall Study|Lost to Follow-up|1|||
130108417|NCT02595528|468358896|FG001|Overall Study|Lost to Follow-up|1|||
130108418|NCT02595528|468358897|FG002|Overall Study|Lost to Follow-up|0|||
130108419|NCT02595528|468358898|FG003|Overall Study|Lost to Follow-up|1|||
130108420|NCT00096382|468358899|FG000|Overall Study|Not treated|1|||
130108421|NCT00096382|468358900|FG001|Overall Study|Not treated|0|||
130108422|NCT00096382|468358899|FG000|Overall Study|Death during treatment|1|||
130108423|NCT00096382|468358900|FG001|Overall Study|Death during treatment|0|||
130108424|NCT00948025|468358902|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
130108425|NCT00948025|468358903|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
130108426|NCT00948025|468358902|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
130108427|NCT00948025|468358903|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
130108428|NCT00948025|468358902|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
130108429|NCT00948025|468358903|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
130108430|NCT01326702|468358904|FG000|Overall Study|Other|1|||
130108431|NCT01326702|468358905|FG001|Overall Study|Other|0|||
130108432|NCT01326702|468358906|FG002|Overall Study|Other|0|||
130108433|NCT01326702|468358907|FG003|Overall Study|Other|0|||
130108434|NCT01326702|468358908|FG004|Overall Study|Other|0|||
130108435|NCT01326702|468358909|FG005|Overall Study|Other|1|||
130108436|NCT01326702|468358910|FG006|Overall Study|Other|0|||
130108437|NCT01326702|468358904|FG000|Overall Study|progressive disease|1|||
130108438|NCT01326702|468358905|FG001|Overall Study|progressive disease|1|||
130108439|NCT01326702|468358906|FG002|Overall Study|progressive disease|3|||
130108440|NCT01326702|468358907|FG003|Overall Study|progressive disease|1|||
130108441|NCT01326702|468358908|FG004|Overall Study|progressive disease|3|||
130108442|NCT01326702|468358909|FG005|Overall Study|progressive disease|2|||
130108443|NCT01326702|468358910|FG006|Overall Study|progressive disease|3|||
130108444|NCT01326702|468358904|FG000|Overall Study|Death|0|||
130306038|NCT04565951|469083530|FG001|Overall Study|Withdrawal by Subject|7|||
130306039|NCT04565951|469083529|FG000|Overall Study|Death|0|||
130306040|NCT04565951|469083530|FG001|Overall Study|Death|1|||
130306041|NCT00429169|469083539|FG000|Overall Study|Lost to Follow-up|0|||
130306042|NCT00429169|469083540|FG001|Overall Study|Lost to Follow-up|1|||
130306043|NCT00429169|469083539|FG000|Overall Study|Ineligibility discovered after entry|2|||
130306044|NCT00429169|469083540|FG001|Overall Study|Ineligibility discovered after entry|1|||
130108445|NCT01326702|468358905|FG001|Overall Study|Death|1|||
130306045|NCT01711645|469083541|FG000|Overall Study|Withdrawal by Subject|8|||
130306046|NCT01711645|469083541|FG000|Overall Study|Lost to Follow-up|6|||
130306047|NCT01711645|469083541|FG000|Overall Study|Physician Decision|5|||
130306048|NCT01746173|469083547|FG000|Overall Study|Disease Progression|2|||
130306049|NCT01371552|469083551|FG000|Part 1, First 3 Days|Inconvenience|0|||
129797806|NCT02537574|467228235|FG002|Overall Study|Adverse Event|2|||
130306050|NCT01371552|469083552|FG001|Part 1, First 3 Days|Inconvenience|0|||
130306051|NCT01371552|469083553|FG002|Part 1, First 3 Days|Inconvenience|1|||
130306052|NCT01371552|469083554|FG003|Part 1, First 3 Days|Inconvenience|0|||
130306053|NCT01371552|469083555|FG004|Part 1, First 3 Days|Inconvenience|0|||
130108446|NCT01326702|468358906|FG002|Overall Study|Death|0|||
130108447|NCT01326702|468358907|FG003|Overall Study|Death|0|||
130108448|NCT01326702|468358908|FG004|Overall Study|Death|0|||
130108449|NCT01326702|468358909|FG005|Overall Study|Death|0|||
130108450|NCT01326702|468358910|FG006|Overall Study|Death|0|||
130108451|NCT01326702|468358904|FG000|Overall Study|Adverse Event|0|||
130108452|NCT01326702|468358905|FG001|Overall Study|Adverse Event|0|||
130108453|NCT01326702|468358906|FG002|Overall Study|Adverse Event|1|||
130108454|NCT01326702|468358907|FG003|Overall Study|Adverse Event|1|||
130108455|NCT01326702|468358908|FG004|Overall Study|Adverse Event|0|||
130108456|NCT01326702|468358909|FG005|Overall Study|Adverse Event|3|||
130306054|NCT01371552|469083556|FG005|Part 1, First 3 Days|Inconvenience|0|||
130306055|NCT02328027|469083557|FG000|Overall Study|Withdrawal by Subject|0|||
130306056|NCT02328027|469083558|FG001|Overall Study|Withdrawal by Subject|1|||
130306057|NCT03304873|469083559|FG000|Overall Study|Lost to Follow-up|1|||
130306058|NCT03304873|469083560|FG001|Overall Study|Lost to Follow-up|8|||
130306059|NCT03319212|469083561|FG000|Overall Study|Discontinued as moving out of local area|0|||
130306060|NCT03319212|469083562|FG001|Overall Study|Discontinued as moving out of local area|1|||
130306061|NCT03319212|469083561|FG000|Overall Study|Adverse Event|2|||
130306062|NCT03319212|469083562|FG001|Overall Study|Adverse Event|2|||
130306063|NCT03319212|469083561|FG000|Overall Study|Withdrawal by Subject|0|||
129889346|NCT03259373|467552563|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
129889347|NCT04894903|467552564|FG000|Overall Study|Death|1|||
130048322|NCT00723840|468133199|FG000|Overall Study|Unspecified reason|2|||
130048323|NCT02853331|468133205|FG000|Overall Study|Death|59|||
130048324|NCT02853331|468133206|FG001|Overall Study|Death|95|||
130048325|NCT02853331|468133205|FG000|Overall Study|Withdrawal by Subject|5|||
130048326|NCT02853331|468133206|FG001|Overall Study|Withdrawal by Subject|9|||
130048327|NCT02853331|468133205|FG000|Overall Study|Ongoing in study|368|||
130048328|NCT02853331|468133206|FG001|Overall Study|Ongoing in study|325|||
130048329|NCT03290300|468133213|FG000|Overall Study|Lost to Follow-up|3|||
130048330|NCT00487279|468133217|FG000|Overall Study|Death|1|||
130048331|NCT00487279|468133218|FG001|Overall Study|Death|0|||
130048332|NCT00487279|468133217|FG000|Overall Study|Withdrawal by Subject|0|||
130048333|NCT00487279|468133218|FG001|Overall Study|Withdrawal by Subject|2|||
130048334|NCT01618656|468133220|FG000|Overall Study|Withdrawal by Subject|7|||
130048335|NCT01618656|468133221|FG001|Overall Study|Withdrawal by Subject|3|||
130048336|NCT01618656|468133220|FG000|Overall Study|Physician Decision|1|||
130048337|NCT01618656|468133221|FG001|Overall Study|Physician Decision|1|||
130048338|NCT01899144|468133222|FG000|Treatment Period 2|Other|1|||
130048339|NCT01899144|468133222|FG000|Treatment Period 3|Other|2|||
130048340|NCT01899144|468133222|FG000|Treatment Period 5|Other|1|||
130048341|NCT00751881|468133223|FG000|Core Treatment Period|Not treated|1|||
130048342|NCT00751881|468133224|FG001|Core Treatment Period|Not treated|1|||
130048343|NCT00751881|468133225|FG002|Core Treatment Period|Not treated|2|||
130048344|NCT00751881|468133223|FG000|Core Treatment Period|Adverse Event|26|||
130048345|NCT00751881|468133224|FG001|Core Treatment Period|Adverse Event|54|||
130048346|NCT00751881|468133225|FG002|Core Treatment Period|Adverse Event|58|||
130048347|NCT00751881|468133223|FG000|Core Treatment Period|Lack of Efficacy|37|||
130048348|NCT00751881|468133224|FG001|Core Treatment Period|Lack of Efficacy|30|||
130048349|NCT00751881|468133225|FG002|Core Treatment Period|Lack of Efficacy|20|||
130048350|NCT00751881|468133223|FG000|Core Treatment Period|Poor compliance to protocol|15|||
130048351|NCT00751881|468133224|FG001|Core Treatment Period|Poor compliance to protocol|3|||
130048352|NCT00751881|468133225|FG002|Core Treatment Period|Poor compliance to protocol|4|||
130048353|NCT00751881|468133223|FG000|Core Treatment Period|Lost to Follow-up|6|||
130048354|NCT00751881|468133224|FG001|Core Treatment Period|Lost to Follow-up|4|||
130048355|NCT00751881|468133225|FG002|Core Treatment Period|Lost to Follow-up|3|||
130048356|NCT00751881|468133223|FG000|Core Treatment Period|Other: protocol deviation|3|||
130048357|NCT00751881|468133224|FG001|Core Treatment Period|Other: protocol deviation|3|||
130048358|NCT00751881|468133225|FG002|Core Treatment Period|Other: protocol deviation|7|||
130048359|NCT00751881|468133223|FG000|Core Treatment Period|Other: wish to parent|5|||
130048360|NCT00751881|468133224|FG001|Core Treatment Period|Other: wish to parent|7|||
130048361|NCT00751881|468133225|FG002|Core Treatment Period|Other: wish to parent|4|||
130048362|NCT00751881|468133223|FG000|Core Treatment Period|Other: personal/family constraints|6|||
130048363|NCT00751881|468133224|FG001|Core Treatment Period|Other: personal/family constraints|7|||
130048364|NCT00751881|468133225|FG002|Core Treatment Period|Other: personal/family constraints|10|||
130048365|NCT00751881|468133223|FG000|Core Treatment Period|Other: MS treatment change|6|||
130048366|NCT00751881|468133224|FG001|Core Treatment Period|Other: MS treatment change|4|||
130048367|NCT00751881|468133225|FG002|Core Treatment Period|Other: MS treatment change|4|||
130048368|NCT00751881|468133223|FG000|Core Treatment Period|Other: tolerability complaints|2|||
130048369|NCT00751881|468133224|FG001|Core Treatment Period|Other: tolerability complaints|0|||
130048370|NCT00751881|468133225|FG002|Core Treatment Period|Other: tolerability complaints|0|||
130048371|NCT00751881|468133223|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
130048372|NCT00751881|468133224|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
130048373|NCT00751881|468133225|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
130048374|NCT00751881|468133223|FG000|Extension Study Period|Adverse Event|18|||
130048375|NCT00751881|468133224|FG001|Extension Study Period|Adverse Event|20|||
130048376|NCT00751881|468133225|FG002|Extension Study Period|Adverse Event|21|||
130048377|NCT00751881|468133223|FG000|Extension Study Period|Lack of Efficacy|14|||
130048378|NCT00751881|468133224|FG001|Extension Study Period|Lack of Efficacy|10|||
130306064|NCT03319212|469083562|FG001|Overall Study|Withdrawal by Subject|1|||
130306065|NCT03319212|469083561|FG000|Overall Study|Lost to Follow-up|0|||
129889348|NCT04894903|467552565|FG001|Overall Study|Death|0|||
130048379|NCT00751881|468133225|FG002|Extension Study Period|Lack of Efficacy|20|||
130048380|NCT00751881|468133223|FG000|Extension Study Period|Lost to Follow-up|4|||
130048381|NCT00751881|468133224|FG001|Extension Study Period|Lost to Follow-up|9|||
130048382|NCT00751881|468133225|FG002|Extension Study Period|Lost to Follow-up|6|||
130108457|NCT01326702|468358910|FG006|Overall Study|Adverse Event|1|||
130108458|NCT01326702|468358904|FG000|Overall Study|Withdrawal by Subject|0|||
130108459|NCT01326702|468358905|FG001|Overall Study|Withdrawal by Subject|0|||
130108460|NCT01326702|468358906|FG002|Overall Study|Withdrawal by Subject|1|||
130108461|NCT01326702|468358907|FG003|Overall Study|Withdrawal by Subject|0|||
130306066|NCT03319212|469083562|FG001|Overall Study|Lost to Follow-up|1|||
130108462|NCT01326702|468358908|FG004|Overall Study|Withdrawal by Subject|1|||
130108463|NCT01326702|468358909|FG005|Overall Study|Withdrawal by Subject|1|||
130108464|NCT01326702|468358910|FG006|Overall Study|Withdrawal by Subject|3|||
130108465|NCT01326702|468358904|FG000|Overall Study|Not Treated|0|||
130108466|NCT01326702|468358905|FG001|Overall Study|Not Treated|0|||
130108467|NCT01326702|468358906|FG002|Overall Study|Not Treated|0|||
130306067|NCT03319212|469083561|FG000|Overall Study|Physician Decision|1|||
130306068|NCT03319212|469083562|FG001|Overall Study|Physician Decision|0|||
130306069|NCT00250276|469083563|FG000|Overall Study|Serious Adverse Event|0|||
130306070|NCT00250276|469083564|FG001|Overall Study|Serious Adverse Event|0|||
130306071|NCT00250276|469083565|FG002|Overall Study|Serious Adverse Event|1|||
130306072|NCT00250276|469083566|FG003|Overall Study|Serious Adverse Event|0|||
130306073|NCT00250276|469083563|FG000|Overall Study|Non-serious Adverse Event|2|||
130306074|NCT00250276|469083564|FG001|Overall Study|Non-serious Adverse Event|0|||
130306075|NCT00250276|469083565|FG002|Overall Study|Non-serious Adverse Event|0|||
130306076|NCT00250276|469083566|FG003|Overall Study|Non-serious Adverse Event|2|||
130306077|NCT00250276|469083563|FG000|Overall Study|Protocol Violation|0|||
130306078|NCT00250276|469083564|FG001|Overall Study|Protocol Violation|1|||
130306079|NCT00250276|469083565|FG002|Overall Study|Protocol Violation|0|||
130306080|NCT00250276|469083566|FG003|Overall Study|Protocol Violation|0|||
130306081|NCT00250276|469083563|FG000|Overall Study|Withdrawal by Subject|1|||
130306082|NCT00250276|469083564|FG001|Overall Study|Withdrawal by Subject|2|||
130306083|NCT00250276|469083565|FG002|Overall Study|Withdrawal by Subject|3|||
130306084|NCT00250276|469083566|FG003|Overall Study|Withdrawal by Subject|2|||
130108468|NCT01326702|468358907|FG003|Overall Study|Not Treated|1|||
130108469|NCT01326702|468358908|FG004|Overall Study|Not Treated|0|||
130108470|NCT01326702|468358909|FG005|Overall Study|Not Treated|1|||
130108471|NCT01326702|468358910|FG006|Overall Study|Not Treated|0|||
130108472|NCT03333382|468358921|FG000|Overall Study|Lost to Follow-up|1|||
130108473|NCT03333382|468358922|FG001|Overall Study|Lost to Follow-up|0|||
130108474|NCT00550420|468358923|FG000|Overall Study|Adverse Event|28|||
130108475|NCT00550420|468358923|FG000|Overall Study|Lost to Follow-up|8|||
130108476|NCT00550420|468358923|FG000|Overall Study|Protocol Violation|11|||
130108477|NCT00550420|468358923|FG000|Overall Study|Withdrawal by Subject|30|||
130108478|NCT00550420|468358923|FG000|Overall Study|Still in study at termination|206|||
130108479|NCT00550420|468358923|FG000|Overall Study|Missing|2|||
130108480|NCT00550420|468358923|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
130108481|NCT00550420|468358923|FG000|Overall Study|Investigators opinion|1|||
130108482|NCT00550420|468358923|FG000|Overall Study|Lack of curative effect|1|||
130108483|NCT00550420|468358923|FG000|Overall Study|Unethical stop of enrollment|2|||
130108484|NCT00550420|468358923|FG000|Overall Study|Caregiver's decision to withdraw|1|||
130108485|NCT00550420|468358923|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
130108486|NCT00550420|468358923|FG000|Overall Study|Exclusion criteria|1|||
130108487|NCT00550420|468358923|FG000|Overall Study|Prohibited medicine|1|||
130108488|NCT02773446|468358929|FG000|First Admission|Withdrawal by Subject|0|||
130108489|NCT02773446|468358930|FG001|First Admission|Withdrawal by Subject|0|||
130108490|NCT02773446|468358931|FG002|First Admission|Withdrawal by Subject|0|||
130108491|NCT02773446|468358932|FG003|First Admission|Withdrawal by Subject|1|||
130108492|NCT02773446|468358933|FG004|First Admission|Withdrawal by Subject|0|||
130108493|NCT02773446|468358934|FG005|First Admission|Withdrawal by Subject|0|||
130108494|NCT02773446|468358929|FG000|First Admission|Lost to Follow-up|1|||
130108495|NCT02773446|468358930|FG001|First Admission|Lost to Follow-up|0|||
130108496|NCT02773446|468358931|FG002|First Admission|Lost to Follow-up|0|||
130108497|NCT02773446|468358932|FG003|First Admission|Lost to Follow-up|0|||
130108498|NCT02773446|468358933|FG004|First Admission|Lost to Follow-up|0|||
130108499|NCT02773446|468358934|FG005|First Admission|Lost to Follow-up|0|||
130108500|NCT04378010|468358935|FG000|Overall Study|Adverse Event|8|||
130108501|NCT04378010|468358936|FG001|Overall Study|Adverse Event|14|||
130108502|NCT04378010|468358937|FG002|Overall Study|Adverse Event|4|||
130108503|NCT04378010|468358935|FG000|Overall Study|Withdrawal by Subject|0|||
130108504|NCT04378010|468358936|FG001|Overall Study|Withdrawal by Subject|2|||
130306085|NCT00250276|469083563|FG000|Overall Study|Migrated/moved from study area|3|||
130108505|NCT04378010|468358937|FG002|Overall Study|Withdrawal by Subject|1|||
130108506|NCT04378010|468358935|FG000|Overall Study|Protocol Violation|2|||
130108507|NCT04378010|468358936|FG001|Overall Study|Protocol Violation|1|||
130108508|NCT04378010|468358937|FG002|Overall Study|Protocol Violation|4|||
130108509|NCT04378010|468358935|FG000|Overall Study|Study terminated by Sponsor|22|||
130306086|NCT00250276|469083564|FG001|Overall Study|Migrated/moved from study area|0|||
130108510|NCT04378010|468358936|FG001|Overall Study|Study terminated by Sponsor|16|||
130108511|NCT04378010|468358937|FG002|Overall Study|Study terminated by Sponsor|22|||
130108512|NCT04378010|468358935|FG000|Overall Study|Subject inability to complete study visit|0|||
130108513|NCT04378010|468358936|FG001|Overall Study|Subject inability to complete study visit|0|||
130108514|NCT04378010|468358937|FG002|Overall Study|Subject inability to complete study visit|1|||
130108515|NCT04378010|468358935|FG000|Overall Study|Subject never dosed|0|||
130108516|NCT04378010|468358936|FG001|Overall Study|Subject never dosed|1|||
130108517|NCT04378010|468358937|FG002|Overall Study|Subject never dosed|0|||
130108518|NCT02513459|468358938|FG000|Overall Study|Adverse Event|7|||
130108519|NCT02513459|468358938|FG000|Overall Study|Withdrew consent|5|||
130108520|NCT02513459|468358938|FG000|Overall Study|Loss of efficacy|2|||
130306087|NCT00250276|469083565|FG002|Overall Study|Migrated/moved from study area|2|||
130306088|NCT00250276|469083566|FG003|Overall Study|Migrated/moved from study area|7|||
130306089|NCT00250276|469083563|FG000|Overall Study|Lost to Follow-up|11|||
130306090|NCT00250276|469083564|FG001|Overall Study|Lost to Follow-up|18|||
130306091|NCT00250276|469083565|FG002|Overall Study|Lost to Follow-up|13|||
130306092|NCT00250276|469083566|FG003|Overall Study|Lost to Follow-up|8|||
130306093|NCT01546688|469083567|FG000|Overall Study|Adverse Event|0|||
130306094|NCT01546688|469083568|FG001|Overall Study|Adverse Event|4|||
130306095|NCT01546688|469083567|FG000|Overall Study|Withdrawal by Subject|2|||
130108521|NCT02513459|468358938|FG000|Overall Study|Pregnancy|2|||
130108522|NCT02513459|468358938|FG000|Overall Study|Subject decision|2|||
130108523|NCT02513459|468358938|FG000|Overall Study|Lack of response|1|||
130108524|NCT02513459|468358938|FG000|Overall Study|Reproductive plans|1|||
130108525|NCT02513459|468358938|FG000|Overall Study|Surgery planned-- not done|1|||
130108526|NCT03237611|468358939|FG000|Overall Study|Withdrawal by Subject|1|||
130108527|NCT03237611|468358939|FG000|Overall Study|Ineligible|1|||
130108528|NCT04023994|468358940|FG000|Overall Study|Lost to Follow-up|0|||
130108529|NCT04023994|468358941|FG001|Overall Study|Lost to Follow-up|1|||
130306096|NCT01546688|469083568|FG001|Overall Study|Withdrawal by Subject|1|||
130306097|NCT01546688|469083567|FG000|Overall Study|Lack of Efficacy|1|||
130306098|NCT01546688|469083568|FG001|Overall Study|Lack of Efficacy|0|||
130306099|NCT01811186|469083569|FG000|Overall Study|Adverse Event|54|||
130306100|NCT01811186|469083570|FG001|Overall Study|Adverse Event|38|||
130306101|NCT01811186|469083569|FG000|Overall Study|Protocol Violation|5|||
130306102|NCT01811186|469083570|FG001|Overall Study|Protocol Violation|6|||
130306103|NCT01811186|469083569|FG000|Overall Study|Withdrawal by Subject|5|||
130306104|NCT01811186|469083570|FG001|Overall Study|Withdrawal by Subject|10|||
130306105|NCT01811186|469083569|FG000|Overall Study|Lack of Efficacy|3|||
130306106|NCT01811186|469083570|FG001|Overall Study|Lack of Efficacy|6|||
130306107|NCT01811186|469083569|FG000|Overall Study|Lost to Follow-up|4|||
130306108|NCT01811186|469083570|FG001|Overall Study|Lost to Follow-up|2|||
130306109|NCT03369236|469083571|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
130306110|NCT03369236|469083572|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
130306111|NCT03369236|469083571|FG000|Open-label Extension Period|Lack of Efficacy|2|||
130306112|NCT03369236|469083572|FG001|Open-label Extension Period|Lack of Efficacy|1|||
130306113|NCT03369236|469083571|FG000|Open-label Extension Period|Adverse Event|0|||
130306114|NCT03369236|469083572|FG001|Open-label Extension Period|Adverse Event|1|||
130306115|NCT03369236|469083571|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
130306116|NCT03369236|469083572|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
130306117|NCT01153724|469083575|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130306118|NCT01153724|469083575|FG000|Treatment Period 2|Adverse Event|1|||
130306119|NCT01153724|469083575|FG000|Treatment Period 2|Other reason not defined above|1|||
130306120|NCT02508428|469083586|FG000|Overall Study|Death|32|||
130306121|NCT02508428|469083587|FG001|Overall Study|Death|33|||
130306122|NCT02508428|469083586|FG000|Overall Study|Liner revised|3|||
130306123|NCT02508428|469083587|FG001|Overall Study|Liner revised|19|||
130306124|NCT02508428|469083586|FG000|Overall Study|Incomplete follow-up|17|||
130108530|NCT04023994|468358942|FG002|Overall Study|Lost to Follow-up|2|||
130108531|NCT04023994|468358943|FG003|Overall Study|Lost to Follow-up|0|||
130108532|NCT04023994|468358944|FG004|Overall Study|Lost to Follow-up|0|||
130108533|NCT04023994|468358945|FG005|Overall Study|Lost to Follow-up|0|||
130108534|NCT04023994|468358940|FG000|Overall Study|Withdrawal by Subject|0|||
130108535|NCT04023994|468358941|FG001|Overall Study|Withdrawal by Subject|0|||
130108536|NCT04023994|468358942|FG002|Overall Study|Withdrawal by Subject|0|||
130108537|NCT04023994|468358943|FG003|Overall Study|Withdrawal by Subject|1|||
130108538|NCT04023994|468358944|FG004|Overall Study|Withdrawal by Subject|0|||
130108539|NCT04023994|468358945|FG005|Overall Study|Withdrawal by Subject|0|||
130306125|NCT02508428|469083587|FG001|Overall Study|Incomplete follow-up|15|||
130306126|NCT00534976|469083592|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
130306127|NCT00534976|469083593|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
130306128|NCT00534976|469083592|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
130306129|NCT00534976|469083593|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
130306130|NCT00534976|469083592|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
130306131|NCT00534976|469083593|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
130108540|NCT00923195|468358946|FG000|Overall Study|Death|0|||
130108541|NCT00923195|468358947|FG001|Overall Study|Death|1|||
130108542|NCT01613131|468358950|FG000|Overall Study|Withdrawal by Subject|3|||
130108543|NCT01613131|468358951|FG001|Overall Study|Withdrawal by Subject|5|||
130108544|NCT00787566|468358952|FG000|Overall Study|AE related to chemotherapy|0|||
130108545|NCT00787566|468358953|FG001|Overall Study|AE related to chemotherapy|1|||
130306132|NCT02123576|469083594|FG000|Overall Study|Adverse Event|1|||
130306133|NCT02123576|469083595|FG001|Overall Study|Adverse Event|0|||
130306134|NCT00934128|469083596|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
130306135|NCT00934128|469083597|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
130306136|NCT00934128|469083596|FG000|First Intervention (2 Hours)|Adverse Event|4|||
130306137|NCT00934128|469083597|FG001|First Intervention (2 Hours)|Adverse Event|1|||
130306138|NCT00934128|469083596|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
130306139|NCT00934128|469083597|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
130306140|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Patient preference|1|||
130306141|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Patient preference|3|||
130306142|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Pain|1|||
130306143|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Pain|0|||
130306144|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Too tired|1|||
130306145|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Too tired|0|||
130306146|NCT00934128|469083596|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
130306147|NCT00934128|469083597|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
130108546|NCT00787566|468358954|FG002|Overall Study|AE related to chemotherapy|0|||
130108547|NCT01814761|468358955|FG000|Overall Study|Other Reasons|1|||
130108548|NCT01814761|468358956|FG001|Overall Study|Other Reasons|10|||
130108549|NCT01814761|468358955|FG000|Overall Study|Ocular Adverse Event|6|||
130108550|NCT01814761|468358956|FG001|Overall Study|Ocular Adverse Event|15|||
130108551|NCT01814761|468358955|FG000|Overall Study|Lost to Follow-up|1|||
130108552|NCT01814761|468358956|FG001|Overall Study|Lost to Follow-up|5|||
130108553|NCT02444182|468358964|FG000|Overall Study|non-compliance|2|||
130108554|NCT02444182|468358965|FG001|Overall Study|non-compliance|1|||
130108555|NCT02444182|468358964|FG000|Overall Study|Lost to Follow-up|0|||
130108556|NCT02444182|468358965|FG001|Overall Study|Lost to Follow-up|4|||
130108557|NCT01169987|468358968|FG000|Overall Study|Withdrawal by Subject|3|||
130108558|NCT01169987|468358968|FG000|Overall Study|Lost to Follow-up|24|||
130108559|NCT01169987|468358968|FG000|Overall Study|Other|4|||
130306148|NCT00934128|469083596|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
130306149|NCT00934128|469083597|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
130306150|NCT02834247|469083598|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
130306151|NCT02834247|469083599|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
130306152|NCT02834247|469083600|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
130306153|NCT02834247|469083601|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
130306154|NCT02834247|469083598|FG000|Dose Escalation Phase|Death|5|||
130306155|NCT02834247|469083599|FG001|Dose Escalation Phase|Death|6|||
130306156|NCT02834247|469083600|FG002|Dose Escalation Phase|Death|5|||
130306157|NCT02834247|469083601|FG003|Dose Escalation Phase|Death|0|||
130306158|NCT02834247|469083598|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
130306159|NCT02834247|469083599|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
130306160|NCT02834247|469083600|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
130306161|NCT02834247|469083601|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
130306162|NCT02834247|469083598|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
130306163|NCT02834247|469083599|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
130306164|NCT02834247|469083600|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130306165|NCT02834247|469083601|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130306166|NCT02834247|469083598|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130306167|NCT02834247|469083599|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130306168|NCT02834247|469083600|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
130306169|NCT02834247|469083601|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
130306170|NCT02834247|469083598|FG000|Dose Expansion Phase|Death|0|||
130306171|NCT02834247|469083599|FG001|Dose Expansion Phase|Death|0|||
130306172|NCT02834247|469083600|FG002|Dose Expansion Phase|Death|0|||
130306173|NCT02834247|469083601|FG003|Dose Expansion Phase|Death|8|||
130306174|NCT02834247|469083598|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
130306175|NCT02834247|469083599|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
130306176|NCT02834247|469083600|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
130108560|NCT01896700|468358972|FG000|Overall Study|Adverse Event|4|||
130108561|NCT01896700|468358973|FG001|Overall Study|Adverse Event|5|||
130108562|NCT01896700|468358972|FG000|Overall Study|Withdrawal by Subject|0|||
130108563|NCT01896700|468358973|FG001|Overall Study|Withdrawal by Subject|1|||
130108564|NCT00423488|468358976|FG000|Overall Study|No evidence of study drug intake|2|||
130108565|NCT00423488|468358977|FG001|Overall Study|No evidence of study drug intake|1|||
130108566|NCT00423488|468358976|FG000|Overall Study|No post baseline data|3|||
130108567|NCT00423488|468358977|FG001|Overall Study|No post baseline data|0|||
130108568|NCT00886782|468358978|FG000|Overall Study|Disease progression|3|||
130306177|NCT02834247|469083601|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
130306178|NCT02834247|469083598|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
130108569|NCT00886782|468358979|FG001|Overall Study|Disease progression|3|||
130108570|NCT00886782|468358980|FG002|Overall Study|Disease progression|3|||
130108571|NCT00886782|468358978|FG000|Overall Study|Study drug toxicity|0|||
130108572|NCT00886782|468358979|FG001|Overall Study|Study drug toxicity|0|||
130108573|NCT00886782|468358980|FG002|Overall Study|Study drug toxicity|1|||
130108574|NCT00886782|468358978|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
130108575|NCT00886782|468358979|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
130108576|NCT00886782|468358980|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
130108577|NCT00849524|468358981|FG000|Overall Study|Lack of Efficacy|3|||
130108578|NCT00068237|468358985|FG000|Overall Study|Ineligible|3|||
130108579|NCT00068237|468358985|FG000|Overall Study|No protocol treatment received|2|||
130108580|NCT01358708|468358986|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
130108581|NCT01358708|468358987|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130108582|NCT01358708|468358986|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130108583|NCT01358708|468358987|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
130108584|NCT03056001|468358988|FG000|Overall Study|Death|24|||
130108585|NCT00363129|468358989|FG000|Overall Study|Withdrawal by Subject|11|||
130108586|NCT00363129|468358990|FG001|Overall Study|Withdrawal by Subject|18|||
130108587|NCT00363129|468358989|FG000|Overall Study|Adverse Event|8|||
130108588|NCT00363129|468358990|FG001|Overall Study|Adverse Event|3|||
130108589|NCT00363129|468358989|FG000|Overall Study|Alternate Treatment|2|||
130108590|NCT00363129|468358990|FG001|Overall Study|Alternate Treatment|4|||
130108591|NCT00363129|468358989|FG000|Overall Study|Other Medical Problems|2|||
130108592|NCT00363129|468358990|FG001|Overall Study|Other Medical Problems|4|||
130108593|NCT00363129|468358989|FG000|Overall Study|Death|0|||
130108594|NCT00363129|468358990|FG001|Overall Study|Death|1|||
130108595|NCT00363129|468358989|FG000|Overall Study|Other Reasons|6|||
130108596|NCT00363129|468358990|FG001|Overall Study|Other Reasons|3|||
130108597|NCT03707522|468358991|FG000|Overall Study|Lost to Follow-up|24|||
130108598|NCT03707522|468358992|FG001|Overall Study|Lost to Follow-up|27|||
130108599|NCT03707522|468358993|FG002|Overall Study|Lost to Follow-up|41|||
130108600|NCT03707522|468358994|FG003|Overall Study|Lost to Follow-up|36|||
130108601|NCT04363736|468358995|FG000|Overall Study|Withdrawal by Subject|1|||
130108602|NCT04363736|468358996|FG001|Overall Study|Withdrawal by Subject|0|||
130108603|NCT04363736|468358995|FG000|Overall Study|Lost to Follow-up|10|||
130108604|NCT04363736|468358996|FG001|Overall Study|Lost to Follow-up|7|||
130108605|NCT04363736|468358995|FG000|Overall Study|Death|8|||
130108606|NCT04363736|468358996|FG001|Overall Study|Death|6|||
130108607|NCT03125915|468358997|FG000|1 Month Follow up|Lost to Follow-up|3|||
130108608|NCT03125915|468358998|FG001|1 Month Follow up|Lost to Follow-up|3|||
130108609|NCT03125915|468358999|FG002|1 Month Follow up|Lost to Follow-up|2|||
130108610|NCT03125915|468359000|FG003|1 Month Follow up|Lost to Follow-up|3|||
130108611|NCT03125915|468358997|FG000|3 Month Follow-up|Lost to Follow-up|6|||
130108612|NCT03125915|468358998|FG001|3 Month Follow-up|Lost to Follow-up|4|||
130108613|NCT03125915|468358999|FG002|3 Month Follow-up|Lost to Follow-up|4|||
130108614|NCT03125915|468359000|FG003|3 Month Follow-up|Lost to Follow-up|2|||
130108615|NCT03125915|468358997|FG000|6 Month Follow-up|Lost to Follow-up|7|||
130108616|NCT03125915|468358998|FG001|6 Month Follow-up|Lost to Follow-up|3|||
130108617|NCT03125915|468358999|FG002|6 Month Follow-up|Lost to Follow-up|6|||
130108618|NCT03125915|468359000|FG003|6 Month Follow-up|Lost to Follow-up|3|||
130108619|NCT00990093|468359001|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
130108620|NCT00990093|468359002|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
130108621|NCT00990093|468359001|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
130108622|NCT00990093|468359002|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
130108623|NCT00990093|468359001|FG000|Test Period 1 (1-14 Days)|Other|1|||
130108624|NCT00990093|468359002|FG001|Test Period 1 (1-14 Days)|Other|0|||
130108625|NCT00990093|468359001|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
130108626|NCT00990093|468359002|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
130108627|NCT00990093|468359001|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
130108628|NCT00990093|468359002|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
130108629|NCT00990093|468359001|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
130108630|NCT00990093|468359002|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
130108631|NCT00990093|468359001|FG000|Test Period 2 (15-28 Days)|Other|0|||
130108632|NCT00990093|468359002|FG001|Test Period 2 (15-28 Days)|Other|1|||
130108633|NCT04556838|468359003|FG000|Overall Study|Withdrawal by Subject|3|||
130108634|NCT04556838|468359004|FG001|Overall Study|Withdrawal by Subject|1|||
130108635|NCT04556838|468359005|FG002|Overall Study|Withdrawal by Subject|2|||
130108636|NCT04556838|468359003|FG000|Overall Study|Adverse Event|0|||
130108637|NCT04556838|468359004|FG001|Overall Study|Adverse Event|1|||
130108638|NCT04556838|468359005|FG002|Overall Study|Adverse Event|1|||
130108639|NCT04556838|468359003|FG000|Overall Study|Lost to Follow-up|0|||
130108640|NCT04556838|468359004|FG001|Overall Study|Lost to Follow-up|0|||
130108641|NCT04556838|468359005|FG002|Overall Study|Lost to Follow-up|2|||
130108642|NCT04556838|468359003|FG000|Overall Study|Subject travel|0|||
130108643|NCT04556838|468359004|FG001|Overall Study|Subject travel|1|||
130108644|NCT04556838|468359005|FG002|Overall Study|Subject travel|0|||
130108645|NCT04556838|468359003|FG000|Overall Study|Physician Decision|1|||
130108646|NCT04556838|468359004|FG001|Overall Study|Physician Decision|0|||
130108647|NCT04556838|468359005|FG002|Overall Study|Physician Decision|0|||
130108648|NCT00995930|468359006|FG000|Overall Study|Protocol deviation|2|||
130108649|NCT00995930|468359007|FG001|Overall Study|Protocol deviation|5|||
130108650|NCT00995930|468359006|FG000|Overall Study|Death|0|||
130108651|NCT00995930|468359007|FG001|Overall Study|Death|1|||
130108652|NCT00995930|468359006|FG000|Overall Study|Administrative problems|4|||
130108653|NCT00995930|468359007|FG001|Overall Study|Administrative problems|2|||
130306179|NCT02834247|469083599|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
130306180|NCT02834247|469083600|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
130108654|NCT00995930|468359006|FG000|Overall Study|Lost to Follow-up|1|||
130108655|NCT00995930|468359007|FG001|Overall Study|Lost to Follow-up|2|||
130108656|NCT00995930|468359006|FG000|Overall Study|Withdrawal by Subject|3|||
130108657|NCT00995930|468359007|FG001|Overall Study|Withdrawal by Subject|4|||
130108658|NCT00995930|468359006|FG000|Overall Study|Adverse Event|11|||
130108659|NCT00995930|468359007|FG001|Overall Study|Adverse Event|14|||
130306181|NCT02834247|469083601|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
130306182|NCT00799266|469085140|FG000|Overall Study|Adverse Event|0|||
130306183|NCT00799266|469085141|FG001|Overall Study|Adverse Event|1|||
130306184|NCT00799266|469085140|FG000|Overall Study|Subject withdrew consent|3|||
130306185|NCT00799266|469085141|FG001|Overall Study|Subject withdrew consent|0|||
130306186|NCT01061359|469085143|FG000|Overall Study|Death|32|||
130306187|NCT01061359|469085143|FG000|Overall Study|Lost to Follow-up|1072|||
130306188|NCT01061359|469085143|FG000|Overall Study|Relapse|187|||
130306189|NCT01061359|469085143|FG000|Overall Study|Secondary neoplasm|11|||
130306190|NCT04273893|469085150|FG000|Overall Study|Withdrawal by Subject|0|||
130306191|NCT04273893|469085151|FG001|Overall Study|Withdrawal by Subject|2|||
130306192|NCT04273893|469085150|FG000|Overall Study|Treatment of Disease Progression|0|||
130306193|NCT04273893|469085151|FG001|Overall Study|Treatment of Disease Progression|2|||
130306194|NCT04273893|469085150|FG000|Overall Study|Death|1|||
130306195|NCT04273893|469085151|FG001|Overall Study|Death|2|||
130306196|NCT04273893|469085150|FG000|Overall Study|Lost to Follow-up|0|||
130306197|NCT04273893|469085151|FG001|Overall Study|Lost to Follow-up|2|||
130306198|NCT04273893|469085150|FG000|Overall Study|Physician Decision|1|||
130306199|NCT04273893|469085151|FG001|Overall Study|Physician Decision|0|||
130306200|NCT01036321|469085153|FG000|Overall Study|Ineligible after randomization|0|||
130306201|NCT01036321|469085154|FG001|Overall Study|Ineligible after randomization|1|||
130306202|NCT01036321|469085153|FG000|Overall Study|Withdrawal by Subject|3|||
130306203|NCT01036321|469085154|FG001|Overall Study|Withdrawal by Subject|2|||
130306204|NCT01036321|469085153|FG000|Overall Study|Adverse Event|2|||
130306205|NCT01036321|469085154|FG001|Overall Study|Adverse Event|1|||
130306206|NCT00381693|469085157|FG000|Overall Study|Death|1|||
130306207|NCT00381693|469085157|FG000|Overall Study|Adverse Event|4|||
130306208|NCT00381693|469085157|FG000|Overall Study|Patient Choice|1|||
130306209|NCT00381693|469085157|FG000|Overall Study|Progression|2|||
130306210|NCT02598297|469085158|FG000|Overall Study|Study terminated by Sponsor|21|||
130306211|NCT02598297|469085159|FG001|Overall Study|Study terminated by Sponsor|23|||
130306212|NCT02598297|469085158|FG000|Overall Study|Adverse Event|1|||
130306213|NCT02598297|469085159|FG001|Overall Study|Adverse Event|1|||
130306214|NCT02598297|469085158|FG000|Overall Study|Physician Decision|1|||
130306215|NCT02598297|469085159|FG001|Overall Study|Physician Decision|0|||
130306216|NCT02598297|469085158|FG000|Overall Study|Subject/guardian decision|1|||
130306217|NCT02598297|469085159|FG001|Overall Study|Subject/guardian decision|0|||
130306218|NCT02598297|469085158|FG000|Overall Study|Followed for survival|1|||
130306219|NCT02598297|469085159|FG001|Overall Study|Followed for survival|0|||
130306220|NCT00394706|469085170|FG000|Overall Study|Withdrawal by Subject|2|||
130306221|NCT00394706|469085171|FG001|Overall Study|Withdrawal by Subject|0|||
130306222|NCT00394706|469085172|FG002|Overall Study|Withdrawal by Subject|1|||
130306223|NCT00394706|469085173|FG003|Overall Study|Withdrawal by Subject|0|||
130306224|NCT00394706|469085174|FG004|Overall Study|Withdrawal by Subject|0|||
130306225|NCT00394706|469085175|FG005|Overall Study|Withdrawal by Subject|2|||
130306226|NCT00394706|469085176|FG006|Overall Study|Withdrawal by Subject|1|||
129797807|NCT02537574|467228233|FG000|Overall Study|Lost to Follow-up|40|||
130108660|NCT01458119|468359008|FG000|Overall Study|Physician Decision|4|||
130108661|NCT01458119|468359008|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
130108662|NCT01458119|468359008|FG000|Overall Study|Pregnancy|1|||
130108663|NCT01458119|468359008|FG000|Overall Study|Death|2|||
130306227|NCT00394706|469085177|FG007|Overall Study|Withdrawal by Subject|0|||
130306228|NCT00394706|469085170|FG000|Overall Study|Lost to Follow-up|2|||
130306229|NCT00394706|469085171|FG001|Overall Study|Lost to Follow-up|2|||
130108664|NCT01458119|468359008|FG000|Overall Study|Adverse Event|1|||
130108665|NCT01458119|468359008|FG000|Overall Study|Consent Withdrawn by Participant|8|||
130306230|NCT00394706|469085172|FG002|Overall Study|Lost to Follow-up|8|||
130306231|NCT00394706|469085173|FG003|Overall Study|Lost to Follow-up|1|||
130108666|NCT01458119|468359008|FG000|Overall Study|Non-compliance With Study Drug|3|||
130306232|NCT00394706|469085174|FG004|Overall Study|Lost to Follow-up|2|||
130306233|NCT00394706|469085175|FG005|Overall Study|Lost to Follow-up|5|||
130306234|NCT00394706|469085176|FG006|Overall Study|Lost to Follow-up|2|||
130306235|NCT00394706|469085177|FG007|Overall Study|Lost to Follow-up|0|||
130306236|NCT02003534|469085181|FG000|Overall Study|Lost to Follow-up|47|||
130108667|NCT05003167|468359009|FG000|Overall Study|Withdrawal by Subject|1|||
130108668|NCT02367781|468359010|FG000|Overall Study|Withdrawal by Subject|20|||
130306237|NCT02506192|469085184|FG000|Overall Study|Withdrawal by Subject|1|||
130306238|NCT02506192|469085185|FG001|Overall Study|Withdrawal by Subject|1|||
130306239|NCT05292131|469085188|FG000|Overall Study|Lost to Follow-up|1|||
130306240|NCT05292131|469085189|FG001|Overall Study|Lost to Follow-up|1|||
130306241|NCT05292131|469085188|FG000|Overall Study|Withdrawal by Subject|0|||
130306242|NCT05292131|469085189|FG001|Overall Study|Withdrawal by Subject|1|||
130306243|NCT06136897|469085190|FG000|Overall Study|Ineligible|3|||
129889349|NCT04894903|467552564|FG000|Overall Study|Pregnancy|1|||
130048383|NCT00751881|468133223|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
130048384|NCT00751881|468133224|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
130108669|NCT02367781|468359011|FG001|Overall Study|Withdrawal by Subject|13|||
130108670|NCT02367781|468359010|FG000|Overall Study|Protocol Violation|0|||
130108671|NCT02367781|468359011|FG001|Overall Study|Protocol Violation|1|||
130108672|NCT02367781|468359010|FG000|Overall Study|Physician Decision|7|||
130108673|NCT02367781|468359011|FG001|Overall Study|Physician Decision|0|||
130108674|NCT02367781|468359010|FG000|Overall Study|Randomized in Error|5|||
130108675|NCT02367781|468359011|FG001|Overall Study|Randomized in Error|4|||
130108676|NCT02367781|468359010|FG000|Overall Study|Non-Compliance|1|||
130108677|NCT02367781|468359011|FG001|Overall Study|Non-Compliance|0|||
130108678|NCT02367781|468359010|FG000|Overall Study|Lost to Follow-up|1|||
130108679|NCT02367781|468359011|FG001|Overall Study|Lost to Follow-up|2|||
130108680|NCT02367781|468359010|FG000|Overall Study|Death|330|||
130108681|NCT02367781|468359011|FG001|Overall Study|Death|176|||
130108682|NCT02367781|468359010|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
130108683|NCT02367781|468359011|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
130108684|NCT02367781|468359010|FG000|Overall Study|Prolonged Hospitalization|1|||
130108685|NCT02367781|468359011|FG001|Overall Study|Prolonged Hospitalization|0|||
130108686|NCT02367781|468359010|FG000|Overall Study|Death Prior First Dose|1|||
130108687|NCT02367781|468359011|FG001|Overall Study|Death Prior First Dose|0|||
130108688|NCT02367781|468359010|FG000|Overall Study|Administrative-Change Facility|1|||
130108689|NCT02367781|468359011|FG001|Overall Study|Administrative-Change Facility|0|||
130108690|NCT02367781|468359010|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
130048385|NCT00751881|468133225|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
130048386|NCT00751881|468133223|FG000|Extension Study Period|Other than specified above|26|||
130048387|NCT00751881|468133224|FG001|Extension Study Period|Other than specified above|30|||
130048388|NCT00751881|468133225|FG002|Extension Study Period|Other than specified above|18|||
130048389|NCT01765764|468133229|FG000|Treatment Period|Adverse Event|1|||
130048390|NCT01765764|468133230|FG001|Treatment Period|Adverse Event|2|||
130048391|NCT01765764|468133231|FG002|Treatment Period|Adverse Event|1|||
130048392|NCT01765764|468133229|FG000|Treatment Period|Lost to Follow-up|0|||
130048393|NCT01765764|468133230|FG001|Treatment Period|Lost to Follow-up|3|||
130048394|NCT01765764|468133231|FG002|Treatment Period|Lost to Follow-up|2|||
130048395|NCT01765764|468133229|FG000|Treatment Period|Personal Reasons|1|||
130048396|NCT01765764|468133230|FG001|Treatment Period|Personal Reasons|2|||
130048397|NCT01765764|468133231|FG002|Treatment Period|Personal Reasons|1|||
130048398|NCT01765764|468133229|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
130048399|NCT01765764|468133230|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
130048400|NCT01765764|468133231|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
130048401|NCT00935220|468133241|FG000|Overall Study|Adverse Event|1|||
130048402|NCT00935220|468133241|FG000|Overall Study|Other reason (not specified)|1|||
130048403|NCT00798967|468133242|FG000|Overall Study|Adverse Event|2|||
130048404|NCT00798967|468133243|FG001|Overall Study|Adverse Event|3|||
130048405|NCT00798967|468133242|FG000|Overall Study|Withdrawal by Subject|0|||
130048406|NCT00798967|468133243|FG001|Overall Study|Withdrawal by Subject|1|||
130048407|NCT00798967|468133242|FG000|Overall Study|Physician Decision|1|||
130048408|NCT00798967|468133243|FG001|Overall Study|Physician Decision|0|||
130048409|NCT00798967|468133242|FG000|Overall Study|Randomized in error by site|1|||
130048410|NCT00798967|468133243|FG001|Overall Study|Randomized in error by site|0|||
130048411|NCT01415440|468133246|FG000|Overall Study|Lost to Follow-up|0|||
130048412|NCT01415440|468133247|FG001|Overall Study|Lost to Follow-up|1|||
130108691|NCT02367781|468359011|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
130108692|NCT02367781|468359010|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
130306244|NCT06136897|469085190|FG000|Overall Study|Mutation status not confirmed|7|||
130306245|NCT06136897|469085190|FG000|Overall Study|Adverse Event|2|||
130306246|NCT06136897|469085190|FG000|Overall Study|Death|1|||
130306247|NCT06136897|469085190|FG000|Overall Study|Disease progression|18|||
130048413|NCT01415440|468133248|FG002|Overall Study|Lost to Follow-up|2|||
130048414|NCT01415440|468133246|FG000|Overall Study|Physician Decision|3|||
130048415|NCT01415440|468133247|FG001|Overall Study|Physician Decision|0|||
130048416|NCT01415440|468133248|FG002|Overall Study|Physician Decision|0|||
130048417|NCT01415440|468133246|FG000|Overall Study|Withdrawal by Subject|1|||
130048418|NCT01415440|468133247|FG001|Overall Study|Withdrawal by Subject|0|||
130048419|NCT01415440|468133248|FG002|Overall Study|Withdrawal by Subject|0|||
130108693|NCT02367781|468359011|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
130108694|NCT02367781|468359010|FG000|Overall Study|Study Terminated by Sponsor|3|||
130108695|NCT02367781|468359011|FG001|Overall Study|Study Terminated by Sponsor|1|||
130108696|NCT02367781|468359010|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
130108697|NCT02367781|468359011|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
130108698|NCT02367781|468359010|FG000|Overall Study|Sponsor Decision|2|||
130108699|NCT02367781|468359011|FG001|Overall Study|Sponsor Decision|0|||
130108700|NCT02367781|468359010|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
130108701|NCT02367781|468359011|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
130108702|NCT01123980|468359014|FG000|Overall Study|Adverse Event|1|||
130108703|NCT01123980|468359015|FG001|Overall Study|Adverse Event|1|||
130108704|NCT01123980|468359014|FG000|Overall Study|Lack of Efficacy|1|||
130108705|NCT01123980|468359015|FG001|Overall Study|Lack of Efficacy|0|||
130108706|NCT01123980|468359014|FG000|Overall Study|Physician Decision|0|||
130108707|NCT01123980|468359015|FG001|Overall Study|Physician Decision|1|||
130108708|NCT01123980|468359014|FG000|Overall Study|Lost to Follow-up|0|||
130108709|NCT01123980|468359015|FG001|Overall Study|Lost to Follow-up|6|||
130108710|NCT01123980|468359014|FG000|Overall Study|Protocol Violation|6|||
130108711|NCT01123980|468359015|FG001|Overall Study|Protocol Violation|6|||
130108712|NCT01123980|468359014|FG000|Overall Study|Withdrawal by Subject|5|||
130108713|NCT01123980|468359015|FG001|Overall Study|Withdrawal by Subject|3|||
130108714|NCT01123980|468359014|FG000|Overall Study|Unclassified|6|||
130108715|NCT01123980|468359015|FG001|Overall Study|Unclassified|7|||
130108716|NCT01225991|468359016|FG000|Overall Study|Withdrawal by Subject|6|||
130108717|NCT02094937|468359017|FG000|8 Weeks in Period 1|Adverse Event|9|||
130108718|NCT02094937|468359018|FG001|8 Weeks in Period 1|Adverse Event|0|||
130108719|NCT02094937|468359019|FG002|8 Weeks in Period 1|Adverse Event|0|||
130108720|NCT02094937|468359020|FG003|8 Weeks in Period 1|Adverse Event|0|||
130108721|NCT02094937|468359017|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
130108722|NCT02094937|468359018|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
130108723|NCT02094937|468359019|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
130108724|NCT02094937|468359020|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
130108725|NCT02094937|468359017|FG000|8 Weeks in Period 1|Protocol Violation|2|||
130108726|NCT02094937|468359018|FG001|8 Weeks in Period 1|Protocol Violation|0|||
130108727|NCT02094937|468359019|FG002|8 Weeks in Period 1|Protocol Violation|0|||
130108728|NCT02094937|468359020|FG003|8 Weeks in Period 1|Protocol Violation|0|||
130108729|NCT02094937|468359017|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
130108730|NCT02094937|468359018|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130108731|NCT02094937|468359019|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130108732|NCT02094937|468359020|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
130108733|NCT02094937|468359017|FG000|8 Weeks in Period 1|Physician Decision|1|||
130108734|NCT02094937|468359018|FG001|8 Weeks in Period 1|Physician Decision|0|||
130108735|NCT02094937|468359019|FG002|8 Weeks in Period 1|Physician Decision|0|||
130108736|NCT02094937|468359020|FG003|8 Weeks in Period 1|Physician Decision|0|||
130108737|NCT02094937|468359017|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
130108738|NCT02094937|468359018|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
130108739|NCT02094937|468359019|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
130108740|NCT02094937|468359020|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
130108741|NCT02094937|468359017|FG000|12 Weeks in Period 2|Adverse Event|0|||
130108742|NCT02094937|468359018|FG001|12 Weeks in Period 2|Adverse Event|2|||
130108743|NCT02094937|468359019|FG002|12 Weeks in Period 2|Adverse Event|4|||
130108744|NCT02094937|468359020|FG003|12 Weeks in Period 2|Adverse Event|1|||
130108745|NCT02094937|468359017|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
130108746|NCT02094937|468359018|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
130108747|NCT02094937|468359019|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
130108748|NCT02094937|468359020|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
130108749|NCT02094937|468359017|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
130108750|NCT02094937|468359018|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
130108751|NCT02094937|468359019|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
130108752|NCT02094937|468359020|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
129889350|NCT04894903|467552565|FG001|Overall Study|Pregnancy|0|||
129889351|NCT04894903|467552564|FG000|Overall Study|Withdrawal by Subject|1|||
129889352|NCT04894903|467552565|FG001|Overall Study|Withdrawal by Subject|1|||
130108753|NCT02094937|468359017|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
130108754|NCT02094937|468359018|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
130108755|NCT02094937|468359019|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
130108756|NCT02094937|468359020|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
130108757|NCT02094937|468359017|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
130108758|NCT02094937|468359018|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
130108759|NCT02094937|468359019|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
130108760|NCT02094937|468359020|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
129889353|NCT04894903|467552564|FG000|Overall Study|moved or exited health system|1|||
130108761|NCT01133392|468359021|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
130108762|NCT01133392|468359022|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
130108763|NCT01133392|468359021|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
130108764|NCT01133392|468359022|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
130108765|NCT03627195|468360892|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
130108766|NCT03627195|468360893|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130108767|NCT03627195|468360894|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130108768|NCT03627195|468360895|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130108769|NCT03627195|468360896|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130108770|NCT03627195|468360897|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
130108771|NCT01835132|468360904|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
130108772|NCT00856778|468360905|FG000|Overall Study|Adverse Event|7|||
130108773|NCT00856778|468360905|FG000|Overall Study|Withdrawal by Subject|10|||
130108774|NCT00856778|468360905|FG000|Overall Study|Study deviation|2|||
130108775|NCT00856778|468360905|FG000|Overall Study|Lost to Follow-up|5|||
130108776|NCT00782275|468360909|FG000|Overall Study|Adverse Event|11|||
130048420|NCT00633139|468133249|FG000|Overall Study|Non compliance|0|||
130048421|NCT00633139|468133250|FG001|Overall Study|Non compliance|0|||
130048422|NCT00633139|468133251|FG002|Overall Study|Non compliance|1|||
130048423|NCT00633139|468133249|FG000|Overall Study|Withdrawal by Subject|0|||
130048424|NCT00633139|468133250|FG001|Overall Study|Withdrawal by Subject|1|||
130048425|NCT00633139|468133251|FG002|Overall Study|Withdrawal by Subject|0|||
130048426|NCT02160977|468133252|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
130048427|NCT02160977|468133253|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
130048428|NCT02160977|468133252|FG000|Three Months After Surgery|Lost to Follow-up|0|||
130048429|NCT02160977|468133253|FG001|Three Months After Surgery|Lost to Follow-up|2|||
130048430|NCT02160977|468133252|FG000|Six Months After Surgery|Lost to Follow-up|2|||
130048431|NCT02160977|468133253|FG001|Six Months After Surgery|Lost to Follow-up|1|||
130048432|NCT01522651|468133257|FG000|Overall Study|Adverse Event|3|||
130048433|NCT01522651|468133258|FG001|Overall Study|Adverse Event|4|||
130048434|NCT01522651|468133259|FG002|Overall Study|Adverse Event|4|||
130048435|NCT01522651|468133260|FG003|Overall Study|Adverse Event|5|||
130048436|NCT01522651|468133261|FG004|Overall Study|Adverse Event|4|||
130048437|NCT01522651|468133257|FG000|Overall Study|Cardioversion|1|||
130048438|NCT01522651|468133258|FG001|Overall Study|Cardioversion|0|||
130048439|NCT01522651|468133259|FG002|Overall Study|Cardioversion|0|||
130048440|NCT01522651|468133260|FG003|Overall Study|Cardioversion|0|||
130048441|NCT01522651|468133261|FG004|Overall Study|Cardioversion|0|||
130048442|NCT01522651|468133257|FG000|Overall Study|Device Malfunction|0|||
130048443|NCT01522651|468133258|FG001|Overall Study|Device Malfunction|1|||
130048444|NCT01522651|468133259|FG002|Overall Study|Device Malfunction|0|||
130048445|NCT01522651|468133260|FG003|Overall Study|Device Malfunction|0|||
130048446|NCT01522651|468133261|FG004|Overall Study|Device Malfunction|0|||
130048447|NCT01522651|468133257|FG000|Overall Study|Investigator's Discretion|0|||
130048448|NCT01522651|468133258|FG001|Overall Study|Investigator's Discretion|1|||
130048449|NCT01522651|468133259|FG002|Overall Study|Investigator's Discretion|0|||
130048450|NCT01522651|468133260|FG003|Overall Study|Investigator's Discretion|0|||
130048451|NCT01522651|468133261|FG004|Overall Study|Investigator's Discretion|0|||
130048452|NCT01522651|468133257|FG000|Overall Study|Protocol Violation|3|||
130048453|NCT01522651|468133258|FG001|Overall Study|Protocol Violation|0|||
130048454|NCT01522651|468133259|FG002|Overall Study|Protocol Violation|0|||
130048455|NCT01522651|468133260|FG003|Overall Study|Protocol Violation|0|||
130048456|NCT01522651|468133261|FG004|Overall Study|Protocol Violation|0|||
130048457|NCT01522651|468133257|FG000|Overall Study|Reason Not Specified|0|||
130048458|NCT01522651|468133258|FG001|Overall Study|Reason Not Specified|0|||
130048459|NCT01522651|468133259|FG002|Overall Study|Reason Not Specified|0|||
130048460|NCT01522651|468133260|FG003|Overall Study|Reason Not Specified|1|||
130048461|NCT01522651|468133261|FG004|Overall Study|Reason Not Specified|0|||
130048462|NCT01522651|468133257|FG000|Overall Study|Participant Non-Compliance|1|||
130108777|NCT00782275|468360909|FG000|Overall Study|Withdrawal by Subject|1|||
130108778|NCT00782275|468360909|FG000|Overall Study|Progressive Disease|21|||
130108779|NCT00782275|468360909|FG000|Overall Study|Physician Decision|4|||
130108780|NCT00782275|468360909|FG000|Overall Study|Not started treatment|1|||
130306248|NCT06136897|469085190|FG000|Overall Study|Other complicating disease|1|||
130306249|NCT06136897|469085190|FG000|Overall Study|Withdrawal by Subject|1|||
130048463|NCT01522651|468133258|FG001|Overall Study|Participant Non-Compliance|0|||
130048464|NCT01522651|468133259|FG002|Overall Study|Participant Non-Compliance|0|||
130048465|NCT01522651|468133260|FG003|Overall Study|Participant Non-Compliance|0|||
130108781|NCT00782275|468360909|FG000|Overall Study|Other|3|||
130306250|NCT06136897|469085190|FG000|Overall Study|Still on treatment|1|||
130048466|NCT01522651|468133261|FG004|Overall Study|Participant Non-Compliance|0|||
130048467|NCT01522651|468133257|FG000|Overall Study|Withdrew Consent|1|||
130048468|NCT01522651|468133258|FG001|Overall Study|Withdrew Consent|1|||
130048469|NCT01522651|468133259|FG002|Overall Study|Withdrew Consent|0|||
130048470|NCT01522651|468133260|FG003|Overall Study|Withdrew Consent|1|||
130048471|NCT01522651|468133261|FG004|Overall Study|Withdrew Consent|1|||
130048472|NCT01522651|468133257|FG000|Overall Study|Randomized but Never Treated|0|||
130048473|NCT01522651|468133258|FG001|Overall Study|Randomized but Never Treated|1|||
130108782|NCT00331773|468360912|FG000|Overall Study|Withdrawal by Subject|6|||
129889354|NCT04894903|467552565|FG001|Overall Study|moved or exited health system|3|||
129889355|NCT01923428|467552569|FG000|Overall Study|Adverse Event|8|||
129889356|NCT01923428|467552570|FG001|Overall Study|Adverse Event|6|||
129889357|NCT01923428|467552571|FG002|Overall Study|Adverse Event|3|||
129889358|NCT01923428|467552572|FG003|Overall Study|Adverse Event|3|||
129889359|NCT01923428|467552569|FG000|Overall Study|Withdrawal by Subject|5|||
129889360|NCT01923428|467552570|FG001|Overall Study|Withdrawal by Subject|3|||
129889361|NCT01923428|467552571|FG002|Overall Study|Withdrawal by Subject|0|||
129889362|NCT01923428|467552572|FG003|Overall Study|Withdrawal by Subject|4|||
129889363|NCT01923428|467552569|FG000|Overall Study|Lost to Follow-up|2|||
129889364|NCT01923428|467552570|FG001|Overall Study|Lost to Follow-up|1|||
129889365|NCT01923428|467552571|FG002|Overall Study|Lost to Follow-up|5|||
129889366|NCT01923428|467552572|FG003|Overall Study|Lost to Follow-up|0|||
129889367|NCT01923428|467552569|FG000|Overall Study|Protocol Violation|3|||
129889368|NCT01923428|467552570|FG001|Overall Study|Protocol Violation|0|||
129889369|NCT01923428|467552571|FG002|Overall Study|Protocol Violation|2|||
129889370|NCT01923428|467552572|FG003|Overall Study|Protocol Violation|1|||
129889371|NCT01923428|467552569|FG000|Overall Study|Non Compliance to treatment|1|||
129889372|NCT01923428|467552570|FG001|Overall Study|Non Compliance to treatment|2|||
129889373|NCT01923428|467552571|FG002|Overall Study|Non Compliance to treatment|0|||
129889374|NCT01923428|467552572|FG003|Overall Study|Non Compliance to treatment|1|||
129889375|NCT01923428|467552569|FG000|Overall Study|Lack of Efficacy|0|||
129889376|NCT01923428|467552570|FG001|Overall Study|Lack of Efficacy|0|||
129889377|NCT01923428|467552571|FG002|Overall Study|Lack of Efficacy|1|||
129889378|NCT01923428|467552572|FG003|Overall Study|Lack of Efficacy|1|||
129889379|NCT02550873|467552573|FG000|Randomized Double Blind|Adverse Event|3|||
129889380|NCT02550873|467552574|FG001|Randomized Double Blind|Adverse Event|1|||
129889381|NCT02550873|467552575|FG002|Randomized Double Blind|Adverse Event|0|||
129889382|NCT02550873|467552573|FG000|Randomized Double Blind|Disease progression|1|||
129889383|NCT02550873|467552574|FG001|Randomized Double Blind|Disease progression|1|||
129889384|NCT02550873|467552575|FG002|Randomized Double Blind|Disease progression|0|||
129889385|NCT02550873|467552573|FG000|Open Label Extension|Study ongoing|0|||
129889386|NCT02550873|467552574|FG001|Open Label Extension|Study ongoing|0|||
129889387|NCT02550873|467552575|FG002|Open Label Extension|Study ongoing|111|||
129889388|NCT01822353|467552576|FG000|Overall Study|Adverse Event|1|||
129889389|NCT01822353|467552577|FG001|Overall Study|Adverse Event|3|||
129889390|NCT01822353|467552578|FG002|Overall Study|Adverse Event|1|||
129889391|NCT01822353|467552576|FG000|Overall Study|Pregnancy|0|||
129889392|NCT01822353|467552577|FG001|Overall Study|Pregnancy|1|||
129889393|NCT01822353|467552578|FG002|Overall Study|Pregnancy|0|||
129889394|NCT01822353|467552576|FG000|Overall Study|Withdrawal by Subject|3|||
129889395|NCT01822353|467552577|FG001|Overall Study|Withdrawal by Subject|1|||
130048474|NCT01522651|468133259|FG002|Overall Study|Randomized but Never Treated|0|||
130048475|NCT01522651|468133260|FG003|Overall Study|Randomized but Never Treated|1|||
130048476|NCT01522651|468133261|FG004|Overall Study|Randomized but Never Treated|1|||
130048477|NCT02658656|468133262|FG000|Screening|Failed eligibility criteria|0|||
130048478|NCT02658656|468133263|FG001|Screening|Failed eligibility criteria|0|||
130048479|NCT02658656|468133264|FG002|Screening|Failed eligibility criteria|263|||
130048480|NCT02658656|468133262|FG000|Randomization|Withdrawal by Subject|8|||
130048481|NCT02658656|468133263|FG001|Randomization|Withdrawal by Subject|7|||
130048482|NCT02658656|468133264|FG002|Randomization|Withdrawal by Subject|0|||
130048483|NCT02658656|468133262|FG000|Randomization|Lost to Follow-up|1|||
130048484|NCT02658656|468133263|FG001|Randomization|Lost to Follow-up|3|||
130048485|NCT02658656|468133264|FG002|Randomization|Lost to Follow-up|0|||
130048486|NCT02658656|468133262|FG000|Randomization|Adverse Event|4|||
130048487|NCT02658656|468133263|FG001|Randomization|Adverse Event|0|||
130048488|NCT02658656|468133264|FG002|Randomization|Adverse Event|0|||
130048489|NCT02658656|468133262|FG000|Randomization|Administrative Termination|3|||
130048490|NCT02658656|468133263|FG001|Randomization|Administrative Termination|1|||
130048491|NCT02658656|468133264|FG002|Randomization|Administrative Termination|0|||
130048492|NCT02658656|468133262|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
130048493|NCT02658656|468133263|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
130048494|NCT02658656|468133264|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
130048495|NCT02658656|468133262|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
130048496|NCT02658656|468133263|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
130048497|NCT02658656|468133264|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
130048498|NCT02658656|468133262|FG000|Randomization|Not eligible for Randomization|1|||
129889396|NCT01822353|467552578|FG002|Overall Study|Withdrawal by Subject|0|||
129889397|NCT00895843|467552579|FG000|Overall Study|Protocol Violation|12|||
129889398|NCT00895843|467552580|FG001|Overall Study|Protocol Violation|12|||
129889399|NCT04963062|467552588|FG000|Overall Study|withdrew by the study team|4|||
129889400|NCT04963062|467552589|FG001|Overall Study|withdrew by the study team|2|||
129889401|NCT01857323|467552590|FG000|Overall Study|Adverse Event|1|||
130048499|NCT02658656|468133263|FG001|Randomization|Not eligible for Randomization|0|||
129889402|NCT01857323|467552590|FG000|Overall Study|Withdrawal by Subject|3|||
130306251|NCT06136897|469085190|FG000|Overall Study|Lost to Follow-up|1|||
130306252|NCT03785405|469085191|FG000|Overall Study|Adverse Event|16|||
130306253|NCT03785405|469085192|FG001|Overall Study|Adverse Event|1|||
130306254|NCT03785405|469085191|FG000|Overall Study|Death|6|||
130306255|NCT03785405|469085192|FG001|Overall Study|Death|4|||
130306256|NCT03785405|469085191|FG000|Overall Study|Guardian decision|4|||
130306257|NCT03785405|469085192|FG001|Overall Study|Guardian decision|1|||
130306258|NCT03785405|469085191|FG000|Overall Study|Lost to Follow-up|1|||
130306259|NCT03785405|469085192|FG001|Overall Study|Lost to Follow-up|0|||
130306260|NCT03785405|469085191|FG000|Overall Study|Physician Decision|8|||
130306261|NCT03785405|469085192|FG001|Overall Study|Physician Decision|5|||
130306262|NCT03785405|469085191|FG000|Overall Study|Participant decision|2|||
130306263|NCT03785405|469085192|FG001|Overall Study|Participant decision|0|||
130306264|NCT03785405|469085191|FG000|Overall Study|Other|1|||
130306265|NCT03785405|469085192|FG001|Overall Study|Other|0|||
130306266|NCT03785405|469085191|FG000|Overall Study|No treatment was received|0|||
130306267|NCT03785405|469085192|FG001|Overall Study|No treatment was received|1|||
130306268|NCT03705559|469085193|FG000|Overall Study|COVID Shut down|1|||
130306269|NCT02881762|469085196|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130306270|NCT02881762|469085197|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130306271|NCT00203424|469085201|FG000|Treatment Period|Withdrawal by Subject|4|||
130306272|NCT00203424|469085201|FG000|Treatment Period|Adverse Event|5|||
130306273|NCT00203424|469085201|FG000|Treatment Period|progressive disease|2|||
130306274|NCT00203424|469085201|FG000|Follow-up Period|Withdrawal by Subject|1|||
130306275|NCT00203424|469085201|FG000|Follow-up Period|progressive disease|4|||
130306276|NCT00203424|469085201|FG000|Follow-up Period|Lost to Follow-up|1|||
130306277|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
130306278|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306279|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306280|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306281|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306282|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
130306283|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
130306284|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306285|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306286|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306287|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306288|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
130306289|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
130306290|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306291|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306292|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306293|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306294|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
130306295|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
130306296|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306297|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306298|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306299|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306300|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
130306301|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
129889403|NCT01857323|467552590|FG000|Overall Study|Non-compliance|1|||
129889404|NCT01857323|467552590|FG000|Overall Study|Protocol Violation|6|||
129889405|NCT01857323|467552590|FG000|Overall Study|Lost to Follow-up|1|||
130306302|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306303|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306304|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
130048500|NCT02658656|468133264|FG002|Randomization|Not eligible for Randomization|0|||
129889406|NCT01857323|467552590|FG000|Overall Study|Other|4|||
130048501|NCT02658656|468133262|FG000|Randomization|Protocol Violation|1|||
130048502|NCT02658656|468133263|FG001|Randomization|Protocol Violation|0|||
130048503|NCT02658656|468133264|FG002|Randomization|Protocol Violation|0|||
130048504|NCT02322892|468134554|FG000|Overall Study|Surgery cancelled|1|||
130048505|NCT02322892|468134555|FG001|Overall Study|Surgery cancelled|2|||
130048506|NCT02322892|468134554|FG000|Overall Study|Met exclusion criteria|0|||
130048507|NCT02322892|468134555|FG001|Overall Study|Met exclusion criteria|1|||
130048508|NCT02322892|468134554|FG000|Overall Study|Protocol Violation|1|||
130048509|NCT02322892|468134555|FG001|Overall Study|Protocol Violation|0|||
130048510|NCT02125331|468134558|FG000|Overall Study|Protocol Violation|1|||
129889407|NCT01857323|467552590|FG000|Overall Study|Did not complete 180 doses|48|||
130048511|NCT02125331|468134559|FG001|Overall Study|Protocol Violation|0|||
130048512|NCT02125331|468134558|FG000|Overall Study|technical problem|2|||
129889408|NCT03873246|467552591|FG000|Overall Study|Adverse Event|1|||
129889409|NCT03873246|467552592|FG001|Overall Study|Adverse Event|3|||
129889410|NCT03873246|467552593|FG002|Overall Study|Adverse Event|3|||
129889411|NCT03873246|467552591|FG000|Overall Study|Lost to Follow-up|4|||
129889412|NCT03873246|467552592|FG001|Overall Study|Lost to Follow-up|4|||
130306305|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306306|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
130306307|NCT01053988|469085202|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
130306308|NCT01053988|469085203|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306309|NCT01053988|469085204|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306310|NCT01053988|469085205|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306311|NCT01053988|469085206|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306312|NCT01053988|469085207|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
130306313|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130306314|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
130306315|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
130306316|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
130306317|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
130306318|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
130306319|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129889413|NCT03873246|467552593|FG002|Overall Study|Lost to Follow-up|5|||
129889414|NCT03873246|467552591|FG000|Overall Study|Protocol Violation|0|||
129889415|NCT03873246|467552592|FG001|Overall Study|Protocol Violation|1|||
129889416|NCT03873246|467552593|FG002|Overall Study|Protocol Violation|0|||
129889417|NCT03873246|467552591|FG000|Overall Study|Withdrawal by Subject|0|||
129889418|NCT03873246|467552592|FG001|Overall Study|Withdrawal by Subject|4|||
129889419|NCT03873246|467552593|FG002|Overall Study|Withdrawal by Subject|1|||
129889420|NCT03658811|467552598|FG000|Overall Study|Lost to Follow-up|3|||
129889421|NCT00885495|467552599|FG000|Overall Study|Adverse Event|1|||
129889422|NCT00885495|467552600|FG001|Overall Study|Adverse Event|2|||
129889423|NCT00885495|467552599|FG000|Overall Study|Protocol Violation|0|||
129889424|NCT00885495|467552600|FG001|Overall Study|Protocol Violation|1|||
129889425|NCT00885495|467552599|FG000|Overall Study|Withdrawal by Subject|1|||
129889426|NCT00885495|467552600|FG001|Overall Study|Withdrawal by Subject|0|||
129889427|NCT01400893|467552601|FG000|Overall Study|Death|27|||
129889428|NCT01400893|467552602|FG001|Overall Study|Death|21|||
129889429|NCT01400893|467552601|FG000|Overall Study|Lost to Follow-up|0|||
129889430|NCT01400893|467552602|FG001|Overall Study|Lost to Follow-up|6|||
129889431|NCT00946647|467552606|FG000|Phase 1 Part|Adverse Event|2|||
129889432|NCT00946647|467552607|FG001|Phase 1 Part|Adverse Event|5|||
129889433|NCT00946647|467552608|FG002|Phase 1 Part|Adverse Event|3|||
129889434|NCT00946647|467552609|FG003|Phase 1 Part|Adverse Event|0|||
129889435|NCT00946647|467552610|FG004|Phase 1 Part|Adverse Event|0|||
129889436|NCT00946647|467552606|FG000|Phase 1 Part|Disease progression|3|||
129889437|NCT00946647|467552607|FG001|Phase 1 Part|Disease progression|6|||
129889438|NCT00946647|467552608|FG002|Phase 1 Part|Disease progression|1|||
129889439|NCT00946647|467552609|FG003|Phase 1 Part|Disease progression|0|||
129889440|NCT00946647|467552610|FG004|Phase 1 Part|Disease progression|0|||
129889441|NCT00946647|467552606|FG000|Phase 1 Part|Withdrawal by Subject|1|||
129889442|NCT00946647|467552607|FG001|Phase 1 Part|Withdrawal by Subject|4|||
129889443|NCT00946647|467552608|FG002|Phase 1 Part|Withdrawal by Subject|3|||
129889444|NCT00946647|467552609|FG003|Phase 1 Part|Withdrawal by Subject|0|||
129889445|NCT00946647|467552610|FG004|Phase 1 Part|Withdrawal by Subject|0|||
130048513|NCT02125331|468134559|FG001|Overall Study|technical problem|0|||
130048514|NCT02125331|468134558|FG000|Overall Study|screen failure|2|||
130048515|NCT02125331|468134559|FG001|Overall Study|screen failure|0|||
130048516|NCT03009539|468134560|FG000|Overall Study|Lost to Follow-up|132|||
130048517|NCT03009539|468134561|FG001|Overall Study|Lost to Follow-up|113|||
130048518|NCT03009539|468134562|FG002|Overall Study|Lost to Follow-up|132|||
130048519|NCT03009539|468134563|FG003|Overall Study|Lost to Follow-up|113|||
130048520|NCT03151148|468134564|FG000|Overall Study|Lost to Follow-up|1|||
130048521|NCT03151148|468134565|FG001|Overall Study|Lost to Follow-up|0|||
130048522|NCT03151148|468134564|FG000|Overall Study|Withdrawal by Subject|1|||
130048523|NCT03151148|468134565|FG001|Overall Study|Withdrawal by Subject|0|||
130048524|NCT00710034|468134566|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
130048525|NCT00710034|468134567|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
130048526|NCT00710034|468134566|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
129889446|NCT00946647|467552606|FG000|Phase 1 Part|Abnormal values|0|||
129889447|NCT00946647|467552607|FG001|Phase 1 Part|Abnormal values|2|||
129889448|NCT00946647|467552608|FG002|Phase 1 Part|Abnormal values|0|||
129889449|NCT00946647|467552609|FG003|Phase 1 Part|Abnormal values|0|||
129889450|NCT00946647|467552610|FG004|Phase 1 Part|Abnormal values|0|||
129889451|NCT00946647|467552606|FG000|Phase 1 Part|Reason missing|0|||
130048527|NCT00710034|468134567|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
129889452|NCT00946647|467552607|FG001|Phase 1 Part|Reason missing|1|||
129889453|NCT00946647|467552608|FG002|Phase 1 Part|Reason missing|0|||
130306320|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130306321|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130306322|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
130306323|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
130306324|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
130306325|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
130306326|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
130306327|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
130306328|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
130306329|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
130306330|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
130306331|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130306332|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
130306333|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130306334|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130306335|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
130306336|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
130306337|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130306338|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
130306339|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
130306340|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
130306341|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
130306342|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
130306343|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130306344|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
130306345|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130306346|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130306347|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130306348|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
130306349|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
130306350|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
130306351|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
130306352|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
130306353|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
130306354|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
130306355|NCT01053988|469085202|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130306356|NCT01053988|469085203|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
130306357|NCT01053988|469085204|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130306358|NCT01053988|469085205|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
130306359|NCT01053988|469085206|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
130306360|NCT01053988|469085207|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130306361|NCT01922271|469085208|FG000|WASHOUT Period|Withdrawal by Subject|1|||
130306362|NCT01922271|469085209|FG001|WASHOUT Period|Withdrawal by Subject|0|||
130306363|NCT01824355|469085210|FG000|Overall Study|Adverse Event|2|||
130306364|NCT01824355|469085210|FG000|Overall Study|unevaluable reference method results per|1|||
130306365|NCT02576795|469085212|FG000|Overall Study|Lost to Follow-up|0|||
130306366|NCT02576795|469085213|FG001|Overall Study|Lost to Follow-up|0|||
130306367|NCT02576795|469085214|FG002|Overall Study|Lost to Follow-up|1|||
130306368|NCT02576795|469085215|FG003|Overall Study|Lost to Follow-up|0|||
130306369|NCT04427072|469085217|FG000|Randomized Treatment Phase|Progressive disease|9|||
130306370|NCT04427072|469085218|FG001|Randomized Treatment Phase|Progressive disease|4|||
130306371|NCT04427072|469085217|FG000|Randomized Treatment Phase|Adverse Event|3|||
130306372|NCT04427072|469085218|FG001|Randomized Treatment Phase|Adverse Event|1|||
130306373|NCT04427072|469085217|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
130306374|NCT04427072|469085218|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
130306375|NCT04427072|469085217|FG000|Randomized Treatment Phase|Death|0|||
130306376|NCT04427072|469085218|FG001|Randomized Treatment Phase|Death|1|||
130306377|NCT04427072|469085217|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
130306378|NCT04427072|469085218|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
130306379|NCT04427072|469085217|FG000|Extension Treatment Phase|Progressive disease|0|||
130306380|NCT04427072|469085218|FG001|Extension Treatment Phase|Progressive disease|5|||
130306381|NCT05232864|469085219|FG000|Overall Study|Adverse Event|0|||
130306382|NCT05232864|469085220|FG001|Overall Study|Adverse Event|1|||
130306383|NCT05232864|469085219|FG000|Overall Study|Study terminated by sponsor|16|||
130306384|NCT05232864|469085220|FG001|Overall Study|Study terminated by sponsor|14|||
130306385|NCT00465452|469085227|FG000|Overall Study|Adverse Event|1|||
130306386|NCT02104947|469085233|FG000|Overall Study|Withdrawal by Subject|10|||
130306387|NCT02104947|469085234|FG001|Overall Study|Withdrawal by Subject|3|||
130306388|NCT02104947|469085233|FG000|Overall Study|Lost to Follow-up|4|||
130306389|NCT02104947|469085234|FG001|Overall Study|Lost to Follow-up|4|||
130306390|NCT02104947|469085233|FG000|Overall Study|Protocol Violation|6|||
130306391|NCT02104947|469085234|FG001|Overall Study|Protocol Violation|8|||
130306392|NCT02104947|469085233|FG000|Overall Study|Adverse Event|57|||
130306393|NCT02104947|469085234|FG001|Overall Study|Adverse Event|38|||
130306394|NCT02104947|469085233|FG000|Overall Study|Other than stated above|2|||
130306395|NCT02104947|469085234|FG001|Overall Study|Other than stated above|3|||
130306396|NCT00145574|469085235|FG000|Double Blind|Adverse Event|0|||
130306397|NCT00145574|469085236|FG001|Double Blind|Adverse Event|3|||
130306398|NCT00145574|469085237|FG002|Double Blind|Adverse Event|1|||
130306399|NCT00145574|469085235|FG000|Double Blind|Withdrawal by Subject|1|||
130306400|NCT00145574|469085236|FG001|Double Blind|Withdrawal by Subject|1|||
130306401|NCT00145574|469085237|FG002|Double Blind|Withdrawal by Subject|1|||
130306402|NCT00145574|469085235|FG000|Double Blind|required restricted medicine|0|||
130306403|NCT00145574|469085236|FG001|Double Blind|required restricted medicine|1|||
130306404|NCT00145574|469085237|FG002|Double Blind|required restricted medicine|0|||
130306405|NCT00145574|469085235|FG000|Open Label Long-term Extension|Adverse Event|0|||
130306406|NCT00145574|469085236|FG001|Open Label Long-term Extension|Adverse Event|0|||
130306407|NCT00145574|469085237|FG002|Open Label Long-term Extension|Adverse Event|5|||
130306408|NCT00145574|469085235|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
130306409|NCT00145574|469085236|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
130306410|NCT00145574|469085237|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
130306411|NCT00145574|469085235|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
130306412|NCT00145574|469085236|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
130306413|NCT00145574|469085237|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
130306414|NCT00145574|469085235|FG000|Open Label Long-term Extension|required restricted medicine|0|||
130306415|NCT00145574|469085236|FG001|Open Label Long-term Extension|required restricted medicine|0|||
130306416|NCT00145574|469085237|FG002|Open Label Long-term Extension|required restricted medicine|1|||
130306417|NCT00858637|469085241|FG000|Active Comparison Phase|Adverse Event|14|||
130306418|NCT00858637|469085242|FG001|Active Comparison Phase|Adverse Event|0|||
130306419|NCT00858637|469085243|FG002|Active Comparison Phase|Adverse Event|0|||
130306420|NCT00858637|469085244|FG003|Active Comparison Phase|Adverse Event|9|||
130306421|NCT00858637|469085245|FG004|Active Comparison Phase|Adverse Event|0|||
130306422|NCT00858637|469085246|FG005|Active Comparison Phase|Adverse Event|0|||
130048528|NCT00710034|468134566|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
130048529|NCT00710034|468134567|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
130048530|NCT00710034|468134566|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
130048531|NCT00710034|468134567|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
130048532|NCT00710034|468134566|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
130048533|NCT00710034|468134567|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
130048534|NCT00710034|468134566|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
130048535|NCT00710034|468134567|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
130048536|NCT00710034|468134566|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
130048537|NCT00710034|468134567|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
130048538|NCT00710034|468134566|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
130048539|NCT00710034|468134567|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
130048540|NCT00710034|468134566|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
130048541|NCT00710034|468134567|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
130048542|NCT00710034|468134566|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
130048543|NCT00710034|468134567|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
130048544|NCT00710034|468134566|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
130306423|NCT00858637|469085241|FG000|Active Comparison Phase|Death|1|||
130306424|NCT00858637|469085242|FG001|Active Comparison Phase|Death|0|||
130306425|NCT00858637|469085243|FG002|Active Comparison Phase|Death|0|||
130306426|NCT00858637|469085244|FG003|Active Comparison Phase|Death|1|||
130306427|NCT00858637|469085245|FG004|Active Comparison Phase|Death|0|||
130306428|NCT00858637|469085246|FG005|Active Comparison Phase|Death|0|||
130306429|NCT00858637|469085241|FG000|Active Comparison Phase|Physician Decision|1|||
130306430|NCT00858637|469085242|FG001|Active Comparison Phase|Physician Decision|0|||
130306431|NCT00858637|469085243|FG002|Active Comparison Phase|Physician Decision|0|||
130306432|NCT00858637|469085244|FG003|Active Comparison Phase|Physician Decision|1|||
130048545|NCT00710034|468134567|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
130048546|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
130306433|NCT00858637|469085245|FG004|Active Comparison Phase|Physician Decision|0|||
130306434|NCT00858637|469085246|FG005|Active Comparison Phase|Physician Decision|0|||
130306435|NCT00858637|469085241|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
130306436|NCT00858637|469085242|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
130306437|NCT00858637|469085243|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
130306438|NCT00858637|469085244|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
130306439|NCT00858637|469085245|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
130306440|NCT00858637|469085246|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
130306441|NCT00858637|469085241|FG000|Active Comparison Phase|Other Reasons|1|||
130306442|NCT00858637|469085242|FG001|Active Comparison Phase|Other Reasons|0|||
130306443|NCT00858637|469085243|FG002|Active Comparison Phase|Other Reasons|0|||
130306444|NCT00858637|469085244|FG003|Active Comparison Phase|Other Reasons|1|||
130306445|NCT00858637|469085245|FG004|Active Comparison Phase|Other Reasons|0|||
130306446|NCT00858637|469085246|FG005|Active Comparison Phase|Other Reasons|0|||
130306447|NCT00858637|469085241|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
130306448|NCT00858637|469085242|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
130306449|NCT00858637|469085243|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
130306450|NCT00858637|469085244|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
130306451|NCT00858637|469085245|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
130306452|NCT00858637|469085246|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
130306453|NCT00858637|469085241|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306454|NCT00858637|469085242|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306455|NCT00858637|469085243|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306456|NCT00858637|469085244|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306457|NCT00858637|469085245|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
130306458|NCT00858637|469085246|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
130108783|NCT00331773|468360913|FG001|Overall Study|Withdrawal by Subject|4|||
130108784|NCT00331773|468360912|FG000|Overall Study|Protocol Violation|10|||
130108785|NCT00331773|468360913|FG001|Overall Study|Protocol Violation|3|||
130108786|NCT00289731|468360914|FG000|Overall Study|Adverse Event|1|||
130108787|NCT00289731|468360915|FG001|Overall Study|Adverse Event|2|||
130108788|NCT00289731|468360916|FG002|Overall Study|Adverse Event|2|||
130108789|NCT00289731|468360914|FG000|Overall Study|Other|1|||
130108790|NCT00289731|468360915|FG001|Overall Study|Other|0|||
130306459|NCT04677504|469085250|FG000|Overall Study|Death|51|||
129889454|NCT00946647|467552609|FG003|Phase 1 Part|Reason missing|0|||
129889455|NCT00946647|467552610|FG004|Phase 1 Part|Reason missing|0|||
130108791|NCT00289731|468360916|FG002|Overall Study|Other|0|||
130108792|NCT02019979|468360917|FG000|Overall Study|study terminated|14|||
130108793|NCT00525031|468360925|FG000|Overall Study|Disease Progression|1|||
130108794|NCT00525031|468360926|FG001|Overall Study|Disease Progression|1|||
130108795|NCT02140164|468360927|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
130108796|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
130108797|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
130108798|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
130108799|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
130108800|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
130108801|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
130108802|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
130108803|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
130108804|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
130108805|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
130108806|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
130108807|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
130108808|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
130108809|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
130108810|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
130108811|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
130108812|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
130108813|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
130108814|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
130306460|NCT04677504|469085251|FG001|Overall Study|Death|49|||
130306461|NCT04677504|469085250|FG000|Overall Study|Progressive Disease|1|||
130306462|NCT04677504|469085251|FG001|Overall Study|Progressive Disease|0|||
130306463|NCT04677504|469085250|FG000|Overall Study|Symptomatic Deterioration|1|||
130306464|NCT04677504|469085251|FG001|Overall Study|Symptomatic Deterioration|0|||
130306465|NCT04677504|469085250|FG000|Overall Study|Withdrawal by Subject|2|||
130306466|NCT04677504|469085251|FG001|Overall Study|Withdrawal by Subject|5|||
130306467|NCT04677504|469085250|FG000|Overall Study|Study Terminated By Sponsor|28|||
130306468|NCT04677504|469085251|FG001|Overall Study|Study Terminated By Sponsor|24|||
130306469|NCT04677504|469085250|FG000|Overall Study|Adverse Event|0|||
130306470|NCT04677504|469085251|FG001|Overall Study|Adverse Event|1|||
130306471|NCT03182907|469085252|FG000|Overall Study|Death|3|||
129889456|NCT00946647|467552606|FG000|Phase ll Part|Untreated|0|||
130108815|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
130306472|NCT03182907|469085253|FG001|Overall Study|Death|0|||
130306473|NCT03182907|469085252|FG000|Overall Study|Protocol Violation|4|||
130108816|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
130108817|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
130108818|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
130306474|NCT03182907|469085253|FG001|Overall Study|Protocol Violation|0|||
130306475|NCT03182907|469085252|FG000|Overall Study|Lost to Follow-up|1|||
130306476|NCT03182907|469085253|FG001|Overall Study|Lost to Follow-up|0|||
130306477|NCT03182907|469085252|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130306478|NCT03182907|469085253|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130306479|NCT04230213|469085263|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
130306480|NCT04230213|469085264|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
130306481|NCT04230213|469085265|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
130108819|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
130108820|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
130108821|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
130108822|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
130108823|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
130108824|NCT01872689|468360932|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
130306482|NCT04230213|469085263|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
130306483|NCT04230213|469085264|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
130306484|NCT04230213|469085265|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
130306485|NCT04230213|469085263|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
130306486|NCT04230213|469085264|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
130306487|NCT04230213|469085265|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
130306488|NCT04230213|469085263|FG000|TP2: Week 10 to Week 16|Other|0|||
130306489|NCT04230213|469085264|FG001|TP2: Week 10 to Week 16|Other|2|||
130306490|NCT04230213|469085265|FG002|TP2: Week 10 to Week 16|Other|1|||
130306491|NCT04230213|469085263|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
130306492|NCT04230213|469085264|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
130306493|NCT04230213|469085265|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
130306494|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
130306495|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
130306496|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
130306497|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
130306498|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
130108825|NCT01872689|468360933|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
130108826|NCT01872689|468360934|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
130108827|NCT01872689|468360935|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
130108828|NCT01872689|468360932|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
130108829|NCT01872689|468360933|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
130108830|NCT01872689|468360934|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
130108831|NCT01872689|468360935|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
130108832|NCT01872689|468360932|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
130108833|NCT01872689|468360933|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
130108834|NCT01872689|468360934|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
130108835|NCT01872689|468360935|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
130108836|NCT01872689|468360932|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130108837|NCT01872689|468360933|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
130108838|NCT01872689|468360934|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130306499|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
130306500|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
130306501|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
130306502|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
130306503|NCT04230213|469085263|FG000|TP3: Week 16 to Week 22|Other|0|||
130306504|NCT04230213|469085264|FG001|TP3: Week 16 to Week 22|Other|1|||
130306505|NCT04230213|469085265|FG002|TP3: Week 16 to Week 22|Other|3|||
130306506|NCT04230213|469085263|FG000|TP4: Week 22 to Week 32|Other|0|||
130306507|NCT04230213|469085264|FG001|TP4: Week 22 to Week 32|Other|5|||
130306508|NCT04230213|469085265|FG002|TP4: Week 22 to Week 32|Other|5|||
130306509|NCT04230213|469085263|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
129797808|NCT02537574|467228234|FG001|Overall Study|Lost to Follow-up|51|||
129797809|NCT02537574|467228235|FG002|Overall Study|Lost to Follow-up|55|||
129797810|NCT02537574|467228233|FG000|Overall Study|Noncompliance with study drug|0|||
129797811|NCT02537574|467228234|FG001|Overall Study|Noncompliance with study drug|1|||
129797812|NCT02537574|467228235|FG002|Overall Study|Noncompliance with study drug|1|||
129797813|NCT02537574|467228233|FG000|Overall Study|Physician Decision|2|||
129797814|NCT02537574|467228234|FG001|Overall Study|Physician Decision|0|||
129797815|NCT02537574|467228235|FG002|Overall Study|Physician Decision|0|||
129797816|NCT02537574|467228233|FG000|Overall Study|Protocol Violation|4|||
129797817|NCT02537574|467228234|FG001|Overall Study|Protocol Violation|2|||
129797818|NCT02537574|467228235|FG002|Overall Study|Protocol Violation|3|||
129797819|NCT02537574|467228233|FG000|Overall Study|Withdrawal by Subject|37|||
130108839|NCT01872689|468360935|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
130108840|NCT01872689|468360932|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
130108841|NCT01872689|468360933|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
130108842|NCT01872689|468360934|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
130108843|NCT01872689|468360935|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
130108844|NCT01872689|468360932|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
130108845|NCT01872689|468360933|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
130108846|NCT01872689|468360934|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
130108847|NCT01872689|468360935|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
130108848|NCT01872689|468360932|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
130108849|NCT01872689|468360933|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
130108850|NCT01872689|468360934|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
130108851|NCT01872689|468360935|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
130108852|NCT00686374|468360939|FG000|Overall Study|Lack of Efficacy|10|||
130108853|NCT00686374|468360939|FG000|Overall Study|Adverse Event|8|||
130108854|NCT00686374|468360939|FG000|Overall Study|Withdrew consent|5|||
130108855|NCT00686374|468360939|FG000|Overall Study|Lost to Follow-up|1|||
130108856|NCT00686374|468360939|FG000|Overall Study|Missing reason|33|||
130108857|NCT00686374|468360939|FG000|Overall Study|Other, not specified|4|||
130306510|NCT04230213|469085264|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
130306511|NCT04230213|469085265|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
130306512|NCT04230213|469085263|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
130306513|NCT04230213|469085264|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
129889457|NCT00946647|467552607|FG001|Phase ll Part|Untreated|0|||
130108858|NCT02143947|468360941|FG000|Overall Study|Lost to Follow-up|4|||
130108859|NCT02143947|468360942|FG001|Overall Study|Lost to Follow-up|2|||
130108860|NCT01244815|468360943|FG000|Overall Study|Not Treated|0|||
130108861|NCT01244815|468360944|FG001|Overall Study|Not Treated|1|||
130108862|NCT01244815|468360945|FG002|Overall Study|Not Treated|0|||
130108863|NCT01244815|468360946|FG003|Overall Study|Not Treated|0|||
130108864|NCT01244815|468360943|FG000|Overall Study|Adverse Event|4|||
130108865|NCT01244815|468360944|FG001|Overall Study|Adverse Event|7|||
130108866|NCT01244815|468360945|FG002|Overall Study|Adverse Event|5|||
130108867|NCT01244815|468360946|FG003|Overall Study|Adverse Event|5|||
130108868|NCT01244815|468360943|FG000|Overall Study|Treatment Failure|0|||
130108869|NCT01244815|468360944|FG001|Overall Study|Treatment Failure|0|||
130108870|NCT01244815|468360945|FG002|Overall Study|Treatment Failure|0|||
130108871|NCT01244815|468360946|FG003|Overall Study|Treatment Failure|1|||
130108872|NCT01244815|468360943|FG000|Overall Study|Lost to Follow-up|3|||
130108873|NCT01244815|468360944|FG001|Overall Study|Lost to Follow-up|2|||
130108874|NCT01244815|468360945|FG002|Overall Study|Lost to Follow-up|3|||
130108875|NCT01244815|468360946|FG003|Overall Study|Lost to Follow-up|2|||
130108876|NCT01244815|468360943|FG000|Overall Study|Withdrawal by Subject|0|||
130108877|NCT01244815|468360944|FG001|Overall Study|Withdrawal by Subject|2|||
130108878|NCT01244815|468360945|FG002|Overall Study|Withdrawal by Subject|0|||
130108879|NCT01244815|468360946|FG003|Overall Study|Withdrawal by Subject|3|||
130108880|NCT01244815|468360943|FG000|Overall Study|Protocol Violation|7|||
130108881|NCT01244815|468360944|FG001|Overall Study|Protocol Violation|4|||
130108882|NCT01244815|468360945|FG002|Overall Study|Protocol Violation|3|||
130108883|NCT01244815|468360946|FG003|Overall Study|Protocol Violation|1|||
130108884|NCT01244815|468360943|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
130108885|NCT01244815|468360944|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
130108886|NCT01244815|468360945|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
130108887|NCT01244815|468360946|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
130108888|NCT00697112|468360948|FG000|Overall Study|Adverse Event|8|||
130108889|NCT00697112|468360948|FG000|Overall Study|Lost to Follow-up|1|||
130108890|NCT00697112|468360948|FG000|Overall Study|Did not meet inclusion criteria|1|||
130108891|NCT03066440|468360951|FG000|Overall Study|Physician Decision|1|||
130108892|NCT03066440|468360952|FG001|Overall Study|Physician Decision|1|||
130108893|NCT03066440|468360951|FG000|Overall Study|Protocol Violation|0|||
130108894|NCT03066440|468360952|FG001|Overall Study|Protocol Violation|2|||
130108895|NCT00736333|468360953|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
130108896|NCT00736333|468360953|FG000|Overall Study|Data Missing|2|||
130108897|NCT00736333|468360953|FG000|Overall Study|Tumor Progression|75|||
130108898|NCT00736333|468360953|FG000|Overall Study|Toxicity|6|||
130108899|NCT00736333|468360953|FG000|Overall Study|Withdrawal by Subject|10|||
130108900|NCT00736333|468360953|FG000|Overall Study|Death|7|||
130108901|NCT00736333|468360953|FG000|Overall Study|Other|4|||
130108902|NCT01106352|468360956|FG000|Overall Study|Subjects untreated|0|||
130108903|NCT01106352|468360957|FG001|Overall Study|Subjects untreated|0|||
130108904|NCT01106352|468360958|FG002|Overall Study|Subjects untreated|0|||
130108905|NCT01106352|468360959|FG003|Overall Study|Subjects untreated|3|||
130108906|NCT01106352|468360960|FG004|Overall Study|Subjects untreated|4|||
130108907|NCT01106352|468360956|FG000|Overall Study|Sponsor Decision|1|||
130306514|NCT04230213|469085265|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
130306515|NCT04230213|469085263|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
130306516|NCT04230213|469085264|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
130306517|NCT04230213|469085265|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
130306518|NCT04230213|469085263|FG000|Follow up: Week 32 to Week 36|Other|0|||
130306519|NCT04230213|469085264|FG001|Follow up: Week 32 to Week 36|Other|1|||
130306520|NCT04230213|469085265|FG002|Follow up: Week 32 to Week 36|Other|1|||
130306521|NCT01957202|469087097|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306522|NCT01957202|469087098|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
130306523|NCT01957202|469087099|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306524|NCT01957202|469087100|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306525|NCT01957202|469087101|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306526|NCT01957202|469087102|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306527|NCT01957202|469087103|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306528|NCT01957202|469087104|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306529|NCT01957202|469087105|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129889458|NCT00946647|467552608|FG002|Phase ll Part|Untreated|0|||
130048547|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
130048548|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
130048549|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
130048550|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Death|8|||
130048551|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Death|3|||
130048552|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
130048553|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
130048554|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
130048555|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
130048556|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
130048557|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
130048558|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
130048559|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
130048560|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
130048561|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
130048562|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
130048563|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
130048564|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
130048565|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
130048566|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
130048567|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
130048568|NCT00494871|468134568|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
130048569|NCT00494871|468134569|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
130048570|NCT00494871|468134568|FG000|Follow-up (FU) Period|Adverse Event|1|||
130048571|NCT00494871|468134569|FG001|Follow-up (FU) Period|Adverse Event|1|||
130048572|NCT00494871|468134568|FG000|Follow-up (FU) Period|Death|13|||
130048573|NCT00494871|468134569|FG001|Follow-up (FU) Period|Death|12|||
130048574|NCT00494871|468134568|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
130048575|NCT00494871|468134569|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
130048576|NCT00494871|468134568|FG000|Follow-up (FU) Period|Physician Decision|0|||
130048577|NCT00494871|468134569|FG001|Follow-up (FU) Period|Physician Decision|1|||
130048578|NCT00494871|468134568|FG000|Follow-up (FU) Period|Protocol Violation|1|||
130048579|NCT00494871|468134569|FG001|Follow-up (FU) Period|Protocol Violation|0|||
130048580|NCT00494871|468134568|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
130048581|NCT00494871|468134569|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
130048582|NCT00494871|468134568|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
130048583|NCT00494871|468134569|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
130048584|NCT04543955|468134570|FG000|Overall Study|Company cancelled study|1|||
130048585|NCT04543955|468134571|FG001|Overall Study|Company cancelled study|0|||
130048586|NCT02601001|468134574|FG000|Dosing Period 2|Adverse Event|0|||
130048587|NCT02601001|468134575|FG001|Dosing Period 2|Adverse Event|0|||
130048588|NCT02601001|468134576|FG002|Dosing Period 2|Adverse Event|0|||
130048589|NCT02601001|468134577|FG003|Dosing Period 2|Adverse Event|0|||
130048590|NCT02601001|468134578|FG004|Dosing Period 2|Adverse Event|0|||
130048591|NCT02601001|468134579|FG005|Dosing Period 2|Adverse Event|0|||
130048592|NCT02601001|468134580|FG006|Dosing Period 2|Adverse Event|1|||
130048593|NCT03504774|468134585|FG000|Overall Study|Adverse Event|2|||
130048594|NCT03504774|468134586|FG001|Overall Study|Adverse Event|0|||
130048595|NCT03504774|468134585|FG000|Overall Study|Lost to Follow-up|0|||
130048596|NCT03504774|468134586|FG001|Overall Study|Lost to Follow-up|1|||
130048597|NCT03504774|468134585|FG000|Overall Study|Protocol Violation|11|||
130048598|NCT03504774|468134586|FG001|Overall Study|Protocol Violation|3|||
130048599|NCT03504774|468134585|FG000|Overall Study|failed wk 52 DBPCFC|1|||
130048600|NCT03504774|468134586|FG001|Overall Study|failed wk 52 DBPCFC|0|||
130048601|NCT00915005|468134592|FG000|Overall Study|Withdrawal by Subject|4|||
130108908|NCT01106352|468360957|FG001|Overall Study|Sponsor Decision|0|||
130108909|NCT01106352|468360958|FG002|Overall Study|Sponsor Decision|0|||
130108910|NCT01106352|468360959|FG003|Overall Study|Sponsor Decision|0|||
130108911|NCT01106352|468360960|FG004|Overall Study|Sponsor Decision|0|||
130108912|NCT01106352|468360956|FG000|Overall Study|Too ill to come in for the visit|0|||
130108913|NCT01106352|468360957|FG001|Overall Study|Too ill to come in for the visit|0|||
130108914|NCT01106352|468360958|FG002|Overall Study|Too ill to come in for the visit|1|||
130108915|NCT01106352|468360959|FG003|Overall Study|Too ill to come in for the visit|0|||
130108916|NCT01106352|468360960|FG004|Overall Study|Too ill to come in for the visit|0|||
130108917|NCT01106352|468360956|FG000|Overall Study|Lost to Follow-up|0|||
130108918|NCT01106352|468360957|FG001|Overall Study|Lost to Follow-up|0|||
130108919|NCT01106352|468360958|FG002|Overall Study|Lost to Follow-up|0|||
130108920|NCT01106352|468360959|FG003|Overall Study|Lost to Follow-up|0|||
130108921|NCT01106352|468360960|FG004|Overall Study|Lost to Follow-up|1|||
130108922|NCT01106352|468360956|FG000|Overall Study|Death|0|||
130108923|NCT01106352|468360957|FG001|Overall Study|Death|0|||
130108924|NCT01106352|468360958|FG002|Overall Study|Death|1|||
130108925|NCT01106352|468360959|FG003|Overall Study|Death|3|||
129889459|NCT00946647|467552609|FG003|Phase ll Part|Untreated|0|||
129889460|NCT00946647|467552610|FG004|Phase ll Part|Untreated|2|||
129889461|NCT00946647|467552606|FG000|Phase ll Part|Adverse Event|0|||
129889462|NCT00946647|467552607|FG001|Phase ll Part|Adverse Event|0|||
129889463|NCT00946647|467552608|FG002|Phase ll Part|Adverse Event|0|||
129889464|NCT00946647|467552609|FG003|Phase ll Part|Adverse Event|10|||
129889465|NCT00946647|467552610|FG004|Phase ll Part|Adverse Event|6|||
129889466|NCT00946647|467552606|FG000|Phase ll Part|Withdrawal by Subject|0|||
130048602|NCT00915005|468134593|FG001|Overall Study|Withdrawal by Subject|4|||
130048603|NCT00915005|468134592|FG000|Overall Study|Patient preferred protons therapy|6|||
130048604|NCT00915005|468134593|FG001|Overall Study|Patient preferred protons therapy|0|||
130048605|NCT00915005|468134592|FG000|Overall Study|Insurance denial|3|||
130048606|NCT00915005|468134593|FG001|Overall Study|Insurance denial|15|||
130048607|NCT03554005|468134596|FG000|Overall Study|Not in participant's best interest|0|||
130048608|NCT03554005|468134597|FG001|Overall Study|Not in participant's best interest|0|||
130048609|NCT03554005|468134598|FG002|Overall Study|Not in participant's best interest|0|||
130048610|NCT03554005|468134599|FG003|Overall Study|Not in participant's best interest|0|||
130048611|NCT03554005|468134600|FG004|Overall Study|Not in participant's best interest|0|||
130048612|NCT03554005|468134601|FG005|Overall Study|Not in participant's best interest|1|||
130048613|NCT03554005|468134596|FG000|Overall Study|Disease Progression|1|||
130048614|NCT03554005|468134597|FG001|Overall Study|Disease Progression|1|||
130048615|NCT03554005|468134598|FG002|Overall Study|Disease Progression|1|||
130048616|NCT03554005|468134599|FG003|Overall Study|Disease Progression|1|||
130048617|NCT03554005|468134600|FG004|Overall Study|Disease Progression|5|||
130048618|NCT03554005|468134601|FG005|Overall Study|Disease Progression|6|||
130048619|NCT03554005|468134596|FG000|Overall Study|Adverse Event|0|||
130048620|NCT03554005|468134597|FG001|Overall Study|Adverse Event|0|||
130048621|NCT03554005|468134598|FG002|Overall Study|Adverse Event|0|||
130048622|NCT03554005|468134599|FG003|Overall Study|Adverse Event|0|||
130048623|NCT03554005|468134600|FG004|Overall Study|Adverse Event|0|||
130048624|NCT03554005|468134601|FG005|Overall Study|Adverse Event|3|||
130048625|NCT03554005|468134596|FG000|Overall Study|Physician Decision|0|||
130048626|NCT03554005|468134597|FG001|Overall Study|Physician Decision|0|||
130048627|NCT03554005|468134598|FG002|Overall Study|Physician Decision|0|||
130048628|NCT03554005|468134599|FG003|Overall Study|Physician Decision|0|||
130048629|NCT03554005|468134600|FG004|Overall Study|Physician Decision|1|||
130048630|NCT03554005|468134601|FG005|Overall Study|Physician Decision|0|||
130048631|NCT03554005|468134596|FG000|Overall Study|Other|0|||
130048632|NCT03554005|468134597|FG001|Overall Study|Other|0|||
130048633|NCT03554005|468134598|FG002|Overall Study|Other|0|||
130048634|NCT03554005|468134599|FG003|Overall Study|Other|0|||
130048635|NCT03554005|468134600|FG004|Overall Study|Other|0|||
130048636|NCT03554005|468134601|FG005|Overall Study|Other|1|||
130048637|NCT00631488|468134602|FG000|Overall Study|Adverse Event|1|||
130048638|NCT00631488|468134603|FG001|Overall Study|Adverse Event|0|||
130048639|NCT00631488|468134604|FG002|Overall Study|Adverse Event|0|||
130048640|NCT00631488|468134602|FG000|Overall Study|Lost to Follow-up|2|||
130048641|NCT00631488|468134603|FG001|Overall Study|Lost to Follow-up|2|||
130048642|NCT00631488|468134604|FG002|Overall Study|Lost to Follow-up|0|||
130048643|NCT00631488|468134602|FG000|Overall Study|Physician Decision|1|||
130048644|NCT00631488|468134603|FG001|Overall Study|Physician Decision|0|||
130048645|NCT00631488|468134604|FG002|Overall Study|Physician Decision|1|||
130048646|NCT00631488|468134602|FG000|Overall Study|Protocol Violation|0|||
130048647|NCT00631488|468134603|FG001|Overall Study|Protocol Violation|0|||
130108926|NCT01106352|468360960|FG004|Overall Study|Death|1|||
130108927|NCT01106352|468360956|FG000|Overall Study|Disease progression|0|||
130108928|NCT01106352|468360957|FG001|Overall Study|Disease progression|0|||
130108929|NCT01106352|468360958|FG002|Overall Study|Disease progression|0|||
130108930|NCT01106352|468360959|FG003|Overall Study|Disease progression|1|||
130108931|NCT01106352|468360960|FG004|Overall Study|Disease progression|0|||
130048648|NCT00631488|468134604|FG002|Overall Study|Protocol Violation|1|||
130108932|NCT01106352|468360956|FG000|Overall Study|Withdrawal by Subject|0|||
130108933|NCT01106352|468360957|FG001|Overall Study|Withdrawal by Subject|0|||
130108934|NCT01106352|468360958|FG002|Overall Study|Withdrawal by Subject|0|||
130306530|NCT01957202|469087106|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306531|NCT01957202|469087107|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306532|NCT01957202|469087108|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306533|NCT01957202|469087109|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306534|NCT01957202|469087110|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306535|NCT01957202|469087111|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306536|NCT01957202|469087112|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306537|NCT01957202|469087113|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
130306538|NCT01957202|469087114|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
130306539|NCT01957202|469087097|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306540|NCT01957202|469087098|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306541|NCT01957202|469087099|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306542|NCT01957202|469087100|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306543|NCT01957202|469087101|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306544|NCT01957202|469087102|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306545|NCT01957202|469087103|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306546|NCT01957202|469087104|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306547|NCT01957202|469087105|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306548|NCT01957202|469087106|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306549|NCT01957202|469087107|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306550|NCT01957202|469087108|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306551|NCT01957202|469087109|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306552|NCT01957202|469087110|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306553|NCT01957202|469087111|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306554|NCT01957202|469087112|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306555|NCT01957202|469087113|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
130306556|NCT01957202|469087114|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
130306557|NCT01456169|469087115|FG000|Overall Study|Adverse Event|1|||
130306558|NCT01456169|469087116|FG001|Overall Study|Adverse Event|2|||
130306559|NCT01456169|469087117|FG002|Overall Study|Adverse Event|7|||
130306560|NCT01456169|469087115|FG000|Overall Study|Major Protocol Deviation|3|||
130306561|NCT01456169|469087116|FG001|Overall Study|Major Protocol Deviation|2|||
130306562|NCT01456169|469087117|FG002|Overall Study|Major Protocol Deviation|3|||
130306563|NCT01456169|469087115|FG000|Overall Study|Voluntary Withdrawal|3|||
130306564|NCT01456169|469087116|FG001|Overall Study|Voluntary Withdrawal|0|||
130306565|NCT01456169|469087117|FG002|Overall Study|Voluntary Withdrawal|2|||
130306566|NCT01456169|469087115|FG000|Overall Study|Lack of Efficacy|2|||
130306567|NCT01456169|469087116|FG001|Overall Study|Lack of Efficacy|0|||
130306568|NCT01456169|469087117|FG002|Overall Study|Lack of Efficacy|0|||
130306569|NCT01456169|469087115|FG000|Overall Study|Other|1|||
130306570|NCT01456169|469087116|FG001|Overall Study|Other|1|||
130306571|NCT01456169|469087117|FG002|Overall Study|Other|0|||
130306572|NCT02342223|469087122|FG000|Overall Study|Lost to Follow-up|1|||
129797820|NCT02537574|467228234|FG001|Overall Study|Withdrawal by Subject|27|||
129797821|NCT02537574|467228235|FG002|Overall Study|Withdrawal by Subject|29|||
130108935|NCT01106352|468360959|FG003|Overall Study|Withdrawal by Subject|3|||
130108936|NCT01106352|468360960|FG004|Overall Study|Withdrawal by Subject|2|||
130108937|NCT01106352|468360956|FG000|Overall Study|Went on hospice|0|||
130108938|NCT01106352|468360957|FG001|Overall Study|Went on hospice|0|||
130108939|NCT01106352|468360958|FG002|Overall Study|Went on hospice|0|||
130108940|NCT01106352|468360959|FG003|Overall Study|Went on hospice|1|||
130108941|NCT01106352|468360960|FG004|Overall Study|Went on hospice|0|||
130108942|NCT01106352|468360956|FG000|Overall Study|Subject entered hospice|0|||
130108943|NCT01106352|468360957|FG001|Overall Study|Subject entered hospice|0|||
130108944|NCT01106352|468360958|FG002|Overall Study|Subject entered hospice|0|||
130306573|NCT01200368|469087127|FG000|Infant Series|Adverse Event|2|||
130306574|NCT01200368|469087128|FG001|Infant Series|Adverse Event|2|||
130306575|NCT01200368|469087129|FG002|Infant Series|Adverse Event|3|||
130306576|NCT01200368|469087127|FG000|Infant Series|Withdrawal by Subject|0|||
130306577|NCT01200368|469087128|FG001|Infant Series|Withdrawal by Subject|2|||
130306578|NCT01200368|469087129|FG002|Infant Series|Withdrawal by Subject|2|||
130306579|NCT01200368|469087127|FG000|Infant Series|Did not meet entrance criteria|0|||
130306580|NCT01200368|469087128|FG001|Infant Series|Did not meet entrance criteria|1|||
130306581|NCT01200368|469087129|FG002|Infant Series|Did not meet entrance criteria|0|||
130108945|NCT01106352|468360959|FG003|Overall Study|Subject entered hospice|1|||
130306582|NCT01200368|469087127|FG000|Infant Series|Randomized, not vaccinated|0|||
130306583|NCT01200368|469087128|FG001|Infant Series|Randomized, not vaccinated|1|||
130306584|NCT01200368|469087129|FG002|Infant Series|Randomized, not vaccinated|1|||
130306585|NCT01200368|469087127|FG000|Infant Series|Other|1|||
130306586|NCT01200368|469087128|FG001|Infant Series|Other|0|||
130306587|NCT01200368|469087129|FG002|Infant Series|Other|0|||
130306588|NCT01200368|469087127|FG000|After Infant Series|Adverse Event|6|||
130108946|NCT01106352|468360960|FG004|Overall Study|Subject entered hospice|0|||
130108947|NCT01106352|468360956|FG000|Overall Study|Home hospice since July 2013|0|||
130108948|NCT01106352|468360957|FG001|Overall Study|Home hospice since July 2013|0|||
130108949|NCT01106352|468360958|FG002|Overall Study|Home hospice since July 2013|0|||
130108950|NCT01106352|468360959|FG003|Overall Study|Home hospice since July 2013|1|||
130108951|NCT01106352|468360960|FG004|Overall Study|Home hospice since July 2013|0|||
130108952|NCT03944707|468360961|FG000|Overall Study|Adverse Event|0|||
130108953|NCT03944707|468360962|FG001|Overall Study|Adverse Event|2|||
130108954|NCT03944707|468360961|FG000|Overall Study|Study terminated by sponsor|12|||
130108955|NCT03944707|468360962|FG001|Overall Study|Study terminated by sponsor|7|||
130108956|NCT03944707|468360961|FG000|Overall Study|Subject decision|0|||
130108957|NCT03944707|468360962|FG001|Overall Study|Subject decision|1|||
130108958|NCT04126733|468360965|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
130108959|NCT04126733|468360965|FG000|Treatment Period|Adverse Event|8|||
130108960|NCT04126733|468360965|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
130108961|NCT04126733|468360965|FG000|Treatment Period|Physician Decision|5|||
130108962|NCT04126733|468360965|FG000|Treatment Period|Death|1|||
130108963|NCT04126733|468360965|FG000|Treatment Period|Other Reasons|2|||
130108964|NCT04126733|468360965|FG000|Active Follow-up Period|Death|13|||
130108965|NCT04126733|468360965|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
130108966|NCT04126733|468360965|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
130108967|NCT04126733|468360965|FG000|Active Follow-up Period|Other Reasons|1|||
130108968|NCT04126733|468360965|FG000|Long-term Follow-up Period|Death|22|||
130108969|NCT04126733|468360965|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
130108970|NCT04126733|468360965|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
130108971|NCT02598193|468360967|FG000|Overall Study|Adverse Event|13|||
130108972|NCT02598193|468360967|FG000|Overall Study|Withdrawal by Subject|1|||
130108973|NCT02598193|468360967|FG000|Overall Study|Listed in active lung transplant list|1|||
130108974|NCT02598193|468360967|FG000|Overall Study|Does not want to take Nintedanib|1|||
130108975|NCT02487979|468360970|FG000|Overall Study|Physician Decision|2|||
130108976|NCT02487979|468360970|FG000|Overall Study|Withdrawal by Subject|2|||
130108977|NCT02487979|468360970|FG000|Overall Study|Progressive Disease|17|||
130108978|NCT00447694|468360971|FG000|Overall Study|Adverse Event|2|||
130108979|NCT00447694|468360971|FG000|Overall Study|Abnormal laboratory value|1|||
130108980|NCT00447694|468360971|FG000|Overall Study|Abnormal test procedure result|1|||
130108981|NCT00447694|468360971|FG000|Overall Study|Withdrawal by Subject|2|||
130108982|NCT02354976|468360976|FG000|Overall Study|Other - reason not specified|1|||
130108983|NCT02354976|468360977|FG001|Overall Study|Other - reason not specified|0|||
130108984|NCT02354976|468360978|FG002|Overall Study|Other - reason not specified|1|||
130108985|NCT02354976|468360976|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
130108986|NCT02354976|468360977|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
130108987|NCT02354976|468360978|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
130108988|NCT02354976|468360976|FG000|Overall Study|Adverse Event|1|||
130108989|NCT02354976|468360977|FG001|Overall Study|Adverse Event|0|||
130108990|NCT02354976|468360978|FG002|Overall Study|Adverse Event|2|||
130108991|NCT00986154|468360979|FG000|Overall Study|Death|136|||
130108992|NCT00986154|468360980|FG001|Overall Study|Death|127|||
130108993|NCT00986154|468360979|FG000|Overall Study|Lost to Follow-up|7|||
130108994|NCT00986154|468360980|FG001|Overall Study|Lost to Follow-up|4|||
130108995|NCT00986154|468360979|FG000|Overall Study|Withdrawal by Subject|32|||
130108996|NCT00986154|468360980|FG001|Overall Study|Withdrawal by Subject|33|||
130108997|NCT00986154|468360979|FG000|Overall Study|investigator/subject decide not continue|6|||
130108998|NCT00986154|468360980|FG001|Overall Study|investigator/subject decide not continue|3|||
130108999|NCT00986154|468360979|FG000|Overall Study|never received study drug|25|||
130109000|NCT00986154|468360980|FG001|Overall Study|never received study drug|27|||
130109001|NCT03726437|468360981|FG000|Overall Study|Lost to Follow-up|85|||
130109002|NCT03726437|468360982|FG001|Overall Study|Lost to Follow-up|76|||
130109003|NCT00068445|468360983|FG000|Randomization|Cancel|1|||
130109004|NCT00068445|468360984|FG001|Randomization|Cancel|3|||
130109005|NCT00068445|468360983|FG000|Randomization|Ineligible|1|||
130109006|NCT00068445|468360984|FG001|Randomization|Ineligible|1|||
130109007|NCT00068445|468360983|FG000|Treatment|Refused Further Treatment|13|||
130109008|NCT00068445|468360984|FG001|Treatment|Refused Further Treatment|10|||
130109009|NCT00068445|468360983|FG000|Treatment|Adverse Event|7|||
130109010|NCT00068445|468360984|FG001|Treatment|Adverse Event|1|||
130109011|NCT00068445|468360983|FG000|Treatment|Other (Specifics not available)|9|||
130109012|NCT00068445|468360984|FG001|Treatment|Other (Specifics not available)|5|||
130109013|NCT03118765|468360986|FG000|Overall Study|Withdrawal by Subject|0|||
130109014|NCT03118765|468360987|FG001|Overall Study|Withdrawal by Subject|0|||
130109015|NCT03118765|468360988|FG002|Overall Study|Withdrawal by Subject|1|||
130109016|NCT03118765|468360989|FG003|Overall Study|Withdrawal by Subject|0|||
130109017|NCT03118765|468360990|FG004|Overall Study|Withdrawal by Subject|0|||
130109018|NCT03118765|468360986|FG000|Overall Study|Adverse Event|1|||
130109019|NCT03118765|468360987|FG001|Overall Study|Adverse Event|1|||
130109020|NCT03118765|468360988|FG002|Overall Study|Adverse Event|1|||
130109021|NCT03118765|468360989|FG003|Overall Study|Adverse Event|1|||
130109022|NCT03118765|468360990|FG004|Overall Study|Adverse Event|1|||
130109023|NCT03118765|468360986|FG000|Overall Study|Non compliance with Study Procedures|0|||
130109024|NCT03118765|468360987|FG001|Overall Study|Non compliance with Study Procedures|0|||
130109025|NCT03118765|468360988|FG002|Overall Study|Non compliance with Study Procedures|0|||
130109026|NCT03118765|468360989|FG003|Overall Study|Non compliance with Study Procedures|1|||
130109027|NCT03118765|468360990|FG004|Overall Study|Non compliance with Study Procedures|0|||
130109028|NCT03118765|468360986|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
130109029|NCT03118765|468360987|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
130109030|NCT03118765|468360988|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
130109031|NCT03118765|468360989|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
130109032|NCT03118765|468360990|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
130109033|NCT03118765|468360986|FG000|Overall Study|COPD Exacerbation|1|||
130109034|NCT03118765|468360987|FG001|Overall Study|COPD Exacerbation|0|||
130109035|NCT03118765|468360988|FG002|Overall Study|COPD Exacerbation|0|||
130109036|NCT03118765|468360989|FG003|Overall Study|COPD Exacerbation|1|||
130109037|NCT03118765|468360990|FG004|Overall Study|COPD Exacerbation|0|||
130109038|NCT03118765|468360986|FG000|Overall Study|Lost to Follow-up|1|||
130109039|NCT03118765|468360987|FG001|Overall Study|Lost to Follow-up|0|||
130109040|NCT03118765|468360988|FG002|Overall Study|Lost to Follow-up|1|||
130109041|NCT03118765|468360989|FG003|Overall Study|Lost to Follow-up|0|||
130109042|NCT03118765|468360990|FG004|Overall Study|Lost to Follow-up|0|||
130109043|NCT03118765|468360986|FG000|Overall Study|Sponsor Decision|1|||
130109044|NCT03118765|468360987|FG001|Overall Study|Sponsor Decision|0|||
130109045|NCT03118765|468360988|FG002|Overall Study|Sponsor Decision|1|||
130109046|NCT03118765|468360989|FG003|Overall Study|Sponsor Decision|0|||
130109047|NCT03118765|468360990|FG004|Overall Study|Sponsor Decision|1|||
130109048|NCT00879970|468360991|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
130109049|NCT00879970|468360992|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
130109050|NCT00879970|468360993|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
130306589|NCT01200368|469087128|FG001|After Infant Series|Adverse Event|6|||
130306590|NCT01200368|469087129|FG002|After Infant Series|Adverse Event|3|||
130306591|NCT01200368|469087127|FG000|After Infant Series|Withdrawal by Subject|10|||
130306592|NCT01200368|469087128|FG001|After Infant Series|Withdrawal by Subject|8|||
130306593|NCT01200368|469087129|FG002|After Infant Series|Withdrawal by Subject|4|||
130306594|NCT01200368|469087127|FG000|After Infant Series|Lost to Follow-up|1|||
130306595|NCT01200368|469087128|FG001|After Infant Series|Lost to Follow-up|0|||
130306596|NCT01200368|469087129|FG002|After Infant Series|Lost to Follow-up|0|||
130048649|NCT03648476|468134605|FG000|Overall Study|Withdrawal by Subject|2|||
130048650|NCT03648476|468134606|FG001|Overall Study|Withdrawal by Subject|1|||
130048651|NCT02855411|468134608|FG000|Overall Study|Study terminated by sponsor|21|||
130048652|NCT02855411|468134608|FG000|Overall Study|Does not meet entrance criteria|14|||
130048653|NCT01996319|468134611|FG000|Overall Study|Protocol Violation|1|||
130048654|NCT01996319|468134612|FG001|Overall Study|Protocol Violation|0|||
130048655|NCT01996319|468134611|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
130048656|NCT01996319|468134612|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
130048657|NCT01996319|468134611|FG000|Overall Study|Adverse Event|2|||
130048658|NCT01996319|468134612|FG001|Overall Study|Adverse Event|2|||
130048659|NCT01671085|468134613|FG000|Overall Study|Withdrawal by Subject|1|||
130048660|NCT01671085|468134614|FG001|Overall Study|Withdrawal by Subject|0|||
130048661|NCT00637273|468134615|FG000|Overall Study|Adverse Event|11|||
130048662|NCT00637273|468134616|FG001|Overall Study|Adverse Event|5|||
130048663|NCT00637273|468134617|FG002|Overall Study|Adverse Event|7|||
130048664|NCT00637273|468134615|FG000|Overall Study|Lost to Follow-up|8|||
130048665|NCT00637273|468134616|FG001|Overall Study|Lost to Follow-up|9|||
130048666|NCT00637273|468134617|FG002|Overall Study|Lost to Follow-up|13|||
130048667|NCT00637273|468134615|FG000|Overall Study|Protocol Violation|2|||
130048668|NCT00637273|468134616|FG001|Overall Study|Protocol Violation|4|||
130048669|NCT00637273|468134617|FG002|Overall Study|Protocol Violation|1|||
130048670|NCT00637273|468134615|FG000|Overall Study|Withdrawal of Consent|18|||
130048671|NCT00637273|468134616|FG001|Overall Study|Withdrawal of Consent|6|||
130048672|NCT00637273|468134617|FG002|Overall Study|Withdrawal of Consent|18|||
130048673|NCT00637273|468134615|FG000|Overall Study|Investigator Decision|1|||
130048674|NCT00637273|468134616|FG001|Overall Study|Investigator Decision|3|||
130048675|NCT00637273|468134617|FG002|Overall Study|Investigator Decision|1|||
130048676|NCT00637273|468134615|FG000|Overall Study|Administrative|2|||
130048677|NCT00637273|468134616|FG001|Overall Study|Administrative|0|||
130109051|NCT00879970|468360994|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
130109052|NCT00879970|468360995|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
130109053|NCT00879970|468360991|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
129797822|NCT02537574|467228233|FG000|Overall Study|Lack of Efficacy|14|||
130048678|NCT00637273|468134617|FG002|Overall Study|Administrative|0|||
130048679|NCT00637273|468134615|FG000|Overall Study|Loss of Glucose Control|1|||
130048680|NCT00637273|468134616|FG001|Overall Study|Loss of Glucose Control|1|||
130048681|NCT00637273|468134617|FG002|Overall Study|Loss of Glucose Control|1|||
130109054|NCT00879970|468360992|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
130306597|NCT01200368|469087127|FG000|After Infant Series|Other|1|||
130048682|NCT00986258|468134618|FG000|Observation Period|Not eligible to be dosed|11|||
130109055|NCT00879970|468360993|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
130109056|NCT00879970|468360994|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
130109057|NCT00879970|468360995|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
130109058|NCT00879970|468360991|FG000|Period 1 TZD Randomization|Death|2|||
130109059|NCT00879970|468360992|FG001|Period 1 TZD Randomization|Death|1|||
130109060|NCT00879970|468360993|FG002|Period 1 TZD Randomization|Death|0|||
130109061|NCT00879970|468360994|FG003|Period 1 TZD Randomization|Death|0|||
130109062|NCT00879970|468360995|FG004|Period 1 TZD Randomization|Death|0|||
130109063|NCT00879970|468360991|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
130109064|NCT00879970|468360992|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
130109065|NCT00879970|468360993|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
130109066|NCT00879970|468360994|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
130109067|NCT00879970|468360995|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
130109068|NCT00879970|468360991|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130109069|NCT00879970|468360992|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130306598|NCT01200368|469087128|FG001|After Infant Series|Other|2|||
130048683|NCT00986258|468134618|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
130109070|NCT00879970|468360993|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
130109071|NCT00879970|468360994|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
130306599|NCT01200368|469087129|FG002|After Infant Series|Other|2|||
130306600|NCT01200368|469087127|FG000|Toddler Dose|Adverse Event|0|||
130306601|NCT01200368|469087128|FG001|Toddler Dose|Adverse Event|3|||
130306602|NCT01200368|469087129|FG002|Toddler Dose|Adverse Event|1|||
130306603|NCT02221674|469087132|FG000|Overall Study|Lost to Follow-up|1|||
130306604|NCT02221674|469087133|FG001|Overall Study|Lost to Follow-up|0|||
130306605|NCT02221674|469087134|FG002|Overall Study|Lost to Follow-up|0|||
130306606|NCT02557542|469087136|FG000|Overall Study|Poor recruitment|3|||
129797823|NCT02537574|467228234|FG001|Overall Study|Lack of Efficacy|16|||
130048684|NCT00986258|468134618|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
130048685|NCT00986258|468134618|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
130048686|NCT00986258|468134618|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
130048687|NCT00986258|468134618|FG000|Titration and Optimal Dose Period|Other|1|||
130048688|NCT00986258|468134618|FG000|Maintenance Period|Adverse Event|5|||
130048689|NCT00986258|468134618|FG000|Maintenance Period|Lack of Efficacy|2|||
130048690|NCT00986258|468134618|FG000|Maintenance Period|Withdrawal by Subject|2|||
130048691|NCT04230486|468134627|FG000|Overall Study|Screen Failure|1|||
130048692|NCT03215264|468134628|FG000|Dose Level 2|Adverse Event|0|||
130048693|NCT03215264|468134629|FG001|Dose Level 2|Adverse Event|1|||
130048694|NCT03215264|468134630|FG002|Dose Level 2|Adverse Event|0|||
130048695|NCT03215264|468134628|FG000|Dose Level 3|Withdrawal by Subject|0|||
130048696|NCT03215264|468134629|FG001|Dose Level 3|Withdrawal by Subject|0|||
130048697|NCT03215264|468134630|FG002|Dose Level 3|Withdrawal by Subject|1|||
130048698|NCT02234583|468134633|FG000|Overall Study|Adverse Event|172|||
130048699|NCT02234583|468134634|FG001|Overall Study|Adverse Event|156|||
130048700|NCT02234583|468134633|FG000|Overall Study|Withdrawal by Subject|109|||
130048701|NCT02234583|468134634|FG001|Overall Study|Withdrawal by Subject|157|||
130048702|NCT02234583|468134633|FG000|Overall Study|Lost to Follow-up|0|||
130048703|NCT02234583|468134634|FG001|Overall Study|Lost to Follow-up|1|||
130048704|NCT02234583|468134633|FG000|Overall Study|Lack of Efficacy|58|||
130048705|NCT02234583|468134634|FG001|Overall Study|Lack of Efficacy|103|||
130048706|NCT02234583|468134633|FG000|Overall Study|Protocol Violation|35|||
130048707|NCT02234583|468134634|FG001|Overall Study|Protocol Violation|42|||
130048708|NCT02234583|468134633|FG000|Overall Study|Other|39|||
130048709|NCT02234583|468134634|FG001|Overall Study|Other|97|||
130048710|NCT02805907|468134635|FG000|Overall Study|Lost to Follow-up|3|||
130048711|NCT02805907|468134636|FG001|Overall Study|Lost to Follow-up|3|||
130048712|NCT03408873|468134637|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
130048713|NCT03408873|468134637|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
130048714|NCT03408873|468134637|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
130048715|NCT03408873|468134637|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
129797824|NCT02537574|467228235|FG002|Overall Study|Lack of Efficacy|15|||
130048716|NCT03408873|468134637|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
130109072|NCT00879970|468360995|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
130109073|NCT00879970|468360991|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130109074|NCT00879970|468360992|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130306607|NCT02557542|469087137|FG001|Overall Study|Poor recruitment|0|||
130306608|NCT04390880|469087138|FG000|Overall Study|Withdrawal by Subject|1|||
130048717|NCT03408873|468134637|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
130048718|NCT01264965|468134638|FG000|Overall Study|Withdrawal by Subject|10|||
130048719|NCT03799718|468134639|FG000|Overall Study|Adverse Event|2|||
130048720|NCT02202031|468134640|FG000|Overall Study|Lost to Follow-up|1|||
130048721|NCT02202031|468134641|FG001|Overall Study|Lost to Follow-up|0|||
130048722|NCT02202031|468134640|FG000|Overall Study|Too Busy|1|||
130048723|NCT02202031|468134641|FG001|Overall Study|Too Busy|3|||
130048724|NCT02202031|468134640|FG000|Overall Study|Illness/Medical Reason|0|||
130306609|NCT00245037|469087139|FG000|Overall Study|Death|17|||
130109075|NCT00879970|468360993|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130109076|NCT00879970|468360994|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
130109077|NCT00879970|468360995|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
130109078|NCT00879970|468360991|FG000|Period 2 Vitamin D Randomization|Death|0|||
130109079|NCT00879970|468360992|FG001|Period 2 Vitamin D Randomization|Death|0|||
130109080|NCT00879970|468360993|FG002|Period 2 Vitamin D Randomization|Death|0|||
130306610|NCT03724890|469087143|FG000|Overall Study|Death|2|||
130306611|NCT03724890|469087144|FG001|Overall Study|Death|6|||
130306612|NCT03724890|469087145|FG002|Overall Study|Death|3|||
130306613|NCT03724890|469087146|FG003|Overall Study|Death|5|||
130306614|NCT03724890|469087147|FG004|Overall Study|Death|2|||
130306615|NCT03724890|469087148|FG005|Overall Study|Death|0|||
130306616|NCT03724890|469087149|FG006|Overall Study|Death|2|||
130306617|NCT03724890|469087150|FG007|Overall Study|Death|3|||
130306618|NCT03724890|469087151|FG008|Overall Study|Death|4|||
130306619|NCT03724890|469087152|FG009|Overall Study|Death|2|||
130306620|NCT03724890|469087153|FG010|Overall Study|Death|2|||
130306621|NCT03724890|469087143|FG000|Overall Study|Lost to Follow-up|0|||
130306622|NCT03724890|469087144|FG001|Overall Study|Lost to Follow-up|3|||
130306623|NCT03724890|469087145|FG002|Overall Study|Lost to Follow-up|0|||
130306624|NCT03724890|469087146|FG003|Overall Study|Lost to Follow-up|1|||
130306625|NCT03724890|469087147|FG004|Overall Study|Lost to Follow-up|2|||
130306626|NCT03724890|469087148|FG005|Overall Study|Lost to Follow-up|2|||
130306627|NCT03724890|469087149|FG006|Overall Study|Lost to Follow-up|1|||
130306628|NCT03724890|469087150|FG007|Overall Study|Lost to Follow-up|0|||
130306629|NCT03724890|469087151|FG008|Overall Study|Lost to Follow-up|2|||
130306630|NCT03724890|469087152|FG009|Overall Study|Lost to Follow-up|0|||
130306631|NCT03724890|469087153|FG010|Overall Study|Lost to Follow-up|0|||
130306632|NCT03724890|469087143|FG000|Overall Study|Withdrawal by Subject|1|||
130306633|NCT03724890|469087144|FG001|Overall Study|Withdrawal by Subject|2|||
130306634|NCT03724890|469087145|FG002|Overall Study|Withdrawal by Subject|1|||
130306635|NCT03724890|469087146|FG003|Overall Study|Withdrawal by Subject|0|||
130306636|NCT03724890|469087147|FG004|Overall Study|Withdrawal by Subject|0|||
130109081|NCT00879970|468360994|FG003|Period 2 Vitamin D Randomization|Death|2|||
130109082|NCT00879970|468360995|FG004|Period 2 Vitamin D Randomization|Death|0|||
130109083|NCT01749033|468360997|FG000|Overall Study|Did not receive allocated intervention|3|||
130109084|NCT01749033|468360998|FG001|Overall Study|Did not receive allocated intervention|3|||
130109085|NCT01749033|468360999|FG002|Overall Study|Did not receive allocated intervention|0|||
130109086|NCT01749033|468360997|FG000|Overall Study|Lost to Follow-up|0|||
130109087|NCT01749033|468360998|FG001|Overall Study|Lost to Follow-up|2|||
130109088|NCT01749033|468360999|FG002|Overall Study|Lost to Follow-up|1|||
130109089|NCT04380701|468361000|FG000|Overall Study|Pregnancy|0|||
130109090|NCT04380701|468361001|FG001|Overall Study|Pregnancy|0|||
130306637|NCT03724890|469087148|FG005|Overall Study|Withdrawal by Subject|1|||
130306638|NCT03724890|469087149|FG006|Overall Study|Withdrawal by Subject|0|||
130109091|NCT04380701|468361002|FG002|Overall Study|Pregnancy|0|||
130109092|NCT04380701|468361003|FG003|Overall Study|Pregnancy|0|||
130306639|NCT03724890|469087150|FG007|Overall Study|Withdrawal by Subject|0|||
130109093|NCT04380701|468361004|FG004|Overall Study|Pregnancy|0|||
130109094|NCT04380701|468361005|FG005|Overall Study|Pregnancy|0|||
130109095|NCT04380701|468361006|FG006|Overall Study|Pregnancy|0|||
130109096|NCT04380701|468361007|FG007|Overall Study|Pregnancy|0|||
130109097|NCT04380701|468361008|FG008|Overall Study|Pregnancy|0|||
130109098|NCT04380701|468361009|FG009|Overall Study|Pregnancy|0|||
130109099|NCT04380701|468361010|FG010|Overall Study|Pregnancy|0|||
130109100|NCT04380701|468361011|FG011|Overall Study|Pregnancy|0|||
130109101|NCT04380701|468361012|FG012|Overall Study|Pregnancy|0|||
130109102|NCT04380701|468361013|FG013|Overall Study|Pregnancy|0|||
130109103|NCT04380701|468361014|FG014|Overall Study|Pregnancy|0|||
130109104|NCT04380701|468361015|FG015|Overall Study|Pregnancy|0|||
130109105|NCT04380701|468361016|FG016|Overall Study|Pregnancy|0|||
130109106|NCT04380701|468361017|FG017|Overall Study|Pregnancy|0|||
130109107|NCT04380701|468361018|FG018|Overall Study|Pregnancy|0|||
130109108|NCT04380701|468361019|FG019|Overall Study|Pregnancy|0|||
130109109|NCT04380701|468361020|FG020|Overall Study|Pregnancy|0|||
130109110|NCT04380701|468361021|FG021|Overall Study|Pregnancy|0|||
130306640|NCT03724890|469087151|FG008|Overall Study|Withdrawal by Subject|2|||
130306641|NCT03724890|469087152|FG009|Overall Study|Withdrawal by Subject|2|||
130306642|NCT03724890|469087153|FG010|Overall Study|Withdrawal by Subject|1|||
130306643|NCT03724890|469087143|FG000|Overall Study|Other|1|||
130306644|NCT03724890|469087144|FG001|Overall Study|Other|0|||
130306645|NCT03724890|469087145|FG002|Overall Study|Other|0|||
130306646|NCT03724890|469087146|FG003|Overall Study|Other|0|||
130306647|NCT03724890|469087147|FG004|Overall Study|Other|0|||
130306648|NCT03724890|469087148|FG005|Overall Study|Other|0|||
130109111|NCT04380701|468361022|FG022|Overall Study|Pregnancy|0|||
130109112|NCT04380701|468361023|FG023|Overall Study|Pregnancy|0|||
130109113|NCT04380701|468361024|FG024|Overall Study|Pregnancy|0|||
130109114|NCT04380701|468361025|FG025|Overall Study|Pregnancy|0|||
130306649|NCT03724890|469087149|FG006|Overall Study|Other|0|||
129797825|NCT02537574|467228233|FG000|Overall Study|Duplicate Patient|1|||
130306650|NCT03724890|469087150|FG007|Overall Study|Other|1|||
130306651|NCT03724890|469087151|FG008|Overall Study|Other|1|||
130306652|NCT03724890|469087152|FG009|Overall Study|Other|0|||
130306653|NCT03724890|469087153|FG010|Overall Study|Other|2|||
130306654|NCT02123823|469087156|FG000|Overall Study|Lack of Efficacy|0|||
130109115|NCT04380701|468361026|FG026|Overall Study|Pregnancy|0|||
130109116|NCT04380701|468361027|FG027|Overall Study|Pregnancy|0|||
130109117|NCT04380701|468361028|FG028|Overall Study|Pregnancy|0|||
130109118|NCT04380701|468361029|FG029|Overall Study|Pregnancy|0|||
130109119|NCT04380701|468361030|FG030|Overall Study|Pregnancy|0|||
130109120|NCT04380701|468361031|FG031|Overall Study|Pregnancy|0|||
130109121|NCT04380701|468361032|FG032|Overall Study|Pregnancy|1|||
130109122|NCT04380701|468361033|FG033|Overall Study|Pregnancy|0|||
130109123|NCT04380701|468361000|FG000|Overall Study|Lost to Follow-up|0|||
130109124|NCT04380701|468361001|FG001|Overall Study|Lost to Follow-up|0|||
130109125|NCT04380701|468361002|FG002|Overall Study|Lost to Follow-up|0|||
130109126|NCT04380701|468361003|FG003|Overall Study|Lost to Follow-up|0|||
130109127|NCT04380701|468361004|FG004|Overall Study|Lost to Follow-up|0|||
130306655|NCT02123823|469087157|FG001|Overall Study|Lack of Efficacy|2|||
130109128|NCT04380701|468361005|FG005|Overall Study|Lost to Follow-up|0|||
130109129|NCT04380701|468361006|FG006|Overall Study|Lost to Follow-up|0|||
130109130|NCT04380701|468361007|FG007|Overall Study|Lost to Follow-up|0|||
130109131|NCT04380701|468361008|FG008|Overall Study|Lost to Follow-up|0|||
130109132|NCT04380701|468361009|FG009|Overall Study|Lost to Follow-up|0|||
130109133|NCT04380701|468361010|FG010|Overall Study|Lost to Follow-up|0|||
130109134|NCT04380701|468361011|FG011|Overall Study|Lost to Follow-up|0|||
130109135|NCT04380701|468361012|FG012|Overall Study|Lost to Follow-up|0|||
130109136|NCT04380701|468361013|FG013|Overall Study|Lost to Follow-up|0|||
130109137|NCT04380701|468361014|FG014|Overall Study|Lost to Follow-up|0|||
130109138|NCT04380701|468361015|FG015|Overall Study|Lost to Follow-up|0|||
130109139|NCT04380701|468361016|FG016|Overall Study|Lost to Follow-up|0|||
130109140|NCT04380701|468361017|FG017|Overall Study|Lost to Follow-up|0|||
130109141|NCT04380701|468361018|FG018|Overall Study|Lost to Follow-up|0|||
130109142|NCT04380701|468361019|FG019|Overall Study|Lost to Follow-up|0|||
130109143|NCT04380701|468361020|FG020|Overall Study|Lost to Follow-up|1|||
130109144|NCT04380701|468361021|FG021|Overall Study|Lost to Follow-up|0|||
130109145|NCT04380701|468361022|FG022|Overall Study|Lost to Follow-up|0|||
130109146|NCT04380701|468361023|FG023|Overall Study|Lost to Follow-up|1|||
130109147|NCT04380701|468361024|FG024|Overall Study|Lost to Follow-up|0|||
130109148|NCT04380701|468361025|FG025|Overall Study|Lost to Follow-up|0|||
130109149|NCT04380701|468361026|FG026|Overall Study|Lost to Follow-up|0|||
130109150|NCT04380701|468361027|FG027|Overall Study|Lost to Follow-up|0|||
130109151|NCT04380701|468361028|FG028|Overall Study|Lost to Follow-up|0|||
130109152|NCT04380701|468361029|FG029|Overall Study|Lost to Follow-up|1|||
130109153|NCT04380701|468361030|FG030|Overall Study|Lost to Follow-up|0|||
130109154|NCT04380701|468361031|FG031|Overall Study|Lost to Follow-up|0|||
130109155|NCT04380701|468361032|FG032|Overall Study|Lost to Follow-up|0|||
130109156|NCT04380701|468361033|FG033|Overall Study|Lost to Follow-up|1|||
130109157|NCT04380701|468361000|FG000|Overall Study|Private reason(s)|0|||
130109158|NCT04380701|468361001|FG001|Overall Study|Private reason(s)|0|||
130109159|NCT04380701|468361002|FG002|Overall Study|Private reason(s)|0|||
130109160|NCT04380701|468361003|FG003|Overall Study|Private reason(s)|0|||
130109161|NCT04380701|468361004|FG004|Overall Study|Private reason(s)|0|||
130109162|NCT04380701|468361005|FG005|Overall Study|Private reason(s)|0|||
130109163|NCT04380701|468361006|FG006|Overall Study|Private reason(s)|1|||
130109164|NCT04380701|468361007|FG007|Overall Study|Private reason(s)|0|||
130109165|NCT04380701|468361008|FG008|Overall Study|Private reason(s)|1|||
130109166|NCT04380701|468361009|FG009|Overall Study|Private reason(s)|1|||
130109167|NCT04380701|468361010|FG010|Overall Study|Private reason(s)|0|||
130109168|NCT04380701|468361011|FG011|Overall Study|Private reason(s)|0|||
130109169|NCT04380701|468361012|FG012|Overall Study|Private reason(s)|0|||
130109170|NCT04380701|468361013|FG013|Overall Study|Private reason(s)|0|||
130109171|NCT04380701|468361014|FG014|Overall Study|Private reason(s)|0|||
130109172|NCT04380701|468361015|FG015|Overall Study|Private reason(s)|0|||
130109173|NCT04380701|468361016|FG016|Overall Study|Private reason(s)|0|||
130109174|NCT04380701|468361017|FG017|Overall Study|Private reason(s)|0|||
130109175|NCT04380701|468361018|FG018|Overall Study|Private reason(s)|0|||
130306656|NCT02123823|469087158|FG002|Overall Study|Lack of Efficacy|8|||
130306657|NCT02123823|469087159|FG003|Overall Study|Lack of Efficacy|10|||
130306658|NCT02123823|469087156|FG000|Overall Study|Progressive disease|3|||
130109176|NCT04380701|468361019|FG019|Overall Study|Private reason(s)|0|||
130109177|NCT04380701|468361020|FG020|Overall Study|Private reason(s)|0|||
130109178|NCT04380701|468361021|FG021|Overall Study|Private reason(s)|0|||
130109179|NCT04380701|468361022|FG022|Overall Study|Private reason(s)|0|||
130109180|NCT04380701|468361023|FG023|Overall Study|Private reason(s)|1|||
130109181|NCT04380701|468361024|FG024|Overall Study|Private reason(s)|0|||
130109182|NCT04380701|468361025|FG025|Overall Study|Private reason(s)|0|||
130109183|NCT04380701|468361026|FG026|Overall Study|Private reason(s)|0|||
130109184|NCT04380701|468361027|FG027|Overall Study|Private reason(s)|0|||
130109185|NCT04380701|468361028|FG028|Overall Study|Private reason(s)|0|||
130109186|NCT04380701|468361029|FG029|Overall Study|Private reason(s)|1|||
130306659|NCT02123823|469087157|FG001|Overall Study|Progressive disease|19|||
130109187|NCT04380701|468361030|FG030|Overall Study|Private reason(s)|0|||
130109188|NCT04380701|468361031|FG031|Overall Study|Private reason(s)|0|||
130109189|NCT04380701|468361032|FG032|Overall Study|Private reason(s)|0|||
130109190|NCT04380701|468361033|FG033|Overall Study|Private reason(s)|0|||
130109191|NCT04380701|468361000|FG000|Overall Study|Withdrawal by Subject|0|||
130109192|NCT04380701|468361001|FG001|Overall Study|Withdrawal by Subject|0|||
130109193|NCT04380701|468361002|FG002|Overall Study|Withdrawal by Subject|0|||
130109194|NCT04380701|468361003|FG003|Overall Study|Withdrawal by Subject|0|||
130109195|NCT04380701|468361004|FG004|Overall Study|Withdrawal by Subject|0|||
130109196|NCT04380701|468361005|FG005|Overall Study|Withdrawal by Subject|0|||
130109197|NCT04380701|468361006|FG006|Overall Study|Withdrawal by Subject|1|||
130109198|NCT04380701|468361007|FG007|Overall Study|Withdrawal by Subject|1|||
130109199|NCT04380701|468361008|FG008|Overall Study|Withdrawal by Subject|0|||
130109200|NCT04380701|468361009|FG009|Overall Study|Withdrawal by Subject|0|||
130109201|NCT04380701|468361010|FG010|Overall Study|Withdrawal by Subject|0|||
130109202|NCT04380701|468361011|FG011|Overall Study|Withdrawal by Subject|1|||
130109203|NCT04380701|468361012|FG012|Overall Study|Withdrawal by Subject|0|||
130109204|NCT04380701|468361013|FG013|Overall Study|Withdrawal by Subject|1|||
130109205|NCT04380701|468361014|FG014|Overall Study|Withdrawal by Subject|0|||
130109206|NCT04380701|468361015|FG015|Overall Study|Withdrawal by Subject|0|||
130109207|NCT04380701|468361016|FG016|Overall Study|Withdrawal by Subject|1|||
130109208|NCT04380701|468361017|FG017|Overall Study|Withdrawal by Subject|0|||
130109209|NCT04380701|468361018|FG018|Overall Study|Withdrawal by Subject|0|||
130109210|NCT04380701|468361019|FG019|Overall Study|Withdrawal by Subject|0|||
130109211|NCT04380701|468361020|FG020|Overall Study|Withdrawal by Subject|0|||
130109212|NCT04380701|468361021|FG021|Overall Study|Withdrawal by Subject|0|||
130109213|NCT04380701|468361022|FG022|Overall Study|Withdrawal by Subject|2|||
130109214|NCT04380701|468361023|FG023|Overall Study|Withdrawal by Subject|2|||
130109215|NCT04380701|468361024|FG024|Overall Study|Withdrawal by Subject|1|||
130109216|NCT04380701|468361025|FG025|Overall Study|Withdrawal by Subject|1|||
130109217|NCT04380701|468361026|FG026|Overall Study|Withdrawal by Subject|0|||
130109218|NCT04380701|468361027|FG027|Overall Study|Withdrawal by Subject|0|||
130109219|NCT04380701|468361028|FG028|Overall Study|Withdrawal by Subject|0|||
130109220|NCT04380701|468361029|FG029|Overall Study|Withdrawal by Subject|0|||
130109221|NCT04380701|468361030|FG030|Overall Study|Withdrawal by Subject|0|||
130109222|NCT04380701|468361031|FG031|Overall Study|Withdrawal by Subject|0|||
130109223|NCT04380701|468361032|FG032|Overall Study|Withdrawal by Subject|0|||
130109224|NCT04380701|468361033|FG033|Overall Study|Withdrawal by Subject|0|||
130109225|NCT04380701|468361000|FG000|Overall Study|Adverse Event|0|||
130109226|NCT04380701|468361001|FG001|Overall Study|Adverse Event|0|||
130109227|NCT04380701|468361002|FG002|Overall Study|Adverse Event|0|||
130109228|NCT04380701|468361003|FG003|Overall Study|Adverse Event|0|||
130109229|NCT04380701|468361004|FG004|Overall Study|Adverse Event|0|||
130109230|NCT04380701|468361005|FG005|Overall Study|Adverse Event|1|||
130109231|NCT04380701|468361006|FG006|Overall Study|Adverse Event|0|||
130109232|NCT04380701|468361007|FG007|Overall Study|Adverse Event|0|||
130109233|NCT04380701|468361008|FG008|Overall Study|Adverse Event|0|||
130109234|NCT04380701|468361009|FG009|Overall Study|Adverse Event|0|||
130109235|NCT04380701|468361010|FG010|Overall Study|Adverse Event|0|||
130109236|NCT04380701|468361011|FG011|Overall Study|Adverse Event|0|||
130109237|NCT04380701|468361012|FG012|Overall Study|Adverse Event|0|||
130109238|NCT04380701|468361013|FG013|Overall Study|Adverse Event|0|||
130109239|NCT04380701|468361014|FG014|Overall Study|Adverse Event|0|||
130109240|NCT04380701|468361015|FG015|Overall Study|Adverse Event|1|||
130109241|NCT04380701|468361016|FG016|Overall Study|Adverse Event|0|||
130109242|NCT04380701|468361017|FG017|Overall Study|Adverse Event|0|||
130109243|NCT04380701|468361018|FG018|Overall Study|Adverse Event|0|||
130109244|NCT04380701|468361019|FG019|Overall Study|Adverse Event|1|||
130109245|NCT04380701|468361020|FG020|Overall Study|Adverse Event|0|||
130109246|NCT04380701|468361021|FG021|Overall Study|Adverse Event|0|||
130109247|NCT04380701|468361022|FG022|Overall Study|Adverse Event|0|||
130109248|NCT04380701|468361023|FG023|Overall Study|Adverse Event|0|||
130109249|NCT04380701|468361024|FG024|Overall Study|Adverse Event|0|||
130109250|NCT04380701|468361025|FG025|Overall Study|Adverse Event|0|||
130306660|NCT02123823|469087158|FG002|Overall Study|Progressive disease|52|||
130306661|NCT02123823|469087159|FG003|Overall Study|Progressive disease|53|||
130109251|NCT04380701|468361026|FG026|Overall Study|Adverse Event|0|||
130109252|NCT04380701|468361027|FG027|Overall Study|Adverse Event|0|||
130109253|NCT04380701|468361028|FG028|Overall Study|Adverse Event|0|||
130109254|NCT04380701|468361029|FG029|Overall Study|Adverse Event|0|||
130109255|NCT04380701|468361030|FG030|Overall Study|Adverse Event|0|||
130109256|NCT04380701|468361031|FG031|Overall Study|Adverse Event|0|||
130109257|NCT04380701|468361032|FG032|Overall Study|Adverse Event|0|||
130109258|NCT04380701|468361033|FG033|Overall Study|Adverse Event|0|||
130109259|NCT04380701|468361000|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
130109260|NCT04380701|468361001|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
130109261|NCT04380701|468361002|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
130109262|NCT04380701|468361003|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
130109263|NCT04380701|468361004|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
130109264|NCT04380701|468361005|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
130109265|NCT04380701|468361006|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
130109266|NCT04380701|468361007|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
130109267|NCT04380701|468361008|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
130109268|NCT04380701|468361009|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
130109269|NCT04380701|468361010|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
130109270|NCT04380701|468361011|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
130109271|NCT04380701|468361012|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
130109272|NCT04380701|468361013|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
130109273|NCT04380701|468361014|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
130109274|NCT04380701|468361015|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
130109275|NCT04380701|468361016|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
130109276|NCT04380701|468361017|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
130109277|NCT04380701|468361018|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
130109278|NCT04380701|468361019|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
130109279|NCT04380701|468361020|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
130109280|NCT04380701|468361021|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
130109281|NCT04380701|468361022|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
130109282|NCT04380701|468361023|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
130109283|NCT04380701|468361024|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
130109284|NCT04380701|468361025|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
130109285|NCT04380701|468361026|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
130109286|NCT04380701|468361027|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
130109287|NCT04380701|468361028|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
130109288|NCT04380701|468361029|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
130109289|NCT04380701|468361030|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
130109290|NCT04380701|468361031|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
130109291|NCT04380701|468361032|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
130306662|NCT02123823|469087156|FG000|Overall Study|Withdrawal by Subject|0|||
130306663|NCT02123823|469087157|FG001|Overall Study|Withdrawal by Subject|0|||
130306664|NCT02123823|469087158|FG002|Overall Study|Withdrawal by Subject|7|||
130306665|NCT02123823|469087159|FG003|Overall Study|Withdrawal by Subject|2|||
130109292|NCT04380701|468361033|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
130109293|NCT04380701|468361000|FG000|Overall Study|Physician Decision|0|||
130109294|NCT04380701|468361001|FG001|Overall Study|Physician Decision|0|||
130109295|NCT04380701|468361002|FG002|Overall Study|Physician Decision|0|||
130109296|NCT04380701|468361003|FG003|Overall Study|Physician Decision|0|||
130109297|NCT04380701|468361004|FG004|Overall Study|Physician Decision|0|||
130109298|NCT04380701|468361005|FG005|Overall Study|Physician Decision|0|||
130109299|NCT04380701|468361006|FG006|Overall Study|Physician Decision|0|||
130109300|NCT04380701|468361007|FG007|Overall Study|Physician Decision|0|||
130109301|NCT04380701|468361008|FG008|Overall Study|Physician Decision|0|||
130109302|NCT04380701|468361009|FG009|Overall Study|Physician Decision|0|||
130109303|NCT04380701|468361010|FG010|Overall Study|Physician Decision|0|||
130109304|NCT04380701|468361011|FG011|Overall Study|Physician Decision|0|||
130109305|NCT04380701|468361012|FG012|Overall Study|Physician Decision|0|||
130109306|NCT04380701|468361013|FG013|Overall Study|Physician Decision|0|||
130109307|NCT04380701|468361014|FG014|Overall Study|Physician Decision|0|||
130109308|NCT04380701|468361015|FG015|Overall Study|Physician Decision|0|||
130109309|NCT04380701|468361016|FG016|Overall Study|Physician Decision|0|||
130109310|NCT04380701|468361017|FG017|Overall Study|Physician Decision|0|||
130109311|NCT04380701|468361018|FG018|Overall Study|Physician Decision|0|||
130109312|NCT04380701|468361019|FG019|Overall Study|Physician Decision|0|||
130109313|NCT04380701|468361020|FG020|Overall Study|Physician Decision|0|||
130109314|NCT04380701|468361021|FG021|Overall Study|Physician Decision|0|||
130109315|NCT04380701|468361022|FG022|Overall Study|Physician Decision|0|||
130109316|NCT04380701|468361023|FG023|Overall Study|Physician Decision|0|||
130109317|NCT04380701|468361024|FG024|Overall Study|Physician Decision|2|||
130109318|NCT04380701|468361025|FG025|Overall Study|Physician Decision|0|||
130109319|NCT04380701|468361026|FG026|Overall Study|Physician Decision|0|||
130109320|NCT04380701|468361027|FG027|Overall Study|Physician Decision|0|||
130109321|NCT04380701|468361028|FG028|Overall Study|Physician Decision|0|||
130109322|NCT04380701|468361029|FG029|Overall Study|Physician Decision|0|||
130109323|NCT04380701|468361030|FG030|Overall Study|Physician Decision|0|||
130109324|NCT04380701|468361031|FG031|Overall Study|Physician Decision|0|||
130109325|NCT04380701|468361032|FG032|Overall Study|Physician Decision|0|||
130109326|NCT04380701|468361033|FG033|Overall Study|Physician Decision|0|||
130109327|NCT04380701|468361000|FG000|Overall Study|Death|0|||
130109328|NCT04380701|468361001|FG001|Overall Study|Death|0|||
130109329|NCT04380701|468361002|FG002|Overall Study|Death|0|||
130109330|NCT04380701|468361003|FG003|Overall Study|Death|0|||
130109331|NCT04380701|468361004|FG004|Overall Study|Death|0|||
130109332|NCT04380701|468361005|FG005|Overall Study|Death|0|||
130109333|NCT04380701|468361006|FG006|Overall Study|Death|0|||
130306666|NCT02123823|469087156|FG000|Overall Study|Adverse Event|0|||
130109334|NCT04380701|468361007|FG007|Overall Study|Death|0|||
130109335|NCT04380701|468361008|FG008|Overall Study|Death|0|||
130109336|NCT04380701|468361009|FG009|Overall Study|Death|0|||
130109337|NCT04380701|468361010|FG010|Overall Study|Death|0|||
130109338|NCT04380701|468361011|FG011|Overall Study|Death|0|||
130109339|NCT04380701|468361012|FG012|Overall Study|Death|0|||
130109340|NCT04380701|468361013|FG013|Overall Study|Death|0|||
130109341|NCT04380701|468361014|FG014|Overall Study|Death|0|||
130109342|NCT04380701|468361015|FG015|Overall Study|Death|0|||
130109343|NCT04380701|468361016|FG016|Overall Study|Death|0|||
130109344|NCT04380701|468361017|FG017|Overall Study|Death|0|||
130109345|NCT04380701|468361018|FG018|Overall Study|Death|0|||
130109346|NCT04380701|468361019|FG019|Overall Study|Death|0|||
130109347|NCT04380701|468361020|FG020|Overall Study|Death|0|||
130109348|NCT04380701|468361021|FG021|Overall Study|Death|0|||
130109349|NCT04380701|468361022|FG022|Overall Study|Death|0|||
130109350|NCT04380701|468361023|FG023|Overall Study|Death|0|||
130109351|NCT04380701|468361024|FG024|Overall Study|Death|1|||
130109352|NCT04380701|468361025|FG025|Overall Study|Death|0|||
130109353|NCT04380701|468361026|FG026|Overall Study|Death|0|||
130109354|NCT04380701|468361027|FG027|Overall Study|Death|0|||
130109355|NCT04380701|468361028|FG028|Overall Study|Death|0|||
130109356|NCT04380701|468361029|FG029|Overall Study|Death|0|||
130109357|NCT04380701|468361030|FG030|Overall Study|Death|0|||
130109358|NCT04380701|468361031|FG031|Overall Study|Death|0|||
130109359|NCT04380701|468361032|FG032|Overall Study|Death|0|||
130109360|NCT04380701|468361033|FG033|Overall Study|Death|0|||
130109361|NCT04380701|468361000|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109362|NCT04380701|468361001|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109363|NCT04380701|468361002|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109364|NCT04380701|468361003|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109365|NCT04380701|468361004|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109366|NCT04380701|468361005|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109367|NCT04380701|468361006|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109368|NCT04380701|468361007|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109369|NCT04380701|468361008|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109370|NCT04380701|468361009|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109371|NCT04380701|468361010|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109372|NCT04380701|468361011|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109373|NCT04380701|468361012|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109374|NCT04380701|468361013|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109375|NCT04380701|468361014|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109376|NCT04380701|468361015|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109377|NCT04380701|468361016|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109378|NCT04380701|468361017|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109379|NCT04380701|468361018|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109380|NCT04380701|468361019|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109381|NCT04380701|468361020|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109382|NCT04380701|468361021|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
130109383|NCT04380701|468361022|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
130109384|NCT04380701|468361023|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
130109385|NCT04380701|468361024|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
130109386|NCT04380701|468361025|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109387|NCT04380701|468361026|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109388|NCT04380701|468361027|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109389|NCT04380701|468361028|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109390|NCT04380701|468361029|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109391|NCT04380701|468361030|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109392|NCT04380701|468361031|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109393|NCT04380701|468361032|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109394|NCT04380701|468361033|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
130109395|NCT00383019|468361034|FG000|Overall Study|Adverse Event|5|||
130109396|NCT00383019|468361035|FG001|Overall Study|Adverse Event|1|||
130109397|NCT00383019|468361034|FG000|Overall Study|Withdrawal by Subject|0|||
130109398|NCT00383019|468361035|FG001|Overall Study|Withdrawal by Subject|1|||
130109399|NCT03439293|468361036|FG000|Overall Study|Death|22|||
130109400|NCT03439293|468361036|FG000|Overall Study|Withdrawal by Subject|8|||
130109401|NCT03439293|468361036|FG000|Overall Study|Lost to Follow-up|2|||
130109402|NCT03439293|468361036|FG000|Overall Study|Reason Not Specified|28|||
130109403|NCT03439293|468361036|FG000|Overall Study|Missing|1|||
130109404|NCT02766400|468361041|FG000|Overall Study|Death|1|||
130109405|NCT02766400|468361042|FG001|Overall Study|Death|2|||
130306667|NCT02123823|469087157|FG001|Overall Study|Adverse Event|0|||
130109406|NCT02766400|468361041|FG000|Overall Study|Withdrawal by Subject|1|||
130109407|NCT02766400|468361042|FG001|Overall Study|Withdrawal by Subject|0|||
130109408|NCT03499249|468361049|FG000|Overall Study|Physician Decision|1|||
130109409|NCT01374906|468361052|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130109410|NCT01374906|468361053|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130109411|NCT01374906|468361052|FG000|Overall Study|Administrative problems|2|||
130109412|NCT01374906|468361053|FG001|Overall Study|Administrative problems|2|||
130109413|NCT01374906|468361052|FG000|Overall Study|Adverse Event|10|||
130109414|NCT01374906|468361053|FG001|Overall Study|Adverse Event|11|||
130109415|NCT01374906|468361052|FG000|Overall Study|Death|0|||
130109416|NCT01374906|468361053|FG001|Overall Study|Death|2|||
130109417|NCT01374906|468361052|FG000|Overall Study|Protocol Violation|2|||
130109418|NCT01374906|468361053|FG001|Overall Study|Protocol Violation|2|||
130109419|NCT01374906|468361052|FG000|Overall Study|Withdrawal by Subject|15|||
130109420|NCT01374906|468361053|FG001|Overall Study|Withdrawal by Subject|9|||
130109421|NCT01374906|468361052|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
130109422|NCT01374906|468361053|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
130109423|NCT00789828|468361054|FG000|Core Period (48 Weeks)|Administrative problems|0|||
130109424|NCT00789828|468361055|FG001|Core Period (48 Weeks)|Administrative problems|1|||
130109425|NCT00789828|468361054|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
130109426|NCT00789828|468361055|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
130109427|NCT00789828|468361054|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
130109428|NCT00789828|468361055|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
130109429|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
130109430|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
130109431|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
130109432|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
130109433|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
130109434|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
130109435|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
130109436|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
130109437|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|Death|1|||
130109438|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|Death|0|||
130109439|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
130109440|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
130109441|NCT00789828|468361054|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
130109442|NCT00789828|468361055|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
130109443|NCT05788237|468361056|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
130109444|NCT05788237|468361057|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
130109445|NCT05788237|468361058|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
130109446|NCT05788237|468361059|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
130109447|NCT05788237|468361056|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
130109448|NCT05788237|468361057|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
130109449|NCT05788237|468361058|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
130109450|NCT05788237|468361059|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
130109451|NCT05788237|468361056|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
130109452|NCT05788237|468361057|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
130109453|NCT05788237|468361058|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
130109454|NCT05788237|468361059|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
130109455|NCT05788237|468361056|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
130109456|NCT05788237|468361057|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
130109457|NCT05788237|468361058|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
130109458|NCT05788237|468361059|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
130109459|NCT05788237|468361056|FG000|SSA (Approximately 2 Months)|Death|0|||
130109460|NCT05788237|468361057|FG001|SSA (Approximately 2 Months)|Death|1|||
130109461|NCT05788237|468361058|FG002|SSA (Approximately 2 Months)|Death|0|||
130109462|NCT05788237|468361059|FG003|SSA (Approximately 2 Months)|Death|0|||
130109463|NCT05788237|468361056|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130109464|NCT05788237|468361057|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130109465|NCT05788237|468361058|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
130109466|NCT05788237|468361059|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
130109467|NCT05788237|468361056|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130109468|NCT05788237|468361057|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130109469|NCT05788237|468361058|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
130109470|NCT05788237|468361059|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
130109471|NCT05788237|468361056|FG000|SSB (Approximately 1 Month)|Other|0|||
130109472|NCT05788237|468361057|FG001|SSB (Approximately 1 Month)|Other|0|||
130109473|NCT05788237|468361058|FG002|SSB (Approximately 1 Month)|Other|0|||
130109474|NCT05788237|468361059|FG003|SSB (Approximately 1 Month)|Other|1|||
130109475|NCT02842086|468361060|FG000|Overall Study|Randomized but Never Treated|6|||
130109476|NCT02842086|468361061|FG001|Overall Study|Randomized but Never Treated|6|||
130109477|NCT02842086|468361060|FG000|Overall Study|Still in Double-Blind Phase|7|||
130109478|NCT02842086|468361061|FG001|Overall Study|Still in Double-Blind Phase|3|||
130109479|NCT02842086|468361060|FG000|Overall Study|Adverse Event|18|||
130306668|NCT02123823|469087158|FG002|Overall Study|Adverse Event|3|||
130306669|NCT02123823|469087159|FG003|Overall Study|Adverse Event|5|||
130306670|NCT01635855|469087161|FG000|Overall Study|Withdrawal by Subject|4|||
130306671|NCT05870865|469087164|FG000|Randomized|Did not receive study treatment|2|||
130306672|NCT05870865|469087165|FG001|Randomized|Did not receive study treatment|4|||
130306673|NCT05870865|469087166|FG002|Randomized|Did not receive study treatment|4|||
130306674|NCT05870865|469087167|FG003|Randomized|Did not receive study treatment|3|||
130306675|NCT05870865|469087164|FG000|Treatment Period|Adverse Event|1|||
130306676|NCT05870865|469087165|FG001|Treatment Period|Adverse Event|1|||
130306677|NCT05870865|469087166|FG002|Treatment Period|Adverse Event|1|||
130306678|NCT05870865|469087167|FG003|Treatment Period|Adverse Event|1|||
130306679|NCT05870865|469087164|FG000|Treatment Period|Lost to Follow-up|0|||
130306680|NCT05870865|469087165|FG001|Treatment Period|Lost to Follow-up|1|||
130306681|NCT05870865|469087166|FG002|Treatment Period|Lost to Follow-up|2|||
130306682|NCT05870865|469087167|FG003|Treatment Period|Lost to Follow-up|0|||
130306683|NCT05870865|469087164|FG000|Treatment Period|Protocol Violation|0|||
130306684|NCT05870865|469087165|FG001|Treatment Period|Protocol Violation|0|||
130306685|NCT05870865|469087166|FG002|Treatment Period|Protocol Violation|0|||
130306686|NCT05870865|469087167|FG003|Treatment Period|Protocol Violation|1|||
130306687|NCT05870865|469087164|FG000|Treatment Period|Withdrawal by Subject|0|||
130306688|NCT05870865|469087165|FG001|Treatment Period|Withdrawal by Subject|1|||
130306689|NCT05870865|469087166|FG002|Treatment Period|Withdrawal by Subject|1|||
130306690|NCT05870865|469087167|FG003|Treatment Period|Withdrawal by Subject|1|||
130306691|NCT03828019|469087171|FG000|Overall Study|Withdrawal by Subject|3|||
130306692|NCT03828019|469087172|FG001|Overall Study|Withdrawal by Subject|8|||
130306693|NCT03828019|469087171|FG000|Overall Study|Lost to Follow-up|1|||
130306694|NCT03828019|469087172|FG001|Overall Study|Lost to Follow-up|6|||
129797826|NCT02537574|467228234|FG001|Overall Study|Duplicate Patient|0|||
130048725|NCT02202031|468134641|FG001|Overall Study|Illness/Medical Reason|2|||
130048726|NCT02202031|468134640|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
130048727|NCT02202031|468134641|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
130048728|NCT02086565|468134650|FG000|Overall Study|Lost to Follow-up|9|||
130048729|NCT02086565|468134651|FG001|Overall Study|Lost to Follow-up|7|||
130048730|NCT02086565|468134650|FG000|Overall Study|Withdrawal by Subject|2|||
130048731|NCT02086565|468134651|FG001|Overall Study|Withdrawal by Subject|1|||
130048732|NCT02086565|468134650|FG000|Overall Study|Death|3|||
130048733|NCT02086565|468134651|FG001|Overall Study|Death|2|||
130048734|NCT02086565|468134650|FG000|Overall Study|withdrawn by research team|2|||
130048735|NCT02086565|468134651|FG001|Overall Study|withdrawn by research team|2|||
130048736|NCT02116972|468134652|FG000|Overall Study|Adverse Event|4|||
130048737|NCT02116972|468134653|FG001|Overall Study|Adverse Event|4|||
130048738|NCT02116972|468134654|FG002|Overall Study|Adverse Event|1|||
130048739|NCT02116972|468134652|FG000|Overall Study|Withdrawal by Subject|1|||
130048740|NCT02116972|468134653|FG001|Overall Study|Withdrawal by Subject|1|||
130109480|NCT02842086|468361061|FG001|Overall Study|Adverse Event|20|||
130109481|NCT02842086|468361060|FG000|Overall Study|Death|3|||
130109482|NCT02842086|468361061|FG001|Overall Study|Death|3|||
130109483|NCT02842086|468361060|FG000|Overall Study|Investigator's Discretion|9|||
130109484|NCT02842086|468361061|FG001|Overall Study|Investigator's Discretion|13|||
130109485|NCT02842086|468361060|FG000|Overall Study|Non-Compliance with Study Drug|9|||
130109486|NCT02842086|468361061|FG001|Overall Study|Non-Compliance with Study Drug|8|||
130109487|NCT02842086|468361060|FG000|Overall Study|Protocol Violation|8|||
130109488|NCT02842086|468361061|FG001|Overall Study|Protocol Violation|4|||
130109489|NCT02842086|468361060|FG000|Overall Study|Withdrew Consent|205|||
130109490|NCT02842086|468361061|FG001|Overall Study|Withdrew Consent|194|||
130306695|NCT03828019|469087171|FG000|Overall Study|Incarcerated|1|||
130306696|NCT03828019|469087172|FG001|Overall Study|Incarcerated|0|||
130306697|NCT03828019|469087171|FG000|Overall Study|Adverse Event|0|||
130306698|NCT03828019|469087172|FG001|Overall Study|Adverse Event|1|||
130306699|NCT03400176|469087173|FG000|Dose Escalation|Progressive disease|1|||
130306700|NCT03400176|469087174|FG001|Dose Escalation|Progressive disease|1|||
130306701|NCT03400176|469087175|FG002|Dose Escalation|Progressive disease|0|||
130306702|NCT03400176|469087176|FG003|Dose Escalation|Progressive disease|0|||
130048741|NCT02116972|468134654|FG002|Overall Study|Withdrawal by Subject|5|||
130306703|NCT03400176|469087177|FG004|Dose Escalation|Progressive disease|1|||
129797827|NCT02537574|467228235|FG002|Overall Study|Duplicate Patient|0|||
130048742|NCT02116972|468134652|FG000|Overall Study|Protocol Violation|1|||
130109491|NCT02842086|468361060|FG000|Overall Study|Lost to Follow-up|274|||
130306704|NCT03400176|469087173|FG000|Dose Escalation|Patient decision|0|||
130306705|NCT03400176|469087174|FG001|Dose Escalation|Patient decision|0|||
130048743|NCT02116972|468134653|FG001|Overall Study|Protocol Violation|0|||
130048744|NCT02116972|468134654|FG002|Overall Study|Protocol Violation|1|||
130048745|NCT02116972|468134652|FG000|Overall Study|Lost to Follow-up|4|||
130306706|NCT03400176|469087175|FG002|Dose Escalation|Patient decision|0|||
130306707|NCT03400176|469087176|FG003|Dose Escalation|Patient decision|0|||
130306708|NCT03400176|469087177|FG004|Dose Escalation|Patient decision|1|||
130306709|NCT03400176|469087173|FG000|Dose Expansion|Patient decision|0|||
130306710|NCT03400176|469087174|FG001|Dose Expansion|Patient decision|0|||
130306711|NCT03400176|469087175|FG002|Dose Expansion|Patient decision|0|||
130306712|NCT03400176|469087176|FG003|Dose Expansion|Patient decision|1|||
130109492|NCT02842086|468361061|FG001|Overall Study|Lost to Follow-up|236|||
130109493|NCT02842086|468361060|FG000|Overall Study|HIV-1 Infection|5|||
130109494|NCT02842086|468361061|FG001|Overall Study|HIV-1 Infection|6|||
130109495|NCT03751124|468361062|FG000|Overall Study|Adverse Event|4|||
130109496|NCT03751124|468361063|FG001|Overall Study|Adverse Event|3|||
130109497|NCT03751124|468361062|FG000|Overall Study|Protocol Deviation|0|||
130109498|NCT03751124|468361063|FG001|Overall Study|Protocol Deviation|1|||
130109499|NCT03751124|468361062|FG000|Overall Study|Lost to Follow-up|6|||
130109500|NCT03751124|468361063|FG001|Overall Study|Lost to Follow-up|4|||
130109501|NCT03751124|468361062|FG000|Overall Study|Withdrawal by Subject|6|||
130109502|NCT03751124|468361063|FG001|Overall Study|Withdrawal by Subject|8|||
130109503|NCT03751124|468361062|FG000|Overall Study|Lack of Efficacy|1|||
130109504|NCT03751124|468361063|FG001|Overall Study|Lack of Efficacy|1|||
130109505|NCT03751124|468361062|FG000|Overall Study|Pregnancy|0|||
130109506|NCT03751124|468361063|FG001|Overall Study|Pregnancy|1|||
130109507|NCT03751124|468361062|FG000|Overall Study|Other|9|||
130109508|NCT03751124|468361063|FG001|Overall Study|Other|9|||
130109509|NCT03751124|468361062|FG000|Overall Study|Participants who did not receive any study drug|0|||
130109510|NCT03751124|468361063|FG001|Overall Study|Participants who did not receive any study drug|1|||
130109511|NCT00555399|468361066|FG000|Overall Study|Withdrawal by Subject|0|||
130109512|NCT00555399|468361067|FG001|Overall Study|Withdrawal by Subject|0|||
130109513|NCT00555399|468361068|FG002|Overall Study|Withdrawal by Subject|1|||
130109514|NCT00555399|468361069|FG003|Overall Study|Withdrawal by Subject|0|||
130109515|NCT00555399|468361070|FG004|Overall Study|Withdrawal by Subject|0|||
130109516|NCT00555399|468361071|FG005|Overall Study|Withdrawal by Subject|0|||
130109517|NCT00555399|468361072|FG006|Overall Study|Withdrawal by Subject|0|||
130109518|NCT00555399|468361073|FG007|Overall Study|Withdrawal by Subject|0|||
130109519|NCT00555399|468361074|FG008|Overall Study|Withdrawal by Subject|0|||
130109520|NCT00555399|468361075|FG009|Overall Study|Withdrawal by Subject|0|||
130109521|NCT00555399|468361076|FG010|Overall Study|Withdrawal by Subject|0|||
130109522|NCT00555399|468361077|FG011|Overall Study|Withdrawal by Subject|1|||
130109523|NCT00555399|468361066|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
130109524|NCT00555399|468361067|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
130109525|NCT00555399|468361068|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
130109526|NCT00555399|468361069|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
130109527|NCT00555399|468361070|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
130109528|NCT00555399|468361071|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
130109529|NCT00555399|468361072|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
130109530|NCT00555399|468361073|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
130109531|NCT00555399|468361074|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
130109532|NCT00555399|468361075|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
130109533|NCT00555399|468361076|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
130109534|NCT00555399|468361077|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
130109535|NCT00343642|468362411|FG000|Overall Study|Lost to Follow-up|0|||
130109536|NCT00343642|468362412|FG001|Overall Study|Lost to Follow-up|1|||
130109537|NCT00343642|468362413|FG002|Overall Study|Lost to Follow-up|0|||
130109538|NCT00343642|468362411|FG000|Overall Study|Pregnancy|1|||
130109539|NCT00343642|468362412|FG001|Overall Study|Pregnancy|0|||
130109540|NCT00343642|468362413|FG002|Overall Study|Pregnancy|2|||
130109541|NCT00343642|468362411|FG000|Overall Study|Withdrawal by Subject|2|||
130109542|NCT00343642|468362412|FG001|Overall Study|Withdrawal by Subject|3|||
130109543|NCT00343642|468362413|FG002|Overall Study|Withdrawal by Subject|4|||
130109544|NCT00343642|468362411|FG000|Overall Study|Adverse Event|0|||
130109545|NCT00343642|468362412|FG001|Overall Study|Adverse Event|0|||
130109546|NCT00343642|468362413|FG002|Overall Study|Adverse Event|1|||
130306713|NCT03400176|469087177|FG004|Dose Expansion|Patient decision|0|||
130306714|NCT03400176|469087173|FG000|Dose Expansion|Adverse Event|0|||
130306715|NCT03400176|469087174|FG001|Dose Expansion|Adverse Event|0|||
130109547|NCT00343642|468362411|FG000|Overall Study|Flare up|6|||
130109548|NCT00343642|468362412|FG001|Overall Study|Flare up|4|||
130109549|NCT00343642|468362413|FG002|Overall Study|Flare up|0|||
130109550|NCT00860574|468362414|FG000|Overall Study|Death|2|||
130109551|NCT00860574|468362414|FG000|Overall Study|Relapse|1|||
130109552|NCT01246986|468362415|FG000|Overall Study|Lost to Follow-up|0|||
130109553|NCT01246986|468362416|FG001|Overall Study|Lost to Follow-up|1|||
130306716|NCT03400176|469087175|FG002|Dose Expansion|Adverse Event|0|||
130306717|NCT03400176|469087176|FG003|Dose Expansion|Adverse Event|1|||
130306718|NCT03400176|469087177|FG004|Dose Expansion|Adverse Event|0|||
130306719|NCT03400176|469087173|FG000|Dose Expansion|Physician Decision|0|||
130306720|NCT03400176|469087174|FG001|Dose Expansion|Physician Decision|0|||
130306721|NCT03400176|469087175|FG002|Dose Expansion|Physician Decision|0|||
130306722|NCT03400176|469087176|FG003|Dose Expansion|Physician Decision|1|||
130306723|NCT03400176|469087177|FG004|Dose Expansion|Physician Decision|0|||
130306724|NCT03400176|469087173|FG000|Dose Expansion|Progressive disease|0|||
130306725|NCT03400176|469087174|FG001|Dose Expansion|Progressive disease|0|||
130306726|NCT03400176|469087175|FG002|Dose Expansion|Progressive disease|1|||
130306727|NCT03400176|469087176|FG003|Dose Expansion|Progressive disease|1|||
130306728|NCT03400176|469087177|FG004|Dose Expansion|Progressive disease|0|||
130306729|NCT00206440|469087178|FG000|Overall Study|Protocol Violation|1|||
130306730|NCT00206440|469087179|FG001|Overall Study|Protocol Violation|2|||
130306731|NCT00206440|469087178|FG000|Overall Study|Adverse Event|4|||
130306732|NCT00206440|469087179|FG001|Overall Study|Adverse Event|2|||
130306733|NCT01298765|469087180|FG000|Titration Period|Adverse Event|26|||
130306734|NCT01298765|469087180|FG000|Titration Period|Death|1|||
130306735|NCT01298765|469087180|FG000|Titration Period|Lack of Efficacy|21|||
130306736|NCT01298765|469087180|FG000|Titration Period|Lost to Follow-up|9|||
130306737|NCT01298765|469087180|FG000|Titration Period|Physician Decision|1|||
130306738|NCT01298765|469087180|FG000|Titration Period|Withdrawal by Subject|10|||
130306739|NCT01298765|469087180|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
130306740|NCT01298765|469087180|FG000|Long-Term Treatment Period|Adverse Event|19|||
130306741|NCT01298765|469087180|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
130306742|NCT01298765|469087180|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
130306743|NCT01298765|469087180|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
130306744|NCT01298765|469087180|FG000|Long-Term Treatment Period|Physician Decision|1|||
130306745|NCT01298765|469087180|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
130306746|NCT00766051|469087182|FG000|Overall Study|Withdrawal by Subject|2|||
130306747|NCT00766051|469087183|FG001|Overall Study|Withdrawal by Subject|0|||
130048746|NCT02116972|468134653|FG001|Overall Study|Lost to Follow-up|3|||
130048747|NCT02116972|468134654|FG002|Overall Study|Lost to Follow-up|1|||
130048748|NCT02116972|468134652|FG000|Overall Study|Lack of Efficacy|6|||
130048749|NCT02116972|468134653|FG001|Overall Study|Lack of Efficacy|6|||
130048750|NCT02116972|468134654|FG002|Overall Study|Lack of Efficacy|5|||
130048751|NCT02116972|468134652|FG000|Overall Study|scheduling conflicts and relocation|3|||
130048752|NCT02116972|468134653|FG001|Overall Study|scheduling conflicts and relocation|3|||
130048753|NCT02116972|468134654|FG002|Overall Study|scheduling conflicts and relocation|6|||
130048754|NCT00784784|468134655|FG000|Overall Study|Withdrawal by Subject|2|||
130048755|NCT00784784|468134656|FG001|Overall Study|Withdrawal by Subject|2|||
130048756|NCT01400971|468134657|FG000|Overall Study|Death|82|||
130048757|NCT01400971|468134657|FG000|Overall Study|Lost to Follow-up|196|||
130048758|NCT01400971|468134657|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
130048759|NCT01400971|468134657|FG000|Overall Study|Physician Decision|57|||
130048760|NCT01400971|468134657|FG000|Overall Study|Withdrawal by Subject|158|||
130048761|NCT01400971|468134657|FG000|Overall Study|Other|422|||
130048762|NCT00863928|468134660|FG000|Overall Study|Protocol Violation|26|||
130048763|NCT00863928|468134661|FG001|Overall Study|Protocol Violation|0|||
130048764|NCT00863928|468134660|FG000|Overall Study|Withdrawal by Subject|3|||
130048765|NCT00863928|468134661|FG001|Overall Study|Withdrawal by Subject|0|||
130048766|NCT00863928|468134660|FG000|Overall Study|surgery cancellation|4|||
130048767|NCT00863928|468134661|FG001|Overall Study|surgery cancellation|0|||
130048768|NCT00863928|468134660|FG000|Overall Study|medication allergy|3|||
130048769|NCT00863928|468134661|FG001|Overall Study|medication allergy|0|||
130048770|NCT03321929|468134662|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
130048771|NCT00530712|468134668|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
130048772|NCT00530712|468134668|FG000|30 Day Follow-up Visit|Missed Visit|5|||
130048773|NCT00530712|468134668|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
130048774|NCT00530712|468134668|FG000|6 Month Follow-up Visit|Missed Visit|3|||
130048775|NCT00530712|468134668|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
130048776|NCT00530712|468134668|FG000|6 Month Follow-up Visit|Death|2|||
130048777|NCT00530712|468134668|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
130048778|NCT00530712|468134668|FG000|12 Month Follow-up Visit|Missed Visit|3|||
130048779|NCT00530712|468134668|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
130048780|NCT00530712|468134668|FG000|12 Month Follow-up Visit|Death|9|||
130048781|NCT03117049|468134676|FG000|Overall Study|Continued the follow-up period|109|||
130048782|NCT03117049|468134677|FG001|Overall Study|Continued the follow-up period|129|||
130048783|NCT03117049|468134676|FG000|Overall Study|Died|82|||
130048784|NCT03117049|468134677|FG001|Overall Study|Died|93|||
130048785|NCT03117049|468134676|FG000|Overall Study|Consent withdrawal|7|||
130048786|NCT03117049|468134677|FG001|Overall Study|Consent withdrawal|6|||
130048787|NCT03117049|468134676|FG000|Overall Study|Missing contact|3|||
130048788|NCT03117049|468134677|FG001|Overall Study|Missing contact|3|||
130048789|NCT00651118|468134678|FG000|Overall Study|Adverse Event|4|||
130048790|NCT00651118|468134679|FG001|Overall Study|Adverse Event|0|||
130306748|NCT03302247|469087186|FG000|Overall Study|the study has closed prematurely|2|||
130306749|NCT03302247|469087186|FG000|Overall Study|Death|1|||
130048791|NCT00651118|468134680|FG002|Overall Study|Adverse Event|1|||
130306750|NCT04090242|469087187|FG000|Overall Study|Withdrawal by Subject|1|||
130306751|NCT04090242|469087188|FG001|Overall Study|Withdrawal by Subject|0|||
130306752|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
130048792|NCT00651118|468134681|FG003|Overall Study|Adverse Event|1|||
130048793|NCT00651118|468134678|FG000|Overall Study|Protocol Violation|2|||
130048794|NCT00651118|468134679|FG001|Overall Study|Protocol Violation|2|||
130048795|NCT00651118|468134680|FG002|Overall Study|Protocol Violation|6|||
130048796|NCT00651118|468134681|FG003|Overall Study|Protocol Violation|2|||
130048797|NCT00651118|468134678|FG000|Overall Study|Lost to Follow-up|2|||
130048798|NCT00651118|468134679|FG001|Overall Study|Lost to Follow-up|0|||
130048799|NCT00651118|468134680|FG002|Overall Study|Lost to Follow-up|1|||
130048800|NCT00651118|468134681|FG003|Overall Study|Lost to Follow-up|2|||
130048801|NCT00651118|468134678|FG000|Overall Study|administrative|1|||
130048802|NCT00651118|468134679|FG001|Overall Study|administrative|4|||
130048803|NCT00651118|468134680|FG002|Overall Study|administrative|2|||
130048804|NCT00651118|468134681|FG003|Overall Study|administrative|1|||
130048805|NCT00651118|468134678|FG000|Overall Study|Withdrawal by Subject|0|||
130048806|NCT00651118|468134679|FG001|Overall Study|Withdrawal by Subject|1|||
130048807|NCT00651118|468134680|FG002|Overall Study|Withdrawal by Subject|1|||
130048808|NCT00651118|468134681|FG003|Overall Study|Withdrawal by Subject|1|||
130048809|NCT00839098|468134682|FG000|Overall Study|Withdrawal by Subject|2|||
130048810|NCT00839098|468134683|FG001|Overall Study|Withdrawal by Subject|1|||
130048811|NCT00839098|468134684|FG002|Overall Study|Withdrawal by Subject|7|||
130048812|NCT00365976|468134687|FG000|Overall Study|Withdrawal by Subject|1|||
130048813|NCT00365976|468134688|FG001|Overall Study|Withdrawal by Subject|5|||
130048814|NCT01850563|468136569|FG000|Overall Study|Not eligible|3|||
130048815|NCT01850563|468136570|FG001|Overall Study|Not eligible|0|||
130048816|NCT04359823|468136571|FG000|Overall Study|Lost to Follow-up|0|||
130048817|NCT04359823|468136572|FG001|Overall Study|Lost to Follow-up|1|||
130048818|NCT04359823|468136571|FG000|Overall Study|Withdrawal by Subject|0|||
130048819|NCT04359823|468136572|FG001|Overall Study|Withdrawal by Subject|1|||
130048820|NCT00408421|468136578|FG000|Treatment Initial Randomization|Adverse Event|5|||
130048821|NCT00408421|468136579|FG001|Treatment Initial Randomization|Adverse Event|9|||
130048822|NCT00408421|468136580|FG002|Treatment Initial Randomization|Adverse Event|0|||
130048823|NCT00408421|468136578|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
130048824|NCT00408421|468136579|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
130048825|NCT00408421|468136580|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
130048826|NCT00408421|468136578|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
130048827|NCT00408421|468136579|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
130048828|NCT00408421|468136580|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
130048829|NCT00408421|468136578|FG000|Treatment Initial Randomization|Physician Decision|1|||
130048830|NCT00408421|468136579|FG001|Treatment Initial Randomization|Physician Decision|0|||
130048831|NCT00408421|468136580|FG002|Treatment Initial Randomization|Physician Decision|0|||
130048832|NCT00408421|468136578|FG000|Treatment Initial Randomization|Protocol Violation|0|||
130048833|NCT00408421|468136579|FG001|Treatment Initial Randomization|Protocol Violation|1|||
130048834|NCT00408421|468136580|FG002|Treatment Initial Randomization|Protocol Violation|0|||
130048835|NCT00408421|468136578|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
130048836|NCT00408421|468136579|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
130048837|NCT00408421|468136580|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
130048838|NCT00408421|468136578|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
130048839|NCT00408421|468136579|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
130048840|NCT00408421|468136580|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
130048841|NCT00408421|468136578|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
130048842|NCT00408421|468136579|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
130048843|NCT00408421|468136580|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
130048844|NCT00408421|468136578|FG000|Treatment Re-Randomization|Adverse Event|2|||
130048845|NCT00408421|468136579|FG001|Treatment Re-Randomization|Adverse Event|2|||
130048846|NCT00408421|468136580|FG002|Treatment Re-Randomization|Adverse Event|4|||
130048847|NCT00408421|468136578|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
130048848|NCT00408421|468136579|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
130048849|NCT00408421|468136580|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
130048850|NCT00408421|468136578|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
130048851|NCT00408421|468136579|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
130048852|NCT00408421|468136580|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
130048853|NCT00408421|468136578|FG000|Treatment Re-Randomization|Physician Decision|1|||
130048854|NCT00408421|468136579|FG001|Treatment Re-Randomization|Physician Decision|3|||
130048855|NCT00408421|468136580|FG002|Treatment Re-Randomization|Physician Decision|0|||
130048856|NCT00408421|468136578|FG000|Treatment Re-Randomization|Protocol Violation|1|||
130306753|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
130048857|NCT00408421|468136579|FG001|Treatment Re-Randomization|Protocol Violation|1|||
130048858|NCT00408421|468136580|FG002|Treatment Re-Randomization|Protocol Violation|0|||
130048859|NCT00408421|468136578|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
130306754|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
130306755|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Death|0|||
130306756|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Death|2|||
130306757|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Death|0|||
130109554|NCT01246986|468362417|FG002|Overall Study|Lost to Follow-up|3|||
130109555|NCT01246986|468362418|FG003|Overall Study|Lost to Follow-up|0|||
130109556|NCT01246986|468362419|FG004|Overall Study|Lost to Follow-up|0|||
130109557|NCT01246986|468362420|FG005|Overall Study|Lost to Follow-up|1|||
130109558|NCT01246986|468362421|FG006|Overall Study|Lost to Follow-up|0|||
130109559|NCT01246986|468362415|FG000|Overall Study|Withdrawal by Subject|3|||
130306758|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
130306759|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
130306760|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
130306761|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
130306762|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
130306763|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
130306764|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
130306765|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
130306766|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
130306767|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
130306768|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
130306769|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
130306770|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
130306771|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
130306772|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
130306773|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Recovery|1|||
130306774|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Recovery|0|||
130306775|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Recovery|1|||
130306776|NCT00195663|469087189|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
130306777|NCT00195663|469087190|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
130306778|NCT00195663|469087191|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
130306779|NCT00195663|469087189|FG000|Open-Label Extension Period|Adverse Event|21|||
130306780|NCT00195663|469087190|FG001|Open-Label Extension Period|Adverse Event|32|||
130306781|NCT00195663|469087191|FG002|Open-Label Extension Period|Adverse Event|36|||
130306782|NCT00195663|469087189|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
130306783|NCT00195663|469087190|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
130306784|NCT00195663|469087191|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
130306785|NCT00195663|469087189|FG000|Open-Label Extension Period|Recovery|0|||
130306786|NCT00195663|469087190|FG001|Open-Label Extension Period|Recovery|2|||
130306787|NCT00195663|469087191|FG002|Open-Label Extension Period|Recovery|2|||
130306788|NCT00195663|469087189|FG000|Open-Label Extension Period|Protocol Violation|3|||
130306789|NCT00195663|469087190|FG001|Open-Label Extension Period|Protocol Violation|4|||
130109560|NCT01246986|468362416|FG001|Overall Study|Withdrawal by Subject|4|||
130109561|NCT01246986|468362417|FG002|Overall Study|Withdrawal by Subject|3|||
130109562|NCT01246986|468362418|FG003|Overall Study|Withdrawal by Subject|0|||
130109563|NCT01246986|468362419|FG004|Overall Study|Withdrawal by Subject|4|||
130109564|NCT01246986|468362420|FG005|Overall Study|Withdrawal by Subject|0|||
130109565|NCT01246986|468362421|FG006|Overall Study|Withdrawal by Subject|0|||
130109566|NCT01416142|468362425|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
130109567|NCT01416142|468362426|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
130109568|NCT01416142|468362427|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
130109569|NCT01335399|468362428|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
130109570|NCT01335399|468362429|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
130109571|NCT01335399|468362428|FG000|Pre-treatment Period|Participant request to discontinue|0|||
130109572|NCT01335399|468362429|FG001|Pre-treatment Period|Participant request to discontinue|1|||
130109573|NCT01335399|468362428|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
130109574|NCT01335399|468362429|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
130109575|NCT01335399|468362428|FG000|Pre-treatment Period|Consent withdrawal|3|||
130109576|NCT01335399|468362429|FG001|Pre-treatment Period|Consent withdrawal|0|||
130109577|NCT01335399|468362428|FG000|Treatment Period|Disease progression|117|||
130109578|NCT01335399|468362429|FG001|Treatment Period|Disease progression|145|||
130306790|NCT00195663|469087191|FG002|Open-Label Extension Period|Protocol Violation|4|||
130306791|NCT00195663|469087189|FG000|Open-Label Extension Period|Death|2|||
130109579|NCT01335399|468362428|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
130109580|NCT01335399|468362429|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
130109581|NCT01335399|468362428|FG000|Treatment Period|Study drug toxicity|52|||
130109582|NCT01335399|468362429|FG001|Treatment Period|Study drug toxicity|64|||
130109583|NCT01335399|468362428|FG000|Treatment Period|Participant request to discontinue|30|||
130306792|NCT00195663|469087190|FG001|Open-Label Extension Period|Death|2|||
130306793|NCT00195663|469087191|FG002|Open-Label Extension Period|Death|2|||
130306794|NCT00195663|469087189|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
130306795|NCT00195663|469087190|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
130306796|NCT00195663|469087191|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
130306797|NCT00195663|469087189|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
130306798|NCT00195663|469087190|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
130306799|NCT00195663|469087191|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
130048860|NCT00408421|468136579|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
130048861|NCT00408421|468136580|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
130048862|NCT02433210|468136584|FG000|Overall Study|Physician Decision|1|||
130048863|NCT02433210|468136585|FG001|Overall Study|Physician Decision|0|||
130048864|NCT02433210|468136586|FG002|Overall Study|Physician Decision|0|||
130048865|NCT01614769|468136591|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
130048866|NCT01614769|468136592|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
130048867|NCT01614769|468136593|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
130048868|NCT01614769|468136594|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
130048869|NCT01614769|468136595|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
130048870|NCT01614769|468136596|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
130048871|NCT01614769|468136591|FG000|Period 1|Protocol Violation|0|||
130048872|NCT01614769|468136592|FG001|Period 1|Protocol Violation|0|||
130048873|NCT01614769|468136593|FG002|Period 1|Protocol Violation|0|||
130048874|NCT01614769|468136594|FG003|Period 1|Protocol Violation|1|||
130048875|NCT01614769|468136595|FG004|Period 1|Protocol Violation|0|||
130048876|NCT01614769|468136596|FG005|Period 1|Protocol Violation|0|||
130048877|NCT01614769|468136591|FG000|Period 1|Withdrawal by Subject|1|||
130048878|NCT01614769|468136592|FG001|Period 1|Withdrawal by Subject|0|||
130048879|NCT01614769|468136593|FG002|Period 1|Withdrawal by Subject|0|||
130048880|NCT01614769|468136594|FG003|Period 1|Withdrawal by Subject|0|||
130048881|NCT01614769|468136595|FG004|Period 1|Withdrawal by Subject|0|||
130048882|NCT01614769|468136596|FG005|Period 1|Withdrawal by Subject|0|||
130048883|NCT01614769|468136591|FG000|Period 3|Withdrawal by Subject|0|||
130048884|NCT01614769|468136592|FG001|Period 3|Withdrawal by Subject|0|||
130048885|NCT01614769|468136593|FG002|Period 3|Withdrawal by Subject|1|||
130048886|NCT01614769|468136594|FG003|Period 3|Withdrawal by Subject|0|||
130048887|NCT01614769|468136595|FG004|Period 3|Withdrawal by Subject|0|||
130048888|NCT01614769|468136596|FG005|Period 3|Withdrawal by Subject|0|||
130048889|NCT03123354|468136597|FG000|Overall Study|Physician Decision|6|||
130048890|NCT01958671|468136600|FG000|Overall Study|Adverse Event|1|||
130048891|NCT01958671|468136601|FG001|Overall Study|Adverse Event|1|||
130048892|NCT01958671|468136602|FG002|Overall Study|Adverse Event|5|||
130048893|NCT01958671|468136600|FG000|Overall Study|Death|1|||
130048894|NCT01958671|468136601|FG001|Overall Study|Death|0|||
130048895|NCT01958671|468136602|FG002|Overall Study|Death|0|||
130048896|NCT01958671|468136600|FG000|Overall Study|Excluded medication|0|||
130048897|NCT01958671|468136601|FG001|Overall Study|Excluded medication|0|||
130048898|NCT01958671|468136602|FG002|Overall Study|Excluded medication|1|||
130048899|NCT01958671|468136600|FG000|Overall Study|Hyperglycemia|0|||
130048900|NCT01958671|468136601|FG001|Overall Study|Hyperglycemia|0|||
130048901|NCT01958671|468136602|FG002|Overall Study|Hyperglycemia|2|||
130048902|NCT01958671|468136600|FG000|Overall Study|Lost to Follow-up|7|||
130048903|NCT01958671|468136601|FG001|Overall Study|Lost to Follow-up|11|||
130048904|NCT01958671|468136602|FG002|Overall Study|Lost to Follow-up|7|||
130048905|NCT01958671|468136600|FG000|Overall Study|Non-compliance with study drug|1|||
130048906|NCT01958671|468136601|FG001|Overall Study|Non-compliance with study drug|1|||
130048907|NCT01958671|468136602|FG002|Overall Study|Non-compliance with study drug|1|||
130048908|NCT01958671|468136600|FG000|Overall Study|Pregnancy|0|||
130048909|NCT01958671|468136601|FG001|Overall Study|Pregnancy|0|||
130048910|NCT01958671|468136602|FG002|Overall Study|Pregnancy|1|||
130048911|NCT01958671|468136600|FG000|Overall Study|Protocol Violation|0|||
130048912|NCT01958671|468136601|FG001|Overall Study|Protocol Violation|1|||
130048913|NCT01958671|468136602|FG002|Overall Study|Protocol Violation|0|||
130048914|NCT01958671|468136600|FG000|Overall Study|Study site terminated by sponsor|1|||
130048915|NCT01958671|468136601|FG001|Overall Study|Study site terminated by sponsor|0|||
130048916|NCT01958671|468136602|FG002|Overall Study|Study site terminated by sponsor|1|||
130048917|NCT01958671|468136600|FG000|Overall Study|Participant moved|0|||
130048918|NCT01958671|468136601|FG001|Overall Study|Participant moved|0|||
130048919|NCT01958671|468136602|FG002|Overall Study|Participant moved|1|||
130048920|NCT01958671|468136600|FG000|Overall Study|Withdrawal by Subject|8|||
130048921|NCT01958671|468136601|FG001|Overall Study|Withdrawal by Subject|10|||
130048922|NCT01958671|468136602|FG002|Overall Study|Withdrawal by Subject|13|||
130048923|NCT04760314|468136603|FG000|Induction Period|Withdrawal by Subject|0|||
130306800|NCT00195663|469087189|FG000|Open-Label Extension Period|Administrative reasons|11|||
130048924|NCT04760314|468136604|FG001|Induction Period|Withdrawal by Subject|1|||
130048925|NCT04760314|468136605|FG002|Induction Period|Withdrawal by Subject|1|||
130048926|NCT04760314|468136606|FG003|Induction Period|Withdrawal by Subject|0|||
130048927|NCT04760314|468136607|FG004|Induction Period|Withdrawal by Subject|0|||
130048928|NCT04760314|468136608|FG005|Induction Period|Withdrawal by Subject|0|||
130048929|NCT04760314|468136609|FG006|Induction Period|Withdrawal by Subject|0|||
130048930|NCT04760314|468136610|FG007|Induction Period|Withdrawal by Subject|0|||
130109584|NCT01335399|468362429|FG001|Treatment Period|Participant request to discontinue|22|||
130109585|NCT01335399|468362428|FG000|Treatment Period|Other reasons|30|||
130109586|NCT01335399|468362429|FG001|Treatment Period|Other reasons|30|||
130109587|NCT01335399|468362428|FG000|Treatment Period|Consent withdrawal|10|||
130109588|NCT01335399|468362429|FG001|Treatment Period|Consent withdrawal|7|||
130109589|NCT01335399|468362428|FG000|Treatment Period|Death|7|||
130109590|NCT01335399|468362429|FG001|Treatment Period|Death|6|||
130109591|NCT01335399|468362428|FG000|Treatment Period|Poor/Non-compliance|3|||
130109592|NCT01335399|468362429|FG001|Treatment Period|Poor/Non-compliance|4|||
130109593|NCT01335399|468362428|FG000|Treatment Period|Lost to Follow-up|2|||
130109594|NCT01335399|468362429|FG001|Treatment Period|Lost to Follow-up|2|||
130109595|NCT01335399|468362428|FG000|Treatment Period|Maximum clinical benefit|1|||
130109596|NCT01335399|468362429|FG001|Treatment Period|Maximum clinical benefit|1|||
130109597|NCT01335399|468362428|FG000|Treatment Period|No longer meet study criteria|1|||
130109598|NCT01335399|468362429|FG001|Treatment Period|No longer meet study criteria|1|||
130109599|NCT01335399|468362428|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
130109600|NCT01335399|468362429|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
130109601|NCT02464059|468362430|FG000|Overall Study|Lost to Follow-up|6|||
130109602|NCT01011907|468362433|FG000|Overall Study|Withdrawal by Subject|13|||
130109603|NCT01011907|468362434|FG001|Overall Study|Withdrawal by Subject|11|||
130109604|NCT01011907|468362433|FG000|Overall Study|Adverse Event|1|||
130109605|NCT01011907|468362434|FG001|Overall Study|Adverse Event|4|||
130109606|NCT00304954|468362435|FG000|Overall Study|Withdrawal by Subject|0|||
130109607|NCT00304954|468362436|FG001|Overall Study|Withdrawal by Subject|0|||
130109608|NCT00304954|468362437|FG002|Overall Study|Withdrawal by Subject|1|||
130109609|NCT00304954|468362438|FG003|Overall Study|Withdrawal by Subject|0|||
130109610|NCT00304954|468362435|FG000|Overall Study|Adverse Event|1|||
130109611|NCT00304954|468362436|FG001|Overall Study|Adverse Event|0|||
130109612|NCT00304954|468362437|FG002|Overall Study|Adverse Event|0|||
130109613|NCT00304954|468362438|FG003|Overall Study|Adverse Event|0|||
130109614|NCT01406873|468362443|FG000|Overall Study|Withdrawal by Subject|1|||
130109615|NCT01406873|468362444|FG001|Overall Study|Withdrawal by Subject|1|||
130109616|NCT03990389|468362445|FG000|Overall Study|Lost to Follow-up|3|||
130109617|NCT03990389|468362446|FG001|Overall Study|Lost to Follow-up|0|||
130109618|NCT00207714|468362447|FG000|Overall Study|Adverse Event|6|||
130109619|NCT00207714|468362448|FG001|Overall Study|Adverse Event|2|||
130109620|NCT00207714|468362449|FG002|Overall Study|Adverse Event|4|||
130109621|NCT00207714|468362450|FG003|Overall Study|Adverse Event|3|||
130109622|NCT00207714|468362451|FG004|Overall Study|Adverse Event|1|||
130306801|NCT00195663|469087190|FG001|Open-Label Extension Period|Administrative reasons|11|||
130306802|NCT00195663|469087191|FG002|Open-Label Extension Period|Administrative reasons|13|||
130306803|NCT03214406|469087192|FG000|Overall Study|did not meet enrollment criteria|9|||
130306804|NCT03214406|469087193|FG001|Overall Study|did not meet enrollment criteria|13|||
130306805|NCT03214406|469087192|FG000|Overall Study|Withdrawal by Subject|1|||
130306806|NCT03214406|469087193|FG001|Overall Study|Withdrawal by Subject|0|||
130306807|NCT03214406|469087192|FG000|Overall Study|Lost to Follow-up|0|||
130306808|NCT03214406|469087193|FG001|Overall Study|Lost to Follow-up|2|||
130306809|NCT00604695|469087194|FG000|Overall Study|Did not receive first bolus.|0|||
130306810|NCT00604695|469087195|FG001|Overall Study|Did not receive first bolus.|4|||
130306811|NCT01098305|469087196|FG000|Overall Study|Lost to Follow-up|31|||
130306812|NCT01098305|469087197|FG001|Overall Study|Lost to Follow-up|33|||
130306813|NCT01180296|469087204|FG000|Overall Study|Protocol Violation|1|||
130306814|NCT01180296|469087205|FG001|Overall Study|Protocol Violation|2|||
130306815|NCT03364309|469087208|FG000|Induction Period|Adverse Event|4|||
130306816|NCT03364309|469087209|FG001|Induction Period|Adverse Event|0|||
130306817|NCT03364309|469087210|FG002|Induction Period|Adverse Event|1|||
130306818|NCT03364309|469087211|FG003|Induction Period|Adverse Event|0|||
130306819|NCT03364309|469087212|FG004|Induction Period|Adverse Event|0|||
130306820|NCT03364309|469087213|FG005|Induction Period|Adverse Event|0|||
130306821|NCT03364309|469087214|FG006|Induction Period|Adverse Event|0|||
130306822|NCT03364309|469087215|FG007|Induction Period|Adverse Event|0|||
130306823|NCT03364309|469087216|FG008|Induction Period|Adverse Event|0|||
130109623|NCT00207714|468362447|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130306824|NCT03364309|469087217|FG009|Induction Period|Adverse Event|0|||
130306825|NCT03364309|469087218|FG010|Induction Period|Adverse Event|0|||
130109624|NCT00207714|468362448|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130109625|NCT00207714|468362449|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130109626|NCT00207714|468362450|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
130109627|NCT00207714|468362451|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
130109628|NCT00207714|468362447|FG000|Overall Study|Other|3|||
130109629|NCT00207714|468362448|FG001|Overall Study|Other|2|||
130306826|NCT03364309|469087219|FG011|Induction Period|Adverse Event|0|||
130306827|NCT03364309|469087220|FG012|Induction Period|Adverse Event|0|||
130306828|NCT03364309|469087221|FG013|Induction Period|Adverse Event|0|||
130306829|NCT03364309|469087222|FG014|Induction Period|Adverse Event|0|||
130306830|NCT03364309|469087223|FG015|Induction Period|Adverse Event|0|||
130306831|NCT03364309|469087224|FG016|Induction Period|Adverse Event|0|||
130306832|NCT03364309|469087225|FG017|Induction Period|Adverse Event|0|||
130306833|NCT03364309|469087226|FG018|Induction Period|Adverse Event|0|||
130306834|NCT03364309|469087208|FG000|Induction Period|Withdrawal by Subject|1|||
130306835|NCT03364309|469087209|FG001|Induction Period|Withdrawal by Subject|3|||
130306836|NCT03364309|469087210|FG002|Induction Period|Withdrawal by Subject|0|||
130306837|NCT03364309|469087211|FG003|Induction Period|Withdrawal by Subject|0|||
130306838|NCT03364309|469087212|FG004|Induction Period|Withdrawal by Subject|0|||
130306839|NCT03364309|469087213|FG005|Induction Period|Withdrawal by Subject|0|||
130306840|NCT03364309|469087214|FG006|Induction Period|Withdrawal by Subject|0|||
130306841|NCT03364309|469087215|FG007|Induction Period|Withdrawal by Subject|0|||
130306842|NCT03364309|469087216|FG008|Induction Period|Withdrawal by Subject|0|||
130306843|NCT03364309|469087217|FG009|Induction Period|Withdrawal by Subject|0|||
130306844|NCT03364309|469087218|FG010|Induction Period|Withdrawal by Subject|0|||
130306845|NCT03364309|469087219|FG011|Induction Period|Withdrawal by Subject|0|||
130306846|NCT03364309|469087220|FG012|Induction Period|Withdrawal by Subject|0|||
130306847|NCT03364309|469087221|FG013|Induction Period|Withdrawal by Subject|0|||
130306848|NCT03364309|469087222|FG014|Induction Period|Withdrawal by Subject|0|||
130306849|NCT03364309|469087223|FG015|Induction Period|Withdrawal by Subject|0|||
130306850|NCT03364309|469087224|FG016|Induction Period|Withdrawal by Subject|0|||
130306851|NCT03364309|469087225|FG017|Induction Period|Withdrawal by Subject|0|||
130109630|NCT00207714|468362449|FG002|Overall Study|Other|5|||
130306852|NCT03364309|469087226|FG018|Induction Period|Withdrawal by Subject|0|||
130306853|NCT03364309|469087208|FG000|Induction Period|Lost to Follow-up|1|||
130306854|NCT03364309|469087209|FG001|Induction Period|Lost to Follow-up|0|||
130306855|NCT03364309|469087210|FG002|Induction Period|Lost to Follow-up|0|||
130306856|NCT03364309|469087211|FG003|Induction Period|Lost to Follow-up|0|||
130306857|NCT03364309|469087212|FG004|Induction Period|Lost to Follow-up|0|||
130306858|NCT03364309|469087213|FG005|Induction Period|Lost to Follow-up|0|||
130306859|NCT03364309|469087214|FG006|Induction Period|Lost to Follow-up|0|||
130306860|NCT03364309|469087215|FG007|Induction Period|Lost to Follow-up|0|||
130306861|NCT03364309|469087216|FG008|Induction Period|Lost to Follow-up|0|||
130306862|NCT03364309|469087217|FG009|Induction Period|Lost to Follow-up|0|||
130306863|NCT03364309|469087218|FG010|Induction Period|Lost to Follow-up|0|||
130306864|NCT03364309|469087219|FG011|Induction Period|Lost to Follow-up|0|||
130306865|NCT03364309|469087220|FG012|Induction Period|Lost to Follow-up|0|||
130306866|NCT03364309|469087221|FG013|Induction Period|Lost to Follow-up|0|||
130306867|NCT03364309|469087222|FG014|Induction Period|Lost to Follow-up|0|||
130306868|NCT03364309|469087223|FG015|Induction Period|Lost to Follow-up|0|||
130306869|NCT03364309|469087224|FG016|Induction Period|Lost to Follow-up|0|||
130306870|NCT03364309|469087225|FG017|Induction Period|Lost to Follow-up|0|||
130306871|NCT03364309|469087226|FG018|Induction Period|Lost to Follow-up|0|||
130306872|NCT03364309|469087208|FG000|Induction Period|Physician Decision|0|||
130306873|NCT03364309|469087209|FG001|Induction Period|Physician Decision|1|||
130306874|NCT03364309|469087210|FG002|Induction Period|Physician Decision|0|||
130306875|NCT03364309|469087211|FG003|Induction Period|Physician Decision|0|||
130306876|NCT03364309|469087212|FG004|Induction Period|Physician Decision|0|||
130306877|NCT03364309|469087213|FG005|Induction Period|Physician Decision|0|||
130306878|NCT03364309|469087214|FG006|Induction Period|Physician Decision|0|||
130306879|NCT03364309|469087215|FG007|Induction Period|Physician Decision|0|||
130306880|NCT03364309|469087216|FG008|Induction Period|Physician Decision|0|||
130306881|NCT03364309|469087217|FG009|Induction Period|Physician Decision|0|||
130109631|NCT00207714|468362450|FG003|Overall Study|Other|1|||
130109632|NCT00207714|468362451|FG004|Overall Study|Other|0|||
130109633|NCT00736099|468362453|FG000|Overall Study|Adverse Event|61|||
130306882|NCT03364309|469087218|FG010|Induction Period|Physician Decision|0|||
130306883|NCT03364309|469087219|FG011|Induction Period|Physician Decision|0|||
130306884|NCT03364309|469087220|FG012|Induction Period|Physician Decision|0|||
130306885|NCT03364309|469087221|FG013|Induction Period|Physician Decision|0|||
130306886|NCT03364309|469087222|FG014|Induction Period|Physician Decision|0|||
130306887|NCT03364309|469087223|FG015|Induction Period|Physician Decision|0|||
130306888|NCT03364309|469087224|FG016|Induction Period|Physician Decision|0|||
130306889|NCT03364309|469087225|FG017|Induction Period|Physician Decision|0|||
130306890|NCT03364309|469087226|FG018|Induction Period|Physician Decision|0|||
130306891|NCT03364309|469087208|FG000|Maintenance Period|Withdrawal by Subject|0|||
130306892|NCT03364309|469087209|FG001|Maintenance Period|Withdrawal by Subject|0|||
130306893|NCT03364309|469087210|FG002|Maintenance Period|Withdrawal by Subject|0|||
130306894|NCT03364309|469087211|FG003|Maintenance Period|Withdrawal by Subject|1|||
130306895|NCT03364309|469087212|FG004|Maintenance Period|Withdrawal by Subject|3|||
130306896|NCT03364309|469087213|FG005|Maintenance Period|Withdrawal by Subject|1|||
130109634|NCT00736099|468362454|FG001|Overall Study|Adverse Event|18|||
130306897|NCT03364309|469087214|FG006|Maintenance Period|Withdrawal by Subject|3|||
130306898|NCT03364309|469087215|FG007|Maintenance Period|Withdrawal by Subject|0|||
130306899|NCT03364309|469087216|FG008|Maintenance Period|Withdrawal by Subject|1|||
130306900|NCT03364309|469087217|FG009|Maintenance Period|Withdrawal by Subject|1|||
130306901|NCT03364309|469087218|FG010|Maintenance Period|Withdrawal by Subject|2|||
130306902|NCT03364309|469087219|FG011|Maintenance Period|Withdrawal by Subject|0|||
130109635|NCT00736099|468362453|FG000|Overall Study|Protocol Violation|10|||
130109636|NCT00736099|468362454|FG001|Overall Study|Protocol Violation|4|||
130109637|NCT00736099|468362453|FG000|Overall Study|Lost to Follow-up|12|||
130109638|NCT00736099|468362454|FG001|Overall Study|Lost to Follow-up|5|||
130109639|NCT00736099|468362453|FG000|Overall Study|Withdrawal by Subject|42|||
130109640|NCT00736099|468362454|FG001|Overall Study|Withdrawal by Subject|13|||
130109641|NCT00736099|468362453|FG000|Overall Study|Lack of Efficacy|15|||
130109642|NCT00736099|468362454|FG001|Overall Study|Lack of Efficacy|8|||
130109643|NCT00736099|468362453|FG000|Overall Study|Other reason|43|||
130109644|NCT00736099|468362454|FG001|Overall Study|Other reason|10|||
130109645|NCT02290028|468362457|FG000|Overall Study|Death|217|||
130109646|NCT02290028|468362457|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
130109647|NCT02290028|468362457|FG000|Overall Study|No longer under care of study physician|76|||
130109648|NCT02290028|468362457|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
130109649|NCT02290028|468362457|FG000|Overall Study|Withdrawal by Subject|52|||
130109650|NCT02290028|468362457|FG000|Overall Study|Study site closure|44|||
130109651|NCT02290028|468362457|FG000|Overall Study|Lost to Follow-up|34|||
130109652|NCT02290028|468362457|FG000|Overall Study|Miscellaneous|10|||
130109653|NCT02290028|468362457|FG000|Overall Study|Transition to EP PASSION|1295|||
130109654|NCT02290028|468362457|FG000|Overall Study|Planned study completion at 12 months|257|||
130109655|NCT03202511|468362458|FG000|Overall Study|Withdrawal by Subject|1|||
130109656|NCT03202511|468362459|FG001|Overall Study|Withdrawal by Subject|0|||
130109657|NCT00833547|468362460|FG000|Overall Study|Withdrawal by Subject|2|||
130109658|NCT00833547|468362461|FG001|Overall Study|Withdrawal by Subject|2|||
130109659|NCT00686790|468362462|FG000|Overall Study|Adverse Event|2|||
130109660|NCT00686790|468362462|FG000|Overall Study|Withdrawal by Subject|1|||
130109661|NCT00686790|468362462|FG000|Overall Study|Death|1|||
130109662|NCT00686790|468362462|FG000|Overall Study|Lost to Follow-up|12|||
130109663|NCT00265083|468362463|FG000|Overall Study|Adverse Event|5|||
130306903|NCT03364309|469087220|FG012|Maintenance Period|Withdrawal by Subject|0|||
130306904|NCT03364309|469087221|FG013|Maintenance Period|Withdrawal by Subject|0|||
130306905|NCT03364309|469087222|FG014|Maintenance Period|Withdrawal by Subject|0|||
130306906|NCT03364309|469087223|FG015|Maintenance Period|Withdrawal by Subject|0|||
130306907|NCT03364309|469087224|FG016|Maintenance Period|Withdrawal by Subject|0|||
130306908|NCT03364309|469087225|FG017|Maintenance Period|Withdrawal by Subject|0|||
130306909|NCT03364309|469087226|FG018|Maintenance Period|Withdrawal by Subject|0|||
130306910|NCT03364309|469087208|FG000|Maintenance Period|Adverse Event|0|||
130306911|NCT03364309|469087209|FG001|Maintenance Period|Adverse Event|0|||
130306912|NCT03364309|469087210|FG002|Maintenance Period|Adverse Event|0|||
130306913|NCT03364309|469087211|FG003|Maintenance Period|Adverse Event|0|||
130306914|NCT03364309|469087212|FG004|Maintenance Period|Adverse Event|2|||
130306915|NCT03364309|469087213|FG005|Maintenance Period|Adverse Event|0|||
130306916|NCT03364309|469087214|FG006|Maintenance Period|Adverse Event|3|||
130306917|NCT03364309|469087215|FG007|Maintenance Period|Adverse Event|0|||
130306918|NCT03364309|469087216|FG008|Maintenance Period|Adverse Event|1|||
130306919|NCT03364309|469087217|FG009|Maintenance Period|Adverse Event|0|||
130306920|NCT03364309|469087218|FG010|Maintenance Period|Adverse Event|2|||
130306921|NCT03364309|469087219|FG011|Maintenance Period|Adverse Event|0|||
130306922|NCT03364309|469087220|FG012|Maintenance Period|Adverse Event|0|||
130306923|NCT03364309|469087221|FG013|Maintenance Period|Adverse Event|0|||
130306924|NCT03364309|469087222|FG014|Maintenance Period|Adverse Event|0|||
130306925|NCT03364309|469087223|FG015|Maintenance Period|Adverse Event|0|||
130306926|NCT03364309|469087224|FG016|Maintenance Period|Adverse Event|0|||
130306927|NCT03364309|469087225|FG017|Maintenance Period|Adverse Event|0|||
130306928|NCT03364309|469087226|FG018|Maintenance Period|Adverse Event|0|||
130306929|NCT03364309|469087208|FG000|Maintenance Period|Relapsed|0|||
130306930|NCT03364309|469087209|FG001|Maintenance Period|Relapsed|0|||
130306931|NCT03364309|469087210|FG002|Maintenance Period|Relapsed|0|||
130306932|NCT03364309|469087211|FG003|Maintenance Period|Relapsed|43|||
130306933|NCT03364309|469087212|FG004|Maintenance Period|Relapsed|7|||
130306934|NCT03364309|469087213|FG005|Maintenance Period|Relapsed|45|||
130306935|NCT03364309|469087214|FG006|Maintenance Period|Relapsed|10|||
130306936|NCT03364309|469087215|FG007|Maintenance Period|Relapsed|2|||
130306937|NCT03364309|469087216|FG008|Maintenance Period|Relapsed|0|||
129889467|NCT00946647|467552607|FG001|Phase ll Part|Withdrawal by Subject|0|||
129889468|NCT00946647|467552608|FG002|Phase ll Part|Withdrawal by Subject|0|||
130109664|NCT00265083|468362464|FG001|Overall Study|Adverse Event|13|||
129889469|NCT00946647|467552609|FG003|Phase ll Part|Withdrawal by Subject|8|||
130109665|NCT00265083|468362465|FG002|Overall Study|Adverse Event|15|||
130109666|NCT00265083|468362463|FG000|Overall Study|Lost to Follow-up|3|||
130109667|NCT00265083|468362464|FG001|Overall Study|Lost to Follow-up|4|||
130109668|NCT00265083|468362465|FG002|Overall Study|Lost to Follow-up|4|||
130306938|NCT03364309|469087217|FG009|Maintenance Period|Relapsed|0|||
130306939|NCT03364309|469087218|FG010|Maintenance Period|Relapsed|0|||
130109669|NCT00265083|468362463|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
130306940|NCT03364309|469087219|FG011|Maintenance Period|Relapsed|0|||
130306941|NCT03364309|469087220|FG012|Maintenance Period|Relapsed|0|||
130306942|NCT03364309|469087221|FG013|Maintenance Period|Relapsed|0|||
130306943|NCT03364309|469087222|FG014|Maintenance Period|Relapsed|0|||
130306944|NCT03364309|469087223|FG015|Maintenance Period|Relapsed|0|||
130306945|NCT03364309|469087224|FG016|Maintenance Period|Relapsed|0|||
130306946|NCT03364309|469087225|FG017|Maintenance Period|Relapsed|0|||
130306947|NCT03364309|469087226|FG018|Maintenance Period|Relapsed|0|||
130306948|NCT03364309|469087208|FG000|Maintenance Period|Lack of Efficacy|0|||
130306949|NCT03364309|469087209|FG001|Maintenance Period|Lack of Efficacy|0|||
130306950|NCT03364309|469087210|FG002|Maintenance Period|Lack of Efficacy|0|||
130306951|NCT03364309|469087211|FG003|Maintenance Period|Lack of Efficacy|0|||
130306952|NCT03364309|469087212|FG004|Maintenance Period|Lack of Efficacy|0|||
130306953|NCT03364309|469087213|FG005|Maintenance Period|Lack of Efficacy|0|||
130306954|NCT03364309|469087214|FG006|Maintenance Period|Lack of Efficacy|0|||
130306955|NCT03364309|469087215|FG007|Maintenance Period|Lack of Efficacy|0|||
130306956|NCT03364309|469087216|FG008|Maintenance Period|Lack of Efficacy|1|||
130306957|NCT03364309|469087217|FG009|Maintenance Period|Lack of Efficacy|3|||
130306958|NCT03364309|469087218|FG010|Maintenance Period|Lack of Efficacy|2|||
130306959|NCT03364309|469087219|FG011|Maintenance Period|Lack of Efficacy|0|||
130306960|NCT03364309|469087220|FG012|Maintenance Period|Lack of Efficacy|0|||
130306961|NCT03364309|469087221|FG013|Maintenance Period|Lack of Efficacy|0|||
130306962|NCT03364309|469087222|FG014|Maintenance Period|Lack of Efficacy|0|||
130306963|NCT03364309|469087223|FG015|Maintenance Period|Lack of Efficacy|0|||
130306964|NCT03364309|469087224|FG016|Maintenance Period|Lack of Efficacy|0|||
130306965|NCT03364309|469087225|FG017|Maintenance Period|Lack of Efficacy|0|||
130306966|NCT03364309|469087226|FG018|Maintenance Period|Lack of Efficacy|0|||
130306967|NCT03364309|469087208|FG000|Maintenance Period|Death|0|||
130306968|NCT03364309|469087209|FG001|Maintenance Period|Death|0|||
130306969|NCT03364309|469087210|FG002|Maintenance Period|Death|0|||
130306970|NCT03364309|469087211|FG003|Maintenance Period|Death|0|||
130306971|NCT03364309|469087212|FG004|Maintenance Period|Death|0|||
130306972|NCT03364309|469087213|FG005|Maintenance Period|Death|0|||
130306973|NCT03364309|469087214|FG006|Maintenance Period|Death|0|||
130306974|NCT03364309|469087215|FG007|Maintenance Period|Death|0|||
130306975|NCT03364309|469087216|FG008|Maintenance Period|Death|1|||
130306976|NCT03364309|469087217|FG009|Maintenance Period|Death|0|||
130306977|NCT03364309|469087218|FG010|Maintenance Period|Death|0|||
130306978|NCT03364309|469087219|FG011|Maintenance Period|Death|0|||
130306979|NCT03364309|469087220|FG012|Maintenance Period|Death|0|||
130306980|NCT03364309|469087221|FG013|Maintenance Period|Death|0|||
130306981|NCT03364309|469087222|FG014|Maintenance Period|Death|0|||
130306982|NCT03364309|469087223|FG015|Maintenance Period|Death|0|||
130306983|NCT03364309|469087224|FG016|Maintenance Period|Death|0|||
130306984|NCT03364309|469087225|FG017|Maintenance Period|Death|0|||
130306985|NCT03364309|469087226|FG018|Maintenance Period|Death|0|||
130306986|NCT03364309|469087208|FG000|Maintenance Period|Lost to Follow-up|0|||
130306987|NCT03364309|469087209|FG001|Maintenance Period|Lost to Follow-up|0|||
130306988|NCT03364309|469087210|FG002|Maintenance Period|Lost to Follow-up|0|||
130306989|NCT03364309|469087211|FG003|Maintenance Period|Lost to Follow-up|0|||
130306990|NCT03364309|469087212|FG004|Maintenance Period|Lost to Follow-up|0|||
130306991|NCT03364309|469087213|FG005|Maintenance Period|Lost to Follow-up|0|||
130306992|NCT03364309|469087214|FG006|Maintenance Period|Lost to Follow-up|0|||
130306993|NCT03364309|469087215|FG007|Maintenance Period|Lost to Follow-up|0|||
130306994|NCT03364309|469087216|FG008|Maintenance Period|Lost to Follow-up|1|||
130306995|NCT03364309|469087217|FG009|Maintenance Period|Lost to Follow-up|0|||
130306996|NCT03364309|469087218|FG010|Maintenance Period|Lost to Follow-up|0|||
130306997|NCT03364309|469087219|FG011|Maintenance Period|Lost to Follow-up|0|||
130306998|NCT03364309|469087220|FG012|Maintenance Period|Lost to Follow-up|0|||
130306999|NCT03364309|469087221|FG013|Maintenance Period|Lost to Follow-up|0|||
130307000|NCT03364309|469087222|FG014|Maintenance Period|Lost to Follow-up|0|||
130307001|NCT03364309|469087223|FG015|Maintenance Period|Lost to Follow-up|0|||
130307002|NCT03364309|469087224|FG016|Maintenance Period|Lost to Follow-up|0|||
130307003|NCT03364309|469087225|FG017|Maintenance Period|Lost to Follow-up|0|||
130048931|NCT04760314|468136611|FG008|Induction Period|Withdrawal by Subject|0|||
130307004|NCT03364309|469087226|FG018|Maintenance Period|Lost to Follow-up|0|||
130307005|NCT03364309|469087208|FG000|Maintenance Period|Miscellaneous|0|||
130307006|NCT03364309|469087209|FG001|Maintenance Period|Miscellaneous|0|||
130307007|NCT03364309|469087210|FG002|Maintenance Period|Miscellaneous|0|||
130307008|NCT03364309|469087211|FG003|Maintenance Period|Miscellaneous|0|||
130307009|NCT03364309|469087212|FG004|Maintenance Period|Miscellaneous|0|||
130307010|NCT03364309|469087213|FG005|Maintenance Period|Miscellaneous|0|||
130307011|NCT03364309|469087214|FG006|Maintenance Period|Miscellaneous|0|||
130307012|NCT03364309|469087215|FG007|Maintenance Period|Miscellaneous|0|||
130307013|NCT03364309|469087216|FG008|Maintenance Period|Miscellaneous|1|||
130307014|NCT03364309|469087217|FG009|Maintenance Period|Miscellaneous|0|||
130307015|NCT03364309|469087218|FG010|Maintenance Period|Miscellaneous|0|||
130307016|NCT03364309|469087219|FG011|Maintenance Period|Miscellaneous|0|||
130307017|NCT03364309|469087220|FG012|Maintenance Period|Miscellaneous|0|||
130307018|NCT03364309|469087221|FG013|Maintenance Period|Miscellaneous|0|||
130307019|NCT03364309|469087222|FG014|Maintenance Period|Miscellaneous|0|||
130307020|NCT03364309|469087223|FG015|Maintenance Period|Miscellaneous|0|||
130307021|NCT03364309|469087224|FG016|Maintenance Period|Miscellaneous|0|||
130307022|NCT03364309|469087225|FG017|Maintenance Period|Miscellaneous|0|||
130307023|NCT03364309|469087226|FG018|Maintenance Period|Miscellaneous|0|||
130307024|NCT03364309|469087208|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307025|NCT03364309|469087209|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307026|NCT03364309|469087210|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307027|NCT03364309|469087211|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307028|NCT03364309|469087212|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307029|NCT03364309|469087213|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307030|NCT03364309|469087214|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307031|NCT03364309|469087215|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307032|NCT03364309|469087216|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307033|NCT03364309|469087217|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307034|NCT03364309|469087218|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307035|NCT03364309|469087219|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307036|NCT03364309|469087220|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307037|NCT03364309|469087221|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130307038|NCT03364309|469087222|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130307039|NCT03364309|469087223|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
130307040|NCT03364309|469087224|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307041|NCT03364309|469087225|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307042|NCT03364309|469087226|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
130307043|NCT03364309|469087208|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307044|NCT03364309|469087209|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307045|NCT03364309|469087210|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307046|NCT03364309|469087211|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307047|NCT03364309|469087212|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307048|NCT03364309|469087213|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307049|NCT03364309|469087214|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307050|NCT03364309|469087215|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307051|NCT03364309|469087216|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307052|NCT03364309|469087217|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307053|NCT03364309|469087218|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307054|NCT03364309|469087219|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307055|NCT03364309|469087220|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307056|NCT03364309|469087221|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307057|NCT03364309|469087222|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
130307058|NCT03364309|469087223|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307059|NCT03364309|469087224|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307060|NCT03364309|469087225|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307061|NCT03364309|469087226|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
130307062|NCT03364309|469087208|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
130307063|NCT03364309|469087209|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
130307064|NCT03364309|469087210|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
130109670|NCT00265083|468362464|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130109671|NCT00265083|468362465|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
130109672|NCT00265083|468362463|FG000|Overall Study|Other|1|||
130109673|NCT00265083|468362464|FG001|Overall Study|Other|12|||
130109674|NCT00265083|468362465|FG002|Overall Study|Other|9|||
130109675|NCT03208933|468362466|FG000|Overall Study|Death|3|||
130109676|NCT03208933|468362466|FG000|Overall Study|Withdrawal by Subject|3|||
130109677|NCT03208933|468362466|FG000|Overall Study|Adverse Event|1|||
130109678|NCT03208933|468362466|FG000|Overall Study|Lost to Follow-up|2|||
130109679|NCT03208933|468362466|FG000|Overall Study|Physician Decision|3|||
130109680|NCT03208933|468362466|FG000|Overall Study|Protocol Violation|1|||
130109681|NCT04242186|468362467|FG000|Overall Study|Death|5|||
130109682|NCT00379587|468362468|FG000|Overall Study|Lost to Follow-up|2|||
130307065|NCT03364309|469087211|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
130307066|NCT03364309|469087212|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
130307067|NCT03364309|469087213|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
130307068|NCT03364309|469087214|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
130307069|NCT03364309|469087215|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
130307070|NCT03364309|469087216|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
130307071|NCT03364309|469087217|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
130307072|NCT03364309|469087218|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
130307073|NCT03364309|469087219|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
130307074|NCT03364309|469087220|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
130307075|NCT03364309|469087221|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
130307076|NCT03364309|469087222|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
130307077|NCT03364309|469087223|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
130307078|NCT03364309|469087224|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
130109683|NCT01070966|468362479|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
130109684|NCT01070966|468362479|FG000|Participants for Safety Evaluation|Off-label use|9|||
130109685|NCT01070966|468362479|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
130109686|NCT01070966|468362479|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
130109687|NCT01070966|468362479|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
130109688|NCT01070966|468362479|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
130109689|NCT01070966|468362479|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
130109690|NCT01070966|468362479|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
130109691|NCT02770716|468362480|FG000|Overall Study|Death|101|||
130109692|NCT02770716|468362481|FG001|Overall Study|Death|45|||
130109693|NCT02770716|468362480|FG000|Overall Study|Withdrawal by Subject|4|||
130109694|NCT02770716|468362481|FG001|Overall Study|Withdrawal by Subject|2|||
130307079|NCT03364309|469087225|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
130307080|NCT03364309|469087226|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
130307081|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307082|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307083|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307084|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307085|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307086|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307087|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307088|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130109695|NCT02770716|468362480|FG000|Overall Study|Lost to Follow-up|1|||
130109696|NCT02770716|468362481|FG001|Overall Study|Lost to Follow-up|0|||
130109697|NCT02770716|468362480|FG000|Overall Study|Various reasons|6|||
130109698|NCT02770716|468362481|FG001|Overall Study|Various reasons|2|||
130109699|NCT01725113|468362482|FG000|Overall Study|Kidney Transplant|1|||
130109700|NCT01725113|468362483|FG001|Overall Study|Kidney Transplant|1|||
130109701|NCT01725113|468362482|FG000|Overall Study|Withdrawal by Subject|0|||
130109702|NCT01725113|468362483|FG001|Overall Study|Withdrawal by Subject|1|||
130109703|NCT03989115|468362484|FG000|Overall Study|Withdrawal by Subject|2|||
130109704|NCT03989115|468362485|FG001|Overall Study|Withdrawal by Subject|1|||
130109705|NCT03989115|468362486|FG002|Overall Study|Withdrawal by Subject|3|||
130109706|NCT03989115|468362487|FG003|Overall Study|Withdrawal by Subject|0|||
130109707|NCT03989115|468362488|FG004|Overall Study|Withdrawal by Subject|17|||
130109708|NCT03989115|468362489|FG005|Overall Study|Withdrawal by Subject|1|||
130109709|NCT03989115|468362490|FG006|Overall Study|Withdrawal by Subject|0|||
130109710|NCT03989115|468362491|FG007|Overall Study|Withdrawal by Subject|0|||
130109711|NCT03989115|468362484|FG000|Overall Study|Sponsor decision to terminate the study|1|||
130109712|NCT03989115|468362485|FG001|Overall Study|Sponsor decision to terminate the study|1|||
130109713|NCT03989115|468362486|FG002|Overall Study|Sponsor decision to terminate the study|0|||
130109714|NCT03989115|468362487|FG003|Overall Study|Sponsor decision to terminate the study|1|||
130109715|NCT03989115|468362488|FG004|Overall Study|Sponsor decision to terminate the study|11|||
130109716|NCT03989115|468362489|FG005|Overall Study|Sponsor decision to terminate the study|0|||
130109717|NCT03989115|468362490|FG006|Overall Study|Sponsor decision to terminate the study|2|||
130109718|NCT03989115|468362491|FG007|Overall Study|Sponsor decision to terminate the study|1|||
130109719|NCT03989115|468362484|FG000|Overall Study|Lost to Follow-up|2|||
130109720|NCT03989115|468362485|FG001|Overall Study|Lost to Follow-up|0|||
130109721|NCT03989115|468362486|FG002|Overall Study|Lost to Follow-up|0|||
130109722|NCT03989115|468362487|FG003|Overall Study|Lost to Follow-up|0|||
130109723|NCT03989115|468362488|FG004|Overall Study|Lost to Follow-up|1|||
130109724|NCT03989115|468362489|FG005|Overall Study|Lost to Follow-up|0|||
130109725|NCT03989115|468362490|FG006|Overall Study|Lost to Follow-up|0|||
130109726|NCT03989115|468362491|FG007|Overall Study|Lost to Follow-up|0|||
130109727|NCT03989115|468362484|FG000|Overall Study|Death|2|||
130109728|NCT03989115|468362485|FG001|Overall Study|Death|2|||
130109729|NCT03989115|468362486|FG002|Overall Study|Death|9|||
130109730|NCT03989115|468362487|FG003|Overall Study|Death|6|||
130109731|NCT03989115|468362488|FG004|Overall Study|Death|31|||
130109732|NCT03989115|468362489|FG005|Overall Study|Death|6|||
130109733|NCT03989115|468362490|FG006|Overall Study|Death|2|||
130109734|NCT03989115|468362491|FG007|Overall Study|Death|3|||
130109735|NCT03989115|468362484|FG000|Overall Study|Other|1|||
130109736|NCT03989115|468362485|FG001|Overall Study|Other|2|||
130109737|NCT03989115|468362486|FG002|Overall Study|Other|0|||
130109738|NCT03989115|468362487|FG003|Overall Study|Other|0|||
130307089|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307090|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130109739|NCT03989115|468362488|FG004|Overall Study|Other|5|||
130109740|NCT03989115|468362489|FG005|Overall Study|Other|0|||
130109741|NCT03989115|468362490|FG006|Overall Study|Other|0|||
130109742|NCT03989115|468362491|FG007|Overall Study|Other|0|||
130109743|NCT01808209|468362492|FG000|Overall Study|Lost to Follow-up|0|||
130109744|NCT01808209|468362493|FG001|Overall Study|Lost to Follow-up|1|||
130109745|NCT02629133|468362499|FG000|Overall Study|Lost to Follow-up|3|||
130307091|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307092|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307093|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307094|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307095|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307096|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130307097|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
130307098|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
130307099|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
130307100|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Adverse Event|0|||
130307101|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Adverse Event|0|||
130307102|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Adverse Event|0|||
130307103|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Adverse Event|0|||
130307104|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Adverse Event|0|||
130307105|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Adverse Event|0|||
130307106|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Adverse Event|0|||
130307107|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Adverse Event|0|||
130307108|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Adverse Event|0|||
130109746|NCT02629133|468362500|FG001|Overall Study|Lost to Follow-up|1|||
130307109|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Adverse Event|0|||
130307110|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Adverse Event|0|||
130307111|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Adverse Event|0|||
130307112|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Adverse Event|0|||
130307113|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Adverse Event|0|||
130307114|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Adverse Event|0|||
130109747|NCT02629133|468362499|FG000|Overall Study|Withdrawal by Subject|1|||
130109748|NCT02629133|468362500|FG001|Overall Study|Withdrawal by Subject|1|||
130109749|NCT03216954|468362501|FG000|Overall Study|Adverse Event|0|||
130307115|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Adverse Event|0|||
130307116|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Adverse Event|2|||
130307117|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Adverse Event|6|||
130307118|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Adverse Event|1|||
130307119|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307120|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307121|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307122|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307123|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307124|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307125|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307126|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307127|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307128|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307129|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307130|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307131|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307132|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307133|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307134|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307135|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307136|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
130307137|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
130307138|NCT03364309|469087208|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
130307139|NCT03364309|469087209|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
130307140|NCT03364309|469087210|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
130307141|NCT03364309|469087211|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
130109750|NCT03216954|468362502|FG001|Overall Study|Adverse Event|0|||
130109751|NCT03216954|468362503|FG002|Overall Study|Adverse Event|1|||
130109752|NCT03216954|468362504|FG003|Overall Study|Adverse Event|0|||
130109753|NCT03216954|468362505|FG004|Overall Study|Adverse Event|1|||
130307142|NCT03364309|469087212|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
130307143|NCT03364309|469087213|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
130307144|NCT03364309|469087214|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
130307145|NCT03364309|469087215|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
130307146|NCT03364309|469087216|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
130307147|NCT03364309|469087217|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
130307148|NCT03364309|469087218|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
130307149|NCT03364309|469087219|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
130307150|NCT03364309|469087220|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
130307151|NCT03364309|469087221|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
130109754|NCT03216954|468362501|FG000|Overall Study|Withdrawal by Subject|2|||
130307152|NCT03364309|469087222|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
130307153|NCT03364309|469087223|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
130307154|NCT03364309|469087224|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
130307155|NCT03364309|469087225|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
130307156|NCT03364309|469087226|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
130307157|NCT00167310|469087227|FG000|Overall Study|Protocol Violation|5|||
130307158|NCT00167310|469087228|FG001|Overall Study|Protocol Violation|3|||
130307159|NCT00167310|469087227|FG000|Overall Study|Withdrawal by Subject|3|||
130307160|NCT00167310|469087228|FG001|Overall Study|Withdrawal by Subject|7|||
130307161|NCT03543137|469087232|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
130307162|NCT03543137|469087233|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
130307163|NCT03543137|469087232|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
130307164|NCT03543137|469087233|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
130307165|NCT03543137|469087232|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
130307166|NCT03543137|469087233|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
130307167|NCT01052077|469087234|FG000|Phase A|Lost to Follow-up|22|||
130307168|NCT01052077|469087235|FG001|Phase A|Lost to Follow-up|0|||
130307169|NCT01052077|469087236|FG002|Phase A|Lost to Follow-up|0|||
130307170|NCT01052077|469087237|FG003|Phase A|Lost to Follow-up|0|||
130307171|NCT01052077|469087234|FG000|Phase A|Adverse Event|32|||
130307172|NCT01052077|469087235|FG001|Phase A|Adverse Event|0|||
130307173|NCT01052077|469087236|FG002|Phase A|Adverse Event|0|||
130307174|NCT01052077|469087237|FG003|Phase A|Adverse Event|0|||
130307175|NCT01052077|469087234|FG000|Phase A|Met Withdrawal Criteria|26|||
130307176|NCT01052077|469087235|FG001|Phase A|Met Withdrawal Criteria|0|||
130307177|NCT01052077|469087236|FG002|Phase A|Met Withdrawal Criteria|0|||
130307178|NCT01052077|469087237|FG003|Phase A|Met Withdrawal Criteria|0|||
130307179|NCT01052077|469087234|FG000|Phase A|Physician Decision|10|||
130307180|NCT01052077|469087235|FG001|Phase A|Physician Decision|0|||
130307181|NCT01052077|469087236|FG002|Phase A|Physician Decision|0|||
130307182|NCT01052077|469087237|FG003|Phase A|Physician Decision|0|||
130307183|NCT01052077|469087234|FG000|Phase A|Withdrawal by Subject|29|||
130307184|NCT01052077|469087235|FG001|Phase A|Withdrawal by Subject|0|||
130307185|NCT01052077|469087236|FG002|Phase A|Withdrawal by Subject|0|||
130307186|NCT01052077|469087237|FG003|Phase A|Withdrawal by Subject|0|||
130307187|NCT01052077|469087234|FG000|Phase A|Protocol Deviation|27|||
130307188|NCT01052077|469087235|FG001|Phase A|Protocol Deviation|0|||
130307189|NCT01052077|469087236|FG002|Phase A|Protocol Deviation|0|||
130307190|NCT01052077|469087237|FG003|Phase A|Protocol Deviation|0|||
130307191|NCT01052077|469087234|FG000|Phase B|Lost to Follow-up|0|||
130307192|NCT01052077|469087235|FG001|Phase B|Lost to Follow-up|2|||
130307193|NCT01052077|469087236|FG002|Phase B|Lost to Follow-up|3|||
130307194|NCT01052077|469087237|FG003|Phase B|Lost to Follow-up|0|||
130307195|NCT01052077|469087234|FG000|Phase B|Adverse Event|0|||
130307196|NCT01052077|469087235|FG001|Phase B|Adverse Event|9|||
130307197|NCT01052077|469087236|FG002|Phase B|Adverse Event|2|||
130307198|NCT01052077|469087237|FG003|Phase B|Adverse Event|0|||
130307199|NCT01052077|469087234|FG000|Phase B|Met Withdrawal Criteria|0|||
130307200|NCT01052077|469087235|FG001|Phase B|Met Withdrawal Criteria|2|||
130307201|NCT01052077|469087236|FG002|Phase B|Met Withdrawal Criteria|1|||
130307202|NCT01052077|469087237|FG003|Phase B|Met Withdrawal Criteria|0|||
130307203|NCT01052077|469087234|FG000|Phase B|Physician Decision|0|||
130307204|NCT01052077|469087235|FG001|Phase B|Physician Decision|1|||
130307205|NCT01052077|469087236|FG002|Phase B|Physician Decision|1|||
130307206|NCT01052077|469087237|FG003|Phase B|Physician Decision|0|||
130307207|NCT01052077|469087234|FG000|Phase B|Withdrawal by Subject|0|||
130307208|NCT01052077|469087235|FG001|Phase B|Withdrawal by Subject|0|||
130307209|NCT01052077|469087236|FG002|Phase B|Withdrawal by Subject|5|||
130307210|NCT01052077|469087237|FG003|Phase B|Withdrawal by Subject|0|||
130307211|NCT01052077|469087234|FG000|Phase B|Protocol Deviation|0|||
130307212|NCT01052077|469087235|FG001|Phase B|Protocol Deviation|3|||
130307213|NCT01052077|469087236|FG002|Phase B|Protocol Deviation|4|||
130307214|NCT01052077|469087237|FG003|Phase B|Protocol Deviation|0|||
130307215|NCT01052077|469087234|FG000|Phase B|Lack of Efficacy|0|||
130307216|NCT01052077|469087235|FG001|Phase B|Lack of Efficacy|1|||
130307217|NCT01052077|469087236|FG002|Phase B|Lack of Efficacy|0|||
130307218|NCT01052077|469087237|FG003|Phase B|Lack of Efficacy|0|||
130307219|NCT01052077|469087234|FG000|Phase A+|Lost to Follow-up|0|||
130307220|NCT01052077|469087235|FG001|Phase A+|Lost to Follow-up|0|||
130307221|NCT01052077|469087236|FG002|Phase A+|Lost to Follow-up|0|||
130307222|NCT01052077|469087237|FG003|Phase A+|Lost to Follow-up|8|||
130307223|NCT01052077|469087234|FG000|Phase A+|Adverse Event|0|||
130307224|NCT01052077|469087235|FG001|Phase A+|Adverse Event|0|||
130307225|NCT01052077|469087236|FG002|Phase A+|Adverse Event|0|||
130307226|NCT01052077|469087237|FG003|Phase A+|Adverse Event|4|||
130307227|NCT01052077|469087234|FG000|Phase A+|Met Withdrawal Criteria|0|||
130307228|NCT01052077|469087235|FG001|Phase A+|Met Withdrawal Criteria|0|||
130307229|NCT01052077|469087236|FG002|Phase A+|Met Withdrawal Criteria|0|||
130307230|NCT01052077|469087237|FG003|Phase A+|Met Withdrawal Criteria|2|||
130307231|NCT01052077|469087234|FG000|Phase A+|Withdrawal by Subject|0|||
130307232|NCT01052077|469087235|FG001|Phase A+|Withdrawal by Subject|0|||
130307233|NCT01052077|469087236|FG002|Phase A+|Withdrawal by Subject|0|||
130307234|NCT01052077|469087237|FG003|Phase A+|Withdrawal by Subject|7|||
130307235|NCT02465203|469087238|FG000|Overall Study|Protocol Violation|1|||
130307236|NCT02465203|469087239|FG001|Overall Study|Protocol Violation|1|||
130307237|NCT02465203|469087240|FG002|Overall Study|Protocol Violation|1|||
130307238|NCT02465203|469087238|FG000|Overall Study|Study terminated by sponsor|50|||
130307239|NCT02465203|469087239|FG001|Overall Study|Study terminated by sponsor|34|||
130307240|NCT02465203|469087240|FG002|Overall Study|Study terminated by sponsor|11|||
130307241|NCT02465203|469087238|FG000|Overall Study|New therapy for study indication|4|||
130307242|NCT02465203|469087239|FG001|Overall Study|New therapy for study indication|0|||
130307243|NCT02465203|469087240|FG002|Overall Study|New therapy for study indication|0|||
130307244|NCT02465203|469087238|FG000|Overall Study|Patient/guardian decision|1|||
130307245|NCT02465203|469087239|FG001|Overall Study|Patient/guardian decision|1|||
130307246|NCT02465203|469087240|FG002|Overall Study|Patient/guardian decision|1|||
130307247|NCT00042991|469087245|FG000|Overall Study|Adverse Event|1|||
130307248|NCT00042991|469087246|FG001|Overall Study|Adverse Event|4|||
130307249|NCT00042991|469087247|FG002|Overall Study|Adverse Event|2|||
130307250|NCT00042991|469087248|FG003|Overall Study|Adverse Event|0|||
130307251|NCT00042991|469087249|FG004|Overall Study|Adverse Event|0|||
130307252|NCT00042991|469087250|FG005|Overall Study|Adverse Event|1|||
130307253|NCT00042991|469087251|FG006|Overall Study|Adverse Event|0|||
130307254|NCT00042991|469087245|FG000|Overall Study|Withdrawal by Subject|0|||
130307255|NCT00042991|469087246|FG001|Overall Study|Withdrawal by Subject|7|||
130307256|NCT00042991|469087247|FG002|Overall Study|Withdrawal by Subject|2|||
130307257|NCT00042991|469087248|FG003|Overall Study|Withdrawal by Subject|0|||
130307258|NCT00042991|469087249|FG004|Overall Study|Withdrawal by Subject|1|||
130307259|NCT00042991|469087250|FG005|Overall Study|Withdrawal by Subject|0|||
130307260|NCT00042991|469087251|FG006|Overall Study|Withdrawal by Subject|0|||
129889470|NCT00946647|467552610|FG004|Phase ll Part|Withdrawal by Subject|6|||
130307261|NCT00042991|469087245|FG000|Overall Study|Disease Progression|5|||
130307262|NCT00042991|469087246|FG001|Overall Study|Disease Progression|29|||
130307263|NCT00042991|469087247|FG002|Overall Study|Disease Progression|2|||
130307264|NCT00042991|469087248|FG003|Overall Study|Disease Progression|2|||
130307265|NCT00042991|469087249|FG004|Overall Study|Disease Progression|1|||
130307266|NCT00042991|469087250|FG005|Overall Study|Disease Progression|4|||
129889471|NCT00946647|467552606|FG000|Phase ll Part|Administrative problems|0|||
130307267|NCT00042991|469087251|FG006|Overall Study|Disease Progression|2|||
130048932|NCT04760314|468136612|FG009|Induction Period|Withdrawal by Subject|0|||
130048933|NCT04760314|468136613|FG010|Induction Period|Withdrawal by Subject|0|||
130048934|NCT04760314|468136603|FG000|Induction Period|Adverse Event|0|||
130048935|NCT04760314|468136604|FG001|Induction Period|Adverse Event|0|||
130048936|NCT04760314|468136605|FG002|Induction Period|Adverse Event|2|||
130048937|NCT04760314|468136606|FG003|Induction Period|Adverse Event|0|||
130048938|NCT04760314|468136607|FG004|Induction Period|Adverse Event|0|||
130048939|NCT04760314|468136608|FG005|Induction Period|Adverse Event|0|||
130048940|NCT04760314|468136609|FG006|Induction Period|Adverse Event|0|||
130048941|NCT04760314|468136610|FG007|Induction Period|Adverse Event|0|||
130048942|NCT04760314|468136611|FG008|Induction Period|Adverse Event|0|||
130048943|NCT04760314|468136612|FG009|Induction Period|Adverse Event|0|||
130048944|NCT04760314|468136613|FG010|Induction Period|Adverse Event|0|||
130048945|NCT04760314|468136603|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048946|NCT04760314|468136604|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048947|NCT04760314|468136605|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048948|NCT04760314|468136606|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
130048949|NCT04760314|468136607|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
130048950|NCT04760314|468136608|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
130048951|NCT04760314|468136609|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
130048952|NCT04760314|468136610|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048953|NCT04760314|468136611|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048954|NCT04760314|468136612|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048955|NCT04760314|468136613|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
130048956|NCT04760314|468136603|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048957|NCT04760314|468136604|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048958|NCT04760314|468136605|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048959|NCT04760314|468136606|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
130048960|NCT04760314|468136607|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048961|NCT04760314|468136608|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
130307268|NCT00042991|469087245|FG000|Overall Study|Alternative Therapy|0|||
130307269|NCT00042991|469087246|FG001|Overall Study|Alternative Therapy|0|||
130307270|NCT00042991|469087247|FG002|Overall Study|Alternative Therapy|0|||
130048962|NCT04760314|468136609|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
130307271|NCT00042991|469087248|FG003|Overall Study|Alternative Therapy|0|||
130307272|NCT00042991|469087249|FG004|Overall Study|Alternative Therapy|1|||
130048963|NCT04760314|468136610|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048964|NCT04760314|468136611|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130307273|NCT00042991|469087250|FG005|Overall Study|Alternative Therapy|0|||
130307274|NCT00042991|469087251|FG006|Overall Study|Alternative Therapy|0|||
130307275|NCT04072887|469087252|FG000|Overall Study|Withdrawal by Subject|3|||
130307276|NCT04072887|469087253|FG001|Overall Study|Withdrawal by Subject|8|||
130307277|NCT04072887|469087254|FG002|Overall Study|Withdrawal by Subject|1|||
130307278|NCT04072887|469087255|FG003|Overall Study|Withdrawal by Subject|3|||
130307279|NCT04072887|469087256|FG004|Overall Study|Withdrawal by Subject|3|||
130307280|NCT04072887|469087257|FG005|Overall Study|Withdrawal by Subject|13|||
130307281|NCT04072887|469087252|FG000|Overall Study|Adverse Event|2|||
130307282|NCT04072887|469087253|FG001|Overall Study|Adverse Event|4|||
130307283|NCT04072887|469087254|FG002|Overall Study|Adverse Event|1|||
130307284|NCT04072887|469087255|FG003|Overall Study|Adverse Event|4|||
130307285|NCT04072887|469087256|FG004|Overall Study|Adverse Event|0|||
130307286|NCT04072887|469087257|FG005|Overall Study|Adverse Event|1|||
130307287|NCT04072887|469087252|FG000|Overall Study|Physician Decision|2|||
130307288|NCT04072887|469087253|FG001|Overall Study|Physician Decision|0|||
130307289|NCT04072887|469087254|FG002|Overall Study|Physician Decision|0|||
130307290|NCT04072887|469087255|FG003|Overall Study|Physician Decision|0|||
130048965|NCT04760314|468136612|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048966|NCT04760314|468136613|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
130048967|NCT04760314|468136603|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048968|NCT04760314|468136604|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048969|NCT04760314|468136605|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048970|NCT04760314|468136606|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048971|NCT04760314|468136607|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
130048972|NCT04760314|468136608|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048973|NCT04760314|468136609|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048974|NCT04760314|468136610|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048975|NCT04760314|468136611|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048976|NCT04760314|468136612|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048977|NCT04760314|468136613|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
130048978|NCT04760314|468136603|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
130048979|NCT04760314|468136604|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
130048980|NCT04760314|468136605|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
130048981|NCT04760314|468136606|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
130048982|NCT04760314|468136607|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
130048983|NCT04760314|468136608|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
130048984|NCT04760314|468136609|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
130048985|NCT04760314|468136610|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
130048986|NCT04760314|468136611|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
130048987|NCT04760314|468136612|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
130048988|NCT04760314|468136613|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
130048989|NCT04760314|468136603|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048990|NCT04760314|468136604|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048991|NCT04760314|468136605|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048992|NCT04760314|468136606|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048993|NCT04760314|468136607|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048994|NCT04760314|468136608|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048995|NCT04760314|468136609|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048996|NCT04760314|468136610|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130048997|NCT04760314|468136611|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130048998|NCT04760314|468136612|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130048999|NCT04760314|468136613|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
130049000|NCT04760314|468136603|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049001|NCT04760314|468136604|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049002|NCT04760314|468136605|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049003|NCT04760314|468136606|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049004|NCT04760314|468136607|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049005|NCT04760314|468136608|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049006|NCT04760314|468136609|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049007|NCT04760314|468136610|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
130049008|NCT04760314|468136611|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
130049009|NCT04760314|468136612|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
130049010|NCT04760314|468136613|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130049011|NCT04760314|468136603|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049012|NCT04760314|468136604|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130109755|NCT03216954|468362502|FG001|Overall Study|Withdrawal by Subject|0|||
130307291|NCT04072887|469087256|FG004|Overall Study|Physician Decision|0|||
130307292|NCT04072887|469087257|FG005|Overall Study|Physician Decision|1|||
130307293|NCT04072887|469087252|FG000|Overall Study|Lost to Follow-up|1|||
130307294|NCT04072887|469087253|FG001|Overall Study|Lost to Follow-up|3|||
130307295|NCT04072887|469087254|FG002|Overall Study|Lost to Follow-up|0|||
130307296|NCT04072887|469087255|FG003|Overall Study|Lost to Follow-up|0|||
130307297|NCT04072887|469087256|FG004|Overall Study|Lost to Follow-up|0|||
130307298|NCT04072887|469087257|FG005|Overall Study|Lost to Follow-up|0|||
130307299|NCT04072887|469087252|FG000|Overall Study|Death|0|||
130307300|NCT04072887|469087253|FG001|Overall Study|Death|2|||
130307301|NCT04072887|469087254|FG002|Overall Study|Death|0|||
130307302|NCT04072887|469087255|FG003|Overall Study|Death|2|||
130307303|NCT04072887|469087256|FG004|Overall Study|Death|3|||
130307304|NCT04072887|469087257|FG005|Overall Study|Death|0|||
130307305|NCT03193736|469087258|FG000|Overall Study|Death|2|||
130307306|NCT03193736|469087258|FG000|Overall Study|Withdrawal by Subject|1|||
130307307|NCT03193736|469087258|FG000|Overall Study|Lost to Follow-up|1|||
130307308|NCT03193736|469087258|FG000|Overall Study|implant not received|1|||
130307309|NCT00423449|469087259|FG000|Overall Study|Clinical Adverse Event|1|||
130307310|NCT00423449|469087260|FG001|Overall Study|Clinical Adverse Event|0|||
130307311|NCT00423449|469087261|FG002|Overall Study|Clinical Adverse Event|1|||
130307312|NCT00423449|469087262|FG003|Overall Study|Clinical Adverse Event|8|||
130307313|NCT00423449|469087263|FG004|Overall Study|Clinical Adverse Event|2|||
130307314|NCT00423449|469087259|FG000|Overall Study|Death|1|||
130307315|NCT00423449|469087260|FG001|Overall Study|Death|0|||
130307316|NCT00423449|469087261|FG002|Overall Study|Death|2|||
130307317|NCT00423449|469087262|FG003|Overall Study|Death|1|||
130307318|NCT00423449|469087263|FG004|Overall Study|Death|1|||
130307319|NCT00423449|469087259|FG000|Overall Study|Progressive Disease|1|||
130307320|NCT00423449|469087260|FG001|Overall Study|Progressive Disease|3|||
130307321|NCT00423449|469087261|FG002|Overall Study|Progressive Disease|8|||
130109756|NCT03216954|468362503|FG002|Overall Study|Withdrawal by Subject|0|||
130109757|NCT03216954|468362504|FG003|Overall Study|Withdrawal by Subject|0|||
130109758|NCT03216954|468362505|FG004|Overall Study|Withdrawal by Subject|0|||
130109759|NCT03216954|468362501|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130109760|NCT03216954|468362502|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
130109761|NCT03216954|468362503|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130109762|NCT03216954|468362504|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130109763|NCT03216954|468362505|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
130109764|NCT01507831|468362506|FG000|Overall Study|Randomized but not treated|0|||
130307322|NCT00423449|469087262|FG003|Overall Study|Progressive Disease|11|||
130307323|NCT00423449|469087263|FG004|Overall Study|Progressive Disease|4|||
130307324|NCT00423449|469087259|FG000|Overall Study|Laboratory Adverse Event|0|||
130307325|NCT00423449|469087260|FG001|Overall Study|Laboratory Adverse Event|1|||
130307326|NCT00423449|469087261|FG002|Overall Study|Laboratory Adverse Event|2|||
130307327|NCT00423449|469087262|FG003|Overall Study|Laboratory Adverse Event|0|||
130307328|NCT00423449|469087263|FG004|Overall Study|Laboratory Adverse Event|0|||
130307329|NCT00423449|469087259|FG000|Overall Study|Other|0|||
130307330|NCT00423449|469087260|FG001|Overall Study|Other|0|||
130307331|NCT00423449|469087261|FG002|Overall Study|Other|0|||
130307332|NCT00423449|469087262|FG003|Overall Study|Other|1|||
130307333|NCT00423449|469087263|FG004|Overall Study|Other|0|||
130307334|NCT00423449|469087259|FG000|Overall Study|Protocol Violation|0|||
130307335|NCT00423449|469087260|FG001|Overall Study|Protocol Violation|0|||
130307336|NCT00423449|469087261|FG002|Overall Study|Protocol Violation|2|||
130307337|NCT00423449|469087262|FG003|Overall Study|Protocol Violation|1|||
130307338|NCT00423449|469087263|FG004|Overall Study|Protocol Violation|0|||
130307339|NCT02697435|469087264|FG000|Overall Study|Withdrawal by Subject|1|||
130307340|NCT02697435|469087265|FG001|Overall Study|Withdrawal by Subject|0|||
130307341|NCT02697435|469087264|FG000|Overall Study|Physician Decision|0|||
130307342|NCT02697435|469087265|FG001|Overall Study|Physician Decision|4|||
130307343|NCT04371666|469087274|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
130307344|NCT04371666|469087275|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
130307345|NCT04371666|469087274|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
130307346|NCT04371666|469087275|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
130307347|NCT04371666|469087274|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
130307348|NCT04371666|469087275|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
130307349|NCT04371666|469087274|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
130307350|NCT04371666|469087275|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
130307351|NCT04371666|469087274|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
130307352|NCT04371666|469087275|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
130307353|NCT04371666|469087274|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
130307354|NCT04371666|469087275|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
130307355|NCT00861471|469087282|FG000|Overall Study|Withdrawal by Subject|1|||
130307356|NCT00861471|469087282|FG000|Overall Study|Adverse Event|2|||
130307357|NCT00861471|469087282|FG000|Overall Study|Lack of Efficacy|3|||
129797828|NCT02537574|467228233|FG000|Overall Study|Patient not Stable|0|||
129797829|NCT02537574|467228234|FG001|Overall Study|Patient not Stable|1|||
130307358|NCT00861471|469087282|FG000|Overall Study|treatment for lumbar laminectomy|1|||
130307359|NCT00861471|469087282|FG000|Overall Study|Physician Decision|2|||
130307360|NCT01445080|469087283|FG000|Overall Study|Adverse Event|5|||
130307361|NCT01445080|469087284|FG001|Overall Study|Adverse Event|3|||
130307362|NCT01445080|469087285|FG002|Overall Study|Adverse Event|11|||
130307363|NCT01445080|469087286|FG003|Overall Study|Adverse Event|6|||
130307364|NCT01445080|469087287|FG004|Overall Study|Adverse Event|2|||
130307365|NCT01445080|469087288|FG005|Overall Study|Adverse Event|3|||
130307366|NCT01445080|469087289|FG006|Overall Study|Adverse Event|0|||
130307367|NCT01445080|469087290|FG007|Overall Study|Adverse Event|3|||
130307368|NCT01445080|469087291|FG008|Overall Study|Adverse Event|10|||
130307369|NCT01445080|469087283|FG000|Overall Study|Physician Decision|0|||
130307370|NCT01445080|469087284|FG001|Overall Study|Physician Decision|0|||
130307371|NCT01445080|469087285|FG002|Overall Study|Physician Decision|1|||
130307372|NCT01445080|469087286|FG003|Overall Study|Physician Decision|0|||
130307373|NCT01445080|469087287|FG004|Overall Study|Physician Decision|0|||
130307374|NCT01445080|469087288|FG005|Overall Study|Physician Decision|3|||
130307375|NCT01445080|469087289|FG006|Overall Study|Physician Decision|2|||
130307376|NCT01445080|469087290|FG007|Overall Study|Physician Decision|2|||
130307377|NCT01445080|469087291|FG008|Overall Study|Physician Decision|0|||
130307378|NCT01445080|469087283|FG000|Overall Study|Withdrawal by Subject|1|||
130307379|NCT01445080|469087284|FG001|Overall Study|Withdrawal by Subject|0|||
130307380|NCT01445080|469087285|FG002|Overall Study|Withdrawal by Subject|0|||
130307381|NCT01445080|469087286|FG003|Overall Study|Withdrawal by Subject|1|||
130307382|NCT01445080|469087287|FG004|Overall Study|Withdrawal by Subject|0|||
130307383|NCT01445080|469087288|FG005|Overall Study|Withdrawal by Subject|0|||
130307384|NCT01445080|469087289|FG006|Overall Study|Withdrawal by Subject|0|||
130307385|NCT01445080|469087290|FG007|Overall Study|Withdrawal by Subject|0|||
130307386|NCT01445080|469087291|FG008|Overall Study|Withdrawal by Subject|2|||
130307387|NCT01445080|469087283|FG000|Overall Study|Ineligible/Inevaluable|1|||
130307388|NCT01445080|469087284|FG001|Overall Study|Ineligible/Inevaluable|2|||
130307389|NCT01445080|469087285|FG002|Overall Study|Ineligible/Inevaluable|0|||
130307390|NCT01445080|469087286|FG003|Overall Study|Ineligible/Inevaluable|1|||
130307391|NCT01445080|469087287|FG004|Overall Study|Ineligible/Inevaluable|2|||
130307392|NCT01445080|469087288|FG005|Overall Study|Ineligible/Inevaluable|3|||
130307393|NCT01445080|469087289|FG006|Overall Study|Ineligible/Inevaluable|0|||
130307394|NCT01445080|469087290|FG007|Overall Study|Ineligible/Inevaluable|0|||
130307395|NCT01445080|469087291|FG008|Overall Study|Ineligible/Inevaluable|6|||
130307396|NCT00445770|469087292|FG000|Overall Study|Adverse Event|9|||
130307397|NCT00445770|469087293|FG001|Overall Study|Adverse Event|15|||
130307398|NCT00445770|469087294|FG002|Overall Study|Adverse Event|19|||
130307399|NCT00445770|469087292|FG000|Overall Study|Lack of Efficacy|38|||
130307400|NCT00445770|469087293|FG001|Overall Study|Lack of Efficacy|13|||
130307401|NCT00445770|469087294|FG002|Overall Study|Lack of Efficacy|6|||
130307402|NCT00445770|469087292|FG000|Overall Study|Lost to Follow-up|0|||
130307403|NCT00445770|469087293|FG001|Overall Study|Lost to Follow-up|2|||
130307404|NCT00445770|469087294|FG002|Overall Study|Lost to Follow-up|0|||
130307405|NCT00445770|469087292|FG000|Overall Study|Other|6|||
130307406|NCT00445770|469087293|FG001|Overall Study|Other|5|||
130307407|NCT00445770|469087294|FG002|Overall Study|Other|6|||
130307408|NCT03857542|469087295|FG000|Overall Study|Adverse Event|1|||
130307409|NCT03857542|469087296|FG001|Overall Study|Adverse Event|3|||
130307410|NCT03857542|469087295|FG000|Overall Study|Withdrawal by Subject|2|||
130307411|NCT03857542|469087296|FG001|Overall Study|Withdrawal by Subject|1|||
130307412|NCT03857542|469087295|FG000|Overall Study|Lost to Follow-up|2|||
130307413|NCT03857542|469087296|FG001|Overall Study|Lost to Follow-up|1|||
130307414|NCT03857542|469087295|FG000|Overall Study|Reason not Specified|1|||
130307415|NCT03857542|469087296|FG001|Overall Study|Reason not Specified|0|||
130307416|NCT03058692|469089155|FG000|Overall Study|Lost to Follow-up|2|||
130307417|NCT03058692|469089156|FG001|Overall Study|Lost to Follow-up|1|||
130307418|NCT03058692|469089155|FG000|Overall Study|Withdrawal by Subject|1|||
130307419|NCT03058692|469089156|FG001|Overall Study|Withdrawal by Subject|1|||
130307420|NCT01698814|469089159|FG000|Overall Study|Adverse Event|0|||
130307421|NCT01698814|469089160|FG001|Overall Study|Adverse Event|2|||
130307422|NCT01698814|469089159|FG000|Overall Study|Lost to Follow-up|0|||
130307423|NCT01698814|469089160|FG001|Overall Study|Lost to Follow-up|1|||
130307424|NCT01698814|469089159|FG000|Overall Study|Pregnancy|1|||
130307425|NCT01698814|469089160|FG001|Overall Study|Pregnancy|0|||
130307426|NCT01698814|469089159|FG000|Overall Study|Randomized in error|1|||
130307427|NCT01698814|469089160|FG001|Overall Study|Randomized in error|0|||
130307428|NCT04014062|469089161|FG000|Period I: Dosing|Medical Grounds|4|||
130307429|NCT04014062|469089162|FG001|Period I: Dosing|Medical Grounds|5|||
130307430|NCT04014062|469089161|FG000|Period I: Dosing|Withdrawal by Subject|3|||
130307431|NCT04014062|469089162|FG001|Period I: Dosing|Withdrawal by Subject|1|||
130307432|NCT03038126|469089164|FG000|Overall Study|Death|1|||
130307433|NCT03038126|469089165|FG001|Overall Study|Death|1|||
130307434|NCT03038126|469089164|FG000|Overall Study|Withdrawal by Subject|5|||
130307435|NCT03038126|469089165|FG001|Overall Study|Withdrawal by Subject|0|||
129797830|NCT02537574|467228235|FG002|Overall Study|Patient not Stable|0|||
130109765|NCT01507831|468362507|FG001|Overall Study|Randomized but not treated|3|||
130109766|NCT01507831|468362506|FG000|Overall Study|Adverse Event|48|||
130109767|NCT01507831|468362507|FG001|Overall Study|Adverse Event|113|||
130109768|NCT01507831|468362506|FG000|Overall Study|Death|6|||
130109769|NCT01507831|468362507|FG001|Overall Study|Death|2|||
130109770|NCT01507831|468362506|FG000|Overall Study|Poor compliance to protocol|38|||
130109771|NCT01507831|468362507|FG001|Overall Study|Poor compliance to protocol|60|||
130307436|NCT03038126|469089164|FG000|Overall Study|Lost to Follow-up|0|||
130109772|NCT01507831|468362506|FG000|Overall Study|Physician Decision|0|||
130109773|NCT01507831|468362507|FG001|Overall Study|Physician Decision|4|||
130109774|NCT01507831|468362506|FG000|Overall Study|Participant moved|5|||
130109775|NCT01507831|468362507|FG001|Overall Study|Participant moved|19|||
130307437|NCT03038126|469089165|FG001|Overall Study|Lost to Follow-up|1|||
130307438|NCT03038126|469089164|FG000|Overall Study|Long Term Hospitalization|2|||
130307439|NCT03038126|469089165|FG001|Overall Study|Long Term Hospitalization|0|||
130307440|NCT03038126|469089164|FG000|Overall Study|Too Ill to Participate|1|||
130307441|NCT03038126|469089165|FG001|Overall Study|Too Ill to Participate|2|||
130307442|NCT01724866|469089166|FG000|Overall Study|Adverse Event|0|||
130307443|NCT01724866|469089167|FG001|Overall Study|Adverse Event|0|||
130307444|NCT01724866|469089168|FG002|Overall Study|Adverse Event|1|||
130307445|NCT01724866|469089169|FG003|Overall Study|Adverse Event|1|||
130307446|NCT01724866|469089166|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130307447|NCT01724866|469089167|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
130307448|NCT01724866|469089168|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130307449|NCT01724866|469089169|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
130307450|NCT01724866|469089166|FG000|Overall Study|Investigator's Discretion|0|||
130307451|NCT01724866|469089167|FG001|Overall Study|Investigator's Discretion|1|||
130307452|NCT01724866|469089168|FG002|Overall Study|Investigator's Discretion|1|||
130307453|NCT01724866|469089169|FG003|Overall Study|Investigator's Discretion|0|||
130307454|NCT01724866|469089166|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
130307455|NCT01724866|469089167|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130307456|NCT01724866|469089168|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130307457|NCT01724866|469089169|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
130307458|NCT01724866|469089166|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
130307459|NCT01724866|469089167|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
130307460|NCT01724866|469089168|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
130307461|NCT01724866|469089169|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
130307462|NCT01424501|469089170|FG000|Overall Study|Withdrawal by Subject|1|||
130307463|NCT01424501|469089171|FG001|Overall Study|Withdrawal by Subject|0|||
130307464|NCT01424501|469089172|FG002|Overall Study|Withdrawal by Subject|1|||
130307465|NCT01424501|469089173|FG003|Overall Study|Withdrawal by Subject|0|||
130307466|NCT01424501|469089174|FG004|Overall Study|Withdrawal by Subject|0|||
130307467|NCT01424501|469089175|FG005|Overall Study|Withdrawal by Subject|0|||
130307468|NCT01424501|469089170|FG000|Overall Study|Lost to Follow-up|0|||
130307469|NCT01424501|469089171|FG001|Overall Study|Lost to Follow-up|1|||
130307470|NCT01424501|469089172|FG002|Overall Study|Lost to Follow-up|1|||
130307471|NCT01424501|469089173|FG003|Overall Study|Lost to Follow-up|0|||
130307472|NCT01424501|469089174|FG004|Overall Study|Lost to Follow-up|0|||
130307473|NCT01424501|469089175|FG005|Overall Study|Lost to Follow-up|0|||
130307474|NCT01980095|469089176|FG000|Overall Study|Lost to Follow-up|6|||
130307475|NCT01980095|469089177|FG001|Overall Study|Lost to Follow-up|7|||
130307476|NCT01980095|469089176|FG000|Overall Study|Withdrawal by Subject|2|||
130307477|NCT01980095|469089177|FG001|Overall Study|Withdrawal by Subject|3|||
130307478|NCT01980095|469089176|FG000|Overall Study|Poor compliance|5|||
130307479|NCT01980095|469089177|FG001|Overall Study|Poor compliance|0|||
130307480|NCT01980095|469089176|FG000|Overall Study|Safety issue|0|||
130307481|NCT01980095|469089177|FG001|Overall Study|Safety issue|1|||
130307482|NCT01980095|469089176|FG000|Overall Study|Study drug discontinued|1|||
130307483|NCT01980095|469089177|FG001|Overall Study|Study drug discontinued|0|||
130307484|NCT01980095|469089176|FG000|Overall Study|Randomized by mistake|1|||
130307485|NCT01980095|469089177|FG001|Overall Study|Randomized by mistake|0|||
130307486|NCT01362608|469089182|FG000|Overall Study|Protocol Violation|0|||
130307487|NCT01362608|469089183|FG001|Overall Study|Protocol Violation|1|||
129797831|NCT02537574|467228233|FG000|Overall Study|Incarceration|0|||
129797832|NCT02537574|467228234|FG001|Overall Study|Incarceration|1|||
130307488|NCT01362608|469089182|FG000|Overall Study|Lost to Follow-up|3|||
130307489|NCT01362608|469089183|FG001|Overall Study|Lost to Follow-up|1|||
130307490|NCT01362608|469089182|FG000|Overall Study|Withdrawal by Subject|1|||
130307491|NCT01362608|469089183|FG001|Overall Study|Withdrawal by Subject|2|||
129797833|NCT02537574|467228235|FG002|Overall Study|Incarceration|0|||
130109776|NCT01507831|468362506|FG000|Overall Study|Consent withdrawn by participant|34|||
130307492|NCT01362608|469089182|FG000|Overall Study|Lack of Efficacy|0|||
130307493|NCT01362608|469089183|FG001|Overall Study|Lack of Efficacy|2|||
130307494|NCT01362608|469089182|FG000|Overall Study|Adverse Event|0|||
130307495|NCT01362608|469089183|FG001|Overall Study|Adverse Event|2|||
130307496|NCT04506502|469089191|FG000|Overall Study|Withdrawal by Subject|1|||
130307497|NCT04506502|469089191|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
129797834|NCT02537574|467228233|FG000|Overall Study|Failed Naloxone Challenge|0|||
129797835|NCT02537574|467228234|FG001|Overall Study|Failed Naloxone Challenge|1|||
129797836|NCT02537574|467228235|FG002|Overall Study|Failed Naloxone Challenge|0|||
129797837|NCT02537574|467228233|FG000|Overall Study|Transportation Issues|0|||
129797838|NCT02537574|467228234|FG001|Overall Study|Transportation Issues|0|||
129797839|NCT02537574|467228235|FG002|Overall Study|Transportation Issues|1|||
129797840|NCT02537574|467228233|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
129797841|NCT02537574|467228234|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
129797842|NCT02537574|467228235|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
129797843|NCT02537574|467228233|FG000|Overall Study|Noncompliance with Protocol|0|||
129797844|NCT02537574|467228234|FG001|Overall Study|Noncompliance with Protocol|0|||
129797845|NCT02537574|467228235|FG002|Overall Study|Noncompliance with Protocol|1|||
129797846|NCT02663687|467228236|FG000|Overall Study|Adverse Event|1|||
130307498|NCT03526146|469089193|FG000|Overall Study|Lost to Follow-up|5|||
130307499|NCT03526146|469089193|FG000|Overall Study|Withdrawal by Subject|6|||
130307500|NCT03526146|469089193|FG000|Overall Study|class canceled due to COVID-19|4|||
130307501|NCT01136408|469089196|FG000|Overall Study|Adverse Event|4|||
130307502|NCT01136408|469089197|FG001|Overall Study|Adverse Event|8|||
130307503|NCT01136408|469089198|FG002|Overall Study|Adverse Event|4|||
130307504|NCT01136408|469089196|FG000|Overall Study|Protocol Violation|1|||
130307505|NCT01136408|469089197|FG001|Overall Study|Protocol Violation|1|||
130307506|NCT01136408|469089198|FG002|Overall Study|Protocol Violation|1|||
130307507|NCT02828436|469089199|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
130307508|NCT02828436|469089200|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
130307509|NCT02828436|469089199|FG000|Period 1|Lost to Follow-up|0|||
130307510|NCT02828436|469089200|FG001|Period 1|Lost to Follow-up|1|||
130307511|NCT02828436|469089199|FG000|Period 2|Withdrawal by Subject|4|||
130307512|NCT02828436|469089200|FG001|Period 2|Withdrawal by Subject|0|||
130307513|NCT02828436|469089199|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
130307514|NCT02828436|469089200|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
130307515|NCT02828436|469089199|FG000|Period 2|Lost to Follow-up|1|||
130307516|NCT02828436|469089200|FG001|Period 2|Lost to Follow-up|0|||
130307517|NCT04421482|469089203|FG000|Overall Study|Physician Decision|1|||
130307518|NCT03010319|469089206|FG000|Overall Study|Adverse Event|15|||
130307519|NCT03010319|469089207|FG001|Overall Study|Adverse Event|9|||
130307520|NCT03010319|469089206|FG000|Overall Study|Withdrawal by Subject|1|||
130307521|NCT03010319|469089207|FG001|Overall Study|Withdrawal by Subject|6|||
130307522|NCT03010319|469089206|FG000|Overall Study|Physician Decision|2|||
130307523|NCT03010319|469089207|FG001|Overall Study|Physician Decision|4|||
130307524|NCT03010319|469089206|FG000|Overall Study|Sponsor requested withdrawal|2|||
130307525|NCT03010319|469089207|FG001|Overall Study|Sponsor requested withdrawal|2|||
130307526|NCT03010319|469089206|FG000|Overall Study|Death|1|||
130307527|NCT03010319|469089207|FG001|Overall Study|Death|0|||
130307528|NCT03010319|469089206|FG000|Overall Study|Lost to Follow-up|0|||
130307529|NCT03010319|469089207|FG001|Overall Study|Lost to Follow-up|1|||
130307530|NCT03010319|469089206|FG000|Overall Study|Other Reason|5|||
130307531|NCT03010319|469089207|FG001|Overall Study|Other Reason|7|||
130307532|NCT02128724|469089208|FG000|Overall Study|Death|1|||
130307533|NCT02128724|469089209|FG001|Overall Study|Death|0|||
130307534|NCT02128724|469089210|FG002|Overall Study|Death|0|||
130307535|NCT02128724|469089211|FG003|Overall Study|Death|0|||
130307536|NCT02128724|469089208|FG000|Overall Study|Adverse Event|0|||
129797847|NCT02663687|467228237|FG001|Overall Study|Adverse Event|0|||
129797848|NCT02663687|467228238|FG002|Overall Study|Adverse Event|0|||
130307537|NCT02128724|469089209|FG001|Overall Study|Adverse Event|1|||
130307538|NCT02128724|469089210|FG002|Overall Study|Adverse Event|0|||
130307539|NCT02128724|469089211|FG003|Overall Study|Adverse Event|0|||
129797849|NCT02663687|467228239|FG003|Overall Study|Adverse Event|0|||
130049013|NCT04760314|468136605|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130307540|NCT02128724|469089208|FG000|Overall Study|Physician Decision|0|||
130307541|NCT02128724|469089209|FG001|Overall Study|Physician Decision|0|||
130307542|NCT02128724|469089210|FG002|Overall Study|Physician Decision|0|||
130307543|NCT02128724|469089211|FG003|Overall Study|Physician Decision|2|||
130307544|NCT02128724|469089208|FG000|Overall Study|Withdrawal by Subject|0|||
130307545|NCT02128724|469089209|FG001|Overall Study|Withdrawal by Subject|0|||
130307546|NCT02128724|469089210|FG002|Overall Study|Withdrawal by Subject|0|||
130307547|NCT02128724|469089211|FG003|Overall Study|Withdrawal by Subject|1|||
130307548|NCT03329092|469089212|FG000|Overall Study|Other|2|||
130307549|NCT03329092|469089213|FG001|Overall Study|Other|2|||
129797850|NCT02663687|467228240|FG004|Overall Study|Adverse Event|0|||
129797851|NCT02663687|467228236|FG000|Overall Study|Other|1|||
129797852|NCT02663687|467228237|FG001|Overall Study|Other|0|||
130109777|NCT01507831|468362507|FG001|Overall Study|Consent withdrawn by participant|72|||
130109778|NCT01507831|468362506|FG000|Overall Study|Related to study drug administration|5|||
130109779|NCT01507831|468362507|FG001|Overall Study|Related to study drug administration|14|||
130109780|NCT01507831|468362506|FG000|Overall Study|Last visit outside protocol visit window|51|||
130109781|NCT01507831|468362507|FG001|Overall Study|Last visit outside protocol visit window|143|||
130109782|NCT01507831|468362506|FG000|Overall Study|Selection criteria finally not met|0|||
130109783|NCT01507831|468362507|FG001|Overall Study|Selection criteria finally not met|1|||
130109784|NCT01507831|468362506|FG000|Overall Study|Site closure|0|||
130109785|NCT01507831|468362507|FG001|Overall Study|Site closure|3|||
130109786|NCT01507831|468362506|FG000|Overall Study|Potential lost to follow-up|3|||
130109787|NCT01507831|468362507|FG001|Overall Study|Potential lost to follow-up|0|||
130109788|NCT01507831|468362506|FG000|Overall Study|Other|3|||
130109789|NCT01507831|468362507|FG001|Overall Study|Other|6|||
130109790|NCT01610167|468362508|FG000|Overall Study|Scheduling conflict.|0|||
130109791|NCT01610167|468362509|FG001|Overall Study|Scheduling conflict.|0|||
130109792|NCT01610167|468362510|FG002|Overall Study|Scheduling conflict.|2|||
130109793|NCT03296553|468362512|FG000|Overall Study|Withdrawal by Subject|1|||
130109794|NCT03296553|468362513|FG001|Overall Study|Withdrawal by Subject|1|||
130109795|NCT03296553|468362512|FG000|Overall Study|Death|1|||
130109796|NCT03296553|468362513|FG001|Overall Study|Death|0|||
130109797|NCT02295280|468362514|FG000|Overall Study|Adverse Event|0|||
130109798|NCT02295280|468362515|FG001|Overall Study|Adverse Event|1|||
130109799|NCT02713243|468362516|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
130109800|NCT02713243|468362517|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
130109801|NCT02713243|468362516|FG000|Overall Study|Administrative problems|0|||
130109802|NCT02713243|468362517|FG001|Overall Study|Administrative problems|1|||
130109803|NCT02713243|468362516|FG000|Overall Study|Protocol deviation|0|||
130109804|NCT02713243|468362517|FG001|Overall Study|Protocol deviation|1|||
130109805|NCT00124449|468362518|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
130109806|NCT00124449|468362519|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
130109807|NCT00124449|468362518|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
130109808|NCT00124449|468362519|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
130109809|NCT00124449|468362518|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
130109810|NCT00124449|468362519|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
130109811|NCT00124449|468362518|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
130109812|NCT00124449|468362519|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
130109813|NCT00124449|468362518|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
130109814|NCT00124449|468362519|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
130109815|NCT00124449|468362518|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
130109816|NCT00124449|468362519|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
130109817|NCT00124449|468362518|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
130109818|NCT00124449|468362519|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
130109819|NCT00124449|468362518|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
130109820|NCT00124449|468362519|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
130109821|NCT00124449|468362518|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
130109822|NCT00124449|468362519|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
130109823|NCT00124449|468362518|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
130109824|NCT00124449|468362519|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
130109825|NCT00124449|468362518|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
129797853|NCT02663687|467228238|FG002|Overall Study|Other|1|||
129797854|NCT02663687|467228239|FG003|Overall Study|Other|0|||
129797855|NCT02663687|467228240|FG004|Overall Study|Other|0|||
129797856|NCT03595774|467228241|FG000|Overall Study|Adverse Event|1|||
129797857|NCT03595774|467228242|FG001|Overall Study|Adverse Event|0|||
129797858|NCT03595774|467228243|FG002|Overall Study|Adverse Event|1|||
129797859|NCT03595774|467228244|FG003|Overall Study|Adverse Event|0|||
129797860|NCT03595774|467228241|FG000|Overall Study|screen failure|0|||
129797861|NCT03595774|467228242|FG001|Overall Study|screen failure|1|||
129797862|NCT03595774|467228243|FG002|Overall Study|screen failure|0|||
130307550|NCT03329092|469089212|FG000|Overall Study|Withdrawal by Subject|16|||
130307551|NCT03329092|469089213|FG001|Overall Study|Withdrawal by Subject|3|||
130307552|NCT03329092|469089212|FG000|Overall Study|Physician Decision|1|||
130307553|NCT03329092|469089213|FG001|Overall Study|Physician Decision|0|||
130307554|NCT03329092|469089212|FG000|Overall Study|Death|17|||
130307555|NCT03329092|469089213|FG001|Overall Study|Death|11|||
130307556|NCT03329092|469089212|FG000|Overall Study|Adverse Event|3|||
130307557|NCT03329092|469089213|FG001|Overall Study|Adverse Event|1|||
129797863|NCT03595774|467228244|FG003|Overall Study|screen failure|1|||
129797864|NCT00117286|467228245|FG000|Overall Study|Adverse Event|12|||
129797865|NCT00117286|467228246|FG001|Overall Study|Adverse Event|6|||
130109826|NCT00124449|468362519|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
130307558|NCT03329092|469089212|FG000|Overall Study|Lost to Follow-up|1|||
130307559|NCT03329092|469089213|FG001|Overall Study|Lost to Follow-up|1|||
129797866|NCT00117286|467228245|FG000|Overall Study|Lost to Follow-up|2|||
129797867|NCT00117286|467228246|FG001|Overall Study|Lost to Follow-up|0|||
130307560|NCT05786508|469089214|FG000|Overall Study|Withdrawal by Subject|2|||
130307561|NCT05786508|469089215|FG001|Overall Study|Withdrawal by Subject|0|||
130307562|NCT04426318|469089216|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
130307563|NCT04426318|469089217|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
130307564|NCT03574779|469089218|FG000|Overall Study|Screening failure|13|||
130307565|NCT03574779|469089219|FG001|Overall Study|Screening failure|83|||
130307566|NCT02588261|469089220|FG000|Overall Study|Study Terminated by Sponsor|157|||
130307567|NCT02588261|469089221|FG001|Overall Study|Study Terminated by Sponsor|142|||
130307568|NCT02588261|469089220|FG000|Overall Study|Protocol Deviation|1|||
130307569|NCT02588261|469089221|FG001|Overall Study|Protocol Deviation|0|||
130307570|NCT02588261|469089220|FG000|Overall Study|Death|1|||
130307571|NCT02588261|469089221|FG001|Overall Study|Death|2|||
130307572|NCT02588261|469089220|FG000|Overall Study|Withdrawal by Subject|12|||
130307573|NCT02588261|469089221|FG001|Overall Study|Withdrawal by Subject|8|||
130307574|NCT02588261|469089220|FG000|Overall Study|Noncompliance with Study Drug|0|||
130307575|NCT02588261|469089221|FG001|Overall Study|Noncompliance with Study Drug|1|||
130307576|NCT02588261|469089220|FG000|Overall Study|Miscellaneous|5|||
130307577|NCT02588261|469089221|FG001|Overall Study|Miscellaneous|4|||
130307578|NCT02588261|469089220|FG000|Overall Study|Progressive Disease|61|||
130307579|NCT02588261|469089221|FG001|Overall Study|Progressive Disease|82|||
130307580|NCT02588261|469089220|FG000|Overall Study|Adverse Event|29|||
130307581|NCT02588261|469089221|FG001|Overall Study|Adverse Event|24|||
130307582|NCT02588261|469089220|FG000|Overall Study|Lost to Follow-up|1|||
130307583|NCT02588261|469089221|FG001|Overall Study|Lost to Follow-up|0|||
130307584|NCT03781778|469089223|FG000|Overall Study|Withdrawal by Subject|2|||
130307585|NCT03781778|469089224|FG001|Overall Study|Withdrawal by Subject|2|||
130307586|NCT02287467|469089225|FG000|Overall Study|Protocol Violation|12|||
130307587|NCT02287467|469089226|FG001|Overall Study|Protocol Violation|9|||
130307588|NCT02652156|469089227|FG000|Overall Study|Physician Decision|1|||
130307589|NCT02652156|469089228|FG001|Overall Study|Physician Decision|0|||
130307590|NCT02652156|469089229|FG002|Overall Study|Physician Decision|0|||
130307591|NCT00108862|469089230|FG000|Overall Study|Death|31|||
130307592|NCT00108862|469089231|FG001|Overall Study|Death|37|||
130307593|NCT00108862|469089230|FG000|Overall Study|Withdrawal by Subject|10|||
130307594|NCT00108862|469089231|FG001|Overall Study|Withdrawal by Subject|6|||
130307595|NCT00108862|469089230|FG000|Overall Study|Lost to Follow-up|27|||
130307596|NCT00108862|469089231|FG001|Overall Study|Lost to Follow-up|19|||
130307597|NCT03534141|469089232|FG000|Overall Study|Enrolled in other clinical trial|1|||
130307598|NCT03534141|469089233|FG001|Overall Study|Enrolled in other clinical trial|0|||
130307599|NCT03534141|469089232|FG000|Overall Study|Liver transplant aborted after randomization|0|||
130307600|NCT03534141|469089233|FG001|Overall Study|Liver transplant aborted after randomization|2|||
130307601|NCT03534141|469089232|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
130307602|NCT03534141|469089233|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
130307603|NCT00517361|469089234|FG000|Overall Study|Death|6|||
130307604|NCT00517361|469089234|FG000|Overall Study|The study was terminated|5|||
130307605|NCT01685697|469089235|FG000|Overall Study|Protocol Violation|3|||
130307606|NCT01685697|469089236|FG001|Overall Study|Protocol Violation|3|||
130307607|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Death|0|||
130307608|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Death|0|||
129797868|NCT00117286|467228245|FG000|Overall Study|Protocol Violation|3|||
130307609|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Death|0|||
130307610|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Death|0|||
130307611|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Death|1|||
130307612|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Death|0|||
130307613|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Death|0|||
130307614|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Death|0|||
130307615|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
130307616|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
130307617|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
130307618|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
130307619|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
130307620|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
130307621|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
130307622|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
130307623|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
130307624|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307625|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307626|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
130307627|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307628|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
130307629|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129797869|NCT00117286|467228246|FG001|Overall Study|Protocol Violation|3|||
129797870|NCT00117286|467228245|FG000|Overall Study|Withdrawal by Subject|6|||
129797871|NCT00117286|467228246|FG001|Overall Study|Withdrawal by Subject|2|||
129797872|NCT00117286|467228245|FG000|Overall Study|Physician Decision|3|||
129797873|NCT00117286|467228246|FG001|Overall Study|Physician Decision|7|||
129797874|NCT00117286|467228245|FG000|Overall Study|Lack of Efficacy|2|||
129797875|NCT00117286|467228246|FG001|Overall Study|Lack of Efficacy|1|||
129797876|NCT00117286|467228245|FG000|Overall Study|Research site closing|0|||
129797877|NCT00117286|467228246|FG001|Overall Study|Research site closing|2|||
129797878|NCT00048061|467228248|FG000|Overall Study|Adverse Event|41|||
129797879|NCT00048061|467228249|FG001|Overall Study|Adverse Event|32|||
129797880|NCT00048061|467228250|FG002|Overall Study|Adverse Event|44|||
129797881|NCT00048061|467228251|FG003|Overall Study|Adverse Event|37|||
129797882|NCT00048061|467228248|FG000|Overall Study|Lost to Follow-up|3|||
129797883|NCT00048061|467228249|FG001|Overall Study|Lost to Follow-up|2|||
129797884|NCT00048061|467228250|FG002|Overall Study|Lost to Follow-up|4|||
129797885|NCT00048061|467228251|FG003|Overall Study|Lost to Follow-up|5|||
129797886|NCT00048061|467228248|FG000|Overall Study|Withdrawal by Subject|20|||
129797887|NCT00048061|467228249|FG001|Overall Study|Withdrawal by Subject|29|||
129797888|NCT00048061|467228250|FG002|Overall Study|Withdrawal by Subject|29|||
129797889|NCT00048061|467228251|FG003|Overall Study|Withdrawal by Subject|32|||
129797890|NCT00048061|467228248|FG000|Overall Study|Did not follow-up|5|||
129797891|NCT00048061|467228249|FG001|Overall Study|Did not follow-up|5|||
129797892|NCT00048061|467228250|FG002|Overall Study|Did not follow-up|4|||
129797893|NCT00048061|467228251|FG003|Overall Study|Did not follow-up|5|||
129797894|NCT00048061|467228248|FG000|Overall Study|Early improvement|6|||
129797895|NCT00048061|467228249|FG001|Overall Study|Early improvement|5|||
129797896|NCT00048061|467228250|FG002|Overall Study|Early improvement|3|||
129797897|NCT00048061|467228251|FG003|Overall Study|Early improvement|0|||
129797898|NCT03555435|467228252|FG000|Overall Study|Lost to Follow-up|17|||
129797899|NCT03555435|467228253|FG001|Overall Study|Lost to Follow-up|19|||
129797900|NCT03555435|467228254|FG002|Overall Study|Lost to Follow-up|8|||
129797901|NCT01323946|467228255|FG000|Overall Study|Lost to Follow-up|0|||
129797902|NCT01323946|467228256|FG001|Overall Study|Lost to Follow-up|1|||
129797903|NCT01323946|467228257|FG002|Overall Study|Lost to Follow-up|0|||
129797904|NCT01323946|467228255|FG000|Overall Study|Parents refused the last blood draw|1|||
129797905|NCT01323946|467228256|FG001|Overall Study|Parents refused the last blood draw|0|||
129797906|NCT01323946|467228257|FG002|Overall Study|Parents refused the last blood draw|0|||
129797907|NCT01323946|467228255|FG000|Overall Study|Withdrawal by Subject|2|||
129797908|NCT01323946|467228256|FG001|Overall Study|Withdrawal by Subject|2|||
130109827|NCT00124449|468362518|FG000|18-Month Untreated Observation Period|Relocated|1|||
130109828|NCT00124449|468362519|FG001|18-Month Untreated Observation Period|Relocated|0|||
130307630|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
130307631|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
130307632|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
130307633|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
130307634|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
130307635|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
130307636|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
130307637|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
130307638|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
130307639|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
130307640|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130307641|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130307642|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
130307643|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
130307644|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
130307645|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
130307646|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
130307647|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
129797909|NCT01323946|467228257|FG002|Overall Study|Withdrawal by Subject|0|||
129889472|NCT00946647|467552607|FG001|Phase ll Part|Administrative problems|0|||
129889473|NCT00946647|467552608|FG002|Phase ll Part|Administrative problems|0|||
130307648|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129797910|NCT01272661|467228260|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
129889474|NCT00946647|467552609|FG003|Phase ll Part|Administrative problems|3|||
129797911|NCT01272661|467228261|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
129797912|NCT01272661|467228262|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
129797913|NCT01243671|467228263|FG000|Overall Study|Adverse Event|3|||
129797914|NCT01243671|467228263|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
129797915|NCT01243671|467228263|FG000|Overall Study|Other|1|||
129797916|NCT00573248|467228269|FG000|Overall Study|scheduling conflicts|15|||
129797917|NCT00573248|467228270|FG001|Overall Study|scheduling conflicts|11|||
129797918|NCT02017171|467228271|FG000|Overall Study|Death|10|||
129797919|NCT02017171|467228272|FG001|Overall Study|Death|4|||
130307649|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130307650|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
130307651|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
130307652|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
130307653|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130307654|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
130307655|NCT00726232|469089237|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
130307656|NCT00726232|469089238|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307657|NCT00726232|469089239|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307658|NCT00726232|469089240|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307659|NCT00726232|469089241|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307660|NCT00726232|469089242|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307661|NCT00726232|469089243|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307662|NCT00726232|469089244|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
130307663|NCT00726232|469089237|FG000|Expansion Phase|Death|0|||
130307664|NCT00726232|469089238|FG001|Expansion Phase|Death|0|||
130307665|NCT00726232|469089239|FG002|Expansion Phase|Death|0|||
130307666|NCT00726232|469089240|FG003|Expansion Phase|Death|0|||
130307667|NCT00726232|469089241|FG004|Expansion Phase|Death|0|||
130307668|NCT00726232|469089242|FG005|Expansion Phase|Death|0|||
130307669|NCT00726232|469089243|FG006|Expansion Phase|Death|0|||
130307670|NCT00726232|469089244|FG007|Expansion Phase|Death|1|||
130307671|NCT00726232|469089237|FG000|Expansion Phase|Adverse Event|0|||
130307672|NCT00726232|469089238|FG001|Expansion Phase|Adverse Event|0|||
130307673|NCT00726232|469089239|FG002|Expansion Phase|Adverse Event|0|||
130307674|NCT00726232|469089240|FG003|Expansion Phase|Adverse Event|0|||
130307675|NCT00726232|469089241|FG004|Expansion Phase|Adverse Event|0|||
130307676|NCT00726232|469089242|FG005|Expansion Phase|Adverse Event|0|||
130307677|NCT00726232|469089243|FG006|Expansion Phase|Adverse Event|6|||
130307678|NCT00726232|469089244|FG007|Expansion Phase|Adverse Event|11|||
130307679|NCT00726232|469089237|FG000|Expansion Phase|Withdrawal by Subject|0|||
130307680|NCT00726232|469089238|FG001|Expansion Phase|Withdrawal by Subject|0|||
130307681|NCT00726232|469089239|FG002|Expansion Phase|Withdrawal by Subject|0|||
130307682|NCT00726232|469089240|FG003|Expansion Phase|Withdrawal by Subject|0|||
130307683|NCT00726232|469089241|FG004|Expansion Phase|Withdrawal by Subject|0|||
130307684|NCT00726232|469089242|FG005|Expansion Phase|Withdrawal by Subject|0|||
130307685|NCT00726232|469089243|FG006|Expansion Phase|Withdrawal by Subject|2|||
130307686|NCT00726232|469089244|FG007|Expansion Phase|Withdrawal by Subject|3|||
130307687|NCT00726232|469089237|FG000|Expansion Phase|Disease progression|0|||
130307688|NCT00726232|469089238|FG001|Expansion Phase|Disease progression|0|||
130307689|NCT00726232|469089239|FG002|Expansion Phase|Disease progression|0|||
130307690|NCT00726232|469089240|FG003|Expansion Phase|Disease progression|0|||
130307691|NCT00726232|469089241|FG004|Expansion Phase|Disease progression|0|||
130307692|NCT00726232|469089242|FG005|Expansion Phase|Disease progression|0|||
130307693|NCT00726232|469089243|FG006|Expansion Phase|Disease progression|4|||
130307694|NCT00726232|469089244|FG007|Expansion Phase|Disease progression|0|||
130307695|NCT00726232|469089237|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
130307696|NCT00726232|469089238|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
130307697|NCT00726232|469089239|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
130307698|NCT00726232|469089240|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
130307699|NCT00726232|469089241|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
130307700|NCT00726232|469089242|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
130307701|NCT00726232|469089243|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
130307702|NCT00726232|469089244|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
130307703|NCT00726232|469089237|FG000|Expansion Phase|Per Investigator: lack of response|0|||
130307704|NCT00726232|469089238|FG001|Expansion Phase|Per Investigator: lack of response|0|||
130307705|NCT00726232|469089239|FG002|Expansion Phase|Per Investigator: lack of response|0|||
129797920|NCT02017171|467228271|FG000|Overall Study|Withdrawal by Subject|23|||
129797921|NCT02017171|467228272|FG001|Overall Study|Withdrawal by Subject|17|||
129797922|NCT02017171|467228271|FG000|Overall Study|Lost to Follow-up|21|||
130307706|NCT00726232|469089240|FG003|Expansion Phase|Per Investigator: lack of response|0|||
130307707|NCT00726232|469089241|FG004|Expansion Phase|Per Investigator: lack of response|0|||
130307708|NCT00726232|469089242|FG005|Expansion Phase|Per Investigator: lack of response|0|||
130307709|NCT00726232|469089243|FG006|Expansion Phase|Per Investigator: lack of response|1|||
130307710|NCT00726232|469089244|FG007|Expansion Phase|Per Investigator: lack of response|7|||
130307711|NCT00726232|469089237|FG000|Expansion Phase|Unspecified reason|0|||
130307712|NCT00726232|469089238|FG001|Expansion Phase|Unspecified reason|0|||
130307713|NCT00726232|469089239|FG002|Expansion Phase|Unspecified reason|0|||
130307714|NCT00726232|469089240|FG003|Expansion Phase|Unspecified reason|0|||
130307715|NCT00726232|469089241|FG004|Expansion Phase|Unspecified reason|0|||
130307716|NCT00726232|469089242|FG005|Expansion Phase|Unspecified reason|0|||
129797923|NCT02017171|467228272|FG001|Overall Study|Lost to Follow-up|20|||
129797924|NCT02017171|467228271|FG000|Overall Study|ESKD|6|||
129797925|NCT02017171|467228272|FG001|Overall Study|ESKD|2|||
129797926|NCT02017171|467228271|FG000|Overall Study|Miscellaneous|2|||
129797927|NCT02017171|467228272|FG001|Overall Study|Miscellaneous|3|||
129797928|NCT03091777|467228273|FG000|Overall Study|Pregnancy|2|||
129797929|NCT03091777|467228274|FG001|Overall Study|Pregnancy|1|||
129797930|NCT03091777|467228275|FG002|Overall Study|Pregnancy|0|||
129797931|NCT03091777|467228273|FG000|Overall Study|Adverse Event|2|||
129797932|NCT03091777|467228274|FG001|Overall Study|Adverse Event|1|||
129797933|NCT03091777|467228275|FG002|Overall Study|Adverse Event|4|||
129797934|NCT03091777|467228273|FG000|Overall Study|Withdrawal by Subject|4|||
129797935|NCT03091777|467228274|FG001|Overall Study|Withdrawal by Subject|2|||
129797936|NCT03091777|467228275|FG002|Overall Study|Withdrawal by Subject|6|||
129797937|NCT03091777|467228273|FG000|Overall Study|Protocol Violation|2|||
129797938|NCT03091777|467228274|FG001|Overall Study|Protocol Violation|1|||
129797939|NCT03091777|467228275|FG002|Overall Study|Protocol Violation|1|||
129797940|NCT03091777|467228273|FG000|Overall Study|Lost to Follow-up|12|||
129797941|NCT03091777|467228274|FG001|Overall Study|Lost to Follow-up|14|||
129797942|NCT03091777|467228275|FG002|Overall Study|Lost to Follow-up|7|||
129797943|NCT03091777|467228273|FG000|Overall Study|Lack of Efficacy|0|||
129797944|NCT03091777|467228274|FG001|Overall Study|Lack of Efficacy|0|||
129797945|NCT03091777|467228275|FG002|Overall Study|Lack of Efficacy|5|||
129797946|NCT03091777|467228273|FG000|Overall Study|Noncompliance with study drug|2|||
129797947|NCT03091777|467228274|FG001|Overall Study|Noncompliance with study drug|3|||
129797948|NCT03091777|467228275|FG002|Overall Study|Noncompliance with study drug|1|||
129797949|NCT03091777|467228273|FG000|Overall Study|Physician Decision|1|||
129797950|NCT03091777|467228274|FG001|Overall Study|Physician Decision|0|||
129797951|NCT03091777|467228275|FG002|Overall Study|Physician Decision|1|||
129797952|NCT03091777|467228273|FG000|Overall Study|Abnormal Laboratory Value|7|||
129797953|NCT03091777|467228274|FG001|Overall Study|Abnormal Laboratory Value|11|||
129797954|NCT03091777|467228275|FG002|Overall Study|Abnormal Laboratory Value|12|||
129797955|NCT02314143|467228276|FG000|Overall Study|Adverse Event|0|||
129889475|NCT00946647|467552610|FG004|Phase ll Part|Administrative problems|8|||
129889476|NCT00946647|467552606|FG000|Phase ll Part|Death|0|||
130049014|NCT04760314|468136606|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130307717|NCT00726232|469089243|FG006|Expansion Phase|Unspecified reason|1|||
130307718|NCT00726232|469089244|FG007|Expansion Phase|Unspecified reason|0|||
130307719|NCT00195091|469089245|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
130307720|NCT04526145|469089248|FG000|Overall Study|Withdrawal by Subject|5|||
130307721|NCT00566852|469089251|FG000|Overall Study|Protocol Violation|22|||
130307722|NCT00566852|469089252|FG001|Overall Study|Protocol Violation|24|||
130307723|NCT00566852|469089251|FG000|Overall Study|Death|95|||
130307724|NCT00566852|469089252|FG001|Overall Study|Death|78|||
130307725|NCT00566852|469089251|FG000|Overall Study|Withdrawal by Subject|30|||
130307726|NCT00566852|469089252|FG001|Overall Study|Withdrawal by Subject|25|||
130307727|NCT00566852|469089251|FG000|Overall Study|Patient refusal|37|||
130307728|NCT00566852|469089252|FG001|Overall Study|Patient refusal|37|||
130307729|NCT00566852|469089251|FG000|Overall Study|Not tested due to disability|6|||
130307730|NCT00566852|469089252|FG001|Overall Study|Not tested due to disability|12|||
130307731|NCT00566852|469089251|FG000|Overall Study|Missing reason not specified|1|||
130307732|NCT00566852|469089252|FG001|Overall Study|Missing reason not specified|2|||
130307733|NCT00566852|469089251|FG000|Overall Study|Missing reason not reported|16|||
130307734|NCT00566852|469089252|FG001|Overall Study|Missing reason not reported|20|||
130307735|NCT04079816|469089253|FG000|Overall Study|Request of Subject|2|||
130307736|NCT04079816|469089253|FG000|Overall Study|Unable to draw samples|1|||
130307737|NCT04137731|469089254|FG000|Overall Study|Surgery Cancellation|1|||
130307738|NCT04137731|469089255|FG001|Overall Study|Surgery Cancellation|2|||
130307739|NCT04137731|469089254|FG000|Overall Study|Withdrawal by Subject|2|||
130307740|NCT04137731|469089255|FG001|Overall Study|Withdrawal by Subject|0|||
130307741|NCT04137731|469089254|FG000|Overall Study|Protocol Violation|0|||
130307742|NCT04137731|469089255|FG001|Overall Study|Protocol Violation|1|||
130307743|NCT00310817|469089256|FG000|Overall Study|AE or Death|3|||
130307744|NCT00310817|469089257|FG001|Overall Study|AE or Death|1|||
130307745|NCT00310817|469089258|FG002|Overall Study|AE or Death|0|||
130307746|NCT00310817|469089259|FG003|Overall Study|AE or Death|0|||
130307747|NCT00310817|469089256|FG000|Overall Study|Withdrawal by Subject|1|||
130307748|NCT00310817|469089257|FG001|Overall Study|Withdrawal by Subject|4|||
130307749|NCT00310817|469089258|FG002|Overall Study|Withdrawal by Subject|6|||
130307750|NCT00310817|469089259|FG003|Overall Study|Withdrawal by Subject|7|||
129889477|NCT00946647|467552607|FG001|Phase ll Part|Death|0|||
129797956|NCT02314143|467228277|FG001|Overall Study|Adverse Event|6|||
129797957|NCT02314143|467228278|FG002|Overall Study|Adverse Event|4|||
129797958|NCT02314143|467228276|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
129797959|NCT02314143|467228277|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
129797960|NCT02314143|467228278|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
129797961|NCT02314143|467228276|FG000|Overall Study|Physician Decision|2|||
129797962|NCT02314143|467228277|FG001|Overall Study|Physician Decision|1|||
129797963|NCT02314143|467228278|FG002|Overall Study|Physician Decision|0|||
129797964|NCT02314143|467228276|FG000|Overall Study|Withdrawal by Subject|1|||
129797965|NCT02314143|467228277|FG001|Overall Study|Withdrawal by Subject|0|||
129797966|NCT02314143|467228278|FG002|Overall Study|Withdrawal by Subject|1|||
129797967|NCT03172910|467229934|FG000|Overall Study|Adverse Event|0|||
129797968|NCT03172910|467229935|FG001|Overall Study|Adverse Event|0|||
129797969|NCT03172910|467229936|FG002|Overall Study|Adverse Event|0|||
129797970|NCT03172910|467229937|FG003|Overall Study|Adverse Event|0|||
130307751|NCT00310817|469089256|FG000|Overall Study|Lost to Follow-up|2|||
130307752|NCT00310817|469089257|FG001|Overall Study|Lost to Follow-up|1|||
130307753|NCT00310817|469089258|FG002|Overall Study|Lost to Follow-up|0|||
130307754|NCT00310817|469089259|FG003|Overall Study|Lost to Follow-up|0|||
130307755|NCT00310817|469089256|FG000|Overall Study|Inappropriate Enrollment|1|||
130307756|NCT00310817|469089257|FG001|Overall Study|Inappropriate Enrollment|0|||
130307757|NCT00310817|469089258|FG002|Overall Study|Inappropriate Enrollment|1|||
130307758|NCT00310817|469089259|FG003|Overall Study|Inappropriate Enrollment|0|||
130307759|NCT00310817|469089256|FG000|Overall Study|Protocol Violation|1|||
130307760|NCT00310817|469089257|FG001|Overall Study|Protocol Violation|1|||
130307761|NCT00310817|469089258|FG002|Overall Study|Protocol Violation|1|||
130307762|NCT00310817|469089259|FG003|Overall Study|Protocol Violation|1|||
130307763|NCT00310817|469089256|FG000|Overall Study|Unable to classify|3|||
130307764|NCT00310817|469089257|FG001|Overall Study|Unable to classify|1|||
130307765|NCT00310817|469089258|FG002|Overall Study|Unable to classify|0|||
130307766|NCT00310817|469089259|FG003|Overall Study|Unable to classify|0|||
130307767|NCT01702246|469089260|FG000|Overall Study|Lost to Follow-up|2|||
130307768|NCT01702246|469089260|FG000|Overall Study|Withdrawal by Subject|2|||
130307769|NCT01702246|469089260|FG000|Overall Study|Physician Decision|1|||
130307770|NCT01587040|469089261|FG000|Overall Study|Protocol Violation|0|||
130307771|NCT01587040|469089262|FG001|Overall Study|Protocol Violation|0|||
130307772|NCT01587040|469089263|FG002|Overall Study|Protocol Violation|1|||
130307773|NCT01587040|469089264|FG003|Overall Study|Protocol Violation|0|||
130307774|NCT01587040|469089261|FG000|Overall Study|Adverse Event|0|||
130307775|NCT01587040|469089262|FG001|Overall Study|Adverse Event|1|||
130307776|NCT01587040|469089263|FG002|Overall Study|Adverse Event|10|||
130307777|NCT01587040|469089264|FG003|Overall Study|Adverse Event|0|||
130307778|NCT01587040|469089261|FG000|Overall Study|Disease progression|12|||
130307779|NCT01587040|469089262|FG001|Overall Study|Disease progression|1|||
130307780|NCT01587040|469089263|FG002|Overall Study|Disease progression|15|||
130307781|NCT01587040|469089264|FG003|Overall Study|Disease progression|3|||
130307782|NCT01587040|469089261|FG000|Overall Study|Other than specified|5|||
130307783|NCT01587040|469089262|FG001|Overall Study|Other than specified|1|||
130307784|NCT01587040|469089263|FG002|Overall Study|Other than specified|11|||
130307785|NCT01587040|469089264|FG003|Overall Study|Other than specified|1|||
130307786|NCT04607837|469089267|FG000|Overall Study|Adverse Event|8|||
130307787|NCT04607837|469089268|FG001|Overall Study|Adverse Event|2|||
130307788|NCT04607837|469089267|FG000|Overall Study|Withdrawal by Subject|8|||
130307789|NCT04607837|469089268|FG001|Overall Study|Withdrawal by Subject|7|||
130307790|NCT04607837|469089267|FG000|Overall Study|Physician Decision|2|||
130307791|NCT04607837|469089268|FG001|Overall Study|Physician Decision|0|||
130307792|NCT04607837|469089267|FG000|Overall Study|Lack of Efficacy|2|||
130307793|NCT04607837|469089268|FG001|Overall Study|Lack of Efficacy|0|||
130307794|NCT04607837|469089267|FG000|Overall Study|Participant terminated by sponsor|1|||
130307795|NCT04607837|469089268|FG001|Overall Study|Participant terminated by sponsor|0|||
130307796|NCT04607837|469089267|FG000|Overall Study|Disease worsening|36|||
130307797|NCT04607837|469089268|FG001|Overall Study|Disease worsening|36|||
130307798|NCT04607837|469089267|FG000|Overall Study|Other|1|||
130307799|NCT04607837|469089268|FG001|Overall Study|Other|0|||
130307800|NCT04346654|469089269|FG000|Overall Study|Adverse Event|2|||
130307801|NCT04346654|469089270|FG001|Overall Study|Adverse Event|0|||
130307802|NCT04346654|469089269|FG000|Overall Study|Non-response|1|||
130307803|NCT04346654|469089270|FG001|Overall Study|Non-response|1|||
130307804|NCT04346654|469089269|FG000|Overall Study|Withdrawal by Subject|2|||
130307805|NCT04346654|469089270|FG001|Overall Study|Withdrawal by Subject|0|||
130307806|NCT04346654|469089269|FG000|Overall Study|Lost to Follow-up|0|||
130307807|NCT04346654|469089270|FG001|Overall Study|Lost to Follow-up|1|||
130307808|NCT04346654|469089269|FG000|Overall Study|Pregnancy|0|||
130307809|NCT04346654|469089270|FG001|Overall Study|Pregnancy|1|||
130307810|NCT05715242|469089271|FG000|Overall Study|Lost to Follow-up|0|||
130307811|NCT05715242|469089272|FG001|Overall Study|Lost to Follow-up|0|||
129797971|NCT03172910|467229938|FG004|Overall Study|Adverse Event|1|||
129797972|NCT01927341|467229942|FG000|Phase 1b|Lost to Follow-up|1|||
130307812|NCT05715242|469089273|FG002|Overall Study|Lost to Follow-up|1|||
130307813|NCT05715242|469089274|FG003|Overall Study|Lost to Follow-up|0|||
130307814|NCT05715242|469089275|FG004|Overall Study|Lost to Follow-up|0|||
130307815|NCT05715242|469089276|FG005|Overall Study|Lost to Follow-up|1|||
130307816|NCT05715242|469089277|FG006|Overall Study|Lost to Follow-up|0|||
129797973|NCT01927341|467229943|FG001|Phase 1b|Lost to Follow-up|0|||
129797974|NCT01927341|467229944|FG002|Phase 1b|Lost to Follow-up|0|||
130307817|NCT05715242|469089278|FG007|Overall Study|Lost to Follow-up|0|||
130307818|NCT05715242|469089279|FG008|Overall Study|Lost to Follow-up|0|||
130307819|NCT05715242|469089280|FG009|Overall Study|Lost to Follow-up|0|||
130307820|NCT05715242|469089281|FG010|Overall Study|Lost to Follow-up|0|||
130109829|NCT01254045|468362520|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
130109830|NCT01254045|468362521|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130109831|NCT01254045|468362522|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130109832|NCT01254045|468362523|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130109833|NCT01254045|468362524|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
130109834|NCT01254045|468362525|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
129797975|NCT01927341|467229945|FG003|Phase 1b|Lost to Follow-up|0|||
130109835|NCT02971605|468362526|FG000|Overall Study|Withdrawal by Subject|1|||
130109836|NCT01021137|468362527|FG000|Overall Study|Lost to Follow-up|9|||
130109837|NCT01021137|468362528|FG001|Overall Study|Lost to Follow-up|4|||
130109838|NCT01021137|468362529|FG002|Overall Study|Lost to Follow-up|2|||
130109839|NCT01021137|468362530|FG003|Overall Study|Lost to Follow-up|6|||
130109840|NCT01021137|468362527|FG000|Overall Study|Withdrawal by Subject|1|||
130109841|NCT01021137|468362528|FG001|Overall Study|Withdrawal by Subject|0|||
130109842|NCT01021137|468362529|FG002|Overall Study|Withdrawal by Subject|0|||
130109843|NCT01021137|468362530|FG003|Overall Study|Withdrawal by Subject|3|||
130109844|NCT02475980|468362533|FG000|Overall Study|Lost to Follow-up|4|||
130109845|NCT02475980|468362533|FG000|Overall Study|Withdrawal by Subject|1|||
130109846|NCT00665626|468362534|FG000|Overall Study|Lack of Efficacy|8|||
130109847|NCT00665626|468362535|FG001|Overall Study|Lack of Efficacy|5|||
130109848|NCT00665626|468362534|FG000|Overall Study|Lost to Follow-up|0|||
130109849|NCT00665626|468362535|FG001|Overall Study|Lost to Follow-up|2|||
130109850|NCT00665626|468362534|FG000|Overall Study|Withdrawal by Subject|0|||
130109851|NCT00665626|468362535|FG001|Overall Study|Withdrawal by Subject|1|||
130109852|NCT00665626|468362534|FG000|Overall Study|Protocol Violation|0|||
130109853|NCT00665626|468362535|FG001|Overall Study|Protocol Violation|2|||
130109854|NCT00665626|468362534|FG000|Overall Study|Adverse Event|1|||
130109855|NCT00665626|468362535|FG001|Overall Study|Adverse Event|9|||
130109856|NCT00665626|468362534|FG000|Overall Study|Due to exclusion criteria|0|||
130109857|NCT00665626|468362535|FG001|Overall Study|Due to exclusion criteria|1|||
130109858|NCT00665626|468362534|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
130109859|NCT00665626|468362535|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
130109860|NCT00665626|468362534|FG000|Overall Study|Unably to comply with dosing regimen|0|||
130109861|NCT00665626|468362535|FG001|Overall Study|Unably to comply with dosing regimen|1|||
130109862|NCT00665626|468362534|FG000|Overall Study|Death|1|||
130109863|NCT00665626|468362535|FG001|Overall Study|Death|0|||
130109864|NCT04147611|468362536|FG000|Overall Study|Physician Decision|0|||
129797976|NCT01927341|467229946|FG004|Phase 1b|Lost to Follow-up|0|||
129797977|NCT01927341|467229942|FG000|Phase 1b|Death|2|||
129797978|NCT01927341|467229943|FG001|Phase 1b|Death|0|||
129797979|NCT01927341|467229944|FG002|Phase 1b|Death|0|||
129797980|NCT01927341|467229945|FG003|Phase 1b|Death|0|||
129797981|NCT01927341|467229946|FG004|Phase 1b|Death|0|||
129797982|NCT01927341|467229942|FG000|Phase 1b|Follow-up completed|7|||
129797983|NCT01927341|467229943|FG001|Phase 1b|Follow-up completed|0|||
129797984|NCT01927341|467229944|FG002|Phase 1b|Follow-up completed|0|||
129797985|NCT01927341|467229945|FG003|Phase 1b|Follow-up completed|0|||
129797986|NCT01927341|467229946|FG004|Phase 1b|Follow-up completed|0|||
129797987|NCT01927341|467229942|FG000|Phase 2|Lost to Follow-up|0|||
129797988|NCT01927341|467229943|FG001|Phase 2|Lost to Follow-up|1|||
129797989|NCT01927341|467229944|FG002|Phase 2|Lost to Follow-up|0|||
129797990|NCT01927341|467229945|FG003|Phase 2|Lost to Follow-up|0|||
129797991|NCT01927341|467229946|FG004|Phase 2|Lost to Follow-up|0|||
129797992|NCT01927341|467229942|FG000|Phase 2|Participant withdrew consent|0|||
129797993|NCT01927341|467229943|FG001|Phase 2|Participant withdrew consent|2|||
129797994|NCT01927341|467229944|FG002|Phase 2|Participant withdrew consent|1|||
129797995|NCT01927341|467229945|FG003|Phase 2|Participant withdrew consent|2|||
129797996|NCT01927341|467229946|FG004|Phase 2|Participant withdrew consent|3|||
129797997|NCT01927341|467229942|FG000|Phase 2|Death|0|||
129797998|NCT01927341|467229943|FG001|Phase 2|Death|4|||
129797999|NCT01927341|467229944|FG002|Phase 2|Death|0|||
130109865|NCT04147611|468362537|FG001|Overall Study|Physician Decision|1|||
130109866|NCT00435825|468362538|FG000|Overall Study|Abnormality of Laboratory Test|0|||
129798000|NCT01927341|467229945|FG003|Phase 2|Death|3|||
129798001|NCT01927341|467229946|FG004|Phase 2|Death|2|||
130109867|NCT00435825|468362539|FG001|Overall Study|Abnormality of Laboratory Test|1|||
130109868|NCT00435825|468362540|FG002|Overall Study|Abnormality of Laboratory Test|0|||
129798002|NCT01927341|467229942|FG000|Phase 2|New cancer therapy|0|||
129798003|NCT01927341|467229943|FG001|Phase 2|New cancer therapy|1|||
129798004|NCT01927341|467229944|FG002|Phase 2|New cancer therapy|0|||
129798005|NCT01927341|467229945|FG003|Phase 2|New cancer therapy|4|||
129798006|NCT01927341|467229946|FG004|Phase 2|New cancer therapy|1|||
129798007|NCT01927341|467229942|FG000|Phase 2|Disease progression|0|||
129798008|NCT01927341|467229943|FG001|Phase 2|Disease progression|1|||
129798009|NCT01927341|467229944|FG002|Phase 2|Disease progression|1|||
129798010|NCT01927341|467229945|FG003|Phase 2|Disease progression|1|||
130109869|NCT00435825|468362541|FG003|Overall Study|Abnormality of Laboratory Test|0|||
130109870|NCT00435825|468362538|FG000|Overall Study|Insufficient Therapeutic Response|3|||
130109871|NCT00435825|468362539|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129798011|NCT01927341|467229946|FG004|Phase 2|Disease progression|0|||
129798012|NCT01927341|467229942|FG000|Phase 2|Follow-up completed|0|||
129798013|NCT01927341|467229943|FG001|Phase 2|Follow-up completed|6|||
129798014|NCT01927341|467229944|FG002|Phase 2|Follow-up completed|3|||
129798015|NCT01927341|467229945|FG003|Phase 2|Follow-up completed|5|||
129798016|NCT01927341|467229946|FG004|Phase 2|Follow-up completed|2|||
129798017|NCT01397201|467229947|FG000|Overall Study|Not treated|0|||
129798018|NCT01397201|467229948|FG001|Overall Study|Not treated|0|||
129798019|NCT01397201|467229949|FG002|Overall Study|Not treated|1|||
129798020|NCT01397201|467229950|FG003|Overall Study|Not treated|0|||
129798021|NCT01397201|467229951|FG004|Overall Study|Not treated|0|||
129798022|NCT01397201|467229947|FG000|Overall Study|Not yet defined|3|||
129798023|NCT01397201|467229948|FG001|Overall Study|Not yet defined|6|||
129798024|NCT01397201|467229949|FG002|Overall Study|Not yet defined|5|||
129798025|NCT01397201|467229950|FG003|Overall Study|Not yet defined|5|||
129798026|NCT01397201|467229951|FG004|Overall Study|Not yet defined|4|||
129798027|NCT01397201|467229947|FG000|Overall Study|Adverse Event|2|||
129798028|NCT01397201|467229948|FG001|Overall Study|Adverse Event|0|||
129798029|NCT01397201|467229949|FG002|Overall Study|Adverse Event|0|||
129798030|NCT01397201|467229950|FG003|Overall Study|Adverse Event|0|||
129798031|NCT01397201|467229951|FG004|Overall Study|Adverse Event|0|||
129798032|NCT00215683|467229952|FG000|Overall Study|Adverse Event|15|||
129798033|NCT00215683|467229953|FG001|Overall Study|Adverse Event|16|||
129798034|NCT00215683|467229954|FG002|Overall Study|Adverse Event|15|||
129798035|NCT00215683|467229952|FG000|Overall Study|Lack of Efficacy|5|||
129798036|NCT00215683|467229953|FG001|Overall Study|Lack of Efficacy|1|||
129798037|NCT00215683|467229954|FG002|Overall Study|Lack of Efficacy|2|||
129798038|NCT00215683|467229952|FG000|Overall Study|Lost to Follow-up|0|||
129798039|NCT00215683|467229953|FG001|Overall Study|Lost to Follow-up|2|||
129798040|NCT00215683|467229954|FG002|Overall Study|Lost to Follow-up|1|||
129798041|NCT00215683|467229952|FG000|Overall Study|Withdrawal by Subject|9|||
129798042|NCT00215683|467229953|FG001|Overall Study|Withdrawal by Subject|4|||
129798043|NCT00215683|467229954|FG002|Overall Study|Withdrawal by Subject|13|||
129798044|NCT00215683|467229952|FG000|Overall Study|Physician Decision|0|||
129798045|NCT00215683|467229953|FG001|Overall Study|Physician Decision|0|||
129798046|NCT00215683|467229954|FG002|Overall Study|Physician Decision|1|||
129798047|NCT00215683|467229952|FG000|Overall Study|Difficult to attend visits|0|||
129798048|NCT00215683|467229953|FG001|Overall Study|Difficult to attend visits|1|||
129798049|NCT00215683|467229954|FG002|Overall Study|Difficult to attend visits|0|||
129798050|NCT00215683|467229952|FG000|Overall Study|No study drug available|0|||
129798051|NCT00215683|467229953|FG001|Overall Study|No study drug available|1|||
129798052|NCT00215683|467229954|FG002|Overall Study|No study drug available|0|||
129798053|NCT00215683|467229952|FG000|Overall Study|Intermittent therapy required|0|||
129798054|NCT00215683|467229953|FG001|Overall Study|Intermittent therapy required|1|||
129798055|NCT00215683|467229954|FG002|Overall Study|Intermittent therapy required|0|||
129798056|NCT01083485|467229955|FG000|Overall Study|Adverse Event|0|||
129798057|NCT01083485|467229956|FG001|Overall Study|Adverse Event|1|||
129798058|NCT01083485|467229955|FG000|Overall Study|Protocol Violation|1|||
129798059|NCT01083485|467229956|FG001|Overall Study|Protocol Violation|0|||
129798060|NCT01083485|467229955|FG000|Overall Study|Withdrawal by Subject|5|||
129798061|NCT01083485|467229956|FG001|Overall Study|Withdrawal by Subject|2|||
129798062|NCT01083485|467229955|FG000|Overall Study|Other|1|||
129798063|NCT01083485|467229956|FG001|Overall Study|Other|0|||
129798064|NCT04493333|467229963|FG000|Overall Study|Withdrawal by Subject|1|||
129798065|NCT04493333|467229964|FG001|Overall Study|Withdrawal by Subject|1|||
130307821|NCT05715242|469089282|FG011|Overall Study|Lost to Follow-up|0|||
130307822|NCT05715242|469089283|FG012|Overall Study|Lost to Follow-up|0|||
130307823|NCT05715242|469089284|FG013|Overall Study|Lost to Follow-up|0|||
130307824|NCT05715242|469089285|FG014|Overall Study|Lost to Follow-up|0|||
130307825|NCT05715242|469089286|FG015|Overall Study|Lost to Follow-up|0|||
130307826|NCT02915978|469089287|FG000|Overall Study|Adverse Event|2|||
130307827|NCT02915978|469089288|FG001|Overall Study|Adverse Event|1|||
130307828|NCT02915978|469089289|FG002|Overall Study|Adverse Event|0|||
130307829|NCT02343406|469089295|FG000|Overall Study|Progressive disease|72|||
130307830|NCT02343406|469089296|FG001|Overall Study|Progressive disease|70|||
130307831|NCT02343406|469089297|FG002|Overall Study|Progressive disease|43|||
130307832|NCT02343406|469089298|FG003|Overall Study|Progressive disease|15|||
129798066|NCT04493333|467229963|FG000|Overall Study|Ineligible|0|||
129798067|NCT04493333|467229964|FG001|Overall Study|Ineligible|1|||
129798068|NCT04493333|467229963|FG000|Overall Study|Noncompliance|2|||
129798069|NCT04493333|467229964|FG001|Overall Study|Noncompliance|1|||
129798070|NCT00451451|467229967|FG000|Overall Study|Adverse Event|11|||
129798071|NCT00451451|467229968|FG001|Overall Study|Adverse Event|21|||
129798072|NCT00451451|467229969|FG002|Overall Study|Adverse Event|26|||
129798073|NCT00451451|467229970|FG003|Overall Study|Adverse Event|10|||
129798074|NCT00451451|467229967|FG000|Overall Study|Lost to Follow-up|11|||
129798075|NCT00451451|467229968|FG001|Overall Study|Lost to Follow-up|9|||
129798076|NCT00451451|467229969|FG002|Overall Study|Lost to Follow-up|8|||
129798077|NCT00451451|467229970|FG003|Overall Study|Lost to Follow-up|11|||
129798078|NCT00451451|467229967|FG000|Overall Study|Consent Withdrawn|14|||
130307833|NCT02343406|469089299|FG004|Overall Study|Progressive disease|5|||
130307834|NCT02343406|469089295|FG000|Overall Study|Adverse Event|6|||
130307835|NCT02343406|469089296|FG001|Overall Study|Adverse Event|8|||
129798079|NCT00451451|467229968|FG001|Overall Study|Consent Withdrawn|9|||
129798080|NCT00451451|467229969|FG002|Overall Study|Consent Withdrawn|17|||
129798081|NCT00451451|467229970|FG003|Overall Study|Consent Withdrawn|17|||
129798082|NCT00451451|467229967|FG000|Overall Study|Investigator Decision|6|||
129798083|NCT00451451|467229968|FG001|Overall Study|Investigator Decision|2|||
129798084|NCT00451451|467229969|FG002|Overall Study|Investigator Decision|1|||
129798085|NCT00451451|467229970|FG003|Overall Study|Investigator Decision|2|||
129798086|NCT00451451|467229967|FG000|Overall Study|Subject Non-Compliance|8|||
129798087|NCT00451451|467229968|FG001|Overall Study|Subject Non-Compliance|4|||
129798088|NCT00451451|467229969|FG002|Overall Study|Subject Non-Compliance|3|||
129798089|NCT00451451|467229970|FG003|Overall Study|Subject Non-Compliance|3|||
129798090|NCT00451451|467229967|FG000|Overall Study|Death|1|||
129798091|NCT00451451|467229968|FG001|Overall Study|Death|0|||
129798092|NCT00451451|467229969|FG002|Overall Study|Death|0|||
129798093|NCT00451451|467229970|FG003|Overall Study|Death|1|||
129798094|NCT00451451|467229967|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
129798095|NCT00451451|467229968|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
129798096|NCT00451451|467229969|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
129798097|NCT00451451|467229970|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
129798098|NCT01002482|467229971|FG000|Overall Study|Withdrawal by Subject|14|||
129798099|NCT01002482|467229972|FG001|Overall Study|Withdrawal by Subject|21|||
129798100|NCT01002482|467229971|FG000|Overall Study|Included twice|1|||
129798101|NCT01002482|467229972|FG001|Overall Study|Included twice|0|||
129798102|NCT01865084|467229973|FG000|Double Blind Period (DB)|Adverse Event|2|||
129798103|NCT01865084|467229974|FG001|Double Blind Period (DB)|Adverse Event|2|||
129798104|NCT01865084|467229975|FG002|Double Blind Period (DB)|Adverse Event|1|||
129798105|NCT01865084|467229973|FG000|Double Blind Period (DB)|Protocol Violation|0|||
129798106|NCT01865084|467229974|FG001|Double Blind Period (DB)|Protocol Violation|0|||
129798107|NCT01865084|467229975|FG002|Double Blind Period (DB)|Protocol Violation|1|||
129798108|NCT01865084|467229973|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
129798109|NCT01865084|467229974|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
129798110|NCT01865084|467229975|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
129798111|NCT01865084|467229973|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
129798112|NCT01865084|467229974|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
129798113|NCT01865084|467229975|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
129798114|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
129798115|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
129889478|NCT00946647|467552608|FG002|Phase ll Part|Death|0|||
129889479|NCT00946647|467552609|FG003|Phase ll Part|Death|7|||
130049015|NCT04760314|468136607|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049016|NCT04760314|468136608|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049017|NCT04760314|468136609|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049018|NCT04760314|468136610|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
130049019|NCT04760314|468136611|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049020|NCT04760314|468136612|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049021|NCT04760314|468136613|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130049022|NCT04760314|468136603|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049023|NCT04760314|468136604|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049024|NCT04760314|468136605|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049025|NCT04760314|468136606|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049026|NCT04760314|468136607|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049027|NCT04760314|468136608|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049028|NCT04760314|468136609|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049029|NCT04760314|468136610|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049030|NCT04760314|468136611|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
130049031|NCT04760314|468136612|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
130049032|NCT04760314|468136613|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130049033|NCT00960440|468136615|FG000|Overall Study|Death|0|||
130049034|NCT00960440|468136616|FG001|Overall Study|Death|0|||
129889480|NCT00946647|467552610|FG004|Phase ll Part|Death|4|||
130049035|NCT00960440|468136617|FG002|Overall Study|Death|0|||
130049036|NCT00960440|468136618|FG003|Overall Study|Death|1|||
130049037|NCT00960440|468136615|FG000|Overall Study|Adverse Event|12|||
130307836|NCT02343406|469089297|FG002|Overall Study|Adverse Event|6|||
129798116|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
129798117|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
129798118|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
129798119|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
129889481|NCT00946647|467552606|FG000|Phase ll Part|Disease progression|0|||
130049038|NCT00960440|468136616|FG001|Overall Study|Adverse Event|12|||
130049039|NCT00960440|468136617|FG002|Overall Study|Adverse Event|4|||
129889482|NCT00946647|467552607|FG001|Phase ll Part|Disease progression|0|||
130049040|NCT00960440|468136618|FG003|Overall Study|Adverse Event|4|||
130049041|NCT00960440|468136615|FG000|Overall Study|Lack of Efficacy|2|||
130049042|NCT00960440|468136616|FG001|Overall Study|Lack of Efficacy|5|||
130049043|NCT00960440|468136617|FG002|Overall Study|Lack of Efficacy|3|||
130049044|NCT00960440|468136618|FG003|Overall Study|Lack of Efficacy|8|||
130049045|NCT00960440|468136615|FG000|Overall Study|Protocol Violation|2|||
130049046|NCT00960440|468136616|FG001|Overall Study|Protocol Violation|8|||
130049047|NCT00960440|468136617|FG002|Overall Study|Protocol Violation|3|||
130049048|NCT00960440|468136618|FG003|Overall Study|Protocol Violation|4|||
130049049|NCT00960440|468136615|FG000|Overall Study|Withdrawal by Subject|9|||
130049050|NCT00960440|468136616|FG001|Overall Study|Withdrawal by Subject|5|||
130049051|NCT00960440|468136617|FG002|Overall Study|Withdrawal by Subject|2|||
130049052|NCT00960440|468136618|FG003|Overall Study|Withdrawal by Subject|1|||
130049053|NCT00960440|468136615|FG000|Overall Study|Other|1|||
130049054|NCT00960440|468136616|FG001|Overall Study|Other|1|||
130049055|NCT00960440|468136617|FG002|Overall Study|Other|1|||
130049056|NCT00960440|468136618|FG003|Overall Study|Other|0|||
130049057|NCT02421120|468136619|FG000|Overall Study|Adverse Event|1|||
130049058|NCT02207530|468136620|FG000|Overall Study|Worsening condition under investigation|78|||
130049059|NCT02207530|468136620|FG000|Overall Study|Patient decision to stop study treatment|5|||
130049060|NCT02207530|468136620|FG000|Overall Study|Adverse Event|8|||
130049061|NCT02345161|468136621|FG000|Overall Study|Withdrawal by Subject|25|||
130049062|NCT02345161|468136622|FG001|Overall Study|Withdrawal by Subject|33|||
130049063|NCT02345161|468136621|FG000|Overall Study|Adverse Event|16|||
130049064|NCT02345161|468136622|FG001|Overall Study|Adverse Event|19|||
130049065|NCT02345161|468136621|FG000|Overall Study|Physician Decision|4|||
130049066|NCT02345161|468136622|FG001|Overall Study|Physician Decision|4|||
130049067|NCT02345161|468136621|FG000|Overall Study|Lost to Follow-up|0|||
130049068|NCT02345161|468136622|FG001|Overall Study|Lost to Follow-up|1|||
130049069|NCT00305006|468136629|FG000|Overall Study|Withdrawal by Subject|1|||
130049070|NCT00305006|468136630|FG001|Overall Study|Withdrawal by Subject|0|||
130049071|NCT00305006|468136629|FG000|Overall Study|Failure to complete pretest|0|||
130049072|NCT00305006|468136630|FG001|Overall Study|Failure to complete pretest|1|||
130049073|NCT02606045|468136634|FG000|Overall Study|Study closed before treament could begin|1|||
130049074|NCT02606045|468136635|FG001|Overall Study|Study closed before treament could begin|2|||
130049075|NCT00907881|468136636|FG000|Overall Study|Lost to Follow-up|59|||
130049076|NCT00907881|468136636|FG000|Overall Study|Noncompliance|5|||
130049077|NCT00907881|468136636|FG000|Overall Study|Withdrawal by Subject|5|||
130049078|NCT00907881|468136636|FG000|Overall Study|Protocol Violation|1|||
130049079|NCT00907881|468136636|FG000|Overall Study|Missing discontinuation information|15|||
130049080|NCT02616029|468136637|FG000|Overall Study|Adverse Event|1|||
130049081|NCT02616029|468136638|FG001|Overall Study|Adverse Event|0|||
130049082|NCT02616029|468136637|FG000|Overall Study|Death|0|||
130049083|NCT02616029|468136638|FG001|Overall Study|Death|1|||
130109872|NCT00435825|468362540|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130109873|NCT00435825|468362541|FG003|Overall Study|Insufficient Therapeutic Response|3|||
130049084|NCT02616029|468136637|FG000|Overall Study|Protocol Violation|1|||
130109874|NCT00435825|468362538|FG000|Overall Study|Other Protocol Violation|1|||
130049085|NCT02616029|468136638|FG001|Overall Study|Protocol Violation|0|||
130049086|NCT02616029|468136637|FG000|Overall Study|Withdrew Consent|1|||
130049087|NCT02616029|468136638|FG001|Overall Study|Withdrew Consent|0|||
130049088|NCT02616029|468136637|FG000|Overall Study|Enrolled and Never Treated|1|||
130049089|NCT02616029|468136638|FG001|Overall Study|Enrolled and Never Treated|1|||
130049090|NCT01740440|468136639|FG000|Overall Study|Lost to Follow-up|3|||
130049091|NCT00339183|468136645|FG000|Overall Study|Adverse Event|5|||
130049092|NCT00339183|468136646|FG001|Overall Study|Adverse Event|3|||
130049093|NCT00339183|468136645|FG000|Overall Study|Withdrawal by Subject|16|||
130049094|NCT00339183|468136646|FG001|Overall Study|Withdrawal by Subject|19|||
130049095|NCT00339183|468136645|FG000|Overall Study|Physician Decision|2|||
130049096|NCT00339183|468136646|FG001|Overall Study|Physician Decision|4|||
130049097|NCT00339183|468136645|FG000|Overall Study|Lost to Follow-up|17|||
130049098|NCT00339183|468136646|FG001|Overall Study|Lost to Follow-up|17|||
130049099|NCT00339183|468136645|FG000|Overall Study|Protocol-specified criteria|12|||
130049100|NCT00339183|468136646|FG001|Overall Study|Protocol-specified criteria|8|||
130049101|NCT00339183|468136645|FG000|Overall Study|Missing reason|3|||
130049102|NCT00339183|468136646|FG001|Overall Study|Missing reason|1|||
130049103|NCT00339183|468136645|FG000|Overall Study|Other|46|||
130049104|NCT00339183|468136646|FG001|Overall Study|Other|40|||
130049105|NCT00339183|468136645|FG000|Overall Study|Ongoing|20|||
130049106|NCT00339183|468136646|FG001|Overall Study|Ongoing|13|||
130049107|NCT00793819|468136647|FG000|Overall Study|Adverse Event|8|||
130049108|NCT00793819|468136648|FG001|Overall Study|Adverse Event|4|||
130049109|NCT00793819|468136647|FG000|Overall Study|Lack of Efficacy|1|||
130049110|NCT00793819|468136648|FG001|Overall Study|Lack of Efficacy|1|||
130049111|NCT00793819|468136647|FG000|Overall Study|Withdrawal by Subject|4|||
130049112|NCT00793819|468136648|FG001|Overall Study|Withdrawal by Subject|3|||
130049113|NCT00793819|468136647|FG000|Overall Study|Lost to Follow-up|1|||
130049114|NCT00793819|468136648|FG001|Overall Study|Lost to Follow-up|1|||
130049115|NCT00446446|468136649|FG000|Overall Study|Death|10|||
130049116|NCT00446446|468136649|FG000|Overall Study|Withdrawal by Subject|6|||
130049117|NCT00446446|468136649|FG000|Overall Study|Other|4|||
130109875|NCT00435825|468362539|FG001|Overall Study|Other Protocol Violation|0|||
130109876|NCT00435825|468362540|FG002|Overall Study|Other Protocol Violation|0|||
130109877|NCT00435825|468362541|FG003|Overall Study|Other Protocol Violation|0|||
130109878|NCT00435825|468362538|FG000|Overall Study|Refused treatment|2|||
130109879|NCT00435825|468362539|FG001|Overall Study|Refused treatment|0|||
130109880|NCT00435825|468362540|FG002|Overall Study|Refused treatment|0|||
130109881|NCT00435825|468362541|FG003|Overall Study|Refused treatment|5|||
130109882|NCT00435825|468362538|FG000|Overall Study|Failure to return|5|||
130109883|NCT00435825|468362539|FG001|Overall Study|Failure to return|0|||
130109884|NCT00435825|468362540|FG002|Overall Study|Failure to return|4|||
130109885|NCT00435825|468362541|FG003|Overall Study|Failure to return|0|||
130109886|NCT00435825|468362538|FG000|Overall Study|Did not receive study drug|1|||
130109887|NCT00435825|468362539|FG001|Overall Study|Did not receive study drug|0|||
130109888|NCT00435825|468362540|FG002|Overall Study|Did not receive study drug|2|||
130109889|NCT00435825|468362541|FG003|Overall Study|Did not receive study drug|0|||
130109890|NCT00435825|468362538|FG000|Overall Study|Did not enter follow-up|0|||
130109891|NCT00435825|468362539|FG001|Overall Study|Did not enter follow-up|4|||
130109892|NCT00435825|468362540|FG002|Overall Study|Did not enter follow-up|1|||
130109893|NCT00435825|468362541|FG003|Overall Study|Did not enter follow-up|3|||
130109894|NCT00435825|468362538|FG000|Overall Study|Did not complete full follow-up period|6|||
130109895|NCT00435825|468362539|FG001|Overall Study|Did not complete full follow-up period|6|||
130109896|NCT00435825|468362540|FG002|Overall Study|Did not complete full follow-up period|4|||
130109897|NCT00435825|468362541|FG003|Overall Study|Did not complete full follow-up period|5|||
130109898|NCT00530439|468362542|FG000|Overall Study|GDM|9|||
130109899|NCT00530439|468362543|FG001|Overall Study|GDM|3|||
130109900|NCT00530439|468362542|FG000|Overall Study|Withdraw|18|||
130109901|NCT00530439|468362543|FG001|Overall Study|Withdraw|14|||
130109902|NCT00530439|468362542|FG000|Overall Study|Missed abortion|1|||
130109903|NCT00530439|468362543|FG001|Overall Study|Missed abortion|4|||
130109904|NCT00530439|468362542|FG000|Overall Study|Misclassification|2|||
130109905|NCT00530439|468362543|FG001|Overall Study|Misclassification|0|||
130109906|NCT00530439|468362542|FG000|Overall Study|Twin pregnancy|0|||
130109907|NCT00530439|468362543|FG001|Overall Study|Twin pregnancy|2|||
130109908|NCT00530439|468362542|FG000|Overall Study|Severe malformation/abortion|0|||
130109909|NCT00530439|468362543|FG001|Overall Study|Severe malformation/abortion|3|||
130109910|NCT01529749|468362544|FG000|Overall Study|Lost to Follow-up|0|||
130109911|NCT01529749|468362545|FG001|Overall Study|Lost to Follow-up|1|||
130109912|NCT01529749|468362546|FG002|Overall Study|Lost to Follow-up|1|||
130109913|NCT01529749|468362547|FG003|Overall Study|Lost to Follow-up|0|||
130109914|NCT01529749|468362544|FG000|Overall Study|Physician Decision|0|||
130109915|NCT01529749|468362545|FG001|Overall Study|Physician Decision|0|||
130109916|NCT01529749|468362546|FG002|Overall Study|Physician Decision|0|||
130109917|NCT01529749|468362547|FG003|Overall Study|Physician Decision|1|||
130109918|NCT01529749|468362544|FG000|Overall Study|Withdrawal by Subject|0|||
130109919|NCT01529749|468362545|FG001|Overall Study|Withdrawal by Subject|1|||
130109920|NCT01529749|468362546|FG002|Overall Study|Withdrawal by Subject|1|||
130109921|NCT01529749|468362547|FG003|Overall Study|Withdrawal by Subject|0|||
130109922|NCT01529749|468362544|FG000|Overall Study|Protocol Violation|0|||
130109923|NCT01529749|468362545|FG001|Overall Study|Protocol Violation|0|||
130109924|NCT01529749|468362546|FG002|Overall Study|Protocol Violation|0|||
130109925|NCT01529749|468362547|FG003|Overall Study|Protocol Violation|1|||
130109926|NCT00378482|468362548|FG000|Overall Study|Lost to Follow-up|1|||
130109927|NCT00378482|468362548|FG000|Overall Study|Lack of Efficacy|8|||
130109928|NCT00378482|468362548|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
130109929|NCT00378482|468362548|FG000|Overall Study|Withdrawal by Subject|4|||
130109930|NCT00378482|468362548|FG000|Overall Study|Adverse Event|9|||
130109931|NCT00534092|468364046|FG000|Overall Study|Lost to Follow-up|1|||
130109932|NCT00534092|468364047|FG001|Overall Study|Lost to Follow-up|0|||
130109933|NCT00534092|468364046|FG000|Overall Study|personal reasons/family concerns|1|||
130109934|NCT00534092|468364047|FG001|Overall Study|personal reasons/family concerns|0|||
130109935|NCT00830063|468364054|FG000|Overall Study|Adverse Event|7|||
130109936|NCT00830063|468364055|FG001|Overall Study|Adverse Event|13|||
130109937|NCT00830063|468364056|FG002|Overall Study|Adverse Event|16|||
130109938|NCT00830063|468364057|FG003|Overall Study|Adverse Event|13|||
130109939|NCT00830063|468364054|FG000|Overall Study|Death|1|||
130109940|NCT00830063|468364055|FG001|Overall Study|Death|0|||
130109941|NCT00830063|468364056|FG002|Overall Study|Death|0|||
130109942|NCT00830063|468364057|FG003|Overall Study|Death|0|||
130109943|NCT00830063|468364054|FG000|Overall Study|Lost to Follow-up|0|||
130109944|NCT00830063|468364055|FG001|Overall Study|Lost to Follow-up|0|||
130109945|NCT00830063|468364056|FG002|Overall Study|Lost to Follow-up|3|||
130109946|NCT00830063|468364057|FG003|Overall Study|Lost to Follow-up|1|||
130109947|NCT00830063|468364054|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
130109948|NCT00830063|468364055|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
130109949|NCT00830063|468364056|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
130109950|NCT00830063|468364057|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
129798120|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
129798121|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
129798122|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
129798123|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
129798124|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
129798125|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
129798126|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
129798127|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
129798128|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
129798129|NCT03607422|467229979|FG000|Overall Study|Adverse Event|7|||
129798130|NCT03607422|467229980|FG001|Overall Study|Adverse Event|3|||
130109951|NCT00830063|468364054|FG000|Overall Study|Lack of Efficacy|51|||
130109952|NCT00830063|468364055|FG001|Overall Study|Lack of Efficacy|23|||
130109953|NCT00830063|468364056|FG002|Overall Study|Lack of Efficacy|25|||
130109954|NCT00830063|468364057|FG003|Overall Study|Lack of Efficacy|32|||
130109955|NCT00830063|468364054|FG000|Overall Study|Other|5|||
130109956|NCT00830063|468364055|FG001|Overall Study|Other|5|||
129798131|NCT03607422|467229981|FG002|Overall Study|Adverse Event|2|||
129798132|NCT03607422|467229982|FG003|Overall Study|Adverse Event|0|||
129798133|NCT03607422|467229983|FG004|Overall Study|Adverse Event|2|||
129798134|NCT03607422|467229984|FG005|Overall Study|Adverse Event|0|||
130109957|NCT00830063|468364056|FG002|Overall Study|Other|8|||
130307837|NCT02343406|469089298|FG003|Overall Study|Adverse Event|3|||
129798135|NCT03607422|467229979|FG000|Overall Study|Withdrawal by Subject|11|||
129798136|NCT03607422|467229980|FG001|Overall Study|Withdrawal by Subject|3|||
129798137|NCT03607422|467229981|FG002|Overall Study|Withdrawal by Subject|6|||
129798138|NCT03607422|467229982|FG003|Overall Study|Withdrawal by Subject|2|||
129798139|NCT03607422|467229983|FG004|Overall Study|Withdrawal by Subject|0|||
129798140|NCT03607422|467229984|FG005|Overall Study|Withdrawal by Subject|0|||
129798141|NCT03607422|467229979|FG000|Overall Study|Lost to Follow-up|0|||
129798142|NCT03607422|467229980|FG001|Overall Study|Lost to Follow-up|0|||
129798143|NCT03607422|467229981|FG002|Overall Study|Lost to Follow-up|1|||
129798144|NCT03607422|467229982|FG003|Overall Study|Lost to Follow-up|0|||
129798145|NCT03607422|467229983|FG004|Overall Study|Lost to Follow-up|0|||
129798146|NCT03607422|467229984|FG005|Overall Study|Lost to Follow-up|0|||
129798147|NCT03607422|467229979|FG000|Overall Study|Other|12|||
129798148|NCT03607422|467229980|FG001|Overall Study|Other|4|||
129798149|NCT03607422|467229981|FG002|Overall Study|Other|1|||
129798150|NCT03607422|467229982|FG003|Overall Study|Other|2|||
129798151|NCT03607422|467229983|FG004|Overall Study|Other|0|||
129798152|NCT03607422|467229984|FG005|Overall Study|Other|2|||
129889483|NCT00946647|467552608|FG002|Phase ll Part|Disease progression|0|||
129889484|NCT00946647|467552609|FG003|Phase ll Part|Disease progression|6|||
130307838|NCT02343406|469089299|FG004|Overall Study|Adverse Event|0|||
130307839|NCT02343406|469089295|FG000|Overall Study|Withdrawal by Subject|6|||
130307840|NCT02343406|469089296|FG001|Overall Study|Withdrawal by Subject|4|||
130307841|NCT02343406|469089297|FG002|Overall Study|Withdrawal by Subject|8|||
130307842|NCT02343406|469089298|FG003|Overall Study|Withdrawal by Subject|3|||
130307843|NCT02343406|469089299|FG004|Overall Study|Withdrawal by Subject|0|||
130307844|NCT02343406|469089295|FG000|Overall Study|Death|2|||
130307845|NCT02343406|469089296|FG001|Overall Study|Death|1|||
130307846|NCT02343406|469089297|FG002|Overall Study|Death|0|||
130307847|NCT02343406|469089298|FG003|Overall Study|Death|0|||
130307848|NCT02343406|469089299|FG004|Overall Study|Death|0|||
130307849|NCT02343406|469089295|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
130307850|NCT02343406|469089296|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
130307851|NCT02343406|469089297|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
130307852|NCT02343406|469089298|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
130307853|NCT02343406|469089299|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
130307854|NCT02343406|469089295|FG000|Overall Study|Other primary malignancy|0|||
130307855|NCT02343406|469089296|FG001|Overall Study|Other primary malignancy|1|||
130307856|NCT02343406|469089297|FG002|Overall Study|Other primary malignancy|0|||
130307857|NCT02343406|469089298|FG003|Overall Study|Other primary malignancy|0|||
130307858|NCT02343406|469089299|FG004|Overall Study|Other primary malignancy|0|||
129798153|NCT03607422|467229979|FG000|Overall Study|Ongoing at Time of Analysis|8|||
129798154|NCT03607422|467229980|FG001|Overall Study|Ongoing at Time of Analysis|0|||
129889485|NCT00946647|467552610|FG004|Phase ll Part|Disease progression|14|||
129798155|NCT03607422|467229981|FG002|Overall Study|Ongoing at Time of Analysis|2|||
129798156|NCT03607422|467229982|FG003|Overall Study|Ongoing at Time of Analysis|1|||
129798157|NCT03607422|467229983|FG004|Overall Study|Ongoing at Time of Analysis|1|||
129798158|NCT03607422|467229984|FG005|Overall Study|Ongoing at Time of Analysis|1|||
129798159|NCT03693170|467229985|FG000|Overall Study|Disease Progression|48|||
129889486|NCT00946647|467552606|FG000|Phase ll Part|Protocol Violation|0|||
130109958|NCT00830063|468364057|FG003|Overall Study|Other|6|||
130109959|NCT00830063|468364054|FG000|Overall Study|Withdrawal by Subject|16|||
130307859|NCT02343406|469089295|FG000|Overall Study|Other, not specified|2|||
130307860|NCT02343406|469089296|FG001|Overall Study|Other, not specified|1|||
129798160|NCT03693170|467229985|FG000|Overall Study|Adverse Event|16|||
129798161|NCT03693170|467229985|FG000|Overall Study|Physician Decision|6|||
129798162|NCT03693170|467229985|FG000|Overall Study|Protocol Violation|2|||
129798163|NCT03693170|467229985|FG000|Overall Study|Death|1|||
129798164|NCT03693170|467229985|FG000|Overall Study|Non compliance with study drug|1|||
129798165|NCT03693170|467229985|FG000|Overall Study|Withdrawal by Subject|1|||
129798166|NCT01442038|467229988|FG000|Overall Study|Death|35|||
129798167|NCT01442038|467229989|FG001|Overall Study|Death|29|||
129798168|NCT01442038|467229988|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
129798169|NCT01442038|467229989|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
129798170|NCT01442038|467229988|FG000|Overall Study|Participant Withdrew Consent|137|||
129798171|NCT01442038|467229989|FG001|Overall Study|Participant Withdrew Consent|102|||
129798172|NCT01442038|467229988|FG000|Overall Study|Lost to Follow-up|37|||
129798173|NCT01442038|467229989|FG001|Overall Study|Lost to Follow-up|51|||
129798174|NCT01442038|467229988|FG000|Overall Study|Adverse Event|26|||
129798175|NCT01442038|467229989|FG001|Overall Study|Adverse Event|15|||
129798176|NCT01442038|467229988|FG000|Overall Study|Protocol Deviation|9|||
129798177|NCT01442038|467229989|FG001|Overall Study|Protocol Deviation|20|||
129798178|NCT01442038|467229988|FG000|Overall Study|Investigator's Discretion|13|||
130049118|NCT00446446|468136649|FG000|Overall Study|Disease Progession|2|||
130049119|NCT00446446|468136649|FG000|Overall Study|Adverse Event|1|||
130049120|NCT00446446|468136649|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
130049121|NCT03964415|468136653|FG000|Overall Study|Sponsor's decision|1563|||
130049122|NCT03964415|468136654|FG001|Overall Study|Sponsor's decision|1528|||
130049123|NCT03964415|468136653|FG000|Overall Study|Lost to Follow-up|139|||
130049124|NCT03964415|468136654|FG001|Overall Study|Lost to Follow-up|146|||
130049125|NCT03964415|468136653|FG000|Overall Study|Withdrawal by Subject|68|||
130049126|NCT03964415|468136654|FG001|Overall Study|Withdrawal by Subject|72|||
130049127|NCT03964415|468136653|FG000|Overall Study|Physician Decision|34|||
130049128|NCT03964415|468136654|FG001|Overall Study|Physician Decision|48|||
130049129|NCT03964415|468136653|FG000|Overall Study|Adverse Event|3|||
130049130|NCT03964415|468136654|FG001|Overall Study|Adverse Event|0|||
130307861|NCT02343406|469089297|FG002|Overall Study|Other, not specified|1|||
130307862|NCT02343406|469089298|FG003|Overall Study|Other, not specified|4|||
130307863|NCT02343406|469089299|FG004|Overall Study|Other, not specified|0|||
130307864|NCT02451124|469089300|FG000|Overall Study|Withdrawal by Subject|1|||
130307865|NCT00958165|469089301|FG000|Overall Study|Lost to Follow-up|5|||
130307866|NCT00958165|469089301|FG000|Overall Study|Not eligible|9|||
130307867|NCT00166439|469089305|FG000|Overall Study|Ineligible|5|||
130307868|NCT00615992|469089306|FG000|Overall Study|Protocol Violation|67|||
130307869|NCT00856297|469089307|FG000|Overall Study|Unable to classify|2|||
130307870|NCT00856297|469089308|FG001|Overall Study|Unable to classify|0|||
130307871|NCT00856297|469089309|FG002|Overall Study|Unable to classify|0|||
130307872|NCT00856297|469089310|FG003|Overall Study|Unable to classify|0|||
130307873|NCT00856297|469089311|FG004|Overall Study|Unable to classify|0|||
130307874|NCT01392547|469091041|FG000|Overall Study|Adverse Event|2|||
130307875|NCT01392547|469091041|FG000|Overall Study|Non-compliance|2|||
130307876|NCT01392547|469091041|FG000|Overall Study|Withdrawal criteria|3|||
130307877|NCT01392547|469091041|FG000|Overall Study|Unclassified|1|||
130307878|NCT00615017|469091042|FG000|Overall Study|Adverse Event|0|||
130307879|NCT00615017|469091043|FG001|Overall Study|Adverse Event|1|||
130307880|NCT00615017|469091044|FG002|Overall Study|Adverse Event|2|||
130307881|NCT00615017|469091045|FG003|Overall Study|Adverse Event|0|||
130307882|NCT00615017|469091046|FG004|Overall Study|Adverse Event|0|||
130307883|NCT00615017|469091047|FG005|Overall Study|Adverse Event|1|||
130307884|NCT00615017|469091042|FG000|Overall Study|Death|0|||
130307885|NCT00615017|469091043|FG001|Overall Study|Death|0|||
130049131|NCT03964415|468136653|FG000|Overall Study|Death|4|||
130307886|NCT00615017|469091044|FG002|Overall Study|Death|2|||
130307887|NCT00615017|469091045|FG003|Overall Study|Death|0|||
130307888|NCT00615017|469091046|FG004|Overall Study|Death|1|||
130307889|NCT00615017|469091047|FG005|Overall Study|Death|1|||
130307890|NCT00615017|469091042|FG000|Overall Study|Sepsis resolved|0|||
130307891|NCT00615017|469091043|FG001|Overall Study|Sepsis resolved|0|||
130307892|NCT00615017|469091044|FG002|Overall Study|Sepsis resolved|1|||
129798179|NCT01442038|467229989|FG001|Overall Study|Investigator's Discretion|16|||
129798180|NCT01442038|467229988|FG000|Overall Study|Study Terminated By Sponsor|2|||
129798181|NCT01442038|467229989|FG001|Overall Study|Study Terminated By Sponsor|3|||
129798182|NCT00089284|467229990|FG000|Overall Study|Adverse event before starting treatment|0|||
129889487|NCT00946647|467552607|FG001|Phase ll Part|Protocol Violation|0|||
130049132|NCT03964415|468136654|FG001|Overall Study|Death|6|||
130307893|NCT00615017|469091045|FG003|Overall Study|Sepsis resolved|0|||
130049133|NCT03964415|468136653|FG000|Overall Study|Protocol Violation|1|||
130049134|NCT03964415|468136654|FG001|Overall Study|Protocol Violation|4|||
130307894|NCT00615017|469091046|FG004|Overall Study|Sepsis resolved|0|||
130307895|NCT00615017|469091047|FG005|Overall Study|Sepsis resolved|0|||
130307896|NCT00615017|469091042|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
130307897|NCT00615017|469091043|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
130307898|NCT00615017|469091044|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
130049135|NCT03964415|468136653|FG000|Overall Study|Other|35|||
130307899|NCT00615017|469091045|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
130307900|NCT00615017|469091046|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
130307901|NCT00615017|469091047|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
130307902|NCT00615017|469091042|FG000|Overall Study|Physician discontinued drug|0|||
130307903|NCT00615017|469091043|FG001|Overall Study|Physician discontinued drug|0|||
130307904|NCT00615017|469091044|FG002|Overall Study|Physician discontinued drug|0|||
130307905|NCT00615017|469091045|FG003|Overall Study|Physician discontinued drug|0|||
130307906|NCT00615017|469091046|FG004|Overall Study|Physician discontinued drug|0|||
130307907|NCT00615017|469091047|FG005|Overall Study|Physician discontinued drug|1|||
130307908|NCT00806988|469091048|FG000|Overall Study|Death|15|||
130307909|NCT00806988|469091049|FG001|Overall Study|Death|16|||
130307910|NCT00806988|469091048|FG000|Overall Study|Withdrawal by Subject|8|||
130307911|NCT00806988|469091049|FG001|Overall Study|Withdrawal by Subject|8|||
130307912|NCT00806988|469091048|FG000|Overall Study|Lost to Follow-up|4|||
130307913|NCT00806988|469091049|FG001|Overall Study|Lost to Follow-up|19|||
130307914|NCT04775953|469091050|FG000|Overall Study|Lost to Follow-up|6|||
130307915|NCT04775953|469091051|FG001|Overall Study|Lost to Follow-up|11|||
130307916|NCT04775953|469091050|FG000|Overall Study|Death|5|||
130307917|NCT04775953|469091051|FG001|Overall Study|Death|4|||
130307918|NCT04775953|469091050|FG000|Overall Study|Withdrawal by Subject|3|||
130307919|NCT04775953|469091051|FG001|Overall Study|Withdrawal by Subject|3|||
130307920|NCT04775953|469091050|FG000|Overall Study|Protocol Violation|2|||
130307921|NCT04775953|469091051|FG001|Overall Study|Protocol Violation|0|||
130307922|NCT04775953|469091050|FG000|Overall Study|Participant non-compliance|0|||
130307923|NCT04775953|469091051|FG001|Overall Study|Participant non-compliance|1|||
130307924|NCT00855959|469091052|FG000|Overall Study|Adverse Event|2|||
130307925|NCT00855959|469091052|FG000|Overall Study|Lost to Follow-up|2|||
130307926|NCT00855959|469091052|FG000|Overall Study|Withdrawal by Subject|3|||
130307927|NCT00855959|469091052|FG000|Overall Study|Pregnancy|1|||
130307928|NCT00855959|469091052|FG000|Overall Study|Incorrect enrolment|1|||
130307929|NCT02813889|469091053|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
130307930|NCT02813889|469091054|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
130307931|NCT00368641|469091055|FG000|Overall Study|Adverse Event|2|||
130307932|NCT00368641|469091056|FG001|Overall Study|Adverse Event|1|||
130307933|NCT00368641|469091055|FG000|Overall Study|Death|1|||
130307934|NCT00368641|469091056|FG001|Overall Study|Death|0|||
130307935|NCT00368641|469091055|FG000|Overall Study|Withdrawal by Subject|1|||
130307936|NCT00368641|469091056|FG001|Overall Study|Withdrawal by Subject|0|||
130307937|NCT00368641|469091055|FG000|Overall Study|Sponsor decision to terminate study|2|||
130307938|NCT00368641|469091056|FG001|Overall Study|Sponsor decision to terminate study|5|||
130307939|NCT02517541|469091063|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
130307940|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
130307941|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
130307942|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
130307943|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
130307944|NCT02517541|469091063|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
130307945|NCT00699608|469091064|FG000|First Intervention|Withdrawal by Subject|0|||
130307946|NCT00699608|469091065|FG001|First Intervention|Withdrawal by Subject|0|||
130307947|NCT00699608|469091066|FG002|First Intervention|Withdrawal by Subject|1|||
130307948|NCT00699608|469091067|FG003|First Intervention|Withdrawal by Subject|0|||
130307949|NCT00699608|469091068|FG004|First Intervention|Withdrawal by Subject|0|||
130307950|NCT00699608|469091069|FG005|First Intervention|Withdrawal by Subject|0|||
130307951|NCT00699608|469091064|FG000|First Intervention|Protocol Violation|0|||
130307952|NCT00699608|469091065|FG001|First Intervention|Protocol Violation|0|||
130307953|NCT00699608|469091066|FG002|First Intervention|Protocol Violation|0|||
130307954|NCT00699608|469091067|FG003|First Intervention|Protocol Violation|0|||
130307955|NCT00699608|469091068|FG004|First Intervention|Protocol Violation|1|||
130307956|NCT00699608|469091069|FG005|First Intervention|Protocol Violation|0|||
130307957|NCT00699608|469091064|FG000|Second Intervention|Adverse Event|0|||
130307958|NCT00699608|469091065|FG001|Second Intervention|Adverse Event|0|||
130307959|NCT00699608|469091066|FG002|Second Intervention|Adverse Event|1|||
130307960|NCT00699608|469091067|FG003|Second Intervention|Adverse Event|0|||
129798183|NCT00089284|467229991|FG001|Overall Study|Adverse event before starting treatment|0|||
129798184|NCT00089284|467229992|FG002|Overall Study|Adverse event before starting treatment|0|||
130307961|NCT00699608|469091068|FG004|Second Intervention|Adverse Event|0|||
130307962|NCT00699608|469091069|FG005|Second Intervention|Adverse Event|0|||
130307963|NCT00699608|469091064|FG000|Second Intervention|Withdrawal by Subject|0|||
130307964|NCT00699608|469091065|FG001|Second Intervention|Withdrawal by Subject|0|||
130307965|NCT00699608|469091066|FG002|Second Intervention|Withdrawal by Subject|0|||
130307966|NCT00699608|469091067|FG003|Second Intervention|Withdrawal by Subject|1|||
130307967|NCT00699608|469091068|FG004|Second Intervention|Withdrawal by Subject|0|||
130307968|NCT00699608|469091069|FG005|Second Intervention|Withdrawal by Subject|0|||
130307969|NCT03078556|469091072|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
130049136|NCT03964415|468136654|FG001|Overall Study|Other|38|||
130049137|NCT03964415|468136653|FG000|Overall Study|Randomized but not treated|6|||
130049138|NCT03964415|468136654|FG001|Overall Study|Randomized but not treated|7|||
130307970|NCT03078556|469091073|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
130307971|NCT03078556|469091074|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
130307972|NCT03078556|469091075|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
130307973|NCT03078556|469091072|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
130307974|NCT03078556|469091073|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
130307975|NCT03078556|469091074|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
130307976|NCT03078556|469091075|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
130307977|NCT03078556|469091072|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
130307978|NCT03078556|469091073|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
130307979|NCT03078556|469091074|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
130307980|NCT03078556|469091075|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
130307981|NCT03078556|469091072|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
130307982|NCT03078556|469091073|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
130307983|NCT03078556|469091074|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
130307984|NCT03078556|469091075|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
130307985|NCT04306510|469091076|FG000|Overall Study|Voluntarily withdrawal|1|||
130307986|NCT04306510|469091076|FG000|Overall Study|Enrolled but Not Treated|1|||
130307987|NCT04720417|469091077|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
130307988|NCT00496080|469091083|FG000|Overall Study|Lost to Follow-up|9|||
130307989|NCT00496080|469091083|FG000|Overall Study|Surgical re-intervention|7|||
130307990|NCT00496080|469091083|FG000|Overall Study|Withdrawal by Subject|5|||
130307991|NCT00496080|469091083|FG000|Overall Study|Physician Decision|6|||
130307992|NCT00570310|469091084|FG000|Overall Study|Adverse Event|1|||
130307993|NCT00570310|469091085|FG001|Overall Study|Adverse Event|2|||
130307994|NCT00570310|469091084|FG000|Overall Study|Lack of Efficacy|1|||
130307995|NCT00570310|469091085|FG001|Overall Study|Lack of Efficacy|4|||
130307996|NCT00887549|469091086|FG000|Induction Therapy|Adverse Event|8|||
130307997|NCT00887549|469091086|FG000|Induction Therapy|Physician Decision|1|||
130307998|NCT00887549|469091086|FG000|Induction Therapy|Progressive Disease|13|||
130307999|NCT00887549|469091086|FG000|Induction Therapy|Death due to Study Disease|4|||
130308000|NCT00887549|469091086|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
130308001|NCT00887549|469091086|FG000|Maintenance Therapy|Adverse Event|16|||
130308002|NCT00887549|469091086|FG000|Maintenance Therapy|Physician Decision|1|||
130308003|NCT00887549|469091086|FG000|Maintenance Therapy|Progressive Disease|25|||
130308004|NCT00887549|469091086|FG000|Maintenance Therapy|Death due to adverse event|1|||
130308005|NCT03472950|469091090|FG000|Overall Study|Lost to Follow-up|0|||
129889488|NCT00946647|467552608|FG002|Phase ll Part|Protocol Violation|0|||
130049139|NCT01734993|468136655|FG000|Overall Study|Adverse Event|1|||
130308006|NCT03472950|469091091|FG001|Overall Study|Lost to Follow-up|1|||
130308007|NCT03472950|469091090|FG000|Overall Study|Adverse Event|0|||
130308008|NCT03472950|469091091|FG001|Overall Study|Adverse Event|3|||
130308009|NCT00377858|469091097|FG000|Overall Study|Withdrawal by Subject|12|||
130308010|NCT00377858|469091098|FG001|Overall Study|Withdrawal by Subject|11|||
130308011|NCT00377858|469091097|FG000|Overall Study|Lost to Follow-up|6|||
130308012|NCT00377858|469091098|FG001|Overall Study|Lost to Follow-up|1|||
130308013|NCT00377858|469091097|FG000|Overall Study|Physician Decision|5|||
130308014|NCT00377858|469091098|FG001|Overall Study|Physician Decision|5|||
130308015|NCT00377858|469091097|FG000|Overall Study|Protocol Violation|3|||
130308016|NCT00377858|469091098|FG001|Overall Study|Protocol Violation|4|||
130308017|NCT00377858|469091097|FG000|Overall Study|Adverse Event|2|||
130308018|NCT00377858|469091098|FG001|Overall Study|Adverse Event|1|||
130308019|NCT00377858|469091097|FG000|Overall Study|Entry Criteria Not Met|2|||
130308020|NCT00377858|469091098|FG001|Overall Study|Entry Criteria Not Met|0|||
130308021|NCT00377858|469091097|FG000|Overall Study|Sponsor Decision|1|||
130308022|NCT00377858|469091098|FG001|Overall Study|Sponsor Decision|2|||
130308023|NCT00377858|469091097|FG000|Overall Study|Death|0|||
130308024|NCT00377858|469091098|FG001|Overall Study|Death|3|||
130308025|NCT04034004|469091103|FG000|Overall Study|Withdrawal by Subject|1|||
130308026|NCT04034004|469091104|FG001|Overall Study|Withdrawal by Subject|2|||
130308027|NCT04034004|469091105|FG002|Overall Study|Withdrawal by Subject|2|||
130308028|NCT04034004|469091106|FG003|Overall Study|Withdrawal by Subject|3|||
130308029|NCT04034004|469091103|FG000|Overall Study|could not find vein to administer IV|2|||
130308030|NCT04034004|469091104|FG001|Overall Study|could not find vein to administer IV|1|||
130308031|NCT04034004|469091105|FG002|Overall Study|could not find vein to administer IV|0|||
130308032|NCT04034004|469091106|FG003|Overall Study|could not find vein to administer IV|0|||
130308033|NCT04034004|469091103|FG000|Overall Study|nurse accidentally unblinded subject|0|||
130308034|NCT04034004|469091104|FG001|Overall Study|nurse accidentally unblinded subject|0|||
130308035|NCT04034004|469091105|FG002|Overall Study|nurse accidentally unblinded subject|0|||
130308036|NCT04034004|469091106|FG003|Overall Study|nurse accidentally unblinded subject|1|||
130308037|NCT01502228|469091114|FG000|Overall Study|Death|1|||
130308038|NCT06964165|469091119|FG000|Overall Study|Withdrawal by Subject|0|||
130308039|NCT06964165|469091120|FG001|Overall Study|Withdrawal by Subject|1|||
130308040|NCT06964165|469091119|FG000|Overall Study|Ongoing at the time of analysis|15|||
130308041|NCT06964165|469091120|FG001|Overall Study|Ongoing at the time of analysis|14|||
130308042|NCT06964165|469091119|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
130308043|NCT06964165|469091120|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
130308044|NCT06964165|469091119|FG000|Overall Study|Participant removed due to non-compliance|0|||
130308045|NCT06964165|469091120|FG001|Overall Study|Participant removed due to non-compliance|1|||
130308046|NCT01514201|469091135|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
130308047|NCT01514201|469091136|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308048|NCT01514201|469091137|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308049|NCT01514201|469091138|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308050|NCT01514201|469091135|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308051|NCT01514201|469091136|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
130308052|NCT01514201|469091137|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
130308053|NCT01514201|469091138|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308054|NCT01514201|469091135|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
130308055|NCT01514201|469091136|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
130308056|NCT01514201|469091137|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
130308057|NCT01514201|469091138|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308058|NCT01514201|469091135|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
130308059|NCT01514201|469091136|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
130308060|NCT01514201|469091137|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308061|NCT01514201|469091138|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308062|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130308063|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130308064|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
130308065|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
130308066|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130308067|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130308068|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
130308069|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
130308070|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130308071|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130308072|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
130308073|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
130308074|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308075|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308076|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
130308077|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
130308078|NCT01514201|469091135|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130308079|NCT01514201|469091136|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130308080|NCT01514201|469091137|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
130308081|NCT01514201|469091138|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
130308082|NCT01514201|469091135|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308083|NCT01514201|469091136|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308084|NCT01514201|469091137|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
130308085|NCT01514201|469091138|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
130308086|NCT01514201|469091135|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308087|NCT01514201|469091136|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308088|NCT01514201|469091137|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
130308089|NCT01514201|469091138|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
130308090|NCT01514201|469091135|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308091|NCT01514201|469091136|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308092|NCT01514201|469091137|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
130308093|NCT01514201|469091138|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
130308094|NCT05888181|469091140|FG000|Overall Study|Lost to Follow-up|1|||
130308095|NCT05888181|469091141|FG001|Overall Study|Lost to Follow-up|1|||
130308096|NCT05888181|469091142|FG002|Overall Study|Lost to Follow-up|0|||
130308097|NCT02534909|469091149|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
130308098|NCT01625000|469091152|FG000|Overall Study|Physician Decision|15|||
130308099|NCT01625000|469091153|FG001|Overall Study|Physician Decision|7|||
130308100|NCT01625000|469091154|FG002|Overall Study|Physician Decision|7|||
130308101|NCT01625000|469091155|FG003|Overall Study|Physician Decision|2|||
130308102|NCT01625000|469091156|FG004|Overall Study|Physician Decision|15|||
130308103|NCT01625000|469091152|FG000|Overall Study|Protocol Violation|3|||
130308104|NCT01625000|469091153|FG001|Overall Study|Protocol Violation|10|||
130308105|NCT01625000|469091154|FG002|Overall Study|Protocol Violation|4|||
130308106|NCT01625000|469091155|FG003|Overall Study|Protocol Violation|1|||
130308107|NCT01625000|469091156|FG004|Overall Study|Protocol Violation|2|||
130308108|NCT01625000|469091152|FG000|Overall Study|Withdrawal by Subject|19|||
130308109|NCT01625000|469091153|FG001|Overall Study|Withdrawal by Subject|16|||
130308110|NCT01625000|469091154|FG002|Overall Study|Withdrawal by Subject|11|||
130308111|NCT01625000|469091155|FG003|Overall Study|Withdrawal by Subject|9|||
130308112|NCT01625000|469091156|FG004|Overall Study|Withdrawal by Subject|17|||
130308113|NCT01625000|469091152|FG000|Overall Study|Adverse Event (including Death)|15|||
130308114|NCT01625000|469091153|FG001|Overall Study|Adverse Event (including Death)|19|||
130308115|NCT01625000|469091154|FG002|Overall Study|Adverse Event (including Death)|11|||
130308116|NCT01625000|469091155|FG003|Overall Study|Adverse Event (including Death)|7|||
130308117|NCT01625000|469091156|FG004|Overall Study|Adverse Event (including Death)|21|||
130308118|NCT00577824|469091159|FG000|Overall Study|Adverse Event|6|||
130308119|NCT00577824|469091160|FG001|Overall Study|Adverse Event|18|||
130308120|NCT00577824|469091161|FG002|Overall Study|Adverse Event|1|||
130308121|NCT00577824|469091159|FG000|Overall Study|Patient decision|0|||
130308122|NCT00577824|469091160|FG001|Overall Study|Patient decision|1|||
130308123|NCT00577824|469091161|FG002|Overall Study|Patient decision|1|||
130308124|NCT00577824|469091159|FG000|Overall Study|Protocol Violation|1|||
130308125|NCT00577824|469091160|FG001|Overall Study|Protocol Violation|1|||
130308126|NCT00577824|469091161|FG002|Overall Study|Protocol Violation|0|||
130308127|NCT00362648|469091162|FG000|Overall Study|Adverse Event|12|||
129798185|NCT00089284|467229993|FG003|Overall Study|Adverse event before starting treatment|0|||
130308128|NCT00362648|469091163|FG001|Overall Study|Adverse Event|21|||
130308129|NCT00362648|469091164|FG002|Overall Study|Adverse Event|1|||
130308130|NCT00362648|469091165|FG003|Overall Study|Adverse Event|0|||
129798186|NCT00089284|467229994|FG004|Overall Study|Adverse event before starting treatment|0|||
129798187|NCT00089284|467229995|FG005|Overall Study|Adverse event before starting treatment|0|||
129798188|NCT00089284|467229996|FG006|Overall Study|Adverse event before starting treatment|1|||
129798189|NCT03646643|467230007|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
129798190|NCT03646643|467230008|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
129798191|NCT03646643|467230007|FG000|Overall Study|Lost to Follow-up|0|||
129798192|NCT03646643|467230008|FG001|Overall Study|Lost to Follow-up|1|||
129798193|NCT04131556|467230009|FG000|Overall Study|Adverse Event|1|||
129798194|NCT04131556|467230009|FG000|Overall Study|Withdrawal by Subject|1|||
130308131|NCT00362648|469091162|FG000|Overall Study|Lost to Follow-up|62|||
130308132|NCT00362648|469091163|FG001|Overall Study|Lost to Follow-up|69|||
130308133|NCT00362648|469091164|FG002|Overall Study|Lost to Follow-up|4|||
130308134|NCT00362648|469091165|FG003|Overall Study|Lost to Follow-up|3|||
130308135|NCT00362648|469091162|FG000|Overall Study|Protocol Violation|4|||
130308136|NCT00362648|469091163|FG001|Overall Study|Protocol Violation|2|||
130308137|NCT00362648|469091164|FG002|Overall Study|Protocol Violation|2|||
130308138|NCT00362648|469091165|FG003|Overall Study|Protocol Violation|2|||
130308139|NCT00362648|469091162|FG000|Overall Study|Withdrawal by Subject|48|||
130308140|NCT00362648|469091163|FG001|Overall Study|Withdrawal by Subject|42|||
130308141|NCT00362648|469091164|FG002|Overall Study|Withdrawal by Subject|2|||
130308142|NCT00362648|469091165|FG003|Overall Study|Withdrawal by Subject|6|||
130308143|NCT03983304|469091166|FG000|Overall Study|Withdrawal by Subject|5|||
130308144|NCT03983304|469091166|FG000|Overall Study|Lost to Follow-up|2|||
130308145|NCT01518374|469091169|FG000|Overall Study|Withdrawal by Subject|2|||
130308146|NCT01518374|469091169|FG000|Overall Study|Protocol Violation|3|||
130308147|NCT01518374|469091169|FG000|Overall Study|Lost to Follow-up|2|||
130308148|NCT04300309|469091170|FG000|Overall Study|Lost to Follow-up|1|||
130308149|NCT04300309|469091171|FG001|Overall Study|Lost to Follow-up|0|||
130308150|NCT02362464|469091174|FG000|Overall Study|Switched to alternative therapy|1|||
130308151|NCT02362464|469091174|FG000|Overall Study|Refused further treatment|1|||
130308152|NCT02362464|469091174|FG000|Overall Study|Physician Decision|4|||
130308153|NCT04752332|469091175|FG000|Overall Study|Adverse Event|3|||
130308154|NCT04752332|469091176|FG001|Overall Study|Adverse Event|1|||
130308155|NCT04752332|469091175|FG000|Overall Study|Disease Relapse|1|||
130308156|NCT04752332|469091176|FG001|Overall Study|Disease Relapse|0|||
130308157|NCT04752332|469091175|FG000|Overall Study|Non-compliance With Study Drug|2|||
130308158|NCT04752332|469091176|FG001|Overall Study|Non-compliance With Study Drug|0|||
130308159|NCT04752332|469091175|FG000|Overall Study|Physician Decision|2|||
130308160|NCT04752332|469091176|FG001|Overall Study|Physician Decision|1|||
130308161|NCT04752332|469091175|FG000|Overall Study|Protocol Violation|1|||
130308162|NCT04752332|469091176|FG001|Overall Study|Protocol Violation|1|||
130308163|NCT04752332|469091175|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
130308164|NCT04752332|469091176|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
130308165|NCT04752332|469091175|FG000|Overall Study|Study Terminated by Sponsor|10|||
130308166|NCT04752332|469091176|FG001|Overall Study|Study Terminated by Sponsor|48|||
130308167|NCT04752332|469091175|FG000|Overall Study|Withdrawal by Subject|11|||
130308168|NCT04752332|469091176|FG001|Overall Study|Withdrawal by Subject|3|||
130308169|NCT00048347|469091177|FG000|Overall Study|Screen failure|2|||
130308170|NCT02058563|469091178|FG000|Overall Study|Lost to Follow-up|26|||
130308171|NCT02058563|469091179|FG001|Overall Study|Lost to Follow-up|22|||
130308172|NCT02058563|469091178|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
130308173|NCT02058563|469091179|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
130308174|NCT02058563|469091178|FG000|Overall Study|Consent Withdrawal|1|||
130308175|NCT02058563|469091179|FG001|Overall Study|Consent Withdrawal|1|||
130308176|NCT02058563|469091178|FG000|Overall Study|Other (patient incarcerated)|0|||
130308177|NCT02058563|469091179|FG001|Overall Study|Other (patient incarcerated)|1|||
130308178|NCT04039217|469091180|FG000|Overall Study|Lost to Follow-up|1|||
130308179|NCT04522141|469091181|FG000|Overall Study|Withdrawal by Subject|1|||
130308180|NCT04522141|469091182|FG001|Overall Study|Withdrawal by Subject|0|||
129798195|NCT04060862|467230012|FG000|Overall Study|Symptomatic Deterioration|1|||
130049140|NCT01734993|468136655|FG000|Overall Study|Lack of Efficacy|1|||
130308181|NCT03508609|469091183|FG000|Overall Study|Withdrawal by Subject|1|||
130308182|NCT00555217|469091184|FG000|Overall Study|Withdrawal by Subject|35|||
130308183|NCT00555217|469091185|FG001|Overall Study|Withdrawal by Subject|31|||
130308184|NCT00555217|469091184|FG000|Overall Study|Lost to Follow-up|19|||
130308185|NCT00555217|469091185|FG001|Overall Study|Lost to Follow-up|20|||
130308186|NCT00555217|469091184|FG000|Overall Study|close out sites|21|||
130308187|NCT00555217|469091185|FG001|Overall Study|close out sites|17|||
130308188|NCT01868477|469091186|FG000|Overall Study|Adverse Event|2|||
130308189|NCT01868477|469091187|FG001|Overall Study|Adverse Event|4|||
130308190|NCT01868477|469091186|FG000|Overall Study|Disease progression|1|||
130308191|NCT01868477|469091187|FG001|Overall Study|Disease progression|1|||
130308192|NCT01868477|469091186|FG000|Overall Study|Withdrawal by Subject|1|||
130308193|NCT01868477|469091187|FG001|Overall Study|Withdrawal by Subject|0|||
130308194|NCT00367835|469091190|FG000|Overall Study|Adverse Event|14|||
130308195|NCT00367835|469091191|FG001|Overall Study|Adverse Event|1|||
130049141|NCT01455428|468136659|FG000|Overall Study|Protocol Violation|2|||
130308196|NCT00367835|469091190|FG000|Overall Study|Protocol Violation|1|||
130308197|NCT00367835|469091191|FG001|Overall Study|Protocol Violation|7|||
130308198|NCT00367835|469091190|FG000|Overall Study|Withdrawal by Subject|7|||
130308199|NCT00367835|469091191|FG001|Overall Study|Withdrawal by Subject|6|||
130308200|NCT00367835|469091190|FG000|Overall Study|Lost to Follow-up|1|||
130308201|NCT00367835|469091191|FG001|Overall Study|Lost to Follow-up|4|||
130308202|NCT00367835|469091190|FG000|Overall Study|Lack of Efficacy|3|||
130308203|NCT00367835|469091191|FG001|Overall Study|Lack of Efficacy|12|||
130308204|NCT00367835|469091190|FG000|Overall Study|Subject in juvenile detention center|1|||
130308205|NCT00367835|469091191|FG001|Overall Study|Subject in juvenile detention center|0|||
130308206|NCT00367835|469091190|FG000|Overall Study|refused blood collection|1|||
130308207|NCT00367835|469091191|FG001|Overall Study|refused blood collection|0|||
130308208|NCT00367835|469091190|FG000|Overall Study|Did not respond to calls|1|||
130308209|NCT00367835|469091191|FG001|Overall Study|Did not respond to calls|0|||
130308210|NCT00367835|469091190|FG000|Overall Study|History of lead poisoning|0|||
130308211|NCT00367835|469091191|FG001|Overall Study|History of lead poisoning|1|||
130308212|NCT03761810|469091193|FG000|Overall Study|Adverse Event|12|||
130308213|NCT03761810|469091194|FG001|Overall Study|Adverse Event|0|||
130308214|NCT03761810|469091193|FG000|Overall Study|Lost to Follow-up|15|||
130308215|NCT03761810|469091194|FG001|Overall Study|Lost to Follow-up|7|||
130308216|NCT03761810|469091193|FG000|Overall Study|Pregnancy|1|||
130308217|NCT03761810|469091194|FG001|Overall Study|Pregnancy|0|||
130308218|NCT03761810|469091193|FG000|Overall Study|Withdrawal by Subject|14|||
130308219|NCT03761810|469091194|FG001|Overall Study|Withdrawal by Subject|5|||
130308220|NCT03761810|469091193|FG000|Overall Study|Physician Decision|1|||
130308221|NCT03761810|469091194|FG001|Overall Study|Physician Decision|0|||
130308222|NCT03761810|469091193|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
130308223|NCT03761810|469091194|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130308224|NCT03761810|469091193|FG000|Overall Study|Other Than Specified|1|||
130308225|NCT03761810|469091194|FG001|Overall Study|Other Than Specified|0|||
130308226|NCT01574651|469091195|FG000|Overall Study|Lost to Follow-up|2|||
130308227|NCT01574651|469091196|FG001|Overall Study|Lost to Follow-up|4|||
130308228|NCT01574651|469091195|FG000|Overall Study|Administrative problems|0|||
130308229|NCT01574651|469091196|FG001|Overall Study|Administrative problems|1|||
130308230|NCT01574651|469091195|FG000|Overall Study|Death|3|||
130308231|NCT01574651|469091196|FG001|Overall Study|Death|3|||
130308232|NCT01574651|469091195|FG000|Overall Study|Patient's inability to use the device|0|||
130308233|NCT01574651|469091196|FG001|Overall Study|Patient's inability to use the device|1|||
130308234|NCT01574651|469091195|FG000|Overall Study|Adverse Event|36|||
130308235|NCT01574651|469091196|FG001|Overall Study|Adverse Event|27|||
130308236|NCT01574651|469091195|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130308237|NCT01574651|469091196|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130308238|NCT01574651|469091195|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130308239|NCT01574651|469091196|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130308240|NCT01574651|469091195|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
130308241|NCT01574651|469091196|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130308242|NCT01574651|469091195|FG000|Overall Study|Protocol Violation|3|||
130308243|NCT01574651|469091196|FG001|Overall Study|Protocol Violation|5|||
130308244|NCT01574651|469091195|FG000|Overall Study|Withdrawal by Subject|9|||
130308245|NCT01574651|469091196|FG001|Overall Study|Withdrawal by Subject|10|||
130308246|NCT03887221|469091197|FG000|Overall Study|Protocol Violation|1|||
130308247|NCT03887221|469091198|FG001|Overall Study|Protocol Violation|0|||
130308248|NCT02092025|469091199|FG000|Overall Study|Case Report Forms Uncollected|44|||
130308249|NCT02092025|469091199|FG000|Overall Study|Protocol Deviation|24|||
130308250|NCT03228212|469091201|FG000|Period 1|Adverse Event|1|||
130308251|NCT03228212|469091202|FG001|Period 1|Adverse Event|0|||
130308252|NCT03228212|469091201|FG000|Period 1|no longer meets eligibility criteria|0|||
130308253|NCT03228212|469091202|FG001|Period 1|no longer meets eligibility criteria|1|||
130308254|NCT03228212|469091201|FG000|Period 2|Lost to Follow-up|1|||
130308255|NCT03228212|469091202|FG001|Period 2|Lost to Follow-up|0|||
130308256|NCT01807299|469091203|FG000|Overall Study|Protocol Violation|3|||
130308257|NCT01807299|469091204|FG001|Overall Study|Protocol Violation|1|||
130308258|NCT01807299|469091205|FG002|Overall Study|Protocol Violation|0|||
130308259|NCT01807299|469091206|FG003|Overall Study|Protocol Violation|2|||
130308260|NCT00811174|469091207|FG000|Overall Study|Protocol Violation|2|||
130308261|NCT00811174|469091207|FG000|Overall Study|Sponsors Decision|1|||
130308262|NCT02451943|469092278|FG000|Overall Study|Withdrawal by Subject|13|||
130308263|NCT02451943|469092279|FG001|Overall Study|Withdrawal by Subject|16|||
130308264|NCT02451943|469092278|FG000|Overall Study|Lost to Follow-up|3|||
130308265|NCT02451943|469092279|FG001|Overall Study|Lost to Follow-up|4|||
130308266|NCT02451943|469092278|FG000|Overall Study|Sponsor Decision|0|||
130308267|NCT02451943|469092279|FG001|Overall Study|Sponsor Decision|4|||
130308268|NCT01101035|469092281|FG000|Overall Study|Adverse Event|191|||
130308269|NCT01101035|469092282|FG001|Overall Study|Adverse Event|172|||
130308270|NCT01101035|469092281|FG000|Overall Study|Major Protocol Deviation|52|||
130308271|NCT01101035|469092282|FG001|Overall Study|Major Protocol Deviation|46|||
130308272|NCT01101035|469092281|FG000|Overall Study|Lost to Follow-up|226|||
130308273|NCT01101035|469092282|FG001|Overall Study|Lost to Follow-up|223|||
130308274|NCT01101035|469092281|FG000|Overall Study|Voluntary Withdrawal|595|||
130308275|NCT01101035|469092282|FG001|Overall Study|Voluntary Withdrawal|587|||
130308276|NCT01101035|469092281|FG000|Overall Study|Reason not Specified|333|||
130308277|NCT01101035|469092282|FG001|Overall Study|Reason not Specified|363|||
130308278|NCT00681629|469092283|FG000|Overall Study|Study termination|4|||
130308279|NCT00681629|469092284|FG001|Overall Study|Study termination|2|||
130308280|NCT00681629|469092283|FG000|Overall Study|Adverse Event|1|||
130308281|NCT00681629|469092284|FG001|Overall Study|Adverse Event|0|||
130308282|NCT01510158|469092292|FG000|Overall Study|Adverse Event|7|||
130308283|NCT01510158|469092293|FG001|Overall Study|Adverse Event|8|||
130308284|NCT01510158|469092294|FG002|Overall Study|Adverse Event|5|||
130308285|NCT01510158|469092292|FG000|Overall Study|Gout flare|1|||
130308286|NCT01510158|469092293|FG001|Overall Study|Gout flare|0|||
130308287|NCT01510158|469092294|FG002|Overall Study|Gout flare|0|||
130308288|NCT01510158|469092292|FG000|Overall Study|Protocol Violation|17|||
130308289|NCT01510158|469092293|FG001|Overall Study|Protocol Violation|16|||
130308290|NCT01510158|469092294|FG002|Overall Study|Protocol Violation|24|||
130308291|NCT01510158|469092292|FG000|Overall Study|Sponsor terminated study.|2|||
130308292|NCT01510158|469092293|FG001|Overall Study|Sponsor terminated study.|0|||
130308293|NCT01510158|469092294|FG002|Overall Study|Sponsor terminated study.|2|||
130308294|NCT01510158|469092292|FG000|Overall Study|Lost to Follow-up|13|||
130308295|NCT01510158|469092293|FG001|Overall Study|Lost to Follow-up|16|||
130308296|NCT01510158|469092294|FG002|Overall Study|Lost to Follow-up|9|||
130308297|NCT01510158|469092292|FG000|Overall Study|Withdrawal by Subject|10|||
130308298|NCT01510158|469092293|FG001|Overall Study|Withdrawal by Subject|13|||
130308299|NCT01510158|469092294|FG002|Overall Study|Withdrawal by Subject|10|||
130308300|NCT01510158|469092292|FG000|Overall Study|Death|1|||
130308301|NCT01510158|469092293|FG001|Overall Study|Death|0|||
130308302|NCT01510158|469092294|FG002|Overall Study|Death|0|||
130308303|NCT01442714|469092296|FG000|Overall Study|Death|11|||
130308304|NCT01442714|469092296|FG000|Overall Study|Withdrawal by Subject|1|||
130308305|NCT03314987|469092297|FG000|Overall Study|Lost to Follow-up|13|||
130308306|NCT03314987|469092298|FG001|Overall Study|Lost to Follow-up|13|||
130308307|NCT02751580|469092299|FG000|Overall Study|Lost to Follow-up|4|||
130308308|NCT02751580|469092299|FG000|Overall Study|Death|2|||
130308309|NCT04829916|469092303|FG000|Overall Study|Withdrawal by Subject|1|||
130049142|NCT01455428|468136660|FG001|Overall Study|Protocol Violation|1|||
130049143|NCT01455428|468136659|FG000|Overall Study|Adverse Event|6|||
130049144|NCT01455428|468136660|FG001|Overall Study|Adverse Event|2|||
130308310|NCT04829916|469092304|FG001|Overall Study|Withdrawal by Subject|0|||
130049145|NCT01455428|468136659|FG000|Overall Study|Lost to Follow-up|1|||
130049146|NCT01455428|468136660|FG001|Overall Study|Lost to Follow-up|1|||
130308311|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Technical problems|0|||
130308312|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Technical problems|0|||
130308313|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Technical problems|0|||
130308314|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Technical problems|1|||
130308315|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130308316|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
130308317|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130308318|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
130308319|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
130308320|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
130308321|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
130308322|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
130308323|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
130308324|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
130308325|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
129798196|NCT04060862|467230012|FG000|Overall Study|Un-specified|6|||
129798197|NCT04060862|467230012|FG000|Overall Study|Progressive disease|12|||
129798198|NCT04060862|467230012|FG000|Overall Study|Physician Decision|1|||
130308326|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
130308327|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Death|0|||
130308328|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Death|3|||
130308329|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Death|1|||
130308330|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Death|0|||
130308331|NCT02152761|469092311|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
130308332|NCT02152761|469092312|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
130308333|NCT02152761|469092313|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
130308334|NCT02152761|469092314|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
130308335|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
130308336|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
130308337|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
130308338|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
130308339|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
130308340|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
130308341|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
130308342|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
130308343|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
130308344|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130308345|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130308346|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
130308347|NCT02152761|469092311|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
130308348|NCT02152761|469092312|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
130308349|NCT02152761|469092313|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
130308350|NCT02152761|469092314|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
130308351|NCT04343755|469092315|FG000|Overall Study|Death|11|||
130308352|NCT04343755|469092315|FG000|Overall Study|Screen Failure|1|||
130308353|NCT03755882|469092316|FG000|Period 1|Protocol Violation|1|||
130308354|NCT03755882|469092317|FG001|Period 1|Protocol Violation|0|||
130308355|NCT03755882|469092316|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
130308356|NCT03755882|469092317|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
130308357|NCT02292446|469092318|FG000|Overall Study|Adverse Event|12|||
130308358|NCT02292446|469092318|FG000|Overall Study|Death|1|||
130308359|NCT02292446|469092318|FG000|Overall Study|Disease progression|2|||
130308360|NCT02292446|469092318|FG000|Overall Study|Subject/guardian decision|2|||
130308361|NCT02292446|469092318|FG000|Overall Study|Withdrawal by Subject|3|||
130308362|NCT01290757|469092321|FG000|Overall Study|Adverse Event|1|||
130308363|NCT01290757|469092322|FG001|Overall Study|Adverse Event|0|||
130308364|NCT01290757|469092321|FG000|Overall Study|Protocol Violation|1|||
130308365|NCT01290757|469092322|FG001|Overall Study|Protocol Violation|1|||
130308366|NCT01290757|469092321|FG000|Overall Study|Other|0|||
130308367|NCT01290757|469092322|FG001|Overall Study|Other|1|||
130308368|NCT03329846|469092324|FG000|Overall Study|Disease progression|4|||
130308369|NCT03329846|469092325|FG001|Overall Study|Disease progression|6|||
130308370|NCT03329846|469092324|FG000|Overall Study|Study drug toxicity|1|||
130308371|NCT03329846|469092325|FG001|Overall Study|Study drug toxicity|0|||
130308372|NCT03329846|469092324|FG000|Overall Study|Participant request to discontinue treatment|0|||
130308373|NCT03329846|469092325|FG001|Overall Study|Participant request to discontinue treatment|1|||
130308374|NCT03329846|469092324|FG000|Overall Study|Participant withdrew consent|1|||
130308375|NCT03329846|469092325|FG001|Overall Study|Participant withdrew consent|0|||
130308376|NCT03329846|469092324|FG000|Overall Study|Other reasons|2|||
130308377|NCT03329846|469092325|FG001|Overall Study|Other reasons|2|||
130308378|NCT00479336|469092326|FG000|Overall Study|Adverse Event|1|||
130308379|NCT00479336|469092327|FG001|Overall Study|Adverse Event|1|||
130308380|NCT00479336|469092328|FG002|Overall Study|Adverse Event|1|||
130308381|NCT00479336|469092329|FG003|Overall Study|Adverse Event|3|||
130308382|NCT00479336|469092326|FG000|Overall Study|Lack of Efficacy|1|||
130308383|NCT00479336|469092327|FG001|Overall Study|Lack of Efficacy|0|||
130308384|NCT00479336|469092328|FG002|Overall Study|Lack of Efficacy|0|||
130308385|NCT00479336|469092329|FG003|Overall Study|Lack of Efficacy|0|||
130308386|NCT00479336|469092326|FG000|Overall Study|Protocol Violation|0|||
130308387|NCT00479336|469092327|FG001|Overall Study|Protocol Violation|1|||
130308388|NCT00479336|469092328|FG002|Overall Study|Protocol Violation|0|||
130308389|NCT00479336|469092329|FG003|Overall Study|Protocol Violation|0|||
130308390|NCT00479336|469092326|FG000|Overall Study|Withdrawal by Subject|1|||
130308391|NCT00479336|469092327|FG001|Overall Study|Withdrawal by Subject|2|||
129798199|NCT01052844|467230017|FG000|Overall Study|Adverse Event|0|||
129798200|NCT01052844|467230018|FG001|Overall Study|Adverse Event|1|||
130308392|NCT00479336|469092328|FG002|Overall Study|Withdrawal by Subject|0|||
130308393|NCT00479336|469092329|FG003|Overall Study|Withdrawal by Subject|0|||
130308394|NCT00479336|469092326|FG000|Overall Study|Physician Decision|0|||
130308395|NCT00479336|469092327|FG001|Overall Study|Physician Decision|1|||
130308396|NCT00479336|469092328|FG002|Overall Study|Physician Decision|0|||
130308397|NCT00479336|469092329|FG003|Overall Study|Physician Decision|2|||
130308398|NCT00479336|469092326|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
130308399|NCT00479336|469092327|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
130308400|NCT00479336|469092328|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
130308401|NCT00479336|469092329|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
130308402|NCT03066193|469092330|FG000|Overall Study|Withdrawal by Subject|1|||
130308403|NCT02021643|469092331|FG000|Overall Study|Enrolled but Never Treated|1|||
130308404|NCT02021643|469092332|FG001|Overall Study|Enrolled but Never Treated|0|||
130308405|NCT02021643|469092333|FG002|Overall Study|Enrolled but Never Treated|0|||
130308406|NCT02021643|469092334|FG003|Overall Study|Enrolled but Never Treated|0|||
130308407|NCT02021643|469092331|FG000|Overall Study|Adverse Event|0|||
130308408|NCT02021643|469092332|FG001|Overall Study|Adverse Event|1|||
130308409|NCT02021643|469092333|FG002|Overall Study|Adverse Event|0|||
130308410|NCT02021643|469092334|FG003|Overall Study|Adverse Event|0|||
130308411|NCT02021643|469092331|FG000|Overall Study|Death|0|||
130308412|NCT02021643|469092332|FG001|Overall Study|Death|1|||
130308413|NCT02021643|469092333|FG002|Overall Study|Death|0|||
130308414|NCT02021643|469092334|FG003|Overall Study|Death|0|||
130308415|NCT02021643|469092331|FG000|Overall Study|Investigator's Discretion|1|||
130308416|NCT02021643|469092332|FG001|Overall Study|Investigator's Discretion|0|||
130308417|NCT02021643|469092333|FG002|Overall Study|Investigator's Discretion|0|||
130308418|NCT02021643|469092334|FG003|Overall Study|Investigator's Discretion|0|||
130308419|NCT02021643|469092331|FG000|Overall Study|Lack of Efficacy|7|||
130308420|NCT02021643|469092332|FG001|Overall Study|Lack of Efficacy|6|||
130308421|NCT02021643|469092333|FG002|Overall Study|Lack of Efficacy|0|||
130308422|NCT02021643|469092334|FG003|Overall Study|Lack of Efficacy|12|||
130308423|NCT02021643|469092331|FG000|Overall Study|Lost to Follow-up|0|||
130308424|NCT02021643|469092332|FG001|Overall Study|Lost to Follow-up|1|||
130308425|NCT02021643|469092333|FG002|Overall Study|Lost to Follow-up|0|||
130308426|NCT02021643|469092334|FG003|Overall Study|Lost to Follow-up|0|||
130308427|NCT02021643|469092331|FG000|Overall Study|Withdrew Consent|0|||
130308428|NCT02021643|469092332|FG001|Overall Study|Withdrew Consent|1|||
130308429|NCT02021643|469092333|FG002|Overall Study|Withdrew Consent|0|||
130308430|NCT02021643|469092334|FG003|Overall Study|Withdrew Consent|0|||
130308431|NCT04854551|469092335|FG000|Overall Study|Withdrawal by Subject|1|||
130308432|NCT04854551|469092336|FG001|Overall Study|Withdrawal by Subject|1|||
130308433|NCT02631551|469092337|FG000|Overall Study|Adverse Event|1|||
130308434|NCT02631551|469092338|FG001|Overall Study|Adverse Event|2|||
130308435|NCT02631551|469092339|FG002|Overall Study|Adverse Event|4|||
130308436|NCT02631551|469092340|FG003|Overall Study|Adverse Event|0|||
130308437|NCT02631551|469092337|FG000|Overall Study|Lack of Efficacy|0|||
130308438|NCT02631551|469092338|FG001|Overall Study|Lack of Efficacy|0|||
130308439|NCT02631551|469092339|FG002|Overall Study|Lack of Efficacy|1|||
130308440|NCT02631551|469092340|FG003|Overall Study|Lack of Efficacy|0|||
130308441|NCT02631551|469092337|FG000|Overall Study|Lost to Follow-up|1|||
130308442|NCT02631551|469092338|FG001|Overall Study|Lost to Follow-up|2|||
130308443|NCT02631551|469092339|FG002|Overall Study|Lost to Follow-up|0|||
130308444|NCT02631551|469092340|FG003|Overall Study|Lost to Follow-up|3|||
130308445|NCT02631551|469092337|FG000|Overall Study|Withdrawal by Subject|2|||
130308446|NCT02631551|469092338|FG001|Overall Study|Withdrawal by Subject|2|||
130308447|NCT02631551|469092339|FG002|Overall Study|Withdrawal by Subject|0|||
130308448|NCT02631551|469092340|FG003|Overall Study|Withdrawal by Subject|5|||
130308449|NCT02631551|469092337|FG000|Overall Study|Protocol deviation|3|||
130308450|NCT02631551|469092338|FG001|Overall Study|Protocol deviation|6|||
130308451|NCT02631551|469092339|FG002|Overall Study|Protocol deviation|3|||
130308452|NCT02631551|469092340|FG003|Overall Study|Protocol deviation|0|||
130308453|NCT02631551|469092337|FG000|Overall Study|Non-compliance with study procedures|0|||
129798201|NCT02545075|467230019|FG000|Randomization|Lost to Follow-up|0|||
129798202|NCT02545075|467230020|FG001|Randomization|Lost to Follow-up|1|||
129798203|NCT02545075|467230019|FG000|Randomization|Withdrawal by Subject|0|||
129798204|NCT02545075|467230020|FG001|Randomization|Withdrawal by Subject|6|||
129798205|NCT02545075|467230019|FG000|Treatment|Disease progression|71|||
129798206|NCT02545075|467230020|FG001|Treatment|Disease progression|32|||
130308454|NCT02631551|469092338|FG001|Overall Study|Non-compliance with study procedures|0|||
130308455|NCT02631551|469092339|FG002|Overall Study|Non-compliance with study procedures|1|||
129798207|NCT02545075|467230019|FG000|Treatment|Participant dicontinued study treatment|7|||
129889489|NCT00946647|467552609|FG003|Phase ll Part|Protocol Violation|4|||
130308456|NCT02631551|469092340|FG003|Overall Study|Non-compliance with study procedures|1|||
130308457|NCT02631551|469092337|FG000|Overall Study|Non-compliance with study drug|1|||
130308458|NCT02631551|469092338|FG001|Overall Study|Non-compliance with study drug|0|||
130308459|NCT02631551|469092339|FG002|Overall Study|Non-compliance with study drug|0|||
130308460|NCT02631551|469092340|FG003|Overall Study|Non-compliance with study drug|0|||
130308461|NCT02631551|469092337|FG000|Overall Study|Other, specific reasons not collected|5|||
130308462|NCT02631551|469092338|FG001|Overall Study|Other, specific reasons not collected|7|||
130308463|NCT02631551|469092339|FG002|Overall Study|Other, specific reasons not collected|2|||
129798208|NCT02545075|467230020|FG001|Treatment|Participant dicontinued study treatment|9|||
129798209|NCT02545075|467230019|FG000|Treatment|Withdrawal by Subject|1|||
130049147|NCT01455428|468136659|FG000|Overall Study|Withdrawal by Subject|2|||
130308464|NCT02631551|469092340|FG003|Overall Study|Other, specific reasons not collected|2|||
130308465|NCT04112303|469092341|FG000|Overall Study|Death|1|||
130308466|NCT05636852|469092349|FG000|Overall Study|Withdrawal by Subject|1|||
130308467|NCT05636852|469092349|FG000|Overall Study|Other than specified|1|||
130308468|NCT01076036|469092350|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
130308469|NCT03088917|469092351|FG000|Overall Study|In care/cured elsewhere|15|||
130308470|NCT03088917|469092351|FG000|Overall Study|Refuse re-evaluation|13|||
130308471|NCT03088917|469092351|FG000|Overall Study|Contact not established|13|||
130308472|NCT03088917|469092351|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
130308473|NCT03088917|469092351|FG000|Overall Study|Moved outside study region|50|||
130308474|NCT01221350|469092352|FG000|Overall Study|Discontinued intervention (GERD)|1|||
130308475|NCT01221350|469092353|FG001|Overall Study|Discontinued intervention (GERD)|0|||
130308476|NCT01221350|469092352|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
130308477|NCT01221350|469092353|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
130308478|NCT01221350|469092352|FG000|Overall Study|Withdrawal by Subject|4|||
130308479|NCT01221350|469092353|FG001|Overall Study|Withdrawal by Subject|2|||
130308480|NCT02735343|469092357|FG000|Overall Study|screen fail|0|||
130308481|NCT02735343|469092358|FG001|Overall Study|screen fail|2|||
130308482|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
130308483|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
130308484|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
130308485|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
130308486|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
130308487|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
130308488|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
130308489|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
130308490|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
130308491|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
130308492|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
130308493|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
130308494|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
130308495|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
130308496|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
130308497|NCT02204072|469092362|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308498|NCT02204072|469092363|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308499|NCT02204072|469092364|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
130308500|NCT02204072|469092365|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308501|NCT02204072|469092366|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
130308502|NCT04209205|469092370|FG000|Overall Study|Adverse Event|2|||
130308503|NCT04209205|469092371|FG001|Overall Study|Adverse Event|3|||
130308504|NCT04209205|469092370|FG000|Overall Study|Lost to Follow-up|3|||
130308505|NCT04209205|469092371|FG001|Overall Study|Lost to Follow-up|1|||
130308506|NCT04209205|469092370|FG000|Overall Study|Physician Decision|1|||
130308507|NCT04209205|469092371|FG001|Overall Study|Physician Decision|1|||
130308508|NCT04209205|469092370|FG000|Overall Study|Subject decision|10|||
130308509|NCT04209205|469092371|FG001|Overall Study|Subject decision|10|||
130308510|NCT04209205|469092370|FG000|Overall Study|Progressive disease|1|||
130308511|NCT04209205|469092371|FG001|Overall Study|Progressive disease|0|||
130308512|NCT04209205|469092370|FG000|Overall Study|Protocol deviation|0|||
130308513|NCT04209205|469092371|FG001|Overall Study|Protocol deviation|1|||
130308514|NCT04209205|469092370|FG000|Overall Study|New therapy for study indication|1|||
130308515|NCT04209205|469092371|FG001|Overall Study|New therapy for study indication|0|||
130308516|NCT04209205|469092370|FG000|Overall Study|Adverse event - placebo not switched|0|||
130308517|NCT04209205|469092371|FG001|Overall Study|Adverse event - placebo not switched|1|||
130308518|NCT04209205|469092370|FG000|Overall Study|Subject decision - placebo not switched|0|||
130049148|NCT01455428|468136660|FG001|Overall Study|Withdrawal by Subject|5|||
130308519|NCT04209205|469092371|FG001|Overall Study|Subject decision - placebo not switched|5|||
130308520|NCT04209205|469092370|FG000|Overall Study|Death - placebo not switched|0|||
130308521|NCT04209205|469092371|FG001|Overall Study|Death - placebo not switched|1|||
130308522|NCT03197376|469092372|FG000|Primary and Booster Phase|Adverse Event|0|||
130308523|NCT03197376|469092373|FG001|Primary and Booster Phase|Adverse Event|0|||
130049149|NCT01455428|468136659|FG000|Overall Study|Did not meet entrance criteria|0|||
130308524|NCT03197376|469092374|FG002|Primary and Booster Phase|Adverse Event|0|||
130308525|NCT03197376|469092375|FG003|Primary and Booster Phase|Adverse Event|1|||
130308526|NCT03197376|469092372|FG000|Primary and Booster Phase|Death|1|||
130049150|NCT01455428|468136660|FG001|Overall Study|Did not meet entrance criteria|2|||
130308527|NCT03197376|469092373|FG001|Primary and Booster Phase|Death|0|||
129798210|NCT02545075|467230020|FG001|Treatment|Withdrawal by Subject|0|||
129798211|NCT02545075|467230019|FG000|Treatment|Adverse event not related to study drug|1|||
130308528|NCT03197376|469092374|FG002|Primary and Booster Phase|Death|0|||
130308529|NCT03197376|469092375|FG003|Primary and Booster Phase|Death|2|||
130308530|NCT03197376|469092372|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
130308531|NCT03197376|469092373|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
130308532|NCT03197376|469092374|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
130308533|NCT03197376|469092375|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
130308534|NCT03197376|469092372|FG000|Primary and Booster Phase|Physician Decision|1|||
130308535|NCT03197376|469092373|FG001|Primary and Booster Phase|Physician Decision|0|||
130308536|NCT03197376|469092374|FG002|Primary and Booster Phase|Physician Decision|1|||
130308537|NCT03197376|469092375|FG003|Primary and Booster Phase|Physician Decision|3|||
130308538|NCT03197376|469092372|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
130308539|NCT03197376|469092373|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
130308540|NCT03197376|469092374|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
130308541|NCT03197376|469092375|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
130308542|NCT03197376|469092372|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
130308543|NCT03197376|469092373|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
130308544|NCT03197376|469092374|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
130308545|NCT03197376|469092375|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
130308546|NCT03197376|469092372|FG000|Primary and Booster Phase|Not vaccine related|1|||
130308547|NCT03197376|469092373|FG001|Primary and Booster Phase|Not vaccine related|2|||
130308548|NCT03197376|469092374|FG002|Primary and Booster Phase|Not vaccine related|0|||
130308549|NCT03197376|469092375|FG003|Primary and Booster Phase|Not vaccine related|6|||
130308550|NCT03197376|469092372|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
130308551|NCT03197376|469092373|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
130308552|NCT03197376|469092374|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
130308553|NCT03197376|469092375|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
130308554|NCT03197376|469092372|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
130308555|NCT03197376|469092373|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
130308556|NCT03197376|469092374|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
130308557|NCT03197376|469092375|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
130308558|NCT03197376|469092372|FG000|Immune Persistence Phase|Not vaccine related|1|||
130308559|NCT03197376|469092373|FG001|Immune Persistence Phase|Not vaccine related|0|||
130308560|NCT03197376|469092374|FG002|Immune Persistence Phase|Not vaccine related|1|||
130308561|NCT03197376|469092375|FG003|Immune Persistence Phase|Not vaccine related|1|||
130308562|NCT01123395|469092376|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
130308563|NCT01123395|469092377|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
130308564|NCT03691571|469092378|FG000|Overall Study|Withdrawal by Subject|9|||
130308565|NCT03691571|469092379|FG001|Overall Study|Withdrawal by Subject|2|||
130308566|NCT00186901|469092382|FG000|Overall Study|Pregnancy|6|||
130308567|NCT00186901|469092383|FG001|Overall Study|Pregnancy|3|||
130308568|NCT00186901|469092384|FG002|Overall Study|Pregnancy|0|||
130308569|NCT00186901|469092382|FG000|Overall Study|Lost to Follow-up|6|||
130308570|NCT00186901|469092383|FG001|Overall Study|Lost to Follow-up|3|||
130308571|NCT00186901|469092384|FG002|Overall Study|Lost to Follow-up|0|||
130308572|NCT00186901|469092382|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
130308573|NCT00186901|469092383|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
130308574|NCT00186901|469092384|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
130308575|NCT00186901|469092382|FG000|Overall Study|ALL relapse or second malignancy|1|||
130308576|NCT00186901|469092383|FG001|Overall Study|ALL relapse or second malignancy|2|||
130308577|NCT00186901|469092384|FG002|Overall Study|ALL relapse or second malignancy|0|||
130308578|NCT00186901|469092382|FG000|Overall Study|Withdrawal by Subject|4|||
130308579|NCT00186901|469092383|FG001|Overall Study|Withdrawal by Subject|5|||
130308580|NCT00186901|469092384|FG002|Overall Study|Withdrawal by Subject|0|||
130308581|NCT00186901|469092382|FG000|Overall Study|Open label|3|||
130308582|NCT00186901|469092383|FG001|Overall Study|Open label|2|||
130308583|NCT00186901|469092384|FG002|Overall Study|Open label|0|||
130308584|NCT00186901|469092382|FG000|Overall Study|Limited adherence to study requirements|20|||
130308585|NCT00186901|469092383|FG001|Overall Study|Limited adherence to study requirements|23|||
130308586|NCT00186901|469092384|FG002|Overall Study|Limited adherence to study requirements|0|||
130308587|NCT00186901|469092382|FG000|Overall Study|Bone Mineral Density > 0|0|||
130308588|NCT00186901|469092383|FG001|Overall Study|Bone Mineral Density > 0|0|||
130308589|NCT00186901|469092384|FG002|Overall Study|Bone Mineral Density > 0|149|||
130308590|NCT00291486|469092390|FG000|Overall Study|Adverse Event|0|||
130308591|NCT00291486|469092391|FG001|Overall Study|Adverse Event|3|||
130308592|NCT00291486|469092392|FG002|Overall Study|Adverse Event|0|||
129798212|NCT02545075|467230020|FG001|Treatment|Adverse event not related to study drug|0|||
129798213|NCT02545075|467230019|FG000|Treatment|Death|1|||
130308593|NCT00291486|469092393|FG003|Overall Study|Adverse Event|1|||
130308594|NCT00291486|469092394|FG004|Overall Study|Adverse Event|0|||
130308595|NCT00291486|469092390|FG000|Overall Study|Withdrawal by Subject|0|||
130308596|NCT00291486|469092391|FG001|Overall Study|Withdrawal by Subject|0|||
130308597|NCT00291486|469092392|FG002|Overall Study|Withdrawal by Subject|0|||
129798214|NCT02545075|467230020|FG001|Treatment|Death|0|||
129798215|NCT02545075|467230019|FG000|Treatment|Participant drug toxicity|1|||
129798216|NCT02545075|467230020|FG001|Treatment|Participant drug toxicity|0|||
129798217|NCT02545075|467230019|FG000|Treatment|Completed treatment|40|||
129798218|NCT02545075|467230020|FG001|Treatment|Completed treatment|12|||
129798219|NCT00736879|467230023|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
129798220|NCT00736879|467230024|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
130049151|NCT01455428|468136659|FG000|Overall Study|Insufficient clinical response|0|||
130308598|NCT00291486|469092393|FG003|Overall Study|Withdrawal by Subject|0|||
130308599|NCT00291486|469092394|FG004|Overall Study|Withdrawal by Subject|1|||
130308600|NCT00291486|469092390|FG000|Overall Study|Disease progression|1|||
130308601|NCT00291486|469092391|FG001|Overall Study|Disease progression|0|||
130308602|NCT00291486|469092392|FG002|Overall Study|Disease progression|1|||
130308603|NCT00291486|469092393|FG003|Overall Study|Disease progression|0|||
130308604|NCT00291486|469092394|FG004|Overall Study|Disease progression|0|||
130308605|NCT01099397|469092395|FG000|Overall Study|Lost to Follow-up|4|||
130308606|NCT01099397|469092395|FG000|Overall Study|Protocol Violation|4|||
130308607|NCT01099397|469092395|FG000|Overall Study|Withdrawal by Subject|5|||
130308608|NCT02487030|469092402|FG000|Overall Study|Lack of Efficacy|2|||
130308609|NCT02487030|469092403|FG001|Overall Study|Lack of Efficacy|4|||
130308610|NCT02487030|469092404|FG002|Overall Study|Lack of Efficacy|1|||
130308611|NCT02487030|469092405|FG003|Overall Study|Lack of Efficacy|0|||
130308612|NCT02487030|469092406|FG004|Overall Study|Lack of Efficacy|1|||
130308613|NCT02487030|469092407|FG005|Overall Study|Lack of Efficacy|0|||
130308614|NCT02487030|469092408|FG006|Overall Study|Lack of Efficacy|0|||
130308615|NCT02487030|469092402|FG000|Overall Study|Lost to Follow-up|0|||
130308616|NCT02487030|469092403|FG001|Overall Study|Lost to Follow-up|0|||
130308617|NCT02487030|469092404|FG002|Overall Study|Lost to Follow-up|1|||
130308618|NCT02487030|469092405|FG003|Overall Study|Lost to Follow-up|1|||
130308619|NCT02487030|469092406|FG004|Overall Study|Lost to Follow-up|0|||
130308620|NCT02487030|469092407|FG005|Overall Study|Lost to Follow-up|1|||
130308621|NCT02487030|469092408|FG006|Overall Study|Lost to Follow-up|0|||
130308622|NCT02487030|469092402|FG000|Overall Study|Adverse Event|0|||
130308623|NCT02487030|469092403|FG001|Overall Study|Adverse Event|0|||
130308624|NCT02487030|469092404|FG002|Overall Study|Adverse Event|0|||
130308625|NCT02487030|469092405|FG003|Overall Study|Adverse Event|1|||
130308626|NCT02487030|469092406|FG004|Overall Study|Adverse Event|0|||
130308627|NCT02487030|469092407|FG005|Overall Study|Adverse Event|0|||
130308628|NCT02487030|469092408|FG006|Overall Study|Adverse Event|0|||
130308629|NCT02487030|469092402|FG000|Overall Study|Death|0|||
130308630|NCT02487030|469092403|FG001|Overall Study|Death|0|||
130308631|NCT02487030|469092404|FG002|Overall Study|Death|0|||
130308632|NCT02487030|469092405|FG003|Overall Study|Death|0|||
130308633|NCT02487030|469092406|FG004|Overall Study|Death|1|||
130308634|NCT02487030|469092407|FG005|Overall Study|Death|0|||
130308635|NCT02487030|469092408|FG006|Overall Study|Death|0|||
130308636|NCT00264537|469092409|FG000|Overall Study|Death|0|||
130308637|NCT00264537|469092410|FG001|Overall Study|Death|3|||
130308638|NCT00264537|469092411|FG002|Overall Study|Death|3|||
130308639|NCT00264537|469092412|FG003|Overall Study|Death|2|||
130308640|NCT00264537|469092409|FG000|Overall Study|Lost to Follow-up|3|||
130308641|NCT00264537|469092410|FG001|Overall Study|Lost to Follow-up|4|||
130308642|NCT00264537|469092411|FG002|Overall Study|Lost to Follow-up|7|||
130308643|NCT00264537|469092412|FG003|Overall Study|Lost to Follow-up|6|||
130308644|NCT00264537|469092409|FG000|Overall Study|Adverse Event|21|||
130308645|NCT00264537|469092410|FG001|Overall Study|Adverse Event|32|||
129798221|NCT00736879|467230025|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
129798222|NCT00736879|467230026|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
129798223|NCT00736879|467230023|FG000|Double Blind Treatment Period|Adverse Event|0|||
129798224|NCT00736879|467230024|FG001|Double Blind Treatment Period|Adverse Event|1|||
130049152|NCT01455428|468136660|FG001|Overall Study|Insufficient clinical response|2|||
130308646|NCT00264537|469092411|FG002|Overall Study|Adverse Event|24|||
129798225|NCT00736879|467230025|FG002|Double Blind Treatment Period|Adverse Event|1|||
129798226|NCT00736879|467230026|FG003|Double Blind Treatment Period|Adverse Event|0|||
129798227|NCT00736879|467230023|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
130308647|NCT00264537|469092412|FG003|Overall Study|Adverse Event|34|||
130308648|NCT00264537|469092409|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
130308649|NCT00264537|469092410|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
130308650|NCT00264537|469092411|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
130308651|NCT00264537|469092412|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
130308652|NCT00264537|469092409|FG000|Overall Study|Other|21|||
129798228|NCT00736879|467230024|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
129798229|NCT00736879|467230025|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
130308653|NCT00264537|469092410|FG001|Overall Study|Other|11|||
130308654|NCT00264537|469092411|FG002|Overall Study|Other|10|||
130308655|NCT00264537|469092412|FG003|Overall Study|Other|11|||
130308656|NCT00264537|469092409|FG000|Overall Study|Not treated|0|||
130308657|NCT00264537|469092410|FG001|Overall Study|Not treated|2|||
130308658|NCT00264537|469092411|FG002|Overall Study|Not treated|1|||
130308659|NCT00264537|469092412|FG003|Overall Study|Not treated|0|||
130109960|NCT00830063|468364055|FG001|Overall Study|Withdrawal by Subject|10|||
130109961|NCT00830063|468364056|FG002|Overall Study|Withdrawal by Subject|16|||
130109962|NCT00830063|468364057|FG003|Overall Study|Withdrawal by Subject|13|||
130109963|NCT00830063|468364054|FG000|Overall Study|Protocol Violation|1|||
130109964|NCT00830063|468364055|FG001|Overall Study|Protocol Violation|0|||
130109965|NCT00830063|468364056|FG002|Overall Study|Protocol Violation|3|||
130109966|NCT00830063|468364057|FG003|Overall Study|Protocol Violation|2|||
130109967|NCT00830063|468364054|FG000|Overall Study|Randomized But Not Treated|0|||
130109968|NCT00830063|468364055|FG001|Overall Study|Randomized But Not Treated|2|||
130109969|NCT00830063|468364056|FG002|Overall Study|Randomized But Not Treated|0|||
130109970|NCT00830063|468364057|FG003|Overall Study|Randomized But Not Treated|2|||
130109971|NCT02323295|468364058|FG000|Overall Study|Adverse Event|0|||
130109972|NCT02323295|468364059|FG001|Overall Study|Adverse Event|1|||
130109973|NCT02323295|468364058|FG000|Overall Study|Withdrawal by Subject|0|||
130109974|NCT02323295|468364059|FG001|Overall Study|Withdrawal by Subject|1|||
130109975|NCT02323295|468364058|FG000|Overall Study|Patient did not have surgery as planned.|0|||
130109976|NCT02323295|468364059|FG001|Overall Study|Patient did not have surgery as planned.|1|||
130109977|NCT00775983|468364060|FG000|Overall Study|Protocol Violation|1|||
130109978|NCT00775983|468364061|FG001|Overall Study|Protocol Violation|2|||
130109979|NCT01155063|468364062|FG000|Overall Study|Adverse Event|1|||
130109980|NCT01155063|468364062|FG000|Overall Study|Withdrawal by Subject|1|||
130109981|NCT01155063|468364062|FG000|Overall Study|Study terminated by sponsor|87|||
130109982|NCT01314703|468364063|FG000|Overall Study|screen failure and closed enrollment|8|||
130109983|NCT00881959|468364066|FG000|Overall Study|Lost to Follow-up|2|||
130109984|NCT00881959|468364067|FG001|Overall Study|Lost to Follow-up|4|||
130109985|NCT01427920|468364075|FG000|Overall Study|Adverse Event|1|||
130109986|NCT01427920|468364076|FG001|Overall Study|Adverse Event|2|||
130109987|NCT01427920|468364075|FG000|Overall Study|Lack of Efficacy|1|||
130109988|NCT01427920|468364076|FG001|Overall Study|Lack of Efficacy|0|||
130109989|NCT01427920|468364075|FG000|Overall Study|Protocol Violation|1|||
130109990|NCT01427920|468364076|FG001|Overall Study|Protocol Violation|3|||
130109991|NCT01427920|468364075|FG000|Overall Study|Withdrawal Criteria|4|||
130109992|NCT01427920|468364076|FG001|Overall Study|Withdrawal Criteria|4|||
130109993|NCT01427920|468364075|FG000|Overall Study|Unclassified|2|||
130109994|NCT01427920|468364076|FG001|Overall Study|Unclassified|8|||
130109995|NCT04228302|468364077|FG000|Overall Study|Adverse Event|0|||
130109996|NCT04228302|468364078|FG001|Overall Study|Adverse Event|0|||
130109997|NCT04228302|468364079|FG002|Overall Study|Adverse Event|0|||
130109998|NCT04228302|468364080|FG003|Overall Study|Adverse Event|0|||
130109999|NCT04228302|468364081|FG004|Overall Study|Adverse Event|1|||
130110000|NCT04228302|468364082|FG005|Overall Study|Adverse Event|0|||
130110001|NCT00751998|468364096|FG000|Overall Study|Lost to Follow-up|7|||
130110002|NCT00751998|468364096|FG000|Overall Study|Death|11|||
130110003|NCT00751998|468364096|FG000|Overall Study|Withdrawal by Subject|2|||
130110004|NCT01965535|468364097|FG000|Overall Study|Lack of Efficacy|2|||
130110005|NCT01965535|468364098|FG001|Overall Study|Lack of Efficacy|1|||
129889490|NCT00946647|467552610|FG004|Phase ll Part|Protocol Violation|2|||
130308660|NCT00999544|469094172|FG000|Overall Study|Withdrawal by Subject|1|||
130308661|NCT02936635|469094177|FG000|Overall Study|Adverse Event|43|||
130308662|NCT02936635|469094178|FG001|Overall Study|Adverse Event|25|||
129889491|NCT00946647|467552606|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
129889492|NCT00946647|467552607|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
129889493|NCT00946647|467552608|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
129889494|NCT00946647|467552609|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
129889495|NCT00946647|467552610|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
129889496|NCT01368211|467552611|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
130049153|NCT01455428|468136659|FG000|Overall Study|Did not receive treatment|1|||
130049154|NCT01455428|468136660|FG001|Overall Study|Did not receive treatment|1|||
130049155|NCT01455428|468136659|FG000|Overall Study|Other|2|||
130049156|NCT01455428|468136660|FG001|Overall Study|Other|4|||
130308663|NCT02936635|469094177|FG000|Overall Study|Progressive Disease|10|||
130308664|NCT02936635|469094178|FG001|Overall Study|Progressive Disease|18|||
130308665|NCT02936635|469094177|FG000|Overall Study|Sponsor Discretion|10|||
130308666|NCT02936635|469094178|FG001|Overall Study|Sponsor Discretion|16|||
130308667|NCT02936635|469094177|FG000|Overall Study|Death|9|||
130308668|NCT02936635|469094178|FG001|Overall Study|Death|15|||
130308669|NCT02936635|469094177|FG000|Overall Study|Withdrawal by Subject|8|||
130308670|NCT02936635|469094178|FG001|Overall Study|Withdrawal by Subject|15|||
130308671|NCT02936635|469094177|FG000|Overall Study|Physician Decision|2|||
130308672|NCT02936635|469094178|FG001|Overall Study|Physician Decision|9|||
130308673|NCT02936635|469094177|FG000|Overall Study|Lost to Follow-up|1|||
130308674|NCT02936635|469094178|FG001|Overall Study|Lost to Follow-up|2|||
130308675|NCT02936635|469094177|FG000|Overall Study|Protocol Violation|1|||
130308676|NCT02936635|469094178|FG001|Overall Study|Protocol Violation|0|||
130308677|NCT02936635|469094177|FG000|Overall Study|Lack of effect/Entry into other study|31|||
130308678|NCT02936635|469094178|FG001|Overall Study|Lack of effect/Entry into other study|65|||
130049157|NCT03303339|468136661|FG000|Overall Study|Death|2|||
130049158|NCT03303339|468136662|FG001|Overall Study|Death|2|||
130049159|NCT03303339|468136663|FG002|Overall Study|Death|2|||
130049160|NCT03303339|468136664|FG003|Overall Study|Death|1|||
130049161|NCT03303339|468136665|FG004|Overall Study|Death|4|||
130049162|NCT03303339|468136666|FG005|Overall Study|Death|2|||
130049163|NCT03303339|468136667|FG006|Overall Study|Death|2|||
130049164|NCT03303339|468136668|FG007|Overall Study|Death|2|||
130049165|NCT03303339|468136669|FG008|Overall Study|Death|3|||
130049166|NCT03303339|468136670|FG009|Overall Study|Death|3|||
130049167|NCT03303339|468136671|FG010|Overall Study|Death|4|||
130049168|NCT03303339|468136672|FG011|Overall Study|Death|24|||
130049169|NCT03303339|468136661|FG000|Overall Study|Study Terminated by Sponsor|0|||
130049170|NCT03303339|468136662|FG001|Overall Study|Study Terminated by Sponsor|0|||
130049171|NCT03303339|468136663|FG002|Overall Study|Study Terminated by Sponsor|0|||
130049172|NCT03303339|468136664|FG003|Overall Study|Study Terminated by Sponsor|0|||
130049173|NCT03303339|468136665|FG004|Overall Study|Study Terminated by Sponsor|0|||
130049174|NCT03303339|468136666|FG005|Overall Study|Study Terminated by Sponsor|0|||
130049175|NCT03303339|468136667|FG006|Overall Study|Study Terminated by Sponsor|0|||
130308679|NCT02407223|469094179|FG000|Overall Study|Adverse Event|1|||
130308680|NCT02407223|469094180|FG001|Overall Study|Adverse Event|0|||
130308681|NCT02407223|469094181|FG002|Overall Study|Adverse Event|1|||
130308682|NCT02407223|469094179|FG000|Overall Study|Lack of Efficacy|6|||
130308683|NCT02407223|469094180|FG001|Overall Study|Lack of Efficacy|6|||
129889497|NCT01368211|467552612|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
129889498|NCT01513967|467552623|FG000|Overall Study|Pregnancy|0|||
130049176|NCT03303339|468136668|FG007|Overall Study|Study Terminated by Sponsor|0|||
130049177|NCT03303339|468136669|FG008|Overall Study|Study Terminated by Sponsor|1|||
130049178|NCT03303339|468136670|FG009|Overall Study|Study Terminated by Sponsor|0|||
130049179|NCT03303339|468136671|FG010|Overall Study|Study Terminated by Sponsor|1|||
130049180|NCT03303339|468136672|FG011|Overall Study|Study Terminated by Sponsor|1|||
130049181|NCT03303339|468136661|FG000|Overall Study|Withdrawal by Subject|1|||
130049182|NCT03303339|468136662|FG001|Overall Study|Withdrawal by Subject|0|||
130110006|NCT02983227|468364099|FG000|Overall Study|Adverse Event|21|||
130110007|NCT02983227|468364100|FG001|Overall Study|Adverse Event|3|||
130110008|NCT02983227|468364099|FG000|Overall Study|Death|3|||
130110009|NCT02983227|468364100|FG001|Overall Study|Death|0|||
130110010|NCT02983227|468364099|FG000|Overall Study|Lack of Efficacy|8|||
130110011|NCT02983227|468364100|FG001|Overall Study|Lack of Efficacy|1|||
130110012|NCT02983227|468364099|FG000|Overall Study|Lost to Follow-up|3|||
130110013|NCT02983227|468364100|FG001|Overall Study|Lost to Follow-up|0|||
130110014|NCT02983227|468364099|FG000|Overall Study|Multiple Reasons|2|||
130110015|NCT02983227|468364100|FG001|Overall Study|Multiple Reasons|1|||
130110016|NCT02983227|468364099|FG000|Overall Study|Physician Decision|3|||
130110017|NCT02983227|468364100|FG001|Overall Study|Physician Decision|1|||
130110018|NCT02983227|468364099|FG000|Overall Study|Withdrawal by Subject|19|||
130110019|NCT02983227|468364100|FG001|Overall Study|Withdrawal by Subject|8|||
130110020|NCT01946282|468364105|FG000|Year 1|Did not return FIT kit|4186|||
130110021|NCT01946282|468364106|FG001|Year 1|Did not return FIT kit|608|||
130110022|NCT01946282|468364107|FG002|Year 1|Did not return FIT kit|654|||
130110023|NCT01946282|468364105|FG000|Year 2|Did not return FIT kit|803|||
130110024|NCT01946282|468364106|FG001|Year 2|Did not return FIT kit|131|||
130110025|NCT01946282|468364107|FG002|Year 2|Did not return FIT kit|115|||
130110026|NCT01946282|468364105|FG000|Year 3|Did not return FIT kit|288|||
130110027|NCT01946282|468364106|FG001|Year 3|Did not return FIT kit|43|||
130110028|NCT01946282|468364107|FG002|Year 3|Did not return FIT kit|30|||
130110029|NCT01493531|468364108|FG000|Overall Study|Adverse Event|4|||
129798230|NCT00736879|467230026|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
129798231|NCT00736879|467230023|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
130110030|NCT01493531|468364109|FG001|Overall Study|Adverse Event|12|||
130110031|NCT01493531|468364110|FG002|Overall Study|Adverse Event|9|||
130110032|NCT01493531|468364108|FG000|Overall Study|Gout flare|3|||
130110033|NCT01493531|468364109|FG001|Overall Study|Gout flare|0|||
129798232|NCT00736879|467230024|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130110034|NCT01493531|468364110|FG002|Overall Study|Gout flare|2|||
129798233|NCT00736879|467230025|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
129798234|NCT00736879|467230026|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
129798235|NCT00736879|467230023|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
130110035|NCT01493531|468364108|FG000|Overall Study|Protocol Violation|8|||
130110036|NCT01493531|468364109|FG001|Overall Study|Protocol Violation|15|||
130110037|NCT01493531|468364110|FG002|Overall Study|Protocol Violation|12|||
130110038|NCT01493531|468364108|FG000|Overall Study|Sponsor terminated study|5|||
130110039|NCT01493531|468364109|FG001|Overall Study|Sponsor terminated study|2|||
130110040|NCT01493531|468364110|FG002|Overall Study|Sponsor terminated study|3|||
130110041|NCT01493531|468364108|FG000|Overall Study|Lost to Follow-up|5|||
129798236|NCT00736879|467230024|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
129798237|NCT00736879|467230025|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
129798238|NCT00736879|467230026|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
129798239|NCT00736879|467230023|FG000|Double Blind Treatment Period|No longer met criteria|0|||
129798240|NCT00736879|467230024|FG001|Double Blind Treatment Period|No longer met criteria|1|||
129798241|NCT00736879|467230025|FG002|Double Blind Treatment Period|No longer met criteria|0|||
129798242|NCT00736879|467230026|FG003|Double Blind Treatment Period|No longer met criteria|0|||
129798243|NCT00736879|467230023|FG000|Double Blind Treatment Period|non-specified|0|||
129798244|NCT00736879|467230024|FG001|Double Blind Treatment Period|non-specified|1|||
129798245|NCT00736879|467230025|FG002|Double Blind Treatment Period|non-specified|0|||
129798246|NCT00736879|467230026|FG003|Double Blind Treatment Period|non-specified|0|||
129798247|NCT00736879|467230023|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
129798248|NCT00736879|467230024|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
129798249|NCT00736879|467230025|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
129798250|NCT00736879|467230026|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
129798251|NCT00736879|467230023|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
129798252|NCT00736879|467230024|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
129798253|NCT00736879|467230025|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
129798254|NCT00736879|467230026|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
129798255|NCT01810432|467230027|FG000|Washout|Protocol Violation|0|||
129798256|NCT01810432|467230028|FG001|Washout|Protocol Violation|1|||
129798257|NCT01810432|467230027|FG000|Washout|Adverse Event|1|||
129798258|NCT01810432|467230028|FG001|Washout|Adverse Event|0|||
129798259|NCT01810432|467230027|FG000|Period 2|Withdrawal by Subject|2|||
129798260|NCT01810432|467230028|FG001|Period 2|Withdrawal by Subject|1|||
129798261|NCT01810432|467230027|FG000|Period 2|Physician Decision|1|||
129798262|NCT01810432|467230028|FG001|Period 2|Physician Decision|0|||
129798263|NCT01810432|467230027|FG000|Period 2|Lost to Follow-up|1|||
129798264|NCT01810432|467230028|FG001|Period 2|Lost to Follow-up|1|||
129798265|NCT02360111|467230029|FG000|Overall Study|Death|2|||
129798266|NCT01933217|467230032|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
129798267|NCT01933217|467230033|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
129798268|NCT01933217|467230032|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
129798269|NCT01933217|467230033|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
129798270|NCT03923738|467230034|FG000|Period 1|Adverse Event|1|||
129798271|NCT03923738|467230034|FG000|Period 1|Withdrawal by Subject|1|||
129798272|NCT00147251|467230037|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
129798273|NCT00147251|467230038|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
129798274|NCT01629706|467230039|FG000|Phase 1 PureVision|Screen Failure|4|||
129798275|NCT01629706|467230039|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
130049183|NCT03303339|468136663|FG002|Overall Study|Withdrawal by Subject|0|||
130049184|NCT03303339|468136664|FG003|Overall Study|Withdrawal by Subject|0|||
130049185|NCT03303339|468136665|FG004|Overall Study|Withdrawal by Subject|0|||
130049186|NCT03303339|468136666|FG005|Overall Study|Withdrawal by Subject|1|||
130308684|NCT02407223|469094181|FG002|Overall Study|Lack of Efficacy|4|||
130308685|NCT02407223|469094179|FG000|Overall Study|Lost to Follow-up|1|||
130308686|NCT02407223|469094180|FG001|Overall Study|Lost to Follow-up|0|||
130308687|NCT02407223|469094181|FG002|Overall Study|Lost to Follow-up|2|||
130308688|NCT02407223|469094179|FG000|Overall Study|Withdrawal by Subject|2|||
130308689|NCT02407223|469094180|FG001|Overall Study|Withdrawal by Subject|4|||
130308690|NCT02407223|469094181|FG002|Overall Study|Withdrawal by Subject|4|||
130308691|NCT02407223|469094179|FG000|Overall Study|Study Terminated by Sponsor|77|||
130308692|NCT02407223|469094180|FG001|Overall Study|Study Terminated by Sponsor|80|||
130308693|NCT02407223|469094181|FG002|Overall Study|Study Terminated by Sponsor|86|||
130308694|NCT02407223|469094179|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
130308695|NCT02407223|469094180|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
130308696|NCT02407223|469094181|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
130308697|NCT02407223|469094179|FG000|Overall Study|Other|29|||
130308698|NCT02407223|469094180|FG001|Overall Study|Other|27|||
130308699|NCT02407223|469094181|FG002|Overall Study|Other|25|||
130308700|NCT04864639|469094182|FG000|Overall Study|Death|1|||
130308701|NCT04864639|469094182|FG000|Overall Study|Lost to Follow-up|1|||
130308702|NCT01478971|469094191|FG000|Standard of Care Period|Adverse Event|1|||
130308703|NCT01478971|469094191|FG000|Standard of Care Period|Withdrawal by Subject|3|||
130308704|NCT01478971|469094191|FG000|Standard of Care Period|Death|8|||
129798276|NCT01629706|467230039|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
129798277|NCT01629706|467230039|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
129798278|NCT01629706|467230039|FG000|Phase 2 Habitual|Screen Failure|6|||
129798279|NCT01629706|467230039|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
129798280|NCT01629706|467230039|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
129798281|NCT01629706|467230039|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
129798282|NCT01629706|467230039|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
130049187|NCT03303339|468136667|FG006|Overall Study|Withdrawal by Subject|1|||
130308705|NCT01478971|469094191|FG000|Standard of Care Period|Lost to Follow-up|9|||
130308706|NCT01478971|469094191|FG000|Standard of Care Period|Other|4|||
130308707|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Adverse Event|1|||
130308708|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
130308709|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Death|4|||
130308710|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
130308711|NCT01478971|469094191|FG000|Peginesatide Treatment Period|Other|4|||
130308712|NCT00584012|469094192|FG000|Overall Study|Withdrawal by Subject|1|||
130308713|NCT01525615|469094193|FG000|Overall Study|Adverse Event|11|||
130308714|NCT01525615|469094194|FG001|Overall Study|Adverse Event|7|||
130308715|NCT01525615|469094195|FG002|Overall Study|Adverse Event|5|||
130308716|NCT01525615|469094193|FG000|Overall Study|Lost to Follow-up|1|||
130308717|NCT01525615|469094194|FG001|Overall Study|Lost to Follow-up|0|||
130308718|NCT01525615|469094195|FG002|Overall Study|Lost to Follow-up|0|||
130308719|NCT01525615|469094193|FG000|Overall Study|Withdrawal by Subject|1|||
130308720|NCT01525615|469094194|FG001|Overall Study|Withdrawal by Subject|0|||
130308721|NCT01525615|469094195|FG002|Overall Study|Withdrawal by Subject|0|||
130308722|NCT01525615|469094193|FG000|Overall Study|Other reason not described above|1|||
130308723|NCT01525615|469094194|FG001|Overall Study|Other reason not described above|0|||
130308724|NCT01525615|469094195|FG002|Overall Study|Other reason not described above|1|||
130308725|NCT04050618|469094196|FG000|First Intervention|Withdrawal by Subject|2|||
130308726|NCT04050618|469094197|FG001|First Intervention|Withdrawal by Subject|0|||
130308727|NCT04050618|469094196|FG000|Second Intervention|Withdrawal by Subject|1|||
130308728|NCT04050618|469094197|FG001|Second Intervention|Withdrawal by Subject|0|||
130308729|NCT04404556|469094198|FG000|Intervention|Withdrawal by Subject|15|||
130308730|NCT04404556|469094199|FG001|Intervention|Withdrawal by Subject|3|||
130308731|NCT04404556|469094198|FG000|Intervention|Did not complete all intervention sessions|2|||
130308732|NCT04404556|469094199|FG001|Intervention|Did not complete all intervention sessions|1|||
130308733|NCT04404556|469094198|FG000|Post-Intervention|Missing Data|1|||
130308734|NCT04404556|469094199|FG001|Post-Intervention|Missing Data|2|||
130308735|NCT04404556|469094198|FG000|Follow-up 1|Withdrawal by Subject|5|||
130308736|NCT04404556|469094199|FG001|Follow-up 1|Withdrawal by Subject|1|||
130308737|NCT04404556|469094198|FG000|Follow-up 1|Missing Data|4|||
130308738|NCT04404556|469094199|FG001|Follow-up 1|Missing Data|7|||
130308739|NCT04404556|469094198|FG000|Follow-up 2|Withdrawal by Subject|1|||
130308740|NCT04404556|469094199|FG001|Follow-up 2|Withdrawal by Subject|1|||
130308741|NCT04404556|469094198|FG000|Follow-up 2|Missing Data|6|||
130308742|NCT04404556|469094199|FG001|Follow-up 2|Missing Data|5|||
130308743|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
130308744|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
130308745|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
130308746|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
130308747|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
130308748|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
130308749|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
130308750|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
130308751|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
130308752|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
130308753|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
130308754|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
130308755|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
130308756|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
130308757|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
130308758|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
130308759|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130308760|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
130308761|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129889499|NCT01513967|467552624|FG001|Overall Study|Pregnancy|0|||
130049188|NCT03303339|468136668|FG007|Overall Study|Withdrawal by Subject|0|||
130308762|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
130308763|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
130308764|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
130308765|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
130308766|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
130308767|NCT03777059|469094200|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
130308768|NCT03777059|469094201|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
130308769|NCT03777059|469094202|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
130308770|NCT03777059|469094203|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
130308771|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
130308772|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
130308773|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
130308774|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
130308775|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
130308776|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
130308777|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
130308778|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
130308779|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
130308780|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
130308781|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
130308782|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
130308783|NCT03777059|469094200|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
130308784|NCT03777059|469094201|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
130308785|NCT03777059|469094202|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
130308786|NCT03777059|469094203|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
130308787|NCT00763386|469094205|FG000|Overall Study|Adverse Event|43|||
130308788|NCT00763386|469094206|FG001|Overall Study|Adverse Event|33|||
130308789|NCT00763386|469094205|FG000|Overall Study|Death|1|||
130308790|NCT00763386|469094206|FG001|Overall Study|Death|2|||
130308791|NCT00763386|469094205|FG000|Overall Study|Lost to Follow-up|3|||
130308792|NCT00763386|469094206|FG001|Overall Study|Lost to Follow-up|3|||
130308793|NCT00763386|469094205|FG000|Overall Study|Withdrawal by Subject|0|||
130308794|NCT00763386|469094206|FG001|Overall Study|Withdrawal by Subject|1|||
130308795|NCT00763386|469094205|FG000|Overall Study|CRF missing|0|||
130308796|NCT00763386|469094206|FG001|Overall Study|CRF missing|1|||
130308797|NCT00763386|469094205|FG000|Overall Study|Study Prosthesis Removed|1|||
130308798|NCT00763386|469094206|FG001|Overall Study|Study Prosthesis Removed|0|||
130308799|NCT00411671|469094207|FG000|Overall Study|Adverse Event|15|||
130308800|NCT00411671|469094207|FG000|Overall Study|Death|2|||
130308801|NCT00411671|469094207|FG000|Overall Study|Lost to Follow-up|3|||
130308802|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
130308803|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308804|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308805|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308806|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
130308807|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
130308808|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308809|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308810|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308811|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
130308812|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
130308813|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308814|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308815|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130308816|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
130049189|NCT03303339|468136669|FG008|Overall Study|Withdrawal by Subject|0|||
130308817|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
130308818|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308819|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308820|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308821|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130308822|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
130308823|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130308824|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130308825|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
130308826|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129798283|NCT01151098|467230040|FG000|Overall Study|Adverse Event|82|||
129798284|NCT01151098|467230040|FG000|Overall Study|Lost to Follow-up|6|||
129798285|NCT01151098|467230040|FG000|Overall Study|Lack of Efficacy|15|||
130110042|NCT01493531|468364109|FG001|Overall Study|Lost to Follow-up|7|||
130110043|NCT01493531|468364110|FG002|Overall Study|Lost to Follow-up|11|||
130110044|NCT01493531|468364108|FG000|Overall Study|Withdrawal by Subject|16|||
130308827|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
130308828|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129798286|NCT01151098|467230040|FG000|Overall Study|Protocol Violation|1|||
129798287|NCT01151098|467230040|FG000|Overall Study|Miscellaneous|13|||
130308829|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130308830|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130308831|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130308832|NCT01173601|469094209|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
130110045|NCT01493531|468364109|FG001|Overall Study|Withdrawal by Subject|13|||
130110046|NCT01493531|468364110|FG002|Overall Study|Withdrawal by Subject|11|||
130110047|NCT01493531|468364108|FG000|Overall Study|Death|0|||
130110048|NCT01493531|468364109|FG001|Overall Study|Death|1|||
130110049|NCT01493531|468364110|FG002|Overall Study|Death|0|||
130110050|NCT01027884|468364117|FG000|Overall Study|Adverse Event|2|||
130110051|NCT01027884|468364118|FG001|Overall Study|Adverse Event|1|||
130110052|NCT01027884|468364117|FG000|Overall Study|Protocol Violation|1|||
130110053|NCT01027884|468364118|FG001|Overall Study|Protocol Violation|0|||
130110054|NCT01027884|468364117|FG000|Overall Study|Non-compliance|1|||
130110055|NCT01027884|468364118|FG001|Overall Study|Non-compliance|1|||
130110056|NCT01027884|468364117|FG000|Overall Study|Withdrawal by Subject|0|||
130110057|NCT01027884|468364118|FG001|Overall Study|Withdrawal by Subject|1|||
130110058|NCT01027884|468364117|FG000|Overall Study|Lost to Follow-up|0|||
130110059|NCT01027884|468364118|FG001|Overall Study|Lost to Follow-up|1|||
130110060|NCT01027884|468364117|FG000|Overall Study|Spinal fixation surgery|0|||
130110061|NCT01027884|468364118|FG001|Overall Study|Spinal fixation surgery|3|||
130110062|NCT03670537|468364119|FG000|Overall Study|Protocol Violation|1|||
130110063|NCT02059187|468364120|FG000|Overall Study|Adverse Event|0|||
130110064|NCT02059187|468364121|FG001|Overall Study|Adverse Event|3|||
130110065|NCT02059187|468364120|FG000|Overall Study|Death|1|||
130110066|NCT02059187|468364121|FG001|Overall Study|Death|1|||
130110067|NCT02059187|468364120|FG000|Overall Study|Lost to Follow-up|9|||
130110068|NCT02059187|468364121|FG001|Overall Study|Lost to Follow-up|8|||
130110069|NCT02059187|468364120|FG000|Overall Study|Non-compliance with study drug|1|||
130110070|NCT02059187|468364121|FG001|Overall Study|Non-compliance with study drug|0|||
130110071|NCT02059187|468364120|FG000|Overall Study|Physician Decision|1|||
130110072|NCT02059187|468364121|FG001|Overall Study|Physician Decision|2|||
130110073|NCT02059187|468364120|FG000|Overall Study|Protocol Violation|1|||
130110074|NCT02059187|468364121|FG001|Overall Study|Protocol Violation|0|||
130110075|NCT02059187|468364120|FG000|Overall Study|Withdrawal by Subject|12|||
130110076|NCT02059187|468364121|FG001|Overall Study|Withdrawal by Subject|8|||
130308833|NCT01173601|469094210|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308834|NCT01173601|469094211|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308835|NCT01173601|469094212|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308836|NCT01173601|469094213|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
130308837|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
130308838|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
130308839|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
130308840|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
130308841|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
130308842|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130308843|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
130308844|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
130308845|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
130308846|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
130308847|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129798288|NCT03343067|467230047|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
129798289|NCT03343067|467230048|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
130308848|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
129798290|NCT03343067|467230049|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
129798291|NCT00116168|467230050|FG000|Overall Study|Lost to Follow-up|6|||
130110077|NCT03070431|468364122|FG000|Overall Study|Withdrawal by Subject|2|||
130110078|NCT03070431|468364122|FG000|Overall Study|Lost to Follow-up|2|||
130110079|NCT01889862|468364123|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
130110080|NCT01889862|468364124|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130110081|NCT01889862|468364125|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130110082|NCT01889862|468364126|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130110083|NCT01889862|468364127|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
130110084|NCT01889862|468364123|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
129798292|NCT00116168|467230051|FG001|Overall Study|Lost to Follow-up|5|||
129798293|NCT00116168|467230052|FG002|Overall Study|Lost to Follow-up|0|||
129798294|NCT00116168|467230053|FG003|Overall Study|Lost to Follow-up|0|||
129798295|NCT02788474|467230054|FG000|Double Blind Treatment Period|Not treated|1|||
129798296|NCT02788474|467230055|FG001|Double Blind Treatment Period|Not treated|0|||
130308849|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
130308850|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
130308851|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
130308852|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130308853|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129798297|NCT02788474|467230054|FG000|Double Blind Treatment Period|Patient's refusal|3|||
129798298|NCT02788474|467230055|FG001|Double Blind Treatment Period|Patient's refusal|0|||
129798299|NCT02788474|467230054|FG000|Double Blind Treatment Period|Adverse Event|6|||
129798300|NCT02788474|467230055|FG001|Double Blind Treatment Period|Adverse Event|4|||
129798301|NCT02788474|467230054|FG000|Open Label Treatment Period|Adverse Event|29|||
129798302|NCT02788474|467230055|FG001|Open Label Treatment Period|Adverse Event|9|||
130049190|NCT03303339|468136670|FG009|Overall Study|Withdrawal by Subject|0|||
130049191|NCT03303339|468136671|FG010|Overall Study|Withdrawal by Subject|0|||
130049192|NCT03303339|468136672|FG011|Overall Study|Withdrawal by Subject|2|||
130049193|NCT03303339|468136661|FG000|Overall Study|Physician Decision|0|||
130049194|NCT03303339|468136662|FG001|Overall Study|Physician Decision|0|||
130049195|NCT03303339|468136663|FG002|Overall Study|Physician Decision|0|||
130049196|NCT03303339|468136664|FG003|Overall Study|Physician Decision|0|||
130049197|NCT03303339|468136665|FG004|Overall Study|Physician Decision|1|||
130049198|NCT03303339|468136666|FG005|Overall Study|Physician Decision|0|||
130049199|NCT03303339|468136667|FG006|Overall Study|Physician Decision|0|||
130049200|NCT03303339|468136668|FG007|Overall Study|Physician Decision|0|||
130049201|NCT03303339|468136669|FG008|Overall Study|Physician Decision|0|||
130049202|NCT03303339|468136670|FG009|Overall Study|Physician Decision|0|||
130049203|NCT03303339|468136671|FG010|Overall Study|Physician Decision|0|||
130049204|NCT03303339|468136672|FG011|Overall Study|Physician Decision|0|||
130049205|NCT03303339|468136661|FG000|Overall Study|Safety/Non-compliance|0|||
130049206|NCT03303339|468136662|FG001|Overall Study|Safety/Non-compliance|0|||
130049207|NCT03303339|468136663|FG002|Overall Study|Safety/Non-compliance|0|||
130049208|NCT03303339|468136664|FG003|Overall Study|Safety/Non-compliance|0|||
130049209|NCT03303339|468136665|FG004|Overall Study|Safety/Non-compliance|0|||
130049210|NCT03303339|468136666|FG005|Overall Study|Safety/Non-compliance|0|||
130049211|NCT03303339|468136667|FG006|Overall Study|Safety/Non-compliance|0|||
130049212|NCT03303339|468136668|FG007|Overall Study|Safety/Non-compliance|0|||
130049213|NCT03303339|468136669|FG008|Overall Study|Safety/Non-compliance|0|||
130049214|NCT03303339|468136670|FG009|Overall Study|Safety/Non-compliance|0|||
130049215|NCT03303339|468136671|FG010|Overall Study|Safety/Non-compliance|0|||
130049216|NCT03303339|468136672|FG011|Overall Study|Safety/Non-compliance|1|||
130049217|NCT04156646|468136673|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
130049218|NCT04156646|468136674|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
130049219|NCT00751101|468136683|FG000|Overall Study|Withdrawal by Subject|1|||
130049220|NCT00751101|468136684|FG001|Overall Study|Withdrawal by Subject|0|||
130049221|NCT00751101|468136683|FG000|Overall Study|No HFS / Never Started Patch/|0|||
130049222|NCT00751101|468136684|FG001|Overall Study|No HFS / Never Started Patch/|4|||
130049223|NCT00751101|468136683|FG000|Overall Study|Never began capecitabine|1|||
130049224|NCT00751101|468136684|FG001|Overall Study|Never began capecitabine|0|||
130049225|NCT00751101|468136683|FG000|Overall Study|Physician Decision|0|||
130049226|NCT00751101|468136684|FG001|Overall Study|Physician Decision|1|||
130049227|NCT01905397|468136687|FG000|Overall Study|Death|0|||
130049228|NCT01905397|468136688|FG001|Overall Study|Death|1|||
130049229|NCT01905397|468136687|FG000|Overall Study|Withdrawal by Subject|2|||
130110085|NCT01889862|468364124|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130308854|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
130308855|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
130308856|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129798303|NCT02788474|467230054|FG000|Open Label Treatment Period|Other than reason specified|1|||
129798304|NCT02788474|467230055|FG001|Open Label Treatment Period|Other than reason specified|0|||
129798305|NCT02788474|467230054|FG000|Open Label Treatment Period|Patient's refusal|1|||
129798306|NCT02788474|467230055|FG001|Open Label Treatment Period|Patient's refusal|3|||
130049230|NCT01905397|468136688|FG001|Overall Study|Withdrawal by Subject|0|||
130049231|NCT01905397|468136687|FG000|Overall Study|Surgery canceled/aborted|9|||
130049232|NCT01905397|468136688|FG001|Overall Study|Surgery canceled/aborted|5|||
130049233|NCT01905397|468136687|FG000|Overall Study|Incision < 7 cm|2|||
130049234|NCT01905397|468136688|FG001|Overall Study|Incision < 7 cm|0|||
130049235|NCT01905397|468136687|FG000|Overall Study|Wrong treatment|1|||
130049236|NCT01905397|468136688|FG001|Overall Study|Wrong treatment|1|||
130049237|NCT01905397|468136687|FG000|Overall Study|Device not applied|3|||
130049238|NCT01905397|468136688|FG001|Overall Study|Device not applied|0|||
130110086|NCT01889862|468364125|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130308857|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
130308858|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
130308859|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130308860|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
130308861|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
130308862|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
130308863|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
130308864|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
130308865|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
130308866|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
130308867|NCT01173601|469094209|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130308868|NCT01173601|469094210|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130308869|NCT01173601|469094211|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
130308870|NCT01173601|469094212|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
130308871|NCT01173601|469094213|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
130308872|NCT03951077|469094214|FG000|Overall Study|Adverse Event|1|||
130308873|NCT03951077|469094215|FG001|Overall Study|Adverse Event|0|||
130308874|NCT03951077|469094216|FG002|Overall Study|Adverse Event|0|||
130308875|NCT03951077|469094217|FG003|Overall Study|Adverse Event|0|||
130308876|NCT03951077|469094218|FG004|Overall Study|Adverse Event|0|||
130308877|NCT03951077|469094219|FG005|Overall Study|Adverse Event|0|||
130308878|NCT03951077|469094214|FG000|Overall Study|Withdrawal by Subject|3|||
130308879|NCT03951077|469094215|FG001|Overall Study|Withdrawal by Subject|3|||
130308880|NCT03951077|469094216|FG002|Overall Study|Withdrawal by Subject|0|||
130308881|NCT03951077|469094217|FG003|Overall Study|Withdrawal by Subject|3|||
130308882|NCT03951077|469094218|FG004|Overall Study|Withdrawal by Subject|3|||
130308883|NCT03951077|469094219|FG005|Overall Study|Withdrawal by Subject|2|||
130308884|NCT03951077|469094214|FG000|Overall Study|Lost to Follow-up|1|||
130308885|NCT03951077|469094215|FG001|Overall Study|Lost to Follow-up|1|||
130308886|NCT03951077|469094216|FG002|Overall Study|Lost to Follow-up|2|||
130308887|NCT03951077|469094217|FG003|Overall Study|Lost to Follow-up|3|||
130308888|NCT03951077|469094218|FG004|Overall Study|Lost to Follow-up|2|||
130308889|NCT03951077|469094219|FG005|Overall Study|Lost to Follow-up|3|||
130308890|NCT03951077|469094214|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
130308891|NCT03951077|469094215|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
130308892|NCT03951077|469094216|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
130308893|NCT03951077|469094217|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
130308894|NCT03951077|469094218|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
130308895|NCT03951077|469094219|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
130308896|NCT03951077|469094214|FG000|Overall Study|Other, Not Specified|12|||
130308897|NCT03951077|469094215|FG001|Overall Study|Other, Not Specified|10|||
130308898|NCT03951077|469094216|FG002|Overall Study|Other, Not Specified|10|||
130308899|NCT03951077|469094217|FG003|Overall Study|Other, Not Specified|5|||
130308900|NCT03951077|469094218|FG004|Overall Study|Other, Not Specified|9|||
130308901|NCT03951077|469094219|FG005|Overall Study|Other, Not Specified|6|||
130308902|NCT03951077|469094214|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
130308903|NCT03951077|469094215|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
130308904|NCT03951077|469094216|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
130308905|NCT03951077|469094217|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
130308906|NCT03951077|469094218|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
130308907|NCT03951077|469094219|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
130308908|NCT01395901|469094222|FG000|Overall Study|Lost to Follow-up|4|||
130308909|NCT01395901|469094223|FG001|Overall Study|Lost to Follow-up|0|||
130308910|NCT01395901|469094222|FG000|Overall Study|Randomized but not received study drug|5|||
130308911|NCT01395901|469094223|FG001|Overall Study|Randomized but not received study drug|4|||
130308912|NCT01395901|469094222|FG000|Overall Study|Adverse Event|0|||
130308913|NCT01395901|469094223|FG001|Overall Study|Adverse Event|1|||
130308914|NCT01395901|469094222|FG000|Overall Study|Withdrawal of consent|1|||
130308915|NCT01395901|469094223|FG001|Overall Study|Withdrawal of consent|0|||
130308916|NCT00713544|469094229|FG000|Overall Study|Adverse Event|5|||
130308917|NCT00713544|469094230|FG001|Overall Study|Adverse Event|3|||
130308918|NCT00713544|469094231|FG002|Overall Study|Adverse Event|7|||
130308919|NCT00713544|469094232|FG003|Overall Study|Adverse Event|7|||
129798307|NCT02788474|467230054|FG000|Open Label Treatment Period|Non-compliance|1|||
129798308|NCT02788474|467230055|FG001|Open Label Treatment Period|Non-compliance|0|||
129798309|NCT05342532|467230058|FG000|Overall Study|Adverse Event|5|||
130308920|NCT00713544|469094233|FG004|Overall Study|Adverse Event|3|||
130308921|NCT00713544|469094234|FG005|Overall Study|Adverse Event|5|||
130308922|NCT00713544|469094229|FG000|Overall Study|Withdrawal by Subject|2|||
129798310|NCT05342532|467230059|FG001|Overall Study|Adverse Event|20|||
129798311|NCT05342532|467230058|FG000|Overall Study|Lost to Follow-up|10|||
129798312|NCT05342532|467230059|FG001|Overall Study|Lost to Follow-up|15|||
130308923|NCT00713544|469094230|FG001|Overall Study|Withdrawal by Subject|0|||
130308924|NCT00713544|469094231|FG002|Overall Study|Withdrawal by Subject|3|||
130308925|NCT00713544|469094232|FG003|Overall Study|Withdrawal by Subject|2|||
130308926|NCT00713544|469094233|FG004|Overall Study|Withdrawal by Subject|3|||
130308927|NCT00713544|469094234|FG005|Overall Study|Withdrawal by Subject|1|||
130308928|NCT00713544|469094229|FG000|Overall Study|Protocol Violation|0|||
130308929|NCT00713544|469094230|FG001|Overall Study|Protocol Violation|0|||
130308930|NCT00713544|469094231|FG002|Overall Study|Protocol Violation|0|||
130308931|NCT00713544|469094232|FG003|Overall Study|Protocol Violation|0|||
130308932|NCT00713544|469094233|FG004|Overall Study|Protocol Violation|0|||
130308933|NCT00713544|469094234|FG005|Overall Study|Protocol Violation|1|||
130308934|NCT00713544|469094229|FG000|Overall Study|Physician Decision|0|||
130308935|NCT00713544|469094230|FG001|Overall Study|Physician Decision|0|||
130308936|NCT00713544|469094231|FG002|Overall Study|Physician Decision|0|||
130308937|NCT00713544|469094232|FG003|Overall Study|Physician Decision|0|||
130308938|NCT00713544|469094233|FG004|Overall Study|Physician Decision|0|||
130308939|NCT00713544|469094234|FG005|Overall Study|Physician Decision|2|||
130308940|NCT00713544|469094229|FG000|Overall Study|Lack of Efficacy|0|||
130308941|NCT00713544|469094230|FG001|Overall Study|Lack of Efficacy|1|||
130308942|NCT00713544|469094231|FG002|Overall Study|Lack of Efficacy|0|||
130308943|NCT00713544|469094232|FG003|Overall Study|Lack of Efficacy|1|||
130308944|NCT00713544|469094233|FG004|Overall Study|Lack of Efficacy|1|||
130308945|NCT00713544|469094234|FG005|Overall Study|Lack of Efficacy|0|||
130308946|NCT00713544|469094229|FG000|Overall Study|Lost to Follow-up|0|||
130308947|NCT00713544|469094230|FG001|Overall Study|Lost to Follow-up|0|||
130308948|NCT00713544|469094231|FG002|Overall Study|Lost to Follow-up|1|||
130308949|NCT00713544|469094232|FG003|Overall Study|Lost to Follow-up|0|||
130308950|NCT00713544|469094233|FG004|Overall Study|Lost to Follow-up|0|||
130308951|NCT00713544|469094234|FG005|Overall Study|Lost to Follow-up|0|||
130308952|NCT00713544|469094229|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308953|NCT00713544|469094230|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
130308954|NCT00713544|469094231|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308955|NCT00713544|469094232|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308956|NCT00713544|469094233|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308957|NCT00713544|469094234|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
130308958|NCT00713544|469094229|FG000|Overall Study|Incorrect enrollment|0|||
130308959|NCT00713544|469094230|FG001|Overall Study|Incorrect enrollment|1|||
130308960|NCT00713544|469094231|FG002|Overall Study|Incorrect enrollment|0|||
130308961|NCT00713544|469094232|FG003|Overall Study|Incorrect enrollment|0|||
130308962|NCT00713544|469094233|FG004|Overall Study|Incorrect enrollment|0|||
130308963|NCT00713544|469094234|FG005|Overall Study|Incorrect enrollment|0|||
130308964|NCT00713544|469094229|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
130308965|NCT00713544|469094230|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
130308966|NCT00713544|469094231|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
130308967|NCT00713544|469094232|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
130308968|NCT00713544|469094233|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
130308969|NCT00713544|469094234|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
130308970|NCT02380287|469094235|FG000|Overall Study|Adverse Event|0|||
130308971|NCT02380287|469094236|FG001|Overall Study|Adverse Event|0|||
130308972|NCT02380287|469094237|FG002|Overall Study|Adverse Event|1|||
130308973|NCT02380287|469094238|FG003|Overall Study|Adverse Event|0|||
130308974|NCT02380287|469094239|FG004|Overall Study|Adverse Event|0|||
130308975|NCT02380287|469094240|FG005|Overall Study|Adverse Event|0|||
130308976|NCT02380287|469094241|FG006|Overall Study|Adverse Event|0|||
130308977|NCT02380287|469094242|FG007|Overall Study|Adverse Event|0|||
130308978|NCT01641601|469094243|FG000|Overall Study|Study discontinued.|3|||
130308979|NCT01641601|469094244|FG001|Overall Study|Study discontinued.|5|||
130308980|NCT00950846|469094247|FG000|Overall Study|Death|6|||
130308981|NCT00950846|469094247|FG000|Overall Study|Lost to Follow-up|3|||
130308982|NCT00950846|469094247|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
130308983|NCT01799226|469094248|FG000|Overall Study|Withdrawal by Subject|1|||
130308984|NCT01799226|469094249|FG001|Overall Study|Withdrawal by Subject|0|||
130308985|NCT01799226|469094248|FG000|Overall Study|Disqualified at Day 14|1|||
130308986|NCT01799226|469094249|FG001|Overall Study|Disqualified at Day 14|0|||
130308987|NCT02178995|469094250|FG000|Double Blind|Adverse Event|0|||
130308988|NCT02178995|469094251|FG001|Double Blind|Adverse Event|0|||
130308989|NCT02178995|469094252|FG002|Double Blind|Adverse Event|0|||
130308990|NCT02178995|469094253|FG003|Double Blind|Adverse Event|0|||
130308991|NCT02178995|469094254|FG004|Double Blind|Adverse Event|0|||
130308992|NCT02178995|469094255|FG005|Double Blind|Adverse Event|1|||
130308993|NCT02178995|469094256|FG006|Double Blind|Adverse Event|0|||
130308994|NCT02178995|469094257|FG007|Double Blind|Adverse Event|1|||
130308995|NCT02178995|469094258|FG008|Double Blind|Adverse Event|1|||
130308996|NCT02178995|469094250|FG000|Double Blind|Lost to Follow-up|0|||
130308997|NCT02178995|469094251|FG001|Double Blind|Lost to Follow-up|1|||
130308998|NCT02178995|469094252|FG002|Double Blind|Lost to Follow-up|0|||
130308999|NCT02178995|469094253|FG003|Double Blind|Lost to Follow-up|0|||
130309000|NCT02178995|469094254|FG004|Double Blind|Lost to Follow-up|0|||
129798313|NCT02057393|467230060|FG000|Overall Study|Withdrawal by Subject|1|||
129798314|NCT02057393|467230060|FG000|Overall Study|Patient did not meet criteria|1|||
129798315|NCT02140775|467230061|FG000|Overall Study|Withdrawal by Subject|30|||
130110087|NCT01889862|468364126|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130110088|NCT01889862|468364127|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
130110089|NCT01889862|468364123|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
130110090|NCT01889862|468364124|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130110091|NCT01889862|468364125|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130309001|NCT02178995|469094255|FG005|Double Blind|Lost to Follow-up|0|||
130309002|NCT02178995|469094256|FG006|Double Blind|Lost to Follow-up|0|||
130309003|NCT02178995|469094257|FG007|Double Blind|Lost to Follow-up|1|||
130309004|NCT02178995|469094258|FG008|Double Blind|Lost to Follow-up|0|||
130309005|NCT02178995|469094250|FG000|Open Label|Adverse Event|2|||
130309006|NCT02178995|469094251|FG001|Open Label|Adverse Event|0|||
130309007|NCT02178995|469094252|FG002|Open Label|Adverse Event|0|||
130309008|NCT02178995|469094253|FG003|Open Label|Adverse Event|0|||
130309009|NCT02178995|469094254|FG004|Open Label|Adverse Event|0|||
130309010|NCT02178995|469094255|FG005|Open Label|Adverse Event|0|||
130309011|NCT02178995|469094256|FG006|Open Label|Adverse Event|0|||
130309012|NCT02178995|469094257|FG007|Open Label|Adverse Event|0|||
130309013|NCT02178995|469094258|FG008|Open Label|Adverse Event|0|||
130309014|NCT02274792|469094259|FG000|Overall Study|Withdrawal by Subject|13|||
130309015|NCT02274792|469094259|FG000|Overall Study|Lost to Follow-up|8|||
130309016|NCT02274792|469094259|FG000|Overall Study|Protocol Specified Criteria|2|||
130309017|NCT02274792|469094259|FG000|Overall Study|Sponsor Decision|2|||
130309018|NCT05258149|469094266|FG000|Period 1|Protocol Deviation|1|||
130309019|NCT05258149|469094267|FG001|Period 1|Protocol Deviation|0|||
130309020|NCT05258149|469094266|FG000|Period 1|Adverse Event|0|||
130309021|NCT05258149|469094267|FG001|Period 1|Adverse Event|1|||
130309022|NCT05258149|469094266|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
130309023|NCT05258149|469094267|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
130309024|NCT05258149|469094266|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130309025|NCT05258149|469094267|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130309026|NCT05258149|469094266|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
130309027|NCT05258149|469094267|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
130309028|NCT00832416|469094270|FG000|Overall Study|Lack of Efficacy|17|||
130309029|NCT00832416|469094271|FG001|Overall Study|Lack of Efficacy|15|||
130309030|NCT00832416|469094272|FG002|Overall Study|Lack of Efficacy|13|||
130309031|NCT00832416|469094273|FG003|Overall Study|Lack of Efficacy|52|||
130309032|NCT00832416|469094270|FG000|Overall Study|Withdrawal by Subject|5|||
130309033|NCT00832416|469094271|FG001|Overall Study|Withdrawal by Subject|7|||
130309034|NCT00832416|469094272|FG002|Overall Study|Withdrawal by Subject|2|||
130309035|NCT00832416|469094273|FG003|Overall Study|Withdrawal by Subject|10|||
129889500|NCT01513967|467552625|FG002|Overall Study|Pregnancy|0|||
130309036|NCT00832416|469094270|FG000|Overall Study|Physician Decision|2|||
130309037|NCT00832416|469094271|FG001|Overall Study|Physician Decision|12|||
130309038|NCT00832416|469094272|FG002|Overall Study|Physician Decision|5|||
130309039|NCT00832416|469094273|FG003|Overall Study|Physician Decision|10|||
129798316|NCT02140775|467230062|FG001|Overall Study|Withdrawal by Subject|7|||
129798317|NCT01172275|467230063|FG000|Overall Study|Lost to Follow-up|1|||
130309040|NCT00832416|469094270|FG000|Overall Study|Administrative|0|||
130309041|NCT00832416|469094271|FG001|Overall Study|Administrative|0|||
130309042|NCT00832416|469094272|FG002|Overall Study|Administrative|0|||
130309043|NCT00832416|469094273|FG003|Overall Study|Administrative|1|||
130309044|NCT00832416|469094270|FG000|Overall Study|Adverse Event|21|||
130309045|NCT00832416|469094271|FG001|Overall Study|Adverse Event|19|||
130309046|NCT00832416|469094272|FG002|Overall Study|Adverse Event|41|||
130309047|NCT00832416|469094273|FG003|Overall Study|Adverse Event|10|||
130309048|NCT00832416|469094270|FG000|Overall Study|Death|1|||
130309049|NCT00832416|469094271|FG001|Overall Study|Death|0|||
130309050|NCT00832416|469094272|FG002|Overall Study|Death|0|||
130309051|NCT00832416|469094273|FG003|Overall Study|Death|0|||
130309052|NCT02741596|469094280|FG000|Overall Study|Adverse Event|1|||
130309053|NCT02741596|469094281|FG001|Overall Study|Adverse Event|5|||
130309054|NCT02741596|469094280|FG000|Overall Study|Lost to Follow-up|1|||
130309055|NCT02741596|469094281|FG001|Overall Study|Lost to Follow-up|1|||
130309056|NCT02741596|469094280|FG000|Overall Study|Physician Decision|2|||
130309057|NCT02741596|469094281|FG001|Overall Study|Physician Decision|1|||
130309058|NCT02741596|469094280|FG000|Overall Study|Pregnancy|3|||
130309059|NCT02741596|469094281|FG001|Overall Study|Pregnancy|1|||
130309060|NCT02741596|469094280|FG000|Overall Study|Other (Unspecified)|0|||
130309061|NCT02741596|469094281|FG001|Overall Study|Other (Unspecified)|3|||
130309062|NCT02741596|469094280|FG000|Overall Study|Subject withdrawn-Other|17|||
130309063|NCT02741596|469094281|FG001|Overall Study|Subject withdrawn-Other|4|||
130309064|NCT02741596|469094280|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
130309065|NCT02741596|469094281|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
130309066|NCT02859246|469094284|FG000|Overall Study|Screen fails|3|||
130309067|NCT02859246|469094284|FG000|Overall Study|Adverse Event|1|||
130309068|NCT02859246|469094284|FG000|Overall Study|Withdrawal by Subject|1|||
130309069|NCT00100789|469094285|FG000|Overall Study|Adverse Event|10|||
130309070|NCT00100789|469094285|FG000|Overall Study|Withdrawal by Subject|1|||
130309071|NCT00100789|469094285|FG000|Overall Study|Progression/relapse|42|||
130309072|NCT00100789|469094285|FG000|Overall Study|Death|2|||
130309073|NCT00100789|469094285|FG000|Overall Study|Not protocol specified|5|||
130309074|NCT00100789|469094285|FG000|Overall Study|Ineligible|3|||
130309075|NCT00100789|469094285|FG000|Overall Study|Never received treatment|1|||
130309076|NCT01746368|469094286|FG000|Overall Study|Lost to Follow-up|2|||
130309077|NCT01746368|469094287|FG001|Overall Study|Lost to Follow-up|0|||
130309078|NCT01746368|469094286|FG000|Overall Study|Withdrawal by Subject|0|||
130309079|NCT01746368|469094287|FG001|Overall Study|Withdrawal by Subject|1|||
130309080|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
130309081|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
130309082|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
130309083|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309084|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309085|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309086|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
130309087|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
130309088|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309089|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129798318|NCT01172275|467230064|FG001|Overall Study|Lost to Follow-up|0|||
129798319|NCT01172275|467230063|FG000|Overall Study|Protocol Violation|1|||
129798320|NCT01172275|467230064|FG001|Overall Study|Protocol Violation|0|||
129798321|NCT04650854|467230069|FG000|Overall Study|Adverse Event|1|||
129798322|NCT04650854|467230070|FG001|Overall Study|Adverse Event|12|||
129798323|NCT04650854|467230071|FG002|Overall Study|Adverse Event|14|||
129798324|NCT04650854|467230069|FG000|Overall Study|Lack of Efficacy|1|||
129798325|NCT04650854|467230070|FG001|Overall Study|Lack of Efficacy|3|||
130049239|NCT01905397|468136687|FG000|Overall Study|Dressing not applied in operating room|1|||
130049240|NCT01905397|468136688|FG001|Overall Study|Dressing not applied in operating room|0|||
130049241|NCT01905397|468136687|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
130049242|NCT01905397|468136688|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
130049243|NCT04172831|468136691|FG000|Overall Study|Adverse Event|21|||
130049244|NCT04172831|468136692|FG001|Overall Study|Adverse Event|9|||
129798326|NCT04650854|467230071|FG002|Overall Study|Lack of Efficacy|6|||
130049245|NCT04172831|468136691|FG000|Overall Study|Lack of Efficacy|2|||
130309090|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309091|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129798327|NCT04650854|467230069|FG000|Overall Study|Lost to Follow-up|1|||
129798328|NCT04650854|467230070|FG001|Overall Study|Lost to Follow-up|1|||
129798329|NCT04650854|467230071|FG002|Overall Study|Lost to Follow-up|0|||
130309092|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309093|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
130309094|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130049246|NCT04172831|468136692|FG001|Overall Study|Lack of Efficacy|8|||
130049247|NCT04172831|468136691|FG000|Overall Study|Physician Decision|0|||
130049248|NCT04172831|468136692|FG001|Overall Study|Physician Decision|1|||
130049249|NCT04172831|468136691|FG000|Overall Study|Withdrawal by Subject|12|||
130049250|NCT04172831|468136692|FG001|Overall Study|Withdrawal by Subject|11|||
130049251|NCT04172831|468136691|FG000|Overall Study|Lost to Follow-up|4|||
130049252|NCT04172831|468136692|FG001|Overall Study|Lost to Follow-up|9|||
130049253|NCT04172831|468136691|FG000|Overall Study|COVID-19 related crisis|3|||
130049254|NCT04172831|468136692|FG001|Overall Study|COVID-19 related crisis|3|||
130049255|NCT04172831|468136691|FG000|Overall Study|Subject non-compliance|1|||
130049256|NCT04172831|468136692|FG001|Overall Study|Subject non-compliance|1|||
130049257|NCT04172831|468136691|FG000|Overall Study|Family emergency|1|||
130049258|NCT04172831|468136692|FG001|Overall Study|Family emergency|0|||
130049259|NCT01041573|468136693|FG000|Overall Study|Withdrawal by Subject|2|||
130049260|NCT01041573|468136694|FG001|Overall Study|Withdrawal by Subject|5|||
130049261|NCT01041573|468136695|FG002|Overall Study|Withdrawal by Subject|2|||
130049262|NCT01041573|468136696|FG003|Overall Study|Withdrawal by Subject|0|||
130049263|NCT01041573|468136693|FG000|Overall Study|Death|1|||
130049264|NCT01041573|468136694|FG001|Overall Study|Death|0|||
130049265|NCT01041573|468136695|FG002|Overall Study|Death|0|||
130049266|NCT01041573|468136696|FG003|Overall Study|Death|0|||
130049267|NCT01041573|468136693|FG000|Overall Study|Lost to Follow-up|0|||
130049268|NCT01041573|468136694|FG001|Overall Study|Lost to Follow-up|1|||
130049269|NCT01041573|468136695|FG002|Overall Study|Lost to Follow-up|2|||
130049270|NCT01041573|468136696|FG003|Overall Study|Lost to Follow-up|1|||
130049271|NCT01041573|468136693|FG000|Overall Study|Adverse Event|0|||
130049272|NCT01041573|468136694|FG001|Overall Study|Adverse Event|2|||
130049273|NCT01041573|468136695|FG002|Overall Study|Adverse Event|0|||
130049274|NCT01041573|468136696|FG003|Overall Study|Adverse Event|0|||
130049275|NCT01041573|468136693|FG000|Overall Study|relocation|1|||
130049276|NCT01041573|468136694|FG001|Overall Study|relocation|4|||
130049277|NCT01041573|468136695|FG002|Overall Study|relocation|3|||
130049278|NCT01041573|468136696|FG003|Overall Study|relocation|1|||
130049279|NCT01041573|468136693|FG000|Overall Study|further blood extraction|0|||
130049280|NCT01041573|468136694|FG001|Overall Study|further blood extraction|1|||
130049281|NCT01041573|468136695|FG002|Overall Study|further blood extraction|0|||
130049282|NCT01041573|468136696|FG003|Overall Study|further blood extraction|0|||
130049283|NCT01041573|468136693|FG000|Overall Study|positive to anti-HCV|1|||
130049284|NCT01041573|468136694|FG001|Overall Study|positive to anti-HCV|0|||
130049285|NCT01041573|468136695|FG002|Overall Study|positive to anti-HCV|0|||
130049286|NCT01041573|468136696|FG003|Overall Study|positive to anti-HCV|0|||
130049287|NCT01276847|468136698|FG000|Overall Study|Withdrawal by Subject|1|||
130049288|NCT01276847|468136699|FG001|Overall Study|Withdrawal by Subject|0|||
130049289|NCT01276847|468136700|FG002|Overall Study|Withdrawal by Subject|0|||
130049290|NCT02119104|468136703|FG000|Overall Study|Protocol Violation|16|||
130049291|NCT02239094|468136705|FG000|Overall Study|Withdrawal by Subject|1|||
130049292|NCT02239094|468136705|FG000|Overall Study|Remitted before started|1|||
130049293|NCT03184701|468136706|FG000|Overall Study|Death|3|||
130049294|NCT03184701|468136706|FG000|Overall Study|Physician Decision|3|||
130049295|NCT03184701|468136706|FG000|Overall Study|Withdrawal by Subject|6|||
130049296|NCT03184701|468136706|FG000|Overall Study|Lost to Follow-up|5|||
130049297|NCT02399475|468136712|FG000|Overall Study|Physician Decision|1|||
130309095|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
130309096|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309097|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309098|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309099|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309100|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
130309101|NCT05280717|469094288|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309102|NCT05280717|469094289|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309103|NCT05280717|469094290|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
130309104|NCT05280717|469094291|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130316270|NCT05767021|469124351|FG000|Overall Study|Assigned Treatment by Mistake|1|||
130316271|NCT04154943|469124355|FG000|Overall Study|Study Ongoing|68|||
130316272|NCT04154943|469124355|FG000|Overall Study|Lost to Follow-up|1|||
130316273|NCT04154943|469124355|FG000|Overall Study|Decision by the Investigator|1|||
130316274|NCT04154943|469124355|FG000|Overall Study|Death|5|||
129889501|NCT01513967|467552626|FG003|Overall Study|Pregnancy|0|||
130049298|NCT02399475|468136713|FG001|Overall Study|Physician Decision|0|||
130049299|NCT02260193|468136714|FG000|Overall Study|Lack of Efficacy|0|||
130049300|NCT02260193|468136715|FG001|Overall Study|Lack of Efficacy|1|||
130049301|NCT02260193|468136716|FG002|Overall Study|Lack of Efficacy|6|||
130110092|NCT01889862|468364126|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130110093|NCT01889862|468364127|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
130110094|NCT01889862|468364123|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
130110095|NCT01889862|468364124|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130110096|NCT01889862|468364125|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130110097|NCT01889862|468364126|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130110098|NCT01889862|468364127|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
130110099|NCT01889862|468364123|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130110100|NCT01889862|468364124|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130110101|NCT01889862|468364125|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
130110102|NCT01889862|468364126|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130110103|NCT01889862|468364127|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
130110104|NCT01889862|468364123|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130110105|NCT01889862|468364124|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130110106|NCT01889862|468364125|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130110107|NCT01889862|468364126|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
130110108|NCT01889862|468364127|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
130110109|NCT01889862|468364123|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
129798330|NCT04650854|467230069|FG000|Overall Study|Withdrawal by Subject|2|||
130110110|NCT01889862|468364124|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130110111|NCT01889862|468364125|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130110112|NCT01889862|468364126|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
130110113|NCT01889862|468364127|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
130110114|NCT01889862|468364123|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130110115|NCT01889862|468364124|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130110116|NCT01889862|468364125|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130110117|NCT01889862|468364126|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
130110118|NCT01889862|468364127|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
130110119|NCT01889862|468364123|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130110120|NCT01889862|468364124|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130110121|NCT01889862|468364125|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130110122|NCT01889862|468364126|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
130110123|NCT01889862|468364127|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
130110124|NCT01889862|468364123|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130110125|NCT01889862|468364124|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130110126|NCT01889862|468364125|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130110127|NCT01889862|468364126|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
130110128|NCT01889862|468364127|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
130110129|NCT00845026|468364128|FG000|Study Period III|Adverse Event|23|||
130110130|NCT00845026|468364129|FG001|Study Period III|Adverse Event|19|||
130110131|NCT00845026|468364128|FG000|Study Period III|Perceived lack of efficacy|27|||
130110132|NCT00845026|468364129|FG001|Study Period III|Perceived lack of efficacy|15|||
130110133|NCT00845026|468364128|FG000|Study Period III|Withdrawal by Subject|19|||
130110134|NCT00845026|468364129|FG001|Study Period III|Withdrawal by Subject|15|||
130110135|NCT00845026|468364128|FG000|Study Period III|Entry Criteria not met|8|||
130110136|NCT00845026|468364129|FG001|Study Period III|Entry Criteria not met|11|||
130110137|NCT00845026|468364128|FG000|Study Period III|Lost to Follow-up|4|||
130110138|NCT00845026|468364129|FG001|Study Period III|Lost to Follow-up|5|||
130110139|NCT00845026|468364128|FG000|Study Period III|Protocol Violation|8|||
130110140|NCT00845026|468364129|FG001|Study Period III|Protocol Violation|1|||
130309105|NCT05280717|469094292|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309106|NCT05280717|469094293|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309107|NCT05280717|469094294|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
130309108|NCT05280717|469094288|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309109|NCT05280717|469094289|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309110|NCT05280717|469094290|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309111|NCT05280717|469094291|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130110141|NCT00845026|468364128|FG000|Study Period III|Scheduled conflict|3|||
130110142|NCT00845026|468364129|FG001|Study Period III|Scheduled conflict|1|||
130110143|NCT00845026|468364128|FG000|Study Period III|Subject is moving or has moved|2|||
130110144|NCT00845026|468364129|FG001|Study Period III|Subject is moving or has moved|4|||
130110145|NCT00845026|468364128|FG000|Study Period III|Transportation issues|1|||
130110146|NCT00845026|468364129|FG001|Study Period III|Transportation issues|1|||
130110147|NCT00845026|468364128|FG000|Study Period IV|Adverse Event|4|||
130110148|NCT00845026|468364129|FG001|Study Period IV|Adverse Event|0|||
130110149|NCT00845026|468364128|FG000|Study Period IV|Perceived lack of efficacy|2|||
130110150|NCT00845026|468364129|FG001|Study Period IV|Perceived lack of efficacy|1|||
130110151|NCT00845026|468364128|FG000|Study Period IV|Protocol Violation|3|||
130110152|NCT00845026|468364129|FG001|Study Period IV|Protocol Violation|1|||
130110153|NCT00845026|468364128|FG000|Study Period IV|Lost to Follow-up|1|||
130110154|NCT00845026|468364129|FG001|Study Period IV|Lost to Follow-up|0|||
130309112|NCT05280717|469094292|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309113|NCT05280717|469094293|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
130309114|NCT05280717|469094294|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
130309115|NCT05280717|469094288|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309116|NCT05280717|469094289|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309117|NCT05280717|469094290|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309118|NCT05280717|469094291|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309119|NCT05280717|469094292|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309120|NCT05280717|469094293|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
130309121|NCT05280717|469094294|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
130309122|NCT00080301|469094295|FG000|Overall Study|Randomized but Never Treated|5|||
130309123|NCT00080301|469094296|FG001|Overall Study|Randomized but Never Treated|10|||
130309124|NCT00080301|469094295|FG000|Overall Study|Still on Treatment as of CSR date|0|||
130309125|NCT00080301|469094296|FG001|Overall Study|Still on Treatment as of CSR date|1|||
130309126|NCT02518971|469094297|FG000|Overall Study|Lost to Follow-up|0|||
130309127|NCT02518971|469094298|FG001|Overall Study|Lost to Follow-up|1|||
130309128|NCT02518971|469094297|FG000|Overall Study|Physician Decision|6|||
130309129|NCT02518971|469094298|FG001|Overall Study|Physician Decision|6|||
130309130|NCT02518971|469094297|FG000|Overall Study|Protocol Violation|6|||
130309131|NCT02518971|469094298|FG001|Overall Study|Protocol Violation|4|||
130309132|NCT02518971|469094297|FG000|Overall Study|Withdrawal by Subject|4|||
130309133|NCT02518971|469094298|FG001|Overall Study|Withdrawal by Subject|5|||
130309134|NCT02518971|469094297|FG000|Overall Study|Side effects|1|||
130309135|NCT02518971|469094298|FG001|Overall Study|Side effects|0|||
130309136|NCT02518971|469094297|FG000|Overall Study|medication lost in mail|0|||
130309137|NCT02518971|469094298|FG001|Overall Study|medication lost in mail|1|||
130309138|NCT02518971|469094297|FG000|Overall Study|eligibility criteria no longer met|6|||
130309139|NCT02518971|469094298|FG001|Overall Study|eligibility criteria no longer met|3|||
130309140|NCT02336230|469094299|FG000|Overall Study|Adverse Event|1|||
130309141|NCT02336230|469094299|FG000|Overall Study|Withdrawal of consent|1|||
130309142|NCT02336230|469094299|FG000|Overall Study|Death|9|||
130309143|NCT02336230|469094299|FG000|Overall Study|Dose not received due to shipping delay|1|||
130309144|NCT02336230|469094299|FG000|Overall Study|Discontinuation of MSC infusion|1|||
130309145|NCT02524171|469094300|FG000|6-month Follow-up|Lost to Follow-up|53|||
130309146|NCT02524171|469094301|FG001|6-month Follow-up|Lost to Follow-up|45|||
130309147|NCT02524171|469094300|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
130309148|NCT02524171|469094301|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
130309149|NCT00757237|469094304|FG000|Overall Study|Lost to Follow-up|0|||
130309150|NCT00757237|469094305|FG001|Overall Study|Lost to Follow-up|1|||
130309151|NCT00757237|469094304|FG000|Overall Study|Protocol Violation|0|||
130110155|NCT00845026|468364128|FG000|Study Period IV|Withdrawal by Subject|4|||
130110156|NCT00845026|468364129|FG001|Study Period IV|Withdrawal by Subject|1|||
130110157|NCT00845026|468364128|FG000|Study Period IV|Entry Criteria Not Met|1|||
130110158|NCT00845026|468364129|FG001|Study Period IV|Entry Criteria Not Met|0|||
130110159|NCT00845026|468364128|FG000|Study Period IV|Subject is moving or has moved|0|||
130110160|NCT00845026|468364129|FG001|Study Period IV|Subject is moving or has moved|1|||
130110161|NCT00845026|468364128|FG000|Study Period IV|Scheduling conflict|1|||
130110162|NCT00845026|468364129|FG001|Study Period IV|Scheduling conflict|0|||
130110163|NCT01325532|468364130|FG000|Overall Study|Withdrawal by Subject|2|||
130110164|NCT01325532|468364131|FG001|Overall Study|Withdrawal by Subject|0|||
130110165|NCT03012815|468364132|FG000|Overall Study|Lost to Follow-up|1|||
130110166|NCT03012815|468364133|FG001|Overall Study|Lost to Follow-up|0|||
130110167|NCT03012815|468364132|FG000|Overall Study|Physician Decision|3|||
130110168|NCT03012815|468364133|FG001|Overall Study|Physician Decision|2|||
130110169|NCT03012815|468364132|FG000|Overall Study|Adverse Event|1|||
130110170|NCT03012815|468364133|FG001|Overall Study|Adverse Event|0|||
130110171|NCT01252238|468364134|FG000|Overall Study|Sponsor terminated study|4|||
130110172|NCT01252238|468364135|FG001|Overall Study|Sponsor terminated study|4|||
130110173|NCT01252238|468364136|FG002|Overall Study|Sponsor terminated study|4|||
130110174|NCT02065791|468364137|FG000|Overall Study|Closed Site|1|||
130110175|NCT02065791|468364138|FG001|Overall Study|Closed Site|1|||
130110176|NCT02065791|468364137|FG000|Overall Study|Withdrawal by Subject|11|||
130309152|NCT00757237|469094305|FG001|Overall Study|Protocol Violation|2|||
129889502|NCT01513967|467552627|FG004|Overall Study|Pregnancy|0|||
129889503|NCT01513967|467552628|FG005|Overall Study|Pregnancy|0|||
130309153|NCT00757237|469094304|FG000|Overall Study|Physician Decision|2|||
130309154|NCT00757237|469094305|FG001|Overall Study|Physician Decision|3|||
130309155|NCT00757237|469094304|FG000|Overall Study|Withdrawal by Subject|8|||
130309156|NCT00757237|469094305|FG001|Overall Study|Withdrawal by Subject|12|||
130309157|NCT00757237|469094304|FG000|Overall Study|Safety or Tolerability|3|||
130110177|NCT02065791|468364138|FG001|Overall Study|Withdrawal by Subject|5|||
130110178|NCT02065791|468364137|FG000|Overall Study|Lost to Follow-up|13|||
130110179|NCT02065791|468364138|FG001|Overall Study|Lost to Follow-up|9|||
129889504|NCT01513967|467552629|FG006|Overall Study|Pregnancy|1|||
129889505|NCT01513967|467552630|FG007|Overall Study|Pregnancy|0|||
130049302|NCT02260193|468136714|FG000|Overall Study|Adverse Event|3|||
130049303|NCT02260193|468136715|FG001|Overall Study|Adverse Event|4|||
130049304|NCT02260193|468136716|FG002|Overall Study|Adverse Event|1|||
130049305|NCT02260193|468136714|FG000|Overall Study|Protocol Violation|0|||
130049306|NCT02260193|468136715|FG001|Overall Study|Protocol Violation|4|||
130049307|NCT02260193|468136716|FG002|Overall Study|Protocol Violation|0|||
130049308|NCT02260193|468136714|FG000|Overall Study|Withdrawal by Subject|3|||
130049309|NCT02260193|468136715|FG001|Overall Study|Withdrawal by Subject|0|||
130049310|NCT02260193|468136716|FG002|Overall Study|Withdrawal by Subject|2|||
130049311|NCT02260193|468136714|FG000|Overall Study|Kidney Transplantation|0|||
130049312|NCT02260193|468136715|FG001|Overall Study|Kidney Transplantation|0|||
130049313|NCT02260193|468136716|FG002|Overall Study|Kidney Transplantation|1|||
130049314|NCT01963117|468136724|FG000|Overall Study|Death|1|||
130049315|NCT01000064|468136725|FG000|Overall Study|Withdrawal by Subject|1|||
130049316|NCT01000064|468136726|FG001|Overall Study|Withdrawal by Subject|1|||
130049317|NCT01518192|468136727|FG000|Overall Study|Lost to Follow-up|29|||
130049318|NCT01518192|468136728|FG001|Overall Study|Lost to Follow-up|26|||
130049319|NCT01518192|468136729|FG002|Overall Study|Lost to Follow-up|35|||
130049320|NCT03090737|468136732|FG000|Overall Study|Other reasons|1|||
130049321|NCT03090737|468136732|FG000|Overall Study|Completed treatment as per protocol|17|||
130049322|NCT03090737|468136732|FG000|Overall Study|Maximum clinical benefit|2|||
130049323|NCT03090737|468136732|FG000|Overall Study|Adverse event unrelated to study drug|7|||
130049324|NCT03090737|468136732|FG000|Overall Study|Study drug toxicity|4|||
130049325|NCT03090737|468136732|FG000|Overall Study|Disease progression|98|||
130049326|NCT03141307|468136733|FG000|In-Hospital|Withdrawal by Subject|0|||
130049327|NCT03141307|468136734|FG001|In-Hospital|Withdrawal by Subject|2|||
130049328|NCT03141307|468136733|FG000|In-Hospital|Protocol Violation|4|||
130049329|NCT03141307|468136734|FG001|In-Hospital|Protocol Violation|0|||
130049330|NCT03141307|468136733|FG000|Follow-Up|Lost to Follow-up|97|||
130049331|NCT03141307|468136734|FG001|Follow-Up|Lost to Follow-up|54|||
130049332|NCT04430582|468136737|FG000|Overall Study|Found to meet exclusionary criteria|1|||
130049333|NCT04430582|468136738|FG001|Overall Study|Found to meet exclusionary criteria|0|||
130049334|NCT04430582|468136737|FG000|Overall Study|Withdrawal by Subject|0|||
130049335|NCT04430582|468136738|FG001|Overall Study|Withdrawal by Subject|1|||
130049336|NCT02574312|468136739|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
130049337|NCT02574312|468136740|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
130049338|NCT04267562|468138613|FG000|Assessed for Eligibility|Screen Failure|64|||
130049339|NCT04267562|468138613|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
130049340|NCT04267562|468138613|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
130049341|NCT04267562|468138613|FG000|Assessed for Eligibility|Site closure|6|||
130049342|NCT04267562|468138613|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
130049343|NCT04267562|468138613|FG000|Assessed for Eligibility|Physician Decision|1|||
130049344|NCT04267562|468138613|FG000|Month 24|Elective hysterectomy|1|||
130049345|NCT04267562|468138613|FG000|Month 24|Lost to Follow-up|1|||
130049346|NCT04267562|468138613|FG000|Month 36|Elective hysterectomy|2|||
130049347|NCT04267562|468138613|FG000|Month 36|Lost to Follow-up|3|||
130049348|NCT02078713|468138614|FG000|Overall Study|Lost to Follow-up|49|||
130049349|NCT02078713|468138615|FG001|Overall Study|Lost to Follow-up|55|||
130049350|NCT02078713|468138616|FG002|Overall Study|Lost to Follow-up|0|||
130049351|NCT02078713|468138617|FG003|Overall Study|Lost to Follow-up|0|||
130049352|NCT02078713|468138614|FG000|Overall Study|Pregnant at baseline|3|||
130049353|NCT02078713|468138615|FG001|Overall Study|Pregnant at baseline|5|||
130049354|NCT02078713|468138616|FG002|Overall Study|Pregnant at baseline|0|||
130049355|NCT02078713|468138617|FG003|Overall Study|Pregnant at baseline|0|||
130049356|NCT02078713|468138614|FG000|Overall Study|Enrolled twice|0|||
130049357|NCT02078713|468138615|FG001|Overall Study|Enrolled twice|1|||
130049358|NCT02078713|468138616|FG002|Overall Study|Enrolled twice|0|||
130049359|NCT02078713|468138617|FG003|Overall Study|Enrolled twice|0|||
130049360|NCT00696657|468138622|FG000|Overall Study|Protocol Violation|0|||
130049361|NCT00696657|468138623|FG001|Overall Study|Protocol Violation|0|||
130049362|NCT00696657|468138624|FG002|Overall Study|Protocol Violation|0|||
130049363|NCT00696657|468138625|FG003|Overall Study|Protocol Violation|0|||
130049364|NCT00696657|468138626|FG004|Overall Study|Protocol Violation|0|||
130049365|NCT00696657|468138627|FG005|Overall Study|Protocol Violation|1|||
130049366|NCT00696657|468138628|FG006|Overall Study|Protocol Violation|0|||
130049367|NCT00696657|468138629|FG007|Overall Study|Protocol Violation|0|||
130049368|NCT00696657|468138630|FG008|Overall Study|Protocol Violation|1|||
130049369|NCT00696657|468138622|FG000|Overall Study|Lack of Efficacy|0|||
130049370|NCT00696657|468138623|FG001|Overall Study|Lack of Efficacy|1|||
130049371|NCT00696657|468138624|FG002|Overall Study|Lack of Efficacy|0|||
130049372|NCT00696657|468138625|FG003|Overall Study|Lack of Efficacy|0|||
130049373|NCT00696657|468138626|FG004|Overall Study|Lack of Efficacy|0|||
130049374|NCT00696657|468138627|FG005|Overall Study|Lack of Efficacy|0|||
130049375|NCT00696657|468138628|FG006|Overall Study|Lack of Efficacy|0|||
130049376|NCT00696657|468138629|FG007|Overall Study|Lack of Efficacy|0|||
130049377|NCT00696657|468138630|FG008|Overall Study|Lack of Efficacy|0|||
130049378|NCT00696657|468138622|FG000|Overall Study|Withdrawal criteria|1|||
130110180|NCT00272961|468364139|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
130110181|NCT00272961|468364140|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130110182|NCT00272961|468364141|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130110183|NCT00272961|468364142|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130110184|NCT00272961|468364143|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
130110185|NCT00272961|468364139|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
130110186|NCT00272961|468364140|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130110187|NCT00272961|468364141|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130110188|NCT00272961|468364142|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130110189|NCT00272961|468364143|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
130110190|NCT00272961|468364139|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
130110191|NCT00272961|468364140|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130110192|NCT00272961|468364141|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130110193|NCT00272961|468364142|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130110194|NCT00272961|468364143|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
130110195|NCT00272961|468364139|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
130110196|NCT00272961|468364140|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130110197|NCT00272961|468364141|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130110198|NCT00272961|468364142|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130110199|NCT00272961|468364143|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
130110200|NCT00272961|468364139|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
130110201|NCT00272961|468364140|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
130110202|NCT00272961|468364141|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
130110203|NCT00272961|468364142|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
130110204|NCT00272961|468364143|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
130110205|NCT00272961|468364139|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
130110206|NCT00272961|468364140|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
130110207|NCT00272961|468364141|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
130110208|NCT00272961|468364142|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
130110209|NCT00272961|468364143|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
130110210|NCT00272961|468364139|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
130110211|NCT00272961|468364140|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
130110212|NCT00272961|468364141|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
130110213|NCT00272961|468364142|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
130110214|NCT00272961|468364143|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
130110215|NCT00272961|468364139|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
130110216|NCT00272961|468364140|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
130110217|NCT00272961|468364141|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
130110218|NCT00272961|468364142|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
130110219|NCT00272961|468364143|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
130110220|NCT00411762|468364150|FG000|Overall Study|Withdrawal by Subject|5|||
130110221|NCT01238211|468364151|FG000|Overall Study|Continues active treatment|31|||
130110222|NCT01238211|468364151|FG000|Overall Study|Adverse Event|7|||
130110223|NCT01238211|468364151|FG000|Overall Study|Death|4|||
130110224|NCT01238211|468364151|FG000|Overall Study|Relapse/Progression|2|||
129798331|NCT04650854|467230070|FG001|Overall Study|Withdrawal by Subject|17|||
129798332|NCT04650854|467230071|FG002|Overall Study|Withdrawal by Subject|9|||
129798333|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
129798334|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
129798335|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
130110225|NCT01238211|468364151|FG000|Overall Study|Withdrawal by Subject|7|||
130110226|NCT01238211|468364151|FG000|Overall Study|Non-protocol treatment|4|||
130110227|NCT01238211|468364151|FG000|Overall Study|Investigator/Patient Decision|3|||
129798336|NCT04650854|467230069|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
129798337|NCT04650854|467230070|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
129798338|NCT04650854|467230071|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
129798339|NCT04650854|467230069|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
129798340|NCT04650854|467230070|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
129798341|NCT04650854|467230071|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
129798342|NCT04650854|467230069|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
129798343|NCT04650854|467230070|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
129798344|NCT04650854|467230071|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
130110228|NCT04428502|468364152|FG000|Overall Study|Did not meet entrance criteria|14|||
129798345|NCT04650854|467230069|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
129798346|NCT04650854|467230070|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
129798347|NCT04650854|467230071|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
129798348|NCT04650854|467230069|FG000|Overall Study|Use of Rescue Medication|0|||
129798349|NCT04650854|467230070|FG001|Overall Study|Use of Rescue Medication|0|||
129798350|NCT04650854|467230071|FG002|Overall Study|Use of Rescue Medication|1|||
129798351|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Sponsor|0|||
129798352|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Sponsor|0|||
129798353|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Sponsor|2|||
129798354|NCT04650854|467230069|FG000|Overall Study|Rescue Medication|0|||
129798355|NCT04650854|467230070|FG001|Overall Study|Rescue Medication|0|||
129798356|NCT04650854|467230071|FG002|Overall Study|Rescue Medication|1|||
129798357|NCT04650854|467230069|FG000|Overall Study|Participant Want to Start a Family|0|||
129798358|NCT04650854|467230070|FG001|Overall Study|Participant Want to Start a Family|0|||
129798359|NCT04650854|467230071|FG002|Overall Study|Participant Want to Start a Family|1|||
129798360|NCT04650854|467230069|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
129798361|NCT04650854|467230070|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
129798362|NCT04650854|467230071|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
129798363|NCT04650854|467230069|FG000|Overall Study|Participant Screened For MG0020|0|||
130110229|NCT00449930|468364155|FG000|Overall Study|Adverse Event|9|||
130110230|NCT00449930|468364156|FG001|Overall Study|Adverse Event|19|||
130110231|NCT00449930|468364155|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
130110232|NCT00449930|468364156|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
129798364|NCT04650854|467230070|FG001|Overall Study|Participant Screened For MG0020|2|||
129798365|NCT04650854|467230071|FG002|Overall Study|Participant Screened For MG0020|3|||
130110233|NCT00449930|468364155|FG000|Overall Study|Lack of Efficacy|10|||
130110234|NCT00449930|468364156|FG001|Overall Study|Lack of Efficacy|1|||
130110235|NCT00449930|468364155|FG000|Overall Study|Lost to Follow-up|9|||
130110236|NCT00449930|468364156|FG001|Overall Study|Lost to Follow-up|14|||
130110237|NCT00449930|468364155|FG000|Overall Study|Physician Decision|1|||
130110238|NCT00449930|468364156|FG001|Overall Study|Physician Decision|2|||
130110239|NCT00449930|468364155|FG000|Overall Study|Protocol Violation|14|||
130110240|NCT00449930|468364156|FG001|Overall Study|Protocol Violation|15|||
130110241|NCT00449930|468364155|FG000|Overall Study|Withdrawal by Subject|16|||
130110242|NCT00449930|468364156|FG001|Overall Study|Withdrawal by Subject|23|||
130110243|NCT00449930|468364155|FG000|Overall Study|Glycemic discontinuation criteria|1|||
130110244|NCT00449930|468364156|FG001|Overall Study|Glycemic discontinuation criteria|1|||
130110245|NCT01864525|468364157|FG000|Overall Study|Adverse Event|1|||
130110246|NCT01864525|468364158|FG001|Overall Study|Adverse Event|0|||
130110247|NCT01890785|468364159|FG000|Third Intervention|Withdrawal by Subject|0|||
130110248|NCT01890785|468364160|FG001|Third Intervention|Withdrawal by Subject|1|||
130110249|NCT01890785|468364161|FG002|Third Intervention|Withdrawal by Subject|0|||
130110250|NCT01890785|468364162|FG003|Third Intervention|Withdrawal by Subject|0|||
130110251|NCT01890785|468364163|FG004|Third Intervention|Withdrawal by Subject|0|||
130110252|NCT01890785|468364164|FG005|Third Intervention|Withdrawal by Subject|0|||
130110253|NCT03712228|468364165|FG000|Treatment Period 1|Lack of Efficacy|0|||
130110254|NCT03712228|468364166|FG001|Treatment Period 1|Lack of Efficacy|0|||
130309158|NCT00757237|469094305|FG001|Overall Study|Safety or Tolerability|5|||
129798366|NCT04650854|467230069|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
129798367|NCT04650854|467230070|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
129798368|NCT04650854|467230071|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
129798369|NCT04650854|467230069|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
129798370|NCT04650854|467230070|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
129798371|NCT04650854|467230071|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
129798372|NCT04650854|467230069|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
129798373|NCT04650854|467230070|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
129798374|NCT04650854|467230071|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
129798375|NCT04650854|467230069|FG000|Overall Study|End Of Study|0|||
129798376|NCT04650854|467230070|FG001|Overall Study|End Of Study|2|||
130110255|NCT03712228|468364167|FG002|Treatment Period 1|Lack of Efficacy|0|||
130309159|NCT00757237|469094304|FG000|Overall Study|Other|0|||
130309160|NCT00757237|469094305|FG001|Overall Study|Other|2|||
130309161|NCT01345188|469094306|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
130309162|NCT01345188|469094306|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
130309163|NCT05150990|469094307|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
130309164|NCT05150990|469094308|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
130309165|NCT05150990|469094307|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
130309166|NCT05150990|469094308|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
130309167|NCT05150990|469094307|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
130309168|NCT05150990|469094308|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
130110256|NCT03712228|468364168|FG003|Treatment Period 1|Lack of Efficacy|0|||
130110257|NCT03712228|468364169|FG004|Treatment Period 1|Lack of Efficacy|0|||
129798377|NCT04650854|467230071|FG002|Overall Study|End Of Study|1|||
130110258|NCT03712228|468364170|FG005|Treatment Period 1|Lack of Efficacy|1|||
130110259|NCT03712228|468364165|FG000|Treatment Period 2|Pregnancy|0|||
130309169|NCT05150990|469094307|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
130110260|NCT03712228|468364166|FG001|Treatment Period 2|Pregnancy|0|||
130309170|NCT05150990|469094308|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
130309171|NCT05150990|469094307|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
130309172|NCT05150990|469094308|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
130309173|NCT05150990|469094307|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
130309174|NCT05150990|469094308|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
130309175|NCT05150990|469094307|FG000|Overall Study|Death (unrelated to the intervention)|1|||
130309176|NCT05150990|469094308|FG001|Overall Study|Death (unrelated to the intervention)|2|||
130309177|NCT00466921|469094309|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
130309178|NCT00466921|469094309|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
130309179|NCT00466921|469094309|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
130309180|NCT00466921|469094309|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
130309181|NCT00466921|469094309|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
130309182|NCT00466921|469094309|FG000|Follow up for a Minimum of 1 Year|Death|6|||
130309183|NCT05447663|469094311|FG000|Overall Study|Study terminated by Sponsor|5|||
130309184|NCT05447663|469094311|FG000|Overall Study|Death|2|||
130309185|NCT05447663|469094311|FG000|Overall Study|Withdrawal by Subject|1|||
130309186|NCT01397461|469094312|FG000|Overall Study|Withdrawal by Subject|2|||
130309187|NCT01397461|469094313|FG001|Overall Study|Withdrawal by Subject|1|||
130309188|NCT01397461|469094314|FG002|Overall Study|Withdrawal by Subject|0|||
130309189|NCT01397461|469094312|FG000|Overall Study|Lost to Follow-up|0|||
130309190|NCT01397461|469094313|FG001|Overall Study|Lost to Follow-up|2|||
130309191|NCT01397461|469094314|FG002|Overall Study|Lost to Follow-up|1|||
130309192|NCT01397461|469094312|FG000|Overall Study|Lack of Efficacy|0|||
130309193|NCT01397461|469094313|FG001|Overall Study|Lack of Efficacy|3|||
130309194|NCT01397461|469094314|FG002|Overall Study|Lack of Efficacy|0|||
130309195|NCT01397461|469094312|FG000|Overall Study|Not treated|0|||
130309196|NCT01397461|469094313|FG001|Overall Study|Not treated|0|||
130309197|NCT01397461|469094314|FG002|Overall Study|Not treated|1|||
130309198|NCT05729568|469094331|FG000|Overall Study|Still on Study|52|||
130309199|NCT05729568|469094332|FG001|Overall Study|Still on Study|26|||
130309200|NCT05729568|469094331|FG000|Overall Study|Randomized but Never Treated|3|||
130309201|NCT05729568|469094332|FG001|Overall Study|Randomized but Never Treated|0|||
130309202|NCT05729568|469094331|FG000|Overall Study|Adverse Event|0|||
130309203|NCT05729568|469094332|FG001|Overall Study|Adverse Event|1|||
130309204|NCT05729568|469094331|FG000|Overall Study|Investigator's Discretion|1|||
130309205|NCT05729568|469094332|FG001|Overall Study|Investigator's Discretion|0|||
130309206|NCT04181762|469094333|FG000|Overall Study|Adverse Event|1|||
130309207|NCT04181762|469094334|FG001|Overall Study|Adverse Event|3|||
130309208|NCT04181762|469094333|FG000|Overall Study|Lost to Follow-up|1|||
130309209|NCT04181762|469094334|FG001|Overall Study|Lost to Follow-up|1|||
130309210|NCT04181762|469094333|FG000|Overall Study|Physician Decision|1|||
130309211|NCT04181762|469094334|FG001|Overall Study|Physician Decision|3|||
130309212|NCT04181762|469094333|FG000|Overall Study|Pregnancy|0|||
130309213|NCT04181762|469094334|FG001|Overall Study|Pregnancy|1|||
130309214|NCT04181762|469094333|FG000|Overall Study|Lack of Efficacy|2|||
130309215|NCT04181762|469094334|FG001|Overall Study|Lack of Efficacy|2|||
130309216|NCT04181762|469094333|FG000|Overall Study|Study terminated by sponsor|95|||
130309217|NCT04181762|469094334|FG001|Overall Study|Study terminated by sponsor|97|||
130309218|NCT04181762|469094333|FG000|Overall Study|Subject decision|11|||
130309219|NCT04181762|469094334|FG001|Overall Study|Subject decision|4|||
130309220|NCT04181762|469094333|FG000|Overall Study|Death|1|||
130309221|NCT04181762|469094334|FG001|Overall Study|Death|1|||
130309222|NCT04181762|469094333|FG000|Overall Study|Protocol deviation|1|||
130309223|NCT04181762|469094334|FG001|Overall Study|Protocol deviation|0|||
130309224|NCT04181762|469094333|FG000|Overall Study|Withdrawal of informed consent|1|||
130309225|NCT04181762|469094334|FG001|Overall Study|Withdrawal of informed consent|3|||
130309226|NCT06041919|469094335|FG000|Overall Study|Lost to Follow-up|1|||
130309227|NCT06041919|469094336|FG001|Overall Study|Lost to Follow-up|0|||
130309228|NCT06041919|469094337|FG002|Overall Study|Lost to Follow-up|0|||
130309229|NCT06041919|469094338|FG003|Overall Study|Lost to Follow-up|0|||
130309230|NCT06041919|469094339|FG004|Overall Study|Lost to Follow-up|0|||
130309231|NCT06041919|469094335|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
130309232|NCT06041919|469094336|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
130309233|NCT06041919|469094337|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
130309234|NCT06041919|469094338|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
130309235|NCT06041919|469094339|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
130309236|NCT00637416|469094342|FG000|Overall Study|Lost to Follow-up|1|||
130309237|NCT00637416|469094343|FG001|Overall Study|Lost to Follow-up|1|||
130110261|NCT03712228|468364167|FG002|Treatment Period 2|Pregnancy|0|||
130309238|NCT00637416|469094342|FG000|Overall Study|Unable to take study drug|0|||
130309239|NCT00637416|469094343|FG001|Overall Study|Unable to take study drug|1|||
130110262|NCT03712228|468364168|FG003|Treatment Period 2|Pregnancy|1|||
130309240|NCT01147055|469094344|FG000|First Intervention Period|Lost to Follow-up|1|||
130309241|NCT01147055|469094345|FG001|First Intervention Period|Lost to Follow-up|0|||
130309242|NCT05236257|469094378|FG000|Overall Study|Ongoing with study treatment|29|||
130309243|NCT05236257|469094379|FG001|Overall Study|Ongoing with study treatment|1|||
130309244|NCT05236257|469094378|FG000|Overall Study|Discontinued study treatment|22|||
130309245|NCT05236257|469094379|FG001|Overall Study|Discontinued study treatment|41|||
130309246|NCT00874848|469094382|FG000|Overall Study|Adverse Event|13|||
130309247|NCT00874848|469094383|FG001|Overall Study|Adverse Event|2|||
130309248|NCT00874848|469094382|FG000|Overall Study|Progressive neoplastic disease|38|||
130309249|NCT00874848|469094383|FG001|Overall Study|Progressive neoplastic disease|18|||
130309250|NCT00874848|469094382|FG000|Overall Study|Withdrawal by Subject|7|||
130309251|NCT00874848|469094383|FG001|Overall Study|Withdrawal by Subject|4|||
130309252|NCT00874848|469094382|FG000|Overall Study|Noncompliance|1|||
130309253|NCT00874848|469094383|FG001|Overall Study|Noncompliance|1|||
130309254|NCT00874848|469094382|FG000|Overall Study|Failure to comply with protocol|0|||
130309255|NCT00874848|469094383|FG001|Overall Study|Failure to comply with protocol|1|||
130309256|NCT00874848|469094382|FG000|Overall Study|Physician Decision|0|||
130309257|NCT00874848|469094383|FG001|Overall Study|Physician Decision|2|||
130309258|NCT02713828|469094385|FG000|Overall Study|Death|2|||
130309259|NCT02713828|469094386|FG001|Overall Study|Death|0|||
130309260|NCT02713828|469094385|FG000|Overall Study|Withdrawal by Subject|1|||
130309261|NCT02713828|469094386|FG001|Overall Study|Withdrawal by Subject|0|||
130309262|NCT02713828|469094385|FG000|Overall Study|study terminated but patient allowed to|2|||
130309263|NCT02713828|469094386|FG001|Overall Study|study terminated but patient allowed to|0|||
130309264|NCT00003199|469094387|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
130309265|NCT00003199|469094387|FG000|Overall Study|Lack of insurance clearance|2|||
130309266|NCT00003199|469094387|FG000|Overall Study|Screen fail|15|||
130309267|NCT03553758|469095888|FG000|Overall Study|Lost to Follow-up|1|||
130309268|NCT00447226|469095889|FG000|12-Week Open-label Phase|Adverse Event|0|||
130309269|NCT00447226|469095890|FG001|12-Week Open-label Phase|Adverse Event|3|||
130309270|NCT00447226|469095889|FG000|12-Week Open-label Phase|Protocol Violation|0|||
130309271|NCT00447226|469095890|FG001|12-Week Open-label Phase|Protocol Violation|1|||
130309272|NCT00447226|469095889|FG000|12-Week Open-label Phase|Disease Progression|0|||
130309273|NCT00447226|469095890|FG001|12-Week Open-label Phase|Disease Progression|20|||
130309274|NCT00447226|469095889|FG000|12-Week Open-label Phase|Physician Decision|0|||
130309275|NCT00447226|469095890|FG001|12-Week Open-label Phase|Physician Decision|1|||
130309276|NCT00447226|469095889|FG000|Double-blind Phase|Disease Progression|4|||
130309277|NCT00447226|469095890|FG001|Double-blind Phase|Disease Progression|3|||
130309278|NCT00502671|469095894|FG000|Overall Study|Disease Progression|13|||
130309279|NCT00502671|469095894|FG000|Overall Study|Personal Reasons|22|||
130309280|NCT00502671|469095894|FG000|Overall Study|Lost to Follow-up|7|||
130309281|NCT00502671|469095894|FG000|Overall Study|Protocol Violation|16|||
130309282|NCT00502671|469095894|FG000|Overall Study|Adverse Event|19|||
130309283|NCT00412893|469095897|FG000|Overall Study|Adverse Event|31|||
130309284|NCT00412893|469095898|FG001|Overall Study|Adverse Event|53|||
130309285|NCT00412893|469095897|FG000|Overall Study|Death|17|||
130309286|NCT00412893|469095898|FG001|Overall Study|Death|21|||
130309287|NCT00412893|469095897|FG000|Overall Study|Insufficient Therapeutic Response|39|||
130309288|NCT00412893|469095898|FG001|Overall Study|Insufficient Therapeutic Response|23|||
130309289|NCT00412893|469095897|FG000|Overall Study|Lost to Follow-up|2|||
130309290|NCT00412893|469095898|FG001|Overall Study|Lost to Follow-up|1|||
130309291|NCT00412893|469095897|FG000|Overall Study|Violation of Selection at Entry|17|||
130309292|NCT00412893|469095898|FG001|Overall Study|Violation of Selection at Entry|10|||
130309293|NCT00412893|469095897|FG000|Overall Study|Other Protocol Violation|10|||
130309294|NCT00412893|469095898|FG001|Overall Study|Other Protocol Violation|6|||
130309295|NCT00412893|469095897|FG000|Overall Study|Did Not Cooperate|12|||
130309296|NCT00412893|469095898|FG001|Overall Study|Did Not Cooperate|9|||
130309297|NCT00412893|469095897|FG000|Overall Study|Administrative Reason|12|||
130309298|NCT00412893|469095898|FG001|Overall Study|Administrative Reason|15|||
130309299|NCT00412893|469095897|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
130309300|NCT00412893|469095898|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
130309301|NCT04473963|469095900|FG000|Overall Study|Withdrawal by Subject|1|||
130309302|NCT04473963|469095901|FG001|Overall Study|Withdrawal by Subject|1|||
130309303|NCT04473963|469095902|FG002|Overall Study|Withdrawal by Subject|0|||
130309304|NCT04473963|469095900|FG000|Overall Study|Not inducible in AF|0|||
130309305|NCT04473963|469095901|FG001|Overall Study|Not inducible in AF|0|||
130309306|NCT04473963|469095902|FG002|Overall Study|Not inducible in AF|2|||
130309307|NCT00587158|469095906|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
130309308|NCT00587158|469095907|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
130309309|NCT00587158|469095906|FG000|Overall Study|Physician Decision|0|||
130309310|NCT00587158|469095907|FG001|Overall Study|Physician Decision|1|||
130309311|NCT00587158|469095906|FG000|Overall Study|Lost to Follow-up|1|||
130309312|NCT00587158|469095907|FG001|Overall Study|Lost to Follow-up|2|||
130309313|NCT00587158|469095906|FG000|Overall Study|Death|0|||
130309314|NCT00587158|469095907|FG001|Overall Study|Death|1|||
130309315|NCT00587158|469095906|FG000|Overall Study|Subject did not want to take study med|0|||
130309316|NCT00587158|469095907|FG001|Overall Study|Subject did not want to take study med|1|||
130309317|NCT02114606|469095908|FG000|Overall Study|Unable to swallow Cytosponge|6|||
130309318|NCT00981461|469095909|FG000|Overall Study|Lost to Follow-up|5|||
129798378|NCT04650854|467230069|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
129798379|NCT04650854|467230070|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
129798380|NCT04650854|467230071|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
129798381|NCT04650854|467230069|FG000|Overall Study|Participant Received Rescue Medication|0|||
129798382|NCT04650854|467230070|FG001|Overall Study|Participant Received Rescue Medication|1|||
130309319|NCT00981461|469095910|FG001|Overall Study|Lost to Follow-up|2|||
130309320|NCT03361293|469095919|FG000|Overall Study|Lost to Follow-up|0|||
130309321|NCT03361293|469095920|FG001|Overall Study|Lost to Follow-up|2|||
130309322|NCT03361293|469095919|FG000|Overall Study|Withdrawal by Subject|1|||
130309323|NCT03361293|469095920|FG001|Overall Study|Withdrawal by Subject|3|||
130309324|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
129798383|NCT04650854|467230071|FG002|Overall Study|Participant Received Rescue Medication|0|||
130309325|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
129798384|NCT04650854|467230069|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
129798385|NCT04650854|467230070|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
130049379|NCT00696657|468138623|FG001|Overall Study|Withdrawal criteria|3|||
130049380|NCT00696657|468138624|FG002|Overall Study|Withdrawal criteria|2|||
130049381|NCT00696657|468138625|FG003|Overall Study|Withdrawal criteria|2|||
130049382|NCT00696657|468138626|FG004|Overall Study|Withdrawal criteria|0|||
130049383|NCT00696657|468138627|FG005|Overall Study|Withdrawal criteria|0|||
130049384|NCT00696657|468138628|FG006|Overall Study|Withdrawal criteria|1|||
130049385|NCT00696657|468138629|FG007|Overall Study|Withdrawal criteria|1|||
130049386|NCT00696657|468138630|FG008|Overall Study|Withdrawal criteria|2|||
130049387|NCT00696657|468138622|FG000|Overall Study|Unclassified|0|||
130049388|NCT00696657|468138623|FG001|Overall Study|Unclassified|1|||
130049389|NCT00696657|468138624|FG002|Overall Study|Unclassified|3|||
130049390|NCT00696657|468138625|FG003|Overall Study|Unclassified|2|||
130049391|NCT00696657|468138626|FG004|Overall Study|Unclassified|4|||
130049392|NCT00696657|468138627|FG005|Overall Study|Unclassified|2|||
130049393|NCT00696657|468138628|FG006|Overall Study|Unclassified|0|||
130049394|NCT00696657|468138629|FG007|Overall Study|Unclassified|0|||
130049395|NCT00696657|468138630|FG008|Overall Study|Unclassified|1|||
130049396|NCT00696657|468138622|FG000|Overall Study|Adverse Event|0|||
130049397|NCT00696657|468138623|FG001|Overall Study|Adverse Event|0|||
130049398|NCT00696657|468138624|FG002|Overall Study|Adverse Event|3|||
130049399|NCT00696657|468138625|FG003|Overall Study|Adverse Event|7|||
130049400|NCT00696657|468138626|FG004|Overall Study|Adverse Event|6|||
130049401|NCT00696657|468138627|FG005|Overall Study|Adverse Event|9|||
130049402|NCT00696657|468138628|FG006|Overall Study|Adverse Event|14|||
130049403|NCT00696657|468138629|FG007|Overall Study|Adverse Event|2|||
130049404|NCT00696657|468138630|FG008|Overall Study|Adverse Event|5|||
130049405|NCT01790438|468138631|FG000|Overall Study|Adverse Event|3|||
130309326|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
130309327|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
130309328|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
130309329|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
130309330|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
130049406|NCT01790438|468138632|FG001|Overall Study|Adverse Event|2|||
130049407|NCT01790438|468138631|FG000|Overall Study|Death|4|||
130049408|NCT01790438|468138632|FG001|Overall Study|Death|0|||
130049409|NCT01790438|468138631|FG000|Overall Study|Lost to Follow-up|5|||
130049410|NCT01790438|468138632|FG001|Overall Study|Lost to Follow-up|2|||
130049411|NCT01790438|468138631|FG000|Overall Study|Withdrawal by Subject|13|||
130049412|NCT01790438|468138632|FG001|Overall Study|Withdrawal by Subject|2|||
130309331|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
129889506|NCT01513967|467552623|FG000|Overall Study|missed a study visit|0|||
129889507|NCT01513967|467552624|FG001|Overall Study|missed a study visit|0|||
130049413|NCT01790438|468138631|FG000|Overall Study|Physician Decision|3|||
130049414|NCT01790438|468138632|FG001|Overall Study|Physician Decision|1|||
130309332|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
130309333|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
130309334|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
130309335|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
130309336|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
130309337|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
130309338|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
130309339|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
130309340|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
130309341|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
130309342|NCT01910402|469095921|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
130309343|NCT01910402|469095922|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
130309344|NCT01910402|469095923|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
130309345|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
130309346|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
130309347|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
130309348|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
130309349|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
130309350|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
130309351|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
130309352|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
130309353|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
130309354|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
130309355|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
130309356|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
130309357|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
130309358|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
130309359|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
130309360|NCT01910402|469095921|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
130110263|NCT03712228|468364169|FG004|Treatment Period 2|Pregnancy|0|||
130110264|NCT03712228|468364170|FG005|Treatment Period 2|Pregnancy|0|||
130110265|NCT03712228|468364165|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130110266|NCT03712228|468364166|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130110267|NCT03712228|468364167|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130110268|NCT03712228|468364168|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130110269|NCT03712228|468364169|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130110270|NCT03712228|468364170|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130110271|NCT01964105|468364171|FG000|Overall Study|Lost to Follow-up|2|||
130110272|NCT01964105|468364172|FG001|Overall Study|Lost to Follow-up|13|||
130110273|NCT01964105|468364173|FG002|Overall Study|Lost to Follow-up|0|||
130110274|NCT00558519|468364174|FG000|Overall Study|Ph+|20|||
130110275|NCT00558519|468364174|FG000|Overall Study|Ineligible|1|||
130110276|NCT00558519|468364174|FG000|Overall Study|Insufficient data|1|||
130110277|NCT00558519|468364174|FG000|Overall Study|Never received treatment|1|||
130110278|NCT03001011|468364175|FG000|Overall Study|Adverse Event|9|||
130110279|NCT03001011|468364176|FG001|Overall Study|Adverse Event|3|||
130110280|NCT03001011|468364175|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
130110281|NCT03001011|468364176|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
130110282|NCT03001011|468364175|FG000|Overall Study|Other than specified above|3|||
130110283|NCT03001011|468364176|FG001|Overall Study|Other than specified above|8|||
130110284|NCT02875067|468364177|FG000|Overall Study|Withdrawal by Subject|1|||
130110285|NCT02875067|468364177|FG000|Overall Study|Withdrawal by Termination of Study|5|||
130110286|NCT00065065|468364178|FG000|Overall Study|Adverse Event|3|||
130110287|NCT00065065|468364179|FG001|Overall Study|Adverse Event|2|||
130110288|NCT00065065|468364178|FG000|Overall Study|Withdrawal by Subject|1|||
130110289|NCT00065065|468364179|FG001|Overall Study|Withdrawal by Subject|5|||
130110290|NCT00065065|468364178|FG000|Overall Study|Lack of Efficacy|4|||
130110291|NCT00065065|468364179|FG001|Overall Study|Lack of Efficacy|11|||
130110292|NCT00065065|468364178|FG000|Overall Study|Other|2|||
130110293|NCT00065065|468364179|FG001|Overall Study|Other|2|||
130110294|NCT01050673|468364183|FG000|Overall Study|Physician Decision|4|||
130110295|NCT01050673|468364184|FG001|Overall Study|Physician Decision|5|||
130110296|NCT05288673|468364185|FG000|Overall Study|Consent withdrawn by subject|0|||
130110297|NCT05288673|468364186|FG001|Overall Study|Consent withdrawn by subject|0|||
130110298|NCT05288673|468364187|FG002|Overall Study|Consent withdrawn by subject|1|||
130110299|NCT03056352|468364188|FG000|Overall Study|Lost to Follow-up|1|||
130110300|NCT00597207|468364193|FG000|Overall Study|Lost to Follow-up|5|||
130110301|NCT00597207|468364194|FG001|Overall Study|Lost to Follow-up|7|||
130110302|NCT00520351|468364195|FG000|First Intervention|Withdrawal by Subject|1|||
130110303|NCT00520351|468364196|FG001|First Intervention|Withdrawal by Subject|1|||
130110304|NCT02278952|468364197|FG000|Overall Study|Insufficient Sample|6|||
130110305|NCT00869089|468364204|FG000|Overall Study|Lost to Follow-up|1|||
130110306|NCT00869089|468364204|FG000|Overall Study|Withdrawal by Subject|1|||
130110307|NCT00869089|468364204|FG000|Overall Study|Screen Fail|1|||
130110308|NCT01559818|468364210|FG000|Overall Study|Physician Decision|1|||
130110309|NCT01559818|468364210|FG000|Overall Study|Pregnancy|1|||
130110310|NCT01559818|468364210|FG000|Overall Study|Study terminated by Sponsor|4|||
130110311|NCT01559818|468364210|FG000|Overall Study|Withdrawal by Subject|1|||
130110312|NCT04071626|468364211|FG000|Overall Study|Withdrawal by Subject|1|||
130110313|NCT04071626|468364212|FG001|Overall Study|Withdrawal by Subject|1|||
130110314|NCT04071626|468364211|FG000|Overall Study|Protocol Violation|0|||
130049415|NCT01790438|468138631|FG000|Overall Study|Sponsor Decision|0|||
130049416|NCT01790438|468138632|FG001|Overall Study|Sponsor Decision|3|||
130049417|NCT01790438|468138631|FG000|Overall Study|Protocol Required Discontinuation|7|||
130049418|NCT01790438|468138632|FG001|Overall Study|Protocol Required Discontinuation|1|||
130049419|NCT02090114|468138636|FG000|Overall Study|Withdrawal by Subject|3|||
130049420|NCT02090114|468138637|FG001|Overall Study|Withdrawal by Subject|6|||
130049421|NCT02090114|468138638|FG002|Overall Study|Withdrawal by Subject|2|||
130049422|NCT02090114|468138639|FG003|Overall Study|Withdrawal by Subject|1|||
130049423|NCT02090114|468138636|FG000|Overall Study|Physician Decision|5|||
130049424|NCT02090114|468138637|FG001|Overall Study|Physician Decision|0|||
130049425|NCT02090114|468138638|FG002|Overall Study|Physician Decision|1|||
130049426|NCT02090114|468138639|FG003|Overall Study|Physician Decision|1|||
130110315|NCT04071626|468364212|FG001|Overall Study|Protocol Violation|1|||
130110316|NCT01375010|468365702|FG000|Overall Study|Lost to Follow-up|8|||
130110317|NCT01375010|468365703|FG001|Overall Study|Lost to Follow-up|2|||
130049427|NCT02090114|468138636|FG000|Overall Study|Adverse Event|1|||
130049428|NCT02090114|468138637|FG001|Overall Study|Adverse Event|2|||
130110318|NCT01375010|468365702|FG000|Overall Study|Withdrawal by Subject|4|||
130110319|NCT01375010|468365703|FG001|Overall Study|Withdrawal by Subject|2|||
130110320|NCT02614703|468365704|FG000|Overall Study|Withdrawal by Subject|7|||
130110321|NCT02614703|468365705|FG001|Overall Study|Withdrawal by Subject|1|||
130110322|NCT02402933|468365706|FG000|Overall Study|Withdrawal by Subject|4|||
130110323|NCT02402933|468365706|FG000|Overall Study|Discontinued; Site Termination|10|||
130110324|NCT01681771|468365709|FG000|Overall Study|Lost to Follow-up|4|||
130110325|NCT01681771|468365710|FG001|Overall Study|Lost to Follow-up|2|||
130110326|NCT01792284|468365715|FG000|Lead-in Period|Adverse Event|15|||
129798386|NCT04650854|467230071|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
129798387|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
129798388|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
129798389|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
129798390|NCT04650854|467230069|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
129798391|NCT04650854|467230070|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
129798392|NCT04650854|467230071|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
130049429|NCT02090114|468138638|FG002|Overall Study|Adverse Event|2|||
130049430|NCT02090114|468138639|FG003|Overall Study|Adverse Event|0|||
130049431|NCT02090114|468138636|FG000|Overall Study|Progressive Disease|20|||
130049432|NCT02090114|468138637|FG001|Overall Study|Progressive Disease|21|||
130049433|NCT02090114|468138638|FG002|Overall Study|Progressive Disease|23|||
130049434|NCT02090114|468138639|FG003|Overall Study|Progressive Disease|6|||
130049435|NCT02090114|468138636|FG000|Overall Study|Death|1|||
130049436|NCT02090114|468138637|FG001|Overall Study|Death|0|||
130049437|NCT02090114|468138638|FG002|Overall Study|Death|1|||
130049438|NCT02090114|468138639|FG003|Overall Study|Death|0|||
130049439|NCT01989546|468138640|FG000|Overall Study|Clinical Progression|1|||
130049440|NCT01989546|468138640|FG000|Overall Study|Disease progression on study|8|||
130049441|NCT01505491|468138645|FG000|Overall Study|Other reason not listed|1|||
130049442|NCT01505491|468138646|FG001|Overall Study|Other reason not listed|0|||
130049443|NCT01505491|468138647|FG002|Overall Study|Other reason not listed|0|||
130049444|NCT01505491|468138645|FG000|Overall Study|Withdrawal by Subject|1|||
130049445|NCT01505491|468138646|FG001|Overall Study|Withdrawal by Subject|1|||
130049446|NCT01505491|468138647|FG002|Overall Study|Withdrawal by Subject|4|||
130049447|NCT01505491|468138645|FG000|Overall Study|Lost to Follow-up|0|||
130049448|NCT01505491|468138646|FG001|Overall Study|Lost to Follow-up|0|||
130049449|NCT01505491|468138647|FG002|Overall Study|Lost to Follow-up|1|||
130049450|NCT00367640|468138656|FG000|Overall Study|Adverse Event|3|||
130049451|NCT00367640|468138657|FG001|Overall Study|Adverse Event|6|||
130049452|NCT00367640|468138658|FG002|Overall Study|Adverse Event|8|||
130049453|NCT00367640|468138659|FG003|Overall Study|Adverse Event|0|||
130049454|NCT00367640|468138656|FG000|Overall Study|Withdrawal by Subject|8|||
130049455|NCT00367640|468138657|FG001|Overall Study|Withdrawal by Subject|11|||
130049456|NCT00367640|468138658|FG002|Overall Study|Withdrawal by Subject|8|||
130049457|NCT00367640|468138659|FG003|Overall Study|Withdrawal by Subject|6|||
130049458|NCT00367640|468138656|FG000|Overall Study|Any other reason not above-mentioned|7|||
130049459|NCT00367640|468138657|FG001|Overall Study|Any other reason not above-mentioned|5|||
130049460|NCT00367640|468138658|FG002|Overall Study|Any other reason not above-mentioned|3|||
130049461|NCT00367640|468138659|FG003|Overall Study|Any other reason not above-mentioned|4|||
130049462|NCT01063751|468138661|FG000|Overall Study|Censored from analyses|42|||
130049463|NCT01063751|468138661|FG000|Overall Study|Withdrawal by Subject|34|||
130049464|NCT01063751|468138661|FG000|Overall Study|Lost to Follow-up|30|||
130049465|NCT01063751|468138661|FG000|Overall Study|Death|13|||
130049466|NCT01063751|468138661|FG000|Overall Study|Sponsored Terminated Study|60|||
130049467|NCT01063751|468138661|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
130049468|NCT01063751|468138661|FG000|Overall Study|Investigator site closed|10|||
130049469|NCT01063751|468138661|FG000|Overall Study|Revision|6|||
130049470|NCT01063751|468138661|FG000|Overall Study|Physician Decision|4|||
130049471|NCT00406315|468138664|FG000|Overall Study|Death|1|||
130049472|NCT00406315|468138664|FG000|Overall Study|Adverse Event|39|||
130049473|NCT00406315|468138664|FG000|Overall Study|Laboratory Abnormality|4|||
130049474|NCT00406315|468138664|FG000|Overall Study|Lack of Efficacy|13|||
130049475|NCT00406315|468138664|FG000|Overall Study|Other|33|||
130049476|NCT00406315|468138664|FG000|Overall Study|Lost to Follow-up|21|||
130049477|NCT00406315|468138664|FG000|Overall Study|Withdrawal by Subject|30|||
130049478|NCT01312428|468138665|FG000|Overall Study|Study Termination|3|||
130049479|NCT01312428|468138666|FG001|Overall Study|Study Termination|4|||
130049480|NCT02214186|468138672|FG000|Overall Study|Lost to Follow-up|1|||
130049481|NCT02214186|468138673|FG001|Overall Study|Lost to Follow-up|1|||
130049482|NCT02214186|468138672|FG000|Overall Study|Protocol Violation|1|||
130049483|NCT02214186|468138673|FG001|Overall Study|Protocol Violation|1|||
130049484|NCT01525849|468138674|FG000|Overall Study|Lost to Follow-up|3|||
130049485|NCT01525849|468138675|FG001|Overall Study|Lost to Follow-up|2|||
130049486|NCT01525849|468138674|FG000|Overall Study|Withdrawal by Subject|1|||
130049487|NCT01525849|468138675|FG001|Overall Study|Withdrawal by Subject|9|||
130049488|NCT01525849|468138674|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
130049489|NCT01525849|468138675|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
130049490|NCT01525849|468138674|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
130049491|NCT01525849|468138675|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
130049492|NCT00611130|468138676|FG000|Overall Study|Lost to Follow-up|25|||
130049493|NCT00611130|468138677|FG001|Overall Study|Lost to Follow-up|29|||
130049494|NCT00611130|468138676|FG000|Overall Study|Protocol noncompliance|7|||
130049495|NCT00611130|468138677|FG001|Overall Study|Protocol noncompliance|6|||
130049496|NCT00611130|468138676|FG000|Overall Study|Withdrawal by Subject|6|||
129798393|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
129798394|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
129798395|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
129798396|NCT04650854|467230069|FG000|Overall Study|Enrollment Cup|0|||
129798397|NCT04650854|467230070|FG001|Overall Study|Enrollment Cup|0|||
129798398|NCT04650854|467230071|FG002|Overall Study|Enrollment Cup|1|||
129798399|NCT05308290|467230072|FG000|Overall Study|Death|1|||
129798400|NCT05308290|467230073|FG001|Overall Study|Death|0|||
129798401|NCT05308290|467230072|FG000|Overall Study|Lost to Follow-up|2|||
129798402|NCT05308290|467230073|FG001|Overall Study|Lost to Follow-up|1|||
129798403|NCT05308290|467230072|FG000|Overall Study|still in study followup|0|||
129798404|NCT05308290|467230073|FG001|Overall Study|still in study followup|1|||
129798405|NCT04437368|467230074|FG000|Overall Study|Death|3|||
129798406|NCT04437368|467230075|FG001|Overall Study|Death|0|||
129798407|NCT04437368|467230076|FG002|Overall Study|Death|2|||
129798408|NCT04437368|467230074|FG000|Overall Study|Study terminated by sponsor|16|||
129798409|NCT04437368|467230075|FG001|Overall Study|Study terminated by sponsor|1|||
129798410|NCT04437368|467230076|FG002|Overall Study|Study terminated by sponsor|25|||
129798411|NCT04437368|467230074|FG000|Overall Study|Withdrawal by Subject|4|||
129798412|NCT04437368|467230075|FG001|Overall Study|Withdrawal by Subject|0|||
129798413|NCT04437368|467230076|FG002|Overall Study|Withdrawal by Subject|3|||
129798414|NCT04437368|467230074|FG000|Overall Study|Sponsor instructions|23|||
129798415|NCT04437368|467230075|FG001|Overall Study|Sponsor instructions|0|||
129798416|NCT04437368|467230076|FG002|Overall Study|Sponsor instructions|0|||
130309361|NCT01910402|469095922|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
130309362|NCT01910402|469095923|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
130309363|NCT00483405|469095926|FG000|Overall Study|Adverse Event|8|||
130309364|NCT00483405|469095926|FG000|Overall Study|Lack of Efficacy|14|||
130309365|NCT00483405|469095926|FG000|Overall Study|Death|3|||
130309366|NCT00483405|469095926|FG000|Overall Study|Withdrawal by Subject|2|||
130309367|NCT00483405|469095926|FG000|Overall Study|Other complicating disease|1|||
130309368|NCT00571038|469095927|FG000|Overall Study|Lost to Follow-up|1|||
130309369|NCT00571038|469095928|FG001|Overall Study|Lost to Follow-up|4|||
130309370|NCT00571038|469095927|FG000|Overall Study|Death|7|||
130309371|NCT00571038|469095928|FG001|Overall Study|Death|5|||
130309372|NCT00571038|469095927|FG000|Overall Study|Withdrawal by Subject|1|||
130309373|NCT00571038|469095928|FG001|Overall Study|Withdrawal by Subject|3|||
130309374|NCT00571038|469095927|FG000|Overall Study|Moved out of state|2|||
130309375|NCT00571038|469095928|FG001|Overall Study|Moved out of state|2|||
130309376|NCT01550757|469095929|FG000|Overall Study|Lost to Follow-up|21|||
130309377|NCT01550757|469095930|FG001|Overall Study|Lost to Follow-up|14|||
130309378|NCT01550757|469095931|FG002|Overall Study|Lost to Follow-up|42|||
130309379|NCT01550757|469095932|FG003|Overall Study|Lost to Follow-up|53|||
130309380|NCT01550757|469095929|FG000|Overall Study|Withdrawal by Subject|2|||
130309381|NCT01550757|469095930|FG001|Overall Study|Withdrawal by Subject|0|||
130309382|NCT01550757|469095931|FG002|Overall Study|Withdrawal by Subject|3|||
130309383|NCT01550757|469095932|FG003|Overall Study|Withdrawal by Subject|1|||
130309384|NCT00740584|469095934|FG000|Overall Study|Withdrawal by Subject|1|||
130309385|NCT00413218|469095936|FG000|Overall Study|Randomized but didn't receive study drug|2|||
130309386|NCT00413218|469095937|FG001|Overall Study|Randomized but didn't receive study drug|8|||
130309387|NCT00413218|469095936|FG000|Overall Study|Death|57|||
130309388|NCT00413218|469095937|FG001|Overall Study|Death|56|||
130309389|NCT00413218|469095936|FG000|Overall Study|Lost to Follow-up|14|||
130309390|NCT00413218|469095937|FG001|Overall Study|Lost to Follow-up|17|||
130309391|NCT00413218|469095936|FG000|Overall Study|Admin|20|||
130309392|NCT00413218|469095937|FG001|Overall Study|Admin|14|||
130309393|NCT00413218|469095936|FG000|Overall Study|Missing|1|||
130309394|NCT00413218|469095937|FG001|Overall Study|Missing|0|||
130309395|NCT00413218|469095936|FG000|Overall Study|Withdrawal by Subject|9|||
130309396|NCT00413218|469095937|FG001|Overall Study|Withdrawal by Subject|1|||
129798417|NCT01982331|467230077|FG000|Received Vaccination 2|Adverse Event|1|||
129798418|NCT01982331|467230078|FG001|Received Vaccination 2|Adverse Event|2|||
129889508|NCT01513967|467552625|FG002|Overall Study|missed a study visit|0|||
130309397|NCT01196026|469095939|FG000|Overall Study|Withdrawal by Subject|1|||
130309398|NCT01196026|469095940|FG001|Overall Study|Withdrawal by Subject|4|||
130309399|NCT01196026|469095941|FG002|Overall Study|Withdrawal by Subject|0|||
129798419|NCT01982331|467230077|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
129798420|NCT01982331|467230078|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
129889509|NCT01513967|467552626|FG003|Overall Study|missed a study visit|0|||
129889510|NCT01513967|467552627|FG004|Overall Study|missed a study visit|0|||
129889511|NCT01513967|467552628|FG005|Overall Study|missed a study visit|0|||
130309400|NCT01196026|469095942|FG003|Overall Study|Withdrawal by Subject|0|||
130309401|NCT01196026|469095943|FG004|Overall Study|Withdrawal by Subject|0|||
130309402|NCT01196026|469095944|FG005|Overall Study|Withdrawal by Subject|0|||
130309403|NCT01196026|469095939|FG000|Overall Study|Lost to Follow-up|0|||
130309404|NCT01196026|469095940|FG001|Overall Study|Lost to Follow-up|3|||
130309405|NCT01196026|469095941|FG002|Overall Study|Lost to Follow-up|0|||
129798421|NCT01982331|467230077|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
129798422|NCT01982331|467230078|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
129798423|NCT01280955|467230088|FG000|Overall Study|Death|2|||
129798424|NCT01280955|467230088|FG000|Overall Study|Withdrawal by Subject|1|||
129798425|NCT04223232|467230089|FG000|Overall Study|Withdrawal by Subject|1|||
129798426|NCT02393690|467230091|FG000|Overall Study|Ineligible|0|||
129798427|NCT02393690|467230092|FG001|Overall Study|Ineligible|1|||
129798428|NCT01674634|467230093|FG000|Overall Study|Withdrawal by Subject|3|||
129798429|NCT01674634|467230093|FG000|Overall Study|Lost to Follow-up|3|||
129798430|NCT02567552|467230094|FG000|Overall Study|Adverse Event|0|||
129798431|NCT02567552|467230095|FG001|Overall Study|Adverse Event|1|||
129798432|NCT03187756|467230096|FG000|Overall Study|Termination of study|4|||
129798433|NCT01074047|467230097|FG000|Treatment Phase|Adverse Event|89|||
129798434|NCT01074047|467230098|FG001|Treatment Phase|Adverse Event|66|||
129798435|NCT01074047|467230097|FG000|Treatment Phase|Disease Progression|16|||
129798436|NCT01074047|467230098|FG001|Treatment Phase|Disease Progression|21|||
129798437|NCT01074047|467230097|FG000|Treatment Phase|Withdrawal by Subject|27|||
129798438|NCT01074047|467230098|FG001|Treatment Phase|Withdrawal by Subject|48|||
129798439|NCT01074047|467230097|FG000|Treatment Phase|Death|53|||
130309406|NCT01196026|469095942|FG003|Overall Study|Lost to Follow-up|0|||
130309407|NCT01196026|469095943|FG004|Overall Study|Lost to Follow-up|1|||
130309408|NCT01196026|469095944|FG005|Overall Study|Lost to Follow-up|0|||
130309409|NCT01196026|469095939|FG000|Overall Study|Other|0|||
130309410|NCT01196026|469095940|FG001|Overall Study|Other|1|||
130309411|NCT01196026|469095941|FG002|Overall Study|Other|0|||
130309412|NCT01196026|469095942|FG003|Overall Study|Other|0|||
130309413|NCT01196026|469095943|FG004|Overall Study|Other|0|||
130309414|NCT01196026|469095944|FG005|Overall Study|Other|0|||
130309415|NCT01687296|469095945|FG000|Overall Study|Lack of Efficacy|1|||
130309416|NCT01687296|469095946|FG001|Overall Study|Lack of Efficacy|1|||
130309417|NCT01687296|469095945|FG000|Overall Study|Protocol Violation|0|||
130309418|NCT01687296|469095946|FG001|Overall Study|Protocol Violation|1|||
130309419|NCT01687296|469095945|FG000|Overall Study|Withdrawal by Subject|6|||
130309420|NCT01687296|469095946|FG001|Overall Study|Withdrawal by Subject|3|||
130309421|NCT03672292|469095950|FG000|Overall Study|Adverse Event|3|||
130309422|NCT03672292|469095951|FG001|Overall Study|Adverse Event|1|||
130309423|NCT03672292|469095950|FG000|Overall Study|Physician Decision|0|||
130309424|NCT03672292|469095951|FG001|Overall Study|Physician Decision|1|||
130309425|NCT03672292|469095950|FG000|Overall Study|Withdrawal by Subject|1|||
130309426|NCT03672292|469095951|FG001|Overall Study|Withdrawal by Subject|2|||
130309427|NCT03797586|469095952|FG000|Overall Study|Lost to Follow-up|3|||
130309428|NCT03797586|469095953|FG001|Overall Study|Lost to Follow-up|6|||
130309429|NCT03797586|469095952|FG000|Overall Study|Death|1|||
130309430|NCT03797586|469095953|FG001|Overall Study|Death|1|||
130309431|NCT03797586|469095952|FG000|Overall Study|Adverse Event|0|||
130309432|NCT03797586|469095953|FG001|Overall Study|Adverse Event|2|||
130309433|NCT02864901|469095954|FG000|Overall Study|Withdrawal by Subject|1|||
130309434|NCT02864901|469095955|FG001|Overall Study|Withdrawal by Subject|0|||
130309435|NCT05730387|469095956|FG000|Overall Study|Stillbirth|0|||
130309436|NCT05730387|469095957|FG001|Overall Study|Stillbirth|262|||
130309437|NCT05730387|469095956|FG000|Overall Study|Died during or after delivery|2|||
130309438|NCT05730387|469095957|FG001|Overall Study|Died during or after delivery|85|||
130309439|NCT05730387|469095956|FG000|Overall Study|Died after being admitted|0|||
130309440|NCT05730387|469095957|FG001|Overall Study|Died after being admitted|44|||
130309441|NCT05730387|469095956|FG000|Overall Study|Lost to Follow-up|69|||
130309442|NCT05730387|469095957|FG001|Overall Study|Lost to Follow-up|77|||
130309443|NCT01219985|469095958|FG000|Overall Study|Physician Decision|20|||
130309444|NCT04797780|469095959|FG000|Overall Study|Lost to Follow-up|1|||
130309445|NCT04797780|469095960|FG001|Overall Study|Lost to Follow-up|1|||
130309446|NCT04797780|469095959|FG000|Overall Study|Withdrawal by Subject|14|||
130309447|NCT04797780|469095960|FG001|Overall Study|Withdrawal by Subject|9|||
130309448|NCT04797780|469095959|FG000|Overall Study|Death|49|||
130309449|NCT04797780|469095960|FG001|Overall Study|Death|20|||
130309450|NCT05973006|469095961|FG000|Overall Study|Early termination|3|||
130309451|NCT05973006|469095962|FG001|Overall Study|Early termination|9|||
130309452|NCT00132808|469095970|FG000|Stratum I|Adverse Event|2|||
130309453|NCT00132808|469095971|FG001|Stratum I|Adverse Event|1|||
130309454|NCT00132808|469095972|FG002|Stratum I|Adverse Event|0|||
129798440|NCT01074047|467230098|FG001|Treatment Phase|Death|58|||
130309455|NCT00132808|469095970|FG000|Stratum I|Lost to Follow-up|3|||
130309456|NCT00132808|469095971|FG001|Stratum I|Lost to Follow-up|4|||
130309457|NCT00132808|469095972|FG002|Stratum I|Lost to Follow-up|1|||
130309458|NCT00132808|469095970|FG000|Stratum I|Withdrawal by Subject|4|||
130309459|NCT00132808|469095971|FG001|Stratum I|Withdrawal by Subject|7|||
130309460|NCT00132808|469095972|FG002|Stratum I|Withdrawal by Subject|3|||
130309461|NCT00132808|469095970|FG000|Stratum I|Abnormal test procedure result (s)|0|||
130309462|NCT00132808|469095971|FG001|Stratum I|Abnormal test procedure result (s)|0|||
129798441|NCT01074047|467230097|FG000|Treatment Phase|Lost to Follow-up|0|||
129798442|NCT01074047|467230098|FG001|Treatment Phase|Lost to Follow-up|1|||
130309463|NCT00132808|469095972|FG002|Stratum I|Abnormal test procedure result (s)|1|||
129798443|NCT01074047|467230097|FG000|Treatment Phase|Protocol Violation|0|||
129798444|NCT01074047|467230098|FG001|Treatment Phase|Protocol Violation|1|||
129798445|NCT01074047|467230097|FG000|Treatment Phase|Miscellaneous|32|||
130049497|NCT00611130|468138677|FG001|Overall Study|Withdrawal by Subject|5|||
130049498|NCT00611130|468138676|FG000|Overall Study|Other|5|||
130049499|NCT00611130|468138677|FG001|Overall Study|Other|4|||
130049500|NCT00611130|468138676|FG000|Overall Study|Incarceration|3|||
130049501|NCT00611130|468138677|FG001|Overall Study|Incarceration|2|||
130049502|NCT00611130|468138676|FG000|Overall Study|Administrative|1|||
130049503|NCT00611130|468138677|FG001|Overall Study|Administrative|1|||
130049504|NCT00611130|468138676|FG000|Overall Study|Adverse Event|1|||
130049505|NCT00611130|468138677|FG001|Overall Study|Adverse Event|0|||
130049506|NCT00611130|468138676|FG000|Overall Study|Death|1|||
130049507|NCT00611130|468138677|FG001|Overall Study|Death|0|||
130049508|NCT02062151|468138678|FG000|Overall Study|screen failure|1|||
130049509|NCT01921270|468138682|FG000|Overall Study|Withdrawal by Subject|1|||
130049510|NCT00844428|468138683|FG000|Screening Period|Screen Failure|3|||
130049511|NCT00844428|468138683|FG000|Extension Treatment Period|Death|1|||
130049512|NCT00844428|468138683|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
130049513|NCT00789477|468138684|FG000|Overall Study|Withdrawal by Subject|2|||
130049514|NCT00789477|468138685|FG001|Overall Study|Withdrawal by Subject|1|||
130049515|NCT00789477|468138686|FG002|Overall Study|Withdrawal by Subject|3|||
130049516|NCT00789477|468138687|FG003|Overall Study|Withdrawal by Subject|2|||
130049517|NCT00789477|468138688|FG004|Overall Study|Withdrawal by Subject|3|||
130049518|NCT00789477|468138684|FG000|Overall Study|Protocol Violation|1|||
130049519|NCT00789477|468138685|FG001|Overall Study|Protocol Violation|0|||
130049520|NCT00789477|468138686|FG002|Overall Study|Protocol Violation|0|||
130049521|NCT00789477|468138687|FG003|Overall Study|Protocol Violation|1|||
130049522|NCT00789477|468138688|FG004|Overall Study|Protocol Violation|0|||
130049523|NCT00789477|468138684|FG000|Overall Study|Adverse Event|3|||
130049524|NCT00789477|468138685|FG001|Overall Study|Adverse Event|3|||
130049525|NCT00789477|468138686|FG002|Overall Study|Adverse Event|1|||
130049526|NCT00789477|468138687|FG003|Overall Study|Adverse Event|0|||
130049527|NCT00789477|468138688|FG004|Overall Study|Adverse Event|0|||
130049528|NCT00789477|468138684|FG000|Overall Study|Death|1|||
130049529|NCT00789477|468138685|FG001|Overall Study|Death|1|||
130049530|NCT00789477|468138686|FG002|Overall Study|Death|2|||
130049531|NCT00789477|468138687|FG003|Overall Study|Death|2|||
130049532|NCT00789477|468138688|FG004|Overall Study|Death|0|||
130049533|NCT00789477|468138684|FG000|Overall Study|Lost to Follow-up|0|||
130049534|NCT00789477|468138685|FG001|Overall Study|Lost to Follow-up|1|||
130049535|NCT00789477|468138686|FG002|Overall Study|Lost to Follow-up|4|||
130049536|NCT00789477|468138687|FG003|Overall Study|Lost to Follow-up|2|||
130049537|NCT00789477|468138688|FG004|Overall Study|Lost to Follow-up|4|||
130049538|NCT00789477|468138684|FG000|Overall Study|Lack of Efficacy|2|||
130049539|NCT00789477|468138685|FG001|Overall Study|Lack of Efficacy|0|||
130049540|NCT00789477|468138686|FG002|Overall Study|Lack of Efficacy|0|||
130049541|NCT00789477|468138687|FG003|Overall Study|Lack of Efficacy|0|||
130049542|NCT00789477|468138688|FG004|Overall Study|Lack of Efficacy|0|||
130049543|NCT00789477|468138684|FG000|Overall Study|Other|2|||
130049544|NCT00789477|468138685|FG001|Overall Study|Other|0|||
130049545|NCT00789477|468138686|FG002|Overall Study|Other|1|||
130049546|NCT00789477|468138687|FG003|Overall Study|Other|3|||
130049547|NCT00789477|468138688|FG004|Overall Study|Other|0|||
130049548|NCT00455858|468138689|FG000|Overall Study|Lost to Follow-up|2|||
130049549|NCT00455858|468138689|FG000|Overall Study|Protocol Violation|1|||
130049550|NCT00455858|468138689|FG000|Overall Study|Lack of Efficacy|1|||
130049551|NCT00455858|468138689|FG000|Overall Study|Well controlled FPG without insulin|1|||
130049552|NCT00455858|468138689|FG000|Overall Study|Withdrawal|1|||
130049553|NCT02092389|468138691|FG000|Overall Study|Adverse Event|1|||
130049554|NCT02092389|468138691|FG000|Overall Study|Other|5|||
130049555|NCT01242020|468138692|FG000|Overall Study|Withdrawal by Subject|2|||
130049556|NCT01242020|468138693|FG001|Overall Study|Withdrawal by Subject|0|||
130049557|NCT01242020|468138692|FG000|Overall Study|Failed screening|1|||
130049558|NCT01242020|468138693|FG001|Overall Study|Failed screening|0|||
130049559|NCT00772967|468138694|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
130049560|NCT00772967|468138695|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
130049561|NCT00772967|468138696|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
130049562|NCT00772967|468138697|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
130049563|NCT00772967|468138698|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
130049564|NCT00772967|468138699|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
130049565|NCT00772967|468138694|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130049566|NCT00772967|468138695|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
130049567|NCT00772967|468138696|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130049568|NCT00772967|468138697|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130049569|NCT00772967|468138698|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130049570|NCT00772967|468138699|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
130049571|NCT00772967|468138694|FG000|Crossover Treatment 3|Adverse Event|0|||
130049572|NCT00772967|468138695|FG001|Crossover Treatment 3|Adverse Event|0|||
130049573|NCT00772967|468138696|FG002|Crossover Treatment 3|Adverse Event|0|||
130110327|NCT01792284|468365716|FG001|Lead-in Period|Adverse Event|0|||
130110328|NCT01792284|468365717|FG002|Lead-in Period|Adverse Event|0|||
130110329|NCT01792284|468365715|FG000|Lead-in Period|Lost to Follow-up|2|||
130110330|NCT01792284|468365716|FG001|Lead-in Period|Lost to Follow-up|0|||
130110331|NCT01792284|468365717|FG002|Lead-in Period|Lost to Follow-up|0|||
130110332|NCT01792284|468365715|FG000|Lead-in Period|Protocol Violation|1|||
130110333|NCT01792284|468365716|FG001|Lead-in Period|Protocol Violation|0|||
130110334|NCT01792284|468365717|FG002|Lead-in Period|Protocol Violation|0|||
130110335|NCT01792284|468365715|FG000|Lead-in Period|Withdrawal by Subject|10|||
130110336|NCT01792284|468365716|FG001|Lead-in Period|Withdrawal by Subject|0|||
130110337|NCT01792284|468365717|FG002|Lead-in Period|Withdrawal by Subject|0|||
130110338|NCT01792284|468365715|FG000|Lead-in Period|Physician Decision|1|||
130110339|NCT01792284|468365716|FG001|Lead-in Period|Physician Decision|0|||
130110340|NCT01792284|468365717|FG002|Lead-in Period|Physician Decision|0|||
130110341|NCT01792284|468365715|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
130110342|NCT01792284|468365716|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
130110343|NCT01792284|468365717|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
130110344|NCT01792284|468365715|FG000|Randomization Period 1|Withdrawal by Subject|0|||
130110345|NCT01792284|468365716|FG001|Randomization Period 1|Withdrawal by Subject|1|||
130110346|NCT01792284|468365717|FG002|Randomization Period 1|Withdrawal by Subject|1|||
130110347|NCT01792284|468365715|FG000|Randomization Period 1|Physician Decision|0|||
130110348|NCT01792284|468365716|FG001|Randomization Period 1|Physician Decision|1|||
129889512|NCT01513967|467552629|FG006|Overall Study|missed a study visit|1|||
130110349|NCT01792284|468365717|FG002|Randomization Period 1|Physician Decision|1|||
130110350|NCT01792284|468365715|FG000|Randomization Period 1|Adverse Event|0|||
130110351|NCT01792284|468365716|FG001|Randomization Period 1|Adverse Event|0|||
130110352|NCT01792284|468365717|FG002|Randomization Period 1|Adverse Event|2|||
130110353|NCT01792284|468365715|FG000|Randomization Period 1|Lost to Follow-up|0|||
130110354|NCT01792284|468365716|FG001|Randomization Period 1|Lost to Follow-up|0|||
130110355|NCT01792284|468365717|FG002|Randomization Period 1|Lost to Follow-up|1|||
130110356|NCT01792284|468365715|FG000|Randomization Period 2|Protocol Violation|0|||
130110357|NCT01792284|468365716|FG001|Randomization Period 2|Protocol Violation|1|||
130110358|NCT01792284|468365717|FG002|Randomization Period 2|Protocol Violation|0|||
130110359|NCT01792284|468365715|FG000|Randomization Period 2|Withdrawal by Subject|0|||
130110360|NCT01792284|468365716|FG001|Randomization Period 2|Withdrawal by Subject|2|||
130110361|NCT01792284|468365717|FG002|Randomization Period 2|Withdrawal by Subject|0|||
130110362|NCT02919475|468365719|FG000|Overall Study|Adverse Event|3|||
130110363|NCT02919475|468365720|FG001|Overall Study|Adverse Event|3|||
130110364|NCT02919475|468365721|FG002|Overall Study|Adverse Event|3|||
130110365|NCT02919475|468365722|FG003|Overall Study|Adverse Event|9|||
130110366|NCT02919475|468365723|FG004|Overall Study|Adverse Event|2|||
130110367|NCT02919475|468365719|FG000|Overall Study|Death|0|||
130110368|NCT02919475|468365720|FG001|Overall Study|Death|1|||
130110369|NCT02919475|468365721|FG002|Overall Study|Death|0|||
130110370|NCT02919475|468365722|FG003|Overall Study|Death|0|||
130110371|NCT02919475|468365723|FG004|Overall Study|Death|0|||
130110372|NCT02919475|468365719|FG000|Overall Study|Lost to Follow-up|0|||
130110373|NCT02919475|468365720|FG001|Overall Study|Lost to Follow-up|0|||
130110374|NCT02919475|468365721|FG002|Overall Study|Lost to Follow-up|0|||
130110375|NCT02919475|468365722|FG003|Overall Study|Lost to Follow-up|1|||
130110376|NCT02919475|468365723|FG004|Overall Study|Lost to Follow-up|0|||
130110377|NCT02919475|468365719|FG000|Overall Study|Withdrawal by Subject|2|||
130110378|NCT02919475|468365720|FG001|Overall Study|Withdrawal by Subject|3|||
130110379|NCT02919475|468365721|FG002|Overall Study|Withdrawal by Subject|1|||
130110380|NCT02919475|468365722|FG003|Overall Study|Withdrawal by Subject|2|||
130110381|NCT02919475|468365723|FG004|Overall Study|Withdrawal by Subject|2|||
130110382|NCT02919475|468365719|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130110383|NCT02919475|468365720|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130110384|NCT02919475|468365721|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130110385|NCT02919475|468365722|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130110386|NCT02919475|468365723|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130110387|NCT02962882|468365726|FG000|Overall Study|Adverse Event|2|||
130309464|NCT00132808|469095970|FG000|Stratum II|Adverse Event|1|||
130309465|NCT00132808|469095971|FG001|Stratum II|Adverse Event|2|||
130309466|NCT00132808|469095972|FG002|Stratum II|Adverse Event|1|||
130309467|NCT00132808|469095970|FG000|Stratum II|Death|1|||
130309468|NCT00132808|469095971|FG001|Stratum II|Death|0|||
130309469|NCT00132808|469095972|FG002|Stratum II|Death|0|||
130309470|NCT00132808|469095970|FG000|Stratum II|Lost to Follow-up|2|||
130049574|NCT00772967|468138697|FG003|Crossover Treatment 3|Adverse Event|0|||
130049575|NCT00772967|468138698|FG004|Crossover Treatment 3|Adverse Event|1|||
130049576|NCT00772967|468138699|FG005|Crossover Treatment 3|Adverse Event|0|||
130049577|NCT01595646|468138700|FG000|Overall Study|Withdrawal by Subject|1|||
130049578|NCT01595646|468138701|FG001|Overall Study|Withdrawal by Subject|0|||
130049579|NCT01595646|468138702|FG002|Overall Study|Withdrawal by Subject|0|||
130049580|NCT01161524|468138705|FG000|Core Study (23 Weeks)|Adverse Event|3|||
130049581|NCT01161524|468138706|FG001|Core Study (23 Weeks)|Adverse Event|0|||
130049582|NCT01161524|468138707|FG002|Core Study (23 Weeks)|Adverse Event|0|||
130049583|NCT01161524|468138705|FG000|Core Study (23 Weeks)|Other|1|||
130049584|NCT01161524|468138706|FG001|Core Study (23 Weeks)|Other|0|||
130049585|NCT01161524|468138707|FG002|Core Study (23 Weeks)|Other|0|||
130049586|NCT01161524|468138705|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
130049587|NCT01161524|468138706|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
130049588|NCT01161524|468138707|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
130049589|NCT01161524|468138705|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
130049590|NCT01161524|468138706|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
130049591|NCT01161524|468138707|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
130049592|NCT01161524|468138705|FG000|Core Study (23 Weeks)|Subject Choice|3|||
130049593|NCT01161524|468138706|FG001|Core Study (23 Weeks)|Subject Choice|2|||
130049594|NCT01161524|468138707|FG002|Core Study (23 Weeks)|Subject Choice|0|||
130049595|NCT01161524|468138705|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
130049596|NCT01161524|468138706|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
130049597|NCT01161524|468138707|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
130049598|NCT01161524|468138705|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
130049599|NCT01161524|468138706|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
130049600|NCT01161524|468138707|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
130049601|NCT01161524|468138705|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
130049602|NCT01161524|468138706|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
130049603|NCT01161524|468138707|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
130049604|NCT01161524|468138705|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
130049605|NCT01161524|468138706|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
130049606|NCT01161524|468138707|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
130049607|NCT01161524|468138705|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
130049608|NCT01161524|468138706|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
130049609|NCT01161524|468138707|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
130049610|NCT00231062|468138714|FG000|Overall Study|Physician Decision|6|||
130049611|NCT01052012|468138715|FG000|Overall Study|Not treated|2|||
130049612|NCT01052012|468138716|FG001|Overall Study|Not treated|5|||
130049613|NCT01052012|468138717|FG002|Overall Study|Not treated|0|||
130049614|NCT01052012|468138718|FG003|Overall Study|Not treated|0|||
130049615|NCT01052012|468138719|FG004|Overall Study|Not treated|11|||
130049616|NCT01052012|468138720|FG005|Overall Study|Not treated|8|||
130049617|NCT01052012|468138715|FG000|Overall Study|Adverse Event|1|||
130049618|NCT01052012|468138716|FG001|Overall Study|Adverse Event|0|||
130049619|NCT01052012|468138717|FG002|Overall Study|Adverse Event|0|||
130049620|NCT01052012|468138718|FG003|Overall Study|Adverse Event|1|||
130049621|NCT01052012|468138719|FG004|Overall Study|Adverse Event|0|||
130049622|NCT01052012|468138720|FG005|Overall Study|Adverse Event|0|||
130049623|NCT01052012|468138715|FG000|Overall Study|Lost to Follow-up|0|||
130049624|NCT01052012|468138716|FG001|Overall Study|Lost to Follow-up|0|||
130049625|NCT01052012|468138717|FG002|Overall Study|Lost to Follow-up|0|||
130049626|NCT01052012|468138718|FG003|Overall Study|Lost to Follow-up|0|||
130309471|NCT00132808|469095971|FG001|Stratum II|Lost to Follow-up|2|||
130309472|NCT00132808|469095972|FG002|Stratum II|Lost to Follow-up|1|||
130309473|NCT00132808|469095970|FG000|Stratum II|Protocol Violation|0|||
130309474|NCT00132808|469095971|FG001|Stratum II|Protocol Violation|2|||
130309475|NCT00132808|469095972|FG002|Stratum II|Protocol Violation|1|||
130049627|NCT01052012|468138719|FG004|Overall Study|Lost to Follow-up|1|||
130049628|NCT01052012|468138720|FG005|Overall Study|Lost to Follow-up|0|||
130049629|NCT01052012|468138715|FG000|Overall Study|Withdrawal by Subject|1|||
130049630|NCT01052012|468138716|FG001|Overall Study|Withdrawal by Subject|1|||
130049631|NCT01052012|468138717|FG002|Overall Study|Withdrawal by Subject|0|||
130049632|NCT01052012|468138718|FG003|Overall Study|Withdrawal by Subject|0|||
130049633|NCT01052012|468138719|FG004|Overall Study|Withdrawal by Subject|3|||
130049634|NCT01052012|468138720|FG005|Overall Study|Withdrawal by Subject|1|||
130049635|NCT01052012|468138715|FG000|Overall Study|Physician Decision|0|||
130049636|NCT01052012|468138716|FG001|Overall Study|Physician Decision|0|||
130309476|NCT00132808|469095970|FG000|Stratum II|Withdrawal by Subject|4|||
129889513|NCT01513967|467552630|FG007|Overall Study|missed a study visit|0|||
129889514|NCT01513967|467552623|FG000|Overall Study|excluded due to positive drug screen|0|||
129889515|NCT01513967|467552624|FG001|Overall Study|excluded due to positive drug screen|0|||
129889516|NCT01513967|467552625|FG002|Overall Study|excluded due to positive drug screen|0|||
129889517|NCT01513967|467552626|FG003|Overall Study|excluded due to positive drug screen|0|||
129889518|NCT01513967|467552627|FG004|Overall Study|excluded due to positive drug screen|0|||
130110388|NCT02962882|468365726|FG000|Overall Study|Withdrawal by Subject|2|||
130110389|NCT02962882|468365726|FG000|Overall Study|Transfer from ICU|32|||
130110390|NCT01663714|468365727|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
130309477|NCT00132808|469095971|FG001|Stratum II|Withdrawal by Subject|9|||
130309478|NCT00132808|469095972|FG002|Stratum II|Withdrawal by Subject|6|||
130309479|NCT00924443|469095981|FG000|Overall Study|Physician Decision|2|||
130309480|NCT00924443|469095981|FG000|Overall Study|Protocol Violation|1|||
130309481|NCT00595478|469095987|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
130309482|NCT00595478|469095988|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
130309483|NCT00595478|469095987|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
130309484|NCT00595478|469095988|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
130309485|NCT03405818|469095991|FG000|Overall Study|Withdrawal by Subject|4|||
130309486|NCT03405818|469095991|FG000|Overall Study|Lost to Follow-up|4|||
130309487|NCT02363959|469095994|FG000|Overall Study|Medical instability|1|||
130309488|NCT02363959|469095995|FG001|Overall Study|Medical instability|0|||
130309489|NCT00950248|469095996|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
130309490|NCT00950248|469095997|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
130110391|NCT01663714|468365727|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
130110392|NCT01663714|468365727|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
130110393|NCT01663714|468365727|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
130110394|NCT01663714|468365727|FG000|Long-Term Follow-Up|Death|4|||
130110395|NCT01663714|468365727|FG000|Long-Term Follow-Up|Non-compliance|1|||
130110396|NCT00597584|468365728|FG000|Overall Study|Adverse Event|4|||
130110397|NCT00597584|468365729|FG001|Overall Study|Adverse Event|2|||
130110398|NCT00597584|468365728|FG000|Overall Study|Death|53|||
130110399|NCT00597584|468365729|FG001|Overall Study|Death|30|||
130110400|NCT00597584|468365728|FG000|Overall Study|Lack of Efficacy|1|||
130110401|NCT00597584|468365729|FG001|Overall Study|Lack of Efficacy|0|||
130309491|NCT00950248|469095998|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
130309492|NCT00950248|469095996|FG000|Year 1: Baseline|worsening of symptoms|2|||
130309493|NCT00950248|469095997|FG001|Year 1: Baseline|worsening of symptoms|0|||
130309494|NCT00950248|469095998|FG002|Year 1: Baseline|worsening of symptoms|0|||
130309495|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
130309496|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
130309497|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
130309498|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
130309499|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
130309500|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
130309501|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|Death|0|||
130309502|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|Death|0|||
130309503|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|Death|1|||
130309504|NCT00950248|469095996|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
130309505|NCT00950248|469095997|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
129889519|NCT01513967|467552628|FG005|Overall Study|excluded due to positive drug screen|0|||
129889520|NCT01513967|467552629|FG006|Overall Study|excluded due to positive drug screen|0|||
129889521|NCT01513967|467552630|FG007|Overall Study|excluded due to positive drug screen|2|||
129889522|NCT01513967|467552623|FG000|Overall Study|Physician Decision|0|||
129889523|NCT01513967|467552624|FG001|Overall Study|Physician Decision|0|||
129889524|NCT01513967|467552625|FG002|Overall Study|Physician Decision|0|||
130110402|NCT00597584|468365728|FG000|Overall Study|Lost to Follow-up|2|||
130110403|NCT00597584|468365729|FG001|Overall Study|Lost to Follow-up|4|||
130110404|NCT00597584|468365728|FG000|Overall Study|Physician Decision|3|||
130110405|NCT00597584|468365729|FG001|Overall Study|Physician Decision|0|||
130110406|NCT00597584|468365728|FG000|Overall Study|Pregnancy|2|||
130110407|NCT00597584|468365729|FG001|Overall Study|Pregnancy|0|||
130110408|NCT00597584|468365728|FG000|Overall Study|Withdrawal by Subject|44|||
130309506|NCT00950248|469095998|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
130309507|NCT01900652|469095999|FG000|Overall Study|Progressive Disease|1|||
130309508|NCT01900652|469096000|FG001|Overall Study|Progressive Disease|0|||
130309509|NCT01900652|469095999|FG000|Overall Study|Consent withdrawn by subject|1|||
130309510|NCT01900652|469096000|FG001|Overall Study|Consent withdrawn by subject|1|||
130309511|NCT01900652|469095999|FG000|Overall Study|Death|3|||
130309512|NCT01900652|469096000|FG001|Overall Study|Death|0|||
130309513|NCT01900652|469095999|FG000|Overall Study|Adverse Event|2|||
130309514|NCT01900652|469096000|FG001|Overall Study|Adverse Event|1|||
130309515|NCT01900652|469095999|FG000|Overall Study|Physician Decision|1|||
130309516|NCT01900652|469096000|FG001|Overall Study|Physician Decision|1|||
130309517|NCT00869518|469096003|FG000|Overall Study|Lost to Follow-up|1|||
130309518|NCT00869518|469096004|FG001|Overall Study|Lost to Follow-up|1|||
130309519|NCT00947115|469096005|FG000|Overall Study|Missed reporting interval|3|||
130309520|NCT00947115|469096006|FG001|Overall Study|Missed reporting interval|4|||
130309521|NCT00947115|469096007|FG002|Overall Study|Missed reporting interval|2|||
130309522|NCT00947115|469096005|FG000|Overall Study|Physician Decision|0|||
130309523|NCT00947115|469096006|FG001|Overall Study|Physician Decision|2|||
130309524|NCT00947115|469096007|FG002|Overall Study|Physician Decision|0|||
130309525|NCT00947115|469096005|FG000|Overall Study|Death|0|||
130309526|NCT00947115|469096006|FG001|Overall Study|Death|1|||
130309527|NCT00947115|469096007|FG002|Overall Study|Death|1|||
130309528|NCT00947115|469096005|FG000|Overall Study|Migrated from study area|2|||
130309529|NCT00947115|469096006|FG001|Overall Study|Migrated from study area|0|||
130309530|NCT00947115|469096007|FG002|Overall Study|Migrated from study area|0|||
130309531|NCT00947115|469096005|FG000|Overall Study|Withdrawal by Subject|1|||
130309532|NCT00947115|469096006|FG001|Overall Study|Withdrawal by Subject|3|||
130309533|NCT00947115|469096007|FG002|Overall Study|Withdrawal by Subject|4|||
130309534|NCT00947115|469096005|FG000|Overall Study|Lost to Follow-up|11|||
130309535|NCT00947115|469096006|FG001|Overall Study|Lost to Follow-up|12|||
130309536|NCT00947115|469096007|FG002|Overall Study|Lost to Follow-up|8|||
130309537|NCT01223183|469096009|FG000|Imaging Day 1|Physician Decision|0|||
130309538|NCT01223183|469096010|FG001|Imaging Day 1|Physician Decision|1|||
130309539|NCT01223183|469096009|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
130309540|NCT01223183|469096010|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
130309541|NCT01223183|469096009|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
130309542|NCT01223183|469096010|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
130309543|NCT00900029|469096013|FG000|Overall Study|Lost to Follow-up|0|||
130309544|NCT00900029|469096014|FG001|Overall Study|Lost to Follow-up|2|||
130309545|NCT00900029|469096015|FG002|Overall Study|Lost to Follow-up|1|||
130309546|NCT00900029|469096016|FG003|Overall Study|Lost to Follow-up|4|||
130309547|NCT00900029|469096017|FG004|Overall Study|Lost to Follow-up|4|||
130309548|NCT00900029|469096013|FG000|Overall Study|Withdrawal by Subject|2|||
130309549|NCT00900029|469096014|FG001|Overall Study|Withdrawal by Subject|2|||
130309550|NCT00900029|469096015|FG002|Overall Study|Withdrawal by Subject|1|||
130309551|NCT00900029|469096016|FG003|Overall Study|Withdrawal by Subject|1|||
130309552|NCT00900029|469096017|FG004|Overall Study|Withdrawal by Subject|1|||
130309553|NCT00900029|469096013|FG000|Overall Study|Adverse Event|0|||
129889525|NCT01513967|467552626|FG003|Overall Study|Physician Decision|0|||
130110409|NCT00597584|468365729|FG001|Overall Study|Withdrawal by Subject|12|||
130110410|NCT00597584|468365728|FG000|Overall Study|Discontinued Dialysis|0|||
130110411|NCT00597584|468365729|FG001|Overall Study|Discontinued Dialysis|1|||
130309554|NCT00900029|469096014|FG001|Overall Study|Adverse Event|0|||
130309555|NCT00900029|469096015|FG002|Overall Study|Adverse Event|1|||
130309556|NCT00900029|469096016|FG003|Overall Study|Adverse Event|1|||
130309557|NCT00900029|469096017|FG004|Overall Study|Adverse Event|1|||
130309558|NCT00900029|469096013|FG000|Overall Study|Death|1|||
130309559|NCT00900029|469096014|FG001|Overall Study|Death|0|||
130309560|NCT00900029|469096015|FG002|Overall Study|Death|0|||
130309561|NCT00900029|469096016|FG003|Overall Study|Death|1|||
130309562|NCT00900029|469096017|FG004|Overall Study|Death|0|||
130309563|NCT00511238|469096020|FG000|Overall Study|Adverse Event|13|||
130309564|NCT00511238|469096021|FG001|Overall Study|Adverse Event|33|||
130309565|NCT00511238|469096020|FG000|Overall Study|Withdrawal by Subject|2|||
130309566|NCT00511238|469096021|FG001|Overall Study|Withdrawal by Subject|22|||
130309567|NCT00511238|469096020|FG000|Overall Study|Progressive Disease|23|||
130309568|NCT00511238|469096021|FG001|Overall Study|Progressive Disease|157|||
130309569|NCT00511238|469096020|FG000|Overall Study|various reasons|4|||
130309570|NCT00511238|469096021|FG001|Overall Study|various reasons|14|||
130309571|NCT03772665|469096022|FG000|Overall Study|Protocol Violation|1|||
130309572|NCT03772665|469096023|FG001|Overall Study|Protocol Violation|0|||
130309573|NCT00163020|469096024|FG000|Overall Study|Lost to Follow-up|0|||
130309574|NCT00163020|469096025|FG001|Overall Study|Lost to Follow-up|2|||
130309575|NCT00922623|469098992|FG000|Overall Study|Other|4|||
130309576|NCT00922623|469098992|FG000|Overall Study|Lost to Follow-up|1|||
130309577|NCT02871635|469098993|FG000|Overall Study|Primary lack of efficacy|4|||
130309578|NCT02871635|469098994|FG001|Overall Study|Primary lack of efficacy|4|||
130309579|NCT02871635|469098993|FG000|Overall Study|Protocol Violation|3|||
130309580|NCT02871635|469098994|FG001|Overall Study|Protocol Violation|1|||
130309581|NCT02871635|469098993|FG000|Overall Study|Lost to Follow-up|1|||
130309582|NCT02871635|469098994|FG001|Overall Study|Lost to Follow-up|2|||
130309583|NCT02871635|469098993|FG000|Overall Study|Pregnancy|0|||
130309584|NCT02871635|469098994|FG001|Overall Study|Pregnancy|2|||
129889526|NCT01513967|467552627|FG004|Overall Study|Physician Decision|0|||
129889527|NCT01513967|467552628|FG005|Overall Study|Physician Decision|1|||
129889528|NCT01513967|467552629|FG006|Overall Study|Physician Decision|0|||
129889529|NCT01513967|467552630|FG007|Overall Study|Physician Decision|0|||
129889530|NCT02711826|467552631|FG000|Overall Study|Physician Decision|0|||
129889531|NCT02711826|467552632|FG001|Overall Study|Physician Decision|0|||
129889532|NCT02711826|467552633|FG002|Overall Study|Physician Decision|0|||
129889533|NCT02711826|467552634|FG003|Overall Study|Physician Decision|1|||
129889534|NCT02711826|467552635|FG004|Overall Study|Physician Decision|0|||
129889535|NCT02711826|467552631|FG000|Overall Study|Withdrawal by Subject|0|||
129889536|NCT02711826|467552632|FG001|Overall Study|Withdrawal by Subject|1|||
129889537|NCT02711826|467552633|FG002|Overall Study|Withdrawal by Subject|0|||
129889538|NCT02711826|467552634|FG003|Overall Study|Withdrawal by Subject|4|||
129889539|NCT02711826|467552635|FG004|Overall Study|Withdrawal by Subject|0|||
129889540|NCT02711826|467552631|FG000|Overall Study|Failure to manufacture cellular product|0|||
129889541|NCT02711826|467552632|FG001|Overall Study|Failure to manufacture cellular product|0|||
129889542|NCT02711826|467552633|FG002|Overall Study|Failure to manufacture cellular product|5|||
129889543|NCT02711826|467552634|FG003|Overall Study|Failure to manufacture cellular product|0|||
129889544|NCT02711826|467552635|FG004|Overall Study|Failure to manufacture cellular product|0|||
129889545|NCT02711826|467552631|FG000|Overall Study|Infusion canceled for active infection|0|||
129889546|NCT02711826|467552632|FG001|Overall Study|Infusion canceled for active infection|1|||
129889547|NCT02711826|467552633|FG002|Overall Study|Infusion canceled for active infection|0|||
129889548|NCT02711826|467552634|FG003|Overall Study|Infusion canceled for active infection|0|||
129889549|NCT02711826|467552635|FG004|Overall Study|Infusion canceled for active infection|0|||
129889550|NCT02711826|467552631|FG000|Overall Study|Screen failures|0|||
129889551|NCT02711826|467552632|FG001|Overall Study|Screen failures|0|||
129889552|NCT02711826|467552633|FG002|Overall Study|Screen failures|0|||
129889553|NCT02711826|467552634|FG003|Overall Study|Screen failures|4|||
130309585|NCT02871635|469098993|FG000|Overall Study|Physician Decision|1|||
130309586|NCT02871635|469098994|FG001|Overall Study|Physician Decision|1|||
130309587|NCT02871635|469098993|FG000|Overall Study|Withdrawal by Subject|3|||
130309588|NCT02871635|469098994|FG001|Overall Study|Withdrawal by Subject|4|||
130309589|NCT02871635|469098993|FG000|Overall Study|Adverse Event|4|||
130309590|NCT02871635|469098994|FG001|Overall Study|Adverse Event|4|||
129798446|NCT01074047|467230098|FG001|Treatment Phase|Miscellaneous|39|||
129798447|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
130309591|NCT02871635|469098993|FG000|Overall Study|Secondary lack of efficacy|2|||
130309592|NCT02871635|469098994|FG001|Overall Study|Secondary lack of efficacy|1|||
130309593|NCT02420379|469098995|FG000|Overall Study|Withdrawal by Subject|0|||
130309594|NCT02420379|469098996|FG001|Overall Study|Withdrawal by Subject|3|||
130309595|NCT02420379|469098995|FG000|Overall Study|Unable to complete due to schooling|0|||
130309596|NCT02420379|469098996|FG001|Overall Study|Unable to complete due to schooling|1|||
130309597|NCT02420379|469098995|FG000|Overall Study|Transitioned to commercial drug|1|||
130309598|NCT02420379|469098996|FG001|Overall Study|Transitioned to commercial drug|0|||
130309599|NCT01402817|469098997|FG000|Overall Study|Withdrawal by Subject|3|||
130309600|NCT01402817|469098997|FG000|Overall Study|Study Suspended by FDA|8|||
130309601|NCT01473732|469098999|FG000|Overall Study|Adverse Event|1|||
130309602|NCT01473732|469099000|FG001|Overall Study|Adverse Event|0|||
130309603|NCT01473732|469098999|FG000|Overall Study|Death|1|||
130309604|NCT01473732|469099000|FG001|Overall Study|Death|0|||
130309605|NCT01217944|469099003|FG000|Overall Study|Protocol Violation|1|||
130309606|NCT01217944|469099004|FG001|Overall Study|Protocol Violation|1|||
130309607|NCT01217944|469099005|FG002|Overall Study|Protocol Violation|0|||
130309608|NCT01217944|469099003|FG000|Overall Study|Lost to Follow-up|3|||
129798448|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
129798449|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
129798450|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
129798451|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Death|116|||
129798452|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Death|124|||
129798453|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
129798454|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
129798455|NCT01074047|467230097|FG000|Extension Phase|Physician Decision|1|||
129798456|NCT01074047|467230098|FG001|Extension Phase|Physician Decision|0|||
129798457|NCT01074047|467230097|FG000|Extension Phase|Adverse Event|5|||
129798458|NCT01074047|467230098|FG001|Extension Phase|Adverse Event|0|||
129798459|NCT01074047|467230097|FG000|Extension Phase|Disease Progression|9|||
129798460|NCT01074047|467230098|FG001|Extension Phase|Disease Progression|0|||
129798461|NCT01074047|467230097|FG000|Extension Phase|Withdrawal by Subject|2|||
129798462|NCT01074047|467230098|FG001|Extension Phase|Withdrawal by Subject|0|||
129798463|NCT01074047|467230097|FG000|Extension Phase|Death|5|||
129798464|NCT01074047|467230098|FG001|Extension Phase|Death|0|||
129798465|NCT01801072|467232083|FG000|Overall Study|Lost to Follow-up|17|||
129798466|NCT01801072|467232084|FG001|Overall Study|Lost to Follow-up|14|||
129798467|NCT01801072|467232083|FG000|Overall Study|Physician Decision|2|||
129798468|NCT01801072|467232084|FG001|Overall Study|Physician Decision|3|||
129798469|NCT01801072|467232083|FG000|Overall Study|Withdrawal by Subject|1|||
130309609|NCT01217944|469099004|FG001|Overall Study|Lost to Follow-up|1|||
129798470|NCT01801072|467232084|FG001|Overall Study|Withdrawal by Subject|0|||
129798471|NCT01801072|467232083|FG000|Overall Study|Protocol Violation|2|||
129798472|NCT01801072|467232084|FG001|Overall Study|Protocol Violation|0|||
129798473|NCT01801072|467232083|FG000|Overall Study|Death|7|||
129798474|NCT01801072|467232084|FG001|Overall Study|Death|8|||
129798475|NCT02247531|467232085|FG000|Overall Study|Adverse Event|3|||
130309610|NCT01217944|469099005|FG002|Overall Study|Lost to Follow-up|0|||
130309611|NCT01217944|469099003|FG000|Overall Study|Withdrawal by Subject|1|||
129798476|NCT02247531|467232086|FG001|Overall Study|Adverse Event|4|||
129798477|NCT02247531|467232087|FG002|Overall Study|Adverse Event|9|||
129798478|NCT02247531|467232085|FG000|Overall Study|Death|8|||
129798479|NCT02247531|467232086|FG001|Overall Study|Death|9|||
129798480|NCT02247531|467232087|FG002|Overall Study|Death|5|||
129798481|NCT02247531|467232085|FG000|Overall Study|Lost to Follow-up|1|||
129798482|NCT02247531|467232086|FG001|Overall Study|Lost to Follow-up|8|||
129798483|NCT02247531|467232087|FG002|Overall Study|Lost to Follow-up|3|||
129798484|NCT02247531|467232085|FG000|Overall Study|Non-compliance|2|||
129798485|NCT02247531|467232086|FG001|Overall Study|Non-compliance|2|||
129798486|NCT02247531|467232087|FG002|Overall Study|Non-compliance|0|||
129798487|NCT02247531|467232085|FG000|Overall Study|Withdrawal by Subject|26|||
129798488|NCT02247531|467232086|FG001|Overall Study|Withdrawal by Subject|31|||
129798489|NCT02247531|467232087|FG002|Overall Study|Withdrawal by Subject|25|||
129798490|NCT02247531|467232085|FG000|Overall Study|Study Terminated by Sponsor|64|||
129798491|NCT02247531|467232086|FG001|Overall Study|Study Terminated by Sponsor|66|||
129798492|NCT02247531|467232087|FG002|Overall Study|Study Terminated by Sponsor|62|||
129798493|NCT02247531|467232085|FG000|Overall Study|Physician Decision|0|||
129798494|NCT02247531|467232086|FG001|Overall Study|Physician Decision|2|||
129798495|NCT02247531|467232087|FG002|Overall Study|Physician Decision|2|||
129798496|NCT02247531|467232085|FG000|Overall Study|Unspecified Reason|2|||
129798497|NCT02247531|467232086|FG001|Overall Study|Unspecified Reason|3|||
129798498|NCT02247531|467232087|FG002|Overall Study|Unspecified Reason|4|||
130309612|NCT01217944|469099004|FG001|Overall Study|Withdrawal by Subject|2|||
130309613|NCT01217944|469099005|FG002|Overall Study|Withdrawal by Subject|0|||
130309614|NCT01217944|469099003|FG000|Overall Study|Lack of Efficacy|1|||
130309615|NCT01217944|469099004|FG001|Overall Study|Lack of Efficacy|0|||
130309616|NCT01217944|469099005|FG002|Overall Study|Lack of Efficacy|0|||
130309617|NCT04098809|469099006|FG000|Overall Study|Withdrawal by Subject|1|||
130309618|NCT04098809|469099007|FG001|Overall Study|Withdrawal by Subject|3|||
130309619|NCT04098809|469099006|FG000|Overall Study|Physician Decision|2|||
130309620|NCT04098809|469099007|FG001|Overall Study|Physician Decision|1|||
130309621|NCT00193206|469099008|FG000|Preoperative Therapy|Lack of Efficacy|2|||
130309622|NCT00193206|469099008|FG000|Preoperative Therapy|Adverse Event|2|||
130309623|NCT00193206|469099008|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
130309624|NCT00193206|469099008|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
130309625|NCT00193206|469099008|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
130309626|NCT00193206|469099008|FG000|Postoperative Therapy|Physician Decision|3|||
130309627|NCT00193206|469099008|FG000|Postoperative Therapy|Intercurrent Illness|2|||
130309628|NCT00193206|469099008|FG000|Postoperative Therapy|Lack of Efficacy|1|||
130309629|NCT00193206|469099008|FG000|Postoperative Therapy|Protocol Violation|1|||
130309630|NCT01426958|469099009|FG000|Overall Study|Adverse Event|2|||
130309631|NCT00991939|469099012|FG000|Overall Study|Lost to Follow-up|0|||
130309632|NCT00991939|469099013|FG001|Overall Study|Lost to Follow-up|1|||
130309633|NCT00991939|469099012|FG000|Overall Study|Withdrawal by Subject|1|||
130309634|NCT00991939|469099013|FG001|Overall Study|Withdrawal by Subject|0|||
130309635|NCT00991939|469099012|FG000|Overall Study|Entire study terminated|4|||
130309636|NCT00991939|469099013|FG001|Overall Study|Entire study terminated|1|||
130309637|NCT02073682|469099018|FG000|Overall Study|Low Creatinine Clearance|1|||
130309638|NCT02073682|469099019|FG001|Overall Study|Low Creatinine Clearance|2|||
130309639|NCT02073682|469099018|FG000|Overall Study|Death|86|||
130309640|NCT02073682|469099019|FG001|Overall Study|Death|100|||
130309641|NCT02073682|469099018|FG000|Overall Study|Cancer Cured|10|||
130309642|NCT02073682|469099019|FG001|Overall Study|Cancer Cured|15|||
130309643|NCT02073682|469099018|FG000|Overall Study|ID: Patient Noncompliance|1|||
130309644|NCT02073682|469099019|FG001|Overall Study|ID: Patient Noncompliance|2|||
130309645|NCT02073682|469099018|FG000|Overall Study|ID: Palliative Treatment Only|10|||
130309646|NCT02073682|469099019|FG001|Overall Study|ID: Palliative Treatment Only|7|||
130309647|NCT02073682|469099018|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
130309648|NCT02073682|469099019|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
130309649|NCT02073682|469099018|FG000|Overall Study|Platelet Count <50,000/mL|1|||
130309650|NCT02073682|469099019|FG001|Overall Study|Platelet Count <50,000/mL|2|||
130309651|NCT02073682|469099018|FG000|Overall Study|Surgery/Medical Procedure|3|||
130309652|NCT02073682|469099019|FG001|Overall Study|Surgery/Medical Procedure|1|||
130309653|NCT02073682|469099018|FG000|Overall Study|Withdrawal by Subject|6|||
130309654|NCT02073682|469099019|FG001|Overall Study|Withdrawal by Subject|8|||
130309655|NCT02073682|469099018|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
130309656|NCT02073682|469099019|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
130309657|NCT02073682|469099018|FG000|Overall Study|Cancer Progression|53|||
130309658|NCT02073682|469099019|FG001|Overall Study|Cancer Progression|33|||
130309659|NCT02073682|469099018|FG000|Overall Study|Protocol Violation|1|||
130309660|NCT02073682|469099019|FG001|Overall Study|Protocol Violation|0|||
130309661|NCT02073682|469099018|FG000|Overall Study|Adverse Event|79|||
130309662|NCT02073682|469099019|FG001|Overall Study|Adverse Event|62|||
130309663|NCT02073682|469099018|FG000|Overall Study|No reason provided|11|||
130309664|NCT02073682|469099019|FG001|Overall Study|No reason provided|9|||
130309665|NCT02073682|469099018|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
130309666|NCT02073682|469099019|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
130309667|NCT02073682|469099018|FG000|Overall Study|Lost to Follow-up|1|||
130309668|NCT02073682|469099019|FG001|Overall Study|Lost to Follow-up|1|||
130309669|NCT02073682|469099018|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
130309670|NCT02073682|469099019|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
130309671|NCT00181766|469099020|FG000|Overall Study|Lost to Follow-up|6|||
129889554|NCT02711826|467552635|FG004|Overall Study|Screen failures|0|||
129889555|NCT02906202|467552636|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
129889556|NCT01960790|467552637|FG000|Overall Study|Survey forms could not be recovered|3|||
130049637|NCT01052012|468138717|FG002|Overall Study|Physician Decision|0|||
130049638|NCT01052012|468138718|FG003|Overall Study|Physician Decision|0|||
130049639|NCT01052012|468138719|FG004|Overall Study|Physician Decision|0|||
130049640|NCT01052012|468138720|FG005|Overall Study|Physician Decision|1|||
130049641|NCT01052012|468138715|FG000|Overall Study|Other|0|||
130049642|NCT01052012|468138716|FG001|Overall Study|Other|0|||
130049643|NCT01052012|468138717|FG002|Overall Study|Other|0|||
130049644|NCT01052012|468138718|FG003|Overall Study|Other|0|||
130049645|NCT01052012|468138719|FG004|Overall Study|Other|1|||
130049646|NCT01052012|468138720|FG005|Overall Study|Other|0|||
130049647|NCT02021812|468138723|FG000|Overall Study|Death|8|||
130049648|NCT02021812|468138723|FG000|Overall Study|Withdrawal by Subject|3|||
130049649|NCT02021812|468138723|FG000|Overall Study|Lost to Follow-up|2|||
130049650|NCT02021812|468138723|FG000|Overall Study|Refuse to return, COVD 19|2|||
130049651|NCT02698423|468138728|FG000|Overall Study|Lost to Follow-up|19|||
130049652|NCT02698423|468138729|FG001|Overall Study|Lost to Follow-up|24|||
130049653|NCT01651260|468138730|FG000|Overall Study|unable to apply product|3|||
130049654|NCT02144220|468138731|FG000|Overall Study|technology incompatibility|9|||
130309672|NCT00181766|469099020|FG000|Overall Study|Adverse Event|4|||
130309673|NCT00181766|469099020|FG000|Overall Study|non-compliance|2|||
130309674|NCT00855816|469099021|FG000|Overall Study|Withdrawal by Subject|22|||
130049655|NCT02144220|468138731|FG000|Overall Study|Lack of Efficacy|4|||
130049656|NCT02144220|468138731|FG000|Overall Study|Physician Decision|3|||
130309675|NCT00855816|469099022|FG001|Overall Study|Withdrawal by Subject|15|||
130309676|NCT00855816|469099021|FG000|Overall Study|Lost to Follow-up|3|||
130309677|NCT00855816|469099022|FG001|Overall Study|Lost to Follow-up|5|||
130309678|NCT00855816|469099021|FG000|Overall Study|Death|1|||
130309679|NCT00855816|469099022|FG001|Overall Study|Death|0|||
130309680|NCT00855816|469099021|FG000|Overall Study|Became ineligible|0|||
130309681|NCT00855816|469099022|FG001|Overall Study|Became ineligible|1|||
130309682|NCT01965704|469099026|FG000|Overall Study|Withdrawal by Subject|2|||
130309683|NCT01965704|469099027|FG001|Overall Study|Withdrawal by Subject|2|||
130309684|NCT01965704|469099028|FG002|Overall Study|Withdrawal by Subject|1|||
130309685|NCT01965704|469099029|FG003|Overall Study|Withdrawal by Subject|1|||
130309686|NCT01965704|469099026|FG000|Overall Study|Delivered at home|1|||
130309687|NCT01965704|469099027|FG001|Overall Study|Delivered at home|1|||
130309688|NCT01965704|469099028|FG002|Overall Study|Delivered at home|0|||
130309689|NCT01965704|469099029|FG003|Overall Study|Delivered at home|0|||
130309690|NCT01965704|469099026|FG000|Overall Study|Experienced complications|0|||
130049657|NCT02144220|468138731|FG000|Overall Study|Withdrawal by Subject|2|||
130049658|NCT02144220|468138731|FG000|Overall Study|Protocol Violation|1|||
130049659|NCT01952015|468138734|FG000|Induction|Protocol Violation|1|||
130049660|NCT01952015|468138734|FG000|Maintenance|Adverse Event|2|||
130049661|NCT01952015|468138734|FG000|Treatment Period 3|Physician Decision|9|||
130049662|NCT01597193|468138735|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
130049663|NCT01597193|468138736|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
130049664|NCT01597193|468138737|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130049665|NCT01597193|468138738|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130049666|NCT01597193|468138739|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130049667|NCT01597193|468138740|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130049668|NCT01597193|468138741|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
130049669|NCT01597193|468138735|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130049670|NCT01597193|468138736|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130049671|NCT01597193|468138737|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130049672|NCT01597193|468138738|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
130049673|NCT01597193|468138739|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
130049674|NCT01597193|468138740|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
130049675|NCT01597193|468138741|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
130049676|NCT01597193|468138735|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
130049677|NCT01597193|468138736|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
130049678|NCT01597193|468138737|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
130049679|NCT01597193|468138738|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
130049680|NCT01597193|468138739|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
130049681|NCT01597193|468138740|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
130049682|NCT01597193|468138741|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
130049683|NCT01597193|468138735|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130049684|NCT01597193|468138736|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130049685|NCT01597193|468138737|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130049686|NCT01597193|468138738|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130049687|NCT01597193|468138739|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130049688|NCT01597193|468138740|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
130049689|NCT01597193|468138741|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
130049690|NCT01597193|468138735|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130049691|NCT01597193|468138736|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130049692|NCT01597193|468138737|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130049693|NCT01597193|468138738|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
130110412|NCT00597584|468365728|FG000|Overall Study|Lost ability to consent|1|||
130309691|NCT01965704|469099027|FG001|Overall Study|Experienced complications|0|||
129798499|NCT01251744|467232092|FG000|Overall Study|Lost to Follow-up|1|||
129798500|NCT01251744|467232093|FG001|Overall Study|Lost to Follow-up|0|||
129798501|NCT01068652|467232094|FG000|Overall Study|Adverse Event|4|||
130110413|NCT00597584|468365729|FG001|Overall Study|Lost ability to consent|1|||
130309692|NCT01965704|469099028|FG002|Overall Study|Experienced complications|2|||
130309693|NCT01965704|469099029|FG003|Overall Study|Experienced complications|2|||
130309694|NCT01965704|469099026|FG000|Overall Study|Adverse Event|0|||
130049694|NCT01597193|468138739|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130049695|NCT01597193|468138740|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
130049696|NCT01597193|468138741|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
130049697|NCT02508701|468138742|FG000|Overall Study|Lost to Follow-up|9|||
130049698|NCT02508701|468138743|FG001|Overall Study|Lost to Follow-up|5|||
130309695|NCT01965704|469099027|FG001|Overall Study|Adverse Event|0|||
130309696|NCT01965704|469099028|FG002|Overall Study|Adverse Event|1|||
129798502|NCT01068652|467232095|FG001|Overall Study|Adverse Event|0|||
130110414|NCT00597584|468365728|FG000|Overall Study|Never dosed|1|||
130110415|NCT00597584|468365729|FG001|Overall Study|Never dosed|0|||
130110416|NCT00597584|468365728|FG000|Overall Study|Relocation|8|||
130110417|NCT00597584|468365729|FG001|Overall Study|Relocation|6|||
130110418|NCT00597584|468365728|FG000|Overall Study|Renal transplant|9|||
130110419|NCT00597584|468365729|FG001|Overall Study|Renal transplant|7|||
130110420|NCT00515073|468365730|FG000|Overall Study|Withdrawal by Subject|1|||
130110421|NCT00515073|468365730|FG000|Overall Study|Physician Decision|1|||
130110422|NCT02791659|468365731|FG000|Overall Study|Protocol Violation|0|||
130110423|NCT02791659|468365732|FG001|Overall Study|Protocol Violation|1|||
130110424|NCT01456052|468365733|FG000|Overall Study|Adverse Event|1|||
130110425|NCT01456052|468365734|FG001|Overall Study|Adverse Event|1|||
130110426|NCT01456052|468365735|FG002|Overall Study|Adverse Event|2|||
130110427|NCT01456052|468365733|FG000|Overall Study|Consent withdrawn|0|||
130110428|NCT01456052|468365734|FG001|Overall Study|Consent withdrawn|2|||
130110429|NCT01456052|468365735|FG002|Overall Study|Consent withdrawn|1|||
130110430|NCT01456052|468365733|FG000|Overall Study|Protocol Violation|0|||
130110431|NCT01456052|468365734|FG001|Overall Study|Protocol Violation|1|||
130110432|NCT01456052|468365735|FG002|Overall Study|Protocol Violation|0|||
130110433|NCT01456052|468365733|FG000|Overall Study|Physician Decision|1|||
130110434|NCT01456052|468365734|FG001|Overall Study|Physician Decision|0|||
130110435|NCT01456052|468365735|FG002|Overall Study|Physician Decision|1|||
130110436|NCT01456052|468365733|FG000|Overall Study|Treatment Failure|0|||
130110437|NCT01456052|468365734|FG001|Overall Study|Treatment Failure|1|||
130110438|NCT01456052|468365735|FG002|Overall Study|Treatment Failure|1|||
130110439|NCT01904383|468365738|FG000|Overall Study|CRF not collected|117|||
130110440|NCT01904383|468365738|FG000|Overall Study|Reason not listed|147|||
130110441|NCT01904383|468365738|FG000|Overall Study|Lost to Follow-up|674|||
130110442|NCT01904383|468365738|FG000|Overall Study|Lack of Efficacy|370|||
130110443|NCT01904383|468365738|FG000|Overall Study|Improvement|141|||
130110444|NCT01904383|468365738|FG000|Overall Study|Adverse Event|271|||
130110445|NCT01904383|468365738|FG000|Overall Study|No patient visit after entry|54|||
130110446|NCT01294592|468365739|FG000|Overall Study|Adverse Event|28|||
130110447|NCT01294592|468365740|FG001|Overall Study|Adverse Event|13|||
130110448|NCT01294592|468365739|FG000|Overall Study|Lack of Efficacy|7|||
130110449|NCT01294592|468365740|FG001|Overall Study|Lack of Efficacy|5|||
130110450|NCT01294592|468365739|FG000|Overall Study|Protocol Violation|1|||
130110451|NCT01294592|468365740|FG001|Overall Study|Protocol Violation|7|||
130110452|NCT01294592|468365739|FG000|Overall Study|Lost to Follow-up|7|||
130110453|NCT01294592|468365740|FG001|Overall Study|Lost to Follow-up|9|||
130110454|NCT01294592|468365739|FG000|Overall Study|Physician Decision|6|||
130110455|NCT01294592|468365740|FG001|Overall Study|Physician Decision|11|||
130110456|NCT01294592|468365739|FG000|Overall Study|Withdrawal by Subject|28|||
130110457|NCT01294592|468365740|FG001|Overall Study|Withdrawal by Subject|28|||
130110458|NCT02762565|468365741|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
130110459|NCT01113710|468365742|FG000|Overall Study|Adverse Event|64|||
130110460|NCT01113710|468365742|FG000|Overall Study|Lack of Efficacy|41|||
130110461|NCT01113710|468365742|FG000|Overall Study|No Information Available|40|||
130110462|NCT01113710|468365742|FG000|Overall Study|Withdrawal by Subject|28|||
130110463|NCT01113710|468365742|FG000|Overall Study|Lost to Follow-up|20|||
130110464|NCT01113710|468365742|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
130110465|NCT01113710|468365742|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
130110466|NCT01113710|468365742|FG000|Overall Study|Lack of Patient's Compliance|8|||
129798503|NCT01068652|467232094|FG000|Overall Study|Lack of Efficacy|0|||
130110467|NCT01113710|468365742|FG000|Overall Study|Other|7|||
130110468|NCT01113710|468365742|FG000|Overall Study|Adverse Event/Other|5|||
130110469|NCT01113710|468365742|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
130110470|NCT01113710|468365742|FG000|Overall Study|Lack of Efficacy/Other|4|||
130110471|NCT01113710|468365742|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
130110472|NCT01113710|468365742|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
130110473|NCT01113710|468365742|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
130110474|NCT01113710|468365742|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
130110475|NCT01113710|468365742|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
130110476|NCT01113710|468365742|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
129798504|NCT01068652|467232095|FG001|Overall Study|Lack of Efficacy|2|||
129798505|NCT01068652|467232094|FG000|Overall Study|Lost to Follow-up|2|||
130110477|NCT01113710|468365742|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
130110478|NCT01113710|468365742|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
130110479|NCT01113710|468365742|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
130110480|NCT01113710|468365742|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
130110481|NCT01113710|468365742|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
130110482|NCT01113710|468365742|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
130110483|NCT01113710|468365742|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
130110484|NCT00623623|468365743|FG000|Overall Study|Previous enrolment into this study|1|||
130110485|NCT00623623|468365744|FG001|Overall Study|Previous enrolment into this study|1|||
130110486|NCT02265952|468365746|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
130110487|NCT02265952|468365747|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
130110488|NCT02265952|468365746|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
130110489|NCT02265952|468365747|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
130110490|NCT01042977|468365748|FG000|Overall Study|Adverse Event|4|||
130110491|NCT01042977|468365749|FG001|Overall Study|Adverse Event|12|||
130110492|NCT01042977|468365748|FG000|Overall Study|Death|2|||
130110493|NCT01042977|468365749|FG001|Overall Study|Death|1|||
130110494|NCT01042977|468365748|FG000|Overall Study|Withdrawal by Subject|8|||
130110495|NCT01042977|468365749|FG001|Overall Study|Withdrawal by Subject|16|||
130110496|NCT01042977|468365748|FG000|Overall Study|Lost to Follow-up|0|||
130110497|NCT01042977|468365749|FG001|Overall Study|Lost to Follow-up|2|||
130110498|NCT01042977|468365748|FG000|Overall Study|Poor/non-compliance|3|||
130110499|NCT01042977|468365749|FG001|Overall Study|Poor/non-compliance|4|||
130110500|NCT01042977|468365748|FG000|Overall Study|Subject no longer meets study criteria|15|||
130110501|NCT01042977|468365749|FG001|Overall Study|Subject no longer meets study criteria|13|||
130110502|NCT01042977|468365748|FG000|Overall Study|Incorrect enrollment|6|||
130110503|NCT01042977|468365749|FG001|Overall Study|Incorrect enrollment|4|||
130110504|NCT01042977|468365748|FG000|Overall Study|Safety|0|||
130110505|NCT01042977|468365749|FG001|Overall Study|Safety|2|||
130110506|NCT01042977|468365748|FG000|Overall Study|Administrative reason by sponsor|0|||
130110507|NCT01042977|468365749|FG001|Overall Study|Administrative reason by sponsor|1|||
130110508|NCT01042977|468365748|FG000|Overall Study|Various|3|||
130110509|NCT01042977|468365749|FG001|Overall Study|Various|0|||
130110510|NCT02499354|468365750|FG000|Overall Study|Withdrawal by Subject|1|||
130110511|NCT02499354|468365751|FG001|Overall Study|Withdrawal by Subject|0|||
129889557|NCT01960790|467552637|FG000|Overall Study|Treat with Humira outside survey period|3|||
129889558|NCT01960790|467552637|FG000|Overall Study|Transferred to another hospital|4|||
129889559|NCT01960790|467552637|FG000|Overall Study|Unevaluable for safety|1|||
129889560|NCT01987830|467552638|FG000|Overall Study|Never received baseline scan|1|||
129889561|NCT03990363|467552639|FG000|Overall Study|Withdrawal by Subject|10|||
129889562|NCT03990363|467552640|FG001|Overall Study|Withdrawal by Subject|9|||
129889563|NCT03990363|467552641|FG002|Overall Study|Withdrawal by Subject|18|||
129889564|NCT03990363|467552642|FG003|Overall Study|Withdrawal by Subject|11|||
129889565|NCT03990363|467552643|FG004|Overall Study|Withdrawal by Subject|9|||
129889566|NCT03990363|467552639|FG000|Overall Study|Physician Decision|1|||
129889567|NCT03990363|467552640|FG001|Overall Study|Physician Decision|0|||
129889568|NCT03990363|467552641|FG002|Overall Study|Physician Decision|0|||
129889569|NCT03990363|467552642|FG003|Overall Study|Physician Decision|0|||
129889570|NCT03990363|467552643|FG004|Overall Study|Physician Decision|0|||
129889571|NCT03990363|467552639|FG000|Overall Study|Adverse Event|1|||
129889572|NCT03990363|467552640|FG001|Overall Study|Adverse Event|3|||
129889573|NCT03990363|467552641|FG002|Overall Study|Adverse Event|2|||
129889574|NCT03990363|467552642|FG003|Overall Study|Adverse Event|2|||
129889575|NCT03990363|467552643|FG004|Overall Study|Adverse Event|0|||
129889576|NCT03990363|467552639|FG000|Overall Study|Death|14|||
129889577|NCT03990363|467552640|FG001|Overall Study|Death|8|||
129889578|NCT03990363|467552641|FG002|Overall Study|Death|14|||
129889579|NCT03990363|467552642|FG003|Overall Study|Death|10|||
129889580|NCT03990363|467552643|FG004|Overall Study|Death|11|||
129889581|NCT03990363|467552639|FG000|Overall Study|Failure to meet randomization criteria|0|||
129889582|NCT03990363|467552640|FG001|Overall Study|Failure to meet randomization criteria|1|||
130049699|NCT02508701|468138744|FG002|Overall Study|Lost to Follow-up|5|||
130049700|NCT02508701|468138745|FG003|Overall Study|Lost to Follow-up|3|||
130049701|NCT01259297|468138746|FG000|Double Blind Randomized Period|Death|1|||
130049702|NCT01259297|468138747|FG001|Double Blind Randomized Period|Death|1|||
130049703|NCT01259297|468138748|FG002|Double Blind Randomized Period|Death|1|||
130049704|NCT01259297|468138749|FG003|Double Blind Randomized Period|Death|2|||
130049705|NCT01259297|468138750|FG004|Double Blind Randomized Period|Death|1|||
130049706|NCT01259297|468138751|FG005|Double Blind Randomized Period|Death|5|||
130049707|NCT01259297|468138752|FG006|Double Blind Randomized Period|Death|2|||
130309697|NCT01965704|469099029|FG003|Overall Study|Adverse Event|1|||
130309698|NCT01965704|469099026|FG000|Overall Study|Did not meet inclusion criteria|0|||
129889583|NCT03990363|467552641|FG002|Overall Study|Failure to meet randomization criteria|1|||
129889584|NCT03990363|467552642|FG003|Overall Study|Failure to meet randomization criteria|0|||
129889585|NCT03990363|467552643|FG004|Overall Study|Failure to meet randomization criteria|0|||
129889586|NCT03990363|467552639|FG000|Overall Study|Lost to Follow-up|0|||
129889587|NCT03990363|467552640|FG001|Overall Study|Lost to Follow-up|0|||
129889588|NCT03990363|467552641|FG002|Overall Study|Lost to Follow-up|0|||
130049708|NCT01259297|468138753|FG007|Double Blind Randomized Period|Death|1|||
130049709|NCT01259297|468138746|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130110512|NCT02424565|468365754|FG000|Period 1 (D0)|Protocol Violation|0|||
130110513|NCT02424565|468365755|FG001|Period 1 (D0)|Protocol Violation|1|||
130110514|NCT03650400|468365756|FG000|Overall Study|Study terminated by sponsor|0|||
130110515|NCT03650400|468365757|FG001|Overall Study|Study terminated by sponsor|5|||
130110516|NCT01759381|468365758|FG000|Overall Study|Death|1|||
130110517|NCT01759381|468365759|FG001|Overall Study|Death|0|||
130049710|NCT01259297|468138747|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130309699|NCT01965704|469099027|FG001|Overall Study|Did not meet inclusion criteria|0|||
130309700|NCT01965704|469099028|FG002|Overall Study|Did not meet inclusion criteria|1|||
130309701|NCT01965704|469099029|FG003|Overall Study|Did not meet inclusion criteria|1|||
130309702|NCT00687804|469099037|FG000|Core Study|Adverse Event|5|||
130309703|NCT00687804|469099038|FG001|Core Study|Adverse Event|3|||
130309704|NCT00687804|469099039|FG002|Core Study|Adverse Event|3|||
130309705|NCT00687804|469099037|FG000|Core Study|Abnormal laboratory value(s)|1|||
130309706|NCT00687804|469099038|FG001|Core Study|Abnormal laboratory value(s)|0|||
130309707|NCT00687804|469099039|FG002|Core Study|Abnormal laboratory value(s)|0|||
130309708|NCT00687804|469099037|FG000|Core Study|Lack of Efficacy|1|||
130309709|NCT00687804|469099038|FG001|Core Study|Lack of Efficacy|1|||
130309710|NCT00687804|469099039|FG002|Core Study|Lack of Efficacy|1|||
130309711|NCT00687804|469099037|FG000|Core Study|Withdrawal by Subject|4|||
130309712|NCT00687804|469099038|FG001|Core Study|Withdrawal by Subject|7|||
130309713|NCT00687804|469099039|FG002|Core Study|Withdrawal by Subject|7|||
130309714|NCT00687804|469099037|FG000|Core Study|Lost to Follow-up|0|||
130309715|NCT00687804|469099038|FG001|Core Study|Lost to Follow-up|1|||
130309716|NCT00687804|469099039|FG002|Core Study|Lost to Follow-up|0|||
130309717|NCT00687804|469099037|FG000|Core Study|Death|2|||
130309718|NCT00687804|469099038|FG001|Core Study|Death|2|||
130309719|NCT00687804|469099039|FG002|Core Study|Death|2|||
130309720|NCT00687804|469099037|FG000|Core Study|Protocol Violation|1|||
130309721|NCT00687804|469099038|FG001|Core Study|Protocol Violation|1|||
130309722|NCT00687804|469099039|FG002|Core Study|Protocol Violation|0|||
129889589|NCT03990363|467552642|FG003|Overall Study|Lost to Follow-up|1|||
130049711|NCT01259297|468138748|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
130049712|NCT01259297|468138749|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
130049713|NCT01259297|468138750|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
130049714|NCT01259297|468138751|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130049715|NCT01259297|468138752|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130049716|NCT01259297|468138753|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
130049717|NCT01259297|468138746|FG000|Double Blind Randomized Period|Other reasons|0|||
130049718|NCT01259297|468138747|FG001|Double Blind Randomized Period|Other reasons|1|||
130049719|NCT01259297|468138748|FG002|Double Blind Randomized Period|Other reasons|0|||
130049720|NCT01259297|468138749|FG003|Double Blind Randomized Period|Other reasons|0|||
130049721|NCT01259297|468138750|FG004|Double Blind Randomized Period|Other reasons|1|||
130049722|NCT01259297|468138751|FG005|Double Blind Randomized Period|Other reasons|2|||
130049723|NCT01259297|468138752|FG006|Double Blind Randomized Period|Other reasons|3|||
130049724|NCT01259297|468138753|FG007|Double Blind Randomized Period|Other reasons|1|||
130049725|NCT00592501|468138754|FG000|Overall Study|Withdrawal by Subject|1|||
130049726|NCT00592501|468138754|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
130049727|NCT03880227|468138758|FG000|First Visit|Withdrawal by Subject|1|||
130049728|NCT03880227|468138759|FG001|First Visit|Withdrawal by Subject|0|||
130049729|NCT03880227|468138760|FG002|First Visit|Withdrawal by Subject|0|||
130049730|NCT03880227|468138761|FG003|First Visit|Withdrawal by Subject|0|||
130049731|NCT03880227|468138758|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
130049732|NCT03880227|468138759|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
130049733|NCT03880227|468138760|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
130049734|NCT03880227|468138761|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
130049735|NCT03880227|468138758|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
130049736|NCT03880227|468138759|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
130049737|NCT03880227|468138760|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
130049738|NCT03880227|468138761|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
130049739|NCT03880227|468138758|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
130049740|NCT03880227|468138759|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
130049741|NCT03880227|468138760|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
130049742|NCT03880227|468138761|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
130049743|NCT01345786|468138765|FG000|Overall Study|Adverse Event|0|||
130049744|NCT01345786|468138766|FG001|Overall Study|Adverse Event|1|||
130049745|NCT01345786|468138767|FG002|Overall Study|Adverse Event|3|||
130049746|NCT01345786|468138768|FG003|Overall Study|Adverse Event|1|||
130049747|NCT01345786|468138765|FG000|Overall Study|Subject withdrew consent|2|||
130049748|NCT01345786|468138766|FG001|Overall Study|Subject withdrew consent|2|||
130309723|NCT00687804|469099037|FG000|Open-Label Extension Study|Adverse Event|2|||
130309724|NCT00687804|469099038|FG001|Open-Label Extension Study|Adverse Event|2|||
129889590|NCT03990363|467552643|FG004|Overall Study|Lost to Follow-up|2|||
130049749|NCT01345786|468138767|FG002|Overall Study|Subject withdrew consent|1|||
130049750|NCT01345786|468138768|FG003|Overall Study|Subject withdrew consent|0|||
130049751|NCT01345786|468138765|FG000|Overall Study|Noncompliance with protocol|1|||
130309725|NCT00687804|469099039|FG002|Open-Label Extension Study|Adverse Event|2|||
130309726|NCT00687804|469099037|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
130110518|NCT00447603|468365761|FG000|Screening|Withdrawal by Subject|1|||
130110519|NCT00447603|468365762|FG001|Screening|Withdrawal by Subject|0|||
130110520|NCT00447603|468365763|FG002|Screening|Withdrawal by Subject|0|||
130309727|NCT00687804|469099038|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
130309728|NCT00687804|469099039|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
130309729|NCT00687804|469099037|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
130309730|NCT00687804|469099038|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
130309731|NCT00687804|469099039|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
130309732|NCT00687804|469099037|FG000|Open-Label Extension Study|Administrative problems|1|||
130309733|NCT00687804|469099038|FG001|Open-Label Extension Study|Administrative problems|1|||
130309734|NCT00687804|469099039|FG002|Open-Label Extension Study|Administrative problems|0|||
130309735|NCT00687804|469099037|FG000|Open-Label Extension Study|Death|2|||
130309736|NCT00687804|469099038|FG001|Open-Label Extension Study|Death|3|||
130309737|NCT00687804|469099039|FG002|Open-Label Extension Study|Death|3|||
130309738|NCT04390243|469099040|FG000|Overall Study|Death|1|||
130309739|NCT04390243|469099040|FG000|Overall Study|Disease Progression|4|||
130309740|NCT04390243|469099040|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
130309741|NCT00799903|469099043|FG000|Overall Study|Investigator Site Closed|25|||
130309742|NCT00799903|469099044|FG001|Overall Study|Investigator Site Closed|23|||
130309743|NCT00799903|469099043|FG000|Overall Study|Withdrawal by Subject|179|||
130309744|NCT00799903|469099044|FG001|Overall Study|Withdrawal by Subject|175|||
130309745|NCT00799903|469099043|FG000|Overall Study|Lost to Follow-up|69|||
130309746|NCT00799903|469099044|FG001|Overall Study|Lost to Follow-up|80|||
130309747|NCT00556998|469099049|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
130309748|NCT00556998|469099049|FG000|Voriconazole Intravenous (IV)|Other|4|||
130309749|NCT00556998|469099049|FG000|Voriconazole Oral|Adverse Event|1|||
130309750|NCT00556998|469099049|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
130309751|NCT00216671|469099058|FG000|Overall Study|Adverse Event|4|||
130309752|NCT00216671|469099059|FG001|Overall Study|Adverse Event|9|||
130309753|NCT00216671|469099058|FG000|Overall Study|Pregnancy|0|||
130309754|NCT00216671|469099059|FG001|Overall Study|Pregnancy|1|||
130309755|NCT00216671|469099058|FG000|Overall Study|Withdrawal by Subject|4|||
130309756|NCT00216671|469099059|FG001|Overall Study|Withdrawal by Subject|2|||
130309757|NCT00216671|469099058|FG000|Overall Study|Refused Injections|3|||
130309758|NCT00216671|469099059|FG001|Overall Study|Refused Injections|13|||
130309759|NCT00216671|469099058|FG000|Overall Study|No Need to Continue Medication|1|||
130309760|NCT00216671|469099059|FG001|Overall Study|No Need to Continue Medication|1|||
130309761|NCT00216671|469099058|FG000|Overall Study|Insufficient Response|9|||
130309762|NCT00216671|469099059|FG001|Overall Study|Insufficient Response|4|||
130309763|NCT00216671|469099058|FG000|Overall Study|Lost to Follow-up|3|||
130309764|NCT00216671|469099059|FG001|Overall Study|Lost to Follow-up|5|||
130309765|NCT00216671|469099058|FG000|Overall Study|Non compliant|2|||
130309766|NCT00216671|469099059|FG001|Overall Study|Non compliant|2|||
130309767|NCT00216671|469099058|FG000|Overall Study|Ineligible|0|||
130309768|NCT00216671|469099059|FG001|Overall Study|Ineligible|2|||
130309769|NCT00216671|469099058|FG000|Overall Study|Physician Decision|1|||
130309770|NCT00216671|469099059|FG001|Overall Study|Physician Decision|1|||
130309771|NCT00216671|469099058|FG000|Overall Study|Protocol Violation|3|||
130309772|NCT00216671|469099059|FG001|Overall Study|Protocol Violation|5|||
130309773|NCT00216671|469099058|FG000|Overall Study|Relapse|1|||
130309774|NCT00216671|469099059|FG001|Overall Study|Relapse|0|||
130309775|NCT00216671|469099058|FG000|Overall Study|Investigator Illness|0|||
130309776|NCT00216671|469099059|FG001|Overall Study|Investigator Illness|1|||
130309777|NCT00216671|469099058|FG000|Overall Study|Patient Moved|0|||
130309778|NCT00216671|469099059|FG001|Overall Study|Patient Moved|1|||
130309779|NCT00216671|469099058|FG000|Overall Study|Ineligible, no efficacy data|2|||
130309780|NCT00216671|469099059|FG001|Overall Study|Ineligible, no efficacy data|2|||
130110521|NCT00447603|468365761|FG000|Screening|Protocol Violation|1|||
130110522|NCT00447603|468365762|FG001|Screening|Protocol Violation|0|||
130110523|NCT00447603|468365763|FG002|Screening|Protocol Violation|0|||
130110524|NCT00447603|468365761|FG000|Screening|Screen Failure|4|||
130110525|NCT00447603|468365762|FG001|Screening|Screen Failure|0|||
130309781|NCT00216671|469099058|FG000|Overall Study|Insufficient Response Adverse Event|2|||
130309782|NCT00216671|469099059|FG001|Overall Study|Insufficient Response Adverse Event|1|||
130309783|NCT04961541|469099060|FG000|Overall Study|Adverse Event|0|||
130309784|NCT04961541|469099061|FG001|Overall Study|Adverse Event|0|||
130309785|NCT04961541|469099062|FG002|Overall Study|Adverse Event|0|||
130309786|NCT04961541|469099063|FG003|Overall Study|Adverse Event|0|||
130309787|NCT04961541|469099064|FG004|Overall Study|Adverse Event|0|||
130309788|NCT04961541|469099065|FG005|Overall Study|Adverse Event|1|||
130309789|NCT04961541|469099066|FG006|Overall Study|Adverse Event|0|||
130309790|NCT04961541|469099067|FG007|Overall Study|Adverse Event|0|||
130309791|NCT04961541|469099068|FG008|Overall Study|Adverse Event|0|||
130110526|NCT00447603|468365763|FG002|Screening|Screen Failure|0|||
130110527|NCT00447603|468365761|FG000|Screening|Study Terminated by Sponsor|15|||
130309792|NCT04961541|469099069|FG009|Overall Study|Adverse Event|0|||
130309793|NCT04961541|469099070|FG010|Overall Study|Adverse Event|0|||
130309794|NCT04961541|469099071|FG011|Overall Study|Adverse Event|0|||
130110528|NCT00447603|468365762|FG001|Screening|Study Terminated by Sponsor|0|||
130110529|NCT00447603|468365763|FG002|Screening|Study Terminated by Sponsor|0|||
130110530|NCT00447603|468365761|FG000|Filter Period|Adverse Event|0|||
130110531|NCT00447603|468365762|FG001|Filter Period|Adverse Event|0|||
130110532|NCT00447603|468365763|FG002|Filter Period|Adverse Event|1|||
130110533|NCT00447603|468365761|FG000|Filter Period|Screen Failure|0|||
130110534|NCT00447603|468365762|FG001|Filter Period|Screen Failure|3|||
130110535|NCT00447603|468365763|FG002|Filter Period|Screen Failure|4|||
130110536|NCT00447603|468365761|FG000|Filter Period|Study terminated by Sponsor|0|||
130110537|NCT00447603|468365762|FG001|Filter Period|Study terminated by Sponsor|1|||
129889591|NCT03990363|467552639|FG000|Overall Study|Non-compliance with study drug|2|||
130110538|NCT00447603|468365763|FG002|Filter Period|Study terminated by Sponsor|10|||
130110539|NCT02732561|468365768|FG000|Overall Study|Lost to Follow-up|1|||
130110540|NCT02732561|468365769|FG001|Overall Study|Lost to Follow-up|1|||
130110541|NCT02732561|468365768|FG000|Overall Study|Withdrawal by Subject|1|||
130110542|NCT02732561|468365769|FG001|Overall Study|Withdrawal by Subject|0|||
130110543|NCT02410837|468365771|FG000|Overall Study|Death|387|||
130110544|NCT02410837|468365771|FG000|Overall Study|Lost to Follow-up|50|||
130110545|NCT02410837|468365771|FG000|Overall Study|Withdrawal by Subject|44|||
129889592|NCT03990363|467552640|FG001|Overall Study|Non-compliance with study drug|1|||
129889593|NCT03990363|467552641|FG002|Overall Study|Non-compliance with study drug|2|||
129889594|NCT03990363|467552642|FG003|Overall Study|Non-compliance with study drug|0|||
129889595|NCT03990363|467552643|FG004|Overall Study|Non-compliance with study drug|0|||
129889596|NCT03990363|467552639|FG000|Overall Study|Study terminated by sponsor|0|||
130049752|NCT01345786|468138766|FG001|Overall Study|Noncompliance with protocol|0|||
130049753|NCT01345786|468138767|FG002|Overall Study|Noncompliance with protocol|1|||
130049754|NCT01345786|468138768|FG003|Overall Study|Noncompliance with protocol|0|||
130049755|NCT01345786|468138765|FG000|Overall Study|Administrative|3|||
130049756|NCT01345786|468138766|FG001|Overall Study|Administrative|5|||
130049757|NCT01345786|468138767|FG002|Overall Study|Administrative|0|||
130049758|NCT01345786|468138768|FG003|Overall Study|Administrative|0|||
130049759|NCT01345786|468138765|FG000|Overall Study|Lost to Follow-up|0|||
130049760|NCT01345786|468138766|FG001|Overall Study|Lost to Follow-up|0|||
130049761|NCT01345786|468138767|FG002|Overall Study|Lost to Follow-up|0|||
130049762|NCT01345786|468138768|FG003|Overall Study|Lost to Follow-up|2|||
130049763|NCT01070784|468138771|FG000|Overall Study|Withdrawal by Subject|6|||
130049764|NCT01070784|468138772|FG001|Overall Study|Withdrawal by Subject|9|||
130049765|NCT01070784|468138771|FG000|Overall Study|Adverse Event|14|||
130049766|NCT01070784|468138772|FG001|Overall Study|Adverse Event|9|||
130049767|NCT02815397|468138774|FG000|Overall Study|Physician Decision|2|||
130049768|NCT02518620|468138775|FG000|Overall Study|Adverse Event|23|||
130049769|NCT02518620|468138776|FG001|Overall Study|Adverse Event|11|||
130049770|NCT02518620|468138775|FG000|Overall Study|Lack of Efficacy|2|||
130049771|NCT02518620|468138776|FG001|Overall Study|Lack of Efficacy|0|||
130049772|NCT02518620|468138775|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130049773|NCT02518620|468138776|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130049774|NCT02518620|468138775|FG000|Overall Study|Physician Decision|1|||
130049775|NCT02518620|468138776|FG001|Overall Study|Physician Decision|1|||
130049776|NCT02518620|468138775|FG000|Overall Study|Sponsor's Decision|0|||
130049777|NCT02518620|468138776|FG001|Overall Study|Sponsor's Decision|3|||
130049778|NCT02518620|468138775|FG000|Overall Study|Lost to Follow-up|1|||
130049779|NCT02518620|468138776|FG001|Overall Study|Lost to Follow-up|1|||
130049780|NCT02518620|468138775|FG000|Overall Study|Withdrawal by Subject|17|||
130049781|NCT02518620|468138776|FG001|Overall Study|Withdrawal by Subject|9|||
130049782|NCT02518620|468138775|FG000|Overall Study|Death|1|||
130049783|NCT02518620|468138776|FG001|Overall Study|Death|0|||
130049784|NCT02518620|468138775|FG000|Overall Study|Pregnancy Wish|3|||
130049785|NCT02518620|468138776|FG001|Overall Study|Pregnancy Wish|0|||
130049786|NCT02518620|468138775|FG000|Overall Study|Pregnancy|1|||
130110546|NCT02410837|468365771|FG000|Overall Study|Physician Decision|6|||
130110547|NCT02410837|468365771|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
130110548|NCT00837577|468365772|FG000|Double-blind Period|Clinical Adverse Event|1|||
130110549|NCT00837577|468365773|FG001|Double-blind Period|Clinical Adverse Event|0|||
129889597|NCT03990363|467552640|FG001|Overall Study|Study terminated by sponsor|1|||
130110550|NCT00837577|468365772|FG000|Double-blind Period|Withdrawal by Subject|1|||
130049787|NCT02518620|468138776|FG001|Overall Study|Pregnancy|0|||
130049788|NCT02518620|468138775|FG000|Overall Study|Relocation|2|||
130049789|NCT02518620|468138776|FG001|Overall Study|Relocation|1|||
130049790|NCT00085540|468138777|FG000|Overall Study|Withdrawal by Subject|0|||
130049791|NCT00085540|468138778|FG001|Overall Study|Withdrawal by Subject|1|||
130049792|NCT00085540|468138777|FG000|Overall Study|Protocol Violation|0|||
130049793|NCT00085540|468138778|FG001|Overall Study|Protocol Violation|1|||
130049794|NCT01605396|468138779|FG000|Overall Study|Adverse Event|5|||
130049795|NCT01605396|468138780|FG001|Overall Study|Adverse Event|3|||
130049796|NCT01605396|468138779|FG000|Overall Study|Lost to Follow-up|1|||
130049797|NCT01605396|468138780|FG001|Overall Study|Lost to Follow-up|0|||
130110551|NCT00837577|468365773|FG001|Double-blind Period|Withdrawal by Subject|0|||
130110552|NCT00837577|468365772|FG000|Open-label Period|Clinical Adverse Event|2|||
130110553|NCT00837577|468365773|FG001|Open-label Period|Clinical Adverse Event|2|||
130110554|NCT00837577|468365772|FG000|Open-label Period|Laboratory Adverse Event|0|||
130110555|NCT00837577|468365773|FG001|Open-label Period|Laboratory Adverse Event|1|||
130110556|NCT00837577|468365772|FG000|Open-label Period|Lack of Efficacy|4|||
130110557|NCT00837577|468365773|FG001|Open-label Period|Lack of Efficacy|3|||
130110558|NCT00837577|468365772|FG000|Open-label Period|Withdrawal by Subject|1|||
130110559|NCT00837577|468365773|FG001|Open-label Period|Withdrawal by Subject|2|||
130110560|NCT00837577|468365772|FG000|Open-label Period|Other Reason|1|||
130110561|NCT00837577|468365773|FG001|Open-label Period|Other Reason|1|||
130110562|NCT03031431|468365776|FG000|Overall Study|Infant removed by maternal request|1|||
130110563|NCT01205529|468365777|FG000|Overall Study|Procedure Cancelled|4|||
130110564|NCT01205529|468365777|FG000|Overall Study|Withdrawal by Subject|2|||
130110565|NCT01205529|468365777|FG000|Overall Study|Physician Decision|4|||
130110566|NCT01205529|468365777|FG000|Overall Study|Unstable post op|15|||
130110567|NCT01205529|468365777|FG000|Overall Study|No longer met criteria|30|||
130110568|NCT00106028|468365782|FG000|Overall Study|Adverse Event|3|||
130110569|NCT00106028|468365783|FG001|Overall Study|Adverse Event|2|||
130110570|NCT00106028|468365782|FG000|Overall Study|Protocol Violation|1|||
130110571|NCT00106028|468365783|FG001|Overall Study|Protocol Violation|1|||
130110572|NCT00106028|468365782|FG000|Overall Study|Withdrawal by Subject|2|||
130110573|NCT00106028|468365783|FG001|Overall Study|Withdrawal by Subject|8|||
130110574|NCT00106028|468365782|FG000|Overall Study|Lost to Follow-up|0|||
130110575|NCT00106028|468365783|FG001|Overall Study|Lost to Follow-up|1|||
130110576|NCT01280981|468365784|FG000|Overall Study|Withdrawal by Subject|11|||
130110577|NCT01280981|468365784|FG000|Overall Study|Protocol Violation|2|||
130110578|NCT01280981|468365784|FG000|Overall Study|Lack of Efficacy|13|||
130110579|NCT01280981|468365784|FG000|Overall Study|Lost to Follow-up|3|||
130110580|NCT01280981|468365784|FG000|Overall Study|Adverse Event|6|||
130110581|NCT01280981|468365784|FG000|Overall Study|Irregular or discontinued menses|3|||
130110582|NCT01280981|468365784|FG000|Overall Study|Failed to return|45|||
130110583|NCT01280981|468365784|FG000|Overall Study|Non-compliance with protocol|3|||
130110584|NCT01280981|468365784|FG000|Overall Study|Withdrawal of consent|3|||
130110585|NCT01280981|468365784|FG000|Overall Study|Elective surgery|2|||
130049798|NCT01605396|468138779|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130049799|NCT01605396|468138780|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130049800|NCT01605396|468138779|FG000|Overall Study|Physician Decision|2|||
130049801|NCT01605396|468138780|FG001|Overall Study|Physician Decision|2|||
130049802|NCT01605396|468138779|FG000|Overall Study|Progressive Disease|23|||
130049803|NCT01605396|468138780|FG001|Overall Study|Progressive Disease|27|||
130049804|NCT01605396|468138779|FG000|Overall Study|Withdrawal by Subject|4|||
130049805|NCT01605396|468138780|FG001|Overall Study|Withdrawal by Subject|2|||
130049806|NCT01605396|468138779|FG000|Overall Study|Transfer Off Study|4|||
130049807|NCT01605396|468138780|FG001|Overall Study|Transfer Off Study|5|||
130049808|NCT03607682|468138783|FG000|Overall Study|Withdrawal by Subject|1|||
130049809|NCT03607682|468138783|FG000|Overall Study|Disease progression|1|||
130049810|NCT00376688|468138784|FG000|Overall Study|Adverse Event|3|||
130049811|NCT00376688|468138784|FG000|Overall Study|Death|1|||
130049812|NCT01770353|468138785|FG000|Overall Study|Progressive disease|2|||
130049813|NCT01770353|468138786|FG001|Overall Study|Progressive disease|1|||
130049814|NCT01770353|468138785|FG000|Overall Study|Adverse Event|0|||
130049815|NCT01770353|468138786|FG001|Overall Study|Adverse Event|1|||
130049816|NCT01770353|468138785|FG000|Overall Study|Protocol Violation|1|||
130049817|NCT01770353|468138786|FG001|Overall Study|Protocol Violation|0|||
130049818|NCT01770353|468138785|FG000|Overall Study|Physician Decision|0|||
130049819|NCT01770353|468138786|FG001|Overall Study|Physician Decision|3|||
130049820|NCT01770353|468138785|FG000|Overall Study|Clinical deterioration|3|||
130049821|NCT01770353|468138786|FG001|Overall Study|Clinical deterioration|6|||
130049822|NCT01770353|468138785|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
130049823|NCT01770353|468138786|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
130049824|NCT00059215|468140678|FG000|Overall Study|Adverse Event|5|||
130049825|NCT00059215|468140679|FG001|Overall Study|Adverse Event|5|||
130049826|NCT00059215|468140680|FG002|Overall Study|Adverse Event|9|||
130049827|NCT00059215|468140681|FG003|Overall Study|Adverse Event|9|||
130110586|NCT01280981|468365784|FG000|Overall Study|Study site closure|1|||
130110587|NCT06371079|468365786|FG000|Overall Study|Missing data|88|||
130110588|NCT06371079|468365787|FG001|Overall Study|Missing data|247|||
130110589|NCT01256398|468365788|FG000|Overall Study|Withdrawal by Subject|1|||
130049828|NCT00059215|468140678|FG000|Overall Study|Death|0|||
130049829|NCT00059215|468140679|FG001|Overall Study|Death|0|||
130049830|NCT00059215|468140680|FG002|Overall Study|Death|3|||
130049831|NCT00059215|468140681|FG003|Overall Study|Death|0|||
130049832|NCT00059215|468140678|FG000|Overall Study|Lost to Follow-up|1|||
130049833|NCT00059215|468140679|FG001|Overall Study|Lost to Follow-up|2|||
130049834|NCT00059215|468140680|FG002|Overall Study|Lost to Follow-up|0|||
130110590|NCT03276962|468365789|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
130110591|NCT03276962|468365790|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
130049835|NCT00059215|468140681|FG003|Overall Study|Lost to Follow-up|0|||
130049836|NCT00059215|468140678|FG000|Overall Study|Withdrawal by Subject|4|||
130110592|NCT03276962|468365791|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
130110593|NCT03276962|468365792|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
130110594|NCT03276962|468365793|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
130110595|NCT03276962|468365789|FG000|Overall Study|Protocol Deviation|2|||
130110596|NCT03276962|468365790|FG001|Overall Study|Protocol Deviation|0|||
130110597|NCT03276962|468365791|FG002|Overall Study|Protocol Deviation|1|||
130110598|NCT03276962|468365792|FG003|Overall Study|Protocol Deviation|2|||
130110599|NCT03276962|468365793|FG004|Overall Study|Protocol Deviation|1|||
130110600|NCT03276962|468365789|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
130110601|NCT03276962|468365790|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
130110602|NCT03276962|468365791|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
130110603|NCT03276962|468365792|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
130110604|NCT03276962|468365793|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
130049837|NCT00059215|468140679|FG001|Overall Study|Withdrawal by Subject|4|||
130049838|NCT00059215|468140680|FG002|Overall Study|Withdrawal by Subject|1|||
130049839|NCT00059215|468140681|FG003|Overall Study|Withdrawal by Subject|3|||
130049840|NCT00059215|468140678|FG000|Overall Study|Protocol Violation|1|||
130049841|NCT00059215|468140679|FG001|Overall Study|Protocol Violation|0|||
130049842|NCT00059215|468140680|FG002|Overall Study|Protocol Violation|1|||
130049843|NCT00059215|468140681|FG003|Overall Study|Protocol Violation|0|||
130049844|NCT00059215|468140678|FG000|Overall Study|Protocol entry criteria not met|1|||
130049845|NCT00059215|468140679|FG001|Overall Study|Protocol entry criteria not met|1|||
130049846|NCT00059215|468140680|FG002|Overall Study|Protocol entry criteria not met|0|||
130049847|NCT00059215|468140681|FG003|Overall Study|Protocol entry criteria not met|2|||
130049848|NCT00059215|468140678|FG000|Overall Study|Physician Decision|1|||
130049849|NCT00059215|468140679|FG001|Overall Study|Physician Decision|2|||
130049850|NCT00059215|468140680|FG002|Overall Study|Physician Decision|1|||
130049851|NCT00059215|468140681|FG003|Overall Study|Physician Decision|1|||
130049852|NCT04439838|468140682|FG000|Overall Study|Withdrawal by Subject|0|||
130049853|NCT04439838|468140683|FG001|Overall Study|Withdrawal by Subject|0|||
130049854|NCT04439838|468140684|FG002|Overall Study|Withdrawal by Subject|0|||
130049855|NCT04439838|468140685|FG003|Overall Study|Withdrawal by Subject|0|||
130049856|NCT04439838|468140686|FG004|Overall Study|Withdrawal by Subject|0|||
130049857|NCT04439838|468140687|FG005|Overall Study|Withdrawal by Subject|0|||
130049858|NCT04439838|468140688|FG006|Overall Study|Withdrawal by Subject|0|||
130049859|NCT04439838|468140689|FG007|Overall Study|Withdrawal by Subject|0|||
130049860|NCT04439838|468140690|FG008|Overall Study|Withdrawal by Subject|1|||
130049861|NCT04494633|468140691|FG000|Overall Study|Lost to Follow-up|5|||
130049862|NCT04494633|468140692|FG001|Overall Study|Lost to Follow-up|3|||
130049863|NCT04494633|468140691|FG000|Overall Study|Protocol Violation|1|||
130049864|NCT04494633|468140692|FG001|Overall Study|Protocol Violation|1|||
130049865|NCT00414310|468140693|FG000|Overall Study|Not treated|1|||
130049866|NCT00414310|468140694|FG001|Overall Study|Not treated|0|||
130049867|NCT01254604|468140695|FG000|Overall Study|Lost to Follow-up|1|||
130049868|NCT01254604|468140696|FG001|Overall Study|Lost to Follow-up|1|||
130049869|NCT01254604|468140695|FG000|Overall Study|Protocol Violation|2|||
130049870|NCT01254604|468140696|FG001|Overall Study|Protocol Violation|2|||
130049871|NCT01254604|468140695|FG000|Overall Study|Withdrawal by Subject|2|||
130049872|NCT01254604|468140696|FG001|Overall Study|Withdrawal by Subject|4|||
130049873|NCT01254604|468140695|FG000|Overall Study|Adverse Event|3|||
130049874|NCT01254604|468140696|FG001|Overall Study|Adverse Event|2|||
130049875|NCT03074162|468140697|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130049876|NCT03074162|468140698|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130049877|NCT03074162|468140699|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
130049878|NCT03074162|468140700|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130049879|NCT03074162|468140701|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130049880|NCT03074162|468140702|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
130049881|NCT03074162|468140697|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130049882|NCT03074162|468140698|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130049883|NCT03074162|468140699|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
130049884|NCT03074162|468140700|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
130049885|NCT03074162|468140701|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
129798506|NCT01068652|467232095|FG001|Overall Study|Lost to Follow-up|1|||
129798507|NCT01068652|467232094|FG000|Overall Study|Protocol Violation|3|||
129798508|NCT01068652|467232095|FG001|Overall Study|Protocol Violation|6|||
129798509|NCT01068652|467232094|FG000|Overall Study|Withdrawal criteria|1|||
129798510|NCT01068652|467232095|FG001|Overall Study|Withdrawal criteria|2|||
129798511|NCT01068652|467232094|FG000|Overall Study|Patient was not eligible|1|||
129798512|NCT01068652|467232095|FG001|Overall Study|Patient was not eligible|0|||
129798513|NCT01068652|467232094|FG000|Overall Study|Unclassified|7|||
129798514|NCT01068652|467232095|FG001|Overall Study|Unclassified|4|||
129798515|NCT02694523|467232096|FG000|Part A|Adverse Event|7|||
130049886|NCT03074162|468140702|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
130309795|NCT04961541|469099072|FG012|Overall Study|Adverse Event|0|||
130309796|NCT04961541|469099073|FG013|Overall Study|Adverse Event|0|||
130309797|NCT04961541|469099060|FG000|Overall Study|Lost to Follow-up|0|||
130309798|NCT04961541|469099061|FG001|Overall Study|Lost to Follow-up|0|||
130309799|NCT04961541|469099062|FG002|Overall Study|Lost to Follow-up|3|||
130309800|NCT04961541|469099063|FG003|Overall Study|Lost to Follow-up|0|||
130309801|NCT04961541|469099064|FG004|Overall Study|Lost to Follow-up|0|||
130309802|NCT04961541|469099065|FG005|Overall Study|Lost to Follow-up|0|||
130309803|NCT04961541|469099066|FG006|Overall Study|Lost to Follow-up|1|||
130309804|NCT04961541|469099067|FG007|Overall Study|Lost to Follow-up|1|||
130309805|NCT04961541|469099068|FG008|Overall Study|Lost to Follow-up|0|||
130309806|NCT04961541|469099069|FG009|Overall Study|Lost to Follow-up|1|||
130309807|NCT04961541|469099070|FG010|Overall Study|Lost to Follow-up|0|||
130309808|NCT04961541|469099071|FG011|Overall Study|Lost to Follow-up|0|||
130309809|NCT04961541|469099072|FG012|Overall Study|Lost to Follow-up|1|||
130309810|NCT04961541|469099073|FG013|Overall Study|Lost to Follow-up|0|||
130309811|NCT04961541|469099060|FG000|Overall Study|Withdrawal by Subject|0|||
130309812|NCT04961541|469099061|FG001|Overall Study|Withdrawal by Subject|0|||
130309813|NCT04961541|469099062|FG002|Overall Study|Withdrawal by Subject|1|||
130309814|NCT04961541|469099063|FG003|Overall Study|Withdrawal by Subject|1|||
130309815|NCT04961541|469099064|FG004|Overall Study|Withdrawal by Subject|0|||
130309816|NCT04961541|469099065|FG005|Overall Study|Withdrawal by Subject|0|||
130309817|NCT04961541|469099066|FG006|Overall Study|Withdrawal by Subject|0|||
130309818|NCT04961541|469099067|FG007|Overall Study|Withdrawal by Subject|0|||
130309819|NCT04961541|469099068|FG008|Overall Study|Withdrawal by Subject|0|||
130309820|NCT04961541|469099069|FG009|Overall Study|Withdrawal by Subject|1|||
130309821|NCT04961541|469099070|FG010|Overall Study|Withdrawal by Subject|0|||
130309822|NCT04961541|469099071|FG011|Overall Study|Withdrawal by Subject|0|||
130309823|NCT04961541|469099072|FG012|Overall Study|Withdrawal by Subject|0|||
130309824|NCT04961541|469099073|FG013|Overall Study|Withdrawal by Subject|0|||
130309825|NCT03539601|469099075|FG000|Overall Study|Withdraw by parent/guardian|1|||
130309826|NCT03539601|469099076|FG001|Overall Study|Withdraw by parent/guardian|0|||
130309827|NCT03539601|469099077|FG002|Overall Study|Withdraw by parent/guardian|1|||
130309828|NCT03539601|469099078|FG003|Overall Study|Withdraw by parent/guardian|0|||
130309829|NCT03539601|469099075|FG000|Overall Study|Adverse Event|0|||
130309830|NCT03539601|469099076|FG001|Overall Study|Adverse Event|2|||
130309831|NCT03539601|469099077|FG002|Overall Study|Adverse Event|0|||
130309832|NCT03539601|469099078|FG003|Overall Study|Adverse Event|0|||
130309833|NCT03539601|469099075|FG000|Overall Study|Lost to Follow-up|2|||
130309834|NCT03539601|469099076|FG001|Overall Study|Lost to Follow-up|4|||
130309835|NCT03539601|469099077|FG002|Overall Study|Lost to Follow-up|5|||
129798516|NCT02694523|467232097|FG001|Part A|Adverse Event|3|||
129798517|NCT02694523|467232098|FG002|Part A|Adverse Event|0|||
129798518|NCT02694523|467232099|FG003|Part A|Adverse Event|0|||
129798519|NCT02694523|467232100|FG004|Part A|Adverse Event|0|||
129798520|NCT02694523|467232101|FG005|Part A|Adverse Event|0|||
129798521|NCT02694523|467232102|FG006|Part A|Adverse Event|0|||
129798522|NCT02694523|467232096|FG000|Part A|Protocol Violation|1|||
129798523|NCT02694523|467232097|FG001|Part A|Protocol Violation|0|||
129798524|NCT02694523|467232098|FG002|Part A|Protocol Violation|0|||
129798525|NCT02694523|467232099|FG003|Part A|Protocol Violation|0|||
129798526|NCT02694523|467232100|FG004|Part A|Protocol Violation|0|||
129798527|NCT02694523|467232101|FG005|Part A|Protocol Violation|0|||
129798528|NCT02694523|467232102|FG006|Part A|Protocol Violation|0|||
129798529|NCT02694523|467232096|FG000|Part A|Lost to Follow-up|1|||
129798530|NCT02694523|467232097|FG001|Part A|Lost to Follow-up|2|||
129798531|NCT02694523|467232098|FG002|Part A|Lost to Follow-up|0|||
129798532|NCT02694523|467232099|FG003|Part A|Lost to Follow-up|0|||
129798533|NCT02694523|467232100|FG004|Part A|Lost to Follow-up|0|||
129798534|NCT02694523|467232101|FG005|Part A|Lost to Follow-up|0|||
129798535|NCT02694523|467232102|FG006|Part A|Lost to Follow-up|0|||
129798536|NCT02694523|467232096|FG000|Part A|Withdrawal by Subject|3|||
129798537|NCT02694523|467232097|FG001|Part A|Withdrawal by Subject|1|||
129798538|NCT02694523|467232098|FG002|Part A|Withdrawal by Subject|0|||
129798539|NCT02694523|467232099|FG003|Part A|Withdrawal by Subject|0|||
130309836|NCT03539601|469099078|FG003|Overall Study|Lost to Follow-up|0|||
130309837|NCT03539601|469099075|FG000|Overall Study|Withdrawal by Subject|2|||
130309838|NCT03539601|469099076|FG001|Overall Study|Withdrawal by Subject|0|||
129798540|NCT02694523|467232100|FG004|Part A|Withdrawal by Subject|0|||
130309839|NCT03539601|469099077|FG002|Overall Study|Withdrawal by Subject|0|||
130309840|NCT03539601|469099078|FG003|Overall Study|Withdrawal by Subject|1|||
130309841|NCT03539601|469099075|FG000|Overall Study|Randomized but not treated|1|||
130309842|NCT03539601|469099076|FG001|Overall Study|Randomized but not treated|1|||
130309843|NCT03539601|469099077|FG002|Overall Study|Randomized but not treated|0|||
129798541|NCT02694523|467232101|FG005|Part A|Withdrawal by Subject|0|||
129889598|NCT03990363|467552641|FG002|Overall Study|Study terminated by sponsor|0|||
130309844|NCT03539601|469099078|FG003|Overall Study|Randomized but not treated|0|||
129798542|NCT02694523|467232102|FG006|Part A|Withdrawal by Subject|0|||
129798543|NCT02694523|467232096|FG000|Part A|Other|1|||
130309845|NCT01970306|469099079|FG000|Overall Study|Not eligible|3|||
130309846|NCT01970306|469099079|FG000|Overall Study|Not able to be treated|9|||
129798544|NCT02694523|467232097|FG001|Part A|Other|1|||
129798545|NCT02694523|467232098|FG002|Part A|Other|0|||
129798546|NCT02694523|467232099|FG003|Part A|Other|0|||
130309847|NCT00226811|469099080|FG000|Overall Study|Death|8|||
130309848|NCT00226811|469099080|FG000|Overall Study|Adverse Event|11|||
130309849|NCT00226811|469099080|FG000|Overall Study|Lack of Efficacy|55|||
130309850|NCT00226811|469099080|FG000|Overall Study|Withdrawal by Subject|2|||
130309851|NCT03081884|469099081|FG000|Overall Study|deferred prostate cancer treatment|1|||
130309852|NCT03081884|469099081|FG000|Overall Study|metastasis managed with systemic therapy|3|||
130309853|NCT03948334|469099083|FG000|Overall Study|Adverse Event|1|||
130309854|NCT03948334|469099084|FG001|Overall Study|Adverse Event|4|||
130309855|NCT03948334|469099083|FG000|Overall Study|Lack of Efficacy|2|||
130309856|NCT03948334|469099084|FG001|Overall Study|Lack of Efficacy|0|||
130309857|NCT03948334|469099083|FG000|Overall Study|Lost to Follow-up|1|||
130309858|NCT03948334|469099084|FG001|Overall Study|Lost to Follow-up|0|||
130309859|NCT03948334|469099083|FG000|Overall Study|Physician Decision|1|||
130309860|NCT03948334|469099084|FG001|Overall Study|Physician Decision|0|||
130309861|NCT03948334|469099083|FG000|Overall Study|Pregnancy|0|||
130309862|NCT03948334|469099084|FG001|Overall Study|Pregnancy|1|||
130309863|NCT03948334|469099083|FG000|Overall Study|Protocol Deviation|1|||
130309864|NCT03948334|469099084|FG001|Overall Study|Protocol Deviation|0|||
130309865|NCT03948334|469099083|FG000|Overall Study|Study terminated by Sponsor|50|||
130309866|NCT03948334|469099084|FG001|Overall Study|Study terminated by Sponsor|51|||
130309867|NCT03948334|469099083|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
130309868|NCT03948334|469099084|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
130309869|NCT01100320|469099087|FG000|Period 1|Withdrawal by Subject|2|||
130309870|NCT01100320|469099088|FG001|Period 1|Withdrawal by Subject|4|||
130309871|NCT01100320|469099087|FG000|Period 1|Positive Drug Screen|1|||
130309872|NCT01100320|469099088|FG001|Period 1|Positive Drug Screen|1|||
130309873|NCT01100320|469099087|FG000|Period 1|Adverse Event|2|||
130309874|NCT01100320|469099088|FG001|Period 1|Adverse Event|2|||
130309875|NCT01100320|469099087|FG000|Period 2|Withdrawal by Subject|1|||
130309876|NCT01100320|469099088|FG001|Period 2|Withdrawal by Subject|1|||
130309877|NCT00550953|469099089|FG000|Overall Study|Adverse Event|4|||
130309878|NCT00550953|469099090|FG001|Overall Study|Adverse Event|3|||
130309879|NCT00550953|469099089|FG000|Overall Study|Not able to visit the site|2|||
130309880|NCT00550953|469099090|FG001|Overall Study|Not able to visit the site|3|||
130309881|NCT00596752|469099091|FG000|Overall Study|Other Reason|44|||
130309882|NCT00596752|469099092|FG001|Overall Study|Other Reason|49|||
130309883|NCT00596752|469099091|FG000|Overall Study|Adverse Event|34|||
130309884|NCT00596752|469099092|FG001|Overall Study|Adverse Event|34|||
130309885|NCT00596752|469099091|FG000|Overall Study|Lost to Follow-up|22|||
130309886|NCT00596752|469099092|FG001|Overall Study|Lost to Follow-up|38|||
130309887|NCT00596752|469099091|FG000|Overall Study|Withdrawal by Subject|12|||
130309888|NCT00596752|469099092|FG001|Overall Study|Withdrawal by Subject|9|||
130309889|NCT00596752|469099091|FG000|Overall Study|Unsatisfactory Compliance|9|||
130309890|NCT00596752|469099092|FG001|Overall Study|Unsatisfactory Compliance|6|||
130309891|NCT00596752|469099091|FG000|Overall Study|Lack of Efficacy|4|||
130309892|NCT00596752|469099092|FG001|Overall Study|Lack of Efficacy|7|||
130309893|NCT00596752|469099091|FG000|Overall Study|Protocol Violation|1|||
130309894|NCT00596752|469099092|FG001|Overall Study|Protocol Violation|0|||
130309895|NCT04669301|469099093|FG000|Overall Study|Lost to Follow-up|0|||
130309896|NCT04669301|469099094|FG001|Overall Study|Lost to Follow-up|1|||
130309897|NCT04669301|469099095|FG002|Overall Study|Lost to Follow-up|0|||
130309898|NCT04669301|469099093|FG000|Overall Study|Withdrawal by Subject|3|||
130309899|NCT04669301|469099094|FG001|Overall Study|Withdrawal by Subject|2|||
130309900|NCT04669301|469099095|FG002|Overall Study|Withdrawal by Subject|0|||
130309901|NCT02940496|469099096|FG000|Overall Study|Adverse Event|1|||
130309902|NCT02940496|469099097|FG001|Overall Study|Adverse Event|0|||
130309903|NCT02940496|469099096|FG000|Overall Study|Death|2|||
129798547|NCT02694523|467232100|FG004|Part A|Other|0|||
130309904|NCT02940496|469099097|FG001|Overall Study|Death|0|||
130309905|NCT02940496|469099096|FG000|Overall Study|Hospice Care|1|||
130309906|NCT02940496|469099097|FG001|Overall Study|Hospice Care|0|||
130309907|NCT02940496|469099096|FG000|Overall Study|No MRE Done|1|||
130309908|NCT02940496|469099097|FG001|Overall Study|No MRE Done|0|||
130309909|NCT02940496|469099096|FG000|Overall Study|MRE Failure|1|||
130309910|NCT02940496|469099097|FG001|Overall Study|MRE Failure|0|||
129798548|NCT02694523|467232101|FG005|Part A|Other|0|||
129798549|NCT02694523|467232102|FG006|Part A|Other|0|||
130309911|NCT00548145|469099102|FG000|Overall Study|Death|0|||
130309912|NCT00548145|469099103|FG001|Overall Study|Death|1|||
129798550|NCT02694523|467232096|FG000|Part B|Adverse Event|0|||
130309913|NCT00548145|469099102|FG000|Overall Study|Withdrawal by Subject|0|||
130309914|NCT00548145|469099103|FG001|Overall Study|Withdrawal by Subject|2|||
129798551|NCT02694523|467232097|FG001|Part B|Adverse Event|0|||
130309915|NCT00548145|469099102|FG000|Overall Study|Physician Decision|1|||
130309916|NCT00548145|469099103|FG001|Overall Study|Physician Decision|1|||
130309917|NCT02119663|469099105|FG000|Overall Study|Disease progression|26|||
130309918|NCT02119663|469099106|FG001|Overall Study|Disease progression|27|||
130309919|NCT02119663|469099105|FG000|Overall Study|Adverse Event|5|||
130309920|NCT02119663|469099106|FG001|Overall Study|Adverse Event|5|||
130309921|NCT02119663|469099105|FG000|Overall Study|Death|3|||
130309922|NCT02119663|469099106|FG001|Overall Study|Death|2|||
130309923|NCT02119663|469099105|FG000|Overall Study|Physician Decision|1|||
130309924|NCT02119663|469099106|FG001|Overall Study|Physician Decision|2|||
130309925|NCT02119663|469099105|FG000|Overall Study|Other unspecified|2|||
130309926|NCT02119663|469099106|FG001|Overall Study|Other unspecified|0|||
130309927|NCT02119663|469099105|FG000|Overall Study|Subject decision|0|||
130309928|NCT02119663|469099106|FG001|Overall Study|Subject decision|1|||
130309929|NCT02119663|469099105|FG000|Overall Study|Study Terminated by the Sponsor|3|||
130309930|NCT02119663|469099106|FG001|Overall Study|Study Terminated by the Sponsor|4|||
130309931|NCT02863328|469099107|FG000|Overall Study|Lost to Follow-up|4|||
130309932|NCT02863328|469099108|FG001|Overall Study|Lost to Follow-up|10|||
130309933|NCT02863328|469099107|FG000|Overall Study|Withdrawal by Subject|7|||
130309934|NCT02863328|469099108|FG001|Overall Study|Withdrawal by Subject|12|||
130309935|NCT02863328|469099107|FG000|Overall Study|Died|0|||
130309936|NCT02863328|469099108|FG001|Overall Study|Died|1|||
130309937|NCT00892775|469099109|FG000|Overall Study|Protocol Violation|1|||
130309938|NCT00892775|469099110|FG001|Overall Study|Protocol Violation|0|||
130309939|NCT00892775|469099109|FG000|Overall Study|Subject difficulties with blood drawing|1|||
130309940|NCT00892775|469099110|FG001|Overall Study|Subject difficulties with blood drawing|0|||
130309941|NCT00892775|469099109|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
130309942|NCT00892775|469099110|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
130309943|NCT00892775|469099109|FG000|Overall Study|Migrated/ moved from study area|1|||
130309944|NCT00892775|469099110|FG001|Overall Study|Migrated/ moved from study area|0|||
130309945|NCT00892775|469099109|FG000|Overall Study|Withdrawal by Subject|0|||
130309946|NCT00892775|469099110|FG001|Overall Study|Withdrawal by Subject|1|||
130309947|NCT00892775|469099109|FG000|Overall Study|Lost to Follow-up|1|||
130309948|NCT00892775|469099110|FG001|Overall Study|Lost to Follow-up|0|||
130309949|NCT00699660|469099111|FG000|Overall Study|Lost to Follow-up|4|||
130309950|NCT00699660|469099112|FG001|Overall Study|Lost to Follow-up|2|||
130309951|NCT00699660|469099111|FG000|Overall Study|missing reports and recording failures|10|||
130309952|NCT00699660|469099112|FG001|Overall Study|missing reports and recording failures|6|||
130309953|NCT00398320|469099113|FG000|Overall Study|Death|1|||
130309954|NCT00398320|469099113|FG000|Overall Study|Adverse Event|4|||
130309955|NCT00398320|469099113|FG000|Overall Study|Physician Decision|1|||
130309956|NCT00064792|469099114|FG000|Overall Study|Withdrawal by Subject|2|||
130309957|NCT00064792|469099115|FG001|Overall Study|Withdrawal by Subject|0|||
130309958|NCT00064792|469099114|FG000|Overall Study|Adverse Event|3|||
130309959|NCT00064792|469099115|FG001|Overall Study|Adverse Event|0|||
130309960|NCT01870726|469099116|FG000|Overall Study|Withdrawal of informed consent|0|||
130309961|NCT01870726|469099117|FG001|Overall Study|Withdrawal of informed consent|0|||
130309962|NCT01870726|469099118|FG002|Overall Study|Withdrawal of informed consent|0|||
130309963|NCT01870726|469099119|FG003|Overall Study|Withdrawal of informed consent|1|||
130309964|NCT01870726|469099120|FG004|Overall Study|Withdrawal of informed consent|0|||
130309965|NCT01870726|469099121|FG005|Overall Study|Withdrawal of informed consent|0|||
130309966|NCT01870726|469099122|FG006|Overall Study|Withdrawal of informed consent|0|||
130309967|NCT01870726|469099116|FG000|Overall Study|Withdrawal by Subject|0|||
130309968|NCT01870726|469099117|FG001|Overall Study|Withdrawal by Subject|1|||
130309969|NCT01870726|469099118|FG002|Overall Study|Withdrawal by Subject|0|||
130309970|NCT01870726|469099119|FG003|Overall Study|Withdrawal by Subject|0|||
130309971|NCT01870726|469099120|FG004|Overall Study|Withdrawal by Subject|0|||
130309972|NCT01870726|469099121|FG005|Overall Study|Withdrawal by Subject|0|||
130309973|NCT01870726|469099122|FG006|Overall Study|Withdrawal by Subject|0|||
130309974|NCT01870726|469099116|FG000|Overall Study|Adverse Event|0|||
130309975|NCT01870726|469099117|FG001|Overall Study|Adverse Event|0|||
130309976|NCT01870726|469099118|FG002|Overall Study|Adverse Event|0|||
130309977|NCT01870726|469099119|FG003|Overall Study|Adverse Event|0|||
130309978|NCT01870726|469099120|FG004|Overall Study|Adverse Event|1|||
130309979|NCT01870726|469099121|FG005|Overall Study|Adverse Event|1|||
130309980|NCT01870726|469099122|FG006|Overall Study|Adverse Event|0|||
130309981|NCT01870726|469099116|FG000|Overall Study|Progressive disease|5|||
130309982|NCT01870726|469099117|FG001|Overall Study|Progressive disease|5|||
130309983|NCT01870726|469099118|FG002|Overall Study|Progressive disease|4|||
130309984|NCT01870726|469099119|FG003|Overall Study|Progressive disease|5|||
130309985|NCT01870726|469099120|FG004|Overall Study|Progressive disease|6|||
130309986|NCT01870726|469099121|FG005|Overall Study|Progressive disease|4|||
130309987|NCT01870726|469099122|FG006|Overall Study|Progressive disease|10|||
130309988|NCT03301350|469099123|FG000|Overall Study|Withdrawal by Subject|4|||
130309989|NCT03301350|469099123|FG000|Overall Study|Adverse Event|1|||
130309990|NCT03301350|469099123|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
130309991|NCT03301350|469099123|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
130309992|NCT03301350|469099123|FG000|Overall Study|no detail provided|1|||
130309993|NCT01248949|469099126|FG000|Overall Study|Lost to Follow-up|2|||
130309994|NCT01248949|469099127|FG001|Overall Study|Lost to Follow-up|2|||
130309995|NCT01248949|469099128|FG002|Overall Study|Lost to Follow-up|2|||
130309996|NCT01248949|469099129|FG003|Overall Study|Lost to Follow-up|1|||
130309997|NCT01248949|469099130|FG004|Overall Study|Lost to Follow-up|0|||
129889599|NCT03990363|467552642|FG003|Overall Study|Study terminated by sponsor|0|||
129889600|NCT03990363|467552643|FG004|Overall Study|Study terminated by sponsor|0|||
129889601|NCT03990363|467552639|FG000|Overall Study|Site terminated by sponsor|2|||
129889602|NCT03990363|467552640|FG001|Overall Study|Site terminated by sponsor|1|||
129889603|NCT03990363|467552641|FG002|Overall Study|Site terminated by sponsor|2|||
129889604|NCT03990363|467552642|FG003|Overall Study|Site terminated by sponsor|0|||
129889605|NCT03990363|467552643|FG004|Overall Study|Site terminated by sponsor|2|||
129889606|NCT03990363|467552639|FG000|Overall Study|Not categorized|5|||
129889607|NCT03990363|467552640|FG001|Overall Study|Not categorized|5|||
129889608|NCT03990363|467552641|FG002|Overall Study|Not categorized|3|||
129889609|NCT03990363|467552642|FG003|Overall Study|Not categorized|2|||
129889610|NCT03990363|467552643|FG004|Overall Study|Not categorized|2|||
129889611|NCT00238420|467552653|FG000|Overall Study|Protocol Violation|1|||
129889612|NCT00238420|467552654|FG001|Overall Study|Protocol Violation|1|||
129889613|NCT00663962|467552655|FG000|Overall Study|somnolence|1|||
129889614|NCT00663962|467552656|FG001|Overall Study|somnolence|0|||
129889615|NCT04140890|467552657|FG000|Overall Study|Withdrawal by Subject|0|||
129889616|NCT04140890|467552658|FG001|Overall Study|Withdrawal by Subject|1|||
129889617|NCT02102464|467552659|FG000|Randomized Study|Withdrawal by Subject|0|||
129889618|NCT02102464|467552660|FG001|Randomized Study|Withdrawal by Subject|1|||
129889619|NCT02102464|467552661|FG002|Randomized Study|Withdrawal by Subject|0|||
129889620|NCT01700348|467552662|FG000|Overall Study|Withdrawal by Subject|22|||
129889621|NCT01700348|467552662|FG000|Overall Study|Lost to Follow-up|1|||
129889622|NCT03958630|467552663|FG000|Overall Study|Withdrawal by Subject|0|||
129889623|NCT03958630|467552664|FG001|Overall Study|Withdrawal by Subject|0|||
129889624|NCT03958630|467552665|FG002|Overall Study|Withdrawal by Subject|1|||
129889625|NCT03958630|467552663|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
129889626|NCT03958630|467552664|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
129889627|NCT03958630|467552665|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
129889628|NCT01824472|467552670|FG000|Overall Study|Lost to Follow-up|0|||
129889629|NCT01824472|467552671|FG001|Overall Study|Lost to Follow-up|0|||
129889630|NCT01824472|467552672|FG002|Overall Study|Lost to Follow-up|1|||
129889631|NCT01824472|467552670|FG000|Overall Study|Withdrawal by Subject|1|||
129889632|NCT01824472|467552671|FG001|Overall Study|Withdrawal by Subject|5|||
129889633|NCT01824472|467552672|FG002|Overall Study|Withdrawal by Subject|3|||
129889634|NCT01824472|467552670|FG000|Overall Study|Ineligible post randomization&screening|0|||
129889635|NCT01824472|467552671|FG001|Overall Study|Ineligible post randomization&screening|2|||
129889636|NCT01824472|467552672|FG002|Overall Study|Ineligible post randomization&screening|0|||
129889637|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
129889638|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
129889639|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
129889640|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
129889641|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
129889642|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
129889643|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
129889644|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
129889645|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
130049887|NCT03074162|468140697|FG000|Period 3|Withdrawal by Subject|1|||
129889646|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
129889647|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
129889648|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
129889649|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
129889650|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
129889651|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
129889652|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
129889653|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
129889654|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
130049888|NCT03074162|468140698|FG001|Period 3|Withdrawal by Subject|0|||
130049889|NCT03074162|468140699|FG002|Period 3|Withdrawal by Subject|0|||
130049890|NCT03074162|468140700|FG003|Period 3|Withdrawal by Subject|0|||
130049891|NCT03074162|468140701|FG004|Period 3|Withdrawal by Subject|1|||
130049892|NCT03074162|468140702|FG005|Period 3|Withdrawal by Subject|0|||
130049893|NCT01993329|468140703|FG000|Period 2|Adverse Event|0|||
130049894|NCT01993329|468140704|FG001|Period 2|Adverse Event|0|||
130049895|NCT01993329|468140705|FG002|Period 2|Adverse Event|0|||
130049896|NCT01993329|468140706|FG003|Period 2|Adverse Event|0|||
130049897|NCT01993329|468140707|FG004|Period 2|Adverse Event|0|||
129889655|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
130049898|NCT01993329|468140708|FG005|Period 2|Adverse Event|1|||
129889656|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
129889657|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
130049899|NCT01993329|468140703|FG000|Wash-out|Personal reasons|0|||
130049900|NCT01993329|468140704|FG001|Wash-out|Personal reasons|1|||
129889658|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
129889659|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
129889660|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
129889661|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Death|1|||
130049901|NCT01993329|468140705|FG002|Wash-out|Personal reasons|0|||
129889662|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Death|0|||
129889663|NCT03040687|467552676|FG000|Overall Study|Withdrawal by Subject|1|||
129889664|NCT03040687|467552677|FG001|Overall Study|Withdrawal by Subject|0|||
129889665|NCT03040687|467552678|FG002|Overall Study|Withdrawal by Subject|0|||
129889666|NCT00810641|467552679|FG000|Overall Study|Withdrawal by Subject|0|||
129889667|NCT00810641|467552680|FG001|Overall Study|Withdrawal by Subject|1|||
129889668|NCT00810641|467552681|FG002|Overall Study|Withdrawal by Subject|2|||
129889669|NCT01556243|467552682|FG000|Overall Study|Ineligible|34|||
129889670|NCT01556243|467552682|FG000|Overall Study|Converted to mastectomy|14|||
129889671|NCT01556243|467552682|FG000|Overall Study|Unable to achieve negative margins|2|||
129889672|NCT01556243|467552682|FG000|Overall Study|Withdrawal by Subject|16|||
129889673|NCT02325713|467552685|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889674|NCT02325713|467552686|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889675|NCT02325713|467552687|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129798552|NCT02694523|467232098|FG002|Part B|Adverse Event|7|||
129798553|NCT02694523|467232099|FG003|Part B|Adverse Event|1|||
129798554|NCT02694523|467232100|FG004|Part B|Adverse Event|1|||
129798555|NCT02694523|467232101|FG005|Part B|Adverse Event|2|||
129798556|NCT02694523|467232102|FG006|Part B|Adverse Event|0|||
129798557|NCT02694523|467232096|FG000|Part B|Protocol Violation|0|||
129798558|NCT02694523|467232097|FG001|Part B|Protocol Violation|0|||
129798559|NCT02694523|467232098|FG002|Part B|Protocol Violation|1|||
129798560|NCT02694523|467232099|FG003|Part B|Protocol Violation|0|||
129798561|NCT02694523|467232100|FG004|Part B|Protocol Violation|0|||
129798562|NCT02694523|467232101|FG005|Part B|Protocol Violation|0|||
129798563|NCT02694523|467232102|FG006|Part B|Protocol Violation|0|||
129798564|NCT02694523|467232096|FG000|Part B|Lost to Follow-up|0|||
129889676|NCT02325713|467552688|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889677|NCT02325713|467552689|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889678|NCT02325713|467552690|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
130049902|NCT01993329|468140706|FG003|Wash-out|Personal reasons|0|||
130049903|NCT01993329|468140707|FG004|Wash-out|Personal reasons|0|||
130049904|NCT01993329|468140708|FG005|Wash-out|Personal reasons|0|||
130049905|NCT02948777|468140709|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
130049906|NCT02311478|468140710|FG000|Overall Study|Withdrawal by Subject|1|||
130049907|NCT02311478|468140710|FG000|Overall Study|Lost to Follow-up|5|||
130049908|NCT02311478|468140710|FG000|Overall Study|Failed IUD Insertion|1|||
130049909|NCT03242928|468140711|FG000|Overall Study|Adverse Event|2|||
130049910|NCT03242928|468140712|FG001|Overall Study|Adverse Event|1|||
130049911|NCT03242928|468140711|FG000|Overall Study|Lost to Follow-up|2|||
130049912|NCT03242928|468140712|FG001|Overall Study|Lost to Follow-up|0|||
130049913|NCT03242928|468140711|FG000|Overall Study|Physician Decision|0|||
130049914|NCT03242928|468140712|FG001|Overall Study|Physician Decision|1|||
130049915|NCT03242928|468140711|FG000|Overall Study|Withdrawal by Subject|5|||
130049916|NCT03242928|468140712|FG001|Overall Study|Withdrawal by Subject|3|||
130049917|NCT03276936|468140713|FG000|Overall Study|Adverse Event|4|||
130049918|NCT03276936|468140714|FG001|Overall Study|Adverse Event|2|||
130049919|NCT03276936|468140713|FG000|Overall Study|Lost to Follow-up|16|||
130049920|NCT03276936|468140714|FG001|Overall Study|Lost to Follow-up|13|||
130049921|NCT03276936|468140713|FG000|Overall Study|Withdrawal by Subject|30|||
130049922|NCT03276936|468140714|FG001|Overall Study|Withdrawal by Subject|20|||
130049923|NCT03276936|468140713|FG000|Overall Study|Not mentioned|6|||
130049924|NCT03276936|468140714|FG001|Overall Study|Not mentioned|3|||
130049925|NCT03041116|468140715|FG000|Double-blind|Death|0|||
130049926|NCT03041116|468140716|FG001|Double-blind|Death|2|||
130049927|NCT03041116|468140715|FG000|Double-blind|Withdrawal by Subject|0|||
130049928|NCT03041116|468140716|FG001|Double-blind|Withdrawal by Subject|4|||
130049929|NCT03041116|468140715|FG000|Open-label|Death|1|||
130049930|NCT03041116|468140716|FG001|Open-label|Death|0|||
130049931|NCT03041116|468140715|FG000|Open-label|Termination of the study by Sponsor|39|||
130049932|NCT03041116|468140716|FG001|Open-label|Termination of the study by Sponsor|37|||
130049933|NCT03041116|468140715|FG000|Open-label|Withdrawal by Subject|1|||
130049934|NCT03041116|468140716|FG001|Open-label|Withdrawal by Subject|0|||
130049935|NCT00943319|468140717|FG000|Overall Study|Death|1|||
130049936|NCT02043301|468140718|FG000|Overall Study|Discontinued|0|||
130309998|NCT01248949|469099126|FG000|Overall Study|Withdrawal by Subject|5|||
129798565|NCT02694523|467232097|FG001|Part B|Lost to Follow-up|0|||
129798566|NCT02694523|467232098|FG002|Part B|Lost to Follow-up|2|||
130049937|NCT02043301|468140719|FG001|Overall Study|Discontinued|1|||
130309999|NCT01248949|469099127|FG001|Overall Study|Withdrawal by Subject|3|||
129798567|NCT02694523|467232099|FG003|Part B|Lost to Follow-up|3|||
129798568|NCT02694523|467232100|FG004|Part B|Lost to Follow-up|2|||
129798569|NCT02694523|467232101|FG005|Part B|Lost to Follow-up|0|||
129798570|NCT02694523|467232102|FG006|Part B|Lost to Follow-up|1|||
129889679|NCT02325713|467552691|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889680|NCT02325713|467552692|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889681|NCT02325713|467552693|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889682|NCT02325713|467552694|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889683|NCT02325713|467552695|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
129889684|NCT02325713|467552696|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889685|NCT02325713|467552697|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889686|NCT02325713|467552698|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889687|NCT02325713|467552699|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889688|NCT02325713|467552700|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889689|NCT02325713|467552685|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
129889690|NCT02325713|467552686|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889691|NCT02325713|467552687|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130310000|NCT01248949|469099128|FG002|Overall Study|Withdrawal by Subject|11|||
129798571|NCT02694523|467232096|FG000|Part B|Withdrawal by Subject|0|||
129798572|NCT02694523|467232097|FG001|Part B|Withdrawal by Subject|0|||
129798573|NCT02694523|467232098|FG002|Part B|Withdrawal by Subject|9|||
129798574|NCT02694523|467232099|FG003|Part B|Withdrawal by Subject|0|||
129798575|NCT02694523|467232100|FG004|Part B|Withdrawal by Subject|1|||
129798576|NCT02694523|467232101|FG005|Part B|Withdrawal by Subject|3|||
129798577|NCT02694523|467232102|FG006|Part B|Withdrawal by Subject|0|||
129798578|NCT02694523|467232096|FG000|Part B|Other|0|||
129798579|NCT02694523|467232097|FG001|Part B|Other|0|||
129798580|NCT02694523|467232098|FG002|Part B|Other|1|||
129798581|NCT02694523|467232099|FG003|Part B|Other|0|||
129798582|NCT02694523|467232100|FG004|Part B|Other|0|||
129798583|NCT02694523|467232101|FG005|Part B|Other|0|||
129798584|NCT02694523|467232102|FG006|Part B|Other|1|||
129798585|NCT04505540|467232105|FG000|Baseline|Protocol Violation|10|||
129798586|NCT04505540|467232105|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
129798587|NCT04505540|467232105|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
129798588|NCT04505540|467232105|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
129798589|NCT04505540|467232105|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
129798590|NCT04505540|467232105|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
129798591|NCT04505540|467232105|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
129798592|NCT04505540|467232105|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
129798593|NCT04505540|467232105|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
129798594|NCT04505540|467232105|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
129798595|NCT04505540|467232105|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
129798596|NCT04505540|467232105|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
129798597|NCT04505540|467232105|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
129798598|NCT05323656|467232108|FG000|Overall Study|Still On-Treatment|6|||
129798599|NCT05323656|467232109|FG001|Overall Study|Still On-Treatment|6|||
129798600|NCT05323656|467232108|FG000|Overall Study|Progressive Disease|15|||
129798601|NCT05323656|467232109|FG001|Overall Study|Progressive Disease|14|||
129798602|NCT05323656|467232108|FG000|Overall Study|Adverse Event|2|||
129798603|NCT05323656|467232109|FG001|Overall Study|Adverse Event|3|||
129798604|NCT05323656|467232108|FG000|Overall Study|Death|1|||
129798605|NCT05323656|467232109|FG001|Overall Study|Death|2|||
129798606|NCT05323656|467232108|FG000|Overall Study|Withdrawal by Subject|1|||
129798607|NCT05323656|467232109|FG001|Overall Study|Withdrawal by Subject|0|||
129798608|NCT05323656|467232108|FG000|Overall Study|Clinical disease progression|0|||
129798609|NCT05323656|467232109|FG001|Overall Study|Clinical disease progression|1|||
129798610|NCT05323656|467232108|FG000|Overall Study|Patient and Investigator decision|1|||
129798611|NCT05323656|467232109|FG001|Overall Study|Patient and Investigator decision|0|||
129798612|NCT05323656|467232108|FG000|Overall Study|Physician Decision|0|||
129798613|NCT05323656|467232109|FG001|Overall Study|Physician Decision|1|||
129798614|NCT03953183|467232110|FG000|Overall Study|Physician Decision|0|||
129798615|NCT03953183|467232111|FG001|Overall Study|Physician Decision|1|||
129798616|NCT03953183|467232110|FG000|Overall Study|Withdrawal by Subject|0|||
129798617|NCT03953183|467232111|FG001|Overall Study|Withdrawal by Subject|1|||
129798618|NCT04508140|467232112|FG000|Overall Study|Adverse Event|2|||
129798619|NCT04508140|467232113|FG001|Overall Study|Adverse Event|2|||
129798620|NCT04508140|467232112|FG000|Overall Study|Withdrawal by Subject|0|||
129798621|NCT04508140|467232113|FG001|Overall Study|Withdrawal by Subject|2|||
129798622|NCT04508140|467232112|FG000|Overall Study|progressive disease|9|||
129798623|NCT04508140|467232113|FG001|Overall Study|progressive disease|3|||
129798624|NCT01298193|467232114|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
129798625|NCT01298193|467232114|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
129798626|NCT01298193|467232114|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
129798627|NCT01298193|467232114|FG000|Efficacy Phase (Second Cycle)|Death|1|||
129798628|NCT04010539|467232115|FG000|Overall Study|Withdrawal by Subject|4|||
129798629|NCT04010539|467232116|FG001|Overall Study|Withdrawal by Subject|1|||
130310001|NCT01248949|469099129|FG003|Overall Study|Withdrawal by Subject|3|||
130310002|NCT01248949|469099130|FG004|Overall Study|Withdrawal by Subject|1|||
130310003|NCT01248949|469099126|FG000|Overall Study|Death|22|||
130310004|NCT01248949|469099127|FG001|Overall Study|Death|7|||
130310005|NCT01248949|469099128|FG002|Overall Study|Death|21|||
130310006|NCT01248949|469099129|FG003|Overall Study|Death|6|||
130310007|NCT01248949|469099130|FG004|Overall Study|Death|2|||
130310008|NCT01248949|469099126|FG000|Overall Study|Alternative Therapy|1|||
130310009|NCT01248949|469099127|FG001|Overall Study|Alternative Therapy|0|||
130310010|NCT01248949|469099128|FG002|Overall Study|Alternative Therapy|0|||
130310011|NCT01248949|469099129|FG003|Overall Study|Alternative Therapy|0|||
130310012|NCT01248949|469099130|FG004|Overall Study|Alternative Therapy|0|||
130310013|NCT01248949|469099126|FG000|Overall Study|Alternative Therapy.|1|||
130310014|NCT01248949|469099127|FG001|Overall Study|Alternative Therapy.|0|||
130310015|NCT01248949|469099128|FG002|Overall Study|Alternative Therapy.|0|||
130310016|NCT01248949|469099129|FG003|Overall Study|Alternative Therapy.|0|||
130310017|NCT01248949|469099130|FG004|Overall Study|Alternative Therapy.|0|||
130310018|NCT01248949|469099126|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
130310019|NCT01248949|469099127|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310020|NCT01248949|469099128|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310021|NCT01248949|469099129|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310022|NCT01248949|469099130|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
130310023|NCT01248949|469099126|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310024|NCT01248949|469099127|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310025|NCT01248949|469099128|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310026|NCT01248949|469099129|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
130310027|NCT01248949|469099130|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
130310028|NCT01248949|469099126|FG000|Overall Study|Participant Went To Hospice|0|||
130310029|NCT01248949|469099127|FG001|Overall Study|Participant Went To Hospice|0|||
130310030|NCT01248949|469099128|FG002|Overall Study|Participant Went To Hospice|1|||
130310031|NCT01248949|469099129|FG003|Overall Study|Participant Went To Hospice|0|||
130310032|NCT01248949|469099130|FG004|Overall Study|Participant Went To Hospice|0|||
130310033|NCT01248949|469099126|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
130310034|NCT01248949|469099127|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310035|NCT01248949|469099128|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310036|NCT01248949|469099129|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310037|NCT01248949|469099130|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
130310038|NCT01248949|469099126|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
130310039|NCT01248949|469099127|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
130310040|NCT01248949|469099128|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
130310041|NCT01248949|469099129|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
130310042|NCT01248949|469099130|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
130310043|NCT01248949|469099126|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310044|NCT01248949|469099127|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
130310045|NCT01248949|469099128|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310046|NCT01248949|469099129|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310047|NCT01248949|469099130|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
130310048|NCT01248949|469099126|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310049|NCT01248949|469099127|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310050|NCT01248949|469099128|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
130310051|NCT01248949|469099129|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310052|NCT01248949|469099130|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
130310053|NCT00286429|469099131|FG000|Overall Study|Adverse Event|4|||
130310054|NCT00286429|469099132|FG001|Overall Study|Adverse Event|1|||
130310055|NCT00286429|469099133|FG002|Overall Study|Adverse Event|6|||
130310056|NCT00286429|469099131|FG000|Overall Study|Lack of Efficacy|52|||
129889692|NCT02325713|467552688|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889693|NCT02325713|467552689|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889694|NCT02325713|467552690|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889695|NCT02325713|467552691|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889696|NCT02325713|467552692|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
130310057|NCT00286429|469099132|FG001|Overall Study|Lack of Efficacy|27|||
130310058|NCT00286429|469099133|FG002|Overall Study|Lack of Efficacy|25|||
130310059|NCT00286429|469099131|FG000|Overall Study|Lost to Follow-up|2|||
130310060|NCT00286429|469099132|FG001|Overall Study|Lost to Follow-up|4|||
130310061|NCT00286429|469099133|FG002|Overall Study|Lost to Follow-up|3|||
130310062|NCT00286429|469099131|FG000|Overall Study|Physician Decision|10|||
130310063|NCT00286429|469099132|FG001|Overall Study|Physician Decision|7|||
130310064|NCT00286429|469099133|FG002|Overall Study|Physician Decision|7|||
130310065|NCT00286429|469099131|FG000|Overall Study|Protocol Violation|3|||
130310066|NCT00286429|469099132|FG001|Overall Study|Protocol Violation|5|||
130310067|NCT00286429|469099133|FG002|Overall Study|Protocol Violation|4|||
130310068|NCT00286429|469099131|FG000|Overall Study|Withdrawal by Subject|3|||
130049938|NCT02043301|468140720|FG002|Overall Study|Discontinued|0|||
130049939|NCT01781429|468140721|FG000|Overall Study|Death|0|||
130049940|NCT01781429|468140722|FG001|Overall Study|Death|0|||
130049941|NCT01781429|468140723|FG002|Overall Study|Death|0|||
130049942|NCT01781429|468140724|FG003|Overall Study|Death|0|||
130049943|NCT01781429|468140725|FG004|Overall Study|Death|0|||
130049944|NCT01781429|468140726|FG005|Overall Study|Death|0|||
130049945|NCT01781429|468140727|FG006|Overall Study|Death|0|||
130049946|NCT01781429|468140728|FG007|Overall Study|Death|0|||
130049947|NCT01781429|468140729|FG008|Overall Study|Death|0|||
130049948|NCT01781429|468140730|FG009|Overall Study|Death|1|||
130049949|NCT01781429|468140731|FG010|Overall Study|Death|0|||
130049950|NCT01781429|468140732|FG011|Overall Study|Death|0|||
130049951|NCT01781429|468140733|FG012|Overall Study|Death|1|||
130049952|NCT01781429|468140734|FG013|Overall Study|Death|0|||
130049953|NCT01781429|468140735|FG014|Overall Study|Death|1|||
130049954|NCT01781429|468140736|FG015|Overall Study|Death|0|||
130049955|NCT01781429|468140721|FG000|Overall Study|Withdrawal by Subject|0|||
130049956|NCT01781429|468140722|FG001|Overall Study|Withdrawal by Subject|0|||
130049957|NCT01781429|468140723|FG002|Overall Study|Withdrawal by Subject|0|||
130049958|NCT01781429|468140724|FG003|Overall Study|Withdrawal by Subject|0|||
130049959|NCT01781429|468140725|FG004|Overall Study|Withdrawal by Subject|0|||
130049960|NCT01781429|468140726|FG005|Overall Study|Withdrawal by Subject|0|||
130049961|NCT01781429|468140727|FG006|Overall Study|Withdrawal by Subject|0|||
130049962|NCT01781429|468140728|FG007|Overall Study|Withdrawal by Subject|0|||
130049963|NCT01781429|468140729|FG008|Overall Study|Withdrawal by Subject|1|||
130049964|NCT01781429|468140730|FG009|Overall Study|Withdrawal by Subject|3|||
130049965|NCT01781429|468140731|FG010|Overall Study|Withdrawal by Subject|1|||
130049966|NCT01781429|468140732|FG011|Overall Study|Withdrawal by Subject|1|||
130310069|NCT00286429|469099132|FG001|Overall Study|Withdrawal by Subject|2|||
130310070|NCT00286429|469099133|FG002|Overall Study|Withdrawal by Subject|6|||
130310071|NCT00286429|469099131|FG000|Overall Study|Administrative Error|1|||
130310072|NCT00286429|469099132|FG001|Overall Study|Administrative Error|1|||
130310073|NCT00286429|469099133|FG002|Overall Study|Administrative Error|1|||
130310074|NCT00286429|469099131|FG000|Overall Study|Administrative Decision|0|||
130310075|NCT00286429|469099132|FG001|Overall Study|Administrative Decision|1|||
130310076|NCT00286429|469099133|FG002|Overall Study|Administrative Decision|0|||
130310077|NCT01746225|469099136|FG000|Overall Study|Death|1|||
130310078|NCT01746225|469099137|FG001|Overall Study|Death|0|||
130310079|NCT01746225|469099138|FG002|Overall Study|Death|1|||
130310080|NCT01746225|469099136|FG000|Overall Study|Withdrawal by Subject|5|||
130310081|NCT01746225|469099137|FG001|Overall Study|Withdrawal by Subject|15|||
130310082|NCT01746225|469099138|FG002|Overall Study|Withdrawal by Subject|19|||
130310083|NCT01746225|469099136|FG000|Overall Study|Physician Decision|14|||
130310084|NCT01746225|469099137|FG001|Overall Study|Physician Decision|11|||
130310085|NCT01746225|469099138|FG002|Overall Study|Physician Decision|3|||
130310086|NCT01746225|469099136|FG000|Overall Study|Adverse Event|15|||
130310087|NCT01746225|469099137|FG001|Overall Study|Adverse Event|12|||
130310088|NCT01746225|469099138|FG002|Overall Study|Adverse Event|17|||
130310089|NCT01746225|469099136|FG000|Overall Study|Continuing Treatment|5|||
130310090|NCT01746225|469099137|FG001|Overall Study|Continuing Treatment|8|||
130310091|NCT01746225|469099138|FG002|Overall Study|Continuing Treatment|3|||
130310092|NCT03915470|469099139|FG000|Overall Study|Death|3|||
130310093|NCT03915470|469099140|FG001|Overall Study|Death|1|||
130310094|NCT03915470|469099139|FG000|Overall Study|Adverse Event|1|||
130310095|NCT03915470|469099140|FG001|Overall Study|Adverse Event|0|||
130310096|NCT03915470|469099139|FG000|Overall Study|Physician Decision|1|||
130310097|NCT03915470|469099140|FG001|Overall Study|Physician Decision|0|||
130310098|NCT03915470|469099139|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
130310099|NCT03915470|469099140|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
130310100|NCT03160898|469099141|FG000|Overall Study|Adverse Event|4|||
130310101|NCT03160898|469099142|FG001|Overall Study|Adverse Event|8|||
130310102|NCT03160898|469099143|FG002|Overall Study|Adverse Event|7|||
130310103|NCT03160898|469099144|FG003|Overall Study|Adverse Event|10|||
130049967|NCT01781429|468140733|FG012|Overall Study|Withdrawal by Subject|5|||
130049968|NCT01781429|468140734|FG013|Overall Study|Withdrawal by Subject|2|||
130049969|NCT01781429|468140735|FG014|Overall Study|Withdrawal by Subject|3|||
130310104|NCT03160898|469099141|FG000|Overall Study|Death|1|||
130310105|NCT03160898|469099142|FG001|Overall Study|Death|0|||
130310106|NCT03160898|469099143|FG002|Overall Study|Death|0|||
130310107|NCT03160898|469099144|FG003|Overall Study|Death|1|||
130310108|NCT03160898|469099141|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
130310109|NCT03160898|469099142|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
130049970|NCT01781429|468140736|FG015|Overall Study|Withdrawal by Subject|0|||
130049971|NCT01781429|468140721|FG000|Overall Study|Disease Progression|1|||
130049972|NCT01781429|468140722|FG001|Overall Study|Disease Progression|0|||
130049973|NCT01781429|468140723|FG002|Overall Study|Disease Progression|1|||
130049974|NCT01781429|468140724|FG003|Overall Study|Disease Progression|1|||
130049975|NCT01781429|468140725|FG004|Overall Study|Disease Progression|1|||
129889697|NCT02325713|467552693|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889698|NCT02325713|467552694|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889699|NCT02325713|467552695|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889700|NCT02325713|467552696|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889701|NCT02325713|467552697|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889702|NCT02325713|467552698|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889703|NCT02325713|467552699|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889704|NCT02325713|467552700|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889705|NCT02325713|467552685|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889706|NCT02325713|467552686|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889707|NCT02325713|467552687|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889708|NCT02325713|467552688|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889709|NCT02325713|467552689|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130310110|NCT03160898|469099143|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
130310111|NCT03160898|469099144|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
130310112|NCT03160898|469099141|FG000|Overall Study|Lost to Follow-up|1|||
130310113|NCT03160898|469099142|FG001|Overall Study|Lost to Follow-up|1|||
130310114|NCT03160898|469099143|FG002|Overall Study|Lost to Follow-up|1|||
130310115|NCT03160898|469099144|FG003|Overall Study|Lost to Follow-up|2|||
130310116|NCT03160898|469099141|FG000|Overall Study|Physician Decision|1|||
130310117|NCT03160898|469099142|FG001|Overall Study|Physician Decision|0|||
130310118|NCT03160898|469099143|FG002|Overall Study|Physician Decision|0|||
130310119|NCT03160898|469099144|FG003|Overall Study|Physician Decision|1|||
130310120|NCT03160898|469099141|FG000|Overall Study|Progressive Disease|4|||
130310121|NCT03160898|469099142|FG001|Overall Study|Progressive Disease|1|||
130310122|NCT03160898|469099143|FG002|Overall Study|Progressive Disease|2|||
130310123|NCT03160898|469099144|FG003|Overall Study|Progressive Disease|1|||
130310124|NCT03160898|469099141|FG000|Overall Study|Protocol Violation|1|||
130310125|NCT03160898|469099142|FG001|Overall Study|Protocol Violation|0|||
130310126|NCT03160898|469099143|FG002|Overall Study|Protocol Violation|2|||
130310127|NCT03160898|469099144|FG003|Overall Study|Protocol Violation|0|||
130310128|NCT03160898|469099141|FG000|Overall Study|Sponsor Discretion|2|||
130310129|NCT03160898|469099142|FG001|Overall Study|Sponsor Discretion|0|||
130310130|NCT03160898|469099143|FG002|Overall Study|Sponsor Discretion|0|||
130310131|NCT03160898|469099144|FG003|Overall Study|Sponsor Discretion|0|||
130310132|NCT03160898|469099141|FG000|Overall Study|Withdrawal by Subject|1|||
130310133|NCT03160898|469099142|FG001|Overall Study|Withdrawal by Subject|3|||
130310134|NCT03160898|469099143|FG002|Overall Study|Withdrawal by Subject|2|||
130310135|NCT03160898|469099144|FG003|Overall Study|Withdrawal by Subject|1|||
130310136|NCT03160898|469099141|FG000|Overall Study|Other|2|||
130310137|NCT03160898|469099142|FG001|Overall Study|Other|0|||
130310138|NCT03160898|469099143|FG002|Overall Study|Other|2|||
130310139|NCT03160898|469099144|FG003|Overall Study|Other|2|||
130310140|NCT03245775|469099145|FG000|Overall Study|Lost to Follow-up|25|||
130310141|NCT03245775|469099146|FG001|Overall Study|Lost to Follow-up|26|||
130310142|NCT03245775|469099147|FG002|Overall Study|Lost to Follow-up|16|||
130310143|NCT03245775|469099148|FG003|Overall Study|Lost to Follow-up|16|||
130310144|NCT02978833|469099155|FG000|Overall Study|Study terminated|1|||
130310145|NCT02978833|469099156|FG001|Overall Study|Study terminated|1|||
130310146|NCT00103740|469099157|FG000|Period 1 - Core|Adverse Event|1|||
130310147|NCT00103740|469099158|FG001|Period 1 - Core|Adverse Event|0|||
130310148|NCT00103740|469099157|FG000|Period 1 - Core|Protocol Violation|3|||
130310149|NCT00103740|469099158|FG001|Period 1 - Core|Protocol Violation|2|||
130310150|NCT00103740|469099157|FG000|Period 1 - Core|Patient withdrew consent|3|||
130310151|NCT00103740|469099158|FG001|Period 1 - Core|Patient withdrew consent|2|||
130310152|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
130310153|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
130310154|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
130310155|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
130310156|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
130310157|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
129889710|NCT02325713|467552690|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889711|NCT02325713|467552691|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889712|NCT02325713|467552692|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130310158|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Death|6|||
129889713|NCT02325713|467552693|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130049976|NCT01781429|468140726|FG005|Overall Study|Disease Progression|4|||
130310159|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Death|2|||
130310160|NCT00103740|469099157|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
130310161|NCT00103740|469099158|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
130310162|NCT02663622|469099165|FG000|Overall Study|Death|3|||
130310163|NCT02663622|469099166|FG001|Overall Study|Death|1|||
130310164|NCT02663622|469099167|FG002|Overall Study|Death|1|||
130310165|NCT02663622|469099168|FG003|Overall Study|Death|8|||
130310166|NCT02663622|469099165|FG000|Overall Study|Protocol Violation|0|||
130310167|NCT02663622|469099166|FG001|Overall Study|Protocol Violation|0|||
130310168|NCT02663622|469099167|FG002|Overall Study|Protocol Violation|0|||
130310169|NCT02663622|469099168|FG003|Overall Study|Protocol Violation|1|||
130310170|NCT02587819|469099169|FG000|Overall Study|Adverse Event|1|||
130310171|NCT02587819|469099169|FG000|Overall Study|Lost to Follow-up|1|||
130310172|NCT01594931|469100610|FG000|Overall Study|Adverse Event|3|||
130310173|NCT01594931|469100611|FG001|Overall Study|Adverse Event|1|||
130310174|NCT01594931|469100612|FG002|Overall Study|Adverse Event|1|||
130310175|NCT01594931|469100610|FG000|Overall Study|Withdrawal by Subject|2|||
130310176|NCT01594931|469100611|FG001|Overall Study|Withdrawal by Subject|1|||
130310177|NCT01594931|469100612|FG002|Overall Study|Withdrawal by Subject|1|||
130310178|NCT01594931|469100610|FG000|Overall Study|Lack of Efficacy|7|||
130310179|NCT01594931|469100611|FG001|Overall Study|Lack of Efficacy|2|||
130310180|NCT01594931|469100612|FG002|Overall Study|Lack of Efficacy|2|||
130310181|NCT01594931|469100610|FG000|Overall Study|Lost to Follow-up|4|||
130310182|NCT01594931|469100611|FG001|Overall Study|Lost to Follow-up|3|||
130310183|NCT01594931|469100612|FG002|Overall Study|Lost to Follow-up|3|||
130310184|NCT01594931|469100610|FG000|Overall Study|Protocol Violation|2|||
130310185|NCT01594931|469100611|FG001|Overall Study|Protocol Violation|1|||
130310186|NCT01594931|469100612|FG002|Overall Study|Protocol Violation|0|||
130310187|NCT01594931|469100610|FG000|Overall Study|No defiined|11|||
130310188|NCT01594931|469100611|FG001|Overall Study|No defiined|4|||
130310189|NCT01594931|469100612|FG002|Overall Study|No defiined|7|||
130310190|NCT01467505|469100614|FG000|Overall Study|Adverse Event|1|||
130310191|NCT01467505|469100615|FG001|Overall Study|Adverse Event|0|||
130310192|NCT01467505|469100614|FG000|Overall Study|Withdrawal by Subject|4|||
130310193|NCT01467505|469100615|FG001|Overall Study|Withdrawal by Subject|0|||
130310194|NCT01467505|469100614|FG000|Overall Study|Study Terminated by Sponsor|28|||
130310195|NCT01467505|469100615|FG001|Overall Study|Study Terminated by Sponsor|3|||
130310196|NCT03449758|469100616|FG000|Overall Study|Major protocol deviation|1|||
130310197|NCT03449758|469100616|FG000|Overall Study|Treatment inefficacy|5|||
130310198|NCT03449758|469100616|FG000|Overall Study|Adverse Event|9|||
130310199|NCT03449758|469100616|FG000|Overall Study|Consent withdrawal|1|||
130310200|NCT03449758|469100616|FG000|Overall Study|Other unspecified reason|3|||
130310201|NCT00086047|469100629|FG000|Overall Study|Lost to Follow-up|7|||
130310202|NCT00086047|469100630|FG001|Overall Study|Lost to Follow-up|6|||
130310203|NCT00086047|469100629|FG000|Overall Study|Physician Decision|0|||
130310204|NCT00086047|469100630|FG001|Overall Study|Physician Decision|1|||
130310205|NCT03579940|469100631|FG000|Period 2|Withdrawal by Subject|0|||
130310206|NCT03579940|469100632|FG001|Period 2|Withdrawal by Subject|0|||
130310207|NCT03579940|469100633|FG002|Period 2|Withdrawal by Subject|1|||
130310208|NCT03579940|469100634|FG003|Period 2|Withdrawal by Subject|0|||
130310209|NCT03579940|469100635|FG004|Period 2|Withdrawal by Subject|0|||
130310210|NCT03579940|469100636|FG005|Period 2|Withdrawal by Subject|0|||
130310211|NCT03579940|469100637|FG006|Period 2|Withdrawal by Subject|0|||
130310212|NCT03579940|469100638|FG007|Period 2|Withdrawal by Subject|0|||
130310213|NCT03579940|469100639|FG008|Period 2|Withdrawal by Subject|0|||
130310214|NCT03579940|469100640|FG009|Period 2|Withdrawal by Subject|0|||
130310215|NCT03579940|469100641|FG010|Period 2|Withdrawal by Subject|0|||
130310216|NCT00671034|469100642|FG000|Overall Study|Adverse Event|5|||
130310217|NCT00671034|469100643|FG001|Overall Study|Adverse Event|7|||
130310218|NCT00671034|469100644|FG002|Overall Study|Adverse Event|1|||
130310219|NCT00671034|469100642|FG000|Overall Study|Death|3|||
130310220|NCT00671034|469100643|FG001|Overall Study|Death|2|||
130310221|NCT00671034|469100644|FG002|Overall Study|Death|1|||
130310222|NCT00671034|469100642|FG000|Overall Study|Physician Decision|12|||
130310223|NCT00671034|469100643|FG001|Overall Study|Physician Decision|4|||
130310224|NCT00671034|469100644|FG002|Overall Study|Physician Decision|5|||
130310225|NCT00671034|469100642|FG000|Overall Study|VHR ALL feature|8|||
130310226|NCT00671034|469100643|FG001|Overall Study|VHR ALL feature|3|||
130310227|NCT00671034|469100644|FG002|Overall Study|VHR ALL feature|5|||
130310228|NCT00671034|469100642|FG000|Overall Study|Refusal|5|||
130310229|NCT00671034|469100643|FG001|Overall Study|Refusal|3|||
130310230|NCT00671034|469100644|FG002|Overall Study|Refusal|5|||
130310231|NCT00671034|469100642|FG000|Overall Study|includes Alternative therapy, etc.|6|||
130049977|NCT01781429|468140727|FG006|Overall Study|Disease Progression|7|||
130310232|NCT00671034|469100643|FG001|Overall Study|includes Alternative therapy, etc.|1|||
130310233|NCT00671034|469100644|FG002|Overall Study|includes Alternative therapy, etc.|7|||
130310234|NCT00853151|469100645|FG000|Overall Study|Adverse Event|1|||
130310235|NCT00853151|469100646|FG001|Overall Study|Adverse Event|4|||
130310236|NCT00853151|469100647|FG002|Overall Study|Adverse Event|2|||
130310237|NCT00853151|469100648|FG003|Overall Study|Adverse Event|0|||
130310238|NCT00853151|469100645|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
130310239|NCT00853151|469100646|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130310240|NCT00853151|469100647|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130310241|NCT00853151|469100648|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
130310242|NCT00853151|469100645|FG000|Overall Study|Lost to Follow-up|2|||
130310243|NCT00853151|469100646|FG001|Overall Study|Lost to Follow-up|0|||
130310244|NCT00853151|469100647|FG002|Overall Study|Lost to Follow-up|3|||
130310245|NCT00853151|469100648|FG003|Overall Study|Lost to Follow-up|0|||
130310246|NCT00853151|469100645|FG000|Overall Study|Death|1|||
130310247|NCT00853151|469100646|FG001|Overall Study|Death|0|||
130310248|NCT00853151|469100647|FG002|Overall Study|Death|0|||
130310249|NCT00853151|469100648|FG003|Overall Study|Death|1|||
130310250|NCT00853151|469100645|FG000|Overall Study|Protocol Violation|0|||
130310251|NCT00853151|469100646|FG001|Overall Study|Protocol Violation|0|||
130310252|NCT00853151|469100647|FG002|Overall Study|Protocol Violation|0|||
130310253|NCT00853151|469100648|FG003|Overall Study|Protocol Violation|1|||
130310254|NCT00853151|469100645|FG000|Overall Study|Withdrawal by Subject|5|||
130310255|NCT00853151|469100646|FG001|Overall Study|Withdrawal by Subject|4|||
130310256|NCT00853151|469100647|FG002|Overall Study|Withdrawal by Subject|2|||
130310257|NCT00853151|469100648|FG003|Overall Study|Withdrawal by Subject|1|||
130310258|NCT00853151|469100645|FG000|Overall Study|Physician Decision|0|||
130310259|NCT00853151|469100646|FG001|Overall Study|Physician Decision|2|||
130310260|NCT00853151|469100647|FG002|Overall Study|Physician Decision|1|||
130310261|NCT00853151|469100648|FG003|Overall Study|Physician Decision|0|||
130310262|NCT00853151|469100645|FG000|Overall Study|Sponsor Decision|0|||
130310263|NCT00853151|469100646|FG001|Overall Study|Sponsor Decision|3|||
130310264|NCT00853151|469100647|FG002|Overall Study|Sponsor Decision|0|||
130310265|NCT00853151|469100648|FG003|Overall Study|Sponsor Decision|0|||
130310266|NCT00269919|469100649|FG000|Overall Study|Other|26|||
130310267|NCT00269919|469100649|FG000|Overall Study|Started but not treated|1|||
130310268|NCT02471014|469100652|FG000|Overall Study|Lost to Follow-up|2|||
130310269|NCT02471014|469100653|FG001|Overall Study|Lost to Follow-up|2|||
130310270|NCT01751984|469100654|FG000|Overall Study|Adverse Event|5|||
130310271|NCT01751984|469100655|FG001|Overall Study|Adverse Event|3|||
130310272|NCT01751984|469100654|FG000|Overall Study|Withdrawal by Subject|0|||
130310273|NCT01751984|469100655|FG001|Overall Study|Withdrawal by Subject|1|||
130310274|NCT01751984|469100654|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
130310275|NCT01751984|469100655|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
130310276|NCT01388907|469100656|FG000|Overall Study|Adverse Event|2|||
130310277|NCT01388907|469100657|FG001|Overall Study|Adverse Event|0|||
130310278|NCT03187132|469100658|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
130310279|NCT03187132|469100659|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
130310280|NCT03187132|469100658|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
130310281|NCT03187132|469100659|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
130310282|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
130310283|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
130310284|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
130310285|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
130310286|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
130310287|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
130310288|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
130310289|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
130310290|NCT03187132|469100658|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
130310291|NCT03187132|469100659|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
130310292|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
130310293|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
130310294|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
130310295|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
130310296|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
130310297|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
130310298|NCT03187132|469100658|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
130310299|NCT03187132|469100659|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
130310300|NCT02045095|469100660|FG000|Overall Study|Other|0|||
130310301|NCT02045095|469100661|FG001|Overall Study|Other|0|||
129889714|NCT02325713|467552694|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
129889715|NCT02325713|467552695|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889716|NCT02325713|467552696|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889717|NCT02325713|467552697|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889718|NCT02325713|467552698|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130049978|NCT01781429|468140728|FG007|Overall Study|Disease Progression|4|||
129889719|NCT02325713|467552699|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130310302|NCT02045095|469100662|FG002|Overall Study|Other|1|||
130310303|NCT02045095|469100663|FG003|Overall Study|Other|0|||
130310304|NCT02045095|469100664|FG004|Overall Study|Other|0|||
130310305|NCT02045095|469100665|FG005|Overall Study|Other|2|||
130310306|NCT02045095|469100666|FG006|Overall Study|Other|0|||
130310307|NCT02045095|469100660|FG000|Overall Study|Progressive Disease|3|||
130310308|NCT02045095|469100661|FG001|Overall Study|Progressive Disease|3|||
130310309|NCT02045095|469100662|FG002|Overall Study|Progressive Disease|2|||
130310310|NCT02045095|469100663|FG003|Overall Study|Progressive Disease|4|||
130310311|NCT02045095|469100664|FG004|Overall Study|Progressive Disease|2|||
130310312|NCT02045095|469100665|FG005|Overall Study|Progressive Disease|4|||
130310313|NCT02045095|469100666|FG006|Overall Study|Progressive Disease|1|||
130310314|NCT02045095|469100660|FG000|Overall Study|Withdrawal by Subject|0|||
130310315|NCT02045095|469100661|FG001|Overall Study|Withdrawal by Subject|0|||
130310316|NCT02045095|469100662|FG002|Overall Study|Withdrawal by Subject|0|||
130310317|NCT02045095|469100663|FG003|Overall Study|Withdrawal by Subject|0|||
130310318|NCT02045095|469100664|FG004|Overall Study|Withdrawal by Subject|3|||
130310319|NCT02045095|469100665|FG005|Overall Study|Withdrawal by Subject|0|||
130310320|NCT02045095|469100666|FG006|Overall Study|Withdrawal by Subject|0|||
130310321|NCT02045095|469100660|FG000|Overall Study|Adverse Event|0|||
130310322|NCT02045095|469100661|FG001|Overall Study|Adverse Event|1|||
130310323|NCT02045095|469100662|FG002|Overall Study|Adverse Event|1|||
130310324|NCT02045095|469100663|FG003|Overall Study|Adverse Event|0|||
130310325|NCT02045095|469100664|FG004|Overall Study|Adverse Event|0|||
130310326|NCT02045095|469100665|FG005|Overall Study|Adverse Event|2|||
130310327|NCT02045095|469100666|FG006|Overall Study|Adverse Event|0|||
130310328|NCT03594773|469100667|FG000|Overall Study|Withdrawal by Subject|3|||
130310329|NCT03594773|469100668|FG001|Overall Study|Withdrawal by Subject|2|||
130310330|NCT03594773|469100667|FG000|Overall Study|Lost to Follow-up|3|||
130310331|NCT03594773|469100668|FG001|Overall Study|Lost to Follow-up|4|||
130310332|NCT00714415|469100670|FG000|Overall Study|Lack of Efficacy|1|||
130310333|NCT00714415|469100671|FG001|Overall Study|Lack of Efficacy|0|||
130310334|NCT00714415|469100670|FG000|Overall Study|Death|1|||
130310335|NCT00714415|469100671|FG001|Overall Study|Death|0|||
130310336|NCT01461707|469100674|FG000|Overall Study|Withdrawal by Subject|1|||
130310337|NCT01461707|469100675|FG001|Overall Study|Withdrawal by Subject|0|||
130310338|NCT03461146|469100681|FG000|Overall Study|Adverse Event|2|||
130310339|NCT03461146|469100681|FG000|Overall Study|Physician Decision|1|||
130310340|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
130310341|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
130310342|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
130310343|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
130310344|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
130310345|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
130310346|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
130310347|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
130310348|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
130310349|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
130310350|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
130310351|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
130310352|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
130310353|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
130310354|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
130310355|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
130310356|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
130310357|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
130310358|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
130310359|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
130310360|NCT03573323|469100682|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
130310361|NCT03573323|469100683|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
130310362|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
130310363|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
130310364|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
130310365|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
130049979|NCT01781429|468140729|FG008|Overall Study|Disease Progression|6|||
130310366|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
129798630|NCT04010539|467232115|FG000|Overall Study|Physician Decision|0|||
129798631|NCT04010539|467232116|FG001|Overall Study|Physician Decision|2|||
129798632|NCT04010539|467232115|FG000|Overall Study|Lost to Follow-up|10|||
129798633|NCT04010539|467232116|FG001|Overall Study|Lost to Follow-up|14|||
130049980|NCT01781429|468140730|FG009|Overall Study|Disease Progression|15|||
130049981|NCT01781429|468140731|FG010|Overall Study|Disease Progression|15|||
130049982|NCT01781429|468140732|FG011|Overall Study|Disease Progression|15|||
130049983|NCT01781429|468140733|FG012|Overall Study|Disease Progression|15|||
130049984|NCT01781429|468140734|FG013|Overall Study|Disease Progression|4|||
130310367|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
130310368|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
130310369|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
130049985|NCT01781429|468140735|FG014|Overall Study|Disease Progression|11|||
130049986|NCT01781429|468140736|FG015|Overall Study|Disease Progression|0|||
130049987|NCT01781429|468140721|FG000|Overall Study|Unacceptable Toxicity|0|||
130049988|NCT01781429|468140722|FG001|Overall Study|Unacceptable Toxicity|0|||
130049989|NCT01781429|468140723|FG002|Overall Study|Unacceptable Toxicity|0|||
130049990|NCT01781429|468140724|FG003|Overall Study|Unacceptable Toxicity|0|||
130049991|NCT01781429|468140725|FG004|Overall Study|Unacceptable Toxicity|0|||
130049992|NCT01781429|468140726|FG005|Overall Study|Unacceptable Toxicity|0|||
130049993|NCT01781429|468140727|FG006|Overall Study|Unacceptable Toxicity|0|||
130049994|NCT01781429|468140728|FG007|Overall Study|Unacceptable Toxicity|0|||
130310370|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
130310371|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
130310372|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
130310373|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
130310374|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
130310375|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
130310376|NCT03573323|469100682|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
130310377|NCT03573323|469100683|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
130310378|NCT01338818|469100691|FG000|Overall Study|Adverse Event|8|||
130310379|NCT01338818|469100691|FG000|Overall Study|Lack of Efficacy|5|||
130310380|NCT01338818|469100691|FG000|Overall Study|no longer require study drug|1|||
129798634|NCT04010539|467232115|FG000|Overall Study|Adverse Event|3|||
129798635|NCT04010539|467232116|FG001|Overall Study|Adverse Event|0|||
129798636|NCT04010539|467232115|FG000|Overall Study|Participant Did Not Receive IP|0|||
129798637|NCT04010539|467232116|FG001|Overall Study|Participant Did Not Receive IP|1|||
129798638|NCT04010539|467232115|FG000|Overall Study|Protocol Deviation|0|||
130310381|NCT01338818|469100691|FG000|Overall Study|Withdrawal by Subject|11|||
130310382|NCT01338818|469100691|FG000|Overall Study|Lost to Follow-up|4|||
130310383|NCT01338818|469100691|FG000|Overall Study|Administrative problems|3|||
130310384|NCT01338818|469100691|FG000|Overall Study|Protocol Deviation|4|||
130310385|NCT02868554|469100692|FG000|Overall Study|Lost to Follow-up|3|||
130310386|NCT02868554|469100693|FG001|Overall Study|Lost to Follow-up|0|||
130310387|NCT02868554|469100694|FG002|Overall Study|Lost to Follow-up|1|||
130310388|NCT02714569|469100695|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
130310389|NCT02714569|469100696|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
130310390|NCT02714569|469100697|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
130310391|NCT02714569|469100698|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
130310392|NCT02714569|469100699|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
130310393|NCT02714569|469100700|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
130310394|NCT02714569|469100701|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
130310395|NCT02714569|469100702|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
130310396|NCT02714569|469100703|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
130310397|NCT02714569|469100704|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
130310398|NCT02714569|469100705|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
130310399|NCT02714569|469100695|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310400|NCT02714569|469100696|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310401|NCT02714569|469100697|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310402|NCT02714569|469100698|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
130310403|NCT02714569|469100699|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310404|NCT02714569|469100700|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310405|NCT02714569|469100701|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310406|NCT02714569|469100702|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129798639|NCT04010539|467232116|FG001|Overall Study|Protocol Deviation|1|||
129798640|NCT04010539|467232115|FG000|Overall Study|Randomized in Error/ Mistake|2|||
129798641|NCT04010539|467232116|FG001|Overall Study|Randomized in Error/ Mistake|0|||
129798642|NCT04010539|467232115|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
129798643|NCT04010539|467232116|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
129798644|NCT00249288|467232117|FG000|Overall Study|Lost to Follow-up|3|||
130049995|NCT01781429|468140729|FG008|Overall Study|Unacceptable Toxicity|0|||
130049996|NCT01781429|468140730|FG009|Overall Study|Unacceptable Toxicity|0|||
130049997|NCT01781429|468140731|FG010|Overall Study|Unacceptable Toxicity|0|||
130049998|NCT01781429|468140732|FG011|Overall Study|Unacceptable Toxicity|2|||
130310407|NCT02714569|469100703|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129798645|NCT00249288|467232118|FG001|Overall Study|Lost to Follow-up|3|||
129798646|NCT00249288|467232117|FG000|Overall Study|Withdrawal by Subject|2|||
129798647|NCT00249288|467232118|FG001|Overall Study|Withdrawal by Subject|2|||
129798648|NCT03059446|467232119|FG000|Overall Study|Adverse Event|11|||
129889720|NCT02325713|467552700|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
130049999|NCT01781429|468140733|FG012|Overall Study|Unacceptable Toxicity|0|||
129798649|NCT03059446|467232119|FG000|Overall Study|Withdrawal of Consent|16|||
129798650|NCT03059446|467232119|FG000|Overall Study|Lost to Follow-up|3|||
130050000|NCT01781429|468140734|FG013|Overall Study|Unacceptable Toxicity|0|||
130310408|NCT02714569|469100704|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310409|NCT02714569|469100705|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
130310410|NCT02714569|469100695|FG000|Part A Third Intervention|Adverse Event|0|||
130310411|NCT02714569|469100696|FG001|Part A Third Intervention|Adverse Event|0|||
130310412|NCT02714569|469100697|FG002|Part A Third Intervention|Adverse Event|1|||
130310413|NCT02714569|469100698|FG003|Part A Third Intervention|Adverse Event|0|||
130310414|NCT02714569|469100699|FG004|Part A Third Intervention|Adverse Event|0|||
130310415|NCT02714569|469100700|FG005|Part A Third Intervention|Adverse Event|0|||
130310416|NCT02714569|469100701|FG006|Part A Third Intervention|Adverse Event|0|||
130310417|NCT02714569|469100702|FG007|Part A Third Intervention|Adverse Event|0|||
130310418|NCT02714569|469100703|FG008|Part A Third Intervention|Adverse Event|0|||
130310419|NCT02714569|469100704|FG009|Part A Third Intervention|Adverse Event|0|||
130310420|NCT02714569|469100705|FG010|Part A Third Intervention|Adverse Event|0|||
130310421|NCT02714569|469100695|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
130310422|NCT02714569|469100696|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310423|NCT02714569|469100697|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310424|NCT02714569|469100698|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310425|NCT02714569|469100699|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310426|NCT02714569|469100700|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
130310427|NCT02714569|469100701|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310428|NCT02714569|469100702|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310429|NCT02714569|469100703|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310430|NCT02714569|469100704|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310431|NCT02714569|469100705|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
130310432|NCT02714569|469100695|FG000|Part B (Overall)|Lost to Follow-up|0|||
130310433|NCT02714569|469100696|FG001|Part B (Overall)|Lost to Follow-up|0|||
130310434|NCT02714569|469100697|FG002|Part B (Overall)|Lost to Follow-up|0|||
130310435|NCT02714569|469100698|FG003|Part B (Overall)|Lost to Follow-up|0|||
130310436|NCT02714569|469100699|FG004|Part B (Overall)|Lost to Follow-up|0|||
130310437|NCT02714569|469100700|FG005|Part B (Overall)|Lost to Follow-up|0|||
130310438|NCT02714569|469100701|FG006|Part B (Overall)|Lost to Follow-up|1|||
130310439|NCT02714569|469100702|FG007|Part B (Overall)|Lost to Follow-up|0|||
130310440|NCT02714569|469100703|FG008|Part B (Overall)|Lost to Follow-up|0|||
130310441|NCT02714569|469100704|FG009|Part B (Overall)|Lost to Follow-up|0|||
130310442|NCT02714569|469100705|FG010|Part B (Overall)|Lost to Follow-up|0|||
130310443|NCT02714569|469100695|FG000|Part B (Overall)|Withdrawal by Subject|0|||
130310444|NCT02714569|469100696|FG001|Part B (Overall)|Withdrawal by Subject|0|||
130310445|NCT02714569|469100697|FG002|Part B (Overall)|Withdrawal by Subject|0|||
130310446|NCT02714569|469100698|FG003|Part B (Overall)|Withdrawal by Subject|0|||
130310447|NCT02714569|469100699|FG004|Part B (Overall)|Withdrawal by Subject|0|||
130310448|NCT02714569|469100700|FG005|Part B (Overall)|Withdrawal by Subject|0|||
130310449|NCT02714569|469100701|FG006|Part B (Overall)|Withdrawal by Subject|0|||
130310450|NCT02714569|469100702|FG007|Part B (Overall)|Withdrawal by Subject|1|||
130310451|NCT02714569|469100703|FG008|Part B (Overall)|Withdrawal by Subject|0|||
130310452|NCT02714569|469100704|FG009|Part B (Overall)|Withdrawal by Subject|1|||
130310453|NCT02714569|469100705|FG010|Part B (Overall)|Withdrawal by Subject|0|||
130310454|NCT02714569|469100695|FG000|Part B (Overall)|Adverse Event|0|||
130310455|NCT02714569|469100696|FG001|Part B (Overall)|Adverse Event|0|||
130310456|NCT02714569|469100697|FG002|Part B (Overall)|Adverse Event|0|||
130310457|NCT02714569|469100698|FG003|Part B (Overall)|Adverse Event|0|||
130310458|NCT02714569|469100699|FG004|Part B (Overall)|Adverse Event|0|||
130310459|NCT02714569|469100700|FG005|Part B (Overall)|Adverse Event|0|||
130310460|NCT02714569|469100701|FG006|Part B (Overall)|Adverse Event|0|||
130310461|NCT02714569|469100702|FG007|Part B (Overall)|Adverse Event|0|||
130310462|NCT02714569|469100703|FG008|Part B (Overall)|Adverse Event|0|||
130310463|NCT02714569|469100704|FG009|Part B (Overall)|Adverse Event|1|||
130310464|NCT02714569|469100705|FG010|Part B (Overall)|Adverse Event|0|||
130310465|NCT00191308|469100706|FG000|Overall Study|Adverse Event|1|||
130310466|NCT01843023|469100707|FG000|Overall Study|Death|1|||
130310467|NCT01843023|469100708|FG001|Overall Study|Death|0|||
130310468|NCT01843023|469100707|FG000|Overall Study|Lost to Follow-up|24|||
130310469|NCT01843023|469100708|FG001|Overall Study|Lost to Follow-up|29|||
130310470|NCT01843023|469100707|FG000|Overall Study|Withdrawal by Subject|8|||
130310471|NCT01843023|469100708|FG001|Overall Study|Withdrawal by Subject|6|||
130310472|NCT00779025|469100709|FG000|Overall Study|Withdrawal by Subject|1|||
130310473|NCT03305770|469100710|FG000|Overall Study|Physician Decision - prior to dispense|0|||
130310474|NCT03305770|469100711|FG001|Overall Study|Physician Decision - prior to dispense|1|||
130310475|NCT03305770|469100710|FG000|Overall Study|Subject moved|1|||
130310476|NCT03305770|469100711|FG001|Overall Study|Subject moved|0|||
129798651|NCT03059446|467232119|FG000|Overall Study|Protocol Violation|1|||
129798652|NCT03059446|467232119|FG000|Overall Study|Study Terminated by Sponsor|131|||
129798653|NCT03059446|467232119|FG000|Overall Study|Reason not Specified|5|||
129798654|NCT02273739|467232120|FG000|Overall Study|Progression of Disease|3|||
130310477|NCT03472326|469100714|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
130310478|NCT03472326|469100715|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
130310479|NCT03472326|469100716|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
130310480|NCT03472326|469100717|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
130310481|NCT03472326|469100714|FG000|Part 2: Combination Therapy|Pregnancy|0|||
130310482|NCT03472326|469100715|FG001|Part 2: Combination Therapy|Pregnancy|0|||
130310483|NCT03472326|469100716|FG002|Part 2: Combination Therapy|Pregnancy|0|||
130310484|NCT03472326|469100717|FG003|Part 2: Combination Therapy|Pregnancy|1|||
130310485|NCT00700713|469100718|FG000|Overall Study|Protocol Violation|1|||
130310486|NCT00700713|469100719|FG001|Overall Study|Protocol Violation|0|||
130310487|NCT00700713|469100720|FG002|Overall Study|Protocol Violation|1|||
130310488|NCT00700713|469100718|FG000|Overall Study|Withdrawal by Subject|0|||
130310489|NCT00700713|469100719|FG001|Overall Study|Withdrawal by Subject|0|||
130310490|NCT00700713|469100720|FG002|Overall Study|Withdrawal by Subject|1|||
130310491|NCT04980612|469100721|FG000|Overall Study|Withdrawal by Subject|7|||
130310492|NCT04980612|469100722|FG001|Overall Study|Withdrawal by Subject|5|||
130310493|NCT02446717|469100723|FG000|Overall Study|Adverse Event|0|||
130310494|NCT02446717|469100724|FG001|Overall Study|Adverse Event|0|||
130310495|NCT02446717|469100725|FG002|Overall Study|Adverse Event|1|||
130310496|NCT02446717|469100726|FG003|Overall Study|Adverse Event|0|||
130310497|NCT02446717|469100727|FG004|Overall Study|Adverse Event|0|||
130310498|NCT02446717|469100723|FG000|Overall Study|Lost to Follow-up|0|||
130310499|NCT02446717|469100724|FG001|Overall Study|Lost to Follow-up|1|||
130310500|NCT02446717|469100725|FG002|Overall Study|Lost to Follow-up|1|||
130310501|NCT02446717|469100726|FG003|Overall Study|Lost to Follow-up|0|||
130310502|NCT02446717|469100727|FG004|Overall Study|Lost to Follow-up|1|||
130310503|NCT02446717|469100723|FG000|Overall Study|Withdrew consent|0|||
129798655|NCT02273739|467232121|FG001|Overall Study|Progression of Disease|4|||
129798656|NCT02273739|467232122|FG002|Overall Study|Progression of Disease|5|||
129798657|NCT02273739|467232123|FG003|Overall Study|Progression of Disease|2|||
129798658|NCT02273739|467232120|FG000|Overall Study|Death|0|||
129798659|NCT02273739|467232121|FG001|Overall Study|Death|0|||
129798660|NCT02273739|467232122|FG002|Overall Study|Death|0|||
129798661|NCT02273739|467232123|FG003|Overall Study|Death|2|||
129798662|NCT02273739|467232120|FG000|Overall Study|Adverse Event|0|||
129798663|NCT02273739|467232121|FG001|Overall Study|Adverse Event|0|||
129798664|NCT02273739|467232122|FG002|Overall Study|Adverse Event|0|||
129798665|NCT02273739|467232123|FG003|Overall Study|Adverse Event|1|||
129798666|NCT02273739|467232120|FG000|Overall Study|Withdrawal by Subject|0|||
129798667|NCT02273739|467232121|FG001|Overall Study|Withdrawal by Subject|0|||
129798668|NCT02273739|467232122|FG002|Overall Study|Withdrawal by Subject|2|||
129798669|NCT02273739|467232123|FG003|Overall Study|Withdrawal by Subject|1|||
129798670|NCT02273739|467232120|FG000|Overall Study|Physician Decision|0|||
129798671|NCT02273739|467232121|FG001|Overall Study|Physician Decision|0|||
129798672|NCT02273739|467232122|FG002|Overall Study|Physician Decision|0|||
129798673|NCT02273739|467232123|FG003|Overall Study|Physician Decision|1|||
129798674|NCT04795622|467232124|FG000|Overall Study|Adverse Event|1|||
129798675|NCT04795622|467232125|FG001|Overall Study|Adverse Event|0|||
129798676|NCT04795622|467232124|FG000|Overall Study|Withdrawal by Subject|3|||
129798677|NCT04795622|467232125|FG001|Overall Study|Withdrawal by Subject|3|||
129798678|NCT04795622|467232124|FG000|Overall Study|Protocol Violation|0|||
129798679|NCT04795622|467232125|FG001|Overall Study|Protocol Violation|2|||
129798680|NCT04795622|467232124|FG000|Overall Study|Lost to Follow-up|2|||
129798681|NCT04795622|467232125|FG001|Overall Study|Lost to Follow-up|3|||
129798682|NCT04795622|467232124|FG000|Overall Study|Other|7|||
129798683|NCT04795622|467232125|FG001|Overall Study|Other|8|||
129798684|NCT02536833|467232129|FG000|Overall Study|Discontinued Before Treatment|0|||
129798685|NCT02536833|467232130|FG001|Overall Study|Discontinued Before Treatment|0|||
129798686|NCT02536833|467232131|FG002|Overall Study|Discontinued Before Treatment|1|||
129798687|NCT02536833|467232132|FG003|Overall Study|Discontinued Before Treatment|2|||
129798688|NCT02536833|467232129|FG000|Overall Study|Adverse Event|1|||
129798689|NCT02536833|467232130|FG001|Overall Study|Adverse Event|3|||
129798690|NCT02536833|467232131|FG002|Overall Study|Adverse Event|4|||
129798691|NCT02536833|467232132|FG003|Overall Study|Adverse Event|1|||
129798692|NCT02536833|467232129|FG000|Overall Study|Lost to Follow-up|2|||
129798693|NCT02536833|467232130|FG001|Overall Study|Lost to Follow-up|1|||
129798694|NCT02536833|467232131|FG002|Overall Study|Lost to Follow-up|2|||
129798695|NCT02536833|467232132|FG003|Overall Study|Lost to Follow-up|2|||
129798696|NCT02536833|467232129|FG000|Overall Study|Physician Decision|0|||
129798697|NCT02536833|467232130|FG001|Overall Study|Physician Decision|0|||
129798698|NCT02536833|467232131|FG002|Overall Study|Physician Decision|0|||
129798699|NCT02536833|467232132|FG003|Overall Study|Physician Decision|1|||
129798700|NCT02536833|467232129|FG000|Overall Study|Site Terminated by Sponsor|2|||
129798701|NCT02536833|467232130|FG001|Overall Study|Site Terminated by Sponsor|2|||
129798702|NCT02536833|467232131|FG002|Overall Study|Site Terminated by Sponsor|2|||
129798703|NCT02536833|467232132|FG003|Overall Study|Site Terminated by Sponsor|2|||
130310504|NCT02446717|469100724|FG001|Overall Study|Withdrew consent|0|||
129798704|NCT02536833|467232129|FG000|Overall Study|Subject Non-Compliance|0|||
129798705|NCT02536833|467232130|FG001|Overall Study|Subject Non-Compliance|1|||
129798706|NCT02536833|467232131|FG002|Overall Study|Subject Non-Compliance|1|||
129798707|NCT02536833|467232132|FG003|Overall Study|Subject Non-Compliance|0|||
129798708|NCT02536833|467232129|FG000|Overall Study|Withdrawal by Subject|4|||
130310505|NCT02446717|469100725|FG002|Overall Study|Withdrew consent|0|||
130310506|NCT02446717|469100726|FG003|Overall Study|Withdrew consent|1|||
130310507|NCT02446717|469100727|FG004|Overall Study|Withdrew consent|0|||
130310508|NCT02680665|469100728|FG000|Overall Study|No visit after the first prescription|5|||
130310509|NCT01327599|469100729|FG000|Overall Study|Adverse Event|1|||
130310510|NCT01327599|469100729|FG000|Overall Study|Could Not Attend Visit|1|||
130310511|NCT01327599|469100729|FG000|Overall Study|Withdrawal of Consent|1|||
130310512|NCT02715609|469100731|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
130310513|NCT02715609|469100732|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
130310514|NCT02715609|469100733|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
130310515|NCT02715609|469100731|FG000|Overall Study|Withdrawal by Subject|0|||
130310516|NCT02715609|469100732|FG001|Overall Study|Withdrawal by Subject|0|||
130310517|NCT02715609|469100733|FG002|Overall Study|Withdrawal by Subject|1|||
130310518|NCT05907395|469100736|FG000|Period 1|No longer met eligibility criteria|0|||
130310519|NCT05907395|469100737|FG001|Period 1|No longer met eligibility criteria|1|||
130310520|NCT05907395|469100738|FG002|Period 1|No longer met eligibility criteria|0|||
130310521|NCT05907395|469100739|FG003|Period 1|No longer met eligibility criteria|0|||
130310522|NCT05907395|469100740|FG004|Period 1|No longer met eligibility criteria|0|||
130310523|NCT05907395|469100741|FG005|Period 1|No longer met eligibility criteria|1|||
130310524|NCT05907395|469100742|FG006|Period 1|No longer met eligibility criteria|1|||
130310525|NCT05907395|469100743|FG007|Period 1|No longer met eligibility criteria|0|||
130310526|NCT05907395|469100744|FG008|Period 1|No longer met eligibility criteria|0|||
130310527|NCT05907395|469100745|FG009|Period 1|No longer met eligibility criteria|0|||
130310528|NCT05907395|469100746|FG010|Period 1|No longer met eligibility criteria|0|||
130310529|NCT05907395|469100747|FG011|Period 1|No longer met eligibility criteria|0|||
130310530|NCT05907395|469100736|FG000|Period 2|Adverse Event|0|||
130310531|NCT05907395|469100737|FG001|Period 2|Adverse Event|0|||
130310532|NCT05907395|469100738|FG002|Period 2|Adverse Event|0|||
130310533|NCT05907395|469100739|FG003|Period 2|Adverse Event|1|||
130310534|NCT05907395|469100740|FG004|Period 2|Adverse Event|0|||
130310535|NCT05907395|469100741|FG005|Period 2|Adverse Event|0|||
130310536|NCT05907395|469100742|FG006|Period 2|Adverse Event|0|||
130310537|NCT05907395|469100743|FG007|Period 2|Adverse Event|1|||
130310538|NCT05907395|469100744|FG008|Period 2|Adverse Event|0|||
130310539|NCT05907395|469100745|FG009|Period 2|Adverse Event|0|||
130310540|NCT05907395|469100746|FG010|Period 2|Adverse Event|0|||
130310541|NCT05907395|469100747|FG011|Period 2|Adverse Event|0|||
130310542|NCT05907395|469100736|FG000|Period 2|Personal reason|0|||
130310543|NCT05907395|469100737|FG001|Period 2|Personal reason|0|||
130310544|NCT05907395|469100738|FG002|Period 2|Personal reason|0|||
130310545|NCT05907395|469100739|FG003|Period 2|Personal reason|0|||
130310546|NCT05907395|469100740|FG004|Period 2|Personal reason|0|||
130310547|NCT05907395|469100741|FG005|Period 2|Personal reason|0|||
130310548|NCT05907395|469100742|FG006|Period 2|Personal reason|0|||
130310549|NCT05907395|469100743|FG007|Period 2|Personal reason|0|||
130310550|NCT05907395|469100744|FG008|Period 2|Personal reason|0|||
130310551|NCT05907395|469100745|FG009|Period 2|Personal reason|1|||
130310552|NCT05907395|469100746|FG010|Period 2|Personal reason|0|||
130310553|NCT05907395|469100747|FG011|Period 2|Personal reason|0|||
130310554|NCT05907395|469100736|FG000|Period 3|Adverse Event|0|||
130310555|NCT05907395|469100737|FG001|Period 3|Adverse Event|0|||
130310556|NCT05907395|469100738|FG002|Period 3|Adverse Event|0|||
130310557|NCT05907395|469100739|FG003|Period 3|Adverse Event|0|||
130310558|NCT05907395|469100740|FG004|Period 3|Adverse Event|1|||
130310559|NCT05907395|469100741|FG005|Period 3|Adverse Event|0|||
130310560|NCT05907395|469100742|FG006|Period 3|Adverse Event|0|||
130310561|NCT05907395|469100743|FG007|Period 3|Adverse Event|0|||
130310562|NCT05907395|469100744|FG008|Period 3|Adverse Event|0|||
129798709|NCT02536833|467232130|FG001|Overall Study|Withdrawal by Subject|3|||
129798710|NCT02536833|467232131|FG002|Overall Study|Withdrawal by Subject|5|||
129798711|NCT02536833|467232132|FG003|Overall Study|Withdrawal by Subject|11|||
129798712|NCT03309046|467232133|FG000|Overall Study|Withdrawal by Subject|4|||
129798713|NCT03309046|467232134|FG001|Overall Study|Withdrawal by Subject|17|||
130310563|NCT05907395|469100745|FG009|Period 3|Adverse Event|0|||
130310564|NCT05907395|469100746|FG010|Period 3|Adverse Event|0|||
130310565|NCT05907395|469100747|FG011|Period 3|Adverse Event|0|||
130310566|NCT04544956|469100748|FG000|Overall Study|Withdrawal by Subject|1|||
130310567|NCT00434109|469100749|FG000|Overall Study|Physician Decision|9|||
130310568|NCT00434109|469100749|FG000|Overall Study|Adverse Event|5|||
130310569|NCT00434109|469100749|FG000|Overall Study|Protocol Violation|1|||
130310570|NCT00434109|469100749|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
130310571|NCT01797263|469102930|FG000|Overall Study|Withdrawal by Subject|21|||
130310572|NCT01797263|469102931|FG001|Overall Study|Withdrawal by Subject|25|||
130310573|NCT01797263|469102930|FG000|Overall Study|Death|1|||
130310574|NCT01797263|469102931|FG001|Overall Study|Death|0|||
130310575|NCT01797263|469102930|FG000|Overall Study|Lost to Follow-up|15|||
129889721|NCT02684903|467552701|FG000|Overall Study|COVID-19 shutdown of lab|4|||
129889722|NCT02684903|467552702|FG001|Overall Study|COVID-19 shutdown of lab|6|||
129889723|NCT02684903|467552701|FG000|Overall Study|Lost to Follow-up|31|||
129889724|NCT02684903|467552702|FG001|Overall Study|Lost to Follow-up|41|||
129889725|NCT00322868|467554472|FG000|Overall Study|disease progression|1|||
129889726|NCT02176928|467554473|FG000|Overall Study|Lost to Follow-up|2|||
129889727|NCT02176928|467554474|FG001|Overall Study|Lost to Follow-up|4|||
129889728|NCT01440049|467554478|FG000|Overall Study|Adverse Event|5|||
129889729|NCT03415022|467554480|FG000|Overall Study|Withdrawal by Subject|1|||
129889730|NCT03415022|467554481|FG001|Overall Study|Withdrawal by Subject|2|||
129889731|NCT03415022|467554480|FG000|Overall Study|COVID-19 Suspension|2|||
129889732|NCT03415022|467554481|FG001|Overall Study|COVID-19 Suspension|3|||
129889733|NCT03415022|467554480|FG000|Overall Study|Lost to Follow-up|2|||
129889734|NCT03415022|467554481|FG001|Overall Study|Lost to Follow-up|0|||
129889735|NCT04466618|467554482|FG000|Overall Study|Withdrawal by Subject|0|||
129889736|NCT04466618|467554483|FG001|Overall Study|Withdrawal by Subject|1|||
129889737|NCT00884286|467554488|FG000|Overall Study|Progressive disease|21|||
129889738|NCT00884286|467554489|FG001|Overall Study|Progressive disease|28|||
129889739|NCT00884286|467554488|FG000|Overall Study|Toxicity|4|||
129889740|NCT00884286|467554489|FG001|Overall Study|Toxicity|1|||
129889741|NCT00884286|467554488|FG000|Overall Study|Death|2|||
129889742|NCT00884286|467554489|FG001|Overall Study|Death|2|||
129889743|NCT00884286|467554488|FG000|Overall Study|Physician Decision|1|||
129889744|NCT00884286|467554489|FG001|Overall Study|Physician Decision|0|||
129889745|NCT00884286|467554488|FG000|Overall Study|Septic shock|1|||
129889746|NCT00884286|467554489|FG001|Overall Study|Septic shock|0|||
129889747|NCT00884286|467554488|FG000|Overall Study|Thrombus in right auricle|1|||
129798714|NCT02764190|467232136|FG000|Overall Study|Lost to Follow-up|17|||
129798715|NCT02764190|467232137|FG001|Overall Study|Lost to Follow-up|13|||
129798716|NCT00089674|467232138|FG000|Overall Study|Physician Decision|4|||
129798717|NCT00089674|467232139|FG001|Overall Study|Physician Decision|2|||
129798718|NCT00089674|467232138|FG000|Overall Study|Adverse Event|23|||
129798719|NCT00089674|467232139|FG001|Overall Study|Adverse Event|29|||
129798720|NCT00089674|467232138|FG000|Overall Study|Withdrawal by Subject|143|||
129798721|NCT00089674|467232139|FG001|Overall Study|Withdrawal by Subject|127|||
129798722|NCT00089674|467232138|FG000|Overall Study|Death|43|||
129798723|NCT00089674|467232139|FG001|Overall Study|Death|43|||
129889748|NCT00884286|467554489|FG001|Overall Study|Thrombus in right auricle|0|||
129889749|NCT00884286|467554488|FG000|Overall Study|Not treated|2|||
129889750|NCT00884286|467554489|FG001|Overall Study|Not treated|1|||
129889751|NCT00884286|467554488|FG000|Overall Study|Comprised lung carcinoma|0|||
129889752|NCT00884286|467554489|FG001|Overall Study|Comprised lung carcinoma|1|||
129889753|NCT01720797|467554490|FG000|Overall Study|Withdrawal by Subject|3|||
129889754|NCT01720797|467554491|FG001|Overall Study|Withdrawal by Subject|0|||
129889755|NCT00661258|467554504|FG000|Overall Study|Death|1|||
129889756|NCT00661258|467554505|FG001|Overall Study|Death|0|||
129889757|NCT00661258|467554504|FG000|Overall Study|caught by police and in detox center|2|||
129889758|NCT00661258|467554505|FG001|Overall Study|caught by police and in detox center|1|||
129889759|NCT01628874|467554506|FG000|Overall Study|Physician Decision|1|||
129889760|NCT01628874|467554507|FG001|Overall Study|Physician Decision|1|||
129889761|NCT01628874|467554506|FG000|Overall Study|Age >4 months|4|||
129889762|NCT01628874|467554507|FG001|Overall Study|Age >4 months|2|||
129889763|NCT03541642|467554508|FG000|Overall Study|Withdrawal by Subject|1|||
129889764|NCT03541642|467554509|FG001|Overall Study|Withdrawal by Subject|2|||
130110605|NCT03276962|468365789|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
130310576|NCT01797263|469102931|FG001|Overall Study|Lost to Follow-up|15|||
130310577|NCT01172535|469102932|FG000|Overall Study|Death|3|||
130310578|NCT01172535|469102932|FG000|Overall Study|Withdrawal by Subject|2|||
130310579|NCT01172535|469102932|FG000|Overall Study|Lost to Follow-up|1|||
129798724|NCT00089674|467232138|FG000|Overall Study|Disease progression|21|||
130310580|NCT01172535|469102932|FG000|Overall Study|Ineligible at study entry|1|||
130310581|NCT01172535|469102932|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130310582|NCT00988598|469102933|FG000|Overall Study|Withdrawal by Subject|2|||
130310583|NCT00988598|469102934|FG001|Overall Study|Withdrawal by Subject|0|||
130310584|NCT01450761|469102939|FG000|Randomization|Subject no longer meets study criteria|1|||
129798725|NCT00089674|467232139|FG001|Overall Study|Disease progression|23|||
129889765|NCT03541642|467554508|FG000|Overall Study|Lost to Follow-up|16|||
129889766|NCT03541642|467554509|FG001|Overall Study|Lost to Follow-up|12|||
129889767|NCT03541642|467554508|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
129889768|NCT03541642|467554509|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
129889769|NCT01083160|467554514|FG000|Overall Study|Adverse Event|1|||
129889770|NCT00918749|467554517|FG000|Overall Study|Adverse Event|1|||
129889771|NCT00918749|467554518|FG001|Overall Study|Adverse Event|0|||
129798726|NCT00089674|467232138|FG000|Overall Study|Ineligibility determined|8|||
129798727|NCT00089674|467232139|FG001|Overall Study|Ineligibility determined|10|||
129889772|NCT00918749|467554519|FG002|Overall Study|Adverse Event|1|||
129889773|NCT00918749|467554517|FG000|Overall Study|Lost to Follow-up|0|||
129889774|NCT00918749|467554518|FG001|Overall Study|Lost to Follow-up|0|||
130310585|NCT01450761|469102940|FG001|Randomization|Subject no longer meets study criteria|2|||
130310586|NCT01450761|469102939|FG000|Randomization|Withdrawal by Subject|2|||
130310587|NCT01450761|469102940|FG001|Randomization|Withdrawal by Subject|0|||
130310588|NCT01450761|469102939|FG000|Randomization|Disease progression|0|||
130310589|NCT01450761|469102940|FG001|Randomization|Disease progression|2|||
130310590|NCT01450761|469102939|FG000|Randomization|Adverse Event unrelated to study drug|1|||
130310591|NCT01450761|469102940|FG001|Randomization|Adverse Event unrelated to study drug|0|||
130310592|NCT01450761|469102939|FG000|Randomization|Other|0|||
130310593|NCT01450761|469102940|FG001|Randomization|Other|1|||
130310594|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Disease progression|33|||
130310595|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Disease progression|32|||
130310596|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
130310597|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
130310598|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
130310599|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
130310600|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
130310601|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
130310602|NCT01450761|469102939|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
130310603|NCT01450761|469102940|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
130310604|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Death|3|||
130310605|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Death|3|||
130310606|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Other|2|||
130310607|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Other|2|||
130310608|NCT01450761|469102939|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
130310609|NCT01450761|469102940|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
130310610|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
130310611|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
130310612|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
130310613|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
130310614|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
130310615|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
130310616|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
130310617|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
130310618|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
130310619|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
130310620|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Death|5|||
130310621|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Death|6|||
130310622|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
130310623|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
130310624|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
130310625|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
130310626|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
130310627|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
130310628|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
130310629|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
130310630|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
130310631|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
130310632|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
130310633|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
130310634|NCT01450761|469102939|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
130310635|NCT01450761|469102940|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
130310636|NCT01818596|469102951|FG000|Overall Study|Enrolled but Not Treated|4|||
130310637|NCT01818596|469102952|FG001|Overall Study|Enrolled but Not Treated|0|||
130310638|NCT01818596|469102951|FG000|Overall Study|Adverse Event|7|||
130310639|NCT01818596|469102952|FG001|Overall Study|Adverse Event|0|||
130310640|NCT01818596|469102951|FG000|Overall Study|Death|3|||
130310641|NCT01818596|469102952|FG001|Overall Study|Death|0|||
130310642|NCT01818596|469102951|FG000|Overall Study|Investigator's Discretion|4|||
130310643|NCT01818596|469102952|FG001|Overall Study|Investigator's Discretion|0|||
130310644|NCT01818596|469102951|FG000|Overall Study|Protocol Violation|1|||
130310645|NCT01818596|469102952|FG001|Overall Study|Protocol Violation|0|||
130310646|NCT01818596|469102951|FG000|Overall Study|Withdrew Consent|5|||
130310647|NCT01818596|469102952|FG001|Overall Study|Withdrew Consent|0|||
130310648|NCT01818596|469102951|FG000|Overall Study|Lost to Follow-up|7|||
130310649|NCT01818596|469102952|FG001|Overall Study|Lost to Follow-up|0|||
130310650|NCT03801174|469102955|FG000|Overall Study|Withdrawal by Subject|14|||
130310651|NCT03801174|469102956|FG001|Overall Study|Withdrawal by Subject|15|||
130310652|NCT03801174|469102955|FG000|Overall Study|Death|1|||
130310653|NCT03801174|469102956|FG001|Overall Study|Death|0|||
130310654|NCT03801174|469102955|FG000|Overall Study|Pregnancy|2|||
130310655|NCT03801174|469102956|FG001|Overall Study|Pregnancy|2|||
130050001|NCT01781429|468140735|FG014|Overall Study|Unacceptable Toxicity|0|||
130310656|NCT03801174|469102955|FG000|Overall Study|Lost to Follow-up|19|||
130310657|NCT03801174|469102956|FG001|Overall Study|Lost to Follow-up|10|||
130310658|NCT03801174|469102955|FG000|Overall Study|Other|4|||
130310659|NCT03801174|469102956|FG001|Overall Study|Other|3|||
130310660|NCT03801174|469102955|FG000|Overall Study|Lack of Efficacy|4|||
130310661|NCT03801174|469102956|FG001|Overall Study|Lack of Efficacy|0|||
130310662|NCT03801174|469102955|FG000|Overall Study|Unwilling to complete activities|5|||
130310663|NCT03801174|469102956|FG001|Overall Study|Unwilling to complete activities|6|||
130310664|NCT03801174|469102955|FG000|Overall Study|Moved out of area|3|||
130310665|NCT03801174|469102956|FG001|Overall Study|Moved out of area|0|||
130310666|NCT00337207|469102959|FG000|Overall Study|Withdrawal by Subject|3|||
130310667|NCT00837213|469102969|FG000|Overall Study|Lost to Follow-up|3|||
130310668|NCT00837213|469102970|FG001|Overall Study|Lost to Follow-up|2|||
130310669|NCT00837213|469102969|FG000|Overall Study|Withdrawal by Subject|2|||
130310670|NCT00837213|469102970|FG001|Overall Study|Withdrawal by Subject|2|||
130310671|NCT00837213|469102969|FG000|Overall Study|not stated|1|||
130310672|NCT00837213|469102970|FG001|Overall Study|not stated|1|||
130310673|NCT02698826|469102972|FG000|Overall Study|Death|13|||
130310674|NCT02698826|469102972|FG000|Overall Study|Adverse Event|1|||
130310675|NCT02915263|469102973|FG000|Overall Study|Covid|3|||
130310676|NCT02915263|469102974|FG001|Overall Study|Covid|2|||
130310677|NCT01879683|469102978|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
130310678|NCT04317040|469102979|FG000|Overall Study|Lost to Follow-up|2|||
130310679|NCT04317040|469102980|FG001|Overall Study|Lost to Follow-up|0|||
130310680|NCT04317040|469102979|FG000|Overall Study|Death|16|||
130310681|NCT04317040|469102980|FG001|Overall Study|Death|18|||
130310682|NCT04317040|469102979|FG000|Overall Study|Withdrawal by Subject|0|||
130310683|NCT04317040|469102980|FG001|Overall Study|Withdrawal by Subject|1|||
130310684|NCT04317040|469102979|FG000|Overall Study|Incomplete assessments|0|||
130310685|NCT04317040|469102980|FG001|Overall Study|Incomplete assessments|1|||
130310686|NCT01177007|469102983|FG000|Overall Study|Lost to Follow-up|2|||
130310687|NCT01177007|469102983|FG000|Overall Study|Death|4|||
130310688|NCT01177007|469102983|FG000|Overall Study|Entered hospice care|5|||
130310689|NCT01177007|469102983|FG000|Overall Study|Required additional Y90 treatment|6|||
130310690|NCT01177007|469102983|FG000|Overall Study|Change in treatment modality|21|||
130310691|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Progressive disease|50|||
130310692|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Progressive disease|110|||
130310693|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Progressive disease|0|||
130310694|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Progressive disease|0|||
130310695|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
130310696|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
130310697|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130310698|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130310699|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Adverse Event|7|||
130310700|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Adverse Event|7|||
130310701|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Adverse Event|0|||
130310702|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Adverse Event|0|||
130310703|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Other|1|||
130310704|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Other|3|||
130310705|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Other|0|||
130050002|NCT01781429|468140736|FG015|Overall Study|Unacceptable Toxicity|0|||
129889775|NCT00918749|467554519|FG002|Overall Study|Lost to Follow-up|1|||
129889776|NCT00918749|467554517|FG000|Overall Study|Withdrawal by Subject|5|||
129889777|NCT00918749|467554518|FG001|Overall Study|Withdrawal by Subject|3|||
129889778|NCT00918749|467554519|FG002|Overall Study|Withdrawal by Subject|5|||
129889779|NCT00918749|467554517|FG000|Overall Study|No Study Medication Taken|1|||
129889780|NCT00918749|467554518|FG001|Overall Study|No Study Medication Taken|0|||
129889781|NCT00918749|467554519|FG002|Overall Study|No Study Medication Taken|0|||
129889782|NCT01951092|467554520|FG000|Overall Study|Lost to Follow-up|10|||
129889783|NCT01951092|467554520|FG000|Overall Study|Incarceration|1|||
129889784|NCT01951092|467554520|FG000|Overall Study|Transfer of Care|1|||
129889785|NCT01712789|467554521|FG000|Overall Study|Lack of Efficacy|2|||
129889786|NCT01712789|467554521|FG000|Overall Study|Lost to Follow-up|1|||
129889787|NCT01712789|467554521|FG000|Overall Study|Progressive Disease|504|||
129889788|NCT01712789|467554521|FG000|Overall Study|Death|57|||
129889789|NCT01712789|467554521|FG000|Overall Study|Adverse Event|52|||
129889790|NCT01712789|467554521|FG000|Overall Study|Miscellaneous|31|||
129889791|NCT01712789|467554521|FG000|Overall Study|Withdrawal by Subject|21|||
129889792|NCT01712789|467554521|FG000|Overall Study|Transition to Commercial Treatment|8|||
129889793|NCT01712789|467554521|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
129889794|NCT01708187|467554522|FG000|Overall Study|Lost to Follow-up|0|||
129889795|NCT01708187|467554523|FG001|Overall Study|Lost to Follow-up|1|||
129889796|NCT00873093|467554524|FG000|Overall Study|Adverse Event|0|||
129889797|NCT00873093|467554525|FG001|Overall Study|Adverse Event|2|||
129889798|NCT00873093|467554526|FG002|Overall Study|Adverse Event|0|||
129889799|NCT00873093|467554527|FG003|Overall Study|Adverse Event|0|||
129889800|NCT00873093|467554528|FG004|Overall Study|Adverse Event|0|||
129889801|NCT00873093|467554524|FG000|Overall Study|Death|0|||
129889802|NCT00873093|467554525|FG001|Overall Study|Death|3|||
129889803|NCT00873093|467554526|FG002|Overall Study|Death|2|||
129889804|NCT00873093|467554527|FG003|Overall Study|Death|0|||
129889805|NCT00873093|467554528|FG004|Overall Study|Death|0|||
129889806|NCT00873093|467554524|FG000|Overall Study|Physician Decision|0|||
129889807|NCT00873093|467554525|FG001|Overall Study|Physician Decision|17|||
129889808|NCT00873093|467554526|FG002|Overall Study|Physician Decision|10|||
129889809|NCT00873093|467554527|FG003|Overall Study|Physician Decision|10|||
129889810|NCT00873093|467554528|FG004|Overall Study|Physician Decision|2|||
129889811|NCT00873093|467554524|FG000|Overall Study|Withdrawal by Subject|1|||
129889812|NCT00873093|467554525|FG001|Overall Study|Withdrawal by Subject|4|||
129889813|NCT00873093|467554526|FG002|Overall Study|Withdrawal by Subject|4|||
129889814|NCT00873093|467554527|FG003|Overall Study|Withdrawal by Subject|0|||
129889815|NCT00873093|467554528|FG004|Overall Study|Withdrawal by Subject|0|||
129889816|NCT00873093|467554524|FG000|Overall Study|Ineligible|0|||
129889817|NCT00873093|467554525|FG001|Overall Study|Ineligible|1|||
129889818|NCT00873093|467554526|FG002|Overall Study|Ineligible|0|||
129889819|NCT00873093|467554527|FG003|Overall Study|Ineligible|1|||
129889820|NCT00873093|467554528|FG004|Overall Study|Ineligible|0|||
129889821|NCT00136916|467554530|FG000|Overall Study|Never received study treatment|3|||
129889822|NCT00136916|467554531|FG001|Overall Study|Never received study treatment|5|||
129889823|NCT00136916|467554530|FG000|Overall Study|Death|1|||
129889824|NCT00136916|467554531|FG001|Overall Study|Death|3|||
129889825|NCT00136916|467554530|FG000|Overall Study|Adverse Event|27|||
129889826|NCT00136916|467554531|FG001|Overall Study|Adverse Event|8|||
129889827|NCT00136916|467554530|FG000|Overall Study|Laboratory abnormality|0|||
129889828|NCT00136916|467554531|FG001|Overall Study|Laboratory abnormality|1|||
129889829|NCT00136916|467554530|FG000|Overall Study|Lack of Efficacy|13|||
129889830|NCT00136916|467554531|FG001|Overall Study|Lack of Efficacy|3|||
129889831|NCT00136916|467554530|FG000|Overall Study|Lost to Follow-up|12|||
129889832|NCT00136916|467554531|FG001|Overall Study|Lost to Follow-up|14|||
129798728|NCT00089674|467232138|FG000|Overall Study|Lost to Follow-up|21|||
129798729|NCT00089674|467232139|FG001|Overall Study|Lost to Follow-up|17|||
129798730|NCT00089674|467232138|FG000|Overall Study|Noncompliance|7|||
129798731|NCT00089674|467232139|FG001|Overall Study|Noncompliance|3|||
129798732|NCT00089674|467232138|FG000|Overall Study|Other|5|||
129798733|NCT00089674|467232139|FG001|Overall Study|Other|9|||
129798734|NCT00089674|467232138|FG000|Overall Study|Requirement for alternative therapy|14|||
129798735|NCT00089674|467232139|FG001|Overall Study|Requirement for alternative therapy|4|||
129798736|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
129889833|NCT00136916|467554530|FG000|Overall Study|Withdrawal by Subject|44|||
129889834|NCT00136916|467554531|FG001|Overall Study|Withdrawal by Subject|46|||
129889835|NCT00136916|467554530|FG000|Overall Study|Other|22|||
129889836|NCT00136916|467554531|FG001|Overall Study|Other|24|||
129798737|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
129798738|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
129798739|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
129889837|NCT00136916|467554530|FG000|Overall Study|Discontinued in follow up period|3|||
129889838|NCT00136916|467554531|FG001|Overall Study|Discontinued in follow up period|0|||
129889839|NCT01152554|467554532|FG000|Overall Study|Withdrawal by Subject|73|||
129889840|NCT01152554|467554533|FG001|Overall Study|Withdrawal by Subject|28|||
129889841|NCT01152554|467554532|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
129889842|NCT01152554|467554533|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
129889843|NCT01152554|467554532|FG000|Overall Study|Adverse Event|67|||
129889844|NCT01152554|467554533|FG001|Overall Study|Adverse Event|14|||
129889845|NCT01152554|467554532|FG000|Overall Study|Severe non-compliance to protocol|36|||
129889846|NCT01152554|467554533|FG001|Overall Study|Severe non-compliance to protocol|14|||
129889847|NCT01152554|467554532|FG000|Overall Study|Condition under investigation worsened|5|||
129889848|NCT01152554|467554533|FG001|Overall Study|Condition under investigation worsened|2|||
129889849|NCT01152554|467554532|FG000|Overall Study|Lack of Efficacy|20|||
129889850|NCT01152554|467554533|FG001|Overall Study|Lack of Efficacy|3|||
129889851|NCT01152554|467554532|FG000|Overall Study|Study-specific withdrawal criteria|17|||
129889852|NCT01152554|467554533|FG001|Overall Study|Study-specific withdrawal criteria|8|||
129889853|NCT01152554|467554532|FG000|Overall Study|Lost to Follow-up|87|||
129889854|NCT01152554|467554533|FG001|Overall Study|Lost to Follow-up|32|||
129889855|NCT01152554|467554532|FG000|Overall Study|Other|28|||
129889856|NCT01152554|467554533|FG001|Overall Study|Other|8|||
129889857|NCT01152554|467554532|FG000|Overall Study|Death|1|||
129889858|NCT01152554|467554533|FG001|Overall Study|Death|1|||
129889859|NCT02117544|467554534|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
129889860|NCT02117544|467554535|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
129889861|NCT02559817|467554536|FG000|Treatment Period|Adverse Event|1|||
129889862|NCT02559817|467554537|FG001|Treatment Period|Adverse Event|0|||
129889863|NCT02559817|467554538|FG002|Treatment Period|Adverse Event|1|||
129889864|NCT02559817|467554539|FG003|Treatment Period|Adverse Event|0|||
129889865|NCT02559817|467554540|FG004|Treatment Period|Adverse Event|0|||
129889866|NCT02559817|467554536|FG000|Treatment Period|Lack of Efficacy|0|||
129889867|NCT02559817|467554537|FG001|Treatment Period|Lack of Efficacy|1|||
129889868|NCT02559817|467554538|FG002|Treatment Period|Lack of Efficacy|0|||
129889869|NCT02559817|467554539|FG003|Treatment Period|Lack of Efficacy|0|||
129889870|NCT02559817|467554540|FG004|Treatment Period|Lack of Efficacy|0|||
129889871|NCT02559817|467554536|FG000|Treatment Period|Lost to Follow-up|0|||
129889872|NCT02559817|467554537|FG001|Treatment Period|Lost to Follow-up|1|||
129889873|NCT02559817|467554538|FG002|Treatment Period|Lost to Follow-up|0|||
129889874|NCT02559817|467554539|FG003|Treatment Period|Lost to Follow-up|1|||
129889875|NCT02559817|467554540|FG004|Treatment Period|Lost to Follow-up|0|||
129889876|NCT02559817|467554536|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
129889877|NCT02559817|467554537|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
129889878|NCT02559817|467554538|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
129889879|NCT02559817|467554539|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
129889880|NCT02559817|467554540|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
129889881|NCT02559817|467554536|FG000|Treatment Period|Protocol Violation|0|||
129889882|NCT02559817|467554537|FG001|Treatment Period|Protocol Violation|0|||
129889883|NCT02559817|467554538|FG002|Treatment Period|Protocol Violation|0|||
129889884|NCT02559817|467554539|FG003|Treatment Period|Protocol Violation|1|||
129889885|NCT02559817|467554540|FG004|Treatment Period|Protocol Violation|0|||
129889886|NCT02806336|467554550|FG000|Overall Study|Physician Decision|1|||
129889887|NCT02806336|467554551|FG001|Overall Study|Physician Decision|0|||
129889888|NCT02806336|467554550|FG000|Overall Study|Withdrawal by Subject|2|||
129889889|NCT02806336|467554551|FG001|Overall Study|Withdrawal by Subject|4|||
129889890|NCT02806336|467554550|FG000|Overall Study|COVID-19 research shut down|3|||
129889891|NCT02806336|467554551|FG001|Overall Study|COVID-19 research shut down|4|||
129889892|NCT02806336|467554550|FG000|Overall Study|Lack of Efficacy|0|||
129889893|NCT02806336|467554551|FG001|Overall Study|Lack of Efficacy|1|||
130050003|NCT01781429|468140721|FG000|Overall Study|Patient Condition Changed|0|||
130310706|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Other|0|||
130310707|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Physician Decision|6|||
130310708|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Physician Decision|3|||
130310709|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Physician Decision|0|||
130310710|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Physician Decision|0|||
130310711|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Death|1|||
130310712|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Death|1|||
130310713|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Death|0|||
130310714|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Death|0|||
130310715|NCT01695135|469102988|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130310716|NCT01695135|469102989|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
130310717|NCT01695135|469102990|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130310718|NCT01695135|469102991|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
130310719|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
130310720|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
130310721|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
130310722|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
130310723|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
130310724|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
130310725|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
130310726|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
130310727|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
130310728|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
130310729|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
130310730|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
130310731|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Other|0|||
130310732|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Other|0|||
130310733|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Other|4|||
130310734|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Other|7|||
130310735|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
130310736|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
130310737|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
130310738|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
130310739|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Death|0|||
130310740|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Death|0|||
130310741|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Death|2|||
130310742|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Death|7|||
130310743|NCT01695135|469102988|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130310744|NCT01695135|469102989|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130310745|NCT01695135|469102990|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
130310746|NCT01695135|469102991|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
130310747|NCT00684996|469102992|FG000|Overall Study|Adverse Event|1|||
130310748|NCT00684996|469102992|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130310749|NCT00684996|469102992|FG000|Overall Study|Progression/relapse|2|||
130310750|NCT00684996|469102992|FG000|Overall Study|Other reasons not protocol specified|1|||
130310751|NCT03030417|469102995|FG000|Dose Expansion|Disease progression before treatment|0|||
130310752|NCT03030417|469102996|FG001|Dose Expansion|Disease progression before treatment|0|||
130310753|NCT03030417|469102997|FG002|Dose Expansion|Disease progression before treatment|0|||
130310754|NCT03030417|469102998|FG003|Dose Expansion|Disease progression before treatment|0|||
130310755|NCT03030417|469102999|FG004|Dose Expansion|Disease progression before treatment|0|||
130310756|NCT03030417|469103000|FG005|Dose Expansion|Disease progression before treatment|0|||
130310757|NCT03030417|469103001|FG006|Dose Expansion|Disease progression before treatment|0|||
130310758|NCT03030417|469103002|FG007|Dose Expansion|Disease progression before treatment|0|||
130310759|NCT03030417|469103003|FG008|Dose Expansion|Disease progression before treatment|0|||
130310760|NCT03030417|469103004|FG009|Dose Expansion|Disease progression before treatment|0|||
130310761|NCT03030417|469103005|FG010|Dose Expansion|Disease progression before treatment|0|||
130310762|NCT03030417|469103006|FG011|Dose Expansion|Disease progression before treatment|0|||
130310763|NCT03030417|469103007|FG012|Dose Expansion|Disease progression before treatment|1|||
130310764|NCT01076959|469103008|FG000|Overall Study|Adverse Event|767|||
130310765|NCT01076959|469103008|FG000|Overall Study|Lack of Efficacy|849|||
130310766|NCT01076959|469103008|FG000|Overall Study|Non-compliance|274|||
130310767|NCT01076959|469103008|FG000|Overall Study|Lost to Follow-up|241|||
130310768|NCT01076959|469103008|FG000|Overall Study|Other|119|||
129889894|NCT01563978|467554554|FG000|Overall Study|Physician Decision|1|||
129889895|NCT01563978|467554555|FG001|Overall Study|Physician Decision|0|||
129889896|NCT01563978|467554554|FG000|Overall Study|Lost to Follow-up|1|||
130310769|NCT01078441|469103009|FG000|Overall Study|Withdrawal by Subject|1|||
130310770|NCT02175017|469103010|FG000|Overall Study|Did not receive the investigational product|1|||
130310771|NCT02175017|469103011|FG001|Overall Study|Did not receive the investigational product|2|||
130310772|NCT02175017|469103010|FG000|Overall Study|Withdrawal by Subject|6|||
130310773|NCT02175017|469103011|FG001|Overall Study|Withdrawal by Subject|3|||
130310774|NCT02175017|469103010|FG000|Overall Study|Met an exclusion criteria|0|||
130310775|NCT02175017|469103011|FG001|Overall Study|Met an exclusion criteria|1|||
130310776|NCT02175017|469103010|FG000|Overall Study|Adverse Event|3|||
130310777|NCT02175017|469103011|FG001|Overall Study|Adverse Event|10|||
130310778|NCT02175017|469103010|FG000|Overall Study|Disease progression|20|||
130310779|NCT02175017|469103011|FG001|Overall Study|Disease progression|27|||
130310780|NCT02175017|469103010|FG000|Overall Study|Other than above reasons|3|||
130310781|NCT02175017|469103011|FG001|Overall Study|Other than above reasons|0|||
130310782|NCT02491983|469103012|FG000|Overall Study|Physician Decision|1|||
130310783|NCT02491983|469103013|FG001|Overall Study|Physician Decision|0|||
130310784|NCT02491983|469103012|FG000|Overall Study|Not meet selection criteria|1|||
130310785|NCT02491983|469103013|FG001|Overall Study|Not meet selection criteria|0|||
130310786|NCT02491983|469103012|FG000|Overall Study|Withdrawal by Subject|0|||
130310787|NCT02491983|469103013|FG001|Overall Study|Withdrawal by Subject|1|||
130310788|NCT04915729|469103014|FG000|Overall Study|Lost to Follow-up|20|||
130310789|NCT04915729|469103015|FG001|Overall Study|Lost to Follow-up|10|||
130310790|NCT04915729|469103014|FG000|Overall Study|Withdrawal by Subject|12|||
130310791|NCT04915729|469103015|FG001|Overall Study|Withdrawal by Subject|5|||
130310792|NCT04915729|469103014|FG000|Overall Study|Death|34|||
130310793|NCT04915729|469103015|FG001|Overall Study|Death|44|||
130310794|NCT04915729|469103014|FG000|Overall Study|not treated|3|||
130310795|NCT04915729|469103015|FG001|Overall Study|not treated|6|||
130310796|NCT04915729|469103014|FG000|Overall Study|Investigator removed subject|1|||
130310797|NCT04915729|469103015|FG001|Overall Study|Investigator removed subject|2|||
130310798|NCT04915729|469103014|FG000|Overall Study|questionnaire result not evaluated|1|||
130310799|NCT04915729|469103015|FG001|Overall Study|questionnaire result not evaluated|0|||
130310800|NCT04915729|469103014|FG000|Overall Study|refuse of hospital visit|1|||
130310801|NCT04915729|469103015|FG001|Overall Study|refuse of hospital visit|3|||
130310802|NCT04915729|469103014|FG000|Overall Study|Subject withdrew|1|||
130310803|NCT04915729|469103015|FG001|Overall Study|Subject withdrew|0|||
130310804|NCT01684202|469103016|FG000|Dose-escalation Period|Adverse Event|0|||
130310805|NCT01684202|469103017|FG001|Dose-escalation Period|Adverse Event|1|||
130310806|NCT01684202|469103018|FG002|Dose-escalation Period|Adverse Event|0|||
130310807|NCT01684202|469103019|FG003|Dose-escalation Period|Adverse Event|0|||
130310808|NCT01684202|469103016|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
130310809|NCT01684202|469103017|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
130310810|NCT01684202|469103018|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
130310811|NCT01684202|469103019|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
130310812|NCT01684202|469103016|FG000|Maintenance Period|Adverse Event|1|||
130310813|NCT01684202|469103017|FG001|Maintenance Period|Adverse Event|1|||
130310814|NCT01684202|469103018|FG002|Maintenance Period|Adverse Event|1|||
130310815|NCT01684202|469103019|FG003|Maintenance Period|Adverse Event|1|||
130310816|NCT01684202|469103016|FG000|Maintenance Period|Physician Decision|0|||
130310817|NCT01684202|469103017|FG001|Maintenance Period|Physician Decision|1|||
130310818|NCT01684202|469103018|FG002|Maintenance Period|Physician Decision|0|||
130310819|NCT01684202|469103019|FG003|Maintenance Period|Physician Decision|0|||
130310820|NCT01684202|469103016|FG000|Maintenance Period|Withdrawal by Subject|0|||
130310821|NCT01684202|469103017|FG001|Maintenance Period|Withdrawal by Subject|1|||
130310822|NCT01684202|469103018|FG002|Maintenance Period|Withdrawal by Subject|0|||
130310823|NCT01684202|469103019|FG003|Maintenance Period|Withdrawal by Subject|0|||
130310824|NCT03710642|469103023|FG000|Overall Study|Adverse Event|5|||
130310825|NCT03710642|469103024|FG001|Overall Study|Adverse Event|1|||
130310826|NCT03710642|469103023|FG000|Overall Study|non-site physician recommendation|1|||
130310827|NCT03710642|469103024|FG001|Overall Study|non-site physician recommendation|0|||
129889897|NCT01563978|467554555|FG001|Overall Study|Lost to Follow-up|0|||
129889898|NCT01563978|467554554|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
129889899|NCT01563978|467554555|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
129889900|NCT01563978|467554554|FG000|Overall Study|Adverse Event|1|||
129889901|NCT01563978|467554555|FG001|Overall Study|Adverse Event|2|||
130310828|NCT03710642|469103023|FG000|Overall Study|Participant unwilling or unable to participate|1|||
130310829|NCT03710642|469103024|FG001|Overall Study|Participant unwilling or unable to participate|1|||
130310830|NCT03710642|469103023|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
130310831|NCT03710642|469103024|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
130310832|NCT03710642|469103023|FG000|Overall Study|NA-no code provided|1|||
130310833|NCT03710642|469103024|FG001|Overall Study|NA-no code provided|0|||
130310834|NCT03710642|469103023|FG000|Overall Study|Withdrawal by Subject|1|||
130310835|NCT03710642|469103024|FG001|Overall Study|Withdrawal by Subject|0|||
130310836|NCT02741635|469103027|FG000|Overall Study|Withdrawal by Subject|1|||
130310837|NCT01427933|469103031|FG000|Overall Study|Withdrawal by Subject|5|||
130310838|NCT01427933|469103032|FG001|Overall Study|Withdrawal by Subject|8|||
130310839|NCT01427933|469103031|FG000|Overall Study|Lost to Follow-up|1|||
130310840|NCT01427933|469103032|FG001|Overall Study|Lost to Follow-up|5|||
129889902|NCT05764239|467554556|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
129889903|NCT05764239|467554556|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
129889904|NCT05764239|467554556|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
129889905|NCT05764239|467554556|FG000|DEP (Part 1)|Adverse Event|1|||
129889906|NCT05764239|467554556|FG000|DEP (Part 1)|Lost to Follow-up|1|||
129889907|NCT05764239|467554556|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
129889908|NCT05764239|467554556|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
129889909|NCT05764239|467554556|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
129889910|NCT05764239|467554556|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
129889911|NCT00057811|467554557|FG000|Overall Study|Lack of Efficacy|1|||
129889912|NCT00057811|467554558|FG001|Overall Study|Lack of Efficacy|4|||
129889913|NCT00057811|467554557|FG000|Overall Study|Physician Decision|1|||
129889914|NCT00057811|467554558|FG001|Overall Study|Physician Decision|0|||
130310841|NCT01427933|469103031|FG000|Overall Study|Other|1|||
130310842|NCT01427933|469103032|FG001|Overall Study|Other|0|||
130310843|NCT01427933|469103031|FG000|Overall Study|Investigator's Decision|1|||
130310844|NCT01427933|469103032|FG001|Overall Study|Investigator's Decision|0|||
130310845|NCT01633541|469103033|FG000|Overall Study|Death|1|||
130310846|NCT01633541|469103034|FG001|Overall Study|Death|0|||
130310847|NCT01010971|469103035|FG000|Overall Study|Adverse Event|2|||
130310848|NCT01010971|469103036|FG001|Overall Study|Adverse Event|4|||
130310849|NCT01010971|469103037|FG002|Overall Study|Adverse Event|3|||
130310850|NCT01010971|469103035|FG000|Overall Study|Withdrawal by Subject|0|||
130310851|NCT01010971|469103036|FG001|Overall Study|Withdrawal by Subject|2|||
130310852|NCT01010971|469103037|FG002|Overall Study|Withdrawal by Subject|5|||
130310853|NCT01010971|469103035|FG000|Overall Study|Lost to Follow-up|0|||
130310854|NCT01010971|469103036|FG001|Overall Study|Lost to Follow-up|2|||
130310855|NCT01010971|469103037|FG002|Overall Study|Lost to Follow-up|3|||
130310856|NCT01010971|469103035|FG000|Overall Study|Other|1|||
130310857|NCT01010971|469103036|FG001|Overall Study|Other|0|||
130310858|NCT01010971|469103037|FG002|Overall Study|Other|2|||
130310859|NCT03386721|469103038|FG000|Overall Study|Death|12|||
130310860|NCT03386721|469103039|FG001|Overall Study|Death|21|||
130310861|NCT03386721|469103040|FG002|Overall Study|Death|2|||
130310862|NCT03386721|469103041|FG003|Overall Study|Death|5|||
130310863|NCT03386721|469103042|FG004|Overall Study|Death|1|||
130310864|NCT03386721|469103043|FG005|Overall Study|Death|12|||
130310865|NCT03386721|469103044|FG006|Overall Study|Death|1|||
130310866|NCT03386721|469103045|FG007|Overall Study|Death|1|||
130310867|NCT03386721|469103046|FG008|Overall Study|Death|12|||
130310868|NCT03386721|469103047|FG009|Overall Study|Death|20|||
130310869|NCT03386721|469103048|FG010|Overall Study|Death|21|||
130310870|NCT03386721|469103049|FG011|Overall Study|Death|21|||
130310871|NCT03386721|469103050|FG012|Overall Study|Death|14|||
130310872|NCT03386721|469103051|FG013|Overall Study|Death|2|||
130310873|NCT03386721|469103052|FG014|Overall Study|Death|1|||
130310874|NCT03386721|469103038|FG000|Overall Study|Lost to Follow-up|1|||
130310875|NCT03386721|469103039|FG001|Overall Study|Lost to Follow-up|3|||
130310876|NCT03386721|469103040|FG002|Overall Study|Lost to Follow-up|0|||
130310877|NCT03386721|469103041|FG003|Overall Study|Lost to Follow-up|0|||
130310878|NCT03386721|469103042|FG004|Overall Study|Lost to Follow-up|0|||
130310879|NCT03386721|469103043|FG005|Overall Study|Lost to Follow-up|2|||
130310880|NCT03386721|469103044|FG006|Overall Study|Lost to Follow-up|1|||
130310881|NCT03386721|469103045|FG007|Overall Study|Lost to Follow-up|0|||
130310882|NCT03386721|469103046|FG008|Overall Study|Lost to Follow-up|1|||
130310883|NCT03386721|469103047|FG009|Overall Study|Lost to Follow-up|2|||
130310884|NCT03386721|469103048|FG010|Overall Study|Lost to Follow-up|1|||
130310885|NCT03386721|469103049|FG011|Overall Study|Lost to Follow-up|0|||
130310886|NCT03386721|469103050|FG012|Overall Study|Lost to Follow-up|0|||
130310887|NCT03386721|469103051|FG013|Overall Study|Lost to Follow-up|0|||
130310888|NCT03386721|469103052|FG014|Overall Study|Lost to Follow-up|0|||
129889915|NCT00057811|467554557|FG000|Overall Study|Withdrawal by Subject|3|||
129889916|NCT00057811|467554558|FG001|Overall Study|Withdrawal by Subject|4|||
129889917|NCT00057811|467554557|FG000|Overall Study|Ineligible|4|||
130310889|NCT03386721|469103038|FG000|Overall Study|Reason not specified|3|||
130310890|NCT03386721|469103039|FG001|Overall Study|Reason not specified|0|||
129889918|NCT00057811|467554558|FG001|Overall Study|Ineligible|2|||
129889919|NCT00057811|467554557|FG000|Overall Study|Inevaluable|1|||
129889920|NCT00057811|467554558|FG001|Overall Study|Inevaluable|2|||
130310891|NCT03386721|469103040|FG002|Overall Study|Reason not specified|0|||
130310892|NCT03386721|469103041|FG003|Overall Study|Reason not specified|0|||
130310893|NCT03386721|469103042|FG004|Overall Study|Reason not specified|0|||
130310894|NCT03386721|469103043|FG005|Overall Study|Reason not specified|3|||
130310895|NCT03386721|469103044|FG006|Overall Study|Reason not specified|1|||
130310896|NCT03386721|469103045|FG007|Overall Study|Reason not specified|0|||
130310897|NCT03386721|469103046|FG008|Overall Study|Reason not specified|0|||
130310898|NCT03386721|469103047|FG009|Overall Study|Reason not specified|1|||
130310899|NCT03386721|469103048|FG010|Overall Study|Reason not specified|2|||
130310900|NCT03386721|469103049|FG011|Overall Study|Reason not specified|6|||
130310901|NCT03386721|469103050|FG012|Overall Study|Reason not specified|1|||
130310902|NCT03386721|469103051|FG013|Overall Study|Reason not specified|0|||
130310903|NCT03386721|469103052|FG014|Overall Study|Reason not specified|0|||
130310904|NCT03386721|469103038|FG000|Overall Study|Progressive Disease|0|||
130310905|NCT03386721|469103039|FG001|Overall Study|Progressive Disease|0|||
130310906|NCT03386721|469103040|FG002|Overall Study|Progressive Disease|1|||
130310907|NCT03386721|469103041|FG003|Overall Study|Progressive Disease|0|||
130310908|NCT03386721|469103042|FG004|Overall Study|Progressive Disease|0|||
130310909|NCT03386721|469103043|FG005|Overall Study|Progressive Disease|1|||
130310910|NCT03386721|469103044|FG006|Overall Study|Progressive Disease|0|||
130310911|NCT03386721|469103045|FG007|Overall Study|Progressive Disease|0|||
130310912|NCT03386721|469103046|FG008|Overall Study|Progressive Disease|2|||
130310913|NCT03386721|469103047|FG009|Overall Study|Progressive Disease|1|||
130310914|NCT03386721|469103048|FG010|Overall Study|Progressive Disease|1|||
130310915|NCT03386721|469103049|FG011|Overall Study|Progressive Disease|0|||
130310916|NCT03386721|469103050|FG012|Overall Study|Progressive Disease|1|||
130310917|NCT03386721|469103051|FG013|Overall Study|Progressive Disease|0|||
130310918|NCT03386721|469103052|FG014|Overall Study|Progressive Disease|0|||
130310919|NCT03386721|469103038|FG000|Overall Study|Site Terminated by Sponsor|5|||
130310920|NCT03386721|469103039|FG001|Overall Study|Site Terminated by Sponsor|5|||
130310921|NCT03386721|469103040|FG002|Overall Study|Site Terminated by Sponsor|0|||
130310922|NCT03386721|469103041|FG003|Overall Study|Site Terminated by Sponsor|0|||
130310923|NCT03386721|469103042|FG004|Overall Study|Site Terminated by Sponsor|1|||
130310924|NCT03386721|469103043|FG005|Overall Study|Site Terminated by Sponsor|3|||
130310925|NCT03386721|469103044|FG006|Overall Study|Site Terminated by Sponsor|0|||
130310926|NCT03386721|469103045|FG007|Overall Study|Site Terminated by Sponsor|1|||
130310927|NCT03386721|469103046|FG008|Overall Study|Site Terminated by Sponsor|4|||
130310928|NCT03386721|469103047|FG009|Overall Study|Site Terminated by Sponsor|5|||
130310929|NCT03386721|469103048|FG010|Overall Study|Site Terminated by Sponsor|3|||
130310930|NCT03386721|469103049|FG011|Overall Study|Site Terminated by Sponsor|11|||
130310931|NCT03386721|469103050|FG012|Overall Study|Site Terminated by Sponsor|6|||
130310932|NCT03386721|469103051|FG013|Overall Study|Site Terminated by Sponsor|0|||
130310933|NCT03386721|469103052|FG014|Overall Study|Site Terminated by Sponsor|0|||
130310934|NCT03386721|469103038|FG000|Overall Study|Symptomatic Deterioration|0|||
130310935|NCT03386721|469103039|FG001|Overall Study|Symptomatic Deterioration|0|||
130310936|NCT03386721|469103040|FG002|Overall Study|Symptomatic Deterioration|0|||
130310937|NCT03386721|469103041|FG003|Overall Study|Symptomatic Deterioration|0|||
130310938|NCT03386721|469103042|FG004|Overall Study|Symptomatic Deterioration|0|||
130310939|NCT03386721|469103043|FG005|Overall Study|Symptomatic Deterioration|0|||
130310940|NCT03386721|469103044|FG006|Overall Study|Symptomatic Deterioration|0|||
130310941|NCT03386721|469103045|FG007|Overall Study|Symptomatic Deterioration|0|||
130310942|NCT03386721|469103046|FG008|Overall Study|Symptomatic Deterioration|1|||
130310943|NCT03386721|469103047|FG009|Overall Study|Symptomatic Deterioration|0|||
130310944|NCT03386721|469103048|FG010|Overall Study|Symptomatic Deterioration|0|||
130310945|NCT03386721|469103049|FG011|Overall Study|Symptomatic Deterioration|1|||
130310946|NCT03386721|469103050|FG012|Overall Study|Symptomatic Deterioration|0|||
130310947|NCT03386721|469103051|FG013|Overall Study|Symptomatic Deterioration|0|||
130310948|NCT03386721|469103052|FG014|Overall Study|Symptomatic Deterioration|0|||
130310949|NCT03386721|469103038|FG000|Overall Study|Withdrawal by Subject|1|||
130310950|NCT03386721|469103039|FG001|Overall Study|Withdrawal by Subject|2|||
130310951|NCT03386721|469103040|FG002|Overall Study|Withdrawal by Subject|0|||
130310952|NCT03386721|469103041|FG003|Overall Study|Withdrawal by Subject|0|||
130310953|NCT03386721|469103042|FG004|Overall Study|Withdrawal by Subject|0|||
130310954|NCT03386721|469103043|FG005|Overall Study|Withdrawal by Subject|0|||
130310955|NCT03386721|469103044|FG006|Overall Study|Withdrawal by Subject|0|||
130310956|NCT03386721|469103045|FG007|Overall Study|Withdrawal by Subject|0|||
130310957|NCT03386721|469103046|FG008|Overall Study|Withdrawal by Subject|2|||
130310958|NCT03386721|469103047|FG009|Overall Study|Withdrawal by Subject|1|||
130310959|NCT03386721|469103048|FG010|Overall Study|Withdrawal by Subject|3|||
130310960|NCT03386721|469103049|FG011|Overall Study|Withdrawal by Subject|2|||
130310961|NCT03386721|469103050|FG012|Overall Study|Withdrawal by Subject|3|||
130310962|NCT03386721|469103051|FG013|Overall Study|Withdrawal by Subject|0|||
130310963|NCT03386721|469103052|FG014|Overall Study|Withdrawal by Subject|0|||
130310964|NCT05114473|469103053|FG000|Overall Study|Lost to Follow-up|2|||
130310965|NCT05114473|469103054|FG001|Overall Study|Lost to Follow-up|2|||
130310966|NCT05114473|469103055|FG002|Overall Study|Lost to Follow-up|0|||
130310967|NCT02330055|469103056|FG000|Overall Study|technical issues|2|||
129889921|NCT00556374|467554559|FG000|Overall Study|Withdrawal by Subject|235|||
129889922|NCT00556374|467554560|FG001|Overall Study|Withdrawal by Subject|205|||
130310968|NCT02330055|469103057|FG001|Overall Study|technical issues|0|||
130310969|NCT02330055|469103056|FG000|Overall Study|participant forgot to wear device|5|||
130310970|NCT02330055|469103057|FG001|Overall Study|participant forgot to wear device|5|||
130310971|NCT02330055|469103056|FG000|Overall Study|data for less than 60 minutes|3|||
130310972|NCT02330055|469103057|FG001|Overall Study|data for less than 60 minutes|3|||
130310973|NCT02330055|469103056|FG000|Overall Study|participant did not sleep|0|||
130310974|NCT02330055|469103057|FG001|Overall Study|participant did not sleep|1|||
130310975|NCT01369784|469103061|FG000|Overall Study|Protocol Violation|12|||
130310976|NCT00782717|469103062|FG000|Overall Study|Adverse Event|2|||
130310977|NCT00782717|469103063|FG001|Overall Study|Adverse Event|5|||
130310978|NCT00782717|469103062|FG000|Overall Study|Patient decision unrelated to AE|6|||
130310979|NCT00782717|469103063|FG001|Overall Study|Patient decision unrelated to AE|3|||
130310980|NCT00782717|469103062|FG000|Overall Study|Noncompliance|2|||
130310981|NCT00782717|469103063|FG001|Overall Study|Noncompliance|1|||
130310982|NCT00782717|469103062|FG000|Overall Study|Treatment failure|3|||
130310983|NCT00782717|469103063|FG001|Overall Study|Treatment failure|14|||
130310984|NCT00782717|469103062|FG000|Overall Study|Enrollment close prior to surgery|1|||
130310985|NCT00782717|469103063|FG001|Overall Study|Enrollment close prior to surgery|0|||
130310986|NCT00782717|469103062|FG000|Overall Study|Did not meet entrance criteria|1|||
130310987|NCT00782717|469103063|FG001|Overall Study|Did not meet entrance criteria|3|||
130310988|NCT00782717|469103062|FG000|Overall Study|Exited in error|0|||
130310989|NCT00782717|469103063|FG001|Overall Study|Exited in error|2|||
129798740|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
129798741|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
129798742|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798743|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798744|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
129798745|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
129798746|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798747|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798748|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
129798749|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
129798750|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
129798751|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
129798752|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
129798753|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
129798754|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798755|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
129798756|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798757|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798758|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798759|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798760|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
129798761|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
129798762|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
129889923|NCT00556374|467554559|FG000|Overall Study|Death|158|||
129889924|NCT00556374|467554560|FG001|Overall Study|Death|127|||
130050004|NCT01781429|468140722|FG001|Overall Study|Patient Condition Changed|0|||
130050005|NCT01781429|468140723|FG002|Overall Study|Patient Condition Changed|0|||
130050006|NCT01781429|468140724|FG003|Overall Study|Patient Condition Changed|0|||
130050007|NCT01781429|468140725|FG004|Overall Study|Patient Condition Changed|0|||
130050008|NCT01781429|468140726|FG005|Overall Study|Patient Condition Changed|0|||
130050009|NCT01781429|468140727|FG006|Overall Study|Patient Condition Changed|0|||
130050010|NCT01781429|468140728|FG007|Overall Study|Patient Condition Changed|0|||
130050011|NCT01781429|468140729|FG008|Overall Study|Patient Condition Changed|0|||
130310990|NCT02905266|469103064|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
130310991|NCT02905266|469103065|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
130310992|NCT02905266|469103064|FG000|Treatment Phase Part 1|Disease Progression|6|||
129889925|NCT00556374|467554559|FG000|Overall Study|Lost to Follow-up|24|||
129889926|NCT00556374|467554560|FG001|Overall Study|Lost to Follow-up|17|||
129889927|NCT00556374|467554559|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
129889928|NCT00556374|467554560|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
129889929|NCT02169219|467554561|FG000|Overall Study|Lack of Efficacy|6|||
129889930|NCT04562779|467554565|FG000|Overall Study|Lost to Follow-up|7|||
129889931|NCT04562779|467554566|FG001|Overall Study|Lost to Follow-up|5|||
129889932|NCT04562779|467554567|FG002|Overall Study|Lost to Follow-up|10|||
129889933|NCT04562779|467554565|FG000|Overall Study|Protocol Violation|2|||
129889934|NCT04562779|467554566|FG001|Overall Study|Protocol Violation|2|||
130050012|NCT01781429|468140730|FG009|Overall Study|Patient Condition Changed|4|||
130050013|NCT01781429|468140731|FG010|Overall Study|Patient Condition Changed|0|||
130050014|NCT01781429|468140732|FG011|Overall Study|Patient Condition Changed|1|||
130050015|NCT01781429|468140733|FG012|Overall Study|Patient Condition Changed|0|||
130050016|NCT01781429|468140734|FG013|Overall Study|Patient Condition Changed|1|||
130050017|NCT01781429|468140735|FG014|Overall Study|Patient Condition Changed|0|||
130050018|NCT01781429|468140736|FG015|Overall Study|Patient Condition Changed|0|||
130110606|NCT03276962|468365790|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
130310993|NCT02905266|469103065|FG001|Treatment Phase Part 1|Disease Progression|7|||
130310994|NCT02905266|469103064|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
130310995|NCT02905266|469103065|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
129889935|NCT04562779|467554567|FG002|Overall Study|Protocol Violation|0|||
130050019|NCT01781429|468140721|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
130050020|NCT01781429|468140722|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
130310996|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
130310997|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
130310998|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
130310999|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
130311000|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
130311001|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
130311002|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Death|0|||
130311003|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Death|1|||
130311004|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
130311005|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
130311006|NCT02905266|469103064|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
130311007|NCT02905266|469103065|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
130311008|NCT02905266|469103064|FG000|Maintenance Phase Part 2|Disease Progression|9|||
130311009|NCT02905266|469103065|FG001|Maintenance Phase Part 2|Disease Progression|2|||
130311010|NCT02905266|469103064|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
130311011|NCT02905266|469103065|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
130311012|NCT02905266|469103064|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
130311013|NCT02905266|469103065|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
130311014|NCT02292719|469103071|FG000|Overall Study|Withdrawal by Subject|0|||
130311015|NCT02292719|469103072|FG001|Overall Study|Withdrawal by Subject|0|||
130311016|NCT02292719|469103073|FG002|Overall Study|Withdrawal by Subject|0|||
130311017|NCT02292719|469103074|FG003|Overall Study|Withdrawal by Subject|1|||
130311018|NCT02292719|469103075|FG004|Overall Study|Withdrawal by Subject|1|||
130311019|NCT02292719|469103076|FG005|Overall Study|Withdrawal by Subject|0|||
130311020|NCT02292719|469103071|FG000|Overall Study|Subject enrolled in new study.|0|||
130311021|NCT02292719|469103072|FG001|Overall Study|Subject enrolled in new study.|0|||
130311022|NCT02292719|469103073|FG002|Overall Study|Subject enrolled in new study.|1|||
130311023|NCT02292719|469103074|FG003|Overall Study|Subject enrolled in new study.|0|||
130311024|NCT02292719|469103075|FG004|Overall Study|Subject enrolled in new study.|0|||
130311025|NCT02292719|469103076|FG005|Overall Study|Subject enrolled in new study.|0|||
130311026|NCT02586727|469103082|FG000|Overall Study|Lost to Follow-up|1|||
130311027|NCT02586727|469103083|FG001|Overall Study|Lost to Follow-up|0|||
130311028|NCT04378270|469103085|FG000|Overall Study|Lack of Efficacy|1|||
130311029|NCT04378270|469103085|FG000|Overall Study|Withdrawal by Subject|1|||
130311030|NCT04378270|469103085|FG000|Overall Study|Screen Failure|1|||
130311031|NCT04378270|469103085|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
130311032|NCT01132313|469103086|FG000|Overall Study|Lack of Efficacy|1|||
130311033|NCT01132313|469103087|FG001|Overall Study|Lack of Efficacy|0|||
130311034|NCT01132313|469103088|FG002|Overall Study|Lack of Efficacy|0|||
130311035|NCT01132313|469103089|FG003|Overall Study|Lack of Efficacy|0|||
130311036|NCT01132313|469103090|FG004|Overall Study|Lack of Efficacy|0|||
130311037|NCT01132313|469103091|FG005|Overall Study|Lack of Efficacy|0|||
130311038|NCT01132313|469103092|FG006|Overall Study|Lack of Efficacy|0|||
130311039|NCT01132313|469103093|FG007|Overall Study|Lack of Efficacy|3|||
130311040|NCT01132313|469103094|FG008|Overall Study|Lack of Efficacy|14|||
130311041|NCT01132313|469103095|FG009|Overall Study|Lack of Efficacy|16|||
130311042|NCT01132313|469103096|FG010|Overall Study|Lack of Efficacy|0|||
130311043|NCT01132313|469103097|FG011|Overall Study|Lack of Efficacy|0|||
130311044|NCT01132313|469103086|FG000|Overall Study|Not treated|2|||
130311045|NCT01132313|469103087|FG001|Overall Study|Not treated|0|||
130311046|NCT01132313|469103088|FG002|Overall Study|Not treated|0|||
130311047|NCT01132313|469103089|FG003|Overall Study|Not treated|0|||
129889936|NCT00333138|467554568|FG000|Core Study (6 Months)|Adverse Event|4|||
129889937|NCT00333138|467554569|FG001|Core Study (6 Months)|Adverse Event|5|||
129889938|NCT00333138|467554570|FG002|Core Study (6 Months)|Adverse Event|8|||
130311048|NCT01132313|469103090|FG004|Overall Study|Not treated|2|||
130311049|NCT01132313|469103091|FG005|Overall Study|Not treated|1|||
130311050|NCT01132313|469103092|FG006|Overall Study|Not treated|3|||
130311051|NCT01132313|469103093|FG007|Overall Study|Not treated|0|||
130311052|NCT01132313|469103094|FG008|Overall Study|Not treated|0|||
130311053|NCT01132313|469103095|FG009|Overall Study|Not treated|0|||
130311054|NCT01132313|469103096|FG010|Overall Study|Not treated|0|||
130311055|NCT01132313|469103097|FG011|Overall Study|Not treated|0|||
130311056|NCT01132313|469103086|FG000|Overall Study|Adverse Event|0|||
129889939|NCT00333138|467554568|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
130311057|NCT01132313|469103087|FG001|Overall Study|Adverse Event|0|||
130311058|NCT01132313|469103088|FG002|Overall Study|Adverse Event|4|||
130311059|NCT01132313|469103089|FG003|Overall Study|Adverse Event|10|||
130311060|NCT01132313|469103090|FG004|Overall Study|Adverse Event|19|||
129889940|NCT00333138|467554569|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
130311061|NCT01132313|469103091|FG005|Overall Study|Adverse Event|6|||
130311062|NCT01132313|469103092|FG006|Overall Study|Adverse Event|5|||
130311063|NCT01132313|469103093|FG007|Overall Study|Adverse Event|3|||
130311064|NCT01132313|469103094|FG008|Overall Study|Adverse Event|7|||
130311065|NCT01132313|469103095|FG009|Overall Study|Adverse Event|2|||
130311066|NCT01132313|469103096|FG010|Overall Study|Adverse Event|0|||
130311067|NCT01132313|469103097|FG011|Overall Study|Adverse Event|0|||
130311068|NCT01132313|469103086|FG000|Overall Study|Protocol Violation|0|||
130311069|NCT01132313|469103087|FG001|Overall Study|Protocol Violation|0|||
130311070|NCT01132313|469103088|FG002|Overall Study|Protocol Violation|0|||
130311071|NCT01132313|469103089|FG003|Overall Study|Protocol Violation|1|||
130311072|NCT01132313|469103090|FG004|Overall Study|Protocol Violation|0|||
130311073|NCT01132313|469103091|FG005|Overall Study|Protocol Violation|0|||
130311074|NCT01132313|469103092|FG006|Overall Study|Protocol Violation|0|||
130311075|NCT01132313|469103093|FG007|Overall Study|Protocol Violation|0|||
130311076|NCT01132313|469103094|FG008|Overall Study|Protocol Violation|0|||
130311077|NCT01132313|469103095|FG009|Overall Study|Protocol Violation|0|||
129798763|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
129798764|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
129798765|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
129798766|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
129798767|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798768|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
129798769|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798770|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798771|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798772|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798773|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798774|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
129798775|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798776|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798777|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798778|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
129798779|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798780|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798781|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798782|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798783|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798784|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
129798785|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
129798786|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
129798787|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
129798788|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
129798789|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
129798790|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
129798791|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798792|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798793|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798794|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798795|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798796|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
129798797|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
129798798|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
129798799|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
129798800|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
129798801|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
129798802|NCT00667420|467232149|FG000|Overall Study|Adverse Event|2|||
129798803|NCT00667420|467232149|FG000|Overall Study|Lack of Efficacy|5|||
129798804|NCT00667420|467232149|FG000|Overall Study|Physician Decision|1|||
129798805|NCT00667420|467232149|FG000|Overall Study|Withdrawal by Subject|2|||
129798806|NCT02961218|467232150|FG000|Overall Study|Lost to Follow-up|0|||
129798807|NCT02961218|467232151|FG001|Overall Study|Lost to Follow-up|2|||
129798808|NCT02961218|467232150|FG000|Overall Study|Physician Decision|0|||
129798809|NCT02961218|467232151|FG001|Overall Study|Physician Decision|2|||
129798810|NCT02961218|467232150|FG000|Overall Study|Subject/Guardian Decision|3|||
129798811|NCT02961218|467232151|FG001|Overall Study|Subject/Guardian Decision|1|||
129798812|NCT00591266|467232154|FG000|Overall Study|Adverse Event|2|||
129798813|NCT00591266|467232155|FG001|Overall Study|Adverse Event|2|||
129798814|NCT00591266|467232156|FG002|Overall Study|Adverse Event|3|||
129798815|NCT00591266|467232154|FG000|Overall Study|Lost to Follow-up|0|||
129798816|NCT00591266|467232155|FG001|Overall Study|Lost to Follow-up|1|||
130311078|NCT01132313|469103096|FG010|Overall Study|Protocol Violation|0|||
130311079|NCT01132313|469103097|FG011|Overall Study|Protocol Violation|0|||
130311080|NCT01132313|469103086|FG000|Overall Study|Lost to Follow-up|0|||
130311081|NCT01132313|469103087|FG001|Overall Study|Lost to Follow-up|0|||
130311082|NCT01132313|469103088|FG002|Overall Study|Lost to Follow-up|1|||
129889941|NCT00333138|467554570|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
129889942|NCT00333138|467554568|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
129889943|NCT00333138|467554569|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
129889944|NCT00333138|467554570|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
129889945|NCT00333138|467554568|FG000|Core Study (6 Months)|Protocol Violation|1|||
129889946|NCT00333138|467554569|FG001|Core Study (6 Months)|Protocol Violation|0|||
129889947|NCT00333138|467554570|FG002|Core Study (6 Months)|Protocol Violation|1|||
129889948|NCT00333138|467554568|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
129889949|NCT00333138|467554569|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
129889950|NCT00333138|467554570|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
129889951|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
129889952|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
129889953|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
129889954|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
129889955|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
130050021|NCT01781429|468140723|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
130050022|NCT01781429|468140724|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
130050023|NCT01781429|468140725|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
130050024|NCT01781429|468140726|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
130050025|NCT01781429|468140727|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
130050026|NCT01781429|468140728|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
130050027|NCT01781429|468140729|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
130050028|NCT01781429|468140730|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
130050029|NCT01781429|468140731|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
130050030|NCT01781429|468140732|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
130050031|NCT01781429|468140733|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
130050032|NCT01781429|468140734|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
130050033|NCT01781429|468140735|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
130050034|NCT01781429|468140736|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
130050035|NCT01781429|468140721|FG000|Overall Study|Enrolled, but not treated|0|||
130050036|NCT01781429|468140722|FG001|Overall Study|Enrolled, but not treated|0|||
130050037|NCT01781429|468140723|FG002|Overall Study|Enrolled, but not treated|0|||
130050038|NCT01781429|468140724|FG003|Overall Study|Enrolled, but not treated|0|||
130050039|NCT01781429|468140725|FG004|Overall Study|Enrolled, but not treated|0|||
130050040|NCT01781429|468140726|FG005|Overall Study|Enrolled, but not treated|0|||
130050041|NCT01781429|468140727|FG006|Overall Study|Enrolled, but not treated|0|||
130050042|NCT01781429|468140728|FG007|Overall Study|Enrolled, but not treated|0|||
130050043|NCT01781429|468140729|FG008|Overall Study|Enrolled, but not treated|0|||
130050044|NCT01781429|468140730|FG009|Overall Study|Enrolled, but not treated|0|||
130050045|NCT01781429|468140731|FG010|Overall Study|Enrolled, but not treated|1|||
130050046|NCT01781429|468140732|FG011|Overall Study|Enrolled, but not treated|0|||
130050047|NCT01781429|468140733|FG012|Overall Study|Enrolled, but not treated|0|||
130050048|NCT01781429|468140734|FG013|Overall Study|Enrolled, but not treated|0|||
130050049|NCT01781429|468140735|FG014|Overall Study|Enrolled, but not treated|0|||
130050050|NCT01781429|468140736|FG015|Overall Study|Enrolled, but not treated|0|||
130050051|NCT00390780|468140737|FG000|Overall Study|Not completed|10|||
130050052|NCT00390780|468140738|FG001|Overall Study|Not completed|4|||
130050053|NCT00390780|468140737|FG000|Overall Study|Protocol Violation|6|||
130050054|NCT00390780|468140738|FG001|Overall Study|Protocol Violation|4|||
130050055|NCT00390780|468140737|FG000|Overall Study|Lost to Follow-up|3|||
130050056|NCT00390780|468140738|FG001|Overall Study|Lost to Follow-up|6|||
130050057|NCT00390780|468140737|FG000|Overall Study|Adverse Event|2|||
130050058|NCT00390780|468140738|FG001|Overall Study|Adverse Event|3|||
130050059|NCT00390780|468140737|FG000|Overall Study|Death|1|||
130050060|NCT00390780|468140738|FG001|Overall Study|Death|3|||
130050061|NCT00390780|468140737|FG000|Overall Study|Withdrawal by Subject|1|||
130050062|NCT00390780|468140738|FG001|Overall Study|Withdrawal by Subject|2|||
130050063|NCT00390780|468140737|FG000|Overall Study|Inclusion criteria not satisfied|0|||
130050064|NCT00390780|468140738|FG001|Overall Study|Inclusion criteria not satisfied|2|||
130050065|NCT00390780|468140737|FG000|Overall Study|Lost to follow up and other reasons|0|||
130050066|NCT00390780|468140738|FG001|Overall Study|Lost to follow up and other reasons|1|||
130050067|NCT00390780|468140737|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
130050068|NCT00390780|468140738|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
130050069|NCT00390780|468140737|FG000|Overall Study|SAE, death|0|||
130050070|NCT00390780|468140738|FG001|Overall Study|SAE, death|1|||
130050071|NCT01070550|468140739|FG000|Overall Study|Adverse Event|43|||
130050072|NCT01070550|468140740|FG001|Overall Study|Adverse Event|1|||
130050073|NCT01070550|468140741|FG002|Overall Study|Adverse Event|3|||
130050074|NCT01070550|468140742|FG003|Overall Study|Adverse Event|0|||
130050075|NCT01070550|468140743|FG004|Overall Study|Adverse Event|0|||
130050076|NCT01070550|468140744|FG005|Overall Study|Adverse Event|0|||
129798817|NCT00591266|467232156|FG002|Overall Study|Lost to Follow-up|0|||
129798818|NCT00591266|467232154|FG000|Overall Study|Protocol Violation|0|||
129798819|NCT00591266|467232155|FG001|Overall Study|Protocol Violation|0|||
129798820|NCT00591266|467232156|FG002|Overall Study|Protocol Violation|1|||
129798821|NCT00591266|467232154|FG000|Overall Study|Withdrawal by Subject|6|||
130050077|NCT01070550|468140739|FG000|Overall Study|Death|20|||
130050078|NCT01070550|468140740|FG001|Overall Study|Death|4|||
130050079|NCT01070550|468140741|FG002|Overall Study|Death|3|||
130050080|NCT01070550|468140742|FG003|Overall Study|Death|0|||
130050081|NCT01070550|468140743|FG004|Overall Study|Death|0|||
130050082|NCT01070550|468140744|FG005|Overall Study|Death|0|||
130050083|NCT01070550|468140739|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
130050084|NCT01070550|468140740|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130050085|NCT01070550|468140741|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130050086|NCT01070550|468140742|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130050087|NCT01070550|468140743|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130050088|NCT01070550|468140744|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130050089|NCT01070550|468140739|FG000|Overall Study|Early termination|3|||
130050090|NCT01070550|468140740|FG001|Overall Study|Early termination|0|||
130050091|NCT01070550|468140741|FG002|Overall Study|Early termination|0|||
130050092|NCT01070550|468140742|FG003|Overall Study|Early termination|0|||
130050093|NCT01070550|468140743|FG004|Overall Study|Early termination|0|||
130050094|NCT01070550|468140744|FG005|Overall Study|Early termination|0|||
130050095|NCT01070550|468140739|FG000|Overall Study|Failed to return|450|||
130050096|NCT01070550|468140740|FG001|Overall Study|Failed to return|33|||
130050097|NCT01070550|468140741|FG002|Overall Study|Failed to return|144|||
130050098|NCT01070550|468140742|FG003|Overall Study|Failed to return|40|||
130050099|NCT01070550|468140743|FG004|Overall Study|Failed to return|1|||
130050100|NCT01070550|468140744|FG005|Overall Study|Failed to return|2|||
130050101|NCT01070550|468140739|FG000|Overall Study|Incomplete treatment|2|||
130050102|NCT01070550|468140740|FG001|Overall Study|Incomplete treatment|0|||
130050103|NCT01070550|468140741|FG002|Overall Study|Incomplete treatment|0|||
130050104|NCT01070550|468140742|FG003|Overall Study|Incomplete treatment|0|||
130050105|NCT01070550|468140743|FG004|Overall Study|Incomplete treatment|0|||
130050106|NCT01070550|468140744|FG005|Overall Study|Incomplete treatment|0|||
130050107|NCT01070550|468140739|FG000|Overall Study|Lab test not done|22|||
130050108|NCT01070550|468140740|FG001|Overall Study|Lab test not done|3|||
130050109|NCT01070550|468140741|FG002|Overall Study|Lab test not done|4|||
130050110|NCT01070550|468140742|FG003|Overall Study|Lab test not done|1|||
130050111|NCT01070550|468140743|FG004|Overall Study|Lab test not done|0|||
130050112|NCT01070550|468140744|FG005|Overall Study|Lab test not done|1|||
130050113|NCT01070550|468140739|FG000|Overall Study|Lack of Efficacy|65|||
130050114|NCT01070550|468140740|FG001|Overall Study|Lack of Efficacy|1|||
130050115|NCT01070550|468140741|FG002|Overall Study|Lack of Efficacy|5|||
130050116|NCT01070550|468140742|FG003|Overall Study|Lack of Efficacy|5|||
130050117|NCT01070550|468140743|FG004|Overall Study|Lack of Efficacy|0|||
130050118|NCT01070550|468140744|FG005|Overall Study|Lack of Efficacy|1|||
130050119|NCT01070550|468140739|FG000|Overall Study|Miscellaneous|12|||
130050120|NCT01070550|468140740|FG001|Overall Study|Miscellaneous|2|||
130050121|NCT01070550|468140741|FG002|Overall Study|Miscellaneous|3|||
130050122|NCT01070550|468140742|FG003|Overall Study|Miscellaneous|1|||
130050123|NCT01070550|468140743|FG004|Overall Study|Miscellaneous|0|||
130050124|NCT01070550|468140744|FG005|Overall Study|Miscellaneous|0|||
130050125|NCT01070550|468140739|FG000|Overall Study|New treatment started|3|||
129798822|NCT00591266|467232155|FG001|Overall Study|Withdrawal by Subject|2|||
130050126|NCT01070550|468140740|FG001|Overall Study|New treatment started|1|||
130050127|NCT01070550|468140741|FG002|Overall Study|New treatment started|0|||
130050128|NCT01070550|468140742|FG003|Overall Study|New treatment started|2|||
130050129|NCT01070550|468140743|FG004|Overall Study|New treatment started|0|||
130311083|NCT01132313|469103089|FG003|Overall Study|Lost to Follow-up|0|||
130311084|NCT01132313|469103090|FG004|Overall Study|Lost to Follow-up|0|||
130311085|NCT01132313|469103091|FG005|Overall Study|Lost to Follow-up|0|||
130311086|NCT01132313|469103092|FG006|Overall Study|Lost to Follow-up|0|||
130311087|NCT01132313|469103093|FG007|Overall Study|Lost to Follow-up|1|||
130311088|NCT01132313|469103094|FG008|Overall Study|Lost to Follow-up|0|||
130311089|NCT01132313|469103095|FG009|Overall Study|Lost to Follow-up|0|||
130311090|NCT01132313|469103096|FG010|Overall Study|Lost to Follow-up|0|||
130311091|NCT01132313|469103097|FG011|Overall Study|Lost to Follow-up|0|||
130311092|NCT01132313|469103086|FG000|Overall Study|Withdrawal by Subject|0|||
130311093|NCT01132313|469103087|FG001|Overall Study|Withdrawal by Subject|0|||
130311094|NCT01132313|469103088|FG002|Overall Study|Withdrawal by Subject|3|||
130311095|NCT01132313|469103089|FG003|Overall Study|Withdrawal by Subject|3|||
130311096|NCT01132313|469103090|FG004|Overall Study|Withdrawal by Subject|6|||
130311097|NCT01132313|469103091|FG005|Overall Study|Withdrawal by Subject|0|||
130311098|NCT01132313|469103092|FG006|Overall Study|Withdrawal by Subject|1|||
130311099|NCT01132313|469103093|FG007|Overall Study|Withdrawal by Subject|0|||
130311100|NCT01132313|469103094|FG008|Overall Study|Withdrawal by Subject|0|||
130311101|NCT01132313|469103095|FG009|Overall Study|Withdrawal by Subject|2|||
130311102|NCT01132313|469103096|FG010|Overall Study|Withdrawal by Subject|0|||
130311103|NCT01132313|469103097|FG011|Overall Study|Withdrawal by Subject|0|||
130311104|NCT01132313|469103086|FG000|Overall Study|Lack of antiviral response|0|||
130311105|NCT01132313|469103087|FG001|Overall Study|Lack of antiviral response|0|||
130311106|NCT01132313|469103088|FG002|Overall Study|Lack of antiviral response|12|||
130311107|NCT01132313|469103089|FG003|Overall Study|Lack of antiviral response|18|||
130311108|NCT01132313|469103090|FG004|Overall Study|Lack of antiviral response|18|||
130311109|NCT01132313|469103091|FG005|Overall Study|Lack of antiviral response|18|||
130311110|NCT01132313|469103092|FG006|Overall Study|Lack of antiviral response|21|||
130311111|NCT01132313|469103093|FG007|Overall Study|Lack of antiviral response|0|||
130311112|NCT01132313|469103094|FG008|Overall Study|Lack of antiviral response|0|||
130311113|NCT01132313|469103095|FG009|Overall Study|Lack of antiviral response|0|||
130311114|NCT01132313|469103096|FG010|Overall Study|Lack of antiviral response|1|||
130311115|NCT01132313|469103097|FG011|Overall Study|Lack of antiviral response|0|||
130311116|NCT01132313|469103086|FG000|Overall Study|Other reason not defined above|0|||
130311117|NCT01132313|469103087|FG001|Overall Study|Other reason not defined above|0|||
130311118|NCT01132313|469103088|FG002|Overall Study|Other reason not defined above|0|||
130311119|NCT01132313|469103089|FG003|Overall Study|Other reason not defined above|0|||
130311120|NCT01132313|469103090|FG004|Overall Study|Other reason not defined above|0|||
130311121|NCT01132313|469103091|FG005|Overall Study|Other reason not defined above|0|||
130311122|NCT01132313|469103092|FG006|Overall Study|Other reason not defined above|0|||
130311123|NCT01132313|469103093|FG007|Overall Study|Other reason not defined above|1|||
130311124|NCT01132313|469103094|FG008|Overall Study|Other reason not defined above|0|||
130311125|NCT01132313|469103095|FG009|Overall Study|Other reason not defined above|0|||
130311126|NCT01132313|469103096|FG010|Overall Study|Other reason not defined above|0|||
130311127|NCT01132313|469103097|FG011|Overall Study|Other reason not defined above|0|||
130311128|NCT03201419|469103098|FG000|Overall Study|Adverse Event|3|||
130311129|NCT03201419|469103099|FG001|Overall Study|Adverse Event|1|||
130311130|NCT03201419|469103100|FG002|Overall Study|Adverse Event|0|||
130311131|NCT03201419|469103101|FG003|Overall Study|Adverse Event|0|||
130311132|NCT03201419|469103102|FG004|Overall Study|Adverse Event|1|||
130311133|NCT03201419|469103103|FG005|Overall Study|Adverse Event|1|||
130311134|NCT03201419|469103104|FG006|Overall Study|Adverse Event|5|||
130311135|NCT03201419|469103105|FG007|Overall Study|Adverse Event|0|||
130311136|NCT03201419|469103106|FG008|Overall Study|Adverse Event|0|||
130311137|NCT03201419|469103098|FG000|Overall Study|Lost to Follow-up|1|||
130311138|NCT03201419|469103099|FG001|Overall Study|Lost to Follow-up|0|||
130311139|NCT03201419|469103100|FG002|Overall Study|Lost to Follow-up|0|||
130311140|NCT03201419|469103101|FG003|Overall Study|Lost to Follow-up|0|||
130311141|NCT03201419|469103102|FG004|Overall Study|Lost to Follow-up|0|||
130311142|NCT03201419|469103103|FG005|Overall Study|Lost to Follow-up|0|||
130311143|NCT03201419|469103104|FG006|Overall Study|Lost to Follow-up|0|||
130311144|NCT03201419|469103105|FG007|Overall Study|Lost to Follow-up|0|||
130311145|NCT03201419|469103106|FG008|Overall Study|Lost to Follow-up|0|||
130311146|NCT03201419|469103098|FG000|Overall Study|Protocol Deviation|0|||
130311147|NCT03201419|469103099|FG001|Overall Study|Protocol Deviation|0|||
130311148|NCT03201419|469103100|FG002|Overall Study|Protocol Deviation|0|||
130311149|NCT03201419|469103101|FG003|Overall Study|Protocol Deviation|0|||
130311150|NCT03201419|469103102|FG004|Overall Study|Protocol Deviation|0|||
130311151|NCT03201419|469103103|FG005|Overall Study|Protocol Deviation|0|||
130311152|NCT03201419|469103104|FG006|Overall Study|Protocol Deviation|1|||
130311153|NCT03201419|469103105|FG007|Overall Study|Protocol Deviation|0|||
130311154|NCT03201419|469103106|FG008|Overall Study|Protocol Deviation|0|||
130311155|NCT03201419|469103098|FG000|Overall Study|Withdrawal by Subject|4|||
130311156|NCT03201419|469103099|FG001|Overall Study|Withdrawal by Subject|2|||
130311157|NCT03201419|469103100|FG002|Overall Study|Withdrawal by Subject|1|||
130311158|NCT03201419|469103101|FG003|Overall Study|Withdrawal by Subject|0|||
130311159|NCT03201419|469103102|FG004|Overall Study|Withdrawal by Subject|0|||
129889956|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
129889957|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
129889958|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
129889959|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
129889960|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
129889961|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
129889962|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
129889963|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
129889964|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
129889965|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
129889966|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
129889967|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
129889968|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
129889969|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
129889970|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
129889971|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
129889972|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
129889973|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
129889974|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
129889975|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Death|0|||
129889976|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Death|1|||
129889977|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Death|0|||
129889978|NCT04630756|467554571|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
129889979|NCT04630756|467554572|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
129889980|NCT04630756|467554573|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
130311160|NCT03201419|469103103|FG005|Overall Study|Withdrawal by Subject|0|||
130311161|NCT03201419|469103104|FG006|Overall Study|Withdrawal by Subject|0|||
130311162|NCT03201419|469103105|FG007|Overall Study|Withdrawal by Subject|1|||
130311163|NCT03201419|469103106|FG008|Overall Study|Withdrawal by Subject|2|||
130311164|NCT03201419|469103098|FG000|Overall Study|Other|0|||
130311165|NCT03201419|469103099|FG001|Overall Study|Other|0|||
130311166|NCT03201419|469103100|FG002|Overall Study|Other|1|||
130311167|NCT03201419|469103101|FG003|Overall Study|Other|0|||
130311168|NCT03201419|469103102|FG004|Overall Study|Other|0|||
130311169|NCT03201419|469103103|FG005|Overall Study|Other|0|||
130311170|NCT03201419|469103104|FG006|Overall Study|Other|0|||
130311171|NCT03201419|469103105|FG007|Overall Study|Other|0|||
130311172|NCT03201419|469103106|FG008|Overall Study|Other|0|||
130311173|NCT01657292|469103108|FG000|Overall Study|Adverse Event|6|||
130311174|NCT01657292|469103108|FG000|Overall Study|Withdrawal by Subject|2|||
130311175|NCT01657292|469103108|FG000|Overall Study|Violation of eligibility criteria|1|||
130311176|NCT01657292|469103108|FG000|Overall Study|Change of therapy|1|||
130311177|NCT00650845|469103109|FG000|Overall Study|Withdrawal by Subject|5|||
130311178|NCT00650845|469103110|FG001|Overall Study|Withdrawal by Subject|0|||
130311179|NCT00650845|469103109|FG000|Overall Study|Protocol Violation|0|||
130311180|NCT00650845|469103110|FG001|Overall Study|Protocol Violation|13|||
130311181|NCT04178720|469103111|FG000|Overall Study|Withdrawal by Subject|2|||
130311182|NCT04178720|469103112|FG001|Overall Study|Withdrawal by Subject|0|||
130311183|NCT04178720|469103111|FG000|Overall Study|Relocation|0|||
130311184|NCT04178720|469103112|FG001|Overall Study|Relocation|1|||
130311185|NCT01301833|469103113|FG000|Overall Study|Adverse Event|7|||
130311186|NCT01301833|469103114|FG001|Overall Study|Adverse Event|5|||
130311187|NCT01301833|469103115|FG002|Overall Study|Adverse Event|5|||
130311188|NCT01301833|469103116|FG003|Overall Study|Adverse Event|5|||
130311189|NCT01301833|469103113|FG000|Overall Study|Lack of Efficacy|1|||
130311190|NCT01301833|469103114|FG001|Overall Study|Lack of Efficacy|1|||
130311191|NCT01301833|469103115|FG002|Overall Study|Lack of Efficacy|0|||
130311192|NCT01301833|469103116|FG003|Overall Study|Lack of Efficacy|0|||
130311193|NCT01301833|469103113|FG000|Overall Study|Physician Decision|3|||
130311194|NCT01301833|469103114|FG001|Overall Study|Physician Decision|1|||
130311195|NCT01301833|469103115|FG002|Overall Study|Physician Decision|1|||
130311196|NCT01301833|469103116|FG003|Overall Study|Physician Decision|0|||
129889981|NCT00847301|467554574|FG000|Overall Study|Adverse Event|35|||
130050130|NCT01070550|468140744|FG005|Overall Study|New treatment started|0|||
130050131|NCT01070550|468140739|FG000|Overall Study|Non-responders|493|||
130311197|NCT01301833|469103113|FG000|Overall Study|Withdrawal by Subject|3|||
130311198|NCT01301833|469103114|FG001|Overall Study|Withdrawal by Subject|1|||
130311199|NCT01301833|469103115|FG002|Overall Study|Withdrawal by Subject|1|||
130311200|NCT01301833|469103116|FG003|Overall Study|Withdrawal by Subject|2|||
130311201|NCT01301833|469103113|FG000|Overall Study|Personal matter|1|||
130311202|NCT01301833|469103114|FG001|Overall Study|Personal matter|0|||
130311203|NCT01301833|469103115|FG002|Overall Study|Personal matter|0|||
130311204|NCT01301833|469103116|FG003|Overall Study|Personal matter|0|||
129798823|NCT00591266|467232156|FG002|Overall Study|Withdrawal by Subject|5|||
129798824|NCT00591266|467232154|FG000|Overall Study|Lack of Efficacy|0|||
129798825|NCT00591266|467232155|FG001|Overall Study|Lack of Efficacy|2|||
129798826|NCT00591266|467232156|FG002|Overall Study|Lack of Efficacy|0|||
129798827|NCT00591266|467232154|FG000|Overall Study|Other|1|||
129798828|NCT00591266|467232155|FG001|Overall Study|Other|4|||
129798829|NCT00591266|467232156|FG002|Overall Study|Other|5|||
129798830|NCT03488927|467232157|FG000|Overall Study|Withdrawal by Subject|44|||
129798831|NCT03488927|467232158|FG001|Overall Study|Withdrawal by Subject|118|||
129798832|NCT03488927|467232159|FG002|Overall Study|Withdrawal by Subject|217|||
129798833|NCT00901927|467232162|FG000|Overall Study|Lack of Efficacy|1|||
130050132|NCT01070550|468140740|FG001|Overall Study|Non-responders|4|||
130311205|NCT03922620|469103117|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
130311206|NCT03922620|469103118|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
130311207|NCT04177212|469103119|FG000|Overall Study|Withdrawal by Subject|9|||
130311208|NCT04177212|469103120|FG001|Overall Study|Withdrawal by Subject|7|||
130311209|NCT04177212|469103119|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
130311210|NCT04177212|469103120|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
130311211|NCT04177212|469103119|FG000|Overall Study|Physician Decision|1|||
130311212|NCT04177212|469103120|FG001|Overall Study|Physician Decision|0|||
130311213|NCT04177212|469103119|FG000|Overall Study|Lost to Follow-up|0|||
130311214|NCT04177212|469103120|FG001|Overall Study|Lost to Follow-up|3|||
130311215|NCT04177212|469103119|FG000|Overall Study|Adverse Event|0|||
130311216|NCT04177212|469103120|FG001|Overall Study|Adverse Event|1|||
130311217|NCT04177212|469103119|FG000|Overall Study|Other|1|||
130311218|NCT04177212|469103120|FG001|Overall Study|Other|2|||
130311219|NCT04725500|469103121|FG000|Screening|Screen Failure|26|||
130311220|NCT04725500|469103121|FG000|Screening|Withdrawal by Subject|1|||
130311221|NCT04725500|469103121|FG000|2 Week Take Home|Screen Fail|5|||
130311222|NCT01792115|469103122|FG000|Overall Study|Lost to Follow-up|0|||
130311223|NCT01792115|469103123|FG001|Overall Study|Lost to Follow-up|1|||
130311224|NCT01792115|469103124|FG002|Overall Study|Lost to Follow-up|0|||
130311225|NCT04618744|469103126|FG000|Overall Study|Adverse Event|0|||
130311226|NCT04618744|469103127|FG001|Overall Study|Adverse Event|1|||
130311227|NCT04618744|469103126|FG000|Overall Study|Withdrawal by Subject|0|||
130311228|NCT04618744|469103127|FG001|Overall Study|Withdrawal by Subject|1|||
130311229|NCT00930930|469103128|FG000|Overall Study|Death|1|||
130311230|NCT00930930|469103129|FG001|Overall Study|Death|0|||
130311231|NCT00930930|469103128|FG000|Overall Study|Physician Decision|1|||
130311232|NCT00930930|469103129|FG001|Overall Study|Physician Decision|0|||
130311233|NCT00930930|469103128|FG000|Overall Study|Adverse Event|13|||
130311234|NCT00930930|469103129|FG001|Overall Study|Adverse Event|3|||
130311235|NCT00930930|469103128|FG000|Overall Study|Withdrawal by Subject|3|||
130311236|NCT00930930|469103129|FG001|Overall Study|Withdrawal by Subject|1|||
130311237|NCT00930930|469103128|FG000|Overall Study|Disease progression|2|||
130311238|NCT00930930|469103129|FG001|Overall Study|Disease progression|3|||
130311239|NCT00930930|469103128|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
130311240|NCT00930930|469103129|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
130311241|NCT00930930|469103128|FG000|Overall Study|patients not compliant|1|||
130311242|NCT00930930|469103129|FG001|Overall Study|patients not compliant|1|||
130311243|NCT02709330|469103130|FG000|Overall Study|Death|5|||
130311244|NCT02709330|469103131|FG001|Overall Study|Death|0|||
130311245|NCT02709330|469103130|FG000|Overall Study|Lost to Follow-up|2|||
130311246|NCT02709330|469103131|FG001|Overall Study|Lost to Follow-up|0|||
130311247|NCT02709330|469103130|FG000|Overall Study|Physician Decision|2|||
130311248|NCT02709330|469103131|FG001|Overall Study|Physician Decision|0|||
130311249|NCT02709330|469103130|FG000|Overall Study|Withdrawal by Subject|4|||
130311250|NCT02709330|469103131|FG001|Overall Study|Withdrawal by Subject|0|||
130311251|NCT01279681|469103132|FG000|Overall Study|Disease Progression|9|||
130311252|NCT01279681|469103133|FG001|Overall Study|Disease Progression|6|||
130311253|NCT01279681|469103132|FG000|Overall Study|Withdrawal by Subject|3|||
130311254|NCT01279681|469103133|FG001|Overall Study|Withdrawal by Subject|4|||
130311255|NCT01279681|469103132|FG000|Overall Study|Adverse Event|2|||
130311256|NCT01279681|469103133|FG001|Overall Study|Adverse Event|3|||
129798834|NCT00901927|467232162|FG000|Overall Study|Protocol Violation|3|||
129798835|NCT00901927|467232162|FG000|Overall Study|Withdrawal by Subject|2|||
130311257|NCT01279681|469103132|FG000|Overall Study|Death|0|||
130311258|NCT01279681|469103133|FG001|Overall Study|Death|1|||
130311259|NCT01279681|469103132|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
129798836|NCT05298306|467232163|FG000|Overall Study|Physician Decision|0|||
129798837|NCT05298306|467232164|FG001|Overall Study|Physician Decision|0|||
130311260|NCT01279681|469103133|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
130311261|NCT01279681|469103132|FG000|Overall Study|Physician Decision|1|||
130311262|NCT01279681|469103133|FG001|Overall Study|Physician Decision|0|||
130311263|NCT01279681|469103132|FG000|Overall Study|Other Reason|0|||
130311264|NCT01279681|469103133|FG001|Overall Study|Other Reason|2|||
130311265|NCT01633788|469105283|FG000|Overall Study|Adverse Event|1|||
130050133|NCT01070550|468140741|FG002|Overall Study|Non-responders|21|||
130311266|NCT01633788|469105284|FG001|Overall Study|Adverse Event|3|||
130311267|NCT01633788|469105285|FG002|Overall Study|Adverse Event|3|||
130311268|NCT01633788|469105286|FG003|Overall Study|Adverse Event|3|||
130311269|NCT01633788|469105283|FG000|Overall Study|Lost to Follow-up|2|||
130311270|NCT01633788|469105284|FG001|Overall Study|Lost to Follow-up|2|||
130311271|NCT01633788|469105285|FG002|Overall Study|Lost to Follow-up|2|||
130311272|NCT01633788|469105286|FG003|Overall Study|Lost to Follow-up|0|||
130311273|NCT01633788|469105283|FG000|Overall Study|Personal Reasons|3|||
130311274|NCT01633788|469105284|FG001|Overall Study|Personal Reasons|1|||
130311275|NCT01633788|469105285|FG002|Overall Study|Personal Reasons|1|||
130311276|NCT01633788|469105286|FG003|Overall Study|Personal Reasons|3|||
130311277|NCT01633788|469105283|FG000|Overall Study|Protocol Violation|1|||
130311278|NCT01633788|469105284|FG001|Overall Study|Protocol Violation|0|||
130311279|NCT01633788|469105285|FG002|Overall Study|Protocol Violation|1|||
130311280|NCT01633788|469105286|FG003|Overall Study|Protocol Violation|0|||
130311281|NCT01633788|469105283|FG000|Overall Study|Other Reasons|0|||
130311282|NCT01633788|469105284|FG001|Overall Study|Other Reasons|2|||
130311283|NCT01633788|469105285|FG002|Overall Study|Other Reasons|3|||
130311284|NCT01633788|469105286|FG003|Overall Study|Other Reasons|7|||
130311285|NCT01929226|469105287|FG000|Overall Study|Lost to Follow-up|4|||
130311286|NCT01929226|469105288|FG001|Overall Study|Lost to Follow-up|0|||
130311287|NCT01929226|469105287|FG000|Overall Study|Withdrawal by Subject|1|||
130311288|NCT01929226|469105288|FG001|Overall Study|Withdrawal by Subject|1|||
130311289|NCT02807623|469105291|FG000|Overall Study|Lost to Follow-up|23|||
130311290|NCT02807623|469105292|FG001|Overall Study|Lost to Follow-up|18|||
130311291|NCT02807623|469105293|FG002|Overall Study|Lost to Follow-up|22|||
130311292|NCT02807623|469105291|FG000|Overall Study|Drug intolerance|0|||
130311293|NCT02807623|469105292|FG001|Overall Study|Drug intolerance|1|||
130311294|NCT02807623|469105293|FG002|Overall Study|Drug intolerance|0|||
130311295|NCT02807623|469105291|FG000|Overall Study|incomplete blood draw|0|||
130311296|NCT02807623|469105292|FG001|Overall Study|incomplete blood draw|2|||
130311297|NCT02807623|469105293|FG002|Overall Study|incomplete blood draw|1|||
130311298|NCT00859547|469105294|FG000|Overall Study|Lost to Follow-up|1|||
130311299|NCT00859547|469105294|FG000|Overall Study|Parent withdrew consent|1|||
130311300|NCT03310723|469105295|FG000|Overall Study|Withdrawal by Subject|0|||
130311301|NCT03310723|469105296|FG001|Overall Study|Withdrawal by Subject|1|||
130311302|NCT03310723|469105295|FG000|Overall Study|Protocol Violation|0|||
130311303|NCT03310723|469105296|FG001|Overall Study|Protocol Violation|2|||
130311304|NCT02098746|469105298|FG000|Overall Study|Changes of Investigator|2|||
130311305|NCT02098746|469105298|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130311306|NCT02098746|469105298|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
130311307|NCT02098746|469105298|FG000|Overall Study|Data Not Available After Treatment|1|||
130311308|NCT01410890|469105299|FG000|Overall Study|Withdrawal by Subject|0|||
130311309|NCT01410890|469105300|FG001|Overall Study|Withdrawal by Subject|1|||
130311310|NCT00217425|469105303|FG000|Overall Study|Never started treatment|2|||
130311311|NCT00217425|469105303|FG000|Overall Study|Patient ineligible|5|||
130311312|NCT00217425|469105303|FG000|Overall Study|Lack of Efficacy|13|||
130311313|NCT00217425|469105303|FG000|Overall Study|Adverse Event|8|||
130311314|NCT00217425|469105303|FG000|Overall Study|Withdrawal by Subject|4|||
129889982|NCT00847301|467554574|FG000|Overall Study|Switch to other anticoagulants|16|||
129889983|NCT00847301|467554574|FG000|Overall Study|Lost to Follow-up|1|||
129889984|NCT00847301|467554574|FG000|Overall Study|No prescription after hospital discharge|1|||
129889985|NCT00847301|467554574|FG000|Overall Study|Other reason not defined above|1|||
129889986|NCT05593211|467554575|FG000|Overall Study|Withdrawal by Subject|1|||
129889987|NCT03077620|467554579|FG000|Overall Study|Unable to place lumbar catheter|1|||
129889988|NCT03077620|467554580|FG001|Overall Study|Unable to place lumbar catheter|0|||
129889989|NCT03077620|467554581|FG002|Overall Study|Unable to place lumbar catheter|1|||
129889990|NCT03077620|467554582|FG003|Overall Study|Unable to place lumbar catheter|0|||
129889991|NCT03077620|467554579|FG000|Overall Study|Withdrawal by Subject|0|||
129889992|NCT03077620|467554580|FG001|Overall Study|Withdrawal by Subject|1|||
129889993|NCT03077620|467554581|FG002|Overall Study|Withdrawal by Subject|0|||
129889994|NCT03077620|467554582|FG003|Overall Study|Withdrawal by Subject|0|||
129889995|NCT03077620|467554579|FG000|Overall Study|Physician Decision|0|||
129889996|NCT03077620|467554580|FG001|Overall Study|Physician Decision|0|||
129889997|NCT03077620|467554581|FG002|Overall Study|Physician Decision|1|||
129889998|NCT03077620|467554582|FG003|Overall Study|Physician Decision|0|||
129889999|NCT03225846|467554583|FG000|Overall Study|Adverse Event|0|||
129890000|NCT03225846|467554584|FG001|Overall Study|Adverse Event|0|||
129890001|NCT03225846|467554585|FG002|Overall Study|Adverse Event|0|||
129890002|NCT03225846|467554586|FG003|Overall Study|Adverse Event|0|||
129890003|NCT03225846|467554587|FG004|Overall Study|Adverse Event|0|||
129890004|NCT03225846|467554588|FG005|Overall Study|Adverse Event|0|||
129890005|NCT03225846|467554589|FG006|Overall Study|Adverse Event|6|||
129890006|NCT03225846|467554583|FG000|Overall Study|Withdrawal by Subject|0|||
129890007|NCT03225846|467554584|FG001|Overall Study|Withdrawal by Subject|1|||
129890008|NCT03225846|467554585|FG002|Overall Study|Withdrawal by Subject|0|||
129890009|NCT03225846|467554586|FG003|Overall Study|Withdrawal by Subject|0|||
129890010|NCT03225846|467554587|FG004|Overall Study|Withdrawal by Subject|0|||
129890011|NCT03225846|467554588|FG005|Overall Study|Withdrawal by Subject|0|||
129890012|NCT03225846|467554589|FG006|Overall Study|Withdrawal by Subject|0|||
130311315|NCT00217425|469105303|FG000|Overall Study|Other complicating disease|1|||
130311316|NCT00217425|469105303|FG000|Overall Study|Other|4|||
130311317|NCT01121146|469105304|FG000|Overall Study|Death|17|||
130311318|NCT01121146|469105305|FG001|Overall Study|Death|15|||
130311319|NCT01121146|469105304|FG000|Overall Study|Adverse Event|2|||
130311320|NCT01121146|469105305|FG001|Overall Study|Adverse Event|11|||
130311321|NCT01121146|469105304|FG000|Overall Study|Lost to Follow-up|7|||
130311322|NCT01121146|469105305|FG001|Overall Study|Lost to Follow-up|16|||
130311323|NCT00997035|469105308|FG000|3-week Followup Visit|Lost to Follow-up|9|||
130311324|NCT00997035|469105309|FG001|3-week Followup Visit|Lost to Follow-up|6|||
130311325|NCT00997035|469105308|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
130311326|NCT00997035|469105309|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
130311327|NCT02544503|469105310|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
130311328|NCT02544503|469105311|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
130311329|NCT02544503|469105310|FG000|Overall Study|Lost to Follow-up|9|||
130311330|NCT02544503|469105311|FG001|Overall Study|Lost to Follow-up|0|||
130311331|NCT02544503|469105310|FG000|Overall Study|Withdrawal by Subject|1|||
130311332|NCT02544503|469105311|FG001|Overall Study|Withdrawal by Subject|0|||
130311333|NCT01080807|469105315|FG000|Overall Study|Adverse Event|9|||
130311334|NCT01080807|469105316|FG001|Overall Study|Adverse Event|1|||
130311335|NCT01080807|469105315|FG000|Overall Study|Lack of Efficacy|0|||
130311336|NCT01080807|469105316|FG001|Overall Study|Lack of Efficacy|1|||
130311337|NCT01080807|469105315|FG000|Overall Study|Withdrawal by Subject|7|||
130311338|NCT01080807|469105316|FG001|Overall Study|Withdrawal by Subject|2|||
130311339|NCT01080807|469105315|FG000|Overall Study|Protocol Violation|7|||
130311340|NCT01080807|469105316|FG001|Overall Study|Protocol Violation|6|||
130311341|NCT01080807|469105315|FG000|Overall Study|Lost to Follow-up|6|||
130311342|NCT01080807|469105316|FG001|Overall Study|Lost to Follow-up|4|||
130311343|NCT01080807|469105315|FG000|Overall Study|Noncompliance with drug administration|1|||
130311344|NCT01080807|469105316|FG001|Overall Study|Noncompliance with drug administration|1|||
130311345|NCT01080807|469105315|FG000|Overall Study|Noncompliance to study procedures|1|||
130311346|NCT01080807|469105316|FG001|Overall Study|Noncompliance to study procedures|1|||
130311347|NCT01080807|469105315|FG000|Overall Study|Began working day shift|0|||
130311348|NCT01080807|469105316|FG001|Overall Study|Began working day shift|2|||
130311349|NCT01080807|469105315|FG000|Overall Study|Laid off or terminated from job|1|||
130311350|NCT01080807|469105316|FG001|Overall Study|Laid off or terminated from job|2|||
130311351|NCT01080807|469105315|FG000|Overall Study|Stopped working consistent night shifts|0|||
130311352|NCT01080807|469105316|FG001|Overall Study|Stopped working consistent night shifts|1|||
130311353|NCT01080807|469105315|FG000|Overall Study|Work schedule changing|1|||
130311354|NCT01080807|469105316|FG001|Overall Study|Work schedule changing|1|||
130311355|NCT01080807|469105315|FG000|Overall Study|Work schedule and travel|0|||
130311356|NCT01080807|469105316|FG001|Overall Study|Work schedule and travel|1|||
130311357|NCT01080807|469105315|FG000|Overall Study|Switched to first shift|1|||
130311358|NCT01080807|469105316|FG001|Overall Study|Switched to first shift|0|||
130311359|NCT01080807|469105315|FG000|Overall Study|Moved away without notifying center|1|||
130311360|NCT01080807|469105316|FG001|Overall Study|Moved away without notifying center|0|||
130311361|NCT03922581|469105319|FG000|Overall Study|Lost to Follow-up|20|||
130311362|NCT03922581|469105320|FG001|Overall Study|Lost to Follow-up|9|||
130311363|NCT03922581|469105319|FG000|Overall Study|Physician Decision|1|||
130311364|NCT03922581|469105320|FG001|Overall Study|Physician Decision|1|||
130311365|NCT03922581|469105319|FG000|Overall Study|Withdrawal by Subject|1|||
130311366|NCT03922581|469105320|FG001|Overall Study|Withdrawal by Subject|0|||
130311367|NCT04685798|469105323|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
130311368|NCT04640311|469105324|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
130311369|NCT04640311|469105325|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311370|NCT04640311|469105326|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311371|NCT04640311|469105327|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311372|NCT04640311|469105328|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311373|NCT04640311|469105329|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311374|NCT04640311|469105330|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311375|NCT04640311|469105331|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311376|NCT04640311|469105332|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311377|NCT04640311|469105333|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311378|NCT04640311|469105334|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129798838|NCT05298306|467232165|FG002|Overall Study|Physician Decision|0|||
130110607|NCT03276962|468365791|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
130311379|NCT04640311|469105335|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311380|NCT04640311|469105336|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311381|NCT04640311|469105324|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311382|NCT04640311|469105325|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
130311383|NCT04640311|469105326|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130050134|NCT01070550|468140742|FG003|Overall Study|Non-responders|20|||
130050135|NCT01070550|468140743|FG004|Overall Study|Non-responders|0|||
130050136|NCT01070550|468140744|FG005|Overall Study|Non-responders|2|||
130050137|NCT01070550|468140739|FG000|Overall Study|Not categorized|33|||
130050138|NCT01070550|468140740|FG001|Overall Study|Not categorized|2|||
130050139|NCT01070550|468140741|FG002|Overall Study|Not categorized|6|||
130050140|NCT01070550|468140742|FG003|Overall Study|Not categorized|1|||
130050141|NCT01070550|468140743|FG004|Overall Study|Not categorized|0|||
130050142|NCT01070550|468140744|FG005|Overall Study|Not categorized|1|||
130050143|NCT01070550|468140739|FG000|Overall Study|Protocol Violation|15|||
130050144|NCT01070550|468140740|FG001|Overall Study|Protocol Violation|1|||
130050145|NCT01070550|468140741|FG002|Overall Study|Protocol Violation|1|||
130050146|NCT01070550|468140742|FG003|Overall Study|Protocol Violation|1|||
130050147|NCT01070550|468140743|FG004|Overall Study|Protocol Violation|0|||
130050148|NCT01070550|468140744|FG005|Overall Study|Protocol Violation|0|||
130050149|NCT01070550|468140739|FG000|Overall Study|Relapse|44|||
130050150|NCT01070550|468140740|FG001|Overall Study|Relapse|5|||
130050151|NCT01070550|468140741|FG002|Overall Study|Relapse|14|||
130050152|NCT01070550|468140742|FG003|Overall Study|Relapse|4|||
130050153|NCT01070550|468140743|FG004|Overall Study|Relapse|0|||
130050154|NCT01070550|468140744|FG005|Overall Study|Relapse|0|||
130050155|NCT01070550|468140739|FG000|Overall Study|Result not available|3|||
130050156|NCT01070550|468140740|FG001|Overall Study|Result not available|1|||
130050157|NCT01070550|468140741|FG002|Overall Study|Result not available|3|||
130050158|NCT01070550|468140742|FG003|Overall Study|Result not available|0|||
130050159|NCT01070550|468140743|FG004|Overall Study|Result not available|0|||
130050160|NCT01070550|468140744|FG005|Overall Study|Result not available|0|||
130050161|NCT01070550|468140739|FG000|Overall Study|Screen failure|1|||
130050162|NCT01070550|468140740|FG001|Overall Study|Screen failure|0|||
130050163|NCT01070550|468140741|FG002|Overall Study|Screen failure|0|||
130050164|NCT01070550|468140742|FG003|Overall Study|Screen failure|0|||
130050165|NCT01070550|468140743|FG004|Overall Study|Screen failure|0|||
130050166|NCT01070550|468140744|FG005|Overall Study|Screen failure|0|||
130050167|NCT01070550|468140739|FG000|Overall Study|Sponsor decision|1|||
130050168|NCT01070550|468140740|FG001|Overall Study|Sponsor decision|0|||
130050169|NCT01070550|468140741|FG002|Overall Study|Sponsor decision|0|||
130050170|NCT01070550|468140742|FG003|Overall Study|Sponsor decision|0|||
130050171|NCT01070550|468140743|FG004|Overall Study|Sponsor decision|0|||
130050172|NCT01070550|468140744|FG005|Overall Study|Sponsor decision|0|||
130050173|NCT01070550|468140739|FG000|Overall Study|Treatment duration shortened|1|||
130050174|NCT01070550|468140740|FG001|Overall Study|Treatment duration shortened|0|||
130050175|NCT01070550|468140741|FG002|Overall Study|Treatment duration shortened|0|||
130050176|NCT01070550|468140742|FG003|Overall Study|Treatment duration shortened|0|||
130050177|NCT01070550|468140743|FG004|Overall Study|Treatment duration shortened|0|||
130050178|NCT01070550|468140744|FG005|Overall Study|Treatment duration shortened|0|||
130050179|NCT01070550|468140739|FG000|Overall Study|Treatment interrupted|7|||
130050180|NCT01070550|468140740|FG001|Overall Study|Treatment interrupted|0|||
130050181|NCT01070550|468140741|FG002|Overall Study|Treatment interrupted|1|||
130050182|NCT01070550|468140742|FG003|Overall Study|Treatment interrupted|1|||
130050183|NCT01070550|468140743|FG004|Overall Study|Treatment interrupted|0|||
130050184|NCT01070550|468140744|FG005|Overall Study|Treatment interrupted|0|||
130050185|NCT01070550|468140739|FG000|Overall Study|Treatment not started|14|||
130050186|NCT01070550|468140740|FG001|Overall Study|Treatment not started|2|||
130050187|NCT01070550|468140741|FG002|Overall Study|Treatment not started|4|||
130050188|NCT01070550|468140742|FG003|Overall Study|Treatment not started|0|||
130050189|NCT01070550|468140743|FG004|Overall Study|Treatment not started|0|||
130050190|NCT01070550|468140744|FG005|Overall Study|Treatment not started|0|||
130050191|NCT01070550|468140739|FG000|Overall Study|Treatment restarted|0|||
129890013|NCT03225846|467554583|FG000|Overall Study|Death|0|||
129890014|NCT03225846|467554584|FG001|Overall Study|Death|1|||
129890015|NCT03225846|467554585|FG002|Overall Study|Death|0|||
129890016|NCT03225846|467554586|FG003|Overall Study|Death|0|||
129890017|NCT03225846|467554587|FG004|Overall Study|Death|0|||
129890018|NCT03225846|467554588|FG005|Overall Study|Death|0|||
129890019|NCT03225846|467554589|FG006|Overall Study|Death|0|||
129890020|NCT03225846|467554583|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890021|NCT03225846|467554584|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890022|NCT03225846|467554585|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
129890023|NCT03225846|467554586|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890024|NCT03225846|467554587|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890025|NCT03225846|467554588|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890026|NCT03225846|467554589|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890027|NCT03225846|467554583|FG000|Overall Study|Patient decision|0|||
129890028|NCT03225846|467554584|FG001|Overall Study|Patient decision|0|||
129890029|NCT03225846|467554585|FG002|Overall Study|Patient decision|0|||
129890030|NCT03225846|467554586|FG003|Overall Study|Patient decision|0|||
129890031|NCT03225846|467554587|FG004|Overall Study|Patient decision|0|||
129890032|NCT03225846|467554588|FG005|Overall Study|Patient decision|0|||
129890033|NCT03225846|467554589|FG006|Overall Study|Patient decision|1|||
129890034|NCT00996580|467554590|FG000|Overall Study|Adverse Event|466|||
129890035|NCT00996580|467554590|FG000|Overall Study|Lost to Follow-up|480|||
129890036|NCT00996580|467554590|FG000|Overall Study|Noncompliance with the protocol|137|||
129890037|NCT00996580|467554590|FG000|Overall Study|Physician Decision|5|||
129890038|NCT00996580|467554590|FG000|Overall Study|Pregnancy|68|||
129890039|NCT00996580|467554590|FG000|Overall Study|Protocol Violation|16|||
129890040|NCT00996580|467554590|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
129890041|NCT00996580|467554590|FG000|Overall Study|Withdrawal by Subject|217|||
129890042|NCT00996580|467554590|FG000|Overall Study|Other|29|||
129890043|NCT04248465|467554591|FG000|Randomized-Controlled Period|Death|12|||
129890044|NCT04248465|467554592|FG001|Randomized-Controlled Period|Death|5|||
129890045|NCT04248465|467554591|FG000|Randomized-Controlled Period|Adverse Event|2|||
129890046|NCT04248465|467554592|FG001|Randomized-Controlled Period|Adverse Event|0|||
129890047|NCT04248465|467554591|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
129890048|NCT04248465|467554592|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
129890049|NCT04248465|467554591|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
129798839|NCT05298306|467232166|FG003|Overall Study|Physician Decision|1|||
129798840|NCT05298306|467232167|FG004|Overall Study|Physician Decision|0|||
129798841|NCT05298306|467232168|FG005|Overall Study|Physician Decision|0|||
129798842|NCT02676466|467232173|FG000|Overall Study|Death|0|||
129798843|NCT02676466|467232174|FG001|Overall Study|Death|2|||
129798844|NCT02676466|467232175|FG002|Overall Study|Death|1|||
129798845|NCT02676466|467232176|FG003|Overall Study|Death|0|||
129798846|NCT02676466|467232177|FG004|Overall Study|Death|0|||
129798847|NCT02676466|467232178|FG005|Overall Study|Death|0|||
130050192|NCT01070550|468140740|FG001|Overall Study|Treatment restarted|1|||
130050193|NCT01070550|468140741|FG002|Overall Study|Treatment restarted|0|||
130050194|NCT01070550|468140742|FG003|Overall Study|Treatment restarted|0|||
130050195|NCT01070550|468140743|FG004|Overall Study|Treatment restarted|0|||
129798848|NCT02676466|467232179|FG006|Overall Study|Death|0|||
130050196|NCT01070550|468140744|FG005|Overall Study|Treatment restarted|0|||
130050197|NCT01070550|468140739|FG000|Overall Study|Treatment stopped|3|||
130050198|NCT01070550|468140740|FG001|Overall Study|Treatment stopped|0|||
130050199|NCT01070550|468140741|FG002|Overall Study|Treatment stopped|0|||
130050200|NCT01070550|468140742|FG003|Overall Study|Treatment stopped|0|||
130050201|NCT01070550|468140743|FG004|Overall Study|Treatment stopped|0|||
130050202|NCT01070550|468140744|FG005|Overall Study|Treatment stopped|0|||
129798849|NCT02676466|467232180|FG007|Overall Study|Death|0|||
129798850|NCT02676466|467232173|FG000|Overall Study|Withdrawal by Subject|4|||
129890050|NCT04248465|467554592|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
129890051|NCT04248465|467554591|FG000|Randomized-Controlled Period|Physician Decision|1|||
129890052|NCT04248465|467554592|FG001|Randomized-Controlled Period|Physician Decision|1|||
129798851|NCT02676466|467232174|FG001|Overall Study|Withdrawal by Subject|3|||
129890053|NCT04248465|467554591|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
129890054|NCT04248465|467554592|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
129798852|NCT02676466|467232175|FG002|Overall Study|Withdrawal by Subject|1|||
129798853|NCT02676466|467232176|FG003|Overall Study|Withdrawal by Subject|0|||
129890055|NCT04248465|467554591|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
130050203|NCT01070550|468140739|FG000|Overall Study|Treatment unavailable|1|||
129798854|NCT02676466|467232177|FG004|Overall Study|Withdrawal by Subject|3|||
129798855|NCT02676466|467232178|FG005|Overall Study|Withdrawal by Subject|1|||
129798856|NCT02676466|467232179|FG006|Overall Study|Withdrawal by Subject|1|||
129890056|NCT04248465|467554592|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
129890057|NCT04248465|467554591|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129890058|NCT04248465|467554592|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
129890059|NCT05708846|467554593|FG000|Overall Study|Death|5|||
130311384|NCT04640311|469105327|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311385|NCT04640311|469105328|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311386|NCT04640311|469105329|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311387|NCT04640311|469105330|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311388|NCT04640311|469105331|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311389|NCT04640311|469105332|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311390|NCT04640311|469105333|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311391|NCT04640311|469105334|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311392|NCT04640311|469105335|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311393|NCT04640311|469105336|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
130311394|NCT04640311|469105324|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311395|NCT04640311|469105325|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
130311396|NCT04640311|469105326|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311397|NCT04640311|469105327|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311398|NCT04640311|469105328|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311399|NCT04640311|469105329|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311400|NCT04640311|469105330|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311401|NCT04640311|469105331|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311402|NCT04640311|469105332|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311403|NCT04640311|469105333|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311404|NCT04640311|469105334|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311405|NCT04640311|469105335|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311406|NCT04640311|469105336|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311407|NCT04640311|469105324|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
130311408|NCT04640311|469105325|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
130311409|NCT04640311|469105326|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
130311410|NCT04640311|469105327|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311411|NCT04640311|469105328|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311412|NCT04640311|469105329|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311413|NCT04640311|469105330|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311414|NCT04640311|469105331|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311415|NCT04640311|469105332|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311416|NCT04640311|469105333|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311417|NCT04640311|469105334|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311418|NCT04640311|469105335|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311419|NCT04640311|469105336|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
130311420|NCT04640311|469105324|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311421|NCT04640311|469105325|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311422|NCT04640311|469105326|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
130311423|NCT04640311|469105327|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311424|NCT04640311|469105328|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311425|NCT04640311|469105329|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311426|NCT04640311|469105330|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311427|NCT04640311|469105331|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311428|NCT04640311|469105332|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311429|NCT04640311|469105333|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311430|NCT04640311|469105334|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311431|NCT04640311|469105335|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311432|NCT04640311|469105336|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
130311433|NCT04640311|469105324|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311434|NCT04640311|469105325|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311435|NCT04640311|469105326|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311436|NCT04640311|469105327|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
130110608|NCT03276962|468365792|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
130311437|NCT04640311|469105328|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311438|NCT04640311|469105329|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311439|NCT04640311|469105330|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
130311440|NCT04640311|469105331|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311441|NCT04640311|469105332|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311442|NCT04640311|469105333|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311443|NCT04640311|469105334|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311444|NCT04640311|469105335|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311445|NCT04640311|469105336|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
130311446|NCT04640311|469105324|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311447|NCT04640311|469105325|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311448|NCT04640311|469105326|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311449|NCT04640311|469105327|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311450|NCT04640311|469105328|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311451|NCT04640311|469105329|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
130311452|NCT04640311|469105330|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311453|NCT04640311|469105331|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311454|NCT04640311|469105332|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
130311455|NCT04640311|469105333|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311456|NCT04640311|469105334|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311457|NCT04640311|469105335|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311458|NCT04640311|469105336|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
130311459|NCT04640311|469105324|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311460|NCT04640311|469105325|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311461|NCT04640311|469105326|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311462|NCT04640311|469105327|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311463|NCT04640311|469105328|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311464|NCT04640311|469105329|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311465|NCT04640311|469105330|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
130311466|NCT04640311|469105331|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311467|NCT04640311|469105332|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311468|NCT04640311|469105333|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311469|NCT04640311|469105334|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
130311470|NCT04640311|469105335|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311471|NCT04640311|469105336|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
130311472|NCT04640311|469105324|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311473|NCT04640311|469105325|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311474|NCT04640311|469105326|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311475|NCT04640311|469105327|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311476|NCT04640311|469105328|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311477|NCT04640311|469105329|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311478|NCT04640311|469105330|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311479|NCT04640311|469105331|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311480|NCT04640311|469105332|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311481|NCT04640311|469105333|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311482|NCT04640311|469105334|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311483|NCT04640311|469105335|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
130311484|NCT04640311|469105336|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
130311485|NCT03956550|469105337|FG000|Overall Study|Sponsor decision|65|||
130311486|NCT03956550|469105338|FG001|Overall Study|Sponsor decision|66|||
130311487|NCT03956550|469105339|FG002|Overall Study|Sponsor decision|64|||
130311488|NCT03956550|469105337|FG000|Overall Study|Adverse Event|0|||
130311489|NCT03956550|469105338|FG001|Overall Study|Adverse Event|1|||
130311490|NCT03956550|469105339|FG002|Overall Study|Adverse Event|0|||
130311491|NCT03956550|469105337|FG000|Overall Study|Withdrawal by Subject|5|||
130311492|NCT03956550|469105338|FG001|Overall Study|Withdrawal by Subject|5|||
130311493|NCT03956550|469105339|FG002|Overall Study|Withdrawal by Subject|6|||
130311494|NCT00592904|469105342|FG000|Overall Study|Adverse Event|15|||
130311495|NCT00592904|469105343|FG001|Overall Study|Adverse Event|25|||
130311496|NCT00592904|469105344|FG002|Overall Study|Adverse Event|13|||
130311497|NCT00592904|469105345|FG003|Overall Study|Adverse Event|5|||
130311498|NCT00592904|469105342|FG000|Overall Study|Protocol Violation|1|||
130311499|NCT00592904|469105343|FG001|Overall Study|Protocol Violation|1|||
130311500|NCT00592904|469105344|FG002|Overall Study|Protocol Violation|0|||
130311501|NCT00592904|469105345|FG003|Overall Study|Protocol Violation|1|||
130311502|NCT00592904|469105342|FG000|Overall Study|Withdrawal by Subject|4|||
130311503|NCT00592904|469105343|FG001|Overall Study|Withdrawal by Subject|16|||
130311504|NCT00592904|469105344|FG002|Overall Study|Withdrawal by Subject|1|||
130311505|NCT00592904|469105345|FG003|Overall Study|Withdrawal by Subject|2|||
130311506|NCT00592904|469105342|FG000|Overall Study|Lack of Efficacy|2|||
130311507|NCT00592904|469105343|FG001|Overall Study|Lack of Efficacy|7|||
130311508|NCT00592904|469105344|FG002|Overall Study|Lack of Efficacy|2|||
130311509|NCT00592904|469105345|FG003|Overall Study|Lack of Efficacy|3|||
130311510|NCT00592904|469105342|FG000|Overall Study|Physician Decision|0|||
130311511|NCT00592904|469105343|FG001|Overall Study|Physician Decision|3|||
130311512|NCT00592904|469105344|FG002|Overall Study|Physician Decision|1|||
130311513|NCT00592904|469105345|FG003|Overall Study|Physician Decision|0|||
130311514|NCT00592904|469105342|FG000|Overall Study|Other|3|||
130311515|NCT00592904|469105343|FG001|Overall Study|Other|3|||
130311516|NCT00592904|469105344|FG002|Overall Study|Other|0|||
130311517|NCT00592904|469105345|FG003|Overall Study|Other|0|||
130311518|NCT01359904|469105346|FG000|Overall Study|Withdrawal by Subject|1|||
130311519|NCT01359904|469105347|FG001|Overall Study|Withdrawal by Subject|0|||
130311520|NCT03191630|469105349|FG000|Overall Study|Lost to Follow-up|7|||
130311521|NCT03191630|469105350|FG001|Overall Study|Lost to Follow-up|7|||
130311522|NCT02640547|469105353|FG000|Overall Study|Failure to Return|1|||
130311523|NCT02640547|469105353|FG000|Overall Study|Withdrawal by Subject|1|||
130311524|NCT02640547|469105353|FG000|Overall Study|Death|6|||
130311525|NCT02640547|469105353|FG000|Overall Study|Miscellaneous|3|||
130311526|NCT02525588|469105354|FG000|Overall Study|Death|3|||
130311527|NCT02525588|469105355|FG001|Overall Study|Death|1|||
130311528|NCT02525588|469105354|FG000|Overall Study|Lost to Follow-up|2|||
130311529|NCT02525588|469105355|FG001|Overall Study|Lost to Follow-up|0|||
130311530|NCT02525588|469105354|FG000|Overall Study|Withdrawal by Subject|1|||
130311531|NCT02525588|469105355|FG001|Overall Study|Withdrawal by Subject|1|||
130311532|NCT02525588|469105354|FG000|Overall Study|Adverse Event|0|||
130311533|NCT02525588|469105355|FG001|Overall Study|Adverse Event|1|||
130311534|NCT03369418|469105358|FG000|Overall Study|Withdrawal by Subject|3|||
130311535|NCT03369418|469105359|FG001|Overall Study|Withdrawal by Subject|3|||
130311536|NCT01485094|469105360|FG000|Overall Study|Adverse Event|1|||
130311537|NCT01485094|469105361|FG001|Overall Study|Adverse Event|1|||
130311538|NCT01485094|469105362|FG002|Overall Study|Adverse Event|1|||
130311539|NCT01485094|469105360|FG000|Overall Study|Lost to Follow-up|1|||
130311540|NCT01485094|469105361|FG001|Overall Study|Lost to Follow-up|0|||
130311541|NCT01485094|469105362|FG002|Overall Study|Lost to Follow-up|0|||
130311542|NCT01485094|469105360|FG000|Overall Study|Withdrawal by Subject|1|||
130311543|NCT01485094|469105361|FG001|Overall Study|Withdrawal by Subject|1|||
130311544|NCT01485094|469105362|FG002|Overall Study|Withdrawal by Subject|0|||
130311545|NCT01367834|469105366|FG000|Overall Study|Withdrawal by Subject|2|||
130311546|NCT01367834|469105367|FG001|Overall Study|Withdrawal by Subject|2|||
130311547|NCT01367834|469105366|FG000|Overall Study|Study was ended.|0|||
130311548|NCT01367834|469105367|FG001|Overall Study|Study was ended.|1|||
130311549|NCT01618669|469105377|FG000|Overall Study|Lost to Follow-up|1|||
130311550|NCT01618669|469105378|FG001|Overall Study|Lost to Follow-up|1|||
130311551|NCT01618669|469105377|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
130311552|NCT01618669|469105378|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
130311553|NCT01618669|469105377|FG000|Overall Study|Adverse Event|16|||
130311554|NCT01618669|469105378|FG001|Overall Study|Adverse Event|7|||
130311555|NCT01618669|469105377|FG000|Overall Study|Protocol Violation|5|||
130311556|NCT01618669|469105378|FG001|Overall Study|Protocol Violation|3|||
130311557|NCT01618669|469105377|FG000|Overall Study|Withdrawal by Subject|9|||
130311558|NCT01618669|469105378|FG001|Overall Study|Withdrawal by Subject|9|||
130311559|NCT01618669|469105377|FG000|Overall Study|Miscellaneous Reason|0|||
130311560|NCT01618669|469105378|FG001|Overall Study|Miscellaneous Reason|1|||
130110609|NCT03276962|468365793|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
130311561|NCT01702558|469105379|FG000|Overall Study|Withdrawal by Subject|0|||
130311562|NCT01702558|469105380|FG001|Overall Study|Withdrawal by Subject|0|||
130311563|NCT01702558|469105381|FG002|Overall Study|Withdrawal by Subject|0|||
130311564|NCT01702558|469105382|FG003|Overall Study|Withdrawal by Subject|12|||
130311565|NCT01702558|469105383|FG004|Overall Study|Withdrawal by Subject|4|||
130311566|NCT01702558|469105379|FG000|Overall Study|Lost to Follow-up|0|||
130311567|NCT01702558|469105380|FG001|Overall Study|Lost to Follow-up|0|||
130110610|NCT03276962|468365789|FG000|Overall Study|Lost to Follow-up|10|||
130311568|NCT01702558|469105381|FG002|Overall Study|Lost to Follow-up|0|||
130311569|NCT01702558|469105382|FG003|Overall Study|Lost to Follow-up|3|||
130311570|NCT01702558|469105383|FG004|Overall Study|Lost to Follow-up|0|||
130311571|NCT01702558|469105379|FG000|Overall Study|Death|4|||
130311572|NCT01702558|469105380|FG001|Overall Study|Death|3|||
130311573|NCT01702558|469105381|FG002|Overall Study|Death|3|||
130311574|NCT01702558|469105382|FG003|Overall Study|Death|16|||
130311575|NCT01702558|469105383|FG004|Overall Study|Death|20|||
130311576|NCT01702558|469105379|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311577|NCT01702558|469105380|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311578|NCT01702558|469105381|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
130311579|NCT01702558|469105382|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311580|NCT01702558|469105383|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
130311581|NCT01702558|469105379|FG000|Overall Study|Study Terminated by Sponsor|0|||
130311582|NCT01702558|469105380|FG001|Overall Study|Study Terminated by Sponsor|1|||
130311583|NCT01702558|469105381|FG002|Overall Study|Study Terminated by Sponsor|0|||
130311584|NCT01702558|469105382|FG003|Overall Study|Study Terminated by Sponsor|0|||
130311585|NCT01702558|469105383|FG004|Overall Study|Study Terminated by Sponsor|1|||
130311586|NCT01702558|469105379|FG000|Overall Study|Other|0|||
130311587|NCT01702558|469105380|FG001|Overall Study|Other|0|||
130311588|NCT01702558|469105381|FG002|Overall Study|Other|0|||
130311589|NCT01702558|469105382|FG003|Overall Study|Other|16|||
130311590|NCT01702558|469105383|FG004|Overall Study|Other|17|||
130311591|NCT03259087|469105388|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311592|NCT03259087|469105389|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311593|NCT03259087|469105390|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311594|NCT03259087|469105391|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
130311595|NCT03259087|469105392|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
130311596|NCT03259087|469105388|FG000|Period 2 of Part 2|Adverse Event|0|||
130311597|NCT03259087|469105389|FG001|Period 2 of Part 2|Adverse Event|0|||
130311598|NCT03259087|469105390|FG002|Period 2 of Part 2|Adverse Event|0|||
130311599|NCT03259087|469105391|FG003|Period 2 of Part 2|Adverse Event|0|||
130311600|NCT03259087|469105392|FG004|Period 2 of Part 2|Adverse Event|1|||
130311601|NCT04950465|469105393|FG000|Overall Study|Lost to Follow-up|1|||
130311602|NCT04950465|469105394|FG001|Overall Study|Lost to Follow-up|0|||
130311603|NCT04950465|469105395|FG002|Overall Study|Lost to Follow-up|0|||
130311604|NCT02366195|469105396|FG000|Overall Study|Protocol-specified criteria|3|||
130311605|NCT02366195|469105396|FG000|Overall Study|Withdrawal by Subject|9|||
130311606|NCT02366195|469105396|FG000|Overall Study|Lost to Follow-up|1|||
130311607|NCT02366195|469105396|FG000|Overall Study|Death|41|||
130311608|NCT01788566|469105397|FG000|Overall Study|Death|4|||
130311609|NCT01788566|469105397|FG000|Overall Study|Adverse Event|1|||
130311610|NCT01788566|469105397|FG000|Overall Study|Clinical Progressive Disease|3|||
130311611|NCT01620086|469105400|FG000|Overall Study|Withdrawal by Subject|3|||
130311612|NCT01620086|469105401|FG001|Overall Study|Withdrawal by Subject|3|||
130311613|NCT01620086|469105402|FG002|Overall Study|Withdrawal by Subject|0|||
130311614|NCT01620086|469105400|FG000|Overall Study|failed study criteria|1|||
130311615|NCT01620086|469105401|FG001|Overall Study|failed study criteria|4|||
130311616|NCT01620086|469105402|FG002|Overall Study|failed study criteria|0|||
130311617|NCT01620086|469105400|FG000|Overall Study|Physician Decision|1|||
130311618|NCT01620086|469105401|FG001|Overall Study|Physician Decision|0|||
130311619|NCT01620086|469105402|FG002|Overall Study|Physician Decision|0|||
130311620|NCT02562716|469105403|FG000|Overall Study|Adverse Event|7|||
130311621|NCT02562716|469105404|FG001|Overall Study|Adverse Event|14|||
130311622|NCT02562716|469105403|FG000|Overall Study|Withdrawal unrelated to AE|7|||
130311623|NCT02562716|469105404|FG001|Overall Study|Withdrawal unrelated to AE|1|||
130311624|NCT02562716|469105403|FG000|Overall Study|Progression|8|||
130311625|NCT02562716|469105404|FG001|Overall Study|Progression|10|||
130311626|NCT02562716|469105403|FG000|Overall Study|Death|2|||
130311627|NCT02562716|469105404|FG001|Overall Study|Death|1|||
130311628|NCT02562716|469105403|FG000|Overall Study|Not protocol specified|4|||
130311629|NCT02562716|469105404|FG001|Overall Study|Not protocol specified|2|||
130311630|NCT01539759|469105405|FG000|Overall Study|Lost to Follow-up|6|||
130311631|NCT01539759|469105406|FG001|Overall Study|Lost to Follow-up|8|||
130311632|NCT01425801|469105407|FG000|Period 1|Withdrawal by Subject|0|||
130311633|NCT01425801|469105408|FG001|Period 1|Withdrawal by Subject|0|||
130311634|NCT01425801|469105409|FG002|Period 1|Withdrawal by Subject|0|||
130311635|NCT01425801|469105410|FG003|Period 1|Withdrawal by Subject|0|||
130311636|NCT01425801|469105411|FG004|Period 1|Withdrawal by Subject|1|||
130311637|NCT01425801|469105412|FG005|Period 1|Withdrawal by Subject|0|||
130311638|NCT01425801|469105407|FG000|Period 2|Withdrawal by Subject|0|||
130311639|NCT01425801|469105408|FG001|Period 2|Withdrawal by Subject|0|||
130311640|NCT01425801|469105409|FG002|Period 2|Withdrawal by Subject|0|||
130311641|NCT01425801|469105410|FG003|Period 2|Withdrawal by Subject|0|||
130311642|NCT01425801|469105411|FG004|Period 2|Withdrawal by Subject|1|||
130311643|NCT01425801|469105412|FG005|Period 2|Withdrawal by Subject|0|||
130311644|NCT01425801|469105407|FG000|Period 3|Stability criteria not fullfilled|0|||
130311645|NCT01425801|469105408|FG001|Period 3|Stability criteria not fullfilled|0|||
130311646|NCT01425801|469105409|FG002|Period 3|Stability criteria not fullfilled|1|||
130311647|NCT01425801|469105410|FG003|Period 3|Stability criteria not fullfilled|0|||
130311648|NCT01425801|469105411|FG004|Period 3|Stability criteria not fullfilled|0|||
129890060|NCT05708846|467554593|FG000|Overall Study|Withdrawal by Subject|20|||
129890061|NCT02036515|467554594|FG000|Overall Study|Adverse Event|1|||
129890062|NCT02036515|467554595|FG001|Overall Study|Adverse Event|1|||
129890063|NCT02036515|467554596|FG002|Overall Study|Adverse Event|2|||
129890064|NCT02036515|467554594|FG000|Overall Study|Lost to Follow-up|0|||
129890065|NCT02036515|467554595|FG001|Overall Study|Lost to Follow-up|2|||
129890066|NCT02036515|467554596|FG002|Overall Study|Lost to Follow-up|0|||
129890067|NCT02036515|467554594|FG000|Overall Study|Non-compliance with study drug|0|||
129890068|NCT02036515|467554595|FG001|Overall Study|Non-compliance with study drug|0|||
129890069|NCT02036515|467554596|FG002|Overall Study|Non-compliance with study drug|2|||
130050204|NCT01070550|468140740|FG001|Overall Study|Treatment unavailable|0|||
130050205|NCT01070550|468140741|FG002|Overall Study|Treatment unavailable|0|||
130050206|NCT01070550|468140742|FG003|Overall Study|Treatment unavailable|0|||
130050207|NCT01070550|468140743|FG004|Overall Study|Treatment unavailable|0|||
130311649|NCT01425801|469105412|FG005|Period 3|Stability criteria not fullfilled|0|||
130311650|NCT01425801|469105407|FG000|Period 4|Not able to maintain visit schedule|0|||
130311651|NCT01425801|469105408|FG001|Period 4|Not able to maintain visit schedule|0|||
130311652|NCT01425801|469105409|FG002|Period 4|Not able to maintain visit schedule|1|||
130311653|NCT01425801|469105410|FG003|Period 4|Not able to maintain visit schedule|0|||
130311654|NCT01425801|469105411|FG004|Period 4|Not able to maintain visit schedule|0|||
130311655|NCT01425801|469105412|FG005|Period 4|Not able to maintain visit schedule|0|||
130311656|NCT02728089|469105413|FG000|Overall Study|Physician Decision|2|||
130311657|NCT02728089|469105413|FG000|Overall Study|Withdrawal by Subject|1|||
130311658|NCT00731679|469105414|FG000|Overall Study|Adverse Event|7|||
130311659|NCT00731679|469105415|FG001|Overall Study|Adverse Event|8|||
130311660|NCT00731679|469105414|FG000|Overall Study|Withdrawal by Subject|8|||
130311661|NCT00731679|469105415|FG001|Overall Study|Withdrawal by Subject|8|||
130311662|NCT00731679|469105414|FG000|Overall Study|Lost to Follow-up|7|||
130311663|NCT00731679|469105415|FG001|Overall Study|Lost to Follow-up|8|||
130311664|NCT00731679|469105414|FG000|Overall Study|Noncompliance|0|||
130311665|NCT00731679|469105415|FG001|Overall Study|Noncompliance|1|||
130311666|NCT00731679|469105414|FG000|Overall Study|Pregnancy|0|||
130311667|NCT00731679|469105415|FG001|Overall Study|Pregnancy|1|||
130311668|NCT02488005|469105418|FG000|Overall Study|Lost to Follow-up|2|||
130311669|NCT02326597|469105425|FG000|Overall Study|Lost to Follow-up|42|||
130311670|NCT02326597|469105426|FG001|Overall Study|Lost to Follow-up|32|||
130050208|NCT01070550|468140744|FG005|Overall Study|Treatment unavailable|0|||
130050209|NCT01070550|468140739|FG000|Overall Study|Treatment was stopped early|7|||
130050210|NCT01070550|468140740|FG001|Overall Study|Treatment was stopped early|0|||
130050211|NCT01070550|468140741|FG002|Overall Study|Treatment was stopped early|0|||
130050212|NCT01070550|468140742|FG003|Overall Study|Treatment was stopped early|0|||
130050213|NCT01070550|468140743|FG004|Overall Study|Treatment was stopped early|0|||
130050214|NCT01070550|468140744|FG005|Overall Study|Treatment was stopped early|0|||
130050215|NCT01070550|468140739|FG000|Overall Study|Other|5|||
130050216|NCT01070550|468140740|FG001|Overall Study|Other|0|||
130050217|NCT01070550|468140741|FG002|Overall Study|Other|0|||
130050218|NCT01070550|468140742|FG003|Overall Study|Other|1|||
130050219|NCT01070550|468140743|FG004|Overall Study|Other|0|||
130050220|NCT01070550|468140744|FG005|Overall Study|Other|0|||
130050221|NCT01070550|468140739|FG000|Overall Study|Withdrawal by Subject|35|||
130050222|NCT01070550|468140740|FG001|Overall Study|Withdrawal by Subject|0|||
130050223|NCT01070550|468140741|FG002|Overall Study|Withdrawal by Subject|3|||
130311671|NCT04089761|469105429|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
130311672|NCT04089761|469105429|FG000|"Run In Phase"|Lost to Follow-up|1|||
130050224|NCT01070550|468140742|FG003|Overall Study|Withdrawal by Subject|0|||
130050225|NCT01070550|468140743|FG004|Overall Study|Withdrawal by Subject|0|||
130311673|NCT04089761|469105429|FG000|"Treatment Phase"|No evaluable data|5|||
130311674|NCT04089761|469105429|FG000|"Treatment Phase"|Lost to Follow-up|1|||
130311675|NCT04739436|469105430|FG000|Overall Study|Lost to Follow-up|21|||
130050226|NCT01070550|468140744|FG005|Overall Study|Withdrawal by Subject|0|||
130050227|NCT01585961|468140745|FG000|Overall Study|Death|6|||
130050228|NCT01585961|468140745|FG000|Overall Study|Physician Decision|1|||
129890070|NCT02036515|467554594|FG000|Overall Study|Screen failure|0|||
129890071|NCT02036515|467554595|FG001|Overall Study|Screen failure|2|||
130050229|NCT01585961|468140745|FG000|Overall Study|Decision to use non-study catheter|1|||
130050230|NCT01585961|468140745|FG000|Overall Study|Withdrawal by Subject|1|||
130050231|NCT01585961|468140745|FG000|Overall Study|Lost to Follow-up|23|||
129798857|NCT02676466|467232180|FG007|Overall Study|Withdrawal by Subject|1|||
129798858|NCT01178073|467232183|FG000|Overall Study|Adverse Event|34|||
129798859|NCT01178073|467232184|FG001|Overall Study|Adverse Event|27|||
129798860|NCT01178073|467232185|FG002|Overall Study|Adverse Event|24|||
130311676|NCT04739436|469105431|FG001|Overall Study|Lost to Follow-up|23|||
130311677|NCT04739436|469105430|FG000|Overall Study|Withdrawal by Subject|4|||
130311678|NCT04739436|469105431|FG001|Overall Study|Withdrawal by Subject|6|||
130311679|NCT04739436|469105430|FG000|Overall Study|not randomized properly|1|||
130311680|NCT04739436|469105431|FG001|Overall Study|not randomized properly|0|||
130311681|NCT04628780|469105432|FG000|Overall Study|Death|0|||
130311682|NCT04628780|469105433|FG001|Overall Study|Death|1|||
130311683|NCT04628780|469105434|FG002|Overall Study|Death|0|||
130311684|NCT04628780|469105435|FG003|Overall Study|Death|0|||
130311685|NCT04628780|469105436|FG004|Overall Study|Death|1|||
130311686|NCT04628780|469105437|FG005|Overall Study|Death|0|||
130311687|NCT04628780|469105432|FG000|Overall Study|Physician Decision|2|||
130311688|NCT04628780|469105433|FG001|Overall Study|Physician Decision|0|||
130311689|NCT04628780|469105434|FG002|Overall Study|Physician Decision|0|||
130311690|NCT04628780|469105435|FG003|Overall Study|Physician Decision|0|||
130311691|NCT04628780|469105436|FG004|Overall Study|Physician Decision|2|||
130311692|NCT04628780|469105437|FG005|Overall Study|Physician Decision|0|||
130311693|NCT04628780|469105432|FG000|Overall Study|Progressive disease|2|||
130311694|NCT04628780|469105433|FG001|Overall Study|Progressive disease|2|||
130311695|NCT04628780|469105434|FG002|Overall Study|Progressive disease|2|||
130311696|NCT04628780|469105435|FG003|Overall Study|Progressive disease|3|||
130311697|NCT04628780|469105436|FG004|Overall Study|Progressive disease|9|||
130311698|NCT04628780|469105437|FG005|Overall Study|Progressive disease|4|||
130311699|NCT04628780|469105432|FG000|Overall Study|Withdrawal by Subject|0|||
130311700|NCT04628780|469105433|FG001|Overall Study|Withdrawal by Subject|1|||
130311701|NCT04628780|469105434|FG002|Overall Study|Withdrawal by Subject|2|||
130311702|NCT04628780|469105435|FG003|Overall Study|Withdrawal by Subject|0|||
130311703|NCT04628780|469105436|FG004|Overall Study|Withdrawal by Subject|3|||
130311704|NCT04628780|469105437|FG005|Overall Study|Withdrawal by Subject|1|||
130311705|NCT04628780|469105432|FG000|Overall Study|Global deterioration of health status|0|||
130311706|NCT04628780|469105433|FG001|Overall Study|Global deterioration of health status|0|||
130311707|NCT04628780|469105434|FG002|Overall Study|Global deterioration of health status|0|||
130311708|NCT04628780|469105435|FG003|Overall Study|Global deterioration of health status|0|||
130311709|NCT04628780|469105436|FG004|Overall Study|Global deterioration of health status|1|||
130311710|NCT04628780|469105437|FG005|Overall Study|Global deterioration of health status|1|||
130311711|NCT03622814|469105439|FG000|Overall Study|Lost to Follow-up|8|||
130311712|NCT03622814|469105440|FG001|Overall Study|Lost to Follow-up|14|||
130311713|NCT01156714|469105443|FG000|Overall Study|Withdrawal by Subject|9|||
130311714|NCT01156714|469105444|FG001|Overall Study|Withdrawal by Subject|4|||
130311715|NCT01156714|469105445|FG002|Overall Study|Withdrawal by Subject|3|||
130311716|NCT04896593|469105451|FG000|Overall Study|Withdrawal by Subject|2|||
130311717|NCT04896593|469105451|FG000|Overall Study|Lost to Follow-up|1|||
130311718|NCT04896593|469105451|FG000|Overall Study|Did not complete onboarding|2|||
130311719|NCT02777827|469105452|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
129798861|NCT01178073|467232183|FG000|Overall Study|Protocol Violation|1|||
129798862|NCT01178073|467232184|FG001|Overall Study|Protocol Violation|1|||
129798863|NCT01178073|467232185|FG002|Overall Study|Protocol Violation|1|||
129798864|NCT01178073|467232183|FG000|Overall Study|Lost to Follow-up|2|||
130311720|NCT02777827|469105453|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311721|NCT02777827|469105454|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
130311722|NCT02777827|469105455|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311723|NCT02777827|469105456|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311724|NCT02777827|469105457|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
130311725|NCT00176462|469105458|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
130311726|NCT00176462|469105459|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
130311727|NCT00176462|469105458|FG000|Induction (4 Weeks)|Death|1|||
130311728|NCT00176462|469105459|FG001|Induction (4 Weeks)|Death|2|||
130311729|NCT00176462|469105458|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
130311730|NCT00176462|469105459|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
130311731|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
130311732|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
130311733|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
130311734|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
130311735|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
130311736|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
129798865|NCT01178073|467232184|FG001|Overall Study|Lost to Follow-up|0|||
129798866|NCT01178073|467232185|FG002|Overall Study|Lost to Follow-up|3|||
130050232|NCT01585961|468140745|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
129798867|NCT01178073|467232183|FG000|Overall Study|Physician Decision|14|||
130311737|NCT00176462|469105458|FG000|Consolidation (12 Weeks)|Not documented|0|||
130311738|NCT00176462|469105459|FG001|Consolidation (12 Weeks)|Not documented|1|||
130311739|NCT00176462|469105458|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
130311740|NCT00176462|469105459|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
130311741|NCT00176462|469105458|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
130311742|NCT00176462|469105459|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
130311743|NCT01408459|469105460|FG000|Overall Study|Withdrawal by Subject|1|||
130311744|NCT01408459|469105461|FG001|Overall Study|Withdrawal by Subject|1|||
130311745|NCT00330759|469106834|FG000|Overall Study|Death|316|||
130311746|NCT00330759|469106835|FG001|Overall Study|Death|310|||
130311747|NCT00330759|469106834|FG000|Overall Study|Disease progression|104|||
130311748|NCT00330759|469106835|FG001|Overall Study|Disease progression|126|||
130311749|NCT00330759|469106834|FG000|Overall Study|Withdrawal by Subject|143|||
130311750|NCT00330759|469106835|FG001|Overall Study|Withdrawal by Subject|124|||
130311751|NCT00330759|469106834|FG000|Overall Study|Adverse Event|48|||
130311752|NCT00330759|469106835|FG001|Overall Study|Adverse Event|36|||
130311753|NCT00330759|469106834|FG000|Overall Study|Participant request|31|||
130311754|NCT00330759|469106835|FG001|Overall Study|Participant request|22|||
130311755|NCT00330759|469106834|FG000|Overall Study|Lost to Follow-up|16|||
130311756|NCT00330759|469106835|FG001|Overall Study|Lost to Follow-up|22|||
130311757|NCT00330759|469106834|FG000|Overall Study|Noncompliance|15|||
130311758|NCT00330759|469106835|FG001|Overall Study|Noncompliance|17|||
130311759|NCT00330759|469106834|FG000|Overall Study|Physician Decision|1|||
130311760|NCT00330759|469106835|FG001|Overall Study|Physician Decision|2|||
130311761|NCT00330759|469106834|FG000|Overall Study|Protocol deviation|0|||
130311762|NCT00330759|469106835|FG001|Overall Study|Protocol deviation|2|||
130311763|NCT00330759|469106834|FG000|Overall Study|Ineligibility determined|2|||
130311764|NCT00330759|469106835|FG001|Overall Study|Ineligibility determined|1|||
130311765|NCT00330759|469106834|FG000|Overall Study|Other|36|||
130311766|NCT00330759|469106835|FG001|Overall Study|Other|44|||
130311767|NCT01380769|469106840|FG000|Overall Study|Withdrawal by Subject|7|||
130311768|NCT01380769|469106841|FG001|Overall Study|Withdrawal by Subject|11|||
130311769|NCT01380769|469106840|FG000|Overall Study|Physician Decision|1|||
130311770|NCT01380769|469106841|FG001|Overall Study|Physician Decision|1|||
130311771|NCT01380769|469106840|FG000|Overall Study|Adverse Event|1|||
130311772|NCT01380769|469106841|FG001|Overall Study|Adverse Event|1|||
130311773|NCT01380769|469106840|FG000|Overall Study|Protocol Violation|0|||
130311774|NCT01380769|469106841|FG001|Overall Study|Protocol Violation|1|||
130311775|NCT03654690|469106842|FG000|Overall Study|Withdrawal by Subject|1|||
130311776|NCT03654690|469106843|FG001|Overall Study|Withdrawal by Subject|0|||
130311777|NCT03654690|469106844|FG002|Overall Study|Withdrawal by Subject|0|||
130311778|NCT00742183|469106847|FG000|Overall Study|Adverse Event|2|||
130311779|NCT00742183|469106848|FG001|Overall Study|Adverse Event|2|||
130311780|NCT00742183|469106847|FG000|Overall Study|Death|1|||
130311781|NCT00742183|469106848|FG001|Overall Study|Death|0|||
130311782|NCT00742183|469106847|FG000|Overall Study|Physician Decision|0|||
130311783|NCT00742183|469106848|FG001|Overall Study|Physician Decision|2|||
130311784|NCT00742183|469106847|FG000|Overall Study|Lost to Follow-up|4|||
130311785|NCT00742183|469106848|FG001|Overall Study|Lost to Follow-up|4|||
130311786|NCT00742183|469106847|FG000|Overall Study|Required skin-graft|1|||
130311787|NCT00742183|469106848|FG001|Overall Study|Required skin-graft|1|||
130311788|NCT00742183|469106847|FG000|Overall Study|Withdrawal by Subject|1|||
130311789|NCT00742183|469106848|FG001|Overall Study|Withdrawal by Subject|0|||
130311790|NCT00742183|469106847|FG000|Overall Study|Lack of Efficacy|0|||
130311791|NCT00742183|469106848|FG001|Overall Study|Lack of Efficacy|3|||
130311792|NCT00786799|469106852|FG000|Overall Study|Lost to Follow-up|1|||
130311793|NCT00786799|469106853|FG001|Overall Study|Lost to Follow-up|1|||
130311794|NCT02223715|469106857|FG000|Overall Study|Death|31|||
130311795|NCT02223715|469106857|FG000|Overall Study|Lost to Follow-up|73|||
130311796|NCT01745367|469106858|FG000|Overall Study|Death|1|||
130311797|NCT01745367|469106859|FG001|Overall Study|Death|0|||
130311798|NCT01745367|469106858|FG000|Overall Study|Withdrawal by Subject|1|||
130311799|NCT01745367|469106859|FG001|Overall Study|Withdrawal by Subject|2|||
130311800|NCT01745367|469106858|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
129798868|NCT01178073|467232184|FG001|Overall Study|Physician Decision|10|||
129798869|NCT01178073|467232185|FG002|Overall Study|Physician Decision|10|||
130311801|NCT01745367|469106859|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
130311802|NCT01745367|469106858|FG000|Overall Study|Other Reasons Unspecified|0|||
130311803|NCT01745367|469106859|FG001|Overall Study|Other Reasons Unspecified|2|||
130311804|NCT03018691|469106863|FG000|Overall Study|Adverse Event|1|||
130311805|NCT03018691|469106864|FG001|Overall Study|Adverse Event|1|||
130110611|NCT03276962|468365790|FG001|Overall Study|Lost to Follow-up|10|||
130110612|NCT03276962|468365791|FG002|Overall Study|Lost to Follow-up|4|||
130311806|NCT03018691|469106865|FG002|Overall Study|Adverse Event|4|||
130311807|NCT03018691|469106863|FG000|Overall Study|Lack of Efficacy|0|||
130311808|NCT03018691|469106864|FG001|Overall Study|Lack of Efficacy|0|||
130311809|NCT03018691|469106865|FG002|Overall Study|Lack of Efficacy|1|||
130311810|NCT03018691|469106863|FG000|Overall Study|Withdrawal by Subject|0|||
130311811|NCT03018691|469106864|FG001|Overall Study|Withdrawal by Subject|0|||
130311812|NCT03018691|469106865|FG002|Overall Study|Withdrawal by Subject|1|||
130311813|NCT03018691|469106863|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130311814|NCT03018691|469106864|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130311815|NCT03018691|469106865|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130311816|NCT01020786|469106870|FG000|Induction Period|Entry Criteria Not Met|2|||
130311817|NCT01020786|469106870|FG000|Induction Period|Adverse Event|10|||
130311818|NCT01020786|469106870|FG000|Induction Period|Progressive Disease|31|||
130311819|NCT01020786|469106870|FG000|Induction Period|Investigator Decision|3|||
130311820|NCT01020786|469106870|FG000|Induction Period|Withdrawal by Subject|3|||
130311821|NCT01020786|469106870|FG000|Maintenance Period|Adverse Event|8|||
130311822|NCT01020786|469106870|FG000|Maintenance Period|Progressive Disease|43|||
130311823|NCT01020786|469106870|FG000|Maintenance Period|Withdrawal by Subject|8|||
130311824|NCT01020786|469106870|FG000|Maintenance Period|Sponsor Decision|1|||
130311825|NCT01521507|469106881|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
130311826|NCT01521507|469106882|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
130311827|NCT01521507|469106881|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
130311828|NCT01521507|469106882|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
130311829|NCT01521507|469106881|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
130311830|NCT01521507|469106882|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
130311831|NCT01521507|469106881|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
130311832|NCT01521507|469106882|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
130311833|NCT01521507|469106881|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
130311834|NCT01521507|469106882|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
130311835|NCT01521507|469106881|FG000|Stage 2: Observational Design|Physician Decision|1|||
130311836|NCT01521507|469106882|FG001|Stage 2: Observational Design|Physician Decision|0|||
130311837|NCT01358825|469106887|FG000|Overall Study|Blood sample not drawn|0|||
130311838|NCT01358825|469106888|FG001|Overall Study|Blood sample not drawn|1|||
130311839|NCT01479868|469106889|FG000|Overall Study|Adverse Event|1|||
130311840|NCT01479868|469106889|FG000|Overall Study|Lost to Follow-up|4|||
130311841|NCT01479868|469106889|FG000|Overall Study|Protocol Violation|1|||
130311842|NCT01479868|469106889|FG000|Overall Study|Withdrawal by Subject|1|||
130311843|NCT01479868|469106889|FG000|Overall Study|Sponsor's Decision|1|||
130311844|NCT01479868|469106889|FG000|Overall Study|Initiation of new HCV Therapy|1|||
130311845|NCT01508169|469106890|FG000|Overall Study|Adverse Event|1|||
130311846|NCT01508169|469106891|FG001|Overall Study|Adverse Event|0|||
130311847|NCT01508169|469106890|FG000|Overall Study|Withdrawal by Subject|1|||
130311848|NCT01508169|469106891|FG001|Overall Study|Withdrawal by Subject|0|||
130311849|NCT01508169|469106890|FG000|Overall Study|Lost to Follow-up|1|||
130311850|NCT01508169|469106891|FG001|Overall Study|Lost to Follow-up|2|||
130311851|NCT01363700|469106897|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311852|NCT01363700|469106898|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
130311853|NCT01363700|469106899|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311854|NCT01363700|469106900|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311855|NCT01363700|469106901|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
130311856|NCT00113841|469106906|FG000|Overall Study|Disease progression|0|||
130311857|NCT00113841|469106907|FG001|Overall Study|Disease progression|2|||
130311858|NCT00113841|469106906|FG000|Overall Study|Non-compliant|1|||
130311859|NCT00113841|469106907|FG001|Overall Study|Non-compliant|0|||
130311860|NCT00580723|469106912|FG000|Overall Study|Did not want to participate in extension|3|||
130311861|NCT00580723|469106912|FG000|Overall Study|Lost to Follow-up|5|||
130311862|NCT05202418|469106913|FG000|Overall Study|Withdrawal by Subject|2|||
130311863|NCT05202418|469106914|FG001|Overall Study|Withdrawal by Subject|1|||
130311864|NCT05202418|469106913|FG000|Overall Study|Lost to Follow-up|1|||
130311865|NCT05202418|469106914|FG001|Overall Study|Lost to Follow-up|1|||
130311866|NCT02753946|469106915|FG000|Overall Study|Adverse Event|7|||
130311867|NCT02753946|469106916|FG001|Overall Study|Adverse Event|6|||
130311868|NCT02753946|469106915|FG000|Overall Study|Withdrawal by Subject|6|||
130311869|NCT02753946|469106916|FG001|Overall Study|Withdrawal by Subject|1|||
130311870|NCT02753946|469106915|FG000|Overall Study|Lack of Efficacy|1|||
130311871|NCT02753946|469106916|FG001|Overall Study|Lack of Efficacy|0|||
130311872|NCT02753946|469106915|FG000|Overall Study|Physician Decision|0|||
130311873|NCT02753946|469106916|FG001|Overall Study|Physician Decision|2|||
129798870|NCT01178073|467232183|FG000|Overall Study|Withdrawal by Subject|10|||
130050233|NCT01258348|468140746|FG000|Overall Study|Adverse Event|1|||
130311874|NCT02519439|469106917|FG000|Overall Study|Study Termination|19|||
130311875|NCT02519439|469106917|FG000|Overall Study|Withdrawal by Subject|1|||
130311876|NCT02519439|469106917|FG000|Overall Study|Adverse Event|1|||
130311877|NCT03901144|469106921|FG000|Overall Study|Lost to Follow-up|1|||
130311878|NCT03901144|469106922|FG001|Overall Study|Lost to Follow-up|1|||
130311879|NCT03901144|469106923|FG002|Overall Study|Lost to Follow-up|1|||
130311880|NCT03901144|469106924|FG003|Overall Study|Lost to Follow-up|1|||
130311881|NCT02294058|469106927|FG000|Overall Study|Adverse Event|16|||
130311882|NCT02294058|469106928|FG001|Overall Study|Adverse Event|7|||
130311883|NCT02294058|469106929|FG002|Overall Study|Adverse Event|13|||
130311884|NCT02294058|469106927|FG000|Overall Study|Lack of Efficacy|3|||
130311885|NCT02294058|469106928|FG001|Overall Study|Lack of Efficacy|3|||
130311886|NCT02294058|469106929|FG002|Overall Study|Lack of Efficacy|0|||
130311887|NCT02294058|469106927|FG000|Overall Study|Lost to Follow-up|1|||
130311888|NCT02294058|469106928|FG001|Overall Study|Lost to Follow-up|0|||
130311889|NCT02294058|469106929|FG002|Overall Study|Lost to Follow-up|2|||
130311890|NCT02294058|469106927|FG000|Overall Study|Withdrawal by Subject|10|||
130311891|NCT02294058|469106928|FG001|Overall Study|Withdrawal by Subject|14|||
130311892|NCT02294058|469106929|FG002|Overall Study|Withdrawal by Subject|13|||
130311893|NCT02294058|469106927|FG000|Overall Study|Physician Decision|2|||
130311894|NCT02294058|469106928|FG001|Overall Study|Physician Decision|1|||
130311895|NCT02294058|469106929|FG002|Overall Study|Physician Decision|0|||
130311896|NCT02294058|469106927|FG000|Overall Study|Miscellaneous|4|||
130311897|NCT02294058|469106928|FG001|Overall Study|Miscellaneous|1|||
130311898|NCT02294058|469106929|FG002|Overall Study|Miscellaneous|1|||
130311899|NCT03575403|469106930|FG000|Overall Study|Adverse Event|1|||
130311900|NCT03575403|469106931|FG001|Overall Study|Adverse Event|0|||
130311901|NCT03575403|469106932|FG002|Overall Study|Adverse Event|0|||
130311902|NCT03575403|469106930|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
130311903|NCT03575403|469106931|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
130311904|NCT03575403|469106932|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
130311905|NCT03359174|469106935|FG000|Overall Study|Adverse Event|1|||
130311906|NCT01332994|469106939|FG000|Overall Study|Adverse Event|34|||
130311907|NCT01332994|469106939|FG000|Overall Study|Death|1|||
130311908|NCT01332994|469106939|FG000|Overall Study|Lack of Efficacy|1|||
130311909|NCT01332994|469106939|FG000|Overall Study|Lost to Follow-up|4|||
130311910|NCT01332994|469106939|FG000|Overall Study|Protocol Violation|6|||
130311911|NCT01332994|469106939|FG000|Overall Study|Withdrawal by Subject|15|||
130311912|NCT01332994|469106939|FG000|Overall Study|Administrative Problem|2|||
130311913|NCT01332994|469106939|FG000|Overall Study|Other|8|||
130311914|NCT02800863|469106940|FG000|Overall Study|Adverse Event|14|||
130311915|NCT02800863|469106940|FG000|Overall Study|Another Device Implanted|1|||
130311916|NCT02800863|469106940|FG000|Overall Study|Device Explanted|1|||
130311917|NCT02800863|469106940|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
130311918|NCT02800863|469106940|FG000|Overall Study|Health Issues|1|||
130311919|NCT02800863|469106940|FG000|Overall Study|Insurance Denial|8|||
130311920|NCT02800863|469106940|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
130311921|NCT02800863|469106940|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
130311922|NCT02800863|469106940|FG000|Overall Study|Screen Failure|1|||
130311923|NCT02800863|469106940|FG000|Overall Study|Sponsor Request|6|||
130311924|NCT02800863|469106940|FG000|Overall Study|Death|3|||
130311925|NCT02800863|469106940|FG000|Overall Study|Subject Implant at Another Facility|1|||
130311926|NCT02800863|469106940|FG000|Overall Study|Lost to Follow-up|26|||
130311927|NCT02800863|469106940|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
130311928|NCT02800863|469106940|FG000|Overall Study|Subject and/or Family Request|64|||
130311929|NCT02800863|469106940|FG000|Overall Study|Trial Failure|81|||
130311930|NCT02800863|469106940|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
130311931|NCT00279916|469106941|FG000|Overall Study|Withdrawal by Subject|4|||
130311932|NCT00279916|469106942|FG001|Overall Study|Withdrawal by Subject|3|||
130311933|NCT00279916|469106941|FG000|Overall Study|Lost to Follow-up|3|||
130311934|NCT00279916|469106942|FG001|Overall Study|Lost to Follow-up|2|||
130311935|NCT02717494|469106944|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
130311936|NCT02717494|469106945|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
130311937|NCT02717494|469106946|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
130311938|NCT02717494|469106944|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
130311939|NCT02717494|469106945|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
130311940|NCT02717494|469106946|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
130311941|NCT02717494|469106944|FG000|First Intervention (Step 1)|Death|0|||
130311942|NCT02717494|469106945|FG001|First Intervention (Step 1)|Death|0|||
130311943|NCT02717494|469106946|FG002|First Intervention (Step 1)|Death|1|||
130311944|NCT02717494|469106944|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
130311945|NCT02717494|469106945|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
130311946|NCT02717494|469106946|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
130311947|NCT00770601|469106947|FG000|Overall Study|Withdrawal by Subject|1|||
130311948|NCT00428948|469106950|FG000|Overall Study|Lost to Follow-up|15|||
130110613|NCT03276962|468365792|FG003|Overall Study|Lost to Follow-up|6|||
130311949|NCT00428948|469106951|FG001|Overall Study|Lost to Follow-up|8|||
130311950|NCT00428948|469106950|FG000|Overall Study|Adverse Event|148|||
130311951|NCT00428948|469106951|FG001|Overall Study|Adverse Event|24|||
130311952|NCT00428948|469106950|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
130311953|NCT00428948|469106951|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
130311954|NCT00428948|469106950|FG000|Overall Study|Investigator Withdrew Subject|3|||
130311955|NCT00428948|469106951|FG001|Overall Study|Investigator Withdrew Subject|4|||
130311956|NCT00428948|469106950|FG000|Overall Study|Subject Withdrew Consent|50|||
130311957|NCT00428948|469106951|FG001|Overall Study|Subject Withdrew Consent|30|||
130311958|NCT00428948|469106950|FG000|Overall Study|Protocol Deviation|1|||
130311959|NCT00428948|469106951|FG001|Overall Study|Protocol Deviation|1|||
130311960|NCT04417361|469106953|FG000|Overall Study|Withdrawal by Subject|1|||
130311961|NCT04417361|469106954|FG001|Overall Study|Withdrawal by Subject|0|||
130311962|NCT04417361|469106953|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
130311963|NCT04417361|469106954|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
130311964|NCT01288989|469106955|FG000|Overall Study|Death|0|||
130311965|NCT01288989|469106956|FG001|Overall Study|Death|0|||
130311966|NCT01288989|469106957|FG002|Overall Study|Death|0|||
130311967|NCT01288989|469106958|FG003|Overall Study|Death|1|||
130311968|NCT01288989|469106959|FG004|Overall Study|Death|0|||
130311969|NCT01288989|469106955|FG000|Overall Study|Dose limiting toxicity|1|||
130311970|NCT01288989|469106956|FG001|Overall Study|Dose limiting toxicity|0|||
130311971|NCT01288989|469106957|FG002|Overall Study|Dose limiting toxicity|0|||
130311972|NCT01288989|469106958|FG003|Overall Study|Dose limiting toxicity|0|||
130311973|NCT01288989|469106959|FG004|Overall Study|Dose limiting toxicity|0|||
130311974|NCT01288989|469106955|FG000|Overall Study|Adverse Event|0|||
130311975|NCT01288989|469106956|FG001|Overall Study|Adverse Event|0|||
130311976|NCT01288989|469106957|FG002|Overall Study|Adverse Event|0|||
130311977|NCT01288989|469106958|FG003|Overall Study|Adverse Event|0|||
130311978|NCT01288989|469106959|FG004|Overall Study|Adverse Event|2|||
130311979|NCT01288989|469106955|FG000|Overall Study|Physician Decision|0|||
130311980|NCT01288989|469106956|FG001|Overall Study|Physician Decision|0|||
130311981|NCT01288989|469106957|FG002|Overall Study|Physician Decision|0|||
130311982|NCT01288989|469106958|FG003|Overall Study|Physician Decision|0|||
130311983|NCT01288989|469106959|FG004|Overall Study|Physician Decision|1|||
130311984|NCT01288989|469106955|FG000|Overall Study|Withdrawal by Subject|0|||
130311985|NCT01288989|469106956|FG001|Overall Study|Withdrawal by Subject|0|||
130311986|NCT01288989|469106957|FG002|Overall Study|Withdrawal by Subject|0|||
130311987|NCT01288989|469106958|FG003|Overall Study|Withdrawal by Subject|0|||
130311988|NCT01288989|469106959|FG004|Overall Study|Withdrawal by Subject|3|||
130311989|NCT00165672|469106961|FG000|Overall Study|Adverse Event|0|||
130311990|NCT00165672|469106962|FG001|Overall Study|Adverse Event|1|||
130311991|NCT04965688|469106968|FG000|Overall Study|Withdrawal by Subject|2|||
130311992|NCT05864586|469106969|FG000|Overall Study|Ineligible|4|||
130311993|NCT05864586|469106970|FG001|Overall Study|Ineligible|12|||
130311994|NCT05864586|469106969|FG000|Overall Study|Pregnancy|0|||
130311995|NCT05864586|469106970|FG001|Overall Study|Pregnancy|1|||
130311996|NCT05864586|469106969|FG000|Overall Study|Withdrawal by Subject|0|||
130311997|NCT05864586|469106970|FG001|Overall Study|Withdrawal by Subject|1|||
130311998|NCT00369577|469106971|FG000|Overall Study|Withdrawal by Subject|0|||
130311999|NCT00369577|469106972|FG001|Overall Study|Withdrawal by Subject|0|||
130312000|NCT00369577|469106973|FG002|Overall Study|Withdrawal by Subject|1|||
130312001|NCT01059318|469106984|FG000|Core Study (26 Week)|Adverse Event|3|||
130312002|NCT01059318|469106984|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
130312003|NCT01059318|469106984|FG000|Extension (36 Week)|Adverse Event|3|||
130312004|NCT00983385|469106985|FG000|Observation Period|Not eligible to be dosed|20|||
130312005|NCT00983385|469106985|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
130312006|NCT00824473|469108395|FG000|Overall Study|Adverse Event|4|||
130312007|NCT00824473|469108396|FG001|Overall Study|Adverse Event|5|||
130312008|NCT00824473|469108395|FG000|Overall Study|Lack of Efficacy|2|||
130312009|NCT00824473|469108396|FG001|Overall Study|Lack of Efficacy|2|||
130312010|NCT00824473|469108395|FG000|Overall Study|Protocol Violation|2|||
130312011|NCT00824473|469108396|FG001|Overall Study|Protocol Violation|0|||
130312012|NCT00824473|469108395|FG000|Overall Study|Non-Compliance|4|||
130312013|NCT00824473|469108396|FG001|Overall Study|Non-Compliance|2|||
130110614|NCT03276962|468365793|FG004|Overall Study|Lost to Follow-up|10|||
130312014|NCT00824473|469108395|FG000|Overall Study|Withdrawal by Subject|2|||
130312015|NCT00824473|469108396|FG001|Overall Study|Withdrawal by Subject|3|||
130312016|NCT00824473|469108395|FG000|Overall Study|Other|1|||
130312017|NCT00824473|469108396|FG001|Overall Study|Other|1|||
130312018|NCT02478463|469108397|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
130312019|NCT02478463|469108397|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
130312020|NCT02478463|469108397|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
130312021|NCT01814527|469108399|FG000|Overall Study|RTP greater than 30 days|6|||
130312022|NCT01814527|469108400|FG001|Overall Study|RTP greater than 30 days|1|||
130312023|NCT04524858|469108401|FG000|Overall Study|Adverse Event|1|||
130312024|NCT00148759|469108408|FG000|Overall Study|Withdrawal by Subject|1|||
130312025|NCT00148759|469108409|FG001|Overall Study|Withdrawal by Subject|1|||
130312026|NCT00148759|469108408|FG000|Overall Study|Lost to Follow-up|1|||
130312027|NCT00148759|469108409|FG001|Overall Study|Lost to Follow-up|0|||
130312028|NCT02721875|469108411|FG000|Overall Study|Progressive disease/relapse|1|||
130312029|NCT02721875|469108412|FG001|Overall Study|Progressive disease/relapse|0|||
130312030|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
130312031|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
130312032|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
130312033|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
130312034|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
130312035|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
130312036|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Death|7|||
130312037|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Death|5|||
130312038|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Death|6|||
130312039|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
130312040|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
130312041|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
130312042|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
130312043|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
130312044|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
130312045|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Other|1|||
130312046|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Other|0|||
130312047|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Other|0|||
130312048|NCT00104650|469108415|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
130312049|NCT00104650|469108416|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
130312050|NCT00104650|469108417|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
130312051|NCT00104650|469108415|FG000|Follow-up Period|Physician Decision|1|||
130312052|NCT00104650|469108416|FG001|Follow-up Period|Physician Decision|1|||
130312053|NCT00104650|469108417|FG002|Follow-up Period|Physician Decision|0|||
130312054|NCT00104650|469108415|FG000|Follow-up Period|Adverse Event|1|||
130312055|NCT00104650|469108416|FG001|Follow-up Period|Adverse Event|0|||
130312056|NCT00104650|469108417|FG002|Follow-up Period|Adverse Event|1|||
130312057|NCT00104650|469108415|FG000|Follow-up Period|Withdrawal by Subject|0|||
130312058|NCT00104650|469108416|FG001|Follow-up Period|Withdrawal by Subject|3|||
130312059|NCT00104650|469108417|FG002|Follow-up Period|Withdrawal by Subject|3|||
130312060|NCT00104650|469108415|FG000|Follow-up Period|Death|6|||
130312061|NCT00104650|469108416|FG001|Follow-up Period|Death|6|||
130312062|NCT00104650|469108417|FG002|Follow-up Period|Death|4|||
130312063|NCT00104650|469108415|FG000|Follow-up Period|Disease progression|3|||
130312064|NCT00104650|469108416|FG001|Follow-up Period|Disease progression|1|||
130312065|NCT00104650|469108417|FG002|Follow-up Period|Disease progression|0|||
130312066|NCT00104650|469108415|FG000|Follow-up Period|Lost to Follow-up|0|||
130312067|NCT00104650|469108416|FG001|Follow-up Period|Lost to Follow-up|1|||
130312068|NCT00104650|469108417|FG002|Follow-up Period|Lost to Follow-up|2|||
130312069|NCT00104650|469108415|FG000|Follow-up Period|Other|0|||
130312070|NCT00104650|469108416|FG001|Follow-up Period|Other|1|||
130312071|NCT00104650|469108417|FG002|Follow-up Period|Other|0|||
130312072|NCT00773513|469108419|FG000|Overall Study|Renal Transplant|254|||
130312073|NCT00773513|469108420|FG001|Overall Study|Renal Transplant|263|||
130312074|NCT00773513|469108419|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
130312075|NCT00773513|469108420|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
130312076|NCT00773513|469108419|FG000|Overall Study|Withdrew Consent|68|||
130050234|NCT01258348|468140747|FG001|Overall Study|Adverse Event|1|||
130312077|NCT00773513|469108420|FG001|Overall Study|Withdrew Consent|69|||
130312078|NCT00773513|469108419|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
130312079|NCT00773513|469108420|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
130312080|NCT00773513|469108419|FG000|Overall Study|Failure to Return|22|||
130312081|NCT00773513|469108420|FG001|Overall Study|Failure to Return|8|||
130312082|NCT00773513|469108419|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130312083|NCT00773513|469108420|FG001|Overall Study|Insufficient Therapeutic Response|18|||
130312084|NCT00773513|469108419|FG000|Overall Study|Reason Not Specified|159|||
130312085|NCT00773513|469108420|FG001|Overall Study|Reason Not Specified|126|||
130312086|NCT00773513|469108419|FG000|Overall Study|Death|531|||
130312087|NCT00773513|469108420|FG001|Overall Study|Death|545|||
130312088|NCT01807598|469108421|FG000|Overall Study|Withdrawal by Subject|4|||
130312089|NCT01807598|469108421|FG000|Overall Study|Adverse Event|1|||
130312090|NCT01807598|469108421|FG000|Overall Study|Other Physician Decision|1|||
130312091|NCT03384940|469108428|FG000|Overall Study|Progressive disease|36|||
130312092|NCT03384940|469108429|FG001|Overall Study|Progressive disease|11|||
130312093|NCT03384940|469108430|FG002|Overall Study|Progressive disease|13|||
130312094|NCT03384940|469108428|FG000|Overall Study|Clinical progression|4|||
130312095|NCT03384940|469108429|FG001|Overall Study|Clinical progression|0|||
130312096|NCT03384940|469108430|FG002|Overall Study|Clinical progression|3|||
130312097|NCT03384940|469108428|FG000|Overall Study|Adverse Event|7|||
130312098|NCT03384940|469108429|FG001|Overall Study|Adverse Event|1|||
130312099|NCT03384940|469108430|FG002|Overall Study|Adverse Event|1|||
130312100|NCT03384940|469108428|FG000|Overall Study|Withdrawal by Subject|3|||
130312101|NCT03384940|469108429|FG001|Overall Study|Withdrawal by Subject|1|||
130312102|NCT03384940|469108430|FG002|Overall Study|Withdrawal by Subject|0|||
130312103|NCT03384940|469108428|FG000|Overall Study|Physician Decision|1|||
130312104|NCT03384940|469108429|FG001|Overall Study|Physician Decision|1|||
130312105|NCT03384940|469108430|FG002|Overall Study|Physician Decision|0|||
130312106|NCT03384940|469108428|FG000|Overall Study|Death|2|||
130312107|NCT03384940|469108429|FG001|Overall Study|Death|1|||
130312108|NCT03384940|469108430|FG002|Overall Study|Death|0|||
130312109|NCT03384940|469108428|FG000|Overall Study|Other|0|||
130312110|NCT03384940|469108429|FG001|Overall Study|Other|0|||
130312111|NCT03384940|469108430|FG002|Overall Study|Other|1|||
130312112|NCT03089580|469108436|FG000|Overall Study|Lost to Follow-up|2|||
130312113|NCT03087513|469108437|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
130312114|NCT04170543|469108438|FG000|Overall Study|Death|1|||
130312115|NCT04170543|469108439|FG001|Overall Study|Death|1|||
130312116|NCT04170543|469108440|FG002|Overall Study|Death|1|||
130312117|NCT04170543|469108441|FG003|Overall Study|Death|1|||
130312118|NCT04170543|469108442|FG004|Overall Study|Death|1|||
130312119|NCT04170543|469108438|FG000|Overall Study|Lost to Follow-up|3|||
130312120|NCT04170543|469108439|FG001|Overall Study|Lost to Follow-up|3|||
130312121|NCT04170543|469108440|FG002|Overall Study|Lost to Follow-up|0|||
130312122|NCT04170543|469108441|FG003|Overall Study|Lost to Follow-up|3|||
130312123|NCT04170543|469108442|FG004|Overall Study|Lost to Follow-up|1|||
130312124|NCT04170543|469108438|FG000|Overall Study|Withdrawal by Subject|13|||
130312125|NCT04170543|469108439|FG001|Overall Study|Withdrawal by Subject|6|||
130312126|NCT04170543|469108440|FG002|Overall Study|Withdrawal by Subject|5|||
130312127|NCT04170543|469108441|FG003|Overall Study|Withdrawal by Subject|4|||
130312128|NCT04170543|469108442|FG004|Overall Study|Withdrawal by Subject|9|||
130312129|NCT04170543|469108438|FG000|Overall Study|Not able to transition to phase 2b|8|||
130312130|NCT04170543|469108439|FG001|Overall Study|Not able to transition to phase 2b|0|||
130312131|NCT04170543|469108440|FG002|Overall Study|Not able to transition to phase 2b|10|||
130312132|NCT04170543|469108441|FG003|Overall Study|Not able to transition to phase 2b|0|||
130312133|NCT04170543|469108442|FG004|Overall Study|Not able to transition to phase 2b|6|||
130312134|NCT04170543|469108438|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
130312135|NCT04170543|469108439|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
130050235|NCT01258348|468140748|FG002|Overall Study|Adverse Event|3|||
130050236|NCT01258348|468140749|FG003|Overall Study|Adverse Event|2|||
130312136|NCT04170543|469108440|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
130312137|NCT04170543|469108441|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
130312138|NCT04170543|469108442|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
130312139|NCT04170543|469108438|FG000|Overall Study|Not Treated|0|||
130312140|NCT04170543|469108439|FG001|Overall Study|Not Treated|0|||
130312141|NCT04170543|469108440|FG002|Overall Study|Not Treated|0|||
130312142|NCT04170543|469108441|FG003|Overall Study|Not Treated|0|||
130312143|NCT04170543|469108442|FG004|Overall Study|Not Treated|2|||
130312144|NCT04170543|469108438|FG000|Overall Study|(CRF)|16|||
130312145|NCT04170543|469108439|FG001|Overall Study|(CRF)|15|||
130312146|NCT04170543|469108440|FG002|Overall Study|(CRF)|12|||
130312147|NCT04170543|469108441|FG003|Overall Study|(CRF)|17|||
130312148|NCT04170543|469108442|FG004|Overall Study|(CRF)|17|||
130312149|NCT04170543|469108438|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
130312150|NCT04170543|469108439|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
130312151|NCT04170543|469108440|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
130312152|NCT04170543|469108441|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
130312153|NCT04170543|469108442|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
130312154|NCT00801216|469108443|FG000|Overall Study|Screening Failure|2|||
130312155|NCT05481359|469108444|FG000|Overall Study|Lost to Follow-up|3|||
130312156|NCT05481359|469108444|FG000|Overall Study|Withdrawal by Subject|1|||
130312157|NCT00452790|469108448|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
130312158|NCT00452790|469108449|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
130312159|NCT00452790|469108448|FG000|Infant Series|Parent/legal guardian request|8|||
130312160|NCT00452790|469108449|FG001|Infant Series|Parent/legal guardian request|6|||
130312161|NCT00452790|469108448|FG000|Infant Series|Failed to return|4|||
130312162|NCT00452790|469108449|FG001|Infant Series|Failed to return|1|||
130312163|NCT00452790|469108448|FG000|Infant Series|Protocol Violation|1|||
130312164|NCT00452790|469108449|FG001|Infant Series|Protocol Violation|3|||
130312165|NCT00452790|469108448|FG000|Infant Series|Lost to Follow-up|2|||
130312166|NCT00452790|469108449|FG001|Infant Series|Lost to Follow-up|2|||
130312167|NCT00452790|469108448|FG000|Infant Series|Adverse Event|1|||
130312168|NCT00452790|469108449|FG001|Infant Series|Adverse Event|2|||
130312169|NCT00452790|469108448|FG000|Infant Series|Other reasons|1|||
130312170|NCT00452790|469108449|FG001|Infant Series|Other reasons|2|||
130312171|NCT00452790|469108448|FG000|Infant Series|Investigator request|0|||
130312172|NCT00452790|469108449|FG001|Infant Series|Investigator request|1|||
130312173|NCT00452790|469108448|FG000|Infant Series|Death|0|||
130312174|NCT00452790|469108449|FG001|Infant Series|Death|1|||
130312175|NCT00452790|469108448|FG000|After Infant Series|Investigator request|10|||
130312176|NCT00452790|469108449|FG001|After Infant Series|Investigator request|10|||
130312177|NCT00452790|469108448|FG000|After Infant Series|Adverse Event|4|||
130312178|NCT00452790|469108449|FG001|After Infant Series|Adverse Event|1|||
130312179|NCT00452790|469108448|FG000|After Infant Series|Parent/legal guardian request|1|||
130312180|NCT00452790|469108449|FG001|After Infant Series|Parent/legal guardian request|3|||
130312181|NCT00452790|469108448|FG000|After Infant Series|Lost to Follow-up|4|||
130312182|NCT00452790|469108449|FG001|After Infant Series|Lost to Follow-up|0|||
130312183|NCT00452790|469108448|FG000|After Infant Series|Failed to return|1|||
130312184|NCT00452790|469108449|FG001|After Infant Series|Failed to return|0|||
130312185|NCT00452790|469108448|FG000|After Infant Series|Other reasons|1|||
130312186|NCT00452790|469108449|FG001|After Infant Series|Other reasons|0|||
130312187|NCT00452790|469108448|FG000|Toddler Dose|Failed to return|0|||
130312188|NCT00452790|469108449|FG001|Toddler Dose|Failed to return|1|||
130312189|NCT00452790|469108448|FG000|Toddler Dose|Parent/legal guardian request|0|||
130312190|NCT00452790|469108449|FG001|Toddler Dose|Parent/legal guardian request|1|||
130312191|NCT00319254|469108465|FG000|Overall Study|Withdrawal by Subject|4|||
130312192|NCT00319254|469108465|FG000|Overall Study|Death|46|||
130312193|NCT00319254|469108465|FG000|Overall Study|Lost to Follow-up|2|||
130312194|NCT00319254|469108465|FG000|Overall Study|Enrolled, Not Treated|2|||
130312195|NCT01505374|469108466|FG000|Overall Study|Lost to Follow-up|1|||
130312196|NCT01505374|469108467|FG001|Overall Study|Lost to Follow-up|0|||
130312197|NCT01712204|469108468|FG000|Overall Study|Adverse Event|3|||
130312198|NCT01712204|469108469|FG001|Overall Study|Adverse Event|1|||
130312199|NCT01712204|469108468|FG000|Overall Study|Withdrawal by Subject|3|||
130312200|NCT01712204|469108469|FG001|Overall Study|Withdrawal by Subject|3|||
130312201|NCT01712204|469108468|FG000|Overall Study|Lost to Follow-up|1|||
130312202|NCT01712204|469108469|FG001|Overall Study|Lost to Follow-up|0|||
130312203|NCT01712204|469108468|FG000|Overall Study|Protocol Violation|1|||
130312204|NCT01712204|469108469|FG001|Overall Study|Protocol Violation|1|||
130312205|NCT02360228|469108470|FG000|Overall Study|Withdrawal by Subject|1|||
130312206|NCT02360228|469108471|FG001|Overall Study|Withdrawal by Subject|0|||
130312207|NCT02360228|469108472|FG002|Overall Study|Withdrawal by Subject|0|||
130312208|NCT02360228|469108470|FG000|Overall Study|Self-discontinued medication|0|||
130312209|NCT02360228|469108471|FG001|Overall Study|Self-discontinued medication|1|||
130312210|NCT02360228|469108472|FG002|Overall Study|Self-discontinued medication|0|||
130312211|NCT02360228|469108470|FG000|Overall Study|Unstable symptoms during screening|0|||
130312212|NCT02360228|469108471|FG001|Overall Study|Unstable symptoms during screening|0|||
130312213|NCT02360228|469108472|FG002|Overall Study|Unstable symptoms during screening|1|||
130312214|NCT02452424|469108475|FG000|Overall Study|Death|2|||
130312215|NCT02452424|469108476|FG001|Overall Study|Death|2|||
130312216|NCT02452424|469108477|FG002|Overall Study|Death|2|||
130312217|NCT02452424|469108478|FG003|Overall Study|Death|6|||
130312218|NCT02452424|469108479|FG004|Overall Study|Death|2|||
130312219|NCT02452424|469108480|FG005|Overall Study|Death|0|||
130312220|NCT02452424|469108481|FG006|Overall Study|Death|5|||
130312221|NCT02452424|469108482|FG007|Overall Study|Death|1|||
130312222|NCT02452424|469108483|FG008|Overall Study|Death|3|||
130312223|NCT02452424|469108484|FG009|Overall Study|Death|1|||
130312224|NCT02452424|469108485|FG010|Overall Study|Death|0|||
130312225|NCT02452424|469108475|FG000|Overall Study|Lost to Follow-up|0|||
130312226|NCT02452424|469108476|FG001|Overall Study|Lost to Follow-up|1|||
130312227|NCT02452424|469108477|FG002|Overall Study|Lost to Follow-up|1|||
130312228|NCT02452424|469108478|FG003|Overall Study|Lost to Follow-up|0|||
130312229|NCT02452424|469108479|FG004|Overall Study|Lost to Follow-up|0|||
130312230|NCT02452424|469108480|FG005|Overall Study|Lost to Follow-up|0|||
130312231|NCT02452424|469108481|FG006|Overall Study|Lost to Follow-up|0|||
130312232|NCT02452424|469108482|FG007|Overall Study|Lost to Follow-up|0|||
130312233|NCT02452424|469108483|FG008|Overall Study|Lost to Follow-up|0|||
130312234|NCT02452424|469108484|FG009|Overall Study|Lost to Follow-up|0|||
130312235|NCT02452424|469108485|FG010|Overall Study|Lost to Follow-up|0|||
130312236|NCT02452424|469108475|FG000|Overall Study|Withdrawal by Subject|0|||
130312237|NCT02452424|469108476|FG001|Overall Study|Withdrawal by Subject|0|||
130312238|NCT02452424|469108477|FG002|Overall Study|Withdrawal by Subject|3|||
130312239|NCT02452424|469108478|FG003|Overall Study|Withdrawal by Subject|2|||
130312240|NCT02452424|469108479|FG004|Overall Study|Withdrawal by Subject|0|||
130312241|NCT02452424|469108480|FG005|Overall Study|Withdrawal by Subject|0|||
130312242|NCT02452424|469108481|FG006|Overall Study|Withdrawal by Subject|1|||
130312243|NCT02452424|469108482|FG007|Overall Study|Withdrawal by Subject|0|||
130312244|NCT02452424|469108483|FG008|Overall Study|Withdrawal by Subject|1|||
130312245|NCT02452424|469108484|FG009|Overall Study|Withdrawal by Subject|1|||
130312246|NCT02452424|469108485|FG010|Overall Study|Withdrawal by Subject|0|||
130312247|NCT02452424|469108475|FG000|Overall Study|Other|0|||
130312248|NCT02452424|469108476|FG001|Overall Study|Other|0|||
130312249|NCT02452424|469108477|FG002|Overall Study|Other|1|||
130312250|NCT02452424|469108478|FG003|Overall Study|Other|0|||
130312251|NCT02452424|469108479|FG004|Overall Study|Other|0|||
130312252|NCT02452424|469108480|FG005|Overall Study|Other|1|||
130312253|NCT02452424|469108481|FG006|Overall Study|Other|4|||
130312254|NCT02452424|469108482|FG007|Overall Study|Other|3|||
130312255|NCT02452424|469108483|FG008|Overall Study|Other|0|||
130312256|NCT02452424|469108484|FG009|Overall Study|Other|0|||
130312257|NCT02452424|469108485|FG010|Overall Study|Other|1|||
130312258|NCT02452424|469108475|FG000|Overall Study|Progressive disease (per RECIST)|0|||
130312259|NCT02452424|469108476|FG001|Overall Study|Progressive disease (per RECIST)|0|||
130312260|NCT02452424|469108477|FG002|Overall Study|Progressive disease (per RECIST)|0|||
130312261|NCT02452424|469108478|FG003|Overall Study|Progressive disease (per RECIST)|0|||
130312262|NCT02452424|469108479|FG004|Overall Study|Progressive disease (per RECIST)|0|||
130312263|NCT02452424|469108480|FG005|Overall Study|Progressive disease (per RECIST)|0|||
130312264|NCT02452424|469108481|FG006|Overall Study|Progressive disease (per RECIST)|0|||
130312265|NCT02452424|469108482|FG007|Overall Study|Progressive disease (per RECIST)|0|||
130312266|NCT02452424|469108483|FG008|Overall Study|Progressive disease (per RECIST)|2|||
130312267|NCT02452424|469108484|FG009|Overall Study|Progressive disease (per RECIST)|0|||
130312268|NCT02452424|469108485|FG010|Overall Study|Progressive disease (per RECIST)|0|||
130312269|NCT02452424|469108475|FG000|Overall Study|Adverse Event|0|||
130312270|NCT02452424|469108476|FG001|Overall Study|Adverse Event|0|||
130312271|NCT02452424|469108477|FG002|Overall Study|Adverse Event|0|||
130312272|NCT02452424|469108478|FG003|Overall Study|Adverse Event|0|||
130312273|NCT02452424|469108479|FG004|Overall Study|Adverse Event|0|||
130312274|NCT02452424|469108480|FG005|Overall Study|Adverse Event|0|||
130312275|NCT02452424|469108481|FG006|Overall Study|Adverse Event|0|||
130312276|NCT02452424|469108482|FG007|Overall Study|Adverse Event|0|||
130312277|NCT02452424|469108483|FG008|Overall Study|Adverse Event|0|||
130312278|NCT02452424|469108484|FG009|Overall Study|Adverse Event|0|||
130312279|NCT02452424|469108485|FG010|Overall Study|Adverse Event|1|||
130312280|NCT01463306|469108486|FG000|Overall Study|Adverse Event|6|||
130312281|NCT01463306|469108487|FG001|Overall Study|Adverse Event|9|||
130312282|NCT01463306|469108488|FG002|Overall Study|Adverse Event|3|||
130312283|NCT01463306|469108486|FG000|Overall Study|Death|3|||
130312284|NCT01463306|469108487|FG001|Overall Study|Death|3|||
130312285|NCT01463306|469108488|FG002|Overall Study|Death|0|||
130312286|NCT01463306|469108486|FG000|Overall Study|Lack of Efficacy|22|||
130312287|NCT01463306|469108487|FG001|Overall Study|Lack of Efficacy|16|||
130312288|NCT01463306|469108488|FG002|Overall Study|Lack of Efficacy|1|||
130312289|NCT01463306|469108486|FG000|Overall Study|Lost to Follow-up|5|||
130312290|NCT01463306|469108487|FG001|Overall Study|Lost to Follow-up|2|||
130312291|NCT01463306|469108488|FG002|Overall Study|Lost to Follow-up|0|||
130312292|NCT01463306|469108486|FG000|Overall Study|Protocol Violation|4|||
130312293|NCT01463306|469108487|FG001|Overall Study|Protocol Violation|0|||
130312294|NCT01463306|469108488|FG002|Overall Study|Protocol Violation|0|||
130312295|NCT01463306|469108486|FG000|Overall Study|Withdrawal by Subject|19|||
130312296|NCT01463306|469108487|FG001|Overall Study|Withdrawal by Subject|9|||
130312297|NCT01463306|469108488|FG002|Overall Study|Withdrawal by Subject|1|||
130312298|NCT01463306|469108486|FG000|Overall Study|Other|26|||
130312299|NCT01463306|469108487|FG001|Overall Study|Other|13|||
130312300|NCT01463306|469108488|FG002|Overall Study|Other|0|||
130312301|NCT01463306|469108486|FG000|Overall Study|Approval expiry at site|1|||
130312302|NCT01463306|469108487|FG001|Overall Study|Approval expiry at site|0|||
130312303|NCT01463306|469108488|FG002|Overall Study|Approval expiry at site|0|||
130312304|NCT04186871|469108491|FG000|Overall Study|Lack of Efficacy|0|||
130312305|NCT04186871|469108492|FG001|Overall Study|Lack of Efficacy|1|||
130312306|NCT04186871|469108493|FG002|Overall Study|Lack of Efficacy|0|||
130312307|NCT04186871|469108494|FG003|Overall Study|Lack of Efficacy|0|||
130312308|NCT04186871|469108495|FG004|Overall Study|Lack of Efficacy|1|||
130312309|NCT04186871|469108496|FG005|Overall Study|Lack of Efficacy|1|||
130312310|NCT04186871|469108491|FG000|Overall Study|Adverse Event|1|||
130312311|NCT04186871|469108492|FG001|Overall Study|Adverse Event|1|||
130312312|NCT04186871|469108493|FG002|Overall Study|Adverse Event|0|||
130312313|NCT04186871|469108494|FG003|Overall Study|Adverse Event|0|||
130312314|NCT04186871|469108495|FG004|Overall Study|Adverse Event|0|||
130312315|NCT04186871|469108496|FG005|Overall Study|Adverse Event|2|||
130312316|NCT04186871|469108491|FG000|Overall Study|Study terminated by sponsor|1|||
130312317|NCT04186871|469108492|FG001|Overall Study|Study terminated by sponsor|2|||
130312318|NCT04186871|469108493|FG002|Overall Study|Study terminated by sponsor|0|||
130312319|NCT04186871|469108494|FG003|Overall Study|Study terminated by sponsor|1|||
130312320|NCT04186871|469108495|FG004|Overall Study|Study terminated by sponsor|0|||
130312321|NCT04186871|469108496|FG005|Overall Study|Study terminated by sponsor|0|||
130312322|NCT04186871|469108491|FG000|Overall Study|Other reasons|0|||
130312323|NCT04186871|469108492|FG001|Overall Study|Other reasons|0|||
130312324|NCT04186871|469108493|FG002|Overall Study|Other reasons|0|||
130312325|NCT04186871|469108494|FG003|Overall Study|Other reasons|0|||
130312326|NCT04186871|469108495|FG004|Overall Study|Other reasons|0|||
130312327|NCT04186871|469108496|FG005|Overall Study|Other reasons|1|||
130312328|NCT04186871|469108491|FG000|Overall Study|Withdrawal by Subject|0|||
130312329|NCT04186871|469108492|FG001|Overall Study|Withdrawal by Subject|0|||
130312330|NCT04186871|469108493|FG002|Overall Study|Withdrawal by Subject|0|||
130312331|NCT04186871|469108494|FG003|Overall Study|Withdrawal by Subject|0|||
130312332|NCT04186871|469108495|FG004|Overall Study|Withdrawal by Subject|0|||
130312333|NCT04186871|469108496|FG005|Overall Study|Withdrawal by Subject|1|||
130312334|NCT04186871|469108491|FG000|Overall Study|Lost to Follow-up|0|||
130312335|NCT04186871|469108492|FG001|Overall Study|Lost to Follow-up|0|||
130312336|NCT04186871|469108493|FG002|Overall Study|Lost to Follow-up|0|||
130312337|NCT04186871|469108494|FG003|Overall Study|Lost to Follow-up|0|||
130312338|NCT04186871|469108495|FG004|Overall Study|Lost to Follow-up|0|||
130312339|NCT04186871|469108496|FG005|Overall Study|Lost to Follow-up|1|||
130312340|NCT03790917|469108497|FG000|Overall Study|Death|1|||
130312341|NCT02464410|469108498|FG000|Overall Study|Death|3|||
130312342|NCT02464410|469108499|FG001|Overall Study|Death|4|||
130312343|NCT02464410|469108498|FG000|Overall Study|Lost to Follow-up|7|||
130312344|NCT02464410|469108499|FG001|Overall Study|Lost to Follow-up|9|||
130312345|NCT02464410|469108498|FG000|Overall Study|Withdrawal by Subject|12|||
130312346|NCT02464410|469108499|FG001|Overall Study|Withdrawal by Subject|3|||
130312347|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
130312348|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
130312349|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
130312350|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
130312351|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
130312352|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
130312353|NCT02679287|469108510|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
130312354|NCT02679287|469108511|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
130312355|NCT02679287|469108510|FG000|Period 2|Work/Scheduling Conflict|1|||
130312356|NCT02679287|469108511|FG001|Period 2|Work/Scheduling Conflict|0|||
130312357|NCT02679287|469108510|FG000|Period 2|Disliked Mobile System|2|||
130312358|NCT02679287|469108511|FG001|Period 2|Disliked Mobile System|0|||
130312359|NCT02679287|469108510|FG000|Period 3|Work/Scheduling Conflict|0|||
130312360|NCT02679287|469108511|FG001|Period 3|Work/Scheduling Conflict|1|||
130312361|NCT01045694|469108513|FG000|Overall Study|Withdrawal by Subject|2|||
130312362|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Death|2|||
130312363|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Death|0|||
130312364|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Death|0|||
130312365|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
130312366|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
130312367|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
130312368|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
130312369|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
130312370|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
130312371|NCT01150097|469108521|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
130312372|NCT01150097|469108522|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
130312373|NCT01150097|469108523|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
130312374|NCT01150097|469108521|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
130312375|NCT01150097|469108522|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
130312376|NCT01150097|469108523|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
130312377|NCT01150097|469108521|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
130312378|NCT01150097|469108522|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
130312379|NCT01150097|469108523|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
130312380|NCT01150097|469108521|FG000|Months 24 to 48 Post-transplantation|Death|2|||
130312381|NCT01150097|469108522|FG001|Months 24 to 48 Post-transplantation|Death|0|||
130312382|NCT01150097|469108523|FG002|Months 24 to 48 Post-transplantation|Death|0|||
130312383|NCT00992459|469108524|FG000|Overall Study|Withdrawal by Subject|0|||
130312384|NCT00992459|469108525|FG001|Overall Study|Withdrawal by Subject|1|||
130312385|NCT00992459|469108524|FG000|Overall Study|Adverse Event|1|||
130312386|NCT00992459|469108525|FG001|Overall Study|Adverse Event|0|||
130312387|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Adverse Event|0|||
130312388|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Adverse Event|1|||
130312389|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Adverse Event|0|||
130312390|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Adverse Event|0|||
130312391|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Adverse Event|0|||
130312392|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Adverse Event|0|||
130312393|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Adverse Event|0|||
130312394|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Adverse Event|1|||
130312395|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Adverse Event|1|||
130312396|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Adverse Event|0|||
130312397|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Adverse Event|0|||
130312398|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Physician Decision|0|||
130312399|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Physician Decision|0|||
130312400|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Physician Decision|1|||
130312401|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Physician Decision|0|||
130312402|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Physician Decision|0|||
130312403|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Physician Decision|0|||
130312404|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Physician Decision|0|||
130312405|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Physician Decision|1|||
130312406|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Physician Decision|0|||
130312407|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Physician Decision|0|||
130312408|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Physician Decision|0|||
130312409|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312410|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
130312411|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
130312412|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312413|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312414|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
130312415|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
130312416|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
130312417|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
130312418|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
130312419|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
130312420|NCT00543387|469108528|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312421|NCT00543387|469108529|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129890072|NCT02036515|467554596|FG002|Overall Study|Screen failure|0|||
130312422|NCT00543387|469108530|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312423|NCT00543387|469108531|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312424|NCT00543387|469108532|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129890073|NCT02036515|467554594|FG000|Overall Study|Withdrawal by Subject|4|||
130312425|NCT00543387|469108533|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312426|NCT00543387|469108534|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
130312427|NCT00543387|469108535|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312428|NCT00543387|469108536|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312429|NCT00543387|469108537|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312430|NCT00543387|469108538|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
130312431|NCT00543387|469108528|FG000|Crossover Participants|Progressive Disease|0|||
130312432|NCT00543387|469108529|FG001|Crossover Participants|Progressive Disease|0|||
130312433|NCT00543387|469108530|FG002|Crossover Participants|Progressive Disease|0|||
130312434|NCT00543387|469108531|FG003|Crossover Participants|Progressive Disease|0|||
130312435|NCT00543387|469108532|FG004|Crossover Participants|Progressive Disease|0|||
130312436|NCT00543387|469108533|FG005|Crossover Participants|Progressive Disease|0|||
130312437|NCT00543387|469108534|FG006|Crossover Participants|Progressive Disease|0|||
130312438|NCT00543387|469108535|FG007|Crossover Participants|Progressive Disease|0|||
130312439|NCT00543387|469108536|FG008|Crossover Participants|Progressive Disease|0|||
130312440|NCT00543387|469108537|FG009|Crossover Participants|Progressive Disease|1|||
130312441|NCT00543387|469108538|FG010|Crossover Participants|Progressive Disease|2|||
130312442|NCT00543387|469108528|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
130312443|NCT00543387|469108529|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
130312444|NCT00543387|469108530|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
130312445|NCT00543387|469108531|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
130312446|NCT00543387|469108532|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
130312447|NCT00543387|469108533|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
130312448|NCT00543387|469108534|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
130312449|NCT00543387|469108535|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
130312450|NCT00543387|469108536|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
130312451|NCT00543387|469108537|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
130312452|NCT00543387|469108538|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
130312453|NCT01114828|469108539|FG000|Overall Study|Adverse Event|1|||
130312454|NCT01114828|469108540|FG001|Overall Study|Adverse Event|1|||
130312455|NCT01114828|469108539|FG000|Overall Study|Lack of Efficacy|0|||
130312456|NCT01114828|469108540|FG001|Overall Study|Lack of Efficacy|2|||
130312457|NCT01114828|469108539|FG000|Overall Study|Protocol Violation|2|||
130312458|NCT01114828|469108540|FG001|Overall Study|Protocol Violation|0|||
130312459|NCT01114828|469108539|FG000|Overall Study|Withdrawal by Subject|0|||
130312460|NCT01114828|469108540|FG001|Overall Study|Withdrawal by Subject|1|||
130312461|NCT00940498|469108541|FG000|Overall Study|Death|2|||
130312462|NCT00940498|469108542|FG001|Overall Study|Death|0|||
130312463|NCT00940498|469108543|FG002|Overall Study|Death|0|||
130312464|NCT00940498|469108544|FG003|Overall Study|Death|1|||
130312465|NCT00940498|469108545|FG004|Overall Study|Death|5|||
130312466|NCT00940498|469108546|FG005|Overall Study|Death|0|||
130312467|NCT00940498|469108547|FG006|Overall Study|Death|1|||
130312468|NCT00940498|469108548|FG007|Overall Study|Death|0|||
130312469|NCT00940498|469108541|FG000|Overall Study|Lost to Follow-up|1|||
130312470|NCT00940498|469108542|FG001|Overall Study|Lost to Follow-up|1|||
130312471|NCT00940498|469108543|FG002|Overall Study|Lost to Follow-up|2|||
130312472|NCT00940498|469108544|FG003|Overall Study|Lost to Follow-up|0|||
130312473|NCT00940498|469108545|FG004|Overall Study|Lost to Follow-up|1|||
130312474|NCT00940498|469108546|FG005|Overall Study|Lost to Follow-up|0|||
130312475|NCT00940498|469108547|FG006|Overall Study|Lost to Follow-up|0|||
130312476|NCT00940498|469108548|FG007|Overall Study|Lost to Follow-up|1|||
130312477|NCT00940498|469108541|FG000|Overall Study|Disease Progression|0|||
130312478|NCT00940498|469108542|FG001|Overall Study|Disease Progression|0|||
130312479|NCT00940498|469108543|FG002|Overall Study|Disease Progression|1|||
130312480|NCT00940498|469108544|FG003|Overall Study|Disease Progression|1|||
130312481|NCT00940498|469108545|FG004|Overall Study|Disease Progression|0|||
130312482|NCT00940498|469108546|FG005|Overall Study|Disease Progression|1|||
130312483|NCT00940498|469108547|FG006|Overall Study|Disease Progression|0|||
130312484|NCT00940498|469108548|FG007|Overall Study|Disease Progression|0|||
130312485|NCT00940498|469108541|FG000|Overall Study|Physician Decision|0|||
130312486|NCT00940498|469108542|FG001|Overall Study|Physician Decision|0|||
130312487|NCT00940498|469108543|FG002|Overall Study|Physician Decision|0|||
130312488|NCT00940498|469108544|FG003|Overall Study|Physician Decision|0|||
130312489|NCT00940498|469108545|FG004|Overall Study|Physician Decision|2|||
130312490|NCT00940498|469108546|FG005|Overall Study|Physician Decision|0|||
130312491|NCT00940498|469108547|FG006|Overall Study|Physician Decision|0|||
130312492|NCT00940498|469108548|FG007|Overall Study|Physician Decision|0|||
130312493|NCT00940498|469108541|FG000|Overall Study|Not treated due to disease related pain|0|||
130050237|NCT01258348|468140750|FG004|Overall Study|Adverse Event|4|||
130050238|NCT01258348|468140746|FG000|Overall Study|Progressive Disease|0|||
130312494|NCT00940498|469108542|FG001|Overall Study|Not treated due to disease related pain|0|||
129798871|NCT01178073|467232184|FG001|Overall Study|Withdrawal by Subject|6|||
129798872|NCT01178073|467232185|FG002|Overall Study|Withdrawal by Subject|8|||
129798873|NCT01178073|467232183|FG000|Overall Study|Missing Completion Status|1|||
129798874|NCT01178073|467232184|FG001|Overall Study|Missing Completion Status|0|||
129890074|NCT02036515|467554595|FG001|Overall Study|Withdrawal by Subject|7|||
129890075|NCT02036515|467554596|FG002|Overall Study|Withdrawal by Subject|9|||
129890076|NCT02036515|467554594|FG000|Overall Study|Hyperglycemia|0|||
129890077|NCT02036515|467554595|FG001|Overall Study|Hyperglycemia|0|||
129890078|NCT02036515|467554596|FG002|Overall Study|Hyperglycemia|1|||
129890079|NCT03621982|467554597|FG000|Overall Study|Withdrawal by Subject|1|||
129890080|NCT03621982|467554598|FG001|Overall Study|Withdrawal by Subject|0|||
129890081|NCT03621982|467554599|FG002|Overall Study|Withdrawal by Subject|0|||
129890082|NCT03621982|467554600|FG003|Overall Study|Withdrawal by Subject|1|||
129890083|NCT03621982|467554601|FG004|Overall Study|Withdrawal by Subject|0|||
129890084|NCT03621982|467554602|FG005|Overall Study|Withdrawal by Subject|1|||
129890085|NCT03621982|467554603|FG006|Overall Study|Withdrawal by Subject|1|||
129890086|NCT03621982|467554604|FG007|Overall Study|Withdrawal by Subject|0|||
129890087|NCT03621982|467554605|FG008|Overall Study|Withdrawal by Subject|1|||
129890088|NCT03621982|467554606|FG009|Overall Study|Withdrawal by Subject|0|||
129890089|NCT03621982|467554607|FG010|Overall Study|Withdrawal by Subject|2|||
129890090|NCT03621982|467554608|FG011|Overall Study|Withdrawal by Subject|1|||
129890091|NCT03621982|467554609|FG012|Overall Study|Withdrawal by Subject|2|||
129890092|NCT03621982|467554610|FG013|Overall Study|Withdrawal by Subject|2|||
129890093|NCT03621982|467554597|FG000|Overall Study|Investigator/Sponsor decision|0|||
129890094|NCT03621982|467554598|FG001|Overall Study|Investigator/Sponsor decision|0|||
129890095|NCT03621982|467554599|FG002|Overall Study|Investigator/Sponsor decision|0|||
129890096|NCT03621982|467554600|FG003|Overall Study|Investigator/Sponsor decision|0|||
129890097|NCT03621982|467554601|FG004|Overall Study|Investigator/Sponsor decision|0|||
129890098|NCT03621982|467554602|FG005|Overall Study|Investigator/Sponsor decision|0|||
129890099|NCT03621982|467554603|FG006|Overall Study|Investigator/Sponsor decision|0|||
129890100|NCT03621982|467554604|FG007|Overall Study|Investigator/Sponsor decision|0|||
129890101|NCT03621982|467554605|FG008|Overall Study|Investigator/Sponsor decision|0|||
129890102|NCT03621982|467554606|FG009|Overall Study|Investigator/Sponsor decision|0|||
129890103|NCT03621982|467554607|FG010|Overall Study|Investigator/Sponsor decision|0|||
129890104|NCT03621982|467554608|FG011|Overall Study|Investigator/Sponsor decision|4|||
129890105|NCT03621982|467554609|FG012|Overall Study|Investigator/Sponsor decision|0|||
129890106|NCT03621982|467554610|FG013|Overall Study|Investigator/Sponsor decision|2|||
129890107|NCT03621982|467554597|FG000|Overall Study|Death|2|||
129890108|NCT03621982|467554598|FG001|Overall Study|Death|4|||
129890109|NCT03621982|467554599|FG002|Overall Study|Death|4|||
129890110|NCT03621982|467554600|FG003|Overall Study|Death|3|||
129890111|NCT03621982|467554601|FG004|Overall Study|Death|8|||
129890112|NCT03621982|467554602|FG005|Overall Study|Death|4|||
129890113|NCT03621982|467554603|FG006|Overall Study|Death|6|||
129890114|NCT03621982|467554604|FG007|Overall Study|Death|3|||
129890115|NCT03621982|467554605|FG008|Overall Study|Death|0|||
129890116|NCT03621982|467554606|FG009|Overall Study|Death|3|||
129890117|NCT03621982|467554607|FG010|Overall Study|Death|8|||
129890118|NCT03621982|467554608|FG011|Overall Study|Death|4|||
129890119|NCT03621982|467554609|FG012|Overall Study|Death|2|||
129890120|NCT03621982|467554610|FG013|Overall Study|Death|2|||
129890121|NCT03621982|467554597|FG000|Overall Study|Lost to Follow-up|0|||
129890122|NCT03621982|467554598|FG001|Overall Study|Lost to Follow-up|0|||
129890123|NCT03621982|467554599|FG002|Overall Study|Lost to Follow-up|1|||
129890124|NCT03621982|467554600|FG003|Overall Study|Lost to Follow-up|0|||
129890125|NCT03621982|467554601|FG004|Overall Study|Lost to Follow-up|0|||
130050239|NCT01258348|468140747|FG001|Overall Study|Progressive Disease|3|||
129890126|NCT03621982|467554602|FG005|Overall Study|Lost to Follow-up|0|||
130050240|NCT01258348|468140748|FG002|Overall Study|Progressive Disease|0|||
130050241|NCT01258348|468140749|FG003|Overall Study|Progressive Disease|2|||
129890127|NCT03621982|467554603|FG006|Overall Study|Lost to Follow-up|1|||
129890128|NCT03621982|467554604|FG007|Overall Study|Lost to Follow-up|0|||
129890129|NCT03621982|467554605|FG008|Overall Study|Lost to Follow-up|0|||
129890130|NCT03621982|467554606|FG009|Overall Study|Lost to Follow-up|1|||
129890131|NCT03621982|467554607|FG010|Overall Study|Lost to Follow-up|0|||
129890132|NCT03621982|467554608|FG011|Overall Study|Lost to Follow-up|0|||
129890133|NCT03621982|467554609|FG012|Overall Study|Lost to Follow-up|0|||
129890134|NCT03621982|467554610|FG013|Overall Study|Lost to Follow-up|0|||
129890135|NCT00442286|467554613|FG000|Overall Study|Death|2|||
129890136|NCT00442286|467554614|FG001|Overall Study|Death|2|||
129890137|NCT00442286|467554613|FG000|Overall Study|Lost to Follow-up|1|||
129890138|NCT00442286|467554614|FG001|Overall Study|Lost to Follow-up|0|||
129890139|NCT00442286|467554613|FG000|Overall Study|Withdrawal by Subject|2|||
129890140|NCT00442286|467554614|FG001|Overall Study|Withdrawal by Subject|0|||
129890141|NCT00442286|467554613|FG000|Overall Study|System explanted|1|||
129890142|NCT00442286|467554614|FG001|Overall Study|System explanted|0|||
129890143|NCT00442286|467554613|FG000|Overall Study|Patient Injury|1|||
129890144|NCT00442286|467554614|FG001|Overall Study|Patient Injury|0|||
129798875|NCT01178073|467232185|FG002|Overall Study|Missing Completion Status|0|||
129798876|NCT01721070|467232186|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
129798877|NCT03497676|467232187|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
129798878|NCT03497676|467232188|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
129798879|NCT03497676|467232189|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
129798880|NCT03497676|467232190|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
129798881|NCT03497676|467232187|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
129798882|NCT03497676|467232188|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
129798883|NCT03497676|467232189|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
129798884|NCT03497676|467232190|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
129798885|NCT03497676|467232187|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
129798886|NCT03497676|467232188|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
129798887|NCT03497676|467232189|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
129798888|NCT03497676|467232190|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
129798889|NCT03497676|467232187|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
129798890|NCT03497676|467232188|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
129798891|NCT03497676|467232189|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
129798892|NCT03497676|467232190|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
129798893|NCT03497676|467232187|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
129798894|NCT03497676|467232188|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
129798895|NCT03497676|467232189|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
129798896|NCT03497676|467232190|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
129798897|NCT03497676|467232187|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
129798898|NCT03497676|467232188|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
129798899|NCT03497676|467232189|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
129798900|NCT03497676|467232190|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
129798901|NCT03497676|467232187|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129798902|NCT03497676|467232188|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129798903|NCT03497676|467232189|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
129798904|NCT03497676|467232190|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129798905|NCT03497676|467232187|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
129798906|NCT03497676|467232188|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
129798907|NCT03497676|467232189|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
129798908|NCT03497676|467232190|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
129798909|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
129798910|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
129798911|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
129798912|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
129798913|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
129798914|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
129798915|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
129798916|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
129798917|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
129798918|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
129798919|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
129890145|NCT01544582|467554615|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
130110615|NCT03276962|468365789|FG000|Overall Study|Other|0|||
130110616|NCT03276962|468365790|FG001|Overall Study|Other|2|||
129890146|NCT01544582|467554616|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
129890147|NCT01544582|467554617|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
129890148|NCT01544582|467554618|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
129890149|NCT01544582|467554615|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
129890150|NCT01544582|467554616|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
129890151|NCT01544582|467554617|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
129890152|NCT01544582|467554618|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
129890153|NCT01544582|467554615|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
129890154|NCT01544582|467554616|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
129890155|NCT01544582|467554617|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
129890156|NCT01544582|467554618|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
129890157|NCT01544582|467554615|FG000|Analysis Population|Physician Decision|0|||
129890158|NCT01544582|467554616|FG001|Analysis Population|Physician Decision|13|||
129890159|NCT01544582|467554617|FG002|Analysis Population|Physician Decision|10|||
129890160|NCT01544582|467554618|FG003|Analysis Population|Physician Decision|9|||
129890161|NCT01544582|467554615|FG000|Analysis Population|Safety Reason|0|||
129890162|NCT01544582|467554616|FG001|Analysis Population|Safety Reason|33|||
129890163|NCT01544582|467554617|FG002|Analysis Population|Safety Reason|31|||
129890164|NCT01544582|467554618|FG003|Analysis Population|Safety Reason|8|||
129890165|NCT01544582|467554615|FG000|Analysis Population|Effectiveness Reason|0|||
129890166|NCT01544582|467554616|FG001|Analysis Population|Effectiveness Reason|48|||
129890167|NCT01544582|467554617|FG002|Analysis Population|Effectiveness Reason|29|||
129890168|NCT01544582|467554618|FG003|Analysis Population|Effectiveness Reason|12|||
129890169|NCT01544582|467554615|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
129890170|NCT01544582|467554616|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
129890171|NCT01544582|467554617|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
129890172|NCT01544582|467554618|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
129890173|NCT01544582|467554615|FG000|Analysis Population|Lost to Follow-up|0|||
129890174|NCT01544582|467554616|FG001|Analysis Population|Lost to Follow-up|6|||
129890175|NCT01544582|467554617|FG002|Analysis Population|Lost to Follow-up|6|||
129890176|NCT01544582|467554618|FG003|Analysis Population|Lost to Follow-up|5|||
129890177|NCT01544582|467554615|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
129890178|NCT01544582|467554616|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
129890179|NCT01544582|467554617|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
129890180|NCT01544582|467554618|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
129890181|NCT01544582|467554615|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129890182|NCT01544582|467554616|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129890183|NCT01544582|467554617|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
129890184|NCT01544582|467554618|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129890185|NCT01544582|467554615|FG000|Analysis Population|Intolerance|0|||
129890186|NCT01544582|467554616|FG001|Analysis Population|Intolerance|1|||
129890187|NCT01544582|467554617|FG002|Analysis Population|Intolerance|0|||
129890188|NCT01544582|467554618|FG003|Analysis Population|Intolerance|0|||
129890189|NCT01544582|467554615|FG000|Analysis Population|Liver Transplantation|0|||
129890190|NCT01544582|467554616|FG001|Analysis Population|Liver Transplantation|0|||
129890191|NCT01544582|467554617|FG002|Analysis Population|Liver Transplantation|1|||
129890192|NCT01544582|467554618|FG003|Analysis Population|Liver Transplantation|0|||
129890193|NCT01544582|467554615|FG000|Analysis Population|No Social Insurance|0|||
129890194|NCT01544582|467554616|FG001|Analysis Population|No Social Insurance|0|||
129890195|NCT01544582|467554617|FG002|Analysis Population|No Social Insurance|1|||
129890196|NCT01544582|467554618|FG003|Analysis Population|No Social Insurance|0|||
129890197|NCT01544582|467554615|FG000|Analysis Population|Poor Adherence|0|||
129890198|NCT01544582|467554616|FG001|Analysis Population|Poor Adherence|0|||
129890199|NCT01544582|467554617|FG002|Analysis Population|Poor Adherence|1|||
129890200|NCT01544582|467554618|FG003|Analysis Population|Poor Adherence|0|||
129890201|NCT01544582|467554615|FG000|Analysis Population|Poor Participant Compliance|0|||
129890202|NCT01544582|467554616|FG001|Analysis Population|Poor Participant Compliance|1|||
129890203|NCT01544582|467554617|FG002|Analysis Population|Poor Participant Compliance|0|||
129890204|NCT01544582|467554618|FG003|Analysis Population|Poor Participant Compliance|0|||
129890205|NCT01544582|467554615|FG000|Analysis Population|Programmed Surgery|0|||
129890206|NCT01544582|467554616|FG001|Analysis Population|Programmed Surgery|1|||
129890207|NCT01544582|467554617|FG002|Analysis Population|Programmed Surgery|0|||
130312495|NCT00940498|469108543|FG002|Overall Study|Not treated due to disease related pain|0|||
130312496|NCT00940498|469108544|FG003|Overall Study|Not treated due to disease related pain|0|||
130312497|NCT00940498|469108545|FG004|Overall Study|Not treated due to disease related pain|1|||
130312498|NCT00940498|469108546|FG005|Overall Study|Not treated due to disease related pain|0|||
130312499|NCT00940498|469108547|FG006|Overall Study|Not treated due to disease related pain|0|||
130312500|NCT00940498|469108548|FG007|Overall Study|Not treated due to disease related pain|0|||
130312501|NCT00549445|469108549|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
130312502|NCT00549445|469108550|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
130312503|NCT03932760|469108551|FG000|Overall Study|Became Ineligible|2|||
130312504|NCT03932760|469108552|FG001|Overall Study|Became Ineligible|5|||
130312505|NCT03932760|469108551|FG000|Overall Study|Withdrawal by Subject|6|||
130312506|NCT03932760|469108552|FG001|Overall Study|Withdrawal by Subject|6|||
130312507|NCT03566082|469108553|FG000|Overall Study|Death|7|||
130312508|NCT03566082|469108553|FG000|Overall Study|Failures (revision required)|2|||
130312509|NCT03566082|469108553|FG000|Overall Study|Lost to Follow-up|8|||
130312510|NCT00227721|469109912|FG000|Overall Study|On study, but never treated.|1|||
130312511|NCT01389882|469109917|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
130312512|NCT01389882|469109918|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
130312513|NCT01389882|469109917|FG000|Overall Study|Withdrawal by Subject|0|||
130312514|NCT01389882|469109918|FG001|Overall Study|Withdrawal by Subject|1|||
130312515|NCT00961181|469109919|FG000|Overall Study|Death|2|||
130312516|NCT00961181|469109919|FG000|Overall Study|Withdrawal by Subject|2|||
130312517|NCT00961181|469109919|FG000|Overall Study|Lost to Follow-up|1|||
130312518|NCT00280917|469109920|FG000|Overall Study|Adverse Event|1|||
130312519|NCT00280917|469109921|FG001|Overall Study|Adverse Event|1|||
130312520|NCT00280917|469109922|FG002|Overall Study|Adverse Event|4|||
130312521|NCT00280917|469109923|FG003|Overall Study|Adverse Event|1|||
130312522|NCT00280917|469109920|FG000|Overall Study|Change Therapy|1|||
130312523|NCT00280917|469109921|FG001|Overall Study|Change Therapy|2|||
130312524|NCT00280917|469109922|FG002|Overall Study|Change Therapy|0|||
130312525|NCT00280917|469109923|FG003|Overall Study|Change Therapy|0|||
130312526|NCT00280917|469109920|FG000|Overall Study|Withdrawal by Subject|0|||
130312527|NCT00280917|469109921|FG001|Overall Study|Withdrawal by Subject|2|||
130312528|NCT00280917|469109922|FG002|Overall Study|Withdrawal by Subject|0|||
130312529|NCT00280917|469109923|FG003|Overall Study|Withdrawal by Subject|1|||
130312530|NCT00280917|469109920|FG000|Overall Study|Noncompliance|0|||
130312531|NCT00280917|469109921|FG001|Overall Study|Noncompliance|1|||
130312532|NCT00280917|469109922|FG002|Overall Study|Noncompliance|2|||
130312533|NCT00280917|469109923|FG003|Overall Study|Noncompliance|0|||
130312534|NCT01276639|469109938|FG000|Week 0 to 16|Death|1|||
130312535|NCT01276639|469109939|FG001|Week 0 to 16|Death|0|||
130312536|NCT01276639|469109940|FG002|Week 0 to 16|Death|0|||
130312537|NCT01276639|469109941|FG003|Week 0 to 16|Death|0|||
130312538|NCT01276639|469109942|FG004|Week 0 to 16|Death|0|||
130312539|NCT01276639|469109938|FG000|Week 0 to 16|Adverse Event|11|||
130312540|NCT01276639|469109939|FG001|Week 0 to 16|Adverse Event|8|||
130312541|NCT01276639|469109940|FG002|Week 0 to 16|Adverse Event|11|||
130312542|NCT01276639|469109941|FG003|Week 0 to 16|Adverse Event|0|||
130312543|NCT01276639|469109942|FG004|Week 0 to 16|Adverse Event|0|||
130312544|NCT01276639|469109938|FG000|Week 0 to 16|Lack of Efficacy|20|||
130312545|NCT01276639|469109939|FG001|Week 0 to 16|Lack of Efficacy|15|||
130312546|NCT01276639|469109940|FG002|Week 0 to 16|Lack of Efficacy|25|||
130312547|NCT01276639|469109941|FG003|Week 0 to 16|Lack of Efficacy|0|||
130312548|NCT01276639|469109942|FG004|Week 0 to 16|Lack of Efficacy|0|||
130312549|NCT01276639|469109938|FG000|Week 0 to 16|Lost to Follow-up|3|||
130312550|NCT01276639|469109939|FG001|Week 0 to 16|Lost to Follow-up|5|||
130312551|NCT01276639|469109940|FG002|Week 0 to 16|Lost to Follow-up|3|||
130312552|NCT01276639|469109941|FG003|Week 0 to 16|Lost to Follow-up|0|||
130312553|NCT01276639|469109942|FG004|Week 0 to 16|Lost to Follow-up|0|||
130312554|NCT01276639|469109938|FG000|Week 0 to 16|Withdrawal by Subject|8|||
130312555|NCT01276639|469109939|FG001|Week 0 to 16|Withdrawal by Subject|5|||
130312556|NCT01276639|469109940|FG002|Week 0 to 16|Withdrawal by Subject|4|||
130312557|NCT01276639|469109941|FG003|Week 0 to 16|Withdrawal by Subject|0|||
130312558|NCT01276639|469109942|FG004|Week 0 to 16|Withdrawal by Subject|0|||
130312559|NCT01276639|469109938|FG000|Week 0 to 16|Other|7|||
130312560|NCT01276639|469109939|FG001|Week 0 to 16|Other|7|||
130312561|NCT01276639|469109940|FG002|Week 0 to 16|Other|2|||
130312562|NCT01276639|469109941|FG003|Week 0 to 16|Other|0|||
130312563|NCT01276639|469109942|FG004|Week 0 to 16|Other|0|||
130312564|NCT01276639|469109938|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
130312565|NCT01276639|469109939|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
130312566|NCT01276639|469109940|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
130312567|NCT01276639|469109941|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
130312568|NCT01276639|469109942|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
130312569|NCT01276639|469109938|FG000|Week 16 to 52|Death|1|||
130312570|NCT01276639|469109939|FG001|Week 16 to 52|Death|0|||
130312571|NCT01276639|469109940|FG002|Week 16 to 52|Death|0|||
130312572|NCT01276639|469109941|FG003|Week 16 to 52|Death|0|||
130312573|NCT01276639|469109942|FG004|Week 16 to 52|Death|0|||
130312574|NCT01276639|469109938|FG000|Week 16 to 52|Adverse Event|10|||
130312575|NCT01276639|469109939|FG001|Week 16 to 52|Adverse Event|13|||
130312576|NCT01276639|469109940|FG002|Week 16 to 52|Adverse Event|0|||
130312577|NCT01276639|469109941|FG003|Week 16 to 52|Adverse Event|1|||
130312578|NCT01276639|469109942|FG004|Week 16 to 52|Adverse Event|3|||
130312579|NCT01276639|469109938|FG000|Week 16 to 52|Lack of Efficacy|99|||
130312580|NCT01276639|469109939|FG001|Week 16 to 52|Lack of Efficacy|71|||
130312581|NCT01276639|469109940|FG002|Week 16 to 52|Lack of Efficacy|0|||
130312582|NCT01276639|469109941|FG003|Week 16 to 52|Lack of Efficacy|14|||
130312583|NCT01276639|469109942|FG004|Week 16 to 52|Lack of Efficacy|13|||
130312584|NCT01276639|469109938|FG000|Week 16 to 52|Lost to Follow-up|3|||
130312585|NCT01276639|469109939|FG001|Week 16 to 52|Lost to Follow-up|1|||
130312586|NCT01276639|469109940|FG002|Week 16 to 52|Lost to Follow-up|0|||
130312587|NCT01276639|469109941|FG003|Week 16 to 52|Lost to Follow-up|0|||
130050242|NCT01258348|468140750|FG004|Overall Study|Progressive Disease|2|||
130050243|NCT01258348|468140746|FG000|Overall Study|Physician Decision|0|||
130050244|NCT01258348|468140747|FG001|Overall Study|Physician Decision|0|||
130050245|NCT01258348|468140748|FG002|Overall Study|Physician Decision|0|||
130312588|NCT01276639|469109942|FG004|Week 16 to 52|Lost to Follow-up|1|||
130312589|NCT01276639|469109938|FG000|Week 16 to 52|Withdrawal by Subject|4|||
130312590|NCT01276639|469109939|FG001|Week 16 to 52|Withdrawal by Subject|4|||
130312591|NCT01276639|469109940|FG002|Week 16 to 52|Withdrawal by Subject|0|||
130312592|NCT01276639|469109941|FG003|Week 16 to 52|Withdrawal by Subject|0|||
130312593|NCT01276639|469109942|FG004|Week 16 to 52|Withdrawal by Subject|1|||
130312594|NCT01276639|469109938|FG000|Week 16 to 52|Other|10|||
130312595|NCT01276639|469109939|FG001|Week 16 to 52|Other|12|||
130312596|NCT01276639|469109940|FG002|Week 16 to 52|Other|0|||
130312597|NCT01276639|469109941|FG003|Week 16 to 52|Other|1|||
130312598|NCT01276639|469109942|FG004|Week 16 to 52|Other|3|||
130312599|NCT00466440|469109947|FG000|Overall Study|Adverse Event|0|||
130312600|NCT00466440|469109948|FG001|Overall Study|Adverse Event|3|||
130312601|NCT00466440|469109949|FG002|Overall Study|Adverse Event|1|||
130312602|NCT00466440|469109947|FG000|Overall Study|Death|1|||
130312603|NCT00466440|469109948|FG001|Overall Study|Death|1|||
130050246|NCT01258348|468140749|FG003|Overall Study|Physician Decision|2|||
130050247|NCT01258348|468140750|FG004|Overall Study|Physician Decision|0|||
130050248|NCT01258348|468140746|FG000|Overall Study|Withdrawal by Subject|0|||
130050249|NCT01258348|468140747|FG001|Overall Study|Withdrawal by Subject|1|||
130050250|NCT01258348|468140748|FG002|Overall Study|Withdrawal by Subject|0|||
130050251|NCT01258348|468140749|FG003|Overall Study|Withdrawal by Subject|0|||
130050252|NCT01258348|468140750|FG004|Overall Study|Withdrawal by Subject|0|||
130050253|NCT00109733|468140751|FG000|Overall Study|Protocol Violation|0|||
130050254|NCT00109733|468140752|FG001|Overall Study|Protocol Violation|1|||
130050255|NCT00109733|468140751|FG000|Overall Study|Stopped taking study drug|1|||
130050256|NCT00109733|468140752|FG001|Overall Study|Stopped taking study drug|1|||
130050257|NCT00109733|468140751|FG000|Overall Study|Non-compliant|0|||
130050258|NCT00109733|468140752|FG001|Overall Study|Non-compliant|1|||
130050259|NCT00109733|468140751|FG000|Overall Study|Could not commit time for study|1|||
130050260|NCT00109733|468140752|FG001|Overall Study|Could not commit time for study|1|||
130050261|NCT06094296|468140757|FG000|Overall Study|Progressive Disease|1|||
130050262|NCT06094296|468140758|FG001|Overall Study|Progressive Disease|0|||
130050263|NCT06094296|468140759|FG002|Overall Study|Progressive Disease|0|||
130050264|NCT06094296|468140760|FG003|Overall Study|Progressive Disease|0|||
130050265|NCT03332667|468140761|FG000|Overall Study|Adverse Event|0|||
130050266|NCT03332667|468140762|FG001|Overall Study|Adverse Event|0|||
130050267|NCT03332667|468140763|FG002|Overall Study|Adverse Event|2|||
130050268|NCT03332667|468140764|FG003|Overall Study|Adverse Event|1|||
130050269|NCT03332667|468140761|FG000|Overall Study|Withdrawal by Subject|2|||
130050270|NCT03332667|468140762|FG001|Overall Study|Withdrawal by Subject|1|||
130050271|NCT03332667|468140763|FG002|Overall Study|Withdrawal by Subject|5|||
130050272|NCT03332667|468140764|FG003|Overall Study|Withdrawal by Subject|1|||
130050273|NCT03332667|468140761|FG000|Overall Study|Disease Progression or Relapse|2|||
130050274|NCT03332667|468140762|FG001|Overall Study|Disease Progression or Relapse|1|||
130050275|NCT03332667|468140763|FG002|Overall Study|Disease Progression or Relapse|3|||
130050276|NCT03332667|468140764|FG003|Overall Study|Disease Progression or Relapse|0|||
130050277|NCT03332667|468140761|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
130312604|NCT00466440|469109949|FG002|Overall Study|Death|0|||
130312605|NCT00466440|469109947|FG000|Overall Study|Progressive disease|13|||
130312606|NCT00466440|469109948|FG001|Overall Study|Progressive disease|5|||
130110617|NCT03276962|468365791|FG002|Overall Study|Other|0|||
130312607|NCT00466440|469109949|FG002|Overall Study|Progressive disease|4|||
130312608|NCT00466440|469109947|FG000|Overall Study|Lost to Follow-up|0|||
130312609|NCT00466440|469109948|FG001|Overall Study|Lost to Follow-up|1|||
130312610|NCT00466440|469109949|FG002|Overall Study|Lost to Follow-up|0|||
130312611|NCT00466440|469109947|FG000|Overall Study|Physician Decision|0|||
130312612|NCT00466440|469109948|FG001|Overall Study|Physician Decision|1|||
130312613|NCT00466440|469109949|FG002|Overall Study|Physician Decision|2|||
130312614|NCT00466440|469109947|FG000|Overall Study|Protocol entry criteria not met|0|||
130312615|NCT00466440|469109948|FG001|Overall Study|Protocol entry criteria not met|0|||
130312616|NCT00466440|469109949|FG002|Overall Study|Protocol entry criteria not met|4|||
130312617|NCT00466440|469109947|FG000|Overall Study|Withdrawal by Subject|0|||
130312618|NCT00466440|469109948|FG001|Overall Study|Withdrawal by Subject|1|||
130312619|NCT00466440|469109949|FG002|Overall Study|Withdrawal by Subject|0|||
130312620|NCT00466440|469109947|FG000|Overall Study|Sponsor decision|0|||
130312621|NCT00466440|469109948|FG001|Overall Study|Sponsor decision|0|||
130312622|NCT00466440|469109949|FG002|Overall Study|Sponsor decision|1|||
130312623|NCT00965081|469109950|FG000|Overall Study|Adverse Event|14|||
130312624|NCT00965081|469109951|FG001|Overall Study|Adverse Event|9|||
130312625|NCT00965081|469109950|FG000|Overall Study|Lack of Efficacy|2|||
130312626|NCT00965081|469109951|FG001|Overall Study|Lack of Efficacy|5|||
130312627|NCT00965081|469109950|FG000|Overall Study|Lost to Follow-up|4|||
130312628|NCT00965081|469109951|FG001|Overall Study|Lost to Follow-up|5|||
130312629|NCT00965081|469109950|FG000|Overall Study|Physician Decision|2|||
130312630|NCT00965081|469109951|FG001|Overall Study|Physician Decision|0|||
130312631|NCT00965081|469109950|FG000|Overall Study|Protocol Violation|2|||
130312632|NCT00965081|469109951|FG001|Overall Study|Protocol Violation|5|||
130312633|NCT00965081|469109950|FG000|Overall Study|Sponsor Decision|1|||
130312634|NCT00965081|469109951|FG001|Overall Study|Sponsor Decision|0|||
130312635|NCT00965081|469109950|FG000|Overall Study|Withdrawal by Subject|4|||
130312636|NCT00965081|469109951|FG001|Overall Study|Withdrawal by Subject|7|||
130312637|NCT00965081|469109950|FG000|Overall Study|Switched to Rescue Arm|5|||
130312638|NCT00965081|469109951|FG001|Overall Study|Switched to Rescue Arm|12|||
130312639|NCT00796666|469109954|FG000|Overall Study|Death|2|||
130312640|NCT00796666|469109955|FG001|Overall Study|Death|4|||
130312641|NCT00796666|469109954|FG000|Overall Study|Withdrawal by Subject|2|||
130312642|NCT00796666|469109955|FG001|Overall Study|Withdrawal by Subject|0|||
130312643|NCT00796666|469109954|FG000|Overall Study|Adverse Event|7|||
130312644|NCT00796666|469109955|FG001|Overall Study|Adverse Event|5|||
130312645|NCT00796666|469109954|FG000|Overall Study|Protocol Violation|1|||
130312646|NCT00796666|469109955|FG001|Overall Study|Protocol Violation|0|||
130312647|NCT00796666|469109954|FG000|Overall Study|Other|1|||
130312648|NCT00796666|469109955|FG001|Overall Study|Other|0|||
130312649|NCT00796666|469109954|FG000|Overall Study|Terminated by sponsor|53|||
130312650|NCT00796666|469109955|FG001|Overall Study|Terminated by sponsor|55|||
130312651|NCT00796666|469109954|FG000|Overall Study|Randomized and not treated|1|||
130312652|NCT00796666|469109955|FG001|Overall Study|Randomized and not treated|0|||
130312653|NCT00256724|469109958|FG000|Overall Study|Physician Decision|2|||
130312654|NCT00256724|469109959|FG001|Overall Study|Physician Decision|5|||
130312655|NCT00256724|469109958|FG000|Overall Study|Protocol Violation|3|||
130312656|NCT00256724|469109959|FG001|Overall Study|Protocol Violation|3|||
130312657|NCT01217463|469109960|FG000|Overall Study|Adverse Event|8|||
130312658|NCT01217463|469109961|FG001|Overall Study|Adverse Event|5|||
130312659|NCT01217463|469109960|FG000|Overall Study|Physician Decision|0|||
130312660|NCT01217463|469109961|FG001|Overall Study|Physician Decision|1|||
130312661|NCT01217463|469109960|FG000|Overall Study|Withdrawal by Subject|3|||
130312662|NCT01217463|469109961|FG001|Overall Study|Withdrawal by Subject|0|||
130312663|NCT01217463|469109960|FG000|Overall Study|Surgery on the Target Limb|0|||
130312664|NCT01217463|469109961|FG001|Overall Study|Surgery on the Target Limb|1|||
130312665|NCT01217463|469109960|FG000|Overall Study|Patient Non-compliant|1|||
130312666|NCT01217463|469109961|FG001|Overall Study|Patient Non-compliant|0|||
130312667|NCT01217463|469109960|FG000|Overall Study|Other|1|||
130312668|NCT01217463|469109961|FG001|Overall Study|Other|1|||
130312669|NCT02090426|469109965|FG000|Overall Study|Lost to Follow-up|12|||
130312670|NCT02090426|469109966|FG001|Overall Study|Lost to Follow-up|6|||
130312671|NCT01141712|469109967|FG000|Overall Study|Disease progression|3|||
130312672|NCT01012258|469109973|FG000|Overall Study|Death|14|||
130312673|NCT01012258|469109973|FG000|Overall Study|Lost to Follow-up|1|||
130312674|NCT01012258|469109973|FG000|Overall Study|Adverse Event|1|||
130312675|NCT01012258|469109973|FG000|Overall Study|Progressive Disease (PD)|18|||
130312676|NCT01012258|469109973|FG000|Overall Study|Symptomatic Deterioration|1|||
130312677|NCT01012258|469109973|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
130312678|NCT01012258|469109973|FG000|Overall Study|Another Tumor Discovered|1|||
130312679|NCT01012258|469109973|FG000|Overall Study|Ongoing|29|||
130312680|NCT03600740|469109974|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
130312681|NCT03571204|469109975|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
130312682|NCT03571204|469109976|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
130312683|NCT03571204|469109977|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
130312684|NCT03571204|469109975|FG000|Overall Study|Physician Decision|0|||
130312685|NCT03571204|469109976|FG001|Overall Study|Physician Decision|1|||
130312686|NCT03571204|469109977|FG002|Overall Study|Physician Decision|0|||
130312687|NCT02396212|469109978|FG000|Overall Study|Adverse Event|1|||
130312688|NCT02396212|469109978|FG000|Overall Study|Lack of Efficacy|2|||
130312689|NCT01623115|469109979|FG000|Overall Study|Randomized but not treated|0|||
130312690|NCT01623115|469109980|FG001|Overall Study|Randomized but not treated|1|||
129890208|NCT01544582|467554618|FG003|Analysis Population|Programmed Surgery|0|||
129890209|NCT01544582|467554615|FG000|Analysis Population|Participant in Jail|0|||
129890210|NCT01544582|467554616|FG001|Analysis Population|Participant in Jail|0|||
129890211|NCT01544582|467554617|FG002|Analysis Population|Participant in Jail|1|||
129890212|NCT01544582|467554618|FG003|Analysis Population|Participant in Jail|0|||
129890213|NCT03428815|467554619|FG000|Overall Study|Lost to Follow-up|2|||
129890214|NCT03428815|467554620|FG001|Overall Study|Lost to Follow-up|2|||
129890215|NCT03428815|467554619|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
129890216|NCT03428815|467554620|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
129890217|NCT03428815|467554619|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
129890218|NCT03428815|467554620|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
129890219|NCT03317379|467554625|FG000|Overall Study|Lost to Follow-up|0|||
129890220|NCT03317379|467554626|FG001|Overall Study|Lost to Follow-up|3|||
129890221|NCT03317379|467554627|FG002|Overall Study|Lost to Follow-up|2|||
129890222|NCT00550173|467554628|FG000|Overall Study|Death|45|||
129890223|NCT00550173|467554629|FG001|Overall Study|Death|38|||
129890224|NCT00550173|467554630|FG002|Overall Study|Death|50|||
129890225|NCT00550173|467554628|FG000|Overall Study|Physician Decision|1|||
129890226|NCT00550173|467554629|FG001|Overall Study|Physician Decision|2|||
129890227|NCT00550173|467554630|FG002|Overall Study|Physician Decision|2|||
129890228|NCT00550173|467554628|FG000|Overall Study|Withdrawal by Subject|9|||
129890229|NCT00550173|467554629|FG001|Overall Study|Withdrawal by Subject|12|||
129890230|NCT00550173|467554630|FG002|Overall Study|Withdrawal by Subject|17|||
129890231|NCT00550173|467554628|FG000|Overall Study|Sponsor Decision|13|||
129890232|NCT00550173|467554629|FG001|Overall Study|Sponsor Decision|7|||
129890233|NCT00550173|467554630|FG002|Overall Study|Sponsor Decision|1|||
129890234|NCT00550173|467554628|FG000|Overall Study|Lost to Follow-up|4|||
129890235|NCT00550173|467554629|FG001|Overall Study|Lost to Follow-up|4|||
129890236|NCT00550173|467554630|FG002|Overall Study|Lost to Follow-up|3|||
129890237|NCT01354106|467554632|FG000|Overall Study|Withdrawal by Subject|2|||
129890238|NCT00107380|467556044|FG000|Overall Study|Adverse Event|7|||
129890239|NCT00107380|467556044|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
129890240|NCT00107380|467556044|FG000|Overall Study|Progression/relapse|4|||
129890241|NCT00107380|467556044|FG000|Overall Study|Death|3|||
129890242|NCT00107380|467556044|FG000|Overall Study|Other - not protocol specified|7|||
129890243|NCT00107380|467556044|FG000|Overall Study|Ineligible|2|||
129890244|NCT03673098|467556045|FG000|Overall Study|Lost to Follow-up|2|||
129890245|NCT03673098|467556046|FG001|Overall Study|Lost to Follow-up|3|||
129890246|NCT03673098|467556045|FG000|Overall Study|Withdrawal by Subject|6|||
129890247|NCT03673098|467556046|FG001|Overall Study|Withdrawal by Subject|1|||
129890248|NCT03673098|467556045|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
129890249|NCT03673098|467556046|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
129890250|NCT01155726|467556052|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
129890251|NCT01155726|467556053|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
129890252|NCT01155726|467556054|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
129890253|NCT01155726|467556055|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
129890254|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Death|0|||
129890255|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Death|2|||
129890256|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
129890257|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
129890258|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
129890259|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
129890260|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
129890261|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
129890262|NCT02459587|467556056|FG000|6-month Follow-up Assessment|Death|2|||
129890263|NCT02459587|467556057|FG001|6-month Follow-up Assessment|Death|1|||
129890264|NCT02459587|467556056|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
129890265|NCT02459587|467556057|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
129890266|NCT02459587|467556056|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
129890267|NCT02459587|467556057|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
129890268|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Death|2|||
129890269|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Death|0|||
129890270|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
129890271|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
129890272|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
129890273|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
129890274|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
129890275|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
129890276|NCT03487666|467556058|FG000|Overall Study|Disease progression|4|||
129890277|NCT03487666|467556059|FG001|Overall Study|Disease progression|2|||
129890278|NCT03487666|467556060|FG002|Overall Study|Disease progression|0|||
129890279|NCT03487666|467556058|FG000|Overall Study|Adverse Event|0|||
129890280|NCT03487666|467556059|FG001|Overall Study|Adverse Event|0|||
129890281|NCT03487666|467556060|FG002|Overall Study|Adverse Event|1|||
129890282|NCT02748512|467556067|FG000|Overall Study|Lost to Follow-up|1|||
129890283|NCT02748512|467556068|FG001|Overall Study|Lost to Follow-up|1|||
129890284|NCT03930186|467556069|FG000|Weeks 0 to 16|Adverse Event|6|||
129798920|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
129798921|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
129798922|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
129798923|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
129798924|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
130312691|NCT01623115|469109979|FG000|Overall Study|Physician Decision|1|||
130312692|NCT01623115|469109980|FG001|Overall Study|Physician Decision|0|||
130312693|NCT01623115|469109979|FG000|Overall Study|Participants moved|1|||
130312694|NCT01623115|469109980|FG001|Overall Study|Participants moved|5|||
130312695|NCT01623115|469109979|FG000|Overall Study|Adverse Event|10|||
129798925|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
129798926|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
129798927|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
129798928|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
129798929|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
129798930|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
129798931|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
129798932|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
129798933|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Adverse Event|0|||
129798934|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Adverse Event|0|||
129798935|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Adverse Event|1|||
129798936|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Adverse Event|1|||
129798937|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
129798938|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
129798939|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
129798940|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
129798941|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
129798942|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
129798943|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
129798944|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
129798945|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
129798946|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
129798947|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
129798948|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
129798949|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Physician Decision|0|||
129798950|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Physician Decision|0|||
129798951|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Physician Decision|3|||
129890285|NCT03930186|467556069|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
129890286|NCT03930186|467556069|FG000|Weeks 16 to 32|Adverse Event|1|||
129890287|NCT03930186|467556069|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
129890288|NCT02264574|467556072|FG000|Overall Study|Death|21|||
129890289|NCT02264574|467556073|FG001|Overall Study|Death|21|||
130050278|NCT03332667|468140762|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
130312696|NCT01623115|469109980|FG001|Overall Study|Adverse Event|13|||
130312697|NCT01623115|469109979|FG000|Overall Study|Poor compliance to protocol|4|||
129890290|NCT02264574|467556072|FG000|Overall Study|Withdrawal by Subject|8|||
129890291|NCT02264574|467556073|FG001|Overall Study|Withdrawal by Subject|6|||
129890292|NCT02264574|467556072|FG000|Overall Study|Other, Not Specified|0|||
129890293|NCT02264574|467556073|FG001|Overall Study|Other, Not Specified|3|||
129890294|NCT02886728|467556077|FG000|Overall Study|Withdrew Consent|31|||
129890295|NCT02886728|467556078|FG001|Overall Study|Withdrew Consent|13|||
129890296|NCT02886728|467556079|FG002|Overall Study|Withdrew Consent|11|||
129890297|NCT02886728|467556080|FG003|Overall Study|Withdrew Consent|47|||
129890298|NCT02886728|467556077|FG000|Overall Study|Lost to Follow-up|12|||
129890299|NCT02886728|467556078|FG001|Overall Study|Lost to Follow-up|6|||
129890300|NCT02886728|467556079|FG002|Overall Study|Lost to Follow-up|13|||
129890301|NCT02886728|467556080|FG003|Overall Study|Lost to Follow-up|12|||
129890302|NCT02886728|467556077|FG000|Overall Study|Adverse Event|13|||
129890303|NCT02886728|467556078|FG001|Overall Study|Adverse Event|5|||
129890304|NCT02886728|467556079|FG002|Overall Study|Adverse Event|5|||
129890305|NCT02886728|467556080|FG003|Overall Study|Adverse Event|11|||
129890306|NCT02886728|467556077|FG000|Overall Study|Investigator's Discretion|11|||
129890307|NCT02886728|467556078|FG001|Overall Study|Investigator's Discretion|7|||
129890308|NCT02886728|467556079|FG002|Overall Study|Investigator's Discretion|5|||
129890309|NCT02886728|467556080|FG003|Overall Study|Investigator's Discretion|11|||
129890310|NCT02886728|467556077|FG000|Overall Study|Death|3|||
129890311|NCT02886728|467556078|FG001|Overall Study|Death|1|||
129890312|NCT02886728|467556079|FG002|Overall Study|Death|0|||
129890313|NCT02886728|467556080|FG003|Overall Study|Death|0|||
129890314|NCT02886728|467556077|FG000|Overall Study|Protocol Violation|0|||
129890315|NCT02886728|467556078|FG001|Overall Study|Protocol Violation|0|||
129890316|NCT02886728|467556079|FG002|Overall Study|Protocol Violation|0|||
129890317|NCT02886728|467556080|FG003|Overall Study|Protocol Violation|4|||
129890318|NCT02886728|467556077|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129890319|NCT02886728|467556078|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129890320|NCT02886728|467556079|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129890321|NCT02886728|467556080|FG003|Overall Study|Non-Compliance with Study Drug|0|||
129890322|NCT02886728|467556077|FG000|Overall Study|Pregnancy|0|||
129890323|NCT02886728|467556078|FG001|Overall Study|Pregnancy|0|||
129890324|NCT02886728|467556079|FG002|Overall Study|Pregnancy|1|||
129890325|NCT02886728|467556080|FG003|Overall Study|Pregnancy|0|||
129890326|NCT02886728|467556077|FG000|Overall Study|Randomized but Not Dosed|1|||
129890327|NCT02886728|467556078|FG001|Overall Study|Randomized but Not Dosed|0|||
129890328|NCT02886728|467556079|FG002|Overall Study|Randomized but Not Dosed|0|||
129890329|NCT02886728|467556080|FG003|Overall Study|Randomized but Not Dosed|2|||
129890330|NCT04990440|467556085|FG000|Overall Study|Sponsor's Decision|0|||
129890331|NCT04990440|467556086|FG001|Overall Study|Sponsor's Decision|0|||
129890332|NCT04990440|467556087|FG002|Overall Study|Sponsor's Decision|1|||
129890333|NCT03712098|467556088|FG000|Overall Study|Lost to Follow-up|3|||
129890334|NCT03712098|467556089|FG001|Overall Study|Lost to Follow-up|7|||
129890335|NCT03712098|467556088|FG000|Overall Study|Withdrawal by Subject|9|||
129890336|NCT03712098|467556089|FG001|Overall Study|Withdrawal by Subject|4|||
129890337|NCT03712098|467556088|FG000|Overall Study|Protocol Violation|2|||
129890338|NCT03712098|467556089|FG001|Overall Study|Protocol Violation|1|||
129798952|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Physician Decision|2|||
129798953|NCT01226043|467232200|FG000|6-week Re-randomization Phase|completed in error|0|||
129798954|NCT01226043|467232201|FG001|6-week Re-randomization Phase|completed in error|0|||
129798955|NCT01226043|467232202|FG002|6-week Re-randomization Phase|completed in error|0|||
129798956|NCT01226043|467232203|FG003|6-week Re-randomization Phase|completed in error|1|||
129798957|NCT01226043|467232200|FG000|30-week Observational Phase|Adverse Event|0|||
129798958|NCT01226043|467232201|FG001|30-week Observational Phase|Adverse Event|0|||
129798959|NCT01226043|467232202|FG002|30-week Observational Phase|Adverse Event|1|||
129798960|NCT01226043|467232203|FG003|30-week Observational Phase|Adverse Event|1|||
129798961|NCT01226043|467232200|FG000|30-week Observational Phase|Protocol Violation|0|||
129798962|NCT01226043|467232201|FG001|30-week Observational Phase|Protocol Violation|0|||
129798963|NCT01226043|467232202|FG002|30-week Observational Phase|Protocol Violation|0|||
129798964|NCT01226043|467232203|FG003|30-week Observational Phase|Protocol Violation|1|||
130050279|NCT03332667|468140763|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
130050280|NCT03332667|468140764|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
130050281|NCT03332667|468140761|FG000|Overall Study|No Treatment Received|0|||
130312698|NCT01623115|469109980|FG001|Overall Study|Poor compliance to protocol|10|||
130312699|NCT01623115|469109979|FG000|Overall Study|Consent withdrawn by participant|2|||
130312700|NCT01623115|469109980|FG001|Overall Study|Consent withdrawn by participant|6|||
130312701|NCT01623115|469109979|FG000|Overall Study|Related to study drug administration|0|||
130312702|NCT01623115|469109980|FG001|Overall Study|Related to study drug administration|2|||
130312703|NCT01623115|469109979|FG000|Overall Study|Last visit outside protocol visit window|14|||
130312704|NCT01623115|469109980|FG001|Overall Study|Last visit outside protocol visit window|26|||
130312705|NCT01623115|469109979|FG000|Overall Study|Site closure|1|||
130312706|NCT01623115|469109980|FG001|Overall Study|Site closure|7|||
130312707|NCT01623115|469109979|FG000|Overall Study|Death|0|||
130312708|NCT01623115|469109980|FG001|Overall Study|Death|4|||
130312709|NCT01623115|469109979|FG000|Overall Study|Other than specified above|0|||
130312710|NCT01623115|469109980|FG001|Overall Study|Other than specified above|3|||
130312711|NCT01454596|469109983|FG000|Overall Study|Death|0|||
130312712|NCT01454596|469109984|FG001|Overall Study|Death|0|||
130312713|NCT01454596|469109985|FG002|Overall Study|Death|0|||
130312714|NCT01454596|469109986|FG003|Overall Study|Death|0|||
130312715|NCT01454596|469109987|FG004|Overall Study|Death|0|||
130312716|NCT01454596|469109988|FG005|Overall Study|Death|0|||
130312717|NCT01454596|469109989|FG006|Overall Study|Death|0|||
130312718|NCT01454596|469109990|FG007|Overall Study|Death|0|||
130312719|NCT01454596|469109991|FG008|Overall Study|Death|0|||
130312720|NCT01454596|469109992|FG009|Overall Study|Death|1|||
130312721|NCT01454596|469109993|FG010|Overall Study|Death|1|||
130312722|NCT01454596|469109994|FG011|Overall Study|Death|0|||
130312723|NCT00857285|469109996|FG000|Overall Study|Adverse Event|4|||
130312724|NCT00857285|469109997|FG001|Overall Study|Adverse Event|2|||
130312725|NCT00857285|469109996|FG000|Overall Study|Lack of Efficacy|0|||
130312726|NCT00857285|469109997|FG001|Overall Study|Lack of Efficacy|2|||
130312727|NCT00857285|469109996|FG000|Overall Study|Protocol Violation|3|||
130312728|NCT00857285|469109997|FG001|Overall Study|Protocol Violation|1|||
130312729|NCT00857285|469109996|FG000|Overall Study|Withdrawal by Subject|4|||
130312730|NCT00857285|469109997|FG001|Overall Study|Withdrawal by Subject|0|||
130312731|NCT00857285|469109996|FG000|Overall Study|Randomization criteria not met|1|||
130312732|NCT00857285|469109997|FG001|Overall Study|Randomization criteria not met|1|||
130312733|NCT00430716|469109998|FG000|Double Blind Phase|Death|1|||
129798965|NCT01226043|467232200|FG000|30-week Observational Phase|Lost to Follow-up|0|||
129798966|NCT01226043|467232201|FG001|30-week Observational Phase|Lost to Follow-up|0|||
129798967|NCT01226043|467232202|FG002|30-week Observational Phase|Lost to Follow-up|2|||
129798968|NCT01226043|467232203|FG003|30-week Observational Phase|Lost to Follow-up|2|||
130312734|NCT00430716|469109999|FG001|Double Blind Phase|Death|0|||
130312735|NCT00430716|469110000|FG002|Double Blind Phase|Death|0|||
130312736|NCT00430716|469109998|FG000|Double Blind Phase|No longer willing to participate|2|||
130312737|NCT00430716|469109999|FG001|Double Blind Phase|No longer willing to participate|1|||
130312738|NCT00430716|469110000|FG002|Double Blind Phase|No longer willing to participate|1|||
130312739|NCT00430716|469109998|FG000|Double Blind Phase|Other|0|||
130312740|NCT00430716|469109999|FG001|Double Blind Phase|Other|2|||
130312741|NCT00430716|469110000|FG002|Double Blind Phase|Other|0|||
130312742|NCT00430716|469109998|FG000|Double Blind Phase|Study terminated by sponsor|1|||
130312743|NCT00430716|469109999|FG001|Double Blind Phase|Study terminated by sponsor|1|||
130312744|NCT00430716|469110000|FG002|Double Blind Phase|Study terminated by sponsor|2|||
130312745|NCT00430716|469109998|FG000|Double Blind Phase|Adverse Event|1|||
130312746|NCT00430716|469109999|FG001|Double Blind Phase|Adverse Event|1|||
129798969|NCT01226043|467232200|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
130312747|NCT00430716|469110000|FG002|Double Blind Phase|Adverse Event|3|||
130312748|NCT00430716|469109998|FG000|Double Blind Phase|Not treated|1|||
130312749|NCT00430716|469109999|FG001|Double Blind Phase|Not treated|0|||
130312750|NCT00430716|469110000|FG002|Double Blind Phase|Not treated|0|||
130312751|NCT00430716|469109998|FG000|Open Label Phase|Lost to Follow-up|1|||
130312752|NCT00430716|469109999|FG001|Open Label Phase|Lost to Follow-up|0|||
129890339|NCT00688259|467556095|FG000|Overall Study|Lost to Follow-up|2|||
129890340|NCT00688259|467556096|FG001|Overall Study|Lost to Follow-up|4|||
129890341|NCT00688259|467556095|FG000|Overall Study|Physician Decision|1|||
129890342|NCT00688259|467556096|FG001|Overall Study|Physician Decision|0|||
129890343|NCT00688259|467556095|FG000|Overall Study|Withdrawal by Subject|2|||
130110618|NCT03276962|468365792|FG003|Overall Study|Other|2|||
130312753|NCT00430716|469110000|FG002|Open Label Phase|Lost to Follow-up|1|||
130312754|NCT00430716|469109998|FG000|Open Label Phase|No longer willing to participate|0|||
130312755|NCT00430716|469109999|FG001|Open Label Phase|No longer willing to participate|1|||
130312756|NCT00430716|469110000|FG002|Open Label Phase|No longer willing to participate|1|||
130312757|NCT00430716|469109998|FG000|Open Label Phase|Other|3|||
130312758|NCT00430716|469109999|FG001|Open Label Phase|Other|1|||
130312759|NCT00430716|469110000|FG002|Open Label Phase|Other|1|||
130312760|NCT00430716|469109998|FG000|Open Label Phase|Protocol Violation|1|||
130312761|NCT00430716|469109999|FG001|Open Label Phase|Protocol Violation|0|||
130312762|NCT00430716|469110000|FG002|Open Label Phase|Protocol Violation|0|||
130312763|NCT00430716|469109998|FG000|Open Label Phase|Study terminated by sponsor|4|||
130312764|NCT00430716|469109999|FG001|Open Label Phase|Study terminated by sponsor|5|||
130312765|NCT00430716|469110000|FG002|Open Label Phase|Study terminated by sponsor|4|||
130312766|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
130312767|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
130312768|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130312769|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130312770|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
130312771|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
130312772|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
130312773|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
130312774|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
130312775|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
130312776|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
130312777|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
130312778|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
130312779|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
130312780|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
130312781|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130312782|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
130312783|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130312784|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129798970|NCT01226043|467232201|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
129798971|NCT01226043|467232202|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
129798972|NCT01226043|467232203|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
129798973|NCT01226043|467232200|FG000|30-week Observational Phase|Physician Decision|0|||
129798974|NCT01226043|467232201|FG001|30-week Observational Phase|Physician Decision|0|||
129798975|NCT01226043|467232202|FG002|30-week Observational Phase|Physician Decision|2|||
129798976|NCT01226043|467232203|FG003|30-week Observational Phase|Physician Decision|2|||
129798977|NCT02204007|467232204|FG000|Overall Study|Surgery Canceled|1|||
129798978|NCT02204007|467232205|FG001|Overall Study|Surgery Canceled|1|||
129798979|NCT00910988|467232206|FG000|Overall Study|Lost to Follow-up|2|||
129798980|NCT00910988|467232207|FG001|Overall Study|Lost to Follow-up|4|||
129798981|NCT00910988|467232208|FG002|Overall Study|Lost to Follow-up|3|||
129798982|NCT00910988|467232209|FG003|Overall Study|Lost to Follow-up|0|||
129798983|NCT03004443|467232210|FG000|Overall Study|Pregnancy|0|||
129798984|NCT03004443|467232211|FG001|Overall Study|Pregnancy|1|||
129798985|NCT00828854|467232212|FG000|Overall Study|Disease Progression|17|||
129798986|NCT00828854|467232212|FG000|Overall Study|Adverse Event|9|||
129798987|NCT00828854|467232212|FG000|Overall Study|Reason not Specified|1|||
129798988|NCT00191646|467232214|FG000|Overall Study|Toxicity|26|||
129798989|NCT00191646|467232215|FG001|Overall Study|Toxicity|37|||
129798990|NCT00191646|467232214|FG000|Overall Study|Disease Progression|5|||
129798991|NCT00191646|467232215|FG001|Overall Study|Disease Progression|6|||
129798992|NCT00191646|467232214|FG000|Overall Study|Physician Decision|20|||
129798993|NCT00191646|467232215|FG001|Overall Study|Physician Decision|11|||
129798994|NCT00191646|467232214|FG000|Overall Study|Withdrawal by Subject|58|||
129798995|NCT00191646|467232215|FG001|Overall Study|Withdrawal by Subject|39|||
129798996|NCT00191646|467232214|FG000|Overall Study|Protocol Violation|5|||
129798997|NCT00191646|467232215|FG001|Overall Study|Protocol Violation|7|||
129798998|NCT00191646|467232214|FG000|Overall Study|Death|6|||
129798999|NCT00191646|467232215|FG001|Overall Study|Death|8|||
129799000|NCT00191646|467232214|FG000|Overall Study|Other|33|||
129799001|NCT00191646|467232215|FG001|Overall Study|Other|34|||
129799002|NCT00191646|467232214|FG000|Overall Study|Missing Data|18|||
129799003|NCT00191646|467232215|FG001|Overall Study|Missing Data|11|||
129799004|NCT05211284|467232220|FG000|Overall Study|Study Terminated|3|||
129799005|NCT05211284|467232221|FG001|Overall Study|Study Terminated|1|||
129799006|NCT03911843|467232222|FG000|Overall Study|Adverse Event|2|||
129890344|NCT00688259|467556096|FG001|Overall Study|Withdrawal by Subject|0|||
129799007|NCT03911843|467232223|FG001|Overall Study|Adverse Event|0|||
129799008|NCT03911843|467232222|FG000|Overall Study|Protocol Violation|2|||
129799009|NCT03911843|467232223|FG001|Overall Study|Protocol Violation|0|||
129799010|NCT03911843|467232222|FG000|Overall Study|Lost to Follow-up|0|||
129799011|NCT03911843|467232223|FG001|Overall Study|Lost to Follow-up|1|||
129799012|NCT01907100|467232224|FG000|Overall Study|PD based on modified RECIST criteria|31|||
130312785|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
130312786|NCT01329978|469110004|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312787|NCT01329978|469110005|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
130050282|NCT03332667|468140762|FG001|Overall Study|No Treatment Received|0|||
130050283|NCT03332667|468140763|FG002|Overall Study|No Treatment Received|1|||
130050284|NCT03332667|468140764|FG003|Overall Study|No Treatment Received|0|||
130050285|NCT04964063|468140765|FG000|Overall Study|Adverse Event|4|||
130050286|NCT04964063|468140765|FG000|Overall Study|Lost to Follow-up|47|||
130050287|NCT04964063|468140765|FG000|Overall Study|Withdrawal by Subject|5|||
130050288|NCT04964063|468140765|FG000|Overall Study|Baseline Tasks Expired|41|||
130050289|NCT04964063|468140765|FG000|Overall Study|Participant withdrawn in error|1|||
130050290|NCT01035606|468140766|FG000|Overall Study|change in health, job demands,family|3|||
130050291|NCT01035606|468140767|FG001|Overall Study|change in health, job demands,family|3|||
130050292|NCT01035606|468140768|FG002|Overall Study|change in health, job demands,family|4|||
130050293|NCT01809262|468140769|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050294|NCT01809262|468140770|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050295|NCT01809262|468140771|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050296|NCT01809262|468140772|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050297|NCT01809262|468140773|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
130050298|NCT01809262|468140774|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050299|NCT01809262|468140775|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050300|NCT01809262|468140776|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050301|NCT01809262|468140777|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050302|NCT01809262|468140778|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
130050303|NCT01809262|468140769|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050304|NCT01809262|468140770|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
130050305|NCT01809262|468140771|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050306|NCT01809262|468140772|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050307|NCT01809262|468140773|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050308|NCT01809262|468140774|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130312788|NCT01329978|469110006|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312789|NCT01329978|469110007|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312790|NCT01329978|469110008|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
130312791|NCT01329978|469110004|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
130312792|NCT01329978|469110005|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
130312793|NCT01329978|469110006|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
130312794|NCT01329978|469110007|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
130312795|NCT01329978|469110008|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
130312796|NCT01329978|469110004|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312797|NCT01329978|469110005|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312798|NCT01329978|469110006|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312799|NCT01329978|469110007|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
130312800|NCT01329978|469110008|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
130312801|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
130312802|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
130312803|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
130312804|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
130312805|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
130312806|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
130312807|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
130312808|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
130312809|NCT01987102|469110015|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
130312810|NCT01987102|469110016|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
130312811|NCT01987102|469110015|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
130312812|NCT01987102|469110016|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
130312813|NCT01236521|469110017|FG000|Overall Study|Withdrawal by Subject|12|||
130312814|NCT01236521|469110018|FG001|Overall Study|Withdrawal by Subject|17|||
130312815|NCT01236521|469110017|FG000|Overall Study|Death|2|||
130312816|NCT01236521|469110018|FG001|Overall Study|Death|1|||
130312817|NCT01236521|469110017|FG000|Overall Study|Lost to Follow-up|9|||
130312818|NCT01236521|469110018|FG001|Overall Study|Lost to Follow-up|7|||
130312819|NCT03116685|469110023|FG000|Overall Study|Physician Decision|0|||
129799013|NCT01907100|467232225|FG001|Overall Study|PD based on modified RECIST criteria|32|||
129799014|NCT01907100|467232226|FG002|Overall Study|PD based on modified RECIST criteria|95|||
129799015|NCT01907100|467232227|FG003|Overall Study|PD based on modified RECIST criteria|92|||
129799016|NCT01907100|467232224|FG000|Overall Study|Withdrawal by Subject|2|||
129799017|NCT01907100|467232225|FG001|Overall Study|Withdrawal by Subject|5|||
130312820|NCT03116685|469110024|FG001|Overall Study|Physician Decision|1|||
130312821|NCT01943591|469110030|FG000|Overall Study|Lost to Follow-up|3|||
130312822|NCT01943591|469110031|FG001|Overall Study|Lost to Follow-up|4|||
130312823|NCT01943591|469110030|FG000|Overall Study|Death|2|||
130312824|NCT01943591|469110031|FG001|Overall Study|Death|7|||
130312825|NCT03790111|469111228|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
130312826|NCT02796677|469111235|FG000|Overall Study|Adverse Event|11|||
130312827|NCT02796677|469111236|FG001|Overall Study|Adverse Event|22|||
130312828|NCT02796677|469111237|FG002|Overall Study|Adverse Event|14|||
130312829|NCT02796677|469111238|FG003|Overall Study|Adverse Event|14|||
130312830|NCT02796677|469111235|FG000|Overall Study|Protocol Violation|7|||
130312831|NCT02796677|469111236|FG001|Overall Study|Protocol Violation|5|||
130312832|NCT02796677|469111237|FG002|Overall Study|Protocol Violation|4|||
130312833|NCT02796677|469111238|FG003|Overall Study|Protocol Violation|8|||
130312834|NCT02796677|469111235|FG000|Overall Study|Lost to Follow-up|1|||
130312835|NCT02796677|469111236|FG001|Overall Study|Lost to Follow-up|5|||
130312836|NCT02796677|469111237|FG002|Overall Study|Lost to Follow-up|2|||
130312837|NCT02796677|469111238|FG003|Overall Study|Lost to Follow-up|2|||
130312838|NCT02796677|469111235|FG000|Overall Study|Lack of Efficacy|7|||
130312839|NCT02796677|469111236|FG001|Overall Study|Lack of Efficacy|9|||
130312840|NCT02796677|469111237|FG002|Overall Study|Lack of Efficacy|14|||
130312841|NCT02796677|469111238|FG003|Overall Study|Lack of Efficacy|20|||
130312842|NCT02796677|469111235|FG000|Overall Study|Withdrawal by Subject|4|||
130312843|NCT02796677|469111236|FG001|Overall Study|Withdrawal by Subject|14|||
130312844|NCT02796677|469111237|FG002|Overall Study|Withdrawal by Subject|6|||
130312845|NCT02796677|469111238|FG003|Overall Study|Withdrawal by Subject|7|||
130312846|NCT02796677|469111235|FG000|Overall Study|Progressive disease|6|||
130312847|NCT02796677|469111236|FG001|Overall Study|Progressive disease|15|||
130312848|NCT02796677|469111237|FG002|Overall Study|Progressive disease|13|||
130312849|NCT02796677|469111238|FG003|Overall Study|Progressive disease|18|||
130312850|NCT02796677|469111235|FG000|Overall Study|Reason not mentioned|2|||
130312851|NCT02796677|469111236|FG001|Overall Study|Reason not mentioned|3|||
130312852|NCT02796677|469111237|FG002|Overall Study|Reason not mentioned|0|||
130312853|NCT02796677|469111238|FG003|Overall Study|Reason not mentioned|5|||
130312854|NCT03811340|469111241|FG000|Overall Study|subjects did not complete the survey.|90|||
130312855|NCT01045967|469111242|FG000|Second Intervention|Protocol Violation|0|||
130312856|NCT01045967|469111243|FG001|Second Intervention|Protocol Violation|1|||
130312857|NCT01777308|469111244|FG000|Overall Study|Withdrawal by Subject|5|||
130312858|NCT01777308|469111245|FG001|Overall Study|Withdrawal by Subject|1|||
130312859|NCT01777308|469111244|FG000|Overall Study|Migrated/moved from study area|1|||
130312860|NCT01777308|469111245|FG001|Overall Study|Migrated/moved from study area|0|||
130312861|NCT01777308|469111244|FG000|Overall Study|Lost to Follow-up|7|||
130312862|NCT01777308|469111245|FG001|Overall Study|Lost to Follow-up|2|||
130312863|NCT01777308|469111244|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
130312864|NCT01777308|469111245|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
130312865|NCT03212326|469111246|FG000|Overall Study|Physician Decision|4|||
130312866|NCT02219464|469111248|FG000|Overall Study|Withdrawal by Subject|1|||
130312867|NCT02219464|469111249|FG001|Overall Study|Withdrawal by Subject|0|||
130312868|NCT02219464|469111248|FG000|Overall Study|case cancelled|1|||
130312869|NCT02219464|469111249|FG001|Overall Study|case cancelled|0|||
130312870|NCT02219464|469111248|FG000|Overall Study|catheter malfunction|1|||
130312871|NCT02219464|469111249|FG001|Overall Study|catheter malfunction|0|||
130312872|NCT01544920|469111262|FG000|Overall Study|Adverse Event|0|||
130312873|NCT01544920|469111263|FG001|Overall Study|Adverse Event|3|||
130312874|NCT01544920|469111262|FG000|Overall Study|Death|0|||
130312875|NCT01544920|469111263|FG001|Overall Study|Death|1|||
130312876|NCT01544920|469111262|FG000|Overall Study|Lost to Follow-up|11|||
130312877|NCT01544920|469111263|FG001|Overall Study|Lost to Follow-up|12|||
129799018|NCT01907100|467232226|FG002|Overall Study|Withdrawal by Subject|10|||
129799019|NCT01907100|467232227|FG003|Overall Study|Withdrawal by Subject|13|||
129799020|NCT01907100|467232224|FG000|Overall Study|Protocol Violation|0|||
129799021|NCT01907100|467232225|FG001|Overall Study|Protocol Violation|0|||
129799022|NCT01907100|467232226|FG002|Overall Study|Protocol Violation|1|||
129799023|NCT01907100|467232227|FG003|Overall Study|Protocol Violation|1|||
129799024|NCT01907100|467232224|FG000|Overall Study|Lost to Follow-up|0|||
129799025|NCT01907100|467232225|FG001|Overall Study|Lost to Follow-up|0|||
129799026|NCT01907100|467232226|FG002|Overall Study|Lost to Follow-up|0|||
129799027|NCT01907100|467232227|FG003|Overall Study|Lost to Follow-up|1|||
129799028|NCT01907100|467232224|FG000|Overall Study|Not treated|2|||
130110619|NCT03276962|468365793|FG004|Overall Study|Other|1|||
130312878|NCT01544920|469111262|FG000|Overall Study|Protocol Violation|0|||
130312879|NCT01544920|469111263|FG001|Overall Study|Protocol Violation|2|||
130312880|NCT01544920|469111262|FG000|Overall Study|Physician Decision|4|||
130312881|NCT01544920|469111263|FG001|Overall Study|Physician Decision|1|||
129799029|NCT01907100|467232225|FG001|Overall Study|Not treated|0|||
129799030|NCT01907100|467232226|FG002|Overall Study|Not treated|1|||
129799031|NCT01907100|467232227|FG003|Overall Study|Not treated|2|||
130312882|NCT01544920|469111262|FG000|Overall Study|Withdrawal by Subject|4|||
130312883|NCT01544920|469111263|FG001|Overall Study|Withdrawal by Subject|4|||
130050309|NCT01809262|468140775|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050310|NCT01809262|468140776|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050311|NCT01809262|468140777|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130312884|NCT00474955|469111266|FG000|Overall Study|Adverse Event|2|||
130312885|NCT00474955|469111266|FG000|Overall Study|Drug unavailability|1|||
130312886|NCT00474955|469111266|FG000|Overall Study|Personal reasons|5|||
130312887|NCT02576639|469111267|FG000|Overall Study|Withdrawal by Subject|1|||
130312888|NCT02576639|469111268|FG001|Overall Study|Withdrawal by Subject|2|||
130312889|NCT02576639|469111269|FG002|Overall Study|Withdrawal by Subject|1|||
130312890|NCT02576639|469111270|FG003|Overall Study|Withdrawal by Subject|0|||
130312891|NCT02576639|469111271|FG004|Overall Study|Withdrawal by Subject|1|||
130312892|NCT02576639|469111267|FG000|Overall Study|Adverse Event|1|||
130312893|NCT02576639|469111268|FG001|Overall Study|Adverse Event|0|||
130312894|NCT02576639|469111269|FG002|Overall Study|Adverse Event|1|||
130312895|NCT02576639|469111270|FG003|Overall Study|Adverse Event|1|||
130312896|NCT02576639|469111271|FG004|Overall Study|Adverse Event|2|||
130312897|NCT02576639|469111267|FG000|Overall Study|Physician Decision|0|||
130312898|NCT02576639|469111268|FG001|Overall Study|Physician Decision|0|||
130312899|NCT02576639|469111269|FG002|Overall Study|Physician Decision|0|||
130312900|NCT02576639|469111270|FG003|Overall Study|Physician Decision|0|||
130312901|NCT02576639|469111271|FG004|Overall Study|Physician Decision|1|||
130312902|NCT01135134|469111272|FG000|Overall Study|Adverse Event|1|||
130312903|NCT01135134|469111273|FG001|Overall Study|Adverse Event|1|||
130312904|NCT01135134|469111272|FG000|Overall Study|Did not meet protocol eligibility|1|||
130312905|NCT01135134|469111273|FG001|Overall Study|Did not meet protocol eligibility|0|||
130312906|NCT00255190|469111274|FG000|Overall Study|Adverse Event|17|||
130312907|NCT00255190|469111275|FG001|Overall Study|Adverse Event|36|||
130312908|NCT00255190|469111274|FG000|Overall Study|Protocol Violation|2|||
130312909|NCT00255190|469111275|FG001|Overall Study|Protocol Violation|2|||
130312910|NCT00255190|469111274|FG000|Overall Study|Lost to Follow-up|10|||
130312911|NCT00255190|469111275|FG001|Overall Study|Lost to Follow-up|27|||
130312912|NCT00255190|469111274|FG000|Overall Study|Withdrew Consent|17|||
130312913|NCT00255190|469111275|FG001|Overall Study|Withdrew Consent|48|||
130050312|NCT01809262|468140778|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
130050313|NCT02064439|468140780|FG000|Overall Study|Adverse Event|51|||
130312914|NCT00255190|469111274|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130312915|NCT00255190|469111275|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
130312916|NCT00255190|469111274|FG000|Overall Study|Erosive esophagitis not healed|0|||
130312917|NCT00255190|469111275|FG001|Overall Study|Erosive esophagitis not healed|20|||
130312918|NCT00255190|469111274|FG000|Overall Study|Various|4|||
130312919|NCT00255190|469111275|FG001|Overall Study|Various|23|||
130050314|NCT02064439|468140781|FG001|Overall Study|Adverse Event|47|||
130312920|NCT01569841|469111278|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
130312921|NCT01569841|469111279|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
130312922|NCT01859923|469111280|FG000|Overall Study|Adverse Event|0|||
130312923|NCT01859923|469111281|FG001|Overall Study|Adverse Event|0|||
130312924|NCT01859923|469111282|FG002|Overall Study|Adverse Event|1|||
130312925|NCT01859923|469111283|FG003|Overall Study|Adverse Event|1|||
130312926|NCT00057863|469111286|FG000|Overall Study|Death|1|||
130312927|NCT00057863|469111286|FG000|Overall Study|Withdrawal by Subject|2|||
130312928|NCT00764361|469111287|FG000|Overall Study|Withdrawal by Subject|2|||
130312929|NCT00764361|469111288|FG001|Overall Study|Withdrawal by Subject|3|||
130312930|NCT00764361|469111287|FG000|Overall Study|Adverse Event|0|||
130312931|NCT00764361|469111288|FG001|Overall Study|Adverse Event|1|||
130312932|NCT02079038|469111292|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
130312933|NCT02079038|469111293|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
130312934|NCT02079038|469111292|FG000|Modified Intent to Treat Population|Death|1|||
130312935|NCT02079038|469111293|FG001|Modified Intent to Treat Population|Death|0|||
130312936|NCT02079038|469111292|FG000|Completed 6 Months|Lost to Follow-up|2|||
130312937|NCT02079038|469111293|FG001|Completed 6 Months|Lost to Follow-up|1|||
130312938|NCT01308736|469111294|FG000|Overall Study|Did not attend a single session|6|||
130312939|NCT01308736|469111295|FG001|Overall Study|Did not attend a single session|5|||
130312940|NCT03634085|469111296|FG000|Overall Study|Adverse Event|1|||
130312941|NCT03634085|469111297|FG001|Overall Study|Adverse Event|0|||
130312942|NCT03634085|469111296|FG000|Overall Study|Withdrawal by Subject|0|||
130312943|NCT03634085|469111297|FG001|Overall Study|Withdrawal by Subject|2|||
130312944|NCT00985465|469111300|FG000|Overall Study|Withdrawal by Subject|1|||
130312945|NCT00985465|469111301|FG001|Overall Study|Withdrawal by Subject|2|||
130312946|NCT00985465|469111300|FG000|Overall Study|Considered to be part of the other group|0|||
130312947|NCT00985465|469111301|FG001|Overall Study|Considered to be part of the other group|1|||
130312948|NCT04701333|469111302|FG000|Overall Study|Lost to Follow-up|3|||
130312949|NCT04701333|469111303|FG001|Overall Study|Lost to Follow-up|7|||
130312950|NCT04701333|469111302|FG000|Overall Study|Withdrawal by Subject|0|||
130312951|NCT04701333|469111303|FG001|Overall Study|Withdrawal by Subject|1|||
130312952|NCT01292187|469111304|FG000|Overall Study|Adverse Event|10|||
130312953|NCT01292187|469111305|FG001|Overall Study|Adverse Event|5|||
130312954|NCT01292187|469111304|FG000|Overall Study|Withdrawal by Subject|6|||
130312955|NCT01292187|469111305|FG001|Overall Study|Withdrawal by Subject|5|||
130312956|NCT01292187|469111304|FG000|Overall Study|All other reasons|1|||
130312957|NCT01292187|469111305|FG001|Overall Study|All other reasons|3|||
130312958|NCT01216202|469111309|FG000|Overall Study|Withdrawal by Subject|8|||
130312959|NCT01216202|469111310|FG001|Overall Study|Withdrawal by Subject|0|||
130312960|NCT01216202|469111309|FG000|Overall Study|Death|0|||
130312961|NCT01216202|469111310|FG001|Overall Study|Death|2|||
130312962|NCT01216202|469111309|FG000|Overall Study|Lost to Follow-up|14|||
130312963|NCT01216202|469111310|FG001|Overall Study|Lost to Follow-up|0|||
130312964|NCT02888106|469111318|FG000|Overall Study|Withdrawal by Subject|1|||
130312965|NCT02888106|469111319|FG001|Overall Study|Withdrawal by Subject|2|||
130312966|NCT02888106|469111320|FG002|Overall Study|Withdrawal by Subject|0|||
130312967|NCT02888106|469111321|FG003|Overall Study|Withdrawal by Subject|1|||
130312968|NCT02888106|469111322|FG004|Overall Study|Withdrawal by Subject|0|||
130312969|NCT02888106|469111323|FG005|Overall Study|Withdrawal by Subject|0|||
130312970|NCT02888106|469111318|FG000|Overall Study|Lost to Follow-up|1|||
130312971|NCT02888106|469111319|FG001|Overall Study|Lost to Follow-up|0|||
130312972|NCT02888106|469111320|FG002|Overall Study|Lost to Follow-up|0|||
130312973|NCT02888106|469111321|FG003|Overall Study|Lost to Follow-up|1|||
130312974|NCT02888106|469111322|FG004|Overall Study|Lost to Follow-up|0|||
130312975|NCT02888106|469111323|FG005|Overall Study|Lost to Follow-up|1|||
130312976|NCT02888106|469111318|FG000|Overall Study|Adverse Event|2|||
130312977|NCT02888106|469111319|FG001|Overall Study|Adverse Event|0|||
129890345|NCT00688259|467556095|FG000|Overall Study|Declined Interview|2|||
130312978|NCT02888106|469111320|FG002|Overall Study|Adverse Event|0|||
130312979|NCT02888106|469111321|FG003|Overall Study|Adverse Event|0|||
130312980|NCT02888106|469111322|FG004|Overall Study|Adverse Event|0|||
130312981|NCT02888106|469111323|FG005|Overall Study|Adverse Event|0|||
130312982|NCT02888106|469111318|FG000|Overall Study|Withdrawal of consent|0|||
130312983|NCT02888106|469111319|FG001|Overall Study|Withdrawal of consent|0|||
130312984|NCT02888106|469111320|FG002|Overall Study|Withdrawal of consent|0|||
130312985|NCT02888106|469111321|FG003|Overall Study|Withdrawal of consent|0|||
130312986|NCT02888106|469111322|FG004|Overall Study|Withdrawal of consent|1|||
130312987|NCT02888106|469111323|FG005|Overall Study|Withdrawal of consent|0|||
130312988|NCT02888106|469111318|FG000|Overall Study|Pregnancy|1|||
130312989|NCT02888106|469111319|FG001|Overall Study|Pregnancy|0|||
130312990|NCT02888106|469111320|FG002|Overall Study|Pregnancy|0|||
130312991|NCT02888106|469111321|FG003|Overall Study|Pregnancy|0|||
130312992|NCT02888106|469111322|FG004|Overall Study|Pregnancy|0|||
130312993|NCT02888106|469111323|FG005|Overall Study|Pregnancy|0|||
130312994|NCT01188772|469111326|FG000|Overall Study|Randomized but Not Treated|0|||
130312995|NCT01188772|469111327|FG001|Overall Study|Randomized but Not Treated|1|||
130312996|NCT01188772|469111328|FG002|Overall Study|Randomized but Not Treated|0|||
130312997|NCT01188772|469111329|FG003|Overall Study|Randomized but Not Treated|0|||
130312998|NCT01188772|469111326|FG000|Overall Study|Adverse Event|0|||
130312999|NCT01188772|469111327|FG001|Overall Study|Adverse Event|1|||
130313000|NCT01188772|469111328|FG002|Overall Study|Adverse Event|2|||
130313001|NCT01188772|469111329|FG003|Overall Study|Adverse Event|0|||
130313002|NCT01188772|469111326|FG000|Overall Study|Lost to Follow-up|4|||
130313003|NCT01188772|469111327|FG001|Overall Study|Lost to Follow-up|1|||
130313004|NCT01188772|469111328|FG002|Overall Study|Lost to Follow-up|1|||
130313005|NCT01188772|469111329|FG003|Overall Study|Lost to Follow-up|1|||
130313006|NCT01188772|469111326|FG000|Overall Study|Non-responder|0|||
130313007|NCT01188772|469111327|FG001|Overall Study|Non-responder|0|||
130313008|NCT01188772|469111328|FG002|Overall Study|Non-responder|3|||
130313009|NCT01188772|469111329|FG003|Overall Study|Non-responder|0|||
130313010|NCT01188772|469111326|FG000|Overall Study|Physician Decision|0|||
130313011|NCT01188772|469111327|FG001|Overall Study|Physician Decision|0|||
130313012|NCT01188772|469111328|FG002|Overall Study|Physician Decision|1|||
130313013|NCT01188772|469111329|FG003|Overall Study|Physician Decision|0|||
130313014|NCT01188772|469111326|FG000|Overall Study|Terminated by Sponsor|0|||
130313015|NCT01188772|469111327|FG001|Overall Study|Terminated by Sponsor|0|||
130313016|NCT01188772|469111328|FG002|Overall Study|Terminated by Sponsor|1|||
130313017|NCT01188772|469111329|FG003|Overall Study|Terminated by Sponsor|0|||
130313018|NCT01188772|469111326|FG000|Overall Study|Treatment Failure|0|||
130313019|NCT01188772|469111327|FG001|Overall Study|Treatment Failure|0|||
130313020|NCT01188772|469111328|FG002|Overall Study|Treatment Failure|1|||
130313021|NCT01188772|469111329|FG003|Overall Study|Treatment Failure|0|||
130313022|NCT01188772|469111326|FG000|Overall Study|Virologic Failure|1|||
130313023|NCT01188772|469111327|FG001|Overall Study|Virologic Failure|0|||
130313024|NCT01188772|469111328|FG002|Overall Study|Virologic Failure|0|||
130313025|NCT01188772|469111329|FG003|Overall Study|Virologic Failure|0|||
130313026|NCT01188772|469111326|FG000|Overall Study|Withdrawal by Subject|0|||
130313027|NCT01188772|469111327|FG001|Overall Study|Withdrawal by Subject|0|||
130313028|NCT01188772|469111328|FG002|Overall Study|Withdrawal by Subject|2|||
130313029|NCT01188772|469111329|FG003|Overall Study|Withdrawal by Subject|0|||
130313030|NCT01433172|469111330|FG000|Overall Study|Withdrawal by Subject|0|||
130313031|NCT01433172|469111331|FG001|Overall Study|Withdrawal by Subject|1|||
130313032|NCT01433172|469111332|FG002|Overall Study|Withdrawal by Subject|0|||
130313033|NCT01433172|469111330|FG000|Overall Study|Disease Progression|0|||
130313034|NCT01433172|469111331|FG001|Overall Study|Disease Progression|0|||
130313035|NCT01433172|469111332|FG002|Overall Study|Disease Progression|1|||
130313036|NCT01433172|469111330|FG000|Overall Study|Death|0|||
130313037|NCT01433172|469111331|FG001|Overall Study|Death|2|||
130313038|NCT01433172|469111332|FG002|Overall Study|Death|0|||
130313039|NCT01894607|469111336|FG000|Overall Study|Ineligible|1|||
130313040|NCT04393493|469111337|FG000|First 4 Days of Intervention|Early improvement|5|||
130313041|NCT04393493|469111338|FG001|First 4 Days of Intervention|Early improvement|7|||
130313042|NCT04303559|469111339|FG000|Overall Study|Study closed due to poor enrollment.|1|||
130313043|NCT01572480|469111340|FG000|Participants Enrolled|Withdrawal by Subject|1|||
130313044|NCT01572480|469111340|FG000|Drug Administration|Discontinued drug/Off Study|1|||
130313045|NCT01572480|469111340|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
130313046|NCT01572480|469111340|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
130313047|NCT04037891|469111341|FG000|Open-label Period|Withdrawal by Subject|1|||
130313048|NCT04037891|469111342|FG001|Open-label Period|Withdrawal by Subject|0|||
130313049|NCT04037891|469111343|FG002|Open-label Period|Withdrawal by Subject|0|||
130313050|NCT04037891|469111341|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
130050315|NCT02064439|468140782|FG002|Overall Study|Adverse Event|46|||
130313051|NCT04037891|469111342|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
130313052|NCT04037891|469111343|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
130313053|NCT03446313|469111344|FG000|Overall Study|Lost to Follow-up|1|||
130313054|NCT03446313|469111345|FG001|Overall Study|Lost to Follow-up|2|||
130313055|NCT03446313|469111344|FG000|Overall Study|Failed primary screening|3|||
130313056|NCT03446313|469111345|FG001|Overall Study|Failed primary screening|0|||
130313057|NCT03446313|469111344|FG000|Overall Study|Diagnosed with terminal cancer|1|||
130313058|NCT03446313|469111345|FG001|Overall Study|Diagnosed with terminal cancer|0|||
130313059|NCT03446313|469111344|FG000|Overall Study|Excluded from analysis|1|||
130313060|NCT03446313|469111345|FG001|Overall Study|Excluded from analysis|1|||
129890346|NCT00688259|467556096|FG001|Overall Study|Declined Interview|3|||
130313061|NCT04491136|469111346|FG000|Overall Study|Patient withdraw informed consent|9|||
130313062|NCT04491136|469111346|FG000|Overall Study|Adverse Event|2|||
130313063|NCT04491136|469111346|FG000|Overall Study|Death|3|||
130313064|NCT04491136|469111346|FG000|Overall Study|Lost to Follow-up|3|||
130313065|NCT04491136|469111346|FG000|Overall Study|Physician Decision|45|||
130313066|NCT04491136|469111346|FG000|Overall Study|sponsor terminated the study early|16|||
130313067|NCT04491136|469111346|FG000|Overall Study|Patient/guardian's decision|1|||
130313068|NCT01611194|469111347|FG000|Overall Study|Lost to Follow-up|0|||
130313069|NCT01611194|469111348|FG001|Overall Study|Lost to Follow-up|1|||
130313070|NCT01611194|469111347|FG000|Overall Study|Withdrawal by Subject|0|||
130313071|NCT01611194|469111348|FG001|Overall Study|Withdrawal by Subject|1|||
130313072|NCT01611194|469111347|FG000|Overall Study|drug use|0|||
130313073|NCT01611194|469111348|FG001|Overall Study|drug use|1|||
130313074|NCT00348673|469111349|FG000|Stage 1|Randomized but not Treated|0|||
130313075|NCT00348673|469111350|FG001|Stage 1|Randomized but not Treated|0|||
130313076|NCT00348673|469111351|FG002|Stage 1|Randomized but not Treated|1|||
130313077|NCT00348673|469111352|FG003|Stage 1|Randomized but not Treated|0|||
130313078|NCT00348673|469111353|FG004|Stage 1|Randomized but not Treated|0|||
130313079|NCT00348673|469111354|FG005|Stage 1|Randomized but not Treated|0|||
130313080|NCT00348673|469111355|FG006|Stage 1|Randomized but not Treated|0|||
130313081|NCT00348673|469111356|FG007|Stage 1|Randomized but not Treated|0|||
130313082|NCT00348673|469111357|FG008|Stage 1|Randomized but not Treated|0|||
130313083|NCT02719171|469113534|FG000|Overall Study|Adverse Event|1|||
130313084|NCT02719171|469113535|FG001|Overall Study|Adverse Event|2|||
130313085|NCT02719171|469113536|FG002|Overall Study|Adverse Event|0|||
130313086|NCT02719171|469113537|FG003|Overall Study|Adverse Event|0|||
130313087|NCT02719171|469113538|FG004|Overall Study|Adverse Event|2|||
130313088|NCT02719171|469113534|FG000|Overall Study|Lost to Follow-up|0|||
130313089|NCT02719171|469113535|FG001|Overall Study|Lost to Follow-up|0|||
130313090|NCT02719171|469113536|FG002|Overall Study|Lost to Follow-up|1|||
130313091|NCT02719171|469113537|FG003|Overall Study|Lost to Follow-up|0|||
130313092|NCT02719171|469113538|FG004|Overall Study|Lost to Follow-up|0|||
130313093|NCT02719171|469113534|FG000|Overall Study|Subject Withdrawal|0|||
130313094|NCT02719171|469113535|FG001|Overall Study|Subject Withdrawal|2|||
130313095|NCT02719171|469113536|FG002|Overall Study|Subject Withdrawal|2|||
130313096|NCT02719171|469113537|FG003|Overall Study|Subject Withdrawal|1|||
130313097|NCT02719171|469113538|FG004|Overall Study|Subject Withdrawal|0|||
130313098|NCT02719171|469113534|FG000|Overall Study|Other|0|||
130313099|NCT02719171|469113535|FG001|Overall Study|Other|0|||
130313100|NCT02719171|469113536|FG002|Overall Study|Other|0|||
130313101|NCT02719171|469113537|FG003|Overall Study|Other|1|||
130313102|NCT02719171|469113538|FG004|Overall Study|Other|0|||
130313103|NCT02614729|469113539|FG000|Overall Study|Withdrawal by Subject|1|||
130313104|NCT02614729|469113540|FG001|Overall Study|Withdrawal by Subject|0|||
130313105|NCT02539797|469113543|FG000|Overall Study|Lost to Follow-up|0|||
130313106|NCT02539797|469113544|FG001|Overall Study|Lost to Follow-up|1|||
130313107|NCT02539797|469113545|FG002|Overall Study|Lost to Follow-up|0|||
130313108|NCT03798717|469113547|FG000|Overall Study|Failed Screening|0|||
130313109|NCT03798717|469113548|FG001|Overall Study|Failed Screening|0|||
130313110|NCT03798717|469113549|FG002|Overall Study|Failed Screening|0|||
130313111|NCT03798717|469113550|FG003|Overall Study|Failed Screening|0|||
130313112|NCT03798717|469113551|FG004|Overall Study|Failed Screening|0|||
130313113|NCT03798717|469113552|FG005|Overall Study|Failed Screening|1|||
130313114|NCT03798717|469113547|FG000|Overall Study|Physician Decision|1|||
130313115|NCT03798717|469113548|FG001|Overall Study|Physician Decision|0|||
130313116|NCT03798717|469113549|FG002|Overall Study|Physician Decision|1|||
130313117|NCT03798717|469113550|FG003|Overall Study|Physician Decision|0|||
130313118|NCT03798717|469113551|FG004|Overall Study|Physician Decision|0|||
130313119|NCT03798717|469113552|FG005|Overall Study|Physician Decision|0|||
130313120|NCT03798717|469113547|FG000|Overall Study|Withdrawal by Subject|0|||
130313121|NCT03798717|469113548|FG001|Overall Study|Withdrawal by Subject|0|||
130110620|NCT03550794|468365802|FG000|Overall Study|No longer met inclusion criteria|1|||
130110621|NCT03550794|468365803|FG001|Overall Study|No longer met inclusion criteria|2|||
130313122|NCT03798717|469113549|FG002|Overall Study|Withdrawal by Subject|0|||
130313123|NCT03798717|469113550|FG003|Overall Study|Withdrawal by Subject|1|||
130313124|NCT03798717|469113551|FG004|Overall Study|Withdrawal by Subject|0|||
130313125|NCT03798717|469113552|FG005|Overall Study|Withdrawal by Subject|0|||
130313126|NCT03798717|469113547|FG000|Overall Study|Lost to Follow-up|1|||
130313127|NCT03798717|469113548|FG001|Overall Study|Lost to Follow-up|0|||
130313128|NCT03798717|469113549|FG002|Overall Study|Lost to Follow-up|0|||
130313129|NCT03798717|469113550|FG003|Overall Study|Lost to Follow-up|1|||
130313130|NCT03798717|469113551|FG004|Overall Study|Lost to Follow-up|0|||
130313131|NCT03798717|469113552|FG005|Overall Study|Lost to Follow-up|0|||
130313132|NCT03798717|469113547|FG000|Overall Study|Adverse Event|0|||
130313133|NCT03798717|469113548|FG001|Overall Study|Adverse Event|1|||
130313134|NCT03798717|469113549|FG002|Overall Study|Adverse Event|0|||
130313135|NCT03798717|469113550|FG003|Overall Study|Adverse Event|0|||
130313136|NCT03798717|469113551|FG004|Overall Study|Adverse Event|0|||
130313137|NCT03798717|469113552|FG005|Overall Study|Adverse Event|0|||
130313138|NCT03798717|469113547|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313139|NCT03798717|469113548|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313140|NCT03798717|469113549|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313141|NCT03798717|469113550|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313142|NCT03798717|469113551|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
130313143|NCT03798717|469113552|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
130313144|NCT04002960|469113554|FG000|Overall Study|Withdrawn prior to Completion|2|||
130313145|NCT00383786|469113569|FG000|Overall Study|Protocol Violation|2|||
130313146|NCT00383786|469113570|FG001|Overall Study|Protocol Violation|6|||
130313147|NCT00383786|469113569|FG000|Overall Study|Withdrawal by Subject|2|||
130313148|NCT00383786|469113570|FG001|Overall Study|Withdrawal by Subject|5|||
130313149|NCT00383786|469113569|FG000|Overall Study|Physician Decision|0|||
130313150|NCT00383786|469113570|FG001|Overall Study|Physician Decision|1|||
130313151|NCT00985673|469113571|FG000|Overall Study|Lost to Follow-up|6|||
130313152|NCT00985673|469113572|FG001|Overall Study|Lost to Follow-up|7|||
130313153|NCT00985673|469113573|FG002|Overall Study|Lost to Follow-up|6|||
130313154|NCT00985673|469113574|FG003|Overall Study|Lost to Follow-up|10|||
130313155|NCT00985673|469113575|FG004|Overall Study|Lost to Follow-up|5|||
130313156|NCT00985673|469113576|FG005|Overall Study|Lost to Follow-up|3|||
130313157|NCT00985673|469113571|FG000|Overall Study|Withdrawal by Subject|0|||
130313158|NCT00985673|469113572|FG001|Overall Study|Withdrawal by Subject|4|||
130313159|NCT00985673|469113573|FG002|Overall Study|Withdrawal by Subject|5|||
130313160|NCT00985673|469113574|FG003|Overall Study|Withdrawal by Subject|2|||
130313161|NCT00985673|469113575|FG004|Overall Study|Withdrawal by Subject|2|||
130313162|NCT00985673|469113576|FG005|Overall Study|Withdrawal by Subject|3|||
130313163|NCT00985673|469113571|FG000|Overall Study|Other|1|||
130313164|NCT00985673|469113572|FG001|Overall Study|Other|0|||
130313165|NCT00985673|469113573|FG002|Overall Study|Other|1|||
130313166|NCT00985673|469113574|FG003|Overall Study|Other|0|||
130313167|NCT00985673|469113575|FG004|Overall Study|Other|1|||
130313168|NCT00985673|469113576|FG005|Overall Study|Other|0|||
130313169|NCT02252146|469113577|FG000|Overall Study|Lack of Efficacy|4|||
130313170|NCT02252146|469113577|FG000|Overall Study|Entered hospice care|1|||
130313171|NCT02252146|469113577|FG000|Overall Study|Inability to travel to study site|1|||
130313172|NCT00531284|469113580|FG000|Overall Study|Progressive Disease|1|||
130313173|NCT00531284|469113581|FG001|Overall Study|Progressive Disease|3|||
130313174|NCT00531284|469113582|FG002|Overall Study|Progressive Disease|5|||
130313175|NCT00531284|469113583|FG003|Overall Study|Progressive Disease|42|||
130313176|NCT00531284|469113584|FG004|Overall Study|Progressive Disease|4|||
130313177|NCT00531284|469113585|FG005|Overall Study|Progressive Disease|4|||
130313178|NCT00531284|469113586|FG006|Overall Study|Progressive Disease|3|||
130313179|NCT00531284|469113587|FG007|Overall Study|Progressive Disease|8|||
130313180|NCT00531284|469113588|FG008|Overall Study|Progressive Disease|6|||
130313181|NCT00531284|469113589|FG009|Overall Study|Progressive Disease|3|||
130313182|NCT00531284|469113590|FG010|Overall Study|Progressive Disease|3|||
130313183|NCT00531284|469113591|FG011|Overall Study|Progressive Disease|14|||
130313184|NCT00531284|469113592|FG012|Overall Study|Progressive Disease|2|||
130313185|NCT00531284|469113593|FG013|Overall Study|Progressive Disease|1|||
130313186|NCT00531284|469113594|FG014|Overall Study|Progressive Disease|2|||
130313187|NCT00531284|469113595|FG015|Overall Study|Progressive Disease|11|||
130313188|NCT00531284|469113596|FG016|Overall Study|Progressive Disease|5|||
130313189|NCT00531284|469113580|FG000|Overall Study|Adverse Event|0|||
130313190|NCT00531284|469113581|FG001|Overall Study|Adverse Event|1|||
130313191|NCT00531284|469113582|FG002|Overall Study|Adverse Event|1|||
130313192|NCT00531284|469113583|FG003|Overall Study|Adverse Event|7|||
129799032|NCT01907100|467232224|FG000|Overall Study|Other than reasons specified|1|||
130313193|NCT00531284|469113584|FG004|Overall Study|Adverse Event|0|||
130313194|NCT00531284|469113585|FG005|Overall Study|Adverse Event|2|||
130313195|NCT00531284|469113586|FG006|Overall Study|Adverse Event|3|||
130313196|NCT00531284|469113587|FG007|Overall Study|Adverse Event|2|||
130313197|NCT00531284|469113588|FG008|Overall Study|Adverse Event|3|||
130313198|NCT00531284|469113589|FG009|Overall Study|Adverse Event|0|||
130313199|NCT00531284|469113590|FG010|Overall Study|Adverse Event|0|||
130313200|NCT00531284|469113591|FG011|Overall Study|Adverse Event|5|||
130313201|NCT00531284|469113592|FG012|Overall Study|Adverse Event|0|||
130313202|NCT00531284|469113593|FG013|Overall Study|Adverse Event|1|||
130313203|NCT00531284|469113594|FG014|Overall Study|Adverse Event|1|||
130313204|NCT00531284|469113595|FG015|Overall Study|Adverse Event|0|||
130313205|NCT00531284|469113596|FG016|Overall Study|Adverse Event|2|||
130313206|NCT00531284|469113580|FG000|Overall Study|Withdrawal by Subject|1|||
130313207|NCT00531284|469113581|FG001|Overall Study|Withdrawal by Subject|0|||
130313208|NCT00531284|469113582|FG002|Overall Study|Withdrawal by Subject|0|||
130313209|NCT00531284|469113583|FG003|Overall Study|Withdrawal by Subject|4|||
130313210|NCT00531284|469113584|FG004|Overall Study|Withdrawal by Subject|0|||
130313211|NCT00531284|469113585|FG005|Overall Study|Withdrawal by Subject|0|||
130313212|NCT00531284|469113586|FG006|Overall Study|Withdrawal by Subject|0|||
130313213|NCT00531284|469113587|FG007|Overall Study|Withdrawal by Subject|0|||
130313214|NCT00531284|469113588|FG008|Overall Study|Withdrawal by Subject|0|||
130313215|NCT00531284|469113589|FG009|Overall Study|Withdrawal by Subject|0|||
130313216|NCT00531284|469113590|FG010|Overall Study|Withdrawal by Subject|0|||
130313217|NCT00531284|469113591|FG011|Overall Study|Withdrawal by Subject|3|||
130313218|NCT00531284|469113592|FG012|Overall Study|Withdrawal by Subject|0|||
130313219|NCT00531284|469113593|FG013|Overall Study|Withdrawal by Subject|1|||
130313220|NCT00531284|469113594|FG014|Overall Study|Withdrawal by Subject|0|||
130313221|NCT00531284|469113595|FG015|Overall Study|Withdrawal by Subject|1|||
130313222|NCT00531284|469113596|FG016|Overall Study|Withdrawal by Subject|1|||
130313223|NCT00531284|469113580|FG000|Overall Study|Other|1|||
130313224|NCT00531284|469113581|FG001|Overall Study|Other|0|||
130313225|NCT00531284|469113582|FG002|Overall Study|Other|0|||
130313226|NCT00531284|469113583|FG003|Overall Study|Other|10|||
130313227|NCT00531284|469113584|FG004|Overall Study|Other|2|||
130313228|NCT00531284|469113585|FG005|Overall Study|Other|1|||
130313229|NCT00531284|469113586|FG006|Overall Study|Other|0|||
130313230|NCT00531284|469113587|FG007|Overall Study|Other|0|||
130313231|NCT00531284|469113588|FG008|Overall Study|Other|2|||
130313232|NCT00531284|469113589|FG009|Overall Study|Other|1|||
130313233|NCT00531284|469113590|FG010|Overall Study|Other|0|||
130313234|NCT00531284|469113591|FG011|Overall Study|Other|2|||
130313235|NCT00531284|469113592|FG012|Overall Study|Other|0|||
130313236|NCT00531284|469113593|FG013|Overall Study|Other|0|||
130313237|NCT00531284|469113594|FG014|Overall Study|Other|1|||
130313238|NCT00531284|469113595|FG015|Overall Study|Other|0|||
130313239|NCT00531284|469113596|FG016|Overall Study|Other|0|||
130313240|NCT00984256|469113597|FG000|Overall Study|Withdrawal by Subject|0|||
130313241|NCT00984256|469113598|FG001|Overall Study|Withdrawal by Subject|1|||
130313242|NCT03057496|469113599|FG000|Overall Study|Withdrawal by Subject|8|||
130313243|NCT03057496|469113599|FG000|Overall Study|Lost to Follow-up|5|||
130313244|NCT03057496|469113599|FG000|Overall Study|Did not use device during home trial|3|||
130313245|NCT03057496|469113599|FG000|Overall Study|Device failure|2|||
130313246|NCT02723773|469113607|FG000|Overall Study|Adverse Event|934|||
130313247|NCT02723773|469113608|FG001|Overall Study|Adverse Event|3|||
130313248|NCT02723773|469113609|FG002|Overall Study|Adverse Event|1|||
130313249|NCT02723773|469113610|FG003|Overall Study|Adverse Event|9|||
130313250|NCT02723773|469113607|FG000|Overall Study|Protocol Violation|1|||
130313251|NCT02723773|469113608|FG001|Overall Study|Protocol Violation|0|||
130313252|NCT02723773|469113609|FG002|Overall Study|Protocol Violation|0|||
130313253|NCT02723773|469113610|FG003|Overall Study|Protocol Violation|0|||
130313254|NCT02723773|469113607|FG000|Overall Study|Withdrawal by Subject|360|||
130313255|NCT02723773|469113608|FG001|Overall Study|Withdrawal by Subject|5|||
130313256|NCT02723773|469113609|FG002|Overall Study|Withdrawal by Subject|6|||
130313257|NCT02723773|469113610|FG003|Overall Study|Withdrawal by Subject|10|||
130313258|NCT02723773|469113607|FG000|Overall Study|Migrated/moved from study area|37|||
130313259|NCT02723773|469113608|FG001|Overall Study|Migrated/moved from study area|0|||
130050316|NCT02064439|468140780|FG000|Overall Study|Death|0|||
130313260|NCT02723773|469113609|FG002|Overall Study|Migrated/moved from study area|0|||
130313261|NCT02723773|469113610|FG003|Overall Study|Migrated/moved from study area|1|||
130313262|NCT02723773|469113607|FG000|Overall Study|Lost to Follow-up|198|||
130313263|NCT02723773|469113608|FG001|Overall Study|Lost to Follow-up|0|||
130313264|NCT02723773|469113609|FG002|Overall Study|Lost to Follow-up|0|||
130313265|NCT02723773|469113610|FG003|Overall Study|Lost to Follow-up|0|||
130313266|NCT02723773|469113607|FG000|Overall Study|Other|189|||
130313267|NCT02723773|469113608|FG001|Overall Study|Other|1|||
130313268|NCT02723773|469113609|FG002|Overall Study|Other|2|||
130313269|NCT02723773|469113610|FG003|Overall Study|Other|2|||
130313270|NCT03347123|469113611|FG000|Overall Study|Death|1|||
130313271|NCT03347123|469113612|FG001|Overall Study|Death|2|||
130313272|NCT03347123|469113613|FG002|Overall Study|Death|0|||
130313273|NCT03347123|469113614|FG003|Overall Study|Death|0|||
130313274|NCT03347123|469113615|FG004|Overall Study|Death|0|||
130313275|NCT03347123|469113616|FG005|Overall Study|Death|0|||
130313276|NCT03347123|469113617|FG006|Overall Study|Death|0|||
130313277|NCT03347123|469113611|FG000|Overall Study|Withdrawal by Subject|1|||
130313278|NCT03347123|469113612|FG001|Overall Study|Withdrawal by Subject|0|||
130313279|NCT03347123|469113613|FG002|Overall Study|Withdrawal by Subject|0|||
130313280|NCT03347123|469113614|FG003|Overall Study|Withdrawal by Subject|0|||
130313281|NCT03347123|469113615|FG004|Overall Study|Withdrawal by Subject|0|||
130313282|NCT03347123|469113616|FG005|Overall Study|Withdrawal by Subject|0|||
130313283|NCT03347123|469113617|FG006|Overall Study|Withdrawal by Subject|0|||
130313284|NCT03347123|469113611|FG000|Overall Study|Reason not Specified|3|||
130313285|NCT03347123|469113612|FG001|Overall Study|Reason not Specified|4|||
130313286|NCT03347123|469113613|FG002|Overall Study|Reason not Specified|0|||
130313287|NCT03347123|469113614|FG003|Overall Study|Reason not Specified|0|||
130313288|NCT03347123|469113615|FG004|Overall Study|Reason not Specified|0|||
130313289|NCT03347123|469113616|FG005|Overall Study|Reason not Specified|0|||
130313290|NCT03347123|469113617|FG006|Overall Study|Reason not Specified|0|||
130313291|NCT01132807|469113620|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
130313292|NCT01132807|469113621|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
130313293|NCT01132807|469113622|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
130313294|NCT01132807|469113620|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
130313295|NCT01132807|469113621|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
130313296|NCT01132807|469113622|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
130313297|NCT01731912|469113625|FG000|Overall Study|noncompliance|2|||
130313298|NCT02222558|469113626|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
130313299|NCT02222558|469113627|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
130313300|NCT02222558|469113628|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
130313301|NCT02222558|469113629|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
130313302|NCT02222558|469113630|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
130313303|NCT02222558|469113631|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
130313304|NCT02222558|469113626|FG000|Period 3|Withdrawal by Subject|0|||
130313305|NCT02222558|469113627|FG001|Period 3|Withdrawal by Subject|0|||
130313306|NCT02222558|469113628|FG002|Period 3|Withdrawal by Subject|0|||
130313307|NCT02222558|469113629|FG003|Period 3|Withdrawal by Subject|0|||
130313308|NCT02222558|469113630|FG004|Period 3|Withdrawal by Subject|0|||
130313309|NCT02222558|469113631|FG005|Period 3|Withdrawal by Subject|1|||
130313310|NCT01285401|469113632|FG000|Overall Study|Prematurely withdrawn from the study|17|||
130313311|NCT01285401|469113633|FG001|Overall Study|Prematurely withdrawn from the study|29|||
130313312|NCT02322281|469113634|FG000|Overall Study|Progressive Disease|42|||
130313313|NCT02322281|469113635|FG001|Overall Study|Progressive Disease|14|||
130313314|NCT02322281|469113636|FG002|Overall Study|Progressive Disease|49|||
130313315|NCT02322281|469113634|FG000|Overall Study|Adverse Event|3|||
130313316|NCT02322281|469113635|FG001|Overall Study|Adverse Event|4|||
130313317|NCT02322281|469113636|FG002|Overall Study|Adverse Event|6|||
130313318|NCT02322281|469113634|FG000|Overall Study|Death|3|||
130313319|NCT02322281|469113635|FG001|Overall Study|Death|3|||
130313320|NCT02322281|469113636|FG002|Overall Study|Death|3|||
130313321|NCT02322281|469113634|FG000|Overall Study|Withdrawal by Subject|1|||
130313322|NCT02322281|469113635|FG001|Overall Study|Withdrawal by Subject|1|||
130313323|NCT02322281|469113636|FG002|Overall Study|Withdrawal by Subject|6|||
130313324|NCT02322281|469113634|FG000|Overall Study|Physician Decision|2|||
129890347|NCT00688259|467556095|FG000|Overall Study|Hospitalized at Follow-up|0|||
129890348|NCT00688259|467556096|FG001|Overall Study|Hospitalized at Follow-up|1|||
129890349|NCT01310868|467556098|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
129890350|NCT02411591|467556099|FG000|Overall Study|Adverse Event|0|||
129890351|NCT02411591|467556100|FG001|Overall Study|Adverse Event|4|||
129890352|NCT02411591|467556101|FG002|Overall Study|Adverse Event|2|||
130050317|NCT02064439|468140781|FG001|Overall Study|Death|2|||
130313325|NCT02322281|469113635|FG001|Overall Study|Physician Decision|0|||
130313326|NCT02322281|469113636|FG002|Overall Study|Physician Decision|5|||
129890353|NCT02411591|467556099|FG000|Overall Study|Withdrawal by Subject|0|||
130313327|NCT02322281|469113634|FG000|Overall Study|Study Terminated by Sponsor|2|||
130313328|NCT02322281|469113635|FG001|Overall Study|Study Terminated by Sponsor|0|||
130313329|NCT02322281|469113636|FG002|Overall Study|Study Terminated by Sponsor|0|||
130313330|NCT02322281|469113634|FG000|Overall Study|Missing|0|||
130313331|NCT02322281|469113635|FG001|Overall Study|Missing|0|||
130050318|NCT02064439|468140782|FG002|Overall Study|Death|3|||
130313332|NCT02322281|469113636|FG002|Overall Study|Missing|1|||
130313333|NCT02322281|469113634|FG000|Overall Study|Miscellaneous|0|||
130313334|NCT02322281|469113635|FG001|Overall Study|Miscellaneous|0|||
130313335|NCT02322281|469113636|FG002|Overall Study|Miscellaneous|4|||
130313336|NCT00936702|469113637|FG000|Overall Study|Disease progression|34|||
130313337|NCT00936702|469113637|FG000|Overall Study|Adverse Event|8|||
130313338|NCT00936702|469113637|FG000|Overall Study|Withdrawal by Subject|2|||
130313339|NCT00936702|469113637|FG000|Overall Study|Alternative Treatment|1|||
130313340|NCT00936702|469113637|FG000|Overall Study|Other|1|||
130313341|NCT02532465|469113638|FG000|Overall Study|Protocol Violation|1|||
130313342|NCT02532465|469113639|FG001|Overall Study|Protocol Violation|0|||
130313343|NCT02532465|469113638|FG000|Overall Study|Lack of Efficacy|0|||
130313344|NCT02532465|469113639|FG001|Overall Study|Lack of Efficacy|1|||
130313345|NCT00354679|469113644|FG000|Overall Study|Patient Not Treated|1|||
130313346|NCT00622505|469113646|FG000|Overall Study|Adverse Event|9|||
130313347|NCT00622505|469113647|FG001|Overall Study|Adverse Event|7|||
130313348|NCT00622505|469113646|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
130313349|NCT00622505|469113647|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
130313350|NCT00622505|469113646|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130313351|NCT00622505|469113647|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130313352|NCT00622505|469113646|FG000|Overall Study|Withdrawal by Subject|12|||
130313353|NCT00622505|469113647|FG001|Overall Study|Withdrawal by Subject|5|||
130313354|NCT00622505|469113646|FG000|Overall Study|Administrative Problems|2|||
130313355|NCT00622505|469113647|FG001|Overall Study|Administrative Problems|4|||
130313356|NCT00622505|469113646|FG000|Overall Study|Death|2|||
130313357|NCT00622505|469113647|FG001|Overall Study|Death|2|||
130313358|NCT02420093|469113650|FG000|Overall Study|Withdrawal by Subject|1|||
130313359|NCT02420093|469113651|FG001|Overall Study|Withdrawal by Subject|1|||
130313360|NCT03244917|469113654|FG000|Overall Study|Lost to Follow-up|2|||
130313361|NCT03244917|469113655|FG001|Overall Study|Lost to Follow-up|2|||
130313362|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313363|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313364|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313365|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313366|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313367|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313368|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313369|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129799033|NCT01907100|467232225|FG001|Overall Study|Other than reasons specified|0|||
130050319|NCT02064439|468140780|FG000|Overall Study|Withdrawal by Subject|29|||
130050320|NCT02064439|468140781|FG001|Overall Study|Withdrawal by Subject|18|||
130050321|NCT02064439|468140782|FG002|Overall Study|Withdrawal by Subject|26|||
130050322|NCT02064439|468140780|FG000|Overall Study|Protocol Violation|3|||
130050323|NCT02064439|468140781|FG001|Overall Study|Protocol Violation|5|||
130050324|NCT02064439|468140782|FG002|Overall Study|Protocol Violation|3|||
130050325|NCT02064439|468140780|FG000|Overall Study|Lost to Follow-up|1|||
130050326|NCT02064439|468140781|FG001|Overall Study|Lost to Follow-up|3|||
130050327|NCT02064439|468140782|FG002|Overall Study|Lost to Follow-up|4|||
130050328|NCT02064439|468140780|FG000|Overall Study|Non-compliance with study medication|21|||
130050329|NCT02064439|468140781|FG001|Overall Study|Non-compliance with study medication|19|||
130050330|NCT02064439|468140782|FG002|Overall Study|Non-compliance with study medication|23|||
130050331|NCT02064439|468140780|FG000|Overall Study|Physician Decision|0|||
130050332|NCT02064439|468140781|FG001|Overall Study|Physician Decision|1|||
130050333|NCT02064439|468140782|FG002|Overall Study|Physician Decision|1|||
130050334|NCT02064439|468140780|FG000|Overall Study|Logistical difficulties|6|||
130050335|NCT02064439|468140781|FG001|Overall Study|Logistical difficulties|5|||
130050336|NCT02064439|468140782|FG002|Overall Study|Logistical difficulties|2|||
130050337|NCT02064439|468140780|FG000|Overall Study|Efficacy outcome reached|18|||
130050338|NCT02064439|468140781|FG001|Overall Study|Efficacy outcome reached|16|||
130050339|NCT02064439|468140782|FG002|Overall Study|Efficacy outcome reached|57|||
130050340|NCT02064439|468140780|FG000|Overall Study|Safety outcome reached|12|||
130050341|NCT02064439|468140781|FG001|Overall Study|Safety outcome reached|20|||
130050342|NCT02064439|468140782|FG002|Overall Study|Safety outcome reached|10|||
130050343|NCT02064439|468140780|FG000|Overall Study|Other|2|||
130050344|NCT02064439|468140781|FG001|Overall Study|Other|2|||
130050345|NCT02064439|468140782|FG002|Overall Study|Other|7|||
130050346|NCT03350750|468140783|FG000|Overall Study|Death|1|||
130050347|NCT03350750|468140784|FG001|Overall Study|Death|1|||
130050348|NCT02433288|468140785|FG000|Overall Study|Severe non-compliance to protocol|13|||
130050349|NCT02433288|468140786|FG001|Overall Study|Severe non-compliance to protocol|7|||
130313370|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313371|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129799034|NCT01907100|467232226|FG002|Overall Study|Other than reasons specified|10|||
130050350|NCT02433288|468140785|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
130050351|NCT02433288|468140786|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
130050352|NCT02433288|468140785|FG000|Overall Study|Withdrawal by Subject|101|||
130050353|NCT02433288|468140786|FG001|Overall Study|Withdrawal by Subject|99|||
130050354|NCT02433288|468140785|FG000|Overall Study|Lost to Follow-up|2|||
130313372|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129799035|NCT01907100|467232227|FG003|Overall Study|Other than reasons specified|6|||
129799036|NCT01907100|467232224|FG000|Overall Study|Adverse event (AE)|6|||
129799037|NCT01907100|467232225|FG001|Overall Study|Adverse event (AE)|3|||
129799038|NCT01907100|467232226|FG002|Overall Study|Adverse event (AE)|22|||
129799039|NCT01907100|467232227|FG003|Overall Study|Adverse event (AE)|23|||
129799040|NCT01907100|467232224|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
129799041|NCT01907100|467232225|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
129799042|NCT01907100|467232226|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
129799043|NCT01907100|467232227|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
129799044|NCT02059005|467232228|FG000|Overall Study|Death|1|||
129799045|NCT02059005|467232229|FG001|Overall Study|Death|3|||
130313373|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313374|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
130313375|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313376|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
130313377|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313378|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313379|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313380|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313381|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
130313382|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313383|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
130313384|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
130313385|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313386|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313387|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313388|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313389|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
130313390|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
130313391|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
130313392|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
130313393|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
130313394|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
130313395|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
130313396|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
130313397|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
130313398|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
130313399|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
130313400|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
130313401|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
130313402|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
130313403|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
130313404|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
130313405|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
130313406|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
130313407|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130313408|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313409|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129799046|NCT02059005|467232228|FG000|Overall Study|Lost to Follow-up|19|||
129799047|NCT02059005|467232229|FG001|Overall Study|Lost to Follow-up|19|||
129799048|NCT02059005|467232228|FG000|Overall Study|Incarceration|0|||
130313410|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130313411|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313412|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313413|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313414|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313415|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313416|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129799049|NCT02059005|467232229|FG001|Overall Study|Incarceration|1|||
129799050|NCT02059005|467232228|FG000|Overall Study|Inpatient|0|||
130313417|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
130313418|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313419|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313420|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313421|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
130313422|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313423|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313424|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313425|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313426|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313427|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313428|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313429|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313430|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313431|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313432|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313433|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313434|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313435|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
130313436|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
130313437|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313438|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313439|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313440|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
130313441|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313442|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313443|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313444|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313445|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313446|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313447|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
130313448|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313449|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313450|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313451|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
130313452|NCT01147666|469113658|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313453|NCT01147666|469113659|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313454|NCT01147666|469113660|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313455|NCT01147666|469113661|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313456|NCT01147666|469113662|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313457|NCT01147666|469113663|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313458|NCT01147666|469113664|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313459|NCT01147666|469113665|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313460|NCT01147666|469113666|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313461|NCT01147666|469113667|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313462|NCT01147666|469113668|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313463|NCT01147666|469113669|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130313464|NCT01147666|469113670|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130313465|NCT01147666|469113671|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
130313466|NCT01147666|469113672|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
130313467|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
130313468|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
130313469|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
130313470|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
130313471|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
130313472|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
130313473|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
130313474|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
130313475|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
130313476|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
130313477|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
130313478|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
130313479|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
129890354|NCT02411591|467556100|FG001|Overall Study|Withdrawal by Subject|3|||
129890355|NCT02411591|467556101|FG002|Overall Study|Withdrawal by Subject|0|||
129799051|NCT02059005|467232229|FG001|Overall Study|Inpatient|1|||
129799052|NCT00739596|467232230|FG000|Overall Study|Adverse Event|12|||
129799053|NCT00739596|467232231|FG001|Overall Study|Adverse Event|6|||
129799054|NCT00739596|467232230|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130313480|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
130313481|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
130313482|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313483|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313484|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313485|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313486|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
130313487|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130313488|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130313489|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130313490|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313491|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130313492|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313493|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313494|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
130313495|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
130313496|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
130313497|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313498|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313499|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313500|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
130313501|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313502|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313503|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313504|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313505|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313506|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313507|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313508|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313509|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313510|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313511|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
130313512|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313513|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313514|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313515|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313516|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313517|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313518|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313519|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313520|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313521|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313522|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129799055|NCT00739596|467232231|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129799056|NCT00739596|467232230|FG000|Overall Study|Patient Withdrew Consent|8|||
129799057|NCT00739596|467232231|FG001|Overall Study|Patient Withdrew Consent|8|||
129799058|NCT00739596|467232230|FG000|Overall Study|Lost to Follow-up|0|||
129799059|NCT00739596|467232231|FG001|Overall Study|Lost to Follow-up|2|||
129799060|NCT00739596|467232230|FG000|Overall Study|Protocol Deviation|1|||
129799061|NCT00739596|467232231|FG001|Overall Study|Protocol Deviation|1|||
129799062|NCT00908011|467232236|FG000|Overall Study|Withdrawal by Subject|2|||
129799063|NCT00908011|467232237|FG001|Overall Study|Withdrawal by Subject|2|||
129799064|NCT00644228|467232238|FG000|Randomization & Eligibility|Ineligible|31|||
129799065|NCT00644228|467232239|FG001|Randomization & Eligibility|Ineligible|21|||
130313523|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313524|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313525|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
130313526|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
130313527|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313528|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130110622|NCT03550794|468365802|FG000|Overall Study|Goals of care changed|1|||
130110623|NCT03550794|468365803|FG001|Overall Study|Goals of care changed|0|||
129799066|NCT00644228|467232238|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
129799067|NCT00644228|467232239|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
130313529|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313530|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
130313531|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313532|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313533|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313534|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313535|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313536|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313537|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
130313538|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313539|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313540|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313541|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
130313542|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313543|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313544|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313545|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313546|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313547|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313548|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313549|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313550|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313551|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313552|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313553|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313554|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
130313555|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313556|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
130313557|NCT01147666|469113658|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313558|NCT01147666|469113659|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313559|NCT01147666|469113660|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129799068|NCT00644228|467232238|FG000|Randomization & Eligibility|Invalid Consent|0|||
129799069|NCT00644228|467232239|FG001|Randomization & Eligibility|Invalid Consent|1|||
129799070|NCT00644228|467232238|FG000|Induction Therapy|Adverse Event|22|||
129799071|NCT00644228|467232239|FG001|Induction Therapy|Adverse Event|55|||
129799072|NCT00644228|467232238|FG000|Induction Therapy|Withdrawal by Subject|10|||
129799073|NCT00644228|467232239|FG001|Induction Therapy|Withdrawal by Subject|3|||
129799074|NCT00644228|467232238|FG000|Induction Therapy|Progression/Relapse|24|||
129799075|NCT00644228|467232239|FG001|Induction Therapy|Progression/Relapse|12|||
129799076|NCT00644228|467232238|FG000|Induction Therapy|Death|3|||
129799077|NCT00644228|467232239|FG001|Induction Therapy|Death|7|||
129799078|NCT00644228|467232238|FG000|Induction Therapy|Not Protocol-Specified|24|||
129799079|NCT00644228|467232239|FG001|Induction Therapy|Not Protocol-Specified|28|||
129799080|NCT00644228|467232238|FG000|Maintenance|Adverse Event|27|||
129799081|NCT00644228|467232239|FG001|Maintenance|Adverse Event|31|||
129799082|NCT00644228|467232238|FG000|Maintenance|Withdrawal by Subject|6|||
129799083|NCT00644228|467232239|FG001|Maintenance|Withdrawal by Subject|4|||
129799084|NCT00644228|467232238|FG000|Maintenance|Progression/Relapse|67|||
129799085|NCT00644228|467232239|FG001|Maintenance|Progression/Relapse|42|||
129799086|NCT00644228|467232238|FG000|Maintenance|Death|3|||
129799087|NCT00644228|467232239|FG001|Maintenance|Death|3|||
129799088|NCT00644228|467232238|FG000|Maintenance|Not Protocol-Specified|14|||
129799089|NCT00644228|467232239|FG001|Maintenance|Not Protocol-Specified|15|||
129799090|NCT00644228|467232238|FG000|Maintenance|On Treatment|26|||
129799091|NCT00644228|467232239|FG001|Maintenance|On Treatment|40|||
129799092|NCT00760084|467232240|FG000|Overall Study|Physician Decision|5|||
129799093|NCT00760084|467232240|FG000|Overall Study|Withdrawal by Subject|2|||
129799094|NCT00760084|467232240|FG000|Overall Study|Progressive Disease|3|||
129799095|NCT02142803|467232241|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
129799096|NCT02142803|467232242|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
129799097|NCT02142803|467232243|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
129799098|NCT02142803|467232244|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
129799099|NCT02718300|467232250|FG000|Overall Study|Death|4|||
129799100|NCT02718300|467232251|FG001|Overall Study|Death|5|||
130313560|NCT01147666|469113661|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313561|NCT01147666|469113662|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313562|NCT01147666|469113663|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313563|NCT01147666|469113664|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313564|NCT01147666|469113665|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313565|NCT01147666|469113666|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313566|NCT01147666|469113667|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129799101|NCT02718300|467232252|FG002|Overall Study|Death|17|||
129799102|NCT02718300|467232250|FG000|Overall Study|Lost to Follow-up|1|||
129799103|NCT02718300|467232251|FG001|Overall Study|Lost to Follow-up|0|||
129799104|NCT02718300|467232252|FG002|Overall Study|Lost to Follow-up|2|||
129799105|NCT02718300|467232250|FG000|Overall Study|Physician Decision|1|||
129799106|NCT02718300|467232251|FG001|Overall Study|Physician Decision|0|||
129799107|NCT02718300|467232252|FG002|Overall Study|Physician Decision|2|||
129799108|NCT02718300|467232250|FG000|Overall Study|Study Terminated by Sponsor|6|||
129799109|NCT02718300|467232251|FG001|Overall Study|Study Terminated by Sponsor|3|||
129799110|NCT02718300|467232252|FG002|Overall Study|Study Terminated by Sponsor|4|||
129799111|NCT02718300|467232250|FG000|Overall Study|Withdrawal by Subject|0|||
129799112|NCT02718300|467232251|FG001|Overall Study|Withdrawal by Subject|4|||
129799113|NCT02718300|467232252|FG002|Overall Study|Withdrawal by Subject|3|||
129799114|NCT02718300|467232250|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
129799115|NCT02718300|467232251|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
129799116|NCT02718300|467232252|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
129799117|NCT03906461|467233422|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
129799118|NCT03906461|467233422|FG000|Completed 12-month Follow-up|Missed Visit|6|||
129799119|NCT00510874|467233423|FG000|Overall Study|Withdrawal by Subject|1|||
129799120|NCT00510874|467233424|FG001|Overall Study|Withdrawal by Subject|1|||
129799121|NCT00510874|467233425|FG002|Overall Study|Withdrawal by Subject|0|||
129799122|NCT00510874|467233426|FG003|Overall Study|Withdrawal by Subject|0|||
129799123|NCT00510874|467233427|FG004|Overall Study|Withdrawal by Subject|3|||
129799124|NCT00510874|467233428|FG005|Overall Study|Withdrawal by Subject|0|||
129799125|NCT00510874|467233429|FG006|Overall Study|Withdrawal by Subject|0|||
129799126|NCT00510874|467233423|FG000|Overall Study|Lost to Follow-up|2|||
129799127|NCT00510874|467233424|FG001|Overall Study|Lost to Follow-up|3|||
129799128|NCT00510874|467233425|FG002|Overall Study|Lost to Follow-up|1|||
129799129|NCT00510874|467233426|FG003|Overall Study|Lost to Follow-up|3|||
129799130|NCT00510874|467233427|FG004|Overall Study|Lost to Follow-up|4|||
129799131|NCT00510874|467233428|FG005|Overall Study|Lost to Follow-up|0|||
129799132|NCT00510874|467233429|FG006|Overall Study|Lost to Follow-up|1|||
129799133|NCT02423109|467233432|FG000|Lens 1|Adverse Event|1|||
129799134|NCT02423109|467233433|FG001|Lens 1|Adverse Event|0|||
129799135|NCT04622735|467233434|FG000|Overall Study|Lost to Follow-up|1|||
129799136|NCT04622735|467233435|FG001|Overall Study|Lost to Follow-up|2|||
129799137|NCT04622735|467233436|FG002|Overall Study|Lost to Follow-up|1|||
129799138|NCT04622735|467233434|FG000|Overall Study|Adverse Event|0|||
129799139|NCT04622735|467233435|FG001|Overall Study|Adverse Event|0|||
129799140|NCT04622735|467233436|FG002|Overall Study|Adverse Event|1|||
129799141|NCT04622735|467233434|FG000|Overall Study|Protocol Violation|1|||
129799142|NCT04622735|467233435|FG001|Overall Study|Protocol Violation|0|||
129799143|NCT04622735|467233436|FG002|Overall Study|Protocol Violation|0|||
129799144|NCT04073368|467233437|FG000|Overall Study|Adverse Event|2|||
129799145|NCT04073368|467233438|FG001|Overall Study|Adverse Event|0|||
129799146|NCT04073368|467233439|FG002|Overall Study|Adverse Event|1|||
129799147|NCT04073368|467233440|FG003|Overall Study|Adverse Event|1|||
129799148|NCT04073368|467233437|FG000|Overall Study|Withdrawal by Subject|2|||
129799149|NCT04073368|467233438|FG001|Overall Study|Withdrawal by Subject|2|||
129799150|NCT04073368|467233439|FG002|Overall Study|Withdrawal by Subject|1|||
129799151|NCT04073368|467233440|FG003|Overall Study|Withdrawal by Subject|1|||
129799152|NCT04073368|467233437|FG000|Overall Study|Lost to Follow-up|1|||
129799153|NCT04073368|467233438|FG001|Overall Study|Lost to Follow-up|1|||
129799154|NCT04073368|467233439|FG002|Overall Study|Lost to Follow-up|1|||
129799155|NCT04073368|467233440|FG003|Overall Study|Lost to Follow-up|0|||
129799156|NCT04073368|467233437|FG000|Overall Study|Protocol Violation|0|||
129799157|NCT04073368|467233438|FG001|Overall Study|Protocol Violation|1|||
129799158|NCT04073368|467233439|FG002|Overall Study|Protocol Violation|0|||
129799159|NCT04073368|467233440|FG003|Overall Study|Protocol Violation|0|||
129799160|NCT04073368|467233437|FG000|Overall Study|Subject noncompliance|7|||
129799161|NCT04073368|467233438|FG001|Overall Study|Subject noncompliance|4|||
129799162|NCT04073368|467233439|FG002|Overall Study|Subject noncompliance|0|||
129799163|NCT04073368|467233440|FG003|Overall Study|Subject noncompliance|0|||
129799164|NCT01229397|467233441|FG000|Overall Study|Withdrawal by Subject|3|||
129799165|NCT01229397|467233442|FG001|Overall Study|Withdrawal by Subject|3|||
129799166|NCT01229397|467233441|FG000|Overall Study|Lost to Follow-up|7|||
129799167|NCT01229397|467233442|FG001|Overall Study|Lost to Follow-up|6|||
129799168|NCT01229397|467233441|FG000|Overall Study|Migrated/moved from study area|1|||
129799169|NCT01229397|467233442|FG001|Overall Study|Migrated/moved from study area|0|||
129799170|NCT03960554|467233451|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
129799171|NCT03960554|467233452|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
129799172|NCT00735254|467233453|FG000|Overall Study|Protocol Violation|1|||
129799173|NCT00735254|467233454|FG001|Overall Study|Protocol Violation|1|||
129799174|NCT00735254|467233455|FG002|Overall Study|Protocol Violation|1|||
129799175|NCT00735254|467233456|FG003|Overall Study|Protocol Violation|0|||
129799176|NCT00751621|467233457|FG000|Overall Study|Adverse Event|1|||
129799177|NCT00751621|467233457|FG000|Overall Study|Withdrawal by Subject|1|||
130313567|NCT01147666|469113668|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313568|NCT01147666|469113669|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130313569|NCT01147666|469113670|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
130313570|NCT01147666|469113671|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
130050355|NCT02433288|468140786|FG001|Overall Study|Lost to Follow-up|14|||
130050356|NCT02433288|468140785|FG000|Overall Study|Death|0|||
130050357|NCT02433288|468140786|FG001|Overall Study|Death|3|||
130050358|NCT01120093|468140791|FG000|Treatment Period 1|Adverse Event|0|||
130050359|NCT01120093|468140792|FG001|Treatment Period 1|Adverse Event|0|||
130050360|NCT01120093|468140793|FG002|Treatment Period 1|Adverse Event|1|||
130050361|NCT01120093|468140794|FG003|Treatment Period 1|Adverse Event|0|||
130050362|NCT01120093|468140795|FG004|Treatment Period 1|Adverse Event|1|||
130050363|NCT01120093|468140791|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130050364|NCT01120093|468140792|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130050365|NCT01120093|468140793|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130050366|NCT01120093|468140794|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130050367|NCT01120093|468140795|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130050368|NCT01120093|468140791|FG000|Treatment Period 2|Adverse Event|0|||
130050369|NCT01120093|468140792|FG001|Treatment Period 2|Adverse Event|0|||
130050370|NCT01120093|468140793|FG002|Treatment Period 2|Adverse Event|0|||
130050371|NCT01120093|468140794|FG003|Treatment Period 2|Adverse Event|1|||
130050372|NCT01120093|468140795|FG004|Treatment Period 2|Adverse Event|0|||
130050373|NCT01120093|468140791|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130050374|NCT01120093|468140792|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130050375|NCT01120093|468140793|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130050376|NCT01120093|468140794|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130050377|NCT01120093|468140795|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130050378|NCT01120093|468140791|FG000|Treatment Period 3|Lack of Efficacy|0|||
130050379|NCT01120093|468140792|FG001|Treatment Period 3|Lack of Efficacy|0|||
130050380|NCT01120093|468140793|FG002|Treatment Period 3|Lack of Efficacy|0|||
130050381|NCT01120093|468140794|FG003|Treatment Period 3|Lack of Efficacy|1|||
130050382|NCT01120093|468140795|FG004|Treatment Period 3|Lack of Efficacy|0|||
130050383|NCT01120093|468140791|FG000|Treatment Period 3|Adverse Event|0|||
130050384|NCT01120093|468140792|FG001|Treatment Period 3|Adverse Event|0|||
130050385|NCT01120093|468140793|FG002|Treatment Period 3|Adverse Event|0|||
130313571|NCT01147666|469113672|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
130313572|NCT02159066|469113673|FG000|Part I|Adverse Event|7|||
130313573|NCT02159066|469113674|FG001|Part I|Adverse Event|5|||
130313574|NCT02159066|469113675|FG002|Part I|Adverse Event|0|||
130313575|NCT02159066|469113676|FG003|Part I|Adverse Event|0|||
130313576|NCT02159066|469113677|FG004|Part I|Adverse Event|0|||
130313577|NCT02159066|469113678|FG005|Part I|Adverse Event|0|||
130313578|NCT02159066|469113673|FG000|Part I|Death|11|||
130313579|NCT02159066|469113674|FG001|Part I|Death|9|||
130313580|NCT02159066|469113675|FG002|Part I|Death|0|||
130313581|NCT02159066|469113676|FG003|Part I|Death|0|||
130313582|NCT02159066|469113677|FG004|Part I|Death|0|||
130313583|NCT02159066|469113678|FG005|Part I|Death|0|||
130313584|NCT02159066|469113673|FG000|Part I|Progressive Disease|37|||
130313585|NCT02159066|469113674|FG001|Part I|Progressive Disease|46|||
130313586|NCT02159066|469113675|FG002|Part I|Progressive Disease|0|||
130313587|NCT02159066|469113676|FG003|Part I|Progressive Disease|0|||
130313588|NCT02159066|469113677|FG004|Part I|Progressive Disease|0|||
130313589|NCT02159066|469113678|FG005|Part I|Progressive Disease|0|||
130313590|NCT02159066|469113673|FG000|Part I|New Therapy for Study Indication|5|||
130313591|NCT02159066|469113674|FG001|Part I|New Therapy for Study Indication|4|||
130313592|NCT02159066|469113675|FG002|Part I|New Therapy for Study Indication|0|||
130313593|NCT02159066|469113676|FG003|Part I|New Therapy for Study Indication|0|||
130313594|NCT02159066|469113677|FG004|Part I|New Therapy for Study Indication|0|||
130313595|NCT02159066|469113678|FG005|Part I|New Therapy for Study Indication|0|||
130313596|NCT02159066|469113673|FG000|Part I|Termination of participants from the study|3|||
130313597|NCT02159066|469113674|FG001|Part I|Termination of participants from the study|3|||
130313598|NCT02159066|469113675|FG002|Part I|Termination of participants from the study|0|||
130313599|NCT02159066|469113676|FG003|Part I|Termination of participants from the study|0|||
130313600|NCT02159066|469113677|FG004|Part I|Termination of participants from the study|0|||
130313601|NCT02159066|469113678|FG005|Part I|Termination of participants from the study|0|||
130313602|NCT02159066|469113673|FG000|Part I|Physician Decision|2|||
130313603|NCT02159066|469113674|FG001|Part I|Physician Decision|9|||
130313604|NCT02159066|469113675|FG002|Part I|Physician Decision|0|||
130313605|NCT02159066|469113676|FG003|Part I|Physician Decision|0|||
130313606|NCT02159066|469113677|FG004|Part I|Physician Decision|0|||
130313607|NCT02159066|469113678|FG005|Part I|Physician Decision|0|||
130313608|NCT02159066|469113673|FG000|Part I|Participant/Guardian Decision|9|||
130313609|NCT02159066|469113674|FG001|Part I|Participant/Guardian Decision|3|||
130313610|NCT02159066|469113675|FG002|Part I|Participant/Guardian Decision|0|||
130313611|NCT02159066|469113676|FG003|Part I|Participant/Guardian Decision|0|||
130313612|NCT02159066|469113677|FG004|Part I|Participant/Guardian Decision|0|||
129799178|NCT00751621|467233457|FG000|Overall Study|Subject moved to another country|1|||
129799179|NCT00751621|467233457|FG000|Overall Study|Poor adherence to asthma treatment|1|||
129799180|NCT02791594|467233458|FG000|Overall Study|Physician Decision|2|||
129799181|NCT02310321|467233459|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
129799182|NCT02310321|467233460|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799183|NCT02310321|467233461|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799184|NCT02310321|467233459|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
129799185|NCT02310321|467233460|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799186|NCT02310321|467233461|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799187|NCT02310321|467233459|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
129799188|NCT02310321|467233460|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799189|NCT02310321|467233461|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799190|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
129799191|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
129799192|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
129799193|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799194|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
129799195|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799196|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
129799197|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
129799198|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
129799199|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
129799200|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
129799201|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
129799202|NCT02310321|467233459|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
129799203|NCT02310321|467233460|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
129799204|NCT02310321|467233461|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
129799205|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
129799206|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
129799207|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
129799208|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
129799209|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
129799210|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
129799211|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
129799212|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
129799213|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
129799214|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
129799215|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
129799216|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
129799217|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
129799218|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
129799219|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
129799220|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
129799221|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
129799222|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
129799223|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
129799224|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
129799225|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
129799226|NCT02310321|467233459|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
129799227|NCT02310321|467233460|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
129799228|NCT02310321|467233461|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
129799229|NCT02310321|467233459|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
129799230|NCT02310321|467233460|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
129799231|NCT02310321|467233461|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
129799232|NCT02310321|467233459|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
129799233|NCT02310321|467233460|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
129799234|NCT02310321|467233461|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
129799235|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
129799236|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
130313613|NCT02159066|469113678|FG005|Part I|Participant/Guardian Decision|0|||
130313614|NCT02159066|469113673|FG000|Part I|Missing Data|1|||
130313615|NCT02159066|469113674|FG001|Part I|Missing Data|0|||
129799237|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
129799238|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
130313616|NCT02159066|469113675|FG002|Part I|Missing Data|0|||
130313617|NCT02159066|469113676|FG003|Part I|Missing Data|0|||
129799239|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
129799240|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
129799241|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
129799242|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
129799243|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
129799244|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
129799245|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
129799246|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
129799247|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
129799248|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
129799249|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
129799250|NCT01698905|467233462|FG000|Overall Study|Adverse Event|4|||
129799251|NCT01698905|467233462|FG000|Overall Study|Physician Decision|2|||
129799252|NCT01698905|467233462|FG000|Overall Study|Pregnancy|1|||
129799253|NCT01698905|467233462|FG000|Overall Study|Protocol Violation|1|||
129799254|NCT01698905|467233462|FG000|Overall Study|Subject/guardian decision|2|||
129799255|NCT01698905|467233462|FG000|Overall Study|Death|1|||
129799256|NCT05896748|467233463|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
129799257|NCT05896748|467233463|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
129799258|NCT05896748|467233463|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
129799259|NCT05896748|467233463|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
129799260|NCT05896748|467233463|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
129799261|NCT02325791|467233466|FG000|Overall Study|Adverse Event|0|||
129799262|NCT02325791|467233467|FG001|Overall Study|Adverse Event|1|||
129799263|NCT02325791|467233468|FG002|Overall Study|Adverse Event|1|||
129799264|NCT02325791|467233469|FG003|Overall Study|Adverse Event|0|||
129799265|NCT02325791|467233466|FG000|Overall Study|Death|0|||
129799266|NCT02325791|467233467|FG001|Overall Study|Death|3|||
129799267|NCT02325791|467233468|FG002|Overall Study|Death|0|||
129799268|NCT02325791|467233469|FG003|Overall Study|Death|1|||
129799269|NCT02325791|467233466|FG000|Overall Study|Lost to Follow-up|0|||
129799270|NCT02325791|467233467|FG001|Overall Study|Lost to Follow-up|15|||
129799271|NCT02325791|467233468|FG002|Overall Study|Lost to Follow-up|14|||
129799272|NCT02325791|467233469|FG003|Overall Study|Lost to Follow-up|9|||
129799273|NCT02325791|467233466|FG000|Overall Study|Physician Decision|0|||
129799274|NCT02325791|467233467|FG001|Overall Study|Physician Decision|1|||
129799275|NCT02325791|467233468|FG002|Overall Study|Physician Decision|1|||
129799276|NCT02325791|467233469|FG003|Overall Study|Physician Decision|0|||
129799277|NCT02325791|467233466|FG000|Overall Study|Protocol Violation|0|||
129799278|NCT02325791|467233467|FG001|Overall Study|Protocol Violation|0|||
129799279|NCT02325791|467233468|FG002|Overall Study|Protocol Violation|1|||
129799280|NCT02325791|467233469|FG003|Overall Study|Protocol Violation|0|||
129799281|NCT02325791|467233466|FG000|Overall Study|Withdrawal by Subject|0|||
129799282|NCT02325791|467233467|FG001|Overall Study|Withdrawal by Subject|5|||
129799283|NCT02325791|467233468|FG002|Overall Study|Withdrawal by Subject|8|||
129799284|NCT02325791|467233469|FG003|Overall Study|Withdrawal by Subject|16|||
129799285|NCT01437878|467233470|FG000|Overall Study|Withdrawal by Subject|1|||
129799286|NCT01437878|467233471|FG001|Overall Study|Withdrawal by Subject|0|||
129799287|NCT01070043|467233472|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
129799288|NCT01070043|467233473|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
129799289|NCT01070043|467233474|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
129799290|NCT01070043|467233472|FG000|Double-Blind Treatment|Adverse Event|0|||
129799291|NCT01070043|467233473|FG001|Double-Blind Treatment|Adverse Event|0|||
129799292|NCT01070043|467233474|FG002|Double-Blind Treatment|Adverse Event|2|||
129799293|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Adverse Event|1|||
129799294|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Adverse Event|0|||
129799295|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Adverse Event|0|||
129799296|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Adverse Event|0|||
129799297|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Adverse Event|0|||
129799298|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799299|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
129799300|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799301|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799302|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799303|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
129799304|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
129799305|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
129799306|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
129799307|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
130050386|NCT01120093|468140794|FG003|Treatment Period 3|Adverse Event|0|||
129799308|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799309|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
129799310|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799311|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799312|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799313|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Reason not specified|0|||
129799314|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Reason not specified|1|||
129799315|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Reason not specified|0|||
129799316|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Reason not specified|0|||
129799317|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Reason not specified|0|||
129799318|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Adverse Event|0|||
129799319|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Adverse Event|0|||
129799320|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Adverse Event|0|||
129799321|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Adverse Event|0|||
129799322|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Adverse Event|3|||
129799323|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Death|0|||
129799324|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Death|0|||
129799325|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Death|0|||
129799326|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Death|0|||
129799327|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Death|1|||
129799328|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
129799329|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
129799330|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
129799331|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
129799332|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
129799333|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Reason not specified|0|||
129799334|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Reason not specified|0|||
129799335|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Reason not specified|0|||
129799336|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Reason not specified|0|||
129799337|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Reason not specified|3|||
129799338|NCT01528215|467233481|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
129799339|NCT01528215|467233482|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
129799340|NCT01528215|467233481|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
129799341|NCT01528215|467233482|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
129799342|NCT01528215|467233481|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
129799343|NCT01528215|467233482|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
129799344|NCT01528215|467233481|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
129799345|NCT01528215|467233482|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
129799346|NCT01462227|467233484|FG000|Second Assignment|Lost to Follow-up|1|||
129799347|NCT01462227|467233485|FG001|Second Assignment|Lost to Follow-up|0|||
129799348|NCT01462227|467233486|FG002|Second Assignment|Lost to Follow-up|0|||
129799349|NCT01462227|467233487|FG003|Second Assignment|Lost to Follow-up|0|||
129799350|NCT01462227|467233484|FG000|Second Assignment|Protocol Violation|0|||
129799351|NCT01462227|467233485|FG001|Second Assignment|Protocol Violation|1|||
129799352|NCT01462227|467233486|FG002|Second Assignment|Protocol Violation|1|||
129799353|NCT01462227|467233487|FG003|Second Assignment|Protocol Violation|0|||
129799354|NCT00586066|467233493|FG000|Overall Study|Lost to Follow-up|6|||
129799355|NCT00586066|467233494|FG001|Overall Study|Lost to Follow-up|3|||
129799356|NCT00586066|467233493|FG000|Overall Study|Lack of Efficacy|5|||
129799357|NCT00586066|467233494|FG001|Overall Study|Lack of Efficacy|3|||
129799358|NCT00586066|467233493|FG000|Overall Study|Adverse Event|2|||
129799359|NCT00586066|467233494|FG001|Overall Study|Adverse Event|2|||
129799360|NCT00586066|467233493|FG000|Overall Study|Physician Decision|1|||
129799361|NCT00586066|467233494|FG001|Overall Study|Physician Decision|0|||
129799362|NCT00586066|467233493|FG000|Overall Study|Withdrawal of consent|4|||
129799363|NCT00586066|467233494|FG001|Overall Study|Withdrawal of consent|2|||
129799364|NCT02750943|467233498|FG000|Overall Study|Lost to Follow-up|1|||
129799365|NCT02750943|467233499|FG001|Overall Study|Lost to Follow-up|2|||
129799366|NCT02750943|467233498|FG000|Overall Study|Withdrawal by Subject|5|||
129799367|NCT02750943|467233499|FG001|Overall Study|Withdrawal by Subject|7|||
129799368|NCT00171054|467233500|FG000|Overall Study|Protocol Violation|1|||
129799369|NCT00171054|467233501|FG001|Overall Study|Protocol Violation|2|||
129799370|NCT00171054|467233500|FG000|Overall Study|Patient withdrew consent|1|||
129799371|NCT00171054|467233501|FG001|Overall Study|Patient withdrew consent|0|||
129799372|NCT00171054|467233500|FG000|Overall Study|Lost to Follow-up|0|||
129799373|NCT00171054|467233501|FG001|Overall Study|Lost to Follow-up|1|||
129799374|NCT00171054|467233500|FG000|Overall Study|Adverse Event|8|||
129799375|NCT00171054|467233501|FG001|Overall Study|Adverse Event|8|||
129799376|NCT00171054|467233500|FG000|Overall Study|Condition no longer required study drug|0|||
129799377|NCT00171054|467233501|FG001|Overall Study|Condition no longer required study drug|1|||
129799378|NCT03635788|467233505|FG000|Step 1|Death|1|||
129799379|NCT03635788|467233506|FG001|Step 1|Death|0|||
129799380|NCT03635788|467233507|FG002|Step 1|Death|0|||
129799381|NCT03635788|467233505|FG000|Step 1|Lost to Follow-up|31|||
129799382|NCT03635788|467233506|FG001|Step 1|Lost to Follow-up|0|||
129799383|NCT03635788|467233507|FG002|Step 1|Lost to Follow-up|0|||
129799384|NCT03635788|467233505|FG000|Step 1|Pregnancy|1|||
129799385|NCT03635788|467233506|FG001|Step 1|Pregnancy|0|||
129799386|NCT03635788|467233507|FG002|Step 1|Pregnancy|0|||
129799387|NCT03635788|467233505|FG000|Step 1|Protocol Violation|8|||
129799388|NCT03635788|467233506|FG001|Step 1|Protocol Violation|0|||
129799389|NCT03635788|467233507|FG002|Step 1|Protocol Violation|0|||
129799390|NCT03635788|467233505|FG000|Step 1|Withdrawal by Subject|13|||
129799391|NCT03635788|467233506|FG001|Step 1|Withdrawal by Subject|0|||
129799392|NCT03635788|467233507|FG002|Step 1|Withdrawal by Subject|0|||
129799393|NCT03635788|467233505|FG000|Step 1|Other reasons|12|||
129799394|NCT03635788|467233506|FG001|Step 1|Other reasons|0|||
129799395|NCT03635788|467233507|FG002|Step 1|Other reasons|0|||
129799396|NCT03635788|467233505|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
129799397|NCT03635788|467233506|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
129799398|NCT03635788|467233507|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
129799399|NCT03635788|467233505|FG000|Step 2|Lost to Follow-up|0|||
129799400|NCT03635788|467233506|FG001|Step 2|Lost to Follow-up|8|||
129799401|NCT03635788|467233507|FG002|Step 2|Lost to Follow-up|15|||
129799402|NCT03635788|467233505|FG000|Step 2|Withdrawal by Subject|0|||
129799403|NCT03635788|467233506|FG001|Step 2|Withdrawal by Subject|6|||
129799404|NCT03635788|467233507|FG002|Step 2|Withdrawal by Subject|6|||
129799405|NCT03635788|467233505|FG000|Step 2|Death|0|||
129799406|NCT03635788|467233506|FG001|Step 2|Death|2|||
129799407|NCT03635788|467233507|FG002|Step 2|Death|0|||
129799408|NCT03635788|467233505|FG000|Step 2|Incarceration|0|||
129799409|NCT03635788|467233506|FG001|Step 2|Incarceration|2|||
129799410|NCT03635788|467233507|FG002|Step 2|Incarceration|0|||
129799411|NCT03635788|467233505|FG000|Step 2|Non-Compliance With Study Requirements|0|||
129799412|NCT03635788|467233506|FG001|Step 2|Non-Compliance With Study Requirements|1|||
129799413|NCT03635788|467233507|FG002|Step 2|Non-Compliance With Study Requirements|1|||
129799414|NCT03635788|467233505|FG000|Step 2|Confounding Medical Condition|0|||
129799415|NCT03635788|467233506|FG001|Step 2|Confounding Medical Condition|0|||
129799416|NCT03635788|467233507|FG002|Step 2|Confounding Medical Condition|1|||
129799417|NCT03635788|467233505|FG000|Step 2|Out Of State With No Plan To Return|0|||
129799418|NCT03635788|467233506|FG001|Step 2|Out Of State With No Plan To Return|1|||
129799419|NCT03635788|467233507|FG002|Step 2|Out Of State With No Plan To Return|0|||
129799420|NCT03635788|467233505|FG000|Step 2|Switched To Injectables|0|||
129799421|NCT03635788|467233506|FG001|Step 2|Switched To Injectables|0|||
129799422|NCT03635788|467233507|FG002|Step 2|Switched To Injectables|1|||
129799423|NCT03635788|467233505|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
129799424|NCT03635788|467233506|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
129799425|NCT03635788|467233507|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
129799426|NCT04669535|467233508|FG000|Overall Study|Death|1|||
129799427|NCT04669535|467233509|FG001|Overall Study|Death|1|||
129799428|NCT04669535|467233510|FG002|Overall Study|Death|0|||
129799429|NCT04669535|467233511|FG003|Overall Study|Death|0|||
129799430|NCT04382755|467233512|FG000|Overall Study|Withdrawal by Subject|1|||
129799431|NCT04382755|467233513|FG001|Overall Study|Withdrawal by Subject|0|||
129799432|NCT04382755|467233512|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
129799433|NCT04382755|467233513|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
129799434|NCT04382755|467233512|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
129799435|NCT04382755|467233513|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
129799436|NCT02452697|467233518|FG000|Overall Study|Physician Decision|4|||
130050387|NCT01120093|468140795|FG004|Treatment Period 3|Adverse Event|1|||
130050388|NCT01120093|468140791|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130050389|NCT01120093|468140792|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130050390|NCT01120093|468140793|FG002|Treatment Period 3|Withdrawal by Subject|1|||
130313618|NCT02159066|469113677|FG004|Part I|Missing Data|0|||
130313619|NCT02159066|469113678|FG005|Part I|Missing Data|0|||
130313620|NCT02159066|469113673|FG000|Part II|Adverse Event|0|||
130313621|NCT02159066|469113674|FG001|Part II|Adverse Event|0|||
130313622|NCT02159066|469113675|FG002|Part II|Adverse Event|1|||
130313623|NCT02159066|469113676|FG003|Part II|Adverse Event|0|||
130313624|NCT02159066|469113677|FG004|Part II|Adverse Event|1|||
130313625|NCT02159066|469113678|FG005|Part II|Adverse Event|1|||
130313626|NCT02159066|469113673|FG000|Part II|Death|0|||
130313627|NCT02159066|469113674|FG001|Part II|Death|0|||
130313628|NCT02159066|469113675|FG002|Part II|Death|1|||
130313629|NCT02159066|469113676|FG003|Part II|Death|0|||
130313630|NCT02159066|469113677|FG004|Part II|Death|2|||
130313631|NCT02159066|469113678|FG005|Part II|Death|1|||
130313632|NCT02159066|469113673|FG000|Part II|Progressive Disease|0|||
130313633|NCT02159066|469113674|FG001|Part II|Progressive Disease|0|||
130313634|NCT02159066|469113675|FG002|Part II|Progressive Disease|35|||
130313635|NCT02159066|469113676|FG003|Part II|Progressive Disease|1|||
130313636|NCT02159066|469113677|FG004|Part II|Progressive Disease|7|||
130313637|NCT02159066|469113678|FG005|Part II|Progressive Disease|4|||
130313638|NCT02159066|469113673|FG000|Part II|New Therapy for Study Indication|0|||
130313639|NCT02159066|469113674|FG001|Part II|New Therapy for Study Indication|0|||
129799437|NCT02452697|467233519|FG001|Overall Study|Physician Decision|4|||
130050391|NCT01120093|468140794|FG003|Treatment Period 3|Withdrawal by Subject|0|||
130313640|NCT02159066|469113675|FG002|Part II|New Therapy for Study Indication|0|||
130313641|NCT02159066|469113676|FG003|Part II|New Therapy for Study Indication|0|||
130313642|NCT02159066|469113677|FG004|Part II|New Therapy for Study Indication|1|||
130313643|NCT02159066|469113678|FG005|Part II|New Therapy for Study Indication|0|||
130313644|NCT02159066|469113673|FG000|Part II|Physician Decision|0|||
129799438|NCT02452697|467233520|FG002|Overall Study|Physician Decision|3|||
129799439|NCT02452697|467233521|FG003|Overall Study|Physician Decision|2|||
129799440|NCT02452697|467233518|FG000|Overall Study|Withdrawal by Subject|1|||
129799441|NCT02452697|467233519|FG001|Overall Study|Withdrawal by Subject|0|||
129799442|NCT02452697|467233520|FG002|Overall Study|Withdrawal by Subject|0|||
129799443|NCT02452697|467233521|FG003|Overall Study|Withdrawal by Subject|0|||
129799444|NCT02452697|467233518|FG000|Overall Study|still in follow-up|2|||
129799445|NCT02452697|467233519|FG001|Overall Study|still in follow-up|2|||
129799446|NCT02452697|467233520|FG002|Overall Study|still in follow-up|1|||
129799447|NCT02452697|467233521|FG003|Overall Study|still in follow-up|3|||
129799448|NCT03552965|467233522|FG000|Overall Study|Death|1|||
129799449|NCT03552965|467233523|FG001|Overall Study|Death|1|||
129799450|NCT03552965|467233522|FG000|Overall Study|Lost to Follow-up|1|||
129799451|NCT03552965|467233523|FG001|Overall Study|Lost to Follow-up|1|||
129799452|NCT03552965|467233522|FG000|Overall Study|Physician Decision|1|||
129799453|NCT03552965|467233523|FG001|Overall Study|Physician Decision|1|||
129799454|NCT03552965|467233522|FG000|Overall Study|Withdrawal by Subject|0|||
129799455|NCT03552965|467233523|FG001|Overall Study|Withdrawal by Subject|2|||
129799456|NCT03552965|467233522|FG000|Overall Study|Continuation not in patient best interest|1|||
129799457|NCT03552965|467233523|FG001|Overall Study|Continuation not in patient best interest|0|||
130050392|NCT01120093|468140795|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130050393|NCT01120093|468140791|FG000|Treatment Period 4|Adverse Event|1|||
130050394|NCT01120093|468140792|FG001|Treatment Period 4|Adverse Event|0|||
130050395|NCT01120093|468140793|FG002|Treatment Period 4|Adverse Event|0|||
130050396|NCT01120093|468140794|FG003|Treatment Period 4|Adverse Event|0|||
130050397|NCT01120093|468140795|FG004|Treatment Period 4|Adverse Event|0|||
130050398|NCT01120093|468140791|FG000|Treatment Period 5|Adverse Event|0|||
130050399|NCT01120093|468140792|FG001|Treatment Period 5|Adverse Event|1|||
130050400|NCT01120093|468140793|FG002|Treatment Period 5|Adverse Event|0|||
130050401|NCT01120093|468140794|FG003|Treatment Period 5|Adverse Event|1|||
130050402|NCT01120093|468140795|FG004|Treatment Period 5|Adverse Event|0|||
130050403|NCT01849250|468140796|FG000|Overall Study|Withdrawal by Subject|1|||
130050404|NCT01849250|468140797|FG001|Overall Study|Withdrawal by Subject|0|||
130050405|NCT01849250|468140796|FG000|Overall Study|Not Evaluable|5|||
130050406|NCT01849250|468140797|FG001|Overall Study|Not Evaluable|3|||
130050407|NCT01849250|468140796|FG000|Overall Study|Screen Failure|1|||
130050408|NCT01849250|468140797|FG001|Overall Study|Screen Failure|0|||
130050409|NCT00257192|468140802|FG000|Overall Study|Adverse Event|21|||
130050410|NCT00257192|468140803|FG001|Overall Study|Adverse Event|10|||
130050411|NCT00257192|468140802|FG000|Overall Study|Laboratory abnormality|1|||
130050412|NCT00257192|468140803|FG001|Overall Study|Laboratory abnormality|1|||
130050413|NCT00257192|468140802|FG000|Overall Study|Lost to Follow-up|3|||
130050414|NCT00257192|468140803|FG001|Overall Study|Lost to Follow-up|3|||
130050415|NCT00257192|468140802|FG000|Overall Study|Insufficient clinical response|18|||
130050416|NCT00257192|468140803|FG001|Overall Study|Insufficient clinical response|18|||
130050417|NCT00257192|468140802|FG000|Overall Study|Withdrawal by Subject|14|||
130050418|NCT00257192|468140803|FG001|Overall Study|Withdrawal by Subject|2|||
130050419|NCT00257192|468140802|FG000|Overall Study|Randomized but not treated|0|||
130050420|NCT00257192|468140803|FG001|Overall Study|Randomized but not treated|1|||
130050421|NCT00257192|468140802|FG000|Overall Study|Study terminated by sponsor|1|||
130050422|NCT00257192|468140803|FG001|Overall Study|Study terminated by sponsor|0|||
130050423|NCT00257192|468140802|FG000|Overall Study|Miscellaneous|0|||
130050424|NCT00257192|468140803|FG001|Overall Study|Miscellaneous|4|||
130050425|NCT00570739|468140804|FG000|Overall Study|Adverse Event|8|||
130050426|NCT00570739|468140805|FG001|Overall Study|Adverse Event|6|||
130050427|NCT00570739|468140806|FG002|Overall Study|Adverse Event|2|||
130050428|NCT00570739|468140807|FG003|Overall Study|Adverse Event|2|||
130050429|NCT00570739|468140804|FG000|Overall Study|Lost to Follow-up|4|||
130050430|NCT00570739|468140805|FG001|Overall Study|Lost to Follow-up|5|||
130050431|NCT00570739|468140806|FG002|Overall Study|Lost to Follow-up|4|||
130050432|NCT00570739|468140807|FG003|Overall Study|Lost to Follow-up|1|||
130050433|NCT00570739|468140804|FG000|Overall Study|Physician Decision|1|||
130050434|NCT00570739|468140805|FG001|Overall Study|Physician Decision|1|||
130050435|NCT00570739|468140806|FG002|Overall Study|Physician Decision|0|||
130050436|NCT00570739|468140807|FG003|Overall Study|Physician Decision|0|||
130050437|NCT00570739|468140804|FG000|Overall Study|Withdrawal by Subject|7|||
130050438|NCT00570739|468140805|FG001|Overall Study|Withdrawal by Subject|7|||
130050439|NCT00570739|468140806|FG002|Overall Study|Withdrawal by Subject|3|||
129799458|NCT03552965|467233522|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
129799459|NCT03552965|467233523|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
129799460|NCT03120624|467233524|FG000|Overall Study|Withdrawal by Subject|0|||
129799461|NCT03120624|467233525|FG001|Overall Study|Withdrawal by Subject|1|||
130050440|NCT00570739|468140807|FG003|Overall Study|Withdrawal by Subject|5|||
130050441|NCT00570739|468140804|FG000|Overall Study|Required restricted medication|0|||
130050442|NCT00570739|468140805|FG001|Overall Study|Required restricted medication|0|||
129799462|NCT03120624|467233526|FG002|Overall Study|Withdrawal by Subject|0|||
130050443|NCT00570739|468140806|FG002|Overall Study|Required restricted medication|1|||
130050444|NCT00570739|468140807|FG003|Overall Study|Required restricted medication|0|||
129799463|NCT03120624|467233527|FG003|Overall Study|Withdrawal by Subject|0|||
129799464|NCT03120624|467233528|FG004|Overall Study|Withdrawal by Subject|0|||
129799465|NCT03120624|467233529|FG005|Overall Study|Withdrawal by Subject|0|||
129799466|NCT03120624|467233530|FG006|Overall Study|Withdrawal by Subject|0|||
129799467|NCT03120624|467233531|FG007|Overall Study|Withdrawal by Subject|0|||
129799468|NCT02477696|467233532|FG000|Overall Study|Death|89|||
130313645|NCT02159066|469113674|FG001|Part II|Physician Decision|0|||
130313646|NCT02159066|469113675|FG002|Part II|Physician Decision|1|||
130313647|NCT02159066|469113676|FG003|Part II|Physician Decision|0|||
130313648|NCT02159066|469113677|FG004|Part II|Physician Decision|0|||
130313649|NCT02159066|469113678|FG005|Part II|Physician Decision|0|||
130313650|NCT02159066|469113673|FG000|Part II|Participant/Guardian Decision|0|||
130313651|NCT02159066|469113674|FG001|Part II|Participant/Guardian Decision|0|||
130313652|NCT02159066|469113675|FG002|Part II|Participant/Guardian Decision|0|||
130313653|NCT02159066|469113676|FG003|Part II|Participant/Guardian Decision|0|||
130313654|NCT02159066|469113677|FG004|Part II|Participant/Guardian Decision|2|||
130313655|NCT02159066|469113678|FG005|Part II|Participant/Guardian Decision|0|||
130313656|NCT00296816|469113694|FG000|Overall Study|Disease Progression|37|||
130313657|NCT00296816|469113694|FG000|Overall Study|Adverse Event|18|||
130313658|NCT00296816|469113694|FG000|Overall Study|Investigator/Participant request|5|||
130313659|NCT00296816|469113694|FG000|Overall Study|Non-compliance|1|||
130313660|NCT00296816|469113694|FG000|Overall Study|Missing for end of treatment|4|||
130313661|NCT00296816|469113694|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
129799469|NCT02477696|467233533|FG001|Overall Study|Death|106|||
129799470|NCT02477696|467233532|FG000|Overall Study|Lost to Follow-up|7|||
129799471|NCT02477696|467233533|FG001|Overall Study|Lost to Follow-up|5|||
129799472|NCT02477696|467233532|FG000|Overall Study|Withdrawal by Subject|37|||
129799473|NCT02477696|467233533|FG001|Overall Study|Withdrawal by Subject|34|||
129799474|NCT02477696|467233532|FG000|Overall Study|Physician Decision|7|||
129799475|NCT02477696|467233533|FG001|Overall Study|Physician Decision|9|||
129799476|NCT02477696|467233532|FG000|Overall Study|Study terminated by sponsor|103|||
129799477|NCT02477696|467233533|FG001|Overall Study|Study terminated by sponsor|99|||
129799478|NCT02477696|467233532|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
129799479|NCT02477696|467233533|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
129799480|NCT02477696|467233532|FG000|Overall Study|Missing/Unknown|2|||
129799481|NCT02477696|467233533|FG001|Overall Study|Missing/Unknown|0|||
129799482|NCT05419908|467233535|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
129799483|NCT05419908|467233536|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
129799484|NCT05419908|467233535|FG000|Overall Study|Serious Adverse Event|0|||
129799485|NCT05419908|467233536|FG001|Overall Study|Serious Adverse Event|2|||
129799486|NCT05419908|467233535|FG000|Overall Study|Withdrawal by Subject|2|||
129799487|NCT05419908|467233536|FG001|Overall Study|Withdrawal by Subject|0|||
129799488|NCT05419908|467233535|FG000|Overall Study|Miscellaneous|1|||
129799489|NCT05419908|467233536|FG001|Overall Study|Miscellaneous|1|||
129799490|NCT02160782|467235130|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
129799491|NCT02160782|467235131|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
129799492|NCT02160782|467235132|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
129799493|NCT02160782|467235133|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
129799494|NCT02160782|467235134|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
129799495|NCT02160782|467235130|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129799496|NCT02160782|467235131|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129799497|NCT02160782|467235132|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129890356|NCT02411591|467556099|FG000|Overall Study|Physician Decision|0|||
129890357|NCT02411591|467556100|FG001|Overall Study|Physician Decision|3|||
129890358|NCT02411591|467556101|FG002|Overall Study|Physician Decision|1|||
129890359|NCT02491892|467556102|FG000|Overall Study|Adverse Event|1|||
129890360|NCT02491892|467556103|FG001|Overall Study|Adverse Event|1|||
129890361|NCT02491892|467556102|FG000|Overall Study|Death|1|||
129890362|NCT02491892|467556103|FG001|Overall Study|Death|1|||
129890363|NCT02491892|467556102|FG000|Overall Study|Lack of Efficacy|37|||
130313662|NCT00296816|469113694|FG000|Overall Study|Poor performance status|1|||
130313663|NCT00296816|469113694|FG000|Overall Study|Relocation to Florida|1|||
130313664|NCT00296816|469113694|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
129799498|NCT02160782|467235133|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
129799499|NCT02160782|467235134|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129799500|NCT02160782|467235130|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129799501|NCT02160782|467235131|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129890364|NCT02491892|467556103|FG001|Overall Study|Lack of Efficacy|36|||
129890365|NCT02491892|467556102|FG000|Overall Study|Refused Treatment|1|||
129890366|NCT02491892|467556103|FG001|Overall Study|Refused Treatment|0|||
130313665|NCT00296816|469113694|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
130313666|NCT00296816|469113694|FG000|Overall Study|Neuropathy/patient preference|1|||
130313667|NCT00296816|469113694|FG000|Overall Study|Proteinuria|1|||
129799502|NCT02160782|467235132|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129799503|NCT02160782|467235133|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
130313668|NCT00296816|469113694|FG000|Overall Study|ineligibility due to radiation treatment|1|||
130313669|NCT01721161|469113695|FG000|Overall Study|Adverse Event|2|||
130313670|NCT01721161|469113696|FG001|Overall Study|Adverse Event|3|||
130313671|NCT01721161|469113695|FG000|Overall Study|Lost to Follow-up|1|||
129799504|NCT02160782|467235134|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129799505|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799506|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799507|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799508|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799509|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
129799510|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799511|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799512|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799513|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799514|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
129799515|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799516|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799517|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799518|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799519|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
129799520|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799521|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799522|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799523|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799524|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
129799525|NCT01104701|467235137|FG000|Overall Study|Withdrawal by Subject|0|||
129799526|NCT01104701|467235138|FG001|Overall Study|Withdrawal by Subject|1|||
130313672|NCT01721161|469113696|FG001|Overall Study|Lost to Follow-up|2|||
130313673|NCT01721161|469113695|FG000|Overall Study|Withdrawal by Subject|1|||
130313674|NCT01721161|469113696|FG001|Overall Study|Withdrawal by Subject|1|||
130313675|NCT01721161|469113695|FG000|Overall Study|Other|0|||
130313676|NCT01721161|469113696|FG001|Overall Study|Other|1|||
130313677|NCT03259555|469113714|FG000|Overall Study|Adverse Event|6|||
130313678|NCT03259555|469113715|FG001|Overall Study|Adverse Event|4|||
130313679|NCT03259555|469113714|FG000|Overall Study|Lack of Efficacy|6|||
130313680|NCT03259555|469113715|FG001|Overall Study|Lack of Efficacy|4|||
130313681|NCT03259555|469113714|FG000|Overall Study|Lost to Follow-up|0|||
130313682|NCT03259555|469113715|FG001|Overall Study|Lost to Follow-up|2|||
130313683|NCT03259555|469113714|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130313684|NCT03259555|469113715|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130313685|NCT03259555|469113714|FG000|Overall Study|Progressive Disease|0|||
130313686|NCT03259555|469113715|FG001|Overall Study|Progressive Disease|2|||
130313687|NCT03259555|469113714|FG000|Overall Study|Withdrawal by Subject|19|||
130313688|NCT03259555|469113715|FG001|Overall Study|Withdrawal by Subject|16|||
130313689|NCT03259555|469113714|FG000|Overall Study|Physician Decision|1|||
130313690|NCT03259555|469113715|FG001|Overall Study|Physician Decision|2|||
130313691|NCT03259555|469113714|FG000|Overall Study|Other|1|||
130313692|NCT03259555|469113715|FG001|Overall Study|Other|0|||
130313693|NCT01125800|469113717|FG000|Phase I|Protocol Violation|0|||
130313694|NCT01125800|469113718|FG001|Phase I|Protocol Violation|3|||
130313695|NCT01125800|469113719|FG002|Phase I|Protocol Violation|1|||
130313696|NCT01125800|469113720|FG003|Phase I|Protocol Violation|1|||
130313697|NCT01125800|469113721|FG004|Phase I|Protocol Violation|0|||
129799527|NCT01104701|467235139|FG002|Overall Study|Withdrawal by Subject|2|||
130110624|NCT03550794|468365802|FG000|Overall Study|Withdrawal by Subject|2|||
130313698|NCT01125800|469113717|FG000|Phase I|Adverse Event|2|||
130313699|NCT01125800|469113718|FG001|Phase I|Adverse Event|2|||
130313700|NCT01125800|469113719|FG002|Phase I|Adverse Event|1|||
130313701|NCT01125800|469113720|FG003|Phase I|Adverse Event|7|||
130313702|NCT01125800|469113721|FG004|Phase I|Adverse Event|0|||
130313703|NCT01125800|469113717|FG000|Phase I|Administrative problems|1|||
130313704|NCT01125800|469113718|FG001|Phase I|Administrative problems|0|||
130313705|NCT01125800|469113719|FG002|Phase I|Administrative problems|0|||
130313706|NCT01125800|469113720|FG003|Phase I|Administrative problems|0|||
130313707|NCT01125800|469113721|FG004|Phase I|Administrative problems|0|||
130313708|NCT01125800|469113717|FG000|Phase I|Withdrawal by Subject|0|||
130313709|NCT01125800|469113718|FG001|Phase I|Withdrawal by Subject|0|||
130313710|NCT01125800|469113719|FG002|Phase I|Withdrawal by Subject|1|||
130313711|NCT01125800|469113720|FG003|Phase I|Withdrawal by Subject|0|||
130313712|NCT01125800|469113721|FG004|Phase I|Withdrawal by Subject|0|||
130313713|NCT01125800|469113717|FG000|Phase I|Disease progression|5|||
130313714|NCT01125800|469113718|FG001|Phase I|Disease progression|4|||
130313715|NCT01125800|469113719|FG002|Phase I|Disease progression|1|||
130313716|NCT01125800|469113720|FG003|Phase I|Disease progression|3|||
130313717|NCT01125800|469113721|FG004|Phase I|Disease progression|0|||
130313718|NCT01125800|469113717|FG000|Phase II|Protocol Violation|0|||
130313719|NCT01125800|469113718|FG001|Phase II|Protocol Violation|0|||
130313720|NCT01125800|469113719|FG002|Phase II|Protocol Violation|0|||
130313721|NCT01125800|469113720|FG003|Phase II|Protocol Violation|0|||
130313722|NCT01125800|469113721|FG004|Phase II|Protocol Violation|1|||
130313723|NCT01125800|469113717|FG000|Phase II|Adverse Event|0|||
130313724|NCT01125800|469113718|FG001|Phase II|Adverse Event|0|||
130313725|NCT01125800|469113719|FG002|Phase II|Adverse Event|0|||
130313726|NCT01125800|469113720|FG003|Phase II|Adverse Event|0|||
130313727|NCT01125800|469113721|FG004|Phase II|Adverse Event|2|||
130313728|NCT01125800|469113717|FG000|Phase II|Disease progression|0|||
130313729|NCT01125800|469113718|FG001|Phase II|Disease progression|0|||
130313730|NCT01125800|469113719|FG002|Phase II|Disease progression|0|||
130313731|NCT01125800|469113720|FG003|Phase II|Disease progression|1|||
130313732|NCT01125800|469113721|FG004|Phase II|Disease progression|8|||
130313733|NCT03370718|469113726|FG000|Overall Study|Withdrawal by Subject|1|||
130313734|NCT04970654|469113729|FG000|Overall Study|Withdrawal by parents/guardian|1|||
130313735|NCT04970654|469113730|FG001|Overall Study|Withdrawal by parents/guardian|2|||
130313736|NCT04970654|469113729|FG000|Overall Study|Unclassified|2|||
130313737|NCT04970654|469113730|FG001|Overall Study|Unclassified|1|||
130313738|NCT04970654|469113729|FG000|Overall Study|Lost to Follow-up|1|||
130313739|NCT04970654|469113730|FG001|Overall Study|Lost to Follow-up|0|||
130313740|NCT06172348|469113733|FG000|Treatment Period 2|Adverse Event|0|||
130313741|NCT06172348|469113734|FG001|Treatment Period 2|Adverse Event|0|||
130313742|NCT06172348|469113735|FG002|Treatment Period 2|Adverse Event|1|||
130313743|NCT06172348|469113736|FG003|Treatment Period 2|Adverse Event|0|||
130313744|NCT06172348|469113737|FG004|Treatment Period 2|Adverse Event|0|||
130313745|NCT06172348|469113738|FG005|Treatment Period 2|Adverse Event|0|||
130313746|NCT01232868|469115935|FG000|Overall Study|Lost to Follow-up|2|||
130313747|NCT01232868|469115936|FG001|Overall Study|Lost to Follow-up|4|||
130313748|NCT04481243|469115937|FG000|Overall Study|Withdrawal by Subject|4|||
130313749|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313750|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
130313751|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313752|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313753|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
130313754|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
130313755|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
130313756|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130313757|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130313758|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
130313759|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
130313760|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
130313761|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130313762|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130313763|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
130313764|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
130313765|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
130313766|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130313767|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130313768|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
130313769|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
130313770|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
130313771|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130313772|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130313773|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
130313774|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
130313775|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
130313776|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130313777|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130313778|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
130313779|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
130313780|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
130313781|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130313782|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130313783|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
130313784|NCT02831764|469115938|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313785|NCT02831764|469115939|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
130313786|NCT02831764|469115940|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313787|NCT02831764|469115941|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313788|NCT02831764|469115942|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
130313789|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130313790|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130313791|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
130313792|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
130313793|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
130313794|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313795|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313796|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
130313797|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313798|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
130313799|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130313800|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130313801|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
130313802|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
130313803|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
130313804|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313805|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313806|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
130313807|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313808|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
130313809|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130313810|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130313811|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
130313812|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
130313813|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
130313814|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130313815|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130313816|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
130313817|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
129799528|NCT01104701|467235140|FG003|Overall Study|Withdrawal by Subject|1|||
129799529|NCT01104701|467235137|FG000|Overall Study|Adverse Event|0|||
129799530|NCT01104701|467235138|FG001|Overall Study|Adverse Event|0|||
130313818|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
130313819|NCT02831764|469115938|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130313820|NCT02831764|469115939|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130313821|NCT02831764|469115940|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
130313822|NCT02831764|469115941|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
130313823|NCT02831764|469115942|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
130313824|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130313825|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129799531|NCT01104701|467235139|FG002|Overall Study|Adverse Event|0|||
129799532|NCT01104701|467235140|FG003|Overall Study|Adverse Event|1|||
129799533|NCT01104701|467235137|FG000|Overall Study|Physician Decision|0|||
129799534|NCT01104701|467235138|FG001|Overall Study|Physician Decision|2|||
129799535|NCT01104701|467235139|FG002|Overall Study|Physician Decision|0|||
129799536|NCT01104701|467235140|FG003|Overall Study|Physician Decision|0|||
129799537|NCT03437512|467235141|FG000|Randomized|Withdrawal by Subject|0|||
129799538|NCT03437512|467235142|FG001|Randomized|Withdrawal by Subject|2|||
129799539|NCT03437512|467235141|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
129799540|NCT03437512|467235142|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
129799541|NCT00674973|467235143|FG000|Overall Study|Insufficient Therapeutic Response|77|||
129799542|NCT00674973|467235144|FG001|Overall Study|Insufficient Therapeutic Response|72|||
129799543|NCT00674973|467235143|FG000|Overall Study|Refused Treatment|1|||
129799544|NCT00674973|467235144|FG001|Overall Study|Refused Treatment|5|||
129799545|NCT00674973|467235143|FG000|Overall Study|Failure to Return|1|||
130313826|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130313827|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
130313828|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
130313829|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313830|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313831|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313832|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
130313833|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
130313834|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313835|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313836|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313837|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
130313838|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
130313839|NCT02831764|469115938|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313840|NCT02831764|469115939|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313841|NCT02831764|469115940|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313842|NCT02831764|469115941|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
130313843|NCT02831764|469115942|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
130313844|NCT02544321|469115947|FG000|Overall Study|Withdrawal by Subject|1|||
130313845|NCT02544321|469115948|FG001|Overall Study|Withdrawal by Subject|2|||
130313846|NCT02544321|469115947|FG000|Overall Study|Adverse Event|1|||
130313847|NCT02544321|469115948|FG001|Overall Study|Adverse Event|1|||
130313848|NCT02544321|469115947|FG000|Overall Study|Protocol Violation|0|||
130313849|NCT02544321|469115948|FG001|Overall Study|Protocol Violation|1|||
130313850|NCT01517750|469115949|FG000|Overall Study|Lost to Follow-up|1|||
129890367|NCT02491892|467556102|FG000|Overall Study|Lost to Follow-up|1|||
129890368|NCT02491892|467556103|FG001|Overall Study|Lost to Follow-up|0|||
129890369|NCT04227340|467556104|FG000|Overall Study|Withdrawal by Subject|3|||
129890370|NCT00683449|467556105|FG000|Overall Study|Lost to Follow-up|0|||
129890371|NCT00683449|467556106|FG001|Overall Study|Lost to Follow-up|1|||
129890372|NCT00683449|467556107|FG002|Overall Study|Lost to Follow-up|0|||
129890373|NCT00683449|467556108|FG003|Overall Study|Lost to Follow-up|0|||
129890374|NCT00683449|467556109|FG004|Overall Study|Lost to Follow-up|0|||
129890375|NCT00577720|467556113|FG000|Overall Study|Adverse Event|2|||
129890376|NCT00577720|467556114|FG001|Overall Study|Adverse Event|1|||
129890377|NCT00577720|467556115|FG002|Overall Study|Adverse Event|0|||
129890378|NCT00577720|467556116|FG003|Overall Study|Adverse Event|4|||
129890379|NCT00577720|467556113|FG000|Overall Study|Lost to Follow-up|0|||
130313851|NCT01517750|469115950|FG001|Overall Study|Lost to Follow-up|2|||
130313852|NCT01517750|469115951|FG002|Overall Study|Lost to Follow-up|4|||
129799546|NCT00674973|467235144|FG001|Overall Study|Failure to Return|0|||
129799547|NCT00674973|467235143|FG000|Overall Study|Adverse Event|2|||
129799548|NCT00674973|467235144|FG001|Overall Study|Adverse Event|9|||
129799549|NCT00674973|467235143|FG000|Overall Study|Death|19|||
129799550|NCT00674973|467235144|FG001|Overall Study|Death|15|||
129799551|NCT00674973|467235143|FG000|Overall Study|Protocol Violation|0|||
129890380|NCT00577720|467556114|FG001|Overall Study|Lost to Follow-up|0|||
129890381|NCT00577720|467556115|FG002|Overall Study|Lost to Follow-up|1|||
130313853|NCT01517750|469115952|FG003|Overall Study|Lost to Follow-up|1|||
130313854|NCT01584232|469115953|FG000|Overall Study|Adverse Event|3|||
130313855|NCT01584232|469115954|FG001|Overall Study|Adverse Event|1|||
130313856|NCT01584232|469115953|FG000|Overall Study|Withdrawal by Subject|2|||
130313857|NCT01584232|469115954|FG001|Overall Study|Withdrawal by Subject|1|||
130313858|NCT01584232|469115953|FG000|Overall Study|Physician Decision|2|||
130313859|NCT01584232|469115954|FG001|Overall Study|Physician Decision|1|||
130313860|NCT01584232|469115953|FG000|Overall Study|Lost to Follow-up|1|||
130313861|NCT01584232|469115954|FG001|Overall Study|Lost to Follow-up|0|||
130313862|NCT01307319|469115955|FG000|Overall Study|Adverse Event|2|||
130313863|NCT01307319|469115956|FG001|Overall Study|Adverse Event|2|||
130313864|NCT01307319|469115957|FG002|Overall Study|Adverse Event|1|||
130313865|NCT01307319|469115955|FG000|Overall Study|Lost to Follow-up|1|||
129890382|NCT00577720|467556116|FG003|Overall Study|Lost to Follow-up|0|||
129890383|NCT00577720|467556113|FG000|Overall Study|Protocol Violation|0|||
129890384|NCT00577720|467556114|FG001|Overall Study|Protocol Violation|0|||
129890385|NCT00577720|467556115|FG002|Overall Study|Protocol Violation|0|||
129890386|NCT00577720|467556116|FG003|Overall Study|Protocol Violation|1|||
129890387|NCT00577720|467556113|FG000|Overall Study|Withdrawal by Subject|2|||
129890388|NCT00577720|467556114|FG001|Overall Study|Withdrawal by Subject|0|||
129890389|NCT00577720|467556115|FG002|Overall Study|Withdrawal by Subject|0|||
129890390|NCT00577720|467556116|FG003|Overall Study|Withdrawal by Subject|2|||
129890391|NCT03100838|467556117|FG000|Overall Study|Adverse Event|1|||
130313866|NCT01307319|469115956|FG001|Overall Study|Lost to Follow-up|0|||
130313867|NCT01307319|469115957|FG002|Overall Study|Lost to Follow-up|1|||
130313868|NCT01307319|469115955|FG000|Overall Study|Protocol Violation|1|||
130313869|NCT01307319|469115956|FG001|Overall Study|Protocol Violation|1|||
130313870|NCT01307319|469115957|FG002|Overall Study|Protocol Violation|0|||
130313871|NCT01307319|469115955|FG000|Overall Study|Withdrawal by Subject|0|||
130313872|NCT01307319|469115956|FG001|Overall Study|Withdrawal by Subject|1|||
130313873|NCT01307319|469115957|FG002|Overall Study|Withdrawal by Subject|2|||
130313874|NCT01307319|469115955|FG000|Overall Study|Other|0|||
130313875|NCT01307319|469115956|FG001|Overall Study|Other|4|||
130313876|NCT01307319|469115957|FG002|Overall Study|Other|3|||
130313877|NCT03629886|469115959|FG000|Overall Study|Migrated / moved from the study area|0|||
130313878|NCT03629886|469115960|FG001|Overall Study|Migrated / moved from the study area|55|||
130313879|NCT03629886|469115959|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
130313880|NCT03629886|469115960|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
130313881|NCT03629886|469115959|FG000|Overall Study|Study vaccine not administrated|0|||
130313882|NCT03629886|469115960|FG001|Overall Study|Study vaccine not administrated|3|||
130313883|NCT03629886|469115959|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
130313884|NCT03629886|469115960|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
130313885|NCT03629886|469115959|FG000|Overall Study|Refused vaccination step of the study|0|||
130313886|NCT03629886|469115960|FG001|Overall Study|Refused vaccination step of the study|44|||
129890392|NCT03100838|467556118|FG001|Overall Study|Adverse Event|0|||
129890393|NCT03100838|467556119|FG002|Overall Study|Adverse Event|0|||
129890394|NCT03100838|467556120|FG003|Overall Study|Adverse Event|0|||
129890395|NCT03100838|467556117|FG000|Overall Study|Physician Decision|1|||
130110625|NCT03550794|468365803|FG001|Overall Study|Withdrawal by Subject|0|||
129890396|NCT03100838|467556118|FG001|Overall Study|Physician Decision|1|||
129890397|NCT03100838|467556119|FG002|Overall Study|Physician Decision|1|||
129890398|NCT03100838|467556120|FG003|Overall Study|Physician Decision|1|||
130313887|NCT02730728|469115961|FG000|Overall Study|Withdrawal by Subject|0|||
130313888|NCT02730728|469115962|FG001|Overall Study|Withdrawal by Subject|1|||
130313889|NCT02730728|469115963|FG002|Overall Study|Withdrawal by Subject|0|||
130313890|NCT02730728|469115961|FG000|Overall Study|Lack of Efficacy|0|||
130313891|NCT02730728|469115962|FG001|Overall Study|Lack of Efficacy|1|||
130313892|NCT02730728|469115963|FG002|Overall Study|Lack of Efficacy|1|||
130313893|NCT01855412|469115964|FG000|Overall Study|Death|77|||
130313894|NCT01855412|469115965|FG001|Overall Study|Death|123|||
130313895|NCT01855412|469115966|FG002|Overall Study|Death|30|||
130313896|NCT01855412|469115964|FG000|Overall Study|Lost to Follow-up|28|||
130313897|NCT01855412|469115965|FG001|Overall Study|Lost to Follow-up|46|||
130313898|NCT01855412|469115966|FG002|Overall Study|Lost to Follow-up|15|||
130313899|NCT01855412|469115964|FG000|Overall Study|Withdrawal by Subject|77|||
130313900|NCT01855412|469115965|FG001|Overall Study|Withdrawal by Subject|123|||
130313901|NCT01855412|469115966|FG002|Overall Study|Withdrawal by Subject|24|||
130313902|NCT01855412|469115964|FG000|Overall Study|Physician Decision|25|||
130313903|NCT01855412|469115965|FG001|Overall Study|Physician Decision|31|||
130313904|NCT01855412|469115966|FG002|Overall Study|Physician Decision|3|||
130313905|NCT01855412|469115964|FG000|Overall Study|Site Closure|4|||
130313906|NCT01855412|469115965|FG001|Overall Study|Site Closure|18|||
130313907|NCT01855412|469115966|FG002|Overall Study|Site Closure|1|||
130313908|NCT01855412|469115964|FG000|Overall Study|Reason not Specified|1|||
130313909|NCT01855412|469115965|FG001|Overall Study|Reason not Specified|2|||
130313910|NCT01855412|469115966|FG002|Overall Study|Reason not Specified|3|||
130313911|NCT01702844|469115967|FG000|Overall Study|Adverse Event|9|||
130313912|NCT01702844|469115967|FG000|Overall Study|Death|1|||
130313913|NCT01702844|469115967|FG000|Overall Study|Withdrawal by Subject|3|||
130313914|NCT01702844|469115967|FG000|Overall Study|Physician Decision|6|||
130313915|NCT03431441|469115968|FG000|Overall Study|Withdrawal by Subject|2|||
130313916|NCT03431441|469115968|FG000|Overall Study|Adverse Event|2|||
130313917|NCT03431441|469115968|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
130313918|NCT00346216|469115969|FG000|Overall Study|Other|181|||
130313919|NCT00346216|469115970|FG001|Overall Study|Other|231|||
130313920|NCT00346216|469115971|FG002|Overall Study|Other|205|||
130313921|NCT00346216|469115969|FG000|Overall Study|No longer willing to participate|600|||
130313922|NCT00346216|469115970|FG001|Overall Study|No longer willing to participate|606|||
130313923|NCT00346216|469115971|FG002|Overall Study|No longer willing to participate|585|||
130313924|NCT00346216|469115969|FG000|Overall Study|Withdrawal by Subject|661|||
130313925|NCT00346216|469115970|FG001|Overall Study|Withdrawal by Subject|692|||
130313926|NCT00346216|469115971|FG002|Overall Study|Withdrawal by Subject|651|||
130313927|NCT00346216|469115969|FG000|Overall Study|Lost to Follow-up|611|||
130313928|NCT00346216|469115970|FG001|Overall Study|Lost to Follow-up|588|||
130313929|NCT00346216|469115971|FG002|Overall Study|Lost to Follow-up|542|||
130313930|NCT00346216|469115969|FG000|Overall Study|Physician Decision|80|||
130313931|NCT00346216|469115970|FG001|Overall Study|Physician Decision|76|||
130313932|NCT00346216|469115971|FG002|Overall Study|Physician Decision|59|||
130313933|NCT00346216|469115969|FG000|Overall Study|Does not meet entrance criteria|13|||
130313934|NCT00346216|469115970|FG001|Overall Study|Does not meet entrance criteria|10|||
130313935|NCT00346216|469115971|FG002|Overall Study|Does not meet entrance criteria|8|||
130313936|NCT00346216|469115969|FG000|Overall Study|Death|189|||
130313937|NCT00346216|469115970|FG001|Overall Study|Death|192|||
130313938|NCT00346216|469115971|FG002|Overall Study|Death|228|||
130313939|NCT00346216|469115969|FG000|Overall Study|Study terminated by sponsor|11|||
130313940|NCT00346216|469115970|FG001|Overall Study|Study terminated by sponsor|4|||
130313941|NCT00346216|469115971|FG002|Overall Study|Study terminated by sponsor|8|||
130313942|NCT00346216|469115969|FG000|Overall Study|Missing Subject Summary Status|62|||
130313943|NCT00346216|469115970|FG001|Overall Study|Missing Subject Summary Status|61|||
130313944|NCT00346216|469115971|FG002|Overall Study|Missing Subject Summary Status|62|||
130313945|NCT02043938|469115977|FG000|Overall Study|Withdrawal by Subject|7|||
130313946|NCT02043938|469115977|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
130313947|NCT02043938|469115977|FG000|Overall Study|No show by subject|1|||
130313948|NCT02043938|469115977|FG000|Overall Study|Investigator decision|1|||
130313949|NCT03985761|469115984|FG000|Overall Study|Withdrawal by Subject|2|||
130313950|NCT03985761|469115985|FG001|Overall Study|Withdrawal by Subject|3|||
130313951|NCT03400852|469115986|FG000|Blinded Treatment Period|Physician Decision|0|||
130110626|NCT03550794|468365802|FG000|Overall Study|Death|0|||
130313952|NCT03400852|469115987|FG001|Blinded Treatment Period|Physician Decision|1|||
130313953|NCT03400852|469115988|FG002|Blinded Treatment Period|Physician Decision|0|||
130313954|NCT03400852|469115986|FG000|Blinded Treatment Period|Adverse Event|1|||
130313955|NCT03400852|469115987|FG001|Blinded Treatment Period|Adverse Event|1|||
130313956|NCT03400852|469115988|FG002|Blinded Treatment Period|Adverse Event|0|||
130313957|NCT03400852|469115986|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
130313958|NCT03400852|469115987|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
130313959|NCT03400852|469115988|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
130313960|NCT03400852|469115986|FG000|Open Label Period|Physician Decision|0|||
130313961|NCT03400852|469115987|FG001|Open Label Period|Physician Decision|0|||
130313962|NCT03400852|469115988|FG002|Open Label Period|Physician Decision|1|||
130313963|NCT03400852|469115986|FG000|Open Label Period|Study terminated by sponsor|0|||
130313964|NCT03400852|469115987|FG001|Open Label Period|Study terminated by sponsor|0|||
130313965|NCT03400852|469115988|FG002|Open Label Period|Study terminated by sponsor|21|||
130313966|NCT00248495|469115989|FG000|Overall Study|Withdrawal by Subject|1|||
130313967|NCT03812380|469115990|FG000|Overall Study|Protocol Violation|3|||
130313968|NCT03812380|469115991|FG001|Overall Study|Protocol Violation|3|||
130313969|NCT03812380|469115990|FG000|Overall Study|Withdrawal by Subject|5|||
130313970|NCT03812380|469115991|FG001|Overall Study|Withdrawal by Subject|4|||
130313971|NCT03812380|469115990|FG000|Overall Study|Early termination of study|14|||
130313972|NCT03812380|469115991|FG001|Overall Study|Early termination of study|14|||
130313973|NCT02648204|469115992|FG000|Overall Study|Withdrawal by Subject|12|||
130313974|NCT02648204|469115993|FG001|Overall Study|Withdrawal by Subject|8|||
130313975|NCT02648204|469115994|FG002|Overall Study|Withdrawal by Subject|2|||
130313976|NCT02648204|469115995|FG003|Overall Study|Withdrawal by Subject|6|||
130313977|NCT02648204|469115992|FG000|Overall Study|Lost to Follow-up|5|||
130313978|NCT02648204|469115993|FG001|Overall Study|Lost to Follow-up|8|||
130313979|NCT02648204|469115994|FG002|Overall Study|Lost to Follow-up|4|||
130313980|NCT02648204|469115995|FG003|Overall Study|Lost to Follow-up|6|||
130313981|NCT02648204|469115992|FG000|Overall Study|Missing follow-up information|4|||
130313982|NCT02648204|469115993|FG001|Overall Study|Missing follow-up information|4|||
130313983|NCT02648204|469115994|FG002|Overall Study|Missing follow-up information|4|||
130313984|NCT02648204|469115995|FG003|Overall Study|Missing follow-up information|2|||
130313985|NCT02648204|469115992|FG000|Overall Study|Death|1|||
130313986|NCT02648204|469115993|FG001|Overall Study|Death|1|||
130313987|NCT02648204|469115994|FG002|Overall Study|Death|2|||
130313988|NCT02648204|469115995|FG003|Overall Study|Death|2|||
130313989|NCT02648204|469115992|FG000|Overall Study|Adverse Event|0|||
130313990|NCT02648204|469115993|FG001|Overall Study|Adverse Event|0|||
130313991|NCT02648204|469115994|FG002|Overall Study|Adverse Event|1|||
130313992|NCT02648204|469115995|FG003|Overall Study|Adverse Event|0|||
130313993|NCT02366312|469116007|FG000|Overall Study|Lost to Follow-up|0|||
130313994|NCT02366312|469116008|FG001|Overall Study|Lost to Follow-up|1|||
130313995|NCT03719131|469116012|FG000|Overall Study|Death|1|||
130313996|NCT03719131|469116013|FG001|Overall Study|Death|2|||
130313997|NCT00619515|469116014|FG000|Overall Study|Study Termination by IRB|73|||
130313998|NCT03294590|469116015|FG000|Overall Study|Lost to Follow-up|105|||
130313999|NCT03294590|469116016|FG001|Overall Study|Lost to Follow-up|107|||
130314000|NCT04862065|469116019|FG000|Screening|Protocol Violation|54|||
130314001|NCT04862065|469116020|FG001|Screening|Protocol Violation|0|||
130314002|NCT04862065|469116021|FG002|Screening|Protocol Violation|0|||
130314003|NCT04862065|469116019|FG000|Screening|Insufficient Sample|1|||
130314004|NCT04862065|469116020|FG001|Screening|Insufficient Sample|0|||
130314005|NCT04862065|469116021|FG002|Screening|Insufficient Sample|0|||
130314006|NCT04862065|469116019|FG000|Follow-Up|Lost to Follow-up|3|||
130314007|NCT04862065|469116020|FG001|Follow-Up|Lost to Follow-up|0|||
130314008|NCT04862065|469116021|FG002|Follow-Up|Lost to Follow-up|0|||
129799552|NCT00674973|467235144|FG001|Overall Study|Protocol Violation|1|||
129799553|NCT05036369|467235147|FG000|Overall Study|Run In non compliance|1|||
129799554|NCT05036369|467235148|FG001|Overall Study|Run In non compliance|2|||
129799555|NCT05036369|467235147|FG000|Overall Study|Change in eligibility criteria|0|||
129799556|NCT05036369|467235148|FG001|Overall Study|Change in eligibility criteria|1|||
129799557|NCT01397162|467235151|FG000|Overall Study|Adverse Event|4|||
129799558|NCT01397162|467235152|FG001|Overall Study|Adverse Event|0|||
130050445|NCT00570739|468140804|FG000|Overall Study|Met discontinuation criteria|1|||
130050446|NCT00570739|468140805|FG001|Overall Study|Met discontinuation criteria|0|||
130050447|NCT00570739|468140806|FG002|Overall Study|Met discontinuation criteria|1|||
130110627|NCT03550794|468365803|FG001|Overall Study|Death|1|||
130314009|NCT01272232|469116025|FG000|Weeks 0-56|Adverse Event|39|||
130314010|NCT01272232|469116026|FG001|Weeks 0-56|Adverse Event|18|||
130314011|NCT01272232|469116027|FG002|Weeks 0-56|Adverse Event|7|||
130314012|NCT01272232|469116025|FG000|Weeks 0-56|Lack of Efficacy|0|||
130314013|NCT01272232|469116026|FG001|Weeks 0-56|Lack of Efficacy|0|||
129799559|NCT01397162|467235153|FG002|Overall Study|Adverse Event|0|||
129799560|NCT01397162|467235154|FG003|Overall Study|Adverse Event|0|||
129799561|NCT01397162|467235155|FG004|Overall Study|Adverse Event|0|||
130314014|NCT01272232|469116027|FG002|Weeks 0-56|Lack of Efficacy|3|||
130314015|NCT01272232|469116025|FG000|Weeks 0-56|Protocol Violation|12|||
130314016|NCT01272232|469116026|FG001|Weeks 0-56|Protocol Violation|8|||
130314017|NCT01272232|469116027|FG002|Weeks 0-56|Protocol Violation|13|||
130314018|NCT01272232|469116025|FG000|Weeks 0-56|Withdrawal criteria|32|||
130314019|NCT01272232|469116026|FG001|Weeks 0-56|Withdrawal criteria|14|||
130314020|NCT01272232|469116027|FG002|Weeks 0-56|Withdrawal criteria|37|||
130314021|NCT01272232|469116025|FG000|Weeks 0-56|Unclassified|16|||
130314022|NCT01272232|469116026|FG001|Weeks 0-56|Unclassified|7|||
130314023|NCT01272232|469116027|FG002|Weeks 0-56|Unclassified|12|||
130314024|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
130314025|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
130314026|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
130314027|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
130314028|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
130314029|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
130314030|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
130314031|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
130314032|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
130314033|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
130314034|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
130314035|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
130314036|NCT01272232|469116025|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
130314037|NCT01272232|469116026|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
130314038|NCT01272232|469116027|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
130314039|NCT00628030|469116030|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
130314040|NCT00628030|469116031|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
130314041|NCT00628030|469116030|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
130314042|NCT00628030|469116031|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
130314043|NCT00628030|469116030|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
130314044|NCT00628030|469116031|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
130314045|NCT01156480|469116033|FG000|Overall Study|change in diagnosis|0|||
130314046|NCT01156480|469116034|FG001|Overall Study|change in diagnosis|1|||
130314047|NCT03367858|469116035|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
130314048|NCT03367858|469116036|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
130314049|NCT03367858|469116035|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
130314050|NCT03367858|469116036|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
130314051|NCT03367858|469116035|FG000|3 Month Follow Up|Lost to Follow-up|8|||
130314052|NCT03367858|469116036|FG001|3 Month Follow Up|Lost to Follow-up|3|||
130314053|NCT03367858|469116035|FG000|3 Month Follow Up|Moved out of study area|2|||
130314054|NCT03367858|469116036|FG001|3 Month Follow Up|Moved out of study area|6|||
130314055|NCT03367858|469116035|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
130314056|NCT03367858|469116036|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
130314057|NCT03367858|469116035|FG000|3 Month Follow Up|MRI contraindication|2|||
130314058|NCT03367858|469116036|FG001|3 Month Follow Up|MRI contraindication|1|||
130314059|NCT03367858|469116035|FG000|3 Month Follow Up|Incarcerated|0|||
130314060|NCT03367858|469116036|FG001|3 Month Follow Up|Incarcerated|1|||
130314061|NCT03367858|469116035|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
130314062|NCT03367858|469116036|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
130314063|NCT03367858|469116035|FG000|6 Month Follow Up|Lost to Follow-up|5|||
130314064|NCT03367858|469116036|FG001|6 Month Follow Up|Lost to Follow-up|2|||
130314065|NCT03367858|469116035|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
130314066|NCT03367858|469116036|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
130314067|NCT03367858|469116035|FG000|12 Month Follow Up|Lost to Follow-up|3|||
130314068|NCT03367858|469116036|FG001|12 Month Follow Up|Lost to Follow-up|3|||
130314069|NCT03367858|469116035|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
130314070|NCT03367858|469116036|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
130314071|NCT04276233|469116037|FG000|Overall Study|Adverse Event|1|||
130314072|NCT04276233|469116037|FG000|Overall Study|Lost to Follow-up|3|||
130314073|NCT04276233|469116037|FG000|Overall Study|Physician Decision|4|||
130314074|NCT04276233|469116037|FG000|Overall Study|Withdrawal by Subject|2|||
130314075|NCT01946139|469116038|FG000|Overall Study|Withdrawal by Subject|8|||
130314076|NCT01946139|469116038|FG000|Overall Study|ineligible|8|||
130314077|NCT01946139|469116038|FG000|Overall Study|Specimens not available|4|||
130314078|NCT03275740|469116045|FG000|Overall Study|Adverse Event|0|||
130314079|NCT03275740|469116046|FG001|Overall Study|Adverse Event|0|||
130314080|NCT03275740|469116047|FG002|Overall Study|Adverse Event|0|||
130314081|NCT03275740|469116048|FG003|Overall Study|Adverse Event|0|||
130314082|NCT03275740|469116049|FG004|Overall Study|Adverse Event|1|||
130314083|NCT03275740|469116050|FG005|Overall Study|Adverse Event|0|||
130314084|NCT03275740|469116051|FG006|Overall Study|Adverse Event|0|||
130314085|NCT03275740|469116052|FG007|Overall Study|Adverse Event|0|||
130314086|NCT03275740|469116053|FG008|Overall Study|Adverse Event|0|||
130314087|NCT03275740|469116054|FG009|Overall Study|Adverse Event|0|||
130314088|NCT03275740|469116055|FG010|Overall Study|Adverse Event|0|||
130314089|NCT03275740|469116056|FG011|Overall Study|Adverse Event|0|||
130314090|NCT03275740|469116045|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314091|NCT03275740|469116046|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129890399|NCT03100838|467556117|FG000|Overall Study|Pregnancy|0|||
129890400|NCT03100838|467556118|FG001|Overall Study|Pregnancy|1|||
129890401|NCT03100838|467556119|FG002|Overall Study|Pregnancy|0|||
129890402|NCT03100838|467556120|FG003|Overall Study|Pregnancy|0|||
129890403|NCT03100838|467556117|FG000|Overall Study|Lost to Follow-up|0|||
129890404|NCT03100838|467556118|FG001|Overall Study|Lost to Follow-up|0|||
129890405|NCT03100838|467556119|FG002|Overall Study|Lost to Follow-up|1|||
129890406|NCT03100838|467556120|FG003|Overall Study|Lost to Follow-up|0|||
129890407|NCT02554513|467556121|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
129890408|NCT02554513|467556122|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
129890409|NCT00184028|467556123|FG000|Overall Study|Death|1|||
129890410|NCT00184028|467556123|FG000|Overall Study|Lack of Efficacy|4|||
129890411|NCT00184028|467556123|FG000|Overall Study|Adverse Event|2|||
129890412|NCT00184028|467556123|FG000|Overall Study|Withdrawal by Subject|1|||
129890413|NCT00184028|467556123|FG000|Overall Study|Non-compliance|2|||
129890414|NCT01354938|467556126|FG000|Overall Study|Lost to Follow-up|1|||
129890415|NCT02335268|467556127|FG000|Overall Study|Physician Decision|5|||
129890416|NCT02335268|467556128|FG001|Overall Study|Physician Decision|1|||
129890417|NCT02335268|467556127|FG000|Overall Study|Lack of Efficacy|2|||
129890418|NCT02335268|467556128|FG001|Overall Study|Lack of Efficacy|1|||
129890419|NCT02335268|467556127|FG000|Overall Study|Adverse Event|5|||
129890420|NCT02335268|467556128|FG001|Overall Study|Adverse Event|2|||
129890421|NCT02335268|467556127|FG000|Overall Study|increase blasts|2|||
129890422|NCT02335268|467556128|FG001|Overall Study|increase blasts|0|||
129890423|NCT02335268|467556127|FG000|Overall Study|Withdrawal by Subject|3|||
129890424|NCT02335268|467556128|FG001|Overall Study|Withdrawal by Subject|2|||
129890425|NCT01192295|467556132|FG000|Overall Study|Adverse Event|3|||
129890426|NCT01192295|467556133|FG001|Overall Study|Adverse Event|7|||
129890427|NCT01192295|467556132|FG000|Overall Study|Withdrawal by Subject|3|||
129890428|NCT01192295|467556133|FG001|Overall Study|Withdrawal by Subject|4|||
129890429|NCT01192295|467556132|FG000|Overall Study|Lost to Follow-up|0|||
129890430|NCT01192295|467556133|FG001|Overall Study|Lost to Follow-up|1|||
129890431|NCT01192295|467556132|FG000|Overall Study|Lack of Efficacy|0|||
129890432|NCT01192295|467556133|FG001|Overall Study|Lack of Efficacy|5|||
129890433|NCT01192295|467556132|FG000|Overall Study|Administrative|4|||
129890434|NCT01192295|467556133|FG001|Overall Study|Administrative|6|||
129890435|NCT03785340|467556136|FG000|Overall Study|Lost to Follow-up|2|||
129890436|NCT03785340|467556137|FG001|Overall Study|Lost to Follow-up|0|||
129890437|NCT03785340|467556136|FG000|Overall Study|Adverse Event|1|||
129890438|NCT03785340|467556137|FG001|Overall Study|Adverse Event|0|||
129890439|NCT01670500|467556143|FG000|Overall Study|Withdrawal by Subject|1|||
129890440|NCT01670500|467556144|FG001|Overall Study|Withdrawal by Subject|0|||
130314092|NCT03275740|469116047|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314093|NCT03275740|469116048|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314094|NCT03275740|469116049|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314095|NCT03275740|469116050|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
130314096|NCT03275740|469116051|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314097|NCT03275740|469116052|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314098|NCT03275740|469116053|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314099|NCT03275740|469116054|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314100|NCT03275740|469116055|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314101|NCT03275740|469116056|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
130314102|NCT03275740|469116045|FG000|Overall Study|Withdrawal by Subject|0|||
130314103|NCT03275740|469116046|FG001|Overall Study|Withdrawal by Subject|0|||
129890441|NCT04320615|467556145|FG000|Overall Study|Withdrawal by Subject|4|||
130314104|NCT03275740|469116047|FG002|Overall Study|Withdrawal by Subject|0|||
129890442|NCT04320615|467556146|FG001|Overall Study|Withdrawal by Subject|10|||
129890443|NCT04320615|467556145|FG000|Overall Study|Physician Decision|2|||
129890444|NCT04320615|467556146|FG001|Overall Study|Physician Decision|0|||
129890445|NCT04320615|467556145|FG000|Overall Study|Other|2|||
129890446|NCT04320615|467556146|FG001|Overall Study|Other|0|||
129890447|NCT04320615|467556145|FG000|Overall Study|Lost to Follow-up|5|||
129890448|NCT04320615|467556146|FG001|Overall Study|Lost to Follow-up|23|||
129890449|NCT04320615|467556145|FG000|Overall Study|Death|35|||
130314105|NCT03275740|469116048|FG003|Overall Study|Withdrawal by Subject|0|||
129890450|NCT04320615|467556146|FG001|Overall Study|Death|71|||
129890451|NCT01449721|467556147|FG000|Overall Study|Physician Decision|0|||
129890452|NCT01449721|467556148|FG001|Overall Study|Physician Decision|1|||
129890453|NCT01449721|467556147|FG000|Overall Study|Physician Decision|0|||
129890454|NCT01449721|467556148|FG001|Overall Study|Physician Decision|1|||
129890455|NCT00003509|467556149|FG000|Overall Study|Not evaluable|5|||
129890456|NCT03285711|467556150|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
129890457|NCT03285711|467556151|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
129890458|NCT03285711|467556152|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
129890459|NCT03285711|467556153|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
129890460|NCT03285711|467556150|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
130314106|NCT03275740|469116049|FG004|Overall Study|Withdrawal by Subject|0|||
130314107|NCT03275740|469116050|FG005|Overall Study|Withdrawal by Subject|0|||
130314108|NCT03275740|469116051|FG006|Overall Study|Withdrawal by Subject|0|||
130314109|NCT03275740|469116052|FG007|Overall Study|Withdrawal by Subject|0|||
130314110|NCT03275740|469116053|FG008|Overall Study|Withdrawal by Subject|1|||
130314111|NCT03275740|469116054|FG009|Overall Study|Withdrawal by Subject|1|||
130314112|NCT03275740|469116055|FG010|Overall Study|Withdrawal by Subject|0|||
130314113|NCT03275740|469116056|FG011|Overall Study|Withdrawal by Subject|0|||
130314114|NCT03827655|469116058|FG000|Overall Study|Death|0|||
130314115|NCT03827655|469116059|FG001|Overall Study|Death|0|||
130314116|NCT03827655|469116060|FG002|Overall Study|Death|0|||
130314117|NCT03827655|469116061|FG003|Overall Study|Death|0|||
130314118|NCT03827655|469116062|FG004|Overall Study|Death|1|||
130314119|NCT03827655|469116058|FG000|Overall Study|Protocol Deviation|1|||
130314120|NCT03827655|469116059|FG001|Overall Study|Protocol Deviation|0|||
130314121|NCT03827655|469116060|FG002|Overall Study|Protocol Deviation|1|||
130314122|NCT03827655|469116061|FG003|Overall Study|Protocol Deviation|1|||
130050448|NCT00570739|468140807|FG003|Overall Study|Met discontinuation criteria|1|||
130050449|NCT00570739|468140804|FG000|Overall Study|Other|0|||
130050450|NCT00570739|468140805|FG001|Overall Study|Other|2|||
130050451|NCT00570739|468140806|FG002|Overall Study|Other|5|||
130050452|NCT00570739|468140807|FG003|Overall Study|Other|3|||
130050453|NCT01844700|468140812|FG000|Overall Study|Lack of Efficacy|1|||
130050454|NCT01844700|468140813|FG001|Overall Study|Lack of Efficacy|0|||
130050455|NCT01844700|468140812|FG000|Overall Study|refused medication switch|1|||
130050456|NCT01844700|468140813|FG001|Overall Study|refused medication switch|0|||
130050457|NCT01844700|468140812|FG000|Overall Study|Withdrawal by Subject|1|||
130050458|NCT01844700|468140813|FG001|Overall Study|Withdrawal by Subject|0|||
130050459|NCT01844700|468140812|FG000|Overall Study|stopped taking meds|0|||
130050460|NCT01844700|468140813|FG001|Overall Study|stopped taking meds|1|||
130050461|NCT02375698|468140814|FG000|Overall Study|Withdrawal by Subject|0|||
130050462|NCT02375698|468140815|FG001|Overall Study|Withdrawal by Subject|2|||
130050463|NCT02375698|468140814|FG000|Overall Study|Physician Decision|2|||
130050464|NCT02375698|468140815|FG001|Overall Study|Physician Decision|0|||
130050465|NCT02680847|468140816|FG000|Overall Study|Other|2|||
130050466|NCT02680847|468140817|FG001|Overall Study|Other|0|||
130050467|NCT02680847|468140818|FG002|Overall Study|Other|0|||
130314123|NCT03827655|469116062|FG004|Overall Study|Protocol Deviation|0|||
130314124|NCT03827655|469116058|FG000|Overall Study|Withdrawal by Subject|3|||
130314125|NCT03827655|469116059|FG001|Overall Study|Withdrawal by Subject|2|||
129799562|NCT01397162|467235151|FG000|Overall Study|Not yet defined|3|||
130050468|NCT02680847|468140816|FG000|Overall Study|No longer met eligibility criteria|2|||
130314126|NCT03827655|469116060|FG002|Overall Study|Withdrawal by Subject|2|||
130314127|NCT03827655|469116061|FG003|Overall Study|Withdrawal by Subject|0|||
130314128|NCT03827655|469116062|FG004|Overall Study|Withdrawal by Subject|1|||
130314129|NCT03827655|469116058|FG000|Overall Study|Reason not Specified|3|||
130050469|NCT02680847|468140817|FG001|Overall Study|No longer met eligibility criteria|2|||
130050470|NCT02680847|468140818|FG002|Overall Study|No longer met eligibility criteria|0|||
130050471|NCT02680847|468140816|FG000|Overall Study|Unwilling to participate in study|1|||
130314130|NCT03827655|469116059|FG001|Overall Study|Reason not Specified|1|||
130314131|NCT03827655|469116060|FG002|Overall Study|Reason not Specified|1|||
129799563|NCT01397162|467235152|FG001|Overall Study|Not yet defined|4|||
129799564|NCT01397162|467235153|FG002|Overall Study|Not yet defined|3|||
130314132|NCT03827655|469116061|FG003|Overall Study|Reason not Specified|1|||
130314133|NCT03827655|469116062|FG004|Overall Study|Reason not Specified|1|||
130314134|NCT02336607|469116063|FG000|Overall Study|Physician Decision|1|||
130314135|NCT02336607|469116064|FG001|Overall Study|Physician Decision|4|||
130314136|NCT02336607|469116065|FG002|Overall Study|Physician Decision|3|||
130314137|NCT02336607|469116066|FG003|Overall Study|Physician Decision|15|||
130314138|NCT02336607|469116063|FG000|Overall Study|Lack of Efficacy|1|||
130314139|NCT02336607|469116064|FG001|Overall Study|Lack of Efficacy|0|||
130314140|NCT02336607|469116065|FG002|Overall Study|Lack of Efficacy|0|||
130314141|NCT02336607|469116066|FG003|Overall Study|Lack of Efficacy|2|||
130314142|NCT02336607|469116063|FG000|Overall Study|Lost to Follow-up|2|||
130314143|NCT02336607|469116064|FG001|Overall Study|Lost to Follow-up|1|||
130314144|NCT02336607|469116065|FG002|Overall Study|Lost to Follow-up|0|||
130314145|NCT02336607|469116066|FG003|Overall Study|Lost to Follow-up|21|||
130314146|NCT02336607|469116063|FG000|Overall Study|Protocol Violation|0|||
130314147|NCT02336607|469116064|FG001|Overall Study|Protocol Violation|1|||
130314148|NCT02336607|469116065|FG002|Overall Study|Protocol Violation|1|||
130314149|NCT02336607|469116066|FG003|Overall Study|Protocol Violation|3|||
130314150|NCT02336607|469116063|FG000|Overall Study|Adverse Event|0|||
130314151|NCT02336607|469116064|FG001|Overall Study|Adverse Event|2|||
129799565|NCT01397162|467235154|FG003|Overall Study|Not yet defined|5|||
129799566|NCT01397162|467235155|FG004|Overall Study|Not yet defined|3|||
129799567|NCT00401531|467235158|FG000|Overall Study|Adverse Event|2|||
129799568|NCT00401531|467235159|FG001|Overall Study|Adverse Event|0|||
129799569|NCT00401531|467235158|FG000|Overall Study|Protocol Violation|3|||
129799570|NCT00401531|467235159|FG001|Overall Study|Protocol Violation|7|||
129799571|NCT00401531|467235158|FG000|Overall Study|Lost to Follow-up|1|||
130050472|NCT02680847|468140817|FG001|Overall Study|Unwilling to participate in study|1|||
130050473|NCT02680847|468140818|FG002|Overall Study|Unwilling to participate in study|0|||
130050474|NCT02680847|468140816|FG000|Overall Study|Lack of Efficacy|0|||
130314152|NCT02336607|469116065|FG002|Overall Study|Adverse Event|2|||
130314153|NCT02336607|469116066|FG003|Overall Study|Adverse Event|26|||
130314154|NCT02336607|469116063|FG000|Overall Study|Withdrawal by Subject|0|||
130314155|NCT02336607|469116064|FG001|Overall Study|Withdrawal by Subject|2|||
130314156|NCT02336607|469116065|FG002|Overall Study|Withdrawal by Subject|0|||
130314157|NCT02336607|469116066|FG003|Overall Study|Withdrawal by Subject|20|||
130314158|NCT02552966|469116067|FG000|Overall Study|Lost to Follow-up|2|||
130314159|NCT02552966|469116067|FG000|Overall Study|Withdrawal by Subject|3|||
130314160|NCT01091675|469116072|FG000|Overall Study|Adverse Event|7|||
129799572|NCT00401531|467235159|FG001|Overall Study|Lost to Follow-up|1|||
129799573|NCT00401531|467235158|FG000|Overall Study|Withdrawal by Subject|3|||
130050475|NCT02680847|468140817|FG001|Overall Study|Lack of Efficacy|0|||
130050476|NCT02680847|468140818|FG002|Overall Study|Lack of Efficacy|2|||
130050477|NCT02680847|468140816|FG000|Overall Study|Adverse Event|0|||
130050478|NCT02680847|468140817|FG001|Overall Study|Adverse Event|0|||
130050479|NCT02680847|468140818|FG002|Overall Study|Adverse Event|1|||
130050480|NCT00803244|468140821|FG000|Overall Study|Adverse Event|1|||
130050481|NCT00803244|468140822|FG001|Overall Study|Adverse Event|2|||
130050482|NCT00803244|468140821|FG000|Overall Study|Withdrawal by Subject|2|||
130050483|NCT00803244|468140822|FG001|Overall Study|Withdrawal by Subject|3|||
130050484|NCT00803244|468140821|FG000|Overall Study|Any other reason not above-mentioned|4|||
130050485|NCT00803244|468140822|FG001|Overall Study|Any other reason not above-mentioned|10|||
130050486|NCT00616239|468140823|FG000|Overall Study|Withdrawal by Subject|2|||
130050487|NCT02873715|468140824|FG000|Overall Study|Lost to Follow-up|84|||
130050488|NCT02873715|468140825|FG001|Overall Study|Lost to Follow-up|94|||
130050489|NCT02873715|468140824|FG000|Overall Study|Withdrawal by Subject|7|||
130050490|NCT02873715|468140825|FG001|Overall Study|Withdrawal by Subject|26|||
130050491|NCT00564629|468140829|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
130050492|NCT00564629|468140830|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
129799574|NCT00401531|467235159|FG001|Overall Study|Withdrawal by Subject|2|||
129799575|NCT03875118|467235160|FG000|Overall Study|Withdrawal by Subject|4|||
129799576|NCT03875118|467235161|FG001|Overall Study|Withdrawal by Subject|4|||
129799577|NCT03956056|467235162|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
130314161|NCT01091675|469116072|FG000|Overall Study|Lack of Efficacy|27|||
130314162|NCT00614380|469116073|FG000|Overall Study|Adverse Event|14|||
130314163|NCT00614380|469116074|FG001|Overall Study|Adverse Event|4|||
130314164|NCT00614380|469116075|FG002|Overall Study|Adverse Event|0|||
130314165|NCT00614380|469116076|FG003|Overall Study|Adverse Event|0|||
130314166|NCT00614380|469116073|FG000|Overall Study|Lost to Follow-up|6|||
129799578|NCT03956056|467235162|FG000|Overall Study|Lack of Efficacy|1|||
129799579|NCT03403374|467235163|FG000|Overall Study|Lost to Follow-up|1|||
130050493|NCT03241173|468140831|FG000|Overall Study|Death|3|||
130050494|NCT03241173|468140832|FG001|Overall Study|Death|2|||
130314167|NCT00614380|469116074|FG001|Overall Study|Lost to Follow-up|1|||
129890461|NCT03285711|467556151|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
129890462|NCT03285711|467556152|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
129890463|NCT03285711|467556153|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
129890464|NCT03285711|467556150|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
129890465|NCT03285711|467556151|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
130314168|NCT00614380|469116075|FG002|Overall Study|Lost to Follow-up|0|||
130314169|NCT00614380|469116076|FG003|Overall Study|Lost to Follow-up|0|||
130314170|NCT00614380|469116073|FG000|Overall Study|Non compliant with the protocol|12|||
130314171|NCT00614380|469116074|FG001|Overall Study|Non compliant with the protocol|2|||
130314172|NCT00614380|469116075|FG002|Overall Study|Non compliant with the protocol|1|||
130314173|NCT00614380|469116076|FG003|Overall Study|Non compliant with the protocol|2|||
130314174|NCT00614380|469116073|FG000|Overall Study|Consent withdrawn|3|||
130314175|NCT00614380|469116074|FG001|Overall Study|Consent withdrawn|1|||
129890466|NCT03285711|467556152|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
129890467|NCT03285711|467556153|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
129890468|NCT03285711|467556150|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129890469|NCT03285711|467556151|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
129890470|NCT03285711|467556152|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129890471|NCT03285711|467556153|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129890472|NCT02431533|467556154|FG000|Overall Study|Withdrawal by Subject|1|||
129890473|NCT02431533|467556155|FG001|Overall Study|Withdrawal by Subject|3|||
129890474|NCT02431533|467556154|FG000|Overall Study|Developed Exclusionary criteria|1|||
129890475|NCT02431533|467556155|FG001|Overall Study|Developed Exclusionary criteria|0|||
129890476|NCT02107443|467556156|FG000|Overall Study|Death|42|||
129890477|NCT02107443|467556157|FG001|Overall Study|Death|30|||
129890478|NCT02107443|467556156|FG000|Overall Study|Study Protocol Violation|3|||
129890479|NCT02107443|467556157|FG001|Overall Study|Study Protocol Violation|1|||
129890480|NCT02107443|467556156|FG000|Overall Study|Registered but Not Eligible|0|||
129890481|NCT02107443|467556157|FG001|Overall Study|Registered but Not Eligible|1|||
129890482|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
129890483|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
129890484|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
129890485|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
130314176|NCT00614380|469116075|FG002|Overall Study|Consent withdrawn|0|||
130314177|NCT00614380|469116076|FG003|Overall Study|Consent withdrawn|0|||
129890486|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Changed Mind|2|||
129890487|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Changed Mind|0|||
129890488|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
129890489|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
129890490|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
129890491|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
129890492|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
129890493|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
129890494|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
129890495|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
129890496|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Other Medical|9|||
129890497|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Other Medical|5|||
129890498|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Disease Progression|4|||
129890499|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Disease Progression|2|||
129890500|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Personal Issues|0|||
129890501|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Personal Issues|3|||
129890502|NCT00333788|467556158|FG000|Overall Study|Adverse Event|44|||
129890503|NCT00333788|467556158|FG000|Overall Study|Lack of Efficacy|80|||
129890504|NCT00333788|467556158|FG000|Overall Study|Lost to Follow-up|2|||
129890505|NCT00333788|467556158|FG000|Overall Study|Withdrawal by Subject|24|||
129890506|NCT00333788|467556158|FG000|Overall Study|Other: Non-compliance|2|||
129890507|NCT00333788|467556158|FG000|Overall Study|Other: Moved|2|||
129890508|NCT00333788|467556158|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
129890509|NCT00333788|467556158|FG000|Overall Study|Other: Investigator decision|1|||
130314178|NCT01670721|469116090|FG000|Overall Study|Participant's decision|15|||
130314179|NCT01670721|469116090|FG000|Overall Study|Other than specified above|38|||
130314180|NCT00191334|469116091|FG000|Overall Study|Adverse Event|4|||
129890510|NCT00333788|467556158|FG000|Overall Study|Other: Quality of life concern|1|||
130314181|NCT00191334|469116091|FG000|Overall Study|Disease Progression or Relapse|8|||
130314182|NCT00191334|469116091|FG000|Overall Study|Physician Decision|1|||
130314183|NCT00191334|469116091|FG000|Overall Study|Withdrawal by Subject|4|||
130314184|NCT05274958|469116092|FG000|Overall Study|Only completed 1 set of PROMs|22|||
130314185|NCT05274958|469116093|FG001|Overall Study|Only completed 1 set of PROMs|35|||
130314186|NCT05579977|469116101|FG000|Treatment Phase|Other|0|||
130314187|NCT05579977|469116102|FG001|Treatment Phase|Other|0|||
130314188|NCT05579977|469116103|FG002|Treatment Phase|Other|0|||
130314189|NCT05579977|469116104|FG003|Treatment Phase|Other|2|||
130314190|NCT05579977|469116105|FG004|Treatment Phase|Other|1|||
130314191|NCT05579977|469116106|FG005|Treatment Phase|Other|2|||
129890511|NCT00333788|467556158|FG000|Overall Study|Other: Sponsor decision|1|||
129890512|NCT00333788|467556158|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
129890513|NCT00333788|467556158|FG000|Overall Study|Other: Medical monitor decision|1|||
129890514|NCT00333788|467556158|FG000|Overall Study|Other: Physician decision|1|||
129890515|NCT00333788|467556158|FG000|Overall Study|Other: Signed consent for another study|1|||
129890516|NCT00729690|467556159|FG000|Overall Study|IT Catheter Malfunction|0|||
129890517|NCT00729690|467556160|FG001|Overall Study|IT Catheter Malfunction|2|||
129890518|NCT00729690|467556161|FG002|Overall Study|IT Catheter Malfunction|2|||
129890519|NCT02886936|467556167|FG000|Overall Study|Lost to Follow-up|4|||
129890520|NCT02886936|467556168|FG001|Overall Study|Lost to Follow-up|3|||
129890521|NCT02886936|467556169|FG002|Overall Study|Lost to Follow-up|0|||
129890522|NCT02320721|467556170|FG000|Overall Study|Adverse Event|6|||
129890523|NCT02320721|467556171|FG001|Overall Study|Adverse Event|6|||
129890524|NCT02320721|467556170|FG000|Overall Study|Lack of Efficacy|2|||
130050495|NCT03241173|468140833|FG002|Overall Study|Death|4|||
130050496|NCT03241173|468140834|FG003|Overall Study|Death|4|||
130050497|NCT03241173|468140835|FG004|Overall Study|Death|2|||
130050498|NCT03241173|468140836|FG005|Overall Study|Death|2|||
130050499|NCT03241173|468140837|FG006|Overall Study|Death|3|||
130050500|NCT03241173|468140838|FG007|Overall Study|Death|1|||
130050501|NCT03241173|468140839|FG008|Overall Study|Death|0|||
130050502|NCT03241173|468140840|FG009|Overall Study|Death|5|||
130050503|NCT03241173|468140841|FG010|Overall Study|Death|4|||
130050504|NCT03241173|468140842|FG011|Overall Study|Death|3|||
130050505|NCT03241173|468140843|FG012|Overall Study|Death|0|||
130050506|NCT03241173|468140844|FG013|Overall Study|Death|0|||
130050507|NCT03241173|468140845|FG014|Overall Study|Death|0|||
130050508|NCT03241173|468140831|FG000|Overall Study|Withdrawal by Subject|0|||
130050509|NCT03241173|468140832|FG001|Overall Study|Withdrawal by Subject|0|||
130050510|NCT03241173|468140833|FG002|Overall Study|Withdrawal by Subject|1|||
130050511|NCT03241173|468140834|FG003|Overall Study|Withdrawal by Subject|0|||
130050512|NCT03241173|468140835|FG004|Overall Study|Withdrawal by Subject|0|||
130050513|NCT03241173|468140836|FG005|Overall Study|Withdrawal by Subject|1|||
130050514|NCT03241173|468140837|FG006|Overall Study|Withdrawal by Subject|0|||
130050515|NCT03241173|468140838|FG007|Overall Study|Withdrawal by Subject|0|||
130050516|NCT03241173|468140839|FG008|Overall Study|Withdrawal by Subject|0|||
130050517|NCT03241173|468140840|FG009|Overall Study|Withdrawal by Subject|0|||
130050518|NCT03241173|468140841|FG010|Overall Study|Withdrawal by Subject|0|||
130050519|NCT03241173|468140842|FG011|Overall Study|Withdrawal by Subject|0|||
130050520|NCT03241173|468140843|FG012|Overall Study|Withdrawal by Subject|0|||
130050521|NCT03241173|468140844|FG013|Overall Study|Withdrawal by Subject|0|||
130050522|NCT03241173|468140845|FG014|Overall Study|Withdrawal by Subject|0|||
130050523|NCT03241173|468140831|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130050524|NCT03241173|468140832|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130050525|NCT03241173|468140833|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130050526|NCT03241173|468140834|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130050527|NCT03241173|468140835|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130050528|NCT03241173|468140836|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130050529|NCT03241173|468140837|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
130050530|NCT03241173|468140838|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130050531|NCT03241173|468140839|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130050532|NCT03241173|468140840|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130050533|NCT03241173|468140841|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
130050534|NCT03241173|468140842|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
130050535|NCT03241173|468140843|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130050536|NCT03241173|468140844|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130050537|NCT03241173|468140845|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
130050538|NCT03241173|468140831|FG000|Overall Study|Lost to Follow-up|0|||
130050539|NCT03241173|468140832|FG001|Overall Study|Lost to Follow-up|0|||
130050540|NCT03241173|468140833|FG002|Overall Study|Lost to Follow-up|0|||
130050541|NCT03241173|468140834|FG003|Overall Study|Lost to Follow-up|0|||
129890525|NCT02320721|467556171|FG001|Overall Study|Lack of Efficacy|0|||
129890526|NCT02320721|467556170|FG000|Overall Study|Poor compliance to protocol|3|||
129890527|NCT02320721|467556171|FG001|Overall Study|Poor compliance to protocol|7|||
130050542|NCT03241173|468140835|FG004|Overall Study|Lost to Follow-up|1|||
130050543|NCT03241173|468140836|FG005|Overall Study|Lost to Follow-up|0|||
130050544|NCT03241173|468140837|FG006|Overall Study|Lost to Follow-up|0|||
130050545|NCT03241173|468140838|FG007|Overall Study|Lost to Follow-up|0|||
130050546|NCT03241173|468140839|FG008|Overall Study|Lost to Follow-up|0|||
130050547|NCT03241173|468140840|FG009|Overall Study|Lost to Follow-up|1|||
129890528|NCT02320721|467556170|FG000|Overall Study|Randomized but not treated|0|||
129890529|NCT02320721|467556171|FG001|Overall Study|Randomized but not treated|1|||
130314192|NCT05579977|469116107|FG006|Treatment Phase|Other|1|||
130314193|NCT05579977|469116108|FG007|Treatment Phase|Other|2|||
130314194|NCT05579977|469116109|FG008|Treatment Phase|Other|2|||
130314195|NCT05579977|469116110|FG009|Treatment Phase|Other|1|||
130314196|NCT05579977|469116111|FG010|Treatment Phase|Other|0|||
130314197|NCT05579977|469116112|FG011|Treatment Phase|Other|0|||
130050548|NCT03241173|468140841|FG010|Overall Study|Lost to Follow-up|0|||
130050549|NCT03241173|468140842|FG011|Overall Study|Lost to Follow-up|0|||
130050550|NCT03241173|468140843|FG012|Overall Study|Lost to Follow-up|0|||
130050551|NCT03241173|468140844|FG013|Overall Study|Lost to Follow-up|0|||
130050552|NCT03241173|468140845|FG014|Overall Study|Lost to Follow-up|0|||
130050553|NCT03634072|468140846|FG000|Overall Study|Early termination of overall study|1|||
130050554|NCT03634072|468140847|FG001|Overall Study|Early termination of overall study|0|||
130050555|NCT03648996|468140849|FG000|Overall Study|Withdrawal by Subject|0|||
130050556|NCT03648996|468140850|FG001|Overall Study|Withdrawal by Subject|2|||
130050557|NCT03648996|468140851|FG002|Overall Study|Withdrawal by Subject|2|||
130050558|NCT03648996|468140849|FG000|Overall Study|Physician Decision|2|||
130050559|NCT03648996|468140850|FG001|Overall Study|Physician Decision|0|||
130050560|NCT03648996|468140851|FG002|Overall Study|Physician Decision|0|||
130050561|NCT00590681|468140852|FG000|Overall Study|Withdrawal by Subject|7|||
130050562|NCT00590681|468140852|FG000|Overall Study|Adverse Event|8|||
130050563|NCT00590681|468140852|FG000|Overall Study|Death|3|||
130050564|NCT00590681|468140852|FG000|Overall Study|Lost to Follow-up|1|||
130050565|NCT00590681|468140852|FG000|Overall Study|disease progression|1|||
130050566|NCT00053846|468140858|FG000|Overall Study|Changed mind|8|||
130050567|NCT00053846|468140859|FG001|Overall Study|Changed mind|13|||
130050568|NCT00053846|468140858|FG000|Overall Study|Became too ill|8|||
130050569|NCT00053846|468140859|FG001|Overall Study|Became too ill|7|||
130050570|NCT00053846|468140858|FG000|Overall Study|Expired|5|||
130050571|NCT00053846|468140859|FG001|Overall Study|Expired|0|||
130050572|NCT00053846|468140858|FG000|Overall Study|Became ineligible|3|||
130050573|NCT00053846|468140859|FG001|Overall Study|Became ineligible|1|||
130050574|NCT00053846|468140858|FG000|Overall Study|Did not return data|1|||
130050575|NCT00053846|468140859|FG001|Overall Study|Did not return data|2|||
130050576|NCT00053846|468140858|FG000|Overall Study|Quit due to side effects|1|||
130050577|NCT00053846|468140859|FG001|Overall Study|Quit due to side effects|3|||
130050578|NCT00053846|468140858|FG000|Overall Study|Pills too large|0|||
130050579|NCT00053846|468140859|FG001|Overall Study|Pills too large|1|||
130050580|NCT00064662|468140860|FG000|Overall Study|Death|1|||
130050581|NCT00064662|468140861|FG001|Overall Study|Death|1|||
130050582|NCT00064662|468140860|FG000|Overall Study|Lost to Follow-up|57|||
130050583|NCT00064662|468140861|FG001|Overall Study|Lost to Follow-up|44|||
130050584|NCT00064662|468140860|FG000|Overall Study|Withdrawal by Subject|14|||
130050585|NCT00064662|468140861|FG001|Overall Study|Withdrawal by Subject|14|||
130050586|NCT00064662|468140860|FG000|Overall Study|Administratively withdrawn|2|||
130050587|NCT00064662|468140861|FG001|Overall Study|Administratively withdrawn|2|||
130050588|NCT00504166|468140865|FG000|Overall Study|Adverse Event|1|||
130050589|NCT00504166|468140866|FG001|Overall Study|Adverse Event|4|||
130050590|NCT00504166|468140865|FG000|Overall Study|Withdrawal by Subject|3|||
130050591|NCT00504166|468140866|FG001|Overall Study|Withdrawal by Subject|6|||
130050592|NCT00504166|468140865|FG000|Overall Study|Physician Decision|1|||
130050593|NCT00504166|468140866|FG001|Overall Study|Physician Decision|1|||
130050594|NCT00504166|468140865|FG000|Overall Study|Lost to Follow-up|1|||
130050595|NCT00504166|468140866|FG001|Overall Study|Lost to Follow-up|3|||
130050596|NCT02229864|468140867|FG000|Overall Study|Death|2|||
130050597|NCT02229864|468140867|FG000|Overall Study|Lost to Follow-up|1|||
130050598|NCT01929044|468140870|FG000|Overall Study|Adverse Event|1|||
130050599|NCT01929044|468140871|FG001|Overall Study|Adverse Event|0|||
130050600|NCT01929044|468140870|FG000|Overall Study|Protocol Violation|9|||
130050601|NCT01929044|468140871|FG001|Overall Study|Protocol Violation|14|||
130050602|NCT01929044|468140870|FG000|Overall Study|Not Treated|1|||
130050603|NCT01929044|468140871|FG001|Overall Study|Not Treated|3|||
130050604|NCT02807454|468140872|FG000|Overall Study|Adverse Event|1|||
130050605|NCT02807454|468140873|FG001|Overall Study|Adverse Event|0|||
130050606|NCT02807454|468140872|FG000|Overall Study|Withdrawal by Subject|0|||
130314198|NCT05579977|469116113|FG012|Treatment Phase|Other|3|||
130314199|NCT05579977|469116101|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
130050607|NCT02807454|468140873|FG001|Overall Study|Withdrawal by Subject|1|||
130050608|NCT02807454|468140872|FG000|Overall Study|Progressive Disease|30|||
130050609|NCT02807454|468140873|FG001|Overall Study|Progressive Disease|3|||
130050610|NCT02807454|468140872|FG000|Overall Study|Other Reasons|1|||
130050611|NCT02807454|468140873|FG001|Overall Study|Other Reasons|1|||
130050612|NCT02582749|468140874|FG000|Overall Study|Study terminated by funder|5|||
130050613|NCT02582749|468140875|FG001|Overall Study|Study terminated by funder|10|||
130050614|NCT02582749|468140874|FG000|Overall Study|Withdrawal by Subject|0|||
130050615|NCT02582749|468140875|FG001|Overall Study|Withdrawal by Subject|1|||
130314200|NCT05579977|469116102|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
130314201|NCT05579977|469116103|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
130050616|NCT02566525|468140876|FG000|Overall Study|Protocol Violation|3|||
130050617|NCT02566525|468140877|FG001|Overall Study|Protocol Violation|5|||
129890530|NCT02320721|467556170|FG000|Overall Study|Hypoglycemia|1|||
129890531|NCT02320721|467556171|FG001|Overall Study|Hypoglycemia|0|||
129890532|NCT02320721|467556170|FG000|Overall Study|Other than specified above|15|||
129890533|NCT02320721|467556171|FG001|Overall Study|Other than specified above|20|||
129890534|NCT04131907|467556172|FG000|Overall Study|Adverse Event|2|||
129890535|NCT04131907|467556173|FG001|Overall Study|Adverse Event|0|||
129890536|NCT04131907|467556174|FG002|Overall Study|Adverse Event|0|||
129890537|NCT04131907|467556172|FG000|Overall Study|Physician Decision|4|||
129890538|NCT04131907|467556173|FG001|Overall Study|Physician Decision|22|||
129890539|NCT04131907|467556174|FG002|Overall Study|Physician Decision|0|||
129890540|NCT04131907|467556172|FG000|Overall Study|Withdrawal by Subject|2|||
129890541|NCT04131907|467556173|FG001|Overall Study|Withdrawal by Subject|0|||
129890542|NCT04131907|467556174|FG002|Overall Study|Withdrawal by Subject|1|||
129890543|NCT04131907|467556172|FG000|Overall Study|Treatment failure|2|||
130314202|NCT05579977|469116104|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
130314203|NCT05579977|469116105|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
130314204|NCT05579977|469116106|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
130314205|NCT05579977|469116107|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
129890544|NCT04131907|467556173|FG001|Overall Study|Treatment failure|0|||
129890545|NCT04131907|467556174|FG002|Overall Study|Treatment failure|1|||
129890546|NCT00245011|467556175|FG000|Overall Study|Lack of Efficacy|1|||
129890547|NCT01388543|467556183|FG000|Day 14|Adverse Event|1|||
129890548|NCT01388543|467556184|FG001|Day 14|Adverse Event|4|||
129890549|NCT00394095|467557464|FG000|Screening|Withdrawal by Subject|1|||
130050618|NCT01663740|468140878|FG000|Overall Study|Lost to Follow-up|1|||
130314206|NCT05579977|469116108|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
130314207|NCT05579977|469116109|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
130314208|NCT05579977|469116110|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
130314209|NCT05579977|469116111|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
130314210|NCT05579977|469116112|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
129890550|NCT00394095|467557465|FG001|Screening|Withdrawal by Subject|0|||
129890551|NCT00394095|467557464|FG000|Randomized|Withdrawal by Subject|5|||
129890552|NCT00394095|467557465|FG001|Randomized|Withdrawal by Subject|1|||
129890553|NCT00394095|467557464|FG000|Randomized|Adverse Event|1|||
130050619|NCT01663740|468140879|FG001|Overall Study|Lost to Follow-up|4|||
129890554|NCT00394095|467557465|FG001|Randomized|Adverse Event|1|||
129799580|NCT01298531|467235164|FG000|Overall Study|Lack of Efficacy|0|||
129799581|NCT01298531|467235165|FG001|Overall Study|Lack of Efficacy|1|||
129799582|NCT01298531|467235164|FG000|Overall Study|Lost to Follow-up|2|||
129799583|NCT01298531|467235165|FG001|Overall Study|Lost to Follow-up|0|||
129799584|NCT01298531|467235164|FG000|Overall Study|Protocol Violation|1|||
129799585|NCT01298531|467235165|FG001|Overall Study|Protocol Violation|1|||
129799586|NCT01298531|467235164|FG000|Overall Study|Adverse Event|4|||
129799587|NCT01298531|467235165|FG001|Overall Study|Adverse Event|3|||
129799588|NCT01298531|467235164|FG000|Overall Study|Does not meet entrance criteria|0|||
129799589|NCT01298531|467235165|FG001|Overall Study|Does not meet entrance criteria|1|||
129799590|NCT01298531|467235164|FG000|Overall Study|Other|2|||
129799591|NCT01298531|467235165|FG001|Overall Study|Other|1|||
129799592|NCT02360995|467235166|FG000|Overall Study|Lost to Follow-up|2|||
129799593|NCT02360995|467235167|FG001|Overall Study|Lost to Follow-up|0|||
129799594|NCT02360995|467235168|FG002|Overall Study|Lost to Follow-up|2|||
129799595|NCT02360995|467235166|FG000|Overall Study|Withdrawal by Subject|0|||
129799596|NCT02360995|467235167|FG001|Overall Study|Withdrawal by Subject|1|||
129799597|NCT02360995|467235168|FG002|Overall Study|Withdrawal by Subject|0|||
129799598|NCT02611960|467235169|FG000|Overall Study|Adverse Event|7|||
129799599|NCT02611960|467235170|FG001|Overall Study|Adverse Event|8|||
129799600|NCT02611960|467235169|FG000|Overall Study|Death|98|||
129799601|NCT02611960|467235170|FG001|Overall Study|Death|92|||
129799602|NCT02611960|467235169|FG000|Overall Study|Withdrawal by Subject|1|||
129799603|NCT02611960|467235170|FG001|Overall Study|Withdrawal by Subject|5|||
129799604|NCT02611960|467235169|FG000|Overall Study|Sponsor Decision|11|||
129799605|NCT02611960|467235170|FG001|Overall Study|Sponsor Decision|11|||
129799606|NCT02395666|467235171|FG000|Overall Study|Physician Decision|3|||
129799607|NCT02395666|467235172|FG001|Overall Study|Physician Decision|0|||
129799608|NCT02395666|467235171|FG000|Overall Study|Lost to Follow-up|1|||
129799609|NCT02395666|467235172|FG001|Overall Study|Lost to Follow-up|0|||
129799610|NCT02395666|467235171|FG000|Overall Study|Withdrawal by Subject|2|||
129799611|NCT02395666|467235172|FG001|Overall Study|Withdrawal by Subject|1|||
129799612|NCT01409434|467235173|FG000|Overall Study|Protocol Violation|4|||
129799613|NCT02213042|467235176|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
129799614|NCT02213042|467235177|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
129799615|NCT02213042|467235178|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
129799616|NCT02213042|467235176|FG000|Overall Study|Adverse Event|2|||
129799617|NCT02213042|467235177|FG001|Overall Study|Adverse Event|1|||
129799618|NCT02213042|467235178|FG002|Overall Study|Adverse Event|0|||
129799619|NCT02213042|467235176|FG000|Overall Study|Withdrawal by Subject|0|||
129799620|NCT02213042|467235177|FG001|Overall Study|Withdrawal by Subject|1|||
129799621|NCT02213042|467235178|FG002|Overall Study|Withdrawal by Subject|1|||
129799622|NCT02213042|467235176|FG000|Overall Study|Protocol Violation|1|||
129799623|NCT02213042|467235177|FG001|Overall Study|Protocol Violation|0|||
129799624|NCT02213042|467235178|FG002|Overall Study|Protocol Violation|0|||
129799625|NCT02213042|467235176|FG000|Overall Study|Investigator discretion|0|||
129799626|NCT02213042|467235177|FG001|Overall Study|Investigator discretion|0|||
129799627|NCT02213042|467235178|FG002|Overall Study|Investigator discretion|1|||
129799628|NCT05314478|467235179|FG000|Overall Study|Physician Decision|1|||
129799629|NCT04629508|467235180|FG000|Overall Study|Adverse Event|1|||
129799630|NCT04629508|467235180|FG000|Overall Study|Death|2|||
129799631|NCT04629508|467235180|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
129799632|NCT02476422|467235181|FG000|Overall Study|Subject/guardian decision|0|||
129799633|NCT02476422|467235182|FG001|Overall Study|Subject/guardian decision|1|||
129799634|NCT00760214|467235184|FG000|Overall Study|Adverse Event|8|||
129799635|NCT00760214|467235185|FG001|Overall Study|Adverse Event|9|||
129799636|NCT00760214|467235186|FG002|Overall Study|Adverse Event|12|||
129799637|NCT00760214|467235184|FG000|Overall Study|Protocol Violation|3|||
129799638|NCT00760214|467235185|FG001|Overall Study|Protocol Violation|0|||
129799639|NCT00760214|467235186|FG002|Overall Study|Protocol Violation|3|||
129799640|NCT00760214|467235184|FG000|Overall Study|Lost to Follow-up|0|||
129799641|NCT00760214|467235185|FG001|Overall Study|Lost to Follow-up|0|||
129799642|NCT00760214|467235186|FG002|Overall Study|Lost to Follow-up|1|||
129799643|NCT00760214|467235184|FG000|Overall Study|Withdrawal by Subject|12|||
129799644|NCT00760214|467235185|FG001|Overall Study|Withdrawal by Subject|14|||
129799645|NCT00760214|467235186|FG002|Overall Study|Withdrawal by Subject|13|||
129799646|NCT00760214|467235184|FG000|Overall Study|Lack of Efficacy|3|||
129890555|NCT00394095|467557464|FG000|Randomized|Overdose|1|||
129890556|NCT00394095|467557465|FG001|Randomized|Overdose|0|||
129890557|NCT00394095|467557464|FG000|Randomized|Lost to Follow-up|1|||
129890558|NCT00394095|467557465|FG001|Randomized|Lost to Follow-up|2|||
129890559|NCT00731042|467557466|FG000|Second Intervention|Did not meet inclusion criteria|0|||
129890560|NCT00731042|467557467|FG001|Second Intervention|Did not meet inclusion criteria|2|||
129890561|NCT04213846|467557468|FG000|Overall Study|Withdrawal by Subject|7|||
129890562|NCT04213846|467557469|FG001|Overall Study|Withdrawal by Subject|6|||
129890563|NCT04213846|467557468|FG000|Overall Study|Lost to Follow-up|15|||
129890564|NCT04213846|467557469|FG001|Overall Study|Lost to Follow-up|21|||
129890565|NCT04423393|467557470|FG000|Overall Study|Withdrawal by Subject|0|||
129890566|NCT04423393|467557471|FG001|Overall Study|Withdrawal by Subject|0|||
129890567|NCT04423393|467557472|FG002|Overall Study|Withdrawal by Subject|0|||
129890568|NCT04423393|467557473|FG003|Overall Study|Withdrawal by Subject|0|||
129890569|NCT04423393|467557474|FG004|Overall Study|Withdrawal by Subject|0|||
129890570|NCT04423393|467557475|FG005|Overall Study|Withdrawal by Subject|1|||
129890571|NCT04423393|467557476|FG006|Overall Study|Withdrawal by Subject|0|||
129890572|NCT04423393|467557477|FG007|Overall Study|Withdrawal by Subject|0|||
129890573|NCT04423393|467557478|FG008|Overall Study|Withdrawal by Subject|0|||
129890574|NCT04423393|467557479|FG009|Overall Study|Withdrawal by Subject|0|||
129890575|NCT04423393|467557480|FG010|Overall Study|Withdrawal by Subject|0|||
129890576|NCT04423393|467557481|FG011|Overall Study|Withdrawal by Subject|0|||
129890577|NCT04423393|467557482|FG012|Overall Study|Withdrawal by Subject|0|||
130314211|NCT05579977|469116113|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
130314212|NCT05579977|469116101|FG000|Treatment Phase|Withdrawal by Subject|2|||
130314213|NCT05579977|469116102|FG001|Treatment Phase|Withdrawal by Subject|0|||
129890578|NCT04423393|467557483|FG013|Overall Study|Withdrawal by Subject|1|||
129890579|NCT04423393|467557484|FG014|Overall Study|Withdrawal by Subject|0|||
129890580|NCT04423393|467557485|FG015|Overall Study|Withdrawal by Subject|0|||
130314214|NCT05579977|469116103|FG002|Treatment Phase|Withdrawal by Subject|0|||
130314215|NCT05579977|469116104|FG003|Treatment Phase|Withdrawal by Subject|1|||
130314216|NCT05579977|469116105|FG004|Treatment Phase|Withdrawal by Subject|2|||
130050620|NCT01663740|468140878|FG000|Overall Study|Other|9|||
130314217|NCT05579977|469116106|FG005|Treatment Phase|Withdrawal by Subject|0|||
130314218|NCT05579977|469116107|FG006|Treatment Phase|Withdrawal by Subject|1|||
130314219|NCT05579977|469116108|FG007|Treatment Phase|Withdrawal by Subject|8|||
130314220|NCT05579977|469116109|FG008|Treatment Phase|Withdrawal by Subject|3|||
130314221|NCT05579977|469116110|FG009|Treatment Phase|Withdrawal by Subject|3|||
130314222|NCT05579977|469116111|FG010|Treatment Phase|Withdrawal by Subject|5|||
130314223|NCT05579977|469116112|FG011|Treatment Phase|Withdrawal by Subject|1|||
130314224|NCT05579977|469116113|FG012|Treatment Phase|Withdrawal by Subject|3|||
130314225|NCT05579977|469116101|FG000|Treatment Phase|Study terminated by sponsor|70|||
130314226|NCT05579977|469116102|FG001|Treatment Phase|Study terminated by sponsor|70|||
130314227|NCT05579977|469116103|FG002|Treatment Phase|Study terminated by sponsor|61|||
130314228|NCT05579977|469116104|FG003|Treatment Phase|Study terminated by sponsor|59|||
130314229|NCT05579977|469116105|FG004|Treatment Phase|Study terminated by sponsor|63|||
130314230|NCT05579977|469116106|FG005|Treatment Phase|Study terminated by sponsor|53|||
130314231|NCT05579977|469116107|FG006|Treatment Phase|Study terminated by sponsor|66|||
130314232|NCT05579977|469116108|FG007|Treatment Phase|Study terminated by sponsor|48|||
130314233|NCT05579977|469116109|FG008|Treatment Phase|Study terminated by sponsor|47|||
130314234|NCT05579977|469116110|FG009|Treatment Phase|Study terminated by sponsor|37|||
130314235|NCT05579977|469116111|FG010|Treatment Phase|Study terminated by sponsor|44|||
130314236|NCT05579977|469116112|FG011|Treatment Phase|Study terminated by sponsor|36|||
130314237|NCT05579977|469116113|FG012|Treatment Phase|Study terminated by sponsor|32|||
130314238|NCT05579977|469116101|FG000|Treatment Phase|Pregnancy|0|||
130314239|NCT05579977|469116102|FG001|Treatment Phase|Pregnancy|0|||
130314240|NCT05579977|469116103|FG002|Treatment Phase|Pregnancy|0|||
130314241|NCT05579977|469116104|FG003|Treatment Phase|Pregnancy|0|||
130314242|NCT05579977|469116105|FG004|Treatment Phase|Pregnancy|0|||
130314243|NCT05579977|469116106|FG005|Treatment Phase|Pregnancy|0|||
130314244|NCT05579977|469116107|FG006|Treatment Phase|Pregnancy|0|||
130314245|NCT05579977|469116108|FG007|Treatment Phase|Pregnancy|0|||
130314246|NCT05579977|469116109|FG008|Treatment Phase|Pregnancy|0|||
130314247|NCT05579977|469116110|FG009|Treatment Phase|Pregnancy|1|||
130314248|NCT05579977|469116111|FG010|Treatment Phase|Pregnancy|0|||
130314249|NCT05579977|469116112|FG011|Treatment Phase|Pregnancy|0|||
130314250|NCT05579977|469116113|FG012|Treatment Phase|Pregnancy|0|||
130314251|NCT05579977|469116101|FG000|Treatment Phase|Physician Decision|0|||
129890581|NCT04423393|467557486|FG016|Overall Study|Withdrawal by Subject|0|||
129890582|NCT04423393|467557487|FG017|Overall Study|Withdrawal by Subject|0|||
129890583|NCT04423393|467557470|FG000|Overall Study|Sponsor Decision|0|||
129890584|NCT04423393|467557471|FG001|Overall Study|Sponsor Decision|0|||
129890585|NCT04423393|467557472|FG002|Overall Study|Sponsor Decision|0|||
129890586|NCT04423393|467557473|FG003|Overall Study|Sponsor Decision|0|||
129890587|NCT04423393|467557474|FG004|Overall Study|Sponsor Decision|0|||
129890588|NCT04423393|467557475|FG005|Overall Study|Sponsor Decision|0|||
130314252|NCT05579977|469116102|FG001|Treatment Phase|Physician Decision|0|||
130314253|NCT05579977|469116103|FG002|Treatment Phase|Physician Decision|0|||
130314254|NCT05579977|469116104|FG003|Treatment Phase|Physician Decision|0|||
130314255|NCT05579977|469116105|FG004|Treatment Phase|Physician Decision|0|||
130314256|NCT05579977|469116106|FG005|Treatment Phase|Physician Decision|0|||
130314257|NCT05579977|469116107|FG006|Treatment Phase|Physician Decision|0|||
130314258|NCT05579977|469116108|FG007|Treatment Phase|Physician Decision|0|||
130314259|NCT05579977|469116109|FG008|Treatment Phase|Physician Decision|0|||
129799647|NCT00760214|467235185|FG001|Overall Study|Lack of Efficacy|2|||
129799648|NCT00760214|467235186|FG002|Overall Study|Lack of Efficacy|4|||
129799649|NCT00760214|467235184|FG000|Overall Study|Pregnancy|0|||
129799650|NCT00760214|467235185|FG001|Overall Study|Pregnancy|0|||
129799651|NCT00760214|467235186|FG002|Overall Study|Pregnancy|1|||
129799652|NCT00760214|467235184|FG000|Overall Study|Physician Decision|1|||
129799653|NCT00760214|467235185|FG001|Overall Study|Physician Decision|1|||
129799654|NCT00760214|467235186|FG002|Overall Study|Physician Decision|1|||
129799655|NCT00760214|467235184|FG000|Overall Study|Other|3|||
129799656|NCT00760214|467235185|FG001|Overall Study|Other|4|||
129799657|NCT00760214|467235186|FG002|Overall Study|Other|6|||
129799658|NCT01134315|467235187|FG000|Overall Study|Adverse Event|1|||
129799659|NCT01134315|467235188|FG001|Overall Study|Adverse Event|2|||
129799660|NCT01134315|467235187|FG000|Overall Study|Other Reason|8|||
129799661|NCT01134315|467235188|FG001|Overall Study|Other Reason|17|||
129799662|NCT01086423|467235190|FG000|Overall Study|Protocol Violation|0|||
129799663|NCT01086423|467235191|FG001|Overall Study|Protocol Violation|0|||
129799664|NCT01086423|467235192|FG002|Overall Study|Protocol Violation|1|||
129799665|NCT01086423|467235190|FG000|Overall Study|Migrated/moved from study area|2|||
129799666|NCT01086423|467235191|FG001|Overall Study|Migrated/moved from study area|0|||
129799667|NCT01086423|467235192|FG002|Overall Study|Migrated/moved from study area|4|||
129799668|NCT01086423|467235190|FG000|Overall Study|Adverse event, fatal|1|||
129799669|NCT01086423|467235191|FG001|Overall Study|Adverse event, fatal|1|||
129799670|NCT01086423|467235192|FG002|Overall Study|Adverse event, fatal|0|||
129799671|NCT01086423|467235190|FG000|Overall Study|Adverse event, non-fatal|2|||
129799672|NCT01086423|467235191|FG001|Overall Study|Adverse event, non-fatal|1|||
129799673|NCT01086423|467235192|FG002|Overall Study|Adverse event, non-fatal|0|||
129799674|NCT01086423|467235190|FG000|Overall Study|Withdrawal by Subject|5|||
129799675|NCT01086423|467235191|FG001|Overall Study|Withdrawal by Subject|1|||
129799676|NCT01086423|467235192|FG002|Overall Study|Withdrawal by Subject|3|||
129799677|NCT01086423|467235190|FG000|Overall Study|Lost to Follow-up|0|||
129799678|NCT01086423|467235191|FG001|Overall Study|Lost to Follow-up|0|||
130314260|NCT05579977|469116110|FG009|Treatment Phase|Physician Decision|0|||
129799679|NCT01086423|467235192|FG002|Overall Study|Lost to Follow-up|1|||
129799680|NCT01130103|467235197|FG000|Randomized Treatment|Adverse Event|1|||
129799681|NCT01130103|467235198|FG001|Randomized Treatment|Adverse Event|1|||
129799682|NCT01130103|467235197|FG000|Randomized Treatment|Lost to Follow-up|1|||
129799683|NCT01130103|467235198|FG001|Randomized Treatment|Lost to Follow-up|0|||
129799684|NCT01130103|467235197|FG000|Randomized Treatment|Protocol Violation|3|||
129799685|NCT01130103|467235198|FG001|Randomized Treatment|Protocol Violation|2|||
129799686|NCT01130103|467235197|FG000|Randomized Treatment|Withdrawal by Subject|1|||
129799687|NCT01130103|467235198|FG001|Randomized Treatment|Withdrawal by Subject|2|||
129799688|NCT01130103|467235197|FG000|Maintenance Treatment|Lack of Efficacy|0|||
129799689|NCT01130103|467235198|FG001|Maintenance Treatment|Lack of Efficacy|1|||
129799690|NCT01130103|467235197|FG000|Maintenance Treatment|Lost to Follow-up|1|||
129799691|NCT01130103|467235198|FG001|Maintenance Treatment|Lost to Follow-up|1|||
129799692|NCT01130103|467235197|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
129799693|NCT01130103|467235198|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
129799694|NCT01465191|467235199|FG000|Overall Study|Protocol Violation|6|||
129799695|NCT01465191|467235200|FG001|Overall Study|Protocol Violation|3|||
129799696|NCT01465191|467235201|FG002|Overall Study|Protocol Violation|3|||
129799697|NCT01465191|467235199|FG000|Overall Study|Lost to Follow-up|3|||
129799698|NCT01465191|467235200|FG001|Overall Study|Lost to Follow-up|6|||
129799699|NCT01465191|467235201|FG002|Overall Study|Lost to Follow-up|4|||
129799700|NCT02992132|467235202|FG000|Overall Study|Adverse Event|4|||
130314261|NCT05579977|469116111|FG010|Treatment Phase|Physician Decision|0|||
130314262|NCT05579977|469116112|FG011|Treatment Phase|Physician Decision|1|||
130314263|NCT05579977|469116113|FG012|Treatment Phase|Physician Decision|0|||
129799701|NCT02992132|467235203|FG001|Overall Study|Adverse Event|1|||
129799702|NCT02992132|467235204|FG002|Overall Study|Adverse Event|3|||
129799703|NCT02992132|467235202|FG000|Overall Study|Lack of Efficacy|2|||
129799704|NCT02992132|467235203|FG001|Overall Study|Lack of Efficacy|0|||
129799705|NCT02992132|467235204|FG002|Overall Study|Lack of Efficacy|0|||
129799706|NCT02992132|467235202|FG000|Overall Study|Non-compliance with study drug|2|||
129799707|NCT02992132|467235203|FG001|Overall Study|Non-compliance with study drug|0|||
129799708|NCT02992132|467235204|FG002|Overall Study|Non-compliance with study drug|0|||
129799709|NCT02992132|467235202|FG000|Overall Study|Progressive disease|1|||
129799710|NCT02992132|467235203|FG001|Overall Study|Progressive disease|0|||
130314264|NCT05579977|469116101|FG000|Treatment Phase|Lost to Follow-up|0|||
130314265|NCT05579977|469116102|FG001|Treatment Phase|Lost to Follow-up|0|||
130314266|NCT05579977|469116103|FG002|Treatment Phase|Lost to Follow-up|0|||
129890589|NCT04423393|467557476|FG006|Overall Study|Sponsor Decision|0|||
129890590|NCT04423393|467557477|FG007|Overall Study|Sponsor Decision|0|||
129890591|NCT04423393|467557478|FG008|Overall Study|Sponsor Decision|0|||
129890592|NCT04423393|467557479|FG009|Overall Study|Sponsor Decision|0|||
129890593|NCT04423393|467557480|FG010|Overall Study|Sponsor Decision|0|||
129890594|NCT04423393|467557481|FG011|Overall Study|Sponsor Decision|0|||
129890595|NCT04423393|467557482|FG012|Overall Study|Sponsor Decision|0|||
129890596|NCT04423393|467557483|FG013|Overall Study|Sponsor Decision|1|||
129890597|NCT04423393|467557484|FG014|Overall Study|Sponsor Decision|0|||
129890598|NCT04423393|467557485|FG015|Overall Study|Sponsor Decision|0|||
129890599|NCT04423393|467557486|FG016|Overall Study|Sponsor Decision|0|||
129890600|NCT04423393|467557487|FG017|Overall Study|Sponsor Decision|0|||
129890601|NCT02692235|467557490|FG000|Overall Study|Withdrawal by Subject|2|||
129890602|NCT02692235|467557491|FG001|Overall Study|Withdrawal by Subject|1|||
129890603|NCT02692235|467557490|FG000|Overall Study|Adverse Event|1|||
129890604|NCT02692235|467557491|FG001|Overall Study|Adverse Event|2|||
129890605|NCT00802841|467557492|FG000|Overall Study|Administrative problems|1|||
129890606|NCT00802841|467557493|FG001|Overall Study|Administrative problems|0|||
129890607|NCT00802841|467557492|FG000|Overall Study|Lost to Follow-up|2|||
129890608|NCT00802841|467557493|FG001|Overall Study|Lost to Follow-up|1|||
129890609|NCT00802841|467557492|FG000|Overall Study|Death|1|||
129890610|NCT00802841|467557493|FG001|Overall Study|Death|2|||
129890611|NCT00802841|467557492|FG000|Overall Study|Adverse Event|8|||
129890612|NCT00802841|467557493|FG001|Overall Study|Adverse Event|2|||
129890613|NCT00802841|467557492|FG000|Overall Study|Disease progression|7|||
129890614|NCT00802841|467557493|FG001|Overall Study|Disease progression|3|||
129890615|NCT00802841|467557492|FG000|Overall Study|Withdrawal by Subject|9|||
129890616|NCT00802841|467557493|FG001|Overall Study|Withdrawal by Subject|5|||
129890617|NCT00802841|467557492|FG000|Overall Study|Protocol deviation|2|||
129890618|NCT00802841|467557493|FG001|Overall Study|Protocol deviation|6|||
129890619|NCT00802841|467557492|FG000|Overall Study|Treatment duration completed|66|||
129890620|NCT00802841|467557493|FG001|Overall Study|Treatment duration completed|76|||
129890621|NCT02711995|467557494|FG000|Washout (90 Days)|Conflicting medication|1|||
129890622|NCT01115998|467557499|FG000|Overall Study|Lost to Follow-up|6|||
129890623|NCT01115998|467557500|FG001|Overall Study|Lost to Follow-up|6|||
129890624|NCT02819479|467557501|FG000|Overall Study|Adverse Event|2|||
129890625|NCT03531905|467557502|FG000|Overall Study|Withdrawal by Subject|3|||
129890626|NCT03531905|467557503|FG001|Overall Study|Withdrawal by Subject|3|||
129890627|NCT03531905|467557504|FG002|Overall Study|Withdrawal by Subject|2|||
129890628|NCT03531905|467557502|FG000|Overall Study|Lost to Follow-up|2|||
129890629|NCT03531905|467557503|FG001|Overall Study|Lost to Follow-up|2|||
129890630|NCT03531905|467557504|FG002|Overall Study|Lost to Follow-up|1|||
129890631|NCT03531905|467557502|FG000|Overall Study|Participant was out of town|1|||
129890632|NCT03531905|467557503|FG001|Overall Study|Participant was out of town|0|||
130314267|NCT05579977|469116104|FG003|Treatment Phase|Lost to Follow-up|1|||
130314268|NCT05579977|469116105|FG004|Treatment Phase|Lost to Follow-up|1|||
129890633|NCT03531905|467557504|FG002|Overall Study|Participant was out of town|0|||
129890634|NCT03531905|467557502|FG000|Overall Study|Could not speak with the participant|1|||
129890635|NCT03531905|467557503|FG001|Overall Study|Could not speak with the participant|0|||
129890636|NCT03531905|467557504|FG002|Overall Study|Could not speak with the participant|0|||
129890637|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
129890638|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
129890639|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
130110628|NCT00729365|468365804|FG000|Overall Study|Physician Decision|33|||
130314269|NCT05579977|469116106|FG005|Treatment Phase|Lost to Follow-up|1|||
130314270|NCT05579977|469116107|FG006|Treatment Phase|Lost to Follow-up|0|||
130314271|NCT05579977|469116108|FG007|Treatment Phase|Lost to Follow-up|1|||
130314272|NCT05579977|469116109|FG008|Treatment Phase|Lost to Follow-up|2|||
130314273|NCT05579977|469116110|FG009|Treatment Phase|Lost to Follow-up|2|||
130314274|NCT05579977|469116111|FG010|Treatment Phase|Lost to Follow-up|1|||
130314275|NCT05579977|469116112|FG011|Treatment Phase|Lost to Follow-up|4|||
130314276|NCT05579977|469116113|FG012|Treatment Phase|Lost to Follow-up|3|||
130314277|NCT05579977|469116101|FG000|Treatment Phase|Death|1|||
130314278|NCT05579977|469116102|FG001|Treatment Phase|Death|0|||
130314279|NCT05579977|469116103|FG002|Treatment Phase|Death|0|||
130314280|NCT05579977|469116104|FG003|Treatment Phase|Death|0|||
130314281|NCT05579977|469116105|FG004|Treatment Phase|Death|0|||
130314282|NCT05579977|469116106|FG005|Treatment Phase|Death|0|||
130314283|NCT05579977|469116107|FG006|Treatment Phase|Death|0|||
130314284|NCT05579977|469116108|FG007|Treatment Phase|Death|0|||
130314285|NCT05579977|469116109|FG008|Treatment Phase|Death|0|||
130314286|NCT05579977|469116110|FG009|Treatment Phase|Death|0|||
130314287|NCT05579977|469116111|FG010|Treatment Phase|Death|0|||
130314288|NCT05579977|469116112|FG011|Treatment Phase|Death|0|||
130314289|NCT05579977|469116113|FG012|Treatment Phase|Death|0|||
130314290|NCT05579977|469116101|FG000|Treatment Phase|Adverse Event|0|||
130314291|NCT05579977|469116102|FG001|Treatment Phase|Adverse Event|3|||
130314292|NCT05579977|469116103|FG002|Treatment Phase|Adverse Event|11|||
129890640|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
129890641|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
129890642|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
129890643|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
129890644|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
129890645|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
129890646|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
129890647|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
129890648|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
129890649|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
129890650|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
129890651|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
129890652|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
129890653|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
129890654|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
129890655|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
129890656|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
129890657|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
129890658|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
129890659|NCT01489020|467557514|FG000|Overall Study|Withdrawal by Subject|1|||
129890660|NCT01489020|467557515|FG001|Overall Study|Withdrawal by Subject|0|||
129890661|NCT01489020|467557516|FG002|Overall Study|Withdrawal by Subject|0|||
129890662|NCT01489020|467557517|FG003|Overall Study|Withdrawal by Subject|0|||
129890663|NCT01489020|467557518|FG004|Overall Study|Withdrawal by Subject|0|||
129890664|NCT01489020|467557519|FG005|Overall Study|Withdrawal by Subject|0|||
129890665|NCT01489020|467557514|FG000|Overall Study|Adverse Event|0|||
129890666|NCT01489020|467557515|FG001|Overall Study|Adverse Event|0|||
129890667|NCT01489020|467557516|FG002|Overall Study|Adverse Event|3|||
129890668|NCT01489020|467557517|FG003|Overall Study|Adverse Event|0|||
129890669|NCT01489020|467557518|FG004|Overall Study|Adverse Event|3|||
129890670|NCT01489020|467557519|FG005|Overall Study|Adverse Event|0|||
129890671|NCT01489020|467557514|FG000|Overall Study|Concomitant disease|0|||
129890672|NCT01489020|467557515|FG001|Overall Study|Concomitant disease|0|||
129890673|NCT01489020|467557516|FG002|Overall Study|Concomitant disease|0|||
129890674|NCT01489020|467557517|FG003|Overall Study|Concomitant disease|0|||
129890675|NCT01489020|467557518|FG004|Overall Study|Concomitant disease|3|||
129890676|NCT01489020|467557519|FG005|Overall Study|Concomitant disease|0|||
129890677|NCT01174550|467557520|FG000|Overall Study|Death|75|||
129890678|NCT01174550|467557521|FG001|Overall Study|Death|74|||
129890679|NCT01174550|467557520|FG000|Overall Study|Lost to Follow-up|652|||
129890680|NCT01174550|467557521|FG001|Overall Study|Lost to Follow-up|510|||
129890681|NCT01174550|467557520|FG000|Overall Study|Withdrawal by Subject|543|||
129890682|NCT01174550|467557521|FG001|Overall Study|Withdrawal by Subject|289|||
129890683|NCT01536262|467557522|FG000|Overall Study|Adverse Event|6|||
129890684|NCT01536262|467557523|FG001|Overall Study|Adverse Event|1|||
129890685|NCT01536262|467557524|FG002|Overall Study|Adverse Event|2|||
129890686|NCT01536262|467557522|FG000|Overall Study|Withdrawal by Subject|1|||
129890687|NCT01536262|467557523|FG001|Overall Study|Withdrawal by Subject|1|||
129890688|NCT01536262|467557524|FG002|Overall Study|Withdrawal by Subject|0|||
129890689|NCT01536262|467557522|FG000|Overall Study|Other than stated above|1|||
129890690|NCT01536262|467557523|FG001|Overall Study|Other than stated above|0|||
129890691|NCT01536262|467557524|FG002|Overall Study|Other than stated above|0|||
129890692|NCT05257837|467557528|FG000|Overall Study|Excluded (did not find the guns)|4|||
129890693|NCT05257837|467557529|FG001|Overall Study|Excluded (did not find the guns)|2|||
129890694|NCT05257837|467557530|FG002|Overall Study|Excluded (did not find the guns)|4|||
129890695|NCT05257837|467557531|FG003|Overall Study|Excluded (did not find the guns)|0|||
129890696|NCT01781611|467557532|FG000|Overall Study|Adverse Event|4|||
129890697|NCT01781611|467557533|FG001|Overall Study|Adverse Event|0|||
129890698|NCT01625338|467557534|FG000|Overall Study|Enrolled but not Treated|0|||
129890699|NCT01625338|467557535|FG001|Overall Study|Enrolled but not Treated|0|||
129890700|NCT01625338|467557536|FG002|Overall Study|Enrolled but not Treated|1|||
129890701|NCT01625338|467557534|FG000|Overall Study|Efficacy Failure|27|||
129890702|NCT01625338|467557535|FG001|Overall Study|Efficacy Failure|39|||
129890703|NCT01625338|467557536|FG002|Overall Study|Efficacy Failure|31|||
129890704|NCT01625338|467557534|FG000|Overall Study|Lost to Follow-up|3|||
129890705|NCT01625338|467557535|FG001|Overall Study|Lost to Follow-up|3|||
129890706|NCT01625338|467557536|FG002|Overall Study|Lost to Follow-up|2|||
129890707|NCT01625338|467557534|FG000|Overall Study|Investigator Decision|0|||
129890708|NCT01625338|467557535|FG001|Overall Study|Investigator Decision|2|||
129890709|NCT01625338|467557536|FG002|Overall Study|Investigator Decision|1|||
129890710|NCT01625338|467557534|FG000|Overall Study|Subject Withdrew Consent|1|||
129890711|NCT01625338|467557535|FG001|Overall Study|Subject Withdrew Consent|0|||
129890712|NCT01625338|467557536|FG002|Overall Study|Subject Withdrew Consent|2|||
129890713|NCT01625338|467557534|FG000|Overall Study|Adverse Event|1|||
129799711|NCT02992132|467235204|FG002|Overall Study|Progressive disease|0|||
129799712|NCT02992132|467235202|FG000|Overall Study|Protocol Violation|2|||
129799713|NCT02992132|467235203|FG001|Overall Study|Protocol Violation|2|||
129799714|NCT02992132|467235204|FG002|Overall Study|Protocol Violation|0|||
129799715|NCT02992132|467235202|FG000|Overall Study|Caregiver withdrew consent|2|||
129799716|NCT02992132|467235203|FG001|Overall Study|Caregiver withdrew consent|3|||
129799717|NCT02992132|467235204|FG002|Overall Study|Caregiver withdrew consent|2|||
129799718|NCT02992132|467235202|FG000|Overall Study|Withdrawal by Subject|0|||
129799719|NCT02992132|467235203|FG001|Overall Study|Withdrawal by Subject|2|||
129799720|NCT02992132|467235204|FG002|Overall Study|Withdrawal by Subject|1|||
129799721|NCT02992132|467235202|FG000|Overall Study|Physician Decision|0|||
129799722|NCT02992132|467235203|FG001|Overall Study|Physician Decision|0|||
129799723|NCT02992132|467235204|FG002|Overall Study|Physician Decision|1|||
129799724|NCT00620464|467235205|FG000|Overall Study|Adverse Event|15|||
129799725|NCT00620464|467235206|FG001|Overall Study|Adverse Event|17|||
129799726|NCT00620464|467235205|FG000|Overall Study|Lost to Follow-up|1|||
129799727|NCT00620464|467235206|FG001|Overall Study|Lost to Follow-up|1|||
129799728|NCT00620464|467235205|FG000|Overall Study|Planning Pregnancy|1|||
129799729|NCT00620464|467235206|FG001|Overall Study|Planning Pregnancy|4|||
129799730|NCT00620464|467235205|FG000|Overall Study|Personal|2|||
129799731|NCT00620464|467235206|FG001|Overall Study|Personal|2|||
129799732|NCT00620464|467235205|FG000|Overall Study|Used prohibited medication|1|||
129799733|NCT00620464|467235206|FG001|Overall Study|Used prohibited medication|0|||
129799734|NCT00467610|467235207|FG000|Overall Study|Withdrawal by Subject|1|||
129799735|NCT01369615|467235208|FG000|Overall Study|Withdrawal by Subject|0|||
129799736|NCT01369615|467235209|FG001|Overall Study|Withdrawal by Subject|1|||
129799737|NCT01369615|467235208|FG000|Overall Study|Lost to Follow-up|0|||
129799738|NCT01369615|467235209|FG001|Overall Study|Lost to Follow-up|1|||
129799739|NCT04263454|467235210|FG000|Overall Study|Adverse Event|0|||
129799740|NCT04263454|467235211|FG001|Overall Study|Adverse Event|2|||
129799741|NCT04263454|467235210|FG000|Overall Study|Physician Decision|3|||
129799742|NCT04263454|467235211|FG001|Overall Study|Physician Decision|5|||
129799743|NCT04263454|467235210|FG000|Overall Study|Poor Data Quality|0|||
129799744|NCT04263454|467235211|FG001|Overall Study|Poor Data Quality|1|||
129799745|NCT00986479|467235212|FG000|Period 1|Improved mood|1|||
129799746|NCT00986479|467235213|FG001|Period 1|Improved mood|0|||
129799747|NCT00986479|467235212|FG000|Period 1|Administrative reasons|1|||
129799748|NCT00986479|467235213|FG001|Period 1|Administrative reasons|0|||
129799749|NCT00237185|467235214|FG000|Core|Adverse Event|3|||
129799750|NCT00237185|467235215|FG001|Core|Adverse Event|4|||
129799751|NCT00237185|467235214|FG000|Core|Abnormal laboratory value|0|||
129799752|NCT00237185|467235215|FG001|Core|Abnormal laboratory value|4|||
129799753|NCT00237185|467235214|FG000|Core|Abnormal test procedure results|1|||
129799754|NCT00237185|467235215|FG001|Core|Abnormal test procedure results|0|||
129799755|NCT00237185|467235214|FG000|Core|Lack of Efficacy|30|||
129799756|NCT00237185|467235215|FG001|Core|Lack of Efficacy|23|||
129799757|NCT00237185|467235214|FG000|Core|Protocol Violation|1|||
129799758|NCT00237185|467235215|FG001|Core|Protocol Violation|1|||
129799759|NCT00237185|467235214|FG000|Core|Withdrawal by Subject|4|||
129799760|NCT00237185|467235215|FG001|Core|Withdrawal by Subject|4|||
129799761|NCT00237185|467235214|FG000|Core|Administrative problems|0|||
129799762|NCT00237185|467235215|FG001|Core|Administrative problems|1|||
129799763|NCT00237185|467235214|FG000|Core|Death|4|||
129799764|NCT00237185|467235215|FG001|Core|Death|0|||
129799765|NCT00237185|467235214|FG000|Core|Determined ineligible post randomization|1|||
129799766|NCT00237185|467235215|FG001|Core|Determined ineligible post randomization|0|||
129799767|NCT00237185|467235214|FG000|Extension|Adverse Event|1|||
129799768|NCT00237185|467235215|FG001|Extension|Adverse Event|0|||
129799769|NCT00237185|467235214|FG000|Extension|Abnormal laboratory value|0|||
129799770|NCT00237185|467235215|FG001|Extension|Abnormal laboratory value|1|||
129799771|NCT00237185|467235214|FG000|Extension|Lack of Efficacy|9|||
129799772|NCT00237185|467235215|FG001|Extension|Lack of Efficacy|14|||
129799773|NCT00237185|467235214|FG000|Extension|Condition no longer required study drug|0|||
129799774|NCT00237185|467235215|FG001|Extension|Condition no longer required study drug|1|||
130050621|NCT01663740|468140879|FG001|Overall Study|Other|2|||
129799775|NCT00237185|467235214|FG000|Extension|Withdrawal by Subject|3|||
129799776|NCT00237185|467235215|FG001|Extension|Withdrawal by Subject|2|||
129799777|NCT00237185|467235214|FG000|Extension|Lost to Follow-up|1|||
129799778|NCT00237185|467235215|FG001|Extension|Lost to Follow-up|0|||
129799779|NCT00237185|467235214|FG000|Extension|Administrative problems|1|||
129799780|NCT00237185|467235215|FG001|Extension|Administrative problems|0|||
129799781|NCT00237185|467235214|FG000|Extension|Death|1|||
129799782|NCT00237185|467235215|FG001|Extension|Death|1|||
129799783|NCT02035475|467235216|FG000|Overall Study|Withdrawal by Subject|4|||
129799784|NCT02035475|467235216|FG000|Overall Study|Physician Decision|1|||
129799785|NCT02035475|467235216|FG000|Overall Study|Equipment Error|1|||
129799786|NCT01231347|467235217|FG000|Overall Study|Full Consent withdrawn|19|||
129799787|NCT01231347|467235218|FG001|Overall Study|Full Consent withdrawn|19|||
129799788|NCT01231347|467235219|FG002|Overall Study|Full Consent withdrawn|11|||
129799789|NCT01231347|467235217|FG000|Overall Study|Lost to Follow-up|4|||
129799790|NCT01231347|467235218|FG001|Overall Study|Lost to Follow-up|2|||
130314293|NCT05579977|469116104|FG003|Treatment Phase|Adverse Event|10|||
130314294|NCT05579977|469116105|FG004|Treatment Phase|Adverse Event|5|||
130314295|NCT05579977|469116106|FG005|Treatment Phase|Adverse Event|17|||
130314296|NCT05579977|469116107|FG006|Treatment Phase|Adverse Event|5|||
130314297|NCT05579977|469116108|FG007|Treatment Phase|Adverse Event|5|||
130314298|NCT05579977|469116109|FG008|Treatment Phase|Adverse Event|12|||
130314299|NCT05579977|469116110|FG009|Treatment Phase|Adverse Event|20|||
130314300|NCT05579977|469116111|FG010|Treatment Phase|Adverse Event|15|||
130314301|NCT05579977|469116112|FG011|Treatment Phase|Adverse Event|24|||
130314302|NCT05579977|469116113|FG012|Treatment Phase|Adverse Event|23|||
130314303|NCT05579977|469116101|FG000|Treatment Phase|Randomized not treated|0|||
130314304|NCT05579977|469116102|FG001|Treatment Phase|Randomized not treated|0|||
130314305|NCT05579977|469116103|FG002|Treatment Phase|Randomized not treated|0|||
130314306|NCT05579977|469116104|FG003|Treatment Phase|Randomized not treated|0|||
130314307|NCT05579977|469116105|FG004|Treatment Phase|Randomized not treated|1|||
130314308|NCT05579977|469116106|FG005|Treatment Phase|Randomized not treated|0|||
130314309|NCT05579977|469116107|FG006|Treatment Phase|Randomized not treated|0|||
130314310|NCT05579977|469116108|FG007|Treatment Phase|Randomized not treated|0|||
130314311|NCT05579977|469116109|FG008|Treatment Phase|Randomized not treated|0|||
130314312|NCT05579977|469116110|FG009|Treatment Phase|Randomized not treated|0|||
130314313|NCT05579977|469116111|FG010|Treatment Phase|Randomized not treated|0|||
130314314|NCT05579977|469116112|FG011|Treatment Phase|Randomized not treated|0|||
130314315|NCT05579977|469116113|FG012|Treatment Phase|Randomized not treated|0|||
130314316|NCT05579977|469116101|FG000|Follow up|Death|1|||
130314317|NCT05579977|469116102|FG001|Follow up|Death|0|||
130314318|NCT05579977|469116103|FG002|Follow up|Death|0|||
130314319|NCT05579977|469116104|FG003|Follow up|Death|0|||
130314320|NCT05579977|469116105|FG004|Follow up|Death|0|||
130314321|NCT05579977|469116106|FG005|Follow up|Death|0|||
130314322|NCT05579977|469116107|FG006|Follow up|Death|0|||
130314323|NCT05579977|469116108|FG007|Follow up|Death|0|||
130314324|NCT05579977|469116109|FG008|Follow up|Death|0|||
130314325|NCT05579977|469116110|FG009|Follow up|Death|0|||
130314326|NCT05579977|469116111|FG010|Follow up|Death|0|||
130314327|NCT05579977|469116112|FG011|Follow up|Death|0|||
130314328|NCT05579977|469116113|FG012|Follow up|Death|0|||
130314329|NCT05579977|469116101|FG000|Follow up|Lost to Follow-up|0|||
130314330|NCT05579977|469116102|FG001|Follow up|Lost to Follow-up|0|||
130314331|NCT05579977|469116103|FG002|Follow up|Lost to Follow-up|0|||
130314332|NCT05579977|469116104|FG003|Follow up|Lost to Follow-up|1|||
130314333|NCT05579977|469116105|FG004|Follow up|Lost to Follow-up|1|||
130314334|NCT05579977|469116106|FG005|Follow up|Lost to Follow-up|2|||
130314335|NCT05579977|469116107|FG006|Follow up|Lost to Follow-up|1|||
130314336|NCT05579977|469116108|FG007|Follow up|Lost to Follow-up|1|||
130314337|NCT05579977|469116109|FG008|Follow up|Lost to Follow-up|3|||
130314338|NCT05579977|469116110|FG009|Follow up|Lost to Follow-up|2|||
130314339|NCT05579977|469116111|FG010|Follow up|Lost to Follow-up|2|||
130314340|NCT05579977|469116112|FG011|Follow up|Lost to Follow-up|4|||
130314341|NCT05579977|469116113|FG012|Follow up|Lost to Follow-up|4|||
130314342|NCT05579977|469116101|FG000|Follow up|Withdrawal by Subject|2|||
130314343|NCT05579977|469116102|FG001|Follow up|Withdrawal by Subject|0|||
130314344|NCT05579977|469116103|FG002|Follow up|Withdrawal by Subject|0|||
130314345|NCT05579977|469116104|FG003|Follow up|Withdrawal by Subject|0|||
130314346|NCT05579977|469116105|FG004|Follow up|Withdrawal by Subject|1|||
130314347|NCT05579977|469116106|FG005|Follow up|Withdrawal by Subject|0|||
130314348|NCT05579977|469116107|FG006|Follow up|Withdrawal by Subject|1|||
130314349|NCT05579977|469116108|FG007|Follow up|Withdrawal by Subject|4|||
130050622|NCT01663740|468140878|FG000|Overall Study|Inclusion/Exclusion not met|1|||
130314350|NCT05579977|469116109|FG008|Follow up|Withdrawal by Subject|2|||
130314351|NCT05579977|469116110|FG009|Follow up|Withdrawal by Subject|3|||
130314352|NCT05579977|469116111|FG010|Follow up|Withdrawal by Subject|3|||
130314353|NCT05579977|469116112|FG011|Follow up|Withdrawal by Subject|1|||
130314354|NCT05579977|469116113|FG012|Follow up|Withdrawal by Subject|3|||
130314355|NCT00866814|469116114|FG000|Overall Study|Lost to Follow-up|12|||
130314356|NCT00866814|469116114|FG000|Overall Study|Adverse Event|2|||
130314357|NCT00866814|469116114|FG000|Overall Study|Physician Decision|1|||
130314358|NCT00866814|469116114|FG000|Overall Study|Death|1|||
130314359|NCT00866814|469116114|FG000|Overall Study|No longer wished to participate|1|||
129799791|NCT01231347|467235219|FG002|Overall Study|Lost to Follow-up|2|||
130314360|NCT00866814|469116114|FG000|Overall Study|Unable to meet follow-up requirements|2|||
130314361|NCT00866814|469116114|FG000|Overall Study|Moved to area without study site|1|||
130314362|NCT01420926|469116117|FG000|Overall Study|Adverse Event|6|||
130314363|NCT01420926|469116118|FG001|Overall Study|Adverse Event|4|||
130314364|NCT01420926|469116117|FG000|Overall Study|Death|18|||
130314365|NCT01420926|469116118|FG001|Overall Study|Death|17|||
130314366|NCT01420926|469116117|FG000|Overall Study|Withdrawal by Subject|11|||
130314367|NCT01420926|469116118|FG001|Overall Study|Withdrawal by Subject|17|||
130314368|NCT01420926|469116117|FG000|Overall Study|Non-protocol treatment|17|||
130314369|NCT01420926|469116118|FG001|Overall Study|Non-protocol treatment|20|||
130314370|NCT01420926|469116117|FG000|Overall Study|Physician Decision|8|||
130314371|NCT01420926|469116118|FG001|Overall Study|Physician Decision|5|||
129799792|NCT01231347|467235217|FG000|Overall Study|Death|202|||
129799793|NCT01231347|467235218|FG001|Overall Study|Death|210|||
129799794|NCT01231347|467235219|FG002|Overall Study|Death|101|||
129799795|NCT01231347|467235217|FG000|Overall Study|other event|7|||
130050623|NCT01663740|468140879|FG001|Overall Study|Inclusion/Exclusion not met|0|||
130050624|NCT01663740|468140878|FG000|Overall Study|Death|0|||
130050625|NCT01663740|468140879|FG001|Overall Study|Death|1|||
130050626|NCT01663740|468140878|FG000|Overall Study|Withdrawal by Subject|2|||
130050627|NCT01663740|468140879|FG001|Overall Study|Withdrawal by Subject|1|||
130050628|NCT01663740|468140878|FG000|Overall Study|No end of study status|3|||
130050629|NCT01663740|468140879|FG001|Overall Study|No end of study status|0|||
130050630|NCT05070429|468142632|FG000|Overall Study|Death|0|||
130050631|NCT05070429|468142633|FG001|Overall Study|Death|4|||
130050632|NCT05070429|468142632|FG000|Overall Study|Withdrawal by Subject|2|||
130050633|NCT05070429|468142633|FG001|Overall Study|Withdrawal by Subject|1|||
130050634|NCT05070429|468142632|FG000|Overall Study|Other|15|||
130050635|NCT05070429|468142633|FG001|Overall Study|Other|5|||
130314372|NCT04564846|469118247|FG000|Overall Study|Withdrawal by Subject|2|||
130314373|NCT04564846|469118248|FG001|Overall Study|Withdrawal by Subject|1|||
130314374|NCT04564846|469118247|FG000|Overall Study|Physician Decision|0|||
130314375|NCT04564846|469118248|FG001|Overall Study|Physician Decision|1|||
130050636|NCT03097328|468142634|FG000|Overall Study|Still on Therapy|2|||
130050637|NCT03097328|468142634|FG000|Overall Study|Progressive Disease|29|||
130110629|NCT00729365|468365805|FG001|Overall Study|Physician Decision|6|||
130314376|NCT04564846|469118247|FG000|Overall Study|Lost to Follow-up|0|||
130314377|NCT04564846|469118248|FG001|Overall Study|Lost to Follow-up|1|||
130314378|NCT04564846|469118247|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
130314379|NCT04564846|469118248|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
130314380|NCT04564846|469118247|FG000|Overall Study|Subject non-compliance|1|||
130314381|NCT04564846|469118248|FG001|Overall Study|Subject non-compliance|0|||
130314382|NCT00865345|469118249|FG000|Overall Study|Withdrawal by Subject|2|||
130314383|NCT04388111|469118252|FG000|Overall Study|Lost to Follow-up|5|||
130314384|NCT04388111|469118253|FG001|Overall Study|Lost to Follow-up|3|||
130314385|NCT04388111|469118252|FG000|Overall Study|Adverse Event|1|||
130314386|NCT04388111|469118253|FG001|Overall Study|Adverse Event|1|||
130314387|NCT04388111|469118252|FG000|Overall Study|Protocol Violation|2|||
130314388|NCT04388111|469118253|FG001|Overall Study|Protocol Violation|4|||
130314389|NCT04388111|469118252|FG000|Overall Study|Withdrawal by Subject|1|||
130314390|NCT04388111|469118253|FG001|Overall Study|Withdrawal by Subject|0|||
130314391|NCT02735239|469118254|FG000|Overall Study|Adverse Event|0|||
129799796|NCT01231347|467235218|FG001|Overall Study|other event|9|||
129799797|NCT01231347|467235219|FG002|Overall Study|other event|3|||
129799798|NCT01702571|467235220|FG000|Overall Study|Death|1067|||
129799799|NCT01702571|467235221|FG001|Overall Study|Death|76|||
129799800|NCT01702571|467235220|FG000|Overall Study|Lost to Follow-up|144|||
129799801|NCT01702571|467235221|FG001|Overall Study|Lost to Follow-up|10|||
129799802|NCT01702571|467235220|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
129799803|NCT01702571|467235221|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
129799804|NCT01702571|467235220|FG000|Overall Study|Investigator Decision|5|||
129799805|NCT01702571|467235221|FG001|Overall Study|Investigator Decision|0|||
129799806|NCT01702571|467235220|FG000|Overall Study|Not Classifiable|1|||
129799807|NCT01702571|467235221|FG001|Overall Study|Not Classifiable|0|||
129799808|NCT01702571|467235220|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
129799809|NCT01702571|467235221|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
129799810|NCT01702571|467235220|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
129799811|NCT01702571|467235221|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
129799812|NCT01702571|467235220|FG000|Overall Study|Progressive Disease|3|||
129799813|NCT01702571|467235221|FG001|Overall Study|Progressive Disease|0|||
129799814|NCT01702571|467235220|FG000|Overall Study|Protocol Violation|2|||
129799815|NCT01702571|467235221|FG001|Overall Study|Protocol Violation|0|||
129799816|NCT01702571|467235220|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
129799817|NCT01702571|467235221|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
129799818|NCT01702571|467235220|FG000|Overall Study|Termination By Sponsor|4|||
129799819|NCT01702571|467235221|FG001|Overall Study|Termination By Sponsor|0|||
129799820|NCT01702571|467235220|FG000|Overall Study|Withdrawal by Subject|177|||
129799821|NCT01702571|467235221|FG001|Overall Study|Withdrawal by Subject|29|||
129799822|NCT02322021|467235222|FG000|Core Phase|Adverse Event|1|||
129799823|NCT02322021|467235223|FG001|Core Phase|Adverse Event|3|||
129799824|NCT02322021|467235224|FG002|Core Phase|Adverse Event|4|||
130050638|NCT03097328|468142634|FG000|Overall Study|Adverse Event|4|||
129799825|NCT02322021|467235225|FG003|Core Phase|Adverse Event|2|||
130050639|NCT03097328|468142634|FG000|Overall Study|Withdrawal by Subject|1|||
130050640|NCT03097328|468142634|FG000|Overall Study|Physician Decision|1|||
130050641|NCT03097328|468142634|FG000|Overall Study|Patient Decision|1|||
129799826|NCT02322021|467235226|FG004|Core Phase|Adverse Event|0|||
129799827|NCT02322021|467235222|FG000|Core Phase|Participant Choice|4|||
129799828|NCT02322021|467235223|FG001|Core Phase|Participant Choice|5|||
130050642|NCT03097328|468142634|FG000|Overall Study|Ineligible for Study Drug|1|||
130314392|NCT02735239|469118255|FG001|Overall Study|Adverse Event|0|||
130314393|NCT02735239|469118256|FG002|Overall Study|Adverse Event|4|||
130314394|NCT02735239|469118257|FG003|Overall Study|Adverse Event|0|||
130314395|NCT02735239|469118258|FG004|Overall Study|Adverse Event|0|||
130314396|NCT02735239|469118259|FG005|Overall Study|Adverse Event|0|||
130314397|NCT02735239|469118254|FG000|Overall Study|Death|1|||
130314398|NCT02735239|469118255|FG001|Overall Study|Death|1|||
129799829|NCT02322021|467235224|FG002|Core Phase|Participant Choice|4|||
129799830|NCT02322021|467235225|FG003|Core Phase|Participant Choice|2|||
130050643|NCT01798134|468142635|FG000|Overall Study|Lost to Follow-up|1|||
130050644|NCT01798134|468142635|FG000|Overall Study|Withdrawal by Subject|3|||
130050645|NCT01798134|468142635|FG000|Overall Study|Death|2|||
130050646|NCT01798134|468142635|FG000|Overall Study|Adverse Event|3|||
130050647|NCT01798134|468142635|FG000|Overall Study|Physician Decision|3|||
130050648|NCT01798134|468142635|FG000|Overall Study|Liver transplant/surgery|4|||
130050649|NCT02023164|468142636|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
130050650|NCT02023164|468142637|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
130050651|NCT02653976|468142638|FG000|Overall Study|Withdrawal by Subject|5|||
130050652|NCT02653976|468142638|FG000|Overall Study|Death|4|||
130050653|NCT00883558|468142639|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
130050654|NCT00883558|468142640|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
130050655|NCT00883558|468142641|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
130050656|NCT00883558|468142639|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
130050657|NCT00883558|468142640|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
130050658|NCT00883558|468142641|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
130050659|NCT00883558|468142639|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
130050660|NCT00883558|468142640|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
130050661|NCT00883558|468142641|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
130050662|NCT00883558|468142639|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
130050663|NCT00883558|468142640|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
130050664|NCT00883558|468142641|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
130050665|NCT00883558|468142639|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
130050666|NCT00883558|468142640|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
130050667|NCT00883558|468142641|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
130050668|NCT02436577|468142642|FG000|Overall Study|Protocol Deviation|0|||
130050669|NCT02436577|468142643|FG001|Overall Study|Protocol Deviation|1|||
130050670|NCT02436577|468142644|FG002|Overall Study|Protocol Deviation|0|||
130050671|NCT02436577|468142645|FG003|Overall Study|Protocol Deviation|0|||
130050672|NCT02436577|468142646|FG004|Overall Study|Protocol Deviation|0|||
130050673|NCT02436577|468142647|FG005|Overall Study|Protocol Deviation|0|||
130050674|NCT03703375|468142651|FG000|Randomization Period|Withdrawal by Subject|0|||
130050675|NCT03703375|468142652|FG001|Randomization Period|Withdrawal by Subject|0|||
130050676|NCT03703375|468142653|FG002|Randomization Period|Withdrawal by Subject|0|||
130050677|NCT03703375|468142654|FG003|Randomization Period|Withdrawal by Subject|1|||
130050678|NCT03703375|468142651|FG000|Randomization Period|Completed safety run-in treatment|7|||
130050679|NCT03703375|468142652|FG001|Randomization Period|Completed safety run-in treatment|0|||
130050680|NCT03703375|468142653|FG002|Randomization Period|Completed safety run-in treatment|0|||
130050681|NCT03703375|468142654|FG003|Randomization Period|Completed safety run-in treatment|0|||
130050682|NCT03703375|468142651|FG000|Treatment Period|Other Reasons|0|||
130050683|NCT03703375|468142652|FG001|Treatment Period|Other Reasons|1|||
130050684|NCT03703375|468142653|FG002|Treatment Period|Other Reasons|0|||
130050685|NCT03703375|468142654|FG003|Treatment Period|Other Reasons|3|||
130050686|NCT03703375|468142651|FG000|Treatment Period|Consent Withdrawal|0|||
130050687|NCT03703375|468142652|FG001|Treatment Period|Consent Withdrawal|0|||
130050688|NCT03703375|468142653|FG002|Treatment Period|Consent Withdrawal|0|||
130050689|NCT03703375|468142654|FG003|Treatment Period|Consent Withdrawal|1|||
130050690|NCT03703375|468142651|FG000|Treatment Period|Death|1|||
130050691|NCT03703375|468142652|FG001|Treatment Period|Death|0|||
130050692|NCT03703375|468142653|FG002|Treatment Period|Death|1|||
130050693|NCT03703375|468142654|FG003|Treatment Period|Death|2|||
130314399|NCT02735239|469118256|FG002|Overall Study|Death|0|||
130314400|NCT02735239|469118257|FG003|Overall Study|Death|0|||
130050694|NCT03703375|468142651|FG000|Treatment Period|Toxicity of Study Treatment|2|||
130050695|NCT03703375|468142652|FG001|Treatment Period|Toxicity of Study Treatment|0|||
130050696|NCT03703375|468142653|FG002|Treatment Period|Toxicity of Study Treatment|4|||
130050697|NCT03703375|468142654|FG003|Treatment Period|Toxicity of Study Treatment|1|||
130050698|NCT03703375|468142651|FG000|Treatment Period|Progression|32|||
130050699|NCT03703375|468142652|FG001|Treatment Period|Progression|1|||
130050700|NCT03703375|468142653|FG002|Treatment Period|Progression|7|||
130050701|NCT03703375|468142654|FG003|Treatment Period|Progression|11|||
130314401|NCT02735239|469118258|FG004|Overall Study|Death|0|||
130050702|NCT03703375|468142651|FG000|Treatment Period|Completed treatment|7|||
130050703|NCT03703375|468142652|FG001|Treatment Period|Completed treatment|2|||
130050704|NCT03703375|468142653|FG002|Treatment Period|Completed treatment|0|||
130314402|NCT02735239|469118259|FG005|Overall Study|Death|0|||
130050705|NCT03703375|468142654|FG003|Treatment Period|Completed treatment|0|||
130050706|NCT02678741|468142657|FG000|Overall Study|Death|4|||
130050707|NCT02678741|468142657|FG000|Overall Study|Withdrawal by Subject|1|||
130050708|NCT02678741|468142657|FG000|Overall Study|ineligible|3|||
130050709|NCT02678741|468142657|FG000|Overall Study|Not RECIST Measurable|2|||
130050710|NCT02678741|468142657|FG000|Overall Study|Lack of Efficacy|10|||
130050711|NCT00903032|468142658|FG000|Overall Study|Withdrawal by Subject|5|||
130050712|NCT00903032|468142659|FG001|Overall Study|Withdrawal by Subject|3|||
130050713|NCT00903032|468142658|FG000|Overall Study|Lost to Follow-up|2|||
130050714|NCT00903032|468142659|FG001|Overall Study|Lost to Follow-up|2|||
130050715|NCT00931892|468142673|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
130050716|NCT00931892|468142674|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
130050717|NCT01876732|468142675|FG000|Overall Study|MMA was not over 800mg/dL|75|||
130050718|NCT01675531|468142676|FG000|Overall Study|Adverse Event|9|||
130050719|NCT01675531|468142676|FG000|Overall Study|Withdrawal by Subject|7|||
130050720|NCT01675531|468142676|FG000|Overall Study|Lack of Efficacy|1|||
130050721|NCT01675531|468142676|FG000|Overall Study|Protocol Violation|8|||
130050722|NCT00623467|468142677|FG000|Overall Study|Lost to Follow-up|1|||
130050723|NCT00623467|468142677|FG000|Overall Study|Protocol Violation|4|||
130050724|NCT00623467|468142677|FG000|Overall Study|Withdrawal by Subject|2|||
129799831|NCT02322021|467235226|FG004|Core Phase|Participant Choice|0|||
129799832|NCT02322021|467235222|FG000|Core Phase|Lost to Follow-up|0|||
129799833|NCT02322021|467235223|FG001|Core Phase|Lost to Follow-up|0|||
129799834|NCT02322021|467235224|FG002|Core Phase|Lost to Follow-up|0|||
129799835|NCT02322021|467235225|FG003|Core Phase|Lost to Follow-up|1|||
129799836|NCT02322021|467235226|FG004|Core Phase|Lost to Follow-up|0|||
130050725|NCT02795988|468142686|FG000|Phase 1b|Withdrawal by Subject|0|||
130050726|NCT02795988|468142687|FG001|Phase 1b|Withdrawal by Subject|1|||
130050727|NCT02795988|468142688|FG002|Phase 1b|Withdrawal by Subject|0|||
130050728|NCT02795988|468142689|FG003|Phase 1b|Withdrawal by Subject|0|||
129799837|NCT02322021|467235222|FG000|Core Phase|Other|0|||
129799838|NCT02322021|467235223|FG001|Core Phase|Other|0|||
129799839|NCT02322021|467235224|FG002|Core Phase|Other|1|||
129799840|NCT02322021|467235225|FG003|Core Phase|Other|0|||
129799841|NCT02322021|467235226|FG004|Core Phase|Other|0|||
129799842|NCT02322021|467235222|FG000|Extension Phase|Adverse Event|0|||
129799843|NCT02322021|467235223|FG001|Extension Phase|Adverse Event|0|||
129799844|NCT02322021|467235224|FG002|Extension Phase|Adverse Event|0|||
129799845|NCT02322021|467235225|FG003|Extension Phase|Adverse Event|0|||
129799846|NCT02322021|467235226|FG004|Extension Phase|Adverse Event|3|||
130050729|NCT02795988|468142690|FG004|Phase 1b|Withdrawal by Subject|0|||
130050730|NCT02795988|468142691|FG005|Phase 1b|Withdrawal by Subject|0|||
129799847|NCT02322021|467235222|FG000|Extension Phase|Participant Choice|0|||
129890714|NCT01625338|467557535|FG001|Overall Study|Adverse Event|0|||
129890715|NCT01625338|467557536|FG002|Overall Study|Adverse Event|1|||
130050731|NCT02795988|468142692|FG006|Phase 1b|Withdrawal by Subject|0|||
130050732|NCT02795988|468142686|FG000|Phase 1b|Death|1|||
130050733|NCT02795988|468142687|FG001|Phase 1b|Death|2|||
130050734|NCT02795988|468142688|FG002|Phase 1b|Death|1|||
130050735|NCT02795988|468142689|FG003|Phase 1b|Death|0|||
130050736|NCT02795988|468142690|FG004|Phase 1b|Death|0|||
130050737|NCT02795988|468142691|FG005|Phase 1b|Death|0|||
130050738|NCT02795988|468142692|FG006|Phase 1b|Death|0|||
130050739|NCT02795988|468142686|FG000|Phase 1b|Physician Decision|0|||
130050740|NCT02795988|468142687|FG001|Phase 1b|Physician Decision|0|||
130050741|NCT02795988|468142688|FG002|Phase 1b|Physician Decision|1|||
130050742|NCT02795988|468142689|FG003|Phase 1b|Physician Decision|0|||
130050743|NCT02795988|468142690|FG004|Phase 1b|Physician Decision|0|||
130050744|NCT02795988|468142691|FG005|Phase 1b|Physician Decision|0|||
130050745|NCT02795988|468142692|FG006|Phase 1b|Physician Decision|0|||
130050746|NCT02795988|468142686|FG000|Phase 1b|Progressive Disease|2|||
130050747|NCT02795988|468142687|FG001|Phase 1b|Progressive Disease|2|||
130050748|NCT02795988|468142688|FG002|Phase 1b|Progressive Disease|0|||
130050749|NCT02795988|468142689|FG003|Phase 1b|Progressive Disease|0|||
129890716|NCT01625338|467557534|FG000|Overall Study|Study Discontinued by Sponsor|0|||
129890717|NCT01625338|467557535|FG001|Overall Study|Study Discontinued by Sponsor|0|||
129890718|NCT01625338|467557536|FG002|Overall Study|Study Discontinued by Sponsor|1|||
130050750|NCT02795988|468142690|FG004|Phase 1b|Progressive Disease|0|||
130050751|NCT02795988|468142691|FG005|Phase 1b|Progressive Disease|0|||
130050752|NCT02795988|468142692|FG006|Phase 1b|Progressive Disease|0|||
130050753|NCT02795988|468142686|FG000|Phase 2|Withdrawal by Subject|0|||
130050754|NCT02795988|468142687|FG001|Phase 2|Withdrawal by Subject|0|||
130050755|NCT02795988|468142688|FG002|Phase 2|Withdrawal by Subject|0|||
130050756|NCT02795988|468142689|FG003|Phase 2|Withdrawal by Subject|1|||
130050757|NCT02795988|468142690|FG004|Phase 2|Withdrawal by Subject|0|||
130050758|NCT02795988|468142691|FG005|Phase 2|Withdrawal by Subject|0|||
129799848|NCT02322021|467235223|FG001|Extension Phase|Participant Choice|0|||
129799849|NCT02322021|467235224|FG002|Extension Phase|Participant Choice|0|||
129799850|NCT02322021|467235225|FG003|Extension Phase|Participant Choice|0|||
130050759|NCT02795988|468142692|FG006|Phase 2|Withdrawal by Subject|0|||
130050760|NCT02795988|468142686|FG000|Phase 2|Death|0|||
130050761|NCT02795988|468142687|FG001|Phase 2|Death|0|||
130050762|NCT02795988|468142688|FG002|Phase 2|Death|0|||
130050763|NCT02795988|468142689|FG003|Phase 2|Death|17|||
130050764|NCT02795988|468142690|FG004|Phase 2|Death|17|||
130050765|NCT02795988|468142691|FG005|Phase 2|Death|0|||
130050766|NCT02795988|468142692|FG006|Phase 2|Death|0|||
130050767|NCT02795988|468142686|FG000|Phase 2|Other|0|||
130050768|NCT02795988|468142687|FG001|Phase 2|Other|0|||
130050769|NCT02795988|468142688|FG002|Phase 2|Other|0|||
130050770|NCT02795988|468142689|FG003|Phase 2|Other|1|||
130050771|NCT02795988|468142690|FG004|Phase 2|Other|0|||
130050772|NCT02795988|468142691|FG005|Phase 2|Other|0|||
130050773|NCT02795988|468142692|FG006|Phase 2|Other|0|||
130050774|NCT02795988|468142686|FG000|Phase 2 Extension|Death|0|||
130050775|NCT02795988|468142687|FG001|Phase 2 Extension|Death|0|||
130050776|NCT02795988|468142688|FG002|Phase 2 Extension|Death|0|||
130050777|NCT02795988|468142689|FG003|Phase 2 Extension|Death|0|||
130050778|NCT02795988|468142690|FG004|Phase 2 Extension|Death|0|||
130050779|NCT02795988|468142691|FG005|Phase 2 Extension|Death|5|||
130050780|NCT02795988|468142692|FG006|Phase 2 Extension|Death|6|||
130050781|NCT02795988|468142686|FG000|Phase 2 Extension|Other reasons|0|||
130050782|NCT02795988|468142687|FG001|Phase 2 Extension|Other reasons|0|||
130050783|NCT02795988|468142688|FG002|Phase 2 Extension|Other reasons|0|||
130050784|NCT02795988|468142689|FG003|Phase 2 Extension|Other reasons|0|||
130050785|NCT02795988|468142690|FG004|Phase 2 Extension|Other reasons|0|||
130050786|NCT02795988|468142691|FG005|Phase 2 Extension|Other reasons|2|||
130050787|NCT02795988|468142692|FG006|Phase 2 Extension|Other reasons|1|||
130050788|NCT02834403|468142693|FG000|Overall Study|Physician Decision|2|||
130050789|NCT02834403|468142694|FG001|Overall Study|Physician Decision|1|||
130050790|NCT02834403|468142695|FG002|Overall Study|Physician Decision|2|||
130050791|NCT02834403|468142696|FG003|Overall Study|Physician Decision|1|||
130050792|NCT02834403|468142697|FG004|Overall Study|Physician Decision|1|||
130314403|NCT02735239|469118254|FG000|Overall Study|Physician Decision|0|||
130314404|NCT02735239|469118255|FG001|Overall Study|Physician Decision|0|||
130314405|NCT02735239|469118256|FG002|Overall Study|Physician Decision|1|||
130314406|NCT02735239|469118257|FG003|Overall Study|Physician Decision|0|||
130314407|NCT02735239|469118258|FG004|Overall Study|Physician Decision|0|||
130314408|NCT02735239|469118259|FG005|Overall Study|Physician Decision|0|||
130050793|NCT02834403|468142698|FG005|Overall Study|Physician Decision|2|||
130050794|NCT02834403|468142699|FG006|Overall Study|Physician Decision|12|||
130050795|NCT02834403|468142693|FG000|Overall Study|Adverse Event|0|||
130050796|NCT02834403|468142694|FG001|Overall Study|Adverse Event|0|||
130110630|NCT00729365|468365806|FG002|Overall Study|Physician Decision|7|||
130314409|NCT02735239|469118254|FG000|Overall Study|Progressive disease|3|||
130314410|NCT02735239|469118255|FG001|Overall Study|Progressive disease|1|||
130314411|NCT02735239|469118256|FG002|Overall Study|Progressive disease|3|||
130314412|NCT02735239|469118257|FG003|Overall Study|Progressive disease|0|||
130314413|NCT02735239|469118258|FG004|Overall Study|Progressive disease|0|||
130314414|NCT02735239|469118259|FG005|Overall Study|Progressive disease|2|||
130314415|NCT02735239|469118254|FG000|Overall Study|Withdrawal by Subject|0|||
130314416|NCT02735239|469118255|FG001|Overall Study|Withdrawal by Subject|1|||
130314417|NCT02735239|469118256|FG002|Overall Study|Withdrawal by Subject|0|||
130314418|NCT02735239|469118257|FG003|Overall Study|Withdrawal by Subject|0|||
130314419|NCT02735239|469118258|FG004|Overall Study|Withdrawal by Subject|0|||
130314420|NCT02735239|469118259|FG005|Overall Study|Withdrawal by Subject|0|||
130314421|NCT00387881|469118260|FG000|Overall Study|Lost to Follow-up|23|||
130314422|NCT00387881|469118261|FG001|Overall Study|Lost to Follow-up|23|||
130314423|NCT00387881|469118260|FG000|Overall Study|Protocol Violation|2|||
130314424|NCT00387881|469118261|FG001|Overall Study|Protocol Violation|12|||
130314425|NCT00387881|469118260|FG000|Overall Study|Withdrawal by Subject|15|||
130314426|NCT00387881|469118261|FG001|Overall Study|Withdrawal by Subject|18|||
130314427|NCT00387881|469118260|FG000|Overall Study|Sponsor terminated Study|0|||
130314428|NCT00387881|469118261|FG001|Overall Study|Sponsor terminated Study|1|||
130314429|NCT00387881|469118260|FG000|Overall Study|Not eligible|6|||
130314430|NCT00387881|469118261|FG001|Overall Study|Not eligible|7|||
130314431|NCT00387881|469118260|FG000|Overall Study|No opportunity to treat headache|32|||
130314432|NCT00387881|469118261|FG001|Overall Study|No opportunity to treat headache|34|||
130314433|NCT00387881|469118260|FG000|Overall Study|Not otherwise specified|11|||
130314434|NCT00387881|469118261|FG001|Overall Study|Not otherwise specified|7|||
130314435|NCT01790594|469118263|FG000|Overall Study|Death|1|||
130314436|NCT01790594|469118264|FG001|Overall Study|Death|0|||
130314437|NCT01790594|469118265|FG002|Overall Study|Death|0|||
130314438|NCT01790594|469118263|FG000|Overall Study|Physician Decision|2|||
130314439|NCT01790594|469118264|FG001|Overall Study|Physician Decision|1|||
130110631|NCT01298596|468365808|FG000|Overall Study|Withdrawal by Subject|1|||
130314440|NCT01790594|469118265|FG002|Overall Study|Physician Decision|0|||
130050797|NCT02834403|468142695|FG002|Overall Study|Adverse Event|0|||
130050798|NCT02834403|468142696|FG003|Overall Study|Adverse Event|0|||
130050799|NCT02834403|468142697|FG004|Overall Study|Adverse Event|1|||
130050800|NCT02834403|468142698|FG005|Overall Study|Adverse Event|1|||
130050801|NCT02834403|468142699|FG006|Overall Study|Adverse Event|3|||
130050802|NCT02834403|468142693|FG000|Overall Study|Withdrawal by Subject|0|||
130314441|NCT01790594|469118263|FG000|Overall Study|Withdrawal by Subject|2|||
130314442|NCT01790594|469118264|FG001|Overall Study|Withdrawal by Subject|0|||
130314443|NCT01790594|469118265|FG002|Overall Study|Withdrawal by Subject|0|||
130314444|NCT01790594|469118263|FG000|Overall Study|Transplant was not done|0|||
130050803|NCT02834403|468142694|FG001|Overall Study|Withdrawal by Subject|1|||
130050804|NCT02834403|468142695|FG002|Overall Study|Withdrawal by Subject|0|||
130050805|NCT02834403|468142696|FG003|Overall Study|Withdrawal by Subject|0|||
130050806|NCT02834403|468142697|FG004|Overall Study|Withdrawal by Subject|1|||
130050807|NCT02834403|468142698|FG005|Overall Study|Withdrawal by Subject|0|||
130050808|NCT02834403|468142699|FG006|Overall Study|Withdrawal by Subject|0|||
130050809|NCT02834403|468142693|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
130050810|NCT02834403|468142694|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
130050811|NCT02834403|468142695|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
130050812|NCT02834403|468142696|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
130050813|NCT02834403|468142697|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
130050814|NCT02834403|468142698|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
130050815|NCT02834403|468142699|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
130050816|NCT02341014|468142700|FG000|Overall Study|Adverse Event|0|||
130050817|NCT02341014|468142701|FG001|Overall Study|Adverse Event|1|||
130050818|NCT02341014|468142702|FG002|Overall Study|Adverse Event|0|||
130050819|NCT02341014|468142703|FG003|Overall Study|Adverse Event|0|||
130050820|NCT02341014|468142704|FG004|Overall Study|Adverse Event|2|||
130050821|NCT04705597|468142705|FG000|Overall Study|Death|16|||
130050822|NCT04705597|468142706|FG001|Overall Study|Death|9|||
130050823|NCT04705597|468142705|FG000|Overall Study|Lost to Follow-up|1|||
130314445|NCT01790594|469118264|FG001|Overall Study|Transplant was not done|0|||
130314446|NCT01790594|469118265|FG002|Overall Study|Transplant was not done|3|||
130314447|NCT01790594|469118263|FG000|Overall Study|Terminated prior to week 76|0|||
130314448|NCT01790594|469118264|FG001|Overall Study|Terminated prior to week 76|2|||
130314449|NCT01790594|469118265|FG002|Overall Study|Terminated prior to week 76|0|||
130314450|NCT03291067|469118266|FG000|Overall Study|Adverse Event|0|||
130314451|NCT03291067|469118267|FG001|Overall Study|Adverse Event|2|||
130314452|NCT03291067|469118268|FG002|Overall Study|Adverse Event|17|||
130314453|NCT03291067|469118269|FG003|Overall Study|Adverse Event|3|||
130314454|NCT03291067|469118266|FG000|Overall Study|Lost to Follow-up|2|||
130314455|NCT03291067|469118267|FG001|Overall Study|Lost to Follow-up|1|||
130314456|NCT03291067|469118268|FG002|Overall Study|Lost to Follow-up|0|||
130314457|NCT03291067|469118269|FG003|Overall Study|Lost to Follow-up|1|||
130314458|NCT03291067|469118266|FG000|Overall Study|Physician Decision|0|||
130314459|NCT03291067|469118267|FG001|Overall Study|Physician Decision|0|||
130314460|NCT03291067|469118268|FG002|Overall Study|Physician Decision|1|||
130314461|NCT03291067|469118269|FG003|Overall Study|Physician Decision|0|||
130314462|NCT03291067|469118266|FG000|Overall Study|Protocol Violation|5|||
130314463|NCT03291067|469118267|FG001|Overall Study|Protocol Violation|3|||
130314464|NCT03291067|469118268|FG002|Overall Study|Protocol Violation|4|||
130314465|NCT03291067|469118269|FG003|Overall Study|Protocol Violation|2|||
130314466|NCT03291067|469118266|FG000|Overall Study|Withdrawal by Subject|3|||
130314467|NCT03291067|469118267|FG001|Overall Study|Withdrawal by Subject|4|||
130314468|NCT03291067|469118268|FG002|Overall Study|Withdrawal by Subject|7|||
130314469|NCT03291067|469118269|FG003|Overall Study|Withdrawal by Subject|5|||
130314470|NCT03291067|469118266|FG000|Overall Study|Other|0|||
130314471|NCT03291067|469118267|FG001|Overall Study|Other|4|||
130314472|NCT03291067|469118268|FG002|Overall Study|Other|4|||
130314473|NCT03291067|469118269|FG003|Overall Study|Other|6|||
130314474|NCT02038153|469118270|FG000|Overall Study|Withdrawal by Subject|1|||
130314475|NCT01050634|469118271|FG000|Overall Study|Enrolled, but Not Treated|56|||
130314476|NCT01050634|469118271|FG000|Overall Study|Death|2|||
130314477|NCT01050634|469118271|FG000|Overall Study|Adverse Event|42|||
130314478|NCT01050634|469118271|FG000|Overall Study|Lost to Follow-up|2|||
130314479|NCT01050634|469118271|FG000|Overall Study|Other|21|||
130314480|NCT01050634|469118271|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
130314481|NCT00496015|469118272|FG000|Overall Study|Other|1|||
130314482|NCT00496015|469118273|FG001|Overall Study|Other|0|||
130314483|NCT00496015|469118274|FG002|Overall Study|Other|0|||
130314484|NCT00496015|469118275|FG003|Overall Study|Other|1|||
130314485|NCT00496015|469118276|FG004|Overall Study|Other|0|||
130314486|NCT00527735|469118277|FG000|Overall Study|Disease progression|47|||
130050824|NCT04705597|468142706|FG001|Overall Study|Lost to Follow-up|0|||
130050825|NCT04705597|468142705|FG000|Overall Study|Withdrawal by Subject|1|||
130050826|NCT04705597|468142706|FG001|Overall Study|Withdrawal by Subject|2|||
130314487|NCT00527735|469118278|FG001|Overall Study|Disease progression|61|||
130314488|NCT00527735|469118279|FG002|Overall Study|Disease progression|53|||
130314489|NCT00527735|469118277|FG000|Overall Study|Death|23|||
130314490|NCT00527735|469118278|FG001|Overall Study|Death|13|||
130314491|NCT00527735|469118279|FG002|Overall Study|Death|15|||
130314492|NCT00527735|469118277|FG000|Overall Study|Completed treatment in treatment phase|14|||
130314493|NCT00527735|469118278|FG001|Overall Study|Completed treatment in treatment phase|13|||
130314494|NCT00527735|469118279|FG002|Overall Study|Completed treatment in treatment phase|18|||
130314495|NCT00527735|469118277|FG000|Overall Study|Adverse Event|10|||
130314496|NCT00527735|469118278|FG001|Overall Study|Adverse Event|6|||
130314497|NCT00527735|469118279|FG002|Overall Study|Adverse Event|7|||
130314498|NCT00527735|469118277|FG000|Overall Study|Not identified|5|||
130314499|NCT00527735|469118278|FG001|Overall Study|Not identified|5|||
130314500|NCT00527735|469118279|FG002|Overall Study|Not identified|5|||
130314501|NCT00527735|469118277|FG000|Overall Study|Withdrawal by Subject|5|||
130314502|NCT00527735|469118278|FG001|Overall Study|Withdrawal by Subject|4|||
130050827|NCT00273858|468142718|FG000|Overall Study|Not completed 24 month observation time|334|||
130050828|NCT00273858|468142718|FG000|Overall Study|Lost to Follow-up|101|||
130050829|NCT00273858|468142718|FG000|Overall Study|Withdrawal by Subject|21|||
130050830|NCT00273858|468142718|FG000|Overall Study|Adverse Event|81|||
130050831|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
130050832|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
130050833|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
130050834|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
130050835|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
130050836|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
130050837|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
130050838|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
130050839|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
130050840|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
130050841|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
130050842|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
130050843|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
130050844|NCT02232516|468142719|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
130050845|NCT02232516|468142719|FG000|Survival Follow-up|Death|15|||
130050846|NCT02232516|468142719|FG000|Survival Follow-up|Withdrawal by Subject|3|||
130050847|NCT02232516|468142719|FG000|Survival Follow-up|Lost to Follow-up|1|||
130050848|NCT02232516|468142719|FG000|Survival Follow-up|Still in follow-up|5|||
130050849|NCT01234402|468142720|FG000|Overall Study|Lost to Follow-up|0|||
130050850|NCT01234402|468142721|FG001|Overall Study|Lost to Follow-up|1|||
130050851|NCT01234402|468142722|FG002|Overall Study|Lost to Follow-up|3|||
130050852|NCT01234402|468142720|FG000|Overall Study|Withdrawal by Subject|1|||
130050853|NCT01234402|468142721|FG001|Overall Study|Withdrawal by Subject|3|||
130050854|NCT01234402|468142722|FG002|Overall Study|Withdrawal by Subject|4|||
130050855|NCT01234402|468142720|FG000|Overall Study|Never treated: Death|0|||
130050856|NCT01234402|468142721|FG001|Overall Study|Never treated: Death|0|||
130050857|NCT01234402|468142722|FG002|Overall Study|Never treated: Death|1|||
130050858|NCT01234402|468142720|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
130050859|NCT01234402|468142721|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
130050860|NCT01234402|468142722|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
130050861|NCT01234402|468142720|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
130050862|NCT01234402|468142721|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
130050863|NCT01234402|468142722|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
130050864|NCT03649321|468142723|FG000|Overall Study|Withdrawal by Subject|1|||
130050865|NCT03649321|468142724|FG001|Overall Study|Withdrawal by Subject|0|||
130050866|NCT03649321|468142723|FG000|Overall Study|Death|1|||
130050867|NCT03649321|468142724|FG001|Overall Study|Death|0|||
130050868|NCT01702363|468142725|FG000|Overall Study|Adverse Event|14|||
130050869|NCT01702363|468142725|FG000|Overall Study|Lack of Efficacy|4|||
130050870|NCT01702363|468142725|FG000|Overall Study|Withdrawal by Subject|2|||
130050871|NCT02184143|468142732|FG000|Overall Study|Withdrawal by Subject|4|||
130050872|NCT02184143|468142733|FG001|Overall Study|Withdrawal by Subject|4|||
130050873|NCT02184143|468142732|FG000|Overall Study|Lost to Follow-up|5|||
130050874|NCT02184143|468142733|FG001|Overall Study|Lost to Follow-up|3|||
130050875|NCT02184143|468142732|FG000|Overall Study|Death|1|||
130050876|NCT02184143|468142733|FG001|Overall Study|Death|0|||
130050877|NCT00321984|468142734|FG000|Overall Study|Adverse Event|9|||
130050878|NCT00321984|468142735|FG001|Overall Study|Adverse Event|6|||
130050879|NCT00321984|468142736|FG002|Overall Study|Adverse Event|8|||
130050880|NCT00321984|468142734|FG000|Overall Study|Protocol Violation|0|||
130050881|NCT00321984|468142735|FG001|Overall Study|Protocol Violation|1|||
130314503|NCT00527735|469118279|FG002|Overall Study|Withdrawal by Subject|3|||
130050882|NCT00321984|468142736|FG002|Overall Study|Protocol Violation|1|||
130050883|NCT00321984|468142734|FG000|Overall Study|Lost to Follow-up|2|||
130050884|NCT00321984|468142735|FG001|Overall Study|Lost to Follow-up|4|||
130050885|NCT00321984|468142736|FG002|Overall Study|Lost to Follow-up|2|||
130050886|NCT00321984|468142734|FG000|Overall Study|Withdrawal by Subject|8|||
130050887|NCT00321984|468142735|FG001|Overall Study|Withdrawal by Subject|6|||
130050888|NCT00321984|468142736|FG002|Overall Study|Withdrawal by Subject|5|||
130314504|NCT00527735|469118277|FG000|Overall Study|No longer met study criteria|2|||
130050889|NCT00321984|468142734|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
130314505|NCT00527735|469118278|FG001|Overall Study|No longer met study criteria|2|||
130314506|NCT00527735|469118279|FG002|Overall Study|No longer met study criteria|1|||
130314507|NCT00527735|469118277|FG000|Overall Study|Lost to Follow-up|0|||
130314508|NCT00527735|469118278|FG001|Overall Study|Lost to Follow-up|0|||
130314509|NCT00527735|469118279|FG002|Overall Study|Lost to Follow-up|3|||
130314510|NCT00527735|469118277|FG000|Overall Study|Poor compliance or noncompliance|0|||
130314511|NCT00527735|469118278|FG001|Overall Study|Poor compliance or noncompliance|1|||
130314512|NCT00527735|469118279|FG002|Overall Study|Poor compliance or noncompliance|1|||
130314513|NCT00527735|469118277|FG000|Overall Study|Completed treatment during maintenance|2|||
130314514|NCT00527735|469118278|FG001|Overall Study|Completed treatment during maintenance|2|||
130314515|NCT00527735|469118279|FG002|Overall Study|Completed treatment during maintenance|1|||
130314516|NCT01535807|469118280|FG000|Overall Study|Withdrawal by Subject|1|||
130314517|NCT01535807|469118281|FG001|Overall Study|Withdrawal by Subject|1|||
130314518|NCT01535807|469118280|FG000|Overall Study|Data collection error|1|||
130314519|NCT01535807|469118281|FG001|Overall Study|Data collection error|1|||
130314520|NCT00404651|469118285|FG000|Overall Study|Serious Adverse Event|0|||
130314521|NCT00404651|469118286|FG001|Overall Study|Serious Adverse Event|0|||
130314522|NCT00404651|469118287|FG002|Overall Study|Serious Adverse Event|2|||
130314523|NCT00404651|469118288|FG003|Overall Study|Serious Adverse Event|0|||
130314524|NCT00404651|469118285|FG000|Overall Study|Protocol Violation|10|||
130314525|NCT00404651|469118286|FG001|Overall Study|Protocol Violation|5|||
130314526|NCT00404651|469118287|FG002|Overall Study|Protocol Violation|14|||
130314527|NCT00404651|469118288|FG003|Overall Study|Protocol Violation|5|||
129799851|NCT02322021|467235226|FG004|Extension Phase|Participant Choice|6|||
129799852|NCT02322021|467235222|FG000|Extension Phase|Other|0|||
129799853|NCT02322021|467235223|FG001|Extension Phase|Other|0|||
129799854|NCT02322021|467235224|FG002|Extension Phase|Other|0|||
129799855|NCT02322021|467235225|FG003|Extension Phase|Other|0|||
129799856|NCT02322021|467235226|FG004|Extension Phase|Other|3|||
129799857|NCT02322021|467235222|FG000|Extension Phase|Lost to Follow-up|0|||
129799858|NCT02322021|467235223|FG001|Extension Phase|Lost to Follow-up|0|||
130050890|NCT00321984|468142735|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
130050891|NCT00321984|468142736|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
130050892|NCT00321984|468142734|FG000|Overall Study|Lack of Efficacy|3|||
130050893|NCT00321984|468142735|FG001|Overall Study|Lack of Efficacy|1|||
130050894|NCT00321984|468142736|FG002|Overall Study|Lack of Efficacy|3|||
130050895|NCT00321984|468142734|FG000|Overall Study|Noncompliant|0|||
130050896|NCT00321984|468142735|FG001|Overall Study|Noncompliant|0|||
130314528|NCT00404651|469118285|FG000|Overall Study|Lost to Follow-up|15|||
130314529|NCT00404651|469118286|FG001|Overall Study|Lost to Follow-up|11|||
130314530|NCT00404651|469118287|FG002|Overall Study|Lost to Follow-up|13|||
130314531|NCT00404651|469118288|FG003|Overall Study|Lost to Follow-up|10|||
130314532|NCT00404651|469118285|FG000|Overall Study|Withdrawal by Subject|14|||
130314533|NCT00404651|469118286|FG001|Overall Study|Withdrawal by Subject|12|||
130314534|NCT00404651|469118287|FG002|Overall Study|Withdrawal by Subject|16|||
130314535|NCT00404651|469118288|FG003|Overall Study|Withdrawal by Subject|6|||
130314536|NCT02123134|469118303|FG000|Overall Study|Withdrawal of consent|3|||
130314537|NCT02123134|469118304|FG001|Overall Study|Withdrawal of consent|2|||
130314538|NCT02123134|469118303|FG000|Overall Study|Administrative decision|0|||
130314539|NCT02123134|469118304|FG001|Overall Study|Administrative decision|1|||
130314540|NCT03010527|469118313|FG000|Overall Study|Death|0|||
130314541|NCT03010527|469118314|FG001|Overall Study|Death|0|||
130314542|NCT03010527|469118315|FG002|Overall Study|Death|1|||
130314543|NCT03010527|469118313|FG000|Overall Study|Adverse Event|0|||
130314544|NCT03010527|469118314|FG001|Overall Study|Adverse Event|4|||
130314545|NCT03010527|469118315|FG002|Overall Study|Adverse Event|2|||
130314546|NCT03010527|469118313|FG000|Overall Study|Protocol Violation|0|||
130314547|NCT03010527|469118314|FG001|Overall Study|Protocol Violation|1|||
130314548|NCT03010527|469118315|FG002|Overall Study|Protocol Violation|0|||
130314549|NCT03010527|469118313|FG000|Overall Study|Lost to Follow-up|0|||
130314550|NCT03010527|469118314|FG001|Overall Study|Lost to Follow-up|2|||
129799859|NCT02322021|467235224|FG002|Extension Phase|Lost to Follow-up|0|||
129799860|NCT02322021|467235225|FG003|Extension Phase|Lost to Follow-up|0|||
130314551|NCT03010527|469118315|FG002|Overall Study|Lost to Follow-up|1|||
130314552|NCT03010527|469118313|FG000|Overall Study|Withdrawal by Subject|0|||
130314553|NCT03010527|469118314|FG001|Overall Study|Withdrawal by Subject|3|||
130314554|NCT03010527|469118315|FG002|Overall Study|Withdrawal by Subject|4|||
130314555|NCT03010527|469118313|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
130314556|NCT03010527|469118314|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
130314557|NCT03010527|469118315|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
130314558|NCT03010527|469118313|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
129799861|NCT02322021|467235226|FG004|Extension Phase|Lost to Follow-up|1|||
130314559|NCT03010527|469118314|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
130314560|NCT03010527|469118315|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
130314561|NCT03010527|469118313|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
130050897|NCT00321984|468142736|FG002|Overall Study|Noncompliant|2|||
130314562|NCT03010527|469118314|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
130050898|NCT00321984|468142734|FG000|Overall Study|Pregnancy|0|||
129799862|NCT02322021|467235222|FG000|Extension Phase|Study terminated by sponsor|0|||
130050899|NCT00321984|468142735|FG001|Overall Study|Pregnancy|1|||
130050900|NCT00321984|468142736|FG002|Overall Study|Pregnancy|0|||
130050901|NCT00321984|468142734|FG000|Overall Study|Per Subject Request|1|||
130050902|NCT00321984|468142735|FG001|Overall Study|Per Subject Request|0|||
130050903|NCT00321984|468142736|FG002|Overall Study|Per Subject Request|0|||
130050904|NCT00321984|468142734|FG000|Overall Study|Per Investigator Request|1|||
130050905|NCT00321984|468142735|FG001|Overall Study|Per Investigator Request|0|||
130050906|NCT00321984|468142736|FG002|Overall Study|Per Investigator Request|0|||
130050907|NCT00321984|468142734|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
130050908|NCT00321984|468142735|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
130050909|NCT00321984|468142736|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
130050910|NCT02142894|468142737|FG000|Overall Study|Protocol Violation|8|||
130050911|NCT02137772|468142742|FG000|Overall Study|Adverse Event|6|||
130050912|NCT02137772|468142743|FG001|Overall Study|Adverse Event|3|||
130050913|NCT02137772|468142742|FG000|Overall Study|Death|71|||
130050914|NCT02137772|468142743|FG001|Overall Study|Death|44|||
130050915|NCT02137772|468142742|FG000|Overall Study|Lost to Follow-up|8|||
130050916|NCT02137772|468142743|FG001|Overall Study|Lost to Follow-up|4|||
130050917|NCT02137772|468142742|FG000|Overall Study|Physician Decision|15|||
130050918|NCT02137772|468142743|FG001|Overall Study|Physician Decision|5|||
130050919|NCT02137772|468142742|FG000|Overall Study|Withdrawal by Subject|28|||
130314563|NCT03010527|469118315|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
130314564|NCT00764699|469118316|FG000|Overall Study|PI left and study terminated|3|||
130314565|NCT01755234|469118317|FG000|Overall Study|Lost to Follow-up|11|||
130314566|NCT01755234|469118318|FG001|Overall Study|Lost to Follow-up|6|||
130314567|NCT01755234|469118317|FG000|Overall Study|Change in surgical case|2|||
130314568|NCT01755234|469118318|FG001|Overall Study|Change in surgical case|1|||
130314569|NCT01755234|469118317|FG000|Overall Study|case cancelled|1|||
130314570|NCT01755234|469118318|FG001|Overall Study|case cancelled|0|||
130314571|NCT01755234|469118317|FG000|Overall Study|Withdrawal by Subject|0|||
130314572|NCT01755234|469118318|FG001|Overall Study|Withdrawal by Subject|1|||
130314573|NCT01755234|469118317|FG000|Overall Study|unblinded|1|||
130314574|NCT01755234|469118318|FG001|Overall Study|unblinded|0|||
130314575|NCT03001557|469118322|FG000|Core Phase|Randomized but not treated|0|||
130314576|NCT03001557|469118323|FG001|Core Phase|Randomized but not treated|0|||
130314577|NCT03001557|469118324|FG002|Core Phase|Randomized but not treated|1|||
130314578|NCT03001557|469118325|FG003|Core Phase|Randomized but not treated|0|||
130314579|NCT03001557|469118326|FG004|Core Phase|Randomized but not treated|0|||
130314580|NCT03001557|469118327|FG005|Core Phase|Randomized but not treated|0|||
130314581|NCT03001557|469118328|FG006|Core Phase|Randomized but not treated|0|||
130314582|NCT03001557|469118329|FG007|Core Phase|Randomized but not treated|0|||
130314583|NCT03001557|469118322|FG000|Extension Phase|Adverse Event|0|||
130314584|NCT03001557|469118323|FG001|Extension Phase|Adverse Event|0|||
130314585|NCT03001557|469118324|FG002|Extension Phase|Adverse Event|0|||
130314586|NCT03001557|469118325|FG003|Extension Phase|Adverse Event|0|||
130314587|NCT03001557|469118326|FG004|Extension Phase|Adverse Event|0|||
130314588|NCT03001557|469118327|FG005|Extension Phase|Adverse Event|2|||
130314589|NCT03001557|469118328|FG006|Extension Phase|Adverse Event|0|||
130314590|NCT03001557|469118329|FG007|Extension Phase|Adverse Event|0|||
130314591|NCT03001557|469118322|FG000|Extension Phase|Withdrawal by Subject|0|||
130314592|NCT03001557|469118323|FG001|Extension Phase|Withdrawal by Subject|0|||
130314593|NCT03001557|469118324|FG002|Extension Phase|Withdrawal by Subject|0|||
130050920|NCT02137772|468142743|FG001|Overall Study|Withdrawal by Subject|17|||
130050921|NCT02137772|468142742|FG000|Overall Study|Non-compliance with study drug|1|||
130050922|NCT02137772|468142743|FG001|Overall Study|Non-compliance with study drug|0|||
130050923|NCT02137772|468142742|FG000|Overall Study|Not treated|3|||
129799863|NCT02322021|467235223|FG001|Extension Phase|Study terminated by sponsor|0|||
130050924|NCT02137772|468142743|FG001|Overall Study|Not treated|2|||
130050925|NCT00443430|468142745|FG000|Overall Study|Lack of Efficacy|3|||
130050926|NCT00443430|468142746|FG001|Overall Study|Lack of Efficacy|3|||
130314594|NCT03001557|469118325|FG003|Extension Phase|Withdrawal by Subject|0|||
130314595|NCT03001557|469118326|FG004|Extension Phase|Withdrawal by Subject|0|||
130314596|NCT03001557|469118327|FG005|Extension Phase|Withdrawal by Subject|1|||
130314597|NCT03001557|469118328|FG006|Extension Phase|Withdrawal by Subject|5|||
130314598|NCT03001557|469118329|FG007|Extension Phase|Withdrawal by Subject|2|||
130314599|NCT03001557|469118322|FG000|Extension Phase|Lost to Follow-up|0|||
130314600|NCT03001557|469118323|FG001|Extension Phase|Lost to Follow-up|0|||
130314601|NCT03001557|469118324|FG002|Extension Phase|Lost to Follow-up|0|||
130314602|NCT03001557|469118325|FG003|Extension Phase|Lost to Follow-up|0|||
130314603|NCT03001557|469118326|FG004|Extension Phase|Lost to Follow-up|0|||
130314604|NCT03001557|469118327|FG005|Extension Phase|Lost to Follow-up|0|||
130314605|NCT03001557|469118328|FG006|Extension Phase|Lost to Follow-up|2|||
130314606|NCT03001557|469118329|FG007|Extension Phase|Lost to Follow-up|1|||
130314607|NCT03001557|469118322|FG000|Extension Phase|Administrative Reason|0|||
130314608|NCT03001557|469118323|FG001|Extension Phase|Administrative Reason|0|||
130314609|NCT03001557|469118324|FG002|Extension Phase|Administrative Reason|0|||
130314610|NCT03001557|469118325|FG003|Extension Phase|Administrative Reason|0|||
130314611|NCT03001557|469118326|FG004|Extension Phase|Administrative Reason|0|||
130314612|NCT03001557|469118327|FG005|Extension Phase|Administrative Reason|1|||
130314613|NCT03001557|469118328|FG006|Extension Phase|Administrative Reason|3|||
130314614|NCT03001557|469118329|FG007|Extension Phase|Administrative Reason|3|||
130314615|NCT03001557|469118322|FG000|Extension Phase|Loss of caregiver|0|||
130314616|NCT03001557|469118323|FG001|Extension Phase|Loss of caregiver|0|||
130314617|NCT03001557|469118324|FG002|Extension Phase|Loss of caregiver|0|||
130314618|NCT03001557|469118325|FG003|Extension Phase|Loss of caregiver|0|||
130314619|NCT03001557|469118326|FG004|Extension Phase|Loss of caregiver|0|||
130314620|NCT03001557|469118327|FG005|Extension Phase|Loss of caregiver|0|||
130314621|NCT03001557|469118328|FG006|Extension Phase|Loss of caregiver|1|||
130314622|NCT03001557|469118329|FG007|Extension Phase|Loss of caregiver|0|||
130314623|NCT03001557|469118322|FG000|Extension Phase|Others|0|||
130314624|NCT03001557|469118323|FG001|Extension Phase|Others|0|||
130314625|NCT03001557|469118324|FG002|Extension Phase|Others|0|||
129799864|NCT02322021|467235224|FG002|Extension Phase|Study terminated by sponsor|0|||
129799865|NCT02322021|467235225|FG003|Extension Phase|Study terminated by sponsor|0|||
129799866|NCT02322021|467235226|FG004|Extension Phase|Study terminated by sponsor|28|||
129799867|NCT02047227|467235227|FG000|Overall Study|Adverse Event|2|||
129799868|NCT02047227|467235228|FG001|Overall Study|Adverse Event|4|||
129799869|NCT02047227|467235227|FG000|Overall Study|Lost to Follow-up|0|||
129799870|NCT02047227|467235228|FG001|Overall Study|Lost to Follow-up|3|||
129799871|NCT02047227|467235227|FG000|Overall Study|Protocol Violation|1|||
129799872|NCT02047227|467235228|FG001|Overall Study|Protocol Violation|0|||
129799873|NCT02047227|467235227|FG000|Overall Study|Spontaneous pregnancy|1|||
129799874|NCT02047227|467235228|FG001|Overall Study|Spontaneous pregnancy|0|||
129799875|NCT02047227|467235227|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
129799876|NCT02047227|467235228|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
129799877|NCT02047227|467235227|FG000|Overall Study|No oocytes retrieved|21|||
129799878|NCT02047227|467235228|FG001|Overall Study|No oocytes retrieved|20|||
129799879|NCT02047227|467235227|FG000|Overall Study|No fertilization|61|||
129799880|NCT02047227|467235228|FG001|Overall Study|No fertilization|51|||
129799881|NCT02047227|467235227|FG000|Overall Study|Intention to freeze all embryos|1|||
129799882|NCT02047227|467235228|FG001|Overall Study|Intention to freeze all embryos|0|||
129799883|NCT02047227|467235227|FG000|Overall Study|All embryos discarded|12|||
129799884|NCT02047227|467235228|FG001|Overall Study|All embryos discarded|11|||
129799885|NCT02047227|467235227|FG000|Overall Study|Other|10|||
129799886|NCT02047227|467235228|FG001|Overall Study|Other|9|||
129799887|NCT01977937|467235237|FG000|Overall Study|Withdrawal by Subject|2|||
129799888|NCT01977937|467235238|FG001|Overall Study|Withdrawal by Subject|1|||
129799889|NCT01977937|467235237|FG000|Overall Study|Adverse Event|1|||
129799890|NCT01977937|467235238|FG001|Overall Study|Adverse Event|0|||
129799891|NCT01977937|467235237|FG000|Overall Study|Physician Decision|0|||
129799892|NCT01977937|467235238|FG001|Overall Study|Physician Decision|1|||
129799893|NCT00915356|467235239|FG000|Overall Study|Withdrawal by Subject|1|||
129799894|NCT00915356|467235240|FG001|Overall Study|Withdrawal by Subject|0|||
129799895|NCT00915356|467235241|FG002|Overall Study|Withdrawal by Subject|0|||
129799896|NCT00915356|467235242|FG003|Overall Study|Withdrawal by Subject|0|||
129799897|NCT00915356|467235243|FG004|Overall Study|Withdrawal by Subject|0|||
129799898|NCT02819518|467235253|FG000|Overall Study|Death|9|||
129799899|NCT02819518|467235254|FG001|Overall Study|Death|12|||
129799900|NCT02819518|467235255|FG002|Overall Study|Death|9|||
129799901|NCT02819518|467235256|FG003|Overall Study|Death|475|||
129799902|NCT02819518|467235257|FG004|Overall Study|Death|244|||
130314626|NCT03001557|469118325|FG003|Extension Phase|Others|0|||
130314627|NCT03001557|469118326|FG004|Extension Phase|Others|0|||
130314628|NCT03001557|469118327|FG005|Extension Phase|Others|1|||
129799903|NCT02819518|467235253|FG000|Overall Study|Withdrawal by Subject|0|||
130314629|NCT03001557|469118328|FG006|Extension Phase|Others|3|||
130314630|NCT03001557|469118329|FG007|Extension Phase|Others|0|||
130314631|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
130314632|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
130314633|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Death|1|||
130050927|NCT00443430|468142745|FG000|Overall Study|Adverse Event|1|||
130050928|NCT00443430|468142746|FG001|Overall Study|Adverse Event|1|||
130050929|NCT02650284|468142751|FG000|Overall Study|Lost to Follow-up|3|||
130050930|NCT02650284|468142752|FG001|Overall Study|Lost to Follow-up|3|||
130050931|NCT02650284|468142751|FG000|Overall Study|Consent incorrectly taken|0|||
130050932|NCT02650284|468142752|FG001|Overall Study|Consent incorrectly taken|1|||
130050933|NCT02084134|468142757|FG000|Overall Study|Protocol Violation|4|||
130050934|NCT02084134|468142758|FG001|Overall Study|Protocol Violation|2|||
130050935|NCT02084134|468142757|FG000|Overall Study|Death|0|||
130050936|NCT02084134|468142758|FG001|Overall Study|Death|1|||
130050937|NCT01165203|468142759|FG000|Active Phase|Serious Adverse Event|1|||
130050938|NCT01165203|468142760|FG001|Active Phase|Serious Adverse Event|0|||
130050939|NCT01165203|468142759|FG000|Active Phase|Withdrawal by Subject|2|||
130050940|NCT01165203|468142760|FG001|Active Phase|Withdrawal by Subject|1|||
130050941|NCT01165203|468142759|FG000|Active Phase|Migrated/moved from study area|0|||
130050942|NCT01165203|468142760|FG001|Active Phase|Migrated/moved from study area|1|||
130050943|NCT01165203|468142759|FG000|Active Phase|Lost to Follow-up|2|||
130050944|NCT01165203|468142760|FG001|Active Phase|Lost to Follow-up|0|||
130050945|NCT01165203|468142759|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
130050946|NCT01165203|468142760|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
130314634|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Death|2|||
130314635|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
130314636|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
130314637|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
130314638|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
130314639|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
130314640|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
130314641|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
130314642|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
130314643|NCT01794000|469118330|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
130314644|NCT01794000|469118331|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
130314645|NCT01794000|469118330|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
130314646|NCT01794000|469118331|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
130314647|NCT01176058|469118333|FG000|Overall Study|Adverse Event|1|||
130314648|NCT01176058|469118334|FG001|Overall Study|Adverse Event|0|||
130314649|NCT01176058|469118333|FG000|Overall Study|Insufficient clinical response|2|||
130314650|NCT01176058|469118334|FG001|Overall Study|Insufficient clinical response|2|||
130050947|NCT01165203|468142759|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
130050948|NCT01165203|468142760|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
130050949|NCT01165203|468142759|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
130050950|NCT01165203|468142760|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
130314651|NCT01176058|469118333|FG000|Overall Study|Insufficient mycological response|0|||
130314652|NCT01176058|469118334|FG001|Overall Study|Insufficient mycological response|1|||
130314653|NCT01176058|469118333|FG000|Overall Study|Withdrawal by Subject|1|||
130050951|NCT01165203|468142759|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
130050952|NCT01165203|468142760|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
130050953|NCT01165203|468142759|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
130050954|NCT01165203|468142760|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
130050955|NCT00374907|468142761|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
130050956|NCT00374907|468142762|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
130050957|NCT00374907|468142761|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
130050958|NCT00374907|468142762|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
130050959|NCT00374907|468142761|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
130050960|NCT00374907|468142762|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
130050961|NCT00374907|468142761|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
130050962|NCT00374907|468142762|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
130050963|NCT00374907|468142761|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
130050964|NCT00374907|468142762|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
130050965|NCT01780389|468142767|FG000|Overall Study|Adverse Event|1|||
130050966|NCT01323673|468142771|FG000|Overall Study|Adverse Event|0|||
130050967|NCT01323673|468142772|FG001|Overall Study|Adverse Event|1|||
130050968|NCT01323673|468142771|FG000|Overall Study|Lost to Follow-up|0|||
130050969|NCT01323673|468142772|FG001|Overall Study|Lost to Follow-up|1|||
130050970|NCT01323673|468142771|FG000|Overall Study|Protocol Violation|1|||
130050971|NCT01323673|468142772|FG001|Overall Study|Protocol Violation|0|||
130050972|NCT01323673|468142771|FG000|Overall Study|Withdrawal by Subject|2|||
130050973|NCT01323673|468142772|FG001|Overall Study|Withdrawal by Subject|3|||
130050974|NCT04598165|468142773|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
130050975|NCT04598165|468142774|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
130050976|NCT04598165|468142773|FG000|Completed 6-week Follow-up|Death|2|||
130050977|NCT04598165|468142774|FG001|Completed 6-week Follow-up|Death|1|||
130050978|NCT04598165|468142773|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
130050979|NCT04598165|468142774|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
130050980|NCT04598165|468142773|FG000|Completed 6-week Follow-up|Ineligible|4|||
130050981|NCT04598165|468142774|FG001|Completed 6-week Follow-up|Ineligible|3|||
130050982|NCT04598165|468142773|FG000|Completed 6-week Follow-up|Partner refusal|0|||
130050983|NCT04598165|468142774|FG001|Completed 6-week Follow-up|Partner refusal|1|||
130050984|NCT04598165|468142773|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
130050985|NCT04598165|468142774|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
130050986|NCT02379923|468142775|FG000|Overall Study|Death|5|||
130050987|NCT00426751|468142776|FG000|Overall Study|Adverse Event|8|||
130050988|NCT00426751|468142777|FG001|Overall Study|Adverse Event|1|||
130050989|NCT00426751|468142776|FG000|Overall Study|Lost to Follow-up|7|||
130050990|NCT00426751|468142777|FG001|Overall Study|Lost to Follow-up|6|||
130050991|NCT00426751|468142776|FG000|Overall Study|Consent Withdrawn|0|||
130050992|NCT00426751|468142777|FG001|Overall Study|Consent Withdrawn|1|||
130050993|NCT00426751|468142776|FG000|Overall Study|Other Reasons|7|||
130050994|NCT00426751|468142777|FG001|Overall Study|Other Reasons|12|||
130050995|NCT01200511|468142778|FG000|Overall Study|Lost to Follow-up|3|||
130050996|NCT01200511|468142778|FG000|Overall Study|Withdrawal by Subject|1|||
130050997|NCT01200511|468142778|FG000|Overall Study|Adverse Event|1|||
130050998|NCT04229446|468142782|FG000|Overall Study|Death|12|||
130050999|NCT04229446|468142783|FG001|Overall Study|Death|10|||
130051000|NCT04229446|468142782|FG000|Overall Study|Lost to Follow-up|5|||
130051001|NCT04229446|468142783|FG001|Overall Study|Lost to Follow-up|8|||
130051002|NCT00337467|468142784|FG000|Overall Study|Adverse Event|3|||
130051003|NCT00337467|468142784|FG000|Overall Study|Subject Withdrew Consent|2|||
130051004|NCT00337467|468142784|FG000|Overall Study|Pregnancy|1|||
130051005|NCT00337467|468142784|FG000|Overall Study|Lost to Follow-up|2|||
130051006|NCT00337467|468142784|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
130051007|NCT04083222|468142785|FG000|Overall Study|Voluntary Withdrawal|0|||
130051008|NCT04083222|468142786|FG001|Overall Study|Voluntary Withdrawal|1|||
130051009|NCT04083222|468142785|FG000|Overall Study|Reason not Specified|0|||
130314654|NCT01176058|469118334|FG001|Overall Study|Withdrawal by Subject|0|||
130314655|NCT03480152|469118335|FG000|Phase I|Signed consent. Died before treatment.|1|||
130314656|NCT03480152|469118336|FG001|Phase I|Signed consent. Died before treatment.|0|||
130051010|NCT04083222|468142786|FG001|Overall Study|Reason not Specified|1|||
130051011|NCT03103750|468142787|FG000|Overall Study|Adverse Event|1|||
130110632|NCT01298596|468365809|FG001|Overall Study|Withdrawal by Subject|1|||
130110633|NCT01298596|468365808|FG000|Overall Study|Death|5|||
130110634|NCT01298596|468365809|FG001|Overall Study|Death|3|||
130110635|NCT01298596|468365808|FG000|Overall Study|Lost to Follow-up|6|||
130314657|NCT03480152|469118337|FG002|Phase I|Signed consent. Died before treatment.|0|||
130314658|NCT00687401|469118338|FG000|Overall Study|Protocol Violation|7|||
129799904|NCT02819518|467235254|FG001|Overall Study|Withdrawal by Subject|0|||
129890719|NCT03639675|467557537|FG000|Overall Study|Withdrawal by Subject|1|||
129890720|NCT02485353|467557538|FG000|Overall Study|Death|1|||
129890721|NCT02485353|467557538|FG000|Overall Study|Disease Progression|1|||
129890722|NCT01021332|467557539|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
129890723|NCT01021332|467557539|FG000|Overall Study|Adverse Event|43|||
129890724|NCT01021332|467557539|FG000|Overall Study|Lack of Efficacy|19|||
129890725|NCT01021332|467557539|FG000|Overall Study|Withdrawal of Consent|23|||
129890726|NCT01021332|467557539|FG000|Overall Study|Lost to Follow-up|4|||
129890727|NCT01021332|467557539|FG000|Overall Study|Protocol Violation|9|||
129890728|NCT01021332|467557539|FG000|Overall Study|Miscellaneous|3|||
129890729|NCT05343455|467557542|FG000|Overall Study|Withdrawal by Subject|4|||
129890730|NCT05343455|467557543|FG001|Overall Study|Withdrawal by Subject|9|||
129890731|NCT05343455|467557544|FG002|Overall Study|Withdrawal by Subject|7|||
129890732|NCT05343455|467557542|FG000|Overall Study|Adverse Event|2|||
129890733|NCT05343455|467557543|FG001|Overall Study|Adverse Event|1|||
129890734|NCT05343455|467557544|FG002|Overall Study|Adverse Event|2|||
129890735|NCT05343455|467557542|FG000|Overall Study|Lost to Follow-up|1|||
129890736|NCT05343455|467557543|FG001|Overall Study|Lost to Follow-up|1|||
129890737|NCT05343455|467557544|FG002|Overall Study|Lost to Follow-up|3|||
129890738|NCT05343455|467557542|FG000|Overall Study|Pregnancy|1|||
129890739|NCT05343455|467557543|FG001|Overall Study|Pregnancy|0|||
129890740|NCT05343455|467557544|FG002|Overall Study|Pregnancy|0|||
129890741|NCT05343455|467557542|FG000|Overall Study|Physician Decision|0|||
129890742|NCT05343455|467557543|FG001|Overall Study|Physician Decision|0|||
129890743|NCT05343455|467557544|FG002|Overall Study|Physician Decision|1|||
129890744|NCT05343455|467557542|FG000|Overall Study|Protocol Violation|0|||
129890745|NCT05343455|467557543|FG001|Overall Study|Protocol Violation|1|||
129890746|NCT05343455|467557544|FG002|Overall Study|Protocol Violation|1|||
129890747|NCT03302910|467557548|FG000|Overall Study|Protocol Violation|1|||
129890748|NCT03302910|467557549|FG001|Overall Study|Protocol Violation|0|||
130314659|NCT00687401|469118338|FG000|Overall Study|Adverse Event|6|||
130314660|NCT00687401|469118338|FG000|Overall Study|Lack of Efficacy|6|||
130314661|NCT00687401|469118338|FG000|Overall Study|Withdrawal by Subject|4|||
130110636|NCT01298596|468365809|FG001|Overall Study|Lost to Follow-up|14|||
130110637|NCT01298596|468365808|FG000|Overall Study|Referred for further management|16|||
130110638|NCT01298596|468365809|FG001|Overall Study|Referred for further management|15|||
130110639|NCT04128696|468365812|FG000|Overall Study|Lost to Follow-up|3|||
130110640|NCT04128696|468365813|FG001|Overall Study|Lost to Follow-up|7|||
130110641|NCT04128696|468365812|FG000|Overall Study|Withdrawal by Subject|12|||
130110642|NCT04128696|468365813|FG001|Overall Study|Withdrawal by Subject|11|||
130110643|NCT04128696|468365812|FG000|Overall Study|Study Closed/Terminated|26|||
130110644|NCT04128696|468365813|FG001|Overall Study|Study Closed/Terminated|38|||
130110645|NCT04128696|468365812|FG000|Overall Study|Physician Decision|2|||
130110646|NCT04128696|468365813|FG001|Overall Study|Physician Decision|3|||
130110647|NCT00585039|468365816|FG000|Overall Study|medication spilled|2|||
130110648|NCT00585039|468365817|FG001|Overall Study|medication spilled|0|||
130110649|NCT01010230|468365818|FG000|Overall Study|Withdrawal by Subject|6|||
130314662|NCT00687401|469118338|FG000|Overall Study|Did not return for visit|3|||
130051012|NCT03103750|468142788|FG001|Overall Study|Adverse Event|0|||
130051013|NCT03103750|468142787|FG000|Overall Study|Lost to Follow-up|1|||
130051014|NCT03103750|468142788|FG001|Overall Study|Lost to Follow-up|0|||
130051015|NCT03103750|468142787|FG000|Overall Study|PET Equipment Related|2|||
130051016|NCT03103750|468142788|FG001|Overall Study|PET Equipment Related|2|||
130051017|NCT04400318|468143976|FG000|Overall Study|Adverse Event|1|||
130051018|NCT04400318|468143977|FG001|Overall Study|Adverse Event|0|||
130051019|NCT04400318|468143976|FG000|Overall Study|Withdrawal by Subject|1|||
130051020|NCT04400318|468143977|FG001|Overall Study|Withdrawal by Subject|1|||
130051021|NCT04400318|468143976|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
130051022|NCT04400318|468143977|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
130051023|NCT01096446|468143978|FG000|Overall Study|Death|1|||
130051024|NCT01096446|468143979|FG001|Overall Study|Death|0|||
129890749|NCT01477749|467557550|FG000|Overall Study|Physician Decision|4|||
129890750|NCT00724061|467557557|FG000|Dose Escalation Phase|Adverse Event|2|||
130051025|NCT01096446|468143978|FG000|Overall Study|Protocol Violation|2|||
130051026|NCT01096446|468143979|FG001|Overall Study|Protocol Violation|0|||
130051027|NCT00747617|468143980|FG000|Overall Study|Lost to Follow-up|3|||
129890751|NCT00724061|467557557|FG000|Dose Escalation Phase|Disease Progression|3|||
129890752|NCT00953160|467557560|FG000|Overall Study|Lost to Follow-up|23|||
130051028|NCT00747617|468143981|FG001|Overall Study|Lost to Follow-up|1|||
130314663|NCT00687401|469118338|FG000|Overall Study|For reasons different from those above|4|||
130314664|NCT02920892|469118339|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
129890753|NCT00953160|467557560|FG000|Overall Study|Withdrawal by Subject|4|||
129890754|NCT02724020|467557563|FG000|Overall Study|Death|16|||
129890755|NCT02724020|467557564|FG001|Overall Study|Death|18|||
129890756|NCT02724020|467557565|FG002|Overall Study|Death|19|||
129890757|NCT02724020|467557563|FG000|Overall Study|Lost to Follow-up|0|||
130051029|NCT02279524|468143982|FG000|Overall Study|Withdrawal by Subject|3|||
130051030|NCT02279524|468143983|FG001|Overall Study|Withdrawal by Subject|6|||
130110650|NCT01010230|468365819|FG001|Overall Study|Withdrawal by Subject|5|||
129890758|NCT02724020|467557564|FG001|Overall Study|Lost to Follow-up|3|||
129890759|NCT02724020|467557565|FG002|Overall Study|Lost to Follow-up|0|||
129890760|NCT02724020|467557563|FG000|Overall Study|Site Terminated by Sponsor|15|||
129890761|NCT02724020|467557564|FG001|Overall Study|Site Terminated by Sponsor|8|||
129890762|NCT02724020|467557565|FG002|Overall Study|Site Terminated by Sponsor|8|||
129890763|NCT02724020|467557563|FG000|Overall Study|Withdrawal by Subject|1|||
129890764|NCT02724020|467557564|FG001|Overall Study|Withdrawal by Subject|3|||
129890765|NCT02724020|467557565|FG002|Overall Study|Withdrawal by Subject|5|||
129890766|NCT00425503|467557566|FG000|Overall Study|Adverse Event|2|||
129890767|NCT00425503|467557566|FG000|Overall Study|Protocol Violation|1|||
129890768|NCT02118714|467557567|FG000|Overall Study|Lost to Follow-up|2|||
129890769|NCT02118714|467557567|FG000|Overall Study|Protocol Violation|1|||
129890770|NCT02954575|467557568|FG000|Overall Study|Withdrawal by Subject|2|||
129890771|NCT02954575|467557568|FG000|Overall Study|Adverse Event|1|||
129890772|NCT01066156|467557570|FG000|Overall Study|ineligible|2|||
129890773|NCT01066156|467557570|FG000|Overall Study|Lost to Follow-up|7|||
129890774|NCT01066156|467557570|FG000|Overall Study|Withdrawal by Subject|1|||
129890775|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
129890776|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
129890777|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
129890778|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
129890779|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
129890780|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
129890781|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
129890782|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
129890783|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
129890784|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
129890785|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
129890786|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
129890787|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
129890788|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
129890789|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
129890790|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
129890791|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
129890792|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
129890793|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
129890794|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
129890795|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
129890796|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
129890797|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
129890798|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
129890799|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
129890800|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
130314665|NCT02920892|469118340|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
130314666|NCT02920892|469118341|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
130314667|NCT02920892|469118339|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
129890801|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
129890802|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
129891099|NCT02408549|467559616|FG000|Overall Study|Study terminated at site|1|||
130051031|NCT02279524|468143984|FG002|Overall Study|Withdrawal by Subject|3|||
130051032|NCT02279524|468143982|FG000|Overall Study|Adverse Event|4|||
130051033|NCT02279524|468143983|FG001|Overall Study|Adverse Event|3|||
130051034|NCT02279524|468143984|FG002|Overall Study|Adverse Event|2|||
130051035|NCT02279524|468143982|FG000|Overall Study|Lost to Follow-up|1|||
130051036|NCT02279524|468143983|FG001|Overall Study|Lost to Follow-up|1|||
130051037|NCT02279524|468143984|FG002|Overall Study|Lost to Follow-up|0|||
130051038|NCT02279524|468143982|FG000|Overall Study|Disallowed medication|1|||
130051039|NCT02279524|468143983|FG001|Overall Study|Disallowed medication|1|||
130051040|NCT02279524|468143984|FG002|Overall Study|Disallowed medication|2|||
130051041|NCT02279524|468143982|FG000|Overall Study|Bariatric surgery|1|||
130051042|NCT02279524|468143983|FG001|Overall Study|Bariatric surgery|0|||
130051043|NCT02279524|468143984|FG002|Overall Study|Bariatric surgery|0|||
130051044|NCT01746732|468143985|FG000|Lead-In Period|Withdrawal by Subject|1|||
130051045|NCT01746732|468143986|FG001|Lead-In Period|Withdrawal by Subject|0|||
130051046|NCT01746732|468143987|FG002|Lead-In Period|Withdrawal by Subject|0|||
130051047|NCT01746732|468143985|FG000|Period 1|Physician Decision|0|||
130051048|NCT01746732|468143986|FG001|Period 1|Physician Decision|1|||
130314668|NCT02920892|469118340|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
130314669|NCT02920892|469118341|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
130051049|NCT01746732|468143987|FG002|Period 1|Physician Decision|0|||
130051050|NCT01746732|468143985|FG000|Period 2|Withdrawal by Subject|0|||
130051051|NCT01746732|468143986|FG001|Period 2|Withdrawal by Subject|0|||
130051052|NCT01746732|468143987|FG002|Period 2|Withdrawal by Subject|2|||
130051053|NCT01746732|468143985|FG000|Period 2|Adverse Event|0|||
130051054|NCT01746732|468143986|FG001|Period 2|Adverse Event|0|||
130051055|NCT01746732|468143987|FG002|Period 2|Adverse Event|1|||
130051056|NCT01746732|468143985|FG000|Period 2|Lost to Follow-up|0|||
130051057|NCT01746732|468143986|FG001|Period 2|Lost to Follow-up|0|||
130051058|NCT01746732|468143987|FG002|Period 2|Lost to Follow-up|1|||
130051059|NCT03509207|468143988|FG000|Overall Study|Death|2|||
130051060|NCT02817555|468143989|FG000|Overall Study|Death|1|||
129799905|NCT02819518|467235255|FG002|Overall Study|Withdrawal by Subject|0|||
130051061|NCT02817555|468143990|FG001|Overall Study|Death|3|||
129799906|NCT02819518|467235256|FG003|Overall Study|Withdrawal by Subject|25|||
130051062|NCT02817555|468143989|FG000|Overall Study|moved away|1|||
130051063|NCT02817555|468143990|FG001|Overall Study|moved away|0|||
129890803|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
129890804|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
129890805|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
129890806|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
129890807|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
129890808|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
129890809|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
129890810|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
129890811|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
129890812|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
129890813|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
129890814|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
129890815|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
129890816|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
129890817|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
129890818|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
129890819|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129890820|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129890821|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129890822|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
129890823|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129890824|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129890825|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
129890826|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129890827|NCT02400307|467557578|FG000|Overall Study|Enrolled and Never Dosed|1|||
129890828|NCT02400307|467557579|FG001|Overall Study|Enrolled and Never Dosed|0|||
129890829|NCT02839681|467557580|FG000|Overall Study|Death|2|||
129890830|NCT03473756|467557584|FG000|Overall Study|Withdrawal by Subject|1|||
129890831|NCT03473756|467557585|FG001|Overall Study|Withdrawal by Subject|4|||
129890832|NCT03473756|467557584|FG000|Overall Study|Adverse Event|6|||
129890833|NCT03473756|467557585|FG001|Overall Study|Adverse Event|7|||
129890834|NCT03473756|467557584|FG000|Overall Study|Lack of Efficacy|3|||
129890835|NCT03473756|467557585|FG001|Overall Study|Lack of Efficacy|10|||
129890836|NCT03473756|467557584|FG000|Overall Study|Physician Decision|0|||
129890837|NCT03473756|467557585|FG001|Overall Study|Physician Decision|2|||
129890838|NCT03473756|467557584|FG000|Overall Study|End of study treatment|0|||
129890839|NCT03473756|467557585|FG001|Overall Study|End of study treatment|2|||
129890840|NCT03473756|467557584|FG000|Overall Study|Lost to Follow-up|0|||
129890841|NCT03473756|467557585|FG001|Overall Study|Lost to Follow-up|1|||
129890842|NCT02148718|467557586|FG000|Overall Study|Protocol Violation|26|||
129890843|NCT02148718|467557586|FG000|Overall Study|Discontinued Study Prematurely|5|||
129890844|NCT01778062|467557587|FG000|Overall Study|Adverse Event|1|||
129890845|NCT01778062|467557588|FG001|Overall Study|Adverse Event|3|||
129890846|NCT01778062|467557587|FG000|Overall Study|Consent Withdrawal|1|||
129890847|NCT01778062|467557588|FG001|Overall Study|Consent Withdrawal|5|||
129890848|NCT01778062|467557587|FG000|Overall Study|major protocol deviation|4|||
129890849|NCT01778062|467557588|FG001|Overall Study|major protocol deviation|3|||
129890850|NCT03387514|467557589|FG000|Overall Study|Withdrawal by Subject|2|||
129890851|NCT03387514|467557589|FG000|Overall Study|Physician Decision|1|||
129890852|NCT03387514|467557589|FG000|Overall Study|Lost to Follow-up|2|||
129890853|NCT04445155|467557598|FG000|Overall Study|Lost to Follow-up|11|||
130051064|NCT02817555|468143989|FG000|Overall Study|transplant|1|||
130051065|NCT02817555|468143990|FG001|Overall Study|transplant|1|||
130051066|NCT02817555|468143989|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
129799907|NCT02819518|467235257|FG004|Overall Study|Withdrawal by Subject|8|||
129799908|NCT02819518|467235253|FG000|Overall Study|Lost to Follow-up|0|||
129799909|NCT02819518|467235254|FG001|Overall Study|Lost to Follow-up|0|||
129799910|NCT02819518|467235255|FG002|Overall Study|Lost to Follow-up|0|||
129799911|NCT02819518|467235256|FG003|Overall Study|Lost to Follow-up|0|||
129799912|NCT02819518|467235257|FG004|Overall Study|Lost to Follow-up|1|||
129799913|NCT02819518|467235253|FG000|Overall Study|Sponsor Decision|1|||
130051067|NCT02817555|468143990|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
130051068|NCT00137436|468143991|FG000|Overall Study|Adverse Event|13|||
130051069|NCT00137436|468143991|FG000|Overall Study|Death|2|||
130051070|NCT00137436|468143991|FG000|Overall Study|Lack of Efficacy|17|||
130051071|NCT00137436|468143991|FG000|Overall Study|Withdrawal by Subject|6|||
130051072|NCT00137436|468143991|FG000|Overall Study|Other|5|||
130051073|NCT00912015|468143995|FG000|Overall Study|Lack of Efficacy|1|||
130051074|NCT00912015|468143996|FG001|Overall Study|Lack of Efficacy|0|||
129890854|NCT04445155|467557599|FG001|Overall Study|Lost to Follow-up|2|||
130051075|NCT00912015|468143997|FG002|Overall Study|Lack of Efficacy|0|||
130051076|NCT00912015|468143998|FG003|Overall Study|Lack of Efficacy|0|||
129799914|NCT02819518|467235254|FG001|Overall Study|Sponsor Decision|1|||
129799915|NCT02819518|467235255|FG002|Overall Study|Sponsor Decision|0|||
130051077|NCT00912015|468143995|FG000|Overall Study|Withdrawal by Subject|8|||
130051078|NCT00912015|468143996|FG001|Overall Study|Withdrawal by Subject|8|||
130051079|NCT00912015|468143997|FG002|Overall Study|Withdrawal by Subject|3|||
130051080|NCT00912015|468143998|FG003|Overall Study|Withdrawal by Subject|0|||
130051081|NCT00912015|468143995|FG000|Overall Study|Protocol Violation|1|||
130051082|NCT00912015|468143996|FG001|Overall Study|Protocol Violation|0|||
130051083|NCT00912015|468143997|FG002|Overall Study|Protocol Violation|0|||
130051084|NCT00912015|468143998|FG003|Overall Study|Protocol Violation|1|||
130051085|NCT00912015|468143995|FG000|Overall Study|Adverse Event|6|||
130051086|NCT00912015|468143996|FG001|Overall Study|Adverse Event|0|||
130051087|NCT00912015|468143997|FG002|Overall Study|Adverse Event|0|||
130051088|NCT00912015|468143998|FG003|Overall Study|Adverse Event|1|||
130051089|NCT01356602|468143999|FG000|Overall Study|Protocol Deviation|0|||
130051090|NCT01356602|468144000|FG001|Overall Study|Protocol Deviation|1|||
130051091|NCT01356602|468144001|FG002|Overall Study|Protocol Deviation|1|||
130051092|NCT01356602|468143999|FG000|Overall Study|Administrative Problems|1|||
130051093|NCT01356602|468144000|FG001|Overall Study|Administrative Problems|4|||
130051094|NCT01356602|468144001|FG002|Overall Study|Administrative Problems|5|||
130051095|NCT01356602|468143999|FG000|Overall Study|Lost to Follow-up|4|||
130051096|NCT01356602|468144000|FG001|Overall Study|Lost to Follow-up|5|||
130051097|NCT01356602|468144001|FG002|Overall Study|Lost to Follow-up|6|||
130051098|NCT01356602|468143999|FG000|Overall Study|Withdrawal by Subject|4|||
130051099|NCT01356602|468144000|FG001|Overall Study|Withdrawal by Subject|3|||
130051100|NCT01356602|468144001|FG002|Overall Study|Withdrawal by Subject|7|||
130051101|NCT01356602|468143999|FG000|Overall Study|Lack of Efficacy|0|||
130051102|NCT01356602|468144000|FG001|Overall Study|Lack of Efficacy|1|||
130051103|NCT01356602|468144001|FG002|Overall Study|Lack of Efficacy|4|||
130051104|NCT01356602|468143999|FG000|Overall Study|Adverse Event|0|||
130051105|NCT01356602|468144000|FG001|Overall Study|Adverse Event|1|||
130051106|NCT01356602|468144001|FG002|Overall Study|Adverse Event|1|||
130051107|NCT01115569|468144002|FG000|Conversion/Titration Phase|Adverse Event|59|||
130051108|NCT01115569|468144003|FG001|Conversion/Titration Phase|Adverse Event|0|||
130051109|NCT01115569|468144002|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
130051110|NCT01115569|468144003|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
130051111|NCT01115569|468144002|FG000|Conversion/Titration Phase|Physician Decision|5|||
130051112|NCT01115569|468144003|FG001|Conversion/Titration Phase|Physician Decision|0|||
130051113|NCT01115569|468144002|FG000|Conversion/Titration Phase|Protocol Violation|68|||
130051114|NCT01115569|468144003|FG001|Conversion/Titration Phase|Protocol Violation|0|||
130051115|NCT01115569|468144002|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
130051116|NCT01115569|468144003|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
130051117|NCT01115569|468144002|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
130051118|NCT01115569|468144003|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
130051119|NCT01115569|468144002|FG000|Maintenance Phase|Adverse Event|0|||
130051120|NCT01115569|468144003|FG001|Maintenance Phase|Adverse Event|43|||
130051121|NCT01115569|468144002|FG000|Maintenance Phase|Lost to Follow-up|0|||
130051122|NCT01115569|468144003|FG001|Maintenance Phase|Lost to Follow-up|8|||
130051123|NCT01115569|468144002|FG000|Maintenance Phase|Physician Decision|0|||
130051124|NCT01115569|468144003|FG001|Maintenance Phase|Physician Decision|3|||
130051125|NCT01115569|468144002|FG000|Maintenance Phase|Protocol Violation|0|||
130051126|NCT01115569|468144003|FG001|Maintenance Phase|Protocol Violation|9|||
130051127|NCT01115569|468144002|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130051128|NCT01115569|468144003|FG001|Maintenance Phase|Withdrawal by Subject|27|||
130051129|NCT01115569|468144002|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
130051130|NCT01115569|468144003|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
130051131|NCT01115569|468144002|FG000|Maintenance Phase|Administrative|0|||
130051132|NCT01115569|468144003|FG001|Maintenance Phase|Administrative|1|||
130051133|NCT02361762|468144004|FG000|Overall Study|Withdrawal by Subject|0|||
130051134|NCT02361762|468144005|FG001|Overall Study|Withdrawal by Subject|1|||
130051135|NCT02361762|468144004|FG000|Overall Study|Lost to Follow-up|0|||
130051136|NCT02361762|468144005|FG001|Overall Study|Lost to Follow-up|1|||
130051137|NCT01931462|468144006|FG000|Overall Study|Withdrawal by Subject|1|||
130051138|NCT02819310|468144007|FG000|Overall Study|Withdrawal by Subject|37|||
130051139|NCT02819310|468144007|FG000|Overall Study|Lost to Follow-up|16|||
130051140|NCT02819310|468144007|FG000|Overall Study|Adverse Event|13|||
130051141|NCT02819310|468144007|FG000|Overall Study|Lack of Efficacy|5|||
130051142|NCT02819310|468144007|FG000|Overall Study|Physician Decision|8|||
130051143|NCT02819310|468144007|FG000|Overall Study|Protocol Violation|30|||
130051144|NCT00625365|468144015|FG000|Overall Study|Withdrawal by Subject|1|||
130051145|NCT00625365|468144015|FG000|Overall Study|No IV access|5|||
130051146|NCT00625365|468144015|FG000|Overall Study|VSD|1|||
130051147|NCT02531373|468144019|FG000|Overall Study|Lack of Efficacy|0|||
130051148|NCT02531373|468144020|FG001|Overall Study|Lack of Efficacy|0|||
130051149|NCT02531373|468144021|FG002|Overall Study|Lack of Efficacy|0|||
130051150|NCT02531373|468144022|FG003|Overall Study|Lack of Efficacy|0|||
130051151|NCT02531373|468144023|FG004|Overall Study|Lack of Efficacy|3|||
130051152|NCT02531373|468144024|FG005|Overall Study|Lack of Efficacy|2|||
130051153|NCT02531373|468144025|FG006|Overall Study|Lack of Efficacy|4|||
129890855|NCT04445155|467557600|FG002|Overall Study|Lost to Follow-up|3|||
129890856|NCT04445155|467557601|FG003|Overall Study|Lost to Follow-up|0|||
129890857|NCT04445155|467557598|FG000|Overall Study|Withdrawal by Subject|8|||
129890858|NCT04445155|467557599|FG001|Overall Study|Withdrawal by Subject|0|||
129890859|NCT04445155|467557600|FG002|Overall Study|Withdrawal by Subject|0|||
129890860|NCT04445155|467557601|FG003|Overall Study|Withdrawal by Subject|0|||
129890861|NCT04445155|467557598|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
129890862|NCT04445155|467557599|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
129891100|NCT01272011|467559617|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
130314670|NCT02920892|469118339|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
130314671|NCT02920892|469118340|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
130314672|NCT02920892|469118341|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
130314673|NCT02920892|469118339|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
130314674|NCT02920892|469118340|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
130051154|NCT02531373|468144026|FG007|Overall Study|Lack of Efficacy|8|||
130051155|NCT02531373|468144027|FG008|Overall Study|Lack of Efficacy|5|||
130051156|NCT02531373|468144019|FG000|Overall Study|Lost to Follow-up|0|||
130051157|NCT02531373|468144020|FG001|Overall Study|Lost to Follow-up|0|||
130051158|NCT02531373|468144021|FG002|Overall Study|Lost to Follow-up|0|||
130051159|NCT02531373|468144022|FG003|Overall Study|Lost to Follow-up|0|||
130051160|NCT02531373|468144023|FG004|Overall Study|Lost to Follow-up|0|||
130051161|NCT02531373|468144024|FG005|Overall Study|Lost to Follow-up|2|||
130051162|NCT02531373|468144025|FG006|Overall Study|Lost to Follow-up|2|||
130051163|NCT02531373|468144026|FG007|Overall Study|Lost to Follow-up|0|||
130051164|NCT02531373|468144027|FG008|Overall Study|Lost to Follow-up|0|||
130051165|NCT02531373|468144019|FG000|Overall Study|Physician Decision|0|||
130051166|NCT02531373|468144020|FG001|Overall Study|Physician Decision|0|||
130051167|NCT02531373|468144021|FG002|Overall Study|Physician Decision|0|||
130051168|NCT02531373|468144022|FG003|Overall Study|Physician Decision|0|||
130051169|NCT02531373|468144023|FG004|Overall Study|Physician Decision|2|||
130051170|NCT02531373|468144024|FG005|Overall Study|Physician Decision|1|||
130051171|NCT02531373|468144025|FG006|Overall Study|Physician Decision|0|||
130051172|NCT02531373|468144026|FG007|Overall Study|Physician Decision|0|||
130051173|NCT02531373|468144027|FG008|Overall Study|Physician Decision|0|||
130051174|NCT02531373|468144019|FG000|Overall Study|Protocol Violation|0|||
130051175|NCT02531373|468144020|FG001|Overall Study|Protocol Violation|0|||
130051176|NCT02531373|468144021|FG002|Overall Study|Protocol Violation|0|||
130051177|NCT02531373|468144022|FG003|Overall Study|Protocol Violation|0|||
130051178|NCT02531373|468144023|FG004|Overall Study|Protocol Violation|0|||
130051179|NCT02531373|468144024|FG005|Overall Study|Protocol Violation|1|||
130051180|NCT02531373|468144025|FG006|Overall Study|Protocol Violation|1|||
130051181|NCT02531373|468144026|FG007|Overall Study|Protocol Violation|0|||
130051182|NCT02531373|468144027|FG008|Overall Study|Protocol Violation|1|||
130051183|NCT02531373|468144019|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130051184|NCT02531373|468144020|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130051185|NCT02531373|468144021|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130051186|NCT02531373|468144022|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130051187|NCT02531373|468144023|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130051188|NCT02531373|468144024|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
130051189|NCT02531373|468144025|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
130051190|NCT02531373|468144026|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
130051191|NCT02531373|468144027|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
130051192|NCT02531373|468144019|FG000|Overall Study|Withdrawal by Subject|0|||
130051193|NCT02531373|468144020|FG001|Overall Study|Withdrawal by Subject|0|||
130051194|NCT02531373|468144021|FG002|Overall Study|Withdrawal by Subject|0|||
130051195|NCT02531373|468144022|FG003|Overall Study|Withdrawal by Subject|0|||
130314675|NCT02920892|469118341|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
130314676|NCT02920892|469118339|FG000|Placebo-Controlled Period|Physician Decision|0|||
129890863|NCT04445155|467557600|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
129890864|NCT04445155|467557601|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
129890865|NCT04445155|467557598|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
129890866|NCT04445155|467557599|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
129890867|NCT04445155|467557600|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
129890868|NCT04445155|467557601|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
129890869|NCT01213173|467557604|FG000|Overall Study|Protocol Violation|2|||
129890870|NCT01213173|467557605|FG001|Overall Study|Protocol Violation|0|||
129890871|NCT01213173|467557604|FG000|Overall Study|Adverse Event|4|||
129890872|NCT01213173|467557605|FG001|Overall Study|Adverse Event|8|||
129890873|NCT01213173|467557604|FG000|Overall Study|Withdrawal by Subject|5|||
129890874|NCT01213173|467557605|FG001|Overall Study|Withdrawal by Subject|5|||
129890875|NCT01213173|467557604|FG000|Overall Study|Incorrect Enrollment|1|||
129890876|NCT01213173|467557605|FG001|Overall Study|Incorrect Enrollment|3|||
129890877|NCT02353832|467557608|FG000|Overall Study|Ineligible after enrollment|1|||
129890878|NCT02353832|467557608|FG000|Overall Study|Lost to Follow-up|1|||
129890879|NCT04880161|467557609|FG000|Overall Study|Withdrawal by Subject|1|||
129890880|NCT04880161|467557610|FG001|Overall Study|Withdrawal by Subject|0|||
129890881|NCT04880161|467557609|FG000|Overall Study|Lack of Compliance|1|||
129890882|NCT04880161|467557610|FG001|Overall Study|Lack of Compliance|1|||
129890883|NCT04880161|467557609|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
129890884|NCT04880161|467557610|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
129890885|NCT04880161|467557609|FG000|Overall Study|Screen Failure|0|||
129890886|NCT04880161|467557610|FG001|Overall Study|Screen Failure|1|||
129890887|NCT01268059|467559542|FG000|Overall Study|Lost to Follow-up|0|||
129890888|NCT01268059|467559543|FG001|Overall Study|Lost to Follow-up|1|||
129890889|NCT01268059|467559544|FG002|Overall Study|Lost to Follow-up|0|||
129890890|NCT01268059|467559545|FG003|Overall Study|Lost to Follow-up|0|||
129890891|NCT01268059|467559542|FG000|Overall Study|Withdrawal by Subject|7|||
130051196|NCT02531373|468144023|FG004|Overall Study|Withdrawal by Subject|3|||
130051197|NCT02531373|468144024|FG005|Overall Study|Withdrawal by Subject|0|||
130051198|NCT02531373|468144025|FG006|Overall Study|Withdrawal by Subject|0|||
130051199|NCT02531373|468144026|FG007|Overall Study|Withdrawal by Subject|0|||
130051200|NCT02531373|468144027|FG008|Overall Study|Withdrawal by Subject|0|||
130051201|NCT00536731|468144028|FG000|Overall Study|Adverse Event|3|||
130051202|NCT00536731|468144029|FG001|Overall Study|Adverse Event|2|||
130051203|NCT00536731|468144030|FG002|Overall Study|Adverse Event|3|||
130051204|NCT00536731|468144028|FG000|Overall Study|Withdrawal by Subject|0|||
130051205|NCT00536731|468144029|FG001|Overall Study|Withdrawal by Subject|2|||
130051206|NCT00536731|468144030|FG002|Overall Study|Withdrawal by Subject|0|||
130051207|NCT00536731|468144028|FG000|Overall Study|Intake of prohibited conc. medication|0|||
130051208|NCT00536731|468144029|FG001|Overall Study|Intake of prohibited conc. medication|0|||
130051209|NCT00536731|468144030|FG002|Overall Study|Intake of prohibited conc. medication|1|||
130051210|NCT00536731|468144028|FG000|Overall Study|Safety reasons|0|||
130051211|NCT00536731|468144029|FG001|Overall Study|Safety reasons|0|||
130051212|NCT00536731|468144030|FG002|Overall Study|Safety reasons|1|||
130051213|NCT00536731|468144028|FG000|Overall Study|Other|1|||
130051214|NCT00536731|468144029|FG001|Overall Study|Other|1|||
130051215|NCT00536731|468144030|FG002|Overall Study|Other|0|||
130051216|NCT00972244|468144031|FG000|Overall Study|Incorrect Enrolment|1|||
130051217|NCT00972244|468144032|FG001|Overall Study|Incorrect Enrolment|0|||
130051218|NCT00972244|468144033|FG002|Overall Study|Incorrect Enrolment|0|||
130051219|NCT00972244|468144034|FG003|Overall Study|Incorrect Enrolment|0|||
130051220|NCT00972244|468144035|FG004|Overall Study|Incorrect Enrolment|0|||
130051221|NCT00972244|468144031|FG000|Overall Study|Adverse Event|0|||
130051222|NCT00972244|468144032|FG001|Overall Study|Adverse Event|1|||
130051223|NCT00972244|468144033|FG002|Overall Study|Adverse Event|1|||
130051224|NCT00972244|468144034|FG003|Overall Study|Adverse Event|0|||
130051225|NCT00972244|468144035|FG004|Overall Study|Adverse Event|0|||
130051226|NCT00972244|468144031|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
130051227|NCT00972244|468144032|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
130051228|NCT00972244|468144033|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
130051229|NCT00972244|468144034|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
130051230|NCT00972244|468144035|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
130051231|NCT00972244|468144031|FG000|Overall Study|Withdrawal by Subject|1|||
129890892|NCT01268059|467559543|FG001|Overall Study|Withdrawal by Subject|4|||
130051232|NCT00972244|468144032|FG001|Overall Study|Withdrawal by Subject|2|||
130051233|NCT00972244|468144033|FG002|Overall Study|Withdrawal by Subject|1|||
130051234|NCT00972244|468144034|FG003|Overall Study|Withdrawal by Subject|0|||
129890893|NCT01268059|467559544|FG002|Overall Study|Withdrawal by Subject|0|||
129890894|NCT01268059|467559545|FG003|Overall Study|Withdrawal by Subject|0|||
129890895|NCT01268059|467559542|FG000|Overall Study|Death|20|||
129890896|NCT01268059|467559543|FG001|Overall Study|Death|30|||
129890897|NCT01268059|467559544|FG002|Overall Study|Death|3|||
129890898|NCT01268059|467559545|FG003|Overall Study|Death|5|||
129890899|NCT01268059|467559542|FG000|Overall Study|Progression of disease|1|||
129890900|NCT01268059|467559543|FG001|Overall Study|Progression of disease|0|||
129890901|NCT01268059|467559544|FG002|Overall Study|Progression of disease|0|||
129890902|NCT01268059|467559545|FG003|Overall Study|Progression of disease|0|||
129890903|NCT03850444|467559546|FG000|Overall Study|Adverse Event|16|||
129890904|NCT03850444|467559547|FG001|Overall Study|Adverse Event|10|||
129890905|NCT03850444|467559546|FG000|Overall Study|Death|87|||
129890906|NCT03850444|467559547|FG001|Overall Study|Death|107|||
129890907|NCT03850444|467559546|FG000|Overall Study|Lost to Follow-up|1|||
129890908|NCT03850444|467559547|FG001|Overall Study|Lost to Follow-up|1|||
129890909|NCT03850444|467559546|FG000|Overall Study|Withdrawal by Subject|1|||
129890910|NCT03850444|467559547|FG001|Overall Study|Withdrawal by Subject|5|||
129890911|NCT03850444|467559546|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
129890912|NCT03850444|467559547|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
129890913|NCT01460381|467559549|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
129890914|NCT01460381|467559550|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
129890915|NCT01333943|467559555|FG000|Overall Study|Known neuropathy|1|||
129890916|NCT01333943|467559556|FG001|Overall Study|Known neuropathy|0|||
129890917|NCT00557505|467559564|FG000|Overall Study|Death|0|||
129890918|NCT00557505|467559565|FG001|Overall Study|Death|0|||
129890919|NCT00557505|467559566|FG002|Overall Study|Death|0|||
129890920|NCT00557505|467559567|FG003|Overall Study|Death|0|||
129890921|NCT00557505|467559568|FG004|Overall Study|Death|0|||
129890922|NCT00557505|467559569|FG005|Overall Study|Death|0|||
129890923|NCT00557505|467559570|FG006|Overall Study|Death|0|||
129890924|NCT00557505|467559571|FG007|Overall Study|Death|0|||
129890925|NCT00557505|467559572|FG008|Overall Study|Death|1|||
129890926|NCT00557505|467559564|FG000|Overall Study|Adverse Event|0|||
129890927|NCT00557505|467559565|FG001|Overall Study|Adverse Event|0|||
129890928|NCT00557505|467559566|FG002|Overall Study|Adverse Event|1|||
129890929|NCT00557505|467559567|FG003|Overall Study|Adverse Event|0|||
129890930|NCT00557505|467559568|FG004|Overall Study|Adverse Event|0|||
129890931|NCT00557505|467559569|FG005|Overall Study|Adverse Event|0|||
129890932|NCT00557505|467559570|FG006|Overall Study|Adverse Event|1|||
129890933|NCT00557505|467559571|FG007|Overall Study|Adverse Event|0|||
129890934|NCT00557505|467559572|FG008|Overall Study|Adverse Event|0|||
129890935|NCT00557505|467559564|FG000|Overall Study|Global deterioration of health|1|||
129890936|NCT00557505|467559565|FG001|Overall Study|Global deterioration of health|0|||
129890937|NCT00557505|467559566|FG002|Overall Study|Global deterioration of health|0|||
129890938|NCT00557505|467559567|FG003|Overall Study|Global deterioration of health|0|||
129890939|NCT00557505|467559568|FG004|Overall Study|Global deterioration of health|0|||
129890940|NCT00557505|467559569|FG005|Overall Study|Global deterioration of health|0|||
129890941|NCT00557505|467559570|FG006|Overall Study|Global deterioration of health|0|||
129890942|NCT00557505|467559571|FG007|Overall Study|Global deterioration of health|0|||
129890943|NCT00557505|467559572|FG008|Overall Study|Global deterioration of health|0|||
129890944|NCT00557505|467559564|FG000|Overall Study|Objective progression or relapse|2|||
129890945|NCT00557505|467559565|FG001|Overall Study|Objective progression or relapse|3|||
129890946|NCT00557505|467559566|FG002|Overall Study|Objective progression or relapse|3|||
129890947|NCT00557505|467559567|FG003|Overall Study|Objective progression or relapse|2|||
129890948|NCT00557505|467559568|FG004|Overall Study|Objective progression or relapse|2|||
129890949|NCT00557505|467559569|FG005|Overall Study|Objective progression or relapse|3|||
129890950|NCT00557505|467559570|FG006|Overall Study|Objective progression or relapse|2|||
129890951|NCT00557505|467559571|FG007|Overall Study|Objective progression or relapse|5|||
129890952|NCT00557505|467559572|FG008|Overall Study|Objective progression or relapse|15|||
129890953|NCT00557505|467559564|FG000|Overall Study|Withdrawal by Subject|0|||
129890954|NCT00557505|467559565|FG001|Overall Study|Withdrawal by Subject|0|||
129890955|NCT00557505|467559566|FG002|Overall Study|Withdrawal by Subject|0|||
129890956|NCT00557505|467559567|FG003|Overall Study|Withdrawal by Subject|1|||
129890957|NCT00557505|467559568|FG004|Overall Study|Withdrawal by Subject|0|||
129890958|NCT00557505|467559569|FG005|Overall Study|Withdrawal by Subject|0|||
129890959|NCT00557505|467559570|FG006|Overall Study|Withdrawal by Subject|0|||
130314677|NCT02920892|469118340|FG001|Placebo-Controlled Period|Physician Decision|0|||
130314678|NCT02920892|469118341|FG002|Placebo-Controlled Period|Physician Decision|1|||
129890960|NCT00557505|467559571|FG007|Overall Study|Withdrawal by Subject|0|||
129890961|NCT00557505|467559572|FG008|Overall Study|Withdrawal by Subject|1|||
129890962|NCT00031447|467559573|FG000|Overall Study|Lost to Follow-up|0|||
129890963|NCT00031447|467559574|FG001|Overall Study|Lost to Follow-up|1|||
129890964|NCT00031447|467559573|FG000|Overall Study|Non-compliant|1|||
129890965|NCT00031447|467559574|FG001|Overall Study|Non-compliant|1|||
129890966|NCT00031447|467559573|FG000|Overall Study|Re-activation of Disease|2|||
129890967|NCT00031447|467559574|FG001|Overall Study|Re-activation of Disease|1|||
130314679|NCT02920892|469118339|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
129890968|NCT00031447|467559573|FG000|Overall Study|Disruption of blinded study drug supply|7|||
129890969|NCT00031447|467559574|FG001|Overall Study|Disruption of blinded study drug supply|4|||
129890970|NCT01636362|467559575|FG000|Overall Study|Physician Decision|6|||
130051235|NCT00972244|468144035|FG004|Overall Study|Withdrawal by Subject|1|||
130051236|NCT00972244|468144031|FG000|Overall Study|Safety|0|||
130051237|NCT00972244|468144032|FG001|Overall Study|Safety|0|||
130051238|NCT00972244|468144033|FG002|Overall Study|Safety|0|||
130051239|NCT00972244|468144034|FG003|Overall Study|Safety|0|||
130051240|NCT00972244|468144035|FG004|Overall Study|Safety|1|||
130051241|NCT00972244|468144031|FG000|Overall Study|Death|1|||
130051242|NCT00972244|468144032|FG001|Overall Study|Death|0|||
130051243|NCT00972244|468144033|FG002|Overall Study|Death|0|||
130051244|NCT00972244|468144034|FG003|Overall Study|Death|0|||
130051245|NCT00972244|468144035|FG004|Overall Study|Death|0|||
130051246|NCT00972244|468144031|FG000|Overall Study|Various|0|||
130051247|NCT00972244|468144032|FG001|Overall Study|Various|0|||
130051248|NCT00972244|468144033|FG002|Overall Study|Various|0|||
130051249|NCT00972244|468144034|FG003|Overall Study|Various|0|||
130051250|NCT00972244|468144035|FG004|Overall Study|Various|2|||
130051251|NCT01597557|468144036|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
130051252|NCT01597557|468144037|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
130051253|NCT02389816|468144046|FG000|Overall Study|Randomized but Not Treated|1|||
130051254|NCT02389816|468144047|FG001|Overall Study|Randomized but Not Treated|0|||
130051255|NCT02389816|468144048|FG002|Overall Study|Randomized but Not Treated|0|||
130051256|NCT02389816|468144046|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
130051257|NCT02389816|468144047|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
130051258|NCT02389816|468144048|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
130051259|NCT02389816|468144046|FG000|Overall Study|Major Protocol Deviation|1|||
130051260|NCT02389816|468144047|FG001|Overall Study|Major Protocol Deviation|0|||
130051261|NCT02389816|468144048|FG002|Overall Study|Major Protocol Deviation|0|||
130051262|NCT02389816|468144046|FG000|Overall Study|Lost to Follow-up|1|||
130051263|NCT02389816|468144047|FG001|Overall Study|Lost to Follow-up|0|||
130051264|NCT02389816|468144048|FG002|Overall Study|Lost to Follow-up|0|||
130051265|NCT02389816|468144046|FG000|Overall Study|Withdrawal of Consent|6|||
130051266|NCT02389816|468144047|FG001|Overall Study|Withdrawal of Consent|4|||
130051267|NCT02389816|468144048|FG002|Overall Study|Withdrawal of Consent|4|||
130051268|NCT02389816|468144046|FG000|Overall Study|Lack of Efficacy|1|||
130051269|NCT02389816|468144047|FG001|Overall Study|Lack of Efficacy|0|||
130051270|NCT02389816|468144048|FG002|Overall Study|Lack of Efficacy|0|||
130051271|NCT02389816|468144046|FG000|Overall Study|Non Compliance with Study Drug|1|||
130051272|NCT02389816|468144047|FG001|Overall Study|Non Compliance with Study Drug|1|||
130051273|NCT02389816|468144048|FG002|Overall Study|Non Compliance with Study Drug|1|||
130051274|NCT02389816|468144046|FG000|Overall Study|Reason not Specified|0|||
130051275|NCT02389816|468144047|FG001|Overall Study|Reason not Specified|2|||
130051276|NCT02389816|468144048|FG002|Overall Study|Reason not Specified|0|||
130051277|NCT02417233|468144049|FG000|Overall Study|Death|4|||
130051278|NCT02417233|468144050|FG001|Overall Study|Death|10|||
130051279|NCT02417233|468144051|FG002|Overall Study|Death|14|||
130051280|NCT02417233|468144049|FG000|Overall Study|Lost to Follow-up|27|||
130051281|NCT02417233|468144050|FG001|Overall Study|Lost to Follow-up|39|||
130051282|NCT02417233|468144051|FG002|Overall Study|Lost to Follow-up|34|||
130051283|NCT02417233|468144049|FG000|Overall Study|Protocol Violation|2|||
130051284|NCT02417233|468144050|FG001|Overall Study|Protocol Violation|0|||
130051285|NCT02417233|468144051|FG002|Overall Study|Protocol Violation|2|||
130051286|NCT02417233|468144049|FG000|Overall Study|Withdrawal by Subject|2|||
130051287|NCT02417233|468144050|FG001|Overall Study|Withdrawal by Subject|1|||
130051288|NCT02417233|468144051|FG002|Overall Study|Withdrawal by Subject|8|||
130051289|NCT02417233|468144049|FG000|Overall Study|Relocation out of study area|1|||
130051290|NCT02417233|468144050|FG001|Overall Study|Relocation out of study area|0|||
130051291|NCT02417233|468144051|FG002|Overall Study|Relocation out of study area|1|||
130051292|NCT02417233|468144049|FG000|Overall Study|Mentally unstable|0|||
130051293|NCT02417233|468144050|FG001|Overall Study|Mentally unstable|1|||
130051294|NCT02417233|468144051|FG002|Overall Study|Mentally unstable|0|||
130051295|NCT01293032|468144052|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
130051296|NCT01293032|468144053|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
130051297|NCT01293032|468144054|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
130051298|NCT01293032|468144055|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
130051299|NCT01293032|468144052|FG000|Treatment|Adverse Event|0|||
130051300|NCT01293032|468144053|FG001|Treatment|Adverse Event|0|||
130051301|NCT01293032|468144054|FG002|Treatment|Adverse Event|1|||
130110651|NCT01010230|468365818|FG000|Overall Study|Lost to Follow-up|4|||
130110652|NCT01010230|468365819|FG001|Overall Study|Lost to Follow-up|2|||
130051302|NCT01293032|468144055|FG003|Treatment|Adverse Event|1|||
130110653|NCT01629693|468365822|FG000|Overall Study|Lost to Follow-up|2|||
130051303|NCT01293032|468144052|FG000|Treatment|Withdrawal by Subject|2|||
130051304|NCT01293032|468144053|FG001|Treatment|Withdrawal by Subject|4|||
130051305|NCT01293032|468144054|FG002|Treatment|Withdrawal by Subject|0|||
130051306|NCT01293032|468144055|FG003|Treatment|Withdrawal by Subject|0|||
130051307|NCT01293032|468144052|FG000|Treatment|Disease Progression, relapse|0|||
130051308|NCT01293032|468144053|FG001|Treatment|Disease Progression, relapse|1|||
130051309|NCT01293032|468144054|FG002|Treatment|Disease Progression, relapse|0|||
130051310|NCT01293032|468144055|FG003|Treatment|Disease Progression, relapse|0|||
130051311|NCT01594476|468144056|FG000|Overall Study|Protocol Violation|1|||
130051312|NCT01594476|468144057|FG001|Overall Study|Protocol Violation|3|||
130051313|NCT02985450|468144061|FG000|Overall Study|Lost to Follow-up|7|||
130051314|NCT00431847|468144062|FG000|Overall Study|completion of less than two study visits|6|||
130051315|NCT00431847|468144063|FG001|Overall Study|completion of less than two study visits|3|||
130051316|NCT00431847|468144064|FG002|Overall Study|completion of less than two study visits|4|||
130051317|NCT00431847|468144065|FG003|Overall Study|completion of less than two study visits|14|||
130051318|NCT00431847|468144066|FG004|Overall Study|completion of less than two study visits|0|||
130051319|NCT00431847|468144062|FG000|Overall Study|Protocol Violation|0|||
130051320|NCT00431847|468144063|FG001|Overall Study|Protocol Violation|0|||
130051321|NCT00431847|468144064|FG002|Overall Study|Protocol Violation|0|||
130051322|NCT00431847|468144065|FG003|Overall Study|Protocol Violation|0|||
130051323|NCT00431847|468144066|FG004|Overall Study|Protocol Violation|1|||
130051324|NCT01469013|468144069|FG000|Part A (Treatment Period)|Adverse Event|1|||
130051325|NCT01469013|468144070|FG001|Part A (Treatment Period)|Adverse Event|0|||
130051326|NCT01469013|468144071|FG002|Part A (Treatment Period)|Adverse Event|0|||
130051327|NCT01469013|468144072|FG003|Part A (Treatment Period)|Adverse Event|0|||
130051328|NCT01469013|468144073|FG004|Part A (Treatment Period)|Adverse Event|1|||
130051329|NCT01469013|468144074|FG005|Part A (Treatment Period)|Adverse Event|0|||
130051330|NCT01469013|468144075|FG006|Part A (Treatment Period)|Adverse Event|0|||
130051331|NCT01469013|468144076|FG007|Part A (Treatment Period)|Adverse Event|0|||
130051332|NCT01469013|468144077|FG008|Part A (Treatment Period)|Adverse Event|0|||
130051333|NCT01469013|468144078|FG009|Part A (Treatment Period)|Adverse Event|0|||
130051334|NCT01469013|468144079|FG010|Part A (Treatment Period)|Adverse Event|0|||
130051335|NCT01469013|468144080|FG011|Part A (Treatment Period)|Adverse Event|0|||
130051336|NCT01469013|468144081|FG012|Part A (Treatment Period)|Adverse Event|0|||
130051337|NCT01469013|468144069|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051338|NCT01469013|468144070|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051339|NCT01469013|468144071|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
130051340|NCT01469013|468144072|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051341|NCT01469013|468144073|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051342|NCT01469013|468144074|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051343|NCT01469013|468144075|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051344|NCT01469013|468144076|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051345|NCT01469013|468144077|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051346|NCT01469013|468144078|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051347|NCT01469013|468144079|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051348|NCT01469013|468144080|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051349|NCT01469013|468144081|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
130051350|NCT01469013|468144069|FG000|Part B (Extension Period)|Adverse Event|0|||
130051351|NCT01469013|468144070|FG001|Part B (Extension Period)|Adverse Event|0|||
130051352|NCT01469013|468144071|FG002|Part B (Extension Period)|Adverse Event|0|||
130051353|NCT01469013|468144072|FG003|Part B (Extension Period)|Adverse Event|0|||
130051354|NCT01469013|468144073|FG004|Part B (Extension Period)|Adverse Event|0|||
130051355|NCT01469013|468144074|FG005|Part B (Extension Period)|Adverse Event|2|||
130051356|NCT01469013|468144075|FG006|Part B (Extension Period)|Adverse Event|5|||
130051357|NCT01469013|468144076|FG007|Part B (Extension Period)|Adverse Event|5|||
130051358|NCT01469013|468144077|FG008|Part B (Extension Period)|Adverse Event|3|||
130051359|NCT01469013|468144078|FG009|Part B (Extension Period)|Adverse Event|3|||
130051360|NCT01469013|468144079|FG010|Part B (Extension Period)|Adverse Event|1|||
130051361|NCT01469013|468144080|FG011|Part B (Extension Period)|Adverse Event|6|||
130051362|NCT01469013|468144081|FG012|Part B (Extension Period)|Adverse Event|3|||
130051363|NCT01469013|468144069|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
130051364|NCT01469013|468144070|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
130051365|NCT01469013|468144071|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
130051366|NCT01469013|468144072|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
130051367|NCT01469013|468144073|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
130051368|NCT01469013|468144074|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
130051369|NCT01469013|468144075|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
130051370|NCT01469013|468144076|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
130051371|NCT01469013|468144077|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
130051372|NCT01469013|468144078|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
130051373|NCT01469013|468144079|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
129799916|NCT02819518|467235256|FG003|Overall Study|Sponsor Decision|34|||
129799917|NCT02819518|467235257|FG004|Overall Study|Sponsor Decision|17|||
129799918|NCT02819518|467235253|FG000|Overall Study|Transferred to extension study|1|||
130051374|NCT01469013|468144080|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
130051375|NCT01469013|468144081|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
130051376|NCT00002663|468144082|FG000|Overall Study|Death|4|||
130051377|NCT00002663|468144083|FG001|Overall Study|Death|1|||
130051378|NCT00002663|468144084|FG002|Overall Study|Death|1|||
130051379|NCT00002663|468144085|FG003|Overall Study|Death|0|||
130051380|NCT00002663|468144086|FG004|Overall Study|Death|0|||
130051381|NCT00002663|468144087|FG005|Overall Study|Death|13|||
130051382|NCT00002663|468144088|FG006|Overall Study|Death|0|||
130314680|NCT02920892|469118340|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
130314681|NCT02920892|469118341|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
130314682|NCT02920892|469118339|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130314683|NCT02920892|469118340|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
130314684|NCT02920892|469118341|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
130051383|NCT00002663|468144089|FG007|Overall Study|Death|1|||
130051384|NCT00002663|468144090|FG008|Overall Study|Death|1|||
130051385|NCT00002663|468144091|FG009|Overall Study|Death|1|||
130051386|NCT00002663|468144082|FG000|Overall Study|Lost to Follow-up|3|||
130051387|NCT00002663|468144083|FG001|Overall Study|Lost to Follow-up|0|||
130051388|NCT00002663|468144084|FG002|Overall Study|Lost to Follow-up|0|||
130051389|NCT00002663|468144085|FG003|Overall Study|Lost to Follow-up|1|||
130051390|NCT00002663|468144086|FG004|Overall Study|Lost to Follow-up|0|||
130051391|NCT00002663|468144087|FG005|Overall Study|Lost to Follow-up|1|||
130051392|NCT00002663|468144088|FG006|Overall Study|Lost to Follow-up|0|||
130051393|NCT00002663|468144089|FG007|Overall Study|Lost to Follow-up|0|||
130051394|NCT00002663|468144090|FG008|Overall Study|Lost to Follow-up|0|||
130051395|NCT00002663|468144091|FG009|Overall Study|Lost to Follow-up|0|||
130051396|NCT00002663|468144082|FG000|Overall Study|Other|0|||
130051397|NCT00002663|468144083|FG001|Overall Study|Other|1|||
130051398|NCT00002663|468144084|FG002|Overall Study|Other|0|||
130051399|NCT00002663|468144085|FG003|Overall Study|Other|0|||
130051400|NCT00002663|468144086|FG004|Overall Study|Other|0|||
130051401|NCT00002663|468144087|FG005|Overall Study|Other|1|||
130051402|NCT00002663|468144088|FG006|Overall Study|Other|1|||
130051403|NCT00002663|468144089|FG007|Overall Study|Other|0|||
130051404|NCT00002663|468144090|FG008|Overall Study|Other|0|||
130051405|NCT00002663|468144091|FG009|Overall Study|Other|0|||
130051406|NCT00002663|468144082|FG000|Overall Study|Physician Decision|0|||
130051407|NCT00002663|468144083|FG001|Overall Study|Physician Decision|0|||
130051408|NCT00002663|468144084|FG002|Overall Study|Physician Decision|0|||
130051409|NCT00002663|468144085|FG003|Overall Study|Physician Decision|0|||
130051410|NCT00002663|468144086|FG004|Overall Study|Physician Decision|1|||
130051411|NCT00002663|468144087|FG005|Overall Study|Physician Decision|0|||
130051412|NCT00002663|468144088|FG006|Overall Study|Physician Decision|0|||
130051413|NCT00002663|468144089|FG007|Overall Study|Physician Decision|0|||
130051414|NCT00002663|468144090|FG008|Overall Study|Physician Decision|1|||
130051415|NCT00002663|468144091|FG009|Overall Study|Physician Decision|1|||
130051416|NCT00002663|468144082|FG000|Overall Study|Adverse Event|0|||
130051417|NCT00002663|468144083|FG001|Overall Study|Adverse Event|0|||
130051418|NCT00002663|468144084|FG002|Overall Study|Adverse Event|0|||
130051419|NCT00002663|468144085|FG003|Overall Study|Adverse Event|1|||
130051420|NCT00002663|468144086|FG004|Overall Study|Adverse Event|0|||
130051421|NCT00002663|468144087|FG005|Overall Study|Adverse Event|0|||
130051422|NCT00002663|468144088|FG006|Overall Study|Adverse Event|0|||
130051423|NCT00002663|468144089|FG007|Overall Study|Adverse Event|1|||
130051424|NCT00002663|468144090|FG008|Overall Study|Adverse Event|0|||
130051425|NCT00002663|468144091|FG009|Overall Study|Adverse Event|0|||
130051426|NCT01603641|468144095|FG000|Overall Study|Did not Receive Treatment|3|||
130051427|NCT01603641|468144095|FG000|Overall Study|Adverse Event|1|||
130051428|NCT01603641|468144095|FG000|Overall Study|Lack of Efficacy|1|||
130051429|NCT01603641|468144095|FG000|Overall Study|Lost to Follow-up|6|||
130051430|NCT01603641|468144095|FG000|Overall Study|Personal Reasons|18|||
130051431|NCT01603641|468144095|FG000|Overall Study|Other Miscellaneous Reasons|6|||
130051432|NCT03161678|468144096|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130051433|NCT03161678|468144097|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130051434|NCT03161678|468144098|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130051435|NCT03161678|468144099|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
130051436|NCT03161678|468144100|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
130051437|NCT03161678|468144101|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
130314685|NCT02920892|469118339|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
130314686|NCT02920892|469118340|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
129799919|NCT02819518|467235254|FG001|Overall Study|Transferred to extension study|1|||
130051438|NCT03161678|468144096|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
130051439|NCT03161678|468144097|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
130051440|NCT03161678|468144098|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
130051441|NCT03161678|468144099|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
130051442|NCT03161678|468144100|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
130051443|NCT03161678|468144101|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
130051444|NCT03161678|468144096|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
130051445|NCT03161678|468144097|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
130051446|NCT03161678|468144098|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
130051447|NCT03161678|468144099|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
130051448|NCT03161678|468144100|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
130051449|NCT03161678|468144101|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
130051450|NCT03161678|468144096|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130314687|NCT02920892|469118341|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
130314688|NCT04486235|469118342|FG000|Overall Study|Pregnancy|1|||
130314689|NCT04486235|469118343|FG001|Overall Study|Pregnancy|0|||
130314690|NCT04486235|469118342|FG000|Overall Study|Lost to Follow-up|1|||
130314691|NCT04486235|469118343|FG001|Overall Study|Lost to Follow-up|0|||
130314692|NCT01092728|469118344|FG000|Overall Study|Withdrawal by Subject|2|||
130314693|NCT01092728|469118345|FG001|Overall Study|Withdrawal by Subject|0|||
130314694|NCT01092728|469118344|FG000|Overall Study|Adverse Event|0|||
130314695|NCT01092728|469118345|FG001|Overall Study|Adverse Event|1|||
130314696|NCT01092728|469118344|FG000|Overall Study|Disease Progression|1|||
130314697|NCT01092728|469118345|FG001|Overall Study|Disease Progression|13|||
130314698|NCT01092728|469118344|FG000|Overall Study|Prohibited Concomitant Medications|1|||
130314699|NCT01092728|469118345|FG001|Overall Study|Prohibited Concomitant Medications|0|||
130314700|NCT00721396|469118346|FG000|Overall Study|Adverse Event|4|||
130314701|NCT00721396|469118347|FG001|Overall Study|Adverse Event|7|||
130314702|NCT00721396|469118348|FG002|Overall Study|Adverse Event|2|||
130314703|NCT00721396|469118349|FG003|Overall Study|Adverse Event|0|||
130314704|NCT00721396|469118346|FG000|Overall Study|Withdrawal by Subject|12|||
130314705|NCT00721396|469118347|FG001|Overall Study|Withdrawal by Subject|15|||
130314706|NCT00721396|469118348|FG002|Overall Study|Withdrawal by Subject|3|||
130314707|NCT00721396|469118349|FG003|Overall Study|Withdrawal by Subject|7|||
130314708|NCT00721396|469118346|FG000|Overall Study|Lost to Follow-up|7|||
130314709|NCT00721396|469118347|FG001|Overall Study|Lost to Follow-up|9|||
130314710|NCT00721396|469118348|FG002|Overall Study|Lost to Follow-up|3|||
130314711|NCT00721396|469118349|FG003|Overall Study|Lost to Follow-up|3|||
130314712|NCT00721396|469118346|FG000|Overall Study|Protocol Violation|4|||
130051451|NCT03161678|468144097|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130051452|NCT03161678|468144098|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130051453|NCT03161678|468144099|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
130051454|NCT03161678|468144100|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130051455|NCT03161678|468144101|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
130051456|NCT00739297|468144102|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
130051457|NCT00739297|468144103|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
130051458|NCT00739297|468144104|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
130051459|NCT00739297|468144105|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
130051460|NCT00739297|468144106|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
130051461|NCT00739297|468144107|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
130051462|NCT00739297|468144108|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
130051463|NCT00739297|468144102|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130051464|NCT00739297|468144103|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130051465|NCT00739297|468144104|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130051466|NCT00739297|468144105|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130051467|NCT00739297|468144106|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
130051468|NCT00739297|468144107|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
130051469|NCT00739297|468144108|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
130051470|NCT01757704|468144109|FG000|Overall Study|Protocol Violation|1|||
130051471|NCT01757704|468144110|FG001|Overall Study|Protocol Violation|3|||
130051472|NCT02890329|468144113|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130051473|NCT02890329|468144114|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
130051474|NCT02890329|468144115|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130051475|NCT02890329|468144116|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130051476|NCT02890329|468144117|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130051477|NCT02890329|468144118|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
130314713|NCT00721396|469118347|FG001|Overall Study|Protocol Violation|3|||
130110654|NCT01629693|468365823|FG001|Overall Study|Lost to Follow-up|4|||
130314714|NCT00721396|469118348|FG002|Overall Study|Protocol Violation|1|||
130314715|NCT00721396|469118349|FG003|Overall Study|Protocol Violation|0|||
130314716|NCT00721396|469118346|FG000|Overall Study|Inappropriate enrollment|0|||
130314717|NCT00721396|469118347|FG001|Overall Study|Inappropriate enrollment|2|||
130314718|NCT00721396|469118348|FG002|Overall Study|Inappropriate enrollment|0|||
130314719|NCT00721396|469118349|FG003|Overall Study|Inappropriate enrollment|0|||
130051478|NCT02890329|468144113|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
130051479|NCT02890329|468144114|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
130051480|NCT02890329|468144115|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130051481|NCT02890329|468144116|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130051482|NCT02890329|468144117|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130051483|NCT02890329|468144118|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
130051484|NCT02890329|468144113|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130051485|NCT02890329|468144114|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130051486|NCT02890329|468144115|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130051487|NCT02890329|468144116|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
130051488|NCT02890329|468144117|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130051489|NCT02890329|468144118|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
130051490|NCT02890329|468144113|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130051491|NCT02890329|468144114|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130051492|NCT02890329|468144115|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
130051493|NCT02890329|468144116|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130051494|NCT02890329|468144117|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130051495|NCT02890329|468144118|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
130051496|NCT02749721|468144119|FG000|Screening|Withdrawal by Subject|1|||
130051497|NCT02749721|468144119|FG000|Screening|Lost to Follow-up|2|||
130051498|NCT02749721|468144119|FG000|Screening|Protocol Violation|3|||
130051499|NCT02749721|468144119|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
130051500|NCT02749721|468144119|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
130051501|NCT00705224|468144120|FG000|Overall Study|Adverse Event|1|||
130051502|NCT00705224|468144120|FG000|Overall Study|Lack of Efficacy|2|||
130051503|NCT00705224|468144120|FG000|Overall Study|Withdrawal by Subject|3|||
130051504|NCT00705224|468144120|FG000|Overall Study|Lost to Follow-up|5|||
130051505|NCT00968253|468144121|FG000|Overall Study|Death|0|||
130051506|NCT00968253|468144122|FG001|Overall Study|Death|0|||
130051507|NCT00968253|468144123|FG002|Overall Study|Death|2|||
130051508|NCT00968253|468144121|FG000|Overall Study|Withdrawal by Subject|0|||
130051509|NCT00968253|468144122|FG001|Overall Study|Withdrawal by Subject|0|||
130051510|NCT00968253|468144123|FG002|Overall Study|Withdrawal by Subject|1|||
130051511|NCT00968253|468144121|FG000|Overall Study|Disease Progression|0|||
130051512|NCT00968253|468144122|FG001|Overall Study|Disease Progression|3|||
130051513|NCT00968253|468144123|FG002|Overall Study|Disease Progression|3|||
130051514|NCT00968253|468144121|FG000|Overall Study|Adverse Event|0|||
130051515|NCT00968253|468144122|FG001|Overall Study|Adverse Event|0|||
130051516|NCT00968253|468144123|FG002|Overall Study|Adverse Event|1|||
130051517|NCT03141086|468144127|FG000|Overall Study|Study Terminated By Sponsor|1|||
130051518|NCT03141086|468144128|FG001|Overall Study|Study Terminated By Sponsor|1|||
130051519|NCT03141086|468144127|FG000|Overall Study|Withdrawal by Subject|0|||
130051520|NCT03141086|468144128|FG001|Overall Study|Withdrawal by Subject|1|||
130051521|NCT03141086|468144127|FG000|Overall Study|Protocol Violation|0|||
130051522|NCT03141086|468144128|FG001|Overall Study|Protocol Violation|1|||
130051523|NCT03141086|468144127|FG000|Overall Study|Adverse Event|0|||
130051524|NCT03141086|468144128|FG001|Overall Study|Adverse Event|2|||
130051525|NCT02488759|468144131|FG000|Overall Study|Disease progression|73|||
130051526|NCT02488759|468144132|FG001|Overall Study|Disease progression|111|||
130051527|NCT02488759|468144133|FG002|Overall Study|Disease progression|62|||
130051528|NCT02488759|468144134|FG003|Overall Study|Disease progression|7|||
130051529|NCT02488759|468144135|FG004|Overall Study|Disease progression|4|||
130051530|NCT02488759|468144136|FG005|Overall Study|Disease progression|2|||
130051531|NCT02488759|468144131|FG000|Overall Study|Study drug toxicity|11|||
130051532|NCT02488759|468144132|FG001|Overall Study|Study drug toxicity|33|||
130051533|NCT02488759|468144133|FG002|Overall Study|Study drug toxicity|31|||
130051534|NCT02488759|468144134|FG003|Overall Study|Study drug toxicity|0|||
130051535|NCT02488759|468144135|FG004|Overall Study|Study drug toxicity|0|||
130051536|NCT02488759|468144136|FG005|Overall Study|Study drug toxicity|2|||
130051537|NCT02488759|468144131|FG000|Overall Study|Adverse event unrelated to study drug|9|||
130051538|NCT02488759|468144132|FG001|Overall Study|Adverse event unrelated to study drug|11|||
130051539|NCT02488759|468144133|FG002|Overall Study|Adverse event unrelated to study drug|7|||
130051540|NCT02488759|468144134|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130051541|NCT02488759|468144135|FG004|Overall Study|Adverse event unrelated to study drug|1|||
130051542|NCT02488759|468144136|FG005|Overall Study|Adverse event unrelated to study drug|0|||
130051543|NCT02488759|468144131|FG000|Overall Study|Participant request to discontinue study treatment|6|||
130051544|NCT02488759|468144132|FG001|Overall Study|Participant request to discontinue study treatment|8|||
130051545|NCT02488759|468144133|FG002|Overall Study|Participant request to discontinue study treatment|4|||
130051546|NCT02488759|468144134|FG003|Overall Study|Participant request to discontinue study treatment|0|||
130051547|NCT02488759|468144135|FG004|Overall Study|Participant request to discontinue study treatment|0|||
130051548|NCT02488759|468144136|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129799920|NCT02819518|467235255|FG002|Overall Study|Transferred to extension study|1|||
129799921|NCT02819518|467235256|FG003|Overall Study|Transferred to extension study|32|||
129799922|NCT02819518|467235257|FG004|Overall Study|Transferred to extension study|11|||
129799923|NCT00880165|467235258|FG000|Overall Study|Withdrawal by Subject|27|||
129799924|NCT00880165|467235259|FG001|Overall Study|Withdrawal by Subject|23|||
129799925|NCT00880165|467235258|FG000|Overall Study|Not diagnosed with OSA|14|||
129799926|NCT00880165|467235259|FG001|Overall Study|Not diagnosed with OSA|8|||
129799927|NCT00880165|467235258|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
129799928|NCT00880165|467235259|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
130051549|NCT02488759|468144131|FG000|Overall Study|Withdrawal by Subject|4|||
130051550|NCT02488759|468144132|FG001|Overall Study|Withdrawal by Subject|0|||
130051551|NCT02488759|468144133|FG002|Overall Study|Withdrawal by Subject|3|||
130051552|NCT02488759|468144134|FG003|Overall Study|Withdrawal by Subject|0|||
130051553|NCT02488759|468144135|FG004|Overall Study|Withdrawal by Subject|0|||
130051554|NCT02488759|468144136|FG005|Overall Study|Withdrawal by Subject|2|||
130051555|NCT02488759|468144131|FG000|Overall Study|Lost to Follow-up|0|||
129890971|NCT01636362|467559575|FG000|Overall Study|Subject healed, not returning|1|||
129890972|NCT01636362|467559575|FG000|Overall Study|Withdrawal by Subject|1|||
129890973|NCT01244763|467559576|FG000|Overall Study|Adverse Event|1|||
129890974|NCT01244763|467559577|FG001|Overall Study|Adverse Event|0|||
129890975|NCT01244763|467559578|FG002|Overall Study|Adverse Event|0|||
129890976|NCT01244763|467559579|FG003|Overall Study|Adverse Event|0|||
129890977|NCT01244763|467559580|FG004|Overall Study|Adverse Event|0|||
129890978|NCT01244763|467559581|FG005|Overall Study|Adverse Event|1|||
129890979|NCT01244763|467559576|FG000|Overall Study|Death|1|||
129890980|NCT01244763|467559577|FG001|Overall Study|Death|0|||
129890981|NCT01244763|467559578|FG002|Overall Study|Death|1|||
129890982|NCT01244763|467559579|FG003|Overall Study|Death|0|||
129890983|NCT01244763|467559580|FG004|Overall Study|Death|2|||
129890984|NCT01244763|467559581|FG005|Overall Study|Death|0|||
129890985|NCT01244763|467559576|FG000|Overall Study|Physician Decision|0|||
129890986|NCT01244763|467559577|FG001|Overall Study|Physician Decision|0|||
129890987|NCT01244763|467559578|FG002|Overall Study|Physician Decision|1|||
129890988|NCT01244763|467559579|FG003|Overall Study|Physician Decision|0|||
129890989|NCT01244763|467559580|FG004|Overall Study|Physician Decision|0|||
129890990|NCT01244763|467559581|FG005|Overall Study|Physician Decision|0|||
129799929|NCT00880165|467235258|FG000|Overall Study|Lost to follow|9|||
129799930|NCT00880165|467235259|FG001|Overall Study|Lost to follow|15|||
129799931|NCT01505647|467235260|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
129799932|NCT01505647|467235261|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
129799933|NCT01505647|467235260|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
129799934|NCT01505647|467235261|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
129799935|NCT01505647|467235260|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
129799936|NCT01505647|467235261|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
129799937|NCT01505647|467235260|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
129799938|NCT01505647|467235261|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
129799939|NCT01505647|467235260|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
129799940|NCT01505647|467235261|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
129799941|NCT00667602|467235262|FG000|Overall Study|Withdrawal by Subject|4|||
129799942|NCT00667602|467235263|FG001|Overall Study|Withdrawal by Subject|9|||
129799943|NCT00667602|467235264|FG002|Overall Study|Withdrawal by Subject|10|||
129799944|NCT00667602|467235262|FG000|Overall Study|Lost to Follow-up|4|||
129799945|NCT00667602|467235263|FG001|Overall Study|Lost to Follow-up|5|||
129799946|NCT00667602|467235264|FG002|Overall Study|Lost to Follow-up|6|||
129799947|NCT00667602|467235262|FG000|Overall Study|Administrative reason|0|||
129799948|NCT00667602|467235263|FG001|Overall Study|Administrative reason|0|||
129799949|NCT00667602|467235264|FG002|Overall Study|Administrative reason|2|||
129799950|NCT00667602|467235262|FG000|Overall Study|Protocol Violation|0|||
129799951|NCT00667602|467235263|FG001|Overall Study|Protocol Violation|1|||
129890991|NCT01244763|467559576|FG000|Overall Study|Withdrawal by Subject|1|||
129890992|NCT01244763|467559577|FG001|Overall Study|Withdrawal by Subject|2|||
129890993|NCT01244763|467559578|FG002|Overall Study|Withdrawal by Subject|0|||
129890994|NCT01244763|467559579|FG003|Overall Study|Withdrawal by Subject|1|||
129890995|NCT01244763|467559580|FG004|Overall Study|Withdrawal by Subject|1|||
129890996|NCT01244763|467559581|FG005|Overall Study|Withdrawal by Subject|2|||
130314720|NCT00721396|469118346|FG000|Overall Study|Administrative reason|3|||
129799952|NCT00667602|467235264|FG002|Overall Study|Protocol Violation|0|||
129799953|NCT00973349|467235272|FG000|Overall Study|Adverse Event|0|||
129799954|NCT00973349|467235273|FG001|Overall Study|Adverse Event|0|||
129799955|NCT00973349|467235274|FG002|Overall Study|Adverse Event|0|||
129799956|NCT00973349|467235275|FG003|Overall Study|Adverse Event|0|||
129799957|NCT00973349|467235276|FG004|Overall Study|Adverse Event|1|||
129799958|NCT00973349|467235277|FG005|Overall Study|Adverse Event|0|||
129799959|NCT00973349|467235278|FG006|Overall Study|Adverse Event|0|||
129799960|NCT00973349|467235279|FG007|Overall Study|Adverse Event|0|||
129799961|NCT00973349|467235280|FG008|Overall Study|Adverse Event|1|||
129799962|NCT00973349|467235281|FG009|Overall Study|Adverse Event|0|||
129799963|NCT00973349|467235282|FG010|Overall Study|Adverse Event|0|||
129799964|NCT00973349|467235283|FG011|Overall Study|Adverse Event|0|||
129799965|NCT00973349|467235284|FG012|Overall Study|Adverse Event|0|||
129799966|NCT00973349|467235285|FG013|Overall Study|Adverse Event|0|||
129799967|NCT00973349|467235286|FG014|Overall Study|Adverse Event|1|||
129799968|NCT00973349|467235287|FG015|Overall Study|Adverse Event|0|||
129799969|NCT00973349|467235272|FG000|Overall Study|Withdrawal by Subject|1|||
129799970|NCT00973349|467235273|FG001|Overall Study|Withdrawal by Subject|2|||
129799971|NCT00973349|467235274|FG002|Overall Study|Withdrawal by Subject|2|||
129799972|NCT00973349|467235275|FG003|Overall Study|Withdrawal by Subject|3|||
129799973|NCT00973349|467235276|FG004|Overall Study|Withdrawal by Subject|2|||
129799974|NCT00973349|467235277|FG005|Overall Study|Withdrawal by Subject|0|||
129799975|NCT00973349|467235278|FG006|Overall Study|Withdrawal by Subject|2|||
129799976|NCT00973349|467235279|FG007|Overall Study|Withdrawal by Subject|2|||
129799977|NCT00973349|467235280|FG008|Overall Study|Withdrawal by Subject|0|||
129799978|NCT00973349|467235281|FG009|Overall Study|Withdrawal by Subject|2|||
129799979|NCT00973349|467235282|FG010|Overall Study|Withdrawal by Subject|0|||
129799980|NCT00973349|467235283|FG011|Overall Study|Withdrawal by Subject|1|||
129799981|NCT00973349|467235284|FG012|Overall Study|Withdrawal by Subject|0|||
129799982|NCT00973349|467235285|FG013|Overall Study|Withdrawal by Subject|0|||
129799983|NCT00973349|467235286|FG014|Overall Study|Withdrawal by Subject|0|||
129799984|NCT00973349|467235287|FG015|Overall Study|Withdrawal by Subject|0|||
129799985|NCT00973349|467235272|FG000|Overall Study|Lost to Follow-up|3|||
129799986|NCT00973349|467235273|FG001|Overall Study|Lost to Follow-up|1|||
129799987|NCT00973349|467235274|FG002|Overall Study|Lost to Follow-up|2|||
129799988|NCT00973349|467235275|FG003|Overall Study|Lost to Follow-up|2|||
129799989|NCT00973349|467235276|FG004|Overall Study|Lost to Follow-up|1|||
129799990|NCT00973349|467235277|FG005|Overall Study|Lost to Follow-up|3|||
129799991|NCT00973349|467235278|FG006|Overall Study|Lost to Follow-up|0|||
129799992|NCT00973349|467235279|FG007|Overall Study|Lost to Follow-up|1|||
129799993|NCT00973349|467235280|FG008|Overall Study|Lost to Follow-up|2|||
129799994|NCT00973349|467235281|FG009|Overall Study|Lost to Follow-up|1|||
129799995|NCT00973349|467235282|FG010|Overall Study|Lost to Follow-up|0|||
129799996|NCT00973349|467235283|FG011|Overall Study|Lost to Follow-up|1|||
129799997|NCT00973349|467235284|FG012|Overall Study|Lost to Follow-up|0|||
129799998|NCT00973349|467235285|FG013|Overall Study|Lost to Follow-up|0|||
129799999|NCT00973349|467235286|FG014|Overall Study|Lost to Follow-up|0|||
129800000|NCT00973349|467235287|FG015|Overall Study|Lost to Follow-up|1|||
129800001|NCT00973349|467235272|FG000|Overall Study|Inappropriate enrolment|0|||
129800002|NCT00973349|467235273|FG001|Overall Study|Inappropriate enrolment|0|||
129800003|NCT00973349|467235274|FG002|Overall Study|Inappropriate enrolment|1|||
129800004|NCT00973349|467235275|FG003|Overall Study|Inappropriate enrolment|0|||
129800005|NCT00973349|467235276|FG004|Overall Study|Inappropriate enrolment|0|||
129800006|NCT00973349|467235277|FG005|Overall Study|Inappropriate enrolment|0|||
129800007|NCT00973349|467235278|FG006|Overall Study|Inappropriate enrolment|0|||
129800008|NCT00973349|467235279|FG007|Overall Study|Inappropriate enrolment|0|||
129800009|NCT00973349|467235280|FG008|Overall Study|Inappropriate enrolment|0|||
129800010|NCT00973349|467235281|FG009|Overall Study|Inappropriate enrolment|2|||
129800011|NCT00973349|467235282|FG010|Overall Study|Inappropriate enrolment|0|||
129800012|NCT00973349|467235283|FG011|Overall Study|Inappropriate enrolment|0|||
129800013|NCT00973349|467235284|FG012|Overall Study|Inappropriate enrolment|1|||
129800014|NCT00973349|467235285|FG013|Overall Study|Inappropriate enrolment|0|||
129800015|NCT00973349|467235286|FG014|Overall Study|Inappropriate enrolment|1|||
129800016|NCT00973349|467235287|FG015|Overall Study|Inappropriate enrolment|1|||
129800017|NCT00973349|467235272|FG000|Overall Study|Protocol Violation|0|||
129800018|NCT00973349|467235273|FG001|Overall Study|Protocol Violation|0|||
129800019|NCT00973349|467235274|FG002|Overall Study|Protocol Violation|0|||
129800020|NCT00973349|467235275|FG003|Overall Study|Protocol Violation|0|||
129800021|NCT00973349|467235276|FG004|Overall Study|Protocol Violation|0|||
129800022|NCT00973349|467235277|FG005|Overall Study|Protocol Violation|0|||
129800023|NCT00973349|467235278|FG006|Overall Study|Protocol Violation|0|||
129800024|NCT00973349|467235279|FG007|Overall Study|Protocol Violation|0|||
129800025|NCT00973349|467235280|FG008|Overall Study|Protocol Violation|1|||
129800026|NCT00973349|467235281|FG009|Overall Study|Protocol Violation|0|||
129800027|NCT00973349|467235282|FG010|Overall Study|Protocol Violation|0|||
129800028|NCT00973349|467235283|FG011|Overall Study|Protocol Violation|0|||
130051556|NCT02488759|468144132|FG001|Overall Study|Lost to Follow-up|0|||
130314721|NCT00721396|469118347|FG001|Overall Study|Administrative reason|0|||
130314722|NCT00721396|469118348|FG002|Overall Study|Administrative reason|1|||
130314723|NCT00721396|469118349|FG003|Overall Study|Administrative reason|0|||
130314724|NCT03546621|469118350|FG000|Overall Study|Withdrawal by Subject|0|||
130051557|NCT02488759|468144133|FG002|Overall Study|Lost to Follow-up|2|||
130314725|NCT03546621|469118351|FG001|Overall Study|Withdrawal by Subject|1|||
130314726|NCT03546621|469118352|FG002|Overall Study|Withdrawal by Subject|2|||
130314727|NCT03546621|469118353|FG003|Overall Study|Withdrawal by Subject|1|||
130314728|NCT03546621|469118350|FG000|Overall Study|Lost to Follow-up|0|||
130314729|NCT03546621|469118351|FG001|Overall Study|Lost to Follow-up|1|||
130314730|NCT03546621|469118352|FG002|Overall Study|Lost to Follow-up|0|||
130314731|NCT03546621|469118353|FG003|Overall Study|Lost to Follow-up|0|||
130314732|NCT03546621|469118350|FG000|Overall Study|Adverse Event|0|||
130314733|NCT03546621|469118351|FG001|Overall Study|Adverse Event|1|||
130314734|NCT03546621|469118352|FG002|Overall Study|Adverse Event|0|||
130314735|NCT03546621|469118353|FG003|Overall Study|Adverse Event|1|||
130314736|NCT03546621|469118350|FG000|Overall Study|Progressive disease|0|||
130314737|NCT03546621|469118351|FG001|Overall Study|Progressive disease|0|||
130314738|NCT03546621|469118352|FG002|Overall Study|Progressive disease|0|||
130314739|NCT03546621|469118353|FG003|Overall Study|Progressive disease|1|||
130314740|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314741|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314742|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314743|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
130314744|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314745|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314746|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314747|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314748|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314749|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
130314750|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
130314751|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
130314752|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314753|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
130314754|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
130314755|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
130314756|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314757|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314758|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314759|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
130314760|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
130314761|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314762|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314763|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314764|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
130314765|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
130314766|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314767|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314768|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314769|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
130314770|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
130314771|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314772|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
130314773|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314774|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
130314775|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
130051558|NCT02488759|468144134|FG003|Overall Study|Lost to Follow-up|0|||
130051559|NCT02488759|468144135|FG004|Overall Study|Lost to Follow-up|0|||
130051560|NCT02488759|468144136|FG005|Overall Study|Lost to Follow-up|0|||
130051561|NCT02488759|468144131|FG000|Overall Study|Maximum clinical benefit|3|||
130051562|NCT02488759|468144132|FG001|Overall Study|Maximum clinical benefit|0|||
130051563|NCT02488759|468144133|FG002|Overall Study|Maximum clinical benefit|1|||
130051564|NCT02488759|468144134|FG003|Overall Study|Maximum clinical benefit|0|||
130051565|NCT02488759|468144135|FG004|Overall Study|Maximum clinical benefit|0|||
130051566|NCT02488759|468144136|FG005|Overall Study|Maximum clinical benefit|0|||
130051567|NCT02488759|468144131|FG000|Overall Study|Other reasons|7|||
130051568|NCT02488759|468144132|FG001|Overall Study|Other reasons|32|||
130051569|NCT02488759|468144133|FG002|Overall Study|Other reasons|23|||
130051570|NCT02488759|468144134|FG003|Overall Study|Other reasons|1|||
130051571|NCT02488759|468144135|FG004|Overall Study|Other reasons|1|||
130314776|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
130051572|NCT02488759|468144136|FG005|Overall Study|Other reasons|1|||
130051573|NCT02429427|468144137|FG000|Overall Study|Adverse Event|220|||
130051574|NCT02429427|468144138|FG001|Overall Study|Adverse Event|92|||
130051575|NCT02429427|468144137|FG000|Overall Study|Protocol Violation|10|||
130051576|NCT02429427|468144138|FG001|Overall Study|Protocol Violation|6|||
130051577|NCT02429427|468144137|FG000|Overall Study|Lost to Follow-up|15|||
130051578|NCT02429427|468144138|FG001|Overall Study|Lost to Follow-up|6|||
130051579|NCT02429427|468144137|FG000|Overall Study|Withdrawal by Subject|64|||
130051580|NCT02429427|468144138|FG001|Overall Study|Withdrawal by Subject|34|||
130051581|NCT02429427|468144137|FG000|Overall Study|Other|62|||
130051582|NCT02429427|468144138|FG001|Overall Study|Other|41|||
130051583|NCT00719732|468144139|FG000|Overall Study|Lost to Follow-up|20|||
130051584|NCT00719732|468144139|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
130051585|NCT00719732|468144139|FG000|Overall Study|Illness not associated with device|1|||
130051586|NCT03625986|468145530|FG000|Randomization Period|Lost to Follow-up|7|||
130051587|NCT03625986|468145531|FG001|Randomization Period|Lost to Follow-up|12|||
130051588|NCT03625986|468145530|FG000|Randomization Period|Withdrawal by Subject|10|||
130051589|NCT03625986|468145531|FG001|Randomization Period|Withdrawal by Subject|6|||
130051590|NCT04920084|468145533|FG000|Overall Study|Adverse Event|1|||
130051591|NCT04920084|468145533|FG000|Overall Study|Lost to Follow-up|2|||
130051592|NCT04920084|468145533|FG000|Overall Study|Withdrawal by Subject|2|||
130051593|NCT00620321|468145534|FG000|Overall Study|Adverse Event|1|||
130051594|NCT00620321|468145535|FG001|Overall Study|Adverse Event|1|||
130051595|NCT00620321|468145534|FG000|Overall Study|Death|1|||
130051596|NCT00620321|468145535|FG001|Overall Study|Death|1|||
130051597|NCT00620321|468145534|FG000|Overall Study|Physician Decision|0|||
130051598|NCT00620321|468145535|FG001|Overall Study|Physician Decision|7|||
130051599|NCT00620321|468145534|FG000|Overall Study|Progressive Disease|5|||
130051600|NCT00620321|468145535|FG001|Overall Study|Progressive Disease|5|||
130051601|NCT00620321|468145534|FG000|Overall Study|Sponsor Decision|0|||
130051602|NCT00620321|468145535|FG001|Overall Study|Sponsor Decision|1|||
130051603|NCT00620321|468145534|FG000|Overall Study|Withdrawal by Subject|1|||
130051604|NCT00620321|468145535|FG001|Overall Study|Withdrawal by Subject|1|||
130051605|NCT04191967|468145536|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
130051606|NCT04191967|468145536|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
130051607|NCT01431144|468145537|FG000|Overall Study|Implant mobility and removal|2|||
130051608|NCT01431144|468145538|FG001|Overall Study|Implant mobility and removal|0|||
130051609|NCT02410902|468145546|FG000|Overall Study|Adverse Event|2|||
130051610|NCT02410902|468145547|FG001|Overall Study|Adverse Event|3|||
130051611|NCT02410902|468145546|FG000|Overall Study|Lost to Follow-up|4|||
130051612|NCT02410902|468145547|FG001|Overall Study|Lost to Follow-up|1|||
130051613|NCT02410902|468145546|FG000|Overall Study|Protocol Violation|1|||
130051614|NCT02410902|468145547|FG001|Overall Study|Protocol Violation|4|||
130051615|NCT02410902|468145546|FG000|Overall Study|Withdrawal by Subject|6|||
130051616|NCT02410902|468145547|FG001|Overall Study|Withdrawal by Subject|8|||
130051617|NCT02410902|468145546|FG000|Overall Study|Non-Compliance|8|||
130051618|NCT02410902|468145547|FG001|Overall Study|Non-Compliance|2|||
130051619|NCT00953043|468145548|FG000|Overall Study|Withdrawal by Subject|4|||
130051620|NCT00953043|468145549|FG001|Overall Study|Withdrawal by Subject|0|||
130110655|NCT01629693|468365822|FG000|Overall Study|Withdrawal by Subject|2|||
130051621|NCT00953043|468145548|FG000|Overall Study|Physician Decision|0|||
130051622|NCT00953043|468145549|FG001|Overall Study|Physician Decision|2|||
130314777|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314778|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314779|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
130314780|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
130051623|NCT01432262|468145550|FG000|Overall Study|Withdrawal by Subject|2|||
130051624|NCT01432262|468145551|FG001|Overall Study|Withdrawal by Subject|1|||
130051625|NCT00165646|468145552|FG000|Overall Study|Adverse Event|1|||
130051626|NCT00165646|468145553|FG001|Overall Study|Adverse Event|1|||
130051627|NCT00165646|468145554|FG002|Overall Study|Adverse Event|1|||
130051628|NCT00165646|468145552|FG000|Overall Study|Lack of Efficacy|1|||
130051629|NCT00165646|468145553|FG001|Overall Study|Lack of Efficacy|2|||
130051630|NCT00165646|468145554|FG002|Overall Study|Lack of Efficacy|0|||
130051631|NCT00165646|468145552|FG000|Overall Study|Withdrawal by Subject|0|||
130051632|NCT00165646|468145553|FG001|Overall Study|Withdrawal by Subject|2|||
130051633|NCT00165646|468145554|FG002|Overall Study|Withdrawal by Subject|1|||
130051634|NCT00165646|468145552|FG000|Overall Study|Physician Decision|2|||
130051635|NCT00165646|468145553|FG001|Overall Study|Physician Decision|0|||
130051636|NCT00165646|468145554|FG002|Overall Study|Physician Decision|2|||
130051637|NCT00165646|468145552|FG000|Overall Study|Protocol Violation|1|||
130051638|NCT00165646|468145553|FG001|Overall Study|Protocol Violation|0|||
130051639|NCT00165646|468145554|FG002|Overall Study|Protocol Violation|0|||
130051640|NCT04657016|468145555|FG000|Overall Study|Adverse Event|2|||
130051641|NCT04657016|468145556|FG001|Overall Study|Adverse Event|4|||
130051642|NCT04657016|468145555|FG000|Overall Study|Death|1|||
130051643|NCT04657016|468145556|FG001|Overall Study|Death|1|||
130051644|NCT04657016|468145555|FG000|Overall Study|Lost to Follow-up|24|||
130051645|NCT04657016|468145556|FG001|Overall Study|Lost to Follow-up|12|||
130051646|NCT04657016|468145555|FG000|Overall Study|Physician Decision|1|||
130051647|NCT04657016|468145556|FG001|Overall Study|Physician Decision|2|||
130051648|NCT04657016|468145555|FG000|Overall Study|Pregnancy|2|||
130051649|NCT04657016|468145556|FG001|Overall Study|Pregnancy|2|||
130051650|NCT04657016|468145555|FG000|Overall Study|Protocol Deviation|1|||
130051651|NCT04657016|468145556|FG001|Overall Study|Protocol Deviation|0|||
130051652|NCT04657016|468145555|FG000|Overall Study|Withdrawal by Subject|28|||
130051653|NCT04657016|468145556|FG001|Overall Study|Withdrawal by Subject|14|||
130051654|NCT04657016|468145555|FG000|Overall Study|Other - as reported by the investigator|6|||
130051655|NCT04657016|468145556|FG001|Overall Study|Other - as reported by the investigator|0|||
130051656|NCT01104558|468145557|FG000|Overall Study|Protocol Violation|6|||
130051657|NCT01104558|468145557|FG000|Overall Study|Missing of primary efficacy assessment|10|||
130051658|NCT01104558|468145557|FG000|Overall Study|Missing of genetic analysis results|1|||
130051659|NCT01755195|468145558|FG000|Overall Study|Participant noncompliance|2|||
130051660|NCT01755195|468145558|FG000|Overall Study|Switched to alternative treatment|4|||
130051661|NCT01755195|468145558|FG000|Overall Study|Withdrawal by Subject|1|||
130051662|NCT01755195|468145558|FG000|Overall Study|Participant refused to start treatment|1|||
130051663|NCT01755195|468145558|FG000|Overall Study|Participant has been consented for another trial|1|||
130051664|NCT01755195|468145558|FG000|Overall Study|Refused further treatment|3|||
130051665|NCT01755195|468145558|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
130051666|NCT03470922|468145559|FG000|Overall Study|Death|107|||
130051667|NCT03470922|468145560|FG001|Overall Study|Death|118|||
130051668|NCT03470922|468145559|FG000|Overall Study|Lost to Follow-up|5|||
130051669|NCT03470922|468145560|FG001|Overall Study|Lost to Follow-up|5|||
130051670|NCT03470922|468145559|FG000|Overall Study|Participant Withdrew Consent|4|||
130314781|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314782|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
130314783|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314784|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
130314785|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314786|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314787|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314788|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314789|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
130314790|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130314791|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314792|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314793|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314794|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130314795|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
130314796|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314797|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314798|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314799|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
130314800|NCT02365649|469118355|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314801|NCT02365649|469118356|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130051671|NCT03470922|468145560|FG001|Overall Study|Participant Withdrew Consent|9|||
130051672|NCT03470922|468145559|FG000|Overall Study|Other reasons|1|||
130051673|NCT03470922|468145560|FG001|Overall Study|Other reasons|0|||
130051674|NCT03470922|468145559|FG000|Overall Study|Not reported|1|||
130051675|NCT03470922|468145560|FG001|Overall Study|Not reported|0|||
130051676|NCT02340819|468145561|FG000|Overall Study|Adverse Event|1|||
130051677|NCT02340819|468145561|FG000|Overall Study|Withdrawal by Subject|2|||
130051678|NCT02340819|468145561|FG000|Overall Study|Discontinued with other reason|1|||
130051679|NCT01793051|468145562|FG000|Overall Study|Withdrawal by Subject|6|||
130051680|NCT01793051|468145563|FG001|Overall Study|Withdrawal by Subject|4|||
130314802|NCT02365649|469118357|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
130314803|NCT02365649|469118358|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314804|NCT02365649|469118359|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314805|NCT02365649|469118360|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314806|NCT02365649|469118361|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129800029|NCT00973349|467235284|FG012|Overall Study|Protocol Violation|0|||
129800030|NCT00973349|467235285|FG013|Overall Study|Protocol Violation|0|||
130051681|NCT01793051|468145562|FG000|Overall Study|Adverse Event|0|||
130051682|NCT01793051|468145563|FG001|Overall Study|Adverse Event|2|||
130051683|NCT01793051|468145562|FG000|Overall Study|Too ill to continue|1|||
130051684|NCT01793051|468145563|FG001|Overall Study|Too ill to continue|0|||
130051685|NCT01793051|468145562|FG000|Overall Study|Switched chemo|1|||
130051686|NCT01793051|468145563|FG001|Overall Study|Switched chemo|1|||
130051687|NCT01793051|468145562|FG000|Overall Study|Lack of compliance|1|||
130051688|NCT01793051|468145563|FG001|Overall Study|Lack of compliance|0|||
130314807|NCT02365649|469118362|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130051689|NCT01793051|468145562|FG000|Overall Study|Requested to be removed from the study|1|||
130314808|NCT02365649|469118363|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130314809|NCT02365649|469118364|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
130051690|NCT01793051|468145563|FG001|Overall Study|Requested to be removed from the study|1|||
130051691|NCT01881620|468145565|FG000|Overall Study|Protocol Violation|4|||
129890997|NCT01244763|467559576|FG000|Overall Study|Lost to Follow-up|0|||
129890998|NCT01244763|467559577|FG001|Overall Study|Lost to Follow-up|1|||
129890999|NCT01244763|467559578|FG002|Overall Study|Lost to Follow-up|0|||
129891000|NCT01244763|467559579|FG003|Overall Study|Lost to Follow-up|0|||
129891001|NCT01244763|467559580|FG004|Overall Study|Lost to Follow-up|0|||
129891002|NCT01244763|467559581|FG005|Overall Study|Lost to Follow-up|0|||
129891003|NCT01244763|467559576|FG000|Overall Study|Enrolled into the Extension Study|0|||
129891004|NCT01244763|467559577|FG001|Overall Study|Enrolled into the Extension Study|0|||
129891005|NCT01244763|467559578|FG002|Overall Study|Enrolled into the Extension Study|0|||
129891006|NCT01244763|467559579|FG003|Overall Study|Enrolled into the Extension Study|0|||
129891007|NCT01244763|467559580|FG004|Overall Study|Enrolled into the Extension Study|0|||
129891008|NCT01244763|467559581|FG005|Overall Study|Enrolled into the Extension Study|1|||
129891009|NCT00519779|467559583|FG000|Overall Study|Withdrawal by Subject|0|||
130051692|NCT01808118|468145568|FG000|Period 1|Adverse Event|15|||
130051693|NCT01808118|468145569|FG001|Period 1|Adverse Event|0|||
130051694|NCT01808118|468145570|FG002|Period 1|Adverse Event|0|||
130051695|NCT01808118|468145568|FG000|Period 1|Withdrew consent|24|||
130051696|NCT01808118|468145569|FG001|Period 1|Withdrew consent|0|||
129891010|NCT00519779|467559584|FG001|Overall Study|Withdrawal by Subject|1|||
129891011|NCT03330119|467559585|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
129891012|NCT03330119|467559586|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
130051697|NCT01808118|468145570|FG002|Period 1|Withdrew consent|0|||
130051698|NCT01808118|468145568|FG000|Period 1|Lost to Follow-up|9|||
129891013|NCT02015663|467559591|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
130051699|NCT01808118|468145569|FG001|Period 1|Lost to Follow-up|0|||
129891014|NCT02015663|467559592|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
129891015|NCT02015663|467559591|FG000|Overall Study|Withdrawal by Subject|1|||
129891016|NCT02015663|467559592|FG001|Overall Study|Withdrawal by Subject|0|||
130051700|NCT01808118|468145570|FG002|Period 1|Lost to Follow-up|0|||
130051701|NCT01808118|468145568|FG000|Period 1|Did not meet criteria for remission|303|||
130051702|NCT01808118|468145569|FG001|Period 1|Did not meet criteria for remission|0|||
130051703|NCT01808118|468145570|FG002|Period 1|Did not meet criteria for remission|0|||
130051704|NCT01808118|468145568|FG000|Period 1|Enrolled in error|7|||
130051705|NCT01808118|468145569|FG001|Period 1|Enrolled in error|0|||
129800031|NCT00973349|467235286|FG014|Overall Study|Protocol Violation|0|||
129800032|NCT00973349|467235287|FG015|Overall Study|Protocol Violation|0|||
129800033|NCT00973349|467235272|FG000|Overall Study|Unable to classify|0|||
129800034|NCT00973349|467235273|FG001|Overall Study|Unable to classify|0|||
129800035|NCT00973349|467235274|FG002|Overall Study|Unable to classify|0|||
129800036|NCT00973349|467235275|FG003|Overall Study|Unable to classify|0|||
129800037|NCT00973349|467235276|FG004|Overall Study|Unable to classify|1|||
129800038|NCT00973349|467235277|FG005|Overall Study|Unable to classify|1|||
129800039|NCT00973349|467235278|FG006|Overall Study|Unable to classify|0|||
129800040|NCT00973349|467235279|FG007|Overall Study|Unable to classify|0|||
129800041|NCT00973349|467235280|FG008|Overall Study|Unable to classify|0|||
129800042|NCT00973349|467235281|FG009|Overall Study|Unable to classify|1|||
130051706|NCT01808118|468145570|FG002|Period 1|Enrolled in error|0|||
130051707|NCT01808118|468145568|FG000|Period 1|Did not meet inclusion criteria|3|||
130051708|NCT01808118|468145569|FG001|Period 1|Did not meet inclusion criteria|0|||
129891017|NCT02015663|467559591|FG000|Overall Study|Protocol Violation|0|||
129891018|NCT02015663|467559592|FG001|Overall Study|Protocol Violation|1|||
130051709|NCT01808118|468145570|FG002|Period 1|Did not meet inclusion criteria|0|||
129800043|NCT00973349|467235282|FG010|Overall Study|Unable to classify|0|||
129891019|NCT02015663|467559591|FG000|Overall Study|Adverse Event|3|||
130051710|NCT01808118|468145568|FG000|Period 1|Non-conformance with inclusion criteria|3|||
129891020|NCT02015663|467559592|FG001|Overall Study|Adverse Event|0|||
129891021|NCT02015663|467559591|FG000|Overall Study|Administrative problems|10|||
129891022|NCT02015663|467559592|FG001|Overall Study|Administrative problems|11|||
129891023|NCT00479674|467559595|FG000|Overall Study|Adverse Event|18|||
129891024|NCT00479674|467559595|FG000|Overall Study|Withdrawal by Subject|6|||
129891025|NCT00479674|467559595|FG000|Overall Study|Physician Decision|14|||
129891026|NCT00479674|467559595|FG000|Overall Study|none provided|3|||
129891027|NCT00146640|467559601|FG000|Overall Study|Adverse Event|12|||
129891028|NCT00146640|467559602|FG001|Overall Study|Adverse Event|10|||
129891029|NCT00146640|467559601|FG000|Overall Study|Medical Reasons|3|||
129891030|NCT00146640|467559602|FG001|Overall Study|Medical Reasons|0|||
129891031|NCT00146640|467559601|FG000|Overall Study|Non-Medical Reasons|8|||
129891032|NCT00146640|467559602|FG001|Overall Study|Non-Medical Reasons|4|||
129891033|NCT02059161|467559603|FG000|Overall Study|Pregnancy|0|||
129891034|NCT02059161|467559604|FG001|Overall Study|Pregnancy|2|||
129891035|NCT02059161|467559603|FG000|Overall Study|Adverse Event|2|||
129891036|NCT02059161|467559604|FG001|Overall Study|Adverse Event|6|||
129891037|NCT02059161|467559603|FG000|Overall Study|Lost to Follow-up|20|||
129891038|NCT02059161|467559604|FG001|Overall Study|Lost to Follow-up|12|||
129891039|NCT02059161|467559603|FG000|Overall Study|Physician Decision|4|||
129891040|NCT02059161|467559604|FG001|Overall Study|Physician Decision|4|||
129891041|NCT02059161|467559603|FG000|Overall Study|Protocol Violation|1|||
129891042|NCT02059161|467559604|FG001|Overall Study|Protocol Violation|1|||
129891043|NCT02059161|467559603|FG000|Overall Study|Withdrawal by Subject|16|||
129891044|NCT02059161|467559604|FG001|Overall Study|Withdrawal by Subject|13|||
129891045|NCT02059161|467559603|FG000|Overall Study|Randomized in error, no study drug|0|||
129891046|NCT02059161|467559604|FG001|Overall Study|Randomized in error, no study drug|1|||
129891047|NCT02059161|467559603|FG000|Overall Study|Non-compliance with study drug|6|||
129891048|NCT02059161|467559604|FG001|Overall Study|Non-compliance with study drug|2|||
129891049|NCT03293485|467559606|FG000|Overall Study|Death|1|||
129891050|NCT03293485|467559606|FG000|Overall Study|Screen Failure|2|||
129891051|NCT03293485|467559606|FG000|Overall Study|Withdrawal by Subject|2|||
129891052|NCT01723826|467559610|FG000|Overall Study|Adverse Event|4|||
129891053|NCT01723826|467559611|FG001|Overall Study|Adverse Event|1|||
129891054|NCT01723826|467559612|FG002|Overall Study|Adverse Event|4|||
129891055|NCT01723826|467559613|FG003|Overall Study|Adverse Event|5|||
129891056|NCT01723826|467559610|FG000|Overall Study|Death according to AE eCRF|2|||
129891057|NCT01723826|467559611|FG001|Overall Study|Death according to AE eCRF|3|||
129891058|NCT01723826|467559612|FG002|Overall Study|Death according to AE eCRF|3|||
129891059|NCT01723826|467559613|FG003|Overall Study|Death according to AE eCRF|7|||
129891060|NCT01723826|467559610|FG000|Overall Study|Lost to Follow-up|1|||
129891061|NCT01723826|467559611|FG001|Overall Study|Lost to Follow-up|3|||
129891062|NCT01723826|467559612|FG002|Overall Study|Lost to Follow-up|1|||
129891063|NCT01723826|467559613|FG003|Overall Study|Lost to Follow-up|1|||
129891064|NCT01723826|467559610|FG000|Overall Study|Non-compliance|0|||
129891065|NCT01723826|467559611|FG001|Overall Study|Non-compliance|1|||
129891066|NCT01723826|467559612|FG002|Overall Study|Non-compliance|3|||
129891067|NCT01723826|467559613|FG003|Overall Study|Non-compliance|3|||
129891068|NCT01723826|467559610|FG000|Overall Study|Non-compliance With Study Drug|0|||
129891069|NCT01723826|467559611|FG001|Overall Study|Non-compliance With Study Drug|1|||
129800044|NCT00973349|467235283|FG011|Overall Study|Unable to classify|0|||
129800045|NCT00973349|467235284|FG012|Overall Study|Unable to classify|0|||
129800046|NCT00973349|467235285|FG013|Overall Study|Unable to classify|0|||
129800047|NCT00973349|467235286|FG014|Overall Study|Unable to classify|0|||
129800048|NCT00973349|467235287|FG015|Overall Study|Unable to classify|0|||
130051711|NCT01808118|468145569|FG001|Period 1|Non-conformance with inclusion criteria|0|||
130051712|NCT01808118|468145570|FG002|Period 1|Non-conformance with inclusion criteria|0|||
130051713|NCT01808118|468145568|FG000|Period 1|Investigator decision: site closure|2|||
130051714|NCT01808118|468145569|FG001|Period 1|Investigator decision: site closure|0|||
130051715|NCT01808118|468145570|FG002|Period 1|Investigator decision: site closure|0|||
130051716|NCT01808118|468145568|FG000|Period 1|Non-compliance per sponsor|1|||
130051717|NCT01808118|468145569|FG001|Period 1|Non-compliance per sponsor|0|||
130051718|NCT01808118|468145570|FG002|Period 1|Non-compliance per sponsor|0|||
130051719|NCT01808118|468145568|FG000|Period 1|Lack of Efficacy|1|||
130051720|NCT01808118|468145569|FG001|Period 1|Lack of Efficacy|0|||
130051721|NCT01808118|468145570|FG002|Period 1|Lack of Efficacy|0|||
130051722|NCT01808118|468145568|FG000|Period 2|Adverse Event|0|||
130051723|NCT01808118|468145569|FG001|Period 2|Adverse Event|4|||
130051724|NCT01808118|468145570|FG002|Period 2|Adverse Event|0|||
130051725|NCT01808118|468145568|FG000|Period 2|Withdrew consent|0|||
130051726|NCT01808118|468145569|FG001|Period 2|Withdrew consent|7|||
130051727|NCT01808118|468145570|FG002|Period 2|Withdrew consent|6|||
130051728|NCT01808118|468145568|FG000|Period 2|Lost to Follow-up|0|||
130051729|NCT01808118|468145569|FG001|Period 2|Lost to Follow-up|0|||
130051730|NCT01808118|468145570|FG002|Period 2|Lost to Follow-up|2|||
130051731|NCT01808118|468145568|FG000|Period 2|Investigator no longer conducting trials|0|||
130051732|NCT01808118|468145569|FG001|Period 2|Investigator no longer conducting trials|1|||
130051733|NCT01808118|468145570|FG002|Period 2|Investigator no longer conducting trials|0|||
130051734|NCT01808118|468145568|FG000|Period 2|Switched to other therapy|0|||
130051735|NCT01808118|468145569|FG001|Period 2|Switched to other therapy|1|||
130051736|NCT01808118|468145570|FG002|Period 2|Switched to other therapy|0|||
130051737|NCT04467164|468145574|FG000|Washout (1 Week)|Lost to Follow-up|2|||
130051738|NCT04467164|468145575|FG001|Washout (1 Week)|Lost to Follow-up|0|||
130051739|NCT01675011|468145583|FG000|Overall Study|Trial terminated by Sponsor|3|||
130051740|NCT01675011|468145584|FG001|Overall Study|Trial terminated by Sponsor|1|||
130051741|NCT00615290|468145585|FG000|Overall Study|Adverse Event|2|||
130051742|NCT00615290|468145585|FG000|Overall Study|Lost to Follow-up|3|||
130051743|NCT00615290|468145585|FG000|Overall Study|Withdrawal by Subject|1|||
130051744|NCT00615290|468145585|FG000|Overall Study|Other|2|||
130051745|NCT01252134|468145586|FG000|Period 1, 8 Hours|Personal Reasons|0|||
130051746|NCT01252134|468145587|FG001|Period 1, 8 Hours|Personal Reasons|1|||
130051747|NCT01252134|468145588|FG002|Period 1, 8 Hours|Personal Reasons|1|||
130051748|NCT01252134|468145589|FG003|Period 1, 8 Hours|Personal Reasons|0|||
130051749|NCT01252134|468145590|FG004|Period 1, 8 Hours|Personal Reasons|0|||
130051750|NCT01252134|468145591|FG005|Period 1, 8 Hours|Personal Reasons|0|||
130051751|NCT03650452|468145592|FG000|Overall Study|Physician Decision|1|||
130051752|NCT03650452|468145593|FG001|Overall Study|Physician Decision|0|||
130051753|NCT03650452|468145592|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
130051754|NCT03650452|468145593|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130051755|NCT03650452|468145592|FG000|Overall Study|Adverse Event|3|||
130051756|NCT03650452|468145593|FG001|Overall Study|Adverse Event|4|||
130051757|NCT03650452|468145592|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
130051758|NCT03650452|468145593|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
130314810|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314811|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314812|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314813|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314814|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314815|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314816|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
129800049|NCT02301988|467235288|FG000|Overall Study|Withdrawal by Subject|2|||
129800050|NCT02301988|467235289|FG001|Overall Study|Withdrawal by Subject|1|||
129800051|NCT02301988|467235288|FG000|Overall Study|Physician Decision|2|||
129800052|NCT02301988|467235289|FG001|Overall Study|Physician Decision|2|||
129800053|NCT02301988|467235288|FG000|Overall Study|Unknown Reason|1|||
129800054|NCT02301988|467235289|FG001|Overall Study|Unknown Reason|3|||
129800055|NCT02301988|467235288|FG000|Overall Study|Lack of Efficacy|3|||
129800056|NCT02301988|467235289|FG001|Overall Study|Lack of Efficacy|2|||
129800057|NCT02301988|467235288|FG000|Overall Study|Death|1|||
129800058|NCT02301988|467235289|FG001|Overall Study|Death|0|||
130051759|NCT02273050|468145594|FG000|Overall Study|Adverse Event|4|||
129800059|NCT02301988|467235288|FG000|Overall Study|Adverse Event|1|||
130051760|NCT02273050|468145595|FG001|Overall Study|Adverse Event|3|||
130051761|NCT02273050|468145596|FG002|Overall Study|Adverse Event|3|||
130051762|NCT02273050|468145594|FG000|Overall Study|Death|0|||
130051763|NCT02273050|468145595|FG001|Overall Study|Death|0|||
130051764|NCT02273050|468145596|FG002|Overall Study|Death|1|||
130051765|NCT02273050|468145594|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
130051766|NCT02273050|468145595|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
130051767|NCT02273050|468145596|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
130051768|NCT02273050|468145594|FG000|Overall Study|Lack of Efficacy|0|||
130314817|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314818|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314819|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
130314820|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314821|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314822|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314823|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314824|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314825|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314826|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
130314827|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
130314828|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
130314829|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
130314830|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314831|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314832|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314833|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314834|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314835|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
130314836|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
130314837|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
130314838|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
130314839|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
130314840|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314841|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314842|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314843|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314844|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314845|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314846|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
130314847|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
130314848|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
130314849|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
130314850|NCT02365649|469118355|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314851|NCT02365649|469118356|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314852|NCT02365649|469118357|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314853|NCT02365649|469118358|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314854|NCT02365649|469118359|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314855|NCT02365649|469118360|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314856|NCT02365649|469118361|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
130314857|NCT02365649|469118362|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314858|NCT02365649|469118363|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
130314859|NCT02365649|469118364|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
130314860|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
130314861|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
130314862|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
130314863|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
130051769|NCT02273050|468145595|FG001|Overall Study|Lack of Efficacy|1|||
130314864|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
130051770|NCT02273050|468145596|FG002|Overall Study|Lack of Efficacy|1|||
130051771|NCT02273050|468145594|FG000|Overall Study|Withdrawal by Subject|17|||
130051772|NCT02273050|468145595|FG001|Overall Study|Withdrawal by Subject|14|||
130051773|NCT02273050|468145596|FG002|Overall Study|Withdrawal by Subject|16|||
130051774|NCT02273050|468145594|FG000|Overall Study|Lost to Follow-up|0|||
130051775|NCT02273050|468145595|FG001|Overall Study|Lost to Follow-up|2|||
130051776|NCT02273050|468145596|FG002|Overall Study|Lost to Follow-up|3|||
130051777|NCT02273050|468145594|FG000|Overall Study|Protocol Violation|3|||
130051778|NCT02273050|468145595|FG001|Overall Study|Protocol Violation|1|||
130051779|NCT02273050|468145596|FG002|Overall Study|Protocol Violation|4|||
130051780|NCT01795898|468145598|FG000|Overall Study|Adverse Event|27|||
130051781|NCT01795898|468145598|FG000|Overall Study|Lost to Follow-up|20|||
130051782|NCT01795898|468145598|FG000|Overall Study|Withdrawal of consent|6|||
130051783|NCT01795898|468145598|FG000|Overall Study|Diagnosed with metastasis|1|||
130051784|NCT01795898|468145598|FG000|Overall Study|No pain|1|||
130051785|NCT01795898|468145598|FG000|Overall Study|Death|1|||
130051786|NCT01795898|468145598|FG000|Overall Study|Withdrew consent & had adverse events|3|||
130051787|NCT01795898|468145598|FG000|Overall Study|Physician Decision|1|||
130051788|NCT03539458|468145599|FG000|Overall Study|Death|1|||
130051789|NCT01703286|468145600|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
130051790|NCT01703286|468145601|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
130051791|NCT01703286|468145602|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
130051792|NCT01703286|468145603|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
130051793|NCT01703286|468145604|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
130051794|NCT01703286|468145605|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
130051795|NCT01703286|468145600|FG000|Period 2 Including Washout|Adverse Event|0|||
130051796|NCT01703286|468145601|FG001|Period 2 Including Washout|Adverse Event|0|||
130051797|NCT01703286|468145602|FG002|Period 2 Including Washout|Adverse Event|0|||
130051798|NCT01703286|468145603|FG003|Period 2 Including Washout|Adverse Event|1|||
130051799|NCT01703286|468145604|FG004|Period 2 Including Washout|Adverse Event|0|||
130051800|NCT01703286|468145605|FG005|Period 2 Including Washout|Adverse Event|0|||
130314865|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
130314866|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
130314867|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
130314868|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
130314869|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
130314870|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
130314871|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
130314872|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
130314873|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
130314874|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
130314875|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
130314876|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
130314877|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
130314878|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
130314879|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
130314880|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
130314881|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
130314882|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
130314883|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
130051801|NCT01984346|468145606|FG000|Overall Study|Physician Decision|4|||
130051802|NCT01984346|468145607|FG001|Overall Study|Physician Decision|2|||
130051803|NCT01984346|468145606|FG000|Overall Study|Withdrawal by Subject|2|||
130051804|NCT01984346|468145607|FG001|Overall Study|Withdrawal by Subject|2|||
129891070|NCT01723826|467559612|FG002|Overall Study|Non-compliance With Study Drug|0|||
129891071|NCT01723826|467559613|FG003|Overall Study|Non-compliance With Study Drug|0|||
129891072|NCT01723826|467559610|FG000|Overall Study|Other Reason|8|||
129891073|NCT01723826|467559611|FG001|Overall Study|Other Reason|6|||
129891074|NCT01723826|467559612|FG002|Overall Study|Other Reason|12|||
129891075|NCT01723826|467559613|FG003|Overall Study|Other Reason|14|||
129891076|NCT01723826|467559610|FG000|Overall Study|Physician Decision|1|||
129891077|NCT01723826|467559611|FG001|Overall Study|Physician Decision|3|||
129891078|NCT01723826|467559612|FG002|Overall Study|Physician Decision|4|||
129891079|NCT01723826|467559613|FG003|Overall Study|Physician Decision|11|||
129891080|NCT01723826|467559610|FG000|Overall Study|Protocol Violation|1|||
129891081|NCT01723826|467559611|FG001|Overall Study|Protocol Violation|1|||
129891082|NCT01723826|467559612|FG002|Overall Study|Protocol Violation|3|||
130051805|NCT01984346|468145606|FG000|Overall Study|Enrollment Closed|8|||
130051806|NCT01984346|468145607|FG001|Overall Study|Enrollment Closed|1|||
130051807|NCT01984346|468145606|FG000|Overall Study|Insurance Coverage|1|||
130051808|NCT01984346|468145607|FG001|Overall Study|Insurance Coverage|0|||
130051809|NCT01984346|468145606|FG000|Overall Study|Intra-operative Exclusion|2|||
130051810|NCT01984346|468145607|FG001|Overall Study|Intra-operative Exclusion|0|||
130314884|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
130314885|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
130314886|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
130314887|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
130314888|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
130314889|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
130314890|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
130314891|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
130314892|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
130314893|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
130314894|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
130314895|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
130314896|NCT02586623|469118369|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
130314897|NCT02586623|469118370|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
130314898|NCT02586623|469118371|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
130314899|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
130314900|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
130314901|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
130314902|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
130314903|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
130314904|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
130314905|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
130314906|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
130314907|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
130314908|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
130314909|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
130314910|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
130314911|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
130314912|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
130314913|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
130314914|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
130314915|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
130314916|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
130314917|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
130314918|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
130314919|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
130314920|NCT02586623|469118369|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
130314921|NCT02586623|469118370|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
130314922|NCT02586623|469118371|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
130314923|NCT02910466|469118374|FG000|Overall Study|Adverse Event|1|||
129891083|NCT01723826|467559613|FG003|Overall Study|Protocol Violation|1|||
129891084|NCT01723826|467559610|FG000|Overall Study|Withdrawal by Subject|10|||
129891085|NCT01723826|467559611|FG001|Overall Study|Withdrawal by Subject|17|||
129800060|NCT02301988|467235289|FG001|Overall Study|Adverse Event|1|||
129800061|NCT05169567|467235290|FG000|Overall Study|On study treatment|116|||
129800062|NCT05169567|467235291|FG001|Overall Study|On study treatment|128|||
129800063|NCT05169567|467235290|FG000|Overall Study|Lost to Follow-up|1|||
129800064|NCT05169567|467235291|FG001|Overall Study|Lost to Follow-up|0|||
129800065|NCT05169567|467235290|FG000|Overall Study|Withdrawal by Subject|25|||
129800066|NCT05169567|467235291|FG001|Overall Study|Withdrawal by Subject|21|||
129800067|NCT01015131|467235292|FG000|Overall Study|Physician Decision|1|||
129800068|NCT01015131|467235292|FG000|Overall Study|Protocol Violation|1|||
129800069|NCT01015131|467235292|FG000|Overall Study|Withdrawal by Subject|2|||
129800070|NCT01015131|467235292|FG000|Overall Study|Other Protocol Specified Criteria|4|||
130051811|NCT00718419|468145612|FG000|Overall Study|Adverse Event|2|||
130051812|NCT00718419|468145613|FG001|Overall Study|Adverse Event|1|||
130051813|NCT00718419|468145612|FG000|Overall Study|Physician Decision|1|||
130314924|NCT02910466|469118374|FG000|Overall Study|Withdrawal by Subject|3|||
130314925|NCT02910466|469118374|FG000|Overall Study|Lost to Follow-up|5|||
130314926|NCT02910466|469118374|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
130314927|NCT02910466|469118374|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
130314928|NCT04332107|469118383|FG000|Day 3|Lost to Follow-up|23|||
130314929|NCT04332107|469118384|FG001|Day 3|Lost to Follow-up|14|||
130314930|NCT04332107|469118383|FG000|Day 3|Missing outcome data|3|||
130314931|NCT04332107|469118384|FG001|Day 3|Missing outcome data|6|||
130314932|NCT04332107|469118383|FG000|Day 14|Lost to Follow-up|13|||
130314933|NCT04332107|469118384|FG001|Day 14|Lost to Follow-up|4|||
130314934|NCT04332107|469118383|FG000|Day 14|Missing outcome data|4|||
130314935|NCT04332107|469118384|FG001|Day 14|Missing outcome data|4|||
130314936|NCT04332107|469118383|FG000|Day 21|Lost to Follow-up|10|||
130314937|NCT04332107|469118384|FG001|Day 21|Lost to Follow-up|2|||
130314938|NCT00871871|469118389|FG000|Part I|Adverse Event|0|||
130314939|NCT00871871|469118390|FG001|Part I|Adverse Event|2|||
130314940|NCT00871871|469118391|FG002|Part I|Adverse Event|0|||
130314941|NCT00871871|469118392|FG003|Part I|Adverse Event|0|||
130314942|NCT00871871|469118389|FG000|Part I|Withdrawal by Subject|3|||
130314943|NCT00871871|469118390|FG001|Part I|Withdrawal by Subject|0|||
130314944|NCT00871871|469118391|FG002|Part I|Withdrawal by Subject|0|||
130314945|NCT00871871|469118392|FG003|Part I|Withdrawal by Subject|0|||
130314946|NCT00871871|469118389|FG000|Part I|Laboratory abnormality|0|||
130314947|NCT00871871|469118390|FG001|Part I|Laboratory abnormality|1|||
130314948|NCT00871871|469118391|FG002|Part I|Laboratory abnormality|0|||
130314949|NCT00871871|469118392|FG003|Part I|Laboratory abnormality|0|||
130314950|NCT00871871|469118389|FG000|Part II|Lack of Efficacy|0|||
130314951|NCT00871871|469118390|FG001|Part II|Lack of Efficacy|0|||
130314952|NCT00871871|469118391|FG002|Part II|Lack of Efficacy|1|||
130314953|NCT00871871|469118392|FG003|Part II|Lack of Efficacy|0|||
130314954|NCT00871871|469118389|FG000|Part II|Withdrawal by Subject|0|||
130314955|NCT00871871|469118390|FG001|Part II|Withdrawal by Subject|0|||
130314956|NCT00871871|469118391|FG002|Part II|Withdrawal by Subject|2|||
130314957|NCT00871871|469118392|FG003|Part II|Withdrawal by Subject|1|||
130314958|NCT00871871|469118389|FG000|Part II|Adverse Event|0|||
130314959|NCT00871871|469118390|FG001|Part II|Adverse Event|0|||
129800071|NCT05430022|467235293|FG000|Overall Study|Withdrawal by Subject|4|||
129800072|NCT05430022|467235294|FG001|Overall Study|Withdrawal by Subject|4|||
129800073|NCT05069259|467235298|FG000|Overall Study|Withdrawal by Subject|1|||
129800074|NCT05069259|467235298|FG000|Overall Study|Sponsor decision|1|||
129800075|NCT03148275|467235299|FG000|Overall Study|Death|6|||
129800076|NCT03148275|467235299|FG000|Overall Study|Adverse Event|3|||
129800077|NCT03148275|467235299|FG000|Overall Study|Liver transplant|2|||
129800078|NCT03148275|467235299|FG000|Overall Study|Patient decision|5|||
129800079|NCT03148275|467235299|FG000|Overall Study|transition to commercial drug|1|||
129800080|NCT03148275|467235299|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
129800081|NCT05098938|467235300|FG000|Overall Study|Adverse Event|4|||
130314960|NCT00871871|469118391|FG002|Part II|Adverse Event|1|||
130314961|NCT00871871|469118392|FG003|Part II|Adverse Event|2|||
130314962|NCT00871871|469118389|FG000|Part II|Protocol Violation|0|||
129800082|NCT05098938|467235301|FG001|Overall Study|Adverse Event|3|||
130314963|NCT00871871|469118390|FG001|Part II|Protocol Violation|0|||
130314964|NCT00871871|469118391|FG002|Part II|Protocol Violation|0|||
130314965|NCT00871871|469118392|FG003|Part II|Protocol Violation|1|||
130314966|NCT01808196|469118396|FG000|Overall Study|Lost to Follow-up|1|||
130314967|NCT00479713|469118397|FG000|Overall Study|Adverse Event|8|||
130314968|NCT00479713|469118398|FG001|Overall Study|Adverse Event|6|||
130314969|NCT00479713|469118397|FG000|Overall Study|Death|1|||
130314970|NCT00479713|469118398|FG001|Overall Study|Death|0|||
130314971|NCT00479713|469118397|FG000|Overall Study|Lost to Follow-up|0|||
130314972|NCT00479713|469118398|FG001|Overall Study|Lost to Follow-up|1|||
130314973|NCT00479713|469118397|FG000|Overall Study|Protocol Violation|0|||
130314974|NCT00479713|469118398|FG001|Overall Study|Protocol Violation|1|||
130314975|NCT00479713|469118397|FG000|Overall Study|Withdrawal by Subject|4|||
130314976|NCT00479713|469118398|FG001|Overall Study|Withdrawal by Subject|1|||
130314977|NCT03863509|469118401|FG000|Overall Study|COVID-19 shutdown period|0|||
130314978|NCT03863509|469118402|FG001|Overall Study|COVID-19 shutdown period|4|||
130314979|NCT03863509|469118403|FG002|Overall Study|COVID-19 shutdown period|0|||
130314980|NCT03863509|469118401|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
130314981|NCT03863509|469118402|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
130314982|NCT03863509|469118403|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
130314983|NCT03863509|469118401|FG000|Overall Study|Lost to Follow-up|8|||
130314984|NCT03863509|469118402|FG001|Overall Study|Lost to Follow-up|0|||
130314985|NCT03863509|469118403|FG002|Overall Study|Lost to Follow-up|2|||
130314986|NCT03863509|469118401|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
130314987|NCT03863509|469118402|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
130314988|NCT03863509|469118403|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
130314989|NCT03863509|469118401|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
130314990|NCT03863509|469118402|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
130314991|NCT03863509|469118403|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
130314992|NCT00141102|469118404|FG000|Overall Study|Adverse Event|233|||
130314993|NCT00141102|469118405|FG001|Overall Study|Adverse Event|305|||
130314994|NCT00141102|469118404|FG000|Overall Study|Laboratory Abnormality|9|||
130314995|NCT00141102|469118405|FG001|Overall Study|Laboratory Abnormality|33|||
130314996|NCT00141102|469118404|FG000|Overall Study|Lack of Efficacy|21|||
130314997|NCT00141102|469118405|FG001|Overall Study|Lack of Efficacy|26|||
130314998|NCT00141102|469118404|FG000|Overall Study|Lost to Follow-up|29|||
130314999|NCT00141102|469118405|FG001|Overall Study|Lost to Follow-up|32|||
130315000|NCT00141102|469118404|FG000|Overall Study|Other|87|||
130315001|NCT00141102|469118405|FG001|Overall Study|Other|76|||
130315002|NCT00141102|469118404|FG000|Overall Study|Withdrawal by Subject|112|||
130315003|NCT00141102|469118405|FG001|Overall Study|Withdrawal by Subject|142|||
130315004|NCT00141102|469118404|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
130315005|NCT00141102|469118405|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
129800083|NCT05098938|467235300|FG000|Overall Study|inclusion/exclusion criteria change|11|||
129800084|NCT05098938|467235301|FG001|Overall Study|inclusion/exclusion criteria change|5|||
129800085|NCT05098938|467235300|FG000|Overall Study|lack of compliance|26|||
130315006|NCT00141102|469118404|FG000|Overall Study|Death|2|||
130315007|NCT00141102|469118405|FG001|Overall Study|Death|2|||
130315008|NCT01063153|469118409|FG000|Overall Study|Found Ineligible During Screening|2|||
130315009|NCT01063153|469118410|FG001|Overall Study|Found Ineligible During Screening|0|||
130315010|NCT01063153|469118409|FG000|Overall Study|Lost to Follow-up|0|||
130315011|NCT01063153|469118410|FG001|Overall Study|Lost to Follow-up|7|||
130315012|NCT01063153|469118409|FG000|Overall Study|Withdrawal by Subject|0|||
130315013|NCT01063153|469118410|FG001|Overall Study|Withdrawal by Subject|1|||
130315014|NCT01063153|469118409|FG000|Overall Study|Physician Decision|0|||
130315015|NCT01063153|469118410|FG001|Overall Study|Physician Decision|4|||
130315016|NCT00350844|469118411|FG000|Overall Study|Lost to Follow-up|1|||
130315017|NCT02775916|469118414|FG000|Overall Study|Adverse Event|1|||
130315018|NCT02775916|469118415|FG001|Overall Study|Adverse Event|0|||
130315019|NCT02775916|469118414|FG000|Overall Study|Subject/Guardian Decision|2|||
130315020|NCT02775916|469118415|FG001|Overall Study|Subject/Guardian Decision|0|||
130315021|NCT03737123|469120805|FG000|Study Treatment|Adverse Event|2|||
130315022|NCT03737123|469120806|FG001|Study Treatment|Adverse Event|0|||
130315023|NCT03737123|469120805|FG000|Study Treatment|Disease Progression|2|||
130315024|NCT03737123|469120806|FG001|Study Treatment|Disease Progression|0|||
130315025|NCT03737123|469120805|FG000|Study Treatment|Withdrawal by Subject|2|||
130315026|NCT03737123|469120806|FG001|Study Treatment|Withdrawal by Subject|0|||
130315027|NCT03737123|469120805|FG000|Follow up|Death|1|||
130315028|NCT03737123|469120806|FG001|Follow up|Death|0|||
130315029|NCT03737123|469120805|FG000|Follow up|Withdrawal by Subject|1|||
130315030|NCT03737123|469120806|FG001|Follow up|Withdrawal by Subject|0|||
130315031|NCT03737123|469120805|FG000|Follow up|Termination of study|4|||
130315032|NCT03737123|469120806|FG001|Follow up|Termination of study|0|||
130315033|NCT02173769|469120807|FG000|Overall Study|Protocol Violation|4|||
130315034|NCT03016312|469120814|FG000|Overall Study|discontinued before the treatment started|0|||
130315035|NCT03016312|469120815|FG001|Overall Study|discontinued before the treatment started|1|||
130315036|NCT03016312|469120814|FG000|Overall Study|Withdrawal by Subject|37|||
130315037|NCT03016312|469120815|FG001|Overall Study|Withdrawal by Subject|44|||
130315038|NCT03016312|469120814|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
130315039|NCT03016312|469120815|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
130315040|NCT03016312|469120814|FG000|Overall Study|Physician Decision|1|||
130315041|NCT03016312|469120815|FG001|Overall Study|Physician Decision|3|||
130315042|NCT03016312|469120814|FG000|Overall Study|Lost to Follow-up|12|||
130315043|NCT03016312|469120815|FG001|Overall Study|Lost to Follow-up|12|||
130315044|NCT03016312|469120814|FG000|Overall Study|Death|210|||
130315045|NCT03016312|469120815|FG001|Overall Study|Death|184|||
130315046|NCT03016312|469120814|FG000|Overall Study|loss to contact|1|||
130315047|NCT03016312|469120815|FG001|Overall Study|loss to contact|0|||
130315048|NCT03016312|469120814|FG000|Overall Study|started a new cancer therapy|1|||
130315049|NCT03016312|469120815|FG001|Overall Study|started a new cancer therapy|0|||
130315050|NCT00308139|469120817|FG000|Overall Study|Adverse Event|20|||
130315051|NCT00308139|469120818|FG001|Overall Study|Adverse Event|14|||
130315052|NCT00308139|469120817|FG000|Overall Study|Lost to Follow-up|13|||
130315053|NCT00308139|469120818|FG001|Overall Study|Lost to Follow-up|8|||
130315054|NCT00308139|469120817|FG000|Overall Study|Protocol Violation|3|||
130315055|NCT00308139|469120818|FG001|Overall Study|Protocol Violation|2|||
130315056|NCT00308139|469120817|FG000|Overall Study|Withdrawal of Consent|40|||
130315057|NCT00308139|469120818|FG001|Overall Study|Withdrawal of Consent|42|||
130315058|NCT00308139|469120817|FG000|Overall Study|Investigator Decision|11|||
130315059|NCT00308139|469120818|FG001|Overall Study|Investigator Decision|10|||
130315060|NCT00308139|469120817|FG000|Overall Study|Loss of Glucose Control|5|||
130315061|NCT00308139|469120818|FG001|Overall Study|Loss of Glucose Control|7|||
130315062|NCT00308139|469120817|FG000|Overall Study|Administrative|1|||
130315063|NCT00308139|469120818|FG001|Overall Study|Administrative|4|||
130315064|NCT00308139|469120817|FG000|Overall Study|Other|1|||
130315065|NCT00308139|469120818|FG001|Overall Study|Other|0|||
130315066|NCT01884077|469120819|FG000|Overall Study|screen fail|0|||
130315067|NCT01884077|469120820|FG001|Overall Study|screen fail|2|||
130315068|NCT01884077|469120819|FG000|Overall Study|canceled surgery|2|||
130315069|NCT01884077|469120820|FG001|Overall Study|canceled surgery|0|||
130315070|NCT01884077|469120819|FG000|Overall Study|Lost to Follow-up|0|||
130315071|NCT01884077|469120820|FG001|Overall Study|Lost to Follow-up|4|||
130315072|NCT01884077|469120819|FG000|Overall Study|study closed|6|||
130315073|NCT01884077|469120820|FG001|Overall Study|study closed|4|||
130051814|NCT00718419|468145613|FG001|Overall Study|Physician Decision|6|||
130315074|NCT00981149|469120821|FG000|Overall Study|Lost to Follow-up|1|||
130315075|NCT00981149|469120822|FG001|Overall Study|Lost to Follow-up|2|||
130315076|NCT00981149|469120821|FG000|Overall Study|Withdrawal by Subject|1|||
130315077|NCT00981149|469120822|FG001|Overall Study|Withdrawal by Subject|1|||
130315078|NCT01220167|469120826|FG000|Period 3|Urine positive for substance abuse|0|||
130315079|NCT01220167|469120827|FG001|Period 3|Urine positive for substance abuse|1|||
130315080|NCT01220167|469120828|FG002|Period 3|Urine positive for substance abuse|0|||
130315081|NCT05789745|469120829|FG000|Overall Study|Withdrawal by Subject|0|||
130315082|NCT05789745|469120830|FG001|Overall Study|Withdrawal by Subject|0|||
130051815|NCT00718419|468145612|FG000|Overall Study|Sponsor decision|0|||
130051816|NCT00718419|468145613|FG001|Overall Study|Sponsor decision|1|||
130051817|NCT00718419|468145612|FG000|Overall Study|Withdrawal by Subject|0|||
130051818|NCT00718419|468145613|FG001|Overall Study|Withdrawal by Subject|5|||
130051819|NCT00718419|468145612|FG000|Overall Study|Progressive Disease|7|||
130051820|NCT00718419|468145613|FG001|Overall Study|Progressive Disease|25|||
130051821|NCT00718419|468145612|FG000|Overall Study|Death Due to Progressive Disease|2|||
130315083|NCT05789745|469120831|FG002|Overall Study|Withdrawal by Subject|0|||
130315084|NCT05789745|469120832|FG003|Overall Study|Withdrawal by Subject|0|||
130315085|NCT05789745|469120833|FG004|Overall Study|Withdrawal by Subject|1|||
130315086|NCT02634333|469120836|FG000|Overall Study|Completed out of Window|3|||
130315087|NCT02634333|469120837|FG001|Overall Study|Completed out of Window|2|||
130315088|NCT02634333|469120836|FG000|Overall Study|Missed Visit|5|||
130315089|NCT02634333|469120837|FG001|Overall Study|Missed Visit|2|||
130315090|NCT02634333|469120836|FG000|Overall Study|Lost to Follow-up|12|||
130315091|NCT02634333|469120837|FG001|Overall Study|Lost to Follow-up|7|||
130315092|NCT02634333|469120836|FG000|Overall Study|Withdrawal by Subject|9|||
130315093|NCT02634333|469120837|FG001|Overall Study|Withdrawal by Subject|13|||
130315094|NCT02634333|469120836|FG000|Overall Study|Death|11|||
130315095|NCT02634333|469120837|FG001|Overall Study|Death|8|||
130315096|NCT04537793|469120838|FG000|Part B (24 Weeks)|Adverse Event|0|||
130315097|NCT04537793|469120839|FG001|Part B (24 Weeks)|Adverse Event|1|||
130315098|NCT01255423|469120840|FG000|Overall Study|Abnormal Laboratory value|3|||
130315099|NCT01255423|469120841|FG001|Overall Study|Abnormal Laboratory value|2|||
130315100|NCT01255423|469120840|FG000|Overall Study|Use of prohibited medications|0|||
130315101|NCT01255423|469120841|FG001|Overall Study|Use of prohibited medications|1|||
130315102|NCT05470387|469120842|FG000|Overall Study|Protocol Violation|0|||
130315103|NCT05470387|469120843|FG001|Overall Study|Protocol Violation|3|||
130315104|NCT01858363|469120848|FG000|Overall Study|Death|35|||
130315105|NCT01858363|469120849|FG001|Overall Study|Death|9|||
130315106|NCT01858363|469120848|FG000|Overall Study|Withdrawal by Subject|28|||
130315107|NCT01858363|469120849|FG001|Overall Study|Withdrawal by Subject|14|||
130315108|NCT01858363|469120848|FG000|Overall Study|Lost to Follow-up|13|||
130315109|NCT01858363|469120849|FG001|Overall Study|Lost to Follow-up|3|||
130315110|NCT00101686|469120850|FG000|Overall Study|Progressive Disease|37|||
130315111|NCT00101686|469120851|FG001|Overall Study|Progressive Disease|28|||
130315112|NCT00101686|469120852|FG002|Overall Study|Progressive Disease|37|||
130315113|NCT00101686|469120853|FG003|Overall Study|Progressive Disease|38|||
130315114|NCT00101686|469120854|FG004|Overall Study|Progressive Disease|28|||
130315115|NCT00101686|469120855|FG005|Overall Study|Progressive Disease|25|||
130315116|NCT00101686|469120856|FG006|Overall Study|Progressive Disease|5|||
130315117|NCT00101686|469120857|FG007|Overall Study|Progressive Disease|7|||
130315118|NCT00101686|469120858|FG008|Overall Study|Progressive Disease|10|||
130315119|NCT00101686|469120859|FG009|Overall Study|Progressive Disease|8|||
130315120|NCT00101686|469120850|FG000|Overall Study|initiation other anti-cancer treatment|4|||
130315121|NCT00101686|469120851|FG001|Overall Study|initiation other anti-cancer treatment|3|||
130315122|NCT00101686|469120852|FG002|Overall Study|initiation other anti-cancer treatment|4|||
130315123|NCT00101686|469120853|FG003|Overall Study|initiation other anti-cancer treatment|3|||
130315124|NCT00101686|469120854|FG004|Overall Study|initiation other anti-cancer treatment|1|||
130315125|NCT00101686|469120855|FG005|Overall Study|initiation other anti-cancer treatment|1|||
130315126|NCT00101686|469120856|FG006|Overall Study|initiation other anti-cancer treatment|2|||
130315127|NCT00101686|469120857|FG007|Overall Study|initiation other anti-cancer treatment|2|||
130315128|NCT00101686|469120858|FG008|Overall Study|initiation other anti-cancer treatment|3|||
130315129|NCT00101686|469120859|FG009|Overall Study|initiation other anti-cancer treatment|3|||
130315130|NCT00101686|469120850|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
130315131|NCT00101686|469120851|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
130315132|NCT00101686|469120852|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
130315133|NCT00101686|469120853|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
130315134|NCT00101686|469120854|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
130315135|NCT00101686|469120855|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
130315136|NCT00101686|469120856|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
130315137|NCT00101686|469120857|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
130315138|NCT00101686|469120858|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
130315139|NCT00101686|469120859|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
130315140|NCT00101686|469120850|FG000|Overall Study|unacceptable toxicity|3|||
130315141|NCT00101686|469120851|FG001|Overall Study|unacceptable toxicity|9|||
130315142|NCT00101686|469120852|FG002|Overall Study|unacceptable toxicity|10|||
130315143|NCT00101686|469120853|FG003|Overall Study|unacceptable toxicity|6|||
130315144|NCT00101686|469120854|FG004|Overall Study|unacceptable toxicity|16|||
130315145|NCT00101686|469120855|FG005|Overall Study|unacceptable toxicity|10|||
130315146|NCT00101686|469120856|FG006|Overall Study|unacceptable toxicity|4|||
130315147|NCT00101686|469120857|FG007|Overall Study|unacceptable toxicity|2|||
130315148|NCT00101686|469120858|FG008|Overall Study|unacceptable toxicity|1|||
130315149|NCT00101686|469120859|FG009|Overall Study|unacceptable toxicity|4|||
130315150|NCT00101686|469120850|FG000|Overall Study|Randomized but did not receive treament|1|||
130315151|NCT00101686|469120851|FG001|Overall Study|Randomized but did not receive treament|6|||
130315152|NCT00101686|469120852|FG002|Overall Study|Randomized but did not receive treament|2|||
130315153|NCT00101686|469120853|FG003|Overall Study|Randomized but did not receive treament|2|||
130315154|NCT00101686|469120854|FG004|Overall Study|Randomized but did not receive treament|2|||
130315155|NCT00101686|469120855|FG005|Overall Study|Randomized but did not receive treament|2|||
130315156|NCT00101686|469120856|FG006|Overall Study|Randomized but did not receive treament|0|||
130315157|NCT00101686|469120857|FG007|Overall Study|Randomized but did not receive treament|1|||
130315158|NCT00101686|469120858|FG008|Overall Study|Randomized but did not receive treament|0|||
130315159|NCT00101686|469120859|FG009|Overall Study|Randomized but did not receive treament|1|||
130315160|NCT00101686|469120850|FG000|Overall Study|intercurrent non-cancer related illness|0|||
130315161|NCT00101686|469120851|FG001|Overall Study|intercurrent non-cancer related illness|0|||
130315162|NCT00101686|469120852|FG002|Overall Study|intercurrent non-cancer related illness|2|||
130315163|NCT00101686|469120853|FG003|Overall Study|intercurrent non-cancer related illness|0|||
130315164|NCT00101686|469120854|FG004|Overall Study|intercurrent non-cancer related illness|1|||
130315165|NCT00101686|469120855|FG005|Overall Study|intercurrent non-cancer related illness|3|||
130315166|NCT00101686|469120856|FG006|Overall Study|intercurrent non-cancer related illness|1|||
130315167|NCT00101686|469120857|FG007|Overall Study|intercurrent non-cancer related illness|0|||
130315168|NCT00101686|469120858|FG008|Overall Study|intercurrent non-cancer related illness|1|||
130315169|NCT00101686|469120859|FG009|Overall Study|intercurrent non-cancer related illness|1|||
130315170|NCT00101686|469120850|FG000|Overall Study|Physician Decision|10|||
130315171|NCT00101686|469120851|FG001|Overall Study|Physician Decision|13|||
130315172|NCT00101686|469120852|FG002|Overall Study|Physician Decision|6|||
130315173|NCT00101686|469120853|FG003|Overall Study|Physician Decision|7|||
130315174|NCT00101686|469120854|FG004|Overall Study|Physician Decision|8|||
130315175|NCT00101686|469120855|FG005|Overall Study|Physician Decision|9|||
130315176|NCT00101686|469120856|FG006|Overall Study|Physician Decision|5|||
130315177|NCT00101686|469120857|FG007|Overall Study|Physician Decision|5|||
130315178|NCT00101686|469120858|FG008|Overall Study|Physician Decision|1|||
130315179|NCT00101686|469120859|FG009|Overall Study|Physician Decision|1|||
130315180|NCT00101686|469120850|FG000|Overall Study|Other|1|||
130315181|NCT00101686|469120851|FG001|Overall Study|Other|4|||
130315182|NCT00101686|469120852|FG002|Overall Study|Other|1|||
130315183|NCT00101686|469120853|FG003|Overall Study|Other|6|||
130315184|NCT00101686|469120854|FG004|Overall Study|Other|2|||
130315185|NCT00101686|469120855|FG005|Overall Study|Other|12|||
130315186|NCT00101686|469120856|FG006|Overall Study|Other|1|||
130315187|NCT00101686|469120857|FG007|Overall Study|Other|5|||
130315188|NCT00101686|469120858|FG008|Overall Study|Other|3|||
130315189|NCT00101686|469120859|FG009|Overall Study|Other|3|||
130315190|NCT00101686|469120850|FG000|Overall Study|Withdrawal by Subject|9|||
130315191|NCT00101686|469120851|FG001|Overall Study|Withdrawal by Subject|8|||
130315192|NCT00101686|469120852|FG002|Overall Study|Withdrawal by Subject|6|||
130315193|NCT00101686|469120853|FG003|Overall Study|Withdrawal by Subject|8|||
130315194|NCT00101686|469120854|FG004|Overall Study|Withdrawal by Subject|8|||
130315195|NCT00101686|469120855|FG005|Overall Study|Withdrawal by Subject|7|||
130315196|NCT00101686|469120856|FG006|Overall Study|Withdrawal by Subject|7|||
130315197|NCT00101686|469120857|FG007|Overall Study|Withdrawal by Subject|7|||
130315198|NCT00101686|469120858|FG008|Overall Study|Withdrawal by Subject|8|||
130315199|NCT00101686|469120859|FG009|Overall Study|Withdrawal by Subject|9|||
130315200|NCT02525471|469120860|FG000|Overall Study|Screen Failure|6|||
130315201|NCT02525471|469120860|FG000|Overall Study|Withdrawal by Subject|4|||
130315202|NCT02525471|469120860|FG000|Overall Study|Death|1|||
130315203|NCT00867165|469120861|FG000|Overall Study|Adverse Event|3|||
130315204|NCT00867165|469120862|FG001|Overall Study|Adverse Event|0|||
130315205|NCT00867165|469120861|FG000|Overall Study|Withdrawal by Subject|1|||
130315206|NCT00867165|469120862|FG001|Overall Study|Withdrawal by Subject|0|||
130315207|NCT00890825|469120863|FG000|Overall Study|Withdrawal by Subject|1|||
130315208|NCT00890825|469120864|FG001|Overall Study|Withdrawal by Subject|0|||
130315209|NCT00890825|469120863|FG000|Overall Study|Alive at data cut off (DCO)|13|||
130315210|NCT00890825|469120864|FG001|Overall Study|Alive at data cut off (DCO)|14|||
130315211|NCT01054456|469120865|FG000|Overall Study|Other|1|||
130315212|NCT03935126|469120868|FG000|Overall Study|Study termination by sponsor|3|||
130315213|NCT03649217|469120869|FG000|Overall Study|subject had severe ataxia not initially found|1|||
130315214|NCT03649217|469120869|FG000|Overall Study|subject had cognitive issues not initially found|1|||
130315215|NCT02520726|469120870|FG000|Overall Study|Lost to Follow-up|3|||
130315216|NCT02520726|469120871|FG001|Overall Study|Lost to Follow-up|2|||
130315217|NCT01506271|469120872|FG000|Overall Study|Progressive disease|0|||
130315218|NCT01506271|469120873|FG001|Overall Study|Progressive disease|1|||
130315219|NCT01506271|469120874|FG002|Overall Study|Progressive disease|0|||
130315220|NCT01506271|469120872|FG000|Overall Study|Protocol Violation|3|||
130315221|NCT01506271|469120873|FG001|Overall Study|Protocol Violation|1|||
130315222|NCT01506271|469120874|FG002|Overall Study|Protocol Violation|0|||
130315223|NCT01506271|469120872|FG000|Overall Study|Death|0|||
130315224|NCT01506271|469120873|FG001|Overall Study|Death|1|||
130315225|NCT01506271|469120874|FG002|Overall Study|Death|0|||
130315226|NCT01506271|469120872|FG000|Overall Study|Adverse Event|0|||
130315227|NCT01506271|469120873|FG001|Overall Study|Adverse Event|2|||
130315228|NCT01506271|469120874|FG002|Overall Study|Adverse Event|0|||
130315229|NCT01506271|469120872|FG000|Overall Study|Insufficient supply of study drug|1|||
130315230|NCT01506271|469120873|FG001|Overall Study|Insufficient supply of study drug|0|||
130315231|NCT01506271|469120874|FG002|Overall Study|Insufficient supply of study drug|0|||
130315232|NCT01506271|469120872|FG000|Overall Study|Withdrawal by Subject|0|||
130315233|NCT01506271|469120873|FG001|Overall Study|Withdrawal by Subject|1|||
130315234|NCT01506271|469120874|FG002|Overall Study|Withdrawal by Subject|1|||
130315235|NCT01506271|469120872|FG000|Overall Study|Lost to Follow-up|0|||
130315236|NCT01506271|469120873|FG001|Overall Study|Lost to Follow-up|1|||
130315237|NCT01506271|469120874|FG002|Overall Study|Lost to Follow-up|2|||
130315238|NCT02021565|469120880|FG000|Baseline Through Intervention|Death|0|||
130315239|NCT02021565|469120881|FG001|Baseline Through Intervention|Death|1|||
130315240|NCT02021565|469120880|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
130315241|NCT02021565|469120881|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
130315242|NCT02021565|469120880|FG000|Baseline Through Intervention|Protocol Violation|0|||
130315243|NCT02021565|469120881|FG001|Baseline Through Intervention|Protocol Violation|7|||
130315244|NCT02021565|469120880|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
130315245|NCT02021565|469120881|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
130315246|NCT02021565|469120880|FG000|3-month Follow-up|Death|3|||
130315247|NCT02021565|469120881|FG001|3-month Follow-up|Death|0|||
130315248|NCT02021565|469120880|FG000|3-month Follow-up|Withdrawal by Subject|4|||
130315249|NCT02021565|469120881|FG001|3-month Follow-up|Withdrawal by Subject|0|||
130315250|NCT02021565|469120880|FG000|3-month Follow-up|Protocol Violation|3|||
130315251|NCT02021565|469120881|FG001|3-month Follow-up|Protocol Violation|2|||
130315252|NCT03040141|469120882|FG000|Overall Study|Death|1|||
130315253|NCT03040141|469120883|FG001|Overall Study|Death|2|||
130315254|NCT03040141|469120884|FG002|Overall Study|Death|3|||
130315255|NCT03040141|469120882|FG000|Overall Study|Withdrawal by Subject|3|||
130315256|NCT03040141|469120883|FG001|Overall Study|Withdrawal by Subject|1|||
130315257|NCT03040141|469120884|FG002|Overall Study|Withdrawal by Subject|1|||
130315258|NCT03040141|469120882|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
130315259|NCT03040141|469120883|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
130315260|NCT03040141|469120884|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
130315261|NCT03040141|469120882|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
130315262|NCT03040141|469120883|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
130315263|NCT03040141|469120884|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
130315264|NCT03318549|469120885|FG000|Overall Study|Withdrawal by Subject|5|||
130315265|NCT03318549|469120886|FG001|Overall Study|Withdrawal by Subject|19|||
130315266|NCT03318549|469120887|FG002|Overall Study|Withdrawal by Subject|2|||
130315267|NCT03318549|469120888|FG003|Overall Study|Withdrawal by Subject|0|||
130315268|NCT03318549|469120889|FG004|Overall Study|Withdrawal by Subject|0|||
130315269|NCT03318549|469120890|FG005|Overall Study|Withdrawal by Subject|0|||
130315270|NCT03318549|469120891|FG006|Overall Study|Withdrawal by Subject|0|||
130315271|NCT03318549|469120885|FG000|Overall Study|Physician Decision|0|||
130315272|NCT03318549|469120886|FG001|Overall Study|Physician Decision|4|||
130315273|NCT03318549|469120887|FG002|Overall Study|Physician Decision|1|||
130315274|NCT03318549|469120888|FG003|Overall Study|Physician Decision|0|||
130315275|NCT03318549|469120889|FG004|Overall Study|Physician Decision|0|||
130315276|NCT03318549|469120890|FG005|Overall Study|Physician Decision|0|||
130315277|NCT03318549|469120891|FG006|Overall Study|Physician Decision|0|||
130315278|NCT03318549|469120885|FG000|Overall Study|Lost to Follow-up|0|||
130315279|NCT03318549|469120886|FG001|Overall Study|Lost to Follow-up|3|||
130315280|NCT03318549|469120887|FG002|Overall Study|Lost to Follow-up|3|||
130315281|NCT03318549|469120888|FG003|Overall Study|Lost to Follow-up|0|||
130315282|NCT03318549|469120889|FG004|Overall Study|Lost to Follow-up|0|||
130315283|NCT03318549|469120890|FG005|Overall Study|Lost to Follow-up|0|||
130315284|NCT03318549|469120891|FG006|Overall Study|Lost to Follow-up|0|||
130315285|NCT01391663|469120892|FG000|Overall Study|Withdrawal by Subject|0|||
130315286|NCT01391663|469120893|FG001|Overall Study|Withdrawal by Subject|0|||
130315287|NCT01391663|469120894|FG002|Overall Study|Withdrawal by Subject|1|||
130315288|NCT01391663|469120895|FG003|Overall Study|Withdrawal by Subject|0|||
130315289|NCT00462306|469120896|FG000|Overall Study|insufficient data|0|||
130315290|NCT00462306|469120897|FG001|Overall Study|insufficient data|13|||
130315291|NCT03515824|469120898|FG000|Overall Study|Death|3|||
130315292|NCT03515824|469120899|FG001|Overall Study|Death|2|||
130315293|NCT03515824|469120900|FG002|Overall Study|Death|6|||
129800086|NCT05098938|467235301|FG001|Overall Study|lack of compliance|19|||
129800087|NCT05098938|467235300|FG000|Overall Study|Lost to Follow-up|37|||
129800088|NCT05098938|467235301|FG001|Overall Study|Lost to Follow-up|40|||
129800089|NCT05098938|467235300|FG000|Overall Study|Lost in treatment period|17|||
129800090|NCT05098938|467235301|FG001|Overall Study|Lost in treatment period|13|||
129800091|NCT05098938|467235300|FG000|Overall Study|Met an exclusion criterion|0|||
129800092|NCT05098938|467235301|FG001|Overall Study|Met an exclusion criterion|3|||
130315294|NCT03515824|469120901|FG003|Overall Study|Death|0|||
130315295|NCT03515824|469120898|FG000|Overall Study|Lost to Follow-up|0|||
130315296|NCT03515824|469120899|FG001|Overall Study|Lost to Follow-up|1|||
130315297|NCT03515824|469120900|FG002|Overall Study|Lost to Follow-up|1|||
130315298|NCT03515824|469120901|FG003|Overall Study|Lost to Follow-up|0|||
130315299|NCT03515824|469120898|FG000|Overall Study|Study terminated by sponsor|0|||
130315300|NCT03515824|469120899|FG001|Overall Study|Study terminated by sponsor|1|||
130315301|NCT03515824|469120900|FG002|Overall Study|Study terminated by sponsor|6|||
130315302|NCT03515824|469120901|FG003|Overall Study|Study terminated by sponsor|0|||
130315303|NCT03515824|469120898|FG000|Overall Study|Status not recorded|0|||
130315304|NCT03515824|469120899|FG001|Overall Study|Status not recorded|0|||
130315305|NCT03515824|469120900|FG002|Overall Study|Status not recorded|2|||
130315306|NCT03515824|469120901|FG003|Overall Study|Status not recorded|0|||
130315307|NCT00920855|469120902|FG000|Overall Study|Adverse Event|1|||
130315308|NCT00920855|469120903|FG001|Overall Study|Adverse Event|1|||
130315309|NCT00920855|469120904|FG002|Overall Study|Adverse Event|4|||
130315310|NCT00920855|469120902|FG000|Overall Study|Withdrawal by Subject|2|||
130315311|NCT00920855|469120903|FG001|Overall Study|Withdrawal by Subject|1|||
130315312|NCT00920855|469120904|FG002|Overall Study|Withdrawal by Subject|6|||
130315313|NCT00920855|469120902|FG000|Overall Study|Disease progression|2|||
130315314|NCT00920855|469120903|FG001|Overall Study|Disease progression|1|||
130315315|NCT00920855|469120904|FG002|Overall Study|Disease progression|10|||
130315316|NCT00920855|469120902|FG000|Overall Study|Noncompliance to study medication|0|||
130315317|NCT00920855|469120903|FG001|Overall Study|Noncompliance to study medication|0|||
130315318|NCT00920855|469120904|FG002|Overall Study|Noncompliance to study medication|1|||
130315319|NCT00920855|469120902|FG000|Overall Study|Response plateau; started maintenance|0|||
130315320|NCT00920855|469120903|FG001|Overall Study|Response plateau; started maintenance|0|||
130315321|NCT00920855|469120904|FG002|Overall Study|Response plateau; started maintenance|1|||
130315322|NCT00539994|469120906|FG000|Overall Study|Lost to Follow-up|2|||
130315323|NCT00539994|469120907|FG001|Overall Study|Lost to Follow-up|1|||
130315324|NCT00539994|469120908|FG002|Overall Study|Lost to Follow-up|0|||
130315325|NCT00539994|469120906|FG000|Overall Study|Withdrawal by Subject|1|||
130315326|NCT00539994|469120907|FG001|Overall Study|Withdrawal by Subject|0|||
130315327|NCT00539994|469120908|FG002|Overall Study|Withdrawal by Subject|1|||
130315328|NCT00539994|469120906|FG000|Overall Study|Physician Decision|0|||
130315329|NCT00539994|469120907|FG001|Overall Study|Physician Decision|0|||
130315330|NCT00539994|469120908|FG002|Overall Study|Physician Decision|1|||
130315331|NCT00510835|469120910|FG000|Overall Study|Withdrawal by Subject|6|||
130315332|NCT00510835|469120911|FG001|Overall Study|Withdrawal by Subject|2|||
130315333|NCT00510835|469120912|FG002|Overall Study|Withdrawal by Subject|2|||
130315334|NCT03084796|469120913|FG000|Overall Study|Adverse Event|4|||
130315335|NCT03084796|469120914|FG001|Overall Study|Adverse Event|5|||
130315336|NCT03084796|469120915|FG002|Overall Study|Adverse Event|6|||
130315337|NCT03084796|469120916|FG003|Overall Study|Adverse Event|2|||
130315338|NCT03084796|469120917|FG004|Overall Study|Adverse Event|3|||
130315339|NCT03084796|469120918|FG005|Overall Study|Adverse Event|5|||
130315340|NCT03084796|469120913|FG000|Overall Study|Withdrawal by Subject|3|||
130315341|NCT03084796|469120914|FG001|Overall Study|Withdrawal by Subject|5|||
130315342|NCT03084796|469120915|FG002|Overall Study|Withdrawal by Subject|2|||
130315343|NCT03084796|469120916|FG003|Overall Study|Withdrawal by Subject|1|||
130315344|NCT03084796|469120917|FG004|Overall Study|Withdrawal by Subject|3|||
130315345|NCT03084796|469120918|FG005|Overall Study|Withdrawal by Subject|0|||
130315346|NCT03084796|469120913|FG000|Overall Study|Protocol Violation|0|||
130315347|NCT03084796|469120914|FG001|Overall Study|Protocol Violation|0|||
130315348|NCT03084796|469120915|FG002|Overall Study|Protocol Violation|1|||
130315349|NCT03084796|469120916|FG003|Overall Study|Protocol Violation|0|||
130315350|NCT03084796|469120917|FG004|Overall Study|Protocol Violation|1|||
130315351|NCT03084796|469120918|FG005|Overall Study|Protocol Violation|1|||
130315352|NCT03084796|469120913|FG000|Overall Study|Lack of Efficacy|0|||
130315353|NCT03084796|469120914|FG001|Overall Study|Lack of Efficacy|0|||
130315354|NCT03084796|469120915|FG002|Overall Study|Lack of Efficacy|1|||
130315355|NCT03084796|469120916|FG003|Overall Study|Lack of Efficacy|0|||
130315356|NCT03084796|469120917|FG004|Overall Study|Lack of Efficacy|1|||
129800093|NCT05098938|467235300|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
130315357|NCT03084796|469120918|FG005|Overall Study|Lack of Efficacy|0|||
130315358|NCT03084796|469120913|FG000|Overall Study|Lost to Follow-up|0|||
130315359|NCT03084796|469120914|FG001|Overall Study|Lost to Follow-up|0|||
130315360|NCT03084796|469120915|FG002|Overall Study|Lost to Follow-up|1|||
130315361|NCT03084796|469120916|FG003|Overall Study|Lost to Follow-up|1|||
130315362|NCT03084796|469120917|FG004|Overall Study|Lost to Follow-up|3|||
130315363|NCT03084796|469120918|FG005|Overall Study|Lost to Follow-up|1|||
130315364|NCT03084796|469120913|FG000|Overall Study|Randomization error|0|||
130315365|NCT03084796|469120914|FG001|Overall Study|Randomization error|0|||
130315366|NCT03084796|469120915|FG002|Overall Study|Randomization error|1|||
130315367|NCT03084796|469120916|FG003|Overall Study|Randomization error|0|||
130315368|NCT03084796|469120917|FG004|Overall Study|Randomization error|0|||
130315369|NCT03084796|469120918|FG005|Overall Study|Randomization error|0|||
130315370|NCT05470985|469120919|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
130315371|NCT05470985|469120920|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
130315372|NCT05470985|469120919|FG000|Double Blind Treatment Period|Physician Decision|0|||
130315373|NCT05470985|469120920|FG001|Double Blind Treatment Period|Physician Decision|1|||
130315374|NCT05470985|469120919|FG000|Long Term Extension|Adverse Event|0|||
130315375|NCT05470985|469120920|FG001|Long Term Extension|Adverse Event|1|||
130315376|NCT05470985|469120919|FG000|Long Term Extension|Study terminated by sponsor|2|||
130315377|NCT05470985|469120920|FG001|Long Term Extension|Study terminated by sponsor|0|||
130315378|NCT02741245|469120924|FG000|Overall Study|Adverse Event|0|||
130315379|NCT02741245|469120925|FG001|Overall Study|Adverse Event|0|||
130315380|NCT02741245|469120926|FG002|Overall Study|Adverse Event|0|||
130315381|NCT02741245|469120927|FG003|Overall Study|Adverse Event|2|||
130315382|NCT02741245|469120928|FG004|Overall Study|Adverse Event|2|||
130315383|NCT02741245|469120924|FG000|Overall Study|Protocol Violation|0|||
130315384|NCT02741245|469120925|FG001|Overall Study|Protocol Violation|1|||
130315385|NCT02741245|469120926|FG002|Overall Study|Protocol Violation|0|||
130315386|NCT02741245|469120927|FG003|Overall Study|Protocol Violation|1|||
130315387|NCT02741245|469120928|FG004|Overall Study|Protocol Violation|0|||
130315388|NCT02741245|469120924|FG000|Overall Study|Withdrawal by Subject|0|||
130315389|NCT02741245|469120925|FG001|Overall Study|Withdrawal by Subject|0|||
130315390|NCT02741245|469120926|FG002|Overall Study|Withdrawal by Subject|0|||
130315391|NCT02741245|469120927|FG003|Overall Study|Withdrawal by Subject|1|||
130315392|NCT02741245|469120928|FG004|Overall Study|Withdrawal by Subject|0|||
130315393|NCT00607087|469120930|FG000|Overall Study|Withdrawal by Subject|9|||
130315394|NCT00607087|469120931|FG001|Overall Study|Withdrawal by Subject|4|||
130315395|NCT00607087|469120932|FG002|Overall Study|Withdrawal by Subject|4|||
130315396|NCT00607087|469120930|FG000|Overall Study|Adverse Event|3|||
130315397|NCT00607087|469120931|FG001|Overall Study|Adverse Event|2|||
130315398|NCT00607087|469120932|FG002|Overall Study|Adverse Event|3|||
130315399|NCT00607087|469120930|FG000|Overall Study|Other reason|1|||
130315400|NCT00607087|469120931|FG001|Overall Study|Other reason|5|||
130315401|NCT00607087|469120932|FG002|Overall Study|Other reason|2|||
130315402|NCT00607087|469120930|FG000|Overall Study|Poor compliance to protocol|1|||
130315403|NCT00607087|469120931|FG001|Overall Study|Poor compliance to protocol|0|||
130315404|NCT00607087|469120932|FG002|Overall Study|Poor compliance to protocol|1|||
130315405|NCT00607087|469120930|FG000|Overall Study|Lost to Follow-up|1|||
130315406|NCT00607087|469120931|FG001|Overall Study|Lost to Follow-up|0|||
130315407|NCT00607087|469120932|FG002|Overall Study|Lost to Follow-up|0|||
130315408|NCT00607087|469120930|FG000|Period 1|Withdrawal by Subject|7|||
130315409|NCT00607087|469120931|FG001|Period 1|Withdrawal by Subject|2|||
130315410|NCT00607087|469120932|FG002|Period 1|Withdrawal by Subject|3|||
130315411|NCT00607087|469120930|FG000|Period 1|Adverse Event|3|||
130315412|NCT00607087|469120931|FG001|Period 1|Adverse Event|0|||
130315413|NCT00607087|469120932|FG002|Period 1|Adverse Event|0|||
130315414|NCT00607087|469120930|FG000|Period 1|Poor compliance to protocol|1|||
130315415|NCT00607087|469120931|FG001|Period 1|Poor compliance to protocol|0|||
130315416|NCT00607087|469120932|FG002|Period 1|Poor compliance to protocol|0|||
130315417|NCT00607087|469120930|FG000|Period 1|Lost to Follow-up|1|||
130315418|NCT00607087|469120931|FG001|Period 1|Lost to Follow-up|0|||
130315419|NCT00607087|469120932|FG002|Period 1|Lost to Follow-up|0|||
130315420|NCT00607087|469120930|FG000|Period 1|Other reason|0|||
130315421|NCT00607087|469120931|FG001|Period 1|Other reason|4|||
130315422|NCT00607087|469120932|FG002|Period 1|Other reason|2|||
130315423|NCT00607087|469120930|FG000|Period 2|Withdrawal by Subject|0|||
130315424|NCT00607087|469120931|FG001|Period 2|Withdrawal by Subject|1|||
130315425|NCT00607087|469120932|FG002|Period 2|Withdrawal by Subject|1|||
130315426|NCT00607087|469120930|FG000|Period 2|Other reason|1|||
130315427|NCT00607087|469120931|FG001|Period 2|Other reason|1|||
130315428|NCT00607087|469120932|FG002|Period 2|Other reason|0|||
130315429|NCT00607087|469120930|FG000|Period 2|Adverse Event|0|||
130315430|NCT00607087|469120931|FG001|Period 2|Adverse Event|1|||
130315431|NCT00607087|469120932|FG002|Period 2|Adverse Event|3|||
130315432|NCT00607087|469120930|FG000|Period 2|Poor compliance to protocol|0|||
130315433|NCT00607087|469120931|FG001|Period 2|Poor compliance to protocol|0|||
130315434|NCT00607087|469120932|FG002|Period 2|Poor compliance to protocol|1|||
130315435|NCT00607087|469120930|FG000|Period 3|Withdrawal by Subject|2|||
130051822|NCT00718419|468145613|FG001|Overall Study|Death Due to Progressive Disease|0|||
130051823|NCT00718419|468145612|FG000|Overall Study|Death Due to Study Drug Related|0|||
130051824|NCT00718419|468145613|FG001|Overall Study|Death Due to Study Drug Related|1|||
130051825|NCT00718419|468145612|FG000|Overall Study|Death Due to Adverse Events|1|||
130315436|NCT00607087|469120931|FG001|Period 3|Withdrawal by Subject|1|||
130315437|NCT00607087|469120932|FG002|Period 3|Withdrawal by Subject|0|||
130315438|NCT00607087|469120930|FG000|Period 3|Adverse Event|0|||
130315439|NCT00607087|469120931|FG001|Period 3|Adverse Event|1|||
130315440|NCT00607087|469120932|FG002|Period 3|Adverse Event|0|||
130315441|NCT00154297|469120934|FG000|Overall Study|Death|5|||
130315442|NCT00154297|469120935|FG001|Overall Study|Death|2|||
130315443|NCT00154297|469120934|FG000|Overall Study|Withdrawal by Subject|0|||
130315444|NCT00154297|469120935|FG001|Overall Study|Withdrawal by Subject|5|||
130315445|NCT00154297|469120934|FG000|Overall Study|Lost to Follow-up|3|||
130051826|NCT00718419|468145613|FG001|Overall Study|Death Due to Adverse Events|0|||
130051827|NCT05058664|468145616|FG000|Overall Study|No follow-up data provided|4|||
130051828|NCT05058664|468145617|FG001|Overall Study|No follow-up data provided|0|||
130051829|NCT05058664|468145618|FG002|Overall Study|No follow-up data provided|2|||
130051830|NCT05058664|468145616|FG000|Overall Study|Withdrawal by Subject|0|||
130051831|NCT05058664|468145617|FG001|Overall Study|Withdrawal by Subject|0|||
130051832|NCT05058664|468145618|FG002|Overall Study|Withdrawal by Subject|1|||
130051833|NCT01879618|468145619|FG000|Overall Study|Does not meet entrance criteria|1|||
130315446|NCT00154297|469120935|FG001|Overall Study|Lost to Follow-up|0|||
130315447|NCT00650767|469120936|FG000|Overall Study|Adverse Event|0|||
130315448|NCT00650767|469120937|FG001|Overall Study|Adverse Event|3|||
130315449|NCT00650767|469120938|FG002|Overall Study|Adverse Event|10|||
130315450|NCT00650767|469120939|FG003|Overall Study|Adverse Event|8|||
130315451|NCT00650767|469120936|FG000|Overall Study|Death|1|||
130315452|NCT00650767|469120937|FG001|Overall Study|Death|0|||
130315453|NCT00650767|469120938|FG002|Overall Study|Death|0|||
130315454|NCT00650767|469120939|FG003|Overall Study|Death|0|||
130315455|NCT00650767|469120936|FG000|Overall Study|Withdrawal by Subject|2|||
130315456|NCT00650767|469120937|FG001|Overall Study|Withdrawal by Subject|4|||
130315457|NCT00650767|469120938|FG002|Overall Study|Withdrawal by Subject|3|||
130315458|NCT00650767|469120939|FG003|Overall Study|Withdrawal by Subject|3|||
130315459|NCT00650767|469120936|FG000|Overall Study|Lost to Follow-up|1|||
130315460|NCT00650767|469120937|FG001|Overall Study|Lost to Follow-up|1|||
130315461|NCT00650767|469120938|FG002|Overall Study|Lost to Follow-up|1|||
130315462|NCT00650767|469120939|FG003|Overall Study|Lost to Follow-up|0|||
130315463|NCT00650767|469120936|FG000|Overall Study|Other|1|||
130315464|NCT00650767|469120937|FG001|Overall Study|Other|1|||
130315465|NCT00650767|469120938|FG002|Overall Study|Other|0|||
130315466|NCT00650767|469120939|FG003|Overall Study|Other|0|||
130315467|NCT01774799|469120940|FG000|Overall Study|Lost to Follow-up|1|||
130315468|NCT01774799|469120941|FG001|Overall Study|Lost to Follow-up|1|||
130315469|NCT01774799|469120942|FG002|Overall Study|Lost to Follow-up|0|||
130315470|NCT01774799|469120943|FG003|Overall Study|Lost to Follow-up|0|||
130315471|NCT00990106|469120944|FG000|Overall Study|"too busy to continue"|1|||
130315472|NCT00990106|469120945|FG001|Overall Study|"too busy to continue"|2|||
130315473|NCT00990106|469120944|FG000|Overall Study|Lost to Follow-up|1|||
130315474|NCT00990106|469120945|FG001|Overall Study|Lost to Follow-up|3|||
130315475|NCT00990106|469120944|FG000|Overall Study|Withdrawal by Subject|2|||
130315476|NCT00990106|469120945|FG001|Overall Study|Withdrawal by Subject|1|||
130315477|NCT00990106|469120944|FG000|Overall Study|opted for open label prazosin|1|||
130315478|NCT00990106|469120945|FG001|Overall Study|opted for open label prazosin|1|||
130315479|NCT00990106|469120944|FG000|Overall Study|relocation/deployment|4|||
130315480|NCT00990106|469120945|FG001|Overall Study|relocation/deployment|1|||
130315481|NCT00990106|469120944|FG000|Overall Study|started exclusionary medication|0|||
130051834|NCT01879618|468145619|FG000|Overall Study|Withdrawal by Subject|1|||
130051835|NCT01879618|468145619|FG000|Overall Study|Surgery;changed schedule; not available|8|||
130051836|NCT01879618|468145619|FG000|Overall Study|Protocol Violation|6|||
130051837|NCT01879618|468145619|FG000|Overall Study|Adverse Event|5|||
130051838|NCT00938327|468145620|FG000|Overall Study|Adverse Event|2|||
130051839|NCT00938327|468145620|FG000|Overall Study|Protocol Violation|1|||
130315482|NCT00990106|469120945|FG001|Overall Study|started exclusionary medication|1|||
130051840|NCT00938327|468145620|FG000|Overall Study|Withdrawal by Subject|4|||
130051841|NCT00938327|468145620|FG000|Overall Study|Lost to Follow-up|37|||
130315483|NCT00990106|469120944|FG000|Overall Study|planned major surgery|0|||
130315484|NCT00990106|469120945|FG001|Overall Study|planned major surgery|1|||
130315485|NCT00990106|469120944|FG000|Overall Study|scheduling conflicts|0|||
130315486|NCT00990106|469120945|FG001|Overall Study|scheduling conflicts|2|||
130315487|NCT03064490|469120948|FG000|Overall Study|Physician Decision|5|||
130315488|NCT04158583|469120952|FG000|Overall Study|Withdrawal by Subject|1|||
130315489|NCT04158583|469120953|FG001|Overall Study|Withdrawal by Subject|1|||
129800094|NCT05098938|467235301|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
130315490|NCT04158583|469120954|FG002|Overall Study|Withdrawal by Subject|0|||
130315491|NCT04158583|469120955|FG003|Overall Study|Withdrawal by Subject|0|||
130315492|NCT04158583|469120956|FG004|Overall Study|Withdrawal by Subject|1|||
130315493|NCT04158583|469120957|FG005|Overall Study|Withdrawal by Subject|0|||
130315494|NCT04158583|469120958|FG006|Overall Study|Withdrawal by Subject|0|||
130315495|NCT04158583|469120959|FG007|Overall Study|Withdrawal by Subject|0|||
130315496|NCT04158583|469120960|FG008|Overall Study|Withdrawal by Subject|2|||
130315497|NCT04158583|469120961|FG009|Overall Study|Withdrawal by Subject|0|||
130315498|NCT04158583|469120952|FG000|Overall Study|Study Terminated by Sponsor|0|||
130315499|NCT04158583|469120953|FG001|Overall Study|Study Terminated by Sponsor|0|||
130315500|NCT04158583|469120954|FG002|Overall Study|Study Terminated by Sponsor|0|||
130315501|NCT04158583|469120955|FG003|Overall Study|Study Terminated by Sponsor|1|||
130315502|NCT04158583|469120956|FG004|Overall Study|Study Terminated by Sponsor|0|||
130315503|NCT04158583|469120957|FG005|Overall Study|Study Terminated by Sponsor|0|||
130315504|NCT04158583|469120958|FG006|Overall Study|Study Terminated by Sponsor|0|||
130315505|NCT04158583|469120959|FG007|Overall Study|Study Terminated by Sponsor|0|||
130315506|NCT04158583|469120960|FG008|Overall Study|Study Terminated by Sponsor|0|||
130315507|NCT04158583|469120961|FG009|Overall Study|Study Terminated by Sponsor|0|||
130315508|NCT04158583|469120952|FG000|Overall Study|Progressive Disease|1|||
130315509|NCT04158583|469120953|FG001|Overall Study|Progressive Disease|0|||
130315510|NCT04158583|469120954|FG002|Overall Study|Progressive Disease|3|||
130315511|NCT04158583|469120955|FG003|Overall Study|Progressive Disease|5|||
130315512|NCT04158583|469120956|FG004|Overall Study|Progressive Disease|0|||
130315513|NCT04158583|469120957|FG005|Overall Study|Progressive Disease|1|||
130315514|NCT04158583|469120958|FG006|Overall Study|Progressive Disease|6|||
130315515|NCT04158583|469120959|FG007|Overall Study|Progressive Disease|2|||
130315516|NCT04158583|469120960|FG008|Overall Study|Progressive Disease|1|||
130315517|NCT04158583|469120961|FG009|Overall Study|Progressive Disease|2|||
130315518|NCT04158583|469120952|FG000|Overall Study|Lost to Follow-up|0|||
130315519|NCT04158583|469120953|FG001|Overall Study|Lost to Follow-up|0|||
130315520|NCT04158583|469120954|FG002|Overall Study|Lost to Follow-up|1|||
130315521|NCT04158583|469120955|FG003|Overall Study|Lost to Follow-up|1|||
130315522|NCT04158583|469120956|FG004|Overall Study|Lost to Follow-up|1|||
130315523|NCT04158583|469120957|FG005|Overall Study|Lost to Follow-up|0|||
130315524|NCT04158583|469120958|FG006|Overall Study|Lost to Follow-up|0|||
130315525|NCT04158583|469120959|FG007|Overall Study|Lost to Follow-up|0|||
130315526|NCT04158583|469120960|FG008|Overall Study|Lost to Follow-up|0|||
130315527|NCT04158583|469120961|FG009|Overall Study|Lost to Follow-up|0|||
130315528|NCT04158583|469120952|FG000|Overall Study|Due To Patient Status|0|||
130315529|NCT04158583|469120953|FG001|Overall Study|Due To Patient Status|0|||
130315530|NCT04158583|469120954|FG002|Overall Study|Due To Patient Status|0|||
130315531|NCT04158583|469120955|FG003|Overall Study|Due To Patient Status|0|||
130315532|NCT04158583|469120956|FG004|Overall Study|Due To Patient Status|0|||
130315533|NCT04158583|469120957|FG005|Overall Study|Due To Patient Status|0|||
130315534|NCT04158583|469120958|FG006|Overall Study|Due To Patient Status|0|||
130315535|NCT04158583|469120959|FG007|Overall Study|Due To Patient Status|0|||
130315536|NCT04158583|469120960|FG008|Overall Study|Due To Patient Status|1|||
130315537|NCT04158583|469120961|FG009|Overall Study|Due To Patient Status|0|||
130315538|NCT04158583|469120952|FG000|Overall Study|Death|3|||
130315539|NCT04158583|469120953|FG001|Overall Study|Death|4|||
130315540|NCT04158583|469120954|FG002|Overall Study|Death|2|||
130315541|NCT04158583|469120955|FG003|Overall Study|Death|2|||
130315542|NCT04158583|469120956|FG004|Overall Study|Death|4|||
130315543|NCT04158583|469120957|FG005|Overall Study|Death|3|||
130315544|NCT04158583|469120958|FG006|Overall Study|Death|5|||
130315545|NCT04158583|469120959|FG007|Overall Study|Death|2|||
130315546|NCT04158583|469120960|FG008|Overall Study|Death|0|||
130315547|NCT04158583|469120961|FG009|Overall Study|Death|1|||
130315548|NCT04158583|469120952|FG000|Overall Study|Clinical Progression Disease|0|||
130315549|NCT04158583|469120953|FG001|Overall Study|Clinical Progression Disease|0|||
130315550|NCT04158583|469120954|FG002|Overall Study|Clinical Progression Disease|0|||
130315551|NCT04158583|469120955|FG003|Overall Study|Clinical Progression Disease|1|||
130315552|NCT04158583|469120956|FG004|Overall Study|Clinical Progression Disease|0|||
130051842|NCT00938327|468145620|FG000|Overall Study|2nd dose received outside of the study|7|||
130051843|NCT00938327|468145620|FG000|Overall Study|Vaccine not received as out of stock|9|||
130051844|NCT02691247|468145621|FG000|Overall Study|Withdrawal by Subject|1|||
130051845|NCT02691247|468145622|FG001|Overall Study|Withdrawal by Subject|2|||
130051846|NCT02691247|468145623|FG002|Overall Study|Withdrawal by Subject|2|||
130051847|NCT02691247|468145621|FG000|Overall Study|Lost to Follow-up|2|||
130051848|NCT02691247|468145622|FG001|Overall Study|Lost to Follow-up|0|||
130051849|NCT02691247|468145623|FG002|Overall Study|Lost to Follow-up|1|||
130051850|NCT02552355|468145624|FG000|Overall Study|Adverse Event|0|||
130051851|NCT02552355|468145625|FG001|Overall Study|Adverse Event|2|||
130051852|NCT02552355|468145626|FG002|Overall Study|Adverse Event|2|||
130051853|NCT02552355|468145627|FG003|Overall Study|Adverse Event|0|||
130051854|NCT02552355|468145624|FG000|Overall Study|Withdrawal by Subject|0|||
130051855|NCT02552355|468145625|FG001|Overall Study|Withdrawal by Subject|0|||
130051856|NCT02552355|468145626|FG002|Overall Study|Withdrawal by Subject|0|||
130051857|NCT02552355|468145627|FG003|Overall Study|Withdrawal by Subject|1|||
130051858|NCT01519245|468145628|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
130051859|NCT01519245|468145629|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
130051860|NCT00933335|468145630|FG000|Overall Study|Lost to Follow-up|1|||
130051861|NCT00933335|468145631|FG001|Overall Study|Lost to Follow-up|3|||
130051862|NCT00933335|468145630|FG000|Overall Study|Withdrawal by Subject|0|||
130051863|NCT00933335|468145631|FG001|Overall Study|Withdrawal by Subject|1|||
130051864|NCT00933335|468145630|FG000|Overall Study|Progressive Disease|0|||
130051865|NCT00933335|468145631|FG001|Overall Study|Progressive Disease|11|||
130051866|NCT00933335|468145630|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
130051867|NCT00933335|468145631|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
130051868|NCT00933335|468145630|FG000|Overall Study|Co-morbid Illness|1|||
130051869|NCT00933335|468145631|FG001|Overall Study|Co-morbid Illness|0|||
130051870|NCT02275026|468145636|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
130051871|NCT02275026|468145636|FG000|Overall Study|Withdrawal by Subject|4|||
130051872|NCT02275026|468145636|FG000|Overall Study|Ineligible due to medical history|13|||
130051873|NCT02275026|468145636|FG000|Overall Study|MRI malfunction precluded testing|1|||
130051874|NCT02275026|468145636|FG000|Overall Study|Ineligible after MRI findings|1|||
130315553|NCT04158583|469120957|FG005|Overall Study|Clinical Progression Disease|0|||
130315554|NCT04158583|469120958|FG006|Overall Study|Clinical Progression Disease|0|||
130315555|NCT04158583|469120959|FG007|Overall Study|Clinical Progression Disease|0|||
130315556|NCT04158583|469120960|FG008|Overall Study|Clinical Progression Disease|0|||
130315557|NCT04158583|469120961|FG009|Overall Study|Clinical Progression Disease|0|||
130315558|NCT04158583|469120952|FG000|Overall Study|Clinical Progression|0|||
130315559|NCT04158583|469120953|FG001|Overall Study|Clinical Progression|0|||
130315560|NCT04158583|469120954|FG002|Overall Study|Clinical Progression|0|||
130315561|NCT04158583|469120955|FG003|Overall Study|Clinical Progression|0|||
130315562|NCT04158583|469120956|FG004|Overall Study|Clinical Progression|1|||
130315563|NCT04158583|469120957|FG005|Overall Study|Clinical Progression|0|||
130315564|NCT04158583|469120958|FG006|Overall Study|Clinical Progression|2|||
130315565|NCT04158583|469120959|FG007|Overall Study|Clinical Progression|0|||
130315566|NCT04158583|469120960|FG008|Overall Study|Clinical Progression|0|||
130315567|NCT04158583|469120961|FG009|Overall Study|Clinical Progression|0|||
130315568|NCT04158583|469120952|FG000|Overall Study|Clinical Deterioration|0|||
130315569|NCT04158583|469120953|FG001|Overall Study|Clinical Deterioration|0|||
130315570|NCT04158583|469120954|FG002|Overall Study|Clinical Deterioration|0|||
130315571|NCT04158583|469120955|FG003|Overall Study|Clinical Deterioration|1|||
130315572|NCT04158583|469120956|FG004|Overall Study|Clinical Deterioration|0|||
130315573|NCT04158583|469120957|FG005|Overall Study|Clinical Deterioration|0|||
130315574|NCT04158583|469120958|FG006|Overall Study|Clinical Deterioration|0|||
130315575|NCT04158583|469120959|FG007|Overall Study|Clinical Deterioration|0|||
130315576|NCT04158583|469120960|FG008|Overall Study|Clinical Deterioration|0|||
129800095|NCT05098938|467235300|FG000|Overall Study|Physician Decision|25|||
130051875|NCT02275026|468145636|FG000|Overall Study|Lost to Follow-up|2|||
130051876|NCT02275026|468145636|FG000|Overall Study|Scanner failure|1|||
130051877|NCT05468086|468145639|FG000|Overall Study|Withdrawal by Subject|3|||
130315577|NCT04158583|469120961|FG009|Overall Study|Clinical Deterioration|1|||
130315578|NCT01871519|469120962|FG000|Overall Study|Death|26|||
130051878|NCT05468086|468145639|FG000|Overall Study|Subject was found ineligible after consent|1|||
130051879|NCT01095250|468145642|FG000|Overall Study|administrative reasons|8|||
130051880|NCT01095250|468145643|FG001|Overall Study|administrative reasons|10|||
130110656|NCT01629693|468365823|FG001|Overall Study|Withdrawal by Subject|2|||
130315579|NCT01871519|469120962|FG000|Overall Study|Lost to Follow-up|15|||
130315580|NCT01871519|469120962|FG000|Overall Study|Withdrawal by Subject|49|||
130315581|NCT02485704|469120963|FG000|Overall Study|Lost to Follow-up|4|||
130315582|NCT02485704|469120964|FG001|Overall Study|Lost to Follow-up|5|||
129800096|NCT05098938|467235301|FG001|Overall Study|Physician Decision|32|||
130051881|NCT01095250|468145644|FG002|Overall Study|administrative reasons|7|||
130051882|NCT01095250|468145645|FG003|Overall Study|administrative reasons|5|||
130315583|NCT02485704|469120963|FG000|Overall Study|Withdrawal by Subject|0|||
130315584|NCT02485704|469120964|FG001|Overall Study|Withdrawal by Subject|3|||
130315585|NCT02485704|469120963|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
130315586|NCT02485704|469120964|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
130315587|NCT01777776|469120965|FG000|Overall Study|Adverse Event|2|||
130315588|NCT01777776|469120966|FG001|Overall Study|Adverse Event|4|||
130315589|NCT01777776|469120967|FG002|Overall Study|Adverse Event|0|||
130315590|NCT01777776|469120968|FG003|Overall Study|Adverse Event|0|||
130315591|NCT01777776|469120965|FG000|Overall Study|Disease Progression|4|||
130315592|NCT01777776|469120966|FG001|Overall Study|Disease Progression|8|||
130315593|NCT01777776|469120967|FG002|Overall Study|Disease Progression|6|||
130315594|NCT01777776|469120968|FG003|Overall Study|Disease Progression|3|||
130315595|NCT01777776|469120965|FG000|Overall Study|Withdrawal by Subject|0|||
130315596|NCT01777776|469120966|FG001|Overall Study|Withdrawal by Subject|0|||
130315597|NCT01777776|469120967|FG002|Overall Study|Withdrawal by Subject|0|||
130315598|NCT01777776|469120968|FG003|Overall Study|Withdrawal by Subject|1|||
130315599|NCT04617782|469122508|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
130315600|NCT04617782|469122508|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
130315601|NCT04617782|469122508|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
130315602|NCT04617782|469122508|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
130315603|NCT04617782|469122508|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
130315604|NCT04617782|469122508|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
130315605|NCT04233801|469122518|FG000|Overall Study|Other than listed|0|||
130315606|NCT04233801|469122519|FG001|Overall Study|Other than listed|0|||
130315607|NCT04233801|469122520|FG002|Overall Study|Other than listed|1|||
130315608|NCT04233801|469122518|FG000|Overall Study|Withdrawal by Subject|0|||
130315609|NCT04233801|469122519|FG001|Overall Study|Withdrawal by Subject|2|||
130315610|NCT04233801|469122520|FG002|Overall Study|Withdrawal by Subject|3|||
130051883|NCT01095250|468145642|FG000|Overall Study|Withdrawal by Subject|0|||
130051884|NCT01095250|468145643|FG001|Overall Study|Withdrawal by Subject|0|||
130051885|NCT01095250|468145644|FG002|Overall Study|Withdrawal by Subject|1|||
130051886|NCT01095250|468145645|FG003|Overall Study|Withdrawal by Subject|0|||
130051887|NCT03596177|468145646|FG000|Single Blind Period|Withdrawal by Subject|1|||
130051888|NCT03596177|468145647|FG001|Single Blind Period|Withdrawal by Subject|1|||
130051889|NCT03596177|468145646|FG000|Single Blind Period|Other|1|||
130051890|NCT03596177|468145647|FG001|Single Blind Period|Other|0|||
130051891|NCT03596177|468145646|FG000|Double Blind Period|Withdrawal by Subject|0|||
130051892|NCT03596177|468145647|FG001|Double Blind Period|Withdrawal by Subject|1|||
130051893|NCT03596177|468145646|FG000|Double Blind Period|Other|0|||
130051894|NCT03596177|468145647|FG001|Double Blind Period|Other|4|||
130051895|NCT03596177|468145646|FG000|Double Blind Period|Death during safety follow-up|0|||
130051896|NCT03596177|468145647|FG001|Double Blind Period|Death during safety follow-up|1|||
130051897|NCT03860844|468145648|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
130051898|NCT03860844|468145649|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
130051899|NCT03860844|468145650|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
130051900|NCT03860844|468145648|FG000|Overall Study|Progressive disease|5|||
130051901|NCT03860844|468145649|FG001|Overall Study|Progressive disease|3|||
130051902|NCT03860844|468145650|FG002|Overall Study|Progressive disease|4|||
130051903|NCT03860844|468145648|FG000|Overall Study|Other, Not related to COVID-19|0|||
130051904|NCT03860844|468145649|FG001|Overall Study|Other, Not related to COVID-19|1|||
130051905|NCT03860844|468145650|FG002|Overall Study|Other, Not related to COVID-19|0|||
130051906|NCT01678807|468145651|FG000|Overall Study|Adverse Event|4|||
130051907|NCT01678807|468145652|FG001|Overall Study|Adverse Event|4|||
130051908|NCT01678807|468145653|FG002|Overall Study|Adverse Event|0|||
129800097|NCT05098938|467235300|FG000|Overall Study|Run in failure in treatment phase|1|||
129800098|NCT05098938|467235301|FG001|Overall Study|Run in failure in treatment phase|1|||
130315611|NCT00928486|469122521|FG000|Overall Study|Adverse Event|2|||
130315612|NCT00928486|469122521|FG000|Overall Study|Disease Progression|7|||
130315613|NCT00928486|469122521|FG000|Overall Study|Withdrawal by Subject|1|||
130315614|NCT01342913|469122522|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
130315615|NCT01342913|469122523|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130315616|NCT01342913|469122524|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
130315617|NCT01342913|469122522|FG000|2-week Run-in Period|Physician Decision|6|||
130315618|NCT01342913|469122523|FG001|2-week Run-in Period|Physician Decision|0|||
130315619|NCT01342913|469122524|FG002|2-week Run-in Period|Physician Decision|0|||
130315620|NCT01342913|469122522|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
130315621|NCT01342913|469122523|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
130315622|NCT01342913|469122524|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
130315623|NCT01342913|469122522|FG000|2-week Run-in Period|Adverse Event|2|||
130315624|NCT01342913|469122523|FG001|2-week Run-in Period|Adverse Event|0|||
130315625|NCT01342913|469122524|FG002|2-week Run-in Period|Adverse Event|0|||
130315626|NCT01342913|469122522|FG000|2-week Run-in Period|Protocol Violation|5|||
130315627|NCT01342913|469122523|FG001|2-week Run-in Period|Protocol Violation|0|||
130315628|NCT01342913|469122524|FG002|2-week Run-in Period|Protocol Violation|0|||
130315629|NCT01342913|469122522|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
130315630|NCT01342913|469122523|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
130315631|NCT01342913|469122524|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
130315632|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130315633|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Adverse Event|3|||
130315634|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Adverse Event|6|||
130315635|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130315636|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
130315637|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
130315638|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130315639|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
130315640|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
130315641|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130315642|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130315643|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
130315644|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130315645|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Physician Decision|2|||
130315646|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Physician Decision|0|||
130315647|NCT01342913|469122522|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130315648|NCT01342913|469122523|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130315649|NCT01342913|469122524|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130315650|NCT04024891|469122528|FG000|Overall Study|Pregnancy|0|||
130315651|NCT04024891|469122529|FG001|Overall Study|Pregnancy|1|||
130315652|NCT01474317|469122540|FG000|Overall Study|Adverse Event|1|||
130315653|NCT01474317|469122540|FG000|Overall Study|Subject ineligible for study|1|||
130315654|NCT00453154|469122543|FG000|Double BIind Maintenance|Adverse Event|0|||
130315655|NCT00453154|469122544|FG001|Double BIind Maintenance|Adverse Event|0|||
130315656|NCT00453154|469122545|FG002|Double BIind Maintenance|Adverse Event|3|||
130315657|NCT00453154|469122546|FG003|Double BIind Maintenance|Adverse Event|12|||
130315658|NCT00453154|469122543|FG000|Double BIind Maintenance|Death|0|||
130315659|NCT00453154|469122544|FG001|Double BIind Maintenance|Death|0|||
130315660|NCT00453154|469122545|FG002|Double BIind Maintenance|Death|2|||
130315661|NCT00453154|469122546|FG003|Double BIind Maintenance|Death|1|||
130315662|NCT00453154|469122543|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
130315663|NCT00453154|469122544|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
130315664|NCT00453154|469122545|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
130315665|NCT00453154|469122546|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
130315666|NCT00453154|469122543|FG000|Double BIind Maintenance|Progression|0|||
130315667|NCT00453154|469122544|FG001|Double BIind Maintenance|Progression|0|||
130315668|NCT00453154|469122545|FG002|Double BIind Maintenance|Progression|29|||
130315669|NCT00453154|469122546|FG003|Double BIind Maintenance|Progression|26|||
130315670|NCT00453154|469122543|FG000|Double BIind Maintenance|Medical Issues|0|||
130315671|NCT00453154|469122544|FG001|Double BIind Maintenance|Medical Issues|0|||
130315672|NCT00453154|469122545|FG002|Double BIind Maintenance|Medical Issues|3|||
130315673|NCT00453154|469122546|FG003|Double BIind Maintenance|Medical Issues|1|||
130315674|NCT00453154|469122543|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
130315675|NCT00453154|469122544|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
130315676|NCT00453154|469122545|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
130315677|NCT00453154|469122546|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
130315678|NCT02152631|469122548|FG000|Overall Study|Adverse Event|32|||
130315679|NCT02152631|469122549|FG001|Overall Study|Adverse Event|4|||
130315680|NCT02152631|469122548|FG000|Overall Study|Withdrawal by Subject|13|||
130315681|NCT02152631|469122549|FG001|Overall Study|Withdrawal by Subject|16|||
130315682|NCT02152631|469122548|FG000|Overall Study|Noncompliance with study drug|1|||
130315683|NCT02152631|469122549|FG001|Overall Study|Noncompliance with study drug|0|||
130315684|NCT02152631|469122548|FG000|Overall Study|Physician Decision|1|||
130315685|NCT02152631|469122549|FG001|Overall Study|Physician Decision|2|||
130315686|NCT02152631|469122548|FG000|Overall Study|Lost to Follow-up|0|||
130315687|NCT02152631|469122549|FG001|Overall Study|Lost to Follow-up|1|||
130315688|NCT02152631|469122548|FG000|Overall Study|On Treatment|19|||
130315689|NCT02152631|469122549|FG001|Overall Study|On Treatment|3|||
130315690|NCT05473026|469122550|FG000|Overall Study|Lost to Follow-up|5|||
130315691|NCT05473026|469122551|FG001|Overall Study|Lost to Follow-up|2|||
130315692|NCT01693029|469122562|FG000|Overall Study|Withdrawal by Subject|15|||
130315693|NCT01693029|469122563|FG001|Overall Study|Withdrawal by Subject|22|||
130315694|NCT01693029|469122562|FG000|Overall Study|Kidney transplantation|7|||
130315695|NCT01693029|469122563|FG001|Overall Study|Kidney transplantation|7|||
130315696|NCT01693029|469122562|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
130315697|NCT01693029|469122563|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
130315698|NCT01693029|469122562|FG000|Overall Study|Protocol Violation|6|||
130315699|NCT01693029|469122563|FG001|Overall Study|Protocol Violation|7|||
130315700|NCT01693029|469122562|FG000|Overall Study|Change in dialysis modality|2|||
130315701|NCT01693029|469122563|FG001|Overall Study|Change in dialysis modality|1|||
130315702|NCT01693029|469122562|FG000|Overall Study|Physician Decision|0|||
130315703|NCT01693029|469122563|FG001|Overall Study|Physician Decision|2|||
130315704|NCT01693029|469122562|FG000|Overall Study|Lost to Follow-up|0|||
130315705|NCT01693029|469122563|FG001|Overall Study|Lost to Follow-up|1|||
130315706|NCT01693029|469122562|FG000|Overall Study|Adverse Event|1|||
130315707|NCT01693029|469122563|FG001|Overall Study|Adverse Event|6|||
130315708|NCT01693029|469122562|FG000|Overall Study|Death|5|||
130315709|NCT01693029|469122563|FG001|Overall Study|Death|8|||
130315710|NCT01693029|469122562|FG000|Overall Study|Non-compliance|2|||
130315711|NCT01693029|469122563|FG001|Overall Study|Non-compliance|1|||
130315712|NCT03683173|469122564|FG000|Completed Follow-up|Unavailable|235|||
130315713|NCT03683173|469122565|FG001|Completed Follow-up|Unavailable|217|||
130315714|NCT03683173|469122564|FG000|Completed Follow-up|Refused|69|||
130315715|NCT03683173|469122565|FG001|Completed Follow-up|Refused|59|||
130315716|NCT03683173|469122564|FG000|Completed Follow-up|Disconnected phone|65|||
130315717|NCT03683173|469122565|FG001|Completed Follow-up|Disconnected phone|95|||
130315718|NCT03683173|469122564|FG000|Completed Follow-up|Health issue/deceased|10|||
130315719|NCT03683173|469122565|FG001|Completed Follow-up|Health issue/deceased|4|||
130315720|NCT03683173|469122564|FG000|Completed Follow-up|Moved away|8|||
130315721|NCT03683173|469122565|FG001|Completed Follow-up|Moved away|1|||
130315722|NCT02647281|469122566|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315723|NCT02647281|469122567|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315724|NCT02647281|469122568|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315725|NCT02647281|469122569|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315726|NCT02647281|469122570|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315727|NCT02647281|469122571|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315728|NCT02647281|469122572|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315729|NCT02647281|469122573|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
130315730|NCT02647281|469122574|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
130315731|NCT05801991|469122575|FG000|Overall Study|Lost to Follow-up|1|||
130315732|NCT05801991|469122576|FG001|Overall Study|Lost to Follow-up|0|||
130315733|NCT02210000|469122577|FG000|Overall Study|Study Terminated|11|||
130315734|NCT02210000|469122578|FG001|Overall Study|Study Terminated|12|||
130315735|NCT02210000|469122577|FG000|Overall Study|Withdrawal by Subject|7|||
130315736|NCT02210000|469122578|FG001|Overall Study|Withdrawal by Subject|1|||
130315737|NCT02210000|469122577|FG000|Overall Study|Adverse Event|1|||
130315738|NCT02210000|469122578|FG001|Overall Study|Adverse Event|5|||
130315739|NCT02210000|469122577|FG000|Overall Study|Lost to Follow-up|0|||
130315740|NCT02210000|469122578|FG001|Overall Study|Lost to Follow-up|2|||
130315741|NCT02210000|469122577|FG000|Overall Study|Physician Decision|0|||
130315742|NCT02210000|469122578|FG001|Overall Study|Physician Decision|1|||
130315743|NCT01329263|469122581|FG000|Overall Study|Lost to Follow-up|4|||
130315744|NCT01329263|469122582|FG001|Overall Study|Lost to Follow-up|21|||
130315745|NCT01329263|469122581|FG000|Overall Study|Withdrawal by Subject|1|||
130315746|NCT01329263|469122582|FG001|Overall Study|Withdrawal by Subject|2|||
130315747|NCT01421017|469122583|FG000|Overall Study|Withdrawal by Subject|2|||
130315748|NCT01421017|469122584|FG001|Overall Study|Withdrawal by Subject|0|||
130315749|NCT01421017|469122585|FG002|Overall Study|Withdrawal by Subject|0|||
130315750|NCT01421017|469122583|FG000|Overall Study|POD|0|||
130315751|NCT01421017|469122584|FG001|Overall Study|POD|6|||
130315752|NCT01421017|469122585|FG002|Overall Study|POD|3|||
130315753|NCT00833040|469122588|FG000|Overall Study|Adverse Event|0|||
130315754|NCT00833040|469122589|FG001|Overall Study|Adverse Event|0|||
130315755|NCT00833040|469122590|FG002|Overall Study|Adverse Event|0|||
130315756|NCT00833040|469122591|FG003|Overall Study|Adverse Event|0|||
130315757|NCT00833040|469122592|FG004|Overall Study|Adverse Event|0|||
130315758|NCT00833040|469122593|FG005|Overall Study|Adverse Event|1|||
130315759|NCT02313766|469122594|FG000|Overall Study|surgery cancelled|1|||
130315760|NCT02313766|469122595|FG001|Overall Study|surgery cancelled|0|||
130315761|NCT02313766|469122596|FG002|Overall Study|surgery cancelled|0|||
130315762|NCT02313766|469122594|FG000|Overall Study|Lost to Follow-up|0|||
130315763|NCT02313766|469122595|FG001|Overall Study|Lost to Follow-up|2|||
130315764|NCT02313766|469122596|FG002|Overall Study|Lost to Follow-up|0|||
130315765|NCT02313766|469122594|FG000|Overall Study|Adverse Event|0|||
130315766|NCT02313766|469122595|FG001|Overall Study|Adverse Event|1|||
130315767|NCT02313766|469122596|FG002|Overall Study|Adverse Event|0|||
130315768|NCT03489863|469122598|FG000|Overall Study|Withdrawal by Subject|0|||
130315769|NCT03489863|469122599|FG001|Overall Study|Withdrawal by Subject|1|||
130315770|NCT02193776|469122600|FG000|Overall Study|Consent withdrawn|1|||
130315771|NCT02193776|469122601|FG001|Overall Study|Consent withdrawn|0|||
130315772|NCT02193776|469122602|FG002|Overall Study|Consent withdrawn|0|||
130315773|NCT02193776|469122603|FG003|Overall Study|Consent withdrawn|0|||
130315774|NCT02193776|469122600|FG000|Overall Study|Failure to comply with protocol|0|||
130315775|NCT02193776|469122601|FG001|Overall Study|Failure to comply with protocol|1|||
130315776|NCT02193776|469122602|FG002|Overall Study|Failure to comply with protocol|0|||
130315777|NCT02193776|469122603|FG003|Overall Study|Failure to comply with protocol|0|||
130315778|NCT02193776|469122600|FG000|Overall Study|Investigator/Sponsor decision|1|||
130315779|NCT02193776|469122601|FG001|Overall Study|Investigator/Sponsor decision|1|||
130315780|NCT02193776|469122602|FG002|Overall Study|Investigator/Sponsor decision|0|||
130315781|NCT02193776|469122603|FG003|Overall Study|Investigator/Sponsor decision|0|||
130315782|NCT02193776|469122600|FG000|Overall Study|Death|1|||
130315783|NCT02193776|469122601|FG001|Overall Study|Death|0|||
130315784|NCT02193776|469122602|FG002|Overall Study|Death|0|||
130315785|NCT02193776|469122603|FG003|Overall Study|Death|0|||
130315786|NCT02193776|469122600|FG000|Overall Study|Adverse event/Specific toxicity|5|||
130315787|NCT02193776|469122601|FG001|Overall Study|Adverse event/Specific toxicity|5|||
130315788|NCT02193776|469122602|FG002|Overall Study|Adverse event/Specific toxicity|2|||
130315789|NCT02193776|469122603|FG003|Overall Study|Adverse event/Specific toxicity|2|||
130315790|NCT00962208|469122605|FG000|Overall Study|Could not achieve good vision|9|||
130315791|NCT00962208|469122606|FG001|Overall Study|Could not achieve good vision|0|||
130315792|NCT00962208|469122605|FG000|Overall Study|Contraindicated to continue study|5|||
130315793|NCT00962208|469122606|FG001|Overall Study|Contraindicated to continue study|1|||
130315794|NCT00962208|469122605|FG000|Overall Study|Lost to Follow-up|0|||
130315795|NCT00962208|469122606|FG001|Overall Study|Lost to Follow-up|9|||
130315796|NCT00791388|469122607|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315797|NCT00791388|469122608|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
130315798|NCT00791388|469122609|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315799|NCT00791388|469122610|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315800|NCT00791388|469122611|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
130315801|NCT00791388|469122607|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
130315802|NCT00791388|469122608|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315803|NCT00791388|469122609|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315804|NCT00791388|469122610|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315805|NCT00791388|469122611|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
130315806|NCT00791388|469122607|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315807|NCT00791388|469122608|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315808|NCT00791388|469122609|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315809|NCT00791388|469122610|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
130315810|NCT00791388|469122611|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
130315811|NCT02995980|469122612|FG000|Overall Study|Lost to Follow-up|14|||
130315812|NCT00657540|469122614|FG000|Overall Study|Lost to Follow-up|1|||
130315813|NCT00657540|469122615|FG001|Overall Study|Lost to Follow-up|4|||
129800099|NCT05098938|467235300|FG000|Overall Study|Withdrawal by Subject|0|||
129800100|NCT05098938|467235301|FG001|Overall Study|Withdrawal by Subject|3|||
130315814|NCT01458639|469122617|FG000|Overall Study|Physician Decision|4|||
130315815|NCT01458639|469122617|FG000|Overall Study|Equipment issue|1|||
130315816|NCT01458639|469122617|FG000|Overall Study|Inability to obtain subject blood sample|1|||
130315817|NCT02656017|469122618|FG000|Overall Study|Study burden|3|||
130315818|NCT02656017|469122619|FG001|Overall Study|Study burden|3|||
130315819|NCT02656017|469122618|FG000|Overall Study|Adverse Event|2|||
130315820|NCT02656017|469122619|FG001|Overall Study|Adverse Event|1|||
130315821|NCT02656017|469122618|FG000|Overall Study|Unable/unwilling to take study medication|2|||
130315822|NCT02656017|469122619|FG001|Overall Study|Unable/unwilling to take study medication|1|||
130315823|NCT02656017|469122618|FG000|Overall Study|Began Tolvaptan|1|||
130315824|NCT02656017|469122619|FG001|Overall Study|Began Tolvaptan|1|||
130315825|NCT02656017|469122618|FG000|Overall Study|Withdrawal by Subject|1|||
130315826|NCT02656017|469122619|FG001|Overall Study|Withdrawal by Subject|0|||
130315827|NCT02792231|469122620|FG000|Overall Study|Patient/guardian decision|32|||
130315828|NCT02792231|469122621|FG001|Overall Study|Patient/guardian decision|42|||
130315829|NCT02792231|469122620|FG000|Overall Study|Adverse Event|15|||
130315830|NCT02792231|469122621|FG001|Overall Study|Adverse Event|11|||
130315831|NCT02792231|469122620|FG000|Overall Study|Physician Decision|14|||
130315832|NCT02792231|469122621|FG001|Overall Study|Physician Decision|12|||
130315833|NCT02792231|469122620|FG000|Overall Study|Lack of Efficacy|7|||
130315834|NCT02792231|469122621|FG001|Overall Study|Lack of Efficacy|9|||
130315835|NCT02792231|469122620|FG000|Overall Study|Lost to Follow-up|9|||
130315836|NCT02792231|469122621|FG001|Overall Study|Lost to Follow-up|5|||
130315837|NCT02792231|469122620|FG000|Overall Study|Pregnancy|1|||
130315838|NCT02792231|469122621|FG001|Overall Study|Pregnancy|3|||
130315839|NCT02792231|469122620|FG000|Overall Study|Non-compliance with study treatment|2|||
130315840|NCT02792231|469122621|FG001|Overall Study|Non-compliance with study treatment|1|||
130315841|NCT02792231|469122620|FG000|Overall Study|Protocol deviation|2|||
130315842|NCT02792231|469122621|FG001|Overall Study|Protocol deviation|0|||
130315843|NCT02792231|469122620|FG000|Overall Study|Technical problems|0|||
130315844|NCT02792231|469122621|FG001|Overall Study|Technical problems|1|||
130315845|NCT05196828|469122622|FG000|Overall Study|Withdrawal by Subject|2|||
130315846|NCT05196828|469122623|FG001|Overall Study|Withdrawal by Subject|0|||
130315847|NCT05196828|469122622|FG000|Overall Study|Lost to Follow-up|0|||
130315848|NCT05196828|469122623|FG001|Overall Study|Lost to Follow-up|4|||
130315849|NCT05196828|469122622|FG000|Overall Study|Adverse Event|1|||
130315850|NCT05196828|469122623|FG001|Overall Study|Adverse Event|0|||
130315851|NCT03309878|469122624|FG000|Overall Study|Adverse Event|1|||
130315852|NCT03309878|469122625|FG001|Overall Study|Adverse Event|0|||
130315853|NCT03309878|469122626|FG002|Overall Study|Adverse Event|0|||
130315854|NCT03309878|469122627|FG003|Overall Study|Adverse Event|0|||
130315855|NCT03309878|469122624|FG000|Overall Study|Did not maintain eligibility|2|||
130315856|NCT03309878|469122625|FG001|Overall Study|Did not maintain eligibility|1|||
130315857|NCT03309878|469122626|FG002|Overall Study|Did not maintain eligibility|0|||
130315858|NCT03309878|469122627|FG003|Overall Study|Did not maintain eligibility|0|||
130315859|NCT03309878|469122624|FG000|Overall Study|Withdrawal by Subject|0|||
130315860|NCT03309878|469122625|FG001|Overall Study|Withdrawal by Subject|1|||
130315861|NCT03309878|469122626|FG002|Overall Study|Withdrawal by Subject|0|||
130315862|NCT03309878|469122627|FG003|Overall Study|Withdrawal by Subject|0|||
130315863|NCT01096316|469122628|FG000|Overall Study|Lost to Follow-up|15|||
130315864|NCT01096316|469122629|FG001|Overall Study|Lost to Follow-up|9|||
130315865|NCT02836652|469122630|FG000|Overall Study|Death|3|||
130315866|NCT02836652|469122631|FG001|Overall Study|Death|3|||
130315867|NCT02836652|469122630|FG000|Overall Study|Transplant/Explant|3|||
130315868|NCT02836652|469122631|FG001|Overall Study|Transplant/Explant|4|||
130315869|NCT02836652|469122630|FG000|Overall Study|Withdrawn|9|||
130315870|NCT02836652|469122631|FG001|Overall Study|Withdrawn|9|||
130315871|NCT02836652|469122630|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
130315872|NCT02836652|469122631|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
130315873|NCT02349633|469122633|FG000|Overall Study|Death|0|||
130315874|NCT02349633|469122634|FG001|Overall Study|Death|1|||
130315875|NCT02349633|469122635|FG002|Overall Study|Death|0|||
130315876|NCT02349633|469122636|FG003|Overall Study|Death|0|||
130315877|NCT02349633|469122637|FG004|Overall Study|Death|0|||
130315878|NCT02349633|469122638|FG005|Overall Study|Death|1|||
130315879|NCT02349633|469122639|FG006|Overall Study|Death|1|||
130315880|NCT02349633|469122640|FG007|Overall Study|Death|1|||
130315881|NCT02349633|469122641|FG008|Overall Study|Death|0|||
130315882|NCT02349633|469122642|FG009|Overall Study|Death|1|||
130315883|NCT02349633|469122643|FG010|Overall Study|Death|0|||
130315884|NCT02349633|469122644|FG011|Overall Study|Death|0|||
130315885|NCT02349633|469122645|FG012|Overall Study|Death|0|||
130315886|NCT02349633|469122646|FG013|Overall Study|Death|0|||
130315887|NCT02349633|469122633|FG000|Overall Study|Withdrawal by Subject|0|||
130315888|NCT02349633|469122634|FG001|Overall Study|Withdrawal by Subject|0|||
130315889|NCT02349633|469122635|FG002|Overall Study|Withdrawal by Subject|0|||
130315890|NCT02349633|469122636|FG003|Overall Study|Withdrawal by Subject|1|||
130315891|NCT02349633|469122637|FG004|Overall Study|Withdrawal by Subject|0|||
130315892|NCT02349633|469122638|FG005|Overall Study|Withdrawal by Subject|0|||
130315893|NCT02349633|469122639|FG006|Overall Study|Withdrawal by Subject|0|||
130315894|NCT02349633|469122640|FG007|Overall Study|Withdrawal by Subject|2|||
129800101|NCT05098938|467235300|FG000|Overall Study|Run-in Failure in early study|505|||
129800102|NCT05098938|467235301|FG001|Overall Study|Run-in Failure in early study|514|||
129800103|NCT05098938|467235300|FG000|Overall Study|IMP delivery missed|1|||
129800104|NCT05098938|467235301|FG001|Overall Study|IMP delivery missed|5|||
130315895|NCT02349633|469122641|FG008|Overall Study|Withdrawal by Subject|2|||
130051909|NCT01678807|468145651|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
130051910|NCT01678807|468145652|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
130051911|NCT01678807|468145653|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130051912|NCT00370149|468145654|FG000|Overall Study|Physician Decision|16|||
130051913|NCT00370149|468145655|FG001|Overall Study|Physician Decision|16|||
130051914|NCT00370149|468145654|FG000|Overall Study|Protocol Violation|1|||
130051915|NCT00370149|468145655|FG001|Overall Study|Protocol Violation|0|||
130051916|NCT00370149|468145654|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
130051917|NCT00370149|468145655|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
130051918|NCT00370149|468145654|FG000|Overall Study|Pre-existing infection|0|||
130051919|NCT00370149|468145655|FG001|Overall Study|Pre-existing infection|1|||
130051920|NCT00370149|468145654|FG000|Overall Study|Antibiotic coated dressing placed|0|||
130051921|NCT00370149|468145655|FG001|Overall Study|Antibiotic coated dressing placed|1|||
130051922|NCT01043185|468147171|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
130051923|NCT01043185|468147172|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
130051924|NCT01043185|468147173|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
130051925|NCT01043185|468147174|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
130051926|NCT01043185|468147175|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
130051927|NCT01043185|468147176|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
130315896|NCT02349633|469122642|FG009|Overall Study|Withdrawal by Subject|1|||
130315897|NCT02349633|469122643|FG010|Overall Study|Withdrawal by Subject|0|||
130315898|NCT02349633|469122644|FG011|Overall Study|Withdrawal by Subject|0|||
130315899|NCT02349633|469122645|FG012|Overall Study|Withdrawal by Subject|0|||
130315900|NCT02349633|469122646|FG013|Overall Study|Withdrawal by Subject|0|||
130315901|NCT02349633|469122633|FG000|Overall Study|Withdrawal of informed consent|0|||
130315902|NCT02349633|469122634|FG001|Overall Study|Withdrawal of informed consent|0|||
130315903|NCT02349633|469122635|FG002|Overall Study|Withdrawal of informed consent|0|||
130315904|NCT02349633|469122636|FG003|Overall Study|Withdrawal of informed consent|1|||
130051928|NCT01043185|468147177|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
130051929|NCT01043185|468147178|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
130051930|NCT01043185|468147179|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
130051931|NCT01043185|468147180|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
130051932|NCT00523341|468147183|FG000|Overall Study|Withdrawal by Subject|399|||
130051933|NCT00523341|468147184|FG001|Overall Study|Withdrawal by Subject|427|||
130051934|NCT00523341|468147183|FG000|Overall Study|Other|181|||
130051935|NCT00523341|468147184|FG001|Overall Study|Other|198|||
130051936|NCT00523341|468147183|FG000|Overall Study|Adverse Event|122|||
130051937|NCT00523341|468147184|FG001|Overall Study|Adverse Event|155|||
130051938|NCT00523341|468147183|FG000|Overall Study|Death|101|||
130051939|NCT00523341|468147184|FG001|Overall Study|Death|110|||
130051940|NCT00523341|468147183|FG000|Overall Study|Lost to Follow-up|73|||
130051941|NCT00523341|468147184|FG001|Overall Study|Lost to Follow-up|61|||
130051942|NCT00523341|468147183|FG000|Overall Study|Non-compliance|20|||
130051943|NCT00523341|468147184|FG001|Overall Study|Non-compliance|13|||
130051944|NCT00523341|468147183|FG000|Overall Study|Physician Decision|14|||
130051945|NCT00523341|468147184|FG001|Overall Study|Physician Decision|13|||
130051946|NCT00523341|468147183|FG000|Overall Study|Requirement for Alternative Therapy|4|||
130051947|NCT00523341|468147184|FG001|Overall Study|Requirement for Alternative Therapy|14|||
130051948|NCT00523341|468147183|FG000|Overall Study|Protocol Deviation|6|||
130051949|NCT00523341|468147184|FG001|Overall Study|Protocol Deviation|5|||
130051950|NCT00523341|468147183|FG000|Overall Study|Ineligibility Determined|3|||
130051951|NCT00523341|468147184|FG001|Overall Study|Ineligibility Determined|4|||
130051952|NCT00523341|468147183|FG000|Overall Study|Disease Progression|1|||
130051953|NCT00523341|468147184|FG001|Overall Study|Disease Progression|0|||
130051954|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130051955|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130051956|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130315905|NCT02349633|469122637|FG004|Overall Study|Withdrawal of informed consent|1|||
130315906|NCT02349633|469122638|FG005|Overall Study|Withdrawal of informed consent|0|||
130315907|NCT02349633|469122639|FG006|Overall Study|Withdrawal of informed consent|0|||
130051957|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
130051958|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130051959|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
130051960|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130051961|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130051962|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
130051963|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
130051964|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130315908|NCT02349633|469122640|FG007|Overall Study|Withdrawal of informed consent|3|||
130051965|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
130315909|NCT02349633|469122641|FG008|Overall Study|Withdrawal of informed consent|0|||
130315910|NCT02349633|469122642|FG009|Overall Study|Withdrawal of informed consent|0|||
130315911|NCT02349633|469122643|FG010|Overall Study|Withdrawal of informed consent|0|||
130315912|NCT02349633|469122644|FG011|Overall Study|Withdrawal of informed consent|0|||
130315913|NCT02349633|469122645|FG012|Overall Study|Withdrawal of informed consent|0|||
130315914|NCT02349633|469122646|FG013|Overall Study|Withdrawal of informed consent|0|||
130315915|NCT02349633|469122633|FG000|Overall Study|Transition to compassionate use|0|||
130315916|NCT02349633|469122634|FG001|Overall Study|Transition to compassionate use|0|||
130315917|NCT02349633|469122635|FG002|Overall Study|Transition to compassionate use|0|||
130315918|NCT02349633|469122636|FG003|Overall Study|Transition to compassionate use|0|||
130315919|NCT02349633|469122637|FG004|Overall Study|Transition to compassionate use|1|||
130315920|NCT02349633|469122638|FG005|Overall Study|Transition to compassionate use|0|||
130315921|NCT02349633|469122639|FG006|Overall Study|Transition to compassionate use|0|||
130315922|NCT02349633|469122640|FG007|Overall Study|Transition to compassionate use|3|||
130315923|NCT02349633|469122641|FG008|Overall Study|Transition to compassionate use|0|||
130315924|NCT02349633|469122642|FG009|Overall Study|Transition to compassionate use|1|||
130315925|NCT02349633|469122643|FG010|Overall Study|Transition to compassionate use|0|||
130315926|NCT02349633|469122644|FG011|Overall Study|Transition to compassionate use|0|||
130315927|NCT02349633|469122645|FG012|Overall Study|Transition to compassionate use|0|||
130315928|NCT02349633|469122646|FG013|Overall Study|Transition to compassionate use|0|||
130315929|NCT02349633|469122633|FG000|Overall Study|Early termination of survival follow-up|0|||
130315930|NCT02349633|469122634|FG001|Overall Study|Early termination of survival follow-up|0|||
130315931|NCT02349633|469122635|FG002|Overall Study|Early termination of survival follow-up|0|||
130315932|NCT02349633|469122636|FG003|Overall Study|Early termination of survival follow-up|0|||
130315933|NCT02349633|469122637|FG004|Overall Study|Early termination of survival follow-up|0|||
130315934|NCT02349633|469122638|FG005|Overall Study|Early termination of survival follow-up|0|||
130315935|NCT02349633|469122639|FG006|Overall Study|Early termination of survival follow-up|0|||
130315936|NCT02349633|469122640|FG007|Overall Study|Early termination of survival follow-up|4|||
130315937|NCT02349633|469122641|FG008|Overall Study|Early termination of survival follow-up|0|||
130315938|NCT02349633|469122642|FG009|Overall Study|Early termination of survival follow-up|0|||
130315939|NCT02349633|469122643|FG010|Overall Study|Early termination of survival follow-up|0|||
130315940|NCT02349633|469122644|FG011|Overall Study|Early termination of survival follow-up|0|||
130315941|NCT02349633|469122645|FG012|Overall Study|Early termination of survival follow-up|0|||
130315942|NCT02349633|469122646|FG013|Overall Study|Early termination of survival follow-up|0|||
130315943|NCT02349633|469122633|FG000|Overall Study|Termination by sponsor|0|||
130315944|NCT02349633|469122634|FG001|Overall Study|Termination by sponsor|0|||
130315945|NCT02349633|469122635|FG002|Overall Study|Termination by sponsor|0|||
130315946|NCT02349633|469122636|FG003|Overall Study|Termination by sponsor|0|||
130315947|NCT02349633|469122637|FG004|Overall Study|Termination by sponsor|0|||
130315948|NCT02349633|469122638|FG005|Overall Study|Termination by sponsor|0|||
130315949|NCT02349633|469122639|FG006|Overall Study|Termination by sponsor|0|||
130315950|NCT02349633|469122640|FG007|Overall Study|Termination by sponsor|1|||
130315951|NCT02349633|469122641|FG008|Overall Study|Termination by sponsor|0|||
130315952|NCT02349633|469122642|FG009|Overall Study|Termination by sponsor|2|||
130315953|NCT02349633|469122643|FG010|Overall Study|Termination by sponsor|0|||
130315954|NCT02349633|469122644|FG011|Overall Study|Termination by sponsor|0|||
130315955|NCT02349633|469122645|FG012|Overall Study|Termination by sponsor|0|||
130315956|NCT02349633|469122646|FG013|Overall Study|Termination by sponsor|0|||
130315957|NCT02349633|469122633|FG000|Overall Study|Other|0|||
130315958|NCT02349633|469122634|FG001|Overall Study|Other|0|||
130315959|NCT02349633|469122635|FG002|Overall Study|Other|0|||
130315960|NCT02349633|469122636|FG003|Overall Study|Other|0|||
130315961|NCT02349633|469122637|FG004|Overall Study|Other|0|||
130315962|NCT02349633|469122638|FG005|Overall Study|Other|0|||
130315963|NCT02349633|469122639|FG006|Overall Study|Other|0|||
130315964|NCT02349633|469122640|FG007|Overall Study|Other|2|||
130315965|NCT02349633|469122641|FG008|Overall Study|Other|0|||
130315966|NCT02349633|469122642|FG009|Overall Study|Other|0|||
130315967|NCT02349633|469122643|FG010|Overall Study|Other|0|||
130315968|NCT02349633|469122644|FG011|Overall Study|Other|0|||
130315969|NCT02349633|469122645|FG012|Overall Study|Other|0|||
130315970|NCT02349633|469122646|FG013|Overall Study|Other|0|||
130315971|NCT01008943|469122648|FG000|Overall Study|Withdrawal by Subject|1|||
130315972|NCT04244253|469122649|FG000|Overall Study|Adverse Event|2|||
130315973|NCT04244253|469122650|FG001|Overall Study|Adverse Event|2|||
130315974|NCT04244253|469122651|FG002|Overall Study|Adverse Event|4|||
130315975|NCT04244253|469122649|FG000|Overall Study|Protocol Violation|1|||
130315976|NCT04244253|469122650|FG001|Overall Study|Protocol Violation|2|||
130315977|NCT04244253|469122651|FG002|Overall Study|Protocol Violation|1|||
130315978|NCT04244253|469122649|FG000|Overall Study|Withdrawal by Subject|0|||
130315979|NCT04244253|469122650|FG001|Overall Study|Withdrawal by Subject|1|||
130315980|NCT04244253|469122651|FG002|Overall Study|Withdrawal by Subject|6|||
130315981|NCT04244253|469122649|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130315982|NCT04244253|469122650|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130315983|NCT04244253|469122651|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130315984|NCT04663321|469122652|FG000|Overall Study|Study terminated by Sponsor|2|||
130315985|NCT04663321|469122653|FG001|Overall Study|Study terminated by Sponsor|1|||
130315986|NCT04663321|469122654|FG002|Overall Study|Study terminated by Sponsor|2|||
130315987|NCT04663321|469122652|FG000|Overall Study|Withdrawal by Subject|10|||
130315988|NCT04663321|469122653|FG001|Overall Study|Withdrawal by Subject|3|||
130315989|NCT04663321|469122654|FG002|Overall Study|Withdrawal by Subject|2|||
130315990|NCT04663321|469122652|FG000|Overall Study|Not provided|0|||
130315991|NCT04663321|469122653|FG001|Overall Study|Not provided|0|||
130315992|NCT04663321|469122654|FG002|Overall Study|Not provided|1|||
130315993|NCT02611479|469122655|FG000|Baseline Enrollment|Exited study|13|||
130315994|NCT02611479|469122655|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
130315995|NCT02611479|469122655|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
130315996|NCT02611479|469122655|FG000|Data Cleaning|No baseline function or pain metrics|2|||
130315997|NCT00423657|469122659|FG000|Overall Study|Withdrew consent|10|||
130315998|NCT00423657|469122660|FG001|Overall Study|Withdrew consent|8|||
130315999|NCT00423657|469122659|FG000|Overall Study|Non-compliance|0|||
130316000|NCT00423657|469122660|FG001|Overall Study|Non-compliance|1|||
130316001|NCT00423657|469122659|FG000|Overall Study|Other|15|||
130316002|NCT00423657|469122660|FG001|Overall Study|Other|16|||
130316003|NCT00423657|469122659|FG000|Overall Study|Request of sponsor/investigator|1|||
130316004|NCT00423657|469122660|FG001|Overall Study|Request of sponsor/investigator|0|||
130316005|NCT02748863|469122661|FG000|Treatment Period 1|Adverse Event|0|||
130316006|NCT02748863|469122662|FG001|Treatment Period 1|Adverse Event|1|||
130316007|NCT02748863|469122663|FG002|Treatment Period 1|Adverse Event|0|||
130316008|NCT02748863|469122664|FG003|Treatment Period 1|Adverse Event|0|||
130316009|NCT02748863|469122665|FG004|Treatment Period 1|Adverse Event|0|||
130316010|NCT02748863|469122661|FG000|Treatment Period 1|Lack of Efficacy|0|||
130316011|NCT02748863|469122662|FG001|Treatment Period 1|Lack of Efficacy|0|||
130316012|NCT02748863|469122663|FG002|Treatment Period 1|Lack of Efficacy|1|||
130316013|NCT02748863|469122664|FG003|Treatment Period 1|Lack of Efficacy|0|||
130316014|NCT02748863|469122665|FG004|Treatment Period 1|Lack of Efficacy|0|||
130316015|NCT02748863|469122661|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130316016|NCT02748863|469122662|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130316017|NCT02748863|469122663|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130316018|NCT02748863|469122664|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130316019|NCT02748863|469122665|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130316020|NCT02748863|469122661|FG000|Treatment Period 2|Lost to Follow-up|2|||
130316021|NCT02748863|469122662|FG001|Treatment Period 2|Lost to Follow-up|0|||
130316022|NCT02748863|469122663|FG002|Treatment Period 2|Lost to Follow-up|0|||
130316023|NCT02748863|469122664|FG003|Treatment Period 2|Lost to Follow-up|0|||
130316024|NCT02748863|469122665|FG004|Treatment Period 2|Lost to Follow-up|0|||
130316025|NCT02748863|469122661|FG000|Treatment Period 2|Adverse Event|3|||
130316026|NCT02748863|469122662|FG001|Treatment Period 2|Adverse Event|2|||
130316027|NCT02748863|469122663|FG002|Treatment Period 2|Adverse Event|0|||
130316028|NCT02748863|469122664|FG003|Treatment Period 2|Adverse Event|2|||
130051966|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130051967|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130051968|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
130051969|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130051970|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130051971|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
130316029|NCT02748863|469122665|FG004|Treatment Period 2|Adverse Event|0|||
130316030|NCT02748863|469122661|FG000|Treatment Period 2|Lack of Efficacy|0|||
130316031|NCT02748863|469122662|FG001|Treatment Period 2|Lack of Efficacy|1|||
130316032|NCT02748863|469122663|FG002|Treatment Period 2|Lack of Efficacy|0|||
130316033|NCT02748863|469122664|FG003|Treatment Period 2|Lack of Efficacy|0|||
130316034|NCT02748863|469122665|FG004|Treatment Period 2|Lack of Efficacy|0|||
130316035|NCT02748863|469122661|FG000|Treatment Period 2|Pregnancy|0|||
130316036|NCT02748863|469122662|FG001|Treatment Period 2|Pregnancy|0|||
130316037|NCT02748863|469122663|FG002|Treatment Period 2|Pregnancy|0|||
130316038|NCT02748863|469122664|FG003|Treatment Period 2|Pregnancy|0|||
130316039|NCT02748863|469122665|FG004|Treatment Period 2|Pregnancy|1|||
130316040|NCT02422498|469122669|FG000|Overall Study|Inevaluable|4|||
130316041|NCT03206216|469122670|FG000|Overall Study|Withdrawal by Subject|0|||
130316042|NCT03206216|469122671|FG001|Overall Study|Withdrawal by Subject|1|||
130316043|NCT01960140|469122672|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
130316044|NCT00657046|469122674|FG000|Overall Study|Adverse Event|1|||
130316045|NCT00657046|469122675|FG001|Overall Study|Adverse Event|1|||
130316046|NCT00657046|469122676|FG002|Overall Study|Adverse Event|0|||
130316047|NCT00657046|469122674|FG000|Overall Study|Protocol Violation|2|||
130316048|NCT00657046|469122675|FG001|Overall Study|Protocol Violation|2|||
130316049|NCT00657046|469122676|FG002|Overall Study|Protocol Violation|0|||
130316050|NCT00657046|469122674|FG000|Overall Study|Withdrawal by Subject|1|||
130316051|NCT00657046|469122675|FG001|Overall Study|Withdrawal by Subject|0|||
130316052|NCT00657046|469122676|FG002|Overall Study|Withdrawal by Subject|0|||
130316053|NCT00657046|469122674|FG000|Overall Study|Death|0|||
130316054|NCT00657046|469122675|FG001|Overall Study|Death|0|||
130316055|NCT00657046|469122676|FG002|Overall Study|Death|1|||
130316056|NCT00657046|469122674|FG000|Overall Study|Surgery|0|||
130316057|NCT00657046|469122675|FG001|Overall Study|Surgery|0|||
130316058|NCT00657046|469122676|FG002|Overall Study|Surgery|1|||
130316059|NCT00377520|469122686|FG000|Overall Study|Ineligible (Prior radiation)|1|||
130051972|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130051973|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130051974|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
130051975|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
130051976|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130051977|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
130051978|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130051979|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130051980|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
130051981|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
130051982|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130051983|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
130051984|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
130051985|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
130051986|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
130051987|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
130051988|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
130316060|NCT00320515|469122691|FG000|Overall Study|Death|33|||
130316061|NCT00320515|469122691|FG000|Overall Study|Lost to Follow-up|6|||
130316062|NCT00320515|469122691|FG000|Overall Study|Physician Decision|2|||
130316063|NCT00320515|469122691|FG000|Overall Study|Withdrawal by Subject|8|||
130316064|NCT00851786|469122692|FG000|Overall Study|Withdrawal by Subject|0|||
130316065|NCT00851786|469122693|FG001|Overall Study|Withdrawal by Subject|1|||
130316066|NCT00851786|469122692|FG000|Overall Study|Protocol Violation|0|||
130316067|NCT00851786|469122693|FG001|Overall Study|Protocol Violation|1|||
130316068|NCT00851786|469122692|FG000|Overall Study|Lost to Follow-up|1|||
129800105|NCT05098938|467235300|FG000|Overall Study|6 months visit was missed|2|||
129800106|NCT05098938|467235301|FG001|Overall Study|6 months visit was missed|0|||
129800107|NCT05098938|467235300|FG000|Overall Study|fit for use was not completed within window|3|||
129800108|NCT05098938|467235301|FG001|Overall Study|fit for use was not completed within window|0|||
129800109|NCT05098938|467235300|FG000|Overall Study|V2 visit was not completed within window|0|||
129800110|NCT05098938|467235301|FG001|Overall Study|V2 visit was not completed within window|1|||
129800111|NCT05098938|467235300|FG000|Overall Study|exclusionary medication use|1|||
129800112|NCT05098938|467235301|FG001|Overall Study|exclusionary medication use|2|||
129800113|NCT05098938|467235300|FG000|Overall Study|change in medication|1|||
129800114|NCT05098938|467235301|FG001|Overall Study|change in medication|0|||
129800115|NCT05098938|467235300|FG000|Overall Study|treatment failure|2|||
129800116|NCT05098938|467235301|FG001|Overall Study|treatment failure|1|||
129800117|NCT01828320|467235302|FG000|Overall Study|Lost to Follow-up|1|||
129800118|NCT01828320|467235303|FG001|Overall Study|Lost to Follow-up|3|||
129800119|NCT01828320|467235302|FG000|Overall Study|Withdrawal by Subject|7|||
129800120|NCT01828320|467235303|FG001|Overall Study|Withdrawal by Subject|2|||
129800121|NCT00426231|467236182|FG000|Overall Study|Withdrawal by Subject|9|||
129800122|NCT00426231|467236183|FG001|Overall Study|Withdrawal by Subject|12|||
129800123|NCT01795638|467236184|FG000|Overall Study|Death|0|||
129800124|NCT01795638|467236185|FG001|Overall Study|Death|3|||
129800125|NCT01795638|467236184|FG000|Overall Study|transferred to quaternary hospital|2|||
129800126|NCT01795638|467236185|FG001|Overall Study|transferred to quaternary hospital|3|||
129800127|NCT01795638|467236184|FG000|Overall Study|Protocol Violation|3|||
129800128|NCT01795638|467236185|FG001|Overall Study|Protocol Violation|0|||
129800129|NCT01795638|467236184|FG000|Overall Study|discharged from hospital|7|||
129800130|NCT01795638|467236185|FG001|Overall Study|discharged from hospital|5|||
129800131|NCT01795638|467236184|FG000|Overall Study|Withdrawal by Subject|1|||
129800132|NCT01795638|467236185|FG001|Overall Study|Withdrawal by Subject|0|||
129800133|NCT00293215|467236186|FG000|Overall Study|Progressive disease|3|||
129800134|NCT00293215|467236187|FG001|Overall Study|Progressive disease|1|||
129800135|NCT00293215|467236186|FG000|Overall Study|Adverse Event|2|||
129800136|NCT00293215|467236187|FG001|Overall Study|Adverse Event|2|||
129800137|NCT01229371|467236188|FG000|Overall Study|Withdrawal by Subject|0|||
129800138|NCT01229371|467236189|FG001|Overall Study|Withdrawal by Subject|1|||
129800139|NCT01229371|467236190|FG002|Overall Study|Withdrawal by Subject|0|||
129800140|NCT01229371|467236191|FG003|Overall Study|Withdrawal by Subject|0|||
129800141|NCT00122109|467236193|FG000|Overall Study|Did not meet criteria|6|||
129800142|NCT00122109|467236194|FG001|Overall Study|Did not meet criteria|7|||
129800143|NCT00267189|467236198|FG000|Overall Study|Patient withdrew consent|1|||
129800144|NCT00267189|467236199|FG001|Overall Study|Patient withdrew consent|1|||
130051989|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
130051990|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
130051991|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
130051992|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
130051993|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
130051994|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
130051995|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
130316069|NCT00851786|469122693|FG001|Overall Study|Lost to Follow-up|0|||
130316070|NCT00851786|469122692|FG000|Overall Study|Incarceration|1|||
130316071|NCT00851786|469122693|FG001|Overall Study|Incarceration|0|||
130316072|NCT00851786|469122692|FG000|Overall Study|Site Closure|1|||
130316073|NCT00851786|469122693|FG001|Overall Study|Site Closure|0|||
130316074|NCT00851786|469122692|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
130316075|NCT00851786|469122693|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
130316076|NCT00445549|469124288|FG000|Overall Study|progressive disease|12|||
130316077|NCT03858049|469124296|FG000|Overall Study|Adverse Event|16|||
130316078|NCT03858049|469124297|FG001|Overall Study|Adverse Event|9|||
130316079|NCT03858049|469124296|FG000|Overall Study|Other|1|||
130316080|NCT03858049|469124297|FG001|Overall Study|Other|1|||
130316081|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
130316082|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
130316083|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
129800145|NCT00267189|467236198|FG000|Overall Study|Death|1|||
129800146|NCT00267189|467236199|FG001|Overall Study|Death|0|||
129800147|NCT00267189|467236198|FG000|Overall Study|Missing|3|||
129800148|NCT00267189|467236199|FG001|Overall Study|Missing|0|||
129800149|NCT01578330|467236204|FG000|Overall Study|Adverse Event|2|||
129800150|NCT01578330|467236204|FG000|Overall Study|Protocol Violation|5|||
130316084|NCT02079740|469124301|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
130316085|NCT02079740|469124302|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
130316086|NCT02079740|469124303|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
129800151|NCT03114488|467236207|FG000|Time Period 2|Withdrawal by Subject|1|||
129800152|NCT03114488|467236208|FG001|Time Period 2|Withdrawal by Subject|3|||
129800153|NCT01225887|467236209|FG000|Overall Study|Ineligible:required test not done|2|||
129800154|NCT01225887|467236209|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
129800155|NCT01225887|467236209|FG000|Overall Study|Ineligible:inadequate pathology|2|||
129800156|NCT01669928|467236210|FG000|First Intervention|Withdrawal by Subject|3|||
129800157|NCT01669928|467236211|FG001|First Intervention|Withdrawal by Subject|5|||
129800158|NCT00925990|467236212|FG000|Overall Study|Adverse Event|1|||
129800159|NCT00925990|467236213|FG001|Overall Study|Adverse Event|3|||
130316087|NCT02079740|469124304|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
130316088|NCT02079740|469124305|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
130316089|NCT02079740|469124306|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
130316090|NCT02079740|469124307|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
130316091|NCT02079740|469124308|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
130316092|NCT02079740|469124309|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
130316093|NCT02079740|469124310|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
130316094|NCT02079740|469124298|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
130316095|NCT02079740|469124299|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
130316096|NCT02079740|469124300|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
130051996|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
130051997|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
130051998|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
130051999|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
130052000|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
130052001|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
130052002|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
130052003|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
130052004|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
130052005|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
130052006|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
130052007|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
130052008|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
130052009|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
130052010|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
130052011|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
130052012|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
130052013|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
130052014|NCT03395197|468147187|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
130052015|NCT03395197|468147188|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
130052016|NCT03395197|468147189|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
130052017|NCT03395197|468147190|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
130052018|NCT03395197|468147191|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
130052019|NCT03395197|468147192|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
130052020|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Death|0|||
130052021|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Death|0|||
130052022|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Death|0|||
130052023|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Death|0|||
130052024|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Death|1|||
130052025|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Death|4|||
130052026|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130052027|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130052028|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130052029|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
130052030|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
130052031|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
130052032|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130052033|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130052034|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130052035|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130052036|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
130052037|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
130052038|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130052039|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130052040|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130052041|NCT03395197|468147190|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
130052042|NCT03395197|468147191|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
130052043|NCT03395197|468147192|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
130052044|NCT03395197|468147187|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
129800160|NCT00925990|467236212|FG000|Overall Study|Withdrawal by Subject|2|||
129800161|NCT00925990|467236213|FG001|Overall Study|Withdrawal by Subject|2|||
130052045|NCT03395197|468147188|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130052046|NCT03395197|468147189|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
130110657|NCT01629693|468365822|FG000|Overall Study|Adverse Event|1|||
129800162|NCT00925990|467236212|FG000|Overall Study|Lost to Follow-up|1|||
130316275|NCT04154943|469124355|FG000|Overall Study|Withdrawal by Subject|4|||
130316276|NCT01239381|469124356|FG000|Overall Study|Protocol Violation|1|||
130316277|NCT01239381|469124356|FG000|Overall Study|Withdrawal by Subject|1|||
130316278|NCT06237049|469124357|FG000|Overall Study|Death|0|||
130316279|NCT06237049|469124358|FG001|Overall Study|Death|0|||
130316280|NCT06237049|469124359|FG002|Overall Study|Death|0|||
130316281|NCT06237049|469124360|FG003|Overall Study|Death|1|||
130316282|NCT06237049|469124357|FG000|Overall Study|Lost to Follow-up|11|||
130316283|NCT06237049|469124358|FG001|Overall Study|Lost to Follow-up|5|||
130316284|NCT06237049|469124359|FG002|Overall Study|Lost to Follow-up|8|||
130316285|NCT06237049|469124360|FG003|Overall Study|Lost to Follow-up|8|||
130316286|NCT06237049|469124357|FG000|Overall Study|Protocol Violation|0|||
130316287|NCT06237049|469124358|FG001|Overall Study|Protocol Violation|1|||
130316288|NCT06237049|469124359|FG002|Overall Study|Protocol Violation|0|||
130316289|NCT06237049|469124360|FG003|Overall Study|Protocol Violation|1|||
130316290|NCT06237049|469124357|FG000|Overall Study|Withdrawal by Subject|4|||
130316291|NCT06237049|469124358|FG001|Overall Study|Withdrawal by Subject|2|||
130316292|NCT06237049|469124359|FG002|Overall Study|Withdrawal by Subject|1|||
130316293|NCT06237049|469124360|FG003|Overall Study|Withdrawal by Subject|0|||
130316294|NCT02738008|469124361|FG000|Overall Study|Study Terminated by Sponsor|1|||
130316295|NCT02738008|469124362|FG001|Overall Study|Study Terminated by Sponsor|5|||
130316296|NCT02738008|469124363|FG002|Overall Study|Study Terminated by Sponsor|3|||
130316297|NCT02738008|469124361|FG000|Overall Study|Adverse Event|0|||
130316298|NCT02738008|469124362|FG001|Overall Study|Adverse Event|1|||
130316299|NCT02738008|469124363|FG002|Overall Study|Adverse Event|2|||
130316300|NCT04621448|469124364|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
130316301|NCT04621448|469124365|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
130316302|NCT04621448|469124366|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
130316303|NCT04621448|469124367|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
130316304|NCT04621448|469124364|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
130316305|NCT04621448|469124365|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
130316306|NCT04621448|469124366|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
130316307|NCT04621448|469124367|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
130316308|NCT04621448|469124364|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
130316309|NCT04621448|469124365|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
130316310|NCT04621448|469124366|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
130316311|NCT04621448|469124367|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
130316312|NCT04621448|469124364|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
130316313|NCT04621448|469124365|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
130316314|NCT04621448|469124366|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
130316315|NCT04621448|469124367|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
130316316|NCT03550378|469124368|FG000|Overall Study|Death|0|||
130316317|NCT03550378|469124369|FG001|Overall Study|Death|1|||
130316318|NCT04590014|469124372|FG000|Overall Study|Withdrawal by Subject|1|||
130316319|NCT04590014|469124373|FG001|Overall Study|Withdrawal by Subject|0|||
130052158|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
130052159|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
130052160|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
130052161|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
130052162|NCT00365716|468147219|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
130052163|NCT00365716|468147220|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
130052164|NCT00365716|468147221|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
130052165|NCT00365716|468147222|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
130052166|NCT00365716|468147223|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
130052167|NCT00365716|468147224|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
130052168|NCT00365716|468147225|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
130052169|NCT00365716|468147219|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
130052170|NCT00365716|468147220|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130052171|NCT00365716|468147221|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130316320|NCT00468299|469124374|FG000|Overall Study|Withdrawal by Subject|0|||
130316321|NCT00468299|469124375|FG001|Overall Study|Withdrawal by Subject|1|||
130316322|NCT04264442|469124378|FG000|Overall Study|Lack of Efficacy|6|||
130316323|NCT04264442|469124378|FG000|Overall Study|Lost to Follow-up|2|||
130316324|NCT04264442|469124378|FG000|Overall Study|Sponsor Decision|23|||
130316325|NCT04264442|469124378|FG000|Overall Study|Withdrawal by Subject|11|||
130316326|NCT04264442|469124378|FG000|Overall Study|Study Termination|5|||
130316327|NCT01384734|469124380|FG000|Overall Study|Adverse Event|0|||
130316328|NCT01384734|469124381|FG001|Overall Study|Adverse Event|3|||
130316329|NCT01384734|469124382|FG002|Overall Study|Adverse Event|0|||
130316330|NCT01384734|469124383|FG003|Overall Study|Adverse Event|2|||
130316331|NCT01384734|469124384|FG004|Overall Study|Adverse Event|7|||
130316332|NCT01384734|469124380|FG000|Overall Study|Death|1|||
130316333|NCT01384734|469124381|FG001|Overall Study|Death|0|||
130316334|NCT01384734|469124382|FG002|Overall Study|Death|1|||
130316335|NCT01384734|469124383|FG003|Overall Study|Death|0|||
130316336|NCT01384734|469124384|FG004|Overall Study|Death|0|||
130316337|NCT01384734|469124380|FG000|Overall Study|Continuation criteria not met|0|||
130316338|NCT01384734|469124381|FG001|Overall Study|Continuation criteria not met|0|||
130316339|NCT01384734|469124382|FG002|Overall Study|Continuation criteria not met|1|||
130316340|NCT01384734|469124383|FG003|Overall Study|Continuation criteria not met|1|||
130316341|NCT01384734|469124384|FG004|Overall Study|Continuation criteria not met|0|||
130316342|NCT01384734|469124380|FG000|Overall Study|Lack of Efficacy|3|||
130316343|NCT01384734|469124381|FG001|Overall Study|Lack of Efficacy|7|||
130316344|NCT01384734|469124382|FG002|Overall Study|Lack of Efficacy|4|||
130316345|NCT01384734|469124383|FG003|Overall Study|Lack of Efficacy|4|||
130316346|NCT01384734|469124384|FG004|Overall Study|Lack of Efficacy|2|||
130316347|NCT01384734|469124380|FG000|Overall Study|Lost to Follow-up|5|||
130316348|NCT01384734|469124381|FG001|Overall Study|Lost to Follow-up|3|||
130316349|NCT01384734|469124382|FG002|Overall Study|Lost to Follow-up|3|||
130316350|NCT01384734|469124383|FG003|Overall Study|Lost to Follow-up|8|||
130316351|NCT01384734|469124384|FG004|Overall Study|Lost to Follow-up|5|||
130316352|NCT01384734|469124380|FG000|Overall Study|Non-compliance with study drug|1|||
130316353|NCT01384734|469124381|FG001|Overall Study|Non-compliance with study drug|2|||
130316354|NCT01384734|469124382|FG002|Overall Study|Non-compliance with study drug|6|||
130316355|NCT01384734|469124383|FG003|Overall Study|Non-compliance with study drug|0|||
130316356|NCT01384734|469124384|FG004|Overall Study|Non-compliance with study drug|2|||
130316357|NCT01384734|469124380|FG000|Overall Study|Pregnancy|0|||
130316358|NCT01384734|469124381|FG001|Overall Study|Pregnancy|1|||
130316359|NCT01384734|469124382|FG002|Overall Study|Pregnancy|0|||
130316360|NCT01384734|469124383|FG003|Overall Study|Pregnancy|0|||
130316361|NCT01384734|469124384|FG004|Overall Study|Pregnancy|1|||
130316362|NCT01384734|469124380|FG000|Overall Study|Sponsor terminated|0|||
130316363|NCT01384734|469124381|FG001|Overall Study|Sponsor terminated|0|||
130316364|NCT01384734|469124382|FG002|Overall Study|Sponsor terminated|0|||
130316365|NCT01384734|469124383|FG003|Overall Study|Sponsor terminated|0|||
130316366|NCT01384734|469124384|FG004|Overall Study|Sponsor terminated|1|||
130316367|NCT01384734|469124380|FG000|Overall Study|Withdrawal by Subject|5|||
130316368|NCT01384734|469124381|FG001|Overall Study|Withdrawal by Subject|5|||
130316369|NCT01384734|469124382|FG002|Overall Study|Withdrawal by Subject|6|||
130316370|NCT01384734|469124383|FG003|Overall Study|Withdrawal by Subject|7|||
130316371|NCT01384734|469124384|FG004|Overall Study|Withdrawal by Subject|9|||
130316372|NCT01384734|469124380|FG000|Overall Study|Investigator relocating|0|||
130316373|NCT01384734|469124381|FG001|Overall Study|Investigator relocating|2|||
130316374|NCT01384734|469124382|FG002|Overall Study|Investigator relocating|0|||
130316375|NCT01384734|469124383|FG003|Overall Study|Investigator relocating|3|||
130316376|NCT01384734|469124384|FG004|Overall Study|Investigator relocating|1|||
130316377|NCT01384734|469124380|FG000|Overall Study|Unable to come back for visit|1|||
130316378|NCT01384734|469124381|FG001|Overall Study|Unable to come back for visit|0|||
130316379|NCT01384734|469124382|FG002|Overall Study|Unable to come back for visit|1|||
130316380|NCT01384734|469124383|FG003|Overall Study|Unable to come back for visit|1|||
130316381|NCT01384734|469124384|FG004|Overall Study|Unable to come back for visit|0|||
130316382|NCT01384734|469124380|FG000|Overall Study|Prison|0|||
130316383|NCT01384734|469124381|FG001|Overall Study|Prison|0|||
130316384|NCT01384734|469124382|FG002|Overall Study|Prison|1|||
130316385|NCT01384734|469124383|FG003|Overall Study|Prison|0|||
129800269|NCT02445391|467236290|FG000|Overall Study|Withdrawal by Subject|0|||
129800270|NCT02445391|467236291|FG001|Overall Study|Withdrawal by Subject|4|||
129800271|NCT02445391|467236292|FG002|Overall Study|Withdrawal by Subject|9|||
129800272|NCT02445391|467236290|FG000|Overall Study|Financial issue|0|||
129800273|NCT02445391|467236291|FG001|Overall Study|Financial issue|0|||
129800274|NCT02445391|467236292|FG002|Overall Study|Financial issue|2|||
129800275|NCT02445391|467236290|FG000|Overall Study|Still on treatment|0|||
129800276|NCT02445391|467236291|FG001|Overall Study|Still on treatment|7|||
129800277|NCT02445391|467236292|FG002|Overall Study|Still on treatment|16|||
129800278|NCT02445391|467236290|FG000|Overall Study|Not start protocol therapy|0|||
129800279|NCT02445391|467236291|FG001|Overall Study|Not start protocol therapy|12|||
129800280|NCT02445391|467236292|FG002|Overall Study|Not start protocol therapy|9|||
129800281|NCT00560885|467236293|FG000|Overall Study|Death|7|||
129800282|NCT00560885|467236293|FG000|Overall Study|Withdrawal by Subject|1|||
129800283|NCT03803683|467236297|FG000|Overall Study|Lost to Follow-up|41|||
129800284|NCT03803683|467236298|FG001|Overall Study|Lost to Follow-up|18|||
129800285|NCT03803683|467236299|FG002|Overall Study|Lost to Follow-up|12|||
129800286|NCT03803683|467236297|FG000|Overall Study|Withdrawal by Subject|9|||
129800287|NCT03803683|467236298|FG001|Overall Study|Withdrawal by Subject|1|||
129800288|NCT03803683|467236299|FG002|Overall Study|Withdrawal by Subject|4|||
129800289|NCT00492050|467236300|FG000|Overall Study|Adverse Event|1|||
129800290|NCT00492050|467236300|FG000|Overall Study|Lack of Efficacy|1|||
129800291|NCT00492050|467236300|FG000|Overall Study|Withdrawal by Subject|3|||
129800292|NCT00492050|467236300|FG000|Overall Study|Unable to collect SCT|2|||
129800293|NCT00492050|467236300|FG000|Overall Study|Progressive Disease|2|||
129800294|NCT00518687|467238023|FG000|Overall Study|Adverse Event|201|||
129800295|NCT00518687|467238024|FG001|Overall Study|Adverse Event|177|||
129891101|NCT01272011|467559618|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
129891102|NCT01272011|467559619|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
129891103|NCT02013687|467559620|FG000|Overall Study|Lost to Follow-up|0|||
129891104|NCT02013687|467559621|FG001|Overall Study|Lost to Follow-up|0|||
129800296|NCT00518687|467238023|FG000|Overall Study|Lost to Follow-up|144|||
129800297|NCT00518687|467238024|FG001|Overall Study|Lost to Follow-up|155|||
129800298|NCT00518687|467238023|FG000|Overall Study|Physician Decision|42|||
129800299|NCT00518687|467238024|FG001|Overall Study|Physician Decision|48|||
129800300|NCT00518687|467238023|FG000|Overall Study|Progressive disease|2|||
129800301|NCT00518687|467238024|FG001|Overall Study|Progressive disease|2|||
129800302|NCT00518687|467238023|FG000|Overall Study|Protocol Violation|8|||
129800303|NCT00518687|467238024|FG001|Overall Study|Protocol Violation|10|||
129800304|NCT00518687|467238023|FG000|Overall Study|Study terminated by sponsor|930|||
129800305|NCT00518687|467238024|FG001|Overall Study|Study terminated by sponsor|918|||
129800306|NCT00518687|467238023|FG000|Overall Study|Withdrawal by Subject|110|||
129800307|NCT00518687|467238024|FG001|Overall Study|Withdrawal by Subject|110|||
129800308|NCT05108922|467238025|FG000|Overall Study|Adverse Event|2|||
129800309|NCT05108922|467238026|FG001|Overall Study|Adverse Event|3|||
129800310|NCT05108922|467238025|FG000|Overall Study|Lost to Follow-up|2|||
129800311|NCT05108922|467238026|FG001|Overall Study|Lost to Follow-up|1|||
129800312|NCT05108922|467238025|FG000|Overall Study|Inadvertent enrollment|0|||
129800313|NCT05108922|467238026|FG001|Overall Study|Inadvertent enrollment|1|||
129800314|NCT05108922|467238025|FG000|Overall Study|Physician Decision|2|||
129800315|NCT05108922|467238026|FG001|Overall Study|Physician Decision|3|||
129800316|NCT05108922|467238025|FG000|Overall Study|Protocol deviation|1|||
129800317|NCT05108922|467238026|FG001|Overall Study|Protocol deviation|0|||
129800318|NCT05108922|467238025|FG000|Overall Study|Screen failure|1|||
130052172|NCT00365716|468147222|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
130052173|NCT00365716|468147223|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
130052174|NCT00365716|468147224|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130052175|NCT00365716|468147225|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
130052176|NCT00365716|468147219|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
130052177|NCT00365716|468147220|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
130052178|NCT00365716|468147221|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
130052179|NCT00365716|468147222|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
130052180|NCT00365716|468147223|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
130316386|NCT01384734|469124384|FG004|Overall Study|Prison|0|||
130316387|NCT01384734|469124380|FG000|Overall Study|As per Exclusion criteria|0|||
130316388|NCT01384734|469124381|FG001|Overall Study|As per Exclusion criteria|1|||
130316389|NCT01384734|469124382|FG002|Overall Study|As per Exclusion criteria|0|||
130316390|NCT01384734|469124383|FG003|Overall Study|As per Exclusion criteria|0|||
130316391|NCT01384734|469124384|FG004|Overall Study|As per Exclusion criteria|0|||
130316392|NCT01384734|469124380|FG000|Overall Study|Missed End of treatment visit|0|||
130316393|NCT01384734|469124381|FG001|Overall Study|Missed End of treatment visit|0|||
130316394|NCT01384734|469124382|FG002|Overall Study|Missed End of treatment visit|0|||
130316395|NCT01384734|469124383|FG003|Overall Study|Missed End of treatment visit|1|||
130316396|NCT01384734|469124384|FG004|Overall Study|Missed End of treatment visit|0|||
130316397|NCT01384734|469124380|FG000|Overall Study|Adhesion problem|0|||
130316398|NCT01384734|469124381|FG001|Overall Study|Adhesion problem|0|||
130316399|NCT01384734|469124382|FG002|Overall Study|Adhesion problem|0|||
130316400|NCT01384734|469124383|FG003|Overall Study|Adhesion problem|1|||
130316401|NCT01384734|469124384|FG004|Overall Study|Adhesion problem|0|||
130316402|NCT01384734|469124380|FG000|Overall Study|Early termination|0|||
130316403|NCT01384734|469124381|FG001|Overall Study|Early termination|0|||
130316404|NCT01384734|469124382|FG002|Overall Study|Early termination|0|||
130316405|NCT01384734|469124383|FG003|Overall Study|Early termination|0|||
130316406|NCT01384734|469124384|FG004|Overall Study|Early termination|1|||
130316407|NCT01384734|469124380|FG000|Overall Study|Physician Decision|1|||
130316408|NCT01384734|469124381|FG001|Overall Study|Physician Decision|0|||
130316409|NCT01384734|469124382|FG002|Overall Study|Physician Decision|0|||
130316410|NCT01384734|469124383|FG003|Overall Study|Physician Decision|0|||
130316411|NCT01384734|469124384|FG004|Overall Study|Physician Decision|0|||
130316412|NCT01290523|469124385|FG000|Overall Study|Death|3|||
130316413|NCT03071263|469124386|FG000|Overall Study|Adverse Event|1|||
130316414|NCT03071263|469124387|FG001|Overall Study|Adverse Event|3|||
130316415|NCT03071263|469124386|FG000|Overall Study|Withdrawal by Subject|1|||
130316416|NCT03071263|469124387|FG001|Overall Study|Withdrawal by Subject|3|||
130316417|NCT03071263|469124386|FG000|Overall Study|Physician Decision|1|||
130316418|NCT03071263|469124387|FG001|Overall Study|Physician Decision|0|||
130316419|NCT03071263|469124386|FG000|Overall Study|Participant moved to another city|0|||
130316420|NCT03071263|469124387|FG001|Overall Study|Participant moved to another city|1|||
130316421|NCT01917747|469124388|FG000|Overall Study|Withdrawal by Subject|1|||
130316422|NCT01917747|469124389|FG001|Overall Study|Withdrawal by Subject|2|||
130316423|NCT01917747|469124388|FG000|Overall Study|Lost to Follow-up|18|||
130316424|NCT01917747|469124389|FG001|Overall Study|Lost to Follow-up|9|||
130316425|NCT00152503|469124391|FG000|Overall Study|Adverse Event|4|||
130316426|NCT02922725|469124392|FG000|Overall Study|Withdrawal by Subject|1|||
130316427|NCT02922725|469124393|FG001|Overall Study|Withdrawal by Subject|0|||
130316428|NCT02922725|469124394|FG002|Overall Study|Withdrawal by Subject|0|||
130316429|NCT01300234|469124395|FG000|Overall Study|Adverse Event|1|||
130316430|NCT01300234|469124396|FG001|Overall Study|Adverse Event|1|||
130316431|NCT01300234|469124395|FG000|Overall Study|Protocol Violation|2|||
130316432|NCT01300234|469124396|FG001|Overall Study|Protocol Violation|3|||
130316433|NCT01300234|469124395|FG000|Overall Study|Withdrawal by Subject|5|||
130316434|NCT01300234|469124396|FG001|Overall Study|Withdrawal by Subject|9|||
130316435|NCT01300234|469124395|FG000|Overall Study|Lost to Follow-up|14|||
130316436|NCT01300234|469124396|FG001|Overall Study|Lost to Follow-up|12|||
130316437|NCT01300234|469124395|FG000|Overall Study|Pregnancy|2|||
130316438|NCT01300234|469124396|FG001|Overall Study|Pregnancy|1|||
130316439|NCT01300234|469124395|FG000|Overall Study|Participant reached stopping critera|2|||
130316440|NCT01300234|469124396|FG001|Overall Study|Participant reached stopping critera|0|||
130316441|NCT01300234|469124395|FG000|Overall Study|Participant stopped medication|1|||
130316442|NCT01300234|469124396|FG001|Overall Study|Participant stopped medication|1|||
130316443|NCT01300234|469124395|FG000|Overall Study|Participant refused return to hospital|1|||
130316444|NCT01300234|469124396|FG001|Overall Study|Participant refused return to hospital|0|||
130316445|NCT03253679|469124397|FG000|Overall Study|Screen Failure|1|||
130316446|NCT04816214|469124399|FG000|Overall Study|Progressive Disease|4|||
130316447|NCT04816214|469124400|FG001|Overall Study|Progressive Disease|0|||
130316448|NCT04816214|469124401|FG002|Overall Study|Progressive Disease|0|||
130316449|NCT04816214|469124399|FG000|Overall Study|Death|1|||
130316450|NCT04816214|469124400|FG001|Overall Study|Death|0|||
130316451|NCT04816214|469124401|FG002|Overall Study|Death|0|||
130316452|NCT04816214|469124399|FG000|Overall Study|Study Terminated by Sponsor|1|||
130316453|NCT04816214|469124400|FG001|Overall Study|Study Terminated by Sponsor|0|||
130316454|NCT04816214|469124401|FG002|Overall Study|Study Terminated by Sponsor|0|||
130316455|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
130316456|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
130316457|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
130316458|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
130316459|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
130316460|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
130316461|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
130316462|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
130316463|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
130316464|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
130316465|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
130316466|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
130316467|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
130316468|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
130316469|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
130316470|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
130316471|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
130316472|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
130316473|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
130316474|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
130316475|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
130316476|NCT00550407|469124402|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
130316477|NCT00550407|469124403|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
130316478|NCT00550407|469124404|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
130316479|NCT00550407|469124402|FG000|26-Week Randomized Phase|Adverse Event|0|||
130316480|NCT00550407|469124403|FG001|26-Week Randomized Phase|Adverse Event|5|||
130316481|NCT00550407|469124404|FG002|26-Week Randomized Phase|Adverse Event|2|||
130316482|NCT00550407|469124402|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
130316483|NCT00550407|469124403|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
130316484|NCT00550407|469124404|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
130316485|NCT00550407|469124402|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
130316486|NCT00550407|469124403|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
130316487|NCT00550407|469124404|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
130316488|NCT00550407|469124402|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
130316489|NCT00550407|469124403|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
130316490|NCT00550407|469124404|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
130316491|NCT00584415|469124405|FG000|Overall Study|Adverse Event|7|||
130316492|NCT05051579|469124406|FG000|Overall Study|Withdrawal by Subject|3|||
130316493|NCT05051579|469124407|FG001|Overall Study|Withdrawal by Subject|5|||
130316494|NCT05051579|469124408|FG002|Overall Study|Withdrawal by Subject|2|||
130316495|NCT05051579|469124409|FG003|Overall Study|Withdrawal by Subject|1|||
130316496|NCT05051579|469124410|FG004|Overall Study|Withdrawal by Subject|4|||
130316497|NCT05051579|469124411|FG005|Overall Study|Withdrawal by Subject|0|||
130316498|NCT05051579|469124412|FG006|Overall Study|Withdrawal by Subject|4|||
130316499|NCT05051579|469124406|FG000|Overall Study|Lost to Follow-up|1|||
130316500|NCT05051579|469124407|FG001|Overall Study|Lost to Follow-up|0|||
129891105|NCT02013687|467559622|FG002|Overall Study|Lost to Follow-up|1|||
129891106|NCT02013687|467559623|FG003|Overall Study|Lost to Follow-up|0|||
130316501|NCT05051579|469124408|FG002|Overall Study|Lost to Follow-up|0|||
130316502|NCT05051579|469124409|FG003|Overall Study|Lost to Follow-up|0|||
130316503|NCT05051579|469124410|FG004|Overall Study|Lost to Follow-up|1|||
130316504|NCT05051579|469124411|FG005|Overall Study|Lost to Follow-up|0|||
129891107|NCT02013687|467559620|FG000|Overall Study|Protocol Violation|0|||
129891108|NCT02013687|467559621|FG001|Overall Study|Protocol Violation|0|||
130316505|NCT05051579|469124412|FG006|Overall Study|Lost to Follow-up|1|||
129891109|NCT02013687|467559622|FG002|Overall Study|Protocol Violation|0|||
129891110|NCT02013687|467559623|FG003|Overall Study|Protocol Violation|1|||
129891111|NCT02013687|467559620|FG000|Overall Study|Withdrawal by Subject|0|||
130316506|NCT05051579|469124406|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316507|NCT05051579|469124407|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316508|NCT05051579|469124408|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316509|NCT05051579|469124409|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316510|NCT05051579|469124410|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316511|NCT05051579|469124411|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
130316512|NCT05051579|469124412|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
130316513|NCT05051579|469124406|FG000|Overall Study|Adverse Event|2|||
130316514|NCT05051579|469124407|FG001|Overall Study|Adverse Event|1|||
130316515|NCT05051579|469124408|FG002|Overall Study|Adverse Event|0|||
130316516|NCT05051579|469124409|FG003|Overall Study|Adverse Event|4|||
130316517|NCT05051579|469124410|FG004|Overall Study|Adverse Event|1|||
130316518|NCT05051579|469124411|FG005|Overall Study|Adverse Event|2|||
130316519|NCT05051579|469124412|FG006|Overall Study|Adverse Event|0|||
130316520|NCT05051579|469124406|FG000|Overall Study|Inadvertent Enrollment|0|||
130316521|NCT05051579|469124407|FG001|Overall Study|Inadvertent Enrollment|0|||
130316522|NCT05051579|469124408|FG002|Overall Study|Inadvertent Enrollment|0|||
130316523|NCT05051579|469124409|FG003|Overall Study|Inadvertent Enrollment|0|||
130316524|NCT05051579|469124410|FG004|Overall Study|Inadvertent Enrollment|0|||
130316525|NCT05051579|469124411|FG005|Overall Study|Inadvertent Enrollment|0|||
130316526|NCT05051579|469124412|FG006|Overall Study|Inadvertent Enrollment|1|||
130316527|NCT05051579|469124406|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316528|NCT05051579|469124407|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
130316529|NCT05051579|469124408|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316530|NCT05051579|469124409|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316531|NCT05051579|469124410|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316532|NCT05051579|469124411|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316533|NCT05051579|469124412|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
130316534|NCT05051579|469124406|FG000|Overall Study|Sponsor Decision|0|||
130316535|NCT05051579|469124407|FG001|Overall Study|Sponsor Decision|0|||
130316536|NCT05051579|469124408|FG002|Overall Study|Sponsor Decision|0|||
130316537|NCT05051579|469124409|FG003|Overall Study|Sponsor Decision|0|||
130316538|NCT05051579|469124410|FG004|Overall Study|Sponsor Decision|1|||
130316539|NCT05051579|469124411|FG005|Overall Study|Sponsor Decision|0|||
130316540|NCT05051579|469124412|FG006|Overall Study|Sponsor Decision|0|||
130316541|NCT05051579|469124406|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316542|NCT05051579|469124407|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316543|NCT05051579|469124408|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316544|NCT05051579|469124409|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316545|NCT05051579|469124410|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
130316546|NCT05051579|469124411|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316547|NCT05051579|469124412|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
130316548|NCT00717249|469124413|FG000|Overall Study|Lens Discomfort|4|||
130316549|NCT00717249|469124414|FG001|Overall Study|Lens Discomfort|1|||
130316550|NCT00717249|469124413|FG000|Overall Study|Unsatisfactory visual Response|0|||
130316551|NCT00717249|469124414|FG001|Overall Study|Unsatisfactory visual Response|2|||
130316552|NCT00717249|469124413|FG000|Overall Study|Adverse Event|4|||
130316553|NCT00717249|469124414|FG001|Overall Study|Adverse Event|2|||
130316554|NCT00717249|469124413|FG000|Overall Study|Lost to Follow-up|2|||
130316555|NCT00717249|469124414|FG001|Overall Study|Lost to Follow-up|0|||
130316556|NCT00717249|469124413|FG000|Overall Study|Withdrawal by Subject|1|||
130316557|NCT00717249|469124414|FG001|Overall Study|Withdrawal by Subject|2|||
130316558|NCT00717249|469124413|FG000|Overall Study|Pregnancy|6|||
130316559|NCT00717249|469124414|FG001|Overall Study|Pregnancy|3|||
130316560|NCT00717249|469124413|FG000|Overall Study|Protocol Violation|0|||
130316561|NCT00717249|469124414|FG001|Overall Study|Protocol Violation|2|||
130316562|NCT00717249|469124413|FG000|Overall Study|Subject became Ineligible|1|||
130316563|NCT00717249|469124414|FG001|Overall Study|Subject became Ineligible|1|||
130316564|NCT00717249|469124413|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
130316565|NCT00717249|469124414|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
130316566|NCT00717249|469124413|FG000|Overall Study|Gastric Surgery|0|||
130316567|NCT00717249|469124414|FG001|Overall Study|Gastric Surgery|1|||
130316568|NCT00717249|469124413|FG000|Overall Study|Diagnosed with Diabetes|1|||
130316569|NCT00717249|469124414|FG001|Overall Study|Diagnosed with Diabetes|0|||
130316570|NCT00717249|469124413|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
130316571|NCT00717249|469124414|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
130316572|NCT00717249|469124413|FG000|Overall Study|Subject relocated|1|||
130316573|NCT00717249|469124414|FG001|Overall Study|Subject relocated|0|||
130316574|NCT00717249|469124413|FG000|Overall Study|Headaches|1|||
130316575|NCT00717249|469124414|FG001|Overall Study|Headaches|0|||
130316576|NCT00360412|469124415|FG000|Overall Study|Adverse Event|37|||
130316577|NCT00360412|469124416|FG001|Overall Study|Adverse Event|65|||
130316578|NCT00360412|469124415|FG000|Overall Study|Protocol Violation|2|||
130316579|NCT00360412|469124416|FG001|Overall Study|Protocol Violation|5|||
130316580|NCT00360412|469124415|FG000|Overall Study|Patient withdrew consent|27|||
130316581|NCT00360412|469124416|FG001|Overall Study|Patient withdrew consent|52|||
130316582|NCT00360412|469124415|FG000|Overall Study|Lack of therapeutic efficacy|46|||
130316583|NCT00360412|469124416|FG001|Overall Study|Lack of therapeutic efficacy|61|||
130316584|NCT00360412|469124415|FG000|Overall Study|Physician Decision|2|||
130316585|NCT00360412|469124416|FG001|Overall Study|Physician Decision|4|||
130316586|NCT00360412|469124415|FG000|Overall Study|Other|5|||
130316587|NCT00360412|469124416|FG001|Overall Study|Other|6|||
130316588|NCT00360412|469124415|FG000|Overall Study|Study termination by Sponsor|214|||
130316589|NCT00360412|469124416|FG001|Overall Study|Study termination by Sponsor|469|||
130316590|NCT05148234|469124417|FG000|Phase I|Ineligible|0|||
130316591|NCT05148234|469124418|FG001|Phase I|Ineligible|0|||
130316592|NCT05148234|469124419|FG002|Phase I|Ineligible|0|||
130316593|NCT05148234|469124420|FG003|Phase I|Ineligible|0|||
130316594|NCT05148234|469124421|FG004|Phase I|Ineligible|0|||
130316595|NCT05148234|469124422|FG005|Phase I|Ineligible|0|||
130316596|NCT05148234|469124423|FG006|Phase I|Ineligible|0|||
130316597|NCT05148234|469124424|FG007|Phase I|Ineligible|1|||
130316598|NCT05148234|469124417|FG000|Phase I|Company closed the trial.|0|||
130316599|NCT05148234|469124418|FG001|Phase I|Company closed the trial.|1|||
129891112|NCT02013687|467559621|FG001|Overall Study|Withdrawal by Subject|0|||
129891113|NCT02013687|467559622|FG002|Overall Study|Withdrawal by Subject|0|||
129891114|NCT02013687|467559623|FG003|Overall Study|Withdrawal by Subject|1|||
129891115|NCT02013687|467559620|FG000|Overall Study|Missed visits due to patient travel|0|||
129891116|NCT02013687|467559621|FG001|Overall Study|Missed visits due to patient travel|0|||
129891117|NCT02013687|467559622|FG002|Overall Study|Missed visits due to patient travel|1|||
129891118|NCT02013687|467559623|FG003|Overall Study|Missed visits due to patient travel|0|||
129891119|NCT01627340|467559624|FG000|Overall Study|Adverse Event|1|||
129891120|NCT01627340|467559625|FG001|Overall Study|Adverse Event|0|||
129891121|NCT01627340|467559624|FG000|Overall Study|Lost to Follow-up|8|||
130316600|NCT05148234|469124419|FG002|Phase I|Company closed the trial.|0|||
130316601|NCT05148234|469124420|FG003|Phase I|Company closed the trial.|0|||
130316602|NCT05148234|469124421|FG004|Phase I|Company closed the trial.|0|||
129891122|NCT01627340|467559625|FG001|Overall Study|Lost to Follow-up|4|||
129891123|NCT01627340|467559624|FG000|Overall Study|Pregnancy|1|||
130316603|NCT05148234|469124422|FG005|Phase I|Company closed the trial.|0|||
129891124|NCT01627340|467559625|FG001|Overall Study|Pregnancy|0|||
130316604|NCT05148234|469124423|FG006|Phase I|Company closed the trial.|0|||
130316605|NCT05148234|469124424|FG007|Phase I|Company closed the trial.|0|||
130316606|NCT03061201|469124425|FG000|Overall Study|Participants Terminated at Month 36|0|||
130316607|NCT03061201|469124426|FG001|Overall Study|Participants Terminated at Month 36|1|||
130052181|NCT00365716|468147224|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
130052182|NCT00365716|468147225|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
130052183|NCT00365716|468147219|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
130052184|NCT00365716|468147220|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
130052185|NCT00365716|468147221|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
130052186|NCT00365716|468147222|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
130052187|NCT00365716|468147223|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
130052188|NCT00365716|468147224|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
130052189|NCT00365716|468147225|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
130052190|NCT00365716|468147219|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
130052191|NCT00365716|468147220|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130052192|NCT00365716|468147221|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130052193|NCT00365716|468147222|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130052194|NCT00365716|468147223|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
130052195|NCT00365716|468147224|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130052196|NCT00365716|468147225|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
130052197|NCT00365716|468147219|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130052198|NCT00365716|468147220|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
130052199|NCT00365716|468147221|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
130052200|NCT00365716|468147222|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129891125|NCT01627340|467559624|FG000|Overall Study|Withdrawal by Subject|2|||
129891126|NCT01627340|467559625|FG001|Overall Study|Withdrawal by Subject|0|||
129891127|NCT01657032|467559626|FG000|Overall Study|Lost to Follow-up|0|||
130052201|NCT00365716|468147223|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130052202|NCT00365716|468147224|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
130052203|NCT00365716|468147225|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129800319|NCT05108922|467238026|FG001|Overall Study|Screen failure|0|||
129800320|NCT05108922|467238025|FG000|Overall Study|Withdrawal by Subject|11|||
129800321|NCT05108922|467238026|FG001|Overall Study|Withdrawal by Subject|8|||
129800322|NCT00282412|467238027|FG000|Overall Study|Death|2|||
129800323|NCT00537238|467238028|FG000|Overall Study|Death|1|||
129800324|NCT00537238|467238029|FG001|Overall Study|Death|2|||
129800325|NCT00537238|467238028|FG000|Overall Study|Adverse Event|31|||
129800326|NCT00537238|467238029|FG001|Overall Study|Adverse Event|22|||
129800327|NCT00537238|467238028|FG000|Overall Study|Lack of Efficacy|20|||
129891128|NCT01657032|467559627|FG001|Overall Study|Lost to Follow-up|7|||
129891129|NCT03633903|467559628|FG000|Overall Study|Withdrawal by Subject|1|||
129891130|NCT03633903|467559629|FG001|Overall Study|Withdrawal by Subject|2|||
130316608|NCT03061201|469124427|FG002|Overall Study|Participants Terminated at Month 36|0|||
130316609|NCT03061201|469124428|FG003|Overall Study|Participants Terminated at Month 36|1|||
130316610|NCT03061201|469124425|FG000|Overall Study|Lost to Follow-up|1|||
130316611|NCT03061201|469124426|FG001|Overall Study|Lost to Follow-up|0|||
130316612|NCT03061201|469124427|FG002|Overall Study|Lost to Follow-up|0|||
130316613|NCT03061201|469124428|FG003|Overall Study|Lost to Follow-up|0|||
130316614|NCT03062358|469124429|FG000|Overall Study|Death|269|||
130316615|NCT03062358|469124430|FG001|Overall Study|Death|145|||
130316616|NCT03062358|469124429|FG000|Overall Study|Withdrawal by Subject|2|||
130316617|NCT03062358|469124430|FG001|Overall Study|Withdrawal by Subject|1|||
130316618|NCT03062358|469124429|FG000|Overall Study|Sponsor Decision|29|||
130316619|NCT03062358|469124430|FG001|Overall Study|Sponsor Decision|7|||
130316620|NCT03861273|469124431|FG000|Screening Phase (3 Weeks)|Other|1|||
130316621|NCT03861273|469124431|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
130316622|NCT03861273|469124431|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
130316623|NCT03861273|469124431|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
130316624|NCT03861273|469124431|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
130316625|NCT03799341|469124432|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
130316626|NCT03799341|469124433|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
130316627|NCT03799341|469124434|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
130316628|NCT03799341|469124432|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
130316629|NCT03799341|469124433|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
130316630|NCT03799341|469124434|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
130316631|NCT03799341|469124432|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
130316632|NCT03799341|469124433|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
130316633|NCT03799341|469124434|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
130316634|NCT03799341|469124432|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
130316635|NCT03799341|469124433|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
130316636|NCT03799341|469124434|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
130316637|NCT03799341|469124432|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
130316638|NCT03799341|469124433|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
130316639|NCT03799341|469124434|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
130316640|NCT03799341|469124432|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
130316641|NCT03799341|469124433|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
130316642|NCT03799341|469124434|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
130316643|NCT01116648|469124435|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
129891131|NCT03633903|467559628|FG000|Overall Study|Lost to Follow-up|5|||
129800328|NCT00537238|467238029|FG001|Overall Study|Lack of Efficacy|21|||
129800329|NCT00537238|467238028|FG000|Overall Study|Lost to Follow-up|12|||
129800330|NCT00537238|467238029|FG001|Overall Study|Lost to Follow-up|8|||
129800331|NCT00537238|467238028|FG000|Overall Study|Withdrawal by Subject|51|||
129800332|NCT00537238|467238029|FG001|Overall Study|Withdrawal by Subject|47|||
129800333|NCT00537238|467238028|FG000|Overall Study|Protocol Violation|15|||
129800334|NCT00537238|467238029|FG001|Overall Study|Protocol Violation|19|||
130052204|NCT00365716|468147219|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
130052205|NCT00365716|468147220|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
130052206|NCT00365716|468147221|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
130052207|NCT00365716|468147222|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
130052208|NCT00365716|468147223|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
129800335|NCT00537238|467238028|FG000|Overall Study|Does not meet entrance criteria|0|||
129800336|NCT00537238|467238029|FG001|Overall Study|Does not meet entrance criteria|2|||
130052209|NCT00365716|468147224|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
130052210|NCT00365716|468147225|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
130052211|NCT00365716|468147219|FG000|Extension 1|Lost to Follow-up|0|||
130052212|NCT00365716|468147220|FG001|Extension 1|Lost to Follow-up|0|||
129891132|NCT03633903|467559629|FG001|Overall Study|Lost to Follow-up|5|||
129891133|NCT05968482|467559630|FG000|First Crossover Period|Withdrawal by Subject|0|||
129891134|NCT05968482|467559631|FG001|First Crossover Period|Withdrawal by Subject|0|||
129891135|NCT05968482|467559632|FG002|First Crossover Period|Withdrawal by Subject|1|||
129891136|NCT05968482|467559633|FG003|First Crossover Period|Withdrawal by Subject|0|||
129891137|NCT05968482|467559634|FG004|First Crossover Period|Withdrawal by Subject|0|||
129891138|NCT05968482|467559635|FG005|First Crossover Period|Withdrawal by Subject|0|||
129891139|NCT05968482|467559630|FG000|First Crossover Period|Adverse Event|0|||
129891140|NCT05968482|467559631|FG001|First Crossover Period|Adverse Event|0|||
129891141|NCT05968482|467559632|FG002|First Crossover Period|Adverse Event|0|||
129891142|NCT05968482|467559633|FG003|First Crossover Period|Adverse Event|0|||
129891143|NCT05968482|467559634|FG004|First Crossover Period|Adverse Event|0|||
129891144|NCT05968482|467559635|FG005|First Crossover Period|Adverse Event|1|||
129891145|NCT05968482|467559630|FG000|Second Crossover Period|Withdrawal by Subject|0|||
129891146|NCT05968482|467559631|FG001|Second Crossover Period|Withdrawal by Subject|0|||
129891147|NCT05968482|467559632|FG002|Second Crossover Period|Withdrawal by Subject|0|||
129891148|NCT05968482|467559633|FG003|Second Crossover Period|Withdrawal by Subject|0|||
129891149|NCT05968482|467559634|FG004|Second Crossover Period|Withdrawal by Subject|1|||
129891150|NCT05968482|467559635|FG005|Second Crossover Period|Withdrawal by Subject|0|||
129891151|NCT05968482|467559630|FG000|Third Crossover Period|Adverse Event|0|||
129891152|NCT05968482|467559631|FG001|Third Crossover Period|Adverse Event|0|||
129891153|NCT05968482|467559632|FG002|Third Crossover Period|Adverse Event|0|||
129891154|NCT05968482|467559633|FG003|Third Crossover Period|Adverse Event|0|||
129891155|NCT05968482|467559634|FG004|Third Crossover Period|Adverse Event|1|||
129891156|NCT05968482|467559635|FG005|Third Crossover Period|Adverse Event|0|||
129891157|NCT05968482|467559630|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
129891158|NCT05968482|467559631|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
129891159|NCT05968482|467559632|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
129891160|NCT05968482|467559633|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
129891161|NCT05968482|467559634|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
129891162|NCT05968482|467559635|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
129891163|NCT01925170|467559637|FG000|Overall Study|Unverified cancer status|53|||
129891164|NCT00761774|467559638|FG000|Overall Study|Adverse Event|17|||
129891165|NCT00761774|467559638|FG000|Overall Study|Lack of Efficacy|37|||
129891166|NCT00761774|467559638|FG000|Overall Study|Lost to Follow-up|2|||
129891167|NCT00761774|467559638|FG000|Overall Study|Withdrawal by Subject|9|||
129891168|NCT00761774|467559638|FG000|Overall Study|Non-compliance|4|||
130316644|NCT01116648|469124436|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
130316645|NCT01116648|469124437|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
130316646|NCT01116648|469124438|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
130316647|NCT01116648|469124439|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
130316648|NCT01116648|469124440|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
130316649|NCT01116648|469124441|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
130316650|NCT01116648|469124442|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
130316651|NCT01116648|469124443|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
130316652|NCT01116648|469124444|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
130316653|NCT01116648|469124445|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
130316654|NCT01116648|469124446|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
130316655|NCT01116648|469124447|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
130316656|NCT01116648|469124448|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
130316657|NCT01116648|469124449|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
130316658|NCT04539938|469124450|FG000|Overall Study|Death|30|||
130316659|NCT04539938|469124450|FG000|Overall Study|Withdrawal by Subject|4|||
130316660|NCT00410956|469124451|FG000|Overall Study|Adverse Event|1|||
130316661|NCT00410956|469124451|FG000|Overall Study|Death|2|||
130316662|NCT00410956|469124451|FG000|Overall Study|Lack of Efficacy|10|||
130316663|NCT00410956|469124451|FG000|Overall Study|Physician Decision|6|||
130316664|NCT01650194|469124452|FG000|Overall Study|Progressive Disease (PD)|35|||
130316665|NCT01650194|469124452|FG000|Overall Study|Withdrawal by Subject|2|||
130316666|NCT01650194|469124452|FG000|Overall Study|Miscellaneous|10|||
130316667|NCT00880698|469124455|FG000|Overall Study|Death|0|||
129891169|NCT00761774|467559638|FG000|Overall Study|End of study|2|||
129891170|NCT00761774|467559638|FG000|Overall Study|Reclassification of seizures|1|||
129891171|NCT00761774|467559638|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
129891172|NCT00761774|467559638|FG000|Overall Study|Sponsor decision|1|||
129891173|NCT00761774|467559638|FG000|Overall Study|Investigator clinical judgement|1|||
129891174|NCT00761774|467559638|FG000|Overall Study|Patient moved out of study area|1|||
130316668|NCT00880698|469124456|FG001|Overall Study|Death|0|||
130316669|NCT00880698|469124457|FG002|Overall Study|Death|1|||
130316670|NCT00880698|469124458|FG003|Overall Study|Death|2|||
130052213|NCT00365716|468147221|FG002|Extension 1|Lost to Follow-up|0|||
130052214|NCT00365716|468147222|FG003|Extension 1|Lost to Follow-up|0|||
130316671|NCT00880698|469124455|FG000|Overall Study|Lost to Follow-up|1|||
130316672|NCT00880698|469124456|FG001|Overall Study|Lost to Follow-up|3|||
130316673|NCT00880698|469124457|FG002|Overall Study|Lost to Follow-up|0|||
130316674|NCT00880698|469124458|FG003|Overall Study|Lost to Follow-up|1|||
130316675|NCT00794950|469124459|FG000|BCG Induction|Withdrawal by Subject|2|||
130316676|NCT00794950|469124459|FG000|BCG Induction|ineligible|3|||
130316677|NCT00794950|469124459|FG000|BCG Induction|noncompliant w. BCG|1|||
130316678|NCT00794950|469124459|FG000|BCG Induction|Adverse Event|1|||
130316679|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
130316680|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
130316681|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
130316682|NCT00794950|469124459|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
130316683|NCT00966654|469125401|FG000|Overall Study|Study was terminated,PI left institution|12|||
130316684|NCT01405768|469125406|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
130316685|NCT01405768|469125407|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
130316686|NCT02869633|469125410|FG000|Overall Study|Death|2|||
130316687|NCT02869633|469125411|FG001|Overall Study|Death|1|||
130316688|NCT02869633|469125410|FG000|Overall Study|Patient refused follow-up|1|||
130316689|NCT02869633|469125411|FG001|Overall Study|Patient refused follow-up|0|||
130316690|NCT02869633|469125410|FG000|Overall Study|Provider discretion|1|||
130316691|NCT02869633|469125411|FG001|Overall Study|Provider discretion|0|||
130316692|NCT02869633|469125410|FG000|Overall Study|Investigator decision|1|||
130316693|NCT02869633|469125411|FG001|Overall Study|Investigator decision|0|||
130316694|NCT02869633|469125410|FG000|Overall Study|Lost to Follow-up|0|||
130316695|NCT02869633|469125411|FG001|Overall Study|Lost to Follow-up|1|||
130316696|NCT02869633|469125410|FG000|Overall Study|Not eligible|6|||
130316697|NCT02869633|469125411|FG001|Overall Study|Not eligible|1|||
130316698|NCT02869633|469125410|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
130316699|NCT02869633|469125411|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
130316700|NCT02869633|469125410|FG000|Overall Study|Withdrawal by Subject|0|||
130316701|NCT02869633|469125411|FG001|Overall Study|Withdrawal by Subject|1|||
130316702|NCT01381016|469125412|FG000|Overall Study|Lost to Follow-up|1|||
130316703|NCT01381016|469125413|FG001|Overall Study|Lost to Follow-up|1|||
130316704|NCT01381016|469125412|FG000|Overall Study|Screen Failure|2|||
130316705|NCT01381016|469125413|FG001|Overall Study|Screen Failure|2|||
130316706|NCT01381016|469125412|FG000|Overall Study|Withdrawal by Subject|0|||
130316707|NCT01381016|469125413|FG001|Overall Study|Withdrawal by Subject|1|||
130316708|NCT01381016|469125412|FG000|Overall Study|Physician Decision|0|||
130316709|NCT01381016|469125413|FG001|Overall Study|Physician Decision|2|||
130316710|NCT01631435|469125414|FG000|Overall Study|Adverse Event|2|||
130316711|NCT01631435|469125414|FG000|Overall Study|Withdrawal by Subject|2|||
130316712|NCT01631435|469125414|FG000|Overall Study|incomplete study procedure|5|||
130316713|NCT01005251|469125418|FG000|Overall Study|Withdrawal by Subject|2|||
130316714|NCT01005251|469125419|FG001|Overall Study|Withdrawal by Subject|5|||
130316715|NCT01005251|469125420|FG002|Overall Study|Withdrawal by Subject|3|||
130316716|NCT01005251|469125421|FG003|Overall Study|Withdrawal by Subject|4|||
130316717|NCT01005251|469125422|FG004|Overall Study|Withdrawal by Subject|9|||
130316718|NCT01005251|469125418|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
130316719|NCT01005251|469125419|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130316720|NCT01005251|469125420|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
130316721|NCT01005251|469125421|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130316722|NCT01005251|469125422|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130316723|NCT01005251|469125418|FG000|Overall Study|Adverse Event|2|||
130316724|NCT01005251|469125419|FG001|Overall Study|Adverse Event|6|||
130052215|NCT00365716|468147223|FG004|Extension 1|Lost to Follow-up|0|||
130316725|NCT01005251|469125420|FG002|Overall Study|Adverse Event|8|||
130316726|NCT01005251|469125421|FG003|Overall Study|Adverse Event|5|||
130316727|NCT01005251|469125422|FG004|Overall Study|Adverse Event|4|||
130316728|NCT01005251|469125418|FG000|Overall Study|Protocol Violation|1|||
130316729|NCT01005251|469125419|FG001|Overall Study|Protocol Violation|0|||
130316730|NCT01005251|469125420|FG002|Overall Study|Protocol Violation|0|||
130316731|NCT01005251|469125421|FG003|Overall Study|Protocol Violation|0|||
130316732|NCT01005251|469125422|FG004|Overall Study|Protocol Violation|2|||
130316733|NCT01005251|469125418|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
130316734|NCT01005251|469125419|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
130316735|NCT01005251|469125420|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
130316736|NCT01005251|469125421|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
130052216|NCT00365716|468147224|FG005|Extension 1|Lost to Follow-up|1|||
130316737|NCT01005251|469125422|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
130316738|NCT01005251|469125418|FG000|Overall Study|Lost to Follow-up|1|||
130316739|NCT01005251|469125419|FG001|Overall Study|Lost to Follow-up|4|||
130316740|NCT01005251|469125420|FG002|Overall Study|Lost to Follow-up|2|||
130316741|NCT01005251|469125421|FG003|Overall Study|Lost to Follow-up|0|||
129891175|NCT00761774|467559638|FG000|Overall Study|Coordinator leaving site|1|||
129891176|NCT00761774|467559638|FG000|Overall Study|Subject IP non-compliance|1|||
129891177|NCT00761774|467559638|FG000|Overall Study|IP stopped by hospital physician|1|||
129891178|NCT01077024|467559641|FG000|Overall Study|Lost to Follow-up|20|||
129891179|NCT01077024|467559642|FG001|Overall Study|Lost to Follow-up|14|||
129891180|NCT01077024|467559641|FG000|Overall Study|Withdrawal by Subject|0|||
129891181|NCT01077024|467559642|FG001|Overall Study|Withdrawal by Subject|2|||
130110730|NCT03705169|468365847|FG002|Overall Study|Concerns about study visit compliance|0|||
130316742|NCT01005251|469125422|FG004|Overall Study|Lost to Follow-up|0|||
130316743|NCT01005251|469125418|FG000|Overall Study|Physician Decision|0|||
130316744|NCT01005251|469125419|FG001|Overall Study|Physician Decision|0|||
130316745|NCT01005251|469125420|FG002|Overall Study|Physician Decision|0|||
130316746|NCT01005251|469125421|FG003|Overall Study|Physician Decision|0|||
130316747|NCT01005251|469125422|FG004|Overall Study|Physician Decision|2|||
130110731|NCT03705169|468365848|FG003|Overall Study|Concerns about study visit compliance|1|||
130110732|NCT03705169|468365849|FG004|Overall Study|Concerns about study visit compliance|0|||
130110733|NCT03705169|468365850|FG005|Overall Study|Concerns about study visit compliance|0|||
130316748|NCT01005251|469125418|FG000|Overall Study|Patient moved|1|||
130316749|NCT01005251|469125419|FG001|Overall Study|Patient moved|0|||
130316750|NCT01005251|469125420|FG002|Overall Study|Patient moved|0|||
130316751|NCT01005251|469125421|FG003|Overall Study|Patient moved|0|||
130316752|NCT01005251|469125422|FG004|Overall Study|Patient moved|0|||
130316753|NCT01005251|469125418|FG000|Overall Study|Wrong drug dispensed|0|||
130316754|NCT01005251|469125419|FG001|Overall Study|Wrong drug dispensed|1|||
130316755|NCT01005251|469125420|FG002|Overall Study|Wrong drug dispensed|0|||
130316756|NCT01005251|469125421|FG003|Overall Study|Wrong drug dispensed|0|||
130316757|NCT01005251|469125422|FG004|Overall Study|Wrong drug dispensed|0|||
130316758|NCT01005251|469125418|FG000|Overall Study|Randomized in error|0|||
130316759|NCT01005251|469125419|FG001|Overall Study|Randomized in error|0|||
130316760|NCT01005251|469125420|FG002|Overall Study|Randomized in error|1|||
130316761|NCT01005251|469125421|FG003|Overall Study|Randomized in error|1|||
130316762|NCT01005251|469125422|FG004|Overall Study|Randomized in error|0|||
130316763|NCT01005251|469125418|FG000|Overall Study|Lack of Efficacy|0|||
130316764|NCT01005251|469125419|FG001|Overall Study|Lack of Efficacy|0|||
130316765|NCT01005251|469125420|FG002|Overall Study|Lack of Efficacy|1|||
130316766|NCT01005251|469125421|FG003|Overall Study|Lack of Efficacy|1|||
130316767|NCT01005251|469125422|FG004|Overall Study|Lack of Efficacy|0|||
130316768|NCT01169103|469125429|FG000|Overall Study|Lost to Follow-up|3|||
130316769|NCT01169103|469125430|FG001|Overall Study|Lost to Follow-up|3|||
130316770|NCT01169103|469125429|FG000|Overall Study|Withdrawal by Subject|3|||
130316771|NCT01169103|469125430|FG001|Overall Study|Withdrawal by Subject|1|||
130316772|NCT00141453|469125431|FG000|Overall Study|Protocol Violation|6|||
130316773|NCT00141453|469125432|FG001|Overall Study|Protocol Violation|5|||
130316774|NCT06039579|469125433|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316775|NCT06039579|469125434|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316776|NCT06039579|469125435|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316777|NCT06039579|469125436|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316778|NCT06039579|469125437|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316779|NCT06039579|469125438|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316780|NCT06039579|469125439|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
130316781|NCT06039579|469125440|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
130316782|NCT02469623|469125445|FG000|Overall Study|Not consented for long-term follow-up|4|||
130316783|NCT02469623|469125445|FG000|Overall Study|Lost to Follow-up|4|||
130316784|NCT02469623|469125445|FG000|Overall Study|Withdrawal by Subject|2|||
130316785|NCT02469623|469125445|FG000|Overall Study|Death|3|||
130316786|NCT02763644|469125446|FG000|Overall Study|Patient/guardian decision|1|||
130316787|NCT02763644|469125447|FG001|Overall Study|Patient/guardian decision|0|||
130316788|NCT02763644|469125446|FG000|Overall Study|Death|1|||
130316789|NCT02763644|469125447|FG001|Overall Study|Death|1|||
130316790|NCT02763644|469125446|FG000|Overall Study|Adverse Event|1|||
130316791|NCT02763644|469125447|FG001|Overall Study|Adverse Event|1|||
130316792|NCT02356159|469125448|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316793|NCT02356159|469125449|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316794|NCT02356159|469125450|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316795|NCT02356159|469125451|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316796|NCT02356159|469125452|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
130316797|NCT02356159|469125453|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
130316798|NCT00861705|469125454|FG000|Overall Study|Never Began Treatment|7|||
130316799|NCT00861705|469125455|FG001|Overall Study|Never Began Treatment|3|||
130316800|NCT00861705|469125456|FG002|Overall Study|Never Began Treatment|0|||
130316801|NCT00861705|469125457|FG003|Overall Study|Never Began Treatment|1|||
130316802|NCT06418152|469125458|FG000|Overall Study|Frequent DBS setting changes|1|||
130316803|NCT06418152|469125458|FG000|Overall Study|Withdrawal by Subject|2|||
130316804|NCT00667628|469125459|FG000|Overall Study|Lost to Follow-up|1|||
130316805|NCT00667628|469125460|FG001|Overall Study|Lost to Follow-up|0|||
130316806|NCT00667628|469125459|FG000|Overall Study|Death|6|||
130316807|NCT00667628|469125460|FG001|Overall Study|Death|6|||
130316808|NCT00667628|469125459|FG000|Overall Study|Investigator Considers in Best Interest|1|||
130316809|NCT00667628|469125460|FG001|Overall Study|Investigator Considers in Best Interest|0|||
130316810|NCT00667628|469125459|FG000|Overall Study|Sponsor Terminated Study|17|||
130316811|NCT00667628|469125460|FG001|Overall Study|Sponsor Terminated Study|21|||
130316812|NCT03360682|469125461|FG000|Overall Study|Adverse Event|3|||
130316813|NCT01962441|469125464|FG000|Randomized Period|Randomized but Never Treated|4|||
130316814|NCT01962441|469125465|FG001|Randomized Period|Randomized but Never Treated|2|||
130316815|NCT01962441|469125466|FG002|Randomized Period|Randomized but Never Treated|3|||
130316816|NCT01962441|469125464|FG000|Randomized Period|Lost to Follow-up|2|||
130316817|NCT01962441|469125465|FG001|Randomized Period|Lost to Follow-up|4|||
130316818|NCT01962441|469125466|FG002|Randomized Period|Lost to Follow-up|4|||
130316819|NCT01962441|469125464|FG000|Randomized Period|Withdrew Consent|3|||
130316820|NCT01962441|469125465|FG001|Randomized Period|Withdrew Consent|3|||
130316821|NCT01962441|469125466|FG002|Randomized Period|Withdrew Consent|2|||
130316822|NCT01962441|469125464|FG000|Randomized Period|Adverse Event|1|||
130316823|NCT01962441|469125465|FG001|Randomized Period|Adverse Event|1|||
130316824|NCT01962441|469125466|FG002|Randomized Period|Adverse Event|0|||
130316825|NCT01962441|469125464|FG000|Randomized Period|Death|0|||
130316826|NCT01962441|469125465|FG001|Randomized Period|Death|0|||
130316827|NCT01962441|469125466|FG002|Randomized Period|Death|2|||
130316828|NCT01962441|469125464|FG000|Randomized Period|Protocol Violation|0|||
130316829|NCT01962441|469125465|FG001|Randomized Period|Protocol Violation|1|||
130316830|NCT01962441|469125466|FG002|Randomized Period|Protocol Violation|0|||
130316831|NCT01962441|469125464|FG000|Retreatment Substudy|Lack of Efficacy|1|||
130316832|NCT01962441|469125465|FG001|Retreatment Substudy|Lack of Efficacy|0|||
130316833|NCT01962441|469125466|FG002|Retreatment Substudy|Lack of Efficacy|0|||
130316834|NCT01962441|469125464|FG000|Retreatment Substudy|Lost to Follow-up|1|||
130052217|NCT00365716|468147225|FG006|Extension 1|Lost to Follow-up|0|||
130052218|NCT00365716|468147219|FG000|Extension 1|Other|0|||
130052219|NCT00365716|468147220|FG001|Extension 1|Other|0|||
130052220|NCT00365716|468147221|FG002|Extension 1|Other|0|||
130052221|NCT00365716|468147222|FG003|Extension 1|Other|0|||
130316835|NCT01962441|469125465|FG001|Retreatment Substudy|Lost to Follow-up|0|||
130052222|NCT00365716|468147223|FG004|Extension 1|Other|0|||
130052223|NCT00365716|468147224|FG005|Extension 1|Other|9|||
130052224|NCT00365716|468147225|FG006|Extension 1|Other|0|||
130052225|NCT00365716|468147219|FG000|Extension 1|Moved|0|||
130052226|NCT00365716|468147220|FG001|Extension 1|Moved|0|||
129800337|NCT00537238|467238028|FG000|Overall Study|Other|44|||
129800338|NCT00537238|467238029|FG001|Overall Study|Other|52|||
129800339|NCT00422097|467238032|FG000|Dose Level 2|Still on treatment|0|||
129800340|NCT00422097|467238033|FG001|Dose Level 2|Still on treatment|1|||
129800341|NCT00422097|467238034|FG002|Dose Level 2|Still on treatment|0|||
129800342|NCT00422097|467238035|FG003|Dose Level 2|Still on treatment|0|||
129800343|NCT00422097|467238036|FG004|Dose Level 2|Still on treatment|0|||
129800344|NCT00422097|467238037|FG005|Dose Level 2|Still on treatment|0|||
129800345|NCT00422097|467238038|FG006|Dose Level 2|Still on treatment|0|||
129800346|NCT00422097|467238039|FG007|Dose Level 2|Still on treatment|0|||
129800347|NCT00736957|467238040|FG000|Overall Study|Adverse Event|43|||
129800348|NCT00736957|467238040|FG000|Overall Study|Withdrawal by Subject|49|||
129800349|NCT00736957|467238040|FG000|Overall Study|violation of eligibility criteria|2|||
129800350|NCT00736957|467238040|FG000|Overall Study|did not attend hospital appointments|1|||
129800351|NCT00736957|467238040|FG000|Overall Study|not eligible for Treatment Period I|22|||
129800352|NCT00736957|467238040|FG000|Overall Study|Physician Decision|5|||
129800353|NCT00331864|467238041|FG000|Overall Study|Adverse Event|30|||
129800354|NCT00331864|467238042|FG001|Overall Study|Adverse Event|1|||
129800355|NCT00331864|467238041|FG000|Overall Study|Lack of Efficacy|4|||
129800356|NCT00331864|467238042|FG001|Overall Study|Lack of Efficacy|0|||
129800357|NCT00331864|467238041|FG000|Overall Study|Protocol Violation|3|||
129800358|NCT00331864|467238042|FG001|Overall Study|Protocol Violation|0|||
129800359|NCT00331864|467238041|FG000|Overall Study|Withdrawal by Subject|10|||
129800360|NCT00331864|467238042|FG001|Overall Study|Withdrawal by Subject|0|||
129800361|NCT00331864|467238041|FG000|Overall Study|Lost to Follow-up|4|||
129800362|NCT00331864|467238042|FG001|Overall Study|Lost to Follow-up|3|||
129800363|NCT00331864|467238041|FG000|Overall Study|Administrative Problems|1|||
129800364|NCT00331864|467238042|FG001|Overall Study|Administrative Problems|0|||
129800365|NCT00331864|467238041|FG000|Overall Study|Death|6|||
129800366|NCT00331864|467238042|FG001|Overall Study|Death|0|||
129800367|NCT01092507|467238043|FG000|Overall Study|Withdrawal by Subject|2|||
130052227|NCT00365716|468147221|FG002|Extension 1|Moved|0|||
130052228|NCT00365716|468147222|FG003|Extension 1|Moved|0|||
130052229|NCT00365716|468147223|FG004|Extension 1|Moved|0|||
130052230|NCT00365716|468147224|FG005|Extension 1|Moved|4|||
130052231|NCT00365716|468147225|FG006|Extension 1|Moved|0|||
130052232|NCT00365716|468147219|FG000|Extension 1|Withdrawal by Subject|0|||
129800368|NCT01092507|467238044|FG001|Overall Study|Withdrawal by Subject|0|||
129800369|NCT05061966|467238055|FG000|Overall Study|Lost to Follow-up|13|||
129800370|NCT05061966|467238056|FG001|Overall Study|Lost to Follow-up|13|||
129800371|NCT02923427|467238063|FG000|Overall Study|convert to laparatomy|2|||
130052233|NCT00365716|468147220|FG001|Extension 1|Withdrawal by Subject|0|||
129800372|NCT02923427|467238064|FG001|Overall Study|convert to laparatomy|2|||
129800373|NCT02923427|467238063|FG000|Overall Study|destaturation|1|||
130052234|NCT00365716|468147221|FG002|Extension 1|Withdrawal by Subject|0|||
130052235|NCT00365716|468147222|FG003|Extension 1|Withdrawal by Subject|0|||
129800374|NCT02923427|467238064|FG001|Overall Study|destaturation|0|||
129800375|NCT02923427|467238063|FG000|Overall Study|can not replace LMA|1|||
129800376|NCT02923427|467238064|FG001|Overall Study|can not replace LMA|0|||
130052236|NCT00365716|468147223|FG004|Extension 1|Withdrawal by Subject|0|||
130052237|NCT00365716|468147224|FG005|Extension 1|Withdrawal by Subject|3|||
129800377|NCT01325623|467238065|FG000|Overall Study|Withdrawal by Subject|3|||
129800378|NCT00145600|467238066|FG000|Overall Study|Death|1|||
129800379|NCT00145600|467238067|FG001|Overall Study|Death|2|||
129800380|NCT00145600|467238068|FG002|Overall Study|Death|2|||
129800381|NCT00145600|467238069|FG003|Overall Study|Death|6|||
129800382|NCT00145600|467238066|FG000|Overall Study|Ineligible|3|||
129800383|NCT00145600|467238067|FG001|Overall Study|Ineligible|0|||
129800384|NCT00145600|467238068|FG002|Overall Study|Ineligible|1|||
129800385|NCT00145600|467238069|FG003|Overall Study|Ineligible|5|||
129800386|NCT00145600|467238066|FG000|Overall Study|Lost to Follow-up|2|||
129800387|NCT00145600|467238067|FG001|Overall Study|Lost to Follow-up|6|||
129800388|NCT00145600|467238068|FG002|Overall Study|Lost to Follow-up|2|||
129800389|NCT00145600|467238069|FG003|Overall Study|Lost to Follow-up|4|||
129800390|NCT00145600|467238066|FG000|Overall Study|Noncompliance|1|||
129800391|NCT00145600|467238067|FG001|Overall Study|Noncompliance|0|||
129800392|NCT00145600|467238068|FG002|Overall Study|Noncompliance|0|||
129800393|NCT00145600|467238069|FG003|Overall Study|Noncompliance|0|||
129800394|NCT00145600|467238066|FG000|Overall Study|Withdrawal by Subject|1|||
129800395|NCT00145600|467238067|FG001|Overall Study|Withdrawal by Subject|2|||
129800396|NCT00145600|467238068|FG002|Overall Study|Withdrawal by Subject|0|||
129800397|NCT00145600|467238069|FG003|Overall Study|Withdrawal by Subject|1|||
129800398|NCT01539642|467238071|FG000|Overall Study|Lack of Efficacy|20|||
129800399|NCT01539642|467238072|FG001|Overall Study|Lack of Efficacy|18|||
129800400|NCT01539642|467238071|FG000|Overall Study|Patient ready for early discharge|8|||
129800401|NCT01539642|467238072|FG001|Overall Study|Patient ready for early discharge|7|||
129800402|NCT01539642|467238071|FG000|Overall Study|Adverse Event|6|||
129800403|NCT01539642|467238072|FG001|Overall Study|Adverse Event|4|||
129800404|NCT01539642|467238071|FG000|Overall Study|Withdrawal by Subject|2|||
129800405|NCT01539642|467238072|FG001|Overall Study|Withdrawal by Subject|2|||
129800406|NCT00761579|467238073|FG000|Overall Study|Adverse Event|10|||
130052238|NCT00365716|468147225|FG006|Extension 1|Withdrawal by Subject|0|||
130052239|NCT00365716|468147219|FG000|Extension 1|Pregnancy|0|||
129800407|NCT00761579|467238073|FG000|Overall Study|Death|2|||
129800408|NCT00761579|467238073|FG000|Overall Study|Lack of Efficacy|21|||
129800409|NCT00761579|467238073|FG000|Overall Study|Lost to Follow-up|16|||
129800410|NCT00761579|467238073|FG000|Overall Study|Pregnancy|1|||
129800411|NCT00761579|467238073|FG000|Overall Study|Withdrawal by Subject|34|||
129800412|NCT00761579|467238073|FG000|Overall Study|Lack of compliance|2|||
129800413|NCT00761579|467238073|FG000|Overall Study|Protocol deviation|1|||
129800414|NCT00761579|467238073|FG000|Overall Study|Drug overdose|1|||
130052240|NCT00365716|468147220|FG001|Extension 1|Pregnancy|0|||
130316836|NCT01962441|469125466|FG002|Retreatment Substudy|Lost to Follow-up|0|||
130316837|NCT04678115|469125469|FG000|Overall Study|Lost to Follow-up|1|||
130316838|NCT04678115|469125470|FG001|Overall Study|Lost to Follow-up|0|||
130316839|NCT04908397|469125471|FG000|Overall Study|Withdrawal by Subject|2|||
130316840|NCT03100149|469125476|FG000|Overall Study|Adverse Event|0|||
130316841|NCT03100149|469125477|FG001|Overall Study|Adverse Event|1|||
130316842|NCT03100149|469125478|FG002|Overall Study|Adverse Event|0|||
130316843|NCT03100149|469125476|FG000|Overall Study|Participant Moved out of Country|0|||
130316844|NCT03100149|469125477|FG001|Overall Study|Participant Moved out of Country|0|||
130316845|NCT03100149|469125478|FG002|Overall Study|Participant Moved out of Country|1|||
130316846|NCT03100149|469125476|FG000|Overall Study|Withdrawal by Subject|0|||
130316847|NCT03100149|469125477|FG001|Overall Study|Withdrawal by Subject|3|||
130316848|NCT03100149|469125478|FG002|Overall Study|Withdrawal by Subject|1|||
130316849|NCT04972162|469125479|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
130316850|NCT04972162|469125480|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
130316851|NCT01928927|469125481|FG000|Overall Study|Lost to Follow-up|1|||
130316852|NCT01928927|469125482|FG001|Overall Study|Lost to Follow-up|0|||
130316853|NCT01928927|469125481|FG000|Overall Study|Withdrawal by Subject|1|||
130316854|NCT01928927|469125482|FG001|Overall Study|Withdrawal by Subject|1|||
130316855|NCT00383552|469126386|FG000|Overall Study|Adverse Event|7|||
130316856|NCT00383552|469126387|FG001|Overall Study|Adverse Event|6|||
130316857|NCT00383552|469126388|FG002|Overall Study|Adverse Event|9|||
130316858|NCT00383552|469126389|FG003|Overall Study|Adverse Event|6|||
130316859|NCT00383552|469126386|FG000|Overall Study|Lack of Efficacy|4|||
130316860|NCT00383552|469126387|FG001|Overall Study|Lack of Efficacy|13|||
130316861|NCT00383552|469126388|FG002|Overall Study|Lack of Efficacy|29|||
130316862|NCT00383552|469126389|FG003|Overall Study|Lack of Efficacy|42|||
130316863|NCT00383552|469126386|FG000|Overall Study|Lost to Follow-up|0|||
130316864|NCT00383552|469126387|FG001|Overall Study|Lost to Follow-up|1|||
130316865|NCT00383552|469126388|FG002|Overall Study|Lost to Follow-up|5|||
130316866|NCT00383552|469126389|FG003|Overall Study|Lost to Follow-up|1|||
130316867|NCT00383552|469126386|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
130316868|NCT00383552|469126387|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
130316869|NCT00383552|469126388|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
130316870|NCT00383552|469126389|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
130316871|NCT00383552|469126386|FG000|Overall Study|Did not wish to continue (related)|1|||
130316872|NCT00383552|469126387|FG001|Overall Study|Did not wish to continue (related)|0|||
130316873|NCT00383552|469126388|FG002|Overall Study|Did not wish to continue (related)|2|||
130316874|NCT00383552|469126389|FG003|Overall Study|Did not wish to continue (related)|3|||
130316875|NCT00383552|469126386|FG000|Overall Study|Noncompliance with the protocol|11|||
130316876|NCT00383552|469126387|FG001|Overall Study|Noncompliance with the protocol|6|||
130316877|NCT00383552|469126388|FG002|Overall Study|Noncompliance with the protocol|8|||
130316878|NCT00383552|469126389|FG003|Overall Study|Noncompliance with the protocol|10|||
130316879|NCT00383552|469126386|FG000|Overall Study|Did not meet protocol eligibility|8|||
130316880|NCT00383552|469126387|FG001|Overall Study|Did not meet protocol eligibility|6|||
130316881|NCT00383552|469126388|FG002|Overall Study|Did not meet protocol eligibility|2|||
130316882|NCT00383552|469126389|FG003|Overall Study|Did not meet protocol eligibility|3|||
130316883|NCT00383552|469126386|FG000|Overall Study|Administrative|1|||
130316884|NCT00383552|469126387|FG001|Overall Study|Administrative|0|||
130316885|NCT00383552|469126388|FG002|Overall Study|Administrative|1|||
130316886|NCT00383552|469126389|FG003|Overall Study|Administrative|1|||
130316887|NCT01393158|469126392|FG000|Overall Study|Adverse Event|1|||
130316888|NCT01393158|469126393|FG001|Overall Study|Adverse Event|0|||
130316889|NCT02055898|469126394|FG000|First Intervention (5 Days)|Physician Decision|2|||
130316890|NCT02055898|469126395|FG001|First Intervention (5 Days)|Physician Decision|0|||
130316891|NCT02055898|469126394|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
130316892|NCT02055898|469126395|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
130316893|NCT01620060|469126396|FG000|Overall Study|Adverse Event|9|||
130316894|NCT01620060|469126396|FG000|Overall Study|Protocol Violation|1|||
129800415|NCT00761579|467238073|FG000|Overall Study|Aggravation of depression|1|||
130316895|NCT01620060|469126396|FG000|Overall Study|Withdrawal by Subject|1|||
130316896|NCT01620060|469126396|FG000|Overall Study|Did not comply with Study Produre|1|||
130316897|NCT01620060|469126396|FG000|Overall Study|Family emergency|1|||
130316898|NCT01620060|469126396|FG000|Overall Study|Per Sponsor Decision|2|||
130316899|NCT00231777|469126397|FG000|Overall Study|Lost to Follow-up|3|||
130316900|NCT00231777|469126398|FG001|Overall Study|Lost to Follow-up|0|||
130316901|NCT00231777|469126397|FG000|Overall Study|Other|3|||
130316902|NCT00231777|469126398|FG001|Overall Study|Other|2|||
130316903|NCT04551989|469126401|FG000|Overall Study|Adverse Event|4|||
130316904|NCT04551989|469126401|FG000|Overall Study|Protocol Violation|3|||
130316905|NCT04551989|469126401|FG000|Overall Study|Lost to Follow-up|1|||
130316906|NCT04551989|469126401|FG000|Overall Study|Physician Decision|3|||
130316907|NCT04698343|469126402|FG000|Overall Study|Withdrawal by Subject|6|||
130316908|NCT04698343|469126402|FG000|Overall Study|Physician Decision|2|||
130316909|NCT04698343|469126402|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
130316910|NCT04698343|469126402|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
130316911|NCT04698343|469126402|FG000|Overall Study|Personal reasons|3|||
130316912|NCT04698343|469126402|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
130316913|NCT00088530|469126403|FG000|Overall Study|Progressive/Relapsed Disease|28|||
130316914|NCT00088530|469126404|FG001|Overall Study|Progressive/Relapsed Disease|39|||
130316915|NCT00088530|469126403|FG000|Overall Study|Adverse Event|15|||
130316916|NCT00088530|469126404|FG001|Overall Study|Adverse Event|9|||
130316917|NCT00088530|469126403|FG000|Overall Study|Withdrawal by Subject|2|||
130316918|NCT00088530|469126404|FG001|Overall Study|Withdrawal by Subject|5|||
130316919|NCT00088530|469126403|FG000|Overall Study|Lost to Follow-up|2|||
130316920|NCT00088530|469126404|FG001|Overall Study|Lost to Follow-up|0|||
130316921|NCT00088530|469126403|FG000|Overall Study|Physician Decision|2|||
130316922|NCT00088530|469126404|FG001|Overall Study|Physician Decision|0|||
130316923|NCT00088530|469126403|FG000|Overall Study|Sponsor decision|0|||
130316924|NCT00088530|469126404|FG001|Overall Study|Sponsor decision|1|||
130316925|NCT00088530|469126403|FG000|Overall Study|Patient never treated|1|||
130316926|NCT00088530|469126404|FG001|Overall Study|Patient never treated|0|||
130316927|NCT00739401|469126405|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
130316928|NCT00739401|469126405|FG000|Overall Study|Death|3|||
130316929|NCT00739401|469126405|FG000|Overall Study|Withdrawal by Subject|4|||
130316930|NCT04575155|469126406|FG000|2 Month|Withdrawal by Subject|1|||
130316931|NCT04575155|469126407|FG001|2 Month|Withdrawal by Subject|1|||
130316932|NCT04575155|469126406|FG000|2 Month|Lost to Follow-up|5|||
130316933|NCT04575155|469126407|FG001|2 Month|Lost to Follow-up|3|||
130316934|NCT04575155|469126406|FG000|2 Month|Ineligible|1|||
130316935|NCT04575155|469126407|FG001|2 Month|Ineligible|0|||
130316936|NCT00467740|469126408|FG000|Overall Study|Adverse Event|0|||
130316937|NCT00467740|469126409|FG001|Overall Study|Adverse Event|0|||
130316938|NCT00467740|469126410|FG002|Overall Study|Adverse Event|1|||
130316939|NCT00467740|469126411|FG003|Overall Study|Adverse Event|0|||
130316940|NCT00467740|469126412|FG004|Overall Study|Adverse Event|0|||
130316941|NCT00467740|469126408|FG000|Overall Study|Protocol Violation|0|||
130316942|NCT00467740|469126409|FG001|Overall Study|Protocol Violation|0|||
130316943|NCT00467740|469126410|FG002|Overall Study|Protocol Violation|1|||
130316944|NCT00467740|469126411|FG003|Overall Study|Protocol Violation|0|||
130316945|NCT00467740|469126412|FG004|Overall Study|Protocol Violation|0|||
130316946|NCT00467740|469126408|FG000|Overall Study|Lost to Follow-up|0|||
130316947|NCT00467740|469126409|FG001|Overall Study|Lost to Follow-up|1|||
130316948|NCT00467740|469126410|FG002|Overall Study|Lost to Follow-up|0|||
130316949|NCT00467740|469126411|FG003|Overall Study|Lost to Follow-up|0|||
130316950|NCT00467740|469126412|FG004|Overall Study|Lost to Follow-up|0|||
130316951|NCT00467740|469126408|FG000|Overall Study|Withdrawal by Subject|1|||
130316952|NCT00467740|469126409|FG001|Overall Study|Withdrawal by Subject|1|||
130316953|NCT00467740|469126410|FG002|Overall Study|Withdrawal by Subject|0|||
130316954|NCT00467740|469126411|FG003|Overall Study|Withdrawal by Subject|1|||
130316955|NCT00467740|469126412|FG004|Overall Study|Withdrawal by Subject|0|||
130316956|NCT00467740|469126408|FG000|Overall Study|Lack of Efficacy|0|||
130316957|NCT00467740|469126409|FG001|Overall Study|Lack of Efficacy|1|||
130316958|NCT00467740|469126410|FG002|Overall Study|Lack of Efficacy|0|||
130316959|NCT00467740|469126411|FG003|Overall Study|Lack of Efficacy|0|||
130316960|NCT00467740|469126412|FG004|Overall Study|Lack of Efficacy|0|||
130316961|NCT02903160|469126413|FG000|Overall Study|Adverse Event|2|||
130316962|NCT02903160|469126413|FG000|Overall Study|Death|1|||
130316963|NCT02903160|469126413|FG000|Overall Study|Lost to Follow-up|2|||
130316964|NCT02903160|469126413|FG000|Overall Study|Withdrawal by Subject|1|||
130316965|NCT02903160|469126413|FG000|Overall Study|Medical Insurance Barriers|1|||
130316966|NCT00730158|469126417|FG000|Overall Study|Withdrawal by Subject|1|||
130316967|NCT00730158|469126418|FG001|Overall Study|Withdrawal by Subject|1|||
130316968|NCT00844376|469126419|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
130316969|NCT00844376|469126420|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
130316970|NCT00660192|469126421|FG000|Overall Study|Lost to Follow-up|2|||
130316971|NCT00660192|469126422|FG001|Overall Study|Lost to Follow-up|3|||
130316972|NCT00982735|469126423|FG000|Overall Study|Lost to Follow-up|6|||
130316973|NCT00982735|469126423|FG000|Overall Study|Patient ineligible for trial|224|||
130316974|NCT01601535|469126426|FG000|Phase 1|Adverse Event|1|||
130316975|NCT01601535|469126427|FG001|Phase 1|Adverse Event|0|||
130316976|NCT01601535|469126428|FG002|Phase 1|Adverse Event|2|||
130316977|NCT01601535|469126429|FG003|Phase 1|Adverse Event|1|||
130316978|NCT01601535|469126430|FG004|Phase 1|Adverse Event|0|||
129891182|NCT01077024|467559641|FG000|Overall Study|Incarcerated|7|||
130052241|NCT00365716|468147221|FG002|Extension 1|Pregnancy|0|||
130052242|NCT00365716|468147222|FG003|Extension 1|Pregnancy|0|||
130052243|NCT00365716|468147223|FG004|Extension 1|Pregnancy|0|||
130052244|NCT00365716|468147224|FG005|Extension 1|Pregnancy|4|||
130052245|NCT00365716|468147225|FG006|Extension 1|Pregnancy|0|||
130052246|NCT00365716|468147219|FG000|Extension 1|Protocol Violation|0|||
130052247|NCT00365716|468147220|FG001|Extension 1|Protocol Violation|0|||
130052248|NCT00365716|468147221|FG002|Extension 1|Protocol Violation|0|||
130052249|NCT00365716|468147222|FG003|Extension 1|Protocol Violation|0|||
130052250|NCT00365716|468147223|FG004|Extension 1|Protocol Violation|0|||
130052251|NCT00365716|468147224|FG005|Extension 1|Protocol Violation|1|||
130052252|NCT00365716|468147225|FG006|Extension 1|Protocol Violation|0|||
130052253|NCT00365716|468147219|FG000|Extension 2|Lost to Follow-up|0|||
130052254|NCT00365716|468147220|FG001|Extension 2|Lost to Follow-up|0|||
130052255|NCT00365716|468147221|FG002|Extension 2|Lost to Follow-up|0|||
129800416|NCT00761579|467238073|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
129800417|NCT00761579|467238073|FG000|Overall Study|Lost survey form|1|||
129800418|NCT00761579|467238073|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
129800419|NCT03611010|467238074|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
129800420|NCT03611010|467238075|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
129800421|NCT03611010|467238076|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
129800422|NCT03611010|467238077|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
129800423|NCT00950911|467238078|FG000|Overall Study|Adverse Event|0|||
129800424|NCT00950911|467238079|FG001|Overall Study|Adverse Event|2|||
129800425|NCT00950911|467238078|FG000|Overall Study|Death|4|||
129800426|NCT00950911|467238079|FG001|Overall Study|Death|6|||
129800427|NCT00950911|467238078|FG000|Overall Study|Disease progression|2|||
129800428|NCT00950911|467238079|FG001|Overall Study|Disease progression|2|||
129800429|NCT00950911|467238078|FG000|Overall Study|Consent withdrawn|1|||
129800430|NCT00950911|467238079|FG001|Overall Study|Consent withdrawn|3|||
129800431|NCT00950911|467238078|FG000|Overall Study|Administrative decision|3|||
129800432|NCT00950911|467238079|FG001|Overall Study|Administrative decision|1|||
129800433|NCT00950911|467238078|FG000|Overall Study|Ineligibility determined|1|||
129800434|NCT00950911|467238079|FG001|Overall Study|Ineligibility determined|0|||
129800435|NCT00950911|467238078|FG000|Overall Study|Noncompliance|1|||
129800436|NCT00950911|467238079|FG001|Overall Study|Noncompliance|0|||
129800437|NCT00950911|467238078|FG000|Overall Study|Poor performance status|0|||
129800438|NCT00950911|467238079|FG001|Overall Study|Poor performance status|1|||
129800439|NCT02063880|467238082|FG000|Overall Study|Death|21|||
129800440|NCT02063880|467238083|FG001|Overall Study|Death|18|||
129800441|NCT02063880|467238082|FG000|Overall Study|Lost to Follow-up|7|||
129800442|NCT02063880|467238083|FG001|Overall Study|Lost to Follow-up|7|||
129800443|NCT02063880|467238082|FG000|Overall Study|Ineligible|0|||
129800444|NCT02063880|467238083|FG001|Overall Study|Ineligible|2|||
129800445|NCT02600351|467238084|FG000|Overall Study|Lack of Efficacy|3|||
129800446|NCT02600351|467238085|FG001|Overall Study|Lack of Efficacy|0|||
129800447|NCT02600351|467238086|FG002|Overall Study|Lack of Efficacy|5|||
129800448|NCT02600351|467238087|FG003|Overall Study|Lack of Efficacy|2|||
129800449|NCT02600351|467238084|FG000|Overall Study|Lost to Follow-up|1|||
129800450|NCT02600351|467238085|FG001|Overall Study|Lost to Follow-up|0|||
129800451|NCT02600351|467238086|FG002|Overall Study|Lost to Follow-up|0|||
129800452|NCT02600351|467238087|FG003|Overall Study|Lost to Follow-up|0|||
129800453|NCT02600351|467238084|FG000|Overall Study|Randomized but Not Treated|1|||
129800454|NCT02600351|467238085|FG001|Overall Study|Randomized but Not Treated|0|||
130052256|NCT00365716|468147222|FG003|Extension 2|Lost to Follow-up|0|||
130052257|NCT00365716|468147223|FG004|Extension 2|Lost to Follow-up|0|||
130052258|NCT00365716|468147224|FG005|Extension 2|Lost to Follow-up|0|||
130052259|NCT00365716|468147225|FG006|Extension 2|Lost to Follow-up|2|||
130052260|NCT00365716|468147219|FG000|Extension 2|Other|0|||
130052261|NCT00365716|468147220|FG001|Extension 2|Other|0|||
130052262|NCT00365716|468147221|FG002|Extension 2|Other|0|||
130052263|NCT00365716|468147222|FG003|Extension 2|Other|0|||
130052264|NCT00365716|468147223|FG004|Extension 2|Other|0|||
130052265|NCT00365716|468147224|FG005|Extension 2|Other|0|||
130052266|NCT00365716|468147225|FG006|Extension 2|Other|3|||
130052267|NCT00365716|468147219|FG000|Extension 2|Withdrawal by Subject|0|||
130110734|NCT03705169|468365851|FG006|Overall Study|Concerns about study visit compliance|0|||
129800455|NCT02600351|467238086|FG002|Overall Study|Randomized but Not Treated|1|||
129800456|NCT02600351|467238087|FG003|Overall Study|Randomized but Not Treated|3|||
129800457|NCT00567593|467238088|FG000|Overall Study|Adverse Event|1|||
129800458|NCT00567593|467238088|FG000|Overall Study|Physician Decision|1|||
129800459|NCT04087213|467238091|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
129800460|NCT04087213|467238091|FG000|In-Facility Introduction|Adverse Event|1|||
130052268|NCT00365716|468147220|FG001|Extension 2|Withdrawal by Subject|0|||
130052269|NCT00365716|468147221|FG002|Extension 2|Withdrawal by Subject|0|||
130052270|NCT00365716|468147222|FG003|Extension 2|Withdrawal by Subject|0|||
130052271|NCT00365716|468147223|FG004|Extension 2|Withdrawal by Subject|0|||
130052272|NCT00365716|468147224|FG005|Extension 2|Withdrawal by Subject|0|||
130052273|NCT00365716|468147225|FG006|Extension 2|Withdrawal by Subject|5|||
130052274|NCT02280291|468147226|FG000|Overall Study|Lost to Follow-up|2|||
129800461|NCT04087213|467238091|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
129800462|NCT04087213|467238091|FG000|Assisted Evaluable Period|Personal reasons|3|||
130316979|NCT01601535|469126431|FG005|Phase 1|Adverse Event|0|||
130316980|NCT01601535|469126426|FG000|Phase 1|Withdrawal by Subject|2|||
130316981|NCT01601535|469126427|FG001|Phase 1|Withdrawal by Subject|1|||
130316982|NCT01601535|469126428|FG002|Phase 1|Withdrawal by Subject|1|||
130316983|NCT01601535|469126429|FG003|Phase 1|Withdrawal by Subject|2|||
130316984|NCT01601535|469126430|FG004|Phase 1|Withdrawal by Subject|0|||
130316985|NCT01601535|469126431|FG005|Phase 1|Withdrawal by Subject|0|||
130316986|NCT01601535|469126426|FG000|Phase 1|Progressive Disease|2|||
130316987|NCT01601535|469126427|FG001|Phase 1|Progressive Disease|3|||
130316988|NCT01601535|469126428|FG002|Phase 1|Progressive Disease|2|||
130316989|NCT01601535|469126429|FG003|Phase 1|Progressive Disease|1|||
130316990|NCT01601535|469126430|FG004|Phase 1|Progressive Disease|0|||
130316991|NCT01601535|469126431|FG005|Phase 1|Progressive Disease|0|||
130316992|NCT01601535|469126426|FG000|Phase 1|Started Another Treatment|1|||
130316993|NCT01601535|469126427|FG001|Phase 1|Started Another Treatment|2|||
130316994|NCT01601535|469126428|FG002|Phase 1|Started Another Treatment|0|||
130316995|NCT01601535|469126429|FG003|Phase 1|Started Another Treatment|0|||
130316996|NCT01601535|469126430|FG004|Phase 1|Started Another Treatment|0|||
130316997|NCT01601535|469126431|FG005|Phase 1|Started Another Treatment|0|||
130316998|NCT01601535|469126426|FG000|Phase 2|Adverse Event|0|||
130316999|NCT01601535|469126427|FG001|Phase 2|Adverse Event|0|||
130317000|NCT01601535|469126428|FG002|Phase 2|Adverse Event|0|||
130317001|NCT01601535|469126429|FG003|Phase 2|Adverse Event|0|||
130317002|NCT01601535|469126430|FG004|Phase 2|Adverse Event|5|||
130317003|NCT01601535|469126431|FG005|Phase 2|Adverse Event|1|||
130317004|NCT01601535|469126426|FG000|Phase 2|Withdrawal by Subject|0|||
130317005|NCT01601535|469126427|FG001|Phase 2|Withdrawal by Subject|0|||
130317006|NCT01601535|469126428|FG002|Phase 2|Withdrawal by Subject|0|||
130317007|NCT01601535|469126429|FG003|Phase 2|Withdrawal by Subject|0|||
130317008|NCT01601535|469126430|FG004|Phase 2|Withdrawal by Subject|8|||
130317009|NCT01601535|469126431|FG005|Phase 2|Withdrawal by Subject|2|||
130317010|NCT01601535|469126426|FG000|Phase 2|Progressive Disease|0|||
130317011|NCT01601535|469126427|FG001|Phase 2|Progressive Disease|0|||
130317012|NCT01601535|469126428|FG002|Phase 2|Progressive Disease|0|||
130317013|NCT01601535|469126429|FG003|Phase 2|Progressive Disease|0|||
130317014|NCT01601535|469126430|FG004|Phase 2|Progressive Disease|5|||
130317015|NCT01601535|469126431|FG005|Phase 2|Progressive Disease|7|||
130317016|NCT01601535|469126426|FG000|Phase 2|Started Another Treatment|0|||
130317017|NCT01601535|469126427|FG001|Phase 2|Started Another Treatment|0|||
130317018|NCT01601535|469126428|FG002|Phase 2|Started Another Treatment|0|||
130317019|NCT01601535|469126429|FG003|Phase 2|Started Another Treatment|0|||
130317020|NCT01601535|469126430|FG004|Phase 2|Started Another Treatment|1|||
130317021|NCT01601535|469126431|FG005|Phase 2|Started Another Treatment|2|||
130317022|NCT01787461|469126434|FG000|Overall Study|Adverse Event|4|||
130317023|NCT01787461|469126435|FG001|Overall Study|Adverse Event|3|||
130317024|NCT01787461|469126434|FG000|Overall Study|Lost to Follow-up|3|||
130317025|NCT01787461|469126435|FG001|Overall Study|Lost to Follow-up|2|||
130317026|NCT01787461|469126434|FG000|Overall Study|No longer met eligibility criteria|1|||
130317027|NCT01787461|469126435|FG001|Overall Study|No longer met eligibility criteria|0|||
130317028|NCT01787461|469126434|FG000|Overall Study|Withdrawal by Subject|3|||
130317029|NCT01787461|469126435|FG001|Overall Study|Withdrawal by Subject|4|||
130317030|NCT01787461|469126434|FG000|Overall Study|Protocol Violation|3|||
130317031|NCT01787461|469126435|FG001|Overall Study|Protocol Violation|0|||
130317032|NCT04879628|469126436|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130317033|NCT04879628|469126437|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130317034|NCT04879628|469126438|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
130317035|NCT04879628|469126439|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
130317036|NCT04879628|469126436|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130317037|NCT04879628|469126437|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130317038|NCT04879628|469126438|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
130317039|NCT04879628|469126439|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
130317040|NCT04879628|469126436|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130317041|NCT04879628|469126437|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130317042|NCT04879628|469126438|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
130317043|NCT04879628|469126439|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
130317044|NCT04879628|469126436|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
130317045|NCT04879628|469126437|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
130317046|NCT04879628|469126438|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
130317047|NCT04879628|469126439|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
130317048|NCT03649074|469126440|FG000|Overall Study|Lost to Follow-up|2|||
130317049|NCT03649074|469126441|FG001|Overall Study|Lost to Follow-up|1|||
130317050|NCT03649074|469126440|FG000|Overall Study|Adverse Event|1|||
129800463|NCT04087213|467238091|FG000|Transition Period B|Renal Transplantation|1|||
130052275|NCT02280291|468147227|FG001|Overall Study|Lost to Follow-up|1|||
130052276|NCT02280291|468147228|FG002|Overall Study|Lost to Follow-up|3|||
130052277|NCT02280291|468147229|FG003|Overall Study|Lost to Follow-up|8|||
130052278|NCT02280291|468147226|FG000|Overall Study|Protocol Violation|1|||
130052279|NCT02280291|468147227|FG001|Overall Study|Protocol Violation|0|||
129800464|NCT01859143|467238092|FG000|Overall Study|Lost to Follow-up|2|||
129800465|NCT01859143|467238093|FG001|Overall Study|Lost to Follow-up|0|||
129800466|NCT02413372|467238097|FG000|Treatment|Lost to Follow-up|0|||
130317051|NCT03649074|469126441|FG001|Overall Study|Adverse Event|0|||
130317052|NCT03649074|469126440|FG000|Overall Study|Physician Decision|1|||
130317053|NCT03649074|469126441|FG001|Overall Study|Physician Decision|0|||
130317054|NCT03649074|469126440|FG000|Overall Study|Withdrawal by Subject|0|||
130317055|NCT03649074|469126441|FG001|Overall Study|Withdrawal by Subject|2|||
130317056|NCT03649074|469126440|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130317057|NCT03649074|469126441|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
130317058|NCT03649074|469126440|FG000|Overall Study|Other|1|||
130317059|NCT03649074|469126441|FG001|Overall Study|Other|0|||
130317060|NCT00556894|469126442|FG000|Overall Study|Adverse Event|2|||
130317061|NCT00556894|469126443|FG001|Overall Study|Adverse Event|3|||
130317062|NCT00556894|469126444|FG002|Overall Study|Adverse Event|3|||
130317063|NCT00556894|469126442|FG000|Overall Study|Death|1|||
130317064|NCT00556894|469126443|FG001|Overall Study|Death|0|||
130317065|NCT00556894|469126444|FG002|Overall Study|Death|0|||
130317066|NCT00556894|469126442|FG000|Overall Study|regulatory decision in Bulgaria|10|||
130317067|NCT00556894|469126443|FG001|Overall Study|regulatory decision in Bulgaria|14|||
130317068|NCT00556894|469126444|FG002|Overall Study|regulatory decision in Bulgaria|13|||
130317069|NCT00556894|469126442|FG000|Overall Study|Change in therapy|2|||
130317070|NCT00556894|469126443|FG001|Overall Study|Change in therapy|1|||
130317071|NCT00556894|469126444|FG002|Overall Study|Change in therapy|2|||
130317072|NCT00556894|469126442|FG000|Overall Study|Withdrawal by Subject|1|||
130317073|NCT00556894|469126443|FG001|Overall Study|Withdrawal by Subject|1|||
130317074|NCT00556894|469126444|FG002|Overall Study|Withdrawal by Subject|1|||
130317075|NCT04612725|469126447|FG000|Overall Study|Adverse Event|1|||
130317076|NCT04612725|469126448|FG001|Overall Study|Adverse Event|3|||
130317077|NCT04612725|469126449|FG002|Overall Study|Adverse Event|1|||
130317078|NCT04612725|469126450|FG003|Overall Study|Adverse Event|0|||
130317079|NCT04612725|469126451|FG004|Overall Study|Adverse Event|1|||
130317080|NCT04612725|469126447|FG000|Overall Study|Lost to Follow-up|0|||
130317081|NCT04612725|469126448|FG001|Overall Study|Lost to Follow-up|1|||
130317082|NCT04612725|469126449|FG002|Overall Study|Lost to Follow-up|0|||
130317083|NCT04612725|469126450|FG003|Overall Study|Lost to Follow-up|0|||
130317084|NCT04612725|469126451|FG004|Overall Study|Lost to Follow-up|0|||
130317085|NCT04612725|469126447|FG000|Overall Study|Physician Decision|2|||
130317086|NCT04612725|469126448|FG001|Overall Study|Physician Decision|0|||
130317087|NCT04612725|469126449|FG002|Overall Study|Physician Decision|0|||
130317088|NCT04612725|469126450|FG003|Overall Study|Physician Decision|0|||
130317089|NCT04612725|469126451|FG004|Overall Study|Physician Decision|0|||
130317090|NCT04612725|469126447|FG000|Overall Study|Study terminated by sponsor|3|||
130317091|NCT04612725|469126448|FG001|Overall Study|Study terminated by sponsor|1|||
130317092|NCT04612725|469126449|FG002|Overall Study|Study terminated by sponsor|2|||
130317093|NCT04612725|469126450|FG003|Overall Study|Study terminated by sponsor|4|||
130317094|NCT04612725|469126451|FG004|Overall Study|Study terminated by sponsor|5|||
130317095|NCT04612725|469126447|FG000|Overall Study|Withdrawal by Subject|8|||
130317096|NCT04612725|469126448|FG001|Overall Study|Withdrawal by Subject|3|||
130317097|NCT04612725|469126449|FG002|Overall Study|Withdrawal by Subject|5|||
130317098|NCT04612725|469126450|FG003|Overall Study|Withdrawal by Subject|1|||
130317099|NCT04612725|469126451|FG004|Overall Study|Withdrawal by Subject|9|||
130317100|NCT04612725|469126447|FG000|Overall Study|Other|0|||
130317101|NCT04612725|469126448|FG001|Overall Study|Other|0|||
130317102|NCT04612725|469126449|FG002|Overall Study|Other|0|||
130317103|NCT04612725|469126450|FG003|Overall Study|Other|0|||
130317104|NCT04612725|469126451|FG004|Overall Study|Other|1|||
130317105|NCT04875195|469126452|FG000|Overall Study|Death|9|||
130317106|NCT04875195|469126453|FG001|Overall Study|Death|3|||
130317107|NCT04875195|469126452|FG000|Overall Study|Withdrawal by Subject|2|||
130317108|NCT04875195|469126453|FG001|Overall Study|Withdrawal by Subject|1|||
130317109|NCT04875195|469126452|FG000|Overall Study|Ongoing in study|49|||
130317110|NCT04875195|469126453|FG001|Overall Study|Ongoing in study|2|||
130317111|NCT05190120|469126454|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130317112|NCT05190120|469126455|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130317113|NCT05190120|469126456|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
130317114|NCT05190120|469126457|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
130317115|NCT05190120|469126454|FG000|Overall Study|Lost to Follow-up|5|||
130317116|NCT05190120|469126455|FG001|Overall Study|Lost to Follow-up|0|||
130317117|NCT05190120|469126456|FG002|Overall Study|Lost to Follow-up|2|||
129891183|NCT01077024|467559642|FG001|Overall Study|Incarcerated|8|||
129891184|NCT01077024|467559641|FG000|Overall Study|Other|4|||
129891185|NCT01077024|467559642|FG001|Overall Study|Other|4|||
129891186|NCT03379233|467559643|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
129891187|NCT03379233|467559644|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
129891188|NCT01603121|467559645|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
129891189|NCT01603121|467559646|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
129891190|NCT02300311|467559649|FG000|Overall Study|Other than the reason specified|1|||
130317118|NCT05190120|469126457|FG003|Overall Study|Lost to Follow-up|3|||
130317119|NCT02354235|469126458|FG000|Overall Study|Adverse Event|2|||
130317120|NCT02354235|469126459|FG001|Overall Study|Adverse Event|2|||
130317121|NCT02354235|469126458|FG000|Overall Study|Physician Decision|0|||
130317122|NCT02354235|469126459|FG001|Overall Study|Physician Decision|1|||
130317123|NCT02354235|469126458|FG000|Overall Study|Withdrawal by Subject|1|||
130317124|NCT02354235|469126459|FG001|Overall Study|Withdrawal by Subject|3|||
130317125|NCT02354235|469126458|FG000|Overall Study|Conflict with the stopping criteria|0|||
130317126|NCT02354235|469126459|FG001|Overall Study|Conflict with the stopping criteria|1|||
130317127|NCT03069352|469126460|FG000|Overall Study|Ongoing|12|||
130317128|NCT03069352|469126461|FG001|Overall Study|Ongoing|40|||
130110735|NCT03705169|468365852|FG007|Overall Study|Concerns about study visit compliance|0|||
130110736|NCT03705169|468365853|FG008|Overall Study|Concerns about study visit compliance|0|||
130110737|NCT03705169|468365854|FG009|Overall Study|Concerns about study visit compliance|0|||
130317129|NCT02621424|469126462|FG000|Overall Study|Withdrawal by Subject|1|||
130110738|NCT00420290|468365855|FG000|Overall Study|Adverse Event|3|||
130110739|NCT00420290|468365856|FG001|Overall Study|Adverse Event|1|||
130317130|NCT02621424|469126463|FG001|Overall Study|Withdrawal by Subject|2|||
130317131|NCT04750642|469126466|FG000|Overall Study|Adverse Event|1|||
130317132|NCT04750642|469126467|FG001|Overall Study|Adverse Event|0|||
130317133|NCT04750642|469126466|FG000|Overall Study|Withdrawal by Subject|0|||
129891191|NCT02300311|467559650|FG001|Overall Study|Other than the reason specified|0|||
129891192|NCT02300311|467559649|FG000|Overall Study|Refused to continue taking medication|18|||
129891193|NCT02300311|467559650|FG001|Overall Study|Refused to continue taking medication|0|||
129891194|NCT00419003|467559651|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
129891195|NCT00419003|467559652|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
129891196|NCT00419003|467559651|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
129891197|NCT00419003|467559652|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
129891198|NCT01656759|467559653|FG000|Overall Study|Protocol Violation|2|||
129891199|NCT01656759|467559654|FG001|Overall Study|Protocol Violation|3|||
129891200|NCT02687919|467559655|FG000|Overall Study|Withdrawal by Subject|6|||
129891201|NCT02687919|467559656|FG001|Overall Study|Withdrawal by Subject|6|||
129891202|NCT02687919|467559655|FG000|Overall Study|Protocol Violation|2|||
129891203|NCT02687919|467559656|FG001|Overall Study|Protocol Violation|0|||
129891204|NCT02531438|467559657|FG000|Overall Study|Adverse Event|7|||
129891205|NCT02531438|467559658|FG001|Overall Study|Adverse Event|9|||
129891206|NCT02531438|467559657|FG000|Overall Study|Lost to Follow-up|0|||
129891207|NCT02531438|467559658|FG001|Overall Study|Lost to Follow-up|3|||
129891208|NCT02531438|467559657|FG000|Overall Study|Withdrawal by Subject|7|||
129891209|NCT02531438|467559658|FG001|Overall Study|Withdrawal by Subject|8|||
129891210|NCT02531438|467559657|FG000|Overall Study|Physician Decision|0|||
129891211|NCT02531438|467559658|FG001|Overall Study|Physician Decision|1|||
129891212|NCT02531438|467559657|FG000|Overall Study|Death|6|||
129891213|NCT02531438|467559658|FG001|Overall Study|Death|3|||
129891214|NCT02531438|467559657|FG000|Overall Study|Randomized, but Not Treated|4|||
129891215|NCT02531438|467559658|FG001|Overall Study|Randomized, but Not Treated|0|||
129891216|NCT02531438|467559657|FG000|Overall Study|Missed EOT/PTE Visit|5|||
129891217|NCT02531438|467559658|FG001|Overall Study|Missed EOT/PTE Visit|2|||
129891218|NCT02531438|467559657|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
129891219|NCT02531438|467559658|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
129891220|NCT00772928|467559659|FG000|Overall Study|Lost to Follow-up|9|||
129891221|NCT00772928|467559660|FG001|Overall Study|Lost to Follow-up|6|||
129891222|NCT00772928|467559659|FG000|Overall Study|Protocol Violation|10|||
130317134|NCT04750642|469126467|FG001|Overall Study|Withdrawal by Subject|1|||
130317135|NCT04750642|469126466|FG000|Overall Study|Protocol Violation|0|||
130317136|NCT04750642|469126467|FG001|Overall Study|Protocol Violation|1|||
130317137|NCT00336024|469126469|FG000|Overall Study|Death|2|||
130317138|NCT00336024|469126470|FG001|Overall Study|Death|1|||
130317139|NCT00336024|469126469|FG000|Overall Study|Physician Decision|4|||
130317140|NCT00336024|469126470|FG001|Overall Study|Physician Decision|1|||
130317141|NCT00336024|469126469|FG000|Overall Study|Protocol Violation|1|||
130317142|NCT00336024|469126470|FG001|Overall Study|Protocol Violation|0|||
130317143|NCT00336024|469126469|FG000|Overall Study|Withdrawal by Subject|1|||
129891223|NCT00772928|467559660|FG001|Overall Study|Protocol Violation|12|||
129891224|NCT00772928|467559659|FG000|Overall Study|Withdrawal by Subject|25|||
129891225|NCT00772928|467559660|FG001|Overall Study|Withdrawal by Subject|22|||
129891226|NCT00772928|467559659|FG000|Overall Study|Did not receive vaccine|0|||
129891227|NCT00772928|467559660|FG001|Overall Study|Did not receive vaccine|1|||
129891228|NCT00801242|467559667|FG000|Overall Study|Adverse Event|10|||
129891229|NCT00801242|467559667|FG000|Overall Study|Withdrawal by Subject|13|||
129800467|NCT02413372|467238098|FG001|Treatment|Lost to Follow-up|2|||
129800468|NCT02413372|467238099|FG002|Treatment|Lost to Follow-up|1|||
129800469|NCT02413372|467238097|FG000|Treatment|Withdrawal by Subject|1|||
129800470|NCT02413372|467238098|FG001|Treatment|Withdrawal by Subject|0|||
129800471|NCT02413372|467238099|FG002|Treatment|Withdrawal by Subject|0|||
129800472|NCT02413372|467238097|FG000|Follow-up|Lost to Follow-up|1|||
130052280|NCT02280291|468147228|FG002|Overall Study|Protocol Violation|0|||
130052281|NCT02280291|468147229|FG003|Overall Study|Protocol Violation|0|||
130052282|NCT02280291|468147226|FG000|Overall Study|Other|1|||
130052283|NCT02280291|468147227|FG001|Overall Study|Other|1|||
130052284|NCT02280291|468147228|FG002|Overall Study|Other|0|||
130052285|NCT02280291|468147229|FG003|Overall Study|Other|0|||
130052286|NCT05761444|468147230|FG000|Overall Study|Protocol Violation|2|||
130052287|NCT05761444|468147231|FG001|Overall Study|Protocol Violation|1|||
130052288|NCT05761444|468147230|FG000|Overall Study|Adverse Event|2|||
130052289|NCT05761444|468147231|FG001|Overall Study|Adverse Event|2|||
130052290|NCT05761444|468147230|FG000|Overall Study|Withdrawal by Subject|3|||
130052291|NCT05761444|468147231|FG001|Overall Study|Withdrawal by Subject|2|||
130052292|NCT05761444|468147230|FG000|Overall Study|Other|1|||
130052293|NCT05761444|468147231|FG001|Overall Study|Other|0|||
130052294|NCT01106534|468147232|FG000|Overall Study|Withdrawal by Subject|18|||
130052295|NCT01106534|468147232|FG000|Overall Study|Lost to Follow-up|2|||
130052296|NCT01106534|468147232|FG000|Overall Study|Death|16|||
130052297|NCT01106534|468147232|FG000|Overall Study|Physician Decision|1|||
130052298|NCT00069576|468147236|FG000|Original Trial|Lost to Follow-up|25|||
130052299|NCT00069576|468147237|FG001|Original Trial|Lost to Follow-up|33|||
130052300|NCT00069576|468147236|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
130052301|NCT00069576|468147237|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
130052302|NCT04430738|468147238|FG000|Phase 1: Dose Escalation|Death|1|||
130052303|NCT04430738|468147239|FG001|Phase 1: Dose Escalation|Death|4|||
130052304|NCT04430738|468147240|FG002|Phase 1: Dose Escalation|Death|4|||
130052305|NCT04430738|468147241|FG003|Phase 1: Dose Escalation|Death|1|||
130052306|NCT04430738|468147242|FG004|Phase 1: Dose Escalation|Death|6|||
130052307|NCT04430738|468147243|FG005|Phase 1: Dose Escalation|Death|0|||
130052308|NCT04430738|468147238|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
130052309|NCT04430738|468147239|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
130052310|NCT04430738|468147240|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
130052311|NCT04430738|468147241|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
130052312|NCT04430738|468147242|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
130052313|NCT04430738|468147243|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
130052314|NCT04430738|468147238|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130052315|NCT04430738|468147239|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
130052316|NCT04430738|468147240|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130052317|NCT04430738|468147241|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
130052318|NCT04430738|468147242|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130052319|NCT04430738|468147243|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
130052320|NCT04430738|468147238|FG000|Phase 1: Dose Escalation|Other|1|||
130052321|NCT04430738|468147239|FG001|Phase 1: Dose Escalation|Other|0|||
130052322|NCT04430738|468147240|FG002|Phase 1: Dose Escalation|Other|0|||
130052323|NCT04430738|468147241|FG003|Phase 1: Dose Escalation|Other|0|||
130052324|NCT04430738|468147242|FG004|Phase 1: Dose Escalation|Other|0|||
130052325|NCT04430738|468147243|FG005|Phase 1: Dose Escalation|Other|0|||
130052326|NCT04430738|468147238|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130052327|NCT04430738|468147239|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130052328|NCT04430738|468147240|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130052329|NCT04430738|468147241|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130052330|NCT04430738|468147242|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
130052331|NCT04430738|468147243|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
130052332|NCT04430738|468147238|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130052333|NCT04430738|468147239|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130052334|NCT04430738|468147240|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129800473|NCT02413372|467238098|FG001|Follow-up|Lost to Follow-up|1|||
129800474|NCT02413372|467238099|FG002|Follow-up|Lost to Follow-up|0|||
129800475|NCT02413372|467238097|FG000|Follow-up|Subject Withdrew Consent|1|||
129800476|NCT02413372|467238098|FG001|Follow-up|Subject Withdrew Consent|0|||
129800477|NCT02413372|467238099|FG002|Follow-up|Subject Withdrew Consent|1|||
129800478|NCT02413372|467238097|FG000|Follow-up|Subject unable to return for visit|0|||
129800479|NCT02413372|467238098|FG001|Follow-up|Subject unable to return for visit|0|||
129800480|NCT02413372|467238099|FG002|Follow-up|Subject unable to return for visit|1|||
129800481|NCT02556203|467238106|FG000|Overall Study|Withdrawal by Subject|21|||
129800482|NCT02556203|467238107|FG001|Overall Study|Withdrawal by Subject|21|||
129800483|NCT02556203|467238106|FG000|Overall Study|Lost to Follow-up|5|||
129891230|NCT00801242|467559667|FG000|Overall Study|Protocol Violation|5|||
129891231|NCT00801242|467559667|FG000|Overall Study|Physician Decision|3|||
129891232|NCT00801242|467559667|FG000|Overall Study|Lost to Follow-up|1|||
129891233|NCT00801242|467559667|FG000|Overall Study|Miscellaneous reasons|20|||
129891234|NCT02015195|467559669|FG000|Overall Study|Adverse Event|0|||
129891235|NCT02015195|467559670|FG001|Overall Study|Adverse Event|0|||
129891236|NCT02015195|467559671|FG002|Overall Study|Adverse Event|0|||
129891237|NCT02015195|467559672|FG003|Overall Study|Adverse Event|1|||
129891238|NCT02015195|467559673|FG004|Overall Study|Adverse Event|0|||
129891239|NCT02015195|467559674|FG005|Overall Study|Adverse Event|0|||
129891240|NCT02015195|467559675|FG006|Overall Study|Adverse Event|0|||
129891241|NCT01318811|467559676|FG000|Overall Study|Physician Decision|1|||
129891242|NCT01318811|467559677|FG001|Overall Study|Physician Decision|1|||
129891243|NCT01318811|467559676|FG000|Overall Study|CRRT stopped for head CT|0|||
129891244|NCT01318811|467559677|FG001|Overall Study|CRRT stopped for head CT|1|||
129891245|NCT01318811|467559676|FG000|Overall Study|Death|0|||
129891246|NCT01318811|467559677|FG001|Overall Study|Death|1|||
129891247|NCT01318811|467559676|FG000|Overall Study|CRRT stopped for head MRI|0|||
129891248|NCT01318811|467559677|FG001|Overall Study|CRRT stopped for head MRI|1|||
129891249|NCT00811187|467559678|FG000|Overall Study|Unable to place device / procedure abort|3|||
129891250|NCT00811187|467559679|FG001|Overall Study|Unable to place device / procedure abort|3|||
129891251|NCT00131911|467559680|FG000|Overall Study|Withdrawal by Subject|1|||
129891252|NCT00131911|467559681|FG001|Overall Study|Withdrawal by Subject|0|||
129891253|NCT00329303|467559682|FG000|Overall Study|Lack of Efficacy|1|||
129891254|NCT00329303|467559683|FG001|Overall Study|Lack of Efficacy|0|||
129891255|NCT00329303|467559682|FG000|Overall Study|Decision of the sponsor|0|||
129891256|NCT00329303|467559683|FG001|Overall Study|Decision of the sponsor|1|||
129891257|NCT00329303|467559682|FG000|Overall Study|Patient no longer available|1|||
129891258|NCT00329303|467559683|FG001|Overall Study|Patient no longer available|0|||
129891259|NCT00329303|467559682|FG000|Overall Study|Patient relocated|0|||
129891260|NCT00329303|467559683|FG001|Overall Study|Patient relocated|1|||
129891261|NCT00994279|467559689|FG000|Overall Study|Withdrawal by Subject|2|||
129891262|NCT00994279|467559690|FG001|Overall Study|Withdrawal by Subject|2|||
130052335|NCT04430738|468147241|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129800484|NCT02556203|467238107|FG001|Overall Study|Lost to Follow-up|5|||
129800485|NCT02556203|467238106|FG000|Overall Study|Adverse Event|1|||
129800486|NCT02556203|467238107|FG001|Overall Study|Adverse Event|0|||
129891263|NCT00994279|467559689|FG000|Overall Study|Toxicity|1|||
130110740|NCT00420290|468365855|FG000|Overall Study|Withdrawal by Subject|0|||
130110741|NCT00420290|468365856|FG001|Overall Study|Withdrawal by Subject|2|||
130110742|NCT00420290|468365855|FG000|Overall Study|did not meet inclusion/exclusion|1|||
130110743|NCT00420290|468365856|FG001|Overall Study|did not meet inclusion/exclusion|1|||
130110744|NCT01963676|468367444|FG000|Overall Study|Withdrawal by Subject|1|||
130110745|NCT01963676|468367445|FG001|Overall Study|Withdrawal by Subject|0|||
130110746|NCT01246973|468367446|FG000|Overall Study|Other|38|||
130110747|NCT01246973|468367447|FG001|Overall Study|Other|25|||
130110748|NCT01246973|468367446|FG000|Overall Study|Adverse Event|16|||
130110749|NCT01246973|468367447|FG001|Overall Study|Adverse Event|9|||
130110750|NCT01246973|468367446|FG000|Overall Study|Withdrawal by Subject|7|||
130110751|NCT01246973|468367447|FG001|Overall Study|Withdrawal by Subject|13|||
130110752|NCT00766506|468367448|FG000|Overall Study|Use rescue medication after 3 hours|3|||
130110753|NCT00766506|468367449|FG001|Overall Study|Use rescue medication after 3 hours|0|||
130110754|NCT00766506|468367448|FG000|Overall Study|Other|2|||
130110755|NCT00766506|468367449|FG001|Overall Study|Other|2|||
130110756|NCT02496221|468367450|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
130110757|NCT02496221|468367451|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
130110758|NCT02496221|468367450|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
130110759|NCT02496221|468367451|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
130110760|NCT02496221|468367450|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
130110761|NCT02496221|468367451|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
130110762|NCT03262233|468367452|FG000|Overall Study|Withdrawal by Subject|12|||
130110763|NCT03262233|468367453|FG001|Overall Study|Withdrawal by Subject|8|||
130110764|NCT03262233|468367454|FG002|Overall Study|Withdrawal by Subject|21|||
130110765|NCT03262233|468367455|FG003|Overall Study|Withdrawal by Subject|13|||
130110766|NCT03262233|468367452|FG000|Overall Study|Declined due to shock|1|||
130110767|NCT03262233|468367453|FG001|Overall Study|Declined due to shock|2|||
130110768|NCT03262233|468367454|FG002|Overall Study|Declined due to shock|2|||
130110769|NCT03262233|468367455|FG003|Overall Study|Declined due to shock|3|||
130110770|NCT03262233|468367452|FG000|Overall Study|Protocol Violation|5|||
130110771|NCT03262233|468367453|FG001|Overall Study|Protocol Violation|10|||
130110772|NCT03262233|468367454|FG002|Overall Study|Protocol Violation|2|||
130110773|NCT03262233|468367455|FG003|Overall Study|Protocol Violation|13|||
130110774|NCT03262233|468367452|FG000|Overall Study|data collection artifact|0|||
130110775|NCT03262233|468367453|FG001|Overall Study|data collection artifact|1|||
130110776|NCT03262233|468367454|FG002|Overall Study|data collection artifact|0|||
130110777|NCT03262233|468367455|FG003|Overall Study|data collection artifact|0|||
130110778|NCT01120600|468367458|FG000|Overall Study|Adverse Event|7|||
130110779|NCT01120600|468367459|FG001|Overall Study|Adverse Event|7|||
130110780|NCT01120600|468367458|FG000|Overall Study|Excessive Bone Loss|0|||
130110781|NCT01120600|468367459|FG001|Overall Study|Excessive Bone Loss|4|||
130110782|NCT01120600|468367458|FG000|Overall Study|Lost to Follow-up|1|||
130110783|NCT01120600|468367459|FG001|Overall Study|Lost to Follow-up|3|||
130110784|NCT01120600|468367458|FG000|Overall Study|Physician Decision|1|||
130110785|NCT01120600|468367459|FG001|Overall Study|Physician Decision|3|||
130110786|NCT01120600|468367458|FG000|Overall Study|Protocol Violation|0|||
130110787|NCT01120600|468367459|FG001|Overall Study|Protocol Violation|4|||
130110788|NCT01120600|468367458|FG000|Overall Study|Withdrawal by Subject|10|||
130110789|NCT01120600|468367459|FG001|Overall Study|Withdrawal by Subject|11|||
130110790|NCT01165242|468367460|FG000|Overall Study|Unreachable Subjects|1|||
130110791|NCT01165242|468367461|FG001|Overall Study|Unreachable Subjects|0|||
130110792|NCT01165242|468367462|FG002|Overall Study|Unreachable Subjects|0|||
130110793|NCT01165242|468367460|FG000|Overall Study|Incarcerated Subjects|0|||
130110794|NCT01165242|468367461|FG001|Overall Study|Incarcerated Subjects|1|||
130110795|NCT01165242|468367462|FG002|Overall Study|Incarcerated Subjects|0|||
130110796|NCT01165242|468367460|FG000|Overall Study|Visit 2 Declined by Subject|0|||
130110797|NCT01165242|468367461|FG001|Overall Study|Visit 2 Declined by Subject|0|||
130110798|NCT01165242|468367462|FG002|Overall Study|Visit 2 Declined by Subject|1|||
130110799|NCT01165242|468367460|FG000|Overall Study|Withdrawal by Subject|0|||
130110800|NCT01165242|468367461|FG001|Overall Study|Withdrawal by Subject|2|||
130110801|NCT01165242|468367462|FG002|Overall Study|Withdrawal by Subject|2|||
130110802|NCT01165242|468367460|FG000|Overall Study|Extended Holiday|0|||
130110803|NCT01165242|468367461|FG001|Overall Study|Extended Holiday|0|||
130110804|NCT01165242|468367462|FG002|Overall Study|Extended Holiday|1|||
130110805|NCT01165242|468367460|FG000|Overall Study|Lost to Follow-up|9|||
130110806|NCT01165242|468367461|FG001|Overall Study|Lost to Follow-up|7|||
130110807|NCT01165242|468367462|FG002|Overall Study|Lost to Follow-up|10|||
130110808|NCT03770000|468367463|FG000|Overall Study|Premature discontinuation due to PD|0|||
130110809|NCT03770000|468367464|FG001|Overall Study|Premature discontinuation due to PD|0|||
130110810|NCT03770000|468367465|FG002|Overall Study|Premature discontinuation due to PD|1|||
130110811|NCT03770000|468367466|FG003|Overall Study|Premature discontinuation due to PD|3|||
130110812|NCT03770000|468367467|FG004|Overall Study|Premature discontinuation due to PD|2|||
130110813|NCT03877237|468367468|FG000|Overall Study|Adverse Event|1|||
130110814|NCT03877237|468367469|FG001|Overall Study|Adverse Event|2|||
130317144|NCT00336024|469126470|FG001|Overall Study|Withdrawal by Subject|2|||
130317145|NCT00336024|469126469|FG000|Overall Study|Failure to fulfill consolidation|1|||
130317146|NCT00336024|469126470|FG001|Overall Study|Failure to fulfill consolidation|1|||
130110815|NCT03877237|468367468|FG000|Overall Study|Death|3|||
130110816|NCT03877237|468367469|FG001|Overall Study|Death|2|||
130317147|NCT00336024|469126469|FG000|Overall Study|Progressive Disease|4|||
130317148|NCT00336024|469126470|FG001|Overall Study|Progressive Disease|7|||
130317149|NCT00336024|469126469|FG000|Overall Study|Ineligible|7|||
130317150|NCT00336024|469126470|FG001|Overall Study|Ineligible|7|||
130317151|NCT00644423|469128515|FG000|Overall Study|Lost to Follow-up|1|||
130317152|NCT00644423|469128516|FG001|Overall Study|Lost to Follow-up|1|||
130317153|NCT01519323|469128521|FG000|Overall Study|Death|3|||
130317154|NCT01519323|469128522|FG001|Overall Study|Death|2|||
130317155|NCT01519323|469128521|FG000|Overall Study|Study terminated by sponsor|0|||
130317156|NCT01519323|469128522|FG001|Overall Study|Study terminated by sponsor|1|||
130317157|NCT03096834|469128533|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
130317158|NCT03096834|469128534|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
130317159|NCT03096834|469128535|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
130317160|NCT03096834|469128536|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
130317161|NCT03096834|469128533|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
130317162|NCT03096834|469128534|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
130317163|NCT03096834|469128535|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
130317164|NCT03096834|469128536|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
130317165|NCT03096834|469128533|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
130317166|NCT03096834|469128534|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
130317167|NCT03096834|469128535|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
130317168|NCT03096834|469128536|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
130317169|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
130317170|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
130317171|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
130317172|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
130317173|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
130317174|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
130317175|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
130317176|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
130317177|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
130317178|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
130317179|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
130317180|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
130317181|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
130317182|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
130317183|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
130317184|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
130317185|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
130317186|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
130317187|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
130317188|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
130317189|NCT03096834|469128533|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
130317190|NCT03096834|469128534|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
130317191|NCT03096834|469128535|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
130317192|NCT03096834|469128536|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
130317193|NCT03096834|469128533|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
130317194|NCT03096834|469128534|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
130317195|NCT03096834|469128535|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
130317196|NCT03096834|469128536|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
130317197|NCT03096834|469128533|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
130317198|NCT03096834|469128534|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
130317199|NCT03096834|469128535|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
130317200|NCT03096834|469128536|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
130317201|NCT03096834|469128533|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130110817|NCT03877237|468367468|FG000|Overall Study|Physician Decision|1|||
130110818|NCT03877237|468367469|FG001|Overall Study|Physician Decision|0|||
130110819|NCT03877237|468367468|FG000|Overall Study|Withdrawal by Subject|0|||
130317202|NCT03096834|469128534|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130317203|NCT03096834|469128535|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
130317204|NCT03096834|469128536|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
130317205|NCT04416204|469128537|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130110820|NCT03877237|468367469|FG001|Overall Study|Withdrawal by Subject|2|||
129800487|NCT04587271|467238108|FG000|Overall Study|Lost to Follow-up|2|||
130110821|NCT00566098|468367472|FG000|Collection of MILs|Withdrawal by Subject|1|||
130110822|NCT00566098|468367472|FG000|Collection of MILs|Relapsed|1|||
130110823|NCT00566098|468367472|FG000|Generation of MILs Product|Relapsed|1|||
130110824|NCT00566098|468367472|FG000|Administration of ASCT+MILs|Death|10|||
130110825|NCT00566098|468367472|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
130110826|NCT01690520|468367475|FG000|Overall Study|Death|25|||
130110827|NCT01690520|468367476|FG001|Overall Study|Death|21|||
130110828|NCT01690520|468367475|FG000|Overall Study|Lost to Follow-up|2|||
130110829|NCT01690520|468367476|FG001|Overall Study|Lost to Follow-up|3|||
130110830|NCT01690520|468367475|FG000|Overall Study|Withdrawal by Subject|2|||
130110831|NCT01690520|468367476|FG001|Overall Study|Withdrawal by Subject|0|||
130110832|NCT01690520|468367475|FG000|Overall Study|Relapse|0|||
130110833|NCT01690520|468367476|FG001|Overall Study|Relapse|1|||
130110834|NCT01690520|468367475|FG000|Overall Study|Other|0|||
130110835|NCT01690520|468367476|FG001|Overall Study|Other|1|||
130110836|NCT01690520|468367475|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
130110837|NCT01690520|468367476|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
130110838|NCT02236754|468367477|FG000|Overall Study|Withdrawal by Subject|1|||
130110839|NCT02236754|468367478|FG001|Overall Study|Withdrawal by Subject|0|||
130110840|NCT04006847|468367479|FG000|Overall Study|Product issue|1|||
130110841|NCT00382291|468367480|FG000|Overall Study|Adverse Event|1|||
130110842|NCT00382291|468367481|FG001|Overall Study|Adverse Event|2|||
130110843|NCT00382291|468367482|FG002|Overall Study|Adverse Event|2|||
130110844|NCT00382291|468367480|FG000|Overall Study|Protocol Violation|1|||
130110845|NCT00382291|468367481|FG001|Overall Study|Protocol Violation|0|||
130110846|NCT00382291|468367482|FG002|Overall Study|Protocol Violation|0|||
130110847|NCT00382291|468367480|FG000|Overall Study|Temporary study suspension|2|||
130110848|NCT00382291|468367481|FG001|Overall Study|Temporary study suspension|2|||
130110849|NCT00382291|468367482|FG002|Overall Study|Temporary study suspension|5|||
130110850|NCT00382291|468367480|FG000|Overall Study|Withdrawal by Subject|0|||
130110851|NCT00382291|468367481|FG001|Overall Study|Withdrawal by Subject|2|||
130110852|NCT00382291|468367482|FG002|Overall Study|Withdrawal by Subject|0|||
130110853|NCT00382291|468367480|FG000|Overall Study|Physician Decision|0|||
130110854|NCT00382291|468367481|FG001|Overall Study|Physician Decision|1|||
130110855|NCT00382291|468367482|FG002|Overall Study|Physician Decision|0|||
130110856|NCT00382291|468367480|FG000|Overall Study|Lack of Efficacy|0|||
130110857|NCT00382291|468367481|FG001|Overall Study|Lack of Efficacy|0|||
130110858|NCT00382291|468367482|FG002|Overall Study|Lack of Efficacy|1|||
130110859|NCT02092961|468367485|FG000|Overall Study|Not reported|1|||
129800488|NCT04587271|467238109|FG001|Overall Study|Lost to Follow-up|2|||
129800489|NCT04587271|467238110|FG002|Overall Study|Lost to Follow-up|0|||
130052336|NCT04430738|468147242|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
130052337|NCT04430738|468147243|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
130052338|NCT05590793|468147244|FG000|Overall Study|Withdrawal by Subject|6|||
130052339|NCT05590793|468147244|FG000|Overall Study|Physician Decision|1|||
130052340|NCT05187013|468147245|FG000|Overall Study|Withdrawal by Subject|1|||
130052341|NCT05187013|468147246|FG001|Overall Study|Withdrawal by Subject|1|||
130052342|NCT05187013|468147247|FG002|Overall Study|Withdrawal by Subject|0|||
130052343|NCT05187013|468147245|FG000|Overall Study|Death|0|||
130052344|NCT05187013|468147246|FG001|Overall Study|Death|1|||
130052345|NCT05187013|468147247|FG002|Overall Study|Death|0|||
130052346|NCT05187013|468147245|FG000|Overall Study|Lost to Follow-up|20|||
130052347|NCT05187013|468147246|FG001|Overall Study|Lost to Follow-up|17|||
130052348|NCT05187013|468147247|FG002|Overall Study|Lost to Follow-up|0|||
130052349|NCT05187013|468147245|FG000|Overall Study|Ongoing Participants|3|||
130052350|NCT05187013|468147246|FG001|Overall Study|Ongoing Participants|5|||
130052351|NCT05187013|468147247|FG002|Overall Study|Ongoing Participants|0|||
130052352|NCT04488822|468147248|FG000|Overall Study|Adverse Event|8|||
130052353|NCT04488822|468147248|FG000|Overall Study|Withdrawal by Subject|1|||
130052354|NCT03838367|468147249|FG000|Overall Study|Early termination of study|3|||
130052355|NCT03838367|468147250|FG001|Overall Study|Early termination of study|4|||
130052356|NCT03838367|468147251|FG002|Overall Study|Early termination of study|3|||
130052357|NCT03838367|468147252|FG003|Overall Study|Early termination of study|0|||
130052358|NCT03406104|468147253|FG000|Overall Study|Lost to Follow-up|2|||
130052359|NCT03406104|468147253|FG000|Overall Study|Withdrawal by Subject|2|||
130052360|NCT03406104|468147253|FG000|Overall Study|due to Covid patient did not want to travel|1|||
130052361|NCT03406104|468147253|FG000|Overall Study|Death|2|||
130052362|NCT02499146|468147262|FG000|Overall Study|Lost to Follow-up|1|||
130052363|NCT02499146|468147262|FG000|Overall Study|Withdrawal by Subject|1|||
130052364|NCT02499146|468147262|FG000|Overall Study|Other|2|||
130052365|NCT02499146|468147262|FG000|Overall Study|Ongoing at date of cut-off|9|||
130052366|NCT02499146|468147262|FG000|Overall Study|Began other treatment/therapy|13|||
130052367|NCT05692154|468147263|FG000|Overall Study|Adverse Event|0|||
130052368|NCT05692154|468147264|FG001|Overall Study|Adverse Event|1|||
130052369|NCT01108809|468147265|FG000|Overall Study|Adverse Event|3|||
130052370|NCT01108809|468147265|FG000|Overall Study|Lost to Follow-up|1|||
130052371|NCT00783705|468147267|FG000|Overall Study|Adverse Event|2|||
130052372|NCT00783705|468147268|FG001|Overall Study|Adverse Event|0|||
130052373|NCT00783705|468147267|FG000|Overall Study|Withdrawal by Subject|3|||
130052374|NCT00783705|468147268|FG001|Overall Study|Withdrawal by Subject|2|||
130052375|NCT00783705|468147267|FG000|Overall Study|Lost to Follow-up|1|||
130052376|NCT00783705|468147268|FG001|Overall Study|Lost to Follow-up|3|||
130052377|NCT01954121|468147269|FG000|Overall Study|Lack of Efficacy|94|||
130052378|NCT01954121|468147270|FG001|Overall Study|Lack of Efficacy|41|||
130052379|NCT01954121|468147269|FG000|Overall Study|Protocol Violation|0|||
130052380|NCT01954121|468147270|FG001|Overall Study|Protocol Violation|2|||
130052381|NCT01954121|468147269|FG000|Overall Study|Lost to Follow-up|5|||
130052382|NCT01954121|468147270|FG001|Overall Study|Lost to Follow-up|6|||
130052383|NCT01954121|468147269|FG000|Overall Study|Withdrawal by Subject|18|||
130052384|NCT01954121|468147270|FG001|Overall Study|Withdrawal by Subject|12|||
129800490|NCT04587271|467238111|FG003|Overall Study|Lost to Follow-up|2|||
130052385|NCT01954121|468147269|FG000|Overall Study|Pregnancy|1|||
130052386|NCT01954121|468147270|FG001|Overall Study|Pregnancy|1|||
130052387|NCT01954121|468147269|FG000|Overall Study|AE, serious fatal|1|||
129800491|NCT04587271|467238112|FG004|Overall Study|Lost to Follow-up|2|||
130052388|NCT01954121|468147270|FG001|Overall Study|AE, serious fatal|0|||
130052389|NCT01954121|468147269|FG000|Overall Study|AE, non-serious non-fatal|5|||
130052390|NCT01954121|468147270|FG001|Overall Study|AE, non-serious non-fatal|22|||
130052391|NCT01954121|468147269|FG000|Overall Study|SAE, non-fatal|1|||
130052392|NCT01954121|468147270|FG001|Overall Study|SAE, non-fatal|4|||
130317206|NCT04416204|469128538|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
130317207|NCT04416204|469128539|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130317208|NCT04416204|469128540|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
130317209|NCT04456504|469128541|FG000|Overall Study|Lost to Follow-up|2|||
130317210|NCT01131507|469128542|FG000|Overall Study|Adverse Event|1|||
130052393|NCT01954121|468147269|FG000|Overall Study|Non-compliant with study procedures|1|||
130052394|NCT01954121|468147270|FG001|Overall Study|Non-compliant with study procedures|0|||
130052395|NCT01954121|468147269|FG000|Overall Study|Non-compliant patient|1|||
130052396|NCT01954121|468147270|FG001|Overall Study|Non-compliant patient|1|||
130052397|NCT01954121|468147269|FG000|Overall Study|Subject did not follow instructions|0|||
130052398|NCT01954121|468147270|FG001|Overall Study|Subject did not follow instructions|2|||
130052399|NCT02588248|468147278|FG000|Overall Study|Physician Decision|4|||
130052400|NCT02588248|468147279|FG001|Overall Study|Physician Decision|3|||
130052401|NCT02504892|468147282|FG000|Overall Study|Adverse event-pneumonitis|2|||
130052402|NCT00576693|468147283|FG000|Overall Study|Lost to Follow-up|7|||
130052403|NCT00576693|468147284|FG001|Overall Study|Lost to Follow-up|11|||
130052404|NCT00576693|468147283|FG000|Overall Study|Withdrawal by Subject|3|||
130052405|NCT00576693|468147284|FG001|Overall Study|Withdrawal by Subject|13|||
130052406|NCT01413178|468147285|FG000|Overall Study|Toxicity|1|||
130052407|NCT01413178|468147286|FG001|Overall Study|Toxicity|0|||
130052408|NCT01413178|468147285|FG000|Overall Study|Ineligible|0|||
130052409|NCT01413178|468147286|FG001|Overall Study|Ineligible|2|||
130052410|NCT03643432|468147287|FG000|Overall Study|Lost to Follow-up|1|||
130052411|NCT03643432|468147288|FG001|Overall Study|Lost to Follow-up|0|||
130317211|NCT01131507|469128542|FG000|Overall Study|Lost to Follow-up|1|||
130317212|NCT01131507|469128542|FG000|Overall Study|Withdrawal by Subject|1|||
130317213|NCT00762359|469128549|FG000|Overall Study|Adverse Event|20|||
130317214|NCT00762359|469128550|FG001|Overall Study|Adverse Event|23|||
130317215|NCT00762359|469128549|FG000|Overall Study|Protocol Violation|21|||
130317216|NCT00762359|469128550|FG001|Overall Study|Protocol Violation|13|||
130317217|NCT00762359|469128549|FG000|Overall Study|Withdrawal by Subject|13|||
130317218|NCT00762359|469128550|FG001|Overall Study|Withdrawal by Subject|10|||
130317219|NCT00762359|469128549|FG000|Overall Study|Lack of Efficacy|0|||
130317220|NCT00762359|469128550|FG001|Overall Study|Lack of Efficacy|4|||
130317221|NCT00762359|469128549|FG000|Overall Study|Institution closed|2|||
130317222|NCT00762359|469128550|FG001|Overall Study|Institution closed|3|||
130317223|NCT00762359|469128549|FG000|Overall Study|Physician Decision|2|||
130317224|NCT00762359|469128550|FG001|Overall Study|Physician Decision|3|||
130317225|NCT00762359|469128549|FG000|Overall Study|Removal|0|||
130317226|NCT00762359|469128550|FG001|Overall Study|Removal|1|||
130317227|NCT00762359|469128549|FG000|Overall Study|Withdrew consent|1|||
130317228|NCT00762359|469128550|FG001|Overall Study|Withdrew consent|0|||
130317229|NCT01453049|469128551|FG000|Overall Study|Protocol Violation|2|||
130317230|NCT01453049|469128552|FG001|Overall Study|Protocol Violation|5|||
130317231|NCT01453049|469128551|FG000|Overall Study|Lost to Follow-up|2|||
130317232|NCT01453049|469128552|FG001|Overall Study|Lost to Follow-up|1|||
130317233|NCT01453049|469128551|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
130317234|NCT01453049|469128552|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
130317235|NCT01453049|469128551|FG000|Overall Study|Withdrawal by Subject|1|||
130317236|NCT01453049|469128552|FG001|Overall Study|Withdrawal by Subject|0|||
130317237|NCT01453049|469128551|FG000|Overall Study|Randomized in Error|1|||
130317238|NCT01453049|469128552|FG001|Overall Study|Randomized in Error|0|||
130317239|NCT00882440|469128553|FG000|Overall Study|Adverse Event|2|||
130317240|NCT00882440|469128554|FG001|Overall Study|Adverse Event|2|||
130317241|NCT00882440|469128555|FG002|Overall Study|Adverse Event|2|||
130317242|NCT00882440|469128556|FG003|Overall Study|Adverse Event|1|||
130317243|NCT00882440|469128557|FG004|Overall Study|Adverse Event|1|||
130052412|NCT00804193|468147289|FG000|Overall Study|Lack of baseline fungus|32|||
130052413|NCT00804193|468147290|FG001|Overall Study|Lack of baseline fungus|31|||
130052414|NCT00804193|468147291|FG002|Overall Study|Lack of baseline fungus|19|||
130052415|NCT00804193|468147289|FG000|Overall Study|Adverse Event|0|||
130052416|NCT00804193|468147290|FG001|Overall Study|Adverse Event|0|||
130317244|NCT00882440|469128558|FG005|Overall Study|Adverse Event|4|||
130317245|NCT00882440|469128559|FG006|Overall Study|Adverse Event|2|||
130317246|NCT00882440|469128553|FG000|Overall Study|Lack of Efficacy|3|||
130317247|NCT00882440|469128554|FG001|Overall Study|Lack of Efficacy|5|||
130317248|NCT00882440|469128555|FG002|Overall Study|Lack of Efficacy|2|||
130317249|NCT00882440|469128556|FG003|Overall Study|Lack of Efficacy|0|||
130317250|NCT00882440|469128557|FG004|Overall Study|Lack of Efficacy|0|||
130052417|NCT00804193|468147291|FG002|Overall Study|Adverse Event|2|||
130317251|NCT00882440|469128558|FG005|Overall Study|Lack of Efficacy|3|||
130052418|NCT00804193|468147289|FG000|Overall Study|Lack of Efficacy|1|||
130317252|NCT00882440|469128559|FG006|Overall Study|Lack of Efficacy|0|||
130317253|NCT00882440|469128553|FG000|Overall Study|Lost to Follow-up|2|||
130317254|NCT00882440|469128554|FG001|Overall Study|Lost to Follow-up|0|||
130317255|NCT00882440|469128555|FG002|Overall Study|Lost to Follow-up|1|||
129800492|NCT04587271|467238113|FG005|Overall Study|Lost to Follow-up|0|||
130052419|NCT00804193|468147290|FG001|Overall Study|Lack of Efficacy|1|||
130052420|NCT00804193|468147291|FG002|Overall Study|Lack of Efficacy|3|||
130052421|NCT00804193|468147289|FG000|Overall Study|Protocol Violation|0|||
130052422|NCT00804193|468147290|FG001|Overall Study|Protocol Violation|8|||
130052423|NCT00804193|468147291|FG002|Overall Study|Protocol Violation|2|||
130052424|NCT00804193|468147289|FG000|Overall Study|Lost to Follow-up|3|||
130052425|NCT00804193|468147290|FG001|Overall Study|Lost to Follow-up|3|||
130052426|NCT00804193|468147291|FG002|Overall Study|Lost to Follow-up|4|||
130052427|NCT00804193|468147289|FG000|Overall Study|Withdrawal by Subject|3|||
130052428|NCT00804193|468147290|FG001|Overall Study|Withdrawal by Subject|1|||
130052429|NCT00804193|468147291|FG002|Overall Study|Withdrawal by Subject|2|||
130052430|NCT04072146|468147294|FG000|Overall Study|Adverse Event|0|||
130052431|NCT04072146|468147295|FG001|Overall Study|Adverse Event|1|||
130052432|NCT01617434|468147296|FG000|Overall Study|Adverse Event|12|||
130052433|NCT01617434|468147297|FG001|Overall Study|Adverse Event|3|||
130052434|NCT01617434|468147296|FG000|Overall Study|Protocol Violation|8|||
130052435|NCT01617434|468147297|FG001|Overall Study|Protocol Violation|7|||
130052436|NCT01617434|468147296|FG000|Overall Study|Withdrawal Criteria|12|||
130052437|NCT01617434|468147297|FG001|Overall Study|Withdrawal Criteria|37|||
130052438|NCT01617434|468147296|FG000|Overall Study|Unclassified|3|||
130052439|NCT01617434|468147297|FG001|Overall Study|Unclassified|4|||
130052440|NCT01987986|468147298|FG000|Overall Study|Lost to Follow-up|1|||
130052441|NCT01987986|468147299|FG001|Overall Study|Lost to Follow-up|0|||
130052442|NCT01987986|468147300|FG002|Overall Study|Lost to Follow-up|0|||
130052443|NCT01987986|468147301|FG003|Overall Study|Lost to Follow-up|0|||
130052444|NCT01987986|468147298|FG000|Overall Study|Adverse Event|1|||
130052445|NCT01987986|468147299|FG001|Overall Study|Adverse Event|0|||
130052446|NCT01987986|468147300|FG002|Overall Study|Adverse Event|2|||
130052447|NCT01987986|468147301|FG003|Overall Study|Adverse Event|0|||
130052448|NCT03283163|468147304|FG000|Overall Study|Lost to Follow-up|1|||
130052449|NCT03283163|468147304|FG000|Overall Study|other life commitments|6|||
130052450|NCT03283163|468147304|FG000|Overall Study|COVID-19 institution wide halting|1|||
130052451|NCT03283163|468147304|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
130052452|NCT03283163|468147304|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
130052453|NCT00237796|468147305|FG000|Overall Study|Baseline and one other ILSS required|10|||
130052454|NCT00237796|468147306|FG001|Overall Study|Baseline and one other ILSS required|5|||
130052455|NCT04238663|468147310|FG000|Overall Study|Lost to Follow-up|0|||
130052456|NCT04238663|468147311|FG001|Overall Study|Lost to Follow-up|1|||
130052457|NCT04238663|468147312|FG002|Overall Study|Lost to Follow-up|0|||
130052458|NCT01193348|468147313|FG000|Screening Period|Screen Failure|5|||
130052459|NCT01193348|468147313|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
130052460|NCT01193348|468147313|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
130052461|NCT01193348|468147313|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
130052462|NCT01193348|468147313|FG000|Extension Treatment Period|Physician Decision|1|||
130052463|NCT01193348|468147313|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
130052464|NCT04070378|468147314|FG000|Overall Study|Withdrawal by Subject|2|||
130052465|NCT04070378|468147314|FG000|Overall Study|Screen Failure|6|||
130052466|NCT04070378|468147314|FG000|Overall Study|Physician Decision|1|||
130052467|NCT04070378|468147314|FG000|Overall Study|Adverse Event|1|||
130052468|NCT03259334|468147315|FG000|Overall Study|Adverse Event|3|||
130052469|NCT03259334|468147316|FG001|Overall Study|Adverse Event|8|||
130052470|NCT03259334|468147317|FG002|Overall Study|Adverse Event|5|||
130052471|NCT03259334|468147315|FG000|Overall Study|Withdrawal by Subject|4|||
130052472|NCT03259334|468147316|FG001|Overall Study|Withdrawal by Subject|2|||
130052473|NCT03259334|468147317|FG002|Overall Study|Withdrawal by Subject|4|||
130052474|NCT03259334|468147315|FG000|Overall Study|Physician Decision|1|||
130052475|NCT03259334|468147316|FG001|Overall Study|Physician Decision|0|||
130052476|NCT03259334|468147317|FG002|Overall Study|Physician Decision|0|||
130052477|NCT03259334|468147315|FG000|Overall Study|Lost to Follow-up|0|||
130052478|NCT03259334|468147316|FG001|Overall Study|Lost to Follow-up|2|||
130052479|NCT03259334|468147317|FG002|Overall Study|Lost to Follow-up|1|||
130052480|NCT03259334|468147315|FG000|Overall Study|Protocol Deviation|0|||
130052481|NCT03259334|468147316|FG001|Overall Study|Protocol Deviation|3|||
130052482|NCT03259334|468147317|FG002|Overall Study|Protocol Deviation|2|||
130052483|NCT03259334|468147315|FG000|Overall Study|Lack of Efficacy|2|||
130052484|NCT03259334|468147316|FG001|Overall Study|Lack of Efficacy|0|||
130052485|NCT03259334|468147317|FG002|Overall Study|Lack of Efficacy|1|||
130052486|NCT03259334|468147315|FG000|Overall Study|Randomized but never treated|0|||
130052487|NCT03259334|468147316|FG001|Overall Study|Randomized but never treated|2|||
130052488|NCT03259334|468147317|FG002|Overall Study|Randomized but never treated|0|||
130052489|NCT00701727|468148444|FG000|First Treatment Period|Adverse Event|0|||
130052490|NCT00701727|468148445|FG001|First Treatment Period|Adverse Event|0|||
130052491|NCT00701727|468148444|FG000|First Treatment Period|Withdrawal by Subject|1|||
130052492|NCT00701727|468148445|FG001|First Treatment Period|Withdrawal by Subject|0|||
130052493|NCT00701727|468148444|FG000|First Treatment Period|sponsor decision|0|||
130110860|NCT02092961|468367486|FG001|Overall Study|Not reported|0|||
130110861|NCT02092961|468367487|FG002|Overall Study|Not reported|1|||
130110862|NCT02092961|468367485|FG000|Overall Study|Study stopped|13|||
130110863|NCT02092961|468367486|FG001|Overall Study|Study stopped|9|||
130110864|NCT02092961|468367487|FG002|Overall Study|Study stopped|12|||
130110865|NCT02092961|468367485|FG000|Overall Study|Lack of therapeutic response|2|||
130110866|NCT02092961|468367486|FG001|Overall Study|Lack of therapeutic response|1|||
130110867|NCT02092961|468367487|FG002|Overall Study|Lack of therapeutic response|3|||
130110868|NCT02092961|468367485|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
130110869|NCT02092961|468367486|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
130110870|NCT02092961|468367487|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
130110871|NCT02092961|468367485|FG000|Overall Study|Adverse Event|2|||
130110872|NCT02092961|468367486|FG001|Overall Study|Adverse Event|4|||
130110873|NCT02092961|468367487|FG002|Overall Study|Adverse Event|0|||
130110874|NCT01623830|468367490|FG000|Overall Study|Withdrawal by Subject|6|||
130110875|NCT01623830|468367491|FG001|Overall Study|Withdrawal by Subject|7|||
130110876|NCT01623830|468367490|FG000|Overall Study|Exclusion from Study|1|||
130110877|NCT01623830|468367491|FG001|Overall Study|Exclusion from Study|2|||
130110878|NCT01169649|468367493|FG000|Overall Study|Patient Not Treated|3|||
130110879|NCT01847313|468367494|FG000|Overall Study|Death|0|||
130110880|NCT01847313|468367495|FG001|Overall Study|Death|1|||
130110881|NCT01847313|468367494|FG000|Overall Study|Withdrawal by Subject|0|||
130110882|NCT01847313|468367495|FG001|Overall Study|Withdrawal by Subject|1|||
130110883|NCT00660790|468367496|FG000|Baseline to 3 Months|Death|1|||
130110884|NCT00660790|468367496|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
130110885|NCT00660790|468367496|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
130110886|NCT03840811|468367497|FG000|Overall Study|Lost to Follow-up|0|||
130110887|NCT03840811|468367498|FG001|Overall Study|Lost to Follow-up|0|||
130110888|NCT03840811|468367499|FG002|Overall Study|Lost to Follow-up|1|||
130110889|NCT01625845|468367500|FG000|Overall Study|Adverse Event|1|||
130110890|NCT01625845|468367501|FG001|Overall Study|Adverse Event|2|||
130110891|NCT01625845|468367500|FG000|Overall Study|Lost to Follow-up|2|||
130110892|NCT01625845|468367501|FG001|Overall Study|Lost to Follow-up|1|||
130110893|NCT01625845|468367500|FG000|Overall Study|Withdrawal by Subject|2|||
130110894|NCT01625845|468367501|FG001|Overall Study|Withdrawal by Subject|0|||
130110895|NCT02853929|468367502|FG000|Overall Study|Lost to Follow-up|3|||
130110896|NCT02853929|468367503|FG001|Overall Study|Lost to Follow-up|0|||
130110897|NCT02853929|468367502|FG000|Overall Study|Withdrawal by Subject|1|||
130110898|NCT02853929|468367503|FG001|Overall Study|Withdrawal by Subject|0|||
130110899|NCT02853929|468367502|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
130110900|NCT02853929|468367503|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
130110901|NCT03549130|468367504|FG000|Overall Study|Adverse Event|0|||
130110902|NCT03549130|468367505|FG001|Overall Study|Adverse Event|1|||
130110903|NCT03549130|468367504|FG000|Overall Study|Lost to Follow-up|0|||
130110904|NCT03549130|468367505|FG001|Overall Study|Lost to Follow-up|1|||
130052494|NCT00701727|468148445|FG001|First Treatment Period|sponsor decision|1|||
130052495|NCT00701727|468148444|FG000|First Treatment Period|Lost to Follow-up|0|||
130052496|NCT00701727|468148445|FG001|First Treatment Period|Lost to Follow-up|1|||
130052497|NCT00701727|468148444|FG000|Second Treatment Period|Withdrawal by Subject|2|||
130052498|NCT00701727|468148445|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130052499|NCT05113953|468148446|FG000|Overall Study|Adverse Event|5|||
130052500|NCT05113953|468148447|FG001|Overall Study|Adverse Event|0|||
130052501|NCT05113953|468148448|FG002|Overall Study|Adverse Event|3|||
130052502|NCT05113953|468148446|FG000|Overall Study|Lost to Follow-up|3|||
130052503|NCT05113953|468148447|FG001|Overall Study|Lost to Follow-up|4|||
130052504|NCT05113953|468148448|FG002|Overall Study|Lost to Follow-up|2|||
130052505|NCT05113953|468148446|FG000|Overall Study|Non-compliance with Study Drug|1|||
130052506|NCT05113953|468148447|FG001|Overall Study|Non-compliance with Study Drug|0|||
130052507|NCT05113953|468148448|FG002|Overall Study|Non-compliance with Study Drug|0|||
130052508|NCT05113953|468148446|FG000|Overall Study|Withdrawal by Subject|2|||
130110905|NCT01078623|468367506|FG000|Treatment Period 1|Adverse Event|1|||
130110906|NCT01078623|468367507|FG001|Treatment Period 1|Adverse Event|1|||
130110907|NCT01078623|468367508|FG002|Treatment Period 1|Adverse Event|1|||
130110908|NCT01078623|468367509|FG003|Treatment Period 1|Adverse Event|0|||
130110909|NCT01078623|468367510|FG004|Treatment Period 1|Adverse Event|0|||
130110910|NCT01078623|468367511|FG005|Treatment Period 1|Adverse Event|0|||
130052509|NCT05113953|468148447|FG001|Overall Study|Withdrawal by Subject|6|||
130052510|NCT05113953|468148448|FG002|Overall Study|Withdrawal by Subject|4|||
130052511|NCT05113953|468148446|FG000|Overall Study|Reason not Specified|2|||
130052512|NCT05113953|468148447|FG001|Overall Study|Reason not Specified|0|||
130110911|NCT01078623|468367512|FG006|Treatment Period 1|Adverse Event|1|||
130110912|NCT01078623|468367513|FG007|Treatment Period 1|Adverse Event|0|||
130110913|NCT01078623|468367514|FG008|Treatment Period 1|Adverse Event|1|||
130110914|NCT01078623|468367515|FG009|Treatment Period 1|Adverse Event|1|||
130110915|NCT01078623|468367516|FG010|Treatment Period 1|Adverse Event|0|||
130110916|NCT01078623|468367517|FG011|Treatment Period 1|Adverse Event|0|||
130110917|NCT01078623|468367518|FG012|Treatment Period 1|Adverse Event|0|||
130110918|NCT01078623|468367519|FG013|Treatment Period 1|Adverse Event|0|||
130110919|NCT01078623|468367520|FG014|Treatment Period 1|Adverse Event|0|||
130110920|NCT01078623|468367521|FG015|Treatment Period 1|Adverse Event|0|||
130110921|NCT01078623|468367522|FG016|Treatment Period 1|Adverse Event|0|||
130110922|NCT01078623|468367523|FG017|Treatment Period 1|Adverse Event|0|||
130110923|NCT01078623|468367524|FG018|Treatment Period 1|Adverse Event|0|||
130110924|NCT01078623|468367525|FG019|Treatment Period 1|Adverse Event|0|||
130110925|NCT01078623|468367506|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130110926|NCT01078623|468367507|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130110927|NCT01078623|468367508|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130110928|NCT01078623|468367509|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130110929|NCT01078623|468367510|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130110930|NCT01078623|468367511|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130110931|NCT01078623|468367512|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130110932|NCT01078623|468367513|FG007|Treatment Period 1|Withdrawal by Subject|1|||
130110933|NCT01078623|468367514|FG008|Treatment Period 1|Withdrawal by Subject|0|||
130110934|NCT01078623|468367515|FG009|Treatment Period 1|Withdrawal by Subject|0|||
130110935|NCT01078623|468367516|FG010|Treatment Period 1|Withdrawal by Subject|1|||
130110936|NCT01078623|468367517|FG011|Treatment Period 1|Withdrawal by Subject|0|||
130110937|NCT01078623|468367518|FG012|Treatment Period 1|Withdrawal by Subject|0|||
130110938|NCT01078623|468367519|FG013|Treatment Period 1|Withdrawal by Subject|0|||
130110939|NCT01078623|468367520|FG014|Treatment Period 1|Withdrawal by Subject|0|||
130110940|NCT01078623|468367521|FG015|Treatment Period 1|Withdrawal by Subject|0|||
130110941|NCT01078623|468367522|FG016|Treatment Period 1|Withdrawal by Subject|0|||
130110942|NCT01078623|468367523|FG017|Treatment Period 1|Withdrawal by Subject|0|||
130110943|NCT01078623|468367524|FG018|Treatment Period 1|Withdrawal by Subject|0|||
130110944|NCT01078623|468367525|FG019|Treatment Period 1|Withdrawal by Subject|0|||
130110945|NCT01078623|468367506|FG000|Treatment Period 1|Protocol Violation|0|||
130110946|NCT01078623|468367507|FG001|Treatment Period 1|Protocol Violation|0|||
130110947|NCT01078623|468367508|FG002|Treatment Period 1|Protocol Violation|0|||
130110948|NCT01078623|468367509|FG003|Treatment Period 1|Protocol Violation|0|||
130110949|NCT01078623|468367510|FG004|Treatment Period 1|Protocol Violation|0|||
130110950|NCT01078623|468367511|FG005|Treatment Period 1|Protocol Violation|1|||
130110951|NCT01078623|468367512|FG006|Treatment Period 1|Protocol Violation|0|||
130110952|NCT01078623|468367513|FG007|Treatment Period 1|Protocol Violation|0|||
130110953|NCT01078623|468367514|FG008|Treatment Period 1|Protocol Violation|0|||
130110954|NCT01078623|468367515|FG009|Treatment Period 1|Protocol Violation|0|||
130110955|NCT01078623|468367516|FG010|Treatment Period 1|Protocol Violation|0|||
130110956|NCT01078623|468367517|FG011|Treatment Period 1|Protocol Violation|0|||
130110957|NCT01078623|468367518|FG012|Treatment Period 1|Protocol Violation|0|||
130110958|NCT01078623|468367519|FG013|Treatment Period 1|Protocol Violation|0|||
130110959|NCT01078623|468367520|FG014|Treatment Period 1|Protocol Violation|0|||
130110960|NCT01078623|468367521|FG015|Treatment Period 1|Protocol Violation|0|||
130110961|NCT01078623|468367522|FG016|Treatment Period 1|Protocol Violation|0|||
130110962|NCT01078623|468367523|FG017|Treatment Period 1|Protocol Violation|0|||
130110963|NCT01078623|468367524|FG018|Treatment Period 1|Protocol Violation|0|||
130110964|NCT01078623|468367525|FG019|Treatment Period 1|Protocol Violation|0|||
130110965|NCT01078623|468367506|FG000|Treatment Period 2|Adverse Event|0|||
130110966|NCT01078623|468367507|FG001|Treatment Period 2|Adverse Event|0|||
130110967|NCT01078623|468367508|FG002|Treatment Period 2|Adverse Event|0|||
130110968|NCT01078623|468367509|FG003|Treatment Period 2|Adverse Event|0|||
130110969|NCT01078623|468367510|FG004|Treatment Period 2|Adverse Event|0|||
130110970|NCT01078623|468367511|FG005|Treatment Period 2|Adverse Event|0|||
130110971|NCT01078623|468367512|FG006|Treatment Period 2|Adverse Event|1|||
130110972|NCT01078623|468367513|FG007|Treatment Period 2|Adverse Event|0|||
130110973|NCT01078623|468367514|FG008|Treatment Period 2|Adverse Event|0|||
130110974|NCT01078623|468367515|FG009|Treatment Period 2|Adverse Event|0|||
130110975|NCT01078623|468367516|FG010|Treatment Period 2|Adverse Event|0|||
130110976|NCT01078623|468367517|FG011|Treatment Period 2|Adverse Event|0|||
130110977|NCT01078623|468367518|FG012|Treatment Period 2|Adverse Event|0|||
130110978|NCT01078623|468367519|FG013|Treatment Period 2|Adverse Event|0|||
130110979|NCT01078623|468367520|FG014|Treatment Period 2|Adverse Event|0|||
130110980|NCT01078623|468367521|FG015|Treatment Period 2|Adverse Event|0|||
130110981|NCT01078623|468367522|FG016|Treatment Period 2|Adverse Event|0|||
130110982|NCT01078623|468367523|FG017|Treatment Period 2|Adverse Event|0|||
130110983|NCT01078623|468367524|FG018|Treatment Period 2|Adverse Event|1|||
130110984|NCT01078623|468367525|FG019|Treatment Period 2|Adverse Event|0|||
130110985|NCT01078623|468367506|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130110986|NCT01078623|468367507|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129800493|NCT04587271|467238108|FG000|Overall Study|Caregiver brought child to visits|0|||
129800494|NCT04587271|467238109|FG001|Overall Study|Caregiver brought child to visits|0|||
129800495|NCT04587271|467238110|FG002|Overall Study|Caregiver brought child to visits|0|||
130110987|NCT01078623|468367508|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130110988|NCT01078623|468367509|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130110989|NCT01078623|468367510|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130110990|NCT01078623|468367511|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129800496|NCT04587271|467238111|FG003|Overall Study|Caregiver brought child to visits|1|||
129800497|NCT04587271|467238112|FG004|Overall Study|Caregiver brought child to visits|0|||
129800498|NCT04587271|467238113|FG005|Overall Study|Caregiver brought child to visits|0|||
129800499|NCT02180165|467238119|FG000|Overall Study|Not Treated|0|||
129800500|NCT02180165|467238120|FG001|Overall Study|Not Treated|0|||
129800501|NCT02180165|467238121|FG002|Overall Study|Not Treated|1|||
129800502|NCT02180165|467238122|FG003|Overall Study|Not Treated|0|||
129800503|NCT02180165|467238119|FG000|Overall Study|Adverse Event|7|||
129800504|NCT02180165|467238120|FG001|Overall Study|Adverse Event|0|||
129800505|NCT02180165|467238121|FG002|Overall Study|Adverse Event|18|||
129800506|NCT02180165|467238122|FG003|Overall Study|Adverse Event|3|||
129800507|NCT02180165|467238119|FG000|Overall Study|Lack of Efficacy|0|||
129800508|NCT02180165|467238120|FG001|Overall Study|Lack of Efficacy|1|||
129800509|NCT02180165|467238121|FG002|Overall Study|Lack of Efficacy|3|||
129800510|NCT02180165|467238122|FG003|Overall Study|Lack of Efficacy|2|||
129800511|NCT02180165|467238119|FG000|Overall Study|Physician Decision|1|||
129800512|NCT02180165|467238120|FG001|Overall Study|Physician Decision|0|||
129800513|NCT02180165|467238121|FG002|Overall Study|Physician Decision|5|||
129800514|NCT02180165|467238122|FG003|Overall Study|Physician Decision|0|||
129800515|NCT02180165|467238119|FG000|Overall Study|Withdrawal by Subject|3|||
129800516|NCT02180165|467238120|FG001|Overall Study|Withdrawal by Subject|0|||
129800517|NCT02180165|467238121|FG002|Overall Study|Withdrawal by Subject|2|||
129800518|NCT02180165|467238122|FG003|Overall Study|Withdrawal by Subject|1|||
129800519|NCT05246397|467238123|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
129800520|NCT02943460|467238124|FG000|Blinded Study Phase|Adverse Event|3|||
129800521|NCT02943460|467238125|FG001|Blinded Study Phase|Adverse Event|0|||
129800522|NCT02943460|467238126|FG002|Blinded Study Phase|Adverse Event|0|||
129800523|NCT02943460|467238124|FG000|Blinded Study Phase|Withdrew Consent|0|||
129800524|NCT02943460|467238125|FG001|Blinded Study Phase|Withdrew Consent|1|||
129800525|NCT02943460|467238126|FG002|Blinded Study Phase|Withdrew Consent|0|||
129800526|NCT02943460|467238124|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
129800527|NCT02943460|467238125|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
129800528|NCT02943460|467238126|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
129800529|NCT02943460|467238124|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
129800530|NCT02943460|467238125|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
129800531|NCT02943460|467238126|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
129800532|NCT02943460|467238124|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
129800533|NCT02943460|467238125|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
129800534|NCT02943460|467238126|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
129800535|NCT03875768|467238127|FG000|Overall Study|Lost to Follow-up|16|||
129800536|NCT03875768|467238128|FG001|Overall Study|Lost to Follow-up|13|||
129800537|NCT03875768|467238127|FG000|Overall Study|Withdrawal by Subject|10|||
129800538|NCT03875768|467238128|FG001|Overall Study|Withdrawal by Subject|21|||
129800539|NCT03875768|467238127|FG000|Overall Study|Did not complete assessment|21|||
129800540|NCT03875768|467238128|FG001|Overall Study|Did not complete assessment|12|||
129800541|NCT03875768|467238127|FG000|Overall Study|Became ineligible|1|||
129800542|NCT03875768|467238128|FG001|Overall Study|Became ineligible|0|||
129800543|NCT01925274|467238129|FG000|Overall Study|Death|1|||
129800544|NCT01925274|467238130|FG001|Overall Study|Death|0|||
129891264|NCT00994279|467559690|FG001|Overall Study|Toxicity|0|||
130052513|NCT05113953|468148448|FG002|Overall Study|Reason not Specified|0|||
130052514|NCT00502307|468148451|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
130052515|NCT00502307|468148452|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
130052516|NCT00502307|468148453|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
130052517|NCT00502307|468148451|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
129800545|NCT01925274|467238131|FG002|Overall Study|Death|0|||
129800546|NCT01925274|467238129|FG000|Overall Study|Lost to Follow-up|0|||
129800547|NCT01925274|467238130|FG001|Overall Study|Lost to Follow-up|1|||
129800548|NCT01925274|467238131|FG002|Overall Study|Lost to Follow-up|0|||
129800549|NCT01925274|467238129|FG000|Overall Study|Withdrawal by Subject|1|||
129800550|NCT01925274|467238130|FG001|Overall Study|Withdrawal by Subject|2|||
129800551|NCT01925274|467238131|FG002|Overall Study|Withdrawal by Subject|0|||
129800552|NCT01925274|467238129|FG000|Overall Study|Study terminated by sponsor|4|||
129800553|NCT01925274|467238130|FG001|Overall Study|Study terminated by sponsor|0|||
130052518|NCT00502307|468148452|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
129800554|NCT01925274|467238131|FG002|Overall Study|Study terminated by sponsor|0|||
129800555|NCT01925274|467238129|FG000|Overall Study|Protocol amendment|1|||
129800556|NCT01925274|467238130|FG001|Overall Study|Protocol amendment|3|||
129800557|NCT01925274|467238131|FG002|Overall Study|Protocol amendment|6|||
129800558|NCT01031381|467238134|FG000|Overall Study|Physician Decision|3|||
129800559|NCT01031381|467238134|FG000|Overall Study|Withdrawal by Subject|6|||
129891265|NCT00994279|467559689|FG000|Overall Study|Multiple reasons|1|||
129800560|NCT00723398|467238135|FG000|Overall Study|Withdrawal by Subject|2|||
129800561|NCT00723398|467238136|FG001|Overall Study|Withdrawal by Subject|6|||
129800562|NCT00723398|467238137|FG002|Overall Study|Withdrawal by Subject|4|||
129800563|NCT00723398|467238138|FG003|Overall Study|Withdrawal by Subject|4|||
130052519|NCT00502307|468148453|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
130052520|NCT00502307|468148451|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
130052521|NCT00502307|468148452|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
130052522|NCT00502307|468148453|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
130052523|NCT00502307|468148451|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
130052524|NCT00502307|468148452|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
130052525|NCT00502307|468148453|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
130052526|NCT00502307|468148451|FG000|Maintenance Period|Progressive disease|80|||
130052527|NCT00502307|468148452|FG001|Maintenance Period|Progressive disease|0|||
130052528|NCT00502307|468148453|FG002|Maintenance Period|Progressive disease|0|||
130052529|NCT00502307|468148451|FG000|Maintenance Period|Discontinued due to other reasons|68|||
130052530|NCT00502307|468148452|FG001|Maintenance Period|Discontinued due to other reasons|0|||
130052531|NCT00502307|468148453|FG002|Maintenance Period|Discontinued due to other reasons|0|||
130052532|NCT02297438|468148456|FG000|Overall Study|Death|79|||
130052533|NCT02297438|468148457|FG001|Overall Study|Death|86|||
130052534|NCT02297438|468148456|FG000|Overall Study|Lost to Follow-up|9|||
130052535|NCT02297438|468148457|FG001|Overall Study|Lost to Follow-up|7|||
130052536|NCT02297438|468148456|FG000|Overall Study|Withdrawal by Subject|7|||
130052537|NCT02297438|468148457|FG001|Overall Study|Withdrawal by Subject|0|||
130052538|NCT02297438|468148456|FG000|Overall Study|Other|9|||
130052539|NCT02297438|468148457|FG001|Overall Study|Other|5|||
130052540|NCT02297438|468148456|FG000|Overall Study|Ongoing|65|||
130052541|NCT02297438|468148457|FG001|Overall Study|Ongoing|73|||
130052542|NCT02042404|468148458|FG000|Overall Study|Death|1|||
130052543|NCT02042404|468148459|FG001|Overall Study|Death|0|||
130052544|NCT02042404|468148458|FG000|Overall Study|Unrelated Adverse Event|3|||
130052545|NCT02042404|468148459|FG001|Overall Study|Unrelated Adverse Event|0|||
130052546|NCT02042404|468148458|FG000|Overall Study|Inability to meet time requirements|1|||
130052547|NCT02042404|468148459|FG001|Overall Study|Inability to meet time requirements|0|||
130052548|NCT00726323|468148460|FG000|Overall Study|Withdrawal by Subject|3|||
130052549|NCT00726323|468148461|FG001|Overall Study|Withdrawal by Subject|1|||
130052550|NCT00726323|468148460|FG000|Overall Study|Physician Decision|1|||
130052551|NCT00726323|468148461|FG001|Overall Study|Physician Decision|0|||
130052552|NCT00726323|468148460|FG000|Overall Study|Progressive disease|23|||
130052553|NCT00726323|468148461|FG001|Overall Study|Progressive disease|16|||
130052554|NCT00726323|468148460|FG000|Overall Study|Clinical progression|0|||
130052555|NCT00726323|468148461|FG001|Overall Study|Clinical progression|3|||
130052556|NCT00726323|468148460|FG000|Overall Study|Adverse Event|9|||
130052557|NCT00726323|468148461|FG001|Overall Study|Adverse Event|9|||
130052558|NCT00726323|468148460|FG000|Overall Study|Death|1|||
130052559|NCT00726323|468148461|FG001|Overall Study|Death|0|||
130052560|NCT00726323|468148460|FG000|Overall Study|Participant wished to discontinue|0|||
130052561|NCT00726323|468148461|FG001|Overall Study|Participant wished to discontinue|1|||
130052562|NCT00726323|468148460|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
130052563|NCT00726323|468148461|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
130052564|NCT03521154|468148462|FG000|Overall Study|Ongoing study at data cut-off|111|||
130052565|NCT03521154|468148463|FG001|Overall Study|Ongoing study at data cut-off|52|||
130052566|NCT00972478|468148465|FG000|Overall Study|Adverse Event|3|||
130052567|NCT00972478|468148466|FG001|Overall Study|Adverse Event|16|||
130052568|NCT00972478|468148465|FG000|Overall Study|Withdrawal by Subject|1|||
130052569|NCT00972478|468148466|FG001|Overall Study|Withdrawal by Subject|8|||
130052570|NCT00972478|468148465|FG000|Overall Study|Progression/Relapse|0|||
130052571|NCT00972478|468148466|FG001|Overall Study|Progression/Relapse|2|||
130052572|NCT00972478|468148465|FG000|Overall Study|Death|0|||
130052573|NCT00972478|468148466|FG001|Overall Study|Death|2|||
130052574|NCT00972478|468148465|FG000|Overall Study|Not protocol specified|1|||
130110991|NCT01078623|468367512|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130110992|NCT01078623|468367513|FG007|Treatment Period 2|Withdrawal by Subject|0|||
130110993|NCT01078623|468367514|FG008|Treatment Period 2|Withdrawal by Subject|0|||
130110994|NCT01078623|468367515|FG009|Treatment Period 2|Withdrawal by Subject|0|||
130110995|NCT01078623|468367516|FG010|Treatment Period 2|Withdrawal by Subject|0|||
130052575|NCT00972478|468148466|FG001|Overall Study|Not protocol specified|1|||
130052576|NCT00972478|468148465|FG000|Overall Study|Ineligible|1|||
130052577|NCT00972478|468148466|FG001|Overall Study|Ineligible|7|||
130052578|NCT00972478|468148465|FG000|Overall Study|Not start protocol treatment|1|||
130052579|NCT00972478|468148466|FG001|Overall Study|Not start protocol treatment|2|||
130052580|NCT02561000|468148467|FG000|Overall Study|Withdrawal by Subject|2|||
130052581|NCT02561000|468148468|FG001|Overall Study|Withdrawal by Subject|3|||
130110996|NCT01078623|468367517|FG011|Treatment Period 2|Withdrawal by Subject|0|||
130110997|NCT01078623|468367518|FG012|Treatment Period 2|Withdrawal by Subject|0|||
130110998|NCT01078623|468367519|FG013|Treatment Period 2|Withdrawal by Subject|0|||
130052582|NCT02561000|468148469|FG002|Overall Study|Withdrawal by Subject|0|||
130052583|NCT02561000|468148467|FG000|Overall Study|Adverse Event|0|||
130052584|NCT02561000|468148468|FG001|Overall Study|Adverse Event|1|||
130052585|NCT02561000|468148469|FG002|Overall Study|Adverse Event|0|||
130052586|NCT01522976|468148470|FG000|Overall Study|Ineligible|4|||
130317256|NCT00882440|469128556|FG003|Overall Study|Lost to Follow-up|1|||
130317257|NCT00882440|469128557|FG004|Overall Study|Lost to Follow-up|1|||
130317258|NCT00882440|469128558|FG005|Overall Study|Lost to Follow-up|0|||
130317259|NCT00882440|469128559|FG006|Overall Study|Lost to Follow-up|1|||
130317260|NCT00882440|469128553|FG000|Overall Study|Protocol Violation|0|||
130317261|NCT00882440|469128554|FG001|Overall Study|Protocol Violation|0|||
130317262|NCT00882440|469128555|FG002|Overall Study|Protocol Violation|1|||
130317263|NCT00882440|469128556|FG003|Overall Study|Protocol Violation|1|||
130317264|NCT00882440|469128557|FG004|Overall Study|Protocol Violation|1|||
130317265|NCT00882440|469128558|FG005|Overall Study|Protocol Violation|0|||
130317266|NCT00882440|469128559|FG006|Overall Study|Protocol Violation|0|||
130317267|NCT00882440|469128553|FG000|Overall Study|Withdrawal by Subject|2|||
130317268|NCT00882440|469128554|FG001|Overall Study|Withdrawal by Subject|1|||
130317269|NCT00882440|469128555|FG002|Overall Study|Withdrawal by Subject|1|||
130317270|NCT00882440|469128556|FG003|Overall Study|Withdrawal by Subject|0|||
130317271|NCT00882440|469128557|FG004|Overall Study|Withdrawal by Subject|6|||
130317272|NCT00882440|469128558|FG005|Overall Study|Withdrawal by Subject|0|||
130317273|NCT00882440|469128559|FG006|Overall Study|Withdrawal by Subject|1|||
130317274|NCT00882440|469128553|FG000|Overall Study|Patient Uncooperative|2|||
130317275|NCT00882440|469128554|FG001|Overall Study|Patient Uncooperative|0|||
130317276|NCT00882440|469128555|FG002|Overall Study|Patient Uncooperative|0|||
130317277|NCT00882440|469128556|FG003|Overall Study|Patient Uncooperative|0|||
130317278|NCT00882440|469128557|FG004|Overall Study|Patient Uncooperative|1|||
130317279|NCT00882440|469128558|FG005|Overall Study|Patient Uncooperative|0|||
130317280|NCT00882440|469128559|FG006|Overall Study|Patient Uncooperative|0|||
130317281|NCT05482308|469128563|FG000|Overall Study|Withdrawal by Subject|1|||
130317282|NCT05482308|469128564|FG001|Overall Study|Withdrawal by Subject|0|||
130317283|NCT05482308|469128563|FG000|Overall Study|No longer meets eligibility criteria|0|||
130317284|NCT05482308|469128564|FG001|Overall Study|No longer meets eligibility criteria|1|||
130317285|NCT01451723|469128566|FG000|Overall Study|study halted|6|||
130317286|NCT01451723|469128567|FG001|Overall Study|study halted|5|||
130317287|NCT00443040|469128570|FG000|Overall Study|Withdrawal by Subject|1|||
130317288|NCT00443040|469128571|FG001|Overall Study|Withdrawal by Subject|0|||
129800564|NCT00723398|467238139|FG004|Overall Study|Withdrawal by Subject|4|||
129800565|NCT00723398|467238135|FG000|Overall Study|Protocol Violation|2|||
129800566|NCT00723398|467238136|FG001|Overall Study|Protocol Violation|1|||
129800567|NCT00723398|467238137|FG002|Overall Study|Protocol Violation|5|||
129800568|NCT00723398|467238138|FG003|Overall Study|Protocol Violation|0|||
129800569|NCT00723398|467238139|FG004|Overall Study|Protocol Violation|0|||
129800570|NCT00723398|467238135|FG000|Overall Study|Physician Decision|2|||
129800571|NCT00723398|467238136|FG001|Overall Study|Physician Decision|2|||
129800572|NCT00723398|467238137|FG002|Overall Study|Physician Decision|5|||
129800573|NCT00723398|467238138|FG003|Overall Study|Physician Decision|0|||
129800574|NCT00723398|467238139|FG004|Overall Study|Physician Decision|1|||
129800575|NCT00723398|467238135|FG000|Overall Study|Adverse Event|0|||
129800576|NCT00723398|467238136|FG001|Overall Study|Adverse Event|5|||
129800577|NCT00723398|467238137|FG002|Overall Study|Adverse Event|3|||
129800578|NCT00723398|467238138|FG003|Overall Study|Adverse Event|1|||
130317289|NCT00443040|469128572|FG002|Overall Study|Withdrawal by Subject|0|||
129800579|NCT00723398|467238139|FG004|Overall Study|Adverse Event|4|||
130317290|NCT00443040|469128570|FG000|Overall Study|Converted to an open laparotomy|3|||
130317291|NCT00443040|469128571|FG001|Overall Study|Converted to an open laparotomy|0|||
130317292|NCT00443040|469128572|FG002|Overall Study|Converted to an open laparotomy|1|||
130317293|NCT04245111|469128576|FG000|Overall Study|Lost to Follow-up|5|||
130317294|NCT04245111|469128577|FG001|Overall Study|Lost to Follow-up|1|||
130317295|NCT04245111|469128578|FG002|Overall Study|Lost to Follow-up|1|||
130317296|NCT03192176|469128584|FG000|Overall Study|Adverse Event|1|||
129800580|NCT00723398|467238135|FG000|Overall Study|Lost to Follow-up|0|||
129800581|NCT00723398|467238136|FG001|Overall Study|Lost to Follow-up|1|||
129800582|NCT00723398|467238137|FG002|Overall Study|Lost to Follow-up|0|||
129800583|NCT00723398|467238138|FG003|Overall Study|Lost to Follow-up|0|||
129800584|NCT00723398|467238139|FG004|Overall Study|Lost to Follow-up|0|||
129800585|NCT00777205|467238142|FG000|Overall Study|Lost to Follow-up|25|||
129800586|NCT00777205|467238143|FG001|Overall Study|Lost to Follow-up|9|||
129800587|NCT00777205|467238142|FG000|Overall Study|Withdrawal by Subject|6|||
129800588|NCT00777205|467238143|FG001|Overall Study|Withdrawal by Subject|4|||
129800589|NCT00777205|467238142|FG000|Overall Study|Death|0|||
129800590|NCT00777205|467238143|FG001|Overall Study|Death|2|||
129800591|NCT00777205|467238142|FG000|Overall Study|Protocol Violation|0|||
130317297|NCT03192176|469128585|FG001|Overall Study|Adverse Event|0|||
130317298|NCT03192176|469128586|FG002|Overall Study|Adverse Event|4|||
129800592|NCT00777205|467238143|FG001|Overall Study|Protocol Violation|56|||
130317299|NCT03192176|469128587|FG003|Overall Study|Adverse Event|5|||
130317300|NCT03192176|469128588|FG004|Overall Study|Adverse Event|3|||
130317301|NCT03192176|469128589|FG005|Overall Study|Adverse Event|2|||
130317302|NCT03192176|469128590|FG006|Overall Study|Adverse Event|3|||
130317303|NCT03192176|469128591|FG007|Overall Study|Adverse Event|3|||
130317304|NCT03192176|469128584|FG000|Overall Study|Lost to Follow-up|0|||
129800593|NCT00100178|467238144|FG000|Overall Study|Lost to Follow-up|0|||
129800594|NCT00100178|467238145|FG001|Overall Study|Lost to Follow-up|6|||
129800595|NCT00100178|467238146|FG002|Overall Study|Lost to Follow-up|5|||
129800596|NCT00100178|467238144|FG000|Overall Study|Adverse Event|2|||
129800597|NCT00100178|467238145|FG001|Overall Study|Adverse Event|2|||
129800598|NCT00100178|467238146|FG002|Overall Study|Adverse Event|1|||
130052587|NCT01522976|468148471|FG001|Overall Study|Ineligible|0|||
130052588|NCT01522976|468148472|FG002|Overall Study|Ineligible|1|||
130052589|NCT01522976|468148470|FG000|Overall Study|Death|7|||
130052590|NCT01522976|468148471|FG001|Overall Study|Death|6|||
130052591|NCT01522976|468148472|FG002|Overall Study|Death|2|||
130052592|NCT01522976|468148470|FG000|Overall Study|Still on treatment|9|||
130052593|NCT01522976|468148471|FG001|Overall Study|Still on treatment|9|||
130052594|NCT01522976|468148472|FG002|Overall Study|Still on treatment|6|||
130052595|NCT01522976|468148470|FG000|Overall Study|Disease progression|28|||
130052596|NCT01522976|468148471|FG001|Overall Study|Disease progression|30|||
130052597|NCT01522976|468148472|FG002|Overall Study|Disease progression|25|||
130052598|NCT01522976|468148470|FG000|Overall Study|Adverse Event|17|||
130052599|NCT01522976|468148471|FG001|Overall Study|Adverse Event|7|||
130052600|NCT01522976|468148472|FG002|Overall Study|Adverse Event|18|||
130052601|NCT01522976|468148470|FG000|Overall Study|Refusal unrelated to adverse event|10|||
130052602|NCT01522976|468148471|FG001|Overall Study|Refusal unrelated to adverse event|13|||
130052603|NCT01522976|468148472|FG002|Overall Study|Refusal unrelated to adverse event|14|||
130052604|NCT01522976|468148470|FG000|Overall Study|Not protocol specified|22|||
130052605|NCT01522976|468148471|FG001|Overall Study|Not protocol specified|27|||
130052606|NCT01522976|468148472|FG002|Overall Study|Not protocol specified|27|||
130052607|NCT04075266|468148475|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
130052608|NCT04075266|468148476|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
130052609|NCT04075266|468148475|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
130317305|NCT03192176|469128585|FG001|Overall Study|Lost to Follow-up|0|||
130317306|NCT03192176|469128586|FG002|Overall Study|Lost to Follow-up|1|||
130317307|NCT03192176|469128587|FG003|Overall Study|Lost to Follow-up|2|||
130317308|NCT03192176|469128588|FG004|Overall Study|Lost to Follow-up|3|||
130052610|NCT04075266|468148476|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
130317309|NCT03192176|469128589|FG005|Overall Study|Lost to Follow-up|1|||
130317310|NCT03192176|469128590|FG006|Overall Study|Lost to Follow-up|1|||
130052611|NCT05132569|468148477|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
130052612|NCT05132569|468148478|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
130052613|NCT05132569|468148477|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
130052614|NCT05132569|468148478|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
130052615|NCT05132569|468148477|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
130052616|NCT05132569|468148478|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
130052617|NCT04102098|468148479|FG000|Main Study Period|Ongoing in study|302|||
130052618|NCT04102098|468148480|FG001|Main Study Period|Ongoing in study|291|||
130052619|NCT04102098|468148479|FG000|Main Study Period|Death|20|||
130052620|NCT04102098|468148480|FG001|Main Study Period|Death|27|||
130052621|NCT04102098|468148479|FG000|Main Study Period|Lost to Follow-up|1|||
130052622|NCT04102098|468148480|FG001|Main Study Period|Lost to Follow-up|1|||
130052623|NCT04102098|468148479|FG000|Main Study Period|Physician Decision|0|||
130052624|NCT04102098|468148480|FG001|Main Study Period|Physician Decision|1|||
130052625|NCT04102098|468148479|FG000|Main Study Period|Withdrawal by Subject|11|||
130052626|NCT04102098|468148480|FG001|Main Study Period|Withdrawal by Subject|14|||
130052627|NCT04102098|468148479|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
130052628|NCT04102098|468148480|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
130052629|NCT04102098|468148479|FG000|Crossover: AS Who Crossed Over|Death|11|||
130052630|NCT04102098|468148480|FG001|Crossover: AS Who Crossed Over|Death|0|||
130052631|NCT04102098|468148479|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
130052632|NCT04102098|468148480|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
130052633|NCT04742907|468148481|FG000|Overall Study|Adverse Event|1|||
130052634|NCT04742907|468148482|FG001|Overall Study|Adverse Event|0|||
130052635|NCT04742907|468148483|FG002|Overall Study|Adverse Event|1|||
130052636|NCT04742907|468148481|FG000|Overall Study|Lost to Follow-up|3|||
130052637|NCT04742907|468148482|FG001|Overall Study|Lost to Follow-up|3|||
130052638|NCT04742907|468148483|FG002|Overall Study|Lost to Follow-up|2|||
130052639|NCT04742907|468148481|FG000|Overall Study|Physician Decision|0|||
130052640|NCT04742907|468148482|FG001|Overall Study|Physician Decision|1|||
130052641|NCT04742907|468148483|FG002|Overall Study|Physician Decision|0|||
130317311|NCT03192176|469128591|FG007|Overall Study|Lost to Follow-up|1|||
130052642|NCT04742907|468148481|FG000|Overall Study|Protocol Violation|1|||
130052643|NCT04742907|468148482|FG001|Overall Study|Protocol Violation|1|||
130052644|NCT04742907|468148483|FG002|Overall Study|Protocol Violation|1|||
130052645|NCT04742907|468148481|FG000|Overall Study|Withdrawal by Subject|5|||
130317312|NCT03192176|469128584|FG000|Overall Study|Physician Decision|1|||
130317313|NCT03192176|469128585|FG001|Overall Study|Physician Decision|0|||
129800599|NCT00100178|467238144|FG000|Overall Study|Withdrawal by Subject|1|||
129800600|NCT00100178|467238145|FG001|Overall Study|Withdrawal by Subject|1|||
130052646|NCT04742907|468148482|FG001|Overall Study|Withdrawal by Subject|6|||
130052647|NCT04742907|468148483|FG002|Overall Study|Withdrawal by Subject|4|||
130317314|NCT03192176|469128586|FG002|Overall Study|Physician Decision|0|||
130317315|NCT03192176|469128587|FG003|Overall Study|Physician Decision|0|||
130317316|NCT03192176|469128588|FG004|Overall Study|Physician Decision|0|||
130317317|NCT03192176|469128589|FG005|Overall Study|Physician Decision|2|||
130317318|NCT03192176|469128590|FG006|Overall Study|Physician Decision|1|||
130317319|NCT03192176|469128591|FG007|Overall Study|Physician Decision|0|||
130317320|NCT03192176|469128584|FG000|Overall Study|Protocol Deviation|1|||
130317321|NCT03192176|469128585|FG001|Overall Study|Protocol Deviation|1|||
129800601|NCT00100178|467238146|FG002|Overall Study|Withdrawal by Subject|1|||
129800602|NCT00100178|467238144|FG000|Overall Study|Physician Decision|6|||
129800603|NCT00100178|467238145|FG001|Overall Study|Physician Decision|1|||
129800604|NCT00100178|467238146|FG002|Overall Study|Physician Decision|3|||
129800605|NCT02477839|467238149|FG000|Overall Study|Adverse Event|0|||
129800606|NCT02477839|467238150|FG001|Overall Study|Adverse Event|1|||
129800607|NCT02477839|467238149|FG000|Overall Study|Protocol Violation|0|||
129800608|NCT02477839|467238150|FG001|Overall Study|Protocol Violation|2|||
129800609|NCT02477839|467238149|FG000|Overall Study|Withdrawal by Subject|3|||
129800610|NCT02477839|467238150|FG001|Overall Study|Withdrawal by Subject|3|||
129800611|NCT02477839|467238149|FG000|Overall Study|Participant had PGS during V6|0|||
129800612|NCT02477839|467238150|FG001|Overall Study|Participant had PGS during V6|1|||
129800613|NCT02477839|467238149|FG000|Overall Study|Parents decided to stop medication|0|||
129800614|NCT02477839|467238150|FG001|Overall Study|Parents decided to stop medication|1|||
129800615|NCT02477839|467238149|FG000|Overall Study|Lack of tolerability|0|||
129800616|NCT02477839|467238150|FG001|Overall Study|Lack of tolerability|1|||
130052648|NCT04742907|468148481|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
130052649|NCT04742907|468148482|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
130052650|NCT04742907|468148483|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
130052651|NCT04742907|468148481|FG000|Overall Study|Did Not Receive the Study Drug|2|||
130052652|NCT04742907|468148482|FG001|Overall Study|Did Not Receive the Study Drug|4|||
130052653|NCT04742907|468148483|FG002|Overall Study|Did Not Receive the Study Drug|4|||
130052654|NCT06150573|468148484|FG000|Overall Study|Did not meet study criteria|1|||
130052655|NCT06150573|468148485|FG001|Overall Study|Did not meet study criteria|0|||
130052656|NCT06150573|468148484|FG000|Overall Study|Adverse Event|1|||
130052657|NCT06150573|468148485|FG001|Overall Study|Adverse Event|0|||
130052658|NCT06150573|468148484|FG000|Overall Study|Lost to Follow-up|0|||
130052659|NCT06150573|468148485|FG001|Overall Study|Lost to Follow-up|1|||
130052660|NCT06150573|468148484|FG000|Overall Study|Protocol Violation|0|||
130052661|NCT06150573|468148485|FG001|Overall Study|Protocol Violation|1|||
130052662|NCT06150573|468148484|FG000|Overall Study|Withdrawal by Subject|2|||
130052663|NCT06150573|468148485|FG001|Overall Study|Withdrawal by Subject|0|||
130052664|NCT00069095|468148486|FG000|Primary Treatment Phase|Ongoing|0|||
130052665|NCT00069095|468148487|FG001|Primary Treatment Phase|Ongoing|0|||
130052666|NCT00069095|468148488|FG002|Primary Treatment Phase|Ongoing|5|||
130052667|NCT00069095|468148489|FG003|Primary Treatment Phase|Ongoing|7|||
130052668|NCT00069095|468148490|FG004|Primary Treatment Phase|Ongoing|7|||
130052669|NCT00069095|468148491|FG005|Primary Treatment Phase|Ongoing|4|||
130052670|NCT00069095|468148486|FG000|Primary Treatment Phase|Admin/Other|29|||
130052671|NCT00069095|468148487|FG001|Primary Treatment Phase|Admin/Other|38|||
130052672|NCT00069095|468148488|FG002|Primary Treatment Phase|Admin/Other|31|||
130052673|NCT00069095|468148489|FG003|Primary Treatment Phase|Admin/Other|45|||
130052674|NCT00069095|468148490|FG004|Primary Treatment Phase|Admin/Other|48|||
130052675|NCT00069095|468148491|FG005|Primary Treatment Phase|Admin/Other|42|||
130052676|NCT00069095|468148486|FG000|Primary Treatment Phase|Adverse Event|99|||
130052677|NCT00069095|468148487|FG001|Primary Treatment Phase|Adverse Event|92|||
130052678|NCT00069095|468148488|FG002|Primary Treatment Phase|Adverse Event|71|||
130052679|NCT00069095|468148489|FG003|Primary Treatment Phase|Adverse Event|72|||
130052680|NCT00069095|468148490|FG004|Primary Treatment Phase|Adverse Event|109|||
130052681|NCT00069095|468148491|FG005|Primary Treatment Phase|Adverse Event|101|||
130317322|NCT03192176|469128586|FG002|Overall Study|Protocol Deviation|0|||
130052682|NCT00069095|468148486|FG000|Primary Treatment Phase|Death|14|||
130052683|NCT00069095|468148487|FG001|Primary Treatment Phase|Death|8|||
130052684|NCT00069095|468148488|FG002|Primary Treatment Phase|Death|2|||
130052685|NCT00069095|468148489|FG003|Primary Treatment Phase|Death|5|||
130052686|NCT00069095|468148490|FG004|Primary Treatment Phase|Death|8|||
130052687|NCT00069095|468148491|FG005|Primary Treatment Phase|Death|8|||
130052688|NCT00069095|468148486|FG000|Primary Treatment Phase|Failure to return|5|||
130052689|NCT00069095|468148487|FG001|Primary Treatment Phase|Failure to return|5|||
130052690|NCT00069095|468148488|FG002|Primary Treatment Phase|Failure to return|0|||
130052691|NCT00069095|468148489|FG003|Primary Treatment Phase|Failure to return|0|||
130052692|NCT00069095|468148490|FG004|Primary Treatment Phase|Failure to return|0|||
130052693|NCT00069095|468148491|FG005|Primary Treatment Phase|Failure to return|2|||
130052694|NCT00069095|468148486|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
130052695|NCT00069095|468148487|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
130052696|NCT00069095|468148488|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
130052697|NCT00069095|468148489|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
130052698|NCT00069095|468148490|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
130052699|NCT00069095|468148491|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
130052700|NCT00069095|468148486|FG000|Primary Treatment Phase|Refused treatment|15|||
130052701|NCT00069095|468148487|FG001|Primary Treatment Phase|Refused treatment|26|||
130052702|NCT00069095|468148488|FG002|Primary Treatment Phase|Refused treatment|17|||
130052703|NCT00069095|468148489|FG003|Primary Treatment Phase|Refused treatment|31|||
130052704|NCT00069095|468148490|FG004|Primary Treatment Phase|Refused treatment|24|||
130052705|NCT00069095|468148491|FG005|Primary Treatment Phase|Refused treatment|27|||
130052706|NCT00069095|468148486|FG000|Primary Treatment Phase|Withdrew|2|||
130052707|NCT00069095|468148487|FG001|Primary Treatment Phase|Withdrew|3|||
130052708|NCT00069095|468148488|FG002|Primary Treatment Phase|Withdrew|8|||
130052709|NCT00069095|468148489|FG003|Primary Treatment Phase|Withdrew|2|||
130052710|NCT00069095|468148490|FG004|Primary Treatment Phase|Withdrew|4|||
130052711|NCT00069095|468148491|FG005|Primary Treatment Phase|Withdrew|9|||
130052712|NCT00069095|468148486|FG000|Primary Treatment Phase|Other Violation|0|||
130052713|NCT00069095|468148487|FG001|Primary Treatment Phase|Other Violation|1|||
130052714|NCT00069095|468148488|FG002|Primary Treatment Phase|Other Violation|1|||
130052715|NCT00069095|468148489|FG003|Primary Treatment Phase|Other Violation|1|||
130052716|NCT00069095|468148490|FG004|Primary Treatment Phase|Other Violation|0|||
130052717|NCT00069095|468148491|FG005|Primary Treatment Phase|Other Violation|1|||
130052718|NCT00069095|468148486|FG000|Primary Treatment Phase|Violation criteria|0|||
130052719|NCT00069095|468148487|FG001|Primary Treatment Phase|Violation criteria|2|||
130052720|NCT00069095|468148488|FG002|Primary Treatment Phase|Violation criteria|4|||
130052721|NCT00069095|468148489|FG003|Primary Treatment Phase|Violation criteria|3|||
130052722|NCT00069095|468148490|FG004|Primary Treatment Phase|Violation criteria|1|||
130052723|NCT00069095|468148491|FG005|Primary Treatment Phase|Violation criteria|5|||
130052724|NCT00069095|468148486|FG000|Post-study Treatment Phase|Missing reason|1|||
130052725|NCT00069095|468148487|FG001|Post-study Treatment Phase|Missing reason|3|||
130052726|NCT00069095|468148488|FG002|Post-study Treatment Phase|Missing reason|12|||
130052727|NCT00069095|468148489|FG003|Post-study Treatment Phase|Missing reason|8|||
130052728|NCT00069095|468148490|FG004|Post-study Treatment Phase|Missing reason|18|||
130052729|NCT00069095|468148491|FG005|Post-study Treatment Phase|Missing reason|17|||
130052730|NCT00069095|468148486|FG000|Post-study Treatment Phase|Adverse Event|2|||
130052731|NCT00069095|468148487|FG001|Post-study Treatment Phase|Adverse Event|3|||
130052732|NCT00069095|468148488|FG002|Post-study Treatment Phase|Adverse Event|1|||
130052733|NCT00069095|468148489|FG003|Post-study Treatment Phase|Adverse Event|0|||
130052734|NCT00069095|468148490|FG004|Post-study Treatment Phase|Adverse Event|5|||
130052735|NCT00069095|468148491|FG005|Post-study Treatment Phase|Adverse Event|1|||
130052736|NCT00069095|468148486|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
130052737|NCT00069095|468148487|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
130052738|NCT00069095|468148488|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
130052739|NCT00069095|468148489|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
130052740|NCT00069095|468148490|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
130052741|NCT00069095|468148491|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
130052742|NCT00069095|468148486|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
130052743|NCT00069095|468148487|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
130052744|NCT00069095|468148488|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
130052745|NCT00069095|468148489|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
130052746|NCT00069095|468148490|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
130052747|NCT00069095|468148491|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
130052748|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
130052749|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130052750|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130052751|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130052752|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
130052753|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
130052754|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant had complete response|1|||
130052755|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant had complete response|1|||
130052756|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant had complete response|0|||
130052757|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant had complete response|0|||
130052758|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant had complete response|0|||
130317323|NCT03192176|469128587|FG003|Overall Study|Protocol Deviation|0|||
130317324|NCT03192176|469128588|FG004|Overall Study|Protocol Deviation|2|||
130317325|NCT03192176|469128589|FG005|Overall Study|Protocol Deviation|0|||
130317326|NCT03192176|469128590|FG006|Overall Study|Protocol Deviation|0|||
130317327|NCT03192176|469128591|FG007|Overall Study|Protocol Deviation|0|||
130317328|NCT03192176|469128584|FG000|Overall Study|Withdrawal by Subject|3|||
130317329|NCT03192176|469128585|FG001|Overall Study|Withdrawal by Subject|4|||
130317330|NCT03192176|469128586|FG002|Overall Study|Withdrawal by Subject|0|||
130317331|NCT03192176|469128587|FG003|Overall Study|Withdrawal by Subject|4|||
130317332|NCT03192176|469128588|FG004|Overall Study|Withdrawal by Subject|3|||
130317333|NCT03192176|469128589|FG005|Overall Study|Withdrawal by Subject|4|||
130317334|NCT03192176|469128590|FG006|Overall Study|Withdrawal by Subject|4|||
130317335|NCT03192176|469128591|FG007|Overall Study|Withdrawal by Subject|2|||
130317336|NCT03192176|469128584|FG000|Overall Study|Miscellaneous|1|||
130317337|NCT03192176|469128585|FG001|Overall Study|Miscellaneous|0|||
130317338|NCT03192176|469128586|FG002|Overall Study|Miscellaneous|1|||
130317339|NCT03192176|469128587|FG003|Overall Study|Miscellaneous|1|||
130317340|NCT03192176|469128588|FG004|Overall Study|Miscellaneous|1|||
130317341|NCT03192176|469128589|FG005|Overall Study|Miscellaneous|2|||
130317342|NCT03192176|469128590|FG006|Overall Study|Miscellaneous|0|||
130317343|NCT03192176|469128591|FG007|Overall Study|Miscellaneous|1|||
130317344|NCT03532542|469128594|FG000|Overall Study|Death|1|||
130317345|NCT03532542|469128595|FG001|Overall Study|Death|0|||
130317346|NCT03532542|469128594|FG000|Overall Study|Study Terminated by Sponsor|41|||
130317347|NCT03532542|469128595|FG001|Overall Study|Study Terminated by Sponsor|65|||
130317348|NCT03532542|469128594|FG000|Overall Study|Withdrawal by Subject|6|||
130317349|NCT03532542|469128595|FG001|Overall Study|Withdrawal by Subject|5|||
130317350|NCT00718510|469128597|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130052759|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant had complete response|0|||
130052760|NCT00069095|468148486|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130052761|NCT00069095|468148487|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
130052762|NCT00069095|468148488|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130052763|NCT00069095|468148489|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130052764|NCT00069095|468148490|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130052765|NCT00069095|468148491|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
130052766|NCT00069095|468148486|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
130052767|NCT00069095|468148487|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
130052768|NCT00069095|468148488|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
130052769|NCT00069095|468148489|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
130052770|NCT00069095|468148490|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
130052771|NCT00069095|468148491|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
130052772|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
130052773|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
130052774|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
130052775|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
130052776|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
130052777|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
130052778|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
130052779|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
130052780|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
130052781|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
130052782|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
130052783|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
130052784|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130052785|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130052786|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130052787|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
130052788|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130052789|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
130052790|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
130052791|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
130052792|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
130052793|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
130052794|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
130052795|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
130052796|NCT00069095|468148486|FG000|Post-study Treatment Phase|Surgery|0|||
130052797|NCT00069095|468148487|FG001|Post-study Treatment Phase|Surgery|0|||
130052798|NCT00069095|468148488|FG002|Post-study Treatment Phase|Surgery|0|||
130052799|NCT00069095|468148489|FG003|Post-study Treatment Phase|Surgery|1|||
130052800|NCT00069095|468148490|FG004|Post-study Treatment Phase|Surgery|1|||
130052801|NCT00069095|468148491|FG005|Post-study Treatment Phase|Surgery|0|||
130317351|NCT00718510|469128598|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130317352|NCT00718510|469128597|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130317353|NCT00718510|469128598|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130317354|NCT02314052|469128599|FG000|Cycle One|Adverse Event|0|||
130317355|NCT02314052|469128600|FG001|Cycle One|Adverse Event|0|||
130317356|NCT02314052|469128601|FG002|Cycle One|Adverse Event|0|||
130317357|NCT02314052|469128602|FG003|Cycle One|Adverse Event|1|||
130317358|NCT02314052|469128603|FG004|Cycle One|Adverse Event|0|||
130317359|NCT02314052|469128604|FG005|Cycle One|Adverse Event|0|||
130317360|NCT00117637|469128605|FG000|First Intervention (Period 1)|Adverse Event|11|||
130317361|NCT00117637|469128606|FG001|First Intervention (Period 1)|Adverse Event|16|||
130317362|NCT00117637|469128605|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
130317363|NCT00117637|469128606|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
130317364|NCT00117637|469128605|FG000|First Intervention (Period 1)|Protocol Violation|1|||
130317365|NCT00117637|469128606|FG001|First Intervention (Period 1)|Protocol Violation|0|||
130317366|NCT00117637|469128605|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
130317367|NCT00117637|469128606|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
130317368|NCT00117637|469128605|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
130317369|NCT00117637|469128606|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
130317370|NCT00117637|469128605|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
130317371|NCT00117637|469128606|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
130052802|NCT00069095|468148486|FG000|Post-study Treatment Phase|Death|0|||
130052803|NCT00069095|468148487|FG001|Post-study Treatment Phase|Death|0|||
130052804|NCT00069095|468148488|FG002|Post-study Treatment Phase|Death|0|||
130052805|NCT00069095|468148489|FG003|Post-study Treatment Phase|Death|0|||
130052806|NCT00069095|468148490|FG004|Post-study Treatment Phase|Death|1|||
130052807|NCT00069095|468148491|FG005|Post-study Treatment Phase|Death|0|||
130052808|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
130052809|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
130052810|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
130052811|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
130052812|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
130052813|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
130052814|NCT00069095|468148486|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130052815|NCT00069095|468148487|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130052816|NCT00069095|468148488|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130052817|NCT00069095|468148489|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130052818|NCT00069095|468148490|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
130052819|NCT00069095|468148491|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
130052820|NCT00069095|468148486|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130052821|NCT00069095|468148487|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130052822|NCT00069095|468148488|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130052823|NCT00069095|468148489|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130052824|NCT00069095|468148490|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
130052825|NCT00069095|468148491|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
130052826|NCT00069095|468148486|FG000|Post-study Treatment Phase|Investigator decision|0|||
130052827|NCT00069095|468148487|FG001|Post-study Treatment Phase|Investigator decision|0|||
130052828|NCT00069095|468148488|FG002|Post-study Treatment Phase|Investigator decision|0|||
130052829|NCT00069095|468148489|FG003|Post-study Treatment Phase|Investigator decision|0|||
130052830|NCT00069095|468148490|FG004|Post-study Treatment Phase|Investigator decision|0|||
130052831|NCT00069095|468148491|FG005|Post-study Treatment Phase|Investigator decision|1|||
130052832|NCT00069095|468148486|FG000|Follow-up Phase|Death|174|||
130052833|NCT00069095|468148487|FG001|Follow-up Phase|Death|206|||
130052834|NCT00069095|468148488|FG002|Follow-up Phase|Death|120|||
130052835|NCT00069095|468148489|FG003|Follow-up Phase|Death|112|||
130052836|NCT00069095|468148490|FG004|Follow-up Phase|Death|92|||
130052837|NCT00069095|468148491|FG005|Follow-up Phase|Death|101|||
130052838|NCT03508622|468148492|FG000|Overall Study|Protocol Violation|1|||
130052839|NCT03508622|468148493|FG001|Overall Study|Protocol Violation|0|||
130052840|NCT03508622|468148492|FG000|Overall Study|Withdrawal by Subject|1|||
130052841|NCT03508622|468148493|FG001|Overall Study|Withdrawal by Subject|0|||
130052842|NCT03508622|468148492|FG000|Overall Study|Lost to Follow-up|16|||
130052843|NCT03508622|468148493|FG001|Overall Study|Lost to Follow-up|0|||
130052844|NCT03508622|468148492|FG000|Overall Study|Incomplete data|0|||
130052845|NCT03508622|468148493|FG001|Overall Study|Incomplete data|24|||
130052846|NCT00210158|468148495|FG000|Overall Study|Protocol Violation|0|||
130052847|NCT00210158|468148496|FG001|Overall Study|Protocol Violation|2|||
130052848|NCT04716933|468148497|FG000|Overall Study|Sponsor Decision|36|||
130052849|NCT04716933|468148498|FG001|Overall Study|Sponsor Decision|33|||
130052850|NCT04716933|468148497|FG000|Overall Study|Death|65|||
130052851|NCT04716933|468148498|FG001|Overall Study|Death|67|||
130052852|NCT03196505|468148501|FG000|Overall Study|Physician Decision|26|||
130052853|NCT03196505|468148502|FG001|Overall Study|Physician Decision|26|||
130052854|NCT01005719|468148503|FG000|Period 1|Adverse Event|0|||
130052855|NCT01005719|468148504|FG001|Period 1|Adverse Event|0|||
130052856|NCT01005719|468148505|FG002|Period 1|Adverse Event|0|||
130317372|NCT00117637|469128605|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
130317373|NCT00117637|469128606|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
130317374|NCT00117637|469128605|FG000|First Intervention (Period 1)|reason not reported|0|||
130317375|NCT00117637|469128606|FG001|First Intervention (Period 1)|reason not reported|1|||
130317376|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Adverse Event|0|||
130317377|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Adverse Event|9|||
130317378|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
130317379|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
130317380|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
130317381|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
130317382|NCT00117637|469128605|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
130317383|NCT00117637|469128606|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
130317384|NCT00117637|469128605|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
130052857|NCT01005719|468148506|FG003|Period 1|Adverse Event|1|||
130052858|NCT01005719|468148507|FG004|Period 1|Adverse Event|0|||
130052859|NCT01005719|468148508|FG005|Period 1|Adverse Event|0|||
130317385|NCT00117637|469128606|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
130317386|NCT00117637|469128605|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
130317387|NCT00117637|469128606|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
130317388|NCT00117637|469128605|FG000|Second Intervention (Period 2)|reason not reported|1|||
130317389|NCT00117637|469128606|FG001|Second Intervention (Period 2)|reason not reported|0|||
130317390|NCT01582061|469128607|FG000|Overall Study|Lack of Efficacy|3|||
130317391|NCT01582061|469128608|FG001|Overall Study|Lack of Efficacy|23|||
130317392|NCT01582061|469128607|FG000|Overall Study|Adverse Event|12|||
130317393|NCT01582061|469128608|FG001|Overall Study|Adverse Event|8|||
130052860|NCT01005719|468148503|FG000|Period 1|Delay in completing study procedures|0|||
130052861|NCT01005719|468148504|FG001|Period 1|Delay in completing study procedures|0|||
130052862|NCT01005719|468148505|FG002|Period 1|Delay in completing study procedures|0|||
130052863|NCT01005719|468148506|FG003|Period 1|Delay in completing study procedures|0|||
130052864|NCT01005719|468148507|FG004|Period 1|Delay in completing study procedures|0|||
130052865|NCT01005719|468148508|FG005|Period 1|Delay in completing study procedures|1|||
130052866|NCT01005719|468148503|FG000|Period 2|Adverse Event|0|||
130052867|NCT01005719|468148504|FG001|Period 2|Adverse Event|0|||
130052868|NCT01005719|468148505|FG002|Period 2|Adverse Event|0|||
130052869|NCT01005719|468148506|FG003|Period 2|Adverse Event|0|||
130052870|NCT01005719|468148507|FG004|Period 2|Adverse Event|1|||
130052871|NCT01005719|468148508|FG005|Period 2|Adverse Event|1|||
130052872|NCT03015610|468148514|FG000|Overall Study|Lost to Follow-up|1|||
130052873|NCT03015610|468148515|FG001|Overall Study|Lost to Follow-up|5|||
130052874|NCT05100199|468148516|FG000|Overall Study|Lost to Follow-up|5|||
130052875|NCT05100199|468148517|FG001|Overall Study|Lost to Follow-up|8|||
130052876|NCT05100199|468148518|FG002|Overall Study|Lost to Follow-up|3|||
130052877|NCT05100199|468148519|FG003|Overall Study|Lost to Follow-up|6|||
130052878|NCT05100199|468148516|FG000|Overall Study|Withdrawal by Subject|3|||
130052879|NCT05100199|468148517|FG001|Overall Study|Withdrawal by Subject|3|||
130052880|NCT05100199|468148518|FG002|Overall Study|Withdrawal by Subject|9|||
130052881|NCT05100199|468148519|FG003|Overall Study|Withdrawal by Subject|7|||
130052882|NCT05100199|468148516|FG000|Overall Study|Other|0|||
130052883|NCT05100199|468148517|FG001|Overall Study|Other|0|||
130052884|NCT05100199|468148518|FG002|Overall Study|Other|1|||
130052885|NCT05100199|468148519|FG003|Overall Study|Other|1|||
130052886|NCT00752609|468148520|FG000|Overall Study|Adverse Event|2|||
130052887|NCT00752609|468148521|FG001|Overall Study|Adverse Event|2|||
130052888|NCT00752609|468148520|FG000|Overall Study|Withdrawal by Subject|3|||
130052889|NCT00752609|468148521|FG001|Overall Study|Withdrawal by Subject|0|||
130052890|NCT00752609|468148520|FG000|Overall Study|Physician Decision|1|||
130052891|NCT00752609|468148521|FG001|Overall Study|Physician Decision|0|||
130052892|NCT00752609|468148520|FG000|Overall Study|Death|1|||
130052893|NCT00752609|468148521|FG001|Overall Study|Death|0|||
130052894|NCT00752609|468148520|FG000|Overall Study|Met exclusion criteria|1|||
130052895|NCT00752609|468148521|FG001|Overall Study|Met exclusion criteria|0|||
130052896|NCT00752609|468148520|FG000|Overall Study|Received Aranesp in error|1|||
130052897|NCT00752609|468148521|FG001|Overall Study|Received Aranesp in error|0|||
130052898|NCT05114590|468148522|FG000|Overall Study|Adverse Event|1|||
130052899|NCT05114590|468148522|FG000|Overall Study|Investigator decision|1|||
130052900|NCT05114590|468148522|FG000|Overall Study|Lost to Follow-up|5|||
130052901|NCT05114590|468148522|FG000|Overall Study|Withdrawal by Subject|5|||
130052902|NCT05114590|468148522|FG000|Overall Study|Other|2|||
130052903|NCT00358917|468148525|FG000|Overall Study|Adverse Event|14|||
130052904|NCT00358917|468148526|FG001|Overall Study|Adverse Event|21|||
130052905|NCT00358917|468148525|FG000|Overall Study|Withdrawal by Subject|5|||
130052906|NCT00358917|468148526|FG001|Overall Study|Withdrawal by Subject|7|||
130052907|NCT00358917|468148525|FG000|Overall Study|Lost to Follow-up|20|||
130052908|NCT00358917|468148526|FG001|Overall Study|Lost to Follow-up|17|||
130052909|NCT00358917|468148525|FG000|Overall Study|Noncompliance|12|||
130052910|NCT00358917|468148526|FG001|Overall Study|Noncompliance|11|||
130052911|NCT00358917|468148525|FG000|Overall Study|Death|2|||
130317394|NCT01582061|469128607|FG000|Overall Study|Withdrawal by Subject|10|||
130317395|NCT01582061|469128608|FG001|Overall Study|Withdrawal by Subject|4|||
130317396|NCT01582061|469128607|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130317397|NCT01582061|469128608|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130317398|NCT01582061|469128607|FG000|Overall Study|Death|0|||
130317399|NCT01582061|469128608|FG001|Overall Study|Death|1|||
130317400|NCT01582061|469128607|FG000|Overall Study|condition no longer requires study drug|1|||
130317401|NCT01582061|469128608|FG001|Overall Study|condition no longer requires study drug|0|||
130317402|NCT01582061|469128607|FG000|Overall Study|Lost to Follow-up|1|||
130317403|NCT01582061|469128608|FG001|Overall Study|Lost to Follow-up|0|||
130317404|NCT02756338|469128609|FG000|Overall Study|Withdrawn by Investigator|1|||
130317405|NCT02756338|469128609|FG000|Overall Study|Device Replaced with Pacemaker|4|||
130317406|NCT00300755|469128614|FG000|Overall Study|Adverse Event|1|||
130317407|NCT00300755|469128615|FG001|Overall Study|Adverse Event|2|||
130317408|NCT00300755|469128616|FG002|Overall Study|Adverse Event|1|||
130317409|NCT00300755|469128614|FG000|Overall Study|Withdrawal by Subject|0|||
130317410|NCT00300755|469128615|FG001|Overall Study|Withdrawal by Subject|2|||
130317411|NCT00300755|469128616|FG002|Overall Study|Withdrawal by Subject|0|||
130317412|NCT00300755|469128614|FG000|Overall Study|Protocol Violation|0|||
130317413|NCT00300755|469128615|FG001|Overall Study|Protocol Violation|0|||
130317414|NCT00300755|469128616|FG002|Overall Study|Protocol Violation|1|||
130317415|NCT02694744|469128620|FG000|Overall Study|Adverse Event|2|||
130317416|NCT02694744|469128621|FG001|Overall Study|Adverse Event|1|||
130317417|NCT02694744|469128620|FG000|Overall Study|Withdrawal by Subject|2|||
130317418|NCT02694744|469128621|FG001|Overall Study|Withdrawal by Subject|1|||
130317419|NCT02694744|469128620|FG000|Overall Study|Physician Decision|1|||
130317420|NCT02694744|469128621|FG001|Overall Study|Physician Decision|2|||
130317421|NCT02694744|469128620|FG000|Overall Study|Lost to Follow-up|1|||
130317422|NCT02694744|469128621|FG001|Overall Study|Lost to Follow-up|0|||
130317423|NCT02694744|469128620|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
130317424|NCT02694744|469128621|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
130052912|NCT00358917|468148526|FG001|Overall Study|Death|3|||
130052913|NCT00358917|468148525|FG000|Overall Study|Virologic failure|11|||
130317425|NCT00686777|469128622|FG000|Overall Study|Adverse Event|2|||
130317426|NCT00686777|469128622|FG000|Overall Study|Pregnancy|1|||
130052914|NCT00358917|468148526|FG001|Overall Study|Virologic failure|8|||
130052915|NCT00358917|468148525|FG000|Overall Study|Unable to Continue Participation|2|||
130052916|NCT00358917|468148526|FG001|Overall Study|Unable to Continue Participation|2|||
130052917|NCT01379534|468148535|FG000|Treatment Phase|Withdrawal by Subject|2|||
130052918|NCT01379534|468148536|FG001|Treatment Phase|Withdrawal by Subject|2|||
130052919|NCT01379534|468148535|FG000|Treatment Phase|Progressive disease|13|||
130052920|NCT01379534|468148536|FG001|Treatment Phase|Progressive disease|22|||
130052921|NCT01379534|468148535|FG000|Treatment Phase|Adverse Event|7|||
130052922|NCT01379534|468148536|FG001|Treatment Phase|Adverse Event|7|||
130052923|NCT01379534|468148535|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
130052924|NCT01379534|468148536|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
130052925|NCT01379534|468148535|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
130052926|NCT01379534|468148536|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
130052927|NCT01379534|468148535|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
130052928|NCT01379534|468148536|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
130052929|NCT01379534|468148535|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
130052930|NCT01379534|468148536|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
130052931|NCT05372575|468148539|FG000|Overall Study|Protocol Violation|7|||
130052932|NCT05372575|468148540|FG001|Overall Study|Protocol Violation|16|||
130052933|NCT04333433|468148543|FG000|Overall Study|Withdrawal by Subject|6|||
130052934|NCT04333433|468148544|FG001|Overall Study|Withdrawal by Subject|3|||
130052935|NCT04333433|468148543|FG000|Overall Study|Death|3|||
130052936|NCT04333433|468148544|FG001|Overall Study|Death|0|||
130052937|NCT04333433|468148543|FG000|Overall Study|Lost to Follow-up|6|||
130052938|NCT04333433|468148544|FG001|Overall Study|Lost to Follow-up|1|||
130052939|NCT04333433|468148543|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
130052940|NCT04333433|468148544|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
130317427|NCT00686777|469128622|FG000|Overall Study|Withdrawal by Subject|2|||
130317428|NCT00686777|469128622|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
130317429|NCT00686777|469128622|FG000|Overall Study|No Visit|1|||
130317430|NCT01945021|469128623|FG000|Overall Study|Adverse Event|1|||
130052941|NCT00320385|468148545|FG000|Overall Study|Lost to Follow-up|7|||
130317431|NCT01945021|469128623|FG000|Overall Study|Withdrawal of consent|12|||
130317432|NCT01945021|469128623|FG000|Overall Study|Lost to Follow-up|5|||
130317433|NCT01945021|469128623|FG000|Overall Study|Death|65|||
130317434|NCT03582215|469128624|FG000|Overall Study|Adverse Event|1|||
130317435|NCT03582215|469128625|FG001|Overall Study|Adverse Event|0|||
130317436|NCT03582215|469128626|FG002|Overall Study|Adverse Event|0|||
130317437|NCT03582215|469128627|FG003|Overall Study|Adverse Event|0|||
130317438|NCT03582215|469128628|FG004|Overall Study|Adverse Event|0|||
130317439|NCT03582215|469128629|FG005|Overall Study|Adverse Event|0|||
130317440|NCT03582215|469128630|FG006|Overall Study|Adverse Event|2|||
130317441|NCT03582215|469128631|FG007|Overall Study|Adverse Event|2|||
130317442|NCT02163902|469128632|FG000|Overall Study|Subject's Request|3|||
130317443|NCT02163902|469128633|FG001|Overall Study|Subject's Request|4|||
130317444|NCT02163902|469128632|FG000|Overall Study|Lost to Follow-up|6|||
130317445|NCT02163902|469128633|FG001|Overall Study|Lost to Follow-up|7|||
130317446|NCT02163902|469128632|FG000|Overall Study|Administrative Decision|2|||
130317447|NCT02163902|469128633|FG001|Overall Study|Administrative Decision|2|||
130317448|NCT02174731|469128634|FG000|Overall Study|Participant decision|67|||
130317449|NCT02174731|469128635|FG001|Overall Study|Participant decision|64|||
130317450|NCT02174731|469128634|FG000|Overall Study|Incorrect enrolment before randomization|0|||
130317451|NCT02174731|469128635|FG001|Overall Study|Incorrect enrolment before randomization|1|||
130317452|NCT02174731|469128634|FG000|Overall Study|Missing|2|||
130317453|NCT02174731|469128635|FG001|Overall Study|Missing|0|||
130317454|NCT03119259|469128636|FG000|Overall Study|Withdrawn as no longer eligible|1|||
130317455|NCT03119259|469128637|FG001|Overall Study|Withdrawn as no longer eligible|0|||
130317456|NCT03119259|469128636|FG000|Overall Study|Withdrawal by Subject|4|||
130317457|NCT03119259|469128637|FG001|Overall Study|Withdrawal by Subject|2|||
130317458|NCT03119259|469128636|FG000|Overall Study|Lost to Follow-up|0|||
130317459|NCT03119259|469128637|FG001|Overall Study|Lost to Follow-up|1|||
130317460|NCT01168349|469128645|FG000|Overall Study|Death|157|||
130317461|NCT01168349|469128645|FG000|Overall Study|Lost to Follow-up|34|||
130317462|NCT01168349|469128645|FG000|Overall Study|Withdrawal by Subject|9|||
130317463|NCT01168349|469128645|FG000|Overall Study|Kidney transplantation|3|||
130317464|NCT01168349|469128645|FG000|Overall Study|Other|22|||
130317465|NCT01168349|469128645|FG000|Overall Study|Protocol Violation|76|||
130317466|NCT03535974|469128646|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
130317467|NCT03535974|469128647|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
130317468|NCT03535974|469128648|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
130317469|NCT03535974|469128646|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
130317470|NCT03535974|469128647|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
130317471|NCT03535974|469128648|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
130317472|NCT04059549|469128649|FG000|Overall Study|Withdrawal by Subject|2|||
130317473|NCT04059549|469128650|FG001|Overall Study|Withdrawal by Subject|0|||
130317474|NCT02678351|469128652|FG000|Overall Study|Withdrawal by Subject|1|||
130317475|NCT00988884|469128653|FG000|Overall Study|Adverse Event|0|||
130317476|NCT00988884|469128654|FG001|Overall Study|Adverse Event|1|||
130317477|NCT00988884|469128653|FG000|Overall Study|Lost to Follow-up|20|||
130317478|NCT00988884|469128654|FG001|Overall Study|Lost to Follow-up|16|||
130317479|NCT00988884|469128653|FG000|Overall Study|Protocol Violation|0|||
130317480|NCT00988884|469128654|FG001|Overall Study|Protocol Violation|1|||
130317481|NCT00988884|469128653|FG000|Overall Study|Withdrawal by Subject|15|||
130317482|NCT00988884|469128654|FG001|Overall Study|Withdrawal by Subject|18|||
129800617|NCT02477839|467238149|FG000|Overall Study|Exclusion criterion|0|||
129800618|NCT02477839|467238150|FG001|Overall Study|Exclusion criterion|1|||
129800619|NCT01439568|467238151|FG000|Overall Study|Lost to Follow-up|1|||
129800620|NCT01439568|467238152|FG001|Overall Study|Lost to Follow-up|0|||
129800621|NCT01439568|467238151|FG000|Overall Study|Withdrawal by Subject|2|||
129800622|NCT01439568|467238152|FG001|Overall Study|Withdrawal by Subject|2|||
129800623|NCT01676727|467238153|FG000|Overall Study|Death|18|||
129800624|NCT01676727|467238153|FG000|Overall Study|Withdrawal by Subject|6|||
129800625|NCT01676727|467238153|FG000|Overall Study|Screening failure|5|||
129800626|NCT01676727|467238153|FG000|Overall Study|Not willing to attend 1-year visit|2|||
129800627|NCT01676727|467238153|FG000|Overall Study|Valve explanted|1|||
129800628|NCT03053271|467238154|FG000|Overall Study|Did not meet randomization criteria|3|||
129800629|NCT03053271|467238154|FG000|Overall Study|Withdrawal by Subject|1|||
129800630|NCT00580970|467238155|FG000|Pre-treatment|Non-compliance|1|||
129800631|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Non-compliance|6|||
129800632|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
129800633|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Physician Decision|4|||
129800634|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
129800635|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Death|1|||
129800636|NCT04137224|467238156|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
129800637|NCT04137224|467238157|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
129800638|NCT04137224|467238156|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
129800639|NCT04137224|467238157|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
129800640|NCT04137224|467238156|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
129800641|NCT04137224|467238157|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
130317483|NCT01919229|469128655|FG000|Overall Study|Subject/guardian decision|0|||
130317484|NCT01919229|469128656|FG001|Overall Study|Subject/guardian decision|0|||
130317485|NCT01919229|469128657|FG002|Overall Study|Subject/guardian decision|1|||
130317486|NCT00626275|469128658|FG000|Part A - Treatment Period 1|Adverse Event|1|||
130317487|NCT00626275|469128659|FG001|Part A - Treatment Period 1|Adverse Event|0|||
130317488|NCT00626275|469128660|FG002|Part A - Treatment Period 1|Adverse Event|0|||
130317489|NCT00626275|469128661|FG003|Part A - Treatment Period 1|Adverse Event|0|||
130317490|NCT00626275|469128662|FG004|Part A - Treatment Period 1|Adverse Event|0|||
130317491|NCT00626275|469128663|FG005|Part A - Treatment Period 1|Adverse Event|0|||
130317492|NCT00626275|469128664|FG006|Part A - Treatment Period 1|Adverse Event|0|||
130317493|NCT00626275|469128665|FG007|Part A - Treatment Period 1|Adverse Event|0|||
130317494|NCT00626275|469128658|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317495|NCT00626275|469128659|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317496|NCT00626275|469128660|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
130317497|NCT00626275|469128661|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317498|NCT00626275|469128662|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317499|NCT00626275|469128663|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317500|NCT00626275|469128664|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317501|NCT00626275|469128665|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
130317502|NCT00626275|469128658|FG000|Part B|Lost to Follow-up|0|||
130317503|NCT00626275|469128659|FG001|Part B|Lost to Follow-up|0|||
130317504|NCT00626275|469128660|FG002|Part B|Lost to Follow-up|0|||
130317505|NCT00626275|469128661|FG003|Part B|Lost to Follow-up|0|||
130317506|NCT00626275|469128662|FG004|Part B|Lost to Follow-up|0|||
130317507|NCT00626275|469128663|FG005|Part B|Lost to Follow-up|0|||
130317508|NCT00626275|469128664|FG006|Part B|Lost to Follow-up|1|||
130317509|NCT00626275|469128665|FG007|Part B|Lost to Follow-up|0|||
130317510|NCT00626275|469128658|FG000|Part B|Withdrawal by Subject|0|||
130317511|NCT00626275|469128659|FG001|Part B|Withdrawal by Subject|0|||
130317512|NCT00626275|469128660|FG002|Part B|Withdrawal by Subject|0|||
130317513|NCT00626275|469128661|FG003|Part B|Withdrawal by Subject|0|||
130317514|NCT00626275|469128662|FG004|Part B|Withdrawal by Subject|0|||
130317515|NCT00626275|469128663|FG005|Part B|Withdrawal by Subject|0|||
130317516|NCT00626275|469128664|FG006|Part B|Withdrawal by Subject|0|||
130052942|NCT00320385|468148546|FG001|Overall Study|Lost to Follow-up|10|||
130052943|NCT00320385|468148545|FG000|Overall Study|Withdrawal by Subject|6|||
130052944|NCT00320385|468148546|FG001|Overall Study|Withdrawal by Subject|7|||
130052945|NCT00320385|468148545|FG000|Overall Study|Sponsor Terminated Study|2|||
130052946|NCT00320385|468148546|FG001|Overall Study|Sponsor Terminated Study|1|||
130052947|NCT00320385|468148545|FG000|Overall Study|Investigator Decision|0|||
130052948|NCT00320385|468148546|FG001|Overall Study|Investigator Decision|1|||
130317517|NCT00626275|469128665|FG007|Part B|Withdrawal by Subject|1|||
130317518|NCT04999839|469128666|FG000|Overall Study|Adverse Event|1|||
130317519|NCT04999839|469128667|FG001|Overall Study|Adverse Event|1|||
130317520|NCT04999839|469128668|FG002|Overall Study|Adverse Event|1|||
130317521|NCT04999839|469128669|FG003|Overall Study|Adverse Event|1|||
130317522|NCT04999839|469128670|FG004|Overall Study|Adverse Event|1|||
130317523|NCT04999839|469128666|FG000|Overall Study|Lost to Follow-up|2|||
130317524|NCT04999839|469128667|FG001|Overall Study|Lost to Follow-up|0|||
130317525|NCT04999839|469128668|FG002|Overall Study|Lost to Follow-up|2|||
130317526|NCT04999839|469128669|FG003|Overall Study|Lost to Follow-up|4|||
130317527|NCT04999839|469128670|FG004|Overall Study|Lost to Follow-up|1|||
130317528|NCT04999839|469128666|FG000|Overall Study|Withdrawal by Subject|6|||
130317529|NCT04999839|469128667|FG001|Overall Study|Withdrawal by Subject|5|||
130317530|NCT04999839|469128668|FG002|Overall Study|Withdrawal by Subject|3|||
130317531|NCT04999839|469128669|FG003|Overall Study|Withdrawal by Subject|2|||
130317532|NCT04999839|469128670|FG004|Overall Study|Withdrawal by Subject|2|||
130317533|NCT04999839|469128666|FG000|Overall Study|Lack of Efficacy|0|||
130317534|NCT04999839|469128667|FG001|Overall Study|Lack of Efficacy|1|||
130317535|NCT04999839|469128668|FG002|Overall Study|Lack of Efficacy|0|||
130317536|NCT04999839|469128669|FG003|Overall Study|Lack of Efficacy|0|||
130317537|NCT04999839|469128670|FG004|Overall Study|Lack of Efficacy|0|||
130317538|NCT04999839|469128666|FG000|Overall Study|Physician Decision|0|||
130317539|NCT04999839|469128667|FG001|Overall Study|Physician Decision|0|||
130317540|NCT04999839|469128668|FG002|Overall Study|Physician Decision|0|||
130317541|NCT04999839|469128669|FG003|Overall Study|Physician Decision|0|||
130317542|NCT04999839|469128670|FG004|Overall Study|Physician Decision|1|||
130317543|NCT04999839|469128666|FG000|Overall Study|Sponsor request|0|||
130317544|NCT04999839|469128667|FG001|Overall Study|Sponsor request|1|||
130317545|NCT04999839|469128668|FG002|Overall Study|Sponsor request|0|||
130317546|NCT04999839|469128669|FG003|Overall Study|Sponsor request|0|||
130317547|NCT04999839|469128670|FG004|Overall Study|Sponsor request|0|||
130317548|NCT04999839|469128666|FG000|Overall Study|Other|0|||
130317549|NCT04999839|469128667|FG001|Overall Study|Other|0|||
130317550|NCT04999839|469128668|FG002|Overall Study|Other|1|||
130317551|NCT04999839|469128669|FG003|Overall Study|Other|0|||
130317552|NCT04999839|469128670|FG004|Overall Study|Other|0|||
130317553|NCT01362348|469128671|FG000|Overall Study|Protocol-defined stopping criteria|9|||
130317554|NCT01362348|469128671|FG000|Overall Study|Study closed/terminated|5|||
130317555|NCT02734693|469128674|FG000|Overall Study|Adverse Event|1|||
130317556|NCT02734693|469128675|FG001|Overall Study|Adverse Event|3|||
130317557|NCT02734693|469128676|FG002|Overall Study|Adverse Event|3|||
130317558|NCT02734693|469128674|FG000|Overall Study|Lack of Efficacy|1|||
130317559|NCT02734693|469128675|FG001|Overall Study|Lack of Efficacy|0|||
130317560|NCT02734693|469128676|FG002|Overall Study|Lack of Efficacy|0|||
130317561|NCT02734693|469128674|FG000|Overall Study|Lost to Follow-up|2|||
130317562|NCT02734693|469128675|FG001|Overall Study|Lost to Follow-up|0|||
130317563|NCT02734693|469128676|FG002|Overall Study|Lost to Follow-up|0|||
130317564|NCT02734693|469128674|FG000|Overall Study|Protocol Violation|1|||
130317565|NCT02734693|469128675|FG001|Overall Study|Protocol Violation|0|||
130317566|NCT02734693|469128676|FG002|Overall Study|Protocol Violation|0|||
130317567|NCT02734693|469128674|FG000|Overall Study|Withdrawal by Subject|1|||
130317568|NCT02734693|469128675|FG001|Overall Study|Withdrawal by Subject|0|||
130317569|NCT02734693|469128676|FG002|Overall Study|Withdrawal by Subject|0|||
130052949|NCT00320385|468148545|FG000|Overall Study|Death|1|||
130052950|NCT00320385|468148546|FG001|Overall Study|Death|2|||
130317570|NCT02898454|469128682|FG000|Overall Study|Adverse Event|4|||
130052951|NCT00320385|468148545|FG000|Overall Study|Serious Adverse Event|1|||
130052952|NCT00320385|468148546|FG001|Overall Study|Serious Adverse Event|0|||
130317571|NCT02898454|469128683|FG001|Overall Study|Adverse Event|1|||
130317572|NCT02898454|469128684|FG002|Overall Study|Adverse Event|2|||
130317573|NCT02898454|469128682|FG000|Overall Study|Protocol Violation|1|||
130317574|NCT02898454|469128683|FG001|Overall Study|Protocol Violation|0|||
130317575|NCT02898454|469128684|FG002|Overall Study|Protocol Violation|1|||
130317576|NCT02898454|469128682|FG000|Overall Study|Lack of Efficacy|4|||
130317577|NCT02898454|469128683|FG001|Overall Study|Lack of Efficacy|1|||
130317578|NCT02898454|469128684|FG002|Overall Study|Lack of Efficacy|0|||
130317579|NCT02898454|469128682|FG000|Overall Study|Withdrawal by Subject|6|||
130317580|NCT02898454|469128683|FG001|Overall Study|Withdrawal by Subject|3|||
130317581|NCT02898454|469128684|FG002|Overall Study|Withdrawal by Subject|3|||
130317582|NCT02898454|469128682|FG000|Overall Study|Lost to Follow-up|1|||
130317583|NCT02898454|469128683|FG001|Overall Study|Lost to Follow-up|0|||
130317584|NCT02898454|469128684|FG002|Overall Study|Lost to Follow-up|0|||
129800642|NCT00566501|467238160|FG000|Overall Study|Adverse Event|68|||
129800643|NCT00566501|467238161|FG001|Overall Study|Adverse Event|59|||
129800644|NCT00566501|467238160|FG000|Overall Study|Medication Non-compliance|5|||
129800645|NCT00566501|467238161|FG001|Overall Study|Medication Non-compliance|0|||
129800646|NCT00566501|467238160|FG000|Overall Study|Protocol Violation|2|||
129800647|NCT00566501|467238161|FG001|Overall Study|Protocol Violation|2|||
129800648|NCT00566501|467238160|FG000|Overall Study|Request of Investigator or Sponsor|6|||
129800649|NCT00566501|467238161|FG001|Overall Study|Request of Investigator or Sponsor|7|||
129800650|NCT00566501|467238160|FG000|Overall Study|Withdrawal by Subject|33|||
129800651|NCT00566501|467238161|FG001|Overall Study|Withdrawal by Subject|30|||
129800652|NCT00566501|467238160|FG000|Overall Study|Lack of Efficacy|8|||
129800653|NCT00566501|467238161|FG001|Overall Study|Lack of Efficacy|3|||
129800654|NCT00566501|467238160|FG000|Overall Study|Other|25|||
129800655|NCT00566501|467238161|FG001|Overall Study|Other|21|||
129800656|NCT00679055|467238164|FG000|Overall Study|Adverse Event|0|||
129800657|NCT00679055|467238165|FG001|Overall Study|Adverse Event|1|||
129800658|NCT00679055|467238164|FG000|Overall Study|Other|0|||
129800659|NCT00679055|467238165|FG001|Overall Study|Other|3|||
129800660|NCT00679055|467238164|FG000|Overall Study|Study Terminated|2|||
129800661|NCT00679055|467238165|FG001|Overall Study|Study Terminated|1|||
129800662|NCT01368432|467238166|FG000|Overall Study|Lost to Follow-up|0|||
129800663|NCT01368432|467238167|FG001|Overall Study|Lost to Follow-up|1|||
129800664|NCT01008150|467238168|FG000|Overall Study|did not receive study drug|1|||
130052953|NCT00320385|468148545|FG000|Overall Study|Withdrew Consent|1|||
130052954|NCT00320385|468148546|FG001|Overall Study|Withdrew Consent|0|||
130052955|NCT00320385|468148545|FG000|Overall Study|Adverse Event|0|||
130052956|NCT00320385|468148546|FG001|Overall Study|Adverse Event|1|||
130052957|NCT00001262|468148550|FG000|Overall Study|Death|10|||
130052958|NCT00001262|468148551|FG001|Overall Study|Death|11|||
130052959|NCT00001262|468148552|FG002|Overall Study|Death|0|||
130052960|NCT00001262|468148550|FG000|Overall Study|Withdrawal by Subject|0|||
130052961|NCT00001262|468148551|FG001|Overall Study|Withdrawal by Subject|3|||
130052962|NCT00001262|468148552|FG002|Overall Study|Withdrawal by Subject|0|||
130052963|NCT00878072|468148554|FG000|Overall Study|Withdrew consent|2|||
130052964|NCT03844633|468148558|FG000|1 Week FU|Lost to Follow-up|0|||
130052965|NCT03844633|468148559|FG001|1 Week FU|Lost to Follow-up|1|||
130052966|NCT03844633|468148560|FG002|1 Week FU|Lost to Follow-up|4|||
130052967|NCT03844633|468148558|FG000|12-month Follow-up|Lost to Follow-up|7|||
130052968|NCT03844633|468148559|FG001|12-month Follow-up|Lost to Follow-up|5|||
130052969|NCT03844633|468148560|FG002|12-month Follow-up|Lost to Follow-up|8|||
130052970|NCT01355068|468148561|FG000|First Intervention Period|Adverse Event|0|||
130052971|NCT01355068|468148562|FG001|First Intervention Period|Adverse Event|1|||
130052972|NCT01355068|468148561|FG000|First Intervention Period|Withdrawal by Subject|0|||
130052973|NCT01355068|468148562|FG001|First Intervention Period|Withdrawal by Subject|1|||
130052974|NCT00524745|468148563|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
130052975|NCT00524745|468148564|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
130052976|NCT00524745|468148565|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
130052977|NCT00524745|468148566|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
130052978|NCT00872170|468148567|FG000|Overall Study|Adverse Event|1|||
130052979|NCT00872170|468148568|FG001|Overall Study|Adverse Event|0|||
130052980|NCT01721408|468148569|FG000|Overall Study|Adverse Event|6|||
130052981|NCT01721408|468148570|FG001|Overall Study|Adverse Event|1|||
130052982|NCT01721408|468148569|FG000|Overall Study|Death|1|||
130052983|NCT01721408|468148570|FG001|Overall Study|Death|0|||
130052984|NCT01721408|468148569|FG000|Overall Study|Insufficient clinical response|15|||
130052985|NCT01721408|468148570|FG001|Overall Study|Insufficient clinical response|6|||
130052986|NCT01721408|468148569|FG000|Overall Study|No longer willing to participate study|9|||
130052987|NCT01721408|468148570|FG001|Overall Study|No longer willing to participate study|10|||
130052988|NCT01721408|468148569|FG000|Overall Study|Protocol Violation|0|||
130052989|NCT01721408|468148570|FG001|Overall Study|Protocol Violation|2|||
130052990|NCT01721408|468148569|FG000|Overall Study|Other|3|||
130052991|NCT01721408|468148570|FG001|Overall Study|Other|3|||
130052992|NCT01721408|468148569|FG000|Overall Study|Lost to Follow-up|1|||
130052993|NCT01721408|468148570|FG001|Overall Study|Lost to Follow-up|2|||
130052994|NCT01721408|468148569|FG000|Overall Study|Does not meet entrance criteria|1|||
130052995|NCT01721408|468148570|FG001|Overall Study|Does not meet entrance criteria|0|||
130052996|NCT03987620|468148571|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
130317585|NCT02898454|469128682|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
130317586|NCT02898454|469128683|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
130317587|NCT02898454|469128684|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
130317588|NCT00647296|469128685|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129800665|NCT01008150|467238169|FG001|Overall Study|did not receive study drug|1|||
129800666|NCT01008150|467238170|FG002|Overall Study|did not receive study drug|1|||
130052997|NCT03987620|468148572|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
130052998|NCT03987620|468148571|FG000|Overall Study|Adverse Event|3|||
130052999|NCT03987620|468148572|FG001|Overall Study|Adverse Event|0|||
130053000|NCT03987620|468148571|FG000|Overall Study|Lost to Follow-up|1|||
130053001|NCT03987620|468148572|FG001|Overall Study|Lost to Follow-up|2|||
130053002|NCT03987620|468148571|FG000|Overall Study|Physician Decision|0|||
130053003|NCT03987620|468148572|FG001|Overall Study|Physician Decision|1|||
130053004|NCT03987620|468148571|FG000|Overall Study|Pregnancy|1|||
130053005|NCT03987620|468148572|FG001|Overall Study|Pregnancy|0|||
130053006|NCT03987620|468148571|FG000|Overall Study|Withdrawal by Subject|7|||
130053007|NCT03987620|468148572|FG001|Overall Study|Withdrawal by Subject|1|||
130053008|NCT03987620|468148571|FG000|Overall Study|Other|2|||
130053009|NCT03987620|468148572|FG001|Overall Study|Other|5|||
130053010|NCT05128162|468148573|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
130053011|NCT05128162|468148573|FG000|Overall Study|Physician Decision|1|||
130053012|NCT05306873|468150360|FG000|Stage 2|Study stopped|1|||
130053013|NCT05306873|468150361|FG001|Stage 2|Study stopped|1|||
130053014|NCT05306873|468150362|FG002|Stage 2|Study stopped|0|||
130053015|NCT05306873|468150363|FG003|Stage 2|Study stopped|0|||
130053016|NCT05306873|468150360|FG000|Stage 2|Stage 2 Treatment Failure|2|||
130053017|NCT05306873|468150361|FG001|Stage 2|Stage 2 Treatment Failure|3|||
130053018|NCT05306873|468150362|FG002|Stage 2|Stage 2 Treatment Failure|0|||
130053019|NCT05306873|468150363|FG003|Stage 2|Stage 2 Treatment Failure|0|||
130053020|NCT05306873|468150360|FG000|Stage 2|Logistical issues due to participant moving|1|||
130053021|NCT05306873|468150361|FG001|Stage 2|Logistical issues due to participant moving|0|||
130053022|NCT05306873|468150362|FG002|Stage 2|Logistical issues due to participant moving|0|||
130053023|NCT05306873|468150363|FG003|Stage 2|Logistical issues due to participant moving|0|||
130053024|NCT05306873|468150360|FG000|Stage 3|Stage 3 Treatment Failure|0|||
130053025|NCT05306873|468150361|FG001|Stage 3|Stage 3 Treatment Failure|0|||
130053026|NCT05306873|468150362|FG002|Stage 3|Stage 3 Treatment Failure|0|||
130053027|NCT05306873|468150363|FG003|Stage 3|Stage 3 Treatment Failure|1|||
130053028|NCT05306873|468150360|FG000|Stage 3|Study Stopped|0|||
130053029|NCT05306873|468150361|FG001|Stage 3|Study Stopped|0|||
130053030|NCT05306873|468150362|FG002|Stage 3|Study Stopped|1|||
130053031|NCT05306873|468150363|FG003|Stage 3|Study Stopped|0|||
130053032|NCT02626819|468150366|FG000|Overall Study|Lost to Follow-up|3|||
130053033|NCT02626819|468150367|FG001|Overall Study|Lost to Follow-up|2|||
130053034|NCT02626819|468150366|FG000|Overall Study|Withdrawal by Subject|1|||
130053035|NCT02626819|468150367|FG001|Overall Study|Withdrawal by Subject|0|||
130053036|NCT02626819|468150366|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
130053037|NCT02626819|468150367|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
130053038|NCT01701583|468150371|FG000|Overall Study|Withdrawal by Subject|2|||
130053039|NCT01701583|468150372|FG001|Overall Study|Withdrawal by Subject|0|||
130053040|NCT01441440|468150373|FG000|Overall Study|Death|1|||
130053041|NCT01441440|468150374|FG001|Overall Study|Death|0|||
130053042|NCT01441440|468150375|FG002|Overall Study|Death|1|||
130053043|NCT01441440|468150373|FG000|Overall Study|Adverse Event|2|||
130053044|NCT01441440|468150374|FG001|Overall Study|Adverse Event|9|||
130110999|NCT01078623|468367520|FG014|Treatment Period 2|Withdrawal by Subject|0|||
130111000|NCT01078623|468367521|FG015|Treatment Period 2|Withdrawal by Subject|0|||
130111001|NCT01078623|468367522|FG016|Treatment Period 2|Withdrawal by Subject|0|||
130111002|NCT01078623|468367523|FG017|Treatment Period 2|Withdrawal by Subject|0|||
130111003|NCT01078623|468367524|FG018|Treatment Period 2|Withdrawal by Subject|0|||
130111004|NCT01078623|468367525|FG019|Treatment Period 2|Withdrawal by Subject|0|||
130111005|NCT01078623|468367506|FG000|Treatment Period 3|Adverse Event|0|||
130111006|NCT01078623|468367507|FG001|Treatment Period 3|Adverse Event|0|||
130111007|NCT01078623|468367508|FG002|Treatment Period 3|Adverse Event|0|||
130111008|NCT01078623|468367509|FG003|Treatment Period 3|Adverse Event|0|||
130111009|NCT01078623|468367510|FG004|Treatment Period 3|Adverse Event|1|||
130111010|NCT01078623|468367511|FG005|Treatment Period 3|Adverse Event|0|||
130111011|NCT01078623|468367512|FG006|Treatment Period 3|Adverse Event|0|||
130111012|NCT01078623|468367513|FG007|Treatment Period 3|Adverse Event|0|||
130111013|NCT01078623|468367514|FG008|Treatment Period 3|Adverse Event|0|||
130111014|NCT01078623|468367515|FG009|Treatment Period 3|Adverse Event|0|||
130111015|NCT01078623|468367516|FG010|Treatment Period 3|Adverse Event|0|||
130111016|NCT01078623|468367517|FG011|Treatment Period 3|Adverse Event|0|||
130111017|NCT01078623|468367518|FG012|Treatment Period 3|Adverse Event|0|||
130111018|NCT01078623|468367519|FG013|Treatment Period 3|Adverse Event|1|||
130111019|NCT01078623|468367520|FG014|Treatment Period 3|Adverse Event|0|||
130111020|NCT01078623|468367521|FG015|Treatment Period 3|Adverse Event|0|||
130111021|NCT01078623|468367522|FG016|Treatment Period 3|Adverse Event|0|||
130111022|NCT01078623|468367523|FG017|Treatment Period 3|Adverse Event|0|||
130111023|NCT01078623|468367524|FG018|Treatment Period 3|Adverse Event|0|||
130111024|NCT01078623|468367525|FG019|Treatment Period 3|Adverse Event|0|||
130111025|NCT01078623|468367506|FG000|Treatment Period 4|Adverse Event|0|||
130111026|NCT01078623|468367507|FG001|Treatment Period 4|Adverse Event|0|||
130111027|NCT01078623|468367508|FG002|Treatment Period 4|Adverse Event|1|||
130111028|NCT01078623|468367509|FG003|Treatment Period 4|Adverse Event|0|||
130111029|NCT01078623|468367510|FG004|Treatment Period 4|Adverse Event|0|||
130111030|NCT01078623|468367511|FG005|Treatment Period 4|Adverse Event|0|||
130111031|NCT01078623|468367512|FG006|Treatment Period 4|Adverse Event|0|||
130111032|NCT01078623|468367513|FG007|Treatment Period 4|Adverse Event|0|||
130111033|NCT01078623|468367514|FG008|Treatment Period 4|Adverse Event|0|||
130111034|NCT01078623|468367515|FG009|Treatment Period 4|Adverse Event|0|||
130111035|NCT01078623|468367516|FG010|Treatment Period 4|Adverse Event|0|||
130111036|NCT01078623|468367517|FG011|Treatment Period 4|Adverse Event|0|||
130111037|NCT01078623|468367518|FG012|Treatment Period 4|Adverse Event|0|||
130111038|NCT01078623|468367519|FG013|Treatment Period 4|Adverse Event|0|||
130111039|NCT01078623|468367520|FG014|Treatment Period 4|Adverse Event|0|||
130111040|NCT01078623|468367521|FG015|Treatment Period 4|Adverse Event|0|||
130111041|NCT01078623|468367522|FG016|Treatment Period 4|Adverse Event|0|||
130111042|NCT01078623|468367523|FG017|Treatment Period 4|Adverse Event|0|||
130111043|NCT01078623|468367524|FG018|Treatment Period 4|Adverse Event|0|||
130111044|NCT01078623|468367525|FG019|Treatment Period 4|Adverse Event|0|||
130111045|NCT01078623|468367506|FG000|Treatment Period 4|Withdrawal by Subject|0|||
130111046|NCT01078623|468367507|FG001|Treatment Period 4|Withdrawal by Subject|0|||
130111047|NCT01078623|468367508|FG002|Treatment Period 4|Withdrawal by Subject|0|||
130111048|NCT01078623|468367509|FG003|Treatment Period 4|Withdrawal by Subject|0|||
130111049|NCT01078623|468367510|FG004|Treatment Period 4|Withdrawal by Subject|0|||
130111050|NCT01078623|468367511|FG005|Treatment Period 4|Withdrawal by Subject|0|||
130111051|NCT01078623|468367512|FG006|Treatment Period 4|Withdrawal by Subject|0|||
130111052|NCT01078623|468367513|FG007|Treatment Period 4|Withdrawal by Subject|0|||
130111053|NCT01078623|468367514|FG008|Treatment Period 4|Withdrawal by Subject|0|||
130111054|NCT01078623|468367515|FG009|Treatment Period 4|Withdrawal by Subject|0|||
130111055|NCT01078623|468367516|FG010|Treatment Period 4|Withdrawal by Subject|0|||
130111056|NCT01078623|468367517|FG011|Treatment Period 4|Withdrawal by Subject|0|||
130111057|NCT01078623|468367518|FG012|Treatment Period 4|Withdrawal by Subject|0|||
130111058|NCT01078623|468367519|FG013|Treatment Period 4|Withdrawal by Subject|0|||
130317589|NCT00647296|469128686|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130111059|NCT01078623|468367520|FG014|Treatment Period 4|Withdrawal by Subject|0|||
130111060|NCT01078623|468367521|FG015|Treatment Period 4|Withdrawal by Subject|1|||
130111061|NCT01078623|468367522|FG016|Treatment Period 4|Withdrawal by Subject|0|||
130317590|NCT00647296|469128687|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
130111062|NCT01078623|468367523|FG017|Treatment Period 4|Withdrawal by Subject|0|||
130111063|NCT01078623|468367524|FG018|Treatment Period 4|Withdrawal by Subject|0|||
130111064|NCT01078623|468367525|FG019|Treatment Period 4|Withdrawal by Subject|0|||
130111065|NCT00463866|468367526|FG000|Overall Study|Adverse Event|70|||
130111066|NCT00463866|468367527|FG001|Overall Study|Adverse Event|93|||
130111067|NCT00463866|468367526|FG000|Overall Study|Withdrawal by Subject|81|||
130111068|NCT00463866|468367527|FG001|Overall Study|Withdrawal by Subject|79|||
130111069|NCT00463866|468367526|FG000|Overall Study|Lost to Follow-up|46|||
130111070|NCT00463866|468367527|FG001|Overall Study|Lost to Follow-up|55|||
130111071|NCT00463866|468367526|FG000|Overall Study|Incorrect Enrolment|64|||
130111072|NCT00463866|468367527|FG001|Overall Study|Incorrect Enrolment|66|||
130111073|NCT00463866|468367526|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
130111074|NCT00463866|468367527|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
130053045|NCT01441440|468150375|FG002|Overall Study|Adverse Event|9|||
130053046|NCT01441440|468150373|FG000|Overall Study|Lost to Follow-up|0|||
130053047|NCT01441440|468150374|FG001|Overall Study|Lost to Follow-up|2|||
130053048|NCT01441440|468150375|FG002|Overall Study|Lost to Follow-up|1|||
130317591|NCT00647296|469128688|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
130317592|NCT00647296|469128685|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
130317593|NCT00647296|469128686|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
130317594|NCT00647296|469128687|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
130317595|NCT00647296|469128688|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
130317596|NCT00647296|469128685|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130317597|NCT00647296|469128686|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
130317598|NCT00647296|469128687|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130317599|NCT00647296|469128688|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
130317600|NCT00647296|469128685|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
130317601|NCT00647296|469128686|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130317602|NCT00647296|469128687|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130317603|NCT00647296|469128688|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
130317604|NCT00647296|469128685|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
130317605|NCT00647296|469128686|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130317606|NCT00647296|469128687|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130317607|NCT00647296|469128688|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
130317608|NCT00647296|469128685|FG000|Part 2: 4-week Placebo Washout|Death|3|||
130317609|NCT00647296|469128686|FG001|Part 2: 4-week Placebo Washout|Death|0|||
130317610|NCT00647296|469128687|FG002|Part 2: 4-week Placebo Washout|Death|0|||
130317611|NCT00647296|469128688|FG003|Part 2: 4-week Placebo Washout|Death|0|||
130317612|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
130317613|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
130317614|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
130317615|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
130317616|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
130317617|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
130317618|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
130317619|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
130317620|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130317621|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
130317622|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130317623|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
130317624|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
130317625|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
130317626|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
130317627|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
130317628|NCT00647296|469128685|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
130317629|NCT00647296|469128686|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
130317630|NCT00647296|469128687|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
130317631|NCT00647296|469128688|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
130317632|NCT03883581|469128689|FG000|Overall Study|Withdrawal by Subject|4|||
130317633|NCT02926638|469128690|FG000|Overall Study|Progression|2|||
130317634|NCT02926638|469128691|FG001|Overall Study|Progression|5|||
130317635|NCT02926638|469128690|FG000|Overall Study|Ineligible|1|||
130317636|NCT02926638|469128691|FG001|Overall Study|Ineligible|0|||
130317637|NCT02926638|469128690|FG000|Overall Study|Not protocol specified|1|||
130317638|NCT02926638|469128691|FG001|Overall Study|Not protocol specified|0|||
130317639|NCT01908426|469129856|FG000|Overall Study|Adverse Event|98|||
130317640|NCT01908426|469129857|FG001|Overall Study|Adverse Event|11|||
130317641|NCT01908426|469129856|FG000|Overall Study|Clinical Deterioration|72|||
130317642|NCT01908426|469129857|FG001|Overall Study|Clinical Deterioration|38|||
130317643|NCT01908426|469129856|FG000|Overall Study|Lack of Efficacy|3|||
130317644|NCT01908426|469129857|FG001|Overall Study|Lack of Efficacy|0|||
130317645|NCT01908426|469129856|FG000|Overall Study|Lost to Follow-up|0|||
130053049|NCT01441440|468150373|FG000|Overall Study|Withdrawal by Subject|11|||
130053050|NCT01441440|468150374|FG001|Overall Study|Withdrawal by Subject|9|||
130053051|NCT01441440|468150375|FG002|Overall Study|Withdrawal by Subject|9|||
130317646|NCT01908426|469129857|FG001|Overall Study|Lost to Follow-up|1|||
130317647|NCT01908426|469129856|FG000|Overall Study|Physician Decision|3|||
130317648|NCT01908426|469129857|FG001|Overall Study|Physician Decision|3|||
130053052|NCT01441440|468150373|FG000|Overall Study|Pregnancy|1|||
130053053|NCT01441440|468150374|FG001|Overall Study|Pregnancy|0|||
130053054|NCT01441440|468150375|FG002|Overall Study|Pregnancy|0|||
130317649|NCT01908426|469129856|FG000|Overall Study|Withdrawal by Subject|11|||
130053055|NCT01441440|468150373|FG000|Overall Study|Lack of Efficacy|1|||
130053056|NCT01441440|468150374|FG001|Overall Study|Lack of Efficacy|0|||
130317650|NCT01908426|469129857|FG001|Overall Study|Withdrawal by Subject|6|||
130317651|NCT01908426|469129856|FG000|Overall Study|Progressive Disease|206|||
130317652|NCT01908426|469129857|FG001|Overall Study|Progressive Disease|152|||
130317653|NCT01908426|469129856|FG000|Overall Study|Protocol Violation|1|||
130317654|NCT01908426|469129857|FG001|Overall Study|Protocol Violation|0|||
130317655|NCT01908426|469129856|FG000|Overall Study|No Study Treatment Given|3|||
130317656|NCT01908426|469129857|FG001|Overall Study|No Study Treatment Given|0|||
130317657|NCT02426580|469129858|FG000|Overall Study|Death|2|||
130317658|NCT02426580|469129859|FG001|Overall Study|Death|2|||
130317659|NCT02426580|469129858|FG000|Overall Study|Lost to Follow-up|0|||
130317660|NCT02426580|469129859|FG001|Overall Study|Lost to Follow-up|9|||
130317661|NCT02426580|469129858|FG000|Overall Study|transfer to hemodialysis|5|||
130317662|NCT02426580|469129859|FG001|Overall Study|transfer to hemodialysis|5|||
130317663|NCT02426580|469129858|FG000|Overall Study|Kidney transplant|3|||
130317664|NCT02426580|469129859|FG001|Overall Study|Kidney transplant|0|||
130317665|NCT02426580|469129858|FG000|Overall Study|Allergic to egg white|1|||
130317666|NCT02426580|469129859|FG001|Overall Study|Allergic to egg white|0|||
130317667|NCT00416624|469129868|FG000|Overall Study|Withdrawal by Subject|1|||
130317668|NCT00416624|469129869|FG001|Overall Study|Withdrawal by Subject|6|||
130317669|NCT00416624|469129870|FG002|Overall Study|Withdrawal by Subject|4|||
130317670|NCT00416624|469129871|FG003|Overall Study|Withdrawal by Subject|9|||
130317671|NCT00416624|469129868|FG000|Overall Study|Death|4|||
130317672|NCT00416624|469129869|FG001|Overall Study|Death|7|||
130317673|NCT00416624|469129870|FG002|Overall Study|Death|7|||
130317674|NCT00416624|469129871|FG003|Overall Study|Death|1|||
130317675|NCT00416624|469129868|FG000|Overall Study|Adverse Event|8|||
130317676|NCT00416624|469129869|FG001|Overall Study|Adverse Event|3|||
130317677|NCT00416624|469129870|FG002|Overall Study|Adverse Event|2|||
130317678|NCT00416624|469129871|FG003|Overall Study|Adverse Event|2|||
130317679|NCT00416624|469129868|FG000|Overall Study|Other|8|||
130317680|NCT00416624|469129869|FG001|Overall Study|Other|11|||
130317681|NCT00416624|469129870|FG002|Overall Study|Other|5|||
130317682|NCT00416624|469129871|FG003|Overall Study|Other|5|||
130317683|NCT00416624|469129868|FG000|Overall Study|Cancel|1|||
130317684|NCT00416624|469129869|FG001|Overall Study|Cancel|0|||
130317685|NCT00416624|469129870|FG002|Overall Study|Cancel|0|||
130317686|NCT00416624|469129871|FG003|Overall Study|Cancel|0|||
130317687|NCT00768989|469129874|FG000|Prior to Week 24|Withdrawal by Subject|1|||
130317688|NCT00768989|469129875|FG001|Prior to Week 24|Withdrawal by Subject|0|||
130317689|NCT00768989|469129874|FG000|Prior to Week 24|Adverse Event|3|||
130317690|NCT00768989|469129875|FG001|Prior to Week 24|Adverse Event|0|||
130317691|NCT00768989|469129874|FG000|Prior to Week 24|Lost to Follow-up|0|||
130317692|NCT00768989|469129875|FG001|Prior to Week 24|Lost to Follow-up|1|||
130317693|NCT00768989|469129874|FG000|Prior to Week 24|Protocol Violation|0|||
130317694|NCT00768989|469129875|FG001|Prior to Week 24|Protocol Violation|2|||
130317695|NCT00768989|469129874|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
130317696|NCT00768989|469129875|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
130317697|NCT00768989|469129874|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
130317698|NCT00768989|469129875|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
130317699|NCT00768989|469129874|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
130317700|NCT00768989|469129875|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
130317701|NCT00768989|469129874|FG000|On or After Week 36|Lack of Efficacy|1|||
130317702|NCT00768989|469129875|FG001|On or After Week 36|Lack of Efficacy|0|||
130317703|NCT00768989|469129874|FG000|On or After Week 36|Adverse Event|0|||
130317704|NCT00768989|469129875|FG001|On or After Week 36|Adverse Event|1|||
130317705|NCT00768989|469129874|FG000|On or After Week 36|Lost to Follow-up|1|||
130317706|NCT00768989|469129875|FG001|On or After Week 36|Lost to Follow-up|0|||
130317707|NCT00768989|469129874|FG000|On or After Week 36|Poor Compliance|1|||
130317708|NCT00768989|469129875|FG001|On or After Week 36|Poor Compliance|0|||
130317709|NCT00768989|469129874|FG000|On or After Week 36|Protocol Violation|1|||
130317710|NCT00768989|469129875|FG001|On or After Week 36|Protocol Violation|0|||
130317711|NCT00768989|469129874|FG000|On or After Week 36|Did not attend termination visit|2|||
130317712|NCT00768989|469129875|FG001|On or After Week 36|Did not attend termination visit|0|||
130317713|NCT00768989|469129874|FG000|On or After Week 36|Sponsor Termination|45|||
130317714|NCT00768989|469129875|FG001|On or After Week 36|Sponsor Termination|26|||
130317715|NCT03661723|469129876|FG000|Overall Study|Disease Progression|4|||
130317716|NCT03661723|469129877|FG001|Overall Study|Disease Progression|24|||
130317717|NCT03661723|469129878|FG002|Overall Study|Disease Progression|4|||
130317718|NCT03661723|469129879|FG003|Overall Study|Disease Progression|19|||
130317719|NCT03661723|469129876|FG000|Overall Study|Withdrawal by Subject|1|||
130317720|NCT03661723|469129877|FG001|Overall Study|Withdrawal by Subject|0|||
130317721|NCT03661723|469129878|FG002|Overall Study|Withdrawal by Subject|2|||
130317722|NCT03661723|469129879|FG003|Overall Study|Withdrawal by Subject|4|||
130317723|NCT03661723|469129876|FG000|Overall Study|Physician Decision|1|||
130317724|NCT03661723|469129877|FG001|Overall Study|Physician Decision|0|||
130317725|NCT03661723|469129878|FG002|Overall Study|Physician Decision|0|||
130317726|NCT03661723|469129879|FG003|Overall Study|Physician Decision|0|||
130053057|NCT01441440|468150375|FG002|Overall Study|Lack of Efficacy|1|||
130053058|NCT01441440|468150373|FG000|Overall Study|Moving|0|||
130053059|NCT01441440|468150374|FG001|Overall Study|Moving|1|||
130053060|NCT01441440|468150375|FG002|Overall Study|Moving|1|||
130053061|NCT01441440|468150373|FG000|Overall Study|Work-related matter|0|||
130317727|NCT03661723|469129876|FG000|Overall Study|Clinical Deterioration|0|||
130317728|NCT03661723|469129877|FG001|Overall Study|Clinical Deterioration|0|||
130317729|NCT03661723|469129878|FG002|Overall Study|Clinical Deterioration|0|||
130317730|NCT03661723|469129879|FG003|Overall Study|Clinical Deterioration|1|||
130317731|NCT03452540|469129883|FG000|Overall Study|Adverse Event|1|||
130317732|NCT03452540|469129883|FG000|Overall Study|Withdrawal by Subject|1|||
130317733|NCT03452540|469129883|FG000|Overall Study|Other SAE and AE|2|||
130317734|NCT01045460|469129886|FG000|Overall Study|Physician Decision|3|||
130317735|NCT01045460|469129887|FG001|Overall Study|Physician Decision|2|||
130317736|NCT01045460|469129886|FG000|Overall Study|Lost to Follow-up|0|||
130317737|NCT01045460|469129887|FG001|Overall Study|Lost to Follow-up|1|||
130317738|NCT01045460|469129886|FG000|Overall Study|Lack of Efficacy|3|||
130317739|NCT01045460|469129887|FG001|Overall Study|Lack of Efficacy|0|||
130317740|NCT00524485|469129888|FG000|Overall Study|Withdrawal by Subject|5|||
130317741|NCT00436332|469129889|FG000|Overall Study|Adverse Event|9|||
130317742|NCT00436332|469129889|FG000|Overall Study|Withdrawal by Subject|2|||
130317743|NCT00436332|469129889|FG000|Overall Study|Progression|59|||
130317744|NCT00436332|469129889|FG000|Overall Study|Death|2|||
130317745|NCT00436332|469129889|FG000|Overall Study|Not Protocol Specified|6|||
130317746|NCT00436332|469129889|FG000|Overall Study|Ineligible|2|||
130317747|NCT00436332|469129889|FG000|Overall Study|Never Received Treatment|3|||
130317748|NCT00472108|469129890|FG000|Overall Study|Lost to Follow-up|0|||
130317749|NCT00472108|469129891|FG001|Overall Study|Lost to Follow-up|1|||
130317750|NCT01339689|469129894|FG000|Overall Study|Adverse Event|1|||
130317751|NCT01339689|469129895|FG001|Overall Study|Adverse Event|2|||
130317752|NCT01339689|469129894|FG000|Overall Study|Lost to Follow-up|9|||
130317753|NCT01339689|469129895|FG001|Overall Study|Lost to Follow-up|3|||
130317754|NCT01339689|469129894|FG000|Overall Study|Withdrawal by Subject|3|||
130317755|NCT01339689|469129895|FG001|Overall Study|Withdrawal by Subject|0|||
130317756|NCT01339689|469129894|FG000|Overall Study|Noncompliance|1|||
130317757|NCT01339689|469129895|FG001|Overall Study|Noncompliance|0|||
130317758|NCT01339689|469129894|FG000|Overall Study|Relocated out of area|0|||
130317759|NCT01339689|469129895|FG001|Overall Study|Relocated out of area|1|||
130317760|NCT01339689|469129894|FG000|Overall Study|Other|2|||
130317761|NCT01339689|469129895|FG001|Overall Study|Other|2|||
130317762|NCT01339689|469129894|FG000|Overall Study|multiple reasons|1|||
130317763|NCT01339689|469129895|FG001|Overall Study|multiple reasons|1|||
130317764|NCT00667888|469129896|FG000|Overall Study|Death|1|||
130317765|NCT00667888|469129897|FG001|Overall Study|Death|1|||
130317766|NCT00667888|469129896|FG000|Overall Study|Withdrawal by Subject|6|||
130053062|NCT01441440|468150374|FG001|Overall Study|Work-related matter|1|||
130053063|NCT01441440|468150375|FG002|Overall Study|Work-related matter|0|||
130053064|NCT01441440|468150373|FG000|Overall Study|Difficllty in keeping the schedule|1|||
130053065|NCT01441440|468150374|FG001|Overall Study|Difficllty in keeping the schedule|1|||
130053066|NCT01441440|468150375|FG002|Overall Study|Difficllty in keeping the schedule|0|||
130053067|NCT02750813|468150376|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
130053068|NCT02750813|468150377|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
130317767|NCT00667888|469129897|FG001|Overall Study|Withdrawal by Subject|3|||
129800667|NCT01008150|467238171|FG003|Overall Study|did not receive study drug|0|||
130317768|NCT00667888|469129896|FG000|Overall Study|Proceed with other treatment|3|||
130317769|NCT00667888|469129897|FG001|Overall Study|Proceed with other treatment|3|||
130317770|NCT00667888|469129896|FG000|Overall Study|Ineligible after SIM|0|||
130317771|NCT00667888|469129897|FG001|Overall Study|Ineligible after SIM|2|||
130317772|NCT00499681|469129898|FG000|Overall Study|toxicity|0|||
130317773|NCT00499681|469129899|FG001|Overall Study|toxicity|1|||
130317774|NCT00499681|469129898|FG000|Overall Study|disease progression|0|||
129800668|NCT03845543|467238173|FG000|Overall Study|Death|25|||
129891266|NCT00994279|467559690|FG001|Overall Study|Multiple reasons|3|||
130053069|NCT02750813|468150376|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
130053070|NCT02750813|468150377|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
130317775|NCT00499681|469129899|FG001|Overall Study|disease progression|1|||
130317776|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
130317777|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
130111075|NCT00463866|468367526|FG000|Overall Study|Safety Reason|1|||
130111076|NCT00463866|468367527|FG001|Overall Study|Safety Reason|3|||
130111077|NCT00463866|468367526|FG000|Overall Study|Mis-Randomization of subject|0|||
130111078|NCT00463866|468367527|FG001|Overall Study|Mis-Randomization of subject|1|||
130111079|NCT00463866|468367526|FG000|Overall Study|Other|22|||
130111080|NCT00463866|468367527|FG001|Overall Study|Other|22|||
130111081|NCT04356573|468367528|FG000|Overall Study|Didn't Qualify|1|||
130111082|NCT04356573|468367529|FG001|Overall Study|Didn't Qualify|0|||
130111083|NCT03568500|468367530|FG000|Overall Study|Lost to Follow-up|1|||
130111084|NCT03568500|468367531|FG001|Overall Study|Lost to Follow-up|1|||
130111085|NCT03568500|468367532|FG002|Overall Study|Lost to Follow-up|2|||
130111086|NCT03568500|468367530|FG000|Overall Study|Adverse Event|1|||
130111087|NCT03568500|468367531|FG001|Overall Study|Adverse Event|1|||
130111088|NCT03568500|468367532|FG002|Overall Study|Adverse Event|2|||
130111089|NCT03568500|468367530|FG000|Overall Study|Physician Decision|1|||
130111090|NCT03568500|468367531|FG001|Overall Study|Physician Decision|0|||
130111091|NCT03568500|468367532|FG002|Overall Study|Physician Decision|0|||
130111092|NCT03568500|468367530|FG000|Overall Study|Withdrawal by Subject|4|||
130111093|NCT03568500|468367531|FG001|Overall Study|Withdrawal by Subject|2|||
130111094|NCT03568500|468367532|FG002|Overall Study|Withdrawal by Subject|0|||
130111095|NCT03568500|468367530|FG000|Overall Study|Technical Problems|2|||
130317778|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Disease progression|75|||
130317779|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Disease progression|59|||
130317780|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Adverse Event|16|||
130317781|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Adverse Event|16|||
130317782|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Death|2|||
130317783|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Death|3|||
130317784|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
130317785|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
130317786|NCT00883779|469129900|FG000|Primary Study Treatment Phase|Other|3|||
130317787|NCT00883779|469129901|FG001|Primary Study Treatment Phase|Other|0|||
130317788|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Adverse Event|2|||
130317789|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Adverse Event|3|||
130317790|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Death|1|||
130317791|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Death|3|||
130317792|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
130317793|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
130317794|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
130317795|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
130317796|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Disease progression|103|||
130317797|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Disease progression|122|||
130317798|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Other|3|||
130317799|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Other|0|||
130317800|NCT00883779|469129900|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
130317801|NCT00883779|469129901|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
130317802|NCT00883779|469129900|FG000|Off-study Phase|Death|185|||
130317803|NCT00883779|469129901|FG001|Off-study Phase|Death|174|||
130317804|NCT00883779|469129900|FG000|Off-study Phase|Refused treatment|1|||
130317805|NCT00883779|469129901|FG001|Off-study Phase|Refused treatment|1|||
130317806|NCT00883779|469129900|FG000|Off-study Phase|Failure to return|5|||
130317807|NCT00883779|469129901|FG001|Off-study Phase|Failure to return|6|||
130317808|NCT00883779|469129900|FG000|Off-study Phase|Other|18|||
130317809|NCT00883779|469129901|FG001|Off-study Phase|Other|21|||
130317810|NCT02140047|469129902|FG000|Overall Study|Withdrawal by parent/guardian|1|||
130317811|NCT02140047|469129903|FG001|Overall Study|Withdrawal by parent/guardian|1|||
130317812|NCT02140047|469129904|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130317813|NCT00079040|469129905|FG000|Overall Study|Withdrew before treatment|1|||
130317814|NCT00079040|469129905|FG000|Overall Study|Ineligible|1|||
130317815|NCT00325897|469129906|FG000|Overall Study|Lost to Follow-up|12|||
130317816|NCT00325897|469129907|FG001|Overall Study|Lost to Follow-up|13|||
130317817|NCT03915717|469129910|FG000|Overall Study|EchoMark Not Implanted|6|||
130317818|NCT03748823|469129912|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
130317819|NCT03748823|469129913|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
130317820|NCT03748823|469129912|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
130317821|NCT03748823|469129913|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
130111096|NCT03568500|468367531|FG001|Overall Study|Technical Problems|1|||
130111097|NCT03568500|468367532|FG002|Overall Study|Technical Problems|0|||
130111098|NCT03568500|468367530|FG000|Overall Study|Participant Noncompliance|1|||
130317822|NCT03748823|469129912|FG000|Extension Period|Withdrawal by Subject|9|||
130317823|NCT03748823|469129913|FG001|Extension Period|Withdrawal by Subject|12|||
130317824|NCT03748823|469129912|FG000|Extension Period|Death|2|||
130317825|NCT03748823|469129913|FG001|Extension Period|Death|2|||
130317826|NCT03748823|469129912|FG000|Extension Period|Other than Specified|0|||
130317827|NCT03748823|469129913|FG001|Extension Period|Other than Specified|1|||
129800669|NCT03845543|467238173|FG000|Overall Study|Withdrawal by Subject|2|||
129800670|NCT03845543|467238173|FG000|Overall Study|Lost to Follow-up|12|||
129800671|NCT03845543|467238173|FG000|Overall Study|Adverse Event|17|||
129800672|NCT01400815|467238176|FG000|Overall Study|Adverse Event|3|||
129800673|NCT01400815|467238177|FG001|Overall Study|Adverse Event|0|||
129800674|NCT01400815|467238176|FG000|Overall Study|Death|0|||
129800675|NCT01400815|467238177|FG001|Overall Study|Death|1|||
129800676|NCT01400815|467238176|FG000|Overall Study|Lost to Follow-up|18|||
129800677|NCT01400815|467238177|FG001|Overall Study|Lost to Follow-up|11|||
129800678|NCT01400815|467238176|FG000|Overall Study|Protocol Violation|0|||
129800679|NCT01400815|467238177|FG001|Overall Study|Protocol Violation|1|||
129800680|NCT01400815|467238176|FG000|Overall Study|Physician Decision|1|||
129800681|NCT01400815|467238177|FG001|Overall Study|Physician Decision|0|||
129800682|NCT01400815|467238176|FG000|Overall Study|Withdrawal by Subject|15|||
129800683|NCT01400815|467238177|FG001|Overall Study|Withdrawal by Subject|8|||
129800684|NCT01400815|467238176|FG000|Overall Study|Subject in jail|1|||
129800685|NCT01400815|467238177|FG001|Overall Study|Subject in jail|0|||
129800686|NCT01123850|467238179|FG000|Overall Study|Slow enrollment|45|||
129800687|NCT00381381|467238188|FG000|Overall Study|Adverse Event|3|||
129800688|NCT00381381|467238188|FG000|Overall Study|Lost to Follow-up|52|||
129800689|NCT00381381|467238188|FG000|Overall Study|Withdrawal by Subject|9|||
129800690|NCT02001181|467238192|FG000|Overall Study|Adverse Event|0|||
129800691|NCT02001181|467238193|FG001|Overall Study|Adverse Event|2|||
130053071|NCT02245568|468150378|FG000|Overall Study|Study terminated by Sponsor|346|||
130053072|NCT02245568|468150378|FG000|Overall Study|Adverse Event|144|||
130053073|NCT02245568|468150378|FG000|Overall Study|Lack of Efficacy|98|||
130053074|NCT02245568|468150378|FG000|Overall Study|Withdrawal by Caregiver|85|||
130053075|NCT02245568|468150378|FG000|Overall Study|Withdrawal by Subject|77|||
130053076|NCT02245568|468150378|FG000|Overall Study|Withdrawal by Legal Representative|31|||
130053077|NCT02245568|468150378|FG000|Overall Study|Missing (Site closure)|16|||
130053078|NCT02245568|468150378|FG000|Overall Study|Physician Decision|14|||
130053079|NCT02245568|468150378|FG000|Overall Study|Non-compliance with study drug|11|||
130053080|NCT02245568|468150378|FG000|Overall Study|Death|9|||
130053081|NCT02245568|468150378|FG000|Overall Study|Blue staining|6|||
130053082|NCT02245568|468150378|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
130317828|NCT03748823|469129912|FG000|Extension Period|Protocol Violation|1|||
130317829|NCT03748823|469129913|FG001|Extension Period|Protocol Violation|0|||
130317830|NCT03748823|469129912|FG000|Extension Period|Lost to Follow-up|0|||
130317831|NCT03748823|469129913|FG001|Extension Period|Lost to Follow-up|1|||
130317832|NCT03748823|469129912|FG000|Extension Period|Lack of Efficacy|0|||
130317833|NCT03748823|469129913|FG001|Extension Period|Lack of Efficacy|1|||
130317834|NCT03748823|469129912|FG000|Extension Period|Physician Decision|1|||
130317835|NCT03748823|469129913|FG001|Extension Period|Physician Decision|2|||
130317836|NCT01664910|469129917|FG000|Overall Study|Adverse Event|0|||
130317837|NCT01664910|469129918|FG001|Overall Study|Adverse Event|0|||
130317838|NCT01664910|469129919|FG002|Overall Study|Adverse Event|1|||
130317839|NCT01011673|469129920|FG000|Randomized|Secondary headache|2|||
130317840|NCT01011673|469129921|FG001|Randomized|Secondary headache|1|||
130317841|NCT01011673|469129920|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
130317842|NCT01011673|469129921|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
130317843|NCT01632020|469129922|FG000|Overall Study|Withdrawal by Subject|1|||
130317844|NCT01632020|469129923|FG001|Overall Study|Withdrawal by Subject|0|||
130317845|NCT01632020|469129922|FG000|Overall Study|Adverse Event|1|||
130317846|NCT01632020|469129923|FG001|Overall Study|Adverse Event|0|||
130317847|NCT00549640|469129925|FG000|Overall Study|Withdrawal by Subject|6|||
130317848|NCT00549640|469129926|FG001|Overall Study|Withdrawal by Subject|12|||
130317849|NCT00549640|469129925|FG000|Overall Study|Adverse Event|5|||
130317850|NCT00549640|469129926|FG001|Overall Study|Adverse Event|0|||
130317851|NCT00549640|469129925|FG000|Overall Study|Lost to Follow-up|7|||
129800692|NCT02001181|467238192|FG000|Overall Study|Lost to Follow-up|1|||
129800693|NCT02001181|467238193|FG001|Overall Study|Lost to Follow-up|0|||
129800694|NCT02001181|467238192|FG000|Overall Study|Withdrawal by Subject|0|||
129800695|NCT02001181|467238193|FG001|Overall Study|Withdrawal by Subject|1|||
129800696|NCT00292318|467238195|FG000|Overall Study|Study terminated by officials|2|||
129800697|NCT00292318|467238196|FG001|Overall Study|Study terminated by officials|1|||
130053083|NCT02245568|468150378|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
130053084|NCT02245568|468150378|FG000|Overall Study|Lost to Follow-up|5|||
129800698|NCT00771316|467238197|FG000|Overall Study|Adverse Event|0|||
129800699|NCT00771316|467238198|FG001|Overall Study|Adverse Event|1|||
130053085|NCT00366548|468150379|FG000|Infant Series|Adverse Event|1|||
130053086|NCT00366548|468150380|FG001|Infant Series|Adverse Event|3|||
130317852|NCT00549640|469129926|FG001|Overall Study|Lost to Follow-up|4|||
130317853|NCT00399516|469129935|FG000|Overall Study|Lost to Follow-up|2|||
130317854|NCT00539981|469129938|FG000|Overall Study|Adverse events (AE)|3|||
130317855|NCT00539981|469129939|FG001|Overall Study|Adverse events (AE)|3|||
130317856|NCT00539981|469129938|FG000|Overall Study|Lost to Follow-up|260|||
130317857|NCT00539981|469129939|FG001|Overall Study|Lost to Follow-up|251|||
130317858|NCT00539981|469129938|FG000|Overall Study|Withdrew consent|22|||
130317859|NCT00539981|469129939|FG001|Overall Study|Withdrew consent|14|||
130053087|NCT00366548|468150379|FG000|Infant Series|Protocol Violation|0|||
130317860|NCT00539981|469129938|FG000|Overall Study|Death|1|||
130317861|NCT00539981|469129939|FG001|Overall Study|Death|1|||
130317862|NCT00539981|469129938|FG000|Overall Study|Other reason-unspecified|9|||
130317863|NCT00539981|469129939|FG001|Overall Study|Other reason-unspecified|13|||
130317864|NCT02675907|469129940|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
130317865|NCT02675907|469129941|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
130317866|NCT02675907|469129940|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
130317867|NCT02675907|469129941|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
130317868|NCT02675907|469129940|FG000|Study Overall|Lack of Efficacy|1|||
130317869|NCT02675907|469129941|FG001|Study Overall|Lack of Efficacy|0|||
130317870|NCT02675907|469129940|FG000|Study Overall|Withdrawal by Subject|2|||
130317871|NCT02675907|469129941|FG001|Study Overall|Withdrawal by Subject|2|||
130317872|NCT02675907|469129940|FG000|Study Overall|Lost to Follow-up|0|||
130317873|NCT02675907|469129941|FG001|Study Overall|Lost to Follow-up|2|||
130317874|NCT01611792|469129942|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
130317875|NCT01611792|469129943|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
130317876|NCT01611792|469129942|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
130317877|NCT01611792|469129943|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
130317878|NCT01129622|469129944|FG000|Overall Study|Withdrawal by Subject|2|||
130317879|NCT00591006|469129945|FG000|Overall Study|Withdrawal by Subject|0|||
130317880|NCT00591006|469129946|FG001|Overall Study|Withdrawal by Subject|0|||
130317881|NCT00591006|469129947|FG002|Overall Study|Withdrawal by Subject|0|||
130317882|NCT00591006|469129948|FG003|Overall Study|Withdrawal by Subject|0|||
130317883|NCT00591006|469129949|FG004|Overall Study|Withdrawal by Subject|0|||
130317884|NCT00591006|469129950|FG005|Overall Study|Withdrawal by Subject|0|||
130317885|NCT00591006|469129951|FG006|Overall Study|Withdrawal by Subject|0|||
130317886|NCT00591006|469129952|FG007|Overall Study|Withdrawal by Subject|0|||
129800700|NCT00771316|467238197|FG000|Overall Study|Patient withdrew consent|1|||
130317887|NCT00591006|469129953|FG008|Overall Study|Withdrawal by Subject|0|||
130317888|NCT00591006|469129954|FG009|Overall Study|Withdrawal by Subject|0|||
130317889|NCT00591006|469129955|FG010|Overall Study|Withdrawal by Subject|0|||
130317890|NCT00591006|469129956|FG011|Overall Study|Withdrawal by Subject|0|||
130317891|NCT00591006|469129957|FG012|Overall Study|Withdrawal by Subject|0|||
130317892|NCT00591006|469129958|FG013|Overall Study|Withdrawal by Subject|0|||
130317893|NCT00591006|469129959|FG014|Overall Study|Withdrawal by Subject|0|||
130317894|NCT00591006|469129960|FG015|Overall Study|Withdrawal by Subject|1|||
130317895|NCT00591006|469129961|FG016|Overall Study|Withdrawal by Subject|0|||
130317896|NCT00591006|469129962|FG017|Overall Study|Withdrawal by Subject|0|||
130317897|NCT00591006|469129963|FG018|Overall Study|Withdrawal by Subject|0|||
130317898|NCT00591006|469129964|FG019|Overall Study|Withdrawal by Subject|0|||
130317899|NCT00591006|469129965|FG020|Overall Study|Withdrawal by Subject|0|||
130317900|NCT00591006|469129966|FG021|Overall Study|Withdrawal by Subject|0|||
130317901|NCT00591006|469129967|FG022|Overall Study|Withdrawal by Subject|0|||
130317902|NCT00591006|469129968|FG023|Overall Study|Withdrawal by Subject|1|||
130317903|NCT00591006|469129945|FG000|Overall Study|Adverse Event|0|||
130317904|NCT00591006|469129946|FG001|Overall Study|Adverse Event|0|||
130317905|NCT00591006|469129947|FG002|Overall Study|Adverse Event|0|||
130317906|NCT00591006|469129948|FG003|Overall Study|Adverse Event|0|||
130317907|NCT00591006|469129949|FG004|Overall Study|Adverse Event|0|||
130317908|NCT00591006|469129950|FG005|Overall Study|Adverse Event|0|||
130317909|NCT00591006|469129951|FG006|Overall Study|Adverse Event|0|||
130317910|NCT00591006|469129952|FG007|Overall Study|Adverse Event|0|||
130111099|NCT03568500|468367531|FG001|Overall Study|Participant Noncompliance|1|||
130111100|NCT03568500|468367532|FG002|Overall Study|Participant Noncompliance|0|||
130111101|NCT04132232|468367545|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
130111102|NCT04132232|468367546|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
130111103|NCT04132232|468367545|FG000|Overall Study|Lost to Follow-up|6|||
130111104|NCT04132232|468367546|FG001|Overall Study|Lost to Follow-up|7|||
130111105|NCT00368537|468367548|FG000|Randomization|No study drug dosed|13|||
130111106|NCT00368537|468367549|FG001|Randomization|No study drug dosed|6|||
130111107|NCT00368537|468367548|FG000|Baseline Participants|Lost to Follow-up|16|||
130111108|NCT00368537|468367549|FG001|Baseline Participants|Lost to Follow-up|17|||
130111109|NCT00368537|468367548|FG000|Baseline Participants|Withdrawal by Subject|6|||
130111110|NCT00368537|468367549|FG001|Baseline Participants|Withdrawal by Subject|4|||
130111111|NCT00368537|468367548|FG000|Baseline Participants|Death|1|||
130111112|NCT00368537|468367549|FG001|Baseline Participants|Death|2|||
130111113|NCT00368537|468367548|FG000|Baseline Participants|No susceptibility|1|||
130111114|NCT00368537|468367549|FG001|Baseline Participants|No susceptibility|0|||
130111115|NCT00368537|468367548|FG000|Baseline Participants|Patient uncompliant|0|||
130111116|NCT00368537|468367549|FG001|Baseline Participants|Patient uncompliant|1|||
130111117|NCT01368276|468367561|FG000|Overall Study|Death|1|||
130111118|NCT01368276|468367562|FG001|Overall Study|Death|10|||
130111119|NCT00685919|468367563|FG000|Overall Study|Withdrawal by Subject|0|||
130111120|NCT00685919|468367564|FG001|Overall Study|Withdrawal by Subject|0|||
130111121|NCT00685919|468367565|FG002|Overall Study|Withdrawal by Subject|1|||
130111122|NCT00685919|468367566|FG003|Overall Study|Withdrawal by Subject|0|||
130111123|NCT00685919|468367563|FG000|Overall Study|Physician Decision|1|||
130111124|NCT00685919|468367564|FG001|Overall Study|Physician Decision|0|||
130111125|NCT00685919|468367565|FG002|Overall Study|Physician Decision|0|||
130111126|NCT00685919|468367566|FG003|Overall Study|Physician Decision|0|||
130111127|NCT01886300|468367573|FG000|Overall Study|Trial terminated by sponsor|16|||
130111128|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
130111129|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
130111130|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
130111131|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
130111132|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
130111133|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
130111134|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
130111135|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
130111136|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
130111137|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
130111138|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
130111139|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
130111140|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
130111141|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
130111142|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
130111143|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
130111144|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
130111145|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
130111146|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
129891267|NCT01606189|467559691|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891268|NCT01606189|467559692|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891269|NCT01606189|467559693|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891270|NCT01606189|467559694|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891271|NCT01606189|467559695|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891272|NCT01606189|467559696|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
129891273|NCT01606189|467559691|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129891274|NCT01606189|467559692|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129891275|NCT01606189|467559693|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129891276|NCT01606189|467559694|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130111147|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
130111148|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
130111149|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
130317911|NCT00591006|469129953|FG008|Overall Study|Adverse Event|0|||
130317912|NCT00591006|469129954|FG009|Overall Study|Adverse Event|0|||
130317913|NCT00591006|469129955|FG010|Overall Study|Adverse Event|0|||
130317914|NCT00591006|469129956|FG011|Overall Study|Adverse Event|0|||
130317915|NCT00591006|469129957|FG012|Overall Study|Adverse Event|0|||
130317916|NCT00591006|469129958|FG013|Overall Study|Adverse Event|0|||
130317917|NCT00591006|469129959|FG014|Overall Study|Adverse Event|0|||
130317918|NCT00591006|469129960|FG015|Overall Study|Adverse Event|0|||
130317919|NCT00591006|469129961|FG016|Overall Study|Adverse Event|0|||
130317920|NCT00591006|469129962|FG017|Overall Study|Adverse Event|0|||
130317921|NCT00591006|469129963|FG018|Overall Study|Adverse Event|0|||
130317922|NCT00591006|469129964|FG019|Overall Study|Adverse Event|0|||
130317923|NCT00591006|469129965|FG020|Overall Study|Adverse Event|0|||
130317924|NCT00591006|469129966|FG021|Overall Study|Adverse Event|0|||
130317925|NCT00591006|469129967|FG022|Overall Study|Adverse Event|1|||
130317926|NCT00591006|469129968|FG023|Overall Study|Adverse Event|0|||
130317927|NCT00689390|469129969|FG000|Overall Study|Adverse Event|19|||
130317928|NCT00689390|469129970|FG001|Overall Study|Adverse Event|0|||
130317929|NCT00689390|469129969|FG000|Overall Study|Lost to Follow-up|179|||
130317930|NCT00689390|469129970|FG001|Overall Study|Lost to Follow-up|7|||
130317931|NCT00689390|469129969|FG000|Overall Study|Withdrawal by Subject|117|||
130317932|NCT00689390|469129970|FG001|Overall Study|Withdrawal by Subject|3|||
130317933|NCT00689390|469129969|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
130317934|NCT00689390|469129970|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
130317935|NCT00689390|469129969|FG000|Overall Study|Non-Compliance With Protocol|21|||
130317936|NCT00689390|469129970|FG001|Overall Study|Non-Compliance With Protocol|0|||
130317937|NCT00689390|469129969|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130317938|NCT00689390|469129970|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130317939|NCT00689390|469129969|FG000|Overall Study|Administrative|37|||
130317940|NCT00689390|469129970|FG001|Overall Study|Administrative|0|||
130317941|NCT02343263|469129971|FG000|Overall Study|Physician Decision|5|||
130317942|NCT02343263|469129972|FG001|Overall Study|Physician Decision|3|||
130317943|NCT02343263|469129973|FG002|Overall Study|Physician Decision|1|||
130317944|NCT00525512|469129991|FG000|Double-Blind Phase|Adverse Event|48|||
130317945|NCT00525512|469129992|FG001|Double-Blind Phase|Adverse Event|28|||
130317946|NCT00525512|469129993|FG002|Double-Blind Phase|Adverse Event|0|||
130317947|NCT00525512|469129994|FG003|Double-Blind Phase|Adverse Event|0|||
130053088|NCT00366548|468150380|FG001|Infant Series|Protocol Violation|1|||
130053089|NCT00366548|468150379|FG000|Infant Series|Withdrawal by Subject|3|||
130053090|NCT00366548|468150380|FG001|Infant Series|Withdrawal by Subject|1|||
130053091|NCT00366548|468150379|FG000|After Infant Series|Withdrawal by Subject|3|||
130053092|NCT00366548|468150380|FG001|After Infant Series|Withdrawal by Subject|1|||
130053093|NCT00366548|468150379|FG000|After Infant Series|Adverse Event|2|||
130053094|NCT00366548|468150380|FG001|After Infant Series|Adverse Event|0|||
130053095|NCT00366548|468150379|FG000|After Infant Series|Lost to Follow-up|1|||
130053096|NCT00366548|468150380|FG001|After Infant Series|Lost to Follow-up|0|||
130053097|NCT02849990|468150381|FG000|Overall Study|Adverse Event|1|||
130053098|NCT02849990|468150381|FG000|Overall Study|Withdrawal by Subject|1|||
130053099|NCT01051986|468150383|FG000|Overall Study|Death|1|||
130053100|NCT01051986|468150384|FG001|Overall Study|Death|0|||
129800701|NCT00771316|467238198|FG001|Overall Study|Patient withdrew consent|0|||
129800702|NCT00771316|467238197|FG000|Overall Study|Discontinued due to early termination|1|||
129800703|NCT00771316|467238198|FG001|Overall Study|Discontinued due to early termination|0|||
129800704|NCT02027376|467238199|FG000|Overall Study|Death|1|||
129800705|NCT02027376|467238200|FG001|Overall Study|Death|0|||
129800706|NCT02027376|467238201|FG002|Overall Study|Death|0|||
129800707|NCT00843726|467238202|FG000|Overall Study|Death|1|||
129800708|NCT00843726|467238203|FG001|Overall Study|Death|0|||
129800709|NCT00843726|467238202|FG000|Overall Study|Withdrawal by Subject|0|||
129800710|NCT00843726|467238203|FG001|Overall Study|Withdrawal by Subject|1|||
129800711|NCT00406718|467238204|FG000|Overall Study|Withdrawal by Subject|2|||
129800712|NCT00406718|467238205|FG001|Overall Study|Withdrawal by Subject|9|||
129800713|NCT00406718|467238206|FG002|Overall Study|Withdrawal by Subject|4|||
129800714|NCT00406718|467238204|FG000|Overall Study|Lost to Follow-up|2|||
129800715|NCT00406718|467238205|FG001|Overall Study|Lost to Follow-up|5|||
130053101|NCT01051986|468150383|FG000|Overall Study|Withdrawal by Subject|2|||
130053102|NCT01051986|468150384|FG001|Overall Study|Withdrawal by Subject|1|||
130053103|NCT01051986|468150383|FG000|Overall Study|Protocol Violation|2|||
130053104|NCT01051986|468150384|FG001|Overall Study|Protocol Violation|3|||
130053105|NCT02273752|468150386|FG000|Overall Study|Trial was terminated early|2|||
130317948|NCT00525512|469129991|FG000|Double-Blind Phase|Protocol Violation|3|||
130317949|NCT00525512|469129992|FG001|Double-Blind Phase|Protocol Violation|1|||
130317950|NCT00525512|469129993|FG002|Double-Blind Phase|Protocol Violation|0|||
130317951|NCT00525512|469129994|FG003|Double-Blind Phase|Protocol Violation|0|||
130317952|NCT00525512|469129991|FG000|Double-Blind Phase|Lost to Follow-up|3|||
130317953|NCT00525512|469129992|FG001|Double-Blind Phase|Lost to Follow-up|7|||
130317954|NCT00525512|469129993|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130317955|NCT00525512|469129994|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129800716|NCT00406718|467238206|FG002|Overall Study|Lost to Follow-up|4|||
129800717|NCT01897714|467239837|FG000|Phase I (Dose Escalation)|Disease progression|3|||
129800718|NCT01897714|467239838|FG001|Phase I (Dose Escalation)|Disease progression|5|||
129800719|NCT01897714|467239839|FG002|Phase I (Dose Escalation)|Disease progression|1|||
129800720|NCT01897714|467239840|FG003|Phase I (Dose Escalation)|Disease progression|3|||
130053106|NCT01725152|468150387|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
130053107|NCT01725152|468150388|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
130053108|NCT01725152|468150387|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
130053109|NCT01725152|468150388|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
130053110|NCT01725152|468150387|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
130053111|NCT01725152|468150388|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
130053112|NCT01725152|468150387|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
130053113|NCT01725152|468150388|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
130053114|NCT02044159|468150389|FG000|Overall Study|Consent declined (deferred consent)|2|||
130053115|NCT02044159|468150390|FG001|Overall Study|Consent declined (deferred consent)|4|||
130053116|NCT02044159|468150389|FG000|Overall Study|No longer eligible, drug not given|1|||
130053117|NCT02044159|468150390|FG001|Overall Study|No longer eligible, drug not given|0|||
130053118|NCT02044159|468150389|FG000|Overall Study|Nurse declined to give study drug|1|||
130053119|NCT02044159|468150390|FG001|Overall Study|Nurse declined to give study drug|0|||
130053120|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
130053121|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130053122|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130053123|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130053124|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
130053125|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
130053126|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130053127|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130053128|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130053129|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
130053130|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
130053131|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130053132|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130053133|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130053134|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
130053135|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
130053136|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130053137|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130053138|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130053139|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
130053140|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
130053141|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130053142|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130053143|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130053144|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
130053145|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
130053146|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130053147|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130053148|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130053149|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
130053150|NCT01111539|468150391|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
130053151|NCT01111539|468150392|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130053152|NCT01111539|468150393|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130053153|NCT01111539|468150394|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130053154|NCT01111539|468150395|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
130053155|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130053156|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130053157|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130053158|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
130053159|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
130111150|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
130111151|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
130111152|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
130053160|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130053161|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130053162|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
130053163|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
130317956|NCT00525512|469129991|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
129800721|NCT01897714|467239841|FG004|Phase I (Dose Escalation)|Disease progression|0|||
130053164|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
130053165|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
130053166|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
130053167|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
130053168|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130053169|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
130053170|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130053171|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130053172|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130053173|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
130053174|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
130053175|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130053176|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130053177|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130053178|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
130053179|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
130053180|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130053181|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130053182|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130317957|NCT00525512|469129992|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
130317958|NCT00525512|469129993|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
130317959|NCT00525512|469129994|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130317960|NCT00525512|469129991|FG000|Double-Blind Phase|Lack of Efficacy|13|||
129800722|NCT01897714|467239842|FG005|Phase I (Dose Escalation)|Disease progression|0|||
129800723|NCT01897714|467239837|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
129800724|NCT01897714|467239838|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
130053183|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
130317961|NCT00525512|469129992|FG001|Double-Blind Phase|Lack of Efficacy|5|||
130317962|NCT00525512|469129993|FG002|Double-Blind Phase|Lack of Efficacy|0|||
130317963|NCT00525512|469129994|FG003|Double-Blind Phase|Lack of Efficacy|0|||
130317964|NCT00525512|469129991|FG000|Double-Blind Phase|Other reason (not specified)|12|||
130317965|NCT00525512|469129992|FG001|Double-Blind Phase|Other reason (not specified)|13|||
130317966|NCT00525512|469129993|FG002|Double-Blind Phase|Other reason (not specified)|0|||
130317967|NCT00525512|469129994|FG003|Double-Blind Phase|Other reason (not specified)|0|||
130317968|NCT00525512|469129991|FG000|Open-Label Phase|Adverse Event|0|||
130317969|NCT00525512|469129992|FG001|Open-Label Phase|Adverse Event|0|||
130317970|NCT00525512|469129993|FG002|Open-Label Phase|Adverse Event|1|||
130317971|NCT00525512|469129994|FG003|Open-Label Phase|Adverse Event|0|||
130317972|NCT00525512|469129991|FG000|Open-Label Phase|Lost to Follow-up|0|||
130317973|NCT00525512|469129992|FG001|Open-Label Phase|Lost to Follow-up|0|||
130317974|NCT00525512|469129993|FG002|Open-Label Phase|Lost to Follow-up|1|||
130317975|NCT00525512|469129994|FG003|Open-Label Phase|Lost to Follow-up|0|||
130317976|NCT00525512|469129991|FG000|Open-Label Phase|Other reason (not specified)|0|||
130317977|NCT00525512|469129992|FG001|Open-Label Phase|Other reason (not specified)|0|||
130317978|NCT00525512|469129993|FG002|Open-Label Phase|Other reason (not specified)|4|||
130317979|NCT00525512|469129994|FG003|Open-Label Phase|Other reason (not specified)|5|||
130317980|NCT03289208|469129995|FG000|Overall Study|Adverse Event|1|||
130317981|NCT03289208|469129996|FG001|Overall Study|Adverse Event|0|||
130317982|NCT03289208|469129997|FG002|Overall Study|Adverse Event|0|||
130317983|NCT03353675|469130002|FG000|Overall Study|Adverse Event|4|||
130317984|NCT00395746|469130005|FG000|Overall Study|Adverse Event|5|||
130317985|NCT00395746|469130006|FG001|Overall Study|Adverse Event|2|||
130317986|NCT00395746|469130007|FG002|Overall Study|Adverse Event|2|||
130317987|NCT00395746|469130005|FG000|Overall Study|Protocol Violation|0|||
130317988|NCT00395746|469130006|FG001|Overall Study|Protocol Violation|1|||
130317989|NCT00395746|469130007|FG002|Overall Study|Protocol Violation|0|||
130317990|NCT00395746|469130005|FG000|Overall Study|Lack of Efficacy|2|||
129800725|NCT01897714|467239839|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
129800726|NCT01897714|467239840|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
129800727|NCT01897714|467239841|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
130317991|NCT00395746|469130006|FG001|Overall Study|Lack of Efficacy|0|||
130317992|NCT00395746|469130007|FG002|Overall Study|Lack of Efficacy|17|||
130317993|NCT00395746|469130005|FG000|Overall Study|Hypoglycaemia|2|||
130317994|NCT00395746|469130006|FG001|Overall Study|Hypoglycaemia|1|||
130317995|NCT00395746|469130007|FG002|Overall Study|Hypoglycaemia|0|||
130317996|NCT00395746|469130005|FG000|Overall Study|Subject decision|0|||
130317997|NCT00395746|469130006|FG001|Overall Study|Subject decision|0|||
130317998|NCT00395746|469130007|FG002|Overall Study|Subject decision|1|||
130317999|NCT00395746|469130005|FG000|Overall Study|Withdrawal of consent|0|||
129800728|NCT01897714|467239842|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
129800729|NCT01897714|467239837|FG000|Phase I (Dose Escalation)|Other|0|||
129800730|NCT01897714|467239838|FG001|Phase I (Dose Escalation)|Other|1|||
129800731|NCT01897714|467239839|FG002|Phase I (Dose Escalation)|Other|0|||
129800732|NCT01897714|467239840|FG003|Phase I (Dose Escalation)|Other|0|||
129800733|NCT01897714|467239841|FG004|Phase I (Dose Escalation)|Other|0|||
129800734|NCT01897714|467239842|FG005|Phase I (Dose Escalation)|Other|0|||
129800735|NCT01897714|467239837|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
130053184|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
130053185|NCT01111539|468150391|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130053186|NCT01111539|468150392|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130318000|NCT00395746|469130006|FG001|Overall Study|Withdrawal of consent|0|||
130318001|NCT00395746|469130007|FG002|Overall Study|Withdrawal of consent|1|||
130318002|NCT00395746|469130005|FG000|Overall Study|Difficultulty in use of device|0|||
130318003|NCT00395746|469130006|FG001|Overall Study|Difficultulty in use of device|0|||
130318004|NCT00395746|469130007|FG002|Overall Study|Difficultulty in use of device|1|||
130318005|NCT00395746|469130005|FG000|Overall Study|Unable to visit site on schedule|1|||
130318006|NCT00395746|469130006|FG001|Overall Study|Unable to visit site on schedule|0|||
130318007|NCT00395746|469130007|FG002|Overall Study|Unable to visit site on schedule|0|||
130318008|NCT03346434|469131891|FG000|Overall Study|Randomized in Error|0|||
130318009|NCT03346434|469131892|FG001|Overall Study|Randomized in Error|0|||
130318010|NCT03346434|469131893|FG002|Overall Study|Randomized in Error|0|||
130318011|NCT03346434|469131894|FG003|Overall Study|Randomized in Error|0|||
130318012|NCT03346434|469131895|FG004|Overall Study|Randomized in Error|1|||
130318013|NCT03346434|469131896|FG005|Overall Study|Randomized in Error|0|||
130318014|NCT03346434|469131891|FG000|Overall Study|Withdrawal by Subject|0|||
130318015|NCT03346434|469131892|FG001|Overall Study|Withdrawal by Subject|0|||
130318016|NCT03346434|469131893|FG002|Overall Study|Withdrawal by Subject|1|||
130318017|NCT03346434|469131894|FG003|Overall Study|Withdrawal by Subject|0|||
130318018|NCT03346434|469131895|FG004|Overall Study|Withdrawal by Subject|1|||
130318019|NCT03346434|469131896|FG005|Overall Study|Withdrawal by Subject|0|||
130318020|NCT03346434|469131891|FG000|Overall Study|Lost to Follow-up|0|||
130318021|NCT03346434|469131892|FG001|Overall Study|Lost to Follow-up|0|||
130318022|NCT03346434|469131893|FG002|Overall Study|Lost to Follow-up|0|||
130318023|NCT03346434|469131894|FG003|Overall Study|Lost to Follow-up|0|||
130318024|NCT03346434|469131895|FG004|Overall Study|Lost to Follow-up|1|||
130318025|NCT03346434|469131896|FG005|Overall Study|Lost to Follow-up|1|||
130318026|NCT03346434|469131891|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318027|NCT03346434|469131892|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318028|NCT03346434|469131893|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318029|NCT03346434|469131894|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
130318030|NCT03346434|469131895|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
130318031|NCT03346434|469131896|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
130318032|NCT03525444|469131897|FG000|Overall Study|Adverse Event|0|||
130318033|NCT03525444|469131898|FG001|Overall Study|Adverse Event|1|||
130318034|NCT03525444|469131897|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
130318035|NCT03525444|469131898|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
130318036|NCT03525444|469131897|FG000|Overall Study|Other|0|||
130318037|NCT03525444|469131898|FG001|Overall Study|Other|1|||
130318038|NCT01419236|469131902|FG000|Overall Study|Adverse Event|1|||
130318039|NCT01419236|469131903|FG001|Overall Study|Adverse Event|0|||
130318040|NCT01419236|469131902|FG000|Overall Study|Lack of Efficacy|0|||
130318041|NCT01419236|469131903|FG001|Overall Study|Lack of Efficacy|1|||
130318042|NCT01419236|469131902|FG000|Overall Study|Lost to Follow-up|1|||
130318043|NCT01419236|469131903|FG001|Overall Study|Lost to Follow-up|0|||
130318044|NCT01419236|469131902|FG000|Overall Study|Physician Decision|1|||
130318045|NCT01419236|469131903|FG001|Overall Study|Physician Decision|0|||
130318046|NCT01419236|469131902|FG000|Overall Study|Withdrawal by Subject|1|||
130318047|NCT01419236|469131903|FG001|Overall Study|Withdrawal by Subject|4|||
130318048|NCT01419236|469131902|FG000|Overall Study|Entry Criteria Not Met|1|||
130318049|NCT01419236|469131903|FG001|Overall Study|Entry Criteria Not Met|0|||
130318050|NCT02250326|469131904|FG000|Treatment|Death|1|||
130318051|NCT02250326|469131905|FG001|Treatment|Death|13|||
130318052|NCT02250326|469131906|FG002|Treatment|Death|2|||
130318053|NCT02250326|469131904|FG000|Treatment|Adverse Event|8|||
130318054|NCT02250326|469131905|FG001|Treatment|Adverse Event|8|||
130318055|NCT02250326|469131906|FG002|Treatment|Adverse Event|9|||
130318056|NCT02250326|469131904|FG000|Treatment|Progressive Disease|42|||
130318057|NCT02250326|469131905|FG001|Treatment|Progressive Disease|40|||
130318058|NCT02250326|469131906|FG002|Treatment|Progressive Disease|47|||
130318059|NCT02250326|469131904|FG000|Treatment|Symptomatic Deterioration|9|||
130318060|NCT02250326|469131905|FG001|Treatment|Symptomatic Deterioration|4|||
130318061|NCT02250326|469131906|FG002|Treatment|Symptomatic Deterioration|10|||
130318062|NCT02250326|469131904|FG000|Treatment|Withdrawal by Subject|11|||
129891277|NCT01606189|467559695|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
130318063|NCT02250326|469131905|FG001|Treatment|Withdrawal by Subject|6|||
130318064|NCT02250326|469131906|FG002|Treatment|Withdrawal by Subject|4|||
130318065|NCT02250326|469131904|FG000|Treatment|Other reasons|8|||
130318066|NCT02250326|469131905|FG001|Treatment|Other reasons|7|||
130318067|NCT02250326|469131906|FG002|Treatment|Other reasons|7|||
130318068|NCT02250326|469131904|FG000|Extension Period|Progressive Disease|0|||
130318069|NCT02250326|469131905|FG001|Extension Period|Progressive Disease|2|||
130318070|NCT02250326|469131906|FG002|Extension Period|Progressive Disease|0|||
130318071|NCT02250326|469131904|FG000|Extension Period|Withdrawal by Subject|0|||
130318072|NCT02250326|469131905|FG001|Extension Period|Withdrawal by Subject|1|||
130318073|NCT02250326|469131906|FG002|Extension Period|Withdrawal by Subject|0|||
130318074|NCT02250326|469131904|FG000|Extension Period|Withdrawal by investigator|0|||
130318075|NCT02250326|469131905|FG001|Extension Period|Withdrawal by investigator|1|||
130053187|NCT01111539|468150393|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130053188|NCT01111539|468150394|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
130053189|NCT01111539|468150395|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
130053190|NCT02808312|468150396|FG000|Overall Study|Enrolled but Never Treated|0|||
130318076|NCT02250326|469131906|FG002|Extension Period|Withdrawal by investigator|0|||
130318077|NCT00866177|469131907|FG000|Overall Study|Withdrawal by Subject|1|||
130318078|NCT00866177|469131907|FG000|Overall Study|Not Treated|151|||
130318079|NCT03585660|469131908|FG000|Overall Study|operator error|1|||
130318080|NCT03585660|469131908|FG000|Overall Study|technical error|2|||
130318081|NCT03585660|469131908|FG000|Overall Study|hip prosthesis|2|||
130318082|NCT03585660|469131908|FG000|Overall Study|did not undergo biopsy|8|||
130318083|NCT03585660|469131908|FG000|Overall Study|scanner problem|2|||
130318084|NCT00435409|469131909|FG000|Overall Study|Protocol Violation|1|||
130318085|NCT00435409|469131910|FG001|Overall Study|Protocol Violation|2|||
130318086|NCT00435409|469131911|FG002|Overall Study|Protocol Violation|0|||
130318087|NCT00435409|469131909|FG000|Overall Study|Lost to Follow-up|1|||
130318088|NCT00435409|469131910|FG001|Overall Study|Lost to Follow-up|2|||
130318089|NCT00435409|469131911|FG002|Overall Study|Lost to Follow-up|0|||
130318090|NCT00435409|469131909|FG000|Overall Study|Death|8|||
130318091|NCT00435409|469131910|FG001|Overall Study|Death|6|||
130318092|NCT00435409|469131911|FG002|Overall Study|Death|6|||
130318093|NCT00435409|469131909|FG000|Overall Study|Objective progression or relapse|158|||
129800736|NCT01897714|467239838|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
129800737|NCT01897714|467239839|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
129800738|NCT01897714|467239840|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
129800739|NCT01897714|467239841|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
129800740|NCT01897714|467239842|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
129800741|NCT01897714|467239837|FG000|Phase II (MTD)|Lost to Follow-up|0|||
129800742|NCT01897714|467239838|FG001|Phase II (MTD)|Lost to Follow-up|0|||
129800743|NCT01897714|467239839|FG002|Phase II (MTD)|Lost to Follow-up|0|||
129800744|NCT01897714|467239840|FG003|Phase II (MTD)|Lost to Follow-up|0|||
129800745|NCT01897714|467239841|FG004|Phase II (MTD)|Lost to Follow-up|1|||
130318094|NCT00435409|469131910|FG001|Overall Study|Objective progression or relapse|93|||
130318095|NCT00435409|469131911|FG002|Overall Study|Objective progression or relapse|58|||
130318096|NCT00435409|469131909|FG000|Overall Study|Global deterioration of health status|0|||
130318097|NCT00435409|469131910|FG001|Overall Study|Global deterioration of health status|0|||
130318098|NCT00435409|469131911|FG002|Overall Study|Global deterioration of health status|4|||
130318099|NCT00435409|469131909|FG000|Overall Study|Withdrawal by Subject|8|||
130318100|NCT00435409|469131910|FG001|Overall Study|Withdrawal by Subject|7|||
130318101|NCT00435409|469131911|FG002|Overall Study|Withdrawal by Subject|1|||
130318102|NCT00435409|469131909|FG000|Overall Study|Other|45|||
130318103|NCT00435409|469131910|FG001|Overall Study|Other|30|||
130318104|NCT00435409|469131911|FG002|Overall Study|Other|1|||
130318105|NCT00435409|469131909|FG000|Overall Study|Adverse Event|0|||
130318106|NCT00435409|469131910|FG001|Overall Study|Adverse Event|0|||
130318107|NCT00435409|469131911|FG002|Overall Study|Adverse Event|8|||
130318108|NCT00435409|469131909|FG000|Overall Study|Sponsor decision|0|||
130318109|NCT00435409|469131910|FG001|Overall Study|Sponsor decision|3|||
130318110|NCT00435409|469131911|FG002|Overall Study|Sponsor decision|0|||
130318111|NCT05635461|469131914|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318112|NCT05635461|469131915|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318113|NCT05635461|469131916|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318114|NCT05635461|469131917|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318115|NCT05635461|469131918|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
130318116|NCT05635461|469131919|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
130318117|NCT05635461|469131914|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318118|NCT05635461|469131915|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
130318119|NCT05635461|469131916|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318120|NCT05635461|469131917|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318121|NCT05635461|469131918|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318122|NCT05635461|469131919|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
130318123|NCT05635461|469131914|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318124|NCT05635461|469131915|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318125|NCT05635461|469131916|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318126|NCT05635461|469131917|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
130318127|NCT05635461|469131918|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318128|NCT05635461|469131919|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
130318129|NCT03760029|469131922|FG000|Overall Study|Death|1|||
130318130|NCT03760029|469131923|FG001|Overall Study|Death|0|||
130318131|NCT03760029|469131924|FG002|Overall Study|Death|0|||
130318132|NCT03760029|469131922|FG000|Overall Study|Lost to Follow-up|0|||
130318133|NCT03760029|469131923|FG001|Overall Study|Lost to Follow-up|2|||
130318134|NCT03760029|469131924|FG002|Overall Study|Lost to Follow-up|1|||
130318135|NCT03760029|469131922|FG000|Overall Study|Withdrawal by Subject|1|||
130318136|NCT03760029|469131923|FG001|Overall Study|Withdrawal by Subject|4|||
130318137|NCT03760029|469131924|FG002|Overall Study|Withdrawal by Subject|1|||
130318138|NCT03760029|469131922|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130318139|NCT03760029|469131923|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130318140|NCT03760029|469131924|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130318141|NCT03760029|469131922|FG000|Overall Study|Other|2|||
130318142|NCT03760029|469131923|FG001|Overall Study|Other|1|||
130318143|NCT03760029|469131924|FG002|Overall Study|Other|0|||
130318144|NCT04890652|469131928|FG000|Overall Study|Withdrawal by Subject|2|||
130318145|NCT02269124|469131935|FG000|Overall Study|Lost to Follow-up|1|||
130318146|NCT02269124|469131936|FG001|Overall Study|Lost to Follow-up|0|||
130318147|NCT02269124|469131935|FG000|Overall Study|Withdrawal by Subject|0|||
130318148|NCT02269124|469131936|FG001|Overall Study|Withdrawal by Subject|2|||
130318149|NCT00614575|469131937|FG000|Overall Study|Adverse Event|106|||
130318150|NCT00614575|469131937|FG000|Overall Study|Lost to Follow-up|55|||
130318151|NCT00614575|469131937|FG000|Overall Study|Lack of Efficacy|14|||
130318152|NCT00614575|469131937|FG000|Overall Study|Withdrawal by Subject|6|||
130318153|NCT00614575|469131937|FG000|Overall Study|Death|3|||
130318154|NCT00614575|469131937|FG000|Overall Study|Physician Decision|2|||
130318155|NCT00614575|469131937|FG000|Overall Study|No data were collected.|18|||
130318156|NCT00614575|469131937|FG000|Overall Study|Irregularly enrolled patients|23|||
130318157|NCT00614575|469131937|FG000|Overall Study|No treatment|1|||
130318158|NCT01600885|469131938|FG000|First Period|Adverse Event|1|||
130318159|NCT01600885|469131939|FG001|First Period|Adverse Event|1|||
130318160|NCT01600885|469131938|FG000|First Period|moved out of area|1|||
130318161|NCT01600885|469131939|FG001|First Period|moved out of area|0|||
130318162|NCT00005906|469131946|FG000|Overall Study|Lack of Efficacy|3|||
129800746|NCT01897714|467239842|FG005|Phase II (MTD)|Lost to Follow-up|0|||
129800747|NCT01897714|467239837|FG000|Phase II (MTD)|Death|0|||
130318163|NCT00286442|469131947|FG000|Overall Study|Hyperglycemic Rescue|19|||
130318164|NCT00286442|469131948|FG001|Overall Study|Hyperglycemic Rescue|17|||
130318165|NCT00286442|469131949|FG002|Overall Study|Hyperglycemic Rescue|25|||
130318166|NCT00286442|469131947|FG000|Overall Study|Adverse Event|7|||
130318167|NCT00286442|469131948|FG001|Overall Study|Adverse Event|6|||
130318168|NCT00286442|469131949|FG002|Overall Study|Adverse Event|1|||
130318169|NCT00286442|469131947|FG000|Overall Study|Protocol Violation|2|||
130318170|NCT00286442|469131948|FG001|Overall Study|Protocol Violation|4|||
130318171|NCT00286442|469131949|FG002|Overall Study|Protocol Violation|2|||
130111153|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
130154854|NCT00958126|468526625|FG004|Overall Study|Moved away from study area|0|||
130318172|NCT00286442|469131947|FG000|Overall Study|Lost to Follow-up|5|||
130318173|NCT00286442|469131948|FG001|Overall Study|Lost to Follow-up|2|||
130318174|NCT00286442|469131949|FG002|Overall Study|Lost to Follow-up|1|||
130318175|NCT00286442|469131947|FG000|Overall Study|Physician Decision|1|||
130318176|NCT00286442|469131948|FG001|Overall Study|Physician Decision|1|||
130318177|NCT00286442|469131949|FG002|Overall Study|Physician Decision|1|||
130318178|NCT00286442|469131947|FG000|Overall Study|Administrative Error|1|||
130318179|NCT00286442|469131948|FG001|Overall Study|Administrative Error|1|||
130318180|NCT00286442|469131949|FG002|Overall Study|Administrative Error|0|||
130318181|NCT00286442|469131947|FG000|Overall Study|Withdrawal by Subject|2|||
130318182|NCT00286442|469131948|FG001|Overall Study|Withdrawal by Subject|14|||
130318183|NCT00286442|469131949|FG002|Overall Study|Withdrawal by Subject|2|||
130318184|NCT04571944|469131952|FG000|Overall Study|Death|1|||
130318185|NCT04571944|469131953|FG001|Overall Study|Death|0|||
130318186|NCT04571944|469131952|FG000|Overall Study|Withdrawal by Subject|3|||
130318187|NCT04571944|469131953|FG001|Overall Study|Withdrawal by Subject|0|||
130318188|NCT04571944|469131952|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
130318189|NCT04571944|469131953|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
130318190|NCT03740048|469131954|FG000|Overall Study|Withdrawal by Subject|1|||
130318191|NCT03740048|469131955|FG001|Overall Study|Withdrawal by Subject|1|||
130318192|NCT03740048|469131954|FG000|Overall Study|Death|1|||
130318193|NCT03740048|469131955|FG001|Overall Study|Death|6|||
130318194|NCT03740048|469131954|FG000|Overall Study|Switched to thrice-weekly HD|2|||
130318195|NCT03740048|469131955|FG001|Overall Study|Switched to thrice-weekly HD|0|||
130318196|NCT03740048|469131954|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
130318197|NCT03740048|469131955|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
130318198|NCT03740048|469131954|FG000|Overall Study|Lost to Follow-up|0|||
130318199|NCT03740048|469131955|FG001|Overall Study|Lost to Follow-up|1|||
130318200|NCT03740048|469131954|FG000|Overall Study|Non-compliance with HD|0|||
130318201|NCT03740048|469131955|FG001|Overall Study|Non-compliance with HD|1|||
130318202|NCT01476722|469131956|FG000|Overall Study|Adverse Event|1|||
130318203|NCT03261336|469131957|FG000|Overall Study|Adverse Event|1|||
130318204|NCT00292942|469131958|FG000|Overall Study|Withdrawal by Subject|0|||
130318205|NCT00292942|469131959|FG001|Overall Study|Withdrawal by Subject|0|||
130318206|NCT00292942|469131960|FG002|Overall Study|Withdrawal by Subject|1|||
130318207|NCT00292942|469131961|FG003|Overall Study|Withdrawal by Subject|0|||
130318208|NCT00292942|469131958|FG000|Overall Study|Adverse Event|0|||
130318209|NCT00292942|469131959|FG001|Overall Study|Adverse Event|0|||
130318210|NCT00292942|469131960|FG002|Overall Study|Adverse Event|0|||
130318211|NCT00292942|469131961|FG003|Overall Study|Adverse Event|1|||
130318212|NCT00651924|469131962|FG000|Overall Study|Withdrawal by PI|0|||
130318213|NCT00651924|469131963|FG001|Overall Study|Withdrawal by PI|2|||
130318214|NCT00651924|469131962|FG000|Overall Study|Withdrawal by Subject|0|||
130053191|NCT02808312|468150397|FG001|Overall Study|Enrolled but Never Treated|0|||
130053192|NCT02808312|468150398|FG002|Overall Study|Enrolled but Never Treated|1|||
130053193|NCT02808312|468150399|FG003|Overall Study|Enrolled but Never Treated|0|||
130053194|NCT02808312|468150400|FG004|Overall Study|Enrolled but Never Treated|0|||
130053195|NCT03628417|468150401|FG000|Overall Study|Death|1|||
130053196|NCT03628417|468150402|FG001|Overall Study|Death|1|||
130053197|NCT00372190|468150408|FG000|Overall Study|Lost to Follow-up|3|||
130053198|NCT00372190|468150409|FG001|Overall Study|Lost to Follow-up|1|||
130053199|NCT01623531|468150410|FG000|Overall Study|Death|1|||
130053200|NCT01623531|468150411|FG001|Overall Study|Death|0|||
130053201|NCT01623531|468150410|FG000|Overall Study|Protocol Violation|2|||
130053202|NCT01623531|468150411|FG001|Overall Study|Protocol Violation|1|||
130053203|NCT01623531|468150410|FG000|Overall Study|Missing data at primary outcome time poi|1|||
130053204|NCT01623531|468150411|FG001|Overall Study|Missing data at primary outcome time poi|1|||
130053205|NCT01429792|468150412|FG000|Overall Study|Other Reasons|67|||
130053206|NCT01429792|468150412|FG000|Overall Study|Unknown Disposition|94|||
130053207|NCT01429792|468150412|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
129800748|NCT01897714|467239838|FG001|Phase II (MTD)|Death|0|||
130053208|NCT01429792|468150412|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
130318215|NCT00651924|469131963|FG001|Overall Study|Withdrawal by Subject|5|||
130318216|NCT00960063|469131964|FG000|Overall Study|Adverse Event|1|||
130318217|NCT00960063|469131965|FG001|Overall Study|Adverse Event|0|||
130318218|NCT00960063|469131966|FG002|Overall Study|Adverse Event|0|||
130318219|NCT00960063|469131964|FG000|Overall Study|Progression of Disease|0|||
130318220|NCT00960063|469131965|FG001|Overall Study|Progression of Disease|0|||
130318221|NCT00960063|469131966|FG002|Overall Study|Progression of Disease|3|||
130318222|NCT05083351|469131968|FG000|Overall Study|Adverse Event|3|||
130318223|NCT05083351|469131968|FG000|Overall Study|Did not meet data inclusion criteria|8|||
130318224|NCT05083351|469131968|FG000|Overall Study|Did not meet eligibility criteria|19|||
130318225|NCT05083351|469131968|FG000|Overall Study|Study Staff Decision|19|||
130318226|NCT01759420|469131970|FG000|Overall Study|Screen failure|5|||
130318227|NCT01759420|469131970|FG000|Overall Study|Inaccurate EKG machine readings|1|||
130318228|NCT04258423|469131979|FG000|Overall Study|Study Closure|2|||
130318229|NCT04258423|469131980|FG001|Overall Study|Study Closure|2|||
130318230|NCT00321789|469131981|FG000|Overall Study|Lost to Follow-up|4|||
130318231|NCT00321789|469131982|FG001|Overall Study|Lost to Follow-up|7|||
130318232|NCT00321789|469131981|FG000|Overall Study|Withdrawal by Subject|6|||
130318233|NCT00321789|469131982|FG001|Overall Study|Withdrawal by Subject|6|||
130318234|NCT00321789|469131981|FG000|Overall Study|Protocol Violation|5|||
130318235|NCT00321789|469131982|FG001|Overall Study|Protocol Violation|3|||
130318236|NCT03309020|469131985|FG000|Overall Study|Death|1|||
130318237|NCT03309020|469131986|FG001|Overall Study|Death|0|||
130318238|NCT03309020|469131985|FG000|Overall Study|Did not undergo surgery|2|||
130318239|NCT03309020|469131986|FG001|Overall Study|Did not undergo surgery|1|||
130318240|NCT02025179|469131987|FG000|Overall Study|Lost to Follow-up|0|||
130318241|NCT02025179|469131988|FG001|Overall Study|Lost to Follow-up|0|||
130318242|NCT02025179|469131989|FG002|Overall Study|Lost to Follow-up|1|||
130318243|NCT00402168|469131990|FG000|Randomized|Lost to Follow-up|1|||
130318244|NCT00402168|469131991|FG001|Randomized|Lost to Follow-up|0|||
130318245|NCT00402168|469131990|FG000|Randomized|Withdrawal by Subject|0|||
130318246|NCT00402168|469131991|FG001|Randomized|Withdrawal by Subject|1|||
130318247|NCT00402168|469131990|FG000|Treatment (up to 12 Months)|Death|0|||
130318248|NCT00402168|469131991|FG001|Treatment (up to 12 Months)|Death|1|||
130318249|NCT00402168|469131990|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
130318250|NCT00402168|469131991|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
130318251|NCT00402168|469131990|FG000|Treatment (up to 12 Months)|non-specified|0|||
130318252|NCT00402168|469131991|FG001|Treatment (up to 12 Months)|non-specified|1|||
130318253|NCT00402168|469131990|FG000|Long Term (LT)|Adverse Event|1|||
130318254|NCT00402168|469131991|FG001|Long Term (LT)|Adverse Event|5|||
130318255|NCT00402168|469131990|FG000|Long Term (LT)|Withdrawal by Subject|4|||
130318256|NCT00402168|469131991|FG001|Long Term (LT)|Withdrawal by Subject|7|||
130318257|NCT00402168|469131990|FG000|Long Term (LT)|Pregnancy|0|||
130318258|NCT00402168|469131991|FG001|Long Term (LT)|Pregnancy|1|||
130318259|NCT00402168|469131990|FG000|Long Term (LT)|Lost to Follow-up|1|||
130318260|NCT00402168|469131991|FG001|Long Term (LT)|Lost to Follow-up|0|||
130318261|NCT00402168|469131990|FG000|Long Term (LT)|Death|4|||
130318262|NCT00402168|469131991|FG001|Long Term (LT)|Death|0|||
130318263|NCT00402168|469131990|FG000|Long Term (LT)|Lack of Efficacy|0|||
130318264|NCT00402168|469131991|FG001|Long Term (LT)|Lack of Efficacy|2|||
130318265|NCT00402168|469131990|FG000|Long Term (LT)|non-specified|1|||
130318266|NCT00402168|469131991|FG001|Long Term (LT)|non-specified|2|||
130318267|NCT00402168|469131990|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
130318268|NCT00402168|469131991|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
130318269|NCT00402168|469131990|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
130318270|NCT00402168|469131991|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
130318271|NCT02362724|469131992|FG000|Overall Study|Withdrawal by Subject|3|||
130318272|NCT02362724|469131993|FG001|Overall Study|Withdrawal by Subject|1|||
130318273|NCT02362724|469131992|FG000|Overall Study|Adverse Event|3|||
130318274|NCT02362724|469131993|FG001|Overall Study|Adverse Event|0|||
130318275|NCT00601835|469131999|FG000|Overall Study|Withdrawal by Subject|9|||
130318276|NCT00601835|469132000|FG001|Overall Study|Withdrawal by Subject|6|||
130318277|NCT00601835|469131999|FG000|Overall Study|Physician Decision|1|||
130318278|NCT00601835|469132000|FG001|Overall Study|Physician Decision|0|||
130318279|NCT00601835|469131999|FG000|Overall Study|Lost to Follow-up|37|||
130318280|NCT00601835|469132000|FG001|Overall Study|Lost to Follow-up|5|||
130318281|NCT00601835|469131999|FG000|Overall Study|Adverse Event|1|||
130053209|NCT01429792|468150412|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
130318282|NCT00601835|469132000|FG001|Overall Study|Adverse Event|1|||
130318283|NCT00601835|469131999|FG000|Overall Study|Relocate|12|||
130053210|NCT01429792|468150412|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
130318284|NCT00601835|469132000|FG001|Overall Study|Relocate|2|||
130318285|NCT03137992|469132005|FG000|Washout Period 1|Adverse Event|1|||
130318286|NCT03137992|469132006|FG001|Washout Period 1|Adverse Event|1|||
130318287|NCT03137992|469132007|FG002|Washout Period 1|Adverse Event|0|||
130318288|NCT03137992|469132008|FG003|Washout Period 1|Adverse Event|0|||
129800749|NCT01897714|467239839|FG002|Phase II (MTD)|Death|0|||
129800750|NCT01897714|467239840|FG003|Phase II (MTD)|Death|0|||
129800751|NCT01897714|467239841|FG004|Phase II (MTD)|Death|25|||
129800752|NCT01897714|467239842|FG005|Phase II (MTD)|Death|10|||
129800753|NCT01897714|467239837|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
129800754|NCT01897714|467239838|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
130111154|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
130318289|NCT03137992|469132009|FG004|Washout Period 1|Adverse Event|0|||
130318290|NCT03137992|469132010|FG005|Washout Period 1|Adverse Event|1|||
130318291|NCT03137992|469132005|FG000|Washout Period 1|Withdrawal by Subject|0|||
130318292|NCT03137992|469132006|FG001|Washout Period 1|Withdrawal by Subject|1|||
130318293|NCT03137992|469132007|FG002|Washout Period 1|Withdrawal by Subject|1|||
130318294|NCT03137992|469132008|FG003|Washout Period 1|Withdrawal by Subject|0|||
130318295|NCT03137992|469132009|FG004|Washout Period 1|Withdrawal by Subject|0|||
130318296|NCT03137992|469132010|FG005|Washout Period 1|Withdrawal by Subject|0|||
130318297|NCT03137992|469132005|FG000|Washout Period 1|Principal Investigator Discretion|0|||
130318298|NCT03137992|469132006|FG001|Washout Period 1|Principal Investigator Discretion|1|||
130318299|NCT03137992|469132007|FG002|Washout Period 1|Principal Investigator Discretion|0|||
130318300|NCT03137992|469132008|FG003|Washout Period 1|Principal Investigator Discretion|0|||
130318301|NCT03137992|469132009|FG004|Washout Period 1|Principal Investigator Discretion|0|||
130318302|NCT03137992|469132010|FG005|Washout Period 1|Principal Investigator Discretion|0|||
130318303|NCT03137992|469132005|FG000|Washout Period 1|COPD Exacerbation|1|||
130318304|NCT03137992|469132006|FG001|Washout Period 1|COPD Exacerbation|1|||
130318305|NCT03137992|469132007|FG002|Washout Period 1|COPD Exacerbation|1|||
130318306|NCT03137992|469132008|FG003|Washout Period 1|COPD Exacerbation|0|||
130318307|NCT03137992|469132009|FG004|Washout Period 1|COPD Exacerbation|1|||
130318308|NCT03137992|469132010|FG005|Washout Period 1|COPD Exacerbation|1|||
130318309|NCT03137992|469132005|FG000|Washout Period 1|Subject Noncompliance|1|||
130318310|NCT03137992|469132006|FG001|Washout Period 1|Subject Noncompliance|0|||
130318311|NCT03137992|469132007|FG002|Washout Period 1|Subject Noncompliance|0|||
130318312|NCT03137992|469132008|FG003|Washout Period 1|Subject Noncompliance|0|||
130318313|NCT03137992|469132009|FG004|Washout Period 1|Subject Noncompliance|1|||
130318314|NCT03137992|469132010|FG005|Washout Period 1|Subject Noncompliance|0|||
130318315|NCT03137992|469132005|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
130318316|NCT03137992|469132006|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
130318317|NCT03137992|469132007|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
130318318|NCT03137992|469132008|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
130318319|NCT03137992|469132009|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
130318320|NCT03137992|469132010|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
130318321|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
130318322|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130318323|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130318324|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
130318325|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
130318326|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
130318327|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Adverse Event|0|||
130318328|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Adverse Event|1|||
130318329|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Adverse Event|0|||
130318330|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Adverse Event|0|||
130318331|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Adverse Event|0|||
130318332|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Adverse Event|0|||
130318333|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318334|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318335|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318336|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
130318337|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318338|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
130318339|NCT03137992|469132005|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318340|NCT03137992|469132006|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
130318341|NCT03137992|469132007|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318342|NCT03137992|469132008|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318343|NCT03137992|469132009|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
130318344|NCT03137992|469132010|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
130318345|NCT03137992|469132005|FG000|Washout Period 2|COPD Exacerbation|1|||
130318346|NCT03137992|469132006|FG001|Washout Period 2|COPD Exacerbation|1|||
130318347|NCT03137992|469132007|FG002|Washout Period 2|COPD Exacerbation|0|||
130318348|NCT03137992|469132008|FG003|Washout Period 2|COPD Exacerbation|0|||
130318349|NCT03137992|469132009|FG004|Washout Period 2|COPD Exacerbation|1|||
130318350|NCT03137992|469132010|FG005|Washout Period 2|COPD Exacerbation|0|||
130318351|NCT03137992|469132005|FG000|Washout Period 2|Subject Non-compliance|0|||
130318352|NCT03137992|469132006|FG001|Washout Period 2|Subject Non-compliance|1|||
130318353|NCT03137992|469132007|FG002|Washout Period 2|Subject Non-compliance|0|||
130318354|NCT03137992|469132008|FG003|Washout Period 2|Subject Non-compliance|0|||
130318355|NCT03137992|469132009|FG004|Washout Period 2|Subject Non-compliance|0|||
129891278|NCT01606189|467559696|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
129891279|NCT00162942|467559697|FG000|Overall Study|Adverse Event|10|||
129891280|NCT00162942|467559698|FG001|Overall Study|Adverse Event|6|||
129891281|NCT00162942|467559697|FG000|Overall Study|Death|1|||
130318356|NCT03137992|469132010|FG005|Washout Period 2|Subject Non-compliance|0|||
130318357|NCT03137992|469132005|FG000|Washout Period 2|Adverse Event|0|||
130318358|NCT03137992|469132006|FG001|Washout Period 2|Adverse Event|0|||
130318359|NCT03137992|469132007|FG002|Washout Period 2|Adverse Event|0|||
130318360|NCT03137992|469132008|FG003|Washout Period 2|Adverse Event|1|||
130318361|NCT03137992|469132009|FG004|Washout Period 2|Adverse Event|1|||
130318362|NCT03137992|469132010|FG005|Washout Period 2|Adverse Event|0|||
130318363|NCT03137992|469132005|FG000|Washout Period 2|Withdrawal by Subject|1|||
130318364|NCT03137992|469132006|FG001|Washout Period 2|Withdrawal by Subject|0|||
130318365|NCT03137992|469132007|FG002|Washout Period 2|Withdrawal by Subject|0|||
130318366|NCT03137992|469132008|FG003|Washout Period 2|Withdrawal by Subject|0|||
130318367|NCT03137992|469132009|FG004|Washout Period 2|Withdrawal by Subject|1|||
130318368|NCT03137992|469132010|FG005|Washout Period 2|Withdrawal by Subject|0|||
130318369|NCT03137992|469132005|FG000|Washout Period 2|Sponsor Decision|0|||
130318370|NCT03137992|469132006|FG001|Washout Period 2|Sponsor Decision|0|||
130318371|NCT03137992|469132007|FG002|Washout Period 2|Sponsor Decision|0|||
130318372|NCT03137992|469132008|FG003|Washout Period 2|Sponsor Decision|0|||
130318373|NCT03137992|469132009|FG004|Washout Period 2|Sponsor Decision|0|||
130318374|NCT03137992|469132010|FG005|Washout Period 2|Sponsor Decision|1|||
130318375|NCT03137992|469132005|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
130318376|NCT03137992|469132006|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
130318377|NCT03137992|469132007|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
130318378|NCT03137992|469132008|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
130053211|NCT01429792|468150412|FG000|Overall Study|Withdrawal by Subject|70|||
130053212|NCT01429792|468150412|FG000|Overall Study|Lost to Follow-up|88|||
130053213|NCT04184622|468150414|FG000|Primary Treatment Period|Adverse Event|6|||
130053214|NCT04184622|468150415|FG001|Primary Treatment Period|Adverse Event|4|||
130053215|NCT04184622|468150416|FG002|Primary Treatment Period|Adverse Event|8|||
130053216|NCT04184622|468150417|FG003|Primary Treatment Period|Adverse Event|6|||
130053217|NCT04184622|468150414|FG000|Primary Treatment Period|Death|4|||
130053218|NCT04184622|468150415|FG001|Primary Treatment Period|Death|4|||
130053219|NCT04184622|468150416|FG002|Primary Treatment Period|Death|2|||
130053220|NCT04184622|468150417|FG003|Primary Treatment Period|Death|1|||
130053221|NCT04184622|468150414|FG000|Primary Treatment Period|Lost to Follow-up|41|||
130053222|NCT04184622|468150415|FG001|Primary Treatment Period|Lost to Follow-up|17|||
130053223|NCT04184622|468150416|FG002|Primary Treatment Period|Lost to Follow-up|15|||
130053224|NCT04184622|468150417|FG003|Primary Treatment Period|Lost to Follow-up|13|||
130053225|NCT04184622|468150414|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
129800755|NCT01897714|467239839|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
130053226|NCT04184622|468150415|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
130053227|NCT04184622|468150416|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
130053228|NCT04184622|468150417|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
130053229|NCT04184622|468150414|FG000|Primary Treatment Period|Physician Decision|0|||
130053230|NCT04184622|468150415|FG001|Primary Treatment Period|Physician Decision|0|||
130053231|NCT04184622|468150416|FG002|Primary Treatment Period|Physician Decision|3|||
130053232|NCT04184622|468150417|FG003|Primary Treatment Period|Physician Decision|1|||
130053233|NCT04184622|468150414|FG000|Primary Treatment Period|Pregnancy|4|||
129800756|NCT01897714|467239840|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
129800757|NCT01897714|467239841|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
129800758|NCT01897714|467239842|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
129800759|NCT01897714|467239837|FG000|Phase II (MTD)|Other|0|||
129800760|NCT01897714|467239838|FG001|Phase II (MTD)|Other|0|||
129800761|NCT01897714|467239839|FG002|Phase II (MTD)|Other|0|||
129800762|NCT01897714|467239840|FG003|Phase II (MTD)|Other|0|||
129800763|NCT01897714|467239841|FG004|Phase II (MTD)|Other|3|||
129800764|NCT01897714|467239842|FG005|Phase II (MTD)|Other|0|||
129800765|NCT00423722|467239843|FG000|Overall Study|Death|4|||
129800766|NCT00423722|467239844|FG001|Overall Study|Death|4|||
129800767|NCT00423722|467239843|FG000|Overall Study|Declined to participate|2|||
129800768|NCT00423722|467239844|FG001|Overall Study|Declined to participate|3|||
129800769|NCT00423722|467239843|FG000|Overall Study|Unable to complete questionnaires|4|||
129800770|NCT00423722|467239844|FG001|Overall Study|Unable to complete questionnaires|4|||
129800771|NCT00423722|467239843|FG000|Overall Study|Withdrawal by Subject|4|||
129800772|NCT00423722|467239844|FG001|Overall Study|Withdrawal by Subject|2|||
129800773|NCT01846104|467239849|FG000|Overall Study|Withdrawal by Subject|1|||
129800774|NCT00851630|467239853|FG000|Overall Study|Death|2|||
129800775|NCT00851630|467239854|FG001|Overall Study|Death|1|||
129800776|NCT00851630|467239853|FG000|Overall Study|Clinical failure|0|||
129800777|NCT00851630|467239854|FG001|Overall Study|Clinical failure|1|||
129800778|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
130053234|NCT04184622|468150415|FG001|Primary Treatment Period|Pregnancy|3|||
130053235|NCT04184622|468150416|FG002|Primary Treatment Period|Pregnancy|4|||
130053236|NCT04184622|468150417|FG003|Primary Treatment Period|Pregnancy|1|||
130053237|NCT04184622|468150414|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
130318379|NCT03137992|469132009|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
130318380|NCT03137992|469132010|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
130318381|NCT03137992|469132005|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130318382|NCT03137992|469132006|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
130318383|NCT03137992|469132007|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
130318384|NCT03137992|469132008|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130318385|NCT03137992|469132009|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
130318386|NCT03137992|469132010|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
130318387|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
130318388|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318389|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
130318390|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318391|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318392|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
130318393|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318394|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318395|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318396|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
130318397|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318398|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
130318399|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|Per study team|1|||
130318400|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|Per study team|0|||
130318401|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|Per study team|0|||
130318402|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|Per study team|0|||
130318403|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|Per study team|0|||
130318404|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|Per study team|0|||
130318405|NCT03137992|469132005|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318406|NCT03137992|469132006|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318407|NCT03137992|469132007|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318408|NCT03137992|469132008|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318409|NCT03137992|469132009|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
130318410|NCT03137992|469132010|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
130318411|NCT02370420|469132011|FG000|Overall Study|Physician Decision|3|||
130318412|NCT02370420|469132012|FG001|Overall Study|Physician Decision|3|||
130318413|NCT02370420|469132011|FG000|Overall Study|Lost to Follow-up|11|||
130318414|NCT02370420|469132012|FG001|Overall Study|Lost to Follow-up|9|||
130318415|NCT03077542|469132013|FG000|Overall Study|Death|4|||
130318416|NCT03077542|469132014|FG001|Overall Study|Death|0|||
130318417|NCT03077542|469132013|FG000|Overall Study|Physician Decision|6|||
130318418|NCT03077542|469132014|FG001|Overall Study|Physician Decision|1|||
130318419|NCT03077542|469132013|FG000|Overall Study|Withdrawal by Subject|0|||
130318420|NCT03077542|469132014|FG001|Overall Study|Withdrawal by Subject|1|||
130318421|NCT00795704|469132015|FG000|Overall Study|Withdrawal by Subject|3|||
130318422|NCT00795704|469132016|FG001|Overall Study|Withdrawal by Subject|2|||
130318423|NCT00795704|469132015|FG000|Overall Study|Adverse Event|1|||
130318424|NCT00795704|469132016|FG001|Overall Study|Adverse Event|1|||
130318425|NCT03980730|469132017|FG000|Overall Study|Study Terminated by Sponsor|0|||
130318426|NCT03980730|469132018|FG001|Overall Study|Study Terminated by Sponsor|3|||
130318427|NCT03980730|469132017|FG000|Overall Study|Adverse Event|2|||
130318428|NCT03980730|469132018|FG001|Overall Study|Adverse Event|0|||
130318429|NCT03980730|469132017|FG000|Overall Study|Sponsor Request|0|||
130318430|NCT03980730|469132018|FG001|Overall Study|Sponsor Request|1|||
130318431|NCT01300728|469132019|FG000|Overall Study|Withdrawal by Subject|1|||
130318432|NCT01300728|469132020|FG001|Overall Study|Withdrawal by Subject|1|||
130318433|NCT01300728|469132019|FG000|Overall Study|Physician Decision|1|||
130318434|NCT01300728|469132020|FG001|Overall Study|Physician Decision|0|||
130053238|NCT04184622|468150415|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
129800779|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
130053239|NCT04184622|468150416|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
130318435|NCT00880620|469132023|FG000|Overall Study|Adverse Event|4|||
130318436|NCT00880620|469132024|FG001|Overall Study|Adverse Event|5|||
130318437|NCT00880620|469132025|FG002|Overall Study|Adverse Event|15|||
130318438|NCT00880620|469132026|FG003|Overall Study|Adverse Event|15|||
130318439|NCT00880620|469132023|FG000|Overall Study|Death|0|||
130318440|NCT00880620|469132024|FG001|Overall Study|Death|0|||
130318441|NCT00880620|469132025|FG002|Overall Study|Death|1|||
130318442|NCT00880620|469132026|FG003|Overall Study|Death|0|||
130318443|NCT00880620|469132023|FG000|Overall Study|Lack of Efficacy|12|||
130318444|NCT00880620|469132024|FG001|Overall Study|Lack of Efficacy|4|||
130318445|NCT00880620|469132025|FG002|Overall Study|Lack of Efficacy|0|||
130318446|NCT00880620|469132026|FG003|Overall Study|Lack of Efficacy|1|||
130318447|NCT00880620|469132023|FG000|Overall Study|Lost to Follow-up|0|||
130318448|NCT00880620|469132024|FG001|Overall Study|Lost to Follow-up|1|||
130318449|NCT00880620|469132025|FG002|Overall Study|Lost to Follow-up|1|||
130318450|NCT00880620|469132026|FG003|Overall Study|Lost to Follow-up|0|||
130318451|NCT00880620|469132023|FG000|Overall Study|Protocol Violation|0|||
130318452|NCT00880620|469132024|FG001|Overall Study|Protocol Violation|1|||
130318453|NCT00880620|469132025|FG002|Overall Study|Protocol Violation|0|||
130318454|NCT00880620|469132026|FG003|Overall Study|Protocol Violation|2|||
130318455|NCT00880620|469132023|FG000|Overall Study|Withdrawal by Subject|4|||
130318456|NCT00880620|469132024|FG001|Overall Study|Withdrawal by Subject|3|||
130318457|NCT00880620|469132025|FG002|Overall Study|Withdrawal by Subject|1|||
130318458|NCT00880620|469132026|FG003|Overall Study|Withdrawal by Subject|3|||
130318459|NCT00880620|469132023|FG000|Overall Study|Noncompliance|0|||
130318460|NCT00880620|469132024|FG001|Overall Study|Noncompliance|0|||
130318461|NCT00880620|469132025|FG002|Overall Study|Noncompliance|1|||
130318462|NCT00880620|469132026|FG003|Overall Study|Noncompliance|1|||
130318463|NCT00880620|469132023|FG000|Overall Study|Other|1|||
130318464|NCT00880620|469132024|FG001|Overall Study|Other|1|||
130318465|NCT00880620|469132025|FG002|Overall Study|Other|2|||
130318466|NCT00880620|469132026|FG003|Overall Study|Other|2|||
130318467|NCT00301808|469132028|FG000|Overall Study|Adverse Event|5|||
130318468|NCT00301808|469132028|FG000|Overall Study|Death|3|||
130318469|NCT00301808|469132028|FG000|Overall Study|Lack of Efficacy|4|||
130318470|NCT05893862|469132035|FG000|Overall Study|Physician Decision|0|||
130318471|NCT05893862|469132036|FG001|Overall Study|Physician Decision|1|||
130318472|NCT05893862|469132037|FG002|Overall Study|Physician Decision|0|||
130318473|NCT05893862|469132038|FG003|Overall Study|Physician Decision|0|||
130318474|NCT05893862|469132039|FG004|Overall Study|Physician Decision|1|||
130318475|NCT05893862|469132040|FG005|Overall Study|Physician Decision|0|||
130318476|NCT05893862|469132035|FG000|Overall Study|Withdrawal by Subject|1|||
130318477|NCT05893862|469132036|FG001|Overall Study|Withdrawal by Subject|7|||
130318478|NCT05893862|469132037|FG002|Overall Study|Withdrawal by Subject|1|||
130318479|NCT05893862|469132038|FG003|Overall Study|Withdrawal by Subject|3|||
130318480|NCT05893862|469132039|FG004|Overall Study|Withdrawal by Subject|3|||
130318481|NCT05893862|469132040|FG005|Overall Study|Withdrawal by Subject|2|||
130318482|NCT05893862|469132035|FG000|Overall Study|Adverse Event|1|||
130318483|NCT05893862|469132036|FG001|Overall Study|Adverse Event|4|||
130318484|NCT05893862|469132037|FG002|Overall Study|Adverse Event|2|||
130318485|NCT05893862|469132038|FG003|Overall Study|Adverse Event|2|||
130318486|NCT05893862|469132039|FG004|Overall Study|Adverse Event|1|||
130318487|NCT05893862|469132040|FG005|Overall Study|Adverse Event|0|||
130318488|NCT02919761|469132041|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
130318489|NCT02919761|469132042|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
130318490|NCT02919761|469132043|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
130318491|NCT02919761|469132041|FG000|Part 1: Open Label|Adverse Event|1|||
130318492|NCT02919761|469132042|FG001|Part 1: Open Label|Adverse Event|0|||
130318493|NCT02919761|469132043|FG002|Part 1: Open Label|Adverse Event|0|||
130318494|NCT02919761|469132041|FG000|Part 1: Open Label|Lost to Follow-up|1|||
130318495|NCT02919761|469132042|FG001|Part 1: Open Label|Lost to Follow-up|0|||
130318496|NCT02919761|469132043|FG002|Part 1: Open Label|Lost to Follow-up|0|||
130318497|NCT02919761|469132041|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
130318498|NCT02919761|469132042|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
130318499|NCT02919761|469132043|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
130318500|NCT02919761|469132041|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
130318501|NCT02919761|469132042|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
130318502|NCT02919761|469132043|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
130318503|NCT02919761|469132041|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
130318504|NCT02919761|469132042|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
130318505|NCT02919761|469132043|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
130318506|NCT02919761|469132041|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
130318507|NCT02919761|469132042|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
130318508|NCT02919761|469132043|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
130318509|NCT02919761|469132041|FG000|Part 1: Open Label|Termination by Sponsor|1|||
130318510|NCT02919761|469132042|FG001|Part 1: Open Label|Termination by Sponsor|0|||
130318511|NCT02919761|469132043|FG002|Part 1: Open Label|Termination by Sponsor|0|||
130318512|NCT02919761|469132041|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
130318513|NCT02919761|469132042|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
130318514|NCT02919761|469132043|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
130318515|NCT02919761|469132041|FG000|Part 2: Double-blind|Adverse Event|0|||
130318516|NCT02919761|469132042|FG001|Part 2: Double-blind|Adverse Event|1|||
130318517|NCT02919761|469132043|FG002|Part 2: Double-blind|Adverse Event|0|||
130318518|NCT02919761|469132041|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
130318519|NCT02919761|469132042|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
130318520|NCT02919761|469132043|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
130318521|NCT02919761|469132041|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
130318522|NCT02919761|469132042|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
130318523|NCT02919761|469132043|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
130318524|NCT02919761|469132041|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
130318525|NCT02919761|469132042|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
130318526|NCT02919761|469132043|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
130318527|NCT02919761|469132041|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
130318528|NCT02919761|469132042|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
130318529|NCT02919761|469132043|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
130318530|NCT02919761|469132041|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
130318531|NCT02919761|469132042|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
130318532|NCT02919761|469132043|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
130318533|NCT02919761|469132041|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
130318534|NCT02919761|469132042|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
130318535|NCT02919761|469132043|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
130318536|NCT02429830|469132046|FG000|Overall Study|Lost to Follow-up|1|||
130318537|NCT02429830|469132046|FG000|Overall Study|Device Explant|2|||
130053240|NCT04184622|468150417|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
130053241|NCT04184622|468150414|FG000|Additional Treatment Period|Adverse Event|1|||
130053242|NCT04184622|468150415|FG001|Additional Treatment Period|Adverse Event|2|||
130053243|NCT04184622|468150416|FG002|Additional Treatment Period|Adverse Event|1|||
130053244|NCT04184622|468150417|FG003|Additional Treatment Period|Adverse Event|0|||
130053245|NCT04184622|468150414|FG000|Additional Treatment Period|Death|0|||
129800780|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
129800781|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
129800782|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
129800783|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
129800784|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
129800785|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
129800786|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
129800787|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
129800788|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
129800789|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
129891282|NCT00162942|467559698|FG001|Overall Study|Death|0|||
130111155|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
130053246|NCT04184622|468150415|FG001|Additional Treatment Period|Death|0|||
130053247|NCT04184622|468150416|FG002|Additional Treatment Period|Death|1|||
130053248|NCT04184622|468150417|FG003|Additional Treatment Period|Death|1|||
130053249|NCT04184622|468150414|FG000|Additional Treatment Period|Lost to Follow-up|6|||
130053250|NCT04184622|468150415|FG001|Additional Treatment Period|Lost to Follow-up|4|||
130053251|NCT04184622|468150416|FG002|Additional Treatment Period|Lost to Follow-up|8|||
130053252|NCT04184622|468150417|FG003|Additional Treatment Period|Lost to Follow-up|6|||
130053253|NCT04184622|468150414|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
130053254|NCT04184622|468150415|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
130053255|NCT04184622|468150416|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
130053256|NCT04184622|468150417|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
130053257|NCT04184622|468150414|FG000|Additional Treatment Period|Physician Decision|0|||
130053258|NCT04184622|468150415|FG001|Additional Treatment Period|Physician Decision|0|||
130053259|NCT04184622|468150416|FG002|Additional Treatment Period|Physician Decision|1|||
130053260|NCT04184622|468150417|FG003|Additional Treatment Period|Physician Decision|0|||
130053261|NCT04184622|468150414|FG000|Additional Treatment Period|Pregnancy|0|||
130053262|NCT04184622|468150415|FG001|Additional Treatment Period|Pregnancy|0|||
130053263|NCT04184622|468150416|FG002|Additional Treatment Period|Pregnancy|0|||
130053264|NCT04184622|468150417|FG003|Additional Treatment Period|Pregnancy|1|||
130053265|NCT04184622|468150414|FG000|Additional Treatment Period|Protocol deviation|0|||
130111156|NCT00528879|468367576|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
129800790|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
129800791|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
129800792|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
129800793|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
129800794|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
129800795|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
129800796|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
129800797|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
129800798|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
129800799|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
129800800|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
129800801|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
129800802|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
129800803|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
129800804|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
129800805|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
129800806|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
129800807|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
129800808|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
129800809|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
129800810|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
129800811|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
129800812|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
129800813|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
129800814|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
129800815|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
129800816|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
129800817|NCT00398411|467239859|FG000|Overall Study|Death|0|||
129800818|NCT00398411|467239860|FG001|Overall Study|Death|1|||
129800819|NCT02095223|467239861|FG000|Overall Study|Withdrawal by Subject|1|||
129800820|NCT02095223|467239862|FG001|Overall Study|Withdrawal by Subject|0|||
129800821|NCT02339285|467239863|FG000|Overall Study|Withdrawal by Subject|0|||
129800822|NCT02339285|467239864|FG001|Overall Study|Withdrawal by Subject|1|||
129800823|NCT02339285|467239865|FG002|Overall Study|Withdrawal by Subject|1|||
129800824|NCT02339285|467239863|FG000|Overall Study|Lost to Follow-up|1|||
129800825|NCT02339285|467239864|FG001|Overall Study|Lost to Follow-up|1|||
129800826|NCT02339285|467239865|FG002|Overall Study|Lost to Follow-up|1|||
129800827|NCT02339285|467239863|FG000|Overall Study|Protocol Deviation|0|||
129800828|NCT02339285|467239864|FG001|Overall Study|Protocol Deviation|1|||
129800829|NCT02339285|467239865|FG002|Overall Study|Protocol Deviation|0|||
129800830|NCT01507298|467239866|FG000|Overall Study|Protocol Violation|0|||
129800831|NCT01507298|467239867|FG001|Overall Study|Protocol Violation|6|||
129800832|NCT03061097|467239868|FG000|Overall Study|Withdrawal by Subject|0|||
129800833|NCT03061097|467239869|FG001|Overall Study|Withdrawal by Subject|3|||
129800834|NCT03911713|467239870|FG000|Overall Study|Lost to Follow-up|0|||
129800835|NCT03911713|467239871|FG001|Overall Study|Lost to Follow-up|2|||
129800836|NCT03911713|467239872|FG002|Overall Study|Lost to Follow-up|0|||
129800837|NCT03911713|467239873|FG003|Overall Study|Lost to Follow-up|0|||
129800838|NCT03911713|467239874|FG004|Overall Study|Lost to Follow-up|0|||
129800839|NCT03911713|467239870|FG000|Overall Study|Other|0|||
129800840|NCT03911713|467239871|FG001|Overall Study|Other|0|||
129800841|NCT03911713|467239872|FG002|Overall Study|Other|0|||
129800842|NCT03911713|467239873|FG003|Overall Study|Other|1|||
129800843|NCT03911713|467239874|FG004|Overall Study|Other|0|||
129800844|NCT03911713|467239870|FG000|Overall Study|Randomized, Never Dosed|1|||
129800845|NCT03911713|467239871|FG001|Overall Study|Randomized, Never Dosed|0|||
129800846|NCT03911713|467239872|FG002|Overall Study|Randomized, Never Dosed|0|||
129800847|NCT03911713|467239873|FG003|Overall Study|Randomized, Never Dosed|1|||
129800848|NCT03911713|467239874|FG004|Overall Study|Randomized, Never Dosed|0|||
129800849|NCT01614600|467239875|FG000|Overall Study|Unacceptable fit|1|||
129800850|NCT01614600|467239875|FG000|Overall Study|Discomfort|1|||
129800851|NCT01614600|467239875|FG000|Overall Study|Unable to remove lens at the end of day|1|||
129800852|NCT01614600|467239875|FG000|Overall Study|Protocol deviation|1|||
129800853|NCT02437513|467239876|FG000|Overall Study|Withdrawal by Subject|2|||
129800854|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
129800855|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
129800856|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
129800857|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
129800858|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
129800859|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
129800860|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
129800861|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
129800862|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
129800863|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
129800864|NCT03347188|467239877|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
129800865|NCT03347188|467239878|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
129800866|NCT03347188|467239877|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
129800867|NCT03347188|467239878|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
129800868|NCT03347188|467239877|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
129800869|NCT03347188|467239878|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
129800870|NCT01845818|467239879|FG000|Overall Study|Withdrawal by Subject|0|||
129800871|NCT01845818|467239880|FG001|Overall Study|Withdrawal by Subject|1|||
129800872|NCT01845818|467239879|FG000|Overall Study|Lost to Follow-up|7|||
129800873|NCT01845818|467239880|FG001|Overall Study|Lost to Follow-up|5|||
129800874|NCT01845818|467239879|FG000|Overall Study|Administrative Reasons|3|||
129800875|NCT01845818|467239880|FG001|Overall Study|Administrative Reasons|1|||
129800876|NCT01845818|467239879|FG000|Overall Study|Serious Adverse Event|1|||
129800877|NCT01845818|467239880|FG001|Overall Study|Serious Adverse Event|1|||
129800878|NCT01845818|467239879|FG000|Overall Study|Other|25|||
129800879|NCT01845818|467239880|FG001|Overall Study|Other|8|||
129800880|NCT01845818|467239879|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
129800881|NCT01845818|467239880|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
129800882|NCT01845818|467239879|FG000|Overall Study|No Follow-Up Data Available|4|||
129800883|NCT01845818|467239880|FG001|Overall Study|No Follow-Up Data Available|1|||
129800884|NCT02186873|467239881|FG000|Overall Study|Adverse Event|1|||
129800885|NCT02186873|467239882|FG001|Overall Study|Adverse Event|3|||
129800886|NCT02186873|467239881|FG000|Overall Study|Lack of Efficacy|0|||
129800887|NCT02186873|467239882|FG001|Overall Study|Lack of Efficacy|1|||
129800888|NCT02186873|467239881|FG000|Overall Study|Lost to Follow-up|1|||
129800889|NCT02186873|467239882|FG001|Overall Study|Lost to Follow-up|2|||
129800890|NCT02186873|467239881|FG000|Overall Study|Withdrawal by Subject|7|||
129800891|NCT02186873|467239882|FG001|Overall Study|Withdrawal by Subject|2|||
129800892|NCT01680965|467239883|FG000|Overall Study|Death|0|||
129800893|NCT01680965|467239884|FG001|Overall Study|Death|0|||
129800894|NCT01680965|467239885|FG002|Overall Study|Death|0|||
129800895|NCT01680965|467239886|FG003|Overall Study|Death|6|||
129800896|NCT00107783|467239887|FG000|Overall Study|Adverse Event|0|||
129800897|NCT00107783|467239888|FG001|Overall Study|Adverse Event|2|||
129800898|NCT00107783|467239887|FG000|Overall Study|Death|0|||
129800899|NCT00107783|467239888|FG001|Overall Study|Death|1|||
129800900|NCT00107783|467239887|FG000|Overall Study|Withdrawal by Subject|2|||
129800901|NCT00107783|467239888|FG001|Overall Study|Withdrawal by Subject|0|||
129800902|NCT00107783|467239887|FG000|Overall Study|Second hip replacement|1|||
129800903|NCT00107783|467239888|FG001|Overall Study|Second hip replacement|1|||
129800904|NCT02231918|467239890|FG000|Overall Study|Withdrawal by Subject|0|||
129800905|NCT02231918|467239891|FG001|Overall Study|Withdrawal by Subject|1|||
129800906|NCT02231918|467239892|FG002|Overall Study|Withdrawal by Subject|0|||
129800907|NCT02231918|467239890|FG000|Overall Study|Adverse Event|0|||
129800908|NCT02231918|467239891|FG001|Overall Study|Adverse Event|0|||
129800909|NCT02231918|467239892|FG002|Overall Study|Adverse Event|1|||
129800910|NCT00137631|467239893|FG000|Overall Study|Lost to Follow-up|37|||
129800911|NCT00137631|467239894|FG001|Overall Study|Lost to Follow-up|41|||
129800912|NCT01871142|467239897|FG000|Overall Study|Adverse Event|1|||
129800913|NCT00598702|467239906|FG000|Overall Study|Other|0|||
129800914|NCT00598702|467239907|FG001|Overall Study|Other|2|||
129800915|NCT00598702|467239908|FG002|Overall Study|Other|0|||
129800916|NCT00598702|467239909|FG003|Overall Study|Other|0|||
129800917|NCT00598702|467239910|FG004|Overall Study|Other|0|||
129800918|NCT00598702|467239911|FG005|Overall Study|Other|1|||
129800919|NCT00598702|467239912|FG006|Overall Study|Other|0|||
129800920|NCT00598702|467239913|FG007|Overall Study|Other|0|||
129800921|NCT00598702|467239906|FG000|Overall Study|Early discharge from hospital|0|||
129800922|NCT00598702|467239907|FG001|Overall Study|Early discharge from hospital|0|||
129800923|NCT00598702|467239908|FG002|Overall Study|Early discharge from hospital|2|||
129800924|NCT00598702|467239909|FG003|Overall Study|Early discharge from hospital|5|||
129800925|NCT00598702|467239910|FG004|Overall Study|Early discharge from hospital|0|||
129800926|NCT00598702|467239911|FG005|Overall Study|Early discharge from hospital|10|||
130053266|NCT04184622|468150415|FG001|Additional Treatment Period|Protocol deviation|0|||
130111157|NCT00528879|468367577|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
129800927|NCT00598702|467239912|FG006|Overall Study|Early discharge from hospital|1|||
129800928|NCT00598702|467239913|FG007|Overall Study|Early discharge from hospital|0|||
129800929|NCT00598702|467239906|FG000|Overall Study|Adverse Event|0|||
129800930|NCT00598702|467239907|FG001|Overall Study|Adverse Event|0|||
129800931|NCT00598702|467239908|FG002|Overall Study|Adverse Event|0|||
129800932|NCT00598702|467239909|FG003|Overall Study|Adverse Event|1|||
129800933|NCT00598702|467239910|FG004|Overall Study|Adverse Event|0|||
129800934|NCT00598702|467239911|FG005|Overall Study|Adverse Event|0|||
129800935|NCT00598702|467239912|FG006|Overall Study|Adverse Event|0|||
129800936|NCT00598702|467239913|FG007|Overall Study|Adverse Event|0|||
129800937|NCT00598702|467239906|FG000|Overall Study|Withdrawal by Subject|0|||
129800938|NCT00598702|467239907|FG001|Overall Study|Withdrawal by Subject|0|||
129800939|NCT00598702|467239908|FG002|Overall Study|Withdrawal by Subject|0|||
129800940|NCT00598702|467239909|FG003|Overall Study|Withdrawal by Subject|1|||
129800941|NCT00598702|467239910|FG004|Overall Study|Withdrawal by Subject|1|||
129800942|NCT00598702|467239911|FG005|Overall Study|Withdrawal by Subject|0|||
130111158|NCT00528879|468367578|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
130111159|NCT00528879|468367579|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
130111160|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
130111161|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
129800943|NCT00598702|467239912|FG006|Overall Study|Withdrawal by Subject|0|||
130111162|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
130053267|NCT04184622|468150416|FG002|Additional Treatment Period|Protocol deviation|1|||
130053268|NCT04184622|468150417|FG003|Additional Treatment Period|Protocol deviation|0|||
130053269|NCT04184622|468150414|FG000|Additional Treatment Period|Site closed|1|||
130053270|NCT04184622|468150415|FG001|Additional Treatment Period|Site closed|0|||
130053271|NCT04184622|468150416|FG002|Additional Treatment Period|Site closed|1|||
130053272|NCT04184622|468150417|FG003|Additional Treatment Period|Site closed|0|||
130053273|NCT04184622|468150414|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
130053274|NCT04184622|468150415|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
130053275|NCT04184622|468150416|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
130053276|NCT04184622|468150417|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
130053277|NCT04184622|468150414|FG000|Safety Follow-up Period|Adverse Event|6|||
130053278|NCT04184622|468150415|FG001|Safety Follow-up Period|Adverse Event|8|||
130053279|NCT04184622|468150416|FG002|Safety Follow-up Period|Adverse Event|9|||
130053280|NCT04184622|468150417|FG003|Safety Follow-up Period|Adverse Event|16|||
130053281|NCT04184622|468150414|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
130053282|NCT04184622|468150415|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
129800944|NCT00598702|467239913|FG007|Overall Study|Withdrawal by Subject|0|||
129800945|NCT00598702|467239906|FG000|Overall Study|Physician Decision|0|||
129800946|NCT00598702|467239907|FG001|Overall Study|Physician Decision|0|||
129800947|NCT00598702|467239908|FG002|Overall Study|Physician Decision|0|||
129800948|NCT00598702|467239909|FG003|Overall Study|Physician Decision|0|||
129800949|NCT00598702|467239910|FG004|Overall Study|Physician Decision|1|||
129800950|NCT00598702|467239911|FG005|Overall Study|Physician Decision|0|||
129800951|NCT00598702|467239912|FG006|Overall Study|Physician Decision|0|||
129800952|NCT00598702|467239913|FG007|Overall Study|Physician Decision|0|||
129800953|NCT00598702|467239906|FG000|Overall Study|Dose limiting toxicity|0|||
129800954|NCT00598702|467239907|FG001|Overall Study|Dose limiting toxicity|0|||
129800955|NCT00598702|467239908|FG002|Overall Study|Dose limiting toxicity|0|||
129800956|NCT00598702|467239909|FG003|Overall Study|Dose limiting toxicity|1|||
129800957|NCT00598702|467239910|FG004|Overall Study|Dose limiting toxicity|1|||
129800958|NCT00598702|467239911|FG005|Overall Study|Dose limiting toxicity|1|||
129800959|NCT00598702|467239912|FG006|Overall Study|Dose limiting toxicity|0|||
129800960|NCT00598702|467239913|FG007|Overall Study|Dose limiting toxicity|0|||
129800961|NCT02106910|467239914|FG000|Overall Study|Lost to Follow-up|1|||
129800962|NCT02106910|467239915|FG001|Overall Study|Lost to Follow-up|1|||
129800963|NCT01675427|467239918|FG000|Overall Study|Withdrawal by Subject|7|||
129800964|NCT01675427|467239918|FG000|Overall Study|Participant Refused Sample Collection|18|||
129800965|NCT01675427|467239918|FG000|Overall Study|Sample not Collected by Mistake|2|||
130053283|NCT04184622|468150416|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
129800966|NCT01675427|467239918|FG000|Overall Study|Lost to Follow-up|5|||
129800967|NCT01675427|467239918|FG000|Overall Study|Other|2|||
129800968|NCT00700570|467239919|FG000|Overall Study|Adverse Event|2|||
129800969|NCT00700570|467239920|FG001|Overall Study|Adverse Event|6|||
129800970|NCT00700570|467239919|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
129800971|NCT00700570|467239920|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
129800972|NCT00700570|467239919|FG000|Overall Study|Disease Progression|8|||
129800973|NCT00700570|467239920|FG001|Overall Study|Disease Progression|11|||
129800974|NCT00700570|467239919|FG000|Overall Study|Withdrawal by Subject|1|||
129800975|NCT00700570|467239920|FG001|Overall Study|Withdrawal by Subject|6|||
129800976|NCT00611533|467239921|FG000|First Intervention (6 Weeks)|Never started study|0|||
129800977|NCT00611533|467239922|FG001|First Intervention (6 Weeks)|Never started study|1|||
129800978|NCT00611533|467239921|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
129800979|NCT00611533|467239922|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129800980|NCT00611533|467239921|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129800981|NCT00611533|467239922|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
129800982|NCT04327674|467239929|FG000|Overall Study|Protocol Violation|19|||
129800983|NCT01461980|467239930|FG000|Overall Study|Other|9|||
129800984|NCT01461980|467239931|FG001|Overall Study|Other|8|||
129800985|NCT01461980|467239932|FG002|Overall Study|Other|6|||
129800986|NCT01461980|467239930|FG000|Overall Study|Medication error|7|||
129800987|NCT01461980|467239931|FG001|Overall Study|Medication error|5|||
129800988|NCT01461980|467239932|FG002|Overall Study|Medication error|6|||
129800989|NCT01461980|467239930|FG000|Overall Study|Adverse Event|12|||
129800990|NCT01461980|467239931|FG001|Overall Study|Adverse Event|5|||
129800991|NCT01461980|467239932|FG002|Overall Study|Adverse Event|6|||
129800992|NCT01461980|467239930|FG000|Overall Study|Protocol Violation|12|||
129800993|NCT01461980|467239931|FG001|Overall Study|Protocol Violation|19|||
129800994|NCT01461980|467239932|FG002|Overall Study|Protocol Violation|16|||
129800995|NCT01461980|467239930|FG000|Overall Study|No longer meets eligibility criteria|18|||
129800996|NCT01461980|467239931|FG001|Overall Study|No longer meets eligibility criteria|9|||
129800997|NCT01461980|467239932|FG002|Overall Study|No longer meets eligibility criteria|19|||
129800998|NCT01461980|467239930|FG000|Overall Study|Lost to Follow-up|52|||
129800999|NCT01461980|467239931|FG001|Overall Study|Lost to Follow-up|53|||
129801000|NCT01461980|467239932|FG002|Overall Study|Lost to Follow-up|51|||
129801001|NCT01461980|467239930|FG000|Overall Study|No longer willing to participate|52|||
129801002|NCT01461980|467239931|FG001|Overall Study|No longer willing to participate|38|||
129801003|NCT01461980|467239932|FG002|Overall Study|No longer willing to participate|54|||
129801004|NCT01461980|467239930|FG000|Overall Study|Randomized but not vaccinated|4|||
129801005|NCT01461980|467239931|FG001|Overall Study|Randomized but not vaccinated|8|||
129801006|NCT01461980|467239932|FG002|Overall Study|Randomized but not vaccinated|7|||
129801007|NCT01938573|467239936|FG000|Overall Study|Lack of Efficacy|1|||
129801008|NCT01938573|467239937|FG001|Overall Study|Lack of Efficacy|0|||
129801009|NCT01938573|467239936|FG000|Overall Study|Operation at other hospital|1|||
129801010|NCT01938573|467239937|FG001|Overall Study|Operation at other hospital|0|||
129801011|NCT01199731|467239941|FG000|Overall Study|Adverse Event|0|||
129801012|NCT01199731|467239942|FG001|Overall Study|Adverse Event|1|||
129801013|NCT01199731|467239943|FG002|Overall Study|Adverse Event|0|||
129801014|NCT01199731|467239941|FG000|Overall Study|Study closed/terminated|7|||
129801015|NCT01199731|467239942|FG001|Overall Study|Study closed/terminated|9|||
129801016|NCT01199731|467239943|FG002|Overall Study|Study closed/terminated|7|||
129801017|NCT01199731|467239941|FG000|Overall Study|Lost to Follow-up|0|||
129801018|NCT01199731|467239942|FG001|Overall Study|Lost to Follow-up|0|||
129801019|NCT01199731|467239943|FG002|Overall Study|Lost to Follow-up|2|||
129801020|NCT01199731|467239941|FG000|Overall Study|Physician Decision|0|||
129801021|NCT01199731|467239942|FG001|Overall Study|Physician Decision|1|||
129801022|NCT01199731|467239943|FG002|Overall Study|Physician Decision|1|||
129801023|NCT01199731|467239941|FG000|Overall Study|Withdrawal by Subject|2|||
129801024|NCT01199731|467239942|FG001|Overall Study|Withdrawal by Subject|0|||
129801025|NCT01199731|467239943|FG002|Overall Study|Withdrawal by Subject|0|||
130111163|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
130111164|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
130111165|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
130111166|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
129801026|NCT00943124|467239944|FG000|Period 1|Withdrawal by Subject|1|||
129801027|NCT00943124|467239945|FG001|Period 1|Withdrawal by Subject|1|||
129801028|NCT00943124|467239944|FG000|Period 1|Did Not Follow Study Procedures|1|||
129801029|NCT00943124|467239945|FG001|Period 1|Did Not Follow Study Procedures|0|||
129801030|NCT00943124|467239944|FG000|Period 1|Personal Reasons|0|||
129801031|NCT00943124|467239945|FG001|Period 1|Personal Reasons|1|||
129801032|NCT02448810|467239947|FG000|Overall Study|Adverse Event|0|||
129801033|NCT02448810|467239948|FG001|Overall Study|Adverse Event|0|||
129801034|NCT02448810|467239949|FG002|Overall Study|Adverse Event|1|||
129801035|NCT02448810|467239950|FG003|Overall Study|Adverse Event|0|||
129801036|NCT02448810|467239951|FG004|Overall Study|Adverse Event|0|||
129801037|NCT02448810|467239952|FG005|Overall Study|Adverse Event|0|||
129801038|NCT02448810|467239953|FG006|Overall Study|Adverse Event|0|||
129801039|NCT02448810|467239954|FG007|Overall Study|Adverse Event|0|||
129801040|NCT02448810|467239947|FG000|Overall Study|Withdrawal by Subject|0|||
129801041|NCT02448810|467239948|FG001|Overall Study|Withdrawal by Subject|0|||
130111167|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
130053284|NCT04184622|468150417|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
130053285|NCT04184622|468150414|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
130053286|NCT04184622|468150415|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
129801042|NCT02448810|467239949|FG002|Overall Study|Withdrawal by Subject|1|||
129801043|NCT02448810|467239950|FG003|Overall Study|Withdrawal by Subject|0|||
129801044|NCT02448810|467239951|FG004|Overall Study|Withdrawal by Subject|3|||
129801045|NCT02448810|467239952|FG005|Overall Study|Withdrawal by Subject|5|||
129801046|NCT02448810|467239953|FG006|Overall Study|Withdrawal by Subject|0|||
129801047|NCT02448810|467239954|FG007|Overall Study|Withdrawal by Subject|2|||
129801048|NCT02448810|467239947|FG000|Overall Study|Other (study terminated by sponsor)|0|||
129801049|NCT02448810|467239948|FG001|Overall Study|Other (study terminated by sponsor)|0|||
129801050|NCT02448810|467239949|FG002|Overall Study|Other (study terminated by sponsor)|0|||
129801051|NCT02448810|467239950|FG003|Overall Study|Other (study terminated by sponsor)|0|||
129801052|NCT02448810|467239951|FG004|Overall Study|Other (study terminated by sponsor)|4|||
129801053|NCT02448810|467239952|FG005|Overall Study|Other (study terminated by sponsor)|2|||
129801054|NCT02448810|467239953|FG006|Overall Study|Other (study terminated by sponsor)|2|||
129801055|NCT02448810|467239954|FG007|Overall Study|Other (study terminated by sponsor)|1|||
129801056|NCT02448810|467239947|FG000|Overall Study|Death|1|||
129801057|NCT02448810|467239948|FG001|Overall Study|Death|0|||
129801058|NCT02448810|467239949|FG002|Overall Study|Death|1|||
129801059|NCT02448810|467239950|FG003|Overall Study|Death|0|||
129801060|NCT02448810|467239951|FG004|Overall Study|Death|1|||
129801061|NCT02448810|467239952|FG005|Overall Study|Death|0|||
129801062|NCT02448810|467239953|FG006|Overall Study|Death|0|||
129801063|NCT02448810|467239954|FG007|Overall Study|Death|0|||
129801064|NCT02448810|467239947|FG000|Overall Study|Other (Progressive disease)|2|||
129801065|NCT02448810|467239948|FG001|Overall Study|Other (Progressive disease)|2|||
129801066|NCT02448810|467239949|FG002|Overall Study|Other (Progressive disease)|0|||
130053287|NCT04184622|468150416|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
130053288|NCT04184622|468150417|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
129801067|NCT02448810|467239950|FG003|Overall Study|Other (Progressive disease)|3|||
129801068|NCT02448810|467239951|FG004|Overall Study|Other (Progressive disease)|23|||
129801069|NCT02448810|467239952|FG005|Overall Study|Other (Progressive disease)|9|||
129801070|NCT02448810|467239953|FG006|Overall Study|Other (Progressive disease)|14|||
129801071|NCT02448810|467239954|FG007|Overall Study|Other (Progressive disease)|5|||
129801072|NCT02448810|467239947|FG000|Overall Study|Lost to Follow-up|0|||
129801073|NCT02448810|467239948|FG001|Overall Study|Lost to Follow-up|1|||
129801074|NCT02448810|467239949|FG002|Overall Study|Lost to Follow-up|0|||
129801075|NCT02448810|467239950|FG003|Overall Study|Lost to Follow-up|0|||
129801076|NCT02448810|467239951|FG004|Overall Study|Lost to Follow-up|0|||
129801077|NCT02448810|467239952|FG005|Overall Study|Lost to Follow-up|0|||
129801078|NCT02448810|467239953|FG006|Overall Study|Lost to Follow-up|0|||
129801079|NCT02448810|467239954|FG007|Overall Study|Lost to Follow-up|0|||
129801080|NCT02448810|467239947|FG000|Overall Study|Other (unspecified)|0|||
129801081|NCT02448810|467239948|FG001|Overall Study|Other (unspecified)|0|||
129801082|NCT02448810|467239949|FG002|Overall Study|Other (unspecified)|0|||
129801083|NCT02448810|467239950|FG003|Overall Study|Other (unspecified)|0|||
129801084|NCT02448810|467239951|FG004|Overall Study|Other (unspecified)|0|||
129801085|NCT02448810|467239952|FG005|Overall Study|Other (unspecified)|0|||
129801086|NCT02448810|467239953|FG006|Overall Study|Other (unspecified)|2|||
129801087|NCT02448810|467239954|FG007|Overall Study|Other (unspecified)|0|||
129801088|NCT00470847|467239957|FG000|Overall Study|Pt still receiving treatment|1|||
129801089|NCT01912963|467239964|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
129801090|NCT01912963|467239965|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
129801091|NCT01912963|467239966|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
129801092|NCT01912963|467239964|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
129801093|NCT01912963|467239965|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
129801094|NCT01912963|467239966|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
129801095|NCT01912963|467239964|FG000|Overall Study|Adverse Event|0|||
129801096|NCT01912963|467239965|FG001|Overall Study|Adverse Event|1|||
129801097|NCT01912963|467239966|FG002|Overall Study|Adverse Event|1|||
129801098|NCT01912963|467239964|FG000|Overall Study|Withdrawal by Subject|0|||
129801099|NCT01912963|467239965|FG001|Overall Study|Withdrawal by Subject|1|||
129801100|NCT01912963|467239966|FG002|Overall Study|Withdrawal by Subject|0|||
129801101|NCT01912963|467239964|FG000|Overall Study|Sought treatment locally|0|||
129801102|NCT01912963|467239965|FG001|Overall Study|Sought treatment locally|1|||
129801103|NCT01912963|467239966|FG002|Overall Study|Sought treatment locally|0|||
129801104|NCT01147172|467239970|FG000|Overall Study|Withdrawal by Subject|2|||
129801105|NCT01147172|467239970|FG000|Overall Study|Lost to Follow-up|2|||
129801106|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Adverse Event|10|||
129801107|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Adverse Event|0|||
129801108|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
129801109|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
129801110|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
129801111|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
130053289|NCT04184622|468150414|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
130053290|NCT04184622|468150415|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
129801112|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
129801113|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
129801114|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
129801115|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
129801116|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Other than specified|3|||
129801117|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Other than specified|1|||
129801118|NCT02787551|467239971|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
129801119|NCT02787551|467239972|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
129801120|NCT02787551|467239971|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
129801121|NCT02787551|467239972|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
129801122|NCT02787551|467239971|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
129801123|NCT02787551|467239972|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
129801124|NCT03112590|467239974|FG000|Overall Study|Adverse Event|0|||
129801125|NCT03112590|467239975|FG001|Overall Study|Adverse Event|1|||
129801126|NCT03112590|467239976|FG002|Overall Study|Adverse Event|0|||
129801127|NCT05156073|467239977|FG000|Overall Study|Patient canceled appointment with PCP|1|||
129801128|NCT02734433|467239978|FG000|Overall Study|Disease progression|1|||
129801129|NCT02734433|467239979|FG001|Overall Study|Disease progression|5|||
129801130|NCT02734433|467239978|FG000|Overall Study|Clinical progression|0|||
130053291|NCT04184622|468150416|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
130053292|NCT04184622|468150417|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
129801131|NCT02734433|467239979|FG001|Overall Study|Clinical progression|1|||
130111168|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
129801132|NCT02734433|467239978|FG000|Overall Study|Withdrawal by Subject|1|||
129801133|NCT02734433|467239979|FG001|Overall Study|Withdrawal by Subject|2|||
129801134|NCT03805646|467239981|FG000|Overall Study|Death|40|||
129801135|NCT03805646|467239982|FG001|Overall Study|Death|49|||
129801136|NCT03805646|467239981|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
129801137|NCT03805646|467239982|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
129801138|NCT05521906|467239983|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
129801139|NCT05521906|467239984|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
129801140|NCT00891462|467241929|FG000|Overall Study|Withdrawal by Subject|9|||
129801141|NCT00891462|467241930|FG001|Overall Study|Withdrawal by Subject|6|||
129801142|NCT00891462|467241931|FG002|Overall Study|Withdrawal by Subject|7|||
129801143|NCT00891462|467241929|FG000|Overall Study|Adverse Event|7|||
129801144|NCT00891462|467241930|FG001|Overall Study|Adverse Event|8|||
129801145|NCT00891462|467241931|FG002|Overall Study|Adverse Event|7|||
129801146|NCT00891462|467241929|FG000|Overall Study|Lack of Efficacy|10|||
129801147|NCT00891462|467241930|FG001|Overall Study|Lack of Efficacy|5|||
129801148|NCT00891462|467241931|FG002|Overall Study|Lack of Efficacy|1|||
129801149|NCT00891462|467241929|FG000|Overall Study|COPD exacerbation|7|||
129801150|NCT00891462|467241930|FG001|Overall Study|COPD exacerbation|4|||
129801151|NCT00891462|467241931|FG002|Overall Study|COPD exacerbation|1|||
129801152|NCT00891462|467241929|FG000|Overall Study|Other Reason|2|||
129801153|NCT00891462|467241930|FG001|Overall Study|Other Reason|5|||
129801154|NCT00891462|467241931|FG002|Overall Study|Other Reason|3|||
129801155|NCT00891462|467241929|FG000|Overall Study|Protocol Violation|2|||
129801156|NCT00891462|467241930|FG001|Overall Study|Protocol Violation|1|||
129801157|NCT00891462|467241931|FG002|Overall Study|Protocol Violation|3|||
129801158|NCT00891462|467241929|FG000|Overall Study|Inclusion/exclusion criteria|0|||
129801159|NCT00891462|467241930|FG001|Overall Study|Inclusion/exclusion criteria|2|||
129801160|NCT00891462|467241931|FG002|Overall Study|Inclusion/exclusion criteria|2|||
129801161|NCT00891462|467241929|FG000|Overall Study|Lost to Follow-up|0|||
129801162|NCT00891462|467241930|FG001|Overall Study|Lost to Follow-up|2|||
129801163|NCT00891462|467241931|FG002|Overall Study|Lost to Follow-up|0|||
129801164|NCT00257608|467241937|FG000|Chemotherapy Phase|Adverse Event|138|||
129801165|NCT00257608|467241938|FG001|Chemotherapy Phase|Adverse Event|0|||
130111169|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
129801166|NCT00257608|467241939|FG002|Chemotherapy Phase|Adverse Event|0|||
129801167|NCT00257608|467241937|FG000|Chemotherapy Phase|Disease progression|139|||
129801168|NCT00257608|467241938|FG001|Chemotherapy Phase|Disease progression|0|||
129801169|NCT00257608|467241939|FG002|Chemotherapy Phase|Disease progression|0|||
129801170|NCT00257608|467241937|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
129801171|NCT00257608|467241938|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
129801172|NCT00257608|467241939|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
129801173|NCT00257608|467241937|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
129801174|NCT00257608|467241938|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
129801175|NCT00257608|467241939|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
129801176|NCT00257608|467241937|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
129801177|NCT00257608|467241938|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
129801178|NCT00257608|467241939|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
129801179|NCT00257608|467241937|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
129801180|NCT00257608|467241938|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801181|NCT00257608|467241939|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801182|NCT00257608|467241937|FG000|Chemotherapy Phase|Physician Decision|28|||
129801183|NCT00257608|467241938|FG001|Chemotherapy Phase|Physician Decision|0|||
129801184|NCT00257608|467241939|FG002|Chemotherapy Phase|Physician Decision|0|||
129801185|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Adverse Event|0|||
129801186|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Adverse Event|34|||
129801187|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Adverse Event|38|||
129801188|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Disease progression|0|||
129801189|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Disease progression|204|||
129801190|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Disease progression|168|||
129801191|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
129801192|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
129801193|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
129801194|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
129801195|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
129801196|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
129801197|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
129801198|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
130111170|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
130111171|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
130111172|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
130111173|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
129801199|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
129801200|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801201|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801202|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
129801203|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
129801204|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
129801205|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
129801206|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Physician Decision|0|||
129801207|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Physician Decision|8|||
129801208|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Physician Decision|11|||
129801209|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
129801210|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
129801211|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
129801212|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Not treated|0|||
129801213|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Not treated|4|||
130111174|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
130111175|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
130111176|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
130111177|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
130111178|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
130111179|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
130111180|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
130111181|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
130111182|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
130111183|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
130111184|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
130111185|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
130111186|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
129801214|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Not treated|7|||
129801215|NCT02171065|467241940|FG000|Overall Study|Withdrawal by Subject|1|||
129801216|NCT02171065|467241941|FG001|Overall Study|Withdrawal by Subject|0|||
129801217|NCT02171065|467241942|FG002|Overall Study|Withdrawal by Subject|0|||
129801218|NCT02171065|467241940|FG000|Overall Study|Lost to Follow-up|0|||
129801219|NCT02171065|467241941|FG001|Overall Study|Lost to Follow-up|0|||
129801220|NCT02171065|467241942|FG002|Overall Study|Lost to Follow-up|1|||
129801221|NCT02598960|467241943|FG000|Treatment Period|Disease Progression|4|||
129801222|NCT02598960|467241944|FG001|Treatment Period|Disease Progression|4|||
129801223|NCT02598960|467241945|FG002|Treatment Period|Disease Progression|4|||
130053293|NCT04184622|468150414|FG000|Safety Follow-up Period|Physician Decision|1|||
130053294|NCT04184622|468150415|FG001|Safety Follow-up Period|Physician Decision|0|||
130053295|NCT04184622|468150416|FG002|Safety Follow-up Period|Physician Decision|0|||
129801224|NCT02598960|467241946|FG003|Treatment Period|Disease Progression|6|||
129801225|NCT02598960|467241947|FG004|Treatment Period|Disease Progression|8|||
130053296|NCT04184622|468150417|FG003|Safety Follow-up Period|Physician Decision|1|||
130053297|NCT04184622|468150414|FG000|Safety Follow-up Period|Pregnancy|1|||
130053298|NCT04184622|468150415|FG001|Safety Follow-up Period|Pregnancy|3|||
130053299|NCT04184622|468150416|FG002|Safety Follow-up Period|Pregnancy|0|||
130053300|NCT04184622|468150417|FG003|Safety Follow-up Period|Pregnancy|6|||
130053301|NCT04184622|468150414|FG000|Safety Follow-up Period|Protocol deviation|1|||
130053302|NCT04184622|468150415|FG001|Safety Follow-up Period|Protocol deviation|0|||
130053303|NCT04184622|468150416|FG002|Safety Follow-up Period|Protocol deviation|0|||
130053304|NCT04184622|468150417|FG003|Safety Follow-up Period|Protocol deviation|0|||
130053305|NCT04184622|468150414|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
129801226|NCT02598960|467241948|FG005|Treatment Period|Disease Progression|2|||
129801227|NCT02598960|467241949|FG006|Treatment Period|Disease Progression|2|||
129801228|NCT02598960|467241950|FG007|Treatment Period|Disease Progression|3|||
129801229|NCT02598960|467241951|FG008|Treatment Period|Disease Progression|7|||
129801230|NCT02598960|467241952|FG009|Treatment Period|Disease Progression|9|||
129801231|NCT02598960|467241953|FG010|Treatment Period|Disease Progression|7|||
129801232|NCT02598960|467241954|FG011|Treatment Period|Disease Progression|143|||
129801233|NCT02598960|467241955|FG012|Treatment Period|Disease Progression|23|||
129801234|NCT02598960|467241943|FG000|Treatment Period|Study drug toxicity|0|||
129801235|NCT02598960|467241944|FG001|Treatment Period|Study drug toxicity|0|||
129801236|NCT02598960|467241945|FG002|Treatment Period|Study drug toxicity|0|||
129801237|NCT02598960|467241946|FG003|Treatment Period|Study drug toxicity|0|||
129801238|NCT02598960|467241947|FG004|Treatment Period|Study drug toxicity|0|||
129801239|NCT02598960|467241948|FG005|Treatment Period|Study drug toxicity|0|||
129801240|NCT02598960|467241949|FG006|Treatment Period|Study drug toxicity|0|||
129801241|NCT02598960|467241950|FG007|Treatment Period|Study drug toxicity|0|||
129801242|NCT02598960|467241951|FG008|Treatment Period|Study drug toxicity|0|||
129801243|NCT02598960|467241952|FG009|Treatment Period|Study drug toxicity|1|||
129801244|NCT02598960|467241953|FG010|Treatment Period|Study drug toxicity|0|||
129801245|NCT02598960|467241954|FG011|Treatment Period|Study drug toxicity|3|||
129801246|NCT02598960|467241955|FG012|Treatment Period|Study drug toxicity|0|||
129801247|NCT02598960|467241943|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
129801248|NCT02598960|467241944|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
129801249|NCT02598960|467241945|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
129801250|NCT02598960|467241946|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
129801251|NCT02598960|467241947|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
129801252|NCT02598960|467241948|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
129801253|NCT02598960|467241949|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
129801254|NCT02598960|467241950|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
129801255|NCT02598960|467241951|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
129801256|NCT02598960|467241952|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
129801257|NCT02598960|467241953|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
129801258|NCT02598960|467241954|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
129801259|NCT02598960|467241955|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
129801260|NCT02598960|467241943|FG000|Treatment Period|participant request to discontinue|0|||
129801261|NCT02598960|467241944|FG001|Treatment Period|participant request to discontinue|1|||
129801262|NCT02598960|467241945|FG002|Treatment Period|participant request to discontinue|0|||
129801263|NCT02598960|467241946|FG003|Treatment Period|participant request to discontinue|0|||
129801264|NCT02598960|467241947|FG004|Treatment Period|participant request to discontinue|1|||
129801265|NCT02598960|467241948|FG005|Treatment Period|participant request to discontinue|0|||
129801266|NCT02598960|467241949|FG006|Treatment Period|participant request to discontinue|0|||
129801267|NCT02598960|467241950|FG007|Treatment Period|participant request to discontinue|0|||
129801268|NCT02598960|467241951|FG008|Treatment Period|participant request to discontinue|0|||
129801269|NCT02598960|467241952|FG009|Treatment Period|participant request to discontinue|0|||
129801270|NCT02598960|467241953|FG010|Treatment Period|participant request to discontinue|1|||
129801271|NCT02598960|467241954|FG011|Treatment Period|participant request to discontinue|4|||
129801272|NCT02598960|467241955|FG012|Treatment Period|participant request to discontinue|0|||
129801273|NCT02598960|467241943|FG000|Treatment Period|participant withdrew consent|0|||
129801274|NCT02598960|467241944|FG001|Treatment Period|participant withdrew consent|0|||
129801275|NCT02598960|467241945|FG002|Treatment Period|participant withdrew consent|0|||
129801276|NCT02598960|467241946|FG003|Treatment Period|participant withdrew consent|0|||
129801277|NCT02598960|467241947|FG004|Treatment Period|participant withdrew consent|0|||
129801278|NCT02598960|467241948|FG005|Treatment Period|participant withdrew consent|0|||
129801279|NCT02598960|467241949|FG006|Treatment Period|participant withdrew consent|0|||
129801280|NCT02598960|467241950|FG007|Treatment Period|participant withdrew consent|0|||
129801281|NCT02598960|467241951|FG008|Treatment Period|participant withdrew consent|0|||
129801282|NCT02598960|467241952|FG009|Treatment Period|participant withdrew consent|0|||
129801283|NCT02598960|467241953|FG010|Treatment Period|participant withdrew consent|0|||
129801284|NCT02598960|467241954|FG011|Treatment Period|participant withdrew consent|3|||
129801285|NCT02598960|467241955|FG012|Treatment Period|participant withdrew consent|0|||
129801286|NCT02598960|467241943|FG000|Treatment Period|No longer meets study criteria|0|||
130053306|NCT04184622|468150415|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
129801287|NCT02598960|467241944|FG001|Treatment Period|No longer meets study criteria|0|||
129801288|NCT02598960|467241945|FG002|Treatment Period|No longer meets study criteria|0|||
129801289|NCT02598960|467241946|FG003|Treatment Period|No longer meets study criteria|0|||
129801290|NCT02598960|467241947|FG004|Treatment Period|No longer meets study criteria|0|||
129801291|NCT02598960|467241948|FG005|Treatment Period|No longer meets study criteria|0|||
129801292|NCT02598960|467241949|FG006|Treatment Period|No longer meets study criteria|0|||
129801293|NCT02598960|467241950|FG007|Treatment Period|No longer meets study criteria|0|||
129801294|NCT02598960|467241951|FG008|Treatment Period|No longer meets study criteria|0|||
129801295|NCT02598960|467241952|FG009|Treatment Period|No longer meets study criteria|0|||
129801296|NCT02598960|467241953|FG010|Treatment Period|No longer meets study criteria|0|||
129801297|NCT02598960|467241954|FG011|Treatment Period|No longer meets study criteria|1|||
129801298|NCT02598960|467241955|FG012|Treatment Period|No longer meets study criteria|0|||
129801299|NCT02598960|467241943|FG000|Treatment Period|Other Reasons|0|||
129801300|NCT02598960|467241944|FG001|Treatment Period|Other Reasons|0|||
129801301|NCT02598960|467241945|FG002|Treatment Period|Other Reasons|0|||
129801302|NCT02598960|467241946|FG003|Treatment Period|Other Reasons|0|||
129801303|NCT02598960|467241947|FG004|Treatment Period|Other Reasons|0|||
129801304|NCT02598960|467241948|FG005|Treatment Period|Other Reasons|0|||
129801305|NCT02598960|467241949|FG006|Treatment Period|Other Reasons|0|||
129801306|NCT02598960|467241950|FG007|Treatment Period|Other Reasons|0|||
130053307|NCT04184622|468150416|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
130053308|NCT04184622|468150417|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
129801307|NCT02598960|467241951|FG008|Treatment Period|Other Reasons|0|||
129801308|NCT02598960|467241952|FG009|Treatment Period|Other Reasons|0|||
129801309|NCT02598960|467241953|FG010|Treatment Period|Other Reasons|0|||
129801310|NCT02598960|467241954|FG011|Treatment Period|Other Reasons|0|||
129801311|NCT02598960|467241955|FG012|Treatment Period|Other Reasons|1|||
129801312|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|Death|1|||
129801313|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|Death|0|||
129801314|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|Death|0|||
129801315|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|Death|0|||
129801316|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|Death|0|||
129801317|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|Death|0|||
129801318|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|Death|0|||
129801319|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|Death|0|||
129801320|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|Death|0|||
129801321|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|Death|1|||
129801322|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|Death|0|||
129801323|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|Death|11|||
129801324|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|Death|2|||
129801325|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801326|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801327|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801328|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801329|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
130053309|NCT01617681|468150418|FG000|Period 1 Double Blind|Adverse Event|2|||
129801330|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801331|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801332|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801333|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801334|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801335|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801336|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
129801337|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801338|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
129801339|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
129801340|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
129801341|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
129801342|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
129801343|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
129801344|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
129801345|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
129801346|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
129801347|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
129801348|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
129801349|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
129801350|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
129801351|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801352|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801353|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801354|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801355|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801356|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801357|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801358|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801359|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801360|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801361|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801362|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
129801363|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801364|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
129801365|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
129801366|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
129801367|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
129801368|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
129801369|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
129801370|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
129801371|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
130053310|NCT01617681|468150419|FG001|Period 1 Double Blind|Adverse Event|0|||
130053311|NCT01617681|468150420|FG002|Period 1 Double Blind|Adverse Event|0|||
130053312|NCT01617681|468150421|FG003|Period 1 Double Blind|Adverse Event|2|||
130053313|NCT01617681|468150422|FG004|Period 1 Double Blind|Adverse Event|0|||
130053314|NCT01617681|468150418|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
129801372|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
129801373|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
129801374|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
129801375|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
129801376|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
129801377|NCT03265665|467241960|FG000|24-week Data Collection|Withdrawal by Subject|2|||
129801378|NCT03265665|467241961|FG001|24-week Data Collection|Withdrawal by Subject|2|||
129801379|NCT03265665|467241960|FG000|24-week Data Collection|Lost to Follow-up|4|||
129801380|NCT03265665|467241961|FG001|24-week Data Collection|Lost to Follow-up|5|||
129801381|NCT03265665|467241960|FG000|36-week Data Collection|Lost to Follow-up|6|||
129801382|NCT03265665|467241961|FG001|36-week Data Collection|Lost to Follow-up|8|||
129801383|NCT01193660|467241962|FG000|Overall Study|Withdrawal by Subject|2|||
129801384|NCT01193660|467241963|FG001|Overall Study|Withdrawal by Subject|3|||
129801385|NCT01193660|467241964|FG002|Overall Study|Withdrawal by Subject|1|||
129801386|NCT01193660|467241962|FG000|Overall Study|Death|1|||
129801387|NCT01193660|467241963|FG001|Overall Study|Death|0|||
129801388|NCT01193660|467241964|FG002|Overall Study|Death|0|||
129801389|NCT01193660|467241962|FG000|Overall Study|Physician Decision|1|||
129801390|NCT01193660|467241963|FG001|Overall Study|Physician Decision|0|||
129801391|NCT01193660|467241964|FG002|Overall Study|Physician Decision|1|||
129801392|NCT00195273|467241965|FG000|Overall Study|Adverse Event|9|||
129801393|NCT00195273|467241966|FG001|Overall Study|Adverse Event|9|||
129801394|NCT00195273|467241965|FG000|Overall Study|Protocol deviation|0|||
129801395|NCT00195273|467241966|FG001|Overall Study|Protocol deviation|1|||
129801396|NCT00195273|467241965|FG000|Overall Study|Lack of Efficacy|3|||
129801397|NCT00195273|467241966|FG001|Overall Study|Lack of Efficacy|1|||
129801398|NCT00195273|467241965|FG000|Overall Study|Procedural complications|9|||
129801399|NCT00195273|467241966|FG001|Overall Study|Procedural complications|3|||
129801400|NCT00595465|467241967|FG000|Overall Study|Adverse Event|4|||
129801401|NCT00595465|467241968|FG001|Overall Study|Adverse Event|3|||
129801402|NCT00595465|467241969|FG002|Overall Study|Adverse Event|3|||
129801403|NCT00595465|467241967|FG000|Overall Study|Pregnancy|0|||
129801404|NCT00595465|467241968|FG001|Overall Study|Pregnancy|0|||
129801405|NCT00595465|467241969|FG002|Overall Study|Pregnancy|1|||
129801406|NCT00595465|467241967|FG000|Overall Study|Protocol Violation|2|||
129801407|NCT00595465|467241968|FG001|Overall Study|Protocol Violation|1|||
129801408|NCT00595465|467241969|FG002|Overall Study|Protocol Violation|0|||
129801409|NCT00595465|467241967|FG000|Overall Study|Lost to Follow-up|0|||
129801410|NCT00595465|467241968|FG001|Overall Study|Lost to Follow-up|0|||
129801411|NCT00595465|467241969|FG002|Overall Study|Lost to Follow-up|2|||
129801412|NCT00595465|467241967|FG000|Overall Study|administrative reason|0|||
129801413|NCT00595465|467241968|FG001|Overall Study|administrative reason|0|||
129801414|NCT00595465|467241969|FG002|Overall Study|administrative reason|1|||
129801415|NCT02595970|467241970|FG000|Overall Study|Withdrawal by Subject|2|||
129801416|NCT02595970|467241970|FG000|Overall Study|Physician Decision|2|||
129801417|NCT02595970|467241970|FG000|Overall Study|Protocol Violation|4|||
129801418|NCT02595970|467241970|FG000|Overall Study|Adverse Event|5|||
129801419|NCT02595970|467241970|FG000|Overall Study|Lack of Efficacy|7|||
130053315|NCT01617681|468150419|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
129801420|NCT04879225|467241971|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
129801421|NCT04879225|467241971|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
129801422|NCT02367131|467241974|FG000|Overall Study|Adverse Event|64|||
129801423|NCT02367131|467241974|FG000|Overall Study|No visit since the first visit|3|||
129801424|NCT02367131|467241974|FG000|Overall Study|Request by patient|53|||
129801425|NCT02367131|467241974|FG000|Overall Study|Improvement/remission|2|||
129801426|NCT02367131|467241974|FG000|Overall Study|No change/progressive disease|78|||
129801427|NCT02367131|467241974|FG000|Overall Study|Other than stated above|20|||
129801428|NCT02367131|467241974|FG000|Overall Study|Not treated|2|||
129801429|NCT02572388|467241975|FG000|Overall Study|Withdrawal by Subject|1|||
129801430|NCT02572388|467241976|FG001|Overall Study|Withdrawal by Subject|1|||
129801431|NCT02572388|467241977|FG002|Overall Study|Withdrawal by Subject|2|||
129801432|NCT02572388|467241978|FG003|Overall Study|Withdrawal by Subject|2|||
129801433|NCT01973569|467241979|FG000|Overall Study|Adverse Event|9|||
129801434|NCT01973569|467241980|FG001|Overall Study|Adverse Event|2|||
129801435|NCT01973569|467241981|FG002|Overall Study|Adverse Event|4|||
129801436|NCT01973569|467241979|FG000|Overall Study|Protocol Violation|2|||
129801437|NCT01973569|467241980|FG001|Overall Study|Protocol Violation|1|||
129801438|NCT01973569|467241981|FG002|Overall Study|Protocol Violation|3|||
129801439|NCT01973569|467241979|FG000|Overall Study|Withdrawal by Subject|7|||
129801440|NCT01973569|467241980|FG001|Overall Study|Withdrawal by Subject|5|||
129801441|NCT01973569|467241981|FG002|Overall Study|Withdrawal by Subject|2|||
129801442|NCT01973569|467241979|FG000|Overall Study|Invasive dental treatment|3|||
129801443|NCT01973569|467241980|FG001|Overall Study|Invasive dental treatment|5|||
129801444|NCT01973569|467241981|FG002|Overall Study|Invasive dental treatment|6|||
129801445|NCT01973569|467241979|FG000|Overall Study|Prohibited concomitant d|1|||
129801446|NCT01973569|467241980|FG001|Overall Study|Prohibited concomitant d|5|||
129801447|NCT01973569|467241981|FG002|Overall Study|Prohibited concomitant d|0|||
129801448|NCT01973569|467241979|FG000|Overall Study|Disease progression|0|||
129801449|NCT01973569|467241980|FG001|Overall Study|Disease progression|3|||
129801450|NCT01973569|467241981|FG002|Overall Study|Disease progression|0|||
129801451|NCT01973569|467241979|FG000|Overall Study|Other|1|||
129801452|NCT01973569|467241980|FG001|Overall Study|Other|1|||
129801453|NCT01973569|467241981|FG002|Overall Study|Other|0|||
129801454|NCT01973569|467241979|FG000|Overall Study|Did not receive study drug|6|||
129801455|NCT01973569|467241980|FG001|Overall Study|Did not receive study drug|3|||
129801456|NCT01973569|467241981|FG002|Overall Study|Did not receive study drug|3|||
129801457|NCT01051466|467241984|FG000|Overall Study|Adverse Event|1|||
129801458|NCT01051466|467241985|FG001|Overall Study|Adverse Event|0|||
129801459|NCT01051466|467241984|FG000|Overall Study|Lost to Follow-up|1|||
129801460|NCT01051466|467241985|FG001|Overall Study|Lost to Follow-up|1|||
129801461|NCT01051466|467241984|FG000|Overall Study|Withdrawal by Subject|5|||
129801462|NCT01051466|467241985|FG001|Overall Study|Withdrawal by Subject|1|||
129801463|NCT01051466|467241984|FG000|Overall Study|Entry Criteria Not Met|0|||
129801464|NCT01051466|467241985|FG001|Overall Study|Entry Criteria Not Met|3|||
129801465|NCT01051466|467241984|FG000|Overall Study|Physician Decision|1|||
129801466|NCT01051466|467241985|FG001|Overall Study|Physician Decision|0|||
129801467|NCT00810108|467241986|FG000|Overall Study|Withdrawal by Subject|1|||
129801468|NCT00810108|467241987|FG001|Overall Study|Withdrawal by Subject|0|||
129801469|NCT02486302|467241995|FG000|Overall Study|Discontinued prematurely|410|||
129801470|NCT02486302|467241995|FG000|Overall Study|Documentation not completed|255|||
129801471|NCT02486302|467241995|FG000|Overall Study|Excluded due to legal reasons|8|||
129801472|NCT02486302|467241995|FG000|Overall Study|Not treated|3|||
129801473|NCT04171765|467241997|FG000|Overall Study|Adverse Event|2|||
129801474|NCT04171765|467241998|FG001|Overall Study|Adverse Event|0|||
129801475|NCT04171765|467241999|FG002|Overall Study|Adverse Event|1|||
129801476|NCT04171765|467242000|FG003|Overall Study|Adverse Event|0|||
129801477|NCT04171765|467241997|FG000|Overall Study|Lost to Follow-up|0|||
129801478|NCT04171765|467241998|FG001|Overall Study|Lost to Follow-up|2|||
129801479|NCT04171765|467241999|FG002|Overall Study|Lost to Follow-up|2|||
129801480|NCT04171765|467242000|FG003|Overall Study|Lost to Follow-up|2|||
129801481|NCT04171765|467241997|FG000|Overall Study|Week 58 visit missed|0|||
129801482|NCT04171765|467241998|FG001|Overall Study|Week 58 visit missed|0|||
129801483|NCT04171765|467241999|FG002|Overall Study|Week 58 visit missed|1|||
129801484|NCT04171765|467242000|FG003|Overall Study|Week 58 visit missed|0|||
129801485|NCT04171765|467241997|FG000|Overall Study|Study terminated by sponsor|2|||
129801486|NCT04171765|467241998|FG001|Overall Study|Study terminated by sponsor|0|||
129801487|NCT04171765|467241999|FG002|Overall Study|Study terminated by sponsor|0|||
129801488|NCT04171765|467242000|FG003|Overall Study|Study terminated by sponsor|0|||
129801489|NCT04171765|467241997|FG000|Overall Study|Withdrawal by Subject|1|||
129801490|NCT04171765|467241998|FG001|Overall Study|Withdrawal by Subject|0|||
129801491|NCT04171765|467241999|FG002|Overall Study|Withdrawal by Subject|0|||
129801492|NCT04171765|467242000|FG003|Overall Study|Withdrawal by Subject|3|||
129801493|NCT00809354|467242001|FG000|Overall Study|Adverse Event|32|||
129801494|NCT00809354|467242002|FG001|Overall Study|Adverse Event|45|||
129801495|NCT00809354|467242003|FG002|Overall Study|Adverse Event|37|||
129801496|NCT00809354|467242004|FG003|Overall Study|Adverse Event|53|||
129801497|NCT00809354|467242005|FG004|Overall Study|Adverse Event|26|||
129801498|NCT00809354|467242006|FG005|Overall Study|Adverse Event|33|||
129801499|NCT00809354|467242007|FG006|Overall Study|Adverse Event|44|||
129801500|NCT00809354|467242008|FG007|Overall Study|Adverse Event|40|||
129801501|NCT00809354|467242009|FG008|Overall Study|Adverse Event|46|||
129801502|NCT00809354|467242010|FG009|Overall Study|Adverse Event|26|||
129801503|NCT00809354|467242001|FG000|Overall Study|Lack of Efficacy|23|||
129801504|NCT00809354|467242002|FG001|Overall Study|Lack of Efficacy|23|||
129801505|NCT00809354|467242003|FG002|Overall Study|Lack of Efficacy|22|||
129801506|NCT00809354|467242004|FG003|Overall Study|Lack of Efficacy|15|||
129801507|NCT00809354|467242005|FG004|Overall Study|Lack of Efficacy|40|||
129801508|NCT00809354|467242006|FG005|Overall Study|Lack of Efficacy|19|||
129801509|NCT00809354|467242007|FG006|Overall Study|Lack of Efficacy|21|||
129801510|NCT00809354|467242008|FG007|Overall Study|Lack of Efficacy|15|||
129801511|NCT00809354|467242009|FG008|Overall Study|Lack of Efficacy|18|||
129801512|NCT00809354|467242010|FG009|Overall Study|Lack of Efficacy|38|||
129801513|NCT00809354|467242001|FG000|Overall Study|Lost to Follow-up|10|||
129801514|NCT00809354|467242002|FG001|Overall Study|Lost to Follow-up|11|||
129801515|NCT00809354|467242003|FG002|Overall Study|Lost to Follow-up|8|||
129801516|NCT00809354|467242004|FG003|Overall Study|Lost to Follow-up|13|||
129801517|NCT00809354|467242005|FG004|Overall Study|Lost to Follow-up|6|||
129801518|NCT00809354|467242006|FG005|Overall Study|Lost to Follow-up|2|||
129801519|NCT00809354|467242007|FG006|Overall Study|Lost to Follow-up|0|||
129801520|NCT00809354|467242008|FG007|Overall Study|Lost to Follow-up|5|||
129801521|NCT00809354|467242009|FG008|Overall Study|Lost to Follow-up|4|||
129801522|NCT00809354|467242010|FG009|Overall Study|Lost to Follow-up|0|||
129801523|NCT00809354|467242001|FG000|Overall Study|Protocol Violation|7|||
129801524|NCT00809354|467242002|FG001|Overall Study|Protocol Violation|14|||
129801525|NCT00809354|467242003|FG002|Overall Study|Protocol Violation|14|||
129801526|NCT00809354|467242004|FG003|Overall Study|Protocol Violation|12|||
129801527|NCT00809354|467242005|FG004|Overall Study|Protocol Violation|14|||
129801528|NCT00809354|467242006|FG005|Overall Study|Protocol Violation|6|||
129801529|NCT00809354|467242007|FG006|Overall Study|Protocol Violation|4|||
129801530|NCT00809354|467242008|FG007|Overall Study|Protocol Violation|6|||
129801531|NCT00809354|467242009|FG008|Overall Study|Protocol Violation|9|||
129801532|NCT00809354|467242010|FG009|Overall Study|Protocol Violation|3|||
129801533|NCT00809354|467242001|FG000|Overall Study|Withdrawal by Subject|32|||
129801534|NCT00809354|467242002|FG001|Overall Study|Withdrawal by Subject|27|||
129801535|NCT00809354|467242003|FG002|Overall Study|Withdrawal by Subject|31|||
129801536|NCT00809354|467242004|FG003|Overall Study|Withdrawal by Subject|33|||
129801537|NCT00809354|467242005|FG004|Overall Study|Withdrawal by Subject|34|||
129801538|NCT00809354|467242006|FG005|Overall Study|Withdrawal by Subject|29|||
129801539|NCT00809354|467242007|FG006|Overall Study|Withdrawal by Subject|27|||
129801540|NCT00809354|467242008|FG007|Overall Study|Withdrawal by Subject|19|||
129801541|NCT00809354|467242009|FG008|Overall Study|Withdrawal by Subject|18|||
129801542|NCT00809354|467242010|FG009|Overall Study|Withdrawal by Subject|20|||
129801543|NCT00809354|467242001|FG000|Overall Study|Other|10|||
129801544|NCT00809354|467242002|FG001|Overall Study|Other|2|||
129801545|NCT00809354|467242003|FG002|Overall Study|Other|7|||
129801546|NCT00809354|467242004|FG003|Overall Study|Other|10|||
129801547|NCT00809354|467242005|FG004|Overall Study|Other|5|||
129801548|NCT00809354|467242006|FG005|Overall Study|Other|3|||
129801549|NCT00809354|467242007|FG006|Overall Study|Other|2|||
129801550|NCT00809354|467242008|FG007|Overall Study|Other|3|||
129801551|NCT00809354|467242009|FG008|Overall Study|Other|4|||
129801552|NCT00809354|467242010|FG009|Overall Study|Other|3|||
129801553|NCT00809354|467242001|FG000|Overall Study|Study terminated by sponsor|138|||
129801554|NCT00809354|467242002|FG001|Overall Study|Study terminated by sponsor|134|||
129801555|NCT00809354|467242003|FG002|Overall Study|Study terminated by sponsor|129|||
129801556|NCT00809354|467242004|FG003|Overall Study|Study terminated by sponsor|120|||
129801557|NCT00809354|467242005|FG004|Overall Study|Study terminated by sponsor|126|||
129801558|NCT00809354|467242006|FG005|Overall Study|Study terminated by sponsor|133|||
129801559|NCT00809354|467242007|FG006|Overall Study|Study terminated by sponsor|124|||
129801560|NCT00809354|467242008|FG007|Overall Study|Study terminated by sponsor|148|||
129801561|NCT00809354|467242009|FG008|Overall Study|Study terminated by sponsor|127|||
129801562|NCT00809354|467242010|FG009|Overall Study|Study terminated by sponsor|135|||
129801563|NCT00809354|467242001|FG000|Overall Study|Withdrawn due to pregnancy|0|||
129801564|NCT00809354|467242002|FG001|Overall Study|Withdrawn due to pregnancy|1|||
129801565|NCT00809354|467242003|FG002|Overall Study|Withdrawn due to pregnancy|0|||
129801566|NCT00809354|467242004|FG003|Overall Study|Withdrawn due to pregnancy|0|||
129801567|NCT00809354|467242005|FG004|Overall Study|Withdrawn due to pregnancy|0|||
129801568|NCT00809354|467242006|FG005|Overall Study|Withdrawn due to pregnancy|0|||
129801569|NCT00809354|467242007|FG006|Overall Study|Withdrawn due to pregnancy|0|||
129801570|NCT00809354|467242008|FG007|Overall Study|Withdrawn due to pregnancy|0|||
129801571|NCT00809354|467242009|FG008|Overall Study|Withdrawn due to pregnancy|0|||
129801572|NCT00809354|467242010|FG009|Overall Study|Withdrawn due to pregnancy|0|||
129801573|NCT00809354|467242001|FG000|Overall Study|Randomized but not Treated|3|||
129801574|NCT00809354|467242002|FG001|Overall Study|Randomized but not Treated|1|||
129801575|NCT00809354|467242003|FG002|Overall Study|Randomized but not Treated|6|||
129801576|NCT00809354|467242004|FG003|Overall Study|Randomized but not Treated|0|||
129801577|NCT00809354|467242005|FG004|Overall Study|Randomized but not Treated|5|||
129801578|NCT00809354|467242006|FG005|Overall Study|Randomized but not Treated|0|||
129801579|NCT00809354|467242007|FG006|Overall Study|Randomized but not Treated|1|||
129801580|NCT00809354|467242008|FG007|Overall Study|Randomized but not Treated|1|||
129801581|NCT00809354|467242009|FG008|Overall Study|Randomized but not Treated|2|||
129801582|NCT00809354|467242010|FG009|Overall Study|Randomized but not Treated|1|||
129801583|NCT00809354|467242001|FG000|Overall Study|Death|0|||
129801584|NCT00809354|467242002|FG001|Overall Study|Death|0|||
129801585|NCT00809354|467242003|FG002|Overall Study|Death|0|||
129801586|NCT00809354|467242004|FG003|Overall Study|Death|0|||
129801587|NCT00809354|467242005|FG004|Overall Study|Death|0|||
129801588|NCT00809354|467242006|FG005|Overall Study|Death|0|||
129801589|NCT00809354|467242007|FG006|Overall Study|Death|0|||
129801590|NCT00809354|467242008|FG007|Overall Study|Death|1|||
129801591|NCT00809354|467242009|FG008|Overall Study|Death|0|||
129801592|NCT00809354|467242010|FG009|Overall Study|Death|0|||
129801593|NCT03257371|467242013|FG000|Overall Study|Lost to Follow-up|1|||
129801594|NCT00631696|467242018|FG000|Overall Study|Entered, not randomized to treatment|1|||
129801595|NCT00631696|467242019|FG001|Overall Study|Entered, not randomized to treatment|1|||
129801596|NCT00631696|467242018|FG000|Overall Study|Discontinued after database release date|1|||
129801597|NCT00631696|467242019|FG001|Overall Study|Discontinued after database release date|0|||
129801598|NCT00631696|467242018|FG000|Overall Study|Follow up after database release date|1|||
129801599|NCT00631696|467242019|FG001|Overall Study|Follow up after database release date|0|||
129801600|NCT00631696|467242018|FG000|Overall Study|Lost to Follow-up|7|||
129801601|NCT00631696|467242019|FG001|Overall Study|Lost to Follow-up|10|||
129801602|NCT00631696|467242018|FG000|Overall Study|Withdrawal by Subject|2|||
129801603|NCT00631696|467242019|FG001|Overall Study|Withdrawal by Subject|9|||
129801604|NCT00631696|467242018|FG000|Overall Study|Other|8|||
129801605|NCT00631696|467242019|FG001|Overall Study|Other|8|||
129801606|NCT00631696|467242018|FG000|Overall Study|Protocol Violation|9|||
129801607|NCT00631696|467242019|FG001|Overall Study|Protocol Violation|9|||
129801608|NCT00631696|467242018|FG000|Overall Study|Study terminated by sponsor|3|||
129801609|NCT00631696|467242019|FG001|Overall Study|Study terminated by sponsor|3|||
129801610|NCT00631696|467242018|FG000|Overall Study|Adverse Event|5|||
129801611|NCT00631696|467242019|FG001|Overall Study|Adverse Event|0|||
130111187|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
129801612|NCT03198078|467242025|FG000|Overall Study|Adverse Event|0|||
129801613|NCT03198078|467242026|FG001|Overall Study|Adverse Event|1|||
130111188|NCT00528879|468367576|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
130111189|NCT00528879|468367577|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
130111190|NCT00528879|468367578|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
130111191|NCT00528879|468367579|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
130111192|NCT04133519|468367580|FG000|Overall Study|Withdrawal by Subject|5|||
130111193|NCT04133519|468367581|FG001|Overall Study|Withdrawal by Subject|4|||
129801614|NCT03198078|467242027|FG002|Overall Study|Adverse Event|2|||
129801615|NCT03198078|467242025|FG000|Overall Study|Lack of Efficacy|0|||
130053316|NCT01617681|468150420|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
130053317|NCT01617681|468150421|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
130053318|NCT01617681|468150422|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
130053319|NCT01617681|468150418|FG000|Period 2 Open Label|Adverse Event|0|||
130053320|NCT01617681|468150419|FG001|Period 2 Open Label|Adverse Event|0|||
130053321|NCT01617681|468150420|FG002|Period 2 Open Label|Adverse Event|0|||
130053322|NCT01617681|468150421|FG003|Period 2 Open Label|Adverse Event|0|||
130053323|NCT01617681|468150422|FG004|Period 2 Open Label|Adverse Event|3|||
130053324|NCT01617681|468150418|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
130053325|NCT01617681|468150419|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
130053326|NCT01617681|468150420|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
130053327|NCT01617681|468150421|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
129801616|NCT03198078|467242026|FG001|Overall Study|Lack of Efficacy|0|||
129801617|NCT03198078|467242027|FG002|Overall Study|Lack of Efficacy|3|||
129801618|NCT03198078|467242025|FG000|Overall Study|Lost to Follow-up|1|||
129801619|NCT03198078|467242026|FG001|Overall Study|Lost to Follow-up|0|||
129801620|NCT03198078|467242027|FG002|Overall Study|Lost to Follow-up|0|||
129801621|NCT03198078|467242025|FG000|Overall Study|Pregnancy|0|||
129801622|NCT03198078|467242026|FG001|Overall Study|Pregnancy|1|||
129801623|NCT03198078|467242027|FG002|Overall Study|Pregnancy|0|||
129801624|NCT03198078|467242025|FG000|Overall Study|Withdrawal by Subject|1|||
129801625|NCT03198078|467242026|FG001|Overall Study|Withdrawal by Subject|0|||
129801626|NCT03198078|467242027|FG002|Overall Study|Withdrawal by Subject|2|||
129801627|NCT03198078|467242025|FG000|Overall Study|Withdrawal by Caregiver|1|||
129801628|NCT03198078|467242026|FG001|Overall Study|Withdrawal by Caregiver|3|||
129801629|NCT03198078|467242027|FG002|Overall Study|Withdrawal by Caregiver|5|||
129801630|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
129801631|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
129801632|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
129801633|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
130053328|NCT01617681|468150422|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
130111194|NCT04133519|468367580|FG000|Overall Study|Protocol Violation|0|||
130053329|NCT01856595|468150430|FG000|Overall Study|Withdrawal by Subject|0|||
130053330|NCT01856595|468150431|FG001|Overall Study|Withdrawal by Subject|1|||
130053331|NCT01856595|468150432|FG002|Overall Study|Withdrawal by Subject|0|||
130053332|NCT01856595|468150433|FG003|Overall Study|Withdrawal by Subject|0|||
130053333|NCT01856595|468150434|FG004|Overall Study|Withdrawal by Subject|0|||
130053334|NCT01856595|468150435|FG005|Overall Study|Withdrawal by Subject|0|||
130053335|NCT01856595|468150436|FG006|Overall Study|Withdrawal by Subject|1|||
130053336|NCT01856595|468150437|FG007|Overall Study|Withdrawal by Subject|0|||
130053337|NCT01856595|468150438|FG008|Overall Study|Withdrawal by Subject|0|||
130053338|NCT04426825|468150440|FG000|Overall Study|Death|17|||
130053339|NCT04426825|468150440|FG000|Overall Study|Lost to Follow-up|1|||
130053340|NCT04426825|468150440|FG000|Overall Study|Study terminated by sponsor|5|||
130053341|NCT01763905|468150446|FG000|Overall Study|Withdrawal by Subject|1|||
130053342|NCT01763905|468150447|FG001|Overall Study|Withdrawal by Subject|1|||
130053343|NCT01763905|468150448|FG002|Overall Study|Withdrawal by Subject|0|||
130053344|NCT01763905|468150449|FG003|Overall Study|Withdrawal by Subject|1|||
129801634|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
129801635|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
129801636|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
129801637|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
129801638|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
129801639|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
129801640|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
129801641|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
129801642|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
129801643|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
129801644|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
129801645|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
129801646|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
129801647|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
129801648|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
129801649|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
129801650|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
129801651|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
129801652|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
129801653|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
130053345|NCT01763905|468150446|FG000|Overall Study|Decision by sponsor|5|||
130053346|NCT01763905|468150447|FG001|Overall Study|Decision by sponsor|0|||
130053347|NCT01763905|468150448|FG002|Overall Study|Decision by sponsor|8|||
129801654|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Death|2|||
129801655|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Death|1|||
130053348|NCT01763905|468150449|FG003|Overall Study|Decision by sponsor|0|||
130053349|NCT01763905|468150446|FG000|Overall Study|Lost to Follow-up|0|||
130053350|NCT01763905|468150447|FG001|Overall Study|Lost to Follow-up|0|||
130053351|NCT01763905|468150448|FG002|Overall Study|Lost to Follow-up|1|||
130053352|NCT01763905|468150449|FG003|Overall Study|Lost to Follow-up|0|||
130053353|NCT01554956|468150452|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
130053354|NCT01554956|468150453|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
130053355|NCT01554956|468150454|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
130053356|NCT01554956|468150452|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
129801656|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Death|0|||
129801657|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Death|0|||
129801658|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
129801659|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
129801660|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
129801661|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
129801662|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129801663|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129801664|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
129801665|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
129801666|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
129801667|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
129801668|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
129801669|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
129801670|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
129801671|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
130053357|NCT01554956|468150453|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
129801672|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
129801673|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
129801674|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
130053358|NCT01554956|468150454|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
129801675|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
129801676|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
129801677|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
129801678|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
129801679|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
129801680|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
129801681|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
129801682|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
129801683|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
129801684|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
129801685|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
129801686|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
129801687|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
129801688|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
129801689|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
129801690|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
130053359|NCT01554956|468150452|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
129801691|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
129801692|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
129801693|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
129801694|NCT01050543|467242032|FG000|Overall Study|Withdrawal by Subject|0|||
129801695|NCT01050543|467242033|FG001|Overall Study|Withdrawal by Subject|2|||
129801696|NCT01050543|467242032|FG000|Overall Study|Protocol Violation|0|||
129801697|NCT01050543|467242033|FG001|Overall Study|Protocol Violation|1|||
129801698|NCT01050543|467242032|FG000|Overall Study|Administrative|4|||
129801699|NCT01050543|467242033|FG001|Overall Study|Administrative|1|||
129801700|NCT00570765|467242034|FG000|DB Phase|Withdrawal by Subject|1|||
129801701|NCT00570765|467242035|FG001|DB Phase|Withdrawal by Subject|0|||
129801702|NCT00570765|467242036|FG002|DB Phase|Withdrawal by Subject|0|||
129801703|NCT00570765|467242037|FG003|DB Phase|Withdrawal by Subject|0|||
129801704|NCT00570765|467242034|FG000|DB Phase|Protocol Violation|0|||
129801705|NCT00570765|467242035|FG001|DB Phase|Protocol Violation|1|||
129801706|NCT00570765|467242036|FG002|DB Phase|Protocol Violation|0|||
129801707|NCT00570765|467242037|FG003|DB Phase|Protocol Violation|0|||
129801708|NCT00570765|467242034|FG000|DB Phase|Adverse Event|3|||
129801709|NCT00570765|467242035|FG001|DB Phase|Adverse Event|6|||
129801710|NCT00570765|467242036|FG002|DB Phase|Adverse Event|0|||
129801711|NCT00570765|467242037|FG003|DB Phase|Adverse Event|0|||
129801712|NCT00570765|467242034|FG000|DB Phase|Did Not Receive Study Drug|0|||
129801713|NCT00570765|467242035|FG001|DB Phase|Did Not Receive Study Drug|0|||
129801714|NCT00570765|467242036|FG002|DB Phase|Did Not Receive Study Drug|1|||
129801715|NCT00570765|467242037|FG003|DB Phase|Did Not Receive Study Drug|0|||
129801716|NCT00570765|467242034|FG000|LTSE Phase|Withdrawal by Subject|0|||
129801717|NCT00570765|467242035|FG001|LTSE Phase|Withdrawal by Subject|0|||
130053360|NCT01554956|468150453|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
130053361|NCT01554956|468150454|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
130053362|NCT01425190|468150462|FG000|Overall Study|Full dose not consumed.|1|||
130053363|NCT01425190|468150463|FG001|Overall Study|Full dose not consumed.|0|||
130053364|NCT01425190|468150464|FG002|Overall Study|Full dose not consumed.|0|||
130053365|NCT01096550|468150472|FG000|Overall Study|discontinued site|10|||
130053366|NCT01096550|468150473|FG001|Overall Study|discontinued site|11|||
130053367|NCT01096550|468150472|FG000|Overall Study|non-regular treatment track at clinic|1|||
130053368|NCT01096550|468150473|FG001|Overall Study|non-regular treatment track at clinic|1|||
130053369|NCT01096550|468150472|FG000|Overall Study|clinic readmission|1|||
129801718|NCT00570765|467242036|FG002|LTSE Phase|Withdrawal by Subject|0|||
129801719|NCT00570765|467242037|FG003|LTSE Phase|Withdrawal by Subject|1|||
129801720|NCT00570765|467242034|FG000|LTSE Phase|Adverse Event|0|||
129801721|NCT00570765|467242035|FG001|LTSE Phase|Adverse Event|0|||
129801722|NCT00570765|467242036|FG002|LTSE Phase|Adverse Event|0|||
130053370|NCT01096550|468150473|FG001|Overall Study|clinic readmission|1|||
129801723|NCT00570765|467242037|FG003|LTSE Phase|Adverse Event|7|||
130111195|NCT04133519|468367581|FG001|Overall Study|Protocol Violation|1|||
130111196|NCT04133519|468367580|FG000|Overall Study|Never started treatment|1|||
130111197|NCT04133519|468367581|FG001|Overall Study|Never started treatment|1|||
130111198|NCT02217345|468367582|FG000|Overall Study|Lost to Follow-up|2|||
130111199|NCT02217345|468367583|FG001|Overall Study|Lost to Follow-up|1|||
130111200|NCT02217345|468367582|FG000|Overall Study|Withdrawal by Subject|3|||
129891283|NCT00162942|467559697|FG000|Overall Study|Withdrawal by Subject|3|||
129891284|NCT00162942|467559698|FG001|Overall Study|Withdrawal by Subject|6|||
129891285|NCT00162942|467559697|FG000|Overall Study|Physician Decision|1|||
129891286|NCT00162942|467559698|FG001|Overall Study|Physician Decision|0|||
129801724|NCT00570765|467242034|FG000|LTSE Phase|Physician Decision|0|||
129801725|NCT00570765|467242035|FG001|LTSE Phase|Physician Decision|0|||
129801726|NCT00570765|467242036|FG002|LTSE Phase|Physician Decision|0|||
129801727|NCT00570765|467242037|FG003|LTSE Phase|Physician Decision|4|||
129801728|NCT03711266|467242038|FG000|Overall Study|Lost to Follow-up|10|||
129801729|NCT00057876|467242039|FG000|Overall Study|Adverse Event|8|||
129801730|NCT00057876|467242040|FG001|Overall Study|Adverse Event|8|||
129801731|NCT00057876|467242039|FG000|Overall Study|Death|2|||
129801732|NCT00057876|467242040|FG001|Overall Study|Death|1|||
129801733|NCT00057876|467242039|FG000|Overall Study|Withdrawal by Subject|5|||
129801734|NCT00057876|467242040|FG001|Overall Study|Withdrawal by Subject|6|||
129801735|NCT00057876|467242039|FG000|Overall Study|Lack of Efficacy|10|||
129801736|NCT00057876|467242040|FG001|Overall Study|Lack of Efficacy|8|||
129801737|NCT00057876|467242039|FG000|Overall Study|Ineligible|1|||
129891287|NCT00162942|467559697|FG000|Overall Study|Enter Open-Label Study|76|||
129891288|NCT00162942|467559698|FG001|Overall Study|Enter Open-Label Study|35|||
130053371|NCT01096550|468150472|FG000|Overall Study|Withdrawal by Subject|0|||
130053372|NCT01096550|468150473|FG001|Overall Study|Withdrawal by Subject|1|||
130053373|NCT01096550|468150472|FG000|Overall Study|non-African American participant|13|||
130053374|NCT01096550|468150473|FG001|Overall Study|non-African American participant|6|||
130053375|NCT01096550|468150472|FG000|Overall Study|Lost to Follow-up|12|||
129801738|NCT00057876|467242040|FG001|Overall Study|Ineligible|2|||
129801739|NCT00057876|467242039|FG000|Overall Study|other reason|2|||
129801740|NCT00057876|467242040|FG001|Overall Study|other reason|2|||
130053376|NCT01096550|468150473|FG001|Overall Study|Lost to Follow-up|9|||
129801741|NCT00057876|467242039|FG000|Overall Study|other complicating disease|1|||
129801742|NCT00057876|467242040|FG001|Overall Study|other complicating disease|0|||
130053377|NCT02538666|468150474|FG000|Pre-Treatment|Disease progression|1|||
130053378|NCT02538666|468150475|FG001|Pre-Treatment|Disease progression|0|||
129801743|NCT00437320|467242043|FG000|Overall Study|Participant request|2|||
129801744|NCT00437320|467242044|FG001|Overall Study|Participant request|1|||
129801745|NCT00437320|467242045|FG002|Overall Study|Participant request|4|||
129801746|NCT01649804|467242052|FG000|Overall Study|Administrative/Other|8|||
129801747|NCT02456103|467242053|FG000|Overall Study|Study Closure|207|||
129801748|NCT02456103|467242053|FG000|Overall Study|Physician Decision|1|||
130053379|NCT02538666|468150476|FG002|Pre-Treatment|Disease progression|0|||
130053380|NCT02538666|468150474|FG000|Pre-Treatment|no longer meets study criteria|1|||
130053381|NCT02538666|468150475|FG001|Pre-Treatment|no longer meets study criteria|0|||
130053382|NCT02538666|468150476|FG002|Pre-Treatment|no longer meets study criteria|0|||
130053383|NCT02538666|468150474|FG000|Pre-Treatment|Withdrew Consent|0|||
129801749|NCT02456103|467242053|FG000|Overall Study|Required prohibited medications|5|||
130053384|NCT02538666|468150475|FG001|Pre-Treatment|Withdrew Consent|1|||
130111201|NCT02217345|468367583|FG001|Overall Study|Withdrawal by Subject|2|||
130111202|NCT02217345|468367582|FG000|Overall Study|Adverse Event|2|||
129801750|NCT02456103|467242053|FG000|Overall Study|Protocol Violation|1|||
129801751|NCT02456103|467242053|FG000|Overall Study|Adverse Event|5|||
129801752|NCT02456103|467242053|FG000|Overall Study|Abnormal Laboratory Value|2|||
129801753|NCT02456103|467242053|FG000|Overall Study|Lost to Follow-up|1|||
129801754|NCT02456103|467242053|FG000|Overall Study|Withdrawal by Subject|24|||
129801755|NCT02028871|467242056|FG000|Overall Study|Positive urine drug screen|1|||
129801756|NCT02028871|467242057|FG001|Overall Study|Positive urine drug screen|1|||
129801757|NCT02028871|467242056|FG000|Overall Study|Withdrawal by Subject|1|||
129801758|NCT02028871|467242057|FG001|Overall Study|Withdrawal by Subject|2|||
129801759|NCT02028871|467242056|FG000|Overall Study|IV placement difficulty|1|||
129801760|NCT02028871|467242057|FG001|Overall Study|IV placement difficulty|0|||
129801761|NCT02028871|467242056|FG000|Overall Study|Current Illness|1|||
129801762|NCT02028871|467242057|FG001|Overall Study|Current Illness|0|||
129801763|NCT01916967|467242063|FG000|Overall Study|Adverse Event|0|||
129801764|NCT01916967|467242064|FG001|Overall Study|Adverse Event|0|||
129801765|NCT01916967|467242065|FG002|Overall Study|Adverse Event|2|||
129801766|NCT01916967|467242063|FG000|Overall Study|Lack of Efficacy|0|||
129801767|NCT01916967|467242064|FG001|Overall Study|Lack of Efficacy|0|||
129801768|NCT01916967|467242065|FG002|Overall Study|Lack of Efficacy|6|||
129801769|NCT01916967|467242063|FG000|Overall Study|Physician Decision|0|||
130053385|NCT02538666|468150476|FG002|Pre-Treatment|Withdrew Consent|1|||
130053386|NCT02538666|468150474|FG000|Treatment|Disease progression|270|||
130053387|NCT02538666|468150475|FG001|Treatment|Disease progression|227|||
129801770|NCT01916967|467242064|FG001|Overall Study|Physician Decision|0|||
129801771|NCT01916967|467242065|FG002|Overall Study|Physician Decision|1|||
130053388|NCT02538666|468150476|FG002|Treatment|Disease progression|165|||
130053389|NCT02538666|468150474|FG000|Treatment|Study drug toxicity|1|||
129801772|NCT01916967|467242063|FG000|Overall Study|Protocol Violation|0|||
129801773|NCT01916967|467242064|FG001|Overall Study|Protocol Violation|1|||
129801774|NCT01916967|467242065|FG002|Overall Study|Protocol Violation|0|||
129801775|NCT00568685|467242066|FG000|Overall Study|Adverse Event|2|||
129801776|NCT00568685|467242067|FG001|Overall Study|Adverse Event|3|||
129801777|NCT00568685|467242068|FG002|Overall Study|Adverse Event|3|||
129801778|NCT00568685|467242066|FG000|Overall Study|Withdrawal by Subject|7|||
130111203|NCT02217345|468367583|FG001|Overall Study|Adverse Event|1|||
129801779|NCT00568685|467242067|FG001|Overall Study|Withdrawal by Subject|2|||
129801780|NCT00568685|467242068|FG002|Overall Study|Withdrawal by Subject|2|||
129801781|NCT00568685|467242066|FG000|Overall Study|Protocol Violation|1|||
129801782|NCT00568685|467242067|FG001|Overall Study|Protocol Violation|0|||
129801783|NCT00568685|467242068|FG002|Overall Study|Protocol Violation|0|||
129801784|NCT02038452|467242069|FG000|Overall Study|Withdrawal by Subject|7|||
129801785|NCT02038452|467242070|FG001|Overall Study|Withdrawal by Subject|9|||
129801786|NCT02038452|467242069|FG000|Overall Study|Lost to Follow-up|31|||
129801787|NCT02038452|467242070|FG001|Overall Study|Lost to Follow-up|28|||
130053390|NCT02538666|468150475|FG001|Treatment|Study drug toxicity|29|||
130053391|NCT02538666|468150476|FG002|Treatment|Study drug toxicity|92|||
130053392|NCT02538666|468150474|FG000|Treatment|Death|0|||
130053393|NCT02538666|468150475|FG001|Treatment|Death|2|||
130053394|NCT02538666|468150476|FG002|Treatment|Death|3|||
130053395|NCT02538666|468150474|FG000|Treatment|Adverse event unrelated to study drug|8|||
130053396|NCT02538666|468150475|FG001|Treatment|Adverse event unrelated to study drug|10|||
130111204|NCT02217345|468367582|FG000|Overall Study|Physician Decision|0|||
130111205|NCT02217345|468367583|FG001|Overall Study|Physician Decision|1|||
130111206|NCT03196791|468367584|FG000|Overall Study|Protocol Violation|7|||
130111207|NCT03196791|468367585|FG001|Overall Study|Protocol Violation|3|||
130111208|NCT03196791|468367584|FG000|Overall Study|Withdrawal by Subject|3|||
130111209|NCT03196791|468367585|FG001|Overall Study|Withdrawal by Subject|2|||
130111210|NCT00373685|468367586|FG000|Overall Study|Death|2|||
130111211|NCT00373685|468367587|FG001|Overall Study|Death|1|||
130111212|NCT00373685|468367586|FG000|Overall Study|Adverse Event|278|||
130111213|NCT00373685|468367587|FG001|Overall Study|Adverse Event|253|||
130111214|NCT00373685|468367586|FG000|Overall Study|Insufficient clinical response|169|||
130053397|NCT02538666|468150476|FG002|Treatment|Adverse event unrelated to study drug|15|||
130053398|NCT02538666|468150474|FG000|Treatment|Participant request to discontinue study treatment|3|||
130053399|NCT02538666|468150475|FG001|Treatment|Participant request to discontinue study treatment|6|||
130053400|NCT02538666|468150476|FG002|Treatment|Participant request to discontinue study treatment|11|||
130053401|NCT02538666|468150474|FG000|Treatment|Participant withdrew consent|2|||
130053402|NCT02538666|468150475|FG001|Treatment|Participant withdrew consent|5|||
130053403|NCT02538666|468150476|FG002|Treatment|Participant withdrew consent|3|||
130053404|NCT02538666|468150474|FG000|Treatment|Lost to Follow-up|0|||
130053405|NCT02538666|468150475|FG001|Treatment|Lost to Follow-up|1|||
130053406|NCT02538666|468150476|FG002|Treatment|Lost to Follow-up|1|||
130053407|NCT02538666|468150474|FG000|Treatment|Maximum clinical benefit|4|||
130053408|NCT02538666|468150475|FG001|Treatment|Maximum clinical benefit|3|||
130053409|NCT02538666|468150476|FG002|Treatment|Maximum clinical benefit|4|||
130053410|NCT02538666|468150474|FG000|Treatment|Poor/non-compliance|0|||
130053411|NCT02538666|468150475|FG001|Treatment|Poor/non-compliance|1|||
130053412|NCT02538666|468150476|FG002|Treatment|Poor/non-compliance|0|||
130053413|NCT02538666|468150474|FG000|Treatment|Participant no longer meets study criteria|0|||
130111215|NCT00373685|468367587|FG001|Overall Study|Insufficient clinical response|119|||
130111216|NCT00373685|468367586|FG000|Overall Study|Did not meet entrance criteria|167|||
130111217|NCT00373685|468367587|FG001|Overall Study|Did not meet entrance criteria|184|||
129801788|NCT01090973|467242075|FG000|Overall Study|Disease progression|1|||
129801789|NCT01626495|467242077|FG000|Overall Study|Adverse Event|3|||
129801790|NCT01626495|467242077|FG000|Overall Study|Disease progression|27|||
129801791|NCT01626495|467242077|FG000|Overall Study|Withdrawal by Subject|1|||
129801792|NCT01626495|467242077|FG000|Overall Study|Administrative problem|1|||
129801793|NCT01626495|467242077|FG000|Overall Study|Death|2|||
129801794|NCT01626495|467242077|FG000|Overall Study|Physician Decision|1|||
129801795|NCT01626495|467242077|FG000|Overall Study|New cancer therapy|16|||
129801796|NCT01626495|467242077|FG000|Overall Study|Manufacturing failure|1|||
129801797|NCT03643159|467242078|FG000|Overall Study|Adverse Event|1|||
129801798|NCT03643159|467242078|FG000|Overall Study|Withdrawal by Subject|1|||
129801799|NCT02887859|467242081|FG000|Overall Study|Ongoing|6|||
129801800|NCT02887859|467242081|FG000|Overall Study|Adverse Event|7|||
129801801|NCT02887859|467242081|FG000|Overall Study|Death|1|||
129801802|NCT02887859|467242081|FG000|Overall Study|Physician Decision|1|||
129801803|NCT01920555|467243385|FG000|Overall Study|Physician Decision|1|||
129801804|NCT01920555|467243386|FG001|Overall Study|Physician Decision|2|||
130111218|NCT00373685|468367586|FG000|Overall Study|Lost to follow up|83|||
130111219|NCT00373685|468367587|FG001|Overall Study|Lost to follow up|103|||
130111220|NCT00373685|468367586|FG000|Overall Study|No longer willing to participate|337|||
129801805|NCT01920555|467243387|FG002|Overall Study|Physician Decision|1|||
129801806|NCT01920555|467243388|FG003|Overall Study|Physician Decision|2|||
129801807|NCT01920555|467243389|FG004|Overall Study|Physician Decision|0|||
130053414|NCT02538666|468150475|FG001|Treatment|Participant no longer meets study criteria|2|||
130053415|NCT02538666|468150476|FG002|Treatment|Participant no longer meets study criteria|0|||
130053416|NCT02538666|468150474|FG000|Treatment|Administrative reason by sponsor|0|||
129801808|NCT01920555|467243385|FG000|Overall Study|Lack of Efficacy|2|||
129801809|NCT01920555|467243386|FG001|Overall Study|Lack of Efficacy|0|||
129801810|NCT01920555|467243387|FG002|Overall Study|Lack of Efficacy|0|||
129801811|NCT01920555|467243388|FG003|Overall Study|Lack of Efficacy|0|||
129801812|NCT01920555|467243389|FG004|Overall Study|Lack of Efficacy|0|||
129801813|NCT01920555|467243385|FG000|Overall Study|Travel Difficulties|1|||
129801814|NCT01920555|467243386|FG001|Overall Study|Travel Difficulties|1|||
129801815|NCT01920555|467243387|FG002|Overall Study|Travel Difficulties|0|||
129801816|NCT01920555|467243388|FG003|Overall Study|Travel Difficulties|0|||
129801817|NCT01920555|467243389|FG004|Overall Study|Travel Difficulties|1|||
129801818|NCT01920555|467243385|FG000|Overall Study|Lost to Follow-up|0|||
129801819|NCT01920555|467243386|FG001|Overall Study|Lost to Follow-up|1|||
129801820|NCT01920555|467243387|FG002|Overall Study|Lost to Follow-up|0|||
129801821|NCT01920555|467243388|FG003|Overall Study|Lost to Follow-up|1|||
129801822|NCT01920555|467243389|FG004|Overall Study|Lost to Follow-up|0|||
129801823|NCT01858376|467243390|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
129801824|NCT01886716|467243393|FG000|Week 1|Lost to Follow-up|0|||
130053417|NCT02538666|468150475|FG001|Treatment|Administrative reason by sponsor|0|||
129801825|NCT01886716|467243394|FG001|Week 1|Lost to Follow-up|0|||
129801826|NCT01886716|467243395|FG002|Week 1|Lost to Follow-up|2|||
129801827|NCT01886716|467243396|FG003|Week 1|Lost to Follow-up|2|||
129801828|NCT01886716|467243393|FG000|Week 2|Lost to Follow-up|3|||
129801829|NCT01886716|467243394|FG001|Week 2|Lost to Follow-up|2|||
129801830|NCT01886716|467243395|FG002|Week 2|Lost to Follow-up|1|||
129801831|NCT01886716|467243396|FG003|Week 2|Lost to Follow-up|3|||
129801832|NCT01886716|467243393|FG000|Week 3|Lost to Follow-up|1|||
129801833|NCT01886716|467243394|FG001|Week 3|Lost to Follow-up|1|||
129801834|NCT01886716|467243395|FG002|Week 3|Lost to Follow-up|0|||
129891289|NCT00162942|467559697|FG000|Overall Study|Alternate Therapy|6|||
129891290|NCT00162942|467559698|FG001|Overall Study|Alternate Therapy|2|||
130053418|NCT02538666|468150476|FG002|Treatment|Administrative reason by sponsor|1|||
129891291|NCT00162942|467559697|FG000|Overall Study|Lack of Efficacy|1|||
129891292|NCT00162942|467559698|FG001|Overall Study|Lack of Efficacy|0|||
129891293|NCT00162942|467559697|FG000|Overall Study|Flare During Active Treatment|7|||
129891294|NCT00162942|467559698|FG001|Overall Study|Flare During Active Treatment|3|||
130053419|NCT02538666|468150474|FG000|Treatment|Other reasons|8|||
130053420|NCT02538666|468150475|FG001|Treatment|Other reasons|15|||
130053421|NCT02538666|468150476|FG002|Treatment|Other reasons|5|||
130053422|NCT02538666|468150474|FG000|Treatment|Not reported|2|||
130053423|NCT02538666|468150475|FG001|Treatment|Not reported|2|||
130053424|NCT02538666|468150476|FG002|Treatment|Not reported|2|||
130053425|NCT04590937|468150477|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
130053426|NCT01544595|468150478|FG000|Status at Week 68|Adverse Event|3|||
130053427|NCT01544595|468150479|FG001|Status at Week 68|Adverse Event|2|||
130053428|NCT01544595|468150480|FG002|Status at Week 68|Adverse Event|1|||
130053429|NCT01544595|468150481|FG003|Status at Week 68|Adverse Event|0|||
130053430|NCT01544595|468150482|FG004|Status at Week 68|Adverse Event|0|||
130053431|NCT01544595|468150483|FG005|Status at Week 68|Adverse Event|0|||
130053432|NCT01544595|468150478|FG000|Status at Week 68|Lack of Efficacy|1|||
130053433|NCT01544595|468150479|FG001|Status at Week 68|Lack of Efficacy|0|||
130053434|NCT01544595|468150480|FG002|Status at Week 68|Lack of Efficacy|0|||
130053435|NCT01544595|468150481|FG003|Status at Week 68|Lack of Efficacy|0|||
130053436|NCT01544595|468150482|FG004|Status at Week 68|Lack of Efficacy|0|||
130053437|NCT01544595|468150483|FG005|Status at Week 68|Lack of Efficacy|0|||
130053438|NCT01544595|468150478|FG000|Status at Week 68|Lost to Follow-up|1|||
130053439|NCT01544595|468150479|FG001|Status at Week 68|Lost to Follow-up|1|||
130053440|NCT01544595|468150480|FG002|Status at Week 68|Lost to Follow-up|0|||
130053441|NCT01544595|468150481|FG003|Status at Week 68|Lost to Follow-up|0|||
130053442|NCT01544595|468150482|FG004|Status at Week 68|Lost to Follow-up|0|||
130053443|NCT01544595|468150483|FG005|Status at Week 68|Lost to Follow-up|0|||
130053444|NCT01544595|468150478|FG000|Status at Week 68|Non-compliance with study treatment|1|||
130053445|NCT01544595|468150479|FG001|Status at Week 68|Non-compliance with study treatment|0|||
130053446|NCT01544595|468150480|FG002|Status at Week 68|Non-compliance with study treatment|0|||
130053447|NCT01544595|468150481|FG003|Status at Week 68|Non-compliance with study treatment|1|||
130053448|NCT01544595|468150482|FG004|Status at Week 68|Non-compliance with study treatment|0|||
130053449|NCT01544595|468150483|FG005|Status at Week 68|Non-compliance with study treatment|0|||
130053450|NCT01544595|468150478|FG000|Status at Week 68|Protocol Violation|2|||
130053451|NCT01544595|468150479|FG001|Status at Week 68|Protocol Violation|0|||
130053452|NCT01544595|468150480|FG002|Status at Week 68|Protocol Violation|1|||
130053453|NCT01544595|468150481|FG003|Status at Week 68|Protocol Violation|1|||
130053454|NCT01544595|468150482|FG004|Status at Week 68|Protocol Violation|0|||
130053455|NCT01544595|468150483|FG005|Status at Week 68|Protocol Violation|0|||
130053456|NCT01544595|468150478|FG000|Status at Week 68|Technical problems|1|||
130053457|NCT01544595|468150479|FG001|Status at Week 68|Technical problems|0|||
129801835|NCT01886716|467243396|FG003|Week 3|Lost to Follow-up|1|||
129801836|NCT03387683|467243400|FG000|Overall Study|In receipt of disallowed medication|1|||
129801837|NCT03387683|467243401|FG001|Overall Study|In receipt of disallowed medication|0|||
129801838|NCT03387683|467243400|FG000|Overall Study|Did not receive treatment|1|||
129801839|NCT03387683|467243401|FG001|Overall Study|Did not receive treatment|0|||
129801840|NCT01954342|467243402|FG000|Overall Study|Missing data from 13-16week study visit|0|||
129801841|NCT01954342|467243403|FG001|Overall Study|Missing data from 13-16week study visit|0|||
129801842|NCT01954342|467243404|FG002|Overall Study|Missing data from 13-16week study visit|0|||
129801843|NCT01954342|467243405|FG003|Overall Study|Missing data from 13-16week study visit|1|||
129801844|NCT01954342|467243402|FG000|Overall Study|Miscarriage|0|||
129801845|NCT01954342|467243403|FG001|Overall Study|Miscarriage|0|||
129801846|NCT01954342|467243404|FG002|Overall Study|Miscarriage|0|||
129801847|NCT01954342|467243405|FG003|Overall Study|Miscarriage|3|||
129801848|NCT01954342|467243402|FG000|Overall Study|Lost to Follow-up|0|||
130053458|NCT01544595|468150480|FG002|Status at Week 68|Technical problems|0|||
130053459|NCT01544595|468150481|FG003|Status at Week 68|Technical problems|1|||
130053460|NCT01544595|468150482|FG004|Status at Week 68|Technical problems|0|||
130053461|NCT01544595|468150483|FG005|Status at Week 68|Technical problems|0|||
130053462|NCT01544595|468150478|FG000|Status at Week 68|Withdrawal by Subject|0|||
130053463|NCT01544595|468150479|FG001|Status at Week 68|Withdrawal by Subject|1|||
130053464|NCT01544595|468150480|FG002|Status at Week 68|Withdrawal by Subject|1|||
130053465|NCT01544595|468150481|FG003|Status at Week 68|Withdrawal by Subject|2|||
130053466|NCT01544595|468150482|FG004|Status at Week 68|Withdrawal by Subject|0|||
130053467|NCT01544595|468150483|FG005|Status at Week 68|Withdrawal by Subject|0|||
130053468|NCT01544595|468150478|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
130053469|NCT01544595|468150479|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
130053470|NCT01544595|468150480|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
129801849|NCT01954342|467243403|FG001|Overall Study|Lost to Follow-up|0|||
129801850|NCT01954342|467243404|FG002|Overall Study|Lost to Follow-up|0|||
129801851|NCT01954342|467243405|FG003|Overall Study|Lost to Follow-up|5|||
129801852|NCT01954342|467243402|FG000|Overall Study|Preterm delivery|0|||
129801853|NCT01954342|467243403|FG001|Overall Study|Preterm delivery|0|||
129801854|NCT01954342|467243404|FG002|Overall Study|Preterm delivery|0|||
129801855|NCT01954342|467243405|FG003|Overall Study|Preterm delivery|3|||
130053471|NCT01544595|468150481|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
130053472|NCT01544595|468150482|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
129801856|NCT01954342|467243402|FG000|Overall Study|Pre-eclampsia|0|||
129801857|NCT01954342|467243403|FG001|Overall Study|Pre-eclampsia|0|||
129801858|NCT01954342|467243404|FG002|Overall Study|Pre-eclampsia|0|||
129801859|NCT01954342|467243405|FG003|Overall Study|Pre-eclampsia|4|||
129801860|NCT01954342|467243402|FG000|Overall Study|Unreliable Data|0|||
129801861|NCT01954342|467243403|FG001|Overall Study|Unreliable Data|0|||
129801862|NCT01954342|467243404|FG002|Overall Study|Unreliable Data|0|||
129801863|NCT01954342|467243405|FG003|Overall Study|Unreliable Data|2|||
129801864|NCT01646073|467243406|FG000|Period A (12 Weeks)|Adverse Event|0|||
129801865|NCT01646073|467243407|FG001|Period A (12 Weeks)|Adverse Event|2|||
129801866|NCT01646073|467243406|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
129801867|NCT01646073|467243407|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
129801868|NCT01646073|467243406|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
129801869|NCT01646073|467243407|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
129801870|NCT01646073|467243406|FG000|Period A (12 Weeks)|Protocol Violation|0|||
129801871|NCT01646073|467243407|FG001|Period A (12 Weeks)|Protocol Violation|1|||
129801872|NCT01646073|467243406|FG000|Period A (12 Weeks)|Other|0|||
129801873|NCT01646073|467243407|FG001|Period A (12 Weeks)|Other|1|||
129801874|NCT01646073|467243406|FG000|Period B (12 Weeks)|Adverse Event|0|||
129801875|NCT01646073|467243407|FG001|Period B (12 Weeks)|Adverse Event|7|||
129801876|NCT01646073|467243406|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
129801877|NCT01646073|467243407|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
129801878|NCT01646073|467243406|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
129801879|NCT01646073|467243407|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
129801880|NCT02410551|467243409|FG000|Overall Study|Adverse Event|1|||
129801881|NCT02410551|467243409|FG000|Overall Study|Withdrawal by Subject|1|||
129801882|NCT02410551|467243409|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
129801883|NCT01739309|467243410|FG000|Overall Study|Adverse Event|1|||
129801884|NCT01739309|467243410|FG000|Overall Study|Withdrawal by Subject|1|||
129801885|NCT01495975|467243411|FG000|Overall Study|Lost to Follow-up|1|||
129801886|NCT01495975|467243412|FG001|Overall Study|Lost to Follow-up|0|||
129801887|NCT05447897|467243415|FG000|Overall Study|Did not participate in survey|2|||
129801888|NCT01934972|467243416|FG000|Overall Study|Withdrawal by Subject|9|||
129801889|NCT01934972|467243417|FG001|Overall Study|Withdrawal by Subject|6|||
129891295|NCT00162942|467559697|FG000|Overall Study|2 or more consecutive treatments missed|1|||
129891296|NCT00162942|467559698|FG001|Overall Study|2 or more consecutive treatments missed|0|||
129891297|NCT02162732|467559699|FG000|Overall Study|Biopsy not performed.|18|||
129801890|NCT03131453|467243418|FG000|Overall Study|Study terminated by Sponsor|424|||
129801891|NCT03131453|467243419|FG001|Overall Study|Study terminated by Sponsor|222|||
129801892|NCT03131453|467243420|FG002|Overall Study|Study terminated by Sponsor|438|||
129801893|NCT03131453|467243418|FG000|Overall Study|Withdrawal by Subject|18|||
129801894|NCT03131453|467243419|FG001|Overall Study|Withdrawal by Subject|7|||
129801895|NCT03131453|467243420|FG002|Overall Study|Withdrawal by Subject|13|||
129801896|NCT03131453|467243418|FG000|Overall Study|Adverse Event|10|||
129801897|NCT03131453|467243419|FG001|Overall Study|Adverse Event|3|||
129801898|NCT03131453|467243420|FG002|Overall Study|Adverse Event|3|||
129801899|NCT03131453|467243418|FG000|Overall Study|Lost to Follow-up|1|||
129801900|NCT03131453|467243419|FG001|Overall Study|Lost to Follow-up|0|||
129801901|NCT03131453|467243420|FG002|Overall Study|Lost to Follow-up|1|||
129801902|NCT03131453|467243418|FG000|Overall Study|Physician Decision|1|||
129801903|NCT03131453|467243419|FG001|Overall Study|Physician Decision|0|||
129801904|NCT03131453|467243420|FG002|Overall Study|Physician Decision|1|||
129801905|NCT03131453|467243418|FG000|Overall Study|Non-compliance with study treatment|1|||
129801906|NCT03131453|467243419|FG001|Overall Study|Non-compliance with study treatment|0|||
129801907|NCT03131453|467243420|FG002|Overall Study|Non-compliance with study treatment|0|||
129801908|NCT03131453|467243418|FG000|Overall Study|Technical problems|1|||
129801909|NCT03131453|467243419|FG001|Overall Study|Technical problems|0|||
129801910|NCT03131453|467243420|FG002|Overall Study|Technical problems|0|||
129801911|NCT03131453|467243418|FG000|Overall Study|Protocol deviation|0|||
129801912|NCT03131453|467243419|FG001|Overall Study|Protocol deviation|1|||
129801913|NCT03131453|467243420|FG002|Overall Study|Protocol deviation|0|||
129801914|NCT02770170|467243423|FG000|Overall Study|Withdrawal by Subject|0|||
129801915|NCT02770170|467243424|FG001|Overall Study|Withdrawal by Subject|0|||
129801916|NCT02770170|467243425|FG002|Overall Study|Withdrawal by Subject|0|||
129801917|NCT02770170|467243426|FG003|Overall Study|Withdrawal by Subject|2|||
129801918|NCT02770170|467243423|FG000|Overall Study|due to pregnancy|1|||
129801919|NCT02770170|467243424|FG001|Overall Study|due to pregnancy|0|||
129801920|NCT02770170|467243425|FG002|Overall Study|due to pregnancy|0|||
129801921|NCT02770170|467243426|FG003|Overall Study|due to pregnancy|0|||
129801922|NCT02770170|467243423|FG000|Overall Study|Lack of Efficacy|2|||
129801923|NCT02770170|467243424|FG001|Overall Study|Lack of Efficacy|0|||
129801924|NCT02770170|467243425|FG002|Overall Study|Lack of Efficacy|0|||
129801925|NCT02770170|467243426|FG003|Overall Study|Lack of Efficacy|1|||
129801926|NCT02770170|467243423|FG000|Overall Study|Adverse Event|4|||
129801927|NCT02770170|467243424|FG001|Overall Study|Adverse Event|3|||
129801928|NCT02770170|467243425|FG002|Overall Study|Adverse Event|5|||
129801929|NCT02770170|467243426|FG003|Overall Study|Adverse Event|3|||
129801930|NCT02770170|467243423|FG000|Overall Study|due to disease worsening|0|||
129801931|NCT02770170|467243424|FG001|Overall Study|due to disease worsening|0|||
129801932|NCT02770170|467243425|FG002|Overall Study|due to disease worsening|0|||
129801933|NCT02770170|467243426|FG003|Overall Study|due to disease worsening|1|||
129801934|NCT00445978|467243427|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
129801935|NCT00445978|467243427|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
129801936|NCT00445978|467243427|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
129801937|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
129801938|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
129801939|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
129801940|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
129801941|NCT00445978|467243427|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
129801942|NCT00445978|467243427|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
129801943|NCT01822496|467243430|FG000|Overall Study|Protocol Violation|2|||
129801944|NCT01822496|467243431|FG001|Overall Study|Protocol Violation|2|||
129801945|NCT01822496|467243432|FG002|Overall Study|Protocol Violation|0|||
129801946|NCT01822496|467243433|FG003|Overall Study|Protocol Violation|1|||
129801947|NCT01822496|467243430|FG000|Overall Study|Withdrawal by Subject|0|||
129801948|NCT01822496|467243431|FG001|Overall Study|Withdrawal by Subject|0|||
129801949|NCT01822496|467243432|FG002|Overall Study|Withdrawal by Subject|0|||
129801950|NCT01822496|467243433|FG003|Overall Study|Withdrawal by Subject|3|||
129801951|NCT00304239|467243434|FG000|Overall Study|Protocol Deviations/Violations|15|||
129801952|NCT00304239|467243435|FG001|Overall Study|Protocol Deviations/Violations|0|||
129801953|NCT00304239|467243434|FG000|Overall Study|Adverse Event|2|||
129801954|NCT00304239|467243435|FG001|Overall Study|Adverse Event|0|||
129801955|NCT02979197|467243436|FG000|Overall Study|Adverse Event|4|||
129801956|NCT02979197|467243437|FG001|Overall Study|Adverse Event|2|||
129801957|NCT02979197|467243438|FG002|Overall Study|Adverse Event|0|||
129801958|NCT02979197|467243436|FG000|Overall Study|Protocol Violation|0|||
129801959|NCT02979197|467243437|FG001|Overall Study|Protocol Violation|1|||
129801960|NCT02979197|467243438|FG002|Overall Study|Protocol Violation|0|||
129891298|NCT00410384|467559700|FG000|Overall Study|Withdrawal by Subject|28|||
129891299|NCT00410384|467559701|FG001|Overall Study|Withdrawal by Subject|17|||
129891300|NCT00410384|467559702|FG002|Overall Study|Withdrawal by Subject|20|||
129891301|NCT00410384|467559700|FG000|Overall Study|Adverse Event|23|||
129891302|NCT00410384|467559701|FG001|Overall Study|Adverse Event|18|||
129891303|NCT00410384|467559702|FG002|Overall Study|Adverse Event|23|||
129891304|NCT00410384|467559700|FG000|Overall Study|Lack of Efficacy|20|||
129891305|NCT00410384|467559701|FG001|Overall Study|Lack of Efficacy|12|||
129891306|NCT00410384|467559702|FG002|Overall Study|Lack of Efficacy|17|||
129891307|NCT00410384|467559700|FG000|Overall Study|Lack of Compliance|2|||
129891308|NCT00410384|467559701|FG001|Overall Study|Lack of Compliance|2|||
129891309|NCT00410384|467559702|FG002|Overall Study|Lack of Compliance|2|||
129891310|NCT00410384|467559700|FG000|Overall Study|Lost to Follow-up|4|||
129891311|NCT00410384|467559701|FG001|Overall Study|Lost to Follow-up|6|||
130053473|NCT01544595|468150483|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
130053474|NCT01544595|468150478|FG000|Status at Week 156|Withdrawal by Subject|9|||
130053475|NCT01544595|468150479|FG001|Status at Week 156|Withdrawal by Subject|10|||
129801961|NCT02979197|467243436|FG000|Overall Study|Subject unable to commit to study dates|0|||
129801962|NCT02979197|467243437|FG001|Overall Study|Subject unable to commit to study dates|1|||
129801963|NCT02979197|467243438|FG002|Overall Study|Subject unable to commit to study dates|0|||
129801964|NCT03438383|467243439|FG000|Overall Study|Protocol Violation|9|||
129801965|NCT03438383|467243440|FG001|Overall Study|Protocol Violation|3|||
129801966|NCT02766465|467243441|FG000|Overall Study|Withdrawal by Subject|0|||
129801967|NCT02766465|467243442|FG001|Overall Study|Withdrawal by Subject|10|||
129801968|NCT01631812|467243443|FG000|Overall Study|Adverse Event|25|||
129801969|NCT01631812|467243443|FG000|Overall Study|Lack of Efficacy|5|||
129801970|NCT01631812|467243443|FG000|Overall Study|Withdrawal by Subject|4|||
129801971|NCT01631812|467243443|FG000|Overall Study|Physician Decision|3|||
129801972|NCT02435069|467243444|FG000|Dose Response - First Intervention|Adverse Event|0|||
129801973|NCT02435069|467243445|FG001|Dose Response - First Intervention|Adverse Event|1|||
129801974|NCT02435069|467243446|FG002|Dose Response - First Intervention|Adverse Event|1|||
129801975|NCT02435069|467243447|FG003|Dose Response - First Intervention|Adverse Event|0|||
129801976|NCT02435069|467243448|FG004|Dose Response - First Intervention|Adverse Event|0|||
129801977|NCT02435069|467243444|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801978|NCT02435069|467243445|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801979|NCT02435069|467243446|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801980|NCT02435069|467243447|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801981|NCT02435069|467243448|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
129801982|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
129801983|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
129801984|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
129801985|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
129801986|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|Death|2|||
129801987|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|Death|2|||
129891312|NCT00410384|467559702|FG002|Overall Study|Lost to Follow-up|6|||
129891313|NCT00410384|467559700|FG000|Overall Study|Protocol Violation|6|||
129891314|NCT00410384|467559701|FG001|Overall Study|Protocol Violation|6|||
129891315|NCT00410384|467559702|FG002|Overall Study|Protocol Violation|6|||
129891316|NCT00410384|467559700|FG000|Overall Study|Physician Decision|3|||
129891317|NCT00410384|467559701|FG001|Overall Study|Physician Decision|3|||
129891318|NCT00410384|467559702|FG002|Overall Study|Physician Decision|4|||
129891319|NCT00410384|467559700|FG000|Overall Study|Other|3|||
129891320|NCT00410384|467559701|FG001|Overall Study|Other|8|||
129891321|NCT00410384|467559702|FG002|Overall Study|Other|4|||
129891322|NCT01167023|467559703|FG000|Overall Study|Lost to Follow-up|0|||
129891323|NCT01167023|467559704|FG001|Overall Study|Lost to Follow-up|1|||
129891324|NCT01167023|467559705|FG002|Overall Study|Lost to Follow-up|1|||
130111221|NCT00373685|468367587|FG001|Overall Study|No longer willing to participate|352|||
130111222|NCT00373685|468367586|FG000|Overall Study|Other|149|||
129891325|NCT01167023|467559703|FG000|Overall Study|Screen Failure|0|||
129891326|NCT01167023|467559704|FG001|Overall Study|Screen Failure|1|||
129891327|NCT01167023|467559705|FG002|Overall Study|Screen Failure|0|||
129891328|NCT01167023|467559703|FG000|Overall Study|Sponsor Decision|0|||
129891329|NCT01167023|467559704|FG001|Overall Study|Sponsor Decision|1|||
129891330|NCT01167023|467559705|FG002|Overall Study|Sponsor Decision|0|||
129891331|NCT01167023|467559703|FG000|Overall Study|Withdrawal by Subject|0|||
129891332|NCT01167023|467559704|FG001|Overall Study|Withdrawal by Subject|0|||
129891333|NCT01167023|467559705|FG002|Overall Study|Withdrawal by Subject|1|||
129891334|NCT01253200|467559708|FG000|Overall Study|Death|1|||
129891335|NCT01253200|467559709|FG001|Overall Study|Death|0|||
129891336|NCT01253200|467559710|FG002|Overall Study|Death|0|||
129891337|NCT01253200|467559711|FG003|Overall Study|Death|0|||
129891338|NCT01253200|467559712|FG004|Overall Study|Death|0|||
129891339|NCT01253200|467559708|FG000|Overall Study|Lost to Follow-up|1|||
129891340|NCT01253200|467559709|FG001|Overall Study|Lost to Follow-up|1|||
129891341|NCT01253200|467559710|FG002|Overall Study|Lost to Follow-up|0|||
129891342|NCT01253200|467559711|FG003|Overall Study|Lost to Follow-up|0|||
129891343|NCT01253200|467559712|FG004|Overall Study|Lost to Follow-up|0|||
129891344|NCT01253200|467559708|FG000|Overall Study|Withdrawal by Subject|2|||
129891345|NCT01253200|467559709|FG001|Overall Study|Withdrawal by Subject|0|||
129891346|NCT01253200|467559710|FG002|Overall Study|Withdrawal by Subject|0|||
129891347|NCT01253200|467559711|FG003|Overall Study|Withdrawal by Subject|0|||
129891348|NCT01253200|467559712|FG004|Overall Study|Withdrawal by Subject|0|||
129891349|NCT01253200|467559708|FG000|Overall Study|Protocol Violation|1|||
129891350|NCT01253200|467559709|FG001|Overall Study|Protocol Violation|4|||
129891351|NCT01253200|467559710|FG002|Overall Study|Protocol Violation|0|||
129891352|NCT01253200|467559711|FG003|Overall Study|Protocol Violation|0|||
129891353|NCT01253200|467559712|FG004|Overall Study|Protocol Violation|5|||
129891354|NCT01253200|467559708|FG000|Overall Study|intents|10|||
129891355|NCT01253200|467559709|FG001|Overall Study|intents|10|||
129891356|NCT01253200|467559710|FG002|Overall Study|intents|1|||
129891357|NCT01253200|467559711|FG003|Overall Study|intents|3|||
129891358|NCT01253200|467559712|FG004|Overall Study|intents|0|||
129891359|NCT01253200|467559708|FG000|Overall Study|Attempts|6|||
129891360|NCT01253200|467559709|FG001|Overall Study|Attempts|4|||
129891361|NCT01253200|467559710|FG002|Overall Study|Attempts|1|||
129891362|NCT01253200|467559711|FG003|Overall Study|Attempts|2|||
129891363|NCT01253200|467559712|FG004|Overall Study|Attempts|0|||
129891364|NCT02049437|467559713|FG000|Period 1|Adverse Event|1|||
129891365|NCT02049437|467559714|FG001|Period 1|Adverse Event|1|||
129891366|NCT02049437|467559713|FG000|Period 1|Adverse Event|1|||
129891367|NCT02049437|467559714|FG001|Period 1|Adverse Event|0|||
129891368|NCT04529538|467559715|FG000|Overall Study|Lost to Follow-up|3|||
129891369|NCT04529538|467559716|FG001|Overall Study|Lost to Follow-up|2|||
129891370|NCT04529538|467559717|FG002|Overall Study|Lost to Follow-up|1|||
129891371|NCT04529538|467559718|FG003|Overall Study|Lost to Follow-up|0|||
129891372|NCT04529538|467559719|FG004|Overall Study|Lost to Follow-up|1|||
129891373|NCT04529538|467559720|FG005|Overall Study|Lost to Follow-up|1|||
129891374|NCT04529538|467559721|FG006|Overall Study|Lost to Follow-up|2|||
129891375|NCT04529538|467559722|FG007|Overall Study|Lost to Follow-up|0|||
129891376|NCT04529538|467559715|FG000|Overall Study|Not eligible at enrollment|0|||
129891377|NCT04529538|467559716|FG001|Overall Study|Not eligible at enrollment|1|||
130053476|NCT01544595|468150480|FG002|Status at Week 156|Withdrawal by Subject|4|||
129891378|NCT04529538|467559717|FG002|Overall Study|Not eligible at enrollment|2|||
129891379|NCT04529538|467559718|FG003|Overall Study|Not eligible at enrollment|1|||
129891380|NCT04529538|467559719|FG004|Overall Study|Not eligible at enrollment|0|||
129891381|NCT04529538|467559720|FG005|Overall Study|Not eligible at enrollment|0|||
129891382|NCT04529538|467559721|FG006|Overall Study|Not eligible at enrollment|0|||
129891383|NCT04529538|467559722|FG007|Overall Study|Not eligible at enrollment|1|||
129891384|NCT04529538|467559715|FG000|Overall Study|Withdrawal by Subject|0|||
129891385|NCT04529538|467559716|FG001|Overall Study|Withdrawal by Subject|1|||
129891386|NCT04529538|467559717|FG002|Overall Study|Withdrawal by Subject|1|||
129891387|NCT04529538|467559718|FG003|Overall Study|Withdrawal by Subject|2|||
129891388|NCT04529538|467559719|FG004|Overall Study|Withdrawal by Subject|0|||
129891389|NCT04529538|467559720|FG005|Overall Study|Withdrawal by Subject|2|||
129891390|NCT04529538|467559721|FG006|Overall Study|Withdrawal by Subject|3|||
130111223|NCT00373685|468367587|FG001|Overall Study|Other|146|||
130053477|NCT01544595|468150481|FG003|Status at Week 156|Withdrawal by Subject|9|||
130053478|NCT01544595|468150482|FG004|Status at Week 156|Withdrawal by Subject|20|||
130053479|NCT01544595|468150483|FG005|Status at Week 156|Withdrawal by Subject|6|||
130053480|NCT01544595|468150478|FG000|Status at Week 156|Adverse Event|9|||
130053481|NCT01544595|468150479|FG001|Status at Week 156|Adverse Event|11|||
130053482|NCT01544595|468150480|FG002|Status at Week 156|Adverse Event|1|||
130053483|NCT01544595|468150481|FG003|Status at Week 156|Adverse Event|3|||
130053484|NCT01544595|468150482|FG004|Status at Week 156|Adverse Event|4|||
130053485|NCT01544595|468150483|FG005|Status at Week 156|Adverse Event|2|||
130053486|NCT01544595|468150478|FG000|Status at Week 156|Lost to Follow-up|4|||
130053487|NCT01544595|468150479|FG001|Status at Week 156|Lost to Follow-up|4|||
130053488|NCT01544595|468150480|FG002|Status at Week 156|Lost to Follow-up|0|||
129801988|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
129801989|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
129801990|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
129801991|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
129801992|NCT01528033|467243449|FG000|Follow Up|No data available|46|||
129801993|NCT01528033|467243450|FG001|Follow Up|No data available|44|||
129801994|NCT02436681|467243453|FG000|Overall Study|Lost to Follow-up|10|||
129801995|NCT02436681|467243453|FG000|Overall Study|Withdrawal by Subject|2|||
129801996|NCT02436681|467243453|FG000|Overall Study|Death|2|||
129801997|NCT02030938|467243456|FG000|Overall Study|Lost to Follow-up|4|||
129801998|NCT02030938|467243456|FG000|Overall Study|Withdrawal by Subject|1|||
129801999|NCT02520661|467243458|FG000|Overall Study|Lost to Follow-up|7|||
129802000|NCT02520661|467243459|FG001|Overall Study|Lost to Follow-up|3|||
129802001|NCT02520661|467243458|FG000|Overall Study|Admitted from ED|49|||
129802002|NCT02520661|467243459|FG001|Overall Study|Admitted from ED|48|||
129802003|NCT02520661|467243458|FG000|Overall Study|ED greater than 24 hours|29|||
129802004|NCT02520661|467243459|FG001|Overall Study|ED greater than 24 hours|38|||
129802005|NCT02520661|467243458|FG000|Overall Study|other ineligibility|14|||
129802006|NCT02520661|467243459|FG001|Overall Study|other ineligibility|22|||
129802007|NCT02520661|467243458|FG000|Overall Study|Withdrawal by Subject|7|||
129802008|NCT02520661|467243459|FG001|Overall Study|Withdrawal by Subject|16|||
129802009|NCT03954132|467243460|FG000|Overall Study|Adverse Event|2|||
129802010|NCT03954132|467243461|FG001|Overall Study|Adverse Event|0|||
129802011|NCT03954132|467243460|FG000|Overall Study|Patient's wish|5|||
129802012|NCT03954132|467243461|FG001|Overall Study|Patient's wish|0|||
129802013|NCT03954132|467243460|FG000|Overall Study|Lost to Follow-up|10|||
129802014|NCT03954132|467243461|FG001|Overall Study|Lost to Follow-up|0|||
129802015|NCT03954132|467243460|FG000|Overall Study|Screening failure|0|||
129802016|NCT03954132|467243461|FG001|Overall Study|Screening failure|1|||
129802017|NCT03954132|467243460|FG000|Overall Study|No registration after Visit 1|5|||
129802018|NCT03954132|467243461|FG001|Overall Study|No registration after Visit 1|2|||
129802019|NCT03954132|467243460|FG000|Overall Study|Other reason than listed|2|||
129802020|NCT03954132|467243461|FG001|Overall Study|Other reason than listed|2|||
129802021|NCT03954132|467243460|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
129802022|NCT03954132|467243461|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
129802023|NCT03954132|467243460|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
129802024|NCT03954132|467243461|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
129802025|NCT00072176|467243464|FG000|Overall Study|Withdrawal by Subject|1|||
129802026|NCT00072176|467243465|FG001|Overall Study|Withdrawal by Subject|0|||
129802027|NCT00072176|467243464|FG000|Overall Study|Protocol Violation|0|||
129802028|NCT00072176|467243465|FG001|Overall Study|Protocol Violation|1|||
129802029|NCT04502979|467243471|FG000|Overall Study|Lost to Follow-up|1|||
129802030|NCT04502979|467243472|FG001|Overall Study|Lost to Follow-up|3|||
129802031|NCT04502979|467243471|FG000|Overall Study|Withdrawal by Subject|2|||
129802032|NCT04502979|467243472|FG001|Overall Study|Withdrawal by Subject|1|||
129802033|NCT00932737|467243480|FG000|Overall Study|Not treated in second episode|1|||
129802034|NCT00932737|467243481|FG001|Overall Study|Not treated in second episode|0|||
129802035|NCT00932737|467243480|FG000|Overall Study|Adverse Event|0|||
129802036|NCT00932737|467243481|FG001|Overall Study|Adverse Event|1|||
129802037|NCT02906332|467243486|FG000|Overall Study|Withdrawal by Subject|1|||
129802038|NCT02949700|467243487|FG000|Phase I|Withdrawal by Subject|1|||
129802039|NCT02949700|467243488|FG001|Phase I|Withdrawal by Subject|1|||
129802040|NCT02949700|467243489|FG002|Phase I|Withdrawal by Subject|0|||
129802041|NCT02949700|467243490|FG003|Phase I|Withdrawal by Subject|0|||
129802042|NCT02949700|467243487|FG000|Phase I|Protocol Violation|1|||
129802043|NCT02949700|467243488|FG001|Phase I|Protocol Violation|0|||
129802044|NCT02949700|467243489|FG002|Phase I|Protocol Violation|0|||
129802045|NCT02949700|467243490|FG003|Phase I|Protocol Violation|0|||
129802046|NCT02949700|467243487|FG000|Phase II|Withdrawal by Subject|0|||
129802047|NCT02949700|467243488|FG001|Phase II|Withdrawal by Subject|0|||
129802048|NCT02949700|467243489|FG002|Phase II|Withdrawal by Subject|0|||
129802049|NCT02949700|467243490|FG003|Phase II|Withdrawal by Subject|2|||
129802050|NCT02949700|467243487|FG000|Phase II|Protocol Violation|0|||
129802051|NCT02949700|467243488|FG001|Phase II|Protocol Violation|0|||
129802052|NCT02949700|467243489|FG002|Phase II|Protocol Violation|1|||
129802053|NCT02949700|467243490|FG003|Phase II|Protocol Violation|3|||
129802054|NCT04399837|467243494|FG000|Overall Study|Other than listed|0|||
129802055|NCT04399837|467243495|FG001|Overall Study|Other than listed|2|||
129802056|NCT04399837|467243496|FG002|Overall Study|Other than listed|2|||
129802057|NCT04399837|467243497|FG003|Overall Study|Other than listed|3|||
129802058|NCT04399837|467243494|FG000|Overall Study|Withdrawal by Subject|1|||
129802059|NCT04399837|467243495|FG001|Overall Study|Withdrawal by Subject|2|||
129802060|NCT04399837|467243496|FG002|Overall Study|Withdrawal by Subject|1|||
129802061|NCT04399837|467243497|FG003|Overall Study|Withdrawal by Subject|1|||
129802062|NCT02628769|467243509|FG000|First Intervention|Adverse Event|1|||
129802063|NCT02628769|467243510|FG001|First Intervention|Adverse Event|0|||
129802064|NCT02628769|467243509|FG000|First Intervention|Withdrawal by Subject|0|||
129802065|NCT02628769|467243510|FG001|First Intervention|Withdrawal by Subject|1|||
129802066|NCT02628769|467243509|FG000|Second Intervention|Adverse Event|2|||
129802067|NCT02628769|467243510|FG001|Second Intervention|Adverse Event|0|||
129802068|NCT02628769|467243509|FG000|Second Intervention|Physician Decision|0|||
129802069|NCT02628769|467243510|FG001|Second Intervention|Physician Decision|1|||
129802070|NCT02024555|467243511|FG000|Overall Study|Lost to Follow-up|1|||
129802071|NCT02024555|467243512|FG001|Overall Study|Lost to Follow-up|1|||
129802072|NCT02024555|467243511|FG000|Overall Study|Withdrawal by Subject|5|||
129802073|NCT02024555|467243512|FG001|Overall Study|Withdrawal by Subject|1|||
129802074|NCT02719327|467243515|FG000|Overall Study|Withdrawal by Subject|11|||
129802075|NCT02719327|467243516|FG001|Overall Study|Withdrawal by Subject|8|||
129802076|NCT03350620|467243517|FG000|Stage 2|Adverse Event|0|||
129802077|NCT03350620|467243518|FG001|Stage 2|Adverse Event|1|||
129802078|NCT03350620|467243519|FG002|Stage 2|Adverse Event|1|||
129802079|NCT03350620|467243517|FG000|Stage 2|Lack of Efficacy|0|||
129802080|NCT03350620|467243518|FG001|Stage 2|Lack of Efficacy|2|||
129802081|NCT03350620|467243519|FG002|Stage 2|Lack of Efficacy|0|||
129802082|NCT03350620|467243517|FG000|Stage 2|Lost to Follow-up|1|||
129802083|NCT03350620|467243518|FG001|Stage 2|Lost to Follow-up|2|||
129802084|NCT03350620|467243519|FG002|Stage 2|Lost to Follow-up|2|||
129891391|NCT04529538|467559722|FG007|Overall Study|Withdrawal by Subject|0|||
130053489|NCT01544595|468150481|FG003|Status at Week 156|Lost to Follow-up|1|||
130053490|NCT01544595|468150482|FG004|Status at Week 156|Lost to Follow-up|4|||
130053491|NCT01544595|468150483|FG005|Status at Week 156|Lost to Follow-up|1|||
130053492|NCT01544595|468150478|FG000|Status at Week 156|Non-compliance with study treatement|0|||
130053493|NCT01544595|468150479|FG001|Status at Week 156|Non-compliance with study treatement|1|||
130053494|NCT01544595|468150480|FG002|Status at Week 156|Non-compliance with study treatement|0|||
130053495|NCT01544595|468150481|FG003|Status at Week 156|Non-compliance with study treatement|1|||
130053496|NCT01544595|468150482|FG004|Status at Week 156|Non-compliance with study treatement|0|||
130053497|NCT01544595|468150483|FG005|Status at Week 156|Non-compliance with study treatement|1|||
129802085|NCT03350620|467243517|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
129802086|NCT03350620|467243518|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
129802087|NCT03350620|467243519|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
129802088|NCT01066000|467243522|FG000|Overall Study|Protocol Violation|4|||
129802089|NCT01066000|467243522|FG000|Overall Study|Death|3|||
129802090|NCT01066000|467243522|FG000|Overall Study|Withdrawal by Subject|1|||
129802091|NCT01066000|467243522|FG000|Overall Study|Adverse Event|1|||
129802092|NCT05268055|467243523|FG000|Overall Study|Lost to Follow-up|68|||
129802093|NCT05268055|467243524|FG001|Overall Study|Lost to Follow-up|68|||
129802094|NCT05268055|467243523|FG000|Overall Study|Withdrawal by Subject|12|||
129802095|NCT05268055|467243524|FG001|Overall Study|Withdrawal by Subject|8|||
129802096|NCT01854658|467245168|FG000|Overall Study|Protocol Violation|6|||
129802097|NCT01854658|467245169|FG001|Overall Study|Protocol Violation|2|||
129802098|NCT01854658|467245170|FG002|Overall Study|Protocol Violation|2|||
129802099|NCT01854658|467245171|FG003|Overall Study|Protocol Violation|1|||
129802100|NCT01854658|467245168|FG000|Overall Study|Physician Decision|7|||
129802101|NCT01854658|467245169|FG001|Overall Study|Physician Decision|5|||
129802102|NCT01854658|467245170|FG002|Overall Study|Physician Decision|2|||
129802103|NCT01854658|467245171|FG003|Overall Study|Physician Decision|4|||
129802104|NCT01854658|467245168|FG000|Overall Study|Lost to Follow-up|8|||
129802105|NCT01854658|467245169|FG001|Overall Study|Lost to Follow-up|9|||
129802106|NCT01854658|467245170|FG002|Overall Study|Lost to Follow-up|8|||
129802107|NCT01854658|467245171|FG003|Overall Study|Lost to Follow-up|4|||
129802108|NCT01854658|467245168|FG000|Overall Study|Withdrawal by Subject|28|||
129802109|NCT01854658|467245169|FG001|Overall Study|Withdrawal by Subject|21|||
129802110|NCT01854658|467245170|FG002|Overall Study|Withdrawal by Subject|29|||
129802111|NCT01854658|467245171|FG003|Overall Study|Withdrawal by Subject|15|||
129802112|NCT01854658|467245168|FG000|Overall Study|Protocol-specified criteria|15|||
129802113|NCT01854658|467245169|FG001|Overall Study|Protocol-specified criteria|15|||
129802114|NCT01854658|467245170|FG002|Overall Study|Protocol-specified criteria|10|||
129802115|NCT01854658|467245171|FG003|Overall Study|Protocol-specified criteria|7|||
129802116|NCT01854658|467245168|FG000|Overall Study|Lack of Efficacy|3|||
129802117|NCT01854658|467245169|FG001|Overall Study|Lack of Efficacy|8|||
129802118|NCT01854658|467245170|FG002|Overall Study|Lack of Efficacy|4|||
129802119|NCT01854658|467245171|FG003|Overall Study|Lack of Efficacy|7|||
129802120|NCT01854658|467245168|FG000|Overall Study|Adverse Event|21|||
129802121|NCT01854658|467245169|FG001|Overall Study|Adverse Event|14|||
129802122|NCT01854658|467245170|FG002|Overall Study|Adverse Event|23|||
129802123|NCT01854658|467245171|FG003|Overall Study|Adverse Event|19|||
129802124|NCT01854658|467245168|FG000|Overall Study|Administrative reasons|5|||
129802125|NCT01854658|467245169|FG001|Overall Study|Administrative reasons|1|||
129802126|NCT01854658|467245170|FG002|Overall Study|Administrative reasons|2|||
129802127|NCT01854658|467245171|FG003|Overall Study|Administrative reasons|2|||
129802128|NCT00697073|467245172|FG000|Overall Study|Withdrawal by Subject|2|||
129802129|NCT00697073|467245172|FG000|Overall Study|Pregnancy|1|||
129802130|NCT00697073|467245172|FG000|Overall Study|non compliance and other|6|||
129802131|NCT02203071|467245173|FG000|Overall Study|Lost to Follow-up|3|||
129802132|NCT02203071|467245174|FG001|Overall Study|Lost to Follow-up|1|||
129802133|NCT03894046|467245175|FG000|Overall Study|Protocol Violation|1|||
129802134|NCT03894046|467245176|FG001|Overall Study|Protocol Violation|0|||
129802135|NCT03894046|467245177|FG002|Overall Study|Protocol Violation|0|||
129802136|NCT03894046|467245175|FG000|Overall Study|Adverse Event|0|||
129802137|NCT03894046|467245176|FG001|Overall Study|Adverse Event|1|||
129802138|NCT03894046|467245177|FG002|Overall Study|Adverse Event|0|||
129802139|NCT03894046|467245175|FG000|Overall Study|Withdrawal by Subject|2|||
129802140|NCT03894046|467245176|FG001|Overall Study|Withdrawal by Subject|3|||
129802141|NCT03894046|467245177|FG002|Overall Study|Withdrawal by Subject|1|||
129802142|NCT03894046|467245175|FG000|Overall Study|Death|15|||
129802143|NCT03894046|467245176|FG001|Overall Study|Death|21|||
129802144|NCT03894046|467245177|FG002|Overall Study|Death|4|||
129802145|NCT03894046|467245175|FG000|Overall Study|No growth of ABC|2|||
129802146|NCT03894046|467245176|FG001|Overall Study|No growth of ABC|1|||
129802147|NCT03894046|467245177|FG002|Overall Study|No growth of ABC|0|||
129802148|NCT03894046|467245175|FG000|Overall Study|Physician Decision|1|||
129802149|NCT03894046|467245176|FG001|Overall Study|Physician Decision|1|||
129802150|NCT03894046|467245177|FG002|Overall Study|Physician Decision|1|||
129802151|NCT03894046|467245175|FG000|Overall Study|Prohibited concomitant medication|1|||
129802152|NCT03894046|467245176|FG001|Overall Study|Prohibited concomitant medication|0|||
129802153|NCT03894046|467245177|FG002|Overall Study|Prohibited concomitant medication|0|||
129802154|NCT03894046|467245175|FG000|Overall Study|Transferred to other arm/group|1|||
129802155|NCT03894046|467245176|FG001|Overall Study|Transferred to other arm/group|1|||
129802156|NCT03894046|467245177|FG002|Overall Study|Transferred to other arm/group|0|||
129802157|NCT02436304|467245187|FG000|Overall Study|Lost to Follow-up|0|||
129802158|NCT02436304|467245188|FG001|Overall Study|Lost to Follow-up|1|||
129802159|NCT02436304|467245189|FG002|Overall Study|Lost to Follow-up|0|||
129802160|NCT02436304|467245187|FG000|Overall Study|Withdrawal by Subject|0|||
129802161|NCT02436304|467245188|FG001|Overall Study|Withdrawal by Subject|1|||
129802162|NCT02436304|467245189|FG002|Overall Study|Withdrawal by Subject|0|||
129802163|NCT02436304|467245187|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
129802164|NCT02436304|467245188|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
129802165|NCT02436304|467245189|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
129802166|NCT03793556|467245190|FG000|Overall Study|Withdrawal by Subject|12|||
129802167|NCT03793556|467245191|FG001|Overall Study|Withdrawal by Subject|1|||
129802168|NCT03793556|467245190|FG000|Overall Study|Lost to Follow-up|1|||
129802169|NCT03793556|467245191|FG001|Overall Study|Lost to Follow-up|1|||
129802170|NCT04416633|467245192|FG000|Overall Study|Death|1|||
129802171|NCT04416633|467245192|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
129802172|NCT04416633|467245192|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
129802173|NCT04416633|467245192|FG000|Overall Study|Adverse Event|6|||
129802174|NCT04416633|467245192|FG000|Overall Study|Withdrawal by Subject|6|||
129802175|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Death|1|||
129802176|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Death|1|||
129802177|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Death|0|||
129802178|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Death|0|||
129802179|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
130053498|NCT01544595|468150478|FG000|Status at Week 156|Physician Decision|0|||
130053499|NCT01544595|468150479|FG001|Status at Week 156|Physician Decision|3|||
130053500|NCT01544595|468150480|FG002|Status at Week 156|Physician Decision|1|||
130053501|NCT01544595|468150481|FG003|Status at Week 156|Physician Decision|0|||
130053502|NCT01544595|468150482|FG004|Status at Week 156|Physician Decision|0|||
130053503|NCT01544595|468150483|FG005|Status at Week 156|Physician Decision|0|||
130053504|NCT01544595|468150478|FG000|Status at Week 156|Pregnancy|2|||
130053505|NCT01544595|468150479|FG001|Status at Week 156|Pregnancy|3|||
130053506|NCT01544595|468150480|FG002|Status at Week 156|Pregnancy|0|||
130053507|NCT01544595|468150481|FG003|Status at Week 156|Pregnancy|0|||
130053508|NCT01544595|468150482|FG004|Status at Week 156|Pregnancy|0|||
130053509|NCT01544595|468150483|FG005|Status at Week 156|Pregnancy|0|||
130053510|NCT01544595|468150478|FG000|Status at Week 156|Protocol Violation|3|||
130053511|NCT01544595|468150479|FG001|Status at Week 156|Protocol Violation|1|||
130053512|NCT01544595|468150480|FG002|Status at Week 156|Protocol Violation|2|||
130053513|NCT01544595|468150481|FG003|Status at Week 156|Protocol Violation|2|||
130053514|NCT01544595|468150482|FG004|Status at Week 156|Protocol Violation|0|||
130053515|NCT01544595|468150483|FG005|Status at Week 156|Protocol Violation|0|||
130053516|NCT01544595|468150478|FG000|Status at Week 156|Technical problems|3|||
129891392|NCT04529538|467559715|FG000|Overall Study|Other|0|||
130053517|NCT01544595|468150479|FG001|Status at Week 156|Technical problems|1|||
130053518|NCT01544595|468150480|FG002|Status at Week 156|Technical problems|0|||
130053519|NCT01544595|468150481|FG003|Status at Week 156|Technical problems|1|||
130053520|NCT01544595|468150482|FG004|Status at Week 156|Technical problems|0|||
130053521|NCT01544595|468150483|FG005|Status at Week 156|Technical problems|0|||
130053522|NCT01544595|468150478|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
130053523|NCT01544595|468150479|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
130053524|NCT01544595|468150480|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
130053525|NCT01544595|468150481|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
130053526|NCT01544595|468150482|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
130053527|NCT01544595|468150483|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
130053528|NCT01544595|468150478|FG000|Status at Week 156|Lack of Efficacy|1|||
130053529|NCT01544595|468150479|FG001|Status at Week 156|Lack of Efficacy|0|||
130053530|NCT01544595|468150480|FG002|Status at Week 156|Lack of Efficacy|1|||
129802180|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
129802181|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
129802182|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
129802183|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
129802184|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
129802185|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
129802186|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
129802187|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
129802188|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
129802189|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
129802190|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
129802191|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
129802192|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
129802193|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
129802194|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
129802195|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Other|1|||
129802196|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Other|0|||
129802197|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Other|0|||
129802198|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Other|0|||
129802199|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130053531|NCT01544595|468150481|FG003|Status at Week 156|Lack of Efficacy|4|||
130053532|NCT01544595|468150482|FG004|Status at Week 156|Lack of Efficacy|10|||
130053533|NCT01544595|468150483|FG005|Status at Week 156|Lack of Efficacy|5|||
130053534|NCT03288779|468150497|FG000|Overall Study|Withdrawal by Subject|3|||
130053535|NCT00601523|468150498|FG000|Overall Study|Adverse Event|42|||
129802200|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
130053536|NCT00601523|468150499|FG001|Overall Study|Adverse Event|14|||
129802201|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
129802202|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
129802203|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
129802204|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
129802205|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
129802206|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
129802207|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
129802208|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
129802209|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
129802210|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
129802211|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Other|0|||
129802212|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Other|0|||
129802213|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Other|0|||
129802214|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Other|1|||
129802215|NCT00785928|467245197|FG000|Treatment Phase|Adverse Event|1|||
129802216|NCT00785928|467245198|FG001|Treatment Phase|Adverse Event|1|||
129802217|NCT00785928|467245199|FG002|Treatment Phase|Adverse Event|2|||
129802218|NCT00785928|467245200|FG003|Treatment Phase|Adverse Event|0|||
129802219|NCT00785928|467245201|FG004|Treatment Phase|Adverse Event|0|||
129802220|NCT00785928|467245202|FG005|Treatment Phase|Adverse Event|0|||
129802221|NCT00785928|467245203|FG006|Treatment Phase|Adverse Event|2|||
129802222|NCT00785928|467245197|FG000|Treatment Phase|Inadequate Response|0|||
129802223|NCT00785928|467245198|FG001|Treatment Phase|Inadequate Response|1|||
129802224|NCT00785928|467245199|FG002|Treatment Phase|Inadequate Response|0|||
129802225|NCT00785928|467245200|FG003|Treatment Phase|Inadequate Response|0|||
129802226|NCT00785928|467245201|FG004|Treatment Phase|Inadequate Response|0|||
129802227|NCT00785928|467245202|FG005|Treatment Phase|Inadequate Response|0|||
129802228|NCT00785928|467245203|FG006|Treatment Phase|Inadequate Response|0|||
129802229|NCT00785928|467245197|FG000|Treatment Phase|Lack of Efficacy|0|||
129802230|NCT00785928|467245198|FG001|Treatment Phase|Lack of Efficacy|1|||
129802231|NCT00785928|467245199|FG002|Treatment Phase|Lack of Efficacy|1|||
129802232|NCT00785928|467245200|FG003|Treatment Phase|Lack of Efficacy|0|||
129802233|NCT00785928|467245201|FG004|Treatment Phase|Lack of Efficacy|0|||
129802234|NCT00785928|467245202|FG005|Treatment Phase|Lack of Efficacy|0|||
129802235|NCT00785928|467245203|FG006|Treatment Phase|Lack of Efficacy|0|||
129802236|NCT00785928|467245197|FG000|Treatment Phase|Physician Decision|0|||
129802237|NCT00785928|467245198|FG001|Treatment Phase|Physician Decision|0|||
129802238|NCT00785928|467245199|FG002|Treatment Phase|Physician Decision|0|||
129802239|NCT00785928|467245200|FG003|Treatment Phase|Physician Decision|0|||
129802240|NCT00785928|467245201|FG004|Treatment Phase|Physician Decision|1|||
129802241|NCT00785928|467245202|FG005|Treatment Phase|Physician Decision|0|||
129802242|NCT00785928|467245203|FG006|Treatment Phase|Physician Decision|0|||
129802243|NCT00785928|467245197|FG000|Treatment Phase|Sponsor Decision|1|||
129802244|NCT00785928|467245198|FG001|Treatment Phase|Sponsor Decision|0|||
129802245|NCT00785928|467245199|FG002|Treatment Phase|Sponsor Decision|0|||
129802246|NCT00785928|467245200|FG003|Treatment Phase|Sponsor Decision|0|||
129802247|NCT00785928|467245201|FG004|Treatment Phase|Sponsor Decision|0|||
129802248|NCT00785928|467245202|FG005|Treatment Phase|Sponsor Decision|0|||
129802249|NCT00785928|467245203|FG006|Treatment Phase|Sponsor Decision|1|||
129891393|NCT04529538|467559716|FG001|Overall Study|Other|1|||
130053537|NCT00601523|468150498|FG000|Overall Study|Lack of Efficacy|3|||
130053538|NCT00601523|468150499|FG001|Overall Study|Lack of Efficacy|0|||
130053539|NCT00601523|468150498|FG000|Overall Study|Protocol Violation|5|||
130053540|NCT00601523|468150499|FG001|Overall Study|Protocol Violation|1|||
130053541|NCT00601523|468150498|FG000|Overall Study|Lost to Follow-up|0|||
130053542|NCT00601523|468150499|FG001|Overall Study|Lost to Follow-up|1|||
130053543|NCT00601523|468150498|FG000|Overall Study|Withdrawal by Subject|18|||
130053544|NCT00601523|468150499|FG001|Overall Study|Withdrawal by Subject|9|||
130053545|NCT00601523|468150498|FG000|Overall Study|Other|9|||
130053546|NCT00601523|468150499|FG001|Overall Study|Other|1|||
130053547|NCT02149836|468150502|FG000|Overall Study|Withdrawal by Subject|1|||
130053548|NCT01204658|468150503|FG000|Primary Phase|Adverse Event|0|||
130053549|NCT01204658|468150504|FG001|Primary Phase|Adverse Event|0|||
130053550|NCT01204658|468150505|FG002|Primary Phase|Adverse Event|1|||
130053551|NCT01204658|468150506|FG003|Primary Phase|Adverse Event|0|||
130053552|NCT01064648|468150511|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
129802250|NCT00785928|467245197|FG000|Treatment Phase|Withdrawal by Subject|1|||
129802251|NCT00785928|467245198|FG001|Treatment Phase|Withdrawal by Subject|2|||
129802252|NCT00785928|467245199|FG002|Treatment Phase|Withdrawal by Subject|0|||
129802253|NCT00785928|467245200|FG003|Treatment Phase|Withdrawal by Subject|0|||
129802254|NCT00785928|467245201|FG004|Treatment Phase|Withdrawal by Subject|1|||
129802255|NCT00785928|467245202|FG005|Treatment Phase|Withdrawal by Subject|0|||
129802256|NCT00785928|467245203|FG006|Treatment Phase|Withdrawal by Subject|0|||
129802257|NCT05021081|467245208|FG000|Phase 2|Subject enrolled in error|1|||
129802258|NCT05021081|467245209|FG001|Phase 2|Subject enrolled in error|1|||
129802259|NCT05021081|467245210|FG002|Phase 2|Subject enrolled in error|0|||
129802260|NCT00369122|467245211|FG000|Overall Study|Ineligible|10|||
129802261|NCT00369122|467245211|FG000|Overall Study|No protocol treatment|1|||
129802262|NCT00408629|467245212|FG000|Overall Study|Adverse Event|13|||
129802263|NCT00408629|467245213|FG001|Overall Study|Adverse Event|27|||
129802264|NCT00408629|467245212|FG000|Overall Study|Withdrawal by Subject|8|||
129802265|NCT00408629|467245213|FG001|Overall Study|Withdrawal by Subject|4|||
129802266|NCT00408629|467245212|FG000|Overall Study|Lost to Follow-up|1|||
129802267|NCT00408629|467245213|FG001|Overall Study|Lost to Follow-up|1|||
129802268|NCT00408629|467245212|FG000|Overall Study|Lack of Efficacy|63|||
129802269|NCT00408629|467245213|FG001|Overall Study|Lack of Efficacy|73|||
129802270|NCT00408629|467245212|FG000|Overall Study|Protocol Violation|1|||
129802271|NCT00408629|467245213|FG001|Overall Study|Protocol Violation|5|||
129802272|NCT00408629|467245212|FG000|Overall Study|Miscellaneous|11|||
129802273|NCT00408629|467245213|FG001|Overall Study|Miscellaneous|15|||
129802274|NCT00191906|467245214|FG000|Study Period II|Adverse Event|0|||
129802275|NCT00191906|467245215|FG001|Study Period II|Adverse Event|1|||
129802276|NCT00191906|467245216|FG002|Study Period II|Adverse Event|0|||
129802277|NCT00191906|467245217|FG003|Study Period II|Adverse Event|0|||
129802278|NCT00191906|467245214|FG000|Study Period II|Withdrawal by Subject|0|||
129802279|NCT00191906|467245215|FG001|Study Period II|Withdrawal by Subject|3|||
129802280|NCT00191906|467245216|FG002|Study Period II|Withdrawal by Subject|0|||
129802281|NCT00191906|467245217|FG003|Study Period II|Withdrawal by Subject|0|||
129802282|NCT00191906|467245214|FG000|Study Period II|Parent/Caregiver Decision|0|||
129802283|NCT00191906|467245215|FG001|Study Period II|Parent/Caregiver Decision|1|||
129802284|NCT00191906|467245216|FG002|Study Period II|Parent/Caregiver Decision|0|||
129802285|NCT00191906|467245217|FG003|Study Period II|Parent/Caregiver Decision|0|||
129802286|NCT00191906|467245214|FG000|Study Period II|Entry Criteria Exclusion|0|||
129802287|NCT00191906|467245215|FG001|Study Period II|Entry Criteria Exclusion|0|||
129802288|NCT00191906|467245216|FG002|Study Period II|Entry Criteria Exclusion|1|||
129802289|NCT00191906|467245217|FG003|Study Period II|Entry Criteria Exclusion|0|||
129802290|NCT00191906|467245214|FG000|Study Period III|Adverse Event|1|||
129802291|NCT00191906|467245215|FG001|Study Period III|Adverse Event|0|||
129802292|NCT00191906|467245216|FG002|Study Period III|Adverse Event|0|||
129802293|NCT00191906|467245217|FG003|Study Period III|Adverse Event|0|||
129802294|NCT00191906|467245214|FG000|Study Period III|Lost to Follow-up|0|||
129802295|NCT00191906|467245215|FG001|Study Period III|Lost to Follow-up|1|||
129802296|NCT00191906|467245216|FG002|Study Period III|Lost to Follow-up|0|||
129802297|NCT00191906|467245217|FG003|Study Period III|Lost to Follow-up|0|||
129802298|NCT00191906|467245214|FG000|Study Period III|Parent/Caregiver Decision|1|||
129802299|NCT00191906|467245215|FG001|Study Period III|Parent/Caregiver Decision|0|||
129802300|NCT00191906|467245216|FG002|Study Period III|Parent/Caregiver Decision|0|||
129802301|NCT00191906|467245217|FG003|Study Period III|Parent/Caregiver Decision|0|||
130111224|NCT00373685|468367586|FG000|Overall Study|Protocol Violation|191|||
130111225|NCT00373685|468367587|FG001|Overall Study|Protocol Violation|182|||
130111226|NCT00373685|468367586|FG000|Overall Study|Final Status Unknown|12|||
130111227|NCT00373685|468367587|FG001|Overall Study|Final Status Unknown|4|||
129802302|NCT00191906|467245214|FG000|Study Period III|Lack of Efficacy|3|||
129802303|NCT00191906|467245215|FG001|Study Period III|Lack of Efficacy|3|||
129802304|NCT00191906|467245216|FG002|Study Period III|Lack of Efficacy|0|||
129802305|NCT00191906|467245217|FG003|Study Period III|Lack of Efficacy|0|||
129802306|NCT00573937|467245218|FG000|Overall Study|Study Terminated|0|||
129802307|NCT00573937|467245219|FG001|Overall Study|Study Terminated|1|||
129802308|NCT00333801|467245220|FG000|Overall Study|Moved to another state|5|||
129802309|NCT00333801|467245221|FG001|Overall Study|Moved to another state|3|||
129802310|NCT00333801|467245220|FG000|Overall Study|Lost to Follow-up|2|||
129802311|NCT00333801|467245221|FG001|Overall Study|Lost to Follow-up|0|||
129802312|NCT00333801|467245220|FG000|Overall Study|Incarcerated|1|||
129802313|NCT00333801|467245221|FG001|Overall Study|Incarcerated|2|||
130053553|NCT01064648|468150512|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
130053554|NCT01064648|468150513|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
130053555|NCT01064648|468150514|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
130053556|NCT01064648|468150511|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
129802314|NCT00333801|467245220|FG000|Overall Study|Withdrawal by Subject|0|||
129802315|NCT00333801|467245221|FG001|Overall Study|Withdrawal by Subject|1|||
129802316|NCT01999114|467245224|FG000|Overall Study|Adverse Event|8|||
129802317|NCT01999114|467245225|FG001|Overall Study|Adverse Event|7|||
129802318|NCT01999114|467245226|FG002|Overall Study|Adverse Event|2|||
129802319|NCT01999114|467245227|FG003|Overall Study|Adverse Event|2|||
129802320|NCT01999114|467245228|FG004|Overall Study|Adverse Event|1|||
129802321|NCT01999114|467245224|FG000|Overall Study|Withdrawal by Subject|0|||
129802322|NCT01999114|467245225|FG001|Overall Study|Withdrawal by Subject|0|||
129802323|NCT01999114|467245226|FG002|Overall Study|Withdrawal by Subject|1|||
129802324|NCT01999114|467245227|FG003|Overall Study|Withdrawal by Subject|0|||
129802325|NCT01999114|467245228|FG004|Overall Study|Withdrawal by Subject|1|||
129802326|NCT01999114|467245224|FG000|Overall Study|Lost to Follow-up|0|||
129802327|NCT01999114|467245225|FG001|Overall Study|Lost to Follow-up|0|||
129802328|NCT01999114|467245226|FG002|Overall Study|Lost to Follow-up|1|||
129802329|NCT01999114|467245227|FG003|Overall Study|Lost to Follow-up|0|||
129802330|NCT01999114|467245228|FG004|Overall Study|Lost to Follow-up|0|||
129802331|NCT01999114|467245224|FG000|Overall Study|Administrative|0|||
129802332|NCT01999114|467245225|FG001|Overall Study|Administrative|0|||
129802333|NCT01999114|467245226|FG002|Overall Study|Administrative|1|||
129802334|NCT01999114|467245227|FG003|Overall Study|Administrative|1|||
129802335|NCT01999114|467245228|FG004|Overall Study|Administrative|2|||
129802336|NCT01497275|467245231|FG000|Overall Study|Death|1|||
129802337|NCT01497275|467245231|FG000|Overall Study|Adverse Event|1|||
129802338|NCT01950169|467245232|FG000|Overall Study|Withdrawal by Subject|2|||
129802339|NCT01950169|467245233|FG001|Overall Study|Withdrawal by Subject|8|||
129802340|NCT01950169|467245234|FG002|Overall Study|Withdrawal by Subject|1|||
129802341|NCT01950169|467245232|FG000|Overall Study|Death|1|||
129802342|NCT01950169|467245233|FG001|Overall Study|Death|0|||
129802343|NCT01950169|467245234|FG002|Overall Study|Death|0|||
129802344|NCT02083081|467245240|FG000|Overall Study|Lost to Follow-up|31|||
129802345|NCT02083081|467245241|FG001|Overall Study|Lost to Follow-up|9|||
129802346|NCT01104155|467245242|FG000|Overall Study|Adverse Event|15|||
129802347|NCT01104155|467245243|FG001|Overall Study|Adverse Event|8|||
129802348|NCT01104155|467245242|FG000|Overall Study|Participant choice|6|||
129802349|NCT01104155|467245243|FG001|Overall Study|Participant choice|5|||
129802350|NCT01104155|467245242|FG000|Overall Study|Withdrawal of consent|1|||
129802351|NCT01104155|467245243|FG001|Overall Study|Withdrawal of consent|1|||
129802352|NCT01104155|467245242|FG000|Overall Study|Other|3|||
129802353|NCT01104155|467245243|FG001|Overall Study|Other|4|||
130053557|NCT01064648|468150512|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
130053558|NCT01064648|468150513|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
130053559|NCT01064648|468150514|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
130053560|NCT01064648|468150511|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
129802354|NCT01484132|467245249|FG000|Overall Study|Lost to Follow-up|8|||
129802355|NCT01484132|467245249|FG000|Overall Study|Difficulty with time commitment|2|||
129802356|NCT01484132|467245249|FG000|Overall Study|Ineligible|1|||
129802357|NCT01484132|467245249|FG000|Overall Study|No pre-treatment urine sample collected|1|||
129802358|NCT01484132|467245249|FG000|Overall Study|No post-treatment urine sample collected|10|||
129802359|NCT03799211|467245250|FG000|Overall Study|Lost to Follow-up|2|||
129802360|NCT03799211|467245251|FG001|Overall Study|Lost to Follow-up|13|||
129891394|NCT04529538|467559717|FG002|Overall Study|Other|0|||
130053561|NCT01064648|468150512|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
130053562|NCT01064648|468150513|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
129891395|NCT04529538|467559718|FG003|Overall Study|Other|0|||
130053563|NCT01064648|468150514|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
130053564|NCT01064648|468150511|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
130053565|NCT01064648|468150512|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
130053566|NCT01064648|468150513|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
130053567|NCT01064648|468150514|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
130053568|NCT01064648|468150511|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
130053569|NCT01064648|468150512|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
130053570|NCT01064648|468150513|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
130053571|NCT01064648|468150514|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
130053572|NCT01064648|468150511|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
130053573|NCT01064648|468150512|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
130053574|NCT01064648|468150513|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
130053575|NCT01064648|468150514|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
129802361|NCT03799211|467245250|FG000|Overall Study|Withdrawal by Subject|2|||
130053576|NCT01064648|468150511|FG000|Phase II|Adverse Event|0|||
130053577|NCT01064648|468150512|FG001|Phase II|Adverse Event|0|||
130111228|NCT00373685|468367586|FG000|Overall Study|Randomized, not treated|51|||
129802362|NCT03799211|467245251|FG001|Overall Study|Withdrawal by Subject|0|||
129802363|NCT00764491|467245252|FG000|Overall Study|Lost to Follow-up|35|||
129802364|NCT00764491|467245253|FG001|Overall Study|Lost to Follow-up|17|||
129802365|NCT03139279|467245256|FG000|Overall Study|Physician Decision|2|||
129802366|NCT03139279|467245257|FG001|Overall Study|Physician Decision|0|||
129802367|NCT03139279|467245256|FG000|Overall Study|Protocol Violation|5|||
129802368|NCT03139279|467245257|FG001|Overall Study|Protocol Violation|4|||
129802369|NCT03139279|467245256|FG000|Overall Study|Withdrawal by Subject|0|||
129802370|NCT03139279|467245257|FG001|Overall Study|Withdrawal by Subject|2|||
129802371|NCT01336569|467245258|FG000|Overall Study|Lost to Follow-up|4|||
129802372|NCT02337738|467245259|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
130053578|NCT01064648|468150513|FG002|Phase II|Adverse Event|15|||
129802373|NCT02337738|467245260|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
129802374|NCT02337738|467245261|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
130053579|NCT01064648|468150514|FG003|Phase II|Adverse Event|8|||
129891396|NCT04529538|467559719|FG004|Overall Study|Other|0|||
129802375|NCT02337738|467245259|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129802376|NCT02337738|467245260|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
129802377|NCT02337738|467245261|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
129802378|NCT02337738|467245259|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
129802379|NCT02337738|467245260|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
129802380|NCT02337738|467245261|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
129802381|NCT02337738|467245259|FG000|Overall Study|Voluntary Withdrawal|10|||
129802382|NCT02337738|467245260|FG001|Overall Study|Voluntary Withdrawal|5|||
129891397|NCT04529538|467559720|FG005|Overall Study|Other|0|||
129802383|NCT02337738|467245261|FG002|Overall Study|Voluntary Withdrawal|2|||
129802384|NCT02337738|467245259|FG000|Overall Study|Lack of Efficacy|2|||
129802385|NCT02337738|467245260|FG001|Overall Study|Lack of Efficacy|4|||
129802386|NCT02337738|467245261|FG002|Overall Study|Lack of Efficacy|0|||
129802387|NCT02337738|467245259|FG000|Overall Study|Investigator's Judgment|1|||
129802388|NCT02337738|467245260|FG001|Overall Study|Investigator's Judgment|1|||
129802389|NCT02337738|467245261|FG002|Overall Study|Investigator's Judgment|3|||
129802390|NCT00406354|467245262|FG000|All Randomized Patients|Protocol Violation|0|||
129802391|NCT00406354|467245263|FG001|All Randomized Patients|Protocol Violation|0|||
129802392|NCT00406354|467245264|FG002|All Randomized Patients|Protocol Violation|1|||
129802393|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
129802394|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
129802395|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
129802396|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Adverse Event|6|||
129802397|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Adverse Event|2|||
129802398|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Adverse Event|1|||
129802399|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
129802400|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
129802401|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
129802402|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
129802403|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
129802404|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
129802405|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Physician Decision|0|||
129802406|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Physician Decision|0|||
129802407|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Physician Decision|1|||
129802408|NCT01460368|467245265|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802409|NCT01460368|467245266|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802410|NCT01460368|467245267|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802411|NCT01460368|467245268|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802412|NCT01460368|467245269|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
129802413|NCT01460368|467245270|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802414|NCT01460368|467245271|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802415|NCT01460368|467245265|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802416|NCT01460368|467245266|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
129802417|NCT01460368|467245267|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802418|NCT01460368|467245268|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802419|NCT01460368|467245269|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802420|NCT01460368|467245270|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802421|NCT01460368|467245271|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
129802422|NCT01460368|467245265|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802423|NCT01460368|467245266|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
129802424|NCT01460368|467245267|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802425|NCT01460368|467245268|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802426|NCT01460368|467245269|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802427|NCT01460368|467245270|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802428|NCT01460368|467245271|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802429|NCT01460368|467245265|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802430|NCT01460368|467245266|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802431|NCT01460368|467245267|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
129802432|NCT01460368|467245268|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802433|NCT01460368|467245269|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802434|NCT01460368|467245270|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802435|NCT01460368|467245271|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
130053580|NCT01064648|468150511|FG000|Phase II|Death|0|||
130053581|NCT01064648|468150512|FG001|Phase II|Death|0|||
130053582|NCT01064648|468150513|FG002|Phase II|Death|4|||
130053583|NCT01064648|468150514|FG003|Phase II|Death|5|||
130053584|NCT01064648|468150511|FG000|Phase II|Withdrawal by Subject|0|||
130111229|NCT00373685|468367587|FG001|Overall Study|Randomized, not treated|77|||
130111230|NCT00575328|468367588|FG000|Overall Study|Adverse Event|1|||
130111231|NCT00575328|468367589|FG001|Overall Study|Adverse Event|1|||
130111232|NCT00575328|468367588|FG000|Overall Study|Lost to Follow-up|2|||
130111233|NCT00575328|468367589|FG001|Overall Study|Lost to Follow-up|1|||
130111234|NCT02124746|468367590|FG000|Overall Study|Adverse Event|2|||
130111235|NCT02124746|468367591|FG001|Overall Study|Adverse Event|1|||
130111236|NCT02124746|468367592|FG002|Overall Study|Adverse Event|2|||
130111237|NCT02124746|468367590|FG000|Overall Study|Death|2|||
130111238|NCT02124746|468367591|FG001|Overall Study|Death|1|||
130111239|NCT02124746|468367592|FG002|Overall Study|Death|3|||
130111240|NCT02124746|468367590|FG000|Overall Study|Lack of Efficacy|3|||
130111241|NCT02124746|468367591|FG001|Overall Study|Lack of Efficacy|2|||
130111242|NCT02124746|468367592|FG002|Overall Study|Lack of Efficacy|2|||
130111243|NCT02124746|468367590|FG000|Overall Study|Physician Decision|6|||
130111244|NCT02124746|468367591|FG001|Overall Study|Physician Decision|4|||
130111245|NCT02124746|468367592|FG002|Overall Study|Physician Decision|5|||
130111246|NCT02124746|468367590|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130111247|NCT02124746|468367591|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130111248|NCT02124746|468367592|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130111249|NCT02124746|468367590|FG000|Overall Study|Withdrawal by Subject|3|||
129802436|NCT01460368|467245265|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802437|NCT01460368|467245266|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802438|NCT01460368|467245267|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
129802439|NCT01460368|467245268|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
129802440|NCT01460368|467245269|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802441|NCT01460368|467245270|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
129802442|NCT01460368|467245271|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802443|NCT00747461|467245278|FG000|Overall Study|study terminated by sponsor|5|||
129802444|NCT00299182|467245294|FG000|Overall Study|Withdrawal by Subject|0|||
129802445|NCT00299182|467245295|FG001|Overall Study|Withdrawal by Subject|0|||
130053585|NCT01064648|468150512|FG001|Phase II|Withdrawal by Subject|0|||
130053586|NCT01064648|468150513|FG002|Phase II|Withdrawal by Subject|2|||
129802446|NCT00299182|467245296|FG002|Overall Study|Withdrawal by Subject|1|||
129802447|NCT00299182|467245297|FG003|Overall Study|Withdrawal by Subject|0|||
129802448|NCT00299182|467245298|FG004|Overall Study|Withdrawal by Subject|1|||
129802449|NCT00299182|467245299|FG005|Overall Study|Withdrawal by Subject|2|||
129802450|NCT00299182|467245300|FG006|Overall Study|Withdrawal by Subject|0|||
129802451|NCT00299182|467245294|FG000|Overall Study|Chemotherapy Changed|0|||
129802452|NCT00299182|467245295|FG001|Overall Study|Chemotherapy Changed|0|||
129802453|NCT00299182|467245296|FG002|Overall Study|Chemotherapy Changed|1|||
129802454|NCT00299182|467245297|FG003|Overall Study|Chemotherapy Changed|0|||
129802455|NCT00299182|467245298|FG004|Overall Study|Chemotherapy Changed|1|||
129802456|NCT00299182|467245299|FG005|Overall Study|Chemotherapy Changed|0|||
129802457|NCT00299182|467245300|FG006|Overall Study|Chemotherapy Changed|1|||
130053587|NCT01064648|468150514|FG003|Phase II|Withdrawal by Subject|5|||
130053588|NCT01064648|468150511|FG000|Phase II|Progression|0|||
130053589|NCT01064648|468150512|FG001|Phase II|Progression|0|||
130053590|NCT01064648|468150513|FG002|Phase II|Progression|21|||
130053591|NCT01064648|468150514|FG003|Phase II|Progression|27|||
129802458|NCT00299182|467245294|FG000|Overall Study|Adverse Event|0|||
129802459|NCT00299182|467245295|FG001|Overall Study|Adverse Event|0|||
129802460|NCT00299182|467245296|FG002|Overall Study|Adverse Event|0|||
129802461|NCT00299182|467245297|FG003|Overall Study|Adverse Event|0|||
129802462|NCT00299182|467245298|FG004|Overall Study|Adverse Event|0|||
129802463|NCT00299182|467245299|FG005|Overall Study|Adverse Event|1|||
129802464|NCT00299182|467245300|FG006|Overall Study|Adverse Event|0|||
129802465|NCT00299182|467245294|FG000|Overall Study|Not Eligible|0|||
129802466|NCT00299182|467245295|FG001|Overall Study|Not Eligible|0|||
129802467|NCT00299182|467245296|FG002|Overall Study|Not Eligible|0|||
130053592|NCT01064648|468150511|FG000|Phase II|Non-protocol specified|0|||
129802468|NCT00299182|467245297|FG003|Overall Study|Not Eligible|0|||
130053593|NCT01064648|468150512|FG001|Phase II|Non-protocol specified|0|||
129802469|NCT00299182|467245298|FG004|Overall Study|Not Eligible|1|||
129802470|NCT00299182|467245299|FG005|Overall Study|Not Eligible|0|||
129802471|NCT00299182|467245300|FG006|Overall Study|Not Eligible|0|||
129802472|NCT01565642|467245305|FG000|Overall Study|Withdrawal by Subject|2|||
129802473|NCT01565642|467245306|FG001|Overall Study|Withdrawal by Subject|1|||
129802474|NCT01898208|467245309|FG000|Overall Study|Positive blood culture|17|||
129802475|NCT01898208|467245310|FG001|Overall Study|Positive blood culture|23|||
129802476|NCT01898208|467245311|FG002|Overall Study|Positive blood culture|15|||
129802477|NCT01898208|467245309|FG000|Overall Study|Death/comfort care within 24 hours|10|||
129802478|NCT01898208|467245310|FG001|Overall Study|Death/comfort care within 24 hours|9|||
129802479|NCT01898208|467245311|FG002|Overall Study|Death/comfort care within 24 hours|8|||
129802480|NCT01898208|467245309|FG000|Overall Study|Negative Gram Stain|6|||
129802481|NCT01898208|467245310|FG001|Overall Study|Negative Gram Stain|9|||
129891398|NCT04529538|467559721|FG006|Overall Study|Other|0|||
129802482|NCT01898208|467245311|FG002|Overall Study|Negative Gram Stain|6|||
129802483|NCT01898208|467245309|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
129802484|NCT01898208|467245310|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
129802485|NCT01898208|467245311|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
129802486|NCT01898208|467245309|FG000|Overall Study|System/Technical Error|1|||
129802487|NCT01898208|467245310|FG001|Overall Study|System/Technical Error|2|||
129802488|NCT01898208|467245311|FG002|Overall Study|System/Technical Error|3|||
129891399|NCT04529538|467559722|FG007|Overall Study|Other|0|||
130111250|NCT02124746|468367591|FG001|Overall Study|Withdrawal by Subject|3|||
130111251|NCT02124746|468367592|FG002|Overall Study|Withdrawal by Subject|0|||
130111252|NCT02124746|468367590|FG000|Overall Study|Study Terminated by Sponsor|0|||
130111253|NCT02124746|468367591|FG001|Overall Study|Study Terminated by Sponsor|0|||
129802489|NCT01898208|467245309|FG000|Overall Study|Lost to Follow-up|3|||
129802490|NCT01898208|467245310|FG001|Overall Study|Lost to Follow-up|1|||
129802491|NCT01898208|467245311|FG002|Overall Study|Lost to Follow-up|1|||
129802492|NCT03001882|467245314|FG000|Overall Study|Death|1|||
129802493|NCT03001882|467245315|FG001|Overall Study|Death|0|||
129802494|NCT03001882|467245316|FG002|Overall Study|Death|0|||
129802495|NCT03001882|467245317|FG003|Overall Study|Death|3|||
129802496|NCT03001882|467245314|FG000|Overall Study|Participant withdrew consent|0|||
129802497|NCT03001882|467245315|FG001|Overall Study|Participant withdrew consent|1|||
129802498|NCT03001882|467245316|FG002|Overall Study|Participant withdrew consent|0|||
129802499|NCT03001882|467245317|FG003|Overall Study|Participant withdrew consent|5|||
129802500|NCT03001882|467245314|FG000|Overall Study|Other reasons|1|||
129802501|NCT03001882|467245315|FG001|Overall Study|Other reasons|2|||
129802502|NCT03001882|467245316|FG002|Overall Study|Other reasons|0|||
129802503|NCT03001882|467245317|FG003|Overall Study|Other reasons|5|||
129802504|NCT03001882|467245314|FG000|Overall Study|Administrative reason by sponsor|0|||
129802505|NCT03001882|467245315|FG001|Overall Study|Administrative reason by sponsor|0|||
129802506|NCT03001882|467245316|FG002|Overall Study|Administrative reason by sponsor|0|||
129802507|NCT03001882|467245317|FG003|Overall Study|Administrative reason by sponsor|1|||
129802508|NCT03001882|467245314|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
129802509|NCT03001882|467245315|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
129802510|NCT03001882|467245316|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
129802511|NCT03001882|467245317|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
129802512|NCT03001882|467245314|FG000|Overall Study|Not reported|0|||
129802513|NCT03001882|467245315|FG001|Overall Study|Not reported|0|||
129802514|NCT03001882|467245316|FG002|Overall Study|Not reported|0|||
129802515|NCT03001882|467245317|FG003|Overall Study|Not reported|6|||
129802516|NCT03001882|467245314|FG000|Overall Study|Maximum clinical benefit|2|||
129802517|NCT03001882|467245315|FG001|Overall Study|Maximum clinical benefit|3|||
129802518|NCT03001882|467245316|FG002|Overall Study|Maximum clinical benefit|0|||
129802519|NCT03001882|467245317|FG003|Overall Study|Maximum clinical benefit|10|||
129802520|NCT03001882|467245314|FG000|Overall Study|AE unrelated to study drug|3|||
129802521|NCT03001882|467245315|FG001|Overall Study|AE unrelated to study drug|3|||
129802522|NCT03001882|467245316|FG002|Overall Study|AE unrelated to study drug|0|||
129802523|NCT03001882|467245317|FG003|Overall Study|AE unrelated to study drug|11|||
129802524|NCT03001882|467245314|FG000|Overall Study|Study Drug Toxicity|8|||
129802525|NCT03001882|467245315|FG001|Overall Study|Study Drug Toxicity|5|||
129802526|NCT03001882|467245316|FG002|Overall Study|Study Drug Toxicity|0|||
129802527|NCT03001882|467245317|FG003|Overall Study|Study Drug Toxicity|37|||
129802528|NCT03001882|467245314|FG000|Overall Study|Disease progression|16|||
129802529|NCT03001882|467245315|FG001|Overall Study|Disease progression|14|||
129802530|NCT03001882|467245316|FG002|Overall Study|Disease progression|1|||
129802531|NCT03001882|467245317|FG003|Overall Study|Disease progression|90|||
129802532|NCT01067976|467245318|FG000|Overall Study|Study drug never administered|20|||
129802533|NCT01067976|467245318|FG000|Overall Study|Study prematurely discontinued|2|||
129802534|NCT00589290|467245319|FG000|Overall Study|Withdrawal by Subject|1|||
129802535|NCT00566111|467245320|FG000|Overall Study|Adverse Event|0|||
129802536|NCT00566111|467245321|FG001|Overall Study|Adverse Event|2|||
129802537|NCT01554397|467245324|FG000|Overall Study|Withdrawal by Subject|1|||
129802538|NCT01554397|467245325|FG001|Overall Study|Withdrawal by Subject|0|||
129802539|NCT01554397|467245324|FG000|Overall Study|Ineligible|7|||
130111254|NCT02124746|468367592|FG002|Overall Study|Study Terminated by Sponsor|6|||
129802540|NCT01554397|467245325|FG001|Overall Study|Ineligible|0|||
129802541|NCT03633617|467247399|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
129802542|NCT03633617|467247400|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
129802543|NCT03633617|467247401|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802544|NCT03633617|467247402|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802545|NCT03633617|467247403|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802546|NCT03633617|467247404|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802547|NCT03633617|467247405|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802548|NCT03633617|467247406|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802549|NCT03633617|467247407|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802550|NCT03633617|467247408|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802551|NCT03633617|467247409|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802552|NCT03633617|467247399|FG000|Part A|Unconfirmed early termination visit|1|||
129802553|NCT03633617|467247400|FG001|Part A|Unconfirmed early termination visit|0|||
129802554|NCT03633617|467247401|FG002|Part A|Unconfirmed early termination visit|0|||
129802555|NCT03633617|467247402|FG003|Part A|Unconfirmed early termination visit|0|||
129802556|NCT03633617|467247403|FG004|Part A|Unconfirmed early termination visit|0|||
130053594|NCT01064648|468150513|FG002|Phase II|Non-protocol specified|5|||
130053595|NCT01064648|468150514|FG003|Phase II|Non-protocol specified|3|||
130053596|NCT01064648|468150511|FG000|Phase II|Under Review|0|||
130053597|NCT01064648|468150512|FG001|Phase II|Under Review|0|||
130053598|NCT01064648|468150513|FG002|Phase II|Under Review|2|||
130053599|NCT01064648|468150514|FG003|Phase II|Under Review|0|||
130053600|NCT00977574|468150515|FG000|Overall Study|Never Treated|4|||
130053601|NCT00977574|468150516|FG001|Overall Study|Never Treated|2|||
130053602|NCT00977574|468150517|FG002|Overall Study|Never Treated|4|||
130053603|NCT05281523|468150518|FG000|Overall Study|Adverse Event|1|||
130111255|NCT02124746|468367590|FG000|Overall Study|Disease Progression|3|||
129802557|NCT03633617|467247404|FG005|Part A|Unconfirmed early termination visit|0|||
129802558|NCT03633617|467247405|FG006|Part A|Unconfirmed early termination visit|0|||
129802559|NCT03633617|467247406|FG007|Part A|Unconfirmed early termination visit|0|||
129802560|NCT03633617|467247407|FG008|Part A|Unconfirmed early termination visit|0|||
129802561|NCT03633617|467247408|FG009|Part A|Unconfirmed early termination visit|0|||
129802562|NCT03633617|467247409|FG010|Part A|Unconfirmed early termination visit|0|||
129802563|NCT03633617|467247399|FG000|Part A|Adverse Event|0|||
129802564|NCT03633617|467247400|FG001|Part A|Adverse Event|1|||
129802565|NCT03633617|467247401|FG002|Part A|Adverse Event|0|||
129802566|NCT03633617|467247402|FG003|Part A|Adverse Event|0|||
129802567|NCT03633617|467247403|FG004|Part A|Adverse Event|0|||
129802568|NCT03633617|467247404|FG005|Part A|Adverse Event|0|||
129802569|NCT03633617|467247405|FG006|Part A|Adverse Event|0|||
129802570|NCT03633617|467247406|FG007|Part A|Adverse Event|0|||
129802571|NCT03633617|467247407|FG008|Part A|Adverse Event|0|||
129802572|NCT03633617|467247408|FG009|Part A|Adverse Event|0|||
129802573|NCT03633617|467247409|FG010|Part A|Adverse Event|0|||
129802574|NCT03633617|467247399|FG000|Part A|Pregnancy|1|||
129802575|NCT03633617|467247400|FG001|Part A|Pregnancy|0|||
129802576|NCT03633617|467247401|FG002|Part A|Pregnancy|0|||
129802577|NCT03633617|467247402|FG003|Part A|Pregnancy|0|||
129802578|NCT03633617|467247403|FG004|Part A|Pregnancy|0|||
129802579|NCT03633617|467247404|FG005|Part A|Pregnancy|0|||
129802580|NCT03633617|467247405|FG006|Part A|Pregnancy|0|||
129802581|NCT03633617|467247406|FG007|Part A|Pregnancy|0|||
129802582|NCT03633617|467247407|FG008|Part A|Pregnancy|0|||
129802583|NCT03633617|467247408|FG009|Part A|Pregnancy|0|||
129802584|NCT03633617|467247409|FG010|Part A|Pregnancy|0|||
129802585|NCT03633617|467247399|FG000|Part A|Withdrawal by Subject|0|||
129802586|NCT03633617|467247400|FG001|Part A|Withdrawal by Subject|1|||
129802587|NCT03633617|467247401|FG002|Part A|Withdrawal by Subject|0|||
129802588|NCT03633617|467247402|FG003|Part A|Withdrawal by Subject|0|||
129802589|NCT03633617|467247403|FG004|Part A|Withdrawal by Subject|0|||
129802590|NCT03633617|467247404|FG005|Part A|Withdrawal by Subject|0|||
129802591|NCT03633617|467247405|FG006|Part A|Withdrawal by Subject|0|||
129802592|NCT03633617|467247406|FG007|Part A|Withdrawal by Subject|0|||
129802593|NCT03633617|467247407|FG008|Part A|Withdrawal by Subject|0|||
129802594|NCT03633617|467247408|FG009|Part A|Withdrawal by Subject|0|||
129802595|NCT03633617|467247409|FG010|Part A|Withdrawal by Subject|0|||
129802596|NCT03633617|467247399|FG000|Part B|Adverse Event|0|||
129802597|NCT03633617|467247400|FG001|Part B|Adverse Event|0|||
129802598|NCT03633617|467247401|FG002|Part B|Adverse Event|2|||
129802599|NCT03633617|467247402|FG003|Part B|Adverse Event|2|||
129802600|NCT03633617|467247403|FG004|Part B|Adverse Event|1|||
129802601|NCT03633617|467247404|FG005|Part B|Adverse Event|0|||
129802602|NCT03633617|467247405|FG006|Part B|Adverse Event|0|||
129802603|NCT03633617|467247406|FG007|Part B|Adverse Event|0|||
129802604|NCT03633617|467247407|FG008|Part B|Adverse Event|0|||
129802605|NCT03633617|467247408|FG009|Part B|Adverse Event|0|||
129802606|NCT03633617|467247409|FG010|Part B|Adverse Event|0|||
129802607|NCT03633617|467247399|FG000|Part B|Withdrawal by Subject|0|||
129802608|NCT03633617|467247400|FG001|Part B|Withdrawal by Subject|0|||
129802609|NCT03633617|467247401|FG002|Part B|Withdrawal by Subject|1|||
129802610|NCT03633617|467247402|FG003|Part B|Withdrawal by Subject|0|||
129802611|NCT03633617|467247403|FG004|Part B|Withdrawal by Subject|2|||
129802612|NCT03633617|467247404|FG005|Part B|Withdrawal by Subject|0|||
129802613|NCT03633617|467247405|FG006|Part B|Withdrawal by Subject|0|||
129802614|NCT03633617|467247406|FG007|Part B|Withdrawal by Subject|0|||
130053604|NCT05281523|468150519|FG001|Overall Study|Adverse Event|1|||
130053605|NCT05281523|468150518|FG000|Overall Study|Physician Decision|1|||
130053606|NCT05281523|468150519|FG001|Overall Study|Physician Decision|1|||
129802615|NCT03633617|467247407|FG008|Part B|Withdrawal by Subject|0|||
129802616|NCT03633617|467247408|FG009|Part B|Withdrawal by Subject|0|||
129802617|NCT03633617|467247409|FG010|Part B|Withdrawal by Subject|0|||
129802618|NCT03633617|467247399|FG000|Part B|Lost to Follow-up|0|||
129802619|NCT03633617|467247400|FG001|Part B|Lost to Follow-up|0|||
129802620|NCT03633617|467247401|FG002|Part B|Lost to Follow-up|0|||
129802621|NCT03633617|467247402|FG003|Part B|Lost to Follow-up|0|||
129802622|NCT03633617|467247403|FG004|Part B|Lost to Follow-up|1|||
129802623|NCT03633617|467247404|FG005|Part B|Lost to Follow-up|0|||
129802624|NCT03633617|467247405|FG006|Part B|Lost to Follow-up|0|||
129802625|NCT03633617|467247406|FG007|Part B|Lost to Follow-up|0|||
129802626|NCT03633617|467247407|FG008|Part B|Lost to Follow-up|0|||
129802627|NCT03633617|467247408|FG009|Part B|Lost to Follow-up|0|||
129802628|NCT03633617|467247409|FG010|Part B|Lost to Follow-up|0|||
129802629|NCT03633617|467247399|FG000|Part B|Physician Decision|0|||
129802630|NCT03633617|467247400|FG001|Part B|Physician Decision|0|||
129802631|NCT03633617|467247401|FG002|Part B|Physician Decision|0|||
129802632|NCT03633617|467247402|FG003|Part B|Physician Decision|0|||
129802633|NCT03633617|467247403|FG004|Part B|Physician Decision|1|||
129802634|NCT03633617|467247404|FG005|Part B|Physician Decision|0|||
129802635|NCT03633617|467247405|FG006|Part B|Physician Decision|0|||
129802636|NCT03633617|467247406|FG007|Part B|Physician Decision|0|||
129802637|NCT03633617|467247407|FG008|Part B|Physician Decision|0|||
129802638|NCT03633617|467247408|FG009|Part B|Physician Decision|0|||
129802639|NCT03633617|467247409|FG010|Part B|Physician Decision|0|||
129802640|NCT03633617|467247399|FG000|Part B|COVID-19 Restrictions|0|||
129802641|NCT03633617|467247400|FG001|Part B|COVID-19 Restrictions|0|||
129802642|NCT03633617|467247401|FG002|Part B|COVID-19 Restrictions|1|||
129802643|NCT03633617|467247402|FG003|Part B|COVID-19 Restrictions|0|||
129802644|NCT03633617|467247403|FG004|Part B|COVID-19 Restrictions|0|||
129802645|NCT03633617|467247404|FG005|Part B|COVID-19 Restrictions|0|||
129802646|NCT03633617|467247405|FG006|Part B|COVID-19 Restrictions|0|||
129802647|NCT03633617|467247406|FG007|Part B|COVID-19 Restrictions|0|||
129802648|NCT03633617|467247407|FG008|Part B|COVID-19 Restrictions|0|||
129802649|NCT03633617|467247408|FG009|Part B|COVID-19 Restrictions|0|||
129802650|NCT03633617|467247409|FG010|Part B|COVID-19 Restrictions|0|||
129802651|NCT03633617|467247399|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802652|NCT03633617|467247400|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802653|NCT03633617|467247401|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
129802654|NCT03633617|467247402|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802655|NCT03633617|467247403|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802656|NCT03633617|467247404|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802657|NCT03633617|467247405|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802658|NCT03633617|467247406|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802659|NCT03633617|467247407|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802660|NCT03633617|467247408|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802661|NCT03633617|467247409|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802662|NCT03633617|467247399|FG000|Part C (& Follow-up)|Adverse Event|0|||
129802663|NCT03633617|467247400|FG001|Part C (& Follow-up)|Adverse Event|0|||
129802664|NCT03633617|467247401|FG002|Part C (& Follow-up)|Adverse Event|0|||
129802665|NCT03633617|467247402|FG003|Part C (& Follow-up)|Adverse Event|0|||
130053607|NCT05281523|468150518|FG000|Overall Study|Withdrawal by Subject|5|||
130053608|NCT05281523|468150519|FG001|Overall Study|Withdrawal by Subject|15|||
129891400|NCT04529538|467559715|FG000|Overall Study|Adverse Event|0|||
129891401|NCT04529538|467559716|FG001|Overall Study|Adverse Event|0|||
129891402|NCT04529538|467559717|FG002|Overall Study|Adverse Event|0|||
129891403|NCT04529538|467559718|FG003|Overall Study|Adverse Event|1|||
129891404|NCT04529538|467559719|FG004|Overall Study|Adverse Event|0|||
129891405|NCT04529538|467559720|FG005|Overall Study|Adverse Event|0|||
130053609|NCT05281523|468150518|FG000|Overall Study|GCP violations|3|||
130053610|NCT05281523|468150519|FG001|Overall Study|GCP violations|4|||
129891406|NCT04529538|467559721|FG006|Overall Study|Adverse Event|0|||
129891407|NCT04529538|467559722|FG007|Overall Study|Adverse Event|0|||
130053611|NCT04491877|468152374|FG000|Overall Study|Protocol Deviation|1|||
130053612|NCT04491877|468152375|FG001|Overall Study|Protocol Deviation|0|||
130053613|NCT04491877|468152376|FG002|Overall Study|Protocol Deviation|2|||
130053614|NCT04491877|468152377|FG003|Overall Study|Protocol Deviation|0|||
129802666|NCT03633617|467247403|FG004|Part C (& Follow-up)|Adverse Event|0|||
129802667|NCT03633617|467247404|FG005|Part C (& Follow-up)|Adverse Event|1|||
129802668|NCT03633617|467247405|FG006|Part C (& Follow-up)|Adverse Event|0|||
129802669|NCT03633617|467247406|FG007|Part C (& Follow-up)|Adverse Event|1|||
129802670|NCT03633617|467247407|FG008|Part C (& Follow-up)|Adverse Event|0|||
129802671|NCT03633617|467247408|FG009|Part C (& Follow-up)|Adverse Event|0|||
130053615|NCT04491877|468152378|FG004|Overall Study|Protocol Deviation|0|||
130053616|NCT04491877|468152379|FG005|Overall Study|Protocol Deviation|0|||
130053617|NCT04491877|468152380|FG006|Overall Study|Protocol Deviation|1|||
130053618|NCT04491877|468152381|FG007|Overall Study|Protocol Deviation|1|||
130053619|NCT04491877|468152382|FG008|Overall Study|Protocol Deviation|0|||
129802672|NCT03633617|467247409|FG010|Part C (& Follow-up)|Adverse Event|0|||
129802673|NCT03633617|467247399|FG000|Part C (& Follow-up)|Pregnancy|0|||
129802674|NCT03633617|467247400|FG001|Part C (& Follow-up)|Pregnancy|0|||
129802675|NCT03633617|467247401|FG002|Part C (& Follow-up)|Pregnancy|0|||
129802676|NCT03633617|467247402|FG003|Part C (& Follow-up)|Pregnancy|0|||
129802677|NCT03633617|467247403|FG004|Part C (& Follow-up)|Pregnancy|0|||
129802678|NCT03633617|467247404|FG005|Part C (& Follow-up)|Pregnancy|0|||
129802679|NCT03633617|467247405|FG006|Part C (& Follow-up)|Pregnancy|0|||
129802680|NCT03633617|467247406|FG007|Part C (& Follow-up)|Pregnancy|0|||
129802681|NCT03633617|467247407|FG008|Part C (& Follow-up)|Pregnancy|0|||
129802682|NCT03633617|467247408|FG009|Part C (& Follow-up)|Pregnancy|1|||
129802683|NCT03633617|467247409|FG010|Part C (& Follow-up)|Pregnancy|0|||
129802684|NCT03633617|467247399|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802685|NCT03633617|467247400|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802686|NCT03633617|467247401|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802687|NCT03633617|467247402|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802688|NCT03633617|467247403|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802689|NCT03633617|467247404|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
129802690|NCT03633617|467247405|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
129802691|NCT03633617|467247406|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802692|NCT03633617|467247407|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
129802693|NCT03633617|467247408|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
129802694|NCT03633617|467247409|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
129802695|NCT03633617|467247399|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
129802696|NCT03633617|467247400|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
129802697|NCT03633617|467247401|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
129891408|NCT04529538|467559715|FG000|Overall Study|Protocol Deviation|0|||
130053620|NCT04491877|468152374|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130053621|NCT04491877|468152375|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130053622|NCT04491877|468152376|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130111256|NCT02124746|468367591|FG001|Overall Study|Disease Progression|6|||
130111257|NCT02124746|468367592|FG002|Overall Study|Disease Progression|4|||
130053623|NCT04491877|468152377|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
129802698|NCT03633617|467247402|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
129802699|NCT03633617|467247403|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
129802700|NCT03633617|467247404|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
129802701|NCT03633617|467247405|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
129891409|NCT04529538|467559716|FG001|Overall Study|Protocol Deviation|0|||
129802702|NCT03633617|467247406|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
129802703|NCT03633617|467247407|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
129802704|NCT03633617|467247408|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
129802705|NCT03633617|467247409|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
129802706|NCT03633617|467247399|FG000|Part C (& Follow-up)|Physician Decision|0|||
129802707|NCT03633617|467247400|FG001|Part C (& Follow-up)|Physician Decision|0|||
129802708|NCT03633617|467247401|FG002|Part C (& Follow-up)|Physician Decision|0|||
129802709|NCT03633617|467247402|FG003|Part C (& Follow-up)|Physician Decision|0|||
129802710|NCT03633617|467247403|FG004|Part C (& Follow-up)|Physician Decision|0|||
129802711|NCT03633617|467247404|FG005|Part C (& Follow-up)|Physician Decision|0|||
129802712|NCT03633617|467247405|FG006|Part C (& Follow-up)|Physician Decision|0|||
129802713|NCT03633617|467247406|FG007|Part C (& Follow-up)|Physician Decision|1|||
129802714|NCT03633617|467247407|FG008|Part C (& Follow-up)|Physician Decision|0|||
129802715|NCT03633617|467247408|FG009|Part C (& Follow-up)|Physician Decision|0|||
129802716|NCT03633617|467247409|FG010|Part C (& Follow-up)|Physician Decision|1|||
129802717|NCT03633617|467247399|FG000|Part C (& Follow-up)|COVID-19 related|0|||
129802718|NCT03633617|467247400|FG001|Part C (& Follow-up)|COVID-19 related|0|||
129802719|NCT03633617|467247401|FG002|Part C (& Follow-up)|COVID-19 related|0|||
129802720|NCT03633617|467247402|FG003|Part C (& Follow-up)|COVID-19 related|0|||
129802721|NCT03633617|467247403|FG004|Part C (& Follow-up)|COVID-19 related|0|||
129802722|NCT03633617|467247404|FG005|Part C (& Follow-up)|COVID-19 related|1|||
129802723|NCT03633617|467247405|FG006|Part C (& Follow-up)|COVID-19 related|0|||
129802724|NCT03633617|467247406|FG007|Part C (& Follow-up)|COVID-19 related|0|||
129802725|NCT03633617|467247407|FG008|Part C (& Follow-up)|COVID-19 related|0|||
129802726|NCT03633617|467247408|FG009|Part C (& Follow-up)|COVID-19 related|0|||
129802727|NCT03633617|467247409|FG010|Part C (& Follow-up)|COVID-19 related|0|||
129802728|NCT03633617|467247399|FG000|Part C (& Follow-up)|Protocol Violation|0|||
129802729|NCT03633617|467247400|FG001|Part C (& Follow-up)|Protocol Violation|0|||
129802730|NCT03633617|467247401|FG002|Part C (& Follow-up)|Protocol Violation|0|||
129802731|NCT03633617|467247402|FG003|Part C (& Follow-up)|Protocol Violation|0|||
130053624|NCT04491877|468152378|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130053625|NCT04491877|468152379|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
130053626|NCT04491877|468152380|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
129802732|NCT03633617|467247403|FG004|Part C (& Follow-up)|Protocol Violation|0|||
129802733|NCT03633617|467247404|FG005|Part C (& Follow-up)|Protocol Violation|0|||
129802734|NCT03633617|467247405|FG006|Part C (& Follow-up)|Protocol Violation|0|||
129802735|NCT03633617|467247406|FG007|Part C (& Follow-up)|Protocol Violation|0|||
129802736|NCT03633617|467247407|FG008|Part C (& Follow-up)|Protocol Violation|0|||
129802737|NCT03633617|467247408|FG009|Part C (& Follow-up)|Protocol Violation|3|||
129802738|NCT03633617|467247409|FG010|Part C (& Follow-up)|Protocol Violation|1|||
129802739|NCT03633617|467247399|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
129802740|NCT03633617|467247400|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
129802741|NCT03633617|467247401|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
129802742|NCT03633617|467247402|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
129802743|NCT03633617|467247403|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
129802744|NCT03633617|467247404|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
129802745|NCT03633617|467247405|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
129802746|NCT03633617|467247406|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
129802747|NCT03633617|467247407|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
129802748|NCT03633617|467247408|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
129802749|NCT03633617|467247409|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
129802750|NCT00629772|467247414|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
129802751|NCT00629772|467247415|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
129802752|NCT00629772|467247414|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
129802753|NCT00629772|467247415|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
129802754|NCT01393301|467247416|FG000|Overall Study|Lost to Follow-up|5|||
129802755|NCT01393301|467247417|FG001|Overall Study|Lost to Follow-up|3|||
129802756|NCT01393301|467247416|FG000|Overall Study|Withdrawal by Subject|2|||
129802757|NCT01393301|467247417|FG001|Overall Study|Withdrawal by Subject|0|||
129802758|NCT01393301|467247416|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
129802759|NCT01393301|467247417|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
129802760|NCT00853073|467247418|FG000|Overall Study|Withdrawal by Subject|3|||
129802761|NCT00853073|467247419|FG001|Overall Study|Withdrawal by Subject|2|||
129802762|NCT02758171|467247420|FG000|Wash-out|Withdrawal by Subject|1|||
129802763|NCT02758171|467247421|FG001|Wash-out|Withdrawal by Subject|0|||
129802764|NCT02758171|467247420|FG000|Wash-out|Other reason|1|||
130053627|NCT04491877|468152381|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
130053628|NCT04491877|468152382|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
130053629|NCT04491877|468152374|FG000|Overall Study|Lost to Follow-up|0|||
129802765|NCT02758171|467247421|FG001|Wash-out|Other reason|0|||
129802766|NCT00722423|467247422|FG000|Overall Study|Protocol Violation|0|||
129802767|NCT00722423|467247423|FG001|Overall Study|Protocol Violation|1|||
129802768|NCT01309165|467247424|FG000|Overall Study|Lost to Follow-up|4|||
129802769|NCT01309165|467247425|FG001|Overall Study|Lost to Follow-up|3|||
129802770|NCT01309165|467247424|FG000|Overall Study|Return to work|1|||
129802771|NCT01309165|467247425|FG001|Overall Study|Return to work|2|||
129802772|NCT01309165|467247424|FG000|Overall Study|Left country|0|||
129802773|NCT01309165|467247425|FG001|Overall Study|Left country|1|||
129802774|NCT01309165|467247424|FG000|Overall Study|No transportation|0|||
129802775|NCT01309165|467247425|FG001|Overall Study|No transportation|1|||
129891410|NCT04529538|467559717|FG002|Overall Study|Protocol Deviation|0|||
130053630|NCT04491877|468152375|FG001|Overall Study|Lost to Follow-up|2|||
130053631|NCT04491877|468152376|FG002|Overall Study|Lost to Follow-up|0|||
130053632|NCT04491877|468152377|FG003|Overall Study|Lost to Follow-up|0|||
130053633|NCT04491877|468152378|FG004|Overall Study|Lost to Follow-up|0|||
130053634|NCT04491877|468152379|FG005|Overall Study|Lost to Follow-up|0|||
130053635|NCT04491877|468152380|FG006|Overall Study|Lost to Follow-up|2|||
130053636|NCT04491877|468152381|FG007|Overall Study|Lost to Follow-up|1|||
130053637|NCT04491877|468152382|FG008|Overall Study|Lost to Follow-up|1|||
129891411|NCT04529538|467559718|FG003|Overall Study|Protocol Deviation|1|||
129891412|NCT04529538|467559719|FG004|Overall Study|Protocol Deviation|0|||
129891413|NCT04529538|467559720|FG005|Overall Study|Protocol Deviation|0|||
129891414|NCT04529538|467559721|FG006|Overall Study|Protocol Deviation|0|||
129891415|NCT04529538|467559722|FG007|Overall Study|Protocol Deviation|0|||
129891416|NCT04529538|467559715|FG000|Overall Study|Physician Decision|0|||
129891417|NCT04529538|467559716|FG001|Overall Study|Physician Decision|0|||
129891418|NCT04529538|467559717|FG002|Overall Study|Physician Decision|0|||
129891419|NCT04529538|467559718|FG003|Overall Study|Physician Decision|0|||
129891420|NCT04529538|467559719|FG004|Overall Study|Physician Decision|0|||
129891421|NCT04529538|467559720|FG005|Overall Study|Physician Decision|1|||
129891422|NCT04529538|467559721|FG006|Overall Study|Physician Decision|0|||
129891423|NCT04529538|467559722|FG007|Overall Study|Physician Decision|1|||
129891424|NCT00235495|467559725|FG000|Overall Study|Death|52|||
129891425|NCT00235495|467559726|FG001|Overall Study|Death|42|||
129891426|NCT00235495|467559725|FG000|Overall Study|Withdrawal by Subject|5|||
129891427|NCT00235495|467559726|FG001|Overall Study|Withdrawal by Subject|3|||
129891428|NCT00235495|467559725|FG000|Overall Study|Lost to Follow-up|11|||
129891429|NCT00235495|467559726|FG001|Overall Study|Lost to Follow-up|13|||
129891430|NCT00235495|467559725|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
129891431|NCT00235495|467559726|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
129979652|NCT00403767|467889417|FG000|Overall Study|Investigator dec./not protocol-related|191|||
130053638|NCT01286272|468152386|FG000|Overall Study|Ineligible after beginning treatment|1|||
130053639|NCT01286272|468152387|FG001|Overall Study|Ineligible after beginning treatment|3|||
130053640|NCT00074412|468152389|FG000|Overall Study|Death|30|||
130053641|NCT00074412|468152390|FG001|Overall Study|Death|26|||
130053642|NCT00074412|468152389|FG000|Overall Study|Lost to Follow-up|52|||
130053643|NCT00074412|468152390|FG001|Overall Study|Lost to Follow-up|58|||
130053644|NCT00418834|468152395|FG000|Overall Study|Adverse Event|16|||
130053645|NCT00418834|468152396|FG001|Overall Study|Adverse Event|9|||
130053646|NCT00418834|468152395|FG000|Overall Study|Lost to Follow-up|0|||
130053647|NCT00418834|468152396|FG001|Overall Study|Lost to Follow-up|1|||
130053648|NCT00418834|468152395|FG000|Overall Study|Protocol Violation|4|||
130053649|NCT00418834|468152396|FG001|Overall Study|Protocol Violation|3|||
129802776|NCT01309165|467247424|FG000|Overall Study|Admitted to hospital for second stroke|1|||
129802777|NCT01309165|467247425|FG001|Overall Study|Admitted to hospital for second stroke|0|||
129802778|NCT05085730|467247427|FG000|Overall Study|Withdrawal by Subject|4|||
129802779|NCT05085730|467247427|FG000|Overall Study|Physician Decision|1|||
129802780|NCT02038881|467247428|FG000|Overall Study|Withdrawal by Subject|0|||
129802781|NCT02038881|467247429|FG001|Overall Study|Withdrawal by Subject|0|||
129802782|NCT02038881|467247430|FG002|Overall Study|Withdrawal by Subject|1|||
129802783|NCT02038881|467247428|FG000|Overall Study|Lost to Follow-up|2|||
129802784|NCT02038881|467247429|FG001|Overall Study|Lost to Follow-up|0|||
129802785|NCT02038881|467247430|FG002|Overall Study|Lost to Follow-up|0|||
129802786|NCT02038881|467247428|FG000|Overall Study|incarcerated|1|||
129802787|NCT02038881|467247429|FG001|Overall Study|incarcerated|0|||
129802788|NCT02038881|467247430|FG002|Overall Study|incarcerated|0|||
129802789|NCT00333840|467247431|FG000|First-line Treatment Period|Adverse Event|38|||
129802790|NCT00333840|467247432|FG001|First-line Treatment Period|Adverse Event|37|||
129802791|NCT00333840|467247433|FG002|First-line Treatment Period|Adverse Event|0|||
129802792|NCT00333840|467247434|FG003|First-line Treatment Period|Adverse Event|0|||
129891432|NCT02192359|467559730|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
129891433|NCT02192359|467559731|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
129891434|NCT02192359|467559732|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
129891435|NCT02192359|467559733|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
129891436|NCT02192359|467559730|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
129802793|NCT00333840|467247431|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
129802794|NCT00333840|467247432|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
129802795|NCT00333840|467247433|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
129802796|NCT00333840|467247434|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
129891437|NCT02192359|467559731|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
130111258|NCT00571922|468367593|FG000|Overall Study|Completion unknown|36|||
130111259|NCT00571922|468367594|FG001|Overall Study|Completion unknown|36|||
130111260|NCT02191579|468367602|FG000|Treatment 1|Multiple Reasons Specified|27|||
130111261|NCT02191579|468367603|FG001|Treatment 1|Multiple Reasons Specified|58|||
130111262|NCT02191579|468367602|FG000|Treatment 2|Multiple Reasons Specified|0|||
130111263|NCT02191579|468367603|FG001|Treatment 2|Multiple Reasons Specified|25|||
130111264|NCT03940586|468367613|FG000|Overall Study|Death|3|||
130111265|NCT03940586|468367614|FG001|Overall Study|Death|2|||
130111266|NCT03940586|468367615|FG002|Overall Study|Death|0|||
130111267|NCT03940586|468367613|FG000|Overall Study|Physician Decision|1|||
130111268|NCT03940586|468367614|FG001|Overall Study|Physician Decision|0|||
130111269|NCT03940586|468367615|FG002|Overall Study|Physician Decision|1|||
130111270|NCT03940586|468367613|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
130111271|NCT03940586|468367614|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
130111272|NCT03940586|468367615|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
130111273|NCT03940586|468367613|FG000|Overall Study|Not Treated|0|||
130111274|NCT03940586|468367614|FG001|Overall Study|Not Treated|2|||
130111275|NCT03940586|468367615|FG002|Overall Study|Not Treated|0|||
130111276|NCT00964223|468367616|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
130111277|NCT03077828|468367617|FG000|Treatment Cycles|Death|1|||
130111278|NCT03077828|468367617|FG000|Treatment Cycles|Withdrawal by Subject|1|||
130111279|NCT03077828|468367617|FG000|Treatment Cycles|Screen Fail|2|||
130111280|NCT03077828|468367617|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
129802797|NCT00333840|467247431|FG000|First-line Treatment Period|Abnormal procedure|2|||
129802798|NCT00333840|467247432|FG001|First-line Treatment Period|Abnormal procedure|0|||
129802799|NCT00333840|467247433|FG002|First-line Treatment Period|Abnormal procedure|0|||
129802800|NCT00333840|467247434|FG003|First-line Treatment Period|Abnormal procedure|0|||
129802801|NCT00333840|467247431|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
129802802|NCT00333840|467247432|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
129802803|NCT00333840|467247433|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802804|NCT00333840|467247434|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802805|NCT00333840|467247431|FG000|First-line Treatment Period|No longer required study drug|21|||
129802806|NCT00333840|467247432|FG001|First-line Treatment Period|No longer required study drug|8|||
129802807|NCT00333840|467247433|FG002|First-line Treatment Period|No longer required study drug|0|||
129802808|NCT00333840|467247434|FG003|First-line Treatment Period|No longer required study drug|0|||
129802809|NCT00333840|467247431|FG000|First-line Treatment Period|Protocol Violation|17|||
129802810|NCT00333840|467247432|FG001|First-line Treatment Period|Protocol Violation|17|||
129802811|NCT00333840|467247433|FG002|First-line Treatment Period|Protocol Violation|0|||
129802812|NCT00333840|467247434|FG003|First-line Treatment Period|Protocol Violation|0|||
129802813|NCT00333840|467247431|FG000|First-line Treatment Period|Subject withdrew consent|57|||
129802814|NCT00333840|467247432|FG001|First-line Treatment Period|Subject withdrew consent|77|||
129802815|NCT00333840|467247433|FG002|First-line Treatment Period|Subject withdrew consent|0|||
129802816|NCT00333840|467247434|FG003|First-line Treatment Period|Subject withdrew consent|0|||
129802817|NCT00333840|467247431|FG000|First-line Treatment Period|Lost to Follow-up|15|||
129802818|NCT00333840|467247432|FG001|First-line Treatment Period|Lost to Follow-up|6|||
129802819|NCT00333840|467247433|FG002|First-line Treatment Period|Lost to Follow-up|0|||
129802820|NCT00333840|467247434|FG003|First-line Treatment Period|Lost to Follow-up|0|||
129802821|NCT00333840|467247431|FG000|First-line Treatment Period|Administrative problems|12|||
129802822|NCT00333840|467247432|FG001|First-line Treatment Period|Administrative problems|6|||
129802823|NCT00333840|467247433|FG002|First-line Treatment Period|Administrative problems|0|||
129802824|NCT00333840|467247434|FG003|First-line Treatment Period|Administrative problems|0|||
129802825|NCT00333840|467247431|FG000|First-line Treatment Period|Death|19|||
129802826|NCT00333840|467247432|FG001|First-line Treatment Period|Death|2|||
129802827|NCT00333840|467247433|FG002|First-line Treatment Period|Death|0|||
129802828|NCT00333840|467247434|FG003|First-line Treatment Period|Death|0|||
129802829|NCT00333840|467247431|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
129802830|NCT00333840|467247432|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
129802831|NCT00333840|467247433|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
129802832|NCT00333840|467247434|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
129802833|NCT00333840|467247431|FG000|Second-line Treatment Period|Adverse Event|0|||
129802834|NCT00333840|467247432|FG001|Second-line Treatment Period|Adverse Event|0|||
129802835|NCT00333840|467247433|FG002|Second-line Treatment Period|Adverse Event|3|||
129802836|NCT00333840|467247434|FG003|Second-line Treatment Period|Adverse Event|34|||
129802837|NCT00333840|467247431|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
129891438|NCT02192359|467559732|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
129891439|NCT02192359|467559733|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
129891440|NCT02192359|467559730|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
129891441|NCT02192359|467559731|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
129891442|NCT02192359|467559732|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
129891443|NCT02192359|467559733|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
129891444|NCT04951479|467559734|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
129891445|NCT05567952|467561109|FG000|Overall Study|Lost to Follow-up|3|||
129891446|NCT05567952|467561110|FG001|Overall Study|Lost to Follow-up|2|||
129891447|NCT05567952|467561109|FG000|Overall Study|Withdrawal by Subject|6|||
129802838|NCT00333840|467247432|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
129891448|NCT05567952|467561110|FG001|Overall Study|Withdrawal by Subject|3|||
129891449|NCT05567952|467561109|FG000|Overall Study|Other|3|||
129891450|NCT05567952|467561110|FG001|Overall Study|Other|1|||
129891451|NCT00777803|467561111|FG000|Overall Study|Lost to Follow-up|12|||
129891452|NCT00777803|467561112|FG001|Overall Study|Lost to Follow-up|5|||
129891453|NCT00777803|467561111|FG000|Overall Study|Adverse Event|1|||
130053650|NCT00418834|468152395|FG000|Overall Study|Withdrawal by Subject|3|||
130053651|NCT00418834|468152396|FG001|Overall Study|Withdrawal by Subject|7|||
130053652|NCT01953328|468152397|FG000|Overall Study|Withdrawal by Subject|0|||
130053653|NCT01953328|468152398|FG001|Overall Study|Withdrawal by Subject|0|||
129802839|NCT00333840|467247433|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
129802840|NCT00333840|467247434|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
130053654|NCT01953328|468152399|FG002|Overall Study|Withdrawal by Subject|0|||
129802841|NCT00333840|467247431|FG000|Second-line Treatment Period|Abnormal procedure|0|||
129802842|NCT00333840|467247432|FG001|Second-line Treatment Period|Abnormal procedure|0|||
129802843|NCT00333840|467247433|FG002|Second-line Treatment Period|Abnormal procedure|0|||
129802844|NCT00333840|467247434|FG003|Second-line Treatment Period|Abnormal procedure|1|||
129802845|NCT00333840|467247431|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802846|NCT00333840|467247432|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802847|NCT00333840|467247433|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
129802848|NCT00333840|467247434|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
129802849|NCT00333840|467247431|FG000|Second-line Treatment Period|No longer required study drug|0|||
129802850|NCT00333840|467247432|FG001|Second-line Treatment Period|No longer required study drug|0|||
129802851|NCT00333840|467247433|FG002|Second-line Treatment Period|No longer required study drug|1|||
129802852|NCT00333840|467247434|FG003|Second-line Treatment Period|No longer required study drug|14|||
129802853|NCT00333840|467247431|FG000|Second-line Treatment Period|Protocol Violation|0|||
129802854|NCT00333840|467247432|FG001|Second-line Treatment Period|Protocol Violation|0|||
129802855|NCT00333840|467247433|FG002|Second-line Treatment Period|Protocol Violation|1|||
129802856|NCT00333840|467247434|FG003|Second-line Treatment Period|Protocol Violation|10|||
129802857|NCT00333840|467247431|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
129802858|NCT00333840|467247432|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
129802859|NCT00333840|467247433|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
129802860|NCT00333840|467247434|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
129802861|NCT00333840|467247431|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
129802862|NCT00333840|467247432|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
129802863|NCT00333840|467247433|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
129802864|NCT00333840|467247434|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
129802865|NCT00333840|467247431|FG000|Second-line Treatment Period|Administrative problems|0|||
129802866|NCT00333840|467247432|FG001|Second-line Treatment Period|Administrative problems|0|||
129802867|NCT00333840|467247433|FG002|Second-line Treatment Period|Administrative problems|0|||
129802868|NCT00333840|467247434|FG003|Second-line Treatment Period|Administrative problems|7|||
129802869|NCT00333840|467247431|FG000|Second-line Treatment Period|Death|0|||
129802870|NCT00333840|467247432|FG001|Second-line Treatment Period|Death|0|||
129802871|NCT00333840|467247433|FG002|Second-line Treatment Period|Death|0|||
129802872|NCT00333840|467247434|FG003|Second-line Treatment Period|Death|9|||
129802873|NCT01453725|467247435|FG000|Overall Study|Adverse Event|3|||
129802874|NCT01453725|467247436|FG001|Overall Study|Adverse Event|3|||
129802875|NCT01453725|467247435|FG000|Overall Study|Lost to Follow-up|4|||
129802876|NCT01453725|467247436|FG001|Overall Study|Lost to Follow-up|0|||
129891454|NCT00777803|467561112|FG001|Overall Study|Adverse Event|0|||
129891455|NCT00777803|467561111|FG000|Overall Study|Non-compliance|2|||
129891456|NCT00777803|467561112|FG001|Overall Study|Non-compliance|2|||
129891457|NCT04096365|467561128|FG000|Overall Study|Adverse Event|1|||
129891458|NCT05310084|467561129|FG000|Overall Study|Withdrawal by Subject|2|||
129891459|NCT05310084|467561130|FG001|Overall Study|Withdrawal by Subject|3|||
129802877|NCT01453725|467247435|FG000|Overall Study|Non-compliance With Protocol|1|||
129891460|NCT05310084|467561129|FG000|Overall Study|Participant availability|0|||
130053655|NCT01953328|468152400|FG003|Overall Study|Withdrawal by Subject|0|||
130053656|NCT01953328|468152401|FG004|Overall Study|Withdrawal by Subject|1|||
130053657|NCT01953328|468152402|FG005|Overall Study|Withdrawal by Subject|0|||
130053658|NCT01953328|468152403|FG006|Overall Study|Withdrawal by Subject|0|||
130053659|NCT01953328|468152404|FG007|Overall Study|Withdrawal by Subject|0|||
130053660|NCT01953328|468152397|FG000|Overall Study|Lost to Follow-up|0|||
130053661|NCT01953328|468152398|FG001|Overall Study|Lost to Follow-up|0|||
130053662|NCT01953328|468152399|FG002|Overall Study|Lost to Follow-up|0|||
130053663|NCT01953328|468152400|FG003|Overall Study|Lost to Follow-up|0|||
129802878|NCT01453725|467247436|FG001|Overall Study|Non-compliance With Protocol|2|||
129802879|NCT01453725|467247435|FG000|Overall Study|Protocol Violation|1|||
129802880|NCT01453725|467247436|FG001|Overall Study|Protocol Violation|0|||
129802881|NCT01453725|467247435|FG000|Overall Study|Withdrawal by Subject|2|||
129802882|NCT01453725|467247436|FG001|Overall Study|Withdrawal by Subject|3|||
129802883|NCT01453725|467247435|FG000|Overall Study|Pregnancy Wish|0|||
129802884|NCT01453725|467247436|FG001|Overall Study|Pregnancy Wish|2|||
129802885|NCT01453725|467247435|FG000|Overall Study|Pregnancy|1|||
129802886|NCT01453725|467247436|FG001|Overall Study|Pregnancy|0|||
129802887|NCT01453725|467247435|FG000|Overall Study|Physician Decision|1|||
129802888|NCT01453725|467247436|FG001|Overall Study|Physician Decision|1|||
129802889|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
129891461|NCT05310084|467561130|FG001|Overall Study|Participant availability|4|||
129891462|NCT05310084|467561129|FG000|Overall Study|Lost to Follow-up|1|||
129802890|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
129802891|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
129891463|NCT05310084|467561130|FG001|Overall Study|Lost to Follow-up|1|||
129891464|NCT05310084|467561129|FG000|Overall Study|Adverse Event|1|||
129891465|NCT05310084|467561130|FG001|Overall Study|Adverse Event|1|||
129802892|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
129891466|NCT05310084|467561129|FG000|Overall Study|Randomized but not vaccinated|4|||
130053664|NCT01953328|468152401|FG004|Overall Study|Lost to Follow-up|1|||
130053665|NCT01953328|468152402|FG005|Overall Study|Lost to Follow-up|0|||
130053666|NCT01953328|468152403|FG006|Overall Study|Lost to Follow-up|0|||
130053667|NCT01953328|468152404|FG007|Overall Study|Lost to Follow-up|0|||
130053668|NCT02364947|468152411|FG000|Overall Study|Withdrawal by Subject|10|||
130053669|NCT02364947|468152412|FG001|Overall Study|Withdrawal by Subject|8|||
130053670|NCT02364947|468152413|FG002|Overall Study|Withdrawal by Subject|9|||
130053671|NCT02364947|468152411|FG000|Overall Study|Adverse Event|45|||
130053672|NCT02364947|468152412|FG001|Overall Study|Adverse Event|33|||
130053673|NCT02364947|468152413|FG002|Overall Study|Adverse Event|11|||
130053674|NCT02364947|468152411|FG000|Overall Study|Protocol Violation|1|||
130053675|NCT02364947|468152412|FG001|Overall Study|Protocol Violation|1|||
130053676|NCT02364947|468152413|FG002|Overall Study|Protocol Violation|1|||
130053677|NCT02364947|468152411|FG000|Overall Study|Physician Decision|3|||
130053678|NCT02364947|468152412|FG001|Overall Study|Physician Decision|2|||
130053679|NCT02364947|468152413|FG002|Overall Study|Physician Decision|5|||
130111281|NCT03077828|468367617|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
130053680|NCT02364947|468152411|FG000|Overall Study|Death|0|||
130111282|NCT03077828|468367617|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
130111283|NCT03077828|468367617|FG000|Follow-up|Patients still in follow-up|15|||
130111284|NCT00345683|468367621|FG000|Overall Study|Lost to Follow-up|19|||
130111285|NCT00345683|468367622|FG001|Overall Study|Lost to Follow-up|7|||
130111286|NCT00345683|468367621|FG000|Overall Study|Other|6|||
129802893|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
129802894|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
129802895|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
129802896|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
129802897|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
129802898|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
129802899|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
129802900|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
129802901|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
129802902|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
129802903|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
130111287|NCT00345683|468367622|FG001|Overall Study|Other|2|||
129802904|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
129802905|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
129802906|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
129802907|NCT03719586|467247447|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
129802908|NCT03719586|467247448|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
129802909|NCT03719586|467247449|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
129802910|NCT03719586|467247450|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
129802911|NCT00178633|467247451|FG000|Overall Study|Lost to Follow-up|6|||
129802912|NCT04810481|467247453|FG000|Overall Study|Disqualified data sets|10|||
129802913|NCT04810481|467247454|FG001|Overall Study|Disqualified data sets|28|||
129802914|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
129802915|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
129802916|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
129802917|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
129802918|NCT00369707|467247457|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
129891467|NCT05310084|467561130|FG001|Overall Study|Randomized but not vaccinated|2|||
129891468|NCT01598987|467561132|FG000|Baseline to Month 12|Administrative problems|2|||
129891469|NCT01598987|467561132|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
129891470|NCT01598987|467561132|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
129802919|NCT00369707|467247457|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
129802920|NCT00369707|467247457|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
129802921|NCT00369707|467247457|FG000|Follow up for 2 Years After Treatment|Death|1|||
129802922|NCT00369707|467247457|FG000|Follow up for 2 Years After Treatment|Other|2|||
129802923|NCT01254292|467247462|FG000|Comparative Phase|Adverse Event|25|||
129802924|NCT01254292|467247463|FG001|Comparative Phase|Adverse Event|25|||
129802925|NCT01254292|467247462|FG000|Comparative Phase|Lost to Follow-up|3|||
129802926|NCT01254292|467247463|FG001|Comparative Phase|Lost to Follow-up|21|||
129802927|NCT01254292|467247462|FG000|Comparative Phase|Pregnancy|2|||
129802928|NCT01254292|467247463|FG001|Comparative Phase|Pregnancy|6|||
129802929|NCT01254292|467247462|FG000|Comparative Phase|Withdrawal by Subject|20|||
130111288|NCT04288115|468367623|FG000|Overall Study|Withdrawal by Subject|0|||
130111289|NCT04288115|468367624|FG001|Overall Study|Withdrawal by Subject|1|||
129802930|NCT01254292|467247463|FG001|Comparative Phase|Withdrawal by Subject|21|||
129802931|NCT01254292|467247462|FG000|Comparative Phase|Protocol Violation|1|||
129802932|NCT01254292|467247463|FG001|Comparative Phase|Protocol Violation|2|||
129802933|NCT01254292|467247462|FG000|Comparative Phase|Wish for pregnancy|4|||
129802934|NCT01254292|467247463|FG001|Comparative Phase|Wish for pregnancy|6|||
129802935|NCT01254292|467247462|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
129802936|NCT01254292|467247463|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
129802937|NCT01254292|467247462|FG000|LCS12 Extension Phase|Adverse Event|9|||
129802938|NCT01254292|467247463|FG001|LCS12 Extension Phase|Adverse Event|0|||
129802939|NCT01254292|467247462|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
129802940|NCT01254292|467247463|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
129802941|NCT01254292|467247462|FG000|LCS12 Extension Phase|Other unknown|4|||
129802942|NCT01254292|467247463|FG001|LCS12 Extension Phase|Other unknown|0|||
129802943|NCT01254292|467247462|FG000|LCS12 Extension Phase|Pregnancy|2|||
129802944|NCT01254292|467247463|FG001|LCS12 Extension Phase|Pregnancy|0|||
129802945|NCT01254292|467247462|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
129802946|NCT01254292|467247463|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
129802947|NCT04674644|467247469|FG000|Overall Study|with missing data|37|||
129802948|NCT01230710|467247475|FG000|Overall Study|Disease Progression|41|||
129802949|NCT01230710|467247475|FG000|Overall Study|Lost to Follow-up|3|||
129802950|NCT01230710|467247475|FG000|Overall Study|Death|4|||
129802951|NCT01230710|467247475|FG000|Overall Study|Withdrawal of Consent|1|||
129802952|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
129802953|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
129802954|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Physician Decision|1|||
129802955|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Physician Decision|0|||
129802956|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
129802957|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
129802958|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
129802959|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
129802960|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Adverse Event|15|||
129802961|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Adverse Event|0|||
129802962|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
129802963|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
129802964|NCT03277690|467247476|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
129802965|NCT03277690|467247477|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
129802966|NCT01691898|467247478|FG000|Overall Study|Death|34|||
129802967|NCT01691898|467247479|FG001|Overall Study|Death|32|||
129802968|NCT01691898|467247480|FG002|Overall Study|Death|6|||
129802969|NCT01691898|467247481|FG003|Overall Study|Death|3|||
129802970|NCT01691898|467247482|FG004|Overall Study|Death|8|||
129802971|NCT01691898|467247483|FG005|Overall Study|Death|31|||
129802972|NCT01691898|467247478|FG000|Overall Study|Adverse Event|0|||
129802973|NCT01691898|467247479|FG001|Overall Study|Adverse Event|1|||
130111290|NCT04288115|468367623|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
130111291|NCT04288115|468367624|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
130111292|NCT05037409|468367627|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
129802974|NCT01691898|467247480|FG002|Overall Study|Adverse Event|0|||
129802975|NCT01691898|467247481|FG003|Overall Study|Adverse Event|1|||
129802976|NCT01691898|467247482|FG004|Overall Study|Adverse Event|1|||
129802977|NCT01691898|467247483|FG005|Overall Study|Adverse Event|0|||
129802978|NCT01691898|467247478|FG000|Overall Study|Progression of Disease|1|||
129891471|NCT01598987|467561132|FG000|Baseline to 24 Month|Administrative problems|2|||
129891472|NCT01598987|467561132|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
129891473|NCT02107274|467561133|FG000|Treatment vs. Placebo|Adverse Event|3|||
129891474|NCT02107274|467561134|FG001|Treatment vs. Placebo|Adverse Event|0|||
129891475|NCT02107274|467561133|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
130053681|NCT02364947|468152412|FG001|Overall Study|Death|1|||
130053682|NCT02364947|468152413|FG002|Overall Study|Death|0|||
130053683|NCT00423085|468152414|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
130053684|NCT00423085|468152415|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
129802979|NCT01691898|467247479|FG001|Overall Study|Progression of Disease|2|||
130053685|NCT00423085|468152416|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
130053686|NCT00423085|468152417|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
130053687|NCT00423085|468152414|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
130053688|NCT00423085|468152415|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
130053689|NCT00423085|468152416|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
130053690|NCT00423085|468152417|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129802980|NCT01691898|467247480|FG002|Overall Study|Progression of Disease|1|||
129802981|NCT01691898|467247481|FG003|Overall Study|Progression of Disease|0|||
129802982|NCT01691898|467247482|FG004|Overall Study|Progression of Disease|0|||
129802983|NCT01691898|467247483|FG005|Overall Study|Progression of Disease|1|||
129802984|NCT01691898|467247478|FG000|Overall Study|Lost to Follow-up|3|||
129802985|NCT01691898|467247479|FG001|Overall Study|Lost to Follow-up|1|||
129802986|NCT01691898|467247480|FG002|Overall Study|Lost to Follow-up|0|||
129802987|NCT01691898|467247481|FG003|Overall Study|Lost to Follow-up|0|||
129802988|NCT01691898|467247482|FG004|Overall Study|Lost to Follow-up|1|||
129802989|NCT01691898|467247483|FG005|Overall Study|Lost to Follow-up|0|||
129802990|NCT01691898|467247478|FG000|Overall Study|Withdrawal by Subject|9|||
129802991|NCT01691898|467247479|FG001|Overall Study|Withdrawal by Subject|8|||
129802992|NCT01691898|467247480|FG002|Overall Study|Withdrawal by Subject|2|||
129802993|NCT01691898|467247481|FG003|Overall Study|Withdrawal by Subject|1|||
129802994|NCT01691898|467247482|FG004|Overall Study|Withdrawal by Subject|3|||
129802995|NCT01691898|467247483|FG005|Overall Study|Withdrawal by Subject|3|||
129802996|NCT01691898|467247478|FG000|Overall Study|Non-Compliance|0|||
129802997|NCT01691898|467247479|FG001|Overall Study|Non-Compliance|0|||
129802998|NCT01691898|467247480|FG002|Overall Study|Non-Compliance|0|||
129891476|NCT02107274|467561134|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
129891477|NCT02107274|467561133|FG000|Control Phase|Lost to Follow-up|1|||
129891478|NCT02107274|467561134|FG001|Control Phase|Lost to Follow-up|1|||
129891479|NCT02107274|467561133|FG000|Control Phase|Death|2|||
129891480|NCT02107274|467561134|FG001|Control Phase|Death|0|||
129802999|NCT01691898|467247481|FG003|Overall Study|Non-Compliance|0|||
129803000|NCT01691898|467247482|FG004|Overall Study|Non-Compliance|1|||
129803001|NCT01691898|467247483|FG005|Overall Study|Non-Compliance|0|||
129803002|NCT00747812|467247484|FG000|Overall Study|Research Site Staff Relocation|5|||
129803003|NCT00747812|467247485|FG001|Overall Study|Research Site Staff Relocation|3|||
129891481|NCT02107274|467561133|FG000|Control Phase|Adverse Event|0|||
129891482|NCT02107274|467561134|FG001|Control Phase|Adverse Event|1|||
129803004|NCT01708161|467247486|FG000|Overall Study|Adverse Event|1|||
129803005|NCT01708161|467247487|FG001|Overall Study|Adverse Event|3|||
129803006|NCT01708161|467247488|FG002|Overall Study|Adverse Event|4|||
129803007|NCT01708161|467247489|FG003|Overall Study|Adverse Event|2|||
129803008|NCT01708161|467247490|FG004|Overall Study|Adverse Event|3|||
129803009|NCT01708161|467247491|FG005|Overall Study|Adverse Event|0|||
129803010|NCT01708161|467247486|FG000|Overall Study|Death|0|||
129803011|NCT01708161|467247487|FG001|Overall Study|Death|0|||
129803012|NCT01708161|467247488|FG002|Overall Study|Death|0|||
129803013|NCT01708161|467247489|FG003|Overall Study|Death|1|||
129803014|NCT01708161|467247490|FG004|Overall Study|Death|0|||
129803015|NCT01708161|467247491|FG005|Overall Study|Death|1|||
129803016|NCT01708161|467247486|FG000|Overall Study|Withdrawal by Subject|0|||
129803017|NCT01708161|467247487|FG001|Overall Study|Withdrawal by Subject|1|||
129803018|NCT01708161|467247488|FG002|Overall Study|Withdrawal by Subject|1|||
129803019|NCT01708161|467247489|FG003|Overall Study|Withdrawal by Subject|0|||
129803020|NCT01708161|467247490|FG004|Overall Study|Withdrawal by Subject|0|||
129803021|NCT01708161|467247491|FG005|Overall Study|Withdrawal by Subject|0|||
129803022|NCT01708161|467247486|FG000|Overall Study|Administrative problems|0|||
129803023|NCT01708161|467247487|FG001|Overall Study|Administrative problems|1|||
129803024|NCT01708161|467247488|FG002|Overall Study|Administrative problems|0|||
129803025|NCT01708161|467247489|FG003|Overall Study|Administrative problems|0|||
129803026|NCT01708161|467247490|FG004|Overall Study|Administrative problems|0|||
129803027|NCT01708161|467247491|FG005|Overall Study|Administrative problems|0|||
129803028|NCT01708161|467247486|FG000|Overall Study|Disease progression|3|||
129803029|NCT01708161|467247487|FG001|Overall Study|Disease progression|5|||
129803030|NCT01708161|467247488|FG002|Overall Study|Disease progression|5|||
129803031|NCT01708161|467247489|FG003|Overall Study|Disease progression|13|||
129803032|NCT01708161|467247490|FG004|Overall Study|Disease progression|3|||
129803033|NCT01708161|467247491|FG005|Overall Study|Disease progression|0|||
129803034|NCT02019277|467247492|FG000|Overall Study|Withdrawal by Subject|3|||
129803035|NCT02019277|467247492|FG000|Overall Study|Death|7|||
129803036|NCT02019277|467247492|FG000|Overall Study|Did no Cooperate|1|||
129803037|NCT02019277|467247492|FG000|Overall Study|Adverse Event|1|||
129803038|NCT02633501|467247494|FG000|Overall Study|Adverse Event|0|||
129803039|NCT02633501|467247495|FG001|Overall Study|Adverse Event|0|||
129803040|NCT02633501|467247496|FG002|Overall Study|Adverse Event|1|||
129803041|NCT02633501|467247497|FG003|Overall Study|Adverse Event|0|||
129803042|NCT02633501|467247498|FG004|Overall Study|Adverse Event|1|||
129803043|NCT02633501|467247499|FG005|Overall Study|Adverse Event|1|||
129803044|NCT02633501|467247494|FG000|Overall Study|Withdrawal by Subject|2|||
129803045|NCT02633501|467247495|FG001|Overall Study|Withdrawal by Subject|1|||
129803046|NCT02633501|467247496|FG002|Overall Study|Withdrawal by Subject|2|||
129803047|NCT02633501|467247497|FG003|Overall Study|Withdrawal by Subject|2|||
129803048|NCT02633501|467247498|FG004|Overall Study|Withdrawal by Subject|1|||
129803049|NCT02633501|467247499|FG005|Overall Study|Withdrawal by Subject|3|||
130111293|NCT05037409|468367628|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
130111294|NCT05037409|468367629|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
129803050|NCT02633501|467247494|FG000|Overall Study|Various other reasons|0|||
129803051|NCT02633501|467247495|FG001|Overall Study|Various other reasons|2|||
129803052|NCT02633501|467247496|FG002|Overall Study|Various other reasons|4|||
129803053|NCT02633501|467247497|FG003|Overall Study|Various other reasons|1|||
129803054|NCT02633501|467247498|FG004|Overall Study|Various other reasons|7|||
129803055|NCT02633501|467247499|FG005|Overall Study|Various other reasons|11|||
129803056|NCT02633501|467247494|FG000|Overall Study|Lost to Follow-up|0|||
129803057|NCT02633501|467247495|FG001|Overall Study|Lost to Follow-up|0|||
129803058|NCT02633501|467247496|FG002|Overall Study|Lost to Follow-up|0|||
129803059|NCT02633501|467247497|FG003|Overall Study|Lost to Follow-up|1|||
129803060|NCT02633501|467247498|FG004|Overall Study|Lost to Follow-up|2|||
129803061|NCT02633501|467247499|FG005|Overall Study|Lost to Follow-up|0|||
129803062|NCT01986140|467247501|FG000|Overall Study|Withdrawal by Subject|31|||
129803063|NCT01986140|467247502|FG001|Overall Study|Withdrawal by Subject|25|||
129803064|NCT01986140|467247501|FG000|Overall Study|alternative treatment|1|||
129803065|NCT01986140|467247502|FG001|Overall Study|alternative treatment|1|||
129803066|NCT01986140|467247501|FG000|Overall Study|found not eligible|3|||
129803067|NCT01986140|467247502|FG001|Overall Study|found not eligible|0|||
129803068|NCT01986140|467247501|FG000|Overall Study|Adverse Event|0|||
129803069|NCT01986140|467247502|FG001|Overall Study|Adverse Event|1|||
129803070|NCT01986140|467247501|FG000|Overall Study|progression disease|0|||
129803071|NCT01986140|467247502|FG001|Overall Study|progression disease|1|||
129803072|NCT02808650|467247508|FG000|Overall Study|Death|0|||
129803073|NCT02808650|467247509|FG001|Overall Study|Death|0|||
129803074|NCT02808650|467247510|FG002|Overall Study|Death|0|||
129803075|NCT02808650|467247511|FG003|Overall Study|Death|0|||
129803076|NCT02808650|467247512|FG004|Overall Study|Death|1|||
129803077|NCT02808650|467247508|FG000|Overall Study|Lack of Efficacy|5|||
129803078|NCT02808650|467247509|FG001|Overall Study|Lack of Efficacy|5|||
129803079|NCT02808650|467247510|FG002|Overall Study|Lack of Efficacy|6|||
130053691|NCT00423085|468152414|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
130053692|NCT00423085|468152415|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
129891483|NCT01036087|467561136|FG000|Overall Study|Adverse Event|2|||
129891484|NCT01036087|467561136|FG000|Overall Study|Lack of Efficacy|1|||
129891485|NCT01021878|467561139|FG000|Overall Study|Lost to Follow-up|4|||
129803080|NCT02808650|467247511|FG003|Overall Study|Lack of Efficacy|5|||
129803081|NCT02808650|467247512|FG004|Overall Study|Lack of Efficacy|4|||
129803082|NCT02808650|467247508|FG000|Overall Study|Physician Decision|1|||
130053693|NCT00423085|468152416|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
130053694|NCT00423085|468152417|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
129803083|NCT02808650|467247509|FG001|Overall Study|Physician Decision|1|||
129803084|NCT02808650|467247510|FG002|Overall Study|Physician Decision|0|||
129803085|NCT02808650|467247511|FG003|Overall Study|Physician Decision|0|||
129803086|NCT02808650|467247512|FG004|Overall Study|Physician Decision|0|||
129803087|NCT02808650|467247508|FG000|Overall Study|Withdrawal by Subject|0|||
129803088|NCT02808650|467247509|FG001|Overall Study|Withdrawal by Subject|0|||
129803089|NCT02808650|467247510|FG002|Overall Study|Withdrawal by Subject|0|||
129803090|NCT02808650|467247511|FG003|Overall Study|Withdrawal by Subject|1|||
129803091|NCT02808650|467247512|FG004|Overall Study|Withdrawal by Subject|1|||
129803092|NCT01069627|467247515|FG000|Overall Study|Disease progression|7|||
129803093|NCT01069627|467247515|FG000|Overall Study|Adverse Event|12|||
129803094|NCT01069627|467247515|FG000|Overall Study|Protocol Violation|1|||
129803095|NCT02939079|467247519|FG000|Overall Study|Adverse Event|2|||
129803096|NCT02939079|467247520|FG001|Overall Study|Adverse Event|1|||
129803097|NCT02939079|467247519|FG000|Overall Study|Lost to Follow-up|0|||
129803098|NCT02939079|467247520|FG001|Overall Study|Lost to Follow-up|2|||
129803099|NCT02939079|467247519|FG000|Overall Study|Protocol Violation|1|||
129803100|NCT02939079|467247520|FG001|Overall Study|Protocol Violation|0|||
129803101|NCT02939079|467247519|FG000|Overall Study|Withdrawal by Subject|0|||
129803102|NCT02939079|467247520|FG001|Overall Study|Withdrawal by Subject|1|||
129803103|NCT02939079|467247519|FG000|Overall Study|relapse during the study|1|||
129803104|NCT02939079|467247520|FG001|Overall Study|relapse during the study|1|||
129803105|NCT04093414|467247521|FG000|3 Month Follow up|Physician Decision|0|||
129803106|NCT04093414|467247522|FG001|3 Month Follow up|Physician Decision|1|||
129803107|NCT04093414|467247521|FG000|6month Follow up|Physician Decision|1|||
129803108|NCT04093414|467247522|FG001|6month Follow up|Physician Decision|3|||
129803109|NCT04209348|467247523|FG000|Overall Study|Lost to Follow-up|1|||
129803110|NCT04209348|467247524|FG001|Overall Study|Lost to Follow-up|0|||
129803111|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
129803112|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
129803113|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Death|1|||
129803114|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Death|0|||
129803115|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
129803116|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
129803117|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
129803118|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
129803119|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
129803120|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
129803121|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
129803122|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
129803123|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
129803124|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
129803125|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
129891486|NCT01021878|467561140|FG001|Overall Study|Lost to Follow-up|3|||
129803126|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
129803127|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
129803128|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
130053695|NCT00423085|468152414|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
130111295|NCT00931385|468367630|FG000|Overall Study|Adverse Event|2|||
129891487|NCT01021878|467561139|FG000|Overall Study|Death|0|||
129803129|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
129803130|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
129803131|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
129803132|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
129803133|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
129803134|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
129803135|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
129803136|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
129803137|NCT02927262|467247527|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
129803138|NCT02927262|467247528|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
129803139|NCT02927262|467247527|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
129803140|NCT02927262|467247528|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
129803141|NCT02927262|467247527|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
129803142|NCT02927262|467247528|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
129803143|NCT00923936|467247529|FG000|Overall Study|progressive disease on study|2|||
129803144|NCT00923936|467247530|FG001|Overall Study|progressive disease on study|1|||
129803145|NCT00923936|467247529|FG000|Overall Study|Adverse Event|2|||
129803146|NCT00923936|467247530|FG001|Overall Study|Adverse Event|1|||
129803147|NCT00923936|467247529|FG000|Overall Study|Lost to follow up|2|||
129803148|NCT00923936|467247530|FG001|Overall Study|Lost to follow up|0|||
129803149|NCT00923936|467247529|FG000|Overall Study|Continuing in follow up period|2|||
129803150|NCT00923936|467247530|FG001|Overall Study|Continuing in follow up period|1|||
129803151|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
129803152|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
129803153|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
129803154|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
129803155|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
129891488|NCT01021878|467561140|FG001|Overall Study|Death|1|||
129803156|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
129891489|NCT01021878|467561139|FG000|Overall Study|Adverse Event|6|||
130053696|NCT00423085|468152415|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
130053697|NCT00423085|468152416|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
130053698|NCT00423085|468152417|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
130053699|NCT00423085|468152414|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
130053700|NCT00423085|468152415|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
129803157|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
129803158|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
130053701|NCT00423085|468152416|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
129803159|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
130053702|NCT00423085|468152417|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
129803160|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
129803161|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
129803162|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
129803163|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
129803164|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
129803165|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
129803166|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
129803167|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
129803168|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
129803169|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
129803170|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
129803171|NCT00471146|467247533|FG000|Overall Study|Adverse Event|32|||
129803172|NCT00471146|467247534|FG001|Overall Study|Adverse Event|33|||
129803173|NCT00471146|467247533|FG000|Overall Study|Withdrawal by Subject|14|||
129803174|NCT00471146|467247534|FG001|Overall Study|Withdrawal by Subject|11|||
129803175|NCT00471146|467247533|FG000|Overall Study|Death|11|||
129803176|NCT00471146|467247534|FG001|Overall Study|Death|12|||
129803177|NCT00471146|467247533|FG000|Overall Study|Lost to Follow-up|4|||
129803178|NCT00471146|467247534|FG001|Overall Study|Lost to Follow-up|2|||
129803179|NCT00471146|467247533|FG000|Overall Study|Protocol Violation|2|||
129803180|NCT00471146|467247534|FG001|Overall Study|Protocol Violation|2|||
129803181|NCT00471146|467247533|FG000|Overall Study|Objective progression or relapse|84|||
129803182|NCT00471146|467247534|FG001|Overall Study|Objective progression or relapse|87|||
129803183|NCT00471146|467247533|FG000|Overall Study|Global deterioration of health status|12|||
129803184|NCT00471146|467247534|FG001|Overall Study|Global deterioration of health status|14|||
129803185|NCT00471146|467247533|FG000|Overall Study|Randomized but not treated|9|||
129803186|NCT00471146|467247534|FG001|Overall Study|Randomized but not treated|8|||
129803187|NCT00471146|467247533|FG000|Overall Study|Other|4|||
129803188|NCT00471146|467247534|FG001|Overall Study|Other|5|||
129803189|NCT05394350|467247535|FG000|Overall Study|Death|2|||
129803190|NCT05394350|467247536|FG001|Overall Study|Death|2|||
129803191|NCT05394350|467247537|FG002|Overall Study|Death|4|||
130053703|NCT00423085|468152414|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
130053704|NCT00423085|468152415|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
130053705|NCT00423085|468152416|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
130053706|NCT00423085|468152417|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
129803192|NCT05394350|467247538|FG003|Overall Study|Death|0|||
130053707|NCT00423085|468152414|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
129803193|NCT05394350|467247539|FG004|Overall Study|Death|1|||
129803194|NCT05394350|467247540|FG005|Overall Study|Death|0|||
129803195|NCT05394350|467247535|FG000|Overall Study|Study terminated by sponsor|1|||
129803196|NCT05394350|467247536|FG001|Overall Study|Study terminated by sponsor|1|||
129803197|NCT05394350|467247537|FG002|Overall Study|Study terminated by sponsor|7|||
129803198|NCT05394350|467247538|FG003|Overall Study|Study terminated by sponsor|3|||
129803199|NCT05394350|467247539|FG004|Overall Study|Study terminated by sponsor|2|||
129803200|NCT05394350|467247540|FG005|Overall Study|Study terminated by sponsor|4|||
129803201|NCT02963935|467247543|FG000|Overall Study|Adverse Event|12|||
129803202|NCT02963935|467247544|FG001|Overall Study|Adverse Event|6|||
129803203|NCT02963935|467247543|FG000|Overall Study|Protocol Violation|2|||
129803204|NCT02963935|467247544|FG001|Overall Study|Protocol Violation|1|||
129803205|NCT02963935|467247543|FG000|Overall Study|Lack of Efficacy|0|||
129803206|NCT02963935|467247544|FG001|Overall Study|Lack of Efficacy|2|||
129803207|NCT02963935|467247543|FG000|Overall Study|Lost to Follow-up|1|||
129803208|NCT02963935|467247544|FG001|Overall Study|Lost to Follow-up|6|||
129803209|NCT02963935|467247543|FG000|Overall Study|Unclassified|13|||
130053708|NCT00423085|468152415|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
129803210|NCT02963935|467247544|FG001|Overall Study|Unclassified|22|||
129803211|NCT00464269|467247545|FG000|Overall Study|Lack of Efficacy|1|||
129803212|NCT00464269|467247546|FG001|Overall Study|Lack of Efficacy|0|||
129803213|NCT00464269|467247547|FG002|Overall Study|Lack of Efficacy|0|||
129803214|NCT00464269|467247548|FG003|Overall Study|Lack of Efficacy|0|||
129803215|NCT00464269|467247545|FG000|Overall Study|Lost to Follow-up|0|||
129803216|NCT00464269|467247546|FG001|Overall Study|Lost to Follow-up|4|||
129803217|NCT00464269|467247547|FG002|Overall Study|Lost to Follow-up|0|||
129803218|NCT00464269|467247548|FG003|Overall Study|Lost to Follow-up|1|||
129803219|NCT00464269|467247545|FG000|Overall Study|Withdrawal by Subject|0|||
130053709|NCT00423085|468152416|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
130053710|NCT00423085|468152417|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
129803220|NCT00464269|467247546|FG001|Overall Study|Withdrawal by Subject|2|||
129803221|NCT00464269|467247547|FG002|Overall Study|Withdrawal by Subject|1|||
129891490|NCT01021878|467561140|FG001|Overall Study|Adverse Event|5|||
129891491|NCT01021878|467561139|FG000|Overall Study|Transplantation|6|||
129891492|NCT01021878|467561140|FG001|Overall Study|Transplantation|1|||
129891493|NCT02424344|467561141|FG000|Overall Study|Lack of Efficacy|0|||
129891494|NCT02424344|467561142|FG001|Overall Study|Lack of Efficacy|1|||
129891495|NCT02424344|467561141|FG000|Overall Study|Withdrawal by Subject|2|||
129891496|NCT02424344|467561142|FG001|Overall Study|Withdrawal by Subject|1|||
129891497|NCT02424344|467561141|FG000|Overall Study|Lost to Follow-up|1|||
129891498|NCT02424344|467561142|FG001|Overall Study|Lost to Follow-up|0|||
129891499|NCT02424344|467561141|FG000|Overall Study|Adverse Event|4|||
129891500|NCT02424344|467561142|FG001|Overall Study|Adverse Event|8|||
129891501|NCT01511536|467561145|FG000|Phase 1|Other|0|||
129891502|NCT01511536|467561146|FG001|Phase 1|Other|1|||
129891503|NCT01511536|467561147|FG002|Phase 1|Other|0|||
129891504|NCT01511536|467561145|FG000|Phase 2|Other|0|||
129891505|NCT01511536|467561146|FG001|Phase 2|Other|0|||
129891506|NCT01511536|467561147|FG002|Phase 2|Other|9|||
129891507|NCT00765362|467561148|FG000|Overall Study|Death|9|||
130111296|NCT00931385|468367631|FG001|Overall Study|Adverse Event|1|||
130111297|NCT00931385|468367632|FG002|Overall Study|Adverse Event|0|||
129891508|NCT00765362|467561148|FG000|Overall Study|Adverse Event|2|||
129891509|NCT00765362|467561148|FG000|Overall Study|Protocol Violation|18|||
129891510|NCT00765362|467561148|FG000|Overall Study|Withdrawal by Subject|13|||
129891511|NCT00765362|467561148|FG000|Overall Study|Lost to Follow-up|95|||
130053711|NCT00423085|468152414|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
130053712|NCT00423085|468152415|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
129803222|NCT00464269|467247548|FG003|Overall Study|Withdrawal by Subject|1|||
129803223|NCT00464269|467247545|FG000|Overall Study|Other reason|3|||
129803224|NCT00464269|467247546|FG001|Overall Study|Other reason|3|||
129803225|NCT00464269|467247547|FG002|Overall Study|Other reason|1|||
129803226|NCT00464269|467247548|FG003|Overall Study|Other reason|1|||
130053713|NCT00423085|468152416|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
129803227|NCT00464269|467247545|FG000|Overall Study|AE, serious fatal|0|||
130053714|NCT00423085|468152417|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
130053715|NCT00423085|468152414|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
129803228|NCT00464269|467247546|FG001|Overall Study|AE, serious fatal|0|||
129803229|NCT00464269|467247547|FG002|Overall Study|AE, serious fatal|1|||
129803230|NCT00464269|467247548|FG003|Overall Study|AE, serious fatal|1|||
129803231|NCT00464269|467247545|FG000|Overall Study|SAE, non-fatal|0|||
129803232|NCT00464269|467247546|FG001|Overall Study|SAE, non-fatal|0|||
130053716|NCT00423085|468152415|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
130053717|NCT00423085|468152416|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
129803233|NCT00464269|467247547|FG002|Overall Study|SAE, non-fatal|0|||
129803234|NCT00464269|467247548|FG003|Overall Study|SAE, non-fatal|1|||
129803235|NCT00464269|467247545|FG000|Overall Study|AE, non-serious non-fatal|2|||
129803236|NCT00464269|467247546|FG001|Overall Study|AE, non-serious non-fatal|8|||
129803237|NCT00464269|467247547|FG002|Overall Study|AE, non-serious non-fatal|3|||
129803238|NCT00464269|467247548|FG003|Overall Study|AE, non-serious non-fatal|4|||
130111298|NCT00931385|468367633|FG003|Overall Study|Adverse Event|3|||
130053718|NCT00423085|468152417|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
130053719|NCT00423085|468152414|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
130053720|NCT00423085|468152415|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
130053721|NCT00423085|468152416|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
130053722|NCT00423085|468152417|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
130053723|NCT00423085|468152414|FG000|52-Week Open-Label Extension Phase|Death|0|||
130053724|NCT00423085|468152415|FG001|52-Week Open-Label Extension Phase|Death|0|||
130053725|NCT00423085|468152416|FG002|52-Week Open-Label Extension Phase|Death|0|||
130053726|NCT00423085|468152417|FG003|52-Week Open-Label Extension Phase|Death|2|||
129803239|NCT00464269|467247545|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129803240|NCT00464269|467247546|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129803241|NCT00464269|467247547|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
129803242|NCT00464269|467247548|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129803243|NCT05055128|467247549|FG000|Overall Study|Adverse Event|0|||
129803244|NCT05055128|467247550|FG001|Overall Study|Adverse Event|0|||
129803245|NCT05055128|467247551|FG002|Overall Study|Adverse Event|0|||
129803246|NCT05055128|467247552|FG003|Overall Study|Adverse Event|1|||
129803247|NCT05055128|467247553|FG004|Overall Study|Adverse Event|1|||
129803248|NCT05055128|467247549|FG000|Overall Study|Protocol Violation|0|||
129803249|NCT05055128|467247550|FG001|Overall Study|Protocol Violation|0|||
129803250|NCT05055128|467247551|FG002|Overall Study|Protocol Violation|0|||
129803251|NCT05055128|467247552|FG003|Overall Study|Protocol Violation|1|||
129803252|NCT05055128|467247553|FG004|Overall Study|Protocol Violation|0|||
129803253|NCT05055128|467247549|FG000|Overall Study|Withdrawal by Subject|5|||
129803254|NCT05055128|467247550|FG001|Overall Study|Withdrawal by Subject|2|||
129803255|NCT05055128|467247551|FG002|Overall Study|Withdrawal by Subject|2|||
129803256|NCT05055128|467247552|FG003|Overall Study|Withdrawal by Subject|4|||
129891512|NCT03019458|467561152|FG000|Overall Study|Death|0|||
129803257|NCT05055128|467247553|FG004|Overall Study|Withdrawal by Subject|2|||
129803258|NCT05055128|467247549|FG000|Overall Study|Randomized By Mistake|0|||
129803259|NCT05055128|467247550|FG001|Overall Study|Randomized By Mistake|1|||
129891513|NCT03019458|467561153|FG001|Overall Study|Death|1|||
130053727|NCT02163993|468152418|FG000|Treatment Period|Adverse Event|0|||
130053728|NCT02163993|468152419|FG001|Treatment Period|Adverse Event|1|||
130053729|NCT02163993|468152420|FG002|Treatment Period|Adverse Event|0|||
130053730|NCT02163993|468152421|FG003|Treatment Period|Adverse Event|0|||
130053731|NCT02163993|468152422|FG004|Treatment Period|Adverse Event|1|||
130053732|NCT02163993|468152418|FG000|Treatment Period|Lost to Follow-up|2|||
130053733|NCT02163993|468152419|FG001|Treatment Period|Lost to Follow-up|3|||
130053734|NCT02163993|468152420|FG002|Treatment Period|Lost to Follow-up|1|||
130053735|NCT02163993|468152421|FG003|Treatment Period|Lost to Follow-up|3|||
130053736|NCT02163993|468152422|FG004|Treatment Period|Lost to Follow-up|1|||
130053737|NCT02163993|468152418|FG000|Treatment Period|Physician Decision|1|||
130053738|NCT02163993|468152419|FG001|Treatment Period|Physician Decision|0|||
130053739|NCT02163993|468152420|FG002|Treatment Period|Physician Decision|0|||
130053740|NCT02163993|468152421|FG003|Treatment Period|Physician Decision|0|||
130053741|NCT02163993|468152422|FG004|Treatment Period|Physician Decision|0|||
130053742|NCT02163993|468152418|FG000|Treatment Period|Protocol Violation|2|||
130053743|NCT02163993|468152419|FG001|Treatment Period|Protocol Violation|1|||
130053744|NCT02163993|468152420|FG002|Treatment Period|Protocol Violation|0|||
130053745|NCT02163993|468152421|FG003|Treatment Period|Protocol Violation|1|||
130053746|NCT02163993|468152422|FG004|Treatment Period|Protocol Violation|2|||
130053747|NCT02163993|468152418|FG000|Treatment Period|Withdrawal by Subject|6|||
130053748|NCT02163993|468152419|FG001|Treatment Period|Withdrawal by Subject|4|||
130053749|NCT02163993|468152420|FG002|Treatment Period|Withdrawal by Subject|1|||
130053750|NCT02163993|468152421|FG003|Treatment Period|Withdrawal by Subject|4|||
130053751|NCT02163993|468152422|FG004|Treatment Period|Withdrawal by Subject|1|||
130053752|NCT02163993|468152418|FG000|Treatment Period|Not treated|1|||
130053753|NCT02163993|468152419|FG001|Treatment Period|Not treated|0|||
130053754|NCT02163993|468152420|FG002|Treatment Period|Not treated|0|||
130053755|NCT02163993|468152421|FG003|Treatment Period|Not treated|1|||
130111299|NCT00931385|468367630|FG000|Overall Study|Protocol Violation|0|||
130053756|NCT02163993|468152422|FG004|Treatment Period|Not treated|2|||
130053757|NCT02163993|468152418|FG000|Post-treatment Period|Adverse Event|0|||
129803260|NCT05055128|467247551|FG002|Overall Study|Randomized By Mistake|0|||
129803261|NCT05055128|467247552|FG003|Overall Study|Randomized By Mistake|0|||
129803262|NCT05055128|467247553|FG004|Overall Study|Randomized By Mistake|0|||
130053758|NCT02163993|468152419|FG001|Post-treatment Period|Adverse Event|0|||
130053759|NCT02163993|468152420|FG002|Post-treatment Period|Adverse Event|1|||
129803263|NCT05055128|467247549|FG000|Overall Study|Other|1|||
130111300|NCT00931385|468367631|FG001|Overall Study|Protocol Violation|0|||
130111301|NCT00931385|468367632|FG002|Overall Study|Protocol Violation|1|||
130111302|NCT00931385|468367633|FG003|Overall Study|Protocol Violation|0|||
130111303|NCT00931385|468367630|FG000|Overall Study|Withdrawal by Subject|0|||
130111304|NCT00931385|468367631|FG001|Overall Study|Withdrawal by Subject|1|||
130111305|NCT00931385|468367632|FG002|Overall Study|Withdrawal by Subject|0|||
130111306|NCT00931385|468367633|FG003|Overall Study|Withdrawal by Subject|1|||
130111307|NCT00931385|468367630|FG000|Overall Study|Lost to Follow-up|0|||
130111308|NCT00931385|468367631|FG001|Overall Study|Lost to Follow-up|0|||
130111309|NCT00931385|468367632|FG002|Overall Study|Lost to Follow-up|0|||
130111310|NCT00931385|468367633|FG003|Overall Study|Lost to Follow-up|1|||
130111311|NCT02046369|468367638|FG000|Overall Study|Adverse Event|3|||
130111312|NCT02046369|468367639|FG001|Overall Study|Adverse Event|3|||
130111313|NCT02046369|468367638|FG000|Overall Study|Lack of Efficacy|3|||
130111314|NCT02046369|468367639|FG001|Overall Study|Lack of Efficacy|3|||
130111315|NCT02046369|468367638|FG000|Overall Study|Lost to Follow-up|3|||
130111316|NCT02046369|468367639|FG001|Overall Study|Lost to Follow-up|3|||
130111317|NCT02046369|468367638|FG000|Overall Study|Protocol Violation|1|||
130111318|NCT02046369|468367639|FG001|Overall Study|Protocol Violation|2|||
129803264|NCT05055128|467247550|FG001|Overall Study|Other|0|||
129803265|NCT05055128|467247551|FG002|Overall Study|Other|0|||
129803266|NCT05055128|467247552|FG003|Overall Study|Other|0|||
129803267|NCT05055128|467247553|FG004|Overall Study|Other|0|||
129803268|NCT02149875|467247554|FG000|Overall Study|Lost to Follow-up|3|||
129803269|NCT02149875|467247555|FG001|Overall Study|Lost to Follow-up|4|||
129803270|NCT02149875|467247556|FG002|Overall Study|Lost to Follow-up|5|||
129803271|NCT02149875|467247554|FG000|Overall Study|Withdrawal by Subject|3|||
129803272|NCT02149875|467247555|FG001|Overall Study|Withdrawal by Subject|2|||
129803273|NCT02149875|467247556|FG002|Overall Study|Withdrawal by Subject|2|||
130111319|NCT02046369|468367638|FG000|Overall Study|Withdrawal by Subject|3|||
130111320|NCT02046369|468367639|FG001|Overall Study|Withdrawal by Subject|6|||
130111321|NCT02046369|468367638|FG000|Overall Study|never received study drug|0|||
129803274|NCT02149875|467247554|FG000|Overall Study|Physician Decision|1|||
130053760|NCT02163993|468152421|FG003|Post-treatment Period|Adverse Event|0|||
130053761|NCT02163993|468152422|FG004|Post-treatment Period|Adverse Event|0|||
130053762|NCT02163993|468152418|FG000|Post-treatment Period|Lost to Follow-up|2|||
130053763|NCT02163993|468152419|FG001|Post-treatment Period|Lost to Follow-up|2|||
130053764|NCT02163993|468152420|FG002|Post-treatment Period|Lost to Follow-up|3|||
130053765|NCT02163993|468152421|FG003|Post-treatment Period|Lost to Follow-up|1|||
130053766|NCT02163993|468152422|FG004|Post-treatment Period|Lost to Follow-up|0|||
130053767|NCT02163993|468152418|FG000|Post-treatment Period|Protocol Violation|0|||
130053768|NCT02163993|468152419|FG001|Post-treatment Period|Protocol Violation|0|||
130053769|NCT02163993|468152420|FG002|Post-treatment Period|Protocol Violation|0|||
130053770|NCT02163993|468152421|FG003|Post-treatment Period|Protocol Violation|0|||
130053771|NCT02163993|468152422|FG004|Post-treatment Period|Protocol Violation|1|||
130053772|NCT02163993|468152418|FG000|Post-treatment Period|Withdrawal by Subject|2|||
130053773|NCT02163993|468152419|FG001|Post-treatment Period|Withdrawal by Subject|4|||
129803275|NCT02149875|467247555|FG001|Overall Study|Physician Decision|2|||
129803276|NCT02149875|467247556|FG002|Overall Study|Physician Decision|2|||
129803277|NCT01385371|467247557|FG000|Overall Study|Adverse Event|54|||
129803278|NCT01385371|467247558|FG001|Overall Study|Adverse Event|19|||
129803279|NCT01385371|467247557|FG000|Overall Study|Lost to Follow-up|16|||
129803280|NCT01385371|467247558|FG001|Overall Study|Lost to Follow-up|16|||
129803281|NCT01385371|467247557|FG000|Overall Study|Withdrawal by Subject|52|||
129803282|NCT01385371|467247558|FG001|Overall Study|Withdrawal by Subject|39|||
129803283|NCT01385371|467247557|FG000|Overall Study|Protocol Violation|25|||
129803284|NCT01385371|467247558|FG001|Overall Study|Protocol Violation|21|||
129803285|NCT01385371|467247557|FG000|Overall Study|Administrative|2|||
130111322|NCT02046369|468367639|FG001|Overall Study|never received study drug|1|||
129803286|NCT01385371|467247558|FG001|Overall Study|Administrative|2|||
130111323|NCT02046369|468367638|FG000|Overall Study|non compliance|1|||
129803287|NCT02478372|467247559|FG000|Overall Study|Protocol Violation|12|||
130111324|NCT02046369|468367639|FG001|Overall Study|non compliance|0|||
130111325|NCT04444752|468367640|FG000|Overall Study|Adverse Event|1|||
129803288|NCT02478372|467247560|FG001|Overall Study|Protocol Violation|8|||
129803289|NCT02478372|467247559|FG000|Overall Study|Lost to Follow-up|1|||
129803290|NCT02478372|467247560|FG001|Overall Study|Lost to Follow-up|4|||
129803291|NCT02478372|467247559|FG000|Overall Study|Death|0|||
129803292|NCT02478372|467247560|FG001|Overall Study|Death|2|||
129803293|NCT02955797|467247563|FG000|Overall Study|Protocol Violation|1|||
130111326|NCT04444752|468367641|FG001|Overall Study|Adverse Event|0|||
130111327|NCT04444752|468367642|FG002|Overall Study|Adverse Event|0|||
130111328|NCT04444752|468367643|FG003|Overall Study|Adverse Event|2|||
130111329|NCT04444752|468367640|FG000|Overall Study|Lost to Follow-up|2|||
130111330|NCT04444752|468367641|FG001|Overall Study|Lost to Follow-up|6|||
130111331|NCT04444752|468367642|FG002|Overall Study|Lost to Follow-up|2|||
130111332|NCT04444752|468367643|FG003|Overall Study|Lost to Follow-up|5|||
130111333|NCT04444752|468367640|FG000|Overall Study|Physician Decision|0|||
130111334|NCT04444752|468367641|FG001|Overall Study|Physician Decision|0|||
130111335|NCT04444752|468367642|FG002|Overall Study|Physician Decision|0|||
130111336|NCT04444752|468367643|FG003|Overall Study|Physician Decision|2|||
130053774|NCT02163993|468152420|FG002|Post-treatment Period|Withdrawal by Subject|0|||
130053775|NCT02163993|468152421|FG003|Post-treatment Period|Withdrawal by Subject|1|||
130053776|NCT02163993|468152422|FG004|Post-treatment Period|Withdrawal by Subject|2|||
130053777|NCT00853489|468152423|FG000|Overall Study|Lost to Follow-up|5|||
130053778|NCT00853489|468152424|FG001|Overall Study|Lost to Follow-up|2|||
130053779|NCT05525975|468152425|FG000|Overall Study|Surgery cancellation|4|||
130053780|NCT05525975|468152426|FG001|Overall Study|Surgery cancellation|5|||
130053781|NCT05525975|468152425|FG000|Overall Study|didn't fill prescription|1|||
130053782|NCT05525975|468152426|FG001|Overall Study|didn't fill prescription|0|||
130053783|NCT05525975|468152425|FG000|Overall Study|Withdrawal by Subject|0|||
129803294|NCT02955797|467247564|FG001|Overall Study|Protocol Violation|0|||
129803295|NCT02955797|467247565|FG002|Overall Study|Protocol Violation|0|||
129803296|NCT02955797|467247566|FG003|Overall Study|Protocol Violation|1|||
129803297|NCT02955797|467247563|FG000|Overall Study|Withdrawal by Subject|2|||
129803298|NCT02955797|467247564|FG001|Overall Study|Withdrawal by Subject|2|||
129803299|NCT02955797|467247565|FG002|Overall Study|Withdrawal by Subject|0|||
129803300|NCT02955797|467247566|FG003|Overall Study|Withdrawal by Subject|1|||
129803301|NCT02955797|467247563|FG000|Overall Study|Lost to Follow-up|0|||
130053784|NCT05525975|468152426|FG001|Overall Study|Withdrawal by Subject|3|||
130053785|NCT01998581|468152428|FG000|Overall Study|Refused repeat treatment|20|||
130111337|NCT04444752|468367640|FG000|Overall Study|Pregnancy|0|||
130053786|NCT01998581|468152429|FG001|Overall Study|Refused repeat treatment|4|||
130053787|NCT01998581|468152428|FG000|Overall Study|Protocol Violation|1|||
130111338|NCT04444752|468367641|FG001|Overall Study|Pregnancy|0|||
130111339|NCT04444752|468367642|FG002|Overall Study|Pregnancy|0|||
130111340|NCT04444752|468367643|FG003|Overall Study|Pregnancy|1|||
129803302|NCT02955797|467247564|FG001|Overall Study|Lost to Follow-up|1|||
130111341|NCT04444752|468367640|FG000|Overall Study|Withdrawal by Subject|6|||
129803303|NCT02955797|467247565|FG002|Overall Study|Lost to Follow-up|0|||
129803304|NCT02955797|467247566|FG003|Overall Study|Lost to Follow-up|0|||
129803305|NCT00961649|467247568|FG000|Overall Study|Adverse Event|4|||
130053788|NCT01998581|468152429|FG001|Overall Study|Protocol Violation|0|||
130053789|NCT01998581|468152428|FG000|Overall Study|Withdrawal by Subject|8|||
130053790|NCT01998581|468152429|FG001|Overall Study|Withdrawal by Subject|1|||
130053791|NCT01998581|468152428|FG000|Overall Study|Lost to Follow-up|12|||
129803306|NCT00961649|467247569|FG001|Overall Study|Adverse Event|0|||
129803307|NCT00961649|467247570|FG002|Overall Study|Adverse Event|0|||
129803308|NCT00961649|467247571|FG003|Overall Study|Adverse Event|2|||
129803309|NCT00961649|467247568|FG000|Overall Study|Inadequate control of IOP|0|||
129803310|NCT00961649|467247569|FG001|Overall Study|Inadequate control of IOP|0|||
129803311|NCT00961649|467247570|FG002|Overall Study|Inadequate control of IOP|0|||
129803312|NCT00961649|467247571|FG003|Overall Study|Inadequate control of IOP|1|||
129803313|NCT00961649|467247568|FG000|Overall Study|Patient has travel plans during holidays|0|||
130053792|NCT01998581|468152429|FG001|Overall Study|Lost to Follow-up|4|||
130053793|NCT01998581|468152428|FG000|Overall Study|Adverse Event|1|||
129803314|NCT00961649|467247569|FG001|Overall Study|Patient has travel plans during holidays|0|||
129891514|NCT01561079|467561154|FG000|Overall Study|Physician Decision|17|||
129891515|NCT01561079|467561154|FG000|Overall Study|Withdrawal by Subject|59|||
129891516|NCT01561079|467561154|FG000|Overall Study|Protocol Violation|2|||
129891517|NCT00664521|467561163|FG000|Overall Study|Adverse Event|4|||
130053794|NCT01998581|468152429|FG001|Overall Study|Adverse Event|1|||
130053795|NCT01998581|468152428|FG000|Overall Study|Other reasons|3|||
130053796|NCT01998581|468152429|FG001|Overall Study|Other reasons|2|||
130053797|NCT01998581|468152428|FG000|Overall Study|Randomized but withdrew before treatment|1|||
130053798|NCT01998581|468152429|FG001|Overall Study|Randomized but withdrew before treatment|0|||
130053799|NCT01251276|468152430|FG000|Overall Study|Protocol Violation|1|||
129803315|NCT00961649|467247570|FG002|Overall Study|Patient has travel plans during holidays|1|||
129803316|NCT00961649|467247571|FG003|Overall Study|Patient has travel plans during holidays|0|||
129803317|NCT00961649|467247568|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
129803318|NCT00961649|467247569|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
129803319|NCT00961649|467247570|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
129803320|NCT00961649|467247571|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
129803321|NCT00961649|467247568|FG000|Overall Study|Study terminated by sponsor|4|||
129803322|NCT00961649|467247569|FG001|Overall Study|Study terminated by sponsor|4|||
129803323|NCT00961649|467247570|FG002|Overall Study|Study terminated by sponsor|4|||
129803324|NCT00961649|467247571|FG003|Overall Study|Study terminated by sponsor|1|||
129803325|NCT02711345|467247572|FG000|Overall Study|Adverse Event|0|||
129803326|NCT02711345|467247573|FG001|Overall Study|Adverse Event|0|||
129803327|NCT02711345|467247574|FG002|Overall Study|Adverse Event|0|||
129803328|NCT02711345|467247575|FG003|Overall Study|Adverse Event|1|||
129803329|NCT02711345|467247576|FG004|Overall Study|Adverse Event|1|||
129803330|NCT02711345|467247577|FG005|Overall Study|Adverse Event|2|||
129803331|NCT02711345|467247578|FG006|Overall Study|Adverse Event|1|||
129803332|NCT02711345|467247579|FG007|Overall Study|Adverse Event|0|||
129803333|NCT02711345|467247580|FG008|Overall Study|Adverse Event|0|||
129803334|NCT02711345|467247581|FG009|Overall Study|Adverse Event|2|||
129803335|NCT02711345|467247572|FG000|Overall Study|Physician Decision|0|||
129803336|NCT02711345|467247573|FG001|Overall Study|Physician Decision|0|||
129803337|NCT02711345|467247574|FG002|Overall Study|Physician Decision|1|||
129803338|NCT02711345|467247575|FG003|Overall Study|Physician Decision|0|||
129803339|NCT02711345|467247576|FG004|Overall Study|Physician Decision|0|||
129803340|NCT02711345|467247577|FG005|Overall Study|Physician Decision|0|||
129803341|NCT02711345|467247578|FG006|Overall Study|Physician Decision|0|||
129803342|NCT02711345|467247579|FG007|Overall Study|Physician Decision|0|||
129803343|NCT02711345|467247580|FG008|Overall Study|Physician Decision|1|||
129803344|NCT02711345|467247581|FG009|Overall Study|Physician Decision|0|||
129803345|NCT02711345|467247572|FG000|Overall Study|Progressive disease|1|||
129803346|NCT02711345|467247573|FG001|Overall Study|Progressive disease|3|||
129803347|NCT02711345|467247574|FG002|Overall Study|Progressive disease|5|||
129803348|NCT02711345|467247575|FG003|Overall Study|Progressive disease|3|||
129803349|NCT02711345|467247576|FG004|Overall Study|Progressive disease|7|||
129803350|NCT02711345|467247577|FG005|Overall Study|Progressive disease|2|||
129803351|NCT02711345|467247578|FG006|Overall Study|Progressive disease|8|||
129803352|NCT02711345|467247579|FG007|Overall Study|Progressive disease|4|||
129803353|NCT02711345|467247580|FG008|Overall Study|Progressive disease|5|||
129803354|NCT02711345|467247581|FG009|Overall Study|Progressive disease|6|||
130053800|NCT01251276|468152431|FG001|Overall Study|Protocol Violation|0|||
130053801|NCT01251276|468152430|FG000|Overall Study|Lost to Follow-up|0|||
130053802|NCT01251276|468152431|FG001|Overall Study|Lost to Follow-up|1|||
129803355|NCT02711345|467247572|FG000|Overall Study|Subject/guardian decision|0|||
129803356|NCT02711345|467247573|FG001|Overall Study|Subject/guardian decision|0|||
129803357|NCT02711345|467247574|FG002|Overall Study|Subject/guardian decision|0|||
129891518|NCT00664521|467561164|FG001|Overall Study|Adverse Event|1|||
129891519|NCT00664521|467561163|FG000|Overall Study|Lost to Follow-up|1|||
129803358|NCT02711345|467247575|FG003|Overall Study|Subject/guardian decision|0|||
129803359|NCT02711345|467247576|FG004|Overall Study|Subject/guardian decision|0|||
129803360|NCT02711345|467247577|FG005|Overall Study|Subject/guardian decision|2|||
129803361|NCT02711345|467247578|FG006|Overall Study|Subject/guardian decision|3|||
129803362|NCT02711345|467247579|FG007|Overall Study|Subject/guardian decision|1|||
129803363|NCT02711345|467247580|FG008|Overall Study|Subject/guardian decision|0|||
129803364|NCT02711345|467247581|FG009|Overall Study|Subject/guardian decision|4|||
129803365|NCT02711345|467247572|FG000|Overall Study|Death|1|||
129803366|NCT02711345|467247573|FG001|Overall Study|Death|0|||
129803367|NCT02711345|467247574|FG002|Overall Study|Death|0|||
129803368|NCT02711345|467247575|FG003|Overall Study|Death|0|||
129803369|NCT02711345|467247576|FG004|Overall Study|Death|0|||
129803370|NCT02711345|467247577|FG005|Overall Study|Death|0|||
129803371|NCT02711345|467247578|FG006|Overall Study|Death|0|||
129803372|NCT02711345|467247579|FG007|Overall Study|Death|1|||
129803373|NCT02711345|467247580|FG008|Overall Study|Death|0|||
129803374|NCT02711345|467247581|FG009|Overall Study|Death|0|||
129803375|NCT01558739|467247584|FG000|Overall Study|Adverse Event|7|||
129803376|NCT01558739|467247584|FG000|Overall Study|Withdrawal by Subject|2|||
129803377|NCT01558739|467247584|FG000|Overall Study|Death|3|||
129803378|NCT01558739|467247584|FG000|Overall Study|Disease Progression|4|||
129803379|NCT01558739|467247584|FG000|Overall Study|Protocol Violation|1|||
129803380|NCT00108433|467249722|FG000|Overall Study|Lack of Efficacy|1|||
129803381|NCT00108433|467249723|FG001|Overall Study|Lack of Efficacy|2|||
129803382|NCT00108433|467249722|FG000|Overall Study|Death|3|||
129803383|NCT00108433|467249723|FG001|Overall Study|Death|0|||
129803384|NCT00108433|467249722|FG000|Overall Study|Adverse Event|3|||
129803385|NCT00108433|467249723|FG001|Overall Study|Adverse Event|1|||
129803386|NCT00108433|467249722|FG000|Overall Study|Other|14|||
129803387|NCT00108433|467249723|FG001|Overall Study|Other|14|||
129803388|NCT00734474|467249731|FG000|Overall Study|Entry Criteria Not Met|0|||
129803389|NCT00734474|467249732|FG001|Overall Study|Entry Criteria Not Met|0|||
129803390|NCT00734474|467249733|FG002|Overall Study|Entry Criteria Not Met|5|||
129803391|NCT00734474|467249734|FG003|Overall Study|Entry Criteria Not Met|0|||
129803392|NCT00734474|467249735|FG004|Overall Study|Entry Criteria Not Met|3|||
129803393|NCT00734474|467249736|FG005|Overall Study|Entry Criteria Not Met|1|||
129803394|NCT00734474|467249737|FG006|Overall Study|Entry Criteria Not Met|0|||
129803395|NCT00734474|467249738|FG007|Overall Study|Entry Criteria Not Met|1|||
129803396|NCT00734474|467249739|FG008|Overall Study|Entry Criteria Not Met|1|||
129803397|NCT00734474|467249731|FG000|Overall Study|Lost to Follow-up|1|||
129803398|NCT00734474|467249732|FG001|Overall Study|Lost to Follow-up|0|||
129803399|NCT00734474|467249733|FG002|Overall Study|Lost to Follow-up|13|||
129803400|NCT00734474|467249734|FG003|Overall Study|Lost to Follow-up|0|||
129803401|NCT00734474|467249735|FG004|Overall Study|Lost to Follow-up|11|||
129803402|NCT00734474|467249736|FG005|Overall Study|Lost to Follow-up|1|||
129803403|NCT00734474|467249737|FG006|Overall Study|Lost to Follow-up|0|||
129803404|NCT00734474|467249738|FG007|Overall Study|Lost to Follow-up|9|||
129803405|NCT00734474|467249739|FG008|Overall Study|Lost to Follow-up|4|||
129803406|NCT00734474|467249731|FG000|Overall Study|Withdrawal by Subject|2|||
129803407|NCT00734474|467249732|FG001|Overall Study|Withdrawal by Subject|1|||
129803408|NCT00734474|467249733|FG002|Overall Study|Withdrawal by Subject|18|||
129803409|NCT00734474|467249734|FG003|Overall Study|Withdrawal by Subject|0|||
129803410|NCT00734474|467249735|FG004|Overall Study|Withdrawal by Subject|24|||
129803411|NCT00734474|467249736|FG005|Overall Study|Withdrawal by Subject|2|||
129803412|NCT00734474|467249737|FG006|Overall Study|Withdrawal by Subject|0|||
129803413|NCT00734474|467249738|FG007|Overall Study|Withdrawal by Subject|36|||
129803414|NCT00734474|467249739|FG008|Overall Study|Withdrawal by Subject|21|||
129803415|NCT00734474|467249731|FG000|Overall Study|Physician Decision|0|||
129803416|NCT00734474|467249732|FG001|Overall Study|Physician Decision|0|||
129803417|NCT00734474|467249733|FG002|Overall Study|Physician Decision|4|||
129803418|NCT00734474|467249734|FG003|Overall Study|Physician Decision|1|||
129803419|NCT00734474|467249735|FG004|Overall Study|Physician Decision|11|||
129803420|NCT00734474|467249736|FG005|Overall Study|Physician Decision|0|||
129803421|NCT00734474|467249737|FG006|Overall Study|Physician Decision|0|||
129803422|NCT00734474|467249738|FG007|Overall Study|Physician Decision|9|||
129803423|NCT00734474|467249739|FG008|Overall Study|Physician Decision|9|||
129803424|NCT00734474|467249731|FG000|Overall Study|Adverse Event|4|||
129803425|NCT00734474|467249732|FG001|Overall Study|Adverse Event|4|||
129803426|NCT00734474|467249733|FG002|Overall Study|Adverse Event|63|||
129803427|NCT00734474|467249734|FG003|Overall Study|Adverse Event|1|||
129803428|NCT00734474|467249735|FG004|Overall Study|Adverse Event|64|||
129803429|NCT00734474|467249736|FG005|Overall Study|Adverse Event|0|||
129803430|NCT00734474|467249737|FG006|Overall Study|Adverse Event|1|||
129803431|NCT00734474|467249738|FG007|Overall Study|Adverse Event|65|||
129803432|NCT00734474|467249739|FG008|Overall Study|Adverse Event|39|||
129803433|NCT00734474|467249731|FG000|Overall Study|Protocol Violation|0|||
129803434|NCT00734474|467249732|FG001|Overall Study|Protocol Violation|0|||
129803435|NCT00734474|467249733|FG002|Overall Study|Protocol Violation|4|||
129803436|NCT00734474|467249734|FG003|Overall Study|Protocol Violation|0|||
129803437|NCT00734474|467249735|FG004|Overall Study|Protocol Violation|3|||
129803438|NCT00734474|467249736|FG005|Overall Study|Protocol Violation|0|||
129803439|NCT00734474|467249737|FG006|Overall Study|Protocol Violation|0|||
129803440|NCT00734474|467249738|FG007|Overall Study|Protocol Violation|3|||
129803441|NCT00734474|467249739|FG008|Overall Study|Protocol Violation|1|||
129803442|NCT00734474|467249731|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
129803443|NCT00734474|467249732|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
129803444|NCT00734474|467249733|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803445|NCT00734474|467249734|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
129803446|NCT00734474|467249735|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803447|NCT00734474|467249736|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
129803448|NCT00734474|467249737|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
129803449|NCT00734474|467249738|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803450|NCT00734474|467249739|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803451|NCT00734474|467249731|FG000|Overall Study|Sponsor Decision|0|||
129803452|NCT00734474|467249732|FG001|Overall Study|Sponsor Decision|0|||
129803453|NCT00734474|467249733|FG002|Overall Study|Sponsor Decision|0|||
130111342|NCT04444752|468367641|FG001|Overall Study|Withdrawal by Subject|5|||
129803454|NCT00734474|467249734|FG003|Overall Study|Sponsor Decision|0|||
129803455|NCT00734474|467249735|FG004|Overall Study|Sponsor Decision|2|||
129803456|NCT00734474|467249736|FG005|Overall Study|Sponsor Decision|0|||
129803457|NCT00734474|467249737|FG006|Overall Study|Sponsor Decision|0|||
129803458|NCT00734474|467249738|FG007|Overall Study|Sponsor Decision|0|||
130053803|NCT01345123|468152432|FG000|Overall Study|participants no longer with health plan|79|||
129803459|NCT00734474|467249739|FG008|Overall Study|Sponsor Decision|0|||
129891520|NCT00664521|467561164|FG001|Overall Study|Lost to Follow-up|0|||
129891521|NCT00664521|467561163|FG000|Overall Study|Other|1|||
129891522|NCT00664521|467561164|FG001|Overall Study|Other|0|||
129891523|NCT02459964|467561165|FG000|Overall Study|Withdrawal by Subject|0|||
129891524|NCT02459964|467561166|FG001|Overall Study|Withdrawal by Subject|0|||
129891525|NCT02459964|467561167|FG002|Overall Study|Withdrawal by Subject|1|||
129891526|NCT02459964|467561165|FG000|Overall Study|Abnormal EKG changes|0|||
129891527|NCT02459964|467561166|FG001|Overall Study|Abnormal EKG changes|0|||
129891528|NCT02459964|467561167|FG002|Overall Study|Abnormal EKG changes|1|||
129891529|NCT00367237|467561168|FG000|Overall Study|Adverse Event|7|||
129891530|NCT00367237|467561169|FG001|Overall Study|Adverse Event|2|||
129891531|NCT00367237|467561168|FG000|Overall Study|Lost to Follow-up|1|||
129891532|NCT00367237|467561169|FG001|Overall Study|Lost to Follow-up|0|||
129891533|NCT00367237|467561168|FG000|Overall Study|Withdrawal by Subject|0|||
129891534|NCT00367237|467561169|FG001|Overall Study|Withdrawal by Subject|4|||
129891535|NCT00367237|467561168|FG000|Overall Study|Protocol Violation|2|||
129891536|NCT00367237|467561169|FG001|Overall Study|Protocol Violation|5|||
129891537|NCT00550732|467561170|FG000|Overall Study|Death|4|||
129891538|NCT00550732|467561170|FG000|Overall Study|Withdrawal by Subject|2|||
129891539|NCT00550732|467561170|FG000|Overall Study|Physician Decision|2|||
129891540|NCT00550732|467561170|FG000|Overall Study|Lost to Follow-up|1|||
129891541|NCT00550732|467561170|FG000|Overall Study|Palliative care|1|||
129891542|NCT00550732|467561170|FG000|Overall Study|Adverse Event|1|||
129891543|NCT02800928|467561177|FG000|Overall Study|Withdrawal by Subject|1|||
129891544|NCT02800928|467561178|FG001|Overall Study|Withdrawal by Subject|1|||
129891545|NCT02800928|467561177|FG000|Overall Study|Protocol Violation|1|||
129891546|NCT02800928|467561178|FG001|Overall Study|Protocol Violation|1|||
129891547|NCT04004208|467561186|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129891548|NCT04004208|467561187|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129891549|NCT04004208|467561186|FG000|Overall Study|Death|3|||
129891550|NCT04004208|467561187|FG001|Overall Study|Death|0|||
129891551|NCT04004208|467561186|FG000|Overall Study|COVID-19 pandemic|1|||
129891552|NCT04004208|467561187|FG001|Overall Study|COVID-19 pandemic|0|||
129891553|NCT04004208|467561186|FG000|Overall Study|Physician Decision|1|||
129891554|NCT04004208|467561187|FG001|Overall Study|Physician Decision|0|||
129891555|NCT04004208|467561186|FG000|Overall Study|Adverse Event|1|||
129891556|NCT04004208|467561187|FG001|Overall Study|Adverse Event|1|||
129891557|NCT00570661|467561195|FG000|Overall Study|Disease worsening|5|||
129891558|NCT00570661|467561195|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
129891559|NCT00570661|467561195|FG000|Overall Study|Adverse Event|1|||
129891560|NCT01734382|467561196|FG000|Part 1|Adverse Event|2|||
129891561|NCT01734382|467561197|FG001|Part 1|Adverse Event|0|||
129891562|NCT01734382|467561198|FG002|Part 1|Adverse Event|0|||
129891563|NCT01734382|467561196|FG000|Part 2|Adverse Event|0|||
129891564|NCT01734382|467561197|FG001|Part 2|Adverse Event|0|||
129891565|NCT01734382|467561198|FG002|Part 2|Adverse Event|1|||
129891566|NCT01734382|467561196|FG000|Part 2|Lack of Efficacy|0|||
129891567|NCT01734382|467561197|FG001|Part 2|Lack of Efficacy|1|||
130053804|NCT01345123|468152433|FG001|Overall Study|participants no longer with health plan|85|||
130053805|NCT01345123|468152434|FG002|Overall Study|participants no longer with health plan|88|||
130053806|NCT03100942|468152435|FG000|Randomized Treatment Period|Withdrew Consent|4|||
130053807|NCT03100942|468152436|FG001|Randomized Treatment Period|Withdrew Consent|5|||
130053808|NCT03100942|468152437|FG002|Randomized Treatment Period|Withdrew Consent|3|||
130053809|NCT03100942|468152438|FG003|Randomized Treatment Period|Withdrew Consent|3|||
130053810|NCT03100942|468152439|FG004|Randomized Treatment Period|Withdrew Consent|0|||
130053811|NCT03100942|468152440|FG005|Randomized Treatment Period|Withdrew Consent|0|||
130053812|NCT03100942|468152441|FG006|Randomized Treatment Period|Withdrew Consent|0|||
130053813|NCT03100942|468152435|FG000|Randomized Treatment Period|Adverse Event|5|||
130053814|NCT03100942|468152436|FG001|Randomized Treatment Period|Adverse Event|2|||
130053815|NCT03100942|468152437|FG002|Randomized Treatment Period|Adverse Event|1|||
130053816|NCT03100942|468152438|FG003|Randomized Treatment Period|Adverse Event|0|||
130053817|NCT03100942|468152439|FG004|Randomized Treatment Period|Adverse Event|0|||
130053818|NCT03100942|468152440|FG005|Randomized Treatment Period|Adverse Event|0|||
130053819|NCT03100942|468152441|FG006|Randomized Treatment Period|Adverse Event|0|||
130053820|NCT03100942|468152435|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
130053821|NCT03100942|468152436|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
129803460|NCT00734474|467249731|FG000|Overall Study|Death|0|||
129803461|NCT00734474|467249732|FG001|Overall Study|Death|0|||
129803462|NCT00734474|467249733|FG002|Overall Study|Death|1|||
129803463|NCT00734474|467249734|FG003|Overall Study|Death|0|||
129803464|NCT00734474|467249735|FG004|Overall Study|Death|0|||
129803465|NCT00734474|467249736|FG005|Overall Study|Death|0|||
129803466|NCT00734474|467249737|FG006|Overall Study|Death|0|||
129803467|NCT00734474|467249738|FG007|Overall Study|Death|2|||
129803468|NCT00734474|467249739|FG008|Overall Study|Death|1|||
129803469|NCT00734474|467249731|FG000|Overall Study|Lack of Efficacy|0|||
129803470|NCT00734474|467249732|FG001|Overall Study|Lack of Efficacy|0|||
129803471|NCT00734474|467249733|FG002|Overall Study|Lack of Efficacy|4|||
129803472|NCT00734474|467249734|FG003|Overall Study|Lack of Efficacy|0|||
129803473|NCT00734474|467249735|FG004|Overall Study|Lack of Efficacy|0|||
129803474|NCT00734474|467249736|FG005|Overall Study|Lack of Efficacy|0|||
129803475|NCT00734474|467249737|FG006|Overall Study|Lack of Efficacy|0|||
129803476|NCT00734474|467249738|FG007|Overall Study|Lack of Efficacy|4|||
129803477|NCT00734474|467249739|FG008|Overall Study|Lack of Efficacy|6|||
129803478|NCT02570074|467249748|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
129803479|NCT02570074|467249749|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
129803480|NCT02497612|467249750|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
129803481|NCT02497612|467249751|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
129803482|NCT02497612|467249752|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
129803483|NCT02497612|467249753|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
129803484|NCT02497612|467249750|FG000|Overall Study|Participant's request|2|||
129803485|NCT02497612|467249751|FG001|Overall Study|Participant's request|3|||
129803486|NCT02497612|467249752|FG002|Overall Study|Participant's request|4|||
130111343|NCT04444752|468367642|FG002|Overall Study|Withdrawal by Subject|3|||
129803487|NCT02497612|467249753|FG003|Overall Study|Participant's request|1|||
129803488|NCT02497612|467249750|FG000|Overall Study|Investigator's judgement|1|||
129803489|NCT02497612|467249751|FG001|Overall Study|Investigator's judgement|0|||
129803490|NCT02497612|467249752|FG002|Overall Study|Investigator's judgement|0|||
130111344|NCT04444752|468367643|FG003|Overall Study|Withdrawal by Subject|4|||
130111345|NCT04444752|468367640|FG000|Overall Study|Protocol Violation|1|||
129803491|NCT02497612|467249753|FG003|Overall Study|Investigator's judgement|2|||
129803492|NCT02497612|467249750|FG000|Overall Study|Adverse Event|3|||
129803493|NCT02497612|467249751|FG001|Overall Study|Adverse Event|1|||
129803494|NCT02497612|467249752|FG002|Overall Study|Adverse Event|4|||
129803495|NCT02497612|467249753|FG003|Overall Study|Adverse Event|1|||
129803496|NCT02497612|467249750|FG000|Overall Study|Lost to Follow-up|1|||
129803497|NCT02497612|467249751|FG001|Overall Study|Lost to Follow-up|1|||
129803498|NCT02497612|467249752|FG002|Overall Study|Lost to Follow-up|0|||
129803499|NCT02497612|467249753|FG003|Overall Study|Lost to Follow-up|1|||
129803500|NCT02497612|467249750|FG000|Overall Study|Other unspecified|1|||
129803501|NCT02497612|467249751|FG001|Overall Study|Other unspecified|1|||
129803502|NCT02497612|467249752|FG002|Overall Study|Other unspecified|2|||
129803503|NCT02497612|467249753|FG003|Overall Study|Other unspecified|0|||
129803504|NCT02497612|467249750|FG000|Overall Study|Not eligible|1|||
129803505|NCT02497612|467249751|FG001|Overall Study|Not eligible|0|||
129891568|NCT01734382|467561198|FG002|Part 2|Lack of Efficacy|1|||
129891569|NCT01734382|467561196|FG000|Part 2|Other|0|||
129891570|NCT01734382|467561197|FG001|Part 2|Other|0|||
129891571|NCT01734382|467561198|FG002|Part 2|Other|1|||
129803506|NCT02497612|467249752|FG002|Overall Study|Not eligible|0|||
129803507|NCT02497612|467249753|FG003|Overall Study|Not eligible|1|||
129803508|NCT02651467|467249754|FG000|Overall Study|Withdrawal by Subject|0|||
129803509|NCT02651467|467249755|FG001|Overall Study|Withdrawal by Subject|0|||
129891572|NCT01734382|467561196|FG000|Part 2|Physician Decision|0|||
129803510|NCT02651467|467249756|FG002|Overall Study|Withdrawal by Subject|2|||
129891573|NCT01734382|467561197|FG001|Part 2|Physician Decision|0|||
129891574|NCT01734382|467561198|FG002|Part 2|Physician Decision|3|||
129891575|NCT01734382|467561196|FG000|Part 2|Protocol Violation|0|||
130053822|NCT03100942|468152437|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
130053823|NCT03100942|468152438|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
130053824|NCT03100942|468152439|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
130053825|NCT03100942|468152440|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
130053826|NCT03100942|468152441|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
130053827|NCT03100942|468152435|FG000|Randomized Treatment Period|Protocol Violation|0|||
130053828|NCT03100942|468152436|FG001|Randomized Treatment Period|Protocol Violation|1|||
130053829|NCT03100942|468152437|FG002|Randomized Treatment Period|Protocol Violation|1|||
130053830|NCT03100942|468152438|FG003|Randomized Treatment Period|Protocol Violation|1|||
129803511|NCT02651467|467249754|FG000|Overall Study|Other (Not specified)|1|||
130053831|NCT03100942|468152439|FG004|Randomized Treatment Period|Protocol Violation|0|||
130053832|NCT03100942|468152440|FG005|Randomized Treatment Period|Protocol Violation|0|||
130053833|NCT03100942|468152441|FG006|Randomized Treatment Period|Protocol Violation|0|||
130053834|NCT03100942|468152435|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
130053835|NCT03100942|468152436|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
130053836|NCT03100942|468152437|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
130053837|NCT03100942|468152438|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
130053838|NCT03100942|468152439|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
130053839|NCT03100942|468152440|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
130053840|NCT03100942|468152441|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
130053841|NCT03100942|468152435|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
130053842|NCT03100942|468152436|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130053843|NCT03100942|468152437|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130053844|NCT03100942|468152438|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
130053845|NCT03100942|468152439|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130053846|NCT03100942|468152440|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130053847|NCT03100942|468152441|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
130053848|NCT03100942|468152435|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130111346|NCT04444752|468367641|FG001|Overall Study|Protocol Violation|1|||
129803512|NCT02651467|467249755|FG001|Overall Study|Other (Not specified)|0|||
129803513|NCT02651467|467249756|FG002|Overall Study|Other (Not specified)|2|||
129803514|NCT00004635|467249757|FG000|Period One|refused|2|||
129803515|NCT00004635|467249758|FG001|Period One|refused|1|||
129803516|NCT00004635|467249757|FG000|Period One|Withdrawal by Subject|1|||
129803517|NCT00004635|467249758|FG001|Period One|Withdrawal by Subject|1|||
129803518|NCT00004635|467249757|FG000|Period One|Protocol Violation|1|||
129803519|NCT00004635|467249758|FG001|Period One|Protocol Violation|0|||
129803520|NCT00004635|467249757|FG000|Period One|PSA did not go <5 ng/mL|1|||
129803521|NCT00004635|467249758|FG001|Period One|PSA did not go <5 ng/mL|0|||
129803522|NCT00004635|467249757|FG000|Period One|second malignancy|1|||
129803523|NCT00004635|467249758|FG001|Period One|second malignancy|0|||
129803524|NCT00004635|467249757|FG000|Period One|progressed|0|||
130053849|NCT03100942|468152436|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130053850|NCT03100942|468152437|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130053851|NCT03100942|468152438|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130053852|NCT03100942|468152439|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130053853|NCT03100942|468152440|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
130053854|NCT03100942|468152441|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
130053855|NCT03456713|468152444|FG000|Overall Study|Lost to Follow-up|1|||
130053856|NCT03456713|468152445|FG001|Overall Study|Lost to Follow-up|0|||
130053857|NCT03456713|468152446|FG002|Overall Study|Lost to Follow-up|0|||
130053858|NCT03456713|468152447|FG003|Overall Study|Lost to Follow-up|0|||
129803525|NCT00004635|467249758|FG001|Period One|progressed|2|||
129803526|NCT00004635|467249757|FG000|Period One|health problem|0|||
129803527|NCT00004635|467249758|FG001|Period One|health problem|1|||
130053859|NCT01263691|468152452|FG000|Overall Study|Lost to Follow-up|1|||
130053860|NCT01263691|468152453|FG001|Overall Study|Lost to Follow-up|0|||
130053861|NCT01263691|468152454|FG002|Overall Study|Lost to Follow-up|1|||
130053862|NCT01263691|468152455|FG003|Overall Study|Lost to Follow-up|1|||
130053863|NCT01263691|468152456|FG004|Overall Study|Lost to Follow-up|0|||
129891576|NCT01734382|467561197|FG001|Part 2|Protocol Violation|1|||
130053864|NCT01263691|468152457|FG005|Overall Study|Lost to Follow-up|0|||
130053865|NCT01263691|468152452|FG000|Overall Study|Withdrawal by Subject|1|||
130053866|NCT01263691|468152453|FG001|Overall Study|Withdrawal by Subject|0|||
130053867|NCT01263691|468152454|FG002|Overall Study|Withdrawal by Subject|0|||
130053868|NCT01263691|468152455|FG003|Overall Study|Withdrawal by Subject|0|||
130053869|NCT01263691|468152456|FG004|Overall Study|Withdrawal by Subject|0|||
130053870|NCT01263691|468152457|FG005|Overall Study|Withdrawal by Subject|0|||
130053871|NCT01263691|468152452|FG000|Overall Study|Adverse Event|1|||
130053872|NCT01263691|468152453|FG001|Overall Study|Adverse Event|0|||
130053873|NCT01263691|468152454|FG002|Overall Study|Adverse Event|0|||
130053874|NCT01263691|468152455|FG003|Overall Study|Adverse Event|0|||
130053875|NCT01263691|468152456|FG004|Overall Study|Adverse Event|0|||
130053876|NCT01263691|468152457|FG005|Overall Study|Adverse Event|0|||
130053877|NCT01028651|468152458|FG000|Overall Study|Death|2|||
130053878|NCT01028651|468152458|FG000|Overall Study|Adverse Event|1|||
130053879|NCT00913978|468152460|FG000|Overall Study|Surgeon choice|1|||
130053880|NCT00913978|468152461|FG001|Overall Study|Surgeon choice|3|||
130053881|NCT01327651|468152465|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
130053882|NCT01327651|468152466|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
130053883|NCT01327651|468152467|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
130053884|NCT01327651|468152468|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
130053885|NCT01327651|468152469|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
130053886|NCT01327651|468152470|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
130053887|NCT01327651|468152471|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
130053888|NCT01327651|468152472|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
130053889|NCT01327651|468152473|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
130053890|NCT01327651|468152465|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
130053891|NCT01327651|468152466|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053892|NCT01327651|468152467|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053893|NCT01327651|468152468|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053894|NCT01327651|468152469|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053895|NCT01327651|468152470|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053896|NCT01327651|468152471|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053897|NCT01327651|468152472|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053898|NCT01327651|468152473|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
130053899|NCT01327651|468152465|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
130053900|NCT01327651|468152466|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
130053901|NCT01327651|468152467|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
130053902|NCT01327651|468152468|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
130053903|NCT01327651|468152469|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
130053904|NCT01327651|468152470|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
130053905|NCT01327651|468152471|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
130053906|NCT01327651|468152472|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
130053907|NCT01327651|468152473|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
130053908|NCT01327651|468152465|FG000|Post Study Follow-up|Lost to Follow-up|0|||
130053909|NCT01327651|468152466|FG001|Post Study Follow-up|Lost to Follow-up|1|||
130053910|NCT01327651|468152467|FG002|Post Study Follow-up|Lost to Follow-up|1|||
130053911|NCT01327651|468152468|FG003|Post Study Follow-up|Lost to Follow-up|0|||
130053912|NCT01327651|468152469|FG004|Post Study Follow-up|Lost to Follow-up|0|||
130053913|NCT01327651|468152470|FG005|Post Study Follow-up|Lost to Follow-up|0|||
130053914|NCT01327651|468152471|FG006|Post Study Follow-up|Lost to Follow-up|4|||
130053915|NCT01327651|468152472|FG007|Post Study Follow-up|Lost to Follow-up|1|||
130053916|NCT01327651|468152473|FG008|Post Study Follow-up|Lost to Follow-up|2|||
130053917|NCT03249792|468152478|FG000|Arms 1, 2, and 4|Death|1|||
130053918|NCT03249792|468152479|FG001|Arms 1, 2, and 4|Death|1|||
130053919|NCT03249792|468152480|FG002|Arms 1, 2, and 4|Death|0|||
130053920|NCT03249792|468152481|FG003|Arms 1, 2, and 4|Death|2|||
130111347|NCT04444752|468367642|FG002|Overall Study|Protocol Violation|0|||
130053921|NCT03249792|468152482|FG004|Arms 1, 2, and 4|Death|3|||
130053922|NCT03249792|468152483|FG005|Arms 1, 2, and 4|Death|2|||
130053923|NCT03249792|468152484|FG006|Arms 1, 2, and 4|Death|2|||
130053924|NCT03249792|468152485|FG007|Arms 1, 2, and 4|Death|4|||
130111348|NCT04444752|468367643|FG003|Overall Study|Protocol Violation|0|||
129803528|NCT00004635|467249757|FG000|Period One|discrepancy in data entry|0|||
129803529|NCT00004635|467249758|FG001|Period One|discrepancy in data entry|1|||
129803530|NCT00004635|467249757|FG000|Period Two|progression|2|||
129803531|NCT00004635|467249758|FG001|Period Two|progression|3|||
129891577|NCT01734382|467561198|FG002|Part 2|Protocol Violation|0|||
129891578|NCT01734382|467561196|FG000|Part 2|Withdrawal by Subject|0|||
129891579|NCT01734382|467561197|FG001|Part 2|Withdrawal by Subject|0|||
129891580|NCT01734382|467561198|FG002|Part 2|Withdrawal by Subject|1|||
129891581|NCT01052662|467561201|FG000|Overall Study|Lost to Follow-up|15|||
129891582|NCT01052662|467561202|FG001|Overall Study|Lost to Follow-up|13|||
129891583|NCT01052662|467561203|FG002|Overall Study|Lost to Follow-up|18|||
129891584|NCT01052662|467561201|FG000|Overall Study|Withdrawal by Subject|3|||
129891585|NCT01052662|467561202|FG001|Overall Study|Withdrawal by Subject|2|||
129891586|NCT01052662|467561203|FG002|Overall Study|Withdrawal by Subject|1|||
129891587|NCT01052662|467561201|FG000|Overall Study|Pharmacy issue|1|||
130053925|NCT03249792|468152486|FG008|Arms 1, 2, and 4|Death|2|||
129891588|NCT01052662|467561202|FG001|Overall Study|Pharmacy issue|3|||
129891589|NCT01052662|467561203|FG002|Overall Study|Pharmacy issue|3|||
129803532|NCT00004635|467249757|FG000|Period Two|Adverse Event|1|||
129803533|NCT00004635|467249758|FG001|Period Two|Adverse Event|0|||
129803534|NCT00004635|467249757|FG000|Period Two|refused|0|||
129803535|NCT00004635|467249758|FG001|Period Two|refused|2|||
129803536|NCT00004635|467249757|FG000|Period Two|health problem|1|||
129803537|NCT00004635|467249758|FG001|Period Two|health problem|1|||
129803538|NCT00004635|467249757|FG000|Period Two|travel issues|0|||
130053926|NCT03249792|468152487|FG009|Arms 1, 2, and 4|Death|1|||
130053927|NCT03249792|468152488|FG010|Arms 1, 2, and 4|Death|7|||
130053928|NCT03249792|468152489|FG011|Arms 1, 2, and 4|Death|7|||
130053929|NCT03249792|468152490|FG012|Arms 1, 2, and 4|Death|12|||
130053930|NCT03249792|468152491|FG013|Arms 1, 2, and 4|Death|7|||
130053931|NCT03249792|468152492|FG014|Arms 1, 2, and 4|Death|0|||
130053932|NCT03249792|468152493|FG015|Arms 1, 2, and 4|Death|4|||
130053933|NCT03249792|468152494|FG016|Arms 1, 2, and 4|Death|4|||
130053934|NCT03249792|468152495|FG017|Arms 1, 2, and 4|Death|12|||
130053935|NCT03249792|468152496|FG018|Arms 1, 2, and 4|Death|6|||
130053936|NCT03249792|468152497|FG019|Arms 1, 2, and 4|Death|4|||
130053937|NCT03249792|468152498|FG020|Arms 1, 2, and 4|Death|2|||
130053938|NCT03249792|468152499|FG021|Arms 1, 2, and 4|Death|3|||
130053939|NCT03249792|468152500|FG022|Arms 1, 2, and 4|Death|1|||
130053940|NCT03249792|468152501|FG023|Arms 1, 2, and 4|Death|1|||
130053941|NCT03249792|468152502|FG024|Arms 1, 2, and 4|Death|4|||
130053942|NCT03249792|468152503|FG025|Arms 1, 2, and 4|Death|0|||
130053943|NCT03249792|468152504|FG026|Arms 1, 2, and 4|Death|0|||
129803539|NCT00004635|467249758|FG001|Period Two|travel issues|1|||
129803540|NCT00004635|467249757|FG000|Period Two|secondary malignancy|1|||
129803541|NCT00004635|467249758|FG001|Period Two|secondary malignancy|1|||
130053944|NCT03249792|468152505|FG027|Arms 1, 2, and 4|Death|0|||
130053945|NCT03249792|468152506|FG028|Arms 1, 2, and 4|Death|0|||
130053946|NCT03249792|468152507|FG029|Arms 1, 2, and 4|Death|0|||
130053947|NCT03249792|468152508|FG030|Arms 1, 2, and 4|Death|0|||
130053948|NCT03249792|468152509|FG031|Arms 1, 2, and 4|Death|0|||
130053949|NCT03249792|468152510|FG032|Arms 1, 2, and 4|Death|0|||
129803542|NCT00004635|467249757|FG000|Period Two|Lost to Follow-up|1|||
129803543|NCT00004635|467249758|FG001|Period Two|Lost to Follow-up|0|||
130053950|NCT03249792|468152478|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053951|NCT03249792|468152479|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129803544|NCT00004635|467249757|FG000|Period Two|discrepancy in data entry|0|||
129891590|NCT01052662|467561201|FG000|Overall Study|Adverse Event|1|||
129803545|NCT00004635|467249758|FG001|Period Two|discrepancy in data entry|1|||
129803546|NCT02024529|467249759|FG000|Overall Study|Withdrawal by Subject|11|||
129803547|NCT02024529|467249760|FG001|Overall Study|Withdrawal by Subject|21|||
129803548|NCT02024529|467249759|FG000|Overall Study|Lost to Follow-up|2|||
129803549|NCT02024529|467249760|FG001|Overall Study|Lost to Follow-up|4|||
129803550|NCT00354614|467249761|FG000|Overall Study|Lack of Efficacy|28|||
129803551|NCT01890746|467249762|FG000|Overall Study|Death|39|||
129803552|NCT01890746|467249763|FG001|Overall Study|Death|30|||
129803553|NCT01890746|467249762|FG000|Overall Study|Adverse Event|1|||
129803554|NCT01890746|467249763|FG001|Overall Study|Adverse Event|0|||
129803555|NCT01890746|467249762|FG000|Overall Study|Lost to Follow-up|4|||
129803556|NCT01890746|467249763|FG001|Overall Study|Lost to Follow-up|1|||
129803557|NCT01890746|467249762|FG000|Overall Study|Physician Decision|3|||
129803558|NCT01890746|467249763|FG001|Overall Study|Physician Decision|2|||
129803559|NCT01890746|467249762|FG000|Overall Study|Withdrawal by Subject|5|||
129803560|NCT01890746|467249763|FG001|Overall Study|Withdrawal by Subject|8|||
129803561|NCT02642029|467249764|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
129803562|NCT02642029|467249765|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803563|NCT02642029|467249766|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803564|NCT02642029|467249767|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803565|NCT02642029|467249768|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803566|NCT02642029|467249769|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803567|NCT02642029|467249764|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803568|NCT02642029|467249765|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
129803569|NCT02642029|467249766|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803570|NCT02642029|467249767|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803571|NCT02642029|467249768|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803572|NCT02642029|467249769|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803573|NCT02642029|467249764|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803574|NCT02642029|467249765|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803575|NCT02642029|467249766|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803576|NCT02642029|467249767|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803577|NCT02642029|467249768|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
129803578|NCT02642029|467249769|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803579|NCT02642029|467249764|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
129803580|NCT02642029|467249765|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
129803581|NCT02642029|467249766|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
129803582|NCT02642029|467249767|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
129803583|NCT02642029|467249768|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
129803584|NCT02642029|467249769|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
129803585|NCT02642029|467249764|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
129803586|NCT02642029|467249765|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803587|NCT02642029|467249766|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803588|NCT02642029|467249767|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803589|NCT02642029|467249768|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803590|NCT02642029|467249769|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803591|NCT02642029|467249764|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
129803592|NCT02642029|467249765|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803593|NCT02642029|467249766|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803594|NCT02642029|467249767|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
130053952|NCT03249792|468152480|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130053953|NCT03249792|468152481|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053954|NCT03249792|468152482|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053955|NCT03249792|468152483|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130053956|NCT03249792|468152484|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
130053957|NCT03249792|468152485|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129803595|NCT02642029|467249768|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803596|NCT02642029|467249769|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803597|NCT01134731|467249771|FG000|Overall Study|Adverse Event|3|||
129803598|NCT01134731|467249772|FG001|Overall Study|Adverse Event|2|||
129803599|NCT01134731|467249773|FG002|Overall Study|Adverse Event|1|||
129803600|NCT01134731|467249771|FG000|Overall Study|Physician Decision|2|||
129803601|NCT01134731|467249772|FG001|Overall Study|Physician Decision|2|||
129803602|NCT01134731|467249773|FG002|Overall Study|Physician Decision|2|||
129803603|NCT01134731|467249771|FG000|Overall Study|Lack of Efficacy|0|||
129803604|NCT01134731|467249772|FG001|Overall Study|Lack of Efficacy|0|||
129803605|NCT01134731|467249773|FG002|Overall Study|Lack of Efficacy|1|||
129803606|NCT01134731|467249771|FG000|Overall Study|Withdrawal by Subject|3|||
129803607|NCT01134731|467249772|FG001|Overall Study|Withdrawal by Subject|3|||
129803608|NCT01134731|467249773|FG002|Overall Study|Withdrawal by Subject|1|||
129803609|NCT01134731|467249771|FG000|Overall Study|Lost to Follow-up|5|||
129803610|NCT01134731|467249772|FG001|Overall Study|Lost to Follow-up|4|||
129803611|NCT01134731|467249773|FG002|Overall Study|Lost to Follow-up|3|||
129803612|NCT00676338|467249774|FG000|Overall Study|Adverse Event|6|||
130111349|NCT04444752|468367640|FG000|Overall Study|Patient moving out of town|1|||
129803613|NCT00676338|467249775|FG001|Overall Study|Adverse Event|6|||
129803614|NCT00676338|467249776|FG002|Overall Study|Adverse Event|5|||
129803615|NCT00676338|467249777|FG003|Overall Study|Adverse Event|1|||
129803616|NCT00676338|467249774|FG000|Overall Study|Lost to Follow-up|4|||
129803617|NCT00676338|467249775|FG001|Overall Study|Lost to Follow-up|1|||
129803618|NCT00676338|467249776|FG002|Overall Study|Lost to Follow-up|3|||
129803619|NCT00676338|467249777|FG003|Overall Study|Lost to Follow-up|4|||
129803620|NCT00676338|467249774|FG000|Overall Study|Physician Decision|3|||
129803621|NCT00676338|467249775|FG001|Overall Study|Physician Decision|3|||
129803622|NCT00676338|467249776|FG002|Overall Study|Physician Decision|2|||
129803623|NCT00676338|467249777|FG003|Overall Study|Physician Decision|3|||
129803624|NCT00676338|467249774|FG000|Overall Study|Protocol Violation|5|||
129803625|NCT00676338|467249775|FG001|Overall Study|Protocol Violation|9|||
129803626|NCT00676338|467249776|FG002|Overall Study|Protocol Violation|2|||
129803627|NCT00676338|467249777|FG003|Overall Study|Protocol Violation|5|||
129803628|NCT00676338|467249774|FG000|Overall Study|Withdrawal by Subject|17|||
129803629|NCT00676338|467249775|FG001|Overall Study|Withdrawal by Subject|9|||
129803630|NCT00676338|467249776|FG002|Overall Study|Withdrawal by Subject|12|||
129891591|NCT01052662|467561202|FG001|Overall Study|Adverse Event|1|||
129803631|NCT00676338|467249777|FG003|Overall Study|Withdrawal by Subject|6|||
129803632|NCT00676338|467249774|FG000|Overall Study|Entry Criteria Not Met|0|||
129803633|NCT00676338|467249775|FG001|Overall Study|Entry Criteria Not Met|2|||
129803634|NCT00676338|467249776|FG002|Overall Study|Entry Criteria Not Met|1|||
129803635|NCT00676338|467249777|FG003|Overall Study|Entry Criteria Not Met|1|||
129803636|NCT00676338|467249774|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
129803637|NCT00676338|467249775|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
129803638|NCT00676338|467249776|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
129803639|NCT00676338|467249777|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
129803640|NCT02122458|467249778|FG000|Overall Study|Withdrawal by Subject|0|||
129803641|NCT02122458|467249779|FG001|Overall Study|Withdrawal by Subject|0|||
129803642|NCT02122458|467249780|FG002|Overall Study|Withdrawal by Subject|0|||
129803643|NCT02122458|467249781|FG003|Overall Study|Withdrawal by Subject|4|||
129803644|NCT02122458|467249782|FG004|Overall Study|Withdrawal by Subject|4|||
129803645|NCT02122458|467249783|FG005|Overall Study|Withdrawal by Subject|4|||
129803646|NCT02122458|467249784|FG006|Overall Study|Withdrawal by Subject|0|||
129803647|NCT02122458|467249778|FG000|Overall Study|Lost to Follow-up|1|||
129803648|NCT02122458|467249779|FG001|Overall Study|Lost to Follow-up|3|||
129803649|NCT02122458|467249780|FG002|Overall Study|Lost to Follow-up|0|||
129803650|NCT02122458|467249781|FG003|Overall Study|Lost to Follow-up|7|||
129803651|NCT02122458|467249782|FG004|Overall Study|Lost to Follow-up|5|||
129803652|NCT02122458|467249783|FG005|Overall Study|Lost to Follow-up|15|||
129803653|NCT02122458|467249784|FG006|Overall Study|Lost to Follow-up|1|||
130053958|NCT03249792|468152486|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
129803654|NCT02122458|467249778|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
129803655|NCT02122458|467249779|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
129891592|NCT01052662|467561203|FG002|Overall Study|Adverse Event|0|||
129891593|NCT01052662|467561201|FG000|Overall Study|Legal Problem|2|||
129803656|NCT02122458|467249780|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803657|NCT02122458|467249781|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803658|NCT02122458|467249782|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
130111350|NCT04444752|468367641|FG001|Overall Study|Patient moving out of town|0|||
129803659|NCT02122458|467249783|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803660|NCT02122458|467249784|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803661|NCT02122458|467249778|FG000|Overall Study|Adverse Event|1|||
129803662|NCT02122458|467249779|FG001|Overall Study|Adverse Event|0|||
129803663|NCT02122458|467249780|FG002|Overall Study|Adverse Event|0|||
129803664|NCT02122458|467249781|FG003|Overall Study|Adverse Event|0|||
129803665|NCT02122458|467249782|FG004|Overall Study|Adverse Event|0|||
129803666|NCT02122458|467249783|FG005|Overall Study|Adverse Event|0|||
129803667|NCT02122458|467249784|FG006|Overall Study|Adverse Event|0|||
129803668|NCT02122458|467249778|FG000|Overall Study|Experimental Error|0|||
129803669|NCT02122458|467249779|FG001|Overall Study|Experimental Error|0|||
129803670|NCT02122458|467249780|FG002|Overall Study|Experimental Error|0|||
129803671|NCT02122458|467249781|FG003|Overall Study|Experimental Error|0|||
129803672|NCT02122458|467249782|FG004|Overall Study|Experimental Error|3|||
129803673|NCT02122458|467249783|FG005|Overall Study|Experimental Error|0|||
129803674|NCT02122458|467249784|FG006|Overall Study|Experimental Error|0|||
129803675|NCT02122458|467249778|FG000|Overall Study|Deployed or Moved|0|||
129803676|NCT02122458|467249779|FG001|Overall Study|Deployed or Moved|0|||
129803677|NCT02122458|467249780|FG002|Overall Study|Deployed or Moved|0|||
129803678|NCT02122458|467249781|FG003|Overall Study|Deployed or Moved|0|||
129803679|NCT02122458|467249782|FG004|Overall Study|Deployed or Moved|1|||
129803680|NCT02122458|467249783|FG005|Overall Study|Deployed or Moved|0|||
129803681|NCT02122458|467249784|FG006|Overall Study|Deployed or Moved|0|||
129803682|NCT02122458|467249778|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
129803683|NCT02122458|467249779|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
129803684|NCT02122458|467249780|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
129803685|NCT02122458|467249781|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
129803686|NCT02122458|467249782|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
129803687|NCT02122458|467249783|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
129803688|NCT02122458|467249784|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
129803689|NCT02122458|467249778|FG000|Overall Study|Noncompliance|0|||
129803690|NCT02122458|467249779|FG001|Overall Study|Noncompliance|1|||
129803691|NCT02122458|467249780|FG002|Overall Study|Noncompliance|0|||
129803692|NCT02122458|467249781|FG003|Overall Study|Noncompliance|0|||
129803693|NCT02122458|467249782|FG004|Overall Study|Noncompliance|0|||
129803694|NCT02122458|467249783|FG005|Overall Study|Noncompliance|0|||
129803695|NCT02122458|467249784|FG006|Overall Study|Noncompliance|0|||
129803696|NCT00412542|467249785|FG000|Overall Study|Withdrawal by Subject|0|||
129803697|NCT00412542|467249786|FG001|Overall Study|Withdrawal by Subject|2|||
129803698|NCT00412542|467249785|FG000|Overall Study|Not Eligible|0|||
129803699|NCT00412542|467249786|FG001|Overall Study|Not Eligible|1|||
129803700|NCT03161093|467249787|FG000|Overall Study|Protocol Violation|11|||
129803701|NCT03161093|467249788|FG001|Overall Study|Protocol Violation|14|||
130053959|NCT03249792|468152487|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130053960|NCT03249792|468152488|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
130053961|NCT03249792|468152489|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
129891594|NCT01052662|467561202|FG001|Overall Study|Legal Problem|0|||
129891595|NCT01052662|467561203|FG002|Overall Study|Legal Problem|0|||
129891596|NCT01052662|467561201|FG000|Overall Study|Administrative|0|||
129891597|NCT01052662|467561202|FG001|Overall Study|Administrative|3|||
129891598|NCT01052662|467561203|FG002|Overall Study|Administrative|0|||
129891599|NCT00087490|467561204|FG000|Overall Study|Death|6|||
129891600|NCT00087490|467561205|FG001|Overall Study|Death|4|||
129891601|NCT00087490|467561204|FG000|Overall Study|Adverse Event|3|||
129891602|NCT00087490|467561205|FG001|Overall Study|Adverse Event|8|||
129891603|NCT00087490|467561204|FG000|Overall Study|Lack of Efficacy|0|||
129891604|NCT00087490|467561205|FG001|Overall Study|Lack of Efficacy|2|||
129891605|NCT00087490|467561204|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
129891606|NCT00087490|467561205|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
129891607|NCT00087490|467561204|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
129891608|NCT00087490|467561205|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
129891609|NCT00087490|467561204|FG000|Overall Study|Randomized but not treated|7|||
129891610|NCT00087490|467561205|FG001|Overall Study|Randomized but not treated|18|||
129891611|NCT02034435|467561206|FG000|Overall Study|Withdrawal by Subject|1|||
129891612|NCT02034435|467561207|FG001|Overall Study|Withdrawal by Subject|0|||
129891613|NCT02034435|467561208|FG002|Overall Study|Withdrawal by Subject|0|||
129891614|NCT02034435|467561209|FG003|Overall Study|Withdrawal by Subject|0|||
129891615|NCT02034435|467561206|FG000|Overall Study|Illness|0|||
129891616|NCT02034435|467561207|FG001|Overall Study|Illness|2|||
129891617|NCT02034435|467561208|FG002|Overall Study|Illness|0|||
129891618|NCT02034435|467561209|FG003|Overall Study|Illness|0|||
129891619|NCT02034435|467561206|FG000|Overall Study|Inadequate IV access|1|||
129891620|NCT02034435|467561207|FG001|Overall Study|Inadequate IV access|0|||
129891621|NCT02034435|467561208|FG002|Overall Study|Inadequate IV access|0|||
129891622|NCT02034435|467561209|FG003|Overall Study|Inadequate IV access|1|||
129891623|NCT00630539|467561210|FG000|Overall Study|Adverse Event|1|||
129891624|NCT00630539|467561211|FG001|Overall Study|Adverse Event|3|||
129891625|NCT00630539|467561212|FG002|Overall Study|Adverse Event|1|||
129891626|NCT00630539|467561213|FG003|Overall Study|Adverse Event|2|||
129891627|NCT00630539|467561210|FG000|Overall Study|Withdrawal by Subject|0|||
130053962|NCT03249792|468152490|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
129803702|NCT03161093|467249789|FG002|Overall Study|Protocol Violation|6|||
129803703|NCT03161093|467249790|FG003|Overall Study|Protocol Violation|13|||
129803704|NCT03161093|467249791|FG004|Overall Study|Protocol Violation|1|||
129803705|NCT03161093|467249792|FG005|Overall Study|Protocol Violation|0|||
129803706|NCT03161093|467249787|FG000|Overall Study|Adverse Event|5|||
129803707|NCT03161093|467249788|FG001|Overall Study|Adverse Event|21|||
129803708|NCT03161093|467249789|FG002|Overall Study|Adverse Event|16|||
129803709|NCT03161093|467249790|FG003|Overall Study|Adverse Event|35|||
129803710|NCT03161093|467249791|FG004|Overall Study|Adverse Event|2|||
129803711|NCT03161093|467249792|FG005|Overall Study|Adverse Event|1|||
129803712|NCT03161093|467249787|FG000|Overall Study|Lack of Efficacy|9|||
129803713|NCT03161093|467249788|FG001|Overall Study|Lack of Efficacy|13|||
129803714|NCT03161093|467249789|FG002|Overall Study|Lack of Efficacy|9|||
129803715|NCT03161093|467249790|FG003|Overall Study|Lack of Efficacy|24|||
129803716|NCT03161093|467249791|FG004|Overall Study|Lack of Efficacy|4|||
129803717|NCT03161093|467249792|FG005|Overall Study|Lack of Efficacy|1|||
129803718|NCT03161093|467249787|FG000|Overall Study|Physician Decision|0|||
129803719|NCT03161093|467249788|FG001|Overall Study|Physician Decision|1|||
129803720|NCT03161093|467249789|FG002|Overall Study|Physician Decision|0|||
129803721|NCT03161093|467249790|FG003|Overall Study|Physician Decision|2|||
129803722|NCT03161093|467249791|FG004|Overall Study|Physician Decision|17|||
129803723|NCT03161093|467249792|FG005|Overall Study|Physician Decision|15|||
129803724|NCT03161093|467249787|FG000|Overall Study|Withdrawal by Subject|24|||
129803725|NCT03161093|467249788|FG001|Overall Study|Withdrawal by Subject|73|||
129803726|NCT03161093|467249789|FG002|Overall Study|Withdrawal by Subject|44|||
129803727|NCT03161093|467249790|FG003|Overall Study|Withdrawal by Subject|97|||
129803728|NCT03161093|467249791|FG004|Overall Study|Withdrawal by Subject|11|||
130053963|NCT03249792|468152491|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
129803729|NCT03161093|467249792|FG005|Overall Study|Withdrawal by Subject|10|||
129803730|NCT03161093|467249787|FG000|Overall Study|Lost to Follow-up|3|||
129803731|NCT03161093|467249788|FG001|Overall Study|Lost to Follow-up|12|||
129803732|NCT03161093|467249789|FG002|Overall Study|Lost to Follow-up|4|||
129803733|NCT03161093|467249790|FG003|Overall Study|Lost to Follow-up|7|||
130053964|NCT03249792|468152492|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129803734|NCT03161093|467249791|FG004|Overall Study|Lost to Follow-up|8|||
129803735|NCT03161093|467249792|FG005|Overall Study|Lost to Follow-up|13|||
129803736|NCT03161093|467249787|FG000|Overall Study|Death|3|||
129803737|NCT03161093|467249788|FG001|Overall Study|Death|9|||
129803738|NCT03161093|467249789|FG002|Overall Study|Death|7|||
129803739|NCT03161093|467249790|FG003|Overall Study|Death|9|||
129803740|NCT03161093|467249791|FG004|Overall Study|Death|0|||
130053965|NCT03249792|468152493|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129803741|NCT03161093|467249792|FG005|Overall Study|Death|0|||
129803742|NCT03161093|467249787|FG000|Overall Study|Unknown - Not reported|0|||
130111351|NCT04444752|468367642|FG002|Overall Study|Patient moving out of town|0|||
130111352|NCT04444752|468367643|FG003|Overall Study|Patient moving out of town|1|||
130111353|NCT04444752|468367640|FG000|Overall Study|Lack of Efficacy|0|||
130111354|NCT04444752|468367641|FG001|Overall Study|Lack of Efficacy|0|||
129803743|NCT03161093|467249788|FG001|Overall Study|Unknown - Not reported|1|||
129803744|NCT03161093|467249789|FG002|Overall Study|Unknown - Not reported|0|||
129803745|NCT03161093|467249790|FG003|Overall Study|Unknown - Not reported|0|||
129803746|NCT03161093|467249791|FG004|Overall Study|Unknown - Not reported|0|||
129803747|NCT03161093|467249792|FG005|Overall Study|Unknown - Not reported|1|||
129803748|NCT01031706|467249793|FG000|Overall Study|Adverse Event|1|||
129803749|NCT01031706|467249794|FG001|Overall Study|Adverse Event|0|||
129803750|NCT01031706|467249793|FG000|Overall Study|Withdrawal by Subject|1|||
129803751|NCT01031706|467249794|FG001|Overall Study|Withdrawal by Subject|1|||
129803752|NCT02124161|467249795|FG000|Overall Study|Other unspecified|0|||
129803753|NCT02124161|467249796|FG001|Overall Study|Other unspecified|1|||
129803754|NCT02124161|467249795|FG000|Overall Study|Death|1|||
129803755|NCT02124161|467249796|FG001|Overall Study|Death|0|||
129803756|NCT02124161|467249795|FG000|Overall Study|Protocol Violation|2|||
129803757|NCT02124161|467249796|FG001|Overall Study|Protocol Violation|1|||
129803758|NCT02124161|467249795|FG000|Overall Study|Withdrawal by Subject|1|||
129803759|NCT02124161|467249796|FG001|Overall Study|Withdrawal by Subject|2|||
129803760|NCT02124161|467249795|FG000|Overall Study|Adverse Event|2|||
129803761|NCT02124161|467249796|FG001|Overall Study|Adverse Event|0|||
129803762|NCT02124161|467249795|FG000|Overall Study|Does not meet entrance criteria|2|||
129803763|NCT02124161|467249796|FG001|Overall Study|Does not meet entrance criteria|3|||
129803764|NCT02124161|467249795|FG000|Overall Study|No longer meets eligibility criteria|5|||
129803765|NCT02124161|467249796|FG001|Overall Study|No longer meets eligibility criteria|4|||
129803766|NCT02124161|467249795|FG000|Overall Study|Lost to Follow-up|3|||
129803767|NCT02124161|467249796|FG001|Overall Study|Lost to Follow-up|4|||
129803768|NCT02517866|467249797|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129803769|NCT02517866|467249798|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129803770|NCT02517866|467249799|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129803771|NCT02517866|467249797|FG000|Overall Study|Significant Protocol Deviation|4|||
129803772|NCT02517866|467249798|FG001|Overall Study|Significant Protocol Deviation|1|||
129803773|NCT02517866|467249799|FG002|Overall Study|Significant Protocol Deviation|0|||
129803774|NCT02517866|467249797|FG000|Overall Study|Lost to Follow-up|1|||
129803775|NCT02517866|467249798|FG001|Overall Study|Lost to Follow-up|0|||
129803776|NCT02517866|467249799|FG002|Overall Study|Lost to Follow-up|0|||
129803777|NCT02517866|467249797|FG000|Overall Study|Voluntary Withdrawal|2|||
129803778|NCT02517866|467249798|FG001|Overall Study|Voluntary Withdrawal|2|||
129803779|NCT02517866|467249799|FG002|Overall Study|Voluntary Withdrawal|0|||
129803780|NCT02517866|467249797|FG000|Overall Study|Investigator Decision|2|||
129803781|NCT02517866|467249798|FG001|Overall Study|Investigator Decision|1|||
129803782|NCT02517866|467249799|FG002|Overall Study|Investigator Decision|0|||
129803783|NCT02517866|467249797|FG000|Overall Study|Reason not specified|2|||
129803784|NCT02517866|467249798|FG001|Overall Study|Reason not specified|0|||
129803785|NCT02517866|467249799|FG002|Overall Study|Reason not specified|0|||
129803786|NCT01147640|467249801|FG000|Overall Study|Adverse Event|2|||
129803787|NCT01147640|467249802|FG001|Overall Study|Adverse Event|0|||
129803788|NCT01147640|467249801|FG000|Overall Study|Physician Decision|1|||
129803789|NCT01147640|467249802|FG001|Overall Study|Physician Decision|0|||
129803790|NCT01147640|467249801|FG000|Overall Study|Withdrawal by Subject|1|||
129803791|NCT01147640|467249802|FG001|Overall Study|Withdrawal by Subject|0|||
129803792|NCT01147640|467249801|FG000|Overall Study|Lost to Follow-up|0|||
129803793|NCT01147640|467249802|FG001|Overall Study|Lost to Follow-up|1|||
129803794|NCT01147640|467249801|FG000|Overall Study|Didn't meet eligibility criteria|1|||
129803795|NCT01147640|467249802|FG001|Overall Study|Didn't meet eligibility criteria|0|||
129803796|NCT01797731|467249804|FG000|Overall Study|Didn't have proper radiographs required|3|||
129803797|NCT01797731|467249805|FG001|Overall Study|Didn't have proper radiographs required|3|||
129803798|NCT00091442|467249807|FG000|Overall Study|Progressive Disease|220|||
129803799|NCT00091442|467249808|FG001|Overall Study|Progressive Disease|189|||
129803800|NCT00091442|467249807|FG000|Overall Study|Physician Decision|61|||
129803801|NCT00091442|467249808|FG001|Overall Study|Physician Decision|58|||
129803802|NCT00091442|467249807|FG000|Overall Study|Withdrawal by Subject|38|||
129803803|NCT00091442|467249808|FG001|Overall Study|Withdrawal by Subject|46|||
129803804|NCT00091442|467249807|FG000|Overall Study|Adverse Event|29|||
129803805|NCT00091442|467249808|FG001|Overall Study|Adverse Event|48|||
129803806|NCT00091442|467249807|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
129803807|NCT00091442|467249808|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
129803808|NCT00091442|467249807|FG000|Overall Study|Death|9|||
129803809|NCT00091442|467249808|FG001|Overall Study|Death|7|||
129803810|NCT00091442|467249807|FG000|Overall Study|Lost to Follow-up|1|||
129803811|NCT00091442|467249808|FG001|Overall Study|Lost to Follow-up|3|||
129803812|NCT00091442|467249807|FG000|Overall Study|Other|2|||
129803813|NCT00091442|467249808|FG001|Overall Study|Other|6|||
130111355|NCT04444752|468367642|FG002|Overall Study|Lack of Efficacy|0|||
130053966|NCT03249792|468152494|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
129803814|NCT05095454|467249813|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
129891628|NCT00630539|467561211|FG001|Overall Study|Withdrawal by Subject|1|||
130053967|NCT03249792|468152495|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053968|NCT03249792|468152496|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130053969|NCT03249792|468152497|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053970|NCT03249792|468152498|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053971|NCT03249792|468152499|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053972|NCT03249792|468152500|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130053973|NCT03249792|468152501|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
130053974|NCT03249792|468152502|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053975|NCT03249792|468152503|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130111356|NCT04444752|468367643|FG003|Overall Study|Lack of Efficacy|1|||
130111357|NCT04444752|468367640|FG000|Overall Study|Death|0|||
130111358|NCT04444752|468367641|FG001|Overall Study|Death|0|||
130111359|NCT04444752|468367642|FG002|Overall Study|Death|1|||
130111360|NCT04444752|468367643|FG003|Overall Study|Death|0|||
130053976|NCT03249792|468152504|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053977|NCT03249792|468152505|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053978|NCT03249792|468152506|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129803815|NCT05095454|467249814|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
129803816|NCT03342963|467249815|FG000|Overall Study|Adverse Event|1|||
129803817|NCT03342963|467249816|FG001|Overall Study|Adverse Event|2|||
129803818|NCT03342963|467249817|FG002|Overall Study|Adverse Event|0|||
129803819|NCT03342963|467249818|FG003|Overall Study|Adverse Event|0|||
129803820|NCT03342963|467249815|FG000|Overall Study|Withdrawal by Subject|1|||
129803821|NCT03342963|467249816|FG001|Overall Study|Withdrawal by Subject|0|||
129803822|NCT03342963|467249817|FG002|Overall Study|Withdrawal by Subject|0|||
129803823|NCT03342963|467249818|FG003|Overall Study|Withdrawal by Subject|0|||
129803824|NCT03605212|467249819|FG000|Treatment Period|Adverse Event|1|||
129803825|NCT03605212|467249820|FG001|Treatment Period|Adverse Event|0|||
129803826|NCT03605212|467249821|FG002|Treatment Period|Adverse Event|0|||
129803827|NCT03605212|467249822|FG003|Treatment Period|Adverse Event|0|||
129803828|NCT03605212|467249823|FG004|Treatment Period|Adverse Event|0|||
129803829|NCT03605212|467249819|FG000|Treatment Period|Physician Decision|0|||
130053979|NCT03249792|468152507|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053980|NCT03249792|468152508|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053981|NCT03249792|468152509|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129803830|NCT03605212|467249820|FG001|Treatment Period|Physician Decision|0|||
129803831|NCT03605212|467249821|FG002|Treatment Period|Physician Decision|0|||
129891629|NCT00630539|467561212|FG002|Overall Study|Withdrawal by Subject|0|||
130053982|NCT03249792|468152510|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
130053983|NCT03249792|468152478|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
130053984|NCT03249792|468152479|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
129803832|NCT03605212|467249822|FG003|Treatment Period|Physician Decision|0|||
129803833|NCT03605212|467249823|FG004|Treatment Period|Physician Decision|1|||
129803834|NCT01756053|467249824|FG000|Period 1 (10 Days)|Protocol Violation|1|||
129803835|NCT01756053|467249825|FG001|Period 1 (10 Days)|Protocol Violation|1|||
129891630|NCT00630539|467561213|FG003|Overall Study|Withdrawal by Subject|1|||
129891631|NCT01700530|467561214|FG000|Overall Study|Withdrawal by Subject|0|||
129891632|NCT01700530|467561215|FG001|Overall Study|Withdrawal by Subject|3|||
130053985|NCT03249792|468152480|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
129891633|NCT01700530|467561216|FG002|Overall Study|Withdrawal by Subject|1|||
130053986|NCT03249792|468152481|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
129803836|NCT01756053|467249824|FG000|Period 2 (10 Days)|Protocol Violation|0|||
129803837|NCT01756053|467249825|FG001|Period 2 (10 Days)|Protocol Violation|2|||
129803838|NCT00285818|467249826|FG000|Overall Study|Withdrawal by Subject|3|||
129803839|NCT00285818|467249827|FG001|Overall Study|Withdrawal by Subject|2|||
129803840|NCT00285818|467249826|FG000|Overall Study|Lost to Follow-up|1|||
129803841|NCT00285818|467249827|FG001|Overall Study|Lost to Follow-up|0|||
129803842|NCT04041375|467249828|FG000|Intervention Phase|Withdrawal by Subject|2|||
129803843|NCT04041375|467249829|FG001|Intervention Phase|Withdrawal by Subject|2|||
129803844|NCT04041375|467249828|FG000|Follow-up Phase|Death|2|||
129803845|NCT04041375|467249829|FG001|Follow-up Phase|Death|0|||
129803846|NCT04041375|467249828|FG000|Follow-up Phase|Lost to Follow-up|2|||
129803847|NCT04041375|467249829|FG001|Follow-up Phase|Lost to Follow-up|1|||
129803848|NCT04041375|467249828|FG000|Follow-up Phase|Too ill|3|||
129803849|NCT04041375|467249829|FG001|Follow-up Phase|Too ill|0|||
129803850|NCT04043728|467249834|FG000|Overall Study|Lost to Follow-up|1|||
129803851|NCT04043728|467249835|FG001|Overall Study|Lost to Follow-up|2|||
130053987|NCT03249792|468152482|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
129803852|NCT04043728|467249836|FG002|Overall Study|Lost to Follow-up|0|||
129803853|NCT01033851|467249837|FG000|Overall Study|Withdrawal by Subject|3|||
129803854|NCT01033851|467249838|FG001|Overall Study|Withdrawal by Subject|7|||
129803855|NCT02349542|467249839|FG000|Overall Study|Withdrawal by Subject|5|||
129803856|NCT02919696|467249842|FG000|Overall Study|Adverse Event|1|||
129891634|NCT02223182|467561223|FG000|Double-Blind Period|Adverse Event|0|||
129803857|NCT02919696|467249843|FG001|Overall Study|Adverse Event|2|||
129803858|NCT02919696|467249842|FG000|Overall Study|Withdrawal by Subject|2|||
129803859|NCT02919696|467249843|FG001|Overall Study|Withdrawal by Subject|1|||
129803860|NCT02919696|467249842|FG000|Overall Study|Sponsor Decision|1|||
129803861|NCT02919696|467249843|FG001|Overall Study|Sponsor Decision|1|||
129803862|NCT02919696|467249842|FG000|Overall Study|Never Treated|0|||
129803863|NCT02919696|467249843|FG001|Overall Study|Never Treated|1|||
129803864|NCT04308304|467249844|FG000|Overall Study|Withdrawal by Subject|4|||
129803865|NCT04308304|467249845|FG001|Overall Study|Withdrawal by Subject|0|||
129803866|NCT04308304|467249844|FG000|Overall Study|Protocol Violation|1|||
129803867|NCT04308304|467249845|FG001|Overall Study|Protocol Violation|0|||
129803868|NCT00945555|467249846|FG000|Overall Study|Referred to another hospital|5|||
129803869|NCT00945555|467249846|FG000|Overall Study|Worsening condition, intensive care unit|1|||
129803870|NCT00945555|467249846|FG000|Overall Study|Withdrawal by Subject|2|||
129803871|NCT00945555|467249846|FG000|Overall Study|Participant continued treatment at home|1|||
129803872|NCT00945555|467249846|FG000|Overall Study|Death|18|||
129803873|NCT00945555|467249846|FG000|Overall Study|Other|1|||
129803874|NCT00484094|467249847|FG000|Overall Study|Discontinued|39|||
129803875|NCT00484094|467249847|FG000|Overall Study|Other|3|||
129803876|NCT01414608|467249848|FG000|Overall Study|Ineligible|5|||
129803877|NCT01414608|467249849|FG001|Overall Study|Ineligible|2|||
129803878|NCT01686828|467249850|FG000|Overall Study|Physician Decision|1|||
129803879|NCT01686828|467249851|FG001|Overall Study|Physician Decision|0|||
129803880|NCT01686828|467249852|FG002|Overall Study|Physician Decision|0|||
129803881|NCT01686828|467249853|FG003|Overall Study|Physician Decision|0|||
129803882|NCT01686828|467249850|FG000|Overall Study|New Job|0|||
129803883|NCT01686828|467249851|FG001|Overall Study|New Job|1|||
129803884|NCT01686828|467249852|FG002|Overall Study|New Job|0|||
130053988|NCT03249792|468152483|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
129803885|NCT01686828|467249853|FG003|Overall Study|New Job|0|||
129891635|NCT02223182|467561224|FG001|Double-Blind Period|Adverse Event|2|||
129891636|NCT02223182|467561225|FG002|Double-Blind Period|Adverse Event|1|||
130053989|NCT03249792|468152484|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
130053990|NCT03249792|468152485|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
130053991|NCT03249792|468152486|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
130053992|NCT03249792|468152487|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
130053993|NCT03249792|468152488|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
129891637|NCT02223182|467561226|FG003|Double-Blind Period|Adverse Event|0|||
129803886|NCT01686828|467249850|FG000|Overall Study|Weight Loss|0|||
129803887|NCT01686828|467249851|FG001|Overall Study|Weight Loss|0|||
129803888|NCT01686828|467249852|FG002|Overall Study|Weight Loss|1|||
129803889|NCT01686828|467249853|FG003|Overall Study|Weight Loss|0|||
129803890|NCT04176705|467249856|FG000|Overall Study|Withdrawal by Subject|4|||
129803891|NCT04176705|467249857|FG001|Overall Study|Withdrawal by Subject|4|||
129803892|NCT04176705|467249856|FG000|Overall Study|Death|1|||
129803893|NCT04176705|467249857|FG001|Overall Study|Death|1|||
129803894|NCT04176705|467249856|FG000|Overall Study|Lost to Follow-up|3|||
129803895|NCT04176705|467249857|FG001|Overall Study|Lost to Follow-up|3|||
129803896|NCT01193842|467249859|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803897|NCT01193842|467249860|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
129803898|NCT01193842|467249861|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803899|NCT01193842|467249862|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803900|NCT01193842|467249863|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803901|NCT01193842|467249859|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
129803902|NCT01193842|467249860|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803903|NCT01193842|467249861|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803904|NCT01193842|467249862|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803905|NCT01193842|467249863|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803906|NCT01193842|467249859|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803907|NCT01193842|467249860|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803908|NCT01193842|467249861|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
129803909|NCT01193842|467249862|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803910|NCT01193842|467249863|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803911|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Death|0|||
129803912|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Death|0|||
129803913|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Death|0|||
129803914|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Death|1|||
129803915|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Death|1|||
129803916|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Adverse Event|0|||
129803917|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Adverse Event|0|||
129803918|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Adverse Event|0|||
129803919|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Adverse Event|5|||
129803920|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Adverse Event|3|||
129803921|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
129803922|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
129803923|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
129803924|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
129803925|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
129803926|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Ineligible|0|||
129803927|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Ineligible|0|||
129803928|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Ineligible|0|||
129803929|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Ineligible|0|||
129803930|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Ineligible|1|||
129803931|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
129803932|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
129803933|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
129803934|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
129803935|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
129891638|NCT02223182|467561223|FG000|Double-Blind Period|Withdrawal by Subject|1|||
129803936|NCT03698331|467249864|FG000|Overall Study|Adverse Event|2|||
129803937|NCT03698331|467249865|FG001|Overall Study|Adverse Event|3|||
129803938|NCT03698331|467249864|FG000|Overall Study|Withdrawal by Subject|1|||
129803939|NCT03698331|467249865|FG001|Overall Study|Withdrawal by Subject|1|||
129803940|NCT03698331|467249864|FG000|Overall Study|Lost to Follow-up|0|||
129803941|NCT03698331|467249865|FG001|Overall Study|Lost to Follow-up|2|||
130053994|NCT03249792|468152489|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
129803942|NCT03698331|467249864|FG000|Overall Study|Non-compliance with study drug|1|||
129803943|NCT03698331|467249865|FG001|Overall Study|Non-compliance with study drug|0|||
129803944|NCT01467583|467249866|FG000|Overall Study|Death|1|||
129803945|NCT01467583|467249867|FG001|Overall Study|Death|1|||
129803946|NCT01467583|467249868|FG002|Overall Study|Death|0|||
129803947|NCT01467583|467249866|FG000|Overall Study|Withdrawal by Subject|1|||
129803948|NCT01467583|467249867|FG001|Overall Study|Withdrawal by Subject|0|||
129803949|NCT01467583|467249868|FG002|Overall Study|Withdrawal by Subject|0|||
129803950|NCT01467583|467249866|FG000|Overall Study|Protocol Violation|0|||
129803951|NCT01467583|467249867|FG001|Overall Study|Protocol Violation|0|||
129803952|NCT01467583|467249868|FG002|Overall Study|Protocol Violation|2|||
129803953|NCT02130024|467249869|FG000|Overall Study|Adverse Event|10|||
129803954|NCT02130024|467249870|FG001|Overall Study|Adverse Event|11|||
129803955|NCT02130024|467249869|FG000|Overall Study|Death|2|||
129803956|NCT02130024|467249870|FG001|Overall Study|Death|2|||
129803957|NCT02130024|467249869|FG000|Overall Study|Lost to Follow-up|1|||
129803958|NCT02130024|467249870|FG001|Overall Study|Lost to Follow-up|1|||
129803959|NCT02130024|467249869|FG000|Overall Study|Physician Decision|1|||
130053995|NCT03249792|468152490|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
130053996|NCT03249792|468152491|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
130053997|NCT03249792|468152492|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
130053998|NCT03249792|468152493|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
130053999|NCT03249792|468152494|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
130054000|NCT03249792|468152495|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
130054001|NCT03249792|468152496|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
130054002|NCT03249792|468152497|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
130054003|NCT03249792|468152498|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
130054004|NCT03249792|468152499|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
130054005|NCT03249792|468152500|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
130054006|NCT03249792|468152501|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
130054007|NCT03249792|468152502|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
130054008|NCT03249792|468152503|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
130054009|NCT03249792|468152504|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
130054010|NCT03249792|468152505|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
130054011|NCT03249792|468152506|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
130054012|NCT03249792|468152507|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
130054013|NCT03249792|468152508|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
130054014|NCT03249792|468152509|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
130054015|NCT03249792|468152510|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
130054016|NCT03249792|468152478|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054017|NCT03249792|468152479|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054018|NCT03249792|468152480|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054019|NCT03249792|468152481|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054020|NCT03249792|468152482|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054021|NCT03249792|468152483|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054022|NCT03249792|468152484|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054023|NCT03249792|468152485|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054024|NCT03249792|468152486|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
130054025|NCT03249792|468152487|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054026|NCT03249792|468152488|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054027|NCT03249792|468152489|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054028|NCT03249792|468152490|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054029|NCT03249792|468152491|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054030|NCT03249792|468152492|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054031|NCT03249792|468152493|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054032|NCT03249792|468152494|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
130054033|NCT03249792|468152495|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
130054034|NCT03249792|468152496|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054035|NCT03249792|468152497|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
130054036|NCT03249792|468152498|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054037|NCT03249792|468152499|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054038|NCT03249792|468152500|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054039|NCT03249792|468152501|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054040|NCT03249792|468152502|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054041|NCT03249792|468152503|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054042|NCT03249792|468152504|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054043|NCT03249792|468152505|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054044|NCT03249792|468152506|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054045|NCT03249792|468152507|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054046|NCT03249792|468152508|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054047|NCT03249792|468152509|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054048|NCT03249792|468152510|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
130054049|NCT03249792|468152478|FG000|Switch Over Period|Withdrawal by Subject|0|||
130054050|NCT03249792|468152479|FG001|Switch Over Period|Withdrawal by Subject|0|||
130054051|NCT03249792|468152480|FG002|Switch Over Period|Withdrawal by Subject|0|||
130054052|NCT03249792|468152481|FG003|Switch Over Period|Withdrawal by Subject|0|||
130054053|NCT03249792|468152482|FG004|Switch Over Period|Withdrawal by Subject|0|||
130054054|NCT03249792|468152483|FG005|Switch Over Period|Withdrawal by Subject|0|||
130054055|NCT03249792|468152484|FG006|Switch Over Period|Withdrawal by Subject|0|||
130054056|NCT03249792|468152485|FG007|Switch Over Period|Withdrawal by Subject|0|||
130054057|NCT03249792|468152486|FG008|Switch Over Period|Withdrawal by Subject|0|||
130054058|NCT03249792|468152487|FG009|Switch Over Period|Withdrawal by Subject|0|||
130054059|NCT03249792|468152488|FG010|Switch Over Period|Withdrawal by Subject|0|||
130054060|NCT03249792|468152489|FG011|Switch Over Period|Withdrawal by Subject|0|||
130054061|NCT03249792|468152490|FG012|Switch Over Period|Withdrawal by Subject|0|||
130054062|NCT03249792|468152491|FG013|Switch Over Period|Withdrawal by Subject|0|||
130054063|NCT03249792|468152492|FG014|Switch Over Period|Withdrawal by Subject|0|||
130054064|NCT03249792|468152493|FG015|Switch Over Period|Withdrawal by Subject|0|||
130054065|NCT03249792|468152494|FG016|Switch Over Period|Withdrawal by Subject|0|||
130054066|NCT03249792|468152495|FG017|Switch Over Period|Withdrawal by Subject|0|||
130054067|NCT03249792|468152496|FG018|Switch Over Period|Withdrawal by Subject|0|||
130054068|NCT03249792|468152497|FG019|Switch Over Period|Withdrawal by Subject|0|||
130054069|NCT03249792|468152498|FG020|Switch Over Period|Withdrawal by Subject|0|||
130054070|NCT03249792|468152499|FG021|Switch Over Period|Withdrawal by Subject|0|||
130054071|NCT03249792|468152500|FG022|Switch Over Period|Withdrawal by Subject|0|||
130054072|NCT03249792|468152501|FG023|Switch Over Period|Withdrawal by Subject|0|||
130054073|NCT03249792|468152502|FG024|Switch Over Period|Withdrawal by Subject|0|||
130054074|NCT03249792|468152503|FG025|Switch Over Period|Withdrawal by Subject|0|||
130054075|NCT03249792|468152504|FG026|Switch Over Period|Withdrawal by Subject|0|||
130054076|NCT03249792|468152505|FG027|Switch Over Period|Withdrawal by Subject|0|||
130054077|NCT03249792|468152506|FG028|Switch Over Period|Withdrawal by Subject|0|||
130054078|NCT03249792|468152507|FG029|Switch Over Period|Withdrawal by Subject|0|||
130054079|NCT03249792|468152508|FG030|Switch Over Period|Withdrawal by Subject|0|||
130054080|NCT03249792|468152509|FG031|Switch Over Period|Withdrawal by Subject|1|||
130054081|NCT03249792|468152510|FG032|Switch Over Period|Withdrawal by Subject|0|||
130054082|NCT03249792|468152478|FG000|Switch Over Period|Progressive Disease|0|||
130054083|NCT03249792|468152479|FG001|Switch Over Period|Progressive Disease|0|||
130054084|NCT03249792|468152480|FG002|Switch Over Period|Progressive Disease|0|||
130054085|NCT03249792|468152481|FG003|Switch Over Period|Progressive Disease|0|||
130054086|NCT03249792|468152482|FG004|Switch Over Period|Progressive Disease|0|||
130054087|NCT03249792|468152483|FG005|Switch Over Period|Progressive Disease|0|||
130054088|NCT03249792|468152484|FG006|Switch Over Period|Progressive Disease|0|||
129803960|NCT02130024|467249870|FG001|Overall Study|Physician Decision|3|||
129803961|NCT02130024|467249869|FG000|Overall Study|Protocol Deviation|4|||
130054089|NCT03249792|468152485|FG007|Switch Over Period|Progressive Disease|0|||
130054090|NCT03249792|468152486|FG008|Switch Over Period|Progressive Disease|0|||
130054091|NCT03249792|468152487|FG009|Switch Over Period|Progressive Disease|0|||
130054092|NCT03249792|468152488|FG010|Switch Over Period|Progressive Disease|0|||
130054093|NCT03249792|468152489|FG011|Switch Over Period|Progressive Disease|0|||
130054094|NCT03249792|468152490|FG012|Switch Over Period|Progressive Disease|0|||
130054095|NCT03249792|468152491|FG013|Switch Over Period|Progressive Disease|0|||
130054096|NCT03249792|468152492|FG014|Switch Over Period|Progressive Disease|0|||
130054097|NCT03249792|468152493|FG015|Switch Over Period|Progressive Disease|0|||
130054098|NCT03249792|468152494|FG016|Switch Over Period|Progressive Disease|0|||
130054099|NCT03249792|468152495|FG017|Switch Over Period|Progressive Disease|0|||
130054100|NCT03249792|468152496|FG018|Switch Over Period|Progressive Disease|0|||
130054101|NCT03249792|468152497|FG019|Switch Over Period|Progressive Disease|0|||
130054102|NCT03249792|468152498|FG020|Switch Over Period|Progressive Disease|0|||
130054103|NCT03249792|468152499|FG021|Switch Over Period|Progressive Disease|0|||
130054104|NCT03249792|468152500|FG022|Switch Over Period|Progressive Disease|0|||
130054105|NCT03249792|468152501|FG023|Switch Over Period|Progressive Disease|0|||
130054106|NCT03249792|468152502|FG024|Switch Over Period|Progressive Disease|0|||
130054107|NCT03249792|468152503|FG025|Switch Over Period|Progressive Disease|0|||
130054108|NCT03249792|468152504|FG026|Switch Over Period|Progressive Disease|1|||
130054109|NCT03249792|468152505|FG027|Switch Over Period|Progressive Disease|0|||
130054110|NCT03249792|468152506|FG028|Switch Over Period|Progressive Disease|1|||
130054111|NCT03249792|468152507|FG029|Switch Over Period|Progressive Disease|2|||
130054112|NCT03249792|468152508|FG030|Switch Over Period|Progressive Disease|1|||
130054113|NCT03249792|468152509|FG031|Switch Over Period|Progressive Disease|0|||
130054114|NCT03249792|468152510|FG032|Switch Over Period|Progressive Disease|1|||
130054115|NCT03249792|468152478|FG000|Switch Over Period|Adverse Event|0|||
130054116|NCT03249792|468152479|FG001|Switch Over Period|Adverse Event|0|||
130054117|NCT03249792|468152480|FG002|Switch Over Period|Adverse Event|0|||
130054118|NCT03249792|468152481|FG003|Switch Over Period|Adverse Event|0|||
130054119|NCT03249792|468152482|FG004|Switch Over Period|Adverse Event|0|||
130054120|NCT03249792|468152483|FG005|Switch Over Period|Adverse Event|0|||
130054121|NCT03249792|468152484|FG006|Switch Over Period|Adverse Event|0|||
130054122|NCT03249792|468152485|FG007|Switch Over Period|Adverse Event|0|||
130054123|NCT03249792|468152486|FG008|Switch Over Period|Adverse Event|0|||
130054124|NCT03249792|468152487|FG009|Switch Over Period|Adverse Event|0|||
130054125|NCT03249792|468152488|FG010|Switch Over Period|Adverse Event|0|||
130054126|NCT03249792|468152489|FG011|Switch Over Period|Adverse Event|0|||
130111361|NCT01759537|468367644|FG000|Overall Study|Death|1|||
130111362|NCT01759537|468367645|FG001|Overall Study|Death|1|||
129803962|NCT02130024|467249870|FG001|Overall Study|Protocol Deviation|0|||
129803963|NCT02130024|467249869|FG000|Overall Study|Site Administration Problems|1|||
129803964|NCT02130024|467249870|FG001|Overall Study|Site Administration Problems|0|||
129803965|NCT02130024|467249869|FG000|Overall Study|Subject Withdrew Consent|6|||
129803966|NCT02130024|467249870|FG001|Overall Study|Subject Withdrew Consent|14|||
129803967|NCT05274165|467249871|FG000|Overall Study|Withdrawal by Subject|3|||
129803968|NCT05274165|467249872|FG001|Overall Study|Withdrawal by Subject|3|||
129803969|NCT02484690|467249873|FG000|Overall Study|Adverse Event|1|||
129803970|NCT02484690|467249874|FG001|Overall Study|Adverse Event|3|||
129803971|NCT02484690|467249875|FG002|Overall Study|Adverse Event|0|||
129803972|NCT02484690|467249876|FG003|Overall Study|Adverse Event|0|||
129803973|NCT02484690|467249877|FG004|Overall Study|Adverse Event|5|||
129803974|NCT02484690|467249873|FG000|Overall Study|Death|0|||
129803975|NCT02484690|467249874|FG001|Overall Study|Death|0|||
129803976|NCT02484690|467249875|FG002|Overall Study|Death|0|||
129803977|NCT02484690|467249876|FG003|Overall Study|Death|0|||
129803978|NCT02484690|467249877|FG004|Overall Study|Death|1|||
129803979|NCT02484690|467249873|FG000|Overall Study|Withdrawal by Subject|1|||
129803980|NCT02484690|467249874|FG001|Overall Study|Withdrawal by Subject|3|||
129803981|NCT02484690|467249875|FG002|Overall Study|Withdrawal by Subject|1|||
129803982|NCT02484690|467249876|FG003|Overall Study|Withdrawal by Subject|2|||
129803983|NCT02484690|467249877|FG004|Overall Study|Withdrawal by Subject|0|||
129803984|NCT02484690|467249873|FG000|Overall Study|Physician Decision|2|||
130111363|NCT01759537|468367644|FG000|Overall Study|Pregnancy|1|||
130054127|NCT03249792|468152490|FG012|Switch Over Period|Adverse Event|0|||
130054128|NCT03249792|468152491|FG013|Switch Over Period|Adverse Event|0|||
130054129|NCT03249792|468152492|FG014|Switch Over Period|Adverse Event|0|||
130054130|NCT03249792|468152493|FG015|Switch Over Period|Adverse Event|0|||
130054131|NCT03249792|468152494|FG016|Switch Over Period|Adverse Event|0|||
130054132|NCT03249792|468152495|FG017|Switch Over Period|Adverse Event|0|||
130054133|NCT03249792|468152496|FG018|Switch Over Period|Adverse Event|0|||
130054134|NCT03249792|468152497|FG019|Switch Over Period|Adverse Event|0|||
130054135|NCT03249792|468152498|FG020|Switch Over Period|Adverse Event|0|||
130054136|NCT03249792|468152499|FG021|Switch Over Period|Adverse Event|0|||
129803985|NCT02484690|467249874|FG001|Overall Study|Physician Decision|0|||
129803986|NCT02484690|467249875|FG002|Overall Study|Physician Decision|1|||
130054137|NCT03249792|468152500|FG022|Switch Over Period|Adverse Event|0|||
130054138|NCT03249792|468152501|FG023|Switch Over Period|Adverse Event|0|||
130054139|NCT03249792|468152502|FG024|Switch Over Period|Adverse Event|0|||
130054140|NCT03249792|468152503|FG025|Switch Over Period|Adverse Event|1|||
130054141|NCT03249792|468152504|FG026|Switch Over Period|Adverse Event|0|||
130054142|NCT03249792|468152505|FG027|Switch Over Period|Adverse Event|1|||
130054143|NCT03249792|468152506|FG028|Switch Over Period|Adverse Event|0|||
130054144|NCT03249792|468152507|FG029|Switch Over Period|Adverse Event|0|||
130054145|NCT03249792|468152508|FG030|Switch Over Period|Adverse Event|0|||
130054146|NCT03249792|468152509|FG031|Switch Over Period|Adverse Event|0|||
130054147|NCT03249792|468152510|FG032|Switch Over Period|Adverse Event|0|||
130054148|NCT01201798|468152518|FG000|Overall Study|Adverse Event|2|||
130054149|NCT01201798|468152519|FG001|Overall Study|Adverse Event|0|||
130054150|NCT01201798|468152518|FG000|Overall Study|Lost to Follow-up|3|||
130054151|NCT01201798|468152519|FG001|Overall Study|Lost to Follow-up|5|||
129803987|NCT02484690|467249876|FG003|Overall Study|Physician Decision|0|||
130054152|NCT01201798|468152518|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
129803988|NCT02484690|467249877|FG004|Overall Study|Physician Decision|0|||
129803989|NCT02484690|467249873|FG000|Overall Study|Lost to Follow-up|0|||
129803990|NCT02484690|467249874|FG001|Overall Study|Lost to Follow-up|0|||
130054153|NCT01201798|468152519|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
129803991|NCT02484690|467249875|FG002|Overall Study|Lost to Follow-up|1|||
129803992|NCT02484690|467249876|FG003|Overall Study|Lost to Follow-up|0|||
129803993|NCT02484690|467249877|FG004|Overall Study|Lost to Follow-up|0|||
129803994|NCT04916769|467249881|FG000|Period 1|Physician Decision|0|||
129803995|NCT04916769|467249882|FG001|Period 1|Physician Decision|0|||
130054154|NCT01201798|468152518|FG000|Overall Study|Noncompliance|1|||
130054155|NCT01201798|468152519|FG001|Overall Study|Noncompliance|0|||
130054156|NCT01201798|468152518|FG000|Overall Study|Protocol Violation|1|||
130054157|NCT01201798|468152519|FG001|Overall Study|Protocol Violation|1|||
130054158|NCT01201798|468152518|FG000|Overall Study|Treatment Failure|1|||
130054159|NCT01201798|468152519|FG001|Overall Study|Treatment Failure|8|||
130054160|NCT00525148|468152521|FG000|Overall Study|Other Adverse Event|3|||
130054161|NCT00525148|468152522|FG001|Overall Study|Other Adverse Event|5|||
130054162|NCT00525148|468152523|FG002|Overall Study|Other Adverse Event|1|||
130054163|NCT00525148|468152524|FG003|Overall Study|Other Adverse Event|8|||
130054164|NCT00525148|468152521|FG000|Overall Study|Progressive disease|18|||
130054165|NCT00525148|468152522|FG001|Overall Study|Progressive disease|30|||
130054166|NCT00525148|468152523|FG002|Overall Study|Progressive disease|6|||
130054167|NCT00525148|468152524|FG003|Overall Study|Progressive disease|49|||
130054168|NCT00525148|468152521|FG000|Overall Study|Refused continuation of study medication|0|||
130054169|NCT00525148|468152522|FG001|Overall Study|Refused continuation of study medication|2|||
130054170|NCT00525148|468152523|FG002|Overall Study|Refused continuation of study medication|0|||
130054171|NCT00525148|468152524|FG003|Overall Study|Refused continuation of study medication|1|||
130054172|NCT00525148|468152521|FG000|Overall Study|Other than stated|2|||
130054173|NCT00525148|468152522|FG001|Overall Study|Other than stated|1|||
130054174|NCT00525148|468152523|FG002|Overall Study|Other than stated|0|||
130054175|NCT00525148|468152524|FG003|Overall Study|Other than stated|3|||
130054176|NCT00114972|468152526|FG000|Overall Study|Withdrawal by Subject|40|||
129803996|NCT04916769|467249883|FG002|Period 1|Physician Decision|0|||
130054177|NCT00114972|468152527|FG001|Overall Study|Withdrawal by Subject|7|||
130054178|NCT00114972|468152526|FG000|Overall Study|Lost to Follow-up|8|||
130054179|NCT00114972|468152527|FG001|Overall Study|Lost to Follow-up|5|||
130054180|NCT00830037|468152528|FG000|Overall Study|Withdrawal by Subject|2|||
130111364|NCT01759537|468367645|FG001|Overall Study|Pregnancy|1|||
129803997|NCT04916769|467249884|FG003|Period 1|Physician Decision|0|||
130054181|NCT00830037|468152529|FG001|Overall Study|Withdrawal by Subject|3|||
130054182|NCT00830037|468152528|FG000|Overall Study|Lost to Follow-up|1|||
130054183|NCT00830037|468152529|FG001|Overall Study|Lost to Follow-up|2|||
130054184|NCT00830037|468152528|FG000|Overall Study|Active when terminated by DSMB|15|||
130054185|NCT00830037|468152529|FG001|Overall Study|Active when terminated by DSMB|14|||
130054186|NCT01555463|468152530|FG000|Treatment|Adverse Event|6|||
130054187|NCT01555463|468152531|FG001|Treatment|Adverse Event|12|||
130054188|NCT01555463|468152530|FG000|Treatment|Withdrawal by Subject|24|||
130054189|NCT01555463|468152531|FG001|Treatment|Withdrawal by Subject|36|||
130054190|NCT01555463|468152530|FG000|Treatment|Lost to Follow-up|28|||
130054191|NCT01555463|468152531|FG001|Treatment|Lost to Follow-up|23|||
130054192|NCT01555463|468152530|FG000|Treatment|Protocol Violation|4|||
130054193|NCT01555463|468152531|FG001|Treatment|Protocol Violation|5|||
130054194|NCT01555463|468152530|FG000|Treatment|Other reason|2|||
130054195|NCT01555463|468152531|FG001|Treatment|Other reason|3|||
130054196|NCT01555463|468152530|FG000|Follow up|Adverse Event|2|||
130054197|NCT01555463|468152531|FG001|Follow up|Adverse Event|5|||
130054198|NCT01555463|468152530|FG000|Follow up|Death|0|||
130054199|NCT01555463|468152531|FG001|Follow up|Death|1|||
130054200|NCT01555463|468152530|FG000|Follow up|Withdrawal by Subject|22|||
130054201|NCT01555463|468152531|FG001|Follow up|Withdrawal by Subject|22|||
130054202|NCT01555463|468152530|FG000|Follow up|Lost to Follow-up|9|||
130054203|NCT01555463|468152531|FG001|Follow up|Lost to Follow-up|10|||
130054204|NCT01555463|468152530|FG000|Follow up|Protocol Violation|2|||
130054205|NCT01555463|468152531|FG001|Follow up|Protocol Violation|4|||
130054206|NCT01555463|468152530|FG000|Follow up|Other reason|3|||
130054207|NCT01555463|468152531|FG001|Follow up|Other reason|3|||
130054208|NCT02026271|468152532|FG000|Overall Study|Adverse Event|2|||
130054209|NCT02026271|468152533|FG001|Overall Study|Adverse Event|3|||
130054210|NCT02026271|468152534|FG002|Overall Study|Adverse Event|2|||
130054211|NCT02026271|468152535|FG003|Overall Study|Adverse Event|3|||
130054212|NCT02026271|468152536|FG004|Overall Study|Adverse Event|0|||
130054213|NCT02026271|468152532|FG000|Overall Study|Withdrawal by Subject|0|||
130054214|NCT02026271|468152533|FG001|Overall Study|Withdrawal by Subject|0|||
130054215|NCT02026271|468152534|FG002|Overall Study|Withdrawal by Subject|0|||
130054216|NCT02026271|468152535|FG003|Overall Study|Withdrawal by Subject|0|||
130054217|NCT02026271|468152536|FG004|Overall Study|Withdrawal by Subject|1|||
130054218|NCT04370028|468152537|FG000|Overall Study|Withdrawal by Subject|695|||
130054219|NCT04370028|468152537|FG000|Overall Study|Protocol Violation|9|||
130054220|NCT04370028|468152537|FG000|Overall Study|Adverse Event|3|||
130054221|NCT04743635|468152538|FG000|Overall Study|Lost to Follow-up|2|||
130054222|NCT04743635|468152539|FG001|Overall Study|Lost to Follow-up|0|||
130054223|NCT03382899|468152540|FG000|Overall Study|Ineligibility Determined|0|||
129891639|NCT02223182|467561224|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129891640|NCT02223182|467561225|FG002|Double-Blind Period|Withdrawal by Subject|1|||
130054224|NCT03382899|468152541|FG001|Overall Study|Ineligibility Determined|1|||
130054225|NCT03382899|468152540|FG000|Overall Study|Lost to Follow-up|0|||
129891641|NCT02223182|467561226|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130054226|NCT03382899|468152541|FG001|Overall Study|Lost to Follow-up|1|||
129891642|NCT02223182|467561223|FG000|Double-Blind Period|Lost to Follow-up|0|||
130054227|NCT03382899|468152540|FG000|Overall Study|Sponsor's decision|31|||
130054228|NCT03382899|468152541|FG001|Overall Study|Sponsor's decision|28|||
129891643|NCT02223182|467561224|FG001|Double-Blind Period|Lost to Follow-up|1|||
129891644|NCT02223182|467561225|FG002|Double-Blind Period|Lost to Follow-up|0|||
129891645|NCT02223182|467561226|FG003|Double-Blind Period|Lost to Follow-up|0|||
129891646|NCT02223182|467561223|FG000|Double-Blind Period|Non Compliance|0|||
129891647|NCT02223182|467561224|FG001|Double-Blind Period|Non Compliance|0|||
129891648|NCT02223182|467561225|FG002|Double-Blind Period|Non Compliance|0|||
129891649|NCT02223182|467561226|FG003|Double-Blind Period|Non Compliance|1|||
130054229|NCT03382899|468152540|FG000|Overall Study|Withdrawal by Subject|0|||
129891650|NCT02223182|467561223|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
130054230|NCT03382899|468152541|FG001|Overall Study|Withdrawal by Subject|5|||
130054231|NCT00540449|468152542|FG000|Overall Study|Adverse Event|12|||
130054232|NCT00540449|468152543|FG001|Overall Study|Adverse Event|32|||
130054233|NCT00540449|468152542|FG000|Overall Study|Sponsor's Decision|1|||
130054234|NCT00540449|468152543|FG001|Overall Study|Sponsor's Decision|1|||
130054235|NCT00540449|468152542|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
130054236|NCT00540449|468152543|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
130054237|NCT00540449|468152542|FG000|Overall Study|Lost to Follow-up|19|||
130054238|NCT00540449|468152543|FG001|Overall Study|Lost to Follow-up|17|||
130054239|NCT00540449|468152542|FG000|Overall Study|Subject Non-Compliant|7|||
130054240|NCT00540449|468152543|FG001|Overall Study|Subject Non-Compliant|5|||
130054241|NCT00540449|468152542|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
130054242|NCT00540449|468152543|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
129803998|NCT04916769|467249885|FG004|Period 1|Physician Decision|0|||
129803999|NCT04916769|467249886|FG005|Period 1|Physician Decision|1|||
130054243|NCT00540449|468152542|FG000|Overall Study|Withdrawal by Subject|10|||
130054244|NCT00540449|468152543|FG001|Overall Study|Withdrawal by Subject|10|||
130054245|NCT00540449|468152542|FG000|Overall Study|Other|1|||
129804000|NCT04916769|467249881|FG000|Period 2|Physician Decision|0|||
129804001|NCT04916769|467249882|FG001|Period 2|Physician Decision|1|||
129804002|NCT04916769|467249883|FG002|Period 2|Physician Decision|0|||
129804003|NCT04916769|467249884|FG003|Period 2|Physician Decision|0|||
129804004|NCT04916769|467249885|FG004|Period 2|Physician Decision|0|||
129804005|NCT04916769|467249886|FG005|Period 2|Physician Decision|0|||
129804006|NCT03672643|467249899|FG000|Overall Study|Adverse Event|3|||
129804007|NCT03672643|467249899|FG000|Overall Study|Death|2|||
129804008|NCT03672643|467249899|FG000|Overall Study|Withdrawal by Subject|1|||
129804009|NCT03672643|467249899|FG000|Overall Study|Progressive disease|11|||
129804010|NCT03672643|467249899|FG000|Overall Study|Global deterioration of health status|1|||
129804011|NCT03672643|467249899|FG000|Overall Study|Refused further treatment|7|||
129804012|NCT03672643|467249899|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
129804013|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
129804014|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804015|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804016|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804017|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804018|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804019|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804020|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
129804021|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804022|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804023|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804024|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804025|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
130054246|NCT00540449|468152543|FG001|Overall Study|Other|4|||
130054247|NCT02426658|468152544|FG000|Overall Study|Withdrawal by Subject|1|||
130054248|NCT02426658|468152544|FG000|Overall Study|Patient expired before treatment|2|||
130054249|NCT00524316|468152545|FG000|Overall Study|Withdrawal by Subject|2|||
129804026|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804027|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
129804028|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804029|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804030|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804031|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804032|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804033|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804034|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
129804035|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804036|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804037|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804038|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804039|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804040|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804041|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
129804042|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804043|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804044|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129891651|NCT02223182|467561224|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
129891652|NCT02223182|467561225|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
129891653|NCT02223182|467561226|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
129891654|NCT02223182|467561223|FG000|Open-Label 500 Period|Adverse Event|1|||
129891655|NCT02223182|467561224|FG001|Open-Label 500 Period|Adverse Event|0|||
129891656|NCT02223182|467561225|FG002|Open-Label 500 Period|Adverse Event|2|||
129891657|NCT02223182|467561226|FG003|Open-Label 500 Period|Adverse Event|1|||
129891658|NCT02223182|467561223|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
130054250|NCT00524316|468152545|FG000|Overall Study|Adverse Event|7|||
130111365|NCT01759537|468367644|FG000|Overall Study|Lost to Follow-up|9|||
129804045|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804046|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804047|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804048|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
129804049|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804050|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804051|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804052|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804053|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804054|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
130054251|NCT00524316|468152545|FG000|Overall Study|Disease Progression|7|||
130054252|NCT01199263|468152546|FG000|Overall Study|Ineligible|0|||
130054253|NCT01199263|468152547|FG001|Overall Study|Ineligible|2|||
130054254|NCT01199263|468152546|FG000|Overall Study|Never Treated|6|||
130054255|NCT01199263|468152547|FG001|Overall Study|Never Treated|0|||
130054256|NCT01402284|468152548|FG000|Overall Study|Withdrawal consent|2|||
130111366|NCT01759537|468367645|FG001|Overall Study|Lost to Follow-up|9|||
130111367|NCT01759537|468367644|FG000|Overall Study|Accident involving jaw fracture|1|||
130111368|NCT01759537|468367645|FG001|Overall Study|Accident involving jaw fracture|1|||
130111369|NCT01759537|468367644|FG000|Overall Study|Subcrestal implant too coronal|1|||
130111370|NCT01759537|468367645|FG001|Overall Study|Subcrestal implant too coronal|1|||
130054257|NCT01402284|468152548|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
130054258|NCT01402284|468152548|FG000|Overall Study|Physician Decision|1|||
130054259|NCT01402284|468152548|FG000|Overall Study|Disease progression on study|10|||
130054260|NCT02928406|468152549|FG000|Overall Study|Death|780|||
129891659|NCT02223182|467561224|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
129891660|NCT02223182|467561225|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
129891661|NCT02223182|467561226|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
129891662|NCT02223182|467561223|FG000|Open-Label 500 Period|Physician Decision|0|||
129891663|NCT02223182|467561224|FG001|Open-Label 500 Period|Physician Decision|0|||
129891664|NCT02223182|467561225|FG002|Open-Label 500 Period|Physician Decision|0|||
129891665|NCT02223182|467561226|FG003|Open-Label 500 Period|Physician Decision|1|||
129891666|NCT02223182|467561223|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
129891667|NCT02223182|467561224|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
129891668|NCT02223182|467561225|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
129891669|NCT02223182|467561226|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
129891670|NCT02223182|467561223|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
129891671|NCT02223182|467561224|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
129891672|NCT02223182|467561225|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
129891673|NCT02223182|467561226|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
129891674|NCT02223182|467561223|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
129891675|NCT02223182|467561224|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
129891676|NCT02223182|467561225|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
129891677|NCT02223182|467561226|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
129891678|NCT02223182|467561223|FG000|Open-Label 300 Period|Non Compliance|0|||
130054261|NCT02928406|468152549|FG000|Overall Study|Progressive disease|3|||
130054262|NCT02928406|468152549|FG000|Overall Study|Lost to Follow-up|49|||
130054263|NCT02928406|468152549|FG000|Overall Study|Non-compliance|2|||
129891679|NCT02223182|467561224|FG001|Open-Label 300 Period|Non Compliance|2|||
129891680|NCT02223182|467561225|FG002|Open-Label 300 Period|Non Compliance|1|||
129891681|NCT02223182|467561226|FG003|Open-Label 300 Period|Non Compliance|0|||
129891682|NCT03714022|467561227|FG000|Overall Study|Adverse Event|1|||
129891683|NCT03714022|467561228|FG001|Overall Study|Adverse Event|0|||
129891684|NCT03714022|467561227|FG000|Overall Study|Consent withdrawal|0|||
129891685|NCT03714022|467561228|FG001|Overall Study|Consent withdrawal|1|||
129891686|NCT03714022|467561227|FG000|Overall Study|Lost to Follow-up|3|||
130054264|NCT02928406|468152549|FG000|Overall Study|Withdrawal by Subject|40|||
130054265|NCT02928406|468152549|FG000|Overall Study|Study terminated by sponsor|57|||
129891687|NCT03714022|467561228|FG001|Overall Study|Lost to Follow-up|2|||
130054266|NCT02928406|468152549|FG000|Overall Study|Physician Decision|1|||
129891688|NCT03289455|467561237|FG000|Overall Study|Death|1|||
129891689|NCT03289455|467561238|FG001|Overall Study|Death|0|||
129891690|NCT03289455|467561239|FG002|Overall Study|Death|0|||
129891691|NCT03289455|467561237|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
129891692|NCT03289455|467561238|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
129891693|NCT03289455|467561239|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
129891694|NCT03289455|467561237|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
130054267|NCT02928406|468152549|FG000|Overall Study|Various reasons|72|||
130054268|NCT05513391|468152554|FG000|Overall Study|Adverse Event|1|||
130054269|NCT05513391|468152555|FG001|Overall Study|Adverse Event|0|||
130054270|NCT05513391|468152554|FG000|Overall Study|Protocol Deviation|0|||
130054271|NCT05513391|468152555|FG001|Overall Study|Protocol Deviation|1|||
129891695|NCT03289455|467561238|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
130054272|NCT05513391|468152554|FG000|Overall Study|Withdrawal by Subject|3|||
130054273|NCT05513391|468152555|FG001|Overall Study|Withdrawal by Subject|1|||
130054274|NCT05513391|468152554|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130054275|NCT05513391|468152555|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129804055|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
129804056|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804057|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804058|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
130054276|NCT05513391|468152554|FG000|Overall Study|Lost to Follow-up|0|||
130054277|NCT05513391|468152555|FG001|Overall Study|Lost to Follow-up|2|||
130054278|NCT04038255|468154480|FG000|Overall Study|Lost to Follow-up|0|||
130054279|NCT04038255|468154481|FG001|Overall Study|Lost to Follow-up|9|||
130054280|NCT04038255|468154482|FG002|Overall Study|Lost to Follow-up|5|||
130054281|NCT04038255|468154480|FG000|Overall Study|Withdrawal by Subject|0|||
129891696|NCT03289455|467561239|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
129804059|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804060|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804061|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804062|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
129804063|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804064|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804065|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804066|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804067|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804068|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804069|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
129804070|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804071|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804072|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804073|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129891697|NCT03289455|467561237|FG000|Overall Study|Progressive disease|3|||
129891698|NCT03289455|467561238|FG001|Overall Study|Progressive disease|4|||
130111371|NCT01677910|468369450|FG000|Double-Blind Treatment Period|Adverse Event|6|||
130054282|NCT04038255|468154481|FG001|Overall Study|Withdrawal by Subject|0|||
130054283|NCT04038255|468154482|FG002|Overall Study|Withdrawal by Subject|1|||
130054284|NCT05183867|468154483|FG000|Overall Study|Withdrawal by Subject|3|||
130054285|NCT05183867|468154484|FG001|Overall Study|Withdrawal by Subject|2|||
130054286|NCT05183867|468154485|FG002|Overall Study|Withdrawal by Subject|0|||
129804074|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804075|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129891699|NCT03289455|467561239|FG002|Overall Study|Progressive disease|5|||
129804076|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
129804077|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804078|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804079|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804080|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129891700|NCT00114959|467561240|FG000|Overall Study|Lack of Efficacy|6|||
130054287|NCT00492856|468154488|FG000|Induction|Adverse Event|2|||
130054288|NCT00492856|468154489|FG001|Induction|Adverse Event|0|||
130054289|NCT00492856|468154490|FG002|Induction|Adverse Event|0|||
130054290|NCT00492856|468154491|FG003|Induction|Adverse Event|0|||
130054291|NCT00492856|468154488|FG000|Induction|Withdrawal by Subject|1|||
130054292|NCT00492856|468154489|FG001|Induction|Withdrawal by Subject|0|||
130054293|NCT00492856|468154490|FG002|Induction|Withdrawal by Subject|0|||
130054294|NCT00492856|468154491|FG003|Induction|Withdrawal by Subject|0|||
129804081|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804082|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804083|NCT04526509|467249900|FG000|Enrolled|Study Terminated by Sponsor|0|||
129804084|NCT04526509|467249901|FG001|Enrolled|Study Terminated by Sponsor|0|||
129804085|NCT04526509|467249902|FG002|Enrolled|Study Terminated by Sponsor|0|||
129891701|NCT00114959|467561240|FG000|Overall Study|Physician Decision|1|||
130111372|NCT01677910|468369451|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129891702|NCT00114959|467561240|FG000|Overall Study|Death|1|||
129891703|NCT01007552|467561246|FG000|Overall Study|Withdrawal by Subject|1|||
129891704|NCT00432159|467563032|FG000|Overall Study|Death|0|||
129891705|NCT00432159|467563033|FG001|Overall Study|Death|1|||
129891706|NCT00432159|467563034|FG002|Overall Study|Death|0|||
129891707|NCT00432159|467563035|FG003|Overall Study|Death|0|||
129804086|NCT04526509|467249903|FG003|Enrolled|Study Terminated by Sponsor|0|||
129804087|NCT04526509|467249904|FG004|Enrolled|Study Terminated by Sponsor|0|||
129804088|NCT04526509|467249905|FG005|Enrolled|Study Terminated by Sponsor|0|||
129804089|NCT04526509|467249906|FG006|Enrolled|Study Terminated by Sponsor|1|||
129804090|NCT04526509|467249900|FG000|Enrolled|Death prior to lymphodepletion|0|||
129804091|NCT04526509|467249901|FG001|Enrolled|Death prior to lymphodepletion|0|||
129804092|NCT04526509|467249902|FG002|Enrolled|Death prior to lymphodepletion|0|||
129804093|NCT04526509|467249903|FG003|Enrolled|Death prior to lymphodepletion|1|||
129804094|NCT04526509|467249904|FG004|Enrolled|Death prior to lymphodepletion|0|||
130054295|NCT00492856|468154488|FG000|Induction|Death|3|||
130054296|NCT00492856|468154489|FG001|Induction|Death|0|||
130054297|NCT00492856|468154490|FG002|Induction|Death|0|||
130054298|NCT00492856|468154491|FG003|Induction|Death|0|||
130054299|NCT00492856|468154488|FG000|Consolidation|Adverse Event|6|||
130054300|NCT00492856|468154489|FG001|Consolidation|Adverse Event|0|||
130054301|NCT00492856|468154490|FG002|Consolidation|Adverse Event|0|||
130054302|NCT00492856|468154491|FG003|Consolidation|Adverse Event|0|||
130054303|NCT00492856|468154488|FG000|Consolidation|Not protocol specified|2|||
130111373|NCT01677910|468369452|FG002|Double-Blind Treatment Period|Adverse Event|3|||
130111374|NCT01677910|468369453|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129891708|NCT00432159|467563036|FG004|Overall Study|Death|0|||
129891709|NCT00432159|467563032|FG000|Overall Study|Failure|9|||
130054304|NCT00492856|468154489|FG001|Consolidation|Not protocol specified|0|||
130054305|NCT00492856|468154490|FG002|Consolidation|Not protocol specified|0|||
129804095|NCT04526509|467249905|FG005|Enrolled|Death prior to lymphodepletion|0|||
129804096|NCT04526509|467249906|FG006|Enrolled|Death prior to lymphodepletion|0|||
129804097|NCT04526509|467249900|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804098|NCT04526509|467249901|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804099|NCT04526509|467249902|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804100|NCT04526509|467249903|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
129804101|NCT04526509|467249904|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804102|NCT04526509|467249905|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
130054306|NCT00492856|468154491|FG003|Consolidation|Not protocol specified|0|||
130054307|NCT00492856|468154488|FG000|Consolidation|Lost to Follow-up|1|||
130054308|NCT00492856|468154489|FG001|Consolidation|Lost to Follow-up|0|||
130054309|NCT00492856|468154490|FG002|Consolidation|Lost to Follow-up|0|||
130054310|NCT00492856|468154491|FG003|Consolidation|Lost to Follow-up|0|||
130111375|NCT01677910|468369450|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130111376|NCT01677910|468369451|FG001|Double-Blind Treatment Period|Physician Decision|0|||
129804103|NCT04526509|467249906|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804104|NCT04526509|467249900|FG000|Enrolled|Physician Decision|0|||
129804105|NCT04526509|467249901|FG001|Enrolled|Physician Decision|1|||
130111377|NCT01677910|468369452|FG002|Double-Blind Treatment Period|Physician Decision|1|||
130111378|NCT01677910|468369453|FG003|Double-Blind Treatment Period|Physician Decision|0|||
130111379|NCT01677910|468369450|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
130111380|NCT01677910|468369451|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
130111381|NCT01677910|468369452|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
130111382|NCT01677910|468369453|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
129804106|NCT04526509|467249902|FG002|Enrolled|Physician Decision|0|||
129804107|NCT04526509|467249903|FG003|Enrolled|Physician Decision|0|||
129804108|NCT04526509|467249904|FG004|Enrolled|Physician Decision|0|||
129804109|NCT04526509|467249905|FG005|Enrolled|Physician Decision|0|||
129804110|NCT04526509|467249906|FG006|Enrolled|Physician Decision|0|||
129804111|NCT04340193|467249908|FG000|Overall Study|Other reason|0|||
129804112|NCT04340193|467249909|FG001|Overall Study|Other reason|0|||
129804113|NCT04340193|467249910|FG002|Overall Study|Other reason|1|||
129804114|NCT04340193|467249908|FG000|Overall Study|Disease recurrence|0|||
129804115|NCT04340193|467249909|FG001|Overall Study|Disease recurrence|1|||
129804116|NCT04340193|467249910|FG002|Overall Study|Disease recurrence|0|||
129804117|NCT04340193|467249908|FG000|Overall Study|Study drug toxicity|1|||
129804118|NCT04340193|467249909|FG001|Overall Study|Study drug toxicity|0|||
129804119|NCT04340193|467249910|FG002|Overall Study|Study drug toxicity|0|||
129804120|NCT04340193|467249908|FG000|Overall Study|Disease progression|1|||
129804121|NCT04340193|467249909|FG001|Overall Study|Disease progression|2|||
129804122|NCT04340193|467249910|FG002|Overall Study|Disease progression|3|||
129804123|NCT04340193|467249908|FG000|Overall Study|Administrative reasons by sponsor|0|||
129804124|NCT04340193|467249909|FG001|Overall Study|Administrative reasons by sponsor|1|||
129804125|NCT04340193|467249910|FG002|Overall Study|Administrative reasons by sponsor|0|||
129804126|NCT04340193|467249908|FG000|Overall Study|Adverse Event|1|||
129804127|NCT04340193|467249909|FG001|Overall Study|Adverse Event|1|||
129804128|NCT04340193|467249910|FG002|Overall Study|Adverse Event|0|||
129804129|NCT01386008|467249911|FG000|Overall Study|exited w/o incident /study discontinued|17|||
129804130|NCT01386008|467249911|FG000|Overall Study|Adverse Event|3|||
129804131|NCT04449861|467249912|FG000|Overall Study|Withdrawal by Subject|4|||
129804132|NCT04449861|467249912|FG000|Overall Study|Lost to Follow-up|5|||
129804133|NCT04449861|467249912|FG000|Overall Study|Death|112|||
130111383|NCT01677910|468369450|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
130111384|NCT01677910|468369451|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
130111385|NCT01677910|468369452|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
130111386|NCT01677910|468369453|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
130111387|NCT01677910|468369450|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
130111388|NCT01677910|468369451|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
130111389|NCT01677910|468369452|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
130111390|NCT01677910|468369453|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
129804134|NCT00976677|467249913|FG000|Overall Study|Adverse Event|1|||
129804135|NCT00976677|467249914|FG001|Overall Study|Adverse Event|0|||
129804136|NCT00976677|467249913|FG000|Overall Study|Withdrawal by Subject|0|||
129804137|NCT00976677|467249914|FG001|Overall Study|Withdrawal by Subject|2|||
129804138|NCT00976677|467249913|FG000|Overall Study|Disease progression|1|||
129804139|NCT00976677|467249914|FG001|Overall Study|Disease progression|1|||
129804140|NCT00976677|467249913|FG000|Overall Study|Trial unblinded|2|||
130111391|NCT01677910|468369450|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129891710|NCT00432159|467563033|FG001|Overall Study|Failure|5|||
129891711|NCT00432159|467563034|FG002|Overall Study|Failure|3|||
129891712|NCT00432159|467563035|FG003|Overall Study|Failure|2|||
129891713|NCT00432159|467563036|FG004|Overall Study|Failure|3|||
129891714|NCT00432159|467563032|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
130054311|NCT00492856|468154488|FG000|Post-consolidation|Adverse Event|0|||
130054312|NCT00492856|468154489|FG001|Post-consolidation|Adverse Event|4|||
130054313|NCT00492856|468154490|FG002|Post-consolidation|Adverse Event|0|||
130054314|NCT00492856|468154491|FG003|Post-consolidation|Adverse Event|1|||
130054315|NCT00492856|468154488|FG000|Post-consolidation|Withdrawal by Subject|0|||
130054316|NCT00492856|468154489|FG001|Post-consolidation|Withdrawal by Subject|4|||
130054317|NCT00492856|468154490|FG002|Post-consolidation|Withdrawal by Subject|0|||
130054318|NCT00492856|468154491|FG003|Post-consolidation|Withdrawal by Subject|0|||
130054319|NCT00492856|468154488|FG000|Post-consolidation|Death|0|||
130054320|NCT00492856|468154489|FG001|Post-consolidation|Death|1|||
130054321|NCT00492856|468154490|FG002|Post-consolidation|Death|0|||
130054322|NCT00492856|468154491|FG003|Post-consolidation|Death|0|||
130054323|NCT00492856|468154488|FG000|Post-consolidation|Not protocol specified|0|||
130054324|NCT00492856|468154489|FG001|Post-consolidation|Not protocol specified|1|||
130054325|NCT00492856|468154490|FG002|Post-consolidation|Not protocol specified|0|||
130054326|NCT00492856|468154491|FG003|Post-consolidation|Not protocol specified|0|||
130054327|NCT00492856|468154488|FG000|Post-consolidation|Lost to Follow-up|0|||
130054328|NCT00492856|468154489|FG001|Post-consolidation|Lost to Follow-up|2|||
130054329|NCT00492856|468154490|FG002|Post-consolidation|Lost to Follow-up|0|||
130054330|NCT00492856|468154491|FG003|Post-consolidation|Lost to Follow-up|0|||
130054331|NCT00492856|468154488|FG000|Post-consolidation|Observation Arm|0|||
130054332|NCT00492856|468154489|FG001|Post-consolidation|Observation Arm|0|||
130054333|NCT00492856|468154490|FG002|Post-consolidation|Observation Arm|27|||
130054334|NCT00492856|468154491|FG003|Post-consolidation|Observation Arm|0|||
130054335|NCT01520324|468154492|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
130054336|NCT03488472|468154493|FG000|Overall Study|disease progression additional mets|1|||
130054337|NCT00441441|468154497|FG000|Overall Study|Adverse Event|2|||
130054338|NCT00441441|468154498|FG001|Overall Study|Adverse Event|1|||
130054339|NCT00441441|468154497|FG000|Overall Study|Protocol Violation|4|||
130054340|NCT00441441|468154498|FG001|Overall Study|Protocol Violation|6|||
130054341|NCT00441441|468154497|FG000|Overall Study|Exacerbation of asthma|1|||
130054342|NCT00441441|468154498|FG001|Overall Study|Exacerbation of asthma|2|||
130054343|NCT00441441|468154497|FG000|Overall Study|Withdrawal by Subject|1|||
130111392|NCT01677910|468369451|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129891715|NCT00432159|467563033|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
129891716|NCT00432159|467563034|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
129891717|NCT00432159|467563035|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
130054344|NCT00441441|468154498|FG001|Overall Study|Withdrawal by Subject|2|||
130054345|NCT00441441|468154497|FG000|Overall Study|Other|3|||
130054346|NCT00441441|468154498|FG001|Overall Study|Other|3|||
130054347|NCT00262080|468154499|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
130054348|NCT00262080|468154500|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130054349|NCT00262080|468154501|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
130054350|NCT00262080|468154499|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
130054351|NCT00262080|468154500|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
130054352|NCT00262080|468154501|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
130054353|NCT00262080|468154499|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
130054354|NCT00262080|468154500|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
130054355|NCT00262080|468154501|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
130054356|NCT00262080|468154499|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
130054357|NCT00262080|468154500|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
130054358|NCT00262080|468154501|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
130054359|NCT00262080|468154499|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
129804141|NCT00976677|467249914|FG001|Overall Study|Trial unblinded|2|||
130054360|NCT00262080|468154500|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
130054361|NCT00262080|468154501|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
130054362|NCT00262080|468154499|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
130054363|NCT00262080|468154500|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
130054364|NCT00262080|468154501|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
130054365|NCT04009096|468154502|FG000|Overall Study|Withdrawal by Subject|0|||
130054366|NCT04009096|468154503|FG001|Overall Study|Withdrawal by Subject|7|||
130054367|NCT04009096|468154504|FG002|Overall Study|Withdrawal by Subject|0|||
130054368|NCT04009096|468154502|FG000|Overall Study|Physician Decision|0|||
130054369|NCT04009096|468154503|FG001|Overall Study|Physician Decision|1|||
130054370|NCT04009096|468154504|FG002|Overall Study|Physician Decision|0|||
130054371|NCT05151471|468154505|FG000|Overall Study|Adverse Event|21|||
130054372|NCT05151471|468154506|FG001|Overall Study|Adverse Event|16|||
130054373|NCT05151471|468154505|FG000|Overall Study|Death|1|||
130054374|NCT05151471|468154506|FG001|Overall Study|Death|0|||
130054375|NCT05151471|468154505|FG000|Overall Study|Lost to Follow-up|0|||
130054376|NCT05151471|468154506|FG001|Overall Study|Lost to Follow-up|1|||
130054377|NCT05151471|468154505|FG000|Overall Study|Withdrawal by Subject|7|||
130054378|NCT05151471|468154506|FG001|Overall Study|Withdrawal by Subject|9|||
130054379|NCT05151471|468154505|FG000|Overall Study|Study terminated by sponsor|49|||
130054380|NCT05151471|468154506|FG001|Overall Study|Study terminated by sponsor|47|||
130054381|NCT05151471|468154505|FG000|Overall Study|Other|2|||
130054382|NCT05151471|468154506|FG001|Overall Study|Other|1|||
130054383|NCT04263142|468154507|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130054384|NCT04263142|468154508|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130054385|NCT04263142|468154509|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130054386|NCT04263142|468154510|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
130054387|NCT04263142|468154511|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
130054388|NCT04263142|468154507|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130054389|NCT04263142|468154508|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130054390|NCT04263142|468154509|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130054391|NCT04263142|468154510|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
130054392|NCT04263142|468154511|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
130054393|NCT00769704|468154512|FG000|Overall Study|Lost to Follow-up|3|||
130054394|NCT00769704|468154513|FG001|Overall Study|Lost to Follow-up|2|||
130054395|NCT00769704|468154512|FG000|Overall Study|Death|95|||
130054396|NCT00769704|468154513|FG001|Overall Study|Death|190|||
130054397|NCT00769704|468154512|FG000|Overall Study|Withdrawal by Subject|12|||
130054398|NCT00769704|468154513|FG001|Overall Study|Withdrawal by Subject|5|||
130054399|NCT00769704|468154512|FG000|Overall Study|Other|1|||
130054400|NCT00769704|468154513|FG001|Overall Study|Other|2|||
130054401|NCT04346628|468154518|FG000|Overall Study|Lost to Follow-up|4|||
130054402|NCT04346628|468154519|FG001|Overall Study|Lost to Follow-up|4|||
130054403|NCT04346628|468154518|FG000|Overall Study|Withdrew (had personal reasons)|2|||
130054404|NCT04346628|468154519|FG001|Overall Study|Withdrew (had personal reasons)|5|||
130054405|NCT04346628|468154518|FG000|Overall Study|Withdrew (medication intolerant)|0|||
130054406|NCT04346628|468154519|FG001|Overall Study|Withdrew (medication intolerant)|3|||
130111393|NCT01677910|468369452|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
130111394|NCT01677910|468369453|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
130054407|NCT04346628|468154518|FG000|Overall Study|Withdrew (declined intervention)|0|||
130054408|NCT04346628|468154519|FG001|Overall Study|Withdrew (declined intervention)|1|||
130054409|NCT01202227|468154522|FG000|Overall Study|Adverse Event|16|||
130054410|NCT01202227|468154522|FG000|Overall Study|Withdrawal by Subject|2|||
130054411|NCT01202227|468154522|FG000|Overall Study|Lack of Efficacy|1|||
130111395|NCT01677910|468369450|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129891718|NCT00432159|467563036|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
130054412|NCT00643487|468154523|FG000|Overall Study|Technical difficulty|3|||
130054413|NCT04402008|468154524|FG000|Overall Study|Adverse Event|0|||
129804142|NCT00976677|467249913|FG000|Overall Study|Unknown/Missing|1|||
129804143|NCT00976677|467249914|FG001|Overall Study|Unknown/Missing|0|||
129804144|NCT03507400|467249915|FG000|Overall Study|discontinued|5|||
129804145|NCT03507400|467249916|FG001|Overall Study|discontinued|1|||
129804146|NCT03507400|467249915|FG000|Overall Study|Lost to Follow-up|8|||
129804147|NCT03507400|467249916|FG001|Overall Study|Lost to Follow-up|6|||
129804148|NCT03507400|467249915|FG000|Overall Study|Protocol Violation|0|||
129804149|NCT03507400|467249916|FG001|Overall Study|Protocol Violation|1|||
129804150|NCT01555983|467249917|FG000|Overall Study|Withdrawal by Subject|1|||
129804151|NCT01555983|467249918|FG001|Overall Study|Withdrawal by Subject|0|||
129804152|NCT01555983|467249919|FG002|Overall Study|Withdrawal by Subject|0|||
129804153|NCT01555983|467249920|FG003|Overall Study|Withdrawal by Subject|0|||
130111396|NCT01677910|468369451|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130111397|NCT01677910|468369452|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
130111398|NCT01677910|468369453|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
130111399|NCT01677910|468369450|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130111400|NCT01677910|468369451|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
130111401|NCT01677910|468369452|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129804154|NCT01555983|467249921|FG004|Overall Study|Withdrawal by Subject|1|||
129804155|NCT01555983|467249922|FG005|Overall Study|Withdrawal by Subject|1|||
129804156|NCT04806503|467251433|FG000|Overall Study|Lost to Follow-up|0|||
129804157|NCT04806503|467251434|FG001|Overall Study|Lost to Follow-up|0|||
129804158|NCT04806503|467251435|FG002|Overall Study|Lost to Follow-up|1|||
129804159|NCT04806503|467251436|FG003|Overall Study|Lost to Follow-up|0|||
129804160|NCT04806503|467251437|FG004|Overall Study|Lost to Follow-up|0|||
129804161|NCT04806503|467251433|FG000|Overall Study|Withdrawal by Subject|1|||
129891719|NCT01929993|467563037|FG000|Overall Study|Protocol Violation|4|||
130054414|NCT04402008|468154525|FG001|Overall Study|Adverse Event|0|||
130054415|NCT04402008|468154526|FG002|Overall Study|Adverse Event|0|||
129804162|NCT04806503|467251434|FG001|Overall Study|Withdrawal by Subject|0|||
129804163|NCT04806503|467251435|FG002|Overall Study|Withdrawal by Subject|1|||
129804164|NCT04806503|467251436|FG003|Overall Study|Withdrawal by Subject|1|||
130054416|NCT04402008|468154527|FG003|Overall Study|Adverse Event|1|||
130054417|NCT04402008|468154528|FG004|Overall Study|Adverse Event|0|||
130054418|NCT04402008|468154529|FG005|Overall Study|Adverse Event|0|||
130054419|NCT04402008|468154530|FG006|Overall Study|Adverse Event|0|||
130054420|NCT04402008|468154524|FG000|Overall Study|Disease Progression|3|||
129804165|NCT04806503|467251437|FG004|Overall Study|Withdrawal by Subject|1|||
129804166|NCT04806503|467251433|FG000|Overall Study|Adverse Event|1|||
129891720|NCT01929993|467563038|FG001|Overall Study|Protocol Violation|6|||
129891721|NCT01929993|467563037|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
129891722|NCT01929993|467563038|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
129891723|NCT01852162|467563039|FG000|Overall Study|Adverse Event|1|||
129891724|NCT01852162|467563040|FG001|Overall Study|Adverse Event|0|||
129891725|NCT01852162|467563039|FG000|Overall Study|Withdrawal by Subject|3|||
129891726|NCT01852162|467563040|FG001|Overall Study|Withdrawal by Subject|1|||
129891727|NCT03660943|467563041|FG000|Overall Study|Adverse Event|5|||
129891728|NCT03660943|467563042|FG001|Overall Study|Adverse Event|3|||
129891729|NCT03660943|467563041|FG000|Overall Study|Death|0|||
129891730|NCT03660943|467563042|FG001|Overall Study|Death|2|||
129891731|NCT03660943|467563041|FG000|Overall Study|Lost to Follow-up|7|||
129891732|NCT03660943|467563042|FG001|Overall Study|Lost to Follow-up|3|||
129891733|NCT03660943|467563041|FG000|Overall Study|Protocol Violation|3|||
129891734|NCT03660943|467563042|FG001|Overall Study|Protocol Violation|5|||
129891735|NCT03660943|467563041|FG000|Overall Study|Withdrawal by Subject|8|||
129891736|NCT03660943|467563042|FG001|Overall Study|Withdrawal by Subject|15|||
129891737|NCT03660943|467563041|FG000|Overall Study|Lack of Efficacy|9|||
129891738|NCT03660943|467563042|FG001|Overall Study|Lack of Efficacy|12|||
129891739|NCT03660943|467563041|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
129891740|NCT03660943|467563042|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
129891741|NCT02892409|467563046|FG000|Overall Study|Adverse Event|1|||
129891742|NCT02892409|467563047|FG001|Overall Study|Adverse Event|0|||
129891743|NCT02892409|467563046|FG000|Overall Study|Withdrawal by Subject|2|||
129891744|NCT02892409|467563047|FG001|Overall Study|Withdrawal by Subject|1|||
129891745|NCT05305040|467563048|FG000|Overall Study|Not Dosed|37|||
129891746|NCT05305040|467563049|FG001|Overall Study|Not Dosed|37|||
129891747|NCT05305040|467563048|FG000|Overall Study|Study Closure|34|||
129891748|NCT05305040|467563049|FG001|Overall Study|Study Closure|46|||
129891749|NCT05305040|467563048|FG000|Overall Study|Death|14|||
129891750|NCT05305040|467563049|FG001|Overall Study|Death|13|||
129891751|NCT05305040|467563048|FG000|Overall Study|Withdrawal by Subject|15|||
129891752|NCT05305040|467563049|FG001|Overall Study|Withdrawal by Subject|10|||
129891753|NCT05305040|467563048|FG000|Overall Study|Other|13|||
129891754|NCT05305040|467563049|FG001|Overall Study|Other|10|||
129891755|NCT05305040|467563048|FG000|Overall Study|Primary Malignancy Relapse|3|||
129891756|NCT05305040|467563049|FG001|Overall Study|Primary Malignancy Relapse|4|||
129891757|NCT05305040|467563048|FG000|Overall Study|Adverse Event|3|||
129891758|NCT05305040|467563049|FG001|Overall Study|Adverse Event|3|||
129891759|NCT05305040|467563048|FG000|Overall Study|Lost to Follow-up|2|||
129891760|NCT05305040|467563049|FG001|Overall Study|Lost to Follow-up|1|||
129891761|NCT05305040|467563048|FG000|Overall Study|Graft versus host disease|2|||
129891762|NCT05305040|467563049|FG001|Overall Study|Graft versus host disease|0|||
129891763|NCT05305040|467563048|FG000|Overall Study|Investigator's Decision|1|||
129891764|NCT05305040|467563049|FG001|Overall Study|Investigator's Decision|1|||
129891765|NCT05305040|467563048|FG000|Overall Study|COVID-19 Reasons|1|||
129891766|NCT05305040|467563049|FG001|Overall Study|COVID-19 Reasons|0|||
129891767|NCT02123966|467563052|FG000|Overall Study|Intercurrent Illness|1|||
129891768|NCT01033643|467563053|FG000|Overall Study|Withdrew Consent|0|||
129891769|NCT01033643|467563054|FG001|Overall Study|Withdrew Consent|3|||
129891770|NCT01033643|467563055|FG002|Overall Study|Withdrew Consent|0|||
129891771|NCT01033643|467563056|FG003|Overall Study|Withdrew Consent|0|||
129891772|NCT01033643|467563057|FG004|Overall Study|Withdrew Consent|0|||
129891773|NCT01033643|467563058|FG005|Overall Study|Withdrew Consent|1|||
129891774|NCT00465361|467563059|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
129891775|NCT02652130|467563060|FG000|Overall Study|Death|1|||
130054421|NCT04402008|468154525|FG001|Overall Study|Disease Progression|2|||
130054422|NCT04402008|468154526|FG002|Overall Study|Disease Progression|3|||
130054423|NCT04402008|468154527|FG003|Overall Study|Disease Progression|3|||
130054424|NCT04402008|468154528|FG004|Overall Study|Disease Progression|4|||
129891776|NCT00751790|467563067|FG000|Overall Study|Lost to Follow-up|1|||
129891777|NCT00751790|467563067|FG000|Overall Study|Death|3|||
129891778|NCT00751790|467563067|FG000|Overall Study|Withdrawal by Subject|1|||
129891779|NCT04337489|467563068|FG000|Overall Study|Withdrawal by Subject|1|||
129891780|NCT01113463|467563073|FG000|Overall Study|Physician Decision|5|||
129891781|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
129891782|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
129891783|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
129891784|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
129891785|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
130054425|NCT04402008|468154529|FG005|Overall Study|Disease Progression|3|||
129891786|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
129891787|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
129891788|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
129891789|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
129891790|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
129891791|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
129891792|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
129891793|NCT01237678|467563074|FG000|Phase II|Adverse Event|0|||
129891794|NCT01237678|467563075|FG001|Phase II|Adverse Event|39|||
129891795|NCT01237678|467563076|FG002|Phase II|Adverse Event|9|||
129891796|NCT01237678|467563074|FG000|Phase II|Death|0|||
129891797|NCT01237678|467563075|FG001|Phase II|Death|0|||
129891798|NCT01237678|467563076|FG002|Phase II|Death|2|||
129891799|NCT01237678|467563074|FG000|Phase II|Lack of Efficacy|0|||
129891800|NCT01237678|467563075|FG001|Phase II|Lack of Efficacy|25|||
129891801|NCT01237678|467563076|FG002|Phase II|Lack of Efficacy|3|||
129891802|NCT01237678|467563074|FG000|Phase II|Withdrawal by Subject|0|||
129891803|NCT01237678|467563075|FG001|Phase II|Withdrawal by Subject|1|||
129891804|NCT01237678|467563076|FG002|Phase II|Withdrawal by Subject|5|||
129891805|NCT01237678|467563074|FG000|Phase II|Completed Cycles 4-6|0|||
129891806|NCT01237678|467563075|FG001|Phase II|Completed Cycles 4-6|11|||
129891807|NCT01237678|467563076|FG002|Phase II|Completed Cycles 4-6|21|||
129891808|NCT01237678|467563074|FG000|Phase II|Sponsor Decision/Study Closed|0|||
129891809|NCT01237678|467563075|FG001|Phase II|Sponsor Decision/Study Closed|18|||
129891810|NCT01237678|467563076|FG002|Phase II|Sponsor Decision/Study Closed|7|||
129891811|NCT01237678|467563074|FG000|Phase II|Randomized but were not treated|0|||
129891812|NCT01237678|467563075|FG001|Phase II|Randomized but were not treated|4|||
129891813|NCT01237678|467563076|FG002|Phase II|Randomized but were not treated|3|||
129891814|NCT03023332|467563077|FG000|Overall Study|Withdrawal by Subject|10|||
129891815|NCT03023332|467563078|FG001|Overall Study|Withdrawal by Subject|5|||
129891816|NCT03023332|467563079|FG002|Overall Study|Withdrawal by Subject|4|||
129891817|NCT03023332|467563080|FG003|Overall Study|Withdrawal by Subject|7|||
129891818|NCT03023332|467563077|FG000|Overall Study|Lost to Follow-up|13|||
130054426|NCT04402008|468154530|FG006|Overall Study|Disease Progression|10|||
129891819|NCT03023332|467563078|FG001|Overall Study|Lost to Follow-up|16|||
129891820|NCT03023332|467563079|FG002|Overall Study|Lost to Follow-up|8|||
129891821|NCT03023332|467563080|FG003|Overall Study|Lost to Follow-up|13|||
129891822|NCT03023332|467563077|FG000|Overall Study|Death|1|||
129891823|NCT03023332|467563078|FG001|Overall Study|Death|0|||
129891824|NCT03023332|467563079|FG002|Overall Study|Death|0|||
129891825|NCT03023332|467563080|FG003|Overall Study|Death|0|||
129891826|NCT01818700|467563081|FG000|Overall Study|Adverse Event|67|||
129891827|NCT01818700|467563081|FG000|Overall Study|Lack of Efficacy|2|||
129891828|NCT01818700|467563081|FG000|Overall Study|Lost to Follow-up|5|||
129891829|NCT01818700|467563081|FG000|Overall Study|Withdrawal by Subject|27|||
129891830|NCT01818700|467563081|FG000|Overall Study|Protocol Violation|2|||
129891831|NCT01818700|467563081|FG000|Overall Study|Other|1|||
129891832|NCT02412761|467563082|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129891833|NCT02412761|467563083|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129891834|NCT02412761|467563084|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129891835|NCT02412761|467563085|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129891836|NCT02412761|467563086|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129891837|NCT02412761|467563087|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129891838|NCT01657682|467563088|FG000|Overall Study|Lost to Follow-up|1|||
129891839|NCT01657682|467563089|FG001|Overall Study|Lost to Follow-up|0|||
129891840|NCT01657682|467563090|FG002|Overall Study|Lost to Follow-up|0|||
129891841|NCT01657682|467563088|FG000|Overall Study|Withdrawal by Subject|0|||
129891842|NCT01657682|467563089|FG001|Overall Study|Withdrawal by Subject|1|||
129891843|NCT01657682|467563090|FG002|Overall Study|Withdrawal by Subject|1|||
129891844|NCT01657682|467563088|FG000|Overall Study|Adverse Event|0|||
129891845|NCT01657682|467563089|FG001|Overall Study|Adverse Event|1|||
129891846|NCT01657682|467563090|FG002|Overall Study|Adverse Event|0|||
130054427|NCT04402008|468154524|FG000|Overall Study|Withdrawal by Subject|0|||
130054428|NCT04402008|468154525|FG001|Overall Study|Withdrawal by Subject|1|||
130054429|NCT04402008|468154526|FG002|Overall Study|Withdrawal by Subject|0|||
129891847|NCT01719861|467563091|FG000|Cycle 1|Death|4|||
129891848|NCT01719861|467563091|FG000|Cycle 2|Death|1|||
130054430|NCT04402008|468154527|FG003|Overall Study|Withdrawal by Subject|0|||
129891849|NCT04833855|467563097|FG000|Overall Study|Decision by sponsor|0|||
129891850|NCT04833855|467563098|FG001|Overall Study|Decision by sponsor|1|||
130054431|NCT04402008|468154528|FG004|Overall Study|Withdrawal by Subject|1|||
129891851|NCT04833855|467563099|FG002|Overall Study|Decision by sponsor|0|||
129891852|NCT04833855|467563100|FG003|Overall Study|Decision by sponsor|0|||
129891853|NCT04833855|467563097|FG000|Overall Study|Withdrawal by Subject|4|||
130054432|NCT04402008|468154529|FG005|Overall Study|Withdrawal by Subject|0|||
130054433|NCT04402008|468154530|FG006|Overall Study|Withdrawal by Subject|0|||
130054434|NCT04402008|468154524|FG000|Overall Study|Sponsor Decision|0|||
129804167|NCT04806503|467251434|FG001|Overall Study|Adverse Event|1|||
129804168|NCT04806503|467251435|FG002|Overall Study|Adverse Event|0|||
129804169|NCT04806503|467251436|FG003|Overall Study|Adverse Event|1|||
129804170|NCT04806503|467251437|FG004|Overall Study|Adverse Event|0|||
129804171|NCT03589469|467251438|FG000|Overall Study|Withdrawal by Subject|8|||
129804172|NCT03589469|467251438|FG000|Overall Study|Physician Decision|20|||
129804173|NCT03589469|467251438|FG000|Overall Study|Death|97|||
129804174|NCT03589469|467251438|FG000|Overall Study|Lost to Follow-up|8|||
129804175|NCT03589469|467251438|FG000|Overall Study|Miscellaneous|1|||
129804176|NCT02008318|467251440|FG000|Overall Study|Adverse Event|4|||
129804177|NCT02008318|467251441|FG001|Overall Study|Adverse Event|0|||
129804178|NCT02008318|467251440|FG000|Overall Study|Physician Decision|2|||
129804179|NCT02008318|467251441|FG001|Overall Study|Physician Decision|0|||
129804180|NCT02008318|467251440|FG000|Overall Study|Progressive Disease|2|||
129804181|NCT02008318|467251441|FG001|Overall Study|Progressive Disease|0|||
129804182|NCT02008318|467251440|FG000|Overall Study|Protocol Violation|1|||
129804183|NCT02008318|467251441|FG001|Overall Study|Protocol Violation|1|||
129804184|NCT02008318|467251440|FG000|Overall Study|Withdrawal by Subject|3|||
129804185|NCT02008318|467251441|FG001|Overall Study|Withdrawal by Subject|0|||
129804186|NCT00371826|467251448|FG000|Core Phase (12 Months)|Adverse Event|15|||
129804187|NCT00371826|467251449|FG001|Core Phase (12 Months)|Adverse Event|4|||
129804188|NCT00371826|467251450|FG002|Core Phase (12 Months)|Adverse Event|9|||
129804189|NCT00371826|467251448|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
129804190|NCT00371826|467251449|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
129804191|NCT00371826|467251450|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
129804192|NCT00371826|467251448|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
129804193|NCT00371826|467251449|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
129804194|NCT00371826|467251450|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
129804195|NCT00371826|467251448|FG000|Core Phase (12 Months)|Protocol Violation|1|||
129804196|NCT00371826|467251449|FG001|Core Phase (12 Months)|Protocol Violation|0|||
129804197|NCT00371826|467251450|FG002|Core Phase (12 Months)|Protocol Violation|1|||
129804198|NCT00371826|467251448|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
129804199|NCT00371826|467251449|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
129804200|NCT00371826|467251450|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
129804201|NCT00371826|467251448|FG000|Core Phase (12 Months)|Administrative problems|1|||
129804202|NCT00371826|467251449|FG001|Core Phase (12 Months)|Administrative problems|0|||
129804203|NCT00371826|467251450|FG002|Core Phase (12 Months)|Administrative problems|8|||
129804204|NCT00371826|467251448|FG000|Core Phase (12 Months)|Graft Loss|0|||
129804205|NCT00371826|467251449|FG001|Core Phase (12 Months)|Graft Loss|1|||
129804206|NCT00371826|467251450|FG002|Core Phase (12 Months)|Graft Loss|0|||
129804207|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Adverse Event|4|||
129804208|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Adverse Event|5|||
129804209|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Adverse Event|0|||
129804210|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
129804211|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
129804212|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
129804213|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
129804214|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
129804215|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
129804216|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
130054435|NCT04402008|468154525|FG001|Overall Study|Sponsor Decision|0|||
129804217|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
129804218|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
129804219|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Administrative problems|0|||
129891854|NCT04833855|467563098|FG001|Overall Study|Withdrawal by Subject|1|||
129891855|NCT04833855|467563099|FG002|Overall Study|Withdrawal by Subject|3|||
129891856|NCT04833855|467563100|FG003|Overall Study|Withdrawal by Subject|1|||
129891857|NCT04833855|467563097|FG000|Overall Study|Lost to Follow-up|1|||
129891858|NCT04833855|467563098|FG001|Overall Study|Lost to Follow-up|0|||
129891859|NCT04833855|467563099|FG002|Overall Study|Lost to Follow-up|2|||
129891860|NCT04833855|467563100|FG003|Overall Study|Lost to Follow-up|2|||
130054436|NCT04402008|468154526|FG002|Overall Study|Sponsor Decision|0|||
129891861|NCT04833855|467563097|FG000|Overall Study|Protocol specified criteria|0|||
130054437|NCT04402008|468154527|FG003|Overall Study|Sponsor Decision|0|||
130054438|NCT04402008|468154528|FG004|Overall Study|Sponsor Decision|0|||
130054439|NCT04402008|468154529|FG005|Overall Study|Sponsor Decision|0|||
129891862|NCT04833855|467563098|FG001|Overall Study|Protocol specified criteria|0|||
129891863|NCT04833855|467563099|FG002|Overall Study|Protocol specified criteria|2|||
129891864|NCT04833855|467563100|FG003|Overall Study|Protocol specified criteria|1|||
129891865|NCT03682536|467563102|FG000|Randomization|Withdrawal by Subject|0|||
129891866|NCT03682536|467563103|FG001|Randomization|Withdrawal by Subject|2|||
129891867|NCT03682536|467563102|FG000|Treatment|Other Reasons|8|||
129891868|NCT03682536|467563103|FG001|Treatment|Other Reasons|7|||
129891869|NCT03682536|467563102|FG000|Treatment|Physician Decision|5|||
129891870|NCT03682536|467563103|FG001|Treatment|Physician Decision|5|||
129891871|NCT03682536|467563102|FG000|Treatment|Protocol Violation|1|||
129891872|NCT03682536|467563103|FG001|Treatment|Protocol Violation|0|||
129891873|NCT03682536|467563102|FG000|Treatment|Study Terminated by Sponsor|1|||
129891874|NCT03682536|467563103|FG001|Treatment|Study Terminated by Sponsor|2|||
129891875|NCT03682536|467563102|FG000|Treatment|Lost to Follow-up|0|||
129891876|NCT03682536|467563103|FG001|Treatment|Lost to Follow-up|1|||
129891877|NCT03682536|467563102|FG000|Treatment|Withdrawal by Subject|16|||
129891878|NCT03682536|467563103|FG001|Treatment|Withdrawal by Subject|18|||
129891879|NCT03682536|467563102|FG000|Treatment|Lack of Efficacy|41|||
129891880|NCT03682536|467563103|FG001|Treatment|Lack of Efficacy|68|||
129891881|NCT03682536|467563102|FG000|Treatment|Disease Progression|9|||
129891882|NCT03682536|467563103|FG001|Treatment|Disease Progression|7|||
129891883|NCT03682536|467563102|FG000|Treatment|Adverse Event|9|||
129891884|NCT03682536|467563103|FG001|Treatment|Adverse Event|5|||
129891885|NCT03682536|467563102|FG000|Treatment|Death|14|||
129891886|NCT03682536|467563103|FG001|Treatment|Death|13|||
129891887|NCT03008122|467563104|FG000|Overall Study|Physician Decision|3|||
129891888|NCT03008122|467563105|FG001|Overall Study|Physician Decision|2|||
129891889|NCT03008122|467563106|FG002|Overall Study|Physician Decision|0|||
129891890|NCT03008122|467563104|FG000|Overall Study|Withdrawal by Subject|1|||
129891891|NCT03008122|467563105|FG001|Overall Study|Withdrawal by Subject|3|||
129891892|NCT03008122|467563106|FG002|Overall Study|Withdrawal by Subject|0|||
129891893|NCT03008122|467563104|FG000|Overall Study|Lost to Follow-up|4|||
129891894|NCT03008122|467563105|FG001|Overall Study|Lost to Follow-up|8|||
129891895|NCT03008122|467563106|FG002|Overall Study|Lost to Follow-up|3|||
129891896|NCT03008122|467563104|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
129891897|NCT03008122|467563105|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129891898|NCT03008122|467563106|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129891899|NCT03008122|467563104|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
130054440|NCT04402008|468154530|FG006|Overall Study|Sponsor Decision|3|||
130054441|NCT04402008|468154524|FG000|Overall Study|Death|0|||
130054442|NCT04402008|468154525|FG001|Overall Study|Death|0|||
130054443|NCT04402008|468154526|FG002|Overall Study|Death|0|||
130054444|NCT04402008|468154527|FG003|Overall Study|Death|0|||
130054445|NCT04402008|468154528|FG004|Overall Study|Death|1|||
129891900|NCT03008122|467563105|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
129891901|NCT03008122|467563106|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
129891902|NCT03008122|467563104|FG000|Overall Study|Death|0|||
129891903|NCT03008122|467563105|FG001|Overall Study|Death|0|||
129891904|NCT03008122|467563106|FG002|Overall Study|Death|1|||
129891905|NCT02338609|467563107|FG000|Overall Study|Physician Decision|1|||
129891906|NCT02338609|467563107|FG000|Overall Study|Death|1|||
130054446|NCT04402008|468154529|FG005|Overall Study|Death|0|||
130054447|NCT04402008|468154530|FG006|Overall Study|Death|2|||
130054448|NCT04402008|468154524|FG000|Overall Study|Other|0|||
129891907|NCT02234310|467563110|FG000|Overall Study|Physician Decision|1|||
129891908|NCT02234310|467563110|FG000|Overall Study|Adverse Event|1|||
129891909|NCT02234310|467563110|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
129891910|NCT02234310|467563110|FG000|Overall Study|Withdrawal by Subject|2|||
129891911|NCT02322775|467563114|FG000|Overall Study|Adverse Event|1|||
129891912|NCT02322775|467563115|FG001|Overall Study|Adverse Event|0|||
130054449|NCT04402008|468154525|FG001|Overall Study|Other|0|||
130054450|NCT04402008|468154526|FG002|Overall Study|Other|0|||
130054451|NCT04402008|468154527|FG003|Overall Study|Other|0|||
130054452|NCT04402008|468154528|FG004|Overall Study|Other|0|||
130054453|NCT04402008|468154529|FG005|Overall Study|Other|0|||
130054454|NCT04402008|468154530|FG006|Overall Study|Other|5|||
129891913|NCT02322775|467563114|FG000|Overall Study|Lost to Follow-up|0|||
129891914|NCT02322775|467563115|FG001|Overall Study|Lost to Follow-up|1|||
130054455|NCT01533935|468154531|FG000|Overall Study|Adverse Event|5|||
130054456|NCT01533935|468154532|FG001|Overall Study|Adverse Event|7|||
129891915|NCT02322775|467563114|FG000|Overall Study|Protocol Violation|1|||
129891916|NCT02322775|467563115|FG001|Overall Study|Protocol Violation|0|||
129891917|NCT02322775|467563114|FG000|Overall Study|Withdrawal by Subject|3|||
129891918|NCT02322775|467563115|FG001|Overall Study|Withdrawal by Subject|4|||
129891919|NCT02322775|467563114|FG000|Overall Study|Not willing to perform all FU visits|0|||
129891920|NCT02322775|467563115|FG001|Overall Study|Not willing to perform all FU visits|1|||
129891921|NCT04482855|467563116|FG000|Overall Study|Lost to Follow-up|1|||
129891922|NCT04482855|467563117|FG001|Overall Study|Lost to Follow-up|0|||
129891923|NCT04482855|467563116|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
129891924|NCT04482855|467563117|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
129891925|NCT04482855|467563116|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
129891926|NCT04482855|467563117|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
129891927|NCT03212365|467563123|FG000|Overall Study|Discharged prior to Xa level|12|||
129891928|NCT03212365|467563124|FG001|Overall Study|Discharged prior to Xa level|8|||
129891929|NCT03212365|467563123|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
130054457|NCT01533935|468154533|FG002|Overall Study|Adverse Event|1|||
130054458|NCT01533935|468154534|FG003|Overall Study|Adverse Event|5|||
130054459|NCT01533935|468154535|FG004|Overall Study|Adverse Event|3|||
130054460|NCT01533935|468154531|FG000|Overall Study|Protocol Violation|0|||
130054461|NCT01533935|468154532|FG001|Overall Study|Protocol Violation|2|||
130054462|NCT01533935|468154533|FG002|Overall Study|Protocol Violation|0|||
130054463|NCT01533935|468154534|FG003|Overall Study|Protocol Violation|0|||
130054464|NCT01533935|468154535|FG004|Overall Study|Protocol Violation|0|||
130054465|NCT01533935|468154531|FG000|Overall Study|Lost to Follow-up|0|||
130054466|NCT01533935|468154532|FG001|Overall Study|Lost to Follow-up|0|||
130054467|NCT01533935|468154533|FG002|Overall Study|Lost to Follow-up|1|||
130054468|NCT01533935|468154534|FG003|Overall Study|Lost to Follow-up|0|||
130054469|NCT01533935|468154535|FG004|Overall Study|Lost to Follow-up|0|||
130054470|NCT01533935|468154531|FG000|Overall Study|Withdrawal by Subject|0|||
130054471|NCT01533935|468154532|FG001|Overall Study|Withdrawal by Subject|4|||
130054472|NCT01533935|468154533|FG002|Overall Study|Withdrawal by Subject|5|||
129804220|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Administrative problems|0|||
129804221|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Administrative problems|2|||
129804222|NCT00385762|467251451|FG000|Overall Study|Adverse Event|1|||
129804223|NCT00385762|467251451|FG000|Overall Study|Lost to Follow-up|1|||
129804224|NCT00231842|467251452|FG000|Overall Study|Withdrawal by Subject|3|||
130054473|NCT01533935|468154534|FG003|Overall Study|Withdrawal by Subject|2|||
130054474|NCT01533935|468154535|FG004|Overall Study|Withdrawal by Subject|4|||
130054475|NCT01533935|468154531|FG000|Overall Study|Other reason not defined above|1|||
130054476|NCT01533935|468154532|FG001|Overall Study|Other reason not defined above|0|||
130054477|NCT01533935|468154533|FG002|Overall Study|Other reason not defined above|1|||
130054478|NCT01533935|468154534|FG003|Overall Study|Other reason not defined above|0|||
130054479|NCT01533935|468154535|FG004|Overall Study|Other reason not defined above|1|||
130054480|NCT03430245|468154536|FG000|Overall Study|Withdrawal by Subject|6|||
130054481|NCT03430245|468154536|FG000|Overall Study|Lost to Follow-up|1|||
130054482|NCT05628181|468154537|FG000|Overall Study|Death|2|||
130054483|NCT05628181|468154538|FG001|Overall Study|Death|4|||
130054484|NCT05628181|468154539|FG002|Overall Study|Death|0|||
130054485|NCT01428063|468154546|FG000|Overall Study|Lack of Efficacy|8|||
129891930|NCT03212365|467563124|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
129891931|NCT03212365|467563123|FG000|Overall Study|Refused study medication|3|||
129891932|NCT03212365|467563124|FG001|Overall Study|Refused study medication|0|||
129891933|NCT03212365|467563123|FG000|Overall Study|Initiated heparin infusion on floor|1|||
129891934|NCT03212365|467563124|FG001|Overall Study|Initiated heparin infusion on floor|1|||
129891935|NCT03212365|467563123|FG000|Overall Study|Unexpected return to OR|1|||
129891936|NCT03212365|467563124|FG001|Overall Study|Unexpected return to OR|1|||
129891937|NCT03212365|467563123|FG000|Overall Study|Medication distribution error|1|||
129891938|NCT03212365|467563124|FG001|Overall Study|Medication distribution error|0|||
129891939|NCT03212365|467563123|FG000|Overall Study|Required epidural placement|1|||
129891940|NCT03212365|467563124|FG001|Overall Study|Required epidural placement|0|||
129891941|NCT03212365|467563123|FG000|Overall Study|Withdrawal by Subject|0|||
129891942|NCT03212365|467563124|FG001|Overall Study|Withdrawal by Subject|1|||
129891943|NCT03212365|467563123|FG000|Overall Study|developed acute renal failure|0|||
129891944|NCT03212365|467563124|FG001|Overall Study|developed acute renal failure|1|||
129891945|NCT02507219|467563125|FG000|Overall Study|Physician Decision|1|||
129891946|NCT02507219|467563126|FG001|Overall Study|Physician Decision|0|||
129891947|NCT02507219|467563127|FG002|Overall Study|Physician Decision|0|||
129891948|NCT02507219|467563128|FG003|Overall Study|Physician Decision|0|||
129891949|NCT02507219|467563129|FG004|Overall Study|Physician Decision|0|||
129891950|NCT02507219|467563130|FG005|Overall Study|Physician Decision|0|||
129891951|NCT02507219|467563125|FG000|Overall Study|Withdrawal by Subject|0|||
129891952|NCT02507219|467563126|FG001|Overall Study|Withdrawal by Subject|0|||
129891953|NCT02507219|467563127|FG002|Overall Study|Withdrawal by Subject|0|||
129891954|NCT02507219|467563128|FG003|Overall Study|Withdrawal by Subject|0|||
129891955|NCT02507219|467563129|FG004|Overall Study|Withdrawal by Subject|1|||
129891956|NCT02507219|467563130|FG005|Overall Study|Withdrawal by Subject|0|||
129891957|NCT05174065|467563135|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
129891958|NCT05174065|467563136|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
129891959|NCT05174065|467563137|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
129891960|NCT05174065|467563135|FG000|Placebo-controlled Period|Other|0|||
129891961|NCT05174065|467563136|FG001|Placebo-controlled Period|Other|1|||
129891962|NCT05174065|467563137|FG002|Placebo-controlled Period|Other|0|||
129891963|NCT05174065|467563135|FG000|Placebo-controlled Period|Adverse Event|1|||
129891964|NCT05174065|467563136|FG001|Placebo-controlled Period|Adverse Event|1|||
129891965|NCT05174065|467563137|FG002|Placebo-controlled Period|Adverse Event|0|||
129891966|NCT05174065|467563135|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
129891967|NCT05174065|467563136|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
129891968|NCT05174065|467563137|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
129891969|NCT05174065|467563135|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
129891970|NCT05174065|467563136|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
129891971|NCT05174065|467563137|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
129891972|NCT05174065|467563135|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
129891973|NCT05174065|467563136|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
129891974|NCT05174065|467563137|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
129891975|NCT01342887|467563143|FG000|Overall Study|Death|2|||
129891976|NCT00209274|467563144|FG000|Overall Study|Missed visit|3|||
129891977|NCT00209274|467563145|FG001|Overall Study|Missed visit|2|||
129891978|NCT00209274|467563144|FG000|Overall Study|Death|32|||
129891979|NCT00209274|467563145|FG001|Overall Study|Death|15|||
129891980|NCT00209274|467563144|FG000|Overall Study|Withdrawal by Subject|30|||
129891981|NCT00209274|467563145|FG001|Overall Study|Withdrawal by Subject|15|||
129891982|NCT00209274|467563144|FG000|Overall Study|Randomized not treated (RNT)|6|||
129891983|NCT00209274|467563145|FG001|Overall Study|Randomized not treated (RNT)|15|||
129891984|NCT02753530|467563146|FG000|Overall Study|Adverse Event|7|||
129891985|NCT02753530|467563147|FG001|Overall Study|Adverse Event|1|||
129891986|NCT02753530|467563146|FG000|Overall Study|Death|0|||
129891987|NCT02753530|467563147|FG001|Overall Study|Death|1|||
129891988|NCT02753530|467563146|FG000|Overall Study|Physician Decision|0|||
129891989|NCT02753530|467563147|FG001|Overall Study|Physician Decision|1|||
129891990|NCT02753530|467563146|FG000|Overall Study|Protocol Violation|1|||
129891991|NCT02753530|467563147|FG001|Overall Study|Protocol Violation|0|||
129891992|NCT02753530|467563146|FG000|Overall Study|Withdrawal by Subject|4|||
129891993|NCT02753530|467563147|FG001|Overall Study|Withdrawal by Subject|3|||
129891994|NCT00429793|467563156|FG000|Overall Study|Improper pre-protocol treatment|3|||
129891995|NCT00429793|467563156|FG000|Overall Study|Required test not done|1|||
129891996|NCT00429793|467563156|FG000|Overall Study|Never treated|1|||
129891997|NCT00429793|467563156|FG000|Overall Study|Non-measurable|1|||
129891998|NCT00097370|467563157|FG000|Stage 1|Adverse Event|3|||
129891999|NCT00097370|467563157|FG000|Stage 1|Withdrawal by Subject|1|||
129892000|NCT00097370|467563157|FG000|Stage 1|Lack of Efficacy|2|||
129892001|NCT00097370|467563157|FG000|Stage 2|Adverse Event|5|||
129892002|NCT00097370|467563157|FG000|Stage 2|Withdrawal by Subject|1|||
129892003|NCT00097370|467563157|FG000|Stage 2|Lack of Efficacy|3|||
129892004|NCT00097370|467563157|FG000|Stage 2|Pregnancy|1|||
129892005|NCT00097370|467563157|FG000|Stage 2|Sponsor Terminated Study|2|||
129892006|NCT00097370|467563157|FG000|Stage 2|Lost to Follow-up|1|||
129892007|NCT00097370|467563157|FG000|Stage 3|Adverse Event|2|||
129892008|NCT00097370|467563157|FG000|Stage 3|Withdrawal by Subject|3|||
129892009|NCT00097370|467563157|FG000|Stage 3|Lack of Efficacy|1|||
129892010|NCT00097370|467563157|FG000|Stage 3|Sponsor Terminated Study|52|||
129892011|NCT00097370|467563157|FG000|Stage 3|Lost to Follow-up|1|||
129892012|NCT02419755|467563158|FG000|Overall Study|Death|1|||
129892013|NCT02419755|467563159|FG001|Overall Study|Death|3|||
129892014|NCT02419755|467563158|FG000|Overall Study|Relapse|0|||
129892015|NCT02419755|467563159|FG001|Overall Study|Relapse|1|||
129892016|NCT02419755|467563158|FG000|Overall Study|Ineligible|1|||
130054486|NCT01428063|468154547|FG001|Overall Study|Lack of Efficacy|4|||
129892017|NCT02419755|467563159|FG001|Overall Study|Ineligible|0|||
130054487|NCT01428063|468154548|FG002|Overall Study|Lack of Efficacy|1|||
129892018|NCT02419755|467563158|FG000|Overall Study|Withdrawal by Subject|1|||
130054488|NCT01428063|468154546|FG000|Overall Study|Adverse Event|2|||
129892019|NCT02419755|467563159|FG001|Overall Study|Withdrawal by Subject|0|||
129892020|NCT02337361|467563161|FG000|3-month Follow-up|Lost to Follow-up|19|||
129892021|NCT02337361|467563162|FG001|3-month Follow-up|Lost to Follow-up|14|||
130054489|NCT01428063|468154547|FG001|Overall Study|Adverse Event|3|||
130054490|NCT01428063|468154548|FG002|Overall Study|Adverse Event|0|||
130054491|NCT01428063|468154546|FG000|Overall Study|Lost to Follow-up|0|||
129892022|NCT02337361|467563161|FG000|6-month Follow-up|Lost to Follow-up|2|||
129892023|NCT02337361|467563162|FG001|6-month Follow-up|Lost to Follow-up|4|||
129892024|NCT02427646|467563163|FG000|Overall Study|Lack of Efficacy|2|||
129892025|NCT02427646|467563164|FG001|Overall Study|Lack of Efficacy|3|||
129892026|NCT02427646|467563163|FG000|Overall Study|Physician Decision|1|||
129892027|NCT02427646|467563164|FG001|Overall Study|Physician Decision|4|||
130054492|NCT01428063|468154547|FG001|Overall Study|Lost to Follow-up|2|||
130054493|NCT01428063|468154548|FG002|Overall Study|Lost to Follow-up|0|||
129892028|NCT02427646|467563163|FG000|Overall Study|Protocol Violation|3|||
129892029|NCT02427646|467563164|FG001|Overall Study|Protocol Violation|3|||
130054494|NCT01428063|468154546|FG000|Overall Study|No longer meets study criteria|0|||
130111402|NCT01677910|468369453|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
130111403|NCT01677910|468369450|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
130111404|NCT01677910|468369451|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
130054495|NCT01428063|468154547|FG001|Overall Study|No longer meets study criteria|1|||
130054496|NCT01428063|468154548|FG002|Overall Study|No longer meets study criteria|0|||
130054497|NCT02284906|468154549|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130054498|NCT02284906|468154550|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130054499|NCT02284906|468154551|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130054500|NCT02284906|468154549|FG000|Overall Study|Major Protocol Deviation|0|||
130054501|NCT02284906|468154550|FG001|Overall Study|Major Protocol Deviation|1|||
130054502|NCT02284906|468154551|FG002|Overall Study|Major Protocol Deviation|0|||
130054503|NCT02284906|468154549|FG000|Overall Study|Voluntary Withdrawal|2|||
130054504|NCT02284906|468154550|FG001|Overall Study|Voluntary Withdrawal|4|||
130054505|NCT02284906|468154551|FG002|Overall Study|Voluntary Withdrawal|5|||
130054506|NCT02284906|468154549|FG000|Overall Study|Study Termination|0|||
130054507|NCT02284906|468154550|FG001|Overall Study|Study Termination|11|||
130054508|NCT02284906|468154551|FG002|Overall Study|Study Termination|14|||
130054509|NCT02284906|468154549|FG000|Overall Study|Reason not Specified|1|||
130054510|NCT02284906|468154550|FG001|Overall Study|Reason not Specified|1|||
130054511|NCT02284906|468154551|FG002|Overall Study|Reason not Specified|0|||
130054512|NCT00850759|468154552|FG000|Overall Study|Lost to Follow-up|7|||
130054513|NCT00850759|468154553|FG001|Overall Study|Lost to Follow-up|5|||
130111405|NCT01677910|468369452|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
130111406|NCT01677910|468369453|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
130111407|NCT01677910|468369450|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
130111408|NCT01677910|468369451|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
130111409|NCT01677910|468369452|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
130111410|NCT01677910|468369453|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
130054514|NCT00850759|468154554|FG002|Overall Study|Lost to Follow-up|5|||
130054515|NCT00850759|468154555|FG003|Overall Study|Lost to Follow-up|3|||
130054516|NCT00532948|468154556|FG000|Overall Study|Protocol Violation|1|||
130054517|NCT00532948|468154557|FG001|Overall Study|Protocol Violation|0|||
130054518|NCT00532948|468154558|FG002|Overall Study|Protocol Violation|0|||
130054519|NCT00532948|468154556|FG000|Overall Study|Death|3|||
130054520|NCT00532948|468154557|FG001|Overall Study|Death|3|||
130054521|NCT00532948|468154558|FG002|Overall Study|Death|4|||
130054522|NCT00532948|468154556|FG000|Overall Study|Violation of selection criteria at entry|0|||
130054523|NCT00532948|468154557|FG001|Overall Study|Violation of selection criteria at entry|1|||
130054524|NCT00532948|468154558|FG002|Overall Study|Violation of selection criteria at entry|0|||
130054525|NCT00532948|468154556|FG000|Overall Study|Failure to return|0|||
130054526|NCT00532948|468154557|FG001|Overall Study|Failure to return|1|||
130054527|NCT00532948|468154558|FG002|Overall Study|Failure to return|0|||
130054528|NCT01753076|468154559|FG000|Overall Study|Adverse Event|17|||
130054529|NCT01753076|468154560|FG001|Overall Study|Adverse Event|18|||
130054530|NCT01753076|468154559|FG000|Overall Study|Lack of Efficacy|3|||
130054531|NCT01753076|468154560|FG001|Overall Study|Lack of Efficacy|1|||
130054532|NCT01753076|468154559|FG000|Overall Study|Lost to Follow-up|2|||
130054533|NCT01753076|468154560|FG001|Overall Study|Lost to Follow-up|1|||
129892030|NCT02427646|467563163|FG000|Overall Study|Bothersome hand weakness|2|||
129892031|NCT02427646|467563164|FG001|Overall Study|Bothersome hand weakness|4|||
129892032|NCT01641861|467563165|FG000|Overall Study|Lost to Follow-up|21|||
129892033|NCT01641861|467563166|FG001|Overall Study|Lost to Follow-up|16|||
129892034|NCT01641861|467563165|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
129892035|NCT01641861|467563166|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
129892036|NCT01641861|467563165|FG000|Overall Study|Died due to drowning|0|||
129892037|NCT01641861|467563166|FG001|Overall Study|Died due to drowning|1|||
129892038|NCT01101542|467563167|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
130054534|NCT01753076|468154559|FG000|Overall Study|Physician Decision|4|||
130054535|NCT01753076|468154560|FG001|Overall Study|Physician Decision|2|||
129892039|NCT01101542|467563167|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
129892040|NCT01101542|467563167|FG000|Year 4 Surveillance Period|Other|287|||
129892041|NCT01101542|467563167|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
129892042|NCT01101542|467563167|FG000|Year 5 Surveillance Period|Pregnancy|1|||
129892043|NCT01101542|467563167|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
129892044|NCT01101542|467563167|FG000|Year 6 Surveillance Period|Pregnancy|1|||
129892045|NCT01101542|467563167|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
129892046|NCT00901485|467563168|FG000|Overall Study|Lack of Efficacy|0|||
130054536|NCT01753076|468154559|FG000|Overall Study|Withdrawal by Subject|14|||
130054537|NCT01753076|468154560|FG001|Overall Study|Withdrawal by Subject|24|||
130054538|NCT01753076|468154559|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
130054539|NCT01753076|468154560|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
130054540|NCT02575079|468154561|FG000|Overall Study|Death|3|||
130054541|NCT02575079|468154562|FG001|Overall Study|Death|0|||
130054542|NCT02575079|468154561|FG000|Overall Study|Withdrawal by Subject|3|||
130054543|NCT02575079|468154562|FG001|Overall Study|Withdrawal by Subject|0|||
130054544|NCT02918266|468154563|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
130054545|NCT02918266|468154564|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054546|NCT02918266|468154565|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054547|NCT02918266|468154566|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054548|NCT02918266|468154567|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054549|NCT02918266|468154568|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054550|NCT02918266|468154569|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
130054551|NCT02918266|468154570|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054552|NCT02918266|468154571|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
130054553|NCT02918266|468154572|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054554|NCT02918266|468154573|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
130054555|NCT01259856|468154580|FG000|Overall Study|Adverse Event|12|||
130054556|NCT01259856|468154581|FG001|Overall Study|Adverse Event|9|||
130054557|NCT01259856|468154580|FG000|Overall Study|Death|0|||
130054558|NCT01259856|468154581|FG001|Overall Study|Death|1|||
130054559|NCT01259856|468154580|FG000|Overall Study|Lack of Efficacy|3|||
130054560|NCT01259856|468154581|FG001|Overall Study|Lack of Efficacy|1|||
130054561|NCT01259856|468154580|FG000|Overall Study|Lost to Follow-up|1|||
130054562|NCT01259856|468154581|FG001|Overall Study|Lost to Follow-up|1|||
130054563|NCT01259856|468154580|FG000|Overall Study|Physician Decision|2|||
129892047|NCT00901485|467563169|FG001|Overall Study|Lack of Efficacy|2|||
130054564|NCT01259856|468154581|FG001|Overall Study|Physician Decision|1|||
129892048|NCT00901485|467563168|FG000|Overall Study|Withdrawal by Subject|1|||
129892049|NCT00901485|467563169|FG001|Overall Study|Withdrawal by Subject|2|||
129892050|NCT01256476|467565302|FG000|Overall Study|Adverse Event|2|||
129892051|NCT01256476|467565303|FG001|Overall Study|Adverse Event|1|||
129892052|NCT01256476|467565302|FG000|Overall Study|Withdrawal by Subject|2|||
129892053|NCT01256476|467565303|FG001|Overall Study|Withdrawal by Subject|1|||
129892054|NCT01256476|467565302|FG000|Overall Study|Lost to Follow-up|1|||
129892055|NCT01256476|467565303|FG001|Overall Study|Lost to Follow-up|2|||
129892056|NCT01256476|467565302|FG000|Overall Study|Persistent ALT or AST elevation|1|||
129892057|NCT01256476|467565303|FG001|Overall Study|Persistent ALT or AST elevation|0|||
129892058|NCT01256476|467565302|FG000|Overall Study|Physician Decision|0|||
129892059|NCT01256476|467565303|FG001|Overall Study|Physician Decision|1|||
129892060|NCT01256476|467565302|FG000|Overall Study|Subject non-compliance|0|||
129892061|NCT01256476|467565303|FG001|Overall Study|Subject non-compliance|1|||
129892062|NCT01256476|467565302|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
129892063|NCT01256476|467565303|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
129892064|NCT00163215|467565304|FG000|Overall Study|Lack of Efficacy|3|||
129892065|NCT00163215|467565304|FG000|Overall Study|Withdrawal by Subject|5|||
129892066|NCT00163215|467565304|FG000|Overall Study|Other|7|||
129892067|NCT05406791|467565309|FG000|Overall Study|Lost to Follow-up|13|||
129892068|NCT05406791|467565310|FG001|Overall Study|Lost to Follow-up|10|||
129892069|NCT01789203|467565311|FG000|Overall Study|Adverse Event|2|||
129892070|NCT01789203|467565312|FG001|Overall Study|Adverse Event|2|||
129892071|NCT01789203|467565311|FG000|Overall Study|Withdrawal by Subject|1|||
129892072|NCT01789203|467565312|FG001|Overall Study|Withdrawal by Subject|0|||
129892073|NCT01789203|467565311|FG000|Overall Study|Death|1|||
130054565|NCT01259856|468154580|FG000|Overall Study|Withdrawal by Subject|9|||
129892074|NCT01789203|467565312|FG001|Overall Study|Death|0|||
129892075|NCT01789203|467565311|FG000|Overall Study|Protocol Violation|2|||
129892076|NCT01789203|467565312|FG001|Overall Study|Protocol Violation|1|||
130054566|NCT01259856|468154581|FG001|Overall Study|Withdrawal by Subject|10|||
130054567|NCT01259856|468154580|FG000|Overall Study|Treatment never started|0|||
130054568|NCT01259856|468154581|FG001|Overall Study|Treatment never started|6|||
129892077|NCT01789203|467565311|FG000|Overall Study|Other|1|||
129892078|NCT01789203|467565312|FG001|Overall Study|Other|1|||
129892079|NCT01789203|467565311|FG000|Overall Study|patient non-adherent|2|||
129892080|NCT01789203|467565312|FG001|Overall Study|patient non-adherent|0|||
129892081|NCT00354029|467565315|FG000|Overall Study|Protocol Violation|4|||
129892082|NCT00354029|467565316|FG001|Overall Study|Protocol Violation|2|||
129892083|NCT00826280|467565317|FG000|Overall Study|Randomized but drug not received|1|||
129892084|NCT00826280|467565318|FG001|Overall Study|Randomized but drug not received|0|||
129892085|NCT00826280|467565319|FG002|Overall Study|Randomized but drug not received|1|||
129892086|NCT00826280|467565317|FG000|Overall Study|Adverse Event|1|||
129892087|NCT00826280|467565318|FG001|Overall Study|Adverse Event|3|||
129892088|NCT00826280|467565319|FG002|Overall Study|Adverse Event|0|||
129892089|NCT00826280|467565317|FG000|Overall Study|Lost to Follow-up|0|||
129892090|NCT00826280|467565318|FG001|Overall Study|Lost to Follow-up|1|||
129892091|NCT00826280|467565319|FG002|Overall Study|Lost to Follow-up|0|||
129892092|NCT00826280|467565317|FG000|Overall Study|Sponsor discontinued subject or study|1|||
129892093|NCT00826280|467565318|FG001|Overall Study|Sponsor discontinued subject or study|0|||
129892094|NCT00826280|467565319|FG002|Overall Study|Sponsor discontinued subject or study|0|||
129892095|NCT00826280|467565317|FG000|Overall Study|Reversible ischemic defect not present|43|||
129892096|NCT00826280|467565318|FG001|Overall Study|Reversible ischemic defect not present|40|||
129892097|NCT00826280|467565319|FG002|Overall Study|Reversible ischemic defect not present|44|||
129892098|NCT00826280|467565317|FG000|Overall Study|Interpretation Failure|1|||
129892099|NCT00826280|467565318|FG001|Overall Study|Interpretation Failure|0|||
129892100|NCT00826280|467565319|FG002|Overall Study|Interpretation Failure|0|||
129892101|NCT00826280|467565317|FG000|Overall Study|Machine Failure|1|||
129892102|NCT00826280|467565318|FG001|Overall Study|Machine Failure|1|||
129892103|NCT00826280|467565319|FG002|Overall Study|Machine Failure|0|||
129892104|NCT00826280|467565317|FG000|Overall Study|One or more non-interpretable scan|0|||
129892105|NCT00826280|467565318|FG001|Overall Study|One or more non-interpretable scan|1|||
129892106|NCT00826280|467565319|FG002|Overall Study|One or more non-interpretable scan|1|||
129892107|NCT03201757|467565320|FG000|Overall Study|Withdrawal by Subject|133|||
129892108|NCT03201757|467565320|FG000|Overall Study|Adverse Event|44|||
129892109|NCT03201757|467565320|FG000|Overall Study|Lost to Follow-up|37|||
129892110|NCT03201757|467565320|FG000|Overall Study|Pregnancy|2|||
129892111|NCT03201757|467565320|FG000|Overall Study|Lack of Efficacy|1|||
129892112|NCT03201757|467565320|FG000|Overall Study|Protocol Violation|20|||
129892113|NCT03201757|467565320|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
129892114|NCT03201757|467565320|FG000|Overall Study|Not Yet Determined|5|||
129892115|NCT03201757|467565320|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
129892116|NCT03201757|467565320|FG000|Overall Study|Other|20|||
129892117|NCT02297503|467565321|FG000|Overall Study|Withdrawal by Subject|1|||
129892118|NCT02297503|467565322|FG001|Overall Study|Withdrawal by Subject|1|||
129892119|NCT02297503|467565321|FG000|Overall Study|Protocol Violation|1|||
129892120|NCT02297503|467565322|FG001|Overall Study|Protocol Violation|0|||
129892121|NCT02297503|467565321|FG000|Overall Study|Pregnancy|0|||
129892122|NCT02297503|467565322|FG001|Overall Study|Pregnancy|1|||
129892123|NCT02297503|467565321|FG000|Overall Study|Lost to Follow-up|0|||
129892124|NCT02297503|467565322|FG001|Overall Study|Lost to Follow-up|1|||
129892125|NCT02297503|467565321|FG000|Overall Study|Medical reason|0|||
129892126|NCT02297503|467565322|FG001|Overall Study|Medical reason|1|||
129892127|NCT02788656|467565324|FG000|Overall Study|Withdrawal by Subject|1|||
129892128|NCT02788656|467565325|FG001|Overall Study|Withdrawal by Subject|0|||
129892129|NCT02263885|467565326|FG000|Overall Study|Withdrawal by Subject|7|||
129892130|NCT02263885|467565326|FG000|Overall Study|Alternative Treatment|3|||
129892131|NCT01403987|467565334|FG000|Overall Study|Residents forgot their secret PIN|18|||
129892132|NCT01403987|467565335|FG001|Overall Study|Residents forgot their secret PIN|17|||
129892133|NCT01403987|467565336|FG002|Overall Study|Residents forgot their secret PIN|18|||
129892134|NCT00180674|467565338|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
129892135|NCT00180674|467565338|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
129892136|NCT01106976|467565339|FG000|Overall Study|Lost to Follow-up|8|||
129892137|NCT03836664|467565343|FG000|Overall Study|Didn't complete forms and lost drug|3|||
129892138|NCT03836664|467565344|FG001|Overall Study|Didn't complete forms and lost drug|3|||
129892139|NCT01427907|467565345|FG000|Overall Study|Withdrawal by Subject|3|||
129892140|NCT01427907|467565346|FG001|Overall Study|Withdrawal by Subject|4|||
129892141|NCT02179918|467565347|FG000|Overall Study|Death|0|||
129892142|NCT02179918|467565348|FG001|Overall Study|Death|0|||
129892143|NCT02179918|467565349|FG002|Overall Study|Death|0|||
129892144|NCT02179918|467565350|FG003|Overall Study|Death|1|||
129892145|NCT02179918|467565351|FG004|Overall Study|Death|0|||
129892146|NCT02179918|467565347|FG000|Overall Study|Lost to Follow-up|0|||
129892147|NCT02179918|467565348|FG001|Overall Study|Lost to Follow-up|0|||
129892148|NCT02179918|467565349|FG002|Overall Study|Lost to Follow-up|1|||
129892149|NCT02179918|467565350|FG003|Overall Study|Lost to Follow-up|0|||
130054569|NCT01259856|468154580|FG000|Overall Study|Study closure by sponsor|40|||
129892150|NCT02179918|467565351|FG004|Overall Study|Lost to Follow-up|0|||
129892151|NCT02179918|467565347|FG000|Overall Study|Progressive Disease|4|||
129892152|NCT02179918|467565348|FG001|Overall Study|Progressive Disease|1|||
129892153|NCT02179918|467565349|FG002|Overall Study|Progressive Disease|1|||
130054570|NCT01259856|468154581|FG001|Overall Study|Study closure by sponsor|41|||
130054571|NCT01259856|468154580|FG000|Overall Study|Patient developed other disease|0|||
130054572|NCT01259856|468154581|FG001|Overall Study|Patient developed other disease|1|||
130054573|NCT01259856|468154580|FG000|Overall Study|Transfer to another study|0|||
130054574|NCT01259856|468154581|FG001|Overall Study|Transfer to another study|1|||
130054575|NCT01259856|468154580|FG000|Overall Study|Unknown/missing|2|||
130054576|NCT01259856|468154581|FG001|Overall Study|Unknown/missing|2|||
130054577|NCT00788775|468154582|FG000|Overall Study|Progressive Disease|8|||
130054578|NCT00788775|468154583|FG001|Overall Study|Progressive Disease|6|||
130054579|NCT00788775|468154582|FG000|Overall Study|Withdrawal by Subject|0|||
129892154|NCT02179918|467565350|FG003|Overall Study|Progressive Disease|2|||
129892155|NCT02179918|467565351|FG004|Overall Study|Progressive Disease|6|||
129892156|NCT02179918|467565347|FG000|Overall Study|Other|0|||
129892157|NCT02179918|467565348|FG001|Overall Study|Other|1|||
129892158|NCT02179918|467565349|FG002|Overall Study|Other|0|||
129892159|NCT02179918|467565350|FG003|Overall Study|Other|0|||
129892160|NCT02179918|467565351|FG004|Overall Study|Other|1|||
129892161|NCT02179918|467565347|FG000|Overall Study|Subject refused further follow-up|0|||
129892162|NCT02179918|467565348|FG001|Overall Study|Subject refused further follow-up|1|||
129892163|NCT02179918|467565349|FG002|Overall Study|Subject refused further follow-up|0|||
129892164|NCT02179918|467565350|FG003|Overall Study|Subject refused further follow-up|0|||
129892165|NCT02179918|467565351|FG004|Overall Study|Subject refused further follow-up|1|||
129892166|NCT00972543|467565356|FG000|Overall Study|Adverse Event|1|||
129892167|NCT00972543|467565357|FG001|Overall Study|Adverse Event|0|||
129892168|NCT00972543|467565356|FG000|Overall Study|Early study termination by sponsor|4|||
129892169|NCT00972543|467565357|FG001|Overall Study|Early study termination by sponsor|1|||
129892170|NCT04537949|467565360|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
129892171|NCT04537949|467565361|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
129892172|NCT04537949|467565362|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
129892173|NCT04537949|467565363|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
130054580|NCT00788775|468154583|FG001|Overall Study|Withdrawal by Subject|2|||
130054581|NCT00788775|468154582|FG000|Overall Study|Patient Non-Compliance|1|||
129892174|NCT04537949|467565364|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
129892175|NCT04537949|467565365|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
129892176|NCT04537949|467565366|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
130054582|NCT00788775|468154583|FG001|Overall Study|Patient Non-Compliance|0|||
130054583|NCT00788775|468154582|FG000|Overall Study|Patient's measurable disease resected.|1|||
130054584|NCT00788775|468154583|FG001|Overall Study|Patient's measurable disease resected.|0|||
130054585|NCT00578864|468154584|FG000|Overall Study|Death|1|||
130054586|NCT00578864|468154585|FG001|Overall Study|Death|0|||
130054587|NCT01253044|468154590|FG000|Overall Study|Lost to Follow-up|38|||
130054588|NCT01253044|468154591|FG001|Overall Study|Lost to Follow-up|29|||
130054589|NCT01087528|468154592|FG000|Overall Study|Withdrawal by Subject|1|||
130054590|NCT01087528|468154592|FG000|Overall Study|Incomplete CE procedure|6|||
130054591|NCT00905307|468154595|FG000|Overall Study|Switched to Open Label Rescue|7|||
130111411|NCT03341273|468369454|FG000|Overall Study|Lost to Follow-up|7|||
129892177|NCT04537949|467565367|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
130054592|NCT00905307|468154596|FG001|Overall Study|Switched to Open Label Rescue|17|||
130054593|NCT00905307|468154597|FG002|Overall Study|Switched to Open Label Rescue|11|||
130054594|NCT00905307|468154598|FG003|Overall Study|Switched to Open Label Rescue|11|||
130111412|NCT03341273|468369455|FG001|Overall Study|Lost to Follow-up|7|||
130111413|NCT03341273|468369454|FG000|Overall Study|Withdrawal by Subject|4|||
129892178|NCT04537949|467565360|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
130111414|NCT03341273|468369455|FG001|Overall Study|Withdrawal by Subject|2|||
130111415|NCT03341273|468369454|FG000|Overall Study|Physician Decision|1|||
130111416|NCT03341273|468369455|FG001|Overall Study|Physician Decision|0|||
129892179|NCT04537949|467565361|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
129892180|NCT04537949|467565362|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
129892181|NCT04537949|467565363|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
129892182|NCT04537949|467565364|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
129892183|NCT04537949|467565365|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
129892184|NCT04537949|467565366|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
129892185|NCT04537949|467565367|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
129892186|NCT04537949|467565360|FG000|Follow-up Phase|Lost to Follow-up|0|||
129892187|NCT04537949|467565361|FG001|Follow-up Phase|Lost to Follow-up|3|||
129892188|NCT04537949|467565362|FG002|Follow-up Phase|Lost to Follow-up|0|||
129892189|NCT04537949|467565363|FG003|Follow-up Phase|Lost to Follow-up|0|||
129892190|NCT04537949|467565364|FG004|Follow-up Phase|Lost to Follow-up|0|||
129892191|NCT04537949|467565365|FG005|Follow-up Phase|Lost to Follow-up|0|||
129892192|NCT04537949|467565366|FG006|Follow-up Phase|Lost to Follow-up|0|||
129892193|NCT04537949|467565367|FG007|Follow-up Phase|Lost to Follow-up|0|||
129892194|NCT04537949|467565360|FG000|Follow-up Phase|personal reasons|0|||
129892195|NCT04537949|467565361|FG001|Follow-up Phase|personal reasons|0|||
129892196|NCT04537949|467565362|FG002|Follow-up Phase|personal reasons|0|||
129892197|NCT04537949|467565363|FG003|Follow-up Phase|personal reasons|1|||
129892198|NCT04537949|467565364|FG004|Follow-up Phase|personal reasons|1|||
129892199|NCT04537949|467565365|FG005|Follow-up Phase|personal reasons|0|||
129892200|NCT04537949|467565366|FG006|Follow-up Phase|personal reasons|0|||
129892201|NCT04537949|467565367|FG007|Follow-up Phase|personal reasons|0|||
129892202|NCT04537949|467565360|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129892203|NCT04537949|467565361|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129892204|NCT04537949|467565362|FG002|Follow-up Phase|Withdrawal by Subject|0|||
129892205|NCT04537949|467565363|FG003|Follow-up Phase|Withdrawal by Subject|0|||
129892206|NCT04537949|467565364|FG004|Follow-up Phase|Withdrawal by Subject|1|||
129892207|NCT04537949|467565365|FG005|Follow-up Phase|Withdrawal by Subject|0|||
129892208|NCT04537949|467565366|FG006|Follow-up Phase|Withdrawal by Subject|0|||
129892209|NCT04537949|467565367|FG007|Follow-up Phase|Withdrawal by Subject|0|||
129892210|NCT04003974|467565369|FG000|Overall Study|Missing|1|||
129892211|NCT04003974|467565370|FG001|Overall Study|Missing|0|||
129892212|NCT04003974|467565369|FG000|Overall Study|Withdrawal by Subject|0|||
129892213|NCT04003974|467565370|FG001|Overall Study|Withdrawal by Subject|2|||
129892214|NCT04296942|467565371|FG000|Overall Study|Study closure by sponsor|1|||
129892215|NCT04296942|467565372|FG001|Overall Study|Study closure by sponsor|0|||
129892216|NCT04296942|467565373|FG002|Overall Study|Study closure by sponsor|0|||
129892217|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
129892218|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
130111417|NCT03341273|468369454|FG000|Overall Study|Protocol Violation|0|||
130111418|NCT03341273|468369455|FG001|Overall Study|Protocol Violation|1|||
129892219|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
129892220|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
129892221|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
129892222|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
129892223|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
129892224|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
129892225|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
129892226|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
129892227|NCT02478359|467565375|FG000|Overall Study|Disenrolled from health plan|106|||
129892228|NCT02478359|467565376|FG001|Overall Study|Disenrolled from health plan|65|||
129892229|NCT00372528|467565377|FG000|Overall Study|Lack of Efficacy|1|||
129892230|NCT00372528|467565377|FG000|Overall Study|Adverse Event|1|||
129892231|NCT00372528|467565377|FG000|Overall Study|Study Terminated by Sponsor|18|||
129892232|NCT00372528|467565377|FG000|Overall Study|Other|1|||
129892233|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
129892234|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
129892235|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
129892236|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
129892237|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
129892238|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
129892239|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
129892240|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
129892241|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
129892242|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
129892243|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
129892244|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
129892245|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
129892246|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
129892247|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
129892248|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
129892249|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
129892250|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
129892251|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
129892252|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
129892253|NCT02240680|467565378|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
129892254|NCT02240680|467565379|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
129892255|NCT02240680|467565380|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
129892256|NCT02240680|467565381|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
129892257|NCT02240680|467565378|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
129892258|NCT02240680|467565379|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
129892259|NCT02240680|467565380|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
129892260|NCT02240680|467565381|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
129892261|NCT02240680|467565378|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
129892262|NCT02240680|467565379|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
129892263|NCT02240680|467565380|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
129892264|NCT02240680|467565381|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
129892265|NCT00562965|467565382|FG000|Overall Study|Withdrawal by Subject|0|||
129892266|NCT00562965|467565383|FG001|Overall Study|Withdrawal by Subject|1|||
129892267|NCT00562965|467565382|FG000|Overall Study|Death|2|||
129892268|NCT00562965|467565383|FG001|Overall Study|Death|4|||
129892269|NCT00562965|467565382|FG000|Overall Study|Lost to Follow-up|1|||
129892270|NCT00562965|467565383|FG001|Overall Study|Lost to Follow-up|0|||
129892271|NCT00562965|467565382|FG000|Overall Study|Other|0|||
129892272|NCT00562965|467565383|FG001|Overall Study|Other|1|||
129892273|NCT00965484|467565387|FG000|Overall Study|Protocol Violation|1|||
129892274|NCT00965484|467565387|FG000|Overall Study|Withdrawal by Subject|1|||
129892275|NCT00848211|467565388|FG000|Overall Study|Protocol Violation|0|||
129892276|NCT00848211|467565389|FG001|Overall Study|Protocol Violation|1|||
129892277|NCT00848211|467565390|FG002|Overall Study|Protocol Violation|1|||
129892278|NCT00848211|467565391|FG003|Overall Study|Protocol Violation|0|||
129892279|NCT00848211|467565388|FG000|Overall Study|Adverse Event|0|||
129892280|NCT00848211|467565389|FG001|Overall Study|Adverse Event|0|||
129892281|NCT00848211|467565390|FG002|Overall Study|Adverse Event|0|||
129892282|NCT00848211|467565391|FG003|Overall Study|Adverse Event|0|||
129892283|NCT01124617|467565392|FG000|Overall Study|Adverse Event|5|||
129892284|NCT01124617|467565393|FG001|Overall Study|Adverse Event|2|||
129892285|NCT01124617|467565392|FG000|Overall Study|Lack of Efficacy|2|||
129892286|NCT01124617|467565393|FG001|Overall Study|Lack of Efficacy|1|||
129892287|NCT01124617|467565392|FG000|Overall Study|Protocol Violation|1|||
129892288|NCT01124617|467565393|FG001|Overall Study|Protocol Violation|1|||
129892289|NCT01124617|467565392|FG000|Overall Study|Withdrawal by Subject|9|||
129892290|NCT01124617|467565393|FG001|Overall Study|Withdrawal by Subject|1|||
129892291|NCT01124617|467565392|FG000|Overall Study|Other|2|||
129892292|NCT01124617|467565393|FG001|Overall Study|Other|1|||
129892293|NCT00945477|467565394|FG000|Overall Study|Adverse Event|3|||
129892294|NCT00945477|467565394|FG000|Overall Study|Lack of Efficacy|2|||
129892295|NCT00945477|467565394|FG000|Overall Study|Withdrawal by Subject|1|||
129892296|NCT00619151|467565395|FG000|Overall Study|Study terminated prior to followup|1|||
129892297|NCT00619151|467565396|FG001|Overall Study|Study terminated prior to followup|0|||
129892298|NCT02825043|467565397|FG000|Overall Study|Lost to Follow-up|4|||
129892299|NCT03582137|467565400|FG000|Overall Study|Adverse Event|1|||
129892300|NCT03582137|467565401|FG001|Overall Study|Adverse Event|0|||
129892301|NCT01982760|467565402|FG000|Overall Study|Physician Decision|1|||
129892302|NCT01982760|467565403|FG001|Overall Study|Physician Decision|0|||
129892303|NCT03704298|467565405|FG000|Overall Study|Death|3|||
129892304|NCT03704298|467565406|FG001|Overall Study|Death|1|||
129892305|NCT03704298|467565407|FG002|Overall Study|Death|1|||
129892306|NCT03704298|467565408|FG003|Overall Study|Death|0|||
129892307|NCT03704298|467565405|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
129892308|NCT03704298|467565406|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
129892309|NCT03704298|467565407|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
129892310|NCT03704298|467565408|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
129892311|NCT03704298|467565405|FG000|Overall Study|Withdrawal by Subject|1|||
129892312|NCT03704298|467565406|FG001|Overall Study|Withdrawal by Subject|0|||
129892313|NCT03704298|467565407|FG002|Overall Study|Withdrawal by Subject|0|||
129892314|NCT03704298|467565408|FG003|Overall Study|Withdrawal by Subject|0|||
129892315|NCT03704298|467565405|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
129892316|NCT03704298|467565406|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
129892317|NCT03704298|467565407|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
129892318|NCT03704298|467565408|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
129892319|NCT02303574|467565411|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892320|NCT02303574|467565412|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892321|NCT02303574|467565413|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
129892322|NCT02303574|467565414|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892323|NCT02303574|467565415|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130054595|NCT00905307|468154599|FG004|Overall Study|Switched to Open Label Rescue|4|||
130054596|NCT00905307|468154600|FG005|Overall Study|Switched to Open Label Rescue|15|||
130054597|NCT00905307|468154595|FG000|Overall Study|Lost to Follow-up|0|||
130054598|NCT00905307|468154596|FG001|Overall Study|Lost to Follow-up|0|||
130054599|NCT00905307|468154597|FG002|Overall Study|Lost to Follow-up|0|||
130054600|NCT00905307|468154598|FG003|Overall Study|Lost to Follow-up|0|||
130054601|NCT00905307|468154599|FG004|Overall Study|Lost to Follow-up|1|||
130054602|NCT00905307|468154600|FG005|Overall Study|Lost to Follow-up|1|||
130054603|NCT00905307|468154595|FG000|Overall Study|Adverse Event|3|||
130111419|NCT03341273|468369454|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
130111420|NCT03341273|468369455|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
130054604|NCT00905307|468154596|FG001|Overall Study|Adverse Event|4|||
130054605|NCT00905307|468154597|FG002|Overall Study|Adverse Event|5|||
130054606|NCT00905307|468154598|FG003|Overall Study|Adverse Event|11|||
130054607|NCT00905307|468154599|FG004|Overall Study|Adverse Event|3|||
130054608|NCT00905307|468154600|FG005|Overall Study|Adverse Event|5|||
130054609|NCT00905307|468154595|FG000|Overall Study|Withdrawal by Subject|5|||
130054610|NCT00905307|468154596|FG001|Overall Study|Withdrawal by Subject|13|||
130054611|NCT00905307|468154597|FG002|Overall Study|Withdrawal by Subject|15|||
130054612|NCT00905307|468154598|FG003|Overall Study|Withdrawal by Subject|11|||
130054613|NCT00905307|468154599|FG004|Overall Study|Withdrawal by Subject|4|||
130054614|NCT00905307|468154600|FG005|Overall Study|Withdrawal by Subject|13|||
130054615|NCT00905307|468154595|FG000|Overall Study|Protocol Violation|1|||
130054616|NCT00905307|468154596|FG001|Overall Study|Protocol Violation|0|||
130054617|NCT00905307|468154597|FG002|Overall Study|Protocol Violation|1|||
130054618|NCT00905307|468154598|FG003|Overall Study|Protocol Violation|0|||
130054619|NCT00905307|468154599|FG004|Overall Study|Protocol Violation|0|||
130054620|NCT00905307|468154600|FG005|Overall Study|Protocol Violation|0|||
130054621|NCT00905307|468154595|FG000|Overall Study|Lack of Efficacy|6|||
130111421|NCT03341273|468369454|FG000|Overall Study|Became ineligible after enrollment|1|||
130054622|NCT00905307|468154596|FG001|Overall Study|Lack of Efficacy|3|||
129892324|NCT02303574|467565416|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892325|NCT02303574|467565417|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892326|NCT02303574|467565418|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892327|NCT02303574|467565419|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892328|NCT02303574|467565420|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
130054623|NCT00905307|468154597|FG002|Overall Study|Lack of Efficacy|5|||
130054624|NCT00905307|468154598|FG003|Overall Study|Lack of Efficacy|4|||
130054625|NCT00905307|468154599|FG004|Overall Study|Lack of Efficacy|4|||
130054626|NCT00905307|468154600|FG005|Overall Study|Lack of Efficacy|8|||
130054627|NCT04060667|468154601|FG000|Overall Study|Lost to Follow-up|75|||
130054628|NCT04060667|468154602|FG001|Overall Study|Lost to Follow-up|10|||
130054629|NCT02702193|468154603|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
130054630|NCT02702193|468154604|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
130054631|NCT02702193|468154603|FG000|4 Month Follow up|Withdrawal by Subject|1|||
130054632|NCT02702193|468154604|FG001|4 Month Follow up|Withdrawal by Subject|0|||
130054633|NCT02702193|468154603|FG000|4 Month Follow up|Lost to Follow-up|17|||
130054634|NCT02702193|468154604|FG001|4 Month Follow up|Lost to Follow-up|18|||
130054635|NCT02702193|468154603|FG000|8 Month Follow up|Withdrawal by Subject|1|||
130054636|NCT02702193|468154604|FG001|8 Month Follow up|Withdrawal by Subject|0|||
130054637|NCT02702193|468154603|FG000|8 Month Follow up|Lost to Follow-up|14|||
130054638|NCT02702193|468154604|FG001|8 Month Follow up|Lost to Follow-up|18|||
130054639|NCT02702193|468154603|FG000|12 Month Follow up|Withdrawal by Subject|1|||
130054640|NCT02702193|468154604|FG001|12 Month Follow up|Withdrawal by Subject|0|||
130054641|NCT02702193|468154603|FG000|12 Month Follow up|Lost to Follow-up|16|||
130054642|NCT02702193|468154604|FG001|12 Month Follow up|Lost to Follow-up|18|||
130054643|NCT01035255|468154605|FG000|Overall Study|Death|724|||
130054644|NCT01035255|468154606|FG001|Overall Study|Death|844|||
130054645|NCT01035255|468154605|FG000|Overall Study|Lost to Follow-up|2|||
130054646|NCT01035255|468154606|FG001|Overall Study|Lost to Follow-up|5|||
130054647|NCT01035255|468154605|FG000|Overall Study|patient's request|15|||
130054648|NCT01035255|468154606|FG001|Overall Study|patient's request|13|||
130054649|NCT00740779|468154608|FG000|Overall Study|Adverse Event|4|||
130054650|NCT00740779|468154609|FG001|Overall Study|Adverse Event|6|||
130054651|NCT00740779|468154610|FG002|Overall Study|Adverse Event|3|||
130054652|NCT00740779|468154608|FG000|Overall Study|Protocol Violation|1|||
130054653|NCT00740779|468154609|FG001|Overall Study|Protocol Violation|1|||
130054654|NCT00740779|468154610|FG002|Overall Study|Protocol Violation|1|||
130054655|NCT00740779|468154608|FG000|Overall Study|Lack of Efficacy|0|||
129892329|NCT02303574|467565411|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892330|NCT02303574|467565412|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892331|NCT02303574|467565413|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892332|NCT02303574|467565414|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130054656|NCT00740779|468154609|FG001|Overall Study|Lack of Efficacy|0|||
129892333|NCT02303574|467565415|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130054657|NCT00740779|468154610|FG002|Overall Study|Lack of Efficacy|2|||
130054658|NCT00740779|468154608|FG000|Overall Study|Withdrawal by Subject|2|||
130054659|NCT00740779|468154609|FG001|Overall Study|Withdrawal by Subject|4|||
130111422|NCT03341273|468369455|FG001|Overall Study|Became ineligible after enrollment|0|||
129892334|NCT02303574|467565416|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
130111423|NCT03341273|468369454|FG000|Overall Study|Not Eligible at Enrollment|0|||
130111424|NCT03341273|468369455|FG001|Overall Study|Not Eligible at Enrollment|1|||
129892335|NCT02303574|467565417|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892336|NCT02303574|467565418|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
129892337|NCT02303574|467565419|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892338|NCT02303574|467565420|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892339|NCT00859014|467565421|FG000|Overall Study|Death|4|||
129892340|NCT00859014|467565421|FG000|Overall Study|Lost to Follow-up|1|||
129892341|NCT04796935|467565422|FG000|Overall Study|Withdrawal by Subject|0|||
129892342|NCT04796935|467565423|FG001|Overall Study|Withdrawal by Subject|1|||
129892343|NCT04796935|467565422|FG000|Overall Study|Physician Decision|0|||
129892344|NCT04796935|467565423|FG001|Overall Study|Physician Decision|1|||
129892345|NCT04796935|467565422|FG000|Overall Study|Device not available|1|||
129892346|NCT04796935|467565423|FG001|Overall Study|Device not available|0|||
129892347|NCT04796935|467565422|FG000|Overall Study|Trained provider not available|1|||
129892348|NCT04796935|467565423|FG001|Overall Study|Trained provider not available|0|||
129892349|NCT00783718|467565424|FG000|Induction Phase|Adverse Event|4|||
129892350|NCT00783718|467565425|FG001|Induction Phase|Adverse Event|0|||
129892351|NCT00783718|467565426|FG002|Induction Phase|Adverse Event|7|||
129892352|NCT00783718|467565427|FG003|Induction Phase|Adverse Event|0|||
129892353|NCT00783718|467565428|FG004|Induction Phase|Adverse Event|0|||
129892354|NCT00783718|467565429|FG005|Induction Phase|Adverse Event|0|||
129892355|NCT00783718|467565430|FG006|Induction Phase|Adverse Event|0|||
129892356|NCT00783718|467565424|FG000|Induction Phase|Protocol Violation|1|||
129892357|NCT00783718|467565425|FG001|Induction Phase|Protocol Violation|1|||
129892358|NCT00783718|467565426|FG002|Induction Phase|Protocol Violation|6|||
129892359|NCT00783718|467565427|FG003|Induction Phase|Protocol Violation|0|||
129892360|NCT00783718|467565428|FG004|Induction Phase|Protocol Violation|0|||
129892361|NCT00783718|467565429|FG005|Induction Phase|Protocol Violation|0|||
129892362|NCT00783718|467565430|FG006|Induction Phase|Protocol Violation|0|||
129892363|NCT00783718|467565424|FG000|Induction Phase|Lack of Efficacy|5|||
129892364|NCT00783718|467565425|FG001|Induction Phase|Lack of Efficacy|2|||
129892365|NCT00783718|467565426|FG002|Induction Phase|Lack of Efficacy|14|||
129892366|NCT00783718|467565427|FG003|Induction Phase|Lack of Efficacy|0|||
129892367|NCT00783718|467565428|FG004|Induction Phase|Lack of Efficacy|0|||
129892368|NCT00783718|467565429|FG005|Induction Phase|Lack of Efficacy|0|||
130054660|NCT00740779|468154610|FG002|Overall Study|Withdrawal by Subject|2|||
130054661|NCT00740779|468154608|FG000|Overall Study|Lost to Follow-up|2|||
130054662|NCT00740779|468154609|FG001|Overall Study|Lost to Follow-up|3|||
130054663|NCT00740779|468154610|FG002|Overall Study|Lost to Follow-up|5|||
130054664|NCT02399813|468154613|FG000|Overall Study|Progressive Disease-Radiographic|2|||
130054665|NCT02399813|468154613|FG000|Overall Study|Death|20|||
130054666|NCT02399813|468154613|FG000|Overall Study|Withdrawal by Subject|3|||
130054667|NCT02399813|468154613|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
130054668|NCT02399813|468154613|FG000|Overall Study|Lost to Follow-up|2|||
130054669|NCT02399813|468154613|FG000|Overall Study|Other than specified|5|||
130054670|NCT00988559|468154614|FG000|Overall Study|Withdrawal by Subject|1|||
130054671|NCT00988559|468154615|FG001|Overall Study|Withdrawal by Subject|1|||
130054672|NCT00988559|468154616|FG002|Overall Study|Withdrawal by Subject|0|||
130054673|NCT00988559|468154617|FG003|Overall Study|Withdrawal by Subject|1|||
130054674|NCT00988559|468154614|FG000|Overall Study|Pregnancy|0|||
130054675|NCT00988559|468154615|FG001|Overall Study|Pregnancy|1|||
130054676|NCT00988559|468154616|FG002|Overall Study|Pregnancy|1|||
130054677|NCT00988559|468154617|FG003|Overall Study|Pregnancy|0|||
130054678|NCT00988559|468154614|FG000|Overall Study|Lost to Follow-up|0|||
130054679|NCT00988559|468154615|FG001|Overall Study|Lost to Follow-up|0|||
130054680|NCT00988559|468154616|FG002|Overall Study|Lost to Follow-up|1|||
130054681|NCT00988559|468154617|FG003|Overall Study|Lost to Follow-up|0|||
130054682|NCT03007953|468154618|FG000|Overall Study|Withdrawal by Subject|5|||
130054683|NCT03007953|468154619|FG001|Overall Study|Withdrawal by Subject|2|||
130054684|NCT03007953|468154618|FG000|Overall Study|Death|5|||
130054685|NCT03007953|468154619|FG001|Overall Study|Death|7|||
130054686|NCT03007953|468154618|FG000|Overall Study|Lost to Follow-up|3|||
130054687|NCT03007953|468154619|FG001|Overall Study|Lost to Follow-up|2|||
130054688|NCT03007953|468154618|FG000|Overall Study|Enrolled in Hospice|3|||
130054689|NCT03007953|468154619|FG001|Overall Study|Enrolled in Hospice|2|||
130054690|NCT03196297|468154620|FG000|Main Period|Withdrawal by Subject|4|||
130054691|NCT03196297|468154620|FG000|Extension Period|Withdrawal by Subject|1|||
130054692|NCT03196297|468154620|FG000|Extension Period|Lack of Efficacy|2|||
130054693|NCT03345836|468154621|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
130054694|NCT03345836|468154622|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
130054695|NCT03345836|468154623|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
130054696|NCT03345836|468154624|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
130054697|NCT03345836|468154625|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
130054698|NCT03345836|468154626|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
130054699|NCT03345836|468154621|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
130054700|NCT03345836|468154622|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
130054701|NCT03345836|468154623|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
130054702|NCT03345836|468154624|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
130054703|NCT03345836|468154625|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
130054704|NCT03345836|468154626|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
130054705|NCT03345836|468154621|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130054706|NCT03345836|468154622|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
130054707|NCT03345836|468154623|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130054708|NCT03345836|468154624|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130054709|NCT03345836|468154625|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130054710|NCT03345836|468154626|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
130054711|NCT03345836|468154621|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
130054712|NCT03345836|468154622|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
130054713|NCT03345836|468154623|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130054714|NCT03345836|468154624|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130054715|NCT03345836|468154625|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130054716|NCT03345836|468154626|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
130054717|NCT03345836|468154621|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
130054718|NCT03345836|468154622|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
130054719|NCT03345836|468154623|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
130054720|NCT03345836|468154624|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
130054721|NCT03345836|468154625|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
130054722|NCT03345836|468154626|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
129892369|NCT00783718|467565430|FG006|Induction Phase|Lack of Efficacy|0|||
130054723|NCT03345836|468154621|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130054724|NCT03345836|468154622|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130054725|NCT03345836|468154623|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130054726|NCT03345836|468154624|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
129892370|NCT00783718|467565424|FG000|Induction Phase|Withdrawal by Subject|3|||
129892371|NCT00783718|467565425|FG001|Induction Phase|Withdrawal by Subject|4|||
129892372|NCT00783718|467565426|FG002|Induction Phase|Withdrawal by Subject|8|||
129892373|NCT00783718|467565427|FG003|Induction Phase|Withdrawal by Subject|0|||
129892374|NCT00783718|467565428|FG004|Induction Phase|Withdrawal by Subject|0|||
129892375|NCT00783718|467565429|FG005|Induction Phase|Withdrawal by Subject|0|||
129892376|NCT00783718|467565430|FG006|Induction Phase|Withdrawal by Subject|0|||
129892377|NCT00783718|467565424|FG000|Induction Phase|Lost to Follow-up|1|||
129892378|NCT00783718|467565425|FG001|Induction Phase|Lost to Follow-up|0|||
129892379|NCT00783718|467565426|FG002|Induction Phase|Lost to Follow-up|1|||
129892380|NCT00783718|467565427|FG003|Induction Phase|Lost to Follow-up|0|||
129892381|NCT00783718|467565428|FG004|Induction Phase|Lost to Follow-up|0|||
129892382|NCT00783718|467565429|FG005|Induction Phase|Lost to Follow-up|0|||
129892383|NCT00783718|467565430|FG006|Induction Phase|Lost to Follow-up|0|||
129892384|NCT00783718|467565424|FG000|Maintenance Phase|Adverse Event|12|||
129892385|NCT00783718|467565425|FG001|Maintenance Phase|Adverse Event|0|||
129892386|NCT00783718|467565426|FG002|Maintenance Phase|Adverse Event|0|||
129892387|NCT00783718|467565427|FG003|Maintenance Phase|Adverse Event|15|||
129892388|NCT00783718|467565428|FG004|Maintenance Phase|Adverse Event|7|||
129892389|NCT00783718|467565429|FG005|Maintenance Phase|Adverse Event|6|||
129892390|NCT00783718|467565430|FG006|Maintenance Phase|Adverse Event|16|||
129892391|NCT00783718|467565424|FG000|Maintenance Phase|Protocol Violation|1|||
129892392|NCT00783718|467565425|FG001|Maintenance Phase|Protocol Violation|0|||
129892393|NCT00783718|467565426|FG002|Maintenance Phase|Protocol Violation|0|||
129892394|NCT00783718|467565427|FG003|Maintenance Phase|Protocol Violation|0|||
129892395|NCT00783718|467565428|FG004|Maintenance Phase|Protocol Violation|0|||
129892396|NCT00783718|467565429|FG005|Maintenance Phase|Protocol Violation|0|||
129892397|NCT00783718|467565430|FG006|Maintenance Phase|Protocol Violation|2|||
129892398|NCT00783718|467565424|FG000|Maintenance Phase|Lack of Efficacy|83|||
129892399|NCT00783718|467565425|FG001|Maintenance Phase|Lack of Efficacy|0|||
129892400|NCT00783718|467565426|FG002|Maintenance Phase|Lack of Efficacy|0|||
129892401|NCT00783718|467565427|FG003|Maintenance Phase|Lack of Efficacy|61|||
129892402|NCT00783718|467565428|FG004|Maintenance Phase|Lack of Efficacy|31|||
129892403|NCT00783718|467565429|FG005|Maintenance Phase|Lack of Efficacy|33|||
129892404|NCT00783718|467565430|FG006|Maintenance Phase|Lack of Efficacy|155|||
129892405|NCT00783718|467565424|FG000|Maintenance Phase|Withdrawal by Subject|6|||
129892406|NCT00783718|467565425|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129892407|NCT00783718|467565426|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129892408|NCT00783718|467565427|FG003|Maintenance Phase|Withdrawal by Subject|2|||
129892409|NCT00783718|467565428|FG004|Maintenance Phase|Withdrawal by Subject|5|||
129892410|NCT00783718|467565429|FG005|Maintenance Phase|Withdrawal by Subject|2|||
129892411|NCT00783718|467565430|FG006|Maintenance Phase|Withdrawal by Subject|20|||
129892412|NCT00783718|467565424|FG000|Maintenance Phase|Lost to Follow-up|3|||
129892413|NCT00783718|467565425|FG001|Maintenance Phase|Lost to Follow-up|0|||
129892414|NCT00783718|467565426|FG002|Maintenance Phase|Lost to Follow-up|0|||
130054727|NCT03345836|468154625|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
130054728|NCT03345836|468154626|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
130054729|NCT03345836|468154621|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130054730|NCT03345836|468154622|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130054731|NCT03345836|468154623|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
130054732|NCT03345836|468154624|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
129892415|NCT00783718|467565427|FG003|Maintenance Phase|Lost to Follow-up|0|||
129892416|NCT00783718|467565428|FG004|Maintenance Phase|Lost to Follow-up|2|||
129892417|NCT00783718|467565429|FG005|Maintenance Phase|Lost to Follow-up|0|||
129892418|NCT00783718|467565430|FG006|Maintenance Phase|Lost to Follow-up|2|||
129892419|NCT01027871|467565432|FG000|Overall Study|Physician Decision|1|||
129892420|NCT01027871|467565433|FG001|Overall Study|Physician Decision|5|||
129892421|NCT01027871|467565434|FG002|Overall Study|Physician Decision|0|||
129892422|NCT01027871|467565432|FG000|Overall Study|Protocol Violation|0|||
129892423|NCT01027871|467565433|FG001|Overall Study|Protocol Violation|2|||
129892424|NCT01027871|467565434|FG002|Overall Study|Protocol Violation|2|||
129892425|NCT01027871|467565432|FG000|Overall Study|Withdrawal by Subject|1|||
129892426|NCT01027871|467565433|FG001|Overall Study|Withdrawal by Subject|2|||
129892427|NCT01027871|467565434|FG002|Overall Study|Withdrawal by Subject|2|||
129892428|NCT01027871|467565432|FG000|Overall Study|Adverse Event|0|||
130054733|NCT03345836|468154625|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
130054734|NCT03345836|468154626|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
130054735|NCT03345836|468154621|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130054736|NCT03345836|468154622|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
129892429|NCT01027871|467565433|FG001|Overall Study|Adverse Event|2|||
129892430|NCT01027871|467565434|FG002|Overall Study|Adverse Event|2|||
129892431|NCT01027871|467565432|FG000|Overall Study|Sponsor Decision|0|||
129892432|NCT01027871|467565433|FG001|Overall Study|Sponsor Decision|2|||
129892433|NCT01027871|467565434|FG002|Overall Study|Sponsor Decision|0|||
129892434|NCT01027871|467565432|FG000|Overall Study|Discontinued Prior to Treatment|0|||
129892435|NCT01027871|467565433|FG001|Overall Study|Discontinued Prior to Treatment|0|||
129892436|NCT01027871|467565434|FG002|Overall Study|Discontinued Prior to Treatment|1|||
129892437|NCT04159896|467565440|FG000|Overall Study|Lack of Efficacy|7|||
129892438|NCT04159896|467565440|FG000|Overall Study|Withdrawal by Subject|1|||
129892439|NCT04159896|467565440|FG000|Overall Study|Adverse Event|1|||
129892440|NCT04159896|467565440|FG000|Overall Study|A transient ischaemic attack|1|||
129892441|NCT02084082|467565441|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
129892442|NCT02084082|467565442|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
129892443|NCT02084082|467565443|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
129892444|NCT02084082|467565444|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
129892445|NCT02084082|467565441|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129892446|NCT02084082|467565442|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129892447|NCT02084082|467565443|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129892448|NCT02084082|467565444|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
129892449|NCT05705167|467565445|FG000|Overall Study|Randomised but not Treated|0|||
129892450|NCT05705167|467565446|FG001|Overall Study|Randomised but not Treated|2|||
129892451|NCT05705167|467565447|FG002|Overall Study|Randomised but not Treated|0|||
129892452|NCT05705167|467565448|FG003|Overall Study|Randomised but not Treated|7|||
129892453|NCT05705167|467565449|FG004|Overall Study|Randomised but not Treated|0|||
129892454|NCT05705167|467565450|FG005|Overall Study|Randomised but not Treated|0|||
129892455|NCT05705167|467565451|FG006|Overall Study|Randomised but not Treated|0|||
129892456|NCT05705167|467565445|FG000|Overall Study|Death|0|||
129892457|NCT05705167|467565446|FG001|Overall Study|Death|0|||
129892458|NCT05705167|467565447|FG002|Overall Study|Death|3|||
129892459|NCT05705167|467565448|FG003|Overall Study|Death|0|||
129892460|NCT05705167|467565449|FG004|Overall Study|Death|1|||
129892461|NCT05705167|467565450|FG005|Overall Study|Death|1|||
129892462|NCT05705167|467565451|FG006|Overall Study|Death|1|||
129892463|NCT05705167|467565445|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892464|NCT05705167|467565446|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892465|NCT05705167|467565447|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
129892466|NCT05705167|467565448|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
129892467|NCT05705167|467565449|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892468|NCT05705167|467565450|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892469|NCT05705167|467565451|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
129892470|NCT04736056|467565452|FG000|Overall Study|Death|0|||
129892471|NCT04736056|467565453|FG001|Overall Study|Death|0|||
129892472|NCT04736056|467565454|FG002|Overall Study|Death|0|||
129892473|NCT04736056|467565455|FG003|Overall Study|Death|1|||
129892474|NCT04736056|467565452|FG000|Overall Study|Lost to Follow-up|1|||
129892475|NCT04736056|467565453|FG001|Overall Study|Lost to Follow-up|0|||
129892476|NCT04736056|467565454|FG002|Overall Study|Lost to Follow-up|1|||
129892477|NCT04736056|467565455|FG003|Overall Study|Lost to Follow-up|1|||
129892478|NCT04736056|467565452|FG000|Overall Study|Withdrawal by Subject|2|||
129892479|NCT04736056|467565453|FG001|Overall Study|Withdrawal by Subject|0|||
129892480|NCT04736056|467565454|FG002|Overall Study|Withdrawal by Subject|0|||
129892481|NCT04736056|467565455|FG003|Overall Study|Withdrawal by Subject|0|||
129892482|NCT04736056|467565452|FG000|Overall Study|Physician Decision|1|||
129892483|NCT04736056|467565453|FG001|Overall Study|Physician Decision|0|||
129892484|NCT04736056|467565454|FG002|Overall Study|Physician Decision|1|||
129892485|NCT04736056|467565455|FG003|Overall Study|Physician Decision|0|||
129892486|NCT02099539|467565460|FG000|Overall Study|Progressive Disease|3|||
129892487|NCT02099539|467565461|FG001|Overall Study|Progressive Disease|2|||
129892488|NCT02099539|467565462|FG002|Overall Study|Progressive Disease|2|||
129892489|NCT02099539|467565463|FG003|Overall Study|Progressive Disease|1|||
129892490|NCT02099539|467565464|FG004|Overall Study|Progressive Disease|4|||
129892491|NCT02099539|467565465|FG005|Overall Study|Progressive Disease|2|||
129892492|NCT02099539|467565466|FG006|Overall Study|Progressive Disease|0|||
129892493|NCT02099539|467565460|FG000|Overall Study|Adverse Event|0|||
129892494|NCT02099539|467565461|FG001|Overall Study|Adverse Event|0|||
129892495|NCT02099539|467565462|FG002|Overall Study|Adverse Event|1|||
129892496|NCT02099539|467565463|FG003|Overall Study|Adverse Event|1|||
129892497|NCT02099539|467565464|FG004|Overall Study|Adverse Event|0|||
129892498|NCT02099539|467565465|FG005|Overall Study|Adverse Event|0|||
129892499|NCT02099539|467565466|FG006|Overall Study|Adverse Event|0|||
129892500|NCT02099539|467565460|FG000|Overall Study|Physician Decision|0|||
129892501|NCT02099539|467565461|FG001|Overall Study|Physician Decision|0|||
129892502|NCT02099539|467565462|FG002|Overall Study|Physician Decision|0|||
129892503|NCT02099539|467565463|FG003|Overall Study|Physician Decision|0|||
129892504|NCT02099539|467565464|FG004|Overall Study|Physician Decision|0|||
129892505|NCT02099539|467565465|FG005|Overall Study|Physician Decision|1|||
129892506|NCT02099539|467565466|FG006|Overall Study|Physician Decision|0|||
129892507|NCT03251378|467565470|FG000|Overall Study|Death|3|||
130054737|NCT03345836|468154623|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130054738|NCT03345836|468154624|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130054739|NCT03345836|468154625|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
130054740|NCT03345836|468154626|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
130054741|NCT03345836|468154621|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
130054742|NCT03345836|468154622|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
130054743|NCT03345836|468154623|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
130054744|NCT03345836|468154624|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
130054745|NCT03345836|468154625|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
130054746|NCT03345836|468154626|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
129892508|NCT03251378|467565471|FG001|Overall Study|Death|2|||
129892509|NCT03251378|467565472|FG002|Overall Study|Death|3|||
129892510|NCT03251378|467565473|FG003|Overall Study|Death|30|||
129892511|NCT03251378|467565474|FG004|Overall Study|Death|24|||
129892512|NCT03251378|467565475|FG005|Overall Study|Death|12|||
129892513|NCT03251378|467565476|FG006|Overall Study|Death|12|||
129892514|NCT03251378|467565470|FG000|Overall Study|Lost to Follow-up|0|||
129892515|NCT03251378|467565471|FG001|Overall Study|Lost to Follow-up|0|||
129892516|NCT03251378|467565472|FG002|Overall Study|Lost to Follow-up|1|||
129892517|NCT03251378|467565473|FG003|Overall Study|Lost to Follow-up|3|||
130111425|NCT03341273|468369454|FG000|Overall Study|Participant incarcerated|1|||
129804225|NCT00231842|467251452|FG000|Overall Study|Did not complete the last 3 cycle|8|||
129892518|NCT03251378|467565474|FG004|Overall Study|Lost to Follow-up|0|||
129892519|NCT03251378|467565475|FG005|Overall Study|Lost to Follow-up|0|||
129892520|NCT03251378|467565476|FG006|Overall Study|Lost to Follow-up|0|||
129892521|NCT03251378|467565470|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
129892522|NCT03251378|467565471|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
129892523|NCT03251378|467565472|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
129892524|NCT03251378|467565473|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
129892525|NCT03251378|467565474|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
129892526|NCT03251378|467565475|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
129892527|NCT03251378|467565476|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
129892528|NCT03251378|467565470|FG000|Overall Study|Progressive disease|2|||
129892529|NCT03251378|467565471|FG001|Overall Study|Progressive disease|0|||
129892530|NCT03251378|467565472|FG002|Overall Study|Progressive disease|0|||
129892531|NCT03251378|467565473|FG003|Overall Study|Progressive disease|1|||
129892532|NCT03251378|467565474|FG004|Overall Study|Progressive disease|0|||
129892533|NCT03251378|467565475|FG005|Overall Study|Progressive disease|0|||
130054747|NCT03345836|468154621|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130054748|NCT03345836|468154622|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130054749|NCT03345836|468154623|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130054750|NCT03345836|468154624|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
129892534|NCT03251378|467565476|FG006|Overall Study|Progressive disease|0|||
129892535|NCT03251378|467565470|FG000|Overall Study|Physician Decision|0|||
129892536|NCT03251378|467565471|FG001|Overall Study|Physician Decision|2|||
129892537|NCT03251378|467565472|FG002|Overall Study|Physician Decision|0|||
129892538|NCT03251378|467565473|FG003|Overall Study|Physician Decision|0|||
129892539|NCT03251378|467565474|FG004|Overall Study|Physician Decision|0|||
129892540|NCT03251378|467565475|FG005|Overall Study|Physician Decision|0|||
129892541|NCT03251378|467565476|FG006|Overall Study|Physician Decision|0|||
129892542|NCT03251378|467565470|FG000|Overall Study|Other|2|||
129892543|NCT03251378|467565471|FG001|Overall Study|Other|3|||
129892544|NCT03251378|467565472|FG002|Overall Study|Other|2|||
129892545|NCT03251378|467565473|FG003|Overall Study|Other|0|||
130111426|NCT03341273|468369455|FG001|Overall Study|Participant incarcerated|0|||
130111427|NCT01717456|468369456|FG000|End of Treatment|Physician Decision|0|||
130111428|NCT01717456|468369457|FG001|End of Treatment|Physician Decision|1|||
130111429|NCT01717456|468369456|FG000|End of Treatment|Lost to Follow-up|0|||
130111430|NCT01717456|468369457|FG001|End of Treatment|Lost to Follow-up|1|||
130111431|NCT01717456|468369456|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
130111432|NCT01717456|468369457|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
130111433|NCT02008721|468369458|FG000|Overall Study|Withdrawal by Subject|5|||
130111434|NCT02008721|468369459|FG001|Overall Study|Withdrawal by Subject|1|||
130111435|NCT02008721|468369458|FG000|Overall Study|Death|4|||
130111436|NCT02008721|468369459|FG001|Overall Study|Death|2|||
130111437|NCT02008721|468369458|FG000|Overall Study|Adverse Event|3|||
130111438|NCT02008721|468369459|FG001|Overall Study|Adverse Event|5|||
130111439|NCT02008721|468369458|FG000|Overall Study|Protocol Violation|3|||
130054751|NCT03345836|468154625|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
130054752|NCT03345836|468154626|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
130054753|NCT03345836|468154621|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
130054754|NCT03345836|468154622|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
130054755|NCT03345836|468154623|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
130054756|NCT03345836|468154624|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
130054757|NCT03345836|468154625|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
130054758|NCT03345836|468154626|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
130054759|NCT00829166|468154629|FG000|Overall Study|Death|305|||
130054760|NCT00829166|468154630|FG001|Overall Study|Death|333|||
130054761|NCT00829166|468154629|FG000|Overall Study|Lost to Follow-up|5|||
130054762|NCT00829166|468154630|FG001|Overall Study|Lost to Follow-up|4|||
130054763|NCT00829166|468154629|FG000|Overall Study|Physician's Decision|4|||
130054764|NCT00829166|468154630|FG001|Overall Study|Physician's Decision|3|||
130054765|NCT00829166|468154629|FG000|Overall Study|Subject's Decision|41|||
130054766|NCT00829166|468154630|FG001|Overall Study|Subject's Decision|55|||
130054767|NCT00829166|468154629|FG000|Overall Study|Sponsor's Decision|137|||
130054768|NCT00829166|468154630|FG001|Overall Study|Sponsor's Decision|98|||
130054769|NCT00829166|468154629|FG000|Overall Study|Reason Not Specified|3|||
130054770|NCT00829166|468154630|FG001|Overall Study|Reason Not Specified|3|||
130054771|NCT01635933|468154631|FG000|Overall Study|Adverse Event|1|||
130054772|NCT01635933|468154632|FG001|Overall Study|Adverse Event|0|||
130054773|NCT01635933|468154631|FG000|Overall Study|Lost to Follow-up|0|||
130054774|NCT01635933|468154632|FG001|Overall Study|Lost to Follow-up|5|||
130054775|NCT01635933|468154631|FG000|Overall Study|Subject decision|1|||
130054776|NCT01635933|468154632|FG001|Overall Study|Subject decision|1|||
130054777|NCT01635933|468154631|FG000|Overall Study|Noncompliance|0|||
130054778|NCT01635933|468154632|FG001|Overall Study|Noncompliance|1|||
130054779|NCT01635933|468154631|FG000|Overall Study|No longer had transportation|0|||
130054780|NCT01635933|468154632|FG001|Overall Study|No longer had transportation|1|||
130054781|NCT03510663|468154633|FG000|Overall Study|Withdrawal by Subject|0|||
130054782|NCT03510663|468154634|FG001|Overall Study|Withdrawal by Subject|1|||
130054783|NCT03510663|468154635|FG002|Overall Study|Withdrawal by Subject|0|||
130054784|NCT03510663|468154636|FG003|Overall Study|Withdrawal by Subject|0|||
130054785|NCT03510663|468154637|FG004|Overall Study|Withdrawal by Subject|0|||
129804226|NCT00573183|467251453|FG000|Overall Study|Lost to Follow-up|52|||
129804227|NCT00573183|467251454|FG001|Overall Study|Lost to Follow-up|50|||
129804228|NCT00573183|467251453|FG000|Overall Study|Withdrawal by Subject|8|||
129804229|NCT00573183|467251454|FG001|Overall Study|Withdrawal by Subject|2|||
129804230|NCT00573183|467251453|FG000|Overall Study|Death|0|||
129804231|NCT00573183|467251454|FG001|Overall Study|Death|1|||
129892546|NCT03251378|467565474|FG004|Overall Study|Other|1|||
129892547|NCT03251378|467565475|FG005|Overall Study|Other|1|||
129892548|NCT03251378|467565476|FG006|Overall Study|Other|1|||
129892549|NCT03251378|467565470|FG000|Overall Study|Other|0|||
129804232|NCT00573183|467251453|FG000|Overall Study|Adverse Event|2|||
129804233|NCT00573183|467251454|FG001|Overall Study|Adverse Event|0|||
129804234|NCT00573183|467251453|FG000|Overall Study|Incarceration|5|||
129804235|NCT00573183|467251454|FG001|Overall Study|Incarceration|8|||
129804236|NCT00573183|467251453|FG000|Overall Study|Other|5|||
129804237|NCT00573183|467251454|FG001|Overall Study|Other|2|||
129804238|NCT02422303|467251457|FG000|Overall Study|Lost to Follow-up|1|||
129804239|NCT02422303|467251458|FG001|Overall Study|Lost to Follow-up|1|||
129804240|NCT03270644|467251465|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
129804241|NCT03270644|467251465|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
129892550|NCT03251378|467565471|FG001|Overall Study|Other|0|||
130054786|NCT03510663|468154638|FG005|Overall Study|Withdrawal by Subject|0|||
130054787|NCT03510663|468154639|FG006|Overall Study|Withdrawal by Subject|0|||
130054788|NCT03510663|468154640|FG007|Overall Study|Withdrawal by Subject|0|||
130054789|NCT02213198|468154644|FG000|Baseline|No show for intake|7|||
129804242|NCT00902668|467251466|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
129892551|NCT03251378|467565472|FG002|Overall Study|Other|0|||
129892552|NCT03251378|467565473|FG003|Overall Study|Other|4|||
129892553|NCT03251378|467565474|FG004|Overall Study|Other|13|||
129892554|NCT03251378|467565475|FG005|Overall Study|Other|0|||
129892555|NCT03251378|467565476|FG006|Overall Study|Other|0|||
129892556|NCT04060680|467565478|FG000|Overall Study|Unsuccessful implant|17|||
129892557|NCT04060680|467565479|FG001|Overall Study|Unsuccessful implant|2|||
129892558|NCT04060680|467565478|FG000|Overall Study|Adverse Event|3|||
129892559|NCT04060680|467565479|FG001|Overall Study|Adverse Event|0|||
129892560|NCT04060680|467565478|FG000|Overall Study|Death|2|||
129892561|NCT04060680|467565479|FG001|Overall Study|Death|0|||
129892562|NCT04060680|467565478|FG000|Overall Study|Study product no longer in use|1|||
129892563|NCT04060680|467565479|FG001|Overall Study|Study product no longer in use|0|||
129892564|NCT04060680|467565478|FG000|Overall Study|Withdrawal by Subject|1|||
129892565|NCT04060680|467565479|FG001|Overall Study|Withdrawal by Subject|0|||
129892566|NCT02956967|467565480|FG000|Overall Study|Adverse Event|3|||
129892567|NCT02956967|467565480|FG000|Overall Study|Reason non-related to neutropenia|10|||
129892568|NCT02956967|467565480|FG000|Overall Study|Lost to Follow-up|5|||
129892569|NCT02956967|467565480|FG000|Overall Study|Missing|1|||
129892570|NCT02956967|467565480|FG000|Overall Study|Termination of Nivestim administration|29|||
129892571|NCT04739423|467565481|FG000|Overall Study|Protocol Violation|0|||
129892572|NCT04739423|467565482|FG001|Overall Study|Protocol Violation|1|||
129892573|NCT04739423|467565483|FG002|Overall Study|Protocol Violation|0|||
129892574|NCT04739423|467565484|FG003|Overall Study|Protocol Violation|0|||
129892575|NCT04739423|467565485|FG004|Overall Study|Protocol Violation|0|||
129892576|NCT04739423|467565486|FG005|Overall Study|Protocol Violation|0|||
129892577|NCT04739423|467565481|FG000|Overall Study|Adverse Event|0|||
129892578|NCT04739423|467565482|FG001|Overall Study|Adverse Event|0|||
129892579|NCT04739423|467565483|FG002|Overall Study|Adverse Event|1|||
129892580|NCT04739423|467565484|FG003|Overall Study|Adverse Event|0|||
129892581|NCT04739423|467565485|FG004|Overall Study|Adverse Event|1|||
129892582|NCT04739423|467565486|FG005|Overall Study|Adverse Event|0|||
129892583|NCT04739423|467565481|FG000|Overall Study|Withdrawal by Subject|0|||
129892584|NCT04739423|467565482|FG001|Overall Study|Withdrawal by Subject|0|||
129892585|NCT04739423|467565483|FG002|Overall Study|Withdrawal by Subject|0|||
129892586|NCT04739423|467565484|FG003|Overall Study|Withdrawal by Subject|0|||
129892587|NCT04739423|467565485|FG004|Overall Study|Withdrawal by Subject|0|||
130054790|NCT02213198|468154645|FG001|Baseline|No show for intake|9|||
130054791|NCT02213198|468154644|FG000|Baseline|Withdrawal by Subject|34|||
130054792|NCT02213198|468154645|FG001|Baseline|Withdrawal by Subject|11|||
130054793|NCT02213198|468154644|FG000|Baseline|transferred out of clinic|7|||
130054794|NCT02213198|468154645|FG001|Baseline|transferred out of clinic|9|||
130054795|NCT02213198|468154644|FG000|Baseline|Lost to Follow-up|40|||
130054796|NCT02213198|468154645|FG001|Baseline|Lost to Follow-up|21|||
130054797|NCT02213198|468154644|FG000|Baseline|incarcerated,violent|0|||
130054798|NCT02213198|468154645|FG001|Baseline|incarcerated,violent|1|||
130054799|NCT02213198|468154644|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
130054800|NCT02213198|468154645|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
130054801|NCT02213198|468154644|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
130054802|NCT02213198|468154645|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
130054803|NCT02213198|468154644|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
130054804|NCT02213198|468154645|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
130054805|NCT02213198|468154644|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
130054806|NCT02213198|468154645|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
130111440|NCT02008721|468369459|FG001|Overall Study|Protocol Violation|2|||
129892588|NCT04739423|467565486|FG005|Overall Study|Withdrawal by Subject|1|||
129892589|NCT00819234|467565490|FG000|Overall Study|Withdrawal by Subject|8|||
129892590|NCT00819234|467565491|FG001|Overall Study|Withdrawal by Subject|13|||
129892591|NCT00819234|467565492|FG002|Overall Study|Withdrawal by Subject|6|||
129892592|NCT00819234|467565493|FG003|Overall Study|Withdrawal by Subject|3|||
129892593|NCT00819234|467565494|FG004|Overall Study|Withdrawal by Subject|0|||
129892594|NCT00819234|467565495|FG005|Overall Study|Withdrawal by Subject|4|||
129892595|NCT00819234|467565496|FG006|Overall Study|Withdrawal by Subject|4|||
129892596|NCT00819234|467565497|FG007|Overall Study|Withdrawal by Subject|8|||
129892597|NCT00819234|467565498|FG008|Overall Study|Withdrawal by Subject|5|||
130054807|NCT02213198|468154644|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
130054808|NCT02213198|468154645|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
130054809|NCT02213198|468154644|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
130054810|NCT02213198|468154645|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
130054811|NCT00905021|468154648|FG000|Overall Study|Adverse Event|2|||
129892598|NCT00819234|467565499|FG009|Overall Study|Withdrawal by Subject|3|||
129892599|NCT00819234|467565490|FG000|Overall Study|Adverse Event|0|||
129892600|NCT00819234|467565491|FG001|Overall Study|Adverse Event|0|||
129892601|NCT00819234|467565492|FG002|Overall Study|Adverse Event|1|||
129892602|NCT00819234|467565493|FG003|Overall Study|Adverse Event|0|||
129892603|NCT00819234|467565494|FG004|Overall Study|Adverse Event|0|||
129892604|NCT00819234|467565495|FG005|Overall Study|Adverse Event|2|||
129892605|NCT00819234|467565496|FG006|Overall Study|Adverse Event|0|||
129892606|NCT00819234|467565497|FG007|Overall Study|Adverse Event|0|||
129892607|NCT00819234|467565498|FG008|Overall Study|Adverse Event|0|||
129892608|NCT00819234|467565499|FG009|Overall Study|Adverse Event|0|||
129892609|NCT00819234|467565490|FG000|Overall Study|Physician Decision|0|||
130054812|NCT00786838|468154649|FG000|Overall Study|Physician Decision|4|||
130054813|NCT00786838|468154649|FG000|Overall Study|Death|4|||
130054814|NCT00786838|468154649|FG000|Overall Study|Adverse Event|6|||
130054815|NCT00786838|468154649|FG000|Overall Study|Progressive disease|31|||
130054816|NCT00786838|468154649|FG000|Overall Study|Withdrawal by Subject|4|||
130111441|NCT03870997|468369462|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
130054817|NCT04937816|468154650|FG000|Overall Study|Study drug stopped, reason missing|5|||
130054818|NCT04937816|468154651|FG001|Overall Study|Study drug stopped, reason missing|3|||
130054819|NCT04937816|468154652|FG002|Overall Study|Study drug stopped, reason missing|4|||
130054820|NCT04937816|468154653|FG003|Overall Study|Study drug stopped, reason missing|6|||
130054821|NCT04937816|468154654|FG004|Overall Study|Study drug stopped, reason missing|1|||
130054822|NCT04937816|468154655|FG005|Overall Study|Study drug stopped, reason missing|0|||
130054823|NCT04937816|468154656|FG006|Overall Study|Study drug stopped, reason missing|0|||
130054824|NCT04937816|468154650|FG000|Overall Study|Other than stated below|173|||
130054825|NCT04937816|468154651|FG001|Overall Study|Other than stated below|143|||
130054826|NCT04937816|468154652|FG002|Overall Study|Other than stated below|125|||
130054827|NCT04937816|468154653|FG003|Overall Study|Other than stated below|44|||
130054828|NCT04937816|468154654|FG004|Overall Study|Other than stated below|45|||
130054829|NCT04937816|468154655|FG005|Overall Study|Other than stated below|28|||
130054830|NCT04937816|468154656|FG006|Overall Study|Other than stated below|31|||
130054831|NCT04937816|468154650|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
130054832|NCT04937816|468154651|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
130054833|NCT04937816|468154652|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
130054834|NCT04937816|468154653|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
130054835|NCT04937816|468154654|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
130054836|NCT04937816|468154655|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
130054837|NCT04937816|468154656|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
130054838|NCT04937816|468154650|FG000|Overall Study|Lost to Follow-up|15|||
130054839|NCT04937816|468154651|FG001|Overall Study|Lost to Follow-up|9|||
130054840|NCT04937816|468154652|FG002|Overall Study|Lost to Follow-up|6|||
130054841|NCT04937816|468154653|FG003|Overall Study|Lost to Follow-up|6|||
130054842|NCT04937816|468154654|FG004|Overall Study|Lost to Follow-up|16|||
130054843|NCT04937816|468154655|FG005|Overall Study|Lost to Follow-up|11|||
130054844|NCT04937816|468154656|FG006|Overall Study|Lost to Follow-up|17|||
130054845|NCT04937816|468154650|FG000|Overall Study|Protocol Violation|15|||
130054846|NCT04937816|468154651|FG001|Overall Study|Protocol Violation|15|||
130054847|NCT04937816|468154652|FG002|Overall Study|Protocol Violation|12|||
130054848|NCT04937816|468154653|FG003|Overall Study|Protocol Violation|30|||
130054849|NCT04937816|468154654|FG004|Overall Study|Protocol Violation|24|||
130054850|NCT04937816|468154655|FG005|Overall Study|Protocol Violation|5|||
130111442|NCT03870997|468369463|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
129892610|NCT00819234|467565491|FG001|Overall Study|Physician Decision|0|||
129892611|NCT00819234|467565492|FG002|Overall Study|Physician Decision|0|||
130054851|NCT04937816|468154656|FG006|Overall Study|Protocol Violation|5|||
130054852|NCT04937816|468154650|FG000|Overall Study|Adverse Event|303|||
130054853|NCT04937816|468154651|FG001|Overall Study|Adverse Event|267|||
130054854|NCT04937816|468154652|FG002|Overall Study|Adverse Event|273|||
130054855|NCT04937816|468154653|FG003|Overall Study|Adverse Event|553|||
130054856|NCT04937816|468154654|FG004|Overall Study|Adverse Event|575|||
129892612|NCT00819234|467565493|FG003|Overall Study|Physician Decision|1|||
129892613|NCT00819234|467565494|FG004|Overall Study|Physician Decision|0|||
130054857|NCT04937816|468154655|FG005|Overall Study|Adverse Event|343|||
129892614|NCT00819234|467565495|FG005|Overall Study|Physician Decision|0|||
129892615|NCT00819234|467565496|FG006|Overall Study|Physician Decision|0|||
129892616|NCT00819234|467565497|FG007|Overall Study|Physician Decision|0|||
129892617|NCT00819234|467565498|FG008|Overall Study|Physician Decision|0|||
129892618|NCT00819234|467565499|FG009|Overall Study|Physician Decision|2|||
129892619|NCT00819234|467565490|FG000|Overall Study|Protocol Violation|0|||
129892620|NCT00819234|467565491|FG001|Overall Study|Protocol Violation|0|||
129892621|NCT00819234|467565492|FG002|Overall Study|Protocol Violation|1|||
129892622|NCT00819234|467565493|FG003|Overall Study|Protocol Violation|0|||
129892623|NCT00819234|467565494|FG004|Overall Study|Protocol Violation|0|||
129892624|NCT00819234|467565495|FG005|Overall Study|Protocol Violation|0|||
129892625|NCT00819234|467565496|FG006|Overall Study|Protocol Violation|0|||
129892626|NCT00819234|467565497|FG007|Overall Study|Protocol Violation|0|||
129892627|NCT00819234|467565498|FG008|Overall Study|Protocol Violation|0|||
129892628|NCT00819234|467565499|FG009|Overall Study|Protocol Violation|0|||
129892629|NCT00819234|467565490|FG000|Overall Study|Lost to Follow-up|2|||
129892630|NCT00819234|467565491|FG001|Overall Study|Lost to Follow-up|2|||
129892631|NCT00819234|467565492|FG002|Overall Study|Lost to Follow-up|0|||
129892632|NCT00819234|467565493|FG003|Overall Study|Lost to Follow-up|2|||
129892633|NCT00819234|467565494|FG004|Overall Study|Lost to Follow-up|1|||
129892634|NCT00819234|467565495|FG005|Overall Study|Lost to Follow-up|1|||
129892635|NCT00819234|467565496|FG006|Overall Study|Lost to Follow-up|1|||
129892636|NCT00819234|467565497|FG007|Overall Study|Lost to Follow-up|1|||
129892637|NCT00819234|467565498|FG008|Overall Study|Lost to Follow-up|1|||
129892638|NCT00819234|467565499|FG009|Overall Study|Lost to Follow-up|2|||
129892639|NCT04091672|467567618|FG000|Overall Study|Death|6|||
130054858|NCT04937816|468154656|FG006|Overall Study|Adverse Event|337|||
130054859|NCT04937816|468154650|FG000|Overall Study|Not treated|4|||
129892640|NCT04091672|467567619|FG001|Overall Study|Death|6|||
129892641|NCT04091672|467567618|FG000|Overall Study|Lost to Follow-up|7|||
130054860|NCT04937816|468154651|FG001|Overall Study|Not treated|2|||
129892642|NCT04091672|467567619|FG001|Overall Study|Lost to Follow-up|7|||
129892643|NCT04091672|467567618|FG000|Overall Study|Withdrawal by Subject|3|||
129892644|NCT04091672|467567619|FG001|Overall Study|Withdrawal by Subject|3|||
129892645|NCT04091672|467567618|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
129892646|NCT04091672|467567619|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
129892647|NCT05296629|467567620|FG000|Overall Study|Withdrawal by Subject|3|||
129892648|NCT05296629|467567621|FG001|Overall Study|Withdrawal by Subject|10|||
130054861|NCT04937816|468154652|FG002|Overall Study|Not treated|2|||
130054862|NCT04937816|468154653|FG003|Overall Study|Not treated|2|||
130054863|NCT04937816|468154654|FG004|Overall Study|Not treated|1|||
130054864|NCT04937816|468154655|FG005|Overall Study|Not treated|4|||
130054865|NCT04937816|468154656|FG006|Overall Study|Not treated|0|||
130054866|NCT00436215|468154657|FG000|Overall Study|Refused further treatment|3|||
130054867|NCT00436215|468154657|FG000|Overall Study|Small bowel obstruction|1|||
130054868|NCT00309777|468154658|FG000|Overall Study|Adverse Event|13|||
130054869|NCT00309777|468154659|FG001|Overall Study|Adverse Event|2|||
130054870|NCT00309777|468154660|FG002|Overall Study|Adverse Event|8|||
130054871|NCT00309777|468154661|FG003|Overall Study|Adverse Event|1|||
130054872|NCT00309777|468154658|FG000|Overall Study|Protocol Violation|4|||
130054873|NCT00309777|468154659|FG001|Overall Study|Protocol Violation|1|||
130054874|NCT00309777|468154660|FG002|Overall Study|Protocol Violation|3|||
130054875|NCT00309777|468154661|FG003|Overall Study|Protocol Violation|1|||
130054876|NCT00309777|468154658|FG000|Overall Study|Withdrawal by Subject|6|||
130054877|NCT00309777|468154659|FG001|Overall Study|Withdrawal by Subject|5|||
130054878|NCT00309777|468154660|FG002|Overall Study|Withdrawal by Subject|7|||
130054879|NCT00309777|468154661|FG003|Overall Study|Withdrawal by Subject|2|||
130054880|NCT00309777|468154658|FG000|Overall Study|Lost to Follow-up|0|||
130054881|NCT00309777|468154659|FG001|Overall Study|Lost to Follow-up|0|||
130054882|NCT00309777|468154660|FG002|Overall Study|Lost to Follow-up|1|||
130054883|NCT00309777|468154661|FG003|Overall Study|Lost to Follow-up|0|||
130054884|NCT00309777|468154658|FG000|Overall Study|Death|0|||
129892649|NCT05296629|467567622|FG002|Overall Study|Withdrawal by Subject|4|||
129892650|NCT05296629|467567620|FG000|Overall Study|Lost to Follow-up|2|||
129892651|NCT05296629|467567621|FG001|Overall Study|Lost to Follow-up|7|||
129892652|NCT05296629|467567622|FG002|Overall Study|Lost to Follow-up|1|||
129892653|NCT05296629|467567620|FG000|Overall Study|Adverse Event|0|||
130111443|NCT03870997|468369464|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
130111444|NCT03870997|468369465|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
130111445|NCT03870997|468369466|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
130111446|NCT03870997|468369467|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
130111447|NCT00267007|468369468|FG000|Overall Study|Withdrawal by Subject|6|||
130111448|NCT00267007|468369469|FG001|Overall Study|Withdrawal by Subject|0|||
130111449|NCT00267007|468369468|FG000|Overall Study|Lost to Follow-up|1|||
130111450|NCT00267007|468369469|FG001|Overall Study|Lost to Follow-up|0|||
130111451|NCT00267007|468369468|FG000|Overall Study|Non-compliance|0|||
130111452|NCT00267007|468369469|FG001|Overall Study|Non-compliance|1|||
130111453|NCT00267007|468369468|FG000|Overall Study|Adverse Event|1|||
130111454|NCT00267007|468369469|FG001|Overall Study|Adverse Event|0|||
130111455|NCT01825876|468369473|FG000|Period 2|Withdrawal by Subject|0|||
129804243|NCT03643575|467251469|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
129804244|NCT03643575|467251470|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
129804245|NCT03643575|467251471|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
129804246|NCT03643575|467251472|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
129804247|NCT03643575|467251473|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
129804248|NCT03643575|467251474|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
129804249|NCT03643575|467251469|FG000|Washout: 7 Days|Adverse Event|1|||
129804250|NCT03643575|467251470|FG001|Washout: 7 Days|Adverse Event|0|||
129804251|NCT03643575|467251471|FG002|Washout: 7 Days|Adverse Event|0|||
129804252|NCT03643575|467251472|FG003|Washout: 7 Days|Adverse Event|0|||
129804253|NCT03643575|467251473|FG004|Washout: 7 Days|Adverse Event|0|||
129804254|NCT03643575|467251474|FG005|Washout: 7 Days|Adverse Event|0|||
129804255|NCT03643575|467251469|FG000|Washout: 7 Days|Non compliance check in|0|||
129804256|NCT03643575|467251470|FG001|Washout: 7 Days|Non compliance check in|1|||
129804257|NCT03643575|467251471|FG002|Washout: 7 Days|Non compliance check in|0|||
129804258|NCT03643575|467251472|FG003|Washout: 7 Days|Non compliance check in|0|||
129804259|NCT03643575|467251473|FG004|Washout: 7 Days|Non compliance check in|0|||
129804260|NCT03643575|467251474|FG005|Washout: 7 Days|Non compliance check in|0|||
129804261|NCT01189604|467251475|FG000|Overall Study|Impossible to visit|0|||
129804262|NCT01189604|467251476|FG001|Overall Study|Impossible to visit|0|||
129804263|NCT01189604|467251477|FG002|Overall Study|Impossible to visit|0|||
129804264|NCT01189604|467251478|FG003|Overall Study|Impossible to visit|0|||
129804265|NCT01189604|467251479|FG004|Overall Study|Impossible to visit|0|||
129804266|NCT01189604|467251480|FG005|Overall Study|Impossible to visit|1|||
129804267|NCT01189604|467251481|FG006|Overall Study|Impossible to visit|0|||
129804268|NCT01189604|467251475|FG000|Overall Study|Adverse Event|0|||
129804269|NCT01189604|467251476|FG001|Overall Study|Adverse Event|1|||
129804270|NCT01189604|467251477|FG002|Overall Study|Adverse Event|0|||
129804271|NCT01189604|467251478|FG003|Overall Study|Adverse Event|0|||
129804272|NCT01189604|467251479|FG004|Overall Study|Adverse Event|2|||
129804273|NCT01189604|467251480|FG005|Overall Study|Adverse Event|0|||
129804274|NCT01189604|467251481|FG006|Overall Study|Adverse Event|1|||
129804275|NCT01189604|467251475|FG000|Overall Study|Withdrawal by Subject|1|||
129804276|NCT01189604|467251476|FG001|Overall Study|Withdrawal by Subject|0|||
129804277|NCT01189604|467251477|FG002|Overall Study|Withdrawal by Subject|0|||
129804278|NCT01189604|467251478|FG003|Overall Study|Withdrawal by Subject|0|||
129804279|NCT01189604|467251479|FG004|Overall Study|Withdrawal by Subject|0|||
129804280|NCT01189604|467251480|FG005|Overall Study|Withdrawal by Subject|0|||
129804281|NCT01189604|467251481|FG006|Overall Study|Withdrawal by Subject|0|||
129804282|NCT00986830|467251484|FG000|Overall Study|Death|1|||
129804283|NCT00986830|467251484|FG000|Overall Study|Lost to Follow-up|1|||
129804284|NCT00986830|467251484|FG000|Overall Study|Lack of Efficacy|1|||
129804285|NCT00986830|467251484|FG000|Overall Study|Unable to access sinus with device|5|||
129804286|NCT01332331|467251486|FG000|Overall Study|Lost to Follow-up|0|||
129804287|NCT01332331|467251487|FG001|Overall Study|Lost to Follow-up|1|||
130054885|NCT00309777|468154659|FG001|Overall Study|Death|1|||
130054886|NCT00309777|468154660|FG002|Overall Study|Death|0|||
129892654|NCT05296629|467567621|FG001|Overall Study|Adverse Event|4|||
130054887|NCT00309777|468154661|FG003|Overall Study|Death|0|||
130054888|NCT05513053|468154662|FG000|Overall Study|Lost to Follow-up|9|||
130054889|NCT05513053|468154663|FG001|Overall Study|Lost to Follow-up|11|||
130054890|NCT05513053|468154662|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130054891|NCT05513053|468154663|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130054892|NCT05513053|468154662|FG000|Overall Study|Withdrawal by Subject|2|||
130054893|NCT05513053|468154663|FG001|Overall Study|Withdrawal by Subject|9|||
130054894|NCT05513053|468154662|FG000|Overall Study|Protocol Violation|6|||
130054895|NCT05513053|468154663|FG001|Overall Study|Protocol Violation|3|||
130054896|NCT05513053|468154662|FG000|Overall Study|Adverse Event|0|||
130054897|NCT05513053|468154663|FG001|Overall Study|Adverse Event|2|||
130054898|NCT03050359|468156312|FG000|Overall Study|Randomized But Not Treated|2|||
130054899|NCT03050359|468156313|FG001|Overall Study|Randomized But Not Treated|0|||
130054900|NCT03050359|468156312|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
130054901|NCT03050359|468156313|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
130054902|NCT03050359|468156312|FG000|Overall Study|Significant Protocol Deviation|2|||
130054903|NCT03050359|468156313|FG001|Overall Study|Significant Protocol Deviation|3|||
130054904|NCT03050359|468156312|FG000|Overall Study|Lost to Follow-up|2|||
130054905|NCT03050359|468156313|FG001|Overall Study|Lost to Follow-up|1|||
130054906|NCT03050359|468156312|FG000|Overall Study|Voluntary Withdrawal|4|||
130054907|NCT03050359|468156313|FG001|Overall Study|Voluntary Withdrawal|6|||
130054908|NCT03050359|468156312|FG000|Overall Study|Pregnancy|1|||
130054909|NCT03050359|468156313|FG001|Overall Study|Pregnancy|0|||
130054910|NCT03050359|468156312|FG000|Overall Study|Reason Not Specified|1|||
130054911|NCT03050359|468156313|FG001|Overall Study|Reason Not Specified|0|||
130054912|NCT02614287|468156314|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
130054913|NCT02614287|468156315|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
130054914|NCT02614287|468156314|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
130054915|NCT02614287|468156315|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
130054916|NCT02614287|468156314|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
130054917|NCT02614287|468156315|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
130054918|NCT02614287|468156314|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
130054919|NCT02614287|468156315|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
130054920|NCT02614287|468156314|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
130054921|NCT02614287|468156315|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
130054922|NCT02614287|468156314|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
130054923|NCT02614287|468156315|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
130054924|NCT02614287|468156314|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
130054925|NCT02614287|468156315|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
130054926|NCT02614287|468156314|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
130054927|NCT02614287|468156315|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
130054928|NCT03580382|468156319|FG000|Overall Study|Early Termination of Study|0|||
130054929|NCT03580382|468156320|FG001|Overall Study|Early Termination of Study|3|||
130054930|NCT05619172|468156321|FG000|Safety Cohort 1|Death|7|||
130054931|NCT05619172|468156322|FG001|Safety Cohort 1|Death|0|||
130054932|NCT05619172|468156321|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
130054933|NCT05619172|468156322|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
130054934|NCT05619172|468156321|FG000|Safety Cohort 2|Death|0|||
130054935|NCT05619172|468156322|FG001|Safety Cohort 2|Death|1|||
130054936|NCT05619172|468156321|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
130054937|NCT05619172|468156322|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
130054938|NCT00450372|468156324|FG000|Overall Study|Physician Decision|1|||
130054939|NCT03010423|468156325|FG000|Overall Study|Study termination|8|||
130054940|NCT00520676|468156326|FG000|Overall Study|Death|84|||
130111456|NCT01825876|468369474|FG001|Period 2|Withdrawal by Subject|1|||
130111457|NCT03751020|468369477|FG000|Overall Study|Withdrawal by Subject|2|||
130111458|NCT03751020|468369478|FG001|Overall Study|Withdrawal by Subject|0|||
130111459|NCT03751020|468369479|FG002|Overall Study|Withdrawal by Subject|0|||
130054941|NCT00520676|468156327|FG001|Overall Study|Death|81|||
130054942|NCT00520676|468156326|FG000|Overall Study|Lost to Follow-up|6|||
130054943|NCT00520676|468156327|FG001|Overall Study|Lost to Follow-up|10|||
130111460|NCT03751020|468369477|FG000|Overall Study|Lost to Follow-up|7|||
130054944|NCT00520676|468156326|FG000|Overall Study|Physician Decision|4|||
129892655|NCT05296629|467567622|FG002|Overall Study|Adverse Event|2|||
129892656|NCT05296629|467567620|FG000|Overall Study|Protocol Violation|0|||
129892657|NCT05296629|467567621|FG001|Overall Study|Protocol Violation|2|||
129892658|NCT05296629|467567622|FG002|Overall Study|Protocol Violation|0|||
129892659|NCT02268396|467567626|FG000|Overall Study|Adverse Event|3|||
129892660|NCT02268396|467567626|FG000|Overall Study|Administrative|2|||
129892661|NCT02268396|467567626|FG000|Overall Study|Withdrawal by Subject|1|||
129892662|NCT02268396|467567626|FG000|Overall Study|Lost to Follow-up|2|||
129892663|NCT02268396|467567626|FG000|Overall Study|Protocol-Specified Criteria|2|||
129892664|NCT02268396|467567626|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
129892665|NCT00231179|467567629|FG000|Overall Study|Lost to Follow-up|21|||
129892666|NCT00231179|467567630|FG001|Overall Study|Lost to Follow-up|21|||
129892667|NCT00231179|467567629|FG000|Overall Study|Withdrawal by Subject|3|||
129892668|NCT00231179|467567630|FG001|Overall Study|Withdrawal by Subject|3|||
129892669|NCT02401529|467567631|FG000|Overall Study|Lost to Follow-up|2|||
129892670|NCT02401529|467567632|FG001|Overall Study|Lost to Follow-up|1|||
129892671|NCT02401529|467567631|FG000|Overall Study|Physician Decision|2|||
129892672|NCT02401529|467567632|FG001|Overall Study|Physician Decision|6|||
129892673|NCT02401529|467567631|FG000|Overall Study|Protocol Violation|5|||
129892674|NCT02401529|467567632|FG001|Overall Study|Protocol Violation|0|||
129892675|NCT02491411|467567635|FG000|Overall Study|Physician Decision|4|||
129892676|NCT04034238|467567636|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
129892677|NCT04034238|467567637|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129892678|NCT04034238|467567638|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129892679|NCT04034238|467567639|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130054945|NCT00520676|468156327|FG001|Overall Study|Physician Decision|1|||
130054946|NCT00520676|468156326|FG000|Overall Study|Withdrawal by Subject|7|||
130054947|NCT00520676|468156327|FG001|Overall Study|Withdrawal by Subject|11|||
130054948|NCT03484923|468156328|FG000|Overall Study|Adverse Event|3|||
129892680|NCT04034238|467567636|FG000|Dose Escalation Phase|Screen failures|0|||
129892681|NCT04034238|467567637|FG001|Dose Escalation Phase|Screen failures|0|||
129892682|NCT04034238|467567638|FG002|Dose Escalation Phase|Screen failures|0|||
129892683|NCT04034238|467567639|FG003|Dose Escalation Phase|Screen failures|2|||
129892684|NCT04034238|467567636|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
129892685|NCT04034238|467567637|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
129892686|NCT04034238|467567638|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
129892687|NCT04034238|467567639|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
129892688|NCT04034238|467567636|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
129892689|NCT04034238|467567637|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
129892690|NCT04034238|467567638|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
129892691|NCT04034238|467567639|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
129892692|NCT01939158|467567640|FG000|Overall Study|Adverse Event|1|||
129892693|NCT01939158|467567641|FG001|Overall Study|Adverse Event|0|||
129892694|NCT01939158|467567642|FG002|Overall Study|Adverse Event|0|||
129892695|NCT01939158|467567643|FG003|Overall Study|Adverse Event|0|||
129892696|NCT01939158|467567640|FG000|Overall Study|Withdrawal by Subject|22|||
129892697|NCT01939158|467567641|FG001|Overall Study|Withdrawal by Subject|25|||
129892698|NCT01939158|467567642|FG002|Overall Study|Withdrawal by Subject|15|||
129892699|NCT01939158|467567643|FG003|Overall Study|Withdrawal by Subject|17|||
129892700|NCT01939158|467567640|FG000|Overall Study|Migrated/moved from study area|5|||
129892701|NCT01939158|467567641|FG001|Overall Study|Migrated/moved from study area|7|||
129892702|NCT01939158|467567642|FG002|Overall Study|Migrated/moved from study area|3|||
129892703|NCT01939158|467567643|FG003|Overall Study|Migrated/moved from study area|6|||
129892704|NCT01939158|467567640|FG000|Overall Study|Lost to Follow-up|18|||
129892705|NCT01939158|467567641|FG001|Overall Study|Lost to Follow-up|17|||
129892706|NCT01939158|467567642|FG002|Overall Study|Lost to Follow-up|17|||
129892707|NCT01939158|467567643|FG003|Overall Study|Lost to Follow-up|17|||
129892708|NCT01939158|467567640|FG000|Overall Study|Death|0|||
129892709|NCT01939158|467567641|FG001|Overall Study|Death|0|||
129892710|NCT01939158|467567642|FG002|Overall Study|Death|1|||
129892711|NCT01939158|467567643|FG003|Overall Study|Death|1|||
129892712|NCT01939158|467567640|FG000|Overall Study|No longer meets eligibility criteria|0|||
129892713|NCT01939158|467567641|FG001|Overall Study|No longer meets eligibility criteria|0|||
129892714|NCT01939158|467567642|FG002|Overall Study|No longer meets eligibility criteria|1|||
129892715|NCT01939158|467567643|FG003|Overall Study|No longer meets eligibility criteria|0|||
129892716|NCT01939158|467567640|FG000|Overall Study|Other|1|||
129892717|NCT01939158|467567641|FG001|Overall Study|Other|3|||
129892718|NCT01939158|467567642|FG002|Overall Study|Other|4|||
129892719|NCT01939158|467567643|FG003|Overall Study|Other|3|||
129892720|NCT02065245|467567646|FG000|Infusion 1|Lost to Follow-up|0|||
129892721|NCT02065245|467567647|FG001|Infusion 1|Lost to Follow-up|0|||
129892722|NCT02065245|467567648|FG002|Infusion 1|Lost to Follow-up|0|||
129892723|NCT02065245|467567649|FG003|Infusion 1|Lost to Follow-up|0|||
129892724|NCT02065245|467567650|FG004|Infusion 1|Lost to Follow-up|0|||
129892725|NCT02065245|467567651|FG005|Infusion 1|Lost to Follow-up|0|||
129892726|NCT02065245|467567652|FG006|Infusion 1|Lost to Follow-up|1|||
129892727|NCT02065245|467567646|FG000|Infusion 1|Death|0|||
129892728|NCT02065245|467567647|FG001|Infusion 1|Death|0|||
129892729|NCT02065245|467567648|FG002|Infusion 1|Death|1|||
129892730|NCT02065245|467567649|FG003|Infusion 1|Death|0|||
129892731|NCT02065245|467567650|FG004|Infusion 1|Death|1|||
129892732|NCT02065245|467567651|FG005|Infusion 1|Death|0|||
130054949|NCT03484923|468156329|FG001|Overall Study|Adverse Event|3|||
129892733|NCT02065245|467567652|FG006|Infusion 1|Death|0|||
130054950|NCT03484923|468156330|FG002|Overall Study|Adverse Event|5|||
129892734|NCT02065245|467567646|FG000|Infusion 2|Death|0|||
129892735|NCT02065245|467567647|FG001|Infusion 2|Death|0|||
129892736|NCT02065245|467567648|FG002|Infusion 2|Death|0|||
129892737|NCT02065245|467567649|FG003|Infusion 2|Death|0|||
129892738|NCT02065245|467567650|FG004|Infusion 2|Death|0|||
129892739|NCT02065245|467567651|FG005|Infusion 2|Death|0|||
129892740|NCT02065245|467567652|FG006|Infusion 2|Death|1|||
129892741|NCT02065245|467567646|FG000|Infusion 3|Lost to Follow-up|1|||
129892742|NCT02065245|467567647|FG001|Infusion 3|Lost to Follow-up|1|||
129892743|NCT02065245|467567648|FG002|Infusion 3|Lost to Follow-up|0|||
129892744|NCT02065245|467567649|FG003|Infusion 3|Lost to Follow-up|0|||
129892745|NCT02065245|467567650|FG004|Infusion 3|Lost to Follow-up|0|||
129892746|NCT02065245|467567651|FG005|Infusion 3|Lost to Follow-up|0|||
129892747|NCT02065245|467567652|FG006|Infusion 3|Lost to Follow-up|0|||
129892748|NCT01518257|467567653|FG000|Overall Study|Lost to Follow-up|1|||
129892749|NCT01518257|467567654|FG001|Overall Study|Lost to Follow-up|0|||
129892750|NCT01518257|467567653|FG000|Overall Study|Other Miscellaneous Reason|1|||
129892751|NCT01518257|467567654|FG001|Overall Study|Other Miscellaneous Reason|0|||
129892752|NCT01304706|467567655|FG000|Overall Study|Adverse Event|2|||
129892753|NCT01304706|467567655|FG000|Overall Study|Lack of Efficacy|1|||
129892754|NCT01304706|467567655|FG000|Overall Study|Death|3|||
129892755|NCT01304706|467567655|FG000|Overall Study|Withdrawal by Subject|3|||
129892756|NCT01304706|467567655|FG000|Overall Study|Lost to Follow-up|7|||
129892757|NCT01304706|467567655|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
129892758|NCT00924664|467567656|FG000|Overall Study|Adverse Event|23|||
129892759|NCT00924664|467567657|FG001|Overall Study|Adverse Event|39|||
129892760|NCT00924664|467567656|FG000|Overall Study|Lack of Efficacy|10|||
129892761|NCT00924664|467567657|FG001|Overall Study|Lack of Efficacy|15|||
129892762|NCT00924664|467567656|FG000|Overall Study|Lost to Follow-up|10|||
129892763|NCT00924664|467567657|FG001|Overall Study|Lost to Follow-up|12|||
129892764|NCT00924664|467567656|FG000|Overall Study|Withdrawal by Subject|47|||
129892765|NCT00924664|467567657|FG001|Overall Study|Withdrawal by Subject|71|||
129892766|NCT00924664|467567656|FG000|Overall Study|Protocol Violation|2|||
129892767|NCT00924664|467567657|FG001|Overall Study|Protocol Violation|5|||
129892768|NCT00924664|467567656|FG000|Overall Study|Pregnancy|1|||
129892769|NCT00924664|467567657|FG001|Overall Study|Pregnancy|1|||
129892770|NCT00924664|467567656|FG000|Overall Study|Death|0|||
129892771|NCT00924664|467567657|FG001|Overall Study|Death|2|||
129892772|NCT00924664|467567656|FG000|Overall Study|Study terminated by sponsor|199|||
129892773|NCT00924664|467567657|FG001|Overall Study|Study terminated by sponsor|330|||
129892774|NCT00924664|467567656|FG000|Overall Study|Other|29|||
129892775|NCT00924664|467567657|FG001|Overall Study|Other|52|||
129892776|NCT00924664|467567656|FG000|Overall Study|Randomized but not Treated|1|||
129804288|NCT01332331|467251486|FG000|Overall Study|Adverse Event|1|||
129804289|NCT01332331|467251487|FG001|Overall Study|Adverse Event|1|||
129804290|NCT01332331|467251486|FG000|Overall Study|Physician Decision|1|||
129804291|NCT01332331|467251487|FG001|Overall Study|Physician Decision|0|||
129804292|NCT00538291|467251488|FG000|Overall Study|Adverse Event|2|||
129804293|NCT00538291|467251488|FG000|Overall Study|Withdrawal by Subject|1|||
129804294|NCT00591344|467251489|FG000|Overall Study|Transportation issues|1|||
129804295|NCT00591344|467251490|FG001|Overall Study|Transportation issues|0|||
129804296|NCT00591344|467251489|FG000|Overall Study|Moved out of state|1|||
129804297|NCT00591344|467251490|FG001|Overall Study|Moved out of state|0|||
129804298|NCT00591344|467251489|FG000|Overall Study|Medical complications|1|||
129804299|NCT00591344|467251490|FG001|Overall Study|Medical complications|3|||
129804300|NCT00591344|467251489|FG000|Overall Study|Underwent DBS|2|||
129804301|NCT00591344|467251490|FG001|Overall Study|Underwent DBS|2|||
129804302|NCT00591344|467251489|FG000|Overall Study|Death|0|||
129804303|NCT00591344|467251490|FG001|Overall Study|Death|1|||
129804304|NCT00591344|467251489|FG000|Overall Study|Lost to Follow-up|0|||
129804305|NCT00591344|467251490|FG001|Overall Study|Lost to Follow-up|1|||
129804306|NCT00591344|467251489|FG000|Overall Study|Did not want to come off medication|0|||
129804307|NCT00591344|467251490|FG001|Overall Study|Did not want to come off medication|1|||
129804308|NCT01672736|467251497|FG000|Overall Study|Available drug expired on 31 May 16|3|||
129892777|NCT00924664|467567657|FG001|Overall Study|Randomized but not Treated|0|||
129892778|NCT03158948|467567658|FG000|Overall Study|Death|1|||
129892779|NCT03158948|467567659|FG001|Overall Study|Death|1|||
129892780|NCT03158948|467567660|FG002|Overall Study|Death|3|||
129804309|NCT01262573|467251498|FG000|Overall Study|Withdrawal by Subject|0|||
129804310|NCT01262573|467251499|FG001|Overall Study|Withdrawal by Subject|1|||
129892781|NCT03158948|467567661|FG003|Overall Study|Death|2|||
129804311|NCT03800173|467251506|FG000|Overall Study|Lost to Follow-up|0|||
129804312|NCT03800173|467251507|FG001|Overall Study|Lost to Follow-up|0|||
129804313|NCT03800173|467251508|FG002|Overall Study|Lost to Follow-up|0|||
129804314|NCT03800173|467251509|FG003|Overall Study|Lost to Follow-up|0|||
129804315|NCT03800173|467251510|FG004|Overall Study|Lost to Follow-up|1|||
129804316|NCT00936611|467251511|FG000|Overall Study|Progressive Disease|3|||
129892782|NCT03158948|467567658|FG000|Overall Study|Physician Decision|0|||
129892783|NCT03158948|467567659|FG001|Overall Study|Physician Decision|0|||
129892784|NCT03158948|467567660|FG002|Overall Study|Physician Decision|0|||
129892785|NCT03158948|467567661|FG003|Overall Study|Physician Decision|1|||
129892786|NCT01876043|467567662|FG000|Overall Study|Death|1|||
129892787|NCT01876043|467567662|FG000|Overall Study|Withdrawal by Subject|1|||
129892788|NCT00079937|467567663|FG000|Overall Study|Adverse Event|2|||
129892789|NCT00079937|467567664|FG001|Overall Study|Adverse Event|1|||
130054951|NCT03484923|468156331|FG003|Overall Study|Adverse Event|11|||
129804317|NCT00936611|467251511|FG000|Overall Study|New Systemic Therapy|22|||
129804318|NCT00936611|467251511|FG000|Overall Study|Lost to Follow-up|1|||
129804319|NCT00936611|467251511|FG000|Overall Study|Withdrawal by Subject|2|||
129804320|NCT00936611|467251511|FG000|Overall Study|Still on Follow-up|1|||
129804321|NCT00936611|467251511|FG000|Overall Study|Still on Active Therapy|7|||
129804322|NCT00936611|467251511|FG000|Overall Study|Ineligible for Study Drug|3|||
129804323|NCT02507973|467251512|FG000|Overall Study|Adverse Event|1|||
129804324|NCT02081183|467251514|FG000|Overall Study|Lost to Follow-up|0|||
130111461|NCT03751020|468369478|FG001|Overall Study|Lost to Follow-up|4|||
130111462|NCT03751020|468369479|FG002|Overall Study|Lost to Follow-up|10|||
130111463|NCT00078819|468369482|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
130111464|NCT00078819|468369483|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
130111465|NCT00078819|468369484|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
130111466|NCT00078819|468369485|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
130111467|NCT00078819|468369482|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
130111468|NCT00078819|468369483|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
130111469|NCT00078819|468369484|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
130111470|NCT00078819|468369485|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
130111471|NCT00078819|468369482|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
130111472|NCT00078819|468369483|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
130111473|NCT00078819|468369484|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
130111474|NCT00078819|468369485|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
129804325|NCT02081183|467251515|FG001|Overall Study|Lost to Follow-up|1|||
129804326|NCT02081183|467251514|FG000|Overall Study|Protocol Violation|1|||
129804327|NCT02081183|467251515|FG001|Overall Study|Protocol Violation|0|||
129804328|NCT02081183|467251514|FG000|Overall Study|Other|3|||
129804329|NCT02081183|467251515|FG001|Overall Study|Other|3|||
129804330|NCT00910273|467251520|FG000|Overall Study|Lack of Efficacy|6|||
129804331|NCT00910273|467251521|FG001|Overall Study|Lack of Efficacy|9|||
129804332|NCT00910273|467251520|FG000|Overall Study|Adverse Event|1|||
129804333|NCT00910273|467251521|FG001|Overall Study|Adverse Event|1|||
129804334|NCT00910273|467251520|FG000|Overall Study|Withdrawal by Subject|1|||
129804335|NCT00910273|467251521|FG001|Overall Study|Withdrawal by Subject|0|||
129804336|NCT00910273|467251520|FG000|Overall Study|Discontinuation of study by sponsor|8|||
129804337|NCT00910273|467251521|FG001|Overall Study|Discontinuation of study by sponsor|2|||
129804338|NCT00910273|467251520|FG000|Overall Study|Protocol Violation|1|||
129804339|NCT00910273|467251521|FG001|Overall Study|Protocol Violation|0|||
129892790|NCT00079937|467567663|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129892791|NCT00079937|467567664|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129892792|NCT00079937|467567663|FG000|Overall Study|Subject no longer requires study drug|3|||
129892793|NCT00079937|467567664|FG001|Overall Study|Subject no longer requires study drug|0|||
129892794|NCT00079937|467567663|FG000|Overall Study|Protocol Violation|8|||
130054952|NCT03484923|468156332|FG004|Overall Study|Adverse Event|1|||
130054953|NCT03484923|468156328|FG000|Overall Study|Death|2|||
130054954|NCT03484923|468156329|FG001|Overall Study|Death|2|||
130054955|NCT03484923|468156330|FG002|Overall Study|Death|3|||
130054956|NCT03484923|468156331|FG003|Overall Study|Death|0|||
130054957|NCT03484923|468156332|FG004|Overall Study|Death|1|||
130054958|NCT03484923|468156328|FG000|Overall Study|Physician Decision|6|||
130054959|NCT03484923|468156329|FG001|Overall Study|Physician Decision|7|||
130054960|NCT03484923|468156330|FG002|Overall Study|Physician Decision|6|||
130054961|NCT03484923|468156331|FG003|Overall Study|Physician Decision|3|||
130111475|NCT00078819|468369482|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
130111476|NCT00078819|468369483|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
130111477|NCT00078819|468369484|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
129804340|NCT00910273|467251520|FG000|Overall Study|Lost to Follow-up|1|||
130054962|NCT03484923|468156332|FG004|Overall Study|Physician Decision|2|||
130054963|NCT03484923|468156328|FG000|Overall Study|Progressive disease|33|||
130054964|NCT03484923|468156329|FG001|Overall Study|Progressive disease|28|||
130054965|NCT03484923|468156330|FG002|Overall Study|Progressive disease|26|||
130054966|NCT03484923|468156331|FG003|Overall Study|Progressive disease|30|||
130054967|NCT03484923|468156332|FG004|Overall Study|Progressive disease|16|||
130054968|NCT03484923|468156328|FG000|Overall Study|Subject Decision|1|||
130054969|NCT03484923|468156329|FG001|Overall Study|Subject Decision|3|||
130054970|NCT03484923|468156330|FG002|Overall Study|Subject Decision|3|||
130054971|NCT03484923|468156331|FG003|Overall Study|Subject Decision|0|||
130054972|NCT03484923|468156332|FG004|Overall Study|Subject Decision|1|||
130054973|NCT03165721|468156337|FG000|Overall Study|Refused further treatment|3|||
130054974|NCT03165721|468156338|FG001|Overall Study|Refused further treatment|0|||
130054975|NCT03165721|468156339|FG002|Overall Study|Refused further treatment|0|||
130054976|NCT03165721|468156337|FG000|Overall Study|Physician Decision|1|||
130054977|NCT03165721|468156338|FG001|Overall Study|Physician Decision|0|||
130054978|NCT03165721|468156339|FG002|Overall Study|Physician Decision|0|||
130054979|NCT01863849|468156340|FG000|Overall Study|Lost to Follow-up|1|||
130054980|NCT01863849|468156341|FG001|Overall Study|Lost to Follow-up|0|||
130054981|NCT01457118|468156342|FG000|Overall Study|Adverse Event|1|||
130054982|NCT01457118|468156343|FG001|Overall Study|Adverse Event|0|||
130054983|NCT01457118|468156344|FG002|Overall Study|Adverse Event|0|||
130054984|NCT01457118|468156345|FG003|Overall Study|Adverse Event|1|||
130054985|NCT01457118|468156342|FG000|Overall Study|Clinical Progression|0|||
130054986|NCT01457118|468156343|FG001|Overall Study|Clinical Progression|1|||
130054987|NCT01457118|468156344|FG002|Overall Study|Clinical Progression|0|||
130054988|NCT01457118|468156345|FG003|Overall Study|Clinical Progression|1|||
130054989|NCT01457118|468156342|FG000|Overall Study|Physician Decision|2|||
130054990|NCT01457118|468156343|FG001|Overall Study|Physician Decision|0|||
130054991|NCT01457118|468156344|FG002|Overall Study|Physician Decision|0|||
130054992|NCT01457118|468156345|FG003|Overall Study|Physician Decision|0|||
130054993|NCT01457118|468156342|FG000|Overall Study|Progressive Disease by RECIST|12|||
130054994|NCT01457118|468156343|FG001|Overall Study|Progressive Disease by RECIST|3|||
130054995|NCT01457118|468156344|FG002|Overall Study|Progressive Disease by RECIST|1|||
130054996|NCT01457118|468156345|FG003|Overall Study|Progressive Disease by RECIST|0|||
130054997|NCT01457118|468156342|FG000|Overall Study|Withdrawal by Subject|5|||
130054998|NCT01457118|468156343|FG001|Overall Study|Withdrawal by Subject|0|||
130054999|NCT01457118|468156344|FG002|Overall Study|Withdrawal by Subject|0|||
130055000|NCT01457118|468156345|FG003|Overall Study|Withdrawal by Subject|0|||
130055001|NCT01718509|468156348|FG000|Overall Study|Lost to Follow-up|18|||
130055002|NCT01718509|468156349|FG001|Overall Study|Lost to Follow-up|15|||
130055003|NCT01718509|468156348|FG000|Overall Study|Withdrawal by Subject|7|||
130055004|NCT01718509|468156349|FG001|Overall Study|Withdrawal by Subject|13|||
129804341|NCT00910273|467251521|FG001|Overall Study|Lost to Follow-up|1|||
129804342|NCT01011738|467251522|FG000|Overall Study|Death|12|||
129804343|NCT01011738|467251523|FG001|Overall Study|Death|3|||
129804344|NCT01011738|467251524|FG002|Overall Study|Death|0|||
129804345|NCT01011738|467251522|FG000|Overall Study|Unknown reasons|312|||
129804346|NCT01011738|467251523|FG001|Overall Study|Unknown reasons|291|||
129804347|NCT01011738|467251524|FG002|Overall Study|Unknown reasons|17|||
129804348|NCT03841448|467251525|FG000|Double-blind Treatment (DBT) Period|Death|1|||
129804349|NCT03841448|467251526|FG001|Double-blind Treatment (DBT) Period|Death|1|||
129804350|NCT03841448|467251527|FG002|Double-blind Treatment (DBT) Period|Death|0|||
129804351|NCT03841448|467251528|FG003|Double-blind Treatment (DBT) Period|Death|0|||
129804352|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
129804353|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
129804354|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
129804355|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
129804356|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Death|0|||
129804357|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Death|0|||
129804358|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Death|0|||
130055005|NCT01718509|468156348|FG000|Overall Study|Adverse Event|5|||
130055006|NCT01718509|468156349|FG001|Overall Study|Adverse Event|7|||
130055007|NCT01718509|468156348|FG000|Overall Study|Other|13|||
130055008|NCT01718509|468156349|FG001|Overall Study|Other|11|||
129804359|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Death|1|||
129804360|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130055009|NCT01718509|468156348|FG000|Overall Study|Protocol Violation|4|||
129804361|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130055010|NCT01718509|468156349|FG001|Overall Study|Protocol Violation|2|||
130055011|NCT01718509|468156348|FG000|Overall Study|Lack of Efficacy|1|||
130055012|NCT01718509|468156349|FG001|Overall Study|Lack of Efficacy|0|||
130055013|NCT00879814|468156352|FG000|Overall Study|Adverse Event|0|||
130055014|NCT00879814|468156353|FG001|Overall Study|Adverse Event|1|||
130055015|NCT00879814|468156354|FG002|Overall Study|Adverse Event|0|||
130055016|NCT00879814|468156355|FG003|Overall Study|Adverse Event|0|||
130055017|NCT00879814|468156352|FG000|Overall Study|Lost to Follow-up|1|||
130055018|NCT00879814|468156353|FG001|Overall Study|Lost to Follow-up|0|||
130055019|NCT00879814|468156354|FG002|Overall Study|Lost to Follow-up|0|||
130055020|NCT00879814|468156355|FG003|Overall Study|Lost to Follow-up|2|||
130055021|NCT00879814|468156352|FG000|Overall Study|Participant Failed to Return|0|||
130055022|NCT00879814|468156353|FG001|Overall Study|Participant Failed to Return|0|||
130055023|NCT00879814|468156354|FG002|Overall Study|Participant Failed to Return|0|||
130055024|NCT00879814|468156355|FG003|Overall Study|Participant Failed to Return|1|||
130055025|NCT00879814|468156352|FG000|Overall Study|Withdrawal by Subject|3|||
130055026|NCT00879814|468156353|FG001|Overall Study|Withdrawal by Subject|1|||
130055027|NCT00879814|468156354|FG002|Overall Study|Withdrawal by Subject|1|||
130055028|NCT00879814|468156355|FG003|Overall Study|Withdrawal by Subject|2|||
130055029|NCT00879814|468156352|FG000|Overall Study|Physician Decision|0|||
130055030|NCT00879814|468156353|FG001|Overall Study|Physician Decision|0|||
130055031|NCT00879814|468156354|FG002|Overall Study|Physician Decision|1|||
130055032|NCT00879814|468156355|FG003|Overall Study|Physician Decision|0|||
130055033|NCT00879814|468156352|FG000|Overall Study|Other|0|||
130055034|NCT00879814|468156353|FG001|Overall Study|Other|0|||
130055035|NCT00879814|468156354|FG002|Overall Study|Other|1|||
130055036|NCT00879814|468156355|FG003|Overall Study|Other|0|||
130055037|NCT00630812|468156368|FG000|Randomisation to First Dose|Adverse Event|1|||
130055038|NCT00630812|468156369|FG001|Randomisation to First Dose|Adverse Event|1|||
130055039|NCT00630812|468156368|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
130055040|NCT00630812|468156369|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
130055041|NCT00630812|468156368|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
130055042|NCT00630812|468156369|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
130055043|NCT00630812|468156368|FG000|Randomisation to First Dose|Protocol Violation|4|||
129892795|NCT00079937|467567664|FG001|Overall Study|Protocol Violation|6|||
130055044|NCT00630812|468156369|FG001|Randomisation to First Dose|Protocol Violation|1|||
130055045|NCT00630812|468156368|FG000|Double Blind Treatment Period|Adverse Event|13|||
130055046|NCT00630812|468156369|FG001|Double Blind Treatment Period|Adverse Event|5|||
130055047|NCT00630812|468156368|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
130055048|NCT00630812|468156369|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
130055049|NCT00630812|468156368|FG000|Double Blind Treatment Period|Physician Decision|2|||
130055050|NCT00630812|468156369|FG001|Double Blind Treatment Period|Physician Decision|1|||
130055051|NCT00630812|468156368|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130055052|NCT00630812|468156369|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130055053|NCT00630812|468156368|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
130055054|NCT00630812|468156369|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
130055055|NCT00630812|468156368|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
130055056|NCT00630812|468156369|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
130055057|NCT00630812|468156368|FG000|Double Blind Treatment Period|Non-compliance|0|||
130055058|NCT00630812|468156369|FG001|Double Blind Treatment Period|Non-compliance|1|||
130055059|NCT01219959|468156370|FG000|Overall Study|Adverse Event|6|||
130055060|NCT01219959|468156371|FG001|Overall Study|Adverse Event|14|||
130055061|NCT01219959|468156370|FG000|Overall Study|Physician Decision|0|||
130055062|NCT01219959|468156371|FG001|Overall Study|Physician Decision|4|||
130055063|NCT01219959|468156370|FG000|Overall Study|Withdrawal by Subject|0|||
130055064|NCT01219959|468156371|FG001|Overall Study|Withdrawal by Subject|2|||
130055065|NCT01219959|468156370|FG000|Overall Study|Renal Transplantation|0|||
130055066|NCT01219959|468156371|FG001|Overall Study|Renal Transplantation|3|||
130055067|NCT01219959|468156370|FG000|Overall Study|Other|1|||
130055068|NCT01219959|468156371|FG001|Overall Study|Other|0|||
130055069|NCT02935634|468156372|FG000|Randomization|Participant withdrew consent|0|||
130055070|NCT02935634|468156373|FG001|Randomization|Participant withdrew consent|1|||
130055071|NCT02935634|468156374|FG002|Randomization|Participant withdrew consent|0|||
130055072|NCT02935634|468156375|FG003|Randomization|Participant withdrew consent|0|||
130055073|NCT02935634|468156376|FG004|Randomization|Participant withdrew consent|0|||
130055074|NCT02935634|468156377|FG005|Randomization|Participant withdrew consent|0|||
130055075|NCT02935634|468156372|FG000|Randomization|Death|2|||
130055076|NCT02935634|468156373|FG001|Randomization|Death|1|||
130055077|NCT02935634|468156374|FG002|Randomization|Death|1|||
130055078|NCT02935634|468156375|FG003|Randomization|Death|0|||
130055079|NCT02935634|468156376|FG004|Randomization|Death|0|||
130055080|NCT02935634|468156377|FG005|Randomization|Death|0|||
130055081|NCT02935634|468156372|FG000|Randomization|Other reasons|0|||
130055082|NCT02935634|468156373|FG001|Randomization|Other reasons|2|||
130055083|NCT02935634|468156374|FG002|Randomization|Other reasons|2|||
130055084|NCT02935634|468156375|FG003|Randomization|Other reasons|0|||
130055085|NCT02935634|468156376|FG004|Randomization|Other reasons|0|||
130055086|NCT02935634|468156377|FG005|Randomization|Other reasons|0|||
130055087|NCT02935634|468156372|FG000|Treatment: Track 1|Disease progression|15|||
130055088|NCT02935634|468156373|FG001|Treatment: Track 1|Disease progression|17|||
130055089|NCT02935634|468156374|FG002|Treatment: Track 1|Disease progression|28|||
130055090|NCT02935634|468156375|FG003|Treatment: Track 1|Disease progression|4|||
130055091|NCT02935634|468156376|FG004|Treatment: Track 1|Disease progression|6|||
130055092|NCT02935634|468156377|FG005|Treatment: Track 1|Disease progression|2|||
130055093|NCT02935634|468156372|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
130055094|NCT02935634|468156373|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
130055095|NCT02935634|468156374|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
130055096|NCT02935634|468156375|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
130055097|NCT02935634|468156376|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
130055098|NCT02935634|468156377|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
130055099|NCT02935634|468156372|FG000|Treatment: Track 1|Lost to Follow-up|1|||
130055100|NCT02935634|468156373|FG001|Treatment: Track 1|Lost to Follow-up|0|||
130055101|NCT02935634|468156374|FG002|Treatment: Track 1|Lost to Follow-up|0|||
130055102|NCT02935634|468156375|FG003|Treatment: Track 1|Lost to Follow-up|0|||
130055103|NCT02935634|468156376|FG004|Treatment: Track 1|Lost to Follow-up|0|||
130055104|NCT02935634|468156377|FG005|Treatment: Track 1|Lost to Follow-up|0|||
130055105|NCT02935634|468156372|FG000|Treatment: Track 1|Study drug toxicity|2|||
130055106|NCT02935634|468156373|FG001|Treatment: Track 1|Study drug toxicity|1|||
130055107|NCT02935634|468156374|FG002|Treatment: Track 1|Study drug toxicity|3|||
130055108|NCT02935634|468156375|FG003|Treatment: Track 1|Study drug toxicity|0|||
130055109|NCT02935634|468156376|FG004|Treatment: Track 1|Study drug toxicity|0|||
130055110|NCT02935634|468156377|FG005|Treatment: Track 1|Study drug toxicity|1|||
130055111|NCT02935634|468156372|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
130055112|NCT02935634|468156373|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
130055113|NCT02935634|468156374|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
130055114|NCT02935634|468156375|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
130055115|NCT02935634|468156376|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
130055116|NCT02935634|468156377|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
130055117|NCT02935634|468156372|FG000|Treatment: Track 1|Participant withdrew consent|2|||
130055118|NCT02935634|468156373|FG001|Treatment: Track 1|Participant withdrew consent|0|||
130055119|NCT02935634|468156374|FG002|Treatment: Track 1|Participant withdrew consent|1|||
130055120|NCT02935634|468156375|FG003|Treatment: Track 1|Participant withdrew consent|0|||
130055121|NCT02935634|468156376|FG004|Treatment: Track 1|Participant withdrew consent|1|||
130055122|NCT02935634|468156377|FG005|Treatment: Track 1|Participant withdrew consent|0|||
130055123|NCT02935634|468156372|FG000|Treatment: Track 1|Other reasons|0|||
130055124|NCT02935634|468156373|FG001|Treatment: Track 1|Other reasons|0|||
130055125|NCT02935634|468156374|FG002|Treatment: Track 1|Other reasons|2|||
130055126|NCT02935634|468156375|FG003|Treatment: Track 1|Other reasons|0|||
130055127|NCT02935634|468156376|FG004|Treatment: Track 1|Other reasons|0|||
130055128|NCT02935634|468156377|FG005|Treatment: Track 1|Other reasons|0|||
130055129|NCT02935634|468156372|FG000|Treatment: Track 2|Disease progression|13|||
130055130|NCT02935634|468156373|FG001|Treatment: Track 2|Disease progression|26|||
130055131|NCT02935634|468156374|FG002|Treatment: Track 2|Disease progression|20|||
130055132|NCT02935634|468156375|FG003|Treatment: Track 2|Disease progression|5|||
130055133|NCT02935634|468156376|FG004|Treatment: Track 2|Disease progression|1|||
130055134|NCT02935634|468156377|FG005|Treatment: Track 2|Disease progression|4|||
130055135|NCT02935634|468156372|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
130055136|NCT02935634|468156373|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
130055137|NCT02935634|468156374|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130055138|NCT02935634|468156375|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130055139|NCT02935634|468156376|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130055140|NCT02935634|468156377|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
130055141|NCT02935634|468156372|FG000|Treatment: Track 2|Study drug toxicity|7|||
130055142|NCT02935634|468156373|FG001|Treatment: Track 2|Study drug toxicity|3|||
130055143|NCT02935634|468156374|FG002|Treatment: Track 2|Study drug toxicity|0|||
130055144|NCT02935634|468156375|FG003|Treatment: Track 2|Study drug toxicity|0|||
130055145|NCT02935634|468156376|FG004|Treatment: Track 2|Study drug toxicity|0|||
130055146|NCT02935634|468156377|FG005|Treatment: Track 2|Study drug toxicity|0|||
130055147|NCT02935634|468156372|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
130055148|NCT02935634|468156373|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
130055149|NCT02935634|468156374|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
130055150|NCT02935634|468156375|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
130055151|NCT02935634|468156376|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
130055152|NCT02935634|468156377|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
130055153|NCT02935634|468156372|FG000|Treatment: Track 2|Participant withdrew consent|0|||
130055154|NCT02935634|468156373|FG001|Treatment: Track 2|Participant withdrew consent|1|||
130055155|NCT02935634|468156374|FG002|Treatment: Track 2|Participant withdrew consent|1|||
130055156|NCT02935634|468156375|FG003|Treatment: Track 2|Participant withdrew consent|0|||
130055157|NCT02935634|468156376|FG004|Treatment: Track 2|Participant withdrew consent|1|||
130055158|NCT02935634|468156377|FG005|Treatment: Track 2|Participant withdrew consent|0|||
130055159|NCT03656926|468156378|FG000|Overall Study|Adverse Event|5|||
130055160|NCT03656926|468156379|FG001|Overall Study|Adverse Event|4|||
130055161|NCT03656926|468156378|FG000|Overall Study|Withdrawal by Subject|7|||
130055162|NCT03656926|468156379|FG001|Overall Study|Withdrawal by Subject|2|||
130055163|NCT03656926|468156378|FG000|Overall Study|Screen fail after randomization|1|||
130055164|NCT03656926|468156379|FG001|Overall Study|Screen fail after randomization|0|||
130055165|NCT03656926|468156378|FG000|Overall Study|PI decision due to patient condition|1|||
130055166|NCT03656926|468156379|FG001|Overall Study|PI decision due to patient condition|0|||
130055167|NCT03656926|468156378|FG000|Overall Study|Patient unresponsiveness|1|||
130055168|NCT03656926|468156379|FG001|Overall Study|Patient unresponsiveness|0|||
130055169|NCT05610176|468156380|FG000|Overall Study|Death|6|||
130055170|NCT00506077|468156381|FG000|Treatment Period 1|Adverse Event|2|||
130055171|NCT00506077|468156382|FG001|Treatment Period 1|Adverse Event|1|||
130055172|NCT00506077|468156381|FG000|Treatment Period 1|Lost to Follow-up|0|||
130055173|NCT00506077|468156382|FG001|Treatment Period 1|Lost to Follow-up|2|||
130055174|NCT00506077|468156381|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130055175|NCT00506077|468156382|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130055176|NCT00506077|468156381|FG000|Treatment Period 2|Adverse Event|0|||
130055177|NCT00506077|468156382|FG001|Treatment Period 2|Adverse Event|1|||
130055178|NCT00506077|468156381|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130055179|NCT00506077|468156382|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130055180|NCT00316303|468156383|FG000|Overall Study|Lost to Follow-up|11|||
130055181|NCT00316303|468156384|FG001|Overall Study|Lost to Follow-up|16|||
130055182|NCT03885726|468156387|FG000|Overall Study|Staffing issues/lost interest|1|||
130055183|NCT03885726|468156387|FG000|Overall Study|Early discharge from hospital|3|||
130055184|NCT01217190|468156388|FG000|Second Dosing|Withdrawal by Subject|0|||
130055185|NCT01217190|468156389|FG001|Second Dosing|Withdrawal by Subject|2|||
130055186|NCT03116399|468156390|FG000|Overall Study|Death|8|||
130055187|NCT03116399|468156391|FG001|Overall Study|Death|3|||
130055188|NCT03116399|468156390|FG000|Overall Study|Lost to Follow-up|7|||
130055189|NCT03116399|468156391|FG001|Overall Study|Lost to Follow-up|11|||
130055190|NCT03116399|468156390|FG000|Overall Study|Investigator Decision|1|||
130055191|NCT03116399|468156391|FG001|Overall Study|Investigator Decision|1|||
130055192|NCT03116399|468156390|FG000|Overall Study|Withdrawal by Subject|24|||
130055193|NCT03116399|468156391|FG001|Overall Study|Withdrawal by Subject|9|||
130055194|NCT02868216|468156394|FG000|Overall Study|Death|0|||
129892796|NCT00079937|467567663|FG000|Overall Study|Withdrawal by Subject|21|||
129892797|NCT00079937|467567664|FG001|Overall Study|Withdrawal by Subject|7|||
129892798|NCT00079937|467567663|FG000|Overall Study|Lost to Follow-up|12|||
129892799|NCT00079937|467567664|FG001|Overall Study|Lost to Follow-up|5|||
129892800|NCT00079937|467567663|FG000|Overall Study|Administrative problems|22|||
129892801|NCT00079937|467567664|FG001|Overall Study|Administrative problems|11|||
129892802|NCT01616563|467567665|FG000|Overall Study|Lost to Follow-up|40|||
129892803|NCT02206685|467567666|FG000|Overall Study|Surgery cancelled/changed|2|||
129892804|NCT02206685|467567667|FG001|Overall Study|Surgery cancelled/changed|3|||
129892805|NCT02206685|467567666|FG000|Overall Study|Withdrawal by Subject|1|||
129892806|NCT02206685|467567667|FG001|Overall Study|Withdrawal by Subject|2|||
129892807|NCT02206685|467567666|FG000|Overall Study|Protocol Violation|2|||
129892808|NCT02206685|467567667|FG001|Overall Study|Protocol Violation|2|||
129892809|NCT01195675|467567671|FG000|Overall Study|Adverse Event|1|||
129892810|NCT01195675|467567671|FG000|Overall Study|Withdrawal by Subject|2|||
129892811|NCT01106287|467567672|FG000|Overall Study|Adverse Event|1|||
129892812|NCT01106287|467567673|FG001|Overall Study|Adverse Event|0|||
129892813|NCT01106287|467567674|FG002|Overall Study|Adverse Event|0|||
129892814|NCT01106287|467567675|FG003|Overall Study|Adverse Event|0|||
129892815|NCT00072475|467567676|FG000|Overall Study|Adverse Event|44|||
129892816|NCT00072475|467567676|FG000|Overall Study|Death|3|||
129892817|NCT00072475|467567676|FG000|Overall Study|Withdrawal by Subject|46|||
130055195|NCT02868216|468156395|FG001|Overall Study|Death|1|||
130055196|NCT02868216|468156394|FG000|Overall Study|coronary artery bypass|1|||
130055197|NCT02868216|468156395|FG001|Overall Study|coronary artery bypass|0|||
130055198|NCT02868216|468156394|FG000|Overall Study|Withdrawal by Subject|7|||
130055199|NCT02868216|468156395|FG001|Overall Study|Withdrawal by Subject|5|||
130055200|NCT01864018|468156398|FG000|Overall Study|Ineligible|3|||
130055201|NCT01864018|468156399|FG001|Overall Study|Ineligible|1|||
130055202|NCT03609359|468156404|FG000|Overall Study|Progression of primary disease (PD)|25|||
130055203|NCT03609359|468156404|FG000|Overall Study|Patient's refusal|1|||
130055204|NCT03609359|468156404|FG000|Overall Study|Physician Decision|1|||
130055205|NCT03609359|468156404|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
130055206|NCT01912729|468156406|FG000|Overall Study|Withdrawal by Subject|0|||
130055207|NCT01912729|468156407|FG001|Overall Study|Withdrawal by Subject|1|||
130055208|NCT00195260|468156408|FG000|Part 1: Dose Escalation|Adverse Event|0|||
130055209|NCT00195260|468156409|FG001|Part 1: Dose Escalation|Adverse Event|1|||
130055210|NCT00195260|468156410|FG002|Part 1: Dose Escalation|Adverse Event|0|||
130055211|NCT00195260|468156411|FG003|Part 1: Dose Escalation|Adverse Event|1|||
130055212|NCT00195260|468156412|FG004|Part 1: Dose Escalation|Adverse Event|1|||
130055213|NCT00195260|468156413|FG005|Part 1: Dose Escalation|Adverse Event|0|||
130055214|NCT00195260|468156414|FG006|Part 1: Dose Escalation|Adverse Event|3|||
130055215|NCT00195260|468156415|FG007|Part 1: Dose Escalation|Adverse Event|0|||
130055216|NCT00195260|468156416|FG008|Part 1: Dose Escalation|Adverse Event|0|||
130055217|NCT00195260|468156417|FG009|Part 1: Dose Escalation|Adverse Event|0|||
130055218|NCT00195260|468156418|FG010|Part 1: Dose Escalation|Adverse Event|0|||
130055219|NCT00195260|468156408|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055220|NCT00195260|468156409|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055221|NCT00195260|468156410|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055222|NCT00195260|468156411|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055223|NCT00195260|468156412|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
130055224|NCT00195260|468156413|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055225|NCT00195260|468156414|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055226|NCT00195260|468156415|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
130055227|NCT00195260|468156416|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129892818|NCT00072475|467567676|FG000|Overall Study|Patient/Investigator Decision|4|||
130055228|NCT00195260|468156417|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055229|NCT00195260|468156418|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
130055230|NCT00195260|468156408|FG000|Part 1: Dose Escalation|Death|0|||
129892819|NCT04730947|467567677|FG000|Overall Study|Withdrawal by Subject|0|||
130055231|NCT00195260|468156409|FG001|Part 1: Dose Escalation|Death|0|||
130055232|NCT00195260|468156410|FG002|Part 1: Dose Escalation|Death|0|||
130055233|NCT00195260|468156411|FG003|Part 1: Dose Escalation|Death|0|||
129892820|NCT04730947|467567678|FG001|Overall Study|Withdrawal by Subject|1|||
129892821|NCT00940017|467567679|FG000|Overall Study|did not meet entrance criteria|3|||
129892822|NCT00940017|467567679|FG000|Overall Study|Adverse Event|1|||
129892823|NCT01450943|467567680|FG000|Overall Study|Screen failure, loss to follow-up|2|||
129892824|NCT01450943|467567681|FG001|Overall Study|Screen failure, loss to follow-up|7|||
130111478|NCT00078819|468369485|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
130111479|NCT00078819|468369482|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
130111480|NCT00078819|468369483|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
130111481|NCT00078819|468369484|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
130111482|NCT00078819|468369485|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
130111483|NCT00078819|468369482|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
130111484|NCT00078819|468369483|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
130111485|NCT00078819|468369484|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
130111486|NCT00078819|468369485|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
130111487|NCT00078819|468369482|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
130111488|NCT00078819|468369483|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
130111489|NCT00078819|468369484|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
130111490|NCT00078819|468369485|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
130111491|NCT00078819|468369482|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
130111492|NCT00078819|468369483|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
130111493|NCT00078819|468369484|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
130111494|NCT00078819|468369485|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
130111495|NCT00667719|468369486|FG000|Overall Study|Adverse Event|39|||
130111496|NCT00667719|468369486|FG000|Overall Study|Abnormal Test Procedure|1|||
130111497|NCT00667719|468369486|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130111498|NCT00667719|468369486|FG000|Overall Study|Protocol Violation|3|||
130111499|NCT00667719|468369486|FG000|Overall Study|Withdrawal by Subject|17|||
130111500|NCT00667719|468369486|FG000|Overall Study|Lost to Follow-up|8|||
129804362|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
129804363|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
129804364|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
129804365|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
129804366|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
129804367|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
129804368|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
129804369|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
129804370|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
129804371|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
130111501|NCT00323609|468369487|FG000|Overall Study|Death|16|||
129804372|NCT00543543|467251529|FG000|Base Study|Adverse Event|1|||
129804373|NCT00543543|467251530|FG001|Base Study|Adverse Event|11|||
129804374|NCT00543543|467251531|FG002|Base Study|Adverse Event|0|||
129892825|NCT01450943|467567682|FG002|Overall Study|Screen failure, loss to follow-up|6|||
129892826|NCT01097655|467567685|FG000|Overall Study|Withdrawal by Subject|1|||
129892827|NCT01097655|467567685|FG000|Overall Study|Subject Documented Twice|1|||
130111502|NCT00323609|468369488|FG001|Overall Study|Death|21|||
130111503|NCT00323609|468369489|FG002|Overall Study|Death|0|||
130111504|NCT00323609|468369490|FG003|Overall Study|Death|0|||
130111505|NCT00323609|468369487|FG000|Overall Study|Lost to Follow-up|9|||
130111506|NCT00323609|468369488|FG001|Overall Study|Lost to Follow-up|10|||
130111507|NCT00323609|468369489|FG002|Overall Study|Lost to Follow-up|0|||
130111508|NCT00323609|468369490|FG003|Overall Study|Lost to Follow-up|0|||
130111509|NCT00323609|468369487|FG000|Overall Study|Physician Decision|2|||
129804375|NCT00543543|467251532|FG003|Base Study|Adverse Event|5|||
129804376|NCT00543543|467251529|FG000|Base Study|Lost to Follow-up|12|||
129804377|NCT00543543|467251530|FG001|Base Study|Lost to Follow-up|749|||
129804378|NCT00543543|467251531|FG002|Base Study|Lost to Follow-up|9|||
129804379|NCT00543543|467251532|FG003|Base Study|Lost to Follow-up|701|||
129804380|NCT00543543|467251529|FG000|Base Study|Physician Decision|0|||
129804381|NCT00543543|467251530|FG001|Base Study|Physician Decision|4|||
129804382|NCT00543543|467251531|FG002|Base Study|Physician Decision|0|||
130055234|NCT00195260|468156412|FG004|Part 1: Dose Escalation|Death|0|||
130055235|NCT00195260|468156413|FG005|Part 1: Dose Escalation|Death|0|||
130055236|NCT00195260|468156414|FG006|Part 1: Dose Escalation|Death|0|||
130055237|NCT00195260|468156415|FG007|Part 1: Dose Escalation|Death|1|||
130055238|NCT00195260|468156416|FG008|Part 1: Dose Escalation|Death|0|||
130055239|NCT00195260|468156417|FG009|Part 1: Dose Escalation|Death|0|||
130055240|NCT00195260|468156418|FG010|Part 1: Dose Escalation|Death|0|||
130055241|NCT00195260|468156408|FG000|Part 1: Dose Escalation|Disease Progression|3|||
130055242|NCT00195260|468156409|FG001|Part 1: Dose Escalation|Disease Progression|2|||
130055243|NCT00195260|468156410|FG002|Part 1: Dose Escalation|Disease Progression|5|||
130055244|NCT00195260|468156411|FG003|Part 1: Dose Escalation|Disease Progression|6|||
130055245|NCT00195260|468156412|FG004|Part 1: Dose Escalation|Disease Progression|4|||
130055246|NCT00195260|468156413|FG005|Part 1: Dose Escalation|Disease Progression|6|||
130055247|NCT00195260|468156414|FG006|Part 1: Dose Escalation|Disease Progression|7|||
130055248|NCT00195260|468156415|FG007|Part 1: Dose Escalation|Disease Progression|4|||
130055249|NCT00195260|468156416|FG008|Part 1: Dose Escalation|Disease Progression|0|||
130055250|NCT00195260|468156417|FG009|Part 1: Dose Escalation|Disease Progression|0|||
130055251|NCT00195260|468156418|FG010|Part 1: Dose Escalation|Disease Progression|0|||
130055252|NCT00195260|468156408|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130055253|NCT00195260|468156409|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130055254|NCT00195260|468156410|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130055255|NCT00195260|468156411|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055256|NCT00195260|468156412|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055257|NCT00195260|468156413|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
130055258|NCT00195260|468156414|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055259|NCT00195260|468156415|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055260|NCT00195260|468156416|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055261|NCT00195260|468156417|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055262|NCT00195260|468156418|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
130055263|NCT00195260|468156408|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130055264|NCT00195260|468156409|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130055265|NCT00195260|468156410|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129804383|NCT00543543|467251532|FG003|Base Study|Physician Decision|7|||
130055266|NCT00195260|468156411|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130055267|NCT00195260|468156412|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130055268|NCT00195260|468156413|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130111510|NCT00323609|468369488|FG001|Overall Study|Physician Decision|0|||
129892828|NCT01097655|467567685|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
129892829|NCT01345292|467567686|FG000|Overall Study|Withdrawal by Subject|2|||
129892830|NCT01345292|467567687|FG001|Overall Study|Withdrawal by Subject|0|||
129892831|NCT01345292|467567688|FG002|Overall Study|Withdrawal by Subject|1|||
129892832|NCT03303105|467567690|FG000|Overall Study|Adverse Event|0|||
129892833|NCT03303105|467567691|FG001|Overall Study|Adverse Event|2|||
129892834|NCT03303105|467567690|FG000|Overall Study|Lack of Efficacy|1|||
129892835|NCT03303105|467567691|FG001|Overall Study|Lack of Efficacy|0|||
129892836|NCT03303105|467567690|FG000|Overall Study|Protocol Violation|1|||
129892837|NCT03303105|467567691|FG001|Overall Study|Protocol Violation|0|||
129892838|NCT03303105|467567690|FG000|Overall Study|Withdrawal by Subject|0|||
129892839|NCT03303105|467567691|FG001|Overall Study|Withdrawal by Subject|2|||
129892840|NCT04822298|467567692|FG000|Overall Study|Death|3|||
129892841|NCT00852475|467567701|FG000|Overall Study|Lost to Follow-up|3|||
129892842|NCT00852475|467567702|FG001|Overall Study|Lost to Follow-up|4|||
129892843|NCT00515086|467567703|FG000|Overall Study|Adverse Event|1|||
129892844|NCT00515086|467567704|FG001|Overall Study|Adverse Event|1|||
129892845|NCT00515086|467567705|FG002|Overall Study|Adverse Event|2|||
129892846|NCT00515086|467567706|FG003|Overall Study|Adverse Event|3|||
129892847|NCT00515086|467567703|FG000|Overall Study|Administrative|1|||
129892848|NCT00515086|467567704|FG001|Overall Study|Administrative|1|||
129892849|NCT00515086|467567705|FG002|Overall Study|Administrative|0|||
129892850|NCT00515086|467567706|FG003|Overall Study|Administrative|0|||
129892851|NCT00515086|467567703|FG000|Overall Study|Withdrawal by Subject|1|||
129892852|NCT00515086|467567704|FG001|Overall Study|Withdrawal by Subject|0|||
129892853|NCT00515086|467567705|FG002|Overall Study|Withdrawal by Subject|0|||
130111511|NCT00323609|468369489|FG002|Overall Study|Physician Decision|0|||
129804384|NCT00543543|467251529|FG000|Base Study|Protocol Violation|0|||
129804385|NCT00543543|467251530|FG001|Base Study|Protocol Violation|6|||
129804386|NCT00543543|467251531|FG002|Base Study|Protocol Violation|0|||
129804387|NCT00543543|467251532|FG003|Base Study|Protocol Violation|6|||
129804388|NCT00543543|467251529|FG000|Base Study|Withdrawal by Subject|7|||
129804389|NCT00543543|467251530|FG001|Base Study|Withdrawal by Subject|482|||
129804390|NCT00543543|467251531|FG002|Base Study|Withdrawal by Subject|5|||
129804391|NCT00543543|467251532|FG003|Base Study|Withdrawal by Subject|503|||
129804392|NCT00543543|467251529|FG000|Extension Study|Adverse Event|0|||
129804393|NCT00543543|467251530|FG001|Extension Study|Adverse Event|0|||
129804394|NCT00543543|467251531|FG002|Extension Study|Adverse Event|0|||
129804395|NCT00543543|467251532|FG003|Extension Study|Adverse Event|5|||
129892854|NCT00515086|467567706|FG003|Overall Study|Withdrawal by Subject|1|||
129892855|NCT00515086|467567703|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130055269|NCT00195260|468156414|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130055270|NCT00195260|468156415|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
130055271|NCT00195260|468156416|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
130055272|NCT00195260|468156417|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
130055273|NCT00195260|468156418|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
130055274|NCT00195260|468156408|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055275|NCT00195260|468156409|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055276|NCT00195260|468156410|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055277|NCT00195260|468156411|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055278|NCT00195260|468156412|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055279|NCT00195260|468156413|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055280|NCT00195260|468156414|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055281|NCT00195260|468156415|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
130055282|NCT00195260|468156416|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
130055283|NCT00195260|468156417|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
130055284|NCT00195260|468156418|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
130055285|NCT00195260|468156408|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055286|NCT00195260|468156409|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055287|NCT00195260|468156410|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055288|NCT00195260|468156411|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055289|NCT00195260|468156412|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055290|NCT00195260|468156413|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055291|NCT00195260|468156414|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055292|NCT00195260|468156415|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
130055293|NCT00195260|468156416|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
130055294|NCT00195260|468156417|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
130055295|NCT00195260|468156418|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
130055296|NCT00195260|468156408|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055297|NCT00195260|468156409|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055298|NCT00195260|468156410|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055299|NCT00195260|468156411|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055300|NCT00195260|468156412|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055301|NCT00195260|468156413|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055302|NCT00195260|468156414|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055303|NCT00195260|468156415|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
130055304|NCT00195260|468156416|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
130055305|NCT00195260|468156417|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
130055306|NCT00195260|468156418|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
130055307|NCT01952834|468156421|FG000|Overall Study|Adverse Event|1|||
130055308|NCT04285346|468156422|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
130055309|NCT04285346|468156423|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
130055310|NCT04285346|468156422|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
130055311|NCT04285346|468156423|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130055312|NCT04285346|468156422|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
130055313|NCT04285346|468156423|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130055314|NCT01975272|468156426|FG000|Overall Study|Excluded after protocol amendment|1|||
130055315|NCT01975272|468156427|FG001|Overall Study|Excluded after protocol amendment|1|||
129804396|NCT00543543|467251529|FG000|Extension Study|Lost to Follow-up|0|||
129804397|NCT00543543|467251530|FG001|Extension Study|Lost to Follow-up|0|||
129804398|NCT00543543|467251531|FG002|Extension Study|Lost to Follow-up|0|||
129892856|NCT00515086|467567704|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130055316|NCT01975272|468156428|FG002|Overall Study|Excluded after protocol amendment|2|||
130055317|NCT00610935|468156429|FG000|Overall Study|Lost to Follow-up|0|||
130055318|NCT00610935|468156430|FG001|Overall Study|Lost to Follow-up|1|||
129804399|NCT00543543|467251532|FG003|Extension Study|Lost to Follow-up|77|||
129804400|NCT00543543|467251529|FG000|Extension Study|Physician Decision|0|||
130055319|NCT00610935|468156429|FG000|Overall Study|Withdrawal by Subject|0|||
130055320|NCT00610935|468156430|FG001|Overall Study|Withdrawal by Subject|2|||
130055321|NCT00610935|468156429|FG000|Overall Study|Sponsor Discontinuation|1|||
130055322|NCT00610935|468156430|FG001|Overall Study|Sponsor Discontinuation|0|||
130055323|NCT00850460|468156433|FG000|Overall Study|Lost to Follow-up|4|||
130055324|NCT00850460|468156434|FG001|Overall Study|Lost to Follow-up|4|||
130055325|NCT02224846|468156435|FG000|Period 1 (Month 3)|Adverse Event|2|||
130055326|NCT02224846|468156436|FG001|Period 1 (Month 3)|Adverse Event|1|||
130055327|NCT02224846|468156435|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
130055328|NCT02224846|468156436|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
130055329|NCT02224846|468156435|FG000|Period 1 (Month 3)|Protocol Violation|4|||
130055330|NCT02224846|468156436|FG001|Period 1 (Month 3)|Protocol Violation|8|||
130055331|NCT02224846|468156435|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
130055332|NCT02224846|468156436|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
130055333|NCT02224846|468156435|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
130055334|NCT02224846|468156436|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
130055335|NCT02224846|468156435|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
130055336|NCT02224846|468156436|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
130055337|NCT02224846|468156435|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
130055338|NCT02224846|468156436|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
130055339|NCT02224846|468156435|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
130055340|NCT02224846|468156436|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
130055341|NCT02224846|468156435|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
130055342|NCT02224846|468156436|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
130055343|NCT02224846|468156435|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
130055344|NCT02224846|468156436|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
130055345|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
130055346|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
130055347|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
130055348|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
130055349|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
130055350|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
130055351|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
130055352|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
130055353|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
130055354|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
130055355|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
130055356|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
130055357|NCT02224846|468156435|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
130055358|NCT02224846|468156436|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
130055359|NCT03280550|468156437|FG000|Overall Study|Withdrawal by Subject|2|||
130055360|NCT03280550|468156438|FG001|Overall Study|Withdrawal by Subject|2|||
130055361|NCT03280550|468156437|FG000|Overall Study|Physician Decision|0|||
130055362|NCT03280550|468156438|FG001|Overall Study|Physician Decision|1|||
130055363|NCT02203838|468156441|FG000|Overall Study|Lack of Efficacy|7|||
130055364|NCT02203838|468156442|FG001|Overall Study|Lack of Efficacy|0|||
130055365|NCT02203838|468156443|FG002|Overall Study|Lack of Efficacy|1|||
130055366|NCT02203838|468156444|FG003|Overall Study|Lack of Efficacy|1|||
130055367|NCT02203838|468156441|FG000|Overall Study|Adverse Event|46|||
130055368|NCT02203838|468156442|FG001|Overall Study|Adverse Event|6|||
130055369|NCT02203838|468156443|FG002|Overall Study|Adverse Event|3|||
130055370|NCT02203838|468156444|FG003|Overall Study|Adverse Event|2|||
130055371|NCT02203838|468156441|FG000|Overall Study|Lost to Follow-up|39|||
130055372|NCT02203838|468156442|FG001|Overall Study|Lost to Follow-up|3|||
130055373|NCT02203838|468156443|FG002|Overall Study|Lost to Follow-up|2|||
130055374|NCT02203838|468156444|FG003|Overall Study|Lost to Follow-up|1|||
130055375|NCT02203838|468156441|FG000|Overall Study|Protocol Violation|7|||
130055376|NCT02203838|468156442|FG001|Overall Study|Protocol Violation|3|||
130111512|NCT00323609|468369490|FG003|Overall Study|Physician Decision|1|||
130111513|NCT00323609|468369487|FG000|Overall Study|Withdrawal by Subject|11|||
130111514|NCT00323609|468369488|FG001|Overall Study|Withdrawal by Subject|23|||
130111515|NCT00323609|468369489|FG002|Overall Study|Withdrawal by Subject|4|||
130111516|NCT00323609|468369490|FG003|Overall Study|Withdrawal by Subject|4|||
130111517|NCT00323609|468369487|FG000|Overall Study|Other non-VCF-related medical condition|3|||
130111518|NCT00323609|468369488|FG001|Overall Study|Other non-VCF-related medical condition|2|||
130111519|NCT00323609|468369489|FG002|Overall Study|Other non-VCF-related medical condition|0|||
130111520|NCT00323609|468369490|FG003|Overall Study|Other non-VCF-related medical condition|0|||
130111521|NCT00323609|468369487|FG000|Overall Study|Sponsor discontinued trial|29|||
130111522|NCT00323609|468369488|FG001|Overall Study|Sponsor discontinued trial|29|||
130111523|NCT00323609|468369489|FG002|Overall Study|Sponsor discontinued trial|0|||
130111524|NCT00323609|468369490|FG003|Overall Study|Sponsor discontinued trial|0|||
130111525|NCT00323609|468369487|FG000|Overall Study|Unrelenting or severe back pain|1|||
130111526|NCT00323609|468369488|FG001|Overall Study|Unrelenting or severe back pain|1|||
130111527|NCT00323609|468369489|FG002|Overall Study|Unrelenting or severe back pain|0|||
130111528|NCT00323609|468369490|FG003|Overall Study|Unrelenting or severe back pain|0|||
130111529|NCT00323609|468369487|FG000|Overall Study|Logistical withdrawal|9|||
130111530|NCT00323609|468369488|FG001|Overall Study|Logistical withdrawal|5|||
130111531|NCT00323609|468369489|FG002|Overall Study|Logistical withdrawal|0|||
130111532|NCT00323609|468369490|FG003|Overall Study|Logistical withdrawal|1|||
130111533|NCT00323609|468369487|FG000|Overall Study|Other reason|11|||
130111534|NCT00323609|468369488|FG001|Overall Study|Other reason|8|||
130111535|NCT00323609|468369489|FG002|Overall Study|Other reason|4|||
130111536|NCT00323609|468369490|FG003|Overall Study|Other reason|9|||
130111537|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111538|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111539|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111540|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
130111541|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111542|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111543|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111544|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111545|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111546|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
130111547|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130111548|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130111549|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Adverse Event|1|||
130111550|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Adverse Event|1|||
130111551|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Adverse Event|1|||
130111552|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Adverse Event|1|||
130111553|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Adverse Event|0|||
130111554|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Adverse Event|0|||
130111555|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Adverse Event|0|||
130111556|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Adverse Event|0|||
130111557|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
130111558|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
130111559|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
130111560|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
130111561|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
130111562|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
129804401|NCT00543543|467251530|FG001|Extension Study|Physician Decision|0|||
129804402|NCT00543543|467251531|FG002|Extension Study|Physician Decision|0|||
129804403|NCT00543543|467251532|FG003|Extension Study|Physician Decision|7|||
130111563|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
130111564|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
130111565|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
130111566|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
130111567|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111568|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111569|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111570|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
130111571|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
130111572|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
129804404|NCT00543543|467251529|FG000|Extension Study|Pregnancy|0|||
130055377|NCT02203838|468156443|FG002|Overall Study|Protocol Violation|0|||
130055378|NCT02203838|468156444|FG003|Overall Study|Protocol Violation|0|||
130055379|NCT02203838|468156441|FG000|Overall Study|Withdrawal by Subject|83|||
130055380|NCT02203838|468156442|FG001|Overall Study|Withdrawal by Subject|10|||
130055381|NCT02203838|468156443|FG002|Overall Study|Withdrawal by Subject|8|||
130055382|NCT02203838|468156444|FG003|Overall Study|Withdrawal by Subject|11|||
130055383|NCT02203838|468156441|FG000|Overall Study|Physician Decision|27|||
130055384|NCT02203838|468156442|FG001|Overall Study|Physician Decision|0|||
130055385|NCT02203838|468156443|FG002|Overall Study|Physician Decision|2|||
130055386|NCT02203838|468156444|FG003|Overall Study|Physician Decision|3|||
130055387|NCT02203838|468156441|FG000|Overall Study|Other|1|||
130055388|NCT02203838|468156442|FG001|Overall Study|Other|0|||
130055389|NCT02203838|468156443|FG002|Overall Study|Other|0|||
130055390|NCT02203838|468156444|FG003|Overall Study|Other|0|||
130055391|NCT01915849|468156448|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
130055392|NCT01915849|468156449|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
130055393|NCT01915849|468156450|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
130055394|NCT01915849|468156451|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
130055395|NCT01915849|468156448|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
130055396|NCT01915849|468156449|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130055397|NCT01915849|468156450|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130055398|NCT01915849|468156451|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
130055399|NCT02689219|468156452|FG000|Overall Study|Death|1|||
130055400|NCT02689219|468156453|FG001|Overall Study|Death|1|||
130055401|NCT02689219|468156452|FG000|Overall Study|Disease Progression|10|||
130055402|NCT02689219|468156453|FG001|Overall Study|Disease Progression|6|||
130055403|NCT01067508|468156454|FG000|Overall Study|Physician Decision|0|||
130055404|NCT01067508|468156455|FG001|Overall Study|Physician Decision|1|||
130055405|NCT01067508|468156454|FG000|Overall Study|Withdrawal by Subject|0|||
130055406|NCT01067508|468156455|FG001|Overall Study|Withdrawal by Subject|1|||
130055407|NCT00444626|468156456|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
130055408|NCT00444626|468156456|FG000|Initial Treatment Period|Adverse Event|1|||
130055409|NCT00444626|468156456|FG000|Initial Treatment Period|Lost to Follow-up|9|||
130055410|NCT02179515|468157842|FG000|Overall Study|switched to alternative treatment|0|||
130055411|NCT02179515|468157843|FG001|Overall Study|switched to alternative treatment|1|||
130055412|NCT02179515|468157844|FG002|Overall Study|switched to alternative treatment|1|||
130055413|NCT02179515|468157842|FG000|Overall Study|Death|0|||
130055414|NCT02179515|468157843|FG001|Overall Study|Death|1|||
130055415|NCT02179515|468157844|FG002|Overall Study|Death|1|||
130055416|NCT02179515|468157842|FG000|Overall Study|refused further treatment|0|||
130055417|NCT02179515|468157843|FG001|Overall Study|refused further treatment|3|||
130055418|NCT02179515|468157844|FG002|Overall Study|refused further treatment|4|||
130055419|NCT02179515|468157842|FG000|Overall Study|Disease progression on study|2|||
129804405|NCT00543543|467251530|FG001|Extension Study|Pregnancy|0|||
129804406|NCT00543543|467251531|FG002|Extension Study|Pregnancy|0|||
129804407|NCT00543543|467251532|FG003|Extension Study|Pregnancy|6|||
129804408|NCT00543543|467251529|FG000|Extension Study|Protocol Violation|0|||
129804409|NCT00543543|467251530|FG001|Extension Study|Protocol Violation|0|||
129804410|NCT00543543|467251531|FG002|Extension Study|Protocol Violation|0|||
129804411|NCT00543543|467251532|FG003|Extension Study|Protocol Violation|11|||
129804412|NCT00543543|467251529|FG000|Extension Study|Withdrawal by Subject|0|||
130055420|NCT02179515|468157843|FG001|Overall Study|Disease progression on study|11|||
130055421|NCT02179515|468157844|FG002|Overall Study|Disease progression on study|8|||
130055422|NCT00115349|468157845|FG000|Overall Study|Study closed due to low enrollment.|11|||
130055423|NCT00115349|468157846|FG001|Overall Study|Study closed due to low enrollment.|9|||
129804413|NCT00543543|467251530|FG001|Extension Study|Withdrawal by Subject|0|||
130055424|NCT00411788|468157852|FG000|Overall Study|Protocol Violation|1|||
130055425|NCT00411788|468157852|FG000|Overall Study|Adverse Event|1|||
130055426|NCT00390416|468157853|FG000|Overall Study|Withdrawal by Subject|1|||
130055427|NCT00390416|468157853|FG000|Overall Study|Not treated|3|||
130111573|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111574|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
129804414|NCT00543543|467251531|FG002|Extension Study|Withdrawal by Subject|0|||
129804415|NCT00543543|467251532|FG003|Extension Study|Withdrawal by Subject|120|||
129804416|NCT01163266|467251533|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
130055428|NCT01728584|468157854|FG000|Overall Study|Adverse Event|1|||
129892857|NCT00515086|467567705|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
130055429|NCT01728584|468157855|FG001|Overall Study|Adverse Event|0|||
129804417|NCT01163266|467251534|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
129804418|NCT01163266|467251535|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
129804419|NCT01163266|467251533|FG000|Overall Study|Lack of Efficacy|1|||
129804420|NCT01163266|467251534|FG001|Overall Study|Lack of Efficacy|3|||
129804421|NCT01163266|467251535|FG002|Overall Study|Lack of Efficacy|1|||
129804422|NCT01163266|467251533|FG000|Overall Study|Noncompliance with Study Drug|0|||
129804423|NCT01163266|467251534|FG001|Overall Study|Noncompliance with Study Drug|2|||
129804424|NCT01163266|467251535|FG002|Overall Study|Noncompliance with Study Drug|0|||
129804425|NCT01163266|467251533|FG000|Overall Study|Protocol Deviations|2|||
129804426|NCT01163266|467251534|FG001|Overall Study|Protocol Deviations|2|||
130055430|NCT01728584|468157856|FG002|Overall Study|Adverse Event|0|||
129804427|NCT01163266|467251535|FG002|Overall Study|Protocol Deviations|5|||
130055431|NCT01728584|468157857|FG003|Overall Study|Adverse Event|0|||
130055432|NCT01728584|468157854|FG000|Overall Study|Physician Decision|4|||
130055433|NCT01728584|468157855|FG001|Overall Study|Physician Decision|0|||
130055434|NCT01728584|468157856|FG002|Overall Study|Physician Decision|1|||
130055435|NCT01728584|468157857|FG003|Overall Study|Physician Decision|0|||
130055436|NCT01728584|468157854|FG000|Overall Study|Withdrawal by Subject|1|||
130055437|NCT01728584|468157855|FG001|Overall Study|Withdrawal by Subject|0|||
129804428|NCT01163266|467251533|FG000|Overall Study|Withdrawal of Consent|5|||
129804429|NCT01163266|467251534|FG001|Overall Study|Withdrawal of Consent|7|||
129804430|NCT01163266|467251535|FG002|Overall Study|Withdrawal of Consent|3|||
129804431|NCT01163266|467251533|FG000|Overall Study|Lost to Follow-up|7|||
130055438|NCT01728584|468157856|FG002|Overall Study|Withdrawal by Subject|0|||
130055439|NCT01728584|468157857|FG003|Overall Study|Withdrawal by Subject|0|||
130055440|NCT01728584|468157854|FG000|Overall Study|Screen failure|1|||
130055441|NCT01728584|468157855|FG001|Overall Study|Screen failure|0|||
130055442|NCT01728584|468157856|FG002|Overall Study|Screen failure|0|||
130055443|NCT01728584|468157857|FG003|Overall Study|Screen failure|0|||
130055444|NCT01728584|468157854|FG000|Overall Study|Other reason (not specified)|1|||
130055445|NCT01728584|468157855|FG001|Overall Study|Other reason (not specified)|0|||
130055446|NCT01728584|468157856|FG002|Overall Study|Other reason (not specified)|0|||
130055447|NCT01728584|468157857|FG003|Overall Study|Other reason (not specified)|1|||
130055448|NCT05906732|468157858|FG000|Overall Study|Withdrawal by Subject|1|||
130055449|NCT05906732|468157859|FG001|Overall Study|Withdrawal by Subject|0|||
130055450|NCT05906732|468157860|FG002|Overall Study|Withdrawal by Subject|0|||
130055451|NCT05906732|468157861|FG003|Overall Study|Withdrawal by Subject|0|||
130055452|NCT05906732|468157858|FG000|Overall Study|Physician Decision|2|||
130055453|NCT05906732|468157859|FG001|Overall Study|Physician Decision|4|||
130055454|NCT05906732|468157860|FG002|Overall Study|Physician Decision|0|||
130055455|NCT05906732|468157861|FG003|Overall Study|Physician Decision|0|||
130055456|NCT01727713|468157868|FG000|Overall Study|Lost to Follow-up|5|||
130055457|NCT01727713|468157868|FG000|Overall Study|Adverse Event|10|||
130055458|NCT01727713|468157868|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
130055459|NCT01727713|468157868|FG000|Overall Study|Withdrawal by Subject|13|||
130055460|NCT01727713|468157868|FG000|Overall Study|Protocol Deviation|2|||
130055461|NCT00471536|468157873|FG000|Overall Study|Withdrawal by Subject|1|||
130055462|NCT02651194|468157874|FG000|Overall Study|Lost to Follow-up|3|||
130055463|NCT02651194|468157874|FG000|Overall Study|Other|2|||
130055464|NCT02496585|468157875|FG000|Overall Study|Death|3|||
130055465|NCT02496585|468157876|FG001|Overall Study|Death|0|||
130055466|NCT02496585|468157875|FG000|Overall Study|Lost to Follow-up|2|||
130055467|NCT02496585|468157876|FG001|Overall Study|Lost to Follow-up|0|||
130055468|NCT02496585|468157875|FG000|Overall Study|Withdrawal by Subject|1|||
129804432|NCT01163266|467251534|FG001|Overall Study|Lost to Follow-up|7|||
129804433|NCT01163266|467251535|FG002|Overall Study|Lost to Follow-up|10|||
129804434|NCT01163266|467251533|FG000|Overall Study|Other|1|||
129804435|NCT01163266|467251534|FG001|Overall Study|Other|1|||
129804436|NCT01163266|467251535|FG002|Overall Study|Other|2|||
129804437|NCT02586064|467251536|FG000|Overall Study|Other Obligations|6|||
130055469|NCT02496585|468157876|FG001|Overall Study|Withdrawal by Subject|2|||
130055470|NCT02496585|468157875|FG000|Overall Study|Progression of Malignancy|4|||
130055471|NCT02496585|468157876|FG001|Overall Study|Progression of Malignancy|1|||
130055472|NCT04891770|468157877|FG000|Overall Study|Withdrew consent|1|||
130055473|NCT04891770|468157878|FG001|Overall Study|Withdrew consent|3|||
130055474|NCT04891770|468157879|FG002|Overall Study|Withdrew consent|0|||
129804438|NCT02586064|467251537|FG001|Overall Study|Other Obligations|6|||
129804439|NCT02586064|467251536|FG000|Overall Study|Other|3|||
129804440|NCT02586064|467251537|FG001|Overall Study|Other|7|||
129804441|NCT02586064|467251536|FG000|Overall Study|Never Started|3|||
130111575|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111576|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111577|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
130111578|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
130111579|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111580|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111581|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111582|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111583|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111584|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
130111585|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111586|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
130111587|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111588|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111589|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111590|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111591|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
130111592|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
130111593|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111594|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111595|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111596|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
130111597|NCT00950599|468369494|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
130111598|NCT00950599|468369495|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
130111599|NCT00950599|468369496|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
130111600|NCT00950599|468369497|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
130111601|NCT00950599|468369498|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
130111602|NCT00950599|468369499|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
130111603|NCT00950599|468369500|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
130111604|NCT00950599|468369501|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
130111605|NCT00950599|468369502|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
130111606|NCT00950599|468369503|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
130111607|NCT00950599|468369494|FG000|Follow-Up Period|Adverse Event|0|||
130111608|NCT00950599|468369495|FG001|Follow-Up Period|Adverse Event|0|||
130111609|NCT00950599|468369496|FG002|Follow-Up Period|Adverse Event|0|||
130111610|NCT00950599|468369497|FG003|Follow-Up Period|Adverse Event|0|||
130111611|NCT00950599|468369498|FG004|Follow-Up Period|Adverse Event|0|||
130111612|NCT00950599|468369499|FG005|Follow-Up Period|Adverse Event|0|||
130111613|NCT00950599|468369500|FG006|Follow-Up Period|Adverse Event|0|||
130111614|NCT00950599|468369501|FG007|Follow-Up Period|Adverse Event|0|||
130111615|NCT00950599|468369502|FG008|Follow-Up Period|Adverse Event|1|||
130111616|NCT00950599|468369503|FG009|Follow-Up Period|Adverse Event|0|||
130111617|NCT00950599|468369494|FG000|Follow-Up Period|Lack of Efficacy|0|||
130111618|NCT00950599|468369495|FG001|Follow-Up Period|Lack of Efficacy|0|||
130111619|NCT00950599|468369496|FG002|Follow-Up Period|Lack of Efficacy|0|||
130111620|NCT00950599|468369497|FG003|Follow-Up Period|Lack of Efficacy|0|||
130111621|NCT00950599|468369498|FG004|Follow-Up Period|Lack of Efficacy|0|||
130111622|NCT00950599|468369499|FG005|Follow-Up Period|Lack of Efficacy|0|||
130111623|NCT00950599|468369500|FG006|Follow-Up Period|Lack of Efficacy|0|||
130111624|NCT00950599|468369501|FG007|Follow-Up Period|Lack of Efficacy|0|||
130111625|NCT00950599|468369502|FG008|Follow-Up Period|Lack of Efficacy|3|||
130111626|NCT00950599|468369503|FG009|Follow-Up Period|Lack of Efficacy|0|||
130111627|NCT00950599|468369494|FG000|Follow-Up Period|Lost to Follow-up|0|||
130111628|NCT00950599|468369495|FG001|Follow-Up Period|Lost to Follow-up|0|||
130111629|NCT00950599|468369496|FG002|Follow-Up Period|Lost to Follow-up|0|||
130111630|NCT00950599|468369497|FG003|Follow-Up Period|Lost to Follow-up|0|||
130111631|NCT00950599|468369498|FG004|Follow-Up Period|Lost to Follow-up|0|||
130111632|NCT00950599|468369499|FG005|Follow-Up Period|Lost to Follow-up|0|||
130111633|NCT00950599|468369500|FG006|Follow-Up Period|Lost to Follow-up|0|||
130055475|NCT04891770|468157877|FG000|Overall Study|Enrolled but never treated|0|||
130055476|NCT04891770|468157878|FG001|Overall Study|Enrolled but never treated|0|||
130055477|NCT04891770|468157879|FG002|Overall Study|Enrolled but never treated|1|||
130055478|NCT04891770|468157877|FG000|Overall Study|Investigator's discretion|0|||
130055479|NCT04891770|468157878|FG001|Overall Study|Investigator's discretion|1|||
130055480|NCT04891770|468157879|FG002|Overall Study|Investigator's discretion|0|||
130055481|NCT00222729|468157883|FG000|Overall Study|Adverse Event|3|||
130055482|NCT00515008|468157884|FG000|Overall Study|Lost to Follow-up|1|||
130055483|NCT00515008|468157885|FG001|Overall Study|Lost to Follow-up|0|||
130055484|NCT00515008|468157884|FG000|Overall Study|Declined|0|||
130055485|NCT00515008|468157885|FG001|Overall Study|Declined|3|||
130055486|NCT00515008|468157884|FG000|Overall Study|Left the Boston Area|1|||
130055487|NCT00515008|468157885|FG001|Overall Study|Left the Boston Area|1|||
130055488|NCT00515008|468157884|FG000|Overall Study|Scheduling conflict|1|||
130055489|NCT00515008|468157885|FG001|Overall Study|Scheduling conflict|0|||
130055490|NCT05091060|468157886|FG000|Overall Study|Lost to Follow-up|1|||
130055491|NCT01798706|468157887|FG000|Overall Study|Adverse Event|15|||
130055492|NCT01798706|468157888|FG001|Overall Study|Adverse Event|10|||
130055493|NCT01798706|468157887|FG000|Overall Study|Lack of Efficacy|0|||
130055494|NCT01798706|468157888|FG001|Overall Study|Lack of Efficacy|2|||
130055495|NCT01798706|468157887|FG000|Overall Study|Poor compliance to protocol|1|||
130055496|NCT01798706|468157888|FG001|Overall Study|Poor compliance to protocol|0|||
130055497|NCT01798706|468157887|FG000|Overall Study|Other than specified above|5|||
130055498|NCT01798706|468157888|FG001|Overall Study|Other than specified above|9|||
130055499|NCT00496873|468157889|FG000|Overall Study|Ineligible|2|||
130055500|NCT00496873|468157889|FG000|Overall Study|Death|2|||
130055501|NCT00496873|468157889|FG000|Overall Study|Withdrawal by Subject|3|||
130055502|NCT02775864|468157890|FG000|Overall Study|Data ended end of 2010|1764|||
130055503|NCT02775864|468157891|FG001|Overall Study|Data ended end of 2010|2880|||
130055504|NCT02775864|468157892|FG002|Overall Study|Data ended end of 2010|1140|||
130055505|NCT02775864|468157893|FG003|Overall Study|Data ended end of 2010|1194|||
130055506|NCT02775864|468157890|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
130055507|NCT02775864|468157891|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
130055508|NCT02775864|468157892|FG002|Overall Study|Medicaid eligibility discontinued|720|||
130055509|NCT02775864|468157893|FG003|Overall Study|Medicaid eligibility discontinued|890|||
130055510|NCT03238235|468157894|FG000|Overall Study|Adverse Event|2|||
130055511|NCT03238235|468157895|FG001|Overall Study|Adverse Event|0|||
130055512|NCT03238235|468157894|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
130055513|NCT03238235|468157895|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
130055514|NCT01318083|468157896|FG000|Overall Study|Adverse Event|4|||
130055515|NCT01318083|468157897|FG001|Overall Study|Adverse Event|1|||
130055516|NCT01318083|468157898|FG002|Overall Study|Adverse Event|2|||
130055517|NCT01318083|468157896|FG000|Overall Study|Withdrawal by Subject|1|||
130055518|NCT01318083|468157897|FG001|Overall Study|Withdrawal by Subject|0|||
130055519|NCT01318083|468157898|FG002|Overall Study|Withdrawal by Subject|2|||
130055520|NCT01318083|468157896|FG000|Overall Study|Lack of Efficacy|0|||
130055521|NCT01318083|468157897|FG001|Overall Study|Lack of Efficacy|0|||
130055522|NCT01318083|468157898|FG002|Overall Study|Lack of Efficacy|1|||
130055523|NCT01318083|468157896|FG000|Overall Study|Treatment Complications|1|||
130055524|NCT01318083|468157897|FG001|Overall Study|Treatment Complications|0|||
130055525|NCT01318083|468157898|FG002|Overall Study|Treatment Complications|0|||
130055526|NCT01318083|468157896|FG000|Overall Study|Lack of Study Medication Compliance|0|||
130055527|NCT01318083|468157897|FG001|Overall Study|Lack of Study Medication Compliance|1|||
130055528|NCT01318083|468157898|FG002|Overall Study|Lack of Study Medication Compliance|0|||
130055529|NCT05896761|468157899|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
130055530|NCT05896761|468157900|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
130055531|NCT05896761|468157899|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
130055532|NCT05896761|468157900|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
130055533|NCT02028338|468157902|FG000|Overall Study|Withdrawal by Subject|3|||
130055534|NCT02028338|468157903|FG001|Overall Study|Withdrawal by Subject|1|||
130055535|NCT02028338|468157902|FG000|Overall Study|Unable to contact participant|1|||
130055536|NCT02028338|468157903|FG001|Overall Study|Unable to contact participant|0|||
130055537|NCT03552549|468157905|FG000|Overall Study|Disease progression|25|||
130055538|NCT03552549|468157906|FG001|Overall Study|Disease progression|17|||
129804442|NCT02586064|467251537|FG001|Overall Study|Never Started|3|||
129804443|NCT02586064|467251536|FG000|Overall Study|Lost Interest|1|||
129804444|NCT02586064|467251537|FG001|Overall Study|Lost Interest|4|||
129804445|NCT02586064|467251536|FG000|Overall Study|Miscellaneous Life Issues|0|||
129804446|NCT02586064|467251537|FG001|Overall Study|Miscellaneous Life Issues|5|||
129804447|NCT02586064|467251536|FG000|Overall Study|Infrequent Attendance|2|||
129804448|NCT02586064|467251537|FG001|Overall Study|Infrequent Attendance|1|||
130055539|NCT03552549|468157905|FG000|Overall Study|Adverse event in first 12 months|12|||
130055540|NCT03552549|468157906|FG001|Overall Study|Adverse event in first 12 months|8|||
130055541|NCT03552549|468157905|FG000|Overall Study|Withdrawal by Subject|7|||
130055542|NCT03552549|468157906|FG001|Overall Study|Withdrawal by Subject|7|||
130055543|NCT03552549|468157905|FG000|Overall Study|Unknown (no reason provided)|4|||
130055544|NCT03552549|468157906|FG001|Overall Study|Unknown (no reason provided)|2|||
130055545|NCT03552549|468157905|FG000|Overall Study|Not in participant's best interest|2|||
130055546|NCT03552549|468157906|FG001|Overall Study|Not in participant's best interest|1|||
130055547|NCT03552549|468157905|FG000|Overall Study|Did not complete study treatment|2|||
130055548|NCT03552549|468157906|FG001|Overall Study|Did not complete study treatment|3|||
130055549|NCT03552549|468157905|FG000|Overall Study|Did not meet eligibility criteria|1|||
130055550|NCT03552549|468157906|FG001|Overall Study|Did not meet eligibility criteria|0|||
130055551|NCT03552549|468157905|FG000|Overall Study|Administrative|0|||
130055552|NCT03552549|468157906|FG001|Overall Study|Administrative|14|||
130055553|NCT02761993|468157916|FG000|Overall Study|Adverse Event|0|||
130055554|NCT02761993|468157917|FG001|Overall Study|Adverse Event|2|||
130055555|NCT02761993|468157918|FG002|Overall Study|Adverse Event|0|||
130055556|NCT02761993|468157916|FG000|Overall Study|Lost to Follow-up|1|||
130055557|NCT02761993|468157917|FG001|Overall Study|Lost to Follow-up|3|||
130055558|NCT02761993|468157918|FG002|Overall Study|Lost to Follow-up|2|||
130055559|NCT02761993|468157916|FG000|Overall Study|Withdrawal by Subject|1|||
130055560|NCT02761993|468157917|FG001|Overall Study|Withdrawal by Subject|1|||
130055561|NCT02761993|468157918|FG002|Overall Study|Withdrawal by Subject|2|||
130055562|NCT02739594|468157921|FG000|Overall Study|Undesired Event|3|||
130055563|NCT02739594|468157922|FG001|Overall Study|Undesired Event|4|||
130055564|NCT02739594|468157921|FG000|Overall Study|Violation of Eligibility Criteria|1|||
130055565|NCT02739594|468157922|FG001|Overall Study|Violation of Eligibility Criteria|2|||
130055566|NCT02739594|468157921|FG000|Overall Study|Protocol Violation|5|||
130055567|NCT02739594|468157922|FG001|Overall Study|Protocol Violation|6|||
130055568|NCT02739594|468157921|FG000|Overall Study|Death|4|||
130055569|NCT02739594|468157922|FG001|Overall Study|Death|2|||
130055570|NCT02739594|468157921|FG000|Overall Study|Renal Insufficiency|4|||
130055571|NCT02739594|468157922|FG001|Overall Study|Renal Insufficiency|6|||
130055572|NCT02739594|468157921|FG000|Overall Study|Administrative Reasons|1|||
130055573|NCT02739594|468157922|FG001|Overall Study|Administrative Reasons|3|||
130055574|NCT02739594|468157921|FG000|Overall Study|Withdrawal by Subject|1|||
130055575|NCT02739594|468157922|FG001|Overall Study|Withdrawal by Subject|1|||
130055576|NCT02739594|468157921|FG000|Overall Study|Lost to Follow-up|0|||
130055577|NCT02739594|468157922|FG001|Overall Study|Lost to Follow-up|1|||
130055578|NCT02739594|468157921|FG000|Overall Study|Elevated Serum Creatinine|0|||
130055579|NCT02739594|468157922|FG001|Overall Study|Elevated Serum Creatinine|1|||
130055580|NCT02739594|468157921|FG000|Overall Study|Other|6|||
130055581|NCT02739594|468157922|FG001|Overall Study|Other|2|||
130055582|NCT01465178|468157925|FG000|Overall Study|Withdrawal by Subject|1|||
130055583|NCT01465178|468157926|FG001|Overall Study|Withdrawal by Subject|0|||
130055584|NCT00527111|468157927|FG000|Overall Study|Adverse Event|14|||
130055585|NCT00527111|468157928|FG001|Overall Study|Adverse Event|13|||
130055586|NCT00527111|468157927|FG000|Overall Study|Death|0|||
130055587|NCT00527111|468157928|FG001|Overall Study|Death|1|||
130055588|NCT00527111|468157927|FG000|Overall Study|Investigator Request|2|||
130055589|NCT00527111|468157928|FG001|Overall Study|Investigator Request|1|||
130055590|NCT00527111|468157927|FG000|Overall Study|Patient Request|2|||
130055591|NCT00527111|468157928|FG001|Overall Study|Patient Request|5|||
130055592|NCT00527111|468157927|FG000|Overall Study|Other|2|||
130055593|NCT00527111|468157928|FG001|Overall Study|Other|2|||
130055594|NCT03827473|468157931|FG000|Overall Study|Withdrawal by Subject|1|||
130055595|NCT03827473|468157932|FG001|Overall Study|Withdrawal by Subject|0|||
130055596|NCT00875017|468157933|FG000|First Intervention|Withdrawal by Subject|1|||
130055597|NCT00875017|468157934|FG001|First Intervention|Withdrawal by Subject|0|||
130055598|NCT00875017|468157935|FG002|First Intervention|Withdrawal by Subject|1|||
130055599|NCT00875017|468157936|FG003|First Intervention|Withdrawal by Subject|0|||
130055600|NCT00875017|468157937|FG004|First Intervention|Withdrawal by Subject|0|||
130055601|NCT00875017|468157938|FG005|First Intervention|Withdrawal by Subject|0|||
130055602|NCT00875017|468157933|FG000|First Intervention|Adverse Event|0|||
130055603|NCT00875017|468157934|FG001|First Intervention|Adverse Event|0|||
130055604|NCT00875017|468157935|FG002|First Intervention|Adverse Event|0|||
130055605|NCT00875017|468157936|FG003|First Intervention|Adverse Event|1|||
130055606|NCT00875017|468157937|FG004|First Intervention|Adverse Event|0|||
130055607|NCT00875017|468157938|FG005|First Intervention|Adverse Event|0|||
130055608|NCT00875017|468157933|FG000|First Intervention|Problems collecting rectal effluent|1|||
130055609|NCT00875017|468157934|FG001|First Intervention|Problems collecting rectal effluent|0|||
130055610|NCT00875017|468157935|FG002|First Intervention|Problems collecting rectal effluent|0|||
130055611|NCT00875017|468157936|FG003|First Intervention|Problems collecting rectal effluent|0|||
130055612|NCT00875017|468157937|FG004|First Intervention|Problems collecting rectal effluent|0|||
130055613|NCT00875017|468157938|FG005|First Intervention|Problems collecting rectal effluent|0|||
130055614|NCT00875017|468157933|FG000|First Intervention|Intolerance to nasogastric tube|0|||
130055615|NCT00875017|468157934|FG001|First Intervention|Intolerance to nasogastric tube|0|||
130055616|NCT00875017|468157935|FG002|First Intervention|Intolerance to nasogastric tube|0|||
130055617|NCT00875017|468157936|FG003|First Intervention|Intolerance to nasogastric tube|0|||
130055618|NCT00875017|468157937|FG004|First Intervention|Intolerance to nasogastric tube|1|||
130055619|NCT00875017|468157938|FG005|First Intervention|Intolerance to nasogastric tube|0|||
130055620|NCT00875017|468157933|FG000|Washout|Problem collecting rectal effluent|0|||
130055621|NCT00875017|468157934|FG001|Washout|Problem collecting rectal effluent|0|||
130055622|NCT00875017|468157935|FG002|Washout|Problem collecting rectal effluent|1|||
130055623|NCT00875017|468157936|FG003|Washout|Problem collecting rectal effluent|0|||
130055624|NCT00875017|468157937|FG004|Washout|Problem collecting rectal effluent|0|||
130055625|NCT00875017|468157938|FG005|Washout|Problem collecting rectal effluent|0|||
130055626|NCT00875017|468157933|FG000|Second Intervention|Adverse Event|0|||
130055627|NCT00875017|468157934|FG001|Second Intervention|Adverse Event|0|||
130055628|NCT00875017|468157935|FG002|Second Intervention|Adverse Event|0|||
130055629|NCT00875017|468157936|FG003|Second Intervention|Adverse Event|1|||
130055630|NCT00875017|468157937|FG004|Second Intervention|Adverse Event|0|||
130055631|NCT00875017|468157938|FG005|Second Intervention|Adverse Event|0|||
130055632|NCT00875017|468157933|FG000|Washout|Problems collecting rectal effluent|0|||
130055633|NCT00875017|468157934|FG001|Washout|Problems collecting rectal effluent|1|||
130055634|NCT00875017|468157935|FG002|Washout|Problems collecting rectal effluent|0|||
130055635|NCT00875017|468157936|FG003|Washout|Problems collecting rectal effluent|0|||
130055636|NCT00875017|468157937|FG004|Washout|Problems collecting rectal effluent|0|||
130055637|NCT00875017|468157938|FG005|Washout|Problems collecting rectal effluent|0|||
130055638|NCT00875017|468157933|FG000|Third Intervention|Adverse Event|0|||
130055639|NCT00875017|468157934|FG001|Third Intervention|Adverse Event|1|||
130055640|NCT00875017|468157935|FG002|Third Intervention|Adverse Event|1|||
130055641|NCT00875017|468157936|FG003|Third Intervention|Adverse Event|0|||
130055642|NCT00875017|468157937|FG004|Third Intervention|Adverse Event|0|||
130055643|NCT00875017|468157938|FG005|Third Intervention|Adverse Event|0|||
130055644|NCT00875017|468157933|FG000|Washout|Withdrawal by Subject|0|||
130055645|NCT00875017|468157934|FG001|Washout|Withdrawal by Subject|0|||
130055646|NCT00875017|468157935|FG002|Washout|Withdrawal by Subject|0|||
130055647|NCT00875017|468157936|FG003|Washout|Withdrawal by Subject|0|||
130055648|NCT00875017|468157937|FG004|Washout|Withdrawal by Subject|1|||
130055649|NCT00875017|468157938|FG005|Washout|Withdrawal by Subject|0|||
130055650|NCT00875017|468157933|FG000|Fourth Intervention|Inability to comply with fasting|0|||
130055651|NCT00875017|468157934|FG001|Fourth Intervention|Inability to comply with fasting|0|||
130055652|NCT00875017|468157935|FG002|Fourth Intervention|Inability to comply with fasting|0|||
130055653|NCT00875017|468157936|FG003|Fourth Intervention|Inability to comply with fasting|0|||
130055654|NCT00875017|468157937|FG004|Fourth Intervention|Inability to comply with fasting|0|||
130055655|NCT00875017|468157938|FG005|Fourth Intervention|Inability to comply with fasting|1|||
130055656|NCT03342469|468157939|FG000|Overall Study|Withdrawal by Subject|0|||
130055657|NCT03342469|468157940|FG001|Overall Study|Withdrawal by Subject|1|||
130055658|NCT03342469|468157941|FG002|Overall Study|Withdrawal by Subject|0|||
130055659|NCT03342469|468157942|FG003|Overall Study|Withdrawal by Subject|0|||
130055660|NCT01477892|468157943|FG000|Overall Study|Withdrawal by Subject|0|||
130055661|NCT01477892|468157944|FG001|Overall Study|Withdrawal by Subject|2|||
130055662|NCT01921257|468157946|FG000|Overall Study|Adverse Event|1|||
130055663|NCT01921257|468157946|FG000|Overall Study|Protocol Violation|1|||
130055664|NCT01921257|468157946|FG000|Overall Study|Withdrawal by Subject|1|||
130055665|NCT05515601|468157951|FG000|Overall Study|Withdrawal by Subject|1|||
130055666|NCT05515601|468157952|FG001|Overall Study|Withdrawal by Subject|3|||
130055667|NCT05515601|468157953|FG002|Overall Study|Withdrawal by Subject|2|||
130055668|NCT05515601|468157954|FG003|Overall Study|Withdrawal by Subject|1|||
130055669|NCT05515601|468157955|FG004|Overall Study|Withdrawal by Subject|1|||
130055670|NCT05515601|468157956|FG005|Overall Study|Withdrawal by Subject|1|||
130055671|NCT05515601|468157951|FG000|Overall Study|Lost to Follow-up|0|||
130055672|NCT05515601|468157952|FG001|Overall Study|Lost to Follow-up|0|||
130055673|NCT05515601|468157953|FG002|Overall Study|Lost to Follow-up|0|||
130055674|NCT05515601|468157954|FG003|Overall Study|Lost to Follow-up|0|||
130055675|NCT05515601|468157955|FG004|Overall Study|Lost to Follow-up|1|||
130055676|NCT05515601|468157956|FG005|Overall Study|Lost to Follow-up|0|||
129804449|NCT02586064|467251536|FG000|Overall Study|Timed Out|2|||
129804450|NCT02586064|467251537|FG001|Overall Study|Timed Out|0|||
129804451|NCT02586064|467251536|FG000|Overall Study|AUD relapse|0|||
129804452|NCT02586064|467251537|FG001|Overall Study|AUD relapse|2|||
129804453|NCT02586064|467251536|FG000|Overall Study|Legal Issue|1|||
129804454|NCT02586064|467251537|FG001|Overall Study|Legal Issue|0|||
129804455|NCT03181893|467251538|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804456|NCT03181893|467251539|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
129804457|NCT03181893|467251540|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130055677|NCT00777491|468157957|FG000|Overall Study|Protocol Violation|0|||
130055678|NCT00777491|468157958|FG001|Overall Study|Protocol Violation|2|||
130055679|NCT00777491|468157957|FG000|Overall Study|Did not receive any protocol treatment|2|||
130055680|NCT00777491|468157958|FG001|Overall Study|Did not receive any protocol treatment|0|||
130055681|NCT00540436|468157961|FG000|First 12-Week Treatment Period|Adverse Event|1|||
130055682|NCT00540436|468157961|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
130055683|NCT00540436|468157961|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
130055684|NCT00540436|468157961|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
130055685|NCT03255291|468157962|FG000|Overall Study|Determined to be ineligible|10|||
130055686|NCT03255291|468157963|FG001|Overall Study|Determined to be ineligible|12|||
130055687|NCT03255291|468157964|FG002|Overall Study|Determined to be ineligible|6|||
130055688|NCT03255291|468157965|FG003|Overall Study|Determined to be ineligible|6|||
130055689|NCT03255291|468157966|FG004|Overall Study|Determined to be ineligible|5|||
130055690|NCT03255291|468157967|FG005|Overall Study|Determined to be ineligible|10|||
130055691|NCT03255291|468157962|FG000|Overall Study|Baseline data collection issues|3|||
130055692|NCT03255291|468157963|FG001|Overall Study|Baseline data collection issues|0|||
130055693|NCT03255291|468157964|FG002|Overall Study|Baseline data collection issues|0|||
130055694|NCT03255291|468157965|FG003|Overall Study|Baseline data collection issues|0|||
130055695|NCT03255291|468157966|FG004|Overall Study|Baseline data collection issues|2|||
130055696|NCT03255291|468157967|FG005|Overall Study|Baseline data collection issues|0|||
130055697|NCT01745393|468157968|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
130055698|NCT01745393|468157969|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
130055699|NCT01745393|468157968|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
130055700|NCT01745393|468157969|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
130055701|NCT01745393|468157968|FG000|12-month Follow-up|Lost to Follow-up|6|||
130055702|NCT01745393|468157969|FG001|12-month Follow-up|Lost to Follow-up|5|||
130055703|NCT00471445|468157971|FG000|Overall Study|Withdrawal by Subject|1|||
130055704|NCT00471445|468157972|FG001|Overall Study|Withdrawal by Subject|1|||
130055705|NCT00471445|468157971|FG000|Overall Study|Ineligible|1|||
130055706|NCT00471445|468157972|FG001|Overall Study|Ineligible|0|||
130055707|NCT00471445|468157971|FG000|Overall Study|Protocol Violation|0|||
130055708|NCT00471445|468157972|FG001|Overall Study|Protocol Violation|1|||
130055709|NCT03591146|468157973|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130055710|NCT03591146|468157974|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
129804458|NCT03181893|467251541|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804459|NCT03181893|467251542|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804460|NCT03181893|467251543|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804461|NCT03181893|467251544|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
130055711|NCT03591146|468157975|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130055712|NCT03591146|468157976|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
130055713|NCT03591146|468157977|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
129804462|NCT03181893|467251545|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804463|NCT03181893|467251546|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804464|NCT03181893|467251547|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804465|NCT03181893|467251548|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804466|NCT03181893|467251538|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
129804467|NCT03181893|467251539|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
129804468|NCT03181893|467251540|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804469|NCT03181893|467251541|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130055714|NCT03591146|468157973|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130055715|NCT03591146|468157974|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
130055716|NCT03591146|468157975|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130055717|NCT03591146|468157976|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130055718|NCT03591146|468157977|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
130055719|NCT03591146|468157973|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130055720|NCT03591146|468157974|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130055721|NCT03591146|468157975|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130055722|NCT03591146|468157976|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
130055723|NCT03591146|468157977|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
130055724|NCT03591146|468157973|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
130055725|NCT03591146|468157974|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
130055726|NCT03591146|468157975|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
130055727|NCT03591146|468157976|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
130055728|NCT03591146|468157977|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
130055729|NCT04737031|468157980|FG000|Overall Study|Patients who did not have a treatment visit|0|||
130055730|NCT04737031|468157981|FG001|Overall Study|Patients who did not have a treatment visit|31|||
130111634|NCT00950599|468369501|FG007|Follow-Up Period|Lost to Follow-up|0|||
129804470|NCT03181893|467251542|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
130055731|NCT04737031|468157982|FG002|Overall Study|Patients who did not have a treatment visit|93|||
130055732|NCT04737031|468157983|FG003|Overall Study|Patients who did not have a treatment visit|227|||
130055733|NCT01511419|468157988|FG000|Dose 2|Physician Decision|1|||
130055734|NCT01511419|468157989|FG001|Dose 2|Physician Decision|0|||
130055735|NCT04594239|468157990|FG000|Overall Study|Withdrawal by Subject|3|||
130055736|NCT04594239|468157991|FG001|Overall Study|Withdrawal by Subject|4|||
130055737|NCT04594239|468157992|FG002|Overall Study|Withdrawal by Subject|2|||
130055738|NCT04594239|468157993|FG003|Overall Study|Withdrawal by Subject|4|||
130055739|NCT04594239|468157990|FG000|Overall Study|Lost to Follow-up|8|||
130055740|NCT04594239|468157991|FG001|Overall Study|Lost to Follow-up|5|||
130055741|NCT04594239|468157992|FG002|Overall Study|Lost to Follow-up|4|||
130055742|NCT04594239|468157993|FG003|Overall Study|Lost to Follow-up|6|||
130055743|NCT04594239|468157990|FG000|Overall Study|Subject relocated|0|||
130055744|NCT04594239|468157991|FG001|Overall Study|Subject relocated|0|||
130055745|NCT04594239|468157992|FG002|Overall Study|Subject relocated|0|||
130055746|NCT04594239|468157993|FG003|Overall Study|Subject relocated|1|||
130055747|NCT00091390|468157994|FG000|Overall Study|Protocol Violation|1|||
130055748|NCT00091390|468157994|FG000|Overall Study|No protocol treatment|3|||
130055749|NCT03229759|468157995|FG000|Overall Study|Screen Failure|30|||
130055750|NCT02326467|468159532|FG000|Overall Study|Withdrawal by Subject|1|||
130055751|NCT00434512|468159533|FG000|Overall Study|Migrated/moved from study area|0|||
130055752|NCT00434512|468159534|FG001|Overall Study|Migrated/moved from study area|0|||
130055753|NCT00434512|468159535|FG002|Overall Study|Migrated/moved from study area|0|||
130055754|NCT00434512|468159536|FG003|Overall Study|Migrated/moved from study area|1|||
130055755|NCT00434512|468159537|FG004|Overall Study|Migrated/moved from study area|1|||
130055756|NCT00434512|468159538|FG005|Overall Study|Migrated/moved from study area|1|||
130055757|NCT00434512|468159533|FG000|Overall Study|Other|0|||
130055758|NCT00434512|468159534|FG001|Overall Study|Other|1|||
130111635|NCT00950599|468369502|FG008|Follow-Up Period|Lost to Follow-up|5|||
130111636|NCT00950599|468369503|FG009|Follow-Up Period|Lost to Follow-up|1|||
130111637|NCT00950599|468369494|FG000|Follow-Up Period|Physician Decision|0|||
129892858|NCT00515086|467567706|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129892859|NCT00515086|467567703|FG000|Overall Study|Lost to Follow-up|1|||
129892860|NCT00515086|467567704|FG001|Overall Study|Lost to Follow-up|0|||
129892861|NCT00515086|467567705|FG002|Overall Study|Lost to Follow-up|0|||
130111638|NCT00950599|468369495|FG001|Follow-Up Period|Physician Decision|0|||
129892862|NCT00515086|467567706|FG003|Overall Study|Lost to Follow-up|0|||
129892863|NCT00515086|467567703|FG000|Overall Study|Study drug no longer required|0|||
130111639|NCT00950599|468369496|FG002|Follow-Up Period|Physician Decision|0|||
130111640|NCT00950599|468369497|FG003|Follow-Up Period|Physician Decision|0|||
130055759|NCT00434512|468159535|FG002|Overall Study|Other|0|||
130055760|NCT00434512|468159536|FG003|Overall Study|Other|0|||
130055761|NCT00434512|468159537|FG004|Overall Study|Other|0|||
130055762|NCT00434512|468159538|FG005|Overall Study|Other|0|||
130055763|NCT01575197|468159541|FG000|Overall Study|Migration out of study area|1|||
130055764|NCT01575197|468159542|FG001|Overall Study|Migration out of study area|5|||
130055765|NCT01575197|468159543|FG002|Overall Study|Migration out of study area|4|||
130055766|NCT01575197|468159541|FG000|Overall Study|SAE|0|||
130055767|NCT01575197|468159542|FG001|Overall Study|SAE|1|||
130055768|NCT01575197|468159543|FG002|Overall Study|SAE|0|||
130055769|NCT01575197|468159541|FG000|Overall Study|Lost to Follow-up|0|||
130055770|NCT01575197|468159542|FG001|Overall Study|Lost to Follow-up|1|||
130055771|NCT01575197|468159543|FG002|Overall Study|Lost to Follow-up|0|||
130055772|NCT01575197|468159541|FG000|Overall Study|Withdrawal by Subject|0|||
130055773|NCT01575197|468159542|FG001|Overall Study|Withdrawal by Subject|1|||
130055774|NCT01575197|468159543|FG002|Overall Study|Withdrawal by Subject|1|||
130055775|NCT01575197|468159541|FG000|Overall Study|Protocol Violation|2|||
130055776|NCT01575197|468159542|FG001|Overall Study|Protocol Violation|1|||
130055777|NCT01575197|468159543|FG002|Overall Study|Protocol Violation|1|||
130055778|NCT00111475|468159547|FG000|Overall Study|Lost to Follow-up|0|||
130055779|NCT00111475|468159548|FG001|Overall Study|Lost to Follow-up|0|||
130055780|NCT00111475|468159549|FG002|Overall Study|Lost to Follow-up|0|||
130055781|NCT00111475|468159550|FG003|Overall Study|Lost to Follow-up|0|||
130055782|NCT00111475|468159551|FG004|Overall Study|Lost to Follow-up|0|||
130055783|NCT00111475|468159552|FG005|Overall Study|Lost to Follow-up|1|||
130055784|NCT00111475|468159553|FG006|Overall Study|Lost to Follow-up|0|||
130055785|NCT00111475|468159554|FG007|Overall Study|Lost to Follow-up|0|||
130055786|NCT00111475|468159555|FG008|Overall Study|Lost to Follow-up|0|||
130055787|NCT00111475|468159556|FG009|Overall Study|Lost to Follow-up|0|||
130055788|NCT03303092|468159557|FG000|Overall Study|Adverse Event|1|||
130055789|NCT03303092|468159558|FG001|Overall Study|Adverse Event|0|||
130055790|NCT03303092|468159559|FG002|Overall Study|Adverse Event|1|||
130055791|NCT03303092|468159557|FG000|Overall Study|Protocol Violation|1|||
129892864|NCT00515086|467567704|FG001|Overall Study|Study drug no longer required|1|||
129892865|NCT00515086|467567705|FG002|Overall Study|Study drug no longer required|0|||
129892866|NCT00515086|467567706|FG003|Overall Study|Study drug no longer required|0|||
129892867|NCT00515086|467567703|FG000|Overall Study|Death|2|||
129892868|NCT00515086|467567704|FG001|Overall Study|Death|0|||
129892869|NCT00515086|467567705|FG002|Overall Study|Death|0|||
129892870|NCT00515086|467567706|FG003|Overall Study|Death|0|||
129892871|NCT02028884|467567707|FG000|Double-blind Period|Adverse Event|5|||
129892872|NCT02028884|467567708|FG001|Double-blind Period|Adverse Event|3|||
129892873|NCT02028884|467567709|FG002|Double-blind Period|Adverse Event|0|||
129892874|NCT02028884|467567707|FG000|Double-blind Period|Eligibility Violation|1|||
129892875|NCT02028884|467567708|FG001|Double-blind Period|Eligibility Violation|0|||
129892876|NCT02028884|467567709|FG002|Double-blind Period|Eligibility Violation|0|||
129892877|NCT02028884|467567707|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
129892878|NCT02028884|467567708|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
129892879|NCT02028884|467567709|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
129892880|NCT02028884|467567707|FG000|Double-blind Period|Withdrawal by Subject|2|||
129892881|NCT02028884|467567708|FG001|Double-blind Period|Withdrawal by Subject|0|||
129892882|NCT02028884|467567709|FG002|Double-blind Period|Withdrawal by Subject|0|||
129892883|NCT02028884|467567707|FG000|Open-label Extension Period|Adverse Event|3|||
129892884|NCT02028884|467567708|FG001|Open-label Extension Period|Adverse Event|1|||
129892885|NCT02028884|467567709|FG002|Open-label Extension Period|Adverse Event|0|||
129892886|NCT02028884|467567707|FG000|Open-label Extension Period|Lack of Efficacy|3|||
129892887|NCT02028884|467567708|FG001|Open-label Extension Period|Lack of Efficacy|0|||
129892888|NCT02028884|467567709|FG002|Open-label Extension Period|Lack of Efficacy|0|||
129892889|NCT02028884|467567707|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
129892890|NCT02028884|467567708|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
129892891|NCT02028884|467567709|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
129892892|NCT02028884|467567707|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129892893|NCT02028884|467567708|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
129892894|NCT02028884|467567709|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
129892895|NCT02028884|467567707|FG000|Open-label Extension Period|Switched to another treatment option|3|||
129892896|NCT02028884|467567708|FG001|Open-label Extension Period|Switched to another treatment option|0|||
129892897|NCT02028884|467567709|FG002|Open-label Extension Period|Switched to another treatment option|0|||
129892898|NCT02373813|467567710|FG000|Run-In Period|Other, Not Specified|5|||
129892899|NCT02373813|467567711|FG001|Run-In Period|Other, Not Specified|0|||
129892900|NCT02373813|467567712|FG002|Run-In Period|Other, Not Specified|0|||
129892901|NCT02373813|467567713|FG003|Run-In Period|Other, Not Specified|0|||
129892902|NCT02373813|467567710|FG000|Run-In Period|Withdrawal by Subject|16|||
129892903|NCT02373813|467567711|FG001|Run-In Period|Withdrawal by Subject|0|||
129892904|NCT02373813|467567712|FG002|Run-In Period|Withdrawal by Subject|0|||
129892905|NCT02373813|467567713|FG003|Run-In Period|Withdrawal by Subject|0|||
129892906|NCT02373813|467567710|FG000|Run-In Period|Decision by Sponsor|11|||
129892907|NCT02373813|467567711|FG001|Run-In Period|Decision by Sponsor|0|||
129892908|NCT02373813|467567712|FG002|Run-In Period|Decision by Sponsor|0|||
129892909|NCT02373813|467567713|FG003|Run-In Period|Decision by Sponsor|0|||
129892910|NCT02373813|467567710|FG000|Run-In Period|Protocol Violation|75|||
129892911|NCT02373813|467567711|FG001|Run-In Period|Protocol Violation|0|||
129892912|NCT02373813|467567712|FG002|Run-In Period|Protocol Violation|0|||
129892913|NCT02373813|467567713|FG003|Run-In Period|Protocol Violation|0|||
129892914|NCT02373813|467567710|FG000|Run-In Period|Lost to Follow-up|2|||
129892915|NCT02373813|467567711|FG001|Run-In Period|Lost to Follow-up|0|||
129892916|NCT02373813|467567712|FG002|Run-In Period|Lost to Follow-up|0|||
129892917|NCT02373813|467567713|FG003|Run-In Period|Lost to Follow-up|0|||
129892918|NCT02373813|467567710|FG000|Run-In Period|Adverse Event|3|||
129892919|NCT02373813|467567711|FG001|Run-In Period|Adverse Event|0|||
129892920|NCT02373813|467567712|FG002|Run-In Period|Adverse Event|0|||
129892921|NCT02373813|467567713|FG003|Run-In Period|Adverse Event|0|||
129892922|NCT02373813|467567710|FG000|Run-In Period|Noncompliance|1|||
130055792|NCT03303092|468159558|FG001|Overall Study|Protocol Violation|5|||
129892923|NCT02373813|467567711|FG001|Run-In Period|Noncompliance|0|||
129892924|NCT02373813|467567712|FG002|Run-In Period|Noncompliance|0|||
129892925|NCT02373813|467567713|FG003|Run-In Period|Noncompliance|0|||
129892926|NCT02373813|467567710|FG000|Run-In Period|Ineligibility Determined|3|||
129892927|NCT02373813|467567711|FG001|Run-In Period|Ineligibility Determined|0|||
129892928|NCT02373813|467567712|FG002|Run-In Period|Ineligibility Determined|0|||
129892929|NCT02373813|467567713|FG003|Run-In Period|Ineligibility Determined|0|||
129892930|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
129892931|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
129892932|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
130055793|NCT03303092|468159559|FG002|Overall Study|Protocol Violation|1|||
130055794|NCT03303092|468159557|FG000|Overall Study|Withdrawal by Subject|1|||
130055795|NCT03303092|468159558|FG001|Overall Study|Withdrawal by Subject|1|||
130055796|NCT03303092|468159559|FG002|Overall Study|Withdrawal by Subject|3|||
130055797|NCT00833248|468159565|FG000|Overall Study|Adverse Event|3|||
130055798|NCT00833248|468159566|FG001|Overall Study|Adverse Event|0|||
130055799|NCT00833248|468159565|FG000|Overall Study|Protocol Violation|1|||
129804471|NCT03181893|467251543|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804472|NCT03181893|467251544|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804473|NCT03181893|467251545|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804474|NCT03181893|467251546|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804475|NCT03181893|467251547|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804476|NCT03181893|467251548|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804477|NCT03181893|467251538|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804478|NCT03181893|467251539|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804479|NCT03181893|467251540|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804480|NCT03181893|467251541|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804481|NCT03181893|467251542|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804482|NCT03181893|467251543|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804483|NCT03181893|467251544|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804484|NCT03181893|467251545|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
129804485|NCT03181893|467251546|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
129804486|NCT03181893|467251547|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804487|NCT03181893|467251548|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804488|NCT03181893|467251538|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804489|NCT03181893|467251539|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804490|NCT03181893|467251540|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804491|NCT03181893|467251541|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804492|NCT03181893|467251542|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804493|NCT03181893|467251543|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804494|NCT03181893|467251544|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804495|NCT03181893|467251545|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804496|NCT03181893|467251546|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804497|NCT03181893|467251547|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
129804498|NCT03181893|467251548|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
130055800|NCT00833248|468159566|FG001|Overall Study|Protocol Violation|2|||
129804499|NCT03181893|467251538|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
130055801|NCT00833248|468159565|FG000|Overall Study|Withdrawal by Subject|0|||
130055802|NCT00833248|468159566|FG001|Overall Study|Withdrawal by Subject|1|||
130055803|NCT02006667|468159567|FG000|Overall Study|Adverse Event|3|||
129804500|NCT03181893|467251539|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804501|NCT03181893|467251540|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804502|NCT03181893|467251541|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804503|NCT03181893|467251542|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804504|NCT03181893|467251543|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804505|NCT03181893|467251544|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804506|NCT03181893|467251545|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804507|NCT03181893|467251546|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804508|NCT03181893|467251547|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804509|NCT03181893|467251548|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
129804510|NCT00968864|467251550|FG000|Overall Study|Protocol exception/ not evaluable|1|||
129804511|NCT04815031|467251551|FG000|Overall Study|No adverse event information (missing information)|33|||
129804512|NCT00586625|467251552|FG000|Overall Study|Adverse Event|6|||
129804513|NCT00586625|467251553|FG001|Overall Study|Adverse Event|6|||
129804514|NCT00586625|467251552|FG000|Overall Study|Protocol Violation|3|||
129804515|NCT00586625|467251553|FG001|Overall Study|Protocol Violation|0|||
130055804|NCT02006667|468159567|FG000|Overall Study|Death|2|||
129804516|NCT00586625|467251552|FG000|Overall Study|Withdrawal by Subject|32|||
129804517|NCT00586625|467251553|FG001|Overall Study|Withdrawal by Subject|10|||
129804518|NCT00586625|467251552|FG000|Overall Study|Subject non-compliance|0|||
130055805|NCT02006667|468159567|FG000|Overall Study|Withdrawal by Subject|1|||
130055806|NCT02939937|468159568|FG000|Overall Study|Adverse Event|5|||
130055807|NCT02939937|468159569|FG001|Overall Study|Adverse Event|0|||
129804519|NCT00586625|467251553|FG001|Overall Study|Subject non-compliance|1|||
129804520|NCT00586625|467251552|FG000|Overall Study|Subject unable to return for visit|2|||
129804521|NCT00586625|467251553|FG001|Overall Study|Subject unable to return for visit|0|||
129804522|NCT02728596|467251554|FG000|Overall Study|Refusal unrelated to adverse event|3|||
129804523|NCT02728596|467251555|FG001|Overall Study|Refusal unrelated to adverse event|6|||
129804524|NCT02728596|467251556|FG002|Overall Study|Refusal unrelated to adverse event|7|||
129804525|NCT02728596|467251557|FG003|Overall Study|Refusal unrelated to adverse event|7|||
129804526|NCT02728596|467251554|FG000|Overall Study|Death|44|||
129804527|NCT02728596|467251555|FG001|Overall Study|Death|42|||
129804528|NCT02728596|467251556|FG002|Overall Study|Death|123|||
129804529|NCT02728596|467251557|FG003|Overall Study|Death|68|||
129804530|NCT04032652|467251564|FG000|Overall Study|The study was terminated and the PI has|1|||
129804531|NCT04032652|467251565|FG001|Overall Study|The study was terminated and the PI has|1|||
129804532|NCT00165984|467251566|FG000|Overall Study|Death|15|||
129804533|NCT03945266|467251567|FG000|Overall Study|Withdrawal by Subject|1|||
129804534|NCT03945266|467251568|FG001|Overall Study|Withdrawal by Subject|0|||
129804535|NCT03945266|467251567|FG000|Overall Study|Miscarriage|0|||
129804536|NCT03945266|467251568|FG001|Overall Study|Miscarriage|2|||
129804537|NCT03945266|467251567|FG000|Overall Study|Lost to Follow-up|1|||
129804538|NCT03945266|467251568|FG001|Overall Study|Lost to Follow-up|0|||
129804539|NCT01736124|467251569|FG000|Post-intervention Assessment|Death|2|||
129892933|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
129892934|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129804540|NCT01736124|467251570|FG001|Post-intervention Assessment|Death|2|||
129804541|NCT01736124|467251569|FG000|Post-intervention Assessment|lost computer access|1|||
129804542|NCT01736124|467251570|FG001|Post-intervention Assessment|lost computer access|1|||
129804543|NCT01736124|467251569|FG000|Post-intervention Assessment|Moved away|3|||
129804544|NCT01736124|467251570|FG001|Post-intervention Assessment|Moved away|1|||
129804545|NCT01736124|467251569|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
129892935|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
129892936|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
129892937|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
129892938|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129804546|NCT01736124|467251570|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
129804547|NCT01736124|467251569|FG000|Post-intervention Assessment|Illness|3|||
129804548|NCT01736124|467251570|FG001|Post-intervention Assessment|Illness|2|||
129804549|NCT01736124|467251569|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
129804550|NCT01736124|467251570|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
129804551|NCT01736124|467251569|FG000|Post-intervention Assessment|Temporarily away|3|||
129804552|NCT01736124|467251570|FG001|Post-intervention Assessment|Temporarily away|1|||
129804553|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
129804554|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
129804555|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
129804556|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
129804557|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
129804558|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
129804559|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
129804560|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
129804561|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
130055808|NCT02939937|468159568|FG000|Overall Study|Lost to Follow-up|1|||
130055809|NCT02939937|468159569|FG001|Overall Study|Lost to Follow-up|3|||
130055810|NCT04281030|468159578|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
130055811|NCT04281030|468159579|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
130055812|NCT04281030|468159578|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
130055813|NCT04281030|468159579|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
130055814|NCT01361009|468159580|FG000|Overall Study|Protocol Violation|116|||
130055815|NCT01826422|468159581|FG000|Overall Study|Withdrawal by Subject|1|||
130055816|NCT01826422|468159582|FG001|Overall Study|Withdrawal by Subject|3|||
130055817|NCT02116660|468159587|FG000|Overall Study|Deteriorating renal function|0|||
130111641|NCT00950599|468369498|FG004|Follow-Up Period|Physician Decision|0|||
130111642|NCT00950599|468369499|FG005|Follow-Up Period|Physician Decision|0|||
129804562|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
129804563|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
129804564|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
129804565|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
129804566|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
129804567|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
129804568|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
129804569|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
129804570|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
129804571|NCT03553927|467251571|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
129804572|NCT03553927|467251572|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
129804573|NCT03553927|467251571|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
129804574|NCT03553927|467251572|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
130111643|NCT00950599|468369500|FG006|Follow-Up Period|Physician Decision|0|||
130111644|NCT00950599|468369501|FG007|Follow-Up Period|Physician Decision|0|||
130111645|NCT00950599|468369502|FG008|Follow-Up Period|Physician Decision|1|||
130111646|NCT00950599|468369503|FG009|Follow-Up Period|Physician Decision|0|||
130111647|NCT00950599|468369494|FG000|Follow-Up Period|Poor/Noncompliance|0|||
130111648|NCT00950599|468369495|FG001|Follow-Up Period|Poor/Noncompliance|0|||
130111649|NCT00950599|468369496|FG002|Follow-Up Period|Poor/Noncompliance|0|||
130111650|NCT00950599|468369497|FG003|Follow-Up Period|Poor/Noncompliance|0|||
130111651|NCT00950599|468369498|FG004|Follow-Up Period|Poor/Noncompliance|0|||
130111652|NCT00950599|468369499|FG005|Follow-Up Period|Poor/Noncompliance|0|||
130111653|NCT00950599|468369500|FG006|Follow-Up Period|Poor/Noncompliance|0|||
130111654|NCT00950599|468369501|FG007|Follow-Up Period|Poor/Noncompliance|0|||
130111655|NCT00950599|468369502|FG008|Follow-Up Period|Poor/Noncompliance|1|||
130111656|NCT00950599|468369503|FG009|Follow-Up Period|Poor/Noncompliance|0|||
130111657|NCT00950599|468369494|FG000|Follow-Up Period|Subject withdrew Consent|0|||
130111658|NCT00950599|468369495|FG001|Follow-Up Period|Subject withdrew Consent|0|||
130111659|NCT00950599|468369496|FG002|Follow-Up Period|Subject withdrew Consent|0|||
130111660|NCT00950599|468369497|FG003|Follow-Up Period|Subject withdrew Consent|0|||
130111661|NCT00950599|468369498|FG004|Follow-Up Period|Subject withdrew Consent|0|||
130111662|NCT00950599|468369499|FG005|Follow-Up Period|Subject withdrew Consent|0|||
130111663|NCT00950599|468369500|FG006|Follow-Up Period|Subject withdrew Consent|0|||
129804575|NCT02423772|467251573|FG000|Overall Study|Lost to Follow-up|3|||
129804576|NCT02423772|467251574|FG001|Overall Study|Lost to Follow-up|3|||
129804577|NCT02423772|467251573|FG000|Overall Study|Did not begin intervention|2|||
129804578|NCT02423772|467251574|FG001|Overall Study|Did not begin intervention|5|||
130111664|NCT00950599|468369501|FG007|Follow-Up Period|Subject withdrew Consent|0|||
129804579|NCT03360747|467251581|FG000|Overall Study|Voluntary Withdrawal|1|||
129804580|NCT01759511|467251582|FG000|Overall Study|Adverse Event|4|||
129804581|NCT01759511|467251582|FG000|Overall Study|Death|2|||
130111665|NCT00950599|468369502|FG008|Follow-Up Period|Subject withdrew Consent|2|||
129804582|NCT01759511|467251582|FG000|Overall Study|Lack of Efficacy|2|||
129804583|NCT01759511|467251582|FG000|Overall Study|Physician Decision|1|||
129804584|NCT01759511|467251582|FG000|Overall Study|Progressive Disease|5|||
129804585|NCT01759511|467251582|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
129804586|NCT01759511|467251582|FG000|Overall Study|Study Terminated by Sponsor|13|||
129804587|NCT01759511|467251582|FG000|Overall Study|Withdrawal by Subject|3|||
129804588|NCT03693300|467252990|FG000|Overall Study|Withdrawal by Subject|6|||
129804589|NCT03693300|467252991|FG001|Overall Study|Withdrawal by Subject|0|||
129804590|NCT03693300|467252990|FG000|Overall Study|Death|50|||
129804591|NCT03693300|467252991|FG001|Overall Study|Death|2|||
129804592|NCT03693300|467252990|FG000|Overall Study|Lost to Follow-up|2|||
129804593|NCT03693300|467252991|FG001|Overall Study|Lost to Follow-up|0|||
129804594|NCT02206048|467252992|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
129804595|NCT04195906|467252995|FG000|Part 1|Adverse Event|3|||
129804596|NCT04195906|467252996|FG001|Part 1|Adverse Event|7|||
129804597|NCT04195906|467252995|FG000|Part 1|Withdrawal by Subject|0|||
129804598|NCT04195906|467252996|FG001|Part 1|Withdrawal by Subject|1|||
129804599|NCT04195906|467252995|FG000|Part 2|Adverse Event|1|||
129804600|NCT04195906|467252996|FG001|Part 2|Adverse Event|1|||
129804601|NCT04195906|467252995|FG000|Part 2|Withdrawal by Subject|0|||
129804602|NCT04195906|467252996|FG001|Part 2|Withdrawal by Subject|3|||
129804603|NCT04195906|467252995|FG000|Part 2|Other|1|||
129804604|NCT04195906|467252996|FG001|Part 2|Other|3|||
129804605|NCT00428792|467252997|FG000|Overall Study|Lack of Efficacy|1|||
129804606|NCT00428792|467252998|FG001|Overall Study|Lack of Efficacy|3|||
129804607|NCT00428792|467252997|FG000|Overall Study|Lost to Follow-up|0|||
129804608|NCT00428792|467252998|FG001|Overall Study|Lost to Follow-up|1|||
129804609|NCT00639678|467252999|FG000|Overall Study|Withdrawal by Subject|3|||
129804610|NCT00639678|467253000|FG001|Overall Study|Withdrawal by Subject|0|||
129804611|NCT00639678|467253001|FG002|Overall Study|Withdrawal by Subject|4|||
129804612|NCT00639678|467253002|FG003|Overall Study|Withdrawal by Subject|0|||
129804613|NCT00639678|467252999|FG000|Overall Study|Lost to Follow-up|1|||
129804614|NCT00639678|467253000|FG001|Overall Study|Lost to Follow-up|0|||
129804615|NCT00639678|467253001|FG002|Overall Study|Lost to Follow-up|6|||
129804616|NCT00639678|467253002|FG003|Overall Study|Lost to Follow-up|0|||
129804617|NCT00639678|467252999|FG000|Overall Study|Adverse Event|0|||
129804618|NCT00639678|467253000|FG001|Overall Study|Adverse Event|1|||
129804619|NCT00639678|467253001|FG002|Overall Study|Adverse Event|0|||
129804620|NCT00639678|467253002|FG003|Overall Study|Adverse Event|0|||
129804621|NCT00639678|467252999|FG000|Overall Study|Lack of Compliance|0|||
129804622|NCT00639678|467253000|FG001|Overall Study|Lack of Compliance|0|||
129804623|NCT00639678|467253001|FG002|Overall Study|Lack of Compliance|1|||
129804624|NCT00639678|467253002|FG003|Overall Study|Lack of Compliance|0|||
129804625|NCT01926015|467253003|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129804626|NCT01926015|467253004|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129804627|NCT01926015|467253003|FG000|Overall Study|Randomized not treated|2|||
129804628|NCT01926015|467253004|FG001|Overall Study|Randomized not treated|0|||
129804629|NCT01364649|467253005|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
129804630|NCT01364649|467253006|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
129804631|NCT01364649|467253005|FG000|Overall Study|Lack of Efficacy|6|||
129804632|NCT01364649|467253006|FG001|Overall Study|Lack of Efficacy|0|||
129804633|NCT01364649|467253005|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
129804634|NCT01364649|467253006|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
129804635|NCT01364649|467253005|FG000|Overall Study|Protocol Deviations|4|||
129804636|NCT01364649|467253006|FG001|Overall Study|Protocol Deviations|8|||
129804637|NCT01364649|467253005|FG000|Overall Study|Withdrawal of Consent|9|||
129804638|NCT01364649|467253006|FG001|Overall Study|Withdrawal of Consent|7|||
129804639|NCT01364649|467253005|FG000|Overall Study|Lost to Follow-up|12|||
129804640|NCT01364649|467253006|FG001|Overall Study|Lost to Follow-up|13|||
129804641|NCT01364649|467253005|FG000|Overall Study|Other|4|||
129804642|NCT01364649|467253006|FG001|Overall Study|Other|1|||
129804643|NCT00615108|467253024|FG000|Overall Study|Adverse Event|122|||
129804644|NCT00615108|467253024|FG000|Overall Study|Other|370|||
129804645|NCT00615108|467253024|FG000|Overall Study|Lost to Follow-up|15|||
129804646|NCT01914757|467253025|FG000|Overall Study|Severe non-compliance to protocol|3|||
129804647|NCT01914757|467253026|FG001|Overall Study|Severe non-compliance to protocol|1|||
129804648|NCT01914757|467253027|FG002|Overall Study|Severe non-compliance to protocol|2|||
129804649|NCT01914757|467253025|FG000|Overall Study|Lost to Follow-up|5|||
129804650|NCT01914757|467253026|FG001|Overall Study|Lost to Follow-up|8|||
129804651|NCT01914757|467253027|FG002|Overall Study|Lost to Follow-up|6|||
129804652|NCT01914757|467253025|FG000|Overall Study|Withdrawal by Subject|15|||
129804653|NCT01914757|467253026|FG001|Overall Study|Withdrawal by Subject|27|||
129804654|NCT01914757|467253027|FG002|Overall Study|Withdrawal by Subject|19|||
129804655|NCT01914757|467253025|FG000|Overall Study|Death|2|||
129804656|NCT01914757|467253026|FG001|Overall Study|Death|2|||
129804657|NCT01914757|467253027|FG002|Overall Study|Death|1|||
129804658|NCT01914757|467253025|FG000|Overall Study|Adverse Event|4|||
129804659|NCT01914757|467253026|FG001|Overall Study|Adverse Event|3|||
129804660|NCT01914757|467253027|FG002|Overall Study|Adverse Event|4|||
129804661|NCT01914757|467253025|FG000|Overall Study|Study specific withdrawal criteria|0|||
129804662|NCT01914757|467253026|FG001|Overall Study|Study specific withdrawal criteria|1|||
129804663|NCT01914757|467253027|FG002|Overall Study|Study specific withdrawal criteria|0|||
129804664|NCT01914757|467253025|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129804665|NCT01914757|467253026|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129804666|NCT01914757|467253027|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
129804667|NCT01914757|467253025|FG000|Overall Study|Other reasons|5|||
129804668|NCT01914757|467253026|FG001|Overall Study|Other reasons|9|||
129804669|NCT01914757|467253027|FG002|Overall Study|Other reasons|4|||
129804670|NCT01426438|467253034|FG000|Overall Study|Lost to Follow-up|1|||
129804671|NCT01426438|467253035|FG001|Overall Study|Lost to Follow-up|3|||
129804672|NCT01426438|467253034|FG000|Overall Study|Off study Treatment|9|||
129804673|NCT01426438|467253035|FG001|Overall Study|Off study Treatment|3|||
129804674|NCT01426438|467253034|FG000|Overall Study|Poor scan quality|3|||
129804675|NCT01426438|467253035|FG001|Overall Study|Poor scan quality|2|||
129804676|NCT01426438|467253034|FG000|Overall Study|Missed Scan|2|||
129804677|NCT01426438|467253035|FG001|Overall Study|Missed Scan|2|||
129804678|NCT02833350|467253036|FG000|Overall Study|Adverse Event|0|||
129804679|NCT02833350|467253037|FG001|Overall Study|Adverse Event|3|||
129804680|NCT02833350|467253038|FG002|Overall Study|Adverse Event|4|||
129804681|NCT02833350|467253039|FG003|Overall Study|Adverse Event|4|||
129804682|NCT02833350|467253040|FG004|Overall Study|Adverse Event|1|||
129804683|NCT02833350|467253041|FG005|Overall Study|Adverse Event|0|||
129804684|NCT02833350|467253042|FG006|Overall Study|Adverse Event|1|||
129804685|NCT02833350|467253036|FG000|Overall Study|Death|0|||
130055818|NCT02116660|468159588|FG001|Overall Study|Deteriorating renal function|1|||
130055819|NCT02116660|468159587|FG000|Overall Study|Adverse Event|1|||
130055820|NCT02116660|468159588|FG001|Overall Study|Adverse Event|1|||
130055821|NCT02116660|468159587|FG000|Overall Study|Withdrawal by Subject|0|||
130055822|NCT02116660|468159588|FG001|Overall Study|Withdrawal by Subject|2|||
130055823|NCT02116660|468159587|FG000|Overall Study|Organization reason|1|||
130055824|NCT02116660|468159588|FG001|Overall Study|Organization reason|0|||
129804686|NCT02833350|467253037|FG001|Overall Study|Death|0|||
129804687|NCT02833350|467253038|FG002|Overall Study|Death|1|||
130055825|NCT05122650|468159591|FG000|Overall Study|Adverse Event|4|||
130055826|NCT05122650|468159592|FG001|Overall Study|Adverse Event|16|||
130055827|NCT05122650|468159593|FG002|Overall Study|Adverse Event|11|||
129804688|NCT02833350|467253039|FG003|Overall Study|Death|0|||
129804689|NCT02833350|467253040|FG004|Overall Study|Death|0|||
129804690|NCT02833350|467253041|FG005|Overall Study|Death|0|||
129804691|NCT02833350|467253042|FG006|Overall Study|Death|0|||
129804692|NCT02833350|467253036|FG000|Overall Study|Lack of Efficacy|0|||
129804693|NCT02833350|467253037|FG001|Overall Study|Lack of Efficacy|2|||
129804694|NCT02833350|467253038|FG002|Overall Study|Lack of Efficacy|1|||
129804695|NCT02833350|467253039|FG003|Overall Study|Lack of Efficacy|4|||
129804696|NCT02833350|467253040|FG004|Overall Study|Lack of Efficacy|0|||
129804697|NCT02833350|467253041|FG005|Overall Study|Lack of Efficacy|1|||
129804698|NCT02833350|467253042|FG006|Overall Study|Lack of Efficacy|1|||
129804699|NCT02833350|467253036|FG000|Overall Study|Lost to Follow-up|0|||
129804700|NCT02833350|467253037|FG001|Overall Study|Lost to Follow-up|1|||
129804701|NCT02833350|467253038|FG002|Overall Study|Lost to Follow-up|0|||
130055828|NCT05122650|468159594|FG003|Overall Study|Adverse Event|12|||
130055829|NCT05122650|468159591|FG000|Overall Study|Lack of Efficacy|0|||
130055830|NCT05122650|468159592|FG001|Overall Study|Lack of Efficacy|1|||
130055831|NCT05122650|468159593|FG002|Overall Study|Lack of Efficacy|1|||
130055832|NCT05122650|468159594|FG003|Overall Study|Lack of Efficacy|2|||
130055833|NCT05122650|468159591|FG000|Overall Study|Lost to Follow-up|1|||
130055834|NCT05122650|468159592|FG001|Overall Study|Lost to Follow-up|1|||
130055835|NCT05122650|468159593|FG002|Overall Study|Lost to Follow-up|3|||
130055836|NCT05122650|468159594|FG003|Overall Study|Lost to Follow-up|0|||
130055837|NCT05122650|468159591|FG000|Overall Study|Non-compliance with study intervention|0|||
129804702|NCT02833350|467253039|FG003|Overall Study|Lost to Follow-up|0|||
129804703|NCT02833350|467253040|FG004|Overall Study|Lost to Follow-up|0|||
129804704|NCT02833350|467253041|FG005|Overall Study|Lost to Follow-up|0|||
129804705|NCT02833350|467253042|FG006|Overall Study|Lost to Follow-up|1|||
129804706|NCT02833350|467253036|FG000|Overall Study|Withdrawal by Subject|3|||
129804707|NCT02833350|467253037|FG001|Overall Study|Withdrawal by Subject|3|||
129804708|NCT02833350|467253038|FG002|Overall Study|Withdrawal by Subject|2|||
129804709|NCT02833350|467253039|FG003|Overall Study|Withdrawal by Subject|0|||
129804710|NCT02833350|467253040|FG004|Overall Study|Withdrawal by Subject|2|||
129804711|NCT02833350|467253041|FG005|Overall Study|Withdrawal by Subject|0|||
130055838|NCT05122650|468159592|FG001|Overall Study|Non-compliance with study intervention|0|||
129804712|NCT02833350|467253042|FG006|Overall Study|Withdrawal by Subject|2|||
129804713|NCT01500031|467253045|FG000|Overall Study|Death|1|||
129804714|NCT01500031|467253045|FG000|Overall Study|Withdrawal by Subject|4|||
130055839|NCT05122650|468159593|FG002|Overall Study|Non-compliance with study intervention|0|||
129804715|NCT01604408|467253046|FG000|Treatment Period 1|Protocol Violation|0|||
129804716|NCT01604408|467253047|FG001|Treatment Period 1|Protocol Violation|1|||
130055840|NCT05122650|468159594|FG003|Overall Study|Non-compliance with study intervention|2|||
130055841|NCT05122650|468159591|FG000|Overall Study|Protocol Violation|0|||
130055842|NCT05122650|468159592|FG001|Overall Study|Protocol Violation|1|||
130055843|NCT05122650|468159593|FG002|Overall Study|Protocol Violation|0|||
129804717|NCT01604408|467253046|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129804718|NCT01604408|467253047|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129804719|NCT01604408|467253046|FG000|Treatment Period 2|Protocol Violation|1|||
129804720|NCT01604408|467253047|FG001|Treatment Period 2|Protocol Violation|0|||
129892939|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
130111666|NCT00950599|468369503|FG009|Follow-Up Period|Subject withdrew Consent|1|||
129892940|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
129804721|NCT01604408|467253046|FG000|Treatment Period 2|Adverse Event|0|||
129804722|NCT01604408|467253047|FG001|Treatment Period 2|Adverse Event|1|||
129804723|NCT01604408|467253046|FG000|Treatment Period 3|Protocol Violation|1|||
129804724|NCT01604408|467253047|FG001|Treatment Period 3|Protocol Violation|1|||
129804725|NCT01604408|467253046|FG000|Treatment Period 3|Adverse Event|0|||
130055844|NCT05122650|468159594|FG003|Overall Study|Protocol Violation|1|||
130055845|NCT05122650|468159591|FG000|Overall Study|Randomized by mistake|0|||
130055846|NCT05122650|468159592|FG001|Overall Study|Randomized by mistake|0|||
130055847|NCT05122650|468159593|FG002|Overall Study|Randomized by mistake|3|||
130055848|NCT05122650|468159594|FG003|Overall Study|Randomized by mistake|2|||
130055849|NCT05122650|468159591|FG000|Overall Study|Sponsor request|0|||
130055850|NCT05122650|468159592|FG001|Overall Study|Sponsor request|1|||
130111667|NCT00971204|468369504|FG000|Overall Study|Did not meet all criteria-not treated|14|||
129804726|NCT01604408|467253047|FG001|Treatment Period 3|Adverse Event|3|||
129804727|NCT01604408|467253046|FG000|Treatment Period 3|Withdrawal by Subject|3|||
129804728|NCT01604408|467253047|FG001|Treatment Period 3|Withdrawal by Subject|1|||
129804729|NCT01604408|467253046|FG000|Treatment Period 3|Sponsor Decision|1|||
129804730|NCT01604408|467253047|FG001|Treatment Period 3|Sponsor Decision|0|||
129804731|NCT01604408|467253046|FG000|Treatment Period 4|Death|1|||
129804732|NCT01604408|467253047|FG001|Treatment Period 4|Death|0|||
129804733|NCT01604408|467253046|FG000|Treatment Period 4|Withdrawal by Subject|2|||
129804734|NCT01604408|467253047|FG001|Treatment Period 4|Withdrawal by Subject|1|||
129804735|NCT01604408|467253046|FG000|Treatment Period 4|Adverse Event|0|||
129804736|NCT01604408|467253047|FG001|Treatment Period 4|Adverse Event|1|||
129892941|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
129892942|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130055851|NCT05122650|468159593|FG002|Overall Study|Sponsor request|1|||
129804737|NCT01604408|467253046|FG000|Treatment Period 5|Adverse Event|4|||
129804738|NCT01604408|467253047|FG001|Treatment Period 5|Adverse Event|0|||
129804739|NCT01604408|467253046|FG000|Treatment Period 6|Lost to Follow-up|0|||
130055852|NCT05122650|468159594|FG003|Overall Study|Sponsor request|2|||
130055853|NCT05122650|468159591|FG000|Overall Study|Withdrawal by Subject|3|||
130055854|NCT05122650|468159592|FG001|Overall Study|Withdrawal by Subject|7|||
130055855|NCT05122650|468159593|FG002|Overall Study|Withdrawal by Subject|4|||
130055856|NCT05122650|468159594|FG003|Overall Study|Withdrawal by Subject|8|||
130055857|NCT05122650|468159591|FG000|Overall Study|Other|5|||
130055858|NCT05122650|468159592|FG001|Overall Study|Other|0|||
130055859|NCT05122650|468159593|FG002|Overall Study|Other|0|||
130111668|NCT00971204|468369504|FG000|Overall Study|Lost to Follow-up|10|||
129804740|NCT01604408|467253047|FG001|Treatment Period 6|Lost to Follow-up|1|||
129804741|NCT01604408|467253046|FG000|Treatment Period 6|Adverse Event|2|||
129804742|NCT01604408|467253047|FG001|Treatment Period 6|Adverse Event|0|||
129804743|NCT01604408|467253046|FG000|Treatment Period 6|Sponsor decision|0|||
129804744|NCT01604408|467253047|FG001|Treatment Period 6|Sponsor decision|1|||
129804745|NCT01604408|467253046|FG000|Observation Period|Adverse Event|1|||
129804746|NCT01604408|467253047|FG001|Observation Period|Adverse Event|1|||
129804747|NCT01604408|467253046|FG000|Observation Period|Withdrawal by Subject|0|||
129804748|NCT01604408|467253047|FG001|Observation Period|Withdrawal by Subject|2|||
129804749|NCT00917501|467253048|FG000|Overall Study|Lost to Follow-up|4|||
129804750|NCT00917501|467253049|FG001|Overall Study|Lost to Follow-up|1|||
129804751|NCT00917501|467253048|FG000|Overall Study|Withdrawal by Subject|3|||
129804752|NCT00917501|467253049|FG001|Overall Study|Withdrawal by Subject|1|||
129804753|NCT00917501|467253048|FG000|Overall Study|Lack of Efficacy|1|||
129804754|NCT00917501|467253049|FG001|Overall Study|Lack of Efficacy|2|||
129804755|NCT00917501|467253048|FG000|Overall Study|trouble swollowing capsules|0|||
129804756|NCT00917501|467253049|FG001|Overall Study|trouble swollowing capsules|1|||
129804757|NCT00808483|467253050|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
129804758|NCT00808483|467253051|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
129804759|NCT00808483|467253050|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
129804760|NCT00808483|467253051|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
129804761|NCT00808483|467253050|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
129804762|NCT00808483|467253051|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
129804763|NCT04553679|467253052|FG000|Overall Study|Withdrawal by Subject|2|||
129804764|NCT04553679|467253053|FG001|Overall Study|Withdrawal by Subject|0|||
129804765|NCT04553679|467253052|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
129804766|NCT04553679|467253053|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
129804767|NCT02357979|467253054|FG000|Overall Study|Lost to Follow-up|5|||
130111669|NCT02436135|468369505|FG000|Overall Study|Progressive Disease|3|||
129804768|NCT02357979|467253055|FG001|Overall Study|Lost to Follow-up|5|||
129804769|NCT03945214|467253056|FG000|Overall Study|Lost to Follow-up|3|||
130111670|NCT02436135|468369506|FG001|Overall Study|Progressive Disease|1|||
129804770|NCT03945214|467253057|FG001|Overall Study|Lost to Follow-up|4|||
129804771|NCT03945214|467253058|FG002|Overall Study|Lost to Follow-up|7|||
129804772|NCT03945214|467253059|FG003|Overall Study|Lost to Follow-up|4|||
129804773|NCT00074984|467253063|FG000|Overall Study|Death|1|||
130111671|NCT02436135|468369505|FG000|Overall Study|Investigator Discretion|1|||
129804774|NCT00074984|467253064|FG001|Overall Study|Death|2|||
129804775|NCT00074984|467253063|FG000|Overall Study|Withdrawal by Subject|2|||
129804776|NCT00074984|467253064|FG001|Overall Study|Withdrawal by Subject|3|||
130055860|NCT05122650|468159594|FG003|Overall Study|Other|0|||
130055861|NCT01842620|468159608|FG000|Period 1|Withdrawal by Subject|1|||
130055862|NCT01842620|468159609|FG001|Period 1|Withdrawal by Subject|0|||
130055863|NCT00256867|468159610|FG000|Overall Study|Adverse Event|0|||
130055864|NCT00256867|468159611|FG001|Overall Study|Adverse Event|1|||
130055865|NCT00256867|468159612|FG002|Overall Study|Adverse Event|1|||
130055866|NCT00256867|468159613|FG003|Overall Study|Adverse Event|1|||
130055867|NCT00256867|468159614|FG004|Overall Study|Adverse Event|2|||
130055868|NCT00256867|468159615|FG005|Overall Study|Adverse Event|2|||
129804777|NCT00074984|467253063|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
129804778|NCT00074984|467253064|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
130055869|NCT00256867|468159616|FG006|Overall Study|Adverse Event|1|||
129804779|NCT01772160|467253068|FG000|Overall Study|Death|3|||
130055870|NCT00256867|468159617|FG007|Overall Study|Adverse Event|4|||
130055871|NCT00256867|468159610|FG000|Overall Study|Lost to Follow-up|2|||
130055872|NCT00256867|468159611|FG001|Overall Study|Lost to Follow-up|2|||
129804780|NCT01772160|467253068|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
129804781|NCT01772160|467253068|FG000|Overall Study|Consent withdrawal|3|||
129804782|NCT01772160|467253068|FG000|Overall Study|Migrated / moved from the study area|4|||
129804783|NCT01772160|467253068|FG000|Overall Study|Lost to Follow-up|30|||
129804784|NCT01772160|467253068|FG000|Overall Study|Other|5|||
129892943|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
129892944|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
129892945|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
129892946|NCT02403674|467567716|FG000|Base Study|Death|1|||
129892947|NCT02403674|467567717|FG001|Base Study|Death|4|||
129892948|NCT02403674|467567716|FG000|Base Study|Adverse Event|11|||
129892949|NCT02403674|467567717|FG001|Base Study|Adverse Event|26|||
129892950|NCT02403674|467567716|FG000|Base Study|Lack of Efficacy|31|||
129892951|NCT02403674|467567717|FG001|Base Study|Lack of Efficacy|23|||
129892952|NCT02403674|467567716|FG000|Base Study|Lost to Follow-up|6|||
129892953|NCT02403674|467567717|FG001|Base Study|Lost to Follow-up|8|||
129892954|NCT02403674|467567716|FG000|Base Study|Withdrawal by Subject|10|||
129892955|NCT02403674|467567717|FG001|Base Study|Withdrawal by Subject|17|||
129892956|NCT02403674|467567716|FG000|Base Study|Physician Decision|2|||
129892957|NCT02403674|467567717|FG001|Base Study|Physician Decision|2|||
129892958|NCT02403674|467567716|FG000|Base Study|Pregnancy|2|||
129892959|NCT02403674|467567717|FG001|Base Study|Pregnancy|2|||
129892960|NCT02403674|467567716|FG000|Base Study|Protocol Violation|8|||
129892961|NCT02403674|467567717|FG001|Base Study|Protocol Violation|4|||
129892962|NCT02403674|467567716|FG000|Base Study|Non-Compliance with study drug|1|||
129892963|NCT02403674|467567717|FG001|Base Study|Non-Compliance with study drug|4|||
129892964|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
129892965|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
129892966|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
129892967|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
129892968|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
129892969|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
129892970|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
129892971|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
129892972|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
130055873|NCT00256867|468159612|FG002|Overall Study|Lost to Follow-up|2|||
130055874|NCT00256867|468159613|FG003|Overall Study|Lost to Follow-up|3|||
129892973|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
129892974|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
130055875|NCT00256867|468159614|FG004|Overall Study|Lost to Follow-up|2|||
130055876|NCT00256867|468159615|FG005|Overall Study|Lost to Follow-up|0|||
129892975|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
129804785|NCT01522248|467253069|FG000|Overall Study|Lost to Follow-up|1|||
129804786|NCT01522248|467253070|FG001|Overall Study|Lost to Follow-up|0|||
129804787|NCT00694707|467253075|FG000|Overall Study|Did Not Receive Treatment|0|||
129804788|NCT00694707|467253076|FG001|Overall Study|Did Not Receive Treatment|0|||
129804789|NCT00694707|467253077|FG002|Overall Study|Did Not Receive Treatment|1|||
129804790|NCT00694707|467253078|FG003|Overall Study|Did Not Receive Treatment|1|||
129804791|NCT00694707|467253079|FG004|Overall Study|Did Not Receive Treatment|1|||
129804792|NCT00694707|467253075|FG000|Overall Study|Adverse Event|22|||
129804793|NCT00694707|467253076|FG001|Overall Study|Adverse Event|14|||
129804794|NCT00694707|467253077|FG002|Overall Study|Adverse Event|8|||
129804795|NCT00694707|467253078|FG003|Overall Study|Adverse Event|12|||
129804796|NCT00694707|467253079|FG004|Overall Study|Adverse Event|13|||
129804797|NCT00694707|467253075|FG000|Overall Study|Insufficient Therapeutic Response|33|||
129804798|NCT00694707|467253076|FG001|Overall Study|Insufficient Therapeutic Response|18|||
129804799|NCT00694707|467253077|FG002|Overall Study|Insufficient Therapeutic Response|17|||
129804800|NCT00694707|467253078|FG003|Overall Study|Insufficient Therapeutic Response|15|||
129804801|NCT00694707|467253079|FG004|Overall Study|Insufficient Therapeutic Response|10|||
129804802|NCT00694707|467253075|FG000|Overall Study|Protocol Violation|1|||
129804803|NCT00694707|467253076|FG001|Overall Study|Protocol Violation|2|||
130111672|NCT02436135|468369506|FG001|Overall Study|Investigator Discretion|2|||
129804804|NCT00694707|467253077|FG002|Overall Study|Protocol Violation|1|||
129804805|NCT00694707|467253078|FG003|Overall Study|Protocol Violation|3|||
129804806|NCT00694707|467253079|FG004|Overall Study|Protocol Violation|1|||
129804807|NCT00694707|467253075|FG000|Overall Study|Withdrawal of Consent|14|||
130055877|NCT00256867|468159616|FG006|Overall Study|Lost to Follow-up|1|||
130055878|NCT00256867|468159617|FG007|Overall Study|Lost to Follow-up|2|||
130055879|NCT00256867|468159610|FG000|Overall Study|Protocol Violation|0|||
129804808|NCT00694707|467253076|FG001|Overall Study|Withdrawal of Consent|18|||
129804809|NCT00694707|467253077|FG002|Overall Study|Withdrawal of Consent|22|||
129804810|NCT00694707|467253078|FG003|Overall Study|Withdrawal of Consent|16|||
129804811|NCT00694707|467253079|FG004|Overall Study|Withdrawal of Consent|15|||
129804812|NCT00694707|467253075|FG000|Overall Study|Lost to Follow-up|0|||
129804813|NCT00694707|467253076|FG001|Overall Study|Lost to Follow-up|1|||
129804814|NCT00694707|467253077|FG002|Overall Study|Lost to Follow-up|2|||
129804815|NCT00694707|467253078|FG003|Overall Study|Lost to Follow-up|0|||
129804816|NCT00694707|467253079|FG004|Overall Study|Lost to Follow-up|0|||
129804817|NCT00694707|467253075|FG000|Overall Study|Jeopardizing Parole Status|1|||
129804818|NCT00694707|467253076|FG001|Overall Study|Jeopardizing Parole Status|0|||
129804819|NCT00694707|467253077|FG002|Overall Study|Jeopardizing Parole Status|0|||
129804820|NCT00694707|467253078|FG003|Overall Study|Jeopardizing Parole Status|0|||
129804821|NCT00694707|467253079|FG004|Overall Study|Jeopardizing Parole Status|0|||
129804822|NCT00694707|467253075|FG000|Overall Study|Death in the Family|1|||
129804823|NCT00694707|467253076|FG001|Overall Study|Death in the Family|0|||
129804824|NCT00694707|467253077|FG002|Overall Study|Death in the Family|0|||
129804825|NCT00694707|467253078|FG003|Overall Study|Death in the Family|0|||
129804826|NCT00694707|467253079|FG004|Overall Study|Death in the Family|0|||
129804827|NCT00694707|467253075|FG000|Overall Study|Arrest by Police|0|||
129804828|NCT00694707|467253076|FG001|Overall Study|Arrest by Police|1|||
129804829|NCT00694707|467253077|FG002|Overall Study|Arrest by Police|0|||
129804830|NCT00694707|467253078|FG003|Overall Study|Arrest by Police|0|||
129804831|NCT00694707|467253079|FG004|Overall Study|Arrest by Police|0|||
129804832|NCT00694707|467253075|FG000|Overall Study|Administrative Reasons|0|||
129804833|NCT00694707|467253076|FG001|Overall Study|Administrative Reasons|1|||
129804834|NCT00694707|467253077|FG002|Overall Study|Administrative Reasons|0|||
129804835|NCT00694707|467253078|FG003|Overall Study|Administrative Reasons|2|||
129804836|NCT00694707|467253079|FG004|Overall Study|Administrative Reasons|0|||
129804837|NCT00694707|467253075|FG000|Overall Study|Notification of Past Head Injury|0|||
129804838|NCT00694707|467253076|FG001|Overall Study|Notification of Past Head Injury|0|||
129804839|NCT00694707|467253077|FG002|Overall Study|Notification of Past Head Injury|0|||
129804840|NCT00694707|467253078|FG003|Overall Study|Notification of Past Head Injury|1|||
129804841|NCT00694707|467253079|FG004|Overall Study|Notification of Past Head Injury|0|||
129804842|NCT01904058|467253084|FG000|Overall Study|Adverse Event|2|||
129892976|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Death|1|||
129892977|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Death|0|||
129892978|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
129804843|NCT01904058|467253085|FG001|Overall Study|Adverse Event|0|||
129804844|NCT01904058|467253086|FG002|Overall Study|Adverse Event|0|||
129804845|NCT01904058|467253087|FG003|Overall Study|Adverse Event|0|||
129804846|NCT01904058|467253084|FG000|Overall Study|Withdrawal by Subject|1|||
129804847|NCT01904058|467253085|FG001|Overall Study|Withdrawal by Subject|0|||
129804848|NCT01904058|467253086|FG002|Overall Study|Withdrawal by Subject|1|||
129804849|NCT01904058|467253087|FG003|Overall Study|Withdrawal by Subject|0|||
129804850|NCT01904058|467253084|FG000|Overall Study|Pregnancy|0|||
129804851|NCT01904058|467253085|FG001|Overall Study|Pregnancy|0|||
129804852|NCT01904058|467253086|FG002|Overall Study|Pregnancy|0|||
129804853|NCT01904058|467253087|FG003|Overall Study|Pregnancy|1|||
129804854|NCT03096483|467253088|FG000|Overall Study|Withdrawal by site|1|||
129804855|NCT02046733|467253090|FG000|Overall Study|never initiated 'treatment visits'|6|||
129804856|NCT02046733|467253091|FG001|Overall Study|never initiated 'treatment visits'|0|||
129804857|NCT00199875|467253096|FG000|Overall Study|Withdrawal by Subject|0|||
129804858|NCT00199875|467253097|FG001|Overall Study|Withdrawal by Subject|0|||
129804859|NCT00199875|467253098|FG002|Overall Study|Withdrawal by Subject|0|||
129804860|NCT00199875|467253099|FG003|Overall Study|Withdrawal by Subject|0|||
129804861|NCT00199875|467253100|FG004|Overall Study|Withdrawal by Subject|1|||
129804862|NCT01024231|467253101|FG000|Overall Study|Other Reasons|1|||
129804863|NCT01024231|467253102|FG001|Overall Study|Other Reasons|2|||
129804864|NCT01024231|467253103|FG002|Overall Study|Other Reasons|0|||
129804865|NCT01024231|467253104|FG003|Overall Study|Other Reasons|0|||
129804866|NCT01024231|467253105|FG004|Overall Study|Other Reasons|2|||
129804867|NCT01024231|467253106|FG005|Overall Study|Other Reasons|0|||
129804868|NCT01024231|467253107|FG006|Overall Study|Other Reasons|1|||
130055880|NCT00256867|468159611|FG001|Overall Study|Protocol Violation|0|||
130055881|NCT00256867|468159612|FG002|Overall Study|Protocol Violation|0|||
129804869|NCT01024231|467253101|FG000|Overall Study|Maximum Clinical Benefit|1|||
129804870|NCT01024231|467253102|FG001|Overall Study|Maximum Clinical Benefit|2|||
129804871|NCT01024231|467253103|FG002|Overall Study|Maximum Clinical Benefit|0|||
129804872|NCT01024231|467253104|FG003|Overall Study|Maximum Clinical Benefit|1|||
129804873|NCT01024231|467253105|FG004|Overall Study|Maximum Clinical Benefit|1|||
129804874|NCT01024231|467253106|FG005|Overall Study|Maximum Clinical Benefit|0|||
129804875|NCT01024231|467253107|FG006|Overall Study|Maximum Clinical Benefit|0|||
129804876|NCT01024231|467253101|FG000|Overall Study|Disease Progression|3|||
129804877|NCT01024231|467253102|FG001|Overall Study|Disease Progression|1|||
129804878|NCT01024231|467253103|FG002|Overall Study|Disease Progression|3|||
129804879|NCT01024231|467253104|FG003|Overall Study|Disease Progression|0|||
129804880|NCT01024231|467253105|FG004|Overall Study|Disease Progression|4|||
129804881|NCT01024231|467253106|FG005|Overall Study|Disease Progression|11|||
129804882|NCT01024231|467253107|FG006|Overall Study|Disease Progression|6|||
129804883|NCT01024231|467253101|FG000|Overall Study|AE unrelated to Study Drug|0|||
129804884|NCT01024231|467253102|FG001|Overall Study|AE unrelated to Study Drug|1|||
129804885|NCT01024231|467253103|FG002|Overall Study|AE unrelated to Study Drug|0|||
129804886|NCT01024231|467253104|FG003|Overall Study|AE unrelated to Study Drug|0|||
129804887|NCT01024231|467253105|FG004|Overall Study|AE unrelated to Study Drug|0|||
129804888|NCT01024231|467253106|FG005|Overall Study|AE unrelated to Study Drug|0|||
129804889|NCT01024231|467253107|FG006|Overall Study|AE unrelated to Study Drug|0|||
129804890|NCT01024231|467253101|FG000|Overall Study|No longer meets criteria|0|||
129804891|NCT01024231|467253102|FG001|Overall Study|No longer meets criteria|0|||
129804892|NCT01024231|467253103|FG002|Overall Study|No longer meets criteria|0|||
129804893|NCT01024231|467253104|FG003|Overall Study|No longer meets criteria|0|||
129804894|NCT01024231|467253105|FG004|Overall Study|No longer meets criteria|1|||
129804895|NCT01024231|467253106|FG005|Overall Study|No longer meets criteria|0|||
129804896|NCT01024231|467253107|FG006|Overall Study|No longer meets criteria|1|||
129804897|NCT01024231|467253101|FG000|Overall Study|Study Drug Toxicity|1|||
129804898|NCT01024231|467253102|FG001|Overall Study|Study Drug Toxicity|6|||
129804899|NCT01024231|467253103|FG002|Overall Study|Study Drug Toxicity|6|||
129804900|NCT01024231|467253104|FG003|Overall Study|Study Drug Toxicity|4|||
130055882|NCT00256867|468159613|FG003|Overall Study|Protocol Violation|1|||
129804901|NCT01024231|467253105|FG004|Overall Study|Study Drug Toxicity|2|||
129804902|NCT01024231|467253106|FG005|Overall Study|Study Drug Toxicity|0|||
129804903|NCT01024231|467253107|FG006|Overall Study|Study Drug Toxicity|7|||
129804904|NCT01024231|467253101|FG000|Overall Study|Death|6|||
129804905|NCT01024231|467253102|FG001|Overall Study|Death|2|||
129804906|NCT01024231|467253103|FG002|Overall Study|Death|1|||
129804907|NCT01024231|467253104|FG003|Overall Study|Death|0|||
129804908|NCT01024231|467253105|FG004|Overall Study|Death|4|||
129804909|NCT01024231|467253106|FG005|Overall Study|Death|3|||
129804910|NCT01024231|467253107|FG006|Overall Study|Death|5|||
129804911|NCT01024231|467253101|FG000|Overall Study|Lost to Follow-up|0|||
129804912|NCT01024231|467253102|FG001|Overall Study|Lost to Follow-up|0|||
129804913|NCT01024231|467253103|FG002|Overall Study|Lost to Follow-up|0|||
129804914|NCT01024231|467253104|FG003|Overall Study|Lost to Follow-up|0|||
129804915|NCT01024231|467253105|FG004|Overall Study|Lost to Follow-up|0|||
129804916|NCT01024231|467253106|FG005|Overall Study|Lost to Follow-up|0|||
129804917|NCT01024231|467253107|FG006|Overall Study|Lost to Follow-up|1|||
129804918|NCT01024231|467253101|FG000|Overall Study|Withdrew Consent|0|||
129804919|NCT01024231|467253102|FG001|Overall Study|Withdrew Consent|1|||
129804920|NCT01024231|467253103|FG002|Overall Study|Withdrew Consent|0|||
129804921|NCT01024231|467253104|FG003|Overall Study|Withdrew Consent|0|||
129804922|NCT01024231|467253105|FG004|Overall Study|Withdrew Consent|0|||
129804923|NCT01024231|467253106|FG005|Overall Study|Withdrew Consent|0|||
129804924|NCT01024231|467253107|FG006|Overall Study|Withdrew Consent|0|||
129804925|NCT01024231|467253101|FG000|Overall Study|Continuing on Treatment|0|||
129804926|NCT01024231|467253102|FG001|Overall Study|Continuing on Treatment|0|||
129804927|NCT01024231|467253103|FG002|Overall Study|Continuing on Treatment|0|||
129804928|NCT01024231|467253104|FG003|Overall Study|Continuing on Treatment|0|||
129804929|NCT01024231|467253105|FG004|Overall Study|Continuing on Treatment|3|||
129804930|NCT01024231|467253106|FG005|Overall Study|Continuing on Treatment|2|||
129804931|NCT01024231|467253107|FG006|Overall Study|Continuing on Treatment|0|||
129804932|NCT01013350|467253108|FG000|Overall Study|Lost to Follow-up|15|||
130055883|NCT00256867|468159614|FG004|Overall Study|Protocol Violation|0|||
129804933|NCT01013350|467253109|FG001|Overall Study|Lost to Follow-up|95|||
129804934|NCT01013350|467253108|FG000|Overall Study|Adverse Event|0|||
129804935|NCT01013350|467253109|FG001|Overall Study|Adverse Event|1|||
129804936|NCT01013350|467253108|FG000|Overall Study|Physician Decision|4|||
129804937|NCT01013350|467253109|FG001|Overall Study|Physician Decision|20|||
129804938|NCT01013350|467253108|FG000|Overall Study|Withdrawal by Subject|15|||
129804939|NCT01013350|467253109|FG001|Overall Study|Withdrawal by Subject|38|||
129804940|NCT01013350|467253108|FG000|Overall Study|Death|3|||
129804941|NCT01013350|467253109|FG001|Overall Study|Death|5|||
130055884|NCT00256867|468159615|FG005|Overall Study|Protocol Violation|1|||
129804942|NCT01013350|467253108|FG000|Overall Study|Participant entered interventional study|0|||
129804943|NCT01013350|467253109|FG001|Overall Study|Participant entered interventional study|8|||
129804944|NCT01013350|467253108|FG000|Overall Study|Other|1|||
129804945|NCT01013350|467253109|FG001|Overall Study|Other|25|||
129804946|NCT02435147|467253111|FG000|Overall Study|non-evaluable DXA scan|11|||
129804947|NCT04128371|467253114|FG000|Overall Study|Lack of Efficacy|1|||
129804948|NCT01346969|467253115|FG000|Overall Study|Withdrawal by Subject|0|||
129804949|NCT01346969|467253116|FG001|Overall Study|Withdrawal by Subject|0|||
129804950|NCT01346969|467253117|FG002|Overall Study|Withdrawal by Subject|1|||
129804951|NCT01346969|467253118|FG003|Overall Study|Withdrawal by Subject|0|||
129804952|NCT01346969|467253115|FG000|Overall Study|Lost to Follow-up|1|||
129804953|NCT01346969|467253116|FG001|Overall Study|Lost to Follow-up|0|||
129804954|NCT01346969|467253117|FG002|Overall Study|Lost to Follow-up|2|||
129804955|NCT01346969|467253118|FG003|Overall Study|Lost to Follow-up|0|||
129804956|NCT01346969|467253115|FG000|Overall Study|Physician Decision|0|||
129804957|NCT01346969|467253116|FG001|Overall Study|Physician Decision|0|||
129804958|NCT01346969|467253117|FG002|Overall Study|Physician Decision|0|||
129804959|NCT01346969|467253118|FG003|Overall Study|Physician Decision|1|||
129804960|NCT01346969|467253115|FG000|Overall Study|Randomized but not treated|1|||
129804961|NCT01346969|467253116|FG001|Overall Study|Randomized but not treated|0|||
129804962|NCT01346969|467253117|FG002|Overall Study|Randomized but not treated|0|||
129804963|NCT01346969|467253118|FG003|Overall Study|Randomized but not treated|0|||
129804964|NCT05736224|467253122|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
130055885|NCT00256867|468159616|FG006|Overall Study|Protocol Violation|0|||
130055886|NCT00256867|468159617|FG007|Overall Study|Protocol Violation|1|||
130055887|NCT00256867|468159610|FG000|Overall Study|Withdrawal by Subject|0|||
129804965|NCT02557295|467253123|FG000|Overall Study|Withdrawal by Subject|9|||
129804966|NCT02557295|467253124|FG001|Overall Study|Withdrawal by Subject|2|||
129804967|NCT02557295|467253125|FG002|Overall Study|Withdrawal by Subject|4|||
129804968|NCT02557295|467253126|FG003|Overall Study|Withdrawal by Subject|0|||
129804969|NCT02557295|467253127|FG004|Overall Study|Withdrawal by Subject|0|||
130055888|NCT00256867|468159611|FG001|Overall Study|Withdrawal by Subject|0|||
130055889|NCT00256867|468159612|FG002|Overall Study|Withdrawal by Subject|1|||
130055890|NCT00256867|468159613|FG003|Overall Study|Withdrawal by Subject|1|||
130055891|NCT00256867|468159614|FG004|Overall Study|Withdrawal by Subject|2|||
130055892|NCT00256867|468159615|FG005|Overall Study|Withdrawal by Subject|2|||
130055893|NCT00256867|468159616|FG006|Overall Study|Withdrawal by Subject|3|||
130055894|NCT00256867|468159617|FG007|Overall Study|Withdrawal by Subject|2|||
130055895|NCT00256867|468159610|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055896|NCT00256867|468159611|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
130055897|NCT00256867|468159612|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055898|NCT00256867|468159613|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055899|NCT00256867|468159614|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055900|NCT00256867|468159615|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055901|NCT00256867|468159616|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055902|NCT00256867|468159617|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
130055903|NCT00256867|468159610|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055904|NCT00256867|468159611|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055905|NCT00256867|468159612|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055906|NCT00256867|468159613|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055907|NCT00256867|468159614|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055908|NCT00256867|468159615|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055909|NCT00256867|468159616|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
130055910|NCT00256867|468159617|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
130055911|NCT00256867|468159610|FG000|Overall Study|Investigator's Decision|0|||
130055912|NCT00256867|468159611|FG001|Overall Study|Investigator's Decision|0|||
130055913|NCT00256867|468159612|FG002|Overall Study|Investigator's Decision|0|||
130055914|NCT00256867|468159613|FG003|Overall Study|Investigator's Decision|0|||
130055915|NCT00256867|468159614|FG004|Overall Study|Investigator's Decision|1|||
130055916|NCT00256867|468159615|FG005|Overall Study|Investigator's Decision|0|||
130055917|NCT00256867|468159616|FG006|Overall Study|Investigator's Decision|0|||
130055918|NCT00256867|468159617|FG007|Overall Study|Investigator's Decision|0|||
130055919|NCT00256867|468159610|FG000|Overall Study|Non-compliance with study medication|0|||
130055920|NCT00256867|468159611|FG001|Overall Study|Non-compliance with study medication|0|||
130055921|NCT00256867|468159612|FG002|Overall Study|Non-compliance with study medication|0|||
130055922|NCT00256867|468159613|FG003|Overall Study|Non-compliance with study medication|0|||
130055923|NCT00256867|468159614|FG004|Overall Study|Non-compliance with study medication|0|||
130055924|NCT00256867|468159615|FG005|Overall Study|Non-compliance with study medication|0|||
130055925|NCT00256867|468159616|FG006|Overall Study|Non-compliance with study medication|0|||
130055926|NCT00256867|468159617|FG007|Overall Study|Non-compliance with study medication|1|||
130055927|NCT00256867|468159610|FG000|Overall Study|Participant travelled Overseas|0|||
130055928|NCT00256867|468159611|FG001|Overall Study|Participant travelled Overseas|1|||
130055929|NCT00256867|468159612|FG002|Overall Study|Participant travelled Overseas|0|||
130055930|NCT00256867|468159613|FG003|Overall Study|Participant travelled Overseas|0|||
130055931|NCT00256867|468159614|FG004|Overall Study|Participant travelled Overseas|0|||
130055932|NCT00256867|468159615|FG005|Overall Study|Participant travelled Overseas|0|||
130055933|NCT00256867|468159616|FG006|Overall Study|Participant travelled Overseas|0|||
130055934|NCT00256867|468159617|FG007|Overall Study|Participant travelled Overseas|0|||
130055935|NCT00256867|468159610|FG000|Overall Study|Participant out of assessment window|0|||
130055936|NCT00256867|468159611|FG001|Overall Study|Participant out of assessment window|0|||
130055937|NCT00256867|468159612|FG002|Overall Study|Participant out of assessment window|1|||
130055938|NCT00256867|468159613|FG003|Overall Study|Participant out of assessment window|0|||
130055939|NCT00256867|468159614|FG004|Overall Study|Participant out of assessment window|0|||
130055940|NCT00256867|468159615|FG005|Overall Study|Participant out of assessment window|0|||
130055941|NCT00256867|468159616|FG006|Overall Study|Participant out of assessment window|0|||
130055942|NCT00256867|468159617|FG007|Overall Study|Participant out of assessment window|0|||
130055943|NCT00256867|468159610|FG000|Overall Study|Withdrawal by participant|0|||
130055944|NCT00256867|468159611|FG001|Overall Study|Withdrawal by participant|0|||
130055945|NCT00256867|468159612|FG002|Overall Study|Withdrawal by participant|0|||
130055946|NCT00256867|468159613|FG003|Overall Study|Withdrawal by participant|0|||
130055947|NCT00256867|468159614|FG004|Overall Study|Withdrawal by participant|0|||
130055948|NCT00256867|468159615|FG005|Overall Study|Withdrawal by participant|1|||
130055949|NCT00256867|468159616|FG006|Overall Study|Withdrawal by participant|0|||
130055950|NCT00256867|468159617|FG007|Overall Study|Withdrawal by participant|0|||
130055951|NCT02993224|468159618|FG000|Core Phase - Period 1|Adverse Event|4|||
130055952|NCT02993224|468159618|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
130055953|NCT02993224|468159618|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
130111673|NCT02436135|468369505|FG000|Overall Study|Adverse Event|1|||
130111674|NCT02436135|468369506|FG001|Overall Study|Adverse Event|0|||
130055954|NCT02993224|468159618|FG000|Core Phase- Period 2|Adverse Event|1|||
130055955|NCT02993224|468159618|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
130055956|NCT02993224|468159618|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
130055957|NCT02993224|468159618|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
130055958|NCT02993224|468159618|FG000|Extension Phase|Adverse Event|3|||
130055959|NCT02993224|468159618|FG000|Extension Phase|Withdrawal by Subject|3|||
130055960|NCT02993224|468159618|FG000|Extension Phase|Lost to Follow-up|2|||
130055961|NCT02993224|468159618|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
130055962|NCT01930799|468159622|FG000|Overall Study|Withdrawal by Subject|3|||
130055963|NCT01930799|468159622|FG000|Overall Study|Lost to Follow-up|5|||
130055964|NCT00952289|468159624|FG000|All Participants|Death|9|||
130055965|NCT00952289|468159625|FG001|All Participants|Death|9|||
130055966|NCT00952289|468159624|FG000|All Participants|Adverse Event|8|||
130055967|NCT00952289|468159625|FG001|All Participants|Adverse Event|8|||
130055968|NCT00952289|468159624|FG000|All Participants|Disease progression|3|||
130055969|NCT00952289|468159625|FG001|All Participants|Disease progression|12|||
130055970|NCT00952289|468159624|FG000|All Participants|Withdrawal by Subject|1|||
130055971|NCT00952289|468159625|FG001|All Participants|Withdrawal by Subject|10|||
130055972|NCT00952289|468159624|FG000|All Participants|Data lost during site relocation|0|||
130055973|NCT00952289|468159625|FG001|All Participants|Data lost during site relocation|1|||
129804970|NCT02557295|467253128|FG005|Overall Study|Withdrawal by Subject|0|||
129804971|NCT02557295|467253129|FG006|Overall Study|Withdrawal by Subject|15|||
130055974|NCT00952289|468159624|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
130055975|NCT00952289|468159625|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
130055976|NCT00952289|468159624|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
129804972|NCT02557295|467253130|FG007|Overall Study|Withdrawal by Subject|1|||
129804973|NCT02557295|467253131|FG008|Overall Study|Withdrawal by Subject|3|||
129804974|NCT02557295|467253123|FG000|Overall Study|Disease Progression|0|||
129804975|NCT02557295|467253124|FG001|Overall Study|Disease Progression|0|||
129804976|NCT02557295|467253125|FG002|Overall Study|Disease Progression|0|||
129804977|NCT02557295|467253126|FG003|Overall Study|Disease Progression|0|||
129804978|NCT02557295|467253127|FG004|Overall Study|Disease Progression|0|||
129804979|NCT02557295|467253128|FG005|Overall Study|Disease Progression|0|||
129804980|NCT02557295|467253129|FG006|Overall Study|Disease Progression|1|||
129804981|NCT02557295|467253130|FG007|Overall Study|Disease Progression|0|||
129804982|NCT02557295|467253131|FG008|Overall Study|Disease Progression|0|||
129804983|NCT02557295|467253123|FG000|Overall Study|Lack of Efficacy|24|||
129804984|NCT02557295|467253124|FG001|Overall Study|Lack of Efficacy|1|||
129804985|NCT02557295|467253125|FG002|Overall Study|Lack of Efficacy|3|||
129804986|NCT02557295|467253126|FG003|Overall Study|Lack of Efficacy|0|||
129804987|NCT02557295|467253127|FG004|Overall Study|Lack of Efficacy|0|||
130055977|NCT00952289|468159625|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
130055978|NCT00952289|468159624|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
130055979|NCT00952289|468159625|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
130055980|NCT00952289|468159624|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
129804988|NCT02557295|467253128|FG005|Overall Study|Lack of Efficacy|0|||
130055981|NCT00952289|468159625|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
130055982|NCT00952289|468159624|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
129804989|NCT02557295|467253129|FG006|Overall Study|Lack of Efficacy|12|||
130055983|NCT00952289|468159625|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
130055984|NCT03136185|468159631|FG000|Overall Study|Adverse Event|0|||
129804990|NCT02557295|467253130|FG007|Overall Study|Lack of Efficacy|1|||
129804991|NCT02557295|467253131|FG008|Overall Study|Lack of Efficacy|0|||
129804992|NCT02557295|467253123|FG000|Overall Study|Adverse Event|16|||
130055985|NCT03136185|468159632|FG001|Overall Study|Adverse Event|1|||
130055986|NCT03136185|468159633|FG002|Overall Study|Adverse Event|3|||
130055987|NCT03136185|468159634|FG003|Overall Study|Adverse Event|1|||
129892979|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
129804993|NCT02557295|467253124|FG001|Overall Study|Adverse Event|2|||
129804994|NCT02557295|467253125|FG002|Overall Study|Adverse Event|3|||
129804995|NCT02557295|467253126|FG003|Overall Study|Adverse Event|0|||
129804996|NCT02557295|467253127|FG004|Overall Study|Adverse Event|0|||
129804997|NCT02557295|467253128|FG005|Overall Study|Adverse Event|0|||
129804998|NCT02557295|467253129|FG006|Overall Study|Adverse Event|2|||
129804999|NCT02557295|467253130|FG007|Overall Study|Adverse Event|1|||
130055988|NCT03136185|468159635|FG004|Overall Study|Adverse Event|2|||
130055989|NCT03136185|468159636|FG005|Overall Study|Adverse Event|2|||
130055990|NCT03136185|468159637|FG006|Overall Study|Adverse Event|5|||
130055991|NCT03136185|468159638|FG007|Overall Study|Adverse Event|1|||
130055992|NCT03136185|468159639|FG008|Overall Study|Adverse Event|1|||
129805000|NCT02557295|467253131|FG008|Overall Study|Adverse Event|1|||
130055993|NCT03136185|468159631|FG000|Overall Study|Death|0|||
130055994|NCT03136185|468159632|FG001|Overall Study|Death|0|||
130055995|NCT03136185|468159633|FG002|Overall Study|Death|0|||
130055996|NCT03136185|468159634|FG003|Overall Study|Death|1|||
130055997|NCT03136185|468159635|FG004|Overall Study|Death|1|||
130055998|NCT03136185|468159636|FG005|Overall Study|Death|0|||
130055999|NCT03136185|468159637|FG006|Overall Study|Death|1|||
130056000|NCT03136185|468159638|FG007|Overall Study|Death|0|||
130056001|NCT03136185|468159639|FG008|Overall Study|Death|0|||
130056002|NCT03136185|468159631|FG000|Overall Study|Physician Decision|3|||
130056003|NCT03136185|468159632|FG001|Overall Study|Physician Decision|1|||
129805001|NCT02557295|467253123|FG000|Overall Study|Lost to Follow-up|4|||
129805002|NCT02557295|467253124|FG001|Overall Study|Lost to Follow-up|0|||
129805003|NCT02557295|467253125|FG002|Overall Study|Lost to Follow-up|0|||
129805004|NCT02557295|467253126|FG003|Overall Study|Lost to Follow-up|0|||
130056004|NCT03136185|468159633|FG002|Overall Study|Physician Decision|1|||
130056005|NCT03136185|468159634|FG003|Overall Study|Physician Decision|2|||
130056006|NCT03136185|468159635|FG004|Overall Study|Physician Decision|1|||
130056007|NCT03136185|468159636|FG005|Overall Study|Physician Decision|2|||
130056008|NCT03136185|468159637|FG006|Overall Study|Physician Decision|1|||
130056009|NCT03136185|468159638|FG007|Overall Study|Physician Decision|0|||
130056010|NCT03136185|468159639|FG008|Overall Study|Physician Decision|1|||
130056011|NCT03136185|468159631|FG000|Overall Study|Protocol Defined Disease Progression|0|||
130056012|NCT03136185|468159632|FG001|Overall Study|Protocol Defined Disease Progression|0|||
130056013|NCT03136185|468159633|FG002|Overall Study|Protocol Defined Disease Progression|1|||
130056014|NCT03136185|468159634|FG003|Overall Study|Protocol Defined Disease Progression|0|||
130056015|NCT03136185|468159635|FG004|Overall Study|Protocol Defined Disease Progression|0|||
130056016|NCT03136185|468159636|FG005|Overall Study|Protocol Defined Disease Progression|1|||
130056017|NCT03136185|468159637|FG006|Overall Study|Protocol Defined Disease Progression|0|||
130056018|NCT03136185|468159638|FG007|Overall Study|Protocol Defined Disease Progression|1|||
130056019|NCT03136185|468159639|FG008|Overall Study|Protocol Defined Disease Progression|1|||
130056020|NCT03136185|468159631|FG000|Overall Study|Withdrawal by Subject|1|||
130056021|NCT03136185|468159632|FG001|Overall Study|Withdrawal by Subject|0|||
130056022|NCT03136185|468159633|FG002|Overall Study|Withdrawal by Subject|1|||
130056023|NCT03136185|468159634|FG003|Overall Study|Withdrawal by Subject|1|||
130056024|NCT03136185|468159635|FG004|Overall Study|Withdrawal by Subject|1|||
130056025|NCT03136185|468159636|FG005|Overall Study|Withdrawal by Subject|1|||
130056026|NCT03136185|468159637|FG006|Overall Study|Withdrawal by Subject|2|||
130056027|NCT03136185|468159638|FG007|Overall Study|Withdrawal by Subject|3|||
130056028|NCT03136185|468159639|FG008|Overall Study|Withdrawal by Subject|3|||
130056029|NCT03136185|468159631|FG000|Overall Study|Not Reported|4|||
130056030|NCT03136185|468159632|FG001|Overall Study|Not Reported|1|||
130056031|NCT03136185|468159633|FG002|Overall Study|Not Reported|0|||
130056032|NCT03136185|468159634|FG003|Overall Study|Not Reported|1|||
130056033|NCT03136185|468159635|FG004|Overall Study|Not Reported|0|||
130056034|NCT03136185|468159636|FG005|Overall Study|Not Reported|2|||
130056035|NCT03136185|468159637|FG006|Overall Study|Not Reported|1|||
130056036|NCT03136185|468159638|FG007|Overall Study|Not Reported|1|||
130056037|NCT03136185|468159639|FG008|Overall Study|Not Reported|0|||
130056038|NCT00364845|468159645|FG000|Overall Study|Adverse Event|1|||
130056039|NCT00364845|468159646|FG001|Overall Study|Adverse Event|0|||
130056040|NCT00364845|468159645|FG000|Overall Study|Withdrawal by Subject|2|||
130056041|NCT00364845|468159646|FG001|Overall Study|Withdrawal by Subject|1|||
130056042|NCT00364845|468159645|FG000|Overall Study|Physician Decision|8|||
130056043|NCT00364845|468159646|FG001|Overall Study|Physician Decision|8|||
130056044|NCT00364845|468159645|FG000|Overall Study|Lost to Follow-up|0|||
130056045|NCT00364845|468159646|FG001|Overall Study|Lost to Follow-up|1|||
130056046|NCT00364845|468159645|FG000|Overall Study|Death|0|||
130056047|NCT00364845|468159646|FG001|Overall Study|Death|1|||
130056048|NCT04160468|468159647|FG000|Overall Study|Lost to Follow-up|19|||
130056049|NCT04160468|468159648|FG001|Overall Study|Lost to Follow-up|4|||
130056050|NCT04160468|468159647|FG000|Overall Study|Randomized but not dosed|6|||
130056051|NCT04160468|468159648|FG001|Overall Study|Randomized but not dosed|0|||
130056052|NCT04160468|468159647|FG000|Overall Study|Withdrawal by Subject|4|||
130056053|NCT04160468|468159648|FG001|Overall Study|Withdrawal by Subject|1|||
130056054|NCT04160468|468159647|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
130056055|NCT04160468|468159648|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
130056056|NCT04160468|468159647|FG000|Overall Study|Participant incarcerated|1|||
130056057|NCT04160468|468159648|FG001|Overall Study|Participant incarcerated|0|||
130056058|NCT01187901|468159649|FG000|Overall Study|Protocol Violation|1|||
130056059|NCT01187901|468159650|FG001|Overall Study|Protocol Violation|0|||
130056060|NCT01187901|468159649|FG000|Overall Study|Lost to Follow-up|1|||
130056061|NCT01187901|468159650|FG001|Overall Study|Lost to Follow-up|2|||
130056062|NCT01187901|468159649|FG000|Overall Study|Unrelated Health Reasons|1|||
130056063|NCT01187901|468159650|FG001|Overall Study|Unrelated Health Reasons|2|||
130056064|NCT01187901|468159649|FG000|Overall Study|Suspected Allergic Reaction|1|||
130056065|NCT01187901|468159650|FG001|Overall Study|Suspected Allergic Reaction|1|||
130056066|NCT01187901|468159649|FG000|Overall Study|Adverse Event|3|||
130056067|NCT01187901|468159650|FG001|Overall Study|Adverse Event|0|||
130056068|NCT01187901|468159649|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
130056069|NCT01187901|468159650|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
130056070|NCT01187901|468159649|FG000|Overall Study|Pregnancy|0|||
130056071|NCT01187901|468159650|FG001|Overall Study|Pregnancy|2|||
130056072|NCT01912768|468159651|FG000|Overall Study|Adverse Event|2|||
130056073|NCT01912768|468159652|FG001|Overall Study|Adverse Event|0|||
130056074|NCT01912768|468159651|FG000|Overall Study|Lost to Follow-up|2|||
130056075|NCT01912768|468159652|FG001|Overall Study|Lost to Follow-up|1|||
130056076|NCT01912768|468159651|FG000|Overall Study|Withdrawal by Subject|5|||
130111675|NCT02436135|468369505|FG000|Overall Study|Withdrawal by Participant|1|||
130056077|NCT01912768|468159652|FG001|Overall Study|Withdrawal by Subject|3|||
130056078|NCT01912768|468159651|FG000|Overall Study|Randomized in error|1|||
130056079|NCT01912768|468159652|FG001|Overall Study|Randomized in error|0|||
130056080|NCT00488033|468159653|FG000|Overall Study|Withdrawal by Subject|1|||
130056081|NCT00488033|468159654|FG001|Overall Study|Withdrawal by Subject|0|||
130056082|NCT01515306|468159655|FG000|Overall Study|Adverse Event|3|||
130056083|NCT01515306|468159656|FG001|Overall Study|Adverse Event|2|||
129892980|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
129892981|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
129892982|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
129892983|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
129892984|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
129892985|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
129892986|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
129892987|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
129892988|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
129892989|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
129892990|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
129892991|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
129892992|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Death|2|||
129892993|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Death|2|||
129892994|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
129892995|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
129892996|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
129892997|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
129892998|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
129892999|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
129893000|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
129893001|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
129893002|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
129893003|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
129893004|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
129893005|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
129805005|NCT02557295|467253127|FG004|Overall Study|Lost to Follow-up|0|||
129805006|NCT02557295|467253128|FG005|Overall Study|Lost to Follow-up|0|||
129805007|NCT02557295|467253129|FG006|Overall Study|Lost to Follow-up|9|||
129805008|NCT02557295|467253130|FG007|Overall Study|Lost to Follow-up|0|||
129805009|NCT02557295|467253131|FG008|Overall Study|Lost to Follow-up|0|||
129805010|NCT02557295|467253123|FG000|Overall Study|Study Close|54|||
129805011|NCT02557295|467253124|FG001|Overall Study|Study Close|3|||
129805012|NCT02557295|467253125|FG002|Overall Study|Study Close|5|||
129805013|NCT02557295|467253126|FG003|Overall Study|Study Close|3|||
129805014|NCT02557295|467253127|FG004|Overall Study|Study Close|0|||
129805015|NCT02557295|467253128|FG005|Overall Study|Study Close|0|||
129805016|NCT02557295|467253129|FG006|Overall Study|Study Close|37|||
129805017|NCT02557295|467253130|FG007|Overall Study|Study Close|3|||
129805018|NCT02557295|467253131|FG008|Overall Study|Study Close|19|||
129805019|NCT02557295|467253123|FG000|Overall Study|except for study close|4|||
129805020|NCT02557295|467253124|FG001|Overall Study|except for study close|0|||
129805021|NCT02557295|467253125|FG002|Overall Study|except for study close|0|||
129805022|NCT02557295|467253126|FG003|Overall Study|except for study close|0|||
129805023|NCT02557295|467253127|FG004|Overall Study|except for study close|0|||
129805024|NCT02557295|467253128|FG005|Overall Study|except for study close|0|||
129805025|NCT02557295|467253129|FG006|Overall Study|except for study close|5|||
129805026|NCT02557295|467253130|FG007|Overall Study|except for study close|1|||
129805027|NCT02557295|467253131|FG008|Overall Study|except for study close|0|||
129805028|NCT03673046|467254919|FG000|Overall Study|Adverse Event|1|||
129805029|NCT03673046|467254920|FG001|Overall Study|Adverse Event|1|||
129805030|NCT03673046|467254919|FG000|Overall Study|Withdrawal by Subject|8|||
129805031|NCT03673046|467254920|FG001|Overall Study|Withdrawal by Subject|2|||
129805032|NCT03817879|467254921|FG000|Overall Study|Drop out|5|||
129805033|NCT03817879|467254922|FG001|Overall Study|Drop out|12|||
129805034|NCT03817879|467254921|FG000|Overall Study|Withdrawal by Subject|0|||
129805035|NCT03817879|467254922|FG001|Overall Study|Withdrawal by Subject|1|||
129805036|NCT01896050|467254923|FG000|Overall Study|Adverse Event|37|||
129805037|NCT01896050|467254924|FG001|Overall Study|Adverse Event|2|||
129805038|NCT01896050|467254923|FG000|Overall Study|Death|1|||
129805039|NCT01896050|467254924|FG001|Overall Study|Death|0|||
129805040|NCT00392015|467254925|FG000|Overall Study|Lost to Follow-up|2|||
129805041|NCT00392015|467254926|FG001|Overall Study|Lost to Follow-up|0|||
129805042|NCT00392015|467254927|FG002|Overall Study|Lost to Follow-up|2|||
129805043|NCT00392015|467254928|FG003|Overall Study|Lost to Follow-up|1|||
129805044|NCT00392015|467254929|FG004|Overall Study|Lost to Follow-up|1|||
129893006|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
129893007|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
129893008|NCT01254305|467567719|FG000|Overall Study|Adverse Event|6|||
129893009|NCT01254305|467567720|FG001|Overall Study|Adverse Event|3|||
129805045|NCT00392015|467254930|FG005|Overall Study|Lost to Follow-up|0|||
129805046|NCT00392015|467254925|FG000|Overall Study|Withdrawal by Subject|0|||
129893010|NCT01254305|467567721|FG002|Overall Study|Adverse Event|2|||
129893011|NCT01254305|467567719|FG000|Overall Study|Lack of Efficacy|1|||
129893012|NCT01254305|467567720|FG001|Overall Study|Lack of Efficacy|0|||
129893013|NCT01254305|467567721|FG002|Overall Study|Lack of Efficacy|1|||
129893014|NCT01254305|467567719|FG000|Overall Study|Protocol Violation|1|||
129893015|NCT01254305|467567720|FG001|Overall Study|Protocol Violation|7|||
129893016|NCT01254305|467567721|FG002|Overall Study|Protocol Violation|3|||
129893017|NCT01254305|467567719|FG000|Overall Study|Withdrawal by Subject|4|||
129893018|NCT01254305|467567720|FG001|Overall Study|Withdrawal by Subject|2|||
129893019|NCT01254305|467567721|FG002|Overall Study|Withdrawal by Subject|4|||
129893020|NCT01254305|467567719|FG000|Overall Study|Lost to Follow-up|10|||
129893021|NCT01254305|467567720|FG001|Overall Study|Lost to Follow-up|6|||
129893022|NCT01254305|467567721|FG002|Overall Study|Lost to Follow-up|5|||
129893023|NCT01254305|467567719|FG000|Overall Study|Other Reasons|0|||
129893024|NCT01254305|467567720|FG001|Overall Study|Other Reasons|0|||
129893025|NCT01254305|467567721|FG002|Overall Study|Other Reasons|2|||
129805047|NCT00392015|467254926|FG001|Overall Study|Withdrawal by Subject|0|||
129805048|NCT00392015|467254927|FG002|Overall Study|Withdrawal by Subject|2|||
129893026|NCT03738241|467567725|FG000|Overall Study|Withdrawal by Subject|0|||
129893027|NCT03738241|467567726|FG001|Overall Study|Withdrawal by Subject|0|||
129805049|NCT00392015|467254928|FG003|Overall Study|Withdrawal by Subject|0|||
129805050|NCT00392015|467254929|FG004|Overall Study|Withdrawal by Subject|0|||
129805051|NCT00392015|467254930|FG005|Overall Study|Withdrawal by Subject|0|||
129805052|NCT00392015|467254925|FG000|Overall Study|Adverse Event|0|||
129805053|NCT00392015|467254926|FG001|Overall Study|Adverse Event|0|||
129805054|NCT00392015|467254927|FG002|Overall Study|Adverse Event|0|||
129805055|NCT00392015|467254928|FG003|Overall Study|Adverse Event|0|||
129805056|NCT00392015|467254929|FG004|Overall Study|Adverse Event|1|||
130056084|NCT01515306|468159655|FG000|Overall Study|Progressive Disease|19|||
130056085|NCT01515306|468159656|FG001|Overall Study|Progressive Disease|9|||
130056086|NCT01515306|468159655|FG000|Overall Study|Withdrawal by Subject|1|||
130056087|NCT01515306|468159656|FG001|Overall Study|Withdrawal by Subject|2|||
130056088|NCT01515306|468159655|FG000|Overall Study|Physician Decision|1|||
130056089|NCT01515306|468159656|FG001|Overall Study|Physician Decision|1|||
130056090|NCT00634244|468159660|FG000|Overall Study|Never started treatment|0|||
130056091|NCT00634244|468159661|FG001|Overall Study|Never started treatment|1|||
130056092|NCT00634244|468159662|FG002|Overall Study|Never started treatment|0|||
130056093|NCT00634244|468159660|FG000|Overall Study|Death|1|||
130056094|NCT00634244|468159661|FG001|Overall Study|Death|6|||
130056095|NCT00634244|468159662|FG002|Overall Study|Death|0|||
130056096|NCT00634244|468159660|FG000|Overall Study|Adverse Event|0|||
130056097|NCT00634244|468159661|FG001|Overall Study|Adverse Event|2|||
130056098|NCT00634244|468159662|FG002|Overall Study|Adverse Event|0|||
130056099|NCT00634244|468159660|FG000|Overall Study|Withdrawal by Subject|0|||
130056100|NCT00634244|468159661|FG001|Overall Study|Withdrawal by Subject|1|||
130056101|NCT00634244|468159662|FG002|Overall Study|Withdrawal by Subject|0|||
130056102|NCT00634244|468159660|FG000|Overall Study|Physician Decision|0|||
130056103|NCT00634244|468159661|FG001|Overall Study|Physician Decision|1|||
130056104|NCT00634244|468159662|FG002|Overall Study|Physician Decision|0|||
130056105|NCT00634244|468159660|FG000|Overall Study|Disease progression/relapse|0|||
130056106|NCT00634244|468159661|FG001|Overall Study|Disease progression/relapse|1|||
130056107|NCT00634244|468159662|FG002|Overall Study|Disease progression/relapse|0|||
130056108|NCT00634244|468159660|FG000|Overall Study|Other complicating disease|0|||
130056109|NCT00634244|468159661|FG001|Overall Study|Other complicating disease|1|||
130056110|NCT00634244|468159662|FG002|Overall Study|Other complicating disease|0|||
130056111|NCT04715230|468159671|FG000|Overall Study|Withdrawal by Subject|1|||
130056112|NCT04715230|468159672|FG001|Overall Study|Withdrawal by Subject|0|||
130056113|NCT04715230|468159673|FG002|Overall Study|Withdrawal by Subject|0|||
130056114|NCT04715230|468159671|FG000|Overall Study|Lost to Follow-up|0|||
130056115|NCT04715230|468159672|FG001|Overall Study|Lost to Follow-up|5|||
130056116|NCT04715230|468159673|FG002|Overall Study|Lost to Follow-up|1|||
130056117|NCT03453151|468159674|FG000|Overall Study|Withdrawal by Subject|1|||
130056118|NCT03453151|468159674|FG000|Overall Study|Physician Decision|3|||
130056119|NCT01468909|468159682|FG000|Overall Study|Never Treated|2|||
130056120|NCT01468909|468159683|FG001|Overall Study|Never Treated|2|||
130056121|NCT00488618|468159693|FG000|Overall Study|Adverse Event|13|||
130056122|NCT00488618|468159694|FG001|Overall Study|Adverse Event|17|||
130056123|NCT00488618|468159693|FG000|Overall Study|Insufficient Therapeutic Response|18|||
130056124|NCT00488618|468159694|FG001|Overall Study|Insufficient Therapeutic Response|11|||
129805057|NCT00392015|467254930|FG005|Overall Study|Adverse Event|0|||
129805058|NCT00392015|467254925|FG000|Overall Study|Previous trial recipient|0|||
129805059|NCT00392015|467254926|FG001|Overall Study|Previous trial recipient|0|||
129805060|NCT00392015|467254927|FG002|Overall Study|Previous trial recipient|0|||
129805061|NCT00392015|467254928|FG003|Overall Study|Previous trial recipient|0|||
129805062|NCT00392015|467254929|FG004|Overall Study|Previous trial recipient|1|||
129805063|NCT00392015|467254930|FG005|Overall Study|Previous trial recipient|0|||
129805064|NCT02925923|467254934|FG000|Overall Study|blood samples hemolyzed|0|||
129893028|NCT03738241|467567727|FG002|Overall Study|Withdrawal by Subject|0|||
129893029|NCT03738241|467567728|FG003|Overall Study|Withdrawal by Subject|0|||
129893030|NCT03738241|467567729|FG004|Overall Study|Withdrawal by Subject|0|||
129893031|NCT03738241|467567730|FG005|Overall Study|Withdrawal by Subject|0|||
129893032|NCT03738241|467567731|FG006|Overall Study|Withdrawal by Subject|0|||
129893033|NCT03738241|467567732|FG007|Overall Study|Withdrawal by Subject|0|||
129893034|NCT03738241|467567733|FG008|Overall Study|Withdrawal by Subject|0|||
129893035|NCT03738241|467567734|FG009|Overall Study|Withdrawal by Subject|1|||
129893036|NCT03738241|467567725|FG000|Overall Study|Physician Decision|0|||
129893037|NCT03738241|467567726|FG001|Overall Study|Physician Decision|0|||
129893038|NCT03738241|467567727|FG002|Overall Study|Physician Decision|0|||
129893039|NCT03738241|467567728|FG003|Overall Study|Physician Decision|0|||
129893040|NCT03738241|467567729|FG004|Overall Study|Physician Decision|0|||
129893041|NCT03738241|467567730|FG005|Overall Study|Physician Decision|0|||
129893042|NCT03738241|467567731|FG006|Overall Study|Physician Decision|0|||
129893043|NCT03738241|467567732|FG007|Overall Study|Physician Decision|0|||
129893044|NCT03738241|467567733|FG008|Overall Study|Physician Decision|1|||
129893045|NCT03738241|467567734|FG009|Overall Study|Physician Decision|0|||
129893046|NCT03738241|467567725|FG000|Overall Study|Adverse Event|1|||
129893047|NCT03738241|467567726|FG001|Overall Study|Adverse Event|0|||
129893048|NCT03738241|467567727|FG002|Overall Study|Adverse Event|0|||
129893049|NCT03738241|467567728|FG003|Overall Study|Adverse Event|0|||
129893050|NCT03738241|467567729|FG004|Overall Study|Adverse Event|0|||
129893051|NCT03738241|467567730|FG005|Overall Study|Adverse Event|0|||
129893052|NCT03738241|467567731|FG006|Overall Study|Adverse Event|0|||
129893053|NCT03738241|467567732|FG007|Overall Study|Adverse Event|0|||
129893054|NCT03738241|467567733|FG008|Overall Study|Adverse Event|0|||
129893055|NCT03738241|467567734|FG009|Overall Study|Adverse Event|0|||
129893056|NCT03169361|467567735|FG000|Overall Study|Protocol Violation|32|||
129893057|NCT00088465|467567736|FG000|Overall Study|Withdrawal by Subject|290|||
129893058|NCT00088465|467567736|FG000|Overall Study|Adverse Event|77|||
129893059|NCT00088465|467567736|FG000|Overall Study|Lost to Follow-up|57|||
129893060|NCT00088465|467567736|FG000|Overall Study|Physician Decision|45|||
129893061|NCT00088465|467567736|FG000|Overall Study|Sponsor Decision|37|||
129893062|NCT00088465|467567736|FG000|Overall Study|Lack of Efficacy|27|||
129893063|NCT00088465|467567736|FG000|Overall Study|Protocol Violation|17|||
129893064|NCT00088465|467567736|FG000|Overall Study|Death|11|||
130056125|NCT00488618|468159693|FG000|Overall Study|Protocol Violation|0|||
130056126|NCT00488618|468159694|FG001|Overall Study|Protocol Violation|2|||
130056127|NCT00488618|468159693|FG000|Overall Study|Withdrawal of Consent|15|||
129893065|NCT00495469|467567737|FG000|Overall Study|Adverse Event|0|||
129893066|NCT00495469|467567738|FG001|Overall Study|Adverse Event|1|||
129893067|NCT00495469|467567739|FG002|Overall Study|Adverse Event|3|||
129893068|NCT00495469|467567740|FG003|Overall Study|Adverse Event|0|||
129805065|NCT02925923|467254935|FG001|Overall Study|blood samples hemolyzed|2|||
129805066|NCT00866788|467254936|FG000|Overall Study|Adverse Event|0|||
129805067|NCT00866788|467254937|FG001|Overall Study|Adverse Event|2|||
129805068|NCT00866788|467254938|FG002|Overall Study|Adverse Event|0|||
129805069|NCT00866788|467254939|FG003|Overall Study|Adverse Event|1|||
129805070|NCT00866788|467254936|FG000|Overall Study|Lost to Follow-up|1|||
129805071|NCT00866788|467254937|FG001|Overall Study|Lost to Follow-up|1|||
129805072|NCT00866788|467254938|FG002|Overall Study|Lost to Follow-up|0|||
129805073|NCT00866788|467254939|FG003|Overall Study|Lost to Follow-up|2|||
129893069|NCT00495469|467567741|FG004|Overall Study|Adverse Event|1|||
129893070|NCT00495469|467567742|FG005|Overall Study|Adverse Event|1|||
129893071|NCT00495469|467567743|FG006|Overall Study|Adverse Event|1|||
129893072|NCT00495469|467567737|FG000|Overall Study|Lost to Follow-up|1|||
129893073|NCT00495469|467567738|FG001|Overall Study|Lost to Follow-up|1|||
130056128|NCT00488618|468159694|FG001|Overall Study|Withdrawal of Consent|13|||
129805074|NCT00866788|467254936|FG000|Overall Study|Withdrawal by Subject|2|||
129805075|NCT00866788|467254937|FG001|Overall Study|Withdrawal by Subject|1|||
129805076|NCT00866788|467254938|FG002|Overall Study|Withdrawal by Subject|0|||
130056129|NCT00488618|468159693|FG000|Overall Study|Lost to Follow-up|1|||
129893074|NCT00495469|467567739|FG002|Overall Study|Lost to Follow-up|3|||
129805077|NCT00866788|467254939|FG003|Overall Study|Withdrawal by Subject|1|||
129805078|NCT00866788|467254936|FG000|Overall Study|Pregnancy|0|||
129805079|NCT00866788|467254937|FG001|Overall Study|Pregnancy|1|||
129805080|NCT00866788|467254938|FG002|Overall Study|Pregnancy|0|||
129805081|NCT00866788|467254939|FG003|Overall Study|Pregnancy|0|||
129805082|NCT00866788|467254936|FG000|Overall Study|Disease progression|3|||
129805083|NCT00866788|467254937|FG001|Overall Study|Disease progression|1|||
129805084|NCT00866788|467254938|FG002|Overall Study|Disease progression|1|||
129805085|NCT00866788|467254939|FG003|Overall Study|Disease progression|0|||
129805086|NCT00866788|467254936|FG000|Overall Study|Physician Decision|0|||
129805087|NCT00866788|467254937|FG001|Overall Study|Physician Decision|0|||
129805088|NCT00866788|467254938|FG002|Overall Study|Physician Decision|1|||
129805089|NCT00866788|467254939|FG003|Overall Study|Physician Decision|1|||
129805090|NCT02742441|467254940|FG000|Overall Study|Lost to Follow-up|4|||
129805091|NCT02742441|467254941|FG001|Overall Study|Lost to Follow-up|4|||
129805092|NCT02742441|467254940|FG000|Overall Study|Withdrawal by Subject|2|||
129805093|NCT02742441|467254941|FG001|Overall Study|Withdrawal by Subject|2|||
129805094|NCT02742441|467254940|FG000|Overall Study|Adverse Event|0|||
129805095|NCT02742441|467254941|FG001|Overall Study|Adverse Event|2|||
129805096|NCT02202837|467254942|FG000|Overall Study|Enbrel treatment discontinued|36|||
129805097|NCT02202837|467254943|FG001|Overall Study|Enbrel treatment discontinued|4|||
129805098|NCT02202837|467254942|FG000|Overall Study|Other|10|||
129805099|NCT02202837|467254943|FG001|Overall Study|Other|0|||
129805100|NCT02202837|467254942|FG000|Overall Study|Lost to Follow-up|7|||
129805101|NCT02202837|467254943|FG001|Overall Study|Lost to Follow-up|1|||
129805102|NCT02281773|467254944|FG000|Overall Study|Adverse Event|6|||
129805103|NCT02281773|467254945|FG001|Overall Study|Adverse Event|1|||
129805104|NCT02281773|467254946|FG002|Overall Study|Adverse Event|4|||
129805105|NCT02281773|467254947|FG003|Overall Study|Adverse Event|8|||
129805106|NCT02281773|467254948|FG004|Overall Study|Adverse Event|9|||
129805107|NCT02281773|467254944|FG000|Overall Study|Protocol Violation|1|||
129805108|NCT02281773|467254945|FG001|Overall Study|Protocol Violation|0|||
129805109|NCT02281773|467254946|FG002|Overall Study|Protocol Violation|0|||
129805110|NCT02281773|467254947|FG003|Overall Study|Protocol Violation|2|||
129805111|NCT02281773|467254948|FG004|Overall Study|Protocol Violation|2|||
129805112|NCT02281773|467254944|FG000|Overall Study|Lost to Follow-up|2|||
129805113|NCT02281773|467254945|FG001|Overall Study|Lost to Follow-up|2|||
129805114|NCT02281773|467254946|FG002|Overall Study|Lost to Follow-up|6|||
129805115|NCT02281773|467254947|FG003|Overall Study|Lost to Follow-up|2|||
129805116|NCT02281773|467254948|FG004|Overall Study|Lost to Follow-up|10|||
129805117|NCT02281773|467254944|FG000|Overall Study|Withdrawal by Subject|2|||
129805118|NCT02281773|467254945|FG001|Overall Study|Withdrawal by Subject|8|||
129805119|NCT02281773|467254946|FG002|Overall Study|Withdrawal by Subject|6|||
129805120|NCT02281773|467254947|FG003|Overall Study|Withdrawal by Subject|6|||
129805121|NCT02281773|467254948|FG004|Overall Study|Withdrawal by Subject|8|||
129805122|NCT02281773|467254944|FG000|Overall Study|Other Reason|0|||
129805123|NCT02281773|467254945|FG001|Overall Study|Other Reason|4|||
129805124|NCT02281773|467254946|FG002|Overall Study|Other Reason|2|||
129805125|NCT02281773|467254947|FG003|Overall Study|Other Reason|3|||
129805126|NCT02281773|467254948|FG004|Overall Study|Other Reason|1|||
129805127|NCT02104752|467254949|FG000|Overall Study|Withdrawal by Subject|1|||
129805128|NCT02104752|467254950|FG001|Overall Study|Withdrawal by Subject|0|||
129805129|NCT02104752|467254949|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
129805130|NCT02104752|467254950|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
129805131|NCT05439941|467254951|FG000|Overall Study|Lack of Efficacy|8|||
129805132|NCT05439941|467254952|FG001|Overall Study|Lack of Efficacy|5|||
129805133|NCT05439941|467254953|FG002|Overall Study|Lack of Efficacy|3|||
129805134|NCT05439941|467254951|FG000|Overall Study|Treatment Failure|0|||
129893075|NCT00495469|467567740|FG003|Overall Study|Lost to Follow-up|1|||
130111676|NCT02436135|468369506|FG001|Overall Study|Withdrawal by Participant|0|||
129805135|NCT05439941|467254952|FG001|Overall Study|Treatment Failure|1|||
129805136|NCT05439941|467254953|FG002|Overall Study|Treatment Failure|0|||
129805137|NCT05439941|467254951|FG000|Overall Study|Adverse Event|1|||
129805138|NCT05439941|467254952|FG001|Overall Study|Adverse Event|3|||
129805139|NCT05439941|467254953|FG002|Overall Study|Adverse Event|0|||
129805140|NCT05439941|467254951|FG000|Overall Study|Adverse Event - Parent Study|1|||
129805141|NCT05439941|467254952|FG001|Overall Study|Adverse Event - Parent Study|0|||
129805142|NCT05439941|467254953|FG002|Overall Study|Adverse Event - Parent Study|0|||
129805143|NCT05439941|467254951|FG000|Overall Study|Pregnancy|1|||
129805144|NCT05439941|467254952|FG001|Overall Study|Pregnancy|0|||
129805145|NCT05439941|467254953|FG002|Overall Study|Pregnancy|0|||
129805146|NCT05439941|467254951|FG000|Overall Study|Withdrawal by Subject|9|||
129805147|NCT05439941|467254952|FG001|Overall Study|Withdrawal by Subject|6|||
129805148|NCT05439941|467254953|FG002|Overall Study|Withdrawal by Subject|10|||
129805149|NCT05439941|467254951|FG000|Overall Study|Non-Compliance|1|||
129805150|NCT05439941|467254952|FG001|Overall Study|Non-Compliance|1|||
129805151|NCT05439941|467254953|FG002|Overall Study|Non-Compliance|1|||
129805152|NCT05439941|467254951|FG000|Overall Study|Lost to Follow-up|2|||
129805153|NCT05439941|467254952|FG001|Overall Study|Lost to Follow-up|2|||
129805154|NCT05439941|467254953|FG002|Overall Study|Lost to Follow-up|0|||
129805155|NCT05439941|467254951|FG000|Overall Study|Physician Decision|1|||
129805156|NCT05439941|467254952|FG001|Overall Study|Physician Decision|0|||
129805157|NCT05439941|467254953|FG002|Overall Study|Physician Decision|0|||
129805158|NCT05439941|467254951|FG000|Overall Study|Trial Termination by Sponsor|78|||
129805159|NCT05439941|467254952|FG001|Overall Study|Trial Termination by Sponsor|83|||
129805160|NCT05439941|467254953|FG002|Overall Study|Trial Termination by Sponsor|65|||
129805161|NCT05439941|467254951|FG000|Overall Study|Other than Reasons Listed|2|||
129805162|NCT05439941|467254952|FG001|Overall Study|Other than Reasons Listed|1|||
129805163|NCT05439941|467254953|FG002|Overall Study|Other than Reasons Listed|0|||
129805164|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
129805165|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
129805166|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
129805167|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
129805168|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
129805169|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
129805170|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
129805171|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
129805172|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
129805173|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
129805174|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
129805175|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
129805176|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
129805177|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
129805178|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
129805179|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
129805180|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
129805181|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
129805182|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
129805183|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
129805184|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
130056130|NCT00488618|468159694|FG001|Overall Study|Lost to Follow-up|0|||
129805185|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
129805186|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
129805187|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
129805188|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
129805189|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
129805190|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
129805191|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
129805192|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
129805193|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
129805194|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
129805195|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129805196|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129805197|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129893076|NCT00495469|467567741|FG004|Overall Study|Lost to Follow-up|0|||
129893077|NCT00495469|467567742|FG005|Overall Study|Lost to Follow-up|0|||
129893078|NCT00495469|467567743|FG006|Overall Study|Lost to Follow-up|0|||
129893079|NCT00495469|467567737|FG000|Overall Study|Protocol Violation|0|||
129893080|NCT00495469|467567738|FG001|Overall Study|Protocol Violation|0|||
129893081|NCT00495469|467567739|FG002|Overall Study|Protocol Violation|0|||
129893082|NCT00495469|467567740|FG003|Overall Study|Protocol Violation|0|||
129893083|NCT00495469|467567741|FG004|Overall Study|Protocol Violation|1|||
129893084|NCT00495469|467567742|FG005|Overall Study|Protocol Violation|2|||
129893085|NCT00495469|467567743|FG006|Overall Study|Protocol Violation|0|||
129893086|NCT00495469|467567737|FG000|Overall Study|Withdrawal by Subject|5|||
129893087|NCT00495469|467567738|FG001|Overall Study|Withdrawal by Subject|3|||
129893088|NCT00495469|467567739|FG002|Overall Study|Withdrawal by Subject|1|||
129893089|NCT00495469|467567740|FG003|Overall Study|Withdrawal by Subject|3|||
129893090|NCT00495469|467567741|FG004|Overall Study|Withdrawal by Subject|3|||
129893091|NCT00495469|467567742|FG005|Overall Study|Withdrawal by Subject|2|||
129893092|NCT00495469|467567743|FG006|Overall Study|Withdrawal by Subject|3|||
129893093|NCT00495469|467567737|FG000|Overall Study|Lack of Efficacy|0|||
129893094|NCT00495469|467567738|FG001|Overall Study|Lack of Efficacy|0|||
129893095|NCT00495469|467567739|FG002|Overall Study|Lack of Efficacy|0|||
129893096|NCT00495469|467567740|FG003|Overall Study|Lack of Efficacy|0|||
129893097|NCT00495469|467567741|FG004|Overall Study|Lack of Efficacy|0|||
129893098|NCT00495469|467567742|FG005|Overall Study|Lack of Efficacy|0|||
129893099|NCT00495469|467567743|FG006|Overall Study|Lack of Efficacy|1|||
129893100|NCT00495469|467567737|FG000|Overall Study|Liver function test abnormality|0|||
129893101|NCT00495469|467567738|FG001|Overall Study|Liver function test abnormality|1|||
129893102|NCT00495469|467567739|FG002|Overall Study|Liver function test abnormality|0|||
130056131|NCT03439748|468160719|FG000|Overall Study|Withdrawal by Subject|11|||
130056132|NCT03439748|468160720|FG001|Overall Study|Withdrawal by Subject|17|||
130056133|NCT05131451|468160721|FG000|Overall Study|Protocol Violation|1|||
130056134|NCT05131451|468160722|FG001|Overall Study|Protocol Violation|0|||
130056135|NCT00782418|468160729|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
130056136|NCT00782418|468160730|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129805198|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129805199|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
129805200|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
129893103|NCT00495469|467567740|FG003|Overall Study|Liver function test abnormality|0|||
129893104|NCT00495469|467567741|FG004|Overall Study|Liver function test abnormality|0|||
130056137|NCT00782418|468160731|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130056138|NCT00782418|468160732|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129805201|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
129805202|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
129893105|NCT00495469|467567742|FG005|Overall Study|Liver function test abnormality|0|||
129893106|NCT00495469|467567743|FG006|Overall Study|Liver function test abnormality|0|||
130056139|NCT00782418|468160733|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130056140|NCT00782418|468160734|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130056141|NCT00782418|468160735|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
130056142|NCT00782418|468160729|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
130056143|NCT00782418|468160730|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130056144|NCT00782418|468160731|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130056145|NCT00782418|468160732|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
129893107|NCT00495469|467567737|FG000|Overall Study|ST depression at randomisation in ECG|0|||
129893108|NCT00495469|467567738|FG001|Overall Study|ST depression at randomisation in ECG|1|||
129893109|NCT00495469|467567739|FG002|Overall Study|ST depression at randomisation in ECG|0|||
129893110|NCT00495469|467567740|FG003|Overall Study|ST depression at randomisation in ECG|0|||
129893111|NCT00495469|467567741|FG004|Overall Study|ST depression at randomisation in ECG|0|||
129893112|NCT00495469|467567742|FG005|Overall Study|ST depression at randomisation in ECG|0|||
129893113|NCT00495469|467567743|FG006|Overall Study|ST depression at randomisation in ECG|0|||
129893114|NCT00448864|467567746|FG000|Overall Study|Death|1|||
129893115|NCT00448864|467567747|FG001|Overall Study|Death|0|||
129893116|NCT00448864|467567748|FG002|Overall Study|Death|0|||
129893117|NCT00448864|467567746|FG000|Overall Study|Lost to Follow-up|3|||
129805203|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
129805204|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
129805205|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
129805206|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
129805207|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
129805208|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
129805209|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
129805210|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
129805211|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
129805212|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
129805213|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
129805214|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
129805215|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
129805216|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
129805217|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
129805218|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
129805219|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
129805220|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
129805221|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
129805222|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
129893118|NCT00448864|467567747|FG001|Overall Study|Lost to Follow-up|1|||
129893119|NCT00448864|467567748|FG002|Overall Study|Lost to Follow-up|0|||
129893120|NCT00448864|467567746|FG000|Overall Study|Physician Decision|1|||
129893121|NCT00448864|467567747|FG001|Overall Study|Physician Decision|0|||
129893122|NCT00448864|467567748|FG002|Overall Study|Physician Decision|1|||
129893123|NCT00448864|467567746|FG000|Overall Study|Withdrawal by Subject|0|||
129893124|NCT00448864|467567747|FG001|Overall Study|Withdrawal by Subject|2|||
129893125|NCT00448864|467567748|FG002|Overall Study|Withdrawal by Subject|0|||
129893126|NCT00448864|467567746|FG000|Overall Study|Protocol Violation|0|||
129893127|NCT00448864|467567747|FG001|Overall Study|Protocol Violation|2|||
129893128|NCT00448864|467567748|FG002|Overall Study|Protocol Violation|0|||
129893129|NCT03606460|467567751|FG000|Overall Study|Lost to Follow-up|1|||
129893130|NCT03606460|467567752|FG001|Overall Study|Lost to Follow-up|8|||
129893131|NCT04170023|467567753|FG000|LTE Period|Withdrawal by Subject|1|||
129893132|NCT04170023|467567754|FG001|LTE Period|Withdrawal by Subject|0|||
129893133|NCT04170023|467567755|FG002|LTE Period|Withdrawal by Subject|0|||
129893134|NCT04170023|467567753|FG000|LTE Period|Study Termination|11|||
129893135|NCT04170023|467567754|FG001|LTE Period|Study Termination|11|||
129893136|NCT04170023|467567755|FG002|LTE Period|Study Termination|5|||
129893137|NCT01414166|467567764|FG000|Overall Study|Adverse Event|10|||
129893138|NCT01414166|467567765|FG001|Overall Study|Adverse Event|2|||
129893139|NCT01414166|467567764|FG000|Overall Study|Lost to Follow-up|4|||
129893140|NCT01414166|467567765|FG001|Overall Study|Lost to Follow-up|1|||
129893141|NCT01414166|467567764|FG000|Overall Study|Non-compliance with study drug|2|||
129893142|NCT01414166|467567765|FG001|Overall Study|Non-compliance with study drug|0|||
129893143|NCT01414166|467567764|FG000|Overall Study|Physician Decision|2|||
129893144|NCT01414166|467567765|FG001|Overall Study|Physician Decision|0|||
129893145|NCT01414166|467567764|FG000|Overall Study|Protocol Violation|2|||
129893146|NCT01414166|467567765|FG001|Overall Study|Protocol Violation|0|||
129893147|NCT01414166|467567764|FG000|Overall Study|Study terminated by Sponsor|68|||
129893148|NCT01414166|467567765|FG001|Overall Study|Study terminated by Sponsor|75|||
129893149|NCT01414166|467567764|FG000|Overall Study|Withdrawal by Subject|3|||
129893150|NCT01414166|467567765|FG001|Overall Study|Withdrawal by Subject|5|||
129893151|NCT03782727|467567766|FG000|Overall Study|Lost to Follow-up|32|||
129893152|NCT01823341|467567769|FG000|Overall Study|Failed run-in|7|||
129893153|NCT01823341|467567769|FG000|Overall Study|Withdrawal by Subject|7|||
129893154|NCT01823341|467567769|FG000|Overall Study|Adverse Event|1|||
129893155|NCT00924560|467567770|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
129893156|NCT00924560|467567771|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
129893157|NCT00924560|467567772|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
129893158|NCT00924560|467567770|FG000|Overall Study|Non Compliance with the Protocol|20|||
129893159|NCT00924560|467567771|FG001|Overall Study|Non Compliance with the Protocol|15|||
129893160|NCT00924560|467567772|FG002|Overall Study|Non Compliance with the Protocol|4|||
129893161|NCT00924560|467567770|FG000|Overall Study|Physician Decision|2|||
129893162|NCT00924560|467567771|FG001|Overall Study|Physician Decision|3|||
129893163|NCT00924560|467567772|FG002|Overall Study|Physician Decision|4|||
129893164|NCT00924560|467567770|FG000|Overall Study|Withdrawal by Subject|50|||
129893165|NCT00924560|467567771|FG001|Overall Study|Withdrawal by Subject|44|||
129893166|NCT00924560|467567772|FG002|Overall Study|Withdrawal by Subject|18|||
129893167|NCT00924560|467567770|FG000|Overall Study|Adverse Event|39|||
129893168|NCT00924560|467567771|FG001|Overall Study|Adverse Event|33|||
129893169|NCT00924560|467567772|FG002|Overall Study|Adverse Event|0|||
129893170|NCT00924560|467567770|FG000|Overall Study|Pregnancy|5|||
129893171|NCT00924560|467567771|FG001|Overall Study|Pregnancy|7|||
129893172|NCT00924560|467567772|FG002|Overall Study|Pregnancy|1|||
129893173|NCT00924560|467567770|FG000|Overall Study|Lost to Follow-up|78|||
129893174|NCT00924560|467567771|FG001|Overall Study|Lost to Follow-up|94|||
129893175|NCT00924560|467567772|FG002|Overall Study|Lost to Follow-up|45|||
129893176|NCT00924560|467567770|FG000|Overall Study|Miscellaneous Reasons|13|||
129893177|NCT00924560|467567771|FG001|Overall Study|Miscellaneous Reasons|10|||
129893178|NCT00924560|467567772|FG002|Overall Study|Miscellaneous Reasons|10|||
129893179|NCT02696226|467567774|FG000|Overall Study|Study terminated - lack of enrollment|1|||
129893180|NCT02696226|467567775|FG001|Overall Study|Study terminated - lack of enrollment|0|||
129893181|NCT02696226|467567776|FG002|Overall Study|Study terminated - lack of enrollment|2|||
130111677|NCT02436135|468369505|FG000|Overall Study|Study Terminated By Sponsor|0|||
130111678|NCT02436135|468369506|FG001|Overall Study|Study Terminated By Sponsor|1|||
129893182|NCT02696226|467567777|FG003|Overall Study|Study terminated - lack of enrollment|0|||
130111679|NCT02729194|468369507|FG000|Overall Study|Withdrawal by Subject|3|||
130111680|NCT00475852|468369508|FG000|Overall Study|Death|444|||
129893183|NCT02909101|467567785|FG000|Overall Study|Lost to Follow-up|1|||
129893184|NCT02909101|467567786|FG001|Overall Study|Lost to Follow-up|1|||
129893185|NCT03073005|467567787|FG000|Overall Study|Death|6|||
129893186|NCT03073005|467567788|FG001|Overall Study|Death|0|||
129893187|NCT03073005|467567789|FG002|Overall Study|Death|7|||
129893188|NCT03073005|467567790|FG003|Overall Study|Death|0|||
129893189|NCT03073005|467567787|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
130111681|NCT00475852|468369509|FG001|Overall Study|Death|456|||
129805223|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
129805224|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
129805225|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
129805226|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
129805227|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
129805228|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
129805229|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
129805230|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
130056146|NCT00782418|468160733|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
130056147|NCT00782418|468160734|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
130056148|NCT00782418|468160735|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
130056149|NCT02324842|468160736|FG000|Overall Study|Lost to Follow-up|1|||
129805231|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
129805232|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
130056150|NCT02324842|468160737|FG001|Overall Study|Lost to Follow-up|1|||
130056151|NCT02324842|468160738|FG002|Overall Study|Lost to Follow-up|2|||
130056152|NCT02750800|468160739|FG000|Overall Study|Adverse Event|18|||
130056153|NCT02750800|468160739|FG000|Overall Study|Lost to Follow-up|12|||
130056154|NCT02750800|468160739|FG000|Overall Study|Investigator decision|53|||
130056155|NCT02750800|468160739|FG000|Overall Study|Patient request|12|||
130056156|NCT02750800|468160739|FG000|Overall Study|Other, not specified|3|||
130056157|NCT03298412|468160740|FG000|Run-in Period|Other, Not Specified|1|||
130056158|NCT03298412|468160740|FG000|Run-in Period|Disease Progression|1|||
130056159|NCT03298412|468160740|FG000|Run-in Period|Ineligibility Determined|1|||
130056160|NCT03298412|468160740|FG000|Run-in Period|Decision by Sponsor|6|||
130056161|NCT01894477|468160741|FG000|Overall Study|Protocol Violation|0|||
130056162|NCT01894477|468160742|FG001|Overall Study|Protocol Violation|1|||
130056163|NCT01894477|468160741|FG000|Overall Study|protocol changed due SC changed to cord|0|||
130056164|NCT01894477|468160742|FG001|Overall Study|protocol changed due SC changed to cord|1|||
130056165|NCT05631548|468160744|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
129805233|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
129805234|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
129805235|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805236|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805237|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805238|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805239|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
129805240|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
129805241|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
129805242|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
129805243|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
129893190|NCT03073005|467567788|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
129893191|NCT03073005|467567789|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
129893192|NCT03073005|467567790|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
129893193|NCT03073005|467567787|FG000|Overall Study|Lost to Follow-up|2|||
129893194|NCT03073005|467567788|FG001|Overall Study|Lost to Follow-up|2|||
129893195|NCT03073005|467567789|FG002|Overall Study|Lost to Follow-up|1|||
129893196|NCT03073005|467567790|FG003|Overall Study|Lost to Follow-up|2|||
129893197|NCT03073005|467567787|FG000|Overall Study|Withdrawal by Subject|0|||
130056166|NCT05631548|468160745|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
130056167|NCT01592409|468160746|FG000|Overall Study|Withdrawal by Subject|0|||
130056168|NCT01592409|468160747|FG001|Overall Study|Withdrawal by Subject|1|||
130056169|NCT01409031|468160752|FG000|Overall Study|transferred to other hosp|1|||
130056170|NCT01409031|468160753|FG001|Overall Study|transferred to other hosp|0|||
130056171|NCT00995345|468160755|FG000|Overall Study|Withdrawal by Subject|4|||
130056172|NCT00995345|468160756|FG001|Overall Study|Withdrawal by Subject|2|||
130056173|NCT00995345|468160757|FG002|Overall Study|Withdrawal by Subject|1|||
130056174|NCT00995345|468160758|FG003|Overall Study|Withdrawal by Subject|3|||
130056175|NCT00995345|468160759|FG004|Overall Study|Withdrawal by Subject|1|||
130056176|NCT00995345|468160755|FG000|Overall Study|Adverse Event|3|||
130056177|NCT00995345|468160756|FG001|Overall Study|Adverse Event|1|||
130056178|NCT00995345|468160757|FG002|Overall Study|Adverse Event|2|||
130056179|NCT00995345|468160758|FG003|Overall Study|Adverse Event|0|||
130056180|NCT00995345|468160759|FG004|Overall Study|Adverse Event|1|||
130056181|NCT00995345|468160755|FG000|Overall Study|Lost to Follow-up|2|||
130056182|NCT00995345|468160756|FG001|Overall Study|Lost to Follow-up|2|||
130056183|NCT00995345|468160757|FG002|Overall Study|Lost to Follow-up|2|||
130056184|NCT00995345|468160758|FG003|Overall Study|Lost to Follow-up|1|||
130056185|NCT00995345|468160759|FG004|Overall Study|Lost to Follow-up|0|||
130056186|NCT00995345|468160755|FG000|Overall Study|all other reasons combined|2|||
130056187|NCT00995345|468160756|FG001|Overall Study|all other reasons combined|2|||
130056188|NCT00995345|468160757|FG002|Overall Study|all other reasons combined|2|||
130056189|NCT00995345|468160758|FG003|Overall Study|all other reasons combined|1|||
130056190|NCT00995345|468160759|FG004|Overall Study|all other reasons combined|3|||
130056191|NCT01860534|468160760|FG000|ROP #1|Needed treatment for ROP|0|||
130056192|NCT01860534|468160761|FG001|ROP #1|Needed treatment for ROP|1|||
130056193|NCT01860534|468160760|FG000|ROP #2|discharged prior to ROP #2|1|||
130056194|NCT01860534|468160761|FG001|ROP #2|discharged prior to ROP #2|0|||
130056195|NCT01934894|468160764|FG000|Overall Study|Adverse Event|1|||
130056196|NCT01934894|468160765|FG001|Overall Study|Adverse Event|2|||
130056197|NCT01934894|468160764|FG000|Overall Study|Death|2|||
130056198|NCT01934894|468160765|FG001|Overall Study|Death|0|||
130056199|NCT01934894|468160764|FG000|Overall Study|Withdrawal by Subject|0|||
130056200|NCT01934894|468160765|FG001|Overall Study|Withdrawal by Subject|1|||
130056201|NCT01934894|468160764|FG000|Overall Study|Progressive Disease|3|||
130056202|NCT01934894|468160765|FG001|Overall Study|Progressive Disease|2|||
130056203|NCT01100307|468160769|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
130056204|NCT01100307|468160770|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
130056205|NCT01100307|468160769|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
130056206|NCT01100307|468160770|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
130056207|NCT01100307|468160769|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
130056208|NCT01100307|468160770|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
130056209|NCT01100307|468160769|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
130056210|NCT01100307|468160770|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
130056211|NCT01100307|468160769|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
130056212|NCT01100307|468160770|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
130056213|NCT01100307|468160769|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
130056214|NCT01100307|468160770|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
130056215|NCT01401010|468160772|FG000|Overall Study|Could not interpret assay results|1|||
130056216|NCT01401010|468160773|FG001|Overall Study|Could not interpret assay results|0|||
130056217|NCT04360187|468160778|FG000|Double-Blind Treatment|Adverse Event|9|||
130056218|NCT04360187|468160779|FG001|Double-Blind Treatment|Adverse Event|11|||
130056219|NCT04360187|468160778|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
130056220|NCT04360187|468160779|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
130056221|NCT04360187|468160778|FG000|Double-Blind Treatment|Physician Decision|1|||
130056222|NCT04360187|468160779|FG001|Double-Blind Treatment|Physician Decision|0|||
130056223|NCT04360187|468160778|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
130056224|NCT04360187|468160779|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
130056225|NCT04360187|468160778|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
130056226|NCT04360187|468160779|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
130056227|NCT04360187|468160778|FG000|Follow-Up|Lost to Follow-up|1|||
130056228|NCT04360187|468160779|FG001|Follow-Up|Lost to Follow-up|0|||
130056229|NCT01423617|468160784|FG000|Overall Study|Lost to Follow-up|0|||
130056230|NCT01423617|468160785|FG001|Overall Study|Lost to Follow-up|1|||
130056231|NCT04369430|468160786|FG000|Overall Study|Adverse Event|2|||
130056232|NCT04369430|468160787|FG001|Overall Study|Adverse Event|3|||
130056233|NCT04369430|468160786|FG000|Overall Study|Death|1|||
130056234|NCT04369430|468160787|FG001|Overall Study|Death|0|||
130056235|NCT04369430|468160786|FG000|Overall Study|Withdrawal by Subject|4|||
130056236|NCT04369430|468160787|FG001|Overall Study|Withdrawal by Subject|3|||
130056237|NCT04369430|468160786|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
130056238|NCT04369430|468160787|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
130056239|NCT04369430|468160786|FG000|Overall Study|Lost to Follow-up|0|||
130056240|NCT04369430|468160787|FG001|Overall Study|Lost to Follow-up|1|||
130111682|NCT00475852|468369508|FG000|Overall Study|Withdrawal by Subject|19|||
130111683|NCT00475852|468369509|FG001|Overall Study|Withdrawal by Subject|24|||
130111684|NCT00475852|468369508|FG000|Overall Study|Lost to Follow-up|54|||
130111685|NCT00475852|468369509|FG001|Overall Study|Lost to Follow-up|68|||
130111686|NCT01361607|468369511|FG000|Overall Study|Adverse Event|38|||
130111687|NCT01361607|468369512|FG001|Overall Study|Adverse Event|29|||
130111688|NCT01361607|468369511|FG000|Overall Study|Withdrawal by Subject|19|||
130111689|NCT01361607|468369512|FG001|Overall Study|Withdrawal by Subject|8|||
130111690|NCT01361607|468369511|FG000|Overall Study|Withdrawal by Investigator|5|||
130111691|NCT01361607|468369512|FG001|Overall Study|Withdrawal by Investigator|3|||
130111692|NCT01361607|468369511|FG000|Overall Study|Lost to Follow-up|1|||
130111693|NCT01361607|468369512|FG001|Overall Study|Lost to Follow-up|0|||
130111694|NCT01361607|468369511|FG000|Overall Study|Met Withdrawal Criteria|1|||
130111695|NCT01361607|468369512|FG001|Overall Study|Met Withdrawal Criteria|1|||
130111696|NCT00297479|468369513|FG000|Overall Study|Lost to Follow-up|37|||
129805244|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
129805245|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
129805246|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
130111697|NCT00297479|468369514|FG001|Overall Study|Lost to Follow-up|54|||
130111698|NCT00297479|468369515|FG002|Overall Study|Lost to Follow-up|51|||
130111699|NCT01664494|468369518|FG000|Overall Study|Withdrawal by Subject|27|||
130111700|NCT01664494|468369518|FG000|Overall Study|Death|18|||
130111701|NCT01664494|468369518|FG000|Overall Study|Other|49|||
130111702|NCT01664494|468369518|FG000|Overall Study|Lost to Follow-up|99|||
129805247|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
129805248|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
129805249|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
129805250|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
129805251|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
129805252|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
129805253|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
129805254|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
129805255|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805256|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805257|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805258|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805259|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
129805260|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
129805261|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
129805262|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
129805263|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
129805264|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
129805265|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
129805266|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
129805267|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
129805268|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
129805269|NCT02336373|467254959|FG000|Overall Study|Protocol closed early|4|||
129805270|NCT02336373|467254959|FG000|Overall Study|Physician Decision|14|||
129805271|NCT00850343|467254960|FG000|Overall Study|Withdrawal by Subject|11|||
129805272|NCT00850343|467254961|FG001|Overall Study|Withdrawal by Subject|0|||
129805273|NCT00850343|467254962|FG002|Overall Study|Withdrawal by Subject|3|||
129805274|NCT00850343|467254963|FG003|Overall Study|Withdrawal by Subject|2|||
129805275|NCT00850343|467254960|FG000|Overall Study|Adverse Event|15|||
129805276|NCT00850343|467254961|FG001|Overall Study|Adverse Event|2|||
129805277|NCT00850343|467254962|FG002|Overall Study|Adverse Event|6|||
129805278|NCT00850343|467254963|FG003|Overall Study|Adverse Event|6|||
129805279|NCT00850343|467254960|FG000|Overall Study|Pregnancy|0|||
129805280|NCT00850343|467254961|FG001|Overall Study|Pregnancy|0|||
129805281|NCT00850343|467254962|FG002|Overall Study|Pregnancy|0|||
129805282|NCT00850343|467254963|FG003|Overall Study|Pregnancy|1|||
129805283|NCT00850343|467254960|FG000|Overall Study|Lack of Efficacy|17|||
129805284|NCT00850343|467254961|FG001|Overall Study|Lack of Efficacy|0|||
129805285|NCT00850343|467254962|FG002|Overall Study|Lack of Efficacy|3|||
129805286|NCT00850343|467254963|FG003|Overall Study|Lack of Efficacy|2|||
129805287|NCT00850343|467254960|FG000|Overall Study|Non-compliance with Study Procedures|1|||
129805288|NCT00850343|467254961|FG001|Overall Study|Non-compliance with Study Procedures|0|||
129805289|NCT00850343|467254962|FG002|Overall Study|Non-compliance with Study Procedures|1|||
129805290|NCT00850343|467254963|FG003|Overall Study|Non-compliance with Study Procedures|1|||
129805291|NCT00850343|467254960|FG000|Overall Study|Physician Decision|2|||
129805292|NCT00850343|467254961|FG001|Overall Study|Physician Decision|1|||
129805293|NCT00850343|467254962|FG002|Overall Study|Physician Decision|1|||
129805294|NCT00850343|467254963|FG003|Overall Study|Physician Decision|1|||
129805295|NCT02764333|467254966|FG000|Overall Study|Ineligible|1|||
129805296|NCT01788046|467254980|FG000|Overall Study|Withdrawal by Subject|12|||
129805297|NCT01788046|467254981|FG001|Overall Study|Withdrawal by Subject|12|||
129805298|NCT01788046|467254980|FG000|Overall Study|Lost to Follow-up|12|||
129805299|NCT01788046|467254981|FG001|Overall Study|Lost to Follow-up|19|||
129805300|NCT01788046|467254980|FG000|Overall Study|Death|7|||
130056241|NCT02435277|468160788|FG000|Overall Study|Adverse Event|1|||
130056242|NCT02435277|468160789|FG001|Overall Study|Adverse Event|1|||
130056243|NCT02435277|468160790|FG002|Overall Study|Adverse Event|0|||
130056244|NCT02435277|468160791|FG003|Overall Study|Adverse Event|0|||
129805301|NCT01788046|467254981|FG001|Overall Study|Death|5|||
129805302|NCT01788046|467254980|FG000|Overall Study|Protocol Specified Criteria|25|||
129805303|NCT01788046|467254981|FG001|Overall Study|Protocol Specified Criteria|1|||
129805304|NCT01856907|467254984|FG000|Overall Study|Pregnancy|0|||
130056245|NCT02435277|468160788|FG000|Overall Study|Withdrawal by Subject|1|||
129805305|NCT01856907|467254985|FG001|Overall Study|Pregnancy|1|||
129805306|NCT01856907|467254986|FG002|Overall Study|Pregnancy|0|||
130056246|NCT02435277|468160789|FG001|Overall Study|Withdrawal by Subject|0|||
129805307|NCT01856907|467254984|FG000|Overall Study|Pregnancy|0|||
130056247|NCT02435277|468160790|FG002|Overall Study|Withdrawal by Subject|0|||
130056248|NCT02435277|468160791|FG003|Overall Study|Withdrawal by Subject|0|||
129805308|NCT01856907|467254985|FG001|Overall Study|Pregnancy|1|||
129805309|NCT01856907|467254986|FG002|Overall Study|Pregnancy|0|||
129805310|NCT01856907|467254984|FG000|Overall Study|Withdrawal by Subject|0|||
129805311|NCT01856907|467254985|FG001|Overall Study|Withdrawal by Subject|1|||
129805312|NCT01856907|467254986|FG002|Overall Study|Withdrawal by Subject|0|||
129893198|NCT03073005|467567788|FG001|Overall Study|Withdrawal by Subject|4|||
129893199|NCT03073005|467567789|FG002|Overall Study|Withdrawal by Subject|4|||
129893200|NCT03073005|467567790|FG003|Overall Study|Withdrawal by Subject|4|||
129893201|NCT01290094|467567791|FG000|Overall Study|Withdrawal by Subject|1|||
129893202|NCT01290094|467567791|FG000|Overall Study|Lost to Follow-up|5|||
129893203|NCT00093795|467569676|FG000|Overall Study|No follow up data|20|||
129893204|NCT00093795|467569677|FG001|Overall Study|No follow up data|16|||
129893205|NCT00093795|467569678|FG002|Overall Study|No follow up data|17|||
129893206|NCT02949271|467569681|FG000|Overall Study|Lack of Efficacy|5|||
129893207|NCT02949271|467569682|FG001|Overall Study|Lack of Efficacy|4|||
129893208|NCT02949271|467569681|FG000|Overall Study|Lost to Follow-up|3|||
129893209|NCT02949271|467569682|FG001|Overall Study|Lost to Follow-up|6|||
130056249|NCT00008138|468160792|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
130056250|NCT00008138|468160792|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
130056251|NCT00008138|468160792|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
130056252|NCT00008138|468160792|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
130056253|NCT00008138|468160792|FG000|Interval Debulking|Withdrawal by Subject|2|||
130056254|NCT00008138|468160792|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
130056255|NCT00008138|468160792|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
130056256|NCT00008138|468160792|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
130056257|NCT02635737|468160793|FG000|Overall Study|Protocol Violation|1|||
130056258|NCT00937768|468160794|FG000|Overall Study|Refused Further Treatment|3|||
130056259|NCT00937768|468160795|FG001|Overall Study|Refused Further Treatment|2|||
130056260|NCT00937768|468160794|FG000|Overall Study|Disease Progression|1|||
130056261|NCT00937768|468160795|FG001|Overall Study|Disease Progression|1|||
130056262|NCT00937768|468160794|FG000|Overall Study|Alternate Treatment|0|||
130056263|NCT00937768|468160795|FG001|Overall Study|Alternate Treatment|1|||
130056264|NCT00937768|468160794|FG000|Overall Study|No Further Funding|4|||
130056265|NCT00937768|468160795|FG001|Overall Study|No Further Funding|4|||
130056266|NCT01687413|468160796|FG000|Overall Study|Withdrawal by Subject|0|||
130056267|NCT01687413|468160797|FG001|Overall Study|Withdrawal by Subject|2|||
130056268|NCT01687413|468160796|FG000|Overall Study|Not eligible|0|||
130056269|NCT01687413|468160797|FG001|Overall Study|Not eligible|2|||
130056270|NCT01687413|468160796|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
130056271|NCT01687413|468160797|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
130056272|NCT04973228|468160798|FG000|Overall Study|Adverse Event|2|||
130056273|NCT04973228|468160799|FG001|Overall Study|Adverse Event|3|||
130056274|NCT04973228|468160798|FG000|Overall Study|Lack of Efficacy|1|||
130056275|NCT04973228|468160799|FG001|Overall Study|Lack of Efficacy|3|||
130056276|NCT04973228|468160798|FG000|Overall Study|Lost to Follow-up|12|||
130056277|NCT04973228|468160799|FG001|Overall Study|Lost to Follow-up|4|||
130056278|NCT04973228|468160798|FG000|Overall Study|Withdrawal by Subject|11|||
130056279|NCT04973228|468160799|FG001|Overall Study|Withdrawal by Subject|4|||
130056280|NCT04973228|468160798|FG000|Overall Study|Did not tolerate application|1|||
130056281|NCT04973228|468160799|FG001|Overall Study|Did not tolerate application|0|||
130056282|NCT04973228|468160798|FG000|Overall Study|Wanted to early terminate and use own product|0|||
130056283|NCT04973228|468160799|FG001|Overall Study|Wanted to early terminate and use own product|1|||
130056284|NCT04973228|468160798|FG000|Overall Study|Missed visits due to new work schedule|1|||
130056285|NCT04973228|468160799|FG001|Overall Study|Missed visits due to new work schedule|0|||
130056286|NCT02678780|468160803|FG000|Overall Study|Adverse Event|11|||
130056287|NCT02678780|468160804|FG001|Overall Study|Adverse Event|14|||
130056288|NCT02678780|468160803|FG000|Overall Study|Withdrawal by Subject|2|||
130056289|NCT02678780|468160804|FG001|Overall Study|Withdrawal by Subject|1|||
130056290|NCT02678780|468160803|FG000|Overall Study|Sponsor discontinuation|7|||
130056291|NCT02678780|468160804|FG001|Overall Study|Sponsor discontinuation|4|||
130056292|NCT02678780|468160803|FG000|Overall Study|Death|1|||
130056293|NCT02678780|468160804|FG001|Overall Study|Death|1|||
130056294|NCT02678780|468160803|FG000|Overall Study|Other|6|||
130056295|NCT02678780|468160804|FG001|Overall Study|Other|8|||
130056296|NCT00992446|468160818|FG000|Overall Study|Disease Progression|1|||
130056297|NCT00992446|468160818|FG000|Overall Study|Withdrawal by Subject|2|||
130056298|NCT00992446|468160818|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
130056299|NCT03675737|468160821|FG000|Overall Study|Death|593|||
130056300|NCT03675737|468160822|FG001|Overall Study|Death|660|||
130056301|NCT03675737|468160821|FG000|Overall Study|Lost to Follow-up|1|||
130056302|NCT03675737|468160822|FG001|Overall Study|Lost to Follow-up|5|||
130056303|NCT03675737|468160821|FG000|Overall Study|Physician Decision|1|||
130056304|NCT03675737|468160822|FG001|Overall Study|Physician Decision|0|||
130056305|NCT03675737|468160821|FG000|Overall Study|Withdrawal by Subject|14|||
130056306|NCT03675737|468160822|FG001|Overall Study|Withdrawal by Subject|12|||
130056307|NCT03675737|468160821|FG000|Overall Study|Ongoing in Study|181|||
130056308|NCT03675737|468160822|FG001|Overall Study|Ongoing in Study|112|||
130056309|NCT02349789|468162411|FG000|Overall Study|Withdrawal by Subject|2|||
130056310|NCT00683475|468162412|FG000|Overall Study|Withdrawal by Subject|1|||
130056311|NCT00683475|468162413|FG001|Overall Study|Withdrawal by Subject|0|||
129893210|NCT02949271|467569681|FG000|Overall Study|Physician Decision|5|||
129893211|NCT02949271|467569682|FG001|Overall Study|Physician Decision|5|||
129893212|NCT02949271|467569681|FG000|Overall Study|Protocol Violation|6|||
129893213|NCT02949271|467569682|FG001|Overall Study|Protocol Violation|3|||
129893214|NCT02949271|467569681|FG000|Overall Study|Withdrawal by Subject|1|||
129893215|NCT02949271|467569682|FG001|Overall Study|Withdrawal by Subject|0|||
129893216|NCT02949271|467569681|FG000|Overall Study|Delivered prior to intervention|7|||
129893217|NCT02949271|467569682|FG001|Overall Study|Delivered prior to intervention|9|||
129893218|NCT02949271|467569681|FG000|Overall Study|Outside the window for cervical dilation|2|||
129893219|NCT02949271|467569682|FG001|Overall Study|Outside the window for cervical dilation|3|||
129893220|NCT05458102|467569683|FG000|Overall Study|Withdrew consent|2|||
129893221|NCT05458102|467569684|FG001|Overall Study|Withdrew consent|0|||
129893222|NCT05458102|467569683|FG000|Overall Study|Adverse Event|1|||
129893223|NCT05458102|467569684|FG001|Overall Study|Adverse Event|0|||
129893224|NCT05458102|467569683|FG000|Overall Study|Enrolled but never treated|1|||
129893225|NCT05458102|467569684|FG001|Overall Study|Enrolled but never treated|0|||
129893226|NCT05458102|467569683|FG000|Overall Study|Protocol Violation|1|||
129893227|NCT05458102|467569684|FG001|Overall Study|Protocol Violation|0|||
129893228|NCT00723294|467569685|FG000|Overall Study|Lobular histology|2|||
129893229|NCT00723294|467569685|FG000|Overall Study|>25% intraductal component|1|||
129893230|NCT00723294|467569685|FG000|Overall Study|No MRI tumor enhancement|1|||
129893231|NCT00723294|467569685|FG000|Overall Study|1.0-Tesla MRI|1|||
129893232|NCT00723294|467569685|FG000|Overall Study|No cryoabalation|2|||
129893233|NCT00723294|467569685|FG000|Overall Study|Did not undergo surgery|1|||
129893234|NCT00723294|467569685|FG000|Overall Study|Treated prior to registration|1|||
129893235|NCT00723294|467569685|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
129893236|NCT00723294|467569685|FG000|Overall Study|Benign lesion|1|||
129893237|NCT00723294|467569685|FG000|Overall Study|Withdrawal by Subject|1|||
129893238|NCT00723294|467569685|FG000|Overall Study|No treatment due to probe failure|1|||
129893239|NCT02703532|467569689|FG000|Overall Study|Withdrawal by Subject|0|||
129893240|NCT02703532|467569690|FG001|Overall Study|Withdrawal by Subject|1|||
129893241|NCT02703532|467569691|FG002|Overall Study|Withdrawal by Subject|0|||
129893242|NCT02703532|467569692|FG003|Overall Study|Withdrawal by Subject|1|||
129893243|NCT02703532|467569689|FG000|Overall Study|Lost to Follow-up|2|||
129893244|NCT02703532|467569690|FG001|Overall Study|Lost to Follow-up|0|||
129893245|NCT02703532|467569691|FG002|Overall Study|Lost to Follow-up|2|||
129893246|NCT02703532|467569692|FG003|Overall Study|Lost to Follow-up|0|||
129893247|NCT02271594|467569695|FG000|Overall Study|Study closed; recruiting failure|19|||
129893248|NCT02271594|467569696|FG001|Overall Study|Study closed; recruiting failure|12|||
129893249|NCT04454567|467569698|FG000|Overall Study|Study Terminated by Sponsor|1|||
129893250|NCT04454567|467569699|FG001|Overall Study|Study Terminated by Sponsor|1|||
129893251|NCT01175707|467569704|FG000|Overall Study|Adverse Event|4|||
129893252|NCT01175707|467569705|FG001|Overall Study|Adverse Event|6|||
129893253|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
129893254|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129893255|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129893256|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
129893257|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
129893258|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
129893259|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
129893260|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
129893261|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
129893262|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
129893263|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
129893264|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
129893265|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
129893266|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
129893267|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129893268|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129893269|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129893270|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
129893271|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893272|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893273|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893274|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893275|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
129893276|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893277|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893278|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893279|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130056312|NCT00683475|468162412|FG000|Overall Study|Never Treated: Adverse Event|2|||
130056313|NCT00683475|468162413|FG001|Overall Study|Never Treated: Adverse Event|3|||
130056314|NCT00683475|468162412|FG000|Overall Study|Never Treated: Progressive Disease|1|||
130056315|NCT00683475|468162413|FG001|Overall Study|Never Treated: Progressive Disease|0|||
130056316|NCT02922634|468162414|FG000|Overall Study|Withdrawal by Subject|5|||
130056317|NCT02922634|468162414|FG000|Overall Study|Did not have their surgery|5|||
130056318|NCT02723604|468162415|FG000|Overall Study|ineligible|1|||
130056319|NCT02723604|468162415|FG000|Overall Study|never received treatment|1|||
130056320|NCT00352755|468162416|FG000|Overall Study|Physician Decision|1|||
130056321|NCT00352755|468162416|FG000|Overall Study|Adverse Event|1|||
130056322|NCT01694420|468162418|FG000|Overall Study|Lost to Follow-up|3|||
130056323|NCT00762372|468162421|FG000|Overall Study|Adverse Event|1|||
130056324|NCT00762372|468162422|FG001|Overall Study|Adverse Event|0|||
130056325|NCT00762372|468162423|FG002|Overall Study|Adverse Event|0|||
130056326|NCT03364335|468162424|FG000|Overall Study|Adverse Event|3|||
130056327|NCT03364335|468162425|FG001|Overall Study|Adverse Event|4|||
130056328|NCT03364335|468162426|FG002|Overall Study|Adverse Event|1|||
130056329|NCT03364335|468162427|FG003|Overall Study|Adverse Event|2|||
130056330|NCT03364335|468162428|FG004|Overall Study|Adverse Event|0|||
130056331|NCT03364335|468162424|FG000|Overall Study|Lost to Follow-up|7|||
130056332|NCT03364335|468162425|FG001|Overall Study|Lost to Follow-up|7|||
130056333|NCT03364335|468162426|FG002|Overall Study|Lost to Follow-up|10|||
130056334|NCT03364335|468162427|FG003|Overall Study|Lost to Follow-up|11|||
130056335|NCT03364335|468162428|FG004|Overall Study|Lost to Follow-up|11|||
130056336|NCT03987919|468162429|FG000|Overall Study|Adverse Event|1|||
130056337|NCT03987919|468162430|FG001|Overall Study|Adverse Event|4|||
130056338|NCT03987919|468162431|FG002|Overall Study|Adverse Event|1|||
130056339|NCT03987919|468162432|FG003|Overall Study|Adverse Event|3|||
130056340|NCT03987919|468162429|FG000|Overall Study|Death|4|||
130056341|NCT03987919|468162430|FG001|Overall Study|Death|4|||
130056342|NCT03987919|468162431|FG002|Overall Study|Death|4|||
130056343|NCT03987919|468162432|FG003|Overall Study|Death|1|||
130056344|NCT03987919|468162429|FG000|Overall Study|Lost to Follow-up|5|||
130056345|NCT03987919|468162430|FG001|Overall Study|Lost to Follow-up|6|||
130056346|NCT03987919|468162431|FG002|Overall Study|Lost to Follow-up|8|||
130056347|NCT03987919|468162432|FG003|Overall Study|Lost to Follow-up|12|||
130056348|NCT03987919|468162429|FG000|Overall Study|Physician Decision|0|||
130056349|NCT03987919|468162430|FG001|Overall Study|Physician Decision|2|||
130056350|NCT03987919|468162431|FG002|Overall Study|Physician Decision|0|||
130056351|NCT03987919|468162432|FG003|Overall Study|Physician Decision|4|||
130056352|NCT03987919|468162429|FG000|Overall Study|Pregnancy|1|||
130056353|NCT03987919|468162430|FG001|Overall Study|Pregnancy|0|||
130056354|NCT03987919|468162431|FG002|Overall Study|Pregnancy|1|||
130056355|NCT03987919|468162432|FG003|Overall Study|Pregnancy|1|||
130056356|NCT03987919|468162429|FG000|Overall Study|Protocol Violation|0|||
130056357|NCT03987919|468162430|FG001|Overall Study|Protocol Violation|1|||
130056358|NCT03987919|468162431|FG002|Overall Study|Protocol Violation|0|||
130056359|NCT03987919|468162432|FG003|Overall Study|Protocol Violation|0|||
130056360|NCT03987919|468162429|FG000|Overall Study|Site terminated by Sponsor|0|||
130056361|NCT03987919|468162430|FG001|Overall Study|Site terminated by Sponsor|0|||
130056362|NCT03987919|468162431|FG002|Overall Study|Site terminated by Sponsor|0|||
130056363|NCT03987919|468162432|FG003|Overall Study|Site terminated by Sponsor|1|||
130056364|NCT03987919|468162429|FG000|Overall Study|Withdrawal by Subject|7|||
130056365|NCT03987919|468162430|FG001|Overall Study|Withdrawal by Subject|7|||
130056366|NCT03987919|468162431|FG002|Overall Study|Withdrawal by Subject|8|||
130056367|NCT03987919|468162432|FG003|Overall Study|Withdrawal by Subject|4|||
129805313|NCT03626168|467254989|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129805314|NCT03626168|467254990|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129805315|NCT03626168|467254989|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
129805316|NCT03626168|467254990|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
129805317|NCT03626168|467254989|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129805318|NCT03626168|467254990|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
129805319|NCT00850070|467254991|FG000|Overall Study|Lack of Efficacy|1|||
129805320|NCT00850070|467254992|FG001|Overall Study|Lack of Efficacy|1|||
129805321|NCT00850070|467254991|FG000|Overall Study|Adverse Event|2|||
129805322|NCT00850070|467254992|FG001|Overall Study|Adverse Event|0|||
129805323|NCT05047770|467254993|FG000|Overall Study|Withdrawal by Subject|15|||
129805324|NCT05047770|467254994|FG001|Overall Study|Withdrawal by Subject|10|||
129805325|NCT05047770|467254995|FG002|Overall Study|Withdrawal by Subject|6|||
129805326|NCT05047770|467254996|FG003|Overall Study|Withdrawal by Subject|12|||
129805327|NCT05047770|467254993|FG000|Overall Study|Lost to Follow-up|7|||
129805328|NCT05047770|467254994|FG001|Overall Study|Lost to Follow-up|5|||
129805329|NCT05047770|467254995|FG002|Overall Study|Lost to Follow-up|12|||
129805330|NCT05047770|467254996|FG003|Overall Study|Lost to Follow-up|13|||
129805331|NCT05047770|467254993|FG000|Overall Study|Other|1|||
129805332|NCT05047770|467254994|FG001|Overall Study|Other|0|||
129805333|NCT05047770|467254995|FG002|Overall Study|Other|1|||
129805334|NCT05047770|467254996|FG003|Overall Study|Other|0|||
129805335|NCT01268150|467255006|FG000|Treatment Phase|Progression of disease|18|||
129805336|NCT01268150|467255006|FG000|Treatment Phase|Adverse Event|3|||
129805337|NCT01268150|467255006|FG000|Treatment Phase|Withdrawal by Subject|3|||
129805338|NCT01268150|467255006|FG000|Treatment Phase|Other|4|||
129805339|NCT01268150|467255006|FG000|Extension Phase|Adverse Event|3|||
129805340|NCT01268150|467255006|FG000|Extension Phase|Disease progression|18|||
129805341|NCT01268150|467255006|FG000|Extension Phase|Other|6|||
129805342|NCT00395733|467255007|FG000|Period 2|Withdrawal by Subject|1|||
129805343|NCT00395733|467255008|FG001|Period 2|Withdrawal by Subject|2|||
129805344|NCT00395733|467255007|FG000|Period 2|Protocol Violation|0|||
129805345|NCT00395733|467255008|FG001|Period 2|Protocol Violation|1|||
129805346|NCT00395733|467255007|FG000|Period 2|Adverse Event|0|||
129805347|NCT00395733|467255008|FG001|Period 2|Adverse Event|2|||
129805348|NCT00395733|467255007|FG000|Period 2|Technical problems|1|||
129893280|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893281|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130056368|NCT03987919|468162429|FG000|Overall Study|Other - as reported by the investigator|1|||
130056369|NCT03987919|468162430|FG001|Overall Study|Other - as reported by the investigator|3|||
130056370|NCT03987919|468162431|FG002|Overall Study|Other - as reported by the investigator|2|||
129805349|NCT00395733|467255008|FG001|Period 2|Technical problems|0|||
129805350|NCT03725852|467255009|FG000|Overall Study|Death|1|||
129805351|NCT03725852|467255010|FG001|Overall Study|Death|0|||
129805352|NCT03725852|467255009|FG000|Overall Study|Withdrawal by Subject|1|||
129805353|NCT03725852|467255010|FG001|Overall Study|Withdrawal by Subject|0|||
129805354|NCT03725852|467255009|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
129805355|NCT03725852|467255010|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
129805356|NCT04738734|467255013|FG000|Overall Study|Withdrawal by Subject|2|||
129805357|NCT04738734|467255014|FG001|Overall Study|Withdrawal by Subject|4|||
129805358|NCT04738734|467255013|FG000|Overall Study|Lost to Follow-up|5|||
130056371|NCT03987919|468162432|FG003|Overall Study|Other - as reported by the investigator|0|||
130056372|NCT01194804|468162433|FG000|Overall Study|Withdrawal by Subject|1|||
130056373|NCT01303380|468162434|FG000|Overall Study|Lack of compliance to study procedures|1|||
130056374|NCT03621943|468162435|FG000|First Randomized Intervention|Lost to Follow-up|51|||
130056375|NCT03621943|468162436|FG001|First Randomized Intervention|Lost to Follow-up|54|||
130056376|NCT03621943|468162435|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
129893282|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893283|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
129893284|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129893285|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129893286|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129893287|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129893288|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129893289|NCT01323660|467569707|FG000|Washout Period (14 Days)|Adverse Event|0|||
129893290|NCT01323660|467569708|FG001|Washout Period (14 Days)|Adverse Event|0|||
130056377|NCT03621943|468162436|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
130056378|NCT03621943|468162435|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
130056379|NCT03621943|468162436|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
130056380|NCT03621943|468162435|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
130056381|NCT03621943|468162436|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
130056382|NCT00315705|468162437|FG000|Phase 1|Refused further treatment|1|||
130056383|NCT00315705|468162437|FG000|Phase 1|Failure to achieve response|8|||
130056384|NCT00315705|468162437|FG000|Phase 1|Disease relapse|4|||
130056385|NCT00315705|468162437|FG000|Phase 1|Scheduled for transplant|9|||
130056386|NCT00315705|468162437|FG000|Phase 1|Death|3|||
130056387|NCT00315705|468162437|FG000|Phase 2|Physician Decision|4|||
130056388|NCT00315705|468162437|FG000|Phase 2|Adverse Event|1|||
130056389|NCT00315705|468162437|FG000|Phase 2|Failure to achieve response|3|||
130056390|NCT00315705|468162437|FG000|Phase 2|Disease relapse|1|||
130056391|NCT00315705|468162437|FG000|Phase 2|Scheduled for transplant|8|||
130056392|NCT00315705|468162437|FG000|Phase 2|Other|1|||
130056393|NCT00315705|468162437|FG000|Phase 2|Death|7|||
130056394|NCT00748553|468162438|FG000|Overall Study|Adverse Event|0|||
130056395|NCT00748553|468162439|FG001|Overall Study|Adverse Event|1|||
130056396|NCT00748553|468162438|FG000|Overall Study|disease progression|2|||
130056397|NCT00748553|468162439|FG001|Overall Study|disease progression|0|||
130056398|NCT00748553|468162438|FG000|Overall Study|noncompliance|1|||
130056399|NCT00748553|468162439|FG001|Overall Study|noncompliance|0|||
130056400|NCT00948818|468162441|FG000|Overall Study|Adverse Event|10|||
130056401|NCT00948818|468162442|FG001|Overall Study|Adverse Event|32|||
130056402|NCT00948818|468162441|FG000|Overall Study|Protocol Violation|9|||
130056403|NCT00948818|468162442|FG001|Overall Study|Protocol Violation|10|||
130056404|NCT00948818|468162441|FG000|Overall Study|Withdrawal by Subject|25|||
130056405|NCT00948818|468162442|FG001|Overall Study|Withdrawal by Subject|25|||
130056406|NCT00948818|468162441|FG000|Overall Study|Lost to Follow-up|10|||
130056407|NCT00948818|468162442|FG001|Overall Study|Lost to Follow-up|17|||
130056408|NCT00948818|468162441|FG000|Overall Study|Lack of Efficacy|4|||
130056409|NCT00948818|468162442|FG001|Overall Study|Lack of Efficacy|5|||
130056410|NCT00948818|468162441|FG000|Overall Study|Other Reason|4|||
130056411|NCT00948818|468162442|FG001|Overall Study|Other Reason|5|||
130056412|NCT01716533|468162443|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
130056413|NCT01716533|468162444|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
130056414|NCT01716533|468162445|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
130056415|NCT01716533|468162446|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
130056416|NCT01716533|468162443|FG000|Overall Study|Withdrawal by Subject|0|||
130056417|NCT01716533|468162444|FG001|Overall Study|Withdrawal by Subject|0|||
130056418|NCT01716533|468162445|FG002|Overall Study|Withdrawal by Subject|0|||
130056419|NCT01716533|468162446|FG003|Overall Study|Withdrawal by Subject|5|||
130056420|NCT01716533|468162443|FG000|Overall Study|Death|0|||
130056421|NCT01716533|468162444|FG001|Overall Study|Death|0|||
130056422|NCT01716533|468162445|FG002|Overall Study|Death|0|||
130056423|NCT01716533|468162446|FG003|Overall Study|Death|2|||
129893291|NCT01323660|467569709|FG002|Washout Period (14 Days)|Adverse Event|0|||
129893292|NCT01323660|467569710|FG003|Washout Period (14 Days)|Adverse Event|0|||
129893293|NCT01323660|467569711|FG004|Washout Period (14 Days)|Adverse Event|1|||
129893294|NCT01323660|467569712|FG005|Washout Period (14 Days)|Adverse Event|0|||
129893295|NCT01323660|467569707|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
129893296|NCT01323660|467569708|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
129893297|NCT01323660|467569709|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
130056424|NCT01716533|468162443|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
130056425|NCT01716533|468162444|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
130056426|NCT01716533|468162445|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
130056427|NCT01716533|468162446|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
130056428|NCT00745368|468162447|FG000|Overall Study|Unable to provide sample|3|||
130056429|NCT03446651|468162451|FG000|Overall Study|Lost to Follow-up|4|||
130056430|NCT03446651|468162452|FG001|Overall Study|Lost to Follow-up|0|||
130056431|NCT03446651|468162451|FG000|Overall Study|Open Label Participants|5|||
130056432|NCT03446651|468162452|FG001|Overall Study|Open Label Participants|0|||
129805359|NCT04738734|467255014|FG001|Overall Study|Lost to Follow-up|2|||
129805360|NCT04738734|467255013|FG000|Overall Study|Physician Decision|0|||
129805361|NCT04738734|467255014|FG001|Overall Study|Physician Decision|1|||
129805362|NCT04738734|467255013|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
129805363|NCT04738734|467255014|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
129805364|NCT01297920|467255017|FG000|Overall Study|Adverse Event|42|||
129805365|NCT01297920|467255018|FG001|Overall Study|Adverse Event|10|||
129805366|NCT01297920|467255019|FG002|Overall Study|Adverse Event|38|||
129805367|NCT01297920|467255017|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
129805368|NCT01297920|467255018|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
129805369|NCT01297920|467255019|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
130056433|NCT05142332|468162453|FG000|Overall Study|Withdrawal by Subject|0|||
130056434|NCT05142332|468162454|FG001|Overall Study|Withdrawal by Subject|1|||
130056435|NCT05142332|468162455|FG002|Overall Study|Withdrawal by Subject|2|||
130056436|NCT05142332|468162456|FG003|Overall Study|Withdrawal by Subject|0|||
130056437|NCT05142332|468162457|FG004|Overall Study|Withdrawal by Subject|0|||
130056438|NCT05142332|468162458|FG005|Overall Study|Withdrawal by Subject|2|||
130056439|NCT05142332|468162459|FG006|Overall Study|Withdrawal by Subject|6|||
130056440|NCT05142332|468162453|FG000|Overall Study|Left ED|3|||
130056441|NCT05142332|468162454|FG001|Overall Study|Left ED|0|||
130056442|NCT05142332|468162455|FG002|Overall Study|Left ED|4|||
130056443|NCT05142332|468162456|FG003|Overall Study|Left ED|6|||
130056444|NCT05142332|468162457|FG004|Overall Study|Left ED|1|||
130056445|NCT05142332|468162458|FG005|Overall Study|Left ED|2|||
130056446|NCT05142332|468162459|FG006|Overall Study|Left ED|6|||
130056447|NCT05142332|468162453|FG000|Overall Study|Physician Decision|0|||
130056448|NCT05142332|468162454|FG001|Overall Study|Physician Decision|0|||
130056449|NCT05142332|468162455|FG002|Overall Study|Physician Decision|2|||
130056450|NCT05142332|468162456|FG003|Overall Study|Physician Decision|1|||
130056451|NCT05142332|468162457|FG004|Overall Study|Physician Decision|0|||
130056452|NCT05142332|468162458|FG005|Overall Study|Physician Decision|0|||
130056453|NCT05142332|468162459|FG006|Overall Study|Physician Decision|3|||
130056454|NCT05142332|468162453|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
130056455|NCT05142332|468162454|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
130056456|NCT05142332|468162455|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
130056457|NCT05142332|468162456|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
130056458|NCT05142332|468162457|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
130056459|NCT05142332|468162458|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
130056460|NCT05142332|468162459|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
130056461|NCT02052778|468162462|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
130056462|NCT02052778|468162463|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
130056463|NCT02052778|468162464|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
130056464|NCT02052778|468162465|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
130056465|NCT02052778|468162466|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
130056466|NCT02052778|468162467|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
130056467|NCT02052778|468162468|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056468|NCT02052778|468162469|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
130056469|NCT02052778|468162470|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
130056470|NCT02052778|468162471|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
130056471|NCT02052778|468162472|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
129805370|NCT01297920|467255017|FG000|Overall Study|Noncompliance|1|||
129805371|NCT01297920|467255018|FG001|Overall Study|Noncompliance|0|||
129893298|NCT01323660|467569710|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
129893299|NCT01323660|467569711|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
129893300|NCT01323660|467569712|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
129893301|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129893302|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129893303|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129893304|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129893305|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129893306|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
129893307|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
129893308|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129893309|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
129893310|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
129893311|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129893312|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
129893313|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893314|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893315|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130056472|NCT02052778|468162473|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
130056473|NCT02052778|468162474|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
130056474|NCT02052778|468162475|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
130056475|NCT02052778|468162476|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056476|NCT02052778|468162477|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056477|NCT02052778|468162478|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056478|NCT02052778|468162479|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056479|NCT02052778|468162480|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056480|NCT02052778|468162481|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056481|NCT02052778|468162482|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056482|NCT02052778|468162483|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
130056483|NCT02052778|468162484|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129893316|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893317|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
130056484|NCT02052778|468162462|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130056485|NCT02052778|468162463|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130056486|NCT02052778|468162464|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130056487|NCT02052778|468162465|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130056488|NCT02052778|468162466|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130056489|NCT02052778|468162467|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130056490|NCT02052778|468162468|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
130056491|NCT02052778|468162469|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
129893318|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
129893319|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129893320|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129893321|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129805372|NCT01297920|467255019|FG002|Overall Study|Noncompliance|0|||
129805373|NCT01297920|467255017|FG000|Overall Study|Protocol Violation|1|||
129805374|NCT01297920|467255018|FG001|Overall Study|Protocol Violation|3|||
129805375|NCT01297920|467255019|FG002|Overall Study|Protocol Violation|0|||
129805376|NCT01297920|467255017|FG000|Overall Study|Inadequate Control of IOP|7|||
129805377|NCT01297920|467255018|FG001|Overall Study|Inadequate Control of IOP|9|||
129805378|NCT01297920|467255019|FG002|Overall Study|Inadequate Control of IOP|17|||
129805379|NCT01297920|467255017|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
129805380|NCT01297920|467255018|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
129805381|NCT01297920|467255019|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
129805382|NCT00474760|467255020|FG000|Overall Study|Death|0|||
129805383|NCT00474760|467255021|FG001|Overall Study|Death|0|||
129805384|NCT00474760|467255022|FG002|Overall Study|Death|0|||
129805385|NCT00474760|467255023|FG003|Overall Study|Death|0|||
129805386|NCT00474760|467255024|FG004|Overall Study|Death|2|||
129805387|NCT00474760|467255025|FG005|Overall Study|Death|0|||
129805388|NCT00474760|467255026|FG006|Overall Study|Death|0|||
129805389|NCT00474760|467255020|FG000|Overall Study|Adverse Event|0|||
129805390|NCT00474760|467255021|FG001|Overall Study|Adverse Event|0|||
129805391|NCT00474760|467255022|FG002|Overall Study|Adverse Event|0|||
129805392|NCT00474760|467255023|FG003|Overall Study|Adverse Event|0|||
129805393|NCT00474760|467255024|FG004|Overall Study|Adverse Event|1|||
129805394|NCT00474760|467255025|FG005|Overall Study|Adverse Event|7|||
129805395|NCT00474760|467255026|FG006|Overall Study|Adverse Event|0|||
129805396|NCT00474760|467255020|FG000|Overall Study|Laboratory abnormality|0|||
129805397|NCT00474760|467255021|FG001|Overall Study|Laboratory abnormality|0|||
129805398|NCT00474760|467255022|FG002|Overall Study|Laboratory abnormality|0|||
129805399|NCT00474760|467255023|FG003|Overall Study|Laboratory abnormality|0|||
129805400|NCT00474760|467255024|FG004|Overall Study|Laboratory abnormality|0|||
129805401|NCT00474760|467255025|FG005|Overall Study|Laboratory abnormality|1|||
130056492|NCT02052778|468162470|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
130056493|NCT02052778|468162471|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056494|NCT02052778|468162472|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056495|NCT02052778|468162473|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130056496|NCT02052778|468162474|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
130056497|NCT02052778|468162475|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
129805402|NCT00474760|467255026|FG006|Overall Study|Laboratory abnormality|0|||
129805403|NCT00474760|467255020|FG000|Overall Study|Withdrawal by Subject|0|||
129805404|NCT00474760|467255021|FG001|Overall Study|Withdrawal by Subject|0|||
129805405|NCT00474760|467255022|FG002|Overall Study|Withdrawal by Subject|0|||
129805406|NCT00474760|467255023|FG003|Overall Study|Withdrawal by Subject|1|||
129805407|NCT00474760|467255024|FG004|Overall Study|Withdrawal by Subject|0|||
129805408|NCT00474760|467255025|FG005|Overall Study|Withdrawal by Subject|1|||
129805409|NCT00474760|467255026|FG006|Overall Study|Withdrawal by Subject|1|||
129805410|NCT00474760|467255020|FG000|Overall Study|Other|0|||
129805411|NCT00474760|467255021|FG001|Overall Study|Other|1|||
129805412|NCT00474760|467255022|FG002|Overall Study|Other|0|||
129805413|NCT00474760|467255023|FG003|Overall Study|Other|0|||
129805414|NCT00474760|467255024|FG004|Overall Study|Other|1|||
130056498|NCT02052778|468162476|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056499|NCT02052778|468162477|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056500|NCT02052778|468162478|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056501|NCT02052778|468162479|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056502|NCT02052778|468162480|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056503|NCT02052778|468162481|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056504|NCT02052778|468162482|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056505|NCT02052778|468162483|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056506|NCT02052778|468162484|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
130056507|NCT02052778|468162462|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056508|NCT02052778|468162463|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056509|NCT02052778|468162464|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056510|NCT02052778|468162465|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056511|NCT02052778|468162466|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056512|NCT02052778|468162467|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056513|NCT02052778|468162468|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056514|NCT02052778|468162469|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056515|NCT02052778|468162470|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056516|NCT02052778|468162471|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056517|NCT02052778|468162472|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056518|NCT02052778|468162473|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056519|NCT02052778|468162474|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056520|NCT02052778|468162475|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
130056521|NCT02052778|468162476|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056522|NCT02052778|468162477|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056523|NCT02052778|468162478|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056524|NCT02052778|468162479|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056525|NCT02052778|468162480|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056526|NCT02052778|468162481|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056527|NCT02052778|468162482|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056528|NCT02052778|468162483|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056529|NCT02052778|468162484|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
130056530|NCT02052778|468162462|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
130056531|NCT02052778|468162463|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
130056532|NCT02052778|468162464|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
130056533|NCT02052778|468162465|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
130056534|NCT02052778|468162466|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
130056535|NCT02052778|468162467|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
130056536|NCT02052778|468162468|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
130056537|NCT02052778|468162469|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
130056538|NCT02052778|468162470|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
130056539|NCT02052778|468162471|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
130056540|NCT02052778|468162472|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
130056541|NCT02052778|468162473|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
130056542|NCT02052778|468162474|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
130056543|NCT02052778|468162475|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
130056544|NCT02052778|468162476|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
130056545|NCT02052778|468162477|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
130056546|NCT02052778|468162478|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
130056547|NCT02052778|468162479|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
130056548|NCT02052778|468162480|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
130056549|NCT02052778|468162481|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
130056550|NCT02052778|468162482|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
130056551|NCT02052778|468162483|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
130056552|NCT02052778|468162484|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
130056553|NCT02052778|468162462|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056554|NCT02052778|468162463|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056555|NCT02052778|468162464|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056556|NCT02052778|468162465|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056557|NCT02052778|468162466|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056558|NCT02052778|468162467|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129805415|NCT00474760|467255025|FG005|Overall Study|Other|0|||
129805416|NCT00474760|467255026|FG006|Overall Study|Other|0|||
129805417|NCT00474760|467255020|FG000|Overall Study|Progressive disease|3|||
129805418|NCT00474760|467255021|FG001|Overall Study|Progressive disease|2|||
129805419|NCT00474760|467255022|FG002|Overall Study|Progressive disease|3|||
129805420|NCT00474760|467255023|FG003|Overall Study|Progressive disease|2|||
129805421|NCT00474760|467255024|FG004|Overall Study|Progressive disease|8|||
129805422|NCT00474760|467255025|FG005|Overall Study|Progressive disease|20|||
129805423|NCT00474760|467255026|FG006|Overall Study|Progressive disease|7|||
129805424|NCT00474760|467255020|FG000|Overall Study|Terminated by sponsor|0|||
129805425|NCT00474760|467255021|FG001|Overall Study|Terminated by sponsor|0|||
129805426|NCT00474760|467255022|FG002|Overall Study|Terminated by sponsor|0|||
129805427|NCT00474760|467255023|FG003|Overall Study|Terminated by sponsor|0|||
129805428|NCT00474760|467255024|FG004|Overall Study|Terminated by sponsor|0|||
129805429|NCT00474760|467255025|FG005|Overall Study|Terminated by sponsor|0|||
129805430|NCT00474760|467255026|FG006|Overall Study|Terminated by sponsor|2|||
129805431|NCT00331422|467255027|FG000|Overall Study|Did not receive entire study regimen|5|||
129805432|NCT02345226|467255028|FG000|Double-Blind Phase|Adverse Event|5|||
129805433|NCT02345226|467255029|FG001|Double-Blind Phase|Adverse Event|6|||
129805434|NCT02345226|467255028|FG000|Double-Blind Phase|Death|3|||
129805435|NCT02345226|467255029|FG001|Double-Blind Phase|Death|0|||
129805436|NCT02345226|467255028|FG000|Double-Blind Phase|Pregnancy|0|||
129805437|NCT02345226|467255029|FG001|Double-Blind Phase|Pregnancy|1|||
129805438|NCT02345226|467255028|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129805439|NCT02345226|467255029|FG001|Double-Blind Phase|Lack of Efficacy|0|||
129805440|NCT02345226|467255028|FG000|Double-Blind Phase|Investigator's Discretion|4|||
129805441|NCT02345226|467255029|FG001|Double-Blind Phase|Investigator's Discretion|3|||
129805442|NCT02345226|467255028|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
129805443|NCT02345226|467255029|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
129805444|NCT02345226|467255028|FG000|Double-Blind Phase|Withdrew Consent|41|||
129805445|NCT02345226|467255029|FG001|Double-Blind Phase|Withdrew Consent|39|||
129805446|NCT02345226|467255028|FG000|Double-Blind Phase|Lost to Follow-up|12|||
129805447|NCT02345226|467255029|FG001|Double-Blind Phase|Lost to Follow-up|16|||
129805448|NCT02345226|467255028|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
129805449|NCT02345226|467255029|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
129805450|NCT02345226|467255028|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129805451|NCT02345226|467255029|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
129893322|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129805452|NCT01710046|467255032|FG000|Overall Study|Lost to Follow-up|1|||
129805453|NCT01710046|467255033|FG001|Overall Study|Lost to Follow-up|0|||
129805454|NCT02282358|467255036|FG000|Overall Study|Nonevaluable|1|||
129893323|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129893324|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129893325|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129893326|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129893327|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129893328|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129893329|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
129893330|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129893331|NCT00278564|467569717|FG000|Overall Study|Lack of Efficacy|4|||
129893332|NCT00051311|467569718|FG000|Overall Study|Starting new study|0|||
129893333|NCT00051311|467569719|FG001|Overall Study|Starting new study|1|||
129893334|NCT00051311|467569718|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
129893335|NCT00051311|467569719|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
129893336|NCT00051311|467569718|FG000|Overall Study|Death of recipient|8|||
129805455|NCT01786148|467255037|FG000|Overall Study|Lost to Follow-up|21|||
129805456|NCT01786148|467255038|FG001|Overall Study|Lost to Follow-up|13|||
129805457|NCT01786148|467255037|FG000|Overall Study|Death|0|||
130056559|NCT02052778|468162468|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056560|NCT02052778|468162469|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056561|NCT02052778|468162470|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
130056562|NCT02052778|468162471|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056563|NCT02052778|468162472|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056564|NCT02052778|468162473|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056565|NCT02052778|468162474|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056566|NCT02052778|468162475|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
130056567|NCT02052778|468162476|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056568|NCT02052778|468162477|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056569|NCT02052778|468162478|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056570|NCT02052778|468162479|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056571|NCT02052778|468162480|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056572|NCT02052778|468162481|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056573|NCT02052778|468162482|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056574|NCT02052778|468162483|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056575|NCT02052778|468162484|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
130056576|NCT02052778|468162462|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056577|NCT02052778|468162463|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056578|NCT02052778|468162464|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056579|NCT02052778|468162465|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056580|NCT02052778|468162466|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056581|NCT02052778|468162467|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
130056582|NCT02052778|468162468|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056583|NCT02052778|468162469|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056584|NCT02052778|468162470|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056585|NCT02052778|468162471|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056586|NCT02052778|468162472|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056587|NCT02052778|468162473|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056588|NCT02052778|468162474|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
130056589|NCT02052778|468162475|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056590|NCT02052778|468162476|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056591|NCT02052778|468162477|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056592|NCT02052778|468162478|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056593|NCT02052778|468162479|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056594|NCT02052778|468162480|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056595|NCT02052778|468162481|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056596|NCT02052778|468162482|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056597|NCT02052778|468162483|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130111703|NCT03412019|468369519|FG000|Overall Study|Withdrawal by Subject|1|||
130111704|NCT03412019|468369520|FG001|Overall Study|Withdrawal by Subject|1|||
130111705|NCT03063632|468369526|FG000|Overall Study|Death|4|||
130111706|NCT03063632|468369527|FG001|Overall Study|Death|6|||
129805458|NCT01786148|467255038|FG001|Overall Study|Death|1|||
129805459|NCT01786148|467255037|FG000|Overall Study|Withdrawal by Subject|0|||
130056598|NCT02052778|468162484|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
130056599|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056600|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056601|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056602|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056603|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056604|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056605|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056606|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056607|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056608|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056609|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056610|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056611|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056612|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130111707|NCT03063632|468369526|FG000|Overall Study|Lost to Follow-up|0|||
130111708|NCT03063632|468369527|FG001|Overall Study|Lost to Follow-up|1|||
129805460|NCT01786148|467255038|FG001|Overall Study|Withdrawal by Subject|7|||
129805461|NCT01786148|467255037|FG000|Overall Study|Incarceration|1|||
129805462|NCT01786148|467255038|FG001|Overall Study|Incarceration|1|||
129805463|NCT01811225|467255047|FG000|Treatment Period 1|Adverse Event|2|||
129805464|NCT01811225|467255048|FG001|Treatment Period 1|Adverse Event|3|||
129805465|NCT01811225|467255047|FG000|Treatment Period 1|Lost to Follow-up|12|||
129805466|NCT01811225|467255048|FG001|Treatment Period 1|Lost to Follow-up|8|||
129805467|NCT01811225|467255047|FG000|Treatment Period 1|transporation|1|||
129805468|NCT01811225|467255048|FG001|Treatment Period 1|transporation|0|||
129805469|NCT01811225|467255047|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
129805470|NCT01811225|467255048|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
129805471|NCT01811225|467255047|FG000|Treatment Period 2|Lost to Follow-up|1|||
129805472|NCT01811225|467255048|FG001|Treatment Period 2|Lost to Follow-up|2|||
129805473|NCT01811225|467255047|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
129805474|NCT01811225|467255048|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
129805475|NCT03896165|467255049|FG000|Overall Study|Withdrawal by Subject|2|||
129805476|NCT02158975|467255050|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
129805477|NCT03000569|467255051|FG000|Overall Study|Withdrawal by Subject|1|||
129805478|NCT03000569|467255052|FG001|Overall Study|Withdrawal by Subject|0|||
129805479|NCT04122534|467255053|FG000|Overall Study|Lost to Follow-up|4|||
129805480|NCT00397215|467255066|FG000|Month 0 (Day 0)|Adverse Event|0|||
129805481|NCT00397215|467255067|FG001|Month 0 (Day 0)|Adverse Event|1|||
129805482|NCT00397215|467255068|FG002|Month 0 (Day 0)|Adverse Event|0|||
129805483|NCT00397215|467255069|FG003|Month 0 (Day 0)|Adverse Event|0|||
129805484|NCT00397215|467255066|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
129805485|NCT00397215|467255067|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
129805486|NCT00397215|467255068|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
129805487|NCT00397215|467255069|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
129805488|NCT00397215|467255066|FG000|Month 0 (Day 0)|Other|4|||
129805489|NCT00397215|467255067|FG001|Month 0 (Day 0)|Other|1|||
129805490|NCT00397215|467255068|FG002|Month 0 (Day 0)|Other|3|||
129805491|NCT00397215|467255069|FG003|Month 0 (Day 0)|Other|3|||
129805492|NCT00397215|467255066|FG000|Month 6 (Day 180)|Adverse Event|0|||
129805493|NCT00397215|467255067|FG001|Month 6 (Day 180)|Adverse Event|3|||
130111709|NCT03063632|468369526|FG000|Overall Study|Withdrawal by Subject|0|||
130111710|NCT03063632|468369527|FG001|Overall Study|Withdrawal by Subject|2|||
130111711|NCT03063632|468369526|FG000|Overall Study|Physician Decision|2|||
130111712|NCT03063632|468369527|FG001|Overall Study|Physician Decision|0|||
130111713|NCT03063632|468369526|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
130111714|NCT03063632|468369527|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
130111715|NCT02570165|468369530|FG000|Overall Study|Adverse Event|1|||
130111716|NCT02570165|468369531|FG001|Overall Study|Adverse Event|0|||
130111717|NCT02570165|468369532|FG002|Overall Study|Adverse Event|2|||
130111718|NCT02570165|468369533|FG003|Overall Study|Adverse Event|0|||
130111719|NCT02570165|468369534|FG004|Overall Study|Adverse Event|0|||
130111720|NCT02570165|468369535|FG005|Overall Study|Adverse Event|0|||
130111721|NCT02570165|468369536|FG006|Overall Study|Adverse Event|0|||
130111722|NCT02570165|468369530|FG000|Overall Study|Lack of Efficacy|0|||
130111723|NCT02570165|468369531|FG001|Overall Study|Lack of Efficacy|1|||
130111724|NCT02570165|468369532|FG002|Overall Study|Lack of Efficacy|0|||
130111725|NCT02570165|468369533|FG003|Overall Study|Lack of Efficacy|0|||
130111726|NCT02570165|468369534|FG004|Overall Study|Lack of Efficacy|4|||
130111727|NCT02570165|468369535|FG005|Overall Study|Lack of Efficacy|0|||
129805494|NCT00397215|467255068|FG002|Month 6 (Day 180)|Adverse Event|2|||
129805495|NCT00397215|467255069|FG003|Month 6 (Day 180)|Adverse Event|0|||
129805496|NCT00397215|467255066|FG000|Month 6 (Day 180)|Other|2|||
129805497|NCT00397215|467255067|FG001|Month 6 (Day 180)|Other|0|||
129805498|NCT00397215|467255068|FG002|Month 6 (Day 180)|Other|3|||
129805499|NCT00397215|467255069|FG003|Month 6 (Day 180)|Other|0|||
129805500|NCT02128932|467255070|FG000|Overall Study|Withdrawal by Subject|11|||
129805501|NCT02128932|467255071|FG001|Overall Study|Withdrawal by Subject|7|||
129805502|NCT02128932|467255072|FG002|Overall Study|Withdrawal by Subject|8|||
129805503|NCT02128932|467255070|FG000|Overall Study|Death|2|||
129805504|NCT02128932|467255071|FG001|Overall Study|Death|0|||
129805505|NCT02128932|467255072|FG002|Overall Study|Death|2|||
129805506|NCT02128932|467255070|FG000|Overall Study|Lost to Follow-up|2|||
130111728|NCT02570165|468369536|FG006|Overall Study|Lack of Efficacy|0|||
129805507|NCT02128932|467255071|FG001|Overall Study|Lost to Follow-up|1|||
130111729|NCT02570165|468369530|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
130111730|NCT02570165|468369531|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
129805508|NCT02128932|467255072|FG002|Overall Study|Lost to Follow-up|1|||
129805509|NCT02128932|467255070|FG000|Overall Study|No reason for withdrawal|12|||
129805510|NCT02128932|467255071|FG001|Overall Study|No reason for withdrawal|11|||
129805511|NCT02128932|467255072|FG002|Overall Study|No reason for withdrawal|7|||
129805512|NCT01361568|467255073|FG000|Overall Study|Adverse Event|0|||
129805513|NCT01361568|467255074|FG001|Overall Study|Adverse Event|0|||
129805514|NCT01361568|467255075|FG002|Overall Study|Adverse Event|0|||
129805515|NCT01361568|467255076|FG003|Overall Study|Adverse Event|0|||
129805516|NCT01361568|467255077|FG004|Overall Study|Adverse Event|1|||
129805517|NCT01361568|467255078|FG005|Overall Study|Adverse Event|0|||
129805518|NCT01361568|467255073|FG000|Overall Study|Physician Decision|0|||
129805519|NCT01361568|467255074|FG001|Overall Study|Physician Decision|0|||
129893337|NCT00051311|467569719|FG001|Overall Study|Death of recipient|8|||
129805520|NCT01361568|467255075|FG002|Overall Study|Physician Decision|0|||
129805521|NCT01361568|467255076|FG003|Overall Study|Physician Decision|0|||
129805522|NCT01361568|467255077|FG004|Overall Study|Physician Decision|0|||
129805523|NCT01361568|467255078|FG005|Overall Study|Physician Decision|1|||
129805524|NCT01361568|467255073|FG000|Overall Study|Withdrawal by Subject|2|||
129805525|NCT01361568|467255074|FG001|Overall Study|Withdrawal by Subject|1|||
129805526|NCT01361568|467255075|FG002|Overall Study|Withdrawal by Subject|0|||
129805527|NCT01361568|467255076|FG003|Overall Study|Withdrawal by Subject|0|||
129805528|NCT01361568|467255077|FG004|Overall Study|Withdrawal by Subject|0|||
129805529|NCT01361568|467255078|FG005|Overall Study|Withdrawal by Subject|1|||
129805530|NCT00657358|467255083|FG000|Overall Study|Lack of Efficacy|6|||
129805531|NCT02959983|467255084|FG000|Overall Study|Protocol Violation|0|||
129805532|NCT02959983|467255085|FG001|Overall Study|Protocol Violation|1|||
129805533|NCT02959983|467255084|FG000|Overall Study|Lack of Efficacy|0|||
129805534|NCT02959983|467255085|FG001|Overall Study|Lack of Efficacy|1|||
129805535|NCT02959983|467255084|FG000|Overall Study|Lost to Follow-up|12|||
129805536|NCT02959983|467255085|FG001|Overall Study|Lost to Follow-up|9|||
129805537|NCT02959983|467255084|FG000|Overall Study|Other|1|||
129805538|NCT02959983|467255085|FG001|Overall Study|Other|1|||
129805539|NCT02959983|467255084|FG000|Overall Study|Physician Decision|1|||
129805540|NCT02959983|467255085|FG001|Overall Study|Physician Decision|0|||
129805541|NCT02959983|467255084|FG000|Overall Study|Adverse Event|5|||
129805542|NCT02959983|467255085|FG001|Overall Study|Adverse Event|1|||
129805543|NCT02959983|467255084|FG000|Overall Study|Withdrawal by Subject|7|||
129805544|NCT02959983|467255085|FG001|Overall Study|Withdrawal by Subject|12|||
129805545|NCT01254630|467255086|FG000|Overall Study|Adverse Event|36|||
129805546|NCT01254630|467255087|FG001|Overall Study|Adverse Event|15|||
129805547|NCT01254630|467255088|FG002|Overall Study|Adverse Event|40|||
129805548|NCT01254630|467255089|FG003|Overall Study|Adverse Event|8|||
129805549|NCT01254630|467255086|FG000|Overall Study|Death|461|||
129805550|NCT01254630|467255087|FG001|Overall Study|Death|151|||
129805551|NCT01254630|467255088|FG002|Overall Study|Death|478|||
129805552|NCT01254630|467255089|FG003|Overall Study|Death|139|||
129805553|NCT01254630|467255086|FG000|Overall Study|Lost to Follow-up|80|||
129805554|NCT01254630|467255087|FG001|Overall Study|Lost to Follow-up|26|||
129805555|NCT01254630|467255088|FG002|Overall Study|Lost to Follow-up|89|||
129805556|NCT01254630|467255089|FG003|Overall Study|Lost to Follow-up|32|||
129805557|NCT01254630|467255086|FG000|Overall Study|Physician Decision|24|||
129805558|NCT01254630|467255087|FG001|Overall Study|Physician Decision|8|||
129805559|NCT01254630|467255088|FG002|Overall Study|Physician Decision|16|||
129805560|NCT01254630|467255089|FG003|Overall Study|Physician Decision|7|||
129805561|NCT01254630|467255086|FG000|Overall Study|Withdrawal by Subject|201|||
129805562|NCT01254630|467255087|FG001|Overall Study|Withdrawal by Subject|94|||
129805563|NCT01254630|467255088|FG002|Overall Study|Withdrawal by Subject|188|||
129805564|NCT01254630|467255089|FG003|Overall Study|Withdrawal by Subject|89|||
129805565|NCT01254630|467255086|FG000|Overall Study|Study terminated by sponsor|0|||
129805566|NCT01254630|467255087|FG001|Overall Study|Study terminated by sponsor|994|||
129805567|NCT01254630|467255088|FG002|Overall Study|Study terminated by sponsor|0|||
129805568|NCT01254630|467255089|FG003|Overall Study|Study terminated by sponsor|1010|||
129805569|NCT01254630|467255086|FG000|Overall Study|Status not recorded|0|||
129805570|NCT01254630|467255087|FG001|Overall Study|Status not recorded|0|||
129805571|NCT01254630|467255088|FG002|Overall Study|Status not recorded|1|||
129805572|NCT01254630|467255089|FG003|Overall Study|Status not recorded|0|||
129805573|NCT02180724|467256724|FG000|Overall Study|Death|26|||
129805574|NCT02180724|467256725|FG001|Overall Study|Death|1|||
129805575|NCT02180724|467256724|FG000|Overall Study|Lost to Follow-up|3|||
129893338|NCT00051311|467569718|FG000|Overall Study|Recipient taken off study|4|||
129805576|NCT02180724|467256725|FG001|Overall Study|Lost to Follow-up|1|||
129805577|NCT02180724|467256724|FG000|Overall Study|Withdrawal by Subject|4|||
129805578|NCT02180724|467256725|FG001|Overall Study|Withdrawal by Subject|2|||
129805579|NCT02180724|467256724|FG000|Overall Study|PI Decision|5|||
129805580|NCT02180724|467256725|FG001|Overall Study|PI Decision|2|||
129805581|NCT02180724|467256724|FG000|Overall Study|Study terminated by sponsor|54|||
129805582|NCT02180724|467256725|FG001|Overall Study|Study terminated by sponsor|8|||
129805583|NCT01824342|467256731|FG000|Overall Study|Withdrawal by Subject|0|||
129805584|NCT01824342|467256732|FG001|Overall Study|Withdrawal by Subject|3|||
129805585|NCT01824342|467256731|FG000|Overall Study|Adverse Event|1|||
129893339|NCT00051311|467569719|FG001|Overall Study|Recipient taken off study|4|||
129893340|NCT03566680|467569730|FG000|Overall Study|Pregnancy|1|||
129893341|NCT03566680|467569730|FG000|Overall Study|Lost to Follow-up|13|||
129893342|NCT03566680|467569730|FG000|Overall Study|Withdrawal by Subject|3|||
129893343|NCT01687270|467569731|FG000|Overall Study|Lack of Efficacy|11|||
129893344|NCT01687270|467569731|FG000|Overall Study|Lost to Follow-up|1|||
129893345|NCT00958009|467569733|FG000|Overall Study|Adverse Event|1|||
129893346|NCT00958009|467569733|FG000|Overall Study|Subject found device difficult to use|1|||
129893347|NCT00558753|467569734|FG000|Overall Study|Lost to Follow-up|5|||
129893348|NCT00558753|467569735|FG001|Overall Study|Lost to Follow-up|7|||
129893349|NCT00578227|467569738|FG000|Overall Study|Lost to Follow-up|0|||
129893350|NCT00578227|467569739|FG001|Overall Study|Lost to Follow-up|1|||
129893351|NCT00578227|467569740|FG002|Overall Study|Lost to Follow-up|1|||
130056613|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
129805586|NCT01824342|467256732|FG001|Overall Study|Adverse Event|1|||
129805587|NCT01824342|467256731|FG000|Overall Study|Disease Progression|1|||
129805588|NCT01824342|467256732|FG001|Overall Study|Disease Progression|1|||
129805589|NCT01824342|467256731|FG000|Overall Study|Physician Decision|5|||
129805590|NCT01824342|467256732|FG001|Overall Study|Physician Decision|0|||
129805591|NCT01824342|467256731|FG000|Overall Study|Death|2|||
129805592|NCT01824342|467256732|FG001|Overall Study|Death|0|||
129805593|NCT01313858|467256737|FG000|Overall Study|Premature Treatment Termination|251|||
129805594|NCT01313858|467256738|FG001|Overall Study|Premature Treatment Termination|219|||
129805595|NCT01313858|467256739|FG002|Overall Study|Premature Treatment Termination|191|||
129805596|NCT01313858|467256737|FG000|Overall Study|Lost to Follow-up|35|||
129805597|NCT01313858|467256738|FG001|Overall Study|Lost to Follow-up|51|||
129805598|NCT01313858|467256739|FG002|Overall Study|Lost to Follow-up|47|||
129805599|NCT02899299|467256740|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
129805600|NCT02899299|467256741|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
130111731|NCT02570165|468369532|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
129805601|NCT02899299|467256740|FG000|Pre-treatment|Participant withdrew consent|1|||
129805602|NCT02899299|467256741|FG001|Pre-treatment|Participant withdrew consent|11|||
129805603|NCT02899299|467256740|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
130111732|NCT02570165|468369533|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
130111733|NCT02570165|468369534|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
130111734|NCT02570165|468369535|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
130111735|NCT02570165|468369536|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
130111736|NCT02570165|468369530|FG000|Overall Study|Lost to Follow-up|0|||
130111737|NCT02570165|468369531|FG001|Overall Study|Lost to Follow-up|0|||
130111738|NCT02570165|468369532|FG002|Overall Study|Lost to Follow-up|1|||
130111739|NCT02570165|468369533|FG003|Overall Study|Lost to Follow-up|1|||
130111740|NCT02570165|468369534|FG004|Overall Study|Lost to Follow-up|0|||
130111741|NCT02570165|468369535|FG005|Overall Study|Lost to Follow-up|0|||
130111742|NCT02570165|468369536|FG006|Overall Study|Lost to Follow-up|0|||
130111743|NCT02570165|468369530|FG000|Overall Study|Physician Decision|0|||
130111744|NCT02570165|468369531|FG001|Overall Study|Physician Decision|1|||
130111745|NCT02570165|468369532|FG002|Overall Study|Physician Decision|0|||
130111746|NCT02570165|468369533|FG003|Overall Study|Physician Decision|0|||
130111747|NCT02570165|468369534|FG004|Overall Study|Physician Decision|0|||
130111748|NCT02570165|468369535|FG005|Overall Study|Physician Decision|0|||
130111749|NCT02570165|468369536|FG006|Overall Study|Physician Decision|0|||
130111750|NCT02570165|468369530|FG000|Overall Study|Withdrawal by Subject|0|||
130111751|NCT02570165|468369531|FG001|Overall Study|Withdrawal by Subject|0|||
130111752|NCT02570165|468369532|FG002|Overall Study|Withdrawal by Subject|0|||
130111753|NCT02570165|468369533|FG003|Overall Study|Withdrawal by Subject|2|||
130111754|NCT02570165|468369534|FG004|Overall Study|Withdrawal by Subject|1|||
130111755|NCT02570165|468369535|FG005|Overall Study|Withdrawal by Subject|0|||
130111756|NCT02570165|468369536|FG006|Overall Study|Withdrawal by Subject|0|||
130111757|NCT02570165|468369530|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
130111758|NCT02570165|468369531|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
130111759|NCT02570165|468369532|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
130111760|NCT02570165|468369533|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
130111761|NCT02570165|468369534|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
130111762|NCT02570165|468369535|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
130111763|NCT02570165|468369536|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
130111764|NCT02570165|468369530|FG000|Overall Study|Withdrawal Request by GSK|0|||
130111765|NCT02570165|468369531|FG001|Overall Study|Withdrawal Request by GSK|0|||
130111766|NCT02570165|468369532|FG002|Overall Study|Withdrawal Request by GSK|2|||
130111767|NCT02570165|468369533|FG003|Overall Study|Withdrawal Request by GSK|0|||
130111768|NCT02570165|468369534|FG004|Overall Study|Withdrawal Request by GSK|0|||
130111769|NCT02570165|468369535|FG005|Overall Study|Withdrawal Request by GSK|0|||
130111770|NCT02570165|468369536|FG006|Overall Study|Withdrawal Request by GSK|0|||
130111771|NCT01789281|468369537|FG000|Overall Study|Disease progression|15|||
130111772|NCT01789281|468369538|FG001|Overall Study|Disease progression|4|||
130111773|NCT01789281|468369537|FG000|Overall Study|Adverse Event|5|||
130111774|NCT01789281|468369538|FG001|Overall Study|Adverse Event|5|||
130111775|NCT01789281|468369537|FG000|Overall Study|Withdrawal by Subject|1|||
130111776|NCT01789281|468369538|FG001|Overall Study|Withdrawal by Subject|0|||
129893352|NCT00578227|467569738|FG000|Overall Study|Withdrawal by Subject|5|||
129893353|NCT00578227|467569739|FG001|Overall Study|Withdrawal by Subject|1|||
130111777|NCT01789281|468369537|FG000|Overall Study|Lost to Follow-up|1|||
130111778|NCT01789281|468369538|FG001|Overall Study|Lost to Follow-up|0|||
130111779|NCT01789281|468369537|FG000|Overall Study|Administrative problems|0|||
130111780|NCT01789281|468369538|FG001|Overall Study|Administrative problems|1|||
130111781|NCT02746705|468369543|FG000|Overall Study|Physician Decision|1|||
130111782|NCT02746705|468369544|FG001|Overall Study|Physician Decision|1|||
130111783|NCT02746705|468369543|FG000|Overall Study|Lost to Follow-up|1|||
130111784|NCT02746705|468369544|FG001|Overall Study|Lost to Follow-up|0|||
130111785|NCT02746705|468369543|FG000|Overall Study|outlier scores deemed not valid|0|||
130111786|NCT02746705|468369544|FG001|Overall Study|outlier scores deemed not valid|1|||
130056614|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
130056615|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
130056616|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
130056617|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
130056618|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
130056619|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
130056620|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
130056621|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
130056622|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056623|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056624|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056625|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056626|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056627|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056628|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056629|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056630|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056631|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056632|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056633|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056634|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056635|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056636|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
130056637|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
130056638|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056639|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
130056640|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
130056641|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
130056642|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
130056643|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
130056644|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
130056645|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056646|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056647|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056648|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056649|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056650|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056651|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056652|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056653|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056654|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056655|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129805604|NCT02899299|467256741|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
129805605|NCT02899299|467256740|FG000|Pre-treatment|Not reported|0|||
129805606|NCT02899299|467256741|FG001|Pre-treatment|Not reported|1|||
129805607|NCT02899299|467256740|FG000|Treatment|Disease Progression|182|||
129805608|NCT02899299|467256741|FG001|Treatment|Disease Progression|43|||
129805609|NCT02899299|467256740|FG000|Treatment|Study Drug Toxicity|60|||
129805610|NCT02899299|467256741|FG001|Treatment|Study Drug Toxicity|24|||
130056656|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056657|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056658|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056659|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
130056660|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
130056661|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
130056662|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056663|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
130056664|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
130056665|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056666|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056667|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
130056668|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129805611|NCT02899299|467256740|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
129805612|NCT02899299|467256741|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
129805613|NCT02899299|467256740|FG000|Treatment|Participant request to discontinue Study treatment|4|||
129805614|NCT02899299|467256741|FG001|Treatment|Participant request to discontinue Study treatment|10|||
129805615|NCT02899299|467256740|FG000|Treatment|Participant withdrew consent|6|||
129805616|NCT02899299|467256741|FG001|Treatment|Participant withdrew consent|3|||
129805617|NCT02899299|467256740|FG000|Treatment|Lost to Follow-up|0|||
129805618|NCT02899299|467256741|FG001|Treatment|Lost to Follow-up|2|||
129805619|NCT02899299|467256740|FG000|Treatment|Maximum Clinical Benefit|11|||
129805620|NCT02899299|467256741|FG001|Treatment|Maximum Clinical Benefit|2|||
129805621|NCT02899299|467256740|FG000|Treatment|Poor/Non-compliance|1|||
129805622|NCT02899299|467256741|FG001|Treatment|Poor/Non-compliance|0|||
129805623|NCT02899299|467256740|FG000|Treatment|Participant no longer meets Study criteria|4|||
129805624|NCT02899299|467256741|FG001|Treatment|Participant no longer meets Study criteria|0|||
129805625|NCT02899299|467256740|FG000|Treatment|Administrative reason by Sponsor|2|||
129805626|NCT02899299|467256741|FG001|Treatment|Administrative reason by Sponsor|0|||
129805627|NCT02899299|467256740|FG000|Treatment|Other reasons|12|||
129805628|NCT02899299|467256741|FG001|Treatment|Other reasons|2|||
129805629|NCT02899299|467256740|FG000|Treatment|Not reported|7|||
129805630|NCT02899299|467256741|FG001|Treatment|Not reported|0|||
129805631|NCT02468232|467256752|FG000|Core Part of Study|Adverse Event|0|||
129805632|NCT02468232|467256753|FG001|Core Part of Study|Adverse Event|1|||
129805633|NCT02468232|467256754|FG002|Core Part of Study|Adverse Event|0|||
129805634|NCT02468232|467256755|FG003|Core Part of Study|Adverse Event|0|||
129805635|NCT02468232|467256752|FG000|Core Part of Study|Death|20|||
129805636|NCT02468232|467256753|FG001|Core Part of Study|Death|17|||
129805637|NCT02468232|467256754|FG002|Core Part of Study|Death|0|||
129805638|NCT02468232|467256755|FG003|Core Part of Study|Death|0|||
129805639|NCT02468232|467256752|FG000|Core Part of Study|Technical Problems|1|||
129805640|NCT02468232|467256753|FG001|Core Part of Study|Technical Problems|1|||
129805641|NCT02468232|467256754|FG002|Core Part of Study|Technical Problems|0|||
129805642|NCT02468232|467256755|FG003|Core Part of Study|Technical Problems|0|||
129805643|NCT02468232|467256752|FG000|OLE Part of Study|Adverse Event|0|||
129805644|NCT02468232|467256753|FG001|OLE Part of Study|Adverse Event|0|||
129805645|NCT02468232|467256754|FG002|OLE Part of Study|Adverse Event|4|||
129805646|NCT02468232|467256755|FG003|OLE Part of Study|Adverse Event|5|||
129805647|NCT02468232|467256752|FG000|OLE Part of Study|Death|0|||
129805648|NCT02468232|467256753|FG001|OLE Part of Study|Death|0|||
129805649|NCT02468232|467256754|FG002|OLE Part of Study|Death|4|||
129805650|NCT02468232|467256755|FG003|OLE Part of Study|Death|2|||
129805651|NCT02468232|467256752|FG000|OLE Part of Study|Physician Decision|0|||
129805652|NCT02468232|467256753|FG001|OLE Part of Study|Physician Decision|0|||
129805653|NCT02468232|467256754|FG002|OLE Part of Study|Physician Decision|4|||
129805654|NCT02468232|467256755|FG003|OLE Part of Study|Physician Decision|0|||
129805655|NCT02468232|467256752|FG000|OLE Part of Study|Subject/Guardian decision|0|||
130056669|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056670|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056671|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056672|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056673|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129805656|NCT02468232|467256753|FG001|OLE Part of Study|Subject/Guardian decision|0|||
129805657|NCT02468232|467256754|FG002|OLE Part of Study|Subject/Guardian decision|2|||
129805658|NCT02468232|467256755|FG003|OLE Part of Study|Subject/Guardian decision|5|||
129805659|NCT00506662|467256756|FG000|Overall Study|Adverse Event|0|||
129805660|NCT00506662|467256757|FG001|Overall Study|Adverse Event|2|||
129805661|NCT00506662|467256756|FG000|Overall Study|Lack of Efficacy|1|||
129805662|NCT00506662|467256757|FG001|Overall Study|Lack of Efficacy|0|||
129805663|NCT00506662|467256756|FG000|Overall Study|Protocol Violation|2|||
129805664|NCT00506662|467256757|FG001|Overall Study|Protocol Violation|4|||
129805665|NCT00506662|467256756|FG000|Overall Study|Trial terminated|10|||
129805666|NCT00506662|467256757|FG001|Overall Study|Trial terminated|16|||
130056674|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056675|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056676|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056677|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056678|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056679|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056680|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056681|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056682|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
130056683|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
130056684|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056685|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056686|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056687|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056688|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056689|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056690|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
130056691|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056692|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056693|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056694|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056695|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056696|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056697|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056698|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056699|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129893354|NCT00578227|467569740|FG002|Overall Study|Withdrawal by Subject|3|||
129893355|NCT00577629|467569741|FG000|Treatment Period|Death|1|||
129893356|NCT00577629|467569741|FG000|Long Term Follow-Up|Death|15|||
129893357|NCT00577629|467569741|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
129893358|NCT00577629|467569741|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
129893359|NCT00577629|467569741|FG000|Long Term Follow-Up|Physician Decision|1|||
129893360|NCT01605136|467569742|FG000|Study Period|Withdrawal by Subject|2|||
129893361|NCT01605136|467569743|FG001|Study Period|Withdrawal by Subject|0|||
129893362|NCT01605136|467569742|FG000|Study Period|Physician Decision|1|||
129893363|NCT01605136|467569743|FG001|Study Period|Physician Decision|1|||
129893364|NCT01605136|467569742|FG000|Study Period|Lost to Follow-up|0|||
129893365|NCT01605136|467569743|FG001|Study Period|Lost to Follow-up|2|||
130056700|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056701|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056702|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056703|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129893366|NCT01605136|467569742|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
129805667|NCT00506662|467256756|FG000|Overall Study|Not recorded|4|||
129805668|NCT00506662|467256757|FG001|Overall Study|Not recorded|6|||
129805669|NCT00246753|467256758|FG000|Overall Study|Withdrawal by Subject|2|||
129805670|NCT00246753|467256758|FG000|Overall Study|Physician Decision|2|||
129805671|NCT00246753|467256758|FG000|Overall Study|Adverse Event|2|||
129805672|NCT00246753|467256758|FG000|Overall Study|Unacceptable toxicity|2|||
129805673|NCT00617851|467256762|FG000|Overall Study|Death|0|||
129805674|NCT00617851|467256763|FG001|Overall Study|Death|0|||
129805675|NCT00617851|467256764|FG002|Overall Study|Death|0|||
129805676|NCT00617851|467256765|FG003|Overall Study|Death|1|||
129805677|NCT00617851|467256762|FG000|Overall Study|Withdrawal by Subject|14|||
129805678|NCT00617851|467256763|FG001|Overall Study|Withdrawal by Subject|7|||
130056704|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056705|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
129805679|NCT00617851|467256764|FG002|Overall Study|Withdrawal by Subject|12|||
129805680|NCT00617851|467256765|FG003|Overall Study|Withdrawal by Subject|4|||
129805681|NCT00617851|467256762|FG000|Overall Study|Lost to Follow-up|27|||
129805682|NCT00617851|467256763|FG001|Overall Study|Lost to Follow-up|29|||
129805683|NCT00617851|467256764|FG002|Overall Study|Lost to Follow-up|31|||
130056706|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
130056707|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129805684|NCT00617851|467256765|FG003|Overall Study|Lost to Follow-up|19|||
129805685|NCT00617851|467256762|FG000|Overall Study|Inappropriate Enrollment|5|||
129805686|NCT00617851|467256763|FG001|Overall Study|Inappropriate Enrollment|4|||
129805687|NCT00617851|467256764|FG002|Overall Study|Inappropriate Enrollment|1|||
129805688|NCT00617851|467256765|FG003|Overall Study|Inappropriate Enrollment|1|||
129805689|NCT00617851|467256762|FG000|Overall Study|Unable to classify|1|||
129805690|NCT00617851|467256763|FG001|Overall Study|Unable to classify|0|||
129805691|NCT00617851|467256764|FG002|Overall Study|Unable to classify|1|||
129805692|NCT00617851|467256765|FG003|Overall Study|Unable to classify|0|||
129805693|NCT01200524|467256766|FG000|Overall Study|Withdrawal by Subject|1|||
129805694|NCT01200524|467256767|FG001|Overall Study|Withdrawal by Subject|1|||
129805695|NCT01200524|467256768|FG002|Overall Study|Withdrawal by Subject|3|||
130056708|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056709|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056710|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
130056711|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056712|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056713|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
130056714|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
130056715|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
130056716|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
130056717|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
130056718|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
130056719|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
130056720|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
130056721|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
130056722|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
129805696|NCT01200524|467256766|FG000|Overall Study|Adverse Event|1|||
130056723|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
129805697|NCT01200524|467256767|FG001|Overall Study|Adverse Event|0|||
129893367|NCT01605136|467569743|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
129893368|NCT01072929|467569744|FG000|Overall Study|Adverse Event|8|||
129893369|NCT01072929|467569745|FG001|Overall Study|Adverse Event|11|||
129893370|NCT01072929|467569746|FG002|Overall Study|Adverse Event|2|||
129893371|NCT01072929|467569744|FG000|Overall Study|Lack of Efficacy|7|||
129893372|NCT01072929|467569745|FG001|Overall Study|Lack of Efficacy|4|||
129893373|NCT01072929|467569746|FG002|Overall Study|Lack of Efficacy|0|||
129893374|NCT01072929|467569744|FG000|Overall Study|Withdrawal by Subject|7|||
129893375|NCT01072929|467569745|FG001|Overall Study|Withdrawal by Subject|15|||
129893376|NCT01072929|467569746|FG002|Overall Study|Withdrawal by Subject|3|||
129893377|NCT01072929|467569744|FG000|Overall Study|Protocol Violation|13|||
129893378|NCT01072929|467569745|FG001|Overall Study|Protocol Violation|11|||
129893379|NCT01072929|467569746|FG002|Overall Study|Protocol Violation|2|||
129893380|NCT01072929|467569744|FG000|Overall Study|Lost to Follow-up|8|||
129893381|NCT01072929|467569745|FG001|Overall Study|Lost to Follow-up|4|||
129893382|NCT01072929|467569746|FG002|Overall Study|Lost to Follow-up|1|||
129893383|NCT01072929|467569744|FG000|Overall Study|Noncompliance with study medication|0|||
129893384|NCT01072929|467569745|FG001|Overall Study|Noncompliance with study medication|3|||
129893385|NCT01072929|467569746|FG002|Overall Study|Noncompliance with study medication|0|||
129893386|NCT01072929|467569744|FG000|Overall Study|Noncompliance with study procedures|1|||
129893387|NCT01072929|467569745|FG001|Overall Study|Noncompliance with study procedures|0|||
129893388|NCT01072929|467569746|FG002|Overall Study|Noncompliance with study procedures|1|||
129893389|NCT01072929|467569744|FG000|Overall Study|Other|0|||
129893390|NCT01072929|467569745|FG001|Overall Study|Other|3|||
129893391|NCT01072929|467569746|FG002|Overall Study|Other|0|||
129893392|NCT04824131|467569747|FG000|CAB LA Oral Phase|Adverse Event|1|||
129893393|NCT04824131|467569747|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
129893394|NCT04824131|467569747|FG000|Step 3|Withdrawal by Subject|2|||
129893395|NCT05489224|467569748|FG000|Treatment Period I|Withdrawal by Subject|6|||
129893396|NCT05489224|467569749|FG001|Treatment Period I|Withdrawal by Subject|5|||
129893397|NCT05489224|467569750|FG002|Treatment Period I|Withdrawal by Subject|0|||
129893398|NCT05489224|467569748|FG000|Treatment Period I|Adverse Event|3|||
129893399|NCT05489224|467569749|FG001|Treatment Period I|Adverse Event|11|||
129893400|NCT05489224|467569750|FG002|Treatment Period I|Adverse Event|0|||
129893401|NCT05489224|467569748|FG000|Treatment Period I|Lost to Follow-up|0|||
129893402|NCT05489224|467569749|FG001|Treatment Period I|Lost to Follow-up|1|||
129893403|NCT05489224|467569750|FG002|Treatment Period I|Lost to Follow-up|0|||
129893404|NCT05489224|467569748|FG000|Treatment Period I|Physician Decision|0|||
129893405|NCT05489224|467569749|FG001|Treatment Period I|Physician Decision|1|||
129893406|NCT05489224|467569750|FG002|Treatment Period I|Physician Decision|0|||
129893407|NCT05489224|467569748|FG000|Treatment Period II up to Week 32|Ongoing|222|||
129893408|NCT05489224|467569749|FG001|Treatment Period II up to Week 32|Ongoing|107|||
130056724|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
130056725|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
130056726|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
130056727|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
130056728|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
130056729|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
130056730|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
130056731|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
130056732|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
130056733|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
130056734|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
130056735|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
130056736|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
130056737|NCT02052778|468162462|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056738|NCT02052778|468162463|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056739|NCT02052778|468162464|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056740|NCT02052778|468162465|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056741|NCT02052778|468162466|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129893409|NCT05489224|467569750|FG002|Treatment Period II up to Week 32|Ongoing|107|||
129893410|NCT05489224|467569748|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
129893411|NCT05489224|467569749|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
130056742|NCT02052778|468162467|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056743|NCT02052778|468162468|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056744|NCT02052778|468162469|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129893412|NCT05489224|467569750|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
129893413|NCT05489224|467569748|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
129893414|NCT05489224|467569749|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
129893415|NCT05489224|467569750|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
129893416|NCT04887285|467569752|FG000|Overall Study|Lost to Follow-up|0|||
129893417|NCT04887285|467569753|FG001|Overall Study|Lost to Follow-up|2|||
129893418|NCT04887285|467569754|FG002|Overall Study|Lost to Follow-up|3|||
129893419|NCT04640571|467569755|FG000|Overall Study|Withdrawal by Subject|0|||
129893420|NCT04640571|467569756|FG001|Overall Study|Withdrawal by Subject|0|||
129893421|NCT04640571|467569757|FG002|Overall Study|Withdrawal by Subject|0|||
129893422|NCT04640571|467569758|FG003|Overall Study|Withdrawal by Subject|0|||
129893423|NCT04640571|467569759|FG004|Overall Study|Withdrawal by Subject|0|||
129893424|NCT04640571|467569760|FG005|Overall Study|Withdrawal by Subject|2|||
129893425|NCT01723774|467569766|FG000|Neoadjuvant|Ki67 > 10%|4|||
129893426|NCT01723774|467569767|FG001|Neoadjuvant|Ki67 > 10%|0|||
129893427|NCT01723774|467569768|FG002|Neoadjuvant|Ki67 > 10%|10|||
129893428|NCT01723774|467569769|FG003|Neoadjuvant|Ki67 > 10%|0|||
129893429|NCT01723774|467569766|FG000|Neoadjuvant|Withdrawal by Subject|3|||
129893430|NCT01723774|467569767|FG001|Neoadjuvant|Withdrawal by Subject|1|||
129893431|NCT01723774|467569768|FG002|Neoadjuvant|Withdrawal by Subject|0|||
129893432|NCT01723774|467569769|FG003|Neoadjuvant|Withdrawal by Subject|0|||
129893433|NCT01723774|467569766|FG000|Neoadjuvant|Disease progression|0|||
129893434|NCT01723774|467569767|FG001|Neoadjuvant|Disease progression|1|||
129893435|NCT01723774|467569768|FG002|Neoadjuvant|Disease progression|1|||
129893436|NCT01723774|467569769|FG003|Neoadjuvant|Disease progression|0|||
129893437|NCT01723774|467569766|FG000|Neoadjuvant|Adverse Event|0|||
129893438|NCT01723774|467569767|FG001|Neoadjuvant|Adverse Event|1|||
129893439|NCT01723774|467569768|FG002|Neoadjuvant|Adverse Event|2|||
130056745|NCT02052778|468162470|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056746|NCT02052778|468162471|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056747|NCT02052778|468162472|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056748|NCT02052778|468162473|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056749|NCT02052778|468162474|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056750|NCT02052778|468162475|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056751|NCT02052778|468162476|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130056752|NCT02052778|468162477|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130056753|NCT02052778|468162478|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130056754|NCT02052778|468162479|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056755|NCT02052778|468162480|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
130056756|NCT02052778|468162481|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056757|NCT02052778|468162482|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056758|NCT02052778|468162483|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056759|NCT02052778|468162484|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
130056760|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056761|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056762|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056763|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056764|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056765|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056766|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056767|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056768|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056769|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056770|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056771|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056772|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056773|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056774|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056775|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056776|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056777|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056778|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056779|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056780|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056781|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
130056782|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
130056783|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056784|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129893440|NCT01723774|467569769|FG003|Neoadjuvant|Adverse Event|0|||
129893441|NCT01723774|467569766|FG000|Neoadjuvant|High estradiol|0|||
130056785|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056786|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129893442|NCT01723774|467569767|FG001|Neoadjuvant|High estradiol|1|||
129805698|NCT01200524|467256768|FG002|Overall Study|Adverse Event|0|||
129805699|NCT01200524|467256766|FG000|Overall Study|Non availability of study nurse|0|||
129805700|NCT01200524|467256767|FG001|Overall Study|Non availability of study nurse|0|||
129805701|NCT01200524|467256768|FG002|Overall Study|Non availability of study nurse|1|||
129805702|NCT01303861|467256769|FG000|Overall Study|Lost to Follow-up|34|||
129805703|NCT01303861|467256770|FG001|Overall Study|Lost to Follow-up|14|||
129805704|NCT01303861|467256771|FG002|Overall Study|Lost to Follow-up|27|||
129805705|NCT01303861|467256772|FG003|Overall Study|Lost to Follow-up|31|||
129805706|NCT01303861|467256769|FG000|Overall Study|Lack of Efficacy|3|||
129805707|NCT01303861|467256770|FG001|Overall Study|Lack of Efficacy|2|||
129805708|NCT01303861|467256771|FG002|Overall Study|Lack of Efficacy|1|||
129805709|NCT01303861|467256772|FG003|Overall Study|Lack of Efficacy|0|||
129805710|NCT01303861|467256769|FG000|Overall Study|Withdrawal by Subject|16|||
129805711|NCT01303861|467256770|FG001|Overall Study|Withdrawal by Subject|8|||
129805712|NCT01303861|467256771|FG002|Overall Study|Withdrawal by Subject|8|||
129805713|NCT01303861|467256772|FG003|Overall Study|Withdrawal by Subject|23|||
129805714|NCT01303861|467256769|FG000|Overall Study|Adverse Event|4|||
129805715|NCT01303861|467256770|FG001|Overall Study|Adverse Event|1|||
129805716|NCT01303861|467256771|FG002|Overall Study|Adverse Event|0|||
129805717|NCT01303861|467256772|FG003|Overall Study|Adverse Event|5|||
129805718|NCT01303861|467256769|FG000|Overall Study|Pregnancy|1|||
129805719|NCT01303861|467256770|FG001|Overall Study|Pregnancy|0|||
129805720|NCT01303861|467256771|FG002|Overall Study|Pregnancy|0|||
129805721|NCT01303861|467256772|FG003|Overall Study|Pregnancy|0|||
129805722|NCT02476201|467256775|FG000|Overall Study|Unable to program MPP|9|||
129805723|NCT02476201|467256775|FG000|Overall Study|Study echo not performed|5|||
129805724|NCT02476201|467256775|FG000|Overall Study|Adverse Event|4|||
129805725|NCT02476201|467256775|FG000|Overall Study|Death|2|||
129805726|NCT02476201|467256775|FG000|Overall Study|Lost to Follow-up|2|||
129805727|NCT02476201|467256775|FG000|Overall Study|MPP programmed to OFF|2|||
129805728|NCT02476201|467256775|FG000|Overall Study|Withdrawal by Subject|1|||
129805729|NCT02476201|467256775|FG000|Overall Study|Unsuccessful implant|1|||
129805730|NCT02248701|467256781|FG000|Overall Study|Withdrawal by Subject|2|||
129805731|NCT02248701|467256782|FG001|Overall Study|Withdrawal by Subject|1|||
129805732|NCT02248701|467256781|FG000|Overall Study|Physician Decision|0|||
129805733|NCT02248701|467256782|FG001|Overall Study|Physician Decision|1|||
129805734|NCT02248701|467256781|FG000|Overall Study|Adverse Event|1|||
129805735|NCT02248701|467256782|FG001|Overall Study|Adverse Event|0|||
129805736|NCT02248701|467256781|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
129805737|NCT02248701|467256782|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
129805738|NCT00845858|467256783|FG000|Overall Study|Withdrawal by Subject|5|||
129805739|NCT00845858|467256784|FG001|Overall Study|Withdrawal by Subject|1|||
130056787|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056788|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056789|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056790|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056791|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056792|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056793|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056794|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056795|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056796|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056797|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056798|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056799|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056800|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056801|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056802|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056803|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056804|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
130056805|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
130056806|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056807|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056808|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056809|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129805740|NCT00845858|467256785|FG002|Overall Study|Withdrawal by Subject|1|||
129805741|NCT00845858|467256783|FG000|Overall Study|Adverse Event|3|||
129805742|NCT00845858|467256784|FG001|Overall Study|Adverse Event|8|||
129805743|NCT00845858|467256785|FG002|Overall Study|Adverse Event|4|||
129805744|NCT00845858|467256783|FG000|Overall Study|Protocol Violation|0|||
129805745|NCT00845858|467256784|FG001|Overall Study|Protocol Violation|0|||
129805746|NCT00845858|467256785|FG002|Overall Study|Protocol Violation|1|||
129805747|NCT00845858|467256783|FG000|Overall Study|not eligible|0|||
130111787|NCT00479401|468369545|FG000|Overall Study|Adverse Event|24|||
130111788|NCT00479401|468369546|FG001|Overall Study|Adverse Event|20|||
130111789|NCT00479401|468369547|FG002|Overall Study|Adverse Event|4|||
130111790|NCT00479401|468369545|FG000|Overall Study|Lack of Efficacy|2|||
130111791|NCT00479401|468369546|FG001|Overall Study|Lack of Efficacy|2|||
130111792|NCT00479401|468369547|FG002|Overall Study|Lack of Efficacy|4|||
130111793|NCT00479401|468369545|FG000|Overall Study|Protocol Violation|2|||
130111794|NCT00479401|468369546|FG001|Overall Study|Protocol Violation|1|||
130111795|NCT00479401|468369547|FG002|Overall Study|Protocol Violation|1|||
130111796|NCT00479401|468369545|FG000|Overall Study|Lost to Follow-up|1|||
130111797|NCT00479401|468369546|FG001|Overall Study|Lost to Follow-up|1|||
130111798|NCT00479401|468369547|FG002|Overall Study|Lost to Follow-up|1|||
130111799|NCT00479401|468369545|FG000|Overall Study|Withdrawal by Subject|16|||
130111800|NCT00479401|468369546|FG001|Overall Study|Withdrawal by Subject|10|||
130111801|NCT00479401|468369547|FG002|Overall Study|Withdrawal by Subject|2|||
130111802|NCT00479401|468369545|FG000|Overall Study|Exclusion criteria, relocation|4|||
130111803|NCT00479401|468369546|FG001|Overall Study|Exclusion criteria, relocation|3|||
130111804|NCT00479401|468369547|FG002|Overall Study|Exclusion criteria, relocation|0|||
130111805|NCT01430104|468369550|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
130111806|NCT04304950|468369561|FG000|Overall Study|Lost to Follow-up|1|||
130111807|NCT04304950|468369562|FG001|Overall Study|Lost to Follow-up|1|||
130111808|NCT02418910|468369563|FG000|Overall Study|Lost to Follow-up|3|||
130111809|NCT02418910|468369563|FG000|Overall Study|Withdrawal by Subject|4|||
130111810|NCT03634488|468369565|FG000|Overall Study|Death|1|||
129805748|NCT00845858|467256784|FG001|Overall Study|not eligible|3|||
129805749|NCT00845858|467256785|FG002|Overall Study|not eligible|2|||
129805750|NCT00880542|467256786|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
129805751|NCT00880542|467256786|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
129805752|NCT00880542|467256786|FG000|REP: Surgical Resection|progressive disease|1|||
130111811|NCT03634488|468369566|FG001|Overall Study|Death|0|||
130111812|NCT03634488|468369567|FG002|Overall Study|Death|0|||
130111813|NCT03634488|468369565|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
130111814|NCT03634488|468369566|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
130111815|NCT03634488|468369567|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
130111816|NCT03182686|468369568|FG000|Overall Study|Lost to Follow-up|2|||
130111817|NCT03182686|468369569|FG001|Overall Study|Lost to Follow-up|0|||
130111818|NCT03182686|468369568|FG000|Overall Study|Adverse Event|2|||
130111819|NCT03182686|468369569|FG001|Overall Study|Adverse Event|0|||
130111820|NCT03182686|468369568|FG000|Overall Study|Withdrawal by Subject|3|||
130111821|NCT03182686|468369569|FG001|Overall Study|Withdrawal by Subject|0|||
130111822|NCT01154127|468369576|FG000|Period 1 (21 Days)|Adverse Event|3|||
130111823|NCT01154127|468369577|FG001|Period 1 (21 Days)|Adverse Event|4|||
130111824|NCT01154127|468369576|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
130111825|NCT01154127|468369577|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
130111826|NCT01154127|468369576|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
130111827|NCT01154127|468369577|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
130111828|NCT01154127|468369576|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
130111829|NCT01154127|468369577|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
130111830|NCT01154127|468369576|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
130111831|NCT01154127|468369577|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
130111832|NCT01697449|468369578|FG000|Overall Study|Disease progression|47|||
130111833|NCT01697449|468369578|FG000|Overall Study|Adverse Event|7|||
130111834|NCT01697449|468369578|FG000|Overall Study|Lost to Follow-up|5|||
130111835|NCT01697449|468369578|FG000|Overall Study|Withdrawal by Subject|2|||
130111836|NCT01697449|468369578|FG000|Overall Study|Physician Decision|1|||
130111837|NCT01697449|468369578|FG000|Overall Study|Death|2|||
129805753|NCT04289623|467256787|FG000|Wave 1 Emails|Email was not delivered|268|||
129805754|NCT04289623|467256788|FG001|Wave 1 Emails|Email was not delivered|257|||
129805755|NCT04289623|467256789|FG002|Wave 1 Emails|Email was not delivered|0|||
130111838|NCT01697449|468369578|FG000|Overall Study|Other|1|||
130111839|NCT01697449|468369578|FG000|Overall Study|Missing|25|||
130111840|NCT02390219|468369579|FG000|Overall Study|Death|1|||
130111841|NCT02390219|468369579|FG000|Overall Study|Physician Decision|1|||
129805756|NCT04289623|467256790|FG003|Wave 1 Emails|Email was not delivered|0|||
129805757|NCT04289623|467256791|FG004|Wave 1 Emails|Email was not delivered|0|||
130111842|NCT02390219|468369579|FG000|Overall Study|Adverse Event|6|||
130111843|NCT02390219|468369579|FG000|Overall Study|Withdrawal by Subject|1|||
130111844|NCT02390219|468369579|FG000|Overall Study|Lost to Follow-up|2|||
129805758|NCT04289623|467256792|FG005|Wave 1 Emails|Email was not delivered|0|||
129805759|NCT03758443|467256793|FG000|Induction Period|Adverse Event|2|||
129805760|NCT03758443|467256794|FG001|Induction Period|Adverse Event|4|||
129805761|NCT03758443|467256795|FG002|Induction Period|Adverse Event|2|||
129805762|NCT03758443|467256796|FG003|Induction Period|Adverse Event|3|||
129805763|NCT03758443|467256793|FG000|Induction Period|Physician Decision|1|||
129805764|NCT03758443|467256794|FG001|Induction Period|Physician Decision|1|||
129805765|NCT03758443|467256795|FG002|Induction Period|Physician Decision|3|||
129805766|NCT03758443|467256796|FG003|Induction Period|Physician Decision|0|||
129805767|NCT03758443|467256793|FG000|Induction Period|Protocol Violation|0|||
129805768|NCT03758443|467256794|FG001|Induction Period|Protocol Violation|0|||
129805769|NCT03758443|467256795|FG002|Induction Period|Protocol Violation|0|||
130111845|NCT02390219|468369579|FG000|Overall Study|Other|2|||
130111846|NCT01169844|468369580|FG000|Overall Study|Adverse Event|0|||
130111847|NCT01169844|468369581|FG001|Overall Study|Adverse Event|1|||
130111848|NCT01169844|468369580|FG000|Overall Study|Patient withdrew consent|4|||
130111849|NCT01169844|468369581|FG001|Overall Study|Patient withdrew consent|0|||
130111850|NCT01169844|468369580|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130111851|NCT01169844|468369581|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130111852|NCT00529568|468369582|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
130111853|NCT00529568|468369583|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
130111854|NCT00529568|468369584|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
130111855|NCT00529568|468369582|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
130111856|NCT00529568|468369583|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
130111857|NCT00529568|468369584|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
130111858|NCT00529568|468369582|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
130111859|NCT00529568|468369583|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
130111860|NCT00529568|468369584|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
130111861|NCT00529568|468369582|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
130111862|NCT00529568|468369583|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
130111863|NCT00529568|468369584|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
130111864|NCT00529568|468369582|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
130111865|NCT00529568|468369583|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
130111866|NCT00529568|468369584|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
130111867|NCT00529568|468369582|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
130111868|NCT00529568|468369583|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
130111869|NCT00529568|468369584|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
130111870|NCT00529568|468369582|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
130111871|NCT00529568|468369583|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
130111872|NCT00529568|468369584|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
130111873|NCT00529568|468369582|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
130111874|NCT00529568|468369583|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
130111875|NCT00529568|468369584|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
130111876|NCT00529568|468369582|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
130111877|NCT00529568|468369583|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
130111878|NCT00529568|468369584|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
130111879|NCT00529568|468369582|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
130111880|NCT00529568|468369583|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
129805770|NCT03758443|467256796|FG003|Induction Period|Protocol Violation|1|||
129805771|NCT03758443|467256793|FG000|Induction Period|Withdrawal by Subject|3|||
129805772|NCT03758443|467256794|FG001|Induction Period|Withdrawal by Subject|2|||
129805773|NCT03758443|467256795|FG002|Induction Period|Withdrawal by Subject|2|||
129805774|NCT03758443|467256796|FG003|Induction Period|Withdrawal by Subject|4|||
129805775|NCT03758443|467256793|FG000|Extended Induction Period|Adverse Event|1|||
129805776|NCT03758443|467256794|FG001|Extended Induction Period|Adverse Event|1|||
129805777|NCT03758443|467256795|FG002|Extended Induction Period|Adverse Event|0|||
130111881|NCT00529568|468369584|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
130111882|NCT00529568|468369582|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
130111883|NCT00529568|468369583|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
130111884|NCT00529568|468369584|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
130111885|NCT01201356|468369585|FG000|Overall Study|Adverse Event|170|||
130111886|NCT01201356|468369585|FG000|Overall Study|Abnormal laboratory value(s)|51|||
130111887|NCT01201356|468369585|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130111888|NCT01201356|468369585|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
130111889|NCT01201356|468369585|FG000|Overall Study|Condition no longer requires study drug|12|||
130111890|NCT01201356|468369585|FG000|Overall Study|Withdrawal by Subject|144|||
130111891|NCT01201356|468369585|FG000|Overall Study|Lost to Follow-up|50|||
130111892|NCT01201356|468369585|FG000|Overall Study|administrative problems|74|||
130111893|NCT01201356|468369585|FG000|Overall Study|Death|16|||
130111894|NCT01201356|468369585|FG000|Overall Study|Protocol Violation|12|||
130111895|NCT00811070|468369586|FG000|Overall Study|Death|0|||
130111896|NCT00811070|468369587|FG001|Overall Study|Death|0|||
130111897|NCT00811070|468369588|FG002|Overall Study|Death|0|||
130111898|NCT00811070|468369589|FG003|Overall Study|Death|2|||
129805778|NCT03758443|467256796|FG003|Extended Induction Period|Adverse Event|1|||
129805779|NCT03758443|467256793|FG000|Extended Induction Period|Lost to Follow-up|1|||
129805780|NCT03758443|467256794|FG001|Extended Induction Period|Lost to Follow-up|0|||
129805781|NCT03758443|467256795|FG002|Extended Induction Period|Lost to Follow-up|0|||
130111899|NCT00811070|468369590|FG004|Overall Study|Death|5|||
130111900|NCT00811070|468369591|FG005|Overall Study|Death|0|||
130111901|NCT00811070|468369586|FG000|Overall Study|Other|1|||
130111902|NCT00811070|468369587|FG001|Overall Study|Other|0|||
130111903|NCT00811070|468369588|FG002|Overall Study|Other|0|||
130056810|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056811|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056812|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056813|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056814|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056815|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056816|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056817|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056818|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056819|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056820|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056821|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056822|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056823|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056824|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056825|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056826|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056827|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
130056828|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
130056829|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056830|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056831|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056832|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130111904|NCT00811070|468369589|FG003|Overall Study|Other|0|||
129805782|NCT03758443|467256796|FG003|Extended Induction Period|Lost to Follow-up|0|||
129805783|NCT03758443|467256793|FG000|Extended Induction Period|Physician Decision|2|||
129805784|NCT03758443|467256794|FG001|Extended Induction Period|Physician Decision|1|||
129805785|NCT03758443|467256795|FG002|Extended Induction Period|Physician Decision|2|||
129805786|NCT03758443|467256796|FG003|Extended Induction Period|Physician Decision|2|||
129805787|NCT03758443|467256793|FG000|Extended Induction Period|Protocol Violation|0|||
130056833|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056834|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056835|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056836|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056837|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056838|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056839|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056840|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056841|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056842|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056843|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056844|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056845|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056846|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056847|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056848|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056849|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056850|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
130056851|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
130056852|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056853|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056854|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056855|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056856|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056857|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056858|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056859|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056860|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129893443|NCT01723774|467569768|FG002|Neoadjuvant|High estradiol|0|||
130056861|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056862|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056863|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056864|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056865|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056866|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056867|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056868|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056869|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056870|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056871|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056872|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056873|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
130056874|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
130056875|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
130056876|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
130056877|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
130056878|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
130056879|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
130056880|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
130056881|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
130056882|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
130056883|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
130056884|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
130056885|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
130056886|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
130056887|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
130056888|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
130056889|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
130056890|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
130056891|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
130056892|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
130056893|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
130056894|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
130056895|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
130056896|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
130056897|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
130056898|NCT02052778|468162462|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056899|NCT02052778|468162463|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056900|NCT02052778|468162464|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056901|NCT02052778|468162465|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056902|NCT02052778|468162466|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056903|NCT02052778|468162467|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056904|NCT02052778|468162468|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056905|NCT02052778|468162469|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056906|NCT02052778|468162470|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056907|NCT02052778|468162471|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056908|NCT02052778|468162472|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056909|NCT02052778|468162473|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056910|NCT02052778|468162474|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056911|NCT02052778|468162475|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056912|NCT02052778|468162476|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056913|NCT02052778|468162477|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056914|NCT02052778|468162478|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056915|NCT02052778|468162479|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056916|NCT02052778|468162480|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056917|NCT02052778|468162481|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056918|NCT02052778|468162482|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056919|NCT02052778|468162483|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
130056920|NCT02052778|468162484|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
130056921|NCT01980706|468162489|FG000|Overall Study|Withdrawal by Subject|9|||
130056922|NCT01980706|468162490|FG001|Overall Study|Withdrawal by Subject|6|||
130056923|NCT01980706|468162491|FG002|Overall Study|Withdrawal by Subject|2|||
130056924|NCT01980706|468162489|FG000|Overall Study|Adverse Event|1|||
130056925|NCT01980706|468162490|FG001|Overall Study|Adverse Event|2|||
130056926|NCT01980706|468162491|FG002|Overall Study|Adverse Event|5|||
130056927|NCT01980706|468162489|FG000|Overall Study|Lost to Follow-up|3|||
130056928|NCT01980706|468162490|FG001|Overall Study|Lost to Follow-up|4|||
130056929|NCT01980706|468162491|FG002|Overall Study|Lost to Follow-up|3|||
130056930|NCT01980706|468162489|FG000|Overall Study|miscellaneous|4|||
130056931|NCT01980706|468162490|FG001|Overall Study|miscellaneous|5|||
130056932|NCT01980706|468162491|FG002|Overall Study|miscellaneous|3|||
130056933|NCT01094730|468162494|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
130056934|NCT01094730|468162495|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
129805788|NCT03758443|467256794|FG001|Extended Induction Period|Protocol Violation|0|||
129805789|NCT03758443|467256795|FG002|Extended Induction Period|Protocol Violation|0|||
129805790|NCT03758443|467256796|FG003|Extended Induction Period|Protocol Violation|1|||
129805791|NCT03758443|467256793|FG000|Extended Induction Period|Withdrawal by Subject|8|||
129805792|NCT03758443|467256794|FG001|Extended Induction Period|Withdrawal by Subject|1|||
129805793|NCT03758443|467256795|FG002|Extended Induction Period|Withdrawal by Subject|7|||
129805794|NCT03758443|467256796|FG003|Extended Induction Period|Withdrawal by Subject|3|||
129805795|NCT03758443|467256793|FG000|Extended Induction Period|Miscellaneous|1|||
129805796|NCT03758443|467256794|FG001|Extended Induction Period|Miscellaneous|0|||
129805797|NCT03758443|467256795|FG002|Extended Induction Period|Miscellaneous|0|||
129805798|NCT03758443|467256796|FG003|Extended Induction Period|Miscellaneous|0|||
129805799|NCT03758443|467256793|FG000|Maintenance Period|Adverse Event|1|||
129805800|NCT03758443|467256794|FG001|Maintenance Period|Adverse Event|2|||
129805801|NCT03758443|467256795|FG002|Maintenance Period|Adverse Event|0|||
129805802|NCT03758443|467256796|FG003|Maintenance Period|Adverse Event|0|||
129805803|NCT03758443|467256793|FG000|Maintenance Period|Lost to Follow-up|0|||
129805804|NCT03758443|467256794|FG001|Maintenance Period|Lost to Follow-up|0|||
129805805|NCT03758443|467256795|FG002|Maintenance Period|Lost to Follow-up|0|||
129805806|NCT03758443|467256796|FG003|Maintenance Period|Lost to Follow-up|1|||
129805807|NCT03758443|467256793|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
129805808|NCT03758443|467256794|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
129805809|NCT03758443|467256795|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
129805810|NCT03758443|467256796|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
129805811|NCT03758443|467256793|FG000|Maintenance Period|Protocol Violation|0|||
129805812|NCT03758443|467256794|FG001|Maintenance Period|Protocol Violation|1|||
129805813|NCT03758443|467256795|FG002|Maintenance Period|Protocol Violation|0|||
129805814|NCT03758443|467256796|FG003|Maintenance Period|Protocol Violation|0|||
129805815|NCT03758443|467256793|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
129805816|NCT03758443|467256794|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
129805817|NCT03758443|467256795|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
129805818|NCT03758443|467256796|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
129805819|NCT03758443|467256793|FG000|Maintenance Period|Withdrawal by Subject|1|||
129805820|NCT03758443|467256794|FG001|Maintenance Period|Withdrawal by Subject|0|||
129805821|NCT03758443|467256795|FG002|Maintenance Period|Withdrawal by Subject|1|||
129805822|NCT03758443|467256796|FG003|Maintenance Period|Withdrawal by Subject|1|||
129805823|NCT03758443|467256793|FG000|Maintenance Period|Miscellaneous|0|||
129805824|NCT03758443|467256794|FG001|Maintenance Period|Miscellaneous|0|||
129805825|NCT03758443|467256795|FG002|Maintenance Period|Miscellaneous|1|||
129805826|NCT03758443|467256796|FG003|Maintenance Period|Miscellaneous|0|||
129805827|NCT03080454|467256797|FG000|Baseline|Adverse Event|2|||
129805828|NCT03080454|467256797|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
129805829|NCT03080454|467256797|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
129805830|NCT01436396|467256798|FG000|Overall Study|Protocol Violation|7|||
129805831|NCT01436396|467256799|FG001|Overall Study|Protocol Violation|5|||
129805832|NCT01436396|467256798|FG000|Overall Study|Adverse Event|1|||
129805833|NCT01436396|467256799|FG001|Overall Study|Adverse Event|2|||
129805834|NCT01436396|467256798|FG000|Overall Study|Withdrawal by Subject|19|||
129805835|NCT01436396|467256799|FG001|Overall Study|Withdrawal by Subject|29|||
129805836|NCT01436396|467256798|FG000|Overall Study|Serious adverse event|2|||
129805837|NCT01436396|467256799|FG001|Overall Study|Serious adverse event|3|||
129805838|NCT01436396|467256798|FG000|Overall Study|Lost to Follow-up|3|||
129805839|NCT01436396|467256799|FG001|Overall Study|Lost to Follow-up|3|||
129805840|NCT00216476|467256800|FG000|Overall Study|Withdrawal by Subject|59|||
129805841|NCT00216476|467256801|FG001|Overall Study|Withdrawal by Subject|72|||
129805842|NCT00216476|467256802|FG002|Overall Study|Withdrawal by Subject|9|||
129805843|NCT00216476|467256800|FG000|Overall Study|Lost to Follow-up|10|||
129805844|NCT00216476|467256801|FG001|Overall Study|Lost to Follow-up|9|||
129805845|NCT00216476|467256802|FG002|Overall Study|Lost to Follow-up|1|||
129805846|NCT00216476|467256800|FG000|Overall Study|Adverse Event|6|||
129805847|NCT00216476|467256801|FG001|Overall Study|Adverse Event|10|||
129805848|NCT00216476|467256802|FG002|Overall Study|Adverse Event|1|||
129805849|NCT00216476|467256800|FG000|Overall Study|Lack of Efficacy|4|||
129805850|NCT00216476|467256801|FG001|Overall Study|Lack of Efficacy|3|||
129805851|NCT00216476|467256802|FG002|Overall Study|Lack of Efficacy|0|||
129805852|NCT00216476|467256800|FG000|Overall Study|Death|2|||
129805853|NCT00216476|467256801|FG001|Overall Study|Death|0|||
129805854|NCT00216476|467256802|FG002|Overall Study|Death|0|||
129805855|NCT00216476|467256800|FG000|Overall Study|Pregnancy|0|||
129805856|NCT00216476|467256801|FG001|Overall Study|Pregnancy|1|||
129805857|NCT00216476|467256802|FG002|Overall Study|Pregnancy|1|||
129805858|NCT00216476|467256800|FG000|Overall Study|Other|0|||
129805859|NCT00216476|467256801|FG001|Overall Study|Other|0|||
129805860|NCT00216476|467256802|FG002|Overall Study|Other|1|||
129805861|NCT00216476|467256800|FG000|Overall Study|Refuses Injection|11|||
129805862|NCT00216476|467256801|FG001|Overall Study|Refuses Injection|0|||
129805863|NCT00216476|467256802|FG002|Overall Study|Refuses Injection|0|||
129805864|NCT00216476|467256800|FG000|Overall Study|No Further Need for Treatment|3|||
130111905|NCT00811070|468369590|FG004|Overall Study|Other|0|||
130111906|NCT00811070|468369591|FG005|Overall Study|Other|0|||
130111907|NCT00811070|468369586|FG000|Overall Study|Withdrawal by Subject|0|||
130111908|NCT00811070|468369587|FG001|Overall Study|Withdrawal by Subject|1|||
130111909|NCT00811070|468369588|FG002|Overall Study|Withdrawal by Subject|0|||
130111910|NCT00811070|468369589|FG003|Overall Study|Withdrawal by Subject|0|||
130111911|NCT00811070|468369590|FG004|Overall Study|Withdrawal by Subject|0|||
130111912|NCT00811070|468369591|FG005|Overall Study|Withdrawal by Subject|0|||
130111913|NCT00811070|468369586|FG000|Overall Study|Physician Decision|0|||
130111914|NCT00811070|468369587|FG001|Overall Study|Physician Decision|0|||
130111915|NCT00811070|468369588|FG002|Overall Study|Physician Decision|0|||
130111916|NCT00811070|468369589|FG003|Overall Study|Physician Decision|0|||
130111917|NCT00811070|468369590|FG004|Overall Study|Physician Decision|0|||
130111918|NCT00811070|468369591|FG005|Overall Study|Physician Decision|1|||
130111919|NCT04079842|468369592|FG000|Overall Study|Request of subject|2|||
130111920|NCT04079842|468369592|FG000|Overall Study|Unable to draw Arterial samples|1|||
130111921|NCT01025193|468369593|FG000|Overall Study|Protocol Violation|1|||
130111922|NCT01025193|468369593|FG000|Overall Study|Adverse Event|3|||
130111923|NCT02904200|468369594|FG000|Overall Study|Withdrawal by Subject|1|||
130111924|NCT02904200|468369595|FG001|Overall Study|Withdrawal by Subject|0|||
130111925|NCT00185211|468369596|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
130111926|NCT00185211|468369597|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
130111927|NCT00185211|468369596|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
130111928|NCT00185211|468369597|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
130111929|NCT00185211|468369596|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
130111930|NCT00185211|468369597|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
130111931|NCT00185211|468369596|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
130111932|NCT00185211|468369597|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
130111933|NCT00185211|468369596|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
130111934|NCT00185211|468369597|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
130111935|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
130111936|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
130111937|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
130111938|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
130111939|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
130111940|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
130111941|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
130111942|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
130111943|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
130111944|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
130111945|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
130111946|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
130111947|NCT00185211|468369596|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
130111948|NCT00185211|468369597|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
130111949|NCT02544633|468371012|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
129893444|NCT01723774|467569769|FG003|Neoadjuvant|High estradiol|0|||
130111950|NCT02544633|468371013|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
130111951|NCT02544633|468371014|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
130111952|NCT02544633|468371015|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
130111953|NCT02544633|468371012|FG000|Treatment Period|Adverse Event|7|||
130111954|NCT02544633|468371013|FG001|Treatment Period|Adverse Event|4|||
130111955|NCT02544633|468371014|FG002|Treatment Period|Adverse Event|0|||
129805865|NCT00216476|467256801|FG001|Overall Study|No Further Need for Treatment|4|||
129805866|NCT00216476|467256802|FG002|Overall Study|No Further Need for Treatment|1|||
129805867|NCT00216476|467256800|FG000|Overall Study|Non-compliance|0|||
129805868|NCT00216476|467256801|FG001|Overall Study|Non-compliance|4|||
129805869|NCT00216476|467256802|FG002|Overall Study|Non-compliance|1|||
129805870|NCT00216476|467256800|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
129805871|NCT00216476|467256801|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
129805872|NCT00216476|467256802|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
129805873|NCT00216476|467256800|FG000|Overall Study|Administrative Reasons|1|||
129805874|NCT00216476|467256801|FG001|Overall Study|Administrative Reasons|1|||
129805875|NCT00216476|467256802|FG002|Overall Study|Administrative Reasons|0|||
129805876|NCT00216476|467256800|FG000|Overall Study|Protocol Deviation|5|||
129805877|NCT00216476|467256801|FG001|Overall Study|Protocol Deviation|1|||
129805878|NCT00216476|467256802|FG002|Overall Study|Protocol Deviation|0|||
129805879|NCT00216476|467256800|FG000|Overall Study|Patient Moved|2|||
129805880|NCT00216476|467256801|FG001|Overall Study|Patient Moved|2|||
130056935|NCT01094730|468162494|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
130056936|NCT01094730|468162495|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
130056937|NCT01094730|468162494|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
130056938|NCT01094730|468162495|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
130056939|NCT01094730|468162494|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
130056940|NCT01094730|468162495|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
130056941|NCT01094730|468162494|FG000|Period 2 (14 Days)|Protocol Violation|2|||
130056942|NCT01094730|468162495|FG001|Period 2 (14 Days)|Protocol Violation|0|||
130056943|NCT01094730|468162494|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
130056944|NCT01094730|468162495|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
130056945|NCT01094730|468162494|FG000|Period 2 (14 Days)|Adverse Event|0|||
130056946|NCT01094730|468162495|FG001|Period 2 (14 Days)|Adverse Event|1|||
130056947|NCT01094730|468162494|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
130056948|NCT01094730|468162495|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
130056949|NCT04171037|468162496|FG000|Overall Study|Lost to Follow-up|1|||
130056950|NCT04171037|468162497|FG001|Overall Study|Lost to Follow-up|0|||
130056951|NCT04171037|468162496|FG000|Overall Study|Physician Decision|3|||
130056952|NCT04171037|468162497|FG001|Overall Study|Physician Decision|3|||
130056953|NCT03135028|468162498|FG000|Overall Study|Death|6|||
130056954|NCT03135028|468162498|FG000|Overall Study|Study Terminated by Sponsor|2|||
130056955|NCT03135028|468162498|FG000|Overall Study|Withdrew Consent|1|||
130056956|NCT00748540|468162499|FG000|Overall Study|Physician Decision|1|||
130056957|NCT01814800|468162501|FG000|Overall Study|Adverse Event|2|||
130056958|NCT01814800|468162501|FG000|Overall Study|Pregnancy|1|||
130056959|NCT01814800|468162501|FG000|Overall Study|Sponsor decision|1|||
130056960|NCT01814800|468162501|FG000|Overall Study|Subject relocation|1|||
130056961|NCT04436822|468162502|FG000|Overall Study|Physician Decision|2|||
130056962|NCT04436822|468162503|FG001|Overall Study|Physician Decision|0|||
130056963|NCT04436822|468162502|FG000|Overall Study|Sponsor request|1|||
130056964|NCT04436822|468162503|FG001|Overall Study|Sponsor request|0|||
130056965|NCT04436822|468162502|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130056966|NCT04436822|468162503|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130056967|NCT04436822|468162502|FG000|Overall Study|Unsuccessful procedure|0|||
130056968|NCT04436822|468162503|FG001|Overall Study|Unsuccessful procedure|1|||
130056969|NCT04436822|468162502|FG000|Overall Study|Withdrawal due to Covid-19|8|||
130056970|NCT04436822|468162503|FG001|Overall Study|Withdrawal due to Covid-19|1|||
130056971|NCT04436822|468162502|FG000|Overall Study|Withdrawal by Subject|1|||
130056972|NCT04436822|468162503|FG001|Overall Study|Withdrawal by Subject|0|||
130056973|NCT04436822|468162502|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
130056974|NCT04436822|468162503|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
130056975|NCT02371759|468162506|FG000|Overall Study|Protocol Violation|3|||
130056976|NCT02371759|468162507|FG001|Overall Study|Protocol Violation|1|||
130056977|NCT02371759|468162508|FG002|Overall Study|Protocol Violation|1|||
130056978|NCT02371759|468162509|FG003|Overall Study|Protocol Violation|0|||
130056979|NCT02371759|468162510|FG004|Overall Study|Protocol Violation|3|||
129805881|NCT00216476|467256802|FG002|Overall Study|Patient Moved|0|||
129805882|NCT02191137|467256803|FG000|Treatment|Death|4|||
129805883|NCT02191137|467256803|FG000|Treatment|Withdrawal by Subject|3|||
129805884|NCT02191137|467256803|FG000|Treatment|Adverse Event|2|||
129805885|NCT02191137|467256803|FG000|Treatment|Other|1|||
129805886|NCT02191137|467256803|FG000|Follow-up|Lost to Follow-up|2|||
129805887|NCT02191137|467256803|FG000|Follow-up|Ongoing/unknown|2|||
129805888|NCT02191137|467256803|FG000|Follow-up|Adverse Event|1|||
130056980|NCT02371759|468162511|FG005|Overall Study|Protocol Violation|1|||
130056981|NCT02371759|468162512|FG006|Overall Study|Protocol Violation|0|||
130056982|NCT02371759|468162513|FG007|Overall Study|Protocol Violation|3|||
130056983|NCT02371759|468162506|FG000|Overall Study|Withdrawal by Subject|0|||
130056984|NCT02371759|468162507|FG001|Overall Study|Withdrawal by Subject|0|||
130056985|NCT02371759|468162508|FG002|Overall Study|Withdrawal by Subject|0|||
130056986|NCT02371759|468162509|FG003|Overall Study|Withdrawal by Subject|0|||
130111956|NCT02544633|468371015|FG003|Treatment Period|Adverse Event|5|||
129805889|NCT00696800|467256804|FG000|Overall Study|Adverse Event|16|||
129805890|NCT00696800|467256805|FG001|Overall Study|Adverse Event|3|||
129805891|NCT00696800|467256804|FG000|Overall Study|Insufficient compliance with medication|2|||
129805892|NCT00696800|467256805|FG001|Overall Study|Insufficient compliance with medication|1|||
130111957|NCT02544633|468371012|FG000|Treatment Period|Lack of Efficacy|17|||
130111958|NCT02544633|468371013|FG001|Treatment Period|Lack of Efficacy|11|||
130111959|NCT02544633|468371014|FG002|Treatment Period|Lack of Efficacy|5|||
130111960|NCT02544633|468371015|FG003|Treatment Period|Lack of Efficacy|5|||
130111961|NCT02544633|468371012|FG000|Treatment Period|Global Deterioration of Health|3|||
130111962|NCT02544633|468371013|FG001|Treatment Period|Global Deterioration of Health|3|||
130111963|NCT02544633|468371014|FG002|Treatment Period|Global Deterioration of Health|0|||
130111964|NCT02544633|468371015|FG003|Treatment Period|Global Deterioration of Health|1|||
130111965|NCT02544633|468371012|FG000|Treatment Period|Withdrawal by Subject|1|||
130111966|NCT02544633|468371013|FG001|Treatment Period|Withdrawal by Subject|0|||
129805893|NCT00696800|467256804|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
129805894|NCT00696800|467256805|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
129805895|NCT00696800|467256804|FG000|Overall Study|Insufficient ovarian response|4|||
129805896|NCT00696800|467256805|FG001|Overall Study|Insufficient ovarian response|1|||
129805897|NCT00696800|467256804|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
129805898|NCT00696800|467256805|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
129805899|NCT00696800|467256804|FG000|Overall Study|Too high ovarian response|6|||
129805900|NCT00696800|467256805|FG001|Overall Study|Too high ovarian response|1|||
129805901|NCT00696800|467256804|FG000|Overall Study|No/too few/bad quality oocytes|4|||
129805902|NCT00696800|467256805|FG001|Overall Study|No/too few/bad quality oocytes|3|||
129805903|NCT00696800|467256804|FG000|Overall Study|No/abnormal fertilization|11|||
129805904|NCT00696800|467256805|FG001|Overall Study|No/abnormal fertilization|13|||
129805905|NCT00696800|467256804|FG000|Overall Study|No/too few/bad quality embryos|24|||
129805906|NCT00696800|467256805|FG001|Overall Study|No/too few/bad quality embryos|18|||
129805907|NCT00696800|467256804|FG000|Overall Study|Other Reasons|5|||
129805908|NCT00696800|467256805|FG001|Overall Study|Other Reasons|3|||
129805909|NCT00696800|467256804|FG000|Overall Study|Not treated|1|||
129805910|NCT00696800|467256805|FG001|Overall Study|Not treated|2|||
129805911|NCT02853344|467256810|FG000|Overall Study|Lost to Follow-up|1|||
129805912|NCT02853344|467256811|FG001|Overall Study|Lost to Follow-up|1|||
129805913|NCT02853344|467256810|FG000|Overall Study|Withdrawal by Subject|2|||
129805914|NCT02853344|467256811|FG001|Overall Study|Withdrawal by Subject|4|||
129805915|NCT02853344|467256810|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
129805916|NCT02853344|467256811|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
129805917|NCT02853344|467256810|FG000|Overall Study|Death|70|||
129805918|NCT02853344|467256811|FG001|Overall Study|Death|112|||
129805919|NCT02913612|467256812|FG000|Overall Study|Lost to Follow-up|6|||
129805920|NCT02913612|467256813|FG001|Overall Study|Lost to Follow-up|5|||
129805921|NCT02913612|467256814|FG002|Overall Study|Lost to Follow-up|2|||
129805922|NCT02913612|467256815|FG003|Overall Study|Lost to Follow-up|0|||
129805923|NCT02913612|467256812|FG000|Overall Study|Physician Decision|1|||
129805924|NCT02913612|467256813|FG001|Overall Study|Physician Decision|4|||
129805925|NCT02913612|467256814|FG002|Overall Study|Physician Decision|1|||
129805926|NCT02913612|467256815|FG003|Overall Study|Physician Decision|0|||
129805927|NCT02913612|467256812|FG000|Overall Study|Withdrawal by Subject|2|||
129805928|NCT02913612|467256813|FG001|Overall Study|Withdrawal by Subject|4|||
129805929|NCT02913612|467256814|FG002|Overall Study|Withdrawal by Subject|0|||
129805930|NCT02913612|467256815|FG003|Overall Study|Withdrawal by Subject|0|||
129805931|NCT02913612|467256812|FG000|Overall Study|Hemangioma resolved|1|||
129805932|NCT02913612|467256813|FG001|Overall Study|Hemangioma resolved|0|||
129805933|NCT02913612|467256814|FG002|Overall Study|Hemangioma resolved|0|||
129805934|NCT02913612|467256815|FG003|Overall Study|Hemangioma resolved|0|||
129805935|NCT02913612|467256812|FG000|Overall Study|Local IRB decision|1|||
129805936|NCT02913612|467256813|FG001|Overall Study|Local IRB decision|0|||
129805937|NCT02913612|467256814|FG002|Overall Study|Local IRB decision|0|||
129805938|NCT02913612|467256815|FG003|Overall Study|Local IRB decision|0|||
129805939|NCT02913612|467256812|FG000|Overall Study|Study drug non-compliance|1|||
129805940|NCT02913612|467256813|FG001|Overall Study|Study drug non-compliance|1|||
130111967|NCT02544633|468371014|FG002|Treatment Period|Withdrawal by Subject|0|||
130111968|NCT02544633|468371015|FG003|Treatment Period|Withdrawal by Subject|0|||
129805941|NCT02913612|467256814|FG002|Overall Study|Study drug non-compliance|0|||
129805942|NCT02913612|467256815|FG003|Overall Study|Study drug non-compliance|0|||
129805943|NCT02913612|467256812|FG000|Overall Study|Insurance issues|0|||
129805944|NCT02913612|467256813|FG001|Overall Study|Insurance issues|1|||
129805945|NCT02913612|467256814|FG002|Overall Study|Insurance issues|0|||
129805946|NCT02913612|467256815|FG003|Overall Study|Insurance issues|0|||
129805947|NCT02913612|467256812|FG000|Overall Study|Needed to treat second hemangioma|0|||
129805948|NCT02913612|467256813|FG001|Overall Study|Needed to treat second hemangioma|1|||
129805949|NCT02913612|467256814|FG002|Overall Study|Needed to treat second hemangioma|0|||
129805950|NCT02913612|467256815|FG003|Overall Study|Needed to treat second hemangioma|0|||
129893445|NCT04319094|467569773|FG000|Baseline|Lost to Follow-up|4|||
130111969|NCT02544633|468371012|FG000|Treatment Period|Lost to Follow-up|0|||
130056987|NCT02371759|468162510|FG004|Overall Study|Withdrawal by Subject|0|||
130056988|NCT02371759|468162511|FG005|Overall Study|Withdrawal by Subject|0|||
130056989|NCT02371759|468162512|FG006|Overall Study|Withdrawal by Subject|0|||
130056990|NCT02371759|468162513|FG007|Overall Study|Withdrawal by Subject|1|||
130056991|NCT03375112|468162516|FG000|Overall Study|Withdrawal by Subject|3|||
130056992|NCT03375112|468162517|FG001|Overall Study|Withdrawal by Subject|0|||
130056993|NCT00243230|468162518|FG000|Double-Blind Period|Adverse Event|0|||
130056994|NCT00243230|468162519|FG001|Double-Blind Period|Adverse Event|2|||
130056995|NCT00243230|468162520|FG002|Double-Blind Period|Adverse Event|2|||
130056996|NCT00243230|468162521|FG003|Double-Blind Period|Adverse Event|0|||
130056997|NCT00243230|468162518|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130056998|NCT00243230|468162519|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130056999|NCT00243230|468162520|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130057000|NCT00243230|468162521|FG003|Double-Blind Period|Withdrawal by Subject|0|||
130057001|NCT00243230|468162518|FG000|Double-Blind Period|Protocol Violation|0|||
130057002|NCT00243230|468162519|FG001|Double-Blind Period|Protocol Violation|0|||
130057003|NCT00243230|468162520|FG002|Double-Blind Period|Protocol Violation|1|||
130057004|NCT00243230|468162521|FG003|Double-Blind Period|Protocol Violation|0|||
130057005|NCT00243230|468162518|FG000|Double-Blind Period|Randomized but Not Treated|0|||
130057006|NCT00243230|468162519|FG001|Double-Blind Period|Randomized but Not Treated|0|||
130057007|NCT00243230|468162520|FG002|Double-Blind Period|Randomized but Not Treated|2|||
130057008|NCT00243230|468162521|FG003|Double-Blind Period|Randomized but Not Treated|0|||
130057009|NCT00243230|468162518|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
130057010|NCT00243230|468162519|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
130057011|NCT00243230|468162520|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
130057012|NCT00243230|468162521|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
130057013|NCT00243230|468162518|FG000|Open Label Period|Adverse Event|0|||
130057014|NCT00243230|468162519|FG001|Open Label Period|Adverse Event|0|||
130057015|NCT00243230|468162520|FG002|Open Label Period|Adverse Event|0|||
130057016|NCT00243230|468162521|FG003|Open Label Period|Adverse Event|2|||
130057017|NCT00243230|468162518|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
130057018|NCT00243230|468162519|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
130057019|NCT00243230|468162520|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
130057020|NCT00243230|468162521|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
130057021|NCT00243230|468162518|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
130057022|NCT00243230|468162519|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
130057023|NCT00243230|468162520|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
130057024|NCT00243230|468162521|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
130057025|NCT00243230|468162518|FG000|Open Label Period|Lost to Follow-up|0|||
130057026|NCT00243230|468162519|FG001|Open Label Period|Lost to Follow-up|0|||
130057027|NCT00243230|468162520|FG002|Open Label Period|Lost to Follow-up|0|||
130057028|NCT00243230|468162521|FG003|Open Label Period|Lost to Follow-up|2|||
130057029|NCT00243230|468162518|FG000|Open Label Period|Withdrawal by Subject|0|||
130057030|NCT00243230|468162519|FG001|Open Label Period|Withdrawal by Subject|0|||
130057031|NCT00243230|468162520|FG002|Open Label Period|Withdrawal by Subject|0|||
130057032|NCT00243230|468162521|FG003|Open Label Period|Withdrawal by Subject|2|||
130057033|NCT00243230|468162518|FG000|Open Label Period|Protocol Violation|0|||
130057034|NCT00243230|468162519|FG001|Open Label Period|Protocol Violation|0|||
130057035|NCT00243230|468162520|FG002|Open Label Period|Protocol Violation|0|||
130057036|NCT00243230|468162521|FG003|Open Label Period|Protocol Violation|2|||
130057037|NCT00243230|468162518|FG000|Open Label Period|Administrative Reason|0|||
130057038|NCT00243230|468162519|FG001|Open Label Period|Administrative Reason|0|||
130057039|NCT00243230|468162520|FG002|Open Label Period|Administrative Reason|0|||
130057040|NCT00243230|468162521|FG003|Open Label Period|Administrative Reason|63|||
130057041|NCT01689207|468162522|FG000|Overall Study|Adverse Event|0|||
130057042|NCT01689207|468162523|FG001|Overall Study|Adverse Event|1|||
130057043|NCT01689207|468162524|FG002|Overall Study|Adverse Event|0|||
130057044|NCT01689207|468162525|FG003|Overall Study|Adverse Event|0|||
130057045|NCT01689207|468162526|FG004|Overall Study|Adverse Event|2|||
130057046|NCT01689207|468162527|FG005|Overall Study|Adverse Event|1|||
130057047|NCT01689207|468162528|FG006|Overall Study|Adverse Event|0|||
130057048|NCT01689207|468162529|FG007|Overall Study|Adverse Event|0|||
130057049|NCT01689207|468162530|FG008|Overall Study|Adverse Event|1|||
130057050|NCT01689207|468162531|FG009|Overall Study|Adverse Event|0|||
129805951|NCT02913612|467256812|FG000|Overall Study|Study completion criteria not met|0|||
130057051|NCT01689207|468162532|FG010|Overall Study|Adverse Event|0|||
130057052|NCT03855137|468162534|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
130057053|NCT03855137|468162535|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
130057054|NCT03855137|468162536|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
130057055|NCT03855137|468162534|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
130057056|NCT03855137|468162535|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
129805952|NCT02913612|467256813|FG001|Overall Study|Study completion criteria not met|1|||
130057057|NCT03855137|468162536|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
129805953|NCT02913612|467256814|FG002|Overall Study|Study completion criteria not met|0|||
129805954|NCT02913612|467256815|FG003|Overall Study|Study completion criteria not met|0|||
129805955|NCT02913612|467256812|FG000|Overall Study|Ineligible|0|||
129805956|NCT02913612|467256813|FG001|Overall Study|Ineligible|1|||
129805957|NCT02913612|467256814|FG002|Overall Study|Ineligible|0|||
129805958|NCT02913612|467256815|FG003|Overall Study|Ineligible|0|||
129805959|NCT00973674|467256818|FG000|Overall Study|Protocol Violation|2|||
129805960|NCT00973674|467256819|FG001|Overall Study|Protocol Violation|0|||
129805961|NCT00071396|467256820|FG000|Overall Study|Withdrawal by Subject|1|||
129805962|NCT00071396|467256820|FG000|Overall Study|Physician Decision|2|||
130057058|NCT03855137|468162534|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
130057059|NCT03855137|468162535|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
130057060|NCT03855137|468162536|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
130057061|NCT03855137|468162534|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
130057062|NCT03855137|468162535|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
130057063|NCT03855137|468162536|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
130057064|NCT03855137|468162534|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
130057065|NCT03855137|468162535|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
130057066|NCT03855137|468162536|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
130057067|NCT03855137|468162534|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
130057068|NCT03855137|468162535|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
130057069|NCT03855137|468162536|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
130057070|NCT03855137|468162534|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
130057071|NCT03855137|468162535|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
130057072|NCT03855137|468162536|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
130057073|NCT03855137|468162534|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
130057074|NCT03855137|468162535|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
130057075|NCT03855137|468162536|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
130057076|NCT03855137|468162534|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
130057077|NCT03855137|468162535|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
130057078|NCT03855137|468162536|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
130057079|NCT03855137|468162534|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
130057080|NCT03855137|468162535|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
130057081|NCT03855137|468162536|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
130057082|NCT02065622|468162541|FG000|Induction Study|Adverse Event|13|||
130057083|NCT02065622|468162542|FG001|Induction Study|Adverse Event|19|||
130057084|NCT02065622|468162543|FG002|Induction Study|Adverse Event|0|||
130057085|NCT02065622|468162544|FG003|Induction Study|Adverse Event|0|||
130057086|NCT02065622|468162545|FG004|Induction Study|Adverse Event|0|||
130057087|NCT02065622|468162541|FG000|Induction Study|Withdrawal by Subject|3|||
130057088|NCT02065622|468162542|FG001|Induction Study|Withdrawal by Subject|5|||
130057089|NCT02065622|468162543|FG002|Induction Study|Withdrawal by Subject|0|||
130057090|NCT02065622|468162544|FG003|Induction Study|Withdrawal by Subject|0|||
130057091|NCT02065622|468162545|FG004|Induction Study|Withdrawal by Subject|0|||
130057092|NCT02065622|468162541|FG000|Induction Study|Lost to Follow-up|1|||
130057093|NCT02065622|468162542|FG001|Induction Study|Lost to Follow-up|0|||
130057094|NCT02065622|468162543|FG002|Induction Study|Lost to Follow-up|0|||
130057095|NCT02065622|468162544|FG003|Induction Study|Lost to Follow-up|0|||
130057096|NCT02065622|468162545|FG004|Induction Study|Lost to Follow-up|0|||
130057097|NCT02065622|468162541|FG000|Induction Study|Lack of Efficacy|22|||
130057098|NCT02065622|468162542|FG001|Induction Study|Lack of Efficacy|27|||
130057099|NCT02065622|468162543|FG002|Induction Study|Lack of Efficacy|0|||
130057100|NCT02065622|468162544|FG003|Induction Study|Lack of Efficacy|0|||
130057101|NCT02065622|468162545|FG004|Induction Study|Lack of Efficacy|0|||
130057102|NCT02065622|468162541|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
130057103|NCT02065622|468162542|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
130057104|NCT02065622|468162543|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130057105|NCT02065622|468162544|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130057106|NCT02065622|468162545|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
130057107|NCT02065622|468162541|FG000|Induction Study|Subject Noncompliance|1|||
130057108|NCT02065622|468162542|FG001|Induction Study|Subject Noncompliance|1|||
129805963|NCT00116428|467256821|FG000|Overall Study|Withdrawal by Subject|2|||
130057109|NCT02065622|468162543|FG002|Induction Study|Subject Noncompliance|0|||
130057110|NCT02065622|468162544|FG003|Induction Study|Subject Noncompliance|0|||
130057111|NCT02065622|468162545|FG004|Induction Study|Subject Noncompliance|0|||
130057112|NCT02065622|468162541|FG000|Induction Study|Other, Not Specified|3|||
130057113|NCT02065622|468162542|FG001|Induction Study|Other, Not Specified|2|||
130057114|NCT02065622|468162543|FG002|Induction Study|Other, Not Specified|0|||
130057115|NCT02065622|468162544|FG003|Induction Study|Other, Not Specified|0|||
130057116|NCT02065622|468162545|FG004|Induction Study|Other, Not Specified|0|||
130111970|NCT02544633|468371013|FG001|Treatment Period|Lost to Follow-up|1|||
129805964|NCT00116428|467256822|FG001|Overall Study|Withdrawal by Subject|5|||
130111971|NCT02544633|468371014|FG002|Treatment Period|Lost to Follow-up|0|||
130111972|NCT02544633|468371015|FG003|Treatment Period|Lost to Follow-up|0|||
130111973|NCT02544633|468371012|FG000|Treatment Period|Death|0|||
130111974|NCT02544633|468371013|FG001|Treatment Period|Death|0|||
129893446|NCT04319094|467569774|FG001|Baseline|Lost to Follow-up|5|||
129893447|NCT04319094|467569773|FG000|Baseline|Protocol Violation|0|||
129893448|NCT04319094|467569774|FG001|Baseline|Protocol Violation|3|||
129893449|NCT04319094|467569773|FG000|Baseline|Withdrawal by Subject|2|||
130111975|NCT02544633|468371014|FG002|Treatment Period|Death|1|||
130111976|NCT02544633|468371015|FG003|Treatment Period|Death|0|||
130111977|NCT02544633|468371012|FG000|Treatment Period|Non-compliance|0|||
130111978|NCT02544633|468371013|FG001|Treatment Period|Non-compliance|0|||
130111979|NCT02544633|468371014|FG002|Treatment Period|Non-compliance|1|||
130111980|NCT02544633|468371015|FG003|Treatment Period|Non-compliance|0|||
130111981|NCT02544633|468371012|FG000|Treatment Period|Clinical Disease Progression|0|||
130111982|NCT02544633|468371013|FG001|Treatment Period|Clinical Disease Progression|0|||
130111983|NCT02544633|468371014|FG002|Treatment Period|Clinical Disease Progression|0|||
130111984|NCT02544633|468371015|FG003|Treatment Period|Clinical Disease Progression|1|||
130111985|NCT02544633|468371012|FG000|Survival Follow-up Period|Death|12|||
130111986|NCT02544633|468371013|FG001|Survival Follow-up Period|Death|14|||
129893450|NCT04319094|467569774|FG001|Baseline|Withdrawal by Subject|1|||
130111987|NCT02544633|468371014|FG002|Survival Follow-up Period|Death|3|||
130111988|NCT02544633|468371015|FG003|Survival Follow-up Period|Death|9|||
130111989|NCT02544633|468371012|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
130111990|NCT02544633|468371013|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
129893451|NCT04319094|467569773|FG000|Post-Intervention|Death|0|||
129893452|NCT04319094|467569774|FG001|Post-Intervention|Death|1|||
129893453|NCT04319094|467569773|FG000|Post-Intervention|Lost to Follow-up|4|||
129893454|NCT04319094|467569774|FG001|Post-Intervention|Lost to Follow-up|4|||
129893455|NCT04319094|467569773|FG000|Post-Intervention|Withdrawal by Subject|8|||
129893456|NCT04319094|467569774|FG001|Post-Intervention|Withdrawal by Subject|5|||
129893457|NCT04319094|467569773|FG000|Post-Intervention|Incomplete Data Collection|1|||
129893458|NCT04319094|467569774|FG001|Post-Intervention|Incomplete Data Collection|3|||
129893459|NCT04319094|467569773|FG000|3-month|Death|1|||
129805965|NCT00116428|467256821|FG000|Overall Study|Did not meet inclusion criteria|1|||
129805966|NCT00116428|467256822|FG001|Overall Study|Did not meet inclusion criteria|0|||
129805967|NCT03452228|467256823|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129893460|NCT04319094|467569774|FG001|3-month|Death|0|||
129893461|NCT04319094|467569773|FG000|3-month|Lost to Follow-up|2|||
129893462|NCT04319094|467569774|FG001|3-month|Lost to Follow-up|2|||
129893463|NCT04319094|467569773|FG000|3-month|Withdrawal by Subject|0|||
129893464|NCT04319094|467569774|FG001|3-month|Withdrawal by Subject|3|||
129893465|NCT04319094|467569773|FG000|3-month|Incomplete data collection|9|||
129893466|NCT04319094|467569774|FG001|3-month|Incomplete data collection|7|||
129893467|NCT04319094|467569773|FG000|6-month|Lost to Follow-up|1|||
129893468|NCT04319094|467569774|FG001|6-month|Lost to Follow-up|1|||
129893469|NCT04319094|467569773|FG000|6-month|Withdrawal by Subject|0|||
129893470|NCT04319094|467569774|FG001|6-month|Withdrawal by Subject|3|||
129893471|NCT04319094|467569773|FG000|6-month|Incomplete data collection|14|||
129805968|NCT03452228|467256824|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
129805969|NCT03452228|467256825|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129805970|NCT03452228|467256823|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129805971|NCT03452228|467256824|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129805972|NCT03452228|467256825|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129805973|NCT03452228|467256823|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
129805974|NCT03452228|467256824|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
129805975|NCT03452228|467256825|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
129805976|NCT03452228|467256823|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129805977|NCT03452228|467256824|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129805978|NCT03452228|467256825|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129805979|NCT02713204|467256826|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
129805980|NCT02713204|467256827|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805981|NCT02713204|467256828|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
129805982|NCT02713204|467256829|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805983|NCT02713204|467256830|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805984|NCT02713204|467256831|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805985|NCT02713204|467256832|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805986|NCT02713204|467256833|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805987|NCT02713204|467256826|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805988|NCT02713204|467256827|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805989|NCT02713204|467256828|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
129805990|NCT02713204|467256829|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805991|NCT02713204|467256830|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805992|NCT02713204|467256831|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129893472|NCT04319094|467569774|FG001|6-month|Incomplete data collection|9|||
129893473|NCT04319094|467569773|FG000|9-month|Lost to Follow-up|8|||
129893474|NCT04319094|467569774|FG001|9-month|Lost to Follow-up|4|||
129893475|NCT04319094|467569773|FG000|9-month|Withdrawal by Subject|0|||
129805993|NCT02713204|467256832|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129893476|NCT04319094|467569774|FG001|9-month|Withdrawal by Subject|1|||
129893477|NCT04319094|467569773|FG000|9-month|Incomplete data collection|8|||
129893478|NCT04319094|467569774|FG001|9-month|Incomplete data collection|5|||
129893479|NCT04319094|467569773|FG000|12-month|Lost to Follow-up|11|||
130057117|NCT02065622|468162541|FG000|Maintenance Study|Adverse Event|0|||
130057118|NCT02065622|468162542|FG001|Maintenance Study|Adverse Event|0|||
130057119|NCT02065622|468162543|FG002|Maintenance Study|Adverse Event|25|||
130057120|NCT02065622|468162544|FG003|Maintenance Study|Adverse Event|22|||
130057121|NCT02065622|468162545|FG004|Maintenance Study|Adverse Event|11|||
130057122|NCT02065622|468162541|FG000|Maintenance Study|Withdrawal by Subject|0|||
130057123|NCT02065622|468162542|FG001|Maintenance Study|Withdrawal by Subject|0|||
130057124|NCT02065622|468162543|FG002|Maintenance Study|Withdrawal by Subject|11|||
130057125|NCT02065622|468162544|FG003|Maintenance Study|Withdrawal by Subject|5|||
130057126|NCT02065622|468162545|FG004|Maintenance Study|Withdrawal by Subject|7|||
130057127|NCT02065622|468162541|FG000|Maintenance Study|Lost to Follow-up|0|||
130057128|NCT02065622|468162542|FG001|Maintenance Study|Lost to Follow-up|0|||
130057129|NCT02065622|468162543|FG002|Maintenance Study|Lost to Follow-up|4|||
130057130|NCT02065622|468162544|FG003|Maintenance Study|Lost to Follow-up|1|||
130057131|NCT02065622|468162545|FG004|Maintenance Study|Lost to Follow-up|1|||
130057132|NCT02065622|468162541|FG000|Maintenance Study|Lack of Efficacy|0|||
130057133|NCT02065622|468162542|FG001|Maintenance Study|Lack of Efficacy|0|||
130057134|NCT02065622|468162543|FG002|Maintenance Study|Lack of Efficacy|70|||
130057135|NCT02065622|468162544|FG003|Maintenance Study|Lack of Efficacy|55|||
130057136|NCT02065622|468162545|FG004|Maintenance Study|Lack of Efficacy|19|||
130057137|NCT02065622|468162541|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
130057138|NCT02065622|468162542|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
130057139|NCT02065622|468162543|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
130057140|NCT02065622|468162544|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
130057141|NCT02065622|468162545|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
130057142|NCT02065622|468162541|FG000|Maintenance Study|Subject Non-Compliance|0|||
130057143|NCT02065622|468162542|FG001|Maintenance Study|Subject Non-Compliance|0|||
130057144|NCT02065622|468162543|FG002|Maintenance Study|Subject Non-Compliance|1|||
130057145|NCT02065622|468162544|FG003|Maintenance Study|Subject Non-Compliance|3|||
130057146|NCT02065622|468162545|FG004|Maintenance Study|Subject Non-Compliance|2|||
130057147|NCT02065622|468162541|FG000|Maintenance Study|Other, Not Specified|0|||
129893480|NCT04319094|467569774|FG001|12-month|Lost to Follow-up|8|||
130057148|NCT02065622|468162542|FG001|Maintenance Study|Other, Not Specified|0|||
130057149|NCT02065622|468162543|FG002|Maintenance Study|Other, Not Specified|6|||
130057150|NCT02065622|468162544|FG003|Maintenance Study|Other, Not Specified|14|||
130057151|NCT02065622|468162545|FG004|Maintenance Study|Other, Not Specified|2|||
129805994|NCT02713204|467256833|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805995|NCT02713204|467256826|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129805996|NCT02713204|467256827|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
129805997|NCT02713204|467256828|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129805998|NCT02713204|467256829|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129805999|NCT02713204|467256830|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806000|NCT02713204|467256831|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806001|NCT02713204|467256832|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806002|NCT02713204|467256833|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806003|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Adverse Event|1|||
129806004|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Adverse Event|0|||
129806005|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Adverse Event|0|||
129806006|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Adverse Event|1|||
129806007|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Adverse Event|1|||
129806008|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Adverse Event|0|||
129806009|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Adverse Event|2|||
129806010|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Adverse Event|1|||
129806011|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Death|0|||
129806012|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Death|0|||
129806013|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Death|0|||
129806014|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Death|1|||
129806015|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Death|0|||
129806016|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Death|1|||
129806017|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Death|0|||
129806018|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Death|3|||
129806019|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806020|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806021|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806022|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
129806023|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806024|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806025|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806026|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806027|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
129806028|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
129806029|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
129806030|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
129806031|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
129806032|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
129806033|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
129806034|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
129806035|NCT00669396|467256834|FG000|Overall Study|Lost to Follow-up|10|||
129806036|NCT00669396|467256835|FG001|Overall Study|Lost to Follow-up|12|||
129806037|NCT04251273|467256836|FG000|Overall Study|Lost to Follow-up|331|||
129806038|NCT04251273|467256837|FG001|Overall Study|Lost to Follow-up|290|||
129806039|NCT04402060|467256838|FG000|Overall Study|Death|1|||
129806040|NCT04402060|467256839|FG001|Overall Study|Death|12|||
129806041|NCT04402060|467256840|FG002|Overall Study|Death|7|||
129806042|NCT04402060|467256838|FG000|Overall Study|Adverse Event|0|||
129806043|NCT04402060|467256839|FG001|Overall Study|Adverse Event|0|||
129806044|NCT04402060|467256840|FG002|Overall Study|Adverse Event|1|||
129806045|NCT04402060|467256838|FG000|Overall Study|Withdrawal by Subject|0|||
129806046|NCT04402060|467256839|FG001|Overall Study|Withdrawal by Subject|1|||
129806047|NCT04402060|467256840|FG002|Overall Study|Withdrawal by Subject|2|||
129806048|NCT04402060|467256838|FG000|Overall Study|Sponsor Request|0|||
129806049|NCT04402060|467256839|FG001|Overall Study|Sponsor Request|2|||
129806050|NCT04402060|467256840|FG002|Overall Study|Sponsor Request|0|||
129806051|NCT04402060|467256838|FG000|Overall Study|Physician Decision|0|||
129806052|NCT04402060|467256839|FG001|Overall Study|Physician Decision|0|||
129806053|NCT04402060|467256840|FG002|Overall Study|Physician Decision|1|||
129806054|NCT04402060|467256838|FG000|Overall Study|Other|0|||
129806055|NCT04402060|467256839|FG001|Overall Study|Other|1|||
129806056|NCT04402060|467256840|FG002|Overall Study|Other|0|||
129806057|NCT00810693|467256843|FG000|Treatment Period|Adverse Event|8|||
129806058|NCT00810693|467256844|FG001|Treatment Period|Adverse Event|1|||
129806059|NCT00810693|467256845|FG002|Treatment Period|Adverse Event|7|||
129806060|NCT00810693|467256843|FG000|Treatment Period|Death|0|||
129806061|NCT00810693|467256844|FG001|Treatment Period|Death|1|||
129806062|NCT00810693|467256845|FG002|Treatment Period|Death|2|||
129806063|NCT00810693|467256843|FG000|Treatment Period|Lack of Efficacy|0|||
129806064|NCT00810693|467256844|FG001|Treatment Period|Lack of Efficacy|0|||
129806065|NCT00810693|467256845|FG002|Treatment Period|Lack of Efficacy|1|||
129806066|NCT00810693|467256843|FG000|Treatment Period|Lost to Follow-up|1|||
129806067|NCT00810693|467256844|FG001|Treatment Period|Lost to Follow-up|0|||
129806068|NCT00810693|467256845|FG002|Treatment Period|Lost to Follow-up|0|||
129806069|NCT00810693|467256843|FG000|Treatment Period|Non-compliance|1|||
129806070|NCT00810693|467256844|FG001|Treatment Period|Non-compliance|0|||
130057152|NCT02065622|468162541|FG000|Maintenance Study|Unknown Reason|0|||
130057153|NCT02065622|468162542|FG001|Maintenance Study|Unknown Reason|0|||
130057154|NCT02065622|468162543|FG002|Maintenance Study|Unknown Reason|0|||
130057155|NCT02065622|468162544|FG003|Maintenance Study|Unknown Reason|1|||
130057156|NCT02065622|468162545|FG004|Maintenance Study|Unknown Reason|0|||
130057157|NCT01767194|468162548|FG000|Overall Study|Adverse Event|1|||
130057158|NCT01767194|468162549|FG001|Overall Study|Adverse Event|1|||
130057159|NCT01767194|468162548|FG000|Overall Study|Death|0|||
130057160|NCT01767194|468162549|FG001|Overall Study|Death|1|||
130057161|NCT01767194|468162548|FG000|Overall Study|Lack of Efficacy|12|||
130057162|NCT01767194|468162549|FG001|Overall Study|Lack of Efficacy|11|||
130057163|NCT01767194|468162548|FG000|Overall Study|Physician Decision|2|||
130057164|NCT01767194|468162549|FG001|Overall Study|Physician Decision|23|||
130057165|NCT01767194|468162548|FG000|Overall Study|Withdrawal by Subject|0|||
130057166|NCT01767194|468162549|FG001|Overall Study|Withdrawal by Subject|1|||
130057167|NCT01767194|468162548|FG000|Overall Study|Ineligible|1|||
130057168|NCT01767194|468162549|FG001|Overall Study|Ineligible|1|||
130057169|NCT01767194|468162548|FG000|Overall Study|Refusal by patient/parent|2|||
130057170|NCT01767194|468162549|FG001|Overall Study|Refusal by patient/parent|4|||
130057171|NCT01767194|468162548|FG000|Overall Study|Criteria not met on time for next cycle|0|||
130057172|NCT01767194|468162549|FG001|Overall Study|Criteria not met on time for next cycle|1|||
130057173|NCT00406640|468162552|FG000|Acute Phase|Adverse Event|18|||
130057174|NCT00406640|468162553|FG001|Acute Phase|Adverse Event|13|||
130057175|NCT00406640|468162552|FG000|Acute Phase|Failed to Return|5|||
130057176|NCT00406640|468162553|FG001|Acute Phase|Failed to Return|1|||
130057177|NCT00406640|468162552|FG000|Acute Phase|Physician Decision|0|||
130057178|NCT00406640|468162553|FG001|Acute Phase|Physician Decision|1|||
130057179|NCT00406640|468162552|FG000|Acute Phase|Lost to Follow-up|7|||
130057180|NCT00406640|468162553|FG001|Acute Phase|Lost to Follow-up|4|||
130057181|NCT00406640|468162552|FG000|Acute Phase|Protocol deviation|4|||
130057182|NCT00406640|468162553|FG001|Acute Phase|Protocol deviation|10|||
130057183|NCT00406640|468162552|FG000|Acute Phase|Protocol Violation|3|||
130057184|NCT00406640|468162553|FG001|Acute Phase|Protocol Violation|2|||
130057185|NCT00406640|468162552|FG000|Acute Phase|Withdrawal by Subject|11|||
130057186|NCT00406640|468162553|FG001|Acute Phase|Withdrawal by Subject|9|||
130057187|NCT00406640|468162552|FG000|Acute Phase|Lack of Efficacy|3|||
130057188|NCT00406640|468162553|FG001|Acute Phase|Lack of Efficacy|3|||
130057189|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
130057190|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
130057191|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Death|1|||
130057192|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Death|0|||
130057193|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
130057194|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
130057195|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
130057196|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
130057197|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
130057198|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
130057199|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|non-compliance|7|||
130057200|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|non-compliance|5|||
130057201|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
130057202|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
130057203|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
130057204|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
130057205|NCT00406640|468162552|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
130057206|NCT00406640|468162553|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
129806071|NCT00810693|467256845|FG002|Treatment Period|Non-compliance|0|||
129806072|NCT00810693|467256843|FG000|Treatment Period|Protocol Violation|1|||
129806073|NCT00810693|467256844|FG001|Treatment Period|Protocol Violation|2|||
129806074|NCT00810693|467256845|FG002|Treatment Period|Protocol Violation|2|||
129806075|NCT00810693|467256843|FG000|Treatment Period|Withdrawal by Subject|6|||
129806076|NCT00810693|467256844|FG001|Treatment Period|Withdrawal by Subject|2|||
129806077|NCT00810693|467256845|FG002|Treatment Period|Withdrawal by Subject|3|||
129806078|NCT00810693|467256843|FG000|Treatment Period|Not treated|0|||
129806079|NCT00810693|467256844|FG001|Treatment Period|Not treated|1|||
129806080|NCT00810693|467256845|FG002|Treatment Period|Not treated|1|||
129806081|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Adverse Event|3|||
129806082|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Adverse Event|1|||
129806083|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Adverse Event|1|||
129806084|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Death|2|||
129806085|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Death|0|||
129806086|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Death|1|||
129806087|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
129806088|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
129806089|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
129806090|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
129806091|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
129806092|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
129806093|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
129806094|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
129806095|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
129806096|NCT03212690|467256846|FG000|Overall Study|Protocol Violation|1|||
129806097|NCT03386474|467256856|FG000|Overall Study|Death|1|||
129806098|NCT03386474|467256857|FG001|Overall Study|Death|0|||
129806099|NCT03386474|467256856|FG000|Overall Study|Adverse Event|0|||
129806100|NCT03386474|467256857|FG001|Overall Study|Adverse Event|1|||
129806101|NCT02155881|467256858|FG000|Overall Study|Withdrawal by Subject|0|||
129806102|NCT02155881|467256859|FG001|Overall Study|Withdrawal by Subject|2|||
129806103|NCT02155881|467256858|FG000|Overall Study|Inappropriately randomized|2|||
129806104|NCT02155881|467256859|FG001|Overall Study|Inappropriately randomized|2|||
129806105|NCT04357782|467256860|FG000|Overall Study|Discharged from hospital|1|||
129806106|NCT04357782|467256861|FG001|Overall Study|Discharged from hospital|0|||
129806107|NCT04357782|467256860|FG000|Overall Study|Death|0|||
129806108|NCT04357782|467256861|FG001|Overall Study|Death|2|||
129806109|NCT03780543|467256862|FG000|Overall Study|Adverse Event|1|||
129806110|NCT03780543|467256863|FG001|Overall Study|Adverse Event|0|||
129806111|NCT03780543|467256864|FG002|Overall Study|Adverse Event|2|||
129806112|NCT03780543|467256862|FG000|Overall Study|Lost to Follow-up|2|||
129806113|NCT03780543|467256863|FG001|Overall Study|Lost to Follow-up|0|||
129806114|NCT03780543|467256864|FG002|Overall Study|Lost to Follow-up|1|||
130057207|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
130057208|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
130057209|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
129806115|NCT03780543|467256862|FG000|Overall Study|Study terminated by Sponsor|8|||
129806116|NCT03780543|467256863|FG001|Overall Study|Study terminated by Sponsor|7|||
129806117|NCT03780543|467256864|FG002|Overall Study|Study terminated by Sponsor|13|||
129806118|NCT03780543|467256862|FG000|Overall Study|Withdrawal by Subject|1|||
129806119|NCT03780543|467256863|FG001|Overall Study|Withdrawal by Subject|8|||
129806120|NCT03780543|467256864|FG002|Overall Study|Withdrawal by Subject|1|||
129806121|NCT03780543|467256862|FG000|Overall Study|Noncompliance with study drug|1|||
129806122|NCT03780543|467256863|FG001|Overall Study|Noncompliance with study drug|0|||
129806123|NCT03780543|467256864|FG002|Overall Study|Noncompliance with study drug|0|||
129806124|NCT00066729|467256865|FG000|Overall Study|Lost to Follow-up|1|||
129806125|NCT00066729|467256865|FG000|Overall Study|Disease progression|1|||
129806126|NCT00287365|467256868|FG000|Overall Study|sample not acquired|13|||
129806127|NCT02298023|467256871|FG000|Overall Study|Withdrawal by Subject|1|||
129806128|NCT02298023|467256872|FG001|Overall Study|Withdrawal by Subject|0|||
129893481|NCT02487446|467569778|FG000|Period 1|Physician Decision|0|||
129893482|NCT02487446|467569779|FG001|Period 1|Physician Decision|1|||
129893483|NCT02487446|467569778|FG000|Period 1|Lack of Efficacy|1|||
129893484|NCT02487446|467569779|FG001|Period 1|Lack of Efficacy|0|||
129893485|NCT02487446|467569778|FG000|Period 1|Protocol deviation|3|||
129806129|NCT02298023|467256873|FG002|Overall Study|Withdrawal by Subject|0|||
129806130|NCT01967173|467256874|FG000|Overall Study|Lost to Follow-up|5|||
129806131|NCT01967173|467256875|FG001|Overall Study|Lost to Follow-up|3|||
129806132|NCT01967173|467256876|FG002|Overall Study|Lost to Follow-up|2|||
129806133|NCT01967173|467256877|FG003|Overall Study|Lost to Follow-up|4|||
129806134|NCT01967173|467256878|FG004|Overall Study|Lost to Follow-up|8|||
129806135|NCT01967173|467256879|FG005|Overall Study|Lost to Follow-up|12|||
129806136|NCT01967173|467256880|FG006|Overall Study|Lost to Follow-up|6|||
129806137|NCT01967173|467256881|FG007|Overall Study|Lost to Follow-up|8|||
129806138|NCT01967173|467256874|FG000|Overall Study|Physician Decision|2|||
129806139|NCT01967173|467256875|FG001|Overall Study|Physician Decision|0|||
129806140|NCT01967173|467256876|FG002|Overall Study|Physician Decision|2|||
129806141|NCT01967173|467256877|FG003|Overall Study|Physician Decision|1|||
129806142|NCT01967173|467256878|FG004|Overall Study|Physician Decision|1|||
129806143|NCT01967173|467256879|FG005|Overall Study|Physician Decision|1|||
130057210|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
130057211|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
130057212|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
130057213|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
130057214|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
130057215|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
130057216|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
130057217|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
130057218|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
130057219|NCT00406640|468162552|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
130057220|NCT00406640|468162553|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
130057221|NCT01454401|468162556|FG000|Overall Study|Death|1|||
130057222|NCT01454401|468162556|FG000|Overall Study|hospitalised|1|||
130057223|NCT01454401|468162556|FG000|Overall Study|osteomyelitis|2|||
130057224|NCT01454401|468162556|FG000|Overall Study|non-adherence|1|||
130057225|NCT00755846|468164296|FG000|Overall Study|Adverse Event|0|||
130057226|NCT00755846|468164297|FG001|Overall Study|Adverse Event|0|||
130057227|NCT00755846|468164298|FG002|Overall Study|Adverse Event|0|||
130057228|NCT00755846|468164299|FG003|Overall Study|Adverse Event|1|||
130057229|NCT00755846|468164300|FG004|Overall Study|Adverse Event|3|||
130057230|NCT00755846|468164301|FG005|Overall Study|Adverse Event|2|||
130057231|NCT00755846|468164296|FG000|Overall Study|Protocol Violation|1|||
130057232|NCT00755846|468164297|FG001|Overall Study|Protocol Violation|1|||
130057233|NCT00755846|468164298|FG002|Overall Study|Protocol Violation|1|||
130057234|NCT00755846|468164299|FG003|Overall Study|Protocol Violation|1|||
130057235|NCT00755846|468164300|FG004|Overall Study|Protocol Violation|1|||
130057236|NCT00755846|468164301|FG005|Overall Study|Protocol Violation|1|||
130057237|NCT00755846|468164296|FG000|Overall Study|Lost to Follow-up|0|||
130057238|NCT00755846|468164297|FG001|Overall Study|Lost to Follow-up|2|||
130057239|NCT00755846|468164298|FG002|Overall Study|Lost to Follow-up|1|||
130057240|NCT00755846|468164299|FG003|Overall Study|Lost to Follow-up|0|||
130057241|NCT00755846|468164300|FG004|Overall Study|Lost to Follow-up|4|||
130057242|NCT00755846|468164301|FG005|Overall Study|Lost to Follow-up|2|||
130057243|NCT00755846|468164296|FG000|Overall Study|Withdrawal by Subject|2|||
130057244|NCT00755846|468164297|FG001|Overall Study|Withdrawal by Subject|3|||
130057245|NCT00755846|468164298|FG002|Overall Study|Withdrawal by Subject|5|||
130057246|NCT00755846|468164299|FG003|Overall Study|Withdrawal by Subject|2|||
130057247|NCT00755846|468164300|FG004|Overall Study|Withdrawal by Subject|0|||
130057248|NCT00755846|468164301|FG005|Overall Study|Withdrawal by Subject|1|||
130057249|NCT00755846|468164296|FG000|Overall Study|Hyperglycemic Rescue|21|||
130057250|NCT00755846|468164297|FG001|Overall Study|Hyperglycemic Rescue|7|||
130057251|NCT00755846|468164298|FG002|Overall Study|Hyperglycemic Rescue|5|||
130057252|NCT00755846|468164299|FG003|Overall Study|Hyperglycemic Rescue|8|||
130057253|NCT00755846|468164300|FG004|Overall Study|Hyperglycemic Rescue|8|||
130057254|NCT00755846|468164301|FG005|Overall Study|Hyperglycemic Rescue|7|||
130057255|NCT00755846|468164296|FG000|Overall Study|Physician Decision|1|||
130057256|NCT00755846|468164297|FG001|Overall Study|Physician Decision|3|||
130057257|NCT00755846|468164298|FG002|Overall Study|Physician Decision|0|||
130057258|NCT00755846|468164299|FG003|Overall Study|Physician Decision|1|||
130057259|NCT00755846|468164300|FG004|Overall Study|Physician Decision|0|||
129893486|NCT02487446|467569779|FG001|Period 1|Protocol deviation|2|||
129893487|NCT02487446|467569778|FG000|Period 1|Lost to Follow-up|2|||
129893488|NCT02487446|467569779|FG001|Period 1|Lost to Follow-up|0|||
129893489|NCT02487446|467569778|FG000|Period 1|Withdrawal by Subject|2|||
129893490|NCT02487446|467569779|FG001|Period 1|Withdrawal by Subject|0|||
129893491|NCT02487446|467569778|FG000|Period 1|Adverse Event|5|||
129893492|NCT02487446|467569779|FG001|Period 1|Adverse Event|5|||
129893493|NCT02487446|467569778|FG000|Washout|Lost to Follow-up|0|||
129893494|NCT02487446|467569779|FG001|Washout|Lost to Follow-up|2|||
129893495|NCT02487446|467569778|FG000|Washout|Withdrawal by Subject|1|||
129893496|NCT02487446|467569779|FG001|Washout|Withdrawal by Subject|4|||
129893497|NCT02487446|467569778|FG000|Washout|Adverse Event|2|||
129893498|NCT02487446|467569779|FG001|Washout|Adverse Event|2|||
129893499|NCT02487446|467569778|FG000|Period 2|Protocol deviation|0|||
129893500|NCT02487446|467569779|FG001|Period 2|Protocol deviation|1|||
129893501|NCT02487446|467569778|FG000|Period 2|Lost to Follow-up|1|||
129893502|NCT02487446|467569779|FG001|Period 2|Lost to Follow-up|1|||
129893503|NCT02487446|467569778|FG000|Period 2|Withdrawal by Subject|1|||
129893504|NCT02487446|467569779|FG001|Period 2|Withdrawal by Subject|1|||
129893505|NCT02487446|467569778|FG000|Period 2|Adverse Event|6|||
129893506|NCT02487446|467569779|FG001|Period 2|Adverse Event|2|||
129893507|NCT01822821|467569780|FG000|Overall Study|Eligible surgery cancelled|1|||
129893508|NCT01822821|467569781|FG001|Overall Study|Eligible surgery cancelled|1|||
129893509|NCT01822821|467569780|FG000|Overall Study|Other reasons|1|||
129893510|NCT01822821|467569781|FG001|Overall Study|Other reasons|0|||
129893511|NCT05780047|467569782|FG000|Overall Study|Did not submit baseline urine test kit|226|||
129893512|NCT05780047|467569782|FG000|Overall Study|Lost to Follow-up|34|||
129893513|NCT05780047|467569782|FG000|Overall Study|Did not submit second urine test kit|124|||
129893514|NCT00764868|467569785|FG000|Overall Study|Adverse Event|18|||
129893515|NCT00764868|467569785|FG000|Overall Study|Withdrawal by Subject|31|||
129893516|NCT00764868|467569785|FG000|Overall Study|Non-compliance|16|||
129893517|NCT00764868|467569785|FG000|Overall Study|Lost to Follow-up|25|||
129893518|NCT00764868|467569785|FG000|Overall Study|Lack of Efficacy|5|||
129893519|NCT00764868|467569785|FG000|Overall Study|Subject moved|7|||
129893520|NCT00764868|467569785|FG000|Overall Study|Pregnancy|3|||
129893521|NCT00764868|467569785|FG000|Overall Study|Prohibited medication|1|||
129893522|NCT00764868|467569785|FG000|Overall Study|Out of town|1|||
129893523|NCT00764868|467569785|FG000|Overall Study|Misuse and compliance of study drug|1|||
129893524|NCT00764868|467569785|FG000|Overall Study|Subject sent to boarding school|1|||
129893525|NCT00764868|467569785|FG000|Overall Study|Met an exclusion criteria|1|||
129893526|NCT00764868|467569785|FG000|Overall Study|Positive drug screen|2|||
129893527|NCT00764868|467569785|FG000|Overall Study|Sponsor requested withdrawal|1|||
129893528|NCT04438785|467569790|FG000|Overall Study|change of weight, give up intervention|2|||
130057260|NCT00755846|468164301|FG005|Overall Study|Physician Decision|1|||
130057261|NCT00755846|468164296|FG000|Overall Study|Administrative Error|0|||
130057262|NCT00755846|468164297|FG001|Overall Study|Administrative Error|1|||
130057263|NCT00755846|468164298|FG002|Overall Study|Administrative Error|0|||
130057264|NCT00755846|468164299|FG003|Overall Study|Administrative Error|0|||
130057265|NCT00755846|468164300|FG004|Overall Study|Administrative Error|0|||
130057266|NCT00755846|468164301|FG005|Overall Study|Administrative Error|0|||
130057267|NCT00755846|468164296|FG000|Overall Study|Participant Non-compliance|0|||
130057268|NCT00755846|468164297|FG001|Overall Study|Participant Non-compliance|0|||
130057269|NCT00755846|468164298|FG002|Overall Study|Participant Non-compliance|0|||
130057270|NCT00755846|468164299|FG003|Overall Study|Participant Non-compliance|0|||
130057271|NCT00755846|468164300|FG004|Overall Study|Participant Non-compliance|1|||
130057272|NCT00755846|468164301|FG005|Overall Study|Participant Non-compliance|0|||
130057273|NCT00311181|468164302|FG000|Overall Study|Final DFTs were not obtained|96|||
130057274|NCT02669862|468164303|FG000|Overall Study|Lost to Follow-up|0|||
130057275|NCT02669862|468164304|FG001|Overall Study|Lost to Follow-up|2|||
130057276|NCT02669862|468164305|FG002|Overall Study|Lost to Follow-up|1|||
130057277|NCT02669862|468164303|FG000|Overall Study|Withdrawal by Subject|2|||
130057278|NCT02669862|468164304|FG001|Overall Study|Withdrawal by Subject|2|||
130057279|NCT02669862|468164305|FG002|Overall Study|Withdrawal by Subject|3|||
130057280|NCT02669862|468164303|FG000|Overall Study|moved|0|||
130057281|NCT02669862|468164304|FG001|Overall Study|moved|1|||
130057282|NCT02669862|468164305|FG002|Overall Study|moved|0|||
130057283|NCT02669862|468164303|FG000|Overall Study|Protocol Violation|0|||
130057284|NCT02669862|468164304|FG001|Overall Study|Protocol Violation|0|||
130057285|NCT02669862|468164305|FG002|Overall Study|Protocol Violation|1|||
130057286|NCT02429258|468164308|FG000|Overall Study|Withdrawal by Subject|2|||
130057287|NCT02429258|468164309|FG001|Overall Study|Withdrawal by Subject|0|||
130057288|NCT02429258|468164308|FG000|Overall Study|Protocol Violation|0|||
130057289|NCT02429258|468164309|FG001|Overall Study|Protocol Violation|1|||
130057290|NCT02397694|468164310|FG000|Double-Blinded Phase|Adverse Event|1|||
130057291|NCT02397694|468164311|FG001|Double-Blinded Phase|Adverse Event|0|||
130057292|NCT02397694|468164310|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
130057293|NCT02397694|468164311|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
130057294|NCT02397694|468164310|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
130057295|NCT02397694|468164311|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
130057296|NCT02397694|468164310|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
130057297|NCT02397694|468164311|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
130057298|NCT02397694|468164310|FG000|Open Label Extension Phase|Protocol Violation|1|||
130057299|NCT02397694|468164311|FG001|Open Label Extension Phase|Protocol Violation|0|||
130057300|NCT02397694|468164310|FG000|Open Label Extension Phase|Withdrew Consent|3|||
130057301|NCT02397694|468164311|FG001|Open Label Extension Phase|Withdrew Consent|1|||
130057302|NCT02397694|468164310|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
130057303|NCT02397694|468164311|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
130057304|NCT02670915|468164312|FG000|Overall Study|Withdrawal by Subject|0|||
130057305|NCT02670915|468164313|FG001|Overall Study|Withdrawal by Subject|1|||
129806144|NCT01967173|467256880|FG006|Overall Study|Physician Decision|1|||
129806145|NCT01967173|467256881|FG007|Overall Study|Physician Decision|0|||
129806146|NCT01967173|467256874|FG000|Overall Study|Lack of Efficacy|2|||
129806147|NCT01967173|467256875|FG001|Overall Study|Lack of Efficacy|0|||
129806148|NCT01967173|467256876|FG002|Overall Study|Lack of Efficacy|2|||
129806149|NCT01967173|467256877|FG003|Overall Study|Lack of Efficacy|2|||
129806150|NCT01967173|467256878|FG004|Overall Study|Lack of Efficacy|0|||
129806151|NCT01967173|467256879|FG005|Overall Study|Lack of Efficacy|1|||
129806152|NCT01967173|467256880|FG006|Overall Study|Lack of Efficacy|0|||
129806153|NCT01967173|467256881|FG007|Overall Study|Lack of Efficacy|2|||
129806154|NCT01967173|467256874|FG000|Overall Study|Pregnancy|0|||
129806155|NCT01967173|467256875|FG001|Overall Study|Pregnancy|0|||
129806156|NCT01967173|467256876|FG002|Overall Study|Pregnancy|0|||
129806157|NCT01967173|467256877|FG003|Overall Study|Pregnancy|0|||
129806158|NCT01967173|467256878|FG004|Overall Study|Pregnancy|0|||
129806159|NCT01967173|467256879|FG005|Overall Study|Pregnancy|0|||
129806160|NCT01967173|467256880|FG006|Overall Study|Pregnancy|1|||
129806161|NCT01967173|467256881|FG007|Overall Study|Pregnancy|1|||
129806162|NCT01967173|467256874|FG000|Overall Study|Adverse Event|0|||
129806163|NCT01967173|467256875|FG001|Overall Study|Adverse Event|0|||
129806164|NCT01967173|467256876|FG002|Overall Study|Adverse Event|0|||
129806165|NCT01967173|467256877|FG003|Overall Study|Adverse Event|0|||
129806166|NCT01967173|467256878|FG004|Overall Study|Adverse Event|0|||
129806167|NCT01967173|467256879|FG005|Overall Study|Adverse Event|0|||
129806168|NCT01967173|467256880|FG006|Overall Study|Adverse Event|0|||
129806169|NCT01967173|467256881|FG007|Overall Study|Adverse Event|1|||
129806170|NCT01967173|467256874|FG000|Overall Study|Withdrawal by Subject|15|||
129806171|NCT01967173|467256875|FG001|Overall Study|Withdrawal by Subject|14|||
129806172|NCT01967173|467256876|FG002|Overall Study|Withdrawal by Subject|10|||
129806173|NCT01967173|467256877|FG003|Overall Study|Withdrawal by Subject|7|||
129806174|NCT01967173|467256878|FG004|Overall Study|Withdrawal by Subject|8|||
129806175|NCT01967173|467256879|FG005|Overall Study|Withdrawal by Subject|9|||
129806176|NCT01967173|467256880|FG006|Overall Study|Withdrawal by Subject|10|||
129806177|NCT01967173|467256881|FG007|Overall Study|Withdrawal by Subject|12|||
129806178|NCT02020577|467256882|FG000|Overall Study|Progressive disease|3|||
129806179|NCT02020577|467256883|FG001|Overall Study|Progressive disease|38|||
129806180|NCT02020577|467256882|FG000|Overall Study|Other AE or clinical progression|0|||
129806181|NCT02020577|467256883|FG001|Overall Study|Other AE or clinical progression|15|||
129806182|NCT02020577|467256882|FG000|Overall Study|Withdrawal by Subject|0|||
129806183|NCT02020577|467256883|FG001|Overall Study|Withdrawal by Subject|1|||
129806184|NCT02020577|467256882|FG000|Overall Study|Other than stated above|0|||
129806185|NCT02020577|467256883|FG001|Overall Study|Other than stated above|1|||
129806186|NCT00241358|467256884|FG000|Overall Study|Determined to be not ineligible|0|||
130057306|NCT02670915|468164314|FG002|Overall Study|Withdrawal by Subject|4|||
130057307|NCT02670915|468164312|FG000|Overall Study|Withdrawal by parent/guardian|4|||
130057308|NCT02670915|468164313|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130057309|NCT02670915|468164314|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130057310|NCT02670915|468164312|FG000|Overall Study|Unclassified|0|||
130057311|NCT02670915|468164313|FG001|Overall Study|Unclassified|3|||
130057312|NCT02670915|468164314|FG002|Overall Study|Unclassified|0|||
130057313|NCT00818207|468164315|FG000|Overall Study|Adverse Event|6|||
130057314|NCT00818207|468164316|FG001|Overall Study|Adverse Event|0|||
130057315|NCT00818207|468164315|FG000|Overall Study|Lost to Follow-up|160|||
130057316|NCT00818207|468164316|FG001|Overall Study|Lost to Follow-up|146|||
130057317|NCT00818207|468164315|FG000|Overall Study|Multiple reasons|11|||
130057318|NCT00818207|468164316|FG001|Overall Study|Multiple reasons|12|||
130057319|NCT00818207|468164315|FG000|Overall Study|Withdrawal by Subject|42|||
130057320|NCT00818207|468164316|FG001|Overall Study|Withdrawal by Subject|104|||
130057321|NCT00818207|468164315|FG000|Overall Study|Death|3|||
130057322|NCT00818207|468164316|FG001|Overall Study|Death|5|||
130057323|NCT02494778|468164317|FG000|Overall Study|Death|3|||
130057324|NCT02494778|468164317|FG000|Overall Study|Other|173|||
130057325|NCT02494778|468164317|FG000|Overall Study|Lack of Efficacy|4|||
130057326|NCT02494778|468164317|FG000|Overall Study|Adverse Event|18|||
130057327|NCT02494778|468164317|FG000|Overall Study|Withdrawal by Subject|20|||
130057328|NCT02494778|468164317|FG000|Overall Study|Lost to Follow-up|2|||
130057329|NCT02494778|468164317|FG000|Overall Study|Noncompliant with study drug admin.|1|||
130057330|NCT02616185|468164318|FG000|Overall Study|Death|0|||
130057331|NCT02616185|468164319|FG001|Overall Study|Death|0|||
129806187|NCT00241358|467256885|FG001|Overall Study|Determined to be not ineligible|1|||
129806188|NCT00241358|467256886|FG002|Overall Study|Determined to be not ineligible|1|||
130057332|NCT02616185|468164320|FG002|Overall Study|Death|0|||
130057333|NCT02616185|468164321|FG003|Overall Study|Death|1|||
130057334|NCT02616185|468164322|FG004|Overall Study|Death|2|||
129806189|NCT02663908|467256887|FG000|Overall Study|Withdrawal by Subject|8|||
129806190|NCT02663908|467256888|FG001|Overall Study|Withdrawal by Subject|5|||
129806191|NCT02663908|467256887|FG000|Overall Study|Lost to Follow-up|1|||
129806192|NCT02663908|467256888|FG001|Overall Study|Lost to Follow-up|5|||
129806193|NCT02663908|467256887|FG000|Overall Study|Adverse Event|13|||
130057335|NCT02616185|468164323|FG005|Overall Study|Death|0|||
130057336|NCT02616185|468164324|FG006|Overall Study|Death|0|||
130057337|NCT02616185|468164325|FG007|Overall Study|Death|2|||
130057338|NCT02616185|468164326|FG008|Overall Study|Death|1|||
130111991|NCT02544633|468371014|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
130111992|NCT02544633|468371015|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
130111993|NCT02544633|468371012|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
130111994|NCT02544633|468371013|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
130111995|NCT02544633|468371014|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
130111996|NCT02544633|468371015|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
130111997|NCT02544633|468371012|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
130111998|NCT02544633|468371013|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
130111999|NCT02544633|468371014|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
130112000|NCT02544633|468371015|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
130112001|NCT01977352|468371016|FG000|Overall Study|Lost to Follow-up|1|||
130112002|NCT01977352|468371017|FG001|Overall Study|Lost to Follow-up|2|||
130112003|NCT02270983|468371018|FG000|Overall Study|Adverse Event|3|||
130112004|NCT02270983|468371019|FG001|Overall Study|Adverse Event|2|||
130112005|NCT02270983|468371020|FG002|Overall Study|Adverse Event|6|||
130112006|NCT02270983|468371018|FG000|Overall Study|Lack of Efficacy|2|||
130112007|NCT02270983|468371019|FG001|Overall Study|Lack of Efficacy|1|||
130112008|NCT02270983|468371020|FG002|Overall Study|Lack of Efficacy|1|||
130112009|NCT02270983|468371018|FG000|Overall Study|Withdrawal by Subject|1|||
130112010|NCT02270983|468371019|FG001|Overall Study|Withdrawal by Subject|0|||
130112011|NCT02270983|468371020|FG002|Overall Study|Withdrawal by Subject|2|||
130057339|NCT02616185|468164318|FG000|Overall Study|Study terminated by sponsor|0|||
130057340|NCT02616185|468164319|FG001|Overall Study|Study terminated by sponsor|0|||
130057341|NCT02616185|468164320|FG002|Overall Study|Study terminated by sponsor|1|||
130057342|NCT02616185|468164321|FG003|Overall Study|Study terminated by sponsor|0|||
130057343|NCT02616185|468164322|FG004|Overall Study|Study terminated by sponsor|0|||
130057344|NCT02616185|468164323|FG005|Overall Study|Study terminated by sponsor|0|||
130057345|NCT02616185|468164324|FG006|Overall Study|Study terminated by sponsor|5|||
130057346|NCT02616185|468164325|FG007|Overall Study|Study terminated by sponsor|2|||
130057347|NCT02616185|468164326|FG008|Overall Study|Study terminated by sponsor|0|||
130057348|NCT02616185|468164318|FG000|Overall Study|Participant refused further follow-up|1|||
130057349|NCT02616185|468164319|FG001|Overall Study|Participant refused further follow-up|1|||
130057350|NCT02616185|468164320|FG002|Overall Study|Participant refused further follow-up|2|||
130057351|NCT02616185|468164321|FG003|Overall Study|Participant refused further follow-up|3|||
130057352|NCT02616185|468164322|FG004|Overall Study|Participant refused further follow-up|4|||
130057353|NCT02616185|468164323|FG005|Overall Study|Participant refused further follow-up|0|||
130057354|NCT02616185|468164324|FG006|Overall Study|Participant refused further follow-up|3|||
130057355|NCT02616185|468164325|FG007|Overall Study|Participant refused further follow-up|4|||
130057356|NCT02616185|468164326|FG008|Overall Study|Participant refused further follow-up|3|||
130057357|NCT02616185|468164318|FG000|Overall Study|Not reported|0|||
130057358|NCT02616185|468164319|FG001|Overall Study|Not reported|0|||
130057359|NCT02616185|468164320|FG002|Overall Study|Not reported|0|||
130057360|NCT02616185|468164321|FG003|Overall Study|Not reported|1|||
130057361|NCT02616185|468164322|FG004|Overall Study|Not reported|3|||
130057362|NCT02616185|468164323|FG005|Overall Study|Not reported|1|||
130057363|NCT02616185|468164324|FG006|Overall Study|Not reported|0|||
130057364|NCT02616185|468164325|FG007|Overall Study|Not reported|5|||
130057365|NCT02616185|468164326|FG008|Overall Study|Not reported|2|||
130057366|NCT03725202|468164327|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
130057367|NCT03725202|468164328|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
130057368|NCT03725202|468164329|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
130057369|NCT03725202|468164330|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130057370|NCT03725202|468164331|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130057371|NCT03725202|468164332|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130057372|NCT03725202|468164333|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130057373|NCT03725202|468164334|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
130057374|NCT03725202|468164327|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
130057375|NCT03725202|468164328|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
130057376|NCT03725202|468164329|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
130057377|NCT03725202|468164330|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130057378|NCT03725202|468164331|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130057379|NCT03725202|468164332|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130112012|NCT02270983|468371018|FG000|Overall Study|Lost to Follow-up|1|||
130057380|NCT03725202|468164333|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130057381|NCT03725202|468164334|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
130057382|NCT03725202|468164327|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
130112013|NCT02270983|468371019|FG001|Overall Study|Lost to Follow-up|1|||
130112014|NCT02270983|468371020|FG002|Overall Study|Lost to Follow-up|2|||
130112015|NCT02270983|468371018|FG000|Overall Study|Protocol Violation|1|||
130112016|NCT02270983|468371019|FG001|Overall Study|Protocol Violation|1|||
130112017|NCT02270983|468371020|FG002|Overall Study|Protocol Violation|1|||
130057383|NCT03725202|468164328|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130057384|NCT03725202|468164329|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130057385|NCT03725202|468164330|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130057386|NCT03725202|468164331|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130057387|NCT03725202|468164332|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130057388|NCT03725202|468164333|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
130112018|NCT02270983|468371018|FG000|Overall Study|family emergency|0|||
130112019|NCT02270983|468371019|FG001|Overall Study|family emergency|1|||
130112020|NCT02270983|468371020|FG002|Overall Study|family emergency|0|||
130112021|NCT02270983|468371018|FG000|Overall Study|study procedure non-compliance|1|||
130112022|NCT02270983|468371019|FG001|Overall Study|study procedure non-compliance|0|||
130112023|NCT02270983|468371020|FG002|Overall Study|study procedure non-compliance|0|||
130112024|NCT02270983|468371018|FG000|Overall Study|moved away from study site|0|||
130112025|NCT02270983|468371019|FG001|Overall Study|moved away from study site|1|||
130112026|NCT02270983|468371020|FG002|Overall Study|moved away from study site|0|||
130112027|NCT00854620|468371023|FG000|Overall Study|Adverse Event|1|||
130112028|NCT00928252|468371024|FG000|Overall Study|Physician Decision|3|||
130112029|NCT01605461|468371026|FG000|Overall Study|Lost to Follow-up|3|||
130112030|NCT01605461|468371026|FG000|Overall Study|Withdrawal by Subject|1|||
130112031|NCT02024698|468371027|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
130112032|NCT02024698|468371028|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
130112033|NCT00275028|468371029|FG000|Overall Study|Withdrew consent before treatment began|1|||
130112034|NCT00275028|468371029|FG000|Overall Study|Withdrawal by Subject|5|||
130112035|NCT00275028|468371029|FG000|Overall Study|Adverse Event|9|||
130112036|NCT00275028|468371029|FG000|Overall Study|Progressive Disease|30|||
130112037|NCT00275028|468371029|FG000|Overall Study|Physician Decision|2|||
130112038|NCT00331630|468371033|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
130112039|NCT00331630|468371033|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
130112040|NCT00331630|468371033|FG000|Follow up for 5 Years|Death|5|||
130112041|NCT00331630|468371033|FG000|Follow up for 5 Years|Data collection was stopped|24|||
130112042|NCT02370784|468371034|FG000|Overall Study|Patient started prohibited medication|0|||
130112043|NCT02370784|468371035|FG001|Overall Study|Patient started prohibited medication|1|||
130112044|NCT03763331|468371038|FG000|Overall Study|Lost to Follow-up|1|||
130112045|NCT03763331|468371039|FG001|Overall Study|Lost to Follow-up|0|||
130112046|NCT03763331|468371038|FG000|Overall Study|Withdrawal by Subject|1|||
130112047|NCT03763331|468371039|FG001|Overall Study|Withdrawal by Subject|0|||
130112048|NCT03763331|468371038|FG000|Overall Study|Non-compliance|0|||
130112049|NCT03763331|468371039|FG001|Overall Study|Non-compliance|3|||
130112050|NCT01312779|468371040|FG000|Overall Study|Withdrawal by Subject|2|||
130112051|NCT01312779|468371040|FG000|Overall Study|Death|3|||
130112052|NCT01312779|468371040|FG000|Overall Study|Not Implanted with Device|27|||
130112053|NCT04741503|468371041|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
130112054|NCT04741503|468371042|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
130112055|NCT04741503|468371043|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
130112056|NCT04741503|468371041|FG000|Initial Enrollment|Overquotas removed|0|||
130112057|NCT04741503|468371042|FG001|Initial Enrollment|Overquotas removed|0|||
130112058|NCT04741503|468371043|FG002|Initial Enrollment|Overquotas removed|186|||
130112059|NCT04741503|468371041|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
130112060|NCT04741503|468371042|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
130112061|NCT04741503|468371043|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
130112062|NCT02280421|468371046|FG000|Washout (2 Weeks)|Adverse Event|0|||
130112063|NCT02280421|468371047|FG001|Washout (2 Weeks)|Adverse Event|1|||
130112064|NCT02280421|468371046|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
130112065|NCT02280421|468371047|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
130112066|NCT02764489|468371057|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
130112067|NCT02764489|468371058|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
130112068|NCT02764489|468371057|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
130112069|NCT02764489|468371058|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
130112070|NCT02764489|468371057|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
130112071|NCT02764489|468371058|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
130112072|NCT02764489|468371057|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
130112073|NCT02764489|468371058|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
130057389|NCT03725202|468164334|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129806194|NCT02663908|467256888|FG001|Overall Study|Adverse Event|11|||
130057390|NCT03725202|468164327|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
130057391|NCT03725202|468164328|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057392|NCT03725202|468164329|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057393|NCT03725202|468164330|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057394|NCT03725202|468164331|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057395|NCT03725202|468164332|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057396|NCT03725202|468164333|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057397|NCT03725202|468164334|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
130057398|NCT03725202|468164327|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
130057399|NCT03725202|468164328|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
130057400|NCT03725202|468164329|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
130057401|NCT03725202|468164330|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130057402|NCT03725202|468164331|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130057403|NCT03725202|468164332|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130057404|NCT03725202|468164333|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130057405|NCT03725202|468164334|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
130057406|NCT03725202|468164327|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057407|NCT03725202|468164328|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057408|NCT03725202|468164329|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
130057409|NCT03725202|468164330|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057410|NCT03725202|468164331|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057411|NCT03725202|468164332|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057412|NCT03725202|468164333|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057413|NCT03725202|468164334|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
130057414|NCT03725202|468164327|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
130057415|NCT03725202|468164328|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
130057416|NCT03725202|468164329|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
130057417|NCT03725202|468164330|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
130057418|NCT03725202|468164331|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
130057419|NCT03725202|468164332|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
130057420|NCT03725202|468164333|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
130057421|NCT03725202|468164334|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
130057422|NCT03725202|468164327|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
130057423|NCT03725202|468164328|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
130057424|NCT03725202|468164329|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
130057425|NCT03725202|468164330|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
130057426|NCT03725202|468164331|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
130057427|NCT03725202|468164332|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
130057428|NCT03725202|468164333|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
130057429|NCT03725202|468164334|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
130057430|NCT03725202|468164327|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130057431|NCT03725202|468164328|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130057432|NCT03725202|468164329|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130057433|NCT03725202|468164330|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
130057434|NCT03725202|468164331|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130057435|NCT03725202|468164332|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
130057436|NCT03725202|468164333|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
130057437|NCT03725202|468164334|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
130112074|NCT00693784|468371059|FG000|Overall Study|Lost to Follow-up|2|||
130057438|NCT03725202|468164327|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130057439|NCT03725202|468164328|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130057440|NCT03725202|468164329|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129893529|NCT04438785|467569791|FG001|Overall Study|change of weight, give up intervention|10|||
129893530|NCT04011033|467569792|FG000|Overall Study|Physician Decision|2|||
130112075|NCT00693784|468371059|FG000|Overall Study|Withdrawal by Subject|2|||
130112076|NCT00326885|468371063|FG000|Overall Study|Adverse Event|1|||
130112077|NCT00326885|468371063|FG000|Overall Study|Withdrawal by Subject|3|||
130112078|NCT00326885|468371063|FG000|Overall Study|Physician Decision|1|||
130112079|NCT00326885|468371063|FG000|Overall Study|Hospice withdrew consent|2|||
130112080|NCT01706198|468371064|FG000|Overall Study|Adverse Event|12|||
130112081|NCT01706198|468371065|FG001|Overall Study|Adverse Event|15|||
130112082|NCT01706198|468371064|FG000|Overall Study|Protocol Violation|7|||
130112083|NCT01706198|468371065|FG001|Overall Study|Protocol Violation|5|||
130112084|NCT01706198|468371064|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
130112085|NCT01706198|468371065|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
130112086|NCT01706198|468371064|FG000|Overall Study|Lost to Follow-up|97|||
130112087|NCT01706198|468371065|FG001|Overall Study|Lost to Follow-up|93|||
130112088|NCT01706198|468371064|FG000|Overall Study|Physician Decision|23|||
130112089|NCT01706198|468371065|FG001|Overall Study|Physician Decision|37|||
130112090|NCT01706198|468371064|FG000|Overall Study|Withdrawal by Subject|23|||
130112091|NCT01706198|468371065|FG001|Overall Study|Withdrawal by Subject|31|||
130112092|NCT04313283|468371067|FG000|Overall Study|did not complete intervention|4|||
130112093|NCT01473758|468371068|FG000|Cycle 1|Adverse Event|10|||
130112094|NCT01473758|468371069|FG001|Cycle 1|Adverse Event|2|||
130112095|NCT01473758|468371070|FG002|Cycle 1|Adverse Event|0|||
130112096|NCT01473758|468371071|FG003|Cycle 1|Adverse Event|0|||
130112097|NCT01473758|468371068|FG000|Cycle 1|Withdrawal by Subject|1|||
130112098|NCT01473758|468371069|FG001|Cycle 1|Withdrawal by Subject|1|||
130112099|NCT01473758|468371070|FG002|Cycle 1|Withdrawal by Subject|0|||
130112100|NCT01473758|468371071|FG003|Cycle 1|Withdrawal by Subject|0|||
130112101|NCT01473758|468371068|FG000|Cycle 2|Adverse Event|0|||
130112102|NCT01473758|468371069|FG001|Cycle 2|Adverse Event|0|||
130112103|NCT01473758|468371070|FG002|Cycle 2|Adverse Event|5|||
130112104|NCT01473758|468371071|FG003|Cycle 2|Adverse Event|0|||
130112105|NCT02763579|468371072|FG000|Global Period|Death|167|||
130112106|NCT02763579|468371073|FG001|Global Period|Death|151|||
130112107|NCT02763579|468371074|FG002|Global Period|Death|0|||
130112108|NCT02763579|468371075|FG003|Global Period|Death|0|||
130112109|NCT02763579|468371072|FG000|Global Period|Lost to Follow-up|2|||
130112110|NCT02763579|468371073|FG001|Global Period|Lost to Follow-up|4|||
130112111|NCT02763579|468371074|FG002|Global Period|Lost to Follow-up|0|||
130112112|NCT02763579|468371075|FG003|Global Period|Lost to Follow-up|0|||
130112113|NCT02763579|468371072|FG000|Global Period|Physician Decision|0|||
130112114|NCT02763579|468371073|FG001|Global Period|Physician Decision|2|||
130112115|NCT02763579|468371074|FG002|Global Period|Physician Decision|0|||
130112116|NCT02763579|468371075|FG003|Global Period|Physician Decision|0|||
130112117|NCT02763579|468371072|FG000|Global Period|Study Terminated By Sponsor|21|||
129806195|NCT02663908|467256887|FG000|Overall Study|Protocol Violation|1|||
129806196|NCT02663908|467256888|FG001|Overall Study|Protocol Violation|2|||
129806197|NCT02663908|467256887|FG000|Overall Study|Lack of therapeutic response|2|||
129806198|NCT02663908|467256888|FG001|Overall Study|Lack of therapeutic response|0|||
129806199|NCT02663908|467256887|FG000|Overall Study|COVID-19|1|||
129806200|NCT02663908|467256888|FG001|Overall Study|COVID-19|0|||
129806201|NCT02663908|467256887|FG000|Overall Study|Site closed|1|||
129806202|NCT02663908|467256888|FG001|Overall Study|Site closed|0|||
129806203|NCT02663908|467256887|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
129806204|NCT02663908|467256888|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
129806205|NCT02663908|467256887|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
129806206|NCT02663908|467256888|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
129806207|NCT02663908|467256887|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
129893531|NCT04011033|467569793|FG001|Overall Study|Physician Decision|3|||
130112118|NCT02763579|468371073|FG001|Global Period|Study Terminated By Sponsor|26|||
130112119|NCT02763579|468371074|FG002|Global Period|Study Terminated By Sponsor|0|||
130112120|NCT02763579|468371075|FG003|Global Period|Study Terminated By Sponsor|0|||
130112121|NCT02763579|468371072|FG000|Global Period|Withdrawal by Subject|12|||
130112122|NCT02763579|468371073|FG001|Global Period|Withdrawal by Subject|18|||
130112123|NCT02763579|468371074|FG002|Global Period|Withdrawal by Subject|0|||
130112124|NCT02763579|468371075|FG003|Global Period|Withdrawal by Subject|0|||
130112125|NCT02763579|468371072|FG000|China Period|Death|0|||
130112126|NCT02763579|468371073|FG001|China Period|Death|0|||
130112127|NCT02763579|468371074|FG002|China Period|Death|46|||
130112128|NCT02763579|468371075|FG003|China Period|Death|48|||
130112129|NCT02763579|468371072|FG000|China Period|Lost to Follow-up|0|||
129806208|NCT02663908|467256888|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
129806209|NCT02663908|467256887|FG000|Overall Study|Death|1|||
129806210|NCT02663908|467256888|FG001|Overall Study|Death|0|||
129806211|NCT02663908|467256887|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
129806212|NCT02663908|467256888|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
129806213|NCT02663908|467256887|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
129893532|NCT04011033|467569792|FG000|Overall Study|Withdrawal by Subject|1|||
130057441|NCT03725202|468164330|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130057442|NCT03725202|468164331|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130057443|NCT03725202|468164332|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130057444|NCT03725202|468164333|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
130057445|NCT03725202|468164334|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
130057446|NCT03725202|468164327|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057447|NCT03725202|468164328|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057448|NCT03725202|468164329|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057449|NCT03725202|468164330|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057450|NCT03725202|468164331|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057451|NCT03725202|468164332|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
130057452|NCT03725202|468164333|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057453|NCT03725202|468164334|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
130057454|NCT03725202|468164327|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130057455|NCT03725202|468164328|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130057456|NCT03725202|468164329|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130057457|NCT03725202|468164330|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
130057458|NCT03725202|468164331|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130057459|NCT03725202|468164332|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
130057460|NCT03725202|468164333|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
130057461|NCT03725202|468164334|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
130057462|NCT01328249|468164337|FG000|Overall Study|Adverse Event|3|||
130057463|NCT01328249|468164338|FG001|Overall Study|Adverse Event|0|||
130057464|NCT01328249|468164337|FG000|Overall Study|Disease progression|1|||
130057465|NCT01328249|468164338|FG001|Overall Study|Disease progression|0|||
130057466|NCT01328249|468164337|FG000|Overall Study|Withdrawal by Subject|1|||
130057467|NCT01328249|468164338|FG001|Overall Study|Withdrawal by Subject|1|||
130057468|NCT01328249|468164337|FG000|Overall Study|Moved before end of treatment visit|1|||
130057469|NCT01328249|468164338|FG001|Overall Study|Moved before end of treatment visit|0|||
130057470|NCT01328249|468164337|FG000|Overall Study|Subject choice|1|||
130057471|NCT01328249|468164338|FG001|Overall Study|Subject choice|1|||
130057472|NCT01328249|468164337|FG000|Overall Study|Protocol Violation|0|||
130057473|NCT01328249|468164338|FG001|Overall Study|Protocol Violation|1|||
130057474|NCT01215734|468164339|FG000|Overall Study|Death|0|||
130057475|NCT01215734|468164340|FG001|Overall Study|Death|1|||
130057476|NCT01346371|468164341|FG000|Overall Study|Lost to Follow-up|2|||
130057477|NCT01346371|468164342|FG001|Overall Study|Lost to Follow-up|0|||
130057478|NCT02330549|468164343|FG000|Overall Study|Adverse Event|1|||
130057479|NCT02330549|468164344|FG001|Overall Study|Adverse Event|0|||
130057480|NCT02330549|468164343|FG000|Overall Study|Subject withdrew consent|2|||
130057481|NCT02330549|468164344|FG001|Overall Study|Subject withdrew consent|1|||
130057482|NCT02330549|468164343|FG000|Overall Study|Failure to meet randomization criteria|1|||
130057483|NCT02330549|468164344|FG001|Overall Study|Failure to meet randomization criteria|0|||
130057484|NCT00495495|468164350|FG000|Overall Study|Protocol Violation|99|||
130057485|NCT01670656|468164354|FG000|Overall Study|Non-compliance with study drug|0|||
130057486|NCT01670656|468164355|FG001|Overall Study|Non-compliance with study drug|0|||
130057487|NCT01670656|468164356|FG002|Overall Study|Non-compliance with study drug|3|||
130057488|NCT01670656|468164357|FG003|Overall Study|Non-compliance with study drug|0|||
130057489|NCT01670656|468164358|FG004|Overall Study|Non-compliance with study drug|1|||
130057490|NCT01670656|468164354|FG000|Overall Study|Pregnancy|0|||
130057491|NCT01670656|468164355|FG001|Overall Study|Pregnancy|0|||
130057492|NCT01670656|468164356|FG002|Overall Study|Pregnancy|0|||
130112130|NCT02763579|468371073|FG001|China Period|Lost to Follow-up|0|||
130112131|NCT02763579|468371074|FG002|China Period|Lost to Follow-up|1|||
130112132|NCT02763579|468371075|FG003|China Period|Lost to Follow-up|1|||
130112133|NCT02763579|468371072|FG000|China Period|Physician Decision|0|||
130112134|NCT02763579|468371073|FG001|China Period|Physician Decision|0|||
130112135|NCT02763579|468371074|FG002|China Period|Physician Decision|0|||
130112136|NCT02763579|468371075|FG003|China Period|Physician Decision|1|||
130112137|NCT02763579|468371072|FG000|China Period|Study Terminated By Sponsor|0|||
130112138|NCT02763579|468371073|FG001|China Period|Study Terminated By Sponsor|0|||
130112139|NCT02763579|468371074|FG002|China Period|Study Terminated By Sponsor|3|||
130112140|NCT02763579|468371075|FG003|China Period|Study Terminated By Sponsor|4|||
130112141|NCT02763579|468371072|FG000|China Period|Withdrawal by Subject|0|||
130112142|NCT02763579|468371073|FG001|China Period|Withdrawal by Subject|0|||
130112143|NCT02763579|468371074|FG002|China Period|Withdrawal by Subject|3|||
130112144|NCT02763579|468371075|FG003|China Period|Withdrawal by Subject|3|||
130112145|NCT02965820|468371076|FG000|Period 2, Second 30 Days|Adverse Event|1|||
130112146|NCT02965820|468371077|FG001|Period 2, Second 30 Days|Adverse Event|1|||
130112147|NCT01967888|468371078|FG000|Overall Study|Lost to Follow-up|6|||
130112148|NCT01967888|468371079|FG001|Overall Study|Lost to Follow-up|4|||
130112149|NCT01967888|468371078|FG000|Overall Study|Withdrawal by Subject|1|||
130112150|NCT01967888|468371079|FG001|Overall Study|Withdrawal by Subject|1|||
130112151|NCT01967888|468371078|FG000|Overall Study|Did Not Have Transplant|1|||
130112152|NCT01967888|468371079|FG001|Overall Study|Did Not Have Transplant|0|||
130112153|NCT01967888|468371078|FG000|Overall Study|Research visit not done, data recorded|1|||
130112154|NCT01967888|468371079|FG001|Overall Study|Research visit not done, data recorded|0|||
130112155|NCT01967888|468371078|FG000|Overall Study|Subject excluded after randomization|1|||
130112156|NCT01967888|468371079|FG001|Overall Study|Subject excluded after randomization|0|||
130112157|NCT01967888|468371078|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
130057493|NCT01670656|468164357|FG003|Overall Study|Pregnancy|0|||
130057494|NCT01670656|468164358|FG004|Overall Study|Pregnancy|1|||
130057495|NCT01670656|468164354|FG000|Overall Study|Withdrawal by Subject|1|||
130057496|NCT01670656|468164355|FG001|Overall Study|Withdrawal by Subject|1|||
130057497|NCT01670656|468164356|FG002|Overall Study|Withdrawal by Subject|0|||
130057498|NCT01670656|468164357|FG003|Overall Study|Withdrawal by Subject|0|||
130057499|NCT01670656|468164358|FG004|Overall Study|Withdrawal by Subject|0|||
130057500|NCT01670656|468164354|FG000|Overall Study|Non-compliance with protocol|0|||
130057501|NCT01670656|468164355|FG001|Overall Study|Non-compliance with protocol|3|||
130057502|NCT01670656|468164356|FG002|Overall Study|Non-compliance with protocol|1|||
130057503|NCT01670656|468164357|FG003|Overall Study|Non-compliance with protocol|1|||
130057504|NCT01670656|468164358|FG004|Overall Study|Non-compliance with protocol|2|||
130057505|NCT01670656|468164354|FG000|Overall Study|Adverse Event|2|||
130057506|NCT01670656|468164355|FG001|Overall Study|Adverse Event|2|||
130057507|NCT01670656|468164356|FG002|Overall Study|Adverse Event|2|||
130057508|NCT01670656|468164357|FG003|Overall Study|Adverse Event|3|||
130057509|NCT01670656|468164358|FG004|Overall Study|Adverse Event|3|||
130057510|NCT01670656|468164354|FG000|Overall Study|Subject withdrew consent|0|||
130057511|NCT01670656|468164355|FG001|Overall Study|Subject withdrew consent|1|||
130057512|NCT01670656|468164356|FG002|Overall Study|Subject withdrew consent|2|||
130112158|NCT01967888|468371079|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
130057513|NCT01670656|468164357|FG003|Overall Study|Subject withdrew consent|1|||
130057514|NCT01670656|468164358|FG004|Overall Study|Subject withdrew consent|1|||
130057515|NCT01670656|468164354|FG000|Overall Study|Lost to Follow-up|0|||
130057516|NCT01670656|468164355|FG001|Overall Study|Lost to Follow-up|0|||
130057517|NCT01670656|468164356|FG002|Overall Study|Lost to Follow-up|0|||
130057518|NCT01670656|468164357|FG003|Overall Study|Lost to Follow-up|0|||
130057519|NCT01670656|468164358|FG004|Overall Study|Lost to Follow-up|3|||
130057520|NCT01670656|468164354|FG000|Overall Study|Subject moved|0|||
130057521|NCT01670656|468164355|FG001|Overall Study|Subject moved|0|||
130057522|NCT01670656|468164356|FG002|Overall Study|Subject moved|0|||
130057523|NCT01670656|468164357|FG003|Overall Study|Subject moved|1|||
130057524|NCT01670656|468164358|FG004|Overall Study|Subject moved|0|||
130057525|NCT00789958|468164359|FG000|Overall Study|Adverse Event|3|||
130057526|NCT00789958|468164359|FG000|Overall Study|Withdrawal by Subject|4|||
130057527|NCT00789958|468164359|FG000|Overall Study|Progression|3|||
130057528|NCT00789958|468164359|FG000|Overall Study|not protocol specified|1|||
130057529|NCT00789958|468164359|FG000|Overall Study|Not eligible/not analyzable|26|||
130057530|NCT03331666|468164360|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
130057531|NCT03331666|468164361|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
130057532|NCT01026389|468164364|FG000|Overall Study|Withdrawal by Subject|1|||
130057533|NCT01026389|468164365|FG001|Overall Study|Withdrawal by Subject|3|||
130057534|NCT01026389|468164364|FG000|Overall Study|change of treatment, patient moved|4|||
130057535|NCT01026389|468164365|FG001|Overall Study|change of treatment, patient moved|2|||
130057536|NCT01995136|468164366|FG000|Overall Study|Change in residence|1|||
130057537|NCT04410198|468164367|FG000|Overall Study|Death|10|||
130057538|NCT04410198|468164367|FG000|Overall Study|Withdrawal by Subject|7|||
130057539|NCT04410198|468164367|FG000|Overall Study|Transferred/Relocation|4|||
130057540|NCT04410198|468164367|FG000|Overall Study|Kidney Transplant|9|||
130057541|NCT04410198|468164367|FG000|Overall Study|Adverse Event|4|||
130057542|NCT04410198|468164367|FG000|Overall Study|Physician Decision|2|||
130057543|NCT04410198|468164367|FG000|Overall Study|Other than specified|1|||
130057544|NCT01830543|468164370|FG000|Overall Study|Subject Decision|19|||
130057545|NCT01830543|468164371|FG001|Overall Study|Subject Decision|21|||
130057546|NCT01830543|468164372|FG002|Overall Study|Subject Decision|57|||
130057547|NCT01830543|468164370|FG000|Overall Study|Adverse Event|91|||
130057548|NCT01830543|468164371|FG001|Overall Study|Adverse Event|77|||
130057549|NCT01830543|468164372|FG002|Overall Study|Adverse Event|76|||
130057550|NCT01830543|468164370|FG000|Overall Study|Death|20|||
130057551|NCT01830543|468164371|FG001|Overall Study|Death|22|||
130057552|NCT01830543|468164372|FG002|Overall Study|Death|22|||
130057553|NCT01830543|468164370|FG000|Overall Study|Protocol Violation|3|||
130057554|NCT01830543|468164371|FG001|Overall Study|Protocol Violation|7|||
130057555|NCT01830543|468164372|FG002|Overall Study|Protocol Violation|7|||
130057556|NCT01830543|468164370|FG000|Overall Study|Physician Decision|11|||
130057557|NCT01830543|468164371|FG001|Overall Study|Physician Decision|5|||
130057558|NCT01830543|468164372|FG002|Overall Study|Physician Decision|12|||
130057559|NCT01830543|468164370|FG000|Overall Study|Withdrawal by consent|3|||
130057560|NCT01830543|468164371|FG001|Overall Study|Withdrawal by consent|3|||
130057561|NCT01830543|468164372|FG002|Overall Study|Withdrawal by consent|3|||
130057562|NCT01830543|468164370|FG000|Overall Study|Other|12|||
130057563|NCT01830543|468164371|FG001|Overall Study|Other|17|||
129806214|NCT02663908|467256888|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
129806215|NCT03308786|467256889|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
129806216|NCT06238362|467256893|FG000|Overall Study|Insufficient total sleep time|1|||
129806217|NCT06238362|467256894|FG001|Overall Study|Insufficient total sleep time|0|||
129806218|NCT06238362|467256893|FG000|Overall Study|Inadequate signal quality|1|||
130057564|NCT01830543|468164372|FG002|Overall Study|Other|37|||
130057565|NCT03583372|468164375|FG000|Overall Study|Withdrawal by Subject|6|||
130057566|NCT03583372|468164376|FG001|Overall Study|Withdrawal by Subject|11|||
130057567|NCT03583372|468164377|FG002|Overall Study|Withdrawal by Subject|7|||
130057568|NCT03583372|468164378|FG003|Overall Study|Withdrawal by Subject|8|||
130057569|NCT03583372|468164375|FG000|Overall Study|Lost to Follow-up|4|||
130057570|NCT03583372|468164376|FG001|Overall Study|Lost to Follow-up|6|||
130057571|NCT03583372|468164377|FG002|Overall Study|Lost to Follow-up|3|||
130057572|NCT03583372|468164378|FG003|Overall Study|Lost to Follow-up|2|||
130057573|NCT03583372|468164375|FG000|Overall Study|Adverse Event|1|||
130057574|NCT03583372|468164376|FG001|Overall Study|Adverse Event|3|||
130057575|NCT03583372|468164377|FG002|Overall Study|Adverse Event|4|||
130057576|NCT03583372|468164378|FG003|Overall Study|Adverse Event|4|||
130057577|NCT03583372|468164375|FG000|Overall Study|Physician Decision|0|||
130057578|NCT03583372|468164376|FG001|Overall Study|Physician Decision|1|||
130057579|NCT03583372|468164377|FG002|Overall Study|Physician Decision|1|||
130057580|NCT03583372|468164378|FG003|Overall Study|Physician Decision|1|||
130057581|NCT03583372|468164375|FG000|Overall Study|Lack of Efficacy|0|||
130057582|NCT03583372|468164376|FG001|Overall Study|Lack of Efficacy|1|||
130057583|NCT03583372|468164377|FG002|Overall Study|Lack of Efficacy|0|||
130057584|NCT03583372|468164378|FG003|Overall Study|Lack of Efficacy|1|||
130057585|NCT03583372|468164375|FG000|Overall Study|Death|1|||
130057586|NCT03583372|468164376|FG001|Overall Study|Death|0|||
130057587|NCT03583372|468164377|FG002|Overall Study|Death|0|||
130057588|NCT03583372|468164378|FG003|Overall Study|Death|0|||
130057589|NCT03583372|468164375|FG000|Overall Study|Protocol Violation|0|||
130057590|NCT03583372|468164376|FG001|Overall Study|Protocol Violation|1|||
130057591|NCT03583372|468164377|FG002|Overall Study|Protocol Violation|0|||
130057592|NCT03583372|468164378|FG003|Overall Study|Protocol Violation|0|||
130057593|NCT03583372|468164375|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
130057594|NCT03583372|468164376|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
130057595|NCT03583372|468164377|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
130057596|NCT03583372|468164378|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
130057597|NCT03583372|468164375|FG000|Overall Study|Did Not Receive Study Drug|0|||
130057598|NCT03583372|468164376|FG001|Overall Study|Did Not Receive Study Drug|1|||
130057599|NCT03583372|468164377|FG002|Overall Study|Did Not Receive Study Drug|0|||
130057600|NCT03583372|468164378|FG003|Overall Study|Did Not Receive Study Drug|0|||
130057601|NCT03583372|468164375|FG000|Overall Study|Captured as Other in the Database|1|||
130057602|NCT03583372|468164376|FG001|Overall Study|Captured as Other in the Database|2|||
130057603|NCT03583372|468164377|FG002|Overall Study|Captured as Other in the Database|4|||
130057604|NCT03583372|468164378|FG003|Overall Study|Captured as Other in the Database|1|||
130057605|NCT01030458|468164389|FG000|Overall Study|Lost to Follow-up|9|||
130057606|NCT01030458|468164390|FG001|Overall Study|Lost to Follow-up|10|||
130057607|NCT01030458|468164389|FG000|Overall Study|Withdrawal by Subject|2|||
130057608|NCT01030458|468164390|FG001|Overall Study|Withdrawal by Subject|3|||
130057609|NCT01030458|468164389|FG000|Overall Study|Logistical reasons|9|||
130057610|NCT01030458|468164390|FG001|Overall Study|Logistical reasons|5|||
130057611|NCT01030458|468164389|FG000|Overall Study|Moved or changed job|6|||
130057612|NCT01030458|468164390|FG001|Overall Study|Moved or changed job|13|||
130057613|NCT01030458|468164389|FG000|Overall Study|Side effect of medication|1|||
130057614|NCT01030458|468164390|FG001|Overall Study|Side effect of medication|1|||
130057615|NCT02420223|468164391|FG000|Overall Study|Adverse Event|1|||
130057616|NCT02420223|468164392|FG001|Overall Study|Adverse Event|0|||
130057617|NCT02420223|468164391|FG000|Overall Study|Physician Decision|0|||
130057618|NCT02420223|468164392|FG001|Overall Study|Physician Decision|2|||
130057619|NCT01842308|468164401|FG000|Overall Study|Withdrawal by Subject|0|||
130057620|NCT01842308|468164402|FG001|Overall Study|Withdrawal by Subject|0|||
130057621|NCT01842308|468164403|FG002|Overall Study|Withdrawal by Subject|0|||
130057622|NCT01842308|468164404|FG003|Overall Study|Withdrawal by Subject|0|||
130057623|NCT01842308|468164405|FG004|Overall Study|Withdrawal by Subject|1|||
130057624|NCT00987623|468164406|FG000|Overall Study|Lost to Follow-up|2|||
130057625|NCT00987623|468164407|FG001|Overall Study|Lost to Follow-up|1|||
130057626|NCT00987623|468164406|FG000|Overall Study|Time/job conflict|2|||
130057627|NCT00987623|468164407|FG001|Overall Study|Time/job conflict|0|||
130057628|NCT00987623|468164406|FG000|Overall Study|Discomfort|1|||
130057629|NCT00987623|468164407|FG001|Overall Study|Discomfort|0|||
130057630|NCT00987623|468164406|FG000|Overall Study|Biomicroscopy|0|||
130057631|NCT00987623|468164407|FG001|Overall Study|Biomicroscopy|1|||
130057632|NCT00987623|468164406|FG000|Overall Study|Influenza|0|||
130057633|NCT00987623|468164407|FG001|Overall Study|Influenza|1|||
130112159|NCT01967888|468371078|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
130057634|NCT04056455|468164408|FG000|Overall Study|Adverse Event|1|||
130057635|NCT04056455|468164409|FG001|Overall Study|Adverse Event|0|||
130112160|NCT01967888|468371079|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
130057636|NCT03521687|468164410|FG000|Overall Study|Adverse Event|4|||
130057637|NCT03521687|468164410|FG000|Overall Study|Physician Decision|1|||
130057638|NCT01151579|468164411|FG000|Overall Study|Physician Decision|3|||
130057639|NCT01151579|468164412|FG001|Overall Study|Physician Decision|1|||
130057640|NCT01151579|468164411|FG000|Overall Study|Withdrawal by Subject|3|||
130057641|NCT01151579|468164412|FG001|Overall Study|Withdrawal by Subject|2|||
130057642|NCT01151579|468164411|FG000|Overall Study|Not meet inclusion criteria|6|||
130057643|NCT01151579|468164412|FG001|Overall Study|Not meet inclusion criteria|4|||
130057644|NCT01276457|468164415|FG000|Core Study|Adverse Event|6|||
130057645|NCT01276457|468164416|FG001|Core Study|Adverse Event|3|||
130057646|NCT01276457|468164415|FG000|Core Study|Lost to Follow-up|1|||
130112161|NCT00553540|468371080|FG000|Overall Study|discharged after first visit|2|||
130112162|NCT00553540|468371081|FG001|Overall Study|discharged after first visit|5|||
130112163|NCT02622074|468371082|FG000|Overall Study|Death|4|||
130112164|NCT02622074|468371083|FG001|Overall Study|Death|0|||
130112165|NCT02622074|468371084|FG002|Overall Study|Death|0|||
130112166|NCT02622074|468371085|FG003|Overall Study|Death|1|||
130112167|NCT02622074|468371086|FG004|Overall Study|Death|1|||
130112168|NCT02622074|468371087|FG005|Overall Study|Death|0|||
130112169|NCT02622074|468371082|FG000|Overall Study|Withdrawal by Subject|0|||
130112170|NCT02622074|468371083|FG001|Overall Study|Withdrawal by Subject|1|||
130112171|NCT02622074|468371084|FG002|Overall Study|Withdrawal by Subject|0|||
130112172|NCT02622074|468371085|FG003|Overall Study|Withdrawal by Subject|0|||
130112173|NCT02622074|468371086|FG004|Overall Study|Withdrawal by Subject|0|||
130112174|NCT02622074|468371087|FG005|Overall Study|Withdrawal by Subject|0|||
130112175|NCT02114931|468371088|FG000|Overall Study|Withdrawal by Subject|15|||
130112176|NCT02114931|468371089|FG001|Overall Study|Withdrawal by Subject|18|||
130112177|NCT02114931|468371088|FG000|Overall Study|Adverse Event|4|||
129893533|NCT04011033|467569793|FG001|Overall Study|Withdrawal by Subject|0|||
130112178|NCT02114931|468371089|FG001|Overall Study|Adverse Event|6|||
130112179|NCT02114931|468371088|FG000|Overall Study|Lost to Follow-up|3|||
130112180|NCT02114931|468371089|FG001|Overall Study|Lost to Follow-up|3|||
130112181|NCT02114931|468371088|FG000|Overall Study|Physician Decision|1|||
129806219|NCT06238362|467256894|FG001|Overall Study|Inadequate signal quality|0|||
129806220|NCT05136690|467256895|FG000|Period 1|Withdrawal by Subject|0|||
129806221|NCT05136690|467256896|FG001|Period 1|Withdrawal by Subject|1|||
129806222|NCT05136690|467256895|FG000|Period 2|Lost to Follow-up|0|||
129806223|NCT05136690|467256896|FG001|Period 2|Lost to Follow-up|3|||
129806224|NCT05136690|467256895|FG000|Period 2|Withdrawal by Subject|0|||
129806225|NCT05136690|467256896|FG001|Period 2|Withdrawal by Subject|1|||
129806226|NCT01863953|467258369|FG000|Overall Study|Adverse Event|0|||
129806227|NCT01863953|467258370|FG001|Overall Study|Adverse Event|0|||
130057647|NCT01276457|468164416|FG001|Core Study|Lost to Follow-up|2|||
130057648|NCT01276457|468164415|FG000|Core Study|Administrative problems|1|||
130057649|NCT01276457|468164416|FG001|Core Study|Administrative problems|1|||
129806228|NCT01863953|467258371|FG002|Overall Study|Adverse Event|1|||
129806229|NCT01626456|467258377|FG000|Overall Study|Withdrawal by Subject|21|||
129806230|NCT01626456|467258378|FG001|Overall Study|Withdrawal by Subject|46|||
130057650|NCT01276457|468164415|FG000|Core Study|Death|2|||
130057651|NCT01276457|468164416|FG001|Core Study|Death|2|||
130057652|NCT01276457|468164415|FG000|Core Study|Lack of Efficacy|3|||
130057653|NCT01276457|468164416|FG001|Core Study|Lack of Efficacy|12|||
130057654|NCT01276457|468164415|FG000|Extension Study|Lost to Follow-up|3|||
130057655|NCT01276457|468164416|FG001|Extension Study|Lost to Follow-up|0|||
130057656|NCT01276457|468164415|FG000|Extension Study|Death|0|||
130057657|NCT01276457|468164416|FG001|Extension Study|Death|1|||
130057658|NCT01276457|468164415|FG000|Extension Study|Lack of Efficacy|3|||
130057659|NCT01276457|468164416|FG001|Extension Study|Lack of Efficacy|1|||
130057660|NCT02065869|468164422|FG000|Overall Study|Death|7|||
130057661|NCT02065869|468164422|FG000|Overall Study|Disease relapse|16|||
130057662|NCT02065869|468164422|FG000|Overall Study|Lost to Follow-up|4|||
130057663|NCT02065869|468164422|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
130057664|NCT02065869|468164422|FG000|Overall Study|Withdrawal by Subject|1|||
130057665|NCT03807739|468164423|FG000|Overall Study|Adverse Event|1|||
130057666|NCT03807739|468164424|FG001|Overall Study|Adverse Event|0|||
130057667|NCT03807739|468164425|FG002|Overall Study|Adverse Event|0|||
130057668|NCT03807739|468164426|FG003|Overall Study|Adverse Event|0|||
130057669|NCT03807739|468164423|FG000|Overall Study|Withdrawal by Subject|1|||
130057670|NCT03807739|468164424|FG001|Overall Study|Withdrawal by Subject|0|||
130057671|NCT03807739|468164425|FG002|Overall Study|Withdrawal by Subject|0|||
130057672|NCT03807739|468164426|FG003|Overall Study|Withdrawal by Subject|0|||
130057673|NCT05118386|468164429|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130057674|NCT05118386|468164430|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130057675|NCT05118386|468164431|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130112182|NCT02114931|468371089|FG001|Overall Study|Physician Decision|2|||
130057676|NCT05118386|468164432|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
130057677|NCT05118386|468164433|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130112183|NCT02114931|468371088|FG000|Overall Study|Other|2|||
130057678|NCT05118386|468164434|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
130057679|NCT05118386|468164429|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130057680|NCT05118386|468164430|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130057681|NCT05118386|468164431|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130057682|NCT05118386|468164432|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130057683|NCT05118386|468164433|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
129893534|NCT02027935|467569794|FG000|Overall Study|Death|1|||
129806231|NCT01626456|467258377|FG000|Overall Study|Adverse Event|2|||
129806232|NCT01626456|467258378|FG001|Overall Study|Adverse Event|27|||
129806233|NCT01626456|467258377|FG000|Overall Study|Lost to Follow-up|2|||
129806234|NCT01626456|467258378|FG001|Overall Study|Lost to Follow-up|27|||
129806235|NCT01626456|467258377|FG000|Overall Study|Lack of Efficacy|6|||
129806236|NCT01626456|467258378|FG001|Overall Study|Lack of Efficacy|7|||
129806237|NCT01626456|467258377|FG000|Overall Study|Physician Decision|1|||
129806238|NCT01626456|467258378|FG001|Overall Study|Physician Decision|4|||
129806239|NCT01626456|467258377|FG000|Overall Study|Protocol Violation|1|||
129806240|NCT01626456|467258378|FG001|Overall Study|Protocol Violation|1|||
129806241|NCT01626456|467258377|FG000|Overall Study|Site Closure|2|||
129806242|NCT01626456|467258378|FG001|Overall Study|Site Closure|3|||
129806243|NCT01626456|467258377|FG000|Overall Study|Incarceration|0|||
129806244|NCT01626456|467258378|FG001|Overall Study|Incarceration|2|||
129806245|NCT04015336|467258379|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
129806246|NCT01868503|467258383|FG000|Overall Study|Withdrawal by Subject|1|||
129806247|NCT01868503|467258383|FG000|Overall Study|Protocol Violation|1|||
129806248|NCT03650556|467258384|FG000|Overall Study|Death|2|||
129806249|NCT03650556|467258384|FG000|Overall Study|Withdrawal by Subject|20|||
129806250|NCT03650556|467258384|FG000|Overall Study|Physician Decision|2|||
129806251|NCT03650556|467258384|FG000|Overall Study|Lost to Follow-up|8|||
129806252|NCT03650556|467258384|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
129806253|NCT03650556|467258384|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
129806254|NCT00691301|467258385|FG000|Overall Study|Adverse Event|10|||
129806255|NCT00691301|467258385|FG000|Overall Study|Death|2|||
129806256|NCT00691301|467258385|FG000|Overall Study|Lack of Efficacy|32|||
129806257|NCT00691301|467258385|FG000|Overall Study|Withdrawal by Subject|4|||
129806258|NCT00691301|467258385|FG000|Overall Study|Concurrent illness|2|||
129806259|NCT00691301|467258385|FG000|Overall Study|other reason|3|||
129806260|NCT00691301|467258385|FG000|Overall Study|Did not initiate study treatment|1|||
129806261|NCT01823146|467258386|FG000|Overall Study|Withdrawal by Subject|0|||
129806262|NCT01823146|467258387|FG001|Overall Study|Withdrawal by Subject|1|||
129806263|NCT01823146|467258386|FG000|Overall Study|Lost to Follow-up|2|||
129806264|NCT01823146|467258387|FG001|Overall Study|Lost to Follow-up|1|||
129806265|NCT00463580|467258388|FG000|Overall Study|Lost to Follow-up|1|||
129806266|NCT00463580|467258389|FG001|Overall Study|Lost to Follow-up|0|||
129806267|NCT00463580|467258388|FG000|Overall Study|Schedule conflict|2|||
129806268|NCT00463580|467258389|FG001|Overall Study|Schedule conflict|0|||
129806269|NCT00463580|467258388|FG000|Overall Study|Medical/psychiatric complications|0|||
129806270|NCT00463580|467258389|FG001|Overall Study|Medical/psychiatric complications|2|||
129806271|NCT03917459|467258390|FG000|Overall Study|Adverse Event|1|||
129806272|NCT03917459|467258391|FG001|Overall Study|Adverse Event|0|||
129806273|NCT03917459|467258390|FG000|Overall Study|Withdrawal by Subject|0|||
129806274|NCT03917459|467258391|FG001|Overall Study|Withdrawal by Subject|1|||
129806275|NCT00491764|467258392|FG000|Overall Study|Adverse Event|1|||
129806276|NCT00491764|467258393|FG001|Overall Study|Adverse Event|2|||
129806277|NCT00491764|467258394|FG002|Overall Study|Adverse Event|4|||
129806278|NCT00491764|467258395|FG003|Overall Study|Adverse Event|4|||
129806279|NCT00491764|467258396|FG004|Overall Study|Adverse Event|0|||
129806280|NCT00491764|467258397|FG005|Overall Study|Adverse Event|1|||
129806281|NCT00491764|467258392|FG000|Overall Study|Lost to Follow-up|0|||
129806282|NCT00491764|467258393|FG001|Overall Study|Lost to Follow-up|1|||
129806283|NCT00491764|467258394|FG002|Overall Study|Lost to Follow-up|0|||
129806284|NCT00491764|467258395|FG003|Overall Study|Lost to Follow-up|1|||
129806285|NCT00491764|467258396|FG004|Overall Study|Lost to Follow-up|0|||
129806286|NCT00491764|467258397|FG005|Overall Study|Lost to Follow-up|3|||
129806287|NCT00491764|467258392|FG000|Overall Study|Withdrawal by Subject|2|||
129806288|NCT00491764|467258393|FG001|Overall Study|Withdrawal by Subject|3|||
129806289|NCT00491764|467258394|FG002|Overall Study|Withdrawal by Subject|1|||
129806290|NCT00491764|467258395|FG003|Overall Study|Withdrawal by Subject|2|||
129806291|NCT00491764|467258396|FG004|Overall Study|Withdrawal by Subject|2|||
129806292|NCT00491764|467258397|FG005|Overall Study|Withdrawal by Subject|4|||
129806293|NCT00491764|467258392|FG000|Overall Study|Non Compliance with the Protocol|1|||
129806294|NCT00491764|467258393|FG001|Overall Study|Non Compliance with the Protocol|0|||
129806295|NCT00491764|467258394|FG002|Overall Study|Non Compliance with the Protocol|0|||
129806296|NCT00491764|467258395|FG003|Overall Study|Non Compliance with the Protocol|0|||
129806297|NCT00491764|467258396|FG004|Overall Study|Non Compliance with the Protocol|0|||
129806298|NCT00491764|467258397|FG005|Overall Study|Non Compliance with the Protocol|0|||
129806299|NCT00491764|467258392|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
129806300|NCT00491764|467258393|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
129806301|NCT00491764|467258394|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
129806302|NCT00491764|467258395|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
129806303|NCT00491764|467258396|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
129806304|NCT00491764|467258397|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
129806305|NCT00491764|467258392|FG000|Overall Study|Administrative|1|||
129806306|NCT00491764|467258393|FG001|Overall Study|Administrative|0|||
129806307|NCT00491764|467258394|FG002|Overall Study|Administrative|2|||
129806308|NCT00491764|467258395|FG003|Overall Study|Administrative|1|||
129806309|NCT00491764|467258396|FG004|Overall Study|Administrative|0|||
129806310|NCT00491764|467258397|FG005|Overall Study|Administrative|0|||
129806311|NCT00697788|467258400|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806312|NCT00697788|467258401|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
129806313|NCT00697788|467258402|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806314|NCT00697788|467258403|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806315|NCT00697788|467258404|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806316|NCT00697788|467258405|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806317|NCT00697788|467258406|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806318|NCT00697788|467258407|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806319|NCT00697788|467258400|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806320|NCT00697788|467258401|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806321|NCT00697788|467258402|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806322|NCT00697788|467258403|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806323|NCT00697788|467258404|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
129806324|NCT00697788|467258405|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806325|NCT00697788|467258406|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806326|NCT00697788|467258407|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806327|NCT00075218|467258416|FG000|Double-Blind Treatment|Adverse Event|23|||
129806328|NCT00075218|467258417|FG001|Double-Blind Treatment|Adverse Event|4|||
129806329|NCT00075218|467258418|FG002|Double-Blind Treatment|Adverse Event|0|||
129806330|NCT00075218|467258416|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
129806331|NCT00075218|467258417|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
129806332|NCT00075218|467258418|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
129806333|NCT00075218|467258416|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
129806334|NCT00075218|467258417|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
129806335|NCT00075218|467258418|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
129806336|NCT00075218|467258416|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
129806337|NCT00075218|467258417|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
129806338|NCT00075218|467258418|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
129806339|NCT00075218|467258416|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
129806340|NCT00075218|467258417|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
129806341|NCT00075218|467258418|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
129806342|NCT00075218|467258416|FG000|Double-Blind Treatment|No study medication taken|2|||
129806343|NCT00075218|467258417|FG001|Double-Blind Treatment|No study medication taken|0|||
129806344|NCT00075218|467258418|FG002|Double-Blind Treatment|No study medication taken|0|||
129806345|NCT00075218|467258416|FG000|Open-Label Treatment|Lack of Efficacy|0|||
129806346|NCT00075218|467258417|FG001|Open-Label Treatment|Lack of Efficacy|0|||
129806347|NCT00075218|467258418|FG002|Open-Label Treatment|Lack of Efficacy|174|||
129806348|NCT00075218|467258416|FG000|Open-Label Treatment|Adverse Event|0|||
129806349|NCT00075218|467258417|FG001|Open-Label Treatment|Adverse Event|0|||
129806350|NCT00075218|467258418|FG002|Open-Label Treatment|Adverse Event|51|||
129806351|NCT00075218|467258416|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
129806352|NCT00075218|467258417|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129806353|NCT00075218|467258418|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
129893535|NCT02027935|467569794|FG000|Overall Study|Lack of Efficacy|5|||
129893536|NCT02027935|467569794|FG000|Overall Study|Study Closure|1|||
129806354|NCT00075218|467258416|FG000|Open-Label Treatment|Decision of Sponsor|0|||
129806355|NCT00075218|467258417|FG001|Open-Label Treatment|Decision of Sponsor|0|||
129806356|NCT00075218|467258418|FG002|Open-Label Treatment|Decision of Sponsor|8|||
129806357|NCT00075218|467258416|FG000|Open-Label Treatment|Protocol Violation|0|||
129806358|NCT00075218|467258417|FG001|Open-Label Treatment|Protocol Violation|0|||
129893537|NCT00689104|467569795|FG000|Overall Study|Eligibility criterion not met|5|||
130112184|NCT02114931|468371089|FG001|Overall Study|Other|1|||
130057684|NCT05118386|468164434|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
130057685|NCT00303108|468164435|FG000|Overall Study|Adverse Event|5|||
130057686|NCT00303108|468164436|FG001|Overall Study|Adverse Event|6|||
130057687|NCT00303108|468164437|FG002|Overall Study|Adverse Event|7|||
130057688|NCT00303108|468164435|FG000|Overall Study|Patient Request|4|||
130057689|NCT00303108|468164436|FG001|Overall Study|Patient Request|2|||
130057690|NCT00303108|468164437|FG002|Overall Study|Patient Request|8|||
130057691|NCT00303108|468164435|FG000|Overall Study|Failed Entry|1|||
130057692|NCT00303108|468164436|FG001|Overall Study|Failed Entry|0|||
130057693|NCT00303108|468164437|FG002|Overall Study|Failed Entry|1|||
130057694|NCT00303108|468164435|FG000|Overall Study|ineligible|2|||
130057695|NCT00303108|468164436|FG001|Overall Study|ineligible|1|||
130057696|NCT00303108|468164437|FG002|Overall Study|ineligible|0|||
130057697|NCT00894413|468164440|FG000|Overall Study|Physician Decision|0|||
130057698|NCT00894413|468164441|FG001|Overall Study|Physician Decision|2|||
130057699|NCT00894413|468164440|FG000|Overall Study|Adverse Event|0|||
130057700|NCT00894413|468164441|FG001|Overall Study|Adverse Event|2|||
130057701|NCT00894413|468164440|FG000|Overall Study|Withdrawal by Subject|0|||
130057702|NCT00894413|468164441|FG001|Overall Study|Withdrawal by Subject|4|||
130057703|NCT03201198|468164442|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
130057704|NCT03201198|468164443|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
130057705|NCT03201198|468164442|FG000|Overall Study|Withdrawal by Subject|2|||
130057706|NCT03201198|468164443|FG001|Overall Study|Withdrawal by Subject|3|||
130057707|NCT02427477|468164448|FG000|Period 1|Adverse Event|1|||
130057708|NCT02427477|468164449|FG001|Period 1|Adverse Event|0|||
130057709|NCT03213626|468164450|FG000|Overall Study|Adverse Event|1|||
130057710|NCT03213626|468164450|FG000|Overall Study|Progressive Disease|6|||
130057711|NCT00786032|468166001|FG000|Overall Study|Death|4|||
130057712|NCT00786032|468166001|FG000|Overall Study|Withdrawal by Subject|14|||
130057713|NCT00786032|468166001|FG000|Overall Study|Did not complete in the timeframe|6|||
130057714|NCT02457182|468166002|FG000|Overall Study|Lost to Follow-up|1|||
130057715|NCT02457182|468166003|FG001|Overall Study|Lost to Follow-up|0|||
130057716|NCT02294318|468166006|FG000|Overall Study|Worsening of drinking|3|||
130057717|NCT02294318|468166007|FG001|Overall Study|Worsening of drinking|0|||
130057718|NCT02294318|468166006|FG000|Overall Study|Not exposed to intervention|0|||
130057719|NCT02294318|468166007|FG001|Overall Study|Not exposed to intervention|2|||
130057720|NCT02702518|468166013|FG000|Overall Study|Lost to Follow-up|3|||
130057721|NCT02702518|468166014|FG001|Overall Study|Lost to Follow-up|4|||
130057722|NCT01000727|468166018|FG000|Overall Study|Lost to Follow-up|41|||
130057723|NCT01000727|468166019|FG001|Overall Study|Lost to Follow-up|43|||
130057724|NCT01000727|468166018|FG000|Overall Study|Withdrawal by Subject|111|||
130057725|NCT01000727|468166019|FG001|Overall Study|Withdrawal by Subject|109|||
130057726|NCT01000727|468166018|FG000|Overall Study|Study closed/terminated|23|||
130057727|NCT01000727|468166019|FG001|Overall Study|Study closed/terminated|24|||
130057728|NCT03137121|468166020|FG000|Overall Study|Withdrawal by Subject|0|||
130057729|NCT03137121|468166021|FG001|Overall Study|Withdrawal by Subject|1|||
130057730|NCT00836277|468166024|FG000|Overall Study|Not evaluable for response|6|||
130057731|NCT03544268|468166025|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
130057732|NCT03544268|468166026|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
130057733|NCT01354353|468166032|FG000|Overall Study|Adverse Event|1|||
130057734|NCT01354353|468166033|FG001|Overall Study|Adverse Event|0|||
130057735|NCT01354353|468166034|FG002|Overall Study|Adverse Event|0|||
130057736|NCT01354353|468166035|FG003|Overall Study|Adverse Event|4|||
130057737|NCT01354353|468166036|FG004|Overall Study|Adverse Event|0|||
130057738|NCT01354353|468166037|FG005|Overall Study|Adverse Event|5|||
130057739|NCT01354353|468166032|FG000|Overall Study|Entry Criteria Not Met|0|||
130057740|NCT01354353|468166033|FG001|Overall Study|Entry Criteria Not Met|0|||
130057741|NCT01354353|468166034|FG002|Overall Study|Entry Criteria Not Met|0|||
130057742|NCT01354353|468166035|FG003|Overall Study|Entry Criteria Not Met|1|||
130057743|NCT01354353|468166036|FG004|Overall Study|Entry Criteria Not Met|1|||
130057744|NCT01354353|468166037|FG005|Overall Study|Entry Criteria Not Met|0|||
130057745|NCT01354353|468166032|FG000|Overall Study|Physician Decision|0|||
130057746|NCT01354353|468166033|FG001|Overall Study|Physician Decision|1|||
130057747|NCT01354353|468166034|FG002|Overall Study|Physician Decision|1|||
130057748|NCT01354353|468166035|FG003|Overall Study|Physician Decision|0|||
130057749|NCT01354353|468166036|FG004|Overall Study|Physician Decision|0|||
130057750|NCT01354353|468166037|FG005|Overall Study|Physician Decision|0|||
130057751|NCT01354353|468166032|FG000|Overall Study|Withdrawal by Subject|2|||
129806359|NCT00075218|467258418|FG002|Open-Label Treatment|Protocol Violation|1|||
130057752|NCT01354353|468166033|FG001|Overall Study|Withdrawal by Subject|0|||
130057753|NCT01354353|468166034|FG002|Overall Study|Withdrawal by Subject|1|||
130057754|NCT01354353|468166035|FG003|Overall Study|Withdrawal by Subject|0|||
130057755|NCT01354353|468166036|FG004|Overall Study|Withdrawal by Subject|0|||
130057756|NCT01354353|468166037|FG005|Overall Study|Withdrawal by Subject|1|||
130057757|NCT00377611|468166040|FG000|Overall Study|Adverse Event|2|||
130057758|NCT00377611|468166041|FG001|Overall Study|Adverse Event|9|||
130057759|NCT00377611|468166040|FG000|Overall Study|Protocol Violation|2|||
130057760|NCT00377611|468166041|FG001|Overall Study|Protocol Violation|0|||
130057761|NCT00377611|468166040|FG000|Overall Study|Withdrawal by Subject|0|||
130057762|NCT00377611|468166041|FG001|Overall Study|Withdrawal by Subject|5|||
130057763|NCT00377611|468166040|FG000|Overall Study|Lost to Follow-up|18|||
130057764|NCT00377611|468166041|FG001|Overall Study|Lost to Follow-up|16|||
130057765|NCT00377611|468166040|FG000|Overall Study|Other|0|||
130057766|NCT00377611|468166041|FG001|Overall Study|Other|3|||
130057767|NCT04831515|468166042|FG000|First Intervention|Adverse Event|0|||
130057768|NCT04831515|468166043|FG001|First Intervention|Adverse Event|1|||
130057769|NCT01640925|468166048|FG000|Overall Study|Withdrawal by Subject|1|||
130057770|NCT01640925|468166049|FG001|Overall Study|Withdrawal by Subject|0|||
130057771|NCT01640925|468166048|FG000|Overall Study|Previously enrolled in this trial|13|||
130057772|NCT01640925|468166049|FG001|Overall Study|Previously enrolled in this trial|11|||
130057773|NCT02156492|468166050|FG000|Period 1|No Reason Given|0|||
130057774|NCT02156492|468166051|FG001|Period 1|No Reason Given|1|||
130057775|NCT02156492|468166052|FG002|Period 1|No Reason Given|0|||
130057776|NCT02156492|468166050|FG000|Period 3|Adverse Event|0|||
130057777|NCT02156492|468166051|FG001|Period 3|Adverse Event|1|||
130057778|NCT02156492|468166052|FG002|Period 3|Adverse Event|0|||
130057779|NCT01332019|468166063|FG000|Overall Study|Was Not Dosed|1|||
130057780|NCT01332019|468166064|FG001|Overall Study|Was Not Dosed|0|||
130057781|NCT01332019|468166063|FG000|Overall Study|Other|16|||
130057782|NCT01332019|468166064|FG001|Overall Study|Other|18|||
130057783|NCT01332019|468166063|FG000|Overall Study|Death|2|||
130057784|NCT01332019|468166064|FG001|Overall Study|Death|1|||
130057785|NCT01332019|468166063|FG000|Overall Study|Physician Decision|4|||
130057786|NCT01332019|468166064|FG001|Overall Study|Physician Decision|3|||
129806360|NCT00075218|467258416|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
130057787|NCT01332019|468166063|FG000|Overall Study|Withdrawal by Subject|73|||
130057788|NCT01332019|468166064|FG001|Overall Study|Withdrawal by Subject|71|||
130057789|NCT01332019|468166063|FG000|Overall Study|Lost to Follow-up|4|||
130057790|NCT01332019|468166064|FG001|Overall Study|Lost to Follow-up|7|||
130057791|NCT01332019|468166063|FG000|Overall Study|Adverse Event|13|||
130057792|NCT01332019|468166064|FG001|Overall Study|Adverse Event|22|||
130057793|NCT00288860|468166069|FG000|Overall Study|Did not complete intake|4|||
130057794|NCT00288860|468166070|FG001|Overall Study|Did not complete intake|8|||
130057795|NCT00288860|468166069|FG000|Overall Study|Death|4|||
130057796|NCT00288860|468166070|FG001|Overall Study|Death|3|||
130057797|NCT00288860|468166069|FG000|Overall Study|Withdrawal by Subject|20|||
130112185|NCT03565211|468371091|FG000|Overall Study|Withdrawal by Subject|2|||
129806361|NCT00075218|467258417|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
129806362|NCT00075218|467258418|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
129806363|NCT03840174|467258419|FG000|Overall Study|Withdrawal by Subject|1|||
130057798|NCT00288860|468166070|FG001|Overall Study|Withdrawal by Subject|15|||
130057799|NCT00288860|468166069|FG000|Overall Study|Lost to Follow-up|74|||
130057800|NCT00288860|468166070|FG001|Overall Study|Lost to Follow-up|71|||
130057801|NCT01104584|468166072|FG000|Overall Study|Study drug never administered|21|||
130057802|NCT01104584|468166072|FG000|Overall Study|Study prematurely discontinued|2|||
130057803|NCT04017442|468166073|FG000|Overall Study|Withdrawal by Subject|0|||
130057804|NCT04017442|468166074|FG001|Overall Study|Withdrawal by Subject|3|||
130057805|NCT04017442|468166073|FG000|Overall Study|Lost to Follow-up|21|||
130057806|NCT04017442|468166074|FG001|Overall Study|Lost to Follow-up|19|||
130057807|NCT02586233|468166075|FG000|Overall Study|Randomized but did not receive treatment|0|||
130057808|NCT02586233|468166076|FG001|Overall Study|Randomized but did not receive treatment|1|||
129806364|NCT03840174|467258420|FG001|Overall Study|Withdrawal by Subject|0|||
129806365|NCT03840174|467258421|FG002|Overall Study|Withdrawal by Subject|0|||
129806366|NCT03840174|467258422|FG003|Overall Study|Withdrawal by Subject|0|||
130057809|NCT02586233|468166077|FG002|Overall Study|Randomized but did not receive treatment|0|||
129806367|NCT00131508|467258423|FG000|Overall Study|Disease progression|0|||
129893538|NCT00689104|467569796|FG001|Overall Study|Eligibility criterion not met|8|||
129893539|NCT00689104|467569797|FG002|Overall Study|Eligibility criterion not met|0|||
130112186|NCT03565211|468371091|FG000|Overall Study|Lost to Follow-up|1|||
130057810|NCT02586233|468166078|FG003|Overall Study|Randomized but did not receive treatment|0|||
130057811|NCT02586233|468166079|FG004|Overall Study|Randomized but did not receive treatment|0|||
130057812|NCT02586233|468166080|FG005|Overall Study|Randomized but did not receive treatment|2|||
130057813|NCT02586233|468166081|FG006|Overall Study|Randomized but did not receive treatment|2|||
130057814|NCT02586233|468166075|FG000|Overall Study|Death|0|||
130057815|NCT02586233|468166076|FG001|Overall Study|Death|1|||
130057816|NCT02586233|468166077|FG002|Overall Study|Death|0|||
130057817|NCT02586233|468166078|FG003|Overall Study|Death|0|||
130057818|NCT02586233|468166079|FG004|Overall Study|Death|2|||
130057819|NCT02586233|468166080|FG005|Overall Study|Death|0|||
129806368|NCT00131508|467258424|FG001|Overall Study|Disease progression|2|||
129806369|NCT00131508|467258423|FG000|Overall Study|Non-Compliance|2|||
129806370|NCT00131508|467258424|FG001|Overall Study|Non-Compliance|4|||
129806371|NCT00131508|467258423|FG000|Overall Study|Withdrawal by Subject|1|||
130057820|NCT02586233|468166081|FG006|Overall Study|Death|0|||
130057821|NCT01757405|468166082|FG000|Overall Study|Lost to Follow-up|1|||
129806372|NCT00131508|467258424|FG001|Overall Study|Withdrawal by Subject|2|||
129806373|NCT05224141|467258426|FG000|Overall Study|Ongoing|75|||
129806374|NCT05224141|467258427|FG001|Overall Study|Ongoing|88|||
130057822|NCT01757405|468166083|FG001|Overall Study|Lost to Follow-up|1|||
130057823|NCT01757405|468166082|FG000|Overall Study|Withdrawal by Subject|0|||
129893540|NCT00689104|467569798|FG003|Overall Study|Eligibility criterion not met|4|||
129893541|NCT00689104|467569795|FG000|Overall Study|Adverse Event|13|||
129893542|NCT00689104|467569796|FG001|Overall Study|Adverse Event|25|||
129893543|NCT00689104|467569797|FG002|Overall Study|Adverse Event|16|||
130057824|NCT01757405|468166083|FG001|Overall Study|Withdrawal by Subject|1|||
130057825|NCT00082758|468166085|FG000|Overall Study|Adverse Event|0|||
130057826|NCT00082758|468166086|FG001|Overall Study|Adverse Event|2|||
130057827|NCT00082758|468166087|FG002|Overall Study|Adverse Event|0|||
129806375|NCT05224141|467258426|FG000|Overall Study|Withdrawal by Subject|2|||
129806376|NCT05224141|467258427|FG001|Overall Study|Withdrawal by Subject|4|||
129806377|NCT05224141|467258426|FG000|Overall Study|Death|153|||
129806378|NCT05224141|467258427|FG001|Overall Study|Death|138|||
129806379|NCT03469934|467258432|FG000|Overall Study|Withdrawal by Subject|0|||
129806380|NCT03469934|467258433|FG001|Overall Study|Withdrawal by Subject|1|||
129806381|NCT04889222|467258435|FG000|Overall Study|Did not meet eligibility criteria|8|||
129806382|NCT04889222|467258435|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
129806383|NCT04889222|467258435|FG000|Overall Study|Did not proceed due to time constraints|5|||
129806384|NCT02639546|467258440|FG000|Overall Study|Death|2|||
129806385|NCT02639546|467258441|FG001|Overall Study|Death|2|||
129806386|NCT02639546|467258442|FG002|Overall Study|Death|1|||
129806387|NCT02639546|467258443|FG003|Overall Study|Death|2|||
129806388|NCT02639546|467258444|FG004|Overall Study|Death|2|||
129806389|NCT02639546|467258445|FG005|Overall Study|Death|2|||
129806390|NCT02639546|467258446|FG006|Overall Study|Death|0|||
129806391|NCT02639546|467258447|FG007|Overall Study|Death|0|||
129806392|NCT02639546|467258440|FG000|Overall Study|Lost to Follow-up|0|||
129806393|NCT02639546|467258441|FG001|Overall Study|Lost to Follow-up|0|||
129806394|NCT02639546|467258442|FG002|Overall Study|Lost to Follow-up|1|||
129806395|NCT02639546|467258443|FG003|Overall Study|Lost to Follow-up|0|||
129806396|NCT02639546|467258444|FG004|Overall Study|Lost to Follow-up|1|||
129806397|NCT02639546|467258445|FG005|Overall Study|Lost to Follow-up|1|||
129806398|NCT02639546|467258446|FG006|Overall Study|Lost to Follow-up|0|||
129806399|NCT02639546|467258447|FG007|Overall Study|Lost to Follow-up|1|||
129806400|NCT02639546|467258440|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
130057828|NCT00082758|468166085|FG000|Overall Study|Lack of Efficacy|12|||
130057829|NCT00082758|468166086|FG001|Overall Study|Lack of Efficacy|13|||
130057830|NCT00082758|468166087|FG002|Overall Study|Lack of Efficacy|0|||
129806401|NCT02639546|467258441|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
129806402|NCT02639546|467258442|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
129806403|NCT02639546|467258443|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
129806404|NCT02639546|467258444|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
130057831|NCT00082758|468166085|FG000|Overall Study|Physician Decision|0|||
129806405|NCT02639546|467258445|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
129893544|NCT00689104|467569798|FG003|Overall Study|Adverse Event|24|||
130057832|NCT00082758|468166086|FG001|Overall Study|Physician Decision|1|||
129806406|NCT02639546|467258446|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
129806407|NCT02639546|467258447|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
129806408|NCT02639546|467258440|FG000|Overall Study|Study Terminated By Sponsor|0|||
129806409|NCT02639546|467258441|FG001|Overall Study|Study Terminated By Sponsor|2|||
129806410|NCT02639546|467258442|FG002|Overall Study|Study Terminated By Sponsor|3|||
129806411|NCT02639546|467258443|FG003|Overall Study|Study Terminated By Sponsor|4|||
129806412|NCT02639546|467258444|FG004|Overall Study|Study Terminated By Sponsor|4|||
129806413|NCT02639546|467258445|FG005|Overall Study|Study Terminated By Sponsor|3|||
129806414|NCT02639546|467258446|FG006|Overall Study|Study Terminated By Sponsor|3|||
129806415|NCT02639546|467258447|FG007|Overall Study|Study Terminated By Sponsor|9|||
129806416|NCT02639546|467258440|FG000|Overall Study|Withdrawal by Subject|2|||
129806417|NCT02639546|467258441|FG001|Overall Study|Withdrawal by Subject|2|||
129806418|NCT02639546|467258442|FG002|Overall Study|Withdrawal by Subject|1|||
129806419|NCT02639546|467258443|FG003|Overall Study|Withdrawal by Subject|0|||
129806420|NCT02639546|467258444|FG004|Overall Study|Withdrawal by Subject|0|||
129806421|NCT02639546|467258445|FG005|Overall Study|Withdrawal by Subject|1|||
129806422|NCT02639546|467258446|FG006|Overall Study|Withdrawal by Subject|2|||
129806423|NCT02639546|467258447|FG007|Overall Study|Withdrawal by Subject|1|||
129806424|NCT00113087|467258448|FG000|Overall Study|Death or Transplant|14|||
129806425|NCT00113087|467258449|FG001|Overall Study|Death or Transplant|16|||
129806426|NCT00113087|467258448|FG000|Overall Study|Family or MD withdrew subject|10|||
129806427|NCT00113087|467258449|FG001|Overall Study|Family or MD withdrew subject|5|||
129806428|NCT02215096|467258450|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
129806429|NCT02215096|467258451|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806430|NCT02215096|467258452|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806431|NCT02215096|467258453|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806432|NCT02215096|467258454|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806433|NCT02215096|467258450|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806434|NCT02215096|467258451|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806435|NCT02215096|467258452|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806436|NCT02215096|467258453|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806437|NCT02215096|467258454|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
129806438|NCT02215096|467258450|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806439|NCT02215096|467258451|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806440|NCT02215096|467258452|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806441|NCT02215096|467258453|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
129806442|NCT02215096|467258454|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806443|NCT02215096|467258450|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
129806444|NCT02215096|467258451|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
129806445|NCT02215096|467258452|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
129806446|NCT02215096|467258453|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
129806447|NCT02215096|467258454|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
129806448|NCT02840721|467258455|FG000|Treatment Period|Adverse Event|1|||
129806449|NCT02840721|467258455|FG000|Follow-Up|Lack of Efficacy|1|||
129806450|NCT02840721|467258455|FG000|Follow-Up|Withdrawal by Subject|4|||
129806451|NCT02840721|467258455|FG000|Follow-Up|Withdrawal of Consent|2|||
129806452|NCT00423514|467258457|FG000|Overall Study|Ineligible|1|||
129806453|NCT00423514|467258458|FG001|Overall Study|Ineligible|0|||
129806454|NCT03685123|467258459|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
129806455|NCT03685123|467258460|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
129806456|NCT03685123|467258461|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
129806457|NCT03685123|467258459|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
129806458|NCT03685123|467258460|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
129806459|NCT03685123|467258461|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
129806460|NCT03685123|467258459|FG000|Weight Loss Phase|Lost to Follow-up|1|||
129806461|NCT03685123|467258460|FG001|Weight Loss Phase|Lost to Follow-up|0|||
129806462|NCT03685123|467258461|FG002|Weight Loss Phase|Lost to Follow-up|0|||
129806463|NCT03685123|467258459|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
129806464|NCT03685123|467258460|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
129806465|NCT03685123|467258461|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
129806466|NCT03685123|467258459|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
129806467|NCT03685123|467258460|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
129806468|NCT03685123|467258461|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
129806469|NCT03685123|467258459|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
130057833|NCT00082758|468166087|FG002|Overall Study|Physician Decision|0|||
130057834|NCT00082758|468166085|FG000|Overall Study|Withdrawal by Subject|3|||
129806470|NCT03685123|467258460|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
129806471|NCT03685123|467258461|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
129806472|NCT00400764|467258462|FG000|Phase Ib|Adverse Event|1|||
129806473|NCT00400764|467258463|FG001|Phase Ib|Adverse Event|0|||
129806474|NCT00400764|467258464|FG002|Phase Ib|Adverse Event|0|||
129806475|NCT00400764|467258465|FG003|Phase Ib|Adverse Event|0|||
130057835|NCT00082758|468166086|FG001|Overall Study|Withdrawal by Subject|0|||
130057836|NCT00082758|468166087|FG002|Overall Study|Withdrawal by Subject|0|||
130057837|NCT00082758|468166085|FG000|Overall Study|Protocol Violation|0|||
130057838|NCT00082758|468166086|FG001|Overall Study|Protocol Violation|1|||
130057839|NCT00082758|468166087|FG002|Overall Study|Protocol Violation|0|||
130057840|NCT00238303|468166088|FG000|Overall Study|Withdrawal by Subject|11|||
130057841|NCT00238303|468166089|FG001|Overall Study|Withdrawal by Subject|1|||
130057842|NCT00238303|468166090|FG002|Overall Study|Withdrawal by Subject|2|||
130057843|NCT00238303|468166088|FG000|Overall Study|Death|1|||
130057844|NCT00238303|468166089|FG001|Overall Study|Death|0|||
130057845|NCT00238303|468166090|FG002|Overall Study|Death|1|||
130057846|NCT00238303|468166088|FG000|Overall Study|Other Medical Problems|2|||
130057847|NCT00238303|468166089|FG001|Overall Study|Other Medical Problems|0|||
130057848|NCT00238303|468166090|FG002|Overall Study|Other Medical Problems|2|||
130057849|NCT00238303|468166088|FG000|Overall Study|Poor tolerance of study treatment|1|||
130057850|NCT00238303|468166089|FG001|Overall Study|Poor tolerance of study treatment|0|||
129806476|NCT00400764|467258466|FG004|Phase Ib|Adverse Event|0|||
129806477|NCT00400764|467258462|FG000|Phase Ib|Death|1|||
129806478|NCT00400764|467258463|FG001|Phase Ib|Death|0|||
129806479|NCT00400764|467258464|FG002|Phase Ib|Death|0|||
129806480|NCT00400764|467258465|FG003|Phase Ib|Death|0|||
129806481|NCT00400764|467258466|FG004|Phase Ib|Death|0|||
129806482|NCT00400764|467258462|FG000|Phase Ib|Disease Progression|4|||
129806483|NCT00400764|467258463|FG001|Phase Ib|Disease Progression|4|||
129806484|NCT00400764|467258464|FG002|Phase Ib|Disease Progression|0|||
129806485|NCT00400764|467258465|FG003|Phase Ib|Disease Progression|0|||
129806486|NCT00400764|467258466|FG004|Phase Ib|Disease Progression|0|||
129806487|NCT00400764|467258462|FG000|Phase II|Death|0|||
129806488|NCT00400764|467258463|FG001|Phase II|Death|0|||
129806489|NCT00400764|467258464|FG002|Phase II|Death|1|||
129806490|NCT00400764|467258465|FG003|Phase II|Death|2|||
129806491|NCT00400764|467258466|FG004|Phase II|Death|0|||
129806492|NCT00400764|467258462|FG000|Phase II|Lost to Follow-up|0|||
129806493|NCT00400764|467258463|FG001|Phase II|Lost to Follow-up|0|||
129806494|NCT00400764|467258464|FG002|Phase II|Lost to Follow-up|1|||
129806495|NCT00400764|467258465|FG003|Phase II|Lost to Follow-up|0|||
129806496|NCT00400764|467258466|FG004|Phase II|Lost to Follow-up|0|||
129806497|NCT00400764|467258462|FG000|Phase II|Physician Decision|0|||
129806498|NCT00400764|467258463|FG001|Phase II|Physician Decision|0|||
129806499|NCT00400764|467258464|FG002|Phase II|Physician Decision|1|||
129893545|NCT00689104|467569795|FG000|Overall Study|Lack of Efficacy|5|||
129893546|NCT00689104|467569796|FG001|Overall Study|Lack of Efficacy|6|||
129893547|NCT00689104|467569797|FG002|Overall Study|Lack of Efficacy|2|||
129893548|NCT00689104|467569798|FG003|Overall Study|Lack of Efficacy|3|||
129893549|NCT00689104|467569795|FG000|Overall Study|Withdrawal by Subject|12|||
129893550|NCT00689104|467569796|FG001|Overall Study|Withdrawal by Subject|11|||
129893551|NCT00689104|467569797|FG002|Overall Study|Withdrawal by Subject|18|||
129893552|NCT00689104|467569798|FG003|Overall Study|Withdrawal by Subject|11|||
129893553|NCT00689104|467569795|FG000|Overall Study|Lost to Follow-up|4|||
129893554|NCT00689104|467569796|FG001|Overall Study|Lost to Follow-up|3|||
129893555|NCT00689104|467569797|FG002|Overall Study|Lost to Follow-up|2|||
129893556|NCT00689104|467569798|FG003|Overall Study|Lost to Follow-up|5|||
129893557|NCT00689104|467569795|FG000|Overall Study|Protocol Violation|2|||
129893558|NCT00689104|467569796|FG001|Overall Study|Protocol Violation|3|||
129893559|NCT00689104|467569797|FG002|Overall Study|Protocol Violation|5|||
129893560|NCT00689104|467569798|FG003|Overall Study|Protocol Violation|3|||
129893561|NCT00689104|467569795|FG000|Overall Study|Randomized but never received study drug|2|||
129893562|NCT00689104|467569796|FG001|Overall Study|Randomized but never received study drug|1|||
129893563|NCT00689104|467569797|FG002|Overall Study|Randomized but never received study drug|1|||
129893564|NCT00689104|467569798|FG003|Overall Study|Randomized but never received study drug|0|||
129893565|NCT00689104|467569795|FG000|Overall Study|Physician Decision|1|||
129893566|NCT00689104|467569796|FG001|Overall Study|Physician Decision|0|||
129893567|NCT00689104|467569797|FG002|Overall Study|Physician Decision|0|||
129893568|NCT00689104|467569798|FG003|Overall Study|Physician Decision|0|||
129893569|NCT00689104|467569795|FG000|Overall Study|Non-compliance with study procedures|0|||
129893570|NCT00689104|467569796|FG001|Overall Study|Non-compliance with study procedures|0|||
129893571|NCT00689104|467569797|FG002|Overall Study|Non-compliance with study procedures|1|||
129806500|NCT00400764|467258465|FG003|Phase II|Physician Decision|1|||
129806501|NCT00400764|467258466|FG004|Phase II|Physician Decision|0|||
129806502|NCT00400764|467258462|FG000|Phase II|Sponsor's decision to terminate|0|||
129806503|NCT00400764|467258463|FG001|Phase II|Sponsor's decision to terminate|0|||
129806504|NCT00400764|467258464|FG002|Phase II|Sponsor's decision to terminate|18|||
129806505|NCT00400764|467258465|FG003|Phase II|Sponsor's decision to terminate|22|||
129806506|NCT00400764|467258466|FG004|Phase II|Sponsor's decision to terminate|11|||
129806507|NCT00400764|467258462|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
129806508|NCT00400764|467258463|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
129806509|NCT00400764|467258464|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
129806510|NCT00400764|467258465|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
129806511|NCT00400764|467258466|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
129806512|NCT00400764|467258462|FG000|Phase II|Withdrawal by Subject|0|||
129806513|NCT00400764|467258463|FG001|Phase II|Withdrawal by Subject|0|||
129806514|NCT00400764|467258464|FG002|Phase II|Withdrawal by Subject|1|||
129806515|NCT00400764|467258465|FG003|Phase II|Withdrawal by Subject|1|||
129893572|NCT00689104|467569798|FG003|Overall Study|Non-compliance with study procedures|0|||
129893573|NCT04873817|467569799|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
129893574|NCT04873817|467569799|FG000|Overall Study|Lost to Follow-up|4|||
129893575|NCT04873817|467569799|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
129893576|NCT04873817|467569799|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
129893577|NCT04873817|467569799|FG000|Overall Study|Other Reasons|3|||
129893578|NCT03590743|467569802|FG000|Overall Study|Withdrawal by Subject|0|||
129893579|NCT03590743|467569803|FG001|Overall Study|Withdrawal by Subject|1|||
129893580|NCT00604786|467569804|FG000|Overall Study|Lost to Follow-up|2|||
129893581|NCT00604786|467569805|FG001|Overall Study|Lost to Follow-up|0|||
129893582|NCT01221181|467569806|FG000|Overall Study|Lost to Follow-up|1|||
129893583|NCT02698436|467569807|FG000|Overall Study|Adverse Event|1|||
129893584|NCT02698436|467569808|FG001|Overall Study|Adverse Event|0|||
129893585|NCT02698436|467569807|FG000|Overall Study|Withdrawal by Subject|3|||
129893586|NCT02698436|467569808|FG001|Overall Study|Withdrawal by Subject|3|||
129893587|NCT02698436|467569807|FG000|Overall Study|Lost to Follow-up|2|||
129893588|NCT02698436|467569808|FG001|Overall Study|Lost to Follow-up|4|||
129893589|NCT02698436|467569807|FG000|Overall Study|Non-compliance with study regimen|1|||
129893590|NCT02698436|467569808|FG001|Overall Study|Non-compliance with study regimen|0|||
129893591|NCT01394991|467569809|FG000|Overall Study|Adverse Event|0|||
129893592|NCT01394991|467569810|FG001|Overall Study|Adverse Event|4|||
129893593|NCT01394991|467569809|FG000|Overall Study|Lack of Efficacy|5|||
129806516|NCT00400764|467258466|FG004|Phase II|Withdrawal by Subject|0|||
129806517|NCT02628938|467258467|FG000|Overall Study|Did not attend the follow up recall|2|||
129893594|NCT01394991|467569810|FG001|Overall Study|Lack of Efficacy|7|||
129893595|NCT01394991|467569809|FG000|Overall Study|Lost to Follow-up|6|||
129893596|NCT01394991|467569810|FG001|Overall Study|Lost to Follow-up|8|||
129893597|NCT01394991|467569809|FG000|Overall Study|Physician Decision|1|||
129806518|NCT02628938|467258468|FG001|Overall Study|Did not attend the follow up recall|2|||
129806519|NCT02628938|467258469|FG002|Overall Study|Did not attend the follow up recall|1|||
129806520|NCT02628938|467258467|FG000|Overall Study|Failure to comply with the instructions|3|||
129806521|NCT02628938|467258468|FG001|Overall Study|Failure to comply with the instructions|0|||
130057851|NCT00238303|468166090|FG002|Overall Study|Poor tolerance of study treatment|1|||
130057852|NCT00238303|468166088|FG000|Overall Study|Adverse Event|0|||
130057853|NCT00238303|468166089|FG001|Overall Study|Adverse Event|1|||
130057854|NCT00238303|468166090|FG002|Overall Study|Adverse Event|3|||
130057855|NCT02561299|468166094|FG000|Overall Study|Death|2|||
130057856|NCT02561299|468166095|FG001|Overall Study|Death|4|||
130057857|NCT02561299|468166094|FG000|Overall Study|Lost to Follow-up|1|||
130057858|NCT02561299|468166095|FG001|Overall Study|Lost to Follow-up|0|||
130057859|NCT02561299|468166094|FG000|Overall Study|Withdrawal by Subject|2|||
130057860|NCT02561299|468166095|FG001|Overall Study|Withdrawal by Subject|2|||
130057861|NCT01248130|468166096|FG000|Overall Study|Protocol Violation|1|||
130057862|NCT01248130|468166097|FG001|Overall Study|Protocol Violation|0|||
130057863|NCT01248130|468166096|FG000|Overall Study|Ineligible|1|||
130057864|NCT01248130|468166097|FG001|Overall Study|Ineligible|0|||
130057865|NCT01358877|468166098|FG000|Overall Study|Death|80|||
130057866|NCT01358877|468166099|FG001|Overall Study|Death|89|||
130057867|NCT01358877|468166098|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
130057868|NCT01358877|468166099|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
130057869|NCT01358877|468166098|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
130057870|NCT01358877|468166099|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
130057871|NCT01358877|468166098|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
130057872|NCT01358877|468166099|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
130057873|NCT01358877|468166098|FG000|Overall Study|Other|142|||
130057874|NCT01358877|468166099|FG001|Overall Study|Other|129|||
130057875|NCT01911845|468166104|FG000|Overall Study|Adverse Event|2|||
130057876|NCT01911845|468166104|FG000|Overall Study|Lost to Follow-up|1|||
130057877|NCT01911845|468166104|FG000|Overall Study|Other (not specified)|3|||
130057878|NCT01994226|468166105|FG000|Overall Study|Protocol Violation|13|||
130057879|NCT01994226|468166106|FG001|Overall Study|Protocol Violation|10|||
130057880|NCT01994226|468166105|FG000|Overall Study|Early Cessation of treatment|6|||
130057881|NCT01994226|468166106|FG001|Overall Study|Early Cessation of treatment|11|||
130057882|NCT00501046|468166111|FG000|Overall Study|Adverse Event|21|||
130057883|NCT00501046|468166112|FG001|Overall Study|Adverse Event|25|||
130057884|NCT00501046|468166111|FG000|Overall Study|Death|23|||
130057885|NCT00501046|468166112|FG001|Overall Study|Death|30|||
130057886|NCT00501046|468166111|FG000|Overall Study|Lost to Follow-up|14|||
130057887|NCT00501046|468166112|FG001|Overall Study|Lost to Follow-up|13|||
130057888|NCT00501046|468166111|FG000|Overall Study|Physician Decision|7|||
130057889|NCT00501046|468166112|FG001|Overall Study|Physician Decision|2|||
130057890|NCT00501046|468166111|FG000|Overall Study|Pregnancy|0|||
130057891|NCT00501046|468166112|FG001|Overall Study|Pregnancy|3|||
130057892|NCT00501046|468166111|FG000|Overall Study|Protocol Violation|2|||
130057893|NCT00501046|468166112|FG001|Overall Study|Protocol Violation|1|||
130057894|NCT00501046|468166111|FG000|Overall Study|Withdrawal by Subject|84|||
130057895|NCT00501046|468166112|FG001|Overall Study|Withdrawal by Subject|83|||
130057896|NCT00501046|468166111|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
130057897|NCT00501046|468166112|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
130057898|NCT02345252|468166118|FG000|Double-Blind Phase|Adverse Event|2|||
130057899|NCT02345252|468166119|FG001|Double-Blind Phase|Adverse Event|3|||
130057900|NCT02345252|468166118|FG000|Double-Blind Phase|Death|1|||
130057901|NCT02345252|468166119|FG001|Double-Blind Phase|Death|2|||
130057902|NCT02345252|468166118|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130057903|NCT02345252|468166119|FG001|Double-Blind Phase|Lack of Efficacy|0|||
130057904|NCT02345252|468166118|FG000|Double-Blind Phase|Investigator's Discretion|4|||
130057905|NCT02345252|468166119|FG001|Double-Blind Phase|Investigator's Discretion|6|||
130057906|NCT02345252|468166118|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
130057907|NCT02345252|468166119|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
130057908|NCT02345252|468166118|FG000|Double-Blind Phase|Protocol Violation|2|||
130057909|NCT02345252|468166119|FG001|Double-Blind Phase|Protocol Violation|1|||
130057910|NCT02345252|468166118|FG000|Double-Blind Phase|Withdrew Consent|21|||
130057911|NCT02345252|468166119|FG001|Double-Blind Phase|Withdrew Consent|23|||
130057912|NCT02345252|468166118|FG000|Double-Blind Phase|Lost to Follow-up|8|||
130057913|NCT02345252|468166119|FG001|Double-Blind Phase|Lost to Follow-up|10|||
130057914|NCT02345252|468166118|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
130057915|NCT02345252|468166119|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
130057916|NCT04507867|468166120|FG000|Overall Study|Death|7|||
130057917|NCT04507867|468166121|FG001|Overall Study|Death|1|||
130057918|NCT01954251|468166125|FG000|Overall Study|Adverse Event|5|||
130057919|NCT01954251|468166126|FG001|Overall Study|Adverse Event|7|||
130057920|NCT01954251|468166125|FG000|Overall Study|Lost to Follow-up|6|||
130057921|NCT01954251|468166126|FG001|Overall Study|Lost to Follow-up|6|||
130057922|NCT01954251|468166125|FG000|Overall Study|Withdrawal by Subject|2|||
130057923|NCT01954251|468166126|FG001|Overall Study|Withdrawal by Subject|6|||
130057924|NCT00779324|468166127|FG000|Overall Study|Lost to Follow-up|2|||
130057925|NCT00779324|468166128|FG001|Overall Study|Lost to Follow-up|1|||
130057926|NCT00779324|468166127|FG000|Overall Study|Withdrawal by Subject|4|||
130057927|NCT00779324|468166128|FG001|Overall Study|Withdrawal by Subject|2|||
130057928|NCT00779324|468166127|FG000|Overall Study|Missed visit|1|||
130057929|NCT00779324|468166128|FG001|Overall Study|Missed visit|1|||
130057930|NCT02207556|468166129|FG000|Overall Study|Physician Decision|1|||
130057931|NCT02207556|468166130|FG001|Overall Study|Physician Decision|0|||
130057932|NCT02207556|468166129|FG000|Overall Study|Withdrawal by Subject|1|||
130057933|NCT02207556|468166130|FG001|Overall Study|Withdrawal by Subject|0|||
130057934|NCT02207556|468166129|FG000|Overall Study|Death|0|||
130057935|NCT02207556|468166130|FG001|Overall Study|Death|5|||
130057936|NCT03558555|468166131|FG000|Overall Study|Lost to Follow-up|2|||
130057937|NCT03558555|468166132|FG001|Overall Study|Lost to Follow-up|1|||
130057938|NCT01958125|468166133|FG000|Overall Study|Missing diary data|2|||
130057939|NCT01958125|468166134|FG001|Overall Study|Missing diary data|6|||
130057940|NCT01958125|468166133|FG000|Overall Study|No headache attacks|0|||
130057941|NCT01958125|468166134|FG001|Overall Study|No headache attacks|2|||
130057942|NCT00617409|468166135|FG000|Overall Study|Withdrawal by Subject|4|||
130057943|NCT00617409|468166136|FG001|Overall Study|Withdrawal by Subject|1|||
130057944|NCT00617409|468166137|FG002|Overall Study|Withdrawal by Subject|2|||
130057945|NCT00617409|468166135|FG000|Overall Study|Adverse Event|0|||
130057946|NCT00617409|468166136|FG001|Overall Study|Adverse Event|2|||
130057947|NCT00617409|468166137|FG002|Overall Study|Adverse Event|3|||
130057948|NCT00617409|468166135|FG000|Overall Study|Disease Progression|8|||
130057949|NCT00617409|468166136|FG001|Overall Study|Disease Progression|8|||
130057950|NCT00617409|468166137|FG002|Overall Study|Disease Progression|18|||
130057951|NCT00617409|468166135|FG000|Overall Study|Death|3|||
130057952|NCT00617409|468166136|FG001|Overall Study|Death|5|||
130057953|NCT00617409|468166137|FG002|Overall Study|Death|4|||
130057954|NCT00617409|468166135|FG000|Overall Study|Alternative Therapy|1|||
130057955|NCT00617409|468166136|FG001|Overall Study|Alternative Therapy|2|||
130057956|NCT00617409|468166137|FG002|Overall Study|Alternative Therapy|0|||
130057957|NCT00781599|468166143|FG000|Overall Study|Lost to Follow-up|7|||
130057958|NCT00781599|468166144|FG001|Overall Study|Lost to Follow-up|4|||
130057959|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
130057960|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
130057961|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
130057962|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
130057963|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130057964|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
130057965|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
130057966|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
130057967|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
130057968|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
130057969|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
130057970|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
130057971|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
130057972|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
130057973|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
130112187|NCT03565211|468371091|FG000|Overall Study|Adverse Event|44|||
130112188|NCT03565211|468371091|FG000|Overall Study|Personal issues|1|||
130112189|NCT01894984|468371095|FG000|Overall Study|Other|314|||
130112190|NCT01894984|468371096|FG001|Overall Study|Other|175|||
130112191|NCT00033631|468371097|FG000|Overall Study|Protocol Violation|14|||
130112192|NCT00033631|468371098|FG001|Overall Study|Protocol Violation|11|||
130112193|NCT00033631|468371097|FG000|Overall Study|Withdrawal by Subject|4|||
130112194|NCT00033631|468371098|FG001|Overall Study|Withdrawal by Subject|4|||
130112195|NCT01827371|468371099|FG000|Overall Study|Adverse Event|0|||
130112196|NCT01827371|468371100|FG001|Overall Study|Adverse Event|0|||
130112197|NCT01827371|468371101|FG002|Overall Study|Adverse Event|4|||
130112198|NCT01827371|468371102|FG003|Overall Study|Adverse Event|2|||
130112199|NCT01827371|468371099|FG000|Overall Study|Lost to Follow-up|0|||
129806522|NCT02628938|467258469|FG002|Overall Study|Failure to comply with the instructions|3|||
129806523|NCT03113916|467258470|FG000|Overall Study|Withdrawal by Subject|9|||
129806524|NCT03113916|467258471|FG001|Overall Study|Withdrawal by Subject|7|||
129806525|NCT03113916|467258470|FG000|Overall Study|Pregnancy|1|||
129806526|NCT03113916|467258471|FG001|Overall Study|Pregnancy|3|||
129806527|NCT03113916|467258470|FG000|Overall Study|Lost to Follow-up|1|||
129806528|NCT03113916|467258471|FG001|Overall Study|Lost to Follow-up|2|||
129806529|NCT00761631|467258472|FG000|Overall Study|Parent/legal guardian request|8|||
129806530|NCT00761631|467258473|FG001|Overall Study|Parent/legal guardian request|3|||
129806531|NCT00761631|467258474|FG002|Overall Study|Parent/legal guardian request|8|||
129806532|NCT00761631|467258475|FG003|Overall Study|Parent/legal guardian request|0|||
129806533|NCT00761631|467258476|FG004|Overall Study|Parent/legal guardian request|5|||
129806534|NCT00761631|467258477|FG005|Overall Study|Parent/legal guardian request|0|||
129806535|NCT00761631|467258472|FG000|Overall Study|Lost to Follow-up|2|||
129806536|NCT00761631|467258473|FG001|Overall Study|Lost to Follow-up|4|||
129806537|NCT00761631|467258474|FG002|Overall Study|Lost to Follow-up|7|||
129806538|NCT00761631|467258475|FG003|Overall Study|Lost to Follow-up|1|||
129806539|NCT00761631|467258476|FG004|Overall Study|Lost to Follow-up|6|||
129806540|NCT00761631|467258477|FG005|Overall Study|Lost to Follow-up|1|||
129806541|NCT00761631|467258472|FG000|Overall Study|Protocol Violation|2|||
129806542|NCT00761631|467258473|FG001|Overall Study|Protocol Violation|0|||
129806543|NCT00761631|467258474|FG002|Overall Study|Protocol Violation|0|||
129806544|NCT00761631|467258475|FG003|Overall Study|Protocol Violation|1|||
129806545|NCT00761631|467258476|FG004|Overall Study|Protocol Violation|5|||
129806546|NCT00761631|467258477|FG005|Overall Study|Protocol Violation|1|||
129806547|NCT00761631|467258472|FG000|Overall Study|Randomized, not treated|1|||
129806548|NCT00761631|467258473|FG001|Overall Study|Randomized, not treated|0|||
129806549|NCT00761631|467258474|FG002|Overall Study|Randomized, not treated|0|||
129806550|NCT00761631|467258475|FG003|Overall Study|Randomized, not treated|0|||
129806551|NCT00761631|467258476|FG004|Overall Study|Randomized, not treated|0|||
129806552|NCT00761631|467258477|FG005|Overall Study|Randomized, not treated|0|||
129806553|NCT00761631|467258472|FG000|Overall Study|Failed to return|1|||
129806554|NCT00761631|467258473|FG001|Overall Study|Failed to return|0|||
129806555|NCT00761631|467258474|FG002|Overall Study|Failed to return|1|||
129806556|NCT00761631|467258475|FG003|Overall Study|Failed to return|1|||
129806557|NCT00761631|467258476|FG004|Overall Study|Failed to return|5|||
129806558|NCT00761631|467258477|FG005|Overall Study|Failed to return|2|||
129806559|NCT00761631|467258472|FG000|Overall Study|Physician Decision|1|||
129806560|NCT00761631|467258473|FG001|Overall Study|Physician Decision|0|||
129806561|NCT00761631|467258474|FG002|Overall Study|Physician Decision|0|||
129806562|NCT00761631|467258475|FG003|Overall Study|Physician Decision|0|||
130057974|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
129806563|NCT00761631|467258476|FG004|Overall Study|Physician Decision|0|||
130057975|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130057976|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130057977|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
130057978|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
130057979|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
130057980|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130057981|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130057982|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130057983|NCT01106625|468166145|FG000|Core Period: Baseline to Week 26|Other|8|||
130057984|NCT01106625|468166146|FG001|Core Period: Baseline to Week 26|Other|7|||
130057985|NCT01106625|468166147|FG002|Core Period: Baseline to Week 26|Other|4|||
130057986|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130057987|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
130057988|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
130057989|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
130057990|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
130057991|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130057992|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130057993|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130057994|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130057995|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130057996|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130057997|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130057998|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
130057999|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130058000|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130058001|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
130058002|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
130112200|NCT01827371|468371100|FG001|Overall Study|Lost to Follow-up|2|||
130112201|NCT01827371|468371101|FG002|Overall Study|Lost to Follow-up|0|||
130112202|NCT01827371|468371102|FG003|Overall Study|Lost to Follow-up|4|||
130112203|NCT01827371|468371099|FG000|Overall Study|Protocol Violation|1|||
130112204|NCT01827371|468371100|FG001|Overall Study|Protocol Violation|0|||
130112205|NCT01827371|468371101|FG002|Overall Study|Protocol Violation|0|||
130112206|NCT01827371|468371102|FG003|Overall Study|Protocol Violation|0|||
130112207|NCT01827371|468371099|FG000|Overall Study|Withdrawal by Subject|1|||
130112208|NCT01827371|468371100|FG001|Overall Study|Withdrawal by Subject|2|||
130112209|NCT01827371|468371101|FG002|Overall Study|Withdrawal by Subject|2|||
130112210|NCT01827371|468371102|FG003|Overall Study|Withdrawal by Subject|3|||
130112211|NCT01827371|468371099|FG000|Overall Study|Physician Decision|0|||
130112212|NCT01827371|468371100|FG001|Overall Study|Physician Decision|1|||
130112213|NCT01827371|468371101|FG002|Overall Study|Physician Decision|0|||
130112214|NCT01827371|468371102|FG003|Overall Study|Physician Decision|1|||
130112215|NCT01827371|468371099|FG000|Overall Study|Temporary study halt to vaccinations|11|||
130112216|NCT01827371|468371100|FG001|Overall Study|Temporary study halt to vaccinations|2|||
130112217|NCT01827371|468371101|FG002|Overall Study|Temporary study halt to vaccinations|5|||
130112218|NCT01827371|468371102|FG003|Overall Study|Temporary study halt to vaccinations|13|||
130112219|NCT01401478|468371110|FG000|Overall Study|Study drug not available|6|||
130112220|NCT01401478|468371110|FG000|Overall Study|Adverse Event|5|||
130112221|NCT01401478|468371110|FG000|Overall Study|Hyperphosphatemia|5|||
130112222|NCT01401478|468371110|FG000|Overall Study|Lost to Follow-up|5|||
130112223|NCT01401478|468371110|FG000|Overall Study|Kidney transplantation|3|||
130112224|NCT01401478|468371110|FG000|Overall Study|Withdrawal by Subject|3|||
130112225|NCT01401478|468371110|FG000|Overall Study|Blood samples not available|1|||
130112226|NCT01401478|468371110|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
130112227|NCT01401478|468371110|FG000|Overall Study|Low intact parathyroid hormone|1|||
130112228|NCT01401478|468371110|FG000|Overall Study|Serious adverse event|1|||
130112229|NCT01684722|468371111|FG000|Overall Study|Lost to Follow-up|78|||
130112230|NCT01684722|468371112|FG001|Overall Study|Lost to Follow-up|56|||
130112231|NCT01684722|468371113|FG002|Overall Study|Lost to Follow-up|75|||
130112232|NCT01684722|468371114|FG003|Overall Study|Lost to Follow-up|89|||
130112233|NCT01684722|468371111|FG000|Overall Study|Death|19|||
130112234|NCT01684722|468371112|FG001|Overall Study|Death|21|||
130112235|NCT01684722|468371113|FG002|Overall Study|Death|19|||
130112236|NCT01684722|468371114|FG003|Overall Study|Death|21|||
130112237|NCT01814137|468371115|FG000|Overall Study|Adverse Event|0|||
130112238|NCT01814137|468371116|FG001|Overall Study|Adverse Event|1|||
130112239|NCT01814137|468371115|FG000|Overall Study|Withdrawal by Subject|2|||
130112240|NCT01814137|468371116|FG001|Overall Study|Withdrawal by Subject|2|||
130112241|NCT01814137|468371115|FG000|Overall Study|Physician Decision|1|||
130112242|NCT01814137|468371116|FG001|Overall Study|Physician Decision|1|||
130112243|NCT01814137|468371115|FG000|Overall Study|Unclassified|2|||
130112244|NCT01814137|468371116|FG001|Overall Study|Unclassified|1|||
130112245|NCT00219557|468371117|FG000|Phase 1|Lack of Efficacy|3|||
130112246|NCT00219557|468371118|FG001|Phase 1|Lack of Efficacy|0|||
130112247|NCT00219557|468371119|FG002|Phase 1|Lack of Efficacy|0|||
130112248|NCT00219557|468371117|FG000|Phase 1|Adverse Event|2|||
130112249|NCT00219557|468371118|FG001|Phase 1|Adverse Event|0|||
130112250|NCT00219557|468371119|FG002|Phase 1|Adverse Event|0|||
130112251|NCT00219557|468371117|FG000|Phase 1|Withdrawal by Subject|1|||
130112252|NCT00219557|468371118|FG001|Phase 1|Withdrawal by Subject|0|||
130112253|NCT00219557|468371119|FG002|Phase 1|Withdrawal by Subject|0|||
130112254|NCT00219557|468371117|FG000|Phase 1|Started chemotherapy at other institute|1|||
130112255|NCT00219557|468371118|FG001|Phase 1|Started chemotherapy at other institute|0|||
130112256|NCT00219557|468371119|FG002|Phase 1|Started chemotherapy at other institute|0|||
130112257|NCT00219557|468371117|FG000|Phase 2|Lack of Efficacy|0|||
130112258|NCT00219557|468371118|FG001|Phase 2|Lack of Efficacy|21|||
130112259|NCT00219557|468371119|FG002|Phase 2|Lack of Efficacy|15|||
130112260|NCT00219557|468371117|FG000|Phase 2|Adverse Event|0|||
130112261|NCT00219557|468371118|FG001|Phase 2|Adverse Event|22|||
130112262|NCT00219557|468371119|FG002|Phase 2|Adverse Event|2|||
130112263|NCT00219557|468371117|FG000|Phase 2|Death|0|||
129806564|NCT00761631|467258477|FG005|Overall Study|Physician Decision|0|||
130112264|NCT00219557|468371118|FG001|Phase 2|Death|8|||
130112265|NCT00219557|468371119|FG002|Phase 2|Death|2|||
130112266|NCT00219557|468371117|FG000|Phase 2|Other|0|||
130112267|NCT00219557|468371118|FG001|Phase 2|Other|8|||
130112268|NCT00219557|468371119|FG002|Phase 2|Other|6|||
130112269|NCT00219557|468371117|FG000|Phase 2|Withdrawal by Subject|0|||
130112270|NCT00219557|468371118|FG001|Phase 2|Withdrawal by Subject|9|||
130112271|NCT00219557|468371119|FG002|Phase 2|Withdrawal by Subject|5|||
130112272|NCT00219557|468371117|FG000|Phase 2|Treatment not received|0|||
129806565|NCT00761631|467258472|FG000|Overall Study|Other|0|||
129806566|NCT00761631|467258473|FG001|Overall Study|Other|0|||
130112273|NCT00219557|468371118|FG001|Phase 2|Treatment not received|1|||
130112274|NCT00219557|468371119|FG002|Phase 2|Treatment not received|3|||
130112275|NCT01427803|468371122|FG000|Overall Study|Lost to Follow-up|32|||
130112276|NCT01427803|468371123|FG001|Overall Study|Lost to Follow-up|26|||
130112277|NCT01427803|468371122|FG000|Overall Study|Withdrawal by Subject|20|||
130112278|NCT01427803|468371123|FG001|Overall Study|Withdrawal by Subject|0|||
129806567|NCT00761631|467258474|FG002|Overall Study|Other|0|||
129806568|NCT00761631|467258475|FG003|Overall Study|Other|0|||
129806569|NCT00761631|467258476|FG004|Overall Study|Other|1|||
129806570|NCT00761631|467258477|FG005|Overall Study|Other|1|||
129806571|NCT01441180|467258483|FG000|Overall Study|Lost to Follow-up|1|||
129806572|NCT01441180|467258484|FG001|Overall Study|Lost to Follow-up|1|||
129806573|NCT01441180|467258485|FG002|Overall Study|Lost to Follow-up|1|||
129806574|NCT01441180|467258483|FG000|Overall Study|Discontinued|0|||
129806575|NCT01441180|467258484|FG001|Overall Study|Discontinued|0|||
129806576|NCT01441180|467258485|FG002|Overall Study|Discontinued|2|||
129806577|NCT01402011|467258488|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
129806578|NCT01402011|467258489|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
129806579|NCT01402011|467258490|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
129806580|NCT01402011|467258488|FG000|Active Treatment Period|Withdrawal by Subject|1|||
129806581|NCT01402011|467258489|FG001|Active Treatment Period|Withdrawal by Subject|3|||
129806582|NCT01402011|467258490|FG002|Active Treatment Period|Withdrawal by Subject|0|||
129806583|NCT01402011|467258488|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
129806584|NCT01402011|467258489|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
129806585|NCT01402011|467258490|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
129806586|NCT02569671|467258491|FG000|Overall Study|Lost to Follow-up|2|||
129806587|NCT02569671|467258492|FG001|Overall Study|Lost to Follow-up|1|||
129806588|NCT02569671|467258491|FG000|Overall Study|Withdrawal by Subject|1|||
129806589|NCT02569671|467258492|FG001|Overall Study|Withdrawal by Subject|3|||
129806590|NCT02612129|467258493|FG000|Single Dose Treatment Period|Screening Failure|1|||
129806591|NCT02612129|467258494|FG001|Single Dose Treatment Period|Screening Failure|0|||
129806592|NCT02612129|467258495|FG002|Single Dose Treatment Period|Screening Failure|0|||
129806593|NCT02612129|467258493|FG000|Continuous Treatment Period|Early Escape|0|||
129806594|NCT02612129|467258494|FG001|Continuous Treatment Period|Early Escape|2|||
129806595|NCT02612129|467258495|FG002|Continuous Treatment Period|Early Escape|0|||
129806596|NCT02612129|467258493|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
129806597|NCT02612129|467258494|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
129806598|NCT02612129|467258495|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
129806599|NCT02612129|467258493|FG000|Continuous Treatment Period|Safety Reasons|0|||
129806600|NCT02612129|467258494|FG001|Continuous Treatment Period|Safety Reasons|3|||
129806601|NCT02612129|467258495|FG002|Continuous Treatment Period|Safety Reasons|0|||
129806602|NCT02612129|467258493|FG000|Continuous Treatment Period|Death|0|||
129806603|NCT02612129|467258494|FG001|Continuous Treatment Period|Death|1|||
129806604|NCT02612129|467258495|FG002|Continuous Treatment Period|Death|0|||
129806605|NCT02612129|467258493|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
129806606|NCT02612129|467258494|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
129806607|NCT02612129|467258495|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
129806608|NCT03487549|467258496|FG000|Overall Study|Protocol Violation|0|||
129806609|NCT03487549|467258497|FG001|Overall Study|Protocol Violation|1|||
129806610|NCT03487549|467258496|FG000|Overall Study|Lost to Follow-up|2|||
129806611|NCT03487549|467258497|FG001|Overall Study|Lost to Follow-up|1|||
129806612|NCT03487549|467258496|FG000|Overall Study|Withdrawal by Subject|2|||
129806613|NCT03487549|467258497|FG001|Overall Study|Withdrawal by Subject|0|||
129806614|NCT01543698|467261028|FG000|Phase 1b|Disease progression|2|||
129806615|NCT01543698|467261029|FG001|Phase 1b|Disease progression|4|||
130112279|NCT01427803|468371122|FG000|Overall Study|Unable to complete full treatment period|6|||
130112280|NCT01427803|468371123|FG001|Overall Study|Unable to complete full treatment period|0|||
130112281|NCT01427803|468371122|FG000|Overall Study|Protocol Violation|1|||
130112282|NCT01427803|468371123|FG001|Overall Study|Protocol Violation|0|||
130112283|NCT01427803|468371122|FG000|Overall Study|Physician Decision|3|||
130112284|NCT01427803|468371123|FG001|Overall Study|Physician Decision|0|||
130112285|NCT01427803|468371122|FG000|Overall Study|did not take product|1|||
130112286|NCT01427803|468371123|FG001|Overall Study|did not take product|0|||
130112287|NCT01571635|468371125|FG000|Overall Study|Adverse Event|3|||
130112288|NCT01571635|468371126|FG001|Overall Study|Adverse Event|0|||
130112289|NCT01571635|468371127|FG002|Overall Study|Adverse Event|2|||
129806616|NCT01543698|467261030|FG002|Phase 1b|Disease progression|3|||
129806617|NCT01543698|467261031|FG003|Phase 1b|Disease progression|2|||
129806618|NCT01543698|467261032|FG004|Phase 1b|Disease progression|10|||
129806619|NCT01543698|467261033|FG005|Phase 1b|Disease progression|6|||
129806620|NCT01543698|467261034|FG006|Phase 1b|Disease progression|5|||
129806621|NCT01543698|467261035|FG007|Phase 1b|Disease progression|3|||
129806622|NCT01543698|467261036|FG008|Phase 1b|Disease progression|4|||
129806623|NCT01543698|467261037|FG009|Phase 1b|Disease progression|5|||
129806624|NCT01543698|467261038|FG010|Phase 1b|Disease progression|1|||
129806625|NCT01543698|467261039|FG011|Phase 1b|Disease progression|0|||
129806626|NCT01543698|467261040|FG012|Phase 1b|Disease progression|0|||
129806627|NCT01543698|467261041|FG013|Phase 1b|Disease progression|0|||
129806628|NCT01543698|467261042|FG014|Phase 1b|Disease progression|0|||
129806629|NCT01543698|467261028|FG000|Phase 1b|Death|0|||
129806630|NCT01543698|467261029|FG001|Phase 1b|Death|0|||
129806631|NCT01543698|467261030|FG002|Phase 1b|Death|1|||
129806632|NCT01543698|467261031|FG003|Phase 1b|Death|1|||
129806633|NCT01543698|467261032|FG004|Phase 1b|Death|0|||
129806634|NCT01543698|467261033|FG005|Phase 1b|Death|0|||
129806635|NCT01543698|467261034|FG006|Phase 1b|Death|0|||
129806636|NCT01543698|467261035|FG007|Phase 1b|Death|0|||
129806637|NCT01543698|467261036|FG008|Phase 1b|Death|0|||
129806638|NCT01543698|467261037|FG009|Phase 1b|Death|0|||
129806639|NCT01543698|467261038|FG010|Phase 1b|Death|1|||
129806640|NCT01543698|467261039|FG011|Phase 1b|Death|0|||
129806641|NCT01543698|467261040|FG012|Phase 1b|Death|0|||
129806642|NCT01543698|467261041|FG013|Phase 1b|Death|0|||
129806643|NCT01543698|467261042|FG014|Phase 1b|Death|0|||
129806644|NCT01543698|467261028|FG000|Phase 1b|Withdrawal by Subject|0|||
129806645|NCT01543698|467261029|FG001|Phase 1b|Withdrawal by Subject|1|||
129806646|NCT01543698|467261030|FG002|Phase 1b|Withdrawal by Subject|0|||
129806647|NCT01543698|467261031|FG003|Phase 1b|Withdrawal by Subject|1|||
129806648|NCT01543698|467261032|FG004|Phase 1b|Withdrawal by Subject|0|||
129806649|NCT01543698|467261033|FG005|Phase 1b|Withdrawal by Subject|0|||
129806650|NCT01543698|467261034|FG006|Phase 1b|Withdrawal by Subject|1|||
129806651|NCT01543698|467261035|FG007|Phase 1b|Withdrawal by Subject|0|||
129806652|NCT01543698|467261036|FG008|Phase 1b|Withdrawal by Subject|0|||
129806653|NCT01543698|467261037|FG009|Phase 1b|Withdrawal by Subject|0|||
129806654|NCT01543698|467261038|FG010|Phase 1b|Withdrawal by Subject|0|||
129806655|NCT01543698|467261039|FG011|Phase 1b|Withdrawal by Subject|0|||
129806656|NCT01543698|467261040|FG012|Phase 1b|Withdrawal by Subject|0|||
129806657|NCT01543698|467261041|FG013|Phase 1b|Withdrawal by Subject|0|||
129806658|NCT01543698|467261042|FG014|Phase 1b|Withdrawal by Subject|0|||
129806659|NCT01543698|467261028|FG000|Phase 1b|Adverse Event|1|||
129806660|NCT01543698|467261029|FG001|Phase 1b|Adverse Event|0|||
129806661|NCT01543698|467261030|FG002|Phase 1b|Adverse Event|0|||
129806662|NCT01543698|467261031|FG003|Phase 1b|Adverse Event|1|||
129806663|NCT01543698|467261032|FG004|Phase 1b|Adverse Event|2|||
129806664|NCT01543698|467261033|FG005|Phase 1b|Adverse Event|2|||
129806665|NCT01543698|467261034|FG006|Phase 1b|Adverse Event|0|||
129806666|NCT01543698|467261035|FG007|Phase 1b|Adverse Event|0|||
129806667|NCT01543698|467261036|FG008|Phase 1b|Adverse Event|1|||
129806668|NCT01543698|467261037|FG009|Phase 1b|Adverse Event|1|||
129806669|NCT01543698|467261038|FG010|Phase 1b|Adverse Event|2|||
129806670|NCT01543698|467261039|FG011|Phase 1b|Adverse Event|0|||
130112290|NCT01571635|468371128|FG003|Overall Study|Adverse Event|3|||
130112291|NCT01571635|468371129|FG004|Overall Study|Adverse Event|5|||
129806671|NCT01543698|467261040|FG012|Phase 1b|Adverse Event|0|||
130112292|NCT01571635|468371125|FG000|Overall Study|Other reasons|2|||
130112293|NCT01571635|468371126|FG001|Overall Study|Other reasons|1|||
130112294|NCT01571635|468371127|FG002|Overall Study|Other reasons|2|||
129806672|NCT01543698|467261041|FG013|Phase 1b|Adverse Event|0|||
129806673|NCT01543698|467261042|FG014|Phase 1b|Adverse Event|0|||
129806674|NCT01543698|467261028|FG000|Phase 1b|Administrative problems|1|||
129806675|NCT01543698|467261029|FG001|Phase 1b|Administrative problems|0|||
129806676|NCT01543698|467261030|FG002|Phase 1b|Administrative problems|0|||
129806677|NCT01543698|467261031|FG003|Phase 1b|Administrative problems|0|||
129806678|NCT01543698|467261032|FG004|Phase 1b|Administrative problems|1|||
129806679|NCT01543698|467261033|FG005|Phase 1b|Administrative problems|0|||
129806680|NCT01543698|467261034|FG006|Phase 1b|Administrative problems|0|||
129806681|NCT01543698|467261035|FG007|Phase 1b|Administrative problems|1|||
129806682|NCT01543698|467261036|FG008|Phase 1b|Administrative problems|0|||
129806683|NCT01543698|467261037|FG009|Phase 1b|Administrative problems|0|||
129893598|NCT01394991|467569810|FG001|Overall Study|Physician Decision|3|||
129893599|NCT01394991|467569809|FG000|Overall Study|Protocol Violation|1|||
129893600|NCT01394991|467569810|FG001|Overall Study|Protocol Violation|1|||
129893601|NCT01394991|467569809|FG000|Overall Study|Withdrawal by Subject|20|||
129893602|NCT01394991|467569810|FG001|Overall Study|Withdrawal by Subject|17|||
129893603|NCT01394991|467569809|FG000|Overall Study|Chemotherapy Termination|10|||
129893604|NCT01394991|467569810|FG001|Overall Study|Chemotherapy Termination|15|||
129893605|NCT01394991|467569809|FG000|Overall Study|Disease Progression|7|||
129893606|NCT01394991|467569810|FG001|Overall Study|Disease Progression|7|||
129893607|NCT01394991|467569809|FG000|Overall Study|Prematurely Termination of Trial|9|||
129893608|NCT01394991|467569810|FG001|Overall Study|Prematurely Termination of Trial|10|||
129893609|NCT04949399|467569815|FG000|Overall Study|Lost to Follow-up|11|||
129893610|NCT04949399|467569816|FG001|Overall Study|Lost to Follow-up|6|||
129893611|NCT04949399|467569815|FG000|Overall Study|Withdrawal by Subject|2|||
129893612|NCT04949399|467569816|FG001|Overall Study|Withdrawal by Subject|3|||
129893613|NCT00814489|467569817|FG000|Overall Study|Other|2|||
129893614|NCT00814489|467569818|FG001|Overall Study|Other|0|||
129893615|NCT00814489|467569819|FG002|Overall Study|Other|1|||
129893616|NCT01712685|467569845|FG000|Overall Study|pt declined to participate before trmt|1|||
129893617|NCT01866917|467569846|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
129893618|NCT01866917|467569847|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
129893619|NCT04610684|467571604|FG000|Study Treatment|Withdrawal by Subject|1|||
129893620|NCT04610684|467571604|FG000|Study Treatment|Disease Progression|2|||
129893621|NCT04610684|467571604|FG000|Follow up|Death|2|||
129893622|NCT04610684|467571604|FG000|Follow up|Withdrawal by Subject|1|||
129893623|NCT01251614|467571608|FG000|Overall Study|Adverse Event|1|||
129893624|NCT01251614|467571609|FG001|Overall Study|Adverse Event|0|||
129893625|NCT01251614|467571610|FG002|Overall Study|Adverse Event|1|||
129893626|NCT01251614|467571608|FG000|Overall Study|Lack of Efficacy|1|||
129893627|NCT01251614|467571609|FG001|Overall Study|Lack of Efficacy|9|||
129893628|NCT01251614|467571610|FG002|Overall Study|Lack of Efficacy|4|||
129893629|NCT01251614|467571608|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
129893630|NCT01251614|467571609|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
129893631|NCT01251614|467571610|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
129893632|NCT01251614|467571608|FG000|Overall Study|Pregnancy|0|||
129893633|NCT01251614|467571609|FG001|Overall Study|Pregnancy|0|||
129893634|NCT01251614|467571610|FG002|Overall Study|Pregnancy|2|||
129893635|NCT01251614|467571608|FG000|Overall Study|Loss of Disease Control|0|||
129893636|NCT01251614|467571609|FG001|Overall Study|Loss of Disease Control|1|||
129893637|NCT01251614|467571610|FG002|Overall Study|Loss of Disease Control|0|||
129893638|NCT01251614|467571608|FG000|Overall Study|Withdrawal by Subject|0|||
129893639|NCT01251614|467571609|FG001|Overall Study|Withdrawal by Subject|2|||
129893640|NCT01251614|467571610|FG002|Overall Study|Withdrawal by Subject|1|||
129893641|NCT01251614|467571608|FG000|Overall Study|Lost to Follow-up|0|||
129893642|NCT01251614|467571609|FG001|Overall Study|Lost to Follow-up|1|||
129893643|NCT01251614|467571610|FG002|Overall Study|Lost to Follow-up|0|||
129893644|NCT02153788|467571611|FG000|Overall Study|Physician Decision|2|||
129893645|NCT02153788|467571612|FG001|Overall Study|Physician Decision|1|||
129893646|NCT01684046|467571616|FG000|Period 1, First 30 Days|Adverse Event|0|||
129893647|NCT01684046|467571617|FG001|Period 1, First 30 Days|Adverse Event|2|||
129893648|NCT04531540|467571620|FG000|Overall Study|Adverse Event|1|||
129893649|NCT04531540|467571620|FG000|Overall Study|Protocol Violation|3|||
129893650|NCT04531540|467571620|FG000|Overall Study|Withdrawal by Subject|4|||
129893651|NCT04531540|467571620|FG000|Overall Study|Found to be Ineligible|1|||
129893652|NCT02688621|467571621|FG000|Overall Study|Pregnancy|1|||
129893653|NCT02688621|467571622|FG001|Overall Study|Pregnancy|3|||
129893654|NCT02688621|467571621|FG000|Overall Study|Lost to Follow-up|38|||
129893655|NCT02688621|467571622|FG001|Overall Study|Lost to Follow-up|15|||
129893656|NCT02688621|467571621|FG000|Overall Study|Withdrawal by Subject|1|||
129893657|NCT02688621|467571622|FG001|Overall Study|Withdrawal by Subject|0|||
129893658|NCT03239210|467571623|FG000|Overall Study|Lost to Follow-up|2|||
129893659|NCT03239210|467571624|FG001|Overall Study|Lost to Follow-up|2|||
129893660|NCT03239210|467571623|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
129893661|NCT03239210|467571624|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
129893662|NCT03239210|467571623|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
129893663|NCT03239210|467571624|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
129893664|NCT01575860|467571625|FG000|Overall Study|Withdrawal by Subject|1|||
129893665|NCT01575860|467571625|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
129893666|NCT01094743|467571627|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
130058003|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
130112295|NCT01571635|468371128|FG003|Overall Study|Other reasons|2|||
129893667|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
129893668|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
129893669|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
129893670|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
129893671|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
129806684|NCT01543698|467261038|FG010|Phase 1b|Administrative problems|2|||
129806685|NCT01543698|467261039|FG011|Phase 1b|Administrative problems|0|||
129806686|NCT01543698|467261040|FG012|Phase 1b|Administrative problems|0|||
129806687|NCT01543698|467261041|FG013|Phase 1b|Administrative problems|0|||
129806688|NCT01543698|467261042|FG014|Phase 1b|Administrative problems|0|||
129806689|NCT01543698|467261028|FG000|Phase 1b|Protocol Violation|2|||
129806690|NCT01543698|467261029|FG001|Phase 1b|Protocol Violation|0|||
129806691|NCT01543698|467261030|FG002|Phase 1b|Protocol Violation|0|||
129806692|NCT01543698|467261031|FG003|Phase 1b|Protocol Violation|0|||
129806693|NCT01543698|467261032|FG004|Phase 1b|Protocol Violation|0|||
129806694|NCT01543698|467261033|FG005|Phase 1b|Protocol Violation|0|||
129806695|NCT01543698|467261034|FG006|Phase 1b|Protocol Violation|0|||
129806696|NCT01543698|467261035|FG007|Phase 1b|Protocol Violation|0|||
129806697|NCT01543698|467261036|FG008|Phase 1b|Protocol Violation|0|||
129806698|NCT01543698|467261037|FG009|Phase 1b|Protocol Violation|0|||
129806699|NCT01543698|467261038|FG010|Phase 1b|Protocol Violation|0|||
129806700|NCT01543698|467261039|FG011|Phase 1b|Protocol Violation|0|||
129806701|NCT01543698|467261040|FG012|Phase 1b|Protocol Violation|0|||
129806702|NCT01543698|467261041|FG013|Phase 1b|Protocol Violation|0|||
129806703|NCT01543698|467261042|FG014|Phase 1b|Protocol Violation|0|||
129806704|NCT01543698|467261028|FG000|Phase 2|Protocol Violation|0|||
129806705|NCT01543698|467261029|FG001|Phase 2|Protocol Violation|0|||
129806706|NCT01543698|467261030|FG002|Phase 2|Protocol Violation|0|||
129806707|NCT01543698|467261031|FG003|Phase 2|Protocol Violation|0|||
129806708|NCT01543698|467261032|FG004|Phase 2|Protocol Violation|0|||
129806709|NCT01543698|467261033|FG005|Phase 2|Protocol Violation|0|||
129806710|NCT01543698|467261034|FG006|Phase 2|Protocol Violation|0|||
129806711|NCT01543698|467261035|FG007|Phase 2|Protocol Violation|0|||
129806712|NCT01543698|467261036|FG008|Phase 2|Protocol Violation|0|||
129806713|NCT01543698|467261037|FG009|Phase 2|Protocol Violation|0|||
129806714|NCT01543698|467261038|FG010|Phase 2|Protocol Violation|0|||
129806715|NCT01543698|467261039|FG011|Phase 2|Protocol Violation|0|||
129806716|NCT01543698|467261040|FG012|Phase 2|Protocol Violation|1|||
129806717|NCT01543698|467261041|FG013|Phase 2|Protocol Violation|0|||
129806718|NCT01543698|467261042|FG014|Phase 2|Protocol Violation|0|||
129806719|NCT01543698|467261028|FG000|Phase 2|Disease progression|0|||
129806720|NCT01543698|467261029|FG001|Phase 2|Disease progression|0|||
129806721|NCT01543698|467261030|FG002|Phase 2|Disease progression|0|||
129806722|NCT01543698|467261031|FG003|Phase 2|Disease progression|0|||
129806723|NCT01543698|467261032|FG004|Phase 2|Disease progression|0|||
129806724|NCT01543698|467261033|FG005|Phase 2|Disease progression|0|||
129806725|NCT01543698|467261034|FG006|Phase 2|Disease progression|0|||
129806726|NCT01543698|467261035|FG007|Phase 2|Disease progression|0|||
129806727|NCT01543698|467261036|FG008|Phase 2|Disease progression|0|||
129806728|NCT01543698|467261037|FG009|Phase 2|Disease progression|0|||
129806729|NCT01543698|467261038|FG010|Phase 2|Disease progression|0|||
129806730|NCT01543698|467261039|FG011|Phase 2|Disease progression|10|||
129806731|NCT01543698|467261040|FG012|Phase 2|Disease progression|21|||
129806732|NCT01543698|467261041|FG013|Phase 2|Disease progression|30|||
129806733|NCT01543698|467261042|FG014|Phase 2|Disease progression|25|||
129806734|NCT01543698|467261028|FG000|Phase 2|Death|0|||
129806735|NCT01543698|467261029|FG001|Phase 2|Death|0|||
129806736|NCT01543698|467261030|FG002|Phase 2|Death|0|||
129806737|NCT01543698|467261031|FG003|Phase 2|Death|0|||
129806738|NCT01543698|467261032|FG004|Phase 2|Death|0|||
129806739|NCT01543698|467261033|FG005|Phase 2|Death|0|||
129806740|NCT01543698|467261034|FG006|Phase 2|Death|0|||
129806741|NCT01543698|467261035|FG007|Phase 2|Death|0|||
129806742|NCT01543698|467261036|FG008|Phase 2|Death|0|||
129806743|NCT01543698|467261037|FG009|Phase 2|Death|0|||
129806744|NCT01543698|467261038|FG010|Phase 2|Death|0|||
129806745|NCT01543698|467261039|FG011|Phase 2|Death|0|||
129806746|NCT01543698|467261040|FG012|Phase 2|Death|1|||
129806747|NCT01543698|467261041|FG013|Phase 2|Death|1|||
129806748|NCT01543698|467261042|FG014|Phase 2|Death|1|||
129806749|NCT01543698|467261028|FG000|Phase 2|Administrative problems|0|||
129806750|NCT01543698|467261029|FG001|Phase 2|Administrative problems|0|||
129806751|NCT01543698|467261030|FG002|Phase 2|Administrative problems|0|||
129806752|NCT01543698|467261031|FG003|Phase 2|Administrative problems|0|||
129806753|NCT01543698|467261032|FG004|Phase 2|Administrative problems|0|||
129806754|NCT01543698|467261033|FG005|Phase 2|Administrative problems|0|||
129806755|NCT01543698|467261034|FG006|Phase 2|Administrative problems|0|||
129806756|NCT01543698|467261035|FG007|Phase 2|Administrative problems|0|||
129806757|NCT01543698|467261036|FG008|Phase 2|Administrative problems|0|||
129806758|NCT01543698|467261037|FG009|Phase 2|Administrative problems|0|||
129806759|NCT01543698|467261038|FG010|Phase 2|Administrative problems|0|||
129806760|NCT01543698|467261039|FG011|Phase 2|Administrative problems|0|||
129806761|NCT01543698|467261040|FG012|Phase 2|Administrative problems|0|||
129806762|NCT01543698|467261041|FG013|Phase 2|Administrative problems|3|||
129806763|NCT01543698|467261042|FG014|Phase 2|Administrative problems|1|||
129806764|NCT01543698|467261028|FG000|Phase 2|Withdrawal by Subject|0|||
129806765|NCT01543698|467261029|FG001|Phase 2|Withdrawal by Subject|0|||
129806766|NCT01543698|467261030|FG002|Phase 2|Withdrawal by Subject|0|||
129806767|NCT01543698|467261031|FG003|Phase 2|Withdrawal by Subject|0|||
129806768|NCT01543698|467261032|FG004|Phase 2|Withdrawal by Subject|0|||
129806769|NCT01543698|467261033|FG005|Phase 2|Withdrawal by Subject|0|||
129806770|NCT01543698|467261034|FG006|Phase 2|Withdrawal by Subject|0|||
129806771|NCT01543698|467261035|FG007|Phase 2|Withdrawal by Subject|0|||
129806772|NCT01543698|467261036|FG008|Phase 2|Withdrawal by Subject|0|||
129806773|NCT01543698|467261037|FG009|Phase 2|Withdrawal by Subject|0|||
129806774|NCT01543698|467261038|FG010|Phase 2|Withdrawal by Subject|0|||
129806775|NCT01543698|467261039|FG011|Phase 2|Withdrawal by Subject|0|||
129806776|NCT01543698|467261040|FG012|Phase 2|Withdrawal by Subject|0|||
129806777|NCT01543698|467261041|FG013|Phase 2|Withdrawal by Subject|3|||
129806778|NCT01543698|467261042|FG014|Phase 2|Withdrawal by Subject|1|||
129806779|NCT01543698|467261028|FG000|Phase 2|Adverse Event|0|||
129806780|NCT01543698|467261029|FG001|Phase 2|Adverse Event|0|||
129806781|NCT01543698|467261030|FG002|Phase 2|Adverse Event|0|||
129806782|NCT01543698|467261031|FG003|Phase 2|Adverse Event|0|||
129806783|NCT01543698|467261032|FG004|Phase 2|Adverse Event|0|||
129806784|NCT01543698|467261033|FG005|Phase 2|Adverse Event|0|||
129806785|NCT01543698|467261034|FG006|Phase 2|Adverse Event|0|||
129806786|NCT01543698|467261035|FG007|Phase 2|Adverse Event|0|||
129806787|NCT01543698|467261036|FG008|Phase 2|Adverse Event|0|||
129806788|NCT01543698|467261037|FG009|Phase 2|Adverse Event|0|||
129806789|NCT01543698|467261038|FG010|Phase 2|Adverse Event|0|||
129806790|NCT01543698|467261039|FG011|Phase 2|Adverse Event|1|||
129806791|NCT01543698|467261040|FG012|Phase 2|Adverse Event|3|||
129806792|NCT01543698|467261041|FG013|Phase 2|Adverse Event|5|||
129806793|NCT01543698|467261042|FG014|Phase 2|Adverse Event|14|||
129806794|NCT00150709|467261043|FG000|Overall Study|Protocol Violation|7|||
129806795|NCT00150709|467261044|FG001|Overall Study|Protocol Violation|8|||
129806796|NCT00150709|467261045|FG002|Overall Study|Protocol Violation|3|||
129806797|NCT00150709|467261046|FG003|Overall Study|Protocol Violation|1|||
129806798|NCT00150709|467261043|FG000|Overall Study|Adverse Event|8|||
129806799|NCT00150709|467261044|FG001|Overall Study|Adverse Event|2|||
129806800|NCT00150709|467261045|FG002|Overall Study|Adverse Event|2|||
129806801|NCT00150709|467261046|FG003|Overall Study|Adverse Event|3|||
129806802|NCT00150709|467261043|FG000|Overall Study|Lack of Efficacy|6|||
129806803|NCT00150709|467261044|FG001|Overall Study|Lack of Efficacy|11|||
129806804|NCT00150709|467261045|FG002|Overall Study|Lack of Efficacy|9|||
129806805|NCT00150709|467261046|FG003|Overall Study|Lack of Efficacy|0|||
129806806|NCT00150709|467261043|FG000|Overall Study|Withdrawal by Subject|7|||
129806807|NCT00150709|467261044|FG001|Overall Study|Withdrawal by Subject|10|||
129806808|NCT00150709|467261045|FG002|Overall Study|Withdrawal by Subject|5|||
129806809|NCT00150709|467261046|FG003|Overall Study|Withdrawal by Subject|0|||
129806810|NCT00150709|467261043|FG000|Overall Study|Lost to Follow-up|3|||
129806811|NCT00150709|467261044|FG001|Overall Study|Lost to Follow-up|2|||
129806812|NCT00150709|467261045|FG002|Overall Study|Lost to Follow-up|0|||
129806813|NCT00150709|467261046|FG003|Overall Study|Lost to Follow-up|0|||
129806814|NCT00150709|467261043|FG000|Overall Study|Sponsor decision|0|||
129893672|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
129893673|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
129893674|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
130058004|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
129893675|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
129893676|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
129893677|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
130112296|NCT01571635|468371129|FG004|Overall Study|Other reasons|1|||
129806815|NCT00150709|467261044|FG001|Overall Study|Sponsor decision|0|||
129806816|NCT00150709|467261045|FG002|Overall Study|Sponsor decision|0|||
129806817|NCT00150709|467261046|FG003|Overall Study|Sponsor decision|1|||
129806818|NCT00150709|467261043|FG000|Overall Study|Site/Investigator discontinued the study|5|||
129806819|NCT00150709|467261044|FG001|Overall Study|Site/Investigator discontinued the study|5|||
129806820|NCT00150709|467261045|FG002|Overall Study|Site/Investigator discontinued the study|2|||
129806821|NCT00150709|467261046|FG003|Overall Study|Site/Investigator discontinued the study|0|||
129806822|NCT00150709|467261043|FG000|Overall Study|Decision of parent(s)|1|||
129806823|NCT00150709|467261044|FG001|Overall Study|Decision of parent(s)|2|||
129806824|NCT00150709|467261045|FG002|Overall Study|Decision of parent(s)|0|||
129806825|NCT00150709|467261046|FG003|Overall Study|Decision of parent(s)|0|||
129806826|NCT00150709|467261043|FG000|Overall Study|Decision of parent(s) and investigator|3|||
129806827|NCT00150709|467261044|FG001|Overall Study|Decision of parent(s) and investigator|0|||
129806828|NCT00150709|467261045|FG002|Overall Study|Decision of parent(s) and investigator|0|||
129806829|NCT00150709|467261046|FG003|Overall Study|Decision of parent(s) and investigator|0|||
129806830|NCT00150709|467261043|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
129806831|NCT00150709|467261044|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
129806832|NCT00150709|467261045|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
129806833|NCT00150709|467261046|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
129893678|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
129893679|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
129893680|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
129893681|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
129893682|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
129893683|NCT02851511|467571628|FG000|Phase I|Physician Decision|0|||
129893684|NCT02851511|467571629|FG001|Phase I|Physician Decision|0|||
129893685|NCT02851511|467571630|FG002|Phase I|Physician Decision|0|||
129893686|NCT02851511|467571631|FG003|Phase I|Physician Decision|1|||
129893687|NCT02851511|467571628|FG000|Phase I|Withdrawal by Subject|2|||
129893688|NCT02851511|467571629|FG001|Phase I|Withdrawal by Subject|1|||
129893689|NCT02851511|467571630|FG002|Phase I|Withdrawal by Subject|0|||
129893690|NCT02851511|467571631|FG003|Phase I|Withdrawal by Subject|3|||
129893691|NCT02851511|467571628|FG000|Phase II|Physician Decision|18|||
129893692|NCT02851511|467571629|FG001|Phase II|Physician Decision|16|||
129893693|NCT02851511|467571630|FG002|Phase II|Physician Decision|0|||
129893694|NCT02851511|467571631|FG003|Phase II|Physician Decision|0|||
129893695|NCT02851511|467571628|FG000|Phase II|Withdrawal by Subject|18|||
129893696|NCT02851511|467571629|FG001|Phase II|Withdrawal by Subject|16|||
129893697|NCT02851511|467571630|FG002|Phase II|Withdrawal by Subject|0|||
129893698|NCT02851511|467571631|FG003|Phase II|Withdrawal by Subject|0|||
129893699|NCT02851511|467571628|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
129893700|NCT02851511|467571629|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
129893701|NCT02851511|467571630|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
129893702|NCT02851511|467571631|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
129893703|NCT02851511|467571628|FG000|Phase II|Lost to Follow-up|0|||
129893704|NCT02851511|467571629|FG001|Phase II|Lost to Follow-up|1|||
129893705|NCT02851511|467571630|FG002|Phase II|Lost to Follow-up|0|||
129893706|NCT02851511|467571631|FG003|Phase II|Lost to Follow-up|0|||
129893707|NCT00003377|467571632|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
129893708|NCT00003377|467571633|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
129893709|NCT00003377|467571634|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
129893710|NCT00003377|467571635|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
129893711|NCT00003377|467571636|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
129893712|NCT00003377|467571632|FG000|Period II|Ureteral stent complications|0|||
129893713|NCT00003377|467571633|FG001|Period II|Ureteral stent complications|0|||
129893714|NCT00003377|467571634|FG002|Period II|Ureteral stent complications|0|||
129893715|NCT00003377|467571635|FG003|Period II|Ureteral stent complications|0|||
129893716|NCT00003377|467571636|FG004|Period II|Ureteral stent complications|1|||
129893717|NCT02256969|467571638|FG000|Overall Study|Screenfailed or withdrew|2|||
129893718|NCT02256969|467571639|FG001|Overall Study|Screenfailed or withdrew|1|||
129893719|NCT02256969|467571640|FG002|Overall Study|Screenfailed or withdrew|1|||
129893720|NCT00372567|467571641|FG000|Phase 3 Study|Adverse Event|5|||
129893721|NCT00372567|467571642|FG001|Phase 3 Study|Adverse Event|1|||
129893722|NCT00372567|467571643|FG002|Phase 3 Study|Adverse Event|1|||
129893723|NCT00372567|467571641|FG000|Phase 3 Study|Death|1|||
129893724|NCT00372567|467571642|FG001|Phase 3 Study|Death|1|||
129893725|NCT00372567|467571643|FG002|Phase 3 Study|Death|0|||
129893726|NCT00372567|467571641|FG000|Phase 3 Study|Protocol Violation|0|||
129893727|NCT00372567|467571642|FG001|Phase 3 Study|Protocol Violation|0|||
129893728|NCT00372567|467571643|FG002|Phase 3 Study|Protocol Violation|1|||
129893729|NCT00372567|467571641|FG000|Phase 3 Study|Objective progression or relapse|10|||
129893730|NCT00372567|467571642|FG001|Phase 3 Study|Objective progression or relapse|13|||
129893731|NCT00372567|467571643|FG002|Phase 3 Study|Objective progression or relapse|4|||
129893732|NCT00372567|467571641|FG000|Phase 3 Study|Global deterioration of health status|0|||
129893733|NCT00372567|467571642|FG001|Phase 3 Study|Global deterioration of health status|1|||
129893734|NCT00372567|467571643|FG002|Phase 3 Study|Global deterioration of health status|0|||
129893735|NCT00372567|467571641|FG000|Phase 3 Study|Other|2|||
129893736|NCT00372567|467571642|FG001|Phase 3 Study|Other|2|||
129893737|NCT00372567|467571643|FG002|Phase 3 Study|Other|1|||
129893738|NCT00372567|467571641|FG000|Phase 3 Study|study terminated by sponsor|13|||
129893739|NCT00372567|467571642|FG001|Phase 3 Study|study terminated by sponsor|8|||
129893740|NCT00372567|467571643|FG002|Phase 3 Study|study terminated by sponsor|5|||
129893741|NCT02347943|467571644|FG000|Overall Study|Study was cancelled|140|||
129893742|NCT02347943|467571645|FG001|Overall Study|Study was cancelled|67|||
129893743|NCT02347943|467571646|FG002|Overall Study|Study was cancelled|45|||
129893744|NCT00303303|467571650|FG000|Overall Study|Withdrawal by Subject|0|||
129893745|NCT00303303|467571651|FG001|Overall Study|Withdrawal by Subject|0|||
129893746|NCT00303303|467571652|FG002|Overall Study|Withdrawal by Subject|1|||
129893747|NCT00582790|467571656|FG000|Overall Study|Rapid progression of disease|1|||
129893748|NCT00480441|467571657|FG000|Screening|Not Eligible|37|||
129893749|NCT00480441|467571658|FG001|Screening|Not Eligible|0|||
129893750|NCT00480441|467571659|FG002|Screening|Not Eligible|0|||
129893751|NCT00480441|467571657|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
129893752|NCT00480441|467571658|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
129893753|NCT00480441|467571659|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
129893754|NCT00480441|467571657|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
129893755|NCT00480441|467571658|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
129893756|NCT00480441|467571659|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
129893757|NCT00480441|467571657|FG000|Baseline Functional MRI|physical contraindication|4|||
129893758|NCT00480441|467571658|FG001|Baseline Functional MRI|physical contraindication|0|||
129893759|NCT00480441|467571659|FG002|Baseline Functional MRI|physical contraindication|0|||
129893760|NCT00480441|467571657|FG000|Randomization|Lost to Follow-up|0|||
129893761|NCT00480441|467571658|FG001|Randomization|Lost to Follow-up|7|||
129893762|NCT00480441|467571659|FG002|Randomization|Lost to Follow-up|2|||
129893763|NCT02374957|467571660|FG000|Overall Study|Patient did not complete forms correctly|1|||
129893764|NCT02374957|467571661|FG001|Overall Study|Patient did not complete forms correctly|0|||
129893765|NCT05349084|467571662|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
129893766|NCT01004263|467571674|FG000|Overall Study|Adverse Event|15|||
129893767|NCT01004263|467571674|FG000|Overall Study|Withdrawal by Subject|58|||
129893768|NCT01004263|467571674|FG000|Overall Study|Protocol Violation|10|||
129893769|NCT01004263|467571674|FG000|Overall Study|Lost to Follow-up|64|||
129893770|NCT01004263|467571674|FG000|Overall Study|Lack of Efficacy|13|||
129893771|NCT01004263|467571674|FG000|Overall Study|Pregnancy|2|||
129893772|NCT01004263|467571674|FG000|Overall Study|Physician Decision|15|||
129893773|NCT01004263|467571674|FG000|Overall Study|Lack of Qualifying Event|2|||
129893774|NCT00821236|467571675|FG000|Overall Study|Lost to Follow-up|3|||
129893775|NCT02096003|467571676|FG000|Overall Study|Protocol Violation|0|||
129893776|NCT02096003|467571677|FG001|Overall Study|Protocol Violation|2|||
129893777|NCT02096003|467571676|FG000|Overall Study|additional surgery|2|||
129893778|NCT02096003|467571677|FG001|Overall Study|additional surgery|1|||
129893779|NCT01511250|467571678|FG000|Overall Study|Withdrawal of Consent|1|||
129893780|NCT01511250|467571679|FG001|Overall Study|Withdrawal of Consent|0|||
129893781|NCT01511250|467571680|FG002|Overall Study|Withdrawal of Consent|0|||
129893782|NCT01511250|467571681|FG003|Overall Study|Withdrawal of Consent|0|||
129893783|NCT01511250|467571682|FG004|Overall Study|Withdrawal of Consent|0|||
129893784|NCT01511250|467571683|FG005|Overall Study|Withdrawal of Consent|0|||
129893785|NCT01511250|467571684|FG006|Overall Study|Withdrawal of Consent|0|||
129893786|NCT01511250|467571685|FG007|Overall Study|Withdrawal of Consent|1|||
129893787|NCT01511250|467571686|FG008|Overall Study|Withdrawal of Consent|1|||
129893788|NCT01511250|467571687|FG009|Overall Study|Withdrawal of Consent|0|||
129893789|NCT01511250|467571678|FG000|Overall Study|Sponsor/Investigator Decision|1|||
129893790|NCT01511250|467571679|FG001|Overall Study|Sponsor/Investigator Decision|0|||
129893791|NCT01511250|467571680|FG002|Overall Study|Sponsor/Investigator Decision|0|||
129893792|NCT01511250|467571681|FG003|Overall Study|Sponsor/Investigator Decision|0|||
129893793|NCT01511250|467571682|FG004|Overall Study|Sponsor/Investigator Decision|0|||
129893794|NCT01511250|467571683|FG005|Overall Study|Sponsor/Investigator Decision|0|||
129893795|NCT01511250|467571684|FG006|Overall Study|Sponsor/Investigator Decision|0|||
129893796|NCT01511250|467571685|FG007|Overall Study|Sponsor/Investigator Decision|0|||
129893797|NCT01511250|467571686|FG008|Overall Study|Sponsor/Investigator Decision|0|||
129893798|NCT01511250|467571687|FG009|Overall Study|Sponsor/Investigator Decision|0|||
129893799|NCT01511250|467571678|FG000|Overall Study|Lost to Follow-up|7|||
129893800|NCT01511250|467571679|FG001|Overall Study|Lost to Follow-up|3|||
129893801|NCT01511250|467571680|FG002|Overall Study|Lost to Follow-up|3|||
129893802|NCT01511250|467571681|FG003|Overall Study|Lost to Follow-up|3|||
129893803|NCT01511250|467571682|FG004|Overall Study|Lost to Follow-up|0|||
129893804|NCT01511250|467571683|FG005|Overall Study|Lost to Follow-up|0|||
130112297|NCT01571635|468371125|FG000|Overall Study|Study terminated by sponsor|0|||
129893805|NCT01511250|467571684|FG006|Overall Study|Lost to Follow-up|2|||
129893806|NCT01511250|467571685|FG007|Overall Study|Lost to Follow-up|3|||
129893807|NCT01511250|467571686|FG008|Overall Study|Lost to Follow-up|13|||
129893808|NCT01511250|467571687|FG009|Overall Study|Lost to Follow-up|5|||
129893809|NCT01511250|467571678|FG000|Overall Study|Protocol Violation|0|||
129893810|NCT01511250|467571679|FG001|Overall Study|Protocol Violation|2|||
129806834|NCT00150709|467261043|FG000|Overall Study|Investigator decision|1|||
129806835|NCT00150709|467261044|FG001|Overall Study|Investigator decision|0|||
129806836|NCT00150709|467261045|FG002|Overall Study|Investigator decision|0|||
129806837|NCT00150709|467261046|FG003|Overall Study|Investigator decision|1|||
129806838|NCT00150709|467261043|FG000|Overall Study|Subject relocated|2|||
129806839|NCT00150709|467261044|FG001|Overall Study|Subject relocated|2|||
129806840|NCT00150709|467261045|FG002|Overall Study|Subject relocated|1|||
129806841|NCT00150709|467261046|FG003|Overall Study|Subject relocated|0|||
129806842|NCT00150709|467261043|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
129806843|NCT00150709|467261044|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
129806844|NCT00150709|467261045|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
129806845|NCT00150709|467261046|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
129806846|NCT00150709|467261043|FG000|Overall Study|Convenience|0|||
129806847|NCT00150709|467261044|FG001|Overall Study|Convenience|1|||
129806848|NCT00150709|467261045|FG002|Overall Study|Convenience|0|||
129806849|NCT00150709|467261046|FG003|Overall Study|Convenience|0|||
129806850|NCT00150709|467261043|FG000|Overall Study|Subject entered new drug study|0|||
129806851|NCT00150709|467261044|FG001|Overall Study|Subject entered new drug study|1|||
129806852|NCT00150709|467261045|FG002|Overall Study|Subject entered new drug study|0|||
129806853|NCT00150709|467261046|FG003|Overall Study|Subject entered new drug study|0|||
129806854|NCT00150709|467261043|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
129806855|NCT00150709|467261044|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
129806856|NCT00150709|467261045|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
129806857|NCT00150709|467261046|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
129806858|NCT00150709|467261043|FG000|Overall Study|Lack of ease of swallowing|0|||
129806859|NCT00150709|467261044|FG001|Overall Study|Lack of ease of swallowing|1|||
129806860|NCT00150709|467261045|FG002|Overall Study|Lack of ease of swallowing|0|||
129806861|NCT00150709|467261046|FG003|Overall Study|Lack of ease of swallowing|0|||
129806862|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Adverse Event|16|||
129806863|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Adverse Event|17|||
129806864|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Adverse Event|13|||
129806865|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Adverse Event|18|||
129806866|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Adverse Event|0|||
129806867|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Adverse Event|0|||
129806868|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Adverse Event|0|||
129806869|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Adverse Event|0|||
129806870|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
129806871|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
129806872|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
129806873|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
129806874|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806875|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806876|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806877|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806878|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
129806879|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
129806880|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
129806881|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
129806882|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
129806883|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
129806884|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
129806885|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
129806886|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
129806887|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
129806888|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
129806889|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
129806890|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806891|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806892|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806893|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806894|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
129806895|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806896|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
129806897|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
129806898|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806899|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806900|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806901|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806902|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
129806903|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
129806904|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
129806905|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
129806906|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
129806907|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
129806908|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
129806909|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
129806910|NCT02975336|467261047|FG000|LTE (104 Weeks)|Adverse Event|0|||
129806911|NCT02975336|467261048|FG001|LTE (104 Weeks)|Adverse Event|0|||
129806912|NCT02975336|467261049|FG002|LTE (104 Weeks)|Adverse Event|0|||
129806913|NCT02975336|467261050|FG003|LTE (104 Weeks)|Adverse Event|0|||
129806914|NCT02975336|467261051|FG004|LTE (104 Weeks)|Adverse Event|7|||
129806915|NCT02975336|467261052|FG005|LTE (104 Weeks)|Adverse Event|4|||
129806916|NCT02975336|467261053|FG006|LTE (104 Weeks)|Adverse Event|2|||
129806917|NCT02975336|467261054|FG007|LTE (104 Weeks)|Adverse Event|0|||
129806918|NCT02975336|467261047|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
129806919|NCT02975336|467261048|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
129806920|NCT02975336|467261049|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
129806921|NCT02975336|467261050|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
129806922|NCT02975336|467261051|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
129806923|NCT02975336|467261052|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
129806924|NCT02975336|467261053|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
129806925|NCT02975336|467261054|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
129806926|NCT02975336|467261047|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
129806927|NCT02975336|467261048|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
129806928|NCT02975336|467261049|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
129806929|NCT02975336|467261050|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
129806930|NCT02975336|467261051|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
129806931|NCT02975336|467261052|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
129806932|NCT02975336|467261053|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
129806933|NCT02975336|467261054|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
129806934|NCT02975336|467261047|FG000|LTE (104 Weeks)|Other|0|||
129806935|NCT02975336|467261048|FG001|LTE (104 Weeks)|Other|0|||
129806936|NCT02975336|467261049|FG002|LTE (104 Weeks)|Other|0|||
129806937|NCT02975336|467261050|FG003|LTE (104 Weeks)|Other|0|||
129806938|NCT02975336|467261051|FG004|LTE (104 Weeks)|Other|55|||
129806939|NCT02975336|467261052|FG005|LTE (104 Weeks)|Other|63|||
129806940|NCT02975336|467261053|FG006|LTE (104 Weeks)|Other|76|||
129806941|NCT02975336|467261054|FG007|LTE (104 Weeks)|Other|72|||
129806942|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
129806943|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
129806944|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
129806945|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
129806946|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
129806947|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
129806948|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
129806949|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
129806950|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
129806951|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129893811|NCT01511250|467571680|FG002|Overall Study|Protocol Violation|1|||
129806952|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806953|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806954|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806955|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806956|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806957|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806958|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
129806959|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129893812|NCT01511250|467571681|FG003|Overall Study|Protocol Violation|0|||
129893813|NCT01511250|467571682|FG004|Overall Study|Protocol Violation|0|||
129893814|NCT01511250|467571683|FG005|Overall Study|Protocol Violation|0|||
129893815|NCT01511250|467571684|FG006|Overall Study|Protocol Violation|0|||
129893816|NCT01511250|467571685|FG007|Overall Study|Protocol Violation|0|||
129893817|NCT01511250|467571686|FG008|Overall Study|Protocol Violation|0|||
129893818|NCT01511250|467571687|FG009|Overall Study|Protocol Violation|0|||
129893819|NCT04668144|467571692|FG000|Overall Study|Protocol Violation|0|||
129893820|NCT04668144|467571693|FG001|Overall Study|Protocol Violation|1|||
129893821|NCT04668144|467571694|FG002|Overall Study|Protocol Violation|2|||
129893822|NCT00916006|467571696|FG000|Overall Study|Adverse Event|1|||
129893823|NCT00916006|467571697|FG001|Overall Study|Adverse Event|1|||
129893824|NCT00916006|467571696|FG000|Overall Study|Withdrawal by Subject|2|||
129893825|NCT00916006|467571697|FG001|Overall Study|Withdrawal by Subject|5|||
129893826|NCT00916006|467571696|FG000|Overall Study|Protocol Violation|0|||
129893827|NCT00916006|467571697|FG001|Overall Study|Protocol Violation|1|||
129893828|NCT02929108|467571702|FG000|Overall Study|Hospice patient death|100|||
129893829|NCT02929108|467571703|FG001|Overall Study|Hospice patient death|64|||
129893830|NCT02929108|467571704|FG002|Overall Study|Hospice patient death|28|||
129893831|NCT02929108|467571705|FG003|Overall Study|Hospice patient death|46|||
129893832|NCT02929108|467571706|FG004|Overall Study|Hospice patient death|55|||
129893833|NCT02929108|467571707|FG005|Overall Study|Hospice patient death|28|||
129893834|NCT02929108|467571708|FG006|Overall Study|Hospice patient death|78|||
129893835|NCT00052962|467571709|FG000|Overall Study|Not evaluable|0|||
129893836|NCT00052962|467571710|FG001|Overall Study|Not evaluable|2|||
129893837|NCT00052962|467571709|FG000|Overall Study|Not randomized/not evaluable|1|||
129893838|NCT00052962|467571710|FG001|Overall Study|Not randomized/not evaluable|0|||
129893839|NCT05487703|467571711|FG000|Overall Study|Other|19|||
129893840|NCT05487703|467571711|FG000|Overall Study|Participant not well|5|||
129893841|NCT05487703|467571711|FG000|Overall Study|Insurance Reasons|6|||
129893842|NCT05487703|467571711|FG000|Overall Study|Physician Decision|19|||
129893843|NCT05487703|467571711|FG000|Overall Study|Lack of Efficacy|60|||
129893844|NCT00832780|467571715|FG000|Overall Study|Death|16|||
129893845|NCT00832780|467571715|FG000|Overall Study|Lost to Follow-up|4|||
129893846|NCT00832780|467571715|FG000|Overall Study|no reason given|2|||
129893847|NCT00832780|467571715|FG000|Overall Study|other complicating condition|2|||
129893848|NCT00832780|467571715|FG000|Overall Study|Physician Decision|1|||
129893849|NCT00665561|467571718|FG000|Overall Study|Death recorded on subject summary pages|75|||
129893850|NCT00665561|467571719|FG001|Overall Study|Death recorded on subject summary pages|75|||
129893851|NCT00665561|467571718|FG000|Overall Study|Does not meet entrance criteria|19|||
129893852|NCT00665561|467571719|FG001|Overall Study|Does not meet entrance criteria|21|||
129893853|NCT00665561|467571718|FG000|Overall Study|Lost to Follow-up|203|||
129893854|NCT00665561|467571719|FG001|Overall Study|Lost to Follow-up|264|||
129893855|NCT00665561|467571718|FG000|Overall Study|Withdrawal by Subject|74|||
129893856|NCT00665561|467571719|FG001|Overall Study|Withdrawal by Subject|65|||
129893857|NCT00665561|467571718|FG000|Overall Study|Other|123|||
129893858|NCT00665561|467571719|FG001|Overall Study|Other|108|||
129893859|NCT00665561|467571718|FG000|Overall Study|Site closed|8|||
129893860|NCT00665561|467571719|FG001|Overall Study|Site closed|0|||
129893861|NCT00665561|467571718|FG000|Overall Study|Withdrawn due to pregnancy|0|||
129893862|NCT00665561|467571719|FG001|Overall Study|Withdrawn due to pregnancy|1|||
129893863|NCT01734811|467571727|FG000|Overall Study|Lost to Follow-up|2|||
129893864|NCT01734811|467571728|FG001|Overall Study|Lost to Follow-up|3|||
129893865|NCT01734811|467571727|FG000|Overall Study|Withdrawal by Subject|2|||
129893866|NCT01734811|467571728|FG001|Overall Study|Withdrawal by Subject|0|||
129893867|NCT00062868|467571729|FG000|Dose Level 1|Death|2|||
129893868|NCT00062868|467571730|FG001|Dose Level 1|Death|0|||
129893869|NCT00062868|467571731|FG002|Dose Level 1|Death|0|||
129893870|NCT00062868|467571732|FG003|Dose Level 1|Death|2|||
129893871|NCT00062868|467571733|FG004|Dose Level 1|Death|0|||
129893872|NCT00062868|467571734|FG005|Dose Level 1|Death|0|||
129893873|NCT00062868|467571735|FG006|Dose Level 1|Death|3|||
129893874|NCT00062868|467571736|FG007|Dose Level 1|Death|0|||
129893875|NCT00062868|467571737|FG008|Dose Level 1|Death|0|||
129893876|NCT00062868|467571738|FG009|Dose Level 1|Death|0|||
129893877|NCT00062868|467571739|FG010|Dose Level 1|Death|0|||
129893878|NCT00062868|467571740|FG011|Dose Level 1|Death|0|||
129893879|NCT00062868|467571741|FG012|Dose Level 1|Death|0|||
129893880|NCT00062868|467571742|FG013|Dose Level 1|Death|0|||
129893881|NCT00062868|467571743|FG014|Dose Level 1|Death|0|||
129893882|NCT00062868|467571744|FG015|Dose Level 1|Death|0|||
129893883|NCT00062868|467571745|FG016|Dose Level 1|Death|0|||
129893884|NCT00062868|467571746|FG017|Dose Level 1|Death|0|||
129893885|NCT00062868|467571747|FG018|Dose Level 1|Death|7|||
129893886|NCT00062868|467571748|FG019|Dose Level 1|Death|0|||
129893887|NCT00062868|467571749|FG020|Dose Level 1|Death|1|||
129893888|NCT00062868|467571729|FG000|Dose Level 1|Lost to Follow-up|0|||
129893889|NCT00062868|467571730|FG001|Dose Level 1|Lost to Follow-up|0|||
129893890|NCT00062868|467571731|FG002|Dose Level 1|Lost to Follow-up|0|||
129893891|NCT00062868|467571732|FG003|Dose Level 1|Lost to Follow-up|0|||
129893892|NCT00062868|467571733|FG004|Dose Level 1|Lost to Follow-up|0|||
129893893|NCT00062868|467571734|FG005|Dose Level 1|Lost to Follow-up|0|||
129893894|NCT00062868|467571735|FG006|Dose Level 1|Lost to Follow-up|0|||
129893895|NCT00062868|467571736|FG007|Dose Level 1|Lost to Follow-up|0|||
129893896|NCT00062868|467571737|FG008|Dose Level 1|Lost to Follow-up|0|||
129893897|NCT00062868|467571738|FG009|Dose Level 1|Lost to Follow-up|0|||
129893898|NCT00062868|467571739|FG010|Dose Level 1|Lost to Follow-up|0|||
129893899|NCT00062868|467571740|FG011|Dose Level 1|Lost to Follow-up|0|||
129893900|NCT00062868|467571741|FG012|Dose Level 1|Lost to Follow-up|1|||
129893901|NCT00062868|467571742|FG013|Dose Level 1|Lost to Follow-up|0|||
129893902|NCT00062868|467571743|FG014|Dose Level 1|Lost to Follow-up|0|||
129893903|NCT00062868|467571744|FG015|Dose Level 1|Lost to Follow-up|0|||
129893904|NCT00062868|467571745|FG016|Dose Level 1|Lost to Follow-up|0|||
129893905|NCT00062868|467571746|FG017|Dose Level 1|Lost to Follow-up|0|||
129893906|NCT00062868|467571747|FG018|Dose Level 1|Lost to Follow-up|2|||
129893907|NCT00062868|467571748|FG019|Dose Level 1|Lost to Follow-up|0|||
129893908|NCT00062868|467571749|FG020|Dose Level 1|Lost to Follow-up|1|||
129893909|NCT00062868|467571729|FG000|Dose Level 2|Death|0|||
129893910|NCT00062868|467571730|FG001|Dose Level 2|Death|3|||
129893911|NCT00062868|467571731|FG002|Dose Level 2|Death|0|||
129893912|NCT00062868|467571732|FG003|Dose Level 2|Death|0|||
129893913|NCT00062868|467571733|FG004|Dose Level 2|Death|2|||
129893914|NCT00062868|467571734|FG005|Dose Level 2|Death|0|||
129893915|NCT00062868|467571735|FG006|Dose Level 2|Death|0|||
129893916|NCT00062868|467571736|FG007|Dose Level 2|Death|0|||
129893917|NCT00062868|467571737|FG008|Dose Level 2|Death|0|||
129893918|NCT00062868|467571738|FG009|Dose Level 2|Death|0|||
129893919|NCT00062868|467571739|FG010|Dose Level 2|Death|1|||
129893920|NCT00062868|467571740|FG011|Dose Level 2|Death|0|||
129893921|NCT00062868|467571741|FG012|Dose Level 2|Death|0|||
129893922|NCT00062868|467571742|FG013|Dose Level 2|Death|0|||
129893923|NCT00062868|467571743|FG014|Dose Level 2|Death|0|||
129893924|NCT00062868|467571744|FG015|Dose Level 2|Death|0|||
129893925|NCT00062868|467571745|FG016|Dose Level 2|Death|2|||
129893926|NCT00062868|467571746|FG017|Dose Level 2|Death|0|||
129893927|NCT00062868|467571747|FG018|Dose Level 2|Death|0|||
129893928|NCT00062868|467571748|FG019|Dose Level 2|Death|0|||
129893929|NCT00062868|467571749|FG020|Dose Level 2|Death|0|||
129893930|NCT00062868|467571729|FG000|Dose Level 2|Lost to Follow-up|0|||
129893931|NCT00062868|467571730|FG001|Dose Level 2|Lost to Follow-up|0|||
129893932|NCT00062868|467571731|FG002|Dose Level 2|Lost to Follow-up|0|||
129893933|NCT00062868|467571732|FG003|Dose Level 2|Lost to Follow-up|0|||
129893934|NCT00062868|467571733|FG004|Dose Level 2|Lost to Follow-up|0|||
129893935|NCT00062868|467571734|FG005|Dose Level 2|Lost to Follow-up|0|||
129893936|NCT00062868|467571735|FG006|Dose Level 2|Lost to Follow-up|0|||
129893937|NCT00062868|467571736|FG007|Dose Level 2|Lost to Follow-up|0|||
129893938|NCT00062868|467571737|FG008|Dose Level 2|Lost to Follow-up|0|||
129893939|NCT00062868|467571738|FG009|Dose Level 2|Lost to Follow-up|0|||
129893940|NCT00062868|467571739|FG010|Dose Level 2|Lost to Follow-up|0|||
129893941|NCT00062868|467571740|FG011|Dose Level 2|Lost to Follow-up|0|||
129893942|NCT00062868|467571741|FG012|Dose Level 2|Lost to Follow-up|0|||
130112298|NCT01571635|468371126|FG001|Overall Study|Study terminated by sponsor|4|||
129893943|NCT00062868|467571742|FG013|Dose Level 2|Lost to Follow-up|1|||
129893944|NCT00062868|467571743|FG014|Dose Level 2|Lost to Follow-up|0|||
129893945|NCT00062868|467571744|FG015|Dose Level 2|Lost to Follow-up|0|||
129893946|NCT00062868|467571745|FG016|Dose Level 2|Lost to Follow-up|1|||
129893947|NCT00062868|467571746|FG017|Dose Level 2|Lost to Follow-up|0|||
129893948|NCT00062868|467571747|FG018|Dose Level 2|Lost to Follow-up|0|||
129893949|NCT00062868|467571748|FG019|Dose Level 2|Lost to Follow-up|0|||
129893950|NCT00062868|467571749|FG020|Dose Level 2|Lost to Follow-up|0|||
129893951|NCT00062868|467571729|FG000|Dose Level 3|Death|0|||
129893952|NCT00062868|467571730|FG001|Dose Level 3|Death|0|||
129893953|NCT00062868|467571731|FG002|Dose Level 3|Death|0|||
129806960|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129893954|NCT00062868|467571732|FG003|Dose Level 3|Death|0|||
129806961|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806962|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806963|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129893955|NCT00062868|467571733|FG004|Dose Level 3|Death|0|||
129893956|NCT00062868|467571734|FG005|Dose Level 3|Death|0|||
129893957|NCT00062868|467571735|FG006|Dose Level 3|Death|0|||
129893958|NCT00062868|467571736|FG007|Dose Level 3|Death|0|||
129893959|NCT00062868|467571737|FG008|Dose Level 3|Death|0|||
129893960|NCT00062868|467571738|FG009|Dose Level 3|Death|0|||
129893961|NCT00062868|467571739|FG010|Dose Level 3|Death|0|||
129893962|NCT00062868|467571740|FG011|Dose Level 3|Death|1|||
129893963|NCT00062868|467571741|FG012|Dose Level 3|Death|0|||
129893964|NCT00062868|467571742|FG013|Dose Level 3|Death|0|||
129893965|NCT00062868|467571743|FG014|Dose Level 3|Death|0|||
129893966|NCT00062868|467571744|FG015|Dose Level 3|Death|0|||
129893967|NCT00062868|467571745|FG016|Dose Level 3|Death|0|||
129893968|NCT00062868|467571746|FG017|Dose Level 3|Death|1|||
129893969|NCT00062868|467571747|FG018|Dose Level 3|Death|0|||
129893970|NCT00062868|467571748|FG019|Dose Level 3|Death|0|||
129893971|NCT00062868|467571749|FG020|Dose Level 3|Death|0|||
129893972|NCT00062868|467571729|FG000|Dose Level 3|Lost to Follow-up|0|||
129893973|NCT00062868|467571730|FG001|Dose Level 3|Lost to Follow-up|0|||
129893974|NCT00062868|467571731|FG002|Dose Level 3|Lost to Follow-up|0|||
129893975|NCT00062868|467571732|FG003|Dose Level 3|Lost to Follow-up|0|||
129893976|NCT00062868|467571733|FG004|Dose Level 3|Lost to Follow-up|0|||
129893977|NCT00062868|467571734|FG005|Dose Level 3|Lost to Follow-up|0|||
129893978|NCT00062868|467571735|FG006|Dose Level 3|Lost to Follow-up|0|||
129893979|NCT00062868|467571736|FG007|Dose Level 3|Lost to Follow-up|0|||
129806964|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806965|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806966|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
129806967|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806968|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806969|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806970|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806971|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806972|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806973|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806974|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
129893980|NCT00062868|467571737|FG008|Dose Level 3|Lost to Follow-up|0|||
129893981|NCT00062868|467571738|FG009|Dose Level 3|Lost to Follow-up|0|||
129893982|NCT00062868|467571739|FG010|Dose Level 3|Lost to Follow-up|0|||
129893983|NCT00062868|467571740|FG011|Dose Level 3|Lost to Follow-up|0|||
129893984|NCT00062868|467571741|FG012|Dose Level 3|Lost to Follow-up|0|||
129893985|NCT00062868|467571742|FG013|Dose Level 3|Lost to Follow-up|0|||
130112299|NCT01571635|468371127|FG002|Overall Study|Study terminated by sponsor|1|||
129893986|NCT00062868|467571743|FG014|Dose Level 3|Lost to Follow-up|1|||
129893987|NCT00062868|467571744|FG015|Dose Level 3|Lost to Follow-up|0|||
129893988|NCT00062868|467571745|FG016|Dose Level 3|Lost to Follow-up|0|||
129893989|NCT00062868|467571746|FG017|Dose Level 3|Lost to Follow-up|0|||
129893990|NCT00062868|467571747|FG018|Dose Level 3|Lost to Follow-up|0|||
129893991|NCT00062868|467571748|FG019|Dose Level 3|Lost to Follow-up|0|||
129893992|NCT00062868|467571749|FG020|Dose Level 3|Lost to Follow-up|0|||
129893993|NCT00062868|467571729|FG000|Dose Level 3|Withdrew|0|||
129893994|NCT00062868|467571730|FG001|Dose Level 3|Withdrew|0|||
129893995|NCT00062868|467571731|FG002|Dose Level 3|Withdrew|2|||
129893996|NCT00062868|467571732|FG003|Dose Level 3|Withdrew|0|||
129893997|NCT00062868|467571733|FG004|Dose Level 3|Withdrew|0|||
129893998|NCT00062868|467571734|FG005|Dose Level 3|Withdrew|0|||
129893999|NCT00062868|467571735|FG006|Dose Level 3|Withdrew|0|||
129894000|NCT00062868|467571736|FG007|Dose Level 3|Withdrew|0|||
129894001|NCT00062868|467571737|FG008|Dose Level 3|Withdrew|0|||
129894002|NCT00062868|467571738|FG009|Dose Level 3|Withdrew|0|||
129894003|NCT00062868|467571739|FG010|Dose Level 3|Withdrew|0|||
129894004|NCT00062868|467571740|FG011|Dose Level 3|Withdrew|0|||
129894005|NCT00062868|467571741|FG012|Dose Level 3|Withdrew|0|||
129894006|NCT00062868|467571742|FG013|Dose Level 3|Withdrew|0|||
129894007|NCT00062868|467571743|FG014|Dose Level 3|Withdrew|0|||
129894008|NCT00062868|467571744|FG015|Dose Level 3|Withdrew|0|||
129894009|NCT00062868|467571745|FG016|Dose Level 3|Withdrew|0|||
129894010|NCT00062868|467571746|FG017|Dose Level 3|Withdrew|0|||
129894011|NCT00062868|467571747|FG018|Dose Level 3|Withdrew|0|||
129894012|NCT00062868|467571748|FG019|Dose Level 3|Withdrew|0|||
129894013|NCT00062868|467571749|FG020|Dose Level 3|Withdrew|0|||
129894014|NCT00725010|467571752|FG000|Overall Study|Toxicity|9|||
129894015|NCT00725010|467571752|FG000|Overall Study|Tumor Progression|7|||
129894016|NCT00725010|467571752|FG000|Overall Study|Withdrawal by Subject|2|||
129894017|NCT00725010|467571752|FG000|Overall Study|Death|1|||
129894018|NCT00725010|467571752|FG000|Overall Study|Lost to Follow-up|1|||
129894019|NCT00725010|467571752|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
129894020|NCT00725010|467571752|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
129894021|NCT00725010|467571752|FG000|Overall Study|No further documentation|1|||
129894022|NCT00725010|467571752|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
129894023|NCT02414828|467571753|FG000|Overall Study|Lost to Follow-up|0|||
129894024|NCT02414828|467571754|FG001|Overall Study|Lost to Follow-up|1|||
129894025|NCT02414828|467571755|FG002|Overall Study|Lost to Follow-up|1|||
129894026|NCT02414828|467571756|FG003|Overall Study|Lost to Follow-up|2|||
129894027|NCT00670540|467571759|FG000|Overall Study|ineligible|17|||
129894028|NCT00670540|467571759|FG000|Overall Study|not living in France|348|||
129894029|NCT00670540|467571759|FG000|Overall Study|refused to participate|189|||
129894030|NCT00670540|467571759|FG000|Overall Study|controls randomised for no follow up|2770|||
129894031|NCT00670540|467571759|FG000|Overall Study|missing information inclusion criteria|1|||
129894032|NCT01515319|467571760|FG000|Overall Study|Withdrawal by Subject|0|||
129894033|NCT01515319|467571761|FG001|Overall Study|Withdrawal by Subject|0|||
129894034|NCT01515319|467571762|FG002|Overall Study|Withdrawal by Subject|0|||
129894035|NCT01515319|467571763|FG003|Overall Study|Withdrawal by Subject|0|||
129894036|NCT01515319|467571764|FG004|Overall Study|Withdrawal by Subject|0|||
129894037|NCT01515319|467571765|FG005|Overall Study|Withdrawal by Subject|0|||
129894038|NCT01515319|467571766|FG006|Overall Study|Withdrawal by Subject|1|||
129894039|NCT01515319|467571767|FG007|Overall Study|Withdrawal by Subject|0|||
129894040|NCT01515319|467571768|FG008|Overall Study|Withdrawal by Subject|0|||
129894041|NCT01515319|467571769|FG009|Overall Study|Withdrawal by Subject|0|||
129894042|NCT01515319|467571760|FG000|Overall Study|Adverse Event|0|||
129894043|NCT01515319|467571761|FG001|Overall Study|Adverse Event|0|||
129894044|NCT01515319|467571762|FG002|Overall Study|Adverse Event|0|||
129894045|NCT01515319|467571763|FG003|Overall Study|Adverse Event|0|||
129894046|NCT01515319|467571764|FG004|Overall Study|Adverse Event|0|||
129894047|NCT01515319|467571765|FG005|Overall Study|Adverse Event|0|||
129894048|NCT01515319|467571766|FG006|Overall Study|Adverse Event|0|||
129894049|NCT01515319|467571767|FG007|Overall Study|Adverse Event|0|||
129894050|NCT01515319|467571768|FG008|Overall Study|Adverse Event|3|||
129894051|NCT01515319|467571769|FG009|Overall Study|Adverse Event|0|||
129894052|NCT01515319|467571760|FG000|Overall Study|Protocol Violation|0|||
129894053|NCT01515319|467571761|FG001|Overall Study|Protocol Violation|0|||
129894054|NCT01515319|467571762|FG002|Overall Study|Protocol Violation|0|||
129894055|NCT01515319|467571763|FG003|Overall Study|Protocol Violation|0|||
129894056|NCT01515319|467571764|FG004|Overall Study|Protocol Violation|0|||
129894057|NCT01515319|467571765|FG005|Overall Study|Protocol Violation|0|||
129894058|NCT01515319|467571766|FG006|Overall Study|Protocol Violation|0|||
129894059|NCT01515319|467571767|FG007|Overall Study|Protocol Violation|0|||
129894060|NCT01515319|467571768|FG008|Overall Study|Protocol Violation|2|||
129894061|NCT01515319|467571769|FG009|Overall Study|Protocol Violation|0|||
129894062|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Adverse Event|5|||
129894063|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Adverse Event|13|||
129894064|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Adverse Event|0|||
129894065|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
129894066|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
130112300|NCT01571635|468371128|FG003|Overall Study|Study terminated by sponsor|3|||
129894067|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
129894068|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
129894069|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
129894070|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
129894071|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
129894072|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
129894073|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
129894074|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
129894075|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
129894076|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
129894077|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
129894078|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
129894079|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
129894080|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Physician Decision|2|||
129894081|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Physician Decision|3|||
129894082|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Physician Decision|0|||
129894083|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
129894084|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
129894085|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
129894086|NCT01449929|467571770|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
129894087|NCT01449929|467571771|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
129894088|NCT01449929|467571772|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
129894089|NCT01449929|467571770|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
129894090|NCT01449929|467571771|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
130058005|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
130058006|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130058007|NCT01106625|468166145|FG000|Extension Period: Week 26 to Week 52|Other|5|||
130058008|NCT01106625|468166146|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130058009|NCT01106625|468166147|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130058010|NCT02509598|468166148|FG000|Overall Study|Withdrawal by Subject|1|||
130058011|NCT02196038|468166149|FG000|Overall Study|Death|16|||
130058012|NCT02196038|468166150|FG001|Overall Study|Death|21|||
130058013|NCT02196038|468166149|FG000|Overall Study|Withdrawal by Subject|0|||
130058014|NCT02196038|468166150|FG001|Overall Study|Withdrawal by Subject|1|||
130058015|NCT02196038|468166149|FG000|Overall Study|Lost to Follow-up|1|||
130058016|NCT02196038|468166150|FG001|Overall Study|Lost to Follow-up|0|||
130058017|NCT01098461|468166153|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
130058018|NCT01098461|468166154|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
130058019|NCT01098461|468166155|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
129894091|NCT01449929|467571772|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
129894092|NCT01449929|467571770|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
130058020|NCT01098461|468166156|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
130058021|NCT01098461|468166153|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
130058022|NCT01098461|468166154|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
130058023|NCT01098461|468166155|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
129894093|NCT01449929|467571771|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
129894094|NCT01449929|467571772|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
130058024|NCT01098461|468166156|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
130112301|NCT01571635|468371129|FG004|Overall Study|Study terminated by sponsor|1|||
130112302|NCT01571635|468371125|FG000|Overall Study|Withdrew consent|1|||
130058025|NCT01098461|468166153|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
130058026|NCT01098461|468166154|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
130058027|NCT01098461|468166155|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
130058028|NCT01098461|468166156|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
130058029|NCT01098461|468166153|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
129894095|NCT01871285|467571773|FG000|First Intervention (1 Day)|Adverse Event|1|||
129894096|NCT01871285|467571774|FG001|First Intervention (1 Day)|Adverse Event|0|||
130058030|NCT01098461|468166154|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
130058031|NCT01098461|468166155|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
130058032|NCT01098461|468166156|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
130058033|NCT01098461|468166153|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
130058034|NCT01098461|468166154|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
130058035|NCT01098461|468166155|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
130058036|NCT01098461|468166156|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
130058037|NCT01098461|468166153|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
130058038|NCT01098461|468166154|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
130058039|NCT01098461|468166155|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
130058040|NCT01098461|468166156|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
130058041|NCT01098461|468166153|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
130058042|NCT01098461|468166154|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
130058043|NCT01098461|468166155|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
130058044|NCT01098461|468166156|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
130058045|NCT01153763|468166159|FG000|Overall Study|Study Closed|16|||
130058046|NCT01153763|468166159|FG000|Overall Study|Lost to Follow-up|1|||
130058047|NCT01153763|468166159|FG000|Overall Study|Physician Decision|2|||
130058048|NCT01153763|468166159|FG000|Overall Study|Withdrawal by Subject|2|||
130058049|NCT01474746|468166160|FG000|Overall Study|Lost to Follow-up|1|||
130058050|NCT01474746|468166161|FG001|Overall Study|Lost to Follow-up|1|||
130058051|NCT01474746|468166160|FG000|Overall Study|Withdrawal by Subject|2|||
130058052|NCT01474746|468166161|FG001|Overall Study|Withdrawal by Subject|1|||
130058053|NCT01766336|468166163|FG000|Overall Study|Adverse Event|11|||
130058054|NCT01766336|468166164|FG001|Overall Study|Adverse Event|8|||
130058055|NCT01766336|468166163|FG000|Overall Study|Death|4|||
130058056|NCT01766336|468166164|FG001|Overall Study|Death|3|||
130058057|NCT01766336|468166163|FG000|Overall Study|Lost to Follow-up|1|||
130058058|NCT01766336|468166164|FG001|Overall Study|Lost to Follow-up|3|||
130058059|NCT01766336|468166163|FG000|Overall Study|Physician Decision|4|||
130058060|NCT01766336|468166164|FG001|Overall Study|Physician Decision|2|||
130058061|NCT01766336|468166163|FG000|Overall Study|Protocol Violation|0|||
130058062|NCT01766336|468166164|FG001|Overall Study|Protocol Violation|1|||
130058063|NCT01766336|468166163|FG000|Overall Study|Sponsor Decision|52|||
130058064|NCT01766336|468166164|FG001|Overall Study|Sponsor Decision|43|||
130058065|NCT01766336|468166163|FG000|Overall Study|Withdrawal by Subject|18|||
130058066|NCT01766336|468166164|FG001|Overall Study|Withdrawal by Subject|15|||
130058067|NCT02605447|468166165|FG000|Overall Study|Death|66|||
130058068|NCT02605447|468166165|FG000|Overall Study|Physician Decision|1|||
130058069|NCT02605447|468166165|FG000|Overall Study|Lost to Follow-up|24|||
130058070|NCT02605447|468166165|FG000|Overall Study|Withdrawal by Subject|10|||
130058071|NCT02605447|468166165|FG000|Overall Study|Not disclosed|1|||
130058072|NCT01116687|468168015|FG000|Overall Study|Withdrawal by Subject|4|||
130058073|NCT00789191|468168018|FG000|Overall Study|Adverse Event|2|||
130058074|NCT00789191|468168019|FG001|Overall Study|Adverse Event|4|||
130058075|NCT00789191|468168018|FG000|Overall Study|Lack of Efficacy|0|||
130058076|NCT00789191|468168019|FG001|Overall Study|Lack of Efficacy|5|||
130058077|NCT00789191|468168018|FG000|Overall Study|Protocol Violation|5|||
130058078|NCT00789191|468168019|FG001|Overall Study|Protocol Violation|3|||
130058079|NCT00789191|468168018|FG000|Overall Study|Withdrawal Criteria|2|||
130058080|NCT00789191|468168019|FG001|Overall Study|Withdrawal Criteria|4|||
130058081|NCT00789191|468168018|FG000|Overall Study|Unclassified|5|||
130058082|NCT00789191|468168019|FG001|Overall Study|Unclassified|3|||
130058083|NCT03497429|468168020|FG000|Overall Study|Progressive disease|3|||
130058084|NCT03497429|468168021|FG001|Overall Study|Progressive disease|4|||
129894097|NCT01871285|467571775|FG002|First Intervention (1 Day)|Adverse Event|0|||
129894098|NCT01871285|467571776|FG003|First Intervention (1 Day)|Adverse Event|0|||
129894099|NCT01871285|467571773|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
129894100|NCT01871285|467571774|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
129894101|NCT01871285|467571775|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
129894102|NCT01871285|467571776|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
129894103|NCT01959880|467571777|FG000|Overall Study|Withdrawal by Subject|11|||
129894104|NCT01959880|467571778|FG001|Overall Study|Withdrawal by Subject|13|||
129894105|NCT01959880|467571779|FG002|Overall Study|Withdrawal by Subject|8|||
129894106|NCT01959880|467571780|FG003|Overall Study|Withdrawal by Subject|7|||
129894107|NCT01959880|467571777|FG000|Overall Study|Death|1|||
129894108|NCT01959880|467571778|FG001|Overall Study|Death|10|||
129894109|NCT01959880|467571779|FG002|Overall Study|Death|1|||
129894110|NCT01959880|467571780|FG003|Overall Study|Death|2|||
129894111|NCT01959880|467571777|FG000|Overall Study|Lost to Follow-up|95|||
129894112|NCT01959880|467571778|FG001|Overall Study|Lost to Follow-up|18|||
129894113|NCT01959880|467571779|FG002|Overall Study|Lost to Follow-up|15|||
129894114|NCT01959880|467571780|FG003|Overall Study|Lost to Follow-up|8|||
129894115|NCT01959880|467571777|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
129894116|NCT01959880|467571778|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
129894117|NCT01959880|467571779|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
129894118|NCT01959880|467571780|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
129894119|NCT01959880|467571777|FG000|Overall Study|Study completed early-FDA approved|1003|||
129894120|NCT01959880|467571778|FG001|Overall Study|Study completed early-FDA approved|311|||
129894121|NCT01959880|467571779|FG002|Overall Study|Study completed early-FDA approved|179|||
129894122|NCT01959880|467571780|FG003|Overall Study|Study completed early-FDA approved|152|||
129894123|NCT01919619|467571781|FG000|Overall Study|Physician Decision|1|||
129894124|NCT01919619|467571782|FG001|Overall Study|Physician Decision|1|||
129894125|NCT03253653|467571787|FG000|Overall Study|Withdrawal by Subject|4|||
129894126|NCT03253653|467571788|FG001|Overall Study|Withdrawal by Subject|1|||
129894127|NCT03253653|467571787|FG000|Overall Study|Protocol Violation|0|||
129894128|NCT03253653|467571788|FG001|Overall Study|Protocol Violation|5|||
129894129|NCT00662909|467571790|FG000|Overall Study|Adverse Event|17|||
129894130|NCT00662909|467571791|FG001|Overall Study|Adverse Event|18|||
129894131|NCT00662909|467571792|FG002|Overall Study|Adverse Event|19|||
129894132|NCT00662909|467571790|FG000|Overall Study|Lack of Efficacy|9|||
129894133|NCT00662909|467571791|FG001|Overall Study|Lack of Efficacy|1|||
129894134|NCT00662909|467571792|FG002|Overall Study|Lack of Efficacy|5|||
129894135|NCT00662909|467571790|FG000|Overall Study|Withdrawal by Subject|29|||
129894136|NCT00662909|467571791|FG001|Overall Study|Withdrawal by Subject|22|||
129894137|NCT00662909|467571792|FG002|Overall Study|Withdrawal by Subject|16|||
129894138|NCT00662909|467571790|FG000|Overall Study|Lost to Follow-up|2|||
129894139|NCT00662909|467571791|FG001|Overall Study|Lost to Follow-up|9|||
129894140|NCT00662909|467571792|FG002|Overall Study|Lost to Follow-up|3|||
129894141|NCT00662909|467571790|FG000|Overall Study|Protocol Violation|7|||
129894142|NCT00662909|467571791|FG001|Overall Study|Protocol Violation|4|||
129894143|NCT00662909|467571792|FG002|Overall Study|Protocol Violation|5|||
130058085|NCT03497429|468168020|FG000|Overall Study|Adverse Event|0|||
130058086|NCT03497429|468168021|FG001|Overall Study|Adverse Event|2|||
130058087|NCT01009983|468168022|FG000|Overall Study|necessary scans not completed|1|||
130058088|NCT00506948|468168023|FG000|Overall Study|Death|4|||
130058089|NCT00506948|468168023|FG000|Overall Study|Adverse Event|5|||
129894144|NCT00662909|467571790|FG000|Overall Study|Randomized- never received study drug|1|||
129894145|NCT00662909|467571791|FG001|Overall Study|Randomized- never received study drug|0|||
129894146|NCT00662909|467571792|FG002|Overall Study|Randomized- never received study drug|0|||
129894147|NCT00662909|467571790|FG000|Overall Study|Non-compliance with study procedures|3|||
129894148|NCT00662909|467571791|FG001|Overall Study|Non-compliance with study procedures|3|||
129894149|NCT00662909|467571792|FG002|Overall Study|Non-compliance with study procedures|2|||
129894150|NCT00662909|467571790|FG000|Overall Study|Physician Decision|1|||
129894151|NCT00662909|467571791|FG001|Overall Study|Physician Decision|1|||
129894152|NCT00662909|467571792|FG002|Overall Study|Physician Decision|2|||
129894153|NCT00662909|467571790|FG000|Overall Study|Eligibility criterion not met|0|||
129894154|NCT00662909|467571791|FG001|Overall Study|Eligibility criterion not met|1|||
129894155|NCT00662909|467571792|FG002|Overall Study|Eligibility criterion not met|1|||
129894156|NCT04978363|467573331|FG000|Overall Study|Other medical issues unrelated to the study|0|||
129894157|NCT04978363|467573332|FG001|Overall Study|Other medical issues unrelated to the study|0|||
129894158|NCT04978363|467573333|FG002|Overall Study|Other medical issues unrelated to the study|0|||
129894159|NCT04978363|467573334|FG003|Overall Study|Other medical issues unrelated to the study|0|||
129894160|NCT04978363|467573335|FG004|Overall Study|Other medical issues unrelated to the study|1|||
129894161|NCT04978363|467573336|FG005|Overall Study|Other medical issues unrelated to the study|0|||
129894162|NCT04978363|467573337|FG006|Overall Study|Other medical issues unrelated to the study|0|||
129894163|NCT04978363|467573338|FG007|Overall Study|Other medical issues unrelated to the study|0|||
129894164|NCT04978363|467573339|FG008|Overall Study|Other medical issues unrelated to the study|0|||
129894165|NCT04978363|467573340|FG009|Overall Study|Other medical issues unrelated to the study|0|||
129894166|NCT04978363|467573341|FG010|Overall Study|Other medical issues unrelated to the study|0|||
129894167|NCT04978363|467573331|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
129894168|NCT04978363|467573332|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
129894169|NCT04978363|467573333|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
129894170|NCT04978363|467573334|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
129894171|NCT04978363|467573335|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
129894172|NCT04978363|467573336|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
129894173|NCT04978363|467573337|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
129894174|NCT04978363|467573338|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
129894175|NCT04978363|467573339|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
129894176|NCT04978363|467573340|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
129894177|NCT04978363|467573341|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
129894178|NCT04978363|467573331|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894179|NCT04978363|467573332|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
129894180|NCT04978363|467573333|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894181|NCT04978363|467573334|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894182|NCT04978363|467573335|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894183|NCT04978363|467573336|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894184|NCT04978363|467573337|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894185|NCT04978363|467573338|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894186|NCT04978363|467573339|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894187|NCT04978363|467573340|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894188|NCT04978363|467573341|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894189|NCT02790606|467573349|FG000|Overall Study|Death|27|||
129894190|NCT02790606|467573349|FG000|Overall Study|Lost to Follow-up|4|||
129894191|NCT02790606|467573349|FG000|Overall Study|Physician Decision|3|||
129894192|NCT02790606|467573349|FG000|Overall Study|Withdrawal by Subject|1|||
129894193|NCT02735915|467573350|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
129894194|NCT02735915|467573350|FG000|Overall Study|Withdrawal following SAE|2|||
129894195|NCT02735915|467573350|FG000|Overall Study|Withdrawal by Subject|1|||
129894196|NCT05328973|467573351|FG000|Overall Study|Withdrawal by Subject|0|||
129894197|NCT05328973|467573352|FG001|Overall Study|Withdrawal by Subject|1|||
129894198|NCT00946114|467573353|FG000|Overall Study|Death|5|||
129894199|NCT00946114|467573354|FG001|Overall Study|Death|2|||
129894200|NCT00946114|467573353|FG000|Overall Study|Other|1|||
129894201|NCT00946114|467573354|FG001|Overall Study|Other|0|||
129894202|NCT00946114|467573353|FG000|Overall Study|Withdrawal by Subject|2|||
129894203|NCT00946114|467573354|FG001|Overall Study|Withdrawal by Subject|0|||
129894204|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
129894205|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
129894206|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
129894207|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
129894208|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
129894209|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
129979653|NCT00403767|467889418|FG001|Overall Study|Investigator dec./not protocol-related|178|||
129894210|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
129894211|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
129894212|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
129894213|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
129894214|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
129894215|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
129894216|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
129894217|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
129894218|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
129894219|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
129894220|NCT00498186|467573358|FG000|Overall Study|Protocol Violation|10|||
129894221|NCT00498186|467573358|FG000|Overall Study|Lack of Efficacy|31|||
129894222|NCT00498186|467573358|FG000|Overall Study|Adverse Event|89|||
129894223|NCT00498186|467573358|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
129894224|NCT00498186|467573358|FG000|Overall Study|Withdrawal by Subject|18|||
129894225|NCT00498186|467573358|FG000|Overall Study|Lost to Follow-up|3|||
129894226|NCT00498186|467573358|FG000|Overall Study|Other|10|||
129894227|NCT03929302|467573359|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
129894228|NCT03929302|467573360|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
129894229|NCT03929302|467573361|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
129894230|NCT03929302|467573359|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
129894231|NCT03929302|467573360|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
129894232|NCT03929302|467573361|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
129894233|NCT03929302|467573359|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
129894234|NCT03929302|467573360|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
129894235|NCT03929302|467573361|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
129894236|NCT02757885|467573362|FG000|Overall Study|Screen Failures|4|||
129894237|NCT00886613|467573363|FG000|Overall Study|Protocol deviation (Part B)|1|||
129894238|NCT00886613|467573364|FG001|Overall Study|Protocol deviation (Part B)|0|||
129894239|NCT00886613|467573365|FG002|Overall Study|Protocol deviation (Part B)|0|||
129894240|NCT00886613|467573363|FG000|Overall Study|Lost to follow-up (Part B)|1|||
129894241|NCT00886613|467573364|FG001|Overall Study|Lost to follow-up (Part B)|0|||
129894242|NCT00886613|467573365|FG002|Overall Study|Lost to follow-up (Part B)|1|||
129894243|NCT00886613|467573363|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
129894244|NCT00886613|467573364|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
129894245|NCT00886613|467573365|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
129894246|NCT00463151|467573374|FG000|Overall Study|Adverse Event|0|||
129894247|NCT00463151|467573375|FG001|Overall Study|Adverse Event|0|||
129894248|NCT00463151|467573376|FG002|Overall Study|Adverse Event|1|||
129894249|NCT00463151|467573377|FG003|Overall Study|Adverse Event|0|||
129894250|NCT00463151|467573374|FG000|Overall Study|Lack of Efficacy|2|||
129894251|NCT00463151|467573375|FG001|Overall Study|Lack of Efficacy|5|||
129894252|NCT00463151|467573376|FG002|Overall Study|Lack of Efficacy|2|||
129894253|NCT00463151|467573377|FG003|Overall Study|Lack of Efficacy|5|||
129894254|NCT00463151|467573374|FG000|Overall Study|Protocol Violation|0|||
129894255|NCT00463151|467573375|FG001|Overall Study|Protocol Violation|0|||
129894256|NCT00463151|467573376|FG002|Overall Study|Protocol Violation|0|||
129894257|NCT00463151|467573377|FG003|Overall Study|Protocol Violation|1|||
129894258|NCT00463151|467573374|FG000|Overall Study|Withdrawal by Subject|0|||
129894259|NCT00463151|467573375|FG001|Overall Study|Withdrawal by Subject|0|||
129894260|NCT00463151|467573376|FG002|Overall Study|Withdrawal by Subject|0|||
129894261|NCT00463151|467573377|FG003|Overall Study|Withdrawal by Subject|1|||
129894262|NCT00293462|467573378|FG000|Overall Study|Withdrawal by Subject|4|||
129894263|NCT00293462|467573379|FG001|Overall Study|Withdrawal by Subject|3|||
129894264|NCT00293462|467573380|FG002|Overall Study|Withdrawal by Subject|8|||
129894265|NCT00293462|467573378|FG000|Overall Study|Death|1|||
129894266|NCT00293462|467573379|FG001|Overall Study|Death|0|||
129894267|NCT00293462|467573380|FG002|Overall Study|Death|0|||
129894268|NCT00293462|467573378|FG000|Overall Study|Lost to Follow-up|0|||
129894269|NCT00293462|467573379|FG001|Overall Study|Lost to Follow-up|1|||
129894270|NCT00293462|467573380|FG002|Overall Study|Lost to Follow-up|0|||
129894271|NCT00293462|467573378|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
129894272|NCT00293462|467573379|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
129894273|NCT00293462|467573380|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
129894274|NCT00293462|467573378|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
129894275|NCT00293462|467573379|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
129894276|NCT00293462|467573380|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
129894277|NCT00293462|467573378|FG000|Overall Study|Refuse Radiation Treatment|1|||
129894278|NCT00293462|467573379|FG001|Overall Study|Refuse Radiation Treatment|0|||
129894279|NCT00293462|467573380|FG002|Overall Study|Refuse Radiation Treatment|0|||
129894280|NCT00293462|467573378|FG000|Overall Study|No Show|0|||
129894281|NCT00293462|467573379|FG001|Overall Study|No Show|0|||
129894282|NCT00293462|467573380|FG002|Overall Study|No Show|1|||
129806975|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806976|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806977|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806978|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806979|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806980|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806981|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806982|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
129806983|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806984|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806985|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806986|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806987|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806988|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806989|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806990|NCT00533897|467261057|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806991|NCT00533897|467261058|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
129806992|NCT00533897|467261059|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
129806993|NCT00533897|467261060|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806994|NCT00533897|467261061|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806995|NCT00533897|467261062|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806996|NCT00533897|467261063|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806997|NCT00533897|467261064|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806998|NCT00533897|467261057|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129806999|NCT00533897|467261058|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807000|NCT00533897|467261059|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
129807001|NCT00533897|467261060|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807002|NCT00533897|467261061|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807003|NCT00533897|467261062|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807004|NCT00533897|467261063|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807005|NCT00533897|467261064|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807006|NCT00533897|467261057|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807007|NCT00533897|467261058|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807008|NCT00533897|467261059|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807009|NCT00533897|467261060|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807010|NCT00533897|467261061|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807011|NCT00533897|467261062|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
129807012|NCT00533897|467261063|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807013|NCT00533897|467261064|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807014|NCT00533897|467261057|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807015|NCT00533897|467261058|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807016|NCT00533897|467261059|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807017|NCT00533897|467261060|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807018|NCT00533897|467261061|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807019|NCT00533897|467261062|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
129979654|NCT00403767|467889417|FG000|Overall Study|Lost to Follow-up|6|||
129979655|NCT00403767|467889418|FG001|Overall Study|Lost to Follow-up|8|||
129894283|NCT00293462|467573378|FG000|Overall Study|Went back to his home country|0|||
129894284|NCT00293462|467573379|FG001|Overall Study|Went back to his home country|0|||
129894285|NCT00293462|467573380|FG002|Overall Study|Went back to his home country|1|||
129894286|NCT00293462|467573378|FG000|Overall Study|Blood clot after chemotherapy|0|||
129894287|NCT00293462|467573379|FG001|Overall Study|Blood clot after chemotherapy|0|||
129894288|NCT00293462|467573380|FG002|Overall Study|Blood clot after chemotherapy|1|||
129894289|NCT00293462|467573378|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
129894290|NCT00293462|467573379|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
129894291|NCT00293462|467573380|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
129894292|NCT00293462|467573378|FG000|Overall Study|Possible Tracheostomy leakage|0|||
129894293|NCT00293462|467573379|FG001|Overall Study|Possible Tracheostomy leakage|1|||
129894294|NCT00293462|467573380|FG002|Overall Study|Possible Tracheostomy leakage|0|||
129894295|NCT00293462|467573378|FG000|Overall Study|Low radiation dose in oral cavity|0|||
129894296|NCT00293462|467573379|FG001|Overall Study|Low radiation dose in oral cavity|1|||
129894297|NCT00293462|467573380|FG002|Overall Study|Low radiation dose in oral cavity|0|||
129894298|NCT00293462|467573378|FG000|Overall Study|Physician Decision|0|||
129894299|NCT00293462|467573379|FG001|Overall Study|Physician Decision|1|||
129894300|NCT00293462|467573380|FG002|Overall Study|Physician Decision|0|||
129894301|NCT00688688|467573381|FG000|Overall Study|Eligibility criterion not met|7|||
129894302|NCT00688688|467573382|FG001|Overall Study|Eligibility criterion not met|7|||
129894303|NCT00688688|467573383|FG002|Overall Study|Eligibility criterion not met|10|||
129894304|NCT00688688|467573381|FG000|Overall Study|Adverse Event|52|||
129894305|NCT00688688|467573382|FG001|Overall Study|Adverse Event|51|||
129894306|NCT00688688|467573383|FG002|Overall Study|Adverse Event|50|||
129894307|NCT00688688|467573381|FG000|Overall Study|Lack of Efficacy|34|||
129894308|NCT00688688|467573382|FG001|Overall Study|Lack of Efficacy|25|||
129894309|NCT00688688|467573383|FG002|Overall Study|Lack of Efficacy|45|||
129894310|NCT00688688|467573381|FG000|Overall Study|Withdrawal by Subject|66|||
129894311|NCT00688688|467573382|FG001|Overall Study|Withdrawal by Subject|75|||
129894312|NCT00688688|467573383|FG002|Overall Study|Withdrawal by Subject|65|||
129894313|NCT00688688|467573381|FG000|Overall Study|Lost to Follow-up|14|||
129894314|NCT00688688|467573382|FG001|Overall Study|Lost to Follow-up|7|||
129894315|NCT00688688|467573383|FG002|Overall Study|Lost to Follow-up|7|||
129894316|NCT00688688|467573381|FG000|Overall Study|Protocol Violation|6|||
129894317|NCT00688688|467573382|FG001|Overall Study|Protocol Violation|9|||
129894318|NCT00688688|467573383|FG002|Overall Study|Protocol Violation|11|||
129894319|NCT00688688|467573381|FG000|Overall Study|Randomized but never received study drug|1|||
129894320|NCT00688688|467573382|FG001|Overall Study|Randomized but never received study drug|0|||
129894321|NCT00688688|467573383|FG002|Overall Study|Randomized but never received study drug|0|||
129894322|NCT00688688|467573381|FG000|Overall Study|Non-compliance with study procedures|5|||
129894323|NCT00688688|467573382|FG001|Overall Study|Non-compliance with study procedures|3|||
129894324|NCT00688688|467573383|FG002|Overall Study|Non-compliance with study procedures|4|||
129894325|NCT00688688|467573381|FG000|Overall Study|Taking exclusionary medications|1|||
129894326|NCT00688688|467573382|FG001|Overall Study|Taking exclusionary medications|0|||
130112303|NCT01571635|468371126|FG001|Overall Study|Withdrew consent|1|||
130112304|NCT01571635|468371127|FG002|Overall Study|Withdrew consent|2|||
129894327|NCT00688688|467573383|FG002|Overall Study|Taking exclusionary medications|0|||
129894328|NCT00688688|467573381|FG000|Overall Study|Site closure|0|||
129894329|NCT00688688|467573382|FG001|Overall Study|Site closure|1|||
129894330|NCT00688688|467573383|FG002|Overall Study|Site closure|0|||
129894331|NCT00688688|467573381|FG000|Overall Study|Violation of exclusion criterion|0|||
129894332|NCT00688688|467573382|FG001|Overall Study|Violation of exclusion criterion|1|||
129894333|NCT00688688|467573383|FG002|Overall Study|Violation of exclusion criterion|0|||
129894334|NCT03283553|467573386|FG000|Patient Participant Flow|Death|5|||
129894335|NCT03283553|467573387|FG001|Patient Participant Flow|Death|10|||
129894336|NCT03283553|467573386|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
129894337|NCT03283553|467573387|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
129894338|NCT03283553|467573386|FG000|Patient Participant Flow|Lost to Follow-up|1|||
130112305|NCT01571635|468371128|FG003|Overall Study|Withdrew consent|3|||
129894339|NCT03283553|467573387|FG001|Patient Participant Flow|Lost to Follow-up|1|||
129894340|NCT03283553|467573386|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
129894341|NCT03283553|467573387|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
129894342|NCT03283553|467573386|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
129894343|NCT03283553|467573387|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
129894344|NCT03283553|467573386|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
129894345|NCT03283553|467573387|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
129894346|NCT03686683|467573388|FG000|Overall Study|Withdrawal by Subject|52|||
129894347|NCT03686683|467573389|FG001|Overall Study|Withdrawal by Subject|32|||
129894348|NCT03686683|467573388|FG000|Overall Study|Lost to Follow-up|23|||
129894349|NCT03686683|467573389|FG001|Overall Study|Lost to Follow-up|19|||
129894350|NCT03686683|467573388|FG000|Overall Study|Adverse Event|1|||
129894351|NCT03686683|467573389|FG001|Overall Study|Adverse Event|0|||
129894352|NCT03686683|467573388|FG000|Overall Study|Death|10|||
129894353|NCT03686683|467573389|FG001|Overall Study|Death|5|||
129894354|NCT03686683|467573388|FG000|Overall Study|Progressive Disease|1|||
129894355|NCT03686683|467573389|FG001|Overall Study|Progressive Disease|1|||
129894356|NCT03686683|467573388|FG000|Overall Study|Noncompliance|1|||
129894357|NCT03686683|467573389|FG001|Overall Study|Noncompliance|0|||
129894358|NCT03686683|467573388|FG000|Overall Study|Physician Decision|1|||
129894359|NCT03686683|467573389|FG001|Overall Study|Physician Decision|1|||
129894360|NCT03686683|467573388|FG000|Overall Study|Screen fail post-randomization|1|||
129894361|NCT03686683|467573389|FG001|Overall Study|Screen fail post-randomization|0|||
129894362|NCT03686683|467573388|FG000|Overall Study|Protocol Violation|3|||
129894363|NCT03686683|467573389|FG001|Overall Study|Protocol Violation|0|||
129894364|NCT03686683|467573388|FG000|Overall Study|No data available|1|||
129894365|NCT03686683|467573389|FG001|Overall Study|No data available|0|||
129894366|NCT03255941|467573390|FG000|Overall Study|Not eligible or refused injection|37|||
129894367|NCT03255941|467573391|FG001|Overall Study|Not eligible or refused injection|44|||
129894368|NCT03255941|467573392|FG002|Overall Study|Not eligible or refused injection|5|||
130058090|NCT00506948|468168023|FG000|Overall Study|Physician Decision|1|||
129894369|NCT03255941|467573393|FG003|Overall Study|Not eligible or refused injection|6|||
129894370|NCT03255941|467573390|FG000|Overall Study|Did not complete exit interview|1|||
129894371|NCT03255941|467573391|FG001|Overall Study|Did not complete exit interview|2|||
129894372|NCT03255941|467573392|FG002|Overall Study|Did not complete exit interview|0|||
129894373|NCT03255941|467573393|FG003|Overall Study|Did not complete exit interview|0|||
129894374|NCT00372060|467573394|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
129894375|NCT00372060|467573395|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
129894376|NCT00372060|467573394|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
129894377|NCT00372060|467573395|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
129894378|NCT00372060|467573394|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
130058091|NCT02174861|468168024|FG000|Overall Study|Decision by sponsor|8|||
130058092|NCT02174861|468168024|FG000|Overall Study|Withdrawal by Subject|124|||
130058093|NCT02174861|468168024|FG000|Overall Study|Lost to Follow-up|26|||
129807020|NCT00533897|467261063|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807021|NCT00533897|467261064|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807022|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807023|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807024|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807025|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807026|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807027|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807028|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
129807029|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
129807030|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Death|0|||
129807031|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Death|0|||
129807032|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Death|0|||
129807033|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Death|0|||
129807034|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Death|0|||
130058094|NCT00165841|468168030|FG000|Overall Study|Adverse Event|2|||
130058095|NCT00165841|468168031|FG001|Overall Study|Adverse Event|3|||
130058096|NCT00165841|468168030|FG000|Overall Study|Lack of Efficacy|6|||
130058097|NCT00165841|468168031|FG001|Overall Study|Lack of Efficacy|33|||
130058098|NCT00165841|468168030|FG000|Overall Study|Lost to Follow-up|4|||
130058099|NCT00165841|468168031|FG001|Overall Study|Lost to Follow-up|4|||
130058100|NCT00165841|468168030|FG000|Overall Study|Withdrawal by Subject|7|||
130058101|NCT00165841|468168031|FG001|Overall Study|Withdrawal by Subject|8|||
130058102|NCT00165841|468168030|FG000|Overall Study|Physician Decision|1|||
130058103|NCT00165841|468168031|FG001|Overall Study|Physician Decision|0|||
130058104|NCT00165841|468168030|FG000|Overall Study|Protocol Violation|6|||
130058105|NCT00165841|468168031|FG001|Overall Study|Protocol Violation|8|||
129807035|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Death|0|||
129807036|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Death|1|||
129807037|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Death|3|||
129807038|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807039|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807040|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807041|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807042|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807043|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807044|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
129807045|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
129807046|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807047|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807048|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807049|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807050|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807051|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807052|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
129807053|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807054|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Adverse Event|0|||
129807055|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Adverse Event|0|||
129807056|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Adverse Event|0|||
129807057|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Adverse Event|0|||
129807058|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Adverse Event|0|||
129807059|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Adverse Event|0|||
129807060|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Adverse Event|2|||
130058106|NCT00165841|468168030|FG000|Overall Study|Other|3|||
129894379|NCT00372060|467573395|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
129894380|NCT00372060|467573394|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
129894381|NCT00372060|467573395|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
129894382|NCT00372060|467573394|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
129894383|NCT00372060|467573395|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
129894384|NCT00372060|467573394|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
129894385|NCT00372060|467573395|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
129894386|NCT01579578|467573396|FG000|Overall Study|Death|4|||
129894387|NCT01579578|467573397|FG001|Overall Study|Death|1|||
129894388|NCT01579578|467573396|FG000|Overall Study|Lost to Follow-up|1|||
129894389|NCT01579578|467573397|FG001|Overall Study|Lost to Follow-up|1|||
129894390|NCT01579578|467573396|FG000|Overall Study|Withdrawal by Subject|2|||
129894391|NCT01579578|467573397|FG001|Overall Study|Withdrawal by Subject|1|||
129894392|NCT01579578|467573396|FG000|Overall Study|Eligibility criteria|3|||
130058107|NCT00165841|468168031|FG001|Overall Study|Other|5|||
130058108|NCT00165841|468168030|FG000|Overall Study|Medication Noncompliance|1|||
130058109|NCT00165841|468168031|FG001|Overall Study|Medication Noncompliance|1|||
129807061|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Adverse Event|5|||
129807062|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Pregnancy|0|||
129807063|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Pregnancy|0|||
129807064|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Pregnancy|0|||
129807065|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Pregnancy|0|||
129807066|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Pregnancy|0|||
129807067|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Pregnancy|0|||
129807068|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Pregnancy|0|||
129807069|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Pregnancy|2|||
129807070|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807071|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807072|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807073|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807074|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807075|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807076|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
129807077|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
129807078|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Other|0|||
129807079|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Other|0|||
129807080|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Other|0|||
129807081|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Other|0|||
129807082|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Other|0|||
129807083|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Other|0|||
129807084|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Other|1|||
129807085|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Other|6|||
129807086|NCT01816074|467261066|FG000|Phase 1|Time commitment issues|0|||
129807087|NCT01816074|467261067|FG001|Phase 1|Time commitment issues|0|||
129807088|NCT01816074|467261068|FG002|Phase 1|Time commitment issues|1|||
129807089|NCT01816074|467261069|FG003|Phase 1|Time commitment issues|0|||
129807090|NCT01816074|467261066|FG000|Phase 2|Time commitment Issues|0|||
129807091|NCT01816074|467261067|FG001|Phase 2|Time commitment Issues|2|||
129807092|NCT01816074|467261068|FG002|Phase 2|Time commitment Issues|0|||
129807093|NCT01816074|467261069|FG003|Phase 2|Time commitment Issues|0|||
129807094|NCT01816074|467261066|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
129807095|NCT01816074|467261067|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
129807096|NCT01816074|467261068|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
129807097|NCT01816074|467261069|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
129807098|NCT01816074|467261066|FG000|Phase 2|Physician Decision|0|||
129807099|NCT01816074|467261067|FG001|Phase 2|Physician Decision|0|||
129807100|NCT01816074|467261068|FG002|Phase 2|Physician Decision|0|||
129807101|NCT01816074|467261069|FG003|Phase 2|Physician Decision|1|||
129807102|NCT01816074|467261066|FG000|Phase 2|Withdrawal by Subject|1|||
129807103|NCT01816074|467261067|FG001|Phase 2|Withdrawal by Subject|0|||
129807104|NCT01816074|467261068|FG002|Phase 2|Withdrawal by Subject|0|||
129807105|NCT01816074|467261069|FG003|Phase 2|Withdrawal by Subject|0|||
129807106|NCT03228433|467261072|FG000|Overall Study|Lost to Follow-up|1|||
129807107|NCT03228433|467261073|FG001|Overall Study|Lost to Follow-up|0|||
129807108|NCT03228433|467261074|FG002|Overall Study|Lost to Follow-up|0|||
129807109|NCT03228433|467261075|FG003|Overall Study|Lost to Follow-up|0|||
129807110|NCT03228433|467261076|FG004|Overall Study|Lost to Follow-up|0|||
129807111|NCT03228433|467261077|FG005|Overall Study|Lost to Follow-up|0|||
129807112|NCT03228433|467261072|FG000|Overall Study|Positive alcohol test|0|||
129807113|NCT03228433|467261073|FG001|Overall Study|Positive alcohol test|0|||
129807114|NCT03228433|467261074|FG002|Overall Study|Positive alcohol test|0|||
129807115|NCT03228433|467261075|FG003|Overall Study|Positive alcohol test|1|||
129807116|NCT03228433|467261076|FG004|Overall Study|Positive alcohol test|0|||
129807117|NCT03228433|467261077|FG005|Overall Study|Positive alcohol test|0|||
129807118|NCT01030536|467261078|FG000|Overall Study|Withdrawal by Subject|0|||
129807119|NCT01030536|467261079|FG001|Overall Study|Withdrawal by Subject|0|||
129894393|NCT01579578|467573397|FG001|Overall Study|Eligibility criteria|9|||
129894394|NCT01579578|467573396|FG000|Overall Study|Ongoing|3|||
129807120|NCT01030536|467261080|FG002|Overall Study|Withdrawal by Subject|1|||
129807121|NCT01030536|467261081|FG003|Overall Study|Withdrawal by Subject|0|||
129807122|NCT01030536|467261082|FG004|Overall Study|Withdrawal by Subject|0|||
129807123|NCT01030536|467261078|FG000|Overall Study|undefined|1|||
129807124|NCT01030536|467261079|FG001|Overall Study|undefined|0|||
129807125|NCT01030536|467261080|FG002|Overall Study|undefined|1|||
129807126|NCT01030536|467261081|FG003|Overall Study|undefined|1|||
129807127|NCT01030536|467261082|FG004|Overall Study|undefined|0|||
129807128|NCT01030536|467261078|FG000|Overall Study|Adverse Event|0|||
129807129|NCT01030536|467261079|FG001|Overall Study|Adverse Event|3|||
129807130|NCT01030536|467261080|FG002|Overall Study|Adverse Event|1|||
129807131|NCT01030536|467261081|FG003|Overall Study|Adverse Event|0|||
129807132|NCT01030536|467261082|FG004|Overall Study|Adverse Event|1|||
129807133|NCT01030536|467261078|FG000|Overall Study|Progressive disease|6|||
129807134|NCT01030536|467261079|FG001|Overall Study|Progressive disease|2|||
129807135|NCT01030536|467261080|FG002|Overall Study|Progressive disease|3|||
129807136|NCT01030536|467261081|FG003|Overall Study|Progressive disease|2|||
129807137|NCT01030536|467261082|FG004|Overall Study|Progressive disease|0|||
129807138|NCT01030536|467261078|FG000|Overall Study|Death|0|||
129807139|NCT01030536|467261079|FG001|Overall Study|Death|1|||
129807140|NCT01030536|467261080|FG002|Overall Study|Death|0|||
129807141|NCT01030536|467261081|FG003|Overall Study|Death|0|||
129807142|NCT01030536|467261082|FG004|Overall Study|Death|0|||
129807143|NCT01419626|467261087|FG000|Overall Study|Protocol Violation|3|||
129807144|NCT01419626|467261088|FG001|Overall Study|Protocol Violation|2|||
129807145|NCT01419626|467261089|FG002|Overall Study|Protocol Violation|2|||
129807146|NCT01419626|467261087|FG000|Overall Study|Withdrawal by Subject|1|||
129807147|NCT01419626|467261088|FG001|Overall Study|Withdrawal by Subject|0|||
129807148|NCT01419626|467261089|FG002|Overall Study|Withdrawal by Subject|0|||
129807149|NCT01419626|467261087|FG000|Overall Study|Lost to Follow-up|0|||
129807150|NCT01419626|467261088|FG001|Overall Study|Lost to Follow-up|1|||
129807151|NCT01419626|467261089|FG002|Overall Study|Lost to Follow-up|1|||
129807152|NCT01365052|467261090|FG000|Overall Study|Adverse Event|4|||
129807153|NCT01365052|467261091|FG001|Overall Study|Adverse Event|4|||
129807154|NCT01146912|467261092|FG000|Overall Study|Already received influenza vaccination|817|||
129807155|NCT01146912|467261093|FG001|Overall Study|Already received influenza vaccination|822|||
129807156|NCT01146912|467261094|FG002|Overall Study|Already received influenza vaccination|13|||
129807157|NCT01146912|467261095|FG003|Overall Study|Already received influenza vaccination|15|||
129807158|NCT01146912|467261096|FG004|Overall Study|Already received influenza vaccination|41|||
129807159|NCT01146912|467261097|FG005|Overall Study|Already received influenza vaccination|61|||
129807160|NCT01146912|467261098|FG006|Overall Study|Already received influenza vaccination|56|||
129807161|NCT01146912|467261099|FG007|Overall Study|Already received influenza vaccination|0|||
129807162|NCT01146912|467261092|FG000|Overall Study|< 14 weeks gestational age|0|||
129807163|NCT01146912|467261093|FG001|Overall Study|< 14 weeks gestational age|0|||
129807164|NCT01146912|467261094|FG002|Overall Study|< 14 weeks gestational age|3|||
129807165|NCT01146912|467261095|FG003|Overall Study|< 14 weeks gestational age|2|||
129807166|NCT01146912|467261096|FG004|Overall Study|< 14 weeks gestational age|0|||
129807167|NCT01146912|467261097|FG005|Overall Study|< 14 weeks gestational age|0|||
129807168|NCT01146912|467261098|FG006|Overall Study|< 14 weeks gestational age|0|||
129807169|NCT01146912|467261099|FG007|Overall Study|< 14 weeks gestational age|0|||
129807170|NCT01146912|467261092|FG000|Overall Study|Duplicate patient|0|||
129807171|NCT01146912|467261093|FG001|Overall Study|Duplicate patient|0|||
129807172|NCT01146912|467261094|FG002|Overall Study|Duplicate patient|1|||
129807173|NCT01146912|467261095|FG003|Overall Study|Duplicate patient|0|||
129807174|NCT01146912|467261096|FG004|Overall Study|Duplicate patient|0|||
129807175|NCT01146912|467261097|FG005|Overall Study|Duplicate patient|0|||
129807176|NCT01146912|467261098|FG006|Overall Study|Duplicate patient|0|||
129807177|NCT01146912|467261099|FG007|Overall Study|Duplicate patient|0|||
129807178|NCT01145625|467261102|FG000|Overall Study|Lost to Follow-up|8|||
129807179|NCT01145625|467261103|FG001|Overall Study|Lost to Follow-up|9|||
129807180|NCT01145625|467261102|FG000|Overall Study|Adverse Event|6|||
129807181|NCT01145625|467261103|FG001|Overall Study|Adverse Event|4|||
129807182|NCT01145625|467261102|FG000|Overall Study|Protocol Violation|3|||
129807183|NCT01145625|467261103|FG001|Overall Study|Protocol Violation|1|||
129807184|NCT01145625|467261102|FG000|Overall Study|Withdrawal by Subject|7|||
129807185|NCT01145625|467261103|FG001|Overall Study|Withdrawal by Subject|16|||
129807186|NCT01145625|467261102|FG000|Overall Study|Pregnancy|0|||
129807187|NCT01145625|467261103|FG001|Overall Study|Pregnancy|1|||
129807188|NCT02202980|467261104|FG000|Overall Study|Lack of Efficacy|1|||
129807189|NCT02202980|467261105|FG001|Overall Study|Lack of Efficacy|0|||
129807190|NCT02202980|467261106|FG002|Overall Study|Lack of Efficacy|7|||
129807191|NCT02202980|467261107|FG003|Overall Study|Lack of Efficacy|0|||
129807192|NCT02202980|467261108|FG004|Overall Study|Lack of Efficacy|3|||
129894395|NCT01579578|467573397|FG001|Overall Study|Ongoing|0|||
129894396|NCT01528709|467573398|FG000|Overall Study|Death|2|||
129894397|NCT01528709|467573399|FG001|Overall Study|Death|0|||
129807193|NCT02202980|467261109|FG005|Overall Study|Lack of Efficacy|1|||
129807194|NCT02202980|467261110|FG006|Overall Study|Lack of Efficacy|11|||
129807195|NCT02202980|467261111|FG007|Overall Study|Lack of Efficacy|2|||
129807196|NCT02202980|467261112|FG008|Overall Study|Lack of Efficacy|2|||
129807197|NCT02202980|467261113|FG009|Overall Study|Lack of Efficacy|0|||
129807198|NCT02202980|467261114|FG010|Overall Study|Lack of Efficacy|0|||
129894398|NCT01528709|467573398|FG000|Overall Study|Withdrawal by Subject|10|||
129807199|NCT02202980|467261115|FG011|Overall Study|Lack of Efficacy|3|||
129807200|NCT02202980|467261116|FG012|Overall Study|Lack of Efficacy|10|||
129807201|NCT02202980|467261117|FG013|Overall Study|Lack of Efficacy|0|||
129807202|NCT02202980|467261104|FG000|Overall Study|Protocol Violation|0|||
129807203|NCT02202980|467261105|FG001|Overall Study|Protocol Violation|0|||
129807204|NCT02202980|467261106|FG002|Overall Study|Protocol Violation|0|||
129807205|NCT02202980|467261107|FG003|Overall Study|Protocol Violation|3|||
129807206|NCT02202980|467261108|FG004|Overall Study|Protocol Violation|3|||
129807207|NCT02202980|467261109|FG005|Overall Study|Protocol Violation|0|||
129807208|NCT02202980|467261110|FG006|Overall Study|Protocol Violation|0|||
129807209|NCT02202980|467261111|FG007|Overall Study|Protocol Violation|0|||
129807210|NCT02202980|467261112|FG008|Overall Study|Protocol Violation|0|||
129807211|NCT02202980|467261113|FG009|Overall Study|Protocol Violation|0|||
129807212|NCT02202980|467261114|FG010|Overall Study|Protocol Violation|0|||
129807213|NCT02202980|467261115|FG011|Overall Study|Protocol Violation|0|||
129807214|NCT02202980|467261116|FG012|Overall Study|Protocol Violation|0|||
129807215|NCT02202980|467261117|FG013|Overall Study|Protocol Violation|0|||
129807216|NCT02202980|467261104|FG000|Overall Study|Lost to Follow-up|0|||
129807217|NCT02202980|467261105|FG001|Overall Study|Lost to Follow-up|1|||
129807218|NCT02202980|467261106|FG002|Overall Study|Lost to Follow-up|1|||
129807219|NCT02202980|467261107|FG003|Overall Study|Lost to Follow-up|1|||
129807220|NCT02202980|467261108|FG004|Overall Study|Lost to Follow-up|0|||
129807221|NCT02202980|467261109|FG005|Overall Study|Lost to Follow-up|0|||
129807222|NCT02202980|467261110|FG006|Overall Study|Lost to Follow-up|0|||
129807223|NCT02202980|467261111|FG007|Overall Study|Lost to Follow-up|1|||
129807224|NCT02202980|467261112|FG008|Overall Study|Lost to Follow-up|1|||
129807225|NCT02202980|467261113|FG009|Overall Study|Lost to Follow-up|0|||
129807226|NCT02202980|467261114|FG010|Overall Study|Lost to Follow-up|0|||
129807227|NCT02202980|467261115|FG011|Overall Study|Lost to Follow-up|0|||
129807228|NCT02202980|467261116|FG012|Overall Study|Lost to Follow-up|1|||
129807229|NCT02202980|467261117|FG013|Overall Study|Lost to Follow-up|0|||
129807230|NCT02202980|467261104|FG000|Overall Study|Withdrew Consent|0|||
129807231|NCT02202980|467261105|FG001|Overall Study|Withdrew Consent|1|||
129807232|NCT02202980|467261106|FG002|Overall Study|Withdrew Consent|2|||
129807233|NCT02202980|467261107|FG003|Overall Study|Withdrew Consent|0|||
129807234|NCT02202980|467261108|FG004|Overall Study|Withdrew Consent|0|||
129807235|NCT02202980|467261109|FG005|Overall Study|Withdrew Consent|0|||
129807236|NCT02202980|467261110|FG006|Overall Study|Withdrew Consent|0|||
129807237|NCT02202980|467261111|FG007|Overall Study|Withdrew Consent|0|||
129807238|NCT02202980|467261112|FG008|Overall Study|Withdrew Consent|1|||
129807239|NCT02202980|467261113|FG009|Overall Study|Withdrew Consent|0|||
129894399|NCT01528709|467573399|FG001|Overall Study|Withdrawal by Subject|15|||
129894400|NCT01528709|467573398|FG000|Overall Study|allergy|1|||
129894401|NCT01528709|467573399|FG001|Overall Study|allergy|0|||
129894402|NCT05124899|467573403|FG000|Overall Study|Lost to Follow-up|3|||
129894403|NCT00647348|467573411|FG000|Overall Study|Lost to Follow-up|3|||
129894404|NCT00647348|467573412|FG001|Overall Study|Lost to Follow-up|6|||
129894405|NCT01417000|467573413|FG000|Overall Study|Death|59|||
129894406|NCT01417000|467573414|FG001|Overall Study|Death|28|||
129894407|NCT01417000|467573413|FG000|Overall Study|Lost to Follow-up|1|||
129894408|NCT01417000|467573414|FG001|Overall Study|Lost to Follow-up|0|||
129894409|NCT01417000|467573413|FG000|Overall Study|Study Terminated by Sponsor|1|||
129894410|NCT01417000|467573414|FG001|Overall Study|Study Terminated by Sponsor|1|||
129894411|NCT02397889|467573423|FG000|Overall Study|Physician Decision|1|||
129894412|NCT02397889|467573424|FG001|Overall Study|Physician Decision|0|||
129894413|NCT00797225|467573436|FG000|Weeks 1 to 12|Adverse Event|0|||
129807240|NCT02202980|467261114|FG010|Overall Study|Withdrew Consent|0|||
129807241|NCT02202980|467261115|FG011|Overall Study|Withdrew Consent|0|||
129807242|NCT02202980|467261116|FG012|Overall Study|Withdrew Consent|0|||
129807243|NCT02202980|467261117|FG013|Overall Study|Withdrew Consent|0|||
129807244|NCT02130570|467261121|FG000|Overall Study|Death|3|||
129807245|NCT02130570|467261122|FG001|Overall Study|Death|5|||
129807246|NCT02130570|467261121|FG000|Overall Study|Withdrawal by Subject|6|||
129807247|NCT02130570|467261122|FG001|Overall Study|Withdrawal by Subject|3|||
129807248|NCT02130570|467261121|FG000|Overall Study|Part of practice that discontinued study|0|||
129807249|NCT02130570|467261122|FG001|Overall Study|Part of practice that discontinued study|5|||
129807250|NCT01696695|467261125|FG000|Overall Study|Disease progression|373|||
129807251|NCT01696695|467261125|FG000|Overall Study|Death|29|||
129807252|NCT01696695|467261125|FG000|Overall Study|Adverse Event|74|||
129807253|NCT01696695|467261125|FG000|Overall Study|Withdrawal by Subject|92|||
129807254|NCT01696695|467261125|FG000|Overall Study|Lost to Follow-up|48|||
129807255|NCT01696695|467261125|FG000|Overall Study|Other|74|||
129807256|NCT01696695|467261125|FG000|Overall Study|Major Protocol Violation|192|||
129807257|NCT01180647|467261128|FG000|Overall Study|Lost to Follow-up|5|||
129807258|NCT01180647|467261129|FG001|Overall Study|Lost to Follow-up|6|||
129807259|NCT00386607|467261130|FG000|Core|Adverse Event|40|||
129807260|NCT00386607|467261131|FG001|Core|Adverse Event|0|||
129807261|NCT00386607|467261130|FG000|Core|Abnormal laboratory value(s)|3|||
129807262|NCT00386607|467261131|FG001|Core|Abnormal laboratory value(s)|0|||
129807263|NCT00386607|467261130|FG000|Core|Unsatisfactory therapeutic effect|23|||
129807264|NCT00386607|467261131|FG001|Core|Unsatisfactory therapeutic effect|0|||
129807265|NCT00386607|467261130|FG000|Core|Condition no longer requires study drug|4|||
129807266|NCT00386607|467261131|FG001|Core|Condition no longer requires study drug|0|||
129807267|NCT00386607|467261130|FG000|Core|Patient withdrew consent|15|||
129807268|NCT00386607|467261131|FG001|Core|Patient withdrew consent|0|||
129807269|NCT00386607|467261130|FG000|Core|Lost to Follow-up|23|||
129894414|NCT00797225|467573437|FG001|Weeks 1 to 12|Adverse Event|0|||
129894415|NCT00797225|467573438|FG002|Weeks 1 to 12|Adverse Event|1|||
129894416|NCT00797225|467573439|FG003|Weeks 1 to 12|Adverse Event|0|||
129894417|NCT00797225|467573440|FG004|Weeks 1 to 12|Adverse Event|0|||
129807270|NCT00386607|467261131|FG001|Core|Lost to Follow-up|0|||
129807271|NCT00386607|467261130|FG000|Core|Administrative problems|1|||
129807272|NCT00386607|467261131|FG001|Core|Administrative problems|0|||
129807273|NCT00386607|467261130|FG000|Core|Protocol Deviation|6|||
129807274|NCT00386607|467261131|FG001|Core|Protocol Deviation|0|||
129807275|NCT00386607|467261130|FG000|Extension|Adverse Event|0|||
129894418|NCT00797225|467573441|FG005|Weeks 1 to 12|Adverse Event|0|||
129894419|NCT00797225|467573442|FG006|Weeks 1 to 12|Adverse Event|0|||
129894420|NCT00797225|467573443|FG007|Weeks 1 to 12|Adverse Event|0|||
129894421|NCT00797225|467573436|FG000|Weeks 1 to 12|Non-compliance|0|||
129807276|NCT00386607|467261131|FG001|Extension|Adverse Event|6|||
129894422|NCT00797225|467573437|FG001|Weeks 1 to 12|Non-compliance|1|||
129807277|NCT00386607|467261130|FG000|Extension|Abnormal laboratory value(s)|0|||
129807278|NCT00386607|467261131|FG001|Extension|Abnormal laboratory value(s)|1|||
129807279|NCT00386607|467261130|FG000|Extension|Administrative problems|0|||
129894423|NCT00797225|467573438|FG002|Weeks 1 to 12|Non-compliance|0|||
129894424|NCT00797225|467573439|FG003|Weeks 1 to 12|Non-compliance|0|||
129894425|NCT00797225|467573440|FG004|Weeks 1 to 12|Non-compliance|0|||
129894426|NCT00797225|467573441|FG005|Weeks 1 to 12|Non-compliance|0|||
129894427|NCT00797225|467573442|FG006|Weeks 1 to 12|Non-compliance|0|||
129894428|NCT00797225|467573443|FG007|Weeks 1 to 12|Non-compliance|0|||
129894429|NCT00797225|467573436|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
129894430|NCT00797225|467573437|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
129894431|NCT00797225|467573438|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
129894432|NCT00797225|467573439|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
129894433|NCT00797225|467573440|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
129894434|NCT00797225|467573441|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
129894435|NCT00797225|467573442|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
129894436|NCT00797225|467573443|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
129894437|NCT00797225|467573436|FG000|Weeks 1 to 12|Sponsor Decision|1|||
129894438|NCT00797225|467573437|FG001|Weeks 1 to 12|Sponsor Decision|0|||
129894439|NCT00797225|467573438|FG002|Weeks 1 to 12|Sponsor Decision|0|||
129894440|NCT00797225|467573439|FG003|Weeks 1 to 12|Sponsor Decision|0|||
129894441|NCT00797225|467573440|FG004|Weeks 1 to 12|Sponsor Decision|0|||
129894442|NCT00797225|467573441|FG005|Weeks 1 to 12|Sponsor Decision|0|||
129894443|NCT00797225|467573442|FG006|Weeks 1 to 12|Sponsor Decision|0|||
129894444|NCT00797225|467573443|FG007|Weeks 1 to 12|Sponsor Decision|0|||
129894445|NCT00797225|467573436|FG000|Weeks 13 to 24|Non-compliance|0|||
129894446|NCT00797225|467573437|FG001|Weeks 13 to 24|Non-compliance|2|||
129894447|NCT00797225|467573438|FG002|Weeks 13 to 24|Non-compliance|0|||
129894448|NCT00797225|467573439|FG003|Weeks 13 to 24|Non-compliance|0|||
129894449|NCT00797225|467573440|FG004|Weeks 13 to 24|Non-compliance|0|||
129894450|NCT00797225|467573441|FG005|Weeks 13 to 24|Non-compliance|0|||
129894451|NCT00797225|467573442|FG006|Weeks 13 to 24|Non-compliance|0|||
129894452|NCT00797225|467573443|FG007|Weeks 13 to 24|Non-compliance|0|||
129894453|NCT00797225|467573436|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
129894454|NCT00797225|467573437|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
129894455|NCT00797225|467573438|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
129894456|NCT00797225|467573439|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
129894457|NCT00797225|467573440|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
129894458|NCT00797225|467573441|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
129894459|NCT00797225|467573442|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
129894460|NCT00797225|467573443|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
129894461|NCT00797225|467573436|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
129894462|NCT00797225|467573437|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
129894463|NCT00797225|467573438|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
129894464|NCT00797225|467573439|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
129894465|NCT00797225|467573440|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
129894466|NCT00797225|467573441|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
129894467|NCT00797225|467573442|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
129894468|NCT00797225|467573443|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
129894469|NCT00797225|467573436|FG000|Weeks 13 to 24|Adverse Event|0|||
129894470|NCT00797225|467573437|FG001|Weeks 13 to 24|Adverse Event|1|||
129894471|NCT00797225|467573438|FG002|Weeks 13 to 24|Adverse Event|0|||
129894472|NCT00797225|467573439|FG003|Weeks 13 to 24|Adverse Event|0|||
129894473|NCT00797225|467573440|FG004|Weeks 13 to 24|Adverse Event|0|||
129894474|NCT00797225|467573441|FG005|Weeks 13 to 24|Adverse Event|0|||
129894475|NCT00797225|467573442|FG006|Weeks 13 to 24|Adverse Event|1|||
129894476|NCT00797225|467573443|FG007|Weeks 13 to 24|Adverse Event|0|||
129894477|NCT00797225|467573436|FG000|Weeks 13 to 24|Sponsor Decision|0|||
129894478|NCT00797225|467573437|FG001|Weeks 13 to 24|Sponsor Decision|0|||
129894479|NCT00797225|467573438|FG002|Weeks 13 to 24|Sponsor Decision|0|||
129894480|NCT00797225|467573439|FG003|Weeks 13 to 24|Sponsor Decision|0|||
129894481|NCT00797225|467573440|FG004|Weeks 13 to 24|Sponsor Decision|0|||
129894482|NCT00797225|467573441|FG005|Weeks 13 to 24|Sponsor Decision|0|||
129894483|NCT00797225|467573442|FG006|Weeks 13 to 24|Sponsor Decision|1|||
129807280|NCT00386607|467261131|FG001|Extension|Administrative problems|1|||
129807281|NCT00386607|467261130|FG000|Extension|Lost to Follow-up|0|||
129807282|NCT00386607|467261131|FG001|Extension|Lost to Follow-up|3|||
129807283|NCT00386607|467261130|FG000|Extension|Patient withdrew consent|0|||
129807284|NCT00386607|467261131|FG001|Extension|Patient withdrew consent|5|||
129807285|NCT00386607|467261130|FG000|Extension|Unsatisfactory therapeutic effect|0|||
129807286|NCT00386607|467261131|FG001|Extension|Unsatisfactory therapeutic effect|1|||
129807287|NCT01927627|467261133|FG000|Overall Study|Adverse Event|3|||
129807288|NCT01927627|467261133|FG000|Overall Study|Lack of Efficacy|1|||
129807289|NCT01927627|467261133|FG000|Overall Study|Financial Concerns|1|||
129807290|NCT00467857|467261134|FG000|Overall Study|Adverse Event|1|||
129807291|NCT00467857|467261135|FG001|Overall Study|Adverse Event|0|||
129807292|NCT00467857|467261134|FG000|Overall Study|Withdrew consent|2|||
129807293|NCT00467857|467261135|FG001|Overall Study|Withdrew consent|0|||
129807294|NCT00467857|467261134|FG000|Overall Study|Death|0|||
129807295|NCT00467857|467261135|FG001|Overall Study|Death|1|||
129807296|NCT00467857|467261134|FG000|Overall Study|Discharged from court service|0|||
129807297|NCT00467857|467261135|FG001|Overall Study|Discharged from court service|1|||
129807298|NCT00467857|467261134|FG000|Overall Study|Emergency care required|0|||
129807299|NCT00467857|467261135|FG001|Overall Study|Emergency care required|1|||
129807300|NCT00467857|467261134|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
129807301|NCT00467857|467261135|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
129807302|NCT00467857|467261134|FG000|Overall Study|Discontinuation reason missing|0|||
129807303|NCT00467857|467261135|FG001|Overall Study|Discontinuation reason missing|3|||
129807304|NCT03208127|467261138|FG000|Overall Study|Death|1|||
129807305|NCT00579098|467261139|FG000|Overall Study|Lost to Follow-up|2|||
129807306|NCT00579098|467261140|FG001|Overall Study|Lost to Follow-up|0|||
129807307|NCT00579098|467261139|FG000|Overall Study|Adverse Event|2|||
129807308|NCT00579098|467261140|FG001|Overall Study|Adverse Event|3|||
129807309|NCT00579098|467261139|FG000|Overall Study|Withdrawal by Subject|2|||
129807310|NCT00579098|467261140|FG001|Overall Study|Withdrawal by Subject|3|||
129807311|NCT00579098|467261139|FG000|Overall Study|AF returned after ablation|3|||
129807312|NCT00579098|467261140|FG001|Overall Study|AF returned after ablation|2|||
129807313|NCT02121522|467261145|FG000|Overall Study|Adverse Event|1|||
129894484|NCT00797225|467573443|FG007|Weeks 13 to 24|Sponsor Decision|0|||
129894485|NCT01928940|467573444|FG000|Overall Study|Adverse Event|0|||
129894486|NCT01928940|467573445|FG001|Overall Study|Adverse Event|1|||
129894487|NCT02954055|467573446|FG000|Overall Study|Did not initiate therapy|6|||
129894488|NCT02954055|467573447|FG001|Overall Study|Did not initiate therapy|1|||
129894489|NCT01352507|467573452|FG000|Treatment Period 1|Adverse Event|3|||
129894490|NCT01352507|467573453|FG001|Treatment Period 1|Adverse Event|0|||
129894491|NCT01352507|467573452|FG000|Treatment Period 1|Lost to Follow-up|3|||
129894492|NCT01352507|467573453|FG001|Treatment Period 1|Lost to Follow-up|4|||
129894493|NCT01352507|467573452|FG000|Treatment Period 1|Withdrawal by Subject|7|||
129894494|NCT01352507|467573453|FG001|Treatment Period 1|Withdrawal by Subject|5|||
129894495|NCT01352507|467573452|FG000|Treatment Period 1|Physician Decision|1|||
129894496|NCT01352507|467573453|FG001|Treatment Period 1|Physician Decision|0|||
129894497|NCT01352507|467573452|FG000|Washout Period|Withdrawal by Subject|0|||
129894498|NCT01352507|467573453|FG001|Washout Period|Withdrawal by Subject|1|||
129894499|NCT01352507|467573452|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
129894500|NCT01352507|467573453|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
129894501|NCT01352507|467573452|FG000|Treatment Period 2|Withdrawal by Subject|4|||
129894502|NCT01352507|467573453|FG001|Treatment Period 2|Withdrawal by Subject|3|||
129894503|NCT01352507|467573452|FG000|Treatment Period 2|Lack of Efficacy|1|||
129894504|NCT01352507|467573453|FG001|Treatment Period 2|Lack of Efficacy|0|||
129894505|NCT03686384|467573454|FG000|Overall Study|Lack of Efficacy|4|||
129894506|NCT03686384|467573455|FG001|Overall Study|Lack of Efficacy|13|||
129894507|NCT03686384|467573454|FG000|Overall Study|Lost to Follow-up|3|||
129894508|NCT03686384|467573455|FG001|Overall Study|Lost to Follow-up|0|||
129894509|NCT03686384|467573454|FG000|Overall Study|Physician Decision|0|||
129894510|NCT03686384|467573455|FG001|Overall Study|Physician Decision|1|||
129894511|NCT03686384|467573454|FG000|Overall Study|Took prohibited medication|0|||
129894512|NCT03686384|467573455|FG001|Overall Study|Took prohibited medication|1|||
129894513|NCT02820051|467573458|FG000|Overall Study|Lost to Follow-up|7|||
129894514|NCT02820051|467573459|FG001|Overall Study|Lost to Follow-up|4|||
129894515|NCT01222247|467573460|FG000|Overall Study|Lost to Follow-up|2|||
129894516|NCT01222247|467573461|FG001|Overall Study|Lost to Follow-up|2|||
129894517|NCT01767909|467573462|FG000|Overall Study|Withdrawal by Subject|4|||
129894518|NCT01767909|467573463|FG001|Overall Study|Withdrawal by Subject|7|||
129894519|NCT01767909|467573462|FG000|Overall Study|Adverse Event|3|||
129894520|NCT01767909|467573463|FG001|Overall Study|Adverse Event|1|||
129894521|NCT01767909|467573462|FG000|Overall Study|Withdrawal by Study Partner|3|||
129894522|NCT01767909|467573463|FG001|Overall Study|Withdrawal by Study Partner|1|||
129894523|NCT01767909|467573462|FG000|Overall Study|Non-Compliance|2|||
129894524|NCT01767909|467573463|FG001|Overall Study|Non-Compliance|0|||
129894525|NCT01767909|467573462|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129894526|NCT01767909|467573463|FG001|Overall Study|Perceived Lack of Efficacy|0|||
129894527|NCT01767909|467573462|FG000|Overall Study|Investigator Recommendation|0|||
129894528|NCT01767909|467573463|FG001|Overall Study|Investigator Recommendation|1|||
129894529|NCT01767909|467573462|FG000|Overall Study|Lost to Follow-up|0|||
129894530|NCT01767909|467573463|FG001|Overall Study|Lost to Follow-up|1|||
129894531|NCT01767909|467573462|FG000|Overall Study|LP uncessessful|0|||
129894532|NCT01767909|467573463|FG001|Overall Study|LP uncessessful|1|||
129894533|NCT04939428|467573464|FG000|Overall Study|Death|0|||
129894534|NCT04939428|467573465|FG001|Overall Study|Death|1|||
129894535|NCT04939428|467573466|FG002|Overall Study|Death|0|||
129894536|NCT04939428|467573464|FG000|Overall Study|Lost to Follow-up|0|||
129894537|NCT04939428|467573465|FG001|Overall Study|Lost to Follow-up|5|||
129894538|NCT04939428|467573466|FG002|Overall Study|Lost to Follow-up|0|||
129894539|NCT04939428|467573464|FG000|Overall Study|Physician Decision|1|||
129894540|NCT04939428|467573465|FG001|Overall Study|Physician Decision|0|||
129894541|NCT04939428|467573466|FG002|Overall Study|Physician Decision|0|||
129894542|NCT04939428|467573464|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129894543|NCT04939428|467573465|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129894544|NCT04939428|467573466|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129894545|NCT04939428|467573464|FG000|Overall Study|Withdrawal by Subject|10|||
129894546|NCT04939428|467573465|FG001|Overall Study|Withdrawal by Subject|11|||
129894547|NCT04939428|467573466|FG002|Overall Study|Withdrawal by Subject|0|||
129894548|NCT04939428|467573464|FG000|Overall Study|Unkown|6|||
129894549|NCT04939428|467573465|FG001|Overall Study|Unkown|3|||
129894550|NCT04939428|467573466|FG002|Overall Study|Unkown|0|||
129894551|NCT04939428|467573464|FG000|Overall Study|Discotinued per protocol|0|||
129894552|NCT04939428|467573465|FG001|Overall Study|Discotinued per protocol|0|||
129894553|NCT04939428|467573466|FG002|Overall Study|Discotinued per protocol|902|||
129894554|NCT04956692|467573469|FG000|Overall Study|Death|115|||
129894555|NCT04956692|467573470|FG001|Overall Study|Death|47|||
129894556|NCT04956692|467573469|FG000|Overall Study|Lost to Follow-up|0|||
129894557|NCT04956692|467573470|FG001|Overall Study|Lost to Follow-up|1|||
129894558|NCT04956692|467573469|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129894559|NCT04956692|467573470|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129894560|NCT04956692|467573469|FG000|Overall Study|Withdrawal by Subject|5|||
129894561|NCT04956692|467573470|FG001|Overall Study|Withdrawal by Subject|2|||
129894562|NCT04956692|467573469|FG000|Overall Study|Ongoing in Study|236|||
129894563|NCT04956692|467573470|FG001|Overall Study|Ongoing in Study|123|||
129894564|NCT04639947|467573471|FG000|Overall Study|Screen fail|1|||
129894565|NCT04863898|467573474|FG000|Overall Study|Away from study clinic during intervention training period|2|||
129894566|NCT04863898|467573474|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
129894567|NCT04863898|467573474|FG000|Overall Study|Lost to Follow-up|3|||
129894568|NCT04863898|467573474|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
129894569|NCT04863898|467573474|FG000|Overall Study|No longer employed at clinic|3|||
129894570|NCT00614744|467573475|FG000|Overall Study|Lost to Follow-up|5|||
129894571|NCT00614744|467573476|FG001|Overall Study|Lost to Follow-up|4|||
129894572|NCT00614744|467573475|FG000|Overall Study|Incomplete for Behavior Issues|0|||
129894573|NCT00614744|467573476|FG001|Overall Study|Incomplete for Behavior Issues|2|||
129894574|NCT00877851|467573477|FG000|Overall Study|Lost to Follow-up|5|||
129894575|NCT00877851|467573478|FG001|Overall Study|Lost to Follow-up|5|||
129894576|NCT00877851|467573477|FG000|Overall Study|computer problem|3|||
129894577|NCT00877851|467573478|FG001|Overall Study|computer problem|0|||
129894578|NCT00877851|467573477|FG000|Overall Study|no longer interested in participating|1|||
129894579|NCT00877851|467573478|FG001|Overall Study|no longer interested in participating|0|||
129894580|NCT00770211|467573486|FG000|Overall Study|Lost to Follow-up|1|||
129894581|NCT00770211|467573487|FG001|Overall Study|Lost to Follow-up|0|||
129894582|NCT00770211|467573486|FG000|Overall Study|Withdrawal by Subject|0|||
129894583|NCT00770211|467573487|FG001|Overall Study|Withdrawal by Subject|2|||
129894584|NCT03005288|467573491|FG000|Overall Study|Withdrawal by Subject|7|||
129894585|NCT03005288|467573492|FG001|Overall Study|Withdrawal by Subject|5|||
129894586|NCT03005288|467573491|FG000|Overall Study|Lost to Follow-up|0|||
129894587|NCT03005288|467573492|FG001|Overall Study|Lost to Follow-up|1|||
129894588|NCT03005288|467573491|FG000|Overall Study|Adverse Event|5|||
129894589|NCT03005288|467573492|FG001|Overall Study|Adverse Event|0|||
129894590|NCT03005288|467573491|FG000|Overall Study|Protocol deviation|0|||
129894591|NCT03005288|467573492|FG001|Overall Study|Protocol deviation|1|||
129894592|NCT03005288|467573491|FG000|Overall Study|Physician Decision|0|||
129894593|NCT03005288|467573492|FG001|Overall Study|Physician Decision|1|||
129894594|NCT03824236|467573493|FG000|Overall Study|Lost to Follow-up|0|||
129894595|NCT03824236|467573494|FG001|Overall Study|Lost to Follow-up|0|||
129894596|NCT03824236|467573495|FG002|Overall Study|Lost to Follow-up|1|||
129894597|NCT00701311|467573496|FG000|Overall Study|Lack of Efficacy|3|||
129894598|NCT00701311|467573496|FG000|Overall Study|Adverse Event|3|||
129894599|NCT00701311|467573496|FG000|Overall Study|Withdrawal by Subject|2|||
129894600|NCT01140347|467573497|FG000|Overall Study|Lost to Follow-up|5|||
129894601|NCT01140347|467573498|FG001|Overall Study|Lost to Follow-up|6|||
129894602|NCT01140347|467573497|FG000|Overall Study|Withdrawal by Subject|13|||
129894603|NCT01140347|467573498|FG001|Overall Study|Withdrawal by Subject|8|||
129894604|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
129894605|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
129894606|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
129894607|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
129894608|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
129894609|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
129894610|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
129894611|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
129894612|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
129894613|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
129894614|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
129894615|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
129894616|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
129894617|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
129894618|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
129894619|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
129894620|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
129894621|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
129894622|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
129894623|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
129894624|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
129894625|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
129894626|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
129894627|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
129894628|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
129894629|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
129894630|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
129894631|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
129894632|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
129894633|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
129894634|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
129894635|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
129894636|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
129894637|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
129894638|NCT00049517|467575142|FG000|Induction|Disease progression|0|||
129894639|NCT00049517|467575143|FG001|Induction|Disease progression|0|||
129894640|NCT00049517|467575144|FG002|Induction|Disease progression|0|||
129894641|NCT00049517|467575145|FG003|Induction|Disease progression|0|||
129894642|NCT00049517|467575146|FG004|Induction|Disease progression|18|||
129894643|NCT00049517|467575147|FG005|Induction|Disease progression|11|||
129894644|NCT00049517|467575142|FG000|Induction|Adverse Event|0|||
129894645|NCT00049517|467575143|FG001|Induction|Adverse Event|0|||
129894646|NCT00049517|467575144|FG002|Induction|Adverse Event|0|||
129894647|NCT00049517|467575145|FG003|Induction|Adverse Event|0|||
129894648|NCT00049517|467575146|FG004|Induction|Adverse Event|5|||
129894649|NCT00049517|467575147|FG005|Induction|Adverse Event|7|||
129894650|NCT00049517|467575142|FG000|Induction|Death|0|||
129894651|NCT00049517|467575143|FG001|Induction|Death|0|||
129894652|NCT00049517|467575144|FG002|Induction|Death|0|||
129894653|NCT00049517|467575145|FG003|Induction|Death|0|||
129894654|NCT00049517|467575146|FG004|Induction|Death|9|||
129894655|NCT00049517|467575147|FG005|Induction|Death|6|||
129894656|NCT00049517|467575142|FG000|Induction|Withdrawal by Subject|0|||
129894657|NCT00049517|467575143|FG001|Induction|Withdrawal by Subject|0|||
129894658|NCT00049517|467575144|FG002|Induction|Withdrawal by Subject|0|||
129894659|NCT00049517|467575145|FG003|Induction|Withdrawal by Subject|0|||
129894660|NCT00049517|467575146|FG004|Induction|Withdrawal by Subject|1|||
129894661|NCT00049517|467575147|FG005|Induction|Withdrawal by Subject|3|||
129894662|NCT00049517|467575142|FG000|Induction|Alternative therapy|0|||
129894663|NCT00049517|467575143|FG001|Induction|Alternative therapy|0|||
129894664|NCT00049517|467575144|FG002|Induction|Alternative therapy|0|||
129894665|NCT00049517|467575145|FG003|Induction|Alternative therapy|0|||
129894666|NCT00049517|467575146|FG004|Induction|Alternative therapy|2|||
129894667|NCT00049517|467575147|FG005|Induction|Alternative therapy|2|||
129894668|NCT00049517|467575142|FG000|Induction|Other complicating disease|0|||
129894669|NCT00049517|467575143|FG001|Induction|Other complicating disease|0|||
129894670|NCT00049517|467575144|FG002|Induction|Other complicating disease|0|||
129894671|NCT00049517|467575145|FG003|Induction|Other complicating disease|0|||
129894672|NCT00049517|467575146|FG004|Induction|Other complicating disease|3|||
129894673|NCT00049517|467575147|FG005|Induction|Other complicating disease|0|||
129894674|NCT00049517|467575142|FG000|Induction|Reasons not reported|0|||
129894675|NCT00049517|467575143|FG001|Induction|Reasons not reported|0|||
129894676|NCT00049517|467575144|FG002|Induction|Reasons not reported|0|||
129894677|NCT00049517|467575145|FG003|Induction|Reasons not reported|0|||
129894678|NCT00049517|467575146|FG004|Induction|Reasons not reported|22|||
129894679|NCT00049517|467575147|FG005|Induction|Reasons not reported|25|||
129807314|NCT00338104|467261148|FG000|Overall Study|Protocol Violation|2|||
129807315|NCT00338104|467261149|FG001|Overall Study|Protocol Violation|1|||
129807316|NCT00338104|467261150|FG002|Overall Study|Protocol Violation|3|||
129807317|NCT00633750|467261151|FG000|Overall Study|Adverse Event|2|||
129807318|NCT00633750|467261151|FG000|Overall Study|Withdrawal by Subject|3|||
129894680|NCT00049517|467575142|FG000|Conditioning/Transplant|Disease progression|14|||
129894681|NCT00049517|467575143|FG001|Conditioning/Transplant|Disease progression|6|||
129894682|NCT00049517|467575144|FG002|Conditioning/Transplant|Disease progression|10|||
129894683|NCT00049517|467575145|FG003|Conditioning/Transplant|Disease progression|6|||
129894684|NCT00049517|467575146|FG004|Conditioning/Transplant|Disease progression|0|||
129894685|NCT00049517|467575147|FG005|Conditioning/Transplant|Disease progression|0|||
129894686|NCT00049517|467575142|FG000|Conditioning/Transplant|Adverse Event|2|||
129894687|NCT00049517|467575143|FG001|Conditioning/Transplant|Adverse Event|1|||
129894688|NCT00049517|467575144|FG002|Conditioning/Transplant|Adverse Event|4|||
129894689|NCT00049517|467575145|FG003|Conditioning/Transplant|Adverse Event|8|||
130058110|NCT00568958|468168036|FG000|Allocation|Withdrawal by Subject|7|||
130058111|NCT00568958|468168037|FG001|Allocation|Withdrawal by Subject|3|||
129894690|NCT00049517|467575146|FG004|Conditioning/Transplant|Adverse Event|0|||
129894691|NCT00049517|467575147|FG005|Conditioning/Transplant|Adverse Event|0|||
129894692|NCT00049517|467575142|FG000|Conditioning/Transplant|Death|1|||
129894693|NCT00049517|467575143|FG001|Conditioning/Transplant|Death|0|||
129894694|NCT00049517|467575144|FG002|Conditioning/Transplant|Death|0|||
129894695|NCT00049517|467575145|FG003|Conditioning/Transplant|Death|2|||
129894696|NCT00049517|467575146|FG004|Conditioning/Transplant|Death|0|||
129894697|NCT00049517|467575147|FG005|Conditioning/Transplant|Death|0|||
129894698|NCT00049517|467575142|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
129894699|NCT00049517|467575143|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
129894700|NCT00049517|467575144|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
129894701|NCT00049517|467575145|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
129894702|NCT00049517|467575146|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
129894703|NCT00049517|467575147|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
129894704|NCT00049517|467575142|FG000|Conditioning/Transplant|Alternative therapy|4|||
129894705|NCT00049517|467575143|FG001|Conditioning/Transplant|Alternative therapy|4|||
129894706|NCT00049517|467575144|FG002|Conditioning/Transplant|Alternative therapy|2|||
129894707|NCT00049517|467575145|FG003|Conditioning/Transplant|Alternative therapy|1|||
129894708|NCT00049517|467575146|FG004|Conditioning/Transplant|Alternative therapy|1|||
129894709|NCT00049517|467575147|FG005|Conditioning/Transplant|Alternative therapy|0|||
129894710|NCT00049517|467575142|FG000|Conditioning/Transplant|Other complicating disease|2|||
129894711|NCT00049517|467575143|FG001|Conditioning/Transplant|Other complicating disease|0|||
129894712|NCT00049517|467575144|FG002|Conditioning/Transplant|Other complicating disease|0|||
129894713|NCT00049517|467575145|FG003|Conditioning/Transplant|Other complicating disease|4|||
129894714|NCT00049517|467575146|FG004|Conditioning/Transplant|Other complicating disease|0|||
129894715|NCT00049517|467575147|FG005|Conditioning/Transplant|Other complicating disease|1|||
129894716|NCT00049517|467575142|FG000|Conditioning/Transplant|Reasons not reported|25|||
129894717|NCT00049517|467575143|FG001|Conditioning/Transplant|Reasons not reported|31|||
129894718|NCT00049517|467575144|FG002|Conditioning/Transplant|Reasons not reported|18|||
129894719|NCT00049517|467575145|FG003|Conditioning/Transplant|Reasons not reported|15|||
129894720|NCT00049517|467575146|FG004|Conditioning/Transplant|Reasons not reported|5|||
129894721|NCT00049517|467575147|FG005|Conditioning/Transplant|Reasons not reported|5|||
129894722|NCT01211665|467575150|FG000|Overall Study|Withdrawal by Subject|1|||
129894723|NCT01211665|467575151|FG001|Overall Study|Withdrawal by Subject|0|||
129894724|NCT01211665|467575150|FG000|Overall Study|Death|1|||
129894725|NCT01211665|467575151|FG001|Overall Study|Death|0|||
129894726|NCT01390857|467575154|FG000|Overall Study|Protocol Violation|2|||
129894727|NCT01390857|467575154|FG000|Overall Study|Lost to Follow-up|1|||
129894728|NCT01390857|467575154|FG000|Overall Study|No Visit after the First Visit|7|||
129894729|NCT01123161|467575155|FG000|Overall Study|Lost to Follow-up|1|||
129894730|NCT01123161|467575156|FG001|Overall Study|Lost to Follow-up|0|||
129894731|NCT01123161|467575155|FG000|Overall Study|Withdrawal by Subject|1|||
129894732|NCT01123161|467575156|FG001|Overall Study|Withdrawal by Subject|0|||
129894733|NCT04541186|467575163|FG000|Main Study|Adverse Event|0|||
129894734|NCT04541186|467575164|FG001|Main Study|Adverse Event|0|||
129894735|NCT04541186|467575165|FG002|Main Study|Adverse Event|4|||
129894736|NCT04541186|467575166|FG003|Main Study|Adverse Event|0|||
129894737|NCT04541186|467575167|FG004|Main Study|Adverse Event|0|||
129894738|NCT04541186|467575163|FG000|Main Study|Investigator Decision|0|||
129894739|NCT04541186|467575164|FG001|Main Study|Investigator Decision|0|||
129894740|NCT04541186|467575165|FG002|Main Study|Investigator Decision|1|||
129894741|NCT04541186|467575166|FG003|Main Study|Investigator Decision|1|||
129894742|NCT04541186|467575167|FG004|Main Study|Investigator Decision|0|||
129894743|NCT04541186|467575163|FG000|Main Study|Withdrawal by Subject|1|||
129894744|NCT04541186|467575164|FG001|Main Study|Withdrawal by Subject|1|||
129894745|NCT04541186|467575165|FG002|Main Study|Withdrawal by Subject|0|||
129894746|NCT04541186|467575166|FG003|Main Study|Withdrawal by Subject|0|||
129894747|NCT04541186|467575167|FG004|Main Study|Withdrawal by Subject|0|||
129894748|NCT04541186|467575163|FG000|Main Study|COVID-19-related Dose Interruption|0|||
129894749|NCT04541186|467575164|FG001|Main Study|COVID-19-related Dose Interruption|0|||
129894750|NCT04541186|467575165|FG002|Main Study|COVID-19-related Dose Interruption|0|||
129894751|NCT04541186|467575166|FG003|Main Study|COVID-19-related Dose Interruption|0|||
129894752|NCT04541186|467575167|FG004|Main Study|COVID-19-related Dose Interruption|1|||
129894753|NCT04541186|467575163|FG000|Main Study|Randomized in Error Not Treated|0|||
129894754|NCT04541186|467575164|FG001|Main Study|Randomized in Error Not Treated|0|||
129894755|NCT04541186|467575165|FG002|Main Study|Randomized in Error Not Treated|1|||
129894756|NCT04541186|467575166|FG003|Main Study|Randomized in Error Not Treated|0|||
129894757|NCT04541186|467575167|FG004|Main Study|Randomized in Error Not Treated|0|||
129894758|NCT04541186|467575163|FG000|Fibrate Expansion Study|Other than Specified|0|||
129894759|NCT04541186|467575164|FG001|Fibrate Expansion Study|Other than Specified|0|||
129894760|NCT04541186|467575165|FG002|Fibrate Expansion Study|Other than Specified|0|||
129894761|NCT04541186|467575166|FG003|Fibrate Expansion Study|Other than Specified|0|||
129894762|NCT04541186|467575167|FG004|Fibrate Expansion Study|Other than Specified|1|||
129894763|NCT00691028|467575168|FG000|Open-label Period|Adverse Event|0|||
129894764|NCT00691028|467575169|FG001|Open-label Period|Adverse Event|0|||
129894765|NCT00691028|467575170|FG002|Open-label Period|Adverse Event|0|||
129894766|NCT00691028|467575171|FG003|Open-label Period|Adverse Event|16|||
129894767|NCT00691028|467575168|FG000|Open-label Period|Withdrawal by Subject|0|||
129894768|NCT00691028|467575169|FG001|Open-label Period|Withdrawal by Subject|0|||
129894769|NCT00691028|467575170|FG002|Open-label Period|Withdrawal by Subject|0|||
129894770|NCT00691028|467575171|FG003|Open-label Period|Withdrawal by Subject|3|||
129894771|NCT00691028|467575168|FG000|Open-label Period|not come to a hospital|0|||
129894772|NCT00691028|467575169|FG001|Open-label Period|not come to a hospital|0|||
129894773|NCT00691028|467575170|FG002|Open-label Period|not come to a hospital|0|||
129894774|NCT00691028|467575171|FG003|Open-label Period|not come to a hospital|1|||
129894775|NCT00691028|467575168|FG000|Double-blind Period|Adverse Event|8|||
129894776|NCT00691028|467575169|FG001|Double-blind Period|Adverse Event|9|||
129894777|NCT00691028|467575170|FG002|Double-blind Period|Adverse Event|6|||
129894778|NCT00691028|467575171|FG003|Double-blind Period|Adverse Event|0|||
129894779|NCT00691028|467575168|FG000|Double-blind Period|Lack of Efficacy|4|||
129894780|NCT00691028|467575169|FG001|Double-blind Period|Lack of Efficacy|3|||
129894781|NCT00691028|467575170|FG002|Double-blind Period|Lack of Efficacy|2|||
129894782|NCT00691028|467575171|FG003|Double-blind Period|Lack of Efficacy|0|||
129894783|NCT00691028|467575168|FG000|Double-blind Period|Withdrawal by Subject|1|||
129894784|NCT00691028|467575169|FG001|Double-blind Period|Withdrawal by Subject|0|||
129894785|NCT00691028|467575170|FG002|Double-blind Period|Withdrawal by Subject|1|||
129894786|NCT00691028|467575171|FG003|Double-blind Period|Withdrawal by Subject|0|||
129894787|NCT00691028|467575168|FG000|Double-blind Period|not come to a hospital.|0|||
129894788|NCT00691028|467575169|FG001|Double-blind Period|not come to a hospital.|1|||
129894789|NCT00691028|467575170|FG002|Double-blind Period|not come to a hospital.|0|||
129894790|NCT00691028|467575171|FG003|Double-blind Period|not come to a hospital.|0|||
129894791|NCT00058058|467575179|FG000|Overall Study|Withdrawal by Subject|4|||
129894792|NCT00058058|467575179|FG000|Overall Study|Ineligible|20|||
129894793|NCT00058058|467575179|FG000|Overall Study|Claustrophobic|5|||
129894794|NCT00058058|467575179|FG000|Overall Study|technical issues|6|||
129894795|NCT00058058|467575179|FG000|Overall Study|Poor positioning, illness,pain|3|||
129894796|NCT03085017|467575180|FG000|Overall Study|Death|0|||
129894797|NCT03085017|467575181|FG001|Overall Study|Death|3|||
129894798|NCT03255018|467575185|FG000|Overall Study|Death on study|0|||
129894799|NCT03255018|467575186|FG001|Overall Study|Death on study|5|||
129894800|NCT03255018|467575185|FG000|Overall Study|Withdrawal by Subject|0|||
129894801|NCT03255018|467575186|FG001|Overall Study|Withdrawal by Subject|2|||
129894802|NCT03681691|467575190|FG000|Overall Study|COVID|1|||
129894803|NCT03681691|467575191|FG001|Overall Study|COVID|0|||
129894804|NCT03681691|467575190|FG000|Overall Study|prolonged bleeding|1|||
129894805|NCT03681691|467575191|FG001|Overall Study|prolonged bleeding|0|||
129894806|NCT03681691|467575190|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
129894807|NCT03681691|467575191|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
129894808|NCT00748969|467575192|FG000|Overall Study|Withdrawal by Subject|1|||
129894809|NCT00748969|467575193|FG001|Overall Study|Withdrawal by Subject|0|||
129894810|NCT00748969|467575192|FG000|Overall Study|Withdrawal by Subject|0|||
129894811|NCT00748969|467575193|FG001|Overall Study|Withdrawal by Subject|1|||
129894812|NCT03613129|467575194|FG000|Pre-treatment Assessment|Protocol Violation|2|||
129894813|NCT03613129|467575195|FG001|Pre-treatment Assessment|Protocol Violation|0|||
129894814|NCT03613129|467575196|FG002|Pre-treatment Assessment|Protocol Violation|0|||
129894815|NCT03613129|467575197|FG003|Pre-treatment Assessment|Protocol Violation|0|||
129894816|NCT03613129|467575198|FG004|Pre-treatment Assessment|Protocol Violation|0|||
129894817|NCT03613129|467575194|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
129894818|NCT03613129|467575195|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894819|NCT03613129|467575196|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894820|NCT03613129|467575197|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894821|NCT03613129|467575198|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894822|NCT02334306|467575199|FG000|Double-blind Period|Adverse Event|0|||
129894823|NCT02334306|467575200|FG001|Double-blind Period|Adverse Event|1|||
129894824|NCT02334306|467575199|FG000|Double-blind Period|Withdrawal by Subject|1|||
129894825|NCT02334306|467575200|FG001|Double-blind Period|Withdrawal by Subject|1|||
129894826|NCT00465985|467575201|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
129894827|NCT00465985|467575202|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
129894828|NCT00465985|467575201|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
129894829|NCT00465985|467575202|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
129894830|NCT00465985|467575201|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
129894831|NCT00465985|467575202|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
129894832|NCT00465985|467575201|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
129894833|NCT00465985|467575202|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
129894834|NCT03532178|467575203|FG000|First Period|Withdrawal by Subject|1|||
129894835|NCT03532178|467575204|FG001|First Period|Withdrawal by Subject|3|||
129894836|NCT03532178|467575203|FG000|First Period|technical issues in data collection Technical issues|0|||
129894837|NCT03532178|467575204|FG001|First Period|technical issues in data collection Technical issues|1|||
129894838|NCT03532178|467575203|FG000|Second Period|Withdrawal by Subject|1|||
129894839|NCT03532178|467575204|FG001|Second Period|Withdrawal by Subject|1|||
129894840|NCT03532178|467575203|FG000|Second Period|Technical issues|0|||
129894841|NCT03532178|467575204|FG001|Second Period|Technical issues|1|||
129894842|NCT03302156|467575205|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
129894843|NCT03302156|467575206|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
129894844|NCT03302156|467575207|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
129894845|NCT02390557|467575208|FG000|Wave 2|Survey non-respondent|72|||
129894846|NCT02390557|467575209|FG001|Wave 2|Survey non-respondent|41|||
129894847|NCT02390557|467575210|FG002|Wave 2|Survey non-respondent|23|||
129894848|NCT03278028|467575214|FG000|Overall Study|Lost to Follow-up|1|||
129894849|NCT03278028|467575215|FG001|Overall Study|Lost to Follow-up|0|||
129894850|NCT03278028|467575214|FG000|Overall Study|Withdrawal by Subject|3|||
129894851|NCT03278028|467575215|FG001|Overall Study|Withdrawal by Subject|1|||
129894852|NCT03278028|467575214|FG000|Overall Study|Pregnancy|0|||
129894853|NCT03278028|467575215|FG001|Overall Study|Pregnancy|1|||
129894854|NCT01360840|467575216|FG000|Overall Study|Ongoing at data cut-off|10|||
129894855|NCT01360840|467575217|FG001|Overall Study|Ongoing at data cut-off|10|||
129894856|NCT01360840|467575218|FG002|Overall Study|Ongoing at data cut-off|9|||
129894857|NCT01813422|467575220|FG000|Overall Study|Withdrawal by Subject|14|||
129894858|NCT01813422|467575221|FG001|Overall Study|Withdrawal by Subject|8|||
129894859|NCT01813422|467575220|FG000|Overall Study|Death|2|||
129894860|NCT01813422|467575221|FG001|Overall Study|Death|3|||
129894861|NCT01813422|467575220|FG000|Overall Study|Sponsor Decision|2|||
129894862|NCT01813422|467575221|FG001|Overall Study|Sponsor Decision|1|||
129894863|NCT01813422|467575220|FG000|Overall Study|Lost to Follow-up|2|||
129894864|NCT01813422|467575221|FG001|Overall Study|Lost to Follow-up|4|||
129894865|NCT01653743|467575222|FG000|Overall Study|Withdrawal by Subject|1|||
129894866|NCT01653743|467575223|FG001|Overall Study|Withdrawal by Subject|0|||
129894867|NCT01653743|467575222|FG000|Overall Study|Investigator discretion|3|||
129894868|NCT01653743|467575223|FG001|Overall Study|Investigator discretion|0|||
129894869|NCT04889118|467575224|FG000|Overall Study|Death|33|||
129894870|NCT04889118|467575225|FG001|Overall Study|Death|37|||
129894871|NCT04889118|467575224|FG000|Overall Study|Ongoing in Study|31|||
129894872|NCT04889118|467575225|FG001|Overall Study|Ongoing in Study|30|||
129894873|NCT01582243|467575234|FG000|Overall Study|Withdrawal by Subject|1|||
129894874|NCT01582243|467575234|FG000|Overall Study|Adverse Event|1|||
129894875|NCT01582243|467575234|FG000|Overall Study|Lost to Follow-up|1|||
129894876|NCT01119703|467575235|FG000|Overall Study|Adverse Event|0|||
129894877|NCT01119703|467575236|FG001|Overall Study|Adverse Event|1|||
129894878|NCT03178201|467575237|FG000|Overall Study|Off study|5|||
129894879|NCT01763047|467575238|FG000|Period 1|Test Article Not Available|4|||
129894880|NCT01763047|467575239|FG001|Period 1|Test Article Not Available|1|||
129894881|NCT01763047|467575238|FG000|Period 1|Protocol Violation|4|||
129894882|NCT01763047|467575239|FG001|Period 1|Protocol Violation|4|||
129894883|NCT01763047|467575238|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
129894884|NCT01763047|467575239|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
129894885|NCT01763047|467575238|FG000|Period 1|Adverse Event|0|||
129894886|NCT01763047|467575239|FG001|Period 1|Adverse Event|1|||
129894887|NCT01763047|467575238|FG000|Period 1|Unsatisfactory Visual Response|0|||
129894888|NCT01763047|467575239|FG001|Period 1|Unsatisfactory Visual Response|3|||
129894889|NCT01763047|467575238|FG000|Period 1|Lens Power Not Available|0|||
129894890|NCT01763047|467575239|FG001|Period 1|Lens Power Not Available|1|||
129894891|NCT01763047|467575238|FG000|Period 1|Study Site office Closed|0|||
129894892|NCT01763047|467575239|FG001|Period 1|Study Site office Closed|1|||
129894893|NCT01763047|467575238|FG000|Period 2|Lens Discomfort|1|||
129894894|NCT01763047|467575239|FG001|Period 2|Lens Discomfort|0|||
129894895|NCT01763047|467575238|FG000|Period 2|No longer meets Eligibility Criteria|1|||
129894896|NCT01763047|467575239|FG001|Period 2|No longer meets Eligibility Criteria|0|||
129894897|NCT01763047|467575238|FG000|Period 2|Study Site office Closed|1|||
129894898|NCT01763047|467575239|FG001|Period 2|Study Site office Closed|1|||
129894899|NCT01763047|467575238|FG000|Period 2|Unsatisfactory Visual Response|1|||
130058112|NCT00568958|468168036|FG000|Allocation|Physician Decision|2|||
130058113|NCT00568958|468168037|FG001|Allocation|Physician Decision|0|||
130058114|NCT00568958|468168036|FG000|Follow-Up|Withdrawal by Subject|6|||
130058115|NCT00568958|468168037|FG001|Follow-Up|Withdrawal by Subject|6|||
130058116|NCT00568958|468168036|FG000|Follow-Up|Physician Decision|1|||
130058117|NCT00568958|468168037|FG001|Follow-Up|Physician Decision|1|||
130058118|NCT00568958|468168036|FG000|Follow-Up|Family Emergency|1|||
130058119|NCT00568958|468168037|FG001|Follow-Up|Family Emergency|0|||
129894900|NCT01763047|467575239|FG001|Period 2|Unsatisfactory Visual Response|1|||
129894901|NCT01763047|467575238|FG000|Period 2|Protocol Violation|0|||
130058120|NCT00568958|468168036|FG000|Follow-Up|Adverse Event|1|||
129894902|NCT01763047|467575239|FG001|Period 2|Protocol Violation|2|||
129894903|NCT01763047|467575238|FG000|Period 2|Unsatisfactory lens Fitting|0|||
129894904|NCT01763047|467575239|FG001|Period 2|Unsatisfactory lens Fitting|1|||
129894905|NCT02282527|467575243|FG000|Overall Study|Lost to Follow-up|0|||
129894906|NCT02282527|467575244|FG001|Overall Study|Lost to Follow-up|1|||
129894907|NCT02282527|467575243|FG000|Overall Study|Lack of home health aid|1|||
129894908|NCT02282527|467575244|FG001|Overall Study|Lack of home health aid|0|||
129894909|NCT00941031|467575245|FG000|Induction Period|Lack of Efficacy|2|||
129894910|NCT00941031|467575246|FG001|Induction Period|Lack of Efficacy|1|||
129894911|NCT00941031|467575247|FG002|Induction Period|Lack of Efficacy|0|||
129894912|NCT00941031|467575248|FG003|Induction Period|Lack of Efficacy|5|||
129894913|NCT00941031|467575249|FG004|Induction Period|Lack of Efficacy|0|||
129894914|NCT00941031|467575250|FG005|Induction Period|Lack of Efficacy|0|||
129894915|NCT00941031|467575251|FG006|Induction Period|Lack of Efficacy|0|||
129894916|NCT00941031|467575245|FG000|Induction Period|Withdrawal by Subject|1|||
129894917|NCT00941031|467575246|FG001|Induction Period|Withdrawal by Subject|2|||
129894918|NCT00941031|467575247|FG002|Induction Period|Withdrawal by Subject|2|||
129894919|NCT00941031|467575248|FG003|Induction Period|Withdrawal by Subject|2|||
129894920|NCT00941031|467575249|FG004|Induction Period|Withdrawal by Subject|0|||
129894921|NCT00941031|467575250|FG005|Induction Period|Withdrawal by Subject|0|||
129894922|NCT00941031|467575251|FG006|Induction Period|Withdrawal by Subject|0|||
129894923|NCT00941031|467575245|FG000|Induction Period|Adminstative Problems|1|||
129894924|NCT00941031|467575246|FG001|Induction Period|Adminstative Problems|1|||
129894925|NCT00941031|467575247|FG002|Induction Period|Adminstative Problems|1|||
129894926|NCT00941031|467575248|FG003|Induction Period|Adminstative Problems|0|||
129894927|NCT00941031|467575249|FG004|Induction Period|Adminstative Problems|0|||
129894928|NCT00941031|467575250|FG005|Induction Period|Adminstative Problems|0|||
129894929|NCT00941031|467575251|FG006|Induction Period|Adminstative Problems|0|||
129894930|NCT00941031|467575245|FG000|Induction Period|Adverse Event|1|||
130058121|NCT00568958|468168037|FG001|Follow-Up|Adverse Event|0|||
130058122|NCT02796391|468168041|FG000|Overall Study|Lost to Follow-up|2|||
130058123|NCT02796391|468168042|FG001|Overall Study|Lost to Follow-up|2|||
130058124|NCT02796391|468168043|FG002|Overall Study|Lost to Follow-up|13|||
130058125|NCT02796391|468168044|FG003|Overall Study|Lost to Follow-up|8|||
130058126|NCT02796391|468168045|FG004|Overall Study|Lost to Follow-up|14|||
130058127|NCT02796391|468168046|FG005|Overall Study|Lost to Follow-up|13|||
130058128|NCT02796391|468168041|FG000|Overall Study|COVID|0|||
129894931|NCT00941031|467575246|FG001|Induction Period|Adverse Event|0|||
129894932|NCT00941031|467575247|FG002|Induction Period|Adverse Event|3|||
129894933|NCT00941031|467575248|FG003|Induction Period|Adverse Event|2|||
129894934|NCT00941031|467575249|FG004|Induction Period|Adverse Event|0|||
129894935|NCT00941031|467575250|FG005|Induction Period|Adverse Event|0|||
129894936|NCT00941031|467575251|FG006|Induction Period|Adverse Event|0|||
129894937|NCT00941031|467575245|FG000|Maintenance Period|Withdrawal by Subject|0|||
129894938|NCT00941031|467575246|FG001|Maintenance Period|Withdrawal by Subject|0|||
129894939|NCT00941031|467575247|FG002|Maintenance Period|Withdrawal by Subject|0|||
129894940|NCT00941031|467575248|FG003|Maintenance Period|Withdrawal by Subject|0|||
129894941|NCT00941031|467575249|FG004|Maintenance Period|Withdrawal by Subject|6|||
129894942|NCT00941031|467575250|FG005|Maintenance Period|Withdrawal by Subject|2|||
129894943|NCT00941031|467575251|FG006|Maintenance Period|Withdrawal by Subject|13|||
129894944|NCT00941031|467575245|FG000|Maintenance Period|Administrative Problems|0|||
129894945|NCT00941031|467575246|FG001|Maintenance Period|Administrative Problems|0|||
129894946|NCT00941031|467575247|FG002|Maintenance Period|Administrative Problems|0|||
129894947|NCT00941031|467575248|FG003|Maintenance Period|Administrative Problems|0|||
129894948|NCT00941031|467575249|FG004|Maintenance Period|Administrative Problems|1|||
129894949|NCT00941031|467575250|FG005|Maintenance Period|Administrative Problems|0|||
129894950|NCT00941031|467575251|FG006|Maintenance Period|Administrative Problems|1|||
129894951|NCT00941031|467575245|FG000|Maintenance Period|Protocol Violation|0|||
129894952|NCT00941031|467575246|FG001|Maintenance Period|Protocol Violation|0|||
129894953|NCT00941031|467575247|FG002|Maintenance Period|Protocol Violation|0|||
129894954|NCT00941031|467575248|FG003|Maintenance Period|Protocol Violation|0|||
129894955|NCT00941031|467575249|FG004|Maintenance Period|Protocol Violation|0|||
129894956|NCT00941031|467575250|FG005|Maintenance Period|Protocol Violation|0|||
129894957|NCT00941031|467575251|FG006|Maintenance Period|Protocol Violation|1|||
129894958|NCT00941031|467575245|FG000|Maintenance Period|Adverse Event|0|||
129894959|NCT00941031|467575246|FG001|Maintenance Period|Adverse Event|0|||
129894960|NCT00941031|467575247|FG002|Maintenance Period|Adverse Event|0|||
130058129|NCT02796391|468168042|FG001|Overall Study|COVID|0|||
130058130|NCT02796391|468168043|FG002|Overall Study|COVID|5|||
130058131|NCT02796391|468168044|FG003|Overall Study|COVID|5|||
130058132|NCT02796391|468168045|FG004|Overall Study|COVID|2|||
130058133|NCT02796391|468168046|FG005|Overall Study|COVID|4|||
130058134|NCT02796391|468168041|FG000|Overall Study|Participant did not like study cigarettes|0|||
130058135|NCT02796391|468168042|FG001|Overall Study|Participant did not like study cigarettes|0|||
130112306|NCT01571635|468371129|FG004|Overall Study|Withdrew consent|0|||
129894961|NCT00941031|467575248|FG003|Maintenance Period|Adverse Event|0|||
129894962|NCT00941031|467575249|FG004|Maintenance Period|Adverse Event|0|||
129894963|NCT00941031|467575250|FG005|Maintenance Period|Adverse Event|2|||
129894964|NCT00941031|467575251|FG006|Maintenance Period|Adverse Event|8|||
129894965|NCT00941031|467575245|FG000|Maintenance Period|Lost to Follow-up|0|||
129894966|NCT00941031|467575246|FG001|Maintenance Period|Lost to Follow-up|0|||
130058136|NCT02796391|468168043|FG002|Overall Study|Participant did not like study cigarettes|3|||
129894967|NCT00941031|467575247|FG002|Maintenance Period|Lost to Follow-up|0|||
129894968|NCT00941031|467575248|FG003|Maintenance Period|Lost to Follow-up|0|||
129894969|NCT00941031|467575249|FG004|Maintenance Period|Lost to Follow-up|2|||
129894970|NCT00941031|467575250|FG005|Maintenance Period|Lost to Follow-up|2|||
129894971|NCT00941031|467575251|FG006|Maintenance Period|Lost to Follow-up|7|||
129894972|NCT00941031|467575245|FG000|Maintenance Period|Lack of Efficacy|0|||
129894973|NCT00941031|467575246|FG001|Maintenance Period|Lack of Efficacy|0|||
129894974|NCT00941031|467575247|FG002|Maintenance Period|Lack of Efficacy|0|||
129894975|NCT00941031|467575248|FG003|Maintenance Period|Lack of Efficacy|0|||
129894976|NCT00941031|467575249|FG004|Maintenance Period|Lack of Efficacy|0|||
129894977|NCT00941031|467575250|FG005|Maintenance Period|Lack of Efficacy|0|||
129894978|NCT00941031|467575251|FG006|Maintenance Period|Lack of Efficacy|13|||
129894979|NCT01872611|467575252|FG000|Overall Study|Adverse Event|3|||
129894980|NCT01872611|467575253|FG001|Overall Study|Adverse Event|1|||
129894981|NCT01872611|467575252|FG000|Overall Study|Adverse Event, prior to treatment|0|||
129894982|NCT01872611|467575253|FG001|Overall Study|Adverse Event, prior to treatment|1|||
129894983|NCT01872611|467575252|FG000|Overall Study|Death|0|||
129894984|NCT01872611|467575253|FG001|Overall Study|Death|1|||
129894985|NCT01872611|467575252|FG000|Overall Study|Death, prior to treatment|0|||
129894986|NCT01872611|467575253|FG001|Overall Study|Death, prior to treatment|1|||
129894987|NCT01872611|467575252|FG000|Overall Study|Lost to Follow-up|8|||
129894988|NCT01872611|467575253|FG001|Overall Study|Lost to Follow-up|1|||
129894989|NCT01872611|467575252|FG000|Overall Study|Physician Decision|1|||
129894990|NCT01872611|467575253|FG001|Overall Study|Physician Decision|0|||
129894991|NCT01872611|467575252|FG000|Overall Study|Withdrawal by Subject|6|||
129894992|NCT01872611|467575253|FG001|Overall Study|Withdrawal by Subject|1|||
129894993|NCT01872611|467575252|FG000|Overall Study|Reason not provided|6|||
129894994|NCT01872611|467575253|FG001|Overall Study|Reason not provided|6|||
129894995|NCT03124108|467575254|FG000|Overall Study|Adverse Event|0|||
129894996|NCT03124108|467575255|FG001|Overall Study|Adverse Event|1|||
129894997|NCT03124108|467575256|FG002|Overall Study|Adverse Event|0|||
129894998|NCT00631917|467575257|FG000|Overall Study|Adverse Event|34|||
129894999|NCT00631917|467575258|FG001|Overall Study|Adverse Event|45|||
129895000|NCT00631917|467575257|FG000|Overall Study|Abnormal laboratory value(s)|2|||
129895001|NCT00631917|467575258|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129895002|NCT00631917|467575257|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129895003|NCT00631917|467575258|FG001|Overall Study|Abnormal test procedure result(s)|2|||
129895004|NCT00631917|467575257|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
129895005|NCT00631917|467575258|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
129895006|NCT00631917|467575257|FG000|Overall Study|No longer required study drug|0|||
129895007|NCT00631917|467575258|FG001|Overall Study|No longer required study drug|1|||
129895008|NCT00631917|467575257|FG000|Overall Study|Protocol deviation|6|||
129895009|NCT00631917|467575258|FG001|Overall Study|Protocol deviation|5|||
129895010|NCT00631917|467575257|FG000|Overall Study|Subject withdrew consent|25|||
129895011|NCT00631917|467575258|FG001|Overall Study|Subject withdrew consent|33|||
129895012|NCT00631917|467575257|FG000|Overall Study|Lost to Follow-up|7|||
129895013|NCT00631917|467575258|FG001|Overall Study|Lost to Follow-up|7|||
129895014|NCT00631917|467575257|FG000|Overall Study|Administrative problems|2|||
129895015|NCT00631917|467575258|FG001|Overall Study|Administrative problems|0|||
129895016|NCT00631917|467575257|FG000|Overall Study|Death|1|||
129895017|NCT00631917|467575258|FG001|Overall Study|Death|0|||
129895018|NCT05650333|467575259|FG000|Treatment Period (7 Days)|Adverse Event|1|||
130058137|NCT02796391|468168044|FG003|Overall Study|Participant did not like study cigarettes|0|||
130058138|NCT02796391|468168045|FG004|Overall Study|Participant did not like study cigarettes|0|||
130058139|NCT02796391|468168046|FG005|Overall Study|Participant did not like study cigarettes|0|||
130058140|NCT02796391|468168041|FG000|Overall Study|Withdrawal by Subject|1|||
130058141|NCT02796391|468168042|FG001|Overall Study|Withdrawal by Subject|1|||
130058142|NCT02796391|468168043|FG002|Overall Study|Withdrawal by Subject|4|||
130058143|NCT02796391|468168044|FG003|Overall Study|Withdrawal by Subject|3|||
130058144|NCT02796391|468168045|FG004|Overall Study|Withdrawal by Subject|4|||
129895019|NCT02616263|467575260|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
130058145|NCT02796391|468168046|FG005|Overall Study|Withdrawal by Subject|3|||
130058146|NCT02796391|468168041|FG000|Overall Study|Adverse Event|0|||
129895020|NCT02616263|467575261|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
129895021|NCT02616263|467575260|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
130058147|NCT02796391|468168042|FG001|Overall Study|Adverse Event|0|||
129895022|NCT02616263|467575261|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
129895023|NCT02616263|467575260|FG000|6 Month to 1.5 Year|Death|1|||
129895024|NCT02616263|467575261|FG001|6 Month to 1.5 Year|Death|0|||
129895025|NCT02616263|467575260|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
129895026|NCT02616263|467575261|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
130058148|NCT02796391|468168043|FG002|Overall Study|Adverse Event|0|||
129895027|NCT02616263|467575260|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
129895028|NCT02616263|467575261|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
129895029|NCT02616263|467575260|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
129895030|NCT02616263|467575261|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
129895031|NCT02939183|467575264|FG000|Overall Study|Death|0|||
129895032|NCT02939183|467575265|FG001|Overall Study|Death|0|||
129895033|NCT02939183|467575266|FG002|Overall Study|Death|1|||
129895034|NCT02939183|467575267|FG003|Overall Study|Death|0|||
129895035|NCT02939183|467575268|FG004|Overall Study|Death|0|||
129895036|NCT02939183|467575269|FG005|Overall Study|Death|2|||
129895037|NCT02939183|467575270|FG006|Overall Study|Death|1|||
129895038|NCT02939183|467575271|FG007|Overall Study|Death|0|||
129895039|NCT02939183|467575272|FG008|Overall Study|Death|0|||
129895040|NCT02939183|467575264|FG000|Overall Study|Sponsor decision|0|||
129895041|NCT02939183|467575265|FG001|Overall Study|Sponsor decision|1|||
129895042|NCT02939183|467575266|FG002|Overall Study|Sponsor decision|0|||
129895043|NCT02939183|467575267|FG003|Overall Study|Sponsor decision|1|||
129895044|NCT02939183|467575268|FG004|Overall Study|Sponsor decision|2|||
129895045|NCT02939183|467575269|FG005|Overall Study|Sponsor decision|0|||
129895046|NCT02939183|467575270|FG006|Overall Study|Sponsor decision|3|||
129895047|NCT02939183|467575271|FG007|Overall Study|Sponsor decision|1|||
129895048|NCT02939183|467575272|FG008|Overall Study|Sponsor decision|4|||
129895049|NCT02939183|467575264|FG000|Overall Study|Withdrawal by Subject|0|||
129895050|NCT02939183|467575265|FG001|Overall Study|Withdrawal by Subject|2|||
129895051|NCT02939183|467575266|FG002|Overall Study|Withdrawal by Subject|0|||
129895052|NCT02939183|467575267|FG003|Overall Study|Withdrawal by Subject|1|||
129895053|NCT02939183|467575268|FG004|Overall Study|Withdrawal by Subject|0|||
129895054|NCT02939183|467575269|FG005|Overall Study|Withdrawal by Subject|0|||
129895055|NCT02939183|467575270|FG006|Overall Study|Withdrawal by Subject|2|||
129895056|NCT02939183|467575271|FG007|Overall Study|Withdrawal by Subject|2|||
129895057|NCT02939183|467575272|FG008|Overall Study|Withdrawal by Subject|2|||
129895058|NCT02939183|467575264|FG000|Overall Study|Not treated due to adverse event|0|||
129895059|NCT02939183|467575265|FG001|Overall Study|Not treated due to adverse event|0|||
129895060|NCT02939183|467575266|FG002|Overall Study|Not treated due to adverse event|0|||
129895061|NCT02939183|467575267|FG003|Overall Study|Not treated due to adverse event|1|||
129895062|NCT02939183|467575268|FG004|Overall Study|Not treated due to adverse event|0|||
129895063|NCT02939183|467575269|FG005|Overall Study|Not treated due to adverse event|0|||
129895064|NCT02939183|467575270|FG006|Overall Study|Not treated due to adverse event|1|||
129895065|NCT02939183|467575271|FG007|Overall Study|Not treated due to adverse event|0|||
129895066|NCT02939183|467575272|FG008|Overall Study|Not treated due to adverse event|0|||
129895067|NCT02696785|467575273|FG000|Blinded Treatment Period|Adverse Event|0|||
129895068|NCT02696785|467575274|FG001|Blinded Treatment Period|Adverse Event|1|||
129895069|NCT02696785|467575275|FG002|Blinded Treatment Period|Adverse Event|3|||
129895070|NCT02696785|467575276|FG003|Blinded Treatment Period|Adverse Event|0|||
129895071|NCT02696785|467575273|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
129895072|NCT02696785|467575274|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
129895073|NCT02696785|467575275|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
129895074|NCT02696785|467575276|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
129895075|NCT02696785|467575273|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
129895076|NCT02696785|467575274|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
129895077|NCT02696785|467575275|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
129895078|NCT02696785|467575276|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
129895079|NCT02696785|467575273|FG000|Blinded Treatment Period|Screen Failure|1|||
129895080|NCT02696785|467575274|FG001|Blinded Treatment Period|Screen Failure|0|||
129895081|NCT02696785|467575275|FG002|Blinded Treatment Period|Screen Failure|0|||
129895082|NCT02696785|467575276|FG003|Blinded Treatment Period|Screen Failure|0|||
129895083|NCT02696785|467575273|FG000|Washout Period|Withdrawal by Subject|0|||
129895084|NCT02696785|467575274|FG001|Washout Period|Withdrawal by Subject|1|||
129895085|NCT02696785|467575275|FG002|Washout Period|Withdrawal by Subject|0|||
129895086|NCT02696785|467575276|FG003|Washout Period|Withdrawal by Subject|0|||
129895087|NCT02696785|467575273|FG000|Washout Period|Lack of Efficacy|0|||
129895088|NCT02696785|467575274|FG001|Washout Period|Lack of Efficacy|1|||
129895089|NCT02696785|467575275|FG002|Washout Period|Lack of Efficacy|0|||
129895090|NCT02696785|467575276|FG003|Washout Period|Lack of Efficacy|0|||
129895091|NCT02696785|467575273|FG000|Extended Treatment Period|Adverse Event|2|||
129895092|NCT02696785|467575274|FG001|Extended Treatment Period|Adverse Event|3|||
129895093|NCT02696785|467575275|FG002|Extended Treatment Period|Adverse Event|2|||
129895094|NCT02696785|467575276|FG003|Extended Treatment Period|Adverse Event|1|||
129895095|NCT02696785|467575273|FG000|Extended Treatment Period|Lack of Efficacy|0|||
129895096|NCT02696785|467575274|FG001|Extended Treatment Period|Lack of Efficacy|1|||
129895097|NCT02696785|467575275|FG002|Extended Treatment Period|Lack of Efficacy|0|||
129895098|NCT02696785|467575276|FG003|Extended Treatment Period|Lack of Efficacy|0|||
129895099|NCT02696785|467575273|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
129895100|NCT02696785|467575274|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
129895101|NCT02696785|467575275|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
129895102|NCT02696785|467575276|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
129895103|NCT02696785|467575273|FG000|Follow-up Period|Adverse Event|0|||
129895104|NCT02696785|467575274|FG001|Follow-up Period|Adverse Event|0|||
129895105|NCT02696785|467575275|FG002|Follow-up Period|Adverse Event|8|||
129895106|NCT02696785|467575276|FG003|Follow-up Period|Adverse Event|2|||
129895107|NCT02696785|467575273|FG000|Follow-up Period|Lost to Follow-up|0|||
129895108|NCT02696785|467575274|FG001|Follow-up Period|Lost to Follow-up|0|||
129895109|NCT02696785|467575275|FG002|Follow-up Period|Lost to Follow-up|0|||
129895110|NCT02696785|467575276|FG003|Follow-up Period|Lost to Follow-up|1|||
129895111|NCT02696785|467575273|FG000|Follow-up Period|Lack of Efficacy|0|||
129895112|NCT02696785|467575274|FG001|Follow-up Period|Lack of Efficacy|0|||
129895113|NCT02696785|467575275|FG002|Follow-up Period|Lack of Efficacy|0|||
129895114|NCT02696785|467575276|FG003|Follow-up Period|Lack of Efficacy|1|||
129895115|NCT02696785|467575273|FG000|Follow-up Period|Withdrawal by Subject|1|||
129895116|NCT02696785|467575274|FG001|Follow-up Period|Withdrawal by Subject|0|||
129895117|NCT02696785|467575275|FG002|Follow-up Period|Withdrawal by Subject|5|||
129895118|NCT02696785|467575276|FG003|Follow-up Period|Withdrawal by Subject|4|||
129895119|NCT03905135|467575277|FG000|Dose Escalation|Adverse Event|1|||
129895120|NCT03905135|467575278|FG001|Dose Escalation|Adverse Event|1|||
129895121|NCT03905135|467575277|FG000|Dose Escalation|Progressive disease|3|||
129895122|NCT03905135|467575278|FG001|Dose Escalation|Progressive disease|1|||
129895123|NCT03905135|467575277|FG000|Dose Escalation|Intercurrent illness|1|||
129895124|NCT03905135|467575278|FG001|Dose Escalation|Intercurrent illness|0|||
129895125|NCT01740557|467575279|FG000|Overall Study|Ineligible|1|||
129895126|NCT01740557|467575279|FG000|Overall Study|Screen failure|1|||
130058149|NCT02796391|468168044|FG003|Overall Study|Adverse Event|1|||
130058150|NCT02796391|468168045|FG004|Overall Study|Adverse Event|0|||
130058151|NCT02796391|468168046|FG005|Overall Study|Adverse Event|0|||
129895127|NCT00490555|467575280|FG000|Overall Study|noncompliant with drug administration|0|||
129895128|NCT00490555|467575281|FG001|Overall Study|noncompliant with drug administration|0|||
129895129|NCT00490555|467575282|FG002|Overall Study|noncompliant with drug administration|2|||
130058152|NCT02796391|468168041|FG000|Overall Study|Protocol Violation|0|||
130058153|NCT02796391|468168042|FG001|Overall Study|Protocol Violation|0|||
130058154|NCT02796391|468168043|FG002|Overall Study|Protocol Violation|0|||
130058155|NCT02796391|468168044|FG003|Overall Study|Protocol Violation|1|||
130058156|NCT02796391|468168045|FG004|Overall Study|Protocol Violation|0|||
130058157|NCT02796391|468168046|FG005|Overall Study|Protocol Violation|0|||
130058158|NCT02681055|468168047|FG000|Weeks 5-12|Adverse Event|1|||
129895130|NCT00490555|467575283|FG003|Overall Study|noncompliant with drug administration|0|||
129895131|NCT01007149|467575288|FG000|Overall Study|Administrative problems|0|||
129895132|NCT01007149|467575289|FG001|Overall Study|Administrative problems|1|||
129895133|NCT01913340|467575290|FG000|Overall Study|Death|2|||
129895134|NCT01913340|467575291|FG001|Overall Study|Death|5|||
129895135|NCT01913340|467575290|FG000|Overall Study|Lost to Follow-up|1|||
129895136|NCT01913340|467575291|FG001|Overall Study|Lost to Follow-up|1|||
130058159|NCT02695524|468168048|FG000|Overall Study|Lost to Follow-up|3|||
130058160|NCT02695524|468168049|FG001|Overall Study|Lost to Follow-up|2|||
130058161|NCT02695524|468168048|FG000|Overall Study|Death|0|||
130058162|NCT02695524|468168049|FG001|Overall Study|Death|1|||
129895137|NCT02320253|467575292|FG000|Overall Study|Withdrawal by Subject|3|||
129895138|NCT02320253|467575293|FG001|Overall Study|Withdrawal by Subject|0|||
129895139|NCT02320253|467575294|FG002|Overall Study|Withdrawal by Subject|0|||
129895140|NCT02320253|467575292|FG000|Overall Study|Lost to Follow-up|2|||
129895141|NCT02320253|467575293|FG001|Overall Study|Lost to Follow-up|2|||
129895142|NCT02320253|467575294|FG002|Overall Study|Lost to Follow-up|1|||
129895143|NCT02320253|467575292|FG000|Overall Study|Death|1|||
129895144|NCT02320253|467575293|FG001|Overall Study|Death|0|||
129895145|NCT02320253|467575294|FG002|Overall Study|Death|1|||
129895146|NCT00603538|467575295|FG000|Overall Study|Adverse Event|0|||
129895147|NCT00603538|467575296|FG001|Overall Study|Adverse Event|4|||
129895148|NCT00603538|467575297|FG002|Overall Study|Adverse Event|2|||
129895149|NCT00603538|467575295|FG000|Overall Study|Objective progression or relapse|3|||
129895150|NCT00603538|467575296|FG001|Overall Study|Objective progression or relapse|0|||
129895151|NCT00603538|467575297|FG002|Overall Study|Objective progression or relapse|0|||
129895152|NCT05750745|467575299|FG000|Overall Study|Adverse Event|1|||
129895153|NCT05750745|467575300|FG001|Overall Study|Adverse Event|0|||
129895154|NCT05750745|467575301|FG002|Overall Study|Adverse Event|0|||
129895155|NCT05750745|467575299|FG000|Overall Study|Protocol Violation|1|||
129895156|NCT05750745|467575300|FG001|Overall Study|Protocol Violation|0|||
129895157|NCT05750745|467575301|FG002|Overall Study|Protocol Violation|0|||
129895158|NCT05750745|467575299|FG000|Overall Study|Withdrawal by Subject|0|||
129895159|NCT05750745|467575300|FG001|Overall Study|Withdrawal by Subject|1|||
129895160|NCT05750745|467575301|FG002|Overall Study|Withdrawal by Subject|0|||
129895161|NCT00359619|467577091|FG000|Overall Study|Adverse Event|0|||
129895162|NCT00359619|467577092|FG001|Overall Study|Adverse Event|0|||
129895163|NCT00359619|467577093|FG002|Overall Study|Adverse Event|1|||
129895164|NCT00359619|467577094|FG003|Overall Study|Adverse Event|0|||
129895165|NCT00359619|467577095|FG004|Overall Study|Adverse Event|0|||
129895166|NCT00359619|467577096|FG005|Overall Study|Adverse Event|0|||
129895167|NCT00359619|467577097|FG006|Overall Study|Adverse Event|1|||
129895168|NCT00359619|467577091|FG000|Overall Study|Withdrawal by Subject|3|||
129895169|NCT00359619|467577092|FG001|Overall Study|Withdrawal by Subject|1|||
129895170|NCT00359619|467577093|FG002|Overall Study|Withdrawal by Subject|4|||
129895171|NCT00359619|467577094|FG003|Overall Study|Withdrawal by Subject|2|||
129895172|NCT00359619|467577095|FG004|Overall Study|Withdrawal by Subject|2|||
129895173|NCT00359619|467577096|FG005|Overall Study|Withdrawal by Subject|0|||
129895174|NCT00359619|467577097|FG006|Overall Study|Withdrawal by Subject|3|||
129895175|NCT00359619|467577091|FG000|Overall Study|Other|1|||
129895176|NCT00359619|467577092|FG001|Overall Study|Other|0|||
129895177|NCT00359619|467577093|FG002|Overall Study|Other|0|||
129895178|NCT00359619|467577094|FG003|Overall Study|Other|0|||
129895179|NCT00359619|467577095|FG004|Overall Study|Other|0|||
129895180|NCT00359619|467577096|FG005|Overall Study|Other|0|||
129895181|NCT00359619|467577097|FG006|Overall Study|Other|0|||
129895182|NCT00359619|467577091|FG000|Overall Study|Lost to Follow-up|4|||
129895183|NCT00359619|467577092|FG001|Overall Study|Lost to Follow-up|4|||
129895184|NCT00359619|467577093|FG002|Overall Study|Lost to Follow-up|2|||
129895185|NCT00359619|467577094|FG003|Overall Study|Lost to Follow-up|1|||
129895186|NCT00359619|467577095|FG004|Overall Study|Lost to Follow-up|1|||
129895187|NCT00359619|467577096|FG005|Overall Study|Lost to Follow-up|5|||
129895188|NCT00359619|467577097|FG006|Overall Study|Lost to Follow-up|0|||
129895189|NCT00256308|467577100|FG000|Overall Study|Death|2|||
129895190|NCT01419717|467577101|FG000|Overall Study|Protocol-specified Criteria|62|||
129895191|NCT01419717|467577101|FG000|Overall Study|Adverse Event|19|||
129895192|NCT01419717|467577101|FG000|Overall Study|Death|17|||
129895193|NCT01419717|467577101|FG000|Overall Study|Withdrawal by Subject|10|||
130058163|NCT00871377|468168052|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129895194|NCT01419717|467577101|FG000|Overall Study|Disease Progression|9|||
129895195|NCT01419717|467577101|FG000|Overall Study|Other|4|||
129895196|NCT01419717|467577101|FG000|Overall Study|Lost to Follow-up|2|||
129895197|NCT01419717|467577101|FG000|Overall Study|Administrative Decision|1|||
129895198|NCT01419717|467577101|FG000|Overall Study|Noncompliance|1|||
129895199|NCT02857283|467577102|FG000|First Exposure|Withdrawal by Subject|1|||
129895200|NCT02857283|467577103|FG001|First Exposure|Withdrawal by Subject|0|||
129895201|NCT00587288|467577104|FG000|Overall Study|Adverse Event|0|||
129895202|NCT00587288|467577105|FG001|Overall Study|Adverse Event|1|||
129895203|NCT00587288|467577104|FG000|Overall Study|Lack of Efficacy|2|||
129895204|NCT00587288|467577105|FG001|Overall Study|Lack of Efficacy|8|||
129895205|NCT00587288|467577104|FG000|Overall Study|Protocol Violation|1|||
129895206|NCT00587288|467577105|FG001|Overall Study|Protocol Violation|0|||
129895207|NCT05074498|467577110|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895208|NCT05074498|467577111|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895209|NCT05074498|467577112|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895210|NCT05074498|467577113|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
129895211|NCT05074498|467577114|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895212|NCT05074498|467577115|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895213|NCT05074498|467577110|FG000|Part 1 (Upto Day 104)|Other|1|||
129895214|NCT05074498|467577111|FG001|Part 1 (Upto Day 104)|Other|0|||
129895215|NCT05074498|467577112|FG002|Part 1 (Upto Day 104)|Other|0|||
129895216|NCT05074498|467577113|FG003|Part 1 (Upto Day 104)|Other|0|||
129895217|NCT05074498|467577114|FG004|Part 1 (Upto Day 104)|Other|0|||
129895218|NCT05074498|467577115|FG005|Part 1 (Upto Day 104)|Other|0|||
129895219|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895220|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895221|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895222|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895223|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
129895224|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895225|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Death|0|||
129895226|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Death|0|||
129895227|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Death|0|||
129895228|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Death|0|||
129895229|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Death|1|||
129895230|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Death|0|||
129895231|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895232|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895233|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895234|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895235|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
129895236|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
129895237|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Other|0|||
129895238|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Other|0|||
129895239|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Other|0|||
129895240|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Other|0|||
129895241|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Other|1|||
129895242|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Other|0|||
129895243|NCT01240356|467577116|FG000|Overall Study|Withdrawal by Subject|2|||
129895244|NCT01240356|467577117|FG001|Overall Study|Withdrawal by Subject|0|||
129895245|NCT01240356|467577116|FG000|Overall Study|MRI contraindication|1|||
129895246|NCT01240356|467577117|FG001|Overall Study|MRI contraindication|0|||
129895247|NCT01244984|467577124|FG000|Overall Study|Adverse Event|2|||
129895248|NCT01244984|467577125|FG001|Overall Study|Adverse Event|11|||
129895249|NCT01244984|467577126|FG002|Overall Study|Adverse Event|2|||
129895250|NCT01244984|467577124|FG000|Overall Study|Protocol Violation|1|||
129895251|NCT01244984|467577125|FG001|Overall Study|Protocol Violation|0|||
129895252|NCT01244984|467577126|FG002|Overall Study|Protocol Violation|0|||
129895253|NCT01244984|467577124|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
129895254|NCT01244984|467577125|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
129895255|NCT01244984|467577126|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
129895256|NCT01244984|467577124|FG000|Overall Study|Withdrawal by Subject|1|||
129895257|NCT01244984|467577125|FG001|Overall Study|Withdrawal by Subject|2|||
129895258|NCT01244984|467577126|FG002|Overall Study|Withdrawal by Subject|2|||
129895259|NCT02072226|467577128|FG000|Overall Study|Lost to Follow-up|11|||
129895260|NCT02072226|467577129|FG001|Overall Study|Lost to Follow-up|7|||
129895261|NCT02072226|467577128|FG000|Overall Study|Patient Non-compliance|2|||
129895262|NCT02072226|467577129|FG001|Overall Study|Patient Non-compliance|3|||
129895263|NCT02072226|467577128|FG000|Overall Study|Death|1|||
129895264|NCT02072226|467577129|FG001|Overall Study|Death|0|||
129895265|NCT02072226|467577128|FG000|Overall Study|Patient Withdrawal of Consent|1|||
129895266|NCT02072226|467577129|FG001|Overall Study|Patient Withdrawal of Consent|0|||
129895267|NCT02095158|467577137|FG000|Overall Study|Adverse Event|14|||
129895268|NCT02095158|467577137|FG000|Overall Study|Lack of Efficacy|3|||
129895269|NCT02095158|467577137|FG000|Overall Study|Pregnancy|1|||
129895270|NCT02095158|467577137|FG000|Overall Study|Lost to Follow-up|20|||
129895271|NCT02095158|467577137|FG000|Overall Study|Personal Reasons|35|||
129895272|NCT02095158|467577137|FG000|Overall Study|Protocol Violation|1|||
129895273|NCT02095158|467577137|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129895274|NCT03424239|467577143|FG000|Overall Study|Withdrawal by Subject|2|||
129895275|NCT01446003|467577145|FG000|Period 1|Protocol Violation|2|||
129895276|NCT01446003|467577146|FG001|Period 1|Protocol Violation|0|||
129895277|NCT01446003|467577145|FG000|Period 2|Adverse Event|1|||
129895278|NCT01446003|467577146|FG001|Period 2|Adverse Event|0|||
129895279|NCT00318656|467577147|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
129895280|NCT00318656|467577148|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
129895281|NCT00318656|467577147|FG000|Overall Study|Did not receive any treatment|0|||
129895282|NCT00318656|467577148|FG001|Overall Study|Did not receive any treatment|1|||
129895283|NCT02042443|467577149|FG000|Overall Study|Adverse Event|2|||
129895284|NCT02042443|467577150|FG001|Overall Study|Adverse Event|1|||
130058164|NCT00871377|468168053|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130058165|NCT00871377|468168054|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
130058166|NCT00871377|468168055|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130058167|NCT00871377|468168056|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130058168|NCT00871377|468168057|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
130058169|NCT00871377|468168052|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129895285|NCT02042443|467577149|FG000|Overall Study|Withdrawal by Subject|0|||
129895286|NCT02042443|467577150|FG001|Overall Study|Withdrawal by Subject|1|||
129895287|NCT02042443|467577149|FG000|Overall Study|Progression|21|||
129895288|NCT02042443|467577150|FG001|Overall Study|Progression|17|||
129895289|NCT02042443|467577149|FG000|Overall Study|not protocol specified|1|||
129895290|NCT02042443|467577150|FG001|Overall Study|not protocol specified|1|||
129895291|NCT02042443|467577149|FG000|Overall Study|Not eligible/not analyzable|3|||
129895292|NCT02042443|467577150|FG001|Overall Study|Not eligible/not analyzable|6|||
129895293|NCT02784704|467577151|FG000|Overall Study|Adverse Event|4|||
129895294|NCT02784704|467577152|FG001|Overall Study|Adverse Event|2|||
129895295|NCT02784704|467577151|FG000|Overall Study|Lost to Follow-up|6|||
129895296|NCT02784704|467577152|FG001|Overall Study|Lost to Follow-up|4|||
129895297|NCT02784704|467577151|FG000|Overall Study|Withdrawal by Subject|1|||
129895298|NCT02784704|467577152|FG001|Overall Study|Withdrawal by Subject|3|||
129895299|NCT02784704|467577151|FG000|Overall Study|Subject Non Compliance|2|||
129895300|NCT02784704|467577152|FG001|Overall Study|Subject Non Compliance|0|||
129895301|NCT00783692|467577155|FG000|Induction Phase|Adverse Event|7|||
129895302|NCT00783692|467577156|FG001|Induction Phase|Adverse Event|9|||
129895303|NCT00783692|467577157|FG002|Induction Phase|Adverse Event|24|||
129895304|NCT00783692|467577158|FG003|Induction Phase|Adverse Event|0|||
129895305|NCT00783692|467577159|FG004|Induction Phase|Adverse Event|0|||
129895306|NCT00783692|467577160|FG005|Induction Phase|Adverse Event|0|||
129895307|NCT00783692|467577161|FG006|Induction Phase|Adverse Event|0|||
129895308|NCT00783692|467577155|FG000|Induction Phase|Protocol Violation|0|||
129895309|NCT00783692|467577156|FG001|Induction Phase|Protocol Violation|0|||
129895310|NCT00783692|467577157|FG002|Induction Phase|Protocol Violation|1|||
129895311|NCT00783692|467577158|FG003|Induction Phase|Protocol Violation|0|||
129895312|NCT00783692|467577159|FG004|Induction Phase|Protocol Violation|0|||
129895313|NCT00783692|467577160|FG005|Induction Phase|Protocol Violation|0|||
129895314|NCT00783692|467577161|FG006|Induction Phase|Protocol Violation|0|||
129895315|NCT00783692|467577155|FG000|Induction Phase|Lack of Efficacy|1|||
129895316|NCT00783692|467577156|FG001|Induction Phase|Lack of Efficacy|3|||
129895317|NCT00783692|467577157|FG002|Induction Phase|Lack of Efficacy|28|||
129895318|NCT00783692|467577158|FG003|Induction Phase|Lack of Efficacy|0|||
129895319|NCT00783692|467577159|FG004|Induction Phase|Lack of Efficacy|0|||
129895320|NCT00783692|467577160|FG005|Induction Phase|Lack of Efficacy|0|||
129895321|NCT00783692|467577161|FG006|Induction Phase|Lack of Efficacy|0|||
129895322|NCT00783692|467577155|FG000|Induction Phase|Withdrawal by Subject|3|||
129895323|NCT00783692|467577156|FG001|Induction Phase|Withdrawal by Subject|9|||
129895324|NCT00783692|467577157|FG002|Induction Phase|Withdrawal by Subject|16|||
129895325|NCT00783692|467577158|FG003|Induction Phase|Withdrawal by Subject|0|||
129895326|NCT00783692|467577159|FG004|Induction Phase|Withdrawal by Subject|0|||
129895327|NCT00783692|467577160|FG005|Induction Phase|Withdrawal by Subject|0|||
129895328|NCT00783692|467577161|FG006|Induction Phase|Withdrawal by Subject|0|||
129895329|NCT00783692|467577155|FG000|Induction Phase|Lost to Follow-up|0|||
129895330|NCT00783692|467577156|FG001|Induction Phase|Lost to Follow-up|0|||
129895331|NCT00783692|467577157|FG002|Induction Phase|Lost to Follow-up|3|||
129895332|NCT00783692|467577158|FG003|Induction Phase|Lost to Follow-up|0|||
129895333|NCT00783692|467577159|FG004|Induction Phase|Lost to Follow-up|0|||
129895334|NCT00783692|467577160|FG005|Induction Phase|Lost to Follow-up|0|||
129895335|NCT00783692|467577161|FG006|Induction Phase|Lost to Follow-up|0|||
129895336|NCT00783692|467577155|FG000|Induction Phase|Other|0|||
129895337|NCT00783692|467577156|FG001|Induction Phase|Other|0|||
129895338|NCT00783692|467577157|FG002|Induction Phase|Other|2|||
129895339|NCT00783692|467577158|FG003|Induction Phase|Other|0|||
129895340|NCT00783692|467577159|FG004|Induction Phase|Other|0|||
129895341|NCT00783692|467577160|FG005|Induction Phase|Other|0|||
129895342|NCT00783692|467577161|FG006|Induction Phase|Other|0|||
129895343|NCT00783692|467577155|FG000|Maintenance Phase|Adverse Event|7|||
129895344|NCT00783692|467577156|FG001|Maintenance Phase|Adverse Event|0|||
129895345|NCT00783692|467577157|FG002|Maintenance Phase|Adverse Event|0|||
129895346|NCT00783692|467577158|FG003|Maintenance Phase|Adverse Event|15|||
129895347|NCT00783692|467577159|FG004|Maintenance Phase|Adverse Event|12|||
129895348|NCT00783692|467577160|FG005|Maintenance Phase|Adverse Event|9|||
129895349|NCT00783692|467577161|FG006|Maintenance Phase|Adverse Event|38|||
129895350|NCT00783692|467577155|FG000|Maintenance Phase|Protocol Violation|0|||
129895351|NCT00783692|467577156|FG001|Maintenance Phase|Protocol Violation|0|||
129895352|NCT00783692|467577157|FG002|Maintenance Phase|Protocol Violation|0|||
129895353|NCT00783692|467577158|FG003|Maintenance Phase|Protocol Violation|1|||
129895354|NCT00783692|467577159|FG004|Maintenance Phase|Protocol Violation|2|||
129895355|NCT00783692|467577160|FG005|Maintenance Phase|Protocol Violation|3|||
129895356|NCT00783692|467577161|FG006|Maintenance Phase|Protocol Violation|4|||
129895357|NCT00783692|467577155|FG000|Maintenance Phase|Lack of Efficacy|79|||
129895358|NCT00783692|467577156|FG001|Maintenance Phase|Lack of Efficacy|0|||
129895359|NCT00783692|467577157|FG002|Maintenance Phase|Lack of Efficacy|0|||
129895360|NCT00783692|467577158|FG003|Maintenance Phase|Lack of Efficacy|64|||
129895361|NCT00783692|467577159|FG004|Maintenance Phase|Lack of Efficacy|58|||
129895362|NCT00783692|467577160|FG005|Maintenance Phase|Lack of Efficacy|48|||
129895363|NCT00783692|467577161|FG006|Maintenance Phase|Lack of Efficacy|177|||
129895364|NCT00783692|467577155|FG000|Maintenance Phase|Withdrawal by Subject|7|||
129895365|NCT00783692|467577156|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129895366|NCT00783692|467577157|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129895367|NCT00783692|467577158|FG003|Maintenance Phase|Withdrawal by Subject|7|||
129895368|NCT00783692|467577159|FG004|Maintenance Phase|Withdrawal by Subject|6|||
129895369|NCT00783692|467577160|FG005|Maintenance Phase|Withdrawal by Subject|9|||
129895370|NCT00783692|467577161|FG006|Maintenance Phase|Withdrawal by Subject|24|||
129895371|NCT00783692|467577155|FG000|Maintenance Phase|Lost to Follow-up|2|||
129895372|NCT00783692|467577156|FG001|Maintenance Phase|Lost to Follow-up|0|||
129807550|NCT03666624|467261170|FG000|Overall Study|participant grieving over recent death of parent|1|||
129807551|NCT03666624|467261171|FG001|Overall Study|participant grieving over recent death of parent|0|||
129807552|NCT03021304|467261172|FG000|Overall Study|Lack of Efficacy|1|||
129807553|NCT00569270|467261174|FG000|Period: First Intervention|Protocol Violation|0|||
129807554|NCT00569270|467261175|FG001|Period: First Intervention|Protocol Violation|1|||
129807555|NCT00492531|467261176|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
129807556|NCT00492531|467261177|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
129807557|NCT03822182|467261178|FG000|Overall Study|Protocol Violation|0|||
129807558|NCT03822182|467261179|FG001|Overall Study|Protocol Violation|1|||
129807559|NCT03822182|467261180|FG002|Overall Study|Protocol Violation|1|||
129807560|NCT00810355|467261181|FG000|Overall Study|Lost to Follow-up|13|||
129807561|NCT00810355|467261182|FG001|Overall Study|Lost to Follow-up|17|||
129807562|NCT00810355|467261183|FG002|Overall Study|Lost to Follow-up|11|||
129807563|NCT00810355|467261181|FG000|Overall Study|Withdrawal by Subject|1|||
129807564|NCT00810355|467261182|FG001|Overall Study|Withdrawal by Subject|0|||
129807565|NCT00810355|467261183|FG002|Overall Study|Withdrawal by Subject|0|||
129807566|NCT00843856|467261186|FG000|Overall Study|Lost to Follow-up|1|||
129807567|NCT00843856|467261187|FG001|Overall Study|Lost to Follow-up|2|||
129807568|NCT01758523|467261188|FG000|Overall Study|Adverse Event|2|||
129807569|NCT01758523|467261189|FG001|Overall Study|Adverse Event|1|||
129807570|NCT01758523|467261188|FG000|Overall Study|Lack of Efficacy|4|||
129807571|NCT01758523|467261189|FG001|Overall Study|Lack of Efficacy|2|||
129807572|NCT01758523|467261188|FG000|Overall Study|Lost to Follow-up|3|||
129807573|NCT01758523|467261189|FG001|Overall Study|Lost to Follow-up|4|||
129807574|NCT01758523|467261188|FG000|Overall Study|Withdrawal by Subject|12|||
129807575|NCT01758523|467261189|FG001|Overall Study|Withdrawal by Subject|7|||
129807576|NCT01893203|467261190|FG000|Overall Study|Withdrawal by Subject|1|||
129807577|NCT00621959|467261191|FG000|Overall Study|Adverse Event|4|||
129807578|NCT00621959|467261192|FG001|Overall Study|Adverse Event|2|||
129807579|NCT00621959|467261191|FG000|Overall Study|Lack of Efficacy|1|||
129807580|NCT00621959|467261192|FG001|Overall Study|Lack of Efficacy|1|||
129807581|NCT00621959|467261191|FG000|Overall Study|Lost to Follow-up|0|||
129807582|NCT00621959|467261192|FG001|Overall Study|Lost to Follow-up|2|||
129807583|NCT00621959|467261191|FG000|Overall Study|Withdrawal by Subject|1|||
129807584|NCT00621959|467261192|FG001|Overall Study|Withdrawal by Subject|1|||
129807585|NCT00621959|467261191|FG000|Overall Study|Other|1|||
129807586|NCT00621959|467261192|FG001|Overall Study|Other|3|||
129807587|NCT00590135|467261193|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
129807588|NCT04729621|467261194|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
129807589|NCT04729621|467261195|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
129807590|NCT04729621|467261196|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
129807591|NCT04729621|467261197|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
130112307|NCT01571635|468371125|FG000|Overall Study|Lack of Efficacy|0|||
129979656|NCT00403767|467889417|FG000|Overall Study|Protocol Violation|142|||
129807592|NCT04729621|467261198|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
129807593|NCT04729621|467261194|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
129807594|NCT04729621|467261195|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
129807595|NCT04729621|467261196|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
129807596|NCT04729621|467261197|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
129807597|NCT04729621|467261198|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
129807598|NCT04729621|467261194|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
129807599|NCT04729621|467261195|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
129807600|NCT04729621|467261196|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
129807601|NCT04729621|467261197|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
129807602|NCT04729621|467261198|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
129895373|NCT00783692|467577157|FG002|Maintenance Phase|Lost to Follow-up|0|||
129895374|NCT00783692|467577158|FG003|Maintenance Phase|Lost to Follow-up|1|||
129895375|NCT00783692|467577159|FG004|Maintenance Phase|Lost to Follow-up|3|||
129895376|NCT00783692|467577160|FG005|Maintenance Phase|Lost to Follow-up|2|||
129895377|NCT00783692|467577161|FG006|Maintenance Phase|Lost to Follow-up|5|||
129895378|NCT00783692|467577155|FG000|Maintenance Phase|Other|0|||
129895379|NCT00783692|467577156|FG001|Maintenance Phase|Other|0|||
129895380|NCT00783692|467577157|FG002|Maintenance Phase|Other|0|||
129895381|NCT00783692|467577158|FG003|Maintenance Phase|Other|1|||
129895382|NCT00783692|467577159|FG004|Maintenance Phase|Other|0|||
129895383|NCT00783692|467577160|FG005|Maintenance Phase|Other|1|||
129895384|NCT00783692|467577161|FG006|Maintenance Phase|Other|1|||
129895385|NCT00768066|467577164|FG000|Overall Study|Did not receive study product injection.|3|||
129895386|NCT00768066|467577165|FG001|Overall Study|Did not receive study product injection.|3|||
129895387|NCT00768066|467577166|FG002|Overall Study|Did not receive study product injection.|0|||
129895388|NCT04831775|467577167|FG000|Overall Study|Lost to Follow-up|11|||
129895389|NCT04831775|467577168|FG001|Overall Study|Lost to Follow-up|13|||
129895390|NCT05550337|467577171|FG000|Overall Study|Lack of Efficacy|0|||
130058170|NCT00871377|468168053|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130058171|NCT00871377|468168054|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130058172|NCT00871377|468168055|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129895391|NCT05550337|467577172|FG001|Overall Study|Lack of Efficacy|0|||
129895392|NCT05550337|467577173|FG002|Overall Study|Lack of Efficacy|1|||
129895393|NCT05550337|467577171|FG000|Overall Study|Adverse Event|1|||
129807603|NCT04729621|467261194|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129807604|NCT04729621|467261195|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129807605|NCT04729621|467261196|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
129807606|NCT04729621|467261197|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
129807607|NCT04729621|467261198|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
129807608|NCT04729621|467261194|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807609|NCT04729621|467261195|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807610|NCT04729621|467261196|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807611|NCT04729621|467261197|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
129807612|NCT04729621|467261198|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807613|NCT04729621|467261194|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
129807614|NCT04729621|467261195|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
129807615|NCT04729621|467261196|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
129807616|NCT04729621|467261197|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
129807617|NCT04729621|467261198|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
129807618|NCT03439657|467261199|FG000|Overall Study|Adverse Event|2|||
129895394|NCT05550337|467577172|FG001|Overall Study|Adverse Event|5|||
129895395|NCT05550337|467577173|FG002|Overall Study|Adverse Event|0|||
129895396|NCT05550337|467577171|FG000|Overall Study|Withdrawal by Subject|8|||
129895397|NCT05550337|467577172|FG001|Overall Study|Withdrawal by Subject|14|||
129807619|NCT03439657|467261200|FG001|Overall Study|Adverse Event|3|||
129807620|NCT03439657|467261199|FG000|Overall Study|Lost to Follow-up|1|||
129807621|NCT03439657|467261200|FG001|Overall Study|Lost to Follow-up|0|||
129807622|NCT03439657|467261199|FG000|Overall Study|Protocol Violation|1|||
129807623|NCT03439657|467261200|FG001|Overall Study|Protocol Violation|1|||
129895398|NCT05550337|467577173|FG002|Overall Study|Withdrawal by Subject|10|||
129807624|NCT03439657|467261199|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
129895399|NCT05550337|467577171|FG000|Overall Study|Pregnancy|0|||
129895400|NCT05550337|467577172|FG001|Overall Study|Pregnancy|0|||
129895401|NCT05550337|467577173|FG002|Overall Study|Pregnancy|1|||
129895402|NCT05550337|467577171|FG000|Overall Study|Protocol Violation|1|||
129895403|NCT05550337|467577172|FG001|Overall Study|Protocol Violation|3|||
129895404|NCT05550337|467577173|FG002|Overall Study|Protocol Violation|4|||
129895405|NCT05550337|467577171|FG000|Overall Study|Physician Decision|2|||
129895406|NCT05550337|467577172|FG001|Overall Study|Physician Decision|1|||
129895407|NCT05550337|467577173|FG002|Overall Study|Physician Decision|1|||
129895408|NCT05550337|467577171|FG000|Overall Study|Lost to Follow-up|16|||
129895409|NCT05550337|467577172|FG001|Overall Study|Lost to Follow-up|11|||
129895410|NCT05550337|467577173|FG002|Overall Study|Lost to Follow-up|11|||
129895411|NCT03115346|467577175|FG000|Overall Study|Did not have AAA surgery|28|||
129895412|NCT03115346|467577176|FG001|Overall Study|Did not have AAA surgery|15|||
129895413|NCT03115346|467577175|FG000|Overall Study|Death|3|||
129895414|NCT03115346|467577176|FG001|Overall Study|Death|1|||
129895415|NCT03115346|467577175|FG000|Overall Study|Withdrawal by Subject|0|||
129895416|NCT03115346|467577176|FG001|Overall Study|Withdrawal by Subject|3|||
129895417|NCT03115346|467577175|FG000|Overall Study|Lost to Follow-up|0|||
129895418|NCT03115346|467577176|FG001|Overall Study|Lost to Follow-up|3|||
129895419|NCT01737268|467577178|FG000|Overall Study|Adverse Event|6|||
129895420|NCT01737268|467577178|FG000|Overall Study|Worsening of Target Disease|2|||
129895421|NCT01737268|467577178|FG000|Overall Study|In consideration of the patient's safety|1|||
129895422|NCT03499600|467577184|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
129895423|NCT03499600|467577185|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
129895424|NCT01137292|467577186|FG000|Overall Study|Death|30|||
129895425|NCT01137292|467577186|FG000|Overall Study|Adverse Event|3|||
129895426|NCT01137292|467577186|FG000|Overall Study|Lack of Efficacy|13|||
129895427|NCT01137292|467577186|FG000|Overall Study|Lost to Follow-up|1|||
129895428|NCT01137292|467577186|FG000|Overall Study|Other|7|||
129895429|NCT02014558|467577189|FG000|Overall Study|Never Received Study Drug|0|||
129895430|NCT02014558|467577190|FG001|Overall Study|Never Received Study Drug|0|||
129895431|NCT02014558|467577191|FG002|Overall Study|Never Received Study Drug|0|||
129895432|NCT02014558|467577192|FG003|Overall Study|Never Received Study Drug|0|||
129895433|NCT02014558|467577193|FG004|Overall Study|Never Received Study Drug|1|||
130058173|NCT00871377|468168056|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
130058174|NCT00871377|468168057|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
129895434|NCT02014558|467577194|FG005|Overall Study|Never Received Study Drug|0|||
129895435|NCT02014558|467577195|FG006|Overall Study|Never Received Study Drug|1|||
130058175|NCT00871377|468168052|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
129895436|NCT02014558|467577196|FG007|Overall Study|Never Received Study Drug|0|||
129895437|NCT02014558|467577197|FG008|Overall Study|Never Received Study Drug|2|||
129895438|NCT02014558|467577198|FG009|Overall Study|Never Received Study Drug|0|||
129895439|NCT02014558|467577199|FG010|Overall Study|Never Received Study Drug|2|||
129895440|NCT02014558|467577200|FG011|Overall Study|Never Received Study Drug|2|||
129895441|NCT02014558|467577201|FG012|Overall Study|Never Received Study Drug|0|||
129895442|NCT02014558|467577189|FG000|Overall Study|Adverse Event|0|||
129895443|NCT02014558|467577190|FG001|Overall Study|Adverse Event|0|||
129895444|NCT02014558|467577191|FG002|Overall Study|Adverse Event|0|||
129895445|NCT02014558|467577192|FG003|Overall Study|Adverse Event|0|||
129895446|NCT02014558|467577193|FG004|Overall Study|Adverse Event|1|||
129895447|NCT02014558|467577194|FG005|Overall Study|Adverse Event|0|||
129895448|NCT02014558|467577195|FG006|Overall Study|Adverse Event|0|||
129895449|NCT02014558|467577196|FG007|Overall Study|Adverse Event|0|||
129895450|NCT02014558|467577197|FG008|Overall Study|Adverse Event|2|||
129895451|NCT02014558|467577198|FG009|Overall Study|Adverse Event|2|||
129895452|NCT02014558|467577199|FG010|Overall Study|Adverse Event|5|||
129895453|NCT02014558|467577200|FG011|Overall Study|Adverse Event|21|||
129895454|NCT02014558|467577201|FG012|Overall Study|Adverse Event|3|||
129895455|NCT02014558|467577189|FG000|Overall Study|Death|1|||
129895456|NCT02014558|467577190|FG001|Overall Study|Death|0|||
129895457|NCT02014558|467577191|FG002|Overall Study|Death|0|||
129895458|NCT02014558|467577192|FG003|Overall Study|Death|0|||
129895459|NCT02014558|467577193|FG004|Overall Study|Death|0|||
129895460|NCT02014558|467577194|FG005|Overall Study|Death|0|||
129895461|NCT02014558|467577195|FG006|Overall Study|Death|1|||
129895462|NCT02014558|467577196|FG007|Overall Study|Death|1|||
129895463|NCT02014558|467577197|FG008|Overall Study|Death|2|||
129895464|NCT02014558|467577198|FG009|Overall Study|Death|5|||
129807625|NCT03439657|467261200|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
129807626|NCT00370071|467261204|FG000|Overall Study|Withdrawal by Subject|2|||
129807627|NCT01999868|467261206|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
129807628|NCT01999868|467261207|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
129807629|NCT01999868|467261208|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
129807630|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
129807631|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
129895465|NCT02014558|467577199|FG010|Overall Study|Death|5|||
129895466|NCT02014558|467577200|FG011|Overall Study|Death|19|||
129807632|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
129807633|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
129807634|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
129807635|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
129895467|NCT02014558|467577201|FG012|Overall Study|Death|2|||
129807636|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
129807637|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
129807638|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
129807639|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
129807640|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
129807641|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
129807642|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
129807643|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
129895468|NCT02014558|467577189|FG000|Overall Study|Lack of Efficacy|1|||
129895469|NCT02014558|467577190|FG001|Overall Study|Lack of Efficacy|2|||
129807644|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
129807645|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
129807646|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
129807647|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
129807648|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
129807649|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
129807650|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
129807651|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
129807652|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
129807653|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
129807654|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
129807655|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
129807656|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
129807657|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
129807658|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
129807659|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
129807660|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
129807661|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
129807662|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
129807663|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
129807664|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
129895470|NCT02014558|467577191|FG002|Overall Study|Lack of Efficacy|1|||
129895471|NCT02014558|467577192|FG003|Overall Study|Lack of Efficacy|1|||
129895472|NCT02014558|467577193|FG004|Overall Study|Lack of Efficacy|0|||
129895473|NCT02014558|467577194|FG005|Overall Study|Lack of Efficacy|0|||
129895474|NCT02014558|467577195|FG006|Overall Study|Lack of Efficacy|1|||
129895475|NCT02014558|467577196|FG007|Overall Study|Lack of Efficacy|3|||
129895476|NCT02014558|467577197|FG008|Overall Study|Lack of Efficacy|3|||
129895477|NCT02014558|467577198|FG009|Overall Study|Lack of Efficacy|3|||
130058176|NCT00871377|468168053|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
129895478|NCT02014558|467577199|FG010|Overall Study|Lack of Efficacy|16|||
129807665|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
129807666|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
129807667|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
129807668|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
129807669|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
129807670|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
129807671|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
129807672|NCT00289016|467261213|FG000|Overall Study|Disease Progression|29|||
129807673|NCT00289016|467261213|FG000|Overall Study|Death|2|||
130112308|NCT01571635|468371126|FG001|Overall Study|Lack of Efficacy|2|||
129895479|NCT02014558|467577200|FG011|Overall Study|Lack of Efficacy|8|||
129807674|NCT00289016|467261213|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
129807675|NCT00289016|467261213|FG000|Overall Study|Withdrawal by Subject|2|||
129807676|NCT00289016|467261213|FG000|Overall Study|Adverse Event|1|||
129807677|NCT00289016|467261213|FG000|Overall Study|Other|1|||
129807678|NCT00319501|467261214|FG000|Double-blind Period|Withdrawal by Subject|0|||
129807679|NCT00319501|467261215|FG001|Double-blind Period|Withdrawal by Subject|3|||
129807680|NCT00319501|467261214|FG000|Double-blind Period|Sponsor Request|1|||
129807681|NCT00319501|467261215|FG001|Double-blind Period|Sponsor Request|0|||
129807682|NCT00319501|467261214|FG000|Double-blind Period|Did not receive treatment|42|||
129807683|NCT00319501|467261215|FG001|Double-blind Period|Did not receive treatment|29|||
129807684|NCT00319501|467261214|FG000|Open-label Period|Adverse Event|5|||
129807685|NCT00319501|467261215|FG001|Open-label Period|Adverse Event|0|||
129807686|NCT00319501|467261214|FG000|Open-label Period|Protocol Violation|6|||
129807687|NCT00319501|467261215|FG001|Open-label Period|Protocol Violation|0|||
129807688|NCT00319501|467261214|FG000|Open-label Period|Withdrawal by Subject|38|||
129807689|NCT00319501|467261215|FG001|Open-label Period|Withdrawal by Subject|0|||
129895480|NCT02014558|467577201|FG012|Overall Study|Lack of Efficacy|5|||
129807690|NCT00319501|467261214|FG000|Open-label Period|Principal Investigator decision|6|||
129807691|NCT00319501|467261215|FG001|Open-label Period|Principal Investigator decision|0|||
129807692|NCT00319501|467261214|FG000|Open-label Period|Sponsor request|12|||
129807693|NCT00319501|467261215|FG001|Open-label Period|Sponsor request|0|||
129807694|NCT00319501|467261214|FG000|Open-label Period|Lost to Follow-up|5|||
129807695|NCT00319501|467261215|FG001|Open-label Period|Lost to Follow-up|0|||
129807696|NCT00319501|467261214|FG000|Open-label Period|Did not receive treatment|33|||
129807697|NCT00319501|467261215|FG001|Open-label Period|Did not receive treatment|0|||
129807698|NCT00319501|467261214|FG000|Open-label Period|Other|11|||
129807699|NCT00319501|467261215|FG001|Open-label Period|Other|0|||
129807700|NCT00319501|467261214|FG000|Open-label Extension Period|Adverse Event|2|||
129807701|NCT00319501|467261215|FG001|Open-label Extension Period|Adverse Event|0|||
129807702|NCT00319501|467261214|FG000|Open-label Extension Period|Did not receive treatment|18|||
129807703|NCT00319501|467261215|FG001|Open-label Extension Period|Did not receive treatment|0|||
129807704|NCT00319501|467261214|FG000|Open-label Extension Period|Other|1|||
129807705|NCT00319501|467261215|FG001|Open-label Extension Period|Other|0|||
129807706|NCT00319501|467261214|FG000|Open-label Extension Period|Principal investigator decision|2|||
129807707|NCT00319501|467261215|FG001|Open-label Extension Period|Principal investigator decision|0|||
129807708|NCT00319501|467261214|FG000|Open-label Extension Period|Sponsor request|26|||
129807709|NCT00319501|467261215|FG001|Open-label Extension Period|Sponsor request|0|||
129807710|NCT00319501|467261214|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
129807711|NCT00319501|467261215|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129807712|NCT02764697|467261222|FG000|Overall Study|Lack of Efficacy|3|||
129807713|NCT00302107|467261223|FG000|Overall Study|Lost to Follow-up|6|||
129807714|NCT00302107|467261224|FG001|Overall Study|Lost to Follow-up|5|||
129807715|NCT00302107|467261223|FG000|Overall Study|Protocol Violation|1|||
129807716|NCT00302107|467261224|FG001|Overall Study|Protocol Violation|0|||
129807717|NCT00302107|467261223|FG000|Overall Study|Relocation|0|||
129807718|NCT00302107|467261224|FG001|Overall Study|Relocation|1|||
129807719|NCT00302107|467261223|FG000|Overall Study|Withdrawal by Subject|0|||
129807720|NCT00302107|467261224|FG001|Overall Study|Withdrawal by Subject|3|||
129807721|NCT00302107|467261223|FG000|Overall Study|Adverse Event|1|||
129807722|NCT00302107|467261224|FG001|Overall Study|Adverse Event|0|||
129807723|NCT01790932|467261225|FG000|Overall Study|Disease Progression|41|||
129807724|NCT01790932|467261225|FG000|Overall Study|Adverse Event|7|||
129807725|NCT01790932|467261225|FG000|Overall Study|Physician Decision|1|||
129807726|NCT01790932|467261225|FG000|Overall Study|Withdrawal by Subject|1|||
129807727|NCT04223973|467261226|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
129807728|NCT04223973|467261227|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
129807729|NCT04223973|467261226|FG000|Overall Study|Adverse Event|4|||
129807730|NCT04223973|467261227|FG001|Overall Study|Adverse Event|0|||
129807731|NCT04223973|467261226|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
129807732|NCT04223973|467261227|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
129807733|NCT04223973|467261226|FG000|Overall Study|Physician Decision|1|||
129807734|NCT04223973|467261227|FG001|Overall Study|Physician Decision|1|||
129807735|NCT04223973|467261226|FG000|Overall Study|Withdrawal by Subject|0|||
129807736|NCT04223973|467261227|FG001|Overall Study|Withdrawal by Subject|1|||
129807737|NCT01757535|467261228|FG000|Overall Study|Disease Relapse|151|||
129807738|NCT01757535|467261229|FG001|Overall Study|Disease Relapse|181|||
129807739|NCT01757535|467261228|FG000|Overall Study|Other Reasons|28|||
129807740|NCT01757535|467261229|FG001|Overall Study|Other Reasons|27|||
129807741|NCT01757535|467261228|FG000|Overall Study|Adverse Event|31|||
129807742|NCT01757535|467261229|FG001|Overall Study|Adverse Event|11|||
129807743|NCT01757535|467261228|FG000|Overall Study|Withdrew Consent|19|||
129807744|NCT01757535|467261229|FG001|Overall Study|Withdrew Consent|13|||
129807745|NCT01757535|467261228|FG000|Overall Study|Physician Decision|7|||
129807746|NCT01757535|467261229|FG001|Overall Study|Physician Decision|0|||
129807747|NCT01757535|467261228|FG000|Overall Study|Death|2|||
129807748|NCT01757535|467261229|FG001|Overall Study|Death|2|||
129807749|NCT00717093|467262520|FG000|Overall Study|Adverse Event|19|||
129807750|NCT00717093|467262521|FG001|Overall Study|Adverse Event|9|||
129807751|NCT00717093|467262520|FG000|Overall Study|Lack of Efficacy|3|||
129807752|NCT00717093|467262521|FG001|Overall Study|Lack of Efficacy|13|||
129807753|NCT00717093|467262520|FG000|Overall Study|Lost to Follow-up|9|||
129807754|NCT00717093|467262521|FG001|Overall Study|Lost to Follow-up|6|||
129807755|NCT00717093|467262520|FG000|Overall Study|Withdrawal by Subject|12|||
129807756|NCT00717093|467262521|FG001|Overall Study|Withdrawal by Subject|19|||
129807757|NCT00717093|467262520|FG000|Overall Study|Other|0|||
129807758|NCT00717093|467262521|FG001|Overall Study|Other|1|||
129807759|NCT00717093|467262520|FG000|Overall Study|Randomized but not treated|1|||
129807760|NCT00717093|467262521|FG001|Overall Study|Randomized but not treated|0|||
129807761|NCT00531934|467262522|FG000|Overall Study|Adverse Event|4|||
129807762|NCT00531934|467262523|FG001|Overall Study|Adverse Event|8|||
129807763|NCT00531934|467262522|FG000|Overall Study|Progression|52|||
129807764|NCT00531934|467262523|FG001|Overall Study|Progression|42|||
129807765|NCT00531934|467262522|FG000|Overall Study|Death|7|||
129807766|NCT00531934|467262523|FG001|Overall Study|Death|10|||
129807767|NCT00531934|467262522|FG000|Overall Study|Withdrawal by Subject|1|||
129807768|NCT00531934|467262523|FG001|Overall Study|Withdrawal by Subject|1|||
129807769|NCT00531934|467262522|FG000|Overall Study|Other|2|||
129807770|NCT00531934|467262523|FG001|Overall Study|Other|2|||
129807771|NCT00217620|467262528|FG000|Overall Study|Adverse Event|2|||
129807772|NCT00217620|467262528|FG000|Overall Study|Progression|31|||
129807773|NCT00217620|467262528|FG000|Overall Study|Not Protocol Specified|4|||
129807774|NCT00217620|467262528|FG000|Overall Study|Ineligible|13|||
129807775|NCT00217620|467262528|FG000|Overall Study|Never received treatment|1|||
129807776|NCT00825682|467262534|FG000|Overall Study|personal reasons/ inconvenience|13|||
129807777|NCT00825682|467262535|FG001|Overall Study|personal reasons/ inconvenience|5|||
130058177|NCT00871377|468168054|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
130058178|NCT00871377|468168055|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
129895481|NCT02014558|467577189|FG000|Overall Study|Lost to Follow-up|0|||
129895482|NCT02014558|467577190|FG001|Overall Study|Lost to Follow-up|0|||
129895483|NCT02014558|467577191|FG002|Overall Study|Lost to Follow-up|0|||
129895484|NCT02014558|467577192|FG003|Overall Study|Lost to Follow-up|0|||
129895485|NCT02014558|467577193|FG004|Overall Study|Lost to Follow-up|0|||
129895486|NCT02014558|467577194|FG005|Overall Study|Lost to Follow-up|0|||
130058179|NCT00871377|468168056|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
130058180|NCT00871377|468168057|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
129895487|NCT02014558|467577195|FG006|Overall Study|Lost to Follow-up|0|||
129895488|NCT02014558|467577196|FG007|Overall Study|Lost to Follow-up|0|||
129895489|NCT02014558|467577197|FG008|Overall Study|Lost to Follow-up|0|||
129895490|NCT02014558|467577198|FG009|Overall Study|Lost to Follow-up|0|||
129895491|NCT02014558|467577199|FG010|Overall Study|Lost to Follow-up|1|||
129895492|NCT02014558|467577200|FG011|Overall Study|Lost to Follow-up|0|||
129895493|NCT02014558|467577201|FG012|Overall Study|Lost to Follow-up|0|||
129895494|NCT02014558|467577189|FG000|Overall Study|Progressive Disease|1|||
130058181|NCT00871377|468168052|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
129807778|NCT01644565|467262538|FG000|Overall Study|Undisclosed Medical History|1|||
129807779|NCT01644565|467262539|FG001|Overall Study|Undisclosed Medical History|0|||
129807780|NCT01644565|467262540|FG002|Overall Study|Undisclosed Medical History|0|||
129807781|NCT01644565|467262541|FG003|Overall Study|Undisclosed Medical History|0|||
129807782|NCT01644565|467262542|FG004|Overall Study|Undisclosed Medical History|0|||
129807783|NCT01644565|467262543|FG005|Overall Study|Undisclosed Medical History|0|||
129807784|NCT01644565|467262544|FG006|Overall Study|Undisclosed Medical History|0|||
129807785|NCT01644565|467262545|FG007|Overall Study|Undisclosed Medical History|0|||
129807786|NCT01644565|467262546|FG008|Overall Study|Undisclosed Medical History|0|||
129807787|NCT01644565|467262538|FG000|Overall Study|Lost to Follow-up|0|||
129807788|NCT01644565|467262539|FG001|Overall Study|Lost to Follow-up|0|||
129807789|NCT01644565|467262540|FG002|Overall Study|Lost to Follow-up|0|||
129807790|NCT01644565|467262541|FG003|Overall Study|Lost to Follow-up|1|||
129807791|NCT01644565|467262542|FG004|Overall Study|Lost to Follow-up|0|||
129807792|NCT01644565|467262543|FG005|Overall Study|Lost to Follow-up|0|||
129807793|NCT01644565|467262544|FG006|Overall Study|Lost to Follow-up|0|||
129807794|NCT01644565|467262545|FG007|Overall Study|Lost to Follow-up|2|||
129807795|NCT01644565|467262546|FG008|Overall Study|Lost to Follow-up|0|||
129807796|NCT01644565|467262538|FG000|Overall Study|Family emergency|0|||
129807797|NCT01644565|467262539|FG001|Overall Study|Family emergency|0|||
129807798|NCT01644565|467262540|FG002|Overall Study|Family emergency|0|||
129807799|NCT01644565|467262541|FG003|Overall Study|Family emergency|0|||
129807800|NCT01644565|467262542|FG004|Overall Study|Family emergency|1|||
129807801|NCT01644565|467262543|FG005|Overall Study|Family emergency|0|||
129807802|NCT01644565|467262544|FG006|Overall Study|Family emergency|0|||
129807803|NCT01644565|467262545|FG007|Overall Study|Family emergency|0|||
129807804|NCT01644565|467262546|FG008|Overall Study|Family emergency|0|||
129807805|NCT01644565|467262538|FG000|Overall Study|Relocation|0|||
129807806|NCT01644565|467262539|FG001|Overall Study|Relocation|0|||
129807807|NCT01644565|467262540|FG002|Overall Study|Relocation|0|||
129807808|NCT01644565|467262541|FG003|Overall Study|Relocation|0|||
129807809|NCT01644565|467262542|FG004|Overall Study|Relocation|0|||
129807810|NCT01644565|467262543|FG005|Overall Study|Relocation|0|||
129807811|NCT01644565|467262544|FG006|Overall Study|Relocation|0|||
129807812|NCT01644565|467262545|FG007|Overall Study|Relocation|0|||
129807813|NCT01644565|467262546|FG008|Overall Study|Relocation|1|||
129895495|NCT02014558|467577190|FG001|Overall Study|Progressive Disease|0|||
129895496|NCT02014558|467577191|FG002|Overall Study|Progressive Disease|1|||
129895497|NCT02014558|467577192|FG003|Overall Study|Progressive Disease|1|||
129895498|NCT02014558|467577193|FG004|Overall Study|Progressive Disease|1|||
129895499|NCT02014558|467577194|FG005|Overall Study|Progressive Disease|2|||
129895500|NCT02014558|467577195|FG006|Overall Study|Progressive Disease|1|||
129895501|NCT02014558|467577196|FG007|Overall Study|Progressive Disease|6|||
129895502|NCT02014558|467577197|FG008|Overall Study|Progressive Disease|5|||
129895503|NCT02014558|467577198|FG009|Overall Study|Progressive Disease|6|||
129895504|NCT02014558|467577199|FG010|Overall Study|Progressive Disease|22|||
129807814|NCT01550289|467262547|FG000|Overall Study|Protocol Violation|1|||
129807815|NCT01550289|467262548|FG001|Overall Study|Protocol Violation|0|||
129807816|NCT01550289|467262547|FG000|Overall Study|Lost to Follow-up|1|||
129807817|NCT01550289|467262548|FG001|Overall Study|Lost to Follow-up|1|||
129807818|NCT01550289|467262547|FG000|Overall Study|Withdrawal by Subject|11|||
129807819|NCT01550289|467262548|FG001|Overall Study|Withdrawal by Subject|3|||
129807820|NCT01897454|467262549|FG000|Overall Study|Withdrawal by Subject|1|||
129807821|NCT00094172|467262552|FG000|Overall Study|Adverse Event|0|||
129807822|NCT00094172|467262553|FG001|Overall Study|Adverse Event|1|||
129807823|NCT00094172|467262552|FG000|Overall Study|Lost to Follow-up|2|||
129807824|NCT00094172|467262553|FG001|Overall Study|Lost to Follow-up|0|||
129807825|NCT00094172|467262552|FG000|Overall Study|Protocol Violation|0|||
129895505|NCT02014558|467577200|FG011|Overall Study|Progressive Disease|31|||
129895506|NCT02014558|467577201|FG012|Overall Study|Progressive Disease|6|||
129807826|NCT00094172|467262553|FG001|Overall Study|Protocol Violation|1|||
129895507|NCT02014558|467577189|FG000|Overall Study|Withdrawal by Subject|0|||
129895508|NCT02014558|467577190|FG001|Overall Study|Withdrawal by Subject|0|||
129807827|NCT00094172|467262552|FG000|Overall Study|Withdrawal by Subject|10|||
129807828|NCT00094172|467262553|FG001|Overall Study|Withdrawal by Subject|5|||
129895509|NCT02014558|467577191|FG002|Overall Study|Withdrawal by Subject|0|||
129807829|NCT00094172|467262552|FG000|Overall Study|Primary endpoint met.|1|||
129807830|NCT00094172|467262553|FG001|Overall Study|Primary endpoint met.|0|||
129807831|NCT00094172|467262552|FG000|Overall Study|Started other MS therapy due to disease|1|||
129807832|NCT00094172|467262553|FG001|Overall Study|Started other MS therapy due to disease|0|||
129807833|NCT01392443|467262558|FG000|Overall Study|Disease progression|30|||
129807834|NCT01392443|467262558|FG000|Overall Study|Adverse Event|24|||
129807835|NCT01392443|467262558|FG000|Overall Study|Death|7|||
129807836|NCT01392443|467262558|FG000|Overall Study|Withdrawal by Subject|5|||
129807837|NCT01392443|467262558|FG000|Overall Study|Lost to Follow-up|1|||
129807838|NCT01392443|467262558|FG000|Overall Study|Protocol Violation|1|||
129807839|NCT01977794|467262559|FG000|Overall Study|Adverse Event|2|||
129807840|NCT01977794|467262560|FG001|Overall Study|Adverse Event|2|||
129807841|NCT01977794|467262559|FG000|Overall Study|Lost to Follow-up|2|||
129807842|NCT01977794|467262560|FG001|Overall Study|Lost to Follow-up|1|||
129895510|NCT02014558|467577192|FG003|Overall Study|Withdrawal by Subject|0|||
129807843|NCT01977794|467262559|FG000|Overall Study|Protocol Violation|1|||
129807844|NCT01977794|467262560|FG001|Overall Study|Protocol Violation|0|||
129807845|NCT01977794|467262559|FG000|Overall Study|Death|1|||
129807846|NCT01977794|467262560|FG001|Overall Study|Death|1|||
129807847|NCT01977794|467262559|FG000|Overall Study|Withdrew consent|2|||
129807848|NCT01977794|467262560|FG001|Overall Study|Withdrew consent|1|||
129807849|NCT01977794|467262559|FG000|Overall Study|Other|0|||
129807850|NCT01977794|467262560|FG001|Overall Study|Other|1|||
129807851|NCT00827502|467262563|FG000|Overall Study|randomized but not treated|11|||
129807852|NCT00827502|467262563|FG000|Overall Study|Adverse Event|1|||
129807853|NCT00827502|467262563|FG000|Overall Study|Lost to Follow-up|4|||
129807854|NCT00827502|467262563|FG000|Overall Study|Withdrawal by Subject|5|||
129807855|NCT02478632|467262564|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
129807856|NCT02478632|467262565|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
129807857|NCT02478632|467262564|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
129807858|NCT02478632|467262565|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
129807859|NCT02478632|467262564|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
129807860|NCT02478632|467262565|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
129807861|NCT03019185|467262566|FG000|Overall Study|Lost to Follow-up|3|||
129807862|NCT03019185|467262567|FG001|Overall Study|Lost to Follow-up|0|||
129895511|NCT02014558|467577193|FG004|Overall Study|Withdrawal by Subject|1|||
129895512|NCT02014558|467577194|FG005|Overall Study|Withdrawal by Subject|0|||
129895513|NCT02014558|467577195|FG006|Overall Study|Withdrawal by Subject|0|||
129895514|NCT02014558|467577196|FG007|Overall Study|Withdrawal by Subject|0|||
129895515|NCT02014558|467577197|FG008|Overall Study|Withdrawal by Subject|0|||
129895516|NCT02014558|467577198|FG009|Overall Study|Withdrawal by Subject|2|||
129895517|NCT02014558|467577199|FG010|Overall Study|Withdrawal by Subject|6|||
129895518|NCT02014558|467577200|FG011|Overall Study|Withdrawal by Subject|10|||
129807863|NCT03019185|467262568|FG002|Overall Study|Lost to Follow-up|2|||
129807864|NCT03019185|467262566|FG000|Overall Study|Withdrawal by Subject|1|||
129807865|NCT03019185|467262567|FG001|Overall Study|Withdrawal by Subject|1|||
129807866|NCT03019185|467262568|FG002|Overall Study|Withdrawal by Subject|0|||
129807867|NCT03019185|467262566|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
129807868|NCT03019185|467262567|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
129807869|NCT03019185|467262568|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
129807870|NCT03019185|467262566|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
129807871|NCT03019185|467262567|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
129807872|NCT03019185|467262568|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
129807873|NCT03355365|467262569|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
129807874|NCT03355365|467262570|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
129807875|NCT03355365|467262569|FG000|Year 1, First Intervention|Protocol Violation|1|||
129807876|NCT03355365|467262570|FG001|Year 1, First Intervention|Protocol Violation|0|||
129807877|NCT03355365|467262569|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
129807878|NCT03355365|467262570|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
129807879|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
129807880|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
130112309|NCT01571635|468371127|FG002|Overall Study|Lack of Efficacy|0|||
129807881|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
129807882|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
129807883|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|severe COVID|0|||
129807884|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|severe COVID|1|||
129807885|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
129807886|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
129807887|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Adverse Event|3|||
129807888|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Adverse Event|0|||
129807889|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
129807890|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
129807891|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
129807892|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
129807893|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Physician Decision|0|||
129807894|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Physician Decision|2|||
129807895|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
129807896|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
129807897|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
129807898|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
129807899|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
129807900|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
129807901|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
129807902|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
129807903|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
129895519|NCT02014558|467577201|FG012|Overall Study|Withdrawal by Subject|0|||
129895520|NCT02014558|467577189|FG000|Overall Study|Miscellaneous|2|||
129895521|NCT02014558|467577190|FG001|Overall Study|Miscellaneous|1|||
129895522|NCT02014558|467577191|FG002|Overall Study|Miscellaneous|1|||
129895523|NCT02014558|467577192|FG003|Overall Study|Miscellaneous|1|||
129895524|NCT02014558|467577193|FG004|Overall Study|Miscellaneous|0|||
129895525|NCT02014558|467577194|FG005|Overall Study|Miscellaneous|1|||
129895526|NCT02014558|467577195|FG006|Overall Study|Miscellaneous|0|||
129895527|NCT02014558|467577196|FG007|Overall Study|Miscellaneous|1|||
129895528|NCT02014558|467577197|FG008|Overall Study|Miscellaneous|1|||
129895529|NCT02014558|467577198|FG009|Overall Study|Miscellaneous|3|||
129895530|NCT02014558|467577199|FG010|Overall Study|Miscellaneous|12|||
129895531|NCT02014558|467577200|FG011|Overall Study|Miscellaneous|11|||
129895532|NCT02014558|467577201|FG012|Overall Study|Miscellaneous|1|||
129895533|NCT04580407|467577202|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
129895534|NCT02068885|467577205|FG000|Overall Study|Withdrew|3|||
129895535|NCT02068885|467577206|FG001|Overall Study|Withdrew|5|||
129895536|NCT02068885|467577207|FG002|Overall Study|Withdrew|8|||
129895537|NCT00828919|467577213|FG000|Overall Study|Death|0|||
129895538|NCT00828919|467577214|FG001|Overall Study|Death|1|||
129895539|NCT00828919|467577215|FG002|Overall Study|Death|2|||
129895540|NCT00828919|467577216|FG003|Overall Study|Death|0|||
129895541|NCT00828919|467577217|FG004|Overall Study|Death|0|||
129895542|NCT00828919|467577213|FG000|Overall Study|Adverse Event|2|||
129895543|NCT00828919|467577214|FG001|Overall Study|Adverse Event|2|||
129895544|NCT00828919|467577215|FG002|Overall Study|Adverse Event|2|||
129895545|NCT00828919|467577216|FG003|Overall Study|Adverse Event|1|||
129895546|NCT00828919|467577217|FG004|Overall Study|Adverse Event|3|||
129807904|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
129807905|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
129807906|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
129807907|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
129807908|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
129807909|NCT01330030|467262581|FG000|Overall Study|Lost to Follow-up|16|||
129807910|NCT01330030|467262582|FG001|Overall Study|Lost to Follow-up|17|||
129807911|NCT01781975|467262598|FG000|Overall Study|Death|1|||
129807912|NCT01781975|467262599|FG001|Overall Study|Death|0|||
129807913|NCT01781975|467262598|FG000|Overall Study|Withdrawal by Subject|1|||
129807914|NCT01781975|467262599|FG001|Overall Study|Withdrawal by Subject|1|||
129807915|NCT02404220|467262601|FG000|Overall Study|Adverse Event|0|||
129807916|NCT02404220|467262602|FG001|Overall Study|Adverse Event|0|||
129807917|NCT02404220|467262603|FG002|Overall Study|Adverse Event|1|||
129807918|NCT02404220|467262604|FG003|Overall Study|Adverse Event|0|||
129807919|NCT02404220|467262601|FG000|Overall Study|Death|5|||
129807920|NCT02404220|467262602|FG001|Overall Study|Death|5|||
129807921|NCT02404220|467262603|FG002|Overall Study|Death|3|||
129807922|NCT02404220|467262604|FG003|Overall Study|Death|8|||
129895547|NCT00828919|467577213|FG000|Overall Study|Objective progression or relapse|4|||
129895548|NCT00828919|467577214|FG001|Overall Study|Objective progression or relapse|4|||
129895549|NCT00828919|467577215|FG002|Overall Study|Objective progression or relapse|11|||
129895550|NCT00828919|467577216|FG003|Overall Study|Objective progression or relapse|0|||
129895551|NCT00828919|467577217|FG004|Overall Study|Objective progression or relapse|5|||
129895552|NCT00828919|467577213|FG000|Overall Study|No longer willing to participate in study|0|||
129895553|NCT00828919|467577214|FG001|Overall Study|No longer willing to participate in study|0|||
129895554|NCT00828919|467577215|FG002|Overall Study|No longer willing to participate in study|2|||
129895555|NCT00828919|467577216|FG003|Overall Study|No longer willing to participate in study|0|||
129895556|NCT00828919|467577217|FG004|Overall Study|No longer willing to participate in study|0|||
129895557|NCT00828919|467577213|FG000|Overall Study|Insufficient Clinical Response|0|||
129895558|NCT00828919|467577214|FG001|Overall Study|Insufficient Clinical Response|1|||
129895559|NCT00828919|467577215|FG002|Overall Study|Insufficient Clinical Response|2|||
129895560|NCT00828919|467577216|FG003|Overall Study|Insufficient Clinical Response|0|||
129895561|NCT00828919|467577217|FG004|Overall Study|Insufficient Clinical Response|0|||
129895562|NCT00828919|467577213|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895563|NCT00828919|467577214|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895564|NCT00828919|467577215|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895565|NCT00828919|467577216|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895566|NCT00828919|467577217|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
129895567|NCT00828919|467577213|FG000|Overall Study|Other|1|||
129895568|NCT00828919|467577214|FG001|Overall Study|Other|0|||
129895569|NCT00828919|467577215|FG002|Overall Study|Other|1|||
129895570|NCT00828919|467577216|FG003|Overall Study|Other|1|||
129895571|NCT00828919|467577217|FG004|Overall Study|Other|0|||
129895572|NCT00828919|467577213|FG000|Overall Study|Lost to Follow-up|0|||
129895573|NCT00828919|467577214|FG001|Overall Study|Lost to Follow-up|1|||
129895574|NCT00828919|467577215|FG002|Overall Study|Lost to Follow-up|0|||
129895575|NCT00828919|467577216|FG003|Overall Study|Lost to Follow-up|0|||
129895576|NCT00828919|467577217|FG004|Overall Study|Lost to Follow-up|0|||
129895577|NCT05567159|467577220|FG000|Overall Study|Adverse Event|4|||
129895578|NCT05567159|467577220|FG000|Overall Study|Physician Decision|3|||
129895579|NCT05567159|467577220|FG000|Overall Study|Protocol deviation|1|||
129895580|NCT03015740|467577223|FG000|Overall Study|Adverse Event|1|||
129895581|NCT03015740|467577224|FG001|Overall Study|Adverse Event|0|||
129895582|NCT03015740|467577225|FG002|Overall Study|Adverse Event|0|||
129895583|NCT03015740|467577223|FG000|Overall Study|Death|3|||
129895584|NCT03015740|467577224|FG001|Overall Study|Death|5|||
130112310|NCT01571635|468371128|FG003|Overall Study|Lack of Efficacy|1|||
129895585|NCT03015740|467577225|FG002|Overall Study|Death|0|||
130112311|NCT01571635|468371129|FG004|Overall Study|Lack of Efficacy|2|||
129895586|NCT03015740|467577223|FG000|Overall Study|Withdrawal by Subject|2|||
129895587|NCT03015740|467577224|FG001|Overall Study|Withdrawal by Subject|0|||
129807923|NCT02404220|467262601|FG000|Overall Study|Progressive Disease|0|||
129807924|NCT02404220|467262602|FG001|Overall Study|Progressive Disease|0|||
129807925|NCT02404220|467262603|FG002|Overall Study|Progressive Disease|1|||
129807926|NCT02404220|467262604|FG003|Overall Study|Progressive Disease|1|||
129807927|NCT02404220|467262601|FG000|Overall Study|Study Terminated by Sponsor|0|||
129895588|NCT03015740|467577225|FG002|Overall Study|Withdrawal by Subject|0|||
129895589|NCT02449044|467577226|FG000|Overall Study|Lost to Follow-up|2|||
129895590|NCT02449044|467577226|FG000|Overall Study|Withdrawal by Subject|13|||
129895591|NCT02449044|467577226|FG000|Overall Study|Adverse Event|30|||
129895592|NCT02449044|467577226|FG000|Overall Study|Met Withdrawal Criteria|7|||
130112312|NCT01722266|468371130|FG000|Overall Study|Withdrawal by Subject|1|||
130112313|NCT01722266|468371131|FG001|Overall Study|Withdrawal by Subject|2|||
130112314|NCT01722266|468371132|FG002|Overall Study|Withdrawal by Subject|0|||
130112315|NCT01722266|468371133|FG003|Overall Study|Withdrawal by Subject|0|||
130112316|NCT01722266|468371130|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
130112317|NCT01722266|468371131|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
130112318|NCT01722266|468371132|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
130112319|NCT01722266|468371133|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
129895593|NCT02449044|467577226|FG000|Overall Study|Physician Decision|9|||
129895594|NCT02449044|467577226|FG000|Overall Study|Sponsor Discontinued Trial|3|||
129895595|NCT02501811|467577228|FG000|Overall Study|Death|1|||
130112320|NCT01722266|468371130|FG000|Overall Study|Dropped out due to Nausea|0|||
130112321|NCT01722266|468371131|FG001|Overall Study|Dropped out due to Nausea|0|||
130112322|NCT01722266|468371132|FG002|Overall Study|Dropped out due to Nausea|2|||
130112323|NCT01722266|468371133|FG003|Overall Study|Dropped out due to Nausea|0|||
130112324|NCT02862535|468371139|FG000|Overall Study|Death|7|||
130112325|NCT02862535|468371140|FG001|Overall Study|Death|3|||
130112326|NCT02862535|468371141|FG002|Overall Study|Death|2|||
130112327|NCT02862535|468371142|FG003|Overall Study|Death|5|||
130112328|NCT02862535|468371139|FG000|Overall Study|Study Terminated by Sponsor|1|||
130112329|NCT02862535|468371140|FG001|Overall Study|Study Terminated by Sponsor|3|||
130112330|NCT02862535|468371141|FG002|Overall Study|Study Terminated by Sponsor|8|||
130112331|NCT02862535|468371142|FG003|Overall Study|Study Terminated by Sponsor|5|||
130112332|NCT02862535|468371139|FG000|Overall Study|Enrolled, not Treated|1|||
130112333|NCT02862535|468371140|FG001|Overall Study|Enrolled, not Treated|0|||
130112334|NCT02862535|468371141|FG002|Overall Study|Enrolled, not Treated|0|||
130112335|NCT02862535|468371142|FG003|Overall Study|Enrolled, not Treated|1|||
130112336|NCT02472977|468371148|FG000|Overall Study|Disease progression|4|||
130112337|NCT02472977|468371149|FG001|Overall Study|Disease progression|25|||
130112338|NCT02472977|468371150|FG002|Overall Study|Disease progression|6|||
130112339|NCT02472977|468371148|FG000|Overall Study|Withdrawal by Subject|0|||
130112340|NCT02472977|468371149|FG001|Overall Study|Withdrawal by Subject|1|||
130112341|NCT02472977|468371150|FG002|Overall Study|Withdrawal by Subject|0|||
130112342|NCT02472977|468371148|FG000|Overall Study|Study drug toxicity|2|||
130112343|NCT02472977|468371149|FG001|Overall Study|Study drug toxicity|0|||
130112344|NCT02472977|468371150|FG002|Overall Study|Study drug toxicity|2|||
130112345|NCT02472977|468371148|FG000|Overall Study|Subject request to discontinue treatment|0|||
130112346|NCT02472977|468371149|FG001|Overall Study|Subject request to discontinue treatment|1|||
130112347|NCT02472977|468371150|FG002|Overall Study|Subject request to discontinue treatment|0|||
130112348|NCT00738920|468371151|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
129895596|NCT02501811|467577229|FG001|Overall Study|Death|3|||
130112349|NCT00738920|468371152|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
129807928|NCT02404220|467262602|FG001|Overall Study|Study Terminated by Sponsor|0|||
129807929|NCT02404220|467262603|FG002|Overall Study|Study Terminated by Sponsor|2|||
129807930|NCT02404220|467262604|FG003|Overall Study|Study Terminated by Sponsor|1|||
129807931|NCT02404220|467262601|FG000|Overall Study|Withdrawal by Subject|0|||
129807932|NCT02404220|467262602|FG001|Overall Study|Withdrawal by Subject|1|||
129807933|NCT02404220|467262603|FG002|Overall Study|Withdrawal by Subject|0|||
129807934|NCT02404220|467262604|FG003|Overall Study|Withdrawal by Subject|0|||
129807935|NCT02404220|467262601|FG000|Overall Study|Enrolled but Never Treated|0|||
129807936|NCT02404220|467262602|FG001|Overall Study|Enrolled but Never Treated|2|||
129807937|NCT02404220|467262603|FG002|Overall Study|Enrolled but Never Treated|0|||
129807938|NCT02404220|467262604|FG003|Overall Study|Enrolled but Never Treated|0|||
129807939|NCT01622231|467262605|FG000|Overall Study|Physician Decision|1|||
129807940|NCT01622231|467262605|FG000|Overall Study|Withdrawal by Subject|1|||
129807941|NCT02905149|467262606|FG000|Overall Study|Lost to Follow-up|2|||
129807942|NCT02905149|467262607|FG001|Overall Study|Lost to Follow-up|0|||
129807943|NCT02329080|467262608|FG000|Overall Study|Adverse Event|1|||
129807944|NCT02329080|467262608|FG000|Overall Study|Death|4|||
129807945|NCT02329080|467262608|FG000|Overall Study|Lack of Efficacy|22|||
129807946|NCT02329080|467262608|FG000|Overall Study|Lost to Follow-up|1|||
129807947|NCT02329080|467262608|FG000|Overall Study|Physician Decision|2|||
129807948|NCT02329080|467262608|FG000|Overall Study|Partial response|4|||
129807949|NCT02329080|467262608|FG000|Overall Study|Complete response|4|||
129807950|NCT01609231|467262615|FG000|Overall Study|Adverse Event|1|||
129807951|NCT01609231|467262616|FG001|Overall Study|Adverse Event|3|||
129807952|NCT01609231|467262615|FG000|Overall Study|Physician Decision|1|||
129807953|NCT01609231|467262616|FG001|Overall Study|Physician Decision|0|||
129807954|NCT01609231|467262615|FG000|Overall Study|Withdrawal by Subject|1|||
129807955|NCT01609231|467262616|FG001|Overall Study|Withdrawal by Subject|0|||
129807956|NCT02846324|467262620|FG000|Overall Study|Other|1|||
129807957|NCT02846324|467262621|FG001|Overall Study|Other|0|||
129807958|NCT02846324|467262622|FG002|Overall Study|Other|0|||
129807959|NCT02846324|467262623|FG003|Overall Study|Other|0|||
129807960|NCT02846324|467262620|FG000|Overall Study|Withdrawal by Subject|1|||
129807961|NCT02846324|467262621|FG001|Overall Study|Withdrawal by Subject|0|||
129807962|NCT02846324|467262622|FG002|Overall Study|Withdrawal by Subject|4|||
129807963|NCT02846324|467262623|FG003|Overall Study|Withdrawal by Subject|0|||
129807964|NCT04203797|467262628|FG000|Overall Study|Adverse Event|1|||
129807965|NCT04203797|467262629|FG001|Overall Study|Adverse Event|0|||
129807966|NCT04203797|467262628|FG000|Overall Study|Did not complete End of Study follow-up|1|||
129807967|NCT04203797|467262629|FG001|Overall Study|Did not complete End of Study follow-up|0|||
129807968|NCT00516074|467262630|FG000|Overall Study|Adverse Event|0|||
129807969|NCT00516074|467262631|FG001|Overall Study|Adverse Event|1|||
129895597|NCT02501811|467577230|FG002|Overall Study|Death|2|||
129895598|NCT02501811|467577231|FG003|Overall Study|Death|3|||
129895599|NCT02501811|467577228|FG000|Overall Study|Withdrawal by Subject|3|||
129895600|NCT02501811|467577229|FG001|Overall Study|Withdrawal by Subject|3|||
129895601|NCT02501811|467577230|FG002|Overall Study|Withdrawal by Subject|2|||
129895602|NCT02501811|467577231|FG003|Overall Study|Withdrawal by Subject|3|||
129895603|NCT02501811|467577228|FG000|Overall Study|Lost to Follow-up|0|||
129895604|NCT02501811|467577229|FG001|Overall Study|Lost to Follow-up|0|||
129895605|NCT02501811|467577230|FG002|Overall Study|Lost to Follow-up|2|||
129895606|NCT02501811|467577231|FG003|Overall Study|Lost to Follow-up|1|||
129895607|NCT02624778|467578489|FG000|Overall Study|Lost to Follow-up|0|||
129895608|NCT02624778|467578490|FG001|Overall Study|Lost to Follow-up|0|||
129895609|NCT02624778|467578491|FG002|Overall Study|Lost to Follow-up|1|||
129895610|NCT02624778|467578492|FG003|Overall Study|Lost to Follow-up|0|||
129895611|NCT02624778|467578493|FG004|Overall Study|Lost to Follow-up|0|||
129895612|NCT02624778|467578494|FG005|Overall Study|Lost to Follow-up|0|||
129807970|NCT00516074|467262630|FG000|Overall Study|Subject Decision|4|||
129807971|NCT00516074|467262631|FG001|Overall Study|Subject Decision|2|||
129807972|NCT00516074|467262630|FG000|Overall Study|Loss of Glucose Control|2|||
129807973|NCT00516074|467262631|FG001|Overall Study|Loss of Glucose Control|0|||
129807974|NCT03540030|467262632|FG000|Overall Study|Withdrawal by Subject|2|||
129807975|NCT03540030|467262633|FG001|Overall Study|Withdrawal by Subject|1|||
129807976|NCT03540030|467262632|FG000|Overall Study|screen fail|7|||
129807977|NCT03540030|467262633|FG001|Overall Study|screen fail|1|||
129807978|NCT03540030|467262632|FG000|Overall Study|never had surgery after signing consent|9|||
129807979|NCT03540030|467262633|FG001|Overall Study|never had surgery after signing consent|1|||
129807980|NCT00003487|467262635|FG000|Overall Study|Not evaluable|2|||
129807981|NCT03855228|467262637|FG000|Overall Study|Adverse Event|2|||
129807982|NCT03855228|467262638|FG001|Overall Study|Adverse Event|4|||
129807983|NCT03855228|467262639|FG002|Overall Study|Adverse Event|4|||
129807984|NCT03855228|467262640|FG003|Overall Study|Adverse Event|8|||
129807985|NCT03855228|467262637|FG000|Overall Study|Treatment Failure|1|||
129807986|NCT03855228|467262638|FG001|Overall Study|Treatment Failure|2|||
129807987|NCT03855228|467262639|FG002|Overall Study|Treatment Failure|1|||
129807988|NCT03855228|467262640|FG003|Overall Study|Treatment Failure|8|||
129807989|NCT03855228|467262637|FG000|Overall Study|Lost to Follow-up|0|||
129807990|NCT03855228|467262638|FG001|Overall Study|Lost to Follow-up|0|||
129895613|NCT02624778|467578495|FG006|Overall Study|Lost to Follow-up|0|||
129807991|NCT03855228|467262639|FG002|Overall Study|Lost to Follow-up|0|||
129807992|NCT03855228|467262640|FG003|Overall Study|Lost to Follow-up|1|||
129807993|NCT03855228|467262637|FG000|Overall Study|Protocol Violation|0|||
129807994|NCT03855228|467262638|FG001|Overall Study|Protocol Violation|1|||
129807995|NCT03855228|467262639|FG002|Overall Study|Protocol Violation|2|||
129807996|NCT03855228|467262640|FG003|Overall Study|Protocol Violation|1|||
129807997|NCT03855228|467262637|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
129807998|NCT03855228|467262638|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
129807999|NCT03855228|467262639|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
129808000|NCT03855228|467262640|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
129895614|NCT02624778|467578496|FG007|Overall Study|Lost to Follow-up|0|||
129808001|NCT00913380|467262643|FG000|Clinical Outcomes|Lost to Follow-up|6|||
129808002|NCT00913380|467262644|FG001|Clinical Outcomes|Lost to Follow-up|6|||
129808003|NCT02004522|467262648|FG000|Overall Study|Adverse Event|55|||
129808004|NCT02004522|467262649|FG001|Overall Study|Adverse Event|6|||
129808005|NCT02004522|467262648|FG000|Overall Study|Withdrawal by Subject|13|||
129808006|NCT02004522|467262649|FG001|Overall Study|Withdrawal by Subject|7|||
129808007|NCT02004522|467262648|FG000|Overall Study|Death|12|||
129808008|NCT02004522|467262649|FG001|Overall Study|Death|3|||
129808009|NCT02004522|467262648|FG000|Overall Study|Physician Decision|3|||
129808010|NCT02004522|467262649|FG001|Overall Study|Physician Decision|4|||
129808011|NCT02004522|467262648|FG000|Overall Study|Protocol Violation|1|||
129808012|NCT02004522|467262649|FG001|Overall Study|Protocol Violation|0|||
129808013|NCT02004522|467262648|FG000|Overall Study|Other is reason listed by PI|4|||
129808014|NCT02004522|467262649|FG001|Overall Study|Other is reason listed by PI|1|||
129808015|NCT02004522|467262648|FG000|Overall Study|Never Dosed|2|||
129808016|NCT02004522|467262649|FG001|Overall Study|Never Dosed|4|||
129808017|NCT02004522|467262648|FG000|Overall Study|Disease Progression|35|||
129808018|NCT02004522|467262649|FG001|Overall Study|Disease Progression|31|||
129808019|NCT02004522|467262648|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
129808020|NCT02004522|467262649|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
129808021|NCT01787331|467262650|FG000|Overall Study|Physician Decision|1|||
129808022|NCT01787331|467262650|FG000|Overall Study|Withdrawal by Subject|1|||
129808023|NCT00667875|467262651|FG000|Overall Study|Adverse Event|0|||
129808024|NCT00667875|467262652|FG001|Overall Study|Adverse Event|2|||
129808025|NCT00667875|467262653|FG002|Overall Study|Adverse Event|6|||
129808026|NCT00667875|467262651|FG000|Overall Study|Withdrawal by Subject|10|||
129808027|NCT00667875|467262652|FG001|Overall Study|Withdrawal by Subject|9|||
129808028|NCT00667875|467262653|FG002|Overall Study|Withdrawal by Subject|7|||
129808029|NCT00450255|467262654|FG000|Overall Study|Prior RFA ablation of liver|1|||
129808030|NCT01696071|467262655|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
129808031|NCT01696071|467262656|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
129808032|NCT00142298|467262659|FG000|Overall Study|Adverse Event|10|||
129808033|NCT00142298|467262660|FG001|Overall Study|Adverse Event|10|||
129808034|NCT00142298|467262661|FG002|Overall Study|Adverse Event|1|||
129808035|NCT00142298|467262662|FG003|Overall Study|Adverse Event|5|||
129808036|NCT00142298|467262663|FG004|Overall Study|Adverse Event|2|||
129808037|NCT00142298|467262664|FG005|Overall Study|Adverse Event|2|||
129808038|NCT00142298|467262665|FG006|Overall Study|Adverse Event|0|||
129808039|NCT00142298|467262666|FG007|Overall Study|Adverse Event|0|||
129808040|NCT00142298|467262667|FG008|Overall Study|Adverse Event|0|||
129808041|NCT00142298|467262668|FG009|Overall Study|Adverse Event|0|||
129808042|NCT00142298|467262659|FG000|Overall Study|Clinical disease progression|1|||
129808043|NCT00142298|467262660|FG001|Overall Study|Clinical disease progression|0|||
129808044|NCT00142298|467262661|FG002|Overall Study|Clinical disease progression|0|||
129808045|NCT00142298|467262662|FG003|Overall Study|Clinical disease progression|0|||
129808046|NCT00142298|467262663|FG004|Overall Study|Clinical disease progression|0|||
129808047|NCT00142298|467262664|FG005|Overall Study|Clinical disease progression|0|||
129808048|NCT00142298|467262665|FG006|Overall Study|Clinical disease progression|0|||
129808049|NCT00142298|467262666|FG007|Overall Study|Clinical disease progression|0|||
129808050|NCT00142298|467262667|FG008|Overall Study|Clinical disease progression|0|||
129808051|NCT00142298|467262668|FG009|Overall Study|Clinical disease progression|0|||
129808052|NCT00142298|467262659|FG000|Overall Study|Death|1|||
129808053|NCT00142298|467262660|FG001|Overall Study|Death|1|||
129808054|NCT00142298|467262661|FG002|Overall Study|Death|1|||
129808055|NCT00142298|467262662|FG003|Overall Study|Death|0|||
129808056|NCT00142298|467262663|FG004|Overall Study|Death|0|||
129895615|NCT02624778|467578497|FG008|Overall Study|Lost to Follow-up|0|||
129895616|NCT02624778|467578489|FG000|Overall Study|Withdrawal by Subject|0|||
129895617|NCT02624778|467578490|FG001|Overall Study|Withdrawal by Subject|1|||
129808057|NCT00142298|467262664|FG005|Overall Study|Death|6|||
129808058|NCT00142298|467262665|FG006|Overall Study|Death|0|||
129808059|NCT00142298|467262666|FG007|Overall Study|Death|0|||
129895618|NCT02624778|467578491|FG002|Overall Study|Withdrawal by Subject|0|||
129895619|NCT02624778|467578492|FG003|Overall Study|Withdrawal by Subject|0|||
129895620|NCT02624778|467578493|FG004|Overall Study|Withdrawal by Subject|0|||
129895621|NCT02624778|467578494|FG005|Overall Study|Withdrawal by Subject|1|||
129895622|NCT02624778|467578495|FG006|Overall Study|Withdrawal by Subject|1|||
129808060|NCT00142298|467262667|FG008|Overall Study|Death|0|||
129808061|NCT00142298|467262668|FG009|Overall Study|Death|0|||
129808062|NCT00142298|467262659|FG000|Overall Study|Lack of Efficacy|44|||
129808063|NCT00142298|467262660|FG001|Overall Study|Lack of Efficacy|62|||
129808064|NCT00142298|467262661|FG002|Overall Study|Lack of Efficacy|9|||
129808065|NCT00142298|467262662|FG003|Overall Study|Lack of Efficacy|12|||
129808066|NCT00142298|467262663|FG004|Overall Study|Lack of Efficacy|1|||
129808067|NCT00142298|467262664|FG005|Overall Study|Lack of Efficacy|0|||
129808068|NCT00142298|467262665|FG006|Overall Study|Lack of Efficacy|0|||
129808069|NCT00142298|467262666|FG007|Overall Study|Lack of Efficacy|1|||
129808070|NCT00142298|467262667|FG008|Overall Study|Lack of Efficacy|0|||
129808071|NCT00142298|467262668|FG009|Overall Study|Lack of Efficacy|0|||
129808072|NCT00142298|467262659|FG000|Overall Study|Non-compliance|15|||
129808073|NCT00142298|467262660|FG001|Overall Study|Non-compliance|13|||
129808074|NCT00142298|467262661|FG002|Overall Study|Non-compliance|0|||
129808075|NCT00142298|467262662|FG003|Overall Study|Non-compliance|6|||
129808076|NCT00142298|467262663|FG004|Overall Study|Non-compliance|1|||
129808077|NCT00142298|467262664|FG005|Overall Study|Non-compliance|0|||
129808078|NCT00142298|467262665|FG006|Overall Study|Non-compliance|0|||
129808079|NCT00142298|467262666|FG007|Overall Study|Non-compliance|3|||
129808080|NCT00142298|467262667|FG008|Overall Study|Non-compliance|3|||
129808081|NCT00142298|467262668|FG009|Overall Study|Non-compliance|0|||
129808082|NCT00142298|467262659|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
129808083|NCT00142298|467262660|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
129895623|NCT02624778|467578496|FG007|Overall Study|Withdrawal by Subject|1|||
129895624|NCT02624778|467578497|FG008|Overall Study|Withdrawal by Subject|1|||
129895625|NCT02624778|467578489|FG000|Overall Study|Adverse Event|0|||
129895626|NCT02624778|467578490|FG001|Overall Study|Adverse Event|0|||
129895627|NCT02624778|467578491|FG002|Overall Study|Adverse Event|0|||
129895628|NCT02624778|467578492|FG003|Overall Study|Adverse Event|0|||
129895629|NCT02624778|467578493|FG004|Overall Study|Adverse Event|0|||
129895630|NCT02624778|467578494|FG005|Overall Study|Adverse Event|0|||
129895631|NCT02624778|467578495|FG006|Overall Study|Adverse Event|0|||
129895632|NCT02624778|467578496|FG007|Overall Study|Adverse Event|0|||
129895633|NCT02624778|467578497|FG008|Overall Study|Adverse Event|2|||
129895634|NCT02624778|467578489|FG000|Overall Study|Death|0|||
129895635|NCT02624778|467578490|FG001|Overall Study|Death|0|||
129895636|NCT02624778|467578491|FG002|Overall Study|Death|0|||
129895637|NCT02624778|467578492|FG003|Overall Study|Death|0|||
129895638|NCT02624778|467578493|FG004|Overall Study|Death|0|||
129895639|NCT02624778|467578494|FG005|Overall Study|Death|0|||
129895640|NCT02624778|467578495|FG006|Overall Study|Death|1|||
129895641|NCT02624778|467578496|FG007|Overall Study|Death|0|||
129895642|NCT02624778|467578497|FG008|Overall Study|Death|0|||
129895643|NCT02624778|467578489|FG000|Overall Study|Physician Decision|0|||
129895644|NCT02624778|467578490|FG001|Overall Study|Physician Decision|0|||
129895645|NCT02624778|467578491|FG002|Overall Study|Physician Decision|0|||
129895646|NCT02624778|467578492|FG003|Overall Study|Physician Decision|0|||
129895647|NCT02624778|467578493|FG004|Overall Study|Physician Decision|0|||
129895648|NCT02624778|467578494|FG005|Overall Study|Physician Decision|0|||
129895649|NCT02624778|467578495|FG006|Overall Study|Physician Decision|0|||
129895650|NCT02624778|467578496|FG007|Overall Study|Physician Decision|3|||
129895651|NCT02624778|467578497|FG008|Overall Study|Physician Decision|3|||
129895652|NCT01537133|467578505|FG000|Overall Study|Withdrawal by Subject|2|||
129895653|NCT01537133|467578506|FG001|Overall Study|Withdrawal by Subject|0|||
129895654|NCT01537133|467578507|FG002|Overall Study|Withdrawal by Subject|0|||
129895655|NCT01537133|467578508|FG003|Overall Study|Withdrawal by Subject|0|||
129895656|NCT01537133|467578505|FG000|Overall Study|Lost to Follow-up|1|||
129895657|NCT01537133|467578506|FG001|Overall Study|Lost to Follow-up|0|||
129895658|NCT01537133|467578507|FG002|Overall Study|Lost to Follow-up|0|||
129895659|NCT01537133|467578508|FG003|Overall Study|Lost to Follow-up|0|||
129895660|NCT00531479|467578509|FG000|Overall Study|Death|68|||
129808084|NCT00142298|467262661|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
129808085|NCT00142298|467262662|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
129808086|NCT00142298|467262663|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
129808087|NCT00142298|467262664|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
129808088|NCT00142298|467262665|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
129808089|NCT00142298|467262666|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
129808090|NCT00142298|467262667|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
129895661|NCT00531479|467578510|FG001|Overall Study|Death|71|||
129895662|NCT00531479|467578509|FG000|Overall Study|Lost to Follow-up|0|||
129895663|NCT00531479|467578510|FG001|Overall Study|Lost to Follow-up|2|||
129895664|NCT00531479|467578509|FG000|Overall Study|Other|0|||
129895665|NCT00531479|467578510|FG001|Overall Study|Other|1|||
129895666|NCT00531479|467578509|FG000|Overall Study|Withdrawal by Subject|6|||
129895667|NCT00531479|467578510|FG001|Overall Study|Withdrawal by Subject|6|||
129895668|NCT00531479|467578509|FG000|Overall Study|Did not receive treatment|2|||
129895669|NCT00531479|467578510|FG001|Overall Study|Did not receive treatment|3|||
129895670|NCT02501629|467578518|FG000|Overall Study|Death|0|||
129895671|NCT02501629|467578519|FG001|Overall Study|Death|1|||
129895672|NCT02501629|467578518|FG000|Overall Study|Withdrawn from study by sponsor|1|||
129979657|NCT00403767|467889418|FG001|Overall Study|Protocol Violation|124|||
129895673|NCT02501629|467578519|FG001|Overall Study|Withdrawn from study by sponsor|0|||
129895674|NCT02501629|467578518|FG000|Overall Study|Early termination by sponsor|1|||
129895675|NCT02501629|467578519|FG001|Overall Study|Early termination by sponsor|0|||
129895676|NCT02501629|467578518|FG000|Overall Study|Withdrawal by Subject|3|||
129895677|NCT02501629|467578519|FG001|Overall Study|Withdrawal by Subject|5|||
129895678|NCT02501629|467578518|FG000|Overall Study|Subject did not return to site|0|||
129895679|NCT02501629|467578519|FG001|Overall Study|Subject did not return to site|1|||
129895680|NCT00868231|467578522|FG000|Treatment Period 1|Adverse Event|0|||
129895681|NCT00868231|467578523|FG001|Treatment Period 1|Adverse Event|0|||
129895682|NCT00868231|467578524|FG002|Treatment Period 1|Adverse Event|0|||
130112350|NCT00738920|468371153|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
129808091|NCT00142298|467262668|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
129808092|NCT00142298|467262659|FG000|Overall Study|Pregnancy|4|||
129808093|NCT00142298|467262660|FG001|Overall Study|Pregnancy|4|||
129808094|NCT00142298|467262661|FG002|Overall Study|Pregnancy|2|||
129808095|NCT00142298|467262662|FG003|Overall Study|Pregnancy|3|||
129808096|NCT00142298|467262663|FG004|Overall Study|Pregnancy|0|||
129808097|NCT00142298|467262664|FG005|Overall Study|Pregnancy|0|||
129808098|NCT00142298|467262665|FG006|Overall Study|Pregnancy|0|||
129808099|NCT00142298|467262666|FG007|Overall Study|Pregnancy|0|||
129808100|NCT00142298|467262667|FG008|Overall Study|Pregnancy|1|||
129808101|NCT00142298|467262668|FG009|Overall Study|Pregnancy|0|||
129808102|NCT00142298|467262659|FG000|Overall Study|Virologic breakthrough|19|||
129808103|NCT00142298|467262660|FG001|Overall Study|Virologic breakthrough|23|||
129808104|NCT00142298|467262661|FG002|Overall Study|Virologic breakthrough|9|||
129808105|NCT00142298|467262662|FG003|Overall Study|Virologic breakthrough|7|||
129808106|NCT00142298|467262663|FG004|Overall Study|Virologic breakthrough|2|||
129808107|NCT00142298|467262664|FG005|Overall Study|Virologic breakthrough|3|||
129808108|NCT00142298|467262665|FG006|Overall Study|Virologic breakthrough|3|||
129808109|NCT00142298|467262666|FG007|Overall Study|Virologic breakthrough|0|||
129808110|NCT00142298|467262667|FG008|Overall Study|Virologic breakthrough|0|||
129808111|NCT00142298|467262668|FG009|Overall Study|Virologic breakthrough|0|||
129895683|NCT00868231|467578525|FG003|Treatment Period 1|Adverse Event|0|||
129895684|NCT00868231|467578526|FG004|Treatment Period 1|Adverse Event|1|||
129895685|NCT00868231|467578527|FG005|Treatment Period 1|Adverse Event|0|||
129895686|NCT00868231|467578522|FG000|Treatment Period 2|Adverse Event|1|||
129895687|NCT00868231|467578523|FG001|Treatment Period 2|Adverse Event|0|||
129895688|NCT00868231|467578524|FG002|Treatment Period 2|Adverse Event|0|||
129895689|NCT00868231|467578525|FG003|Treatment Period 2|Adverse Event|0|||
129895690|NCT00868231|467578526|FG004|Treatment Period 2|Adverse Event|0|||
129895691|NCT00868231|467578527|FG005|Treatment Period 2|Adverse Event|0|||
129895692|NCT00868231|467578522|FG000|Treatment Period 3|Adverse Event|0|||
129895693|NCT00868231|467578523|FG001|Treatment Period 3|Adverse Event|0|||
129808112|NCT00142298|467262659|FG000|Overall Study|Other- not specified|0|||
129808113|NCT00142298|467262660|FG001|Overall Study|Other- not specified|3|||
129808114|NCT00142298|467262661|FG002|Overall Study|Other- not specified|0|||
129808115|NCT00142298|467262662|FG003|Overall Study|Other- not specified|1|||
129895694|NCT00868231|467578524|FG002|Treatment Period 3|Adverse Event|1|||
129895695|NCT00868231|467578525|FG003|Treatment Period 3|Adverse Event|0|||
129895696|NCT00868231|467578526|FG004|Treatment Period 3|Adverse Event|0|||
129895697|NCT00868231|467578527|FG005|Treatment Period 3|Adverse Event|0|||
129895698|NCT01124162|467578532|FG000|First Intervention|Adverse Event|2|||
129895699|NCT01124162|467578533|FG001|First Intervention|Adverse Event|0|||
130058182|NCT00871377|468168053|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
130058183|NCT00871377|468168054|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
130058184|NCT00871377|468168055|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
130058185|NCT00871377|468168056|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
130058186|NCT00871377|468168057|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
130058187|NCT00871377|468168052|FG000|Third Intervention (10 Weeks)|Death|0|||
129895700|NCT01124162|467578532|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129895701|NCT01124162|467578533|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129895702|NCT02680756|467578536|FG000|Overall Study|Adverse Event|10|||
129895703|NCT02680756|467578537|FG001|Overall Study|Adverse Event|2|||
129895704|NCT02680756|467578536|FG000|Overall Study|Lost to Follow-up|7|||
129808116|NCT00142298|467262663|FG004|Overall Study|Other- not specified|0|||
129808117|NCT00142298|467262664|FG005|Overall Study|Other- not specified|0|||
129808118|NCT00142298|467262665|FG006|Overall Study|Other- not specified|0|||
129808119|NCT00142298|467262666|FG007|Overall Study|Other- not specified|0|||
129808120|NCT00142298|467262667|FG008|Overall Study|Other- not specified|0|||
129808121|NCT00142298|467262668|FG009|Overall Study|Other- not specified|0|||
129808122|NCT00142298|467262659|FG000|Overall Study|Lost to Follow-up|0|||
129808123|NCT00142298|467262660|FG001|Overall Study|Lost to Follow-up|0|||
129808124|NCT00142298|467262661|FG002|Overall Study|Lost to Follow-up|0|||
129808125|NCT00142298|467262662|FG003|Overall Study|Lost to Follow-up|0|||
129808126|NCT00142298|467262663|FG004|Overall Study|Lost to Follow-up|0|||
129808127|NCT00142298|467262664|FG005|Overall Study|Lost to Follow-up|0|||
129808128|NCT00142298|467262665|FG006|Overall Study|Lost to Follow-up|2|||
129808129|NCT00142298|467262666|FG007|Overall Study|Lost to Follow-up|0|||
129808130|NCT00142298|467262667|FG008|Overall Study|Lost to Follow-up|0|||
129808131|NCT00142298|467262668|FG009|Overall Study|Lost to Follow-up|0|||
129808132|NCT00142298|467262659|FG000|Overall Study|Treatment Failure|0|||
129808133|NCT00142298|467262660|FG001|Overall Study|Treatment Failure|0|||
129808134|NCT00142298|467262661|FG002|Overall Study|Treatment Failure|0|||
129808135|NCT00142298|467262662|FG003|Overall Study|Treatment Failure|0|||
129895705|NCT02680756|467578537|FG001|Overall Study|Lost to Follow-up|6|||
129895706|NCT02680756|467578536|FG000|Overall Study|Withdrawal by Subject|5|||
130058188|NCT00871377|468168053|FG001|Third Intervention (10 Weeks)|Death|0|||
129808136|NCT00142298|467262663|FG004|Overall Study|Treatment Failure|0|||
129808137|NCT00142298|467262664|FG005|Overall Study|Treatment Failure|2|||
129808138|NCT00142298|467262665|FG006|Overall Study|Treatment Failure|2|||
129808139|NCT00142298|467262666|FG007|Overall Study|Treatment Failure|0|||
129808140|NCT00142298|467262667|FG008|Overall Study|Treatment Failure|0|||
129895707|NCT02680756|467578537|FG001|Overall Study|Withdrawal by Subject|5|||
129895708|NCT02680756|467578536|FG000|Overall Study|Physician Decision|4|||
130058189|NCT00871377|468168054|FG002|Third Intervention (10 Weeks)|Death|0|||
129808141|NCT00142298|467262668|FG009|Overall Study|Treatment Failure|0|||
129808142|NCT00300274|467262669|FG000|Overall Study|Withdrawal by Subject|12|||
129808143|NCT00300274|467262670|FG001|Overall Study|Withdrawal by Subject|3|||
129808144|NCT00300274|467262671|FG002|Overall Study|Withdrawal by Subject|14|||
129808145|NCT00300274|467262669|FG000|Overall Study|Lost to Follow-up|3|||
129808146|NCT00300274|467262670|FG001|Overall Study|Lost to Follow-up|4|||
129808147|NCT00300274|467262671|FG002|Overall Study|Lost to Follow-up|5|||
129808148|NCT00300274|467262669|FG000|Overall Study|Death|31|||
129808149|NCT00300274|467262670|FG001|Overall Study|Death|20|||
129808150|NCT00300274|467262671|FG002|Overall Study|Death|25|||
129808151|NCT00300274|467262669|FG000|Overall Study|Re-transplant|0|||
129808152|NCT00300274|467262670|FG001|Overall Study|Re-transplant|0|||
129808153|NCT00300274|467262671|FG002|Overall Study|Re-transplant|1|||
129808154|NCT05147428|467262674|FG000|Overall Study|Removed prior to mailing|289|||
129808155|NCT05147428|467262675|FG001|Overall Study|Removed prior to mailing|306|||
129808156|NCT05147428|467262676|FG002|Overall Study|Removed prior to mailing|270|||
129808157|NCT05147428|467262674|FG000|Overall Study|Died or disenrolled during blackout period|239|||
129808158|NCT05147428|467262675|FG001|Overall Study|Died or disenrolled during blackout period|278|||
129808159|NCT05147428|467262676|FG002|Overall Study|Died or disenrolled during blackout period|273|||
129808160|NCT03689530|467263945|FG000|Overall Study|Withdrawal by Subject|53|||
129808161|NCT03689530|467263946|FG001|Overall Study|Withdrawal by Subject|16|||
129808162|NCT04622306|467263950|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
129808163|NCT04622306|467263951|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
129808164|NCT04622306|467263952|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
129808165|NCT04622306|467263953|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
129895709|NCT02680756|467578537|FG001|Overall Study|Physician Decision|1|||
129895710|NCT02680756|467578536|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
129808166|NCT04622306|467263954|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
129808167|NCT04622306|467263955|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
129808168|NCT04622306|467263950|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808169|NCT04622306|467263951|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808170|NCT04622306|467263952|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
129895711|NCT02680756|467578537|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
129808171|NCT04622306|467263953|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
129895712|NCT02680756|467578536|FG000|Overall Study|Blood transfusion for any reason|0|||
129895713|NCT02680756|467578537|FG001|Overall Study|Blood transfusion for any reason|1|||
129895714|NCT02680756|467578536|FG000|Overall Study|Death|1|||
129895715|NCT02680756|467578537|FG001|Overall Study|Death|0|||
129895716|NCT02680756|467578536|FG000|Overall Study|Protocol Violation|1|||
129895717|NCT02680756|467578537|FG001|Overall Study|Protocol Violation|0|||
129895718|NCT02680756|467578536|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
129895719|NCT02680756|467578537|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
129895720|NCT02680756|467578536|FG000|Overall Study|None of above or not recorded|3|||
129808172|NCT04622306|467263954|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808173|NCT04622306|467263955|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808174|NCT00736944|467263956|FG000|Induction|Death|1|||
129808175|NCT00736944|467263956|FG000|Definitive Treatment|Physician Decision|1|||
129808176|NCT01601132|467263957|FG000|Overall Study|Patient withdrew consent|1|||
129808177|NCT01601132|467263957|FG000|Overall Study|Protocol deviation|1|||
129808178|NCT00142935|467263958|FG000|Overall Study|Other reason|1|||
129808179|NCT00142935|467263959|FG001|Overall Study|Other reason|1|||
129808180|NCT00142935|467263960|FG002|Overall Study|Other reason|1|||
129808181|NCT00142935|467263958|FG000|Overall Study|Lost to Follow-up|2|||
129808182|NCT00142935|467263959|FG001|Overall Study|Lost to Follow-up|5|||
129808183|NCT00142935|467263960|FG002|Overall Study|Lost to Follow-up|5|||
129808184|NCT00142935|467263958|FG000|Overall Study|Death|0|||
129808185|NCT00142935|467263959|FG001|Overall Study|Death|2|||
129808186|NCT00142935|467263960|FG002|Overall Study|Death|1|||
129895721|NCT02680756|467578537|FG001|Overall Study|None of above or not recorded|2|||
129895722|NCT01516892|467578539|FG000|Overall Study|Adverse Event|25|||
129895723|NCT01516892|467578539|FG000|Overall Study|Lack of Efficacy|35|||
129895724|NCT01516892|467578539|FG000|Overall Study|Pregnancy|5|||
129895725|NCT01516892|467578539|FG000|Overall Study|Lost to Follow-up|82|||
129895726|NCT01516892|467578539|FG000|Overall Study|Subject Withdrew Consent|92|||
129895727|NCT01516892|467578539|FG000|Overall Study|Protocol Violation|60|||
129895728|NCT01516892|467578539|FG000|Overall Study|Other Miscellaneous Reasons|43|||
129895729|NCT01516892|467578539|FG000|Overall Study|Missing|1|||
129895730|NCT04381494|467578540|FG000|Overall Study|Early termination of trial|19|||
129895731|NCT04381494|467578540|FG000|Overall Study|Investigator's discretion|1|||
129895732|NCT04381494|467578540|FG000|Overall Study|Withdrawal by Subject|9|||
129895733|NCT04381494|467578540|FG000|Overall Study|NSCLC disease progression|4|||
129895734|NCT04381494|467578540|FG000|Overall Study|Device-Related Adverse Event|2|||
129895735|NCT04310579|467578541|FG000|Overall Study|Adverse Event|0|||
129895736|NCT04310579|467578542|FG001|Overall Study|Adverse Event|0|||
129895737|NCT04310579|467578543|FG002|Overall Study|Adverse Event|0|||
129895738|NCT04310579|467578544|FG003|Overall Study|Adverse Event|0|||
129895739|NCT04310579|467578545|FG004|Overall Study|Adverse Event|0|||
130058190|NCT00871377|468168055|FG003|Third Intervention (10 Weeks)|Death|1|||
130058191|NCT00871377|468168056|FG004|Third Intervention (10 Weeks)|Death|0|||
129895740|NCT04310579|467578546|FG005|Overall Study|Adverse Event|0|||
129895741|NCT04310579|467578547|FG006|Overall Study|Adverse Event|2|||
129895742|NCT04310579|467578548|FG007|Overall Study|Adverse Event|0|||
130058192|NCT00871377|468168057|FG005|Third Intervention (10 Weeks)|Death|0|||
129895743|NCT04310579|467578549|FG008|Overall Study|Adverse Event|1|||
129895744|NCT04310579|467578550|FG009|Overall Study|Adverse Event|1|||
129895745|NCT04310579|467578551|FG010|Overall Study|Adverse Event|0|||
129808187|NCT02980783|467263962|FG000|Overall Study|Lost to Follow-up|1|||
129808188|NCT02589405|467263965|FG000|Overall Study|Adverse Event|3|||
129808189|NCT02589405|467263965|FG000|Overall Study|Withdrawal by Subject|1|||
129808190|NCT04545060|467263968|FG000|Overall Study|Adverse Event|0|||
129808191|NCT04545060|467263969|FG001|Overall Study|Adverse Event|1|||
129808192|NCT04545060|467263968|FG000|Overall Study|Death|0|||
129808193|NCT04545060|467263969|FG001|Overall Study|Death|5|||
129808194|NCT04545060|467263968|FG000|Overall Study|Lost to Follow-up|10|||
129808195|NCT04545060|467263969|FG001|Overall Study|Lost to Follow-up|13|||
129808196|NCT04545060|467263968|FG000|Overall Study|Physician Decision|3|||
129808197|NCT04545060|467263969|FG001|Overall Study|Physician Decision|0|||
129808198|NCT04545060|467263968|FG000|Overall Study|Withdrawal by Subject|17|||
129808199|NCT04545060|467263969|FG001|Overall Study|Withdrawal by Subject|22|||
129808200|NCT00619177|467263972|FG000|Overall Study|Adverse Event|18|||
129808201|NCT00619177|467263972|FG000|Overall Study|Lost to Follow-up|2|||
129808202|NCT00619177|467263972|FG000|Overall Study|Lack of Efficacy|1|||
129808203|NCT00619177|467263972|FG000|Overall Study|Missing termination information|481|||
129808204|NCT00619177|467263972|FG000|Overall Study|Not specified reasons|6|||
129808205|NCT03082261|467263973|FG000|Overall Study|Death|4|||
129808206|NCT03082261|467263973|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
129808207|NCT03082261|467263973|FG000|Overall Study|Insurance denial|1|||
129808208|NCT03082261|467263973|FG000|Overall Study|Peripheral lead added|1|||
129808209|NCT03082261|467263973|FG000|Overall Study|Withdrawal by Subject|40|||
129808210|NCT03082261|467263973|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
129808211|NCT03082261|467263973|FG000|Overall Study|Subject implanted with device other than study device|1|||
129808212|NCT03082261|467263973|FG000|Overall Study|Lost to Follow-up|14|||
129808213|NCT03082261|467263973|FG000|Overall Study|Subject moved to a different state|1|||
129808214|NCT03082261|467263973|FG000|Overall Study|Subject non-compliance|2|||
129808215|NCT03082261|467263973|FG000|Overall Study|Subject participation terminated by investigator|9|||
129895746|NCT04310579|467578541|FG000|Overall Study|Withdrawal by Subject|0|||
129895747|NCT04310579|467578542|FG001|Overall Study|Withdrawal by Subject|0|||
129895748|NCT04310579|467578543|FG002|Overall Study|Withdrawal by Subject|0|||
129895749|NCT04310579|467578544|FG003|Overall Study|Withdrawal by Subject|0|||
129808216|NCT03082261|467263973|FG000|Overall Study|Subject participation terminated by sponsor|4|||
129808217|NCT03082261|467263973|FG000|Overall Study|System explant|19|||
129808218|NCT03082261|467263973|FG000|Overall Study|Unable to place lead(s)|2|||
129808219|NCT03082261|467263973|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
129808220|NCT01032174|467263978|FG000|Overall Study|Adverse Event|0|||
129808221|NCT01032174|467263979|FG001|Overall Study|Adverse Event|1|||
129808222|NCT00702689|467263980|FG000|Overall Study|Withdrawal by Subject|4|||
129808223|NCT00702689|467263980|FG000|Overall Study|Recurrent malignancy|1|||
129808224|NCT00702689|467263980|FG000|Overall Study|Adverse Event|1|||
129808225|NCT01281137|467263983|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
129808226|NCT01281137|467263984|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
129808227|NCT01281137|467263983|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
129895750|NCT04310579|467578545|FG004|Overall Study|Withdrawal by Subject|0|||
129895751|NCT04310579|467578546|FG005|Overall Study|Withdrawal by Subject|1|||
129808228|NCT01281137|467263984|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
129808229|NCT01281137|467263983|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
129808230|NCT01281137|467263984|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
129808231|NCT01281137|467263983|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
129808232|NCT01281137|467263984|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
129808233|NCT01281137|467263983|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
129808234|NCT01281137|467263984|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
129808235|NCT02761733|467263987|FG000|Overall Study|Death|3|||
129808236|NCT02761733|467263988|FG001|Overall Study|Death|5|||
129808237|NCT02761733|467263989|FG002|Overall Study|Death|1|||
129808238|NCT02761733|467263990|FG003|Overall Study|Death|1|||
129808239|NCT02761733|467263987|FG000|Overall Study|Lost to Follow-up|6|||
129808240|NCT02761733|467263988|FG001|Overall Study|Lost to Follow-up|7|||
129808241|NCT02761733|467263989|FG002|Overall Study|Lost to Follow-up|0|||
129808242|NCT02761733|467263990|FG003|Overall Study|Lost to Follow-up|3|||
129808243|NCT02761733|467263987|FG000|Overall Study|Physician Decision|4|||
129808244|NCT02761733|467263988|FG001|Overall Study|Physician Decision|0|||
129808245|NCT02761733|467263989|FG002|Overall Study|Physician Decision|0|||
129808246|NCT02761733|467263990|FG003|Overall Study|Physician Decision|0|||
129808247|NCT02761733|467263987|FG000|Overall Study|Withdrawal by Subject|2|||
129808248|NCT02761733|467263988|FG001|Overall Study|Withdrawal by Subject|0|||
129808249|NCT02761733|467263989|FG002|Overall Study|Withdrawal by Subject|0|||
129808250|NCT02761733|467263990|FG003|Overall Study|Withdrawal by Subject|0|||
129808251|NCT02761733|467263987|FG000|Overall Study|Discharged from Study Site|10|||
129808252|NCT02761733|467263988|FG001|Overall Study|Discharged from Study Site|9|||
129808253|NCT02761733|467263989|FG002|Overall Study|Discharged from Study Site|25|||
129808254|NCT02761733|467263990|FG003|Overall Study|Discharged from Study Site|11|||
129808255|NCT02761733|467263987|FG000|Overall Study|Cognitive Impairment|5|||
129808256|NCT02761733|467263988|FG001|Overall Study|Cognitive Impairment|0|||
129808257|NCT02761733|467263989|FG002|Overall Study|Cognitive Impairment|1|||
129808258|NCT02761733|467263990|FG003|Overall Study|Cognitive Impairment|0|||
129808259|NCT01986907|467263993|FG000|Overall Study|Adverse Event|11|||
129808260|NCT01986907|467263993|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
129808261|NCT01986907|467263993|FG000|Overall Study|Protocol Violation|4|||
129808262|NCT01986907|467263993|FG000|Overall Study|Withdrawal by Subject|76|||
129808263|NCT01986907|467263993|FG000|Overall Study|Lost to Follow-up|38|||
129808264|NCT01986907|467263993|FG000|Overall Study|Death|9|||
129808265|NCT04295772|467263997|FG000|Overall Study|Protocol Violation|1|||
129808266|NCT04295772|467263998|FG001|Overall Study|Protocol Violation|0|||
129808267|NCT04295772|467263997|FG000|Overall Study|Ongoing for safety monitoring|14|||
129808268|NCT04295772|467263998|FG001|Overall Study|Ongoing for safety monitoring|1|||
129808269|NCT04295772|467263997|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
129808270|NCT04295772|467263998|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
129808271|NCT03576495|467264011|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
129808272|NCT03576495|467264012|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
129808273|NCT03608254|467264014|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
129808274|NCT03608254|467264014|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
129808275|NCT00239590|467264016|FG000|Randomized|Lost to Follow-up|0|||
129808276|NCT00239590|467264017|FG001|Randomized|Lost to Follow-up|1|||
129808277|NCT00239590|467264016|FG000|Randomized|Withdrawal by Subject|0|||
129808278|NCT00239590|467264017|FG001|Randomized|Withdrawal by Subject|1|||
129808279|NCT00239590|467264016|FG000|Completed Study Protocol|Adverse Event|1|||
129808280|NCT00239590|467264017|FG001|Completed Study Protocol|Adverse Event|1|||
129808281|NCT00239590|467264016|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
129808282|NCT00239590|467264017|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
129808283|NCT02362269|467264020|FG000|Overall Study|Moved|1|||
129808284|NCT02362269|467264021|FG001|Overall Study|Moved|0|||
129808285|NCT02362269|467264020|FG000|Overall Study|Lost to Follow-up|0|||
129808286|NCT02362269|467264021|FG001|Overall Study|Lost to Follow-up|6|||
129808287|NCT01903031|467264022|FG000|Overall Study|Not Able to Attend Clinic|1|||
129808288|NCT01903031|467264023|FG001|Overall Study|Not Able to Attend Clinic|1|||
129808289|NCT01903031|467264024|FG002|Overall Study|Not Able to Attend Clinic|0|||
129808290|NCT01903031|467264022|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
129808291|NCT01903031|467264023|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
129808292|NCT01903031|467264024|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
129808293|NCT01903031|467264022|FG000|Overall Study|Adverse Event|0|||
129895752|NCT04310579|467578547|FG006|Overall Study|Withdrawal by Subject|0|||
129895753|NCT04310579|467578548|FG007|Overall Study|Withdrawal by Subject|0|||
129895754|NCT04310579|467578549|FG008|Overall Study|Withdrawal by Subject|0|||
129808294|NCT01903031|467264023|FG001|Overall Study|Adverse Event|1|||
129808295|NCT01903031|467264024|FG002|Overall Study|Adverse Event|0|||
129808296|NCT01903031|467264022|FG000|Overall Study|Withdrawal by Subject|0|||
129895755|NCT04310579|467578550|FG009|Overall Study|Withdrawal by Subject|0|||
129895756|NCT04310579|467578551|FG010|Overall Study|Withdrawal by Subject|0|||
130058193|NCT01395368|468168059|FG000|Overall Study|Physician Decision|14|||
129808297|NCT01903031|467264023|FG001|Overall Study|Withdrawal by Subject|1|||
129808298|NCT01903031|467264024|FG002|Overall Study|Withdrawal by Subject|1|||
129808299|NCT01903031|467264022|FG000|Overall Study|Protocol Violation|0|||
129808300|NCT01903031|467264023|FG001|Overall Study|Protocol Violation|0|||
129808301|NCT01903031|467264024|FG002|Overall Study|Protocol Violation|2|||
129808302|NCT01903031|467264022|FG000|Overall Study|Lost to Follow-up|0|||
129808303|NCT01903031|467264023|FG001|Overall Study|Lost to Follow-up|0|||
129808304|NCT01903031|467264024|FG002|Overall Study|Lost to Follow-up|1|||
129808305|NCT01903031|467264022|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
129808306|NCT01903031|467264023|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
129808307|NCT01903031|467264024|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
129808308|NCT00447005|467264025|FG000|Overall Study|Adverse Event|1|||
129808309|NCT00447005|467264025|FG000|Overall Study|Lack of Efficacy|11|||
129808310|NCT01484275|467264029|FG000|Overall Study|Study terminated by sponsor|28|||
129808311|NCT01484275|467264030|FG001|Overall Study|Study terminated by sponsor|32|||
129808312|NCT01484275|467264029|FG000|Overall Study|Other|10|||
129808313|NCT01484275|467264030|FG001|Overall Study|Other|0|||
129808314|NCT01484275|467264029|FG000|Overall Study|Death|3|||
129808315|NCT01484275|467264030|FG001|Overall Study|Death|4|||
129808316|NCT01484275|467264029|FG000|Overall Study|Withdrawal by Subject|1|||
129808317|NCT01484275|467264030|FG001|Overall Study|Withdrawal by Subject|5|||
129808318|NCT01484275|467264029|FG000|Overall Study|Lost to Follow-up|1|||
129808319|NCT01484275|467264030|FG001|Overall Study|Lost to Follow-up|1|||
129808320|NCT04154930|467264033|FG000|Overall Study|Withdrawal by Subject|15|||
129808321|NCT04154930|467264034|FG001|Overall Study|Withdrawal by Subject|6|||
129808322|NCT04154930|467264033|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
129808323|NCT04154930|467264034|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
129808324|NCT04154930|467264033|FG000|Overall Study|Lost to Follow-up|14|||
129808325|NCT04154930|467264034|FG001|Overall Study|Lost to Follow-up|6|||
129808326|NCT04154930|467264033|FG000|Overall Study|Other|6|||
129808327|NCT04154930|467264034|FG001|Overall Study|Other|0|||
129808328|NCT00722800|467264039|FG000|Overall Study|Withdrawal by Subject|1|||
129808329|NCT00722800|467264040|FG001|Overall Study|Withdrawal by Subject|0|||
129808330|NCT00722800|467264039|FG000|Overall Study|Physician Decision|1|||
129808331|NCT00722800|467264040|FG001|Overall Study|Physician Decision|0|||
129808332|NCT02130297|467264043|FG000|Overall Study|Lost to Follow-up|4|||
129808333|NCT00806351|467264057|FG000|Overall Study|Death|5|||
129808334|NCT00806351|467264058|FG001|Overall Study|Death|4|||
129808335|NCT00508755|467264063|FG000|Overall Study|Withdrawal by Subject|1|||
129808336|NCT04439201|467264069|FG000|Overall Study|Ineligible|2|||
129808337|NCT04439201|467264069|FG000|Overall Study|Never start protocol therapy|1|||
129808338|NCT04439201|467264069|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
129808339|NCT04439201|467264069|FG000|Overall Study|Mutation status not confirmed|4|||
129808340|NCT04439201|467264069|FG000|Overall Study|Adverse Event|1|||
129808341|NCT04439201|467264069|FG000|Overall Study|Death|7|||
129808342|NCT04439201|467264069|FG000|Overall Study|Withdrawal by Subject|2|||
129808343|NCT04439201|467264069|FG000|Overall Study|Disease progression|20|||
129895757|NCT04310579|467578541|FG000|Overall Study|Positive COVID-19 test|0|||
129895758|NCT04310579|467578542|FG001|Overall Study|Positive COVID-19 test|0|||
129808344|NCT04439201|467264069|FG000|Overall Study|Alternative therapy|1|||
129808345|NCT04439201|467264069|FG000|Overall Study|Physician Decision|1|||
129808346|NCT03730012|467264070|FG000|Overall Study|Adverse Event|0|||
129808347|NCT03730012|467264071|FG001|Overall Study|Adverse Event|1|||
129808348|NCT03730012|467264070|FG000|Overall Study|Lack of Efficacy|1|||
129808349|NCT03730012|467264071|FG001|Overall Study|Lack of Efficacy|5|||
129808350|NCT03730012|467264070|FG000|Overall Study|Withdrawal by Subject|0|||
129808351|NCT03730012|467264071|FG001|Overall Study|Withdrawal by Subject|1|||
129808352|NCT03730012|467264070|FG000|Overall Study|Miscellaneous|2|||
129808353|NCT03730012|467264071|FG001|Overall Study|Miscellaneous|1|||
129808354|NCT04680052|467265680|FG000|Overall Study|Ongoing|244|||
129808355|NCT04680052|467265681|FG001|Overall Study|Ongoing|229|||
129808356|NCT04680052|467265682|FG002|Overall Study|Ongoing|39|||
129808357|NCT04680052|467265683|FG003|Overall Study|Ongoing|46|||
129808358|NCT04680052|467265680|FG000|Overall Study|Death|15|||
129808359|NCT04680052|467265681|FG001|Overall Study|Death|22|||
129808360|NCT04680052|467265682|FG002|Overall Study|Death|7|||
129808361|NCT04680052|467265683|FG003|Overall Study|Death|1|||
129808362|NCT04680052|467265680|FG000|Overall Study|Lost to Follow-up|3|||
129808363|NCT04680052|467265681|FG001|Overall Study|Lost to Follow-up|2|||
129808364|NCT04680052|467265682|FG002|Overall Study|Lost to Follow-up|0|||
129808365|NCT04680052|467265683|FG003|Overall Study|Lost to Follow-up|1|||
129808366|NCT04680052|467265680|FG000|Overall Study|Withdrawal by Subject|11|||
129808367|NCT04680052|467265681|FG001|Overall Study|Withdrawal by Subject|19|||
129808368|NCT04680052|467265682|FG002|Overall Study|Withdrawal by Subject|7|||
129808369|NCT04680052|467265683|FG003|Overall Study|Withdrawal by Subject|5|||
129808370|NCT04680052|467265680|FG000|Overall Study|Missing|0|||
129808371|NCT04680052|467265681|FG001|Overall Study|Missing|1|||
129808372|NCT04680052|467265682|FG002|Overall Study|Missing|0|||
129808373|NCT04680052|467265683|FG003|Overall Study|Missing|0|||
129808374|NCT04680052|467265680|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129808375|NCT04680052|467265681|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
129808376|NCT04680052|467265682|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129808377|NCT04680052|467265683|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129808378|NCT04680052|467265680|FG000|Overall Study|Physician Decision|0|||
129808379|NCT04680052|467265681|FG001|Overall Study|Physician Decision|1|||
129808380|NCT04680052|467265682|FG002|Overall Study|Physician Decision|0|||
129808381|NCT04680052|467265683|FG003|Overall Study|Physician Decision|0|||
129808382|NCT03320057|467265684|FG000|Overall Study|Lost to Follow-up|4|||
129808383|NCT03320057|467265685|FG001|Overall Study|Lost to Follow-up|17|||
129808384|NCT03320057|467265684|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
129808385|NCT03320057|467265685|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
129808386|NCT01367002|467265686|FG000|Overall Study|Withdrawal by Subject|1|||
129808387|NCT01367002|467265687|FG001|Overall Study|Withdrawal by Subject|0|||
129808388|NCT01367002|467265686|FG000|Overall Study|Physician Decision|0|||
129808389|NCT01367002|467265687|FG001|Overall Study|Physician Decision|2|||
129808390|NCT06956170|467265688|FG000|Overall Study|Death|2|||
129808391|NCT06956170|467265689|FG001|Overall Study|Death|1|||
129808392|NCT06956170|467265688|FG000|Overall Study|Withdrawal by Subject|1|||
129808393|NCT06956170|467265689|FG001|Overall Study|Withdrawal by Subject|0|||
129808394|NCT06956170|467265688|FG000|Overall Study|Ongoing|7|||
129808395|NCT06956170|467265689|FG001|Overall Study|Ongoing|10|||
129808396|NCT01516437|467265690|FG000|Overall Study|Reason not specified|0|||
129808397|NCT01516437|467265691|FG001|Overall Study|Reason not specified|0|||
129808398|NCT01516437|467265692|FG002|Overall Study|Reason not specified|1|||
129808399|NCT01516437|467265693|FG003|Overall Study|Reason not specified|1|||
129808400|NCT00316719|467265696|FG000|Overall Study|Adverse Event|0|||
129808401|NCT00316719|467265697|FG001|Overall Study|Adverse Event|6|||
129808402|NCT00316719|467265696|FG000|Overall Study|Consent withdrawn|2|||
129808403|NCT00316719|467265697|FG001|Overall Study|Consent withdrawn|0|||
129808404|NCT02400333|467265700|FG000|Overall Study|Withdrawal by Subject|0|||
129808405|NCT02400333|467265701|FG001|Overall Study|Withdrawal by Subject|1|||
129808406|NCT02400333|467265702|FG002|Overall Study|Withdrawal by Subject|0|||
129808407|NCT02400333|467265703|FG003|Overall Study|Withdrawal by Subject|1|||
129808408|NCT02400333|467265700|FG000|Overall Study|Protocol Violation|1|||
129808409|NCT02400333|467265701|FG001|Overall Study|Protocol Violation|0|||
129808410|NCT02400333|467265702|FG002|Overall Study|Protocol Violation|2|||
129808411|NCT02400333|467265703|FG003|Overall Study|Protocol Violation|1|||
129808412|NCT02468674|467265704|FG000|Overall Study|Adverse Event|0|||
129808413|NCT02468674|467265705|FG001|Overall Study|Adverse Event|0|||
129808414|NCT02468674|467265706|FG002|Overall Study|Adverse Event|0|||
129808415|NCT02468674|467265707|FG003|Overall Study|Adverse Event|1|||
129895759|NCT04310579|467578543|FG002|Overall Study|Positive COVID-19 test|0|||
129808416|NCT02468674|467265708|FG004|Overall Study|Adverse Event|0|||
129808417|NCT02468674|467265709|FG005|Overall Study|Adverse Event|1|||
129808418|NCT02468674|467265710|FG006|Overall Study|Adverse Event|0|||
129808419|NCT02468674|467265711|FG007|Overall Study|Adverse Event|0|||
129808420|NCT02468674|467265712|FG008|Overall Study|Adverse Event|0|||
129808421|NCT02468674|467265704|FG000|Overall Study|Lost to Follow-up|1|||
129808422|NCT02468674|467265705|FG001|Overall Study|Lost to Follow-up|0|||
129808423|NCT02468674|467265706|FG002|Overall Study|Lost to Follow-up|0|||
129808424|NCT02468674|467265707|FG003|Overall Study|Lost to Follow-up|0|||
129808425|NCT02468674|467265708|FG004|Overall Study|Lost to Follow-up|0|||
129808426|NCT02468674|467265709|FG005|Overall Study|Lost to Follow-up|0|||
129808427|NCT02468674|467265710|FG006|Overall Study|Lost to Follow-up|0|||
129808428|NCT02468674|467265711|FG007|Overall Study|Lost to Follow-up|1|||
129808429|NCT02468674|467265712|FG008|Overall Study|Lost to Follow-up|1|||
129808430|NCT02468674|467265704|FG000|Overall Study|Physician Decision|0|||
129808431|NCT02468674|467265705|FG001|Overall Study|Physician Decision|0|||
129808432|NCT02468674|467265706|FG002|Overall Study|Physician Decision|0|||
129808433|NCT02468674|467265707|FG003|Overall Study|Physician Decision|0|||
129808434|NCT02468674|467265708|FG004|Overall Study|Physician Decision|0|||
129895760|NCT04310579|467578544|FG003|Overall Study|Positive COVID-19 test|0|||
129895761|NCT04310579|467578545|FG004|Overall Study|Positive COVID-19 test|0|||
129895762|NCT04310579|467578546|FG005|Overall Study|Positive COVID-19 test|0|||
129895763|NCT04310579|467578547|FG006|Overall Study|Positive COVID-19 test|0|||
129895764|NCT04310579|467578548|FG007|Overall Study|Positive COVID-19 test|0|||
129895765|NCT04310579|467578549|FG008|Overall Study|Positive COVID-19 test|0|||
129895766|NCT04310579|467578550|FG009|Overall Study|Positive COVID-19 test|0|||
129895767|NCT04310579|467578551|FG010|Overall Study|Positive COVID-19 test|1|||
129895768|NCT03635112|467578552|FG000|Overall Study|Adverse Event|5|||
129895769|NCT03635112|467578553|FG001|Overall Study|Adverse Event|9|||
129895770|NCT03635112|467578554|FG002|Overall Study|Adverse Event|14|||
129895771|NCT03635112|467578552|FG000|Overall Study|Lost to Follow-up|1|||
129895772|NCT03635112|467578553|FG001|Overall Study|Lost to Follow-up|0|||
129895773|NCT03635112|467578554|FG002|Overall Study|Lost to Follow-up|1|||
129895774|NCT03635112|467578552|FG000|Overall Study|Physician Decision|5|||
129895775|NCT03635112|467578553|FG001|Overall Study|Physician Decision|7|||
129808435|NCT02468674|467265709|FG005|Overall Study|Physician Decision|0|||
129808436|NCT02468674|467265710|FG006|Overall Study|Physician Decision|1|||
129808437|NCT02468674|467265711|FG007|Overall Study|Physician Decision|0|||
129808438|NCT02468674|467265712|FG008|Overall Study|Physician Decision|0|||
129895776|NCT03635112|467578554|FG002|Overall Study|Physician Decision|5|||
129895777|NCT03635112|467578552|FG000|Overall Study|Protocol Violation|0|||
129895778|NCT03635112|467578553|FG001|Overall Study|Protocol Violation|0|||
129895779|NCT03635112|467578554|FG002|Overall Study|Protocol Violation|1|||
129895780|NCT03635112|467578552|FG000|Overall Study|Study Terminated by Sponsor|11|||
129895781|NCT03635112|467578553|FG001|Overall Study|Study Terminated by Sponsor|17|||
129895782|NCT03635112|467578554|FG002|Overall Study|Study Terminated by Sponsor|21|||
129895783|NCT03635112|467578552|FG000|Overall Study|Withdrawal by Subject|4|||
129895784|NCT03635112|467578553|FG001|Overall Study|Withdrawal by Subject|9|||
129895785|NCT03635112|467578554|FG002|Overall Study|Withdrawal by Subject|7|||
129895786|NCT03635112|467578552|FG000|Overall Study|Miscellaneous|0|||
129895787|NCT03635112|467578553|FG001|Overall Study|Miscellaneous|0|||
129895788|NCT03635112|467578554|FG002|Overall Study|Miscellaneous|1|||
129895789|NCT03006341|467578556|FG000|Overall Study|Not linked in the EMR|25069|||
129895790|NCT03006341|467578557|FG001|Overall Study|Not linked in the EMR|67505|||
129895791|NCT03006341|467578558|FG002|Overall Study|Not linked in the EMR|30993|||
129895792|NCT03006341|467578559|FG003|Overall Study|Not linked in the EMR|10685|||
129895793|NCT02950545|467578562|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895794|NCT02950545|467578563|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895795|NCT02950545|467578564|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129808439|NCT02468674|467265704|FG000|Overall Study|Patient/Guardian Decision|0|||
129808440|NCT02468674|467265705|FG001|Overall Study|Patient/Guardian Decision|0|||
129808441|NCT02468674|467265706|FG002|Overall Study|Patient/Guardian Decision|0|||
129808442|NCT02468674|467265707|FG003|Overall Study|Patient/Guardian Decision|0|||
129808443|NCT02468674|467265708|FG004|Overall Study|Patient/Guardian Decision|1|||
129808444|NCT02468674|467265709|FG005|Overall Study|Patient/Guardian Decision|0|||
129895796|NCT02950545|467578565|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895797|NCT02950545|467578566|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895798|NCT02950545|467578567|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
129895799|NCT02950545|467578562|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
129895800|NCT02950545|467578563|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
129895801|NCT02950545|467578564|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
129895802|NCT02950545|467578565|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
129895803|NCT02950545|467578566|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
129895804|NCT02950545|467578567|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
129895805|NCT02950545|467578562|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895806|NCT02950545|467578563|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895807|NCT02950545|467578564|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895808|NCT02950545|467578565|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895809|NCT02950545|467578566|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
129895810|NCT02950545|467578567|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895811|NCT02950545|467578562|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
129895812|NCT02950545|467578563|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895813|NCT02950545|467578564|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895814|NCT02950545|467578565|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895815|NCT02950545|467578566|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895816|NCT02950545|467578567|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895817|NCT02950545|467578562|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895818|NCT02950545|467578563|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895819|NCT02950545|467578564|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895820|NCT02950545|467578565|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895821|NCT02950545|467578566|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895822|NCT02950545|467578567|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
129895823|NCT03101592|467578568|FG000|Overall Study|participant files could not be located|111|||
129895824|NCT03101592|467578569|FG001|Overall Study|participant files could not be located|170|||
129808445|NCT02468674|467265710|FG006|Overall Study|Patient/Guardian Decision|0|||
129808446|NCT02468674|467265711|FG007|Overall Study|Patient/Guardian Decision|2|||
129808447|NCT02468674|467265712|FG008|Overall Study|Patient/Guardian Decision|1|||
129808448|NCT02468674|467265704|FG000|Overall Study|Protocol Deviation|0|||
129808449|NCT02468674|467265705|FG001|Overall Study|Protocol Deviation|0|||
129895825|NCT03101592|467578570|FG002|Overall Study|participant files could not be located|118|||
129895826|NCT01770860|467578571|FG000|Overall Study|Withdrawal by Subject|4|||
129895827|NCT01770860|467578571|FG000|Overall Study|Lost to Follow-up|1|||
129895828|NCT01770860|467578571|FG000|Overall Study|Administrative decision made by the PI|1|||
129808450|NCT02468674|467265706|FG002|Overall Study|Protocol Deviation|0|||
129895829|NCT03398356|467578574|FG000|Before Treatment|Lost to Follow-up|1|||
129895830|NCT03398356|467578575|FG001|Before Treatment|Lost to Follow-up|2|||
129895831|NCT03398356|467578576|FG002|Before Treatment|Lost to Follow-up|0|||
129808451|NCT02468674|467265707|FG003|Overall Study|Protocol Deviation|0|||
129808452|NCT02468674|467265708|FG004|Overall Study|Protocol Deviation|0|||
129808453|NCT02468674|467265709|FG005|Overall Study|Protocol Deviation|0|||
129808454|NCT02468674|467265710|FG006|Overall Study|Protocol Deviation|0|||
129808455|NCT02468674|467265711|FG007|Overall Study|Protocol Deviation|1|||
129808456|NCT02468674|467265712|FG008|Overall Study|Protocol Deviation|1|||
129808457|NCT02280304|467265714|FG000|Overall Study|Lost to Follow-up|7|||
129808458|NCT02280304|467265715|FG001|Overall Study|Lost to Follow-up|8|||
129808459|NCT01890473|467265722|FG000|Overall Study|Lost to Follow-up|1|||
129808460|NCT01890473|467265723|FG001|Overall Study|Lost to Follow-up|0|||
129808461|NCT01890473|467265722|FG000|Overall Study|Poor/non-compliance|1|||
129808462|NCT01890473|467265723|FG001|Overall Study|Poor/non-compliance|0|||
129808463|NCT00934089|467265724|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
129808464|NCT00934089|467265725|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
129808465|NCT00934089|467265724|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
129808466|NCT00934089|467265725|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
129808467|NCT00003473|467265726|FG000|Overall Study|Three patients were not evaluable.|3|||
129808468|NCT01546207|467265729|FG000|Overall Study|Death|1|||
129895832|NCT03398356|467578574|FG000|Before Treatment|drug intolerance|2|||
129895833|NCT03398356|467578575|FG001|Before Treatment|drug intolerance|1|||
129895834|NCT03398356|467578576|FG002|Before Treatment|drug intolerance|0|||
129895835|NCT03398356|467578574|FG000|Before Treatment|Withdrawal by Subject|0|||
129895836|NCT03398356|467578575|FG001|Before Treatment|Withdrawal by Subject|5|||
129895837|NCT03398356|467578576|FG002|Before Treatment|Withdrawal by Subject|0|||
129895838|NCT03398356|467578574|FG000|Before Treatment|Physician Decision|0|||
129895839|NCT03398356|467578575|FG001|Before Treatment|Physician Decision|0|||
129895840|NCT03398356|467578576|FG002|Before Treatment|Physician Decision|11|||
129895841|NCT03398356|467578574|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
129895842|NCT03398356|467578575|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
129895843|NCT03398356|467578576|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
129895844|NCT03432533|467578579|FG000|Overall Study|Lost to Follow-up|1|||
129895845|NCT03432533|467578580|FG001|Overall Study|Lost to Follow-up|2|||
129895846|NCT03432533|467578579|FG000|Overall Study|Withdrawal by Subject|14|||
129895847|NCT03432533|467578580|FG001|Overall Study|Withdrawal by Subject|9|||
129895848|NCT01648283|467578581|FG000|Overall Study|Withdrawal by Subject|14|||
129895849|NCT00601640|467578586|FG000|Overall Study|Withdrawal by Subject|3|||
129895850|NCT00601640|467578587|FG001|Overall Study|Withdrawal by Subject|0|||
129808469|NCT00713323|467265730|FG000|Overall Study|Adverse Event|75|||
129808470|NCT00713323|467265730|FG000|Overall Study|Withdrawal by Subject|15|||
129808471|NCT00713323|467265730|FG000|Overall Study|Lost to Follow-up|11|||
129808472|NCT00713323|467265730|FG000|Overall Study|Lack of Efficacy|36|||
129895851|NCT00601640|467578588|FG002|Overall Study|Withdrawal by Subject|7|||
129895852|NCT00601640|467578586|FG000|Overall Study|Death|1|||
129895853|NCT00601640|467578587|FG001|Overall Study|Death|0|||
129895854|NCT00601640|467578588|FG002|Overall Study|Death|0|||
129808473|NCT00713323|467265730|FG000|Overall Study|Low creatine clearance at screening|1|||
129808474|NCT00713323|467265730|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
129808475|NCT00713323|467265730|FG000|Overall Study|Surgery cured allodynic pain|1|||
129808476|NCT00713323|467265730|FG000|Overall Study|Pain free|1|||
129808477|NCT00713323|467265730|FG000|Overall Study|Non-compliance|1|||
129808478|NCT00713323|467265730|FG000|Overall Study|Pain resolved|1|||
129808479|NCT00713323|467265730|FG000|Overall Study|Subject travelling to USA|1|||
129808480|NCT00713323|467265730|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
129808481|NCT00713323|467265730|FG000|Overall Study|Treatment that may interact with Sativex|1|||
129808482|NCT01947582|467265736|FG000|Overall Study|Withdrawal by Subject|1|||
129808483|NCT01826604|467265737|FG000|Overall Study|Lost to Follow-up|8|||
129808484|NCT01826604|467265738|FG001|Overall Study|Lost to Follow-up|9|||
129808485|NCT00491075|467265739|FG000|Overall Study|Withdrawal by Subject|1|||
129808486|NCT00491075|467265739|FG000|Overall Study|Physician Decision|1|||
129808487|NCT01603355|467265740|FG000|Overall Study|Lack of Efficacy|2|||
129808488|NCT05350410|467265744|FG000|Overall Study|Withdrawal by Subject|1|||
129808489|NCT01952145|467265745|FG000|Overall Study|Protocol Violation|2|||
129808490|NCT01952145|467265746|FG001|Overall Study|Protocol Violation|1|||
129808491|NCT01952145|467265745|FG000|Overall Study|Death|0|||
129808492|NCT01952145|467265746|FG001|Overall Study|Death|1|||
129808493|NCT01952145|467265745|FG000|Overall Study|Adverse Event|9|||
129808494|NCT01952145|467265746|FG001|Overall Study|Adverse Event|0|||
129808495|NCT01952145|467265745|FG000|Overall Study|Withdrawal Criteria|16|||
129808496|NCT01952145|467265746|FG001|Overall Study|Withdrawal Criteria|11|||
129808497|NCT01952145|467265745|FG000|Overall Study|Unclassified|1|||
129808498|NCT01952145|467265746|FG001|Overall Study|Unclassified|1|||
129808499|NCT04138810|467265750|FG000|Overall Study|Withdrawal by Subject|0|||
129808500|NCT04138810|467265751|FG001|Overall Study|Withdrawal by Subject|1|||
129808501|NCT04138810|467265750|FG000|Overall Study|Subject cancelled surgery|1|||
129808502|NCT04138810|467265751|FG001|Overall Study|Subject cancelled surgery|0|||
129895855|NCT00601640|467578586|FG000|Overall Study|Adverse Event|0|||
129895856|NCT00601640|467578587|FG001|Overall Study|Adverse Event|4|||
129895857|NCT00601640|467578588|FG002|Overall Study|Adverse Event|2|||
129808503|NCT00753766|467265752|FG000|Overall Study|Physician Decision|1|||
129808504|NCT00753766|467265753|FG001|Overall Study|Physician Decision|0|||
129808505|NCT00839852|467265754|FG000|Overall Study|Adverse Event|10|||
129808506|NCT00839852|467265754|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129808507|NCT00839852|467265754|FG000|Overall Study|Protocol Violation|9|||
129808508|NCT00839852|467265754|FG000|Overall Study|Withdrawal of Consent|16|||
129808509|NCT00839852|467265754|FG000|Overall Study|Lost to Follow-up|7|||
129808510|NCT00839852|467265754|FG000|Overall Study|Lack of Compliance While in Jail|1|||
129808511|NCT00839852|467265754|FG000|Overall Study|Pregnancy|1|||
129808512|NCT00494299|467265755|FG000|Overall Study|Adverse Event|93|||
129808513|NCT00494299|467265756|FG001|Overall Study|Adverse Event|13|||
129895858|NCT00601640|467578586|FG000|Overall Study|intercurrent illness|1|||
129895859|NCT00601640|467578587|FG001|Overall Study|intercurrent illness|0|||
129808514|NCT00494299|467265755|FG000|Overall Study|Lost to Follow-up|1|||
129808515|NCT00494299|467265756|FG001|Overall Study|Lost to Follow-up|0|||
129808516|NCT00494299|467265755|FG000|Overall Study|Physician Decision|0|||
129808517|NCT00494299|467265756|FG001|Overall Study|Physician Decision|2|||
129808518|NCT00494299|467265755|FG000|Overall Study|Protocol Violation|1|||
129808519|NCT00494299|467265756|FG001|Overall Study|Protocol Violation|2|||
129808520|NCT00494299|467265755|FG000|Overall Study|Withdrawal by Subject|8|||
129808521|NCT00494299|467265756|FG001|Overall Study|Withdrawal by Subject|3|||
129808522|NCT00494299|467265755|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
129808523|NCT00494299|467265756|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
129895860|NCT00601640|467578588|FG002|Overall Study|intercurrent illness|0|||
129895861|NCT00601640|467578586|FG000|Overall Study|change in eligibility status|0|||
129808524|NCT00494299|467265755|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
129808525|NCT00494299|467265756|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
129808526|NCT00494299|467265755|FG000|Overall Study|Site Closed by Sponsor|6|||
129808527|NCT00494299|467265756|FG001|Overall Study|Site Closed by Sponsor|0|||
129808528|NCT00494299|467265755|FG000|Overall Study|Protocol Driven Decision Point|11|||
129808529|NCT00494299|467265756|FG001|Overall Study|Protocol Driven Decision Point|22|||
129808530|NCT02805972|467265761|FG000|Washout Period|Lost to Follow-up|3|||
129808531|NCT02805972|467265762|FG001|Washout Period|Lost to Follow-up|0|||
129808532|NCT01206166|467265764|FG000|Overall Study|No evaluable data|2|||
129808533|NCT01206166|467265765|FG001|Overall Study|No evaluable data|3|||
129808534|NCT00932126|467265766|FG000|Overall Study|Adverse Event|0|||
129808535|NCT00932126|467265767|FG001|Overall Study|Adverse Event|0|||
129808536|NCT00932126|467265768|FG002|Overall Study|Adverse Event|0|||
129808537|NCT00932126|467265769|FG003|Overall Study|Adverse Event|0|||
129808538|NCT00932126|467265770|FG004|Overall Study|Adverse Event|0|||
129808539|NCT00932126|467265771|FG005|Overall Study|Adverse Event|0|||
129808540|NCT00932126|467265772|FG006|Overall Study|Adverse Event|1|||
129808541|NCT00932126|467265773|FG007|Overall Study|Adverse Event|2|||
129808542|NCT00932126|467265766|FG000|Overall Study|Protocol Violation|0|||
129808543|NCT00932126|467265767|FG001|Overall Study|Protocol Violation|0|||
129808544|NCT00932126|467265768|FG002|Overall Study|Protocol Violation|0|||
129808545|NCT00932126|467265769|FG003|Overall Study|Protocol Violation|0|||
129808546|NCT00932126|467265770|FG004|Overall Study|Protocol Violation|1|||
129808547|NCT00932126|467265771|FG005|Overall Study|Protocol Violation|0|||
129808548|NCT00932126|467265772|FG006|Overall Study|Protocol Violation|0|||
129808549|NCT00932126|467265773|FG007|Overall Study|Protocol Violation|0|||
129808550|NCT00932126|467265766|FG000|Overall Study|Withdrawal by Subject|0|||
129808551|NCT00932126|467265767|FG001|Overall Study|Withdrawal by Subject|0|||
129808552|NCT00932126|467265768|FG002|Overall Study|Withdrawal by Subject|1|||
129808553|NCT00932126|467265769|FG003|Overall Study|Withdrawal by Subject|0|||
129808554|NCT00932126|467265770|FG004|Overall Study|Withdrawal by Subject|0|||
129808555|NCT00932126|467265771|FG005|Overall Study|Withdrawal by Subject|0|||
129808556|NCT00932126|467265772|FG006|Overall Study|Withdrawal by Subject|0|||
129808557|NCT00932126|467265773|FG007|Overall Study|Withdrawal by Subject|1|||
129808558|NCT00932126|467265766|FG000|Overall Study|Objective progression or relapse|3|||
129808559|NCT00932126|467265767|FG001|Overall Study|Objective progression or relapse|3|||
129808560|NCT00932126|467265768|FG002|Overall Study|Objective progression or relapse|2|||
129808561|NCT00932126|467265769|FG003|Overall Study|Objective progression or relapse|3|||
129808562|NCT00932126|467265770|FG004|Overall Study|Objective progression or relapse|3|||
129808563|NCT00932126|467265771|FG005|Overall Study|Objective progression or relapse|3|||
129808564|NCT00932126|467265772|FG006|Overall Study|Objective progression or relapse|3|||
129895862|NCT00601640|467578587|FG001|Overall Study|change in eligibility status|1|||
129895863|NCT00601640|467578588|FG002|Overall Study|change in eligibility status|1|||
129808565|NCT00932126|467265773|FG007|Overall Study|Objective progression or relapse|5|||
129808566|NCT00932126|467265766|FG000|Overall Study|Other|0|||
129808567|NCT00932126|467265767|FG001|Overall Study|Other|0|||
129808568|NCT00932126|467265768|FG002|Overall Study|Other|0|||
129808569|NCT00932126|467265769|FG003|Overall Study|Other|0|||
129895864|NCT00530777|467578589|FG000|Overall Study|Lost to Follow-up|0|||
129895865|NCT00530777|467578590|FG001|Overall Study|Lost to Follow-up|1|||
129895866|NCT00530777|467578589|FG000|Overall Study|Death|1|||
129895867|NCT00530777|467578590|FG001|Overall Study|Death|2|||
129895868|NCT00530777|467578589|FG000|Overall Study|Physician Decision|1|||
129808570|NCT00932126|467265770|FG004|Overall Study|Other|1|||
129808571|NCT00932126|467265771|FG005|Overall Study|Other|0|||
129808572|NCT00932126|467265772|FG006|Overall Study|Other|1|||
129808573|NCT00932126|467265773|FG007|Overall Study|Other|2|||
129808574|NCT02716805|467265774|FG000|Overall Study|Progressive disease|2|||
129808575|NCT02716805|467265775|FG001|Overall Study|Progressive disease|0|||
129808576|NCT02716805|467265776|FG002|Overall Study|Progressive disease|0|||
129808577|NCT02716805|467265777|FG003|Overall Study|Progressive disease|0|||
129808578|NCT00066365|467265778|FG000|Overall Study|Adverse Event|1|||
129808579|NCT00066365|467265779|FG001|Overall Study|Adverse Event|0|||
129808580|NCT00066365|467265778|FG000|Overall Study|Lack of Efficacy|15|||
129808581|NCT00066365|467265779|FG001|Overall Study|Lack of Efficacy|12|||
129808582|NCT00066365|467265778|FG000|Overall Study|Physician Decision|1|||
129808583|NCT00066365|467265779|FG001|Overall Study|Physician Decision|0|||
129808584|NCT00066365|467265778|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
129808585|NCT00066365|467265779|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
129808586|NCT00066365|467265778|FG000|Overall Study|Ineligible|4|||
129808587|NCT00066365|467265779|FG001|Overall Study|Ineligible|2|||
129808588|NCT02635776|467265784|FG000|Overall Study|Physician Decision|1|||
129808589|NCT02635776|467265785|FG001|Overall Study|Physician Decision|0|||
129808590|NCT02635776|467265784|FG000|Overall Study|Adverse Event|51|||
129808591|NCT02635776|467265785|FG001|Overall Study|Adverse Event|3|||
129808592|NCT02635776|467265784|FG000|Overall Study|Withdrawal by Subject|41|||
129808593|NCT02635776|467265785|FG001|Overall Study|Withdrawal by Subject|7|||
129808594|NCT02635776|467265784|FG000|Overall Study|Lost to Follow-up|4|||
129895869|NCT00530777|467578590|FG001|Overall Study|Physician Decision|0|||
129808595|NCT02635776|467265785|FG001|Overall Study|Lost to Follow-up|0|||
129808596|NCT02635776|467265784|FG000|Overall Study|Other reasons|5|||
129808597|NCT02635776|467265785|FG001|Overall Study|Other reasons|1|||
129808598|NCT00788073|467265786|FG000|STX209 Then Placebo|Adverse Event|1|||
129808599|NCT00788073|467265787|FG001|STX209 Then Placebo|Adverse Event|0|||
129808600|NCT00788073|467265786|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
129895870|NCT00530777|467578589|FG000|Overall Study|Withdrawal by Subject|0|||
129808601|NCT00788073|467265787|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
129808602|NCT00788073|467265786|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
129808603|NCT00788073|467265787|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
129808604|NCT00788073|467265786|FG000|STX209 Then Placebo|unable to return due to travel|0|||
129808605|NCT00788073|467265787|FG001|STX209 Then Placebo|unable to return due to travel|1|||
129808606|NCT00788073|467265786|FG000|Placebo Then STX209|Adverse Event|2|||
129808607|NCT00788073|467265787|FG001|Placebo Then STX209|Adverse Event|0|||
129808608|NCT00788073|467265786|FG000|Placebo Then STX209|Protocol Violation|0|||
129808609|NCT00788073|467265787|FG001|Placebo Then STX209|Protocol Violation|1|||
129808610|NCT02058693|467265790|FG000|Phase 1|Withdrawal by Subject|3|||
129808611|NCT02058693|467265791|FG001|Phase 1|Withdrawal by Subject|2|||
129808612|NCT02058693|467265790|FG000|Phase 1|Adverse Event|0|||
129808613|NCT02058693|467265791|FG001|Phase 1|Adverse Event|1|||
129895871|NCT00530777|467578590|FG001|Overall Study|Withdrawal by Subject|1|||
129895872|NCT00530777|467578589|FG000|Overall Study|Unable to adhere to visit schedule|5|||
129808614|NCT02058693|467265790|FG000|Phase 1|Lack of Efficacy|1|||
129808615|NCT02058693|467265791|FG001|Phase 1|Lack of Efficacy|0|||
129808616|NCT02058693|467265790|FG000|Phase 1|Physician Decision|1|||
129808617|NCT02058693|467265791|FG001|Phase 1|Physician Decision|1|||
129808618|NCT02058693|467265790|FG000|Phase 2|Withdrawal by Subject|0|||
129808619|NCT02058693|467265791|FG001|Phase 2|Withdrawal by Subject|2|||
129808620|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
129808621|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
129808622|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
129808623|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
129808624|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808625|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808626|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808627|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808628|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808629|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808630|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808631|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808632|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
129808633|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
129808634|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
129808635|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808636|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808637|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808638|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808639|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808640|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808641|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808642|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808643|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808644|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
129808645|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
129808646|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808647|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808648|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808649|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808650|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808651|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808652|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808653|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808654|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129895873|NCT00530777|467578590|FG001|Overall Study|Unable to adhere to visit schedule|1|||
129895874|NCT03382821|467578597|FG000|Overall Study|Did not receive allocated intervention.|0|||
129808655|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808656|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
129808657|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
129808658|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
129808659|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
129808660|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
129808661|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
129808662|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
129808663|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
129895875|NCT03382821|467578598|FG001|Overall Study|Did not receive allocated intervention.|3|||
129895876|NCT00282438|467578599|FG000|Overall Study|Lack of Efficacy|1|||
129895877|NCT00282438|467578600|FG001|Overall Study|Lack of Efficacy|0|||
129895878|NCT00282438|467578599|FG000|Overall Study|Death|0|||
129895879|NCT00282438|467578600|FG001|Overall Study|Death|1|||
129895880|NCT01008748|467578610|FG000|Overall Study|Lost to Follow-up|80|||
129895881|NCT01008748|467578610|FG000|Overall Study|Other|1|||
129895882|NCT02775435|467578611|FG000|Overall Study|Adverse Event|32|||
129895883|NCT02775435|467578612|FG001|Overall Study|Adverse Event|27|||
129895884|NCT02775435|467578611|FG000|Overall Study|Lost to Follow-up|2|||
129895885|NCT02775435|467578612|FG001|Overall Study|Lost to Follow-up|2|||
129895886|NCT02775435|467578611|FG000|Overall Study|Sponsor decision|44|||
129895887|NCT02775435|467578612|FG001|Overall Study|Sponsor decision|19|||
129895888|NCT02775435|467578611|FG000|Overall Study|Withdrawal by Subject|4|||
129895889|NCT02775435|467578612|FG001|Overall Study|Withdrawal by Subject|9|||
129895890|NCT02775435|467578611|FG000|Overall Study|Death|196|||
129895891|NCT02775435|467578612|FG001|Overall Study|Death|224|||
129895892|NCT01268566|467578613|FG000|Overall Study|Lost to Follow-up|1|||
129895893|NCT01268566|467578613|FG000|Overall Study|Withdrawal by Subject|12|||
129895894|NCT01268566|467578613|FG000|Overall Study|Death|30|||
129895895|NCT02138916|467578614|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
129895896|NCT02138916|467578615|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
129895897|NCT02138916|467578616|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
129895898|NCT02138916|467578614|FG000|Overall Study|Death|14|||
129895899|NCT02138916|467578615|FG001|Overall Study|Death|11|||
129895900|NCT02138916|467578616|FG002|Overall Study|Death|12|||
129808664|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
129895901|NCT02138916|467578614|FG000|Overall Study|Withdrawal by Subject|27|||
129895902|NCT02138916|467578615|FG001|Overall Study|Withdrawal by Subject|31|||
129895903|NCT02138916|467578616|FG002|Overall Study|Withdrawal by Subject|32|||
129895904|NCT02138916|467578614|FG000|Overall Study|Study specific withdrawal criteria|0|||
129895905|NCT02138916|467578615|FG001|Overall Study|Study specific withdrawal criteria|0|||
129895906|NCT02138916|467578616|FG002|Overall Study|Study specific withdrawal criteria|1|||
129895907|NCT02138916|467578614|FG000|Overall Study|incorrect enrolment|1|||
129895908|NCT02138916|467578615|FG001|Overall Study|incorrect enrolment|1|||
129895909|NCT02138916|467578616|FG002|Overall Study|incorrect enrolment|0|||
130058194|NCT01395368|468168059|FG000|Overall Study|Withdrawal by Subject|2|||
129808665|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
129808666|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
130058195|NCT03072719|468168064|FG000|Overall Study|Adverse Event|1|||
129808667|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
129808668|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808669|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808670|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808671|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808672|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808673|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
129808674|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808675|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808676|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808677|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808678|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
129808679|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
129808680|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808681|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808682|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808683|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808684|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808685|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
129808686|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
129895910|NCT02138916|467578614|FG000|Overall Study|Severe non-compliance|1|||
129895911|NCT02138916|467578615|FG001|Overall Study|Severe non-compliance|2|||
129895912|NCT02138916|467578616|FG002|Overall Study|Severe non-compliance|1|||
129895913|NCT02138916|467578614|FG000|Overall Study|Lost to Follow-up|4|||
129895914|NCT02138916|467578615|FG001|Overall Study|Lost to Follow-up|2|||
129895915|NCT02138916|467578616|FG002|Overall Study|Lost to Follow-up|3|||
129895916|NCT02138916|467578614|FG000|Overall Study|Adverse Event|4|||
129895917|NCT02138916|467578615|FG001|Overall Study|Adverse Event|4|||
129895918|NCT02138916|467578616|FG002|Overall Study|Adverse Event|3|||
129895919|NCT04794179|467578617|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
129895920|NCT04794179|467578618|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
129895921|NCT01190176|467578621|FG000|Overall Study|Withdrawal by Subject|1|||
130058196|NCT03072719|468168065|FG001|Overall Study|Adverse Event|1|||
130058197|NCT00882999|468168066|FG000|Overall Study|Adverse Event|0|||
130058198|NCT00882999|468168067|FG001|Overall Study|Adverse Event|0|||
130058199|NCT00882999|468168068|FG002|Overall Study|Adverse Event|0|||
130058200|NCT00882999|468168069|FG003|Overall Study|Adverse Event|0|||
130058201|NCT00882999|468168070|FG004|Overall Study|Adverse Event|1|||
129895922|NCT01190176|467578621|FG000|Overall Study|Lost to Follow-up|1|||
130058202|NCT00882999|468168071|FG005|Overall Study|Adverse Event|0|||
129808687|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
129808688|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808689|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808690|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808691|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808692|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808693|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808694|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808695|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808696|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808697|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
129808698|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808699|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808700|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808701|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808702|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808703|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808704|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
129808705|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
129808706|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
129808707|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
129808708|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
129808709|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
129808710|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
129808711|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
129808712|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
129808713|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
129808714|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
129808715|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
129808716|NCT00347360|467265810|FG000|Overall Study|Adverse Event|1|||
129808717|NCT00347360|467265811|FG001|Overall Study|Adverse Event|2|||
130058203|NCT00882999|468168072|FG006|Overall Study|Adverse Event|0|||
130058204|NCT00882999|468168066|FG000|Overall Study|Death|0|||
130058205|NCT00882999|468168067|FG001|Overall Study|Death|1|||
130058206|NCT00882999|468168068|FG002|Overall Study|Death|0|||
130058207|NCT00882999|468168069|FG003|Overall Study|Death|0|||
130058208|NCT00882999|468168070|FG004|Overall Study|Death|0|||
130058209|NCT00882999|468168071|FG005|Overall Study|Death|0|||
129808718|NCT00347360|467265812|FG002|Overall Study|Adverse Event|0|||
129808719|NCT00347360|467265813|FG003|Overall Study|Adverse Event|4|||
129808720|NCT00347360|467265814|FG004|Overall Study|Adverse Event|1|||
129808721|NCT00347360|467265815|FG005|Overall Study|Adverse Event|2|||
129895923|NCT03697460|467578622|FG000|Overall Study|Withdrawal by Subject|3|||
129808722|NCT00347360|467265816|FG006|Overall Study|Adverse Event|2|||
129895924|NCT00445692|467578624|FG000|Overall Study|Adverse Event|11|||
129808723|NCT00347360|467265817|FG007|Overall Study|Adverse Event|0|||
130058210|NCT00882999|468168072|FG006|Overall Study|Death|0|||
130058211|NCT00882999|468168066|FG000|Overall Study|Withdrawal by Subject|7|||
129808724|NCT00347360|467265818|FG008|Overall Study|Adverse Event|2|||
129808725|NCT00347360|467265819|FG009|Overall Study|Adverse Event|3|||
129808726|NCT00347360|467265820|FG010|Overall Study|Adverse Event|3|||
129808727|NCT00347360|467265821|FG011|Overall Study|Adverse Event|1|||
129808728|NCT00347360|467265822|FG012|Overall Study|Adverse Event|3|||
129808729|NCT00347360|467265823|FG013|Overall Study|Adverse Event|2|||
129808730|NCT00347360|467265824|FG014|Overall Study|Adverse Event|2|||
129808731|NCT00347360|467265810|FG000|Overall Study|Lost to Follow-up|0|||
129808732|NCT00347360|467265811|FG001|Overall Study|Lost to Follow-up|0|||
129808733|NCT00347360|467265812|FG002|Overall Study|Lost to Follow-up|0|||
129808734|NCT00347360|467265813|FG003|Overall Study|Lost to Follow-up|2|||
129808735|NCT00347360|467265814|FG004|Overall Study|Lost to Follow-up|1|||
129808736|NCT00347360|467265815|FG005|Overall Study|Lost to Follow-up|1|||
129808737|NCT00347360|467265816|FG006|Overall Study|Lost to Follow-up|0|||
129808738|NCT00347360|467265817|FG007|Overall Study|Lost to Follow-up|1|||
129808739|NCT00347360|467265818|FG008|Overall Study|Lost to Follow-up|1|||
129808740|NCT00347360|467265819|FG009|Overall Study|Lost to Follow-up|2|||
129808741|NCT00347360|467265820|FG010|Overall Study|Lost to Follow-up|0|||
129808742|NCT00347360|467265821|FG011|Overall Study|Lost to Follow-up|0|||
129808743|NCT00347360|467265822|FG012|Overall Study|Lost to Follow-up|1|||
129808744|NCT00347360|467265823|FG013|Overall Study|Lost to Follow-up|0|||
129808745|NCT00347360|467265824|FG014|Overall Study|Lost to Follow-up|0|||
129808746|NCT00347360|467265810|FG000|Overall Study|Protocol Violation|2|||
129808747|NCT00347360|467265811|FG001|Overall Study|Protocol Violation|3|||
129808748|NCT00347360|467265812|FG002|Overall Study|Protocol Violation|1|||
129808749|NCT00347360|467265813|FG003|Overall Study|Protocol Violation|2|||
129808750|NCT00347360|467265814|FG004|Overall Study|Protocol Violation|1|||
129808751|NCT00347360|467265815|FG005|Overall Study|Protocol Violation|2|||
129808752|NCT00347360|467265816|FG006|Overall Study|Protocol Violation|0|||
129808753|NCT00347360|467265817|FG007|Overall Study|Protocol Violation|0|||
129808754|NCT00347360|467265818|FG008|Overall Study|Protocol Violation|1|||
129808755|NCT00347360|467265819|FG009|Overall Study|Protocol Violation|2|||
129808756|NCT00347360|467265820|FG010|Overall Study|Protocol Violation|0|||
129808757|NCT00347360|467265821|FG011|Overall Study|Protocol Violation|0|||
129808758|NCT00347360|467265822|FG012|Overall Study|Protocol Violation|0|||
129808759|NCT00347360|467265823|FG013|Overall Study|Protocol Violation|1|||
129808760|NCT00347360|467265824|FG014|Overall Study|Protocol Violation|0|||
129808761|NCT00347360|467265810|FG000|Overall Study|Withdrawal by Subject|0|||
129808762|NCT00347360|467265811|FG001|Overall Study|Withdrawal by Subject|1|||
129808763|NCT00347360|467265812|FG002|Overall Study|Withdrawal by Subject|2|||
129808764|NCT00347360|467265813|FG003|Overall Study|Withdrawal by Subject|4|||
129808765|NCT00347360|467265814|FG004|Overall Study|Withdrawal by Subject|1|||
129808766|NCT00347360|467265815|FG005|Overall Study|Withdrawal by Subject|2|||
129808767|NCT00347360|467265816|FG006|Overall Study|Withdrawal by Subject|1|||
129808768|NCT00347360|467265817|FG007|Overall Study|Withdrawal by Subject|1|||
129808769|NCT00347360|467265818|FG008|Overall Study|Withdrawal by Subject|1|||
129808770|NCT00347360|467265819|FG009|Overall Study|Withdrawal by Subject|1|||
129808771|NCT00347360|467265820|FG010|Overall Study|Withdrawal by Subject|0|||
129808772|NCT00347360|467265821|FG011|Overall Study|Withdrawal by Subject|3|||
129808773|NCT00347360|467265822|FG012|Overall Study|Withdrawal by Subject|4|||
129895925|NCT00445692|467578624|FG000|Overall Study|Lack of Efficacy|5|||
129895926|NCT03425539|467578626|FG000|Overall Study|Randomized but not treated|0|||
129895927|NCT03425539|467578627|FG001|Overall Study|Randomized but not treated|1|||
129895928|NCT03425539|467578626|FG000|Overall Study|Adverse Event|2|||
129895929|NCT03425539|467578627|FG001|Overall Study|Adverse Event|2|||
129808774|NCT00347360|467265823|FG013|Overall Study|Withdrawal by Subject|2|||
129808775|NCT00347360|467265824|FG014|Overall Study|Withdrawal by Subject|1|||
129808776|NCT00347360|467265810|FG000|Overall Study|Lack of Efficacy|1|||
129808777|NCT00347360|467265811|FG001|Overall Study|Lack of Efficacy|1|||
129808778|NCT00347360|467265812|FG002|Overall Study|Lack of Efficacy|3|||
129895930|NCT03425539|467578626|FG000|Overall Study|Withdrawal by Subject|3|||
129808779|NCT00347360|467265813|FG003|Overall Study|Lack of Efficacy|1|||
129808780|NCT00347360|467265814|FG004|Overall Study|Lack of Efficacy|0|||
129895931|NCT03425539|467578627|FG001|Overall Study|Withdrawal by Subject|0|||
129808781|NCT00347360|467265815|FG005|Overall Study|Lack of Efficacy|1|||
129808782|NCT00347360|467265816|FG006|Overall Study|Lack of Efficacy|0|||
129895932|NCT03425539|467578626|FG000|Overall Study|Lost to Follow-up|0|||
129895933|NCT03425539|467578627|FG001|Overall Study|Lost to Follow-up|1|||
129895934|NCT02040844|467578632|FG000|Overall Study|Adverse Event|0|||
129808783|NCT00347360|467265817|FG007|Overall Study|Lack of Efficacy|1|||
129808784|NCT00347360|467265818|FG008|Overall Study|Lack of Efficacy|1|||
129808785|NCT00347360|467265819|FG009|Overall Study|Lack of Efficacy|0|||
129808786|NCT00347360|467265820|FG010|Overall Study|Lack of Efficacy|0|||
129808787|NCT00347360|467265821|FG011|Overall Study|Lack of Efficacy|0|||
129808788|NCT00347360|467265822|FG012|Overall Study|Lack of Efficacy|0|||
129808789|NCT00347360|467265823|FG013|Overall Study|Lack of Efficacy|0|||
129808790|NCT00347360|467265824|FG014|Overall Study|Lack of Efficacy|0|||
129808791|NCT00347360|467265810|FG000|Overall Study|Reason not listed/blank|1|||
129808792|NCT00347360|467265811|FG001|Overall Study|Reason not listed/blank|0|||
129808793|NCT00347360|467265812|FG002|Overall Study|Reason not listed/blank|0|||
129808794|NCT00347360|467265813|FG003|Overall Study|Reason not listed/blank|0|||
129808795|NCT00347360|467265814|FG004|Overall Study|Reason not listed/blank|0|||
129808796|NCT00347360|467265815|FG005|Overall Study|Reason not listed/blank|0|||
129808797|NCT00347360|467265816|FG006|Overall Study|Reason not listed/blank|1|||
129808798|NCT00347360|467265817|FG007|Overall Study|Reason not listed/blank|0|||
129808799|NCT00347360|467265818|FG008|Overall Study|Reason not listed/blank|0|||
129808800|NCT00347360|467265819|FG009|Overall Study|Reason not listed/blank|0|||
129808801|NCT00347360|467265820|FG010|Overall Study|Reason not listed/blank|0|||
129808802|NCT00347360|467265821|FG011|Overall Study|Reason not listed/blank|0|||
129808803|NCT00347360|467265822|FG012|Overall Study|Reason not listed/blank|0|||
129808804|NCT00347360|467265823|FG013|Overall Study|Reason not listed/blank|1|||
129808805|NCT00347360|467265824|FG014|Overall Study|Reason not listed/blank|0|||
129808806|NCT00347360|467265810|FG000|Overall Study|Per sponsors instruction|0|||
129808807|NCT00347360|467265811|FG001|Overall Study|Per sponsors instruction|1|||
129808808|NCT00347360|467265812|FG002|Overall Study|Per sponsors instruction|0|||
129808809|NCT00347360|467265813|FG003|Overall Study|Per sponsors instruction|0|||
129808810|NCT00347360|467265814|FG004|Overall Study|Per sponsors instruction|0|||
129808811|NCT00347360|467265815|FG005|Overall Study|Per sponsors instruction|0|||
129808812|NCT00347360|467265816|FG006|Overall Study|Per sponsors instruction|0|||
129808813|NCT00347360|467265817|FG007|Overall Study|Per sponsors instruction|0|||
129808814|NCT00347360|467265818|FG008|Overall Study|Per sponsors instruction|0|||
129808815|NCT00347360|467265819|FG009|Overall Study|Per sponsors instruction|0|||
129808816|NCT00347360|467265820|FG010|Overall Study|Per sponsors instruction|0|||
129808817|NCT00347360|467265821|FG011|Overall Study|Per sponsors instruction|0|||
129808818|NCT00347360|467265822|FG012|Overall Study|Per sponsors instruction|0|||
129895935|NCT02040844|467578633|FG001|Overall Study|Adverse Event|0|||
129895936|NCT02040844|467578634|FG002|Overall Study|Adverse Event|1|||
129895937|NCT02040844|467578632|FG000|Overall Study|Withdrawal by Subject|16|||
129895938|NCT02040844|467578633|FG001|Overall Study|Withdrawal by Subject|22|||
129895939|NCT02040844|467578634|FG002|Overall Study|Withdrawal by Subject|25|||
129895940|NCT02040844|467578632|FG000|Overall Study|Lost to Follow-up|12|||
129895941|NCT02040844|467578633|FG001|Overall Study|Lost to Follow-up|9|||
129895942|NCT02040844|467578634|FG002|Overall Study|Lost to Follow-up|13|||
129895943|NCT02040844|467578632|FG000|Overall Study|Missing|13|||
129895944|NCT02040844|467578633|FG001|Overall Study|Missing|3|||
129895945|NCT02040844|467578634|FG002|Overall Study|Missing|2|||
129808819|NCT00347360|467265823|FG013|Overall Study|Per sponsors instruction|0|||
129808820|NCT00347360|467265824|FG014|Overall Study|Per sponsors instruction|0|||
129895946|NCT02040844|467578632|FG000|Overall Study|Non-specified|8|||
129808821|NCT00347360|467265810|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
129895947|NCT02040844|467578633|FG001|Overall Study|Non-specified|2|||
129808822|NCT00347360|467265811|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
129808823|NCT00347360|467265812|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
129808824|NCT00347360|467265813|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
129808825|NCT00347360|467265814|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
129808826|NCT00347360|467265815|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
129808827|NCT00347360|467265816|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
129895948|NCT02040844|467578634|FG002|Overall Study|Non-specified|5|||
129895949|NCT02040844|467578632|FG000|Overall Study|Concomitant medication|1|||
129895950|NCT02040844|467578633|FG001|Overall Study|Concomitant medication|3|||
129895951|NCT02040844|467578634|FG002|Overall Study|Concomitant medication|1|||
129895952|NCT01560949|467578637|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
129895953|NCT01560949|467578637|FG000|Surgery Phase|Physician Decision|3|||
129808828|NCT00347360|467265817|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
129808829|NCT00347360|467265818|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
129808830|NCT00347360|467265819|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
129808831|NCT00347360|467265820|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
129808832|NCT00347360|467265821|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
129808833|NCT00347360|467265822|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
129808834|NCT00347360|467265823|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
129808835|NCT00347360|467265824|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
129808836|NCT00347360|467265810|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
129808837|NCT00347360|467265811|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
129808838|NCT00347360|467265812|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
129808839|NCT00347360|467265813|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
129808840|NCT00347360|467265814|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
129808841|NCT00347360|467265815|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
129808842|NCT00347360|467265816|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
129808843|NCT00347360|467265817|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
129808844|NCT00347360|467265818|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
129808845|NCT00347360|467265819|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
129808846|NCT00347360|467265820|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
129808847|NCT00347360|467265821|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
129808848|NCT00347360|467265822|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
129808849|NCT00347360|467265823|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
129808850|NCT00347360|467265824|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
129808851|NCT00347360|467265810|FG000|Overall Study|Abnormal lab values|0|||
129808852|NCT00347360|467265811|FG001|Overall Study|Abnormal lab values|0|||
129808853|NCT00347360|467265812|FG002|Overall Study|Abnormal lab values|0|||
129808854|NCT00347360|467265813|FG003|Overall Study|Abnormal lab values|0|||
129808855|NCT00347360|467265814|FG004|Overall Study|Abnormal lab values|0|||
129808856|NCT00347360|467265815|FG005|Overall Study|Abnormal lab values|0|||
129808857|NCT00347360|467265816|FG006|Overall Study|Abnormal lab values|1|||
129808858|NCT00347360|467265817|FG007|Overall Study|Abnormal lab values|0|||
129808859|NCT00347360|467265818|FG008|Overall Study|Abnormal lab values|0|||
129808860|NCT00347360|467265819|FG009|Overall Study|Abnormal lab values|0|||
129808861|NCT00347360|467265820|FG010|Overall Study|Abnormal lab values|0|||
129808862|NCT00347360|467265821|FG011|Overall Study|Abnormal lab values|0|||
129808863|NCT00347360|467265822|FG012|Overall Study|Abnormal lab values|0|||
129808864|NCT00347360|467265823|FG013|Overall Study|Abnormal lab values|0|||
129808865|NCT00347360|467265824|FG014|Overall Study|Abnormal lab values|0|||
129808866|NCT00347360|467265810|FG000|Overall Study|PI recommended early withdrawal|0|||
129808867|NCT00347360|467265811|FG001|Overall Study|PI recommended early withdrawal|0|||
129808868|NCT00347360|467265812|FG002|Overall Study|PI recommended early withdrawal|0|||
129808869|NCT00347360|467265813|FG003|Overall Study|PI recommended early withdrawal|0|||
129808870|NCT00347360|467265814|FG004|Overall Study|PI recommended early withdrawal|0|||
129808871|NCT00347360|467265815|FG005|Overall Study|PI recommended early withdrawal|0|||
129808872|NCT00347360|467265816|FG006|Overall Study|PI recommended early withdrawal|0|||
129808873|NCT00347360|467265817|FG007|Overall Study|PI recommended early withdrawal|0|||
129808874|NCT00347360|467265818|FG008|Overall Study|PI recommended early withdrawal|0|||
129808875|NCT00347360|467265819|FG009|Overall Study|PI recommended early withdrawal|1|||
129808876|NCT00347360|467265820|FG010|Overall Study|PI recommended early withdrawal|0|||
129808877|NCT00347360|467265821|FG011|Overall Study|PI recommended early withdrawal|0|||
129808878|NCT00347360|467265822|FG012|Overall Study|PI recommended early withdrawal|0|||
129808879|NCT00347360|467265823|FG013|Overall Study|PI recommended early withdrawal|0|||
129808880|NCT00347360|467265824|FG014|Overall Study|PI recommended early withdrawal|0|||
129808881|NCT00347360|467265810|FG000|Overall Study|Did not meet criteria before ABPM|0|||
129808882|NCT00347360|467265811|FG001|Overall Study|Did not meet criteria before ABPM|0|||
129808883|NCT00347360|467265812|FG002|Overall Study|Did not meet criteria before ABPM|0|||
129808884|NCT00347360|467265813|FG003|Overall Study|Did not meet criteria before ABPM|0|||
129808885|NCT00347360|467265814|FG004|Overall Study|Did not meet criteria before ABPM|0|||
129808886|NCT00347360|467265815|FG005|Overall Study|Did not meet criteria before ABPM|0|||
129808887|NCT00347360|467265816|FG006|Overall Study|Did not meet criteria before ABPM|0|||
129808888|NCT00347360|467265817|FG007|Overall Study|Did not meet criteria before ABPM|0|||
129808889|NCT00347360|467265818|FG008|Overall Study|Did not meet criteria before ABPM|0|||
129808890|NCT00347360|467265819|FG009|Overall Study|Did not meet criteria before ABPM|0|||
129808891|NCT00347360|467265820|FG010|Overall Study|Did not meet criteria before ABPM|1|||
129808892|NCT00347360|467265821|FG011|Overall Study|Did not meet criteria before ABPM|0|||
129808893|NCT00347360|467265822|FG012|Overall Study|Did not meet criteria before ABPM|0|||
129808894|NCT00347360|467265823|FG013|Overall Study|Did not meet criteria before ABPM|0|||
129808895|NCT00347360|467265824|FG014|Overall Study|Did not meet criteria before ABPM|0|||
129808896|NCT00347360|467265810|FG000|Overall Study|Randomized in error|0|||
129808897|NCT00347360|467265811|FG001|Overall Study|Randomized in error|0|||
129808898|NCT00347360|467265812|FG002|Overall Study|Randomized in error|0|||
129808899|NCT00347360|467265813|FG003|Overall Study|Randomized in error|0|||
129808900|NCT00347360|467265814|FG004|Overall Study|Randomized in error|0|||
129808901|NCT00347360|467265815|FG005|Overall Study|Randomized in error|0|||
129808902|NCT00347360|467265816|FG006|Overall Study|Randomized in error|0|||
129808903|NCT00347360|467265817|FG007|Overall Study|Randomized in error|0|||
129808904|NCT00347360|467265818|FG008|Overall Study|Randomized in error|0|||
129808905|NCT00347360|467265819|FG009|Overall Study|Randomized in error|0|||
129808906|NCT00347360|467265820|FG010|Overall Study|Randomized in error|0|||
129808907|NCT00347360|467265821|FG011|Overall Study|Randomized in error|1|||
129808908|NCT00347360|467265822|FG012|Overall Study|Randomized in error|0|||
129808909|NCT00347360|467265823|FG013|Overall Study|Randomized in error|0|||
129808910|NCT00347360|467265824|FG014|Overall Study|Randomized in error|0|||
129808911|NCT00347360|467265810|FG000|Overall Study|Failed inclusion criteria #4|0|||
129808912|NCT00347360|467265811|FG001|Overall Study|Failed inclusion criteria #4|0|||
129808913|NCT00347360|467265812|FG002|Overall Study|Failed inclusion criteria #4|0|||
129808914|NCT00347360|467265813|FG003|Overall Study|Failed inclusion criteria #4|0|||
129808915|NCT00347360|467265814|FG004|Overall Study|Failed inclusion criteria #4|0|||
129808916|NCT00347360|467265815|FG005|Overall Study|Failed inclusion criteria #4|0|||
129808917|NCT00347360|467265816|FG006|Overall Study|Failed inclusion criteria #4|0|||
129808918|NCT00347360|467265817|FG007|Overall Study|Failed inclusion criteria #4|0|||
129808919|NCT00347360|467265818|FG008|Overall Study|Failed inclusion criteria #4|0|||
129808920|NCT00347360|467265819|FG009|Overall Study|Failed inclusion criteria #4|0|||
129808921|NCT00347360|467265820|FG010|Overall Study|Failed inclusion criteria #4|0|||
129808922|NCT00347360|467265821|FG011|Overall Study|Failed inclusion criteria #4|1|||
129808923|NCT00347360|467265822|FG012|Overall Study|Failed inclusion criteria #4|0|||
129808924|NCT00347360|467265823|FG013|Overall Study|Failed inclusion criteria #4|0|||
129895954|NCT00681811|467578640|FG000|Overall Study|Adverse Event|1|||
129808925|NCT00347360|467265824|FG014|Overall Study|Failed inclusion criteria #4|0|||
129808926|NCT00347360|467265810|FG000|Overall Study|Prolonged duration between visits|0|||
129808927|NCT00347360|467265811|FG001|Overall Study|Prolonged duration between visits|0|||
129808928|NCT00347360|467265812|FG002|Overall Study|Prolonged duration between visits|0|||
129808929|NCT00347360|467265813|FG003|Overall Study|Prolonged duration between visits|0|||
129808930|NCT00347360|467265814|FG004|Overall Study|Prolonged duration between visits|0|||
129808931|NCT00347360|467265815|FG005|Overall Study|Prolonged duration between visits|0|||
129808932|NCT00347360|467265816|FG006|Overall Study|Prolonged duration between visits|0|||
129808933|NCT00347360|467265817|FG007|Overall Study|Prolonged duration between visits|0|||
129808934|NCT00347360|467265818|FG008|Overall Study|Prolonged duration between visits|0|||
129808935|NCT00347360|467265819|FG009|Overall Study|Prolonged duration between visits|0|||
129808936|NCT00347360|467265820|FG010|Overall Study|Prolonged duration between visits|0|||
129808937|NCT00347360|467265821|FG011|Overall Study|Prolonged duration between visits|0|||
129808938|NCT00347360|467265822|FG012|Overall Study|Prolonged duration between visits|1|||
129808939|NCT00347360|467265823|FG013|Overall Study|Prolonged duration between visits|0|||
129808940|NCT00347360|467265824|FG014|Overall Study|Prolonged duration between visits|0|||
129808941|NCT00347360|467265810|FG000|Overall Study|Subject left town, ran out of study drug|0|||
129808942|NCT00347360|467265811|FG001|Overall Study|Subject left town, ran out of study drug|0|||
129808943|NCT00347360|467265812|FG002|Overall Study|Subject left town, ran out of study drug|0|||
129808944|NCT00347360|467265813|FG003|Overall Study|Subject left town, ran out of study drug|0|||
129808945|NCT00347360|467265814|FG004|Overall Study|Subject left town, ran out of study drug|0|||
129808946|NCT00347360|467265815|FG005|Overall Study|Subject left town, ran out of study drug|0|||
129808947|NCT00347360|467265816|FG006|Overall Study|Subject left town, ran out of study drug|0|||
129808948|NCT00347360|467265817|FG007|Overall Study|Subject left town, ran out of study drug|0|||
129808949|NCT00347360|467265818|FG008|Overall Study|Subject left town, ran out of study drug|0|||
129895955|NCT00681811|467578641|FG001|Overall Study|Adverse Event|1|||
129895956|NCT00681811|467578640|FG000|Overall Study|Withdrawal by Subject|2|||
129895957|NCT00681811|467578641|FG001|Overall Study|Withdrawal by Subject|2|||
129895958|NCT00681811|467578640|FG000|Overall Study|Non-compliance|0|||
129895959|NCT00681811|467578641|FG001|Overall Study|Non-compliance|1|||
129895960|NCT01562743|467578644|FG000|Overall Study|Adverse Event|29|||
129895961|NCT01562743|467578644|FG000|Overall Study|Lack of Efficacy|3|||
129895962|NCT01562743|467578644|FG000|Overall Study|Withdrawal by Subject|13|||
129895963|NCT01562743|467578644|FG000|Overall Study|Protocol Violation|1|||
129895964|NCT01562743|467578644|FG000|Overall Study|Discontinuation criteria|2|||
129895965|NCT01562743|467578644|FG000|Overall Study|Lost to Follow-up|2|||
129808950|NCT00347360|467265819|FG009|Overall Study|Subject left town, ran out of study drug|0|||
129808951|NCT00347360|467265820|FG010|Overall Study|Subject left town, ran out of study drug|0|||
129808952|NCT00347360|467265821|FG011|Overall Study|Subject left town, ran out of study drug|0|||
129808953|NCT00347360|467265822|FG012|Overall Study|Subject left town, ran out of study drug|0|||
129808954|NCT00347360|467265823|FG013|Overall Study|Subject left town, ran out of study drug|1|||
129895966|NCT01562743|467578644|FG000|Overall Study|Physician Decision|2|||
129895967|NCT05349864|467580386|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
129895968|NCT05349864|467580387|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
129895969|NCT02321540|467580391|FG000|Overall Study|Death|0|||
129895970|NCT02321540|467580392|FG001|Overall Study|Death|1|||
129895971|NCT02321540|467580391|FG000|Overall Study|Progression|3|||
129895972|NCT02321540|467580392|FG001|Overall Study|Progression|9|||
129895973|NCT00003656|467580397|FG000|Overall Study|Adverse Event|0|||
129895974|NCT00003656|467580398|FG001|Overall Study|Adverse Event|1|||
129895975|NCT01941316|467580399|FG000|Overall Study|Adverse Event|0|||
129895976|NCT01941316|467580400|FG001|Overall Study|Adverse Event|1|||
129895977|NCT01941316|467580401|FG002|Overall Study|Adverse Event|0|||
129895978|NCT01941316|467580402|FG003|Overall Study|Adverse Event|7|||
129895979|NCT01941316|467580399|FG000|Overall Study|Progressive Disease|3|||
129895980|NCT01941316|467580400|FG001|Overall Study|Progressive Disease|6|||
129895981|NCT01941316|467580401|FG002|Overall Study|Progressive Disease|2|||
129895982|NCT01941316|467580402|FG003|Overall Study|Progressive Disease|29|||
129895983|NCT01941316|467580399|FG000|Overall Study|Withdrawal by Subject|0|||
129895984|NCT01941316|467580400|FG001|Overall Study|Withdrawal by Subject|2|||
129895985|NCT01941316|467580401|FG002|Overall Study|Withdrawal by Subject|1|||
129895986|NCT01941316|467580402|FG003|Overall Study|Withdrawal by Subject|8|||
129895987|NCT01941316|467580399|FG000|Overall Study|Death|0|||
129895988|NCT01941316|467580400|FG001|Overall Study|Death|0|||
129895989|NCT01941316|467580401|FG002|Overall Study|Death|0|||
129895990|NCT01941316|467580402|FG003|Overall Study|Death|3|||
129895991|NCT01941316|467580399|FG000|Overall Study|Physician Decision|0|||
129895992|NCT01941316|467580400|FG001|Overall Study|Physician Decision|0|||
129895993|NCT01941316|467580401|FG002|Overall Study|Physician Decision|0|||
129895994|NCT01941316|467580402|FG003|Overall Study|Physician Decision|3|||
129895995|NCT01941316|467580399|FG000|Overall Study|Protocol Violation|0|||
129895996|NCT01941316|467580400|FG001|Overall Study|Protocol Violation|0|||
129895997|NCT01941316|467580401|FG002|Overall Study|Protocol Violation|0|||
129895998|NCT01941316|467580402|FG003|Overall Study|Protocol Violation|3|||
129895999|NCT01941316|467580399|FG000|Overall Study|Intercurrent illness|0|||
129896000|NCT01941316|467580400|FG001|Overall Study|Intercurrent illness|0|||
129896001|NCT01941316|467580401|FG002|Overall Study|Intercurrent illness|0|||
129896002|NCT01941316|467580402|FG003|Overall Study|Intercurrent illness|1|||
129896003|NCT01941316|467580399|FG000|Overall Study|Other, not specified|0|||
129896004|NCT01941316|467580400|FG001|Overall Study|Other, not specified|0|||
129896005|NCT01941316|467580401|FG002|Overall Study|Other, not specified|0|||
129896006|NCT01941316|467580402|FG003|Overall Study|Other, not specified|1|||
129896007|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
129896008|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
129896009|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
129896010|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Other|1|||
129896011|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
129896012|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
129896013|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
129896014|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Other|1|||
129896015|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
129896016|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
129896017|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
129896018|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Death|3|||
129896019|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Death|0|||
129896020|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Death|0|||
129896021|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
129896022|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129896023|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129896024|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
129808955|NCT00347360|467265824|FG014|Overall Study|Subject left town, ran out of study drug|0|||
129808956|NCT00347360|467265810|FG000|Overall Study|Subject refuse to sign updated consent|0|||
129808957|NCT00347360|467265811|FG001|Overall Study|Subject refuse to sign updated consent|0|||
129808958|NCT00347360|467265812|FG002|Overall Study|Subject refuse to sign updated consent|0|||
129808959|NCT00347360|467265813|FG003|Overall Study|Subject refuse to sign updated consent|0|||
129808960|NCT00347360|467265814|FG004|Overall Study|Subject refuse to sign updated consent|0|||
129808961|NCT00347360|467265815|FG005|Overall Study|Subject refuse to sign updated consent|0|||
129808962|NCT00347360|467265816|FG006|Overall Study|Subject refuse to sign updated consent|0|||
129808963|NCT00347360|467265817|FG007|Overall Study|Subject refuse to sign updated consent|0|||
129808964|NCT00347360|467265818|FG008|Overall Study|Subject refuse to sign updated consent|0|||
129808965|NCT00347360|467265819|FG009|Overall Study|Subject refuse to sign updated consent|0|||
129808966|NCT00347360|467265820|FG010|Overall Study|Subject refuse to sign updated consent|0|||
129808967|NCT00347360|467265821|FG011|Overall Study|Subject refuse to sign updated consent|0|||
129808968|NCT00347360|467265822|FG012|Overall Study|Subject refuse to sign updated consent|0|||
129808969|NCT00347360|467265823|FG013|Overall Study|Subject refuse to sign updated consent|0|||
129808970|NCT00347360|467265824|FG014|Overall Study|Subject refuse to sign updated consent|1|||
129808971|NCT00347360|467265810|FG000|Overall Study|Visits conflicted with new job|0|||
129808972|NCT00347360|467265811|FG001|Overall Study|Visits conflicted with new job|0|||
129808973|NCT00347360|467265812|FG002|Overall Study|Visits conflicted with new job|0|||
129808974|NCT00347360|467265813|FG003|Overall Study|Visits conflicted with new job|0|||
129808975|NCT00347360|467265814|FG004|Overall Study|Visits conflicted with new job|0|||
129808976|NCT00347360|467265815|FG005|Overall Study|Visits conflicted with new job|0|||
129808977|NCT00347360|467265816|FG006|Overall Study|Visits conflicted with new job|1|||
129808978|NCT00347360|467265817|FG007|Overall Study|Visits conflicted with new job|0|||
129808979|NCT00347360|467265818|FG008|Overall Study|Visits conflicted with new job|0|||
129808980|NCT00347360|467265819|FG009|Overall Study|Visits conflicted with new job|0|||
129808981|NCT00347360|467265820|FG010|Overall Study|Visits conflicted with new job|0|||
129808982|NCT00347360|467265821|FG011|Overall Study|Visits conflicted with new job|0|||
129808983|NCT00347360|467265822|FG012|Overall Study|Visits conflicted with new job|0|||
129808984|NCT00347360|467265823|FG013|Overall Study|Visits conflicted with new job|0|||
129808985|NCT00347360|467265824|FG014|Overall Study|Visits conflicted with new job|0|||
129808986|NCT01449539|467265825|FG000|Overall Study|Withdrawal by Subject|3|||
129808987|NCT01449539|467265825|FG000|Overall Study|Toxicity not study related|1|||
129808988|NCT02187744|467265828|FG000|Study|Participant refused further follow-up|1|||
129808989|NCT02187744|467265829|FG001|Study|Participant refused further follow-up|0|||
129808990|NCT02187744|467265828|FG000|Study|Other|2|||
129808991|NCT02187744|467265829|FG001|Study|Other|1|||
129808992|NCT02187744|467265828|FG000|Study|Lost to Follow-up|0|||
129808993|NCT02187744|467265829|FG001|Study|Lost to Follow-up|2|||
129808994|NCT02187744|467265828|FG000|Study|Related adverse event, not serious|0|||
129808995|NCT02187744|467265829|FG001|Study|Related adverse event, not serious|2|||
129808996|NCT02187744|467265828|FG000|Study|Death|1|||
129808997|NCT02187744|467265829|FG001|Study|Death|0|||
129808998|NCT02187744|467265828|FG000|Study|Related adverse event, serious non-fatal|0|||
129808999|NCT02187744|467265829|FG001|Study|Related adverse event, serious non-fatal|1|||
129809000|NCT02187744|467265828|FG000|Treatment|Death|1|||
129809001|NCT02187744|467265829|FG001|Treatment|Death|0|||
129809002|NCT02187744|467265828|FG000|Treatment|Related adverse event, serious non-fatal|0|||
129896025|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
129896026|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
129896027|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
129896028|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
129896029|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
129896030|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
129896031|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
129896032|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
129896033|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
129896034|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
129896035|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
129896036|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Other|1|||
129896037|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Other|0|||
129896038|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Other|0|||
129896039|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
129896040|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129896041|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129896042|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129896043|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
129896044|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129896045|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
129896046|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
129896047|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
129896048|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
129896049|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
129896050|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
129896051|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129896052|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
129896053|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129896054|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129896055|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
129896056|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
129896057|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
129896058|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
129896059|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
129896060|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
129896061|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
129896062|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
129896063|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
129896064|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
129896065|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
129896066|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
129896067|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
129896068|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
129896069|NCT00197236|467580420|FG000|Overall Study|Adverse Event|1|||
129896070|NCT00197236|467580421|FG001|Overall Study|Adverse Event|0|||
129896071|NCT00197236|467580422|FG002|Overall Study|Adverse Event|1|||
129896072|NCT00197236|467580420|FG000|Overall Study|Lost to Follow-up|5|||
129896073|NCT00197236|467580421|FG001|Overall Study|Lost to Follow-up|14|||
129896074|NCT00197236|467580422|FG002|Overall Study|Lost to Follow-up|6|||
129896075|NCT00197236|467580420|FG000|Overall Study|Protocol Violation|0|||
129896076|NCT00197236|467580421|FG001|Overall Study|Protocol Violation|0|||
129896077|NCT00197236|467580422|FG002|Overall Study|Protocol Violation|1|||
129896078|NCT00197236|467580420|FG000|Overall Study|Withdrawal by Subject|7|||
129896079|NCT00197236|467580421|FG001|Overall Study|Withdrawal by Subject|3|||
129896080|NCT00197236|467580422|FG002|Overall Study|Withdrawal by Subject|11|||
129896081|NCT00197236|467580420|FG000|Overall Study|Study drug/medication expiration|1|||
129896082|NCT00197236|467580421|FG001|Overall Study|Study drug/medication expiration|0|||
129896083|NCT00197236|467580422|FG002|Overall Study|Study drug/medication expiration|3|||
129896084|NCT00197236|467580420|FG000|Overall Study|Returned out of specified time window|0|||
129896085|NCT00197236|467580421|FG001|Overall Study|Returned out of specified time window|0|||
129896086|NCT00197236|467580422|FG002|Overall Study|Returned out of specified time window|1|||
129896087|NCT03885596|467580423|FG000|Overall Study|Withdrawal by Subject|2|||
129896088|NCT03885596|467580424|FG001|Overall Study|Withdrawal by Subject|1|||
129896089|NCT03885596|467580425|FG002|Overall Study|Withdrawal by Subject|0|||
129896090|NCT03885596|467580426|FG003|Overall Study|Withdrawal by Subject|0|||
129896091|NCT03852433|467580427|FG000|Overall Study|Withdrawal of consent|5|||
129896092|NCT03852433|467580428|FG001|Overall Study|Withdrawal of consent|8|||
129896093|NCT03852433|467580429|FG002|Overall Study|Withdrawal of consent|1|||
129896094|NCT03852433|467580430|FG003|Overall Study|Withdrawal of consent|1|||
129896095|NCT03852433|467580427|FG000|Overall Study|Adverse Event|1|||
129896096|NCT03852433|467580428|FG001|Overall Study|Adverse Event|1|||
129896097|NCT03852433|467580429|FG002|Overall Study|Adverse Event|1|||
129896098|NCT03852433|467580430|FG003|Overall Study|Adverse Event|1|||
129896099|NCT03852433|467580427|FG000|Overall Study|Lost to Follow-up|0|||
129896100|NCT03852433|467580428|FG001|Overall Study|Lost to Follow-up|1|||
129896101|NCT03852433|467580429|FG002|Overall Study|Lost to Follow-up|0|||
129896102|NCT03852433|467580430|FG003|Overall Study|Lost to Follow-up|1|||
129896103|NCT03852433|467580427|FG000|Overall Study|Pregnancy|0|||
129896104|NCT03852433|467580428|FG001|Overall Study|Pregnancy|1|||
129896105|NCT03852433|467580429|FG002|Overall Study|Pregnancy|1|||
129896106|NCT03852433|467580430|FG003|Overall Study|Pregnancy|0|||
129896107|NCT03852433|467580427|FG000|Overall Study|Protocol Violation|0|||
129896108|NCT03852433|467580428|FG001|Overall Study|Protocol Violation|0|||
129896109|NCT03852433|467580429|FG002|Overall Study|Protocol Violation|1|||
129896110|NCT03852433|467580430|FG003|Overall Study|Protocol Violation|1|||
129896111|NCT03852433|467580427|FG000|Overall Study|Death|0|||
129896112|NCT03852433|467580428|FG001|Overall Study|Death|0|||
129896113|NCT03852433|467580429|FG002|Overall Study|Death|1|||
129896114|NCT03852433|467580430|FG003|Overall Study|Death|0|||
129896115|NCT03852433|467580427|FG000|Overall Study|Lack of Efficacy|0|||
129896116|NCT03852433|467580428|FG001|Overall Study|Lack of Efficacy|1|||
129896117|NCT03852433|467580429|FG002|Overall Study|Lack of Efficacy|0|||
129896118|NCT03852433|467580430|FG003|Overall Study|Lack of Efficacy|0|||
129896119|NCT03852433|467580427|FG000|Overall Study|Non-compliance with study drug|0|||
129896120|NCT03852433|467580428|FG001|Overall Study|Non-compliance with study drug|0|||
129896121|NCT03852433|467580429|FG002|Overall Study|Non-compliance with study drug|0|||
129896122|NCT03852433|467580430|FG003|Overall Study|Non-compliance with study drug|1|||
129896123|NCT03852433|467580427|FG000|Overall Study|Physician Decision|1|||
129896124|NCT03852433|467580428|FG001|Overall Study|Physician Decision|0|||
129896125|NCT03852433|467580429|FG002|Overall Study|Physician Decision|0|||
129896126|NCT03852433|467580430|FG003|Overall Study|Physician Decision|0|||
129896127|NCT03852433|467580427|FG000|Overall Study|Randomized but never treated|1|||
129896128|NCT03852433|467580428|FG001|Overall Study|Randomized but never treated|0|||
129896129|NCT03852433|467580429|FG002|Overall Study|Randomized but never treated|0|||
129896130|NCT03852433|467580430|FG003|Overall Study|Randomized but never treated|0|||
129896131|NCT01076335|467580431|FG000|Overall Study|Withdrawal by Subject|3|||
129896132|NCT01076335|467580431|FG000|Overall Study|Withdrawal without treatment|1|||
129896133|NCT01835899|467580433|FG000|Overall Study|Adverse Event|0|||
129896134|NCT01835899|467580434|FG001|Overall Study|Adverse Event|0|||
129896135|NCT01835899|467580435|FG002|Overall Study|Adverse Event|1|||
129896136|NCT01835899|467580433|FG000|Overall Study|Other than stated above|0|||
129896137|NCT01835899|467580434|FG001|Overall Study|Other than stated above|1|||
129896138|NCT01835899|467580435|FG002|Overall Study|Other than stated above|0|||
129896139|NCT03168438|467580437|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
129896140|NCT03168438|467580438|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
129896141|NCT05015478|467580441|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
129896142|NCT05015478|467580442|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
129896143|NCT05015478|467580443|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
129896144|NCT05015478|467580444|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
130058212|NCT00882999|468168067|FG001|Overall Study|Withdrawal by Subject|6|||
130058213|NCT00882999|468168068|FG002|Overall Study|Withdrawal by Subject|3|||
130058214|NCT00882999|468168069|FG003|Overall Study|Withdrawal by Subject|3|||
129896145|NCT00654238|467580449|FG000|Overall Study|Screen Failures|4|||
129896146|NCT01348087|467580459|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
129896147|NCT01348087|467580459|FG000|Overall Study|Administrative problems|79|||
129896148|NCT01348087|467580459|FG000|Overall Study|protocol deviation|1|||
129896149|NCT01348087|467580459|FG000|Overall Study|Lost to Follow-up|1|||
129896150|NCT01348087|467580459|FG000|Overall Study|Subject withdrew consent|7|||
129896151|NCT01348087|467580459|FG000|Overall Study|Adverse Event|25|||
129896152|NCT00117988|467580462|FG000|Overall Study|Death|3|||
129896153|NCT00117988|467580462|FG000|Overall Study|Adverse Event|1|||
129896154|NCT05096884|467580463|FG000|Overall Study|Excluded based on negative tilt table test|4|||
129896155|NCT01096056|467580466|FG000|Overall Study|Lost to Follow-up|0|||
129896156|NCT01096056|467580467|FG001|Overall Study|Lost to Follow-up|1|||
129896157|NCT03781804|467580469|FG000|Overall Study|Adverse Event|2|||
129896158|NCT03781804|467580470|FG001|Overall Study|Adverse Event|2|||
129896159|NCT03781804|467580471|FG002|Overall Study|Adverse Event|3|||
129896160|NCT03781804|467580469|FG000|Overall Study|Lost to Follow-up|1|||
129896161|NCT03781804|467580470|FG001|Overall Study|Lost to Follow-up|1|||
129896162|NCT03781804|467580471|FG002|Overall Study|Lost to Follow-up|2|||
129896163|NCT03781804|467580469|FG000|Overall Study|Lack of Efficacy|4|||
129809003|NCT02187744|467265829|FG001|Treatment|Related adverse event, serious non-fatal|1|||
129809004|NCT02187744|467265828|FG000|Treatment|Related adverse event, not serious|0|||
129809005|NCT02187744|467265829|FG001|Treatment|Related adverse event, not serious|2|||
129809006|NCT02187744|467265828|FG000|Treatment|Lost to Follow-up|0|||
129809007|NCT02187744|467265829|FG001|Treatment|Lost to Follow-up|1|||
129809008|NCT02187744|467265828|FG000|Treatment|Other|2|||
129809009|NCT02187744|467265829|FG001|Treatment|Other|0|||
129809010|NCT02187744|467265828|FG000|Treatment|Participant refused continued treatment|1|||
129809011|NCT02187744|467265829|FG001|Treatment|Participant refused continued treatment|1|||
129809012|NCT01972568|467265830|FG000|Overall Study|Other events|3|||
129809013|NCT01972568|467265831|FG001|Overall Study|Other events|0|||
129809014|NCT01972568|467265832|FG002|Overall Study|Other events|0|||
129809015|NCT01972568|467265830|FG000|Overall Study|Lack of Efficacy|0|||
129809016|NCT01972568|467265831|FG001|Overall Study|Lack of Efficacy|1|||
129809017|NCT01972568|467265832|FG002|Overall Study|Lack of Efficacy|2|||
129809018|NCT01972568|467265830|FG000|Overall Study|Protocol Violation|1|||
129809019|NCT01972568|467265831|FG001|Overall Study|Protocol Violation|2|||
129809020|NCT01972568|467265832|FG002|Overall Study|Protocol Violation|2|||
129809021|NCT01972568|467265830|FG000|Overall Study|Withdrawal by Subject|6|||
129809022|NCT01972568|467265831|FG001|Overall Study|Withdrawal by Subject|3|||
129809023|NCT01972568|467265832|FG002|Overall Study|Withdrawal by Subject|7|||
129809024|NCT01972568|467265830|FG000|Overall Study|Lost to Follow-up|1|||
129809025|NCT01972568|467265831|FG001|Overall Study|Lost to Follow-up|0|||
129896164|NCT03781804|467580470|FG001|Overall Study|Lack of Efficacy|2|||
129896165|NCT03781804|467580471|FG002|Overall Study|Lack of Efficacy|9|||
129896166|NCT03781804|467580469|FG000|Overall Study|Protocol Violation|0|||
129896167|NCT03781804|467580470|FG001|Overall Study|Protocol Violation|0|||
129896168|NCT03781804|467580471|FG002|Overall Study|Protocol Violation|1|||
130112351|NCT00738920|468371151|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
129896169|NCT03781804|467580469|FG000|Overall Study|Withdrawal by Subject|0|||
129896170|NCT03781804|467580470|FG001|Overall Study|Withdrawal by Subject|1|||
129896171|NCT03781804|467580471|FG002|Overall Study|Withdrawal by Subject|1|||
129896172|NCT03781804|467580469|FG000|Overall Study|Reason not provided|2|||
129896173|NCT03781804|467580470|FG001|Overall Study|Reason not provided|2|||
129896174|NCT03781804|467580471|FG002|Overall Study|Reason not provided|0|||
129896175|NCT00337818|467580472|FG000|Overall Study|Lost to Follow-up|289|||
129896176|NCT00337818|467580473|FG001|Overall Study|Lost to Follow-up|91|||
129896177|NCT00337818|467580474|FG002|Overall Study|Lost to Follow-up|107|||
129896178|NCT04678830|467580475|FG000|Overall Study|Lack of Efficacy|2|||
129896179|NCT04678830|467580476|FG001|Overall Study|Lack of Efficacy|0|||
129809026|NCT01972568|467265832|FG002|Overall Study|Lost to Follow-up|0|||
129809027|NCT01972568|467265830|FG000|Overall Study|Adverse Event|5|||
129809028|NCT01972568|467265831|FG001|Overall Study|Adverse Event|6|||
129809029|NCT01972568|467265832|FG002|Overall Study|Adverse Event|5|||
129809030|NCT02572401|467265833|FG000|Overall Study|Lost to Follow-up|5|||
129809031|NCT02572401|467265834|FG001|Overall Study|Lost to Follow-up|8|||
129809032|NCT02572401|467265835|FG002|Overall Study|Lost to Follow-up|9|||
129809033|NCT02572401|467265836|FG003|Overall Study|Lost to Follow-up|9|||
129809034|NCT02572401|467265833|FG000|Overall Study|Death|0|||
129809035|NCT02572401|467265834|FG001|Overall Study|Death|0|||
129809036|NCT02572401|467265835|FG002|Overall Study|Death|0|||
129809037|NCT02572401|467265836|FG003|Overall Study|Death|1|||
129809038|NCT00306189|467265837|FG000|Overall Study|Physician Decision|0|||
129809039|NCT00306189|467265838|FG001|Overall Study|Physician Decision|0|||
129809040|NCT00306189|467265839|FG002|Overall Study|Physician Decision|0|||
129809041|NCT00306189|467265840|FG003|Overall Study|Physician Decision|1|||
129809042|NCT00306189|467265837|FG000|Overall Study|Adverse Event|3|||
129809043|NCT00306189|467265838|FG001|Overall Study|Adverse Event|3|||
129809044|NCT00306189|467265839|FG002|Overall Study|Adverse Event|2|||
129809045|NCT00306189|467265840|FG003|Overall Study|Adverse Event|2|||
129809046|NCT00306189|467265837|FG000|Overall Study|Withdrawal by Subject|4|||
129809047|NCT00306189|467265838|FG001|Overall Study|Withdrawal by Subject|2|||
129809048|NCT00306189|467265839|FG002|Overall Study|Withdrawal by Subject|8|||
129809049|NCT00306189|467265840|FG003|Overall Study|Withdrawal by Subject|1|||
129809050|NCT00306189|467265837|FG000|Overall Study|Ineligibility determined|1|||
129809051|NCT00306189|467265838|FG001|Overall Study|Ineligibility determined|1|||
130112352|NCT00738920|468371152|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
129809052|NCT00306189|467265839|FG002|Overall Study|Ineligibility determined|1|||
129809053|NCT00306189|467265840|FG003|Overall Study|Ineligibility determined|1|||
129809054|NCT00306189|467265837|FG000|Overall Study|Other|1|||
129809055|NCT00306189|467265838|FG001|Overall Study|Other|0|||
129809056|NCT00306189|467265839|FG002|Overall Study|Other|0|||
129809057|NCT00306189|467265840|FG003|Overall Study|Other|0|||
129809058|NCT00945893|467265841|FG000|Overall Study|Lost to Follow-up|2|||
129809059|NCT00945893|467265842|FG001|Overall Study|Lost to Follow-up|8|||
129809060|NCT00945893|467265841|FG000|Overall Study|Withdrawal of consent|1|||
129809061|NCT00945893|467265842|FG001|Overall Study|Withdrawal of consent|2|||
129809062|NCT01187433|467265843|FG000|Overall Study|Protocol Violation|6|||
129809063|NCT01187433|467265844|FG001|Overall Study|Protocol Violation|2|||
129809064|NCT01187433|467265843|FG000|Overall Study|Withdrawal by Subject|5|||
129809065|NCT01187433|467265844|FG001|Overall Study|Withdrawal by Subject|2|||
129809066|NCT00437983|467265846|FG000|Overall Study|Adverse Event|6|||
129809067|NCT00437983|467265847|FG001|Overall Study|Adverse Event|6|||
129896180|NCT04678830|467580475|FG000|Overall Study|Withdrawal by Subject|0|||
129896181|NCT04678830|467580476|FG001|Overall Study|Withdrawal by Subject|1|||
129896182|NCT03563053|467580479|FG000|Overall Study|Withdrawal by Subject|17|||
129896183|NCT03563053|467580479|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
129896184|NCT03563053|467580479|FG000|Overall Study|Adverse Event|3|||
129896185|NCT03563053|467580479|FG000|Overall Study|Physician Decision|1|||
129896186|NCT03563053|467580479|FG000|Overall Study|study terminated by sponsor|71|||
129896187|NCT01836458|467580480|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129896188|NCT01836458|467580481|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129896189|NCT01836458|467580482|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
129896190|NCT01836458|467580483|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
129896191|NCT02189863|467580484|FG000|First 2 Weeks|Motion Sickness|4|||
129896192|NCT02189863|467580485|FG001|First 2 Weeks|Motion Sickness|2|||
129896193|NCT03369951|467580487|FG000|Overall Study|Withdrawal by Subject|3|||
129896194|NCT03369951|467580487|FG000|Overall Study|Death|1|||
129896195|NCT03369951|467580487|FG000|Overall Study|Lost to Follow-up|1|||
129896196|NCT03369951|467580487|FG000|Overall Study|Protocol Violation|1|||
129896197|NCT03677375|467580491|FG000|Overall Study|Incomplete procedure|8|||
129896198|NCT03677375|467580491|FG000|Overall Study|Adverse Event|3|||
129809068|NCT00437983|467265846|FG000|Overall Study|Protocol Violation|2|||
129809069|NCT00437983|467265847|FG001|Overall Study|Protocol Violation|1|||
129809070|NCT00437983|467265846|FG000|Overall Study|Withdrawal by Subject|5|||
129809071|NCT00437983|467265847|FG001|Overall Study|Withdrawal by Subject|6|||
129809072|NCT00672646|467265850|FG000|Overall Study|Lost to Follow-up|0|||
129809073|NCT00672646|467265851|FG001|Overall Study|Lost to Follow-up|1|||
129809074|NCT00672646|467265852|FG002|Overall Study|Lost to Follow-up|2|||
129809075|NCT00672646|467265850|FG000|Overall Study|Withdrawal by Subject|0|||
129809076|NCT00672646|467265851|FG001|Overall Study|Withdrawal by Subject|0|||
129809077|NCT00672646|467265852|FG002|Overall Study|Withdrawal by Subject|1|||
129809078|NCT00242216|467265853|FG000|Overall Study|Lost to Follow-up|12|||
129809079|NCT00242216|467265854|FG001|Overall Study|Lost to Follow-up|17|||
129809080|NCT00242216|467265853|FG000|Overall Study|Death|4|||
129809081|NCT00242216|467265854|FG001|Overall Study|Death|2|||
129809082|NCT00242216|467265853|FG000|Overall Study|Lack of Efficacy|1|||
129809083|NCT00242216|467265854|FG001|Overall Study|Lack of Efficacy|2|||
129809084|NCT00242216|467265853|FG000|Overall Study|no medicaiton dispensed|1|||
129809085|NCT00242216|467265854|FG001|Overall Study|no medicaiton dispensed|1|||
129809086|NCT00678080|467265855|FG000|Overall Study|Physician Decision|2|||
129809087|NCT00678080|467265856|FG001|Overall Study|Physician Decision|0|||
129809088|NCT00678080|467265855|FG000|Overall Study|Lost to Follow-up|1|||
129809089|NCT00678080|467265856|FG001|Overall Study|Lost to Follow-up|0|||
129809090|NCT00678080|467265855|FG000|Overall Study|Withdrawal by Subject|0|||
129809091|NCT00678080|467265856|FG001|Overall Study|Withdrawal by Subject|1|||
129809092|NCT01034631|467267571|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
129809093|NCT01034631|467267572|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
129809094|NCT01034631|467267573|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
129809095|NCT01034631|467267571|FG000|Phase II|Not Evaluable per protocol|0|||
129809096|NCT01034631|467267572|FG001|Phase II|Not Evaluable per protocol|0|||
129809097|NCT01034631|467267573|FG002|Phase II|Not Evaluable per protocol|2|||
129809098|NCT01034631|467267571|FG000|Phase II|Determined Ineligible per protocol|0|||
129809099|NCT01034631|467267572|FG001|Phase II|Determined Ineligible per protocol|1|||
129809100|NCT01034631|467267573|FG002|Phase II|Determined Ineligible per protocol|0|||
130058215|NCT00882999|468168070|FG004|Overall Study|Withdrawal by Subject|6|||
130058216|NCT00882999|468168071|FG005|Overall Study|Withdrawal by Subject|5|||
129809101|NCT03372096|467267575|FG000|Overall Study|Study Closed|8|||
129809102|NCT00680017|467267576|FG000|Overall Study|Adverse Event|13|||
129809103|NCT00680017|467267577|FG001|Overall Study|Adverse Event|7|||
129809104|NCT00680017|467267576|FG000|Overall Study|Withdrawal by Subject|2|||
129809105|NCT00680017|467267577|FG001|Overall Study|Withdrawal by Subject|5|||
129809106|NCT00680017|467267576|FG000|Overall Study|Lost to Follow-up|2|||
129809107|NCT00680017|467267577|FG001|Overall Study|Lost to Follow-up|0|||
129809108|NCT05074667|467267578|FG000|Overall Study|Death|1|||
129809109|NCT05074667|467267578|FG000|Overall Study|Withdrawal by Subject|4|||
129896199|NCT03677375|467580491|FG000|Overall Study|Physician Decision|1|||
129896200|NCT00561574|467580497|FG000|Overall Study|Adverse Event|21|||
129896201|NCT00561574|467580498|FG001|Overall Study|Adverse Event|24|||
129896202|NCT00561574|467580497|FG000|Overall Study|Lack of Efficacy|11|||
129896203|NCT00561574|467580498|FG001|Overall Study|Lack of Efficacy|21|||
129896204|NCT00561574|467580497|FG000|Overall Study|Withdrawal by Subject|4|||
129896205|NCT00561574|467580498|FG001|Overall Study|Withdrawal by Subject|4|||
129896206|NCT00561574|467580497|FG000|Overall Study|Reason Unrelated to Trial|6|||
129896207|NCT00561574|467580498|FG001|Overall Study|Reason Unrelated to Trial|2|||
129896208|NCT00561574|467580497|FG000|Overall Study|Lost to Follow-up|1|||
129896209|NCT00561574|467580498|FG001|Overall Study|Lost to Follow-up|0|||
129896210|NCT00561574|467580497|FG000|Overall Study|Other|5|||
129896211|NCT00561574|467580498|FG001|Overall Study|Other|7|||
129896212|NCT03971357|467580499|FG000|Overall Study|Lack of Efficacy|0|||
129896213|NCT03971357|467580500|FG001|Overall Study|Lack of Efficacy|1|||
129896214|NCT00630864|467580507|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
129896215|NCT00630864|467580507|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
129896216|NCT00124982|467580508|FG000|Short-term Period|Death|1|||
129896217|NCT00124982|467580509|FG001|Short-term Period|Death|1|||
129896218|NCT00124982|467580510|FG002|Short-term Period|Death|0|||
129896219|NCT00124982|467580508|FG000|Short-term Period|Adverse Event|17|||
129896220|NCT00124982|467580509|FG001|Short-term Period|Adverse Event|22|||
129896221|NCT00124982|467580510|FG002|Short-term Period|Adverse Event|0|||
129896222|NCT00124982|467580508|FG000|Short-term Period|Lack of Efficacy|32|||
129896223|NCT00124982|467580509|FG001|Short-term Period|Lack of Efficacy|73|||
129896224|NCT00124982|467580510|FG002|Short-term Period|Lack of Efficacy|0|||
129896225|NCT00124982|467580508|FG000|Short-term Period|Lost to Follow-up|8|||
129896226|NCT00124982|467580509|FG001|Short-term Period|Lost to Follow-up|5|||
129896227|NCT00124982|467580510|FG002|Short-term Period|Lost to Follow-up|0|||
129896228|NCT00124982|467580508|FG000|Short-term Period|Withdrawal of Consent|7|||
129896229|NCT00124982|467580509|FG001|Short-term Period|Withdrawal of Consent|9|||
129896230|NCT00124982|467580510|FG002|Short-term Period|Withdrawal of Consent|0|||
129896231|NCT00124982|467580508|FG000|Short-term Period|Poor/Non-compliance|3|||
129896232|NCT00124982|467580509|FG001|Short-term Period|Poor/Non-compliance|1|||
129896233|NCT00124982|467580510|FG002|Short-term Period|Poor/Non-compliance|0|||
129896234|NCT00124982|467580508|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
129896235|NCT00124982|467580509|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
129896236|NCT00124982|467580510|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
129896237|NCT00124982|467580508|FG000|Short-term Period|Participant Decision|1|||
129896238|NCT00124982|467580509|FG001|Short-term Period|Participant Decision|0|||
129896239|NCT00124982|467580510|FG002|Short-term Period|Participant Decision|0|||
129896240|NCT00124982|467580508|FG000|Short-term Period|Participant Chose Own Doctor|0|||
129896241|NCT00124982|467580509|FG001|Short-term Period|Participant Chose Own Doctor|1|||
129809110|NCT05074667|467267578|FG000|Overall Study|Lost to Follow-up|10|||
129809111|NCT05154578|467267581|FG000|Overall Study|Withdrawal by Subject|2|||
129809112|NCT05154578|467267582|FG001|Overall Study|Withdrawal by Subject|3|||
129809113|NCT05154578|467267583|FG002|Overall Study|Withdrawal by Subject|2|||
129809114|NCT05154578|467267584|FG003|Overall Study|Withdrawal by Subject|4|||
129809115|NCT05154578|467267585|FG004|Overall Study|Withdrawal by Subject|0|||
129809116|NCT05154578|467267581|FG000|Overall Study|Lost to Follow-up|0|||
129809117|NCT05154578|467267582|FG001|Overall Study|Lost to Follow-up|1|||
129809118|NCT05154578|467267583|FG002|Overall Study|Lost to Follow-up|0|||
129809119|NCT05154578|467267584|FG003|Overall Study|Lost to Follow-up|3|||
129809120|NCT05154578|467267585|FG004|Overall Study|Lost to Follow-up|0|||
129809121|NCT05154578|467267581|FG000|Overall Study|Adverse Event|0|||
129809122|NCT05154578|467267582|FG001|Overall Study|Adverse Event|0|||
129809123|NCT05154578|467267583|FG002|Overall Study|Adverse Event|0|||
129809124|NCT05154578|467267584|FG003|Overall Study|Adverse Event|1|||
129809125|NCT05154578|467267585|FG004|Overall Study|Adverse Event|0|||
129809126|NCT05154578|467267581|FG000|Overall Study|Relocated to another province|0|||
129809127|NCT05154578|467267582|FG001|Overall Study|Relocated to another province|0|||
129809128|NCT05154578|467267583|FG002|Overall Study|Relocated to another province|1|||
129809129|NCT05154578|467267584|FG003|Overall Study|Relocated to another province|0|||
129809130|NCT05154578|467267585|FG004|Overall Study|Relocated to another province|1|||
129809131|NCT05154578|467267581|FG000|Overall Study|Baby loss|0|||
129809132|NCT05154578|467267582|FG001|Overall Study|Baby loss|1|||
129809133|NCT05154578|467267583|FG002|Overall Study|Baby loss|0|||
129809134|NCT05154578|467267584|FG003|Overall Study|Baby loss|0|||
129809135|NCT05154578|467267585|FG004|Overall Study|Baby loss|0|||
129809136|NCT00864721|467267591|FG000|Overall Study|Patient request|11|||
129809137|NCT00864721|467267591|FG000|Overall Study|Hospitalized|1|||
129809138|NCT00864721|467267591|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
129809139|NCT00864721|467267591|FG000|Overall Study|Adverse Event|21|||
129809140|NCT01705730|467267592|FG000|Overall Study|Lack of Efficacy|1|||
129809141|NCT01705730|467267592|FG000|Overall Study|Adverse Event|3|||
129809142|NCT01705730|467267592|FG000|Overall Study|Lost to Follow-up|1|||
129809143|NCT01705730|467267592|FG000|Overall Study|Reason not Specified|4|||
129809144|NCT01773733|467267593|FG000|Overall Study|Adverse Event|3286|||
129809145|NCT01773733|467267594|FG001|Overall Study|Adverse Event|540|||
129809146|NCT01773733|467267593|FG000|Overall Study|Pregnancy|28|||
129809147|NCT01773733|467267594|FG001|Overall Study|Pregnancy|0|||
129809148|NCT01773733|467267593|FG000|Overall Study|Other different categories of not compl|55415|||
129809149|NCT01773733|467267594|FG001|Overall Study|Other different categories of not compl|7781|||
129809150|NCT00705289|467267595|FG000|Overall Study|Subject or treating physician's choice|131|||
129809151|NCT02601027|467267596|FG000|Registration to Surgery|Withdrawal by Subject|20|||
129809152|NCT02601027|467267597|FG001|Registration to Surgery|Withdrawal by Subject|10|||
129809153|NCT02609828|467267598|FG000|Overall Study|Adverse Event|8|||
129809154|NCT02609828|467267599|FG001|Overall Study|Adverse Event|1|||
129809155|NCT02609828|467267600|FG002|Overall Study|Adverse Event|0|||
129809156|NCT02609828|467267601|FG003|Overall Study|Adverse Event|6|||
129809157|NCT02609828|467267598|FG000|Overall Study|Death|15|||
129809158|NCT02609828|467267599|FG001|Overall Study|Death|1|||
129809159|NCT02609828|467267600|FG002|Overall Study|Death|1|||
129809160|NCT02609828|467267601|FG003|Overall Study|Death|19|||
129809161|NCT02609828|467267598|FG000|Overall Study|Insufficient clinical response|2|||
129809162|NCT02609828|467267599|FG001|Overall Study|Insufficient clinical response|1|||
129809163|NCT02609828|467267600|FG002|Overall Study|Insufficient clinical response|0|||
129809164|NCT02609828|467267601|FG003|Overall Study|Insufficient clinical response|0|||
129809165|NCT02609828|467267598|FG000|Overall Study|Lost to Follow-up|0|||
129809166|NCT02609828|467267599|FG001|Overall Study|Lost to Follow-up|0|||
129809167|NCT02609828|467267600|FG002|Overall Study|Lost to Follow-up|0|||
129809168|NCT02609828|467267601|FG003|Overall Study|Lost to Follow-up|1|||
129809169|NCT02609828|467267598|FG000|Overall Study|Protocol Violation|2|||
129809170|NCT02609828|467267599|FG001|Overall Study|Protocol Violation|0|||
129809171|NCT02609828|467267600|FG002|Overall Study|Protocol Violation|0|||
129809172|NCT02609828|467267601|FG003|Overall Study|Protocol Violation|1|||
129809173|NCT02609828|467267598|FG000|Overall Study|Withdrawal by Subject|12|||
129809174|NCT02609828|467267599|FG001|Overall Study|Withdrawal by Subject|1|||
129809175|NCT02609828|467267600|FG002|Overall Study|Withdrawal by Subject|0|||
129809176|NCT02609828|467267601|FG003|Overall Study|Withdrawal by Subject|10|||
129809177|NCT02609828|467267598|FG000|Overall Study|Other|3|||
129809178|NCT02609828|467267599|FG001|Overall Study|Other|0|||
129809179|NCT02609828|467267600|FG002|Overall Study|Other|0|||
129809180|NCT02609828|467267601|FG003|Overall Study|Other|6|||
129809181|NCT02609828|467267598|FG000|Overall Study|Randomized but not treated|1|||
129809182|NCT02609828|467267599|FG001|Overall Study|Randomized but not treated|0|||
129809183|NCT02609828|467267600|FG002|Overall Study|Randomized but not treated|0|||
129809184|NCT02609828|467267601|FG003|Overall Study|Randomized but not treated|0|||
129809185|NCT03758066|467267602|FG000|Overall Study|Lost to Follow-up|14|||
129809186|NCT00762385|467267605|FG000|First Intervention|Lens Issue|1|||
129809187|NCT00762385|467267606|FG001|First Intervention|Lens Issue|1|||
129809188|NCT00762385|467267605|FG000|First Intervention|Lost to Follow-up|0|||
129809189|NCT00762385|467267606|FG001|First Intervention|Lost to Follow-up|2|||
129809190|NCT00762385|467267605|FG000|First Intervention|Ineligible|1|||
129809191|NCT00762385|467267606|FG001|First Intervention|Ineligible|0|||
129809192|NCT00762385|467267605|FG000|First Intervention|Protocol Violation|0|||
129809193|NCT00762385|467267606|FG001|First Intervention|Protocol Violation|1|||
129809194|NCT00762385|467267605|FG000|Second Intervention|Protocol Violation|3|||
129809195|NCT00762385|467267606|FG001|Second Intervention|Protocol Violation|3|||
129809196|NCT01540838|467267607|FG000|Overall Study|Open nasogastric tube|9|||
129809197|NCT01540838|467267608|FG001|Overall Study|Open nasogastric tube|7|||
129809198|NCT01540838|467267607|FG000|Overall Study|Treatment doses missing|8|||
129809199|NCT01540838|467267608|FG001|Overall Study|Treatment doses missing|12|||
129809200|NCT01540838|467267607|FG000|Overall Study|Additional antibiotic treatment|1|||
129809201|NCT01540838|467267608|FG001|Overall Study|Additional antibiotic treatment|2|||
129809202|NCT01540838|467267607|FG000|Overall Study|Died before treatment initiation|1|||
129809203|NCT01540838|467267608|FG001|Overall Study|Died before treatment initiation|1|||
129809204|NCT01540838|467267607|FG000|Overall Study|Not BM. Other treatment|3|||
129809205|NCT01540838|467267608|FG001|Overall Study|Not BM. Other treatment|1|||
129809206|NCT04891978|467267609|FG000|Baseline|Protocol Violation|2|||
129809207|NCT04891978|467267610|FG001|Baseline|Protocol Violation|1|||
129809208|NCT04891978|467267611|FG002|Baseline|Protocol Violation|0|||
129809209|NCT04891978|467267609|FG000|Baseline|Missing AIRQ|1|||
129809210|NCT04891978|467267610|FG001|Baseline|Missing AIRQ|0|||
129809211|NCT04891978|467267611|FG002|Baseline|Missing AIRQ|0|||
129809212|NCT04891978|467267609|FG000|Baseline|Did not attend a baseline visit|0|||
129809213|NCT04891978|467267610|FG001|Baseline|Did not attend a baseline visit|0|||
129809214|NCT04891978|467267611|FG002|Baseline|Did not attend a baseline visit|9|||
129809215|NCT03641339|467267612|FG000|Overall Study|Physician Decision|1|||
129809216|NCT03641339|467267613|FG001|Overall Study|Physician Decision|0|||
129809217|NCT03641339|467267614|FG002|Overall Study|Physician Decision|0|||
129809218|NCT03641339|467267615|FG003|Overall Study|Physician Decision|0|||
129809219|NCT03641339|467267616|FG004|Overall Study|Physician Decision|0|||
129809220|NCT03641339|467267617|FG005|Overall Study|Physician Decision|0|||
129809221|NCT03641339|467267612|FG000|Overall Study|Withdrawal by Subject|0|||
129809222|NCT03641339|467267613|FG001|Overall Study|Withdrawal by Subject|2|||
129809223|NCT03641339|467267614|FG002|Overall Study|Withdrawal by Subject|0|||
129809224|NCT03641339|467267615|FG003|Overall Study|Withdrawal by Subject|2|||
129809225|NCT03641339|467267616|FG004|Overall Study|Withdrawal by Subject|0|||
129809226|NCT03641339|467267617|FG005|Overall Study|Withdrawal by Subject|1|||
129809227|NCT03863197|467267618|FG000|Overall Study|Lost to Follow-up|2|||
129809228|NCT03863197|467267619|FG001|Overall Study|Lost to Follow-up|3|||
129809229|NCT03863197|467267618|FG000|Overall Study|Withdrawal by Subject|4|||
129809230|NCT03863197|467267619|FG001|Overall Study|Withdrawal by Subject|0|||
129809231|NCT03863197|467267618|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
129809232|NCT03863197|467267619|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
129809233|NCT05338216|467267620|FG000|Overall Study|Withdrawal by Subject|1|||
129809234|NCT05338216|467267621|FG001|Overall Study|Withdrawal by Subject|1|||
129809235|NCT01065597|467267622|FG000|Overall Study|Adverse Event|1|||
129809236|NCT00413244|467267625|FG000|Overall Study|Withdrawal by Subject|10|||
129809237|NCT00413244|467267626|FG001|Overall Study|Withdrawal by Subject|1|||
129809238|NCT00446251|467267627|FG000|Overall Study|On-study Transplants|2|||
129809239|NCT00446251|467267627|FG000|Overall Study|Rituximab Infusion Reaction|2|||
129809240|NCT00446251|467267627|FG000|Overall Study|Lost to Follow-up|1|||
129809241|NCT02264639|467267629|FG000|Overall Study|Death (after completing single-dose phase)|1|||
129809242|NCT02264639|467267630|FG001|Overall Study|Death (after completing single-dose phase)|0|||
129809243|NCT02264639|467267631|FG002|Overall Study|Death (after completing single-dose phase)|0|||
129809244|NCT02264639|467267632|FG003|Overall Study|Death (after completing single-dose phase)|0|||
129809245|NCT02264639|467267633|FG004|Overall Study|Death (after completing single-dose phase)|0|||
129809246|NCT02264639|467267629|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
129809247|NCT02264639|467267630|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129896242|NCT00124982|467580510|FG002|Short-term Period|Participant Chose Own Doctor|0|||
129896243|NCT00124982|467580508|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
129809248|NCT02264639|467267631|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129809249|NCT02264639|467267632|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129809250|NCT02264639|467267633|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129809251|NCT02264639|467267629|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809252|NCT02264639|467267630|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809253|NCT02264639|467267631|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
129809254|NCT02264639|467267632|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809255|NCT02264639|467267633|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809256|NCT02264639|467267629|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129809257|NCT02264639|467267630|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129809258|NCT02264639|467267631|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129809259|NCT02264639|467267632|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129896244|NCT00124982|467580509|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
129896245|NCT00124982|467580510|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
129896246|NCT00124982|467580508|FG000|Short-term Period|Participant Had Lymphopenia|1|||
129896247|NCT00124982|467580509|FG001|Short-term Period|Participant Had Lymphopenia|0|||
129896248|NCT00124982|467580510|FG002|Short-term Period|Participant Had Lymphopenia|0|||
129896249|NCT00124982|467580508|FG000|Long-term Period|Death|0|||
129896250|NCT00124982|467580509|FG001|Long-term Period|Death|0|||
129896251|NCT00124982|467580510|FG002|Long-term Period|Death|1|||
129896252|NCT00124982|467580508|FG000|Long-term Period|Adverse Event|0|||
129896253|NCT00124982|467580509|FG001|Long-term Period|Adverse Event|0|||
129896254|NCT00124982|467580510|FG002|Long-term Period|Adverse Event|17|||
129896255|NCT00124982|467580508|FG000|Long-term Period|Lack of Efficacy|0|||
129896256|NCT00124982|467580509|FG001|Long-term Period|Lack of Efficacy|0|||
129896257|NCT00124982|467580510|FG002|Long-term Period|Lack of Efficacy|46|||
129896258|NCT00124982|467580508|FG000|Long-term Period|Lost to Follow-up|0|||
129896259|NCT00124982|467580509|FG001|Long-term Period|Lost to Follow-up|0|||
129809260|NCT02264639|467267633|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
129896260|NCT00124982|467580510|FG002|Long-term Period|Lost to Follow-up|4|||
129896261|NCT00124982|467580508|FG000|Long-term Period|Withdrawal by Subject|0|||
129896262|NCT00124982|467580509|FG001|Long-term Period|Withdrawal by Subject|0|||
129896263|NCT00124982|467580510|FG002|Long-term Period|Withdrawal by Subject|16|||
129896264|NCT00124982|467580508|FG000|Long-term Period|Pregnancy|0|||
129896265|NCT00124982|467580509|FG001|Long-term Period|Pregnancy|0|||
129896266|NCT00124982|467580510|FG002|Long-term Period|Pregnancy|1|||
129896267|NCT00124982|467580508|FG000|Long-term Period|Poor/Non-compliance|0|||
129896268|NCT00124982|467580509|FG001|Long-term Period|Poor/Non-compliance|0|||
129896269|NCT00124982|467580510|FG002|Long-term Period|Poor/Non-compliance|2|||
129896270|NCT00124982|467580508|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
129896271|NCT00124982|467580509|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
129896272|NCT00124982|467580510|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
129896273|NCT00124982|467580508|FG000|Long-term Period|Neurologist Recommendation|0|||
129896274|NCT00124982|467580509|FG001|Long-term Period|Neurologist Recommendation|0|||
129896275|NCT00124982|467580510|FG002|Long-term Period|Neurologist Recommendation|1|||
129896276|NCT00430677|467580511|FG000|Short-term Period|Death|1|||
129896277|NCT00430677|467580512|FG001|Short-term Period|Death|1|||
129896278|NCT00430677|467580513|FG002|Short-term Period|Death|5|||
129896279|NCT00430677|467580511|FG000|Short-term Period|Adverse Event|15|||
129896280|NCT00430677|467580512|FG001|Short-term Period|Adverse Event|13|||
129896281|NCT00430677|467580513|FG002|Short-term Period|Adverse Event|9|||
129896282|NCT00430677|467580511|FG000|Short-term Period|Lack of Efficacy|5|||
129896283|NCT00430677|467580512|FG001|Short-term Period|Lack of Efficacy|6|||
129896284|NCT00430677|467580513|FG002|Short-term Period|Lack of Efficacy|4|||
129896285|NCT00430677|467580511|FG000|Short-term Period|Withdrawal by Subject|1|||
129896286|NCT00430677|467580512|FG001|Short-term Period|Withdrawal by Subject|1|||
129896287|NCT00430677|467580513|FG002|Short-term Period|Withdrawal by Subject|2|||
129896288|NCT00430677|467580511|FG000|Short-term Period|Participant no longer met study criteria|1|||
129896289|NCT00430677|467580512|FG001|Short-term Period|Participant no longer met study criteria|1|||
129896290|NCT00430677|467580513|FG002|Short-term Period|Participant no longer met study criteria|2|||
129896291|NCT00430677|467580511|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
129896292|NCT00430677|467580512|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
129896293|NCT00430677|467580513|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
129896294|NCT00430677|467580511|FG000|Short-term Period|Pregnancy|0|||
129896295|NCT00430677|467580512|FG001|Short-term Period|Pregnancy|2|||
129896296|NCT00430677|467580513|FG002|Short-term Period|Pregnancy|0|||
129896297|NCT00430677|467580511|FG000|Long-term Extension Period|Death|1|||
129896298|NCT00430677|467580512|FG001|Long-term Extension Period|Death|0|||
129896299|NCT00430677|467580513|FG002|Long-term Extension Period|Death|0|||
129896300|NCT00430677|467580511|FG000|Long-term Extension Period|Adverse Event|3|||
129809261|NCT01416272|467267634|FG000|Overall Study|Unacceptable distance visual acuity|2|||
129809262|NCT01416272|467267634|FG000|Overall Study|Lost to Follow-up|1|||
129809263|NCT01416272|467267634|FG000|Overall Study|Study related complaints|1|||
129809264|NCT04545554|467267639|FG000|Overall Study|Withdrawal by Subject|0|||
129809265|NCT04545554|467267640|FG001|Overall Study|Withdrawal by Subject|0|||
129809266|NCT04545554|467267641|FG002|Overall Study|Withdrawal by Subject|0|||
129809267|NCT04545554|467267642|FG003|Overall Study|Withdrawal by Subject|1|||
129809268|NCT04545554|467267643|FG004|Overall Study|Withdrawal by Subject|0|||
129809269|NCT04545554|467267644|FG005|Overall Study|Withdrawal by Subject|0|||
129809270|NCT00660673|467267645|FG000|Overall Study|Adverse Event|84|||
129896301|NCT00430677|467580512|FG001|Long-term Extension Period|Adverse Event|2|||
129896302|NCT00430677|467580513|FG002|Long-term Extension Period|Adverse Event|5|||
129896303|NCT00430677|467580511|FG000|Long-term Extension Period|Lack of Efficacy|5|||
129896304|NCT00430677|467580512|FG001|Long-term Extension Period|Lack of Efficacy|3|||
129809271|NCT00660673|467267645|FG000|Overall Study|Lack of Efficacy|7|||
129809272|NCT00660673|467267645|FG000|Overall Study|Withdrawal by Subject|22|||
129809273|NCT00660673|467267645|FG000|Overall Study|Administrative|2|||
129896305|NCT00430677|467580513|FG002|Long-term Extension Period|Lack of Efficacy|8|||
129896306|NCT00430677|467580511|FG000|Long-term Extension Period|Lost to Follow-up|1|||
129896307|NCT00430677|467580512|FG001|Long-term Extension Period|Lost to Follow-up|1|||
129896308|NCT00430677|467580513|FG002|Long-term Extension Period|Lost to Follow-up|1|||
129896309|NCT00430677|467580511|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
129896310|NCT00430677|467580512|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
129896311|NCT00430677|467580513|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
129896312|NCT00430677|467580511|FG000|Long-term Extension Period|Pregnancy|1|||
129896313|NCT00430677|467580512|FG001|Long-term Extension Period|Pregnancy|1|||
129896314|NCT00430677|467580513|FG002|Long-term Extension Period|Pregnancy|0|||
129896315|NCT00430677|467580511|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
129896316|NCT00430677|467580512|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
129896317|NCT00430677|467580513|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
129896318|NCT00430677|467580511|FG000|Long-term Extension Period|Other|2|||
129896319|NCT00430677|467580512|FG001|Long-term Extension Period|Other|1|||
129896320|NCT00430677|467580513|FG002|Long-term Extension Period|Other|1|||
129896321|NCT00430677|467580511|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
129896322|NCT00430677|467580512|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
129896323|NCT00430677|467580513|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
129896324|NCT01555762|467580516|FG000|Overall Study|No information on Bevacizumab intake|11|||
129896325|NCT01555762|467580516|FG000|Overall Study|Missing start date of infusion|8|||
129896326|NCT01555762|467580516|FG000|Overall Study|75 years old or more ticked No|1|||
129896327|NCT01555762|467580516|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
129896328|NCT01555762|467580516|FG000|Overall Study|Death linked to progression of disease|165|||
129896329|NCT01555762|467580516|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
129896330|NCT01555762|467580516|FG000|Overall Study|Investigator's decision|10|||
129896331|NCT01555762|467580516|FG000|Overall Study|Participant not wishing to continue|5|||
129896332|NCT01555762|467580516|FG000|Overall Study|Missing data|1|||
129896333|NCT01555762|467580516|FG000|Overall Study|Death linked to an adverse event|14|||
129896334|NCT01333514|467580517|FG000|Overall Study|Withdrawal by Subject|1|||
129896335|NCT01333514|467580518|FG001|Overall Study|Withdrawal by Subject|0|||
129896336|NCT00836810|467580521|FG000|Overall Study|New diagnosis|1|||
129896337|NCT00836810|467580522|FG001|Overall Study|New diagnosis|0|||
129896338|NCT03102242|467580523|FG000|Overall Study|Adverse Event|2|||
129896339|NCT00389519|467580524|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
129896340|NCT00389519|467580525|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
129896341|NCT00389519|467580526|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
129896342|NCT00389519|467580527|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
129896343|NCT00389519|467580524|FG000|Placebo Run-In|Withdrawal by Subject|19|||
129896344|NCT00389519|467580525|FG001|Placebo Run-In|Withdrawal by Subject|0|||
129896345|NCT00389519|467580526|FG002|Placebo Run-In|Withdrawal by Subject|0|||
129896346|NCT00389519|467580527|FG003|Placebo Run-In|Withdrawal by Subject|0|||
129896347|NCT00389519|467580524|FG000|Placebo Run-In|Reason not specified|40|||
129896348|NCT00389519|467580525|FG001|Placebo Run-In|Reason not specified|0|||
129896349|NCT00389519|467580526|FG002|Placebo Run-In|Reason not specified|0|||
129896350|NCT00389519|467580527|FG003|Placebo Run-In|Reason not specified|0|||
129896351|NCT00389519|467580524|FG000|Randomized|Did not receive study drug|2|||
129896352|NCT00389519|467580525|FG001|Randomized|Did not receive study drug|0|||
129896353|NCT00389519|467580526|FG002|Randomized|Did not receive study drug|0|||
129896354|NCT00389519|467580527|FG003|Randomized|Did not receive study drug|0|||
129896355|NCT00389519|467580524|FG000|Treated|Adverse Event|1|||
129896356|NCT00389519|467580525|FG001|Treated|Adverse Event|0|||
129896357|NCT00389519|467580526|FG002|Treated|Adverse Event|0|||
129896358|NCT00389519|467580527|FG003|Treated|Adverse Event|2|||
129896359|NCT00389519|467580524|FG000|Treated|Reason not specified|1|||
129896360|NCT00389519|467580525|FG001|Treated|Reason not specified|1|||
129896361|NCT00389519|467580526|FG002|Treated|Reason not specified|0|||
129896362|NCT00389519|467580527|FG003|Treated|Reason not specified|2|||
129896363|NCT01311713|467580530|FG000|Overall Study|Death|0|||
129896364|NCT01311713|467580531|FG001|Overall Study|Death|0|||
129809274|NCT00660673|467267645|FG000|Overall Study|Protocol Violation|2|||
129809275|NCT05213481|467267647|FG000|Overall Study|Adverse Event|3|||
129809276|NCT05213481|467267647|FG000|Overall Study|Lost to Follow-up|1|||
129896365|NCT01311713|467580532|FG002|Overall Study|Death|1|||
129896366|NCT01311713|467580533|FG003|Overall Study|Death|1|||
129896367|NCT01311713|467580534|FG004|Overall Study|Death|0|||
129896368|NCT01311713|467580535|FG005|Overall Study|Death|1|||
129896369|NCT01311713|467580536|FG006|Overall Study|Death|0|||
129896370|NCT01311713|467580530|FG000|Overall Study|Adverse Event|0|||
129896371|NCT01311713|467580531|FG001|Overall Study|Adverse Event|1|||
129896372|NCT01311713|467580532|FG002|Overall Study|Adverse Event|0|||
129896373|NCT01311713|467580533|FG003|Overall Study|Adverse Event|2|||
129896374|NCT01311713|467580534|FG004|Overall Study|Adverse Event|0|||
129896375|NCT01311713|467580535|FG005|Overall Study|Adverse Event|0|||
129896376|NCT01311713|467580536|FG006|Overall Study|Adverse Event|2|||
129896377|NCT01311713|467580530|FG000|Overall Study|Withdrawal by Subject|0|||
129896378|NCT01311713|467580531|FG001|Overall Study|Withdrawal by Subject|1|||
129896379|NCT01311713|467580532|FG002|Overall Study|Withdrawal by Subject|1|||
129896380|NCT01311713|467580533|FG003|Overall Study|Withdrawal by Subject|0|||
129896381|NCT01311713|467580534|FG004|Overall Study|Withdrawal by Subject|0|||
129896382|NCT01311713|467580535|FG005|Overall Study|Withdrawal by Subject|1|||
129896383|NCT01311713|467580536|FG006|Overall Study|Withdrawal by Subject|2|||
129896384|NCT01311713|467580530|FG000|Overall Study|Disease progression|3|||
129896385|NCT01311713|467580531|FG001|Overall Study|Disease progression|4|||
129896386|NCT01311713|467580532|FG002|Overall Study|Disease progression|3|||
129896387|NCT01311713|467580533|FG003|Overall Study|Disease progression|2|||
129896388|NCT01311713|467580534|FG004|Overall Study|Disease progression|4|||
129896389|NCT01311713|467580535|FG005|Overall Study|Disease progression|4|||
129896390|NCT01311713|467580536|FG006|Overall Study|Disease progression|5|||
129896391|NCT01311713|467580530|FG000|Overall Study|Lost to Follow-up|0|||
129896392|NCT01311713|467580531|FG001|Overall Study|Lost to Follow-up|0|||
129896393|NCT01311713|467580532|FG002|Overall Study|Lost to Follow-up|1|||
129896394|NCT01311713|467580533|FG003|Overall Study|Lost to Follow-up|0|||
129896395|NCT01311713|467580534|FG004|Overall Study|Lost to Follow-up|0|||
129896396|NCT01311713|467580535|FG005|Overall Study|Lost to Follow-up|0|||
129896397|NCT01311713|467580536|FG006|Overall Study|Lost to Follow-up|0|||
129896398|NCT01311713|467580530|FG000|Overall Study|Stopped taking study medication|0|||
129896399|NCT01311713|467580531|FG001|Overall Study|Stopped taking study medication|0|||
129896400|NCT01311713|467580532|FG002|Overall Study|Stopped taking study medication|0|||
129896401|NCT01311713|467580533|FG003|Overall Study|Stopped taking study medication|1|||
129896402|NCT01311713|467580534|FG004|Overall Study|Stopped taking study medication|1|||
129896403|NCT01311713|467580535|FG005|Overall Study|Stopped taking study medication|0|||
129896404|NCT01311713|467580536|FG006|Overall Study|Stopped taking study medication|0|||
129896405|NCT01311713|467580530|FG000|Overall Study|Enrolled but not treated|0|||
129896406|NCT01311713|467580531|FG001|Overall Study|Enrolled but not treated|0|||
129896407|NCT01311713|467580532|FG002|Overall Study|Enrolled but not treated|1|||
129896408|NCT01311713|467580533|FG003|Overall Study|Enrolled but not treated|0|||
129896409|NCT01311713|467580534|FG004|Overall Study|Enrolled but not treated|0|||
129896410|NCT01311713|467580535|FG005|Overall Study|Enrolled but not treated|0|||
129896411|NCT01311713|467580536|FG006|Overall Study|Enrolled but not treated|0|||
129896412|NCT01311713|467580530|FG000|Overall Study|Other than specified|0|||
130058217|NCT00882999|468168072|FG006|Overall Study|Withdrawal by Subject|5|||
130058218|NCT00882999|468168066|FG000|Overall Study|Lost to Follow-up|0|||
130058219|NCT00882999|468168067|FG001|Overall Study|Lost to Follow-up|1|||
130058220|NCT00882999|468168068|FG002|Overall Study|Lost to Follow-up|1|||
130058221|NCT00882999|468168069|FG003|Overall Study|Lost to Follow-up|2|||
130058222|NCT00882999|468168070|FG004|Overall Study|Lost to Follow-up|1|||
130058223|NCT00882999|468168071|FG005|Overall Study|Lost to Follow-up|1|||
129809277|NCT00415168|467267651|FG000|Overall Study|Death|26|||
129809278|NCT00415168|467267651|FG000|Overall Study|Lost to Follow-up|3|||
129809279|NCT00415168|467267651|FG000|Overall Study|Physician Decision|13|||
129809280|NCT00415168|467267651|FG000|Overall Study|Sponsor Decision|4|||
129809281|NCT00415168|467267651|FG000|Overall Study|Withdrawal by Subject|6|||
129809282|NCT01387789|467267655|FG000|Overall Study|Adverse Event|5|||
129809283|NCT01387789|467267655|FG000|Overall Study|Lack of Efficacy|2|||
129809284|NCT01387789|467267655|FG000|Overall Study|Lost to Follow-up|1|||
129809285|NCT02059408|467267658|FG000|Overall Study|Did not get tested|0|||
129809286|NCT02059408|467267659|FG001|Overall Study|Did not get tested|330|||
129809287|NCT02059408|467267660|FG002|Overall Study|Did not get tested|358|||
129809288|NCT02993757|467267661|FG000|Overall Study|Non compliance with the protocol|155|||
129809289|NCT02993757|467267662|FG001|Overall Study|Non compliance with the protocol|170|||
129809290|NCT02993757|467267661|FG000|Overall Study|Lost to Follow-up|1|||
129896413|NCT01311713|467580531|FG001|Overall Study|Other than specified|1|||
129896414|NCT01311713|467580532|FG002|Overall Study|Other than specified|2|||
129896415|NCT01311713|467580533|FG003|Overall Study|Other than specified|0|||
129896416|NCT01311713|467580534|FG004|Overall Study|Other than specified|0|||
129896417|NCT01311713|467580535|FG005|Overall Study|Other than specified|0|||
129896418|NCT01311713|467580536|FG006|Overall Study|Other than specified|0|||
129896419|NCT00946192|467580537|FG000|Overall Study|Lost to Follow-up|6|||
129896420|NCT00946192|467580538|FG001|Overall Study|Lost to Follow-up|11|||
130058224|NCT00882999|468168072|FG006|Overall Study|Lost to Follow-up|2|||
130058225|NCT00882999|468168066|FG000|Overall Study|Physician Decision|1|||
130058226|NCT00882999|468168067|FG001|Overall Study|Physician Decision|0|||
130058227|NCT00882999|468168068|FG002|Overall Study|Physician Decision|0|||
130058228|NCT00882999|468168069|FG003|Overall Study|Physician Decision|0|||
130058229|NCT00882999|468168070|FG004|Overall Study|Physician Decision|0|||
130058230|NCT00882999|468168071|FG005|Overall Study|Physician Decision|1|||
130058231|NCT00882999|468168072|FG006|Overall Study|Physician Decision|1|||
130058232|NCT00436566|468168082|FG000|Overall Study|Withdrawal by Subject|2|||
130058233|NCT00436566|468168082|FG000|Overall Study|Protocol Violation|1|||
130058234|NCT01188564|468168083|FG000|Double-blind Phase|randomized not treated|1|||
130058235|NCT01188564|468168084|FG001|Double-blind Phase|randomized not treated|0|||
130058236|NCT00668200|468168100|FG000|Overall Study|Withdrawal by Subject|2|||
130058237|NCT00668200|468168100|FG000|Overall Study|Lost to Follow-up|1|||
130058238|NCT01496430|468168101|FG000|Overall Study|Adverse Event|0|||
130058239|NCT01496430|468168102|FG001|Overall Study|Adverse Event|0|||
130058240|NCT01496430|468168103|FG002|Overall Study|Adverse Event|1|||
130058241|NCT01496430|468168101|FG000|Overall Study|Major Protocol Deviation|0|||
130058242|NCT01496430|468168102|FG001|Overall Study|Major Protocol Deviation|0|||
130058243|NCT01496430|468168103|FG002|Overall Study|Major Protocol Deviation|1|||
130058244|NCT01496430|468168101|FG000|Overall Study|Lost to Follow-up|2|||
129896421|NCT00946192|467580539|FG002|Overall Study|Lost to Follow-up|9|||
129896422|NCT00946192|467580537|FG000|Overall Study|Withdrawal by Subject|10|||
129809291|NCT02993757|467267662|FG001|Overall Study|Lost to Follow-up|0|||
129809292|NCT02993757|467267661|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
129809293|NCT02993757|467267662|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
129809294|NCT00957580|467267665|FG000|Overall Study|Ongoing at data cut-off|0|||
129809295|NCT00957580|467267666|FG001|Overall Study|Ongoing at data cut-off|1|||
129809296|NCT00957580|467267667|FG002|Overall Study|Ongoing at data cut-off|0|||
129809297|NCT00957580|467267665|FG000|Overall Study|Enrolled but not treated|0|||
129809298|NCT00957580|467267666|FG001|Overall Study|Enrolled but not treated|1|||
129809299|NCT00957580|467267667|FG002|Overall Study|Enrolled but not treated|0|||
129809300|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129896423|NCT00946192|467580538|FG001|Overall Study|Withdrawal by Subject|7|||
129896424|NCT00946192|467580539|FG002|Overall Study|Withdrawal by Subject|3|||
129896425|NCT00946192|467580537|FG000|Overall Study|Did not start medication|2|||
129896426|NCT00946192|467580538|FG001|Overall Study|Did not start medication|0|||
129896427|NCT00946192|467580539|FG002|Overall Study|Did not start medication|0|||
130058245|NCT01496430|468168102|FG001|Overall Study|Lost to Follow-up|3|||
130058246|NCT01496430|468168103|FG002|Overall Study|Lost to Follow-up|1|||
130058247|NCT01496430|468168101|FG000|Overall Study|Voluntary Withdrawal|2|||
130058248|NCT01496430|468168102|FG001|Overall Study|Voluntary Withdrawal|1|||
130058249|NCT01496430|468168103|FG002|Overall Study|Voluntary Withdrawal|6|||
130058250|NCT01496430|468168101|FG000|Overall Study|Principal Investigator Discretion|0|||
130058251|NCT01496430|468168102|FG001|Overall Study|Principal Investigator Discretion|1|||
130058252|NCT01496430|468168103|FG002|Overall Study|Principal Investigator Discretion|1|||
130058253|NCT01496430|468168101|FG000|Overall Study|Other|2|||
130058254|NCT01496430|468168102|FG001|Overall Study|Other|0|||
130058255|NCT01496430|468168103|FG002|Overall Study|Other|0|||
130058256|NCT00997321|468168104|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
130058257|NCT00997321|468168105|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
130058258|NCT02512068|468168110|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
130058259|NCT02512068|468168111|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
130058260|NCT02512068|468168110|FG000|Overall Study|Major Protocol Deviation|1|||
130058261|NCT02512068|468168111|FG001|Overall Study|Major Protocol Deviation|0|||
130058262|NCT02512068|468168110|FG000|Overall Study|Voluntary Withdrawal|0|||
130058263|NCT02512068|468168111|FG001|Overall Study|Voluntary Withdrawal|1|||
130058264|NCT02512068|468168110|FG000|Overall Study|Lack of Efficacy|0|||
130058265|NCT02512068|468168111|FG001|Overall Study|Lack of Efficacy|1|||
130058266|NCT02512068|468168110|FG000|Overall Study|Reason Not Specified|3|||
129809301|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129809302|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
130058267|NCT02512068|468168111|FG001|Overall Study|Reason Not Specified|5|||
129809303|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
129809304|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
129809305|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
129809306|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129809307|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
129809308|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809309|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
129809310|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809311|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809312|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809313|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809314|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809315|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
129809316|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129896428|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
129896429|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
129896430|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
129896431|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
129896432|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
129896433|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
129809317|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809318|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
129809319|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809320|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809321|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809322|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809323|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809324|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Other|0|||
129809325|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Other|0|||
129809326|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Other|1|||
129809327|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Other|1|||
129809328|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Other|2|||
129809329|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Other|0|||
129809330|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Other|0|||
129809331|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Other|0|||
129809332|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809333|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809334|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809335|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809336|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
129809337|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809338|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809339|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
130112353|NCT00738920|468371153|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
130058268|NCT04544709|468168121|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
130058269|NCT02045212|468168122|FG000|Overall Study|Adverse Event|0|||
130058270|NCT02045212|468168123|FG001|Overall Study|Adverse Event|1|||
130058271|NCT02045212|468168122|FG000|Overall Study|Withdrawal by Subject|1|||
130058272|NCT02045212|468168123|FG001|Overall Study|Withdrawal by Subject|0|||
130058273|NCT02045212|468168122|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
130058274|NCT02045212|468168123|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
130058275|NCT02402218|468168127|FG000|Overall Study|Did not pickup study medication|12|||
130058276|NCT02402218|468168128|FG001|Overall Study|Did not pickup study medication|9|||
129896434|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
129896435|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
129896436|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Death|1|||
129896437|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Death|0|||
129896438|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
129896439|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
129896440|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
129896441|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
129896442|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
129896443|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
129896444|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
129896445|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
129896446|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
129896447|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
129896448|NCT01080131|467580540|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
129896449|NCT01080131|467580541|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
129896450|NCT01080131|467580540|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
129896451|NCT01080131|467580541|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
129896452|NCT01080131|467580540|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
129896453|NCT01080131|467580541|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
129896454|NCT04155424|467580542|FG000|Overall Study|Other than specified|3|||
129896455|NCT04155424|467580542|FG000|Overall Study|Withdrawal by Subject|1|||
129896456|NCT04155424|467580542|FG000|Overall Study|Adverse Event|1|||
129896457|NCT04159506|467580543|FG000|Overall Study|Lost to Follow-up|2|||
129896458|NCT04159506|467580544|FG001|Overall Study|Lost to Follow-up|5|||
129896459|NCT00797862|467582074|FG000|Overall Study|Adverse Event|86|||
129896460|NCT00797862|467582075|FG001|Overall Study|Adverse Event|44|||
130058277|NCT02402218|468168129|FG002|Overall Study|Did not pickup study medication|13|||
130058278|NCT02402218|468168127|FG000|Overall Study|Lack of Efficacy|0|||
129896461|NCT00797862|467582076|FG002|Overall Study|Adverse Event|58|||
130058279|NCT02402218|468168128|FG001|Overall Study|Lack of Efficacy|1|||
130058280|NCT02402218|468168129|FG002|Overall Study|Lack of Efficacy|1|||
130058281|NCT02402218|468168127|FG000|Overall Study|Death|1|||
130058282|NCT02402218|468168128|FG001|Overall Study|Death|0|||
130112354|NCT00738920|468371151|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
130112355|NCT00738920|468371152|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
130112356|NCT00738920|468371153|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
130058283|NCT02402218|468168129|FG002|Overall Study|Death|0|||
130058284|NCT02402218|468168127|FG000|Overall Study|Reinfection|0|||
130058285|NCT02402218|468168128|FG001|Overall Study|Reinfection|0|||
130058286|NCT02402218|468168129|FG002|Overall Study|Reinfection|1|||
130058287|NCT02402218|468168127|FG000|Overall Study|Adverse Event|0|||
130058288|NCT02402218|468168128|FG001|Overall Study|Adverse Event|2|||
130058289|NCT02402218|468168129|FG002|Overall Study|Adverse Event|1|||
130058290|NCT02402218|468168127|FG000|Overall Study|Withdrawal by Subject|1|||
129809340|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
129809341|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
129809342|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
129809343|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
129809344|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
129809345|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
129809346|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
129809347|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
129809348|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809349|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809350|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809351|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809352|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809353|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809354|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809355|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809356|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809357|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
129809358|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809359|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809360|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809361|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809362|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809363|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809364|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Other|0|||
129809365|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Other|1|||
129809366|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Other|1|||
129809367|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Other|0|||
129809368|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Other|0|||
129809369|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Other|0|||
129809370|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Other|0|||
129809371|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Other|0|||
129809372|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
129809373|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
129809374|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809375|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
129809376|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809377|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809378|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
129809379|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809380|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809381|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129896462|NCT00797862|467582074|FG000|Overall Study|Abnormal Test Procedure Result|0|||
129896463|NCT00797862|467582075|FG001|Overall Study|Abnormal Test Procedure Result|1|||
129896464|NCT00797862|467582076|FG002|Overall Study|Abnormal Test Procedure Result|1|||
129896465|NCT00797862|467582074|FG000|Overall Study|Lack of Efficacy|1|||
129896466|NCT00797862|467582075|FG001|Overall Study|Lack of Efficacy|7|||
129896467|NCT00797862|467582076|FG002|Overall Study|Lack of Efficacy|6|||
129896468|NCT00797862|467582074|FG000|Overall Study|No longer required study medication|1|||
129896469|NCT00797862|467582075|FG001|Overall Study|No longer required study medication|0|||
129896470|NCT00797862|467582076|FG002|Overall Study|No longer required study medication|0|||
129896471|NCT00797862|467582074|FG000|Overall Study|Withdrawal by Subject|14|||
129896472|NCT00797862|467582075|FG001|Overall Study|Withdrawal by Subject|7|||
129896473|NCT00797862|467582076|FG002|Overall Study|Withdrawal by Subject|7|||
129896474|NCT00797862|467582074|FG000|Overall Study|Lost to Follow-up|11|||
129896475|NCT00797862|467582075|FG001|Overall Study|Lost to Follow-up|0|||
129896476|NCT00797862|467582076|FG002|Overall Study|Lost to Follow-up|5|||
129896477|NCT00797862|467582074|FG000|Overall Study|Administrative Problem|4|||
129896478|NCT00797862|467582075|FG001|Overall Study|Administrative Problem|0|||
129896479|NCT00797862|467582076|FG002|Overall Study|Administrative Problem|0|||
129896480|NCT00797862|467582074|FG000|Overall Study|Protocol Violation|4|||
129896481|NCT00797862|467582075|FG001|Overall Study|Protocol Violation|6|||
129896482|NCT00797862|467582076|FG002|Overall Study|Protocol Violation|8|||
129896483|NCT00797862|467582074|FG000|Overall Study|Mis-randomized|3|||
129896484|NCT00797862|467582075|FG001|Overall Study|Mis-randomized|3|||
129896485|NCT00797862|467582076|FG002|Overall Study|Mis-randomized|1|||
129896486|NCT00409708|467582080|FG000|Treatment|Abnormal test procedure result(s)|1|||
129896487|NCT00409708|467582081|FG001|Treatment|Abnormal test procedure result(s)|0|||
129896488|NCT00409708|467582080|FG000|Treatment|Lack of Efficacy|0|||
129896489|NCT00409708|467582081|FG001|Treatment|Lack of Efficacy|1|||
129896490|NCT00409708|467582080|FG000|Treatment|Protocol Violation|6|||
129896491|NCT00409708|467582081|FG001|Treatment|Protocol Violation|2|||
129896492|NCT00409708|467582080|FG000|Treatment|Withdrawal by Subject|3|||
129896493|NCT00409708|467582081|FG001|Treatment|Withdrawal by Subject|8|||
129896494|NCT00409708|467582080|FG000|Treatment|Lost to Follow-up|0|||
129896495|NCT00409708|467582081|FG001|Treatment|Lost to Follow-up|6|||
129896496|NCT00409708|467582080|FG000|Treatment|Administrative problems|5|||
130058291|NCT02402218|468168128|FG001|Overall Study|Withdrawal by Subject|1|||
130058292|NCT02402218|468168129|FG002|Overall Study|Withdrawal by Subject|1|||
129896497|NCT00409708|467582081|FG001|Treatment|Administrative problems|0|||
129896498|NCT00409708|467582080|FG000|Washout|Lack of Efficacy|9|||
129896499|NCT00409708|467582081|FG001|Washout|Lack of Efficacy|1|||
129896500|NCT00409708|467582080|FG000|Washout|Protocol Violation|0|||
129809382|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809383|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809384|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809385|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809386|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
129809387|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809388|NCT03113071|467267676|FG000|Overall Study|Withdrawal by Subject|1|||
129809389|NCT03113071|467267677|FG001|Overall Study|Withdrawal by Subject|0|||
129809390|NCT01602120|467267678|FG000|Overall Study|Adverse Event|3|||
129809391|NCT01602120|467267679|FG001|Overall Study|Adverse Event|6|||
129809392|NCT01602120|467267680|FG002|Overall Study|Adverse Event|0|||
129809393|NCT01602120|467267681|FG003|Overall Study|Adverse Event|2|||
129809394|NCT01602120|467267678|FG000|Overall Study|Death|0|||
129809395|NCT01602120|467267679|FG001|Overall Study|Death|4|||
129809396|NCT01602120|467267680|FG002|Overall Study|Death|0|||
129809397|NCT01602120|467267681|FG003|Overall Study|Death|0|||
129809398|NCT01602120|467267678|FG000|Overall Study|Lost to Follow-up|0|||
130058293|NCT00369668|468168131|FG000|Overall Study|Lack of Efficacy|4|||
129809399|NCT01602120|467267679|FG001|Overall Study|Lost to Follow-up|1|||
130058294|NCT00369668|468168132|FG001|Overall Study|Lack of Efficacy|5|||
130058295|NCT00369668|468168133|FG002|Overall Study|Lack of Efficacy|7|||
130058296|NCT03126539|468168141|FG000|Overall Study|Lost to Follow-up|1|||
130058297|NCT03126539|468168142|FG001|Overall Study|Lost to Follow-up|1|||
129809400|NCT01602120|467267680|FG002|Overall Study|Lost to Follow-up|0|||
129809401|NCT01602120|467267681|FG003|Overall Study|Lost to Follow-up|1|||
129809402|NCT01602120|467267678|FG000|Overall Study|Protocol Violation|1|||
129809403|NCT01602120|467267679|FG001|Overall Study|Protocol Violation|1|||
129809404|NCT01602120|467267680|FG002|Overall Study|Protocol Violation|0|||
130058298|NCT03126539|468168143|FG002|Overall Study|Lost to Follow-up|1|||
130058299|NCT03126539|468168144|FG003|Overall Study|Lost to Follow-up|0|||
130058300|NCT03126539|468168145|FG004|Overall Study|Lost to Follow-up|0|||
130058301|NCT03352414|468168146|FG000|Overall Study|Ineligible by operative criteria|12|||
130058302|NCT03352414|468168147|FG001|Overall Study|Ineligible by operative criteria|10|||
130058303|NCT02632110|468168148|FG000|Overall Study|Withdrawal by Subject|1|||
130058304|NCT02632110|468168149|FG001|Overall Study|Withdrawal by Subject|1|||
129809405|NCT01602120|467267681|FG003|Overall Study|Protocol Violation|0|||
130058305|NCT02632110|468168150|FG002|Overall Study|Withdrawal by Subject|0|||
130058306|NCT02632110|468168151|FG003|Overall Study|Withdrawal by Subject|0|||
129896501|NCT00409708|467582081|FG001|Washout|Protocol Violation|1|||
129896502|NCT00409708|467582080|FG000|Washout|Withdrawal by Subject|11|||
129896503|NCT00409708|467582081|FG001|Washout|Withdrawal by Subject|5|||
129896504|NCT00409708|467582080|FG000|Washout|Lost to Follow-up|1|||
129809406|NCT01602120|467267678|FG000|Overall Study|Non-compliance|0|||
129809407|NCT01602120|467267679|FG001|Overall Study|Non-compliance|3|||
129809408|NCT01602120|467267680|FG002|Overall Study|Non-compliance|0|||
129809409|NCT01602120|467267681|FG003|Overall Study|Non-compliance|1|||
129809410|NCT01602120|467267678|FG000|Overall Study|Withdrawal by Subject|8|||
129809411|NCT01602120|467267679|FG001|Overall Study|Withdrawal by Subject|17|||
129809412|NCT01602120|467267680|FG002|Overall Study|Withdrawal by Subject|0|||
129809413|NCT01602120|467267681|FG003|Overall Study|Withdrawal by Subject|3|||
129809414|NCT01602120|467267678|FG000|Overall Study|Study Terminated by Sponsor|12|||
129809415|NCT01602120|467267679|FG001|Overall Study|Study Terminated by Sponsor|24|||
129809416|NCT01602120|467267680|FG002|Overall Study|Study Terminated by Sponsor|17|||
129809417|NCT01602120|467267681|FG003|Overall Study|Study Terminated by Sponsor|44|||
129809418|NCT01602120|467267678|FG000|Overall Study|Physician Decision|2|||
129809419|NCT01602120|467267679|FG001|Overall Study|Physician Decision|3|||
129809420|NCT01602120|467267680|FG002|Overall Study|Physician Decision|0|||
129809421|NCT01602120|467267681|FG003|Overall Study|Physician Decision|0|||
129809422|NCT01602120|467267678|FG000|Overall Study|Unspecified Reason|3|||
129809423|NCT01602120|467267679|FG001|Overall Study|Unspecified Reason|1|||
129896505|NCT00409708|467582081|FG001|Washout|Lost to Follow-up|3|||
129896506|NCT01474538|467582084|FG000|Treatment Period 1|Death|1|||
129896507|NCT01474538|467582085|FG001|Treatment Period 1|Death|0|||
130058307|NCT02632110|468168152|FG004|Overall Study|Withdrawal by Subject|1|||
130058308|NCT02632110|468168153|FG005|Overall Study|Withdrawal by Subject|1|||
130058309|NCT02632110|468168154|FG006|Overall Study|Withdrawal by Subject|3|||
130058310|NCT02632110|468168155|FG007|Overall Study|Withdrawal by Subject|3|||
130058311|NCT02632110|468168156|FG008|Overall Study|Withdrawal by Subject|1|||
130058312|NCT02632110|468168157|FG009|Overall Study|Withdrawal by Subject|1|||
130058313|NCT00516269|468168160|FG000|Overall Study|Adverse Event|2|||
130058314|NCT00516269|468168161|FG001|Overall Study|Adverse Event|1|||
130058315|NCT00516269|468168160|FG000|Overall Study|Lost to Follow-up|0|||
130058316|NCT00516269|468168161|FG001|Overall Study|Lost to Follow-up|1|||
130058317|NCT00516269|468168160|FG000|Overall Study|Protocol Violation|0|||
130058318|NCT00516269|468168161|FG001|Overall Study|Protocol Violation|1|||
130058319|NCT00142519|468168162|FG000|Overall Study|Not Treated|7|||
130058320|NCT00142519|468168163|FG001|Overall Study|Not Treated|9|||
130058321|NCT00142519|468168162|FG000|Overall Study|Protocol Violation|1|||
130058322|NCT00142519|468168163|FG001|Overall Study|Protocol Violation|0|||
130058323|NCT00142519|468168162|FG000|Overall Study|Withdrawal by Subject|10|||
130058324|NCT00142519|468168163|FG001|Overall Study|Withdrawal by Subject|7|||
130058325|NCT02596711|468168164|FG000|Overall Study|Lost to Follow-up|1|||
130058326|NCT02596711|468168165|FG001|Overall Study|Lost to Follow-up|2|||
130058327|NCT02596711|468168166|FG002|Overall Study|Lost to Follow-up|3|||
130058328|NCT01005732|468168167|FG000|Overall Study|Lost to Follow-up|10|||
130058329|NCT01005732|468168167|FG000|Overall Study|Death|1|||
130058330|NCT01552928|468168168|FG000|Period 3|Adverse Event|0|||
129809424|NCT01602120|467267680|FG002|Overall Study|Unspecified Reason|0|||
129809425|NCT01602120|467267681|FG003|Overall Study|Unspecified Reason|2|||
129809426|NCT01681472|467267689|FG000|Overall Study|Adverse Event|0|||
129809427|NCT01681472|467267690|FG001|Overall Study|Adverse Event|1|||
129809428|NCT01681472|467267691|FG002|Overall Study|Adverse Event|0|||
129809429|NCT01681472|467267692|FG003|Overall Study|Adverse Event|0|||
129809430|NCT01999179|467267705|FG000|Overall Study|Adverse Event|1|||
129809431|NCT01999179|467267705|FG000|Overall Study|Lost to Follow-up|1|||
129809432|NCT01999179|467267705|FG000|Overall Study|Change in Therapy|3|||
129809433|NCT01999179|467267705|FG000|Overall Study|New catheter|2|||
129809434|NCT03128411|467267709|FG000|Treatment Phase|Adverse Event|21|||
129809435|NCT03128411|467267709|FG000|Treatment Phase|Physician Decision|1|||
129809436|NCT03128411|467267709|FG000|Treatment Phase|Other|2|||
129809437|NCT03128411|467267709|FG000|Long Term Follow-up Phase|Death|2|||
129809438|NCT02900976|467267714|FG000|Overall Study|Adverse Event|0|||
129809439|NCT02900976|467267715|FG001|Overall Study|Adverse Event|1|||
129809440|NCT02900976|467267714|FG000|Overall Study|Physician Decision|0|||
129809441|NCT02900976|467267715|FG001|Overall Study|Physician Decision|2|||
129809442|NCT02900976|467267714|FG000|Overall Study|Progressive disease|0|||
129809443|NCT02900976|467267715|FG001|Overall Study|Progressive disease|6|||
129809444|NCT06934993|467267716|FG000|Overall Study|Withdrawal by Subject|29|||
129809445|NCT06934993|467267716|FG000|Overall Study|elevated postoperative creatinine level|11|||
129809446|NCT06934993|467267716|FG000|Overall Study|Death|3|||
129809447|NCT03128047|467267717|FG000|Overall Study|Withdrawal by Subject|1|||
129809448|NCT00739674|467269309|FG000|Overall Study|Screening failures|19|||
129809449|NCT00739674|467269310|FG001|Overall Study|Screening failures|17|||
129809450|NCT00739674|467269309|FG000|Overall Study|Site 212 removal|19|||
129809451|NCT00739674|467269310|FG001|Overall Study|Site 212 removal|13|||
129809452|NCT00739674|467269309|FG000|Overall Study|No follow-up data|33|||
130058331|NCT01552928|468168169|FG001|Period 3|Adverse Event|0|||
130058332|NCT01552928|468168170|FG002|Period 3|Adverse Event|1|||
129896508|NCT01474538|467582084|FG000|Treatment Period 1|Physician Decision|1|||
129896509|NCT01474538|467582085|FG001|Treatment Period 1|Physician Decision|0|||
130058333|NCT01552928|468168171|FG003|Period 3|Adverse Event|0|||
130058334|NCT04570657|468168173|FG000|Overall Study|Adverse Event|0|||
130058335|NCT04570657|468168174|FG001|Overall Study|Adverse Event|0|||
130058336|NCT04570657|468168175|FG002|Overall Study|Adverse Event|1|||
129809453|NCT00739674|467269310|FG001|Overall Study|No follow-up data|18|||
129809454|NCT00739674|467269309|FG000|Overall Study|Dietician consultation >30 days|1|||
129809455|NCT00739674|467269310|FG001|Overall Study|Dietician consultation >30 days|9|||
129809456|NCT00739674|467269309|FG000|Overall Study|Adverse Event|22|||
129809457|NCT00739674|467269310|FG001|Overall Study|Adverse Event|13|||
130058337|NCT04570657|468168173|FG000|Overall Study|Lost to Follow-up|0|||
130058338|NCT04570657|468168174|FG001|Overall Study|Lost to Follow-up|0|||
129809458|NCT00739674|467269309|FG000|Overall Study|Death|1|||
129809459|NCT00739674|467269310|FG001|Overall Study|Death|0|||
129809460|NCT00739674|467269309|FG000|Overall Study|Lack of Efficacy|1|||
129809461|NCT00739674|467269310|FG001|Overall Study|Lack of Efficacy|0|||
129809462|NCT00739674|467269309|FG000|Overall Study|Lost to Follow-up|52|||
129809463|NCT00739674|467269310|FG001|Overall Study|Lost to Follow-up|30|||
129809464|NCT00739674|467269309|FG000|Overall Study|Protocol Violation|5|||
129809465|NCT00739674|467269310|FG001|Overall Study|Protocol Violation|5|||
129809466|NCT00739674|467269309|FG000|Overall Study|Withdrawal by Subject|9|||
129809467|NCT00739674|467269310|FG001|Overall Study|Withdrawal by Subject|9|||
129809468|NCT00739674|467269309|FG000|Overall Study|Reason missing|2|||
129809469|NCT00739674|467269310|FG001|Overall Study|Reason missing|0|||
129809470|NCT00739674|467269309|FG000|Overall Study|Clinic closed|6|||
129809471|NCT00739674|467269310|FG001|Overall Study|Clinic closed|4|||
129809472|NCT00739674|467269309|FG000|Overall Study|Patient moved|3|||
129809473|NCT00739674|467269310|FG001|Overall Study|Patient moved|2|||
129809474|NCT00739674|467269309|FG000|Overall Study|Non compliant|4|||
129809475|NCT00739674|467269310|FG001|Overall Study|Non compliant|0|||
129809476|NCT00739674|467269309|FG000|Overall Study|Unable to attend visit|3|||
129809477|NCT00739674|467269310|FG001|Overall Study|Unable to attend visit|1|||
129809478|NCT00739674|467269309|FG000|Overall Study|Home monitoring off meds|1|||
129809479|NCT00739674|467269310|FG001|Overall Study|Home monitoring off meds|0|||
129809480|NCT00739674|467269309|FG000|Overall Study|Erectile dysfunction|0|||
129809481|NCT00739674|467269310|FG001|Overall Study|Erectile dysfunction|1|||
129809482|NCT01594281|467269311|FG000|Interventional Core Phase|Protocol Deviation|1|||
129809483|NCT01594281|467269312|FG001|Interventional Core Phase|Protocol Deviation|0|||
129809484|NCT01594281|467269313|FG002|Interventional Core Phase|Protocol Deviation|0|||
129809485|NCT01594281|467269311|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
129809486|NCT01594281|467269312|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
129809487|NCT01594281|467269313|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
129809488|NCT01594281|467269311|FG000|Interventional Core Phase|Death|1|||
129809489|NCT01594281|467269312|FG001|Interventional Core Phase|Death|1|||
129809490|NCT01594281|467269313|FG002|Interventional Core Phase|Death|2|||
129809491|NCT01594281|467269311|FG000|Interventional Core Phase|Lost to Follow-up|1|||
129809492|NCT01594281|467269312|FG001|Interventional Core Phase|Lost to Follow-up|4|||
129809493|NCT01594281|467269313|FG002|Interventional Core Phase|Lost to Follow-up|1|||
129809494|NCT01594281|467269311|FG000|Interventional Core Phase|Adverse Event|4|||
129809495|NCT01594281|467269312|FG001|Interventional Core Phase|Adverse Event|4|||
129809496|NCT01594281|467269313|FG002|Interventional Core Phase|Adverse Event|4|||
129809497|NCT01594281|467269311|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
129809498|NCT01594281|467269312|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
129809499|NCT01594281|467269313|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
129809500|NCT01594281|467269311|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
129896510|NCT01474538|467582084|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129809501|NCT01594281|467269312|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
129896511|NCT01474538|467582085|FG001|Treatment Period 1|Withdrawal by Subject|3|||
129896512|NCT01474538|467582084|FG000|Treatment Period 1|Protocol Violation|0|||
129896513|NCT01474538|467582085|FG001|Treatment Period 1|Protocol Violation|1|||
129809502|NCT01594281|467269313|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
129809503|NCT01594281|467269311|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
129809504|NCT01594281|467269312|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
129809505|NCT01594281|467269313|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
129809506|NCT04805541|467269315|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
129809507|NCT00283400|467269319|FG000|Overall Study|Withdrawal by Subject|1|||
129809508|NCT00283400|467269320|FG001|Overall Study|Withdrawal by Subject|1|||
129809509|NCT00283400|467269321|FG002|Overall Study|Withdrawal by Subject|0|||
129809510|NCT00283400|467269322|FG003|Overall Study|Withdrawal by Subject|0|||
129809511|NCT00283400|467269319|FG000|Overall Study|Death|1|||
129809512|NCT00283400|467269320|FG001|Overall Study|Death|0|||
129809513|NCT00283400|467269321|FG002|Overall Study|Death|1|||
129809514|NCT00283400|467269322|FG003|Overall Study|Death|0|||
129809515|NCT01560403|467269323|FG000|Overall Study|Lost to Follow-up|0|||
129809516|NCT01560403|467269324|FG001|Overall Study|Lost to Follow-up|1|||
129809517|NCT03166735|467269325|FG000|Overall Study|Not Treated|1|||
129809518|NCT03166735|467269326|FG001|Overall Study|Not Treated|0|||
129809519|NCT03166735|467269327|FG002|Overall Study|Not Treated|0|||
129809520|NCT03166735|467269328|FG003|Overall Study|Not Treated|0|||
129809521|NCT03166735|467269329|FG004|Overall Study|Not Treated|0|||
129809522|NCT03166735|467269325|FG000|Overall Study|follow-up not completed as planned|0|||
129809523|NCT03166735|467269326|FG001|Overall Study|follow-up not completed as planned|1|||
129809524|NCT03166735|467269327|FG002|Overall Study|follow-up not completed as planned|1|||
129809525|NCT03166735|467269328|FG003|Overall Study|follow-up not completed as planned|0|||
129809526|NCT03166735|467269329|FG004|Overall Study|follow-up not completed as planned|1|||
129809527|NCT03166735|467269325|FG000|Overall Study|Withdrawal by Subject|0|||
129809528|NCT03166735|467269326|FG001|Overall Study|Withdrawal by Subject|0|||
129809529|NCT03166735|467269327|FG002|Overall Study|Withdrawal by Subject|1|||
129809530|NCT03166735|467269328|FG003|Overall Study|Withdrawal by Subject|1|||
129809531|NCT03166735|467269329|FG004|Overall Study|Withdrawal by Subject|2|||
129809532|NCT03166735|467269325|FG000|Overall Study|Lost to Follow-up|0|||
129809533|NCT03166735|467269326|FG001|Overall Study|Lost to Follow-up|2|||
129809534|NCT03166735|467269327|FG002|Overall Study|Lost to Follow-up|1|||
129809535|NCT03166735|467269328|FG003|Overall Study|Lost to Follow-up|0|||
129809536|NCT03166735|467269329|FG004|Overall Study|Lost to Follow-up|1|||
129809537|NCT01020981|467269332|FG000|Overall Study|Did not return mailed survey|74|||
129809538|NCT01020981|467269333|FG001|Overall Study|Did not return mailed survey|58|||
129809539|NCT01020981|467269332|FG000|Overall Study|Survey returned undeliverable|8|||
129809540|NCT01020981|467269333|FG001|Overall Study|Survey returned undeliverable|32|||
129809541|NCT01020981|467269332|FG000|Overall Study|Participant declined to complete survey|2|||
129809542|NCT01020981|467269333|FG001|Overall Study|Participant declined to complete survey|0|||
129809543|NCT00040365|467269336|FG000|Overall Study|Death|1|||
129809544|NCT00040365|467269336|FG000|Overall Study|Progressive disease|7|||
129809545|NCT00040365|467269336|FG000|Overall Study|Lost to Follow-up|3|||
129809546|NCT00541931|467269337|FG000|Overall Study|Adverse Event|1|||
129809547|NCT00541931|467269338|FG001|Overall Study|Adverse Event|0|||
129809548|NCT00541931|467269337|FG000|Overall Study|Lost to Follow-up|3|||
129809549|NCT00541931|467269338|FG001|Overall Study|Lost to Follow-up|3|||
129809550|NCT00541931|467269337|FG000|Overall Study|Withdrawal by Subject|1|||
129809551|NCT00541931|467269338|FG001|Overall Study|Withdrawal by Subject|0|||
129809552|NCT00541931|467269337|FG000|Overall Study|Transportation Issue|0|||
129809553|NCT00541931|467269338|FG001|Overall Study|Transportation Issue|1|||
129809554|NCT02555683|467269339|FG000|Overall Study|Physician Decision|1|||
129809555|NCT02555683|467269340|FG001|Overall Study|Physician Decision|0|||
129809556|NCT02555683|467269341|FG002|Overall Study|Physician Decision|2|||
130058339|NCT04570657|468168175|FG002|Overall Study|Lost to Follow-up|1|||
130058340|NCT04570657|468168173|FG000|Overall Study|Physician Decision|0|||
130058341|NCT04570657|468168174|FG001|Overall Study|Physician Decision|1|||
130058342|NCT04570657|468168175|FG002|Overall Study|Physician Decision|0|||
130058343|NCT04570657|468168173|FG000|Overall Study|Withdrawal by Subject|1|||
130058344|NCT04570657|468168174|FG001|Overall Study|Withdrawal by Subject|2|||
130058345|NCT04570657|468168175|FG002|Overall Study|Withdrawal by Subject|2|||
130058346|NCT01079962|468168176|FG000|Overall Study|Adverse Event|2|||
130058347|NCT01079962|468168177|FG001|Overall Study|Adverse Event|2|||
130058348|NCT01079962|468168176|FG000|Overall Study|Withdrawal by Subject|5|||
130058349|NCT01079962|468168177|FG001|Overall Study|Withdrawal by Subject|7|||
130058350|NCT01079962|468168176|FG000|Overall Study|Protocol Violation|2|||
130058351|NCT01079962|468168177|FG001|Overall Study|Protocol Violation|2|||
130058352|NCT01079962|468168176|FG000|Overall Study|No blood pressure (BP) control|3|||
130058353|NCT01079962|468168177|FG001|Overall Study|No blood pressure (BP) control|0|||
130058354|NCT01079962|468168176|FG000|Overall Study|Inclusion/exclusion criteria|1|||
130058355|NCT01079962|468168177|FG001|Overall Study|Inclusion/exclusion criteria|3|||
130058356|NCT01079962|468168176|FG000|Overall Study|Participant not returning for next visit|1|||
130058357|NCT01079962|468168177|FG001|Overall Study|Participant not returning for next visit|0|||
130058358|NCT01079962|468168176|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
130058359|NCT01079962|468168177|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
130058360|NCT01331239|468168178|FG000|Part II: Core Study|Adverse Event|0|||
130058361|NCT01331239|468168179|FG001|Part II: Core Study|Adverse Event|3|||
130058362|NCT01331239|468168180|FG002|Part II: Core Study|Adverse Event|0|||
130058363|NCT01331239|468168178|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
130058364|NCT01331239|468168179|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
130058365|NCT01331239|468168180|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
130058366|NCT01331239|468168178|FG000|Part II: Core Study|Withdrawal by Subject|0|||
130058367|NCT01331239|468168179|FG001|Part II: Core Study|Withdrawal by Subject|2|||
130058368|NCT01331239|468168180|FG002|Part II: Core Study|Withdrawal by Subject|0|||
130058369|NCT01331239|468168178|FG000|Part II: Core Study|Administrative problems|0|||
130058370|NCT01331239|468168179|FG001|Part II: Core Study|Administrative problems|1|||
130058371|NCT01331239|468168180|FG002|Part II: Core Study|Administrative problems|0|||
130058372|NCT00946530|468168181|FG000|Overall Study|Withdrawal by Subject|0|||
130058373|NCT00946530|468168182|FG001|Overall Study|Withdrawal by Subject|3|||
130058374|NCT00946530|468168183|FG002|Overall Study|Withdrawal by Subject|0|||
129809557|NCT02555683|467269339|FG000|Overall Study|Lost to Follow-up|2|||
129809558|NCT02555683|467269340|FG001|Overall Study|Lost to Follow-up|1|||
129809559|NCT02555683|467269341|FG002|Overall Study|Lost to Follow-up|2|||
129809560|NCT02555683|467269339|FG000|Overall Study|Technical Problems|1|||
129809561|NCT02555683|467269340|FG001|Overall Study|Technical Problems|1|||
129809562|NCT02555683|467269341|FG002|Overall Study|Technical Problems|0|||
129809563|NCT02555683|467269339|FG000|Overall Study|Protocol deviation|0|||
129809564|NCT02555683|467269340|FG001|Overall Study|Protocol deviation|1|||
129809565|NCT02555683|467269341|FG002|Overall Study|Protocol deviation|0|||
129809566|NCT02555683|467269339|FG000|Overall Study|Lack of Efficacy|2|||
129809567|NCT02555683|467269340|FG001|Overall Study|Lack of Efficacy|0|||
129809568|NCT02555683|467269341|FG002|Overall Study|Lack of Efficacy|0|||
129809569|NCT02555683|467269339|FG000|Overall Study|Death|0|||
129809570|NCT02555683|467269340|FG001|Overall Study|Death|1|||
130058375|NCT00946530|468168184|FG003|Overall Study|Withdrawal by Subject|3|||
130058376|NCT00946530|468168181|FG000|Overall Study|Physician Decision|1|||
130058377|NCT00946530|468168182|FG001|Overall Study|Physician Decision|1|||
130058378|NCT00946530|468168183|FG002|Overall Study|Physician Decision|1|||
130058379|NCT00946530|468168184|FG003|Overall Study|Physician Decision|1|||
129809571|NCT02555683|467269341|FG002|Overall Study|Death|2|||
129809572|NCT02555683|467269339|FG000|Overall Study|Adverse Event|1|||
129809573|NCT02555683|467269340|FG001|Overall Study|Adverse Event|0|||
129896514|NCT01474538|467582084|FG000|Treatment Period 2|Death|1|||
130058380|NCT01008995|468168187|FG000|Controlled Period|Adverse Event|1|||
129809574|NCT02555683|467269341|FG002|Overall Study|Adverse Event|1|||
130058381|NCT01008995|468168188|FG001|Controlled Period|Adverse Event|2|||
130058382|NCT01008995|468168189|FG002|Controlled Period|Adverse Event|0|||
130058383|NCT01008995|468168190|FG003|Controlled Period|Adverse Event|0|||
130058384|NCT01008995|468168187|FG000|Controlled Period|Other|2|||
130058385|NCT01008995|468168188|FG001|Controlled Period|Other|1|||
130058386|NCT01008995|468168189|FG002|Controlled Period|Other|0|||
130058387|NCT01008995|468168190|FG003|Controlled Period|Other|0|||
130058388|NCT01008995|468168187|FG000|After Controlled Period|Adverse Event|0|||
130058389|NCT01008995|468168188|FG001|After Controlled Period|Adverse Event|0|||
129809575|NCT02555683|467269339|FG000|Overall Study|Subject/guardian decision|12|||
129809576|NCT02555683|467269340|FG001|Overall Study|Subject/guardian decision|12|||
129809577|NCT02555683|467269341|FG002|Overall Study|Subject/guardian decision|22|||
129809578|NCT02555683|467269339|FG000|Overall Study|Death post Treatment/safety period|0|||
129809579|NCT02555683|467269340|FG001|Overall Study|Death post Treatment/safety period|1|||
129809580|NCT02555683|467269341|FG002|Overall Study|Death post Treatment/safety period|0|||
129809581|NCT01086033|467269344|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
129809582|NCT01086033|467269344|FG000|Overall Study|Lost to Follow-up|86|||
129809583|NCT01086033|467269344|FG000|Overall Study|Adverse Event|42|||
129809584|NCT01086033|467269344|FG000|Overall Study|Withdrawal by Subject|41|||
129809585|NCT01086033|467269344|FG000|Overall Study|Other|14|||
129896515|NCT01474538|467582085|FG001|Treatment Period 2|Death|0|||
129896516|NCT01474538|467582084|FG000|Treatment Period 2|Adverse Event|1|||
129809586|NCT01086033|467269344|FG000|Overall Study|Other|13|||
129809587|NCT01086033|467269344|FG000|Overall Study|AE and Withdrew Consent|5|||
129809588|NCT01086033|467269344|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
129896517|NCT01474538|467582085|FG001|Treatment Period 2|Adverse Event|1|||
129896518|NCT01474538|467582084|FG000|Treatment Period 2|Withdrawal by Subject|2|||
129896519|NCT01474538|467582085|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130058390|NCT01008995|468168189|FG002|After Controlled Period|Adverse Event|1|||
130058391|NCT01008995|468168190|FG003|After Controlled Period|Adverse Event|1|||
130058392|NCT01008995|468168187|FG000|After Controlled Period|Other|0|||
130058393|NCT01008995|468168188|FG001|After Controlled Period|Other|0|||
130058394|NCT01008995|468168189|FG002|After Controlled Period|Other|1|||
130058395|NCT01008995|468168190|FG003|After Controlled Period|Other|0|||
129809589|NCT01086033|467269344|FG000|Overall Study|Withdrew consent and Other Reason|4|||
129809590|NCT01086033|467269344|FG000|Overall Study|AE and Lack of Efficacy|4|||
129896520|NCT01474538|467582084|FG000|Treatment Period 2|Sponsor decision|1|||
129896521|NCT01474538|467582085|FG001|Treatment Period 2|Sponsor decision|0|||
130058396|NCT02625324|468170324|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
130058397|NCT02625324|468170324|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
129809591|NCT01086033|467269344|FG000|Overall Study|Death|1|||
129809592|NCT01086033|467269344|FG000|Overall Study|AE and Lost to Follow-up|1|||
129809593|NCT01086033|467269344|FG000|Overall Study|AE and Other Reason|1|||
129809594|NCT01086033|467269344|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
129809595|NCT04572633|467269345|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
129809596|NCT02924571|467269346|FG000|Overall Study|Lost to Follow-up|1|||
129809597|NCT02924571|467269347|FG001|Overall Study|Lost to Follow-up|1|||
129809598|NCT02924571|467269348|FG002|Overall Study|Lost to Follow-up|0|||
129809599|NCT00434954|467269352|FG000|Overall Study|Adverse Event|17|||
129809600|NCT00434954|467269353|FG001|Overall Study|Adverse Event|2|||
129809601|NCT00434954|467269352|FG000|Overall Study|Entry criteria not met|14|||
129809602|NCT00434954|467269353|FG001|Overall Study|Entry criteria not met|16|||
129809603|NCT00434954|467269352|FG000|Overall Study|Lost to Follow-up|0|||
129809604|NCT00434954|467269353|FG001|Overall Study|Lost to Follow-up|1|||
129809605|NCT00434954|467269352|FG000|Overall Study|Physician Decision|6|||
129809606|NCT00434954|467269353|FG001|Overall Study|Physician Decision|3|||
129809607|NCT00434954|467269352|FG000|Overall Study|Protocol Violation|36|||
129809608|NCT00434954|467269353|FG001|Overall Study|Protocol Violation|27|||
129809609|NCT00434954|467269352|FG000|Overall Study|Sponsor decision|1|||
129809610|NCT00434954|467269353|FG001|Overall Study|Sponsor decision|0|||
129809611|NCT00434954|467269352|FG000|Overall Study|Subject decision|8|||
129809612|NCT00434954|467269353|FG001|Overall Study|Subject decision|22|||
129809613|NCT00894166|467269354|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
129809614|NCT00894166|467269355|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
129809615|NCT00894166|467269356|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
129809616|NCT00894166|467269357|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
129809617|NCT00894166|467269358|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
129809618|NCT00894166|467269359|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
129809619|NCT00894166|467269360|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
129809620|NCT00894166|467269361|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
129809621|NCT00894166|467269354|FG000|Overall Study|Death|0|||
129809622|NCT00894166|467269355|FG001|Overall Study|Death|0|||
129809623|NCT00894166|467269356|FG002|Overall Study|Death|0|||
130058398|NCT02625324|468170324|FG000|6-Month Follow-up Subject Accountability|Death|5|||
130058399|NCT02625324|468170324|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
130058400|NCT02625324|468170324|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
130058401|NCT02625324|468170324|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
129809624|NCT00894166|467269357|FG003|Overall Study|Death|1|||
129809625|NCT00894166|467269358|FG004|Overall Study|Death|0|||
129809626|NCT00894166|467269359|FG005|Overall Study|Death|0|||
129809627|NCT00894166|467269360|FG006|Overall Study|Death|0|||
129809628|NCT00894166|467269361|FG007|Overall Study|Death|0|||
129809629|NCT03750955|467269369|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
129809630|NCT03750955|467269370|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
129809631|NCT03750955|467269369|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
129809632|NCT03750955|467269370|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
129809633|NCT01180985|467269373|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
129809634|NCT01180985|467269374|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
129809635|NCT00129272|467269379|FG000|Overall Study|Lost to Follow-up|12|||
129809636|NCT00129272|467269380|FG001|Overall Study|Lost to Follow-up|11|||
129809637|NCT00129272|467269379|FG000|Overall Study|Withdrawal by Subject|5|||
129809638|NCT00129272|467269380|FG001|Overall Study|Withdrawal by Subject|11|||
129809639|NCT03345914|467269381|FG000|Overall Study|Transition to another study at week 16|80|||
130058402|NCT02625324|468170324|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
130058403|NCT02625324|468170324|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
129809640|NCT03345914|467269382|FG001|Overall Study|Transition to another study at week 16|86|||
130058404|NCT02625324|468170324|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
129896522|NCT01474538|467582084|FG000|Treatment Period 2|Physician Decision|0|||
129809641|NCT03345914|467269383|FG002|Overall Study|Transition to another study at week 16|78|||
129809642|NCT03345914|467269381|FG000|Overall Study|Transition to OLE during follow-up|37|||
129809643|NCT03345914|467269382|FG001|Overall Study|Transition to OLE during follow-up|33|||
129809644|NCT03345914|467269383|FG002|Overall Study|Transition to OLE during follow-up|39|||
129809645|NCT03345914|467269381|FG000|Overall Study|Physician Decision|0|||
129809646|NCT03345914|467269382|FG001|Overall Study|Physician Decision|1|||
129809647|NCT03345914|467269383|FG002|Overall Study|Physician Decision|1|||
129809648|NCT03345914|467269381|FG000|Overall Study|Withdrawal by Subject|5|||
129809649|NCT03345914|467269382|FG001|Overall Study|Withdrawal by Subject|1|||
129809650|NCT03345914|467269383|FG002|Overall Study|Withdrawal by Subject|2|||
129809651|NCT03345914|467269381|FG000|Overall Study|Other|1|||
129809652|NCT03345914|467269382|FG001|Overall Study|Other|1|||
129809653|NCT03345914|467269383|FG002|Overall Study|Other|1|||
129809654|NCT03345914|467269381|FG000|Overall Study|Ongoing|0|||
129809655|NCT03345914|467269382|FG001|Overall Study|Ongoing|0|||
129809656|NCT03345914|467269383|FG002|Overall Study|Ongoing|1|||
129809657|NCT00885846|467269389|FG000|Overall Study|Withdrawal by Subject|2|||
129896523|NCT01474538|467582085|FG001|Treatment Period 2|Physician Decision|1|||
129896524|NCT01474538|467582084|FG000|Treatment Period 2|Protocol Violation|1|||
129896525|NCT01474538|467582085|FG001|Treatment Period 2|Protocol Violation|0|||
129896526|NCT01456780|467582086|FG000|Overall Study|Lost to Follow-up|3|||
129896527|NCT01456780|467582087|FG001|Overall Study|Lost to Follow-up|3|||
129896528|NCT01456780|467582088|FG002|Overall Study|Lost to Follow-up|0|||
129896529|NCT03120676|467582091|FG000|Overall Study|Not treated|1|||
129896530|NCT00926393|467582092|FG000|Overall Study|Withdrawal by Subject|1|||
129896531|NCT00926393|467582093|FG001|Overall Study|Withdrawal by Subject|2|||
129896532|NCT00926393|467582092|FG000|Overall Study|Adverse Event|1|||
129896533|NCT00926393|467582093|FG001|Overall Study|Adverse Event|1|||
129896534|NCT02333630|467582094|FG000|Overall Study|Lost to Follow-up|5|||
129896535|NCT02333630|467582095|FG001|Overall Study|Lost to Follow-up|2|||
129896536|NCT00984282|467582096|FG000|Double Blind Treatment|Adverse Event|40|||
129896537|NCT00984282|467582097|FG001|Double Blind Treatment|Adverse Event|6|||
129896538|NCT00984282|467582096|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
129896539|NCT00984282|467582097|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
129809658|NCT00885846|467269390|FG001|Overall Study|Withdrawal by Subject|5|||
129896540|NCT00984282|467582096|FG000|Double Blind Treatment|Physician Decision|1|||
129896541|NCT00984282|467582097|FG001|Double Blind Treatment|Physician Decision|2|||
129896542|NCT00984282|467582096|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
129896543|NCT00984282|467582097|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
129809659|NCT00885846|467269391|FG002|Overall Study|Withdrawal by Subject|2|||
129809660|NCT01786668|467269393|FG000|Overall Study|Adverse Event|0|||
129809661|NCT01786668|467269394|FG001|Overall Study|Adverse Event|1|||
130058405|NCT02625324|468170324|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
130058406|NCT02625324|468170324|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
130058407|NCT02625324|468170324|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130058408|NCT02625324|468170324|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
130058409|NCT02625324|468170324|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130058410|NCT02625324|468170324|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130058411|NCT02625324|468170324|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
130058412|NCT02625324|468170324|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130058413|NCT00424528|468170329|FG000|Overall Study|Adverse Event|2|||
130058414|NCT00424528|468170330|FG001|Overall Study|Adverse Event|1|||
130058415|NCT00424528|468170331|FG002|Overall Study|Adverse Event|2|||
130058416|NCT00424528|468170329|FG000|Overall Study|Protocol Violation|1|||
129809662|NCT01786668|467269395|FG002|Overall Study|Adverse Event|1|||
129809663|NCT01786668|467269396|FG003|Overall Study|Adverse Event|2|||
130058417|NCT00424528|468170330|FG001|Overall Study|Protocol Violation|1|||
130058418|NCT00424528|468170331|FG002|Overall Study|Protocol Violation|0|||
130058419|NCT00424528|468170329|FG000|Overall Study|Lost to Follow-up|0|||
130058420|NCT00424528|468170330|FG001|Overall Study|Lost to Follow-up|1|||
130058421|NCT00424528|468170331|FG002|Overall Study|Lost to Follow-up|0|||
130058422|NCT00424528|468170329|FG000|Overall Study|noncompliance with study requirements|2|||
130058423|NCT00424528|468170330|FG001|Overall Study|noncompliance with study requirements|1|||
130058424|NCT00424528|468170331|FG002|Overall Study|noncompliance with study requirements|2|||
129809664|NCT01786668|467269393|FG000|Overall Study|Withdrawal by Subject|0|||
129809665|NCT01786668|467269394|FG001|Overall Study|Withdrawal by Subject|0|||
129809666|NCT01786668|467269395|FG002|Overall Study|Withdrawal by Subject|3|||
129809667|NCT01786668|467269396|FG003|Overall Study|Withdrawal by Subject|1|||
129809668|NCT01786668|467269393|FG000|Overall Study|Pregnancy|0|||
129809669|NCT01786668|467269394|FG001|Overall Study|Pregnancy|0|||
129809670|NCT01786668|467269395|FG002|Overall Study|Pregnancy|0|||
129809671|NCT01786668|467269396|FG003|Overall Study|Pregnancy|1|||
129809672|NCT01786668|467269393|FG000|Overall Study|Lost to Follow-up|1|||
129896544|NCT00984282|467582096|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
129896545|NCT00984282|467582097|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
129896546|NCT00984282|467582096|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
129896547|NCT00984282|467582097|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
129896548|NCT00984282|467582096|FG000|Double Blind Treatment|Lost to Follow-up|3|||
129896549|NCT00984282|467582097|FG001|Double Blind Treatment|Lost to Follow-up|0|||
129896550|NCT00984282|467582096|FG000|Double Blind Treatment|Death|8|||
129809673|NCT01786668|467269394|FG001|Overall Study|Lost to Follow-up|0|||
129809674|NCT01786668|467269395|FG002|Overall Study|Lost to Follow-up|1|||
129809675|NCT01786668|467269396|FG003|Overall Study|Lost to Follow-up|0|||
129809676|NCT03570697|467269397|FG000|Overall Study|Lost to Follow-up|0|||
129896551|NCT00984282|467582097|FG001|Double Blind Treatment|Death|4|||
129896552|NCT00984282|467582096|FG000|Double Blind Treatment|Not treated|0|||
129896553|NCT00984282|467582097|FG001|Double Blind Treatment|Not treated|1|||
129896554|NCT00984282|467582096|FG000|Double Blind Treatment|Switched to commercial drug|6|||
129896555|NCT00984282|467582097|FG001|Double Blind Treatment|Switched to commercial drug|1|||
130058425|NCT00967226|468170333|FG000|Overall Study|Adverse Event|0|||
130058426|NCT00967226|468170334|FG001|Overall Study|Adverse Event|5|||
130058427|NCT00967226|468170333|FG000|Overall Study|Protocol Violation|2|||
130058428|NCT00967226|468170334|FG001|Overall Study|Protocol Violation|0|||
130058429|NCT00967226|468170333|FG000|Overall Study|Physician Decision|0|||
129809677|NCT03570697|467269398|FG001|Overall Study|Lost to Follow-up|1|||
129809678|NCT03570697|467269397|FG000|Overall Study|Death|2|||
130058430|NCT00967226|468170334|FG001|Overall Study|Physician Decision|1|||
130058431|NCT00254293|468170335|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129809679|NCT03570697|467269398|FG001|Overall Study|Death|0|||
129809680|NCT03570697|467269397|FG000|Overall Study|Withdrawal by Subject|4|||
129809681|NCT03570697|467269398|FG001|Overall Study|Withdrawal by Subject|2|||
130058432|NCT00254293|468170336|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
129809682|NCT01776840|467269399|FG000|Overall Study|Lost to Follow-up|12|||
130058433|NCT00254293|468170337|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
130058434|NCT00254293|468170338|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
129809683|NCT01776840|467269400|FG001|Overall Study|Lost to Follow-up|7|||
129809684|NCT01776840|467269399|FG000|Overall Study|Withdrawal by Subject|32|||
130058435|NCT00254293|468170339|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129809685|NCT01776840|467269400|FG001|Overall Study|Withdrawal by Subject|48|||
129809686|NCT01776840|467269399|FG000|Overall Study|Sponsor decision|89|||
130058436|NCT00254293|468170340|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129809687|NCT01776840|467269400|FG001|Overall Study|Sponsor decision|87|||
130058437|NCT00254293|468170341|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129809688|NCT00493025|467269402|FG000|Overall Study|Physician Decision|19|||
129809689|NCT03068455|467269403|FG000|Pre-treatment Period|Disease progression|0|||
129809690|NCT03068455|467269404|FG001|Pre-treatment Period|Disease progression|1|||
129809691|NCT03068455|467269403|FG000|Pre-treatment Period|Participant withdrew consent|1|||
129809692|NCT03068455|467269404|FG001|Pre-treatment Period|Participant withdrew consent|1|||
129809693|NCT03068455|467269403|FG000|Pre-treatment Period|Poor/non-compliance|0|||
129896556|NCT00984282|467582096|FG000|Double Blind Treatment|protocol driven decision point|1|||
129896557|NCT00984282|467582097|FG001|Double Blind Treatment|protocol driven decision point|1|||
129896558|NCT00984282|467582096|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
129896559|NCT00984282|467582097|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
129896560|NCT00984282|467582096|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
129896561|NCT00984282|467582097|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
129896562|NCT00984282|467582096|FG000|Open-label Treatment|Adverse Event|20|||
129896563|NCT00984282|467582097|FG001|Open-label Treatment|Adverse Event|30|||
129896564|NCT00984282|467582096|FG000|Open-label Treatment|Withdrawal by Subject|6|||
129896565|NCT00984282|467582097|FG001|Open-label Treatment|Withdrawal by Subject|21|||
129896566|NCT00984282|467582096|FG000|Open-label Treatment|Death|7|||
129896567|NCT00984282|467582097|FG001|Open-label Treatment|Death|15|||
129896568|NCT00984282|467582096|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
129896569|NCT00984282|467582097|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
129896570|NCT00984282|467582096|FG000|Open-label Treatment|Lost to Follow-up|1|||
129896571|NCT00984282|467582097|FG001|Open-label Treatment|Lost to Follow-up|1|||
129896572|NCT00984282|467582096|FG000|Open-label Treatment|Patient convenience|1|||
129896573|NCT00984282|467582097|FG001|Open-label Treatment|Patient convenience|0|||
129896574|NCT00984282|467582096|FG000|Open-label Treatment|Non-compliant with study medication|1|||
129896575|NCT00984282|467582097|FG001|Open-label Treatment|Non-compliant with study medication|0|||
129896576|NCT00984282|467582096|FG000|Open-label Treatment|Target lesion removed|0|||
129896577|NCT00984282|467582097|FG001|Open-label Treatment|Target lesion removed|1|||
129896578|NCT00984282|467582096|FG000|Open-label Treatment|Protocol driven decision point|1|||
129896579|NCT00984282|467582097|FG001|Open-label Treatment|Protocol driven decision point|1|||
129896580|NCT00984282|467582096|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
129896581|NCT00984282|467582097|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
129896582|NCT00984282|467582096|FG000|Open-label Treatment|Switched to commercial drug|6|||
129896583|NCT00984282|467582097|FG001|Open-label Treatment|Switched to commercial drug|7|||
129896584|NCT00984282|467582096|FG000|Open-label Treatment|Physician Decision|1|||
129896585|NCT00984282|467582097|FG001|Open-label Treatment|Physician Decision|0|||
129896586|NCT00984282|467582096|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
129896587|NCT00984282|467582097|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
129896588|NCT00984282|467582096|FG000|Long Term Follow-up|Death|27|||
129896589|NCT00984282|467582097|FG001|Long Term Follow-up|Death|68|||
129896590|NCT00984282|467582096|FG000|Long Term Follow-up|Lost to Follow-up|3|||
129896591|NCT00984282|467582097|FG001|Long Term Follow-up|Lost to Follow-up|6|||
129896592|NCT00984282|467582096|FG000|Long Term Follow-up|Protocol driven decision point|25|||
129896593|NCT00984282|467582097|FG001|Long Term Follow-up|Protocol driven decision point|26|||
129896594|NCT00984282|467582096|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
129896595|NCT00984282|467582097|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
129896596|NCT00984282|467582096|FG000|Long Term Follow-up|Switched to commercial drug|4|||
129896597|NCT00984282|467582097|FG001|Long Term Follow-up|Switched to commercial drug|2|||
129896598|NCT00984282|467582096|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
129896599|NCT00984282|467582097|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
129896600|NCT02223793|467582098|FG000|Overall Study|Lost to Follow-up|10|||
129896601|NCT02223793|467582099|FG001|Overall Study|Lost to Follow-up|1|||
129896602|NCT02223793|467582100|FG002|Overall Study|Lost to Follow-up|2|||
129896603|NCT02223793|467582098|FG000|Overall Study|Withdrawal by Subject|3|||
129896604|NCT02223793|467582099|FG001|Overall Study|Withdrawal by Subject|2|||
129896605|NCT02223793|467582100|FG002|Overall Study|Withdrawal by Subject|3|||
129896606|NCT02223793|467582098|FG000|Overall Study|Moved/studycenter unable to participate|4|||
129809694|NCT03068455|467269404|FG001|Pre-treatment Period|Poor/non-compliance|1|||
129809695|NCT03068455|467269403|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
129809696|NCT03068455|467269404|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
129809697|NCT03068455|467269403|FG000|Pre-treatment Period|Not reported|2|||
129809698|NCT03068455|467269404|FG001|Pre-treatment Period|Not reported|1|||
129809699|NCT03068455|467269403|FG000|Treatment Period|Disease progression|166|||
129809700|NCT03068455|467269404|FG001|Treatment Period|Disease progression|208|||
129809701|NCT03068455|467269403|FG000|Treatment Period|Study drug toxicity|317|||
129809702|NCT03068455|467269404|FG001|Treatment Period|Study drug toxicity|104|||
129809703|NCT03068455|467269403|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
129809704|NCT03068455|467269404|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
129809705|NCT03068455|467269403|FG000|Treatment Period|Participant request to stop therapy|33|||
129809706|NCT03068455|467269404|FG001|Treatment Period|Participant request to stop therapy|20|||
129809707|NCT03068455|467269403|FG000|Treatment Period|Participant withdrew consent|5|||
129809708|NCT03068455|467269404|FG001|Treatment Period|Participant withdrew consent|10|||
129809709|NCT03068455|467269403|FG000|Treatment Period|Poor/non-compliance|3|||
129809710|NCT03068455|467269404|FG001|Treatment Period|Poor/non-compliance|0|||
129809711|NCT03068455|467269403|FG000|Treatment Period|Participant no longer meets study criteria|1|||
129809712|NCT03068455|467269404|FG001|Treatment Period|Participant no longer meets study criteria|3|||
129809713|NCT03068455|467269403|FG000|Treatment Period|Other reasons|12|||
129809714|NCT03068455|467269404|FG001|Treatment Period|Other reasons|4|||
129809715|NCT03173313|467269408|FG000|Overall Study|Lost to Follow-up|2|||
129809716|NCT03173313|467269409|FG001|Overall Study|Lost to Follow-up|3|||
129809717|NCT03173313|467269408|FG000|Overall Study|Withdrawal by Subject|0|||
129809718|NCT03173313|467269409|FG001|Overall Study|Withdrawal by Subject|1|||
129809719|NCT03173313|467269408|FG000|Overall Study|Death|5|||
129809720|NCT03173313|467269409|FG001|Overall Study|Death|0|||
129809721|NCT03173313|467269408|FG000|Overall Study|Physician Decision|1|||
129809722|NCT03173313|467269409|FG001|Overall Study|Physician Decision|0|||
129809723|NCT03173313|467269408|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
129809724|NCT03173313|467269409|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
129809725|NCT03173313|467269408|FG000|Overall Study|Bone Fracture|1|||
129809726|NCT03173313|467269409|FG001|Overall Study|Bone Fracture|0|||
129809727|NCT01876420|467269410|FG000|Overall Study|Missed 30 day visit|1|||
129809728|NCT04515394|467269414|FG000|Overall Study|Participant did not receive treatment|1|||
129809729|NCT01042678|467269415|FG000|Overall Study|Physician Decision|1|||
129809730|NCT01042678|467269416|FG001|Overall Study|Physician Decision|0|||
129809731|NCT01042678|467269417|FG002|Overall Study|Physician Decision|0|||
129809732|NCT01042678|467269418|FG003|Overall Study|Physician Decision|0|||
129809733|NCT01042678|467269419|FG004|Overall Study|Physician Decision|0|||
129809734|NCT01042678|467269420|FG005|Overall Study|Physician Decision|0|||
129809735|NCT01058655|467269424|FG000|Overall Study|Withdrawal by Subject|1|||
129809736|NCT01058655|467269425|FG001|Overall Study|Withdrawal by Subject|0|||
129809737|NCT01058655|467269426|FG002|Overall Study|Withdrawal by Subject|3|||
129896607|NCT02223793|467582099|FG001|Overall Study|Moved/studycenter unable to participate|6|||
129896608|NCT02223793|467582100|FG002|Overall Study|Moved/studycenter unable to participate|8|||
129896609|NCT00315055|467582101|FG000|Overall Study|Protocol Violation|2|||
129896610|NCT00315055|467582102|FG001|Overall Study|Protocol Violation|4|||
129896611|NCT00315055|467582101|FG000|Overall Study|Lost to Follow-up|1|||
129896612|NCT00315055|467582102|FG001|Overall Study|Lost to Follow-up|1|||
129896613|NCT02359435|467582103|FG000|Overall Study|Lost to Follow-up|4|||
129896614|NCT02359435|467582104|FG001|Overall Study|Lost to Follow-up|4|||
129896615|NCT01289119|467582105|FG000|Overall Study|Adverse Event|2|||
129896616|NCT01289119|467582106|FG001|Overall Study|Adverse Event|1|||
129896617|NCT01289119|467582107|FG002|Overall Study|Adverse Event|0|||
129896618|NCT01289119|467582108|FG003|Overall Study|Adverse Event|2|||
129896619|NCT01289119|467582109|FG004|Overall Study|Adverse Event|1|||
129896620|NCT01289119|467582110|FG005|Overall Study|Adverse Event|0|||
129896621|NCT01289119|467582105|FG000|Overall Study|Major Protocol Deviation|2|||
129896622|NCT01289119|467582106|FG001|Overall Study|Major Protocol Deviation|1|||
129896623|NCT01289119|467582107|FG002|Overall Study|Major Protocol Deviation|3|||
129896624|NCT01289119|467582108|FG003|Overall Study|Major Protocol Deviation|0|||
129896625|NCT01289119|467582109|FG004|Overall Study|Major Protocol Deviation|2|||
129896626|NCT01289119|467582110|FG005|Overall Study|Major Protocol Deviation|1|||
129896627|NCT01289119|467582105|FG000|Overall Study|Lost to Follow-up|0|||
129896628|NCT01289119|467582106|FG001|Overall Study|Lost to Follow-up|3|||
129896629|NCT01289119|467582107|FG002|Overall Study|Lost to Follow-up|0|||
129896630|NCT01289119|467582108|FG003|Overall Study|Lost to Follow-up|0|||
129896631|NCT01289119|467582109|FG004|Overall Study|Lost to Follow-up|0|||
129896632|NCT01289119|467582110|FG005|Overall Study|Lost to Follow-up|1|||
129896633|NCT01289119|467582105|FG000|Overall Study|Withdrawal by Subject|4|||
129896634|NCT01289119|467582106|FG001|Overall Study|Withdrawal by Subject|2|||
129896635|NCT01289119|467582107|FG002|Overall Study|Withdrawal by Subject|4|||
129896636|NCT01289119|467582108|FG003|Overall Study|Withdrawal by Subject|3|||
129896637|NCT01289119|467582109|FG004|Overall Study|Withdrawal by Subject|1|||
129896638|NCT01289119|467582110|FG005|Overall Study|Withdrawal by Subject|1|||
129896639|NCT01289119|467582105|FG000|Overall Study|Pregnancy|0|||
129896640|NCT01289119|467582106|FG001|Overall Study|Pregnancy|1|||
129896641|NCT01289119|467582107|FG002|Overall Study|Pregnancy|0|||
129896642|NCT01289119|467582108|FG003|Overall Study|Pregnancy|0|||
129896643|NCT01289119|467582109|FG004|Overall Study|Pregnancy|0|||
129896644|NCT01289119|467582110|FG005|Overall Study|Pregnancy|0|||
129896645|NCT01289119|467582105|FG000|Overall Study|Lack of Efficacy|0|||
129896646|NCT01289119|467582106|FG001|Overall Study|Lack of Efficacy|1|||
129896647|NCT01289119|467582107|FG002|Overall Study|Lack of Efficacy|1|||
129896648|NCT01289119|467582108|FG003|Overall Study|Lack of Efficacy|1|||
129896649|NCT01289119|467582109|FG004|Overall Study|Lack of Efficacy|1|||
129896650|NCT01289119|467582110|FG005|Overall Study|Lack of Efficacy|1|||
129896651|NCT01289119|467582105|FG000|Overall Study|Other|1|||
129896652|NCT01289119|467582106|FG001|Overall Study|Other|0|||
129896653|NCT01289119|467582107|FG002|Overall Study|Other|1|||
129896654|NCT01289119|467582108|FG003|Overall Study|Other|0|||
129896655|NCT01289119|467582109|FG004|Overall Study|Other|0|||
129896656|NCT01289119|467582110|FG005|Overall Study|Other|0|||
129896657|NCT01704846|467582111|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129896658|NCT01704846|467582112|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129896659|NCT00530335|467582113|FG000|Overall Study|Adverse Event|3|||
129896660|NCT00530335|467582113|FG000|Overall Study|Protocol Violation|1|||
129896661|NCT00530335|467582113|FG000|Overall Study|Withdrawal by Subject|1|||
129896662|NCT00530335|467582113|FG000|Overall Study|Physician Decision|1|||
129896663|NCT04577183|467582114|FG000|Overall Study|Death|1|||
129896664|NCT04577183|467582114|FG000|Overall Study|Withdrawal by Subject|3|||
129896665|NCT04577183|467582114|FG000|Overall Study|Early termination|2|||
129809738|NCT01058655|467269427|FG003|Overall Study|Withdrawal by Subject|4|||
129809739|NCT01058655|467269424|FG000|Overall Study|Prolonged Treatment Delay|0|||
129809740|NCT01058655|467269425|FG001|Overall Study|Prolonged Treatment Delay|0|||
129809741|NCT01058655|467269426|FG002|Overall Study|Prolonged Treatment Delay|0|||
129809742|NCT01058655|467269427|FG003|Overall Study|Prolonged Treatment Delay|2|||
130058438|NCT00254293|468170335|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129809743|NCT01058655|467269424|FG000|Overall Study|Symptomatic Deterioration|0|||
129809744|NCT01058655|467269425|FG001|Overall Study|Symptomatic Deterioration|0|||
129809745|NCT01058655|467269426|FG002|Overall Study|Symptomatic Deterioration|0|||
129809746|NCT01058655|467269427|FG003|Overall Study|Symptomatic Deterioration|1|||
129809747|NCT01058655|467269424|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
129809748|NCT01058655|467269425|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
129809749|NCT01058655|467269426|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
129809750|NCT01058655|467269427|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
129809751|NCT01058655|467269424|FG000|Overall Study|Death|0|||
129809752|NCT01058655|467269425|FG001|Overall Study|Death|1|||
129809753|NCT01058655|467269426|FG002|Overall Study|Death|1|||
129809754|NCT01058655|467269427|FG003|Overall Study|Death|0|||
129809755|NCT01058655|467269424|FG000|Overall Study|Disease Progression|1|||
129809756|NCT01058655|467269425|FG001|Overall Study|Disease Progression|2|||
129809757|NCT01058655|467269426|FG002|Overall Study|Disease Progression|4|||
129809758|NCT01058655|467269427|FG003|Overall Study|Disease Progression|24|||
129809759|NCT01058655|467269424|FG000|Overall Study|Other|0|||
129809760|NCT01058655|467269425|FG001|Overall Study|Other|0|||
129809761|NCT01058655|467269426|FG002|Overall Study|Other|0|||
129809762|NCT01058655|467269427|FG003|Overall Study|Other|4|||
129809763|NCT04472429|467269428|FG000|Randomized Period|Ongoing|90|||
129809764|NCT04472429|467269429|FG001|Randomized Period|Ongoing|40|||
129809765|NCT04472429|467269430|FG002|Randomized Period|Ongoing|0|||
129809766|NCT04472429|467269428|FG000|Randomized Period|Death|52|||
129809767|NCT04472429|467269429|FG001|Randomized Period|Death|37|||
129809768|NCT04472429|467269430|FG002|Randomized Period|Death|0|||
129809769|NCT04472429|467269428|FG000|Randomized Period|Lost to Follow-up|4|||
129896666|NCT00938340|467582118|FG000|Overall Study|Withdrawal by Subject|3|||
129809770|NCT04472429|467269429|FG001|Randomized Period|Lost to Follow-up|0|||
129809771|NCT04472429|467269430|FG002|Randomized Period|Lost to Follow-up|0|||
129809772|NCT04472429|467269428|FG000|Randomized Period|Physician Decision|1|||
129809773|NCT04472429|467269429|FG001|Randomized Period|Physician Decision|2|||
129809774|NCT04472429|467269430|FG002|Randomized Period|Physician Decision|0|||
129809775|NCT04472429|467269428|FG000|Randomized Period|Withdrawal by Subject|6|||
129809776|NCT04472429|467269429|FG001|Randomized Period|Withdrawal by Subject|5|||
129809777|NCT04472429|467269430|FG002|Randomized Period|Withdrawal by Subject|0|||
129809778|NCT04472429|467269428|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
129809779|NCT04472429|467269429|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
129809780|NCT04472429|467269430|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
129809781|NCT04472429|467269428|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
129809782|NCT04472429|467269429|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
129809783|NCT04472429|467269430|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
129809784|NCT04472429|467269428|FG000|Open-label Monotherapy Period|Ongoing|0|||
129809785|NCT04472429|467269429|FG001|Open-label Monotherapy Period|Ongoing|0|||
129809786|NCT04472429|467269430|FG002|Open-label Monotherapy Period|Ongoing|32|||
129809787|NCT04472429|467269428|FG000|Open-label Monotherapy Period|Death|0|||
129809788|NCT04472429|467269429|FG001|Open-label Monotherapy Period|Death|0|||
129809789|NCT04472429|467269430|FG002|Open-label Monotherapy Period|Death|35|||
129809790|NCT04472429|467269428|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
129809791|NCT04472429|467269429|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
129809792|NCT04472429|467269430|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
129809793|NCT02319837|467269433|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
129896667|NCT00938340|467582118|FG000|Overall Study|Protocol Violation|1|||
129809794|NCT02319837|467269434|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
129809795|NCT02319837|467269435|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
129809796|NCT02319837|467269433|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
129809797|NCT02319837|467269434|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
129809798|NCT02319837|467269435|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
129896668|NCT00938340|467582118|FG000|Overall Study|Adverse Event|1|||
129896669|NCT02534896|467582119|FG000|Overall Study|Adverse Event|2|||
129809799|NCT02319837|467269433|FG000|Study Treatment Phase|Adverse Event|73|||
129809800|NCT02319837|467269434|FG001|Study Treatment Phase|Adverse Event|36|||
129809801|NCT02319837|467269435|FG002|Study Treatment Phase|Adverse Event|63|||
129809802|NCT02319837|467269433|FG000|Study Treatment Phase|Development of castration resistance|0|||
129809803|NCT02319837|467269434|FG001|Study Treatment Phase|Development of castration resistance|2|||
129809804|NCT02319837|467269435|FG002|Study Treatment Phase|Development of castration resistance|0|||
129809805|NCT02319837|467269433|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
129809806|NCT02319837|467269434|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
129809807|NCT02319837|467269435|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
129809808|NCT02319837|467269433|FG000|Study Treatment Phase|Protocol Violation|2|||
129809809|NCT02319837|467269434|FG001|Study Treatment Phase|Protocol Violation|2|||
129809810|NCT02319837|467269435|FG002|Study Treatment Phase|Protocol Violation|1|||
129809811|NCT02319837|467269433|FG000|Study Treatment Phase|Lost to Follow-up|0|||
129809812|NCT02319837|467269434|FG001|Study Treatment Phase|Lost to Follow-up|1|||
129809813|NCT02319837|467269435|FG002|Study Treatment Phase|Lost to Follow-up|0|||
129896670|NCT02534896|467582120|FG001|Overall Study|Adverse Event|1|||
129896671|NCT02534896|467582121|FG002|Overall Study|Adverse Event|1|||
129896672|NCT02534896|467582119|FG000|Overall Study|Insufficient therapeutic response|2|||
129809814|NCT02319837|467269433|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
129809815|NCT02319837|467269434|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
129809816|NCT02319837|467269435|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
129809817|NCT02319837|467269433|FG000|Study Treatment Phase|Other|0|||
129809818|NCT02319837|467269434|FG001|Study Treatment Phase|Other|1|||
129809819|NCT02319837|467269435|FG002|Study Treatment Phase|Other|0|||
129809820|NCT02319837|467269433|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
129809821|NCT02319837|467269434|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
129809822|NCT02319837|467269435|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
129809823|NCT02319837|467269433|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
129809824|NCT02319837|467269434|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
129809825|NCT02319837|467269435|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
129809826|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
129809827|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
129809828|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
129809829|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
129809830|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
129809831|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
129809832|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
129809833|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
129809834|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
129809835|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
129809836|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
129809837|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
129809838|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Death|33|||
129809839|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Death|54|||
129809840|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Death|42|||
129809841|NCT01313312|467269436|FG000|Overall Study|Adverse Event|5|||
129809842|NCT01313312|467269436|FG000|Overall Study|Withdrawal by Subject|18|||
129809843|NCT01313312|467269436|FG000|Overall Study|Lack of Efficacy|3|||
129809844|NCT01313312|467269436|FG000|Overall Study|Investigator Decision|1|||
129809845|NCT01313312|467269436|FG000|Overall Study|Observational Phase|1|||
129809846|NCT01313312|467269436|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
129809847|NCT01313312|467269436|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
129809848|NCT01254331|467269438|FG000|Initial Phase|Adverse Event|3|||
129809849|NCT01254331|467269438|FG000|Initial Phase|Withdrawal by Subject|1|||
129809850|NCT01254331|467269438|FG000|Initial Phase|Pregnancy|1|||
129809851|NCT01254331|467269438|FG000|Extension Phase|Lack of Efficacy|1|||
129809852|NCT01254331|467269438|FG000|Extension Phase|Lost to Follow-up|3|||
129809853|NCT00892047|467269439|FG000|Overall Study|Adverse Event|2|||
129809854|NCT00892047|467269440|FG001|Overall Study|Adverse Event|2|||
129809855|NCT00892047|467269439|FG000|Overall Study|subject burden|2|||
129809856|NCT00892047|467269440|FG001|Overall Study|subject burden|3|||
129809857|NCT00892047|467269439|FG000|Overall Study|Lack of Efficacy|0|||
129809858|NCT00892047|467269440|FG001|Overall Study|Lack of Efficacy|2|||
129809859|NCT05306977|467269441|FG000|Overall Study|Withdrawal by Subject|1|||
129809860|NCT01612858|467269446|FG000|Overall Study|Withdrawal by Subject|5|||
129809861|NCT01612858|467269447|FG001|Overall Study|Withdrawal by Subject|1|||
129809862|NCT00660699|467269450|FG000|Overall Study|Withdrawal by Subject|2|||
129809863|NCT01752985|467269451|FG000|Treatment Period|Subject request to discontinue treatment|1|||
129809864|NCT01752985|467269452|FG001|Treatment Period|Subject request to discontinue treatment|0|||
129809865|NCT01752985|467269453|FG002|Treatment Period|Subject request to discontinue treatment|1|||
129809866|NCT01752985|467269451|FG000|Treatment Period|Subject no longer meets study criteria|0|||
129809867|NCT01752985|467269452|FG001|Treatment Period|Subject no longer meets study criteria|1|||
129809868|NCT01752985|467269453|FG002|Treatment Period|Subject no longer meets study criteria|1|||
129809869|NCT01752985|467269451|FG000|Treatment Period|Adverse Event|2|||
129896673|NCT02534896|467582120|FG001|Overall Study|Insufficient therapeutic response|0|||
129896674|NCT02534896|467582121|FG002|Overall Study|Insufficient therapeutic response|0|||
129896675|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
129896676|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
129896677|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
129896678|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
129896679|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Adverse Event|198|||
129896680|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Adverse Event|0|||
129896681|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Adverse Event|0|||
129896682|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Adverse Event|0|||
129809870|NCT01752985|467269452|FG001|Treatment Period|Adverse Event|1|||
129809871|NCT01752985|467269453|FG002|Treatment Period|Adverse Event|2|||
129809872|NCT01752985|467269451|FG000|Treatment Period|Withdrawal by Subject|1|||
129809873|NCT01752985|467269452|FG001|Treatment Period|Withdrawal by Subject|1|||
129809874|NCT01752985|467269453|FG002|Treatment Period|Withdrawal by Subject|0|||
129809875|NCT01752985|467269451|FG000|Treatment Period|Lost to Follow-up|0|||
129809876|NCT01752985|467269452|FG001|Treatment Period|Lost to Follow-up|0|||
129809877|NCT01752985|467269453|FG002|Treatment Period|Lost to Follow-up|1|||
129809878|NCT01995825|467270968|FG000|Overall Study|Withdrawal by Subject|1|||
129809879|NCT01995825|467270969|FG001|Overall Study|Withdrawal by Subject|0|||
129809880|NCT01385566|467270970|FG000|Overall Study|Lost to Follow-up|1|||
129809881|NCT01385566|467270971|FG001|Overall Study|Lost to Follow-up|0|||
129809882|NCT01385566|467270972|FG002|Overall Study|Lost to Follow-up|0|||
129809883|NCT01385566|467270973|FG003|Overall Study|Lost to Follow-up|0|||
129809884|NCT01385566|467270974|FG004|Overall Study|Lost to Follow-up|0|||
129809885|NCT01385566|467270975|FG005|Overall Study|Lost to Follow-up|0|||
129809886|NCT01385566|467270970|FG000|Overall Study|Withdrawal by Subject|0|||
129809887|NCT01385566|467270971|FG001|Overall Study|Withdrawal by Subject|0|||
129809888|NCT01385566|467270972|FG002|Overall Study|Withdrawal by Subject|0|||
129809889|NCT01385566|467270973|FG003|Overall Study|Withdrawal by Subject|1|||
129809890|NCT01385566|467270974|FG004|Overall Study|Withdrawal by Subject|0|||
129809891|NCT01385566|467270975|FG005|Overall Study|Withdrawal by Subject|0|||
129809892|NCT00403234|467270978|FG000|Overall Study|Withdrawal by Subject|0|||
129896683|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Death|62|||
129896684|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Death|0|||
129896685|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Death|0|||
129809893|NCT00403234|467270979|FG001|Overall Study|Withdrawal by Subject|1|||
129809894|NCT00403234|467270980|FG002|Overall Study|Withdrawal by Subject|0|||
129809895|NCT00403234|467270981|FG003|Overall Study|Withdrawal by Subject|0|||
129809896|NCT00403234|467270978|FG000|Overall Study|Adverse Event|1|||
129809897|NCT00403234|467270979|FG001|Overall Study|Adverse Event|0|||
129809898|NCT00403234|467270980|FG002|Overall Study|Adverse Event|1|||
129809899|NCT00403234|467270981|FG003|Overall Study|Adverse Event|0|||
129809900|NCT04092582|467270982|FG000|Overall Study|Death|1|||
129809901|NCT04092582|467270983|FG001|Overall Study|Death|1|||
129809902|NCT04092582|467270982|FG000|Overall Study|Withdrawal by Subject|4|||
129809903|NCT04092582|467270983|FG001|Overall Study|Withdrawal by Subject|1|||
129809904|NCT04092582|467270982|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
129809905|NCT04092582|467270983|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
129809906|NCT00560105|467270990|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
129809907|NCT00560105|467270991|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
129809908|NCT02025621|467270997|FG000|Overall Study|Withdrawal by Subject|1|||
129809909|NCT02025621|467270998|FG001|Overall Study|Withdrawal by Subject|0|||
129809910|NCT02025621|467270997|FG000|Overall Study|Death|0|||
129809911|NCT02025621|467270998|FG001|Overall Study|Death|1|||
129809912|NCT02025621|467270997|FG000|Overall Study|No longer eligible|10|||
129809913|NCT02025621|467270998|FG001|Overall Study|No longer eligible|15|||
129809914|NCT02025621|467270997|FG000|Overall Study|Surgery initiated before infusion|3|||
129809915|NCT02025621|467270998|FG001|Overall Study|Surgery initiated before infusion|3|||
129809916|NCT01871532|467270999|FG000|Overall Study|Withdrawal by Subject|1|||
129809917|NCT01871532|467271000|FG001|Overall Study|Withdrawal by Subject|2|||
129809918|NCT02195583|467271002|FG000|Overall Study|Lost to Follow-up|1|||
129809919|NCT02195583|467271002|FG000|Overall Study|Withdrawal by Subject|4|||
129809920|NCT02195583|467271002|FG000|Overall Study|Adverse Event|2|||
129809921|NCT02195583|467271002|FG000|Overall Study|Other Reason|2|||
129809922|NCT01709513|467271003|FG000|Overall Study|Randomized but not treated|0|||
129809923|NCT01709513|467271004|FG001|Overall Study|Randomized but not treated|1|||
129896686|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Death|0|||
129896687|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
129896688|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
129896689|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
129896690|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
129896691|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Complicating disease|13|||
129809924|NCT01709513|467271005|FG002|Overall Study|Randomized but not treated|0|||
129896692|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Complicating disease|0|||
129896693|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Complicating disease|0|||
129896694|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Complicating disease|0|||
129809925|NCT01709513|467271003|FG000|Overall Study|Adverse Event|16|||
129809926|NCT01709513|467271004|FG001|Overall Study|Adverse Event|31|||
129809927|NCT01709513|467271005|FG002|Overall Study|Adverse Event|23|||
129809928|NCT01709513|467271003|FG000|Overall Study|Poor compliance to protocol|2|||
129809929|NCT01709513|467271004|FG001|Overall Study|Poor compliance to protocol|0|||
129809930|NCT01709513|467271005|FG002|Overall Study|Poor compliance to protocol|0|||
129809931|NCT01709513|467271003|FG000|Overall Study|Other|3|||
129809932|NCT01709513|467271004|FG001|Overall Study|Other|11|||
129809933|NCT01709513|467271005|FG002|Overall Study|Other|7|||
129809934|NCT04218695|467271006|FG000|Overall Study|Adverse Event|1|||
129809935|NCT04218695|467271007|FG001|Overall Study|Adverse Event|0|||
129809936|NCT00983437|467271008|FG000|Overall Study|Adverse Event|9|||
129896695|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
129896696|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
129896697|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
130058439|NCT00254293|468170336|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129809937|NCT00983437|467271008|FG000|Overall Study|Lack of Efficacy|1|||
129809938|NCT00983437|467271008|FG000|Overall Study|Withdrawal by Subject|8|||
129809939|NCT00983437|467271008|FG000|Overall Study|Noncompliance to Study Procedures|1|||
129809940|NCT00983437|467271008|FG000|Overall Study|Lost to Follow-up|2|||
129809941|NCT00983437|467271008|FG000|Overall Study|Other Reason|26|||
129809942|NCT01543958|467271009|FG000|Overall Study|Loss to follow-up|3|||
129809943|NCT01543958|467271009|FG000|Overall Study|ART initiation|1|||
129809944|NCT04019288|467271010|FG000|Overall Study|Death|1|||
129809945|NCT04019288|467271011|FG001|Overall Study|Death|0|||
129809946|NCT04019288|467271012|FG002|Overall Study|Death|0|||
129809947|NCT01945281|467271013|FG000|Overall Study|Adverse Event|1|||
129809948|NCT01945281|467271014|FG001|Overall Study|Adverse Event|0|||
129809949|NCT01945281|467271013|FG000|Overall Study|Death|3|||
129809950|NCT01945281|467271014|FG001|Overall Study|Death|3|||
129809951|NCT01945281|467271013|FG000|Overall Study|Physician Decision|1|||
129809952|NCT01945281|467271014|FG001|Overall Study|Physician Decision|1|||
129809953|NCT01945281|467271013|FG000|Overall Study|Technical Problems|1|||
129809954|NCT01945281|467271014|FG001|Overall Study|Technical Problems|0|||
129809955|NCT04401423|467271016|FG000|Overall Study|Withdrawal by Subject|3|||
129809956|NCT04401423|467271017|FG001|Overall Study|Withdrawal by Subject|1|||
129809957|NCT04401423|467271016|FG000|Overall Study|Physician Decision|2|||
129809958|NCT04401423|467271017|FG001|Overall Study|Physician Decision|1|||
129809959|NCT01702805|467271018|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
130058440|NCT00254293|468170337|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
129809960|NCT01702805|467271019|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
129809961|NCT01702805|467271018|FG000|Overall Study|Incomplete Follow-up|18|||
129809962|NCT01702805|467271019|FG001|Overall Study|Incomplete Follow-up|15|||
129809963|NCT01702805|467271018|FG000|Overall Study|Vital Status Assessment Only|40|||
129809964|NCT01702805|467271019|FG001|Overall Study|Vital Status Assessment Only|39|||
129809965|NCT01702805|467271018|FG000|Overall Study|Lost to Follow-up|5|||
130058441|NCT00254293|468170338|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129809966|NCT01702805|467271019|FG001|Overall Study|Lost to Follow-up|5|||
129809967|NCT00181155|467271023|FG000|Overall Study|Physician Decision|1|||
129809968|NCT00181155|467271024|FG001|Overall Study|Physician Decision|0|||
129809969|NCT00181155|467271023|FG000|Overall Study|Withdrawal by Subject|1|||
129809970|NCT00181155|467271024|FG001|Overall Study|Withdrawal by Subject|0|||
129809971|NCT01788228|467271025|FG000|Overall Study|Migrated/moved from study area|1|||
129809972|NCT01788228|467271026|FG001|Overall Study|Migrated/moved from study area|0|||
129809973|NCT01548287|467271030|FG000|Screening|No reason provided|0|||
129809974|NCT01548287|467271031|FG001|Screening|No reason provided|0|||
129809975|NCT01548287|467271032|FG002|Screening|No reason provided|0|||
129809976|NCT01548287|467271033|FG003|Screening|No reason provided|0|||
130058442|NCT00254293|468170339|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129809977|NCT01548287|467271034|FG004|Screening|No reason provided|9|||
129809978|NCT01548287|467271030|FG000|Screening|Did not meet eligibility criteria|0|||
129809979|NCT01548287|467271031|FG001|Screening|Did not meet eligibility criteria|0|||
129809980|NCT01548287|467271032|FG002|Screening|Did not meet eligibility criteria|0|||
129809981|NCT01548287|467271033|FG003|Screening|Did not meet eligibility criteria|0|||
129809982|NCT01548287|467271034|FG004|Screening|Did not meet eligibility criteria|74|||
129809983|NCT01548287|467271030|FG000|Randomized Period|Did not meet inclusion criteria|0|||
129809984|NCT01548287|467271031|FG001|Randomized Period|Did not meet inclusion criteria|0|||
129809985|NCT01548287|467271032|FG002|Randomized Period|Did not meet inclusion criteria|2|||
129809986|NCT01548287|467271033|FG003|Randomized Period|Did not meet inclusion criteria|0|||
129809987|NCT01548287|467271034|FG004|Randomized Period|Did not meet inclusion criteria|0|||
129809988|NCT01548287|467271030|FG000|Randomized Period|Adverse Event|0|||
129809989|NCT01548287|467271031|FG001|Randomized Period|Adverse Event|2|||
129809990|NCT01548287|467271032|FG002|Randomized Period|Adverse Event|5|||
129809991|NCT01548287|467271033|FG003|Randomized Period|Adverse Event|0|||
129809992|NCT01548287|467271034|FG004|Randomized Period|Adverse Event|0|||
129809993|NCT02762578|467271035|FG000|Overall Study|Adverse Event|1|||
129809994|NCT02762578|467271036|FG001|Overall Study|Adverse Event|6|||
129809995|NCT02762578|467271035|FG000|Overall Study|Protocol Violation|4|||
129809996|NCT02762578|467271036|FG001|Overall Study|Protocol Violation|2|||
129809997|NCT02762578|467271035|FG000|Overall Study|Withdrawal by Subject|4|||
129809998|NCT02762578|467271036|FG001|Overall Study|Withdrawal by Subject|2|||
129809999|NCT02762578|467271035|FG000|Overall Study|Unclassified|6|||
129810000|NCT02762578|467271036|FG001|Overall Study|Unclassified|0|||
129810001|NCT00259610|467271037|FG000|Overall Study|Withdrawal by Subject|33|||
129810002|NCT00259610|467271038|FG001|Overall Study|Withdrawal by Subject|25|||
129810003|NCT00259610|467271039|FG002|Overall Study|Withdrawal by Subject|29|||
129810004|NCT00259610|467271040|FG003|Overall Study|Withdrawal by Subject|19|||
129810005|NCT00259610|467271037|FG000|Overall Study|Lost to Follow-up|19|||
129810006|NCT00259610|467271038|FG001|Overall Study|Lost to Follow-up|8|||
129810007|NCT00259610|467271039|FG002|Overall Study|Lost to Follow-up|18|||
129810008|NCT00259610|467271040|FG003|Overall Study|Lost to Follow-up|15|||
129810009|NCT00259610|467271037|FG000|Overall Study|Physician Decision|6|||
129810010|NCT00259610|467271038|FG001|Overall Study|Physician Decision|4|||
129810011|NCT00259610|467271039|FG002|Overall Study|Physician Decision|7|||
129810012|NCT00259610|467271040|FG003|Overall Study|Physician Decision|2|||
129810013|NCT00259610|467271037|FG000|Overall Study|Death|1|||
130058443|NCT00254293|468170340|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130058444|NCT00254293|468170341|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
130058445|NCT00254293|468170335|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130058446|NCT00254293|468170336|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130058447|NCT00254293|468170337|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
129810014|NCT00259610|467271038|FG001|Overall Study|Death|1|||
129810015|NCT00259610|467271039|FG002|Overall Study|Death|2|||
129810016|NCT00259610|467271040|FG003|Overall Study|Death|0|||
129810017|NCT00259610|467271037|FG000|Overall Study|non medical reason|6|||
129810018|NCT00259610|467271038|FG001|Overall Study|non medical reason|2|||
129810019|NCT00259610|467271039|FG002|Overall Study|non medical reason|10|||
129810020|NCT00259610|467271040|FG003|Overall Study|non medical reason|3|||
129810021|NCT00259610|467271037|FG000|Overall Study|Adverse Event|3|||
129810022|NCT00259610|467271038|FG001|Overall Study|Adverse Event|4|||
129810023|NCT00259610|467271039|FG002|Overall Study|Adverse Event|5|||
129810024|NCT00259610|467271040|FG003|Overall Study|Adverse Event|2|||
129810025|NCT00259610|467271037|FG000|Overall Study|Serious Adverse Event|8|||
129810026|NCT00259610|467271038|FG001|Overall Study|Serious Adverse Event|2|||
129810027|NCT00259610|467271039|FG002|Overall Study|Serious Adverse Event|2|||
129810028|NCT00259610|467271040|FG003|Overall Study|Serious Adverse Event|2|||
129810029|NCT01611155|467271043|FG000|Overall Study|Adverse Event|1|||
129810030|NCT01611155|467271044|FG001|Overall Study|Adverse Event|1|||
129810031|NCT01611155|467271043|FG000|Overall Study|Refused further treatment|6|||
129810032|NCT01611155|467271044|FG001|Overall Study|Refused further treatment|4|||
129810033|NCT01611155|467271043|FG000|Overall Study|Disease progression|1|||
129810034|NCT01611155|467271044|FG001|Overall Study|Disease progression|0|||
129810035|NCT01611155|467271043|FG000|Overall Study|Withdrawal by Subject|1|||
129810036|NCT01611155|467271044|FG001|Overall Study|Withdrawal by Subject|0|||
129810037|NCT01611155|467271043|FG000|Overall Study|Alternative treatment|0|||
129810038|NCT01611155|467271044|FG001|Overall Study|Alternative treatment|1|||
129810039|NCT01611155|467271043|FG000|Overall Study|Ineligible patient|0|||
129810040|NCT01611155|467271044|FG001|Overall Study|Ineligible patient|1|||
129810041|NCT02699593|467271045|FG000|Period 1|Unsatisfactory Visual Response|0|||
129810042|NCT02699593|467271046|FG001|Period 1|Unsatisfactory Visual Response|1|||
129810043|NCT02699593|467271045|FG000|Period 1|Torn Contact Len|4|||
129810044|NCT02699593|467271046|FG001|Period 1|Torn Contact Len|3|||
129810045|NCT02699593|467271045|FG000|Period 1|Protocol Violation|0|||
129810046|NCT02699593|467271046|FG001|Period 1|Protocol Violation|1|||
129810047|NCT02699593|467271045|FG000|Period 1|Withdrawal by Subject|0|||
129810048|NCT02699593|467271046|FG001|Period 1|Withdrawal by Subject|1|||
129810049|NCT02699593|467271045|FG000|Period 1|Adverse Event|1|||
129810050|NCT02699593|467271046|FG001|Period 1|Adverse Event|1|||
129810051|NCT02699593|467271045|FG000|Period 2|Adverse Event|1|||
129810052|NCT02699593|467271046|FG001|Period 2|Adverse Event|1|||
129810053|NCT02699593|467271045|FG000|Period 2|Lost Contact Lens|0|||
129810054|NCT02699593|467271046|FG001|Period 2|Lost Contact Lens|1|||
129810055|NCT02699593|467271045|FG000|Period 2|Torn Contact Lens|1|||
129810056|NCT02699593|467271046|FG001|Period 2|Torn Contact Lens|0|||
129810057|NCT00868608|467271047|FG000|Overall Study|Withdrawal by Subject|3|||
129810058|NCT00868608|467271048|FG001|Overall Study|Withdrawal by Subject|1|||
129810059|NCT00868608|467271049|FG002|Overall Study|Withdrawal by Subject|0|||
129810060|NCT00868608|467271047|FG000|Overall Study|Lost to Follow-up|3|||
129810061|NCT00868608|467271048|FG001|Overall Study|Lost to Follow-up|0|||
129810062|NCT00868608|467271049|FG002|Overall Study|Lost to Follow-up|1|||
129810063|NCT00868608|467271047|FG000|Overall Study|Death|16|||
129810064|NCT00868608|467271048|FG001|Overall Study|Death|2|||
129810065|NCT00868608|467271049|FG002|Overall Study|Death|4|||
129810066|NCT00868608|467271047|FG000|Overall Study|Other - Unspecified|1|||
129810067|NCT00868608|467271048|FG001|Overall Study|Other - Unspecified|0|||
129810068|NCT00868608|467271049|FG002|Overall Study|Other - Unspecified|0|||
129810069|NCT03344796|467271050|FG000|Overall Study|Lost to Follow-up|0|||
129810070|NCT03344796|467271051|FG001|Overall Study|Lost to Follow-up|0|||
129810071|NCT03344796|467271052|FG002|Overall Study|Lost to Follow-up|0|||
129810072|NCT03344796|467271053|FG003|Overall Study|Lost to Follow-up|0|||
129810073|NCT03344796|467271054|FG004|Overall Study|Lost to Follow-up|0|||
129810074|NCT03344796|467271055|FG005|Overall Study|Lost to Follow-up|2|||
129810075|NCT02564796|467271058|FG000|Overall Study|Physician Decision|2|||
129810076|NCT02564796|467271059|FG001|Overall Study|Physician Decision|2|||
129810077|NCT00453063|467271060|FG000|Overall Study|Adverse Event|1|||
129810078|NCT00453063|467271061|FG001|Overall Study|Adverse Event|2|||
129810079|NCT00453063|467271060|FG000|Overall Study|Withdrawal by Subject|1|||
129810080|NCT00453063|467271061|FG001|Overall Study|Withdrawal by Subject|1|||
130058448|NCT00254293|468170338|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129810081|NCT00453063|467271060|FG000|Overall Study|Protocol Violation|1|||
129810082|NCT00453063|467271061|FG001|Overall Study|Protocol Violation|0|||
129810083|NCT00289783|467271062|FG000|Primary Phase|Adverse Event|10|||
129810084|NCT00289783|467271063|FG001|Primary Phase|Adverse Event|1|||
129810085|NCT00289783|467271062|FG000|Primary Phase|Protocol Violation|27|||
129810086|NCT00289783|467271063|FG001|Primary Phase|Protocol Violation|6|||
129810087|NCT00289783|467271062|FG000|Primary Phase|Withdrawal by Subject|93|||
129810088|NCT00289783|467271063|FG001|Primary Phase|Withdrawal by Subject|40|||
130058449|NCT00254293|468170339|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129810089|NCT00289783|467271062|FG000|Primary Phase|Lost to Follow-up|60|||
129810090|NCT00289783|467271063|FG001|Primary Phase|Lost to Follow-up|14|||
129810091|NCT00289783|467271062|FG000|Primary Phase|Migration from the study area|26|||
129896698|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
129896699|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
129896700|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
129896701|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
129896702|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
129896703|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Non-compliance|4|||
129896704|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Non-compliance|0|||
129810092|NCT00289783|467271063|FG001|Primary Phase|Migration from the study area|10|||
129810093|NCT00289783|467271062|FG000|Primary Phase|Other|32|||
129810094|NCT00289783|467271063|FG001|Primary Phase|Other|12|||
129810095|NCT00289783|467271062|FG000|Fourth Dose Phase|Adverse Event|1|||
129810096|NCT00289783|467271063|FG001|Fourth Dose Phase|Adverse Event|0|||
129810097|NCT00289783|467271062|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
129810098|NCT00289783|467271063|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
129810099|NCT00289783|467271062|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
129810100|NCT00289783|467271063|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
129810101|NCT00289783|467271062|FG000|Fourth Dose Phase|Migration from the study area|1|||
129810102|NCT00289783|467271063|FG001|Fourth Dose Phase|Migration from the study area|1|||
129810103|NCT00289783|467271062|FG000|Fourth Dose Phase|Other|22|||
129810104|NCT00289783|467271063|FG001|Fourth Dose Phase|Other|10|||
129810105|NCT00566995|467271066|FG000|Overall Study|Toxicity|4|||
129810106|NCT00566995|467271066|FG000|Overall Study|Withdrew consent|3|||
129810107|NCT03298867|467271076|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
129810108|NCT03298867|467271077|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
129810109|NCT03298867|467271076|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
129810110|NCT03298867|467271077|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
129810111|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
129810112|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
129810113|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
129810114|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
129810115|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
129810116|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
129810117|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
129810118|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
129810119|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
129810120|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
129810121|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
129810122|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
129810123|NCT03298867|467271076|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
129810124|NCT03298867|467271077|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
129810125|NCT00228384|467271078|FG000|Overall Study|Death|9|||
129810126|NCT00228384|467271079|FG001|Overall Study|Death|3|||
129810127|NCT00228384|467271078|FG000|Overall Study|Lost to Follow-up|6|||
129810128|NCT00228384|467271079|FG001|Overall Study|Lost to Follow-up|10|||
129810129|NCT00228384|467271078|FG000|Overall Study|Surgical Intervention (bypass)|5|||
129810130|NCT00228384|467271079|FG001|Overall Study|Surgical Intervention (bypass)|5|||
129810131|NCT00228384|467271078|FG000|Overall Study|Withdrawal by Subject|9|||
129810132|NCT00228384|467271079|FG001|Overall Study|Withdrawal by Subject|10|||
129810133|NCT00228384|467271078|FG000|Overall Study|Physician Decision|0|||
129810134|NCT00228384|467271079|FG001|Overall Study|Physician Decision|1|||
129810135|NCT01785069|467271081|FG000|Overall Study|Implanted with nonstudy device|1|||
129810136|NCT01785069|467271082|FG001|Overall Study|Implanted with nonstudy device|2|||
129810137|NCT01785069|467271083|FG002|Overall Study|Implanted with nonstudy device|1|||
129810138|NCT01785069|467271084|FG003|Overall Study|Implanted with nonstudy device|0|||
129810139|NCT01785069|467271081|FG000|Overall Study|Death|0|||
129810140|NCT01785069|467271082|FG001|Overall Study|Death|0|||
129810141|NCT01785069|467271083|FG002|Overall Study|Death|2|||
129810142|NCT01785069|467271084|FG003|Overall Study|Death|0|||
129810143|NCT01785069|467271081|FG000|Overall Study|Subject choice|2|||
129810144|NCT01785069|467271082|FG001|Overall Study|Subject choice|2|||
129810145|NCT01785069|467271083|FG002|Overall Study|Subject choice|0|||
129810146|NCT01785069|467271084|FG003|Overall Study|Subject choice|1|||
129810147|NCT01785069|467271081|FG000|Overall Study|Lost to Follow-up|1|||
129810148|NCT01785069|467271082|FG001|Overall Study|Lost to Follow-up|2|||
129810149|NCT01785069|467271083|FG002|Overall Study|Lost to Follow-up|4|||
129810150|NCT01785069|467271084|FG003|Overall Study|Lost to Follow-up|1|||
129810151|NCT01785069|467271081|FG000|Overall Study|Reason not Specified|1|||
129810152|NCT01785069|467271082|FG001|Overall Study|Reason not Specified|2|||
129810153|NCT01785069|467271083|FG002|Overall Study|Reason not Specified|1|||
129810154|NCT01785069|467271084|FG003|Overall Study|Reason not Specified|4|||
129810155|NCT01785069|467271081|FG000|Overall Study|Not evaluable|7|||
129810156|NCT01785069|467271082|FG001|Overall Study|Not evaluable|4|||
129810157|NCT01785069|467271083|FG002|Overall Study|Not evaluable|5|||
129810158|NCT01785069|467271084|FG003|Overall Study|Not evaluable|8|||
129810159|NCT05358444|467271093|FG000|Overall Study|Withdrawal by Subject|0|||
129810160|NCT05358444|467271094|FG001|Overall Study|Withdrawal by Subject|1|||
129810161|NCT05358444|467271093|FG000|Overall Study|Lost to Follow-up|0|||
129810162|NCT05358444|467271094|FG001|Overall Study|Lost to Follow-up|3|||
129810163|NCT04997304|467271097|FG000|Overall Study|Lost to Follow-up|11|||
129810164|NCT04997304|467271097|FG000|Overall Study|Death|1|||
129810165|NCT04997304|467271097|FG000|Overall Study|Withdrawal by Subject|14|||
129810166|NCT01453361|467271098|FG000|Overall Study|Disease Progression|6|||
129810167|NCT01453361|467271098|FG000|Overall Study|Screen-Failures|10|||
129810168|NCT02323113|467273147|FG000|Overall Study|Adverse Event|3|||
129810169|NCT02323113|467273148|FG001|Overall Study|Adverse Event|3|||
129810170|NCT02323113|467273149|FG002|Overall Study|Adverse Event|2|||
129810171|NCT02323113|467273150|FG003|Overall Study|Adverse Event|5|||
129810172|NCT02323113|467273151|FG004|Overall Study|Adverse Event|8|||
129810173|NCT02323113|467273152|FG005|Overall Study|Adverse Event|3|||
129810174|NCT02323113|467273153|FG006|Overall Study|Adverse Event|6|||
129810175|NCT02323113|467273154|FG007|Overall Study|Adverse Event|0|||
129810176|NCT02323113|467273147|FG000|Overall Study|Progressive Disease|0|||
129810177|NCT02323113|467273148|FG001|Overall Study|Progressive Disease|1|||
129810178|NCT02323113|467273149|FG002|Overall Study|Progressive Disease|1|||
129810179|NCT02323113|467273150|FG003|Overall Study|Progressive Disease|0|||
129810180|NCT02323113|467273151|FG004|Overall Study|Progressive Disease|0|||
129810181|NCT02323113|467273152|FG005|Overall Study|Progressive Disease|3|||
129810182|NCT02323113|467273153|FG006|Overall Study|Progressive Disease|0|||
129810183|NCT02323113|467273154|FG007|Overall Study|Progressive Disease|0|||
129810184|NCT02323113|467273147|FG000|Overall Study|Symptomatic Deterioration|0|||
129810185|NCT02323113|467273148|FG001|Overall Study|Symptomatic Deterioration|0|||
129810186|NCT02323113|467273149|FG002|Overall Study|Symptomatic Deterioration|1|||
129810187|NCT02323113|467273150|FG003|Overall Study|Symptomatic Deterioration|0|||
129810188|NCT02323113|467273151|FG004|Overall Study|Symptomatic Deterioration|1|||
129810189|NCT02323113|467273152|FG005|Overall Study|Symptomatic Deterioration|0|||
129810190|NCT02323113|467273153|FG006|Overall Study|Symptomatic Deterioration|0|||
129896705|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Non-compliance|0|||
129896706|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Non-compliance|0|||
129896707|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Pain|4|||
129896708|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Pain|0|||
129896709|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Pain|0|||
129896710|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Pain|0|||
129896711|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
130094770|NCT02441517|468302492|FG000|Overall Study|Study Terminated by Sponsor|1|||
130112357|NCT00738920|468371151|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
130058450|NCT00254293|468170340|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130058451|NCT00254293|468170341|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
130058452|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Death|0|||
130058453|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Death|0|||
130058454|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Death|1|||
130058455|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Death|0|||
130058456|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Death|0|||
130058457|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Death|0|||
130058458|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Death|0|||
130112358|NCT00738920|468371152|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
130058459|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
130058460|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130058461|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
130058462|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130058463|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
130058464|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
130058465|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
129810191|NCT02323113|467273154|FG007|Overall Study|Symptomatic Deterioration|0|||
129810192|NCT02323113|467273147|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
129810193|NCT02323113|467273148|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
129810194|NCT02323113|467273149|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810195|NCT02323113|467273150|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810196|NCT02323113|467273151|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810197|NCT02323113|467273152|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
129810198|NCT02323113|467273153|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810199|NCT02323113|467273154|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810200|NCT02323113|467273147|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810201|NCT02323113|467273148|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
129810202|NCT02323113|467273149|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810203|NCT02323113|467273150|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810204|NCT02323113|467273151|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129896712|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
129896713|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
129896714|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
129896715|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Hospice care|1|||
129896716|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Hospice care|0|||
129896717|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Hospice care|0|||
129896718|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Hospice care|0|||
129896719|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Physician Decision|1|||
129896720|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Physician Decision|0|||
129896721|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Physician Decision|0|||
129810205|NCT02323113|467273152|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810206|NCT02323113|467273153|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810207|NCT02323113|467273154|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810208|NCT01663532|467273155|FG000|Overall Study|Lost to Follow-up|9|||
129810209|NCT01663532|467273156|FG001|Overall Study|Lost to Follow-up|10|||
129810210|NCT01663532|467273155|FG000|Overall Study|Adverse Event|7|||
129810211|NCT01663532|467273156|FG001|Overall Study|Adverse Event|13|||
129810212|NCT01663532|467273155|FG000|Overall Study|Met Withdrawal Criteria|7|||
129810213|NCT01663532|467273156|FG001|Overall Study|Met Withdrawal Criteria|6|||
129810214|NCT01663532|467273155|FG000|Overall Study|Physician Decision|1|||
129810215|NCT01663532|467273156|FG001|Overall Study|Physician Decision|1|||
129810216|NCT01663532|467273155|FG000|Overall Study|Withdrawal by Subject|35|||
129810217|NCT01663532|467273156|FG001|Overall Study|Withdrawal by Subject|17|||
129810218|NCT01663532|467273155|FG000|Overall Study|Lack of Efficacy|15|||
129810219|NCT01663532|467273156|FG001|Overall Study|Lack of Efficacy|60|||
129810220|NCT03539081|467273161|FG000|Overall Study|Withdrawal by Subject|2|||
129810221|NCT03539081|467273162|FG001|Overall Study|Withdrawal by Subject|3|||
129810222|NCT03539081|467273163|FG002|Overall Study|Withdrawal by Subject|0|||
129810223|NCT03539081|467273161|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
129810224|NCT03539081|467273162|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
129810225|NCT03539081|467273163|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
129810226|NCT00799383|467273168|FG000|Overall Study|Protocol Violation|1|||
129810227|NCT00799383|467273169|FG001|Overall Study|Protocol Violation|1|||
129810228|NCT00799383|467273168|FG000|Overall Study|Adverse Event|0|||
129810229|NCT00799383|467273169|FG001|Overall Study|Adverse Event|1|||
129810230|NCT00799383|467273168|FG000|Overall Study|Lost to Follow-up|1|||
129810231|NCT00799383|467273169|FG001|Overall Study|Lost to Follow-up|2|||
129810232|NCT00799383|467273168|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
129810233|NCT00799383|467273169|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
129810234|NCT00799383|467273168|FG000|Overall Study|Withdrawal by Subject|0|||
129810235|NCT00799383|467273169|FG001|Overall Study|Withdrawal by Subject|1|||
129810236|NCT02165215|467273181|FG000|Induction Phase|Adverse Event|1|||
129810237|NCT02165215|467273182|FG001|Induction Phase|Adverse Event|0|||
129810238|NCT02165215|467273183|FG002|Induction Phase|Adverse Event|0|||
129810239|NCT02165215|467273181|FG000|Induction Phase|Withdrawal by Subject|10|||
129810240|NCT02165215|467273182|FG001|Induction Phase|Withdrawal by Subject|0|||
129810241|NCT02165215|467273183|FG002|Induction Phase|Withdrawal by Subject|0|||
129810242|NCT02165215|467273181|FG000|Induction Phase|Protocol Violation|1|||
129810243|NCT02165215|467273182|FG001|Induction Phase|Protocol Violation|0|||
129896722|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Physician Decision|0|||
129810244|NCT02165215|467273183|FG002|Induction Phase|Protocol Violation|0|||
129896723|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
129896724|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
129896725|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
129896726|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
129896727|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
130058466|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
130058467|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
129896728|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
130058468|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
130058469|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
129810245|NCT02165215|467273181|FG000|Induction Phase|Physician Decision|1|||
129810246|NCT02165215|467273182|FG001|Induction Phase|Physician Decision|0|||
129810247|NCT02165215|467273183|FG002|Induction Phase|Physician Decision|0|||
129810248|NCT02165215|467273181|FG000|Induction Phase|Lack of Efficacy|2|||
129810249|NCT02165215|467273182|FG001|Induction Phase|Lack of Efficacy|0|||
129810250|NCT02165215|467273183|FG002|Induction Phase|Lack of Efficacy|0|||
129810251|NCT02165215|467273181|FG000|Induction Phase|Non-Compliance|2|||
129810252|NCT02165215|467273182|FG001|Induction Phase|Non-Compliance|0|||
129896729|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
129896730|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
129896731|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
129896732|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
129896733|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
129896734|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
129896735|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Death|0|||
129896736|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Death|8|||
129896737|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Death|2|||
129896738|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Death|13|||
129896739|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
129896740|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
129896741|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
129896742|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
129896743|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
129896744|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
129896745|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
129896746|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
129896747|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
129896748|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
129896749|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
129896750|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
129896751|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
129896752|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
129896753|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
129896754|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
129896755|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
129896756|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
129810253|NCT02165215|467273183|FG002|Induction Phase|Non-Compliance|0|||
129810254|NCT02165215|467273181|FG000|Induction Phase|Lost to Follow-up|6|||
129810255|NCT02165215|467273182|FG001|Induction Phase|Lost to Follow-up|0|||
129896757|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
130058470|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
129810256|NCT02165215|467273183|FG002|Induction Phase|Lost to Follow-up|0|||
129810257|NCT02165215|467273181|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129896758|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
129896759|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
129810258|NCT02165215|467273182|FG001|Maintenance Phase|Withdrawal by Subject|7|||
129810259|NCT02165215|467273183|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129810260|NCT02165215|467273181|FG000|Maintenance Phase|Multiple reasons|0|||
129810261|NCT02165215|467273182|FG001|Maintenance Phase|Multiple reasons|2|||
129810262|NCT02165215|467273183|FG002|Maintenance Phase|Multiple reasons|1|||
129810263|NCT02165215|467273181|FG000|Maintenance Phase|Lost to Follow-up|0|||
129810264|NCT02165215|467273182|FG001|Maintenance Phase|Lost to Follow-up|2|||
129810265|NCT02165215|467273183|FG002|Maintenance Phase|Lost to Follow-up|0|||
129810266|NCT02165215|467273181|FG000|Maintenance Phase|Adverse Event|0|||
129810267|NCT02165215|467273182|FG001|Maintenance Phase|Adverse Event|1|||
129810268|NCT02165215|467273183|FG002|Maintenance Phase|Adverse Event|1|||
129810269|NCT00612040|467273184|FG000|Overall Study|Adverse Event|0|||
129810270|NCT00612040|467273185|FG001|Overall Study|Adverse Event|2|||
130058471|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
130058472|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
130058473|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130058474|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130058475|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
130058476|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130058477|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130058478|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
130058479|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129810271|NCT00612040|467273186|FG002|Overall Study|Adverse Event|1|||
129810272|NCT00612040|467273184|FG000|Overall Study|Protocol Violation|1|||
129810273|NCT00612040|467273185|FG001|Overall Study|Protocol Violation|2|||
129810274|NCT00612040|467273186|FG002|Overall Study|Protocol Violation|1|||
129810275|NCT00612040|467273184|FG000|Overall Study|Lack of Efficacy|2|||
129810276|NCT00612040|467273185|FG001|Overall Study|Lack of Efficacy|1|||
129810277|NCT00612040|467273186|FG002|Overall Study|Lack of Efficacy|0|||
129810278|NCT00612040|467273184|FG000|Overall Study|Unclassified|2|||
129896760|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
129896761|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
129896762|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
129896763|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
129810279|NCT00612040|467273185|FG001|Overall Study|Unclassified|2|||
129810280|NCT00612040|467273186|FG002|Overall Study|Unclassified|5|||
129810281|NCT02021331|467273187|FG000|Overall Study|Adverse Event|0|||
129810282|NCT02021331|467273188|FG001|Overall Study|Adverse Event|2|||
129810283|NCT00319553|467273191|FG000|Overall Study|Protocol Violation|1|||
129810284|NCT00319553|467273192|FG001|Overall Study|Protocol Violation|2|||
129810285|NCT00319553|467273191|FG000|Overall Study|Lost to Follow-up|2|||
129810286|NCT00319553|467273192|FG001|Overall Study|Lost to Follow-up|1|||
129810287|NCT00319553|467273191|FG000|Overall Study|Withdrawal by Subject|1|||
129810288|NCT00319553|467273192|FG001|Overall Study|Withdrawal by Subject|1|||
129810289|NCT01896102|467273193|FG000|Overall Study|Death|1|||
129810290|NCT01896102|467273193|FG000|Overall Study|Participant to receive allogenic transplant|2|||
129810291|NCT01281865|467273202|FG000|Overall Study|Adverse Event|1|||
129810292|NCT01281865|467273203|FG001|Overall Study|Adverse Event|1|||
129810293|NCT01281865|467273202|FG000|Overall Study|Withdrawal by Subject|1|||
129810294|NCT01281865|467273203|FG001|Overall Study|Withdrawal by Subject|0|||
129810295|NCT01281865|467273202|FG000|Overall Study|Lack of Efficacy|1|||
129810296|NCT01281865|467273203|FG001|Overall Study|Lack of Efficacy|0|||
129896764|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
129896765|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
129810297|NCT02747875|467273204|FG000|Overall Study|Physician Decision|1|||
129810298|NCT02747875|467273205|FG001|Overall Study|Physician Decision|0|||
129810299|NCT02747875|467273204|FG000|Overall Study|Adverse Event|0|||
130058480|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130058481|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129896766|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
129810300|NCT02747875|467273205|FG001|Overall Study|Adverse Event|1|||
129810301|NCT03478657|467273206|FG000|Overall Study|Withdrawal by Subject|0|||
130058482|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
130058483|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130058484|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130058485|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129810302|NCT03478657|467273207|FG001|Overall Study|Withdrawal by Subject|1|||
129810303|NCT02590003|467273208|FG000|Overall Study|Death|1|||
129810304|NCT02590003|467273209|FG001|Overall Study|Death|2|||
129810305|NCT01849783|467273211|FG000|Overall Study|Adverse Event|5|||
129810306|NCT01849783|467273211|FG000|Overall Study|Death|2|||
129810307|NCT01849783|467273211|FG000|Overall Study|Physician Decision|1|||
129810308|NCT01849783|467273211|FG000|Overall Study|Withdrawal by Subject|1|||
129810309|NCT01849783|467273211|FG000|Overall Study|Unable to comply|2|||
129810310|NCT01849783|467273211|FG000|Overall Study|Disease progression|11|||
129810311|NCT03948581|467273212|FG000|Overall Study|Lost to Follow-up|0|||
129810312|NCT03948581|467273213|FG001|Overall Study|Lost to Follow-up|1|||
129810313|NCT04457336|467273216|FG000|Period 2: Part A|Withdrawal by Subject|0|||
129810314|NCT04457336|467273217|FG001|Period 2: Part A|Withdrawal by Subject|1|||
129810315|NCT04457336|467273218|FG002|Period 2: Part A|Withdrawal by Subject|1|||
129810316|NCT04457336|467273219|FG003|Period 2: Part A|Withdrawal by Subject|1|||
129810317|NCT04457336|467273220|FG004|Period 2: Part A|Withdrawal by Subject|0|||
129810318|NCT04457336|467273221|FG005|Period 2: Part A|Withdrawal by Subject|0|||
129810319|NCT04457336|467273222|FG006|Period 2: Part A|Withdrawal by Subject|0|||
129810320|NCT04457336|467273223|FG007|Period 2: Part A|Withdrawal by Subject|0|||
129810321|NCT04457336|467273216|FG000|Period 2: Part A|Adverse Event|0|||
129810322|NCT04457336|467273217|FG001|Period 2: Part A|Adverse Event|0|||
129810323|NCT04457336|467273218|FG002|Period 2: Part A|Adverse Event|1|||
129810324|NCT04457336|467273219|FG003|Period 2: Part A|Adverse Event|1|||
129810325|NCT04457336|467273220|FG004|Period 2: Part A|Adverse Event|0|||
129810326|NCT04457336|467273221|FG005|Period 2: Part A|Adverse Event|0|||
129810327|NCT04457336|467273222|FG006|Period 2: Part A|Adverse Event|0|||
129810328|NCT04457336|467273223|FG007|Period 2: Part A|Adverse Event|0|||
129810329|NCT04457336|467273216|FG000|Period 2: Part A|Study Terminated|0|||
129810330|NCT04457336|467273217|FG001|Period 2: Part A|Study Terminated|0|||
129810331|NCT04457336|467273218|FG002|Period 2: Part A|Study Terminated|1|||
129810332|NCT04457336|467273219|FG003|Period 2: Part A|Study Terminated|0|||
129810333|NCT04457336|467273220|FG004|Period 2: Part A|Study Terminated|0|||
129810334|NCT04457336|467273221|FG005|Period 2: Part A|Study Terminated|0|||
129810335|NCT04457336|467273222|FG006|Period 2: Part A|Study Terminated|0|||
129810336|NCT04457336|467273223|FG007|Period 2: Part A|Study Terminated|0|||
129810337|NCT04457336|467273216|FG000|Period 2: Part A|Protocol Violation|0|||
130058486|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
130058487|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130058488|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130058489|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
129810338|NCT04457336|467273217|FG001|Period 2: Part A|Protocol Violation|1|||
129810339|NCT04457336|467273218|FG002|Period 2: Part A|Protocol Violation|0|||
129810340|NCT04457336|467273219|FG003|Period 2: Part A|Protocol Violation|0|||
129810341|NCT04457336|467273220|FG004|Period 2: Part A|Protocol Violation|0|||
130058490|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130058491|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129810342|NCT04457336|467273221|FG005|Period 2: Part A|Protocol Violation|0|||
129810343|NCT04457336|467273222|FG006|Period 2: Part A|Protocol Violation|0|||
129810344|NCT04457336|467273223|FG007|Period 2: Part A|Protocol Violation|0|||
129810345|NCT04457336|467273216|FG000|Period 2: Part A|Lost to Follow-up|0|||
129810346|NCT04457336|467273217|FG001|Period 2: Part A|Lost to Follow-up|1|||
129810347|NCT04457336|467273218|FG002|Period 2: Part A|Lost to Follow-up|0|||
129810348|NCT04457336|467273219|FG003|Period 2: Part A|Lost to Follow-up|0|||
130112359|NCT00738920|468371153|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
130058492|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130058493|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
130058494|NCT00254293|468170335|FG000|LTE Open Label Variable SC Dosing|Other|0|||
130058495|NCT00254293|468170336|FG001|LTE Open Label Variable SC Dosing|Other|0|||
130058496|NCT00254293|468170337|FG002|LTE Open Label Variable SC Dosing|Other|2|||
130058497|NCT00254293|468170338|FG003|LTE Open Label Variable SC Dosing|Other|0|||
129810349|NCT04457336|467273220|FG004|Period 2: Part A|Lost to Follow-up|0|||
130058498|NCT00254293|468170339|FG004|LTE Open Label Variable SC Dosing|Other|0|||
130058499|NCT00254293|468170340|FG005|LTE Open Label Variable SC Dosing|Other|0|||
130094771|NCT01018680|468303839|FG000|Overall Study|Adverse Event|23|||
129810350|NCT04457336|467273221|FG005|Period 2: Part A|Lost to Follow-up|0|||
129810351|NCT04457336|467273222|FG006|Period 2: Part A|Lost to Follow-up|0|||
129810352|NCT04457336|467273223|FG007|Period 2: Part A|Lost to Follow-up|0|||
129810353|NCT04457336|467273216|FG000|Period 2: Part A|Other|0|||
129810354|NCT04457336|467273217|FG001|Period 2: Part A|Other|1|||
129810355|NCT04457336|467273218|FG002|Period 2: Part A|Other|0|||
129810356|NCT04457336|467273219|FG003|Period 2: Part A|Other|0|||
129810357|NCT04457336|467273220|FG004|Period 2: Part A|Other|0|||
129810358|NCT04457336|467273221|FG005|Period 2: Part A|Other|0|||
129810359|NCT04457336|467273222|FG006|Period 2: Part A|Other|0|||
129810360|NCT04457336|467273223|FG007|Period 2: Part A|Other|0|||
129810361|NCT04457336|467273216|FG000|Period 2: Part A|Physician Decision|0|||
129810362|NCT04457336|467273217|FG001|Period 2: Part A|Physician Decision|0|||
129810363|NCT04457336|467273218|FG002|Period 2: Part A|Physician Decision|0|||
129810364|NCT04457336|467273219|FG003|Period 2: Part A|Physician Decision|1|||
129810365|NCT04457336|467273220|FG004|Period 2: Part A|Physician Decision|0|||
129810366|NCT04457336|467273221|FG005|Period 2: Part A|Physician Decision|0|||
129810367|NCT04457336|467273222|FG006|Period 2: Part A|Physician Decision|0|||
129810368|NCT04457336|467273223|FG007|Period 2: Part A|Physician Decision|0|||
129810369|NCT04457336|467273216|FG000|Period 3: Part B|Study Terminated|0|||
129810370|NCT04457336|467273217|FG001|Period 3: Part B|Study Terminated|0|||
129810371|NCT04457336|467273218|FG002|Period 3: Part B|Study Terminated|0|||
129810372|NCT04457336|467273219|FG003|Period 3: Part B|Study Terminated|0|||
129810373|NCT04457336|467273220|FG004|Period 3: Part B|Study Terminated|1|||
129810374|NCT04457336|467273221|FG005|Period 3: Part B|Study Terminated|10|||
129810375|NCT04457336|467273222|FG006|Period 3: Part B|Study Terminated|13|||
129810376|NCT04457336|467273223|FG007|Period 3: Part B|Study Terminated|0|||
129810377|NCT04457336|467273216|FG000|Period 3: Part B|Withdrawal by Subject|0|||
129810378|NCT04457336|467273217|FG001|Period 3: Part B|Withdrawal by Subject|0|||
129810379|NCT04457336|467273218|FG002|Period 3: Part B|Withdrawal by Subject|0|||
129810380|NCT04457336|467273219|FG003|Period 3: Part B|Withdrawal by Subject|0|||
129810381|NCT04457336|467273220|FG004|Period 3: Part B|Withdrawal by Subject|0|||
129810382|NCT04457336|467273221|FG005|Period 3: Part B|Withdrawal by Subject|1|||
130058500|NCT00254293|468170341|FG006|LTE Open Label Variable SC Dosing|Other|0|||
129810383|NCT04457336|467273222|FG006|Period 3: Part B|Withdrawal by Subject|2|||
129810384|NCT04457336|467273223|FG007|Period 3: Part B|Withdrawal by Subject|0|||
129896767|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
129896768|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
129896769|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
129896770|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
129896771|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
129896772|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
129896773|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
129896774|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
130058501|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Death|0|||
130058502|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Death|0|||
130058503|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Death|0|||
130058504|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Death|0|||
130058505|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Death|0|||
130058506|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Death|0|||
130058507|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Death|3|||
130058508|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
130058509|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
130058510|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
129896775|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
130058511|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
130058512|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
130058513|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
129810385|NCT04457336|467273216|FG000|Period 4: Part C|Study Terminated|0|||
129810386|NCT04457336|467273217|FG001|Period 4: Part C|Study Terminated|0|||
129810387|NCT04457336|467273218|FG002|Period 4: Part C|Study Terminated|0|||
129810388|NCT04457336|467273219|FG003|Period 4: Part C|Study Terminated|0|||
129810389|NCT04457336|467273220|FG004|Period 4: Part C|Study Terminated|0|||
129810390|NCT04457336|467273221|FG005|Period 4: Part C|Study Terminated|0|||
129810391|NCT04457336|467273222|FG006|Period 4: Part C|Study Terminated|0|||
129810392|NCT04457336|467273223|FG007|Period 4: Part C|Study Terminated|30|||
129810393|NCT04457336|467273216|FG000|Period 4: Part C|Adverse Event|0|||
129810394|NCT04457336|467273217|FG001|Period 4: Part C|Adverse Event|0|||
129810395|NCT04457336|467273218|FG002|Period 4: Part C|Adverse Event|0|||
129810396|NCT04457336|467273219|FG003|Period 4: Part C|Adverse Event|0|||
129810397|NCT04457336|467273220|FG004|Period 4: Part C|Adverse Event|0|||
129810398|NCT04457336|467273221|FG005|Period 4: Part C|Adverse Event|0|||
129810399|NCT04457336|467273222|FG006|Period 4: Part C|Adverse Event|0|||
129810400|NCT04457336|467273223|FG007|Period 4: Part C|Adverse Event|2|||
129810401|NCT04457336|467273216|FG000|Period 4: Part C|Site Terminated|0|||
129810402|NCT04457336|467273217|FG001|Period 4: Part C|Site Terminated|0|||
129810403|NCT04457336|467273218|FG002|Period 4: Part C|Site Terminated|0|||
129810404|NCT04457336|467273219|FG003|Period 4: Part C|Site Terminated|0|||
129810405|NCT04457336|467273220|FG004|Period 4: Part C|Site Terminated|0|||
129810406|NCT04457336|467273221|FG005|Period 4: Part C|Site Terminated|0|||
129810407|NCT04457336|467273222|FG006|Period 4: Part C|Site Terminated|0|||
129810408|NCT04457336|467273223|FG007|Period 4: Part C|Site Terminated|1|||
129810409|NCT04457336|467273216|FG000|Period 4: Part C|Other|0|||
129810410|NCT04457336|467273217|FG001|Period 4: Part C|Other|0|||
129810411|NCT04457336|467273218|FG002|Period 4: Part C|Other|0|||
129810412|NCT04457336|467273219|FG003|Period 4: Part C|Other|0|||
129810413|NCT04457336|467273220|FG004|Period 4: Part C|Other|0|||
129810414|NCT04457336|467273221|FG005|Period 4: Part C|Other|0|||
129810415|NCT04457336|467273222|FG006|Period 4: Part C|Other|0|||
129810416|NCT04457336|467273223|FG007|Period 4: Part C|Other|2|||
129810417|NCT04457336|467273216|FG000|Period 4: Part C|Withdrawal by Subject|0|||
129810418|NCT04457336|467273217|FG001|Period 4: Part C|Withdrawal by Subject|0|||
129810419|NCT04457336|467273218|FG002|Period 4: Part C|Withdrawal by Subject|0|||
129810420|NCT04457336|467273219|FG003|Period 4: Part C|Withdrawal by Subject|0|||
129810421|NCT04457336|467273220|FG004|Period 4: Part C|Withdrawal by Subject|0|||
129810422|NCT04457336|467273221|FG005|Period 4: Part C|Withdrawal by Subject|0|||
129810423|NCT04457336|467273222|FG006|Period 4: Part C|Withdrawal by Subject|0|||
129896776|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
129810424|NCT04457336|467273223|FG007|Period 4: Part C|Withdrawal by Subject|3|||
129810425|NCT03330288|467273230|FG000|Overall Study|Other reason|1|||
129810426|NCT03330288|467273231|FG001|Overall Study|Other reason|1|||
129810427|NCT03330288|467273230|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
129810428|NCT03330288|467273231|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
129810429|NCT03330288|467273230|FG000|Overall Study|Adverse Event|1|||
129810430|NCT03330288|467273231|FG001|Overall Study|Adverse Event|0|||
129810431|NCT03330288|467273230|FG000|Overall Study|Withdrawal by Subject|1|||
129810432|NCT03330288|467273231|FG001|Overall Study|Withdrawal by Subject|0|||
129810433|NCT03330288|467273230|FG000|Overall Study|Lost to Follow-up|26|||
129810434|NCT03330288|467273231|FG001|Overall Study|Lost to Follow-up|7|||
129810435|NCT02693119|467273235|FG000|Open-Label Period|Withdrawal by Subject|0|||
129810436|NCT02693119|467273236|FG001|Open-Label Period|Withdrawal by Subject|1|||
129810437|NCT01719783|467273239|FG000|Dose 2|Physician Decision|1|||
129810438|NCT01719783|467273240|FG001|Dose 2|Physician Decision|0|||
129810439|NCT01350492|467273241|FG000|Intervention|Lost to Follow-up|2|||
129810440|NCT01350492|467273242|FG001|Intervention|Lost to Follow-up|5|||
129810441|NCT01350492|467273241|FG000|Intervention|Withdrawal by Subject|3|||
129810442|NCT01350492|467273242|FG001|Intervention|Withdrawal by Subject|1|||
129810443|NCT01350492|467273241|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
129810444|NCT01350492|467273242|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
129810445|NCT01350492|467273241|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
129810446|NCT01350492|467273242|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
129810447|NCT00939640|467273243|FG000|Overall Study|Physician Decision|1|||
129810448|NCT00005044|467273248|FG000|Overall Study|Protocol Violation|37|||
129810449|NCT00005044|467273249|FG001|Overall Study|Protocol Violation|46|||
129810450|NCT00005044|467273248|FG000|Overall Study|Withdrawal by Subject|1|||
129810451|NCT00005044|467273249|FG001|Overall Study|Withdrawal by Subject|5|||
129810452|NCT00005044|467273248|FG000|Overall Study|No protocol treatment|0|||
129810453|NCT00005044|467273249|FG001|Overall Study|No protocol treatment|1|||
129810454|NCT03988088|467273250|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
129810455|NCT03988088|467273251|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
129810456|NCT03988088|467273252|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
129810457|NCT03988088|467273253|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
129810458|NCT03988088|467273250|FG000|Open-Label Addendum|Lost to Follow-up|0|||
129810459|NCT03988088|467273251|FG001|Open-Label Addendum|Lost to Follow-up|0|||
129810460|NCT03988088|467273252|FG002|Open-Label Addendum|Lost to Follow-up|1|||
129810461|NCT03988088|467273253|FG003|Open-Label Addendum|Lost to Follow-up|0|||
129810462|NCT04431453|467273254|FG000|Overall Study|Withdrew Consent|0|||
129810463|NCT04431453|467273255|FG001|Overall Study|Withdrew Consent|1|||
129810464|NCT04431453|467273256|FG002|Overall Study|Withdrew Consent|0|||
129810465|NCT04431453|467273257|FG003|Overall Study|Withdrew Consent|2|||
129810466|NCT04431453|467273258|FG004|Overall Study|Withdrew Consent|0|||
129810467|NCT04431453|467273259|FG005|Overall Study|Withdrew Consent|0|||
129810468|NCT04431453|467273260|FG006|Overall Study|Withdrew Consent|0|||
129810469|NCT04431453|467273261|FG007|Overall Study|Withdrew Consent|0|||
129810470|NCT04431453|467273254|FG000|Overall Study|Death|1|||
129810471|NCT04431453|467273255|FG001|Overall Study|Death|0|||
129810472|NCT04431453|467273256|FG002|Overall Study|Death|0|||
129810473|NCT04431453|467273257|FG003|Overall Study|Death|0|||
129810474|NCT04431453|467273258|FG004|Overall Study|Death|0|||
129810475|NCT04431453|467273259|FG005|Overall Study|Death|0|||
129810476|NCT04431453|467273260|FG006|Overall Study|Death|0|||
129810477|NCT04431453|467273261|FG007|Overall Study|Death|1|||
129810478|NCT04431453|467273254|FG000|Overall Study|Lost to Follow-up|0|||
129810479|NCT04431453|467273255|FG001|Overall Study|Lost to Follow-up|0|||
129810480|NCT04431453|467273256|FG002|Overall Study|Lost to Follow-up|1|||
129810481|NCT04431453|467273257|FG003|Overall Study|Lost to Follow-up|1|||
129810482|NCT04431453|467273258|FG004|Overall Study|Lost to Follow-up|0|||
129810483|NCT04431453|467273259|FG005|Overall Study|Lost to Follow-up|0|||
129810484|NCT04431453|467273260|FG006|Overall Study|Lost to Follow-up|0|||
129810485|NCT04431453|467273261|FG007|Overall Study|Lost to Follow-up|0|||
129896777|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
129896778|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
129896779|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Pain|0|||
129896780|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Pain|0|||
129896781|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Pain|0|||
129896782|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Pain|1|||
129896783|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
130058514|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
129810486|NCT04431453|467273254|FG000|Overall Study|Enrolled but Never Treated|0|||
129810487|NCT04431453|467273255|FG001|Overall Study|Enrolled but Never Treated|0|||
129810488|NCT04431453|467273256|FG002|Overall Study|Enrolled but Never Treated|0|||
129810489|NCT04431453|467273257|FG003|Overall Study|Enrolled but Never Treated|0|||
129810490|NCT04431453|467273258|FG004|Overall Study|Enrolled but Never Treated|1|||
129810491|NCT04431453|467273259|FG005|Overall Study|Enrolled but Never Treated|0|||
129810492|NCT04431453|467273260|FG006|Overall Study|Enrolled but Never Treated|0|||
129810493|NCT04431453|467273261|FG007|Overall Study|Enrolled but Never Treated|0|||
129896784|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
130058515|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
130058516|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129810494|NCT01768286|467273263|FG000|Overall Study|Randomized But Not Treated|0|||
129810495|NCT01768286|467273264|FG001|Overall Study|Randomized But Not Treated|0|||
129810496|NCT01768286|467273265|FG002|Overall Study|Randomized But Not Treated|1|||
129810497|NCT01768286|467273266|FG003|Overall Study|Randomized But Not Treated|0|||
129810498|NCT01768286|467273263|FG000|Overall Study|Lack of Efficacy|7|||
129810499|NCT01768286|467273264|FG001|Overall Study|Lack of Efficacy|4|||
129810500|NCT01768286|467273265|FG002|Overall Study|Lack of Efficacy|0|||
129810501|NCT01768286|467273266|FG003|Overall Study|Lack of Efficacy|1|||
129810502|NCT01768286|467273263|FG000|Overall Study|Withdrew Consent|0|||
129810503|NCT01768286|467273264|FG001|Overall Study|Withdrew Consent|0|||
129810504|NCT01768286|467273265|FG002|Overall Study|Withdrew Consent|1|||
129810505|NCT01768286|467273266|FG003|Overall Study|Withdrew Consent|0|||
129810506|NCT02083965|467273267|FG000|Treatment Period|Other|1|||
129810507|NCT02083965|467273268|FG001|Treatment Period|Other|0|||
129810508|NCT04502433|467273271|FG000|Overall Study|Death|2|||
129810509|NCT04502433|467273272|FG001|Overall Study|Death|4|||
129810510|NCT04502433|467273271|FG000|Overall Study|Lost to Follow-up|1|||
129810511|NCT04502433|467273272|FG001|Overall Study|Lost to Follow-up|0|||
129810512|NCT04502433|467273271|FG000|Overall Study|Physician Decision|0|||
129810513|NCT04502433|467273272|FG001|Overall Study|Physician Decision|1|||
129810514|NCT02935842|467273273|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
129810515|NCT02935842|467273274|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
129810516|NCT02935842|467273275|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
129810517|NCT02935842|467273276|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
129810518|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
129810519|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
129810520|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
129810521|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
129810522|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
129810523|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
129810524|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
129810525|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
129810526|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
129810527|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
129810528|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
129810529|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
129810530|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
129810531|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
129810532|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
129810533|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
129810534|NCT00911547|467273277|FG000|Overall Study|Adverse Event|8|||
129810535|NCT00911547|467273278|FG001|Overall Study|Adverse Event|27|||
129810536|NCT00911547|467273279|FG002|Overall Study|Adverse Event|11|||
129810537|NCT00911547|467273280|FG003|Overall Study|Adverse Event|6|||
129810538|NCT00911547|467273277|FG000|Overall Study|Lost to Follow-up|0|||
129896785|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
129896786|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
129896787|NCT04353037|467582126|FG000|Overall Study|Lost to Follow-up|0|||
129896788|NCT04353037|467582127|FG001|Overall Study|Lost to Follow-up|1|||
129896789|NCT04353037|467582128|FG002|Overall Study|Lost to Follow-up|2|||
129896790|NCT04353037|467582129|FG003|Overall Study|Lost to Follow-up|3|||
129896791|NCT04353037|467582126|FG000|Overall Study|Withdrawal by Subject|0|||
129810539|NCT00911547|467273278|FG001|Overall Study|Lost to Follow-up|0|||
129810540|NCT00911547|467273279|FG002|Overall Study|Lost to Follow-up|2|||
129810541|NCT00911547|467273280|FG003|Overall Study|Lost to Follow-up|1|||
129810542|NCT00911547|467273277|FG000|Overall Study|Protocol Violation|0|||
129810543|NCT00911547|467273278|FG001|Overall Study|Protocol Violation|5|||
129810544|NCT00911547|467273279|FG002|Overall Study|Protocol Violation|5|||
129810545|NCT00911547|467273280|FG003|Overall Study|Protocol Violation|1|||
129896792|NCT04353037|467582127|FG001|Overall Study|Withdrawal by Subject|2|||
129896793|NCT04353037|467582128|FG002|Overall Study|Withdrawal by Subject|3|||
129896794|NCT04353037|467582129|FG003|Overall Study|Withdrawal by Subject|5|||
129810546|NCT00911547|467273277|FG000|Overall Study|Withdrawal by Subject|3|||
129810547|NCT00911547|467273278|FG001|Overall Study|Withdrawal by Subject|10|||
129810548|NCT00911547|467273279|FG002|Overall Study|Withdrawal by Subject|4|||
129810549|NCT00911547|467273280|FG003|Overall Study|Withdrawal by Subject|8|||
129810550|NCT01201785|467273281|FG000|Overall Study|Lost to Follow-up|16|||
129896795|NCT04353037|467582126|FG000|Overall Study|Adverse Event|0|||
129896796|NCT04353037|467582127|FG001|Overall Study|Adverse Event|0|||
129896797|NCT04353037|467582128|FG002|Overall Study|Adverse Event|2|||
129896798|NCT04353037|467582129|FG003|Overall Study|Adverse Event|0|||
129810551|NCT04545385|467273284|FG000|Overall Study|Withdrawal by Subject|2|||
129896799|NCT04353037|467582126|FG000|Overall Study|Exposure Change|0|||
129896800|NCT04353037|467582127|FG001|Overall Study|Exposure Change|0|||
129810552|NCT04545385|467273285|FG001|Overall Study|Withdrawal by Subject|0|||
129810553|NCT04545385|467273284|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
129810554|NCT04545385|467273285|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
129810555|NCT04545385|467273284|FG000|Overall Study|Study termination|10|||
129810556|NCT04545385|467273285|FG001|Overall Study|Study termination|10|||
129810557|NCT04545385|467273284|FG000|Overall Study|Sponsor decision|2|||
129810558|NCT04545385|467273285|FG001|Overall Study|Sponsor decision|2|||
129810559|NCT04545385|467273284|FG000|Overall Study|Other than specified|1|||
129810560|NCT04545385|467273285|FG001|Overall Study|Other than specified|0|||
130094772|NCT01018680|468303840|FG001|Overall Study|Adverse Event|40|||
129810561|NCT00915278|467273286|FG000|Overall Study|Death|1|||
129810562|NCT00915278|467273287|FG001|Overall Study|Death|0|||
129810563|NCT00915278|467273288|FG002|Overall Study|Death|0|||
129810564|NCT00915278|467273289|FG003|Overall Study|Death|0|||
129810565|NCT00915278|467273290|FG004|Overall Study|Death|0|||
129810566|NCT00915278|467273291|FG005|Overall Study|Death|0|||
129810567|NCT00915278|467273286|FG000|Overall Study|Lost to Follow-up|0|||
129810568|NCT00915278|467273287|FG001|Overall Study|Lost to Follow-up|1|||
129810569|NCT00915278|467273288|FG002|Overall Study|Lost to Follow-up|0|||
129810570|NCT00915278|467273289|FG003|Overall Study|Lost to Follow-up|0|||
129810571|NCT00915278|467273290|FG004|Overall Study|Lost to Follow-up|0|||
129810572|NCT00915278|467273291|FG005|Overall Study|Lost to Follow-up|0|||
129810573|NCT00915278|467273286|FG000|Overall Study|Withdrawal by Subject|0|||
129810574|NCT00915278|467273287|FG001|Overall Study|Withdrawal by Subject|1|||
129810575|NCT00915278|467273288|FG002|Overall Study|Withdrawal by Subject|0|||
129810576|NCT00915278|467273289|FG003|Overall Study|Withdrawal by Subject|0|||
129810577|NCT00915278|467273290|FG004|Overall Study|Withdrawal by Subject|1|||
129810578|NCT00915278|467273291|FG005|Overall Study|Withdrawal by Subject|4|||
129810579|NCT00915278|467273286|FG000|Overall Study|Adverse Event|4|||
129810580|NCT00915278|467273287|FG001|Overall Study|Adverse Event|1|||
129810581|NCT00915278|467273288|FG002|Overall Study|Adverse Event|0|||
129896801|NCT04353037|467582128|FG002|Overall Study|Exposure Change|0|||
129896802|NCT04353037|467582129|FG003|Overall Study|Exposure Change|2|||
129896803|NCT03710564|467582130|FG000|Overall Study|Study Terminated by Sponsor|104|||
129810582|NCT00915278|467273289|FG003|Overall Study|Adverse Event|0|||
129810583|NCT00915278|467273290|FG004|Overall Study|Adverse Event|0|||
129896804|NCT03710564|467582131|FG001|Overall Study|Study Terminated by Sponsor|55|||
129810584|NCT00915278|467273291|FG005|Overall Study|Adverse Event|0|||
129810585|NCT00915278|467273286|FG000|Overall Study|Progressive disease/clinical progression|0|||
130058517|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129810586|NCT00915278|467273287|FG001|Overall Study|Progressive disease/clinical progression|0|||
129810587|NCT00915278|467273288|FG002|Overall Study|Progressive disease/clinical progression|0|||
129810588|NCT00915278|467273289|FG003|Overall Study|Progressive disease/clinical progression|3|||
129810589|NCT00915278|467273290|FG004|Overall Study|Progressive disease/clinical progression|1|||
129810590|NCT00915278|467273291|FG005|Overall Study|Progressive disease/clinical progression|2|||
129810591|NCT00915278|467273286|FG000|Overall Study|Infusion related AEs|0|||
129810592|NCT00915278|467273287|FG001|Overall Study|Infusion related AEs|0|||
129810593|NCT00915278|467273288|FG002|Overall Study|Infusion related AEs|0|||
129810594|NCT00915278|467273289|FG003|Overall Study|Infusion related AEs|0|||
129810595|NCT00915278|467273290|FG004|Overall Study|Infusion related AEs|0|||
129810596|NCT00915278|467273291|FG005|Overall Study|Infusion related AEs|2|||
129810597|NCT00915278|467273286|FG000|Overall Study|Admission to hospice|0|||
129810598|NCT00915278|467273287|FG001|Overall Study|Admission to hospice|0|||
129810599|NCT00915278|467273288|FG002|Overall Study|Admission to hospice|1|||
129810600|NCT00915278|467273289|FG003|Overall Study|Admission to hospice|0|||
129810601|NCT00915278|467273290|FG004|Overall Study|Admission to hospice|0|||
129810602|NCT00915278|467273291|FG005|Overall Study|Admission to hospice|0|||
129810603|NCT02151110|467273292|FG000|Overall Study|Withdrawal by Subject|0|||
129810604|NCT02151110|467273293|FG001|Overall Study|Withdrawal by Subject|0|||
129810605|NCT02151110|467273294|FG002|Overall Study|Withdrawal by Subject|0|||
129810606|NCT02151110|467273295|FG003|Overall Study|Withdrawal by Subject|0|||
129810607|NCT02151110|467273296|FG004|Overall Study|Withdrawal by Subject|0|||
129810608|NCT02151110|467273297|FG005|Overall Study|Withdrawal by Subject|0|||
129810609|NCT02151110|467273298|FG006|Overall Study|Withdrawal by Subject|0|||
129810610|NCT02151110|467273299|FG007|Overall Study|Withdrawal by Subject|1|||
129810611|NCT02151110|467273292|FG000|Overall Study|Lost to Follow-up|0|||
129810612|NCT02151110|467273293|FG001|Overall Study|Lost to Follow-up|0|||
129810613|NCT02151110|467273294|FG002|Overall Study|Lost to Follow-up|0|||
129810614|NCT02151110|467273295|FG003|Overall Study|Lost to Follow-up|0|||
129810615|NCT02151110|467273296|FG004|Overall Study|Lost to Follow-up|0|||
129810616|NCT02151110|467273297|FG005|Overall Study|Lost to Follow-up|0|||
129810617|NCT02151110|467273298|FG006|Overall Study|Lost to Follow-up|0|||
129810618|NCT02151110|467273299|FG007|Overall Study|Lost to Follow-up|2|||
129810619|NCT02369016|467273300|FG000|Overall Study|AE associated with clinical disease progression|2|||
129810620|NCT02369016|467273301|FG001|Overall Study|AE associated with clinical disease progression|1|||
129810621|NCT02369016|467273300|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
129810622|NCT02369016|467273301|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
129810623|NCT02369016|467273300|FG000|Overall Study|Progressive disease - clinical progression|1|||
129810624|NCT02369016|467273301|FG001|Overall Study|Progressive disease - clinical progression|4|||
129810625|NCT02369016|467273300|FG000|Overall Study|withdrawal by patient|4|||
129810626|NCT02369016|467273301|FG001|Overall Study|withdrawal by patient|0|||
129810627|NCT02369016|467273300|FG000|Overall Study|Progressive disease - radiological progression|6|||
129810628|NCT02369016|467273301|FG001|Overall Study|Progressive disease - radiological progression|2|||
129810629|NCT02229383|467273302|FG000|Overall Study|Adverse Event|7|||
129810630|NCT02229383|467273303|FG001|Overall Study|Adverse Event|4|||
129810631|NCT02229383|467273302|FG000|Overall Study|Death|0|||
129810632|NCT02229383|467273303|FG001|Overall Study|Death|1|||
129810633|NCT02229383|467273302|FG000|Overall Study|Lost to Follow-up|5|||
129810634|NCT02229383|467273303|FG001|Overall Study|Lost to Follow-up|3|||
129810635|NCT02229383|467273302|FG000|Overall Study|Withdrawal by Subject|4|||
129810636|NCT02229383|467273303|FG001|Overall Study|Withdrawal by Subject|6|||
129810637|NCT02229383|467273302|FG000|Overall Study|Did not receive treatment|1|||
129810638|NCT02229383|467273303|FG001|Overall Study|Did not receive treatment|0|||
129810639|NCT02229383|467273302|FG000|Overall Study|Other|3|||
129810640|NCT02229383|467273303|FG001|Overall Study|Other|8|||
129810641|NCT01201850|467273308|FG000|Overall Study|Tumor progression|4|||
129810642|NCT01817530|467273314|FG000|Overall Study|Exclusionary Medication Received|0|||
129810643|NCT01817530|467273315|FG001|Overall Study|Exclusionary Medication Received|0|||
129810644|NCT01817530|467273316|FG002|Overall Study|Exclusionary Medication Received|0|||
129810645|NCT01817530|467273317|FG003|Overall Study|Exclusionary Medication Received|0|||
129810646|NCT01817530|467273318|FG004|Overall Study|Exclusionary Medication Received|1|||
129810647|NCT01817530|467273319|FG005|Overall Study|Exclusionary Medication Received|0|||
129810648|NCT01817530|467273320|FG006|Overall Study|Exclusionary Medication Received|0|||
129810649|NCT01817530|467273321|FG007|Overall Study|Exclusionary Medication Received|0|||
129810650|NCT01817530|467273314|FG000|Overall Study|Adverse Event|6|||
129810651|NCT01817530|467273315|FG001|Overall Study|Adverse Event|3|||
129810652|NCT01817530|467273316|FG002|Overall Study|Adverse Event|2|||
129810653|NCT01817530|467273317|FG003|Overall Study|Adverse Event|5|||
129896805|NCT03710564|467582130|FG000|Overall Study|Withdrawal by Subject|57|||
129810654|NCT01817530|467273318|FG004|Overall Study|Adverse Event|0|||
129810655|NCT01817530|467273319|FG005|Overall Study|Adverse Event|10|||
129810656|NCT01817530|467273320|FG006|Overall Study|Adverse Event|5|||
129810657|NCT01817530|467273321|FG007|Overall Study|Adverse Event|8|||
129810658|NCT01817530|467273314|FG000|Overall Study|Subject Noncompliant|3|||
129810659|NCT01817530|467273315|FG001|Overall Study|Subject Noncompliant|1|||
129810660|NCT01817530|467273316|FG002|Overall Study|Subject Noncompliant|0|||
129810661|NCT01817530|467273317|FG003|Overall Study|Subject Noncompliant|4|||
129810662|NCT01817530|467273318|FG004|Overall Study|Subject Noncompliant|0|||
129810663|NCT01817530|467273319|FG005|Overall Study|Subject Noncompliant|1|||
129810664|NCT01817530|467273320|FG006|Overall Study|Subject Noncompliant|1|||
129810665|NCT01817530|467273321|FG007|Overall Study|Subject Noncompliant|1|||
129810666|NCT01817530|467273314|FG000|Overall Study|Lack of Efficacy|1|||
129810667|NCT01817530|467273315|FG001|Overall Study|Lack of Efficacy|0|||
129810668|NCT01817530|467273316|FG002|Overall Study|Lack of Efficacy|0|||
129810669|NCT01817530|467273317|FG003|Overall Study|Lack of Efficacy|0|||
129810670|NCT01817530|467273318|FG004|Overall Study|Lack of Efficacy|0|||
129810671|NCT01817530|467273319|FG005|Overall Study|Lack of Efficacy|1|||
129810672|NCT01817530|467273320|FG006|Overall Study|Lack of Efficacy|0|||
129810673|NCT01817530|467273321|FG007|Overall Study|Lack of Efficacy|1|||
129810674|NCT01817530|467273314|FG000|Overall Study|Pregnancy|0|||
129810675|NCT01817530|467273315|FG001|Overall Study|Pregnancy|0|||
129810676|NCT01817530|467273316|FG002|Overall Study|Pregnancy|0|||
129810677|NCT01817530|467273317|FG003|Overall Study|Pregnancy|0|||
129810678|NCT01817530|467273318|FG004|Overall Study|Pregnancy|0|||
129810679|NCT01817530|467273319|FG005|Overall Study|Pregnancy|1|||
129810680|NCT01817530|467273320|FG006|Overall Study|Pregnancy|0|||
129810681|NCT01817530|467273321|FG007|Overall Study|Pregnancy|0|||
129810682|NCT01817530|467273314|FG000|Overall Study|Other|0|||
129810683|NCT01817530|467273315|FG001|Overall Study|Other|1|||
129810684|NCT01817530|467273316|FG002|Overall Study|Other|0|||
129810685|NCT01817530|467273317|FG003|Overall Study|Other|0|||
129810686|NCT01817530|467273318|FG004|Overall Study|Other|1|||
129810687|NCT01817530|467273319|FG005|Overall Study|Other|0|||
129810688|NCT01817530|467273320|FG006|Overall Study|Other|5|||
129810689|NCT01817530|467273321|FG007|Overall Study|Other|0|||
129810690|NCT01817530|467273314|FG000|Overall Study|Surgery or Invasive Intervention|1|||
129810691|NCT01817530|467273315|FG001|Overall Study|Surgery or Invasive Intervention|0|||
129810692|NCT01817530|467273316|FG002|Overall Study|Surgery or Invasive Intervention|0|||
129810693|NCT01817530|467273317|FG003|Overall Study|Surgery or Invasive Intervention|0|||
129810694|NCT01817530|467273318|FG004|Overall Study|Surgery or Invasive Intervention|1|||
129810695|NCT01817530|467273319|FG005|Overall Study|Surgery or Invasive Intervention|1|||
129810696|NCT01817530|467273320|FG006|Overall Study|Surgery or Invasive Intervention|1|||
129810697|NCT01817530|467273321|FG007|Overall Study|Surgery or Invasive Intervention|0|||
129810698|NCT01817530|467273314|FG000|Overall Study|Consent Withdrawn by Subject|3|||
129810699|NCT01817530|467273315|FG001|Overall Study|Consent Withdrawn by Subject|4|||
129810700|NCT01817530|467273316|FG002|Overall Study|Consent Withdrawn by Subject|7|||
129810701|NCT01817530|467273317|FG003|Overall Study|Consent Withdrawn by Subject|3|||
129810702|NCT01817530|467273318|FG004|Overall Study|Consent Withdrawn by Subject|5|||
129810703|NCT01817530|467273319|FG005|Overall Study|Consent Withdrawn by Subject|3|||
129810704|NCT01817530|467273320|FG006|Overall Study|Consent Withdrawn by Subject|3|||
129810705|NCT01817530|467273321|FG007|Overall Study|Consent Withdrawn by Subject|10|||
129810706|NCT01817530|467273314|FG000|Overall Study|Lost to Follow-up|1|||
129810707|NCT01817530|467273315|FG001|Overall Study|Lost to Follow-up|4|||
129810708|NCT01817530|467273316|FG002|Overall Study|Lost to Follow-up|2|||
129810709|NCT01817530|467273317|FG003|Overall Study|Lost to Follow-up|1|||
129810710|NCT01817530|467273318|FG004|Overall Study|Lost to Follow-up|3|||
129810711|NCT01817530|467273319|FG005|Overall Study|Lost to Follow-up|2|||
129810712|NCT01817530|467273320|FG006|Overall Study|Lost to Follow-up|8|||
129810713|NCT01817530|467273321|FG007|Overall Study|Lost to Follow-up|4|||
129810714|NCT00404235|467273322|FG000|Overall Study|Withdrawal by Subject|1|||
129810715|NCT00404235|467273323|FG001|Overall Study|Withdrawal by Subject|2|||
129810716|NCT00594659|467273324|FG000|Overall Study|Lost to Follow-up|13|||
129810717|NCT00594659|467273325|FG001|Overall Study|Lost to Follow-up|9|||
129810718|NCT00594659|467273326|FG002|Overall Study|Lost to Follow-up|7|||
129810719|NCT04560998|467273332|FG000|Overall Study|Withdrawal by Subject|18|||
129810720|NCT04560998|467273333|FG001|Overall Study|Withdrawal by Subject|12|||
129810721|NCT04560998|467273332|FG000|Overall Study|Lost to Follow-up|8|||
129810722|NCT04560998|467273333|FG001|Overall Study|Lost to Follow-up|5|||
129810723|NCT04560998|467273332|FG000|Overall Study|Physician Decision|4|||
129810724|NCT04560998|467273333|FG001|Overall Study|Physician Decision|0|||
129810725|NCT01798004|467274927|FG000|Overall Study|Death|2|||
129810726|NCT01798004|467274927|FG000|Overall Study|Lack of Efficacy|8|||
129810727|NCT01798004|467274927|FG000|Overall Study|Physician Decision|25|||
129810728|NCT01798004|467274927|FG000|Overall Study|Withdrawal by Subject|4|||
129810729|NCT01798004|467274927|FG000|Overall Study|Ineligible|4|||
129810730|NCT01798004|467274927|FG000|Overall Study|Patient/parent refusal|7|||
129810731|NCT01798004|467274927|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
129810732|NCT01798004|467274927|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
129810733|NCT03281577|467274930|FG000|Overall Study|Adverse Event|0|||
129810734|NCT03281577|467274931|FG001|Overall Study|Adverse Event|0|||
129810735|NCT03281577|467274932|FG002|Overall Study|Adverse Event|0|||
129810736|NCT03281577|467274933|FG003|Overall Study|Adverse Event|1|||
129810737|NCT03281577|467274930|FG000|Overall Study|Withdrawal by Subject|1|||
129810738|NCT03281577|467274931|FG001|Overall Study|Withdrawal by Subject|0|||
129810739|NCT03281577|467274932|FG002|Overall Study|Withdrawal by Subject|0|||
129810740|NCT03281577|467274933|FG003|Overall Study|Withdrawal by Subject|0|||
129810741|NCT00443261|467274934|FG000|Overall Study|Death|1|||
129810742|NCT01433991|467274936|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
129810743|NCT01433991|467274937|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
129810744|NCT01433991|467274938|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
129810745|NCT01433991|467274939|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
129810746|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
129810747|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
129810748|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
129810749|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
129810750|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
129810751|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
129810752|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
129810753|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
129810754|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
129810755|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
129896806|NCT03710564|467582131|FG001|Overall Study|Withdrawal by Subject|25|||
129896807|NCT03710564|467582130|FG000|Overall Study|Death|10|||
129896808|NCT03710564|467582131|FG001|Overall Study|Death|4|||
129896809|NCT03710564|467582130|FG000|Overall Study|Lost to Follow-up|5|||
129896810|NCT03710564|467582131|FG001|Overall Study|Lost to Follow-up|4|||
129896811|NCT03710564|467582130|FG000|Overall Study|Protocol Violation|3|||
129896812|NCT03710564|467582131|FG001|Overall Study|Protocol Violation|2|||
129896813|NCT03710564|467582130|FG000|Overall Study|Adverse Event|3|||
129896814|NCT03710564|467582131|FG001|Overall Study|Adverse Event|0|||
129896815|NCT03710564|467582130|FG000|Overall Study|Physician Decision|2|||
129896816|NCT03710564|467582131|FG001|Overall Study|Physician Decision|3|||
129896817|NCT01674569|467582132|FG000|Overall Study|Adverse Event|0|||
130058518|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129896818|NCT01674569|467582133|FG001|Overall Study|Adverse Event|2|||
129896819|NCT01674569|467582134|FG002|Overall Study|Adverse Event|0|||
130058519|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129896820|NCT01674569|467582135|FG003|Overall Study|Adverse Event|1|||
129896821|NCT01674569|467582136|FG004|Overall Study|Adverse Event|2|||
129896822|NCT01674569|467582137|FG005|Overall Study|Adverse Event|2|||
129896823|NCT01674569|467582132|FG000|Overall Study|Protocol Violation|0|||
130058520|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129810756|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
129810757|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
129810758|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
129896824|NCT01674569|467582133|FG001|Overall Study|Protocol Violation|1|||
129896825|NCT01674569|467582134|FG002|Overall Study|Protocol Violation|1|||
129896826|NCT01674569|467582135|FG003|Overall Study|Protocol Violation|0|||
130058521|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
130058522|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130058523|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130058524|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130058525|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130058526|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130058527|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
130058528|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
129810759|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
129810760|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
129810761|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
129810762|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
129810763|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
129810764|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
129810765|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
129810766|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
129810767|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
129810768|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
129810769|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
129810770|NCT01673867|467274944|FG000|Randomization|Adverse event unrelated to study drug|1|||
129810771|NCT01673867|467274945|FG001|Randomization|Adverse event unrelated to study drug|0|||
129810772|NCT01673867|467274944|FG000|Randomization|Participant request to discontinue study treatment|0|||
129810773|NCT01673867|467274945|FG001|Randomization|Participant request to discontinue study treatment|4|||
129810774|NCT01673867|467274944|FG000|Randomization|Withdrawal by participant|0|||
129810775|NCT01673867|467274945|FG001|Randomization|Withdrawal by participant|12|||
129810776|NCT01673867|467274944|FG000|Randomization|Lost to Follow-up|0|||
129810777|NCT01673867|467274945|FG001|Randomization|Lost to Follow-up|1|||
129810778|NCT01673867|467274944|FG000|Randomization|Participant no longer meets study criteria|4|||
129810779|NCT01673867|467274945|FG001|Randomization|Participant no longer meets study criteria|5|||
129810780|NCT01673867|467274944|FG000|Treatment|Disease Progression|208|||
129810781|NCT01673867|467274945|FG001|Treatment|Disease Progression|178|||
129810782|NCT01673867|467274944|FG000|Treatment|Study Drug Toxicity|23|||
129810783|NCT01673867|467274945|FG001|Treatment|Study Drug Toxicity|43|||
129810784|NCT01673867|467274944|FG000|Treatment|Death|2|||
129810785|NCT01673867|467274945|FG001|Treatment|Death|3|||
129810786|NCT01673867|467274944|FG000|Treatment|Adverse event unrelated to study drug|23|||
129810787|NCT01673867|467274945|FG001|Treatment|Adverse event unrelated to study drug|10|||
129810788|NCT01673867|467274944|FG000|Treatment|Participant request to discontinue study treatment|7|||
129810789|NCT01673867|467274945|FG001|Treatment|Participant request to discontinue study treatment|17|||
129810790|NCT01673867|467274944|FG000|Treatment|Withdrawal by participant|5|||
129810791|NCT01673867|467274945|FG001|Treatment|Withdrawal by participant|5|||
129810792|NCT01673867|467274944|FG000|Treatment|Maximum clinical benefit|1|||
129810793|NCT01673867|467274945|FG001|Treatment|Maximum clinical benefit|10|||
129810794|NCT01673867|467274944|FG000|Treatment|Participant no longer meets study criteria|2|||
129810795|NCT01673867|467274945|FG001|Treatment|Participant no longer meets study criteria|0|||
129810796|NCT01673867|467274944|FG000|Treatment|Administrative reason by sponsor|3|||
129810797|NCT01673867|467274945|FG001|Treatment|Administrative reason by sponsor|0|||
129810798|NCT01673867|467274944|FG000|Treatment|Other reason|11|||
129810799|NCT01673867|467274945|FG001|Treatment|Other reason|2|||
129810800|NCT02550106|467274946|FG000|Overall Study|Adverse Event|1|||
129810801|NCT02550106|467274946|FG000|Overall Study|Lack of Efficacy|3|||
129810802|NCT02550106|467274946|FG000|Overall Study|Protocol Violation|6|||
129810803|NCT02550106|467274946|FG000|Overall Study|Withdrawal by Subject|2|||
129810804|NCT00354744|467274947|FG000|Overall Study|Adverse Event|2|||
129810805|NCT00354744|467274947|FG000|Overall Study|Death|2|||
129810806|NCT00354744|467274947|FG000|Overall Study|Lack of Efficacy|11|||
129810807|NCT00354744|467274947|FG000|Overall Study|Lost to Follow-up|2|||
129810808|NCT00354744|467274947|FG000|Overall Study|Physician Decision|11|||
129896827|NCT01674569|467582136|FG004|Overall Study|Protocol Violation|0|||
129896828|NCT01674569|467582137|FG005|Overall Study|Protocol Violation|0|||
129810809|NCT00354744|467274947|FG000|Overall Study|Withdrawal by Subject|14|||
129810810|NCT01193530|467274948|FG000|Overall Study|Withdrawal by Subject|2|||
129810811|NCT01193530|467274949|FG001|Overall Study|Withdrawal by Subject|2|||
129810812|NCT01193530|467274948|FG000|Overall Study|Began Contraindicated Therapy|1|||
129810813|NCT01193530|467274949|FG001|Overall Study|Began Contraindicated Therapy|0|||
129810814|NCT01193530|467274948|FG000|Overall Study|Lost Light Box|0|||
129810815|NCT01193530|467274949|FG001|Overall Study|Lost Light Box|1|||
129810816|NCT01193530|467274948|FG000|Overall Study|Returned home - out of state|0|||
129810817|NCT01193530|467274949|FG001|Overall Study|Returned home - out of state|1|||
129810818|NCT01193530|467274948|FG000|Overall Study|Non-Compliance|0|||
129810819|NCT01193530|467274949|FG001|Overall Study|Non-Compliance|1|||
129810820|NCT00926328|467274952|FG000|Overall Study|Lost to Follow-up|12|||
129810821|NCT00926328|467274953|FG001|Overall Study|Lost to Follow-up|14|||
129896829|NCT01674569|467582132|FG000|Overall Study|Withdrawal by Subject|0|||
129896830|NCT01674569|467582133|FG001|Overall Study|Withdrawal by Subject|0|||
130058529|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130058530|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130058531|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130058532|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130058533|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130058534|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
130058535|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
130058536|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130058537|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130058538|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130058539|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130058540|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
130058541|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129810822|NCT00726986|467274954|FG000|Induction Phase|Adverse Event|4|||
129810823|NCT00726986|467274954|FG000|Induction Phase|Withdrawal by Subject|2|||
129810824|NCT00726986|467274954|FG000|Induction Phase|Death|2|||
129810825|NCT00726986|467274954|FG000|Induction Phase|Lack of Efficacy|5|||
129810826|NCT00726986|467274954|FG000|Induction Phase|Secondary Disease|2|||
129810827|NCT00726986|467274954|FG000|Maintenance Phase|Adverse Event|1|||
129810828|NCT00726986|467274954|FG000|Maintenance Phase|Lack of Efficacy|2|||
129810829|NCT00289133|467274955|FG000|Overall Study|Non-study device implanted|12|||
129810830|NCT00289133|467274956|FG001|Overall Study|Non-study device implanted|0|||
129810831|NCT00289133|467274955|FG000|Overall Study|Protocol Violation|32|||
129810832|NCT00289133|467274956|FG001|Overall Study|Protocol Violation|38|||
129810833|NCT00289133|467274955|FG000|Overall Study|Withdrawal by Subject|9|||
129810834|NCT00289133|467274956|FG001|Overall Study|Withdrawal by Subject|10|||
129810835|NCT00289133|467274955|FG000|Overall Study|Death|5|||
129810836|NCT00289133|467274956|FG001|Overall Study|Death|10|||
129810837|NCT00289133|467274955|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
129810838|NCT00289133|467274956|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
129810839|NCT00289133|467274955|FG000|Overall Study|Physician Decision|41|||
130058542|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
130058543|NCT00254293|468170335|FG000|LTE Open Label Fixed Dosing|Other|0|||
130058544|NCT00254293|468170336|FG001|LTE Open Label Fixed Dosing|Other|0|||
130058545|NCT00254293|468170337|FG002|LTE Open Label Fixed Dosing|Other|0|||
130058546|NCT00254293|468170338|FG003|LTE Open Label Fixed Dosing|Other|0|||
130058547|NCT00254293|468170339|FG004|LTE Open Label Fixed Dosing|Other|0|||
130058548|NCT00254293|468170340|FG005|LTE Open Label Fixed Dosing|Other|0|||
130058549|NCT00254293|468170341|FG006|LTE Open Label Fixed Dosing|Other|1|||
130058550|NCT03196193|468170348|FG000|Overall Study|Adverse Event|1|||
130058551|NCT03196193|468170349|FG001|Overall Study|Adverse Event|0|||
130058552|NCT03196193|468170348|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
129810840|NCT00289133|467274956|FG001|Overall Study|Physician Decision|45|||
129810841|NCT00289133|467274955|FG000|Overall Study|Revision|8|||
129810842|NCT00289133|467274956|FG001|Overall Study|Revision|6|||
129810843|NCT00289133|467274955|FG000|Overall Study|Lost to Follow-up|92|||
129810844|NCT00289133|467274956|FG001|Overall Study|Lost to Follow-up|115|||
129810845|NCT01513343|467274959|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
129810846|NCT01513343|467274960|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
129810847|NCT01513343|467274959|FG000|Post Data Collection|Dropped/withdrew from study|7|||
129810848|NCT01513343|467274960|FG001|Post Data Collection|Dropped/withdrew from study|1|||
129810849|NCT01513343|467274959|FG000|Post Data Collection|Lost to Follow-up|10|||
129810850|NCT01513343|467274960|FG001|Post Data Collection|Lost to Follow-up|23|||
129810851|NCT01513343|467274959|FG000|6-month Follow-up|Lost to Follow-up|28|||
129810852|NCT01513343|467274960|FG001|6-month Follow-up|Lost to Follow-up|17|||
129810853|NCT01513343|467274959|FG000|12-month Follow-up|Lost to Follow-up|10|||
129810854|NCT01513343|467274960|FG001|12-month Follow-up|Lost to Follow-up|3|||
129810855|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
129810856|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
129810857|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Progression|3|||
129810858|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
129810859|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Death|2|||
129810860|NCT00064337|467274961|FG000|Transplant|Adverse Event|9|||
129810861|NCT00064337|467274961|FG000|Transplant|Not protocol-specified|5|||
129810862|NCT00064337|467274961|FG000|Transplant|Death|3|||
129810863|NCT00064337|467274961|FG000|Transplant|Patient Refusal|2|||
129810864|NCT00064337|467274961|FG000|Transplant|Progression|2|||
129810865|NCT00064337|467274961|FG000|Maintenance|Adverse Event|3|||
129810866|NCT00064337|467274961|FG000|Maintenance|Progression|2|||
129810867|NCT00064337|467274961|FG000|Maintenance|On treatment at time of analysis|2|||
129810868|NCT00064337|467274961|FG000|Maintenance|Not protocol-specified|2|||
129810869|NCT00064337|467274961|FG000|Maintenance|Death|1|||
129810870|NCT01397890|467274962|FG000|Overall Study|Withdrawal by Subject|7|||
129810871|NCT01397890|467274963|FG001|Overall Study|Withdrawal by Subject|11|||
129810872|NCT01397890|467274962|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
129810873|NCT01397890|467274963|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
129810874|NCT01397890|467274962|FG000|Overall Study|Death|2|||
129810875|NCT01397890|467274963|FG001|Overall Study|Death|3|||
129810876|NCT01397890|467274962|FG000|Overall Study|Lost to Follow-up|1|||
129810877|NCT01397890|467274963|FG001|Overall Study|Lost to Follow-up|4|||
129810878|NCT01397890|467274962|FG000|Overall Study|Condition under Investigation Worsened|1|||
129810879|NCT01397890|467274963|FG001|Overall Study|Condition under Investigation Worsened|3|||
129810880|NCT01397890|467274962|FG000|Overall Study|Adverse Event|1|||
129810881|NCT01397890|467274963|FG001|Overall Study|Adverse Event|2|||
129810882|NCT01397890|467274962|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
129810883|NCT01397890|467274963|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
129810884|NCT01397890|467274962|FG000|Overall Study|Others|2|||
129810885|NCT01397890|467274963|FG001|Overall Study|Others|1|||
129810886|NCT00002651|467274964|FG000|Induction|Adverse Event|44|||
129810887|NCT00002651|467274965|FG001|Induction|Adverse Event|0|||
129810888|NCT00002651|467274966|FG002|Induction|Adverse Event|0|||
129810889|NCT00002651|467274964|FG000|Induction|Refusal unrelated to adverse event|50|||
129810890|NCT00002651|467274965|FG001|Induction|Refusal unrelated to adverse event|0|||
129810891|NCT00002651|467274966|FG002|Induction|Refusal unrelated to adverse event|0|||
129810892|NCT00002651|467274964|FG000|Induction|Progression/relapse|274|||
129810893|NCT00002651|467274965|FG001|Induction|Progression/relapse|0|||
129810894|NCT00002651|467274966|FG002|Induction|Progression/relapse|0|||
129810895|NCT00002651|467274964|FG000|Induction|Death|62|||
129810896|NCT00002651|467274965|FG001|Induction|Death|0|||
129810897|NCT00002651|467274966|FG002|Induction|Death|0|||
129810898|NCT00002651|467274964|FG000|Induction|Other|823|||
129810899|NCT00002651|467274965|FG001|Induction|Other|0|||
129810900|NCT00002651|467274966|FG002|Induction|Other|0|||
129810901|NCT00002651|467274964|FG000|Induction|not eligible|90|||
129810902|NCT00002651|467274965|FG001|Induction|not eligible|0|||
129810903|NCT00002651|467274966|FG002|Induction|not eligible|0|||
129810904|NCT00002651|467274964|FG000|Consolidation and Randomization|Adverse Event|0|||
129810905|NCT00002651|467274965|FG001|Consolidation and Randomization|Adverse Event|36|||
129810906|NCT00002651|467274966|FG002|Consolidation and Randomization|Adverse Event|14|||
129810907|NCT00002651|467274964|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
129810908|NCT00002651|467274965|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
129810909|NCT00002651|467274966|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
129810910|NCT00002651|467274964|FG000|Consolidation and Randomization|Progression/relapse|0|||
129810911|NCT00002651|467274965|FG001|Consolidation and Randomization|Progression/relapse|295|||
129810912|NCT00002651|467274966|FG002|Consolidation and Randomization|Progression/relapse|298|||
129810913|NCT00002651|467274964|FG000|Consolidation and Randomization|Death|0|||
129810914|NCT00002651|467274965|FG001|Consolidation and Randomization|Death|38|||
129810915|NCT00002651|467274966|FG002|Consolidation and Randomization|Death|48|||
129810916|NCT00002651|467274964|FG000|Consolidation and Randomization|Other|0|||
129810917|NCT00002651|467274965|FG001|Consolidation and Randomization|Other|314|||
129810918|NCT00002651|467274966|FG002|Consolidation and Randomization|Other|313|||
130058553|NCT03196193|468170349|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
130058554|NCT02709083|468170350|FG000|Overall Study|Original PI left institution|7|||
130058555|NCT01697267|468170352|FG000|Overall Study|Death|3|||
130058556|NCT01697267|468170353|FG001|Overall Study|Death|1|||
130058557|NCT01697267|468170352|FG000|Overall Study|Withdrawal by Subject|5|||
130058558|NCT01697267|468170353|FG001|Overall Study|Withdrawal by Subject|5|||
130058559|NCT01697267|468170352|FG000|Overall Study|Adverse Event|2|||
129810919|NCT00002651|467274964|FG000|Consolidation and Randomization|not eligible|0|||
129810920|NCT00002651|467274965|FG001|Consolidation and Randomization|not eligible|102|||
129810921|NCT00002651|467274966|FG002|Consolidation and Randomization|not eligible|112|||
129810922|NCT03741062|467274969|FG000|Overall Study|Protocol Violation|1|||
129810923|NCT03741062|467274970|FG001|Overall Study|Protocol Violation|0|||
129810924|NCT02763462|467274973|FG000|Overall Study|Protocol Violation|6|||
129810925|NCT03417219|467274974|FG000|Overall Study|Lost to Follow-up|0|||
129810926|NCT03417219|467274975|FG001|Overall Study|Lost to Follow-up|3|||
129810927|NCT00261807|467274976|FG000|Overall Study|Lost to Follow-up|2|||
129810928|NCT00261807|467274976|FG000|Overall Study|Adverse Event|2|||
129810929|NCT00261807|467274976|FG000|Overall Study|Death|1|||
129810930|NCT00261807|467274976|FG000|Overall Study|Protocol Violation|2|||
129810931|NCT02527161|467274979|FG000|Overall Study|Failed MRI|52|||
129810932|NCT02527161|467274979|FG000|Overall Study|Withdrawal by Subject|19|||
129810933|NCT02527161|467274979|FG000|Overall Study|Delay in or unfit for surgery|16|||
129810934|NCT02527161|467274979|FG000|Overall Study|MRI contraindication|6|||
129810935|NCT02527161|467274979|FG000|Overall Study|Consent violation|4|||
129810936|NCT02527161|467274979|FG000|Overall Study|Only Recruited to Part A|27|||
129810937|NCT02527161|467274979|FG000|Overall Study|Physician Decision|1|||
129810938|NCT02527161|467274979|FG000|Overall Study|Adverse Event|1|||
129810939|NCT02527161|467274979|FG000|Overall Study|Lost to Follow-up|6|||
129810940|NCT05209360|467274980|FG000|Overall Study|Withdrawal by Subject|0|||
129810941|NCT05209360|467274981|FG001|Overall Study|Withdrawal by Subject|0|||
129810942|NCT05209360|467274982|FG002|Overall Study|Withdrawal by Subject|1|||
129810943|NCT05209360|467274983|FG003|Overall Study|Withdrawal by Subject|0|||
129810944|NCT05209360|467274984|FG004|Overall Study|Withdrawal by Subject|0|||
129810945|NCT05209360|467274985|FG005|Overall Study|Withdrawal by Subject|0|||
129810946|NCT02100514|467274986|FG000|Treatment Period|Adverse Event|0|||
129810947|NCT02100514|467274987|FG001|Treatment Period|Adverse Event|5|||
129810948|NCT02100514|467274988|FG002|Treatment Period|Adverse Event|0|||
129810949|NCT02100514|467274989|FG003|Treatment Period|Adverse Event|0|||
129810950|NCT02100514|467274990|FG004|Treatment Period|Adverse Event|0|||
129810951|NCT02100514|467274986|FG000|Treatment Period|Death|2|||
129810952|NCT02100514|467274987|FG001|Treatment Period|Death|2|||
129810953|NCT02100514|467274988|FG002|Treatment Period|Death|0|||
129810954|NCT02100514|467274989|FG003|Treatment Period|Death|0|||
129810955|NCT02100514|467274990|FG004|Treatment Period|Death|0|||
129810956|NCT02100514|467274986|FG000|Treatment Period|Lost to Follow-up|5|||
129810957|NCT02100514|467274987|FG001|Treatment Period|Lost to Follow-up|17|||
129810958|NCT02100514|467274988|FG002|Treatment Period|Lost to Follow-up|0|||
129810959|NCT02100514|467274989|FG003|Treatment Period|Lost to Follow-up|0|||
129810960|NCT02100514|467274990|FG004|Treatment Period|Lost to Follow-up|0|||
129810961|NCT02100514|467274986|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810962|NCT02100514|467274987|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
129810963|NCT02100514|467274988|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810964|NCT02100514|467274989|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810965|NCT02100514|467274990|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810966|NCT02100514|467274986|FG000|Treatment Period|Protocol Violation|1|||
129810967|NCT02100514|467274987|FG001|Treatment Period|Protocol Violation|1|||
129810968|NCT02100514|467274988|FG002|Treatment Period|Protocol Violation|0|||
129810969|NCT02100514|467274989|FG003|Treatment Period|Protocol Violation|0|||
129810970|NCT02100514|467274990|FG004|Treatment Period|Protocol Violation|0|||
130058560|NCT01697267|468170353|FG001|Overall Study|Adverse Event|1|||
130058561|NCT01697267|468170352|FG000|Overall Study|Lost to Follow-up|2|||
130058562|NCT01697267|468170353|FG001|Overall Study|Lost to Follow-up|4|||
130058563|NCT01697267|468170352|FG000|Overall Study|Physician Decision|2|||
130058564|NCT01697267|468170353|FG001|Overall Study|Physician Decision|4|||
129810971|NCT02100514|467274986|FG000|Treatment Period|Withdrawal by Subject|12|||
129810972|NCT02100514|467274987|FG001|Treatment Period|Withdrawal by Subject|37|||
129810973|NCT02100514|467274988|FG002|Treatment Period|Withdrawal by Subject|0|||
130058565|NCT04031404|468170354|FG000|Baseline|Lost to Follow-up|0|||
129810974|NCT02100514|467274989|FG003|Treatment Period|Withdrawal by Subject|0|||
129810975|NCT02100514|467274990|FG004|Treatment Period|Withdrawal by Subject|0|||
129810976|NCT02100514|467274986|FG000|Treatment Period|Other|9|||
129810977|NCT02100514|467274987|FG001|Treatment Period|Other|11|||
129810978|NCT02100514|467274988|FG002|Treatment Period|Other|0|||
129810979|NCT02100514|467274989|FG003|Treatment Period|Other|0|||
129810980|NCT02100514|467274990|FG004|Treatment Period|Other|0|||
129810981|NCT02100514|467274986|FG000|Extension Period|Withdrew consent|0|||
129810982|NCT02100514|467274987|FG001|Extension Period|Withdrew consent|0|||
129810983|NCT02100514|467274988|FG002|Extension Period|Withdrew consent|2|||
129810984|NCT02100514|467274989|FG003|Extension Period|Withdrew consent|0|||
129810985|NCT02100514|467274990|FG004|Extension Period|Withdrew consent|0|||
129810986|NCT00724932|467274991|FG000|Overall Study|Lost to Follow-up|1|||
129810987|NCT00724932|467274992|FG001|Overall Study|Lost to Follow-up|0|||
129810988|NCT00724932|467274991|FG000|Overall Study|Not treated|4|||
129810989|NCT00724932|467274992|FG001|Overall Study|Not treated|3|||
129810990|NCT00762229|467274993|FG000|Overall Study|Lost to Follow-up|1|||
129810991|NCT00762229|467274994|FG001|Overall Study|Lost to Follow-up|1|||
129810992|NCT00762229|467274993|FG000|Overall Study|did not recveive intervention|0|||
129810993|NCT00762229|467274994|FG001|Overall Study|did not recveive intervention|1|||
129810994|NCT04203498|467274997|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
129810995|NCT04203498|467274998|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
129810996|NCT04203498|467274997|FG000|Overall Study|Withdrawal of patient consent|7|||
129810997|NCT04203498|467274998|FG001|Overall Study|Withdrawal of patient consent|2|||
129810998|NCT04203498|467274997|FG000|Overall Study|Adverse Event|4|||
129810999|NCT04203498|467274998|FG001|Overall Study|Adverse Event|1|||
129811000|NCT04203498|467274997|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
129811001|NCT04203498|467274998|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
129811002|NCT04203498|467274997|FG000|Overall Study|Did not receive IMP|2|||
129811003|NCT04203498|467274998|FG001|Overall Study|Did not receive IMP|0|||
129811004|NCT01235689|467275000|FG000|Overall Study|Adverse Event|12|||
129811005|NCT01235689|467275001|FG001|Overall Study|Adverse Event|16|||
129811006|NCT01235689|467275000|FG000|Overall Study|Lack of Efficacy|12|||
129811007|NCT01235689|467275001|FG001|Overall Study|Lack of Efficacy|5|||
129811008|NCT01235689|467275000|FG000|Overall Study|Withdrawal by Subject|3|||
130058566|NCT04031404|468170355|FG001|Baseline|Lost to Follow-up|1|||
130058567|NCT04031404|468170354|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
129811009|NCT01235689|467275001|FG001|Overall Study|Withdrawal by Subject|4|||
129811010|NCT01235689|467275000|FG000|Overall Study|Lost to Follow-up|1|||
129811011|NCT01235689|467275001|FG001|Overall Study|Lost to Follow-up|2|||
129811012|NCT01235689|467275000|FG000|Overall Study|Miscellaneous|1|||
129811013|NCT01235689|467275001|FG001|Overall Study|Miscellaneous|5|||
129811014|NCT01443078|467275002|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
129811015|NCT01443078|467275002|FG000|Overall Study|Withdrawal by Subject|1|||
129811016|NCT01443078|467275002|FG000|Overall Study|Patient had brain mets|1|||
129811017|NCT00389597|467275007|FG000|Overall Study|Lost to Follow-up|8|||
129811018|NCT00389597|467275008|FG001|Overall Study|Lost to Follow-up|6|||
129896831|NCT01674569|467582134|FG002|Overall Study|Withdrawal by Subject|1|||
129896832|NCT01674569|467582135|FG003|Overall Study|Withdrawal by Subject|0|||
129896833|NCT01674569|467582136|FG004|Overall Study|Withdrawal by Subject|0|||
129896834|NCT01674569|467582137|FG005|Overall Study|Withdrawal by Subject|0|||
129896835|NCT04555044|467582145|FG000|Overall Study|Adverse Event|0|||
129896836|NCT04555044|467582146|FG001|Overall Study|Adverse Event|1|||
129896837|NCT04088188|467582148|FG000|Overall Study|Withdrawal by Subject|2|||
129896838|NCT04088188|467582149|FG001|Overall Study|Withdrawal by Subject|0|||
129896839|NCT04088188|467582148|FG000|Overall Study|Adverse Event|2|||
129896840|NCT04088188|467582149|FG001|Overall Study|Adverse Event|0|||
129896841|NCT03601507|467582152|FG000|Overall Study|Adverse Event|1|||
129896842|NCT02107014|467582155|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
129896843|NCT03761784|467582156|FG000|Overall Study|Adverse Event|4|||
129896844|NCT03761784|467582157|FG001|Overall Study|Adverse Event|0|||
129896845|NCT03761784|467582156|FG000|Overall Study|Lost to Follow-up|10|||
129811019|NCT00389597|467275009|FG002|Overall Study|Lost to Follow-up|4|||
129811020|NCT00389597|467275010|FG003|Overall Study|Lost to Follow-up|6|||
129811021|NCT02106975|467275013|FG000|Overall Study|Death|25|||
129811022|NCT02106975|467275014|FG001|Overall Study|Death|39|||
129811023|NCT03546062|467275015|FG000|Overall Study|Adverse Event|6|||
129811024|NCT03546062|467275016|FG001|Overall Study|Adverse Event|5|||
129811025|NCT03546062|467275017|FG002|Overall Study|Adverse Event|8|||
129811026|NCT00087607|467275018|FG000|Overall Study|Adverse Event|14|||
129811027|NCT00087607|467275019|FG001|Overall Study|Adverse Event|24|||
129811028|NCT00087607|467275018|FG000|Overall Study|Death|0|||
129811029|NCT00087607|467275019|FG001|Overall Study|Death|1|||
129811030|NCT00087607|467275018|FG000|Overall Study|Insufficient Therapeutic Response|53|||
129811031|NCT00087607|467275019|FG001|Overall Study|Insufficient Therapeutic Response|42|||
129811032|NCT00087607|467275018|FG000|Overall Study|Failure to return|21|||
129811033|NCT00087607|467275019|FG001|Overall Study|Failure to return|17|||
129811034|NCT00087607|467275018|FG000|Overall Study|Withdrew Consent|12|||
129811035|NCT00087607|467275019|FG001|Overall Study|Withdrew Consent|16|||
129811036|NCT00087607|467275018|FG000|Overall Study|Administrative|12|||
129811037|NCT00087607|467275019|FG001|Overall Study|Administrative|12|||
129811038|NCT00087607|467275018|FG000|Overall Study|Refused Treatment|5|||
129811039|NCT00087607|467275019|FG001|Overall Study|Refused Treatment|7|||
129811040|NCT00087607|467275018|FG000|Overall Study|Other Protocol Violation|5|||
129811041|NCT00087607|467275019|FG001|Overall Study|Other Protocol Violation|2|||
129811042|NCT00087607|467275018|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129811043|NCT00087607|467275019|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129811044|NCT02015754|467275020|FG000|Overall Study|Disease progression|5|||
129811045|NCT02015754|467275020|FG000|Overall Study|Change in treatment modality|5|||
129811046|NCT02015754|467275020|FG000|Overall Study|Lost to Follow-up|1|||
129811047|NCT00939770|467275024|FG000|Overall Study|Adverse Event|1|||
129811048|NCT00939770|467275025|FG001|Overall Study|Adverse Event|1|||
129811049|NCT00939770|467275026|FG002|Overall Study|Adverse Event|0|||
129811050|NCT00939770|467275027|FG003|Overall Study|Adverse Event|0|||
129811051|NCT00939770|467275028|FG004|Overall Study|Adverse Event|6|||
129811052|NCT00939770|467275029|FG005|Overall Study|Adverse Event|2|||
129811053|NCT00939770|467275030|FG006|Overall Study|Adverse Event|1|||
129811054|NCT00939770|467275031|FG007|Overall Study|Adverse Event|1|||
129811055|NCT00939770|467275024|FG000|Overall Study|Lack of Efficacy|4|||
129811056|NCT00939770|467275025|FG001|Overall Study|Lack of Efficacy|6|||
129811057|NCT00939770|467275026|FG002|Overall Study|Lack of Efficacy|13|||
129811058|NCT00939770|467275027|FG003|Overall Study|Lack of Efficacy|9|||
129811059|NCT00939770|467275028|FG004|Overall Study|Lack of Efficacy|16|||
129811060|NCT00939770|467275029|FG005|Overall Study|Lack of Efficacy|8|||
129811061|NCT00939770|467275030|FG006|Overall Study|Lack of Efficacy|11|||
129811062|NCT00939770|467275031|FG007|Overall Study|Lack of Efficacy|1|||
129811063|NCT00939770|467275024|FG000|Overall Study|Lost to Follow-up|0|||
129811064|NCT00939770|467275025|FG001|Overall Study|Lost to Follow-up|0|||
129811065|NCT00939770|467275026|FG002|Overall Study|Lost to Follow-up|0|||
129811066|NCT00939770|467275027|FG003|Overall Study|Lost to Follow-up|0|||
129811067|NCT00939770|467275028|FG004|Overall Study|Lost to Follow-up|1|||
129811068|NCT00939770|467275029|FG005|Overall Study|Lost to Follow-up|0|||
129811069|NCT00939770|467275030|FG006|Overall Study|Lost to Follow-up|0|||
129811070|NCT00939770|467275031|FG007|Overall Study|Lost to Follow-up|0|||
129811071|NCT00939770|467275024|FG000|Overall Study|Physician Decision|0|||
129811072|NCT00939770|467275025|FG001|Overall Study|Physician Decision|0|||
129811073|NCT00939770|467275026|FG002|Overall Study|Physician Decision|2|||
129811074|NCT00939770|467275027|FG003|Overall Study|Physician Decision|0|||
129811075|NCT00939770|467275028|FG004|Overall Study|Physician Decision|7|||
129811076|NCT00939770|467275029|FG005|Overall Study|Physician Decision|1|||
129811077|NCT00939770|467275030|FG006|Overall Study|Physician Decision|0|||
129811078|NCT00939770|467275031|FG007|Overall Study|Physician Decision|6|||
129811079|NCT00939770|467275024|FG000|Overall Study|Protocol Violation|0|||
129811080|NCT00939770|467275025|FG001|Overall Study|Protocol Violation|0|||
129811081|NCT00939770|467275026|FG002|Overall Study|Protocol Violation|0|||
129811082|NCT00939770|467275027|FG003|Overall Study|Protocol Violation|0|||
129811083|NCT00939770|467275028|FG004|Overall Study|Protocol Violation|1|||
129811084|NCT00939770|467275029|FG005|Overall Study|Protocol Violation|0|||
129811085|NCT00939770|467275030|FG006|Overall Study|Protocol Violation|0|||
129811086|NCT00939770|467275031|FG007|Overall Study|Protocol Violation|0|||
129811087|NCT00939770|467275024|FG000|Overall Study|Withdrawal by Subject|0|||
129811088|NCT00939770|467275025|FG001|Overall Study|Withdrawal by Subject|1|||
129811089|NCT00939770|467275026|FG002|Overall Study|Withdrawal by Subject|5|||
129811090|NCT00939770|467275027|FG003|Overall Study|Withdrawal by Subject|2|||
129811091|NCT00939770|467275028|FG004|Overall Study|Withdrawal by Subject|6|||
129811092|NCT00939770|467275029|FG005|Overall Study|Withdrawal by Subject|0|||
129811093|NCT00939770|467275030|FG006|Overall Study|Withdrawal by Subject|2|||
129811094|NCT00939770|467275031|FG007|Overall Study|Withdrawal by Subject|2|||
129811095|NCT03137537|467275032|FG000|Overall Study|Adverse Event|0|||
129811096|NCT03137537|467275033|FG001|Overall Study|Adverse Event|1|||
129811097|NCT00293033|467275034|FG000|Open-label Titration Period|Adverse Event|10|||
129811098|NCT00293033|467275034|FG000|Open-label Titration Period|Death|3|||
129811099|NCT00293033|467275034|FG000|Open-label Titration Period|Lack of Efficacy|5|||
129811100|NCT00293033|467275034|FG000|Open-label Titration Period|Protocol Violation|2|||
129811101|NCT00293033|467275034|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
129811102|NCT00293033|467275034|FG000|Open-label Titration Period|Noncompliance and other|27|||
129811103|NCT00293033|467275034|FG000|Double-blind Treatment Period|Adverse Event|3|||
129811104|NCT00293033|467275034|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
129811105|NCT00293033|467275034|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
129811106|NCT00293033|467275034|FG000|Double-blind Treatment Period|Noncompliance|4|||
129811107|NCT00816595|467275035|FG000|Overall Study|Withdrawal by Subject|2|||
129811108|NCT00816595|467275036|FG001|Overall Study|Withdrawal by Subject|0|||
129811109|NCT00365508|467275040|FG000|Overall Study|Lost to Follow-up|139|||
129811110|NCT00365508|467275041|FG001|Overall Study|Lost to Follow-up|154|||
129811111|NCT00873912|467275049|FG000|Overall Study|Withdrawal by Subject|1|||
129811112|NCT00873912|467275050|FG001|Overall Study|Withdrawal by Subject|0|||
129811113|NCT00873912|467275049|FG000|Overall Study|Lost to Follow-up|2|||
129811114|NCT00873912|467275050|FG001|Overall Study|Lost to Follow-up|0|||
129811115|NCT01466153|467275051|FG000|Overall Study|Disease Progression|2|||
129811116|NCT01466153|467275052|FG001|Overall Study|Disease Progression|2|||
129811117|NCT01466153|467275053|FG002|Overall Study|Disease Progression|0|||
129811118|NCT01466153|467275051|FG000|Overall Study|Adverse Event|14|||
129811119|NCT01466153|467275052|FG001|Overall Study|Adverse Event|13|||
129811120|NCT01466153|467275053|FG002|Overall Study|Adverse Event|17|||
129811121|NCT01466153|467275051|FG000|Overall Study|Withdrawal of Consent|2|||
129811122|NCT01466153|467275052|FG001|Overall Study|Withdrawal of Consent|0|||
129811123|NCT01466153|467275053|FG002|Overall Study|Withdrawal of Consent|0|||
129811124|NCT01466153|467275051|FG000|Overall Study|Investigator Discretion|3|||
129811125|NCT01466153|467275052|FG001|Overall Study|Investigator Discretion|2|||
129811126|NCT01466153|467275053|FG002|Overall Study|Investigator Discretion|2|||
129811127|NCT01466153|467275051|FG000|Overall Study|Randomized-Not Treated|2|||
129811128|NCT01466153|467275052|FG001|Overall Study|Randomized-Not Treated|3|||
129811129|NCT01466153|467275053|FG002|Overall Study|Randomized-Not Treated|4|||
129811130|NCT01466153|467275051|FG000|Overall Study|Other-Unspecified|6|||
129811131|NCT01466153|467275052|FG001|Overall Study|Other-Unspecified|4|||
129811132|NCT01466153|467275053|FG002|Overall Study|Other-Unspecified|2|||
129811133|NCT05695209|467275060|FG000|3-months|Withdrawal by Subject|2|||
129811134|NCT05695209|467275061|FG001|3-months|Withdrawal by Subject|0|||
129811135|NCT05695209|467275060|FG000|3-months|Unable to contact for 3-month data collection|0|||
129811136|NCT05695209|467275061|FG001|3-months|Unable to contact for 3-month data collection|1|||
129811137|NCT05695209|467275060|FG000|6-months|Lost to Follow-up|1|||
129811138|NCT05695209|467275061|FG001|6-months|Lost to Follow-up|1|||
129811139|NCT03749447|467276341|FG000|Overall Study|Adverse Event|11|||
129811140|NCT03749447|467276342|FG001|Overall Study|Adverse Event|3|||
129811141|NCT03749447|467276341|FG000|Overall Study|Death|1|||
129811142|NCT03749447|467276342|FG001|Overall Study|Death|1|||
129811143|NCT03749447|467276341|FG000|Overall Study|Lost to Follow-up|2|||
129811144|NCT03749447|467276342|FG001|Overall Study|Lost to Follow-up|2|||
129811145|NCT03749447|467276341|FG000|Overall Study|Reason Not Specified|0|||
129811146|NCT03749447|467276342|FG001|Overall Study|Reason Not Specified|3|||
129811147|NCT03749447|467276341|FG000|Overall Study|Physician Decision|4|||
129811148|NCT03749447|467276342|FG001|Overall Study|Physician Decision|3|||
129811149|NCT03749447|467276341|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
129811150|NCT03749447|467276342|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
129811151|NCT03749447|467276341|FG000|Overall Study|Study Terminated By Sponsor|112|||
129811152|NCT03749447|467276342|FG001|Overall Study|Study Terminated By Sponsor|105|||
129811153|NCT03749447|467276341|FG000|Overall Study|Withdrawal by Subject|12|||
129811154|NCT03749447|467276342|FG001|Overall Study|Withdrawal by Subject|6|||
129811155|NCT03749447|467276341|FG000|Overall Study|Non-compliance With Study Drug|0|||
129811156|NCT03749447|467276342|FG001|Overall Study|Non-compliance With Study Drug|1|||
129811157|NCT03486223|467276347|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
129811158|NCT03486223|467276348|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
129811159|NCT02279420|467276349|FG000|Overall Study|Lost to Follow-up|23|||
129811160|NCT01153347|467276352|FG000|Overall Study|Withdrawal by Subject|7|||
129811161|NCT01153347|467276353|FG001|Overall Study|Withdrawal by Subject|7|||
129811162|NCT01153347|467276354|FG002|Overall Study|Withdrawal by Subject|7|||
129811163|NCT01153347|467276355|FG003|Overall Study|Withdrawal by Subject|7|||
129811164|NCT01153347|467276352|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129811165|NCT01153347|467276353|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129811166|NCT01153347|467276354|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
129811167|NCT01153347|467276355|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129811168|NCT01153347|467276352|FG000|Overall Study|Adverse Event|3|||
129811169|NCT01153347|467276353|FG001|Overall Study|Adverse Event|9|||
129811170|NCT01153347|467276354|FG002|Overall Study|Adverse Event|21|||
129811171|NCT01153347|467276355|FG003|Overall Study|Adverse Event|7|||
129811172|NCT01153347|467276352|FG000|Overall Study|Severe non-compliance to protocol|6|||
129811173|NCT01153347|467276353|FG001|Overall Study|Severe non-compliance to protocol|7|||
129811174|NCT01153347|467276354|FG002|Overall Study|Severe non-compliance to protocol|4|||
129811175|NCT01153347|467276355|FG003|Overall Study|Severe non-compliance to protocol|3|||
129811176|NCT01153347|467276352|FG000|Overall Study|Condition under investigation worsened|1|||
129811177|NCT01153347|467276353|FG001|Overall Study|Condition under investigation worsened|1|||
129811178|NCT01153347|467276354|FG002|Overall Study|Condition under investigation worsened|0|||
129811179|NCT01153347|467276355|FG003|Overall Study|Condition under investigation worsened|0|||
129811180|NCT01153347|467276352|FG000|Overall Study|Lack of Efficacy|2|||
129896846|NCT03761784|467582157|FG001|Overall Study|Lost to Follow-up|7|||
129896847|NCT03761784|467582156|FG000|Overall Study|Pregnancy|1|||
129896848|NCT03761784|467582157|FG001|Overall Study|Pregnancy|0|||
129896849|NCT03761784|467582156|FG000|Overall Study|Protocol Violation|2|||
129896850|NCT03761784|467582157|FG001|Overall Study|Protocol Violation|0|||
130112360|NCT00738920|468371151|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
129896851|NCT03761784|467582156|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
129896852|NCT03761784|467582157|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
129896853|NCT03761784|467582156|FG000|Overall Study|Withdrawal by Subject|9|||
129896854|NCT03761784|467582157|FG001|Overall Study|Withdrawal by Subject|4|||
129896855|NCT03761784|467582156|FG000|Overall Study|Physician Decision|1|||
129896856|NCT03761784|467582157|FG001|Overall Study|Physician Decision|0|||
129896857|NCT03761784|467582156|FG000|Overall Study|Other Than Specified|1|||
129896858|NCT03761784|467582157|FG001|Overall Study|Other Than Specified|0|||
129896859|NCT00586339|467582158|FG000|Overall Study|Withdrawal by Subject|1|||
129896860|NCT00586339|467582159|FG001|Overall Study|Withdrawal by Subject|3|||
129896861|NCT00586339|467582160|FG002|Overall Study|Withdrawal by Subject|1|||
129896862|NCT00586339|467582158|FG000|Overall Study|Migrated/moved from study area|3|||
129811181|NCT01153347|467276353|FG001|Overall Study|Lack of Efficacy|2|||
130058568|NCT04031404|468170355|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
130058569|NCT04031404|468170354|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
130058570|NCT04031404|468170355|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
130058571|NCT04031404|468170354|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
130058572|NCT04031404|468170355|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
130058573|NCT04031404|468170354|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
130058574|NCT04031404|468170355|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
130058575|NCT00831441|468170356|FG000|Randomized|Death|82|||
130058576|NCT00831441|468170357|FG001|Randomized|Death|81|||
130058577|NCT00831441|468170356|FG000|Randomized|Adverse Event|248|||
130058578|NCT00831441|468170357|FG001|Randomized|Adverse Event|321|||
130058579|NCT00831441|468170356|FG000|Randomized|Emergency procedure|2|||
130058580|NCT00831441|468170357|FG001|Randomized|Emergency procedure|2|||
130058581|NCT00831441|468170356|FG000|Randomized|Elective procedure|26|||
130058582|NCT00831441|468170357|FG001|Randomized|Elective procedure|25|||
130058583|NCT00831441|468170356|FG000|Randomized|Physician Decision|26|||
130058584|NCT00831441|468170357|FG001|Randomized|Physician Decision|35|||
130058585|NCT00831441|468170356|FG000|Randomized|No longer met criteria|13|||
130058586|NCT00831441|468170357|FG001|Randomized|No longer met criteria|19|||
130058587|NCT00831441|468170356|FG000|Randomized|Withdrawal by Subject|178|||
130058588|NCT00831441|468170357|FG001|Randomized|Withdrawal by Subject|212|||
130058589|NCT00831441|468170356|FG000|Randomized|Lost to Follow-up|26|||
130058590|NCT00831441|468170357|FG001|Randomized|Lost to Follow-up|35|||
129811182|NCT01153347|467276354|FG002|Overall Study|Lack of Efficacy|0|||
129811183|NCT01153347|467276355|FG003|Overall Study|Lack of Efficacy|4|||
129811184|NCT01153347|467276352|FG000|Overall Study|Study-specific withdrawal criteria|4|||
129811185|NCT01153347|467276353|FG001|Overall Study|Study-specific withdrawal criteria|3|||
129811186|NCT01153347|467276354|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129811187|NCT01153347|467276355|FG003|Overall Study|Study-specific withdrawal criteria|2|||
129811188|NCT01153347|467276352|FG000|Overall Study|Lost to Follow-up|4|||
129811189|NCT01153347|467276353|FG001|Overall Study|Lost to Follow-up|9|||
129811190|NCT01153347|467276354|FG002|Overall Study|Lost to Follow-up|11|||
129811191|NCT01153347|467276355|FG003|Overall Study|Lost to Follow-up|8|||
129811192|NCT01153347|467276352|FG000|Overall Study|Other|5|||
129811193|NCT01153347|467276353|FG001|Overall Study|Other|5|||
129811194|NCT01153347|467276354|FG002|Overall Study|Other|4|||
129811195|NCT01153347|467276355|FG003|Overall Study|Other|0|||
129811196|NCT01153347|467276352|FG000|Overall Study|Death|1|||
129811197|NCT01153347|467276353|FG001|Overall Study|Death|0|||
129811198|NCT01153347|467276354|FG002|Overall Study|Death|0|||
129811199|NCT01153347|467276355|FG003|Overall Study|Death|0|||
129811200|NCT00297830|467276356|FG000|6 Month Visit|Death|1|||
129811201|NCT00297830|467276357|FG001|6 Month Visit|Death|0|||
129811202|NCT00297830|467276358|FG002|6 Month Visit|Death|2|||
129811203|NCT00297830|467276356|FG000|6 Month Visit|Withdrawal by Subject|2|||
130058591|NCT00831441|468170356|FG000|Randomized|Administrative reason by sponsor|2780|||
130058592|NCT00831441|468170357|FG001|Randomized|Administrative reason by sponsor|2671|||
130058593|NCT00831441|468170356|FG000|Randomized|poor/non-compliance|30|||
130058594|NCT00831441|468170357|FG001|Randomized|poor/non-compliance|38|||
129811204|NCT00297830|467276357|FG001|6 Month Visit|Withdrawal by Subject|1|||
129811205|NCT00297830|467276358|FG002|6 Month Visit|Withdrawal by Subject|1|||
129811206|NCT00297830|467276356|FG000|6 Month Visit|Adverse Event|0|||
129811207|NCT00297830|467276357|FG001|6 Month Visit|Adverse Event|1|||
129811208|NCT00297830|467276358|FG002|6 Month Visit|Adverse Event|0|||
129811209|NCT00297830|467276356|FG000|12 Month Visit|Lost to Follow-up|1|||
129811210|NCT00297830|467276357|FG001|12 Month Visit|Lost to Follow-up|0|||
129811211|NCT00297830|467276358|FG002|12 Month Visit|Lost to Follow-up|0|||
129811212|NCT00297830|467276356|FG000|12 Month Visit|Adverse Event|0|||
129811213|NCT00297830|467276357|FG001|12 Month Visit|Adverse Event|3|||
129811214|NCT00297830|467276358|FG002|12 Month Visit|Adverse Event|0|||
129811215|NCT00297830|467276356|FG000|12 Month Visit|Withdrawal by Subject|0|||
129811216|NCT00297830|467276357|FG001|12 Month Visit|Withdrawal by Subject|3|||
129811217|NCT00297830|467276358|FG002|12 Month Visit|Withdrawal by Subject|0|||
129811218|NCT05096221|467276361|FG000|Part 2|Physician Decision|0|||
129811219|NCT05096221|467276362|FG001|Part 2|Physician Decision|1|||
129811220|NCT04678661|467276364|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
129811221|NCT04678661|467276365|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
129811222|NCT04678661|467276364|FG000|Overall Study|Protocol Violation|2|||
129811223|NCT04678661|467276365|FG001|Overall Study|Protocol Violation|0|||
129811224|NCT04678661|467276364|FG000|Overall Study|Withdrawal by Subject|1|||
129811225|NCT04678661|467276365|FG001|Overall Study|Withdrawal by Subject|0|||
129811226|NCT04678661|467276364|FG000|Overall Study|Lost to Follow-up|2|||
129811227|NCT04678661|467276365|FG001|Overall Study|Lost to Follow-up|0|||
129811228|NCT04678661|467276364|FG000|Overall Study|Death|2|||
129811229|NCT04678661|467276365|FG001|Overall Study|Death|0|||
129811230|NCT03094169|467276366|FG000|Overall Study|Lack of Efficacy|0|||
129811231|NCT03094169|467276367|FG001|Overall Study|Lack of Efficacy|0|||
129811232|NCT03094169|467276368|FG002|Overall Study|Lack of Efficacy|0|||
129811233|NCT03094169|467276369|FG003|Overall Study|Lack of Efficacy|0|||
129811234|NCT03094169|467276370|FG004|Overall Study|Lack of Efficacy|0|||
129811235|NCT03094169|467276371|FG005|Overall Study|Lack of Efficacy|0|||
129811236|NCT03094169|467276372|FG006|Overall Study|Lack of Efficacy|0|||
129811237|NCT03094169|467276373|FG007|Overall Study|Lack of Efficacy|21|||
129811238|NCT03094169|467276366|FG000|Overall Study|Adverse Event|0|||
129811239|NCT03094169|467276367|FG001|Overall Study|Adverse Event|0|||
129811240|NCT03094169|467276368|FG002|Overall Study|Adverse Event|0|||
129811241|NCT03094169|467276369|FG003|Overall Study|Adverse Event|0|||
129811242|NCT03094169|467276370|FG004|Overall Study|Adverse Event|0|||
129811243|NCT03094169|467276371|FG005|Overall Study|Adverse Event|0|||
129811244|NCT03094169|467276372|FG006|Overall Study|Adverse Event|0|||
129811245|NCT03094169|467276373|FG007|Overall Study|Adverse Event|2|||
129811246|NCT03094169|467276366|FG000|Overall Study|Withdrawal by Subject|0|||
129811247|NCT03094169|467276367|FG001|Overall Study|Withdrawal by Subject|0|||
129811248|NCT03094169|467276368|FG002|Overall Study|Withdrawal by Subject|0|||
129811249|NCT03094169|467276369|FG003|Overall Study|Withdrawal by Subject|0|||
129811250|NCT03094169|467276370|FG004|Overall Study|Withdrawal by Subject|0|||
130112361|NCT00738920|468371152|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
129811251|NCT03094169|467276371|FG005|Overall Study|Withdrawal by Subject|0|||
129811252|NCT03094169|467276372|FG006|Overall Study|Withdrawal by Subject|1|||
129811253|NCT03094169|467276373|FG007|Overall Study|Withdrawal by Subject|1|||
130112362|NCT00738920|468371153|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
129811254|NCT03094169|467276366|FG000|Overall Study|Trial Termination|0|||
129811255|NCT03094169|467276367|FG001|Overall Study|Trial Termination|0|||
129811256|NCT03094169|467276368|FG002|Overall Study|Trial Termination|0|||
129811257|NCT03094169|467276369|FG003|Overall Study|Trial Termination|0|||
130058595|NCT00831441|468170356|FG000|Randomized|non-specified|276|||
130058596|NCT00831441|468170357|FG001|Randomized|non-specified|266|||
129811258|NCT03094169|467276370|FG004|Overall Study|Trial Termination|0|||
129811259|NCT03094169|467276371|FG005|Overall Study|Trial Termination|0|||
129811260|NCT03094169|467276372|FG006|Overall Study|Trial Termination|0|||
129811261|NCT03094169|467276373|FG007|Overall Study|Trial Termination|1|||
129811262|NCT04645953|467276374|FG000|Overall Study|Lost to Follow-up|2|||
129811263|NCT04645953|467276375|FG001|Overall Study|Lost to Follow-up|1|||
129811264|NCT04645953|467276376|FG002|Overall Study|Lost to Follow-up|1|||
129811265|NCT04645953|467276374|FG000|Overall Study|Withdrawal by Subject|0|||
129811266|NCT04645953|467276375|FG001|Overall Study|Withdrawal by Subject|1|||
129811267|NCT04645953|467276376|FG002|Overall Study|Withdrawal by Subject|0|||
129811268|NCT04645953|467276374|FG000|Overall Study|Physician Decision|0|||
129811269|NCT04645953|467276375|FG001|Overall Study|Physician Decision|1|||
129811270|NCT04645953|467276376|FG002|Overall Study|Physician Decision|0|||
129811271|NCT04645953|467276374|FG000|Overall Study|Discontinued Prior to Dosing|0|||
129811272|NCT04645953|467276375|FG001|Overall Study|Discontinued Prior to Dosing|0|||
129811273|NCT04645953|467276376|FG002|Overall Study|Discontinued Prior to Dosing|2|||
129811274|NCT04613375|467276377|FG000|Overall Study|Death|198|||
129811275|NCT04613375|467276377|FG000|Overall Study|Withdrawal by Subject|3|||
129811276|NCT01921387|467276378|FG000|Overall Study|Adverse Event|1|||
129811277|NCT01706146|467276381|FG000|Overall Study|Withdrawal by Subject|1|||
129811278|NCT01706146|467276381|FG000|Overall Study|Adverse Event|3|||
129811279|NCT01706146|467276381|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
129811280|NCT00675948|467276382|FG000|Overall Study|Adverse Event|23|||
129811281|NCT00675948|467276383|FG001|Overall Study|Adverse Event|1|||
129811282|NCT00675948|467276382|FG000|Overall Study|Lack of Efficacy|3|||
129811283|NCT00675948|467276383|FG001|Overall Study|Lack of Efficacy|0|||
129811284|NCT00675948|467276382|FG000|Overall Study|Withdrawal by Subject|7|||
129811285|NCT00675948|467276383|FG001|Overall Study|Withdrawal by Subject|0|||
130058597|NCT00831441|468170356|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
130058598|NCT00831441|468170357|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
130058599|NCT00831441|468170356|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
130058600|NCT00831441|468170357|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
130058601|NCT00831441|468170356|FG000|Follow Up (30 Days)|Death|63|||
130058602|NCT00831441|468170357|FG001|Follow Up (30 Days)|Death|86|||
130058603|NCT00831441|468170356|FG000|Follow Up (30 Days)|non-specified|16|||
130058604|NCT00831441|468170357|FG001|Follow Up (30 Days)|non-specified|26|||
130058605|NCT00831441|468170356|FG000|Follow Up (30 Days)|missing end of study status|0|||
130058606|NCT00831441|468170357|FG001|Follow Up (30 Days)|missing end of study status|1|||
130058607|NCT05674344|468170358|FG000|Overall Study|Screen Fail|21|||
130058608|NCT05674344|468170358|FG000|Overall Study|Incomplete study procedures|3|||
130058609|NCT00111917|468170359|FG000|Overall Study|Withdrawal by Subject|1|||
130058610|NCT00111917|468170360|FG001|Overall Study|Withdrawal by Subject|1|||
130058611|NCT00798655|468170361|FG000|Overall Study|Did not receive at least one dose of pan|2|||
130058612|NCT00343291|468170362|FG000|Overall Study|Adverse Event|13|||
129811286|NCT00675948|467276382|FG000|Overall Study|Lost to Follow-up|2|||
129811287|NCT00675948|467276383|FG001|Overall Study|Lost to Follow-up|0|||
129811288|NCT00675948|467276382|FG000|Overall Study|Protocol Violation|1|||
129811289|NCT00675948|467276383|FG001|Overall Study|Protocol Violation|0|||
129811290|NCT00675948|467276382|FG000|Overall Study|Pain under control|1|||
129811291|NCT00675948|467276383|FG001|Overall Study|Pain under control|0|||
129811292|NCT00675948|467276382|FG000|Overall Study|Sponsor decision|0|||
129811293|NCT00675948|467276383|FG001|Overall Study|Sponsor decision|1|||
129811294|NCT00675948|467276382|FG000|Overall Study|Patient died|1|||
129811295|NCT00675948|467276383|FG001|Overall Study|Patient died|0|||
129811296|NCT00675948|467276382|FG000|Overall Study|Patient unable to comply with diaries|1|||
129811297|NCT00675948|467276383|FG001|Overall Study|Patient unable to comply with diaries|0|||
129811298|NCT00675948|467276382|FG000|Overall Study|Patient feels unable to take medication|0|||
130058613|NCT00343291|468170363|FG001|Overall Study|Adverse Event|13|||
130058614|NCT00343291|468170362|FG000|Overall Study|Death|3|||
130058615|NCT00343291|468170363|FG001|Overall Study|Death|2|||
130058616|NCT00343291|468170362|FG000|Overall Study|Progressive disease|33|||
130058617|NCT00343291|468170363|FG001|Overall Study|Progressive disease|34|||
129896863|NCT00586339|467582159|FG001|Overall Study|Migrated/moved from study area|2|||
129896864|NCT00586339|467582160|FG002|Overall Study|Migrated/moved from study area|4|||
129896865|NCT00586339|467582158|FG000|Overall Study|Lost to Follow-up|3|||
129896866|NCT00586339|467582159|FG001|Overall Study|Lost to Follow-up|2|||
129896867|NCT00586339|467582160|FG002|Overall Study|Lost to Follow-up|1|||
129896868|NCT04305912|467582163|FG000|First Intervention|COVID-19 Suspension|2|||
129896869|NCT04305912|467582164|FG001|First Intervention|COVID-19 Suspension|0|||
129896870|NCT04305912|467582163|FG000|First Intervention|Withdrawal by Subject|0|||
129896871|NCT04305912|467582164|FG001|First Intervention|Withdrawal by Subject|1|||
129896872|NCT04305912|467582163|FG000|Second Intervention|Adverse Event|0|||
129896873|NCT04305912|467582164|FG001|Second Intervention|Adverse Event|1|||
129896874|NCT01649427|467582165|FG000|Overall Study|Adverse Event|1|||
129896875|NCT01649427|467582166|FG001|Overall Study|Adverse Event|1|||
129896876|NCT01649427|467582165|FG000|Overall Study|Withdrawal by Subject|8|||
129896877|NCT01649427|467582166|FG001|Overall Study|Withdrawal by Subject|7|||
129896878|NCT01649427|467582165|FG000|Overall Study|Lost to Follow-up|0|||
129896879|NCT01649427|467582166|FG001|Overall Study|Lost to Follow-up|1|||
129896880|NCT01649427|467582165|FG000|Overall Study|Graft loss|0|||
129896881|NCT01649427|467582166|FG001|Overall Study|Graft loss|1|||
129896882|NCT01649427|467582165|FG000|Overall Study|Surgical problems during nephrectomy|2|||
129896883|NCT01649427|467582166|FG001|Overall Study|Surgical problems during nephrectomy|2|||
129896884|NCT05196737|467582170|FG000|Non-intervention Week|Lost to Follow-up|2|||
129896885|NCT05196737|467582170|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
129896886|NCT04888585|467582171|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
129896887|NCT04888585|467582172|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
129896888|NCT04888585|467582173|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
129896889|NCT04888585|467582174|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
129896890|NCT04888585|467582175|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
129896891|NCT04888585|467582176|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896892|NCT04888585|467582177|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
130058618|NCT00343291|468170362|FG000|Overall Study|Withdrawal by Subject|0|||
130058619|NCT00343291|468170363|FG001|Overall Study|Withdrawal by Subject|2|||
130058620|NCT00343291|468170362|FG000|Overall Study|Other|8|||
130058621|NCT00343291|468170363|FG001|Overall Study|Other|5|||
130058622|NCT00960934|468170364|FG000|Overall Study|Adverse Event|2|||
129811299|NCT00675948|467276383|FG001|Overall Study|Patient feels unable to take medication|1|||
129811300|NCT02582983|467276384|FG000|Overall Study|Death|3|||
129811301|NCT02582983|467276384|FG000|Overall Study|Withdrawal by Subject|2|||
129811302|NCT02582983|467276384|FG000|Overall Study|Adverse Event|1|||
129811303|NCT01081678|467276390|FG000|Overall Study|Ineligibility Determined|0|||
129811304|NCT01081678|467276391|FG001|Overall Study|Ineligibility Determined|0|||
129811305|NCT01081678|467276392|FG002|Overall Study|Ineligibility Determined|1|||
129811306|NCT01081678|467276393|FG003|Overall Study|Ineligibility Determined|1|||
129811307|NCT01081678|467276390|FG000|Overall Study|Noncompliance|3|||
129811308|NCT01081678|467276391|FG001|Overall Study|Noncompliance|4|||
129811309|NCT01081678|467276392|FG002|Overall Study|Noncompliance|5|||
129896893|NCT04888585|467582178|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129811310|NCT01081678|467276393|FG003|Overall Study|Noncompliance|2|||
129811311|NCT01081678|467276390|FG000|Overall Study|Adverse Event|2|||
129811312|NCT01081678|467276391|FG001|Overall Study|Adverse Event|1|||
129896894|NCT04888585|467582179|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896895|NCT04888585|467582180|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896896|NCT04888585|467582181|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896897|NCT04888585|467582171|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130058623|NCT00960934|468170365|FG001|Overall Study|Adverse Event|3|||
130058624|NCT00960934|468170366|FG002|Overall Study|Adverse Event|3|||
129811313|NCT01081678|467276392|FG002|Overall Study|Adverse Event|2|||
129811314|NCT01081678|467276393|FG003|Overall Study|Adverse Event|2|||
129811315|NCT01081678|467276390|FG000|Overall Study|Withdrawal by Subject|15|||
129811316|NCT01081678|467276391|FG001|Overall Study|Withdrawal by Subject|7|||
129811317|NCT01081678|467276392|FG002|Overall Study|Withdrawal by Subject|17|||
129811318|NCT01081678|467276393|FG003|Overall Study|Withdrawal by Subject|14|||
129811319|NCT01081678|467276390|FG000|Overall Study|Administrative Decision|1|||
129811320|NCT01081678|467276391|FG001|Overall Study|Administrative Decision|0|||
129811321|NCT01081678|467276392|FG002|Overall Study|Administrative Decision|0|||
129811322|NCT01081678|467276393|FG003|Overall Study|Administrative Decision|1|||
129811323|NCT01081678|467276390|FG000|Overall Study|Lost to Follow-up|4|||
129811324|NCT01081678|467276391|FG001|Overall Study|Lost to Follow-up|1|||
129811325|NCT01081678|467276392|FG002|Overall Study|Lost to Follow-up|4|||
129811326|NCT01081678|467276393|FG003|Overall Study|Lost to Follow-up|3|||
129811327|NCT01081678|467276390|FG000|Overall Study|Death|2|||
129811328|NCT01081678|467276391|FG001|Overall Study|Death|2|||
129811329|NCT01081678|467276392|FG002|Overall Study|Death|2|||
129811330|NCT01081678|467276393|FG003|Overall Study|Death|6|||
129811331|NCT01081678|467276390|FG000|Overall Study|Other|0|||
129811332|NCT01081678|467276391|FG001|Overall Study|Other|1|||
129811333|NCT01081678|467276392|FG002|Overall Study|Other|0|||
129811334|NCT01081678|467276393|FG003|Overall Study|Other|0|||
129811335|NCT00444912|467276394|FG000|Overall Study|Death|1|||
129811336|NCT00444912|467276395|FG001|Overall Study|Death|2|||
129811337|NCT00444912|467276394|FG000|Overall Study|Lost to Follow-up|1|||
129811338|NCT00444912|467276395|FG001|Overall Study|Lost to Follow-up|0|||
129811339|NCT00444912|467276394|FG000|Overall Study|Participant Failed Mobilization|1|||
129811340|NCT00444912|467276395|FG001|Overall Study|Participant Failed Mobilization|0|||
129811341|NCT01007812|467276398|FG000|Period 1, One Week|Lost to Follow-up|0|||
129811342|NCT01007812|467276399|FG001|Period 1, One Week|Lost to Follow-up|1|||
129811343|NCT01007812|467276398|FG000|Period 1, One Week|Discomfort|1|||
129811344|NCT01007812|467276399|FG001|Period 1, One Week|Discomfort|0|||
129811345|NCT01091974|467276400|FG000|Overall Study|Did not start intervention|3|||
129811346|NCT01091974|467276401|FG001|Overall Study|Did not start intervention|1|||
129811347|NCT01091974|467276402|FG002|Overall Study|Did not start intervention|3|||
129896898|NCT04888585|467582172|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
129896899|NCT04888585|467582173|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
130058625|NCT00960934|468170367|FG003|Overall Study|Adverse Event|2|||
129896900|NCT04888585|467582174|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
129896901|NCT04888585|467582175|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
130058626|NCT00960934|468170368|FG004|Overall Study|Adverse Event|4|||
130058627|NCT00960934|468170369|FG005|Overall Study|Adverse Event|3|||
129811348|NCT01091974|467276403|FG003|Overall Study|Did not start intervention|1|||
130058628|NCT00960934|468170364|FG000|Overall Study|Lack of Efficacy|1|||
129811349|NCT01091974|467276400|FG000|Overall Study|resumed sleep medication|0|||
129811350|NCT01091974|467276401|FG001|Overall Study|resumed sleep medication|0|||
129811351|NCT01091974|467276402|FG002|Overall Study|resumed sleep medication|1|||
129811352|NCT01091974|467276403|FG003|Overall Study|resumed sleep medication|2|||
129811353|NCT01091974|467276400|FG000|Overall Study|Withdrawal by Subject|1|||
129811354|NCT01091974|467276401|FG001|Overall Study|Withdrawal by Subject|3|||
129811355|NCT01091974|467276402|FG002|Overall Study|Withdrawal by Subject|2|||
129811356|NCT01091974|467276403|FG003|Overall Study|Withdrawal by Subject|2|||
129896902|NCT04888585|467582176|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129896903|NCT04888585|467582177|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129811357|NCT01091974|467276400|FG000|Overall Study|side-effects|1|||
129811358|NCT01091974|467276401|FG001|Overall Study|side-effects|1|||
129811359|NCT01091974|467276402|FG002|Overall Study|side-effects|0|||
129811360|NCT01091974|467276403|FG003|Overall Study|side-effects|2|||
129811361|NCT02499783|467276404|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
129811362|NCT02499783|467276405|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
129811363|NCT02499783|467276406|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
129811364|NCT02499783|467276404|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
129811365|NCT02499783|467276405|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
129811366|NCT02499783|467276406|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
129811367|NCT02499783|467276404|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
129811368|NCT02499783|467276405|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
129811369|NCT02499783|467276406|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
129811370|NCT02499783|467276404|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
129811371|NCT02499783|467276405|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
129811372|NCT02499783|467276406|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
129811373|NCT02499783|467276404|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
129811374|NCT02499783|467276405|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
129811375|NCT02499783|467276406|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
129811376|NCT02499783|467276404|FG000|DB Period: Weeks 0-8|Other|1|||
129811377|NCT02499783|467276405|FG001|DB Period: Weeks 0-8|Other|1|||
129811378|NCT02499783|467276406|FG002|DB Period: Weeks 0-8|Other|0|||
129811379|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
129811380|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
129811381|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
129811382|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
129811383|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
129811384|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
129811385|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
129811386|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
129811387|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
129811388|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
129811389|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
129811390|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
129811391|NCT01866293|467276407|FG000|Overall Study|Adverse Event|2|||
129811392|NCT00555971|467276409|FG000|Overall Study|Adverse Event|1|||
129811393|NCT00555971|467276410|FG001|Overall Study|Adverse Event|1|||
129811394|NCT00518284|467276411|FG000|Overall Study|Adverse Event|0|||
129811395|NCT00518284|467276412|FG001|Overall Study|Adverse Event|1|||
129811396|NCT00518284|467276413|FG002|Overall Study|Adverse Event|0|||
129811397|NCT00518284|467276414|FG003|Overall Study|Adverse Event|0|||
129811398|NCT00518284|467276411|FG000|Overall Study|Study Termination|0|||
129811399|NCT00518284|467276412|FG001|Overall Study|Study Termination|2|||
129811400|NCT00518284|467276413|FG002|Overall Study|Study Termination|1|||
129811401|NCT00518284|467276414|FG003|Overall Study|Study Termination|2|||
129811402|NCT00801632|467276415|FG000|Overall Study|Re-transplant|1|||
129811403|NCT00621582|467276416|FG000|Overall Study|Adverse Event|7|||
129811404|NCT00621582|467276416|FG000|Overall Study|Protocol Violation|57|||
129811405|NCT00621582|467276416|FG000|Overall Study|Lost to Follow-up|24|||
129811406|NCT00621582|467276416|FG000|Overall Study|issues not identified by investigators|18|||
129811407|NCT01387932|467276418|FG000|Randomized and Treated|Physician Decision|3|||
129811408|NCT01387932|467276419|FG001|Randomized and Treated|Physician Decision|2|||
129811409|NCT01387932|467276418|FG000|Randomized and Treated|Withdrawal by Subject|4|||
129896904|NCT04888585|467582178|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129811410|NCT01387932|467276419|FG001|Randomized and Treated|Withdrawal by Subject|2|||
129811411|NCT01387932|467276418|FG000|Survival Follow-up|Liver Transplant|24|||
129811412|NCT01387932|467276419|FG001|Survival Follow-up|Liver Transplant|28|||
129811413|NCT01387932|467276418|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
129811414|NCT01387932|467276419|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
129811415|NCT01387932|467276418|FG000|Survival Follow-up|Withdrawal by Subject|2|||
130058629|NCT00960934|468170365|FG001|Overall Study|Lack of Efficacy|0|||
130058630|NCT00960934|468170366|FG002|Overall Study|Lack of Efficacy|0|||
130058631|NCT00960934|468170367|FG003|Overall Study|Lack of Efficacy|0|||
130058632|NCT00960934|468170368|FG004|Overall Study|Lack of Efficacy|0|||
130058633|NCT00960934|468170369|FG005|Overall Study|Lack of Efficacy|0|||
130058634|NCT00960934|468170364|FG000|Overall Study|Lost to Follow-up|0|||
130058635|NCT00960934|468170365|FG001|Overall Study|Lost to Follow-up|1|||
130058636|NCT00960934|468170366|FG002|Overall Study|Lost to Follow-up|0|||
129896905|NCT04888585|467582179|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
130058637|NCT00960934|468170367|FG003|Overall Study|Lost to Follow-up|0|||
129896906|NCT04888585|467582180|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129811416|NCT01387932|467276419|FG001|Survival Follow-up|Withdrawal by Subject|4|||
129811417|NCT01387932|467276418|FG000|Survival Follow-up|Lost to Follow-up|6|||
129811418|NCT01387932|467276419|FG001|Survival Follow-up|Lost to Follow-up|5|||
129811419|NCT00205881|467276420|FG000|Overall Study|Withdrawal by Subject|16|||
129811420|NCT02217878|467276426|FG000|Overall Study|required morphine due to chest pain|1|||
129811421|NCT02217878|467276427|FG001|Overall Study|required morphine due to chest pain|2|||
129811422|NCT02217878|467276426|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
129811423|NCT02217878|467276427|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
129811424|NCT00334958|467276428|FG000|Overall Study|Medication Noncompliance|0|||
129811425|NCT00334958|467276429|FG001|Overall Study|Medication Noncompliance|3|||
129811426|NCT00334958|467276428|FG000|Overall Study|Protocol Violation|2|||
129811427|NCT00334958|467276429|FG001|Overall Study|Protocol Violation|2|||
129811428|NCT00334958|467276428|FG000|Overall Study|Request of the investigator or sponsor|0|||
129811429|NCT00334958|467276429|FG001|Overall Study|Request of the investigator or sponsor|1|||
129811430|NCT00334958|467276428|FG000|Overall Study|Withdrawal by Subject|7|||
129811431|NCT00334958|467276429|FG001|Overall Study|Withdrawal by Subject|4|||
129811432|NCT00334958|467276428|FG000|Overall Study|Adverse Event|27|||
129811433|NCT00334958|467276429|FG001|Overall Study|Adverse Event|12|||
129811434|NCT00334958|467276428|FG000|Overall Study|Other|1|||
129811435|NCT00334958|467276429|FG001|Overall Study|Other|2|||
129811436|NCT00622401|467276430|FG000|Overall Study|Disease progression prior to treatment|3|||
129811437|NCT00622401|467276431|FG001|Overall Study|Disease progression prior to treatment|2|||
129811438|NCT00622401|467276432|FG002|Overall Study|Disease progression prior to treatment|0|||
129811439|NCT00781274|467276436|FG000|Overall Study|Withdrawal by Subject|2|||
129811440|NCT02021773|467276440|FG000|Overall Study|Adverse Event|1|||
129811441|NCT02021773|467276441|FG001|Overall Study|Adverse Event|4|||
129811442|NCT02021773|467276442|FG002|Overall Study|Adverse Event|3|||
129811443|NCT02021773|467276440|FG000|Overall Study|Lack of Efficacy|2|||
129811444|NCT02021773|467276441|FG001|Overall Study|Lack of Efficacy|2|||
129811445|NCT02021773|467276442|FG002|Overall Study|Lack of Efficacy|2|||
129811446|NCT02021773|467276440|FG000|Overall Study|Protocol Violation|2|||
129811447|NCT02021773|467276441|FG001|Overall Study|Protocol Violation|3|||
129811448|NCT02021773|467276442|FG002|Overall Study|Protocol Violation|1|||
129811449|NCT02021773|467276440|FG000|Overall Study|Withdrawal by Subject|3|||
129811450|NCT02021773|467276441|FG001|Overall Study|Withdrawal by Subject|4|||
129811451|NCT02021773|467276442|FG002|Overall Study|Withdrawal by Subject|5|||
129811452|NCT02021773|467276440|FG000|Overall Study|Lost to Follow-up|1|||
129811453|NCT02021773|467276441|FG001|Overall Study|Lost to Follow-up|3|||
129811454|NCT02021773|467276442|FG002|Overall Study|Lost to Follow-up|0|||
129811455|NCT02021773|467276440|FG000|Overall Study|Reason not specified|3|||
129811456|NCT02021773|467276441|FG001|Overall Study|Reason not specified|0|||
129811457|NCT02021773|467276442|FG002|Overall Study|Reason not specified|0|||
129811458|NCT02243696|467276443|FG000|Overall Study|Death|282|||
129811459|NCT02243696|467276443|FG000|Overall Study|Withdrawal by Subject|79|||
129811460|NCT02243696|467276443|FG000|Overall Study|Lost to Follow-up|57|||
129811461|NCT02243696|467276443|FG000|Overall Study|Subject No Longer has Study System|42|||
129811462|NCT02243696|467276443|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
129811463|NCT02243696|467276443|FG000|Overall Study|Study Terminated for EP PASSION|961|||
129811464|NCT01534962|467276444|FG000|Overall Study|Randomized but did not start treatment|2|||
129811465|NCT01534962|467276445|FG001|Overall Study|Randomized but did not start treatment|0|||
129811466|NCT01534962|467276446|FG002|Overall Study|Randomized but did not start treatment|0|||
129896907|NCT04888585|467582181|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129896908|NCT04888585|467582171|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896909|NCT04888585|467582172|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129811467|NCT01534962|467276447|FG003|Overall Study|Randomized but did not start treatment|1|||
129811468|NCT01534962|467276444|FG000|Overall Study|Discontinued at AF recurrence|35|||
129811469|NCT01534962|467276445|FG001|Overall Study|Discontinued at AF recurrence|26|||
129811470|NCT01534962|467276446|FG002|Overall Study|Discontinued at AF recurrence|24|||
129811471|NCT01534962|467276447|FG003|Overall Study|Discontinued at AF recurrence|31|||
129811472|NCT00190671|467276448|FG000|Overall Study|Satisfactory Response|4|||
129811473|NCT00190671|467276449|FG001|Overall Study|Satisfactory Response|7|||
129811474|NCT00190671|467276448|FG000|Overall Study|Lack of Efficacy|19|||
129896910|NCT04888585|467582173|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
129811475|NCT00190671|467276449|FG001|Overall Study|Lack of Efficacy|24|||
129811476|NCT00190671|467276448|FG000|Overall Study|Death from Study Disease|1|||
129811477|NCT00190671|467276449|FG001|Overall Study|Death from Study Disease|1|||
129811478|NCT00190671|467276448|FG000|Overall Study|Adverse Event|3|||
129811479|NCT00190671|467276449|FG001|Overall Study|Adverse Event|2|||
129811480|NCT00190671|467276448|FG000|Overall Study|Clinical Relapse|0|||
129811481|NCT00190671|467276449|FG001|Overall Study|Clinical Relapse|1|||
129811482|NCT00190671|467276448|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
129811483|NCT00190671|467276449|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
129811484|NCT00190671|467276448|FG000|Overall Study|Death from Other Causes|0|||
129811485|NCT00190671|467276449|FG001|Overall Study|Death from Other Causes|2|||
129811486|NCT00190671|467276448|FG000|Overall Study|Protocol Violation|0|||
129811487|NCT00190671|467276449|FG001|Overall Study|Protocol Violation|1|||
129811488|NCT00190671|467276448|FG000|Overall Study|Withdrawal by Subject|0|||
129811489|NCT00190671|467276449|FG001|Overall Study|Withdrawal by Subject|2|||
129811490|NCT00191269|467276450|FG000|Overall Study|Protocol Violation|0|||
129811491|NCT00191269|467276451|FG001|Overall Study|Protocol Violation|2|||
129811492|NCT00191269|467276450|FG000|Overall Study|Adverse Event|1|||
129811493|NCT00191269|467276451|FG001|Overall Study|Adverse Event|4|||
129811494|NCT00191269|467276450|FG000|Overall Study|Progression of Disease|4|||
129811495|NCT00191269|467276451|FG001|Overall Study|Progression of Disease|42|||
129811496|NCT00191269|467276450|FG000|Overall Study|Lack of Efficacy|1|||
129811497|NCT00191269|467276451|FG001|Overall Study|Lack of Efficacy|5|||
129811498|NCT00191269|467276450|FG000|Overall Study|Withdrawal by Subject|0|||
129811499|NCT00191269|467276451|FG001|Overall Study|Withdrawal by Subject|1|||
129811500|NCT00191269|467276450|FG000|Overall Study|Pathologic Aggrevation|0|||
129811501|NCT00191269|467276451|FG001|Overall Study|Pathologic Aggrevation|1|||
129811502|NCT00191269|467276450|FG000|Overall Study|Physician Decision|0|||
129811503|NCT00191269|467276451|FG001|Overall Study|Physician Decision|3|||
129811504|NCT00668707|467276457|FG000|Overall Study|Cancer Recurrence|58|||
129811505|NCT00668707|467276458|FG001|Overall Study|Cancer Recurrence|58|||
129811506|NCT00668707|467276457|FG000|Overall Study|Withdrawal by Subject|117|||
129811507|NCT00668707|467276458|FG001|Overall Study|Withdrawal by Subject|100|||
129811508|NCT00668707|467276457|FG000|Overall Study|Lost to Follow-up|3|||
129811509|NCT00668707|467276458|FG001|Overall Study|Lost to Follow-up|6|||
129811510|NCT00668707|467276457|FG000|Overall Study|Protocol Violation|10|||
129811511|NCT00668707|467276458|FG001|Overall Study|Protocol Violation|12|||
129811512|NCT00668707|467276457|FG000|Overall Study|Death|11|||
129811513|NCT00668707|467276458|FG001|Overall Study|Death|4|||
129811514|NCT00191139|467276460|FG000|Overall Study|Adverse Event|2|||
129811515|NCT00191139|467276461|FG001|Overall Study|Adverse Event|6|||
129811516|NCT00191139|467276460|FG000|Overall Study|Death|2|||
129811517|NCT00191139|467276461|FG001|Overall Study|Death|0|||
129811518|NCT00191139|467276460|FG000|Overall Study|Withdrawal by Subject|0|||
129811519|NCT00191139|467276461|FG001|Overall Study|Withdrawal by Subject|3|||
129811520|NCT00191139|467276460|FG000|Overall Study|Disease Progression|0|||
129896911|NCT04888585|467582174|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130058638|NCT00960934|468170368|FG004|Overall Study|Lost to Follow-up|0|||
130058639|NCT00960934|468170369|FG005|Overall Study|Lost to Follow-up|0|||
129811521|NCT00191139|467276461|FG001|Overall Study|Disease Progression|1|||
129811522|NCT00191139|467276460|FG000|Overall Study|Other|1|||
129811523|NCT00191139|467276461|FG001|Overall Study|Other|2|||
129811524|NCT03338010|467276462|FG000|Overall Study|Withdrawal by Subject|14|||
129811525|NCT03338010|467276463|FG001|Overall Study|Withdrawal by Subject|8|||
129811526|NCT03338010|467276462|FG000|Overall Study|Lost to Follow-up|4|||
129811527|NCT03338010|467276463|FG001|Overall Study|Lost to Follow-up|2|||
129811528|NCT03338010|467276462|FG000|Overall Study|Adverse Event|3|||
129811529|NCT03338010|467276463|FG001|Overall Study|Adverse Event|2|||
129811530|NCT03338010|467276462|FG000|Overall Study|Physician Decision|2|||
129811531|NCT03338010|467276463|FG001|Overall Study|Physician Decision|2|||
129811532|NCT03338010|467276462|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129811533|NCT03338010|467276463|FG001|Overall Study|Non-Compliance with Study Drug|3|||
129896912|NCT04888585|467582175|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
129811534|NCT03338010|467276462|FG000|Overall Study|Protocol Violation|0|||
129811535|NCT03338010|467276463|FG001|Overall Study|Protocol Violation|1|||
130058640|NCT00960934|468170364|FG000|Overall Study|Other|2|||
129811536|NCT01146665|467276466|FG000|Overall Study|Withdrawal by Subject|10|||
129811537|NCT01146665|467276467|FG001|Overall Study|Withdrawal by Subject|16|||
129811538|NCT02465515|467276468|FG000|Overall Study|Investigator site closed|4|||
129811539|NCT02465515|467276469|FG001|Overall Study|Investigator site closed|5|||
129811540|NCT02465515|467276468|FG000|Overall Study|Withdrawal by Subject|74|||
129811541|NCT02465515|467276469|FG001|Overall Study|Withdrawal by Subject|43|||
129811542|NCT02465515|467276468|FG000|Overall Study|Physician Decision|8|||
129811543|NCT02465515|467276469|FG001|Overall Study|Physician Decision|12|||
129811544|NCT02465515|467276468|FG000|Overall Study|Lost to Follow-up|68|||
129811545|NCT02465515|467276469|FG001|Overall Study|Lost to Follow-up|51|||
130058641|NCT00960934|468170365|FG001|Overall Study|Other|1|||
130058642|NCT00960934|468170366|FG002|Overall Study|Other|5|||
129811546|NCT00751933|467276470|FG000|Overall Study|Withdrawal by Subject|0|||
129811547|NCT00751933|467276471|FG001|Overall Study|Withdrawal by Subject|1|||
129811548|NCT00751933|467276472|FG002|Overall Study|Withdrawal by Subject|0|||
129811549|NCT00751933|467276473|FG003|Overall Study|Withdrawal by Subject|0|||
129811550|NCT00751933|467276470|FG000|Overall Study|Physician Decision|0|||
129811551|NCT00751933|467276471|FG001|Overall Study|Physician Decision|0|||
129811552|NCT00751933|467276472|FG002|Overall Study|Physician Decision|1|||
129811553|NCT00751933|467276473|FG003|Overall Study|Physician Decision|1|||
129811554|NCT03846804|467276474|FG000|Overall Study|Refused blood draw|1|||
129811555|NCT03846804|467276474|FG000|Overall Study|Protocol Violation|1|||
129811556|NCT05248867|467276476|FG000|Double-blind Period|Lost to Follow-up|0|||
129811557|NCT05248867|467276477|FG001|Double-blind Period|Lost to Follow-up|3|||
129811558|NCT05248867|467276478|FG002|Double-blind Period|Lost to Follow-up|0|||
129811559|NCT05248867|467276479|FG003|Double-blind Period|Lost to Follow-up|0|||
129811560|NCT05248867|467276480|FG004|Double-blind Period|Lost to Follow-up|0|||
129811561|NCT05248867|467276481|FG005|Double-blind Period|Lost to Follow-up|0|||
129811562|NCT05248867|467276476|FG000|Double-blind Period|Withdrawal by Subject|5|||
129811563|NCT05248867|467276477|FG001|Double-blind Period|Withdrawal by Subject|14|||
129811564|NCT05248867|467276478|FG002|Double-blind Period|Withdrawal by Subject|0|||
129811565|NCT05248867|467276479|FG003|Double-blind Period|Withdrawal by Subject|0|||
129811566|NCT05248867|467276480|FG004|Double-blind Period|Withdrawal by Subject|0|||
129811567|NCT05248867|467276481|FG005|Double-blind Period|Withdrawal by Subject|0|||
129811568|NCT05248867|467276476|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811569|NCT05248867|467276477|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
129811570|NCT05248867|467276478|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811571|NCT05248867|467276479|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811572|NCT05248867|467276480|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811573|NCT05248867|467276481|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811574|NCT05248867|467276476|FG000|Double-blind Period|Other, not specified|3|||
129811575|NCT05248867|467276477|FG001|Double-blind Period|Other, not specified|8|||
129811576|NCT05248867|467276478|FG002|Double-blind Period|Other, not specified|0|||
129811577|NCT05248867|467276479|FG003|Double-blind Period|Other, not specified|0|||
129811578|NCT05248867|467276480|FG004|Double-blind Period|Other, not specified|0|||
129811579|NCT05248867|467276481|FG005|Double-blind Period|Other, not specified|0|||
129811580|NCT05248867|467276476|FG000|Open-label Period|Withdrawal by Subject|0|||
129811581|NCT05248867|467276477|FG001|Open-label Period|Withdrawal by Subject|0|||
129811582|NCT05248867|467276478|FG002|Open-label Period|Withdrawal by Subject|3|||
129811583|NCT05248867|467276479|FG003|Open-label Period|Withdrawal by Subject|1|||
129811584|NCT05248867|467276480|FG004|Open-label Period|Withdrawal by Subject|7|||
129811585|NCT05248867|467276481|FG005|Open-label Period|Withdrawal by Subject|9|||
129811586|NCT05248867|467276476|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811587|NCT05248867|467276477|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811588|NCT05248867|467276478|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811589|NCT05248867|467276479|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
129811590|NCT05248867|467276480|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811591|NCT05248867|467276481|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811592|NCT05248867|467276476|FG000|Open-label Period|Lost to Follow-up|0|||
129811593|NCT05248867|467276477|FG001|Open-label Period|Lost to Follow-up|0|||
129811594|NCT05248867|467276478|FG002|Open-label Period|Lost to Follow-up|0|||
129811595|NCT05248867|467276479|FG003|Open-label Period|Lost to Follow-up|0|||
129811596|NCT05248867|467276480|FG004|Open-label Period|Lost to Follow-up|5|||
129811597|NCT05248867|467276481|FG005|Open-label Period|Lost to Follow-up|2|||
129811598|NCT05248867|467276476|FG000|Open-label Period|COVID-19 Infection|0|||
129811599|NCT05248867|467276477|FG001|Open-label Period|COVID-19 Infection|0|||
129811600|NCT05248867|467276478|FG002|Open-label Period|COVID-19 Infection|0|||
129811601|NCT05248867|467276479|FG003|Open-label Period|COVID-19 Infection|0|||
129811602|NCT05248867|467276480|FG004|Open-label Period|COVID-19 Infection|1|||
129811603|NCT05248867|467276481|FG005|Open-label Period|COVID-19 Infection|0|||
129811604|NCT05248867|467276476|FG000|Open-label Period|Other, not specified|0|||
129811605|NCT05248867|467276477|FG001|Open-label Period|Other, not specified|0|||
129811606|NCT05248867|467276478|FG002|Open-label Period|Other, not specified|0|||
129811607|NCT05248867|467276479|FG003|Open-label Period|Other, not specified|0|||
129811608|NCT05248867|467276480|FG004|Open-label Period|Other, not specified|4|||
129811609|NCT05248867|467276481|FG005|Open-label Period|Other, not specified|0|||
129811610|NCT00345839|467276483|FG000|Overall Study|Withdrawal by Subject|91|||
129811611|NCT00345839|467276484|FG001|Overall Study|Withdrawal by Subject|98|||
129811612|NCT00345839|467276483|FG000|Overall Study|Lost to Follow-up|58|||
129811613|NCT00345839|467276484|FG001|Overall Study|Lost to Follow-up|61|||
129811614|NCT00743483|467276489|FG000|Baseline Period|Physician Decision|1|||
129811615|NCT00743483|467276489|FG000|Treatment Period|Adverse Event|1|||
129811616|NCT01088997|467276490|FG000|Overall Study|Physician Decision|1|||
129811617|NCT01088997|467276491|FG001|Overall Study|Physician Decision|1|||
129811618|NCT01088997|467276490|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
129811619|NCT01088997|467276491|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
129811620|NCT01088997|467276490|FG000|Overall Study|Excluded prior to receiving drug|1|||
129811621|NCT01088997|467276491|FG001|Overall Study|Excluded prior to receiving drug|1|||
129811622|NCT01218113|467278625|FG000|Overall Study|Withdrawal by Subject|1|||
129811623|NCT01218113|467278626|FG001|Overall Study|Withdrawal by Subject|0|||
129811624|NCT01218113|467278627|FG002|Overall Study|Withdrawal by Subject|1|||
129811625|NCT01218113|467278625|FG000|Overall Study|Lost to Follow-up|4|||
129811626|NCT01218113|467278626|FG001|Overall Study|Lost to Follow-up|1|||
129811627|NCT01218113|467278627|FG002|Overall Study|Lost to Follow-up|4|||
129811628|NCT01218113|467278625|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
129811629|NCT01218113|467278626|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
129811630|NCT01218113|467278627|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
129811631|NCT00967668|467278628|FG000|Overall Study|Withdrawal by Subject|13|||
129811632|NCT00967668|467278629|FG001|Overall Study|Withdrawal by Subject|8|||
129811633|NCT00967668|467278630|FG002|Overall Study|Withdrawal by Subject|8|||
129811634|NCT00967668|467278628|FG000|Overall Study|Death|0|||
129811635|NCT00967668|467278629|FG001|Overall Study|Death|2|||
129811636|NCT00967668|467278630|FG002|Overall Study|Death|4|||
129811637|NCT00967668|467278628|FG000|Overall Study|Removed due to behavior|1|||
129811638|NCT00967668|467278629|FG001|Overall Study|Removed due to behavior|1|||
129811639|NCT00967668|467278630|FG002|Overall Study|Removed due to behavior|2|||
129811640|NCT00967668|467278628|FG000|Overall Study|Refused Year 2|11|||
129811641|NCT00967668|467278629|FG001|Overall Study|Refused Year 2|6|||
129811642|NCT00967668|467278630|FG002|Overall Study|Refused Year 2|4|||
129811643|NCT00967668|467278628|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
129811644|NCT00967668|467278629|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
129811645|NCT00967668|467278630|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
129811646|NCT00967668|467278628|FG000|Overall Study|Lost to Follow-up|15|||
129811647|NCT00967668|467278629|FG001|Overall Study|Lost to Follow-up|9|||
129811648|NCT00967668|467278630|FG002|Overall Study|Lost to Follow-up|16|||
129811649|NCT00967668|467278628|FG000|Overall Study|Refused 12-mo assessment|3|||
129811650|NCT00967668|467278629|FG001|Overall Study|Refused 12-mo assessment|1|||
129811651|NCT00967668|467278630|FG002|Overall Study|Refused 12-mo assessment|9|||
129811652|NCT00967668|467278628|FG000|Overall Study|Pregnancy|1|||
129811653|NCT00967668|467278629|FG001|Overall Study|Pregnancy|0|||
129811654|NCT00967668|467278630|FG002|Overall Study|Pregnancy|0|||
129811655|NCT00115739|467278631|FG000|Overall Study|Lost to Follow-up|3|||
129811656|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
129811657|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
129811658|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
129811659|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
130058643|NCT00960934|468170367|FG003|Overall Study|Other|4|||
130058644|NCT00960934|468170368|FG004|Overall Study|Other|2|||
130058645|NCT00960934|468170369|FG005|Overall Study|Other|2|||
129811660|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
129811661|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
129811662|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
129811663|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
129811664|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
129811665|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
129896913|NCT04888585|467582176|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
130058646|NCT00960934|468170364|FG000|Overall Study|Physician Decision|0|||
130058647|NCT00960934|468170365|FG001|Overall Study|Physician Decision|1|||
129896914|NCT04888585|467582177|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896915|NCT04888585|467582178|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896916|NCT04888585|467582179|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896917|NCT04888585|467582180|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896918|NCT04888585|467582181|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896919|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
130058648|NCT00960934|468170366|FG002|Overall Study|Physician Decision|0|||
129811666|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
129811667|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
129811668|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
129811669|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
129811670|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
129811671|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
129811672|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
129811673|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
129811674|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
129811675|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
129811676|NCT01970397|467278644|FG000|Overall Study|Adverse Event|0|||
129811677|NCT01970397|467278645|FG001|Overall Study|Adverse Event|1|||
129811678|NCT01970397|467278644|FG000|Overall Study|Lost to Follow-up|0|||
129811679|NCT01970397|467278645|FG001|Overall Study|Lost to Follow-up|1|||
129811680|NCT01970397|467278644|FG000|Overall Study|Personal Reasons|1|||
129811681|NCT01970397|467278645|FG001|Overall Study|Personal Reasons|2|||
129811682|NCT01970397|467278644|FG000|Overall Study|Protocol Violation|1|||
129811683|NCT01970397|467278645|FG001|Overall Study|Protocol Violation|1|||
129811684|NCT03305575|467278648|FG000|Overall Study|Physician Decision|1|||
129811685|NCT03305575|467278649|FG001|Overall Study|Physician Decision|0|||
129811686|NCT01819831|467278662|FG000|Overall Study|Withdrawal by Subject|1|||
129811687|NCT02034110|467278669|FG000|Overall Study|Physician Decision|0|||
129811688|NCT02034110|467278670|FG001|Overall Study|Physician Decision|0|||
129811689|NCT02034110|467278671|FG002|Overall Study|Physician Decision|0|||
129811690|NCT02034110|467278672|FG003|Overall Study|Physician Decision|0|||
129811691|NCT02034110|467278673|FG004|Overall Study|Physician Decision|2|||
129811692|NCT02034110|467278674|FG005|Overall Study|Physician Decision|0|||
129811693|NCT02034110|467278675|FG006|Overall Study|Physician Decision|1|||
129811694|NCT02034110|467278676|FG007|Overall Study|Physician Decision|0|||
129811695|NCT02034110|467278669|FG000|Overall Study|Lost to Follow-up|1|||
129811696|NCT02034110|467278670|FG001|Overall Study|Lost to Follow-up|0|||
129811697|NCT02034110|467278671|FG002|Overall Study|Lost to Follow-up|0|||
129811698|NCT02034110|467278672|FG003|Overall Study|Lost to Follow-up|0|||
129811699|NCT02034110|467278673|FG004|Overall Study|Lost to Follow-up|1|||
129811700|NCT02034110|467278674|FG005|Overall Study|Lost to Follow-up|0|||
129811701|NCT02034110|467278675|FG006|Overall Study|Lost to Follow-up|1|||
129811702|NCT02034110|467278676|FG007|Overall Study|Lost to Follow-up|0|||
129811703|NCT02034110|467278669|FG000|Overall Study|Withdrawal by Subject|5|||
129811704|NCT02034110|467278670|FG001|Overall Study|Withdrawal by Subject|7|||
129811705|NCT02034110|467278671|FG002|Overall Study|Withdrawal by Subject|0|||
129811706|NCT02034110|467278672|FG003|Overall Study|Withdrawal by Subject|3|||
129811707|NCT02034110|467278673|FG004|Overall Study|Withdrawal by Subject|7|||
129811708|NCT02034110|467278674|FG005|Overall Study|Withdrawal by Subject|0|||
129811709|NCT02034110|467278675|FG006|Overall Study|Withdrawal by Subject|3|||
129811710|NCT02034110|467278676|FG007|Overall Study|Withdrawal by Subject|1|||
129811711|NCT02034110|467278669|FG000|Overall Study|Study closed by sponsor|6|||
129811712|NCT02034110|467278670|FG001|Overall Study|Study closed by sponsor|2|||
129811713|NCT02034110|467278671|FG002|Overall Study|Study closed by sponsor|0|||
129811714|NCT02034110|467278672|FG003|Overall Study|Study closed by sponsor|6|||
129811715|NCT02034110|467278673|FG004|Overall Study|Study closed by sponsor|7|||
129811716|NCT02034110|467278674|FG005|Overall Study|Study closed by sponsor|0|||
129811717|NCT02034110|467278675|FG006|Overall Study|Study closed by sponsor|42|||
129811718|NCT02034110|467278676|FG007|Overall Study|Study closed by sponsor|0|||
129811719|NCT02835820|467278679|FG000|Overall Study|Baseline Screen Failure|0|||
129811720|NCT02835820|467278680|FG001|Overall Study|Baseline Screen Failure|3|||
129811721|NCT01751178|467278683|FG000|Overall Study|Adverse Event|2|||
129811722|NCT01751178|467278684|FG001|Overall Study|Adverse Event|0|||
129811723|NCT01751178|467278685|FG002|Overall Study|Adverse Event|0|||
129811724|NCT01751178|467278683|FG000|Overall Study|Other Reason (unknown)|1|||
129811725|NCT01751178|467278684|FG001|Overall Study|Other Reason (unknown)|0|||
129811726|NCT01751178|467278685|FG002|Overall Study|Other Reason (unknown)|2|||
129811727|NCT00288054|467278686|FG000|Overall Study|Protocol Violation|2|||
129811728|NCT00288054|467278686|FG000|Overall Study|Lack of Efficacy|16|||
129811729|NCT00288054|467278686|FG000|Overall Study|Adverse Event|3|||
129811730|NCT00288054|467278686|FG000|Overall Study|Withdrawal by Subject|1|||
129811731|NCT00288054|467278686|FG000|Overall Study|Not protocol specified|2|||
129811732|NCT03733470|467278699|FG000|Overall Study|PI Decision|1|||
129811733|NCT03733470|467278700|FG001|Overall Study|PI Decision|1|||
129811734|NCT01010061|467278701|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
129811735|NCT01010061|467278702|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
129811736|NCT01010061|467278701|FG000|Overall Study|Disease Progression|2|||
129811737|NCT01010061|467278702|FG001|Overall Study|Disease Progression|8|||
129811738|NCT01010061|467278701|FG000|Overall Study|Withdrew Consent|5|||
129811739|NCT01010061|467278702|FG001|Overall Study|Withdrew Consent|1|||
129811740|NCT01010061|467278701|FG000|Overall Study|Death|3|||
129811741|NCT01010061|467278702|FG001|Overall Study|Death|6|||
130058649|NCT00960934|468170367|FG003|Overall Study|Physician Decision|0|||
129811742|NCT01010061|467278701|FG000|Overall Study|Administrative/Other|0|||
129811743|NCT01010061|467278702|FG001|Overall Study|Administrative/Other|1|||
130058650|NCT00960934|468170368|FG004|Overall Study|Physician Decision|0|||
129811744|NCT01010061|467278701|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
129811745|NCT01010061|467278702|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129811746|NCT01010061|467278701|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129811747|NCT01010061|467278702|FG001|Overall Study|Insufficient Therapeutic Response|5|||
129811748|NCT01010061|467278701|FG000|Overall Study|Violation of Selection Criteria|0|||
129811749|NCT01010061|467278702|FG001|Overall Study|Violation of Selection Criteria|1|||
129811750|NCT01010061|467278701|FG000|Overall Study|Did Not Receive Treatment|2|||
129811751|NCT01010061|467278702|FG001|Overall Study|Did Not Receive Treatment|2|||
129811752|NCT03470441|467278703|FG000|Overall Study|Death|0|||
129811753|NCT03470441|467278704|FG001|Overall Study|Death|1|||
129811754|NCT03470441|467278705|FG002|Overall Study|Death|1|||
130058651|NCT00960934|468170369|FG005|Overall Study|Physician Decision|0|||
130058652|NCT00960934|468170364|FG000|Overall Study|Progressive Disease|1|||
130058653|NCT00960934|468170365|FG001|Overall Study|Progressive Disease|1|||
130058654|NCT00960934|468170366|FG002|Overall Study|Progressive Disease|0|||
130058655|NCT00960934|468170367|FG003|Overall Study|Progressive Disease|0|||
130058656|NCT00960934|468170368|FG004|Overall Study|Progressive Disease|1|||
130058657|NCT00960934|468170369|FG005|Overall Study|Progressive Disease|1|||
130058658|NCT00960934|468170364|FG000|Overall Study|Protocol Violation|3|||
129811755|NCT03470441|467278706|FG003|Overall Study|Death|0|||
129811756|NCT03470441|467278703|FG000|Overall Study|Adverse Event|0|||
129811757|NCT03470441|467278704|FG001|Overall Study|Adverse Event|0|||
129811758|NCT03470441|467278705|FG002|Overall Study|Adverse Event|0|||
129811759|NCT03470441|467278706|FG003|Overall Study|Adverse Event|1|||
129811760|NCT03470441|467278703|FG000|Overall Study|Withdrawal by Subject|1|||
129811761|NCT03470441|467278704|FG001|Overall Study|Withdrawal by Subject|4|||
129811762|NCT03470441|467278705|FG002|Overall Study|Withdrawal by Subject|1|||
129811763|NCT03470441|467278706|FG003|Overall Study|Withdrawal by Subject|3|||
129811764|NCT03768414|467278707|FG000|Overall Study|Adverse Event or side effects|72|||
129811765|NCT03768414|467278708|FG001|Overall Study|Adverse Event or side effects|28|||
129811766|NCT03768414|467278707|FG000|Overall Study|Refusal unrelated to adverse event|33|||
129811767|NCT03768414|467278708|FG001|Overall Study|Refusal unrelated to adverse event|33|||
129811768|NCT03768414|467278707|FG000|Overall Study|Progression/relapse|132|||
129811769|NCT03768414|467278708|FG001|Overall Study|Progression/relapse|60|||
129811770|NCT03768414|467278707|FG000|Overall Study|Death|9|||
129811771|NCT03768414|467278708|FG001|Overall Study|Death|6|||
129811772|NCT03768414|467278707|FG000|Overall Study|Other - not protocol specified|45|||
129811773|NCT03768414|467278708|FG001|Overall Study|Other - not protocol specified|18|||
129811774|NCT03768414|467278707|FG000|Overall Study|Reason under review|3|||
129811775|NCT03768414|467278708|FG001|Overall Study|Reason under review|2|||
129811776|NCT02571777|467278709|FG000|Overall Study|Subject/guardian decision|34|||
129811777|NCT02571777|467278710|FG001|Overall Study|Subject/guardian decision|26|||
129811778|NCT02571777|467278711|FG002|Overall Study|Subject/guardian decision|26|||
129811779|NCT02571777|467278712|FG003|Overall Study|Subject/guardian decision|25|||
129811780|NCT02571777|467278713|FG004|Overall Study|Subject/guardian decision|27|||
129811781|NCT02571777|467278709|FG000|Overall Study|Protocol Deviation|2|||
129811782|NCT02571777|467278710|FG001|Overall Study|Protocol Deviation|3|||
129811783|NCT02571777|467278711|FG002|Overall Study|Protocol Deviation|4|||
129811784|NCT02571777|467278712|FG003|Overall Study|Protocol Deviation|8|||
129811785|NCT02571777|467278713|FG004|Overall Study|Protocol Deviation|4|||
129811786|NCT02571777|467278709|FG000|Overall Study|Death|1|||
129811787|NCT02571777|467278710|FG001|Overall Study|Death|1|||
129811788|NCT02571777|467278711|FG002|Overall Study|Death|4|||
129811789|NCT02571777|467278712|FG003|Overall Study|Death|0|||
129811790|NCT02571777|467278713|FG004|Overall Study|Death|0|||
129811791|NCT02571777|467278709|FG000|Overall Study|Lost to Follow-up|1|||
129811792|NCT02571777|467278710|FG001|Overall Study|Lost to Follow-up|1|||
129811793|NCT02571777|467278711|FG002|Overall Study|Lost to Follow-up|2|||
129811794|NCT02571777|467278712|FG003|Overall Study|Lost to Follow-up|0|||
129811795|NCT02571777|467278713|FG004|Overall Study|Lost to Follow-up|1|||
129811796|NCT02571777|467278709|FG000|Overall Study|Physician Decision|1|||
129811797|NCT02571777|467278710|FG001|Overall Study|Physician Decision|7|||
129811798|NCT02571777|467278711|FG002|Overall Study|Physician Decision|5|||
129811799|NCT02571777|467278712|FG003|Overall Study|Physician Decision|2|||
129811800|NCT02571777|467278713|FG004|Overall Study|Physician Decision|4|||
129811801|NCT02571777|467278709|FG000|Overall Study|Pregnancy|0|||
129811802|NCT02571777|467278710|FG001|Overall Study|Pregnancy|0|||
129811803|NCT02571777|467278711|FG002|Overall Study|Pregnancy|0|||
129811804|NCT02571777|467278712|FG003|Overall Study|Pregnancy|2|||
129811805|NCT02571777|467278713|FG004|Overall Study|Pregnancy|0|||
129811806|NCT03095612|467278721|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811807|NCT03095612|467278722|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
129811808|NCT03095612|467278723|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811809|NCT03095612|467278724|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811810|NCT03095612|467278725|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130058659|NCT00960934|468170365|FG001|Overall Study|Protocol Violation|4|||
129811811|NCT03095612|467278726|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
130058660|NCT00960934|468170366|FG002|Overall Study|Protocol Violation|0|||
129811812|NCT03095612|467278727|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811813|NCT04447794|467278728|FG000|Overall Study|Lost to Follow-up|2|||
129811814|NCT04447794|467278729|FG001|Overall Study|Lost to Follow-up|3|||
129811815|NCT04447794|467278730|FG002|Overall Study|Lost to Follow-up|8|||
129811816|NCT04447794|467278728|FG000|Overall Study|Withdrawal by Subject|1|||
129811817|NCT04447794|467278729|FG001|Overall Study|Withdrawal by Subject|1|||
129811818|NCT04447794|467278730|FG002|Overall Study|Withdrawal by Subject|0|||
129811819|NCT02571075|467278733|FG000|Overall Study|Lost to Follow-up|20|||
129811820|NCT02571075|467278734|FG001|Overall Study|Lost to Follow-up|24|||
129811821|NCT00963937|467278737|FG000|Overall Study|Protocol Violation|1|||
129811822|NCT00963937|467278738|FG001|Overall Study|Protocol Violation|1|||
129811823|NCT00963937|467278739|FG002|Overall Study|Protocol Violation|0|||
129811824|NCT00963937|467278737|FG000|Overall Study|Physician Decision|18|||
129811825|NCT00963937|467278738|FG001|Overall Study|Physician Decision|10|||
129811826|NCT00963937|467278739|FG002|Overall Study|Physician Decision|4|||
129811827|NCT02197520|467278743|FG000|Period 1|Withdrawal by Subject|1|||
129811828|NCT02197520|467278744|FG001|Period 1|Withdrawal by Subject|0|||
129811829|NCT02197520|467278743|FG000|Period 2|Adverse Event|0|||
129811830|NCT02197520|467278744|FG001|Period 2|Adverse Event|2|||
129811831|NCT02197520|467278743|FG000|Period 2|Withdrawal by Subject|1|||
129811832|NCT02197520|467278744|FG001|Period 2|Withdrawal by Subject|0|||
129811833|NCT00369824|467278745|FG000|Overall Study|Adverse Event|0|||
129811834|NCT00369824|467278746|FG001|Overall Study|Adverse Event|2|||
129811835|NCT00369824|467278747|FG002|Overall Study|Adverse Event|0|||
130058661|NCT00960934|468170367|FG003|Overall Study|Protocol Violation|3|||
130058662|NCT00960934|468170368|FG004|Overall Study|Protocol Violation|3|||
130058663|NCT00960934|468170369|FG005|Overall Study|Protocol Violation|2|||
129811836|NCT00369824|467278748|FG003|Overall Study|Adverse Event|0|||
129811837|NCT00369824|467278749|FG004|Overall Study|Adverse Event|1|||
129811838|NCT00369824|467278750|FG005|Overall Study|Adverse Event|0|||
129811839|NCT00369824|467278745|FG000|Overall Study|Protocol Violation|0|||
129811840|NCT00369824|467278746|FG001|Overall Study|Protocol Violation|1|||
129811841|NCT00369824|467278747|FG002|Overall Study|Protocol Violation|0|||
129811842|NCT00369824|467278748|FG003|Overall Study|Protocol Violation|1|||
129811843|NCT00369824|467278749|FG004|Overall Study|Protocol Violation|1|||
129811844|NCT00369824|467278750|FG005|Overall Study|Protocol Violation|0|||
129811845|NCT00369824|467278745|FG000|Overall Study|Withdrawal by Subject|9|||
129811846|NCT00369824|467278746|FG001|Overall Study|Withdrawal by Subject|5|||
129811847|NCT00369824|467278747|FG002|Overall Study|Withdrawal by Subject|5|||
129811848|NCT00369824|467278748|FG003|Overall Study|Withdrawal by Subject|4|||
129811849|NCT00369824|467278749|FG004|Overall Study|Withdrawal by Subject|6|||
129811850|NCT00369824|467278750|FG005|Overall Study|Withdrawal by Subject|2|||
129811851|NCT00369824|467278745|FG000|Overall Study|Lost to Follow-up|6|||
129811852|NCT00369824|467278746|FG001|Overall Study|Lost to Follow-up|11|||
129811853|NCT00369824|467278747|FG002|Overall Study|Lost to Follow-up|7|||
129811854|NCT00369824|467278748|FG003|Overall Study|Lost to Follow-up|8|||
129811855|NCT00369824|467278749|FG004|Overall Study|Lost to Follow-up|9|||
129811856|NCT00369824|467278750|FG005|Overall Study|Lost to Follow-up|6|||
129811857|NCT00369824|467278745|FG000|Overall Study|Other|0|||
129811858|NCT00369824|467278746|FG001|Overall Study|Other|0|||
129811859|NCT00369824|467278747|FG002|Overall Study|Other|0|||
129811860|NCT00369824|467278748|FG003|Overall Study|Other|2|||
129811861|NCT00369824|467278749|FG004|Overall Study|Other|1|||
129811862|NCT00369824|467278750|FG005|Overall Study|Other|3|||
129811863|NCT04528732|467278757|FG000|Overall Study|Death|1|||
129811864|NCT04528732|467278758|FG001|Overall Study|Death|0|||
129811865|NCT04528732|467278759|FG002|Overall Study|Death|1|||
129811866|NCT04528732|467278757|FG000|Overall Study|Lost to Follow-up|0|||
129811867|NCT04528732|467278758|FG001|Overall Study|Lost to Follow-up|1|||
129811868|NCT04528732|467278759|FG002|Overall Study|Lost to Follow-up|2|||
129811869|NCT03408483|467278760|FG000|Overall Study|Physician Decision|3|||
129811870|NCT03408483|467278761|FG001|Overall Study|Physician Decision|3|||
129811871|NCT03408483|467278760|FG000|Overall Study|Lost to Follow-up|3|||
130058664|NCT00960934|468170364|FG000|Overall Study|Withdrawal by Subject|5|||
129811872|NCT03408483|467278761|FG001|Overall Study|Lost to Follow-up|0|||
129811873|NCT02094677|467278762|FG000|Overall Study|Screening|3|||
129811874|NCT02094677|467278763|FG001|Overall Study|Screening|1|||
129811875|NCT05399641|467278764|FG000|Overall Study|Adverse Event|0|||
129811876|NCT05399641|467278765|FG001|Overall Study|Adverse Event|1|||
129811877|NCT05399641|467278766|FG002|Overall Study|Adverse Event|1|||
129811878|NCT05399641|467278764|FG000|Overall Study|Lost to Follow-up|1|||
129811879|NCT05399641|467278765|FG001|Overall Study|Lost to Follow-up|2|||
129811880|NCT05399641|467278766|FG002|Overall Study|Lost to Follow-up|2|||
130058665|NCT00960934|468170365|FG001|Overall Study|Withdrawal by Subject|6|||
129811881|NCT05399641|467278764|FG000|Overall Study|Physician Decision|1|||
129811882|NCT05399641|467278765|FG001|Overall Study|Physician Decision|3|||
129811883|NCT05399641|467278766|FG002|Overall Study|Physician Decision|3|||
129811884|NCT05399641|467278764|FG000|Overall Study|Withdrawal by Subject|4|||
129811885|NCT05399641|467278765|FG001|Overall Study|Withdrawal by Subject|11|||
129811886|NCT05399641|467278766|FG002|Overall Study|Withdrawal by Subject|7|||
129811887|NCT05399641|467278764|FG000|Overall Study|Reason not defined|3|||
129811888|NCT05399641|467278765|FG001|Overall Study|Reason not defined|5|||
129811889|NCT05399641|467278766|FG002|Overall Study|Reason not defined|6|||
129811890|NCT01300650|467278767|FG000|Overall Study|Adverse Event|1|||
129811891|NCT01702961|467278768|FG000|Overall Study|Additional treatment|3|||
129811892|NCT01702961|467278768|FG000|Overall Study|Progressive disease|5|||
129811893|NCT01702961|467278768|FG000|Overall Study|Relapse|20|||
129811894|NCT01702961|467278768|FG000|Overall Study|Death|6|||
129811895|NCT01702961|467278768|FG000|Overall Study|Lost to Follow-up|2|||
129811896|NCT01702961|467278768|FG000|Overall Study|Ongoing|11|||
129811897|NCT00674362|467278771|FG000|Double Blind|Adverse Event|6|||
129811898|NCT00674362|467278772|FG001|Double Blind|Adverse Event|6|||
129811899|NCT00674362|467278771|FG000|Double Blind|Lack of Efficacy|2|||
129811900|NCT00674362|467278772|FG001|Double Blind|Lack of Efficacy|6|||
129811901|NCT00674362|467278771|FG000|Double Blind|Loss of efficacy|0|||
129811902|NCT00674362|467278772|FG001|Double Blind|Loss of efficacy|1|||
129811903|NCT00674362|467278771|FG000|Double Blind|Withdrawal by Subject|4|||
129811904|NCT00674362|467278772|FG001|Double Blind|Withdrawal by Subject|3|||
129811905|NCT00674362|467278771|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
129811906|NCT00674362|467278772|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
129811907|NCT00674362|467278771|FG000|Double Blind|Other: Surgery|0|||
129811908|NCT00674362|467278772|FG001|Double Blind|Other: Surgery|1|||
129811909|NCT00674362|467278771|FG000|Open Label|Adverse Event|1|||
129811910|NCT00674362|467278772|FG001|Open Label|Adverse Event|0|||
129811911|NCT00674362|467278771|FG000|Open Label|Other: Subject moved to extension study|1|||
129811912|NCT00674362|467278772|FG001|Open Label|Other: Subject moved to extension study|0|||
129811913|NCT00923156|467278773|FG000|Overall Study|Adverse Event|0|||
129811914|NCT00923156|467278774|FG001|Overall Study|Adverse Event|2|||
129811915|NCT00923156|467278775|FG002|Overall Study|Adverse Event|1|||
129811916|NCT00923156|467278773|FG000|Overall Study|Abnormal laboratory values|0|||
129811917|NCT00923156|467278774|FG001|Overall Study|Abnormal laboratory values|0|||
129811918|NCT00923156|467278775|FG002|Overall Study|Abnormal laboratory values|1|||
129811919|NCT00923156|467278773|FG000|Overall Study|Withdrawal by Subject|0|||
129811920|NCT00923156|467278774|FG001|Overall Study|Withdrawal by Subject|1|||
129811921|NCT00923156|467278775|FG002|Overall Study|Withdrawal by Subject|0|||
129811922|NCT00923156|467278773|FG000|Overall Study|Death|0|||
129811923|NCT00923156|467278774|FG001|Overall Study|Death|1|||
129811924|NCT00923156|467278775|FG002|Overall Study|Death|0|||
129811925|NCT00923156|467278773|FG000|Overall Study|Lack of Efficacy|0|||
129811926|NCT00923156|467278774|FG001|Overall Study|Lack of Efficacy|0|||
129811927|NCT00923156|467278775|FG002|Overall Study|Lack of Efficacy|1|||
129811928|NCT04066023|467278777|FG000|Overall Study|Adverse Event|0|||
129811929|NCT04066023|467278778|FG001|Overall Study|Adverse Event|0|||
129811930|NCT04066023|467278779|FG002|Overall Study|Adverse Event|1|||
129811931|NCT04066023|467278777|FG000|Overall Study|Sponsor decision|3|||
129811932|NCT04066023|467278778|FG001|Overall Study|Sponsor decision|6|||
129811933|NCT04066023|467278779|FG002|Overall Study|Sponsor decision|2|||
130058666|NCT00960934|468170366|FG002|Overall Study|Withdrawal by Subject|4|||
130058667|NCT00960934|468170367|FG003|Overall Study|Withdrawal by Subject|5|||
129811934|NCT04066023|467278777|FG000|Overall Study|Physician Decision|0|||
129811935|NCT04066023|467278778|FG001|Overall Study|Physician Decision|0|||
129811936|NCT04066023|467278779|FG002|Overall Study|Physician Decision|1|||
129811937|NCT04066023|467278777|FG000|Overall Study|Lost to Follow-up|0|||
129811938|NCT04066023|467278778|FG001|Overall Study|Lost to Follow-up|1|||
129811939|NCT04066023|467278779|FG002|Overall Study|Lost to Follow-up|1|||
129811940|NCT04066023|467278777|FG000|Overall Study|Noncompliance|0|||
129811941|NCT04066023|467278778|FG001|Overall Study|Noncompliance|1|||
129811942|NCT04066023|467278779|FG002|Overall Study|Noncompliance|1|||
129811943|NCT03386448|467278780|FG000|Overall Study|Adverse Event|0|||
129811944|NCT03386448|467278781|FG001|Overall Study|Adverse Event|2|||
129811945|NCT03583697|467278782|FG000|Overall Study|Withdrawal by Subject|0|||
129811946|NCT03583697|467278783|FG001|Overall Study|Withdrawal by Subject|0|||
130058668|NCT00960934|468170368|FG004|Overall Study|Withdrawal by Subject|5|||
130058669|NCT00960934|468170369|FG005|Overall Study|Withdrawal by Subject|7|||
129811947|NCT03583697|467278784|FG002|Overall Study|Withdrawal by Subject|1|||
129811948|NCT03583697|467278782|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
129811949|NCT03583697|467278783|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
129811950|NCT03583697|467278784|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
129811951|NCT00114530|467278785|FG000|Overall Study|Death|3|||
129811952|NCT00114530|467278786|FG001|Overall Study|Death|11|||
130058670|NCT00960934|468170364|FG000|Overall Study|Study Terminated by Sponsor|50|||
130058671|NCT00960934|468170365|FG001|Overall Study|Study Terminated by Sponsor|46|||
130058672|NCT00960934|468170366|FG002|Overall Study|Study Terminated by Sponsor|52|||
129811953|NCT00114530|467278785|FG000|Overall Study|Lost to Follow-up|1|||
129811954|NCT00114530|467278786|FG001|Overall Study|Lost to Follow-up|1|||
129811955|NCT00114530|467278785|FG000|Overall Study|Physician Decision|1|||
129811956|NCT00114530|467278786|FG001|Overall Study|Physician Decision|1|||
129811957|NCT00114530|467278785|FG000|Overall Study|Withdrawal by Subject|2|||
129811958|NCT00114530|467278786|FG001|Overall Study|Withdrawal by Subject|6|||
129811959|NCT00114530|467278785|FG000|Overall Study|Breast Cancer|1|||
129811960|NCT00114530|467278786|FG001|Overall Study|Breast Cancer|0|||
129811961|NCT00114530|467278785|FG000|Overall Study|Subject decision after endpoint failure|0|||
129811962|NCT00114530|467278786|FG001|Overall Study|Subject decision after endpoint failure|1|||
129811963|NCT00114530|467278785|FG000|Overall Study|Ineligible|1|||
129811964|NCT00114530|467278786|FG001|Overall Study|Ineligible|0|||
129811965|NCT02538029|467278787|FG000|Overall Study|unable to complete cognitive assessments|1|||
129811966|NCT02538029|467278788|FG001|Overall Study|unable to complete cognitive assessments|0|||
129811967|NCT02538029|467278789|FG002|Overall Study|unable to complete cognitive assessments|1|||
129811968|NCT01064310|467278790|FG000|Period 1|Adverse Event|7|||
129811969|NCT01064310|467278791|FG001|Period 1|Adverse Event|10|||
129811970|NCT01064310|467278792|FG002|Period 1|Adverse Event|0|||
129811971|NCT01064310|467278790|FG000|Period 1|Physician Decision|1|||
129811972|NCT01064310|467278791|FG001|Period 1|Physician Decision|0|||
129811973|NCT01064310|467278792|FG002|Period 1|Physician Decision|0|||
129811974|NCT01064310|467278790|FG000|Period 1|Withdrawal by Subject|2|||
129811975|NCT01064310|467278791|FG001|Period 1|Withdrawal by Subject|2|||
129811976|NCT01064310|467278792|FG002|Period 1|Withdrawal by Subject|0|||
129811977|NCT01064310|467278790|FG000|Period 1|Lack of Efficacy|3|||
129811978|NCT01064310|467278791|FG001|Period 1|Lack of Efficacy|5|||
129811979|NCT01064310|467278792|FG002|Period 1|Lack of Efficacy|0|||
129811980|NCT01064310|467278790|FG000|Period 1|Entered Open-label Period|1|||
129811981|NCT01064310|467278791|FG001|Period 1|Entered Open-label Period|1|||
129811982|NCT01064310|467278792|FG002|Period 1|Entered Open-label Period|0|||
129811983|NCT01064310|467278790|FG000|Period 2|Adverse Event|2|||
129811984|NCT01064310|467278791|FG001|Period 2|Adverse Event|1|||
129811985|NCT01064310|467278792|FG002|Period 2|Adverse Event|0|||
129811986|NCT01064310|467278790|FG000|Period 2|Physician Decision|0|||
129811987|NCT01064310|467278791|FG001|Period 2|Physician Decision|1|||
129811988|NCT01064310|467278792|FG002|Period 2|Physician Decision|0|||
129811989|NCT01064310|467278790|FG000|Period 2|Entered Open-label Period|1|||
129811990|NCT01064310|467278791|FG001|Period 2|Entered Open-label Period|0|||
129811991|NCT01064310|467278792|FG002|Period 2|Entered Open-label Period|0|||
129811992|NCT01064310|467278790|FG000|Period 2|Lack of Efficacy|1|||
129811993|NCT01064310|467278791|FG001|Period 2|Lack of Efficacy|4|||
129811994|NCT01064310|467278792|FG002|Period 2|Lack of Efficacy|0|||
129811995|NCT01064310|467278790|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
129811996|NCT01064310|467278791|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
129811997|NCT01064310|467278792|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
129811998|NCT01064310|467278790|FG000|Open Label Pazopinib|Adverse Event|0|||
129811999|NCT01064310|467278791|FG001|Open Label Pazopinib|Adverse Event|0|||
129812000|NCT01064310|467278792|FG002|Open Label Pazopinib|Adverse Event|12|||
129812001|NCT01064310|467278790|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
129812002|NCT01064310|467278791|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
129812003|NCT01064310|467278792|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
129812004|NCT01064310|467278790|FG000|Open Label Pazopinib|Physician Decision|0|||
129812005|NCT01064310|467278791|FG001|Open Label Pazopinib|Physician Decision|0|||
129812006|NCT01064310|467278792|FG002|Open Label Pazopinib|Physician Decision|20|||
129812007|NCT00679432|467278793|FG000|Overall Study|Adverse Event|5|||
129812008|NCT00679432|467278794|FG001|Overall Study|Adverse Event|6|||
129812009|NCT00679432|467278795|FG002|Overall Study|Adverse Event|10|||
129812010|NCT00679432|467278796|FG003|Overall Study|Adverse Event|7|||
129812011|NCT00679432|467278793|FG000|Overall Study|Protocol Violation|1|||
129812012|NCT00679432|467278794|FG001|Overall Study|Protocol Violation|1|||
129812013|NCT00679432|467278795|FG002|Overall Study|Protocol Violation|2|||
129812014|NCT00679432|467278796|FG003|Overall Study|Protocol Violation|1|||
129812015|NCT00679432|467278793|FG000|Overall Study|Withdrawal by Subject|8|||
129812016|NCT00679432|467278794|FG001|Overall Study|Withdrawal by Subject|11|||
129812017|NCT00679432|467278795|FG002|Overall Study|Withdrawal by Subject|10|||
129812018|NCT00679432|467278796|FG003|Overall Study|Withdrawal by Subject|9|||
129812019|NCT00679432|467278793|FG000|Overall Study|Lost to Follow-up|1|||
129812020|NCT00679432|467278794|FG001|Overall Study|Lost to Follow-up|5|||
129812021|NCT00679432|467278795|FG002|Overall Study|Lost to Follow-up|4|||
129812022|NCT00679432|467278796|FG003|Overall Study|Lost to Follow-up|2|||
129812023|NCT00679432|467278793|FG000|Overall Study|Physician Decision|3|||
129812024|NCT00679432|467278794|FG001|Overall Study|Physician Decision|2|||
129812025|NCT00679432|467278795|FG002|Overall Study|Physician Decision|2|||
129812026|NCT00679432|467278796|FG003|Overall Study|Physician Decision|2|||
129812027|NCT00679432|467278793|FG000|Overall Study|Sponsor decision|1|||
129812028|NCT00679432|467278794|FG001|Overall Study|Sponsor decision|0|||
129812029|NCT00679432|467278795|FG002|Overall Study|Sponsor decision|0|||
129812030|NCT00679432|467278796|FG003|Overall Study|Sponsor decision|0|||
129812031|NCT00679432|467278793|FG000|Overall Study|Lack of Efficacy|13|||
129812032|NCT00679432|467278794|FG001|Overall Study|Lack of Efficacy|9|||
129812033|NCT00679432|467278795|FG002|Overall Study|Lack of Efficacy|14|||
129812034|NCT00679432|467278796|FG003|Overall Study|Lack of Efficacy|8|||
129812035|NCT00679432|467278793|FG000|Overall Study|Infectious colitis, normal histology|5|||
129812036|NCT00679432|467278794|FG001|Overall Study|Infectious colitis, normal histology|4|||
129812037|NCT00679432|467278795|FG002|Overall Study|Infectious colitis, normal histology|8|||
129812038|NCT00679432|467278796|FG003|Overall Study|Infectious colitis, normal histology|3|||
129812039|NCT00679432|467278793|FG000|Overall Study|Randomization error, return to prior Rx|0|||
129812040|NCT00679432|467278794|FG001|Overall Study|Randomization error, return to prior Rx|0|||
129812041|NCT00679432|467278795|FG002|Overall Study|Randomization error, return to prior Rx|3|||
129812042|NCT00679432|467278796|FG003|Overall Study|Randomization error, return to prior Rx|0|||
129812043|NCT02339584|467278797|FG000|Overall Study|Adverse Event|11|||
129812044|NCT02339584|467278798|FG001|Overall Study|Adverse Event|7|||
129896920|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896921|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896922|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896923|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896924|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896925|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896926|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
130058673|NCT00960934|468170367|FG003|Overall Study|Study Terminated by Sponsor|50|||
130058674|NCT00960934|468170368|FG004|Overall Study|Study Terminated by Sponsor|49|||
129812045|NCT02339584|467278797|FG000|Overall Study|Lack of Efficacy|0|||
129812046|NCT02339584|467278798|FG001|Overall Study|Lack of Efficacy|1|||
129812047|NCT02339584|467278797|FG000|Overall Study|Physician Decision|1|||
129812048|NCT02339584|467278798|FG001|Overall Study|Physician Decision|2|||
129812049|NCT02339584|467278797|FG000|Overall Study|Protocol Violation|1|||
129812050|NCT02339584|467278798|FG001|Overall Study|Protocol Violation|1|||
129812051|NCT02339584|467278797|FG000|Overall Study|Withdrawal by Subject|2|||
129812052|NCT02339584|467278798|FG001|Overall Study|Withdrawal by Subject|4|||
129812053|NCT01084083|467278799|FG000|Overall Study|Adverse Event|5|||
129812054|NCT01084083|467278799|FG000|Overall Study|Death|1|||
129812055|NCT01084083|467278799|FG000|Overall Study|Withdrawal by Subject|2|||
129812056|NCT01084083|467278799|FG000|Overall Study|Complicating disease|1|||
129812057|NCT01084083|467278799|FG000|Overall Study|Other|2|||
129812058|NCT01084083|467278799|FG000|Overall Study|Never started assigned therapy|1|||
129812059|NCT01980940|467278800|FG000|Overall Study|Protocol Violation|0|||
129812060|NCT01980940|467278801|FG001|Overall Study|Protocol Violation|0|||
129812061|NCT01980940|467278802|FG002|Overall Study|Protocol Violation|0|||
129812062|NCT01980940|467278803|FG003|Overall Study|Protocol Violation|0|||
129812063|NCT01980940|467278804|FG004|Overall Study|Protocol Violation|0|||
129812064|NCT01980940|467278805|FG005|Overall Study|Protocol Violation|2|||
129812065|NCT01980940|467278806|FG006|Overall Study|Protocol Violation|0|||
129812066|NCT01980940|467278807|FG007|Overall Study|Protocol Violation|0|||
129812067|NCT05996718|467280239|FG000|Overall Study|Lost to Follow-up|3|||
129812068|NCT01713686|467280240|FG000|Overall Study|Lost to Follow-up|9|||
130058675|NCT00960934|468170369|FG005|Overall Study|Study Terminated by Sponsor|49|||
130058676|NCT05254613|468170375|FG000|Overall Study|Lost to Follow-up|0|||
129812069|NCT01713686|467280240|FG000|Overall Study|Withdrawal by Subject|6|||
129812070|NCT04840615|467280241|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
129812071|NCT04840615|467280242|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
129812072|NCT04840615|467280243|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
129812073|NCT00709761|467280247|FG000|Overall Study|Withdrawal by Subject|8|||
129812074|NCT00709761|467280247|FG000|Overall Study|study closed/terminated|17|||
129812075|NCT00709761|467280247|FG000|Overall Study|Lost to Follow-up|2|||
129812076|NCT01606800|467280248|FG000|Overall Study|Adverse Event|3|||
129812077|NCT01606800|467280249|FG001|Overall Study|Adverse Event|1|||
129812078|NCT01606800|467280248|FG000|Overall Study|Participant withdrew consent|0|||
129812079|NCT01606800|467280249|FG001|Overall Study|Participant withdrew consent|1|||
129812080|NCT01606800|467280248|FG000|Overall Study|Missing completion status|2|||
129812081|NCT01606800|467280249|FG001|Overall Study|Missing completion status|0|||
129812082|NCT00717197|467280254|FG000|Overall Study|Unable to purchase study drug|5|||
129812083|NCT00717197|467280254|FG000|Overall Study|Tumor Progression|1|||
129812084|NCT00717197|467280254|FG000|Overall Study|Physician Decision|1|||
129812085|NCT00982137|467280255|FG000|Overall Study|Lost to Follow-up|0|||
129812086|NCT00982137|467280256|FG001|Overall Study|Lost to Follow-up|0|||
129812087|NCT00982137|467280257|FG002|Overall Study|Lost to Follow-up|0|||
129812088|NCT00982137|467280258|FG003|Overall Study|Lost to Follow-up|1|||
129812089|NCT00982137|467280255|FG000|Overall Study|Withdrawal by Subject|0|||
129812090|NCT00982137|467280256|FG001|Overall Study|Withdrawal by Subject|1|||
129812091|NCT00982137|467280257|FG002|Overall Study|Withdrawal by Subject|0|||
129812092|NCT00982137|467280258|FG003|Overall Study|Withdrawal by Subject|0|||
129812093|NCT03311724|467280259|FG000|Overall Study|Physician Decision|0|||
129812094|NCT03311724|467280260|FG001|Overall Study|Physician Decision|0|||
129812095|NCT03311724|467280261|FG002|Overall Study|Physician Decision|0|||
129812096|NCT03311724|467280262|FG003|Overall Study|Physician Decision|1|||
129812097|NCT03311724|467280259|FG000|Overall Study|Protocol Violation|1|||
129812098|NCT03311724|467280260|FG001|Overall Study|Protocol Violation|0|||
129812099|NCT03311724|467280261|FG002|Overall Study|Protocol Violation|1|||
129812100|NCT03311724|467280262|FG003|Overall Study|Protocol Violation|0|||
129812101|NCT03311724|467280259|FG000|Overall Study|Withdrawal by Subject|1|||
129812102|NCT03311724|467280260|FG001|Overall Study|Withdrawal by Subject|1|||
129812103|NCT03311724|467280261|FG002|Overall Study|Withdrawal by Subject|0|||
129812104|NCT03311724|467280262|FG003|Overall Study|Withdrawal by Subject|0|||
129812105|NCT03311724|467280259|FG000|Overall Study|Lost to Follow-up|1|||
129812106|NCT03311724|467280260|FG001|Overall Study|Lost to Follow-up|0|||
129812107|NCT03311724|467280261|FG002|Overall Study|Lost to Follow-up|0|||
129812108|NCT03311724|467280262|FG003|Overall Study|Lost to Follow-up|0|||
129812109|NCT03311724|467280259|FG000|Overall Study|Sponsor Decision|0|||
129812110|NCT03311724|467280260|FG001|Overall Study|Sponsor Decision|0|||
129812111|NCT03311724|467280261|FG002|Overall Study|Sponsor Decision|1|||
129812112|NCT03311724|467280262|FG003|Overall Study|Sponsor Decision|0|||
129812113|NCT00395304|467280263|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129812114|NCT00395304|467280264|FG001|Treatment Period 1|Withdrawal by Subject|3|||
129812115|NCT00395304|467280265|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129812116|NCT00395304|467280266|FG003|Treatment Period 1|Withdrawal by Subject|2|||
129812117|NCT00395304|467280267|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129812118|NCT00395304|467280268|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129812119|NCT00395304|467280263|FG000|Treatment Period 1|Lost to Follow-up|1|||
129812120|NCT00395304|467280264|FG001|Treatment Period 1|Lost to Follow-up|0|||
129812121|NCT00395304|467280265|FG002|Treatment Period 1|Lost to Follow-up|0|||
129812122|NCT00395304|467280266|FG003|Treatment Period 1|Lost to Follow-up|1|||
129812123|NCT00395304|467280267|FG004|Treatment Period 1|Lost to Follow-up|0|||
129812124|NCT00395304|467280268|FG005|Treatment Period 1|Lost to Follow-up|1|||
129812125|NCT00395304|467280263|FG000|Treatment Period 1|Physician Decision|0|||
129812126|NCT00395304|467280264|FG001|Treatment Period 1|Physician Decision|1|||
129812127|NCT00395304|467280265|FG002|Treatment Period 1|Physician Decision|0|||
129812128|NCT00395304|467280266|FG003|Treatment Period 1|Physician Decision|0|||
129812129|NCT00395304|467280267|FG004|Treatment Period 1|Physician Decision|0|||
129812130|NCT00395304|467280268|FG005|Treatment Period 1|Physician Decision|0|||
129812131|NCT00395304|467280263|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129812132|NCT00395304|467280264|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129812133|NCT00395304|467280265|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129812134|NCT00395304|467280266|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129812135|NCT00395304|467280267|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129812136|NCT00395304|467280268|FG005|Treatment Period 2|Withdrawal by Subject|2|||
129812137|NCT00395304|467280263|FG000|Treatment Period 2|Lost to Follow-up|0|||
129812138|NCT00395304|467280264|FG001|Treatment Period 2|Lost to Follow-up|3|||
129812139|NCT00395304|467280265|FG002|Treatment Period 2|Lost to Follow-up|0|||
130058677|NCT05254613|468170376|FG001|Overall Study|Lost to Follow-up|0|||
130058678|NCT05254613|468170377|FG002|Overall Study|Lost to Follow-up|1|||
129812140|NCT00395304|467280266|FG003|Treatment Period 2|Lost to Follow-up|0|||
129812141|NCT00395304|467280267|FG004|Treatment Period 2|Lost to Follow-up|0|||
129812142|NCT00395304|467280268|FG005|Treatment Period 2|Lost to Follow-up|0|||
129812143|NCT00395304|467280263|FG000|Treatment Period 2|Physician Decision|0|||
129812144|NCT00395304|467280264|FG001|Treatment Period 2|Physician Decision|0|||
129812145|NCT00395304|467280265|FG002|Treatment Period 2|Physician Decision|1|||
130058679|NCT00839423|468170380|FG000|Overall Study|Adverse Event|4|||
129812146|NCT00395304|467280266|FG003|Treatment Period 2|Physician Decision|0|||
129896927|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896928|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896929|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
129812147|NCT00395304|467280267|FG004|Treatment Period 2|Physician Decision|0|||
129812148|NCT00395304|467280268|FG005|Treatment Period 2|Physician Decision|0|||
129812149|NCT00395304|467280263|FG000|Treatment Period 2|Other|0|||
129812150|NCT00395304|467280264|FG001|Treatment Period 2|Other|1|||
129812151|NCT00395304|467280265|FG002|Treatment Period 2|Other|0|||
129812152|NCT00395304|467280266|FG003|Treatment Period 2|Other|0|||
129812153|NCT00395304|467280267|FG004|Treatment Period 2|Other|0|||
129812154|NCT00395304|467280268|FG005|Treatment Period 2|Other|0|||
129812155|NCT00395304|467280263|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129812156|NCT00395304|467280264|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129812157|NCT00395304|467280265|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129812158|NCT00395304|467280266|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129812159|NCT00395304|467280267|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129812160|NCT00395304|467280268|FG005|Treatment Period 3|Withdrawal by Subject|1|||
129812161|NCT00395304|467280263|FG000|Treatment Period 3|Lost to Follow-up|1|||
129812162|NCT00395304|467280264|FG001|Treatment Period 3|Lost to Follow-up|1|||
129812163|NCT00395304|467280265|FG002|Treatment Period 3|Lost to Follow-up|0|||
129812164|NCT00395304|467280266|FG003|Treatment Period 3|Lost to Follow-up|0|||
129812165|NCT00395304|467280267|FG004|Treatment Period 3|Lost to Follow-up|0|||
129812166|NCT00395304|467280268|FG005|Treatment Period 3|Lost to Follow-up|0|||
129812167|NCT00395304|467280263|FG000|Treatment Period 3|Physician Decision|0|||
129812168|NCT00395304|467280264|FG001|Treatment Period 3|Physician Decision|1|||
129812169|NCT00395304|467280265|FG002|Treatment Period 3|Physician Decision|0|||
129812170|NCT00395304|467280266|FG003|Treatment Period 3|Physician Decision|0|||
129812171|NCT00395304|467280267|FG004|Treatment Period 3|Physician Decision|0|||
129812172|NCT00395304|467280268|FG005|Treatment Period 3|Physician Decision|0|||
129812173|NCT00395304|467280263|FG000|Treatment Period 3|Other|0|||
129812174|NCT00395304|467280264|FG001|Treatment Period 3|Other|0|||
129812175|NCT00395304|467280265|FG002|Treatment Period 3|Other|0|||
129812176|NCT00395304|467280266|FG003|Treatment Period 3|Other|1|||
129812177|NCT00395304|467280267|FG004|Treatment Period 3|Other|0|||
129812178|NCT00395304|467280268|FG005|Treatment Period 3|Other|0|||
129812179|NCT01389817|467280269|FG000|Overall Study|Physician Decision|1|||
129812180|NCT01389817|467280270|FG001|Overall Study|Physician Decision|0|||
129812181|NCT01389817|467280269|FG000|Overall Study|Lost to Follow-up|1|||
129812182|NCT01389817|467280270|FG001|Overall Study|Lost to Follow-up|0|||
129812183|NCT01389817|467280269|FG000|Overall Study|Withdrawal by Subject|2|||
129812184|NCT01389817|467280270|FG001|Overall Study|Withdrawal by Subject|0|||
129812185|NCT01749137|467280271|FG000|Overall Study|Adverse Event|4|||
129812186|NCT01749137|467280272|FG001|Overall Study|Adverse Event|4|||
129812187|NCT01749137|467280271|FG000|Overall Study|Lost to Follow-up|2|||
129812188|NCT01749137|467280272|FG001|Overall Study|Lost to Follow-up|3|||
129812189|NCT01749137|467280271|FG000|Overall Study|Physician Decision|1|||
129812190|NCT01749137|467280272|FG001|Overall Study|Physician Decision|0|||
129812191|NCT01749137|467280271|FG000|Overall Study|Withdrawal by Subject|8|||
129812192|NCT01749137|467280272|FG001|Overall Study|Withdrawal by Subject|4|||
129896930|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129896931|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129812193|NCT01434667|467280280|FG000|Overall Study|Lost to Follow-up|5|||
129812194|NCT01434667|467280281|FG001|Overall Study|Lost to Follow-up|10|||
129812195|NCT00621985|467280286|FG000|Dexamethasone Admission|Adverse Event|1|||
129812196|NCT02587234|467280287|FG000|Overall Study|Withdrawal by Subject|1|||
129812197|NCT02587234|467280288|FG001|Overall Study|Withdrawal by Subject|1|||
129812198|NCT02587234|467280287|FG000|Overall Study|Lost to Follow-up|0|||
129812199|NCT02587234|467280288|FG001|Overall Study|Lost to Follow-up|2|||
129812200|NCT01877265|467280289|FG000|Treatment Period 1|Sponsor Decision|0|||
129812201|NCT01877265|467280290|FG001|Treatment Period 1|Sponsor Decision|0|||
129812202|NCT01877265|467280291|FG002|Treatment Period 1|Sponsor Decision|1|||
129812203|NCT01877265|467280292|FG003|Treatment Period 1|Sponsor Decision|0|||
129812204|NCT01877265|467280293|FG004|Treatment Period 1|Sponsor Decision|0|||
129812205|NCT01877265|467280294|FG005|Treatment Period 1|Sponsor Decision|0|||
129812206|NCT01877265|467280289|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812207|NCT01877265|467280290|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812208|NCT01877265|467280291|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812209|NCT01877265|467280292|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812210|NCT01877265|467280293|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812211|NCT01877265|467280294|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
129812212|NCT01877265|467280289|FG000|Treatment Period 3|Lost to Follow-up|1|||
129812213|NCT01877265|467280290|FG001|Treatment Period 3|Lost to Follow-up|0|||
129812214|NCT01877265|467280291|FG002|Treatment Period 3|Lost to Follow-up|0|||
129812215|NCT01877265|467280292|FG003|Treatment Period 3|Lost to Follow-up|0|||
129812216|NCT01877265|467280293|FG004|Treatment Period 3|Lost to Follow-up|0|||
129812217|NCT01877265|467280294|FG005|Treatment Period 3|Lost to Follow-up|0|||
129812218|NCT03068130|467280297|FG000|Overall Study|Adverse Event|19|||
129812219|NCT03068130|467280297|FG000|Overall Study|Death|14|||
129812220|NCT03068130|467280297|FG000|Overall Study|Lost to Follow-up|4|||
129812221|NCT03068130|467280297|FG000|Overall Study|Withdrawal by Subject|26|||
129812222|NCT03068130|467280297|FG000|Overall Study|Administrative Reasons|3|||
129812223|NCT03068130|467280297|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
129812224|NCT03068130|467280297|FG000|Overall Study|Study terminated by sponsor|194|||
129812225|NCT03535844|467280302|FG000|Overall Study|Withdrawal by Subject|0|||
129812226|NCT03535844|467280303|FG001|Overall Study|Withdrawal by Subject|1|||
129812227|NCT03130257|467280304|FG000|Overall Study|Withdrawal by Subject|1|||
129812228|NCT03130257|467280305|FG001|Overall Study|Withdrawal by Subject|0|||
129812229|NCT03130257|467280306|FG002|Overall Study|Withdrawal by Subject|2|||
129812230|NCT00160693|467280308|FG000|Overall Study|Adverse Event|97|||
129812231|NCT00160693|467280308|FG000|Overall Study|Lack of Efficacy|30|||
129812232|NCT00160693|467280308|FG000|Overall Study|Protocol Violation|24|||
129812233|NCT00160693|467280308|FG000|Overall Study|Lost to Follow-up|15|||
129812234|NCT00160693|467280308|FG000|Overall Study|Withdrawal by Subject|54|||
129812235|NCT00160693|467280308|FG000|Overall Study|Study terminated by sponsor|15|||
129812236|NCT03039283|467280311|FG000|Overall Study|Protocol Violation|2|||
129812237|NCT01867424|467280312|FG000|Overall Study|Patient noncompliance|2|||
129812238|NCT01867424|467280313|FG001|Overall Study|Patient noncompliance|1|||
129812239|NCT01056653|467280314|FG000|Overall Study|Lost to Follow-up|0|||
129812240|NCT01056653|467280315|FG001|Overall Study|Lost to Follow-up|0|||
129812241|NCT01056653|467280316|FG002|Overall Study|Lost to Follow-up|2|||
129812242|NCT05386680|467280317|FG000|Overall Study|Guardian decision|2|||
129812243|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
129812244|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
129812245|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
129812246|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
129812247|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812248|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812249|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812250|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812251|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812252|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812253|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812254|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
129812255|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
129812256|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
129812257|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
129812258|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812259|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812260|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812261|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812262|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812263|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129896932|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130058680|NCT00839423|468170381|FG001|Overall Study|Adverse Event|3|||
130058681|NCT00839423|468170382|FG002|Overall Study|Adverse Event|7|||
130058682|NCT00839423|468170383|FG003|Overall Study|Adverse Event|16|||
130058683|NCT00839423|468170380|FG000|Overall Study|Lack of Efficacy|6|||
130058684|NCT00839423|468170381|FG001|Overall Study|Lack of Efficacy|6|||
129812264|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812265|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
129812266|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
129812267|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
129812268|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
129812269|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812270|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812271|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812272|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812273|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812274|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812275|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812276|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130058685|NCT00839423|468170382|FG002|Overall Study|Lack of Efficacy|3|||
130058686|NCT00839423|468170383|FG003|Overall Study|Lack of Efficacy|2|||
130058687|NCT00839423|468170380|FG000|Overall Study|Non-compliance|0|||
129812277|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
130058688|NCT00839423|468170381|FG001|Overall Study|Non-compliance|0|||
130058689|NCT00839423|468170382|FG002|Overall Study|Non-compliance|0|||
129896933|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129812278|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812279|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
129812280|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812281|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812282|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812283|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812284|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812285|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812286|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812287|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
129812288|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
129812289|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
129812290|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
129812291|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812292|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812293|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812294|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812295|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812296|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812297|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812298|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
129812299|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
129812300|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
129812301|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
129812302|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812303|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812304|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812305|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812306|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812307|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812308|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812309|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
129812310|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
129812311|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
129812312|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
129812313|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812314|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812315|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812316|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
130058690|NCT00839423|468170383|FG003|Overall Study|Non-compliance|1|||
130058691|NCT00839423|468170380|FG000|Overall Study|Protocol Violation|0|||
129812317|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812318|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812319|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812320|NCT01847274|467280318|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812321|NCT01847274|467280319|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812322|NCT01847274|467280320|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812323|NCT01847274|467280321|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812324|NCT01847274|467280322|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812325|NCT01847274|467280323|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
129812326|NCT01847274|467280324|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812327|NCT01847274|467280325|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812328|NCT01847274|467280326|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812329|NCT01847274|467280327|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812330|NCT01847274|467280328|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812331|NCT01847274|467280318|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812332|NCT01847274|467280319|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812333|NCT01847274|467280320|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812334|NCT01847274|467280321|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812335|NCT01847274|467280322|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
129812336|NCT01847274|467280323|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812337|NCT01847274|467280324|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129896934|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
130058692|NCT00839423|468170381|FG001|Overall Study|Protocol Violation|1|||
130058693|NCT00839423|468170382|FG002|Overall Study|Protocol Violation|2|||
130058694|NCT00839423|468170383|FG003|Overall Study|Protocol Violation|0|||
130058695|NCT00839423|468170380|FG000|Overall Study|Withdrawal of consent|4|||
130058696|NCT00839423|468170381|FG001|Overall Study|Withdrawal of consent|0|||
130058697|NCT00839423|468170382|FG002|Overall Study|Withdrawal of consent|4|||
130058698|NCT00839423|468170383|FG003|Overall Study|Withdrawal of consent|1|||
130058699|NCT00839423|468170380|FG000|Overall Study|Lost to Follow-up|1|||
129812338|NCT01847274|467280325|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812339|NCT01847274|467280326|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812340|NCT01847274|467280327|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812341|NCT01847274|467280328|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812342|NCT01847274|467280318|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812343|NCT01847274|467280319|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812344|NCT01847274|467280320|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812345|NCT01847274|467280321|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812346|NCT01847274|467280322|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812347|NCT01847274|467280323|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812348|NCT01847274|467280324|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
129812349|NCT01847274|467280325|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812350|NCT01847274|467280326|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812351|NCT01847274|467280327|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812352|NCT01847274|467280328|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812353|NCT01847274|467280318|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812354|NCT01847274|467280319|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812355|NCT01847274|467280320|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812356|NCT01847274|467280321|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812357|NCT01847274|467280322|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812358|NCT01847274|467280323|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812359|NCT01847274|467280324|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
129812360|NCT01847274|467280325|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812361|NCT01847274|467280326|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129896935|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
129896936|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
130112363|NCT00738920|468371151|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
129812362|NCT01847274|467280327|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812363|NCT01847274|467280328|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
130058700|NCT00839423|468170381|FG001|Overall Study|Lost to Follow-up|0|||
130058701|NCT00839423|468170382|FG002|Overall Study|Lost to Follow-up|1|||
129812364|NCT01847274|467280318|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
130058702|NCT00839423|468170383|FG003|Overall Study|Lost to Follow-up|0|||
130058703|NCT00839423|468170380|FG000|Overall Study|Administrative or other reasons|3|||
130058704|NCT00839423|468170381|FG001|Overall Study|Administrative or other reasons|0|||
130058705|NCT00839423|468170382|FG002|Overall Study|Administrative or other reasons|1|||
130058706|NCT00839423|468170383|FG003|Overall Study|Administrative or other reasons|0|||
130058707|NCT04348656|468170384|FG000|Overall Study|Withdrawal by Subject|2|||
130058708|NCT04348656|468170385|FG001|Overall Study|Withdrawal by Subject|0|||
130058709|NCT04348656|468170384|FG000|Overall Study|Lost to Follow-up|11|||
130058710|NCT04348656|468170385|FG001|Overall Study|Lost to Follow-up|6|||
130058711|NCT02387372|468170386|FG000|Overall Study|Not Treated|1|||
130058712|NCT02387372|468170387|FG001|Overall Study|Not Treated|0|||
130058713|NCT00937560|468170388|FG000|Initial Treatment|Death|6|||
130058714|NCT00937560|468170388|FG000|Initial Treatment|Withdraw consent|3|||
130058715|NCT00937560|468170388|FG000|Initial Treatment|Adverse Event|1|||
130058716|NCT00937560|468170388|FG000|Initial Treatment|Lost to Follow-up|1|||
130058717|NCT00937560|468170388|FG000|Initial Treatment|No end of study page|10|||
130058718|NCT00937560|468170388|FG000|Maintenance Treatment|Death|12|||
130058719|NCT00937560|468170388|FG000|Maintenance Treatment|Withdraw consent|5|||
130058720|NCT00937560|468170388|FG000|Maintenance Treatment|According to protocol|1|||
130058721|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
130058722|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
130058723|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
130058724|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
130058725|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
130058726|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
130058727|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
130058728|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
129812365|NCT01847274|467280319|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812366|NCT01847274|467280320|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812367|NCT01847274|467280321|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812368|NCT01847274|467280322|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812369|NCT01847274|467280323|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812370|NCT01847274|467280324|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
129812371|NCT01847274|467280325|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812372|NCT01847274|467280326|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812373|NCT01847274|467280327|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812374|NCT01847274|467280328|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812375|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812376|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812377|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812378|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812379|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812380|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812381|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812382|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
129812383|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
129812384|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
129812385|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
129812386|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812387|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812388|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812389|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812390|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812391|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812392|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812393|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
129896937|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
129896938|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
129896939|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
129896940|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
129896941|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896942|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896943|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896944|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896945|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896946|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
129896947|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
129896948|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
129896949|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
129896950|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
129896951|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
129896952|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896953|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896954|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896955|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896956|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896957|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
129896958|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
129896959|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
129896960|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
129896961|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
129896962|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
129896963|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896964|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896965|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896966|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896967|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896968|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
130058729|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
130058730|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
130058731|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
130058732|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
130058733|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
130058734|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
130058735|NCT00848549|468170389|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
130058736|NCT00848549|468170390|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
130058737|NCT00848549|468170389|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
130058738|NCT00848549|468170390|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
130058739|NCT00848549|468170389|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
130058740|NCT00848549|468170390|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
130058741|NCT00848549|468170389|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
130058742|NCT00848549|468170390|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
129812394|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812395|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
129812396|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812397|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130058743|NCT00848549|468170389|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
130058744|NCT00848549|468170390|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
130058745|NCT00848549|468170389|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
130058746|NCT00848549|468170390|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
129812398|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129896969|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
130058747|NCT00848549|468170389|FG000|E2090-E044-314 (Extension Study)|Other|5|||
130058748|NCT00848549|468170390|FG001|E2090-E044-314 (Extension Study)|Other|6|||
129896970|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
130058749|NCT02106455|468170393|FG000|Overall Study|Case Report Form Uncollected|6|||
130058750|NCT02106455|468170393|FG000|Overall Study|Protocol Deviation|2|||
130058751|NCT01576016|468170394|FG000|Lead Safety|Death|132|||
130058752|NCT01576016|468170395|FG001|Lead Safety|Death|0|||
130058753|NCT01576016|468170394|FG000|Lead Safety|Withdrawal by Subject|81|||
130058754|NCT01576016|468170395|FG001|Lead Safety|Withdrawal by Subject|0|||
130058755|NCT01576016|468170394|FG000|Lead Safety|System Explanted without Replacement|24|||
130058756|NCT01576016|468170395|FG001|Lead Safety|System Explanted without Replacement|0|||
130058757|NCT01576016|468170394|FG000|Lead Safety|Physician Decision|14|||
129812399|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812400|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
130058758|NCT01576016|468170395|FG001|Lead Safety|Physician Decision|0|||
130058759|NCT01576016|468170394|FG000|Lead Safety|Lost to Follow-up|13|||
130058760|NCT01576016|468170395|FG001|Lead Safety|Lost to Follow-up|0|||
130058761|NCT01576016|468170394|FG000|Lead Safety|Unsuccessful implant|2|||
130058762|NCT01576016|468170395|FG001|Lead Safety|Unsuccessful implant|0|||
130058763|NCT01576016|468170394|FG000|Lead Safety|Sponsor request|1|||
130058764|NCT01576016|468170395|FG001|Lead Safety|Sponsor request|0|||
130058765|NCT01576016|468170394|FG000|Lead Safety|Device replaced with CRT-D|1|||
129812401|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812402|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812403|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812404|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
129812405|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812406|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
129812407|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
129812408|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812409|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812410|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812411|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812412|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130058766|NCT01576016|468170395|FG001|Lead Safety|Device replaced with CRT-D|0|||
130058767|NCT01576016|468170394|FG000|Lead Safety|Patient on Palliative Care|1|||
130058768|NCT01576016|468170395|FG001|Lead Safety|Patient on Palliative Care|0|||
130058769|NCT01576016|468170394|FG000|Lead Safety|Patient noncompliance|1|||
129812413|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
130058770|NCT01576016|468170395|FG001|Lead Safety|Patient noncompliance|0|||
130058771|NCT01576016|468170394|FG000|Lead Safety|Too far from study site|1|||
130058772|NCT01576016|468170395|FG001|Lead Safety|Too far from study site|0|||
130058773|NCT01576016|468170394|FG000|Lead Safety|System deactivated|1|||
129812414|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129896971|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
130058774|NCT01576016|468170395|FG001|Lead Safety|System deactivated|0|||
129896972|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
129812415|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812416|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812417|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
129812418|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812419|NCT03727230|467280329|FG000|Overall Study|Lost to Follow-up|12|||
129812420|NCT04377620|467280331|FG000|Overall Study|Death|42|||
129812421|NCT04377620|467280332|FG001|Overall Study|Death|48|||
129812422|NCT04377620|467280333|FG002|Overall Study|Death|36|||
129812423|NCT04377620|467280331|FG000|Overall Study|Withdrawal by Subject|0|||
129812424|NCT04377620|467280332|FG001|Overall Study|Withdrawal by Subject|2|||
129812425|NCT04377620|467280333|FG002|Overall Study|Withdrawal by Subject|0|||
129812426|NCT02849678|467280334|FG000|Overall Study|Protocol Violation|3|||
130058775|NCT01576016|468170394|FG000|Lead Safety|Patient no longer followed by study PI|1|||
130058776|NCT01576016|468170395|FG001|Lead Safety|Patient no longer followed by study PI|0|||
130058777|NCT01576016|468170394|FG000|MRI Safety|Withdrawal by Subject|0|||
130058778|NCT01576016|468170395|FG001|MRI Safety|Withdrawal by Subject|10|||
130058779|NCT01576016|468170394|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
130058780|NCT01576016|468170395|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
130058781|NCT01576016|468170394|FG000|MRI Safety|Has not yet completed MRI scan|0|||
130058782|NCT01576016|468170395|FG001|MRI Safety|Has not yet completed MRI scan|56|||
130058783|NCT01576016|468170394|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
130058784|NCT01576016|468170395|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
130058785|NCT02488551|468170398|FG000|Overall Study|Lost to Follow-up|4|||
129812427|NCT02849678|467280335|FG001|Overall Study|Protocol Violation|6|||
129812428|NCT00289991|467280336|FG000|Overall Study|Death|35|||
129812429|NCT00289991|467280337|FG001|Overall Study|Death|38|||
129812430|NCT00289991|467280336|FG000|Overall Study|Adverse Event|15|||
129812431|NCT00289991|467280337|FG001|Overall Study|Adverse Event|13|||
129812432|NCT00289991|467280336|FG000|Overall Study|Failure of prophylaxis|1|||
129812433|NCT00289991|467280337|FG001|Overall Study|Failure of prophylaxis|1|||
129812434|NCT00289991|467280336|FG000|Overall Study|Fungal breakthrough infection|0|||
129812435|NCT00289991|467280337|FG001|Overall Study|Fungal breakthrough infection|1|||
129812436|NCT00289991|467280336|FG000|Overall Study|Lost to Follow-up|0|||
130112364|NCT00738920|468371152|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
130112365|NCT00738920|468371153|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
130112366|NCT00738920|468371151|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
130112367|NCT00738920|468371152|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
130112368|NCT00738920|468371153|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
130112369|NCT00738920|468371151|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
130112370|NCT00738920|468371152|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
130112371|NCT00738920|468371153|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
130112372|NCT00738920|468371151|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
130112373|NCT00738920|468371152|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
130112374|NCT00738920|468371153|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
130112375|NCT00738920|468371151|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
130112376|NCT00738920|468371152|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
130112377|NCT00738920|468371153|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
130112378|NCT03372083|468373357|FG000|Overall Study|Adverse Event|3|||
129812437|NCT00289991|467280337|FG001|Overall Study|Lost to Follow-up|1|||
129812438|NCT00289991|467280336|FG000|Overall Study|Withdrawal by Subject|2|||
130112379|NCT03372083|468373357|FG000|Overall Study|Physician Decision|1|||
130112380|NCT03372083|468373357|FG000|Overall Study|Withdrawal by Subject|1|||
129812439|NCT00289991|467280337|FG001|Overall Study|Withdrawal by Subject|12|||
129812440|NCT00289991|467280336|FG000|Overall Study|Other|5|||
129812441|NCT00289991|467280337|FG001|Overall Study|Other|14|||
129812442|NCT01606007|467280340|FG000|Overall Study|Reason 'Other' in the protocol|0|||
129812443|NCT01606007|467280341|FG001|Overall Study|Reason 'Other' in the protocol|1|||
129812444|NCT01606007|467280342|FG002|Overall Study|Reason 'Other' in the protocol|1|||
129812445|NCT01606007|467280340|FG000|Overall Study|Pregnancy|0|||
129812446|NCT01606007|467280341|FG001|Overall Study|Pregnancy|1|||
129812447|NCT01606007|467280342|FG002|Overall Study|Pregnancy|1|||
129812448|NCT01606007|467280340|FG000|Overall Study|Withdrawal by Subject|8|||
129812449|NCT01606007|467280341|FG001|Overall Study|Withdrawal by Subject|6|||
129812450|NCT01606007|467280342|FG002|Overall Study|Withdrawal by Subject|1|||
129812451|NCT01606007|467280340|FG000|Overall Study|Adverse Event|0|||
129896973|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896974|NCT04927975|467582182|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
129896975|NCT04927975|467582183|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
129896976|NCT04927975|467582184|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
129896977|NCT04927975|467582185|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
129896978|NCT04927975|467582186|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
129896979|NCT04927975|467582187|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
129896980|NCT04927975|467582182|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129896981|NCT04927975|467582183|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129896982|NCT04927975|467582184|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129896983|NCT04927975|467582185|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
129812452|NCT01606007|467280341|FG001|Overall Study|Adverse Event|1|||
129812453|NCT01606007|467280342|FG002|Overall Study|Adverse Event|1|||
129896984|NCT04927975|467582186|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
129812454|NCT01606007|467280340|FG000|Overall Study|discontinue study treatment|0|||
129812455|NCT01606007|467280341|FG001|Overall Study|discontinue study treatment|2|||
129812456|NCT01606007|467280342|FG002|Overall Study|discontinue study treatment|1|||
129812457|NCT01606007|467280340|FG000|Overall Study|Lost to Follow-up|6|||
129812458|NCT01606007|467280341|FG001|Overall Study|Lost to Follow-up|8|||
129812459|NCT01606007|467280342|FG002|Overall Study|Lost to Follow-up|5|||
129812460|NCT01606007|467280340|FG000|Overall Study|Poor/Non-compliance|1|||
129812461|NCT01606007|467280341|FG001|Overall Study|Poor/Non-compliance|0|||
129812462|NCT01606007|467280342|FG002|Overall Study|Poor/Non-compliance|0|||
129812463|NCT03706079|467280343|FG000|Predecessor Study|Death|0|||
129812464|NCT03706079|467280344|FG001|Predecessor Study|Death|2|||
129812465|NCT03706079|467280345|FG002|Predecessor Study|Death|0|||
129812466|NCT03706079|467280346|FG003|Predecessor Study|Death|1|||
129812467|NCT03706079|467280347|FG004|Predecessor Study|Death|0|||
129812468|NCT03706079|467280348|FG005|Predecessor Study|Death|0|||
129812469|NCT03706079|467280343|FG000|Predecessor Study|Lost to Follow-up|5|||
129812470|NCT03706079|467280344|FG001|Predecessor Study|Lost to Follow-up|2|||
129812471|NCT03706079|467280345|FG002|Predecessor Study|Lost to Follow-up|0|||
129812472|NCT03706079|467280346|FG003|Predecessor Study|Lost to Follow-up|0|||
129812473|NCT03706079|467280347|FG004|Predecessor Study|Lost to Follow-up|1|||
129812474|NCT03706079|467280348|FG005|Predecessor Study|Lost to Follow-up|0|||
129812475|NCT03706079|467280343|FG000|Predecessor Study|Withdrawal by Subject|8|||
129812476|NCT03706079|467280344|FG001|Predecessor Study|Withdrawal by Subject|15|||
129812477|NCT03706079|467280345|FG002|Predecessor Study|Withdrawal by Subject|0|||
129812478|NCT03706079|467280346|FG003|Predecessor Study|Withdrawal by Subject|5|||
129812479|NCT03706079|467280347|FG004|Predecessor Study|Withdrawal by Subject|2|||
129812480|NCT03706079|467280348|FG005|Predecessor Study|Withdrawal by Subject|0|||
130058786|NCT02488551|468170399|FG001|Overall Study|Lost to Follow-up|7|||
129812481|NCT03706079|467280343|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
129896985|NCT04927975|467582187|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129896986|NCT04927975|467582182|FG000|Period 1 (Baseline-Week 24)|Death|0|||
130058787|NCT02488551|468170400|FG002|Overall Study|Lost to Follow-up|0|||
129812482|NCT03706079|467280344|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
129812483|NCT03706079|467280345|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812484|NCT03706079|467280346|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
130058788|NCT02488551|468170401|FG003|Overall Study|Lost to Follow-up|0|||
130058789|NCT02488551|468170398|FG000|Overall Study|Military Deployment|1|||
130058790|NCT02488551|468170399|FG001|Overall Study|Military Deployment|1|||
130058791|NCT02488551|468170400|FG002|Overall Study|Military Deployment|0|||
130058792|NCT02488551|468170401|FG003|Overall Study|Military Deployment|0|||
130058793|NCT03364608|468170404|FG000|Overall Study|Withdrawal by Subject|4|||
130058794|NCT03364608|468170404|FG000|Overall Study|Protocol Violation|2|||
130058795|NCT03364608|468170404|FG000|Overall Study|Lost to Follow-up|2|||
130058796|NCT03888391|468170419|FG000|Overall Study|Lost to Follow-up|15|||
129812485|NCT03706079|467280347|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812486|NCT03706079|467280348|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812487|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812488|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
130058797|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
130058798|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058799|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058800|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058801|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058802|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058803|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129812489|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812490|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812491|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812492|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
129812493|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
129812494|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812495|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
129812496|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812497|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812498|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812499|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
129812500|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
130058804|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058805|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130058806|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
130058807|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058808|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058809|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058810|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058811|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058812|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058813|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058814|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130058815|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
130058816|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058817|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058818|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058819|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058820|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058821|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058822|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058823|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130058824|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
130058825|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058826|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058827|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058828|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058829|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058830|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058831|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058832|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
130058833|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
130058834|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058835|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058836|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058837|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058838|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058839|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058840|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058841|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130058842|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
130058843|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058844|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058845|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058846|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058847|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058848|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058849|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058850|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130058851|NCT02175771|468170420|FG000|Run-In Period (Pre-assignment)|Other|8|||
130058852|NCT02175771|468170421|FG001|Run-In Period (Pre-assignment)|Other|0|||
130058853|NCT02175771|468170422|FG002|Run-In Period (Pre-assignment)|Other|0|||
130058854|NCT02175771|468170423|FG003|Run-In Period (Pre-assignment)|Other|0|||
130058855|NCT02175771|468170424|FG004|Run-In Period (Pre-assignment)|Other|0|||
130058856|NCT02175771|468170425|FG005|Run-In Period (Pre-assignment)|Other|0|||
130058857|NCT02175771|468170426|FG006|Run-In Period (Pre-assignment)|Other|0|||
130058858|NCT02175771|468170427|FG007|Run-In Period (Pre-assignment)|Other|0|||
130058859|NCT02175771|468170428|FG008|Run-In Period (Pre-assignment)|Other|0|||
130058860|NCT02175771|468170420|FG000|Treatment Period|Adverse Event|0|||
130058861|NCT02175771|468170421|FG001|Treatment Period|Adverse Event|2|||
130058862|NCT02175771|468170422|FG002|Treatment Period|Adverse Event|1|||
130058863|NCT02175771|468170423|FG003|Treatment Period|Adverse Event|1|||
130058864|NCT02175771|468170424|FG004|Treatment Period|Adverse Event|1|||
130058865|NCT02175771|468170425|FG005|Treatment Period|Adverse Event|3|||
130058866|NCT02175771|468170426|FG006|Treatment Period|Adverse Event|2|||
130058867|NCT02175771|468170427|FG007|Treatment Period|Adverse Event|0|||
130058868|NCT02175771|468170428|FG008|Treatment Period|Adverse Event|1|||
130058869|NCT02175771|468170420|FG000|Treatment Period|Withdrawal by Subject|0|||
130058870|NCT02175771|468170421|FG001|Treatment Period|Withdrawal by Subject|9|||
130058871|NCT02175771|468170422|FG002|Treatment Period|Withdrawal by Subject|3|||
130058872|NCT02175771|468170423|FG003|Treatment Period|Withdrawal by Subject|6|||
130058873|NCT02175771|468170424|FG004|Treatment Period|Withdrawal by Subject|2|||
130058874|NCT02175771|468170425|FG005|Treatment Period|Withdrawal by Subject|4|||
130058875|NCT02175771|468170426|FG006|Treatment Period|Withdrawal by Subject|2|||
130058876|NCT02175771|468170427|FG007|Treatment Period|Withdrawal by Subject|9|||
130058877|NCT02175771|468170428|FG008|Treatment Period|Withdrawal by Subject|2|||
130058878|NCT02175771|468170420|FG000|Treatment Period|Noncompliance|0|||
129812501|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812502|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812503|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812504|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812505|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812506|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812507|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812508|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
129812509|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812510|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
129812511|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
129812512|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
129812513|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
129896987|NCT04927975|467582183|FG001|Period 1 (Baseline-Week 24)|Death|0|||
129896988|NCT04927975|467582184|FG002|Period 1 (Baseline-Week 24)|Death|0|||
129896989|NCT04927975|467582185|FG003|Period 1 (Baseline-Week 24)|Death|0|||
129896990|NCT04927975|467582186|FG004|Period 1 (Baseline-Week 24)|Death|0|||
129896991|NCT04927975|467582187|FG005|Period 1 (Baseline-Week 24)|Death|1|||
129896992|NCT04927975|467582182|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
129896993|NCT04927975|467582183|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
129896994|NCT04927975|467582184|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
129896995|NCT04927975|467582185|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
129896996|NCT04927975|467582186|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
129896997|NCT04927975|467582187|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
129896998|NCT04927975|467582182|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
129896999|NCT04927975|467582183|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897000|NCT04927975|467582184|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897001|NCT04927975|467582185|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
129897002|NCT04927975|467582186|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897003|NCT04927975|467582187|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897004|NCT03568162|467582189|FG000|Overall Study|Adverse Event|0|||
129897005|NCT03568162|467582190|FG001|Overall Study|Adverse Event|1|||
129897006|NCT03568162|467582191|FG002|Overall Study|Adverse Event|2|||
129897007|NCT03568162|467582192|FG003|Overall Study|Adverse Event|0|||
129897008|NCT03568162|467582193|FG004|Overall Study|Adverse Event|0|||
129897009|NCT03568162|467582194|FG005|Overall Study|Adverse Event|1|||
129897010|NCT03568162|467582189|FG000|Overall Study|Death|0|||
129897011|NCT03568162|467582190|FG001|Overall Study|Death|0|||
129897012|NCT03568162|467582191|FG002|Overall Study|Death|0|||
129897013|NCT03568162|467582192|FG003|Overall Study|Death|0|||
129897014|NCT03568162|467582193|FG004|Overall Study|Death|1|||
129897015|NCT03568162|467582194|FG005|Overall Study|Death|0|||
129897016|NCT03568162|467582189|FG000|Overall Study|Lost to Follow-up|3|||
129897017|NCT03568162|467582190|FG001|Overall Study|Lost to Follow-up|2|||
129897018|NCT03568162|467582191|FG002|Overall Study|Lost to Follow-up|4|||
129897019|NCT03568162|467582192|FG003|Overall Study|Lost to Follow-up|2|||
129897020|NCT03568162|467582193|FG004|Overall Study|Lost to Follow-up|3|||
129897021|NCT03568162|467582194|FG005|Overall Study|Lost to Follow-up|2|||
129897022|NCT03568162|467582189|FG000|Overall Study|Physician Decision|0|||
129897023|NCT03568162|467582190|FG001|Overall Study|Physician Decision|1|||
129897024|NCT03568162|467582191|FG002|Overall Study|Physician Decision|1|||
129897025|NCT03568162|467582192|FG003|Overall Study|Physician Decision|0|||
129897026|NCT03568162|467582193|FG004|Overall Study|Physician Decision|1|||
129897027|NCT03568162|467582194|FG005|Overall Study|Physician Decision|0|||
129897028|NCT03568162|467582189|FG000|Overall Study|Pregnancy|0|||
129897029|NCT03568162|467582190|FG001|Overall Study|Pregnancy|0|||
130058879|NCT02175771|468170421|FG001|Treatment Period|Noncompliance|1|||
129897030|NCT03568162|467582191|FG002|Overall Study|Pregnancy|0|||
129897031|NCT03568162|467582192|FG003|Overall Study|Pregnancy|1|||
130058880|NCT02175771|468170422|FG002|Treatment Period|Noncompliance|2|||
129812514|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
129812515|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
129812516|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
129812517|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Death|8|||
129812518|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Death|2|||
129812519|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Death|2|||
129812520|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Death|1|||
129812521|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Death|0|||
129812522|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Death|0|||
129812523|NCT00968513|467280349|FG000|Overall Study|Death|4|||
129812524|NCT00968513|467280350|FG001|Overall Study|Death|10|||
129812525|NCT00968513|467280351|FG002|Overall Study|Death|15|||
129812526|NCT05379231|467280352|FG000|Home Visit|Withdrawal by Subject|2|||
129812527|NCT05379231|467280352|FG000|In-lab Visit|Withdrawal by Subject|2|||
129812528|NCT01203098|467280359|FG000|Overall Study|Adverse Event|3|||
129812529|NCT01203098|467280360|FG001|Overall Study|Adverse Event|1|||
129812530|NCT01203098|467280361|FG002|Overall Study|Adverse Event|7|||
129812531|NCT01203098|467280359|FG000|Overall Study|Lost to Follow-up|0|||
129812532|NCT01203098|467280360|FG001|Overall Study|Lost to Follow-up|0|||
129812533|NCT01203098|467280361|FG002|Overall Study|Lost to Follow-up|1|||
129812534|NCT01203098|467280359|FG000|Overall Study|Physician Decision|2|||
129812535|NCT01203098|467280360|FG001|Overall Study|Physician Decision|2|||
129812536|NCT01203098|467280361|FG002|Overall Study|Physician Decision|0|||
129812537|NCT01203098|467280359|FG000|Overall Study|Withdrawal by Subject|1|||
129812538|NCT01203098|467280360|FG001|Overall Study|Withdrawal by Subject|1|||
129812539|NCT01203098|467280361|FG002|Overall Study|Withdrawal by Subject|3|||
129812540|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
129812541|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
129812542|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
129812543|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
129812544|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
129812545|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
129812546|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
129812547|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
129812548|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
129812549|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
129812550|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
129812551|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
129812552|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
129812553|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
129812554|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
129812555|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
129812556|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
129812557|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
129812558|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
129812559|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
129812560|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812561|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812562|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
129812563|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812564|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812565|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812566|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812567|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
129812568|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812569|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812570|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
129812571|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812572|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812573|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812574|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812575|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812576|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
129812577|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812578|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812579|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812580|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
129812581|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
129812582|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
129812583|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
129812584|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
129812585|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129812586|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
130058881|NCT02175771|468170423|FG003|Treatment Period|Noncompliance|0|||
130058882|NCT02175771|468170424|FG004|Treatment Period|Noncompliance|0|||
130058883|NCT02175771|468170425|FG005|Treatment Period|Noncompliance|0|||
130058884|NCT02175771|468170426|FG006|Treatment Period|Noncompliance|0|||
130058885|NCT02175771|468170427|FG007|Treatment Period|Noncompliance|0|||
130058886|NCT02175771|468170428|FG008|Treatment Period|Noncompliance|1|||
130058887|NCT02175771|468170420|FG000|Treatment Period|Protocol Violation|0|||
130058888|NCT02175771|468170421|FG001|Treatment Period|Protocol Violation|0|||
130058889|NCT02175771|468170422|FG002|Treatment Period|Protocol Violation|0|||
130058890|NCT02175771|468170423|FG003|Treatment Period|Protocol Violation|0|||
130058891|NCT02175771|468170424|FG004|Treatment Period|Protocol Violation|0|||
130058892|NCT02175771|468170425|FG005|Treatment Period|Protocol Violation|0|||
130058893|NCT02175771|468170426|FG006|Treatment Period|Protocol Violation|0|||
130058894|NCT02175771|468170427|FG007|Treatment Period|Protocol Violation|1|||
130058895|NCT02175771|468170428|FG008|Treatment Period|Protocol Violation|0|||
130058896|NCT02175771|468170420|FG000|Treatment Period|Disease progression|0|||
130058897|NCT02175771|468170421|FG001|Treatment Period|Disease progression|0|||
130058898|NCT02175771|468170422|FG002|Treatment Period|Disease progression|0|||
130058899|NCT02175771|468170423|FG003|Treatment Period|Disease progression|0|||
130058900|NCT02175771|468170424|FG004|Treatment Period|Disease progression|0|||
130058901|NCT02175771|468170425|FG005|Treatment Period|Disease progression|0|||
130058902|NCT02175771|468170426|FG006|Treatment Period|Disease progression|0|||
129897032|NCT03568162|467582193|FG004|Overall Study|Pregnancy|0|||
130058903|NCT02175771|468170427|FG007|Treatment Period|Disease progression|2|||
130058904|NCT02175771|468170428|FG008|Treatment Period|Disease progression|0|||
130058905|NCT02175771|468170420|FG000|Treatment Period|Lost to Follow-up|0|||
129897033|NCT03568162|467582194|FG005|Overall Study|Pregnancy|0|||
130058906|NCT02175771|468170421|FG001|Treatment Period|Lost to Follow-up|3|||
130058907|NCT02175771|468170422|FG002|Treatment Period|Lost to Follow-up|1|||
130058908|NCT02175771|468170423|FG003|Treatment Period|Lost to Follow-up|3|||
130058909|NCT02175771|468170424|FG004|Treatment Period|Lost to Follow-up|1|||
130058910|NCT02175771|468170425|FG005|Treatment Period|Lost to Follow-up|2|||
130058911|NCT02175771|468170426|FG006|Treatment Period|Lost to Follow-up|1|||
130058912|NCT02175771|468170427|FG007|Treatment Period|Lost to Follow-up|2|||
130058913|NCT02175771|468170428|FG008|Treatment Period|Lost to Follow-up|2|||
130058914|NCT02175771|468170420|FG000|Treatment Period|Lack of Efficacy|0|||
130058915|NCT02175771|468170421|FG001|Treatment Period|Lack of Efficacy|0|||
130058916|NCT02175771|468170422|FG002|Treatment Period|Lack of Efficacy|0|||
130058917|NCT02175771|468170423|FG003|Treatment Period|Lack of Efficacy|0|||
130058918|NCT02175771|468170424|FG004|Treatment Period|Lack of Efficacy|0|||
130058919|NCT02175771|468170425|FG005|Treatment Period|Lack of Efficacy|1|||
130058920|NCT02175771|468170426|FG006|Treatment Period|Lack of Efficacy|0|||
130058921|NCT02175771|468170427|FG007|Treatment Period|Lack of Efficacy|1|||
129812587|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
129897034|NCT03568162|467582189|FG000|Overall Study|Protocol Violation|1|||
130058922|NCT02175771|468170428|FG008|Treatment Period|Lack of Efficacy|0|||
130058923|NCT02175771|468170420|FG000|Treatment Period|Other|0|||
129812588|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129812589|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129812590|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
129812591|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
129812592|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
129812593|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
129812594|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
129812595|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812596|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
129812597|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812598|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812599|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812600|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129812601|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129897035|NCT03568162|467582190|FG001|Overall Study|Protocol Violation|0|||
129897036|NCT03568162|467582191|FG002|Overall Study|Protocol Violation|1|||
130058924|NCT02175771|468170421|FG001|Treatment Period|Other|1|||
130058925|NCT02175771|468170422|FG002|Treatment Period|Other|0|||
130058926|NCT02175771|468170423|FG003|Treatment Period|Other|3|||
129812602|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129812603|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
129812604|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129812605|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812606|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812607|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
129812608|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812609|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812610|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Change of location|0|||
129812611|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Change of location|0|||
129812612|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Change of location|0|||
129812613|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Change of location|1|||
129812614|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Change of location|0|||
129812615|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
129812616|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
129812617|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
129812618|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
129812619|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
129812620|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812621|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812622|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812623|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812624|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
129812625|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
129812626|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812627|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812628|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812629|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812630|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
129812631|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
129812632|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
129812633|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
129812634|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
129812635|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
129812636|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
129812637|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
129812638|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
129812639|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
129812640|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
129812641|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
129812642|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
129812643|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
129812644|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
129812645|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Death|0|||
129812646|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Death|1|||
129812647|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Death|0|||
129812648|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Death|1|||
129812649|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Death|0|||
129812650|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Change of location|1|||
129812651|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Change of location|1|||
129812652|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Change of location|0|||
129812653|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Change of location|1|||
129812654|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Change of location|0|||
129812655|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
129812656|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
129812657|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
129812658|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
129812659|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
130058927|NCT02175771|468170424|FG004|Treatment Period|Other|1|||
130058928|NCT02175771|468170425|FG005|Treatment Period|Other|0|||
130058929|NCT02175771|468170426|FG006|Treatment Period|Other|0|||
130058930|NCT02175771|468170427|FG007|Treatment Period|Other|2|||
129897037|NCT03568162|467582192|FG003|Overall Study|Protocol Violation|1|||
130058931|NCT02175771|468170428|FG008|Treatment Period|Other|0|||
130058932|NCT02232087|468170429|FG000|Overall Study|Withdrawal by Subject|2|||
130058933|NCT02232087|468170430|FG001|Overall Study|Withdrawal by Subject|0|||
129812660|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812661|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812662|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
129812663|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812664|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812665|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812666|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812667|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
129812668|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812669|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812670|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812671|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812672|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812673|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812674|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
129812675|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
129812676|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812677|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812678|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812679|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812680|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812681|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812682|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812683|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
129812684|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812685|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
129812686|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
129812687|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
129812688|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
129812689|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
129812690|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
129812691|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
129812692|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
130058934|NCT02232087|468170431|FG002|Overall Study|Withdrawal by Subject|0|||
129812693|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
129812694|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
129812695|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812696|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
129812697|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812698|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812699|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812700|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
129812701|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
129812702|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
129812703|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
129812704|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
129812705|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Missing|0|||
129812706|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Missing|0|||
129812707|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Missing|2|||
129812708|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Missing|0|||
129812709|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Missing|0|||
129812710|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812711|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812712|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812713|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812714|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
129812715|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129812716|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129812717|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
129812718|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129897038|NCT03568162|467582193|FG004|Overall Study|Protocol Violation|1|||
130058935|NCT02232087|468170432|FG003|Overall Study|Withdrawal by Subject|0|||
130058936|NCT02232087|468170433|FG004|Overall Study|Withdrawal by Subject|0|||
129812719|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129812720|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
129812721|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
129812722|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
129812723|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
129812724|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
129812725|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812726|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812727|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
129812728|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812729|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812730|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812731|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812732|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812733|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
129812734|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812735|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
129812736|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812737|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812738|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812739|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812740|NCT03851705|467280367|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
129812741|NCT03851705|467280368|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129812742|NCT03851705|467280369|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129812743|NCT03851705|467280370|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129812744|NCT03851705|467280367|FG000|Part 1: Double-Blind Period|Other reason|1|||
129812745|NCT03851705|467280368|FG001|Part 1: Double-Blind Period|Other reason|0|||
129812746|NCT03851705|467280369|FG002|Part 1: Double-Blind Period|Other reason|0|||
129812747|NCT03851705|467280370|FG003|Part 1: Double-Blind Period|Other reason|0|||
129812748|NCT03851705|467280367|FG000|Part 2: Open-Label Period|Other reason|0|||
129812749|NCT03851705|467280368|FG001|Part 2: Open-Label Period|Other reason|0|||
129812750|NCT03851705|467280369|FG002|Part 2: Open-Label Period|Other reason|0|||
129812751|NCT03851705|467280370|FG003|Part 2: Open-Label Period|Other reason|1|||
129812752|NCT03851705|467280367|FG000|Part 2: Open-Label Period|Death|0|||
129812753|NCT03851705|467280368|FG001|Part 2: Open-Label Period|Death|0|||
129812754|NCT03851705|467280369|FG002|Part 2: Open-Label Period|Death|3|||
129812755|NCT03851705|467280370|FG003|Part 2: Open-Label Period|Death|0|||
129812756|NCT03851705|467280367|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
129812757|NCT03851705|467280368|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
129812758|NCT03851705|467280369|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
129812759|NCT03851705|467280370|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
129812760|NCT01496807|467280374|FG000|Overall Study|Progressive Disease|21|||
129812761|NCT01496807|467280374|FG000|Overall Study|Participant preference/toxicity|8|||
129812762|NCT01496807|467280374|FG000|Overall Study|Change in diagnosis|1|||
129812763|NCT02591290|467280381|FG000|Overall Study|Withdrawal by Subject|2|||
129812764|NCT01306942|467280382|FG000|Phase I|Adverse Event|2|||
129812765|NCT01306942|467280383|FG001|Phase I|Adverse Event|2|||
129812766|NCT01306942|467280384|FG002|Phase I|Adverse Event|0|||
129812767|NCT01306942|467280385|FG003|Phase I|Adverse Event|0|||
129812768|NCT01306942|467280382|FG000|Phase I|Physician Decision|3|||
129812769|NCT01306942|467280383|FG001|Phase I|Physician Decision|1|||
129812770|NCT01306942|467280384|FG002|Phase I|Physician Decision|0|||
129812771|NCT01306942|467280385|FG003|Phase I|Physician Decision|0|||
129812772|NCT01306942|467280382|FG000|Phase II|Adverse Event|0|||
129812773|NCT01306942|467280383|FG001|Phase II|Adverse Event|0|||
129812774|NCT01306942|467280384|FG002|Phase II|Adverse Event|0|||
129812775|NCT01306942|467280385|FG003|Phase II|Adverse Event|6|||
129812776|NCT01306942|467280382|FG000|Phase II|Physician Decision|2|||
129812777|NCT01306942|467280383|FG001|Phase II|Physician Decision|0|||
129812778|NCT01306942|467280384|FG002|Phase II|Physician Decision|0|||
129812779|NCT01306942|467280385|FG003|Phase II|Physician Decision|5|||
129812780|NCT01306942|467280382|FG000|Phase II|Withdrawal by Subject|0|||
129812781|NCT01306942|467280383|FG001|Phase II|Withdrawal by Subject|0|||
129812782|NCT01306942|467280384|FG002|Phase II|Withdrawal by Subject|0|||
129812783|NCT01306942|467280385|FG003|Phase II|Withdrawal by Subject|2|||
129812784|NCT01306942|467280382|FG000|Phase II|Death|0|||
129812785|NCT01306942|467280383|FG001|Phase II|Death|0|||
129812786|NCT01306942|467280384|FG002|Phase II|Death|0|||
129812787|NCT01306942|467280385|FG003|Phase II|Death|1|||
129812788|NCT01306942|467280382|FG000|Phase II|Not finished treatment|0|||
129812789|NCT01306942|467280383|FG001|Phase II|Not finished treatment|0|||
129812790|NCT01306942|467280384|FG002|Phase II|Not finished treatment|0|||
129812791|NCT01306942|467280385|FG003|Phase II|Not finished treatment|1|||
129812792|NCT01306942|467280382|FG000|Phase II|Protocol Violation|0|||
129812793|NCT01306942|467280383|FG001|Phase II|Protocol Violation|0|||
129812794|NCT01306942|467280384|FG002|Phase II|Protocol Violation|0|||
129812795|NCT01306942|467280385|FG003|Phase II|Protocol Violation|1|||
129812796|NCT01390649|467280392|FG000|Overall Study|Physician Decision|1|||
129812797|NCT00282984|467280393|FG000|Overall Study|Death|2|||
129812798|NCT00282984|467280394|FG001|Overall Study|Death|5|||
129812799|NCT00282984|467280393|FG000|Overall Study|Adverse Event|8|||
129812800|NCT00282984|467280394|FG001|Overall Study|Adverse Event|5|||
129812801|NCT00282984|467280393|FG000|Overall Study|Lack of Efficacy|0|||
129812802|NCT00282984|467280394|FG001|Overall Study|Lack of Efficacy|2|||
129812803|NCT00282984|467280393|FG000|Overall Study|Lost to Follow-up|14|||
129812804|NCT00282984|467280394|FG001|Overall Study|Lost to Follow-up|10|||
129812805|NCT00282984|467280393|FG000|Overall Study|Withdrawal by Participant|22|||
129812806|NCT00282984|467280394|FG001|Overall Study|Withdrawal by Participant|34|||
129812807|NCT00282984|467280393|FG000|Overall Study|Participant stopped study medication|2|||
129812808|NCT00282984|467280394|FG001|Overall Study|Participant stopped study medication|2|||
129812809|NCT00282984|467280393|FG000|Overall Study|Participant only allowed phone follow-up|0|||
129812810|NCT00282984|467280394|FG001|Overall Study|Participant only allowed phone follow-up|1|||
129812811|NCT00282984|467280393|FG000|Overall Study|Participant used antipsychosis meds|0|||
129812812|NCT00282984|467280394|FG001|Overall Study|Participant used antipsychosis meds|1|||
129812813|NCT00282984|467280393|FG000|Overall Study|lack of motivation|1|||
129812814|NCT00282984|467280394|FG001|Overall Study|lack of motivation|0|||
129812815|NCT00282984|467280393|FG000|Overall Study|in prison|0|||
129812816|NCT00282984|467280394|FG001|Overall Study|in prison|1|||
129812817|NCT00282984|467280393|FG000|Overall Study|Protocol Violation|2|||
129812818|NCT00282984|467280394|FG001|Overall Study|Protocol Violation|0|||
129812819|NCT01128842|467280399|FG000|Overall Study|Adverse Event|1|||
129812820|NCT01128842|467280399|FG000|Overall Study|Disease Progression|6|||
129812821|NCT00824720|467280400|FG000|Overall Study|failed plug insertion|3|||
129812822|NCT00824720|467280401|FG001|Overall Study|failed plug insertion|1|||
129812823|NCT00824720|467280402|FG002|Overall Study|failed plug insertion|0|||
129812824|NCT00824720|467280400|FG000|Overall Study|Protocol Violation|0|||
129812825|NCT00824720|467280401|FG001|Overall Study|Protocol Violation|0|||
129812826|NCT00824720|467280402|FG002|Overall Study|Protocol Violation|1|||
129812827|NCT04731363|467280411|FG000|Overall Study|Could not obtain samples|0|||
129812828|NCT04731363|467280412|FG001|Overall Study|Could not obtain samples|1|||
129812829|NCT04731363|467280413|FG002|Overall Study|Could not obtain samples|0|||
129812830|NCT04731363|467280414|FG003|Overall Study|Could not obtain samples|0|||
129812831|NCT04731363|467280411|FG000|Overall Study|Physician Decision|0|||
129812832|NCT04731363|467280412|FG001|Overall Study|Physician Decision|1|||
129812833|NCT04731363|467280413|FG002|Overall Study|Physician Decision|0|||
129812834|NCT04731363|467280414|FG003|Overall Study|Physician Decision|0|||
129812835|NCT00688753|467282216|FG000|Overall Study|Disease progression|55|||
129812836|NCT00688753|467282216|FG000|Overall Study|Missing|1|||
129812837|NCT00688753|467282216|FG000|Overall Study|Death|9|||
129812838|NCT00688753|467282216|FG000|Overall Study|Withdrawal by Subject|3|||
129812839|NCT00688753|467282216|FG000|Overall Study|Adverse Event|20|||
129812840|NCT00688753|467282216|FG000|Overall Study|Protocol Violation|1|||
129812841|NCT00688753|467282216|FG000|Overall Study|Lost to Follow-up|3|||
129812842|NCT03187197|467282217|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
129812843|NCT03187197|467282218|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
129812844|NCT03187197|467282219|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
129812845|NCT03187197|467282217|FG000|Overall Study|Withdrawal by Subject|8|||
129812846|NCT03187197|467282218|FG001|Overall Study|Withdrawal by Subject|63|||
129812847|NCT03187197|467282219|FG002|Overall Study|Withdrawal by Subject|4|||
129812848|NCT03187197|467282217|FG000|Overall Study|Lost to Follow-up|1|||
129812849|NCT03187197|467282218|FG001|Overall Study|Lost to Follow-up|60|||
129812850|NCT03187197|467282219|FG002|Overall Study|Lost to Follow-up|7|||
129812851|NCT03187197|467282217|FG000|Overall Study|Adverse Event|6|||
129812852|NCT03187197|467282218|FG001|Overall Study|Adverse Event|29|||
129812853|NCT03187197|467282219|FG002|Overall Study|Adverse Event|0|||
129897039|NCT03568162|467582194|FG005|Overall Study|Protocol Violation|1|||
129812854|NCT03187197|467282217|FG000|Overall Study|Death|0|||
129812855|NCT03187197|467282218|FG001|Overall Study|Death|11|||
129812856|NCT03187197|467282219|FG002|Overall Study|Death|0|||
129812857|NCT03187197|467282217|FG000|Overall Study|Administrative problem|1|||
129812858|NCT03187197|467282218|FG001|Overall Study|Administrative problem|1|||
129812859|NCT03187197|467282219|FG002|Overall Study|Administrative problem|0|||
129812860|NCT03187197|467282217|FG000|Overall Study|Reason not listed|2|||
129812861|NCT03187197|467282218|FG001|Overall Study|Reason not listed|54|||
129897040|NCT03568162|467582189|FG000|Overall Study|Withdrawal by Subject|15|||
129812862|NCT03187197|467282219|FG002|Overall Study|Reason not listed|1|||
129812863|NCT03187197|467282217|FG000|Overall Study|Missing|1|||
129812864|NCT03187197|467282218|FG001|Overall Study|Missing|32|||
129812865|NCT03187197|467282219|FG002|Overall Study|Missing|3|||
129812866|NCT03187197|467282217|FG000|Overall Study|Status missing|2|||
129812867|NCT03187197|467282218|FG001|Overall Study|Status missing|33|||
129812868|NCT03187197|467282219|FG002|Overall Study|Status missing|3|||
129812869|NCT03187197|467282217|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
129812870|NCT03187197|467282218|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
129812871|NCT03187197|467282219|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
129812872|NCT00259649|467282220|FG000|Overall Study|Lost to Follow-up|7|||
129812873|NCT00259649|467282220|FG000|Overall Study|irregular menses|3|||
129812874|NCT02200211|467282223|FG000|Overall Study|Lost to Follow-up|7|||
129812875|NCT02200211|467282224|FG001|Overall Study|Lost to Follow-up|7|||
129812876|NCT02200211|467282225|FG002|Overall Study|Lost to Follow-up|1|||
129812877|NCT02200211|467282226|FG003|Overall Study|Lost to Follow-up|2|||
129812878|NCT02200211|467282223|FG000|Overall Study|Withdrawal by Subject|1|||
129812879|NCT02200211|467282224|FG001|Overall Study|Withdrawal by Subject|0|||
129812880|NCT02200211|467282225|FG002|Overall Study|Withdrawal by Subject|0|||
129812881|NCT02200211|467282226|FG003|Overall Study|Withdrawal by Subject|0|||
129812882|NCT00381485|467282227|FG000|Open-Label Run-In Period|Adverse Event|9|||
129812883|NCT00381485|467282228|FG001|Open-Label Run-In Period|Adverse Event|0|||
129812884|NCT00381485|467282229|FG002|Open-Label Run-In Period|Adverse Event|0|||
129812885|NCT00381485|467282230|FG003|Open-Label Run-In Period|Adverse Event|0|||
129812886|NCT00381485|467282227|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
129812887|NCT00381485|467282228|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
129812888|NCT00381485|467282229|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
129812889|NCT00381485|467282230|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
129812890|NCT00381485|467282227|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
129812891|NCT00381485|467282228|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
129812892|NCT00381485|467282229|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
129812893|NCT00381485|467282230|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
129812894|NCT00381485|467282227|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
129812895|NCT00381485|467282228|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
129812896|NCT00381485|467282229|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
129812897|NCT00381485|467282230|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
129812898|NCT00381485|467282227|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
129812899|NCT00381485|467282228|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
129812900|NCT00381485|467282229|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
129812901|NCT00381485|467282230|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
129812902|NCT00381485|467282227|FG000|Open-Label Run-In Period|Treatment failure|1|||
129812903|NCT00381485|467282228|FG001|Open-Label Run-In Period|Treatment failure|0|||
129812904|NCT00381485|467282229|FG002|Open-Label Run-In Period|Treatment failure|0|||
129812905|NCT00381485|467282230|FG003|Open-Label Run-In Period|Treatment failure|0|||
129812906|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129812907|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129812908|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Adverse Event|2|||
129812909|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Adverse Event|5|||
129812910|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129812911|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
129812912|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
129812913|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
129812914|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129812915|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
129812916|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
129812917|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
129812918|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
129812919|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
129812920|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
129812921|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
129812922|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
129812923|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129812924|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
129812925|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129812926|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
129812927|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
129812928|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
129812929|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
129812930|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
129812931|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
129812932|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
129812933|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
129812934|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Administrative|0|||
129812935|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Administrative|1|||
129897041|NCT03568162|467582190|FG001|Overall Study|Withdrawal by Subject|15|||
129897042|NCT03568162|467582191|FG002|Overall Study|Withdrawal by Subject|26|||
129812936|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Administrative|0|||
129812937|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Administrative|1|||
129812938|NCT01235351|467282231|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
129812939|NCT01235351|467282232|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
129812940|NCT01918774|467282233|FG000|Overall Study|Lost prior to first CBTw session|4|||
129812941|NCT01918774|467282233|FG000|Overall Study|Lost to Follow-up|1|||
129812942|NCT01687998|467282234|FG000|Overall Study|Withdrawal by Subject|49|||
129812943|NCT01687998|467282235|FG001|Overall Study|Withdrawal by Subject|51|||
129812944|NCT01687998|467282234|FG000|Overall Study|Known to be Alive at Study End|54|||
129812945|NCT01687998|467282235|FG001|Overall Study|Known to be Alive at Study End|62|||
129812946|NCT01687998|467282234|FG000|Overall Study|Lost to Follow-up|9|||
129812947|NCT01687998|467282235|FG001|Overall Study|Lost to Follow-up|7|||
129812948|NCT00126191|467282240|FG000|Overall Study|Physician Decision|0|||
129812949|NCT00126191|467282241|FG001|Overall Study|Physician Decision|1|||
129812950|NCT00126191|467282240|FG000|Overall Study|Death|0|||
129812951|NCT00126191|467282241|FG001|Overall Study|Death|1|||
129812952|NCT01898806|467282242|FG000|Overall Study|Withdrawal by Subject|2|||
129812953|NCT01898806|467282242|FG000|Overall Study|Physician Decision|1|||
129812954|NCT01648101|467282243|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
129812955|NCT01648101|467282244|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
129812956|NCT01648101|467282245|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
129812957|NCT01648101|467282243|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
129812958|NCT01648101|467282244|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
129812959|NCT01648101|467282245|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
129812960|NCT01648101|467282243|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
129812961|NCT01648101|467282244|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
129812962|NCT01648101|467282245|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
129812963|NCT01648101|467282243|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
129812964|NCT01648101|467282244|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
129812965|NCT01648101|467282245|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
129812966|NCT01648101|467282243|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
129812967|NCT01648101|467282244|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
129812968|NCT01648101|467282245|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
129812969|NCT01648101|467282243|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
129812970|NCT01648101|467282244|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
129812971|NCT01648101|467282245|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
129812972|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
129812973|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
129812974|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
129812975|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
129812976|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
129812977|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
129812978|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
129812979|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
129812980|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
129812981|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
129812982|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
129812983|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
129812984|NCT01648101|467282243|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
129812985|NCT01648101|467282244|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
129812986|NCT01648101|467282245|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
129812987|NCT03003390|467282246|FG000|Overall Study|Physician Decision|2|||
129812988|NCT03003390|467282247|FG001|Overall Study|Physician Decision|0|||
129812989|NCT03003390|467282246|FG000|Overall Study|Parent refused intervention|2|||
129812990|NCT03003390|467282247|FG001|Overall Study|Parent refused intervention|0|||
129812991|NCT00307294|467282260|FG000|Overall Study|Withdrawal by Subject|1|||
129812992|NCT00612690|467282261|FG000|Overall Study|Lost to Follow-up|72|||
129812993|NCT00612690|467282262|FG001|Overall Study|Lost to Follow-up|98|||
129812994|NCT00612690|467282261|FG000|Overall Study|Withdrawal by Subject|32|||
129812995|NCT00612690|467282262|FG001|Overall Study|Withdrawal by Subject|20|||
129812996|NCT00612690|467282261|FG000|Overall Study|Withdrawal by Site|11|||
129812997|NCT00612690|467282262|FG001|Overall Study|Withdrawal by Site|0|||
129812998|NCT02980601|467282264|FG000|Overall Study|Lost to Follow-up|2|||
129812999|NCT02980601|467282265|FG001|Overall Study|Lost to Follow-up|2|||
129813000|NCT02980601|467282264|FG000|Overall Study|Death|0|||
129813001|NCT02980601|467282265|FG001|Overall Study|Death|1|||
129813002|NCT02980601|467282264|FG000|Overall Study|Graft loss|1|||
129813003|NCT02980601|467282265|FG001|Overall Study|Graft loss|0|||
129813004|NCT02980601|467282264|FG000|Overall Study|Failed to sign consent|2|||
129813005|NCT02980601|467282265|FG001|Overall Study|Failed to sign consent|0|||
129813006|NCT00844831|467282266|FG000|Overall Study|Withdrawal by Subject|4|||
129813007|NCT00844831|467282266|FG000|Overall Study|Adverse Event|1|||
129813008|NCT00844831|467282266|FG000|Overall Study|Physician Decision|1|||
129813009|NCT01575769|467282267|FG000|Overall Study|Adverse Event|1|||
129813010|NCT01575769|467282267|FG000|Overall Study|Study terminated by sponsor|40|||
129813011|NCT01581931|467282274|FG000|Washout|Adverse Event|0|||
129813012|NCT01581931|467282275|FG001|Washout|Adverse Event|1|||
129813013|NCT03156543|467282276|FG000|Overall Study|Withdrawal by Subject|1|||
129813014|NCT03156543|467282277|FG001|Overall Study|Withdrawal by Subject|0|||
129813015|NCT02954237|467282278|FG000|Overall Study|Withdrawal by Subject|25|||
129813016|NCT02954237|467282278|FG000|Overall Study|Missed visit|16|||
129813017|NCT02954237|467282278|FG000|Overall Study|Death|2|||
129813018|NCT00674700|467282279|FG000|Year 1|Adverse Event|17|||
129813019|NCT00674700|467282280|FG001|Year 1|Adverse Event|20|||
129813020|NCT00674700|467282281|FG002|Year 1|Adverse Event|5|||
129813021|NCT00674700|467282279|FG000|Year 1|Withdrawal by Subject|7|||
129813022|NCT00674700|467282280|FG001|Year 1|Withdrawal by Subject|7|||
129813023|NCT00674700|467282281|FG002|Year 1|Withdrawal by Subject|6|||
129813024|NCT00674700|467282279|FG000|Year 1|Any other reason not above-mentioned|7|||
129813025|NCT00674700|467282280|FG001|Year 1|Any other reason not above-mentioned|7|||
129813026|NCT00674700|467282281|FG002|Year 1|Any other reason not above-mentioned|6|||
129813027|NCT00674700|467282279|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
129813028|NCT00674700|467282280|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
129813029|NCT00674700|467282281|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
129813030|NCT00674700|467282279|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
129813031|NCT00674700|467282280|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
129813032|NCT00674700|467282281|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
129813033|NCT00674700|467282279|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
129813034|NCT00674700|467282280|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
129813035|NCT00674700|467282281|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
129813036|NCT03797014|467282283|FG000|Overall Study|Withdrawal by Subject|1|||
129813037|NCT03797014|467282283|FG000|Overall Study|Lost to Follow-up|1|||
129813038|NCT03797014|467282283|FG000|Overall Study|Protocol Violation|1|||
129813039|NCT02871297|467282284|FG000|Overall Study|Adverse Event|34|||
129813040|NCT02871297|467282284|FG000|Overall Study|Lack of Efficacy|10|||
129813041|NCT02871297|467282284|FG000|Overall Study|Non-compliance with study drug|15|||
129813042|NCT02871297|467282284|FG000|Overall Study|Protocol Violation|3|||
129813043|NCT02871297|467282284|FG000|Overall Study|Withdrawal by Subject|20|||
129813044|NCT02871297|467282284|FG000|Overall Study|Lost to Follow-up|13|||
129813045|NCT02871297|467282284|FG000|Overall Study|Rolled over to 13546A|2|||
129813046|NCT02871297|467282284|FG000|Overall Study|Other than specified|39|||
129813047|NCT02966028|467282288|FG000|Overall Study|Adverse Event|7|||
129813048|NCT02966028|467282289|FG001|Overall Study|Adverse Event|13|||
129813049|NCT02966028|467282290|FG002|Overall Study|Adverse Event|10|||
129813050|NCT02966028|467282288|FG000|Overall Study|Physician Decision|1|||
129813051|NCT02966028|467282289|FG001|Overall Study|Physician Decision|0|||
129813052|NCT02966028|467282290|FG002|Overall Study|Physician Decision|2|||
129813053|NCT02966028|467282288|FG000|Overall Study|Withdrawal by Subject|7|||
129813054|NCT02966028|467282289|FG001|Overall Study|Withdrawal by Subject|5|||
129813055|NCT02966028|467282290|FG002|Overall Study|Withdrawal by Subject|5|||
129813056|NCT02966028|467282288|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
129813057|NCT02966028|467282289|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
129813058|NCT02966028|467282290|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
129813059|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
129813060|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
129813061|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
129813062|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813063|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813064|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813065|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813066|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
129813067|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
129813068|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
129813069|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813070|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813071|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813072|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813073|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
129813074|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813075|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813076|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813077|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129897043|NCT03568162|467582192|FG003|Overall Study|Withdrawal by Subject|22|||
129813078|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813079|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813080|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813081|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813082|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
129813083|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813084|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813085|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813086|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813087|NCT04115839|467282291|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
129813088|NCT04115839|467282292|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
129813089|NCT04115839|467282293|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
129813090|NCT04115839|467282294|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
129813091|NCT04115839|467282295|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
129813092|NCT04115839|467282296|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
129813093|NCT04115839|467282297|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
129813094|NCT04115839|467282291|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813095|NCT04115839|467282292|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813096|NCT04115839|467282293|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813097|NCT04115839|467282294|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
129813098|NCT04115839|467282295|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
129813099|NCT04115839|467282296|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813100|NCT04115839|467282297|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813101|NCT00691015|467282301|FG000|Overall Study|Refused further treatment|1|||
129813102|NCT04160195|467282304|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
129813103|NCT04160195|467282305|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
129813104|NCT00590720|467282308|FG000|Overall Study|Lost to Follow-up|1|||
129813105|NCT00590720|467282309|FG001|Overall Study|Lost to Follow-up|0|||
129813106|NCT00590720|467282308|FG000|Overall Study|Withdrawal by Subject|0|||
129813107|NCT00590720|467282309|FG001|Overall Study|Withdrawal by Subject|1|||
129813108|NCT04189081|467282311|FG000|Overall Study|Lost to Follow-up|1|||
129813109|NCT04189081|467282312|FG001|Overall Study|Lost to Follow-up|0|||
129813110|NCT04189081|467282313|FG002|Overall Study|Lost to Follow-up|0|||
129813111|NCT04189081|467282311|FG000|Overall Study|Withdrawal by Subject|0|||
129813112|NCT04189081|467282312|FG001|Overall Study|Withdrawal by Subject|0|||
129813113|NCT04189081|467282313|FG002|Overall Study|Withdrawal by Subject|1|||
129813114|NCT01619423|467282314|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
129813115|NCT01619423|467282315|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
129813116|NCT01619423|467282316|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
129813117|NCT01619423|467282317|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
129813118|NCT00913497|467282320|FG000|Overall Study|Adverse Event|1|||
129813119|NCT00913497|467282320|FG000|Overall Study|Withdrawal by Subject|2|||
129813120|NCT02002091|467282321|FG000|Screening|Lost to Follow-up|10|||
129813121|NCT02002091|467282322|FG001|Screening|Lost to Follow-up|12|||
129813122|NCT02002091|467282321|FG000|Screening|Death|3|||
129813123|NCT02002091|467282322|FG001|Screening|Death|2|||
129813124|NCT03385564|467282324|FG000|Overall Study|Adverse Event|0|||
129813125|NCT03385564|467282325|FG001|Overall Study|Adverse Event|0|||
129813126|NCT03385564|467282326|FG002|Overall Study|Adverse Event|3|||
129813127|NCT03385564|467282327|FG003|Overall Study|Adverse Event|3|||
129813128|NCT03385564|467282324|FG000|Overall Study|Other than listed|0|||
129813129|NCT03385564|467282325|FG001|Overall Study|Other than listed|0|||
129813130|NCT03385564|467282326|FG002|Overall Study|Other than listed|0|||
129813131|NCT03385564|467282327|FG003|Overall Study|Other than listed|5|||
129813132|NCT03385564|467282324|FG000|Overall Study|Withdrawal by Subject|0|||
129813133|NCT03385564|467282325|FG001|Overall Study|Withdrawal by Subject|1|||
129813134|NCT03385564|467282326|FG002|Overall Study|Withdrawal by Subject|1|||
129813135|NCT03385564|467282327|FG003|Overall Study|Withdrawal by Subject|0|||
129813136|NCT03385564|467282324|FG000|Overall Study|Lack of Efficacy|0|||
129813137|NCT03385564|467282325|FG001|Overall Study|Lack of Efficacy|0|||
129813138|NCT03385564|467282326|FG002|Overall Study|Lack of Efficacy|0|||
129813139|NCT03385564|467282327|FG003|Overall Study|Lack of Efficacy|1|||
129813140|NCT03385564|467282324|FG000|Overall Study|Death|0|||
129813141|NCT03385564|467282325|FG001|Overall Study|Death|0|||
129813142|NCT03385564|467282326|FG002|Overall Study|Death|1|||
129813143|NCT03385564|467282327|FG003|Overall Study|Death|0|||
129813144|NCT00457301|467282336|FG000|Overall Study|Withdrawal by Subject|3|||
129813145|NCT00457301|467282337|FG001|Overall Study|Withdrawal by Subject|3|||
129813146|NCT00457301|467282336|FG000|Overall Study|Censored out of the study|15|||
129813147|NCT00457301|467282337|FG001|Overall Study|Censored out of the study|14|||
129813148|NCT00457301|467282336|FG000|Overall Study|Death|5|||
129813149|NCT00457301|467282337|FG001|Overall Study|Death|7|||
129813150|NCT00478231|467282338|FG000|Overall Study|Death|7|||
129813151|NCT00478231|467282338|FG000|Overall Study|Lack of Efficacy|47|||
129813152|NCT00478231|467282338|FG000|Overall Study|Lost to Follow-up|7|||
129813153|NCT00478231|467282338|FG000|Overall Study|Withdrawal by Subject|6|||
129813154|NCT00478231|467282338|FG000|Overall Study|Other|9|||
129813155|NCT00478231|467282338|FG000|Overall Study|Adverse Event|5|||
129813156|NCT00478231|467282338|FG000|Overall Study|Randomized, not treated|3|||
129813157|NCT00001880|467282340|FG000|Overall Study|Death|14|||
129813158|NCT00873015|467282341|FG000|Overall Study|Withdrawal by Subject|0|||
129813159|NCT00873015|467282342|FG001|Overall Study|Withdrawal by Subject|1|||
129813160|NCT00873015|467282343|FG002|Overall Study|Withdrawal by Subject|0|||
129813161|NCT00873015|467282344|FG003|Overall Study|Withdrawal by Subject|0|||
129813162|NCT04094883|467282345|FG000|Overall Study|Withdrawal by Subject|1|||
129813163|NCT01382212|467282346|FG000|Overall Study|Kidney transplant|1|||
129813164|NCT01382212|467282346|FG000|Overall Study|Withdrew consent|1|||
129813165|NCT01273597|467282347|FG000|Overall Study|Adverse Event|5|||
129813166|NCT01273597|467282347|FG000|Overall Study|Underwent Kidney Transplantation|2|||
129813167|NCT01273597|467282347|FG000|Overall Study|Reason Not Reported|1|||
129813168|NCT03329573|467282350|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
129813169|NCT03329573|467282351|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
129813170|NCT03329573|467282352|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
129813171|NCT03329573|467282353|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
129813172|NCT03329573|467282350|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
129813173|NCT03329573|467282351|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
129813174|NCT03329573|467282352|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129813175|NCT03329573|467282353|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129813176|NCT03329573|467282350|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
129813177|NCT03329573|467282351|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
129813178|NCT03329573|467282352|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
129813179|NCT03329573|467282353|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
129813180|NCT03329573|467282350|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
129813181|NCT03329573|467282351|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
129813182|NCT03329573|467282352|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
129813183|NCT03329573|467282353|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
129813184|NCT02777333|467282356|FG000|Overall Study|Withdrawal by Subject|0|||
129813185|NCT02777333|467282357|FG001|Overall Study|Withdrawal by Subject|1|||
129813186|NCT02777333|467282356|FG000|Overall Study|Lost to Follow-up|0|||
129813187|NCT02777333|467282357|FG001|Overall Study|Lost to Follow-up|1|||
129813188|NCT00837811|467282358|FG000|Overall Study|Adverse Event|4|||
129813189|NCT00837811|467282359|FG001|Overall Study|Adverse Event|6|||
129813190|NCT00837811|467282360|FG002|Overall Study|Adverse Event|0|||
129813191|NCT00837811|467282358|FG000|Overall Study|Death|1|||
129813192|NCT00837811|467282359|FG001|Overall Study|Death|1|||
129813193|NCT00837811|467282360|FG002|Overall Study|Death|0|||
129813194|NCT00837811|467282358|FG000|Overall Study|Lack of Efficacy|0|||
129813195|NCT00837811|467282359|FG001|Overall Study|Lack of Efficacy|11|||
129813196|NCT00837811|467282360|FG002|Overall Study|Lack of Efficacy|0|||
129813197|NCT00837811|467282358|FG000|Overall Study|Lost to Follow-up|1|||
129813198|NCT00837811|467282359|FG001|Overall Study|Lost to Follow-up|3|||
129813199|NCT00837811|467282360|FG002|Overall Study|Lost to Follow-up|0|||
129813200|NCT00837811|467282358|FG000|Overall Study|Physician Decision|0|||
129813201|NCT00837811|467282359|FG001|Overall Study|Physician Decision|2|||
129813202|NCT00837811|467282360|FG002|Overall Study|Physician Decision|1|||
129813203|NCT00837811|467282358|FG000|Overall Study|Withdrawal by Subject|1|||
129813204|NCT00837811|467282359|FG001|Overall Study|Withdrawal by Subject|9|||
129813205|NCT00837811|467282360|FG002|Overall Study|Withdrawal by Subject|0|||
129813206|NCT00837811|467282358|FG000|Overall Study|Sponsor Decision|0|||
129813207|NCT00837811|467282359|FG001|Overall Study|Sponsor Decision|2|||
129813208|NCT00837811|467282360|FG002|Overall Study|Sponsor Decision|0|||
129813209|NCT03307967|467282361|FG000|Overall Study|Lost to Follow-up|4|||
129813210|NCT02578316|467282362|FG000|Extension Phase|Progression of disease|6|||
129813211|NCT05372419|467282363|FG000|Overall Study|Protocol Deviation|1|||
129813212|NCT05372419|467282363|FG000|Overall Study|Withdrawal by Subject|5|||
129897044|NCT03568162|467582193|FG004|Overall Study|Withdrawal by Subject|6|||
129813213|NCT05372419|467282363|FG000|Overall Study|Lost to Follow-up|7|||
129813214|NCT04362072|467282367|FG000|Treatment|Adverse Event|1|||
129813215|NCT04362072|467282367|FG000|Treatment|Death|9|||
129813216|NCT04362072|467282367|FG000|Treatment|Physician Decision|2|||
129813217|NCT04362072|467282367|FG000|Treatment|Progressive disease|27|||
129813218|NCT04362072|467282367|FG000|Treatment|Withdrawal by Subject|4|||
129897045|NCT03568162|467582194|FG005|Overall Study|Withdrawal by Subject|9|||
129897046|NCT03568162|467582189|FG000|Overall Study|Others|3|||
129897047|NCT03568162|467582190|FG001|Overall Study|Others|4|||
129813219|NCT04362072|467282367|FG000|Treatment|Global deterioration of health status|1|||
129813220|NCT04362072|467282367|FG000|Treatment|Switched to commercial Lorlatinib|13|||
129813221|NCT04362072|467282367|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
129813222|NCT04362072|467282367|FG000|Treatment|Other|3|||
129813223|NCT04362072|467282367|FG000|Follow up|Death|2|||
129813224|NCT04362072|467282367|FG000|Follow up|Other|2|||
129813225|NCT01133522|467282368|FG000|Overall Study|Withdrawal by Subject|0|||
129813226|NCT01133522|467282369|FG001|Overall Study|Withdrawal by Subject|1|||
129813227|NCT01133522|467282370|FG002|Overall Study|Withdrawal by Subject|0|||
129897048|NCT03568162|467582191|FG002|Overall Study|Others|1|||
129813228|NCT01133522|467282371|FG003|Overall Study|Withdrawal by Subject|1|||
129813229|NCT01133522|467282372|FG004|Overall Study|Withdrawal by Subject|0|||
129813230|NCT01133522|467282373|FG005|Overall Study|Withdrawal by Subject|0|||
129813231|NCT01133522|467282374|FG006|Overall Study|Withdrawal by Subject|0|||
129813232|NCT01133522|467282375|FG007|Overall Study|Withdrawal by Subject|0|||
129813233|NCT01133522|467282376|FG008|Overall Study|Withdrawal by Subject|0|||
129813234|NCT01133522|467282377|FG009|Overall Study|Withdrawal by Subject|0|||
129813235|NCT01133522|467282368|FG000|Overall Study|Physician Decision|0|||
129813236|NCT01133522|467282369|FG001|Overall Study|Physician Decision|0|||
129813237|NCT01133522|467282370|FG002|Overall Study|Physician Decision|0|||
129813238|NCT01133522|467282371|FG003|Overall Study|Physician Decision|0|||
129813239|NCT01133522|467282372|FG004|Overall Study|Physician Decision|1|||
129813240|NCT01133522|467282373|FG005|Overall Study|Physician Decision|0|||
129813241|NCT01133522|467282374|FG006|Overall Study|Physician Decision|0|||
129813242|NCT01133522|467282375|FG007|Overall Study|Physician Decision|0|||
129813243|NCT01133522|467282376|FG008|Overall Study|Physician Decision|0|||
129813244|NCT01133522|467282377|FG009|Overall Study|Physician Decision|0|||
129813245|NCT02513394|467282380|FG000|Overall Study|Withdrawal by Subject|11|||
129813246|NCT02513394|467282381|FG001|Overall Study|Withdrawal by Subject|23|||
129813247|NCT02513394|467282380|FG000|Overall Study|Ineligible|1|||
129813248|NCT02513394|467282381|FG001|Overall Study|Ineligible|0|||
129813249|NCT04292743|467282382|FG000|Overall Study|Physician Decision|1|||
129813250|NCT04292743|467282383|FG001|Overall Study|Physician Decision|3|||
129813251|NCT04292743|467282384|FG002|Overall Study|Physician Decision|0|||
129813252|NCT04292743|467282385|FG003|Overall Study|Physician Decision|0|||
129813253|NCT04292743|467282382|FG000|Overall Study|Withdrawal by Subject|0|||
129813254|NCT04292743|467282383|FG001|Overall Study|Withdrawal by Subject|5|||
129813255|NCT04292743|467282384|FG002|Overall Study|Withdrawal by Subject|0|||
129813256|NCT04292743|467282385|FG003|Overall Study|Withdrawal by Subject|0|||
129813257|NCT04292743|467282382|FG000|Overall Study|Death|0|||
129813258|NCT04292743|467282383|FG001|Overall Study|Death|1|||
129813259|NCT04292743|467282384|FG002|Overall Study|Death|0|||
129813260|NCT04292743|467282385|FG003|Overall Study|Death|0|||
129813261|NCT04292743|467282382|FG000|Overall Study|Progression of Disease|2|||
129813262|NCT04292743|467282383|FG001|Overall Study|Progression of Disease|5|||
129813263|NCT04292743|467282384|FG002|Overall Study|Progression of Disease|0|||
129813264|NCT04292743|467282385|FG003|Overall Study|Progression of Disease|0|||
129813265|NCT04292743|467282382|FG000|Overall Study|No Treatment per protocol|0|||
129813266|NCT04292743|467282383|FG001|Overall Study|No Treatment per protocol|2|||
129813267|NCT04292743|467282384|FG002|Overall Study|No Treatment per protocol|0|||
129813268|NCT04292743|467282385|FG003|Overall Study|No Treatment per protocol|0|||
129813269|NCT05766423|467282386|FG000|Overall Study|Withdrawal by Subject|1|||
129813270|NCT05766423|467282387|FG001|Overall Study|Withdrawal by Subject|0|||
129813271|NCT05766423|467282386|FG000|Overall Study|Consented, not scheduled|3|||
129813272|NCT05766423|467282387|FG001|Overall Study|Consented, not scheduled|5|||
129813273|NCT02385045|467284119|FG000|Overall Study|Endoscopy could not be completed|4|||
129813274|NCT00042289|467284121|FG000|Overall Study|Lost to Follow-up|3|||
129813275|NCT00042289|467284122|FG001|Overall Study|Lost to Follow-up|0|||
129813276|NCT00042289|467284123|FG002|Overall Study|Lost to Follow-up|0|||
129813277|NCT00042289|467284124|FG003|Overall Study|Lost to Follow-up|1|||
129813278|NCT00042289|467284125|FG004|Overall Study|Lost to Follow-up|3|||
129813279|NCT00042289|467284126|FG005|Overall Study|Lost to Follow-up|3|||
129813280|NCT00042289|467284127|FG006|Overall Study|Lost to Follow-up|6|||
129813281|NCT00042289|467284128|FG007|Overall Study|Lost to Follow-up|1|||
129813282|NCT00042289|467284129|FG008|Overall Study|Lost to Follow-up|1|||
129813283|NCT00042289|467284130|FG009|Overall Study|Lost to Follow-up|0|||
129813284|NCT00042289|467284131|FG010|Overall Study|Lost to Follow-up|0|||
129813285|NCT00042289|467284132|FG011|Overall Study|Lost to Follow-up|0|||
129813286|NCT00042289|467284133|FG012|Overall Study|Lost to Follow-up|0|||
129813287|NCT00042289|467284134|FG013|Overall Study|Lost to Follow-up|0|||
129813288|NCT00042289|467284135|FG014|Overall Study|Lost to Follow-up|0|||
129813289|NCT00042289|467284136|FG015|Overall Study|Lost to Follow-up|1|||
129813290|NCT00042289|467284137|FG016|Overall Study|Lost to Follow-up|1|||
129813291|NCT00042289|467284138|FG017|Overall Study|Lost to Follow-up|0|||
130058937|NCT02232087|468170434|FG005|Overall Study|Withdrawal by Subject|1|||
129813292|NCT00042289|467284139|FG018|Overall Study|Lost to Follow-up|3|||
129813293|NCT00042289|467284140|FG019|Overall Study|Lost to Follow-up|2|||
129813294|NCT00042289|467284141|FG020|Overall Study|Lost to Follow-up|0|||
129813295|NCT00042289|467284142|FG021|Overall Study|Lost to Follow-up|0|||
129813296|NCT00042289|467284143|FG022|Overall Study|Lost to Follow-up|0|||
129813297|NCT00042289|467284144|FG023|Overall Study|Lost to Follow-up|0|||
129813298|NCT00042289|467284145|FG024|Overall Study|Lost to Follow-up|0|||
129813299|NCT00042289|467284146|FG025|Overall Study|Lost to Follow-up|0|||
129813300|NCT00042289|467284147|FG026|Overall Study|Lost to Follow-up|2|||
129813301|NCT00042289|467284148|FG027|Overall Study|Lost to Follow-up|2|||
129813302|NCT00042289|467284149|FG028|Overall Study|Lost to Follow-up|2|||
129813303|NCT00042289|467284150|FG029|Overall Study|Lost to Follow-up|0|||
129813304|NCT00042289|467284151|FG030|Overall Study|Lost to Follow-up|0|||
129813305|NCT00042289|467284152|FG031|Overall Study|Lost to Follow-up|2|||
129813306|NCT00042289|467284153|FG032|Overall Study|Lost to Follow-up|1|||
129813307|NCT00042289|467284154|FG033|Overall Study|Lost to Follow-up|1|||
129813308|NCT00042289|467284155|FG034|Overall Study|Lost to Follow-up|1|||
129813309|NCT00042289|467284156|FG035|Overall Study|Lost to Follow-up|2|||
129813310|NCT00042289|467284157|FG036|Overall Study|Lost to Follow-up|1|||
129813311|NCT00042289|467284158|FG037|Overall Study|Lost to Follow-up|1|||
129813312|NCT00042289|467284159|FG038|Overall Study|Lost to Follow-up|0|||
129813313|NCT00042289|467284160|FG039|Overall Study|Lost to Follow-up|5|||
129813314|NCT00042289|467284161|FG040|Overall Study|Lost to Follow-up|0|||
129813315|NCT00042289|467284162|FG041|Overall Study|Lost to Follow-up|2|||
129813316|NCT00042289|467284163|FG042|Overall Study|Lost to Follow-up|2|||
129813317|NCT00042289|467284164|FG043|Overall Study|Lost to Follow-up|0|||
129813318|NCT00042289|467284165|FG044|Overall Study|Lost to Follow-up|0|||
129813319|NCT00042289|467284166|FG045|Overall Study|Lost to Follow-up|1|||
129813320|NCT00042289|467284167|FG046|Overall Study|Lost to Follow-up|0|||
129813321|NCT00042289|467284121|FG000|Overall Study|Other reason|0|||
129813322|NCT00042289|467284122|FG001|Overall Study|Other reason|0|||
129813323|NCT00042289|467284123|FG002|Overall Study|Other reason|0|||
129813324|NCT00042289|467284124|FG003|Overall Study|Other reason|2|||
129813325|NCT00042289|467284125|FG004|Overall Study|Other reason|0|||
129813326|NCT00042289|467284126|FG005|Overall Study|Other reason|0|||
129813327|NCT00042289|467284127|FG006|Overall Study|Other reason|0|||
129813328|NCT00042289|467284128|FG007|Overall Study|Other reason|0|||
129813329|NCT00042289|467284129|FG008|Overall Study|Other reason|0|||
129813330|NCT00042289|467284130|FG009|Overall Study|Other reason|0|||
129813331|NCT00042289|467284131|FG010|Overall Study|Other reason|0|||
129813332|NCT00042289|467284132|FG011|Overall Study|Other reason|0|||
129813333|NCT00042289|467284133|FG012|Overall Study|Other reason|0|||
129813334|NCT00042289|467284134|FG013|Overall Study|Other reason|0|||
129813335|NCT00042289|467284135|FG014|Overall Study|Other reason|0|||
129813336|NCT00042289|467284136|FG015|Overall Study|Other reason|0|||
129813337|NCT00042289|467284137|FG016|Overall Study|Other reason|0|||
129813338|NCT00042289|467284138|FG017|Overall Study|Other reason|0|||
129813339|NCT00042289|467284139|FG018|Overall Study|Other reason|1|||
129813340|NCT00042289|467284140|FG019|Overall Study|Other reason|0|||
129813341|NCT00042289|467284141|FG020|Overall Study|Other reason|0|||
129813342|NCT00042289|467284142|FG021|Overall Study|Other reason|0|||
129813343|NCT00042289|467284143|FG022|Overall Study|Other reason|0|||
129813344|NCT00042289|467284144|FG023|Overall Study|Other reason|1|||
129813345|NCT00042289|467284145|FG024|Overall Study|Other reason|0|||
129813346|NCT00042289|467284146|FG025|Overall Study|Other reason|0|||
129813347|NCT00042289|467284147|FG026|Overall Study|Other reason|1|||
129813348|NCT00042289|467284148|FG027|Overall Study|Other reason|0|||
129813349|NCT00042289|467284149|FG028|Overall Study|Other reason|3|||
129813350|NCT00042289|467284150|FG029|Overall Study|Other reason|0|||
129813351|NCT00042289|467284151|FG030|Overall Study|Other reason|0|||
129813352|NCT00042289|467284152|FG031|Overall Study|Other reason|1|||
129813353|NCT00042289|467284153|FG032|Overall Study|Other reason|0|||
129813354|NCT00042289|467284154|FG033|Overall Study|Other reason|1|||
129813355|NCT00042289|467284155|FG034|Overall Study|Other reason|0|||
129813356|NCT00042289|467284156|FG035|Overall Study|Other reason|2|||
129813357|NCT00042289|467284157|FG036|Overall Study|Other reason|0|||
129813358|NCT00042289|467284158|FG037|Overall Study|Other reason|0|||
129813359|NCT00042289|467284159|FG038|Overall Study|Other reason|0|||
129813360|NCT00042289|467284160|FG039|Overall Study|Other reason|0|||
129813361|NCT00042289|467284161|FG040|Overall Study|Other reason|0|||
129813362|NCT00042289|467284162|FG041|Overall Study|Other reason|0|||
129813363|NCT00042289|467284163|FG042|Overall Study|Other reason|0|||
129813364|NCT00042289|467284164|FG043|Overall Study|Other reason|1|||
129813365|NCT00042289|467284165|FG044|Overall Study|Other reason|0|||
129813366|NCT00042289|467284166|FG045|Overall Study|Other reason|0|||
129813367|NCT00042289|467284167|FG046|Overall Study|Other reason|0|||
129813368|NCT00042289|467284121|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129813369|NCT00042289|467284122|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129813370|NCT00042289|467284123|FG002|Overall Study|Severe debilitation, unable to continue|0|||
129813371|NCT00042289|467284124|FG003|Overall Study|Severe debilitation, unable to continue|0|||
129813372|NCT00042289|467284125|FG004|Overall Study|Severe debilitation, unable to continue|0|||
129813373|NCT00042289|467284126|FG005|Overall Study|Severe debilitation, unable to continue|0|||
129813374|NCT00042289|467284127|FG006|Overall Study|Severe debilitation, unable to continue|0|||
129813375|NCT00042289|467284128|FG007|Overall Study|Severe debilitation, unable to continue|0|||
129813376|NCT00042289|467284129|FG008|Overall Study|Severe debilitation, unable to continue|0|||
129813377|NCT00042289|467284130|FG009|Overall Study|Severe debilitation, unable to continue|0|||
129813378|NCT00042289|467284131|FG010|Overall Study|Severe debilitation, unable to continue|0|||
129813379|NCT00042289|467284132|FG011|Overall Study|Severe debilitation, unable to continue|0|||
129813380|NCT00042289|467284133|FG012|Overall Study|Severe debilitation, unable to continue|0|||
129813381|NCT00042289|467284134|FG013|Overall Study|Severe debilitation, unable to continue|0|||
129813382|NCT00042289|467284135|FG014|Overall Study|Severe debilitation, unable to continue|0|||
129897049|NCT03568162|467582192|FG003|Overall Study|Others|4|||
129813383|NCT00042289|467284136|FG015|Overall Study|Severe debilitation, unable to continue|0|||
129813384|NCT00042289|467284137|FG016|Overall Study|Severe debilitation, unable to continue|0|||
129813385|NCT00042289|467284138|FG017|Overall Study|Severe debilitation, unable to continue|0|||
129813386|NCT00042289|467284139|FG018|Overall Study|Severe debilitation, unable to continue|0|||
129813387|NCT00042289|467284140|FG019|Overall Study|Severe debilitation, unable to continue|0|||
129813388|NCT00042289|467284141|FG020|Overall Study|Severe debilitation, unable to continue|0|||
129813389|NCT00042289|467284142|FG021|Overall Study|Severe debilitation, unable to continue|1|||
129813390|NCT00042289|467284143|FG022|Overall Study|Severe debilitation, unable to continue|0|||
129813391|NCT00042289|467284144|FG023|Overall Study|Severe debilitation, unable to continue|1|||
129813392|NCT00042289|467284145|FG024|Overall Study|Severe debilitation, unable to continue|0|||
129813393|NCT00042289|467284146|FG025|Overall Study|Severe debilitation, unable to continue|0|||
129813394|NCT00042289|467284147|FG026|Overall Study|Severe debilitation, unable to continue|0|||
129813395|NCT00042289|467284148|FG027|Overall Study|Severe debilitation, unable to continue|1|||
129813396|NCT00042289|467284149|FG028|Overall Study|Severe debilitation, unable to continue|0|||
129813397|NCT00042289|467284150|FG029|Overall Study|Severe debilitation, unable to continue|0|||
129813398|NCT00042289|467284151|FG030|Overall Study|Severe debilitation, unable to continue|0|||
129813399|NCT00042289|467284152|FG031|Overall Study|Severe debilitation, unable to continue|1|||
129813400|NCT00042289|467284153|FG032|Overall Study|Severe debilitation, unable to continue|1|||
129813401|NCT00042289|467284154|FG033|Overall Study|Severe debilitation, unable to continue|0|||
129813402|NCT00042289|467284155|FG034|Overall Study|Severe debilitation, unable to continue|0|||
129813403|NCT00042289|467284156|FG035|Overall Study|Severe debilitation, unable to continue|0|||
129813404|NCT00042289|467284157|FG036|Overall Study|Severe debilitation, unable to continue|0|||
129813405|NCT00042289|467284158|FG037|Overall Study|Severe debilitation, unable to continue|0|||
129813406|NCT00042289|467284159|FG038|Overall Study|Severe debilitation, unable to continue|0|||
129813407|NCT00042289|467284160|FG039|Overall Study|Severe debilitation, unable to continue|0|||
129813408|NCT00042289|467284161|FG040|Overall Study|Severe debilitation, unable to continue|0|||
129813409|NCT00042289|467284162|FG041|Overall Study|Severe debilitation, unable to continue|0|||
129813410|NCT00042289|467284163|FG042|Overall Study|Severe debilitation, unable to continue|0|||
129813411|NCT00042289|467284164|FG043|Overall Study|Severe debilitation, unable to continue|0|||
129813412|NCT00042289|467284165|FG044|Overall Study|Severe debilitation, unable to continue|0|||
129813413|NCT00042289|467284166|FG045|Overall Study|Severe debilitation, unable to continue|0|||
129813414|NCT00042289|467284167|FG046|Overall Study|Severe debilitation, unable to continue|0|||
129813415|NCT00042289|467284121|FG000|Overall Study|Site closed|0|||
129813416|NCT00042289|467284122|FG001|Overall Study|Site closed|0|||
129813417|NCT00042289|467284123|FG002|Overall Study|Site closed|0|||
129813418|NCT00042289|467284124|FG003|Overall Study|Site closed|0|||
129813419|NCT00042289|467284125|FG004|Overall Study|Site closed|0|||
129813420|NCT00042289|467284126|FG005|Overall Study|Site closed|0|||
129813421|NCT00042289|467284127|FG006|Overall Study|Site closed|0|||
129813422|NCT00042289|467284128|FG007|Overall Study|Site closed|0|||
129813423|NCT00042289|467284129|FG008|Overall Study|Site closed|0|||
129813424|NCT00042289|467284130|FG009|Overall Study|Site closed|0|||
130058938|NCT02232087|468170429|FG000|Overall Study|poor inhalation technique|0|||
129813425|NCT00042289|467284131|FG010|Overall Study|Site closed|0|||
129813426|NCT00042289|467284132|FG011|Overall Study|Site closed|0|||
129813427|NCT00042289|467284133|FG012|Overall Study|Site closed|0|||
129813428|NCT00042289|467284134|FG013|Overall Study|Site closed|0|||
129813429|NCT00042289|467284135|FG014|Overall Study|Site closed|0|||
129813430|NCT00042289|467284136|FG015|Overall Study|Site closed|0|||
129813431|NCT00042289|467284137|FG016|Overall Study|Site closed|0|||
129813432|NCT00042289|467284138|FG017|Overall Study|Site closed|0|||
129813433|NCT00042289|467284139|FG018|Overall Study|Site closed|0|||
129813434|NCT00042289|467284140|FG019|Overall Study|Site closed|0|||
129813435|NCT00042289|467284141|FG020|Overall Study|Site closed|0|||
129813436|NCT00042289|467284142|FG021|Overall Study|Site closed|0|||
129813437|NCT00042289|467284143|FG022|Overall Study|Site closed|0|||
129813438|NCT00042289|467284144|FG023|Overall Study|Site closed|0|||
129813439|NCT00042289|467284145|FG024|Overall Study|Site closed|0|||
129813440|NCT00042289|467284146|FG025|Overall Study|Site closed|0|||
129813441|NCT00042289|467284147|FG026|Overall Study|Site closed|0|||
129813442|NCT00042289|467284148|FG027|Overall Study|Site closed|0|||
129813443|NCT00042289|467284149|FG028|Overall Study|Site closed|0|||
129813444|NCT00042289|467284150|FG029|Overall Study|Site closed|0|||
129813445|NCT00042289|467284151|FG030|Overall Study|Site closed|0|||
129813446|NCT00042289|467284152|FG031|Overall Study|Site closed|3|||
130058939|NCT02232087|468170430|FG001|Overall Study|poor inhalation technique|1|||
129813447|NCT00042289|467284153|FG032|Overall Study|Site closed|0|||
129813448|NCT00042289|467284154|FG033|Overall Study|Site closed|0|||
129813449|NCT00042289|467284155|FG034|Overall Study|Site closed|0|||
129813450|NCT00042289|467284156|FG035|Overall Study|Site closed|0|||
129813451|NCT00042289|467284157|FG036|Overall Study|Site closed|1|||
129813452|NCT00042289|467284158|FG037|Overall Study|Site closed|0|||
129813453|NCT00042289|467284159|FG038|Overall Study|Site closed|0|||
129813454|NCT00042289|467284160|FG039|Overall Study|Site closed|0|||
129813455|NCT00042289|467284161|FG040|Overall Study|Site closed|0|||
129813456|NCT00042289|467284162|FG041|Overall Study|Site closed|0|||
129813457|NCT00042289|467284163|FG042|Overall Study|Site closed|1|||
129813458|NCT00042289|467284164|FG043|Overall Study|Site closed|0|||
129813459|NCT00042289|467284165|FG044|Overall Study|Site closed|0|||
129813460|NCT00042289|467284166|FG045|Overall Study|Site closed|0|||
129813461|NCT00042289|467284167|FG046|Overall Study|Site closed|0|||
129813462|NCT00042289|467284121|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
129813463|NCT00042289|467284122|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
129813464|NCT00042289|467284123|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
129813465|NCT00042289|467284124|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
129813466|NCT00042289|467284125|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
129813467|NCT00042289|467284126|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
129813468|NCT00042289|467284127|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
129813469|NCT00042289|467284128|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
129813470|NCT00042289|467284129|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
129813471|NCT00042289|467284130|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
129813472|NCT00042289|467284131|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
129813473|NCT00042289|467284132|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
129813474|NCT00042289|467284133|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
129813475|NCT00042289|467284134|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
129813476|NCT00042289|467284135|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
129813477|NCT00042289|467284136|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
129813478|NCT00042289|467284137|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
129813479|NCT00042289|467284138|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
129813480|NCT00042289|467284139|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
129813481|NCT00042289|467284140|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
129813482|NCT00042289|467284141|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
129813483|NCT00042289|467284142|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
129813484|NCT00042289|467284143|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
129813485|NCT00042289|467284144|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
129813486|NCT00042289|467284145|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
129813487|NCT00042289|467284146|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
129813488|NCT00042289|467284147|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
129813489|NCT00042289|467284148|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
129813490|NCT00042289|467284149|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
129813491|NCT00042289|467284150|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
129813492|NCT00042289|467284151|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
129813493|NCT00042289|467284152|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
129813494|NCT00042289|467284153|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
129813495|NCT00042289|467284154|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
129813496|NCT00042289|467284155|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
129813497|NCT00042289|467284156|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
129813498|NCT00042289|467284157|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
129813499|NCT00042289|467284158|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
129813500|NCT00042289|467284159|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
129813501|NCT00042289|467284160|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
129813502|NCT00042289|467284161|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
129813503|NCT00042289|467284162|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
129813504|NCT00042289|467284163|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
129813505|NCT00042289|467284164|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
129813506|NCT00042289|467284165|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
129813507|NCT00042289|467284166|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
129813508|NCT00042289|467284167|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
129813509|NCT00042289|467284121|FG000|Overall Study|Protocol Violation|0|||
129813510|NCT00042289|467284122|FG001|Overall Study|Protocol Violation|0|||
129813511|NCT00042289|467284123|FG002|Overall Study|Protocol Violation|0|||
129813512|NCT00042289|467284124|FG003|Overall Study|Protocol Violation|0|||
129813513|NCT00042289|467284125|FG004|Overall Study|Protocol Violation|0|||
129813514|NCT00042289|467284126|FG005|Overall Study|Protocol Violation|1|||
129813515|NCT00042289|467284127|FG006|Overall Study|Protocol Violation|0|||
129813516|NCT00042289|467284128|FG007|Overall Study|Protocol Violation|1|||
129813517|NCT00042289|467284129|FG008|Overall Study|Protocol Violation|0|||
129813518|NCT00042289|467284130|FG009|Overall Study|Protocol Violation|0|||
129813519|NCT00042289|467284131|FG010|Overall Study|Protocol Violation|0|||
129813520|NCT00042289|467284132|FG011|Overall Study|Protocol Violation|0|||
129813521|NCT00042289|467284133|FG012|Overall Study|Protocol Violation|0|||
129813522|NCT00042289|467284134|FG013|Overall Study|Protocol Violation|0|||
129813523|NCT00042289|467284135|FG014|Overall Study|Protocol Violation|0|||
130058940|NCT02232087|468170431|FG002|Overall Study|poor inhalation technique|0|||
130058941|NCT02232087|468170432|FG003|Overall Study|poor inhalation technique|0|||
130058942|NCT02232087|468170433|FG004|Overall Study|poor inhalation technique|0|||
130058943|NCT02232087|468170434|FG005|Overall Study|poor inhalation technique|2|||
130058944|NCT02232087|468170429|FG000|Overall Study|protocol stop criteria|0|||
129813524|NCT00042289|467284136|FG015|Overall Study|Protocol Violation|0|||
129813525|NCT00042289|467284137|FG016|Overall Study|Protocol Violation|0|||
129813526|NCT00042289|467284138|FG017|Overall Study|Protocol Violation|0|||
129813527|NCT00042289|467284139|FG018|Overall Study|Protocol Violation|0|||
129813528|NCT00042289|467284140|FG019|Overall Study|Protocol Violation|0|||
129813529|NCT00042289|467284141|FG020|Overall Study|Protocol Violation|0|||
129813530|NCT00042289|467284142|FG021|Overall Study|Protocol Violation|0|||
129813531|NCT00042289|467284143|FG022|Overall Study|Protocol Violation|0|||
129813532|NCT00042289|467284144|FG023|Overall Study|Protocol Violation|1|||
129813533|NCT00042289|467284145|FG024|Overall Study|Protocol Violation|1|||
129813534|NCT00042289|467284146|FG025|Overall Study|Protocol Violation|0|||
129813535|NCT00042289|467284147|FG026|Overall Study|Protocol Violation|2|||
129813536|NCT00042289|467284148|FG027|Overall Study|Protocol Violation|0|||
129813537|NCT00042289|467284149|FG028|Overall Study|Protocol Violation|0|||
129813538|NCT00042289|467284150|FG029|Overall Study|Protocol Violation|0|||
129813539|NCT00042289|467284151|FG030|Overall Study|Protocol Violation|1|||
129813540|NCT00042289|467284152|FG031|Overall Study|Protocol Violation|0|||
129813541|NCT00042289|467284153|FG032|Overall Study|Protocol Violation|0|||
129813542|NCT00042289|467284154|FG033|Overall Study|Protocol Violation|0|||
129813543|NCT00042289|467284155|FG034|Overall Study|Protocol Violation|0|||
129813544|NCT00042289|467284156|FG035|Overall Study|Protocol Violation|0|||
129813545|NCT00042289|467284157|FG036|Overall Study|Protocol Violation|0|||
129813546|NCT00042289|467284158|FG037|Overall Study|Protocol Violation|0|||
129813547|NCT00042289|467284159|FG038|Overall Study|Protocol Violation|0|||
129813548|NCT00042289|467284160|FG039|Overall Study|Protocol Violation|0|||
129813549|NCT00042289|467284161|FG040|Overall Study|Protocol Violation|0|||
129813550|NCT00042289|467284162|FG041|Overall Study|Protocol Violation|1|||
129813551|NCT00042289|467284163|FG042|Overall Study|Protocol Violation|1|||
129813552|NCT00042289|467284164|FG043|Overall Study|Protocol Violation|1|||
129813553|NCT00042289|467284165|FG044|Overall Study|Protocol Violation|0|||
129813554|NCT00042289|467284166|FG045|Overall Study|Protocol Violation|0|||
129813555|NCT00042289|467284167|FG046|Overall Study|Protocol Violation|0|||
129813556|NCT00042289|467284121|FG000|Overall Study|Withdrawal by Subject|4|||
129813557|NCT00042289|467284122|FG001|Overall Study|Withdrawal by Subject|1|||
129813558|NCT00042289|467284123|FG002|Overall Study|Withdrawal by Subject|0|||
129813559|NCT00042289|467284124|FG003|Overall Study|Withdrawal by Subject|2|||
129813560|NCT00042289|467284125|FG004|Overall Study|Withdrawal by Subject|0|||
129813561|NCT00042289|467284126|FG005|Overall Study|Withdrawal by Subject|2|||
129813562|NCT00042289|467284127|FG006|Overall Study|Withdrawal by Subject|0|||
129813563|NCT00042289|467284128|FG007|Overall Study|Withdrawal by Subject|0|||
129813564|NCT00042289|467284129|FG008|Overall Study|Withdrawal by Subject|0|||
129813565|NCT00042289|467284130|FG009|Overall Study|Withdrawal by Subject|1|||
129813566|NCT00042289|467284131|FG010|Overall Study|Withdrawal by Subject|0|||
129813567|NCT00042289|467284132|FG011|Overall Study|Withdrawal by Subject|0|||
129813568|NCT00042289|467284133|FG012|Overall Study|Withdrawal by Subject|2|||
129813569|NCT00042289|467284134|FG013|Overall Study|Withdrawal by Subject|0|||
129813570|NCT00042289|467284135|FG014|Overall Study|Withdrawal by Subject|0|||
129813571|NCT00042289|467284136|FG015|Overall Study|Withdrawal by Subject|0|||
129813572|NCT00042289|467284137|FG016|Overall Study|Withdrawal by Subject|0|||
129813573|NCT00042289|467284138|FG017|Overall Study|Withdrawal by Subject|0|||
129813574|NCT00042289|467284139|FG018|Overall Study|Withdrawal by Subject|0|||
129813575|NCT00042289|467284140|FG019|Overall Study|Withdrawal by Subject|0|||
129813576|NCT00042289|467284141|FG020|Overall Study|Withdrawal by Subject|0|||
129813577|NCT00042289|467284142|FG021|Overall Study|Withdrawal by Subject|1|||
129813578|NCT00042289|467284143|FG022|Overall Study|Withdrawal by Subject|1|||
129813579|NCT00042289|467284144|FG023|Overall Study|Withdrawal by Subject|1|||
129813580|NCT00042289|467284145|FG024|Overall Study|Withdrawal by Subject|0|||
129813581|NCT00042289|467284146|FG025|Overall Study|Withdrawal by Subject|0|||
130058945|NCT02232087|468170430|FG001|Overall Study|protocol stop criteria|1|||
130058946|NCT02232087|468170431|FG002|Overall Study|protocol stop criteria|0|||
130058947|NCT02232087|468170432|FG003|Overall Study|protocol stop criteria|1|||
129813582|NCT00042289|467284147|FG026|Overall Study|Withdrawal by Subject|1|||
129813583|NCT00042289|467284148|FG027|Overall Study|Withdrawal by Subject|0|||
129813584|NCT00042289|467284149|FG028|Overall Study|Withdrawal by Subject|2|||
129813585|NCT00042289|467284150|FG029|Overall Study|Withdrawal by Subject|0|||
129813586|NCT00042289|467284151|FG030|Overall Study|Withdrawal by Subject|0|||
129813587|NCT00042289|467284152|FG031|Overall Study|Withdrawal by Subject|1|||
129813588|NCT00042289|467284153|FG032|Overall Study|Withdrawal by Subject|2|||
129813589|NCT00042289|467284154|FG033|Overall Study|Withdrawal by Subject|1|||
129813590|NCT00042289|467284155|FG034|Overall Study|Withdrawal by Subject|0|||
129813591|NCT00042289|467284156|FG035|Overall Study|Withdrawal by Subject|0|||
130058948|NCT02232087|468170433|FG004|Overall Study|protocol stop criteria|0|||
130058949|NCT02232087|468170434|FG005|Overall Study|protocol stop criteria|0|||
129813592|NCT00042289|467284157|FG036|Overall Study|Withdrawal by Subject|0|||
129813593|NCT00042289|467284158|FG037|Overall Study|Withdrawal by Subject|1|||
129813594|NCT00042289|467284159|FG038|Overall Study|Withdrawal by Subject|0|||
129813595|NCT00042289|467284160|FG039|Overall Study|Withdrawal by Subject|0|||
129813596|NCT00042289|467284161|FG040|Overall Study|Withdrawal by Subject|0|||
129813597|NCT00042289|467284162|FG041|Overall Study|Withdrawal by Subject|0|||
129813598|NCT00042289|467284163|FG042|Overall Study|Withdrawal by Subject|1|||
129813599|NCT00042289|467284164|FG043|Overall Study|Withdrawal by Subject|0|||
129813600|NCT00042289|467284165|FG044|Overall Study|Withdrawal by Subject|0|||
129813601|NCT00042289|467284166|FG045|Overall Study|Withdrawal by Subject|0|||
129813602|NCT00042289|467284167|FG046|Overall Study|Withdrawal by Subject|0|||
129813603|NCT00745823|467284169|FG000|Overall Study|Adverse Event|5|||
129813604|NCT00745823|467284170|FG001|Overall Study|Adverse Event|3|||
129813605|NCT00745823|467284169|FG000|Overall Study|Lack of Efficacy|20|||
129813606|NCT00745823|467284170|FG001|Overall Study|Lack of Efficacy|6|||
129813607|NCT00745823|467284169|FG000|Overall Study|Lost to Follow-up|10|||
129813608|NCT00745823|467284170|FG001|Overall Study|Lost to Follow-up|11|||
129813609|NCT00745823|467284169|FG000|Overall Study|Physician Decision|10|||
129813610|NCT00745823|467284170|FG001|Overall Study|Physician Decision|5|||
129813611|NCT00745823|467284169|FG000|Overall Study|Pregnancy|0|||
129813612|NCT00745823|467284170|FG001|Overall Study|Pregnancy|4|||
129813613|NCT00745823|467284169|FG000|Overall Study|Withdrawal by Subject|14|||
129813614|NCT00745823|467284170|FG001|Overall Study|Withdrawal by Subject|8|||
129813615|NCT00745823|467284169|FG000|Overall Study|Study Terminated by Sponsor|326|||
129813616|NCT00745823|467284170|FG001|Overall Study|Study Terminated by Sponsor|349|||
129813617|NCT02955602|467284176|FG000|Overall Study|Adverse Event|0|||
129813618|NCT02955602|467284177|FG001|Overall Study|Adverse Event|3|||
129813619|NCT02955602|467284178|FG002|Overall Study|Adverse Event|0|||
129813620|NCT02955602|467284176|FG000|Overall Study|Withdrawal of informed consent|1|||
129813621|NCT02955602|467284177|FG001|Overall Study|Withdrawal of informed consent|3|||
129813622|NCT02955602|467284178|FG002|Overall Study|Withdrawal of informed consent|2|||
129813623|NCT02955602|467284176|FG000|Overall Study|Lost to Follow-up|0|||
129813624|NCT02955602|467284177|FG001|Overall Study|Lost to Follow-up|0|||
129813625|NCT02955602|467284178|FG002|Overall Study|Lost to Follow-up|1|||
129813626|NCT02955602|467284176|FG000|Overall Study|Other|0|||
129813627|NCT02955602|467284177|FG001|Overall Study|Other|1|||
129813628|NCT02955602|467284178|FG002|Overall Study|Other|3|||
129813629|NCT03000439|467284180|FG000|Open Label Part 1|Adverse Event|6|||
129813630|NCT03000439|467284181|FG001|Open Label Part 1|Adverse Event|0|||
129813631|NCT03000439|467284182|FG002|Open Label Part 1|Adverse Event|0|||
129813632|NCT03000439|467284183|FG003|Open Label Part 1|Adverse Event|0|||
129813633|NCT03000439|467284180|FG000|Open Label Part 1|Other|2|||
129813634|NCT03000439|467284181|FG001|Open Label Part 1|Other|0|||
129813635|NCT03000439|467284182|FG002|Open Label Part 1|Other|0|||
129813636|NCT03000439|467284183|FG003|Open Label Part 1|Other|0|||
129813637|NCT03000439|467284180|FG000|Open Label Part 1|Insufficient clinical response|16|||
129813638|NCT03000439|467284181|FG001|Open Label Part 1|Insufficient clinical response|0|||
129813639|NCT03000439|467284182|FG002|Open Label Part 1|Insufficient clinical response|0|||
129813640|NCT03000439|467284183|FG003|Open Label Part 1|Insufficient clinical response|0|||
129813641|NCT03000439|467284180|FG000|Open Label Part 2|Other|0|||
129813642|NCT03000439|467284181|FG001|Open Label Part 2|Other|5|||
129813643|NCT03000439|467284182|FG002|Open Label Part 2|Other|0|||
129813644|NCT03000439|467284183|FG003|Open Label Part 2|Other|0|||
129813645|NCT03000439|467284180|FG000|Open Label Part 2|Insufficient clinical response|0|||
129813646|NCT03000439|467284181|FG001|Open Label Part 2|Insufficient clinical response|12|||
129813647|NCT03000439|467284182|FG002|Open Label Part 2|Insufficient clinical response|0|||
129813648|NCT03000439|467284183|FG003|Open Label Part 2|Insufficient clinical response|0|||
129813649|NCT03000439|467284180|FG000|Double Blind Phase|Adverse Event|0|||
129813650|NCT03000439|467284181|FG001|Double Blind Phase|Adverse Event|0|||
129813651|NCT03000439|467284182|FG002|Double Blind Phase|Adverse Event|2|||
129813652|NCT03000439|467284183|FG003|Double Blind Phase|Adverse Event|1|||
129813653|NCT03000439|467284180|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
129813654|NCT03000439|467284181|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
129813655|NCT03000439|467284182|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
129813656|NCT03000439|467284183|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
129813657|NCT03000439|467284180|FG000|Double Blind Phase|Other|0|||
129813658|NCT03000439|467284181|FG001|Double Blind Phase|Other|0|||
129813659|NCT03000439|467284182|FG002|Double Blind Phase|Other|10|||
129813660|NCT03000439|467284183|FG003|Double Blind Phase|Other|11|||
129813661|NCT03000439|467284180|FG000|Double Blind Phase|Insufficient clinical response|0|||
129813662|NCT03000439|467284181|FG001|Double Blind Phase|Insufficient clinical response|0|||
129813663|NCT03000439|467284182|FG002|Double Blind Phase|Insufficient clinical response|0|||
129813664|NCT03000439|467284183|FG003|Double Blind Phase|Insufficient clinical response|2|||
129813665|NCT02370160|467284184|FG000|Overall Study|Death|3|||
129813666|NCT02370160|467284185|FG001|Overall Study|Death|4|||
129813667|NCT02370160|467284186|FG002|Overall Study|Death|1|||
129813668|NCT00592384|467284187|FG000|Overall Study|Withdrawal by Subject|5|||
129813669|NCT00592384|467284188|FG001|Overall Study|Withdrawal by Subject|6|||
129813670|NCT02151591|467284190|FG000|Overall Study|Lost to Follow-up|6|||
129813671|NCT02151591|467284191|FG001|Overall Study|Lost to Follow-up|3|||
129813672|NCT00684593|467284197|FG000|Overall Study|Adverse Event|0|||
129813673|NCT00684593|467284198|FG001|Overall Study|Adverse Event|2|||
129813674|NCT01001377|467284199|FG000|Overall Study|Ineligibility determined|2|||
129813675|NCT01001377|467284200|FG001|Overall Study|Ineligibility determined|0|||
129813676|NCT01001377|467284199|FG000|Overall Study|Withdrawal by Subject|19|||
129813677|NCT01001377|467284200|FG001|Overall Study|Withdrawal by Subject|20|||
129813678|NCT01001377|467284199|FG000|Overall Study|Lost to Follow-up|14|||
129813679|NCT01001377|467284200|FG001|Overall Study|Lost to Follow-up|17|||
129813680|NCT01001377|467284199|FG000|Overall Study|Death|391|||
129813681|NCT01001377|467284200|FG001|Overall Study|Death|384|||
129813682|NCT02193867|467284204|FG000|Overall Study|Death|2|||
129813683|NCT02193867|467284204|FG000|Overall Study|Sponsor Study Termination|2|||
129813684|NCT00964860|467284205|FG000|Overall Study|Withdrawal by Subject|0|||
129813685|NCT00964860|467284206|FG001|Overall Study|Withdrawal by Subject|1|||
129813686|NCT03716024|467284207|FG000|Overall Study|Randomized, not Treated|7|||
129813687|NCT03716024|467284208|FG001|Overall Study|Randomized, not Treated|8|||
129813688|NCT03716024|467284207|FG000|Overall Study|Adverse Event|1|||
129813689|NCT03716024|467284208|FG001|Overall Study|Adverse Event|2|||
129813690|NCT03716024|467284207|FG000|Overall Study|Treatment Failure|1|||
129813691|NCT03716024|467284208|FG001|Overall Study|Treatment Failure|0|||
129813692|NCT03716024|467284207|FG000|Overall Study|Lost to Follow-up|2|||
129813693|NCT03716024|467284208|FG001|Overall Study|Lost to Follow-up|6|||
129813694|NCT03716024|467284207|FG000|Overall Study|Withdrawal by Subject|0|||
129813695|NCT03716024|467284208|FG001|Overall Study|Withdrawal by Subject|1|||
129813696|NCT03716024|467284207|FG000|Overall Study|Missing Reason|0|||
129813697|NCT03716024|467284208|FG001|Overall Study|Missing Reason|1|||
129813698|NCT00867568|467284209|FG000|Overall Study|Lack of Efficacy|10|||
129813699|NCT00867568|467284209|FG000|Overall Study|Adverse Event|4|||
129813700|NCT00867568|467284209|FG000|Overall Study|Withdrawal by Subject|1|||
129813701|NCT03600818|467284214|FG000|Overall Study|Adverse Event|4|||
129813702|NCT03600818|467284215|FG001|Overall Study|Adverse Event|7|||
129813703|NCT03600818|467284214|FG000|Overall Study|Lack of Efficacy|9|||
129813704|NCT03600818|467284215|FG001|Overall Study|Lack of Efficacy|4|||
129813705|NCT03600818|467284214|FG000|Overall Study|Withdrawal by Subject|4|||
129813706|NCT03600818|467284215|FG001|Overall Study|Withdrawal by Subject|3|||
129813707|NCT03600818|467284214|FG000|Overall Study|Other-unspecified|5|||
129813708|NCT03600818|467284215|FG001|Overall Study|Other-unspecified|3|||
129813709|NCT03600818|467284214|FG000|Overall Study|Randomized and not treated|0|||
129813710|NCT03600818|467284215|FG001|Overall Study|Randomized and not treated|1|||
129813711|NCT04930965|467284219|FG000|Overall Study|Lost to Follow-up|7|||
129813712|NCT04930965|467284220|FG001|Overall Study|Lost to Follow-up|5|||
129813713|NCT01471171|467284223|FG000|Treatment Period 1|Adverse Event|4|||
129813714|NCT01471171|467284224|FG001|Treatment Period 1|Adverse Event|1|||
129813715|NCT01471171|467284223|FG000|Treatment Period 2|Adverse Event|1|||
129813716|NCT01471171|467284224|FG001|Treatment Period 2|Adverse Event|0|||
129813717|NCT03478930|467284225|FG000|Overall Study|Adverse Event|0|||
129813718|NCT03478930|467284226|FG001|Overall Study|Adverse Event|1|||
129813719|NCT03478930|467284225|FG000|Overall Study|Lack of Efficacy|3|||
129813720|NCT03478930|467284226|FG001|Overall Study|Lack of Efficacy|3|||
129813721|NCT03478930|467284225|FG000|Overall Study|Withdrawal by Subject|6|||
129813722|NCT03478930|467284226|FG001|Overall Study|Withdrawal by Subject|5|||
129813723|NCT00705484|467284231|FG000|Overall Study|Adverse Event|28|||
129813724|NCT00705484|467284232|FG001|Overall Study|Adverse Event|27|||
129813725|NCT00705484|467284231|FG000|Overall Study|Lost to Follow-up|169|||
129813726|NCT00705484|467284232|FG001|Overall Study|Lost to Follow-up|250|||
129813727|NCT00705484|467284231|FG000|Overall Study|Withdrawal by Subject|96|||
129813728|NCT00705484|467284232|FG001|Overall Study|Withdrawal by Subject|72|||
129813729|NCT00705484|467284231|FG000|Overall Study|Administrative|89|||
129813730|NCT00705484|467284232|FG001|Overall Study|Administrative|59|||
129813731|NCT02340975|467284234|FG000|Overall Study|Death|6|||
129813732|NCT02340975|467284235|FG001|Overall Study|Death|23|||
129813733|NCT02340975|467284236|FG002|Overall Study|Death|21|||
129813734|NCT02340975|467284237|FG003|Overall Study|Death|7|||
129813735|NCT02340975|467284238|FG004|Overall Study|Death|21|||
129813736|NCT02340975|467284239|FG005|Overall Study|Death|13|||
129813737|NCT02340975|467284234|FG000|Overall Study|Lost to Follow-up|0|||
129813738|NCT02340975|467284235|FG001|Overall Study|Lost to Follow-up|0|||
129813739|NCT02340975|467284236|FG002|Overall Study|Lost to Follow-up|0|||
129813740|NCT02340975|467284237|FG003|Overall Study|Lost to Follow-up|0|||
129813741|NCT02340975|467284238|FG004|Overall Study|Lost to Follow-up|2|||
129813742|NCT02340975|467284239|FG005|Overall Study|Lost to Follow-up|0|||
129813743|NCT02340975|467284234|FG000|Overall Study|Withdrawal by Subject|0|||
129813744|NCT02340975|467284235|FG001|Overall Study|Withdrawal by Subject|0|||
129813745|NCT02340975|467284236|FG002|Overall Study|Withdrawal by Subject|3|||
129813746|NCT02340975|467284237|FG003|Overall Study|Withdrawal by Subject|3|||
129813747|NCT02340975|467284238|FG004|Overall Study|Withdrawal by Subject|2|||
129813748|NCT02340975|467284239|FG005|Overall Study|Withdrawal by Subject|0|||
129813749|NCT02340975|467284234|FG000|Overall Study|Other|0|||
129813750|NCT02340975|467284235|FG001|Overall Study|Other|4|||
129813751|NCT02340975|467284236|FG002|Overall Study|Other|0|||
129813752|NCT02340975|467284237|FG003|Overall Study|Other|2|||
129813753|NCT02340975|467284238|FG004|Overall Study|Other|0|||
129813754|NCT02340975|467284239|FG005|Overall Study|Other|6|||
129813755|NCT02228460|467284242|FG000|Overall Study|Adverse Event|1|||
129813756|NCT02228460|467284242|FG000|Overall Study|Lost to Follow-up|1|||
129813757|NCT01243892|467284243|FG000|Overall Study|Did not meet eligibility criteria|2|||
129813758|NCT01243892|467284244|FG001|Overall Study|Did not meet eligibility criteria|0|||
129813759|NCT03982368|467284252|FG000|Overall Study|Adverse Event|6|||
129813760|NCT03982368|467284253|FG001|Overall Study|Adverse Event|4|||
129813761|NCT03982368|467284254|FG002|Overall Study|Adverse Event|3|||
129813762|NCT03982368|467284252|FG000|Overall Study|Lost to Follow-up|2|||
129813763|NCT03982368|467284253|FG001|Overall Study|Lost to Follow-up|1|||
129813764|NCT03982368|467284254|FG002|Overall Study|Lost to Follow-up|0|||
129813765|NCT03982368|467284252|FG000|Overall Study|Withdrawal by Subject|1|||
129813766|NCT03982368|467284253|FG001|Overall Study|Withdrawal by Subject|2|||
129813767|NCT03982368|467284254|FG002|Overall Study|Withdrawal by Subject|0|||
129813768|NCT03982368|467284252|FG000|Overall Study|unknow|4|||
129813769|NCT03982368|467284253|FG001|Overall Study|unknow|0|||
129813770|NCT03982368|467284254|FG002|Overall Study|unknow|2|||
129813771|NCT03087643|467284257|FG000|Overall Study|Withdrawal by Subject|2|||
129813772|NCT03087643|467284258|FG001|Overall Study|Withdrawal by Subject|4|||
129813773|NCT03087643|467284257|FG000|Overall Study|Death|2|||
129813774|NCT03087643|467284258|FG001|Overall Study|Death|2|||
129813775|NCT02083783|467284259|FG000|Overall Study|Withdrawal by Subject|1|||
129813776|NCT02083783|467284260|FG001|Overall Study|Withdrawal by Subject|0|||
129813777|NCT01546883|467284263|FG000|Overall Study|Withdrawal by Subject|3|||
129813778|NCT01546883|467284263|FG000|Overall Study|Adverse Event|4|||
129813779|NCT01546883|467284263|FG000|Overall Study|Lost to Follow-up|2|||
129813780|NCT01546883|467284263|FG000|Overall Study|early closure of study|2|||
129813781|NCT01546883|467284263|FG000|Overall Study|other unrelated illness|1|||
129813782|NCT02256631|467284267|FG000|Overall Study|Lost to Follow-up|1|||
129813783|NCT02256631|467284268|FG001|Overall Study|Lost to Follow-up|1|||
129813784|NCT02256631|467284269|FG002|Overall Study|Lost to Follow-up|0|||
129813785|NCT02256631|467284270|FG003|Overall Study|Lost to Follow-up|2|||
129813786|NCT02256631|467284271|FG004|Overall Study|Lost to Follow-up|0|||
129813787|NCT02256631|467284272|FG005|Overall Study|Lost to Follow-up|4|||
129813788|NCT02256631|467284273|FG006|Overall Study|Lost to Follow-up|1|||
129813789|NCT02256631|467284267|FG000|Overall Study|Withdrawal by Subject|0|||
129813790|NCT02256631|467284268|FG001|Overall Study|Withdrawal by Subject|0|||
129813791|NCT02256631|467284269|FG002|Overall Study|Withdrawal by Subject|0|||
129813792|NCT02256631|467284270|FG003|Overall Study|Withdrawal by Subject|1|||
129813793|NCT02256631|467284271|FG004|Overall Study|Withdrawal by Subject|1|||
129813794|NCT02256631|467284272|FG005|Overall Study|Withdrawal by Subject|0|||
129813795|NCT02256631|467284273|FG006|Overall Study|Withdrawal by Subject|1|||
129813796|NCT02256631|467284267|FG000|Overall Study|Unable to get to clinic|0|||
129813797|NCT02256631|467284268|FG001|Overall Study|Unable to get to clinic|2|||
129813798|NCT02256631|467284269|FG002|Overall Study|Unable to get to clinic|0|||
129813799|NCT02256631|467284270|FG003|Overall Study|Unable to get to clinic|1|||
129813800|NCT02256631|467284271|FG004|Overall Study|Unable to get to clinic|0|||
129813801|NCT02256631|467284272|FG005|Overall Study|Unable to get to clinic|1|||
129813802|NCT02256631|467284273|FG006|Overall Study|Unable to get to clinic|2|||
129813803|NCT03035409|467284276|FG000|Overall Study|Adverse Event|5|||
129813804|NCT03035409|467284276|FG000|Overall Study|Death|2|||
129813805|NCT03035409|467284276|FG000|Overall Study|Withdrawal by Subject|2|||
129813806|NCT03035409|467284276|FG000|Overall Study|Non compliance|4|||
129813807|NCT03035409|467284276|FG000|Overall Study|Patient was jittery|1|||
129813808|NCT03035409|467284276|FG000|Overall Study|Did not like Questionnaire|1|||
129813809|NCT03035409|467284276|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
129813810|NCT03035409|467284276|FG000|Overall Study|Did not like taking drugs|1|||
129813811|NCT01552694|467284279|FG000|Overall Study|Lost to Follow-up|0|||
129813812|NCT01552694|467284280|FG001|Overall Study|Lost to Follow-up|1|||
129813813|NCT01552694|467284279|FG000|Overall Study|Protocol Violation|0|||
129813814|NCT01552694|467284280|FG001|Overall Study|Protocol Violation|1|||
129813815|NCT03724032|467284281|FG000|Overall Study|Physician Decision|1|||
129813816|NCT03724032|467284282|FG001|Overall Study|Physician Decision|0|||
129813817|NCT03724032|467284283|FG002|Overall Study|Physician Decision|0|||
129813818|NCT03724032|467284281|FG000|Overall Study|Protocol Violation|2|||
129813819|NCT03724032|467284282|FG001|Overall Study|Protocol Violation|2|||
129813820|NCT03724032|467284283|FG002|Overall Study|Protocol Violation|1|||
129813821|NCT00361569|467284287|FG000|Overall Study|Protocol Violation|3|||
129813822|NCT00361569|467284288|FG001|Overall Study|Protocol Violation|2|||
129813823|NCT00361569|467284289|FG002|Overall Study|Protocol Violation|4|||
129813824|NCT00361569|467284290|FG003|Overall Study|Protocol Violation|2|||
129813825|NCT00361569|467284287|FG000|Overall Study|Withdrawal by Subject|2|||
129813826|NCT00361569|467284288|FG001|Overall Study|Withdrawal by Subject|1|||
129813827|NCT00361569|467284289|FG002|Overall Study|Withdrawal by Subject|9|||
129813828|NCT00361569|467284290|FG003|Overall Study|Withdrawal by Subject|14|||
129813829|NCT00361569|467284287|FG000|Overall Study|Adverse Event|3|||
129813830|NCT00361569|467284288|FG001|Overall Study|Adverse Event|5|||
129813831|NCT00361569|467284289|FG002|Overall Study|Adverse Event|2|||
129813832|NCT00361569|467284290|FG003|Overall Study|Adverse Event|2|||
129813833|NCT00361569|467284287|FG000|Overall Study|Lost to Follow-up|2|||
129813834|NCT00361569|467284288|FG001|Overall Study|Lost to Follow-up|3|||
129813835|NCT00361569|467284289|FG002|Overall Study|Lost to Follow-up|3|||
129813836|NCT00361569|467284290|FG003|Overall Study|Lost to Follow-up|2|||
129813837|NCT00361569|467284287|FG000|Overall Study|Not specified by investigator|2|||
129813838|NCT00361569|467284288|FG001|Overall Study|Not specified by investigator|0|||
129813839|NCT00361569|467284289|FG002|Overall Study|Not specified by investigator|0|||
129813840|NCT00361569|467284290|FG003|Overall Study|Not specified by investigator|1|||
129813841|NCT02639065|467284291|FG000|Study Treatment|Disease Progression|13|||
129813842|NCT02639065|467284291|FG000|Study Treatment|Adverse Event|9|||
129813843|NCT02639065|467284291|FG000|Study Treatment|Withdrawal by Subject|1|||
129813844|NCT02639065|467284291|FG000|Follow up|Subject refused to follow up|1|||
129813845|NCT02639065|467284291|FG000|Follow up|Symptomatic Deterioration|2|||
129813846|NCT02639065|467284291|FG000|Follow up|Death|2|||
129813847|NCT02639065|467284291|FG000|Follow up|Study Terminated|1|||
129813848|NCT02639065|467284291|FG000|Follow up|Disease Progression|3|||
129813849|NCT00481078|467284292|FG000|Overall Study|Progression of disease|11|||
129813850|NCT00481078|467284293|FG001|Overall Study|Progression of disease|11|||
129813851|NCT00481078|467284292|FG000|Overall Study|Adverse Event|15|||
129813852|NCT00481078|467284293|FG001|Overall Study|Adverse Event|3|||
129813853|NCT00481078|467284292|FG000|Overall Study|Death|5|||
129813854|NCT00481078|467284293|FG001|Overall Study|Death|3|||
129813855|NCT00481078|467284292|FG000|Overall Study|Intercurrent illness|1|||
129813856|NCT00481078|467284293|FG001|Overall Study|Intercurrent illness|0|||
129813857|NCT00481078|467284292|FG000|Overall Study|Withdrawal by Subject|7|||
129813858|NCT00481078|467284293|FG001|Overall Study|Withdrawal by Subject|1|||
129813859|NCT00481078|467284292|FG000|Overall Study|Information not available|1|||
129813860|NCT00481078|467284293|FG001|Overall Study|Information not available|0|||
129813861|NCT00481078|467284292|FG000|Overall Study|Received other treatment|2|||
129813862|NCT00481078|467284293|FG001|Overall Study|Received other treatment|1|||
129813863|NCT00481078|467284292|FG000|Overall Study|Brain metastasis|0|||
129813864|NCT00481078|467284293|FG001|Overall Study|Brain metastasis|1|||
129813865|NCT01558271|467284294|FG000|Overall Study|Adverse Event|6|||
129813866|NCT01558271|467284295|FG001|Overall Study|Adverse Event|3|||
129813867|NCT01558271|467284296|FG002|Overall Study|Adverse Event|4|||
129813868|NCT01558271|467284294|FG000|Overall Study|Lost to Follow-up|1|||
129813869|NCT01558271|467284295|FG001|Overall Study|Lost to Follow-up|0|||
129813870|NCT01558271|467284296|FG002|Overall Study|Lost to Follow-up|0|||
129813871|NCT01558271|467284294|FG000|Overall Study|Protocol Violation|1|||
129813872|NCT01558271|467284295|FG001|Overall Study|Protocol Violation|0|||
129813873|NCT01558271|467284296|FG002|Overall Study|Protocol Violation|0|||
129813874|NCT01558271|467284294|FG000|Overall Study|Withdrawal by Subject|10|||
129813875|NCT01558271|467284295|FG001|Overall Study|Withdrawal by Subject|6|||
129813876|NCT01558271|467284296|FG002|Overall Study|Withdrawal by Subject|12|||
129813877|NCT01558271|467284294|FG000|Overall Study|Physician Decision|0|||
129813878|NCT01558271|467284295|FG001|Overall Study|Physician Decision|2|||
129813879|NCT01558271|467284296|FG002|Overall Study|Physician Decision|1|||
129813880|NCT01845831|467284297|FG000|Inpatient Phase|Withdrawal by Subject|1|||
129813881|NCT01845831|467284298|FG001|Inpatient Phase|Withdrawal by Subject|1|||
129813882|NCT01845831|467284299|FG002|Inpatient Phase|Withdrawal by Subject|0|||
129813883|NCT01845831|467284300|FG003|Inpatient Phase|Withdrawal by Subject|0|||
129813884|NCT01845831|467284301|FG004|Inpatient Phase|Withdrawal by Subject|0|||
129813885|NCT00221403|467284302|FG000|Overall Study|Protocol Violation|1|||
129813886|NCT00221403|467284303|FG001|Overall Study|Protocol Violation|0|||
129813887|NCT00221403|467284304|FG002|Overall Study|Protocol Violation|0|||
129813888|NCT00221403|467284302|FG000|Overall Study|Physician Decision|1|||
129897050|NCT03568162|467582193|FG004|Overall Study|Others|2|||
129897051|NCT03568162|467582194|FG005|Overall Study|Others|1|||
129897052|NCT03717194|467582195|FG000|Overall Study|Withdrawal by Subject|2|||
129897053|NCT03717194|467582196|FG001|Overall Study|Withdrawal by Subject|4|||
129813889|NCT00221403|467284303|FG001|Overall Study|Physician Decision|0|||
129813890|NCT00221403|467284304|FG002|Overall Study|Physician Decision|0|||
129813891|NCT00221403|467284302|FG000|Overall Study|Withdrawal by Subject|0|||
129813892|NCT00221403|467284303|FG001|Overall Study|Withdrawal by Subject|3|||
129813893|NCT00221403|467284304|FG002|Overall Study|Withdrawal by Subject|0|||
129813894|NCT00221403|467284302|FG000|Overall Study|Lack of Efficacy|0|||
129813895|NCT00221403|467284303|FG001|Overall Study|Lack of Efficacy|1|||
129813896|NCT00221403|467284304|FG002|Overall Study|Lack of Efficacy|0|||
129813897|NCT00221403|467284302|FG000|Overall Study|Adverse Event|0|||
129813898|NCT00221403|467284303|FG001|Overall Study|Adverse Event|1|||
129813899|NCT00221403|467284304|FG002|Overall Study|Adverse Event|0|||
129813900|NCT02610725|467284305|FG000|Overall Study|Lost to Follow-up|197|||
129813901|NCT02610725|467284305|FG000|Overall Study|self-reported contraindication|9|||
129813902|NCT00826943|467284306|FG000|Overall Study|Withdrawal by Subject|0|||
129813903|NCT00826943|467284307|FG001|Overall Study|Withdrawal by Subject|0|||
129813904|NCT00826943|467284308|FG002|Overall Study|Withdrawal by Subject|0|||
129813905|NCT00826943|467284309|FG003|Overall Study|Withdrawal by Subject|0|||
129813906|NCT00826943|467284310|FG004|Overall Study|Withdrawal by Subject|1|||
129813907|NCT00826943|467284311|FG005|Overall Study|Withdrawal by Subject|0|||
129813908|NCT01348165|467284312|FG000|Overall Study|Adverse Event|0|||
129813909|NCT01348165|467284313|FG001|Overall Study|Adverse Event|0|||
129813910|NCT01348165|467284314|FG002|Overall Study|Adverse Event|0|||
129813911|NCT01348165|467284315|FG003|Overall Study|Adverse Event|0|||
129813912|NCT01348165|467284316|FG004|Overall Study|Adverse Event|0|||
129813913|NCT01348165|467284317|FG005|Overall Study|Adverse Event|0|||
129813914|NCT01348165|467284318|FG006|Overall Study|Adverse Event|1|||
129813915|NCT00074152|467284319|FG000|Overall Study|Death|21|||
129813916|NCT00074152|467284320|FG001|Overall Study|Death|9|||
129813917|NCT00074152|467284319|FG000|Overall Study|Lack of Efficacy|34|||
129813918|NCT00074152|467284320|FG001|Overall Study|Lack of Efficacy|24|||
129813919|NCT01063868|467284322|FG000|Overall Study|Adverse Event|9|||
129813920|NCT01063868|467284323|FG001|Overall Study|Adverse Event|7|||
129813921|NCT01063868|467284322|FG000|Overall Study|Withdrawal by Subject|3|||
129813922|NCT01063868|467284323|FG001|Overall Study|Withdrawal by Subject|1|||
129813923|NCT01063868|467284322|FG000|Overall Study|Study Terminated By Sponsor|23|||
129813924|NCT01063868|467284323|FG001|Overall Study|Study Terminated By Sponsor|4|||
129813925|NCT02469298|467286211|FG000|Overall Study|Protocol Violation|0|||
129813926|NCT02469298|467286212|FG001|Overall Study|Protocol Violation|1|||
129813927|NCT02469298|467286213|FG002|Overall Study|Protocol Violation|1|||
129813928|NCT02469298|467286214|FG003|Overall Study|Protocol Violation|0|||
129813929|NCT02469298|467286211|FG000|Overall Study|Lost to Follow-up|1|||
129813930|NCT02469298|467286212|FG001|Overall Study|Lost to Follow-up|0|||
129813931|NCT02469298|467286213|FG002|Overall Study|Lost to Follow-up|1|||
129813932|NCT02469298|467286214|FG003|Overall Study|Lost to Follow-up|0|||
129813933|NCT02469298|467286211|FG000|Overall Study|Physician Decision|0|||
129813934|NCT02469298|467286212|FG001|Overall Study|Physician Decision|0|||
129813935|NCT02469298|467286213|FG002|Overall Study|Physician Decision|0|||
129813936|NCT02469298|467286214|FG003|Overall Study|Physician Decision|1|||
129813937|NCT02469298|467286211|FG000|Overall Study|Withdrawal by Subject|0|||
129813938|NCT02469298|467286212|FG001|Overall Study|Withdrawal by Subject|0|||
129813939|NCT02469298|467286213|FG002|Overall Study|Withdrawal by Subject|0|||
129813940|NCT02469298|467286214|FG003|Overall Study|Withdrawal by Subject|1|||
129813941|NCT01664533|467286217|FG000|Overall Study|Death|42|||
129813942|NCT01664533|467286217|FG000|Overall Study|Lost to Follow-up|3|||
129813943|NCT01664533|467286217|FG000|Overall Study|Study termination|9|||
129813944|NCT01664533|467286217|FG000|Overall Study|Protocol Violation|3|||
129813945|NCT00290888|467286218|FG000|Overall Study|Physician Decision|3|||
129813946|NCT00290888|467286219|FG001|Overall Study|Physician Decision|1|||
129813947|NCT02397278|467286226|FG000|Overall Study|Withdrawal by Subject|0|||
129813948|NCT02397278|467286227|FG001|Overall Study|Withdrawal by Subject|2|||
129813949|NCT02397278|467286226|FG000|Overall Study|Deemed ineligible following surgery|1|||
129813950|NCT02397278|467286227|FG001|Overall Study|Deemed ineligible following surgery|1|||
129813951|NCT01397084|467286232|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
129813952|NCT01397084|467286232|FG000|Overall Study|Protocol Violation|2|||
129813953|NCT01397084|467286232|FG000|Overall Study|Adverse Event|2|||
129897054|NCT03717194|467582195|FG000|Overall Study|Adverse Event|1|||
129813954|NCT01397084|467286232|FG000|Overall Study|Withdrawal by Subject|1|||
129813955|NCT01397084|467286232|FG000|Overall Study|Lost to Follow-up|1|||
129813956|NCT01397084|467286232|FG000|Overall Study|Used other proton pump inhibitor|1|||
129813957|NCT02853604|467286233|FG000|Overall Study|Withdrawal by Subject|12|||
129897055|NCT03717194|467582196|FG001|Overall Study|Adverse Event|1|||
129897056|NCT02081391|467582198|FG000|12-hour Treatment|Withdrawal by Subject|3|||
129897057|NCT02081391|467582199|FG001|12-hour Treatment|Withdrawal by Subject|2|||
129897058|NCT02081391|467582200|FG002|12-hour Treatment|Withdrawal by Subject|0|||
129813958|NCT02853604|467286234|FG001|Overall Study|Withdrawal by Subject|35|||
129813959|NCT02853604|467286233|FG000|Overall Study|Lost to Follow-up|4|||
129813960|NCT02853604|467286234|FG001|Overall Study|Lost to Follow-up|8|||
129813961|NCT02853604|467286233|FG000|Overall Study|Death|1|||
129813962|NCT02853604|467286234|FG001|Overall Study|Death|5|||
129813963|NCT02853604|467286233|FG000|Overall Study|Miscellaneous|11|||
129813964|NCT02853604|467286234|FG001|Overall Study|Miscellaneous|2|||
129813965|NCT02853604|467286233|FG000|Overall Study|Progressive Disease|0|||
129813966|NCT02853604|467286234|FG001|Overall Study|Progressive Disease|2|||
129897059|NCT02081391|467582201|FG003|12-hour Treatment|Withdrawal by Subject|0|||
129813967|NCT04213079|467286235|FG000|Overall Study|Lost to Follow-up|0|||
129813968|NCT04213079|467286236|FG001|Overall Study|Lost to Follow-up|2|||
129813969|NCT04343261|467286237|FG000|Overall Study|Adverse Event|1|||
129813970|NCT04343261|467286237|FG000|Overall Study|received inadequate amount of antibodies|7|||
129813971|NCT05275400|467286241|FG000|Treatment Period|Adverse Event|7|||
129813972|NCT05275400|467286242|FG001|Treatment Period|Adverse Event|1|||
129813973|NCT05275400|467286241|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
129813974|NCT05275400|467286242|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
129813975|NCT05275400|467286241|FG000|Treatment Period|Death|5|||
129813976|NCT05275400|467286242|FG001|Treatment Period|Death|2|||
129813977|NCT05275400|467286241|FG000|Treatment Period|Protocol Violation|1|||
129813978|NCT05275400|467286242|FG001|Treatment Period|Protocol Violation|0|||
129813979|NCT05275400|467286241|FG000|Treatment Period|Physician Decision|5|||
129813980|NCT05275400|467286242|FG001|Treatment Period|Physician Decision|4|||
129813981|NCT05275400|467286241|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
129813982|NCT05275400|467286242|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
129813983|NCT05275400|467286241|FG000|Treatment Period|Withdrawal by Subject|30|||
129813984|NCT05275400|467286242|FG001|Treatment Period|Withdrawal by Subject|12|||
129813985|NCT05275400|467286241|FG000|Treatment Period|Lost to Follow-up|1|||
129813986|NCT05275400|467286242|FG001|Treatment Period|Lost to Follow-up|5|||
129813987|NCT05275400|467286241|FG000|Treatment Period|Lack of Efficacy|1|||
129813988|NCT05275400|467286242|FG001|Treatment Period|Lack of Efficacy|0|||
129813989|NCT05275400|467286241|FG000|Treatment Period|Sponsor Decision|1|||
129813990|NCT05275400|467286242|FG001|Treatment Period|Sponsor Decision|0|||
129813991|NCT05275400|467286241|FG000|Follow-Up Period|Death|2|||
129813992|NCT05275400|467286242|FG001|Follow-Up Period|Death|0|||
129813993|NCT05275400|467286241|FG000|Follow-Up Period|Protocol Violation|1|||
129813994|NCT05275400|467286242|FG001|Follow-Up Period|Protocol Violation|0|||
129813995|NCT05275400|467286241|FG000|Follow-Up Period|Withdrawal by Subject|3|||
129813996|NCT05275400|467286242|FG001|Follow-Up Period|Withdrawal by Subject|0|||
129813997|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Physician Decision|0|||
129813998|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Physician Decision|1|||
129813999|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Physician Decision|0|||
129814000|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
129814001|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
129814002|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
129814003|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
129814004|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
129814005|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
129814006|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Other|4|||
129814007|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Other|4|||
129814008|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Other|0|||
129814009|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
129814010|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
129814011|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
129814012|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Screen Failure|0|||
129814013|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Screen Failure|0|||
129814014|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Screen Failure|1|||
129814015|NCT02585960|467286243|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
129814016|NCT02585960|467286244|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
129814017|NCT02585960|467286245|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
129814018|NCT02585960|467286243|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
129814019|NCT02585960|467286244|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
129814020|NCT02585960|467286245|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
129814021|NCT03639935|467286246|FG000|Overall Study|Death|3|||
129814022|NCT03639935|467286246|FG000|Overall Study|Adverse Event|1|||
129814023|NCT06333613|467286247|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
129814024|NCT03616600|467286249|FG000|Overall Study|Withdrawal by Subject|1|||
129814025|NCT03616600|467286250|FG001|Overall Study|Withdrawal by Subject|0|||
129814026|NCT03648541|467286251|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
129814027|NCT03648541|467286252|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
129814028|NCT03648541|467286251|FG000|Re-induction Period Only|Lack of Efficacy|7|||
129814029|NCT03648541|467286252|FG001|Re-induction Period Only|Lack of Efficacy|0|||
129814030|NCT03648541|467286251|FG000|Maintenance Period Only|Missing|0|||
129814031|NCT03648541|467286252|FG001|Maintenance Period Only|Missing|1|||
129814032|NCT03648541|467286251|FG000|Maintenance Period Only|Other not listed below|0|||
129814033|NCT03648541|467286252|FG001|Maintenance Period Only|Other not listed below|4|||
129814034|NCT03648541|467286251|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
129814035|NCT03648541|467286252|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
129814036|NCT03648541|467286251|FG000|Maintenance Period Only|Protocol Violation|0|||
129814037|NCT03648541|467286252|FG001|Maintenance Period Only|Protocol Violation|1|||
129814038|NCT03648541|467286251|FG000|Maintenance Period Only|Lack of Efficacy|0|||
129814039|NCT03648541|467286252|FG001|Maintenance Period Only|Lack of Efficacy|18|||
129814040|NCT03648541|467286251|FG000|Maintenance Period Only|Adverse Event|0|||
129814041|NCT03648541|467286252|FG001|Maintenance Period Only|Adverse Event|4|||
129814042|NCT03648541|467286251|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
129814043|NCT03648541|467286252|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
129814044|NCT04623216|467286255|FG000|Overall Study|Death|5|||
129814045|NCT04623216|467286256|FG001|Overall Study|Death|2|||
129814046|NCT04623216|467286257|FG002|Overall Study|Death|0|||
129814047|NCT04623216|467286258|FG003|Overall Study|Death|0|||
129814048|NCT04623216|467286255|FG000|Overall Study|Terminated by Sponsor|3|||
129814049|NCT04623216|467286256|FG001|Overall Study|Terminated by Sponsor|2|||
129814050|NCT04623216|467286257|FG002|Overall Study|Terminated by Sponsor|2|||
129814051|NCT04623216|467286258|FG003|Overall Study|Terminated by Sponsor|0|||
129814052|NCT04623216|467286255|FG000|Overall Study|Physician Decision|1|||
129814053|NCT04623216|467286256|FG001|Overall Study|Physician Decision|0|||
129814054|NCT04623216|467286257|FG002|Overall Study|Physician Decision|0|||
129814055|NCT04623216|467286258|FG003|Overall Study|Physician Decision|0|||
129814056|NCT01651039|467286259|FG000|Overall Study|Non-evaluables|5|||
129814057|NCT01651039|467286259|FG000|Overall Study|Physician Decision|2|||
129814058|NCT01651039|467286259|FG000|Overall Study|Withdrawal by Subject|1|||
129814059|NCT01651039|467286259|FG000|Overall Study|Progressive Disease|22|||
129814060|NCT02059395|467286260|FG000|Overall Study|Lost to Follow-up|2|||
129814061|NCT02059395|467286261|FG001|Overall Study|Lost to Follow-up|4|||
129814062|NCT00134082|467286262|FG000|Overall Study|Adverse Event|2|||
129814063|NCT00134082|467286262|FG000|Overall Study|Death|1|||
129814064|NCT01488370|467286263|FG000|Overall Study|Protocol Violation|0|||
129814065|NCT01488370|467286264|FG001|Overall Study|Protocol Violation|1|||
129814066|NCT01488370|467286265|FG002|Overall Study|Protocol Violation|1|||
129814067|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
129814068|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
129814069|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
129814070|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
129814071|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
129814072|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
129814073|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
129814074|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
129814075|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
129814076|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
129814077|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
129814078|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
129814079|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
129814080|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
129814081|NCT00044083|467286266|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
129814082|NCT00044083|467286267|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
129814083|NCT00044083|467286266|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
129814084|NCT00044083|467286267|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
129814085|NCT00044083|467286266|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
129814086|NCT00044083|467286267|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
129814087|NCT00119106|467286270|FG000|Overall Study|HIV infected at baseline|179|||
129814088|NCT00119106|467286271|FG001|Overall Study|HIV infected at baseline|178|||
129814089|NCT03066804|467286272|FG000|Overall Study|Physician Decision|0|||
129814090|NCT03066804|467286273|FG001|Overall Study|Physician Decision|4|||
129814091|NCT03066804|467286272|FG000|Overall Study|Death|23|||
129814092|NCT03066804|467286273|FG001|Overall Study|Death|17|||
129814093|NCT03066804|467286272|FG000|Overall Study|Withdrawal by Subject|19|||
129814094|NCT03066804|467286273|FG001|Overall Study|Withdrawal by Subject|25|||
129814095|NCT03066804|467286272|FG000|Overall Study|Lost to Follow-up|2|||
129814096|NCT03066804|467286273|FG001|Overall Study|Lost to Follow-up|0|||
129814097|NCT03066804|467286272|FG000|Overall Study|Adverse Event|2|||
129814098|NCT03066804|467286273|FG001|Overall Study|Adverse Event|3|||
129814099|NCT03066804|467286272|FG000|Overall Study|Technical problems|5|||
129814100|NCT03066804|467286273|FG001|Overall Study|Technical problems|1|||
129814101|NCT00329238|467286274|FG000|Overall Study|Adverse Event|147|||
129814102|NCT00329238|467286275|FG001|Overall Study|Adverse Event|129|||
129814103|NCT00329238|467286274|FG000|Overall Study|Protocol Violation|23|||
129814104|NCT00329238|467286275|FG001|Overall Study|Protocol Violation|34|||
129814105|NCT00329238|467286274|FG000|Overall Study|Lost to Follow-up|2|||
129814106|NCT00329238|467286275|FG001|Overall Study|Lost to Follow-up|6|||
129814107|NCT00329238|467286274|FG000|Overall Study|Withdrawal by Subject|64|||
129814108|NCT00329238|467286275|FG001|Overall Study|Withdrawal by Subject|58|||
129814109|NCT00329238|467286274|FG000|Overall Study|Other reason (not specified)|40|||
129814110|NCT00329238|467286275|FG001|Overall Study|Other reason (not specified)|54|||
129814111|NCT05393895|467286278|FG000|Overall Study|Adverse Event|2|||
129814112|NCT05393895|467286279|FG001|Overall Study|Adverse Event|3|||
129814113|NCT05393895|467286278|FG000|Overall Study|Lost to Follow-up|4|||
129814114|NCT05393895|467286279|FG001|Overall Study|Lost to Follow-up|3|||
129814115|NCT05393895|467286278|FG000|Overall Study|Protocol Violation|1|||
129814116|NCT05393895|467286279|FG001|Overall Study|Protocol Violation|0|||
129814117|NCT05393895|467286278|FG000|Overall Study|Withdrawal by Subject|1|||
129814118|NCT05393895|467286279|FG001|Overall Study|Withdrawal by Subject|4|||
129814119|NCT05537883|467286282|FG000|Overall Study|revisional surgery|4|||
129814120|NCT05537883|467286283|FG001|Overall Study|revisional surgery|2|||
129814121|NCT05537883|467286282|FG000|Overall Study|surgeries were cancelled|0|||
129814122|NCT05537883|467286283|FG001|Overall Study|surgeries were cancelled|2|||
129814123|NCT05537883|467286282|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
129814124|NCT05537883|467286283|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
129814125|NCT01328431|467286284|FG000|Baseline|Protocol Violation|0|||
129814126|NCT01328431|467286285|FG001|Baseline|Protocol Violation|2|||
129814127|NCT01328431|467286284|FG000|1 Month (1M)|Lost to Follow-up|55|||
129814128|NCT01328431|467286285|FG001|1 Month (1M)|Lost to Follow-up|58|||
129814129|NCT01328431|467286284|FG000|3 Month (3M)|Death|2|||
129814130|NCT01328431|467286285|FG001|3 Month (3M)|Death|2|||
129814131|NCT01328431|467286284|FG000|3 Month (3M)|Lost to Follow-up|75|||
129814132|NCT01328431|467286285|FG001|3 Month (3M)|Lost to Follow-up|70|||
129814133|NCT01328431|467286284|FG000|12 Month (12M)|Death|2|||
129814134|NCT01328431|467286285|FG001|12 Month (12M)|Death|6|||
129814135|NCT01328431|467286284|FG000|12 Month (12M)|Lost to Follow-up|82|||
129814136|NCT01328431|467286285|FG001|12 Month (12M)|Lost to Follow-up|91|||
129814137|NCT02296320|467286292|FG000|Overall Study|Withdrawal by Subject|4|||
129814138|NCT02296320|467286293|FG001|Overall Study|Withdrawal by Subject|0|||
129814139|NCT02296320|467286294|FG002|Overall Study|Withdrawal by Subject|2|||
129814140|NCT02296320|467286292|FG000|Overall Study|Death|24|||
129814141|NCT02296320|467286293|FG001|Overall Study|Death|3|||
129814142|NCT02296320|467286294|FG002|Overall Study|Death|27|||
129814143|NCT02296320|467286292|FG000|Overall Study|Lost to Follow-up|5|||
129814144|NCT02296320|467286293|FG001|Overall Study|Lost to Follow-up|2|||
129814145|NCT02296320|467286294|FG002|Overall Study|Lost to Follow-up|7|||
129814146|NCT02296320|467286292|FG000|Overall Study|Not treated|2|||
129814147|NCT02296320|467286293|FG001|Overall Study|Not treated|0|||
129814148|NCT02296320|467286294|FG002|Overall Study|Not treated|0|||
129814149|NCT02296320|467286292|FG000|Overall Study|Not - specified|0|||
129814150|NCT02296320|467286293|FG001|Overall Study|Not - specified|0|||
129814151|NCT02296320|467286294|FG002|Overall Study|Not - specified|1|||
129814152|NCT03310021|467286298|FG000|Overall Study|Withdrawal by Subject|0|||
129814153|NCT03310021|467286299|FG001|Overall Study|Withdrawal by Subject|0|||
129814154|NCT03310021|467286300|FG002|Overall Study|Withdrawal by Subject|0|||
129814155|NCT03310021|467286301|FG003|Overall Study|Withdrawal by Subject|0|||
129814156|NCT03310021|467286302|FG004|Overall Study|Withdrawal by Subject|0|||
130058950|NCT02232087|468170429|FG000|Overall Study|Adverse Event|0|||
130058951|NCT02232087|468170430|FG001|Overall Study|Adverse Event|0|||
130058952|NCT02232087|468170431|FG002|Overall Study|Adverse Event|0|||
129814157|NCT03310021|467286303|FG005|Overall Study|Withdrawal by Subject|0|||
129814158|NCT03310021|467286304|FG006|Overall Study|Withdrawal by Subject|1|||
129814159|NCT03310021|467286305|FG007|Overall Study|Withdrawal by Subject|0|||
129814160|NCT03310021|467286306|FG008|Overall Study|Withdrawal by Subject|0|||
129814161|NCT03310021|467286307|FG009|Overall Study|Withdrawal by Subject|0|||
129814162|NCT03310021|467286308|FG010|Overall Study|Withdrawal by Subject|0|||
129814163|NCT03310021|467286309|FG011|Overall Study|Withdrawal by Subject|0|||
129814164|NCT03310021|467286310|FG012|Overall Study|Withdrawal by Subject|0|||
129814165|NCT03310021|467286311|FG013|Overall Study|Withdrawal by Subject|0|||
129814166|NCT03310021|467286312|FG014|Overall Study|Withdrawal by Subject|0|||
129814167|NCT03310021|467286313|FG015|Overall Study|Withdrawal by Subject|0|||
129814168|NCT03310021|467286314|FG016|Overall Study|Withdrawal by Subject|0|||
129814169|NCT03310021|467286315|FG017|Overall Study|Withdrawal by Subject|0|||
129814170|NCT03310021|467286316|FG018|Overall Study|Withdrawal by Subject|0|||
129814171|NCT03310021|467286317|FG019|Overall Study|Withdrawal by Subject|0|||
129814172|NCT03310021|467286298|FG000|Overall Study|Lost to Follow-up|0|||
129814173|NCT03310021|467286299|FG001|Overall Study|Lost to Follow-up|0|||
129814174|NCT03310021|467286300|FG002|Overall Study|Lost to Follow-up|0|||
129814175|NCT03310021|467286301|FG003|Overall Study|Lost to Follow-up|0|||
129814176|NCT03310021|467286302|FG004|Overall Study|Lost to Follow-up|0|||
129814177|NCT03310021|467286303|FG005|Overall Study|Lost to Follow-up|0|||
129814178|NCT03310021|467286304|FG006|Overall Study|Lost to Follow-up|0|||
129814179|NCT03310021|467286305|FG007|Overall Study|Lost to Follow-up|0|||
129814180|NCT03310021|467286306|FG008|Overall Study|Lost to Follow-up|0|||
129814181|NCT03310021|467286307|FG009|Overall Study|Lost to Follow-up|0|||
129814182|NCT03310021|467286308|FG010|Overall Study|Lost to Follow-up|1|||
129814183|NCT03310021|467286309|FG011|Overall Study|Lost to Follow-up|0|||
129814184|NCT03310021|467286310|FG012|Overall Study|Lost to Follow-up|0|||
129814185|NCT03310021|467286311|FG013|Overall Study|Lost to Follow-up|0|||
129814186|NCT03310021|467286312|FG014|Overall Study|Lost to Follow-up|0|||
129814187|NCT03310021|467286313|FG015|Overall Study|Lost to Follow-up|0|||
129814188|NCT03310021|467286314|FG016|Overall Study|Lost to Follow-up|0|||
129814189|NCT03310021|467286315|FG017|Overall Study|Lost to Follow-up|0|||
129814190|NCT03310021|467286316|FG018|Overall Study|Lost to Follow-up|0|||
129814191|NCT03310021|467286317|FG019|Overall Study|Lost to Follow-up|0|||
129814192|NCT01427972|467286328|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814193|NCT01427972|467286329|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129897060|NCT02081391|467582198|FG000|12-hour Treatment|Physician Decision|4|||
129897061|NCT02081391|467582199|FG001|12-hour Treatment|Physician Decision|1|||
129814194|NCT01427972|467286330|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814195|NCT01427972|467286331|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814196|NCT01427972|467286332|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814197|NCT01427972|467286333|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
130058953|NCT02232087|468170432|FG003|Overall Study|Adverse Event|0|||
129814198|NCT01427972|467286334|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814199|NCT01427972|467286335|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
129814200|NCT01427972|467286336|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814201|NCT01427972|467286337|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814202|NCT01427972|467286338|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814203|NCT01427972|467286339|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814204|NCT01427972|467286328|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814205|NCT01427972|467286329|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814206|NCT01427972|467286330|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814207|NCT01427972|467286331|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814208|NCT01427972|467286332|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814209|NCT01427972|467286333|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
129814210|NCT01427972|467286334|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814211|NCT01427972|467286335|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814212|NCT01427972|467286336|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814213|NCT01427972|467286337|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814214|NCT01427972|467286338|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814215|NCT01427972|467286339|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814216|NCT01427972|467286328|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814217|NCT01427972|467286329|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
129814218|NCT01427972|467286330|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814219|NCT01427972|467286331|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814220|NCT01427972|467286332|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814221|NCT01427972|467286333|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814222|NCT01427972|467286334|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814223|NCT01427972|467286335|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814224|NCT01427972|467286336|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814225|NCT01427972|467286337|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814226|NCT01427972|467286338|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814227|NCT01427972|467286339|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814228|NCT00799422|467286343|FG000|First Week of Wear|Lost to Follow-up|0|||
129814229|NCT00799422|467286344|FG001|First Week of Wear|Lost to Follow-up|0|||
129814230|NCT00799422|467286345|FG002|First Week of Wear|Lost to Follow-up|1|||
129814231|NCT00799422|467286346|FG003|First Week of Wear|Lost to Follow-up|0|||
129814232|NCT00799422|467286347|FG004|First Week of Wear|Lost to Follow-up|0|||
129814233|NCT00799422|467286348|FG005|First Week of Wear|Lost to Follow-up|0|||
129814234|NCT00799422|467286343|FG000|First Week of Wear|Adverse Event|0|||
129814235|NCT00799422|467286344|FG001|First Week of Wear|Adverse Event|0|||
129814236|NCT00799422|467286345|FG002|First Week of Wear|Adverse Event|0|||
129814237|NCT00799422|467286346|FG003|First Week of Wear|Adverse Event|1|||
129814238|NCT00799422|467286347|FG004|First Week of Wear|Adverse Event|0|||
129814239|NCT00799422|467286348|FG005|First Week of Wear|Adverse Event|0|||
129814240|NCT00530946|467286349|FG000|Overall Study|Adverse Event|1|||
129814241|NCT00530946|467286350|FG001|Overall Study|Adverse Event|2|||
129814242|NCT00530946|467286351|FG002|Overall Study|Adverse Event|1|||
129814243|NCT00530946|467286352|FG003|Overall Study|Adverse Event|1|||
129814244|NCT00530946|467286349|FG000|Overall Study|Protocol Violation|0|||
129814245|NCT00530946|467286350|FG001|Overall Study|Protocol Violation|0|||
129814246|NCT00530946|467286351|FG002|Overall Study|Protocol Violation|0|||
129814247|NCT00530946|467286352|FG003|Overall Study|Protocol Violation|1|||
129814248|NCT00530946|467286349|FG000|Overall Study|Noncompliance|1|||
129814249|NCT00530946|467286350|FG001|Overall Study|Noncompliance|0|||
129814250|NCT00530946|467286351|FG002|Overall Study|Noncompliance|0|||
130058954|NCT02232087|468170433|FG004|Overall Study|Adverse Event|1|||
129814251|NCT00530946|467286352|FG003|Overall Study|Noncompliance|0|||
129814252|NCT00622284|467286353|FG000|Overall Study|Lack of Efficacy|45|||
129814253|NCT00622284|467286354|FG001|Overall Study|Lack of Efficacy|15|||
129814254|NCT00622284|467286353|FG000|Overall Study|Adverse Event|61|||
129814255|NCT00622284|467286354|FG001|Overall Study|Adverse Event|90|||
129814256|NCT00622284|467286353|FG000|Overall Study|Protocol Violation|12|||
129814257|NCT00622284|467286354|FG001|Overall Study|Protocol Violation|5|||
129814258|NCT00622284|467286353|FG000|Overall Study|Lost to Follow-up|11|||
129814259|NCT00622284|467286354|FG001|Overall Study|Lost to Follow-up|13|||
129814260|NCT00622284|467286353|FG000|Overall Study|Withdrawal by Subject|27|||
129814261|NCT00622284|467286354|FG001|Overall Study|Withdrawal by Subject|24|||
129814262|NCT00622284|467286353|FG000|Overall Study|Other reason (not specified)|33|||
129814263|NCT00622284|467286354|FG001|Overall Study|Other reason (not specified)|24|||
130058955|NCT02232087|468170434|FG005|Overall Study|Adverse Event|0|||
129814264|NCT00880009|467286355|FG000|Overall Study|Study terminated by sponsor|14|||
129814265|NCT00880009|467286355|FG000|Overall Study|Withdrawal by Subject|1|||
129814266|NCT00880009|467286355|FG000|Overall Study|Protocol Violation|1|||
129814267|NCT02412618|467286358|FG000|Overall Study|Withdrawal by Subject|1|||
129814268|NCT02412618|467286359|FG001|Overall Study|Withdrawal by Subject|1|||
129814269|NCT02412618|467286358|FG000|Overall Study|Expulsion|1|||
129814270|NCT02412618|467286359|FG001|Overall Study|Expulsion|1|||
129814271|NCT01253408|467286361|FG000|Overall Study|Adverse Event|0|||
129814272|NCT01253408|467286362|FG001|Overall Study|Adverse Event|1|||
129814273|NCT01253408|467286363|FG002|Overall Study|Adverse Event|0|||
129814274|NCT00629707|467286367|FG000|Overall Study|Withdrawal by Subject|0|||
129814275|NCT00629707|467286368|FG001|Overall Study|Withdrawal by Subject|1|||
129814276|NCT00629707|467286367|FG000|Overall Study|Physician Decision|0|||
129814277|NCT00629707|467286368|FG001|Overall Study|Physician Decision|1|||
129814278|NCT03736447|467286369|FG000|Overall Study|Adverse Event|5|||
129814279|NCT03736447|467286370|FG001|Overall Study|Adverse Event|1|||
129814280|NCT03736447|467286369|FG000|Overall Study|Withdrawal by Subject|5|||
129814281|NCT03736447|467286370|FG001|Overall Study|Withdrawal by Subject|1|||
129814282|NCT03736447|467286369|FG000|Overall Study|Lost to Follow-up|1|||
129814283|NCT03736447|467286370|FG001|Overall Study|Lost to Follow-up|0|||
129814284|NCT03736447|467286369|FG000|Overall Study|Physician Decision|1|||
129814285|NCT03736447|467286370|FG001|Overall Study|Physician Decision|0|||
129814286|NCT03736447|467286369|FG000|Overall Study|Continued commitment to study treatment|3|||
129814287|NCT03736447|467286370|FG001|Overall Study|Continued commitment to study treatment|0|||
129814288|NCT03736447|467286369|FG000|Overall Study|Taste aversion to study product|0|||
129814289|NCT03736447|467286370|FG001|Overall Study|Taste aversion to study product|1|||
129814290|NCT02619175|467286371|FG000|Overall Study|Withdrawal by Subject|1|||
129814291|NCT02619175|467286372|FG001|Overall Study|Withdrawal by Subject|0|||
129814292|NCT02619175|467286371|FG000|Overall Study|foot pain|1|||
129814293|NCT02619175|467286372|FG001|Overall Study|foot pain|0|||
129814294|NCT02657369|467286373|FG000|Overall Study|Death|27|||
129814295|NCT02657369|467286373|FG000|Overall Study|Study terminated by sponsor|7|||
129814296|NCT01594762|467286374|FG000|Overall Study|Withdrawal by Subject|1|||
129814297|NCT01594762|467286375|FG001|Overall Study|Withdrawal by Subject|0|||
129814298|NCT01594762|467286374|FG000|Overall Study|Lost to Follow-up|10|||
129814299|NCT01594762|467286375|FG001|Overall Study|Lost to Follow-up|10|||
129814300|NCT03547583|467286376|FG000|Overall Study|Adverse Event|16|||
129897062|NCT02081391|467582200|FG002|12-hour Treatment|Physician Decision|0|||
129814301|NCT03547583|467286377|FG001|Overall Study|Adverse Event|11|||
129814302|NCT03547583|467286378|FG002|Overall Study|Adverse Event|10|||
129814303|NCT03547583|467286376|FG000|Overall Study|Death|11|||
129814304|NCT03547583|467286377|FG001|Overall Study|Death|7|||
129814305|NCT03547583|467286378|FG002|Overall Study|Death|4|||
129814306|NCT03547583|467286376|FG000|Overall Study|Lost to Follow-up|1|||
129814307|NCT03547583|467286377|FG001|Overall Study|Lost to Follow-up|0|||
129814308|NCT03547583|467286378|FG002|Overall Study|Lost to Follow-up|0|||
129814309|NCT03547583|467286376|FG000|Overall Study|Non-compliance with study drug|0|||
129814310|NCT03547583|467286377|FG001|Overall Study|Non-compliance with study drug|0|||
129814311|NCT03547583|467286378|FG002|Overall Study|Non-compliance with study drug|1|||
129814312|NCT03547583|467286376|FG000|Overall Study|Physician Decision|1|||
129814313|NCT03547583|467286377|FG001|Overall Study|Physician Decision|0|||
129814314|NCT03547583|467286378|FG002|Overall Study|Physician Decision|3|||
129814315|NCT03547583|467286376|FG000|Overall Study|Protocol Violation|2|||
129814316|NCT03547583|467286377|FG001|Overall Study|Protocol Violation|1|||
129814317|NCT03547583|467286378|FG002|Overall Study|Protocol Violation|1|||
129814318|NCT03547583|467286376|FG000|Overall Study|Withdrawal by Subject|12|||
129814319|NCT03547583|467286377|FG001|Overall Study|Withdrawal by Subject|19|||
129814320|NCT03547583|467286378|FG002|Overall Study|Withdrawal by Subject|10|||
129814321|NCT03547583|467286376|FG000|Overall Study|Other|2|||
129814322|NCT03547583|467286377|FG001|Overall Study|Other|2|||
129814323|NCT03547583|467286378|FG002|Overall Study|Other|3|||
129814324|NCT00382252|467286379|FG000|Overall Study|Death|4|||
129814325|NCT00382252|467286379|FG000|Overall Study|Protocol Violation|8|||
129897063|NCT02081391|467582201|FG003|12-hour Treatment|Physician Decision|0|||
129897064|NCT02081391|467582198|FG000|12-hour Treatment|Lack of Efficacy|3|||
129897065|NCT02081391|467582199|FG001|12-hour Treatment|Lack of Efficacy|0|||
129897066|NCT02081391|467582200|FG002|12-hour Treatment|Lack of Efficacy|0|||
129897067|NCT02081391|467582201|FG003|12-hour Treatment|Lack of Efficacy|0|||
129897068|NCT02081391|467582198|FG000|12-hour Treatment|Adverse Event|4|||
129897069|NCT02081391|467582199|FG001|12-hour Treatment|Adverse Event|2|||
129897070|NCT02081391|467582200|FG002|12-hour Treatment|Adverse Event|0|||
129897071|NCT02081391|467582201|FG003|12-hour Treatment|Adverse Event|0|||
129814326|NCT00382252|467286379|FG000|Overall Study|Not treated by RFA|1|||
129814327|NCT05570500|467286385|FG000|Overall Study|Lost to Follow-up|7|||
129814328|NCT05570500|467286386|FG001|Overall Study|Lost to Follow-up|5|||
129814329|NCT04706091|467286387|FG000|Treatment 2|Withdrawal by Subject|1|||
129814330|NCT04706091|467286388|FG001|Treatment 2|Withdrawal by Subject|0|||
129814331|NCT02612727|467286389|FG000|Overall Study|Parent request|4|||
129814332|NCT02612727|467286390|FG001|Overall Study|Parent request|1|||
129814333|NCT02612727|467286389|FG000|Overall Study|Needed treatment incompatible with PT|1|||
129814334|NCT02612727|467286390|FG001|Overall Study|Needed treatment incompatible with PT|1|||
129814335|NCT02612727|467286389|FG000|Overall Study|Direct hyperbilirubinemia|0|||
129814336|NCT02612727|467286390|FG001|Overall Study|Direct hyperbilirubinemia|2|||
129814337|NCT01446289|467286391|FG000|Overall Study|Withdrawal by Subject|1|||
129814338|NCT01446289|467286392|FG001|Overall Study|Withdrawal by Subject|0|||
129814339|NCT01446289|467286393|FG002|Overall Study|Withdrawal by Subject|1|||
129814340|NCT01446289|467286394|FG003|Overall Study|Withdrawal by Subject|0|||
129814341|NCT02302807|467286395|FG000|Overall Study|Withdrawal by Subject|28|||
129814342|NCT02302807|467286396|FG001|Overall Study|Withdrawal by Subject|11|||
129814343|NCT02302807|467286395|FG000|Overall Study|Lost to Follow-up|4|||
129814344|NCT02302807|467286396|FG001|Overall Study|Lost to Follow-up|6|||
129814345|NCT02302807|467286395|FG000|Overall Study|Death|397|||
129814346|NCT02302807|467286396|FG001|Overall Study|Death|385|||
129814347|NCT02302807|467286395|FG000|Overall Study|Study Terminated By Sponsor|35|||
129814348|NCT02302807|467286396|FG001|Overall Study|Study Terminated By Sponsor|64|||
129814349|NCT02302807|467286395|FG000|Overall Study|Physician Decision|0|||
129814350|NCT02302807|467286396|FG001|Overall Study|Physician Decision|1|||
129814351|NCT05243641|467286397|FG000|Overall Study|Adverse Event|3|||
129814352|NCT05243641|467286398|FG001|Overall Study|Adverse Event|0|||
129814353|NCT05243641|467286399|FG002|Overall Study|Adverse Event|0|||
129814354|NCT05243641|467286400|FG003|Overall Study|Adverse Event|1|||
129814355|NCT05243641|467286401|FG004|Overall Study|Adverse Event|0|||
129814356|NCT05243641|467286402|FG005|Overall Study|Adverse Event|0|||
129814357|NCT05243641|467286397|FG000|Overall Study|Disease progression|4|||
129814358|NCT05243641|467286398|FG001|Overall Study|Disease progression|0|||
129814359|NCT05243641|467286399|FG002|Overall Study|Disease progression|0|||
129814360|NCT05243641|467286400|FG003|Overall Study|Disease progression|2|||
129814361|NCT05243641|467286401|FG004|Overall Study|Disease progression|0|||
129814362|NCT05243641|467286402|FG005|Overall Study|Disease progression|0|||
129814363|NCT04518306|467286403|FG000|Double-Blind Period|Run in failure|0|||
129814364|NCT04518306|467286404|FG001|Double-Blind Period|Run in failure|0|||
129814365|NCT04518306|467286405|FG002|Double-Blind Period|Run in failure|1|||
129814366|NCT04518306|467286403|FG000|Double-Blind Period|Adverse Event|0|||
129814367|NCT04518306|467286404|FG001|Double-Blind Period|Adverse Event|2|||
129814368|NCT04518306|467286405|FG002|Double-Blind Period|Adverse Event|2|||
129814369|NCT04518306|467286403|FG000|Double-Blind Period|Lost to Follow-up|1|||
129814370|NCT04518306|467286404|FG001|Double-Blind Period|Lost to Follow-up|2|||
129814371|NCT04518306|467286405|FG002|Double-Blind Period|Lost to Follow-up|2|||
129814372|NCT04518306|467286403|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
129814373|NCT04518306|467286404|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
129814374|NCT04518306|467286405|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
129814375|NCT04518306|467286403|FG000|Double-Blind Period|Other|0|||
129814376|NCT04518306|467286404|FG001|Double-Blind Period|Other|2|||
129814377|NCT04518306|467286405|FG002|Double-Blind Period|Other|0|||
129814378|NCT04518306|467286403|FG000|Double-Blind Period|Missing|0|||
129814379|NCT04518306|467286404|FG001|Double-Blind Period|Missing|1|||
129814380|NCT04518306|467286405|FG002|Double-Blind Period|Missing|0|||
129814381|NCT03904043|467286406|FG000|Overall Study|Adverse Event|1|||
129814382|NCT03904043|467286407|FG001|Overall Study|Adverse Event|1|||
129814383|NCT03904043|467286406|FG000|Overall Study|Withdrawal by Subject|1|||
129814384|NCT03904043|467286407|FG001|Overall Study|Withdrawal by Subject|0|||
129814385|NCT03904043|467286406|FG000|Overall Study|Non-compliance|1|||
129814386|NCT03904043|467286407|FG001|Overall Study|Non-compliance|0|||
129814387|NCT03904043|467286406|FG000|Overall Study|Did not start treatment|1|||
129814388|NCT03904043|467286407|FG001|Overall Study|Did not start treatment|0|||
129814389|NCT04487730|467288277|FG000|Overall Study|Withdrawal by Subject|3|||
129814390|NCT04487730|467288278|FG001|Overall Study|Withdrawal by Subject|1|||
129814391|NCT04487730|467288277|FG000|Overall Study|Lost to Follow-up|0|||
129814392|NCT04487730|467288278|FG001|Overall Study|Lost to Follow-up|1|||
129814393|NCT04487730|467288277|FG000|Overall Study|Physician Decision|0|||
129814394|NCT04487730|467288278|FG001|Overall Study|Physician Decision|1|||
129814395|NCT01473836|467288279|FG000|Overall Study|Adverse Event|4|||
129814396|NCT01473836|467288279|FG000|Overall Study|Lack of Efficacy|1|||
129814397|NCT01473836|467288279|FG000|Overall Study|Does not meet entrance criteria|1|||
129814398|NCT03291808|467288280|FG000|Overall Study|Lost to Follow-up|6|||
129814399|NCT03291808|467288280|FG000|Overall Study|Research burden|4|||
129814400|NCT03364023|467288281|FG000|Overall Study|Lost to Follow-up|3|||
129814401|NCT03364023|467288281|FG000|Overall Study|Death|14|||
130058956|NCT04069156|468170435|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
130058957|NCT04069156|468170436|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
129814402|NCT01892293|467288282|FG000|Overall Study|Apheresed but not treated|4|||
129814403|NCT03602482|467288283|FG000|Overall Study|Withdrawal by Subject|6|||
129814404|NCT03602482|467288284|FG001|Overall Study|Withdrawal by Subject|7|||
129814405|NCT03602482|467288285|FG002|Overall Study|Withdrawal by Subject|0|||
129814406|NCT03602482|467288286|FG003|Overall Study|Withdrawal by Subject|0|||
129814407|NCT02601469|467288287|FG000|Overall Study|Enrolled in Error|1|||
129814408|NCT02601469|467288288|FG001|Overall Study|Enrolled in Error|0|||
129814409|NCT04980040|467288289|FG000|Overall Study|Violated the Inclusion Criteria|260|||
129814410|NCT04980040|467288289|FG000|Overall Study|Violated the Administration & Dosage|225|||
129814411|NCT04980040|467288289|FG000|Overall Study|Lost to Safety-Follow-up|4|||
129814412|NCT04980040|467288289|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
129814413|NCT00618072|467288295|FG000|Overall Study|Lost to Follow-up|2|||
129814414|NCT00618072|467288296|FG001|Overall Study|Lost to Follow-up|0|||
129814415|NCT00618072|467288297|FG002|Overall Study|Lost to Follow-up|3|||
129814416|NCT00618072|467288295|FG000|Overall Study|Physician Decision|0|||
129897072|NCT02081391|467582198|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
129897073|NCT02081391|467582199|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
129897074|NCT02081391|467582200|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
129897075|NCT02081391|467582201|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
129897076|NCT02081391|467582198|FG000|12-hour Treatment|Further reasons|2|||
129814417|NCT00618072|467288296|FG001|Overall Study|Physician Decision|1|||
129814418|NCT00618072|467288297|FG002|Overall Study|Physician Decision|1|||
129814419|NCT03292588|467288298|FG000|Overall Study|Death|1|||
129814420|NCT03292588|467288299|FG001|Overall Study|Death|0|||
129814421|NCT03292588|467288298|FG000|Overall Study|Lost to Follow-up|12|||
129814422|NCT03292588|467288299|FG001|Overall Study|Lost to Follow-up|16|||
129814423|NCT03292588|467288298|FG000|Overall Study|Physician Decision|0|||
129814424|NCT03292588|467288299|FG001|Overall Study|Physician Decision|1|||
129814425|NCT03292588|467288298|FG000|Overall Study|Withdrawal by Subject|4|||
129814426|NCT03292588|467288299|FG001|Overall Study|Withdrawal by Subject|4|||
129814427|NCT03292588|467288298|FG000|Overall Study|Move out of town|1|||
129814428|NCT03292588|467288299|FG001|Overall Study|Move out of town|0|||
129814429|NCT03292588|467288298|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
129814430|NCT03292588|467288299|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
129814431|NCT00062374|467288300|FG000|Overall Study|Not treated|12|||
129814432|NCT03633695|467288303|FG000|Overall Study|Lost to Follow-up|4|||
129814433|NCT03633695|467288304|FG001|Overall Study|Lost to Follow-up|5|||
129814434|NCT03633695|467288303|FG000|Overall Study|Discontinued|8|||
129814435|NCT03633695|467288304|FG001|Overall Study|Discontinued|4|||
129814436|NCT00617773|467288312|FG000|Overall Study|Physician Decision|1|||
129814437|NCT00617773|467288312|FG000|Overall Study|Lack of compliance with the protocol|1|||
129814438|NCT00617773|467288312|FG000|Overall Study|Withdrawal by Subject|1|||
129814439|NCT00617773|467288312|FG000|Overall Study|Death|1|||
129814440|NCT00617773|467288312|FG000|Overall Study|Progressive disease|19|||
129814441|NCT00617773|467288312|FG000|Overall Study|Protocol Violation|1|||
129814442|NCT01751867|467288313|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
129814443|NCT01751867|467288314|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
129814444|NCT01751867|467288313|FG000|Overall Study|Diease Progression|4|||
129814445|NCT01751867|467288314|FG001|Overall Study|Diease Progression|18|||
129814446|NCT01751867|467288313|FG000|Overall Study|Adverse Event|8|||
129814447|NCT01751867|467288314|FG001|Overall Study|Adverse Event|15|||
129814448|NCT01751867|467288313|FG000|Overall Study|Poor Compliance|0|||
129814449|NCT01751867|467288314|FG001|Overall Study|Poor Compliance|5|||
129814450|NCT01751867|467288313|FG000|Overall Study|Withdrawal by Subject|3|||
129814451|NCT01751867|467288314|FG001|Overall Study|Withdrawal by Subject|1|||
129814452|NCT01751867|467288313|FG000|Overall Study|Physician Decision|4|||
129814453|NCT01751867|467288314|FG001|Overall Study|Physician Decision|7|||
129814454|NCT01751867|467288313|FG000|Overall Study|Protocol Violation|0|||
129814455|NCT01751867|467288314|FG001|Overall Study|Protocol Violation|2|||
129814456|NCT01751867|467288313|FG000|Overall Study|Death|0|||
129814457|NCT01751867|467288314|FG001|Overall Study|Death|5|||
129814458|NCT01751867|467288313|FG000|Overall Study|Other|11|||
129814459|NCT01751867|467288314|FG001|Overall Study|Other|37|||
129814460|NCT01751867|467288313|FG000|Overall Study|Randomized but not treated.|2|||
129814461|NCT01751867|467288314|FG001|Overall Study|Randomized but not treated.|1|||
129814462|NCT04932096|467288315|FG000|Overall Study|Withdrawal by Subject|1|||
129814463|NCT04932096|467288316|FG001|Overall Study|Withdrawal by Subject|1|||
129814464|NCT04932096|467288315|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
129814465|NCT04932096|467288316|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
129814466|NCT02170298|467288317|FG000|Overall Study|Withdrawal by Subject|0|||
129814467|NCT02170298|467288318|FG001|Overall Study|Withdrawal by Subject|1|||
129814468|NCT02170298|467288317|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
129814469|NCT02170298|467288318|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
129814470|NCT01976338|467288319|FG000|Overall Study|Physician Decision|0|||
129897077|NCT02081391|467582199|FG001|12-hour Treatment|Further reasons|1|||
129814471|NCT01976338|467288320|FG001|Overall Study|Physician Decision|1|||
129814472|NCT01976338|467288319|FG000|Overall Study|Lost to Follow-up|3|||
129814473|NCT01976338|467288320|FG001|Overall Study|Lost to Follow-up|0|||
129814474|NCT01976338|467288319|FG000|Overall Study|Withdrawal by Subject|5|||
129814475|NCT01976338|467288320|FG001|Overall Study|Withdrawal by Subject|2|||
129814476|NCT01976338|467288319|FG000|Overall Study|Adverse Event|5|||
129814477|NCT01976338|467288320|FG001|Overall Study|Adverse Event|1|||
129814478|NCT00777608|467288321|FG000|Overall Study|Lost to Follow-up|1|||
129814479|NCT00777608|467288322|FG001|Overall Study|Lost to Follow-up|1|||
129814480|NCT00777608|467288321|FG000|Overall Study|Withdrawal by Subject|1|||
129814481|NCT00777608|467288322|FG001|Overall Study|Withdrawal by Subject|3|||
129814482|NCT00777608|467288321|FG000|Overall Study|Protocol Violation|1|||
129814483|NCT00777608|467288322|FG001|Overall Study|Protocol Violation|0|||
130058958|NCT04069156|468170435|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
130058959|NCT04069156|468170436|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
130058960|NCT04069156|468170435|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
130058961|NCT04069156|468170436|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
129814484|NCT00777608|467288321|FG000|Overall Study|Investigator Decision|1|||
129814485|NCT00777608|467288322|FG001|Overall Study|Investigator Decision|2|||
129814486|NCT03766581|467288323|FG000|Randomization|Other reasons|2|||
129814487|NCT03766581|467288324|FG001|Randomization|Other reasons|1|||
129814488|NCT03766581|467288325|FG002|Randomization|Other reasons|0|||
129814489|NCT03766581|467288326|FG003|Randomization|Other reasons|1|||
129814490|NCT03766581|467288327|FG004|Randomization|Other reasons|0|||
129814491|NCT03766581|467288328|FG005|Randomization|Other reasons|0|||
129814492|NCT03766581|467288329|FG006|Randomization|Other reasons|0|||
129814493|NCT03766581|467288330|FG007|Randomization|Other reasons|0|||
129814494|NCT03766581|467288323|FG000|Randomization|Participant no longer meets study criteria|5|||
129814495|NCT03766581|467288324|FG001|Randomization|Participant no longer meets study criteria|3|||
129814496|NCT03766581|467288325|FG002|Randomization|Participant no longer meets study criteria|4|||
129814497|NCT03766581|467288326|FG003|Randomization|Participant no longer meets study criteria|0|||
129814498|NCT03766581|467288327|FG004|Randomization|Participant no longer meets study criteria|2|||
129814499|NCT03766581|467288328|FG005|Randomization|Participant no longer meets study criteria|3|||
129814500|NCT03766581|467288329|FG006|Randomization|Participant no longer meets study criteria|0|||
129814501|NCT03766581|467288330|FG007|Randomization|Participant no longer meets study criteria|1|||
129814502|NCT03766581|467288323|FG000|Randomization|Participant request to discontinue study treatment|1|||
129814503|NCT03766581|467288324|FG001|Randomization|Participant request to discontinue study treatment|0|||
129814504|NCT03766581|467288325|FG002|Randomization|Participant request to discontinue study treatment|0|||
129814505|NCT03766581|467288326|FG003|Randomization|Participant request to discontinue study treatment|0|||
129814506|NCT03766581|467288327|FG004|Randomization|Participant request to discontinue study treatment|1|||
129814507|NCT03766581|467288328|FG005|Randomization|Participant request to discontinue study treatment|2|||
129814508|NCT03766581|467288329|FG006|Randomization|Participant request to discontinue study treatment|0|||
129814509|NCT03766581|467288330|FG007|Randomization|Participant request to discontinue study treatment|0|||
129814510|NCT03766581|467288323|FG000|Randomization|Participant withdrew consent|1|||
129814511|NCT03766581|467288324|FG001|Randomization|Participant withdrew consent|0|||
129814512|NCT03766581|467288325|FG002|Randomization|Participant withdrew consent|1|||
129814513|NCT03766581|467288326|FG003|Randomization|Participant withdrew consent|2|||
129814514|NCT03766581|467288327|FG004|Randomization|Participant withdrew consent|1|||
129814515|NCT03766581|467288328|FG005|Randomization|Participant withdrew consent|1|||
129814516|NCT03766581|467288329|FG006|Randomization|Participant withdrew consent|0|||
129814517|NCT03766581|467288330|FG007|Randomization|Participant withdrew consent|0|||
129814518|NCT03766581|467288323|FG000|Treatment|Adverse Event|82|||
129814519|NCT03766581|467288324|FG001|Treatment|Adverse Event|44|||
129814520|NCT03766581|467288325|FG002|Treatment|Adverse Event|47|||
129814521|NCT03766581|467288326|FG003|Treatment|Adverse Event|46|||
129814522|NCT03766581|467288327|FG004|Treatment|Adverse Event|50|||
129814523|NCT03766581|467288328|FG005|Treatment|Adverse Event|77|||
129814524|NCT03766581|467288329|FG006|Treatment|Adverse Event|5|||
129814525|NCT03766581|467288330|FG007|Treatment|Adverse Event|2|||
129814526|NCT03766581|467288323|FG000|Treatment|Participant request to discontinue treatment|34|||
129814527|NCT03766581|467288324|FG001|Treatment|Participant request to discontinue treatment|6|||
129814528|NCT03766581|467288325|FG002|Treatment|Participant request to discontinue treatment|10|||
129814529|NCT03766581|467288326|FG003|Treatment|Participant request to discontinue treatment|10|||
129814530|NCT03766581|467288327|FG004|Treatment|Participant request to discontinue treatment|14|||
129814531|NCT03766581|467288328|FG005|Treatment|Participant request to discontinue treatment|15|||
129814532|NCT03766581|467288329|FG006|Treatment|Participant request to discontinue treatment|0|||
129814533|NCT03766581|467288330|FG007|Treatment|Participant request to discontinue treatment|1|||
129814534|NCT03766581|467288323|FG000|Treatment|Participant withdrew consent|11|||
129814535|NCT03766581|467288324|FG001|Treatment|Participant withdrew consent|4|||
129814536|NCT03766581|467288325|FG002|Treatment|Participant withdrew consent|5|||
129814537|NCT03766581|467288326|FG003|Treatment|Participant withdrew consent|5|||
129814538|NCT03766581|467288327|FG004|Treatment|Participant withdrew consent|4|||
129814539|NCT03766581|467288328|FG005|Treatment|Participant withdrew consent|4|||
129814540|NCT03766581|467288329|FG006|Treatment|Participant withdrew consent|0|||
129814541|NCT03766581|467288330|FG007|Treatment|Participant withdrew consent|0|||
129814542|NCT03766581|467288323|FG000|Treatment|Death|1|||
129814543|NCT03766581|467288324|FG001|Treatment|Death|0|||
130058962|NCT04069156|468170435|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
129814544|NCT03766581|467288325|FG002|Treatment|Death|0|||
129814545|NCT03766581|467288326|FG003|Treatment|Death|0|||
129814546|NCT03766581|467288327|FG004|Treatment|Death|0|||
129814547|NCT03766581|467288328|FG005|Treatment|Death|0|||
129814548|NCT03766581|467288329|FG006|Treatment|Death|0|||
129814549|NCT03766581|467288330|FG007|Treatment|Death|0|||
129814550|NCT03766581|467288323|FG000|Treatment|Lost to Follow-up|1|||
129814551|NCT03766581|467288324|FG001|Treatment|Lost to Follow-up|0|||
129814552|NCT03766581|467288325|FG002|Treatment|Lost to Follow-up|0|||
129814553|NCT03766581|467288326|FG003|Treatment|Lost to Follow-up|1|||
129814554|NCT03766581|467288327|FG004|Treatment|Lost to Follow-up|0|||
129814555|NCT03766581|467288328|FG005|Treatment|Lost to Follow-up|0|||
129814556|NCT03766581|467288329|FG006|Treatment|Lost to Follow-up|0|||
129814557|NCT03766581|467288330|FG007|Treatment|Lost to Follow-up|0|||
129814558|NCT03766581|467288323|FG000|Treatment|Poor/Non compliance|2|||
129814559|NCT03766581|467288324|FG001|Treatment|Poor/Non compliance|2|||
129814560|NCT03766581|467288325|FG002|Treatment|Poor/Non compliance|1|||
129814561|NCT03766581|467288326|FG003|Treatment|Poor/Non compliance|1|||
129814562|NCT03766581|467288327|FG004|Treatment|Poor/Non compliance|1|||
129814563|NCT03766581|467288328|FG005|Treatment|Poor/Non compliance|1|||
129814564|NCT03766581|467288329|FG006|Treatment|Poor/Non compliance|0|||
129814565|NCT03766581|467288330|FG007|Treatment|Poor/Non compliance|0|||
129814566|NCT03766581|467288323|FG000|Treatment|Participant no longer meets study criteria|9|||
129814567|NCT03766581|467288324|FG001|Treatment|Participant no longer meets study criteria|1|||
129814568|NCT03766581|467288325|FG002|Treatment|Participant no longer meets study criteria|5|||
129814569|NCT03766581|467288326|FG003|Treatment|Participant no longer meets study criteria|4|||
129814570|NCT03766581|467288327|FG004|Treatment|Participant no longer meets study criteria|4|||
129814571|NCT03766581|467288328|FG005|Treatment|Participant no longer meets study criteria|4|||
129814572|NCT03766581|467288329|FG006|Treatment|Participant no longer meets study criteria|2|||
129814573|NCT03766581|467288330|FG007|Treatment|Participant no longer meets study criteria|0|||
129814574|NCT03766581|467288323|FG000|Treatment|Other reasons|13|||
129814575|NCT03766581|467288324|FG001|Treatment|Other reasons|8|||
129814576|NCT03766581|467288325|FG002|Treatment|Other reasons|3|||
129814577|NCT03766581|467288326|FG003|Treatment|Other reasons|7|||
129814578|NCT03766581|467288327|FG004|Treatment|Other reasons|3|||
129814579|NCT03766581|467288328|FG005|Treatment|Other reasons|3|||
129814580|NCT03766581|467288329|FG006|Treatment|Other reasons|0|||
129814581|NCT03766581|467288330|FG007|Treatment|Other reasons|0|||
129814582|NCT00520936|467288331|FG000|Overall Study|Physician Decision|0|||
129814583|NCT00520936|467288332|FG001|Overall Study|Physician Decision|2|||
129814584|NCT00520936|467288333|FG002|Overall Study|Physician Decision|1|||
129814585|NCT00520936|467288334|FG003|Overall Study|Physician Decision|0|||
129814586|NCT00520936|467288335|FG004|Overall Study|Physician Decision|0|||
129814587|NCT00520936|467288336|FG005|Overall Study|Physician Decision|0|||
129814588|NCT00520936|467288337|FG006|Overall Study|Physician Decision|0|||
129814589|NCT00520936|467288338|FG007|Overall Study|Physician Decision|0|||
129814590|NCT00520936|467288331|FG000|Overall Study|Withdrawal by Subject|0|||
129814591|NCT00520936|467288332|FG001|Overall Study|Withdrawal by Subject|0|||
129814592|NCT00520936|467288333|FG002|Overall Study|Withdrawal by Subject|0|||
129814593|NCT00520936|467288334|FG003|Overall Study|Withdrawal by Subject|0|||
129814594|NCT00520936|467288335|FG004|Overall Study|Withdrawal by Subject|0|||
129814595|NCT00520936|467288336|FG005|Overall Study|Withdrawal by Subject|0|||
129814596|NCT00520936|467288337|FG006|Overall Study|Withdrawal by Subject|0|||
129814597|NCT00520936|467288338|FG007|Overall Study|Withdrawal by Subject|1|||
129814598|NCT00520936|467288331|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
129814599|NCT00520936|467288332|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
129814600|NCT00520936|467288333|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
129814601|NCT00520936|467288334|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
129814602|NCT00520936|467288335|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
129814603|NCT00520936|467288336|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
129814604|NCT00520936|467288337|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
129814605|NCT00520936|467288338|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
129814606|NCT00520936|467288331|FG000|Overall Study|Death|0|||
129814607|NCT00520936|467288332|FG001|Overall Study|Death|0|||
129814608|NCT00520936|467288333|FG002|Overall Study|Death|0|||
129814609|NCT00520936|467288334|FG003|Overall Study|Death|0|||
129814610|NCT00520936|467288335|FG004|Overall Study|Death|0|||
129814611|NCT00520936|467288336|FG005|Overall Study|Death|0|||
129814612|NCT00520936|467288337|FG006|Overall Study|Death|1|||
129814613|NCT00520936|467288338|FG007|Overall Study|Death|0|||
129814614|NCT00520936|467288331|FG000|Overall Study|Protocol Violation|0|||
129814615|NCT00520936|467288332|FG001|Overall Study|Protocol Violation|1|||
129814616|NCT00520936|467288333|FG002|Overall Study|Protocol Violation|1|||
129814617|NCT00520936|467288334|FG003|Overall Study|Protocol Violation|0|||
129814618|NCT00520936|467288335|FG004|Overall Study|Protocol Violation|1|||
129814619|NCT00520936|467288336|FG005|Overall Study|Protocol Violation|0|||
129814620|NCT00520936|467288337|FG006|Overall Study|Protocol Violation|1|||
129814621|NCT00520936|467288338|FG007|Overall Study|Protocol Violation|0|||
129897078|NCT02081391|467582200|FG002|12-hour Treatment|Further reasons|0|||
129814622|NCT00587054|467288340|FG000|Overall Study|Patient not treated|9|||
129814623|NCT02099708|467288353|FG000|Overall Study|Data Not Available|30|||
129814624|NCT02099708|467288353|FG000|Overall Study|Lost to Follow-up|141|||
129814625|NCT02099708|467288353|FG000|Overall Study|Other|29|||
129814626|NCT05466682|467288357|FG000|Overall Study|Withdrawal by Subject|0|||
129814627|NCT05466682|467288358|FG001|Overall Study|Withdrawal by Subject|2|||
129814628|NCT05466682|467288357|FG000|Overall Study|Lost to Follow-up|2|||
129814629|NCT05466682|467288358|FG001|Overall Study|Lost to Follow-up|1|||
129814630|NCT01697566|467288359|FG000|Overall Study|Withdrawal by Subject|0|||
129814631|NCT01697566|467288360|FG001|Overall Study|Withdrawal by Subject|0|||
129814632|NCT01697566|467288361|FG002|Overall Study|Withdrawal by Subject|1|||
129814633|NCT01697566|467288362|FG003|Overall Study|Withdrawal by Subject|1|||
129814634|NCT01697566|467288359|FG000|Overall Study|Final biopsy not obtained|0|||
129814635|NCT01697566|467288360|FG001|Overall Study|Final biopsy not obtained|0|||
129814636|NCT01697566|467288361|FG002|Overall Study|Final biopsy not obtained|1|||
129814637|NCT01697566|467288362|FG003|Overall Study|Final biopsy not obtained|0|||
129814638|NCT03953820|467288364|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
129814639|NCT03953820|467288365|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
129814640|NCT03953820|467288366|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
129814641|NCT03953820|467288364|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
129814642|NCT03953820|467288365|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
129814643|NCT03953820|467288366|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
129814644|NCT03322631|467288372|FG000|Overall Study|Withdrawal by Subject|0|||
129814645|NCT03322631|467288373|FG001|Overall Study|Withdrawal by Subject|1|||
129814646|NCT03322631|467288374|FG002|Overall Study|Withdrawal by Subject|0|||
129814647|NCT03322631|467288375|FG003|Overall Study|Withdrawal by Subject|0|||
129814648|NCT03322631|467288372|FG000|Overall Study|Adverse Event|0|||
129814649|NCT03322631|467288373|FG001|Overall Study|Adverse Event|0|||
129814650|NCT03322631|467288374|FG002|Overall Study|Adverse Event|1|||
129814651|NCT03322631|467288375|FG003|Overall Study|Adverse Event|0|||
129814652|NCT02378961|467288376|FG000|Overall Study|Lack of Efficacy|4|||
129814653|NCT02378961|467288377|FG001|Overall Study|Lack of Efficacy|2|||
129814654|NCT02378961|467288378|FG002|Overall Study|Lack of Efficacy|0|||
129814655|NCT02378961|467288379|FG003|Overall Study|Lack of Efficacy|1|||
129814656|NCT02378961|467288376|FG000|Overall Study|Death|0|||
129814657|NCT02378961|467288377|FG001|Overall Study|Death|0|||
129814658|NCT02378961|467288378|FG002|Overall Study|Death|1|||
129814659|NCT02378961|467288379|FG003|Overall Study|Death|0|||
129814660|NCT01217801|467288380|FG000|Period 1|Protocol Violation|1|||
129814661|NCT01217801|467288381|FG001|Period 1|Protocol Violation|1|||
129814662|NCT01217801|467288380|FG000|Period 1|Withdrawal by Subject|0|||
129814663|NCT01217801|467288381|FG001|Period 1|Withdrawal by Subject|1|||
129814664|NCT04967443|467288385|FG000|Open Label Treatment|Death|1|||
129814665|NCT04967443|467288386|FG001|Open Label Treatment|Death|0|||
129814666|NCT04967443|467288387|FG002|Open Label Treatment|Death|0|||
129814667|NCT04967443|467288388|FG003|Open Label Treatment|Death|0|||
129814668|NCT04967443|467288389|FG004|Open Label Treatment|Death|0|||
129814669|NCT04967443|467288390|FG005|Open Label Treatment|Death|0|||
129814670|NCT04967443|467288391|FG006|Open Label Treatment|Death|0|||
129814671|NCT04967443|467288392|FG007|Open Label Treatment|Death|0|||
129814672|NCT04967443|467288385|FG000|Open Label Treatment|Lost to Follow-up|0|||
129814673|NCT04967443|467288386|FG001|Open Label Treatment|Lost to Follow-up|0|||
129814674|NCT04967443|467288387|FG002|Open Label Treatment|Lost to Follow-up|1|||
129814675|NCT04967443|467288388|FG003|Open Label Treatment|Lost to Follow-up|0|||
129814676|NCT04967443|467288389|FG004|Open Label Treatment|Lost to Follow-up|0|||
129814677|NCT04967443|467288390|FG005|Open Label Treatment|Lost to Follow-up|0|||
129814678|NCT04967443|467288391|FG006|Open Label Treatment|Lost to Follow-up|0|||
129814679|NCT04967443|467288392|FG007|Open Label Treatment|Lost to Follow-up|0|||
129814680|NCT04967443|467288385|FG000|Open Label Treatment|Withdrawal by Subject|0|||
129814681|NCT04967443|467288386|FG001|Open Label Treatment|Withdrawal by Subject|1|||
129814682|NCT04967443|467288387|FG002|Open Label Treatment|Withdrawal by Subject|0|||
129814683|NCT04967443|467288388|FG003|Open Label Treatment|Withdrawal by Subject|1|||
129814684|NCT04967443|467288389|FG004|Open Label Treatment|Withdrawal by Subject|0|||
129814685|NCT04967443|467288390|FG005|Open Label Treatment|Withdrawal by Subject|1|||
129814686|NCT04967443|467288391|FG006|Open Label Treatment|Withdrawal by Subject|2|||
129814687|NCT04967443|467288392|FG007|Open Label Treatment|Withdrawal by Subject|3|||
129814688|NCT04967443|467288385|FG000|Follow-Up|Death|1|||
130058963|NCT04069156|468170436|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
129814689|NCT04967443|467288386|FG001|Follow-Up|Death|0|||
129814690|NCT04967443|467288387|FG002|Follow-Up|Death|0|||
129814691|NCT04967443|467288388|FG003|Follow-Up|Death|0|||
129814692|NCT04967443|467288389|FG004|Follow-Up|Death|0|||
129814693|NCT04967443|467288390|FG005|Follow-Up|Death|0|||
129814694|NCT04967443|467288391|FG006|Follow-Up|Death|0|||
129814695|NCT04967443|467288392|FG007|Follow-Up|Death|0|||
129814696|NCT04967443|467288385|FG000|Follow-Up|Lost to Follow-up|0|||
129814697|NCT04967443|467288386|FG001|Follow-Up|Lost to Follow-up|0|||
129814698|NCT04967443|467288387|FG002|Follow-Up|Lost to Follow-up|1|||
129814699|NCT04967443|467288388|FG003|Follow-Up|Lost to Follow-up|1|||
129814700|NCT04967443|467288389|FG004|Follow-Up|Lost to Follow-up|0|||
129814701|NCT04967443|467288390|FG005|Follow-Up|Lost to Follow-up|0|||
129814702|NCT04967443|467288391|FG006|Follow-Up|Lost to Follow-up|0|||
129814703|NCT04967443|467288392|FG007|Follow-Up|Lost to Follow-up|0|||
129814704|NCT04967443|467288385|FG000|Follow-Up|Withdrawal by Subject|0|||
130058964|NCT04096326|468170437|FG000|Overall Study|Withdrawal by Subject|0|||
129814705|NCT04967443|467288386|FG001|Follow-Up|Withdrawal by Subject|1|||
129814706|NCT04967443|467288387|FG002|Follow-Up|Withdrawal by Subject|0|||
129814707|NCT04967443|467288388|FG003|Follow-Up|Withdrawal by Subject|1|||
129814708|NCT04967443|467288389|FG004|Follow-Up|Withdrawal by Subject|0|||
129814709|NCT04967443|467288390|FG005|Follow-Up|Withdrawal by Subject|1|||
129814710|NCT04967443|467288391|FG006|Follow-Up|Withdrawal by Subject|2|||
129814711|NCT04967443|467288392|FG007|Follow-Up|Withdrawal by Subject|3|||
129814712|NCT02405780|467288393|FG000|Period I|Adverse Event|8|||
129814713|NCT02405780|467288394|FG001|Period I|Adverse Event|0|||
129814714|NCT02405780|467288395|FG002|Period I|Adverse Event|3|||
129814715|NCT02405780|467288396|FG003|Period I|Adverse Event|7|||
129814716|NCT02405780|467288393|FG000|Period I|Medical reasons|1|||
129814717|NCT02405780|467288394|FG001|Period I|Medical reasons|1|||
129814718|NCT02405780|467288395|FG002|Period I|Medical reasons|0|||
129814719|NCT02405780|467288396|FG003|Period I|Medical reasons|1|||
129814720|NCT02405780|467288393|FG000|Period I|Screening Failure|1|||
129814721|NCT02405780|467288394|FG001|Period I|Screening Failure|0|||
129814722|NCT02405780|467288395|FG002|Period I|Screening Failure|1|||
129814723|NCT02405780|467288396|FG003|Period I|Screening Failure|0|||
129814724|NCT02405780|467288393|FG000|Period I|Withdrawal by Subject|9|||
129814725|NCT02405780|467288394|FG001|Period I|Withdrawal by Subject|1|||
129814726|NCT02405780|467288395|FG002|Period I|Withdrawal by Subject|3|||
129814727|NCT02405780|467288396|FG003|Period I|Withdrawal by Subject|4|||
129814728|NCT02405780|467288393|FG000|Period I|Non-compliance with study procedures|8|||
129814729|NCT02405780|467288394|FG001|Period I|Non-compliance with study procedures|6|||
129814730|NCT02405780|467288395|FG002|Period I|Non-compliance with study procedures|8|||
129814731|NCT02405780|467288396|FG003|Period I|Non-compliance with study procedures|11|||
129814732|NCT02405780|467288393|FG000|Period II|Adverse Event|3|||
129814733|NCT02405780|467288394|FG001|Period II|Adverse Event|5|||
129814734|NCT02405780|467288395|FG002|Period II|Adverse Event|4|||
129814735|NCT02405780|467288396|FG003|Period II|Adverse Event|11|||
129814736|NCT02405780|467288393|FG000|Period II|Medical reason|0|||
129814737|NCT02405780|467288394|FG001|Period II|Medical reason|1|||
129814738|NCT02405780|467288395|FG002|Period II|Medical reason|0|||
129814739|NCT02405780|467288396|FG003|Period II|Medical reason|0|||
129814740|NCT02405780|467288393|FG000|Period II|Pregnancy|0|||
129814741|NCT02405780|467288394|FG001|Period II|Pregnancy|0|||
129814742|NCT02405780|467288395|FG002|Period II|Pregnancy|1|||
129814743|NCT02405780|467288396|FG003|Period II|Pregnancy|0|||
129814744|NCT02405780|467288393|FG000|Period II|Withdrawal by Subject|7|||
129814745|NCT02405780|467288394|FG001|Period II|Withdrawal by Subject|4|||
129814746|NCT02405780|467288395|FG002|Period II|Withdrawal by Subject|0|||
129814747|NCT02405780|467288396|FG003|Period II|Withdrawal by Subject|3|||
129814748|NCT02405780|467288393|FG000|Period II|Non-compliance with study procedures|5|||
129814749|NCT02405780|467288394|FG001|Period II|Non-compliance with study procedures|2|||
129814750|NCT02405780|467288395|FG002|Period II|Non-compliance with study procedures|7|||
129814751|NCT02405780|467288396|FG003|Period II|Non-compliance with study procedures|4|||
129814752|NCT01654536|467288397|FG000|Overall Study|Lost to Follow-up|5|||
129814753|NCT01654536|467288398|FG001|Overall Study|Lost to Follow-up|5|||
129814754|NCT01654536|467288397|FG000|Overall Study|Physician Decision|12|||
129814755|NCT01654536|467288398|FG001|Overall Study|Physician Decision|8|||
129814756|NCT01654536|467288397|FG000|Overall Study|Withdrawal by Subject|27|||
129814757|NCT01654536|467288398|FG001|Overall Study|Withdrawal by Subject|25|||
129814758|NCT04502693|467288402|FG000|Overall Study|Adverse Event|7|||
129814759|NCT04502693|467288403|FG001|Overall Study|Adverse Event|6|||
129814760|NCT04502693|467288404|FG002|Overall Study|Adverse Event|11|||
129814761|NCT04502693|467288405|FG003|Overall Study|Adverse Event|1|||
129814762|NCT04502693|467288402|FG000|Overall Study|Lost to Follow-up|32|||
129814763|NCT04502693|467288403|FG001|Overall Study|Lost to Follow-up|36|||
129814764|NCT04502693|467288404|FG002|Overall Study|Lost to Follow-up|69|||
129814765|NCT04502693|467288405|FG003|Overall Study|Lost to Follow-up|4|||
129814766|NCT04502693|467288402|FG000|Overall Study|Protocol Violation|8|||
129814767|NCT04502693|467288403|FG001|Overall Study|Protocol Violation|8|||
129814768|NCT04502693|467288404|FG002|Overall Study|Protocol Violation|16|||
129814769|NCT04502693|467288405|FG003|Overall Study|Protocol Violation|1|||
129814770|NCT04502693|467288402|FG000|Overall Study|Withdrawal by Subject|46|||
129814771|NCT04502693|467288403|FG001|Overall Study|Withdrawal by Subject|38|||
129814772|NCT04502693|467288404|FG002|Overall Study|Withdrawal by Subject|54|||
129814773|NCT04502693|467288405|FG003|Overall Study|Withdrawal by Subject|7|||
129814774|NCT04502693|467288402|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
129814775|NCT04502693|467288403|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
129814776|NCT04502693|467288404|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
129814777|NCT04502693|467288405|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129814778|NCT04502693|467288402|FG000|Overall Study|Other|1|||
129814779|NCT04502693|467288403|FG001|Overall Study|Other|0|||
129814780|NCT04502693|467288404|FG002|Overall Study|Other|1|||
129814781|NCT04502693|467288405|FG003|Overall Study|Other|1|||
129814782|NCT00602797|467288406|FG000|Overall Study|Adverse Event|1|||
129814783|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
129814784|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
129814785|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
129814786|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
129814787|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
129814788|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
129814789|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
129814790|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
129814791|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
129814792|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
130058965|NCT04096326|468170438|FG001|Overall Study|Withdrawal by Subject|0|||
129814793|NCT03943147|467288409|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
129814794|NCT03943147|467288410|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
129814795|NCT01318993|467288411|FG000|Overall Study|Adverse Event|53|||
129814796|NCT01318993|467288411|FG000|Overall Study|Lack of Efficacy|121|||
129814797|NCT01318993|467288411|FG000|Overall Study|Protocol Violation|3|||
129814798|NCT01318993|467288411|FG000|Overall Study|Protocol based stopping criteria|6|||
129814799|NCT01318993|467288411|FG000|Overall Study|Study closed or terminated|174|||
129814800|NCT01318993|467288411|FG000|Overall Study|Lost to Follow-up|4|||
129814801|NCT01318993|467288411|FG000|Overall Study|Physician Decision|13|||
129814802|NCT01318993|467288411|FG000|Overall Study|Withdrawal by Subject|24|||
129814803|NCT03334539|467288412|FG000|Overall Study|Adverse Event|3|||
129814804|NCT03334539|467288413|FG001|Overall Study|Adverse Event|5|||
129814805|NCT03334539|467288414|FG002|Overall Study|Adverse Event|0|||
129814806|NCT03334539|467288412|FG000|Overall Study|Withdrawal by Subject|0|||
129814807|NCT03334539|467288413|FG001|Overall Study|Withdrawal by Subject|1|||
129814808|NCT03334539|467288414|FG002|Overall Study|Withdrawal by Subject|1|||
129814809|NCT03334539|467288412|FG000|Overall Study|Administrative Reasons|1|||
129814810|NCT03334539|467288413|FG001|Overall Study|Administrative Reasons|0|||
129814811|NCT03334539|467288414|FG002|Overall Study|Administrative Reasons|0|||
129814812|NCT03334539|467288412|FG000|Overall Study|Hypertension Not Controlled|0|||
129814813|NCT03334539|467288413|FG001|Overall Study|Hypertension Not Controlled|1|||
129814814|NCT03334539|467288414|FG002|Overall Study|Hypertension Not Controlled|0|||
129814815|NCT00968201|467288415|FG000|Base Study - (Period II)|Adverse Event|8|||
129814816|NCT00968201|467288416|FG001|Base Study - (Period II)|Adverse Event|0|||
129814817|NCT00968201|467288417|FG002|Base Study - (Period II)|Adverse Event|16|||
129814818|NCT00968201|467288415|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
129814819|NCT00968201|467288416|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
129814820|NCT00968201|467288417|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
129814821|NCT00968201|467288415|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
129814822|NCT00968201|467288416|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
129814823|NCT00968201|467288417|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
129814824|NCT00968201|467288415|FG000|Base Study - (Period II)|Protocol Violation|12|||
129814825|NCT00968201|467288416|FG001|Base Study - (Period II)|Protocol Violation|0|||
129814826|NCT00968201|467288417|FG002|Base Study - (Period II)|Protocol Violation|12|||
129814827|NCT00968201|467288415|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
129814828|NCT00968201|467288416|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
129814829|NCT00968201|467288417|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
129814830|NCT00968201|467288415|FG000|Base Study - (Period II)|Site Error|0|||
129814831|NCT00968201|467288416|FG001|Base Study - (Period II)|Site Error|0|||
129814832|NCT00968201|467288417|FG002|Base Study - (Period II)|Site Error|1|||
129814833|NCT00968201|467288415|FG000|Extension Study - (Period III)|Adverse Event|0|||
129814834|NCT00968201|467288416|FG001|Extension Study - (Period III)|Adverse Event|5|||
129814835|NCT00968201|467288417|FG002|Extension Study - (Period III)|Adverse Event|22|||
129814836|NCT00968201|467288415|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
129814837|NCT00968201|467288416|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
129814838|NCT00968201|467288417|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
129814839|NCT00968201|467288415|FG000|Extension Study - (Period III)|Protocol Violation|0|||
129814840|NCT00968201|467288416|FG001|Extension Study - (Period III)|Protocol Violation|17|||
129814841|NCT00968201|467288417|FG002|Extension Study - (Period III)|Protocol Violation|14|||
129814842|NCT00968201|467288415|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
129814843|NCT00968201|467288416|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
129814844|NCT00968201|467288417|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
129814845|NCT00968201|467288415|FG000|Extension Study - (Period III)|Patient Relocated|0|||
129814846|NCT00968201|467288416|FG001|Extension Study - (Period III)|Patient Relocated|1|||
129814847|NCT00968201|467288417|FG002|Extension Study - (Period III)|Patient Relocated|1|||
129814848|NCT00968201|467288415|FG000|Extension Study - (Period III)|Noncompliance|0|||
129814849|NCT00968201|467288416|FG001|Extension Study - (Period III)|Noncompliance|0|||
129814850|NCT00968201|467288417|FG002|Extension Study - (Period III)|Noncompliance|3|||
129814851|NCT00968201|467288415|FG000|Extension Study - (Period III)|Other|0|||
129814852|NCT00968201|467288416|FG001|Extension Study - (Period III)|Other|0|||
129814853|NCT00968201|467288417|FG002|Extension Study - (Period III)|Other|2|||
130058966|NCT04096326|468170439|FG002|Overall Study|Withdrawal by Subject|0|||
130058967|NCT04096326|468170440|FG003|Overall Study|Withdrawal by Subject|0|||
130058968|NCT04096326|468170441|FG004|Overall Study|Withdrawal by Subject|0|||
130058969|NCT04096326|468170442|FG005|Overall Study|Withdrawal by Subject|0|||
130058970|NCT04096326|468170443|FG006|Overall Study|Withdrawal by Subject|1|||
130058971|NCT04096326|468170444|FG007|Overall Study|Withdrawal by Subject|0|||
130058972|NCT04096326|468170445|FG008|Overall Study|Withdrawal by Subject|0|||
130058973|NCT04096326|468170446|FG009|Overall Study|Withdrawal by Subject|0|||
130058974|NCT04096326|468170437|FG000|Overall Study|Lost to Follow-up|0|||
130058975|NCT04096326|468170438|FG001|Overall Study|Lost to Follow-up|1|||
130058976|NCT04096326|468170439|FG002|Overall Study|Lost to Follow-up|0|||
130058977|NCT04096326|468170440|FG003|Overall Study|Lost to Follow-up|0|||
130058978|NCT04096326|468170441|FG004|Overall Study|Lost to Follow-up|0|||
130058979|NCT04096326|468170442|FG005|Overall Study|Lost to Follow-up|0|||
130058980|NCT04096326|468170443|FG006|Overall Study|Lost to Follow-up|0|||
130058981|NCT04096326|468170444|FG007|Overall Study|Lost to Follow-up|0|||
130058982|NCT04096326|468170445|FG008|Overall Study|Lost to Follow-up|0|||
130058983|NCT04096326|468170446|FG009|Overall Study|Lost to Follow-up|0|||
130058984|NCT04096326|468170437|FG000|Overall Study|COVID-19-related reasons|0|||
129814854|NCT00968201|467288415|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
129814855|NCT00968201|467288416|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
129814856|NCT00968201|467288417|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
129814857|NCT04974697|467288419|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
129814858|NCT04974697|467288419|FG000|Overall Study|Lens discomfort|1|||
129814859|NCT02010775|467288420|FG000|Overall Study|Adverse Event|0|||
129814860|NCT02010775|467288421|FG001|Overall Study|Adverse Event|0|||
129814861|NCT02010775|467288422|FG002|Overall Study|Adverse Event|0|||
129814862|NCT02010775|467288423|FG003|Overall Study|Adverse Event|0|||
129814863|NCT02010775|467288424|FG004|Overall Study|Adverse Event|1|||
129814864|NCT02010775|467288420|FG000|Overall Study|Pregnancy|0|||
129814865|NCT02010775|467288421|FG001|Overall Study|Pregnancy|0|||
129814866|NCT02010775|467288422|FG002|Overall Study|Pregnancy|2|||
129814867|NCT02010775|467288423|FG003|Overall Study|Pregnancy|0|||
129814868|NCT02010775|467288424|FG004|Overall Study|Pregnancy|0|||
129814869|NCT02010775|467288420|FG000|Overall Study|Lost to Follow-up|2|||
129814870|NCT02010775|467288421|FG001|Overall Study|Lost to Follow-up|0|||
129814871|NCT02010775|467288422|FG002|Overall Study|Lost to Follow-up|0|||
129814872|NCT02010775|467288423|FG003|Overall Study|Lost to Follow-up|1|||
129814873|NCT02010775|467288424|FG004|Overall Study|Lost to Follow-up|1|||
129814874|NCT02010775|467288420|FG000|Overall Study|Personal Reasons|3|||
129814875|NCT02010775|467288421|FG001|Overall Study|Personal Reasons|3|||
129814876|NCT02010775|467288422|FG002|Overall Study|Personal Reasons|1|||
129814877|NCT02010775|467288423|FG003|Overall Study|Personal Reasons|2|||
129814878|NCT02010775|467288424|FG004|Overall Study|Personal Reasons|4|||
129814879|NCT02030041|467288427|FG000|Overall Study|Withdrawal by Subject|2|||
129814880|NCT02030041|467288428|FG001|Overall Study|Withdrawal by Subject|2|||
129814881|NCT02030041|467288429|FG002|Overall Study|Withdrawal by Subject|1|||
129814882|NCT01197560|467288430|FG000|Overall Study|Adverse Event|6|||
129814883|NCT01197560|467288431|FG001|Overall Study|Adverse Event|8|||
129814884|NCT01197560|467288430|FG000|Overall Study|Death|3|||
129814885|NCT01197560|467288431|FG001|Overall Study|Death|5|||
129814886|NCT01197560|467288430|FG000|Overall Study|Withdrawal by Subject|1|||
129814887|NCT01197560|467288431|FG001|Overall Study|Withdrawal by Subject|1|||
129814888|NCT01197560|467288430|FG000|Overall Study|Disease progression|40|||
129814889|NCT01197560|467288431|FG001|Overall Study|Disease progression|35|||
129814890|NCT01197560|467288430|FG000|Overall Study|Miscellaneous|4|||
129814891|NCT01197560|467288431|FG001|Overall Study|Miscellaneous|3|||
129814892|NCT01197560|467288430|FG000|Overall Study|Missing|0|||
129814893|NCT01197560|467288431|FG001|Overall Study|Missing|1|||
129814894|NCT05201703|467288432|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
129814895|NCT05201703|467288433|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
129814896|NCT05201703|467288432|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
129814897|NCT05201703|467288433|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
129814898|NCT02006719|467288434|FG000|Overall Study|Withdrawal by Subject|10|||
129814899|NCT02006719|467288435|FG001|Overall Study|Withdrawal by Subject|2|||
129814900|NCT02006719|467288434|FG000|Overall Study|Lost to Follow-up|5|||
129814901|NCT02006719|467288435|FG001|Overall Study|Lost to Follow-up|1|||
129814902|NCT02006719|467288434|FG000|Overall Study|Protocol Violation|2|||
129814903|NCT02006719|467288435|FG001|Overall Study|Protocol Violation|0|||
129814904|NCT02006719|467288434|FG000|Overall Study|Adverse Event|1|||
130058985|NCT04096326|468170438|FG001|Overall Study|COVID-19-related reasons|0|||
129814905|NCT02006719|467288435|FG001|Overall Study|Adverse Event|1|||
129814906|NCT02006719|467288434|FG000|Overall Study|Other/Unknown|0|||
129814907|NCT02006719|467288435|FG001|Overall Study|Other/Unknown|1|||
130058986|NCT04096326|468170439|FG002|Overall Study|COVID-19-related reasons|0|||
130058987|NCT04096326|468170440|FG003|Overall Study|COVID-19-related reasons|0|||
129814908|NCT02166905|467288439|FG000|Overall Study|Withdrawal by Subject|1|||
129814909|NCT02166905|467288440|FG001|Overall Study|Withdrawal by Subject|0|||
129814910|NCT02166905|467288441|FG002|Overall Study|Withdrawal by Subject|0|||
129814911|NCT02166905|467288442|FG003|Overall Study|Withdrawal by Subject|0|||
129814912|NCT02617628|467288443|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
129814913|NCT02617628|467288444|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
129814914|NCT03278873|467288448|FG000|Overall Study|Withdrawal by Subject|0|||
129814915|NCT03278873|467288449|FG001|Overall Study|Withdrawal by Subject|1|||
129814916|NCT03278873|467288450|FG002|Overall Study|Withdrawal by Subject|0|||
129814917|NCT03278873|467288451|FG003|Overall Study|Withdrawal by Subject|0|||
129814918|NCT03278873|467288448|FG000|Overall Study|Sponsor's decision|0|||
129814919|NCT03278873|467288449|FG001|Overall Study|Sponsor's decision|1|||
129814920|NCT03278873|467288450|FG002|Overall Study|Sponsor's decision|0|||
129814921|NCT03278873|467288451|FG003|Overall Study|Sponsor's decision|0|||
129814922|NCT03278873|467288448|FG000|Overall Study|Early Termination|2|||
129814923|NCT03278873|467288449|FG001|Overall Study|Early Termination|6|||
129814924|NCT03278873|467288450|FG002|Overall Study|Early Termination|0|||
129814925|NCT03278873|467288451|FG003|Overall Study|Early Termination|4|||
129814926|NCT03278873|467288448|FG000|Overall Study|Lost to Follow-up|0|||
129814927|NCT03278873|467288449|FG001|Overall Study|Lost to Follow-up|0|||
129814928|NCT03278873|467288450|FG002|Overall Study|Lost to Follow-up|2|||
129814929|NCT03278873|467288451|FG003|Overall Study|Lost to Follow-up|0|||
129814930|NCT03278873|467288448|FG000|Overall Study|The patient decided to withdraw via email|1|||
129814931|NCT03278873|467288449|FG001|Overall Study|The patient decided to withdraw via email|0|||
129814932|NCT03278873|467288450|FG002|Overall Study|The patient decided to withdraw via email|0|||
129814933|NCT03278873|467288451|FG003|Overall Study|The patient decided to withdraw via email|0|||
129814934|NCT03278873|467288448|FG000|Overall Study|The patient was unresponsive to contact|0|||
129814935|NCT03278873|467288449|FG001|Overall Study|The patient was unresponsive to contact|0|||
129814936|NCT03278873|467288450|FG002|Overall Study|The patient was unresponsive to contact|0|||
129814937|NCT03278873|467288451|FG003|Overall Study|The patient was unresponsive to contact|4|||
129814938|NCT03278873|467288448|FG000|Overall Study|The patient wished to participate no longer|0|||
129814939|NCT03278873|467288449|FG001|Overall Study|The patient wished to participate no longer|1|||
129814940|NCT03278873|467288450|FG002|Overall Study|The patient wished to participate no longer|0|||
129814941|NCT03278873|467288451|FG003|Overall Study|The patient wished to participate no longer|0|||
129814942|NCT03278873|467288448|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
129814943|NCT03278873|467288449|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
129814944|NCT03278873|467288450|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
129814945|NCT03278873|467288451|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
129814946|NCT02801331|467288452|FG000|Overall Study|Transferred to another hospital|8|||
129814947|NCT02801331|467288453|FG001|Overall Study|Transferred to another hospital|7|||
129814948|NCT02801331|467288452|FG000|Overall Study|Withdrawal by Subject|0|||
129814949|NCT02801331|467288453|FG001|Overall Study|Withdrawal by Subject|4|||
129814950|NCT02801331|467288452|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
129814951|NCT02801331|467288453|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
129814952|NCT04698187|467288460|FG000|Overall Study|Withdrawal by Subject|7|||
129814953|NCT04698187|467288460|FG000|Overall Study|Death|21|||
129814954|NCT04698187|467288460|FG000|Overall Study|Sponsor Decision|15|||
129814955|NCT04698187|467288460|FG000|Overall Study|In-transit Disease|1|||
129814956|NCT00540514|467290019|FG000|Overall Study|Still on treatment|3|||
129814957|NCT00540514|467290020|FG001|Overall Study|Still on treatment|0|||
129814958|NCT00540514|467290019|FG000|Overall Study|Unacceptable Toxicity|61|||
129814959|NCT00540514|467290020|FG001|Overall Study|Unacceptable Toxicity|62|||
129814960|NCT00540514|467290019|FG000|Overall Study|Adverse Event|20|||
129814961|NCT00540514|467290020|FG001|Overall Study|Adverse Event|24|||
129814962|NCT00540514|467290019|FG000|Overall Study|Physician Decision|86|||
129814963|NCT00540514|467290020|FG001|Overall Study|Physician Decision|99|||
129814964|NCT00540514|467290019|FG000|Overall Study|Protocol Deviation|3|||
129814965|NCT00540514|467290020|FG001|Overall Study|Protocol Deviation|4|||
129814966|NCT00540514|467290019|FG000|Overall Study|Lost to Follow-up|1|||
129814967|NCT00540514|467290020|FG001|Overall Study|Lost to Follow-up|1|||
129814968|NCT00540514|467290019|FG000|Overall Study|Withdrawal by Subject|65|||
129814969|NCT00540514|467290020|FG001|Overall Study|Withdrawal by Subject|67|||
129814970|NCT00540514|467290019|FG000|Overall Study|Excluded prior to treatment|7|||
129814971|NCT00540514|467290020|FG001|Overall Study|Excluded prior to treatment|7|||
129814972|NCT00540514|467290019|FG000|Overall Study|Paclitaxel not available|0|||
129814973|NCT00540514|467290020|FG001|Overall Study|Paclitaxel not available|2|||
129814974|NCT02501473|467290021|FG000|Overall Study|Study Terminated|2|||
129814975|NCT02501473|467290022|FG001|Overall Study|Study Terminated|3|||
129814976|NCT02501473|467290023|FG002|Overall Study|Study Terminated|7|||
129814977|NCT02501473|467290024|FG003|Overall Study|Study Terminated|9|||
129814978|NCT02501473|467290025|FG004|Overall Study|Study Terminated|2|||
129814979|NCT02501473|467290026|FG005|Overall Study|Study Terminated|10|||
129814980|NCT02501473|467290027|FG006|Overall Study|Study Terminated|1|||
129814981|NCT02501473|467290028|FG007|Overall Study|Study Terminated|0|||
129814982|NCT02501473|467290021|FG000|Overall Study|Withdrawal by Subject|0|||
129814983|NCT02501473|467290022|FG001|Overall Study|Withdrawal by Subject|0|||
129814984|NCT02501473|467290023|FG002|Overall Study|Withdrawal by Subject|3|||
129814985|NCT02501473|467290024|FG003|Overall Study|Withdrawal by Subject|3|||
129814986|NCT02501473|467290025|FG004|Overall Study|Withdrawal by Subject|2|||
129814987|NCT02501473|467290026|FG005|Overall Study|Withdrawal by Subject|2|||
129814988|NCT02501473|467290027|FG006|Overall Study|Withdrawal by Subject|0|||
129814989|NCT02501473|467290028|FG007|Overall Study|Withdrawal by Subject|0|||
129814990|NCT02501473|467290021|FG000|Overall Study|Death|0|||
129814991|NCT02501473|467290022|FG001|Overall Study|Death|0|||
129814992|NCT02501473|467290023|FG002|Overall Study|Death|1|||
129814993|NCT02501473|467290024|FG003|Overall Study|Death|1|||
129814994|NCT02501473|467290025|FG004|Overall Study|Death|0|||
129814995|NCT02501473|467290026|FG005|Overall Study|Death|1|||
129814996|NCT02501473|467290027|FG006|Overall Study|Death|0|||
129814997|NCT02501473|467290028|FG007|Overall Study|Death|0|||
129814998|NCT02501473|467290021|FG000|Overall Study|Lost to Follow-up|1|||
129814999|NCT02501473|467290022|FG001|Overall Study|Lost to Follow-up|0|||
129815000|NCT02501473|467290023|FG002|Overall Study|Lost to Follow-up|1|||
129815001|NCT02501473|467290024|FG003|Overall Study|Lost to Follow-up|0|||
129815002|NCT02501473|467290025|FG004|Overall Study|Lost to Follow-up|0|||
129815003|NCT02501473|467290026|FG005|Overall Study|Lost to Follow-up|1|||
129815004|NCT02501473|467290027|FG006|Overall Study|Lost to Follow-up|0|||
129815005|NCT02501473|467290028|FG007|Overall Study|Lost to Follow-up|0|||
129815006|NCT02501473|467290021|FG000|Overall Study|Reason not specified|0|||
129815007|NCT02501473|467290022|FG001|Overall Study|Reason not specified|0|||
129815008|NCT02501473|467290023|FG002|Overall Study|Reason not specified|1|||
129815009|NCT02501473|467290024|FG003|Overall Study|Reason not specified|1|||
129815010|NCT02501473|467290025|FG004|Overall Study|Reason not specified|0|||
129815011|NCT02501473|467290026|FG005|Overall Study|Reason not specified|0|||
129815012|NCT02501473|467290027|FG006|Overall Study|Reason not specified|0|||
129815013|NCT02501473|467290028|FG007|Overall Study|Reason not specified|0|||
129815014|NCT00907777|467290029|FG000|Overall Study|Withdrawal by Subject|0|||
129815015|NCT00907777|467290030|FG001|Overall Study|Withdrawal by Subject|1|||
129815016|NCT00105469|467290041|FG000|Overall Study|Adverse Event|9|||
129815017|NCT00105469|467290042|FG001|Overall Study|Adverse Event|8|||
129815018|NCT00105469|467290041|FG000|Overall Study|Protocol Violation|4|||
129815019|NCT00105469|467290042|FG001|Overall Study|Protocol Violation|0|||
129815020|NCT00105469|467290041|FG000|Overall Study|Withdrawal by Subject|2|||
129815021|NCT00105469|467290042|FG001|Overall Study|Withdrawal by Subject|3|||
129815022|NCT00105469|467290041|FG000|Overall Study|Lost to Follow-up|1|||
129815023|NCT00105469|467290042|FG001|Overall Study|Lost to Follow-up|0|||
129815024|NCT00105469|467290041|FG000|Overall Study|Lack of Efficacy|2|||
129815025|NCT00105469|467290042|FG001|Overall Study|Lack of Efficacy|0|||
129815026|NCT00105469|467290041|FG000|Overall Study|Other Reason|4|||
129815027|NCT00105469|467290042|FG001|Overall Study|Other Reason|0|||
129815028|NCT00599924|467290044|FG000|Overall Study|Lack of Efficacy|3|||
129815029|NCT00599924|467290045|FG001|Overall Study|Lack of Efficacy|5|||
129815030|NCT00599924|467290046|FG002|Overall Study|Lack of Efficacy|1|||
129815031|NCT00599924|467290047|FG003|Overall Study|Lack of Efficacy|2|||
129815032|NCT00599924|467290048|FG004|Overall Study|Lack of Efficacy|3|||
129815033|NCT00599924|467290049|FG005|Overall Study|Lack of Efficacy|2|||
129815034|NCT00599924|467290050|FG006|Overall Study|Lack of Efficacy|0|||
129815035|NCT00599924|467290044|FG000|Overall Study|Adverse Event|0|||
129815036|NCT00599924|467290045|FG001|Overall Study|Adverse Event|0|||
129815037|NCT00599924|467290046|FG002|Overall Study|Adverse Event|0|||
129815038|NCT00599924|467290047|FG003|Overall Study|Adverse Event|2|||
129815039|NCT00599924|467290048|FG004|Overall Study|Adverse Event|0|||
129815040|NCT00599924|467290049|FG005|Overall Study|Adverse Event|0|||
129815041|NCT00599924|467290050|FG006|Overall Study|Adverse Event|2|||
129815042|NCT00599924|467290044|FG000|Overall Study|Death|0|||
129897079|NCT02081391|467582201|FG003|12-hour Treatment|Further reasons|0|||
129897080|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
129897081|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
129897082|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
129897083|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
129897084|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
129897085|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
129815043|NCT00599924|467290045|FG001|Overall Study|Death|0|||
129815044|NCT00599924|467290046|FG002|Overall Study|Death|0|||
129815045|NCT00599924|467290047|FG003|Overall Study|Death|2|||
129815046|NCT00599924|467290048|FG004|Overall Study|Death|0|||
129815047|NCT00599924|467290049|FG005|Overall Study|Death|2|||
129815048|NCT00599924|467290050|FG006|Overall Study|Death|1|||
129815049|NCT00599924|467290044|FG000|Overall Study|Protocol Violation|0|||
129815050|NCT00599924|467290045|FG001|Overall Study|Protocol Violation|0|||
129815051|NCT00599924|467290046|FG002|Overall Study|Protocol Violation|0|||
129815052|NCT00599924|467290047|FG003|Overall Study|Protocol Violation|1|||
129815053|NCT00599924|467290048|FG004|Overall Study|Protocol Violation|0|||
129815054|NCT00599924|467290049|FG005|Overall Study|Protocol Violation|0|||
129815055|NCT00599924|467290050|FG006|Overall Study|Protocol Violation|0|||
129815056|NCT00599924|467290044|FG000|Overall Study|Withdrawal by Subject|0|||
129815057|NCT00599924|467290045|FG001|Overall Study|Withdrawal by Subject|0|||
129815058|NCT00599924|467290046|FG002|Overall Study|Withdrawal by Subject|1|||
129815059|NCT00599924|467290047|FG003|Overall Study|Withdrawal by Subject|0|||
129815060|NCT00599924|467290048|FG004|Overall Study|Withdrawal by Subject|1|||
129815061|NCT00599924|467290049|FG005|Overall Study|Withdrawal by Subject|0|||
129815062|NCT00599924|467290050|FG006|Overall Study|Withdrawal by Subject|0|||
129815063|NCT00599924|467290044|FG000|Overall Study|Other|0|||
129815064|NCT00599924|467290045|FG001|Overall Study|Other|0|||
129815065|NCT00599924|467290046|FG002|Overall Study|Other|0|||
129815066|NCT00599924|467290047|FG003|Overall Study|Other|1|||
129815067|NCT00599924|467290048|FG004|Overall Study|Other|2|||
129815068|NCT00599924|467290049|FG005|Overall Study|Other|0|||
129815069|NCT00599924|467290050|FG006|Overall Study|Other|2|||
129815070|NCT01806298|467290051|FG000|Overall Study|Adverse Event|3|||
129815071|NCT01806298|467290051|FG000|Overall Study|Protocol Non-compliance|1|||
129815072|NCT01806298|467290051|FG000|Overall Study|Withdrawal by Subject|1|||
129815073|NCT01806298|467290051|FG000|Overall Study|Other|5|||
129815074|NCT03808545|467290052|FG000|Overall Study|Withdrawal by Subject|1|||
129815075|NCT03808545|467290053|FG001|Overall Study|Withdrawal by Subject|1|||
129815076|NCT05035550|467290064|FG000|Overall Study|Withdrawal by Subject|3|||
129815077|NCT05035550|467290065|FG001|Overall Study|Withdrawal by Subject|0|||
129815078|NCT01396148|467290066|FG000|Overall Study|Patient Decision|1|||
129815079|NCT02732119|467290069|FG000|Phase I|Adverse Event|1|||
129815080|NCT02732119|467290070|FG001|Phase I|Adverse Event|3|||
129815081|NCT02732119|467290071|FG002|Phase I|Adverse Event|1|||
129815082|NCT02732119|467290072|FG003|Phase I|Adverse Event|0|||
129815083|NCT02732119|467290073|FG004|Phase I|Adverse Event|0|||
129815084|NCT02732119|467290069|FG000|Phase I|Progressive disease|7|||
129815085|NCT02732119|467290070|FG001|Phase I|Progressive disease|3|||
129815086|NCT02732119|467290071|FG002|Phase I|Progressive disease|2|||
129815087|NCT02732119|467290072|FG003|Phase I|Progressive disease|0|||
129815088|NCT02732119|467290073|FG004|Phase I|Progressive disease|0|||
129815089|NCT02732119|467290069|FG000|Phase I|Protocol deviation|0|||
129815090|NCT02732119|467290070|FG001|Phase I|Protocol deviation|1|||
129815091|NCT02732119|467290071|FG002|Phase I|Protocol deviation|0|||
129815092|NCT02732119|467290072|FG003|Phase I|Protocol deviation|0|||
129815093|NCT02732119|467290073|FG004|Phase I|Protocol deviation|0|||
129815094|NCT02732119|467290069|FG000|Phase I|Physician Decision|0|||
129815095|NCT02732119|467290070|FG001|Phase I|Physician Decision|3|||
129815096|NCT02732119|467290071|FG002|Phase I|Physician Decision|4|||
129815097|NCT02732119|467290072|FG003|Phase I|Physician Decision|0|||
129815098|NCT02732119|467290073|FG004|Phase I|Physician Decision|0|||
129815099|NCT02732119|467290069|FG000|Phase II|Adverse Event|0|||
129815100|NCT02732119|467290070|FG001|Phase II|Adverse Event|0|||
129815101|NCT02732119|467290071|FG002|Phase II|Adverse Event|0|||
129815102|NCT02732119|467290072|FG003|Phase II|Adverse Event|3|||
129815103|NCT02732119|467290073|FG004|Phase II|Adverse Event|3|||
129815104|NCT02732119|467290069|FG000|Phase II|Death|0|||
129815105|NCT02732119|467290070|FG001|Phase II|Death|0|||
129815106|NCT02732119|467290071|FG002|Phase II|Death|0|||
129815107|NCT02732119|467290072|FG003|Phase II|Death|1|||
129815108|NCT02732119|467290073|FG004|Phase II|Death|0|||
129815109|NCT02732119|467290069|FG000|Phase II|Progressive dissease|0|||
129815110|NCT02732119|467290070|FG001|Phase II|Progressive dissease|0|||
129815111|NCT02732119|467290071|FG002|Phase II|Progressive dissease|0|||
129815112|NCT02732119|467290072|FG003|Phase II|Progressive dissease|30|||
129815113|NCT02732119|467290073|FG004|Phase II|Progressive dissease|23|||
129815114|NCT02732119|467290069|FG000|Phase II|Study terminated by sponsor|0|||
129815115|NCT02732119|467290070|FG001|Phase II|Study terminated by sponsor|0|||
129815116|NCT02732119|467290071|FG002|Phase II|Study terminated by sponsor|0|||
129815117|NCT02732119|467290072|FG003|Phase II|Study terminated by sponsor|2|||
129815118|NCT02732119|467290073|FG004|Phase II|Study terminated by sponsor|2|||
129815119|NCT02732119|467290069|FG000|Phase II|Other|0|||
129815120|NCT02732119|467290070|FG001|Phase II|Other|0|||
129815121|NCT02732119|467290071|FG002|Phase II|Other|0|||
129815122|NCT02732119|467290072|FG003|Phase II|Other|2|||
129815123|NCT02732119|467290073|FG004|Phase II|Other|0|||
129815124|NCT02732119|467290069|FG000|Phase II|Physician Decision|0|||
129815125|NCT02732119|467290070|FG001|Phase II|Physician Decision|0|||
129815126|NCT02732119|467290071|FG002|Phase II|Physician Decision|0|||
129815127|NCT02732119|467290072|FG003|Phase II|Physician Decision|8|||
129815128|NCT02732119|467290073|FG004|Phase II|Physician Decision|5|||
129815129|NCT00003479|467290074|FG000|Overall Study|Not evaluable|3|||
129815130|NCT02128113|467290077|FG000|Overall Study|Withdrawal by Subject|3|||
129815131|NCT02128113|467290078|FG001|Overall Study|Withdrawal by Subject|1|||
129815132|NCT02128113|467290079|FG002|Overall Study|Withdrawal by Subject|0|||
129815133|NCT02128113|467290077|FG000|Overall Study|Protocol Violation|0|||
129815134|NCT02128113|467290078|FG001|Overall Study|Protocol Violation|1|||
129815135|NCT02128113|467290079|FG002|Overall Study|Protocol Violation|0|||
129815136|NCT02128113|467290077|FG000|Overall Study|Surgery cancelled|0|||
129815137|NCT02128113|467290078|FG001|Overall Study|Surgery cancelled|1|||
129815138|NCT02128113|467290079|FG002|Overall Study|Surgery cancelled|0|||
129815139|NCT02128113|467290077|FG000|Overall Study|Adverse Event|0|||
129815140|NCT02128113|467290078|FG001|Overall Study|Adverse Event|0|||
129815141|NCT02128113|467290079|FG002|Overall Study|Adverse Event|1|||
129815142|NCT01061177|467290080|FG000|Overall Study|Adverse Event|117|||
129815143|NCT01061177|467290080|FG000|Overall Study|Withdrawal by Subject|27|||
129815144|NCT01061177|467290080|FG000|Overall Study|Disease progression|17|||
129815145|NCT01061177|467290080|FG000|Overall Study|Protocol Violation|11|||
129815146|NCT01061177|467290080|FG000|Overall Study|Lost to Follow-up|9|||
129815147|NCT01061177|467290080|FG000|Overall Study|New cancer therapy|9|||
129815148|NCT01061177|467290080|FG000|Overall Study|Abnormal laboratory values|6|||
129815149|NCT01061177|467290080|FG000|Overall Study|Abnormal test procedure results|4|||
129815150|NCT01061177|467290080|FG000|Overall Study|Administratie problems|4|||
129815151|NCT01061177|467290080|FG000|Overall Study|Death|4|||
129815152|NCT02244606|467290093|FG000|Overall Study|Adverse Event|0|||
129815153|NCT02244606|467290094|FG001|Overall Study|Adverse Event|1|||
129815154|NCT02244606|467290095|FG002|Overall Study|Adverse Event|1|||
129815155|NCT02244606|467290096|FG003|Overall Study|Adverse Event|0|||
129815156|NCT02244606|467290093|FG000|Overall Study|Lost to Follow-up|2|||
129815157|NCT02244606|467290094|FG001|Overall Study|Lost to Follow-up|2|||
129815158|NCT02244606|467290095|FG002|Overall Study|Lost to Follow-up|1|||
129815159|NCT02244606|467290096|FG003|Overall Study|Lost to Follow-up|0|||
129815160|NCT02244606|467290093|FG000|Overall Study|Protocol Violation|0|||
129815161|NCT02244606|467290094|FG001|Overall Study|Protocol Violation|0|||
129815162|NCT02244606|467290095|FG002|Overall Study|Protocol Violation|0|||
129815163|NCT02244606|467290096|FG003|Overall Study|Protocol Violation|1|||
129815164|NCT02244606|467290093|FG000|Overall Study|Withdrawal by Subject|1|||
129815165|NCT02244606|467290094|FG001|Overall Study|Withdrawal by Subject|1|||
129815166|NCT02244606|467290095|FG002|Overall Study|Withdrawal by Subject|0|||
129815167|NCT02244606|467290096|FG003|Overall Study|Withdrawal by Subject|0|||
129815168|NCT02244606|467290093|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
129815169|NCT02244606|467290094|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
129815170|NCT02244606|467290095|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
129815171|NCT02244606|467290096|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
129815172|NCT00553644|467290097|FG000|Overall Study|Adverse Event|17|||
129815173|NCT00553644|467290097|FG000|Overall Study|Withdrawal by Subject|4|||
129815174|NCT00553644|467290097|FG000|Overall Study|Physician Decision|1|||
129815175|NCT00553644|467290097|FG000|Overall Study|Alternative therapy|6|||
129815176|NCT02197247|467290098|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
129815177|NCT02197247|467290098|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
129815178|NCT02197247|467290098|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
129815179|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
129815180|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
129815181|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
129815182|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
129815183|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
129815184|NCT01930123|467290106|FG000|Overall Study|Adverse Event|1|||
129815185|NCT01930123|467290107|FG001|Overall Study|Adverse Event|0|||
129815186|NCT01930123|467290106|FG000|Overall Study|Physician Decision|21|||
129815187|NCT01930123|467290107|FG001|Overall Study|Physician Decision|8|||
129815188|NCT01930123|467290106|FG000|Overall Study|Withdrawal by Subject|1|||
129815189|NCT01930123|467290107|FG001|Overall Study|Withdrawal by Subject|0|||
129815190|NCT01447433|467290110|FG000|Overall Study|Lost to Follow-up|0|||
129815191|NCT01447433|467290111|FG001|Overall Study|Lost to Follow-up|2|||
129815192|NCT01447433|467290110|FG000|Overall Study|Withdrawal by Subject|3|||
129815193|NCT01447433|467290111|FG001|Overall Study|Withdrawal by Subject|3|||
129815194|NCT01447433|467290110|FG000|Overall Study|Protocol Violation|1|||
129815195|NCT01447433|467290111|FG001|Overall Study|Protocol Violation|1|||
129815196|NCT00036270|467290112|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
129815197|NCT00036270|467290113|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
129897086|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
129897087|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
129897088|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
129897089|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
129815198|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
129815199|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
129815200|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
129815201|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
129815202|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
129815203|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
129815204|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Other|277|||
129815205|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Other|288|||
129815206|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
129815207|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
129815208|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
129815209|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
129815210|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
129815211|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
129815212|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
129815213|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
129815214|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
129815215|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
129815216|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
129815217|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
129815218|NCT01964430|467290114|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
129815219|NCT01964430|467290115|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
129815220|NCT01964430|467290114|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
129815221|NCT01964430|467290115|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
129815222|NCT01964430|467290114|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
129815223|NCT01964430|467290115|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
129815224|NCT01964430|467290114|FG000|Treatment Period|Adverse Event|71|||
129815225|NCT01964430|467290115|FG001|Treatment Period|Adverse Event|37|||
129815226|NCT01964430|467290114|FG000|Treatment Period|Withdrawal by Subject|36|||
129815227|NCT01964430|467290115|FG001|Treatment Period|Withdrawal by Subject|27|||
129815228|NCT01964430|467290114|FG000|Treatment Period|Death|1|||
129815229|NCT01964430|467290115|FG001|Treatment Period|Death|3|||
129815230|NCT01964430|467290114|FG000|Treatment Period|Protocol Deviation|0|||
129815231|NCT01964430|467290115|FG001|Treatment Period|Protocol Deviation|1|||
129815232|NCT01964430|467290114|FG000|Treatment Period|Physician Decision|5|||
129815233|NCT01964430|467290115|FG001|Treatment Period|Physician Decision|4|||
129815234|NCT01964430|467290114|FG000|Treatment Period|Disease Relapse|28|||
129815235|NCT01964430|467290115|FG001|Treatment Period|Disease Relapse|38|||
129815236|NCT01964430|467290114|FG000|Treatment Period|Other reasons|1|||
129815237|NCT01964430|467290115|FG001|Treatment Period|Other reasons|3|||
129815238|NCT02516163|467290116|FG000|Overall Study|Withdrawal by Subject|1|||
129815239|NCT02516163|467290116|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
129815240|NCT02516163|467290116|FG000|Overall Study|Unfit/delay in surgery|3|||
129815241|NCT02516163|467290116|FG000|Overall Study|Use of incorrect measurement technique|5|||
129815242|NCT02516163|467290116|FG000|Overall Study|Data not recorded|2|||
129815243|NCT02516163|467290116|FG000|Overall Study|MRI contraindication exclusion|6|||
129815244|NCT02801396|467290117|FG000|Period 1|Withdrawal by Subject|0|||
129815245|NCT02801396|467290118|FG001|Period 1|Withdrawal by Subject|0|||
129815246|NCT02801396|467290119|FG002|Period 1|Withdrawal by Subject|0|||
129815247|NCT02801396|467290120|FG003|Period 1|Withdrawal by Subject|0|||
129815248|NCT02801396|467290121|FG004|Period 1|Withdrawal by Subject|1|||
129815249|NCT02801396|467290122|FG005|Period 1|Withdrawal by Subject|0|||
129815250|NCT01658072|467290125|FG000|Overall Study|Protocol Violation|4|||
129815251|NCT01658072|467290126|FG001|Overall Study|Protocol Violation|2|||
129815252|NCT01874054|467290128|FG000|Overall Study|Withdrawal by Subject|3|||
129815253|NCT01874054|467290128|FG000|Overall Study|Study Termination by Sponsor|42|||
129815254|NCT01874054|467290128|FG000|Overall Study|Lost to Follow-up|5|||
129815255|NCT01874054|467290128|FG000|Overall Study|Death|5|||
129815256|NCT00702923|467290129|FG000|Overall Study|Adverse Event|1|||
130058988|NCT04096326|468170441|FG004|Overall Study|COVID-19-related reasons|1|||
130058989|NCT04096326|468170442|FG005|Overall Study|COVID-19-related reasons|5|||
130058990|NCT04096326|468170443|FG006|Overall Study|COVID-19-related reasons|0|||
130058991|NCT04096326|468170444|FG007|Overall Study|COVID-19-related reasons|0|||
130058992|NCT04096326|468170445|FG008|Overall Study|COVID-19-related reasons|0|||
130058993|NCT04096326|468170446|FG009|Overall Study|COVID-19-related reasons|0|||
130058994|NCT00194025|468170447|FG000|Overall Study|Adverse Event|1|||
130058995|NCT00194025|468170447|FG000|Overall Study|non-adherence with study medication|4|||
129815257|NCT00291577|467290130|FG000|Overall Study|Adverse Event|1|||
129815258|NCT00291577|467290130|FG000|Overall Study|Other|4|||
129815259|NCT00291577|467290130|FG000|Overall Study|Withdrawal by Subject|2|||
129815260|NCT00291577|467290130|FG000|Overall Study|Lack of Efficacy|14|||
129815261|NCT01587001|467290136|FG000|Overall Study|Lost to Follow-up|2|||
129815262|NCT01587001|467290137|FG001|Overall Study|Lost to Follow-up|0|||
129815263|NCT01587001|467290136|FG000|Overall Study|Insufficient samples to complete testing|4|||
129815264|NCT01587001|467290137|FG001|Overall Study|Insufficient samples to complete testing|1|||
129815265|NCT02756013|467290140|FG000|Overall Study|Adverse Event|1|||
129815266|NCT02756013|467290140|FG000|Overall Study|Hypersensitivity|1|||
130058996|NCT01088438|468170460|FG000|Overall Study|Withdrawal by Subject|11|||
130058997|NCT01088438|468170461|FG001|Overall Study|Withdrawal by Subject|6|||
130058998|NCT01088438|468170460|FG000|Overall Study|Lost to Follow-up|18|||
129815267|NCT03706456|467290141|FG000|Overall Study|Adverse Event|1|||
129815268|NCT03706456|467290141|FG000|Overall Study|Lack of Efficacy|2|||
129815269|NCT02784431|467290142|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
129815270|NCT02784431|467290142|FG000|Overall Study|Early Study Termination|19|||
129815271|NCT02605824|467290143|FG000|Overall Study|Physician Decision|1|||
129815272|NCT02605824|467290144|FG001|Overall Study|Physician Decision|0|||
129815273|NCT00393029|467290145|FG000|Overall Study|Not treated|0|||
129815274|NCT00393029|467290146|FG001|Overall Study|Not treated|1|||
129815275|NCT04659161|467290147|FG000|Overall Study|Adverse Event|10|||
129815276|NCT04659161|467290148|FG001|Overall Study|Adverse Event|6|||
129815277|NCT04659161|467290147|FG000|Overall Study|Withdrawal by Subject|13|||
129815278|NCT04659161|467290148|FG001|Overall Study|Withdrawal by Subject|12|||
129815279|NCT04659161|467290147|FG000|Overall Study|Other|9|||
129815280|NCT04659161|467290148|FG001|Overall Study|Other|8|||
129815281|NCT03715530|467290149|FG000|Overall Study|Lost to Follow-up|3|||
129815282|NCT03715530|467290150|FG001|Overall Study|Lost to Follow-up|1|||
129815283|NCT03715530|467290151|FG002|Overall Study|Lost to Follow-up|2|||
129815284|NCT01929343|467290152|FG000|Overall Study|Physician Decision|0|||
129815285|NCT01929343|467290153|FG001|Overall Study|Physician Decision|2|||
129815286|NCT01929343|467290154|FG002|Overall Study|Physician Decision|0|||
129815287|NCT01929343|467290152|FG000|Overall Study|Withdrawal by Subject|1|||
129815288|NCT01929343|467290153|FG001|Overall Study|Withdrawal by Subject|0|||
129815289|NCT01929343|467290154|FG002|Overall Study|Withdrawal by Subject|0|||
129815290|NCT02197130|467290157|FG000|Overall Study|Adverse Event|13|||
129815291|NCT02197130|467290158|FG001|Overall Study|Adverse Event|4|||
129815292|NCT02197130|467290159|FG002|Overall Study|Adverse Event|23|||
129815293|NCT02197130|467290157|FG000|Overall Study|Death|0|||
129815294|NCT02197130|467290158|FG001|Overall Study|Death|1|||
129815295|NCT02197130|467290159|FG002|Overall Study|Death|0|||
129815296|NCT02197130|467290157|FG000|Overall Study|Lost to Follow-up|2|||
129815297|NCT02197130|467290158|FG001|Overall Study|Lost to Follow-up|0|||
129815298|NCT02197130|467290159|FG002|Overall Study|Lost to Follow-up|1|||
129815299|NCT02197130|467290157|FG000|Overall Study|Does not meet entrance criteria|0|||
129815300|NCT02197130|467290158|FG001|Overall Study|Does not meet entrance criteria|0|||
129815301|NCT02197130|467290159|FG002|Overall Study|Does not meet entrance criteria|1|||
129815302|NCT02197130|467290157|FG000|Overall Study|Withdrawal by Subject|0|||
129815303|NCT02197130|467290158|FG001|Overall Study|Withdrawal by Subject|3|||
129815304|NCT02197130|467290159|FG002|Overall Study|Withdrawal by Subject|4|||
129815305|NCT02197130|467290157|FG000|Overall Study|Other|1|||
129815306|NCT02197130|467290158|FG001|Overall Study|Other|0|||
129815307|NCT02197130|467290159|FG002|Overall Study|Other|3|||
129815308|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815309|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
129815310|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815311|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
129815312|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
129815313|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815314|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815315|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815316|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815317|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815318|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815319|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815320|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815321|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815322|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815323|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
129815324|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
129815325|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
129815326|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815327|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815328|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815329|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815330|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815331|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815332|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815333|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815334|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815335|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815336|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815337|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815338|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815339|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815340|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815341|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
129815342|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815343|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815344|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815345|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815346|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815347|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815348|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815349|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815350|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815351|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815352|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815353|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815354|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
129815355|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815356|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815357|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815358|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815359|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815360|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815361|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815362|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815363|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815364|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815365|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815366|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815367|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815368|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815369|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815370|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815371|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815372|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
129815373|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815374|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815375|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815376|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815377|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815378|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815379|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815380|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815381|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815382|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815383|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815384|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
129815385|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
129815386|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
129815387|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
129815388|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815389|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815390|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815391|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815392|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815393|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815394|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815395|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815396|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815397|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815398|NCT01737697|467290165|FG000|Subacute Phase|Adverse Event|0|||
129815399|NCT01737697|467290166|FG001|Subacute Phase|Adverse Event|0|||
129897090|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
129815400|NCT01737697|467290167|FG002|Subacute Phase|Adverse Event|0|||
129815401|NCT01737697|467290168|FG003|Subacute Phase|Adverse Event|0|||
129815402|NCT01737697|467290169|FG004|Subacute Phase|Adverse Event|0|||
129815403|NCT01737697|467290170|FG005|Subacute Phase|Adverse Event|1|||
129815404|NCT01737697|467290171|FG006|Subacute Phase|Adverse Event|1|||
129815405|NCT01737697|467290172|FG007|Subacute Phase|Adverse Event|1|||
129815406|NCT01737697|467290173|FG008|Subacute Phase|Adverse Event|1|||
129815407|NCT01737697|467290174|FG009|Subacute Phase|Adverse Event|1|||
129815408|NCT01737697|467290175|FG010|Subacute Phase|Adverse Event|4|||
129815409|NCT01737697|467290176|FG011|Subacute Phase|Adverse Event|1|||
129815410|NCT01737697|467290177|FG012|Subacute Phase|Adverse Event|1|||
129815411|NCT01737697|467290178|FG013|Subacute Phase|Adverse Event|0|||
129815412|NCT01737697|467290179|FG014|Subacute Phase|Adverse Event|0|||
129815413|NCT01737697|467290165|FG000|Subacute Phase|Withdrawal by Subject|0|||
129815414|NCT01737697|467290166|FG001|Subacute Phase|Withdrawal by Subject|0|||
129815415|NCT01737697|467290167|FG002|Subacute Phase|Withdrawal by Subject|0|||
129815416|NCT01737697|467290168|FG003|Subacute Phase|Withdrawal by Subject|0|||
129815417|NCT01737697|467290169|FG004|Subacute Phase|Withdrawal by Subject|0|||
129815418|NCT01737697|467290170|FG005|Subacute Phase|Withdrawal by Subject|1|||
129815419|NCT01737697|467290171|FG006|Subacute Phase|Withdrawal by Subject|0|||
129815420|NCT01737697|467290172|FG007|Subacute Phase|Withdrawal by Subject|2|||
129815421|NCT01737697|467290173|FG008|Subacute Phase|Withdrawal by Subject|0|||
129815422|NCT01737697|467290174|FG009|Subacute Phase|Withdrawal by Subject|1|||
129815423|NCT01737697|467290175|FG010|Subacute Phase|Withdrawal by Subject|0|||
129815424|NCT01737697|467290176|FG011|Subacute Phase|Withdrawal by Subject|1|||
129815425|NCT01737697|467290177|FG012|Subacute Phase|Withdrawal by Subject|1|||
129815426|NCT01737697|467290178|FG013|Subacute Phase|Withdrawal by Subject|1|||
129815427|NCT01737697|467290179|FG014|Subacute Phase|Withdrawal by Subject|0|||
129815428|NCT01737697|467290165|FG000|Subacute Phase|Lost to Follow-up|0|||
129815429|NCT01737697|467290166|FG001|Subacute Phase|Lost to Follow-up|0|||
129815430|NCT01737697|467290167|FG002|Subacute Phase|Lost to Follow-up|0|||
129815431|NCT01737697|467290168|FG003|Subacute Phase|Lost to Follow-up|0|||
129815432|NCT01737697|467290169|FG004|Subacute Phase|Lost to Follow-up|0|||
129815433|NCT01737697|467290170|FG005|Subacute Phase|Lost to Follow-up|0|||
129815434|NCT01737697|467290171|FG006|Subacute Phase|Lost to Follow-up|0|||
129815435|NCT01737697|467290172|FG007|Subacute Phase|Lost to Follow-up|0|||
129815436|NCT01737697|467290173|FG008|Subacute Phase|Lost to Follow-up|0|||
129815437|NCT01737697|467290174|FG009|Subacute Phase|Lost to Follow-up|0|||
129815438|NCT01737697|467290175|FG010|Subacute Phase|Lost to Follow-up|0|||
129815439|NCT01737697|467290176|FG011|Subacute Phase|Lost to Follow-up|0|||
129815440|NCT01737697|467290177|FG012|Subacute Phase|Lost to Follow-up|0|||
129815441|NCT01737697|467290178|FG013|Subacute Phase|Lost to Follow-up|0|||
129815442|NCT01737697|467290179|FG014|Subacute Phase|Lost to Follow-up|1|||
129815443|NCT01737697|467290165|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
129815444|NCT01737697|467290166|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
129815445|NCT01737697|467290167|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
129815446|NCT01737697|467290168|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
129815447|NCT01737697|467290169|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
129815448|NCT01737697|467290170|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
129815449|NCT01737697|467290171|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
129815450|NCT01737697|467290172|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
129815451|NCT01737697|467290173|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
129815452|NCT01737697|467290174|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
129815453|NCT01737697|467290175|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
129815454|NCT01737697|467290176|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
129815455|NCT01737697|467290177|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
129815456|NCT01737697|467290178|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
129815457|NCT01737697|467290179|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
129815458|NCT01737697|467290165|FG000|Subacute Phase|Protocol Violation|0|||
129815459|NCT01737697|467290166|FG001|Subacute Phase|Protocol Violation|0|||
129815460|NCT01737697|467290167|FG002|Subacute Phase|Protocol Violation|0|||
129815461|NCT01737697|467290168|FG003|Subacute Phase|Protocol Violation|0|||
129815462|NCT01737697|467290169|FG004|Subacute Phase|Protocol Violation|0|||
129815463|NCT01737697|467290170|FG005|Subacute Phase|Protocol Violation|1|||
129815464|NCT01737697|467290171|FG006|Subacute Phase|Protocol Violation|0|||
129815465|NCT01737697|467290172|FG007|Subacute Phase|Protocol Violation|0|||
129815466|NCT01737697|467290173|FG008|Subacute Phase|Protocol Violation|0|||
129815467|NCT01737697|467290174|FG009|Subacute Phase|Protocol Violation|0|||
129815468|NCT01737697|467290175|FG010|Subacute Phase|Protocol Violation|1|||
129815469|NCT01737697|467290176|FG011|Subacute Phase|Protocol Violation|0|||
129815470|NCT01737697|467290177|FG012|Subacute Phase|Protocol Violation|0|||
129815471|NCT01737697|467290178|FG013|Subacute Phase|Protocol Violation|0|||
129815472|NCT01737697|467290179|FG014|Subacute Phase|Protocol Violation|0|||
129815473|NCT01737697|467290165|FG000|Subacute Phase|Physician Decision|0|||
129815474|NCT01737697|467290166|FG001|Subacute Phase|Physician Decision|0|||
129815475|NCT01737697|467290167|FG002|Subacute Phase|Physician Decision|0|||
129815476|NCT01737697|467290168|FG003|Subacute Phase|Physician Decision|0|||
129815477|NCT01737697|467290169|FG004|Subacute Phase|Physician Decision|0|||
129815478|NCT01737697|467290170|FG005|Subacute Phase|Physician Decision|0|||
129815479|NCT01737697|467290171|FG006|Subacute Phase|Physician Decision|0|||
129815480|NCT01737697|467290172|FG007|Subacute Phase|Physician Decision|0|||
129815481|NCT01737697|467290173|FG008|Subacute Phase|Physician Decision|1|||
129815482|NCT01737697|467290174|FG009|Subacute Phase|Physician Decision|0|||
129815483|NCT01737697|467290175|FG010|Subacute Phase|Physician Decision|0|||
129815484|NCT01737697|467290176|FG011|Subacute Phase|Physician Decision|0|||
129815485|NCT01737697|467290177|FG012|Subacute Phase|Physician Decision|0|||
129815486|NCT01737697|467290178|FG013|Subacute Phase|Physician Decision|0|||
129815487|NCT01737697|467290179|FG014|Subacute Phase|Physician Decision|0|||
129815488|NCT01737697|467290165|FG000|Subacute Phase|Death|0|||
129815489|NCT01737697|467290166|FG001|Subacute Phase|Death|0|||
129815490|NCT01737697|467290167|FG002|Subacute Phase|Death|0|||
129815491|NCT01737697|467290168|FG003|Subacute Phase|Death|0|||
129815492|NCT01737697|467290169|FG004|Subacute Phase|Death|0|||
129815493|NCT01737697|467290170|FG005|Subacute Phase|Death|0|||
129815494|NCT01737697|467290171|FG006|Subacute Phase|Death|0|||
129815495|NCT01737697|467290172|FG007|Subacute Phase|Death|0|||
129815496|NCT01737697|467290173|FG008|Subacute Phase|Death|0|||
129815497|NCT01737697|467290174|FG009|Subacute Phase|Death|0|||
129815498|NCT01737697|467290175|FG010|Subacute Phase|Death|1|||
129815499|NCT01737697|467290176|FG011|Subacute Phase|Death|0|||
129815500|NCT01737697|467290177|FG012|Subacute Phase|Death|0|||
129815501|NCT01737697|467290178|FG013|Subacute Phase|Death|0|||
129815502|NCT01737697|467290179|FG014|Subacute Phase|Death|0|||
129815503|NCT03338998|467290181|FG000|Treatment Period|Withdrawal by Subject|1|||
129815504|NCT03338998|467290182|FG001|Treatment Period|Withdrawal by Subject|1|||
129815505|NCT03338998|467290181|FG000|Treatment Period|Adverse Event|0|||
129815506|NCT03338998|467290182|FG001|Treatment Period|Adverse Event|2|||
129815507|NCT03338998|467290181|FG000|Treatment Period|Protocol deviation|1|||
129815508|NCT03338998|467290182|FG001|Treatment Period|Protocol deviation|0|||
129815509|NCT03338998|467290181|FG000|Treatment Period|Physician Decision|2|||
129815510|NCT03338998|467290182|FG001|Treatment Period|Physician Decision|0|||
129815511|NCT03338998|467290181|FG000|Treatment Period|Subject failed swallow test|4|||
129815512|NCT03338998|467290182|FG001|Treatment Period|Subject failed swallow test|0|||
129815513|NCT03338998|467290181|FG000|Safety Follow-Up Period|Adverse Event|0|||
129815514|NCT03338998|467290182|FG001|Safety Follow-Up Period|Adverse Event|1|||
129815515|NCT03338998|467290181|FG000|Safety Follow-Up Period|Protocol deviation|1|||
129815516|NCT03338998|467290182|FG001|Safety Follow-Up Period|Protocol deviation|0|||
129815517|NCT03338998|467290181|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
129815518|NCT03338998|467290182|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
129815519|NCT03288129|467290183|FG000|Overall Study|Adverse Event|10|||
129815520|NCT03288129|467290183|FG000|Overall Study|Lost to Follow-up|3|||
129815521|NCT03288129|467290183|FG000|Overall Study|Withdrawal by Subject|3|||
129815522|NCT03288129|467290183|FG000|Overall Study|Withdrawal of consent/assent|1|||
129815523|NCT03288129|467290183|FG000|Overall Study|Other|5|||
130058999|NCT01088438|468170461|FG001|Overall Study|Lost to Follow-up|30|||
130059000|NCT00511342|468170462|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
130059001|NCT00511342|468170463|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
130059002|NCT00511342|468170462|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
130059003|NCT00511342|468170463|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
129815524|NCT00558558|467290188|FG000|Overall Study|Unable to swallow|1|||
129815525|NCT00558558|467290188|FG000|Overall Study|Withdrawal by Subject|1|||
129815526|NCT00558558|467290188|FG000|Overall Study|Lack of Efficacy|4|||
129815527|NCT05255068|467292334|FG000|Overall Study|Lost to Follow-up|0|||
129815528|NCT05255068|467292335|FG001|Overall Study|Lost to Follow-up|1|||
129815529|NCT00980057|467292340|FG000|Overall Study|Death|13|||
129815530|NCT00980057|467292341|FG001|Overall Study|Death|3|||
129815531|NCT00980057|467292340|FG000|Overall Study|Adverse Event|0|||
129815532|NCT00980057|467292341|FG001|Overall Study|Adverse Event|1|||
129815533|NCT00980057|467292340|FG000|Overall Study|Physician Decision|4|||
129815534|NCT00980057|467292341|FG001|Overall Study|Physician Decision|0|||
129815535|NCT00980057|467292340|FG000|Overall Study|Lost to Follow-up|1|||
129815536|NCT00980057|467292341|FG001|Overall Study|Lost to Follow-up|0|||
129815537|NCT00980057|467292340|FG000|Overall Study|Withdrawal by Subject|1|||
129815538|NCT00980057|467292341|FG001|Overall Study|Withdrawal by Subject|1|||
129815539|NCT01408485|467292345|FG000|Overall Study|Withdrawal by Subject|21|||
129815540|NCT01315678|467292346|FG000|Overall Study|Withdrawal by Subject|7|||
129815541|NCT01315678|467292347|FG001|Overall Study|Withdrawal by Subject|3|||
129815542|NCT01315678|467292346|FG000|Overall Study|Adverse Event|3|||
129815543|NCT01315678|467292347|FG001|Overall Study|Adverse Event|1|||
129815544|NCT01315678|467292346|FG000|Overall Study|Lost to Follow-up|1|||
129815545|NCT01315678|467292347|FG001|Overall Study|Lost to Follow-up|0|||
129815546|NCT01315678|467292346|FG000|Overall Study|similar reason to those listed above|3|||
129815547|NCT01315678|467292347|FG001|Overall Study|similar reason to those listed above|2|||
129815548|NCT00331682|467292348|FG000|Overall Study|Adverse Event|1|||
129815549|NCT00790023|467292349|FG000|Overall Study|Adverse Event|2|||
129815550|NCT00790023|467292350|FG001|Overall Study|Adverse Event|1|||
129815551|NCT00790023|467292351|FG002|Overall Study|Adverse Event|4|||
129815552|NCT00790023|467292349|FG000|Overall Study|Protocol Violation|2|||
129815553|NCT00790023|467292350|FG001|Overall Study|Protocol Violation|4|||
130059004|NCT00511342|468170462|FG000|Overall Study|Pregnancy|0|||
129815554|NCT00790023|467292351|FG002|Overall Study|Protocol Violation|2|||
129815555|NCT00790023|467292349|FG000|Overall Study|Withdrawal by Subject|2|||
129815556|NCT00790023|467292350|FG001|Overall Study|Withdrawal by Subject|0|||
129815557|NCT00790023|467292351|FG002|Overall Study|Withdrawal by Subject|6|||
129815558|NCT00790023|467292349|FG000|Overall Study|Lost to Follow-up|0|||
129815559|NCT00790023|467292350|FG001|Overall Study|Lost to Follow-up|0|||
129815560|NCT00790023|467292351|FG002|Overall Study|Lost to Follow-up|1|||
130059005|NCT00511342|468170463|FG001|Overall Study|Pregnancy|1|||
129815561|NCT00790023|467292349|FG000|Overall Study|Other|5|||
129815562|NCT00790023|467292350|FG001|Overall Study|Other|5|||
129897091|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
129897092|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
129815563|NCT00790023|467292351|FG002|Overall Study|Other|8|||
129815564|NCT01338792|467292352|FG000|Overall Study|Adverse Event|2|||
129815565|NCT01338792|467292352|FG000|Overall Study|Death|1|||
129815566|NCT01338792|467292352|FG000|Overall Study|Withdrawal by Subject|1|||
129815567|NCT00573469|467292353|FG000|Overall Study|Adverse Event|1|||
129815568|NCT00573469|467292354|FG001|Overall Study|Adverse Event|1|||
129815569|NCT00573469|467292355|FG002|Overall Study|Adverse Event|1|||
129815570|NCT00573469|467292353|FG000|Overall Study|Withdrawal by Subject|0|||
129815571|NCT00573469|467292354|FG001|Overall Study|Withdrawal by Subject|2|||
129815572|NCT00573469|467292355|FG002|Overall Study|Withdrawal by Subject|0|||
129815573|NCT00573469|467292353|FG000|Overall Study|Other|5|||
129815574|NCT00573469|467292354|FG001|Overall Study|Other|1|||
129815575|NCT00573469|467292355|FG002|Overall Study|Other|3|||
129815576|NCT02468414|467292356|FG000|Overall Study|Early Study Termination by Sponsor|1|||
129815577|NCT02468414|467292357|FG001|Overall Study|Early Study Termination by Sponsor|0|||
129815578|NCT02468414|467292356|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
129815579|NCT02468414|467292357|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
129815580|NCT02468414|467292356|FG000|Overall Study|Screen Failure|1|||
129815581|NCT02468414|467292357|FG001|Overall Study|Screen Failure|0|||
129815582|NCT00004978|467292358|FG000|Overall Study|Death|107|||
129815583|NCT00004978|467292359|FG001|Overall Study|Death|116|||
129815584|NCT00004978|467292358|FG000|Overall Study|Lost to Follow-up|101|||
129815585|NCT00004978|467292359|FG001|Overall Study|Lost to Follow-up|108|||
129815586|NCT00004978|467292358|FG000|Overall Study|Withdrawal by Subject|17|||
129815587|NCT00004978|467292359|FG001|Overall Study|Withdrawal by Subject|26|||
129815588|NCT00004978|467292358|FG000|Overall Study|site closure - not in analysis cohort|19|||
129815589|NCT00004978|467292359|FG001|Overall Study|site closure - not in analysis cohort|20|||
129815590|NCT01652703|467292360|FG000|Overall Study|Withdrawal by Subject|0|||
129815591|NCT01652703|467292361|FG001|Overall Study|Withdrawal by Subject|1|||
129815592|NCT01652703|467292362|FG002|Overall Study|Withdrawal by Subject|3|||
129815593|NCT01652703|467292363|FG003|Overall Study|Withdrawal by Subject|1|||
129815594|NCT01652703|467292364|FG004|Overall Study|Withdrawal by Subject|0|||
129815595|NCT01652703|467292365|FG005|Overall Study|Withdrawal by Subject|1|||
129815596|NCT01652703|467292360|FG000|Overall Study|Other|0|||
129815597|NCT01652703|467292361|FG001|Overall Study|Other|0|||
129815598|NCT01652703|467292362|FG002|Overall Study|Other|0|||
129815599|NCT01652703|467292363|FG003|Overall Study|Other|1|||
129815600|NCT01652703|467292364|FG004|Overall Study|Other|1|||
129815601|NCT01652703|467292365|FG005|Overall Study|Other|1|||
129815602|NCT03555591|467292369|FG000|Overall Study|Protocol Violation|77|||
129815603|NCT00187486|467292370|FG000|Overall Study|Protocol Violation|1|||
129815604|NCT02380677|467292371|FG000|Overall Study|Adverse Event|0|||
129815605|NCT02380677|467292372|FG001|Overall Study|Adverse Event|0|||
129815606|NCT02380677|467292373|FG002|Overall Study|Adverse Event|0|||
129815607|NCT02380677|467292374|FG003|Overall Study|Adverse Event|1|||
129815608|NCT02380677|467292375|FG004|Overall Study|Adverse Event|1|||
129815609|NCT02380677|467292376|FG005|Overall Study|Adverse Event|4|||
129815610|NCT02380677|467292377|FG006|Overall Study|Adverse Event|2|||
129815611|NCT02380677|467292378|FG007|Overall Study|Adverse Event|2|||
129815612|NCT02380677|467292379|FG008|Overall Study|Adverse Event|2|||
129815613|NCT02380677|467292380|FG009|Overall Study|Adverse Event|1|||
129815614|NCT02380677|467292381|FG010|Overall Study|Adverse Event|2|||
129815615|NCT02380677|467292382|FG011|Overall Study|Adverse Event|1|||
129815616|NCT02380677|467292371|FG000|Overall Study|Physician Decision|1|||
129815617|NCT02380677|467292372|FG001|Overall Study|Physician Decision|0|||
129815618|NCT02380677|467292373|FG002|Overall Study|Physician Decision|1|||
129815619|NCT02380677|467292374|FG003|Overall Study|Physician Decision|1|||
129815620|NCT02380677|467292375|FG004|Overall Study|Physician Decision|0|||
129815621|NCT02380677|467292376|FG005|Overall Study|Physician Decision|0|||
129815622|NCT02380677|467292377|FG006|Overall Study|Physician Decision|0|||
129815623|NCT02380677|467292378|FG007|Overall Study|Physician Decision|0|||
129815624|NCT02380677|467292379|FG008|Overall Study|Physician Decision|0|||
129815625|NCT02380677|467292380|FG009|Overall Study|Physician Decision|0|||
129815626|NCT02380677|467292381|FG010|Overall Study|Physician Decision|0|||
129815627|NCT02380677|467292382|FG011|Overall Study|Physician Decision|0|||
129815628|NCT02380677|467292371|FG000|Overall Study|Lack of Efficacy|0|||
129815629|NCT02380677|467292372|FG001|Overall Study|Lack of Efficacy|1|||
129815630|NCT02380677|467292373|FG002|Overall Study|Lack of Efficacy|2|||
129815631|NCT02380677|467292374|FG003|Overall Study|Lack of Efficacy|0|||
129815632|NCT02380677|467292375|FG004|Overall Study|Lack of Efficacy|4|||
129815633|NCT02380677|467292376|FG005|Overall Study|Lack of Efficacy|1|||
129815634|NCT02380677|467292377|FG006|Overall Study|Lack of Efficacy|1|||
129815635|NCT02380677|467292378|FG007|Overall Study|Lack of Efficacy|2|||
129815636|NCT02380677|467292379|FG008|Overall Study|Lack of Efficacy|2|||
129815637|NCT02380677|467292380|FG009|Overall Study|Lack of Efficacy|0|||
129815638|NCT02380677|467292381|FG010|Overall Study|Lack of Efficacy|2|||
129815639|NCT02380677|467292382|FG011|Overall Study|Lack of Efficacy|1|||
129815640|NCT02380677|467292371|FG000|Overall Study|Withdrawal by Subject|0|||
129815641|NCT02380677|467292372|FG001|Overall Study|Withdrawal by Subject|0|||
129815642|NCT02380677|467292373|FG002|Overall Study|Withdrawal by Subject|0|||
129815643|NCT02380677|467292374|FG003|Overall Study|Withdrawal by Subject|0|||
129815644|NCT02380677|467292375|FG004|Overall Study|Withdrawal by Subject|0|||
129815645|NCT02380677|467292376|FG005|Overall Study|Withdrawal by Subject|0|||
129815646|NCT02380677|467292377|FG006|Overall Study|Withdrawal by Subject|0|||
129815647|NCT02380677|467292378|FG007|Overall Study|Withdrawal by Subject|0|||
129815648|NCT02380677|467292379|FG008|Overall Study|Withdrawal by Subject|0|||
129815649|NCT02380677|467292380|FG009|Overall Study|Withdrawal by Subject|1|||
129815650|NCT02380677|467292381|FG010|Overall Study|Withdrawal by Subject|0|||
129815651|NCT02380677|467292382|FG011|Overall Study|Withdrawal by Subject|3|||
129815652|NCT02380677|467292371|FG000|Overall Study|Other|0|||
129815653|NCT02380677|467292372|FG001|Overall Study|Other|0|||
129815654|NCT02380677|467292373|FG002|Overall Study|Other|0|||
129815655|NCT02380677|467292374|FG003|Overall Study|Other|1|||
129815656|NCT02380677|467292375|FG004|Overall Study|Other|1|||
129815657|NCT02380677|467292376|FG005|Overall Study|Other|1|||
129815658|NCT02380677|467292377|FG006|Overall Study|Other|0|||
129815659|NCT02380677|467292378|FG007|Overall Study|Other|0|||
129815660|NCT02380677|467292379|FG008|Overall Study|Other|0|||
129815661|NCT02380677|467292380|FG009|Overall Study|Other|0|||
129815662|NCT02380677|467292381|FG010|Overall Study|Other|0|||
129815663|NCT02380677|467292382|FG011|Overall Study|Other|0|||
129815664|NCT01029795|467292387|FG000|Overall Study|Entry Criteria Not Met|2|||
129815665|NCT01029795|467292388|FG001|Overall Study|Entry Criteria Not Met|1|||
129815666|NCT01029795|467292387|FG000|Overall Study|Physician Decision|2|||
129815667|NCT01029795|467292388|FG001|Overall Study|Physician Decision|1|||
129815668|NCT01029795|467292387|FG000|Overall Study|Sponsor Decision|11|||
129815669|NCT01029795|467292388|FG001|Overall Study|Sponsor Decision|17|||
129815670|NCT01029795|467292387|FG000|Overall Study|Withdrawal by Subject|1|||
129815671|NCT01029795|467292388|FG001|Overall Study|Withdrawal by Subject|3|||
129815672|NCT03217175|467292389|FG000|Overall Study|Physician Decision|4|||
129815673|NCT03217175|467292390|FG001|Overall Study|Physician Decision|1|||
129815674|NCT01806545|467292396|FG000|Overall Study|Adverse Event|2|||
129815675|NCT01806545|467292397|FG001|Overall Study|Adverse Event|3|||
129815676|NCT01806545|467292396|FG000|Overall Study|Lost to Follow-up|1|||
129815677|NCT01806545|467292397|FG001|Overall Study|Lost to Follow-up|0|||
129815678|NCT01806545|467292396|FG000|Overall Study|Withdrawal by Subject|3|||
129815679|NCT01806545|467292397|FG001|Overall Study|Withdrawal by Subject|2|||
129815680|NCT01508650|467292398|FG000|Overall Study|Lost to Follow-up|0|||
129815681|NCT01508650|467292399|FG001|Overall Study|Lost to Follow-up|3|||
129815682|NCT02064894|467292400|FG000|Overall Study|Withdrawal by Subject|43|||
129815683|NCT02064894|467292401|FG001|Overall Study|Withdrawal by Subject|102|||
129815684|NCT02064894|467292402|FG002|Overall Study|Withdrawal by Subject|115|||
129815685|NCT00884312|467292411|FG000|Overall Study|Non-fatal Progressive Disease|0|||
129815686|NCT00884312|467292412|FG001|Overall Study|Non-fatal Progressive Disease|8|||
129815687|NCT00884312|467292411|FG000|Overall Study|Fatal Progressive Disease|0|||
129815688|NCT00884312|467292412|FG001|Overall Study|Fatal Progressive Disease|1|||
129897093|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
129897094|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
129897095|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
129897096|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
129897097|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
129897098|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
129897099|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
129897100|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
129897101|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
129897102|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
129897103|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
129815689|NCT00884312|467292411|FG000|Overall Study|Non-fatal Adverse Event|1|||
129815690|NCT00884312|467292412|FG001|Overall Study|Non-fatal Adverse Event|0|||
129815691|NCT00884312|467292411|FG000|Overall Study|Fatal Adverse Event|1|||
129815692|NCT00884312|467292412|FG001|Overall Study|Fatal Adverse Event|4|||
129815693|NCT00884312|467292411|FG000|Overall Study|Withdrawal by Subject|0|||
129815694|NCT00884312|467292412|FG001|Overall Study|Withdrawal by Subject|6|||
129815695|NCT00884312|467292411|FG000|Overall Study|Physician Decision|0|||
129815696|NCT00884312|467292412|FG001|Overall Study|Physician Decision|1|||
129815697|NCT00884312|467292411|FG000|Overall Study|Other|0|||
129815698|NCT00884312|467292412|FG001|Overall Study|Other|4|||
129815699|NCT00884312|467292411|FG000|Overall Study|Did Not Receive Study Drug|0|||
129815700|NCT00884312|467292412|FG001|Overall Study|Did Not Receive Study Drug|1|||
129815701|NCT00224042|467292413|FG000|Overall Study|Adverse Event|2|||
129815702|NCT00224042|467292414|FG001|Overall Study|Adverse Event|1|||
129815703|NCT00224042|467292413|FG000|Overall Study|Protocol Violation|0|||
129815704|NCT00224042|467292414|FG001|Overall Study|Protocol Violation|1|||
129815705|NCT00224042|467292413|FG000|Overall Study|Physician Decision|0|||
129815706|NCT00224042|467292414|FG001|Overall Study|Physician Decision|1|||
129815707|NCT00224042|467292413|FG000|Overall Study|Did not meet lab incusion criteria|2|||
129815708|NCT00224042|467292414|FG001|Overall Study|Did not meet lab incusion criteria|3|||
129815709|NCT00224042|467292413|FG000|Overall Study|Other|2|||
129815710|NCT00224042|467292414|FG001|Overall Study|Other|0|||
129815711|NCT00840450|467292415|FG000|Overall Study|Adverse Event|1|||
129815712|NCT00840450|467292415|FG000|Overall Study|Lack of Efficacy|2|||
129815713|NCT00617123|467292416|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
129815714|NCT00617123|467292417|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
129815715|NCT00617123|467292416|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
129815716|NCT00617123|467292417|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
129815717|NCT00617123|467292416|FG000|Referral Screening Period|Adverse Event|0|||
129815718|NCT00617123|467292417|FG001|Referral Screening Period|Adverse Event|1|||
129815719|NCT00617123|467292416|FG000|Study Treatment Period|Withdrawal by Subject|8|||
129815720|NCT00617123|467292417|FG001|Study Treatment Period|Withdrawal by Subject|12|||
129815721|NCT00617123|467292416|FG000|Study Treatment Period|Adverse Event|7|||
129815722|NCT00617123|467292417|FG001|Study Treatment Period|Adverse Event|3|||
129815723|NCT00617123|467292416|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
129815724|NCT00617123|467292417|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
129815725|NCT00617123|467292416|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
129815726|NCT00617123|467292417|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
129815727|NCT00133952|467292419|FG000|Overall Study|Adverse Event|1|||
129815728|NCT00133952|467292420|FG001|Overall Study|Adverse Event|2|||
129815729|NCT00133952|467292419|FG000|Overall Study|Death|3|||
129815730|NCT00133952|467292420|FG001|Overall Study|Death|2|||
129815731|NCT00133952|467292419|FG000|Overall Study|Lost to Follow-up|9|||
129815732|NCT00133952|467292420|FG001|Overall Study|Lost to Follow-up|14|||
129815733|NCT00133952|467292419|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
129815734|NCT00133952|467292420|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
129815735|NCT00133952|467292419|FG000|Overall Study|Protocol Violation|1|||
129815736|NCT00133952|467292420|FG001|Overall Study|Protocol Violation|1|||
129815737|NCT00133952|467292419|FG000|Overall Study|Withdrawal by Subject|20|||
129815738|NCT00133952|467292420|FG001|Overall Study|Withdrawal by Subject|4|||
129815739|NCT00133952|467292419|FG000|Overall Study|Physician Decision|4|||
129815740|NCT00133952|467292420|FG001|Overall Study|Physician Decision|3|||
129815741|NCT00133952|467292419|FG000|Overall Study|Sponsor Decision|0|||
129815742|NCT00133952|467292420|FG001|Overall Study|Sponsor Decision|1|||
129815743|NCT00299104|467292421|FG000|Treatment Period|Adverse Event|14|||
129815744|NCT00299104|467292422|FG001|Treatment Period|Adverse Event|9|||
129815745|NCT00299104|467292423|FG002|Treatment Period|Adverse Event|7|||
129815746|NCT00299104|467292421|FG000|Treatment Period|Death|1|||
129815747|NCT00299104|467292422|FG001|Treatment Period|Death|1|||
129815748|NCT00299104|467292423|FG002|Treatment Period|Death|1|||
129815749|NCT00299104|467292421|FG000|Treatment Period|Insufficient therapeutic response|34|||
129815750|NCT00299104|467292422|FG001|Treatment Period|Insufficient therapeutic response|13|||
129815751|NCT00299104|467292423|FG002|Treatment Period|Insufficient therapeutic response|8|||
129815752|NCT00299104|467292421|FG000|Treatment Period|Failure to return|9|||
129815753|NCT00299104|467292422|FG001|Treatment Period|Failure to return|8|||
129815754|NCT00299104|467292423|FG002|Treatment Period|Failure to return|8|||
129815755|NCT00299104|467292421|FG000|Treatment Period|Violation of selection criteria|1|||
129815756|NCT00299104|467292422|FG001|Treatment Period|Violation of selection criteria|2|||
129815757|NCT00299104|467292423|FG002|Treatment Period|Violation of selection criteria|0|||
129815758|NCT00299104|467292421|FG000|Treatment Period|Protocol Violation|1|||
129815759|NCT00299104|467292422|FG001|Treatment Period|Protocol Violation|1|||
129815760|NCT00299104|467292423|FG002|Treatment Period|Protocol Violation|0|||
129815761|NCT00299104|467292421|FG000|Treatment Period|Refused treatment|9|||
129815762|NCT00299104|467292422|FG001|Treatment Period|Refused treatment|2|||
129815763|NCT00299104|467292423|FG002|Treatment Period|Refused treatment|2|||
129815764|NCT00299104|467292421|FG000|Treatment Period|Withdrew consent|14|||
129815765|NCT00299104|467292422|FG001|Treatment Period|Withdrew consent|19|||
129815766|NCT00299104|467292423|FG002|Treatment Period|Withdrew consent|9|||
129815767|NCT00299104|467292421|FG000|Treatment Period|Administrative reasons|106|||
129815768|NCT00299104|467292422|FG001|Treatment Period|Administrative reasons|120|||
129815769|NCT00299104|467292423|FG002|Treatment Period|Administrative reasons|137|||
129815770|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Death|3|||
129815771|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Death|2|||
129815772|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Death|1|||
129815773|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
129897104|NCT01458275|467582202|FG000|Overall Study|Adverse Event|3|||
129815774|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
129815775|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
129815776|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
129815777|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
129815778|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
129815779|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
129815780|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
129815781|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
129815782|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
129815783|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
129815784|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
129815785|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
129815786|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
129815787|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
129815788|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
129815789|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
129815790|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
129815791|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
129815792|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
129815793|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
129815794|NCT00847379|467292424|FG000|Overall Study|Study terminated by Sponsor|59|||
129815795|NCT00847379|467292425|FG001|Overall Study|Study terminated by Sponsor|57|||
129815796|NCT00847379|467292426|FG002|Overall Study|Study terminated by Sponsor|57|||
129815797|NCT00003499|467292427|FG000|Overall Study|Not evaluable|8|||
129815798|NCT01727297|467292428|FG000|Overall Study|Death|13|||
129815799|NCT01727297|467292429|FG001|Overall Study|Death|0|||
129815800|NCT01727297|467292428|FG000|Overall Study|Protocol Violation|1|||
129815801|NCT01727297|467292429|FG001|Overall Study|Protocol Violation|10|||
129815802|NCT01727297|467292428|FG000|Overall Study|Adverse Event|3|||
129815803|NCT01727297|467292429|FG001|Overall Study|Adverse Event|1|||
129815804|NCT01727297|467292428|FG000|Overall Study|Lost to Follow-up|11|||
129815805|NCT01727297|467292429|FG001|Overall Study|Lost to Follow-up|0|||
129815806|NCT01727297|467292428|FG000|Overall Study|Withdrawal by Subject|26|||
129815807|NCT01727297|467292429|FG001|Overall Study|Withdrawal by Subject|27|||
129815808|NCT01727297|467292428|FG000|Overall Study|Physician Decision|19|||
129815809|NCT01727297|467292429|FG001|Overall Study|Physician Decision|5|||
129815810|NCT01727297|467292428|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
129815811|NCT01727297|467292429|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
129815812|NCT02042183|467292430|FG000|Overall Study|Physician Decision|7|||
129815813|NCT02042183|467292431|FG001|Overall Study|Physician Decision|2|||
129815814|NCT02042183|467292430|FG000|Overall Study|Lack of Efficacy|4|||
129815815|NCT02042183|467292431|FG001|Overall Study|Lack of Efficacy|3|||
129815816|NCT02042183|467292430|FG000|Overall Study|Non-compliance with Study Drug|2|||
129815817|NCT02042183|467292431|FG001|Overall Study|Non-compliance with Study Drug|3|||
129815818|NCT02042183|467292430|FG000|Overall Study|Adverse Event|17|||
129815819|NCT02042183|467292431|FG001|Overall Study|Adverse Event|6|||
129815820|NCT02042183|467292430|FG000|Overall Study|Other|3|||
129815821|NCT02042183|467292431|FG001|Overall Study|Other|3|||
129815822|NCT02042183|467292430|FG000|Overall Study|Withdrawal by Subject|21|||
129815823|NCT02042183|467292431|FG001|Overall Study|Withdrawal by Subject|16|||
129815824|NCT02042183|467292430|FG000|Overall Study|Site Terminated by Sponsor|2|||
129815825|NCT02042183|467292431|FG001|Overall Study|Site Terminated by Sponsor|1|||
129815826|NCT02042183|467292430|FG000|Overall Study|Lost to Follow-up|9|||
129815827|NCT02042183|467292431|FG001|Overall Study|Lost to Follow-up|2|||
129815828|NCT02864498|467292432|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
129815829|NCT02864498|467292433|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
129815830|NCT02864498|467292434|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
129815831|NCT02864498|467292432|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
129815832|NCT02864498|467292433|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
129815833|NCT02864498|467292434|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
129815834|NCT02864498|467292432|FG000|Overall Study|Investigator Discretion|0|||
129815835|NCT02864498|467292433|FG001|Overall Study|Investigator Discretion|2|||
129815836|NCT02864498|467292434|FG002|Overall Study|Investigator Discretion|1|||
129815837|NCT02864498|467292432|FG000|Overall Study|Lost to Follow-up|8|||
130059006|NCT00511342|468170462|FG000|Overall Study|Pregnancy wish|0|||
129815838|NCT02864498|467292433|FG001|Overall Study|Lost to Follow-up|6|||
129815839|NCT02864498|467292434|FG002|Overall Study|Lost to Follow-up|3|||
129815840|NCT02864498|467292432|FG000|Overall Study|Lack of Efficacy|5|||
129815841|NCT02864498|467292433|FG001|Overall Study|Lack of Efficacy|3|||
129815842|NCT02864498|467292434|FG002|Overall Study|Lack of Efficacy|3|||
129815843|NCT02864498|467292432|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
129815844|NCT02864498|467292433|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
129815845|NCT02864498|467292434|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
130059007|NCT00511342|468170463|FG001|Overall Study|Pregnancy wish|1|||
130059008|NCT00511342|468170462|FG000|Overall Study|Lost to Follow-up|1|||
130059009|NCT00511342|468170463|FG001|Overall Study|Lost to Follow-up|5|||
129897105|NCT01458275|467582203|FG001|Overall Study|Adverse Event|4|||
130059010|NCT00511342|468170462|FG000|Overall Study|Other Reason|2|||
129815846|NCT02864498|467292432|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
129815847|NCT02864498|467292433|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
129815848|NCT02864498|467292434|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
129815849|NCT02864498|467292432|FG000|Overall Study|Subject moved out of the country.|0|||
129815850|NCT02864498|467292433|FG001|Overall Study|Subject moved out of the country.|0|||
129815851|NCT02864498|467292434|FG002|Overall Study|Subject moved out of the country.|1|||
129815852|NCT00378378|467292435|FG000|Overall Study|Withdrawal by Subject|0|||
129815853|NCT00378378|467292436|FG001|Overall Study|Withdrawal by Subject|1|||
129815854|NCT00378378|467292437|FG002|Overall Study|Withdrawal by Subject|0|||
129815855|NCT00378378|467292435|FG000|Overall Study|Treatment Failure|0|||
129815856|NCT00378378|467292436|FG001|Overall Study|Treatment Failure|0|||
129815857|NCT00378378|467292437|FG002|Overall Study|Treatment Failure|1|||
129815858|NCT00378378|467292435|FG000|Overall Study|Non-compliance with protocol|0|||
129815859|NCT00378378|467292436|FG001|Overall Study|Non-compliance with protocol|0|||
129815860|NCT00378378|467292437|FG002|Overall Study|Non-compliance with protocol|1|||
129815861|NCT03782792|467292440|FG000|Overall Study|Patient left the country|0|||
129815862|NCT03782792|467292441|FG001|Overall Study|Patient left the country|1|||
129815863|NCT03782792|467292440|FG000|Overall Study|Withdrawal by Subject|1|||
129815864|NCT03782792|467292441|FG001|Overall Study|Withdrawal by Subject|2|||
129815865|NCT00851747|467292443|FG000|Overall Study|Physician Decision|6|||
129815866|NCT00851747|467292444|FG001|Overall Study|Physician Decision|6|||
129815867|NCT00851747|467292445|FG002|Overall Study|Physician Decision|6|||
129815868|NCT01854710|467292446|FG000|Overall Study|Withdrawal by Subject|2|||
129815869|NCT01854710|467292447|FG001|Overall Study|Withdrawal by Subject|1|||
129815870|NCT01854710|467292448|FG002|Overall Study|Withdrawal by Subject|0|||
129815871|NCT01854710|467292449|FG003|Overall Study|Withdrawal by Subject|0|||
129815872|NCT01854710|467292450|FG004|Overall Study|Withdrawal by Subject|0|||
129815873|NCT01854710|467292451|FG005|Overall Study|Withdrawal by Subject|0|||
129815874|NCT01854710|467292446|FG000|Overall Study|CRI procedural error|2|||
129815875|NCT01854710|467292447|FG001|Overall Study|CRI procedural error|2|||
129815876|NCT01854710|467292448|FG002|Overall Study|CRI procedural error|2|||
129815877|NCT01854710|467292449|FG003|Overall Study|CRI procedural error|2|||
129815878|NCT01854710|467292450|FG004|Overall Study|CRI procedural error|2|||
129815879|NCT01854710|467292451|FG005|Overall Study|CRI procedural error|2|||
129815880|NCT00370032|467292452|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
129815881|NCT00370032|467292453|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
129815882|NCT00370032|467292452|FG000|Washout Period|Withdrawal by Subject|0|||
129815883|NCT00370032|467292453|FG001|Washout Period|Withdrawal by Subject|1|||
129815884|NCT00370032|467292452|FG000|Washout Period|Lost to Follow-up|0|||
129815885|NCT00370032|467292453|FG001|Washout Period|Lost to Follow-up|1|||
129815886|NCT00370032|467292452|FG000|Washout Period|Adverse Event|1|||
129815887|NCT00370032|467292453|FG001|Washout Period|Adverse Event|0|||
129815888|NCT00370032|467292452|FG000|Follow-up Period|Withdrawal by Subject|1|||
129815889|NCT00370032|467292453|FG001|Follow-up Period|Withdrawal by Subject|0|||
129815890|NCT01537393|467292454|FG000|Overall Study|Exclude prior to study|32|||
129815891|NCT01537393|467292455|FG001|Overall Study|Exclude prior to study|44|||
129815892|NCT01537393|467292454|FG000|Overall Study|Death|20|||
129815893|NCT01537393|467292455|FG001|Overall Study|Death|32|||
129815894|NCT01537393|467292454|FG000|Overall Study|Withdrawal by Subject|18|||
129815895|NCT01537393|467292455|FG001|Overall Study|Withdrawal by Subject|17|||
129815896|NCT01537393|467292454|FG000|Overall Study|Lost to Follow-up|53|||
129815897|NCT01537393|467292455|FG001|Overall Study|Lost to Follow-up|48|||
129815898|NCT01537393|467292454|FG000|Overall Study|Failure - Regrafted|28|||
129815899|NCT01537393|467292455|FG001|Overall Study|Failure - Regrafted|43|||
129815900|NCT01537393|467292454|FG000|Overall Study|Failure - Not regrafted|2|||
129815901|NCT01537393|467292455|FG001|Overall Study|Failure - Not regrafted|6|||
129815902|NCT01537393|467292454|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
129815903|NCT01537393|467292455|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
129815904|NCT01578187|467292456|FG000|Usability Phase|Withdrawal by Subject|1|||
129815905|NCT03208244|467292462|FG000|Overall Study|Death|1|||
129815906|NCT01709162|467292463|FG000|Overall Study|Disease progression|3|||
129815907|NCT01709162|467292464|FG001|Overall Study|Disease progression|3|||
129815908|NCT01709162|467292463|FG000|Overall Study|Study drug toxicity|2|||
129815909|NCT01709162|467292464|FG001|Overall Study|Study drug toxicity|0|||
129815910|NCT01709162|467292463|FG000|Overall Study|Administrative reason by sponsor|0|||
129815911|NCT01709162|467292464|FG001|Overall Study|Administrative reason by sponsor|1|||
129815912|NCT01709162|467292463|FG000|Overall Study|Other|1|||
129815913|NCT01709162|467292464|FG001|Overall Study|Other|0|||
129815914|NCT01709162|467292463|FG000|Overall Study|Withdrawal by Subject|0|||
129815915|NCT01709162|467292464|FG001|Overall Study|Withdrawal by Subject|1|||
129815916|NCT01844518|467292467|FG000|Overall Study|Adverse Event|7|||
129815917|NCT01844518|467292468|FG001|Overall Study|Adverse Event|1|||
129897106|NCT01458275|467582204|FG002|Overall Study|Adverse Event|1|||
129815918|NCT01844518|467292467|FG000|Overall Study|Lack of Efficacy|17|||
129815919|NCT01844518|467292468|FG001|Overall Study|Lack of Efficacy|5|||
130059011|NCT00511342|468170463|FG001|Overall Study|Other Reason|2|||
130059012|NCT05373706|468170466|FG000|Overall Study|Lost to Follow-up|2|||
130059013|NCT05373706|468170467|FG001|Overall Study|Lost to Follow-up|2|||
130059014|NCT03628508|468170471|FG000|Overall Study|Lost to Follow-up|1|||
130059015|NCT00807846|468170473|FG000|Overall Study|Adverse Event|5|||
130059016|NCT00807846|468170474|FG001|Overall Study|Adverse Event|0|||
130059017|NCT00807846|468170473|FG000|Overall Study|Lack of Efficacy|2|||
130059018|NCT00807846|468170474|FG001|Overall Study|Lack of Efficacy|0|||
129815920|NCT01844518|467292467|FG000|Overall Study|Participant's request to discontinue|4|||
129815921|NCT01844518|467292468|FG001|Overall Study|Participant's request to discontinue|1|||
129815922|NCT01844518|467292467|FG000|Overall Study|Poor/Non-compliance|1|||
129815923|NCT01844518|467292468|FG001|Overall Study|Poor/Non-compliance|0|||
129815924|NCT01844518|467292467|FG000|Overall Study|No Longer Met Study Criteria|2|||
129815925|NCT01844518|467292468|FG001|Overall Study|No Longer Met Study Criteria|0|||
129815926|NCT01844518|467292467|FG000|Overall Study|Withdrawal by Subject|9|||
129815927|NCT01844518|467292468|FG001|Overall Study|Withdrawal by Subject|0|||
129815928|NCT01844518|467292467|FG000|Overall Study|Pregnancy|1|||
129815929|NCT01844518|467292468|FG001|Overall Study|Pregnancy|0|||
129815930|NCT04584645|467292470|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
129815931|NCT04584645|467292471|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
129815932|NCT00390468|467292472|FG000|Overall Study|Protocol Violation|2|||
129815933|NCT00390468|467292472|FG000|Overall Study|Lack of Efficacy|1|||
129815934|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
129815935|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
129815936|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
129815937|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
129815938|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
129815939|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
129815940|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
129815941|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
129815942|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
129815943|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
129815944|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
129815945|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
129815946|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
129815947|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
129815948|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
129815949|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
129815950|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
129815951|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
129815952|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
129815953|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
129815954|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
129815955|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
129815956|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
129815957|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
129815958|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
129815959|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
129815960|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
129815961|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815962|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815963|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815964|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815965|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815966|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815967|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815968|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815969|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815970|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815971|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815972|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130059019|NCT00807846|468170473|FG000|Overall Study|Protocol Violation|2|||
130059020|NCT00807846|468170474|FG001|Overall Study|Protocol Violation|1|||
130059021|NCT00807846|468170473|FG000|Overall Study|Withdrawal by Subject|2|||
129815973|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815974|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815975|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130059022|NCT00807846|468170474|FG001|Overall Study|Withdrawal by Subject|1|||
130059023|NCT00807846|468170473|FG000|Overall Study|Other|1|||
129815976|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815977|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130059024|NCT00807846|468170474|FG001|Overall Study|Other|2|||
129815978|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
130059025|NCT01081873|468170475|FG000|Overall Study|Death|86|||
129815979|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815980|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815981|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815982|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815983|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815984|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815985|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815986|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
129815987|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
130059026|NCT01081873|468170475|FG000|Overall Study|Withdrawal by Subject|10|||
129815988|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815989|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815990|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815991|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815992|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815993|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815994|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815995|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815996|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815997|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815998|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815999|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816000|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816001|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816002|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816003|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816004|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816005|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816006|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816007|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816008|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816009|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816010|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816011|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816012|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
129816013|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
129816014|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816015|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816016|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816017|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816018|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816019|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816020|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816021|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816022|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816023|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816024|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816025|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816026|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816027|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816028|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816029|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816030|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816031|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816032|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816033|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816034|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816035|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816036|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816037|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816038|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
129897107|NCT01458275|467582202|FG000|Overall Study|Lost to Follow-up|3|||
130059027|NCT01081873|468170475|FG000|Overall Study|Lost to Follow-up|142|||
130059028|NCT01081873|468170475|FG000|Overall Study|Progression of prostate cancer|13|||
129816039|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
129816040|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816041|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816042|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816043|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816044|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816045|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816046|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816047|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816048|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816049|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816050|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816051|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816052|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816053|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816054|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816055|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816056|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816057|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816058|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816059|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816060|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816061|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816062|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816063|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816064|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816065|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816066|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
129816067|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
129816068|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816069|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
129816070|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816071|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816072|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816073|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816074|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816075|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816076|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816077|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816078|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816079|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816080|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816081|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816082|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816083|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816084|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816085|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816086|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816087|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816088|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816089|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816090|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Death|0|||
129816091|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Death|0|||
129816092|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Death|1|||
129816093|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Death|0|||
129816094|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Death|0|||
129816095|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Death|0|||
130059029|NCT01081873|468170475|FG000|Overall Study|Other|47|||
130059030|NCT03011840|468170477|FG000|Overall Study|Not received PIL in post PIL phase|0|||
130059031|NCT03011840|468170478|FG001|Overall Study|Not received PIL in post PIL phase|21|||
130059032|NCT02491073|468170479|FG000|Overall Study|screen failure|1|||
130059033|NCT02491073|468170480|FG001|Overall Study|screen failure|0|||
130059034|NCT03738566|468170481|FG000|Initial Study Phase|Withdrawal by Subject|1|||
130059035|NCT03738566|468170482|FG001|Initial Study Phase|Withdrawal by Subject|1|||
130059036|NCT03738566|468170483|FG002|Initial Study Phase|Withdrawal by Subject|2|||
130059037|NCT03738566|468170484|FG003|Initial Study Phase|Withdrawal by Subject|0|||
130059038|NCT03738566|468170481|FG000|Initial Study Phase|Death|0|||
130059039|NCT03738566|468170482|FG001|Initial Study Phase|Death|1|||
129816096|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Death|0|||
129816097|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Death|0|||
129816098|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Death|0|||
129897108|NCT01458275|467582203|FG001|Overall Study|Lost to Follow-up|2|||
129897109|NCT01458275|467582204|FG002|Overall Study|Lost to Follow-up|5|||
130059040|NCT03738566|468170483|FG002|Initial Study Phase|Death|0|||
130059041|NCT03738566|468170484|FG003|Initial Study Phase|Death|0|||
130059042|NCT03738566|468170481|FG000|Initial Study Phase|Treatment failure|5|||
129816099|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Death|0|||
129816100|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Death|0|||
129816101|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Death|0|||
129816102|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Death|0|||
129816103|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Death|0|||
129816104|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Death|0|||
129816105|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Death|0|||
129816106|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Death|0|||
129816107|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Death|0|||
129816108|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Death|0|||
129816109|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Death|0|||
129816110|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Death|0|||
129816111|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Death|0|||
129816112|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Death|0|||
129816113|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Death|0|||
129816114|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Death|0|||
129816115|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Death|0|||
129816116|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816117|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816118|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
129816119|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
129816120|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
129816121|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
129816122|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
129816123|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816124|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816125|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816126|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816127|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816128|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816129|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816130|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816131|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816132|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816133|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816134|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816135|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816136|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816137|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816138|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816139|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816140|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816141|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816142|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816143|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816144|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
129816145|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816146|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816147|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816148|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816149|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816150|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816151|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816152|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816153|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816154|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816155|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816156|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816157|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816158|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816159|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816160|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816161|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129897110|NCT01458275|467582202|FG000|Overall Study|Protocol Violation|5|||
129816162|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816163|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816164|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816165|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816166|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816167|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816168|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816169|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816170|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
129816171|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816172|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816173|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816174|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816175|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816176|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816177|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816178|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816179|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816180|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129897111|NCT01458275|467582203|FG001|Overall Study|Protocol Violation|5|||
129897112|NCT01458275|467582204|FG002|Overall Study|Protocol Violation|2|||
129897113|NCT01458275|467582202|FG000|Overall Study|Withdrawal by Subject|3|||
129897114|NCT01458275|467582203|FG001|Overall Study|Withdrawal by Subject|2|||
129897115|NCT01458275|467582204|FG002|Overall Study|Withdrawal by Subject|1|||
129897116|NCT02926937|467582205|FG000|Overall Study|Adverse Event|0|||
129897117|NCT02926937|467582206|FG001|Overall Study|Adverse Event|1|||
129897118|NCT02926937|467582207|FG002|Overall Study|Adverse Event|1|||
129897119|NCT02926937|467582205|FG000|Overall Study|Poor Compliance to Protocol|1|||
129897120|NCT02926937|467582206|FG001|Overall Study|Poor Compliance to Protocol|0|||
129897121|NCT02926937|467582207|FG002|Overall Study|Poor Compliance to Protocol|0|||
129897122|NCT02926937|467582205|FG000|Overall Study|Lost to Follow-up|4|||
129897123|NCT02926937|467582206|FG001|Overall Study|Lost to Follow-up|5|||
129897124|NCT02926937|467582207|FG002|Overall Study|Lost to Follow-up|0|||
129897125|NCT02926937|467582205|FG000|Overall Study|At the Participant's own Request|11|||
129897126|NCT02926937|467582206|FG001|Overall Study|At the Participant's own Request|5|||
129897127|NCT02926937|467582207|FG002|Overall Study|At the Participant's own Request|8|||
129897128|NCT02926937|467582205|FG000|Overall Study|Reason not Specified|3|||
129897129|NCT02926937|467582206|FG001|Overall Study|Reason not Specified|4|||
129897130|NCT02926937|467582207|FG002|Overall Study|Reason not Specified|2|||
129897131|NCT01559090|467582208|FG000|Stage I|Withdrawal by Subject|2|||
129897132|NCT01559090|467582209|FG001|Stage I|Withdrawal by Subject|2|||
129897133|NCT01559090|467582210|FG002|Stage I|Withdrawal by Subject|3|||
129897134|NCT01559090|467582208|FG000|Stage II|Withdrawal by Subject|1|||
129897135|NCT01559090|467582209|FG001|Stage II|Withdrawal by Subject|0|||
129897136|NCT01559090|467582210|FG002|Stage II|Withdrawal by Subject|0|||
129897137|NCT03722446|467582211|FG000|Overall Study|Protocol Violation|15|||
129897138|NCT03722446|467582212|FG001|Overall Study|Protocol Violation|2|||
129897139|NCT02908464|467582213|FG000|Overall Study|Withdrawal by Subject|2|||
129897140|NCT02908464|467582214|FG001|Overall Study|Withdrawal by Subject|1|||
129897141|NCT02908464|467582213|FG000|Overall Study|Found ineligible after randomization|0|||
129897142|NCT02908464|467582214|FG001|Overall Study|Found ineligible after randomization|2|||
129897143|NCT01168401|467584274|FG000|Overall Study|Lost to Follow-up|1|||
129897144|NCT01168401|467584275|FG001|Overall Study|Lost to Follow-up|1|||
129897145|NCT01168401|467584276|FG002|Overall Study|Lost to Follow-up|2|||
129897146|NCT01168401|467584277|FG003|Overall Study|Lost to Follow-up|1|||
129897147|NCT01168401|467584278|FG004|Overall Study|Lost to Follow-up|0|||
129816181|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816182|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816183|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816184|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816185|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816186|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816187|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816188|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816189|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129897148|NCT01168401|467584279|FG005|Overall Study|Lost to Follow-up|0|||
129897149|NCT01168401|467584280|FG006|Overall Study|Lost to Follow-up|0|||
129897150|NCT01168401|467584281|FG007|Overall Study|Lost to Follow-up|0|||
129897151|NCT01168401|467584282|FG008|Overall Study|Lost to Follow-up|0|||
129897152|NCT01168401|467584283|FG009|Overall Study|Lost to Follow-up|0|||
129897153|NCT01168401|467584284|FG010|Overall Study|Lost to Follow-up|0|||
129816190|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816191|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816192|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816193|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816194|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816195|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816196|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
129816197|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816198|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816199|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816200|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816201|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816202|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816203|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816204|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816205|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816206|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816207|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816208|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816209|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816210|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816211|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816212|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816213|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816214|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816215|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816216|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816217|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816218|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816219|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816220|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816221|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816222|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816223|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816224|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
129816225|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
129816226|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
129816227|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816228|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816229|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816230|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816231|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816232|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816233|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816234|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816235|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816236|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816237|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816238|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816239|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816240|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816241|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816242|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816243|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816244|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816245|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816246|NCT03129100|467292473|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816247|NCT03129100|467292474|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816248|NCT03129100|467292475|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816249|NCT03129100|467292476|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816250|NCT03129100|467292477|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816251|NCT03129100|467292478|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816252|NCT03129100|467292479|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816253|NCT03129100|467292480|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816254|NCT03129100|467292481|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816255|NCT03129100|467292482|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
129816256|NCT03129100|467292483|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816257|NCT03129100|467292484|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816258|NCT03129100|467292485|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816259|NCT03129100|467292486|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816260|NCT03129100|467292487|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816261|NCT03129100|467292488|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816262|NCT03129100|467292489|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816263|NCT03129100|467292490|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816264|NCT03129100|467292491|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816265|NCT03129100|467292492|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816266|NCT03129100|467292493|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816267|NCT03129100|467292494|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816268|NCT03129100|467292495|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816269|NCT03129100|467292496|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816270|NCT03129100|467292497|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816271|NCT03129100|467292498|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816272|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816273|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816274|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816275|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816276|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816277|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816278|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816279|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816280|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816281|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816282|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816283|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
129816284|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816285|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816286|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816287|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816288|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816289|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816290|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816291|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816292|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816293|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816294|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816295|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816296|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816297|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816298|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816299|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816300|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816301|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816302|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816303|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816304|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816305|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816306|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816307|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816308|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816309|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
129816310|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
129816311|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
129816312|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
129816313|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816314|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816315|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130059043|NCT03738566|468170482|FG001|Initial Study Phase|Treatment failure|0|||
130059044|NCT03738566|468170483|FG002|Initial Study Phase|Treatment failure|0|||
130059045|NCT03738566|468170484|FG003|Initial Study Phase|Treatment failure|0|||
130059046|NCT03738566|468170481|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
130059047|NCT03738566|468170482|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
130059048|NCT03738566|468170483|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
129816316|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816317|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130059049|NCT03738566|468170484|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
130059050|NCT01072539|468170485|FG000|Overall Study|Treated prior to the Site Initiation|1|||
130059051|NCT01072539|468170485|FG000|Overall Study|Protocol Violation|2|||
130059052|NCT00115804|468170486|FG000|Overall Study|Adverse Event|2|||
129816318|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816319|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816320|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816321|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
130112381|NCT02266706|468373358|FG000|Overall Study|Withdrawal by Subject|0|||
129816322|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816323|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816324|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816325|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816326|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816327|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816328|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816329|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816330|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816331|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816332|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816333|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816334|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816335|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
129816336|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816337|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
129816338|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
129816339|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816340|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816341|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816342|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816343|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816344|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816345|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816346|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816347|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816348|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816349|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816350|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816351|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816352|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816353|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816354|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816355|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816356|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816357|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816358|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816359|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816360|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816361|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816362|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816363|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816364|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816365|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
129816366|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129897154|NCT01168401|467584274|FG000|Overall Study|Withdrawal by Subject|0|||
130112382|NCT02266706|468373359|FG001|Overall Study|Withdrawal by Subject|1|||
129816367|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816368|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816369|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816370|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816371|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816372|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816373|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816374|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816375|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816376|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816377|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816378|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816379|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816380|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816381|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816382|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816383|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816384|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816385|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816386|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816387|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816388|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
129816389|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816390|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
129816391|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
129816392|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816393|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816394|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816395|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816396|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816397|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816398|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816399|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816400|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816401|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816402|NCT03129100|467292473|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816403|NCT03129100|467292474|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130059053|NCT01752842|468170487|FG000|Overall Study|Adverse Event|3|||
130059054|NCT01752842|468170488|FG001|Overall Study|Adverse Event|0|||
130059055|NCT01752842|468170487|FG000|Overall Study|Withdrawal by Subject|0|||
130059056|NCT01752842|468170488|FG001|Overall Study|Withdrawal by Subject|2|||
130059057|NCT01683071|468170489|FG000|Part 1|Lack of Efficacy|1|||
130059058|NCT01683071|468170490|FG001|Part 1|Lack of Efficacy|0|||
130059059|NCT01683071|468170491|FG002|Part 1|Lack of Efficacy|0|||
130059060|NCT01683071|468170492|FG003|Part 1|Lack of Efficacy|3|||
130059061|NCT01683071|468170493|FG004|Part 1|Lack of Efficacy|0|||
130059062|NCT01683071|468170494|FG005|Part 1|Lack of Efficacy|0|||
130059063|NCT01683071|468170489|FG000|Part 1|Withdrawal by Subject|1|||
130059064|NCT01683071|468170490|FG001|Part 1|Withdrawal by Subject|2|||
130059065|NCT01683071|468170491|FG002|Part 1|Withdrawal by Subject|2|||
130059066|NCT01683071|468170492|FG003|Part 1|Withdrawal by Subject|1|||
130059067|NCT01683071|468170493|FG004|Part 1|Withdrawal by Subject|0|||
130059068|NCT01683071|468170494|FG005|Part 1|Withdrawal by Subject|0|||
130059069|NCT01683071|468170489|FG000|Part 1|Surgery Cancelled|1|||
130059070|NCT01683071|468170490|FG001|Part 1|Surgery Cancelled|0|||
130059071|NCT01683071|468170491|FG002|Part 1|Surgery Cancelled|0|||
130059072|NCT01683071|468170492|FG003|Part 1|Surgery Cancelled|0|||
129816404|NCT03129100|467292475|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816405|NCT03129100|467292476|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816406|NCT03129100|467292477|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816407|NCT03129100|467292478|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816408|NCT03129100|467292479|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816409|NCT03129100|467292480|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816410|NCT03129100|467292481|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816411|NCT03129100|467292482|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816412|NCT03129100|467292483|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816413|NCT03129100|467292484|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130059073|NCT01683071|468170493|FG004|Part 1|Surgery Cancelled|0|||
130059074|NCT01683071|468170494|FG005|Part 1|Surgery Cancelled|0|||
130059075|NCT01683071|468170489|FG000|Part 1|Did not receive study drug|1|||
130059076|NCT01683071|468170490|FG001|Part 1|Did not receive study drug|0|||
129816414|NCT03129100|467292485|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816415|NCT03129100|467292486|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816416|NCT03129100|467292487|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816417|NCT03129100|467292488|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816418|NCT03129100|467292489|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816419|NCT03129100|467292490|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
129816420|NCT03129100|467292491|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
130059077|NCT01683071|468170491|FG002|Part 1|Did not receive study drug|0|||
130059078|NCT01683071|468170492|FG003|Part 1|Did not receive study drug|1|||
130059079|NCT01683071|468170493|FG004|Part 1|Did not receive study drug|0|||
130059080|NCT01683071|468170494|FG005|Part 1|Did not receive study drug|0|||
129816421|NCT03129100|467292492|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
129816422|NCT03129100|467292493|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816423|NCT03129100|467292494|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816424|NCT03129100|467292495|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816425|NCT03129100|467292496|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816426|NCT03129100|467292497|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816427|NCT03129100|467292498|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816428|NCT03129100|467292473|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816429|NCT03129100|467292474|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816430|NCT03129100|467292475|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816431|NCT03129100|467292476|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816432|NCT03129100|467292477|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816433|NCT03129100|467292478|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816434|NCT03129100|467292479|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816435|NCT03129100|467292480|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816436|NCT03129100|467292481|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816437|NCT03129100|467292482|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816438|NCT03129100|467292483|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816439|NCT03129100|467292484|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816440|NCT03129100|467292485|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816441|NCT03129100|467292486|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816442|NCT03129100|467292487|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816443|NCT03129100|467292488|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816444|NCT03129100|467292489|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816445|NCT03129100|467292490|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816446|NCT03129100|467292491|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816447|NCT03129100|467292492|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816448|NCT03129100|467292493|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
129816449|NCT03129100|467292494|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816450|NCT03129100|467292495|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816451|NCT03129100|467292496|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816452|NCT03129100|467292497|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816453|NCT03129100|467292498|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816454|NCT03129100|467292473|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
129816455|NCT03129100|467292474|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
129816456|NCT03129100|467292475|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
129816457|NCT03129100|467292476|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
129816458|NCT03129100|467292477|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
129816459|NCT03129100|467292478|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
129816460|NCT03129100|467292479|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
129816461|NCT03129100|467292480|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
129816462|NCT03129100|467292481|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
129816463|NCT03129100|467292482|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
129816464|NCT03129100|467292483|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
129816465|NCT03129100|467292484|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
129816466|NCT03129100|467292485|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
129816467|NCT03129100|467292486|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
129816468|NCT03129100|467292487|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
130059081|NCT01683071|468170489|FG000|Part 1|Early termination; met exclusion criteria|0|||
129816469|NCT03129100|467292488|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
129816470|NCT03129100|467292489|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
129816471|NCT03129100|467292490|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
129816472|NCT03129100|467292491|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
129816473|NCT03129100|467292492|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
129816474|NCT03129100|467292493|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
130059082|NCT01683071|468170490|FG001|Part 1|Early termination; met exclusion criteria|2|||
129816475|NCT03129100|467292494|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
129816476|NCT03129100|467292495|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
129816477|NCT03129100|467292496|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
129816478|NCT03129100|467292497|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
129816479|NCT03129100|467292498|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
129816480|NCT03129100|467292473|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816481|NCT03129100|467292474|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816482|NCT03129100|467292475|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816483|NCT03129100|467292476|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816484|NCT03129100|467292477|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816485|NCT03129100|467292478|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816486|NCT03129100|467292479|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816487|NCT03129100|467292480|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816488|NCT03129100|467292481|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816489|NCT03129100|467292482|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816490|NCT03129100|467292483|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816491|NCT03129100|467292484|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816492|NCT03129100|467292485|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816493|NCT03129100|467292486|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816494|NCT03129100|467292487|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816495|NCT03129100|467292488|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816496|NCT03129100|467292489|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816497|NCT03129100|467292490|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816498|NCT03129100|467292491|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816499|NCT03129100|467292492|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816500|NCT03129100|467292493|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
129816501|NCT03129100|467292494|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816502|NCT03129100|467292495|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816503|NCT03129100|467292496|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816504|NCT03129100|467292497|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816505|NCT03129100|467292498|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816506|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
129816507|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
129816508|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
129816509|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
129816510|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
129816511|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
129816512|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
129816513|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
129816514|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
129816515|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
129816516|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
129816517|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
129816518|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
129816519|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
129816520|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
129816521|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
129816522|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
129816523|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
129816524|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
129816525|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
129816526|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
129816527|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
129816528|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
129816529|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
129816530|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
129816531|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
129816532|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129897155|NCT01168401|467584275|FG001|Overall Study|Withdrawal by Subject|0|||
129897156|NCT01168401|467584276|FG002|Overall Study|Withdrawal by Subject|0|||
130059083|NCT01683071|468170491|FG002|Part 1|Early termination; met exclusion criteria|1|||
130059084|NCT01683071|468170492|FG003|Part 1|Early termination; met exclusion criteria|0|||
129816533|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816534|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816535|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816536|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816537|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816538|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816539|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816540|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816541|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816542|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129897157|NCT01168401|467584277|FG003|Overall Study|Withdrawal by Subject|1|||
129897158|NCT01168401|467584278|FG004|Overall Study|Withdrawal by Subject|0|||
129897159|NCT01168401|467584279|FG005|Overall Study|Withdrawal by Subject|0|||
129816543|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816544|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816545|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816546|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816547|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816548|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816549|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816550|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816551|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816552|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816553|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816554|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816555|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816556|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
130059085|NCT01683071|468170493|FG004|Part 1|Early termination; met exclusion criteria|0|||
130059086|NCT01683071|468170494|FG005|Part 1|Early termination; met exclusion criteria|0|||
130059087|NCT01683071|468170489|FG000|Part 2|Lack of Efficacy|0|||
130059088|NCT01683071|468170490|FG001|Part 2|Lack of Efficacy|0|||
129816557|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
129816558|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816559|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816560|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816561|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816562|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130059089|NCT01683071|468170491|FG002|Part 2|Lack of Efficacy|0|||
130059090|NCT01683071|468170492|FG003|Part 2|Lack of Efficacy|0|||
130059091|NCT01683071|468170493|FG004|Part 2|Lack of Efficacy|3|||
130059092|NCT01683071|468170494|FG005|Part 2|Lack of Efficacy|4|||
130059093|NCT01683071|468170489|FG000|Part 2|Lost to Follow-up|0|||
130059094|NCT01683071|468170490|FG001|Part 2|Lost to Follow-up|0|||
130059095|NCT01683071|468170491|FG002|Part 2|Lost to Follow-up|0|||
130059096|NCT01683071|468170492|FG003|Part 2|Lost to Follow-up|0|||
130059097|NCT01683071|468170493|FG004|Part 2|Lost to Follow-up|2|||
130059098|NCT01683071|468170494|FG005|Part 2|Lost to Follow-up|0|||
130059099|NCT01683071|468170489|FG000|Part 2|Withdrawal by Subject|0|||
130059100|NCT01683071|468170490|FG001|Part 2|Withdrawal by Subject|0|||
130059101|NCT01683071|468170491|FG002|Part 2|Withdrawal by Subject|0|||
130059102|NCT01683071|468170492|FG003|Part 2|Withdrawal by Subject|0|||
130059103|NCT01683071|468170493|FG004|Part 2|Withdrawal by Subject|3|||
130059104|NCT01683071|468170494|FG005|Part 2|Withdrawal by Subject|3|||
130059105|NCT01683071|468170489|FG000|Part 2|Surgery cancelled|0|||
130059106|NCT01683071|468170490|FG001|Part 2|Surgery cancelled|0|||
130059107|NCT01683071|468170491|FG002|Part 2|Surgery cancelled|0|||
130059108|NCT01683071|468170492|FG003|Part 2|Surgery cancelled|0|||
130059109|NCT01683071|468170493|FG004|Part 2|Surgery cancelled|4|||
130059110|NCT01683071|468170494|FG005|Part 2|Surgery cancelled|2|||
130059111|NCT01683071|468170489|FG000|Part 2|Did not receive study drug|0|||
130059112|NCT01683071|468170490|FG001|Part 2|Did not receive study drug|0|||
130059113|NCT01683071|468170491|FG002|Part 2|Did not receive study drug|0|||
130059114|NCT01683071|468170492|FG003|Part 2|Did not receive study drug|0|||
130059115|NCT01683071|468170493|FG004|Part 2|Did not receive study drug|2|||
130059116|NCT01683071|468170494|FG005|Part 2|Did not receive study drug|1|||
130059117|NCT01683071|468170489|FG000|Part 2|Met exclusion criterion|0|||
130059118|NCT01683071|468170490|FG001|Part 2|Met exclusion criterion|0|||
130059119|NCT01683071|468170491|FG002|Part 2|Met exclusion criterion|0|||
130059120|NCT01683071|468170492|FG003|Part 2|Met exclusion criterion|0|||
130059121|NCT01683071|468170493|FG004|Part 2|Met exclusion criterion|1|||
130059122|NCT01683071|468170494|FG005|Part 2|Met exclusion criterion|1|||
130059123|NCT01683071|468170489|FG000|Part 2|Protocol deviation|0|||
130059124|NCT01683071|468170490|FG001|Part 2|Protocol deviation|0|||
129816563|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816564|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816565|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816566|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130059125|NCT01683071|468170491|FG002|Part 2|Protocol deviation|0|||
130059126|NCT01683071|468170492|FG003|Part 2|Protocol deviation|0|||
130059127|NCT01683071|468170493|FG004|Part 2|Protocol deviation|1|||
129816567|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816568|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816569|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816570|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130059128|NCT01683071|468170494|FG005|Part 2|Protocol deviation|2|||
130059129|NCT01683071|468170489|FG000|Part 2|Withdrawal by investigator decision|0|||
130059130|NCT01683071|468170490|FG001|Part 2|Withdrawal by investigator decision|0|||
130059131|NCT01683071|468170491|FG002|Part 2|Withdrawal by investigator decision|0|||
129816571|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
130059132|NCT01683071|468170492|FG003|Part 2|Withdrawal by investigator decision|0|||
130059133|NCT01683071|468170493|FG004|Part 2|Withdrawal by investigator decision|1|||
130059134|NCT01683071|468170494|FG005|Part 2|Withdrawal by investigator decision|2|||
130059135|NCT01968187|468170495|FG000|Overall Study|Adverse Event|0|||
130059136|NCT01968187|468170496|FG001|Overall Study|Adverse Event|1|||
129816572|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816573|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816574|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816575|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816576|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816577|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816578|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816579|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816580|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816581|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
129816582|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
129816583|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
129816584|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816585|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816586|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816587|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816588|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816589|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816590|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816591|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816592|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816593|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816594|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816595|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816596|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816597|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816598|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816599|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816600|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816601|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816602|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816603|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816604|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816605|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816606|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816607|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816608|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
129816609|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816610|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816611|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816612|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816613|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816614|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816615|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816616|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816617|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816618|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816619|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816620|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816621|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816622|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816623|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130059137|NCT01968187|468170495|FG000|Overall Study|Randomized but not treated|1|||
130059138|NCT01968187|468170496|FG001|Overall Study|Randomized but not treated|0|||
130059139|NCT01877382|468170497|FG000|Dose Escalation|Progressive disease|2|||
129816624|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816625|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816626|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
130059140|NCT01877382|468170498|FG001|Dose Escalation|Progressive disease|0|||
130059141|NCT01877382|468170499|FG002|Dose Escalation|Progressive disease|1|||
130059142|NCT01877382|468170500|FG003|Dose Escalation|Progressive disease|6|||
129816627|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816628|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816629|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816630|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816631|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816632|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816633|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816634|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816635|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
129816636|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
129816637|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
129816638|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
129816639|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
129816640|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
129816641|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
129816642|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
129816643|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
129816644|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
129816645|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
129816646|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
129816647|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
129816648|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
129816649|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
129816650|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
129816651|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
129816652|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
129816653|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
129816654|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
129816655|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
129816656|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
129816657|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
129816658|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
129816659|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
129816660|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
129816661|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
129816662|NCT03845985|467292499|FG000|Overall Study|Lost to Follow-up|2|||
129816663|NCT03845985|467292500|FG001|Overall Study|Lost to Follow-up|1|||
129816664|NCT03845985|467292499|FG000|Overall Study|Physician Decision|1|||
129816665|NCT03845985|467292500|FG001|Overall Study|Physician Decision|0|||
129816666|NCT03845985|467292499|FG000|Overall Study|Withdrawal by Subject|4|||
129816667|NCT03845985|467292500|FG001|Overall Study|Withdrawal by Subject|1|||
129816668|NCT03302234|467292505|FG000|Overall Study|Death|191|||
129816669|NCT03302234|467292506|FG001|Overall Study|Death|192|||
129816670|NCT03302234|467292505|FG000|Overall Study|Withdrawal by Subject|2|||
129816671|NCT03302234|467292506|FG001|Overall Study|Withdrawal by Subject|2|||
129816672|NCT03302234|467292505|FG000|Overall Study|Sponsor Decision|90|||
129816673|NCT03302234|467292506|FG001|Overall Study|Sponsor Decision|89|||
129816674|NCT03302234|467292505|FG000|Overall Study|Laryngeal carcinoma|0|||
129816675|NCT03302234|467292506|FG001|Overall Study|Laryngeal carcinoma|1|||
129816676|NCT03302234|467292505|FG000|Overall Study|Not Reported|1|||
129816677|NCT03302234|467292506|FG001|Overall Study|Not Reported|0|||
129816678|NCT02795832|467292509|FG000|Overall Study|Adverse Event|0|||
129816679|NCT02795832|467292510|FG001|Overall Study|Adverse Event|0|||
129816680|NCT02795832|467292511|FG002|Overall Study|Adverse Event|0|||
129816681|NCT02795832|467292512|FG003|Overall Study|Adverse Event|0|||
129816682|NCT02795832|467292513|FG004|Overall Study|Adverse Event|0|||
129816683|NCT02795832|467292514|FG005|Overall Study|Adverse Event|3|||
129816684|NCT04523220|467292515|FG000|Main Treatment Period|Physician Decision|1|||
129816685|NCT04523220|467292516|FG001|Main Treatment Period|Physician Decision|1|||
129816686|NCT04523220|467292517|FG002|Main Treatment Period|Physician Decision|0|||
129816687|NCT04523220|467292515|FG000|Main Treatment Period|Other|5|||
129816688|NCT04523220|467292516|FG001|Main Treatment Period|Other|2|||
129816689|NCT04523220|467292517|FG002|Main Treatment Period|Other|4|||
129816690|NCT04523220|467292515|FG000|Main Treatment Period|Subject Decision|5|||
129816691|NCT04523220|467292516|FG001|Main Treatment Period|Subject Decision|7|||
129816692|NCT04523220|467292517|FG002|Main Treatment Period|Subject Decision|3|||
129816693|NCT04523220|467292515|FG000|Main Treatment Period|Death|5|||
129816694|NCT04523220|467292516|FG001|Main Treatment Period|Death|11|||
130059143|NCT01877382|468170501|FG004|Dose Escalation|Progressive disease|1|||
130059144|NCT01877382|468170502|FG005|Dose Escalation|Progressive disease|0|||
130059145|NCT01877382|468170503|FG006|Dose Escalation|Progressive disease|3|||
129816695|NCT04523220|467292517|FG002|Main Treatment Period|Death|4|||
129816696|NCT04523220|467292515|FG000|Main Treatment Period|Adverse Event|11|||
129816697|NCT04523220|467292516|FG001|Main Treatment Period|Adverse Event|9|||
129816698|NCT04523220|467292517|FG002|Main Treatment Period|Adverse Event|9|||
129816699|NCT04523220|467292515|FG000|Main Treatment Period|Withdrawal by Subject|3|||
129816700|NCT04523220|467292516|FG001|Main Treatment Period|Withdrawal by Subject|3|||
129816701|NCT04523220|467292517|FG002|Main Treatment Period|Withdrawal by Subject|4|||
129816702|NCT04523220|467292515|FG000|Main Treatment Period|Study drug never adminstered|10|||
129816703|NCT04523220|467292516|FG001|Main Treatment Period|Study drug never adminstered|3|||
129816704|NCT04523220|467292517|FG002|Main Treatment Period|Study drug never adminstered|5|||
129816705|NCT04523220|467292515|FG000|Extension Treatment Period|Physician Decision|1|||
129816706|NCT04523220|467292516|FG001|Extension Treatment Period|Physician Decision|0|||
129816707|NCT04523220|467292517|FG002|Extension Treatment Period|Physician Decision|3|||
129816708|NCT04523220|467292515|FG000|Extension Treatment Period|Other|2|||
129816709|NCT04523220|467292516|FG001|Extension Treatment Period|Other|6|||
129816710|NCT04523220|467292517|FG002|Extension Treatment Period|Other|6|||
129816711|NCT04523220|467292515|FG000|Extension Treatment Period|Subject Decision|5|||
129816712|NCT04523220|467292516|FG001|Extension Treatment Period|Subject Decision|2|||
129816713|NCT04523220|467292517|FG002|Extension Treatment Period|Subject Decision|4|||
129816714|NCT04523220|467292515|FG000|Extension Treatment Period|Death|6|||
129816715|NCT04523220|467292516|FG001|Extension Treatment Period|Death|4|||
129816716|NCT04523220|467292517|FG002|Extension Treatment Period|Death|7|||
129816717|NCT04523220|467292515|FG000|Extension Treatment Period|Adverse Event|6|||
129816718|NCT04523220|467292516|FG001|Extension Treatment Period|Adverse Event|7|||
129816719|NCT04523220|467292517|FG002|Extension Treatment Period|Adverse Event|9|||
129816720|NCT04523220|467292515|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
129816721|NCT04523220|467292516|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
129816722|NCT04523220|467292517|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
129816723|NCT04523220|467292515|FG000|Extension Treatment Period|Study drug never administered|0|||
129816724|NCT04523220|467292516|FG001|Extension Treatment Period|Study drug never administered|1|||
129816725|NCT04523220|467292517|FG002|Extension Treatment Period|Study drug never administered|0|||
129816726|NCT00571948|467292518|FG000|Overall Study|Lost to Follow-up|2|||
129816727|NCT00571948|467292519|FG001|Overall Study|Lost to Follow-up|0|||
129816728|NCT00571948|467292518|FG000|Overall Study|Withdrawal by Subject|1|||
129816729|NCT00571948|467292519|FG001|Overall Study|Withdrawal by Subject|2|||
129816730|NCT00571948|467292518|FG000|Overall Study|Protocol Violation|3|||
129816731|NCT00571948|467292519|FG001|Overall Study|Protocol Violation|3|||
129816732|NCT00571948|467292518|FG000|Overall Study|infant refused study meal|3|||
129816733|NCT00571948|467292519|FG001|Overall Study|infant refused study meal|4|||
129816734|NCT00571948|467292518|FG000|Overall Study|Parent were afraid of blood colection|2|||
129816735|NCT00571948|467292519|FG001|Overall Study|Parent were afraid of blood colection|5|||
129816736|NCT04112784|467292520|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
129816737|NCT04112784|467292520|FG000|Overall Study|Screen Failures|4|||
129816738|NCT00256750|467292521|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
129816739|NCT00256750|467292522|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
129816740|NCT00256750|467292523|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
129816741|NCT00256750|467292521|FG000|Transplanted Pre-Treatment|Other|2|||
129816742|NCT00256750|467292522|FG001|Transplanted Pre-Treatment|Other|0|||
129816743|NCT00256750|467292523|FG002|Transplanted Pre-Treatment|Other|0|||
129816744|NCT00256750|467292521|FG000|Transplanted Pre-Treatment|Death|1|||
129816745|NCT00256750|467292522|FG001|Transplanted Pre-Treatment|Death|0|||
129816746|NCT00256750|467292523|FG002|Transplanted Pre-Treatment|Death|0|||
129816747|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
129816748|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
129816749|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
129816750|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Death|3|||
129816751|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Death|2|||
129816752|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Death|4|||
129816753|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
129816754|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
130059146|NCT01877382|468170504|FG007|Dose Escalation|Progressive disease|10|||
130059147|NCT01877382|468170505|FG008|Dose Escalation|Progressive disease|4|||
130059148|NCT01877382|468170506|FG009|Dose Escalation|Progressive disease|2|||
130059149|NCT01877382|468170507|FG010|Dose Escalation|Progressive disease|3|||
129816755|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
129816756|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
129816757|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
129816758|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
129816759|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Other|5|||
129816760|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Other|4|||
129816761|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Other|2|||
130059150|NCT01877382|468170508|FG011|Dose Escalation|Progressive disease|3|||
130059151|NCT01877382|468170509|FG012|Dose Escalation|Progressive disease|13|||
129816762|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
129816763|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
129816764|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
129816765|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
129816766|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
129816767|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
129816768|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
129816769|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
129816770|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
129816771|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
129816772|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
129816773|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
129816774|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Death|3|||
129816775|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Death|0|||
129816776|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Death|0|||
129816777|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
129816778|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
129816779|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
129816780|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Other|2|||
129816781|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Other|0|||
129816782|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Other|1|||
129816783|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
129816784|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
129816785|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
129816786|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
129816787|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
129816788|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
129816789|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Death|0|||
129816790|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Death|2|||
129816791|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Death|1|||
129816792|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
129816793|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
129816794|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
129816795|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
129816796|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
129816797|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
129816798|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
129816799|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
129816800|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
129816801|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Other|0|||
129816802|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Other|1|||
129816803|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Other|1|||
129816804|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
129816805|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
129816806|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
129816807|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
129816808|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
129816809|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
129816810|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
129816811|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
129816812|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
129816813|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
129816814|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
129816815|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
129816816|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
129816817|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
129816818|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
129816819|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
129816820|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
129816821|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
129816822|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
129816823|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
129816824|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
129816825|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
129816826|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
129816827|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
129816828|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
129816829|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
129816830|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
129816831|NCT00211510|467292524|FG000|Overall Study|Physician Decision|3|||
129816832|NCT00211510|467292525|FG001|Overall Study|Physician Decision|1|||
129816833|NCT00211510|467292524|FG000|Overall Study|Withdrawal by Subject|3|||
129816834|NCT00211510|467292525|FG001|Overall Study|Withdrawal by Subject|1|||
129816835|NCT01962896|467292526|FG000|Overall Study|Lack of Efficacy|4|||
129816836|NCT01949506|467292529|FG000|Overall Study|Physician Decision|1|||
129816837|NCT02915016|467292530|FG000|Overall Study|Lost to Follow-up|4|||
129816838|NCT02915016|467292531|FG001|Overall Study|Lost to Follow-up|2|||
129816839|NCT02915016|467292532|FG002|Overall Study|Lost to Follow-up|5|||
129816840|NCT02915016|467292533|FG003|Overall Study|Lost to Follow-up|3|||
129816841|NCT02915016|467292534|FG004|Overall Study|Lost to Follow-up|5|||
129816842|NCT02915016|467292535|FG005|Overall Study|Lost to Follow-up|2|||
129816843|NCT02915016|467292536|FG006|Overall Study|Lost to Follow-up|8|||
129816844|NCT02915016|467292537|FG007|Overall Study|Lost to Follow-up|2|||
129816845|NCT02915016|467292530|FG000|Overall Study|Physician Decision|0|||
129816846|NCT02915016|467292531|FG001|Overall Study|Physician Decision|0|||
129816847|NCT02915016|467292532|FG002|Overall Study|Physician Decision|1|||
129816848|NCT02915016|467292533|FG003|Overall Study|Physician Decision|0|||
129816849|NCT02915016|467292534|FG004|Overall Study|Physician Decision|0|||
129816850|NCT02915016|467292535|FG005|Overall Study|Physician Decision|1|||
129816851|NCT02915016|467292536|FG006|Overall Study|Physician Decision|2|||
129816852|NCT02915016|467292537|FG007|Overall Study|Physician Decision|0|||
129816853|NCT02915016|467292530|FG000|Overall Study|Withdrawal by Subject|2|||
129816854|NCT02915016|467292531|FG001|Overall Study|Withdrawal by Subject|0|||
129816855|NCT02915016|467292532|FG002|Overall Study|Withdrawal by Subject|1|||
129816856|NCT02915016|467292533|FG003|Overall Study|Withdrawal by Subject|0|||
129816857|NCT02915016|467292534|FG004|Overall Study|Withdrawal by Subject|1|||
129816858|NCT02915016|467292535|FG005|Overall Study|Withdrawal by Subject|3|||
129816859|NCT02915016|467292536|FG006|Overall Study|Withdrawal by Subject|1|||
129816860|NCT02915016|467292537|FG007|Overall Study|Withdrawal by Subject|1|||
129816861|NCT02915016|467292530|FG000|Overall Study|Elected not to continue|0|||
129816862|NCT02915016|467292531|FG001|Overall Study|Elected not to continue|0|||
129816863|NCT02915016|467292532|FG002|Overall Study|Elected not to continue|0|||
129816864|NCT02915016|467292533|FG003|Overall Study|Elected not to continue|1|||
129816865|NCT02915016|467292534|FG004|Overall Study|Elected not to continue|0|||
129816866|NCT02915016|467292535|FG005|Overall Study|Elected not to continue|0|||
129816867|NCT02915016|467292536|FG006|Overall Study|Elected not to continue|1|||
129816868|NCT02915016|467292537|FG007|Overall Study|Elected not to continue|0|||
129816869|NCT02915016|467292530|FG000|Overall Study|HIV infection|1|||
129816870|NCT02915016|467292531|FG001|Overall Study|HIV infection|1|||
129816871|NCT02915016|467292532|FG002|Overall Study|HIV infection|1|||
129816872|NCT02915016|467292533|FG003|Overall Study|HIV infection|0|||
129816873|NCT02915016|467292534|FG004|Overall Study|HIV infection|1|||
129816874|NCT02915016|467292535|FG005|Overall Study|HIV infection|0|||
129816875|NCT02915016|467292536|FG006|Overall Study|HIV infection|0|||
129816876|NCT02915016|467292537|FG007|Overall Study|HIV infection|0|||
129816877|NCT02915016|467292530|FG000|Overall Study|Participant unable to adhere|0|||
129816878|NCT02915016|467292531|FG001|Overall Study|Participant unable to adhere|0|||
129816879|NCT02915016|467292532|FG002|Overall Study|Participant unable to adhere|0|||
129816880|NCT02915016|467292533|FG003|Overall Study|Participant unable to adhere|0|||
129816881|NCT02915016|467292534|FG004|Overall Study|Participant unable to adhere|0|||
129816882|NCT02915016|467292535|FG005|Overall Study|Participant unable to adhere|0|||
129816883|NCT02915016|467292536|FG006|Overall Study|Participant unable to adhere|0|||
129816884|NCT02915016|467292537|FG007|Overall Study|Participant unable to adhere|1|||
129816885|NCT05425745|467292547|FG000|Overall Study|Withdrawal of Consent|3|||
129816886|NCT05425745|467292548|FG001|Overall Study|Withdrawal of Consent|3|||
129816887|NCT05425745|467292547|FG000|Overall Study|Death|2|||
129816888|NCT05425745|467292548|FG001|Overall Study|Death|3|||
129816889|NCT05425745|467292547|FG000|Overall Study|Lost to Follow-up|1|||
129816890|NCT05425745|467292548|FG001|Overall Study|Lost to Follow-up|2|||
129816891|NCT05425745|467292547|FG000|Overall Study|Adverse Event|0|||
129816892|NCT05425745|467292548|FG001|Overall Study|Adverse Event|1|||
129816893|NCT05425745|467292547|FG000|Overall Study|Did not return for end of study visit|0|||
129816894|NCT05425745|467292548|FG001|Overall Study|Did not return for end of study visit|1|||
129816895|NCT05425745|467292547|FG000|Overall Study|End of study visit completed by phone|1|||
129816896|NCT05425745|467292548|FG001|Overall Study|End of study visit completed by phone|0|||
129816897|NCT05425745|467292547|FG000|Overall Study|Subject decision|1|||
129816898|NCT05425745|467292548|FG001|Overall Study|Subject decision|0|||
129816899|NCT02820753|467294152|FG000|2 Month|Withdrawal by Subject|3|||
129816900|NCT02820753|467294153|FG001|2 Month|Withdrawal by Subject|3|||
129816901|NCT02820753|467294152|FG000|2 Month|Lost to Follow-up|24|||
129816902|NCT02820753|467294153|FG001|2 Month|Lost to Follow-up|26|||
129816903|NCT02820753|467294152|FG000|2 Month|Stopped per NIH Hold|51|||
129816904|NCT02820753|467294153|FG001|2 Month|Stopped per NIH Hold|13|||
129816905|NCT02820753|467294152|FG000|6 Month|Withdrawal by Subject|2|||
129816906|NCT02820753|467294153|FG001|6 Month|Withdrawal by Subject|2|||
129816907|NCT02820753|467294152|FG000|6 Month|Lost to Follow-up|20|||
129816908|NCT02820753|467294153|FG001|6 Month|Lost to Follow-up|27|||
129816909|NCT02820753|467294152|FG000|6 Month|Stopped per NIH Hold|81|||
129816910|NCT02820753|467294153|FG001|6 Month|Stopped per NIH Hold|81|||
129816911|NCT02820753|467294152|FG000|6 Month|Death|0|||
129816912|NCT02820753|467294153|FG001|6 Month|Death|1|||
129816913|NCT02161731|467294154|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
129816914|NCT02161731|467294155|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
129816915|NCT02161731|467294154|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
129816916|NCT02161731|467294155|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
129816917|NCT03761277|467294156|FG000|Enrollment to Implant|Screen Failure|17|||
129816918|NCT03761277|467294156|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
129816919|NCT03761277|467294156|FG000|Enrollment to Implant|Physician Decision|2|||
129816920|NCT03761277|467294156|FG000|Enrollment to Implant|Site Closure|3|||
129816921|NCT03761277|467294156|FG000|Enrollment to Implant|Sponsor Request|2|||
129816922|NCT03761277|467294156|FG000|Post-Implant to 6 Months|Adverse Event|2|||
129816923|NCT03761277|467294156|FG000|Post-Implant to 6 Months|Death|1|||
129816924|NCT03761277|467294156|FG000|Post-Implant to 6 Months|Site Closure|2|||
129816925|NCT03761277|467294156|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
129816926|NCT03761277|467294156|FG000|6 Months to 12 Months|Physician Decision|2|||
129816927|NCT03761277|467294156|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
129816928|NCT02155608|467294157|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
129816929|NCT02155608|467294158|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
129816930|NCT02155608|467294157|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
129816931|NCT02155608|467294158|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
129816932|NCT01532414|467294159|FG000|Overall Study|Lost to Follow-up|3|||
129816933|NCT01532414|467294160|FG001|Overall Study|Lost to Follow-up|0|||
129816934|NCT01532414|467294161|FG002|Overall Study|Lost to Follow-up|1|||
129816935|NCT01532414|467294159|FG000|Overall Study|Withdrawal by Subject|3|||
129816936|NCT01532414|467294160|FG001|Overall Study|Withdrawal by Subject|0|||
129816937|NCT01532414|467294161|FG002|Overall Study|Withdrawal by Subject|0|||
129816938|NCT01532414|467294159|FG000|Overall Study|No V6 semen sample|0|||
129816939|NCT01532414|467294160|FG001|Overall Study|No V6 semen sample|1|||
129816940|NCT01532414|467294161|FG002|Overall Study|No V6 semen sample|0|||
129816941|NCT01532414|467294159|FG000|Overall Study|Adverse Event|0|||
129816942|NCT01532414|467294160|FG001|Overall Study|Adverse Event|1|||
129816943|NCT01532414|467294161|FG002|Overall Study|Adverse Event|1|||
129816944|NCT01532414|467294159|FG000|Overall Study|Unable to complete 24 hour PK|0|||
129816945|NCT01532414|467294160|FG001|Overall Study|Unable to complete 24 hour PK|0|||
129816946|NCT01532414|467294161|FG002|Overall Study|Unable to complete 24 hour PK|1|||
129816947|NCT01532414|467294159|FG000|Overall Study|Withdrawn by sponsor|1|||
129816948|NCT01532414|467294160|FG001|Overall Study|Withdrawn by sponsor|0|||
129816949|NCT01532414|467294161|FG002|Overall Study|Withdrawn by sponsor|0|||
129816950|NCT00429273|467294165|FG000|Overall Study|Lost to Follow-up|1|||
129816951|NCT00429273|467294166|FG001|Overall Study|Lost to Follow-up|2|||
129816952|NCT00429273|467294167|FG002|Overall Study|Lost to Follow-up|2|||
129816953|NCT00429273|467294165|FG000|Overall Study|Physician Decision|6|||
129816954|NCT00429273|467294166|FG001|Overall Study|Physician Decision|5|||
129816955|NCT00429273|467294167|FG002|Overall Study|Physician Decision|5|||
129816956|NCT00429273|467294165|FG000|Overall Study|Adverse Event|1|||
129816957|NCT00429273|467294166|FG001|Overall Study|Adverse Event|1|||
129816958|NCT00429273|467294167|FG002|Overall Study|Adverse Event|2|||
129816959|NCT01438957|467294168|FG000|Overall Study|Physician Decision|1|||
129816960|NCT01438957|467294169|FG001|Overall Study|Physician Decision|1|||
129816961|NCT01438957|467294170|FG002|Overall Study|Physician Decision|0|||
129816962|NCT01438957|467294171|FG003|Overall Study|Physician Decision|1|||
129816963|NCT01438957|467294172|FG004|Overall Study|Physician Decision|0|||
129816964|NCT03052725|467294173|FG000|Overall Study|Adverse Event|2|||
129816965|NCT03052725|467294174|FG001|Overall Study|Adverse Event|0|||
129816966|NCT03052725|467294173|FG000|Overall Study|Withdrawal by Subject|3|||
129816967|NCT03052725|467294174|FG001|Overall Study|Withdrawal by Subject|4|||
129816968|NCT03052725|467294173|FG000|Overall Study|Pregnancy|0|||
129816969|NCT03052725|467294174|FG001|Overall Study|Pregnancy|1|||
129816970|NCT03052725|467294173|FG000|Overall Study|Site closure|0|||
129816971|NCT03052725|467294174|FG001|Overall Study|Site closure|1|||
129816972|NCT03052725|467294173|FG000|Overall Study|Study terminated by sponsor|143|||
129816973|NCT03052725|467294174|FG001|Overall Study|Study terminated by sponsor|144|||
129816974|NCT00727025|467294180|FG000|Overall Study|Physician Decision|23|||
129816975|NCT02548650|467294187|FG000|Triple Therapy|Adverse Event|1|||
129816976|NCT02548650|467294188|FG001|Triple Therapy|Adverse Event|0|||
129816977|NCT02548650|467294187|FG000|Triple Therapy|Withdrawal by Subject|0|||
129816978|NCT02548650|467294188|FG001|Triple Therapy|Withdrawal by Subject|4|||
129816979|NCT02548650|467294187|FG000|Double Therapy|Adverse Event|1|||
129816980|NCT02548650|467294188|FG001|Double Therapy|Adverse Event|1|||
129816981|NCT02548650|467294187|FG000|Double Therapy|Withdrawal by Subject|0|||
129816982|NCT02548650|467294188|FG001|Double Therapy|Withdrawal by Subject|1|||
129816983|NCT01909674|467294189|FG000|Overall Study|Withdrawal by Subject|5|||
129816984|NCT01909674|467294190|FG001|Overall Study|Withdrawal by Subject|2|||
129816985|NCT00521014|467294191|FG000|Overall Study|Inevaluable, not treated|1|||
129816986|NCT02969369|467294192|FG000|Study|Adverse Event|1|||
129816987|NCT02969369|467294193|FG001|Study|Adverse Event|6|||
129816988|NCT02969369|467294192|FG000|Study|Lack of Efficacy|0|||
130059152|NCT01877382|468170510|FG013|Dose Escalation|Progressive disease|1|||
130059153|NCT01877382|468170511|FG014|Dose Escalation|Progressive disease|0|||
130059154|NCT01877382|468170497|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
130059155|NCT01877382|468170498|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059156|NCT01877382|468170499|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059157|NCT01877382|468170500|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
129816989|NCT02969369|467294193|FG001|Study|Lack of Efficacy|1|||
129816990|NCT02969369|467294192|FG000|Study|Lost to Follow-up|0|||
129816991|NCT02969369|467294193|FG001|Study|Lost to Follow-up|1|||
129816992|NCT02969369|467294192|FG000|Study|Withdrawal by Subject|3|||
129816993|NCT02969369|467294193|FG001|Study|Withdrawal by Subject|5|||
129816994|NCT02969369|467294192|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
129816995|NCT02969369|467294193|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
129816996|NCT02969369|467294192|FG000|Double-blind Period|Adverse Event|1|||
129816997|NCT02969369|467294193|FG001|Double-blind Period|Adverse Event|5|||
129816998|NCT02969369|467294192|FG000|Double-blind Period|Lost to Follow-up|0|||
129816999|NCT02969369|467294193|FG001|Double-blind Period|Lost to Follow-up|1|||
129817000|NCT02969369|467294192|FG000|Double-blind Period|Withdrawal by Subject|2|||
129817001|NCT02969369|467294193|FG001|Double-blind Period|Withdrawal by Subject|3|||
129817002|NCT02969369|467294192|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
129817003|NCT02969369|467294193|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
129817004|NCT02969369|467294192|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
129817005|NCT02969369|467294193|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
129817006|NCT02969369|467294192|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
129817007|NCT02969369|467294193|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
129817008|NCT02969369|467294192|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
129817009|NCT02969369|467294193|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
129817010|NCT04390191|467294194|FG000|Overall Study|Withdrawal by Subject|1|||
129817011|NCT04390191|467294195|FG001|Overall Study|Withdrawal by Subject|0|||
129817012|NCT02794883|467294196|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
129817013|NCT02794883|467294197|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
129817014|NCT02794883|467294198|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
129817015|NCT02794883|467294196|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
129817016|NCT02794883|467294197|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
129817017|NCT02794883|467294198|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
129817018|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
129817019|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
129817020|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
129817021|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
129817022|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
129817023|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
129817024|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
129817025|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
129817026|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
129817027|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
129817028|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
129817029|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
129817030|NCT02794883|467294196|FG000|Follow-up Period (up to 2 Years)|Death|12|||
129817031|NCT02794883|467294197|FG001|Follow-up Period (up to 2 Years)|Death|10|||
129817032|NCT02794883|467294198|FG002|Follow-up Period (up to 2 Years)|Death|10|||
129817033|NCT03978832|467294199|FG000|Overall Study|Adverse Event|1|||
129817034|NCT03978832|467294199|FG000|Overall Study|Lost to Follow-up|1|||
129817035|NCT03978832|467294199|FG000|Overall Study|Withdrawal by Subject|6|||
129817036|NCT03978832|467294199|FG000|Overall Study|Physician Decision|2|||
129817037|NCT03978832|467294199|FG000|Overall Study|did not pass screening criteria|44|||
129817038|NCT00407797|467294206|FG000|Overall Study|Lost to Follow-up|2|||
129817039|NCT00407797|467294206|FG000|Overall Study|Adverse Event|6|||
129817040|NCT00407797|467294206|FG000|Overall Study|Other|7|||
129817041|NCT00407797|467294206|FG000|Overall Study|Withdrawal by Subject|3|||
129817042|NCT01812174|467294207|FG000|Overall Study|Death|1|||
129817043|NCT01812174|467294208|FG001|Overall Study|Death|0|||
129817044|NCT01812174|467294207|FG000|Overall Study|Protocol Violation|2|||
129817045|NCT01812174|467294208|FG001|Overall Study|Protocol Violation|0|||
129817046|NCT03132220|467294210|FG000|Overall Study|Lost to Follow-up|17|||
129817047|NCT03132220|467294211|FG001|Overall Study|Lost to Follow-up|8|||
129817048|NCT03132220|467294210|FG000|Overall Study|Withdrawal by Subject|1|||
129817049|NCT03132220|467294211|FG001|Overall Study|Withdrawal by Subject|4|||
129817050|NCT01051323|467294214|FG000|Overall Study|Discontinuation of treatment|103|||
129817051|NCT01051323|467294214|FG000|Overall Study|Transplantation|28|||
129897160|NCT01168401|467584280|FG006|Overall Study|Withdrawal by Subject|0|||
129817052|NCT01051323|467294214|FG000|Overall Study|Dialysis dependency|22|||
129817053|NCT01051323|467294214|FG000|Overall Study|Withdrawal by Subject|13|||
129817054|NCT01051323|467294214|FG000|Overall Study|Lost to Follow-up|31|||
129817055|NCT01051323|467294214|FG000|Overall Study|Death|129|||
129817056|NCT01051323|467294214|FG000|Overall Study|Hospitalization|28|||
129817057|NCT01051323|467294214|FG000|Overall Study|Other|148|||
129817058|NCT01051323|467294214|FG000|Overall Study|Missing|37|||
129817059|NCT00601458|467294215|FG000|Overall Study|Dosing Error|1|||
129817060|NCT00601458|467294216|FG001|Overall Study|Dosing Error|0|||
129817061|NCT00601458|467294217|FG002|Overall Study|Dosing Error|0|||
129817062|NCT00601458|467294215|FG000|Overall Study|Incomplete Data|0|||
129817063|NCT00601458|467294216|FG001|Overall Study|Incomplete Data|2|||
129817064|NCT00601458|467294217|FG002|Overall Study|Incomplete Data|0|||
129817065|NCT00601458|467294215|FG000|Overall Study|Protocol Violation|3|||
129817066|NCT00601458|467294216|FG001|Overall Study|Protocol Violation|2|||
129817067|NCT00601458|467294217|FG002|Overall Study|Protocol Violation|1|||
129817068|NCT00601458|467294215|FG000|Overall Study|Early Termination|0|||
129817069|NCT00601458|467294216|FG001|Overall Study|Early Termination|1|||
129817070|NCT00601458|467294217|FG002|Overall Study|Early Termination|1|||
129817071|NCT00518986|467294218|FG000|Overall Study|Adverse Event|12|||
129817072|NCT00518986|467294219|FG001|Overall Study|Adverse Event|7|||
129817073|NCT00518986|467294218|FG000|Overall Study|Lack of Efficacy|0|||
129817074|NCT00518986|467294219|FG001|Overall Study|Lack of Efficacy|2|||
129817075|NCT00518986|467294218|FG000|Overall Study|Lost to Follow-up|3|||
129817076|NCT00518986|467294219|FG001|Overall Study|Lost to Follow-up|2|||
129817077|NCT00518986|467294218|FG000|Overall Study|Physician Decision|0|||
129817078|NCT00518986|467294219|FG001|Overall Study|Physician Decision|3|||
129817079|NCT00518986|467294218|FG000|Overall Study|Protocol Violation|5|||
129817080|NCT00518986|467294219|FG001|Overall Study|Protocol Violation|7|||
129817081|NCT00518986|467294218|FG000|Overall Study|Withdrawal by Subject|4|||
129817082|NCT00518986|467294219|FG001|Overall Study|Withdrawal by Subject|4|||
129817083|NCT00518986|467294218|FG000|Overall Study|Non-Specific|2|||
129817084|NCT00518986|467294219|FG001|Overall Study|Non-Specific|1|||
129817085|NCT05683249|467294220|FG000|Overall Study|Adverse Event|3|||
129817086|NCT05683249|467294221|FG001|Overall Study|Adverse Event|1|||
129817087|NCT05683249|467294220|FG000|Overall Study|Lack of Efficacy|0|||
129817088|NCT05683249|467294221|FG001|Overall Study|Lack of Efficacy|2|||
129817089|NCT05683249|467294220|FG000|Overall Study|Lost to Follow-up|6|||
129817090|NCT05683249|467294221|FG001|Overall Study|Lost to Follow-up|5|||
129817091|NCT05683249|467294220|FG000|Overall Study|Non-compliance with Study Drug|2|||
129817092|NCT05683249|467294221|FG001|Overall Study|Non-compliance with Study Drug|0|||
129817093|NCT05683249|467294220|FG000|Overall Study|Protocol Violation|6|||
129817094|NCT05683249|467294221|FG001|Overall Study|Protocol Violation|3|||
129817095|NCT05683249|467294220|FG000|Overall Study|Withdrawal by Subject|9|||
129817096|NCT05683249|467294221|FG001|Overall Study|Withdrawal by Subject|8|||
129817097|NCT05683249|467294220|FG000|Overall Study|Other|0|||
129817098|NCT05683249|467294221|FG001|Overall Study|Other|2|||
129817099|NCT05229406|467294222|FG000|Overall Study|Withdrawal by Subject|1|||
129817100|NCT05229406|467294223|FG001|Overall Study|Withdrawal by Subject|2|||
129817101|NCT01637272|467294225|FG000|Overall Study|Adverse Event|6|||
129817102|NCT01637272|467294225|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129817103|NCT01637272|467294225|FG000|Overall Study|Withdrawal by Subject|3|||
129817104|NCT01637272|467294225|FG000|Overall Study|Lost to Follow-up|2|||
129817105|NCT01637272|467294225|FG000|Overall Study|completed core, did not enter ext. phase|4|||
129817106|NCT01637272|467294225|FG000|Overall Study|Administrative problems|1|||
129817107|NCT01637272|467294225|FG000|Overall Study|Protocol Violation|2|||
129817108|NCT01496612|467294226|FG000|1st Intervention|Adverse Event|1|||
129817109|NCT01496612|467294227|FG001|1st Intervention|Adverse Event|0|||
129817110|NCT01496612|467294226|FG000|1st Intervention|Withdrawal by Subject|1|||
129817111|NCT01496612|467294227|FG001|1st Intervention|Withdrawal by Subject|0|||
129817112|NCT03708328|467294235|FG000|Overall Study|Death|3|||
129817113|NCT03708328|467294236|FG001|Overall Study|Death|3|||
129817114|NCT03708328|467294237|FG002|Overall Study|Death|4|||
129817115|NCT03708328|467294238|FG003|Overall Study|Death|2|||
129817116|NCT03708328|467294239|FG004|Overall Study|Death|2|||
129817117|NCT03708328|467294240|FG005|Overall Study|Death|13|||
129817118|NCT03708328|467294241|FG006|Overall Study|Death|26|||
129817119|NCT03708328|467294242|FG007|Overall Study|Death|18|||
129817120|NCT03708328|467294243|FG008|Overall Study|Death|13|||
129817121|NCT03708328|467294244|FG009|Overall Study|Death|8|||
129817122|NCT03708328|467294235|FG000|Overall Study|Lost to Follow-up|0|||
129817123|NCT03708328|467294236|FG001|Overall Study|Lost to Follow-up|1|||
129817124|NCT03708328|467294237|FG002|Overall Study|Lost to Follow-up|0|||
129817125|NCT03708328|467294238|FG003|Overall Study|Lost to Follow-up|1|||
129817126|NCT03708328|467294239|FG004|Overall Study|Lost to Follow-up|0|||
129817127|NCT03708328|467294240|FG005|Overall Study|Lost to Follow-up|3|||
129817128|NCT03708328|467294241|FG006|Overall Study|Lost to Follow-up|3|||
129817129|NCT03708328|467294242|FG007|Overall Study|Lost to Follow-up|0|||
129817130|NCT03708328|467294243|FG008|Overall Study|Lost to Follow-up|0|||
129817131|NCT03708328|467294244|FG009|Overall Study|Lost to Follow-up|1|||
129817132|NCT03708328|467294235|FG000|Overall Study|Physician Decision|0|||
129817133|NCT03708328|467294236|FG001|Overall Study|Physician Decision|0|||
129817134|NCT03708328|467294237|FG002|Overall Study|Physician Decision|0|||
129817135|NCT03708328|467294238|FG003|Overall Study|Physician Decision|0|||
129817136|NCT03708328|467294239|FG004|Overall Study|Physician Decision|0|||
129817137|NCT03708328|467294240|FG005|Overall Study|Physician Decision|1|||
129817138|NCT03708328|467294241|FG006|Overall Study|Physician Decision|0|||
129817139|NCT03708328|467294242|FG007|Overall Study|Physician Decision|0|||
129817140|NCT03708328|467294243|FG008|Overall Study|Physician Decision|0|||
129817141|NCT03708328|467294244|FG009|Overall Study|Physician Decision|0|||
129817142|NCT03708328|467294235|FG000|Overall Study|Withdrawal by Subject|0|||
129817143|NCT03708328|467294236|FG001|Overall Study|Withdrawal by Subject|0|||
129817144|NCT03708328|467294237|FG002|Overall Study|Withdrawal by Subject|0|||
129817145|NCT03708328|467294238|FG003|Overall Study|Withdrawal by Subject|0|||
129817146|NCT03708328|467294239|FG004|Overall Study|Withdrawal by Subject|1|||
129817147|NCT03708328|467294240|FG005|Overall Study|Withdrawal by Subject|0|||
129817148|NCT03708328|467294241|FG006|Overall Study|Withdrawal by Subject|2|||
129817149|NCT03708328|467294242|FG007|Overall Study|Withdrawal by Subject|4|||
129817150|NCT03708328|467294243|FG008|Overall Study|Withdrawal by Subject|1|||
129817151|NCT03708328|467294244|FG009|Overall Study|Withdrawal by Subject|5|||
129817152|NCT03708328|467294235|FG000|Overall Study|Study Closed Locally|0|||
129817153|NCT03708328|467294236|FG001|Overall Study|Study Closed Locally|0|||
129817154|NCT03708328|467294237|FG002|Overall Study|Study Closed Locally|0|||
129817155|NCT03708328|467294238|FG003|Overall Study|Study Closed Locally|0|||
129817156|NCT03708328|467294239|FG004|Overall Study|Study Closed Locally|0|||
129817157|NCT03708328|467294240|FG005|Overall Study|Study Closed Locally|0|||
129817158|NCT03708328|467294241|FG006|Overall Study|Study Closed Locally|0|||
129817159|NCT03708328|467294242|FG007|Overall Study|Study Closed Locally|1|||
129817160|NCT03708328|467294243|FG008|Overall Study|Study Closed Locally|0|||
129817161|NCT03708328|467294244|FG009|Overall Study|Study Closed Locally|0|||
129817162|NCT03708328|467294235|FG000|Overall Study|Study Ended By Sponsor|0|||
129817163|NCT03708328|467294236|FG001|Overall Study|Study Ended By Sponsor|0|||
129817164|NCT03708328|467294237|FG002|Overall Study|Study Ended By Sponsor|0|||
129817165|NCT03708328|467294238|FG003|Overall Study|Study Ended By Sponsor|0|||
129817166|NCT03708328|467294239|FG004|Overall Study|Study Ended By Sponsor|0|||
129817167|NCT03708328|467294240|FG005|Overall Study|Study Ended By Sponsor|1|||
129817168|NCT03708328|467294241|FG006|Overall Study|Study Ended By Sponsor|0|||
129817169|NCT03708328|467294242|FG007|Overall Study|Study Ended By Sponsor|1|||
129817170|NCT03708328|467294243|FG008|Overall Study|Study Ended By Sponsor|0|||
129897161|NCT01168401|467584281|FG007|Overall Study|Withdrawal by Subject|0|||
129897162|NCT01168401|467584282|FG008|Overall Study|Withdrawal by Subject|0|||
129897163|NCT01168401|467584283|FG009|Overall Study|Withdrawal by Subject|0|||
129897164|NCT01168401|467584284|FG010|Overall Study|Withdrawal by Subject|0|||
129897165|NCT00672256|467584286|FG000|Overall Study|PI dropped, bad data|44|||
129897166|NCT01268891|467584294|FG000|Overall Study|Adverse Event|3|||
129897167|NCT01268891|467584295|FG001|Overall Study|Adverse Event|7|||
129897168|NCT01268891|467584294|FG000|Overall Study|Lack of Efficacy|1|||
129897169|NCT01268891|467584295|FG001|Overall Study|Lack of Efficacy|0|||
129897170|NCT01268891|467584294|FG000|Overall Study|Withdrawal of Consent|3|||
129897171|NCT01268891|467584295|FG001|Overall Study|Withdrawal of Consent|1|||
129897172|NCT01268891|467584294|FG000|Overall Study|Administrative or other reason(s)|1|||
129897173|NCT01268891|467584295|FG001|Overall Study|Administrative or other reason(s)|0|||
129897174|NCT00991276|467584296|FG000|First Intervention Period|Adverse Event|0|||
129897175|NCT00991276|467584297|FG001|First Intervention Period|Adverse Event|1|||
129897176|NCT00991276|467584298|FG002|First Intervention Period|Adverse Event|0|||
129897177|NCT00991276|467584299|FG003|First Intervention Period|Adverse Event|1|||
129897178|NCT00991276|467584300|FG004|First Intervention Period|Adverse Event|0|||
129897179|NCT00991276|467584301|FG005|First Intervention Period|Adverse Event|0|||
129897180|NCT00991276|467584296|FG000|First Intervention Period|Protocol Violation|0|||
129897181|NCT00991276|467584297|FG001|First Intervention Period|Protocol Violation|0|||
129897182|NCT00991276|467584298|FG002|First Intervention Period|Protocol Violation|0|||
129897183|NCT00991276|467584299|FG003|First Intervention Period|Protocol Violation|0|||
129897184|NCT00991276|467584300|FG004|First Intervention Period|Protocol Violation|2|||
129897185|NCT00991276|467584301|FG005|First Intervention Period|Protocol Violation|0|||
129897186|NCT00991276|467584296|FG000|First Intervention Period|Insufficient clinical response|0|||
129897187|NCT00991276|467584297|FG001|First Intervention Period|Insufficient clinical response|0|||
129817171|NCT03708328|467294244|FG009|Overall Study|Study Ended By Sponsor|0|||
129817172|NCT03708328|467294235|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817173|NCT03708328|467294236|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817174|NCT03708328|467294237|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129897188|NCT00991276|467584298|FG002|First Intervention Period|Insufficient clinical response|0|||
129897189|NCT00991276|467584299|FG003|First Intervention Period|Insufficient clinical response|0|||
129897190|NCT00991276|467584300|FG004|First Intervention Period|Insufficient clinical response|1|||
129897191|NCT00991276|467584301|FG005|First Intervention Period|Insufficient clinical response|0|||
129817175|NCT03708328|467294238|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817176|NCT03708328|467294239|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817177|NCT03708328|467294240|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817178|NCT03708328|467294241|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817179|NCT03708328|467294242|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817180|NCT03708328|467294243|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
130059158|NCT01877382|468170501|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059159|NCT01877382|468170502|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059160|NCT01877382|468170503|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
130059161|NCT01877382|468170504|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059162|NCT01877382|468170505|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059163|NCT01877382|468170506|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129817181|NCT03708328|467294244|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817182|NCT02695329|467294247|FG000|Overall Study|Adverse Event|1|||
129817183|NCT02695329|467294248|FG001|Overall Study|Adverse Event|0|||
129817184|NCT02695329|467294247|FG000|Overall Study|Poor X-ray quality for measurement|4|||
129817185|NCT02695329|467294248|FG001|Overall Study|Poor X-ray quality for measurement|5|||
129817186|NCT03648983|467294250|FG000|Overall Study|Study was terminated due to PI departure|95|||
129817187|NCT01269463|467294251|FG000|First Intervention|Withdrawal by Subject|1|||
129817188|NCT01269463|467294252|FG001|First Intervention|Withdrawal by Subject|0|||
129817189|NCT01269463|467294251|FG000|First Intervention|Adverse Event|1|||
129817190|NCT01269463|467294252|FG001|First Intervention|Adverse Event|0|||
129817191|NCT01269463|467294251|FG000|First Intervention|Lack of Efficacy|0|||
129817192|NCT01269463|467294252|FG001|First Intervention|Lack of Efficacy|1|||
129817193|NCT01269463|467294251|FG000|First Intervention|Physician Decision|0|||
129817194|NCT01269463|467294252|FG001|First Intervention|Physician Decision|1|||
129817195|NCT04404361|467294256|FG000|Overall Study|Death|12|||
129817196|NCT04404361|467294257|FG001|Overall Study|Death|12|||
129817197|NCT04404361|467294256|FG000|Overall Study|Withdrawal by Subject|13|||
129817198|NCT04404361|467294257|FG001|Overall Study|Withdrawal by Subject|5|||
129817199|NCT04404361|467294256|FG000|Overall Study|Lost to Follow-up|6|||
129817200|NCT04404361|467294257|FG001|Overall Study|Lost to Follow-up|3|||
129817201|NCT04404361|467294256|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
129817202|NCT04404361|467294257|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
129817203|NCT02862171|467294258|FG000|Overall Study|Death|1|||
129817204|NCT02862171|467294258|FG000|Overall Study|Lost to Follow-up|13|||
129817205|NCT02862171|467294258|FG000|Overall Study|Withdrawal by Subject|57|||
129817206|NCT02862171|467294258|FG000|Overall Study|Non-compliance|4|||
129817207|NCT02862171|467294258|FG000|Overall Study|HIV-1 seroconversion|18|||
129817208|NCT02549937|467294260|FG000|Overall Study|Death|0|||
129817209|NCT02549937|467294261|FG001|Overall Study|Death|1|||
129817210|NCT02549937|467294262|FG002|Overall Study|Death|0|||
129817211|NCT02549937|467294263|FG003|Overall Study|Death|1|||
129817212|NCT02549937|467294264|FG004|Overall Study|Death|0|||
129817213|NCT02549937|467294265|FG005|Overall Study|Death|8|||
129817214|NCT02549937|467294266|FG006|Overall Study|Death|0|||
129817215|NCT02549937|467294267|FG007|Overall Study|Death|0|||
129817216|NCT02549937|467294268|FG008|Overall Study|Death|19|||
129817217|NCT02549937|467294260|FG000|Overall Study|No follow up required|3|||
129817218|NCT02549937|467294261|FG001|Overall Study|No follow up required|6|||
129897192|NCT00991276|467584296|FG000|First Intervention Period|Other|0|||
129897193|NCT00991276|467584297|FG001|First Intervention Period|Other|0|||
129897194|NCT00991276|467584298|FG002|First Intervention Period|Other|0|||
129897195|NCT00991276|467584299|FG003|First Intervention Period|Other|1|||
129897196|NCT00991276|467584300|FG004|First Intervention Period|Other|1|||
129897197|NCT00991276|467584301|FG005|First Intervention Period|Other|0|||
129897198|NCT00991276|467584296|FG000|First Intervention Period|Withdrawal by Subject|0|||
129897199|NCT00991276|467584297|FG001|First Intervention Period|Withdrawal by Subject|1|||
129897200|NCT00991276|467584298|FG002|First Intervention Period|Withdrawal by Subject|0|||
129897201|NCT00991276|467584299|FG003|First Intervention Period|Withdrawal by Subject|1|||
129897202|NCT00991276|467584300|FG004|First Intervention Period|Withdrawal by Subject|0|||
129897203|NCT00991276|467584301|FG005|First Intervention Period|Withdrawal by Subject|1|||
129897204|NCT00991276|467584296|FG000|First Intervention Period|Lost to Follow-up|0|||
129897205|NCT00991276|467584297|FG001|First Intervention Period|Lost to Follow-up|1|||
129817219|NCT02549937|467294262|FG002|Overall Study|No follow up required|3|||
129817220|NCT02549937|467294263|FG003|Overall Study|No follow up required|8|||
129897206|NCT00991276|467584298|FG002|First Intervention Period|Lost to Follow-up|0|||
129897207|NCT00991276|467584299|FG003|First Intervention Period|Lost to Follow-up|1|||
129897208|NCT00991276|467584300|FG004|First Intervention Period|Lost to Follow-up|0|||
129897209|NCT00991276|467584301|FG005|First Intervention Period|Lost to Follow-up|0|||
129897210|NCT00991276|467584296|FG000|Second Intervention Period|Adverse Event|0|||
129897211|NCT00991276|467584297|FG001|Second Intervention Period|Adverse Event|2|||
129817221|NCT02549937|467294264|FG004|Overall Study|No follow up required|12|||
129817222|NCT02549937|467294265|FG005|Overall Study|No follow up required|21|||
129817223|NCT02549937|467294266|FG006|Overall Study|No follow up required|9|||
129817224|NCT02549937|467294267|FG007|Overall Study|No follow up required|11|||
129817225|NCT02549937|467294268|FG008|Overall Study|No follow up required|0|||
129817226|NCT02549937|467294260|FG000|Overall Study|Other|0|||
129817227|NCT02549937|467294261|FG001|Overall Study|Other|0|||
129817228|NCT02549937|467294262|FG002|Overall Study|Other|0|||
129817229|NCT02549937|467294263|FG003|Overall Study|Other|0|||
129817230|NCT02549937|467294264|FG004|Overall Study|Other|1|||
129817231|NCT02549937|467294265|FG005|Overall Study|Other|0|||
129817232|NCT02549937|467294266|FG006|Overall Study|Other|3|||
129817233|NCT02549937|467294267|FG007|Overall Study|Other|2|||
129817234|NCT02549937|467294268|FG008|Overall Study|Other|3|||
129817235|NCT02549937|467294260|FG000|Overall Study|Lost to Follow-up|0|||
129817236|NCT02549937|467294261|FG001|Overall Study|Lost to Follow-up|0|||
129817237|NCT02549937|467294262|FG002|Overall Study|Lost to Follow-up|0|||
129817238|NCT02549937|467294263|FG003|Overall Study|Lost to Follow-up|0|||
129817239|NCT02549937|467294264|FG004|Overall Study|Lost to Follow-up|0|||
129817240|NCT02549937|467294265|FG005|Overall Study|Lost to Follow-up|0|||
129817241|NCT02549937|467294266|FG006|Overall Study|Lost to Follow-up|0|||
129817242|NCT02549937|467294267|FG007|Overall Study|Lost to Follow-up|0|||
129817243|NCT02549937|467294268|FG008|Overall Study|Lost to Follow-up|3|||
129817244|NCT02549937|467294260|FG000|Overall Study|Withdrawal by Subject|0|||
129817245|NCT02549937|467294261|FG001|Overall Study|Withdrawal by Subject|0|||
129817246|NCT02549937|467294262|FG002|Overall Study|Withdrawal by Subject|0|||
129817247|NCT02549937|467294263|FG003|Overall Study|Withdrawal by Subject|0|||
129817248|NCT02549937|467294264|FG004|Overall Study|Withdrawal by Subject|0|||
129817249|NCT02549937|467294265|FG005|Overall Study|Withdrawal by Subject|1|||
129817250|NCT02549937|467294266|FG006|Overall Study|Withdrawal by Subject|4|||
129817251|NCT02549937|467294267|FG007|Overall Study|Withdrawal by Subject|3|||
129817252|NCT02549937|467294268|FG008|Overall Study|Withdrawal by Subject|2|||
129817253|NCT02549937|467294260|FG000|Overall Study|Sponsor Decision|0|||
129817254|NCT02549937|467294261|FG001|Overall Study|Sponsor Decision|0|||
129817255|NCT02549937|467294262|FG002|Overall Study|Sponsor Decision|0|||
129817256|NCT02549937|467294263|FG003|Overall Study|Sponsor Decision|0|||
129817257|NCT02549937|467294264|FG004|Overall Study|Sponsor Decision|0|||
129817258|NCT02549937|467294265|FG005|Overall Study|Sponsor Decision|0|||
129817259|NCT02549937|467294266|FG006|Overall Study|Sponsor Decision|0|||
129817260|NCT02549937|467294267|FG007|Overall Study|Sponsor Decision|0|||
129817261|NCT02549937|467294268|FG008|Overall Study|Sponsor Decision|6|||
129817262|NCT03930797|467294269|FG000|Overall Study|Lost to Follow-up|3|||
129817263|NCT03930797|467294270|FG001|Overall Study|Lost to Follow-up|10|||
129817264|NCT00662012|467294271|FG000|Overall Study|Lost to Follow-up|85|||
129817265|NCT00662012|467294271|FG000|Overall Study|Death|1|||
129817266|NCT00662012|467294271|FG000|Overall Study|Withdrawal by Subject|1|||
129817267|NCT02144012|467294274|FG000|Overall Study|Adverse Event|1|||
129817268|NCT02144012|467294275|FG001|Overall Study|Adverse Event|0|||
129817269|NCT02144012|467294274|FG000|Overall Study|Death|1|||
129817270|NCT02144012|467294275|FG001|Overall Study|Death|0|||
129817271|NCT02144012|467294274|FG000|Overall Study|Withdrawal by Subject|11|||
129817272|NCT02144012|467294275|FG001|Overall Study|Withdrawal by Subject|3|||
129817273|NCT02144012|467294274|FG000|Overall Study|Study Terminated by Sponsor|18|||
129817274|NCT02144012|467294275|FG001|Overall Study|Study Terminated by Sponsor|12|||
129817275|NCT02144012|467294274|FG000|Overall Study|Other|3|||
129817276|NCT02144012|467294275|FG001|Overall Study|Other|0|||
129817277|NCT02674529|467295840|FG000|Overall Study|Lost to Follow-up|1|||
129817278|NCT02674529|467295841|FG001|Overall Study|Lost to Follow-up|2|||
129817279|NCT02674529|467295840|FG000|Overall Study|Withdrawal by Subject|2|||
129817280|NCT02674529|467295841|FG001|Overall Study|Withdrawal by Subject|1|||
129817281|NCT02674529|467295840|FG000|Overall Study|Physician Decision|0|||
129817282|NCT02674529|467295841|FG001|Overall Study|Physician Decision|1|||
129817283|NCT02674529|467295840|FG000|Overall Study|Protocol Violation|0|||
129817284|NCT02674529|467295841|FG001|Overall Study|Protocol Violation|1|||
129817285|NCT02891850|467295842|FG000|Overall Study|Adverse Event|3|||
129817286|NCT02891850|467295843|FG001|Overall Study|Adverse Event|0|||
129817287|NCT02891850|467295842|FG000|Overall Study|Death|0|||
129817288|NCT02891850|467295843|FG001|Overall Study|Death|4|||
129817289|NCT02891850|467295842|FG000|Overall Study|Physician Decision|1|||
129817290|NCT02891850|467295843|FG001|Overall Study|Physician Decision|0|||
129817291|NCT02891850|467295842|FG000|Overall Study|Pregnancy|1|||
129817292|NCT02891850|467295843|FG001|Overall Study|Pregnancy|0|||
129817293|NCT02891850|467295842|FG000|Overall Study|Withdrawal by Subject|2|||
129817294|NCT02891850|467295843|FG001|Overall Study|Withdrawal by Subject|3|||
129817295|NCT00630396|467295844|FG000|Overall Study|Death|4|||
129817296|NCT00630396|467295844|FG000|Overall Study|Lost to Follow-up|3|||
129817297|NCT00903695|467295848|FG000|Overall Study|medical exclusion after 1st testing|1|||
129817298|NCT00903695|467295849|FG001|Overall Study|medical exclusion after 1st testing|0|||
129817299|NCT00903695|467295848|FG000|Overall Study|lung cancer|1|||
129817300|NCT00903695|467295849|FG001|Overall Study|lung cancer|0|||
129817301|NCT00543140|467295850|FG000|Overall Study|Lost to Follow-up|33|||
130059164|NCT01877382|468170507|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129817302|NCT00543140|467295850|FG000|Overall Study|Withdrawal by Subject|13|||
129817303|NCT00543140|467295850|FG000|Overall Study|Protocol Violation|10|||
129817304|NCT00543140|467295850|FG000|Overall Study|Insufficient weight loss|10|||
129817305|NCT00543140|467295850|FG000|Overall Study|SAE leading to explant of SAGB|3|||
129817306|NCT00543140|467295850|FG000|Overall Study|Death|1|||
129817307|NCT00543140|467295850|FG000|Overall Study|Subject moved|1|||
129817308|NCT00543140|467295850|FG000|Overall Study|Conversion to different procedure|1|||
129817309|NCT00578812|467295851|FG000|Overall Study|Not treated|6|||
129817310|NCT00578812|467295852|FG001|Overall Study|Not treated|7|||
129817311|NCT04532164|467295855|FG000|Overall Study|Adverse Event|1|||
129817312|NCT04532164|467295855|FG000|Overall Study|Protocol Violation|5|||
129817313|NCT04532164|467295855|FG000|Overall Study|Lost to Follow-up|1|||
129817314|NCT04532164|467295855|FG000|Overall Study|Found to be Ineligible|3|||
129817315|NCT04532164|467295855|FG000|Overall Study|Withdrawal by Subject|14|||
129817316|NCT02269241|467295862|FG000|Overall Study|Lost to Follow-up|269|||
129817317|NCT02269241|467295862|FG000|Overall Study|Withdrawal by Subject|155|||
129817318|NCT02269241|467295862|FG000|Overall Study|Protocol Violation|1|||
129817319|NCT02269241|467295862|FG000|Overall Study|Physician Decision|7|||
129817320|NCT02269241|467295862|FG000|Overall Study|Pregnancy|15|||
129817321|NCT02269241|467295862|FG000|Overall Study|Wish for pregnancy|5|||
129817322|NCT02269241|467295862|FG000|Overall Study|Development of an exclusion criteria|16|||
129817323|NCT02269241|467295862|FG000|Overall Study|Adverse Event|113|||
129817324|NCT02269241|467295862|FG000|Overall Study|At the specific request of the sponsor|20|||
129817325|NCT02269241|467295862|FG000|Overall Study|Several reasons not classified|53|||
129817326|NCT02269241|467295862|FG000|Overall Study|Screening failures|546|||
129817327|NCT02270957|467295863|FG000|Overall Study|Lack of Efficacy|2|||
129817328|NCT02270957|467295864|FG001|Overall Study|Lack of Efficacy|4|||
129817329|NCT02270957|467295863|FG000|Overall Study|Adverse Event|2|||
129817330|NCT02270957|467295864|FG001|Overall Study|Adverse Event|0|||
129817331|NCT01218204|467295865|FG000|Part B Washout|Adverse Event|0|||
129817332|NCT01218204|467295866|FG001|Part B Washout|Adverse Event|1|||
129817333|NCT01218204|467295867|FG002|Part B Washout|Adverse Event|0|||
129817334|NCT01218204|467295868|FG003|Part B Washout|Adverse Event|0|||
129817335|NCT01218204|467295865|FG000|Part B Washout|Lost to Follow-up|0|||
129817336|NCT01218204|467295866|FG001|Part B Washout|Lost to Follow-up|2|||
129817337|NCT01218204|467295867|FG002|Part B Washout|Lost to Follow-up|0|||
129817338|NCT01218204|467295868|FG003|Part B Washout|Lost to Follow-up|0|||
129817339|NCT01218204|467295865|FG000|Part B Washout|Physician Decision|0|||
129817340|NCT01218204|467295866|FG001|Part B Washout|Physician Decision|14|||
129817341|NCT01218204|467295867|FG002|Part B Washout|Physician Decision|0|||
129817342|NCT01218204|467295868|FG003|Part B Washout|Physician Decision|0|||
129817343|NCT01218204|467295865|FG000|Part B Washout|Withdrawal by Subject|0|||
129817344|NCT01218204|467295866|FG001|Part B Washout|Withdrawal by Subject|14|||
129817345|NCT01218204|467295867|FG002|Part B Washout|Withdrawal by Subject|0|||
129817346|NCT01218204|467295868|FG003|Part B Washout|Withdrawal by Subject|0|||
129817347|NCT01218204|467295865|FG000|Part B Washout|Reached defined stopping criteria|0|||
129817348|NCT01218204|467295866|FG001|Part B Washout|Reached defined stopping criteria|2|||
129817349|NCT01218204|467295867|FG002|Part B Washout|Reached defined stopping criteria|0|||
129817350|NCT01218204|467295868|FG003|Part B Washout|Reached defined stopping criteria|0|||
129817351|NCT01218204|467295865|FG000|Part B Washout|Did not meet continuation criteria|0|||
129817352|NCT01218204|467295866|FG001|Part B Washout|Did not meet continuation criteria|112|||
129817353|NCT01218204|467295867|FG002|Part B Washout|Did not meet continuation criteria|0|||
129817354|NCT01218204|467295868|FG003|Part B Washout|Did not meet continuation criteria|0|||
129817355|NCT01218204|467295865|FG000|Part B Run-in|Adverse Event|0|||
129817356|NCT01218204|467295866|FG001|Part B Run-in|Adverse Event|0|||
129817357|NCT01218204|467295867|FG002|Part B Run-in|Adverse Event|1|||
129817358|NCT01218204|467295868|FG003|Part B Run-in|Adverse Event|0|||
129817359|NCT01218204|467295865|FG000|Part B Run-in|Protocol Violation|0|||
129817360|NCT01218204|467295866|FG001|Part B Run-in|Protocol Violation|0|||
129817361|NCT01218204|467295867|FG002|Part B Run-in|Protocol Violation|2|||
129817362|NCT01218204|467295868|FG003|Part B Run-in|Protocol Violation|0|||
129817363|NCT01218204|467295865|FG000|Part B Run-in|Withdrawal by Subject|0|||
129817364|NCT01218204|467295866|FG001|Part B Run-in|Withdrawal by Subject|0|||
129817365|NCT01218204|467295867|FG002|Part B Run-in|Withdrawal by Subject|3|||
129817366|NCT01218204|467295868|FG003|Part B Run-in|Withdrawal by Subject|0|||
129817367|NCT01218204|467295865|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
129817368|NCT01218204|467295866|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
129817369|NCT01218204|467295867|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
129817370|NCT01218204|467295868|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
129897212|NCT00991276|467584298|FG002|Second Intervention Period|Adverse Event|0|||
129817371|NCT01218204|467295865|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
129817372|NCT01218204|467295866|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
129817373|NCT01218204|467295867|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
129817374|NCT01218204|467295868|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
129817375|NCT00545168|467295869|FG000|Overall Study|Lost to Follow-up|5|||
129817376|NCT00545168|467295870|FG001|Overall Study|Lost to Follow-up|5|||
129817377|NCT00545168|467295871|FG002|Overall Study|Lost to Follow-up|5|||
129817378|NCT00545168|467295869|FG000|Overall Study|Withdrawal by Subject|9|||
129817379|NCT00545168|467295870|FG001|Overall Study|Withdrawal by Subject|0|||
129817380|NCT00545168|467295871|FG002|Overall Study|Withdrawal by Subject|13|||
129817381|NCT00545168|467295869|FG000|Overall Study|Protocol Violation|1|||
129817382|NCT00545168|467295870|FG001|Overall Study|Protocol Violation|0|||
129817383|NCT00545168|467295871|FG002|Overall Study|Protocol Violation|1|||
129817384|NCT00545168|467295869|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
129817385|NCT00545168|467295870|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
129817386|NCT00545168|467295871|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
129817387|NCT01987505|467295872|FG000|Overall Study|Other|9|||
129817388|NCT01987505|467295872|FG000|Overall Study|Withdrawal by Subject|2|||
129817389|NCT01987505|467295872|FG000|Overall Study|Other Reason|2|||
129817390|NCT01987505|467295872|FG000|Overall Study|Lost to Follow-up|15|||
129817391|NCT01987505|467295872|FG000|Overall Study|Investigator Decision|2|||
129817392|NCT01987505|467295872|FG000|Overall Study|Death|4|||
129817393|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
129817394|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
129817395|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
129817396|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
129817397|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
129817398|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
129817399|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Death|3|||
129817400|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Death|2|||
129817401|NCT00489541|467295873|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
129817402|NCT00489541|467295874|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
129817403|NCT00489541|467295873|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
129817404|NCT00489541|467295874|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
129817405|NCT05131646|467295875|FG000|Overall Study|Withdrawal by Subject|1|||
129817406|NCT05131646|467295876|FG001|Overall Study|Withdrawal by Subject|0|||
129817407|NCT05131646|467295877|FG002|Overall Study|Withdrawal by Subject|0|||
129817408|NCT03266107|467295878|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
129817409|NCT03266107|467295878|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
129817410|NCT03266107|467295878|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
129817411|NCT03266107|467295878|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
129817412|NCT01191801|467295883|FG000|Overall Study|Death|36|||
129817413|NCT01191801|467295884|FG001|Overall Study|Death|12|||
129817414|NCT01191801|467295883|FG000|Overall Study|Lack of Efficacy|176|||
129817415|NCT01191801|467295884|FG001|Overall Study|Lack of Efficacy|258|||
129817416|NCT01191801|467295883|FG000|Overall Study|Adverse Event|9|||
129817417|NCT01191801|467295884|FG001|Overall Study|Adverse Event|8|||
129817418|NCT01191801|467295883|FG000|Overall Study|Protocol Violation|2|||
129817419|NCT01191801|467295884|FG001|Overall Study|Protocol Violation|4|||
129817420|NCT01191801|467295883|FG000|Overall Study|Physician Decision|47|||
129817421|NCT01191801|467295884|FG001|Overall Study|Physician Decision|24|||
129817422|NCT01191801|467295883|FG000|Overall Study|Withdrawal by Subject|1|||
129817423|NCT01191801|467295884|FG001|Overall Study|Withdrawal by Subject|4|||
129817424|NCT01191801|467295883|FG000|Overall Study|Not Provided|45|||
129817425|NCT01191801|467295884|FG001|Overall Study|Not Provided|27|||
129817426|NCT05147350|467295892|FG000|Overall Study|Death|2|||
129817427|NCT05147350|467295893|FG001|Overall Study|Death|3|||
129817428|NCT05147350|467295894|FG002|Overall Study|Death|3|||
129817429|NCT05147350|467295895|FG003|Overall Study|Death|2|||
129817430|NCT05147350|467295896|FG004|Overall Study|Death|2|||
129817431|NCT05147350|467295897|FG005|Overall Study|Death|1|||
129817432|NCT05147350|467295898|FG006|Overall Study|Death|1|||
129817433|NCT05147350|467295899|FG007|Overall Study|Death|3|||
129817434|NCT05147350|467295892|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
129817435|NCT05147350|467295893|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
129817436|NCT05147350|467295894|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
129817437|NCT05147350|467295895|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
129817438|NCT05147350|467295896|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
129817439|NCT05147350|467295897|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
129817440|NCT05147350|467295898|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
129817441|NCT05147350|467295899|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
129817442|NCT05147350|467295892|FG000|Overall Study|Withdrawal by Subject|0|||
129817443|NCT05147350|467295893|FG001|Overall Study|Withdrawal by Subject|0|||
129817444|NCT05147350|467295894|FG002|Overall Study|Withdrawal by Subject|3|||
129817445|NCT05147350|467295895|FG003|Overall Study|Withdrawal by Subject|1|||
129817446|NCT05147350|467295896|FG004|Overall Study|Withdrawal by Subject|1|||
129817447|NCT05147350|467295897|FG005|Overall Study|Withdrawal by Subject|0|||
129817448|NCT05147350|467295898|FG006|Overall Study|Withdrawal by Subject|1|||
129817449|NCT05147350|467295899|FG007|Overall Study|Withdrawal by Subject|0|||
129817450|NCT05147350|467295892|FG000|Overall Study|Other Reasons|0|||
129817451|NCT05147350|467295893|FG001|Overall Study|Other Reasons|0|||
129817452|NCT05147350|467295894|FG002|Overall Study|Other Reasons|2|||
129817453|NCT05147350|467295895|FG003|Overall Study|Other Reasons|0|||
129817454|NCT05147350|467295896|FG004|Overall Study|Other Reasons|0|||
129817455|NCT05147350|467295897|FG005|Overall Study|Other Reasons|2|||
129817456|NCT05147350|467295898|FG006|Overall Study|Other Reasons|1|||
129817457|NCT05147350|467295899|FG007|Overall Study|Other Reasons|1|||
129817458|NCT01539538|467295900|FG000|Overall Study|Adverse Event|13|||
129817459|NCT01539538|467295901|FG001|Overall Study|Adverse Event|18|||
129817460|NCT01539538|467295900|FG000|Overall Study|Lack of Efficacy|13|||
129817461|NCT01539538|467295901|FG001|Overall Study|Lack of Efficacy|16|||
129817462|NCT01539538|467295900|FG000|Overall Study|Withdrawal by Subject|2|||
129817463|NCT01539538|467295901|FG001|Overall Study|Withdrawal by Subject|3|||
129817464|NCT01539538|467295900|FG000|Overall Study|PCA no longer required or PCA problem|3|||
129817465|NCT01539538|467295901|FG001|Overall Study|PCA no longer required or PCA problem|7|||
129817466|NCT01192516|467295906|FG000|Overall Study|Lost to Follow-up|7|||
129817467|NCT01192516|467295907|FG001|Overall Study|Lost to Follow-up|10|||
129817468|NCT01192516|467295908|FG002|Overall Study|Lost to Follow-up|7|||
129817469|NCT01192516|467295906|FG000|Overall Study|Withdrawal by Subject|4|||
129817470|NCT01192516|467295907|FG001|Overall Study|Withdrawal by Subject|4|||
129817471|NCT01192516|467295908|FG002|Overall Study|Withdrawal by Subject|1|||
129817472|NCT01192516|467295906|FG000|Overall Study|started new treatment|5|||
129817473|NCT01192516|467295907|FG001|Overall Study|started new treatment|1|||
129817474|NCT01192516|467295908|FG002|Overall Study|started new treatment|0|||
129817475|NCT01192516|467295906|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
129817476|NCT01192516|467295907|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
129817477|NCT01192516|467295908|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
129817478|NCT01256008|467295909|FG000|Overall Study|Lost to Follow-up|6|||
129817479|NCT01256008|467295910|FG001|Overall Study|Lost to Follow-up|4|||
129817480|NCT01256008|467295911|FG002|Overall Study|Lost to Follow-up|11|||
129817481|NCT01256008|467295909|FG000|Overall Study|Withdrawal by Subject|2|||
129817482|NCT01256008|467295910|FG001|Overall Study|Withdrawal by Subject|3|||
129817483|NCT01256008|467295911|FG002|Overall Study|Withdrawal by Subject|10|||
129817484|NCT02321800|467295914|FG000|Overall Study|Withdrawal by Subject|3|||
129817485|NCT02321800|467295915|FG001|Overall Study|Withdrawal by Subject|3|||
129817486|NCT02321800|467295914|FG000|Overall Study|Death|1|||
129817487|NCT02321800|467295915|FG001|Overall Study|Death|0|||
129817488|NCT02321800|467295914|FG000|Overall Study|Protocol Violation|1|||
129817489|NCT02321800|467295915|FG001|Overall Study|Protocol Violation|0|||
129817490|NCT02321800|467295914|FG000|Overall Study|Lost to Follow-up|10|||
129817491|NCT02321800|467295915|FG001|Overall Study|Lost to Follow-up|4|||
129817492|NCT02321800|467295914|FG000|Overall Study|Adverse Event|2|||
129817493|NCT02321800|467295915|FG001|Overall Study|Adverse Event|3|||
129817494|NCT02321800|467295914|FG000|Overall Study|Other, Miscellaneous|3|||
129817495|NCT02321800|467295915|FG001|Overall Study|Other, Miscellaneous|1|||
129817496|NCT01336764|467295919|FG000|Overall Study|Withdrawal by Subject|5|||
129817497|NCT01336764|467295920|FG001|Overall Study|Withdrawal by Subject|5|||
129817498|NCT00730132|467295921|FG000|Overall Study|Protocol Violation|154|||
130059165|NCT01877382|468170508|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059166|NCT01877382|468170509|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059167|NCT01877382|468170510|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059168|NCT01877382|468170511|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129817499|NCT00730132|467295921|FG000|Overall Study|Death|1|||
129817500|NCT01626391|467295922|FG000|Overall Study|Physician Decision|1|||
129817501|NCT01626391|467295923|FG001|Overall Study|Physician Decision|0|||
129817502|NCT01626391|467295922|FG000|Overall Study|Withdrawal by Subject|1|||
129817503|NCT01626391|467295923|FG001|Overall Study|Withdrawal by Subject|0|||
129817504|NCT00320411|467295924|FG000|Overall Study|No investigational product admin.|4|||
129817505|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
129817506|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
129817507|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817508|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817509|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817510|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817511|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
129817512|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
129817513|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817514|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817515|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817516|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817517|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
129817518|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
129817519|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817520|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817521|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817522|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817523|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
129817524|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
129817525|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817526|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817527|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817528|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817529|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
129817530|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
129817531|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817532|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817533|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817534|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817535|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817536|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
129817537|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817538|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817539|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817540|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817541|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Other|0|||
129817542|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Other|1|||
129817543|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Other|0|||
129817544|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Other|0|||
129817545|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Other|0|||
129817546|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Other|0|||
129817547|NCT00843024|467295926|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
129817548|NCT00843024|467295927|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
129817549|NCT00843024|467295928|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
129817550|NCT00843024|467295929|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
129817551|NCT00843024|467295930|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
129817552|NCT00843024|467295931|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
129817553|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129817554|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
129817555|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
129817556|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
129817557|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
129817558|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
129817559|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817560|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817561|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817562|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
129817563|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817564|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
129817565|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
129817566|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
129817567|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
129817568|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
129817569|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
129817570|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
129817571|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Physician Decision|0|||
129817572|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Physician Decision|0|||
129817573|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Physician Decision|0|||
129817574|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Physician Decision|3|||
129817575|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Physician Decision|1|||
129817576|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Physician Decision|1|||
129817577|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129817578|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129817579|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129817580|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Adverse Event|0|||
129817581|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Adverse Event|1|||
129817582|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Adverse Event|1|||
129817583|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817584|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817585|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817586|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817587|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
129817588|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817589|NCT01032837|467295932|FG000|Overall Study|Adverse event/internal illness|0|||
129817590|NCT01032837|467295933|FG001|Overall Study|Adverse event/internal illness|1|||
129817591|NCT01032837|467295934|FG002|Overall Study|Adverse event/internal illness|0|||
129817592|NCT01032837|467295935|FG003|Overall Study|Adverse event/internal illness|1|||
129817593|NCT01032837|467295932|FG000|Overall Study|Withdrew consent|0|||
129817594|NCT01032837|467295933|FG001|Overall Study|Withdrew consent|2|||
129817595|NCT01032837|467295934|FG002|Overall Study|Withdrew consent|0|||
129817596|NCT01032837|467295935|FG003|Overall Study|Withdrew consent|1|||
129817597|NCT01032837|467295932|FG000|Overall Study|Failed to return|0|||
129817598|NCT01032837|467295933|FG001|Overall Study|Failed to return|0|||
129817599|NCT01032837|467295934|FG002|Overall Study|Failed to return|1|||
129817600|NCT01032837|467295935|FG003|Overall Study|Failed to return|0|||
129817601|NCT01032837|467295932|FG000|Overall Study|Refused treatment|0|||
129817602|NCT01032837|467295933|FG001|Overall Study|Refused treatment|0|||
129817603|NCT01032837|467295934|FG002|Overall Study|Refused treatment|0|||
129817604|NCT01032837|467295935|FG003|Overall Study|Refused treatment|1|||
129817605|NCT02615145|467295937|FG000|Overall Study|Did Not Start Treatment|0|||
129817606|NCT02615145|467295938|FG001|Overall Study|Did Not Start Treatment|0|||
129817607|NCT02615145|467295939|FG002|Overall Study|Did Not Start Treatment|1|||
129817608|NCT02615145|467295940|FG003|Overall Study|Did Not Start Treatment|1|||
129817609|NCT02615145|467295937|FG000|Overall Study|Failure to Return|20|||
129817610|NCT02615145|467295938|FG001|Overall Study|Failure to Return|10|||
129817611|NCT02615145|467295939|FG002|Overall Study|Failure to Return|7|||
129817612|NCT02615145|467295940|FG003|Overall Study|Failure to Return|0|||
129817613|NCT02615145|467295937|FG000|Overall Study|Death|2|||
129817614|NCT02615145|467295938|FG001|Overall Study|Death|3|||
129817615|NCT02615145|467295939|FG002|Overall Study|Death|0|||
129817616|NCT02615145|467295940|FG003|Overall Study|Death|0|||
129817617|NCT02615145|467295937|FG000|Overall Study|Other, Not Specified|5|||
129817618|NCT02615145|467295938|FG001|Overall Study|Other, Not Specified|2|||
129817619|NCT02615145|467295939|FG002|Overall Study|Other, Not Specified|0|||
129817620|NCT02615145|467295940|FG003|Overall Study|Other, Not Specified|0|||
129817621|NCT03727347|467295941|FG000|Overall Study|Withdrawal by Subject|2|||
129817622|NCT03727347|467295941|FG000|Overall Study|Lost to Follow-up|1|||
129817623|NCT01487200|467295944|FG000|Overall Study|Withdrawal by Subject|0|||
129817624|NCT01487200|467295945|FG001|Overall Study|Withdrawal by Subject|1|||
129817625|NCT01487200|467295946|FG002|Overall Study|Withdrawal by Subject|0|||
129817626|NCT01487200|467295947|FG003|Overall Study|Withdrawal by Subject|0|||
129817627|NCT02837783|467295948|FG000|Overall Study|Adverse Event|1|||
129817628|NCT02837783|467295949|FG001|Overall Study|Adverse Event|0|||
129817629|NCT02837783|467295948|FG000|Overall Study|Other, Not Specified|1|||
129817630|NCT02837783|467295949|FG001|Overall Study|Other, Not Specified|2|||
129817631|NCT02216591|467295950|FG000|Overall Study|Lost to Follow-up|0|||
129817632|NCT02216591|467295951|FG001|Overall Study|Lost to Follow-up|1|||
129817633|NCT01866930|467295952|FG000|Treatment Period|Other|1|||
129817634|NCT01866930|467295953|FG001|Treatment Period|Other|0|||
129817635|NCT01866930|467295952|FG000|Treatment Period|Death|0|||
129817636|NCT01866930|467295953|FG001|Treatment Period|Death|2|||
129817637|NCT01866930|467295952|FG000|Treatment Period|Poor/non compliance|0|||
129817638|NCT01866930|467295953|FG001|Treatment Period|Poor/non compliance|2|||
129817639|NCT01866930|467295952|FG000|Treatment Period|No longer meets study criteria|0|||
129817640|NCT01866930|467295953|FG001|Treatment Period|No longer meets study criteria|1|||
129817641|NCT01866930|467295952|FG000|Treatment Period|Withdrawal by Subject|2|||
129817642|NCT01866930|467295953|FG001|Treatment Period|Withdrawal by Subject|8|||
129817643|NCT01866930|467295952|FG000|Treatment Period|Lack of Efficacy|1|||
129817644|NCT01866930|467295953|FG001|Treatment Period|Lack of Efficacy|9|||
129817645|NCT01866930|467295952|FG000|Treatment Period|Adverse Event|4|||
129817646|NCT01866930|467295953|FG001|Treatment Period|Adverse Event|12|||
129817647|NCT01866930|467295952|FG000|Treatment Period|Lost to Follow-up|1|||
129817648|NCT01866930|467295953|FG001|Treatment Period|Lost to Follow-up|1|||
129817649|NCT01866930|467295952|FG000|Follow-up Period|Lost to Follow-up|1|||
129817650|NCT01866930|467295953|FG001|Follow-up Period|Lost to Follow-up|1|||
129817651|NCT01866930|467295952|FG000|Follow-up Period|Other|1|||
129817652|NCT01866930|467295953|FG001|Follow-up Period|Other|5|||
129817653|NCT01866930|467295952|FG000|Follow-up Period|No longer required per protocol|1|||
129817654|NCT01866930|467295953|FG001|Follow-up Period|No longer required per protocol|0|||
129817655|NCT01866930|467295952|FG000|Follow-up Period|Withdrawal by Subject|3|||
129817656|NCT01866930|467295953|FG001|Follow-up Period|Withdrawal by Subject|3|||
129817657|NCT00279305|467295956|FG000|Overall Study|Pregnancy|1|||
129817658|NCT00279305|467295957|FG001|Overall Study|Pregnancy|0|||
129817659|NCT00279305|467295956|FG000|Overall Study|Withdrawal by Subject|2|||
129817660|NCT00279305|467295957|FG001|Overall Study|Withdrawal by Subject|0|||
129817661|NCT00279305|467295956|FG000|Overall Study|Dificulting establishing IV|1|||
129817662|NCT00279305|467295957|FG001|Overall Study|Dificulting establishing IV|0|||
129817663|NCT00279305|467295956|FG000|Overall Study|FDA Safety Alert|4|||
129817664|NCT00279305|467295957|FG001|Overall Study|FDA Safety Alert|1|||
129817665|NCT01744197|467295964|FG000|Overall Study|Received 1 patch|2|||
129817666|NCT01744197|467295965|FG001|Overall Study|Received 1 patch|1|||
129817667|NCT01744197|467295964|FG000|Overall Study|No patch received|2|||
129817668|NCT01744197|467295965|FG001|Overall Study|No patch received|2|||
129817669|NCT00317356|467295966|FG000|Overall Study|Adverse Event|0|||
129817670|NCT00317356|467295967|FG001|Overall Study|Adverse Event|0|||
129817671|NCT00317356|467295968|FG002|Overall Study|Adverse Event|1|||
129817672|NCT00317356|467295969|FG003|Overall Study|Adverse Event|0|||
129817673|NCT00317356|467295966|FG000|Overall Study|Lack of Efficacy|1|||
129817674|NCT00317356|467295967|FG001|Overall Study|Lack of Efficacy|1|||
129817675|NCT00317356|467295968|FG002|Overall Study|Lack of Efficacy|0|||
129817676|NCT00317356|467295969|FG003|Overall Study|Lack of Efficacy|3|||
129817677|NCT00317356|467295966|FG000|Overall Study|Physician Decision|0|||
129817678|NCT00317356|467295967|FG001|Overall Study|Physician Decision|1|||
129817679|NCT00317356|467295968|FG002|Overall Study|Physician Decision|0|||
129817680|NCT00317356|467295969|FG003|Overall Study|Physician Decision|0|||
129817681|NCT00621153|467295976|FG000|Overall Study|Safety Reason|8|||
129817682|NCT00621153|467295977|FG001|Overall Study|Safety Reason|7|||
129817683|NCT00621153|467295976|FG000|Overall Study|Adverse Event|3|||
129817684|NCT00621153|467295977|FG001|Overall Study|Adverse Event|2|||
129817685|NCT00621153|467295976|FG000|Overall Study|Lost to Follow-up|5|||
129817686|NCT00621153|467295977|FG001|Overall Study|Lost to Follow-up|1|||
129817687|NCT00621153|467295976|FG000|Overall Study|Withdrawal by Subject|4|||
129817688|NCT00621153|467295977|FG001|Overall Study|Withdrawal by Subject|5|||
129817689|NCT00753415|467295978|FG000|Part A|Disease progression|1|||
129817690|NCT00753415|467295979|FG001|Part A|Disease progression|0|||
129817691|NCT00753415|467295980|FG002|Part A|Disease progression|1|||
129817692|NCT00753415|467295981|FG003|Part A|Disease progression|2|||
129817693|NCT00753415|467295982|FG004|Part A|Disease progression|0|||
129817694|NCT00753415|467295983|FG005|Part A|Disease progression|0|||
129817695|NCT00753415|467295984|FG006|Part A|Disease progression|0|||
129817696|NCT00753415|467295985|FG007|Part A|Disease progression|0|||
130112383|NCT02266706|468373360|FG002|Overall Study|Withdrawal by Subject|1|||
130112384|NCT02266706|468373361|FG003|Overall Study|Withdrawal by Subject|0|||
130112385|NCT02266706|468373362|FG004|Overall Study|Withdrawal by Subject|0|||
130112386|NCT02266706|468373363|FG005|Overall Study|Withdrawal by Subject|1|||
130112387|NCT02266706|468373364|FG006|Overall Study|Withdrawal by Subject|0|||
130112388|NCT02266706|468373365|FG007|Overall Study|Withdrawal by Subject|0|||
130112389|NCT02266706|468373366|FG008|Overall Study|Withdrawal by Subject|0|||
130112390|NCT02266706|468373358|FG000|Overall Study|Screen failure|0|||
130112391|NCT02266706|468373359|FG001|Overall Study|Screen failure|0|||
130112392|NCT02266706|468373360|FG002|Overall Study|Screen failure|0|||
130112393|NCT02266706|468373361|FG003|Overall Study|Screen failure|0|||
130112394|NCT02266706|468373362|FG004|Overall Study|Screen failure|0|||
130112395|NCT02266706|468373363|FG005|Overall Study|Screen failure|1|||
130112396|NCT02266706|468373364|FG006|Overall Study|Screen failure|1|||
130112397|NCT02266706|468373365|FG007|Overall Study|Screen failure|0|||
130112398|NCT02266706|468373366|FG008|Overall Study|Screen failure|0|||
130112399|NCT02266706|468373358|FG000|Overall Study|Enrollment in another study|0|||
130112400|NCT02266706|468373359|FG001|Overall Study|Enrollment in another study|0|||
130112401|NCT02266706|468373360|FG002|Overall Study|Enrollment in another study|0|||
130112402|NCT02266706|468373361|FG003|Overall Study|Enrollment in another study|1|||
130112403|NCT02266706|468373362|FG004|Overall Study|Enrollment in another study|0|||
130112404|NCT02266706|468373363|FG005|Overall Study|Enrollment in another study|0|||
130112405|NCT02266706|468373364|FG006|Overall Study|Enrollment in another study|0|||
130112406|NCT02266706|468373365|FG007|Overall Study|Enrollment in another study|0|||
130112407|NCT02266706|468373366|FG008|Overall Study|Enrollment in another study|0|||
130112408|NCT00409188|468373367|FG000|Overall Study|Ongoing at data cut-off|383|||
130112409|NCT00409188|468373368|FG001|Overall Study|Ongoing at data cut-off|175|||
130112410|NCT02257632|468373374|FG000|Overall Study|Withdrawal by Subject|0|||
130112411|NCT02257632|468373375|FG001|Overall Study|Withdrawal by Subject|1|||
130112412|NCT02257632|468373374|FG000|Overall Study|Adverse Event|1|||
130112413|NCT02257632|468373375|FG001|Overall Study|Adverse Event|2|||
130112414|NCT01393990|468373376|FG000|Overall Study|Adverse Event|0|||
129817697|NCT00753415|467295986|FG008|Part A|Disease progression|0|||
129817698|NCT00753415|467295987|FG009|Part A|Disease progression|0|||
129817699|NCT00753415|467295978|FG000|Part A|Withdrawal by Subject|0|||
129817700|NCT00753415|467295979|FG001|Part A|Withdrawal by Subject|0|||
129897213|NCT00991276|467584299|FG003|Second Intervention Period|Adverse Event|1|||
129817701|NCT00753415|467295980|FG002|Part A|Withdrawal by Subject|1|||
129817702|NCT00753415|467295981|FG003|Part A|Withdrawal by Subject|0|||
129817703|NCT00753415|467295982|FG004|Part A|Withdrawal by Subject|0|||
129817704|NCT00753415|467295983|FG005|Part A|Withdrawal by Subject|0|||
129817705|NCT00753415|467295984|FG006|Part A|Withdrawal by Subject|0|||
129817706|NCT00753415|467295985|FG007|Part A|Withdrawal by Subject|0|||
130112415|NCT01393990|468373377|FG001|Overall Study|Adverse Event|0|||
129817707|NCT00753415|467295986|FG008|Part A|Withdrawal by Subject|0|||
129817708|NCT00753415|467295987|FG009|Part A|Withdrawal by Subject|0|||
130112416|NCT01393990|468373378|FG002|Overall Study|Adverse Event|0|||
130112417|NCT01393990|468373379|FG003|Overall Study|Adverse Event|0|||
129817709|NCT00753415|467295978|FG000|Part B|Lost to Follow-up|0|||
129817710|NCT00753415|467295979|FG001|Part B|Lost to Follow-up|0|||
129817711|NCT00753415|467295980|FG002|Part B|Lost to Follow-up|0|||
129817712|NCT00753415|467295981|FG003|Part B|Lost to Follow-up|0|||
129817713|NCT00753415|467295982|FG004|Part B|Lost to Follow-up|0|||
129817714|NCT00753415|467295983|FG005|Part B|Lost to Follow-up|0|||
129817715|NCT00753415|467295984|FG006|Part B|Lost to Follow-up|0|||
129817716|NCT00753415|467295985|FG007|Part B|Lost to Follow-up|1|||
129817717|NCT00753415|467295986|FG008|Part B|Lost to Follow-up|1|||
129817718|NCT00753415|467295987|FG009|Part B|Lost to Follow-up|0|||
129817719|NCT00753415|467295978|FG000|Part B|Disease progression|0|||
129817720|NCT00753415|467295979|FG001|Part B|Disease progression|0|||
129817721|NCT00753415|467295980|FG002|Part B|Disease progression|0|||
129817722|NCT00753415|467295981|FG003|Part B|Disease progression|0|||
129817723|NCT00753415|467295982|FG004|Part B|Disease progression|0|||
129817724|NCT00753415|467295983|FG005|Part B|Disease progression|0|||
129817725|NCT00753415|467295984|FG006|Part B|Disease progression|0|||
129817726|NCT00753415|467295985|FG007|Part B|Disease progression|0|||
129817727|NCT00753415|467295986|FG008|Part B|Disease progression|2|||
129817728|NCT00753415|467295987|FG009|Part B|Disease progression|1|||
129817729|NCT04212650|467295988|FG000|Overall Study|Withdrawal by Subject|1|||
129817730|NCT04212650|467295989|FG001|Overall Study|Withdrawal by Subject|0|||
129817731|NCT04419714|467295990|FG000|Overall Study|Technical Fault|5|||
129817732|NCT04419714|467295990|FG000|Overall Study|Protocol Deviation|2|||
129817733|NCT04419714|467295990|FG000|Overall Study|Withdrawal by Subject|1|||
129897214|NCT00991276|467584300|FG004|Second Intervention Period|Adverse Event|1|||
129897215|NCT00991276|467584301|FG005|Second Intervention Period|Adverse Event|0|||
129897216|NCT00991276|467584296|FG000|Second Intervention Period|Protocol Violation|1|||
129897217|NCT00991276|467584297|FG001|Second Intervention Period|Protocol Violation|0|||
129897218|NCT00991276|467584298|FG002|Second Intervention Period|Protocol Violation|0|||
129897219|NCT00991276|467584299|FG003|Second Intervention Period|Protocol Violation|0|||
129897220|NCT00991276|467584300|FG004|Second Intervention Period|Protocol Violation|0|||
129897221|NCT00991276|467584301|FG005|Second Intervention Period|Protocol Violation|0|||
129897222|NCT00991276|467584296|FG000|Second Intervention Period|Other|0|||
129897223|NCT00991276|467584297|FG001|Second Intervention Period|Other|0|||
129897224|NCT00991276|467584298|FG002|Second Intervention Period|Other|0|||
129897225|NCT00991276|467584299|FG003|Second Intervention Period|Other|1|||
129897226|NCT00991276|467584300|FG004|Second Intervention Period|Other|0|||
129897227|NCT00991276|467584301|FG005|Second Intervention Period|Other|1|||
129897228|NCT00991276|467584296|FG000|Third Intervention Period|Protocol Violation|1|||
129897229|NCT00991276|467584297|FG001|Third Intervention Period|Protocol Violation|0|||
129897230|NCT00991276|467584298|FG002|Third Intervention Period|Protocol Violation|0|||
129897231|NCT00991276|467584299|FG003|Third Intervention Period|Protocol Violation|0|||
129897232|NCT00991276|467584300|FG004|Third Intervention Period|Protocol Violation|0|||
129897233|NCT00991276|467584301|FG005|Third Intervention Period|Protocol Violation|0|||
129897234|NCT00991276|467584296|FG000|Third Intervention Period|Other|0|||
129897235|NCT00991276|467584297|FG001|Third Intervention Period|Other|0|||
129897236|NCT00991276|467584298|FG002|Third Intervention Period|Other|0|||
129897237|NCT00991276|467584299|FG003|Third Intervention Period|Other|0|||
129897238|NCT00991276|467584300|FG004|Third Intervention Period|Other|0|||
129897239|NCT00991276|467584301|FG005|Third Intervention Period|Other|1|||
129897240|NCT00991276|467584296|FG000|Third Intervention Period|Adverse Event|0|||
129897241|NCT00991276|467584297|FG001|Third Intervention Period|Adverse Event|0|||
129897242|NCT00991276|467584298|FG002|Third Intervention Period|Adverse Event|1|||
129897243|NCT00991276|467584299|FG003|Third Intervention Period|Adverse Event|0|||
129897244|NCT00991276|467584300|FG004|Third Intervention Period|Adverse Event|0|||
129897245|NCT00991276|467584301|FG005|Third Intervention Period|Adverse Event|0|||
129897246|NCT00991276|467584296|FG000|Third Intervention Period|Withdrawal by Subject|0|||
130059169|NCT01877382|468170497|FG000|Dose Escalation|Clinical progression|0|||
130059170|NCT01877382|468170498|FG001|Dose Escalation|Clinical progression|1|||
130059171|NCT01877382|468170499|FG002|Dose Escalation|Clinical progression|0|||
130059172|NCT01877382|468170500|FG003|Dose Escalation|Clinical progression|2|||
130059173|NCT01877382|468170501|FG004|Dose Escalation|Clinical progression|0|||
129897247|NCT00991276|467584297|FG001|Third Intervention Period|Withdrawal by Subject|0|||
129897248|NCT00991276|467584298|FG002|Third Intervention Period|Withdrawal by Subject|0|||
129897249|NCT00991276|467584299|FG003|Third Intervention Period|Withdrawal by Subject|1|||
129897250|NCT00991276|467584300|FG004|Third Intervention Period|Withdrawal by Subject|0|||
129897251|NCT00991276|467584301|FG005|Third Intervention Period|Withdrawal by Subject|0|||
129897252|NCT01720043|467584302|FG000|Overall Study|Withdrawal by Subject|1|||
129897253|NCT01688973|467584303|FG000|Overall Study|Ineligible|2|||
129897254|NCT01688973|467584304|FG001|Overall Study|Ineligible|3|||
129897255|NCT00711646|467584305|FG000|Overall Study|Adverse Event|6|||
129897256|NCT00711646|467584306|FG001|Overall Study|Adverse Event|1|||
129897257|NCT00711646|467584305|FG000|Overall Study|Withdrawal by Subject|4|||
129897258|NCT00711646|467584306|FG001|Overall Study|Withdrawal by Subject|0|||
129897259|NCT00711646|467584305|FG000|Overall Study|Protocol Violation|0|||
129897260|NCT00711646|467584306|FG001|Overall Study|Protocol Violation|1|||
130059174|NCT01877382|468170502|FG005|Dose Escalation|Clinical progression|0|||
129817734|NCT04023526|467297483|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
129817735|NCT04023526|467297484|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
129817736|NCT04023526|467297483|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
129817737|NCT04023526|467297484|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
129817738|NCT00056316|467297486|FG000|Overall Study|Withdrawal by Subject|2|||
129817739|NCT00056316|467297487|FG001|Overall Study|Withdrawal by Subject|2|||
129817740|NCT00056316|467297486|FG000|Overall Study|Death/NH placement of pt|1|||
129817741|NCT00056316|467297487|FG001|Overall Study|Death/NH placement of pt|1|||
129817742|NCT02599129|467297489|FG000|Overall Study|Lack of Efficacy|2|||
129817743|NCT02599129|467297490|FG001|Overall Study|Lack of Efficacy|2|||
130059175|NCT01877382|468170503|FG006|Dose Escalation|Clinical progression|1|||
129817744|NCT02599129|467297489|FG000|Overall Study|Lost to Follow-up|1|||
129817745|NCT02599129|467297490|FG001|Overall Study|Lost to Follow-up|0|||
129817746|NCT02599129|467297489|FG000|Overall Study|Withdrawal by Subject|2|||
129817747|NCT02599129|467297490|FG001|Overall Study|Withdrawal by Subject|1|||
129817748|NCT03489720|467297491|FG000|Overall Study|Withdrawal by Subject|2|||
129817749|NCT03489720|467297492|FG001|Overall Study|Withdrawal by Subject|0|||
129817750|NCT00166114|467297498|FG000|Overall Study|Protocol Violation|2|||
129817751|NCT00166114|467297499|FG001|Overall Study|Protocol Violation|1|||
129817752|NCT00166114|467297498|FG000|Overall Study|Withdrawal by Subject|10|||
129817753|NCT00166114|467297499|FG001|Overall Study|Withdrawal by Subject|4|||
129817754|NCT00166114|467297498|FG000|Overall Study|Adverse Event|2|||
129817755|NCT00166114|467297499|FG001|Overall Study|Adverse Event|1|||
129817756|NCT00127660|467297506|FG000|Overall Study|Protocol Violation|3|||
129817757|NCT00127660|467297507|FG001|Overall Study|Protocol Violation|3|||
129817758|NCT00127660|467297508|FG002|Overall Study|Protocol Violation|5|||
129817759|NCT00127660|467297509|FG003|Overall Study|Protocol Violation|0|||
129817760|NCT05228132|467297510|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
129817761|NCT05228132|467297510|FG000|Overall Study|Adverse Event|3|||
129817762|NCT05228132|467297510|FG000|Overall Study|Lost to Follow-up|1|||
129817763|NCT05228132|467297510|FG000|Overall Study|Arteriovenous-fistula mature|1|||
129817764|NCT00420927|467297513|FG000|Period 1|Adverse Event|19|||
129817765|NCT00420927|467297514|FG001|Period 1|Adverse Event|15|||
129817766|NCT00420927|467297515|FG002|Period 1|Adverse Event|0|||
129817767|NCT00420927|467297516|FG003|Period 1|Adverse Event|0|||
129817768|NCT00420927|467297517|FG004|Period 1|Adverse Event|0|||
129817769|NCT00420927|467297518|FG005|Period 1|Adverse Event|0|||
129817770|NCT00420927|467297519|FG006|Period 1|Adverse Event|0|||
129817771|NCT00420927|467297513|FG000|Period 1|Withdrawal by Subject|7|||
129817772|NCT00420927|467297514|FG001|Period 1|Withdrawal by Subject|12|||
129817773|NCT00420927|467297515|FG002|Period 1|Withdrawal by Subject|0|||
129817774|NCT00420927|467297516|FG003|Period 1|Withdrawal by Subject|0|||
129817775|NCT00420927|467297517|FG004|Period 1|Withdrawal by Subject|0|||
129817776|NCT00420927|467297518|FG005|Period 1|Withdrawal by Subject|0|||
129817777|NCT00420927|467297519|FG006|Period 1|Withdrawal by Subject|0|||
129817778|NCT00420927|467297513|FG000|Period 1|Lost to Follow-up|8|||
129817779|NCT00420927|467297514|FG001|Period 1|Lost to Follow-up|6|||
129817780|NCT00420927|467297515|FG002|Period 1|Lost to Follow-up|0|||
129817781|NCT00420927|467297516|FG003|Period 1|Lost to Follow-up|0|||
129817782|NCT00420927|467297517|FG004|Period 1|Lost to Follow-up|0|||
129817783|NCT00420927|467297518|FG005|Period 1|Lost to Follow-up|0|||
129817784|NCT00420927|467297519|FG006|Period 1|Lost to Follow-up|0|||
129817785|NCT00420927|467297513|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
129817786|NCT00420927|467297514|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
129817787|NCT00420927|467297515|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817788|NCT00420927|467297516|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817789|NCT00420927|467297517|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817790|NCT00420927|467297518|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
130059176|NCT01877382|468170504|FG007|Dose Escalation|Clinical progression|0|||
130059177|NCT01877382|468170505|FG008|Dose Escalation|Clinical progression|0|||
130059178|NCT01877382|468170506|FG009|Dose Escalation|Clinical progression|1|||
130059179|NCT01877382|468170507|FG010|Dose Escalation|Clinical progression|0|||
130059180|NCT01877382|468170508|FG011|Dose Escalation|Clinical progression|0|||
130059181|NCT01877382|468170509|FG012|Dose Escalation|Clinical progression|2|||
130059182|NCT01877382|468170510|FG013|Dose Escalation|Clinical progression|1|||
130059183|NCT01877382|468170511|FG014|Dose Escalation|Clinical progression|0|||
129817791|NCT00420927|467297519|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817792|NCT00420927|467297513|FG000|Period 1|Death|2|||
129817793|NCT00420927|467297514|FG001|Period 1|Death|0|||
129817794|NCT00420927|467297515|FG002|Period 1|Death|0|||
129817795|NCT00420927|467297516|FG003|Period 1|Death|0|||
129817796|NCT00420927|467297517|FG004|Period 1|Death|0|||
129817797|NCT00420927|467297518|FG005|Period 1|Death|0|||
129817798|NCT00420927|467297519|FG006|Period 1|Death|0|||
129817799|NCT00420927|467297513|FG000|Period 1|Subject moved/relocated|0|||
129817800|NCT00420927|467297514|FG001|Period 1|Subject moved/relocated|2|||
129817801|NCT00420927|467297515|FG002|Period 1|Subject moved/relocated|0|||
129817802|NCT00420927|467297516|FG003|Period 1|Subject moved/relocated|0|||
129817803|NCT00420927|467297517|FG004|Period 1|Subject moved/relocated|0|||
130059184|NCT01877382|468170497|FG000|Dose Escalation|Adverse Event|0|||
130059185|NCT01877382|468170498|FG001|Dose Escalation|Adverse Event|0|||
130059186|NCT01877382|468170499|FG002|Dose Escalation|Adverse Event|0|||
130059187|NCT01877382|468170500|FG003|Dose Escalation|Adverse Event|4|||
130059188|NCT01877382|468170501|FG004|Dose Escalation|Adverse Event|1|||
130059189|NCT01877382|468170502|FG005|Dose Escalation|Adverse Event|2|||
130059190|NCT01877382|468170503|FG006|Dose Escalation|Adverse Event|1|||
130059191|NCT01877382|468170504|FG007|Dose Escalation|Adverse Event|2|||
130059192|NCT01877382|468170505|FG008|Dose Escalation|Adverse Event|0|||
130059193|NCT01877382|468170506|FG009|Dose Escalation|Adverse Event|0|||
130059194|NCT01877382|468170507|FG010|Dose Escalation|Adverse Event|0|||
130059195|NCT01877382|468170508|FG011|Dose Escalation|Adverse Event|0|||
130059196|NCT01877382|468170509|FG012|Dose Escalation|Adverse Event|1|||
130059197|NCT01877382|468170510|FG013|Dose Escalation|Adverse Event|0|||
130059198|NCT01877382|468170511|FG014|Dose Escalation|Adverse Event|0|||
130059199|NCT01877382|468170497|FG000|Dose Escalation|Withdrawal by Subject|0|||
130059200|NCT01877382|468170498|FG001|Dose Escalation|Withdrawal by Subject|0|||
130059201|NCT01877382|468170499|FG002|Dose Escalation|Withdrawal by Subject|0|||
129817804|NCT00420927|467297518|FG005|Period 1|Subject moved/relocated|0|||
129817805|NCT00420927|467297519|FG006|Period 1|Subject moved/relocated|0|||
129817806|NCT00420927|467297513|FG000|Period 1|Noncompliant with study drug|1|||
129817807|NCT00420927|467297514|FG001|Period 1|Noncompliant with study drug|1|||
129817808|NCT00420927|467297515|FG002|Period 1|Noncompliant with study drug|0|||
129817809|NCT00420927|467297516|FG003|Period 1|Noncompliant with study drug|0|||
129817810|NCT00420927|467297517|FG004|Period 1|Noncompliant with study drug|0|||
129817811|NCT00420927|467297518|FG005|Period 1|Noncompliant with study drug|0|||
129817812|NCT00420927|467297519|FG006|Period 1|Noncompliant with study drug|0|||
129817813|NCT00420927|467297513|FG000|Period 1|Randomization error|1|||
129817814|NCT00420927|467297514|FG001|Period 1|Randomization error|0|||
129817815|NCT00420927|467297515|FG002|Period 1|Randomization error|0|||
129817816|NCT00420927|467297516|FG003|Period 1|Randomization error|0|||
129817817|NCT00420927|467297517|FG004|Period 1|Randomization error|0|||
129817818|NCT00420927|467297518|FG005|Period 1|Randomization error|0|||
129817819|NCT00420927|467297519|FG006|Period 1|Randomization error|0|||
129817820|NCT00420927|467297513|FG000|Period 1|Suspected tuberculosis/positive test|1|||
129817821|NCT00420927|467297514|FG001|Period 1|Suspected tuberculosis/positive test|1|||
129817822|NCT00420927|467297515|FG002|Period 1|Suspected tuberculosis/positive test|0|||
129817823|NCT00420927|467297516|FG003|Period 1|Suspected tuberculosis/positive test|0|||
129817824|NCT00420927|467297517|FG004|Period 1|Suspected tuberculosis/positive test|0|||
129817825|NCT00420927|467297518|FG005|Period 1|Suspected tuberculosis/positive test|0|||
129817826|NCT00420927|467297519|FG006|Period 1|Suspected tuberculosis/positive test|0|||
129817827|NCT00420927|467297513|FG000|Period 1|Study site closure|0|||
129817828|NCT00420927|467297514|FG001|Period 1|Study site closure|1|||
129817829|NCT00420927|467297515|FG002|Period 1|Study site closure|0|||
129817830|NCT00420927|467297516|FG003|Period 1|Study site closure|0|||
129817831|NCT00420927|467297517|FG004|Period 1|Study site closure|0|||
129817832|NCT00420927|467297518|FG005|Period 1|Study site closure|0|||
129817833|NCT00420927|467297519|FG006|Period 1|Study site closure|0|||
129817834|NCT00420927|467297513|FG000|Period 1|Subject received new diagnosis|0|||
129817835|NCT00420927|467297514|FG001|Period 1|Subject received new diagnosis|2|||
129817836|NCT00420927|467297515|FG002|Period 1|Subject received new diagnosis|0|||
129817837|NCT00420927|467297516|FG003|Period 1|Subject received new diagnosis|0|||
130059202|NCT01877382|468170500|FG003|Dose Escalation|Withdrawal by Subject|0|||
130059203|NCT01877382|468170501|FG004|Dose Escalation|Withdrawal by Subject|0|||
130059204|NCT01877382|468170502|FG005|Dose Escalation|Withdrawal by Subject|3|||
130059205|NCT01877382|468170503|FG006|Dose Escalation|Withdrawal by Subject|2|||
130059206|NCT01877382|468170504|FG007|Dose Escalation|Withdrawal by Subject|1|||
130059207|NCT01877382|468170505|FG008|Dose Escalation|Withdrawal by Subject|1|||
130059208|NCT01877382|468170506|FG009|Dose Escalation|Withdrawal by Subject|0|||
130059209|NCT01877382|468170507|FG010|Dose Escalation|Withdrawal by Subject|0|||
130059210|NCT01877382|468170508|FG011|Dose Escalation|Withdrawal by Subject|0|||
130059211|NCT01877382|468170509|FG012|Dose Escalation|Withdrawal by Subject|0|||
130059212|NCT01877382|468170510|FG013|Dose Escalation|Withdrawal by Subject|0|||
130059213|NCT01877382|468170511|FG014|Dose Escalation|Withdrawal by Subject|0|||
130059214|NCT01877382|468170497|FG000|Dose Escalation|Protocol Violation|0|||
129817838|NCT00420927|467297517|FG004|Period 1|Subject received new diagnosis|0|||
129817839|NCT00420927|467297518|FG005|Period 1|Subject received new diagnosis|0|||
129817840|NCT00420927|467297519|FG006|Period 1|Subject received new diagnosis|0|||
129817841|NCT00420927|467297513|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
130059215|NCT01877382|468170498|FG001|Dose Escalation|Protocol Violation|0|||
130059216|NCT01877382|468170499|FG002|Dose Escalation|Protocol Violation|0|||
130059217|NCT01877382|468170500|FG003|Dose Escalation|Protocol Violation|0|||
130059218|NCT01877382|468170501|FG004|Dose Escalation|Protocol Violation|0|||
130059219|NCT01877382|468170502|FG005|Dose Escalation|Protocol Violation|0|||
129817842|NCT00420927|467297514|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
129817843|NCT00420927|467297515|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
129817844|NCT00420927|467297516|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
130059220|NCT01877382|468170503|FG006|Dose Escalation|Protocol Violation|1|||
130059221|NCT01877382|468170504|FG007|Dose Escalation|Protocol Violation|0|||
130059222|NCT01877382|468170505|FG008|Dose Escalation|Protocol Violation|0|||
129817845|NCT00420927|467297517|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
129817846|NCT00420927|467297518|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
129817847|NCT00420927|467297519|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
129817848|NCT00420927|467297513|FG000|Period 1|Failed to meet entry criteria|8|||
129817849|NCT00420927|467297514|FG001|Period 1|Failed to meet entry criteria|7|||
129817850|NCT00420927|467297515|FG002|Period 1|Failed to meet entry criteria|0|||
129817851|NCT00420927|467297516|FG003|Period 1|Failed to meet entry criteria|0|||
129817852|NCT00420927|467297517|FG004|Period 1|Failed to meet entry criteria|0|||
130059223|NCT01877382|468170506|FG009|Dose Escalation|Protocol Violation|0|||
130059224|NCT01877382|468170507|FG010|Dose Escalation|Protocol Violation|0|||
130059225|NCT01877382|468170508|FG011|Dose Escalation|Protocol Violation|0|||
130059226|NCT01877382|468170509|FG012|Dose Escalation|Protocol Violation|0|||
130059227|NCT01877382|468170510|FG013|Dose Escalation|Protocol Violation|0|||
130059228|NCT01877382|468170511|FG014|Dose Escalation|Protocol Violation|0|||
130059229|NCT01877382|468170497|FG000|Dose Escalation|Study terminated by sponsor|0|||
130059230|NCT01877382|468170498|FG001|Dose Escalation|Study terminated by sponsor|0|||
130059231|NCT01877382|468170499|FG002|Dose Escalation|Study terminated by sponsor|0|||
129817853|NCT00420927|467297518|FG005|Period 1|Failed to meet entry criteria|0|||
129817854|NCT00420927|467297519|FG006|Period 1|Failed to meet entry criteria|0|||
129817855|NCT00420927|467297513|FG000|Period 1|Took prohibited medication|1|||
129817856|NCT00420927|467297514|FG001|Period 1|Took prohibited medication|3|||
129817857|NCT00420927|467297515|FG002|Period 1|Took prohibited medication|0|||
129817858|NCT00420927|467297516|FG003|Period 1|Took prohibited medication|0|||
129817859|NCT00420927|467297517|FG004|Period 1|Took prohibited medication|0|||
129817860|NCT00420927|467297518|FG005|Period 1|Took prohibited medication|0|||
129817861|NCT00420927|467297519|FG006|Period 1|Took prohibited medication|0|||
129817862|NCT00420927|467297513|FG000|Period 2|Adverse Event|0|||
129817863|NCT00420927|467297514|FG001|Period 2|Adverse Event|0|||
129817864|NCT00420927|467297515|FG002|Period 2|Adverse Event|7|||
129817865|NCT00420927|467297516|FG003|Period 2|Adverse Event|3|||
129817866|NCT00420927|467297517|FG004|Period 2|Adverse Event|17|||
129817867|NCT00420927|467297518|FG005|Period 2|Adverse Event|6|||
129817868|NCT00420927|467297519|FG006|Period 2|Adverse Event|20|||
129817869|NCT00420927|467297513|FG000|Period 2|Withdrawal by Subject|0|||
129817870|NCT00420927|467297514|FG001|Period 2|Withdrawal by Subject|0|||
129817871|NCT00420927|467297515|FG002|Period 2|Withdrawal by Subject|1|||
129817872|NCT00420927|467297516|FG003|Period 2|Withdrawal by Subject|3|||
129817873|NCT00420927|467297517|FG004|Period 2|Withdrawal by Subject|11|||
129817874|NCT00420927|467297518|FG005|Period 2|Withdrawal by Subject|2|||
129817875|NCT00420927|467297519|FG006|Period 2|Withdrawal by Subject|12|||
129817876|NCT00420927|467297513|FG000|Period 2|Lost to Follow-up|0|||
129817877|NCT00420927|467297514|FG001|Period 2|Lost to Follow-up|0|||
129817878|NCT00420927|467297515|FG002|Period 2|Lost to Follow-up|2|||
129817879|NCT00420927|467297516|FG003|Period 2|Lost to Follow-up|2|||
129817880|NCT00420927|467297517|FG004|Period 2|Lost to Follow-up|6|||
129817881|NCT00420927|467297518|FG005|Period 2|Lost to Follow-up|3|||
129817882|NCT00420927|467297519|FG006|Period 2|Lost to Follow-up|9|||
129817883|NCT00420927|467297513|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
129817884|NCT00420927|467297514|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
129817885|NCT00420927|467297515|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
129817886|NCT00420927|467297516|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
129817887|NCT00420927|467297517|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
129817888|NCT00420927|467297518|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
129817889|NCT00420927|467297519|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
129817890|NCT00420927|467297513|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
129817891|NCT00420927|467297514|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
129817892|NCT00420927|467297515|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
130059232|NCT01877382|468170500|FG003|Dose Escalation|Study terminated by sponsor|0|||
130059233|NCT01877382|468170501|FG004|Dose Escalation|Study terminated by sponsor|0|||
130059234|NCT01877382|468170502|FG005|Dose Escalation|Study terminated by sponsor|0|||
130059235|NCT01877382|468170503|FG006|Dose Escalation|Study terminated by sponsor|0|||
130059236|NCT01877382|468170504|FG007|Dose Escalation|Study terminated by sponsor|1|||
130059237|NCT01877382|468170505|FG008|Dose Escalation|Study terminated by sponsor|1|||
130112418|NCT01393990|468373380|FG004|Overall Study|Adverse Event|0|||
129817893|NCT00420927|467297516|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
129817894|NCT00420927|467297517|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
129817895|NCT00420927|467297518|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
129817896|NCT00420927|467297519|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
129817897|NCT00420927|467297513|FG000|Period 2|Subject unable to find transportation|0|||
129817898|NCT00420927|467297514|FG001|Period 2|Subject unable to find transportation|0|||
129817899|NCT00420927|467297515|FG002|Period 2|Subject unable to find transportation|0|||
129817900|NCT00420927|467297516|FG003|Period 2|Subject unable to find transportation|0|||
129817901|NCT00420927|467297517|FG004|Period 2|Subject unable to find transportation|0|||
129817902|NCT00420927|467297518|FG005|Period 2|Subject unable to find transportation|0|||
129817903|NCT00420927|467297519|FG006|Period 2|Subject unable to find transportation|1|||
129817904|NCT00420927|467297513|FG000|Period 2|Physician Decision|0|||
129817905|NCT00420927|467297514|FG001|Period 2|Physician Decision|0|||
129817906|NCT00420927|467297515|FG002|Period 2|Physician Decision|0|||
129817907|NCT00420927|467297516|FG003|Period 2|Physician Decision|0|||
129817908|NCT00420927|467297517|FG004|Period 2|Physician Decision|1|||
129817909|NCT00420927|467297518|FG005|Period 2|Physician Decision|1|||
129817910|NCT00420927|467297519|FG006|Period 2|Physician Decision|0|||
129817911|NCT00420927|467297513|FG000|Period 2|Sponsor decision|0|||
129817912|NCT00420927|467297514|FG001|Period 2|Sponsor decision|0|||
129817913|NCT00420927|467297515|FG002|Period 2|Sponsor decision|1|||
129817914|NCT00420927|467297516|FG003|Period 2|Sponsor decision|0|||
129817915|NCT00420927|467297517|FG004|Period 2|Sponsor decision|0|||
129817916|NCT00420927|467297518|FG005|Period 2|Sponsor decision|0|||
129817917|NCT00420927|467297519|FG006|Period 2|Sponsor decision|1|||
129817918|NCT00420927|467297513|FG000|Period 2|Randomization error|0|||
129817919|NCT00420927|467297514|FG001|Period 2|Randomization error|0|||
129817920|NCT00420927|467297515|FG002|Period 2|Randomization error|0|||
129817921|NCT00420927|467297516|FG003|Period 2|Randomization error|0|||
129817922|NCT00420927|467297517|FG004|Period 2|Randomization error|1|||
129817923|NCT00420927|467297518|FG005|Period 2|Randomization error|1|||
129817924|NCT00420927|467297519|FG006|Period 2|Randomization error|0|||
129817925|NCT00420927|467297513|FG000|Period 2|Noncompliant with study drug|0|||
129817926|NCT00420927|467297514|FG001|Period 2|Noncompliant with study drug|0|||
129817927|NCT00420927|467297515|FG002|Period 2|Noncompliant with study drug|0|||
129817928|NCT00420927|467297516|FG003|Period 2|Noncompliant with study drug|1|||
129817929|NCT00420927|467297517|FG004|Period 2|Noncompliant with study drug|0|||
129817930|NCT00420927|467297518|FG005|Period 2|Noncompliant with study drug|0|||
129817931|NCT00420927|467297519|FG006|Period 2|Noncompliant with study drug|2|||
129817932|NCT00420927|467297513|FG000|Period 2|Methotrexate intolerance|0|||
129817933|NCT00420927|467297514|FG001|Period 2|Methotrexate intolerance|0|||
129817934|NCT00420927|467297515|FG002|Period 2|Methotrexate intolerance|0|||
129817935|NCT00420927|467297516|FG003|Period 2|Methotrexate intolerance|0|||
129817936|NCT00420927|467297517|FG004|Period 2|Methotrexate intolerance|0|||
129817937|NCT00420927|467297518|FG005|Period 2|Methotrexate intolerance|0|||
129817938|NCT00420927|467297519|FG006|Period 2|Methotrexate intolerance|1|||
129817939|NCT00420927|467297513|FG000|Period 2|Took prohibited medication|0|||
129817940|NCT00420927|467297514|FG001|Period 2|Took prohibited medication|0|||
129817941|NCT00420927|467297515|FG002|Period 2|Took prohibited medication|0|||
129817942|NCT00420927|467297516|FG003|Period 2|Took prohibited medication|0|||
129817943|NCT00420927|467297517|FG004|Period 2|Took prohibited medication|1|||
129817944|NCT00420927|467297518|FG005|Period 2|Took prohibited medication|0|||
129817945|NCT00420927|467297519|FG006|Period 2|Took prohibited medication|0|||
129817946|NCT03018704|467297520|FG000|Overall Study|Lost to Follow-up|1|||
129817947|NCT03018704|467297521|FG001|Overall Study|Lost to Follow-up|1|||
129817948|NCT00642460|467297525|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817949|NCT00642460|467297526|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
129817950|NCT00642460|467297527|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
129817951|NCT00642460|467297528|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817952|NCT00642460|467297529|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817953|NCT00642460|467297530|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817954|NCT00642460|467297525|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
129817955|NCT00642460|467297526|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817956|NCT00642460|467297527|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817957|NCT00642460|467297528|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817958|NCT00642460|467297529|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817959|NCT00642460|467297530|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817960|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
129817961|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
129817962|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817963|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817964|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817965|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817966|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Death|0|||
129817967|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Death|1|||
129817968|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Death|0|||
129817969|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Death|2|||
129817970|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Death|0|||
129817971|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Death|0|||
129817972|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
129817973|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
129817974|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129897261|NCT00711646|467584305|FG000|Overall Study|Lost to Follow-up|1|||
129897262|NCT00711646|467584306|FG001|Overall Study|Lost to Follow-up|0|||
130059238|NCT01877382|468170506|FG009|Dose Escalation|Study terminated by sponsor|0|||
130059239|NCT01877382|468170507|FG010|Dose Escalation|Study terminated by sponsor|0|||
130059240|NCT01877382|468170508|FG011|Dose Escalation|Study terminated by sponsor|0|||
130059241|NCT01877382|468170509|FG012|Dose Escalation|Study terminated by sponsor|3|||
130059242|NCT01877382|468170510|FG013|Dose Escalation|Study terminated by sponsor|0|||
130059243|NCT01877382|468170511|FG014|Dose Escalation|Study terminated by sponsor|0|||
130059244|NCT01877382|468170497|FG000|Dose Escalation|Death|0|||
130059245|NCT01877382|468170498|FG001|Dose Escalation|Death|0|||
130059246|NCT01877382|468170499|FG002|Dose Escalation|Death|0|||
130059247|NCT01877382|468170500|FG003|Dose Escalation|Death|0|||
130059248|NCT01877382|468170501|FG004|Dose Escalation|Death|0|||
130059249|NCT01877382|468170502|FG005|Dose Escalation|Death|0|||
130059250|NCT01877382|468170503|FG006|Dose Escalation|Death|0|||
130059251|NCT01877382|468170504|FG007|Dose Escalation|Death|1|||
130059252|NCT01877382|468170505|FG008|Dose Escalation|Death|0|||
130059253|NCT01877382|468170506|FG009|Dose Escalation|Death|0|||
130059254|NCT01877382|468170507|FG010|Dose Escalation|Death|0|||
130059255|NCT01877382|468170508|FG011|Dose Escalation|Death|0|||
129817975|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129817976|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129817977|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129817978|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
129817979|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
129817980|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817981|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817982|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817983|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817984|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817985|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
129817986|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817987|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817988|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817989|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817990|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817991|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817992|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817993|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
129817994|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817995|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817996|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129817997|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129817998|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129817999|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129818000|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
129818001|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
129818002|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818003|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818004|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818005|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818006|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
129818007|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
129818008|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818009|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818010|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818011|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818012|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
129818013|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
129818014|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818015|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
130059256|NCT01877382|468170509|FG012|Dose Escalation|Death|1|||
130059257|NCT01877382|468170510|FG013|Dose Escalation|Death|1|||
130059258|NCT01877382|468170511|FG014|Dose Escalation|Death|0|||
130059259|NCT01877382|468170497|FG000|Dose Expansion|Progressive disease|0|||
130059260|NCT01877382|468170498|FG001|Dose Expansion|Progressive disease|0|||
130059261|NCT01877382|468170499|FG002|Dose Expansion|Progressive disease|0|||
130059262|NCT01877382|468170500|FG003|Dose Expansion|Progressive disease|0|||
130059263|NCT01877382|468170501|FG004|Dose Expansion|Progressive disease|0|||
130059264|NCT01877382|468170502|FG005|Dose Expansion|Progressive disease|0|||
130059265|NCT01877382|468170503|FG006|Dose Expansion|Progressive disease|0|||
130059266|NCT01877382|468170504|FG007|Dose Expansion|Progressive disease|0|||
129818016|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818017|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818018|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
129818019|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
129818020|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Other|0|||
129818021|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Other|0|||
129818022|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Other|0|||
129818023|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Other|0|||
129818024|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Other|2|||
129818025|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Other|2|||
129818026|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Death|0|||
129818027|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Death|0|||
129818028|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Death|0|||
129818029|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Death|0|||
129818030|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Death|0|||
129818031|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Death|3|||
129818032|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818033|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818034|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818035|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818036|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818037|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
129818038|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818039|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818040|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818041|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818042|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
129818043|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
129818044|NCT02557646|467297533|FG000|Overall Study|Adverse Event|40|||
129818045|NCT02557646|467297533|FG000|Overall Study|Death|1|||
129818046|NCT02557646|467297533|FG000|Overall Study|Lack of Efficacy|186|||
129818047|NCT02557646|467297533|FG000|Overall Study|Withdrawal by Subject|18|||
129818048|NCT02557646|467297533|FG000|Overall Study|Lost to Follow-up|17|||
129818049|NCT02557646|467297533|FG000|Overall Study|Other|14|||
129818050|NCT04448171|467297534|FG000|Overall Study|Procedure Cancelled|1|||
129818051|NCT04448171|467297535|FG001|Overall Study|Procedure Cancelled|0|||
129818052|NCT04448171|467297534|FG000|Overall Study|Protocol Violation|1|||
129818053|NCT04448171|467297535|FG001|Overall Study|Protocol Violation|0|||
129818054|NCT02088047|467297536|FG000|Overall Study|Withdrawal by Subject|1|||
130059267|NCT01877382|468170505|FG008|Dose Expansion|Progressive disease|0|||
130059268|NCT01877382|468170506|FG009|Dose Expansion|Progressive disease|0|||
130059269|NCT01877382|468170507|FG010|Dose Expansion|Progressive disease|0|||
130059270|NCT01877382|468170508|FG011|Dose Expansion|Progressive disease|0|||
130059271|NCT01877382|468170509|FG012|Dose Expansion|Progressive disease|0|||
130059272|NCT01877382|468170510|FG013|Dose Expansion|Progressive disease|0|||
130059273|NCT01877382|468170511|FG014|Dose Expansion|Progressive disease|11|||
130059274|NCT01877382|468170497|FG000|Dose Expansion|Clinical progression|0|||
130059275|NCT01877382|468170498|FG001|Dose Expansion|Clinical progression|0|||
130059276|NCT01877382|468170499|FG002|Dose Expansion|Clinical progression|0|||
130059277|NCT01877382|468170500|FG003|Dose Expansion|Clinical progression|0|||
130059278|NCT01877382|468170501|FG004|Dose Expansion|Clinical progression|0|||
130059279|NCT01877382|468170502|FG005|Dose Expansion|Clinical progression|0|||
130059280|NCT01877382|468170503|FG006|Dose Expansion|Clinical progression|0|||
130059281|NCT01877382|468170504|FG007|Dose Expansion|Clinical progression|0|||
130059282|NCT01877382|468170505|FG008|Dose Expansion|Clinical progression|0|||
130059283|NCT01877382|468170506|FG009|Dose Expansion|Clinical progression|0|||
130059284|NCT01877382|468170507|FG010|Dose Expansion|Clinical progression|0|||
130059285|NCT01877382|468170508|FG011|Dose Expansion|Clinical progression|0|||
130059286|NCT01877382|468170509|FG012|Dose Expansion|Clinical progression|0|||
130059287|NCT01877382|468170510|FG013|Dose Expansion|Clinical progression|0|||
130059288|NCT01877382|468170511|FG014|Dose Expansion|Clinical progression|6|||
130059289|NCT01877382|468170497|FG000|Dose Expansion|Adverse Event|0|||
130059290|NCT01877382|468170498|FG001|Dose Expansion|Adverse Event|0|||
130059291|NCT01877382|468170499|FG002|Dose Expansion|Adverse Event|0|||
130059292|NCT01877382|468170500|FG003|Dose Expansion|Adverse Event|0|||
129818055|NCT02088047|467297537|FG001|Overall Study|Withdrawal by Subject|0|||
129818056|NCT04605484|467297540|FG000|Overall Study|Lost to Follow-up|0|||
129818057|NCT04605484|467297541|FG001|Overall Study|Lost to Follow-up|1|||
129818058|NCT04605484|467297542|FG002|Overall Study|Lost to Follow-up|1|||
130059293|NCT01877382|468170501|FG004|Dose Expansion|Adverse Event|0|||
130059294|NCT01877382|468170502|FG005|Dose Expansion|Adverse Event|0|||
130059295|NCT01877382|468170503|FG006|Dose Expansion|Adverse Event|0|||
130059296|NCT01877382|468170504|FG007|Dose Expansion|Adverse Event|0|||
130059297|NCT01877382|468170505|FG008|Dose Expansion|Adverse Event|0|||
130059298|NCT01877382|468170506|FG009|Dose Expansion|Adverse Event|0|||
130059299|NCT01877382|468170507|FG010|Dose Expansion|Adverse Event|0|||
130059300|NCT01877382|468170508|FG011|Dose Expansion|Adverse Event|0|||
130059301|NCT01877382|468170509|FG012|Dose Expansion|Adverse Event|0|||
130059302|NCT01877382|468170510|FG013|Dose Expansion|Adverse Event|0|||
130059303|NCT01877382|468170511|FG014|Dose Expansion|Adverse Event|1|||
130059304|NCT01877382|468170497|FG000|Dose Expansion|Death|0|||
129818059|NCT04605484|467297540|FG000|Overall Study|Other|0|||
129818060|NCT04605484|467297541|FG001|Overall Study|Other|1|||
129818061|NCT04605484|467297542|FG002|Overall Study|Other|0|||
129818062|NCT00459953|467297543|FG000|Overall Study|not analyzed-household member in study|1|||
129818063|NCT00459953|467297544|FG001|Overall Study|not analyzed-household member in study|1|||
129818064|NCT01233258|467297546|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818065|NCT01233258|467297547|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818066|NCT01233258|467297548|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818067|NCT01233258|467297549|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
129818068|NCT01233258|467297550|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818069|NCT01233258|467297551|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
129818070|NCT01233258|467297546|FG000|First Intervention (6 Months)|Protocol Violation|0|||
129818071|NCT01233258|467297547|FG001|First Intervention (6 Months)|Protocol Violation|0|||
129818072|NCT01233258|467297548|FG002|First Intervention (6 Months)|Protocol Violation|1|||
129818073|NCT01233258|467297549|FG003|First Intervention (6 Months)|Protocol Violation|0|||
129818074|NCT01233258|467297550|FG004|First Intervention (6 Months)|Protocol Violation|0|||
129818075|NCT01233258|467297551|FG005|First Intervention (6 Months)|Protocol Violation|0|||
129818076|NCT01233258|467297546|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
129818077|NCT01233258|467297547|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818078|NCT01233258|467297548|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818079|NCT01233258|467297549|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818080|NCT01233258|467297550|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818081|NCT01233258|467297551|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818082|NCT01049308|467297552|FG000|Pill Counts|Withdrawal by Subject|83|||
129818083|NCT03926169|467297557|FG000|Period A|Adverse Event|2|||
129818084|NCT03926169|467297558|FG001|Period A|Adverse Event|2|||
129818085|NCT03926169|467297559|FG002|Period A|Adverse Event|1|||
129818086|NCT03926169|467297557|FG000|Period A|Withdrawal by Subject|2|||
129818087|NCT03926169|467297558|FG001|Period A|Withdrawal by Subject|2|||
129818088|NCT03926169|467297559|FG002|Period A|Withdrawal by Subject|2|||
129818089|NCT03926169|467297557|FG000|Period A|Lost to Follow-up|3|||
129818090|NCT03926169|467297558|FG001|Period A|Lost to Follow-up|1|||
129818091|NCT03926169|467297559|FG002|Period A|Lost to Follow-up|0|||
129818092|NCT03926169|467297557|FG000|Period A|Lack of Efficacy|0|||
129818093|NCT03926169|467297558|FG001|Period A|Lack of Efficacy|2|||
129818094|NCT03926169|467297559|FG002|Period A|Lack of Efficacy|2|||
129818095|NCT03926169|467297557|FG000|Period A|COVID-19 Infection|0|||
129818096|NCT03926169|467297558|FG001|Period A|COVID-19 Infection|1|||
129818097|NCT03926169|467297559|FG002|Period A|COVID-19 Infection|0|||
129818098|NCT03926169|467297557|FG000|Period A|COVID-19 Logistical Restrictions|0|||
129818099|NCT03926169|467297558|FG001|Period A|COVID-19 Logistical Restrictions|2|||
129818100|NCT03926169|467297559|FG002|Period A|COVID-19 Logistical Restrictions|1|||
130059305|NCT01877382|468170498|FG001|Dose Expansion|Death|0|||
130059306|NCT01877382|468170499|FG002|Dose Expansion|Death|0|||
130059307|NCT01877382|468170500|FG003|Dose Expansion|Death|0|||
129818101|NCT03926169|467297557|FG000|Period A|Other, Not Specified|1|||
129818102|NCT03926169|467297558|FG001|Period A|Other, Not Specified|0|||
129818103|NCT03926169|467297559|FG002|Period A|Other, Not Specified|0|||
129818104|NCT03926169|467297557|FG000|Period B|Adverse Event|3|||
129818105|NCT03926169|467297558|FG001|Period B|Adverse Event|1|||
129818106|NCT03926169|467297559|FG002|Period B|Adverse Event|1|||
129818107|NCT03926169|467297557|FG000|Period B|Withdrawal by Subject|1|||
129818108|NCT03926169|467297558|FG001|Period B|Withdrawal by Subject|3|||
129818109|NCT03926169|467297559|FG002|Period B|Withdrawal by Subject|0|||
129818110|NCT03926169|467297557|FG000|Period B|Lack of Efficacy|3|||
129818111|NCT03926169|467297558|FG001|Period B|Lack of Efficacy|1|||
129818112|NCT03926169|467297559|FG002|Period B|Lack of Efficacy|1|||
129818113|NCT03926169|467297557|FG000|Period B|Lost to Follow-up|1|||
129818114|NCT03926169|467297558|FG001|Period B|Lost to Follow-up|1|||
129818115|NCT03926169|467297559|FG002|Period B|Lost to Follow-up|4|||
129818116|NCT03926169|467297557|FG000|Period B|Other, Not Specified|62|||
129818117|NCT03926169|467297558|FG001|Period B|Other, Not Specified|57|||
129818118|NCT03926169|467297559|FG002|Period B|Other, Not Specified|65|||
129818119|NCT02439138|467297561|FG000|Overall Study|Adverse Event|1|||
129818120|NCT02439138|467297561|FG000|Overall Study|PI decision to terminate the study|2|||
129818121|NCT00006237|467297562|FG000|Overall Study|Adverse Event|39|||
129818122|NCT00006237|467297563|FG001|Overall Study|Adverse Event|29|||
129818123|NCT00006237|467297562|FG000|Overall Study|Death|1|||
129818124|NCT00006237|467297563|FG001|Overall Study|Death|0|||
129818125|NCT00006237|467297562|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
130059308|NCT01877382|468170501|FG004|Dose Expansion|Death|0|||
129818126|NCT00006237|467297563|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
129818127|NCT00006237|467297562|FG000|Overall Study|Progression/relapse|54|||
129818128|NCT00006237|467297563|FG001|Overall Study|Progression/relapse|2|||
129818129|NCT00006237|467297562|FG000|Overall Study|Not eligible|9|||
129818130|NCT00006237|467297563|FG001|Overall Study|Not eligible|20|||
129818131|NCT00006237|467297562|FG000|Overall Study|Withdrawal by Subject|0|||
129818132|NCT00006237|467297563|FG001|Overall Study|Withdrawal by Subject|1|||
129818133|NCT00006237|467297562|FG000|Overall Study|Not protocol specified|14|||
129818134|NCT00006237|467297563|FG001|Overall Study|Not protocol specified|5|||
129818135|NCT01846416|467297564|FG000|Treatment Phase|Death|2|||
129818136|NCT01846416|467297565|FG001|Treatment Phase|Death|9|||
129818137|NCT01846416|467297566|FG002|Treatment Phase|Death|1|||
129818138|NCT01846416|467297564|FG000|Treatment Phase|Withdrawal by Subject|2|||
129818139|NCT01846416|467297565|FG001|Treatment Phase|Withdrawal by Subject|4|||
129818140|NCT01846416|467297566|FG002|Treatment Phase|Withdrawal by Subject|2|||
129818141|NCT01846416|467297564|FG000|Treatment Phase|Other|1|||
129818142|NCT01846416|467297565|FG001|Treatment Phase|Other|5|||
129818143|NCT01846416|467297566|FG002|Treatment Phase|Other|1|||
129818144|NCT01846416|467297564|FG000|Treatment Phase|Physician Decision|1|||
129818145|NCT01846416|467297565|FG001|Treatment Phase|Physician Decision|2|||
129818146|NCT01846416|467297566|FG002|Treatment Phase|Physician Decision|0|||
129897263|NCT00711646|467584305|FG000|Overall Study|administrative decision|0|||
129818147|NCT01846416|467297564|FG000|Treatment Phase|Adverse Event|3|||
129818148|NCT01846416|467297565|FG001|Treatment Phase|Adverse Event|4|||
129818149|NCT01846416|467297566|FG002|Treatment Phase|Adverse Event|0|||
129818150|NCT01846416|467297564|FG000|Treatment Phase|Non-compliance|0|||
129818151|NCT01846416|467297565|FG001|Treatment Phase|Non-compliance|2|||
129818152|NCT01846416|467297566|FG002|Treatment Phase|Non-compliance|0|||
129818153|NCT01846416|467297564|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
129818154|NCT01846416|467297565|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
129818155|NCT01846416|467297566|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
129818156|NCT01846416|467297564|FG000|Treatment Phase|Progressive Disease|21|||
129818157|NCT01846416|467297565|FG001|Treatment Phase|Progressive Disease|63|||
129818158|NCT01846416|467297566|FG002|Treatment Phase|Progressive Disease|9|||
129818159|NCT01846416|467297564|FG000|Survival Follow-up|Death|21|||
129818160|NCT01846416|467297565|FG001|Survival Follow-up|Death|62|||
129818161|NCT01846416|467297566|FG002|Survival Follow-up|Death|9|||
129818162|NCT01846416|467297564|FG000|Survival Follow-up|Lost to Follow-up|0|||
129818163|NCT01846416|467297565|FG001|Survival Follow-up|Lost to Follow-up|2|||
129818164|NCT01846416|467297566|FG002|Survival Follow-up|Lost to Follow-up|2|||
129818165|NCT01846416|467297564|FG000|Survival Follow-up|Withdrawal by Subject|2|||
129818166|NCT01846416|467297565|FG001|Survival Follow-up|Withdrawal by Subject|7|||
129818167|NCT01846416|467297566|FG002|Survival Follow-up|Withdrawal by Subject|0|||
129818168|NCT01846416|467297564|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
129818169|NCT01846416|467297565|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
129818170|NCT01846416|467297566|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
129818171|NCT01846416|467297564|FG000|Survival Follow-up|Other|3|||
129818172|NCT01846416|467297565|FG001|Survival Follow-up|Other|1|||
129818173|NCT01846416|467297566|FG002|Survival Follow-up|Other|1|||
129818174|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
129818175|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
129818176|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
129818177|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818178|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818179|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818180|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818181|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818182|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818183|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818184|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818185|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
129818186|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129897264|NCT00711646|467584306|FG001|Overall Study|administrative decision|1|||
129897265|NCT00711646|467584305|FG000|Overall Study|patient non-compliance|1|||
129818187|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
129818188|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818189|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818190|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129897266|NCT00711646|467584306|FG001|Overall Study|patient non-compliance|0|||
129818191|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818192|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818193|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818194|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129897267|NCT00269399|467584307|FG000|Overall Study|Lack of Efficacy|27|||
129818195|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818196|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
129818197|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
129818198|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
129818199|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818200|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818201|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818202|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818203|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818204|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818205|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818206|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818207|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
129818208|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
129818209|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818210|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818211|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818212|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818213|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818214|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818215|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818216|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818217|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818218|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
129818219|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
129818220|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
129818221|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818222|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
130059309|NCT01877382|468170502|FG005|Dose Expansion|Death|0|||
130059310|NCT01877382|468170503|FG006|Dose Expansion|Death|0|||
130059311|NCT01877382|468170504|FG007|Dose Expansion|Death|0|||
129818223|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818224|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818225|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818226|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818227|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818228|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818229|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818230|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
129818231|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
129818232|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818233|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818234|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818235|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818236|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818237|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818238|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818239|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818240|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818241|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
129818242|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818243|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818244|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818245|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818246|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818247|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818248|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818249|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818250|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818251|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818252|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818253|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818254|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818255|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
130059312|NCT01877382|468170505|FG008|Dose Expansion|Death|0|||
130059313|NCT01877382|468170506|FG009|Dose Expansion|Death|0|||
130059314|NCT01877382|468170507|FG010|Dose Expansion|Death|0|||
129818256|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
129818257|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818258|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818259|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818260|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818261|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818262|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818263|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818264|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818265|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818266|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818267|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
129818268|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818269|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818270|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818271|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818272|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818273|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818274|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818275|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818276|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
129818277|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
129818278|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
129818279|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818280|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818281|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818282|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818283|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818284|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818285|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818286|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818287|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
129818288|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
129818289|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
129818290|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818291|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818292|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818293|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818294|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818295|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818296|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818297|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818298|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
129818299|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818300|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
129818301|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818302|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818303|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818304|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818305|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818306|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818307|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818308|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818309|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
129818310|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818311|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818312|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818313|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818314|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818315|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818316|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818317|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818318|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818319|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818320|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129897268|NCT00269399|467584308|FG001|Overall Study|Lack of Efficacy|10|||
130059315|NCT01877382|468170508|FG011|Dose Expansion|Death|0|||
130059316|NCT01877382|468170509|FG012|Dose Expansion|Death|0|||
130059317|NCT01877382|468170510|FG013|Dose Expansion|Death|0|||
130059318|NCT01877382|468170511|FG014|Dose Expansion|Death|1|||
130059319|NCT01877382|468170497|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059320|NCT01877382|468170498|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059321|NCT01877382|468170499|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059322|NCT01877382|468170500|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059323|NCT01877382|468170501|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059324|NCT01877382|468170502|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059325|NCT01877382|468170503|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129818321|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818322|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818323|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
129818324|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
129818325|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
129818326|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
129818327|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818328|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818329|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818330|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818331|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818332|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818333|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818334|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818335|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
129818336|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818337|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818338|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818339|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818340|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818341|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818342|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818343|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818344|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818345|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
129818346|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
129818347|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
129818348|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
129818349|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818350|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818351|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818352|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818353|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818354|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818355|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818356|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
129818357|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
129818358|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818359|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
129818360|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818361|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818362|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
130059326|NCT01877382|468170504|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059327|NCT01877382|468170505|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129818363|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818364|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818365|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818366|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818367|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
129818368|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
129818369|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
129818370|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
129818371|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818372|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
130059328|NCT01877382|468170506|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059329|NCT01877382|468170507|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129818373|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818374|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818375|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818376|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818377|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818378|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818379|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
129818380|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
129818381|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818382|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818383|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818384|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818385|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818386|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818387|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818388|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818389|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818390|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818391|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
129818392|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818393|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818394|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818395|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818396|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818397|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818398|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818399|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818400|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818401|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
129818402|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818403|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818404|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818405|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818406|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818407|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818408|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818409|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818410|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818411|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
129818412|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818413|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818414|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818415|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818416|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818417|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818418|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818419|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818420|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818421|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818422|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818423|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818424|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
129818425|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818426|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
129818427|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818428|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818429|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
130059330|NCT01877382|468170508|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129818430|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129897269|NCT00269399|467584307|FG000|Overall Study|Adverse Event|10|||
129818431|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818432|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818433|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818434|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818435|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
129818436|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818437|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
129818438|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818439|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818440|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818441|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818442|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818443|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818444|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818445|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818446|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
129818447|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818448|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
129818449|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818450|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818451|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818452|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818453|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818454|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818455|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818456|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818457|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
129818458|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818459|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
129818460|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
129818461|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
129818462|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
129818463|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
129818464|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
129818465|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
129818466|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
129818467|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
129818468|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
129818469|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
129818470|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
129818471|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
129818472|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
129818473|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
129818474|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
129818475|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
129818476|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
129818477|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
129818478|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
129818479|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
129818480|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
129818481|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
129818482|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818483|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818484|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818485|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818486|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818487|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818488|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818489|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818490|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818491|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818492|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
129818493|NCT00039130|467297580|FG000|Overall Study|Adverse Event|11|||
129818494|NCT00039130|467297580|FG000|Overall Study|Death|9|||
129818495|NCT00039130|467297580|FG000|Overall Study|Withdrawal by Subject|3|||
129818496|NCT00039130|467297580|FG000|Overall Study|Progression|2|||
129818497|NCT00039130|467297580|FG000|Overall Study|Subsequent treatment|2|||
129818498|NCT00039130|467297580|FG000|Overall Study|Physician Decision|3|||
129818499|NCT01950741|467297581|FG000|Overall Study|Lost to Follow-up|1|||
129818500|NCT01950741|467297581|FG000|Overall Study|Death|1|||
129818501|NCT01950741|467297581|FG000|Overall Study|Withdrawal by Subject|1|||
129897270|NCT00269399|467584308|FG001|Overall Study|Adverse Event|4|||
129818502|NCT02521870|467297582|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818503|NCT02521870|467297583|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
129818504|NCT02521870|467297584|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818505|NCT02521870|467297585|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818506|NCT02521870|467297586|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818507|NCT02521870|467297587|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818508|NCT02521870|467297588|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818509|NCT02521870|467297589|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818510|NCT02521870|467297590|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818511|NCT02521870|467297591|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818512|NCT02521870|467297592|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818513|NCT02521870|467297593|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818514|NCT02521870|467297582|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
129818515|NCT02521870|467297583|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
129818516|NCT02521870|467297584|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
129818517|NCT02521870|467297585|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
129818518|NCT02521870|467297586|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
129818519|NCT02521870|467297587|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
130059331|NCT01877382|468170509|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059332|NCT01877382|468170510|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
130059333|NCT01877382|468170511|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
129818520|NCT02521870|467297588|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
129818521|NCT02521870|467297589|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
129818522|NCT02521870|467297590|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
129818523|NCT02521870|467297591|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
129818524|NCT02521870|467297592|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
129818525|NCT02521870|467297593|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
129818526|NCT02521870|467297582|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
129818527|NCT02521870|467297583|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
129818528|NCT02521870|467297584|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
129818529|NCT02521870|467297585|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
129818530|NCT02521870|467297586|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
129818531|NCT02521870|467297587|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
129818532|NCT02521870|467297588|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
129818533|NCT02521870|467297589|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
129818534|NCT02521870|467297590|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
129818535|NCT02521870|467297591|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
129818536|NCT02521870|467297592|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
129818537|NCT02521870|467297593|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
129818538|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818539|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818540|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818541|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818542|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
129818543|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818544|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818545|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818546|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818547|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818548|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
129818549|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818550|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
129818551|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
129818552|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
129818553|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
129818554|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
129818555|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
129818556|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
129818557|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
129818558|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
129818559|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
129818560|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
129818561|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
129818562|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
129818563|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
129818564|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
129818565|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
129818566|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
129818567|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
129818568|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
129818569|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
129818570|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
129818571|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
129818572|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
129818573|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
129818574|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Death|0|||
129818575|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Death|0|||
129818576|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Death|0|||
129818577|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Death|0|||
129818578|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Death|1|||
129818579|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Death|1|||
129818580|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Death|3|||
129818581|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Death|1|||
129818582|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Death|1|||
129818583|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Death|5|||
129818584|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Death|2|||
129818585|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Death|2|||
129818586|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Other|0|||
129818587|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Other|0|||
129818588|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Other|0|||
129818589|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Other|0|||
129818590|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Other|10|||
129818591|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Other|3|||
129818592|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Other|2|||
129818593|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Other|0|||
129818594|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Other|10|||
129818595|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Other|5|||
129818596|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Other|1|||
129818597|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Other|7|||
129818598|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818599|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818600|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818601|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818602|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
129818603|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818604|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818605|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818606|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818607|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818608|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818609|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818610|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818611|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818612|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818613|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818614|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
129818615|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818616|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818617|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818618|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818619|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818620|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818621|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818622|NCT00519831|467297594|FG000|Overall Study|Adverse Event|3|||
129818623|NCT02854631|467297595|FG000|Overall Study|Adverse Event|1|||
129818624|NCT02854631|467297596|FG001|Overall Study|Adverse Event|2|||
129818625|NCT02854631|467297595|FG000|Overall Study|Withdrew Consent|3|||
129818626|NCT02854631|467297596|FG001|Overall Study|Withdrew Consent|2|||
129818627|NCT02854631|467297595|FG000|Overall Study|Investigator's Discretion|2|||
129818628|NCT02854631|467297596|FG001|Overall Study|Investigator's Discretion|0|||
129818629|NCT02854631|467297595|FG000|Overall Study|Death|12|||
129818630|NCT02854631|467297596|FG001|Overall Study|Death|8|||
129818631|NCT02854631|467297595|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
129818632|NCT02854631|467297596|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
129818633|NCT02854631|467297595|FG000|Overall Study|Protocol Violation|0|||
129818634|NCT02854631|467297596|FG001|Overall Study|Protocol Violation|1|||
129818635|NCT02854631|467297595|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
129818636|NCT02854631|467297596|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
129818637|NCT02854631|467297595|FG000|Overall Study|Lost to Follow-up|4|||
129818638|NCT02854631|467297596|FG001|Overall Study|Lost to Follow-up|2|||
129818639|NCT03200860|467297597|FG000|Overall Study|Withdrawal by Subject|1|||
129818640|NCT03200860|467297598|FG001|Overall Study|Withdrawal by Subject|0|||
129818641|NCT04342897|467297599|FG000|Overall Study|Death|7|||
129818642|NCT04342897|467297600|FG001|Overall Study|Death|4|||
129818643|NCT04342897|467297599|FG000|Overall Study|Lost to Follow-up|6|||
129818644|NCT04342897|467297600|FG001|Overall Study|Lost to Follow-up|6|||
129818645|NCT04342897|467297599|FG000|Overall Study|Withdrawal by Subject|1|||
129818646|NCT04342897|467297600|FG001|Overall Study|Withdrawal by Subject|2|||
129818647|NCT02634320|467297602|FG000|Overall Study|Adverse Event|2|||
129818648|NCT02634320|467297602|FG000|Overall Study|Lost to Follow-up|3|||
129818649|NCT02634320|467297602|FG000|Overall Study|Moved out of area|2|||
129818650|NCT02634320|467297602|FG000|Overall Study|Out of window for study visits|1|||
129818651|NCT02634320|467297602|FG000|Overall Study|Protocol Violation|1|||
129818652|NCT02634320|467297602|FG000|Overall Study|Withdrawal by Subject|5|||
129818653|NCT02634320|467297602|FG000|Overall Study|Lack of Efficacy|2|||
129818654|NCT03919799|467297606|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
129818655|NCT03919799|467297607|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
129818656|NCT03919799|467297608|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
129818657|NCT03919799|467297609|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
129818658|NCT03919799|467297610|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
129818659|NCT03919799|467297606|FG000|DB Period (28 Weeks)|Adverse Event|1|||
129818660|NCT03919799|467297607|FG001|DB Period (28 Weeks)|Adverse Event|1|||
129818661|NCT03919799|467297608|FG002|DB Period (28 Weeks)|Adverse Event|1|||
129818662|NCT03919799|467297609|FG003|DB Period (28 Weeks)|Adverse Event|0|||
129818663|NCT03919799|467297610|FG004|DB Period (28 Weeks)|Adverse Event|0|||
129818664|NCT03919799|467297606|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818665|NCT03919799|467297607|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
129818666|NCT03919799|467297608|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818667|NCT03919799|467297609|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818668|NCT03919799|467297610|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818669|NCT03919799|467297606|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818670|NCT03919799|467297607|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
129818671|NCT03919799|467297608|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818672|NCT03919799|467297609|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818673|NCT03919799|467297610|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818674|NCT03919799|467297606|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
129818675|NCT03919799|467297607|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
129818676|NCT03919799|467297608|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
129818677|NCT03919799|467297609|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
129818678|NCT03919799|467297610|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
129818679|NCT04656691|467297615|FG000|Overall Study|Adverse Event|1|||
129818680|NCT03199274|467297616|FG000|Overall Study|Withdrawal by Subject|4|||
129818681|NCT03199274|467297617|FG001|Overall Study|Withdrawal by Subject|0|||
129818682|NCT03199274|467297616|FG000|Overall Study|Lost to Follow-up|0|||
129818683|NCT03199274|467297617|FG001|Overall Study|Lost to Follow-up|1|||
129818684|NCT03199274|467297616|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
129818685|NCT03199274|467297617|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
129818686|NCT05980182|467297623|FG000|Overall Study|Lost to Follow-up|10|||
129818687|NCT05475236|467297624|FG000|Overall Study|Withdrawal by Subject|0|||
129818688|NCT05475236|467297625|FG001|Overall Study|Withdrawal by Subject|1|||
129818689|NCT00638378|467298788|FG000|Overall Study|Death|2|||
130059334|NCT04095286|468170512|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059335|NCT04095286|468170513|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
130059336|NCT04095286|468170514|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059337|NCT04095286|468170515|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059338|NCT04095286|468170516|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129818690|NCT00638378|467298788|FG000|Overall Study|Adverse Event|1|||
129818691|NCT00638378|467298788|FG000|Overall Study|Disease progression|15|||
129818692|NCT00638378|467298788|FG000|Overall Study|Physician Decision|4|||
129818693|NCT01411774|467298806|FG000|Overall Study|Withdrawal by Subject|0|||
129818694|NCT01411774|467298807|FG001|Overall Study|Withdrawal by Subject|3|||
129818695|NCT02990910|467298813|FG000|Overall Study|Lack of Efficacy|6|||
129818696|NCT02990910|467298814|FG001|Overall Study|Lack of Efficacy|10|||
129818697|NCT00309387|467298819|FG000|Overall Study|Death|72|||
129818698|NCT00309387|467298820|FG001|Overall Study|Death|73|||
129818699|NCT00309387|467298819|FG000|Overall Study|Lost to Follow-up|70|||
129818700|NCT00309387|467298820|FG001|Overall Study|Lost to Follow-up|86|||
129818701|NCT02483520|467298821|FG000|Overall Study|Lost to Follow-up|3|||
130059339|NCT04095286|468170517|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059340|NCT04095286|468170512|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
130112419|NCT01393990|468373381|FG005|Overall Study|Adverse Event|0|||
129818702|NCT02483520|467298822|FG001|Overall Study|Lost to Follow-up|4|||
129818703|NCT02483520|467298821|FG000|Overall Study|Withdrawal by Subject|4|||
129818704|NCT02483520|467298822|FG001|Overall Study|Withdrawal by Subject|14|||
129818705|NCT02483520|467298821|FG000|Overall Study|Hospitalized|2|||
129818706|NCT02483520|467298822|FG001|Overall Study|Hospitalized|3|||
129818707|NCT02483520|467298821|FG000|Overall Study|Moved to LTC|2|||
129818708|NCT02483520|467298822|FG001|Overall Study|Moved to LTC|3|||
129818709|NCT03902574|467298832|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
129818710|NCT03902574|467298833|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
130059341|NCT04095286|468170513|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130059342|NCT04095286|468170514|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130059343|NCT04095286|468170515|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130059344|NCT04095286|468170516|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130059345|NCT04095286|468170517|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
130059346|NCT04095286|468170512|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130059347|NCT04095286|468170513|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130059348|NCT04095286|468170514|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
130059349|NCT04095286|468170515|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130059350|NCT04095286|468170516|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130059351|NCT04095286|468170517|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
130059352|NCT04095286|468170512|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059353|NCT04095286|468170513|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059354|NCT04095286|468170514|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
130059355|NCT04095286|468170515|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059356|NCT04095286|468170516|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059357|NCT04095286|468170517|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
130059358|NCT04095286|468170512|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130059359|NCT04095286|468170513|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130059360|NCT04095286|468170514|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130059361|NCT04095286|468170515|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130059362|NCT04095286|468170516|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
130059363|NCT04095286|468170517|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
130059364|NCT02020031|468172294|FG000|Overall Study|Physician Decision|1|||
130059365|NCT02020031|468172295|FG001|Overall Study|Physician Decision|1|||
130059366|NCT04092816|468172299|FG000|Overall Study|Lost to Follow-up|1|||
130059367|NCT04092816|468172300|FG001|Overall Study|Lost to Follow-up|2|||
130059368|NCT02115113|468172301|FG000|Participants in Run-in Period|Death|0|||
130059369|NCT02115113|468172302|FG001|Participants in Run-in Period|Death|0|||
130059370|NCT02115113|468172303|FG002|Participants in Run-in Period|Death|1|||
130059371|NCT02115113|468172301|FG000|Participants in Run-in Period|Administrative problems|0|||
130059372|NCT02115113|468172302|FG001|Participants in Run-in Period|Administrative problems|0|||
130059373|NCT02115113|468172303|FG002|Participants in Run-in Period|Administrative problems|1|||
130059374|NCT02115113|468172301|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
130059375|NCT02115113|468172302|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
130059376|NCT02115113|468172303|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
130059377|NCT02115113|468172301|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
130059378|NCT02115113|468172302|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
130059379|NCT02115113|468172303|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
129818711|NCT03902574|467298834|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
129818712|NCT04492618|467298836|FG000|Overall Study|Withdrawal by Subject|1|||
129818713|NCT02101060|467298841|FG000|Overall Study|Adverse Event|1|||
129818714|NCT02101060|467298842|FG001|Overall Study|Adverse Event|0|||
129818715|NCT02101060|467298841|FG000|Overall Study|Withdrawal by Subject|1|||
129818716|NCT02101060|467298842|FG001|Overall Study|Withdrawal by Subject|1|||
129818717|NCT02101060|467298841|FG000|Overall Study|Lost to Follow-up|3|||
129818718|NCT02101060|467298842|FG001|Overall Study|Lost to Follow-up|3|||
129818719|NCT00743340|467298846|FG000|Overall Study|Study medication non-compliance|1|||
129818720|NCT00743340|467298846|FG000|Overall Study|Lost to Follow-up|1|||
129818721|NCT00743340|467298846|FG000|Overall Study|Withdrawal from the Study|5|||
129818722|NCT00743340|467298846|FG000|Overall Study|Protocol Violation|1|||
129818723|NCT00743340|467298846|FG000|Overall Study|Virologic failure|8|||
129818724|NCT00743340|467298846|FG000|Overall Study|Pregnancy|1|||
129818725|NCT00743340|467298846|FG000|Overall Study|Rolled over to other Gilead Study|23|||
129818726|NCT00743340|467298846|FG000|Overall Study|Participant Relocated|1|||
129818727|NCT01402492|467298851|FG000|Overall Study|Withdrawal by Subject|17|||
129818728|NCT01402492|467298852|FG001|Overall Study|Withdrawal by Subject|11|||
129818729|NCT01402492|467298853|FG002|Overall Study|Withdrawal by Subject|11|||
129818730|NCT01402492|467298851|FG000|Overall Study|Adverse Event|2|||
129818731|NCT01402492|467298852|FG001|Overall Study|Adverse Event|3|||
129818732|NCT01402492|467298853|FG002|Overall Study|Adverse Event|4|||
129818733|NCT01402492|467298851|FG000|Overall Study|Physician Decision|0|||
129818734|NCT01402492|467298852|FG001|Overall Study|Physician Decision|3|||
129818735|NCT01402492|467298853|FG002|Overall Study|Physician Decision|0|||
129818736|NCT01402492|467298851|FG000|Overall Study|Incarcerated (N=3)|2|||
130059380|NCT02115113|468172301|FG000|Participants Randomized|Lost to Follow-up|1|||
129818737|NCT01402492|467298852|FG001|Overall Study|Incarcerated (N=3)|0|||
129818738|NCT01402492|467298853|FG002|Overall Study|Incarcerated (N=3)|1|||
129818739|NCT00814164|467298854|FG000|Overall Study|Progression|7|||
129818740|NCT00814164|467298854|FG000|Overall Study|not stated|7|||
129818741|NCT00814164|467298854|FG000|Overall Study|Death|5|||
129818742|NCT01169493|467298860|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
129818743|NCT01169493|467298861|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
129818744|NCT01169493|467298862|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
129818745|NCT01169493|467298863|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
129818746|NCT01169493|467298864|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
129818747|NCT01169493|467298865|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
129818748|NCT01169493|467298860|FG000|Period 3 (6 Months)|Adverse Event|0|||
129818749|NCT01169493|467298861|FG001|Period 3 (6 Months)|Adverse Event|1|||
129818750|NCT01169493|467298862|FG002|Period 3 (6 Months)|Adverse Event|0|||
129818751|NCT01169493|467298863|FG003|Period 3 (6 Months)|Adverse Event|0|||
129818752|NCT01169493|467298864|FG004|Period 3 (6 Months)|Adverse Event|0|||
129818753|NCT01169493|467298865|FG005|Period 3 (6 Months)|Adverse Event|0|||
129818754|NCT01169493|467298860|FG000|Period 3 (6 Months)|Physician Decision|0|||
129818755|NCT01169493|467298861|FG001|Period 3 (6 Months)|Physician Decision|1|||
129818756|NCT01169493|467298862|FG002|Period 3 (6 Months)|Physician Decision|1|||
129818757|NCT01169493|467298863|FG003|Period 3 (6 Months)|Physician Decision|0|||
129818758|NCT01169493|467298864|FG004|Period 3 (6 Months)|Physician Decision|0|||
129818759|NCT01169493|467298865|FG005|Period 3 (6 Months)|Physician Decision|0|||
129818760|NCT02266225|467298869|FG000|Overall Study|Lost to Follow-up|2|||
129818761|NCT02266225|467298869|FG000|Overall Study|Death|1|||
129818762|NCT02266225|467298869|FG000|Overall Study|Withdrawal by Subject|13|||
129818763|NCT02246660|467298870|FG000|Overall Study|Withdrawal by Subject|0|||
129818764|NCT02246660|467298871|FG001|Overall Study|Withdrawal by Subject|1|||
129818765|NCT02246660|467298872|FG002|Overall Study|Withdrawal by Subject|0|||
129818766|NCT02246660|467298870|FG000|Overall Study|Death|0|||
129818767|NCT02246660|467298871|FG001|Overall Study|Death|0|||
129818768|NCT02246660|467298872|FG002|Overall Study|Death|1|||
129818769|NCT00660309|467298875|FG000|Overall Study|Adverse Event|2|||
129818770|NCT00660309|467298876|FG001|Overall Study|Adverse Event|0|||
129818771|NCT00660309|467298875|FG000|Overall Study|Withdrawal by Subject|0|||
129818772|NCT00660309|467298876|FG001|Overall Study|Withdrawal by Subject|3|||
129818773|NCT02573311|467298879|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
129818774|NCT02573311|467298880|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
129818775|NCT02573311|467298879|FG000|Disposition for Part 2|Physician Decision|25|||
129818776|NCT02573311|467298880|FG001|Disposition for Part 2|Physician Decision|7|||
129818777|NCT02573311|467298879|FG000|Disposition for Part 2|Adverse Event|36|||
129818778|NCT02573311|467298880|FG001|Disposition for Part 2|Adverse Event|5|||
129818779|NCT02573311|467298879|FG000|Disposition for Part 2|Lost to Follow-up|76|||
129818780|NCT02573311|467298880|FG001|Disposition for Part 2|Lost to Follow-up|7|||
129818781|NCT02573311|467298879|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
129818782|NCT02573311|467298880|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
129818783|NCT02573311|467298879|FG000|Disposition for Part 2|Investigator decision|0|||
129818784|NCT02573311|467298880|FG001|Disposition for Part 2|Investigator decision|1|||
129818785|NCT02573311|467298879|FG000|Disposition for Part 2|Other than specified above|13|||
129818786|NCT02573311|467298880|FG001|Disposition for Part 2|Other than specified above|3|||
129818787|NCT04171531|467298882|FG000|Overall Study|Lost to Follow-up|4|||
129818788|NCT04171531|467298883|FG001|Overall Study|Lost to Follow-up|5|||
129818789|NCT04171531|467298882|FG000|Overall Study|Consent only through 6 months|1|||
129818790|NCT04171531|467298883|FG001|Overall Study|Consent only through 6 months|1|||
129818791|NCT04171531|467298882|FG000|Overall Study|Insurance did not cover procedure|0|||
129818792|NCT04171531|467298883|FG001|Overall Study|Insurance did not cover procedure|1|||
129818793|NCT04171531|467298882|FG000|Overall Study|Physician Decision|0|||
129818794|NCT04171531|467298883|FG001|Overall Study|Physician Decision|3|||
129818795|NCT04171531|467298882|FG000|Overall Study|Withdrawal by Subject|1|||
129818796|NCT04171531|467298883|FG001|Overall Study|Withdrawal by Subject|5|||
129818797|NCT03366337|467298886|FG000|Overall Study|Lost to Follow-up|1|||
129818798|NCT03366337|467298887|FG001|Overall Study|Lost to Follow-up|0|||
129818799|NCT03366337|467298888|FG002|Overall Study|Lost to Follow-up|1|||
129818800|NCT03366337|467298889|FG003|Overall Study|Lost to Follow-up|0|||
129818801|NCT03366337|467298886|FG000|Overall Study|Withdrawal by Subject|2|||
129818802|NCT03366337|467298887|FG001|Overall Study|Withdrawal by Subject|0|||
129818803|NCT03366337|467298888|FG002|Overall Study|Withdrawal by Subject|1|||
129818804|NCT03366337|467298889|FG003|Overall Study|Withdrawal by Subject|1|||
129818805|NCT05288062|467298891|FG000|Overall Study|Ineligible|0|||
129818806|NCT05288062|467298892|FG001|Overall Study|Ineligible|0|||
129818807|NCT05288062|467298893|FG002|Overall Study|Ineligible|1|||
129818808|NCT05288062|467298894|FG003|Overall Study|Ineligible|0|||
129818809|NCT05288062|467298891|FG000|Overall Study|Withdrawal by Subject|0|||
129818810|NCT05288062|467298892|FG001|Overall Study|Withdrawal by Subject|0|||
129818811|NCT05288062|467298893|FG002|Overall Study|Withdrawal by Subject|1|||
129818812|NCT05288062|467298894|FG003|Overall Study|Withdrawal by Subject|0|||
129818813|NCT01370356|467298895|FG000|Overall Study|Death|1|||
129818814|NCT01370356|467298896|FG001|Overall Study|Death|0|||
129818815|NCT01370356|467298895|FG000|Overall Study|Lack of Efficacy|6|||
129818816|NCT01370356|467298896|FG001|Overall Study|Lack of Efficacy|28|||
129818817|NCT01370356|467298895|FG000|Overall Study|Lost to Follow-up|76|||
129818818|NCT01370356|467298896|FG001|Overall Study|Lost to Follow-up|81|||
129818819|NCT01370356|467298895|FG000|Overall Study|Withdrawal by Subject|54|||
129818820|NCT01370356|467298896|FG001|Overall Study|Withdrawal by Subject|59|||
129818821|NCT01370356|467298895|FG000|Overall Study|Reason not specified|39|||
129818822|NCT01370356|467298896|FG001|Overall Study|Reason not specified|43|||
129818823|NCT01370356|467298895|FG000|Overall Study|Protocol Violation|3|||
129818824|NCT01370356|467298896|FG001|Overall Study|Protocol Violation|3|||
129818825|NCT01370356|467298895|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
129818826|NCT01370356|467298896|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
129818827|NCT01370356|467298895|FG000|Overall Study|AE Not Related to Study Drug|1|||
129818828|NCT01370356|467298896|FG001|Overall Study|AE Not Related to Study Drug|4|||
129818829|NCT00040664|467298897|FG000|Overall Study|Adverse Event|12|||
129818830|NCT00040664|467298898|FG001|Overall Study|Adverse Event|3|||
129818831|NCT00040664|467298899|FG002|Overall Study|Adverse Event|2|||
129818832|NCT00040664|467298900|FG003|Overall Study|Adverse Event|7|||
129818833|NCT00040664|467298897|FG000|Overall Study|Lack of Efficacy|9|||
129818834|NCT00040664|467298898|FG001|Overall Study|Lack of Efficacy|2|||
129818835|NCT00040664|467298899|FG002|Overall Study|Lack of Efficacy|3|||
129818836|NCT00040664|467298900|FG003|Overall Study|Lack of Efficacy|4|||
129818837|NCT00040664|467298897|FG000|Overall Study|Insufficient CD4 response|1|||
129818838|NCT00040664|467298898|FG001|Overall Study|Insufficient CD4 response|0|||
129818839|NCT00040664|467298899|FG002|Overall Study|Insufficient CD4 response|1|||
129818840|NCT00040664|467298900|FG003|Overall Study|Insufficient CD4 response|0|||
129818841|NCT00040664|467298897|FG000|Overall Study|Lost to Follow-up|4|||
129818842|NCT00040664|467298898|FG001|Overall Study|Lost to Follow-up|2|||
129818843|NCT00040664|467298899|FG002|Overall Study|Lost to Follow-up|0|||
129818844|NCT00040664|467298900|FG003|Overall Study|Lost to Follow-up|2|||
129818845|NCT00040664|467298897|FG000|Overall Study|Protocol Violation|2|||
129818846|NCT00040664|467298898|FG001|Overall Study|Protocol Violation|1|||
129818847|NCT00040664|467298899|FG002|Overall Study|Protocol Violation|0|||
129818848|NCT00040664|467298900|FG003|Overall Study|Protocol Violation|1|||
129818849|NCT00040664|467298897|FG000|Overall Study|Withdrawal by Subject|7|||
129818850|NCT00040664|467298898|FG001|Overall Study|Withdrawal by Subject|0|||
129818851|NCT00040664|467298899|FG002|Overall Study|Withdrawal by Subject|3|||
129818852|NCT00040664|467298900|FG003|Overall Study|Withdrawal by Subject|4|||
129818853|NCT00040664|467298897|FG000|Overall Study|Pregnancy|3|||
129818854|NCT00040664|467298898|FG001|Overall Study|Pregnancy|0|||
129818855|NCT00040664|467298899|FG002|Overall Study|Pregnancy|0|||
129818856|NCT00040664|467298900|FG003|Overall Study|Pregnancy|3|||
129818857|NCT00040664|467298897|FG000|Overall Study|Medication adherence/compliance problems|8|||
129818858|NCT00040664|467298898|FG001|Overall Study|Medication adherence/compliance problems|2|||
129818859|NCT00040664|467298899|FG002|Overall Study|Medication adherence/compliance problems|1|||
129818860|NCT00040664|467298900|FG003|Overall Study|Medication adherence/compliance problems|5|||
129818861|NCT00040664|467298897|FG000|Overall Study|Poor taste|2|||
129818862|NCT00040664|467298898|FG001|Overall Study|Poor taste|0|||
129818863|NCT00040664|467298899|FG002|Overall Study|Poor taste|2|||
129818864|NCT00040664|467298900|FG003|Overall Study|Poor taste|0|||
129818865|NCT00040664|467298897|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
129818866|NCT00040664|467298898|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
129818867|NCT00040664|467298899|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
129818868|NCT00040664|467298900|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
129818869|NCT00040664|467298897|FG000|Overall Study|Change of formulation|2|||
129818870|NCT00040664|467298898|FG001|Overall Study|Change of formulation|2|||
129818871|NCT00040664|467298899|FG002|Overall Study|Change of formulation|0|||
129818872|NCT00040664|467298900|FG003|Overall Study|Change of formulation|0|||
129818873|NCT00040664|467298897|FG000|Overall Study|Non-viability of oral suspension|1|||
129818874|NCT00040664|467298898|FG001|Overall Study|Non-viability of oral suspension|0|||
129818875|NCT00040664|467298899|FG002|Overall Study|Non-viability of oral suspension|1|||
129818876|NCT00040664|467298900|FG003|Overall Study|Non-viability of oral suspension|0|||
129818877|NCT00729651|467298901|FG000|Overall Study|Withdrawal by Subject|5|||
129818878|NCT00729651|467298902|FG001|Overall Study|Withdrawal by Subject|6|||
129818879|NCT00729651|467298901|FG000|Overall Study|Lost to Follow-up|5|||
129818880|NCT00729651|467298902|FG001|Overall Study|Lost to Follow-up|4|||
129818881|NCT00729651|467298901|FG000|Overall Study|Protocol Violation|0|||
129818882|NCT00729651|467298902|FG001|Overall Study|Protocol Violation|1|||
129818883|NCT00729651|467298901|FG000|Overall Study|Adverse Event|7|||
129818884|NCT00729651|467298902|FG001|Overall Study|Adverse Event|3|||
129818885|NCT00729651|467298901|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
129818886|NCT00729651|467298902|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
129818887|NCT00729651|467298901|FG000|Overall Study|Subject's private reason|2|||
129818888|NCT00729651|467298902|FG001|Overall Study|Subject's private reason|0|||
129818889|NCT01218243|467298903|FG000|Overall Study|Lack of Efficacy|1|||
129818890|NCT01218243|467298904|FG001|Overall Study|Lack of Efficacy|1|||
129818891|NCT01218243|467298903|FG000|Overall Study|Lost to Follow-up|3|||
129818892|NCT01218243|467298904|FG001|Overall Study|Lost to Follow-up|3|||
129818893|NCT01218243|467298903|FG000|Overall Study|Protocol Violation|5|||
129818894|NCT01218243|467298904|FG001|Overall Study|Protocol Violation|10|||
129818895|NCT00844896|467298911|FG000|Overall Study|Lost to Follow-up|12|||
129818896|NCT00844896|467298912|FG001|Overall Study|Lost to Follow-up|16|||
130059381|NCT02115113|468172302|FG001|Participants Randomized|Lost to Follow-up|0|||
130059382|NCT02115113|468172303|FG002|Participants Randomized|Lost to Follow-up|0|||
130059383|NCT02115113|468172301|FG000|Participants Randomized|Death|1|||
130059384|NCT02115113|468172302|FG001|Participants Randomized|Death|0|||
130059385|NCT02115113|468172303|FG002|Participants Randomized|Death|0|||
130059386|NCT02395653|468172304|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
130059387|NCT02395653|468172304|FG000|Overall Study|Consent Withdrawn at Screening|1|||
130059388|NCT02395653|468172304|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
130059389|NCT02395653|468172304|FG000|Overall Study|Investigator Decision at Screening|1|||
130059390|NCT02395653|468172304|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
130059391|NCT02395653|468172304|FG000|Overall Study|Withdrawal by Subject|1|||
130059392|NCT02395653|468172304|FG000|Overall Study|Lost to Follow-up|1|||
130059393|NCT00605722|468172305|FG000|Overall Study|Adverse Event|6|||
130059394|NCT00605722|468172305|FG000|Overall Study|Insufficient therapeutic response|44|||
129818897|NCT00844896|467298911|FG000|Overall Study|Parents did not have time to complete|0|||
129818898|NCT00844896|467298912|FG001|Overall Study|Parents did not have time to complete|1|||
129818899|NCT02233647|467298913|FG000|Overall Study|Adverse Event|1|||
129818900|NCT02846779|467298917|FG000|Overall Study|Lost Enrollment|83|||
129818901|NCT02846779|467298918|FG001|Overall Study|Lost Enrollment|82|||
129818902|NCT02846779|467298919|FG002|Overall Study|Lost Enrollment|86|||
129818903|NCT02846779|467298917|FG000|Overall Study|Less than 31 days of follow-up|56|||
129818904|NCT02846779|467298918|FG001|Overall Study|Less than 31 days of follow-up|45|||
129818905|NCT02846779|467298919|FG002|Overall Study|Less than 31 days of follow-up|52|||
129818906|NCT02324569|467300870|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129818907|NCT02324569|467300871|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
129818908|NCT02324569|467300870|FG000|Overall Study|Voluntary Withdrawal|3|||
129818909|NCT02324569|467300871|FG001|Overall Study|Voluntary Withdrawal|6|||
129818910|NCT02324569|467300870|FG000|Overall Study|Lack of Efficacy|2|||
129818911|NCT02324569|467300871|FG001|Overall Study|Lack of Efficacy|3|||
129818912|NCT02324569|467300870|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
129818913|NCT02324569|467300871|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
129818914|NCT02324569|467300870|FG000|Overall Study|Inconvenient Schedule|2|||
129818915|NCT02324569|467300871|FG001|Overall Study|Inconvenient Schedule|0|||
129818916|NCT01943292|467300878|FG000|Overall Study|Withdrawal by Subject|1|||
129818917|NCT01943292|467300879|FG001|Overall Study|Withdrawal by Subject|0|||
129818918|NCT01943292|467300880|FG002|Overall Study|Withdrawal by Subject|0|||
129818919|NCT00911820|467300881|FG000|Overall Study|RECIST progression|12|||
129818920|NCT00911820|467300882|FG001|Overall Study|RECIST progression|8|||
129818921|NCT00911820|467300881|FG000|Overall Study|Adverse Event|8|||
129818922|NCT00911820|467300882|FG001|Overall Study|Adverse Event|8|||
129818923|NCT00911820|467300881|FG000|Overall Study|Clinical Progression|7|||
129818924|NCT00911820|467300882|FG001|Overall Study|Clinical Progression|5|||
129818925|NCT00911820|467300881|FG000|Overall Study|Physician Decision|5|||
129818926|NCT00911820|467300882|FG001|Overall Study|Physician Decision|9|||
129818927|NCT00911820|467300881|FG000|Overall Study|Decline in Performance Status|4|||
129818928|NCT00911820|467300882|FG001|Overall Study|Decline in Performance Status|2|||
129818929|NCT00911820|467300881|FG000|Overall Study|Withdrawal by Subject|3|||
129818930|NCT00911820|467300882|FG001|Overall Study|Withdrawal by Subject|4|||
129818931|NCT00911820|467300881|FG000|Overall Study|Death|1|||
129818932|NCT00911820|467300882|FG001|Overall Study|Death|2|||
129818933|NCT00911820|467300881|FG000|Overall Study|Pursue surgery|1|||
129818934|NCT00911820|467300882|FG001|Overall Study|Pursue surgery|1|||
129818935|NCT00911820|467300881|FG000|Overall Study|Pursue Radiation|1|||
129818936|NCT00911820|467300882|FG001|Overall Study|Pursue Radiation|0|||
129818937|NCT00911820|467300881|FG000|Overall Study|Still on Therapy|2|||
129818938|NCT00911820|467300882|FG001|Overall Study|Still on Therapy|2|||
129818939|NCT00911820|467300881|FG000|Overall Study|Pathology Not Confirmed|1|||
129818940|NCT00911820|467300882|FG001|Overall Study|Pathology Not Confirmed|0|||
129818941|NCT00911820|467300881|FG000|Overall Study|Withdraw before Receive Treatment|0|||
129818942|NCT00911820|467300882|FG001|Overall Study|Withdraw before Receive Treatment|2|||
129818943|NCT01852110|467300883|FG000|Overall Study|Adverse Event|12|||
129818944|NCT01852110|467300884|FG001|Overall Study|Adverse Event|5|||
129818945|NCT01852110|467300885|FG002|Overall Study|Adverse Event|0|||
130059395|NCT00605722|468172305|FG000|Overall Study|Failure to return|1|||
129818946|NCT01852110|467300886|FG003|Overall Study|Adverse Event|0|||
129818947|NCT01852110|467300887|FG004|Overall Study|Adverse Event|0|||
129818948|NCT01852110|467300888|FG005|Overall Study|Adverse Event|0|||
129818949|NCT01852110|467300883|FG000|Overall Study|Lost to Follow-up|1|||
129818950|NCT01852110|467300884|FG001|Overall Study|Lost to Follow-up|3|||
129818951|NCT01852110|467300885|FG002|Overall Study|Lost to Follow-up|0|||
129818952|NCT01852110|467300886|FG003|Overall Study|Lost to Follow-up|0|||
129818953|NCT01852110|467300887|FG004|Overall Study|Lost to Follow-up|0|||
129818954|NCT01852110|467300888|FG005|Overall Study|Lost to Follow-up|0|||
129818955|NCT01852110|467300883|FG000|Overall Study|Non-compliance with Study Drug|2|||
130059396|NCT00296725|468172308|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
130059397|NCT00296725|468172308|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
130059398|NCT00296725|468172308|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
130059399|NCT02622724|468172309|FG000|Overall Study|Death|51|||
130059400|NCT02622724|468172310|FG001|Overall Study|Death|53|||
130059401|NCT02622724|468172309|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
129818956|NCT01852110|467300884|FG001|Overall Study|Non-compliance with Study Drug|1|||
129818957|NCT01852110|467300885|FG002|Overall Study|Non-compliance with Study Drug|0|||
129818958|NCT01852110|467300886|FG003|Overall Study|Non-compliance with Study Drug|0|||
129818959|NCT01852110|467300887|FG004|Overall Study|Non-compliance with Study Drug|0|||
129818960|NCT01852110|467300888|FG005|Overall Study|Non-compliance with Study Drug|0|||
129818961|NCT01852110|467300883|FG000|Overall Study|Physician Decision|1|||
129818962|NCT01852110|467300884|FG001|Overall Study|Physician Decision|0|||
129818963|NCT01852110|467300885|FG002|Overall Study|Physician Decision|0|||
129818964|NCT01852110|467300886|FG003|Overall Study|Physician Decision|0|||
129818965|NCT01852110|467300887|FG004|Overall Study|Physician Decision|0|||
129818966|NCT01852110|467300888|FG005|Overall Study|Physician Decision|0|||
129818967|NCT01852110|467300883|FG000|Overall Study|Protocol Violation|0|||
129818968|NCT01852110|467300884|FG001|Overall Study|Protocol Violation|1|||
129818969|NCT01852110|467300885|FG002|Overall Study|Protocol Violation|0|||
129818970|NCT01852110|467300886|FG003|Overall Study|Protocol Violation|0|||
129818971|NCT01852110|467300887|FG004|Overall Study|Protocol Violation|0|||
129818972|NCT01852110|467300888|FG005|Overall Study|Protocol Violation|0|||
129818973|NCT01852110|467300883|FG000|Overall Study|Study Terminated by Sponsor|30|||
129818974|NCT01852110|467300884|FG001|Overall Study|Study Terminated by Sponsor|32|||
129818975|NCT01852110|467300885|FG002|Overall Study|Study Terminated by Sponsor|0|||
129818976|NCT01852110|467300886|FG003|Overall Study|Study Terminated by Sponsor|0|||
129818977|NCT01852110|467300887|FG004|Overall Study|Study Terminated by Sponsor|0|||
129818978|NCT01852110|467300888|FG005|Overall Study|Study Terminated by Sponsor|0|||
129818979|NCT01852110|467300883|FG000|Overall Study|Withdrawal by Subject|4|||
129818980|NCT01852110|467300884|FG001|Overall Study|Withdrawal by Subject|4|||
129818981|NCT01852110|467300885|FG002|Overall Study|Withdrawal by Subject|0|||
129818982|NCT01852110|467300886|FG003|Overall Study|Withdrawal by Subject|0|||
129818983|NCT01852110|467300887|FG004|Overall Study|Withdrawal by Subject|0|||
129818984|NCT01852110|467300888|FG005|Overall Study|Withdrawal by Subject|0|||
129818985|NCT00410046|467300891|FG000|Overall Study|Adverse Event|3|||
129818986|NCT00410046|467300891|FG000|Overall Study|Withdrawal by Subject|1|||
129818987|NCT00410046|467300891|FG000|Overall Study|Lost to Follow-up|1|||
129818988|NCT03098550|467300892|FG000|Overall Study|Disease Progression|30|||
129818989|NCT03098550|467300893|FG001|Overall Study|Disease Progression|19|||
129818990|NCT03098550|467300894|FG002|Overall Study|Disease Progression|41|||
129818991|NCT03098550|467300892|FG000|Overall Study|Study Drug Toxicity|2|||
129818992|NCT03098550|467300893|FG001|Overall Study|Study Drug Toxicity|1|||
129818993|NCT03098550|467300894|FG002|Overall Study|Study Drug Toxicity|0|||
129818994|NCT03098550|467300892|FG000|Overall Study|Death|1|||
129818995|NCT03098550|467300893|FG001|Overall Study|Death|0|||
129818996|NCT03098550|467300894|FG002|Overall Study|Death|0|||
129818997|NCT03098550|467300892|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
129818998|NCT03098550|467300893|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
129818999|NCT03098550|467300894|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
129819000|NCT03098550|467300892|FG000|Overall Study|Administrative reason by sponsor|0|||
129819001|NCT03098550|467300893|FG001|Overall Study|Administrative reason by sponsor|0|||
129819002|NCT03098550|467300894|FG002|Overall Study|Administrative reason by sponsor|1|||
129819003|NCT03098550|467300892|FG000|Overall Study|Other reasons|2|||
129819004|NCT03098550|467300893|FG001|Overall Study|Other reasons|0|||
129819005|NCT03098550|467300894|FG002|Overall Study|Other reasons|0|||
129819006|NCT00381095|467300902|FG000|Overall Study|Death|3|||
129819007|NCT00381095|467300903|FG001|Overall Study|Death|4|||
129819008|NCT00381095|467300902|FG000|Overall Study|Lack of Efficacy|2|||
129819009|NCT00381095|467300903|FG001|Overall Study|Lack of Efficacy|4|||
129819010|NCT00381095|467300902|FG000|Overall Study|Other|2|||
129819011|NCT00381095|467300903|FG001|Overall Study|Other|2|||
129819012|NCT00381095|467300902|FG000|Overall Study|Protocol Violation|1|||
130059402|NCT02622724|468172310|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
130059403|NCT02622724|468172309|FG000|Overall Study|Early termination of study|38|||
129819013|NCT00381095|467300903|FG001|Overall Study|Protocol Violation|1|||
129819014|NCT00381095|467300902|FG000|Overall Study|Withdrawal by Subject|3|||
129819015|NCT00381095|467300903|FG001|Overall Study|Withdrawal by Subject|3|||
129819016|NCT00381095|467300902|FG000|Overall Study|Adverse Event|2|||
129819017|NCT00381095|467300903|FG001|Overall Study|Adverse Event|7|||
129819018|NCT01104493|467300904|FG000|Overall Study|Lost to Follow-up|0|||
129819019|NCT01104493|467300905|FG001|Overall Study|Lost to Follow-up|2|||
129819020|NCT01342796|467300907|FG000|Overall Study|Withdrawal by Subject|2|||
129819021|NCT01342796|467300908|FG001|Overall Study|Withdrawal by Subject|0|||
130059404|NCT02622724|468172310|FG001|Overall Study|Early termination of study|43|||
129819022|NCT01342796|467300907|FG000|Overall Study|Lost to Follow-up|0|||
129819023|NCT01342796|467300908|FG001|Overall Study|Lost to Follow-up|3|||
129819024|NCT01342796|467300907|FG000|Overall Study|Inappropriate enrollment|1|||
130059405|NCT00333619|468172311|FG000|Overall Study|Death|12|||
130059406|NCT00333619|468172312|FG001|Overall Study|Death|6|||
129819025|NCT01342796|467300908|FG001|Overall Study|Inappropriate enrollment|0|||
129819026|NCT02485301|467300909|FG000|Overall Study|Serious Adverse Events|2|||
129819027|NCT02485301|467300910|FG001|Overall Study|Serious Adverse Events|1|||
129819028|NCT02485301|467300909|FG000|Overall Study|Protocol Violation|0|||
129819029|NCT02485301|467300910|FG001|Overall Study|Protocol Violation|1|||
129819030|NCT02485301|467300909|FG000|Overall Study|Withdrawal by Subject|6|||
129819031|NCT02485301|467300910|FG001|Overall Study|Withdrawal by Subject|7|||
129819032|NCT02485301|467300909|FG000|Overall Study|Migrated/moved from study area|10|||
129819033|NCT02485301|467300910|FG001|Overall Study|Migrated/moved from study area|19|||
129819034|NCT02485301|467300909|FG000|Overall Study|Lost to Follow-up|17|||
129819035|NCT02485301|467300910|FG001|Overall Study|Lost to Follow-up|17|||
129819036|NCT02485301|467300909|FG000|Overall Study|Other|3|||
129819037|NCT02485301|467300910|FG001|Overall Study|Other|4|||
129819038|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819039|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819040|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819041|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819042|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819043|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819044|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
129819045|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819046|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819047|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819048|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819049|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819050|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819051|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
129819052|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819053|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819054|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819055|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819056|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819057|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819058|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
129819059|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819060|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819061|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819062|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819063|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819064|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819065|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
129819066|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
129819067|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
129819068|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
129819069|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
129819070|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
129819071|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
129819072|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
129819073|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
129819074|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
129819075|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
129819076|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
129819077|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
129819078|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
129819079|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
129819080|NCT01059825|467300914|FG000|Treatment Period|Lost to Follow-up|2|||
129819081|NCT01059825|467300915|FG001|Treatment Period|Lost to Follow-up|1|||
129819082|NCT01059825|467300916|FG002|Treatment Period|Lost to Follow-up|0|||
129819083|NCT01059825|467300917|FG003|Treatment Period|Lost to Follow-up|1|||
129819084|NCT01059825|467300918|FG004|Treatment Period|Lost to Follow-up|2|||
129819085|NCT01059825|467300919|FG005|Treatment Period|Lost to Follow-up|0|||
129819086|NCT01059825|467300920|FG006|Treatment Period|Lost to Follow-up|0|||
129819087|NCT01059825|467300914|FG000|Treatment Period|Withdrawal by Subject|3|||
129819088|NCT01059825|467300915|FG001|Treatment Period|Withdrawal by Subject|0|||
129819089|NCT01059825|467300916|FG002|Treatment Period|Withdrawal by Subject|1|||
129819090|NCT01059825|467300917|FG003|Treatment Period|Withdrawal by Subject|5|||
129819091|NCT01059825|467300918|FG004|Treatment Period|Withdrawal by Subject|4|||
129819092|NCT01059825|467300919|FG005|Treatment Period|Withdrawal by Subject|1|||
129819093|NCT01059825|467300920|FG006|Treatment Period|Withdrawal by Subject|0|||
129819094|NCT01059825|467300914|FG000|Treatment Period|Other reason not specified|1|||
129819095|NCT01059825|467300915|FG001|Treatment Period|Other reason not specified|2|||
129819096|NCT01059825|467300916|FG002|Treatment Period|Other reason not specified|1|||
129819097|NCT01059825|467300917|FG003|Treatment Period|Other reason not specified|2|||
129819098|NCT01059825|467300918|FG004|Treatment Period|Other reason not specified|0|||
129819099|NCT01059825|467300919|FG005|Treatment Period|Other reason not specified|0|||
129819100|NCT01059825|467300920|FG006|Treatment Period|Other reason not specified|0|||
129819101|NCT01059825|467300914|FG000|Treatment Period|Protocol Violation|0|||
129819102|NCT01059825|467300915|FG001|Treatment Period|Protocol Violation|0|||
129819103|NCT01059825|467300916|FG002|Treatment Period|Protocol Violation|1|||
129819104|NCT01059825|467300917|FG003|Treatment Period|Protocol Violation|1|||
129819105|NCT01059825|467300918|FG004|Treatment Period|Protocol Violation|1|||
129819106|NCT01059825|467300919|FG005|Treatment Period|Protocol Violation|1|||
129819107|NCT01059825|467300920|FG006|Treatment Period|Protocol Violation|0|||
129819108|NCT01059825|467300914|FG000|Treatment Period|Adverse event related to study drug|1|||
129819109|NCT01059825|467300915|FG001|Treatment Period|Adverse event related to study drug|0|||
129819110|NCT01059825|467300916|FG002|Treatment Period|Adverse event related to study drug|1|||
129819111|NCT01059825|467300917|FG003|Treatment Period|Adverse event related to study drug|1|||
129819112|NCT01059825|467300918|FG004|Treatment Period|Adverse event related to study drug|0|||
129819113|NCT01059825|467300919|FG005|Treatment Period|Adverse event related to study drug|0|||
129819114|NCT01059825|467300920|FG006|Treatment Period|Adverse event related to study drug|0|||
129819115|NCT01059825|467300914|FG000|Treatment Period|Insufficient clinical response|3|||
129819116|NCT01059825|467300915|FG001|Treatment Period|Insufficient clinical response|0|||
129819117|NCT01059825|467300916|FG002|Treatment Period|Insufficient clinical response|0|||
129819118|NCT01059825|467300917|FG003|Treatment Period|Insufficient clinical response|0|||
129819119|NCT01059825|467300918|FG004|Treatment Period|Insufficient clinical response|0|||
129819120|NCT01059825|467300919|FG005|Treatment Period|Insufficient clinical response|0|||
129819121|NCT01059825|467300920|FG006|Treatment Period|Insufficient clinical response|0|||
129819122|NCT01059825|467300914|FG000|Treatment Period|Adverse event not related to study drug|0|||
129819123|NCT01059825|467300915|FG001|Treatment Period|Adverse event not related to study drug|1|||
129819124|NCT01059825|467300916|FG002|Treatment Period|Adverse event not related to study drug|2|||
129819125|NCT01059825|467300917|FG003|Treatment Period|Adverse event not related to study drug|1|||
129819126|NCT01059825|467300918|FG004|Treatment Period|Adverse event not related to study drug|1|||
129819127|NCT01059825|467300919|FG005|Treatment Period|Adverse event not related to study drug|1|||
129819128|NCT01059825|467300920|FG006|Treatment Period|Adverse event not related to study drug|0|||
129819129|NCT02495168|467300921|FG000|Overall Study|Other than Specified|18|||
129819130|NCT02495168|467300922|FG001|Overall Study|Other than Specified|22|||
129819131|NCT02495168|467300923|FG002|Overall Study|Other than Specified|5|||
129819132|NCT02495168|467300921|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
129819133|NCT02495168|467300922|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
129819134|NCT02495168|467300923|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
129819135|NCT02495168|467300921|FG000|Overall Study|Physician Decision|1|||
129819136|NCT02495168|467300922|FG001|Overall Study|Physician Decision|1|||
129819137|NCT02495168|467300923|FG002|Overall Study|Physician Decision|0|||
129819138|NCT02495168|467300921|FG000|Overall Study|Lost to Follow-up|10|||
129819139|NCT02495168|467300922|FG001|Overall Study|Lost to Follow-up|6|||
129819140|NCT02495168|467300923|FG002|Overall Study|Lost to Follow-up|1|||
129819141|NCT02495168|467300921|FG000|Overall Study|Withdrawal by Subject|1|||
129819142|NCT02495168|467300922|FG001|Overall Study|Withdrawal by Subject|4|||
129819143|NCT02495168|467300923|FG002|Overall Study|Withdrawal by Subject|2|||
129819144|NCT02495168|467300921|FG000|Overall Study|Protocol Violation|0|||
129819145|NCT02495168|467300922|FG001|Overall Study|Protocol Violation|10|||
129819146|NCT02495168|467300923|FG002|Overall Study|Protocol Violation|1|||
129819147|NCT02495168|467300921|FG000|Overall Study|Adverse Event|4|||
129819148|NCT02495168|467300922|FG001|Overall Study|Adverse Event|8|||
129819149|NCT02495168|467300923|FG002|Overall Study|Adverse Event|3|||
129819150|NCT02495168|467300921|FG000|Overall Study|Lack of Efficacy|0|||
129819151|NCT02495168|467300922|FG001|Overall Study|Lack of Efficacy|0|||
129819152|NCT02495168|467300923|FG002|Overall Study|Lack of Efficacy|3|||
129819153|NCT04626297|467300926|FG000|Overall Study|Adverse Event|5|||
129819154|NCT04626297|467300927|FG001|Overall Study|Adverse Event|3|||
129819155|NCT04626297|467300926|FG000|Overall Study|Lost to Follow-up|7|||
129819156|NCT04626297|467300927|FG001|Overall Study|Lost to Follow-up|3|||
129819157|NCT04626297|467300926|FG000|Overall Study|Protocol Violation|5|||
129819158|NCT04626297|467300927|FG001|Overall Study|Protocol Violation|1|||
129819159|NCT04626297|467300926|FG000|Overall Study|Withdrawal by Subject|20|||
129819160|NCT04626297|467300927|FG001|Overall Study|Withdrawal by Subject|6|||
129819161|NCT04626297|467300926|FG000|Overall Study|Sponsor decision|2|||
129819162|NCT04626297|467300927|FG001|Overall Study|Sponsor decision|1|||
129819163|NCT03521934|467300934|FG000|Overall Study|Death|65|||
129819164|NCT03521934|467300935|FG001|Overall Study|Death|73|||
129819165|NCT03521934|467300934|FG000|Overall Study|Withdrawal by Subject|18|||
129819166|NCT03521934|467300935|FG001|Overall Study|Withdrawal by Subject|23|||
129819167|NCT03521934|467300934|FG000|Overall Study|Site Terminated by Sponsor|39|||
129819168|NCT03521934|467300935|FG001|Overall Study|Site Terminated by Sponsor|35|||
129819169|NCT03521934|467300934|FG000|Overall Study|Study Terminated by Sponsor|483|||
129819170|NCT03521934|467300935|FG001|Overall Study|Study Terminated by Sponsor|477|||
129819171|NCT03521934|467300934|FG000|Overall Study|Reason not Specified|3|||
129819172|NCT03521934|467300935|FG001|Overall Study|Reason not Specified|6|||
129819173|NCT03020160|467300936|FG000|Overall Study|Withdrawal by Subject|1|||
129819174|NCT03020160|467300937|FG001|Overall Study|Withdrawal by Subject|0|||
129819175|NCT01513473|467300938|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
129819176|NCT01513473|467300939|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
129819177|NCT01513473|467300938|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
129819178|NCT01513473|467300939|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
129819179|NCT01513473|467300938|FG000|Main Trial (26 Weeks)|Unclassified|0|||
129819180|NCT01513473|467300939|FG001|Main Trial (26 Weeks)|Unclassified|2|||
129819181|NCT01513473|467300938|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
129819182|NCT01513473|467300939|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
129819183|NCT01513473|467300938|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
129819184|NCT01513473|467300939|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
129819185|NCT03462082|467300940|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819186|NCT03462082|467300941|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819187|NCT03462082|467300942|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819188|NCT03462082|467300943|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819189|NCT03462082|467300944|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819190|NCT03462082|467300945|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819191|NCT03462082|467300946|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
129819192|NCT03462082|467300947|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
129819193|NCT01425281|467300952|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
129819194|NCT01425281|467300953|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
129819195|NCT01425281|467300952|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
129819196|NCT01425281|467300953|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
129819197|NCT01425281|467300952|FG000|At 180-day Clinical Follow-up|Death|0|||
129819198|NCT01425281|467300953|FG001|At 180-day Clinical Follow-up|Death|1|||
129819199|NCT01425281|467300952|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
129819200|NCT01425281|467300953|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
129819201|NCT01425281|467300952|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
129819202|NCT01425281|467300953|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
129819203|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
129819204|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
129819205|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Death|2|||
129819206|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Death|0|||
129819207|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
129819208|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
129819209|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
129819210|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
129819211|NCT01425281|467300952|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
129819212|NCT01425281|467300953|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
129819213|NCT01425281|467300952|FG000|At 3-year Clinical Follow-up|Death|2|||
129819214|NCT01425281|467300953|FG001|At 3-year Clinical Follow-up|Death|3|||
129819215|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Death|7|||
129819216|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Death|3|||
129819217|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
129819218|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
129819219|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
129819220|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
129819221|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
129819222|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
129819223|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
129819224|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
129819225|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Death|2|||
129819226|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Death|0|||
129819227|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
129819228|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
129819229|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
129819230|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
129819231|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
129819232|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
129819233|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Left Oranization|1|||
129819234|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Left Oranization|1|||
129819235|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
129819236|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
129819237|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
129819238|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
129819239|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
129819240|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
129819241|NCT03454997|467300954|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
129819242|NCT03454997|467300955|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
129819243|NCT03454997|467300954|FG000|Overall Study|Client with SMI - Left organization|0|||
129819244|NCT03454997|467300955|FG001|Overall Study|Client with SMI - Left organization|1|||
129819245|NCT03454997|467300954|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
129819246|NCT03454997|467300955|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
129819247|NCT00299975|467300957|FG000|Overall Study|Adverse Event|1|||
129819248|NCT00299975|467300958|FG001|Overall Study|Adverse Event|0|||
129819249|NCT00299975|467300959|FG002|Overall Study|Adverse Event|2|||
129819250|NCT00299975|467300957|FG000|Overall Study|Pregnancy|0|||
129819251|NCT00299975|467300958|FG001|Overall Study|Pregnancy|0|||
129819252|NCT00299975|467300959|FG002|Overall Study|Pregnancy|1|||
129819253|NCT00299975|467300957|FG000|Overall Study|Lack of Efficacy|1|||
129819254|NCT00299975|467300958|FG001|Overall Study|Lack of Efficacy|0|||
129819255|NCT00299975|467300959|FG002|Overall Study|Lack of Efficacy|1|||
129819256|NCT00299975|467300957|FG000|Overall Study|Lost to Follow-up|1|||
129819257|NCT00299975|467300958|FG001|Overall Study|Lost to Follow-up|0|||
129819258|NCT00299975|467300959|FG002|Overall Study|Lost to Follow-up|0|||
129819259|NCT00299975|467300957|FG000|Overall Study|Withdrawal by Subject|0|||
129819260|NCT00299975|467300958|FG001|Overall Study|Withdrawal by Subject|1|||
129819261|NCT00299975|467300959|FG002|Overall Study|Withdrawal by Subject|3|||
129819262|NCT00299975|467300957|FG000|Overall Study|Physician Decision|0|||
129819263|NCT00299975|467300958|FG001|Overall Study|Physician Decision|0|||
129819264|NCT00299975|467300959|FG002|Overall Study|Physician Decision|1|||
129819265|NCT00982878|467300960|FG000|Overall Study|Physician Decision|1|||
129819266|NCT03167411|467300961|FG000|Overall Study|Adverse Event|0|||
129819267|NCT03167411|467300962|FG001|Overall Study|Adverse Event|1|||
129819268|NCT02627144|467300965|FG000|Overall Study|Serious adverse event|32|||
129819269|NCT02627144|467300965|FG000|Overall Study|Cancer progression|171|||
129819270|NCT02627144|467300965|FG000|Overall Study|Death from cancer|20|||
129819271|NCT02627144|467300965|FG000|Overall Study|Death from other cause|8|||
129819272|NCT02627144|467300965|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
129819273|NCT02627144|467300965|FG000|Overall Study|Administrative reasons|65|||
129819274|NCT02627144|467300965|FG000|Overall Study|Lost to Follow-up|8|||
129819275|NCT02627144|467300965|FG000|Overall Study|Enrolled, not treated|6|||
129819276|NCT02627144|467300965|FG000|Overall Study|Other|17|||
129819277|NCT01906008|467300970|FG000|Overall Study|Lost to Follow-up|2|||
129819278|NCT01906008|467300971|FG001|Overall Study|Lost to Follow-up|0|||
129819279|NCT01906008|467300970|FG000|Overall Study|Oxaliplatin toxicity|2|||
129819280|NCT01906008|467300971|FG001|Overall Study|Oxaliplatin toxicity|0|||
129819281|NCT01906008|467300970|FG000|Overall Study|Protocol Violation|0|||
129819282|NCT01906008|467300971|FG001|Overall Study|Protocol Violation|1|||
129819283|NCT01906008|467300970|FG000|Overall Study|Withdrawal by Subject|1|||
129819284|NCT01906008|467300971|FG001|Overall Study|Withdrawal by Subject|5|||
129819285|NCT01906008|467300970|FG000|Overall Study|Did not start study med|3|||
129819286|NCT01906008|467300971|FG001|Overall Study|Did not start study med|4|||
129819287|NCT01906008|467300970|FG000|Overall Study|Oxaliplatin stops|10|||
129819288|NCT01906008|467300971|FG001|Overall Study|Oxaliplatin stops|8|||
129819289|NCT01906008|467300970|FG000|Overall Study|Hospice|1|||
129819290|NCT01906008|467300971|FG001|Overall Study|Hospice|0|||
129819291|NCT01906008|467300970|FG000|Overall Study|Physician Decision|3|||
129819292|NCT01906008|467300971|FG001|Overall Study|Physician Decision|3|||
129819293|NCT01906008|467300970|FG000|Overall Study|Lack of compliance of study med|5|||
129819294|NCT01906008|467300971|FG001|Overall Study|Lack of compliance of study med|3|||
129819295|NCT01906008|467300970|FG000|Overall Study|Adverse Event|0|||
130059407|NCT00333619|468172311|FG000|Overall Study|Withdrawal by Subject|6|||
130059408|NCT00333619|468172312|FG001|Overall Study|Withdrawal by Subject|1|||
130059409|NCT00333619|468172311|FG000|Overall Study|Lost to Follow-up|3|||
130059410|NCT00333619|468172312|FG001|Overall Study|Lost to Follow-up|3|||
130059411|NCT01626352|468172313|FG000|Overall Study|Disease Progression|3|||
129819296|NCT01906008|467300971|FG001|Overall Study|Adverse Event|3|||
129819297|NCT02651922|467300973|FG000|Overall Study|due to exclusion criteria|2|||
129819298|NCT00171730|467300975|FG000|Overall Study|Adverse Event|3|||
129819299|NCT00171730|467300975|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129819300|NCT00171730|467300975|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
129819301|NCT00171730|467300975|FG000|Overall Study|Withdrawal by Subject|3|||
129819302|NCT02220205|467300976|FG000|Overall Study|Withdrawal by Subject|1|||
129819303|NCT02220205|467300977|FG001|Overall Study|Withdrawal by Subject|0|||
129819304|NCT01465997|467300978|FG000|Overall Study|Adverse Event|12|||
129819305|NCT01465997|467300979|FG001|Overall Study|Adverse Event|22|||
129819306|NCT01465997|467300978|FG000|Overall Study|Lack of Efficacy|13|||
129819307|NCT01465997|467300979|FG001|Overall Study|Lack of Efficacy|1|||
129819308|NCT01465997|467300978|FG000|Overall Study|Protocol Violation|1|||
129819309|NCT01465997|467300979|FG001|Overall Study|Protocol Violation|4|||
130059412|NCT01626352|468172313|FG000|Overall Study|Intercurrent Illness|2|||
129819310|NCT01465997|467300978|FG000|Overall Study|Lost to Follow-up|6|||
129819311|NCT01465997|467300979|FG001|Overall Study|Lost to Follow-up|9|||
129819312|NCT01465997|467300978|FG000|Overall Study|Withdrawal by Subject|32|||
129819313|NCT01465997|467300979|FG001|Overall Study|Withdrawal by Subject|35|||
129819314|NCT01465997|467300978|FG000|Overall Study|investigator's decision|1|||
129819315|NCT01465997|467300979|FG001|Overall Study|investigator's decision|1|||
129819316|NCT01465997|467300978|FG000|Overall Study|Death|0|||
129819317|NCT01465997|467300979|FG001|Overall Study|Death|1|||
129819318|NCT01465997|467300978|FG000|Overall Study|sponsor's decision|1|||
129819319|NCT01465997|467300979|FG001|Overall Study|sponsor's decision|1|||
129819320|NCT01465997|467300978|FG000|Overall Study|subject withdrew consent|1|||
129819321|NCT01465997|467300979|FG001|Overall Study|subject withdrew consent|0|||
129819322|NCT01465997|467300978|FG000|Overall Study|local lab unblinded site|1|||
129819323|NCT01465997|467300979|FG001|Overall Study|local lab unblinded site|0|||
129819324|NCT01465997|467300978|FG000|Overall Study|withdrew before follow-up|0|||
129819325|NCT01465997|467300979|FG001|Overall Study|withdrew before follow-up|13|||
129819326|NCT01465997|467300978|FG000|Overall Study|decision by site staff|0|||
129819327|NCT01465997|467300979|FG001|Overall Study|decision by site staff|1|||
129819328|NCT01465997|467300978|FG000|Overall Study|subject left participation SP0993|0|||
129819329|NCT01465997|467300979|FG001|Overall Study|subject left participation SP0993|1|||
129819330|NCT04862585|467300980|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
129819331|NCT04862585|467300981|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
129819332|NCT04862585|467300980|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
129819333|NCT04862585|467300981|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
129819334|NCT04862585|467300980|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
129819335|NCT04862585|467300981|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
129819336|NCT04862585|467300980|FG000|Overall Study|one withdrew without providing a reason|0|||
129819337|NCT04862585|467300981|FG001|Overall Study|one withdrew without providing a reason|1|||
129819338|NCT00211809|467300982|FG000|Overall Study|Lack of Efficacy|1|||
129819339|NCT00211809|467300982|FG000|Overall Study|Lost to Follow-up|2|||
129819340|NCT00211809|467300982|FG000|Overall Study|Pregnancy|1|||
129819341|NCT00211809|467300982|FG000|Overall Study|side effects|2|||
129819342|NCT00496470|467300983|FG000|Overall Study|Adverse Event|8|||
129819343|NCT00496470|467300984|FG001|Overall Study|Adverse Event|10|||
129819344|NCT00496470|467300983|FG000|Overall Study|Withdrawal by Subject|5|||
129819345|NCT00496470|467300984|FG001|Overall Study|Withdrawal by Subject|12|||
129819346|NCT00496470|467300983|FG000|Overall Study|Incorrectly enrolled|13|||
129819347|NCT00496470|467300984|FG001|Overall Study|Incorrectly enrolled|5|||
129819348|NCT00496470|467300983|FG000|Overall Study|Other reason|0|||
129819349|NCT00496470|467300984|FG001|Overall Study|Other reason|2|||
129819350|NCT01217814|467300985|FG000|Overall Study|Adverse Event|1|||
129819351|NCT01217814|467300986|FG001|Overall Study|Adverse Event|1|||
129819352|NCT01217814|467300987|FG002|Overall Study|Adverse Event|0|||
129819353|NCT01217814|467300985|FG000|Overall Study|Lack of Efficacy|0|||
129819354|NCT01217814|467300986|FG001|Overall Study|Lack of Efficacy|0|||
129819355|NCT01217814|467300987|FG002|Overall Study|Lack of Efficacy|1|||
129819356|NCT01756898|467300988|FG000|Overall Study|Adverse Event|7|||
129819357|NCT01756898|467300989|FG001|Overall Study|Adverse Event|1|||
129819358|NCT01756898|467300990|FG002|Overall Study|Adverse Event|0|||
129819359|NCT01756898|467300991|FG003|Overall Study|Adverse Event|0|||
129819360|NCT01756898|467300988|FG000|Overall Study|Lack of Efficacy|4|||
129819361|NCT01756898|467300989|FG001|Overall Study|Lack of Efficacy|7|||
129819362|NCT01756898|467300990|FG002|Overall Study|Lack of Efficacy|6|||
129819363|NCT01756898|467300991|FG003|Overall Study|Lack of Efficacy|6|||
129819364|NCT01756898|467300988|FG000|Overall Study|Lost to Follow-up|2|||
129819365|NCT01756898|467300989|FG001|Overall Study|Lost to Follow-up|4|||
129819366|NCT01756898|467300990|FG002|Overall Study|Lost to Follow-up|2|||
129819367|NCT01756898|467300991|FG003|Overall Study|Lost to Follow-up|3|||
129819368|NCT01756898|467300988|FG000|Overall Study|Protocol Violation|1|||
129819369|NCT01756898|467300989|FG001|Overall Study|Protocol Violation|2|||
129819370|NCT01756898|467300990|FG002|Overall Study|Protocol Violation|2|||
129819371|NCT01756898|467300991|FG003|Overall Study|Protocol Violation|1|||
129819372|NCT01756898|467300988|FG000|Overall Study|Withdrew Consent|5|||
129819373|NCT01756898|467300989|FG001|Overall Study|Withdrew Consent|3|||
129819374|NCT01756898|467300990|FG002|Overall Study|Withdrew Consent|5|||
129819375|NCT01756898|467300991|FG003|Overall Study|Withdrew Consent|6|||
129897271|NCT00269399|467584307|FG000|Overall Study|Withdrawal by Subject|2|||
130059413|NCT01626352|468172313|FG000|Overall Study|Death|2|||
129819376|NCT01756898|467300988|FG000|Overall Study|Other|0|||
129819377|NCT01756898|467300989|FG001|Overall Study|Other|2|||
129819378|NCT01756898|467300990|FG002|Overall Study|Other|2|||
129819379|NCT01756898|467300991|FG003|Overall Study|Other|0|||
129819380|NCT00496054|467300996|FG000|Overall Study|Adverse Event|1|||
129819381|NCT00496054|467300996|FG000|Overall Study|Lost to Follow-up|7|||
129819382|NCT00471328|467301003|FG000|Core Phase|Adverse Event|18|||
129819383|NCT00471328|467301004|FG001|Core Phase|Adverse Event|6|||
129819384|NCT00471328|467301003|FG000|Core Phase|Death|8|||
130059414|NCT01626352|468172313|FG000|Overall Study|Withdrawal by Subject|1|||
130059415|NCT01626352|468172313|FG000|Overall Study|Non-Compliance|1|||
130059416|NCT01626352|468172313|FG000|Overall Study|Never Treated|1|||
130059417|NCT02338492|468172320|FG000|Overall Study|Death|32|||
130059418|NCT02338492|468172320|FG000|Overall Study|Adverse Event|3|||
130059419|NCT02338492|468172320|FG000|Overall Study|Lost to Follow-up|4|||
130059420|NCT02338492|468172320|FG000|Overall Study|Reason not captured above|6|||
130059421|NCT01071096|468172321|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
130059422|NCT01071096|468172322|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
130059423|NCT03421964|468172328|FG000|Overall Study|Lost to Follow-up|11|||
130059424|NCT03421964|468172329|FG001|Overall Study|Lost to Follow-up|21|||
130059425|NCT03421964|468172328|FG000|Overall Study|Withdrawal by Subject|9|||
130059426|NCT03421964|468172329|FG001|Overall Study|Withdrawal by Subject|3|||
130059427|NCT03421964|468172328|FG000|Overall Study|Incarcerated|1|||
130059428|NCT03421964|468172329|FG001|Overall Study|Incarcerated|0|||
130059429|NCT03421964|468172328|FG000|Overall Study|Inpt Treatment Facility|1|||
130059430|NCT03421964|468172329|FG001|Overall Study|Inpt Treatment Facility|1|||
130059431|NCT03421964|468172328|FG000|Overall Study|Virtual Platform Issues|1|||
130059432|NCT03421964|468172329|FG001|Overall Study|Virtual Platform Issues|1|||
130059433|NCT00229203|468172330|FG000|Overall Study|Progressive disease|18|||
130059434|NCT00229203|468172331|FG001|Overall Study|Progressive disease|9|||
130059435|NCT00229203|468172330|FG000|Overall Study|Toxicity|6|||
130059436|NCT00229203|468172331|FG001|Overall Study|Toxicity|1|||
130059437|NCT00229203|468172330|FG000|Overall Study|Death|4|||
130059438|NCT00229203|468172331|FG001|Overall Study|Death|2|||
130059439|NCT00229203|468172330|FG000|Overall Study|Other|3|||
130059440|NCT00229203|468172331|FG001|Overall Study|Other|3|||
130059441|NCT00229203|468172330|FG000|Overall Study|Withdrawal by Subject|1|||
130059442|NCT00229203|468172331|FG001|Overall Study|Withdrawal by Subject|4|||
130059443|NCT03607838|468172332|FG000|Overall Study|Lack of Efficacy|14|||
130059444|NCT03607838|468172333|FG001|Overall Study|Lack of Efficacy|20|||
130059445|NCT03607838|468172332|FG000|Overall Study|Withdrawal by Subject|13|||
130059446|NCT03607838|468172333|FG001|Overall Study|Withdrawal by Subject|8|||
130059447|NCT03607838|468172332|FG000|Overall Study|Lost to Follow-up|6|||
130059448|NCT03607838|468172333|FG001|Overall Study|Lost to Follow-up|11|||
130059449|NCT03607838|468172332|FG000|Overall Study|Adverse Event|2|||
130059450|NCT03607838|468172333|FG001|Overall Study|Adverse Event|2|||
130059451|NCT03607838|468172332|FG000|Overall Study|Physician Decision|2|||
130059452|NCT03607838|468172333|FG001|Overall Study|Physician Decision|0|||
130059453|NCT03607838|468172332|FG000|Overall Study|Failure to meet randomization criteria|1|||
130059454|NCT03607838|468172333|FG001|Overall Study|Failure to meet randomization criteria|2|||
129819385|NCT00471328|467301004|FG001|Core Phase|Death|4|||
129819386|NCT00471328|467301003|FG000|Core Phase|Withdrawal by Subject|2|||
129819387|NCT00471328|467301004|FG001|Core Phase|Withdrawal by Subject|2|||
129819388|NCT00471328|467301003|FG000|Core Phase|Abnormal laboratory value|1|||
129819389|NCT00471328|467301004|FG001|Core Phase|Abnormal laboratory value|0|||
129819390|NCT00471328|467301003|FG000|Core Phase|Disease Progression|78|||
129819391|NCT00471328|467301004|FG001|Core Phase|Disease Progression|53|||
129819392|NCT00471328|467301003|FG000|Core Phase|Administrative Problem|0|||
129819393|NCT00471328|467301004|FG001|Core Phase|Administrative Problem|1|||
129819394|NCT00471328|467301003|FG000|Core Phase|Protocol Deviation|0|||
129819395|NCT00471328|467301004|FG001|Core Phase|Protocol Deviation|1|||
129819396|NCT00471328|467301003|FG000|Extension Phase|Adverse Event|3|||
129819397|NCT00471328|467301004|FG001|Extension Phase|Adverse Event|12|||
129819398|NCT00471328|467301003|FG000|Extension Phase|Withdrawal by Subject|0|||
129897272|NCT00269399|467584308|FG001|Overall Study|Withdrawal by Subject|5|||
130059455|NCT03607838|468172332|FG000|Overall Study|Pregnancy|1|||
130059456|NCT03607838|468172333|FG001|Overall Study|Pregnancy|0|||
130059457|NCT03607838|468172332|FG000|Overall Study|Protocol Violation|1|||
129897273|NCT00269399|467584307|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
129897274|NCT00269399|467584308|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
129897275|NCT00269399|467584307|FG000|Overall Study|Other|0|||
130059458|NCT03607838|468172333|FG001|Overall Study|Protocol Violation|0|||
130059459|NCT03607838|468172332|FG000|Overall Study|Due to work|1|||
130059460|NCT03607838|468172333|FG001|Overall Study|Due to work|0|||
130059461|NCT03607838|468172332|FG000|Overall Study|Litigation|0|||
130059462|NCT03607838|468172333|FG001|Overall Study|Litigation|1|||
130059463|NCT03607838|468172332|FG000|Overall Study|Temperature excursion for study drug|0|||
130059464|NCT03607838|468172333|FG001|Overall Study|Temperature excursion for study drug|1|||
130059465|NCT03607838|468172332|FG000|Overall Study|Change of mind|0|||
130059466|NCT03607838|468172333|FG001|Overall Study|Change of mind|1|||
129819399|NCT00471328|467301004|FG001|Extension Phase|Withdrawal by Subject|2|||
129819400|NCT00471328|467301003|FG000|Extension Phase|Death|1|||
129819401|NCT00471328|467301004|FG001|Extension Phase|Death|7|||
129819402|NCT00471328|467301003|FG000|Extension Phase|Protocol Deviation|3|||
130059467|NCT02411201|468172334|FG000|Overall Study|Adverse Event|2|||
130059468|NCT02411201|468172334|FG000|Overall Study|Withdrawal by Subject|2|||
130059469|NCT02411201|468172334|FG000|Overall Study|Age group completed|2|||
130059470|NCT01260467|468172335|FG000|Overall Study|Withdrawal by Subject|2|||
129819403|NCT00471328|467301004|FG001|Extension Phase|Protocol Deviation|1|||
129819404|NCT00471328|467301003|FG000|Extension Phase|Treatment duration as per protocol|0|||
129819405|NCT00471328|467301004|FG001|Extension Phase|Treatment duration as per protocol|1|||
129819406|NCT00471328|467301003|FG000|Extension Phase|Disease Progression|32|||
129819407|NCT00471328|467301004|FG001|Extension Phase|Disease Progression|44|||
129819408|NCT00471328|467301003|FG000|Extension Phase|New cancer Therapy|1|||
129819409|NCT00471328|467301004|FG001|Extension Phase|New cancer Therapy|0|||
129819410|NCT00471328|467301003|FG000|Extension Phase|Administrative Problem|1|||
129819411|NCT00471328|467301004|FG001|Extension Phase|Administrative Problem|0|||
129819412|NCT01835587|467301005|FG000|Overall Study|Disease Recurrence or Relapse|0|||
129819413|NCT01835587|467301006|FG001|Overall Study|Disease Recurrence or Relapse|3|||
129819414|NCT01835587|467301007|FG002|Overall Study|Disease Recurrence or Relapse|0|||
129819415|NCT01835587|467301008|FG003|Overall Study|Disease Recurrence or Relapse|3|||
129819416|NCT01835587|467301005|FG000|Overall Study|Withdrawal by Subject|2|||
129819417|NCT01835587|467301006|FG001|Overall Study|Withdrawal by Subject|0|||
129819418|NCT01835587|467301007|FG002|Overall Study|Withdrawal by Subject|0|||
129819419|NCT01835587|467301008|FG003|Overall Study|Withdrawal by Subject|3|||
129819420|NCT01835587|467301005|FG000|Overall Study|Adverse Event|0|||
129819421|NCT01835587|467301006|FG001|Overall Study|Adverse Event|0|||
129819422|NCT01835587|467301007|FG002|Overall Study|Adverse Event|2|||
129819423|NCT01835587|467301008|FG003|Overall Study|Adverse Event|2|||
129819424|NCT01835587|467301005|FG000|Overall Study|Death|0|||
129819425|NCT01835587|467301006|FG001|Overall Study|Death|0|||
129819426|NCT01835587|467301007|FG002|Overall Study|Death|0|||
129819427|NCT01835587|467301008|FG003|Overall Study|Death|1|||
129819428|NCT01835587|467301005|FG000|Overall Study|Miscellaneous|0|||
129819429|NCT01835587|467301006|FG001|Overall Study|Miscellaneous|1|||
129819430|NCT01835587|467301007|FG002|Overall Study|Miscellaneous|0|||
129819431|NCT01835587|467301008|FG003|Overall Study|Miscellaneous|0|||
129819432|NCT02132130|467301009|FG000|Overall Study|Lost to Follow-up|0|||
129819433|NCT02132130|467301010|FG001|Overall Study|Lost to Follow-up|2|||
129819434|NCT02132130|467301011|FG002|Overall Study|Lost to Follow-up|0|||
129819435|NCT02132130|467301012|FG003|Overall Study|Lost to Follow-up|0|||
129819436|NCT02132130|467301009|FG000|Overall Study|Withdrawal by Subject|0|||
129819437|NCT02132130|467301010|FG001|Overall Study|Withdrawal by Subject|0|||
129819438|NCT02132130|467301011|FG002|Overall Study|Withdrawal by Subject|0|||
129819439|NCT02132130|467301012|FG003|Overall Study|Withdrawal by Subject|1|||
129819440|NCT00838578|467301013|FG000|Overall Study|Protocol Violation|2|||
129819441|NCT00357968|467301014|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
129819442|NCT00357968|467301015|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
129819443|NCT00357968|467301014|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
129819444|NCT00357968|467301015|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
129819445|NCT00439244|467301032|FG000|Overall Study|Adverse Event|5|||
129819446|NCT00439244|467301033|FG001|Overall Study|Adverse Event|2|||
129819447|NCT00439244|467301034|FG002|Overall Study|Adverse Event|3|||
129819448|NCT00439244|467301032|FG000|Overall Study|Withdrawal by Subject|3|||
129819449|NCT00439244|467301033|FG001|Overall Study|Withdrawal by Subject|1|||
129819450|NCT00439244|467301034|FG002|Overall Study|Withdrawal by Subject|2|||
129819451|NCT00439244|467301032|FG000|Overall Study|Lost to Follow-up|2|||
129819452|NCT00439244|467301033|FG001|Overall Study|Lost to Follow-up|1|||
129819453|NCT00439244|467301034|FG002|Overall Study|Lost to Follow-up|2|||
129819454|NCT00439244|467301032|FG000|Overall Study|Death|0|||
129819455|NCT00439244|467301033|FG001|Overall Study|Death|1|||
129819456|NCT00439244|467301034|FG002|Overall Study|Death|0|||
129819457|NCT00439244|467301032|FG000|Overall Study|Protocol Violation|0|||
129819458|NCT00439244|467301033|FG001|Overall Study|Protocol Violation|1|||
129819459|NCT00439244|467301034|FG002|Overall Study|Protocol Violation|0|||
129819460|NCT00439244|467301032|FG000|Overall Study|Administrative problems|1|||
129819461|NCT00439244|467301033|FG001|Overall Study|Administrative problems|0|||
129819462|NCT00439244|467301034|FG002|Overall Study|Administrative problems|0|||
129819463|NCT04102020|467301035|FG000|Overall Study|Adverse Event|1|||
129819464|NCT04102020|467301036|FG001|Overall Study|Adverse Event|0|||
129819465|NCT04102020|467301037|FG002|Overall Study|Adverse Event|0|||
129819466|NCT04102020|467301038|FG003|Overall Study|Adverse Event|1|||
129819467|NCT04102020|467301039|FG004|Overall Study|Adverse Event|0|||
129819468|NCT04102020|467301035|FG000|Overall Study|Withdrawal by Subject|0|||
129819469|NCT04102020|467301036|FG001|Overall Study|Withdrawal by Subject|1|||
129819470|NCT04102020|467301037|FG002|Overall Study|Withdrawal by Subject|1|||
129819471|NCT04102020|467301038|FG003|Overall Study|Withdrawal by Subject|1|||
129819472|NCT04102020|467301039|FG004|Overall Study|Withdrawal by Subject|1|||
129819473|NCT04102020|467301035|FG000|Overall Study|Death|1|||
129819474|NCT04102020|467301036|FG001|Overall Study|Death|4|||
129819475|NCT04102020|467301037|FG002|Overall Study|Death|1|||
129819476|NCT04102020|467301038|FG003|Overall Study|Death|1|||
129819477|NCT04102020|467301039|FG004|Overall Study|Death|0|||
129819478|NCT04102020|467301035|FG000|Overall Study|Physician Decision|1|||
129819479|NCT04102020|467301036|FG001|Overall Study|Physician Decision|2|||
129819480|NCT04102020|467301037|FG002|Overall Study|Physician Decision|2|||
129819481|NCT04102020|467301038|FG003|Overall Study|Physician Decision|0|||
129819482|NCT04102020|467301039|FG004|Overall Study|Physician Decision|1|||
129819483|NCT04102020|467301035|FG000|Overall Study|COVID-19 Infection|1|||
129819484|NCT04102020|467301036|FG001|Overall Study|COVID-19 Infection|0|||
129819485|NCT04102020|467301037|FG002|Overall Study|COVID-19 Infection|0|||
129819486|NCT04102020|467301038|FG003|Overall Study|COVID-19 Infection|0|||
129819487|NCT04102020|467301039|FG004|Overall Study|COVID-19 Infection|0|||
129819488|NCT04102020|467301035|FG000|Overall Study|Not disclosed|5|||
129819489|NCT04102020|467301036|FG001|Overall Study|Not disclosed|3|||
129819490|NCT04102020|467301037|FG002|Overall Study|Not disclosed|8|||
129819491|NCT04102020|467301038|FG003|Overall Study|Not disclosed|0|||
129819492|NCT04102020|467301039|FG004|Overall Study|Not disclosed|1|||
129819493|NCT04102020|467301035|FG000|Overall Study|MIssing|1|||
129819494|NCT04102020|467301036|FG001|Overall Study|MIssing|0|||
129819495|NCT04102020|467301037|FG002|Overall Study|MIssing|1|||
129819496|NCT04102020|467301038|FG003|Overall Study|MIssing|1|||
129819497|NCT04102020|467301039|FG004|Overall Study|MIssing|1|||
129819498|NCT04102020|467301035|FG000|Overall Study|Continuing in ongoing study|13|||
129819499|NCT04102020|467301036|FG001|Overall Study|Continuing in ongoing study|13|||
129819500|NCT04102020|467301037|FG002|Overall Study|Continuing in ongoing study|7|||
129819501|NCT04102020|467301038|FG003|Overall Study|Continuing in ongoing study|26|||
129819502|NCT04102020|467301039|FG004|Overall Study|Continuing in ongoing study|12|||
129819503|NCT04600921|467301042|FG000|Overall Study|Withdrawal by Subject|3|||
129819504|NCT04600921|467301043|FG001|Overall Study|Withdrawal by Subject|5|||
129819505|NCT04600921|467301042|FG000|Overall Study|Death|0|||
129819506|NCT04600921|467301043|FG001|Overall Study|Death|1|||
129819507|NCT02239978|467302677|FG000|Overall Study|Withdrawal by Subject|2|||
129819508|NCT02239978|467302678|FG001|Overall Study|Withdrawal by Subject|0|||
129819509|NCT00996216|467302684|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
129819510|NCT00996216|467302684|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
129819511|NCT00996216|467302684|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
129819512|NCT00482612|467302691|FG000|In-treatment Period|No study medication administered|0|||
129819513|NCT00482612|467302692|FG001|In-treatment Period|No study medication administered|0|||
129819514|NCT00482612|467302693|FG002|In-treatment Period|No study medication administered|1|||
129819515|NCT00482612|467302694|FG003|In-treatment Period|No study medication administered|0|||
129819516|NCT00482612|467302691|FG000|Follow-up Period|Other|4|||
129819517|NCT00482612|467302692|FG001|Follow-up Period|Other|2|||
129819518|NCT00482612|467302693|FG002|Follow-up Period|Other|1|||
129819519|NCT00482612|467302694|FG003|Follow-up Period|Other|2|||
129819520|NCT00482612|467302691|FG000|Follow-up Period|Lack of compliance|0|||
129819521|NCT00482612|467302692|FG001|Follow-up Period|Lack of compliance|0|||
129819522|NCT00482612|467302693|FG002|Follow-up Period|Lack of compliance|1|||
129819523|NCT00482612|467302694|FG003|Follow-up Period|Lack of compliance|0|||
129819524|NCT00482612|467302691|FG000|Follow-up Period|Lost to Follow-up|0|||
129819525|NCT00482612|467302692|FG001|Follow-up Period|Lost to Follow-up|4|||
129819526|NCT00482612|467302693|FG002|Follow-up Period|Lost to Follow-up|2|||
129819527|NCT00482612|467302694|FG003|Follow-up Period|Lost to Follow-up|1|||
129819528|NCT00482612|467302691|FG000|Follow-up Period|Adverse Event|4|||
129819529|NCT00482612|467302692|FG001|Follow-up Period|Adverse Event|7|||
129819530|NCT00482612|467302693|FG002|Follow-up Period|Adverse Event|9|||
129819531|NCT00482612|467302694|FG003|Follow-up Period|Adverse Event|0|||
129819532|NCT00482612|467302691|FG000|Follow-up Period|Lack of Efficacy|2|||
129819533|NCT00482612|467302692|FG001|Follow-up Period|Lack of Efficacy|0|||
129819534|NCT00482612|467302693|FG002|Follow-up Period|Lack of Efficacy|1|||
129819535|NCT00482612|467302694|FG003|Follow-up Period|Lack of Efficacy|0|||
129897276|NCT00269399|467584308|FG001|Overall Study|Other|4|||
129897277|NCT00269399|467584307|FG000|Overall Study|Development of exclusion criteria|0|||
129897278|NCT00269399|467584308|FG001|Overall Study|Development of exclusion criteria|1|||
129819536|NCT00482612|467302691|FG000|Follow-up Period|Withdrawal by Subject|3|||
129819537|NCT00482612|467302692|FG001|Follow-up Period|Withdrawal by Subject|5|||
129819538|NCT00482612|467302693|FG002|Follow-up Period|Withdrawal by Subject|7|||
129819539|NCT00482612|467302694|FG003|Follow-up Period|Withdrawal by Subject|2|||
129819540|NCT00482612|467302691|FG000|Follow-up Period|Reasons not related to trial|1|||
129819541|NCT00482612|467302692|FG001|Follow-up Period|Reasons not related to trial|0|||
129819542|NCT00482612|467302693|FG002|Follow-up Period|Reasons not related to trial|1|||
129819543|NCT00482612|467302694|FG003|Follow-up Period|Reasons not related to trial|3|||
129819544|NCT01366521|467302695|FG000|Overall Study|Adverse Event|1|||
129819545|NCT01366521|467302696|FG001|Overall Study|Adverse Event|0|||
129819546|NCT01366521|467302697|FG002|Overall Study|Adverse Event|0|||
129819547|NCT01366521|467302698|FG003|Overall Study|Adverse Event|0|||
129819548|NCT01366521|467302695|FG000|Overall Study|Protocol Violation|0|||
129819549|NCT01366521|467302696|FG001|Overall Study|Protocol Violation|0|||
129819550|NCT01366521|467302697|FG002|Overall Study|Protocol Violation|1|||
129819551|NCT01366521|467302698|FG003|Overall Study|Protocol Violation|0|||
129897279|NCT03441360|467584309|FG000|Overall Study|Radiological disease progression|5|||
129819552|NCT01366521|467302695|FG000|Overall Study|Physician Decision|0|||
129819553|NCT01366521|467302696|FG001|Overall Study|Physician Decision|0|||
129819554|NCT01366521|467302697|FG002|Overall Study|Physician Decision|1|||
129819555|NCT01366521|467302698|FG003|Overall Study|Physician Decision|0|||
129819556|NCT01366521|467302695|FG000|Overall Study|Withdrawal by Subject|0|||
129819557|NCT01366521|467302696|FG001|Overall Study|Withdrawal by Subject|1|||
129819558|NCT01366521|467302697|FG002|Overall Study|Withdrawal by Subject|0|||
129819559|NCT01366521|467302698|FG003|Overall Study|Withdrawal by Subject|0|||
129819560|NCT00684307|467302699|FG000|Overall Study|Adverse Event|11|||
129819561|NCT00684307|467302700|FG001|Overall Study|Adverse Event|6|||
129819562|NCT00684307|467302701|FG002|Overall Study|Adverse Event|15|||
129819563|NCT00684307|467302702|FG003|Overall Study|Adverse Event|16|||
129819564|NCT00684307|467302703|FG004|Overall Study|Adverse Event|8|||
129819565|NCT00684307|467302699|FG000|Overall Study|Development of increasing Liver Function|0|||
129819566|NCT00684307|467302700|FG001|Overall Study|Development of increasing Liver Function|2|||
129819567|NCT00684307|467302701|FG002|Overall Study|Development of increasing Liver Function|0|||
129819568|NCT00684307|467302702|FG003|Overall Study|Development of increasing Liver Function|1|||
129819569|NCT00684307|467302703|FG004|Overall Study|Development of increasing Liver Function|0|||
129819570|NCT00684307|467302699|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
129819571|NCT00684307|467302700|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
129819572|NCT00684307|467302701|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
129819573|NCT00684307|467302702|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
129819574|NCT00684307|467302703|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
129819575|NCT00684307|467302699|FG000|Overall Study|Incorrect enrolment or randomization|4|||
129819576|NCT00684307|467302700|FG001|Overall Study|Incorrect enrolment or randomization|0|||
129819577|NCT00684307|467302701|FG002|Overall Study|Incorrect enrolment or randomization|0|||
129819578|NCT00684307|467302702|FG003|Overall Study|Incorrect enrolment or randomization|0|||
129819579|NCT00684307|467302703|FG004|Overall Study|Incorrect enrolment or randomization|0|||
129819580|NCT00684307|467302699|FG000|Overall Study|Interupted IP for more than 7 days|0|||
129819581|NCT00684307|467302700|FG001|Overall Study|Interupted IP for more than 7 days|4|||
129819582|NCT00684307|467302701|FG002|Overall Study|Interupted IP for more than 7 days|1|||
129819583|NCT00684307|467302702|FG003|Overall Study|Interupted IP for more than 7 days|3|||
129819584|NCT00684307|467302703|FG004|Overall Study|Interupted IP for more than 7 days|3|||
129819585|NCT00684307|467302699|FG000|Overall Study|Severe non compliance to protocol|1|||
129819586|NCT00684307|467302700|FG001|Overall Study|Severe non compliance to protocol|0|||
129819587|NCT00684307|467302701|FG002|Overall Study|Severe non compliance to protocol|0|||
129819588|NCT00684307|467302702|FG003|Overall Study|Severe non compliance to protocol|1|||
129819589|NCT00684307|467302703|FG004|Overall Study|Severe non compliance to protocol|2|||
129819590|NCT00684307|467302699|FG000|Overall Study|Participant not willing to continue|7|||
129819591|NCT00684307|467302700|FG001|Overall Study|Participant not willing to continue|10|||
129819592|NCT00684307|467302701|FG002|Overall Study|Participant not willing to continue|11|||
129819593|NCT00684307|467302702|FG003|Overall Study|Participant not willing to continue|5|||
129819594|NCT00684307|467302703|FG004|Overall Study|Participant not willing to continue|8|||
129819595|NCT00684307|467302699|FG000|Overall Study|Criteria from the CSR|0|||
129819596|NCT00684307|467302700|FG001|Overall Study|Criteria from the CSR|0|||
129819597|NCT00684307|467302701|FG002|Overall Study|Criteria from the CSR|1|||
129819598|NCT00684307|467302702|FG003|Overall Study|Criteria from the CSR|3|||
129819599|NCT00684307|467302703|FG004|Overall Study|Criteria from the CSR|3|||
129819600|NCT00759031|467302704|FG000|First Intervention (1 Day)|Physician Decision|1|||
129819601|NCT00759031|467302705|FG001|First Intervention (1 Day)|Physician Decision|0|||
129819602|NCT00759031|467302704|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129819603|NCT00759031|467302705|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129819604|NCT00759031|467302704|FG000|First Intervention (1 Day)|Screening failure|1|||
129819605|NCT00759031|467302705|FG001|First Intervention (1 Day)|Screening failure|0|||
129819606|NCT02430311|467302706|FG000|Part A|Adverse Event|0|||
129819607|NCT02430311|467302707|FG001|Part A|Adverse Event|1|||
129819608|NCT02430311|467302706|FG000|Part A|Withdrawal by Subject|1|||
129819609|NCT02430311|467302707|FG001|Part A|Withdrawal by Subject|0|||
129819610|NCT02430311|467302706|FG000|Part B|Meet study-specific withdrawal criteria|6|||
129819611|NCT02430311|467302707|FG001|Part B|Meet study-specific withdrawal criteria|6|||
129819612|NCT02430311|467302706|FG000|Part B|Withdrawal by Subject|2|||
129819613|NCT02430311|467302707|FG001|Part B|Withdrawal by Subject|2|||
129819614|NCT02430311|467302706|FG000|Part B|Adverse Event|1|||
129819615|NCT02430311|467302707|FG001|Part B|Adverse Event|0|||
129819616|NCT02430311|467302706|FG000|Part B|Death|1|||
129819617|NCT02430311|467302707|FG001|Part B|Death|0|||
129819618|NCT03506815|467302708|FG000|Overall Study|Adverse Event|8|||
130059471|NCT02546674|468172344|FG000|Overall Study|Adverse Event|19|||
129897280|NCT03441360|467584310|FG001|Overall Study|Radiological disease progression|6|||
129897281|NCT03441360|467584311|FG002|Overall Study|Radiological disease progression|4|||
129819619|NCT03506815|467302709|FG001|Overall Study|Adverse Event|0|||
129819620|NCT03506815|467302708|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
129819621|NCT03506815|467302709|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
129819622|NCT03506815|467302708|FG000|Overall Study|Protocol Violation|1|||
129897282|NCT03441360|467584309|FG000|Overall Study|Clinical disease progression|2|||
130059472|NCT02546674|468172344|FG000|Overall Study|Death|1|||
129819623|NCT03506815|467302709|FG001|Overall Study|Protocol Violation|0|||
129819624|NCT03506815|467302708|FG000|Overall Study|Elective Surgery|1|||
129819625|NCT03506815|467302709|FG001|Overall Study|Elective Surgery|0|||
129819626|NCT04160091|467302710|FG000|Overall Study|Terminated by Sponsor|7|||
129819627|NCT04160091|467302711|FG001|Overall Study|Terminated by Sponsor|3|||
129819628|NCT04160091|467302712|FG002|Overall Study|Terminated by Sponsor|5|||
129819629|NCT04160091|467302713|FG003|Overall Study|Terminated by Sponsor|2|||
129819630|NCT04160091|467302710|FG000|Overall Study|Noncompliance|0|||
129819631|NCT04160091|467302711|FG001|Overall Study|Noncompliance|0|||
129819632|NCT04160091|467302712|FG002|Overall Study|Noncompliance|0|||
129819633|NCT04160091|467302713|FG003|Overall Study|Noncompliance|1|||
129819634|NCT04160091|467302710|FG000|Overall Study|Withdrawal by Subject|0|||
129819635|NCT04160091|467302711|FG001|Overall Study|Withdrawal by Subject|0|||
129819636|NCT04160091|467302712|FG002|Overall Study|Withdrawal by Subject|0|||
129819637|NCT04160091|467302713|FG003|Overall Study|Withdrawal by Subject|1|||
129819638|NCT01599234|467302718|FG000|Overall Study|Adverse Event|9|||
129819639|NCT01599234|467302719|FG001|Overall Study|Adverse Event|5|||
129819640|NCT01599234|467302718|FG000|Overall Study|Withdrawal by Subject|2|||
129819641|NCT01599234|467302719|FG001|Overall Study|Withdrawal by Subject|1|||
129819642|NCT01599234|467302718|FG000|Overall Study|Lost to Follow-up|1|||
129819643|NCT01599234|467302719|FG001|Overall Study|Lost to Follow-up|2|||
129819644|NCT01599234|467302718|FG000|Overall Study|Lack of Efficacy|2|||
129819645|NCT01599234|467302719|FG001|Overall Study|Lack of Efficacy|4|||
129819646|NCT01599234|467302718|FG000|Overall Study|Unable to operate spray|1|||
129819647|NCT01599234|467302719|FG001|Overall Study|Unable to operate spray|0|||
129819648|NCT01599234|467302718|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
129819649|NCT01599234|467302719|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
129819650|NCT01599234|467302718|FG000|Overall Study|Death|1|||
129819651|NCT01599234|467302719|FG001|Overall Study|Death|0|||
129819652|NCT01599234|467302718|FG000|Overall Study|Patient would not stop driving|1|||
129819653|NCT01599234|467302719|FG001|Overall Study|Patient would not stop driving|0|||
129819654|NCT01599234|467302718|FG000|Overall Study|Contra-indication discovered|0|||
129819655|NCT01599234|467302719|FG001|Overall Study|Contra-indication discovered|1|||
129819656|NCT01599234|467302718|FG000|Overall Study|Pregnancy|0|||
129819657|NCT01599234|467302719|FG001|Overall Study|Pregnancy|1|||
129819658|NCT02899988|467302729|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
129819659|NCT02899988|467302730|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
129819660|NCT02899988|467302731|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819661|NCT02899988|467302732|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819662|NCT02899988|467302733|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819663|NCT02899988|467302734|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819664|NCT02899988|467302735|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819665|NCT02899988|467302736|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819666|NCT02899988|467302737|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819667|NCT02899988|467302738|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819668|NCT02899988|467302739|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819669|NCT02899988|467302729|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
129819670|NCT02899988|467302730|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
129819671|NCT02899988|467302731|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
129819672|NCT02899988|467302732|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
129819673|NCT02899988|467302733|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129819674|NCT02899988|467302734|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
129819675|NCT02899988|467302735|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
129819676|NCT02899988|467302736|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
129819677|NCT02899988|467302737|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
129819678|NCT02899988|467302738|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
129819679|NCT02899988|467302739|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
129819680|NCT02899988|467302729|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
129819681|NCT02899988|467302730|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
129819682|NCT02899988|467302731|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
129819683|NCT02899988|467302732|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
129819684|NCT02899988|467302733|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
129819685|NCT02899988|467302734|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
129819686|NCT02899988|467302735|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
129819687|NCT02899988|467302736|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
129819688|NCT02899988|467302737|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
129819689|NCT02899988|467302738|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
129819690|NCT02899988|467302739|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
129819691|NCT02899988|467302729|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819692|NCT02899988|467302730|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819693|NCT02899988|467302731|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819694|NCT02899988|467302732|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819695|NCT02899988|467302733|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
129819696|NCT02899988|467302734|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819697|NCT02899988|467302735|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
129819698|NCT02899988|467302736|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819699|NCT02899988|467302737|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819700|NCT02899988|467302738|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819701|NCT02899988|467302739|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
129819702|NCT02899988|467302729|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819703|NCT02899988|467302730|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819704|NCT02899988|467302731|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819705|NCT02899988|467302732|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819706|NCT02899988|467302733|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819707|NCT02899988|467302734|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
129819708|NCT02899988|467302735|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819709|NCT02899988|467302736|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
129819710|NCT02899988|467302737|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819711|NCT02899988|467302738|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819712|NCT02899988|467302739|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819713|NCT02899988|467302729|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819714|NCT02899988|467302730|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819715|NCT02899988|467302731|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819716|NCT02899988|467302732|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819717|NCT02899988|467302733|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
129819718|NCT02899988|467302734|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819719|NCT02899988|467302735|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
129819720|NCT02899988|467302736|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
129819721|NCT02899988|467302737|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
129819722|NCT02899988|467302738|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819723|NCT02899988|467302739|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
129819724|NCT01401283|467302740|FG000|Overall Study|surgery cancelled|5|||
129819725|NCT01401283|467302741|FG001|Overall Study|surgery cancelled|8|||
129819726|NCT01401283|467302740|FG000|Overall Study|preoperative arrhythmia|5|||
129819727|NCT01401283|467302741|FG001|Overall Study|preoperative arrhythmia|0|||
129819728|NCT01401283|467302740|FG000|Overall Study|no central venous access|0|||
129819729|NCT01401283|467302741|FG001|Overall Study|no central venous access|1|||
129819730|NCT01401283|467302740|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
129819731|NCT01401283|467302741|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
129819732|NCT02433483|467302742|FG000|Overall Study|Unacceptable toxicity|1|||
129819733|NCT02433483|467302742|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
129819734|NCT04271605|467302746|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
129819735|NCT03342690|467302747|FG000|Overall Study|Missing Information|9|||
129819736|NCT03342690|467302747|FG000|Overall Study|Protocol Violation|16|||
129819737|NCT00085631|467302748|FG000|Overall Study|Missing Data|4|||
129819738|NCT00085631|467302749|FG001|Overall Study|Missing Data|11|||
129819739|NCT00085631|467302750|FG002|Overall Study|Missing Data|7|||
129819740|NCT00411645|467302751|FG000|Overall Study|Consent Withdrawn|13|||
129819741|NCT00411645|467302752|FG001|Overall Study|Consent Withdrawn|22|||
129819742|NCT00411645|467302751|FG000|Overall Study|Death|56|||
129819743|NCT00411645|467302752|FG001|Overall Study|Death|135|||
129819744|NCT00411645|467302751|FG000|Overall Study|Investigator/Sponsor Decision|10|||
129819745|NCT00411645|467302752|FG001|Overall Study|Investigator/Sponsor Decision|7|||
129819746|NCT00411645|467302751|FG000|Overall Study|Lost to Follow-up|2|||
129819747|NCT00411645|467302752|FG001|Overall Study|Lost to Follow-up|0|||
129819748|NCT01750242|467302755|FG000|Overall Study|Unreadable Images|3|||
129819749|NCT01025752|467302767|FG000|Overall Study|Lost to Follow-up|7|||
129819750|NCT01025752|467302768|FG001|Overall Study|Lost to Follow-up|10|||
129819751|NCT01025752|467302767|FG000|Overall Study|Physician Decision|1|||
129819752|NCT01025752|467302768|FG001|Overall Study|Physician Decision|3|||
129819753|NCT01417234|467302771|FG000|Overall Study|Subject non-compliant|3|||
129819754|NCT00023764|467302772|FG000|Overall Study|Other|1|||
129819755|NCT00023764|467302772|FG000|Overall Study|Adverse Event|4|||
129819756|NCT00023764|467302772|FG000|Overall Study|Withdrawal by Subject|1|||
129819757|NCT00023764|467302772|FG000|Overall Study|Progression of disease|6|||
129819758|NCT00023764|467302772|FG000|Overall Study|patient received other treatment|1|||
129819759|NCT00023764|467302772|FG000|Overall Study|delay in obtaining staging images|1|||
129819760|NCT04294472|467302773|FG000|Overall Study|Adverse Event|0|||
129897283|NCT03441360|467584310|FG001|Overall Study|Clinical disease progression|2|||
129819761|NCT04294472|467302774|FG001|Overall Study|Adverse Event|1|||
129819762|NCT04294472|467302775|FG002|Overall Study|Adverse Event|1|||
129819763|NCT04294472|467302773|FG000|Overall Study|Randomized but not treated|0|||
129897284|NCT03441360|467584311|FG002|Overall Study|Clinical disease progression|0|||
129897285|NCT03441360|467584309|FG000|Overall Study|Adverse Event|1|||
129897286|NCT03441360|467584310|FG001|Overall Study|Adverse Event|0|||
129897287|NCT03441360|467584311|FG002|Overall Study|Adverse Event|1|||
129897288|NCT03396835|467584312|FG000|Overall Study|Withdrawn prior to completion|1|||
129819764|NCT04294472|467302774|FG001|Overall Study|Randomized but not treated|1|||
129819765|NCT04294472|467302775|FG002|Overall Study|Randomized but not treated|1|||
129819766|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
129819767|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130059473|NCT02546674|468172344|FG000|Overall Study|Lost to Follow-up|1|||
130059474|NCT02546674|468172344|FG000|Overall Study|Physician Decision|13|||
130059475|NCT02546674|468172344|FG000|Overall Study|Pregnancy|1|||
130059476|NCT02546674|468172344|FG000|Overall Study|Progressive Disease|2|||
130059477|NCT02546674|468172344|FG000|Overall Study|Protocol Deviation|2|||
130059478|NCT02546674|468172344|FG000|Overall Study|Subject/Guardian Decision|6|||
130059479|NCT02546674|468172344|FG000|Overall Study|Withdrawal of Informed Consent|3|||
130059480|NCT01163253|468172345|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
130059481|NCT01163253|468172346|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
130059482|NCT01163253|468172345|FG000|Overall Study|Study Terminated by Sponsor|978|||
130059483|NCT01163253|468172346|FG001|Overall Study|Study Terminated by Sponsor|349|||
130059484|NCT01163253|468172345|FG000|Overall Study|Protocol Violation|43|||
130059485|NCT01163253|468172346|FG001|Overall Study|Protocol Violation|12|||
130059486|NCT01163253|468172345|FG000|Overall Study|Withdrawal by Subject|199|||
130059487|NCT01163253|468172346|FG001|Overall Study|Withdrawal by Subject|50|||
130059488|NCT01163253|468172345|FG000|Overall Study|Medication Error|1|||
130059489|NCT01163253|468172346|FG001|Overall Study|Medication Error|0|||
130059490|NCT01163253|468172345|FG000|Overall Study|Lost to Follow-up|125|||
130059491|NCT01163253|468172346|FG001|Overall Study|Lost to Follow-up|23|||
130059492|NCT01163253|468172345|FG000|Overall Study|Insufficient Clinical Response|423|||
130059493|NCT01163253|468172346|FG001|Overall Study|Insufficient Clinical Response|29|||
130059494|NCT01163253|468172345|FG000|Overall Study|Adverse Event|300|||
130059495|NCT01163253|468172346|FG001|Overall Study|Adverse Event|78|||
130059496|NCT01163253|468172345|FG000|Overall Study|Death|17|||
130059497|NCT01163253|468172346|FG001|Overall Study|Death|5|||
130059498|NCT01163253|468172345|FG000|Overall Study|Ongoing|13|||
130059499|NCT01163253|468172346|FG001|Overall Study|Ongoing|4|||
129819768|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
129819769|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
129819770|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129819771|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129819772|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
129819773|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
129819774|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Other|1|||
129819775|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Other|4|||
129819776|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Other|3|||
129819777|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Other|6|||
129819778|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
129819779|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
129819780|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
129819781|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
129819782|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
129819783|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
129819784|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
129819785|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
129819786|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129819787|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129819788|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
129819789|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
129819790|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
129819791|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
129819792|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
129819793|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
129819794|NCT06149247|467302790|FG000|Overall Study|Adverse Event|0|||
129819795|NCT06149247|467302791|FG001|Overall Study|Adverse Event|1|||
130059500|NCT01163253|468172345|FG000|Overall Study|Other Unspecified|170|||
130059501|NCT01163253|468172346|FG001|Overall Study|Other Unspecified|34|||
130059502|NCT02492997|468172347|FG000|Overall Study|Withdrawal by Subject|1|||
130059503|NCT02492997|468172348|FG001|Overall Study|Withdrawal by Subject|0|||
130059504|NCT02492997|468172347|FG000|Overall Study|Gained Weight|1|||
130059505|NCT02492997|468172348|FG001|Overall Study|Gained Weight|0|||
130059506|NCT02492997|468172347|FG000|Overall Study|Lost to Follow-up|0|||
130059507|NCT02492997|468172348|FG001|Overall Study|Lost to Follow-up|1|||
130059508|NCT00423735|468172349|FG000|Overall Study|Ineligible / No protocol treatment|8|||
130059509|NCT00423735|468172350|FG001|Overall Study|Ineligible / No protocol treatment|6|||
129819796|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
129819797|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819798|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
129819799|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
130059510|NCT00423735|468172351|FG002|Overall Study|Ineligible / No protocol treatment|0|||
129819800|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819801|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819802|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819803|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819804|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819805|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
129819806|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
129819807|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
129819808|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819809|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819810|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819811|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819812|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819813|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819814|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819815|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
129819816|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819817|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819818|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819819|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819820|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819821|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819822|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819823|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
129819824|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819825|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819826|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819827|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819828|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819829|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819830|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819831|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819832|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819833|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
129819834|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
129819835|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
129819836|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
129819837|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
129819838|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819839|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819840|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819841|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819842|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819843|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
129819844|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819845|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819846|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819847|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819848|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819849|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819850|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819851|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
129819852|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
129819853|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
129819854|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
129819855|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
129819856|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819857|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819858|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819859|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819860|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819861|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
129819862|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819863|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
129819864|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
129819865|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819866|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819867|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819868|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819869|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819870|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819871|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819872|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819873|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819874|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
129819875|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819876|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819877|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819878|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819879|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819880|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
129819881|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819882|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819883|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
129819884|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819885|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819886|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
129819887|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
129819888|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
129819889|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
129819890|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
129819891|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
129819892|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
129819893|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
129819894|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
129819895|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819896|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819897|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819898|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819899|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819900|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819901|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819902|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
129819903|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
129819904|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819905|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819906|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819907|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819908|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819909|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819910|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819911|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
129819912|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
129819913|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819914|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819915|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819916|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819917|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819918|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819919|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819920|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
129819921|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819922|NCT04786990|467302801|FG000|Overall Study|Withdrawal by Subject|1|||
129819923|NCT04786990|467302801|FG000|Overall Study|Adverse Event|1|||
129819924|NCT04786990|467302801|FG000|Overall Study|Lost to Follow-up|1|||
129819925|NCT04786990|467302801|FG000|Overall Study|Noncompliance|1|||
129819926|NCT04786990|467302801|FG000|Overall Study|Unable to complete site visits|1|||
129819927|NCT04786990|467302801|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
129819928|NCT01782222|467302802|FG000|Overall Study|Adverse Event|4|||
129819929|NCT01782222|467302803|FG001|Overall Study|Adverse Event|5|||
129819930|NCT01782222|467302804|FG002|Overall Study|Adverse Event|3|||
129819931|NCT01782222|467302802|FG000|Overall Study|Lack of Efficacy|2|||
129819932|NCT01782222|467302803|FG001|Overall Study|Lack of Efficacy|1|||
129819933|NCT01782222|467302804|FG002|Overall Study|Lack of Efficacy|0|||
129819934|NCT01782222|467302802|FG000|Overall Study|Protocol Violation|1|||
129819935|NCT01782222|467302803|FG001|Overall Study|Protocol Violation|0|||
129819936|NCT01782222|467302804|FG002|Overall Study|Protocol Violation|0|||
129819937|NCT01782222|467302802|FG000|Overall Study|Withdrawal by Subject|1|||
129819938|NCT01782222|467302803|FG001|Overall Study|Withdrawal by Subject|4|||
129819939|NCT01782222|467302804|FG002|Overall Study|Withdrawal by Subject|1|||
129819940|NCT01782222|467302802|FG000|Overall Study|Moved to other state|0|||
129819941|NCT01782222|467302803|FG001|Overall Study|Moved to other state|1|||
129819942|NCT01782222|467302804|FG002|Overall Study|Moved to other state|0|||
129819943|NCT01500694|467302805|FG000|Overall Study|Adverse Event|4|||
129819944|NCT01500694|467302806|FG001|Overall Study|Adverse Event|3|||
129819945|NCT01500694|467302805|FG000|Overall Study|Protocol Violation|0|||
129819946|NCT01500694|467302806|FG001|Overall Study|Protocol Violation|1|||
129819947|NCT01500694|467302805|FG000|Overall Study|Withdrawal by Subject|23|||
129819948|NCT01500694|467302806|FG001|Overall Study|Withdrawal by Subject|14|||
129819949|NCT01500694|467302805|FG000|Overall Study|Lost to Follow-up|2|||
130112420|NCT01393990|468373382|FG006|Overall Study|Adverse Event|0|||
129819950|NCT01500694|467302806|FG001|Overall Study|Lost to Follow-up|3|||
129819951|NCT01500694|467302805|FG000|Overall Study|Lack of Efficacy|14|||
129819952|NCT01500694|467302806|FG001|Overall Study|Lack of Efficacy|5|||
129819953|NCT01500694|467302805|FG000|Overall Study|Other|9|||
129819954|NCT01500694|467302806|FG001|Overall Study|Other|3|||
129819955|NCT00833794|467302809|FG000|Open-label Phase|Adverse Event|225|||
129819956|NCT00833794|467302810|FG001|Open-label Phase|Adverse Event|0|||
129819957|NCT00833794|467302809|FG000|Open-label Phase|Lack of Efficacy|28|||
129819958|NCT00833794|467302810|FG001|Open-label Phase|Lack of Efficacy|0|||
129819959|NCT00833794|467302809|FG000|Open-label Phase|Withdrawal by Subject|48|||
129819960|NCT00833794|467302810|FG001|Open-label Phase|Withdrawal by Subject|0|||
129819961|NCT00833794|467302809|FG000|Open-label Phase|Physician Decision|20|||
129819962|NCT00833794|467302810|FG001|Open-label Phase|Physician Decision|0|||
129819963|NCT00833794|467302809|FG000|Open-label Phase|Administrative reason|1|||
129819964|NCT00833794|467302810|FG001|Open-label Phase|Administrative reason|0|||
129819965|NCT00833794|467302809|FG000|Open-label Phase|Protocol Violation|47|||
129819966|NCT00833794|467302810|FG001|Open-label Phase|Protocol Violation|0|||
129819967|NCT00833794|467302809|FG000|Open-label Phase|Did not complete wash-out period|12|||
129819968|NCT00833794|467302810|FG001|Open-label Phase|Did not complete wash-out period|0|||
129819969|NCT00833794|467302809|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
129819970|NCT00833794|467302810|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
129819971|NCT00833794|467302809|FG000|Double-blind Phase|Adverse Event|44|||
129819972|NCT00833794|467302810|FG001|Double-blind Phase|Adverse Event|11|||
129819973|NCT00833794|467302809|FG000|Double-blind Phase|Lack of Efficacy|34|||
129819974|NCT00833794|467302810|FG001|Double-blind Phase|Lack of Efficacy|22|||
129819975|NCT00833794|467302809|FG000|Double-blind Phase|Withdrawal by Subject|23|||
129819976|NCT00833794|467302810|FG001|Double-blind Phase|Withdrawal by Subject|6|||
129819977|NCT00833794|467302809|FG000|Double-blind Phase|Physician Decision|4|||
129819978|NCT00833794|467302810|FG001|Double-blind Phase|Physician Decision|7|||
129819979|NCT00833794|467302809|FG000|Double-blind Phase|Administrative reason|1|||
129819980|NCT00833794|467302810|FG001|Double-blind Phase|Administrative reason|3|||
129819981|NCT04051008|467302811|FG000|Overall Study|Withdrawal by Subject|2|||
129819982|NCT04051008|467302812|FG001|Overall Study|Withdrawal by Subject|0|||
129819983|NCT04051008|467302813|FG002|Overall Study|Withdrawal by Subject|1|||
129819984|NCT03310775|467302823|FG000|Overall Study|Lost to Follow-up|2|||
129819985|NCT03310775|467302824|FG001|Overall Study|Lost to Follow-up|3|||
129819986|NCT03310775|467302823|FG000|Overall Study|aggravation of depression|0|||
129819987|NCT03310775|467302824|FG001|Overall Study|aggravation of depression|1|||
129819988|NCT00600483|467302825|FG000|Overall Study|Lost to Follow-up|26|||
129819989|NCT00600483|467302826|FG001|Overall Study|Lost to Follow-up|47|||
129819990|NCT00600483|467302825|FG000|Overall Study|Randomized but not treated|10|||
129819991|NCT00600483|467302826|FG001|Overall Study|Randomized but not treated|0|||
129819992|NCT01482884|467302827|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
129819993|NCT01482884|467302828|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
129819994|NCT01482884|467302827|FG000|Overall Study|Protocol Violation|1|||
129819995|NCT01482884|467302828|FG001|Overall Study|Protocol Violation|0|||
129819996|NCT01482884|467302827|FG000|Overall Study|Lost to Follow-up|2|||
129819997|NCT01482884|467302828|FG001|Overall Study|Lost to Follow-up|2|||
129819998|NCT01482884|467302827|FG000|Overall Study|Lack of Efficacy|0|||
129819999|NCT01482884|467302828|FG001|Overall Study|Lack of Efficacy|1|||
129820000|NCT01482884|467302827|FG000|Overall Study|Adverse Event|2|||
129820001|NCT01482884|467302828|FG001|Overall Study|Adverse Event|1|||
129820002|NCT01482884|467302827|FG000|Overall Study|Withdrawal by Subject|8|||
129820003|NCT01482884|467302828|FG001|Overall Study|Withdrawal by Subject|13|||
129820004|NCT00580606|467302829|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
129820005|NCT00580606|467302830|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
129820006|NCT00580606|467302829|FG000|Open Label (OL)|Withdrawal by Subject|4|||
129820007|NCT00580606|467302830|FG001|Open Label (OL)|Withdrawal by Subject|6|||
129820008|NCT00580606|467302829|FG000|Open Label (OL)|Dosing Symptoms|0|||
130112421|NCT01393990|468373383|FG007|Overall Study|Adverse Event|0|||
129820009|NCT00580606|467302830|FG001|Open Label (OL)|Dosing Symptoms|1|||
129820010|NCT00580606|467302829|FG000|Open Label (OL)|Lost to Follow-up|0|||
129820011|NCT00580606|467302830|FG001|Open Label (OL)|Lost to Follow-up|1|||
130112422|NCT01393990|468373384|FG008|Overall Study|Adverse Event|0|||
130112423|NCT01393990|468373385|FG009|Overall Study|Adverse Event|0|||
130112424|NCT01393990|468373386|FG010|Overall Study|Adverse Event|0|||
130112425|NCT01393990|468373387|FG011|Overall Study|Adverse Event|0|||
130112426|NCT01393990|468373388|FG012|Overall Study|Adverse Event|0|||
130112427|NCT01393990|468373389|FG013|Overall Study|Adverse Event|0|||
130112428|NCT01393990|468373390|FG014|Overall Study|Adverse Event|1|||
130112429|NCT01393990|468373391|FG015|Overall Study|Adverse Event|1|||
130112430|NCT01393990|468373392|FG016|Overall Study|Adverse Event|0|||
130112431|NCT01393990|468373393|FG017|Overall Study|Adverse Event|0|||
130112432|NCT01393990|468373376|FG000|Overall Study|Progressive Disease|1|||
130112433|NCT01393990|468373377|FG001|Overall Study|Progressive Disease|0|||
130112434|NCT01393990|468373378|FG002|Overall Study|Progressive Disease|0|||
130112435|NCT01393990|468373379|FG003|Overall Study|Progressive Disease|1|||
130112436|NCT01393990|468373380|FG004|Overall Study|Progressive Disease|1|||
130112437|NCT01393990|468373381|FG005|Overall Study|Progressive Disease|1|||
130112438|NCT01393990|468373382|FG006|Overall Study|Progressive Disease|1|||
130112439|NCT01393990|468373383|FG007|Overall Study|Progressive Disease|1|||
130112440|NCT01393990|468373384|FG008|Overall Study|Progressive Disease|3|||
130112441|NCT01393990|468373385|FG009|Overall Study|Progressive Disease|1|||
130112442|NCT01393990|468373386|FG010|Overall Study|Progressive Disease|0|||
130112443|NCT01393990|468373387|FG011|Overall Study|Progressive Disease|0|||
130112444|NCT01393990|468373388|FG012|Overall Study|Progressive Disease|0|||
130112445|NCT01393990|468373389|FG013|Overall Study|Progressive Disease|1|||
130112446|NCT01393990|468373390|FG014|Overall Study|Progressive Disease|6|||
130112447|NCT01393990|468373391|FG015|Overall Study|Progressive Disease|1|||
130112448|NCT01393990|468373392|FG016|Overall Study|Progressive Disease|0|||
130112449|NCT01393990|468373393|FG017|Overall Study|Progressive Disease|0|||
130112450|NCT01393990|468373376|FG000|Overall Study|Death|0|||
130112451|NCT01393990|468373377|FG001|Overall Study|Death|0|||
130112452|NCT01393990|468373378|FG002|Overall Study|Death|0|||
130112453|NCT01393990|468373379|FG003|Overall Study|Death|0|||
130112454|NCT01393990|468373380|FG004|Overall Study|Death|1|||
130112455|NCT01393990|468373381|FG005|Overall Study|Death|0|||
130112456|NCT01393990|468373382|FG006|Overall Study|Death|0|||
130112457|NCT01393990|468373383|FG007|Overall Study|Death|0|||
130112458|NCT01393990|468373384|FG008|Overall Study|Death|0|||
130112459|NCT01393990|468373385|FG009|Overall Study|Death|0|||
130112460|NCT01393990|468373386|FG010|Overall Study|Death|0|||
130112461|NCT01393990|468373387|FG011|Overall Study|Death|0|||
130112462|NCT01393990|468373388|FG012|Overall Study|Death|0|||
130112463|NCT01393990|468373389|FG013|Overall Study|Death|1|||
130112464|NCT01393990|468373390|FG014|Overall Study|Death|1|||
130112465|NCT01393990|468373391|FG015|Overall Study|Death|0|||
130112466|NCT01393990|468373392|FG016|Overall Study|Death|0|||
130112467|NCT01393990|468373393|FG017|Overall Study|Death|0|||
130112468|NCT01393990|468373376|FG000|Overall Study|Withdrawal by Subject|0|||
130112469|NCT01393990|468373377|FG001|Overall Study|Withdrawal by Subject|0|||
130112470|NCT01393990|468373378|FG002|Overall Study|Withdrawal by Subject|0|||
130112471|NCT01393990|468373379|FG003|Overall Study|Withdrawal by Subject|0|||
129820012|NCT00580606|467302829|FG000|Open Label (OL)|Pregnancy|0|||
129820013|NCT00580606|467302830|FG001|Open Label (OL)|Pregnancy|1|||
129820014|NCT00580606|467302829|FG000|Open Label (OL)|Non-compliance|2|||
129820015|NCT00580606|467302830|FG001|Open Label (OL)|Non-compliance|0|||
129820016|NCT00580606|467302829|FG000|Open Label (OL)|Physician Decision|1|||
129820017|NCT00580606|467302830|FG001|Open Label (OL)|Physician Decision|1|||
129820018|NCT00580606|467302829|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
129820019|NCT00580606|467302830|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
129820020|NCT03655691|467302833|FG000|Overall Study|Adverse Event|0|||
129820021|NCT03655691|467302834|FG001|Overall Study|Adverse Event|0|||
129820022|NCT03655691|467302835|FG002|Overall Study|Adverse Event|1|||
129820023|NCT03655691|467302833|FG000|Overall Study|Lost to Follow-up|1|||
129820024|NCT03655691|467302834|FG001|Overall Study|Lost to Follow-up|1|||
129820025|NCT03655691|467302835|FG002|Overall Study|Lost to Follow-up|2|||
129820026|NCT03655691|467302833|FG000|Overall Study|Protocol Violation|0|||
129820027|NCT03655691|467302834|FG001|Overall Study|Protocol Violation|1|||
129820028|NCT03655691|467302835|FG002|Overall Study|Protocol Violation|0|||
129820029|NCT03655691|467302833|FG000|Overall Study|Withdrawal by Subject|1|||
129820030|NCT03655691|467302834|FG001|Overall Study|Withdrawal by Subject|1|||
130112472|NCT01393990|468373380|FG004|Overall Study|Withdrawal by Subject|0|||
129820031|NCT03655691|467302835|FG002|Overall Study|Withdrawal by Subject|0|||
129820032|NCT01325584|467302838|FG000|Overall Study|Death|1|||
129820033|NCT00887978|467302839|FG000|Overall Study|Adverse Event|18|||
129820034|NCT00887978|467302840|FG001|Overall Study|Adverse Event|5|||
130112473|NCT01393990|468373381|FG005|Overall Study|Withdrawal by Subject|0|||
130112474|NCT01393990|468373382|FG006|Overall Study|Withdrawal by Subject|0|||
130112475|NCT01393990|468373383|FG007|Overall Study|Withdrawal by Subject|0|||
130112476|NCT01393990|468373384|FG008|Overall Study|Withdrawal by Subject|0|||
130112477|NCT01393990|468373385|FG009|Overall Study|Withdrawal by Subject|0|||
130112478|NCT01393990|468373386|FG010|Overall Study|Withdrawal by Subject|0|||
130112479|NCT01393990|468373387|FG011|Overall Study|Withdrawal by Subject|0|||
129820035|NCT00887978|467302839|FG000|Overall Study|Clinical Worsening|4|||
129820036|NCT00887978|467302840|FG001|Overall Study|Clinical Worsening|4|||
129820037|NCT00887978|467302839|FG000|Overall Study|Death|2|||
129820038|NCT00887978|467302840|FG001|Overall Study|Death|3|||
129820039|NCT00887978|467302839|FG000|Overall Study|Withdrawal by Subject|1|||
129820040|NCT00887978|467302840|FG001|Overall Study|Withdrawal by Subject|2|||
129820041|NCT00887978|467302839|FG000|Overall Study|Lost to Follow-up|0|||
129820042|NCT00887978|467302840|FG001|Overall Study|Lost to Follow-up|1|||
129820043|NCT05353985|467302847|FG000|Overall Study|Adverse Event|5|||
129820044|NCT05353985|467302848|FG001|Overall Study|Adverse Event|7|||
129820045|NCT05353985|467302847|FG000|Overall Study|Lost to Follow-up|1|||
129820046|NCT05353985|467302848|FG001|Overall Study|Lost to Follow-up|1|||
129820047|NCT05353985|467302847|FG000|Overall Study|Protocol Violation|1|||
129820048|NCT05353985|467302848|FG001|Overall Study|Protocol Violation|0|||
129820049|NCT05353985|467302847|FG000|Overall Study|Withdrawal by Subject|13|||
129820050|NCT05353985|467302848|FG001|Overall Study|Withdrawal by Subject|17|||
129820051|NCT05353985|467302847|FG000|Overall Study|Reason Not Specified|1|||
129820052|NCT05353985|467302848|FG001|Overall Study|Reason Not Specified|0|||
129820053|NCT05353985|467302847|FG000|Overall Study|Randomized in Error & Not Treated|0|||
129820054|NCT05353985|467302848|FG001|Overall Study|Randomized in Error & Not Treated|1|||
129820055|NCT00793403|467304703|FG000|Overall Study|Other|73|||
129820056|NCT00842712|467304704|FG000|Safety Run-in Part|Adverse Event|0|||
129820057|NCT00842712|467304705|FG001|Safety Run-in Part|Adverse Event|1|||
129820058|NCT00842712|467304706|FG002|Safety Run-in Part|Adverse Event|0|||
129820059|NCT00842712|467304707|FG003|Safety Run-in Part|Adverse Event|0|||
129820060|NCT00842712|467304708|FG004|Safety Run-in Part|Adverse Event|0|||
129820061|NCT00842712|467304709|FG005|Safety Run-in Part|Adverse Event|0|||
129820062|NCT00842712|467304710|FG006|Safety Run-in Part|Adverse Event|0|||
129820063|NCT00842712|467304704|FG000|Safety Run-in Part|Progressive disease|3|||
129820064|NCT00842712|467304705|FG001|Safety Run-in Part|Progressive disease|1|||
129820065|NCT00842712|467304706|FG002|Safety Run-in Part|Progressive disease|0|||
129820066|NCT00842712|467304707|FG003|Safety Run-in Part|Progressive disease|1|||
129820067|NCT00842712|467304708|FG004|Safety Run-in Part|Progressive disease|0|||
129820068|NCT00842712|467304709|FG005|Safety Run-in Part|Progressive disease|0|||
129820069|NCT00842712|467304710|FG006|Safety Run-in Part|Progressive disease|0|||
129820070|NCT00842712|467304704|FG000|Randomized Part|Randomized but not treated|0|||
129820071|NCT00842712|467304705|FG001|Randomized Part|Randomized but not treated|0|||
129820072|NCT00842712|467304706|FG002|Randomized Part|Randomized but not treated|0|||
129820073|NCT00842712|467304707|FG003|Randomized Part|Randomized but not treated|0|||
129820074|NCT00842712|467304708|FG004|Randomized Part|Randomized but not treated|0|||
129820075|NCT00842712|467304709|FG005|Randomized Part|Randomized but not treated|1|||
129820076|NCT00842712|467304710|FG006|Randomized Part|Randomized but not treated|4|||
129820077|NCT00842712|467304704|FG000|Randomized Part|Ongoing at cut-off date|0|||
129820078|NCT00842712|467304705|FG001|Randomized Part|Ongoing at cut-off date|0|||
129820079|NCT00842712|467304706|FG002|Randomized Part|Ongoing at cut-off date|0|||
129820080|NCT00842712|467304707|FG003|Randomized Part|Ongoing at cut-off date|0|||
129820081|NCT00842712|467304708|FG004|Randomized Part|Ongoing at cut-off date|0|||
129820082|NCT00842712|467304709|FG005|Randomized Part|Ongoing at cut-off date|0|||
129820083|NCT00842712|467304710|FG006|Randomized Part|Ongoing at cut-off date|2|||
129820084|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820085|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820086|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820087|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820088|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
129820089|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
129820090|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820091|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820092|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820093|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820094|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Other|1|||
129820095|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Other|1|||
129820096|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Other|0|||
129820097|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Other|0|||
129820098|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Other|0|||
129820099|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
129820100|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
129820101|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
129820102|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
129820103|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
129820104|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820105|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820106|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820107|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
129820108|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820109|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129897289|NCT03396835|467584312|FG000|Overall Study|Did not meet criteria for data analysis|1|||
129820110|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129820111|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129820112|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
129820113|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129820114|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
129820115|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
129820116|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
129820117|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
129820118|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
129820119|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Other|0|||
129820120|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Other|1|||
129820121|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Other|1|||
129820122|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Other|0|||
129820123|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Other|0|||
129820124|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
129820125|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
129820126|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
129820127|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
129820128|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
129820129|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820130|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820131|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820132|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
129820133|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820134|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820135|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820136|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820137|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
129820138|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820139|NCT01384760|467304717|FG000|Overall Study|Lost to Follow-up|0|||
129820140|NCT01384760|467304718|FG001|Overall Study|Lost to Follow-up|6|||
129820141|NCT01384760|467304717|FG000|Overall Study|Protocol Violation|16|||
129820142|NCT01384760|467304718|FG001|Overall Study|Protocol Violation|0|||
129820143|NCT00963547|467304719|FG000|Overall Study|Adverse Event|0|||
129820144|NCT00963547|467304720|FG001|Overall Study|Adverse Event|1|||
129820145|NCT00963547|467304721|FG002|Overall Study|Adverse Event|0|||
129820146|NCT00963547|467304722|FG003|Overall Study|Adverse Event|1|||
129820147|NCT00963547|467304723|FG004|Overall Study|Adverse Event|0|||
129820148|NCT00963547|467304724|FG005|Overall Study|Adverse Event|0|||
129820149|NCT00963547|467304725|FG006|Overall Study|Adverse Event|0|||
129820150|NCT00963547|467304719|FG000|Overall Study|Physician Decision|1|||
129820151|NCT00963547|467304720|FG001|Overall Study|Physician Decision|1|||
129820152|NCT00963547|467304721|FG002|Overall Study|Physician Decision|0|||
129820153|NCT00963547|467304722|FG003|Overall Study|Physician Decision|0|||
129820154|NCT00963547|467304723|FG004|Overall Study|Physician Decision|0|||
129820155|NCT00963547|467304724|FG005|Overall Study|Physician Decision|0|||
129820156|NCT00963547|467304725|FG006|Overall Study|Physician Decision|0|||
129820157|NCT00963547|467304719|FG000|Overall Study|Progressive Disease|3|||
129820158|NCT00963547|467304720|FG001|Overall Study|Progressive Disease|8|||
129820159|NCT00963547|467304721|FG002|Overall Study|Progressive Disease|9|||
129820160|NCT00963547|467304722|FG003|Overall Study|Progressive Disease|5|||
129820161|NCT00963547|467304723|FG004|Overall Study|Progressive Disease|0|||
129820162|NCT00963547|467304724|FG005|Overall Study|Progressive Disease|0|||
129820163|NCT00963547|467304725|FG006|Overall Study|Progressive Disease|0|||
129820164|NCT00963547|467304719|FG000|Overall Study|Withdrawal by Subject|0|||
129820165|NCT00963547|467304720|FG001|Overall Study|Withdrawal by Subject|0|||
129820166|NCT00963547|467304721|FG002|Overall Study|Withdrawal by Subject|3|||
129820167|NCT00963547|467304722|FG003|Overall Study|Withdrawal by Subject|0|||
129820168|NCT00963547|467304723|FG004|Overall Study|Withdrawal by Subject|0|||
129820169|NCT00963547|467304724|FG005|Overall Study|Withdrawal by Subject|0|||
129820170|NCT00963547|467304725|FG006|Overall Study|Withdrawal by Subject|0|||
129820171|NCT00963547|467304719|FG000|Overall Study|Reason Unknown|0|||
129820172|NCT00963547|467304720|FG001|Overall Study|Reason Unknown|1|||
129820173|NCT00963547|467304721|FG002|Overall Study|Reason Unknown|0|||
129820174|NCT00963547|467304722|FG003|Overall Study|Reason Unknown|0|||
129820175|NCT00963547|467304723|FG004|Overall Study|Reason Unknown|0|||
129820176|NCT00963547|467304724|FG005|Overall Study|Reason Unknown|0|||
129820177|NCT00963547|467304725|FG006|Overall Study|Reason Unknown|0|||
129820178|NCT00660023|467304731|FG000|Overall Study|Adverse Event|2|||
129820179|NCT00660023|467304731|FG000|Overall Study|Death|8|||
129820180|NCT00660023|467304731|FG000|Overall Study|Blood Transfusion|5|||
129820181|NCT00660023|467304731|FG000|Overall Study|Renal Transplantation|3|||
129820182|NCT00660023|467304731|FG000|Overall Study|Withdrawal by Subject|1|||
129820183|NCT00660023|467304731|FG000|Overall Study|Missed Pregnancy Test|1|||
129820184|NCT00660023|467304731|FG000|Overall Study|Other Screening Failure|9|||
129820185|NCT04180488|467304732|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
129820186|NCT04180488|467304733|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
129897290|NCT03467724|467584313|FG000|Overall Study|Lost to Follow-up|5|||
129820187|NCT04180488|467304734|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
129820188|NCT04180488|467304735|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
129820189|NCT04180488|467304736|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
129820190|NCT04180488|467304737|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
129820191|NCT04180488|467304732|FG000|Overall Study|Withdrawal by Subject|8|||
129820192|NCT04180488|467304733|FG001|Overall Study|Withdrawal by Subject|4|||
129820193|NCT04180488|467304734|FG002|Overall Study|Withdrawal by Subject|5|||
129820194|NCT04180488|467304735|FG003|Overall Study|Withdrawal by Subject|2|||
129820195|NCT04180488|467304736|FG004|Overall Study|Withdrawal by Subject|8|||
129820196|NCT04180488|467304737|FG005|Overall Study|Withdrawal by Subject|6|||
129820197|NCT04180488|467304732|FG000|Overall Study|Adverse Event|3|||
129820198|NCT04180488|467304733|FG001|Overall Study|Adverse Event|2|||
129820199|NCT04180488|467304734|FG002|Overall Study|Adverse Event|0|||
129820200|NCT04180488|467304735|FG003|Overall Study|Adverse Event|0|||
129820201|NCT04180488|467304736|FG004|Overall Study|Adverse Event|0|||
129820202|NCT04180488|467304737|FG005|Overall Study|Adverse Event|0|||
129820203|NCT04180488|467304732|FG000|Overall Study|Poor compliance to protocol|0|||
129820204|NCT04180488|467304733|FG001|Overall Study|Poor compliance to protocol|0|||
129820205|NCT04180488|467304734|FG002|Overall Study|Poor compliance to protocol|1|||
129820206|NCT04180488|467304735|FG003|Overall Study|Poor compliance to protocol|0|||
129820207|NCT04180488|467304736|FG004|Overall Study|Poor compliance to protocol|0|||
129820208|NCT04180488|467304737|FG005|Overall Study|Poor compliance to protocol|0|||
129820209|NCT01327885|467304743|FG000|Overall Study|Disease progression-according to RECIST|173|||
129820210|NCT01327885|467304744|FG001|Overall Study|Disease progression-according to RECIST|165|||
129820211|NCT01327885|467304743|FG000|Overall Study|Clinical progression|24|||
129820212|NCT01327885|467304744|FG001|Overall Study|Clinical progression|27|||
129820213|NCT01327885|467304743|FG000|Overall Study|Adverse Event|14|||
129820214|NCT01327885|467304744|FG001|Overall Study|Adverse Event|10|||
129820215|NCT01327885|467304743|FG000|Overall Study|Subject choice|5|||
129820216|NCT01327885|467304744|FG001|Overall Study|Subject choice|10|||
129820217|NCT01327885|467304743|FG000|Overall Study|Other|8|||
129820218|NCT01327885|467304744|FG001|Overall Study|Other|6|||
129820219|NCT01327885|467304743|FG000|Overall Study|Withdrawal of consent from study|3|||
129820220|NCT01327885|467304744|FG001|Overall Study|Withdrawal of consent from study|4|||
129820221|NCT01327885|467304743|FG000|Overall Study|Not treated|1|||
129820222|NCT01327885|467304744|FG001|Overall Study|Not treated|1|||
129820223|NCT01327885|467304743|FG000|Overall Study|Administrative decision|0|||
129820224|NCT01327885|467304744|FG001|Overall Study|Administrative decision|1|||
129820225|NCT03824912|467304747|FG000|Overall Study|Lost to Follow-up|18|||
129820226|NCT03824912|467304748|FG001|Overall Study|Lost to Follow-up|15|||
129820227|NCT03824912|467304749|FG002|Overall Study|Lost to Follow-up|8|||
129820228|NCT03824912|467304747|FG000|Overall Study|Negative Baseline Culture Result|118|||
129820229|NCT03824912|467304748|FG001|Overall Study|Negative Baseline Culture Result|112|||
129820230|NCT03824912|467304749|FG002|Overall Study|Negative Baseline Culture Result|57|||
129820231|NCT03824912|467304747|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129820232|NCT03824912|467304748|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129820233|NCT03824912|467304749|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129820234|NCT03824912|467304747|FG000|Overall Study|Protocol Violation|1|||
129820235|NCT03824912|467304748|FG001|Overall Study|Protocol Violation|4|||
129820236|NCT03824912|467304749|FG002|Overall Study|Protocol Violation|1|||
129820237|NCT03824912|467304747|FG000|Overall Study|Withdrawal by Subject|3|||
129820238|NCT03824912|467304748|FG001|Overall Study|Withdrawal by Subject|2|||
129820239|NCT03824912|467304749|FG002|Overall Study|Withdrawal by Subject|1|||
129820240|NCT03824912|467304747|FG000|Overall Study|Participation in another study|0|||
129820241|NCT03824912|467304748|FG001|Overall Study|Participation in another study|1|||
129820242|NCT03824912|467304749|FG002|Overall Study|Participation in another study|0|||
129820243|NCT02511184|467304750|FG000|Overall Study|Death|1|||
129820244|NCT02511184|467304751|FG001|Overall Study|Death|0|||
129820245|NCT02511184|467304750|FG000|Overall Study|Lost to Follow-up|0|||
129820246|NCT02511184|467304751|FG001|Overall Study|Lost to Follow-up|1|||
129820247|NCT02511184|467304750|FG000|Overall Study|Study terminated by sponsor|1|||
129820248|NCT02511184|467304751|FG001|Overall Study|Study terminated by sponsor|5|||
129820249|NCT02511184|467304750|FG000|Overall Study|Withdrawal by Subject|0|||
129820250|NCT02511184|467304751|FG001|Overall Study|Withdrawal by Subject|1|||
129820251|NCT01963403|467304754|FG000|Overall Study|Lost to Follow-up|2|||
129820252|NCT01963403|467304755|FG001|Overall Study|Lost to Follow-up|3|||
129820253|NCT01963403|467304754|FG000|Overall Study|Implant removal|0|||
129820254|NCT01963403|467304755|FG001|Overall Study|Implant removal|1|||
129897291|NCT03467724|467584313|FG000|Overall Study|Withdrawal by Subject|1|||
129820255|NCT00549302|467304758|FG000|Double-Blind|Death|2|||
129820256|NCT00549302|467304759|FG001|Double-Blind|Death|9|||
129820257|NCT00549302|467304760|FG002|Double-Blind|Death|0|||
129820258|NCT00549302|467304758|FG000|Double-Blind|Adverse Event|3|||
129820259|NCT00549302|467304759|FG001|Double-Blind|Adverse Event|16|||
129820260|NCT00549302|467304760|FG002|Double-Blind|Adverse Event|0|||
129820261|NCT00549302|467304758|FG000|Double-Blind|Withdrawal by Subject|3|||
129820262|NCT00549302|467304759|FG001|Double-Blind|Withdrawal by Subject|8|||
129820263|NCT00549302|467304760|FG002|Double-Blind|Withdrawal by Subject|0|||
129820264|NCT00549302|467304758|FG000|Double-Blind|Investigator Decision|1|||
129820265|NCT00549302|467304759|FG001|Double-Blind|Investigator Decision|5|||
129820266|NCT00549302|467304760|FG002|Double-Blind|Investigator Decision|0|||
129820267|NCT00549302|467304758|FG000|Double-Blind|Sponsor Decision|0|||
129820268|NCT00549302|467304759|FG001|Double-Blind|Sponsor Decision|1|||
129820269|NCT00549302|467304760|FG002|Double-Blind|Sponsor Decision|0|||
129820270|NCT00549302|467304758|FG000|Double-Blind|Lost to Follow-up|1|||
129820271|NCT00549302|467304759|FG001|Double-Blind|Lost to Follow-up|2|||
129820272|NCT00549302|467304760|FG002|Double-Blind|Lost to Follow-up|0|||
129820273|NCT00549302|467304758|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
129820274|NCT00549302|467304759|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
129820275|NCT00549302|467304760|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
129820276|NCT00549302|467304758|FG000|Double-Blind|New condition or starts new therapy|0|||
129820277|NCT00549302|467304759|FG001|Double-Blind|New condition or starts new therapy|2|||
129820278|NCT00549302|467304760|FG002|Double-Blind|New condition or starts new therapy|0|||
129820279|NCT00549302|467304758|FG000|Open-Label|Adverse Event|0|||
129820280|NCT00549302|467304759|FG001|Open-Label|Adverse Event|0|||
129820281|NCT00549302|467304760|FG002|Open-Label|Adverse Event|11|||
129820282|NCT00549302|467304758|FG000|Open-Label|Death|0|||
129820283|NCT00549302|467304759|FG001|Open-Label|Death|0|||
129820284|NCT00549302|467304760|FG002|Open-Label|Death|40|||
129820285|NCT00549302|467304758|FG000|Open-Label|Investigator Decision|0|||
129820286|NCT00549302|467304759|FG001|Open-Label|Investigator Decision|0|||
129820287|NCT00549302|467304760|FG002|Open-Label|Investigator Decision|5|||
129820288|NCT00549302|467304758|FG000|Open-Label|Lost to Follow-up|0|||
129820289|NCT00549302|467304759|FG001|Open-Label|Lost to Follow-up|0|||
129820290|NCT00549302|467304760|FG002|Open-Label|Lost to Follow-up|2|||
129820291|NCT00549302|467304758|FG000|Open-Label|Other|0|||
129820292|NCT00549302|467304759|FG001|Open-Label|Other|0|||
129820293|NCT00549302|467304760|FG002|Open-Label|Other|3|||
129820294|NCT00549302|467304758|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
129820295|NCT00549302|467304759|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
129820296|NCT00549302|467304760|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
129820297|NCT00549302|467304758|FG000|Open-Label|Withdrawal by Subject|0|||
129820298|NCT00549302|467304759|FG001|Open-Label|Withdrawal by Subject|0|||
129820299|NCT00549302|467304760|FG002|Open-Label|Withdrawal by Subject|6|||
129820300|NCT03585504|467304761|FG000|Overall Study|Lost to Follow-up|26|||
129820301|NCT03585504|467304762|FG001|Overall Study|Lost to Follow-up|29|||
129820302|NCT01414114|467304763|FG000|Overall Study|Adverse Event|2|||
129820303|NCT01414114|467304763|FG000|Overall Study|Withdrawal by Subject|1|||
129820304|NCT01414114|467304763|FG000|Overall Study|Other|2|||
129820305|NCT00105482|467304764|FG000|Overall Study|Adverse Event|1|||
129820306|NCT00105482|467304765|FG001|Overall Study|Adverse Event|1|||
129820307|NCT00105482|467304764|FG000|Overall Study|Lost to Follow-up|26|||
129820308|NCT00105482|467304765|FG001|Overall Study|Lost to Follow-up|17|||
129820309|NCT00105482|467304764|FG000|Overall Study|Withdrawal by Subject|0|||
129820310|NCT00105482|467304765|FG001|Overall Study|Withdrawal by Subject|1|||
129820311|NCT00105482|467304764|FG000|Overall Study|Lost Interest|29|||
129820312|NCT00105482|467304765|FG001|Overall Study|Lost Interest|32|||
129820313|NCT00105482|467304764|FG000|Overall Study|Scheduling Conflict|2|||
129820314|NCT00105482|467304765|FG001|Overall Study|Scheduling Conflict|3|||
129820315|NCT00105482|467304764|FG000|Overall Study|Withdrawn by PI|1|||
129820316|NCT00105482|467304765|FG001|Overall Study|Withdrawn by PI|1|||
129820317|NCT05620563|467304766|FG000|Overall Study|Adverse Event|3|||
129820318|NCT05620563|467304767|FG001|Overall Study|Adverse Event|1|||
129820319|NCT05620563|467304766|FG000|Overall Study|Lost to Follow-up|0|||
129820320|NCT05620563|467304767|FG001|Overall Study|Lost to Follow-up|2|||
129820321|NCT05620563|467304766|FG000|Overall Study|Protocol Deviation|1|||
129820322|NCT05620563|467304767|FG001|Overall Study|Protocol Deviation|2|||
129897292|NCT03467724|467584313|FG000|Overall Study|Protocol Violation|1|||
129897293|NCT03467724|467584313|FG000|Overall Study|Adverse Event|1|||
129820323|NCT05620563|467304766|FG000|Overall Study|Withdrawal by Subject|3|||
129820324|NCT05620563|467304767|FG001|Overall Study|Withdrawal by Subject|3|||
129820325|NCT05620563|467304766|FG000|Overall Study|Physician Decision|0|||
129820326|NCT05620563|467304767|FG001|Overall Study|Physician Decision|1|||
129820327|NCT02085785|467304772|FG000|Overall Study|Withdrawal by Subject|2|||
129820328|NCT02085785|467304773|FG001|Overall Study|Withdrawal by Subject|1|||
129820329|NCT02085785|467304772|FG000|Overall Study|Lost to Follow-up|0|||
129820330|NCT02085785|467304773|FG001|Overall Study|Lost to Follow-up|1|||
129820331|NCT00779467|467304774|FG000|Overall Study|Lack of Efficacy|11|||
129820332|NCT00779467|467304775|FG001|Overall Study|Lack of Efficacy|2|||
129820333|NCT00779467|467304776|FG002|Overall Study|Lack of Efficacy|6|||
129820334|NCT00779467|467304777|FG003|Overall Study|Lack of Efficacy|11|||
129820335|NCT00779467|467304774|FG000|Overall Study|failed inclusion criteria|3|||
129820336|NCT00779467|467304775|FG001|Overall Study|failed inclusion criteria|3|||
129820337|NCT00779467|467304776|FG002|Overall Study|failed inclusion criteria|1|||
129820338|NCT00779467|467304777|FG003|Overall Study|failed inclusion criteria|2|||
129820339|NCT00779467|467304774|FG000|Overall Study|missing data|1|||
129820340|NCT00779467|467304775|FG001|Overall Study|missing data|0|||
129820341|NCT00779467|467304776|FG002|Overall Study|missing data|1|||
129820342|NCT00779467|467304777|FG003|Overall Study|missing data|4|||
129820343|NCT00779467|467304774|FG000|Overall Study|technical issue|0|||
129820344|NCT00779467|467304775|FG001|Overall Study|technical issue|0|||
129820345|NCT00779467|467304776|FG002|Overall Study|technical issue|2|||
129820346|NCT00779467|467304777|FG003|Overall Study|technical issue|1|||
129820347|NCT00779467|467304774|FG000|Overall Study|unavailable research staff|0|||
129820348|NCT00779467|467304775|FG001|Overall Study|unavailable research staff|0|||
129820349|NCT00779467|467304776|FG002|Overall Study|unavailable research staff|0|||
129820350|NCT00779467|467304777|FG003|Overall Study|unavailable research staff|1|||
129820351|NCT02692703|467304778|FG000|Overall Study|Lost to Follow-up|1|||
129820352|NCT02692703|467304778|FG000|Overall Study|Other|1|||
129820353|NCT04118166|467304779|FG000|Overall Study|Adverse Event|1|||
129820354|NCT05048784|467304780|FG000|Period 1|Adverse Event|3|||
129820355|NCT05048784|467304781|FG001|Period 1|Adverse Event|1|||
129820356|NCT05048784|467304782|FG002|Period 1|Adverse Event|0|||
129820357|NCT05048784|467304783|FG003|Period 1|Adverse Event|0|||
129820358|NCT05048784|467304780|FG000|Period 2|Lost to Follow-up|0|||
129820359|NCT05048784|467304781|FG001|Period 2|Lost to Follow-up|1|||
129820360|NCT05048784|467304782|FG002|Period 2|Lost to Follow-up|0|||
129820361|NCT05048784|467304783|FG003|Period 2|Lost to Follow-up|0|||
129820362|NCT04016285|467304786|FG000|Overall Study|Did not progress to surgery|2|||
129820363|NCT04016285|467304787|FG001|Overall Study|Did not progress to surgery|5|||
129820364|NCT04016285|467304786|FG000|Overall Study|Failed to collect outcome data|5|||
129820365|NCT04016285|467304787|FG001|Overall Study|Failed to collect outcome data|3|||
129820366|NCT00284050|467304789|FG000|Overall Study|Adverse Event|1|||
129820367|NCT00284050|467304790|FG001|Overall Study|Adverse Event|1|||
129820368|NCT00284050|467304791|FG002|Overall Study|Adverse Event|1|||
129820369|NCT00284050|467304789|FG000|Overall Study|Lack of Efficacy|0|||
129820370|NCT00284050|467304790|FG001|Overall Study|Lack of Efficacy|1|||
129820371|NCT00284050|467304791|FG002|Overall Study|Lack of Efficacy|3|||
129820372|NCT00284050|467304789|FG000|Overall Study|Protocol Violation|0|||
129820373|NCT00284050|467304790|FG001|Overall Study|Protocol Violation|1|||
129820374|NCT00284050|467304791|FG002|Overall Study|Protocol Violation|2|||
129820375|NCT00284050|467304789|FG000|Overall Study|Withdrawal by Subject|2|||
129820376|NCT00284050|467304790|FG001|Overall Study|Withdrawal by Subject|2|||
129820377|NCT00284050|467304791|FG002|Overall Study|Withdrawal by Subject|2|||
129820378|NCT00284050|467304789|FG000|Overall Study|Lost to Follow-up|1|||
129820379|NCT00284050|467304790|FG001|Overall Study|Lost to Follow-up|0|||
129820380|NCT00284050|467304791|FG002|Overall Study|Lost to Follow-up|1|||
129820381|NCT00284050|467304789|FG000|Overall Study|Death|1|||
129820382|NCT00284050|467304790|FG001|Overall Study|Death|0|||
129820383|NCT00284050|467304791|FG002|Overall Study|Death|0|||
129820384|NCT02573350|467304793|FG000|Overall Study|Lost to Follow-up|2|||
129820385|NCT02573350|467304794|FG001|Overall Study|Lost to Follow-up|1|||
129820386|NCT02573350|467304793|FG000|Overall Study|Adverse Event|3|||
129820387|NCT02573350|467304794|FG001|Overall Study|Adverse Event|4|||
129820388|NCT02573350|467304793|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
129820389|NCT02573350|467304794|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
129820390|NCT02573350|467304793|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
129820391|NCT02573350|467304794|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
129820392|NCT02573350|467304793|FG000|Overall Study|Subject withdrew consent to participate|6|||
129820393|NCT02573350|467304794|FG001|Overall Study|Subject withdrew consent to participate|1|||
129820394|NCT02573350|467304793|FG000|Overall Study|Protocol Deviation|1|||
129820395|NCT02573350|467304794|FG001|Overall Study|Protocol Deviation|1|||
129820396|NCT02708121|467304797|FG000|Overall Study|Withdrawn by Study Team|1|||
129820397|NCT02708121|467304798|FG001|Overall Study|Withdrawn by Study Team|1|||
129820398|NCT02708121|467304797|FG000|Overall Study|Withdrawal by Subject|0|||
129820399|NCT02708121|467304798|FG001|Overall Study|Withdrawal by Subject|4|||
129820400|NCT01833520|467304799|FG000|Overall Study|Lack of Efficacy|3|||
129820401|NCT01833520|467304800|FG001|Overall Study|Lack of Efficacy|3|||
129820402|NCT01833520|467304801|FG002|Overall Study|Lack of Efficacy|8|||
129820403|NCT01833520|467304802|FG003|Overall Study|Lack of Efficacy|3|||
129820404|NCT02547649|467304803|FG000|Overall Study|Lost to Follow-up|3|||
129820405|NCT02547649|467304804|FG001|Overall Study|Lost to Follow-up|1|||
129820406|NCT02547649|467304805|FG002|Overall Study|Lost to Follow-up|1|||
129820407|NCT02547649|467304803|FG000|Overall Study|Not vaccinated|0|||
129820408|NCT02547649|467304804|FG001|Overall Study|Not vaccinated|0|||
129820409|NCT02547649|467304805|FG002|Overall Study|Not vaccinated|1|||
129820410|NCT02547649|467304803|FG000|Overall Study|Withdrawal by Subject|0|||
129820411|NCT02547649|467304804|FG001|Overall Study|Withdrawal by Subject|4|||
129820412|NCT02547649|467304805|FG002|Overall Study|Withdrawal by Subject|2|||
129820413|NCT01484197|467304810|FG000|Treatment Period 1|Adverse Event|1|||
129820414|NCT01484197|467304811|FG001|Treatment Period 1|Adverse Event|0|||
129820415|NCT01484197|467304812|FG002|Treatment Period 1|Adverse Event|0|||
129820416|NCT01484197|467304813|FG003|Treatment Period 1|Adverse Event|0|||
130112480|NCT01393990|468373388|FG012|Overall Study|Withdrawal by Subject|0|||
129820417|NCT01484197|467304810|FG000|Treatment Period 2|Subject withdrew consent|0|||
129820418|NCT01484197|467304811|FG001|Treatment Period 2|Subject withdrew consent|0|||
129820419|NCT01484197|467304812|FG002|Treatment Period 2|Subject withdrew consent|0|||
129820420|NCT01484197|467304813|FG003|Treatment Period 2|Subject withdrew consent|1|||
129820421|NCT02706691|467304815|FG000|Overall Study|Adverse Event|1|||
129820422|NCT01980992|467304816|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
129820423|NCT01980992|467304817|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
129820424|NCT01980992|467304816|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
129820425|NCT01980992|467304817|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
129820426|NCT01980992|467304816|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
129820427|NCT01980992|467304817|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
129820428|NCT01980992|467304816|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
129820429|NCT01980992|467304817|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
129820430|NCT01980992|467304816|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
129820431|NCT01980992|467304817|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
129820432|NCT01980992|467304816|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
129820433|NCT01980992|467304817|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
129820434|NCT05025241|467304821|FG000|Screening|Failed Screening|5|||
129820435|NCT05025241|467304821|FG000|Treatment and Follow Up|Adverse Event|3|||
129820436|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129897294|NCT02236559|467584323|FG000|Overall Study|Met Exclusion|3|||
129897295|NCT02236559|467584324|FG001|Overall Study|Met Exclusion|6|||
130112481|NCT01393990|468373389|FG013|Overall Study|Withdrawal by Subject|0|||
130112482|NCT01393990|468373390|FG014|Overall Study|Withdrawal by Subject|1|||
130112483|NCT01393990|468373391|FG015|Overall Study|Withdrawal by Subject|1|||
130112484|NCT01393990|468373392|FG016|Overall Study|Withdrawal by Subject|0|||
130112485|NCT01393990|468373393|FG017|Overall Study|Withdrawal by Subject|0|||
130112486|NCT01859390|468373394|FG000|Overall Study|Insufficient Sputum Collected|1|||
130112487|NCT01859390|468373395|FG001|Overall Study|Insufficient Sputum Collected|3|||
130112488|NCT01859390|468373394|FG000|Overall Study|Sample Missing Collection Date|0|||
130112489|NCT01859390|468373395|FG001|Overall Study|Sample Missing Collection Date|1|||
130112490|NCT01859390|468373394|FG000|Overall Study|Tube Cracked|0|||
130112491|NCT01859390|468373395|FG001|Overall Study|Tube Cracked|2|||
130112492|NCT01859390|468373394|FG000|Overall Study|Shipment Error|0|||
130112493|NCT01859390|468373395|FG001|Overall Study|Shipment Error|1|||
130112494|NCT02038634|468373397|FG000|Overall Study|Lost to Follow-up|0|||
130112495|NCT02038634|468373398|FG001|Overall Study|Lost to Follow-up|1|||
130112496|NCT01664052|468373399|FG000|Phase 1|No device placement|6|||
130112497|NCT01664052|468373400|FG001|Phase 1|No device placement|0|||
130112498|NCT01664052|468373399|FG000|Phase 1|No HSG 1 hr post placement|1|||
130112499|NCT01664052|468373400|FG001|Phase 1|No HSG 1 hr post placement|0|||
130112500|NCT01664052|468373399|FG000|Phase 2|No device placement|0|||
130112501|NCT01664052|468373400|FG001|Phase 2|No device placement|4|||
130112502|NCT01084005|468373401|FG000|Overall Study|Adverse Event|1|||
130112503|NCT01084005|468373402|FG001|Overall Study|Adverse Event|8|||
130112504|NCT01084005|468373401|FG000|Overall Study|Protocol Violation|3|||
130112505|NCT01084005|468373402|FG001|Overall Study|Protocol Violation|7|||
130112506|NCT01084005|468373401|FG000|Overall Study|Withdrawal by Subject|1|||
130112507|NCT01084005|468373402|FG001|Overall Study|Withdrawal by Subject|1|||
130112508|NCT00549198|468373403|FG000|Overall Study|Adverse Event|28|||
130112509|NCT00549198|468373404|FG001|Overall Study|Adverse Event|26|||
130112510|NCT00549198|468373403|FG000|Overall Study|Insufficient Viral Load Response|4|||
130112511|NCT00549198|468373404|FG001|Overall Study|Insufficient Viral Load Response|2|||
130112512|NCT00549198|468373403|FG000|Overall Study|Protocol-defined Virological Failure|7|||
130112513|NCT00549198|468373404|FG001|Overall Study|Protocol-defined Virological Failure|0|||
130112514|NCT00549198|468373403|FG000|Overall Study|Non-compliance|2|||
130112515|NCT00549198|468373404|FG001|Overall Study|Non-compliance|4|||
130112516|NCT00549198|468373403|FG000|Overall Study|Lost to Follow-up|7|||
130112517|NCT00549198|468373404|FG001|Overall Study|Lost to Follow-up|8|||
130112518|NCT00549198|468373403|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
130112519|NCT00549198|468373404|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
130112520|NCT00549198|468373403|FG000|Overall Study|Protocol Violation|7|||
130112521|NCT00549198|468373404|FG001|Overall Study|Protocol Violation|2|||
130112522|NCT00549198|468373403|FG000|Overall Study|Investigator Decision|4|||
130112523|NCT00549198|468373404|FG001|Overall Study|Investigator Decision|3|||
130112524|NCT00549198|468373403|FG000|Overall Study|Withdrawal by Subject|7|||
130112525|NCT00549198|468373404|FG001|Overall Study|Withdrawal by Subject|7|||
130112526|NCT00549198|468373403|FG000|Overall Study|Disease Progression|1|||
130112527|NCT00549198|468373404|FG001|Overall Study|Disease Progression|0|||
130112528|NCT00549198|468373403|FG000|Overall Study|Participant Moved|2|||
129897296|NCT02236559|467584323|FG000|Overall Study|Did not Meet Inclusion|3|||
129897297|NCT02236559|467584324|FG001|Overall Study|Did not Meet Inclusion|3|||
129897298|NCT02236559|467584323|FG000|Overall Study|Subject Did Not Consent|4|||
129820437|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
129820438|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820439|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820440|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820441|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820442|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
129820443|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
129820444|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
129820445|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
129820446|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
129820447|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
129820448|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
129820449|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
129820450|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
129820451|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
129820452|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
129820453|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
129820454|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820455|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820456|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820457|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820458|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
129820459|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820460|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820461|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
129820462|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820463|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820464|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820465|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820466|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
129820467|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
129820468|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
129820469|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
129820470|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
129820471|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
129820472|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820473|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820474|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820475|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
129820476|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820477|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820478|NCT02603419|467304823|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820479|NCT02603419|467304824|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820480|NCT02603419|467304825|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820481|NCT02603419|467304826|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820482|NCT02603419|467304827|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820483|NCT02603419|467304828|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
129820484|NCT02603419|467304823|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820485|NCT02603419|467304824|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820486|NCT02603419|467304825|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820487|NCT02603419|467304826|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820488|NCT02603419|467304827|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820489|NCT02603419|467304828|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
129820490|NCT02603419|467304823|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820491|NCT02603419|467304824|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820492|NCT02603419|467304825|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820493|NCT02603419|467304826|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820494|NCT02603419|467304827|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820495|NCT02603419|467304828|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
129820496|NCT02850965|467304829|FG000|Overall Study|Other than listed|3|||
129820497|NCT02850965|467304830|FG001|Overall Study|Other than listed|4|||
129820498|NCT02850965|467304829|FG000|Overall Study|Protocol Violation|0|||
129820499|NCT02850965|467304830|FG001|Overall Study|Protocol Violation|2|||
129897299|NCT02236559|467584324|FG001|Overall Study|Subject Did Not Consent|2|||
130059511|NCT02864940|468172354|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
130059512|NCT02864940|468172355|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
130059513|NCT00579501|468172360|FG000|Overall Study|Death|1|||
130059514|NCT00579501|468172360|FG000|Overall Study|End of neoadjuvant therapy|25|||
130059515|NCT00579501|468172360|FG000|Overall Study|toxicity|1|||
130059516|NCT00579501|468172360|FG000|Overall Study|Secondary lesion|1|||
130059517|NCT00579501|468172360|FG000|Overall Study|Radiation therapy before surgery|1|||
130059518|NCT03364673|468172361|FG000|Overall Study|Withdrawal by Subject|2|||
130059519|NCT03364673|468172361|FG000|Overall Study|Injury unrelated to study|3|||
130059520|NCT03025217|468172362|FG000|Overall Study|Pregnancy|1|||
130059521|NCT03025217|468172362|FG000|Overall Study|Lost to Follow-up|1|||
130059522|NCT03025217|468172362|FG000|Overall Study|Not eligible, poor English|2|||
130059523|NCT02208024|468172363|FG000|Overall Study|Withdrawal by Subject|1|||
130059524|NCT04804033|468172364|FG000|Period 1: DBT Phase|Adverse Event|1|||
130059525|NCT04804033|468172365|FG001|Period 1: DBT Phase|Adverse Event|5|||
130059526|NCT04804033|468172366|FG002|Period 1: DBT Phase|Adverse Event|3|||
130059527|NCT04804033|468172367|FG003|Period 1: DBT Phase|Adverse Event|4|||
130059528|NCT04804033|468172364|FG000|Period 1: DBT Phase|Death|1|||
130059529|NCT04804033|468172365|FG001|Period 1: DBT Phase|Death|0|||
130059530|NCT04804033|468172366|FG002|Period 1: DBT Phase|Death|0|||
130059531|NCT04804033|468172367|FG003|Period 1: DBT Phase|Death|0|||
130059532|NCT04804033|468172364|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
130059533|NCT04804033|468172365|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
130059534|NCT04804033|468172366|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
130059535|NCT04804033|468172367|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
129897300|NCT02236559|467584323|FG000|Overall Study|Physician Decision|1|||
129897301|NCT02236559|467584324|FG001|Overall Study|Physician Decision|1|||
129897302|NCT02236559|467584323|FG000|Overall Study|Withdrawal by Subject|1|||
129897303|NCT02236559|467584324|FG001|Overall Study|Withdrawal by Subject|0|||
129897304|NCT03721016|467584325|FG000|Overall Study|Adverse Event|0|||
129897305|NCT03721016|467584326|FG001|Overall Study|Adverse Event|1|||
129897306|NCT03721016|467584327|FG002|Overall Study|Adverse Event|1|||
129897307|NCT03721016|467584325|FG000|Overall Study|Withdrawal by Subject|8|||
129897308|NCT03721016|467584326|FG001|Overall Study|Withdrawal by Subject|16|||
129897309|NCT03721016|467584327|FG002|Overall Study|Withdrawal by Subject|13|||
129897310|NCT03721016|467584325|FG000|Overall Study|Lost to Follow-up|4|||
129897311|NCT03721016|467584326|FG001|Overall Study|Lost to Follow-up|6|||
129897312|NCT03721016|467584327|FG002|Overall Study|Lost to Follow-up|5|||
129897313|NCT03721016|467584325|FG000|Overall Study|Physician Decision|0|||
129897314|NCT03721016|467584326|FG001|Overall Study|Physician Decision|1|||
129897315|NCT03721016|467584327|FG002|Overall Study|Physician Decision|2|||
129897316|NCT03721016|467584325|FG000|Overall Study|Protocol Violation|0|||
129897317|NCT03721016|467584326|FG001|Overall Study|Protocol Violation|1|||
129897318|NCT03721016|467584327|FG002|Overall Study|Protocol Violation|0|||
129897319|NCT03721016|467584325|FG000|Overall Study|Site terminated by sponsor|3|||
129897320|NCT03721016|467584326|FG001|Overall Study|Site terminated by sponsor|7|||
129897321|NCT03721016|467584327|FG002|Overall Study|Site terminated by sponsor|6|||
129897322|NCT03721016|467584325|FG000|Overall Study|Subject exited early due to COVID-19|1|||
129897323|NCT03721016|467584326|FG001|Overall Study|Subject exited early due to COVID-19|0|||
129897324|NCT03721016|467584327|FG002|Overall Study|Subject exited early due to COVID-19|0|||
129897325|NCT01149681|467584330|FG000|Overall Study|Withdrawal by Subject|7|||
129897326|NCT01149681|467584330|FG000|Overall Study|Progressive disease|1|||
129897327|NCT01149681|467584330|FG000|Overall Study|Physician Decision|2|||
129897328|NCT01149681|467584330|FG000|Overall Study|adverse events nonrelated study drug|2|||
129897329|NCT02232178|467584331|FG000|Overall Study|Lost to Follow-up|0|||
129897330|NCT02232178|467584332|FG001|Overall Study|Lost to Follow-up|1|||
129897331|NCT02232178|467584333|FG002|Overall Study|Lost to Follow-up|0|||
129897332|NCT02232178|467584331|FG000|Overall Study|ineligibility|0|||
129897333|NCT02232178|467584332|FG001|Overall Study|ineligibility|0|||
129897334|NCT02232178|467584333|FG002|Overall Study|ineligibility|1|||
129897335|NCT02232178|467584331|FG000|Overall Study|surgical complication|1|||
129897336|NCT02232178|467584332|FG001|Overall Study|surgical complication|0|||
129897337|NCT02232178|467584333|FG002|Overall Study|surgical complication|0|||
129897338|NCT00817635|467584334|FG000|Overall Study|Adverse Event|1|||
129897339|NCT00817635|467584335|FG001|Overall Study|Adverse Event|0|||
129897340|NCT00817635|467584336|FG002|Overall Study|Adverse Event|0|||
129897341|NCT00817635|467584337|FG003|Overall Study|Adverse Event|1|||
129897342|NCT00817635|467584338|FG004|Overall Study|Adverse Event|1|||
129897343|NCT00817635|467584334|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129897344|NCT00817635|467584335|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
129897345|NCT00817635|467584336|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129897346|NCT00817635|467584337|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
129897347|NCT00817635|467584338|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
129897348|NCT00817635|467584334|FG000|Overall Study|Withdrawal by Subject|2|||
129897349|NCT00817635|467584335|FG001|Overall Study|Withdrawal by Subject|1|||
129897350|NCT00817635|467584336|FG002|Overall Study|Withdrawal by Subject|0|||
129820500|NCT02850965|467304829|FG000|Overall Study|Lost to Follow-up|5|||
129820501|NCT02850965|467304830|FG001|Overall Study|Lost to Follow-up|3|||
129820502|NCT02850965|467304829|FG000|Overall Study|Lack of Efficacy|4|||
129820503|NCT02850965|467304830|FG001|Overall Study|Lack of Efficacy|8|||
129820504|NCT02850965|467304829|FG000|Overall Study|Adverse Event|3|||
129820505|NCT02850965|467304830|FG001|Overall Study|Adverse Event|2|||
129820506|NCT02850965|467304829|FG000|Overall Study|Withdrawal by Subject|3|||
129820507|NCT02850965|467304830|FG001|Overall Study|Withdrawal by Subject|4|||
129820508|NCT02850965|467304829|FG000|Overall Study|Physician Decision|0|||
129820509|NCT02850965|467304830|FG001|Overall Study|Physician Decision|1|||
129820510|NCT02850965|467304829|FG000|Overall Study|Randomized but not treated|0|||
129820511|NCT02850965|467304830|FG001|Overall Study|Randomized but not treated|1|||
129820512|NCT02007109|467304836|FG000|Overall Study|Diary not returned or excluded|102|||
129820513|NCT02007109|467304836|FG000|Overall Study|Excluded - Age<7yo|9|||
129820514|NCT01858389|467304838|FG000|Overall Study|Death|1|||
129820515|NCT01858389|467304839|FG001|Overall Study|Death|3|||
129820516|NCT01858389|467304838|FG000|Overall Study|Study terminated by sponsor|0|||
129820517|NCT01858389|467304839|FG001|Overall Study|Study terminated by sponsor|2|||
129820518|NCT01858389|467304838|FG000|Overall Study|Withdrawal by Subject|0|||
129820519|NCT01858389|467304839|FG001|Overall Study|Withdrawal by Subject|1|||
129820520|NCT01858389|467304838|FG000|Overall Study|Progressive disease|10|||
129820521|NCT01858389|467304839|FG001|Overall Study|Progressive disease|11|||
129820522|NCT01858389|467304838|FG000|Overall Study|Other|2|||
129820523|NCT01858389|467304839|FG001|Overall Study|Other|4|||
129820524|NCT01858389|467304838|FG000|Overall Study|Adverse Event|3|||
129820525|NCT01858389|467304839|FG001|Overall Study|Adverse Event|1|||
129820526|NCT01858389|467304838|FG000|Overall Study|Did not receive treatment|0|||
129820527|NCT01858389|467304839|FG001|Overall Study|Did not receive treatment|3|||
129820528|NCT03572062|467304840|FG000|Overall Study|Adverse Event|0|||
129820529|NCT03572062|467304841|FG001|Overall Study|Adverse Event|0|||
129820530|NCT03572062|467304842|FG002|Overall Study|Adverse Event|0|||
129820531|NCT03572062|467304843|FG003|Overall Study|Adverse Event|0|||
129820532|NCT03572062|467304844|FG004|Overall Study|Adverse Event|0|||
129820533|NCT03572062|467304845|FG005|Overall Study|Adverse Event|0|||
129820534|NCT03572062|467304846|FG006|Overall Study|Adverse Event|0|||
129820535|NCT03572062|467304847|FG007|Overall Study|Adverse Event|0|||
129820536|NCT03572062|467304848|FG008|Overall Study|Adverse Event|1|||
129820537|NCT03572062|467304849|FG009|Overall Study|Adverse Event|3|||
129820538|NCT03572062|467304840|FG000|Overall Study|Death|0|||
129820539|NCT03572062|467304841|FG001|Overall Study|Death|0|||
129820540|NCT03572062|467304842|FG002|Overall Study|Death|0|||
129820541|NCT03572062|467304843|FG003|Overall Study|Death|0|||
129820542|NCT03572062|467304844|FG004|Overall Study|Death|0|||
129820543|NCT03572062|467304845|FG005|Overall Study|Death|1|||
129820544|NCT03572062|467304846|FG006|Overall Study|Death|0|||
129820545|NCT03572062|467304847|FG007|Overall Study|Death|0|||
129820546|NCT03572062|467304848|FG008|Overall Study|Death|0|||
129820547|NCT03572062|467304849|FG009|Overall Study|Death|0|||
129820548|NCT03572062|467304840|FG000|Overall Study|Lost to Follow-up|0|||
129820549|NCT03572062|467304841|FG001|Overall Study|Lost to Follow-up|0|||
129820550|NCT03572062|467304842|FG002|Overall Study|Lost to Follow-up|0|||
129820551|NCT03572062|467304843|FG003|Overall Study|Lost to Follow-up|0|||
129820552|NCT03572062|467304844|FG004|Overall Study|Lost to Follow-up|0|||
129820553|NCT03572062|467304845|FG005|Overall Study|Lost to Follow-up|1|||
129820554|NCT03572062|467304846|FG006|Overall Study|Lost to Follow-up|1|||
129820555|NCT03572062|467304847|FG007|Overall Study|Lost to Follow-up|0|||
129820556|NCT03572062|467304848|FG008|Overall Study|Lost to Follow-up|0|||
129820557|NCT03572062|467304849|FG009|Overall Study|Lost to Follow-up|0|||
129820558|NCT03572062|467304840|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820559|NCT03572062|467304841|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820560|NCT03572062|467304842|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820561|NCT03572062|467304843|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820562|NCT03572062|467304844|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820563|NCT03572062|467304845|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820564|NCT03572062|467304846|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820565|NCT03572062|467304847|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820566|NCT03572062|467304848|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
129820567|NCT03572062|467304849|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820568|NCT03572062|467304840|FG000|Overall Study|Study Terminated By Sponsor|0|||
129820569|NCT03572062|467304841|FG001|Overall Study|Study Terminated By Sponsor|0|||
129820570|NCT03572062|467304842|FG002|Overall Study|Study Terminated By Sponsor|0|||
129820571|NCT03572062|467304843|FG003|Overall Study|Study Terminated By Sponsor|0|||
129820572|NCT03572062|467304844|FG004|Overall Study|Study Terminated By Sponsor|0|||
129820573|NCT03572062|467304845|FG005|Overall Study|Study Terminated By Sponsor|0|||
129820574|NCT03572062|467304846|FG006|Overall Study|Study Terminated By Sponsor|0|||
129820575|NCT03572062|467304847|FG007|Overall Study|Study Terminated By Sponsor|0|||
129820576|NCT03572062|467304848|FG008|Overall Study|Study Terminated By Sponsor|29|||
129820577|NCT03572062|467304849|FG009|Overall Study|Study Terminated By Sponsor|27|||
129820578|NCT03572062|467304840|FG000|Overall Study|Physician Decision|0|||
129820579|NCT03572062|467304841|FG001|Overall Study|Physician Decision|0|||
129820580|NCT03572062|467304842|FG002|Overall Study|Physician Decision|0|||
129820581|NCT03572062|467304843|FG003|Overall Study|Physician Decision|0|||
129820582|NCT03572062|467304844|FG004|Overall Study|Physician Decision|0|||
129820583|NCT03572062|467304845|FG005|Overall Study|Physician Decision|0|||
129820584|NCT03572062|467304846|FG006|Overall Study|Physician Decision|0|||
129820585|NCT03572062|467304847|FG007|Overall Study|Physician Decision|0|||
129820586|NCT03572062|467304848|FG008|Overall Study|Physician Decision|1|||
129820587|NCT03572062|467304849|FG009|Overall Study|Physician Decision|0|||
129820588|NCT03572062|467304840|FG000|Overall Study|Withdrawal by Subject|0|||
129820589|NCT03572062|467304841|FG001|Overall Study|Withdrawal by Subject|0|||
129820590|NCT03572062|467304842|FG002|Overall Study|Withdrawal by Subject|0|||
129820591|NCT03572062|467304843|FG003|Overall Study|Withdrawal by Subject|0|||
129820592|NCT03572062|467304844|FG004|Overall Study|Withdrawal by Subject|0|||
129820593|NCT03572062|467304845|FG005|Overall Study|Withdrawal by Subject|0|||
129820594|NCT03572062|467304846|FG006|Overall Study|Withdrawal by Subject|0|||
129820595|NCT03572062|467304847|FG007|Overall Study|Withdrawal by Subject|0|||
129820596|NCT03572062|467304848|FG008|Overall Study|Withdrawal by Subject|0|||
129820597|NCT03572062|467304849|FG009|Overall Study|Withdrawal by Subject|1|||
129820598|NCT03572062|467304840|FG000|Overall Study|Randomized But Not Treated|0|||
129820599|NCT03572062|467304841|FG001|Overall Study|Randomized But Not Treated|0|||
129820600|NCT03572062|467304842|FG002|Overall Study|Randomized But Not Treated|0|||
129820601|NCT03572062|467304843|FG003|Overall Study|Randomized But Not Treated|0|||
129820602|NCT03572062|467304844|FG004|Overall Study|Randomized But Not Treated|1|||
129820603|NCT03572062|467304845|FG005|Overall Study|Randomized But Not Treated|2|||
129820604|NCT03572062|467304846|FG006|Overall Study|Randomized But Not Treated|0|||
129820605|NCT03572062|467304847|FG007|Overall Study|Randomized But Not Treated|1|||
129820606|NCT03572062|467304848|FG008|Overall Study|Randomized But Not Treated|0|||
129820607|NCT03572062|467304849|FG009|Overall Study|Randomized But Not Treated|0|||
129820608|NCT00458211|467304850|FG000|Overall Study|Lack of Efficacy|12|||
129820609|NCT00458211|467304850|FG000|Overall Study|Withdrawal by Subject|2|||
129820610|NCT00458211|467304850|FG000|Overall Study|Protocol Violation|2|||
129820611|NCT00646776|467304851|FG000|Overall Study|Adverse Event|1|||
129820612|NCT00646776|467304852|FG001|Overall Study|Adverse Event|9|||
129820613|NCT00646776|467304851|FG000|Overall Study|Investigator discretion|0|||
129820614|NCT00646776|467304852|FG001|Overall Study|Investigator discretion|4|||
129820615|NCT00126568|467304853|FG000|Overall Study|Death|2|||
129820616|NCT03031678|467304855|FG000|Overall Study|Study closed prior to completion|1|||
129820617|NCT01753856|467304856|FG000|Overall Study|Adverse Event|1|||
129820618|NCT01753856|467304857|FG001|Overall Study|Adverse Event|0|||
129820619|NCT01753856|467304856|FG000|Overall Study|Withdrawal by Subject|0|||
129820620|NCT01753856|467304857|FG001|Overall Study|Withdrawal by Subject|2|||
129820621|NCT01753856|467304856|FG000|Overall Study|Sponsor Decision|2|||
129820622|NCT01753856|467304857|FG001|Overall Study|Sponsor Decision|0|||
129820623|NCT00434330|467304862|FG000|Overall Study|Adverse Event|0|||
129820624|NCT00434330|467304863|FG001|Overall Study|Adverse Event|0|||
129820625|NCT00434330|467304864|FG002|Overall Study|Adverse Event|1|||
129820626|NCT00434330|467304865|FG003|Overall Study|Adverse Event|0|||
129820627|NCT00434330|467304866|FG004|Overall Study|Adverse Event|0|||
129820628|NCT00434330|467304867|FG005|Overall Study|Adverse Event|0|||
129820629|NCT00434330|467304862|FG000|Overall Study|Death|1|||
129820630|NCT00434330|467304863|FG001|Overall Study|Death|0|||
129820631|NCT00434330|467304864|FG002|Overall Study|Death|0|||
129820632|NCT00434330|467304865|FG003|Overall Study|Death|0|||
129820633|NCT00434330|467304866|FG004|Overall Study|Death|1|||
129820634|NCT00434330|467304867|FG005|Overall Study|Death|1|||
129820635|NCT00434330|467304862|FG000|Overall Study|Withdrawal by Subject|0|||
129820636|NCT00434330|467304863|FG001|Overall Study|Withdrawal by Subject|0|||
129820637|NCT00434330|467304864|FG002|Overall Study|Withdrawal by Subject|1|||
129820638|NCT00434330|467304865|FG003|Overall Study|Withdrawal by Subject|1|||
129820639|NCT00434330|467304866|FG004|Overall Study|Withdrawal by Subject|0|||
129820640|NCT00434330|467304867|FG005|Overall Study|Withdrawal by Subject|0|||
129820641|NCT00434330|467304862|FG000|Overall Study|Renal transplant|0|||
129820642|NCT00434330|467304863|FG001|Overall Study|Renal transplant|0|||
129820643|NCT00434330|467304864|FG002|Overall Study|Renal transplant|0|||
129820644|NCT00434330|467304865|FG003|Overall Study|Renal transplant|1|||
129820645|NCT00434330|467304866|FG004|Overall Study|Renal transplant|0|||
129820646|NCT00434330|467304867|FG005|Overall Study|Renal transplant|0|||
129820647|NCT00434330|467304862|FG000|Overall Study|Subject Not Compliant With Study|0|||
129820648|NCT00434330|467304863|FG001|Overall Study|Subject Not Compliant With Study|0|||
129820649|NCT00434330|467304864|FG002|Overall Study|Subject Not Compliant With Study|1|||
129820650|NCT00434330|467304865|FG003|Overall Study|Subject Not Compliant With Study|0|||
129820651|NCT00434330|467304866|FG004|Overall Study|Subject Not Compliant With Study|0|||
129820652|NCT00434330|467304867|FG005|Overall Study|Subject Not Compliant With Study|0|||
129820653|NCT03278613|467304868|FG000|Overall Study|Lost to Follow-up|3|||
129820654|NCT03278613|467304869|FG001|Overall Study|Lost to Follow-up|1|||
129820655|NCT04847557|467304870|FG000|Overall Study|Adverse Event|1|||
129820656|NCT04847557|467304871|FG001|Overall Study|Adverse Event|0|||
129820657|NCT04847557|467304870|FG000|Overall Study|Death|19|||
129820658|NCT04847557|467304871|FG001|Overall Study|Death|15|||
129820659|NCT04847557|467304870|FG000|Overall Study|Lost to Follow-up|3|||
129820660|NCT04847557|467304871|FG001|Overall Study|Lost to Follow-up|6|||
129820661|NCT04847557|467304870|FG000|Overall Study|Physician Decision|1|||
129820662|NCT04847557|467304871|FG001|Overall Study|Physician Decision|0|||
129820663|NCT04847557|467304870|FG000|Overall Study|Protocol Violation|0|||
129820664|NCT04847557|467304871|FG001|Overall Study|Protocol Violation|1|||
129820665|NCT04847557|467304870|FG000|Overall Study|Withdrawal by Subject|8|||
129820666|NCT04847557|467304871|FG001|Overall Study|Withdrawal by Subject|14|||
129820667|NCT02700815|467307375|FG000|Overall Study|Adverse Event|0|||
129820668|NCT02700815|467307376|FG001|Overall Study|Adverse Event|6|||
129820669|NCT02700815|467307377|FG002|Overall Study|Adverse Event|2|||
129820670|NCT02700815|467307378|FG003|Overall Study|Adverse Event|3|||
129820671|NCT02700815|467307375|FG000|Overall Study|Lack of Efficacy|0|||
129820672|NCT02700815|467307376|FG001|Overall Study|Lack of Efficacy|0|||
129820673|NCT02700815|467307377|FG002|Overall Study|Lack of Efficacy|1|||
129820674|NCT02700815|467307378|FG003|Overall Study|Lack of Efficacy|2|||
129820675|NCT02700815|467307375|FG000|Overall Study|Lost to Follow-up|1|||
129820676|NCT02700815|467307376|FG001|Overall Study|Lost to Follow-up|0|||
129820677|NCT02700815|467307377|FG002|Overall Study|Lost to Follow-up|0|||
129820678|NCT02700815|467307378|FG003|Overall Study|Lost to Follow-up|1|||
129820679|NCT02700815|467307375|FG000|Overall Study|Refusal to continue medication|0|||
129820680|NCT02700815|467307376|FG001|Overall Study|Refusal to continue medication|1|||
129820681|NCT02700815|467307377|FG002|Overall Study|Refusal to continue medication|0|||
129820682|NCT02700815|467307378|FG003|Overall Study|Refusal to continue medication|1|||
129820683|NCT02700815|467307375|FG000|Overall Study|Withdrawal by Subject|0|||
129820684|NCT02700815|467307376|FG001|Overall Study|Withdrawal by Subject|0|||
129820685|NCT02700815|467307377|FG002|Overall Study|Withdrawal by Subject|1|||
129820686|NCT02700815|467307378|FG003|Overall Study|Withdrawal by Subject|0|||
129820687|NCT02154490|467307379|FG000|Overall Study|No tissue submitted|23|||
129820688|NCT02154490|467307379|FG000|Overall Study|No biomarker results|167|||
129820689|NCT02154490|467307379|FG000|Overall Study|Not assigned to a sub-study|270|||
129820690|NCT02154490|467307379|FG000|Overall Study|Did not register to a sub-study|749|||
129820691|NCT02961751|467307382|FG000|Overall Study|Lost to Follow-up|11|||
129820692|NCT02961751|467307382|FG000|Overall Study|Physician Decision|2|||
129820693|NCT02961751|467307382|FG000|Overall Study|Not Eligible at Enrollment|1|||
129820694|NCT02961751|467307382|FG000|Overall Study|Protocol Violation|1|||
129820695|NCT02989194|467307388|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
129820696|NCT02989194|467307389|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
129820697|NCT02989194|467307390|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
129820698|NCT02989194|467307388|FG000|Overall Study|Lost to Follow-up|0|||
129820699|NCT02989194|467307389|FG001|Overall Study|Lost to Follow-up|1|||
129820700|NCT02989194|467307390|FG002|Overall Study|Lost to Follow-up|0|||
129820701|NCT02989194|467307388|FG000|Overall Study|Withdrawal by Subject|0|||
129820702|NCT02989194|467307389|FG001|Overall Study|Withdrawal by Subject|1|||
129820703|NCT02989194|467307390|FG002|Overall Study|Withdrawal by Subject|0|||
129820704|NCT01549860|467307391|FG000|Overall Study|Withdrawal by Subject|1|||
129820705|NCT01549860|467307392|FG001|Overall Study|Withdrawal by Subject|0|||
129820706|NCT01549860|467307391|FG000|Overall Study|Physician Decision|1|||
129820707|NCT01549860|467307392|FG001|Overall Study|Physician Decision|1|||
129820708|NCT01224431|467307395|FG000|Overall Study|not randomized|0|||
129820709|NCT01224431|467307396|FG001|Overall Study|not randomized|4|||
129820710|NCT01224431|467307395|FG000|Overall Study|no video record|0|||
129820711|NCT01224431|467307396|FG001|Overall Study|no video record|1|||
129820712|NCT02041286|467307399|FG000|Overall Study|Adverse Event|1|||
129820713|NCT01349790|467307415|FG000|Overall Study|Investigator Judgement|3|||
129820714|NCT01349790|467307415|FG000|Overall Study|Death|2|||
129820715|NCT01349790|467307415|FG000|Overall Study|Withdrawal by Patient|2|||
129820716|NCT01349790|467307415|FG000|Overall Study|Adverse Event|1|||
129820717|NCT01349790|467307415|FG000|Overall Study|Lost to Follow-up|1|||
129820718|NCT00885105|467307416|FG000|Overall Study|Withdrawal by Subject|0|||
129820719|NCT00885105|467307417|FG001|Overall Study|Withdrawal by Subject|8|||
129820720|NCT00885105|467307416|FG000|Overall Study|Adverse Event|1|||
129820721|NCT00885105|467307417|FG001|Overall Study|Adverse Event|0|||
129820722|NCT00885105|467307416|FG000|Overall Study|Protocol Violation|0|||
129820723|NCT00885105|467307417|FG001|Overall Study|Protocol Violation|2|||
129820724|NCT03519932|467307418|FG000|First Intervention|Adverse Event|1|||
129820725|NCT03519932|467307419|FG001|First Intervention|Adverse Event|3|||
129820726|NCT02254486|467307420|FG000|Overall Study|Adverse Event|1|||
129820727|NCT02254486|467307421|FG001|Overall Study|Adverse Event|1|||
129820728|NCT02254486|467307420|FG000|Overall Study|Lack of Efficacy|1|||
129820729|NCT02254486|467307421|FG001|Overall Study|Lack of Efficacy|0|||
129820730|NCT02254486|467307420|FG000|Overall Study|Lost to Follow-up|2|||
129820731|NCT02254486|467307421|FG001|Overall Study|Lost to Follow-up|4|||
129820732|NCT02254486|467307420|FG000|Overall Study|Protocol Violation|1|||
129820733|NCT02254486|467307421|FG001|Overall Study|Protocol Violation|2|||
129820734|NCT02254486|467307420|FG000|Overall Study|Withdrawal by Subject|17|||
129820735|NCT02254486|467307421|FG001|Overall Study|Withdrawal by Subject|15|||
129820736|NCT02254486|467307420|FG000|Overall Study|GFR<60mL/min|16|||
129820737|NCT02254486|467307421|FG001|Overall Study|GFR<60mL/min|21|||
129820738|NCT02254486|467307420|FG000|Overall Study|Various|12|||
129820739|NCT02254486|467307421|FG001|Overall Study|Various|12|||
129820740|NCT01350414|467307422|FG000|Overall Study|Lost to Follow-up|13|||
129820741|NCT01350414|467307422|FG000|Overall Study|Withdrawal by Subject|4|||
129820742|NCT01350414|467307422|FG000|Overall Study|Physician Decision|2|||
129820743|NCT02743520|467307423|FG000|Overall Study|Withdrawal by Subject|1|||
129820744|NCT01749514|467307424|FG000|Overall Study|Lost to Follow-up|0|||
129820745|NCT01749514|467307425|FG001|Overall Study|Lost to Follow-up|0|||
129820746|NCT01749514|467307426|FG002|Overall Study|Lost to Follow-up|0|||
129820747|NCT01749514|467307427|FG003|Overall Study|Lost to Follow-up|0|||
129820748|NCT01749514|467307428|FG004|Overall Study|Lost to Follow-up|0|||
129820749|NCT01749514|467307429|FG005|Overall Study|Lost to Follow-up|0|||
129820750|NCT01749514|467307430|FG006|Overall Study|Lost to Follow-up|0|||
129820751|NCT01749514|467307431|FG007|Overall Study|Lost to Follow-up|1|||
129820752|NCT01749514|467307424|FG000|Overall Study|Withdrawal by Subject|0|||
129820753|NCT01749514|467307425|FG001|Overall Study|Withdrawal by Subject|0|||
129820754|NCT01749514|467307426|FG002|Overall Study|Withdrawal by Subject|0|||
129820755|NCT01749514|467307427|FG003|Overall Study|Withdrawal by Subject|0|||
129820756|NCT01749514|467307428|FG004|Overall Study|Withdrawal by Subject|0|||
129820757|NCT01749514|467307429|FG005|Overall Study|Withdrawal by Subject|1|||
129820758|NCT01749514|467307430|FG006|Overall Study|Withdrawal by Subject|0|||
129820759|NCT01749514|467307431|FG007|Overall Study|Withdrawal by Subject|1|||
129820760|NCT01749514|467307424|FG000|Overall Study|Not Reported|0|||
129820761|NCT01749514|467307425|FG001|Overall Study|Not Reported|0|||
129820762|NCT01749514|467307426|FG002|Overall Study|Not Reported|0|||
129820763|NCT01749514|467307427|FG003|Overall Study|Not Reported|0|||
129820764|NCT01749514|467307428|FG004|Overall Study|Not Reported|0|||
129820765|NCT01749514|467307429|FG005|Overall Study|Not Reported|0|||
129820766|NCT01749514|467307430|FG006|Overall Study|Not Reported|0|||
129820767|NCT01749514|467307431|FG007|Overall Study|Not Reported|5|||
129820768|NCT01979016|467307433|FG000|Overall Study|Withdrawal by Subject|2|||
129820769|NCT01979016|467307434|FG001|Overall Study|Withdrawal by Subject|0|||
129820770|NCT01979016|467307433|FG000|Overall Study|Adverse Event|0|||
129820771|NCT01979016|467307434|FG001|Overall Study|Adverse Event|1|||
129820772|NCT00938639|467307435|FG000|Overall Study|Moved away from study area|0|||
129820773|NCT00938639|467307436|FG001|Overall Study|Moved away from study area|1|||
129820774|NCT00938639|467307435|FG000|Overall Study|Lost to Follow-up|1|||
129820775|NCT00938639|467307436|FG001|Overall Study|Lost to Follow-up|2|||
129820776|NCT00938639|467307435|FG000|Overall Study|Family issues|1|||
129820777|NCT00938639|467307436|FG001|Overall Study|Family issues|1|||
129820778|NCT00938639|467307435|FG000|Overall Study|Participant noncompliance|1|||
129820779|NCT00938639|467307436|FG001|Overall Study|Participant noncompliance|0|||
129820780|NCT02509156|467307437|FG000|Randomized Phase|Death|1|||
129820781|NCT02509156|467307438|FG001|Randomized Phase|Death|0|||
129820782|NCT02509156|467307437|FG000|Randomized Phase|Withdrawal by Subject|1|||
129820783|NCT02509156|467307438|FG001|Randomized Phase|Withdrawal by Subject|1|||
129820784|NCT04326231|467307439|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
129820785|NCT03765918|467307442|FG000|Overall Study|Death|109|||
129820786|NCT03765918|467307443|FG001|Overall Study|Death|127|||
129820787|NCT03765918|467307442|FG000|Overall Study|Lost to Follow-up|2|||
129820788|NCT03765918|467307443|FG001|Overall Study|Lost to Follow-up|3|||
129820789|NCT03765918|467307442|FG000|Overall Study|Withdrawal by Subject|12|||
129820790|NCT03765918|467307443|FG001|Overall Study|Withdrawal by Subject|16|||
129820791|NCT03765918|467307442|FG000|Overall Study|Participants Ongoing|240|||
129820792|NCT03765918|467307443|FG001|Overall Study|Participants Ongoing|205|||
129820793|NCT04202965|467307444|FG000|Overall Study|Adverse Event|3|||
129820794|NCT04202965|467307444|FG000|Overall Study|Did not meet inclusion criteria|1|||
129820795|NCT00006903|467307445|FG000|Overall Study|Still receiving treatment|0|||
129820796|NCT00006903|467307446|FG001|Overall Study|Still receiving treatment|0|||
129820797|NCT00006903|467307447|FG002|Overall Study|Still receiving treatment|1|||
129897351|NCT00817635|467584337|FG003|Overall Study|Withdrawal by Subject|1|||
129820798|NCT00006903|467307445|FG000|Overall Study|Refused further treatment|0|||
129820799|NCT00006903|467307446|FG001|Overall Study|Refused further treatment|2|||
129820800|NCT00006903|467307447|FG002|Overall Study|Refused further treatment|1|||
129820801|NCT00006903|467307445|FG000|Overall Study|Adverse Event|0|||
129820802|NCT00006903|467307446|FG001|Overall Study|Adverse Event|0|||
129820803|NCT00006903|467307447|FG002|Overall Study|Adverse Event|1|||
129820804|NCT00006903|467307445|FG000|Overall Study|Death|0|||
129820805|NCT00006903|467307446|FG001|Overall Study|Death|1|||
129820806|NCT00006903|467307447|FG002|Overall Study|Death|0|||
129820807|NCT00006903|467307445|FG000|Overall Study|Patient never treated|0|||
129820808|NCT00006903|467307446|FG001|Overall Study|Patient never treated|0|||
129820809|NCT00006903|467307447|FG002|Overall Study|Patient never treated|1|||
129820810|NCT00006903|467307445|FG000|Overall Study|Ineligible|10|||
129897352|NCT00817635|467584338|FG004|Overall Study|Withdrawal by Subject|2|||
130112529|NCT00549198|468373404|FG001|Overall Study|Participant Moved|0|||
130112530|NCT00549198|468373403|FG000|Overall Study|Participant not able to perform Week 96|1|||
130112531|NCT00549198|468373404|FG001|Overall Study|Participant not able to perform Week 96|0|||
130112532|NCT00549198|468373403|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
130112533|NCT00549198|468373404|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
130112534|NCT00549198|468373403|FG000|Overall Study|Prohibited Medication|1|||
130112535|NCT00549198|468373404|FG001|Overall Study|Prohibited Medication|2|||
130112536|NCT00549198|468373403|FG000|Overall Study|Participant planning pregnancy|1|||
130112537|NCT00549198|468373404|FG001|Overall Study|Participant planning pregnancy|0|||
130112538|NCT00549198|468373403|FG000|Overall Study|Participant overweight, no scan possible|1|||
130112539|NCT00549198|468373404|FG001|Overall Study|Participant overweight, no scan possible|0|||
130112540|NCT00549198|468373403|FG000|Overall Study|No scan facilities|0|||
130112541|NCT00549198|468373404|FG001|Overall Study|No scan facilities|2|||
130112542|NCT00549198|468373403|FG000|Overall Study|Pregnancy|0|||
130112543|NCT00549198|468373404|FG001|Overall Study|Pregnancy|3|||
130112544|NCT00549198|468373403|FG000|Overall Study|Not Exposed to Study Drug|3|||
130112545|NCT00549198|468373404|FG001|Overall Study|Not Exposed to Study Drug|4|||
130112546|NCT02480010|468373409|FG000|Overall Study|Adverse Event|3|||
130112547|NCT02480010|468373410|FG001|Overall Study|Adverse Event|1|||
130112548|NCT02480010|468373409|FG000|Overall Study|Death|1|||
130112549|NCT02480010|468373410|FG001|Overall Study|Death|0|||
130112550|NCT02480010|468373409|FG000|Overall Study|Insufficient therapeutic response|31|||
130112551|NCT02480010|468373410|FG001|Overall Study|Insufficient therapeutic response|29|||
130112552|NCT02480010|468373409|FG000|Overall Study|Refused Treatment|0|||
130112553|NCT02480010|468373410|FG001|Overall Study|Refused Treatment|3|||
130112554|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
130112555|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130112556|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130112557|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130112558|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130112559|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130112560|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
130112561|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
130112562|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130112563|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130112564|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130112565|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130112566|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130112567|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
130112568|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
130112569|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
130112570|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
130112571|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
130112572|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
130112573|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
130112574|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
130112575|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
130112576|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130112577|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130112578|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130112579|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130112580|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130112581|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
130112582|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
130112583|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130112584|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130112585|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130112586|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130112587|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130112588|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
130112589|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
130112590|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
130112591|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
130112592|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
130112593|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
130112594|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
130112595|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
129820811|NCT00006903|467307446|FG001|Overall Study|Ineligible|1|||
129820812|NCT00006903|467307447|FG002|Overall Study|Ineligible|2|||
129820813|NCT01366209|467307452|FG000|Overall Study|Adverse Event|6|||
129820814|NCT01366209|467307453|FG001|Overall Study|Adverse Event|7|||
129820815|NCT01366209|467307452|FG000|Overall Study|Withdrawal by Subject|4|||
129820816|NCT01366209|467307453|FG001|Overall Study|Withdrawal by Subject|4|||
129820817|NCT01366209|467307452|FG000|Overall Study|Death|12|||
129820818|NCT01366209|467307453|FG001|Overall Study|Death|19|||
129820819|NCT01366209|467307452|FG000|Overall Study|Lung transplantation|6|||
129820820|NCT01366209|467307453|FG001|Overall Study|Lung transplantation|1|||
129820821|NCT01366209|467307452|FG000|Overall Study|Lost to Follow-up|2|||
129820822|NCT01366209|467307453|FG001|Overall Study|Lost to Follow-up|1|||
129820823|NCT01366209|467307452|FG000|Overall Study|Physician Decision|1|||
129820824|NCT01366209|467307453|FG001|Overall Study|Physician Decision|0|||
129820825|NCT01366209|467307452|FG000|Overall Study|Sponsors decision|0|||
129820826|NCT01366209|467307453|FG001|Overall Study|Sponsors decision|1|||
129820827|NCT01366209|467307452|FG000|Overall Study|Withdrew consent|4|||
129820828|NCT01366209|467307453|FG001|Overall Study|Withdrew consent|3|||
129820829|NCT02670837|467307454|FG000|Overall Study|Death|2|||
129820830|NCT02670837|467307455|FG001|Overall Study|Death|0|||
129820831|NCT02670837|467307456|FG002|Overall Study|Death|0|||
129820832|NCT01053221|467307457|FG000|Overall Study|The study was closed prematurely|5|||
129820833|NCT01053221|467307458|FG001|Overall Study|The study was closed prematurely|9|||
129820834|NCT00752232|467307459|FG000|Overall Study|Protocol Violation|0|||
129820835|NCT00752232|467307460|FG001|Overall Study|Protocol Violation|0|||
129820836|NCT00752232|467307461|FG002|Overall Study|Protocol Violation|0|||
129820837|NCT00752232|467307462|FG003|Overall Study|Protocol Violation|0|||
129820838|NCT00752232|467307463|FG004|Overall Study|Protocol Violation|0|||
129820839|NCT00752232|467307464|FG005|Overall Study|Protocol Violation|1|||
129820840|NCT00752232|467307465|FG006|Overall Study|Protocol Violation|0|||
129820841|NCT00752232|467307459|FG000|Overall Study|Caregiver request|2|||
129820842|NCT00752232|467307460|FG001|Overall Study|Caregiver request|0|||
129820843|NCT00752232|467307461|FG002|Overall Study|Caregiver request|0|||
129820844|NCT00752232|467307462|FG003|Overall Study|Caregiver request|0|||
129820845|NCT00752232|467307463|FG004|Overall Study|Caregiver request|1|||
129820846|NCT00752232|467307464|FG005|Overall Study|Caregiver request|0|||
129820847|NCT00752232|467307465|FG006|Overall Study|Caregiver request|0|||
129820848|NCT00752232|467307459|FG000|Overall Study|Investigator request|0|||
129820849|NCT00752232|467307460|FG001|Overall Study|Investigator request|0|||
129820850|NCT00752232|467307461|FG002|Overall Study|Investigator request|0|||
129820851|NCT00752232|467307462|FG003|Overall Study|Investigator request|0|||
129820852|NCT00752232|467307463|FG004|Overall Study|Investigator request|1|||
129820853|NCT00752232|467307464|FG005|Overall Study|Investigator request|0|||
129820854|NCT00752232|467307465|FG006|Overall Study|Investigator request|0|||
129820855|NCT00752232|467307459|FG000|Overall Study|Subject request|0|||
129820856|NCT00752232|467307460|FG001|Overall Study|Subject request|0|||
129820857|NCT00752232|467307461|FG002|Overall Study|Subject request|1|||
129820858|NCT00752232|467307462|FG003|Overall Study|Subject request|0|||
129820859|NCT00752232|467307463|FG004|Overall Study|Subject request|0|||
129820860|NCT00752232|467307464|FG005|Overall Study|Subject request|0|||
129820861|NCT00752232|467307465|FG006|Overall Study|Subject request|0|||
129820862|NCT00752232|467307459|FG000|Overall Study|Group home admission|0|||
129820863|NCT00752232|467307460|FG001|Overall Study|Group home admission|0|||
129820864|NCT00752232|467307461|FG002|Overall Study|Group home admission|0|||
129820865|NCT00752232|467307462|FG003|Overall Study|Group home admission|1|||
129820866|NCT00752232|467307463|FG004|Overall Study|Group home admission|0|||
129820867|NCT00752232|467307464|FG005|Overall Study|Group home admission|0|||
129820868|NCT00752232|467307465|FG006|Overall Study|Group home admission|0|||
129820869|NCT00752232|467307459|FG000|Overall Study|Caregiver could not attend the subject|0|||
129820870|NCT00752232|467307460|FG001|Overall Study|Caregiver could not attend the subject|0|||
129820871|NCT00752232|467307461|FG002|Overall Study|Caregiver could not attend the subject|0|||
129820872|NCT00752232|467307462|FG003|Overall Study|Caregiver could not attend the subject|0|||
129820873|NCT00752232|467307463|FG004|Overall Study|Caregiver could not attend the subject|1|||
129820874|NCT00752232|467307464|FG005|Overall Study|Caregiver could not attend the subject|0|||
129820875|NCT00752232|467307465|FG006|Overall Study|Caregiver could not attend the subject|0|||
129820876|NCT01919723|467307466|FG000|Overall Study|Blood Samples Hemolyzed|2|||
129897353|NCT00817635|467584334|FG000|Overall Study|Lost to Follow-up|0|||
129897354|NCT00817635|467584335|FG001|Overall Study|Lost to Follow-up|1|||
129897355|NCT00817635|467584336|FG002|Overall Study|Lost to Follow-up|0|||
129820877|NCT01919723|467307467|FG001|Overall Study|Blood Samples Hemolyzed|2|||
129820878|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
129820879|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
129820880|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
129820881|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
129820882|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
129820883|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
129820884|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
129897356|NCT00817635|467584337|FG003|Overall Study|Lost to Follow-up|1|||
129820885|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
129820886|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
129820887|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
129820888|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Death|2|||
129820889|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Death|1|||
129820890|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Death|4|||
129820891|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Death|0|||
129820892|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Death|0|||
129820893|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
129820894|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
129820895|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
129820896|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
129820897|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
129820898|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Other Reason|1|||
129820899|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Other Reason|3|||
129820900|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Other Reason|2|||
129820901|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Other Reason|0|||
129820902|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Other Reason|0|||
129820903|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Never treated|2|||
129820904|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Never treated|3|||
129820905|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Never treated|1|||
129820906|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Never treated|0|||
129820907|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Never treated|4|||
129820908|NCT00555321|467307468|FG000|Long-term Extension Phase|Adverse Event|2|||
129820909|NCT00555321|467307469|FG001|Long-term Extension Phase|Adverse Event|5|||
129820910|NCT00555321|467307470|FG002|Long-term Extension Phase|Adverse Event|2|||
129820911|NCT00555321|467307471|FG003|Long-term Extension Phase|Adverse Event|1|||
129820912|NCT00555321|467307472|FG004|Long-term Extension Phase|Adverse Event|0|||
129820913|NCT00555321|467307468|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
129820914|NCT00555321|467307469|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
129820915|NCT00555321|467307470|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
129820916|NCT00555321|467307471|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
129820917|NCT00555321|467307472|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
129820918|NCT00555321|467307468|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
129820919|NCT00555321|467307469|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
129820920|NCT00555321|467307470|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
129820921|NCT00555321|467307471|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
129820922|NCT00555321|467307472|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
129820923|NCT00555321|467307468|FG000|Long-term Extension Phase|Death|2|||
129820924|NCT00555321|467307469|FG001|Long-term Extension Phase|Death|0|||
129820925|NCT00555321|467307470|FG002|Long-term Extension Phase|Death|0|||
129820926|NCT00555321|467307471|FG003|Long-term Extension Phase|Death|3|||
129820927|NCT00555321|467307472|FG004|Long-term Extension Phase|Death|0|||
129820928|NCT00555321|467307468|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820929|NCT00555321|467307469|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820930|NCT00555321|467307470|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820931|NCT00555321|467307471|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820932|NCT00555321|467307472|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
129820933|NCT00555321|467307468|FG000|Long-term Extension Phase|Other Reason|1|||
129820934|NCT00555321|467307469|FG001|Long-term Extension Phase|Other Reason|0|||
129820935|NCT00555321|467307470|FG002|Long-term Extension Phase|Other Reason|2|||
129820936|NCT00555321|467307471|FG003|Long-term Extension Phase|Other Reason|0|||
129820937|NCT00555321|467307472|FG004|Long-term Extension Phase|Other Reason|0|||
129820938|NCT00582166|467307475|FG000|Overall Study|Death|1|||
129820939|NCT00582166|467307475|FG000|Overall Study|Ineligible pathology|1|||
129820940|NCT02532972|467307476|FG000|Overall Study|Withdrawal by Subject|1|||
130059536|NCT04804033|468172364|FG000|Period 1: DBT Phase|Non-compliance|1|||
130059537|NCT04804033|468172365|FG001|Period 1: DBT Phase|Non-compliance|0|||
130059538|NCT04804033|468172366|FG002|Period 1: DBT Phase|Non-compliance|1|||
130059539|NCT04804033|468172367|FG003|Period 1: DBT Phase|Non-compliance|2|||
129820941|NCT01606436|467307477|FG000|Overall Study|Withdrawal by Subject|0|||
129820942|NCT01606436|467307478|FG001|Overall Study|Withdrawal by Subject|0|||
129820943|NCT01606436|467307479|FG002|Overall Study|Withdrawal by Subject|1|||
129820944|NCT01606436|467307480|FG003|Overall Study|Withdrawal by Subject|1|||
129820945|NCT01606436|467307481|FG004|Overall Study|Withdrawal by Subject|1|||
129820946|NCT01606436|467307482|FG005|Overall Study|Withdrawal by Subject|0|||
129820947|NCT01606436|467307477|FG000|Overall Study|Adverse Event|0|||
129820948|NCT01606436|467307478|FG001|Overall Study|Adverse Event|0|||
129820949|NCT01606436|467307479|FG002|Overall Study|Adverse Event|1|||
129820950|NCT01606436|467307480|FG003|Overall Study|Adverse Event|0|||
129820951|NCT01606436|467307481|FG004|Overall Study|Adverse Event|0|||
129820952|NCT01606436|467307482|FG005|Overall Study|Adverse Event|0|||
129820953|NCT01606436|467307477|FG000|Overall Study|Sponsor Decision|0|||
129820954|NCT01606436|467307478|FG001|Overall Study|Sponsor Decision|0|||
129820955|NCT01606436|467307479|FG002|Overall Study|Sponsor Decision|0|||
129820956|NCT01606436|467307480|FG003|Overall Study|Sponsor Decision|1|||
129820957|NCT01606436|467307481|FG004|Overall Study|Sponsor Decision|0|||
129820958|NCT01606436|467307482|FG005|Overall Study|Sponsor Decision|0|||
129820959|NCT02859454|467307483|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
129820960|NCT03944954|467307484|FG000|Overall Study|Withdrawal by Subject|22|||
129820961|NCT03944954|467307485|FG001|Overall Study|Withdrawal by Subject|4|||
129820962|NCT03944954|467307484|FG000|Overall Study|Lost to Follow-up|18|||
129820963|NCT03944954|467307485|FG001|Overall Study|Lost to Follow-up|0|||
129820964|NCT03944954|467307484|FG000|Overall Study|Failed Medical Screening|7|||
129820965|NCT03944954|467307485|FG001|Overall Study|Failed Medical Screening|0|||
129820966|NCT02268084|467307486|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
129820967|NCT02268084|467307487|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
129820968|NCT02268084|467307486|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
129820969|NCT02268084|467307487|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
129820970|NCT05227027|467307488|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
129820971|NCT05227027|467307489|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
129820972|NCT03334448|467307493|FG000|Washout|Personal Reason|0|||
129820973|NCT03334448|467307494|FG001|Washout|Personal Reason|1|||
129820974|NCT03334448|467307495|FG002|Washout|Personal Reason|0|||
129820975|NCT03334448|467307496|FG003|Washout|Personal Reason|0|||
129820976|NCT03334448|467307493|FG000|Washout|Protocol Violation|0|||
129820977|NCT03334448|467307494|FG001|Washout|Protocol Violation|0|||
129820978|NCT03334448|467307495|FG002|Washout|Protocol Violation|0|||
129820979|NCT03334448|467307496|FG003|Washout|Protocol Violation|1|||
129820980|NCT01683383|467307498|FG000|Overall Study|Infant was not transported|1|||
129820981|NCT01683383|467307499|FG001|Overall Study|Infant was not transported|0|||
129820982|NCT00855920|467307500|FG000|Overall Study|Protocol Violation|0|||
129820983|NCT00855920|467307501|FG001|Overall Study|Protocol Violation|0|||
129820984|NCT00855920|467307502|FG002|Overall Study|Protocol Violation|2|||
129820985|NCT00855920|467307500|FG000|Overall Study|Adverse Event|2|||
129820986|NCT00855920|467307501|FG001|Overall Study|Adverse Event|1|||
129820987|NCT00855920|467307502|FG002|Overall Study|Adverse Event|1|||
129820988|NCT00855920|467307500|FG000|Overall Study|Lack of Efficacy|2|||
129820989|NCT00855920|467307501|FG001|Overall Study|Lack of Efficacy|2|||
129820990|NCT00855920|467307502|FG002|Overall Study|Lack of Efficacy|2|||
129820991|NCT00855920|467307500|FG000|Overall Study|Withdrawal by Subject|2|||
129820992|NCT00855920|467307501|FG001|Overall Study|Withdrawal by Subject|3|||
129820993|NCT00855920|467307502|FG002|Overall Study|Withdrawal by Subject|2|||
129820994|NCT00855920|467307500|FG000|Overall Study|Lost to Follow-up|1|||
129820995|NCT00855920|467307501|FG001|Overall Study|Lost to Follow-up|0|||
129820996|NCT00855920|467307502|FG002|Overall Study|Lost to Follow-up|2|||
129820997|NCT00855920|467307500|FG000|Overall Study|Death|0|||
129820998|NCT00855920|467307501|FG001|Overall Study|Death|1|||
129820999|NCT00855920|467307502|FG002|Overall Study|Death|0|||
129821000|NCT00855920|467307500|FG000|Overall Study|Decision by the sponsor|0|||
129821001|NCT00855920|467307501|FG001|Overall Study|Decision by the sponsor|1|||
129821002|NCT00855920|467307502|FG002|Overall Study|Decision by the sponsor|1|||
129821003|NCT00855920|467307500|FG000|Overall Study|Other than specified above|1|||
129821004|NCT00855920|467307501|FG001|Overall Study|Other than specified above|1|||
129821005|NCT00855920|467307502|FG002|Overall Study|Other than specified above|1|||
129821006|NCT00996307|467307503|FG000|Overall Study|Adverse Event|0|||
129821007|NCT00996307|467307504|FG001|Overall Study|Adverse Event|1|||
129821008|NCT00996307|467307505|FG002|Overall Study|Adverse Event|0|||
129821009|NCT00996307|467307506|FG003|Overall Study|Adverse Event|0|||
129821010|NCT00996307|467307503|FG000|Overall Study|Withdrawal by Subject|3|||
129821011|NCT00996307|467307504|FG001|Overall Study|Withdrawal by Subject|2|||
129821012|NCT00996307|467307505|FG002|Overall Study|Withdrawal by Subject|5|||
129821013|NCT00996307|467307506|FG003|Overall Study|Withdrawal by Subject|5|||
129897357|NCT00817635|467584338|FG004|Overall Study|Lost to Follow-up|0|||
129821014|NCT00996307|467307503|FG000|Overall Study|Lost to Follow-up|13|||
129821015|NCT00996307|467307504|FG001|Overall Study|Lost to Follow-up|13|||
129821016|NCT00996307|467307505|FG002|Overall Study|Lost to Follow-up|7|||
129821017|NCT00996307|467307506|FG003|Overall Study|Lost to Follow-up|15|||
129821018|NCT00996307|467307503|FG000|Overall Study|Administrative reason|0|||
129821019|NCT00996307|467307504|FG001|Overall Study|Administrative reason|1|||
129821020|NCT00996307|467307505|FG002|Overall Study|Administrative reason|0|||
129821021|NCT00996307|467307506|FG003|Overall Study|Administrative reason|0|||
129821022|NCT00996307|467307503|FG000|Overall Study|Unable to classify|4|||
129821023|NCT00996307|467307504|FG001|Overall Study|Unable to classify|0|||
129821024|NCT00996307|467307505|FG002|Overall Study|Unable to classify|2|||
129821025|NCT00996307|467307506|FG003|Overall Study|Unable to classify|1|||
129821026|NCT02496611|467307509|FG000|Overall Study|Lost to Follow-up|2|||
130112596|NCT00606684|468373420|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
130112597|NCT00606684|468373421|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129821027|NCT02496611|467307510|FG001|Overall Study|Lost to Follow-up|1|||
129821028|NCT02496611|467307509|FG000|Overall Study|Withdrawal by Subject|5|||
129821029|NCT02496611|467307510|FG001|Overall Study|Withdrawal by Subject|2|||
129821030|NCT02788357|467307514|FG000|Overall Study|Lost to Follow-up|3|||
129821031|NCT02788357|467307515|FG001|Overall Study|Lost to Follow-up|0|||
129821032|NCT01365910|467307516|FG000|Overall Study|Withdrawal by Subject|7|||
129821033|NCT01365910|467307516|FG000|Overall Study|disease progression|18|||
129821034|NCT01365910|467307516|FG000|Overall Study|Adverse Event|3|||
129821035|NCT01365910|467307516|FG000|Overall Study|other complicating disease|1|||
129821036|NCT01365910|467307516|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
129821037|NCT00371137|467307517|FG000|Overall Study|Adverse Event|20|||
129821038|NCT00371137|467307518|FG001|Overall Study|Adverse Event|35|||
129821039|NCT00371137|467307519|FG002|Overall Study|Adverse Event|42|||
129821040|NCT00371137|467307517|FG000|Overall Study|Withdrawal by Subject|11|||
129821041|NCT00371137|467307518|FG001|Overall Study|Withdrawal by Subject|10|||
129821042|NCT00371137|467307519|FG002|Overall Study|Withdrawal by Subject|15|||
129821043|NCT00371137|467307517|FG000|Overall Study|Lost to Follow-up|6|||
129821044|NCT00371137|467307518|FG001|Overall Study|Lost to Follow-up|3|||
129821045|NCT00371137|467307519|FG002|Overall Study|Lost to Follow-up|5|||
129821046|NCT00371137|467307517|FG000|Overall Study|Lack of Efficacy|30|||
129821047|NCT00371137|467307518|FG001|Overall Study|Lack of Efficacy|12|||
129821048|NCT00371137|467307519|FG002|Overall Study|Lack of Efficacy|13|||
129821049|NCT00371137|467307517|FG000|Overall Study|Sponsor Decision|2|||
129821050|NCT00371137|467307518|FG001|Overall Study|Sponsor Decision|1|||
129821051|NCT00371137|467307519|FG002|Overall Study|Sponsor Decision|2|||
130112598|NCT00606684|468373422|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130112599|NCT00606684|468373423|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130112600|NCT00606684|468373424|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130112601|NCT00606684|468373425|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130112602|NCT00606684|468373426|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
130112603|NCT00606684|468373420|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130112604|NCT00606684|468373421|FG001|Double-Blind Treatment Period|Adverse Event|3|||
130112605|NCT00606684|468373422|FG002|Double-Blind Treatment Period|Adverse Event|2|||
130112606|NCT00606684|468373423|FG003|Double-Blind Treatment Period|Adverse Event|4|||
130112607|NCT00606684|468373424|FG004|Double-Blind Treatment Period|Adverse Event|2|||
130112608|NCT00606684|468373425|FG005|Double-Blind Treatment Period|Adverse Event|0|||
130112609|NCT00606684|468373426|FG006|Double-Blind Treatment Period|Adverse Event|1|||
130112610|NCT00606684|468373420|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
130112611|NCT00606684|468373421|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
130112612|NCT00606684|468373422|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
130112613|NCT00606684|468373423|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
130112614|NCT00606684|468373424|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
130112615|NCT00606684|468373425|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
130112616|NCT00606684|468373426|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
130112617|NCT00606684|468373420|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130112618|NCT00606684|468373421|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
130112619|NCT00606684|468373422|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
130112620|NCT00606684|468373423|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
130112621|NCT00606684|468373424|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
130112622|NCT00606684|468373425|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
130112623|NCT00606684|468373426|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
130112624|NCT00606684|468373420|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
130112625|NCT00606684|468373421|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
130112626|NCT00606684|468373422|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
130112627|NCT00606684|468373423|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
130112628|NCT00606684|468373424|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
130112629|NCT00606684|468373425|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
130112630|NCT00606684|468373426|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
130112631|NCT00606684|468373420|FG000|Double-Blind Treatment Period|Physician Decision|0|||
130112632|NCT00606684|468373421|FG001|Double-Blind Treatment Period|Physician Decision|5|||
130112633|NCT00606684|468373422|FG002|Double-Blind Treatment Period|Physician Decision|1|||
130112634|NCT00606684|468373423|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129821052|NCT00371137|467307517|FG000|Overall Study|Physician Decision|1|||
129821053|NCT00371137|467307518|FG001|Overall Study|Physician Decision|1|||
129821054|NCT00371137|467307519|FG002|Overall Study|Physician Decision|1|||
129821055|NCT00371137|467307517|FG000|Overall Study|Protocol Violation|2|||
129821056|NCT00371137|467307518|FG001|Overall Study|Protocol Violation|1|||
129821057|NCT00371137|467307519|FG002|Overall Study|Protocol Violation|1|||
129821058|NCT00536198|467307520|FG000|Overall Study|Lost to Follow-up|15|||
129821059|NCT00536198|467307521|FG001|Overall Study|Lost to Follow-up|14|||
129821060|NCT00536198|467307520|FG000|Overall Study|Withdrawal by Subject|16|||
129821061|NCT00536198|467307521|FG001|Overall Study|Withdrawal by Subject|12|||
129821062|NCT00536198|467307520|FG000|Overall Study|Adverse Event|2|||
129821063|NCT00536198|467307521|FG001|Overall Study|Adverse Event|2|||
129821064|NCT00536198|467307520|FG000|Overall Study|Rescue|3|||
129821065|NCT00536198|467307521|FG001|Overall Study|Rescue|9|||
129821066|NCT00536198|467307520|FG000|Overall Study|Pregnancy|1|||
129821067|NCT00536198|467307521|FG001|Overall Study|Pregnancy|1|||
129821068|NCT00536198|467307520|FG000|Overall Study|Protocol Violation|0|||
129821069|NCT00536198|467307521|FG001|Overall Study|Protocol Violation|1|||
129821070|NCT02013791|467307522|FG000|Period 1|Lost to Follow-up|0|||
129821071|NCT02013791|467307523|FG001|Period 1|Lost to Follow-up|0|||
129821072|NCT02013791|467307524|FG002|Period 1|Lost to Follow-up|0|||
129821073|NCT02013791|467307525|FG003|Period 1|Lost to Follow-up|1|||
129821074|NCT02013791|467307526|FG004|Period 1|Lost to Follow-up|0|||
129821075|NCT02013791|467307527|FG005|Period 1|Lost to Follow-up|0|||
129821076|NCT02013791|467307528|FG006|Period 1|Lost to Follow-up|1|||
129821077|NCT02013791|467307529|FG007|Period 1|Lost to Follow-up|1|||
129821078|NCT02013791|467307530|FG008|Period 1|Lost to Follow-up|0|||
129821079|NCT02013791|467307522|FG000|Period 1|Other Miscellaneous Reasons|0|||
129821080|NCT02013791|467307523|FG001|Period 1|Other Miscellaneous Reasons|2|||
129821081|NCT02013791|467307524|FG002|Period 1|Other Miscellaneous Reasons|0|||
129821082|NCT02013791|467307525|FG003|Period 1|Other Miscellaneous Reasons|0|||
129821083|NCT02013791|467307526|FG004|Period 1|Other Miscellaneous Reasons|0|||
129821084|NCT02013791|467307527|FG005|Period 1|Other Miscellaneous Reasons|0|||
129821085|NCT02013791|467307528|FG006|Period 1|Other Miscellaneous Reasons|0|||
129821086|NCT02013791|467307529|FG007|Period 1|Other Miscellaneous Reasons|0|||
129821087|NCT02013791|467307530|FG008|Period 1|Other Miscellaneous Reasons|0|||
129821088|NCT03798483|467307531|FG000|Overall Study|Lost to Follow-up|2|||
129821089|NCT01666782|467307532|FG000|Overall Study|Received 2 doses of vaccine|0|||
129821090|NCT01666782|467307533|FG001|Overall Study|Received 2 doses of vaccine|1|||
129821091|NCT01666782|467307532|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
129821092|NCT01666782|467307533|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
129821093|NCT01691781|467307545|FG000|Overall Study|Withdrawal by Subject|4|||
129821094|NCT01691781|467307546|FG001|Overall Study|Withdrawal by Subject|3|||
129821095|NCT01691781|467307545|FG000|Overall Study|Physician Decision|1|||
129821096|NCT01691781|467307546|FG001|Overall Study|Physician Decision|1|||
129821097|NCT01691781|467307545|FG000|Overall Study|Protocol Violation|2|||
129821098|NCT01691781|467307546|FG001|Overall Study|Protocol Violation|2|||
129821099|NCT01691781|467307545|FG000|Overall Study|Adverse Event|0|||
129821100|NCT01691781|467307546|FG001|Overall Study|Adverse Event|1|||
129821101|NCT01605877|467307547|FG000|Overall Study|Withdrawal by Subject|1|||
129821102|NCT01918085|467307550|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
129821103|NCT01918085|467307551|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
129821104|NCT00687323|467307558|FG000|Overall Study|Death|25|||
129821105|NCT00687323|467307558|FG000|Overall Study|Withdrawal by Subject|1|||
129821106|NCT00687323|467307558|FG000|Overall Study|Excluded from efficacy evaluations|6|||
129821107|NCT00687323|467307558|FG000|Overall Study|Screen failure|148|||
129821108|NCT00679302|467307561|FG000|Overall Study|Lost to Follow-up|8|||
129821109|NCT00679302|467307562|FG001|Overall Study|Lost to Follow-up|4|||
129821110|NCT05109442|467307565|FG000|Overall Study|Withdrawal by Subject|0|||
129821111|NCT05109442|467307566|FG001|Overall Study|Withdrawal by Subject|0|||
129821112|NCT05109442|467307567|FG002|Overall Study|Withdrawal by Subject|1|||
129821113|NCT05109442|467307568|FG003|Overall Study|Withdrawal by Subject|0|||
129821114|NCT05109442|467307569|FG004|Overall Study|Withdrawal by Subject|0|||
129821115|NCT05109442|467307570|FG005|Overall Study|Withdrawal by Subject|0|||
129821116|NCT05109442|467307565|FG000|Overall Study|Adverse Event|0|||
129821117|NCT05109442|467307566|FG001|Overall Study|Adverse Event|1|||
129821118|NCT05109442|467307567|FG002|Overall Study|Adverse Event|5|||
129821119|NCT05109442|467307568|FG003|Overall Study|Adverse Event|0|||
129821120|NCT05109442|467307569|FG004|Overall Study|Adverse Event|0|||
129821121|NCT05109442|467307570|FG005|Overall Study|Adverse Event|2|||
129821122|NCT05109442|467307565|FG000|Overall Study|Death|0|||
129821123|NCT05109442|467307566|FG001|Overall Study|Death|0|||
129821124|NCT05109442|467307567|FG002|Overall Study|Death|4|||
129821125|NCT05109442|467307568|FG003|Overall Study|Death|0|||
129821126|NCT05109442|467307569|FG004|Overall Study|Death|0|||
129821127|NCT05109442|467307570|FG005|Overall Study|Death|1|||
129821128|NCT05109442|467307565|FG000|Overall Study|Physician Decision|1|||
129821129|NCT05109442|467307566|FG001|Overall Study|Physician Decision|0|||
129821130|NCT05109442|467307567|FG002|Overall Study|Physician Decision|1|||
129821131|NCT05109442|467307568|FG003|Overall Study|Physician Decision|0|||
129821132|NCT05109442|467307569|FG004|Overall Study|Physician Decision|0|||
129821133|NCT05109442|467307570|FG005|Overall Study|Physician Decision|2|||
129821134|NCT05109442|467307565|FG000|Overall Study|Other than listed|0|||
129821135|NCT05109442|467307566|FG001|Overall Study|Other than listed|0|||
129821136|NCT05109442|467307567|FG002|Overall Study|Other than listed|9|||
129821137|NCT05109442|467307568|FG003|Overall Study|Other than listed|2|||
129821138|NCT05109442|467307569|FG004|Overall Study|Other than listed|0|||
129821139|NCT05109442|467307570|FG005|Overall Study|Other than listed|8|||
129821140|NCT05109442|467307565|FG000|Overall Study|Lack of Efficacy|3|||
129821141|NCT05109442|467307566|FG001|Overall Study|Lack of Efficacy|5|||
129821142|NCT05109442|467307567|FG002|Overall Study|Lack of Efficacy|29|||
129821143|NCT05109442|467307568|FG003|Overall Study|Lack of Efficacy|10|||
129821144|NCT05109442|467307569|FG004|Overall Study|Lack of Efficacy|11|||
129821145|NCT05109442|467307570|FG005|Overall Study|Lack of Efficacy|17|||
129821146|NCT04853225|467307571|FG000|Overall Study|Withdrawal by Subject|81|||
129821147|NCT04853225|467307572|FG001|Overall Study|Withdrawal by Subject|4|||
129821148|NCT04853225|467307573|FG002|Overall Study|Withdrawal by Subject|1|||
129821149|NCT04853225|467307571|FG000|Overall Study|Physician Decision|12|||
129821150|NCT04853225|467307572|FG001|Overall Study|Physician Decision|4|||
129821151|NCT04853225|467307573|FG002|Overall Study|Physician Decision|1|||
129821152|NCT04853225|467307571|FG000|Overall Study|Lost to Follow-up|50|||
129821153|NCT04853225|467307572|FG001|Overall Study|Lost to Follow-up|0|||
129821154|NCT04853225|467307573|FG002|Overall Study|Lost to Follow-up|0|||
129821155|NCT04853225|467307571|FG000|Overall Study|Other|102|||
129821156|NCT04853225|467307572|FG001|Overall Study|Other|11|||
129821157|NCT04853225|467307573|FG002|Overall Study|Other|5|||
129821158|NCT04853225|467307571|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
129821159|NCT04853225|467307572|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
129821160|NCT04853225|467307573|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
129821161|NCT04853225|467307571|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
129821162|NCT04853225|467307572|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
129821163|NCT04853225|467307573|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
129821164|NCT03918447|467307574|FG000|Overall Study|Death|1|||
129821165|NCT03918447|467307575|FG001|Overall Study|Death|0|||
129821166|NCT03918447|467307574|FG000|Overall Study|Lost to Follow-up|13|||
129821167|NCT03918447|467307575|FG001|Overall Study|Lost to Follow-up|6|||
129821168|NCT03918447|467307574|FG000|Overall Study|Withdrawal by Subject|19|||
129821169|NCT03918447|467307575|FG001|Overall Study|Withdrawal by Subject|17|||
129821170|NCT03918447|467307574|FG000|Overall Study|Study Terminated by Sponsor|195|||
129821171|NCT03918447|467307575|FG001|Overall Study|Study Terminated by Sponsor|197|||
129821172|NCT03918447|467307574|FG000|Overall Study|Reason not Specified|0|||
129821173|NCT03918447|467307575|FG001|Overall Study|Reason not Specified|1|||
129821174|NCT01405456|467307576|FG000|Overall Study|Lost to Follow-up|2|||
129821175|NCT01405456|467307577|FG001|Overall Study|Lost to Follow-up|1|||
129821176|NCT01405456|467307576|FG000|Overall Study|Physician Decision|1|||
129821177|NCT01405456|467307577|FG001|Overall Study|Physician Decision|0|||
129821178|NCT01937559|467307578|FG000|Overall Study|Physician Decision|3|||
129821179|NCT01937559|467307579|FG001|Overall Study|Physician Decision|3|||
129821180|NCT01937559|467307580|FG002|Overall Study|Physician Decision|0|||
129821181|NCT01937559|467307578|FG000|Overall Study|Withdrawal by Subject|6|||
129821182|NCT01937559|467307579|FG001|Overall Study|Withdrawal by Subject|4|||
129821183|NCT01937559|467307580|FG002|Overall Study|Withdrawal by Subject|0|||
129821184|NCT01937559|467307578|FG000|Overall Study|screen fail|2|||
129821185|NCT01937559|467307579|FG001|Overall Study|screen fail|4|||
129821186|NCT01937559|467307580|FG002|Overall Study|screen fail|0|||
129821187|NCT03909295|467308977|FG000|Overall Study|Adverse Event|2|||
129821188|NCT03909295|467308977|FG000|Overall Study|Study terminated by sponsor|50|||
129821189|NCT00720434|467308978|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
129821190|NCT00720434|467308979|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
129821191|NCT00720434|467308980|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
129821192|NCT00720434|467308981|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
129821193|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
129821194|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
129821195|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
129821196|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
129821197|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
129821198|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
129821199|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
129821200|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
129821201|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
129821202|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
129821203|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
129821204|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
129821205|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Other|4|||
129821206|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Other|3|||
129821207|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Other|3|||
129821208|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Other|2|||
129821209|NCT03138889|467308989|FG000|Overall Study|Withdrawal by Subject|5|||
129821210|NCT03138889|467308990|FG001|Overall Study|Withdrawal by Subject|5|||
129821211|NCT03138889|467308991|FG002|Overall Study|Withdrawal by Subject|0|||
129821212|NCT03138889|467308992|FG003|Overall Study|Withdrawal by Subject|2|||
129821213|NCT03138889|467308993|FG004|Overall Study|Withdrawal by Subject|1|||
129821214|NCT03138889|467308994|FG005|Overall Study|Withdrawal by Subject|3|||
129821215|NCT03138889|467308995|FG006|Overall Study|Withdrawal by Subject|0|||
129821216|NCT03138889|467308996|FG007|Overall Study|Withdrawal by Subject|1|||
129821217|NCT02289690|467308999|FG000|Overall Study|Adverse Event Related to Progression|0|||
129821218|NCT02289690|467309000|FG001|Overall Study|Adverse Event Related to Progression|1|||
129821219|NCT02289690|467309001|FG002|Overall Study|Adverse Event Related to Progression|1|||
129821220|NCT02289690|467309002|FG003|Overall Study|Adverse Event Related to Progression|0|||
129821221|NCT02289690|467309003|FG004|Overall Study|Adverse Event Related to Progression|1|||
129821222|NCT02289690|467309004|FG005|Overall Study|Adverse Event Related to Progression|0|||
129821223|NCT02289690|467309005|FG006|Overall Study|Adverse Event Related to Progression|1|||
129821224|NCT02289690|467309006|FG007|Overall Study|Adverse Event Related to Progression|0|||
129821225|NCT02289690|467309007|FG008|Overall Study|Adverse Event Related to Progression|0|||
129821226|NCT02289690|467309008|FG009|Overall Study|Adverse Event Related to Progression|0|||
129821227|NCT02289690|467308999|FG000|Overall Study|Withdrawal by Subject|1|||
129821228|NCT02289690|467309000|FG001|Overall Study|Withdrawal by Subject|0|||
129821229|NCT02289690|467309001|FG002|Overall Study|Withdrawal by Subject|0|||
129821230|NCT02289690|467309002|FG003|Overall Study|Withdrawal by Subject|0|||
129821231|NCT02289690|467309003|FG004|Overall Study|Withdrawal by Subject|1|||
129821232|NCT02289690|467309004|FG005|Overall Study|Withdrawal by Subject|1|||
129821233|NCT02289690|467309005|FG006|Overall Study|Withdrawal by Subject|0|||
129821234|NCT02289690|467309006|FG007|Overall Study|Withdrawal by Subject|0|||
129821235|NCT02289690|467309007|FG008|Overall Study|Withdrawal by Subject|4|||
129821236|NCT02289690|467309008|FG009|Overall Study|Withdrawal by Subject|2|||
129821237|NCT02289690|467308999|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
129821238|NCT02289690|467309000|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
129821239|NCT02289690|467309001|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
129821240|NCT02289690|467309002|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
129821241|NCT02289690|467309003|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
129821242|NCT02289690|467309004|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
129821243|NCT02289690|467309005|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
129821244|NCT02289690|467309006|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
129821245|NCT02289690|467309007|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
129821246|NCT02289690|467309008|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
129821247|NCT02289690|467308999|FG000|Overall Study|Lost to Follow-up|0|||
129821248|NCT02289690|467309000|FG001|Overall Study|Lost to Follow-up|0|||
129821249|NCT02289690|467309001|FG002|Overall Study|Lost to Follow-up|0|||
129821250|NCT02289690|467309002|FG003|Overall Study|Lost to Follow-up|0|||
129821251|NCT02289690|467309003|FG004|Overall Study|Lost to Follow-up|0|||
129821252|NCT02289690|467309004|FG005|Overall Study|Lost to Follow-up|0|||
129821253|NCT02289690|467309005|FG006|Overall Study|Lost to Follow-up|0|||
129821254|NCT02289690|467309006|FG007|Overall Study|Lost to Follow-up|1|||
129821255|NCT02289690|467309007|FG008|Overall Study|Lost to Follow-up|0|||
129821256|NCT02289690|467309008|FG009|Overall Study|Lost to Follow-up|2|||
129821257|NCT02289690|467308999|FG000|Overall Study|Death|0|||
129821258|NCT02289690|467309000|FG001|Overall Study|Death|0|||
129821259|NCT02289690|467309001|FG002|Overall Study|Death|0|||
129821260|NCT02289690|467309002|FG003|Overall Study|Death|0|||
129821261|NCT02289690|467309003|FG004|Overall Study|Death|0|||
129821262|NCT02289690|467309004|FG005|Overall Study|Death|0|||
129821263|NCT02289690|467309005|FG006|Overall Study|Death|0|||
129821264|NCT02289690|467309006|FG007|Overall Study|Death|49|||
129821265|NCT02289690|467309007|FG008|Overall Study|Death|45|||
129821266|NCT02289690|467309008|FG009|Overall Study|Death|41|||
129821267|NCT02289690|467308999|FG000|Overall Study|Sponsor Discontinued Study|0|||
129821268|NCT02289690|467309000|FG001|Overall Study|Sponsor Discontinued Study|0|||
129821269|NCT02289690|467309001|FG002|Overall Study|Sponsor Discontinued Study|0|||
129821270|NCT02289690|467309002|FG003|Overall Study|Sponsor Discontinued Study|0|||
129821271|NCT02289690|467309003|FG004|Overall Study|Sponsor Discontinued Study|0|||
129821272|NCT02289690|467309004|FG005|Overall Study|Sponsor Discontinued Study|0|||
129821273|NCT02289690|467309005|FG006|Overall Study|Sponsor Discontinued Study|0|||
129821274|NCT02289690|467309006|FG007|Overall Study|Sponsor Discontinued Study|9|||
129821275|NCT02289690|467309007|FG008|Overall Study|Sponsor Discontinued Study|7|||
129821276|NCT02289690|467309008|FG009|Overall Study|Sponsor Discontinued Study|15|||
129821277|NCT02289690|467308999|FG000|Overall Study|Other|0|||
129821278|NCT02289690|467309000|FG001|Overall Study|Other|0|||
129821279|NCT02289690|467309001|FG002|Overall Study|Other|0|||
129821280|NCT02289690|467309002|FG003|Overall Study|Other|1|||
129821281|NCT02289690|467309003|FG004|Overall Study|Other|1|||
129821282|NCT02289690|467309004|FG005|Overall Study|Other|0|||
129821283|NCT02289690|467309005|FG006|Overall Study|Other|1|||
129821284|NCT02289690|467309006|FG007|Overall Study|Other|2|||
129821285|NCT02289690|467309007|FG008|Overall Study|Other|3|||
129821286|NCT02289690|467309008|FG009|Overall Study|Other|1|||
129821287|NCT04166435|467309015|FG000|Overall Study|2 patients ineligible for response|2|||
129821288|NCT00865124|467309018|FG000|Overall Study|Physician Decision|2|||
129821289|NCT00865124|467309019|FG001|Overall Study|Physician Decision|1|||
129821290|NCT00865124|467309020|FG002|Overall Study|Physician Decision|0|||
129821291|NCT00865124|467309018|FG000|Overall Study|Withdrawn consent|2|||
129821292|NCT00865124|467309019|FG001|Overall Study|Withdrawn consent|0|||
129821293|NCT00865124|467309020|FG002|Overall Study|Withdrawn consent|0|||
129821294|NCT04983264|467309021|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
129821295|NCT04983264|467309022|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
129821296|NCT04983264|467309023|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
129821297|NCT04983264|467309021|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
129821298|NCT04983264|467309022|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
129821299|NCT04983264|467309023|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
129821300|NCT03042533|467309028|FG000|Overall Study|MD left program|1|||
129821301|NCT03042533|467309029|FG001|Overall Study|MD left program|4|||
129821302|NCT03042533|467309030|FG002|Overall Study|MD left program|1|||
129821303|NCT02551731|467309039|FG000|Overall Study|Withdrawal by Subject|2|||
129821304|NCT01678911|467309046|FG000|Second Intervention|Lost to Follow-up|2|||
129821305|NCT01678911|467309047|FG001|Second Intervention|Lost to Follow-up|0|||
129821306|NCT00356369|467309048|FG000|Active Phase|Withdrawal by Subject|2|||
129821307|NCT00356369|467309049|FG001|Active Phase|Withdrawal by Subject|1|||
129821308|NCT02117648|467309053|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
129821309|NCT02117648|467309053|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
129821310|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
129821311|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
129821312|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
129821313|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
129821314|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
129821315|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
129821316|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
129821317|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
129821318|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
129821319|NCT01985867|467309054|FG000|Overall Study|Lost to Follow-up|3|||
129821320|NCT01985867|467309055|FG001|Overall Study|Lost to Follow-up|4|||
129821321|NCT01985867|467309054|FG000|Overall Study|Adverse Event|3|||
129821322|NCT01985867|467309055|FG001|Overall Study|Adverse Event|2|||
129821323|NCT01985867|467309054|FG000|Overall Study|Lack of Efficacy|1|||
129821324|NCT01985867|467309055|FG001|Overall Study|Lack of Efficacy|0|||
129821325|NCT00553514|467309058|FG000|Overall Study|Protocol deviation|0|||
129821326|NCT00553514|467309059|FG001|Overall Study|Protocol deviation|0|||
129821327|NCT00553514|467309060|FG002|Overall Study|Protocol deviation|0|||
129821328|NCT00553514|467309061|FG003|Overall Study|Protocol deviation|1|||
129821329|NCT00553514|467309062|FG004|Overall Study|Protocol deviation|0|||
129821330|NCT00553514|467309058|FG000|Overall Study|Lack of ovarian response|4|||
129821331|NCT00553514|467309059|FG001|Overall Study|Lack of ovarian response|5|||
129821332|NCT00553514|467309060|FG002|Overall Study|Lack of ovarian response|5|||
129821333|NCT00553514|467309061|FG003|Overall Study|Lack of ovarian response|5|||
129821334|NCT00553514|467309062|FG004|Overall Study|Lack of ovarian response|6|||
129821335|NCT00553514|467309058|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
129821336|NCT00553514|467309059|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129821337|NCT00553514|467309060|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129821338|NCT00553514|467309061|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129821339|NCT00553514|467309062|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129821340|NCT00553514|467309058|FG000|Overall Study|Risk of multiple pregnancy|0|||
129821341|NCT00553514|467309059|FG001|Overall Study|Risk of multiple pregnancy|2|||
130059540|NCT04804033|468172364|FG000|Period 1: DBT Phase|Other|0|||
130059541|NCT04804033|468172365|FG001|Period 1: DBT Phase|Other|1|||
130059542|NCT04804033|468172366|FG002|Period 1: DBT Phase|Other|0|||
130059543|NCT04804033|468172367|FG003|Period 1: DBT Phase|Other|0|||
130059544|NCT04804033|468172364|FG000|Period 1: DBT Phase|Pregnancy|2|||
130059545|NCT04804033|468172365|FG001|Period 1: DBT Phase|Pregnancy|0|||
130059546|NCT04804033|468172366|FG002|Period 1: DBT Phase|Pregnancy|0|||
130059547|NCT04804033|468172367|FG003|Period 1: DBT Phase|Pregnancy|0|||
130059548|NCT04804033|468172364|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
130059549|NCT04804033|468172365|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
130059550|NCT04804033|468172366|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
130059551|NCT04804033|468172367|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
129821342|NCT00553514|467309060|FG002|Overall Study|Risk of multiple pregnancy|0|||
129821343|NCT00553514|467309061|FG003|Overall Study|Risk of multiple pregnancy|1|||
129821344|NCT00553514|467309062|FG004|Overall Study|Risk of multiple pregnancy|0|||
129821345|NCT00553514|467309058|FG000|Overall Study|Other|1|||
129821346|NCT00553514|467309059|FG001|Overall Study|Other|1|||
129821347|NCT00553514|467309060|FG002|Overall Study|Other|0|||
129821348|NCT00553514|467309061|FG003|Overall Study|Other|0|||
129821349|NCT00553514|467309062|FG004|Overall Study|Other|1|||
130059552|NCT04804033|468172364|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
130059553|NCT04804033|468172365|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
129821350|NCT01442675|467309069|FG000|Overall Study|Protocol Violation|6|||
129821351|NCT01442675|467309069|FG000|Overall Study|Lost to Follow-up|2|||
129821352|NCT01442675|467309069|FG000|Overall Study|Withdrawal by Subject|4|||
129821353|NCT04502589|467309070|FG000|Overall Study|Physician Decision|1|||
129821354|NCT04502589|467309071|FG001|Overall Study|Physician Decision|0|||
129821355|NCT02725710|467309074|FG000|Overall Study|Lost to Follow-up|1|||
129821356|NCT02725710|467309075|FG001|Overall Study|Lost to Follow-up|0|||
129821357|NCT01927367|467309078|FG000|Overall Study|Withdrawal by Subject|7|||
129821358|NCT01927367|467309079|FG001|Overall Study|Withdrawal by Subject|4|||
129821359|NCT01927367|467309078|FG000|Overall Study|No baseline data|0|||
129821360|NCT01927367|467309079|FG001|Overall Study|No baseline data|1|||
129821361|NCT00598832|467309082|FG000|Overall Study|Lack of Efficacy|3|||
129821362|NCT00598832|467309083|FG001|Overall Study|Lack of Efficacy|7|||
129821363|NCT00598832|467309082|FG000|Overall Study|Adverse Event|6|||
129821364|NCT00598832|467309083|FG001|Overall Study|Adverse Event|2|||
129821365|NCT00598832|467309082|FG000|Overall Study|Withdrawal by Subject|25|||
129821366|NCT00598832|467309083|FG001|Overall Study|Withdrawal by Subject|36|||
129821367|NCT00598832|467309082|FG000|Overall Study|Protocol Violation|0|||
129821368|NCT00598832|467309083|FG001|Overall Study|Protocol Violation|2|||
129821369|NCT00598832|467309082|FG000|Overall Study|Lost to Follow-up|24|||
129821370|NCT00598832|467309083|FG001|Overall Study|Lost to Follow-up|29|||
129821371|NCT00598832|467309082|FG000|Overall Study|Pregnancy|2|||
129821372|NCT00598832|467309083|FG001|Overall Study|Pregnancy|2|||
129821373|NCT00598832|467309082|FG000|Overall Study|Physician Decision|1|||
129821374|NCT00598832|467309083|FG001|Overall Study|Physician Decision|4|||
129821375|NCT00598832|467309082|FG000|Overall Study|Non compliance|1|||
129821376|NCT00598832|467309083|FG001|Overall Study|Non compliance|0|||
129821377|NCT02760069|467309084|FG000|Overall Study|Withdrawal by Subject|0|||
129821378|NCT02760069|467309085|FG001|Overall Study|Withdrawal by Subject|1|||
129821379|NCT02760069|467309086|FG002|Overall Study|Withdrawal by Subject|1|||
129821380|NCT02142959|467309096|FG000|Overall Study|Adverse Event|1|||
129821381|NCT02142959|467309097|FG001|Overall Study|Adverse Event|0|||
129821382|NCT02142959|467309098|FG002|Overall Study|Adverse Event|0|||
129821383|NCT02142959|467309096|FG000|Overall Study|Death|0|||
129821384|NCT02142959|467309097|FG001|Overall Study|Death|1|||
129821385|NCT02142959|467309098|FG002|Overall Study|Death|0|||
129821386|NCT02142959|467309096|FG000|Overall Study|Withdrawal by Subject|3|||
129821387|NCT02142959|467309097|FG001|Overall Study|Withdrawal by Subject|1|||
129821388|NCT02142959|467309098|FG002|Overall Study|Withdrawal by Subject|3|||
129821389|NCT02142959|467309096|FG000|Overall Study|Administrative Reasons|1|||
129821390|NCT02142959|467309097|FG001|Overall Study|Administrative Reasons|0|||
129821391|NCT02142959|467309098|FG002|Overall Study|Administrative Reasons|1|||
129821392|NCT02142959|467309096|FG000|Overall Study|Missing|0|||
129821393|NCT02142959|467309097|FG001|Overall Study|Missing|1|||
129821394|NCT02142959|467309098|FG002|Overall Study|Missing|0|||
129821395|NCT02142959|467309096|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
129821396|NCT02142959|467309097|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
129821397|NCT02142959|467309098|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
129821398|NCT02142959|467309096|FG000|Overall Study|Patient didn't complete end of study visit|0|||
129821399|NCT02142959|467309097|FG001|Overall Study|Patient didn't complete end of study visit|0|||
129821400|NCT02142959|467309098|FG002|Overall Study|Patient didn't complete end of study visit|1|||
129821401|NCT03547687|467309099|FG000|Overall Study|Withdrawal by Subject|1|||
129821402|NCT03547687|467309099|FG000|Overall Study|Death|1|||
129821403|NCT02547454|467309103|FG000|Overall Study|Due to hemodialysis|53|||
129821404|NCT02547454|467309103|FG000|Overall Study|Due to transplantation|1|||
129821405|NCT02547454|467309103|FG000|Overall Study|Due to no further need to treat|4|||
129821406|NCT02547454|467309103|FG000|Overall Study|Death|38|||
129821407|NCT02547454|467309103|FG000|Overall Study|Lost to Follow-up|26|||
129821408|NCT02547454|467309103|FG000|Overall Study|Other|39|||
129821409|NCT02547454|467309103|FG000|Overall Study|No data|11|||
129821410|NCT03694821|467309105|FG000|Overall Study|Study terminated|4|||
129821411|NCT03694821|467309106|FG001|Overall Study|Study terminated|8|||
129821412|NCT03694821|467309107|FG002|Overall Study|Study terminated|4|||
129821413|NCT00203996|467309108|FG000|Overall Study|Lost to Follow-up|0|||
129821414|NCT00203996|467309109|FG001|Overall Study|Lost to Follow-up|0|||
129821415|NCT00203996|467309110|FG002|Overall Study|Lost to Follow-up|0|||
129821416|NCT00203996|467309111|FG003|Overall Study|Lost to Follow-up|1|||
129821417|NCT00203996|467309112|FG004|Overall Study|Lost to Follow-up|0|||
129821418|NCT00203996|467309113|FG005|Overall Study|Lost to Follow-up|0|||
129821419|NCT00203996|467309114|FG006|Overall Study|Lost to Follow-up|0|||
129821420|NCT00203996|467309115|FG007|Overall Study|Lost to Follow-up|0|||
129897358|NCT00817635|467584334|FG000|Overall Study|Administrative Problems|0|||
129897359|NCT00817635|467584335|FG001|Overall Study|Administrative Problems|0|||
129897360|NCT00817635|467584336|FG002|Overall Study|Administrative Problems|0|||
129897361|NCT00817635|467584337|FG003|Overall Study|Administrative Problems|0|||
129897362|NCT00817635|467584338|FG004|Overall Study|Administrative Problems|1|||
129821421|NCT00203996|467309116|FG008|Overall Study|Lost to Follow-up|0|||
129897363|NCT00817635|467584334|FG000|Overall Study|Protocol Violation|5|||
129897364|NCT00817635|467584335|FG001|Overall Study|Protocol Violation|1|||
129821422|NCT00203996|467309117|FG009|Overall Study|Lost to Follow-up|0|||
129821423|NCT00203996|467309108|FG000|Overall Study|Protocol Violation|0|||
129821424|NCT00203996|467309109|FG001|Overall Study|Protocol Violation|0|||
129821425|NCT00203996|467309110|FG002|Overall Study|Protocol Violation|0|||
129821426|NCT00203996|467309111|FG003|Overall Study|Protocol Violation|6|||
129821427|NCT00203996|467309112|FG004|Overall Study|Protocol Violation|1|||
129821428|NCT00203996|467309113|FG005|Overall Study|Protocol Violation|0|||
129821429|NCT00203996|467309114|FG006|Overall Study|Protocol Violation|0|||
129821430|NCT00203996|467309115|FG007|Overall Study|Protocol Violation|0|||
129821431|NCT00203996|467309116|FG008|Overall Study|Protocol Violation|0|||
129821432|NCT00203996|467309117|FG009|Overall Study|Protocol Violation|0|||
129821433|NCT00203996|467309108|FG000|Overall Study|Physician Decision|0|||
129821434|NCT00203996|467309109|FG001|Overall Study|Physician Decision|0|||
129821435|NCT00203996|467309110|FG002|Overall Study|Physician Decision|0|||
129821436|NCT00203996|467309111|FG003|Overall Study|Physician Decision|2|||
129821437|NCT00203996|467309112|FG004|Overall Study|Physician Decision|0|||
129821438|NCT00203996|467309113|FG005|Overall Study|Physician Decision|0|||
129821439|NCT00203996|467309114|FG006|Overall Study|Physician Decision|0|||
129821440|NCT00203996|467309115|FG007|Overall Study|Physician Decision|0|||
129821441|NCT00203996|467309116|FG008|Overall Study|Physician Decision|0|||
129821442|NCT00203996|467309117|FG009|Overall Study|Physician Decision|1|||
129821443|NCT00203996|467309108|FG000|Overall Study|CPAP machine malfunction|0|||
129821444|NCT00203996|467309109|FG001|Overall Study|CPAP machine malfunction|0|||
129821445|NCT00203996|467309110|FG002|Overall Study|CPAP machine malfunction|0|||
129821446|NCT00203996|467309111|FG003|Overall Study|CPAP machine malfunction|1|||
129821447|NCT00203996|467309112|FG004|Overall Study|CPAP machine malfunction|0|||
129821448|NCT00203996|467309113|FG005|Overall Study|CPAP machine malfunction|0|||
129821449|NCT00203996|467309114|FG006|Overall Study|CPAP machine malfunction|0|||
129821450|NCT00203996|467309115|FG007|Overall Study|CPAP machine malfunction|0|||
129821451|NCT00203996|467309116|FG008|Overall Study|CPAP machine malfunction|0|||
129821452|NCT00203996|467309117|FG009|Overall Study|CPAP machine malfunction|0|||
129821453|NCT00203996|467309108|FG000|Overall Study|Scheduling issue|0|||
129821454|NCT00203996|467309109|FG001|Overall Study|Scheduling issue|0|||
129821455|NCT00203996|467309110|FG002|Overall Study|Scheduling issue|0|||
129821456|NCT00203996|467309111|FG003|Overall Study|Scheduling issue|0|||
129821457|NCT00203996|467309112|FG004|Overall Study|Scheduling issue|0|||
129821458|NCT00203996|467309113|FG005|Overall Study|Scheduling issue|0|||
129821459|NCT00203996|467309114|FG006|Overall Study|Scheduling issue|0|||
129821460|NCT00203996|467309115|FG007|Overall Study|Scheduling issue|2|||
129821461|NCT00203996|467309116|FG008|Overall Study|Scheduling issue|0|||
129821462|NCT00203996|467309117|FG009|Overall Study|Scheduling issue|0|||
129821463|NCT03064451|467309118|FG000|Overall Study|Lost to Follow-up|1|||
129821464|NCT03064451|467309118|FG000|Overall Study|Mapping Failure|4|||
129821465|NCT03064451|467309118|FG000|Overall Study|Exited prior to procedure|8|||
129821466|NCT03064451|467309118|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
129821467|NCT00750204|467309119|FG000|Overall Study|study halted prematurely|1|||
129821468|NCT00750204|467309120|FG001|Overall Study|study halted prematurely|1|||
129821469|NCT00850564|467309121|FG000|Overall Study|Withdrawal by Subject|2|||
129821470|NCT01774968|467309122|FG000|Overall Study|Adverse Event|4|||
129821471|NCT01774968|467309123|FG001|Overall Study|Adverse Event|4|||
129821472|NCT01774968|467309122|FG000|Overall Study|Death|0|||
129821473|NCT01774968|467309123|FG001|Overall Study|Death|1|||
129821474|NCT01774968|467309122|FG000|Overall Study|Lost to Follow-up|1|||
129821475|NCT01774968|467309123|FG001|Overall Study|Lost to Follow-up|3|||
129821476|NCT01774968|467309122|FG000|Overall Study|Physician Decision|5|||
129821477|NCT01774968|467309123|FG001|Overall Study|Physician Decision|1|||
129821478|NCT01774968|467309122|FG000|Overall Study|Protocol Violation|14|||
129821479|NCT01774968|467309123|FG001|Overall Study|Protocol Violation|13|||
129821480|NCT01774968|467309122|FG000|Overall Study|Sponsor Decision|0|||
129821481|NCT01774968|467309123|FG001|Overall Study|Sponsor Decision|2|||
129821482|NCT01774968|467309122|FG000|Overall Study|Withdrawal by Subject|6|||
129821483|NCT01774968|467309123|FG001|Overall Study|Withdrawal by Subject|11|||
129821484|NCT05355805|467309126|FG000|Overall Study|Lost to Follow-up|6|||
129897365|NCT00817635|467584336|FG002|Overall Study|Protocol Violation|3|||
129821485|NCT05355805|467309127|FG001|Overall Study|Lost to Follow-up|11|||
129821486|NCT05355805|467309128|FG002|Overall Study|Lost to Follow-up|10|||
129821487|NCT05355805|467309129|FG003|Overall Study|Lost to Follow-up|6|||
129821488|NCT05355805|467309126|FG000|Overall Study|Decision by Sponsor|0|||
129821489|NCT05355805|467309127|FG001|Overall Study|Decision by Sponsor|0|||
129821490|NCT05355805|467309128|FG002|Overall Study|Decision by Sponsor|1|||
129821491|NCT05355805|467309129|FG003|Overall Study|Decision by Sponsor|0|||
129821492|NCT05355805|467309126|FG000|Overall Study|Withdrawal by Subject|7|||
129821493|NCT05355805|467309127|FG001|Overall Study|Withdrawal by Subject|14|||
129821494|NCT05355805|467309128|FG002|Overall Study|Withdrawal by Subject|15|||
129821495|NCT05355805|467309129|FG003|Overall Study|Withdrawal by Subject|13|||
129821496|NCT02167893|467309130|FG000|Overall Study|Investigator transferred|85|||
129821497|NCT02167893|467309130|FG000|Overall Study|Investigator health reasons|10|||
129821498|NCT02167893|467309130|FG000|Overall Study|Case report forms not collected|68|||
129821499|NCT04818840|467309131|FG000|Overall Study|Lost to Follow-up|0|||
129821500|NCT04818840|467309132|FG001|Overall Study|Lost to Follow-up|5|||
129821501|NCT04818840|467309131|FG000|Overall Study|Physician Decision|1|||
129821502|NCT04818840|467309132|FG001|Overall Study|Physician Decision|0|||
129821503|NCT04818840|467309131|FG000|Overall Study|Site Terminated by Sponsor|0|||
129821504|NCT04818840|467309132|FG001|Overall Study|Site Terminated by Sponsor|3|||
129821505|NCT04818840|467309131|FG000|Overall Study|Study Terminated by Sponsor|43|||
129821506|NCT04818840|467309132|FG001|Overall Study|Study Terminated by Sponsor|7|||
129821507|NCT04818840|467309131|FG000|Overall Study|Withdrawal by Subject|0|||
129821508|NCT04818840|467309132|FG001|Overall Study|Withdrawal by Subject|1|||
129821509|NCT00524368|467310558|FG000|Overall Study|Adverse Event|10|||
129821510|NCT00524368|467310559|FG001|Overall Study|Adverse Event|12|||
129821511|NCT00524368|467310558|FG000|Overall Study|Lost to Follow-up|9|||
129821512|NCT00524368|467310559|FG001|Overall Study|Lost to Follow-up|13|||
129821513|NCT00524368|467310558|FG000|Overall Study|Withdrawal by Subject|4|||
129821514|NCT00524368|467310559|FG001|Overall Study|Withdrawal by Subject|5|||
129821515|NCT00524368|467310558|FG000|Overall Study|Non-compliant|8|||
130059554|NCT04804033|468172366|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
130059555|NCT04804033|468172367|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
130059556|NCT04804033|468172364|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
130059557|NCT04804033|468172365|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
130059558|NCT04804033|468172366|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
130059559|NCT04804033|468172367|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
130059560|NCT04804033|468172364|FG000|Period 2: OLE Phase|Adverse Event|3|||
130059561|NCT04804033|468172365|FG001|Period 2: OLE Phase|Adverse Event|4|||
130059562|NCT04804033|468172366|FG002|Period 2: OLE Phase|Adverse Event|2|||
130059563|NCT04804033|468172367|FG003|Period 2: OLE Phase|Adverse Event|0|||
130059564|NCT04804033|468172364|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
130059565|NCT04804033|468172365|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
130059566|NCT04804033|468172366|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
130059567|NCT04804033|468172367|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
130059568|NCT04804033|468172364|FG000|Period 2: OLE Phase|Non-compliance|2|||
130059569|NCT04804033|468172365|FG001|Period 2: OLE Phase|Non-compliance|2|||
130059570|NCT04804033|468172366|FG002|Period 2: OLE Phase|Non-compliance|0|||
130059571|NCT04804033|468172367|FG003|Period 2: OLE Phase|Non-compliance|1|||
130059572|NCT04804033|468172364|FG000|Period 2: OLE Phase|Other|0|||
130059573|NCT04804033|468172365|FG001|Period 2: OLE Phase|Other|2|||
130059574|NCT04804033|468172366|FG002|Period 2: OLE Phase|Other|0|||
130059575|NCT04804033|468172367|FG003|Period 2: OLE Phase|Other|0|||
130059576|NCT04804033|468172364|FG000|Period 2: OLE Phase|Physician Decision|1|||
129821516|NCT00524368|467310559|FG001|Overall Study|Non-compliant|9|||
129821517|NCT00524368|467310558|FG000|Overall Study|Reached a Virologic Endpoint|3|||
129821518|NCT00524368|467310559|FG001|Overall Study|Reached a Virologic Endpoint|2|||
129821519|NCT00524368|467310558|FG000|Overall Study|Sponsor's Decision|2|||
129821520|NCT00524368|467310559|FG001|Overall Study|Sponsor's Decision|0|||
129821521|NCT00524368|467310558|FG000|Overall Study|Ineligible to Continue the study|2|||
129821522|NCT00524368|467310559|FG001|Overall Study|Ineligible to Continue the study|5|||
129821523|NCT00524368|467310558|FG000|Overall Study|Other|3|||
129821524|NCT00524368|467310559|FG001|Overall Study|Other|2|||
129821525|NCT00793598|467310560|FG000|Overall Study|Patient Request|0|||
129821526|NCT00793598|467310561|FG001|Overall Study|Patient Request|1|||
129821527|NCT00793598|467310562|FG002|Overall Study|Patient Request|0|||
129821528|NCT00793598|467310563|FG003|Overall Study|Patient Request|0|||
129821529|NCT00793598|467310564|FG004|Overall Study|Patient Request|0|||
129821530|NCT00793598|467310565|FG005|Overall Study|Patient Request|0|||
129821531|NCT00793598|467310566|FG006|Overall Study|Patient Request|0|||
129821532|NCT00793598|467310567|FG007|Overall Study|Patient Request|0|||
129821533|NCT00793598|467310560|FG000|Overall Study|Protocol Violation|0|||
129821534|NCT00793598|467310561|FG001|Overall Study|Protocol Violation|0|||
129821535|NCT00793598|467310562|FG002|Overall Study|Protocol Violation|0|||
130059577|NCT04804033|468172365|FG001|Period 2: OLE Phase|Physician Decision|1|||
130059578|NCT04804033|468172366|FG002|Period 2: OLE Phase|Physician Decision|0|||
130059579|NCT04804033|468172367|FG003|Period 2: OLE Phase|Physician Decision|0|||
129821536|NCT00793598|467310563|FG003|Overall Study|Protocol Violation|0|||
129821537|NCT00793598|467310564|FG004|Overall Study|Protocol Violation|0|||
129821538|NCT00793598|467310565|FG005|Overall Study|Protocol Violation|0|||
129821539|NCT00793598|467310566|FG006|Overall Study|Protocol Violation|0|||
129821540|NCT00793598|467310567|FG007|Overall Study|Protocol Violation|1|||
129821541|NCT00793598|467310560|FG000|Overall Study|Subject not dosed|0|||
129821542|NCT00793598|467310561|FG001|Overall Study|Subject not dosed|0|||
129821543|NCT00793598|467310562|FG002|Overall Study|Subject not dosed|0|||
129821544|NCT00793598|467310563|FG003|Overall Study|Subject not dosed|0|||
129821545|NCT00793598|467310564|FG004|Overall Study|Subject not dosed|0|||
129821546|NCT00793598|467310565|FG005|Overall Study|Subject not dosed|1|||
129821547|NCT00793598|467310566|FG006|Overall Study|Subject not dosed|0|||
130059580|NCT04804033|468172364|FG000|Period 2: OLE Phase|Pregnancy|0|||
130059581|NCT04804033|468172365|FG001|Period 2: OLE Phase|Pregnancy|0|||
130059582|NCT04804033|468172366|FG002|Period 2: OLE Phase|Pregnancy|2|||
130059583|NCT04804033|468172367|FG003|Period 2: OLE Phase|Pregnancy|0|||
129821548|NCT00793598|467310567|FG007|Overall Study|Subject not dosed|0|||
129821549|NCT02373202|467310578|FG000|Overall Study|Adverse Event|2|||
129821550|NCT02373202|467310579|FG001|Overall Study|Adverse Event|5|||
129821551|NCT02373202|467310580|FG002|Overall Study|Adverse Event|2|||
129821552|NCT02373202|467310581|FG003|Overall Study|Adverse Event|1|||
129821553|NCT02373202|467310578|FG000|Overall Study|Lack of Efficacy|0|||
129821554|NCT02373202|467310579|FG001|Overall Study|Lack of Efficacy|0|||
129821555|NCT02373202|467310580|FG002|Overall Study|Lack of Efficacy|1|||
129821556|NCT02373202|467310581|FG003|Overall Study|Lack of Efficacy|0|||
129821557|NCT02373202|467310578|FG000|Overall Study|Other|0|||
129821558|NCT02373202|467310579|FG001|Overall Study|Other|1|||
129821559|NCT02373202|467310580|FG002|Overall Study|Other|0|||
129821560|NCT02373202|467310581|FG003|Overall Study|Other|0|||
129821561|NCT01411228|467310583|FG000|Overall Study|Lost to Follow-up|0|||
129821562|NCT01411228|467310584|FG001|Overall Study|Lost to Follow-up|0|||
129821563|NCT01411228|467310585|FG002|Overall Study|Lost to Follow-up|1|||
129821564|NCT01411228|467310583|FG000|Overall Study|Withdrawal by Subject|1|||
129821565|NCT01411228|467310584|FG001|Overall Study|Withdrawal by Subject|0|||
129821566|NCT01411228|467310585|FG002|Overall Study|Withdrawal by Subject|0|||
129821567|NCT02141282|467310586|FG000|Overall Study|Adverse event, not related to progression|8|||
129821568|NCT02141282|467310587|FG001|Overall Study|Adverse event, not related to progression|1|||
129821569|NCT02141282|467310588|FG002|Overall Study|Adverse event, not related to progression|3|||
129821570|NCT02141282|467310589|FG003|Overall Study|Adverse event, not related to progression|1|||
129821571|NCT02141282|467310586|FG000|Overall Study|Adverse event, related to progression|1|||
129821572|NCT02141282|467310587|FG001|Overall Study|Adverse event, related to progression|0|||
129821573|NCT02141282|467310588|FG002|Overall Study|Adverse event, related to progression|2|||
129821574|NCT02141282|467310589|FG003|Overall Study|Adverse event, related to progression|0|||
129821575|NCT02141282|467310586|FG000|Overall Study|COVID-19 infection|1|||
129821576|NCT02141282|467310587|FG001|Overall Study|COVID-19 infection|0|||
129821577|NCT02141282|467310588|FG002|Overall Study|COVID-19 infection|0|||
129821578|NCT02141282|467310589|FG003|Overall Study|COVID-19 infection|0|||
129821579|NCT02141282|467310586|FG000|Overall Study|Lost to Follow-up|0|||
129821580|NCT02141282|467310587|FG001|Overall Study|Lost to Follow-up|0|||
129821581|NCT02141282|467310588|FG002|Overall Study|Lost to Follow-up|4|||
129821582|NCT02141282|467310589|FG003|Overall Study|Lost to Follow-up|2|||
129821583|NCT02141282|467310586|FG000|Overall Study|Other, not specified|14|||
129821584|NCT02141282|467310587|FG001|Overall Study|Other, not specified|11|||
129821585|NCT02141282|467310588|FG002|Overall Study|Other, not specified|23|||
129821586|NCT02141282|467310589|FG003|Overall Study|Other, not specified|9|||
129821587|NCT02141282|467310586|FG000|Overall Study|Progressive disease, Richter's|4|||
129821588|NCT02141282|467310587|FG001|Overall Study|Progressive disease, Richter's|1|||
129821589|NCT02141282|467310588|FG002|Overall Study|Progressive disease, Richter's|1|||
129821590|NCT02141282|467310589|FG003|Overall Study|Progressive disease, Richter's|1|||
129821591|NCT02141282|467310586|FG000|Overall Study|Progressive disease per protocol|12|||
129821592|NCT02141282|467310587|FG001|Overall Study|Progressive disease per protocol|7|||
129821593|NCT02141282|467310588|FG002|Overall Study|Progressive disease per protocol|9|||
129821594|NCT02141282|467310589|FG003|Overall Study|Progressive disease per protocol|2|||
129821595|NCT02141282|467310586|FG000|Overall Study|Stem cell transplant|1|||
129821596|NCT02141282|467310587|FG001|Overall Study|Stem cell transplant|0|||
129821597|NCT02141282|467310588|FG002|Overall Study|Stem cell transplant|1|||
129821598|NCT02141282|467310589|FG003|Overall Study|Stem cell transplant|0|||
129821599|NCT02141282|467310586|FG000|Overall Study|Study terminated by Sponsor|0|||
129821600|NCT02141282|467310587|FG001|Overall Study|Study terminated by Sponsor|1|||
129821601|NCT02141282|467310588|FG002|Overall Study|Study terminated by Sponsor|0|||
129821602|NCT02141282|467310589|FG003|Overall Study|Study terminated by Sponsor|0|||
129821603|NCT02141282|467310586|FG000|Overall Study|Subject non-compliance|0|||
129821604|NCT02141282|467310587|FG001|Overall Study|Subject non-compliance|0|||
129821605|NCT02141282|467310588|FG002|Overall Study|Subject non-compliance|1|||
129821606|NCT02141282|467310589|FG003|Overall Study|Subject non-compliance|0|||
129821607|NCT02141282|467310586|FG000|Overall Study|Withdrew consent|2|||
129821608|NCT02141282|467310587|FG001|Overall Study|Withdrew consent|0|||
129821609|NCT02141282|467310588|FG002|Overall Study|Withdrew consent|4|||
129821610|NCT02141282|467310589|FG003|Overall Study|Withdrew consent|0|||
129821611|NCT01752907|467310592|FG000|Overall Study|Withdrawal by Subject|4|||
129821612|NCT01752907|467310593|FG001|Overall Study|Withdrawal by Subject|10|||
129821613|NCT01752907|467310592|FG000|Overall Study|Lost to Follow-up|2|||
129821614|NCT01752907|467310593|FG001|Overall Study|Lost to Follow-up|1|||
129821615|NCT01752907|467310592|FG000|Overall Study|Decision by Sponsor|6|||
129821616|NCT01752907|467310593|FG001|Overall Study|Decision by Sponsor|9|||
129821617|NCT02670083|467310600|FG000|Overall Study|Adverse Event|16|||
129821618|NCT02670083|467310601|FG001|Overall Study|Adverse Event|13|||
129821619|NCT02670083|467310600|FG000|Overall Study|Death|4|||
129821620|NCT02670083|467310601|FG001|Overall Study|Death|6|||
129821621|NCT02670083|467310600|FG000|Overall Study|Lost to Follow-up|2|||
129821622|NCT02670083|467310601|FG001|Overall Study|Lost to Follow-up|2|||
129821623|NCT02670083|467310600|FG000|Overall Study|Multiple Reasons|9|||
129897366|NCT00817635|467584337|FG003|Overall Study|Protocol Violation|2|||
130059584|NCT04804033|468172364|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
130059585|NCT04804033|468172365|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
130059586|NCT04804033|468172366|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
130059587|NCT04804033|468172367|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
130059588|NCT04804033|468172364|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
130059589|NCT04804033|468172365|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
130059590|NCT04804033|468172366|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
130059591|NCT04804033|468172367|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
130059592|NCT04804033|468172364|FG000|Period 2: OLE Phase|Not reported|0|||
130059593|NCT04804033|468172365|FG001|Period 2: OLE Phase|Not reported|2|||
130059594|NCT04804033|468172366|FG002|Period 2: OLE Phase|Not reported|0|||
130059595|NCT04804033|468172367|FG003|Period 2: OLE Phase|Not reported|0|||
130059596|NCT04804033|468172364|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
130059597|NCT04804033|468172365|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
130059598|NCT04804033|468172366|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
130059599|NCT04804033|468172367|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
130059600|NCT04804033|468172364|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
130059601|NCT04804033|468172365|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
130059602|NCT04804033|468172366|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
130059603|NCT04804033|468172367|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
130059604|NCT04804033|468172364|FG000|Period 3: Follow-up Phase|Other|0|||
130059605|NCT04804033|468172365|FG001|Period 3: Follow-up Phase|Other|1|||
130059606|NCT04804033|468172366|FG002|Period 3: Follow-up Phase|Other|2|||
130059607|NCT04804033|468172367|FG003|Period 3: Follow-up Phase|Other|1|||
129821624|NCT02670083|467310601|FG001|Overall Study|Multiple Reasons|9|||
129821625|NCT02670083|467310600|FG000|Overall Study|Physician Decision|0|||
129821626|NCT02670083|467310601|FG001|Overall Study|Physician Decision|2|||
129821627|NCT02670083|467310600|FG000|Overall Study|Study Terminated By Sponsor|257|||
129821628|NCT02670083|467310601|FG001|Overall Study|Study Terminated By Sponsor|254|||
129821629|NCT02670083|467310600|FG000|Overall Study|Symptomatic Deterioration|0|||
129821630|NCT02670083|467310601|FG001|Overall Study|Symptomatic Deterioration|2|||
129821631|NCT02670083|467310600|FG000|Overall Study|Withdrawal by Subject|32|||
129821632|NCT02670083|467310601|FG001|Overall Study|Withdrawal by Subject|31|||
129821633|NCT02670083|467310600|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129821634|NCT02670083|467310601|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129821635|NCT02057406|467310603|FG000|Overall Study|Physician Decision|0|||
129821636|NCT02057406|467310604|FG001|Overall Study|Physician Decision|0|||
129821637|NCT02057406|467310605|FG002|Overall Study|Physician Decision|2|||
129821638|NCT02057406|467310603|FG000|Overall Study|Withdrawal by Subject|0|||
129821639|NCT02057406|467310604|FG001|Overall Study|Withdrawal by Subject|2|||
129821640|NCT02057406|467310605|FG002|Overall Study|Withdrawal by Subject|0|||
129821641|NCT02057406|467310603|FG000|Overall Study|Lost to Follow-up|0|||
129821642|NCT02057406|467310604|FG001|Overall Study|Lost to Follow-up|0|||
129821643|NCT02057406|467310605|FG002|Overall Study|Lost to Follow-up|1|||
129821644|NCT02057406|467310603|FG000|Overall Study|Death|1|||
129821645|NCT02057406|467310604|FG001|Overall Study|Death|0|||
129821646|NCT02057406|467310605|FG002|Overall Study|Death|0|||
129821647|NCT02057406|467310603|FG000|Overall Study|Protocol Violation|0|||
129897367|NCT00817635|467584338|FG004|Overall Study|Protocol Violation|3|||
129897368|NCT01020838|467584343|FG000|Overall Study|Death|90|||
129897369|NCT01020838|467584343|FG000|Overall Study|Adverse Event|1|||
129897370|NCT01020838|467584343|FG000|Overall Study|Withdrawal by Subject|9|||
129897371|NCT01020838|467584343|FG000|Overall Study|Lost to Follow-up|6|||
129897372|NCT01020838|467584343|FG000|Overall Study|Most common: Study ended by sponsor|77|||
129897373|NCT01167426|467584344|FG000|Overall Study|Lost to Follow-up|6|||
129897374|NCT01167426|467584344|FG000|Overall Study|Protocol Violation|1|||
129897375|NCT01167426|467584344|FG000|Overall Study|Withdrawal by Subject|2|||
129897376|NCT01167426|467584344|FG000|Overall Study|Sponsor Decision|1|||
129897377|NCT02993471|467584345|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
129897378|NCT02993471|467584345|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
129897379|NCT01908634|467584347|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
129897380|NCT01908634|467584347|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
129897381|NCT04176458|467584348|FG000|Overall Study|Covid 19|4|||
129897382|NCT01570751|467584349|FG000|Period A (16 Weeks)|Protocol Violation|1|||
130059608|NCT04804033|468172364|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
129821648|NCT02057406|467310604|FG001|Overall Study|Protocol Violation|1|||
129821649|NCT02057406|467310605|FG002|Overall Study|Protocol Violation|0|||
129821650|NCT02057406|467310603|FG000|Overall Study|Patient transportation issues|0|||
129821651|NCT02057406|467310604|FG001|Overall Study|Patient transportation issues|0|||
129897383|NCT01570751|467584350|FG001|Period A (16 Weeks)|Protocol Violation|1|||
129897384|NCT01570751|467584349|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
129897385|NCT01570751|467584350|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
129897386|NCT01570751|467584349|FG000|Period A (16 Weeks)|Unclassified|2|||
129897387|NCT01570751|467584350|FG001|Period A (16 Weeks)|Unclassified|3|||
130059609|NCT04804033|468172365|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
129821652|NCT02057406|467310605|FG002|Overall Study|Patient transportation issues|1|||
129821653|NCT02425046|467310606|FG000|Overall Study|Lost to Follow-up|52|||
129821654|NCT02425046|467310607|FG001|Overall Study|Lost to Follow-up|50|||
129821655|NCT02425046|467310608|FG002|Overall Study|Lost to Follow-up|56|||
129821656|NCT02425046|467310606|FG000|Overall Study|Withdrawal by Subject|16|||
129821657|NCT02425046|467310607|FG001|Overall Study|Withdrawal by Subject|12|||
129821658|NCT02425046|467310608|FG002|Overall Study|Withdrawal by Subject|0|||
129821659|NCT03654651|467310609|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129821660|NCT03654651|467310610|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
129821661|NCT02904512|467310615|FG000|Overall Study|Withdrawal by Subject|1|||
129821662|NCT02904512|467310616|FG001|Overall Study|Withdrawal by Subject|0|||
129821663|NCT02904512|467310615|FG000|Overall Study|Transferred to ICU|1|||
129821664|NCT02904512|467310616|FG001|Overall Study|Transferred to ICU|0|||
129821665|NCT02904512|467310615|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
129821666|NCT02904512|467310616|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
129821667|NCT00267046|467310623|FG000|Overall Study|Disease progression|4|||
129821668|NCT00267046|467310624|FG001|Overall Study|Disease progression|2|||
129821669|NCT00267046|467310623|FG000|Overall Study|Chemotoxicity|2|||
129821670|NCT00267046|467310624|FG001|Overall Study|Chemotoxicity|0|||
129821671|NCT00267046|467310623|FG000|Overall Study|Open-label palifermin|2|||
129821672|NCT00267046|467310624|FG001|Overall Study|Open-label palifermin|7|||
129821673|NCT00267046|467310623|FG000|Overall Study|Surgery|3|||
129821674|NCT00267046|467310624|FG001|Overall Study|Surgery|1|||
129821675|NCT00267046|467310623|FG000|Overall Study|Withdrawal by Subject|1|||
129821676|NCT00267046|467310624|FG001|Overall Study|Withdrawal by Subject|0|||
129821677|NCT00267046|467310623|FG000|Overall Study|Radiation|0|||
129821678|NCT00267046|467310624|FG001|Overall Study|Radiation|1|||
129821679|NCT00460408|467310625|FG000|Overall Study|Adverse Event|1|||
129821680|NCT00460408|467310626|FG001|Overall Study|Adverse Event|0|||
129821681|NCT00460408|467310627|FG002|Overall Study|Adverse Event|0|||
129821682|NCT00460408|467310628|FG003|Overall Study|Adverse Event|0|||
129821683|NCT00460408|467310625|FG000|Overall Study|Death|7|||
129821684|NCT00460408|467310626|FG001|Overall Study|Death|0|||
129821685|NCT00460408|467310627|FG002|Overall Study|Death|0|||
129821686|NCT00460408|467310628|FG003|Overall Study|Death|0|||
129821687|NCT00460408|467310625|FG000|Overall Study|Lost to Follow-up|11|||
129821688|NCT00460408|467310626|FG001|Overall Study|Lost to Follow-up|0|||
129821689|NCT00460408|467310627|FG002|Overall Study|Lost to Follow-up|1|||
129821690|NCT00460408|467310628|FG003|Overall Study|Lost to Follow-up|0|||
129821691|NCT00460408|467310625|FG000|Overall Study|Withdrawal by Subject|31|||
129821692|NCT00460408|467310626|FG001|Overall Study|Withdrawal by Subject|0|||
129821693|NCT00460408|467310627|FG002|Overall Study|Withdrawal by Subject|0|||
129821694|NCT00460408|467310628|FG003|Overall Study|Withdrawal by Subject|0|||
129821695|NCT00460408|467310625|FG000|Overall Study|Insufficient clinical response|5|||
129821696|NCT00460408|467310626|FG001|Overall Study|Insufficient clinical response|1|||
129821697|NCT00460408|467310627|FG002|Overall Study|Insufficient clinical response|5|||
129821698|NCT00460408|467310628|FG003|Overall Study|Insufficient clinical response|0|||
129821699|NCT00460408|467310625|FG000|Overall Study|Other|12|||
129821700|NCT00460408|467310626|FG001|Overall Study|Other|2|||
129821701|NCT00460408|467310627|FG002|Overall Study|Other|0|||
129821702|NCT00460408|467310628|FG003|Overall Study|Other|0|||
129821703|NCT01986985|467310629|FG000|Overall Study|Withdrawal by Subject|4|||
129821704|NCT01986985|467310629|FG000|Overall Study|Scan not completed due to malfunction|3|||
129821705|NCT02288559|467310631|FG000|Overall Study|Adverse Event|1|||
129821706|NCT02288559|467310632|FG001|Overall Study|Adverse Event|1|||
130059610|NCT04804033|468172366|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
129821707|NCT02288559|467310633|FG002|Overall Study|Adverse Event|5|||
129821708|NCT02288559|467310634|FG003|Overall Study|Adverse Event|0|||
129821709|NCT02288559|467310631|FG000|Overall Study|Death|0|||
130059611|NCT04804033|468172367|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
129821710|NCT02288559|467310632|FG001|Overall Study|Death|0|||
129821711|NCT02288559|467310633|FG002|Overall Study|Death|1|||
129821712|NCT02288559|467310634|FG003|Overall Study|Death|0|||
129821713|NCT02288559|467310631|FG000|Overall Study|Lost to Follow-up|0|||
129821714|NCT02288559|467310632|FG001|Overall Study|Lost to Follow-up|0|||
129821715|NCT02288559|467310633|FG002|Overall Study|Lost to Follow-up|0|||
129821716|NCT02288559|467310634|FG003|Overall Study|Lost to Follow-up|1|||
129821717|NCT02288559|467310631|FG000|Overall Study|Withdrawal by Subject|0|||
129821718|NCT02288559|467310632|FG001|Overall Study|Withdrawal by Subject|0|||
129821719|NCT02288559|467310633|FG002|Overall Study|Withdrawal by Subject|2|||
129821720|NCT02288559|467310634|FG003|Overall Study|Withdrawal by Subject|1|||
129821721|NCT02288559|467310631|FG000|Overall Study|Reason Not Specified|0|||
129821722|NCT02288559|467310632|FG001|Overall Study|Reason Not Specified|0|||
129821723|NCT02288559|467310633|FG002|Overall Study|Reason Not Specified|3|||
129821724|NCT02288559|467310634|FG003|Overall Study|Reason Not Specified|0|||
129821725|NCT03303079|467310635|FG000|Overall Study|Adverse Event|0|||
129821726|NCT03303079|467310636|FG001|Overall Study|Adverse Event|1|||
129821727|NCT03303079|467310637|FG002|Overall Study|Adverse Event|3|||
129821728|NCT03303079|467310635|FG000|Overall Study|Protocol Violation|5|||
129821729|NCT03303079|467310636|FG001|Overall Study|Protocol Violation|4|||
129821730|NCT03303079|467310637|FG002|Overall Study|Protocol Violation|7|||
129821731|NCT03303079|467310635|FG000|Overall Study|Withdrawal by Subject|2|||
129821732|NCT03303079|467310636|FG001|Overall Study|Withdrawal by Subject|4|||
129821733|NCT03303079|467310637|FG002|Overall Study|Withdrawal by Subject|2|||
129821734|NCT03303079|467310635|FG000|Overall Study|Other than specified|0|||
129821735|NCT03303079|467310636|FG001|Overall Study|Other than specified|2|||
129821736|NCT03303079|467310637|FG002|Overall Study|Other than specified|0|||
129821737|NCT02005445|467310638|FG000|Overall Study|Dual study enrollment|0|||
129821738|NCT02005445|467310639|FG001|Overall Study|Dual study enrollment|1|||
129821739|NCT01111149|467310640|FG000|Overall Study|Protocol Violation|1|||
129821740|NCT01111149|467310641|FG001|Overall Study|Protocol Violation|1|||
129821741|NCT01111149|467310642|FG002|Overall Study|Protocol Violation|2|||
129821742|NCT01111149|467310640|FG000|Overall Study|Withdrawal by Subject|1|||
129821743|NCT01111149|467310641|FG001|Overall Study|Withdrawal by Subject|0|||
129821744|NCT01111149|467310642|FG002|Overall Study|Withdrawal by Subject|2|||
129821745|NCT00759954|467310643|FG000|Overall Study|Personal reason|1|||
129821746|NCT00759954|467310644|FG001|Overall Study|Personal reason|0|||
129821747|NCT00759954|467310643|FG000|Overall Study|Adverse Event|1|||
129821748|NCT00759954|467310644|FG001|Overall Study|Adverse Event|2|||
129821749|NCT00137046|467310652|FG000|Overall Study|Death|2|||
129821750|NCT00137046|467310653|FG001|Overall Study|Death|1|||
129821751|NCT00137046|467310652|FG000|Overall Study|Adverse Event|16|||
129821752|NCT00137046|467310653|FG001|Overall Study|Adverse Event|5|||
129821753|NCT00137046|467310652|FG000|Overall Study|Laboratory Abnormality|2|||
129821754|NCT00137046|467310653|FG001|Overall Study|Laboratory Abnormality|0|||
129821755|NCT00137046|467310652|FG000|Overall Study|Lack of Efficacy|13|||
129821756|NCT00137046|467310653|FG001|Overall Study|Lack of Efficacy|1|||
129821757|NCT00137046|467310652|FG000|Overall Study|Lost to Follow-up|8|||
129821758|NCT00137046|467310653|FG001|Overall Study|Lost to Follow-up|24|||
129821759|NCT00137046|467310652|FG000|Overall Study|Other|23|||
129821760|NCT00137046|467310653|FG001|Overall Study|Other|19|||
129821761|NCT00137046|467310652|FG000|Overall Study|Withdrawal by Subject|33|||
129821762|NCT00137046|467310653|FG001|Overall Study|Withdrawal by Subject|42|||
129821763|NCT00137046|467310652|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
129821764|NCT00137046|467310653|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
129821765|NCT00137046|467310652|FG000|Overall Study|Withdrew prior to study treatment|1|||
129821766|NCT00137046|467310653|FG001|Overall Study|Withdrew prior to study treatment|1|||
129821767|NCT00160251|467310654|FG000|Prior to Amendment 2|Adverse Event|2|||
129821768|NCT00160251|467310655|FG001|Prior to Amendment 2|Adverse Event|1|||
129821769|NCT00160251|467310656|FG002|Prior to Amendment 2|Adverse Event|3|||
129821770|NCT00160251|467310657|FG003|Prior to Amendment 2|Adverse Event|1|||
129821771|NCT00160251|467310658|FG004|Prior to Amendment 2|Adverse Event|1|||
129821772|NCT00160251|467310659|FG005|Prior to Amendment 2|Adverse Event|1|||
129821773|NCT00160251|467310660|FG006|Prior to Amendment 2|Adverse Event|1|||
129821774|NCT00160251|467310661|FG007|Prior to Amendment 2|Adverse Event|0|||
129821775|NCT00160251|467310654|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
129821776|NCT00160251|467310655|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
129821777|NCT00160251|467310656|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
129821778|NCT00160251|467310657|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
129821779|NCT00160251|467310658|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
129821780|NCT00160251|467310659|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
129821781|NCT00160251|467310660|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
129821782|NCT00160251|467310661|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
129821783|NCT00160251|467310654|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
129821784|NCT00160251|467310655|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
129821785|NCT00160251|467310656|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
129821786|NCT00160251|467310657|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
129821787|NCT00160251|467310658|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
129821788|NCT00160251|467310659|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
129821789|NCT00160251|467310660|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
129821790|NCT00160251|467310661|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
129821791|NCT00160251|467310654|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
129821792|NCT00160251|467310655|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
129821793|NCT00160251|467310656|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
129821794|NCT00160251|467310657|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
129897388|NCT01570751|467584349|FG000|Period B (16 Weeks)|Adverse Event|1|||
129897389|NCT01570751|467584350|FG001|Period B (16 Weeks)|Adverse Event|0|||
130059612|NCT04804033|468172364|FG000|Period 3: Follow-up Phase|Not reported|18|||
129821795|NCT00160251|467310658|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
129821796|NCT00160251|467310659|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
129821797|NCT00160251|467310660|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
129821798|NCT00160251|467310661|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
129821799|NCT00160251|467310654|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
129821800|NCT00160251|467310655|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
129821801|NCT00160251|467310656|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
129821802|NCT00160251|467310657|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
129821803|NCT00160251|467310658|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
129821804|NCT00160251|467310659|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
129821805|NCT00160251|467310660|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
129821806|NCT00160251|467310661|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
129821807|NCT00160251|467310654|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
129821808|NCT00160251|467310655|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
129821809|NCT00160251|467310656|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
129821810|NCT00160251|467310657|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
129821811|NCT00160251|467310658|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
129821812|NCT00160251|467310659|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
129821813|NCT00160251|467310660|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
129821814|NCT00160251|467310661|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
129821815|NCT00160251|467310654|FG000|Post-amendment 2|Adverse Event|0|||
129821816|NCT00160251|467310655|FG001|Post-amendment 2|Adverse Event|0|||
129821817|NCT00160251|467310656|FG002|Post-amendment 2|Adverse Event|0|||
129821818|NCT00160251|467310657|FG003|Post-amendment 2|Adverse Event|0|||
129821819|NCT00160251|467310658|FG004|Post-amendment 2|Adverse Event|0|||
129821820|NCT00160251|467310659|FG005|Post-amendment 2|Adverse Event|0|||
129821821|NCT00160251|467310660|FG006|Post-amendment 2|Adverse Event|0|||
129821822|NCT00160251|467310661|FG007|Post-amendment 2|Adverse Event|20|||
129821823|NCT00160251|467310654|FG000|Post-amendment 2|Lack of Efficacy|0|||
129821824|NCT00160251|467310655|FG001|Post-amendment 2|Lack of Efficacy|0|||
129821825|NCT00160251|467310656|FG002|Post-amendment 2|Lack of Efficacy|0|||
129821826|NCT00160251|467310657|FG003|Post-amendment 2|Lack of Efficacy|0|||
129821827|NCT00160251|467310658|FG004|Post-amendment 2|Lack of Efficacy|0|||
129821828|NCT00160251|467310659|FG005|Post-amendment 2|Lack of Efficacy|0|||
129821829|NCT00160251|467310660|FG006|Post-amendment 2|Lack of Efficacy|0|||
129821830|NCT00160251|467310661|FG007|Post-amendment 2|Lack of Efficacy|24|||
129821831|NCT00160251|467310654|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821832|NCT00160251|467310655|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821833|NCT00160251|467310656|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821834|NCT00160251|467310657|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821835|NCT00160251|467310658|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821836|NCT00160251|467310659|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821837|NCT00160251|467310660|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821838|NCT00160251|467310661|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
129821839|NCT02730455|467310663|FG000|Overall Study|Death|5|||
129821840|NCT02730455|467310664|FG001|Overall Study|Death|6|||
129821841|NCT02730455|467310665|FG002|Overall Study|Death|4|||
129821842|NCT02730455|467310663|FG000|Overall Study|Consent withdrawn|2|||
129821843|NCT02730455|467310664|FG001|Overall Study|Consent withdrawn|4|||
129821844|NCT02730455|467310665|FG002|Overall Study|Consent withdrawn|1|||
129821845|NCT02730455|467310663|FG000|Overall Study|Lost to Follow-up|3|||
129821846|NCT02730455|467310664|FG001|Overall Study|Lost to Follow-up|1|||
129821847|NCT02730455|467310665|FG002|Overall Study|Lost to Follow-up|4|||
129821848|NCT02730455|467310663|FG000|Overall Study|Other|1|||
129821849|NCT02730455|467310664|FG001|Overall Study|Other|1|||
129821850|NCT02730455|467310665|FG002|Overall Study|Other|2|||
129821851|NCT02730455|467310663|FG000|Overall Study|Other|2|||
129821852|NCT02730455|467310664|FG001|Overall Study|Other|2|||
129821853|NCT02730455|467310665|FG002|Overall Study|Other|0|||
129821854|NCT01018186|467310672|FG000|2-week Run-in Period|Protocol Violation|1|||
129821855|NCT01018186|467310673|FG001|2-week Run-in Period|Protocol Violation|0|||
129821856|NCT01018186|467310674|FG002|2-week Run-in Period|Protocol Violation|0|||
129821857|NCT01018186|467310675|FG003|2-week Run-in Period|Protocol Violation|0|||
129821858|NCT01018186|467310672|FG000|2-week Run-in Period|Lost to Follow-up|2|||
129821859|NCT01018186|467310673|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129821860|NCT01018186|467310674|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129821861|NCT01018186|467310675|FG003|2-week Run-in Period|Lost to Follow-up|0|||
129821862|NCT01018186|467310672|FG000|2-week Run-in Period|Physician Decision|3|||
129897390|NCT01570751|467584349|FG000|Period B (16 Weeks)|Protocol Violation|0|||
129897391|NCT01570751|467584350|FG001|Period B (16 Weeks)|Protocol Violation|1|||
129897392|NCT00588666|467584352|FG000|Overall Study|Adverse Event|4|||
129821863|NCT01018186|467310673|FG001|2-week Run-in Period|Physician Decision|0|||
129821864|NCT01018186|467310674|FG002|2-week Run-in Period|Physician Decision|0|||
129821865|NCT01018186|467310675|FG003|2-week Run-in Period|Physician Decision|0|||
129821866|NCT01018186|467310672|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
129821867|NCT01018186|467310673|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129821868|NCT01018186|467310674|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129821869|NCT01018186|467310675|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
129821870|NCT01018186|467310672|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
129897393|NCT04582877|467584357|FG000|Overall Study|Did not use device measurement|5|||
129897394|NCT04582877|467584357|FG000|Overall Study|No fractional flow reserve test results|2|||
129821871|NCT01018186|467310673|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129821872|NCT01018186|467310674|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129821873|NCT01018186|467310675|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129821874|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
129821875|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
129821876|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
129821877|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
129821878|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
129821879|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
129821880|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
129821881|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
129821882|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
129821883|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
129821884|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
129821885|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
129821886|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
129821887|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
129821888|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
129821889|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
129821890|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
129821891|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
129821892|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
129821893|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
129821894|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
129821895|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
129821896|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
129821897|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
129821898|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129821899|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
129821900|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
129821901|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
129821902|NCT03049280|467310676|FG000|Overall Study|Physician Decision|1|||
129821903|NCT03552198|467310677|FG000|Overall Study|Lost to Follow-up|42|||
129821904|NCT03552198|467310678|FG001|Overall Study|Lost to Follow-up|48|||
129821905|NCT03552198|467310679|FG002|Overall Study|Lost to Follow-up|15|||
129821906|NCT03552198|467310680|FG003|Overall Study|Lost to Follow-up|19|||
129821907|NCT03552198|467310677|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
129821908|NCT03552198|467310678|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
129821909|NCT03552198|467310679|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
129821910|NCT03552198|467310680|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
129821911|NCT03552198|467310677|FG000|Overall Study|Did not receive air alerts|1|||
129821912|NCT03552198|467310678|FG001|Overall Study|Did not receive air alerts|0|||
129821913|NCT03552198|467310679|FG002|Overall Study|Did not receive air alerts|0|||
129821914|NCT03552198|467310680|FG003|Overall Study|Did not receive air alerts|1|||
129821915|NCT03235154|467310681|FG000|Overall Study|Withdrawal by Subject|1|||
129821916|NCT03235154|467310681|FG000|Overall Study|Adverse Event|1|||
129821917|NCT03235154|467310681|FG000|Overall Study|Lost to Follow-up|2|||
129821918|NCT00276744|467310682|FG000|PART A|Reason unknown|98|||
129821919|NCT00640601|467310688|FG000|Overall Study|Adverse Event|43|||
129821920|NCT00640601|467310688|FG000|Overall Study|Withdrawal by Subject|20|||
129821921|NCT00640601|467310688|FG000|Overall Study|Protocol Violation|6|||
129821922|NCT00640601|467310688|FG000|Overall Study|Lack of Efficacy|16|||
129821923|NCT00640601|467310688|FG000|Overall Study|Lost to Follow-up|9|||
129821924|NCT00640601|467310688|FG000|Overall Study|Physician Decision|8|||
129821925|NCT00640601|467310688|FG000|Overall Study|treatment naive, combination therapy|10|||
129821926|NCT03681405|467310689|FG000|Overall Study|Found to be ineligible after randomized|1|||
129821927|NCT03681405|467310690|FG001|Overall Study|Found to be ineligible after randomized|0|||
129821928|NCT03978520|467310691|FG000|Overall Study|Adverse Event|2|||
129821929|NCT03978520|467310692|FG001|Overall Study|Adverse Event|5|||
129821930|NCT03978520|467310693|FG002|Overall Study|Adverse Event|3|||
129821931|NCT03978520|467310694|FG003|Overall Study|Adverse Event|5|||
129821932|NCT03978520|467310695|FG004|Overall Study|Adverse Event|6|||
129821933|NCT03978520|467310691|FG000|Overall Study|Withdrawal by Subject|10|||
129821934|NCT03978520|467310692|FG001|Overall Study|Withdrawal by Subject|4|||
129821935|NCT03978520|467310693|FG002|Overall Study|Withdrawal by Subject|5|||
129821936|NCT03978520|467310694|FG003|Overall Study|Withdrawal by Subject|6|||
129821937|NCT03978520|467310695|FG004|Overall Study|Withdrawal by Subject|5|||
129821938|NCT03978520|467310691|FG000|Overall Study|Lost to Follow-up|2|||
129821939|NCT03978520|467310692|FG001|Overall Study|Lost to Follow-up|2|||
129897395|NCT04582877|467584357|FG000|Overall Study|Protocol Violation|1|||
129897396|NCT04012853|467584358|FG000|Overall Study|Withdrawal by Subject|1|||
129821940|NCT03978520|467310693|FG002|Overall Study|Lost to Follow-up|2|||
129821941|NCT03978520|467310694|FG003|Overall Study|Lost to Follow-up|0|||
129821942|NCT03978520|467310695|FG004|Overall Study|Lost to Follow-up|1|||
129821943|NCT03978520|467310691|FG000|Overall Study|COVID-19 infection|0|||
129821944|NCT03978520|467310692|FG001|Overall Study|COVID-19 infection|1|||
129821945|NCT03978520|467310693|FG002|Overall Study|COVID-19 infection|0|||
129821946|NCT03978520|467310694|FG003|Overall Study|COVID-19 infection|0|||
129821947|NCT03978520|467310695|FG004|Overall Study|COVID-19 infection|0|||
129821948|NCT03978520|467310691|FG000|Overall Study|Other, not specified|9|||
129821949|NCT03978520|467310692|FG001|Overall Study|Other, not specified|4|||
129821950|NCT03978520|467310693|FG002|Overall Study|Other, not specified|1|||
129821951|NCT03978520|467310694|FG003|Overall Study|Other, not specified|1|||
129821952|NCT03978520|467310695|FG004|Overall Study|Other, not specified|2|||
129821953|NCT03978520|467310691|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
129821954|NCT03978520|467310692|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
129821955|NCT03978520|467310693|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
129821956|NCT03978520|467310694|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
129821957|NCT03978520|467310695|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
129821958|NCT02860169|467310696|FG000|Part A|Withdrawal by Subject|1|||
129821959|NCT02860169|467310696|FG000|Part A|Other (Screening failure)|6|||
129821960|NCT02860169|467310696|FG000|Part A|Other (Survey not completed)|3|||
129821961|NCT02860169|467310696|FG000|Part A|Other (did not completed consent)|1|||
129821962|NCT02860169|467310696|FG000|Part B|Other (Screening failure)|10|||
129821963|NCT02860169|467310696|FG000|Part B|Withdrawal by Subject|1|||
129821964|NCT02860169|467310696|FG000|Part C|Other (Screening failure)|1|||
129821965|NCT01648205|467310699|FG000|Placebo|Pregnancy|1|||
129821966|NCT01648205|467310699|FG000|Placebo|Withdrawal by Subject|1|||
129821967|NCT01648205|467310699|FG000|Placebo|Protocol Violation|2|||
129821968|NCT01648205|467310699|FG000|Ranolazine|Death|1|||
129821969|NCT01648205|467310699|FG000|Ranolazine|Withdrawal by Subject|1|||
129821970|NCT01648205|467310699|FG000|Ranolazine|Protocol Violation|3|||
129821971|NCT03667924|467310702|FG000|Baseline Completed|Lost to Follow-up|0|||
129821972|NCT03667924|467310703|FG001|Baseline Completed|Lost to Follow-up|2|||
129821973|NCT03667924|467310704|FG002|Baseline Completed|Lost to Follow-up|0|||
129821974|NCT03667924|467310702|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
129821975|NCT03667924|467310703|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
129821976|NCT03667924|467310704|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
129821977|NCT03667924|467310702|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
129821978|NCT03667924|467310703|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
129821979|NCT03667924|467310704|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
129821980|NCT03667924|467310702|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
129821981|NCT03667924|467310703|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
129821982|NCT03667924|467310704|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
129821983|NCT03667924|467310702|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
129821984|NCT03667924|467310703|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
129821985|NCT03667924|467310704|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
129821986|NCT03667924|467310702|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
129821987|NCT03667924|467310703|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
129821988|NCT03667924|467310704|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
129821989|NCT03667924|467310702|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
129821990|NCT03667924|467310703|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
129821991|NCT03667924|467310704|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
129821992|NCT04557371|467310710|FG000|Overall Study|Covid-19-related|0|||
129821993|NCT04557371|467310711|FG001|Overall Study|Covid-19-related|1|||
129821994|NCT04557371|467310712|FG002|Overall Study|Covid-19-related|0|||
129821995|NCT04557371|467310710|FG000|Overall Study|Withdrawal by Subject|0|||
129821996|NCT04557371|467310711|FG001|Overall Study|Withdrawal by Subject|1|||
129821997|NCT04557371|467310712|FG002|Overall Study|Withdrawal by Subject|0|||
129821998|NCT04557371|467310710|FG000|Overall Study|Adverse Event|1|||
129821999|NCT04557371|467310711|FG001|Overall Study|Adverse Event|0|||
129822000|NCT04557371|467310712|FG002|Overall Study|Adverse Event|0|||
129822001|NCT00897104|467310715|FG000|Overall Study|Lost to Follow-up|12|||
129822002|NCT00897104|467310716|FG001|Overall Study|Lost to Follow-up|17|||
129822003|NCT00897104|467310717|FG002|Overall Study|Lost to Follow-up|2|||
129822004|NCT00897104|467310715|FG000|Overall Study|Pregnancy|0|||
129822005|NCT00897104|467310716|FG001|Overall Study|Pregnancy|1|||
129822006|NCT00897104|467310717|FG002|Overall Study|Pregnancy|0|||
129822007|NCT00897104|467310715|FG000|Overall Study|Protocol Violation|0|||
129822008|NCT00897104|467310716|FG001|Overall Study|Protocol Violation|1|||
129822009|NCT00897104|467310717|FG002|Overall Study|Protocol Violation|0|||
129822010|NCT00897104|467310715|FG000|Overall Study|Withdrawal by Subject|23|||
130059613|NCT04804033|468172365|FG001|Period 3: Follow-up Phase|Not reported|15|||
130059614|NCT04804033|468172366|FG002|Period 3: Follow-up Phase|Not reported|1|||
130059615|NCT04804033|468172367|FG003|Period 3: Follow-up Phase|Not reported|4|||
130059616|NCT00209170|468172368|FG000|Overall Study|Adverse Event|0|||
130059617|NCT00209170|468172369|FG001|Overall Study|Adverse Event|1|||
129822011|NCT00897104|467310716|FG001|Overall Study|Withdrawal by Subject|27|||
129822012|NCT00897104|467310717|FG002|Overall Study|Withdrawal by Subject|3|||
129822013|NCT00897104|467310715|FG000|Overall Study|Abnormal Prestudy Labs|2|||
129822014|NCT00897104|467310716|FG001|Overall Study|Abnormal Prestudy Labs|0|||
129822015|NCT00897104|467310717|FG002|Overall Study|Abnormal Prestudy Labs|0|||
129822016|NCT00897104|467310715|FG000|Overall Study|Abnormal Baseline ECG|2|||
129822017|NCT00897104|467310716|FG001|Overall Study|Abnormal Baseline ECG|2|||
129822018|NCT00897104|467310717|FG002|Overall Study|Abnormal Baseline ECG|0|||
129822019|NCT00897104|467310715|FG000|Overall Study|Need for Concom. Med.|0|||
129822020|NCT00897104|467310716|FG001|Overall Study|Need for Concom. Med.|1|||
129822021|NCT00897104|467310717|FG002|Overall Study|Need for Concom. Med.|1|||
129822022|NCT00897104|467310715|FG000|Overall Study|Lack of Migraine Attack|20|||
129822023|NCT00897104|467310716|FG001|Overall Study|Lack of Migraine Attack|22|||
129822024|NCT00897104|467310717|FG002|Overall Study|Lack of Migraine Attack|1|||
129822025|NCT00897104|467310715|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129822026|NCT00897104|467310716|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129822027|NCT00897104|467310717|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129822028|NCT00897104|467310715|FG000|Overall Study|Other|3|||
129822029|NCT00897104|467310716|FG001|Overall Study|Other|0|||
129822030|NCT00897104|467310717|FG002|Overall Study|Other|0|||
129822031|NCT00897104|467310715|FG000|Overall Study|Protocol Violation|1|||
129822032|NCT00897104|467310716|FG001|Overall Study|Protocol Violation|0|||
129822033|NCT00897104|467310717|FG002|Overall Study|Protocol Violation|0|||
129822034|NCT00897104|467310715|FG000|Overall Study|Withdrawal by Subject|0|||
129822035|NCT00897104|467310716|FG001|Overall Study|Withdrawal by Subject|0|||
129822036|NCT00897104|467310717|FG002|Overall Study|Withdrawal by Subject|1|||
129822037|NCT00477971|467310718|FG000|Overall Study|Disease progression|6|||
129822038|NCT00477971|467310719|FG001|Overall Study|Disease progression|0|||
129822039|NCT00477971|467310718|FG000|Overall Study|Withdrawal by Subject|3|||
129822040|NCT00477971|467310719|FG001|Overall Study|Withdrawal by Subject|1|||
129822041|NCT00477971|467310718|FG000|Overall Study|Adverse Event|3|||
129822042|NCT00477971|467310719|FG001|Overall Study|Adverse Event|0|||
129822043|NCT00477971|467310718|FG000|Overall Study|Death|2|||
129822044|NCT00477971|467310719|FG001|Overall Study|Death|4|||
129822045|NCT00477971|467310718|FG000|Overall Study|Alternative treatment|3|||
129822046|NCT00477971|467310719|FG001|Overall Study|Alternative treatment|1|||
129822047|NCT00531232|467313180|FG000|Overall Study|Investigator decision|0|||
129822048|NCT00531232|467313181|FG001|Overall Study|Investigator decision|0|||
129822049|NCT00531232|467313182|FG002|Overall Study|Investigator decision|4|||
129822050|NCT00531232|467313180|FG000|Overall Study|Participants refused further treatment|0|||
129822051|NCT00531232|467313181|FG001|Overall Study|Participants refused further treatment|1|||
129822052|NCT00531232|467313182|FG002|Overall Study|Participants refused further treatment|2|||
129822053|NCT00531232|467313180|FG000|Overall Study|Adverse events (AEs)|1|||
129822054|NCT00531232|467313181|FG001|Overall Study|Adverse events (AEs)|2|||
129822055|NCT00531232|467313182|FG002|Overall Study|Adverse events (AEs)|2|||
129822056|NCT00531232|467313180|FG000|Overall Study|Treatment failure|1|||
129822057|NCT00531232|467313181|FG001|Overall Study|Treatment failure|3|||
129822058|NCT00531232|467313182|FG002|Overall Study|Treatment failure|7|||
129822059|NCT00531232|467313180|FG000|Overall Study|Disease recurrence|0|||
129822060|NCT00531232|467313181|FG001|Overall Study|Disease recurrence|0|||
129822061|NCT00531232|467313182|FG002|Overall Study|Disease recurrence|1|||
129822062|NCT00531232|467313180|FG000|Overall Study|Deceased|2|||
129822063|NCT00531232|467313181|FG001|Overall Study|Deceased|2|||
129822064|NCT00531232|467313182|FG002|Overall Study|Deceased|2|||
129822065|NCT00531232|467313180|FG000|Overall Study|Withdrawal by Subject|0|||
129822066|NCT00531232|467313181|FG001|Overall Study|Withdrawal by Subject|1|||
130059618|NCT00209170|468172368|FG000|Overall Study|Withdrawal by Subject|2|||
129822067|NCT00531232|467313182|FG002|Overall Study|Withdrawal by Subject|2|||
129822068|NCT00531232|467313180|FG000|Overall Study|Other|0|||
129822069|NCT00531232|467313181|FG001|Overall Study|Other|0|||
129822070|NCT00531232|467313182|FG002|Overall Study|Other|5|||
129822071|NCT02345850|467313188|FG000|Overall Study|Not transplanted|10|||
129822072|NCT02345850|467313189|FG001|Overall Study|Not transplanted|5|||
129822073|NCT02345850|467313190|FG002|Overall Study|Not transplanted|4|||
129822074|NCT02345850|467313188|FG000|Overall Study|Lost to Follow-up|2|||
129822075|NCT02345850|467313189|FG001|Overall Study|Lost to Follow-up|3|||
129822076|NCT02345850|467313190|FG002|Overall Study|Lost to Follow-up|2|||
129822077|NCT02345850|467313188|FG000|Overall Study|Withdrawal by Subject|1|||
129822078|NCT02345850|467313189|FG001|Overall Study|Withdrawal by Subject|0|||
129822079|NCT02345850|467313190|FG002|Overall Study|Withdrawal by Subject|0|||
129822080|NCT01991067|467313197|FG000|Overall Study|Lost to Follow-up|6|||
130059619|NCT00209170|468172369|FG001|Overall Study|Withdrawal by Subject|1|||
130059620|NCT00209170|468172368|FG000|Overall Study|Lack of Efficacy|0|||
129822081|NCT01991067|467313198|FG001|Overall Study|Lost to Follow-up|5|||
129822082|NCT00464087|467313202|FG000|Overall Study|No PCI per inclusion criteria|0|||
129822083|NCT00464087|467313203|FG001|Overall Study|No PCI per inclusion criteria|0|||
129822084|NCT00464087|467313204|FG002|Overall Study|No PCI per inclusion criteria|29|||
129822085|NCT00609492|467313205|FG000|Overall Study|Withdrawal by Subject|0|||
129822086|NCT00609492|467313206|FG001|Overall Study|Withdrawal by Subject|2|||
129822087|NCT00609492|467313207|FG002|Overall Study|Withdrawal by Subject|3|||
129822088|NCT00609492|467313205|FG000|Overall Study|Lost to Follow-up|1|||
129822089|NCT00609492|467313206|FG001|Overall Study|Lost to Follow-up|1|||
129822090|NCT00609492|467313207|FG002|Overall Study|Lost to Follow-up|4|||
129822091|NCT00418314|467313208|FG000|Overall Study|Withdrawal by Subject|1|||
129822092|NCT00418314|467313209|FG001|Overall Study|Withdrawal by Subject|2|||
129822093|NCT02692716|467313210|FG000|Overall Study|Lost to Follow-up|2|||
129822094|NCT02692716|467313211|FG001|Overall Study|Lost to Follow-up|5|||
129822095|NCT02692716|467313210|FG000|Overall Study|Withdrawal by Subject|3|||
129822096|NCT02692716|467313211|FG001|Overall Study|Withdrawal by Subject|1|||
129822097|NCT02782780|467313216|FG000|Overall Study|dropped out after randomization.|7|||
129822098|NCT02782780|467313217|FG001|Overall Study|dropped out after randomization.|5|||
129822099|NCT02782780|467313216|FG000|Overall Study|Protocol Violation|0|||
129822100|NCT02782780|467313217|FG001|Overall Study|Protocol Violation|2|||
129822101|NCT03562481|467313218|FG000|First Intervention|Lost to Follow-up|1|||
129822102|NCT03562481|467313219|FG001|First Intervention|Lost to Follow-up|0|||
129822103|NCT00856284|467313220|FG000|Overall Study|Hyperglycemic rescue|231|||
129822104|NCT00856284|467313221|FG001|Overall Study|Hyperglycemic rescue|201|||
129822105|NCT00856284|467313222|FG002|Overall Study|Hyperglycemic rescue|235|||
129822106|NCT00856284|467313220|FG000|Overall Study|Adverse Event|60|||
129822107|NCT00856284|467313221|FG001|Overall Study|Adverse Event|74|||
129822108|NCT00856284|467313222|FG002|Overall Study|Adverse Event|82|||
129822109|NCT00856284|467313220|FG000|Overall Study|Major protocol deviation|24|||
129822110|NCT00856284|467313221|FG001|Overall Study|Major protocol deviation|16|||
129822111|NCT00856284|467313222|FG002|Overall Study|Major protocol deviation|15|||
129822112|NCT00856284|467313220|FG000|Overall Study|Lost to Follow-up|20|||
129822113|NCT00856284|467313221|FG001|Overall Study|Lost to Follow-up|22|||
129822114|NCT00856284|467313222|FG002|Overall Study|Lost to Follow-up|28|||
129822115|NCT00856284|467313220|FG000|Overall Study|Voluntary withdrawal|48|||
129822116|NCT00856284|467313221|FG001|Overall Study|Voluntary withdrawal|52|||
129822117|NCT00856284|467313222|FG002|Overall Study|Voluntary withdrawal|62|||
129822118|NCT00856284|467313220|FG000|Overall Study|Pregnancy|1|||
130059621|NCT00209170|468172369|FG001|Overall Study|Lack of Efficacy|1|||
130059622|NCT00543569|468172370|FG000|Overall Study|Death|2|||
130059623|NCT00543569|468172371|FG001|Overall Study|Death|2|||
130059624|NCT00543569|468172372|FG002|Overall Study|Death|3|||
130059625|NCT00543569|468172373|FG003|Overall Study|Death|1|||
130059626|NCT00543569|468172370|FG000|Overall Study|Lost to Follow-up|0|||
130059627|NCT00543569|468172371|FG001|Overall Study|Lost to Follow-up|0|||
130059628|NCT00543569|468172372|FG002|Overall Study|Lost to Follow-up|1|||
130059629|NCT00543569|468172373|FG003|Overall Study|Lost to Follow-up|1|||
130059630|NCT00543569|468172370|FG000|Overall Study|Miscellaneous Reasons|7|||
129822119|NCT00856284|467313221|FG001|Overall Study|Pregnancy|2|||
129822120|NCT00856284|467313222|FG002|Overall Study|Pregnancy|0|||
129822121|NCT00856284|467313220|FG000|Overall Study|Investigator discretion|9|||
129822122|NCT00856284|467313221|FG001|Overall Study|Investigator discretion|8|||
129822123|NCT00856284|467313222|FG002|Overall Study|Investigator discretion|10|||
129822124|NCT00856284|467313220|FG000|Overall Study|Other|15|||
129822125|NCT00856284|467313221|FG001|Overall Study|Other|17|||
129822126|NCT00856284|467313222|FG002|Overall Study|Other|14|||
130059631|NCT00543569|468172371|FG001|Overall Study|Miscellaneous Reasons|3|||
130059632|NCT00543569|468172372|FG002|Overall Study|Miscellaneous Reasons|11|||
129822127|NCT00856284|467313220|FG000|Overall Study|Randomized in error|0|||
129822128|NCT00856284|467313221|FG001|Overall Study|Randomized in error|0|||
129822129|NCT00856284|467313222|FG002|Overall Study|Randomized in error|1|||
129822130|NCT03247530|467313226|FG000|Overall Study|Withdrawal by caregiver|19|||
129822131|NCT03247530|467313227|FG001|Overall Study|Withdrawal by caregiver|8|||
129822132|NCT03247530|467313228|FG002|Overall Study|Withdrawal by caregiver|10|||
129822133|NCT03247530|467313226|FG000|Overall Study|Lost to Follow-up|3|||
129822134|NCT03247530|467313227|FG001|Overall Study|Lost to Follow-up|9|||
129822135|NCT03247530|467313228|FG002|Overall Study|Lost to Follow-up|6|||
129822136|NCT03247530|467313226|FG000|Overall Study|Adverse Event|2|||
129822137|NCT03247530|467313227|FG001|Overall Study|Adverse Event|5|||
129822138|NCT03247530|467313228|FG002|Overall Study|Adverse Event|2|||
129822139|NCT03247530|467313226|FG000|Overall Study|Failure to follow procedure|1|||
129822140|NCT03247530|467313227|FG001|Overall Study|Failure to follow procedure|1|||
129822141|NCT03247530|467313228|FG002|Overall Study|Failure to follow procedure|1|||
129822142|NCT03247530|467313226|FG000|Overall Study|Withdrawal by Subject|1|||
129822143|NCT03247530|467313227|FG001|Overall Study|Withdrawal by Subject|1|||
129822144|NCT03247530|467313228|FG002|Overall Study|Withdrawal by Subject|0|||
130059633|NCT00543569|468172373|FG003|Overall Study|Miscellaneous Reasons|4|||
130059634|NCT00543569|468172370|FG000|Overall Study|Randomized but never received study drug|3|||
129822145|NCT03247530|467313226|FG000|Overall Study|Study medication misuse|0|||
129822146|NCT03247530|467313227|FG001|Overall Study|Study medication misuse|1|||
129822147|NCT03247530|467313228|FG002|Overall Study|Study medication misuse|0|||
129822148|NCT03247530|467313226|FG000|Overall Study|Other, multiple categories|1|||
129822149|NCT03247530|467313227|FG001|Overall Study|Other, multiple categories|3|||
129822150|NCT03247530|467313228|FG002|Overall Study|Other, multiple categories|1|||
129822151|NCT01442493|467313232|FG000|Overall Study|withdrawn from study|3|||
129822152|NCT01442493|467313233|FG001|Overall Study|withdrawn from study|2|||
129822153|NCT03315208|467313235|FG000|Overall Study|Lost to Follow-up|11|||
129822154|NCT03315208|467313236|FG001|Overall Study|Lost to Follow-up|6|||
129822155|NCT03315208|467313235|FG000|Overall Study|Withdrawal by Subject|2|||
129822156|NCT03315208|467313236|FG001|Overall Study|Withdrawal by Subject|0|||
129822157|NCT02875860|467313237|FG000|Overall Study|Withdrawal by Subject|0|||
129822158|NCT02875860|467313238|FG001|Overall Study|Withdrawal by Subject|1|||
129822159|NCT02320149|467313239|FG000|Overall Study|Adverse Event|3|||
129822160|NCT02320149|467313240|FG001|Overall Study|Adverse Event|7|||
129822161|NCT02320149|467313239|FG000|Overall Study|Withdrawal of Consent|28|||
129822162|NCT02320149|467313240|FG001|Overall Study|Withdrawal of Consent|32|||
129822163|NCT02320149|467313239|FG000|Overall Study|Lost to Follow-up|21|||
129822164|NCT02320149|467313240|FG001|Overall Study|Lost to Follow-up|34|||
129822165|NCT02320149|467313239|FG000|Overall Study|Protocol Violation|2|||
129822166|NCT02320149|467313240|FG001|Overall Study|Protocol Violation|1|||
129822167|NCT02320149|467313239|FG000|Overall Study|Noncompliance with Study Treatment|7|||
129822168|NCT02320149|467313240|FG001|Overall Study|Noncompliance with Study Treatment|2|||
129822169|NCT02320149|467313239|FG000|Overall Study|Lack of Efficacy|0|||
129822170|NCT02320149|467313240|FG001|Overall Study|Lack of Efficacy|1|||
129822171|NCT02320149|467313239|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129822172|NCT02320149|467313240|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129822173|NCT01156311|467313244|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
129822174|NCT01156311|467313245|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
129822175|NCT01156311|467313246|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
129822176|NCT01156311|467313247|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
129822177|NCT01156311|467313244|FG000|2-Month Monotherapy Period|Physician Decision|0|||
129822178|NCT01156311|467313245|FG001|2-Month Monotherapy Period|Physician Decision|1|||
129822179|NCT01156311|467313246|FG002|2-Month Monotherapy Period|Physician Decision|0|||
129822180|NCT01156311|467313247|FG003|2-Month Monotherapy Period|Physician Decision|0|||
129822181|NCT01156311|467313244|FG000|2-Month Monotherapy Period|Other|1|||
129822182|NCT01156311|467313245|FG001|2-Month Monotherapy Period|Other|0|||
129822183|NCT01156311|467313246|FG002|2-Month Monotherapy Period|Other|0|||
129822184|NCT01156311|467313247|FG003|2-Month Monotherapy Period|Other|0|||
129822185|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
129822186|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
129822187|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
129822188|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
129822189|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
129822190|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
129822191|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
129822192|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
129822193|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
129822194|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
129822195|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
129822196|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
129822197|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
129822198|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
129822199|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
129822200|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
129822201|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Other|0|||
129822202|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Other|0|||
129822203|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Other|1|||
129822204|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Other|2|||
129822205|NCT01741701|467313248|FG000|Overall Study|Adverse Event|5|||
129822206|NCT01741701|467313249|FG001|Overall Study|Adverse Event|1|||
129822207|NCT01741701|467313248|FG000|Overall Study|Withdrawal by Subject|0|||
129822208|NCT01741701|467313249|FG001|Overall Study|Withdrawal by Subject|1|||
129822209|NCT01359449|467313254|FG000|Overall Study|Lost to Follow-up|1|||
129822210|NCT01359449|467313255|FG001|Overall Study|Lost to Follow-up|0|||
129822211|NCT01359449|467313254|FG000|Overall Study|Protocol Violation|0|||
129822212|NCT01359449|467313255|FG001|Overall Study|Protocol Violation|2|||
129822213|NCT01359449|467313254|FG000|Overall Study|Withdrawal by Subject|3|||
129822214|NCT01359449|467313255|FG001|Overall Study|Withdrawal by Subject|2|||
130112635|NCT00606684|468373424|FG004|Double-Blind Treatment Period|Physician Decision|3|||
129822215|NCT00372112|467313256|FG000|Overall Study|Adverse Event|0|||
129822216|NCT00372112|467313257|FG001|Overall Study|Adverse Event|1|||
129822217|NCT00372112|467313258|FG002|Overall Study|Adverse Event|1|||
129822218|NCT00372112|467313259|FG003|Overall Study|Adverse Event|1|||
129822219|NCT00372112|467313256|FG000|Overall Study|Withdrawal by Subject|0|||
129822220|NCT00372112|467313257|FG001|Overall Study|Withdrawal by Subject|0|||
129822221|NCT00372112|467313258|FG002|Overall Study|Withdrawal by Subject|2|||
129822222|NCT00372112|467313259|FG003|Overall Study|Withdrawal by Subject|1|||
129822223|NCT00372112|467313256|FG000|Overall Study|Exacerbation|0|||
129822224|NCT00372112|467313257|FG001|Overall Study|Exacerbation|0|||
129822225|NCT00372112|467313258|FG002|Overall Study|Exacerbation|0|||
129822226|NCT00372112|467313259|FG003|Overall Study|Exacerbation|1|||
129822227|NCT00372112|467313256|FG000|Overall Study|PR >240 at Visit 3|0|||
129822228|NCT00372112|467313257|FG001|Overall Study|PR >240 at Visit 3|0|||
129822229|NCT00372112|467313258|FG002|Overall Study|PR >240 at Visit 3|0|||
129822230|NCT00372112|467313259|FG003|Overall Study|PR >240 at Visit 3|1|||
129822231|NCT00372112|467313256|FG000|Overall Study|Hepatitis B|1|||
129822232|NCT00372112|467313257|FG001|Overall Study|Hepatitis B|0|||
129822233|NCT00372112|467313258|FG002|Overall Study|Hepatitis B|0|||
129822234|NCT00372112|467313259|FG003|Overall Study|Hepatitis B|0|||
129822235|NCT00372112|467313256|FG000|Overall Study|Other-protocol violation|0|||
129822236|NCT00372112|467313257|FG001|Overall Study|Other-protocol violation|0|||
130059635|NCT00543569|468172371|FG001|Overall Study|Randomized but never received study drug|3|||
130059636|NCT00543569|468172372|FG002|Overall Study|Randomized but never received study drug|5|||
130059637|NCT00543569|468172373|FG003|Overall Study|Randomized but never received study drug|3|||
130059638|NCT03150095|468172374|FG000|Overall Study|Death|0|||
130059639|NCT03150095|468172375|FG001|Overall Study|Death|1|||
130059640|NCT03150095|468172374|FG000|Overall Study|Lost to Follow-up|1|||
130059641|NCT03150095|468172375|FG001|Overall Study|Lost to Follow-up|1|||
130059642|NCT03150095|468172374|FG000|Overall Study|Withdrawal by Subject|4|||
130059643|NCT03150095|468172375|FG001|Overall Study|Withdrawal by Subject|0|||
130059644|NCT03150095|468172374|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
130059645|NCT03150095|468172375|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
130059646|NCT02124707|468172376|FG000|Overall Study|Adverse Event|5|||
130059647|NCT02124707|468172376|FG000|Overall Study|Physician Decision|1|||
130059648|NCT02124707|468172376|FG000|Overall Study|Death|1|||
130059649|NCT00089479|468172385|FG000|Overall Study|Death|108|||
129822237|NCT00372112|467313258|FG002|Overall Study|Other-protocol violation|1|||
129822238|NCT00372112|467313259|FG003|Overall Study|Other-protocol violation|0|||
129822239|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
129822240|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
129822241|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
129822242|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
129822243|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
129822244|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
129822245|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
129822246|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
129822247|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Patient Request|1|||
129822248|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Patient Request|0|||
129822249|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
129822250|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
129822251|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Other|1|||
129822252|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Other|0|||
129822253|NCT04649060|467313274|FG000|Crossover (Arm B)|Adverse Event|0|||
129822254|NCT04649060|467313275|FG001|Crossover (Arm B)|Adverse Event|1|||
129822255|NCT04649060|467313274|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
129822256|NCT04649060|467313275|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
129822257|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
129822258|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
129822259|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
129822260|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
129822261|NCT03033394|467313276|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
129822262|NCT02036294|467313277|FG000|Overall Study|Death|7|||
129822263|NCT02036294|467313278|FG001|Overall Study|Death|8|||
129822264|NCT02036294|467313277|FG000|Overall Study|Withdrawal by Subject|2|||
129822265|NCT02036294|467313278|FG001|Overall Study|Withdrawal by Subject|3|||
129822266|NCT01830972|467313279|FG000|Part II|Withdrawal by Subject|2|||
129822267|NCT01830972|467313280|FG001|Part II|Withdrawal by Subject|2|||
129822268|NCT01830972|467313279|FG000|Part III|Withdrawal by Subject|1|||
129822269|NCT01830972|467313280|FG001|Part III|Withdrawal by Subject|0|||
129822270|NCT01830972|467313279|FG000|Part III|Noncompliance|1|||
129822271|NCT01830972|467313280|FG001|Part III|Noncompliance|0|||
129822272|NCT01830972|467313279|FG000|Part IV|Withdrawal by Subject|2|||
129822273|NCT01830972|467313280|FG001|Part IV|Withdrawal by Subject|1|||
129822274|NCT01830972|467313279|FG000|Part IV|Non-Compliance|1|||
129822275|NCT01830972|467313280|FG001|Part IV|Non-Compliance|0|||
130059650|NCT00089479|468172386|FG001|Overall Study|Death|75|||
130059651|NCT00089479|468172385|FG000|Overall Study|Withdrawal by Subject|86|||
130059652|NCT00089479|468172386|FG001|Overall Study|Withdrawal by Subject|107|||
130059653|NCT00089479|468172385|FG000|Overall Study|Lost to Follow-up|137|||
129822276|NCT01426373|467313284|FG000|Overall Study|Adverse Event|6|||
129822277|NCT01426373|467313284|FG000|Overall Study|Lost to Follow-up|14|||
129822278|NCT01426373|467313284|FG000|Overall Study|Participant Convenience|10|||
129822279|NCT01426373|467313284|FG000|Overall Study|Miscellaneous Reasons|4|||
129822280|NCT04952402|467313285|FG000|Overall Study|Lost to Follow-up|1|||
129822281|NCT04952402|467313286|FG001|Overall Study|Lost to Follow-up|3|||
129822282|NCT04952402|467313285|FG000|Overall Study|Lack Of Venous Access|0|||
129822283|NCT04952402|467313286|FG001|Overall Study|Lack Of Venous Access|1|||
129822284|NCT00726661|467313287|FG000|Overall Study|Lost to Follow-up|36|||
129822285|NCT00726661|467313288|FG001|Overall Study|Lost to Follow-up|11|||
129822286|NCT00726661|467313287|FG000|Overall Study|Withdrawal by Subject|17|||
129822287|NCT00726661|467313288|FG001|Overall Study|Withdrawal by Subject|13|||
129822288|NCT00726661|467313287|FG000|Overall Study|Trial terminated by sponsor|214|||
129822289|NCT00726661|467313288|FG001|Overall Study|Trial terminated by sponsor|187|||
129822290|NCT00726661|467313287|FG000|Overall Study|Death|475|||
129822291|NCT00726661|467313288|FG001|Overall Study|Death|159|||
129822292|NCT00726661|467313287|FG000|Overall Study|Physician Decision|25|||
129822293|NCT00726661|467313288|FG001|Overall Study|Physician Decision|13|||
129822294|NCT00726661|467313287|FG000|Overall Study|Other|47|||
129822295|NCT00726661|467313288|FG001|Overall Study|Other|35|||
129822296|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
129822297|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
129822298|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
129822299|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
129822300|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
129822301|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
129822302|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
129822303|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
129822304|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
129822305|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
129822306|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
129822307|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
129822308|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
129822309|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
129822310|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
129822311|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
129822312|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
129822313|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
129822314|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
129822315|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
129822316|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
129822317|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
129822318|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
129822319|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
129822320|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
129822321|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
129822322|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
129822323|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
129822324|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
129822325|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
129822326|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
129822327|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
129822328|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
129822329|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
129822330|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
129822331|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
129822332|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
129822333|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
129822334|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
129822335|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
129822336|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
129822337|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
129822338|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
129822339|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
129822340|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
129822341|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
129822342|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
129897397|NCT04012853|467584359|FG001|Overall Study|Withdrawal by Subject|1|||
129822343|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
129822344|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
129822345|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
129822346|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
129822347|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
129822348|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
129822349|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
129822350|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
129822351|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
129822352|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
129822353|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
129822354|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
129822355|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
129822356|NCT01574326|467313294|FG000|Overall Study|Randomized but not treated|0|||
129822357|NCT01574326|467313295|FG001|Overall Study|Randomized but not treated|1|||
129822358|NCT01574326|467313294|FG000|Overall Study|Withdrawal by Participant|2|||
129822359|NCT01574326|467313295|FG001|Overall Study|Withdrawal by Participant|4|||
129822360|NCT01574326|467313294|FG000|Overall Study|Physician Decision|5|||
129822361|NCT01574326|467313295|FG001|Overall Study|Physician Decision|3|||
129822362|NCT01574326|467313294|FG000|Overall Study|Adverse Event|1|||
129822363|NCT01574326|467313295|FG001|Overall Study|Adverse Event|3|||
129822364|NCT01574326|467313294|FG000|Overall Study|Other: Mainly kidney transplant|8|||
129822365|NCT01574326|467313295|FG001|Overall Study|Other: Mainly kidney transplant|8|||
129822366|NCT04997161|467313318|FG000|Overall Study|Study terminated by sponsor|3|||
129822367|NCT00005937|467313319|FG000|Overall Study|Lack of Efficacy|5|||
129822368|NCT01574612|467313320|FG000|Overall Study|Adverse Event|3|||
129822369|NCT01574612|467313320|FG000|Overall Study|non compliant with drug|2|||
129822370|NCT01574612|467313320|FG000|Overall Study|Withdrawal by Subject|1|||
129822371|NCT01574612|467313320|FG000|Overall Study|Lost to Follow-up|2|||
129822372|NCT02407704|467313323|FG000|Overall Study|Lost to Follow-up|0|||
129822373|NCT02407704|467313324|FG001|Overall Study|Lost to Follow-up|0|||
129822374|NCT02407704|467313325|FG002|Overall Study|Lost to Follow-up|0|||
129822375|NCT02407704|467313326|FG003|Overall Study|Lost to Follow-up|2|||
129822376|NCT02407704|467313323|FG000|Overall Study|Protocol Violation|0|||
129822377|NCT02407704|467313324|FG001|Overall Study|Protocol Violation|0|||
129822378|NCT02407704|467313325|FG002|Overall Study|Protocol Violation|0|||
129822379|NCT02407704|467313326|FG003|Overall Study|Protocol Violation|1|||
129822380|NCT02407704|467313323|FG000|Overall Study|Withdrawal by Subject|0|||
129822381|NCT02407704|467313324|FG001|Overall Study|Withdrawal by Subject|0|||
129822382|NCT02407704|467313325|FG002|Overall Study|Withdrawal by Subject|1|||
129822383|NCT02407704|467313326|FG003|Overall Study|Withdrawal by Subject|0|||
129822384|NCT01957644|467313329|FG000|Overall Study|Adverse Event|4|||
129822385|NCT01957644|467313330|FG001|Overall Study|Adverse Event|2|||
129822386|NCT01957644|467313331|FG002|Overall Study|Adverse Event|0|||
129822387|NCT01957644|467313332|FG003|Overall Study|Adverse Event|0|||
129822388|NCT01957644|467313333|FG004|Overall Study|Adverse Event|1|||
129822389|NCT01957644|467313329|FG000|Overall Study|Progressive disease / relapse|0|||
129822390|NCT01957644|467313330|FG001|Overall Study|Progressive disease / relapse|1|||
129822391|NCT01957644|467313331|FG002|Overall Study|Progressive disease / relapse|0|||
129822392|NCT01957644|467313332|FG003|Overall Study|Progressive disease / relapse|1|||
129822393|NCT01957644|467313333|FG004|Overall Study|Progressive disease / relapse|0|||
129822394|NCT01957644|467313329|FG000|Overall Study|Other reason|1|||
129822395|NCT01957644|467313330|FG001|Overall Study|Other reason|2|||
129822396|NCT01957644|467313331|FG002|Overall Study|Other reason|1|||
129822397|NCT01957644|467313332|FG003|Overall Study|Other reason|1|||
129822398|NCT01957644|467313333|FG004|Overall Study|Other reason|0|||
129822399|NCT01957644|467313329|FG000|Overall Study|Withdrawal by Subject|1|||
129822400|NCT01957644|467313330|FG001|Overall Study|Withdrawal by Subject|0|||
129822401|NCT01957644|467313331|FG002|Overall Study|Withdrawal by Subject|0|||
129822402|NCT01957644|467313332|FG003|Overall Study|Withdrawal by Subject|0|||
129822403|NCT01957644|467313333|FG004|Overall Study|Withdrawal by Subject|0|||
129822404|NCT01957644|467313329|FG000|Overall Study|Protocol Violation|0|||
129822405|NCT01957644|467313330|FG001|Overall Study|Protocol Violation|1|||
129822406|NCT01957644|467313331|FG002|Overall Study|Protocol Violation|0|||
129897398|NCT04012853|467584358|FG000|Overall Study|Protocol Violation|1|||
129897399|NCT04012853|467584359|FG001|Overall Study|Protocol Violation|0|||
129897400|NCT04012853|467584358|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
129897401|NCT04012853|467584359|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
129897402|NCT03055767|467584360|FG000|Open-Label Period|Lost to Follow-up|0|||
129897403|NCT03055767|467584361|FG001|Open-Label Period|Lost to Follow-up|0|||
129897404|NCT03055767|467584362|FG002|Open-Label Period|Lost to Follow-up|2|||
129897405|NCT03055767|467584363|FG003|Open-Label Period|Lost to Follow-up|0|||
129897406|NCT03055767|467584360|FG000|Open-Label Period|Withdrawal by Subject|0|||
129897407|NCT03055767|467584361|FG001|Open-Label Period|Withdrawal by Subject|0|||
129897408|NCT03055767|467584362|FG002|Open-Label Period|Withdrawal by Subject|0|||
129897409|NCT03055767|467584363|FG003|Open-Label Period|Withdrawal by Subject|1|||
129822407|NCT01957644|467313332|FG003|Overall Study|Protocol Violation|0|||
129822408|NCT01957644|467313333|FG004|Overall Study|Protocol Violation|0|||
129822409|NCT04044716|467313334|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
129822410|NCT04044716|467313335|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
129822411|NCT04044716|467313336|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
129822412|NCT04044716|467313334|FG000|Overall Study|Lost to Follow-up|2|||
129822413|NCT04044716|467313335|FG001|Overall Study|Lost to Follow-up|3|||
129822414|NCT04044716|467313336|FG002|Overall Study|Lost to Follow-up|0|||
129822415|NCT01324999|467313337|FG000|Overall Study|Adverse Event|3|||
129822416|NCT01324999|467313337|FG000|Overall Study|Withdrawal by Subject|2|||
129822417|NCT00230607|467313338|FG000|Overall Study|Other|3|||
129822418|NCT00071513|467313339|FG000|Intervention Component|Withdrawal by Subject|2|||
129822419|NCT00071513|467313340|FG001|Intervention Component|Withdrawal by Subject|3|||
129822420|NCT00071513|467313339|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
129822421|NCT00071513|467313340|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
129822422|NCT01244425|467313342|FG000|Overall Study|Withdrawal by Subject|2|||
129822423|NCT01244425|467313343|FG001|Overall Study|Withdrawal by Subject|2|||
129822424|NCT01244425|467313342|FG000|Overall Study|Adverse Event|1|||
129822425|NCT01244425|467313343|FG001|Overall Study|Adverse Event|1|||
129822426|NCT02743871|467313344|FG000|Overall Study|Lost to Follow-up|0|||
129822427|NCT02743871|467313345|FG001|Overall Study|Lost to Follow-up|0|||
129822428|NCT02743871|467313346|FG002|Overall Study|Lost to Follow-up|0|||
129822429|NCT02743871|467313347|FG003|Overall Study|Lost to Follow-up|1|||
129822430|NCT02743871|467313348|FG004|Overall Study|Lost to Follow-up|0|||
129822431|NCT02743871|467313349|FG005|Overall Study|Lost to Follow-up|0|||
129822432|NCT02743871|467313350|FG006|Overall Study|Lost to Follow-up|1|||
129822433|NCT02743871|467313351|FG007|Overall Study|Lost to Follow-up|0|||
129822434|NCT02743871|467313352|FG008|Overall Study|Lost to Follow-up|0|||
129822435|NCT02743871|467313353|FG009|Overall Study|Lost to Follow-up|0|||
129822436|NCT02743871|467313354|FG010|Overall Study|Lost to Follow-up|0|||
129822437|NCT02743871|467313355|FG011|Overall Study|Lost to Follow-up|2|||
129822438|NCT02743871|467313356|FG012|Overall Study|Lost to Follow-up|0|||
129822439|NCT02743871|467313357|FG013|Overall Study|Lost to Follow-up|0|||
129822440|NCT02743871|467313344|FG000|Overall Study|Withdrawal by Subject|0|||
129822441|NCT02743871|467313345|FG001|Overall Study|Withdrawal by Subject|0|||
129822442|NCT02743871|467313346|FG002|Overall Study|Withdrawal by Subject|0|||
129822443|NCT02743871|467313347|FG003|Overall Study|Withdrawal by Subject|0|||
129822444|NCT02743871|467313348|FG004|Overall Study|Withdrawal by Subject|0|||
129822445|NCT02743871|467313349|FG005|Overall Study|Withdrawal by Subject|0|||
129822446|NCT02743871|467313350|FG006|Overall Study|Withdrawal by Subject|0|||
129822447|NCT02743871|467313351|FG007|Overall Study|Withdrawal by Subject|0|||
129822448|NCT02743871|467313352|FG008|Overall Study|Withdrawal by Subject|0|||
129822449|NCT02743871|467313353|FG009|Overall Study|Withdrawal by Subject|0|||
129822450|NCT02743871|467313354|FG010|Overall Study|Withdrawal by Subject|1|||
129822451|NCT02743871|467313355|FG011|Overall Study|Withdrawal by Subject|0|||
129822452|NCT02743871|467313356|FG012|Overall Study|Withdrawal by Subject|12|||
129822453|NCT02743871|467313357|FG013|Overall Study|Withdrawal by Subject|6|||
129822454|NCT02743871|467313344|FG000|Overall Study|Adverse Event|1|||
129822455|NCT02743871|467313345|FG001|Overall Study|Adverse Event|0|||
129822456|NCT02743871|467313346|FG002|Overall Study|Adverse Event|0|||
130059654|NCT00089479|468172386|FG001|Overall Study|Lost to Follow-up|107|||
129822457|NCT02743871|467313347|FG003|Overall Study|Adverse Event|0|||
129822458|NCT02743871|467313348|FG004|Overall Study|Adverse Event|0|||
129822459|NCT02743871|467313349|FG005|Overall Study|Adverse Event|0|||
129822460|NCT02743871|467313350|FG006|Overall Study|Adverse Event|0|||
129822461|NCT02743871|467313351|FG007|Overall Study|Adverse Event|0|||
129822462|NCT02743871|467313352|FG008|Overall Study|Adverse Event|0|||
129822463|NCT02743871|467313353|FG009|Overall Study|Adverse Event|0|||
129822464|NCT02743871|467313354|FG010|Overall Study|Adverse Event|0|||
129822465|NCT02743871|467313355|FG011|Overall Study|Adverse Event|0|||
129822466|NCT02743871|467313356|FG012|Overall Study|Adverse Event|0|||
129822467|NCT02743871|467313357|FG013|Overall Study|Adverse Event|0|||
129822468|NCT02743871|467313344|FG000|Overall Study|Other|0|||
129822469|NCT02743871|467313345|FG001|Overall Study|Other|0|||
129822470|NCT02743871|467313346|FG002|Overall Study|Other|0|||
130059655|NCT01124448|468172389|FG000|Overall Study|Lost to Follow-up|0|||
129822471|NCT02743871|467313347|FG003|Overall Study|Other|0|||
129822472|NCT02743871|467313348|FG004|Overall Study|Other|0|||
129822473|NCT02743871|467313349|FG005|Overall Study|Other|0|||
129822474|NCT02743871|467313350|FG006|Overall Study|Other|0|||
129822475|NCT02743871|467313351|FG007|Overall Study|Other|0|||
129822476|NCT02743871|467313352|FG008|Overall Study|Other|0|||
129822477|NCT02743871|467313353|FG009|Overall Study|Other|0|||
129822478|NCT02743871|467313354|FG010|Overall Study|Other|0|||
129822479|NCT02743871|467313355|FG011|Overall Study|Other|1|||
129822480|NCT02743871|467313356|FG012|Overall Study|Other|1|||
129822481|NCT02743871|467313357|FG013|Overall Study|Other|1|||
129822482|NCT02743871|467313344|FG000|Overall Study|Protocol Violation|0|||
129822483|NCT02743871|467313345|FG001|Overall Study|Protocol Violation|0|||
129822484|NCT02743871|467313346|FG002|Overall Study|Protocol Violation|0|||
129822485|NCT02743871|467313347|FG003|Overall Study|Protocol Violation|0|||
129822486|NCT02743871|467313348|FG004|Overall Study|Protocol Violation|0|||
129822487|NCT02743871|467313349|FG005|Overall Study|Protocol Violation|0|||
129822488|NCT02743871|467313350|FG006|Overall Study|Protocol Violation|0|||
129822489|NCT02743871|467313351|FG007|Overall Study|Protocol Violation|0|||
129822490|NCT02743871|467313352|FG008|Overall Study|Protocol Violation|0|||
129822491|NCT02743871|467313353|FG009|Overall Study|Protocol Violation|0|||
129822492|NCT02743871|467313354|FG010|Overall Study|Protocol Violation|0|||
129822493|NCT02743871|467313355|FG011|Overall Study|Protocol Violation|0|||
129822494|NCT02743871|467313356|FG012|Overall Study|Protocol Violation|2|||
129822495|NCT02743871|467313357|FG013|Overall Study|Protocol Violation|0|||
129822496|NCT02848651|467313358|FG000|Overall Study|Death|85|||
129822497|NCT02848651|467313358|FG000|Overall Study|Lost to Follow-up|1|||
129822498|NCT02848651|467313358|FG000|Overall Study|Non-Compliance|1|||
129822499|NCT02848651|467313358|FG000|Overall Study|Symptomatic Deterioration|1|||
129822500|NCT02848651|467313358|FG000|Overall Study|Physician Decision|4|||
129822501|NCT02848651|467313358|FG000|Overall Study|Withdrawal by Subject|14|||
129822502|NCT01059799|467313365|FG000|Overall Study|Adverse Event|2|||
129822503|NCT01059799|467313366|FG001|Overall Study|Adverse Event|3|||
129822504|NCT01059799|467313365|FG000|Overall Study|Lack of Efficacy|1|||
129822505|NCT01059799|467313366|FG001|Overall Study|Lack of Efficacy|0|||
129822506|NCT01059799|467313365|FG000|Overall Study|Protocol Violation|3|||
129822507|NCT01059799|467313366|FG001|Overall Study|Protocol Violation|2|||
129822508|NCT01059799|467313365|FG000|Overall Study|Withdrawal criteria|13|||
129822509|NCT01059799|467313366|FG001|Overall Study|Withdrawal criteria|2|||
129822510|NCT01059799|467313365|FG000|Overall Study|Other|12|||
129822511|NCT01059799|467313366|FG001|Overall Study|Other|3|||
129822512|NCT03700671|467313367|FG000|Overall Study|Lack of Efficacy|1|||
129822513|NCT03700671|467313368|FG001|Overall Study|Lack of Efficacy|2|||
129822514|NCT04203238|467315031|FG000|Overall Study|Withdrawal by Subject|1|||
129822515|NCT04203238|467315032|FG001|Overall Study|Withdrawal by Subject|1|||
129822516|NCT04203238|467315031|FG000|Overall Study|Covid-19|3|||
129822517|NCT04203238|467315032|FG001|Overall Study|Covid-19|0|||
129822518|NCT01955733|467315033|FG000|Period 1|Lost to Follow-up|1|||
129822519|NCT01955733|467315034|FG001|Period 1|Lost to Follow-up|0|||
129822520|NCT01955733|467315035|FG002|Period 1|Lost to Follow-up|0|||
129822521|NCT01955733|467315033|FG000|Period 2|Adverse Event|1|||
129822522|NCT01955733|467315034|FG001|Period 2|Adverse Event|0|||
129822523|NCT01955733|467315035|FG002|Period 2|Adverse Event|0|||
129822524|NCT01955733|467315033|FG000|Period 2|Physician Decision|0|||
129822525|NCT01955733|467315034|FG001|Period 2|Physician Decision|0|||
129822526|NCT01955733|467315035|FG002|Period 2|Physician Decision|1|||
129822527|NCT01955733|467315033|FG000|Period 2|Withdrawal by Subject|1|||
129822528|NCT01955733|467315034|FG001|Period 2|Withdrawal by Subject|3|||
129822529|NCT01955733|467315035|FG002|Period 2|Withdrawal by Subject|2|||
129822530|NCT01955733|467315033|FG000|Period 2|Study terminated by sponsor|8|||
129822531|NCT01955733|467315034|FG001|Period 2|Study terminated by sponsor|14|||
129822532|NCT01955733|467315035|FG002|Period 2|Study terminated by sponsor|16|||
129822533|NCT01955733|467315033|FG000|Period 2|Lost to Follow-up|2|||
129822534|NCT01955733|467315034|FG001|Period 2|Lost to Follow-up|0|||
129822535|NCT01955733|467315035|FG002|Period 2|Lost to Follow-up|0|||
129822536|NCT01955733|467315033|FG000|Period 2|Other not defined above|0|||
129822537|NCT01955733|467315034|FG001|Period 2|Other not defined above|2|||
129822538|NCT01955733|467315035|FG002|Period 2|Other not defined above|2|||
129822539|NCT00733408|467315036|FG000|Overall Study|Adverse Event|4|||
129822540|NCT02762266|467315037|FG000|Overall Study|Physician Decision|2|||
129822541|NCT02762266|467315038|FG001|Overall Study|Physician Decision|0|||
129822542|NCT01438424|467315039|FG000|Overall Study|Continuing treatment|29|||
129822543|NCT01438424|467315039|FG000|Overall Study|Minimal virologic response|95|||
129822544|NCT01438424|467315039|FG000|Overall Study|Not identified|55|||
129822545|NCT01438424|467315039|FG000|Overall Study|Withdrawal by Subject|104|||
129822546|NCT01438424|467315039|FG000|Overall Study|Progression of chronic hepatitis B|22|||
129822547|NCT01438424|467315039|FG000|Overall Study|Death|22|||
129822548|NCT01438424|467315039|FG000|Overall Study|Adverse Event|17|||
129822549|NCT01438424|467315039|FG000|Overall Study|Lost to Follow-up|17|||
129822550|NCT01438424|467315039|FG000|Overall Study|Abnormal laboratory test result|14|||
129822551|NCT01438424|467315039|FG000|Overall Study|Need for drug prohibited by protocol|14|||
129822552|NCT01438424|467315039|FG000|Overall Study|Pregnancy|7|||
129822553|NCT01438424|467315039|FG000|Overall Study|No longer met inclusion criteria|1|||
129822554|NCT01438424|467315039|FG000|Overall Study|Participant noncompliance|20|||
129822555|NCT02064868|467315044|FG000|Overall Study|Lost to Follow-up|14|||
129822556|NCT02064868|467315045|FG001|Overall Study|Lost to Follow-up|8|||
129822557|NCT02064868|467315044|FG000|Overall Study|Physician Decision|1|||
129822558|NCT02064868|467315045|FG001|Overall Study|Physician Decision|0|||
129822559|NCT02064868|467315044|FG000|Overall Study|Withdrawal by Subject|14|||
129822560|NCT02064868|467315045|FG001|Overall Study|Withdrawal by Subject|3|||
129822561|NCT02064868|467315044|FG000|Overall Study|Technical Problems or Missing|5|||
129822562|NCT02064868|467315045|FG001|Overall Study|Technical Problems or Missing|2|||
129822563|NCT00931762|467315049|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
129822564|NCT00931762|467315049|FG000|Overall Study|Administrative Problems|5|||
129822565|NCT00931762|467315049|FG000|Overall Study|Death|1|||
129822566|NCT00931762|467315049|FG000|Overall Study|Disease Progression|3|||
129822567|NCT00931762|467315049|FG000|Overall Study|Adverse Event (s)|11|||
129822568|NCT00931762|467315049|FG000|Overall Study|Subject withdrew consent|13|||
129822569|NCT02664441|467315050|FG000|Randomization|Withdrawal by Subject|0|||
129822570|NCT02664441|467315051|FG001|Randomization|Withdrawal by Subject|1|||
129822571|NCT02664441|467315050|FG000|36-week Randomized Trial|Adverse Event|2|||
129822572|NCT02664441|467315051|FG001|36-week Randomized Trial|Adverse Event|0|||
129822573|NCT02664441|467315050|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
129822574|NCT02664441|467315051|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
129822575|NCT02664441|467315050|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
129822576|NCT02664441|467315051|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
129822577|NCT02664441|467315050|FG000|18-week Open Label Extension|Adverse Event|1|||
129822578|NCT02664441|467315051|FG001|18-week Open Label Extension|Adverse Event|0|||
129822579|NCT02664441|467315050|FG000|18-week Open Label Extension|Physician Decision|1|||
129822580|NCT02664441|467315051|FG001|18-week Open Label Extension|Physician Decision|0|||
129822581|NCT02664441|467315050|FG000|18-week Open Label Extension|Death|1|||
129822582|NCT02664441|467315051|FG001|18-week Open Label Extension|Death|0|||
129822583|NCT02664441|467315050|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
129822584|NCT02664441|467315051|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
129822585|NCT01413191|467315052|FG000|Overall Study|Lost to Follow-up|5|||
129822586|NCT01413191|467315052|FG000|Overall Study|Disease Progression|5|||
129822587|NCT01413191|467315052|FG000|Overall Study|Death|1|||
129822588|NCT01702454|467315053|FG000|Overall Study|Consent withdrawal|0|||
129822589|NCT01702454|467315054|FG001|Overall Study|Consent withdrawal|1|||
129822590|NCT01702454|467315053|FG000|Overall Study|Migrated/moved from study area|0|||
130059656|NCT01124448|468172390|FG001|Overall Study|Lost to Follow-up|3|||
130059657|NCT01124448|468172389|FG000|Overall Study|Protocol Violation|2|||
130059658|NCT01124448|468172390|FG001|Overall Study|Protocol Violation|0|||
130059659|NCT03198754|468172392|FG000|Overall Study|Withdrawal by Subject|5|||
130059660|NCT03198754|468172393|FG001|Overall Study|Withdrawal by Subject|4|||
130059661|NCT03198754|468172392|FG000|Overall Study|Lost to Follow-up|4|||
130059662|NCT03198754|468172393|FG001|Overall Study|Lost to Follow-up|3|||
130059663|NCT03198754|468172392|FG000|Overall Study|Ineligible|2|||
130059664|NCT03198754|468172393|FG001|Overall Study|Ineligible|1|||
130059665|NCT00421343|468172398|FG000|Overall Study|Death|1|||
130059666|NCT00421343|468172398|FG000|Overall Study|Withdrawal by Subject|2|||
130059667|NCT00421343|468172398|FG000|Overall Study|Lost to Follow-up|3|||
130059668|NCT01952730|468172402|FG000|Overall Study|FDA shut down core lab used by study|1|||
130059669|NCT00305253|468172407|FG000|Overall Study|Withdrawal by Subject|0|||
130059670|NCT00305253|468172408|FG001|Overall Study|Withdrawal by Subject|1|||
130059671|NCT01479374|468172412|FG000|Overall Study|Adverse Event|2|||
130059672|NCT01479374|468172413|FG001|Overall Study|Adverse Event|1|||
130059673|NCT01479374|468172414|FG002|Overall Study|Adverse Event|0|||
130059674|NCT01479374|468172412|FG000|Overall Study|Lost to Follow-up|1|||
130059675|NCT01479374|468172413|FG001|Overall Study|Lost to Follow-up|2|||
130059676|NCT01479374|468172414|FG002|Overall Study|Lost to Follow-up|0|||
130059677|NCT01479374|468172412|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
129822591|NCT01702454|467315054|FG001|Overall Study|Migrated/moved from study area|1|||
129822592|NCT01702454|467315053|FG000|Overall Study|Lost to Follow-up|3|||
129822593|NCT01702454|467315054|FG001|Overall Study|Lost to Follow-up|6|||
129822594|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
129822595|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
129822596|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
129822597|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
129822598|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
129822599|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
129822600|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
129822601|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
129822602|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
129897410|NCT02759731|467584364|FG000|Overall Study|Did not complete treatment.|8|||
129897411|NCT00763282|467584369|FG000|Overall Study|Withdrawal by Subject|6|||
130059678|NCT01479374|468172413|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
130059679|NCT01479374|468172414|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
130059680|NCT01479374|468172412|FG000|Overall Study|Other|0|||
130059681|NCT01479374|468172413|FG001|Overall Study|Other|4|||
129822603|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
129822604|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
129822605|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
129897412|NCT00763282|467584370|FG001|Overall Study|Withdrawal by Subject|5|||
129897413|NCT00763282|467584369|FG000|Overall Study|Death|4|||
130059682|NCT01479374|468172414|FG002|Overall Study|Other|5|||
130059683|NCT01606761|468172415|FG000|Prior to Week 24|Lost to Follow-up|0|||
129822606|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
129822607|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
129822608|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
129822609|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
129822610|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
129822611|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
129822612|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
129822613|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
129822614|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
129822615|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
129822616|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
129822617|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
129822618|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
129822619|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
129822620|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
129822621|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
129822622|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
129822623|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
129822624|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
129822625|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
129822626|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
129822627|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
129822628|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
129822629|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
129822630|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
129822631|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
129822632|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
129822633|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
129822634|NCT01529346|467315060|FG000|Overall Study|Lost to Follow-up|2|||
129822635|NCT01529346|467315061|FG001|Overall Study|Lost to Follow-up|0|||
129822636|NCT01529346|467315062|FG002|Overall Study|Lost to Follow-up|1|||
129822637|NCT01529346|467315063|FG003|Overall Study|Lost to Follow-up|0|||
129822638|NCT01529346|467315064|FG004|Overall Study|Lost to Follow-up|0|||
129822639|NCT01529346|467315060|FG000|Overall Study|Other|0|||
129822640|NCT01529346|467315061|FG001|Overall Study|Other|1|||
129822641|NCT01529346|467315062|FG002|Overall Study|Other|1|||
129822642|NCT01529346|467315063|FG003|Overall Study|Other|0|||
129822643|NCT01529346|467315064|FG004|Overall Study|Other|0|||
129822644|NCT00589914|467315070|FG000|Overall Study|Adverse Event|19|||
129822645|NCT00589914|467315071|FG001|Overall Study|Adverse Event|10|||
129822646|NCT00589914|467315070|FG000|Overall Study|Death|2|||
129822647|NCT00589914|467315071|FG001|Overall Study|Death|0|||
129822648|NCT00589914|467315070|FG000|Overall Study|Lack of Efficacy|40|||
129822649|NCT00589914|467315071|FG001|Overall Study|Lack of Efficacy|43|||
129822650|NCT00589914|467315070|FG000|Overall Study|Lost to Follow-up|11|||
129822651|NCT00589914|467315071|FG001|Overall Study|Lost to Follow-up|18|||
129822652|NCT00589914|467315070|FG000|Overall Study|Pregnancy|1|||
129822653|NCT00589914|467315071|FG001|Overall Study|Pregnancy|0|||
129822654|NCT00589914|467315070|FG000|Overall Study|Withdrawal by Subject|55|||
129822655|NCT00589914|467315071|FG001|Overall Study|Withdrawal by Subject|49|||
129822656|NCT00589914|467315070|FG000|Overall Study|Other|22|||
129822657|NCT00589914|467315071|FG001|Overall Study|Other|17|||
129822658|NCT01594125|467315072|FG000|Overall Study|Withdrawal by Subject|1|||
129822659|NCT01594125|467315073|FG001|Overall Study|Withdrawal by Subject|0|||
129822660|NCT01594125|467315074|FG002|Overall Study|Withdrawal by Subject|0|||
129822661|NCT01594125|467315075|FG003|Overall Study|Withdrawal by Subject|1|||
129822662|NCT01594125|467315076|FG004|Overall Study|Withdrawal by Subject|0|||
129822663|NCT01594125|467315072|FG000|Overall Study|Progressive Disease|3|||
129822664|NCT01594125|467315073|FG001|Overall Study|Progressive Disease|12|||
129822665|NCT01594125|467315074|FG002|Overall Study|Progressive Disease|3|||
129822666|NCT01594125|467315075|FG003|Overall Study|Progressive Disease|3|||
129822667|NCT01594125|467315076|FG004|Overall Study|Progressive Disease|7|||
129822668|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
129822669|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
129822670|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
129822671|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
129822672|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
129822673|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
129822674|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
129822675|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
129822676|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
129822677|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
129822678|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
129822679|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
129822680|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
129822681|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
129822682|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
129822683|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
129822684|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
129822685|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
129822686|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
129822687|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
129822688|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
129822689|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
129822690|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
129822691|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
129822692|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
129822693|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
129822694|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
129822695|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
129822696|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
129822697|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
129822698|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Death|3|||
129822699|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Death|3|||
129822700|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Death|0|||
129822701|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Death|0|||
129822702|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
129822703|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
129822704|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
129822705|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
129822706|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
129822707|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
129822708|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
129822709|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
129822710|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
129822711|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
129822712|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
129822713|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
129822714|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
129822715|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
129822716|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
129822717|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
129822718|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
129822719|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
129822720|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
129822721|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
129822722|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
129822723|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
129822724|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
129822725|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
129822726|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Other|6|||
129822727|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Other|3|||
129822728|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Other|0|||
129822729|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Other|0|||
129822730|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
129822731|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
129822732|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
129822733|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
129822734|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Adverse Event|0|||
129822735|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Adverse Event|0|||
129822736|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Adverse Event|6|||
129822737|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Adverse Event|8|||
129897414|NCT00763282|467584370|FG001|Overall Study|Death|3|||
129897415|NCT00763282|467584369|FG000|Overall Study|Lost to Follow-up|22|||
129897416|NCT00763282|467584370|FG001|Overall Study|Lost to Follow-up|26|||
129897417|NCT00742274|467584371|FG000|Overall Study|Death|1|||
129822738|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Death|0|||
129897418|NCT00742274|467584372|FG001|Overall Study|Death|0|||
129897419|NCT00742274|467584371|FG000|Overall Study|Withdrawal by Subject|1|||
129822739|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Death|0|||
129822740|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Death|7|||
129822741|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Death|4|||
129822742|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
129822743|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
129822744|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
129822745|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
129822746|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
129822747|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
129822748|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
129822749|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
129822750|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129822751|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129822752|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
129822753|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
129822754|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
129822755|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
129822756|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
129822757|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
129822758|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Physician Decision|0|||
129822759|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Physician Decision|0|||
130059684|NCT01606761|468172416|FG001|Prior to Week 24|Lost to Follow-up|3|||
129822760|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Physician Decision|8|||
129822761|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Physician Decision|5|||
129822762|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Other|0|||
129822763|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Other|0|||
129822764|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Other|9|||
129822765|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Other|9|||
129822766|NCT04876274|467315089|FG000|Overall Study|Lost to Follow-up|9|||
129822767|NCT04876274|467315090|FG001|Overall Study|Lost to Follow-up|12|||
129822768|NCT03454893|467315091|FG000|Overall Study|Study Terminated by the Sponsor|5|||
129822769|NCT03454893|467315091|FG000|Overall Study|Did not pass screening|4|||
129822770|NCT01948050|467315094|FG000|Overall Study|Withdrawal by Subject|0|||
129822771|NCT01948050|467315095|FG001|Overall Study|Withdrawal by Subject|1|||
129822772|NCT00558025|467315096|FG000|Overall Study|Adverse Event|1|||
129822773|NCT00558025|467315097|FG001|Overall Study|Adverse Event|1|||
129822774|NCT00558025|467315096|FG000|Overall Study|Withdrawal by Subject|2|||
129822775|NCT00558025|467315097|FG001|Overall Study|Withdrawal by Subject|2|||
129822776|NCT00558025|467315096|FG000|Overall Study|Protocol Violation|1|||
129822777|NCT00558025|467315097|FG001|Overall Study|Protocol Violation|0|||
129822778|NCT00449540|467315098|FG000|Pretreatment Phase|No migraine experienced|66|||
129822779|NCT00449540|467315099|FG001|Pretreatment Phase|No migraine experienced|0|||
129822780|NCT00449540|467315100|FG002|Pretreatment Phase|No migraine experienced|0|||
129822781|NCT00449540|467315098|FG000|Treatment Phase|did not experience or treat migraine|0|||
129822782|NCT00449540|467315099|FG001|Treatment Phase|did not experience or treat migraine|20|||
129822783|NCT00449540|467315100|FG002|Treatment Phase|did not experience or treat migraine|17|||
129822784|NCT00010374|467315103|FG000|Overall Study|False positive phrenic nerve test|1|||
129822785|NCT01961323|467315104|FG000|Overall Study|Withdrawal by Subject|7|||
129822786|NCT01961323|467315104|FG000|Overall Study|Lost to Follow-up|8|||
129822787|NCT01961323|467315104|FG000|Overall Study|screen failure|34|||
129822788|NCT01881776|467315108|FG000|Overall Study|Lost to Follow-up|1|||
129822789|NCT01881776|467315109|FG001|Overall Study|Lost to Follow-up|2|||
129822790|NCT01881776|467315110|FG002|Overall Study|Lost to Follow-up|1|||
129822791|NCT01881776|467315108|FG000|Overall Study|Protocol Violation|0|||
129822792|NCT01881776|467315109|FG001|Overall Study|Protocol Violation|2|||
129822793|NCT01881776|467315110|FG002|Overall Study|Protocol Violation|1|||
129822794|NCT02393547|467315113|FG000|Overall Study|Adverse Event|2|||
129822795|NCT02393547|467315113|FG000|Overall Study|Withdrawal by Subject|3|||
129822796|NCT02393547|467315113|FG000|Overall Study|Lost to Follow-up|1|||
129822797|NCT02205814|467315114|FG000|Overall Study|Lost to Follow-up|0|||
129822798|NCT02205814|467315115|FG001|Overall Study|Lost to Follow-up|0|||
129822799|NCT02205814|467315116|FG002|Overall Study|Lost to Follow-up|0|||
129822800|NCT02205814|467315117|FG003|Overall Study|Lost to Follow-up|1|||
130059685|NCT01606761|468172417|FG002|Prior to Week 24|Lost to Follow-up|2|||
129822801|NCT02205814|467315114|FG000|Overall Study|Lack of Efficacy|1|||
129822802|NCT02205814|467315115|FG001|Overall Study|Lack of Efficacy|0|||
129822803|NCT02205814|467315116|FG002|Overall Study|Lack of Efficacy|1|||
129822804|NCT02205814|467315117|FG003|Overall Study|Lack of Efficacy|1|||
130059686|NCT01606761|468172418|FG003|Prior to Week 24|Lost to Follow-up|0|||
130059687|NCT01606761|468172419|FG004|Prior to Week 24|Lost to Follow-up|0|||
129822805|NCT02205814|467315114|FG000|Overall Study|Physician Decision|0|||
129822806|NCT02205814|467315115|FG001|Overall Study|Physician Decision|0|||
129822807|NCT02205814|467315116|FG002|Overall Study|Physician Decision|1|||
130059688|NCT01606761|468172415|FG000|Prior to Week 24|Withdrawal by Subject|12|||
129822808|NCT02205814|467315117|FG003|Overall Study|Physician Decision|0|||
129822809|NCT02205814|467315114|FG000|Overall Study|Protocol Violation|1|||
129822810|NCT02205814|467315115|FG001|Overall Study|Protocol Violation|0|||
129822811|NCT02205814|467315116|FG002|Overall Study|Protocol Violation|0|||
129822812|NCT02205814|467315117|FG003|Overall Study|Protocol Violation|1|||
129822813|NCT02205814|467315114|FG000|Overall Study|Withdrawal by Subject|0|||
129822814|NCT02205814|467315115|FG001|Overall Study|Withdrawal by Subject|1|||
129822815|NCT02205814|467315116|FG002|Overall Study|Withdrawal by Subject|2|||
129822816|NCT02205814|467315117|FG003|Overall Study|Withdrawal by Subject|1|||
129822817|NCT02205814|467315114|FG000|Overall Study|not compliant with study procedures|0|||
129822818|NCT02205814|467315115|FG001|Overall Study|not compliant with study procedures|0|||
129822819|NCT02205814|467315116|FG002|Overall Study|not compliant with study procedures|1|||
129822820|NCT02205814|467315117|FG003|Overall Study|not compliant with study procedures|0|||
129822821|NCT00143403|467315118|FG000|Overall Study|Adverse Event|3|||
129822822|NCT00143403|467315119|FG001|Overall Study|Adverse Event|8|||
129822823|NCT00143403|467315118|FG000|Overall Study|Death|1|||
129822824|NCT00143403|467315119|FG001|Overall Study|Death|0|||
129822825|NCT00143403|467315118|FG000|Overall Study|Withdrawal by Subject|3|||
129822826|NCT00143403|467315119|FG001|Overall Study|Withdrawal by Subject|12|||
129822827|NCT00143403|467315118|FG000|Overall Study|Relapse|15|||
129822828|NCT00143403|467315119|FG001|Overall Study|Relapse|7|||
129822829|NCT00143403|467315118|FG000|Overall Study|Protocol Violation|2|||
129822830|NCT00143403|467315119|FG001|Overall Study|Protocol Violation|2|||
129822831|NCT00143403|467315118|FG000|Overall Study|specified by site|4|||
129822832|NCT00143403|467315119|FG001|Overall Study|specified by site|9|||
129822833|NCT00143403|467315118|FG000|Overall Study|Randomized Not Treated|7|||
129822834|NCT00143403|467315119|FG001|Overall Study|Randomized Not Treated|8|||
129822835|NCT00514540|467315120|FG000|First-Line Chemo|Withdrawal by Subject|1|||
129822836|NCT00514540|467315120|FG000|First-Line Chemo|Protocol Violation|7|||
129822837|NCT00514540|467315120|FG000|Second-Line|Physician/Patient Decision|31|||
129822838|NCT02326025|467315123|FG000|Overall Study|Adverse Event|3|||
129822839|NCT02326025|467315124|FG001|Overall Study|Adverse Event|0|||
129822840|NCT02326025|467315123|FG000|Overall Study|Physician Decision|1|||
129822841|NCT02326025|467315124|FG001|Overall Study|Physician Decision|2|||
129822842|NCT02326025|467315123|FG000|Overall Study|Physician and Participant Decision|1|||
129822843|NCT02326025|467315124|FG001|Overall Study|Physician and Participant Decision|0|||
129822844|NCT02326025|467315123|FG000|Overall Study|Withdrawal by Subject|0|||
129822845|NCT02326025|467315124|FG001|Overall Study|Withdrawal by Subject|2|||
129822846|NCT02326025|467315123|FG000|Overall Study|Protocol Violation|0|||
129822847|NCT02326025|467315124|FG001|Overall Study|Protocol Violation|1|||
130059689|NCT01606761|468172416|FG001|Prior to Week 24|Withdrawal by Subject|10|||
129822848|NCT01714635|467315134|FG000|Overall Study|Discontinued|1|||
129822849|NCT01714635|467315135|FG001|Overall Study|Discontinued|0|||
129822850|NCT01714635|467315136|FG002|Overall Study|Discontinued|2|||
129822851|NCT01714635|467315134|FG000|Overall Study|Missed 6-month exam|1|||
129822852|NCT01714635|467315135|FG001|Overall Study|Missed 6-month exam|0|||
129822853|NCT01714635|467315136|FG002|Overall Study|Missed 6-month exam|0|||
129822854|NCT01846611|467315137|FG000|Overall Study|Lost to Follow-up|4|||
129822855|NCT01846611|467315138|FG001|Overall Study|Lost to Follow-up|6|||
129822856|NCT01846611|467315137|FG000|Overall Study|Withdrawal by Subject|15|||
129822857|NCT01846611|467315138|FG001|Overall Study|Withdrawal by Subject|19|||
129822858|NCT01846611|467315137|FG000|Overall Study|Other|19|||
129822859|NCT01846611|467315138|FG001|Overall Study|Other|18|||
129822860|NCT00662363|467315139|FG000|Overall Study|Withdrawal by Subject|6|||
129822861|NCT00662363|467315140|FG001|Overall Study|Withdrawal by Subject|5|||
129822862|NCT00662363|467315139|FG000|Overall Study|Adverse Event|0|||
129822863|NCT00662363|467315140|FG001|Overall Study|Adverse Event|3|||
129822864|NCT00662363|467315139|FG000|Overall Study|Discharged early from rehab|4|||
129822865|NCT00662363|467315140|FG001|Overall Study|Discharged early from rehab|1|||
129822866|NCT00662363|467315139|FG000|Overall Study|Protocol Violation|1|||
129822867|NCT00662363|467315140|FG001|Overall Study|Protocol Violation|1|||
129822868|NCT02744391|467315141|FG000|Overall Study|Lost to Follow-up|9|||
129822869|NCT02744391|467315141|FG000|Overall Study|Physician Decision|2|||
130059690|NCT01606761|468172417|FG002|Prior to Week 24|Withdrawal by Subject|9|||
130059691|NCT01606761|468172418|FG003|Prior to Week 24|Withdrawal by Subject|0|||
129822870|NCT02744391|467315141|FG000|Overall Study|Withdrawal by Subject|3|||
129822871|NCT01428453|467315142|FG000|Overall Study|Adverse Event|2|||
129822872|NCT01428453|467315143|FG001|Overall Study|Adverse Event|7|||
129822873|NCT01428453|467315142|FG000|Overall Study|Protocol Violation|1|||
129822874|NCT01428453|467315143|FG001|Overall Study|Protocol Violation|0|||
129822875|NCT01428453|467315142|FG000|Overall Study|Lost to Follow-up|0|||
129822876|NCT01428453|467315143|FG001|Overall Study|Lost to Follow-up|1|||
129822877|NCT01428453|467315142|FG000|Overall Study|Withdrawal by Subject|3|||
129822878|NCT01428453|467315143|FG001|Overall Study|Withdrawal by Subject|1|||
129822879|NCT01996709|467315144|FG000|Overall Study|Withdrawal by Subject|1|||
129822880|NCT01996709|467315145|FG001|Overall Study|Withdrawal by Subject|0|||
129822881|NCT01996709|467315144|FG000|Overall Study|Lost to Follow-up|3|||
129822882|NCT01996709|467315145|FG001|Overall Study|Lost to Follow-up|0|||
129822883|NCT01996709|467315144|FG000|Overall Study|Subject Non-Compliant|1|||
129822884|NCT01996709|467315145|FG001|Overall Study|Subject Non-Compliant|0|||
129822885|NCT01996709|467315144|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129822886|NCT01996709|467315145|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
129822887|NCT03789318|467315154|FG000|Overall Study|Adverse Event|0|||
129822888|NCT03789318|467315155|FG001|Overall Study|Adverse Event|0|||
129822889|NCT03789318|467315156|FG002|Overall Study|Adverse Event|1|||
129822890|NCT03789318|467315157|FG003|Overall Study|Adverse Event|1|||
129822891|NCT03789318|467315158|FG004|Overall Study|Adverse Event|0|||
129822892|NCT03789318|467315154|FG000|Overall Study|Lost to Follow-up|0|||
129822893|NCT03789318|467315155|FG001|Overall Study|Lost to Follow-up|0|||
129822894|NCT03789318|467315156|FG002|Overall Study|Lost to Follow-up|1|||
129822895|NCT03789318|467315157|FG003|Overall Study|Lost to Follow-up|0|||
129822896|NCT03789318|467315158|FG004|Overall Study|Lost to Follow-up|0|||
129822897|NCT03789318|467315154|FG000|Overall Study|Withdrawal by Subject|0|||
129822898|NCT03789318|467315155|FG001|Overall Study|Withdrawal by Subject|0|||
129822899|NCT03789318|467315156|FG002|Overall Study|Withdrawal by Subject|1|||
129822900|NCT03789318|467315157|FG003|Overall Study|Withdrawal by Subject|0|||
129822901|NCT03789318|467315158|FG004|Overall Study|Withdrawal by Subject|0|||
129822902|NCT02480114|467315159|FG000|Overall Study|Not completing surveys|3|||
129822903|NCT02480114|467315160|FG001|Overall Study|Not completing surveys|2|||
129822904|NCT02480114|467315159|FG000|Overall Study|Withdrawal by Subject|2|||
129822905|NCT02480114|467315160|FG001|Overall Study|Withdrawal by Subject|4|||
129822906|NCT02480114|467315159|FG000|Overall Study|Disease progression|3|||
129822907|NCT02480114|467315160|FG001|Overall Study|Disease progression|0|||
129822908|NCT02480114|467315159|FG000|Overall Study|Improper completion of survey|1|||
129822909|NCT02480114|467315160|FG001|Overall Study|Improper completion of survey|1|||
129822910|NCT02480114|467315159|FG000|Overall Study|Not eligible|0|||
129822911|NCT02480114|467315160|FG001|Overall Study|Not eligible|1|||
129822912|NCT01535053|467315161|FG000|Overall Study|Ineligible|1|||
129822913|NCT01535053|467315162|FG001|Overall Study|Ineligible|2|||
129822914|NCT00512707|467315163|FG000|Overall Study|Lost to Follow-up|5|||
129822915|NCT00512707|467315164|FG001|Overall Study|Lost to Follow-up|11|||
129822916|NCT00512707|467315163|FG000|Overall Study|Developed skin irritation|2|||
129822917|NCT00512707|467315164|FG001|Overall Study|Developed skin irritation|1|||
129822918|NCT00512707|467315163|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
129822919|NCT00512707|467315164|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
129822920|NCT00512707|467315163|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
129822921|NCT00512707|467315164|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
129822922|NCT01317160|467315165|FG000|Overall Study|Incorrect inclusion|1|||
129822923|NCT01317160|467315166|FG001|Overall Study|Incorrect inclusion|1|||
129822924|NCT01317160|467315165|FG000|Overall Study|Lost to Follow-up|3|||
129822925|NCT01317160|467315166|FG001|Overall Study|Lost to Follow-up|3|||
129822926|NCT01317160|467315165|FG000|Overall Study|Withdrawal by Subject|0|||
129822927|NCT01317160|467315166|FG001|Overall Study|Withdrawal by Subject|2|||
129822928|NCT04405037|467315173|FG000|Overall Study|Withdrawal by Subject|1|||
129822929|NCT04405037|467315174|FG001|Overall Study|Withdrawal by Subject|0|||
129822930|NCT04405037|467315173|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
129822931|NCT04405037|467315174|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
129822932|NCT01134783|467316474|FG000|Overall Study|Pregnancy|16|||
129822933|NCT01134783|467316475|FG001|Overall Study|Pregnancy|8|||
129822934|NCT01134783|467316474|FG000|Overall Study|Withdrawal by Subject|15|||
129822935|NCT01134783|467316475|FG001|Overall Study|Withdrawal by Subject|9|||
129822936|NCT01134783|467316474|FG000|Overall Study|Lost to Follow-up|5|||
129822937|NCT01134783|467316475|FG001|Overall Study|Lost to Follow-up|20|||
129822938|NCT04221009|467316476|FG000|Overall Study|Withdrawal by Subject|4|||
129822939|NCT04232124|467316477|FG000|Overall Study|Lost to Follow-up|3|||
129822940|NCT02329730|467316478|FG000|Overall Study|Protocol Violation|0|||
129822941|NCT02329730|467316479|FG001|Overall Study|Protocol Violation|0|||
129822942|NCT02329730|467316480|FG002|Overall Study|Protocol Violation|0|||
129822943|NCT02329730|467316481|FG003|Overall Study|Protocol Violation|0|||
129822944|NCT02329730|467316482|FG004|Overall Study|Protocol Violation|2|||
129822945|NCT02329730|467316483|FG005|Overall Study|Protocol Violation|2|||
129822946|NCT02329730|467316484|FG006|Overall Study|Protocol Violation|0|||
129822947|NCT02329730|467316485|FG007|Overall Study|Protocol Violation|0|||
129822948|NCT02329730|467316486|FG008|Overall Study|Protocol Violation|0|||
129822949|NCT02329730|467316487|FG009|Overall Study|Protocol Violation|0|||
129822950|NCT02329730|467316488|FG010|Overall Study|Protocol Violation|0|||
129822951|NCT02329730|467316489|FG011|Overall Study|Protocol Violation|0|||
129822952|NCT02329730|467316478|FG000|Overall Study|Withdrawal by Subject|0|||
129822953|NCT02329730|467316479|FG001|Overall Study|Withdrawal by Subject|0|||
129822954|NCT02329730|467316480|FG002|Overall Study|Withdrawal by Subject|0|||
129822955|NCT02329730|467316481|FG003|Overall Study|Withdrawal by Subject|0|||
129822956|NCT02329730|467316482|FG004|Overall Study|Withdrawal by Subject|1|||
129822957|NCT02329730|467316483|FG005|Overall Study|Withdrawal by Subject|0|||
129822958|NCT02329730|467316484|FG006|Overall Study|Withdrawal by Subject|1|||
129822959|NCT02329730|467316485|FG007|Overall Study|Withdrawal by Subject|1|||
129822960|NCT02329730|467316486|FG008|Overall Study|Withdrawal by Subject|1|||
129822961|NCT02329730|467316487|FG009|Overall Study|Withdrawal by Subject|1|||
129822962|NCT02329730|467316488|FG010|Overall Study|Withdrawal by Subject|0|||
129822963|NCT02329730|467316489|FG011|Overall Study|Withdrawal by Subject|0|||
129822964|NCT02392247|467316494|FG000|Overall Study|Withdrawal by Subject|1|||
129822965|NCT02392247|467316494|FG000|Overall Study|Surgery cancelled; no data|1|||
129822966|NCT03010254|467316495|FG000|Overall Study|Adverse Event|0|||
129822967|NCT03010254|467316496|FG001|Overall Study|Adverse Event|1|||
129822968|NCT03010254|467316495|FG000|Overall Study|Lost to Follow-up|4|||
129822969|NCT03010254|467316496|FG001|Overall Study|Lost to Follow-up|0|||
129822970|NCT03010254|467316495|FG000|Overall Study|Withdrawal by Subject|1|||
129822971|NCT03010254|467316496|FG001|Overall Study|Withdrawal by Subject|1|||
129822972|NCT03010254|467316495|FG000|Overall Study|Other|2|||
129822973|NCT03010254|467316496|FG001|Overall Study|Other|3|||
129822974|NCT01404325|467316497|FG000|Overall Study|Lost to Follow-up|1|||
129822975|NCT01404325|467316498|FG001|Overall Study|Lost to Follow-up|0|||
129822976|NCT01404325|467316497|FG000|Overall Study|Death|2|||
129822977|NCT01404325|467316498|FG001|Overall Study|Death|0|||
129822978|NCT01404325|467316497|FG000|Overall Study|Graft loss/Retransplantation|1|||
129822979|NCT01404325|467316498|FG001|Overall Study|Graft loss/Retransplantation|0|||
129822980|NCT01404325|467316497|FG000|Overall Study|non-specified reason|0|||
129822981|NCT01404325|467316498|FG001|Overall Study|non-specified reason|2|||
129822982|NCT03312933|467316503|FG000|Overall Study|Protocol Violation|15|||
129822983|NCT03312933|467316503|FG000|Overall Study|Lost to Follow-up|36|||
129822984|NCT03312933|467316503|FG000|Overall Study|Withdrawal by Subject|3|||
129822985|NCT00224055|467316509|FG000|Overall Study|Adverse Event|9|||
129822986|NCT00224055|467316510|FG001|Overall Study|Adverse Event|3|||
129822987|NCT00224055|467316509|FG000|Overall Study|Lost to Follow-up|1|||
129822988|NCT00224055|467316510|FG001|Overall Study|Lost to Follow-up|2|||
129822989|NCT00224055|467316509|FG000|Overall Study|Protocol Violation|1|||
129822990|NCT00224055|467316510|FG001|Overall Study|Protocol Violation|1|||
129822991|NCT00224055|467316509|FG000|Overall Study|Inclusion Violation|3|||
129822992|NCT00224055|467316510|FG001|Overall Study|Inclusion Violation|6|||
129822993|NCT00224055|467316509|FG000|Overall Study|Withdrawal by Subject|0|||
129822994|NCT00224055|467316510|FG001|Overall Study|Withdrawal by Subject|2|||
129822995|NCT00224055|467316509|FG000|Overall Study|Other|1|||
129822996|NCT00224055|467316510|FG001|Overall Study|Other|0|||
129822997|NCT04317066|467316511|FG000|Overall Study|Sponsor decision|5|||
129822998|NCT04317066|467316511|FG000|Overall Study|Death|2|||
129822999|NCT00848081|467316514|FG000|Overall Study|Adverse Event|6|||
129823000|NCT00848081|467316515|FG001|Overall Study|Adverse Event|7|||
129823001|NCT00848081|467316514|FG000|Overall Study|Protocol Violation|8|||
129823002|NCT00848081|467316515|FG001|Overall Study|Protocol Violation|5|||
129823003|NCT00848081|467316514|FG000|Overall Study|Lost to Follow-up|1|||
129823004|NCT00848081|467316515|FG001|Overall Study|Lost to Follow-up|0|||
129823005|NCT00848081|467316514|FG000|Overall Study|Physician Decision|0|||
129823006|NCT00848081|467316515|FG001|Overall Study|Physician Decision|3|||
129823007|NCT00848081|467316514|FG000|Overall Study|Withdrawal by Subject|5|||
129823008|NCT00848081|467316515|FG001|Overall Study|Withdrawal by Subject|3|||
129823009|NCT02014597|467316516|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
129823010|NCT02014597|467316517|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
129823011|NCT00754624|467316518|FG000|Overall Study|Adverse Event|16|||
129823012|NCT00754624|467316518|FG000|Overall Study|Death|1|||
129823013|NCT00754624|467316518|FG000|Overall Study|Physician Decision|8|||
129823014|NCT00754624|467316518|FG000|Overall Study|Protocol Violation|1|||
129823015|NCT00754624|467316518|FG000|Overall Study|Withdrawal by Subject|28|||
129823016|NCT00754624|467316518|FG000|Overall Study|Various|12|||
129823017|NCT00754624|467316518|FG000|Overall Study|Lost to Follow-up|3|||
129823018|NCT00710710|467316521|FG000|Overall Study|Consent withdrawn|2|||
129823019|NCT00710710|467316522|FG001|Overall Study|Consent withdrawn|2|||
129823020|NCT00710710|467316521|FG000|Overall Study|Protocol Violation|0|||
129823021|NCT00710710|467316522|FG001|Overall Study|Protocol Violation|1|||
129823022|NCT00710710|467316521|FG000|Overall Study|Adverse Event|3|||
129823023|NCT00710710|467316522|FG001|Overall Study|Adverse Event|3|||
129823024|NCT00710710|467316521|FG000|Overall Study|Progressive disease|40|||
129823025|NCT00710710|467316522|FG001|Overall Study|Progressive disease|38|||
129823026|NCT00715078|467316523|FG000|Overall Study|Death|29|||
130112636|NCT00606684|468373425|FG005|Double-Blind Treatment Period|Physician Decision|1|||
130112637|NCT00606684|468373426|FG006|Double-Blind Treatment Period|Physician Decision|2|||
129823027|NCT00715078|467316524|FG001|Overall Study|Death|36|||
129823028|NCT00715078|467316525|FG002|Overall Study|Death|36|||
129823029|NCT00715078|467316523|FG000|Overall Study|Withdrawal by Subject|1|||
129823030|NCT00715078|467316524|FG001|Overall Study|Withdrawal by Subject|0|||
129823031|NCT00715078|467316525|FG002|Overall Study|Withdrawal by Subject|1|||
129823032|NCT00715078|467316523|FG000|Overall Study|Unable to start due to disease prog.|0|||
129823033|NCT00715078|467316524|FG001|Overall Study|Unable to start due to disease prog.|0|||
129823034|NCT00715078|467316525|FG002|Overall Study|Unable to start due to disease prog.|1|||
129823035|NCT02618434|467316532|FG000|Overall Study|Withdrawal by Subject|0|||
129823036|NCT02618434|467316533|FG001|Overall Study|Withdrawal by Subject|2|||
129823037|NCT02618434|467316534|FG002|Overall Study|Withdrawal by Subject|3|||
129823038|NCT02618434|467316532|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
129823039|NCT02618434|467316533|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129823040|NCT02618434|467316534|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
129823041|NCT02618434|467316532|FG000|Overall Study|Lost to Follow-up|3|||
129823042|NCT02618434|467316533|FG001|Overall Study|Lost to Follow-up|1|||
129823043|NCT02618434|467316534|FG002|Overall Study|Lost to Follow-up|3|||
129823044|NCT02618434|467316532|FG000|Overall Study|Adverse Event|1|||
129823045|NCT02618434|467316533|FG001|Overall Study|Adverse Event|0|||
129823046|NCT02618434|467316534|FG002|Overall Study|Adverse Event|12|||
129823047|NCT02618434|467316532|FG000|Overall Study|Physician Decision|0|||
129823048|NCT02618434|467316533|FG001|Overall Study|Physician Decision|1|||
129823049|NCT02618434|467316534|FG002|Overall Study|Physician Decision|0|||
129823050|NCT02618434|467316532|FG000|Overall Study|Protocol Violation|0|||
129823051|NCT02618434|467316533|FG001|Overall Study|Protocol Violation|0|||
129823052|NCT02618434|467316534|FG002|Overall Study|Protocol Violation|1|||
129823053|NCT02618434|467316532|FG000|Overall Study|Other, Multiple categories|1|||
129823054|NCT02618434|467316533|FG001|Overall Study|Other, Multiple categories|1|||
129823055|NCT02618434|467316534|FG002|Overall Study|Other, Multiple categories|1|||
129823056|NCT03590041|467316535|FG000|Overall Study|Protocol Violation|4|||
129823057|NCT03590041|467316536|FG001|Overall Study|Protocol Violation|3|||
129823058|NCT03590041|467316535|FG000|Overall Study|No session data recorded|14|||
129823059|NCT03590041|467316536|FG001|Overall Study|No session data recorded|2|||
129823060|NCT01402544|467316537|FG000|Overall Study|Withdrawal by Subject|6|||
129823061|NCT00142584|467316538|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
129823062|NCT00142584|467316539|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
129823063|NCT00142584|467316538|FG000|Overall Study|Withdrawal by Subject|30|||
129823064|NCT00142584|467316539|FG001|Overall Study|Withdrawal by Subject|16|||
129823065|NCT00142584|467316538|FG000|Overall Study|Lost to Follow-up|22|||
129823066|NCT00142584|467316539|FG001|Overall Study|Lost to Follow-up|12|||
129823067|NCT00142584|467316538|FG000|Overall Study|Adverse Event|14|||
129823068|NCT00142584|467316539|FG001|Overall Study|Adverse Event|5|||
129823069|NCT00142584|467316538|FG000|Overall Study|Protocol Violation|4|||
129823070|NCT00142584|467316539|FG001|Overall Study|Protocol Violation|7|||
129823071|NCT00142584|467316538|FG000|Overall Study|Treatment Failure|2|||
129823072|NCT00142584|467316539|FG001|Overall Study|Treatment Failure|0|||
129823073|NCT01314443|467316541|FG000|Overall Study|Withdrawal by Subject|2|||
129823074|NCT01314443|467316542|FG001|Overall Study|Withdrawal by Subject|1|||
129823075|NCT01314443|467316543|FG002|Overall Study|Withdrawal by Subject|1|||
129823076|NCT01314443|467316544|FG003|Overall Study|Withdrawal by Subject|1|||
129823077|NCT01314443|467316541|FG000|Overall Study|Protocol Violation|2|||
129823078|NCT01314443|467316542|FG001|Overall Study|Protocol Violation|2|||
129823079|NCT01314443|467316543|FG002|Overall Study|Protocol Violation|1|||
129823080|NCT01314443|467316544|FG003|Overall Study|Protocol Violation|1|||
129823081|NCT02709785|467316546|FG000|Overall Study|Withdrawal by Subject|1|||
129823082|NCT02709785|467316547|FG001|Overall Study|Withdrawal by Subject|2|||
129823083|NCT02709785|467316548|FG002|Overall Study|Withdrawal by Subject|1|||
129823084|NCT00276159|467316551|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
129823085|NCT00333866|467316552|FG000|Overall Study|Adverse Event|23|||
129823086|NCT00333866|467316553|FG001|Overall Study|Adverse Event|37|||
129823087|NCT00333866|467316554|FG002|Overall Study|Adverse Event|38|||
129823088|NCT00333866|467316555|FG003|Overall Study|Adverse Event|47|||
129823089|NCT00333866|467316552|FG000|Overall Study|Other|3|||
129823090|NCT00333866|467316553|FG001|Overall Study|Other|2|||
129823091|NCT00333866|467316554|FG002|Overall Study|Other|2|||
129823092|NCT00333866|467316555|FG003|Overall Study|Other|2|||
129823093|NCT00333866|467316552|FG000|Overall Study|Lack of Efficacy|8|||
129823094|NCT00333866|467316553|FG001|Overall Study|Lack of Efficacy|6|||
129823095|NCT00333866|467316554|FG002|Overall Study|Lack of Efficacy|3|||
129823096|NCT00333866|467316555|FG003|Overall Study|Lack of Efficacy|5|||
129897420|NCT00742274|467584372|FG001|Overall Study|Withdrawal by Subject|2|||
129897421|NCT00742274|467584371|FG000|Overall Study|Removed for medical reasons|1|||
129897422|NCT00742274|467584372|FG001|Overall Study|Removed for medical reasons|1|||
129823097|NCT00333866|467316552|FG000|Overall Study|Lost to Follow-up|1|||
129897423|NCT00335556|467584375|FG000|Overall Study|Death|0|||
129823098|NCT00333866|467316553|FG001|Overall Study|Lost to Follow-up|2|||
129823099|NCT00333866|467316554|FG002|Overall Study|Lost to Follow-up|2|||
129823100|NCT00333866|467316555|FG003|Overall Study|Lost to Follow-up|2|||
129823101|NCT00333866|467316552|FG000|Overall Study|Withdrawal by Subject|8|||
129823102|NCT00333866|467316553|FG001|Overall Study|Withdrawal by Subject|14|||
129897424|NCT00335556|467584376|FG001|Overall Study|Death|5|||
129823103|NCT00333866|467316554|FG002|Overall Study|Withdrawal by Subject|4|||
129823104|NCT00333866|467316555|FG003|Overall Study|Withdrawal by Subject|9|||
129823105|NCT00333866|467316552|FG000|Overall Study|Randomized but not Treated|5|||
129823106|NCT00333866|467316553|FG001|Overall Study|Randomized but not Treated|3|||
129823107|NCT00333866|467316554|FG002|Overall Study|Randomized but not Treated|2|||
129823108|NCT00333866|467316555|FG003|Overall Study|Randomized but not Treated|1|||
129823109|NCT02927431|467316559|FG000|Overall Study|Withdrawal by Subject|0|||
129823110|NCT02927431|467316560|FG001|Overall Study|Withdrawal by Subject|0|||
129823111|NCT02927431|467316561|FG002|Overall Study|Withdrawal by Subject|1|||
129823112|NCT00673465|467316564|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823113|NCT00673465|467316565|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823114|NCT00673465|467316566|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823115|NCT00673465|467316567|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823116|NCT00673465|467316568|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
129823117|NCT00673465|467316569|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
129823118|NCT00673465|467316570|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823119|NCT00673465|467316571|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823120|NCT00673465|467316572|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823121|NCT00673465|467316573|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823122|NCT00673465|467316574|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823123|NCT00673465|467316575|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823124|NCT00673465|467316564|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823125|NCT00673465|467316565|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823126|NCT00673465|467316566|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823127|NCT00673465|467316567|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823128|NCT00673465|467316568|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
129823129|NCT00673465|467316569|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823130|NCT00673465|467316570|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823131|NCT00673465|467316571|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823132|NCT00673465|467316572|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823133|NCT00673465|467316573|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823134|NCT00673465|467316574|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823135|NCT00673465|467316575|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823136|NCT00429104|467316576|FG000|Overall Study|Protocol Violation|1|||
129823137|NCT01829191|467316577|FG000|Overall Study|Relocation|0|||
129823138|NCT01829191|467316578|FG001|Overall Study|Relocation|1|||
129823139|NCT01829191|467316577|FG000|Overall Study|Lens discomfort|0|||
129823140|NCT01829191|467316578|FG001|Overall Study|Lens discomfort|3|||
129823141|NCT01829191|467316577|FG000|Overall Study|Lens handling difficulty|1|||
129823142|NCT01829191|467316578|FG001|Overall Study|Lens handling difficulty|4|||
129823143|NCT01829191|467316577|FG000|Overall Study|Protocol Violation|4|||
129823144|NCT01829191|467316578|FG001|Overall Study|Protocol Violation|1|||
129823145|NCT01829191|467316577|FG000|Overall Study|Withdrawal by Subject|2|||
129823146|NCT01829191|467316578|FG001|Overall Study|Withdrawal by Subject|3|||
129823147|NCT01829191|467316577|FG000|Overall Study|Lost to Follow-up|0|||
129823148|NCT01829191|467316578|FG001|Overall Study|Lost to Follow-up|1|||
129823149|NCT01829191|467316577|FG000|Overall Study|Subject was fit for ortho - k|0|||
129823150|NCT01829191|467316578|FG001|Overall Study|Subject was fit for ortho - k|1|||
129823151|NCT01907815|467316579|FG000|Overall Study|Withdrawal by Subject|1|||
129823152|NCT01907815|467316580|FG001|Overall Study|Withdrawal by Subject|0|||
129823153|NCT01276353|467316581|FG000|Double-blind|Adverse Event|2|||
129823154|NCT01276353|467316582|FG001|Double-blind|Adverse Event|0|||
129823155|NCT01276353|467316581|FG000|Double-blind|Withdrawal by Subject|1|||
129823156|NCT01276353|467316582|FG001|Double-blind|Withdrawal by Subject|0|||
129823157|NCT01276353|467316581|FG000|Extension|Adverse Event|2|||
129823158|NCT01276353|467316582|FG001|Extension|Adverse Event|5|||
129823159|NCT01276353|467316581|FG000|Extension|Withdrawal by Subject|1|||
129823160|NCT01276353|467316582|FG001|Extension|Withdrawal by Subject|2|||
129823161|NCT01276353|467316581|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
129823162|NCT01276353|467316582|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
129823163|NCT01276353|467316581|FG000|Extension|Physician Decision|1|||
129823164|NCT01276353|467316582|FG001|Extension|Physician Decision|0|||
129823165|NCT01276353|467316581|FG000|Extension|Prohibited concomitant medications|0|||
129823166|NCT01276353|467316582|FG001|Extension|Prohibited concomitant medications|1|||
129823167|NCT00587639|467316583|FG000|Overall Study|Withdrawal by Subject|1|||
129823168|NCT01996982|467316584|FG000|Overall Study|PI/team left institution|7|||
129823169|NCT01195415|467316585|FG000|Overall Study|No repeat biopsy due to progression|2|||
129823170|NCT00533845|467316586|FG000|Overall Study|Physician Decision|1|||
129823171|NCT00533845|467316587|FG001|Overall Study|Physician Decision|0|||
129823172|NCT01288469|467316593|FG000|Overall Study|Adverse Event|4|||
129823173|NCT01288469|467316594|FG001|Overall Study|Adverse Event|1|||
129823174|NCT01288469|467316595|FG002|Overall Study|Adverse Event|1|||
129823175|NCT01288469|467316593|FG000|Overall Study|Poor compliance to protocol|0|||
129823176|NCT01288469|467316594|FG001|Overall Study|Poor compliance to protocol|1|||
129823177|NCT01288469|467316595|FG002|Overall Study|Poor compliance to protocol|0|||
129823178|NCT01288469|467316593|FG000|Overall Study|Participant Moved|1|||
130059692|NCT01606761|468172419|FG004|Prior to Week 24|Withdrawal by Subject|0|||
129823179|NCT01288469|467316594|FG001|Overall Study|Participant Moved|0|||
129823180|NCT01288469|467316595|FG002|Overall Study|Participant Moved|0|||
129823181|NCT01288469|467316593|FG000|Overall Study|Consent withdrawn by subject|1|||
129823182|NCT01288469|467316594|FG001|Overall Study|Consent withdrawn by subject|1|||
129823183|NCT01288469|467316595|FG002|Overall Study|Consent withdrawn by subject|1|||
129823184|NCT01288469|467316593|FG000|Overall Study|Exclusion criteria finally met|1|||
129823185|NCT01288469|467316594|FG001|Overall Study|Exclusion criteria finally met|0|||
129823186|NCT01288469|467316595|FG002|Overall Study|Exclusion criteria finally met|0|||
129823187|NCT00110149|467316596|FG000|Overall Study|Physician Decision|3|||
129823188|NCT00563381|467316597|FG000|Overall Study|Adverse Event|264|||
129823189|NCT00563381|467316598|FG001|Overall Study|Adverse Event|292|||
129823190|NCT00563381|467316597|FG000|Overall Study|Protocol Violation|66|||
129823191|NCT00563381|467316598|FG001|Overall Study|Protocol Violation|74|||
129823192|NCT00563381|467316597|FG000|Overall Study|Lost to Follow-up|7|||
129823193|NCT00563381|467316598|FG001|Overall Study|Lost to Follow-up|15|||
129823194|NCT00563381|467316597|FG000|Overall Study|Withdrawal by Subject|192|||
129823195|NCT00563381|467316598|FG001|Overall Study|Withdrawal by Subject|209|||
129823196|NCT00563381|467316597|FG000|Overall Study|Lack of Efficacy|32|||
129823197|NCT00563381|467316598|FG001|Overall Study|Lack of Efficacy|24|||
129823198|NCT00563381|467316597|FG000|Overall Study|Individual different reasons|24|||
129823199|NCT00563381|467316598|FG001|Overall Study|Individual different reasons|34|||
129823200|NCT02452398|467316601|FG000|Overall Study|Adverse Event|1|||
129823201|NCT02452398|467316601|FG000|Overall Study|Lost to Follow-up|28|||
129823202|NCT02452398|467316601|FG000|Overall Study|Physician Decision|2|||
129823203|NCT02452398|467316601|FG000|Overall Study|Withdrawal by Subject|6|||
129823204|NCT02452398|467316601|FG000|Overall Study|Moved away|4|||
129823205|NCT00001723|467316605|FG000|Overall Study|Lack of Efficacy|6|||
129823206|NCT00001723|467316606|FG001|Overall Study|Lack of Efficacy|7|||
129823207|NCT00001723|467316605|FG000|Overall Study|Lack of family interest|4|||
129823208|NCT00001723|467316606|FG001|Overall Study|Lack of family interest|5|||
129823209|NCT00001723|467316605|FG000|Overall Study|Lost to Follow-up|2|||
129823210|NCT00001723|467316606|FG001|Overall Study|Lost to Follow-up|2|||
129823211|NCT00001723|467316605|FG000|Overall Study|medication intolerance|1|||
129823212|NCT00001723|467316606|FG001|Overall Study|medication intolerance|2|||
129823213|NCT00927784|467316607|FG000|Overall Study|Death|1|||
129823214|NCT00927784|467316608|FG001|Overall Study|Death|0|||
129823215|NCT00927784|467316607|FG000|Overall Study|Withdrawal by Subject|1|||
129823216|NCT00927784|467316608|FG001|Overall Study|Withdrawal by Subject|0|||
129823217|NCT02170051|467316609|FG000|Overall Study|Withdrawal by Subject|10|||
129823218|NCT02170051|467316610|FG001|Overall Study|Withdrawal by Subject|10|||
129823219|NCT02170051|467316609|FG000|Overall Study|Lost to Follow-up|1|||
129823220|NCT02170051|467316610|FG001|Overall Study|Lost to Follow-up|3|||
129823221|NCT02643082|467316611|FG000|Period 1|Adverse Event|1|||
129823222|NCT02643082|467316612|FG001|Period 1|Adverse Event|0|||
129823223|NCT01867021|467316613|FG000|Overall Study|Adverse Event|0|||
129823224|NCT01867021|467316614|FG001|Overall Study|Adverse Event|1|||
129823225|NCT01867021|467316613|FG000|Overall Study|Not Eligible|0|||
129823226|NCT01867021|467316614|FG001|Overall Study|Not Eligible|1|||
129823227|NCT01867021|467316613|FG000|Overall Study|Death|1|||
129823228|NCT01867021|467316614|FG001|Overall Study|Death|0|||
129823229|NCT01867021|467316613|FG000|Overall Study|Lost to Follow-up|0|||
129823230|NCT01867021|467316614|FG001|Overall Study|Lost to Follow-up|2|||
129823231|NCT01867021|467316613|FG000|Overall Study|Withdrawal by Subject|1|||
129823232|NCT01867021|467316614|FG001|Overall Study|Withdrawal by Subject|6|||
129823233|NCT00881712|467316615|FG000|Overall Study|Death|1|||
129823234|NCT00881712|467316616|FG001|Overall Study|Death|0|||
129823235|NCT00881712|467316617|FG002|Overall Study|Death|0|||
129823236|NCT00881712|467316615|FG000|Overall Study|Withdrawal by Subject|1|||
129823237|NCT00881712|467316616|FG001|Overall Study|Withdrawal by Subject|0|||
129823238|NCT00881712|467316617|FG002|Overall Study|Withdrawal by Subject|0|||
129823239|NCT02505867|467316620|FG000|Overall Study|Lack of Efficacy|6|||
129823240|NCT02505867|467316621|FG001|Overall Study|Lack of Efficacy|6|||
129823241|NCT01862874|467316622|FG000|Overall Study|Randomized not treated|1|||
129823242|NCT01862874|467316623|FG001|Overall Study|Randomized not treated|0|||
129823243|NCT01862874|467316622|FG000|Overall Study|Adverse Event|0|||
129823244|NCT01862874|467316623|FG001|Overall Study|Adverse Event|3|||
129823245|NCT01862874|467316622|FG000|Overall Study|Lost to Follow-up|26|||
129823246|NCT01862874|467316623|FG001|Overall Study|Lost to Follow-up|29|||
129823247|NCT01862874|467316622|FG000|Overall Study|Physician Decision|5|||
129823248|NCT01862874|467316623|FG001|Overall Study|Physician Decision|3|||
129823249|NCT01862874|467316622|FG000|Overall Study|Withdrawn by parent/guardian|1|||
129823250|NCT01862874|467316623|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129823251|NCT01862874|467316622|FG000|Overall Study|Withdrawal by Subject|46|||
129823252|NCT01862874|467316623|FG001|Overall Study|Withdrawal by Subject|40|||
129823253|NCT01862874|467316622|FG000|Overall Study|Death|0|||
129823254|NCT01862874|467316623|FG001|Overall Study|Death|1|||
129823255|NCT02260921|467316624|FG000|Overall Study|Adverse Event|1|||
129823256|NCT02260921|467316625|FG001|Overall Study|Adverse Event|0|||
129823257|NCT02260921|467316624|FG000|Overall Study|Lost to Follow-up|4|||
129823258|NCT02260921|467316625|FG001|Overall Study|Lost to Follow-up|3|||
129823259|NCT02260921|467316624|FG000|Overall Study|Withdraw Consent|4|||
129823260|NCT02260921|467316625|FG001|Overall Study|Withdraw Consent|1|||
129823261|NCT02260921|467316624|FG000|Overall Study|Death|1|||
129823262|NCT02260921|467316625|FG001|Overall Study|Death|0|||
129823263|NCT02260921|467316624|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
129823264|NCT02260921|467316625|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
129823265|NCT03241342|467316631|FG000|Overall Study|Adverse Event|5|||
129823266|NCT03241342|467316632|FG001|Overall Study|Adverse Event|8|||
129823267|NCT03241342|467316633|FG002|Overall Study|Adverse Event|4|||
129823268|NCT03241342|467316631|FG000|Overall Study|Lack of Efficacy|0|||
129823269|NCT03241342|467316632|FG001|Overall Study|Lack of Efficacy|0|||
129823270|NCT03241342|467316633|FG002|Overall Study|Lack of Efficacy|1|||
129823271|NCT03241342|467316631|FG000|Overall Study|noncompliance with study drug|2|||
129823272|NCT03241342|467316632|FG001|Overall Study|noncompliance with study drug|1|||
129823273|NCT03241342|467316633|FG002|Overall Study|noncompliance with study drug|1|||
129823274|NCT03241342|467316631|FG000|Overall Study|sponsor decision|0|||
129823275|NCT03241342|467316632|FG001|Overall Study|sponsor decision|1|||
129823276|NCT03241342|467316633|FG002|Overall Study|sponsor decision|2|||
129823277|NCT03241342|467316631|FG000|Overall Study|not reported|15|||
129823278|NCT03241342|467316632|FG001|Overall Study|not reported|21|||
129823279|NCT03241342|467316633|FG002|Overall Study|not reported|19|||
129823280|NCT02068443|467318505|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129823281|NCT02068443|467318506|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
129823282|NCT02068443|467318507|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
129823283|NCT02068443|467318505|FG000|Overall Study|Voluntary Withdrawal|4|||
129823284|NCT02068443|467318506|FG001|Overall Study|Voluntary Withdrawal|0|||
129823285|NCT02068443|467318507|FG002|Overall Study|Voluntary Withdrawal|1|||
129823286|NCT02068443|467318505|FG000|Overall Study|Lack of Efficacy|2|||
129823287|NCT02068443|467318506|FG001|Overall Study|Lack of Efficacy|1|||
129823288|NCT02068443|467318507|FG002|Overall Study|Lack of Efficacy|0|||
129823289|NCT02068443|467318505|FG000|Overall Study|Other Reason Not Specified|1|||
129897425|NCT00335556|467584377|FG002|Overall Study|Death|0|||
129897426|NCT00335556|467584378|FG003|Overall Study|Death|0|||
129897427|NCT00335556|467584379|FG004|Overall Study|Death|1|||
129897428|NCT00335556|467584380|FG005|Overall Study|Death|0|||
129897429|NCT00335556|467584375|FG000|Overall Study|Lack of Efficacy|0|||
129897430|NCT00335556|467584376|FG001|Overall Study|Lack of Efficacy|19|||
129897431|NCT00335556|467584377|FG002|Overall Study|Lack of Efficacy|3|||
129897432|NCT00335556|467584378|FG003|Overall Study|Lack of Efficacy|3|||
129897433|NCT00335556|467584379|FG004|Overall Study|Lack of Efficacy|0|||
129897434|NCT00335556|467584380|FG005|Overall Study|Lack of Efficacy|1|||
129897435|NCT00335556|467584375|FG000|Overall Study|Physician Decision|0|||
129897436|NCT00335556|467584376|FG001|Overall Study|Physician Decision|6|||
129897437|NCT00335556|467584377|FG002|Overall Study|Physician Decision|2|||
129897438|NCT00335556|467584378|FG003|Overall Study|Physician Decision|1|||
129897439|NCT00335556|467584379|FG004|Overall Study|Physician Decision|0|||
129897440|NCT00335556|467584380|FG005|Overall Study|Physician Decision|0|||
129897441|NCT00335556|467584375|FG000|Overall Study|Ineligible|2|||
129897442|NCT00335556|467584376|FG001|Overall Study|Ineligible|0|||
129897443|NCT00335556|467584377|FG002|Overall Study|Ineligible|0|||
129897444|NCT00335556|467584378|FG003|Overall Study|Ineligible|0|||
129897445|NCT00335556|467584379|FG004|Overall Study|Ineligible|0|||
129897446|NCT00335556|467584380|FG005|Overall Study|Ineligible|0|||
129823290|NCT02068443|467318506|FG001|Overall Study|Other Reason Not Specified|0|||
129823291|NCT02068443|467318507|FG002|Overall Study|Other Reason Not Specified|0|||
129823292|NCT01986855|467318508|FG000|Overall Study|Adverse Event|1|||
129823293|NCT01986855|467318509|FG001|Overall Study|Adverse Event|0|||
129823294|NCT01986855|467318510|FG002|Overall Study|Adverse Event|0|||
129823295|NCT01986855|467318508|FG000|Overall Study|Death|3|||
129823296|NCT01986855|467318509|FG001|Overall Study|Death|4|||
129823297|NCT01986855|467318510|FG002|Overall Study|Death|4|||
129823298|NCT01986855|467318508|FG000|Overall Study|Lost to Follow-up|2|||
129823299|NCT01986855|467318509|FG001|Overall Study|Lost to Follow-up|1|||
129823300|NCT01986855|467318510|FG002|Overall Study|Lost to Follow-up|0|||
129823301|NCT01986855|467318508|FG000|Overall Study|Screen Failure|0|||
129897447|NCT00335556|467584375|FG000|Overall Study|Refusal of further protocol therapy|0|||
129823302|NCT01986855|467318509|FG001|Overall Study|Screen Failure|1|||
129823303|NCT01986855|467318510|FG002|Overall Study|Screen Failure|0|||
129823304|NCT01986855|467318508|FG000|Overall Study|Participant Moved|0|||
129823305|NCT01986855|467318509|FG001|Overall Study|Participant Moved|0|||
129823306|NCT01986855|467318510|FG002|Overall Study|Participant Moved|2|||
129823307|NCT01986855|467318508|FG000|Overall Study|Withdrawal by Subject|7|||
129823308|NCT01986855|467318509|FG001|Overall Study|Withdrawal by Subject|8|||
129823309|NCT01986855|467318510|FG002|Overall Study|Withdrawal by Subject|5|||
129897448|NCT00335556|467584376|FG001|Overall Study|Refusal of further protocol therapy|4|||
129897449|NCT00335556|467584377|FG002|Overall Study|Refusal of further protocol therapy|0|||
129823310|NCT00664742|467318511|FG000|Overall Study|Withdrawn due to adverse events|3|||
129823311|NCT00664742|467318511|FG000|Overall Study|Withdrawal by Subject|31|||
129823312|NCT00664742|467318511|FG000|Overall Study|Lost to Follow-up|92|||
129897450|NCT00335556|467584378|FG003|Overall Study|Refusal of further protocol therapy|1|||
129897451|NCT00335556|467584379|FG004|Overall Study|Refusal of further protocol therapy|0|||
129823313|NCT02825992|467318512|FG000|Overall Study|Withdrawal by Subject|4|||
129823314|NCT02825992|467318512|FG000|Overall Study|Lost to Follow-up|2|||
129823315|NCT02825992|467318512|FG000|Overall Study|Procedure terminated|2|||
129823316|NCT02279173|467318513|FG000|Overall Study|Protocol-specified Criteria|67|||
129823317|NCT02279173|467318513|FG000|Overall Study|Withdrawal by Subject|20|||
129823318|NCT02279173|467318513|FG000|Overall Study|Decision by Sponsor|4|||
129823319|NCT02279173|467318513|FG000|Overall Study|Lost to Follow-up|3|||
129823320|NCT00157950|467318514|FG000|Overall Study|Death|1|||
129823321|NCT00157950|467318515|FG001|Overall Study|Death|0|||
129823322|NCT00386776|467318520|FG000|Overall Study|Withdrawal by Subject|8|||
129823323|NCT01500629|467318521|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
129823324|NCT01500629|467318522|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
129823325|NCT00588848|467318523|FG000|Overall Study|Physician Decision|0|||
129823326|NCT00588848|467318524|FG001|Overall Study|Physician Decision|3|||
129823327|NCT01499667|467318525|FG000|Overall Study|administrative problems|4|||
129823328|NCT01499667|467318526|FG001|Overall Study|administrative problems|5|||
129823329|NCT01499667|467318527|FG002|Overall Study|administrative problems|5|||
129823330|NCT01499667|467318525|FG000|Overall Study|Protocol Violation|1|||
129823331|NCT01499667|467318526|FG001|Overall Study|Protocol Violation|3|||
129823332|NCT01499667|467318527|FG002|Overall Study|Protocol Violation|2|||
129823333|NCT01499667|467318525|FG000|Overall Study|Adverse Event|0|||
129823334|NCT01499667|467318526|FG001|Overall Study|Adverse Event|2|||
129823335|NCT01499667|467318527|FG002|Overall Study|Adverse Event|2|||
129823336|NCT01499667|467318525|FG000|Overall Study|Withdrawal by Subject|2|||
129823337|NCT01499667|467318526|FG001|Overall Study|Withdrawal by Subject|1|||
129823338|NCT01499667|467318527|FG002|Overall Study|Withdrawal by Subject|1|||
129823339|NCT01499667|467318525|FG000|Overall Study|Lack of Efficacy|2|||
129823340|NCT01499667|467318526|FG001|Overall Study|Lack of Efficacy|0|||
129823341|NCT01499667|467318527|FG002|Overall Study|Lack of Efficacy|0|||
129823342|NCT02902965|467318528|FG000|Overall Study|Withdrawal by Subject|10|||
129823343|NCT02673489|467318529|FG000|Treatment Period|Lost to Follow-up|3|||
129823344|NCT02673489|467318530|FG001|Treatment Period|Lost to Follow-up|0|||
129823345|NCT02673489|467318529|FG000|Treatment Period|Participant request to discontinue|1|||
129823346|NCT02673489|467318530|FG001|Treatment Period|Participant request to discontinue|1|||
129823347|NCT02673489|467318529|FG000|Treatment Period|Participant moved to another province|1|||
129823348|NCT02673489|467318530|FG001|Treatment Period|Participant moved to another province|0|||
129823349|NCT02673489|467318529|FG000|Treatment Period|Participant was incarcerated|0|||
129823350|NCT02673489|467318530|FG001|Treatment Period|Participant was incarcerated|1|||
129823351|NCT02673489|467318529|FG000|Treatment Period|Adverse Event|0|||
129823352|NCT02673489|467318530|FG001|Treatment Period|Adverse Event|1|||
129823353|NCT02673489|467318529|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
129823354|NCT02673489|467318530|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
129823355|NCT02673489|467318529|FG000|Follow Up Period|Unable to return for follow-up|0|||
129823356|NCT02673489|467318530|FG001|Follow Up Period|Unable to return for follow-up|1|||
129823357|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
129823358|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
129823359|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
129823360|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
129823361|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
129897452|NCT00335556|467584380|FG005|Overall Study|Refusal of further protocol therapy|0|||
129897453|NCT02365298|467584383|FG000|Period 2|incorrect Rx dispensed|1|||
129897454|NCT02365298|467584384|FG001|Period 2|incorrect Rx dispensed|0|||
129897455|NCT02365298|467584383|FG000|Period 2|Discontinued at request of Sponsor|1|||
129897456|NCT02365298|467584384|FG001|Period 2|Discontinued at request of Sponsor|0|||
129897457|NCT02365298|467584383|FG000|Period 2|Test Article longer available|0|||
129897458|NCT02365298|467584384|FG001|Period 2|Test Article longer available|1|||
129897459|NCT02365298|467584383|FG000|Period 2|Protocol Violation|0|||
129897460|NCT02365298|467584384|FG001|Period 2|Protocol Violation|1|||
129897461|NCT01878890|467584385|FG000|Overall Study|Protocol Violation|0|||
129897462|NCT01878890|467584386|FG001|Overall Study|Protocol Violation|1|||
129897463|NCT01878890|467584387|FG002|Overall Study|Protocol Violation|0|||
129897464|NCT01878890|467584388|FG003|Overall Study|Protocol Violation|0|||
129897465|NCT02974010|467584389|FG000|Overall Study|Lost to Follow-up|3|||
129897466|NCT02974010|467584390|FG001|Overall Study|Lost to Follow-up|1|||
129897467|NCT02974010|467584391|FG002|Overall Study|Lost to Follow-up|0|||
130059693|NCT01606761|468172415|FG000|Prior to Week 24|Adverse Event|11|||
129823362|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
129823363|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
129823364|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
129823365|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
129823366|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
129897468|NCT02974010|467584392|FG003|Overall Study|Lost to Follow-up|0|||
129897469|NCT02974010|467584389|FG000|Overall Study|Withdrawal by Subject|2|||
130059694|NCT01606761|468172416|FG001|Prior to Week 24|Adverse Event|18|||
130059695|NCT01606761|468172417|FG002|Prior to Week 24|Adverse Event|22|||
129823367|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
129823368|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
129823369|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
129823370|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
129823371|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
129823372|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
129823373|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
129823374|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
129823375|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Death|4|||
129823376|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Death|1|||
129823377|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
129823378|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
129823379|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
129823380|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
129823381|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
129823382|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
129823383|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
129823384|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
129823385|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
129823386|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
129823387|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
129823388|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
129823389|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
129823390|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
129823391|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
129823392|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
129823393|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
129823394|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
129823395|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
129823396|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
129823397|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
129823398|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
129823399|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
129823400|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
129823401|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
129823402|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
129823403|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
129823404|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
129823405|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
129823406|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
129823407|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
129823408|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
129823409|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
129823410|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
129823411|NCT02335489|467318533|FG000|Overall Study|Sponsor terminated study|4|||
129823412|NCT02335489|467318533|FG000|Overall Study|Lost to Follow-up|1|||
129823413|NCT02335489|467318533|FG000|Overall Study|Withdrawal by Subject|2|||
129823414|NCT02335489|467318533|FG000|Overall Study|Physician Decision|2|||
129823415|NCT02335489|467318533|FG000|Overall Study|Lack of Efficacy|1|||
129823416|NCT00503308|467318534|FG000|Overall Study|Protocol Violation|2|||
129823417|NCT00503308|467318535|FG001|Overall Study|Protocol Violation|1|||
129823418|NCT02233309|467318537|FG000|Overall Study|Physician Decision|5|||
129823419|NCT00232817|467318538|FG000|Overall Study|Protocol Violation|2|||
129823420|NCT00232817|467318539|FG001|Overall Study|Protocol Violation|1|||
129823421|NCT00799487|467318540|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
129897470|NCT02974010|467584390|FG001|Overall Study|Withdrawal by Subject|1|||
129897471|NCT02974010|467584391|FG002|Overall Study|Withdrawal by Subject|0|||
129897472|NCT02974010|467584392|FG003|Overall Study|Withdrawal by Subject|0|||
129897473|NCT02974010|467584389|FG000|Overall Study|Adverse Event|0|||
129897474|NCT02974010|467584390|FG001|Overall Study|Adverse Event|1|||
129823422|NCT00799487|467318541|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
129823423|NCT00799487|467318542|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
129823424|NCT00799487|467318540|FG000|Dose Adjustment Period|Adverse Event|2|||
129823425|NCT00799487|467318541|FG001|Dose Adjustment Period|Adverse Event|0|||
129823426|NCT00799487|467318542|FG002|Dose Adjustment Period|Adverse Event|0|||
129823427|NCT00799487|467318540|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
129823428|NCT00799487|467318541|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
129897475|NCT02974010|467584391|FG002|Overall Study|Adverse Event|0|||
129823429|NCT00799487|467318542|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
129823430|NCT00799487|467318540|FG000|Dose Adjustment Period|Investigator Discretion|2|||
129823431|NCT00799487|467318541|FG001|Dose Adjustment Period|Investigator Discretion|0|||
129823432|NCT00799487|467318542|FG002|Dose Adjustment Period|Investigator Discretion|0|||
129823433|NCT00799487|467318540|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
129823434|NCT00799487|467318541|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
129823435|NCT00799487|467318542|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
129823436|NCT00799487|467318540|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
129823437|NCT00799487|467318541|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
129823438|NCT00799487|467318542|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
129823439|NCT00799487|467318540|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
129823440|NCT00799487|467318541|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
129823441|NCT00799487|467318542|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
129823442|NCT00799487|467318540|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
129823443|NCT00799487|467318541|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
129823444|NCT00799487|467318542|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
129823445|NCT00799487|467318540|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
129823446|NCT00799487|467318541|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
129823447|NCT00799487|467318542|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
129823448|NCT00799487|467318540|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
129823449|NCT00799487|467318541|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
129823450|NCT00799487|467318542|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
129823451|NCT00799487|467318540|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
129823452|NCT00799487|467318541|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
129823453|NCT00799487|467318542|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
129823454|NCT00799487|467318540|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
129823455|NCT00799487|467318541|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
129823456|NCT00799487|467318542|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
129823457|NCT04481750|467318543|FG000|Period 1 (Fasted)|Adverse Event|0|||
129823458|NCT04481750|467318544|FG001|Period 1 (Fasted)|Adverse Event|0|||
129823459|NCT04481750|467318545|FG002|Period 1 (Fasted)|Adverse Event|1|||
129823460|NCT04481750|467318546|FG003|Period 1 (Fasted)|Adverse Event|0|||
129823461|NCT04481750|467318547|FG004|Period 1 (Fasted)|Adverse Event|0|||
129823462|NCT04481750|467318548|FG005|Period 1 (Fasted)|Adverse Event|0|||
129823463|NCT04481750|467318549|FG006|Period 1 (Fasted)|Adverse Event|0|||
129823464|NCT04481750|467318550|FG007|Period 1 (Fasted)|Adverse Event|0|||
129823465|NCT04481750|467318551|FG008|Period 1 (Fasted)|Adverse Event|0|||
129823466|NCT04481750|467318552|FG009|Period 1 (Fasted)|Adverse Event|0|||
129823467|NCT04481750|467318553|FG010|Period 1 (Fasted)|Adverse Event|0|||
129823468|NCT03263442|467318554|FG000|Inpatient Phase|Death|1|||
129823469|NCT03263442|467318555|FG001|Inpatient Phase|Death|0|||
129823470|NCT03263442|467318554|FG000|Inpatient Phase|Withdrawal by Subject|1|||
129823471|NCT03263442|467318555|FG001|Inpatient Phase|Withdrawal by Subject|0|||
129823472|NCT03263442|467318554|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
129823473|NCT03263442|467318555|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
129823474|NCT03263442|467318554|FG000|1-month Follow-Up|Lost to Follow-up|1|||
129823475|NCT03263442|467318555|FG001|1-month Follow-Up|Lost to Follow-up|0|||
129823476|NCT03263442|467318554|FG000|3-month Follow-Up|Lost to Follow-up|1|||
129823477|NCT03263442|467318555|FG001|3-month Follow-Up|Lost to Follow-up|3|||
129823478|NCT03263442|467318554|FG000|6-month Follow-Up|Lost to Follow-up|2|||
129823479|NCT03263442|467318555|FG001|6-month Follow-Up|Lost to Follow-up|2|||
129823480|NCT01463878|467318556|FG000|Overall Study|no longer met criteria for tube feed|2|||
129823481|NCT01463878|467318557|FG001|Overall Study|no longer met criteria for tube feed|2|||
129823482|NCT02436889|467318558|FG000|Overall Study|No improvement in symptoms|1|||
129823483|NCT02436889|467318559|FG001|Overall Study|No improvement in symptoms|0|||
129823484|NCT02436889|467318558|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
129823485|NCT02436889|467318559|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
129897476|NCT02974010|467584392|FG003|Overall Study|Adverse Event|0|||
129897477|NCT02974010|467584389|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
129897478|NCT02974010|467584390|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
129897479|NCT02974010|467584391|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
129897480|NCT02974010|467584392|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
129897481|NCT02974010|467584389|FG000|Overall Study|Lack of Efficacy|0|||
129897482|NCT02974010|467584390|FG001|Overall Study|Lack of Efficacy|0|||
129823486|NCT01084174|467318560|FG000|Overall Study|gastrointestinal symptoms|1|||
129823487|NCT01084174|467318561|FG001|Overall Study|gastrointestinal symptoms|1|||
129823488|NCT01084174|467318560|FG000|Overall Study|Eosinophilic esophagitis|0|||
129823489|NCT01084174|467318561|FG001|Overall Study|Eosinophilic esophagitis|1|||
129823490|NCT01084174|467318560|FG000|Overall Study|Anaphylaxis|0|||
129823491|NCT01084174|467318561|FG001|Overall Study|Anaphylaxis|1|||
129823492|NCT01084174|467318560|FG000|Overall Study|Participant noncompliance|0|||
129823493|NCT01084174|467318561|FG001|Overall Study|Participant noncompliance|1|||
129823494|NCT01034462|467318562|FG000|Overall Study|Adverse Event|7|||
129823495|NCT01034462|467318563|FG001|Overall Study|Adverse Event|17|||
129823496|NCT01034462|467318562|FG000|Overall Study|Lack of Efficacy|4|||
129823497|NCT01034462|467318563|FG001|Overall Study|Lack of Efficacy|4|||
129823498|NCT01034462|467318562|FG000|Overall Study|Protocol Violation|10|||
129823499|NCT01034462|467318563|FG001|Overall Study|Protocol Violation|7|||
129823500|NCT01034462|467318562|FG000|Overall Study|Withdrawal by Subject|9|||
129823501|NCT01034462|467318563|FG001|Overall Study|Withdrawal by Subject|8|||
129823502|NCT01034462|467318562|FG000|Overall Study|Lost to Follow-up|14|||
129823503|NCT01034462|467318563|FG001|Overall Study|Lost to Follow-up|16|||
129823504|NCT01034462|467318562|FG000|Overall Study|Other reasons|1|||
129823505|NCT01034462|467318563|FG001|Overall Study|Other reasons|2|||
129823506|NCT01484873|467318564|FG000|Overall Study|Withdrawal by Subject|2|||
129823507|NCT02564042|467318565|FG000|Overall Study|Adverse Event|4|||
129823508|NCT02564042|467318566|FG001|Overall Study|Adverse Event|4|||
129823509|NCT02564042|467318567|FG002|Overall Study|Adverse Event|3|||
129823510|NCT02564042|467318568|FG003|Overall Study|Adverse Event|0|||
129823511|NCT02564042|467318569|FG004|Overall Study|Adverse Event|0|||
129823512|NCT02564042|467318570|FG005|Overall Study|Adverse Event|1|||
129823513|NCT02564042|467318565|FG000|Overall Study|Lost to Follow-up|1|||
129823514|NCT02564042|467318566|FG001|Overall Study|Lost to Follow-up|1|||
129823515|NCT02564042|467318567|FG002|Overall Study|Lost to Follow-up|1|||
129823516|NCT02564042|467318568|FG003|Overall Study|Lost to Follow-up|0|||
129823517|NCT02564042|467318569|FG004|Overall Study|Lost to Follow-up|1|||
129823518|NCT02564042|467318570|FG005|Overall Study|Lost to Follow-up|1|||
129823519|NCT02564042|467318565|FG000|Overall Study|Physician Decision|1|||
129823520|NCT02564042|467318566|FG001|Overall Study|Physician Decision|0|||
129823521|NCT02564042|467318567|FG002|Overall Study|Physician Decision|0|||
129823522|NCT02564042|467318568|FG003|Overall Study|Physician Decision|1|||
129823523|NCT02564042|467318569|FG004|Overall Study|Physician Decision|0|||
129823524|NCT02564042|467318570|FG005|Overall Study|Physician Decision|0|||
129823525|NCT02564042|467318565|FG000|Overall Study|Withdrawal by Subject|5|||
129823526|NCT02564042|467318566|FG001|Overall Study|Withdrawal by Subject|3|||
129823527|NCT02564042|467318567|FG002|Overall Study|Withdrawal by Subject|2|||
129823528|NCT02564042|467318568|FG003|Overall Study|Withdrawal by Subject|2|||
129823529|NCT02564042|467318569|FG004|Overall Study|Withdrawal by Subject|10|||
129823530|NCT02564042|467318570|FG005|Overall Study|Withdrawal by Subject|12|||
129823531|NCT01549392|467318571|FG000|Overall Study|Withdrawal by Subject|1|||
129823532|NCT01549392|467318572|FG001|Overall Study|Withdrawal by Subject|0|||
129823533|NCT01356966|467318573|FG000|Overall Study|Withdrawal by Subject|1|||
129823534|NCT01356966|467318574|FG001|Overall Study|Withdrawal by Subject|2|||
129823535|NCT01356966|467318573|FG000|Overall Study|Physician Decision|1|||
129823536|NCT01356966|467318574|FG001|Overall Study|Physician Decision|0|||
129823537|NCT02743806|467318575|FG000|Overall Study|Adverse Event|9|||
129823538|NCT02743806|467318575|FG000|Overall Study|Lost to Follow-up|8|||
129823539|NCT02743806|467318575|FG000|Overall Study|Voluntary Withdrawal|54|||
129823540|NCT02743806|467318575|FG000|Overall Study|Study Termination|65|||
129823541|NCT02743806|467318575|FG000|Overall Study|Pregnancy|6|||
129823542|NCT02743806|467318575|FG000|Overall Study|No Longer Clinically Benefiting|27|||
129823543|NCT02743806|467318575|FG000|Overall Study|Reason Not Specified|12|||
129823544|NCT00849381|467318576|FG000|Overall Study|Adverse Event|1|||
129823545|NCT00849381|467318576|FG000|Overall Study|Lost to Follow-up|129|||
129823546|NCT00849381|467318576|FG000|Overall Study|Protocol Violation|5|||
129823547|NCT00849381|467318576|FG000|Overall Study|Withdrawal by Subject|6|||
129823548|NCT00849381|467318576|FG000|Overall Study|Other|4|||
129823549|NCT02289898|467318581|FG000|Overall Study|Death|5|||
129823550|NCT02289898|467318582|FG001|Overall Study|Death|4|||
129823551|NCT02289898|467318583|FG002|Overall Study|Death|3|||
129823552|NCT02289898|467318581|FG000|Overall Study|Physician Decision|2|||
129823553|NCT02289898|467318582|FG001|Overall Study|Physician Decision|5|||
129823554|NCT02289898|467318583|FG002|Overall Study|Physician Decision|2|||
129823555|NCT02289898|467318581|FG000|Overall Study|Withdrawal by Subject|0|||
129823556|NCT02289898|467318582|FG001|Overall Study|Withdrawal by Subject|4|||
129823557|NCT02289898|467318583|FG002|Overall Study|Withdrawal by Subject|1|||
129823558|NCT02289898|467318581|FG000|Overall Study|Adverse Event|3|||
129823559|NCT02289898|467318582|FG001|Overall Study|Adverse Event|5|||
129823560|NCT02289898|467318583|FG002|Overall Study|Adverse Event|5|||
129823561|NCT02289898|467318581|FG000|Overall Study|Disease progression|34|||
129823562|NCT02289898|467318582|FG001|Overall Study|Disease progression|28|||
129823563|NCT02289898|467318583|FG002|Overall Study|Disease progression|34|||
129823564|NCT02289898|467318581|FG000|Overall Study|Use of another anticancer therapy|0|||
129823565|NCT02289898|467318582|FG001|Overall Study|Use of another anticancer therapy|0|||
129823566|NCT02289898|467318583|FG002|Overall Study|Use of another anticancer therapy|1|||
129823567|NCT02289898|467318581|FG000|Overall Study|Other|8|||
129823568|NCT02289898|467318582|FG001|Overall Study|Other|7|||
129823569|NCT02289898|467318583|FG002|Overall Study|Other|10|||
129823570|NCT01828281|467318584|FG000|Overall Study|Withdrawal by Subject|1|||
129823571|NCT01828281|467318585|FG001|Overall Study|Withdrawal by Subject|0|||
129823572|NCT03070782|467318586|FG000|Overall Study|Adverse Event|3|||
129823573|NCT03070782|467318587|FG001|Overall Study|Adverse Event|0|||
129823574|NCT03070782|467318588|FG002|Overall Study|Adverse Event|3|||
129823575|NCT03070782|467318589|FG003|Overall Study|Adverse Event|1|||
129823576|NCT03070782|467318590|FG004|Overall Study|Adverse Event|6|||
129823577|NCT03070782|467318591|FG005|Overall Study|Adverse Event|2|||
129823578|NCT03070782|467318586|FG000|Overall Study|Withdrawal by Subject|2|||
129823579|NCT03070782|467318587|FG001|Overall Study|Withdrawal by Subject|1|||
129823580|NCT03070782|467318588|FG002|Overall Study|Withdrawal by Subject|1|||
129823581|NCT03070782|467318589|FG003|Overall Study|Withdrawal by Subject|0|||
129823582|NCT03070782|467318590|FG004|Overall Study|Withdrawal by Subject|4|||
129823583|NCT03070782|467318591|FG005|Overall Study|Withdrawal by Subject|3|||
129823584|NCT03070782|467318586|FG000|Overall Study|Reason Not Specified|2|||
129823585|NCT03070782|467318587|FG001|Overall Study|Reason Not Specified|0|||
129823586|NCT03070782|467318588|FG002|Overall Study|Reason Not Specified|0|||
129823587|NCT03070782|467318589|FG003|Overall Study|Reason Not Specified|1|||
129823588|NCT03070782|467318590|FG004|Overall Study|Reason Not Specified|2|||
129823589|NCT03070782|467318591|FG005|Overall Study|Reason Not Specified|1|||
129823590|NCT03070782|467318586|FG000|Overall Study|Ineligibility|0|||
129823591|NCT03070782|467318587|FG001|Overall Study|Ineligibility|0|||
129823592|NCT03070782|467318588|FG002|Overall Study|Ineligibility|0|||
129823593|NCT03070782|467318589|FG003|Overall Study|Ineligibility|1|||
129823594|NCT03070782|467318590|FG004|Overall Study|Ineligibility|0|||
129823595|NCT03070782|467318591|FG005|Overall Study|Ineligibility|1|||
129823596|NCT03070782|467318586|FG000|Overall Study|Pregnancy|0|||
129823597|NCT03070782|467318587|FG001|Overall Study|Pregnancy|0|||
129823598|NCT03070782|467318588|FG002|Overall Study|Pregnancy|0|||
129823599|NCT03070782|467318589|FG003|Overall Study|Pregnancy|1|||
129823600|NCT03070782|467318590|FG004|Overall Study|Pregnancy|0|||
129823601|NCT03070782|467318591|FG005|Overall Study|Pregnancy|0|||
129823602|NCT03070782|467318586|FG000|Overall Study|Investigator Judgement|0|||
129823603|NCT03070782|467318587|FG001|Overall Study|Investigator Judgement|0|||
129823604|NCT03070782|467318588|FG002|Overall Study|Investigator Judgement|0|||
129823605|NCT03070782|467318589|FG003|Overall Study|Investigator Judgement|1|||
129823606|NCT03070782|467318590|FG004|Overall Study|Investigator Judgement|0|||
129823607|NCT03070782|467318591|FG005|Overall Study|Investigator Judgement|0|||
129823608|NCT01083576|467318592|FG000|Overall Study|Treatment Failure|6|||
129823609|NCT01083576|467318593|FG001|Overall Study|Treatment Failure|1|||
129823610|NCT03527966|467318594|FG000|Overall Study|Lost to Follow-up|3|||
129823611|NCT03527966|467318595|FG001|Overall Study|Lost to Follow-up|0|||
129823612|NCT02746874|467318596|FG000|Overall Study|Withdrawal by Subject|0|||
129823613|NCT02746874|467318597|FG001|Overall Study|Withdrawal by Subject|1|||
129823614|NCT02746874|467318596|FG000|Overall Study|Surgery Date Changed|0|||
129823615|NCT02746874|467318597|FG001|Overall Study|Surgery Date Changed|2|||
129823616|NCT00022633|467318600|FG000|Overall Study|Adverse Event|11|||
129823617|NCT00022633|467318601|FG001|Overall Study|Adverse Event|1|||
129823618|NCT00022633|467318600|FG000|Overall Study|Refusal unrelated to adverse event|1|||
129823619|NCT00022633|467318601|FG001|Overall Study|Refusal unrelated to adverse event|0|||
129823620|NCT00022633|467318600|FG000|Overall Study|Progression/relapse|9|||
129823621|NCT00022633|467318601|FG001|Overall Study|Progression/relapse|2|||
129823622|NCT00022633|467318600|FG000|Overall Study|Death|4|||
129823623|NCT00022633|467318601|FG001|Overall Study|Death|0|||
129823624|NCT00022633|467318600|FG000|Overall Study|Other - not protocol specified|3|||
129823625|NCT00022633|467318601|FG001|Overall Study|Other - not protocol specified|2|||
129823626|NCT00022633|467318600|FG000|Overall Study|Ineligible|4|||
129823627|NCT00022633|467318601|FG001|Overall Study|Ineligible|0|||
129823628|NCT00487747|467318602|FG000|Overall Study|Adverse Event|1|||
129823629|NCT00487747|467318602|FG000|Overall Study|Lost to Follow-up|9|||
130059696|NCT01606761|468172418|FG003|Prior to Week 24|Adverse Event|0|||
129823630|NCT00487747|467318602|FG000|Overall Study|Lack of Efficacy|1|||
129823631|NCT03402386|467318613|FG000|Overall Study|Adverse Event|3|||
130059697|NCT01606761|468172419|FG004|Prior to Week 24|Adverse Event|0|||
129823632|NCT03402386|467318613|FG000|Overall Study|Physician Decision|1|||
130059698|NCT01606761|468172415|FG000|Prior to Week 24|Lack of Efficacy|15|||
129823633|NCT03402386|467318613|FG000|Overall Study|Difficult to control Hb|2|||
129823634|NCT02485574|467318620|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
129823635|NCT00255047|467318622|FG000|Overall Study|Serious Adverse Events|2|||
129823636|NCT00255047|467318623|FG001|Overall Study|Serious Adverse Events|1|||
129823637|NCT00255047|467318624|FG002|Overall Study|Serious Adverse Events|2|||
129823638|NCT00255047|467318625|FG003|Overall Study|Serious Adverse Events|1|||
129823639|NCT00255047|467318622|FG000|Overall Study|Adverse Event|0|||
129823640|NCT00255047|467318623|FG001|Overall Study|Adverse Event|3|||
129823641|NCT00255047|467318624|FG002|Overall Study|Adverse Event|2|||
129823642|NCT00255047|467318625|FG003|Overall Study|Adverse Event|1|||
129823643|NCT00255047|467318622|FG000|Overall Study|Protocol Violation|13|||
129823644|NCT00255047|467318623|FG001|Overall Study|Protocol Violation|13|||
129823645|NCT00255047|467318624|FG002|Overall Study|Protocol Violation|16|||
129823646|NCT00255047|467318625|FG003|Overall Study|Protocol Violation|20|||
130059699|NCT01606761|468172416|FG001|Prior to Week 24|Lack of Efficacy|14|||
130059700|NCT01606761|468172417|FG002|Prior to Week 24|Lack of Efficacy|8|||
130059701|NCT01606761|468172418|FG003|Prior to Week 24|Lack of Efficacy|0|||
130059702|NCT01606761|468172419|FG004|Prior to Week 24|Lack of Efficacy|0|||
130059703|NCT01606761|468172415|FG000|Prior to Week 24|Physician Decision|0|||
130059704|NCT01606761|468172416|FG001|Prior to Week 24|Physician Decision|3|||
130059705|NCT01606761|468172417|FG002|Prior to Week 24|Physician Decision|1|||
129823647|NCT00255047|467318622|FG000|Overall Study|Lost to Follow-up|9|||
130059706|NCT01606761|468172418|FG003|Prior to Week 24|Physician Decision|0|||
130059707|NCT01606761|468172419|FG004|Prior to Week 24|Physician Decision|0|||
130059708|NCT01606761|468172415|FG000|Prior to Week 24|Other|4|||
130059709|NCT01606761|468172416|FG001|Prior to Week 24|Other|7|||
130059710|NCT01606761|468172417|FG002|Prior to Week 24|Other|5|||
130059711|NCT01606761|468172418|FG003|Prior to Week 24|Other|0|||
130059712|NCT01606761|468172419|FG004|Prior to Week 24|Other|0|||
130059713|NCT01606761|468172415|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
130059714|NCT01606761|468172416|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
130059715|NCT01606761|468172417|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
130059716|NCT01606761|468172418|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
130059717|NCT01606761|468172419|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
130059718|NCT01606761|468172415|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
130059719|NCT01606761|468172416|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
130059720|NCT01606761|468172417|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
130059721|NCT01606761|468172418|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
130059722|NCT01606761|468172419|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
130059723|NCT01606761|468172415|FG000|Week 24 to Week 52|Adverse Event|0|||
130059724|NCT01606761|468172416|FG001|Week 24 to Week 52|Adverse Event|11|||
130059725|NCT01606761|468172417|FG002|Week 24 to Week 52|Adverse Event|14|||
130059726|NCT01606761|468172418|FG003|Week 24 to Week 52|Adverse Event|3|||
130059727|NCT01606761|468172419|FG004|Week 24 to Week 52|Adverse Event|15|||
130059728|NCT01606761|468172415|FG000|Week 24 to Week 52|Death|0|||
130059729|NCT01606761|468172416|FG001|Week 24 to Week 52|Death|0|||
130059730|NCT01606761|468172417|FG002|Week 24 to Week 52|Death|2|||
129823648|NCT00255047|467318623|FG001|Overall Study|Lost to Follow-up|8|||
129823649|NCT00255047|467318624|FG002|Overall Study|Lost to Follow-up|5|||
129823650|NCT00255047|467318625|FG003|Overall Study|Lost to Follow-up|6|||
129823651|NCT00255047|467318622|FG000|Overall Study|Withdrawal by Subject|24|||
129823652|NCT00255047|467318623|FG001|Overall Study|Withdrawal by Subject|23|||
129823653|NCT00255047|467318624|FG002|Overall Study|Withdrawal by Subject|25|||
129823654|NCT00255047|467318625|FG003|Overall Study|Withdrawal by Subject|18|||
129823655|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
129823656|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
129823657|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
129823658|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
129823659|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
129823660|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
129823661|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
129823662|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
129823663|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
129823664|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
129823665|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
129823666|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
129823667|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
129823668|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
129823669|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
129823670|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
129823671|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
129823672|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
129823673|NCT01333059|467318629|FG000|Overall Study|Physician Decision|3|||
129823674|NCT01333059|467318630|FG001|Overall Study|Physician Decision|3|||
129823675|NCT01333059|467318629|FG000|Overall Study|Protocol Violation|3|||
129823676|NCT01333059|467318630|FG001|Overall Study|Protocol Violation|0|||
129823677|NCT01348347|467318631|FG000|Overall Study|Withdrawal by Subject|1|||
130059731|NCT01606761|468172418|FG003|Week 24 to Week 52|Death|1|||
130059732|NCT01606761|468172419|FG004|Week 24 to Week 52|Death|0|||
130059733|NCT01606761|468172415|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
129823678|NCT01348347|467318632|FG001|Overall Study|Withdrawal by Subject|1|||
129823679|NCT01348347|467318633|FG002|Overall Study|Withdrawal by Subject|1|||
129823680|NCT01348347|467318631|FG000|Overall Study|Progressive disease|2|||
129823681|NCT01348347|467318632|FG001|Overall Study|Progressive disease|5|||
129823682|NCT01348347|467318633|FG002|Overall Study|Progressive disease|5|||
129823683|NCT00748033|467318634|FG000|Overall Study|Adverse Event|0|||
129823684|NCT00748033|467318635|FG001|Overall Study|Adverse Event|1|||
129823685|NCT03060629|467318636|FG000|Overall Study|Death|4|||
130059734|NCT01606761|468172416|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
130059735|NCT01606761|468172417|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
130059736|NCT01606761|468172418|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
130059737|NCT01606761|468172419|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
129823686|NCT03060629|467318637|FG001|Overall Study|Death|5|||
129823687|NCT03060629|467318636|FG000|Overall Study|Withdrawal by Subject|50|||
129823688|NCT03060629|467318637|FG001|Overall Study|Withdrawal by Subject|35|||
129823689|NCT03060629|467318636|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
129823690|NCT03060629|467318637|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
129823691|NCT03060629|467318636|FG000|Overall Study|Participant Relocate|15|||
129823692|NCT03060629|467318637|FG001|Overall Study|Participant Relocate|15|||
129823693|NCT03060629|467318636|FG000|Overall Study|Unable to Contact Participant|34|||
129823694|NCT03060629|467318637|FG001|Overall Study|Unable to Contact Participant|23|||
129823695|NCT03060629|467318636|FG000|Overall Study|Investigator Decision|7|||
129823696|NCT03060629|467318637|FG001|Overall Study|Investigator Decision|7|||
129823697|NCT03060629|467318636|FG000|Overall Study|Study Terminated by Sponsor|1100|||
129823698|NCT03060629|467318637|FG001|Overall Study|Study Terminated by Sponsor|1123|||
129823699|NCT03060629|467318636|FG000|Overall Study|Other|4|||
129823700|NCT03060629|467318637|FG001|Overall Study|Other|4|||
129823701|NCT01405742|467318638|FG000|Overall Study|Lost to Follow-up|1|||
129823702|NCT01405742|467318639|FG001|Overall Study|Lost to Follow-up|0|||
129823703|NCT03672747|467318641|FG000|Overall Study|Lost to Follow-up|1|||
129823704|NCT03672747|467318642|FG001|Overall Study|Lost to Follow-up|1|||
129823705|NCT03672747|467318643|FG002|Overall Study|Lost to Follow-up|2|||
129823706|NCT03672747|467318644|FG003|Overall Study|Lost to Follow-up|2|||
129823707|NCT03672747|467318645|FG004|Overall Study|Lost to Follow-up|2|||
129823708|NCT03672747|467318646|FG005|Overall Study|Lost to Follow-up|1|||
129823709|NCT01782495|467318650|FG000|Overall Study|Adverse Event|0|||
129823710|NCT01782495|467318651|FG001|Overall Study|Adverse Event|0|||
129823711|NCT01782495|467318652|FG002|Overall Study|Adverse Event|0|||
129823712|NCT01782495|467318653|FG003|Overall Study|Adverse Event|0|||
129823713|NCT01782495|467318654|FG004|Overall Study|Adverse Event|0|||
129823714|NCT01782495|467318655|FG005|Overall Study|Adverse Event|0|||
129823715|NCT01782495|467318656|FG006|Overall Study|Adverse Event|0|||
129823716|NCT01782495|467318657|FG007|Overall Study|Adverse Event|2|||
129823717|NCT01782495|467318658|FG008|Overall Study|Adverse Event|0|||
129823718|NCT01782495|467318659|FG009|Overall Study|Adverse Event|0|||
129823719|NCT01782495|467318660|FG010|Overall Study|Adverse Event|0|||
129823720|NCT01782495|467318650|FG000|Overall Study|Withdrew Consent|0|||
129823721|NCT01782495|467318651|FG001|Overall Study|Withdrew Consent|1|||
129823722|NCT01782495|467318652|FG002|Overall Study|Withdrew Consent|0|||
129823723|NCT01782495|467318653|FG003|Overall Study|Withdrew Consent|0|||
129823724|NCT01782495|467318654|FG004|Overall Study|Withdrew Consent|0|||
129823725|NCT01782495|467318655|FG005|Overall Study|Withdrew Consent|0|||
129823726|NCT01782495|467318656|FG006|Overall Study|Withdrew Consent|0|||
129823727|NCT01782495|467318657|FG007|Overall Study|Withdrew Consent|1|||
129823728|NCT01782495|467318658|FG008|Overall Study|Withdrew Consent|0|||
129823729|NCT01782495|467318659|FG009|Overall Study|Withdrew Consent|0|||
129823730|NCT01782495|467318660|FG010|Overall Study|Withdrew Consent|0|||
129823731|NCT03428360|467318661|FG000|Overall Study|Informed consent withdrawn|5|||
129823732|NCT03428360|467318661|FG000|Overall Study|Withdrawal by Subject|4|||
129823733|NCT03428360|467318661|FG000|Overall Study|Lost to Follow-up|5|||
129823734|NCT03428360|467318661|FG000|Overall Study|Physician Decision|2|||
129823735|NCT03428360|467318661|FG000|Overall Study|Informed consent withdrawn|5|||
129823736|NCT03428360|467318661|FG000|Overall Study|Study terminated by sponsor|10|||
129823737|NCT03428360|467318661|FG000|Overall Study|Non-compliant with study|1|||
129823738|NCT03428360|467318661|FG000|Overall Study|Non-compliant with study drug|3|||
129823739|NCT03428360|467318661|FG000|Overall Study|Death|3|||
129823740|NCT03428360|467318661|FG000|Overall Study|Adverse Event|1|||
129823741|NCT03428360|467318661|FG000|Overall Study|Not on antiepileptic drug|1|||
129823742|NCT03334903|467318665|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
129823743|NCT03334903|467318666|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
129823744|NCT03334903|467318665|FG000|Overall Study|Protocol Violation|1|||
129823745|NCT03334903|467318666|FG001|Overall Study|Protocol Violation|3|||
129823746|NCT03334903|467318665|FG000|Overall Study|Surgery postponed|1|||
129823747|NCT03334903|467318666|FG001|Overall Study|Surgery postponed|0|||
129823748|NCT03334903|467318665|FG000|Overall Study|Adverse Event|1|||
129823749|NCT03334903|467318666|FG001|Overall Study|Adverse Event|1|||
129823750|NCT03334903|467318665|FG000|Overall Study|Withdrawal by Subject|0|||
129823751|NCT03334903|467318666|FG001|Overall Study|Withdrawal by Subject|1|||
129823752|NCT03032705|467318667|FG000|Overall Study|Lost to Follow-up|16|||
129823753|NCT03032705|467318668|FG001|Overall Study|Lost to Follow-up|17|||
129823754|NCT03032705|467318667|FG000|Overall Study|did not quality|6|||
129823755|NCT03032705|467318668|FG001|Overall Study|did not quality|6|||
129823756|NCT02759471|467318669|FG000|Overall Study|discomfort|2|||
129823757|NCT02927080|467320197|FG000|Overall Study|Withdrawal by Subject|0|||
129823758|NCT02927080|467320198|FG001|Overall Study|Withdrawal by Subject|0|||
129823759|NCT02927080|467320199|FG002|Overall Study|Withdrawal by Subject|0|||
129823760|NCT02927080|467320200|FG003|Overall Study|Withdrawal by Subject|0|||
129823761|NCT02927080|467320201|FG004|Overall Study|Withdrawal by Subject|1|||
129823762|NCT02927080|467320202|FG005|Overall Study|Withdrawal by Subject|0|||
129823763|NCT02927080|467320203|FG006|Overall Study|Withdrawal by Subject|1|||
129823764|NCT02927080|467320204|FG007|Overall Study|Withdrawal by Subject|1|||
129823765|NCT02927080|467320205|FG008|Overall Study|Withdrawal by Subject|0|||
129823766|NCT02927080|467320206|FG009|Overall Study|Withdrawal by Subject|2|||
129823767|NCT02927080|467320197|FG000|Overall Study|Willingness to comply with protocol|0|||
129823768|NCT02927080|467320198|FG001|Overall Study|Willingness to comply with protocol|0|||
129823769|NCT02927080|467320199|FG002|Overall Study|Willingness to comply with protocol|0|||
129823770|NCT02927080|467320200|FG003|Overall Study|Willingness to comply with protocol|0|||
129823771|NCT02927080|467320201|FG004|Overall Study|Willingness to comply with protocol|0|||
129823772|NCT02927080|467320202|FG005|Overall Study|Willingness to comply with protocol|0|||
129823773|NCT02927080|467320203|FG006|Overall Study|Willingness to comply with protocol|0|||
129823774|NCT02927080|467320204|FG007|Overall Study|Willingness to comply with protocol|0|||
129823775|NCT02927080|467320205|FG008|Overall Study|Willingness to comply with protocol|0|||
129823776|NCT02927080|467320206|FG009|Overall Study|Willingness to comply with protocol|1|||
129823777|NCT02927080|467320197|FG000|Overall Study|Study terminated by Sponsor|0|||
129823778|NCT02927080|467320198|FG001|Overall Study|Study terminated by Sponsor|0|||
129823779|NCT02927080|467320199|FG002|Overall Study|Study terminated by Sponsor|0|||
129823780|NCT02927080|467320200|FG003|Overall Study|Study terminated by Sponsor|0|||
129823781|NCT02927080|467320201|FG004|Overall Study|Study terminated by Sponsor|0|||
129823782|NCT02927080|467320202|FG005|Overall Study|Study terminated by Sponsor|0|||
129823783|NCT02927080|467320203|FG006|Overall Study|Study terminated by Sponsor|6|||
129823784|NCT02927080|467320204|FG007|Overall Study|Study terminated by Sponsor|7|||
129823785|NCT02927080|467320205|FG008|Overall Study|Study terminated by Sponsor|2|||
129823786|NCT02927080|467320206|FG009|Overall Study|Study terminated by Sponsor|3|||
129823787|NCT02927080|467320197|FG000|Overall Study|Adverse Event|0|||
129823788|NCT02927080|467320198|FG001|Overall Study|Adverse Event|1|||
129823789|NCT02927080|467320199|FG002|Overall Study|Adverse Event|0|||
129823790|NCT02927080|467320200|FG003|Overall Study|Adverse Event|0|||
129823791|NCT02927080|467320201|FG004|Overall Study|Adverse Event|0|||
129823792|NCT02927080|467320202|FG005|Overall Study|Adverse Event|0|||
129823793|NCT02927080|467320203|FG006|Overall Study|Adverse Event|0|||
130059738|NCT01606761|468172415|FG000|Week 24 to Week 52|Physician Decision|0|||
129823794|NCT02927080|467320204|FG007|Overall Study|Adverse Event|1|||
129823795|NCT02927080|467320205|FG008|Overall Study|Adverse Event|0|||
129823796|NCT02927080|467320206|FG009|Overall Study|Adverse Event|1|||
129823797|NCT02927080|467320197|FG000|Overall Study|Other|0|||
129823798|NCT02927080|467320198|FG001|Overall Study|Other|0|||
129823799|NCT02927080|467320199|FG002|Overall Study|Other|0|||
129823800|NCT02927080|467320200|FG003|Overall Study|Other|0|||
129823801|NCT02927080|467320201|FG004|Overall Study|Other|0|||
129823802|NCT02927080|467320202|FG005|Overall Study|Other|0|||
129823803|NCT02927080|467320203|FG006|Overall Study|Other|1|||
129823804|NCT02927080|467320204|FG007|Overall Study|Other|0|||
129823805|NCT02927080|467320205|FG008|Overall Study|Other|1|||
129823806|NCT02927080|467320206|FG009|Overall Study|Other|0|||
129823807|NCT02892760|467320207|FG000|Overall Study|Withdrawal by Subject|3|||
129823808|NCT02259582|467320208|FG000|Overall Study|Physician Decision|0|||
129823809|NCT02259582|467320209|FG001|Overall Study|Physician Decision|1|||
129823810|NCT02259582|467320210|FG002|Overall Study|Physician Decision|0|||
129823811|NCT02259582|467320208|FG000|Overall Study|Death|0|||
129823812|NCT02259582|467320209|FG001|Overall Study|Death|0|||
129823813|NCT02259582|467320210|FG002|Overall Study|Death|1|||
129823814|NCT02259582|467320208|FG000|Overall Study|Adverse Event|1|||
129823815|NCT02259582|467320209|FG001|Overall Study|Adverse Event|0|||
129823816|NCT02259582|467320210|FG002|Overall Study|Adverse Event|1|||
129823817|NCT02259582|467320208|FG000|Overall Study|Withdrawal by Subject|0|||
129823818|NCT02259582|467320209|FG001|Overall Study|Withdrawal by Subject|0|||
129823819|NCT02259582|467320210|FG002|Overall Study|Withdrawal by Subject|1|||
129823820|NCT02259582|467320208|FG000|Overall Study|Disease progression|14|||
129823821|NCT02259582|467320209|FG001|Overall Study|Disease progression|15|||
129823822|NCT02259582|467320210|FG002|Overall Study|Disease progression|17|||
129823823|NCT02259582|467320208|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
130059739|NCT01606761|468172416|FG001|Week 24 to Week 52|Physician Decision|1|||
130059740|NCT01606761|468172417|FG002|Week 24 to Week 52|Physician Decision|1|||
129823824|NCT02259582|467320209|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
129823825|NCT02259582|467320210|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
129823826|NCT00531050|467320211|FG000|Part 1: Period 1|Adverse Event|0|||
129823827|NCT00531050|467320212|FG001|Part 1: Period 1|Adverse Event|1|||
129823828|NCT00531050|467320213|FG002|Part 1: Period 1|Adverse Event|0|||
129823829|NCT00531050|467320214|FG003|Part 1: Period 1|Adverse Event|0|||
129823830|NCT00531050|467320215|FG004|Part 1: Period 1|Adverse Event|0|||
129823831|NCT00531050|467320216|FG005|Part 1: Period 1|Adverse Event|0|||
129823832|NCT00531050|467320211|FG000|Part 1: Period 1|Protocol Deviation|0|||
129823833|NCT00531050|467320212|FG001|Part 1: Period 1|Protocol Deviation|0|||
129823834|NCT00531050|467320213|FG002|Part 1: Period 1|Protocol Deviation|0|||
129823835|NCT00531050|467320214|FG003|Part 1: Period 1|Protocol Deviation|1|||
129823836|NCT00531050|467320215|FG004|Part 1: Period 1|Protocol Deviation|0|||
129823837|NCT00531050|467320216|FG005|Part 1: Period 1|Protocol Deviation|0|||
129823838|NCT00531050|467320211|FG000|Part 1: Period 3|Adverse Event|1|||
129823839|NCT00531050|467320212|FG001|Part 1: Period 3|Adverse Event|0|||
129823840|NCT00531050|467320213|FG002|Part 1: Period 3|Adverse Event|0|||
129823841|NCT00531050|467320214|FG003|Part 1: Period 3|Adverse Event|0|||
129823842|NCT00531050|467320215|FG004|Part 1: Period 3|Adverse Event|0|||
129823843|NCT00531050|467320216|FG005|Part 1: Period 3|Adverse Event|0|||
129823844|NCT00531050|467320211|FG000|Part 2: Period 1|Adverse Event|0|||
129823845|NCT00531050|467320212|FG001|Part 2: Period 1|Adverse Event|0|||
129823846|NCT00531050|467320213|FG002|Part 2: Period 1|Adverse Event|0|||
129823847|NCT00531050|467320214|FG003|Part 2: Period 1|Adverse Event|0|||
129823848|NCT00531050|467320215|FG004|Part 2: Period 1|Adverse Event|0|||
129823849|NCT00531050|467320216|FG005|Part 2: Period 1|Adverse Event|1|||
129823850|NCT00531050|467320211|FG000|Part 2: Period 3|Abnormal test procedure|1|||
129823851|NCT00531050|467320212|FG001|Part 2: Period 3|Abnormal test procedure|0|||
129823852|NCT00531050|467320213|FG002|Part 2: Period 3|Abnormal test procedure|0|||
129823853|NCT00531050|467320214|FG003|Part 2: Period 3|Abnormal test procedure|0|||
129823854|NCT00531050|467320215|FG004|Part 2: Period 3|Abnormal test procedure|0|||
129823855|NCT00531050|467320216|FG005|Part 2: Period 3|Abnormal test procedure|1|||
129823856|NCT00475176|467320219|FG000|Overall Study|Adverse Event|2|||
129823857|NCT00475176|467320219|FG000|Overall Study|Withdrawal by Subject|1|||
129823858|NCT00475176|467320219|FG000|Overall Study|Protocol Violation|1|||
129823859|NCT03804879|467320220|FG000|Overall Study|Adverse Event|3|||
129823860|NCT03804879|467320221|FG001|Overall Study|Adverse Event|0|||
129823861|NCT03804879|467320220|FG000|Overall Study|Study Terminated By Sponsor|10|||
129823862|NCT03804879|467320221|FG001|Overall Study|Study Terminated By Sponsor|12|||
129823863|NCT03804879|467320220|FG000|Overall Study|Withdrawal by Subject|3|||
129823864|NCT03804879|467320221|FG001|Overall Study|Withdrawal by Subject|1|||
129823865|NCT01585428|467320222|FG000|Overall Study|Death during treatment|1|||
129823866|NCT01585428|467320223|FG001|Overall Study|Death during treatment|0|||
129823867|NCT04273217|467320225|FG000|Overall Study|Lost to Follow-up|0|||
129823868|NCT04273217|467320226|FG001|Overall Study|Lost to Follow-up|0|||
129823869|NCT04273217|467320227|FG002|Overall Study|Lost to Follow-up|0|||
129823870|NCT04273217|467320228|FG003|Overall Study|Lost to Follow-up|0|||
129823871|NCT04273217|467320229|FG004|Overall Study|Lost to Follow-up|0|||
129823872|NCT04273217|467320230|FG005|Overall Study|Lost to Follow-up|1|||
129823873|NCT04273217|467320225|FG000|Overall Study|Participant non-compliance|0|||
129823874|NCT04273217|467320226|FG001|Overall Study|Participant non-compliance|0|||
129823875|NCT04273217|467320227|FG002|Overall Study|Participant non-compliance|0|||
129823876|NCT04273217|467320228|FG003|Overall Study|Participant non-compliance|0|||
129823877|NCT04273217|467320229|FG004|Overall Study|Participant non-compliance|1|||
129823878|NCT04273217|467320230|FG005|Overall Study|Participant non-compliance|0|||
129823879|NCT04273217|467320225|FG000|Overall Study|Positive urine drug screen|1|||
129823880|NCT04273217|467320226|FG001|Overall Study|Positive urine drug screen|0|||
129823881|NCT04273217|467320227|FG002|Overall Study|Positive urine drug screen|1|||
129823882|NCT04273217|467320228|FG003|Overall Study|Positive urine drug screen|0|||
129823883|NCT04273217|467320229|FG004|Overall Study|Positive urine drug screen|0|||
129823884|NCT04273217|467320230|FG005|Overall Study|Positive urine drug screen|1|||
129823885|NCT01988103|467320231|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
129823886|NCT01988103|467320232|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
129823887|NCT01988103|467320233|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
129823888|NCT01988103|467320234|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
129823889|NCT01988103|467320235|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
129823890|NCT01988103|467320231|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
129823891|NCT01988103|467320232|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
129823892|NCT01988103|467320233|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
129823893|NCT01988103|467320234|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
129823894|NCT01988103|467320235|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
129823895|NCT01988103|467320231|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
129823896|NCT01988103|467320232|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
129823897|NCT01988103|467320233|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
129823898|NCT01988103|467320234|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129823899|NCT01988103|467320235|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129823900|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
129823901|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
129823902|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
129823903|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
129823904|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
129823905|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
129823906|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
129823907|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
129823908|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
129823909|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
129823910|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
129823911|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
129823912|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
129823913|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
129823914|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
129823915|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
129823916|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
129823917|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
129823918|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
129823919|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
129823920|NCT00311623|467320242|FG000|Overall Study|Physician Decision|0|||
129823921|NCT00311623|467320243|FG001|Overall Study|Physician Decision|0|||
129823922|NCT00311623|467320244|FG002|Overall Study|Physician Decision|2|||
129823923|NCT03998189|467320245|FG000|Overall Study|Lack of Efficacy|0|||
129823924|NCT03998189|467320246|FG001|Overall Study|Lack of Efficacy|1|||
129823925|NCT03414424|467320247|FG000|Overall Study|Screened out after consent|0|||
129823926|NCT03414424|467320248|FG001|Overall Study|Screened out after consent|2|||
129823927|NCT03414424|467320247|FG000|Overall Study|Lost to Follow-up|0|||
129823928|NCT03414424|467320248|FG001|Overall Study|Lost to Follow-up|1|||
129823929|NCT01949051|467320254|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
129823930|NCT01949051|467320255|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823931|NCT01949051|467320256|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823932|NCT01949051|467320257|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
129823933|NCT01949051|467320258|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823934|NCT01949051|467320259|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823935|NCT01949051|467320254|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
129823936|NCT01949051|467320255|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823937|NCT01949051|467320256|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823938|NCT01949051|467320257|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823939|NCT01949051|467320258|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823940|NCT01949051|467320259|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823941|NCT01949051|467320254|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823942|NCT01949051|467320255|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823943|NCT01949051|467320256|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823944|NCT01949051|467320257|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823945|NCT01949051|467320258|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823946|NCT01949051|467320259|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
129823947|NCT01949051|467320254|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823948|NCT01949051|467320255|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
129823949|NCT01949051|467320256|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823950|NCT01949051|467320257|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823951|NCT01949051|467320258|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823952|NCT01949051|467320259|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823953|NCT01949051|467320254|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823954|NCT01949051|467320255|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823955|NCT01949051|467320256|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
129823956|NCT01949051|467320257|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823957|NCT01949051|467320258|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823958|NCT01949051|467320259|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823959|NCT02611778|467320261|FG000|Overall Study|Withdrawal by Subject|2|||
129823960|NCT02611778|467320262|FG001|Overall Study|Withdrawal by Subject|8|||
129823961|NCT02611778|467320261|FG000|Overall Study|Adverse Event|1|||
129823962|NCT02611778|467320262|FG001|Overall Study|Adverse Event|2|||
129823963|NCT02611778|467320261|FG000|Overall Study|Death|2|||
129823964|NCT02611778|467320262|FG001|Overall Study|Death|1|||
129823965|NCT02611778|467320261|FG000|Overall Study|Protocol Violation|1|||
129823966|NCT02611778|467320262|FG001|Overall Study|Protocol Violation|0|||
129823967|NCT02611778|467320261|FG000|Overall Study|Lost to Follow-up|3|||
129823968|NCT02611778|467320262|FG001|Overall Study|Lost to Follow-up|1|||
129823969|NCT02611778|467320261|FG000|Overall Study|Need for alternative treatment|1|||
129823970|NCT02611778|467320262|FG001|Overall Study|Need for alternative treatment|0|||
129823971|NCT02611778|467320261|FG000|Overall Study|Other Reason|2|||
129823972|NCT02611778|467320262|FG001|Overall Study|Other Reason|1|||
129823973|NCT02956486|467320277|FG000|Core Phase|Adverse Event|51|||
129823974|NCT02956486|467320278|FG001|Core Phase|Adverse Event|88|||
129823975|NCT02956486|467320279|FG002|Core Phase|Adverse Event|0|||
129823976|NCT02956486|467320277|FG000|Core Phase|Lost to Follow-up|8|||
129823977|NCT02956486|467320278|FG001|Core Phase|Lost to Follow-up|6|||
129823978|NCT02956486|467320279|FG002|Core Phase|Lost to Follow-up|0|||
129823979|NCT02956486|467320277|FG000|Core Phase|Inadequate therapeutic effect|4|||
129823980|NCT02956486|467320278|FG001|Core Phase|Inadequate therapeutic effect|5|||
129823981|NCT02956486|467320279|FG002|Core Phase|Inadequate therapeutic effect|0|||
129823982|NCT02956486|467320277|FG000|Core Phase|Withdrawal by Subject|101|||
129823983|NCT02956486|467320278|FG001|Core Phase|Withdrawal by Subject|104|||
129823984|NCT02956486|467320279|FG002|Core Phase|Withdrawal by Subject|0|||
130059741|NCT01606761|468172418|FG003|Week 24 to Week 52|Physician Decision|0|||
130059742|NCT01606761|468172419|FG004|Week 24 to Week 52|Physician Decision|0|||
130059743|NCT01606761|468172415|FG000|Week 24 to Week 52|Other|0|||
129823985|NCT02956486|467320277|FG000|Core Phase|Study terminated by sponsor|888|||
129823986|NCT02956486|467320278|FG001|Core Phase|Study terminated by sponsor|848|||
129823987|NCT02956486|467320279|FG002|Core Phase|Study terminated by sponsor|0|||
129823988|NCT02956486|467320277|FG000|Core Phase|Other|27|||
129823989|NCT02956486|467320278|FG001|Core Phase|Other|18|||
129823990|NCT02956486|467320279|FG002|Core Phase|Other|0|||
129823991|NCT02956486|467320277|FG000|Core Phase|Not treated|0|||
129823992|NCT02956486|467320278|FG001|Core Phase|Not treated|3|||
129823993|NCT02956486|467320279|FG002|Core Phase|Not treated|0|||
129823994|NCT02956486|467320277|FG000|Extension Phase|Adverse Event|0|||
129823995|NCT02956486|467320278|FG001|Extension Phase|Adverse Event|0|||
129823996|NCT02956486|467320279|FG002|Extension Phase|Adverse Event|2|||
129823997|NCT02956486|467320277|FG000|Extension Phase|Study terminated by sponsor|0|||
129823998|NCT02956486|467320278|FG001|Extension Phase|Study terminated by sponsor|0|||
129823999|NCT02956486|467320279|FG002|Extension Phase|Study terminated by sponsor|16|||
129824000|NCT02956486|467320277|FG000|Extension Phase|Not Treated|0|||
129824001|NCT02956486|467320278|FG001|Extension Phase|Not Treated|0|||
129824002|NCT02956486|467320279|FG002|Extension Phase|Not Treated|1|||
129824003|NCT03325075|467320282|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
129824004|NCT03325075|467320283|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
129824005|NCT03325075|467320284|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
129824006|NCT03325075|467320285|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
129824007|NCT03325075|467320282|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129824008|NCT03325075|467320283|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
129824009|NCT03325075|467320284|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129824010|NCT03325075|467320285|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129824011|NCT03325075|467320282|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
129824012|NCT03325075|467320283|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
129824013|NCT03325075|467320284|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
129824014|NCT03325075|467320285|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
129824015|NCT00422591|467320286|FG000|Overall Study|Physician Decision|4|||
129824016|NCT00422591|467320286|FG000|Overall Study|Withdrawal by Subject|2|||
129824017|NCT01408914|467320289|FG000|Overall Study|Could not complete tx in protocol period|5|||
129824018|NCT01408914|467320290|FG001|Overall Study|Could not complete tx in protocol period|5|||
129824019|NCT01408914|467320291|FG002|Overall Study|Could not complete tx in protocol period|6|||
129824020|NCT01408914|467320289|FG000|Overall Study|Lost to Follow-up|4|||
129824021|NCT01408914|467320290|FG001|Overall Study|Lost to Follow-up|1|||
129824022|NCT01408914|467320291|FG002|Overall Study|Lost to Follow-up|2|||
129824023|NCT01408914|467320289|FG000|Overall Study|Physician Decision|1|||
129824024|NCT01408914|467320290|FG001|Overall Study|Physician Decision|1|||
129824025|NCT01408914|467320291|FG002|Overall Study|Physician Decision|0|||
129824026|NCT01408914|467320289|FG000|Overall Study|Withdrawal by Subject|1|||
129824027|NCT01408914|467320290|FG001|Overall Study|Withdrawal by Subject|0|||
129824028|NCT01408914|467320291|FG002|Overall Study|Withdrawal by Subject|1|||
129824029|NCT01408914|467320289|FG000|Overall Study|Moved out of study jurisdiction|1|||
129824030|NCT01408914|467320290|FG001|Overall Study|Moved out of study jurisdiction|1|||
129824031|NCT01408914|467320291|FG002|Overall Study|Moved out of study jurisdiction|0|||
129824032|NCT01408914|467320289|FG000|Overall Study|Late exclusion|0|||
129824033|NCT01408914|467320290|FG001|Overall Study|Late exclusion|3|||
129824034|NCT01408914|467320291|FG002|Overall Study|Late exclusion|3|||
129824035|NCT01408914|467320289|FG000|Overall Study|Change in local TB/HIV norms|0|||
129824036|NCT01408914|467320290|FG001|Overall Study|Change in local TB/HIV norms|1|||
129824037|NCT01408914|467320291|FG002|Overall Study|Change in local TB/HIV norms|1|||
129824038|NCT00330616|467320294|FG000|Overall Study|Adverse Event|13|||
129824039|NCT00330616|467320294|FG000|Overall Study|Lack of Efficacy|1|||
129824040|NCT00330616|467320294|FG000|Overall Study|Lost to Follow-up|2|||
129824041|NCT00330616|467320294|FG000|Overall Study|Withdrawal by Subject|4|||
129824042|NCT00330616|467320294|FG000|Overall Study|Other|1|||
129824043|NCT00811473|467320295|FG000|Overall Study|Adverse Event|3|||
129824044|NCT00811473|467320296|FG001|Overall Study|Adverse Event|12|||
130059744|NCT01606761|468172416|FG001|Week 24 to Week 52|Other|1|||
129824045|NCT00811473|467320295|FG000|Overall Study|Lost to Follow-up|5|||
130059745|NCT01606761|468172417|FG002|Week 24 to Week 52|Other|5|||
129824046|NCT00811473|467320296|FG001|Overall Study|Lost to Follow-up|1|||
129824047|NCT00811473|467320295|FG000|Overall Study|Withdrawal by Subject|2|||
129824048|NCT00811473|467320296|FG001|Overall Study|Withdrawal by Subject|4|||
129824049|NCT00811473|467320295|FG000|Overall Study|Severe non-compliance to protocol|2|||
129824050|NCT00811473|467320296|FG001|Overall Study|Severe non-compliance to protocol|4|||
129824051|NCT00811473|467320295|FG000|Overall Study|Lack of therapeutic response|4|||
129824052|NCT00811473|467320296|FG001|Overall Study|Lack of therapeutic response|1|||
129824053|NCT00811473|467320295|FG000|Overall Study|Condition under investigation worsened|1|||
130059746|NCT01606761|468172418|FG003|Week 24 to Week 52|Other|2|||
130059747|NCT01606761|468172419|FG004|Week 24 to Week 52|Other|2|||
129824054|NCT00811473|467320296|FG001|Overall Study|Condition under investigation worsened|3|||
129824055|NCT00811473|467320295|FG000|Overall Study|Other 2|4|||
129824056|NCT00811473|467320296|FG001|Overall Study|Other 2|1|||
129824057|NCT00811473|467320295|FG000|Overall Study|Incorrect Enrollment|1|||
129824058|NCT00811473|467320296|FG001|Overall Study|Incorrect Enrollment|0|||
129824059|NCT00811473|467320295|FG000|Overall Study|Safety Reasons|1|||
129824060|NCT00811473|467320296|FG001|Overall Study|Safety Reasons|0|||
129824061|NCT00667368|467320304|FG000|Overall Study|Lost to Follow-up|176|||
129824062|NCT00667368|467320305|FG001|Overall Study|Lost to Follow-up|155|||
129824063|NCT00667368|467320304|FG000|Overall Study|Discontinued early|24|||
129824064|NCT00667368|467320305|FG001|Overall Study|Discontinued early|17|||
129824065|NCT01585194|467320308|FG000|Overall Study|Withdrawal by Subject|1|||
129824066|NCT01585194|467320308|FG000|Overall Study|Physician Decision|2|||
129824067|NCT01585194|467320308|FG000|Overall Study|Lack of insurance|1|||
129824068|NCT00732615|467320309|FG000|Overall Study|Withdrawal by Subject|3|||
129824069|NCT00732615|467320310|FG001|Overall Study|Withdrawal by Subject|1|||
129824070|NCT00732615|467320309|FG000|Overall Study|Lost to Follow-up|0|||
129824071|NCT00732615|467320310|FG001|Overall Study|Lost to Follow-up|1|||
129824072|NCT00732615|467320309|FG000|Overall Study|Adverse Event|0|||
129824073|NCT00732615|467320310|FG001|Overall Study|Adverse Event|2|||
129824074|NCT00732615|467320309|FG000|Overall Study|Physician Decision|3|||
129824075|NCT00732615|467320310|FG001|Overall Study|Physician Decision|0|||
129824076|NCT00732615|467320309|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
129824077|NCT00732615|467320310|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
129824078|NCT03566823|467320311|FG000|Overall Study|Lack of Efficacy|0|||
129824079|NCT03566823|467320312|FG001|Overall Study|Lack of Efficacy|1|||
129824080|NCT03566823|467320313|FG002|Overall Study|Lack of Efficacy|0|||
129824081|NCT03566823|467320311|FG000|Overall Study|Withdrawal by Subject|1|||
129824082|NCT03566823|467320312|FG001|Overall Study|Withdrawal by Subject|2|||
129824083|NCT03566823|467320313|FG002|Overall Study|Withdrawal by Subject|0|||
129824084|NCT03566823|467320311|FG000|Overall Study|Adverse Event|1|||
129824085|NCT03566823|467320312|FG001|Overall Study|Adverse Event|0|||
129824086|NCT03566823|467320313|FG002|Overall Study|Adverse Event|2|||
129824087|NCT02733367|467320314|FG000|Overall Study|Withdrawal by Subject|6|||
129824088|NCT00191789|467320317|FG000|Overall Study|Adverse Event|5|||
129824089|NCT00191789|467320317|FG000|Overall Study|Patient: Satisfactory Response|5|||
129824090|NCT00191789|467320317|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
129824091|NCT00191789|467320317|FG000|Overall Study|Withdrawal by Subject|4|||
129824092|NCT00191789|467320317|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
129824093|NCT00191789|467320317|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
129824094|NCT00191789|467320317|FG000|Overall Study|Death - Not Study-Drug Related|1|||
129824095|NCT01922089|467320320|FG000|Overall Study|Adverse Event|18|||
129824096|NCT01922089|467320321|FG001|Overall Study|Adverse Event|13|||
129824097|NCT01922089|467320320|FG000|Overall Study|Protocol Deviation|10|||
129824098|NCT01922089|467320321|FG001|Overall Study|Protocol Deviation|7|||
129824099|NCT01922089|467320320|FG000|Overall Study|Withdrawal by Subject|3|||
129824100|NCT01922089|467320321|FG001|Overall Study|Withdrawal by Subject|4|||
129824101|NCT01922089|467320320|FG000|Overall Study|administrative problems|4|||
129824102|NCT01922089|467320321|FG001|Overall Study|administrative problems|1|||
129824103|NCT01922089|467320320|FG000|Overall Study|Physician Decision|2|||
129824104|NCT01922089|467320321|FG001|Overall Study|Physician Decision|3|||
129824105|NCT01922089|467320320|FG000|Overall Study|Death|2|||
129824106|NCT01922089|467320321|FG001|Overall Study|Death|1|||
129824107|NCT01922089|467320320|FG000|Overall Study|Lost to Follow-up|0|||
129824108|NCT01922089|467320321|FG001|Overall Study|Lost to Follow-up|1|||
129824109|NCT04903626|467320325|FG000|Overall Study|Lost to Follow-up|6|||
129824110|NCT04903626|467320325|FG000|Overall Study|Withdrawal by Subject|1|||
129824111|NCT04903626|467320325|FG000|Overall Study|Other, Not Specified|1|||
129824112|NCT00165776|467320329|FG000|Overall Study|Lack of Efficacy|0|||
129824113|NCT00165776|467320330|FG001|Overall Study|Lack of Efficacy|0|||
129824114|NCT00165776|467320331|FG002|Overall Study|Lack of Efficacy|0|||
129824115|NCT00165776|467320332|FG003|Overall Study|Lack of Efficacy|1|||
129824116|NCT00165776|467320329|FG000|Overall Study|Withdrawal by Subject|4|||
130059748|NCT01606761|468172415|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
129824117|NCT00165776|467320330|FG001|Overall Study|Withdrawal by Subject|1|||
129824118|NCT00165776|467320331|FG002|Overall Study|Withdrawal by Subject|2|||
130059749|NCT01606761|468172416|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
129824119|NCT00165776|467320332|FG003|Overall Study|Withdrawal by Subject|0|||
129824120|NCT00165776|467320329|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
129824121|NCT00165776|467320330|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
129824122|NCT00165776|467320331|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
129824123|NCT00165776|467320332|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
129824124|NCT01850524|467320341|FG000|Overall Study|Lost to Follow-up|5|||
129824125|NCT01850524|467320342|FG001|Overall Study|Lost to Follow-up|10|||
129824126|NCT01850524|467320341|FG000|Overall Study|Withdrawal by Subject|24|||
129824127|NCT01850524|467320342|FG001|Overall Study|Withdrawal by Subject|22|||
129824128|NCT01850524|467320341|FG000|Overall Study|Reason not Specified|142|||
129824129|NCT01850524|467320342|FG001|Overall Study|Reason not Specified|141|||
129824130|NCT00368355|467320343|FG000|Overall Study|Adverse Event|1|||
129824131|NCT00368355|467320344|FG001|Overall Study|Adverse Event|0|||
129824132|NCT00368355|467320343|FG000|Overall Study|Death|2|||
129824133|NCT00368355|467320344|FG001|Overall Study|Death|4|||
129824134|NCT00368355|467320343|FG000|Overall Study|Relapse|6|||
129824135|NCT00368355|467320344|FG001|Overall Study|Relapse|10|||
129824136|NCT00368355|467320343|FG000|Overall Study|Subsequent transplant|0|||
129824137|NCT00368355|467320344|FG001|Overall Study|Subsequent transplant|3|||
129824138|NCT00368355|467320343|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
129824139|NCT00368355|467320344|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
129824140|NCT00396591|467320349|FG000|Overall Study|Disease Progression|13|||
129824141|NCT00396591|467320349|FG000|Overall Study|Adverse Event|2|||
129824142|NCT00396591|467320349|FG000|Overall Study|Participant request|1|||
129824143|NCT01013701|467320350|FG000|Overall Study|study prematurely terminated|7|||
129824144|NCT02671422|467320353|FG000|Overall Study|Lost to Follow-up|1|||
129824145|NCT02671422|467320353|FG000|Overall Study|Adverse Event|68|||
129824146|NCT02671422|467320353|FG000|Overall Study|Lack of Efficacy|1|||
129824147|NCT02671422|467320353|FG000|Overall Study|Lost to Follow-up|4|||
129824148|NCT02671422|467320353|FG000|Overall Study|Withdrawal by Subject|7|||
129824149|NCT02671422|467320353|FG000|Overall Study|Progressive Disease|156|||
129824150|NCT02671422|467320353|FG000|Overall Study|Worsening of Disease|4|||
129824151|NCT02671422|467320353|FG000|Overall Study|Sponsor decision|5|||
129824152|NCT02671422|467320353|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
129824153|NCT02671422|467320353|FG000|Overall Study|Not treated with Vargatef®|3|||
129824154|NCT02671422|467320353|FG000|Overall Study|Other not defined above|3|||
129824155|NCT04772755|467320354|FG000|Overall Study|Withdrawal by Subject|1|||
129824156|NCT04772755|467320355|FG001|Overall Study|Withdrawal by Subject|0|||
129824157|NCT04772755|467320354|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
129824158|NCT04772755|467320355|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
129824159|NCT01905657|467320356|FG000|Overall Study|Adverse Event|23|||
129824160|NCT01905657|467320357|FG001|Overall Study|Adverse Event|17|||
130059750|NCT01606761|468172417|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
130059751|NCT01606761|468172418|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
130059752|NCT01606761|468172419|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
129824161|NCT01905657|467320358|FG002|Overall Study|Adverse Event|18|||
129824162|NCT01905657|467320356|FG000|Overall Study|Clinical Progression|103|||
129824163|NCT01905657|467320357|FG001|Overall Study|Clinical Progression|78|||
129824164|NCT01905657|467320358|FG002|Overall Study|Clinical Progression|59|||
129824165|NCT01905657|467320356|FG000|Overall Study|Death|40|||
129824166|NCT01905657|467320357|FG001|Overall Study|Death|43|||
129824167|NCT01905657|467320358|FG002|Overall Study|Death|47|||
129824168|NCT01905657|467320356|FG000|Overall Study|Excluded Medication|13|||
129824169|NCT01905657|467320357|FG001|Overall Study|Excluded Medication|16|||
129824170|NCT01905657|467320358|FG002|Overall Study|Excluded Medication|9|||
129824171|NCT01905657|467320356|FG000|Overall Study|Lost to Follow-up|1|||
129824172|NCT01905657|467320357|FG001|Overall Study|Lost to Follow-up|2|||
129824173|NCT01905657|467320358|FG002|Overall Study|Lost to Follow-up|1|||
129824174|NCT01905657|467320356|FG000|Overall Study|Physician Decision|5|||
129824175|NCT01905657|467320357|FG001|Overall Study|Physician Decision|8|||
129824176|NCT01905657|467320358|FG002|Overall Study|Physician Decision|12|||
129824177|NCT01905657|467320356|FG000|Overall Study|Protocol Violation|2|||
129824178|NCT01905657|467320357|FG001|Overall Study|Protocol Violation|1|||
129824179|NCT01905657|467320358|FG002|Overall Study|Protocol Violation|1|||
129824180|NCT01905657|467320356|FG000|Overall Study|Screen Failure|0|||
129824181|NCT01905657|467320357|FG001|Overall Study|Screen Failure|1|||
129824182|NCT01905657|467320358|FG002|Overall Study|Screen Failure|0|||
129824183|NCT01905657|467320356|FG000|Overall Study|Withdrawal by Subject|15|||
129824184|NCT01905657|467320357|FG001|Overall Study|Withdrawal by Subject|21|||
129824185|NCT01905657|467320358|FG002|Overall Study|Withdrawal by Subject|53|||
129824186|NCT01905657|467320356|FG000|Overall Study|Sponsor Decision|1|||
129824187|NCT01905657|467320357|FG001|Overall Study|Sponsor Decision|0|||
129824188|NCT01905657|467320358|FG002|Overall Study|Sponsor Decision|0|||
129824189|NCT04702997|467320359|FG000|Overall Study|Withdrawal by Subject|1|||
129824190|NCT04702997|467320360|FG001|Overall Study|Withdrawal by Subject|1|||
129824191|NCT01386554|467320365|FG000|Overall Study|Lost to Follow-up|0|||
129824192|NCT01386554|467320366|FG001|Overall Study|Lost to Follow-up|0|||
129824193|NCT01386554|467320367|FG002|Overall Study|Lost to Follow-up|1|||
129824194|NCT01386554|467320365|FG000|Overall Study|Adverse Event|2|||
129824195|NCT01386554|467320366|FG001|Overall Study|Adverse Event|5|||
129824196|NCT01386554|467320367|FG002|Overall Study|Adverse Event|2|||
129824197|NCT01386554|467320365|FG000|Overall Study|Progressive disease|1|||
129824198|NCT01386554|467320366|FG001|Overall Study|Progressive disease|2|||
129824199|NCT01386554|467320367|FG002|Overall Study|Progressive disease|2|||
129824200|NCT01386554|467320365|FG000|Overall Study|Administration of live vaccines|0|||
129824201|NCT01386554|467320366|FG001|Overall Study|Administration of live vaccines|1|||
129824202|NCT01386554|467320367|FG002|Overall Study|Administration of live vaccines|0|||
129824203|NCT01386554|467320365|FG000|Overall Study|Investigator discretion|0|||
129824204|NCT01386554|467320366|FG001|Overall Study|Investigator discretion|0|||
129824205|NCT01386554|467320367|FG002|Overall Study|Investigator discretion|1|||
129824206|NCT01386554|467320365|FG000|Overall Study|Reason not collected|0|||
129824207|NCT01386554|467320366|FG001|Overall Study|Reason not collected|1|||
129824208|NCT01386554|467320367|FG002|Overall Study|Reason not collected|0|||
129824209|NCT02879305|467320369|FG000|Overall Study|Investigator Site Closed|55|||
129824210|NCT02879305|467320370|FG001|Overall Study|Investigator Site Closed|57|||
129824211|NCT02879305|467320369|FG000|Overall Study|Withdrawal by Subject|44|||
129824212|NCT02879305|467320370|FG001|Overall Study|Withdrawal by Subject|42|||
129824213|NCT02879305|467320369|FG000|Overall Study|Lost to Follow-up|17|||
129824214|NCT02879305|467320370|FG001|Overall Study|Lost to Follow-up|12|||
129824215|NCT02879305|467320369|FG000|Overall Study|Other|1|||
129824216|NCT02879305|467320370|FG001|Overall Study|Other|0|||
129824217|NCT00001596|467322311|FG000|Overall Study|Death|1|||
129824218|NCT00001596|467322312|FG001|Overall Study|Death|0|||
129824219|NCT00001596|467322311|FG000|Overall Study|Withdrawal by Subject|3|||
129824220|NCT00001596|467322312|FG001|Overall Study|Withdrawal by Subject|1|||
129824221|NCT00001596|467322311|FG000|Overall Study|Study Termination|12|||
129824222|NCT00001596|467322312|FG001|Overall Study|Study Termination|9|||
129824223|NCT00001596|467322311|FG000|Overall Study|Adverse Event|1|||
129824224|NCT00001596|467322312|FG001|Overall Study|Adverse Event|0|||
129824225|NCT00463346|467322313|FG000|Overall Study|Withdrawal by Subject|3|||
129824226|NCT00463346|467322314|FG001|Overall Study|Withdrawal by Subject|3|||
129824227|NCT04067544|467322317|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
129824228|NCT02282020|467322320|FG000|Overall Study|Objective Disease Progression|128|||
129824229|NCT02282020|467322321|FG001|Overall Study|Objective Disease Progression|30|||
129824230|NCT02282020|467322320|FG000|Overall Study|Adverse Event|18|||
129824231|NCT02282020|467322321|FG001|Overall Study|Adverse Event|15|||
129824232|NCT02282020|467322320|FG000|Overall Study|Withdrawal by Subject|7|||
129824233|NCT02282020|467322321|FG001|Overall Study|Withdrawal by Subject|10|||
129824234|NCT02282020|467322320|FG000|Overall Study|Miscellaneous|5|||
129824235|NCT02282020|467322321|FG001|Overall Study|Miscellaneous|19|||
129824236|NCT02282020|467322320|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
129824237|NCT02282020|467322321|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
129824238|NCT02282020|467322320|FG000|Overall Study|Developed Discontinuation Criteria|0|||
129824239|NCT02282020|467322321|FG001|Overall Study|Developed Discontinuation Criteria|2|||
129824240|NCT02282020|467322320|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
129824241|NCT02282020|467322321|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
129824242|NCT00082355|467322322|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
129824243|NCT00082355|467322322|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
129824244|NCT00082355|467322322|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
129824245|NCT00759863|467322324|FG000|Overall Study|Death, moved, or lost contact|20|||
129824246|NCT00759863|467322325|FG001|Overall Study|Death, moved, or lost contact|18|||
129824247|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
129824248|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
129824249|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
129824250|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
129824251|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
129824252|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
129824253|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
129824254|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
129824255|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Other|4|||
129824256|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Other|1|||
129824257|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
129824258|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
129824259|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
129824260|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
129824261|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
129824262|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
129824263|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Death|1|||
129824264|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Death|0|||
129824265|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
129824266|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
129824267|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
129824268|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
129824269|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
129824270|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
129824271|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
129824272|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
129824273|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Other|1|||
129824274|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Other|0|||
129824275|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
129824276|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
129824277|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
129824278|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
129824279|NCT00460031|467322335|FG000|Overall Study|Adverse Event|5|||
129824280|NCT00460031|467322335|FG000|Overall Study|Withdrawal by Subject|5|||
129824281|NCT00460031|467322335|FG000|Overall Study|Death|1|||
129824282|NCT04532099|467322336|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
129824283|NCT04532099|467322337|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
129824284|NCT04532099|467322338|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
129824285|NCT00644995|467322348|FG000|Overall Study|Lost to Follow-up|1|||
129824286|NCT00644995|467322349|FG001|Overall Study|Lost to Follow-up|4|||
129824287|NCT00644995|467322348|FG000|Overall Study|Refused|1|||
129824288|NCT00644995|467322349|FG001|Overall Study|Refused|0|||
129824289|NCT02066233|467322355|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
129824290|NCT02066233|467322356|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
129824291|NCT00103142|467322357|FG000|Overall Study|Adverse Event|1|||
129824292|NCT00103142|467322358|FG001|Overall Study|Adverse Event|0|||
129824293|NCT00103142|467322357|FG000|Overall Study|Progression of disease|2|||
129824294|NCT00103142|467322358|FG001|Overall Study|Progression of disease|1|||
129824295|NCT02772081|467322359|FG000|Overall Study|Physician Decision|1|||
129824296|NCT02772081|467322360|FG001|Overall Study|Physician Decision|1|||
129824297|NCT02772081|467322359|FG000|Overall Study|Death|1|||
129824298|NCT02772081|467322360|FG001|Overall Study|Death|1|||
129824299|NCT02598076|467322361|FG000|Overall Study|Lost to Follow-up|2|||
129824300|NCT02598076|467322362|FG001|Overall Study|Lost to Follow-up|3|||
129824301|NCT01946425|467322363|FG000|Overall Study|Protocol Violation|1|||
129824302|NCT01946425|467322364|FG001|Overall Study|Protocol Violation|0|||
129824303|NCT01946425|467322363|FG000|Overall Study|Withdrawal by Subject|1|||
129824304|NCT01946425|467322364|FG001|Overall Study|Withdrawal by Subject|0|||
129824305|NCT03227029|467322365|FG000|Overall Study|Child Wheezed (no treatment)|0|||
129824306|NCT03227029|467322366|FG001|Overall Study|Child Wheezed (no treatment)|1|||
129824307|NCT03227029|467322367|FG002|Overall Study|Child Wheezed (no treatment)|0|||
129824308|NCT03227029|467322365|FG000|Overall Study|No post RSV season visit due to COVID|3|||
129824309|NCT03227029|467322366|FG001|Overall Study|No post RSV season visit due to COVID|3|||
129824310|NCT03227029|467322367|FG002|Overall Study|No post RSV season visit due to COVID|2|||
129824311|NCT03227029|467322365|FG000|Overall Study|Not able to get to clinic|0|||
129824312|NCT03227029|467322366|FG001|Overall Study|Not able to get to clinic|0|||
129824313|NCT03227029|467322367|FG002|Overall Study|Not able to get to clinic|1|||
129824314|NCT03227029|467322365|FG000|Overall Study|Withdrawal by Subject|1|||
129824315|NCT03227029|467322366|FG001|Overall Study|Withdrawal by Subject|0|||
129824316|NCT03227029|467322367|FG002|Overall Study|Withdrawal by Subject|0|||
129824317|NCT03227029|467322365|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
129824318|NCT03227029|467322366|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
129824319|NCT03227029|467322367|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
129824320|NCT00390858|467322368|FG000|Overall Study|Adverse Event|6|||
129824321|NCT00390858|467322369|FG001|Overall Study|Adverse Event|2|||
129824322|NCT00390858|467322368|FG000|Overall Study|Lack of Efficacy|0|||
129824323|NCT00390858|467322369|FG001|Overall Study|Lack of Efficacy|1|||
129824324|NCT00390858|467322368|FG000|Overall Study|Withdrawal by Subject|3|||
129824325|NCT00390858|467322369|FG001|Overall Study|Withdrawal by Subject|4|||
129824326|NCT01113801|467322370|FG000|Overall Study|Adverse Event|4|||
129824327|NCT01113801|467322371|FG001|Overall Study|Adverse Event|0|||
129824328|NCT01113801|467322372|FG002|Overall Study|Adverse Event|2|||
129824329|NCT01113801|467322373|FG003|Overall Study|Adverse Event|6|||
129824330|NCT01113801|467322370|FG000|Overall Study|Death|4|||
129824331|NCT01113801|467322371|FG001|Overall Study|Death|5|||
129824332|NCT01113801|467322372|FG002|Overall Study|Death|3|||
129824333|NCT01113801|467322373|FG003|Overall Study|Death|4|||
129824334|NCT01113801|467322370|FG000|Overall Study|Protocol Violation|0|||
129824335|NCT01113801|467322371|FG001|Overall Study|Protocol Violation|1|||
129824336|NCT01113801|467322372|FG002|Overall Study|Protocol Violation|0|||
129824337|NCT01113801|467322373|FG003|Overall Study|Protocol Violation|0|||
130059753|NCT01606761|468172415|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
130059754|NCT01606761|468172416|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
130059755|NCT01606761|468172417|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
129824338|NCT01113801|467322370|FG000|Overall Study|Withdrawal by Subject|9|||
129824339|NCT01113801|467322371|FG001|Overall Study|Withdrawal by Subject|7|||
129824340|NCT01113801|467322372|FG002|Overall Study|Withdrawal by Subject|7|||
129824341|NCT01113801|467322373|FG003|Overall Study|Withdrawal by Subject|8|||
129824342|NCT01113801|467322370|FG000|Overall Study|Physician Decision|2|||
129824343|NCT01113801|467322371|FG001|Overall Study|Physician Decision|2|||
129824344|NCT01113801|467322372|FG002|Overall Study|Physician Decision|3|||
129824345|NCT01113801|467322373|FG003|Overall Study|Physician Decision|3|||
129824346|NCT01113801|467322370|FG000|Overall Study|Sponsor Decision|15|||
129824347|NCT01113801|467322371|FG001|Overall Study|Sponsor Decision|21|||
129824348|NCT01113801|467322372|FG002|Overall Study|Sponsor Decision|20|||
129824349|NCT01113801|467322373|FG003|Overall Study|Sponsor Decision|15|||
129824350|NCT01113801|467322370|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
129824351|NCT01113801|467322371|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
129824352|NCT01113801|467322372|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
129824353|NCT01113801|467322373|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
129824354|NCT01506479|467322374|FG000|Overall Study|Lost to Follow-up|1|||
129824355|NCT01506479|467322375|FG001|Overall Study|Lost to Follow-up|2|||
129824356|NCT01506479|467322376|FG002|Overall Study|Lost to Follow-up|2|||
129824357|NCT01506479|467322374|FG000|Overall Study|Withdrawal by Subject|1|||
129824358|NCT01506479|467322375|FG001|Overall Study|Withdrawal by Subject|2|||
129824359|NCT01506479|467322376|FG002|Overall Study|Withdrawal by Subject|1|||
129824360|NCT01506479|467322374|FG000|Overall Study|Missing assessment|1|||
129824361|NCT01506479|467322375|FG001|Overall Study|Missing assessment|0|||
129824362|NCT01506479|467322376|FG002|Overall Study|Missing assessment|0|||
129824363|NCT01506479|467322374|FG000|Overall Study|Adverse Event|0|||
129824364|NCT01506479|467322375|FG001|Overall Study|Adverse Event|1|||
129824365|NCT01506479|467322376|FG002|Overall Study|Adverse Event|0|||
129824366|NCT01782859|467322377|FG000|Overall Study|Protocol Violation|6|||
129824367|NCT01782859|467322378|FG001|Overall Study|Protocol Violation|6|||
129824368|NCT01782859|467322377|FG000|Overall Study|Withdrawal by Subject|0|||
129824369|NCT01782859|467322378|FG001|Overall Study|Withdrawal by Subject|1|||
129824370|NCT03318315|467322381|FG000|Overall Study|Lost to Follow-up|3|||
129824371|NCT03318315|467322382|FG001|Overall Study|Lost to Follow-up|2|||
129824372|NCT03318315|467322383|FG002|Overall Study|Lost to Follow-up|1|||
129824373|NCT03318315|467322381|FG000|Overall Study|Protocol Violation|1|||
129824374|NCT03318315|467322382|FG001|Overall Study|Protocol Violation|1|||
129824375|NCT03318315|467322383|FG002|Overall Study|Protocol Violation|1|||
129824376|NCT03318315|467322381|FG000|Overall Study|Withdrawal by Subject|0|||
129824377|NCT03318315|467322382|FG001|Overall Study|Withdrawal by Subject|0|||
129824378|NCT03318315|467322383|FG002|Overall Study|Withdrawal by Subject|2|||
129824379|NCT01896531|467322384|FG000|Overall Study|Death|57|||
129824380|NCT01896531|467322385|FG001|Overall Study|Death|59|||
129824381|NCT01896531|467322384|FG000|Overall Study|Lost to Follow-up|3|||
129824382|NCT01896531|467322385|FG001|Overall Study|Lost to Follow-up|0|||
129824383|NCT01896531|467322384|FG000|Overall Study|Non-compliance|0|||
129824384|NCT01896531|467322385|FG001|Overall Study|Non-compliance|1|||
129824385|NCT01896531|467322384|FG000|Overall Study|Study Ended by Sponsor|7|||
129824386|NCT01896531|467322385|FG001|Overall Study|Study Ended by Sponsor|20|||
129824387|NCT01896531|467322384|FG000|Overall Study|Withdrawal by Subject|3|||
129824388|NCT01896531|467322385|FG001|Overall Study|Withdrawal by Subject|2|||
129824389|NCT01896531|467322384|FG000|Overall Study|Death Prior to Treatment|1|||
129824390|NCT01896531|467322385|FG001|Overall Study|Death Prior to Treatment|0|||
129824391|NCT00770289|467322388|FG000|Overall Study|Other|6|||
129824392|NCT02659631|467322389|FG000|Overall Study|Lost to Follow-up|0|||
129824393|NCT02659631|467322390|FG001|Overall Study|Lost to Follow-up|0|||
129824394|NCT02659631|467322391|FG002|Overall Study|Lost to Follow-up|2|||
129824395|NCT02659631|467322392|FG003|Overall Study|Lost to Follow-up|0|||
129824396|NCT02659631|467322393|FG004|Overall Study|Lost to Follow-up|0|||
129824397|NCT02659631|467322394|FG005|Overall Study|Lost to Follow-up|1|||
129824398|NCT02659631|467322395|FG006|Overall Study|Lost to Follow-up|0|||
129824399|NCT02659631|467322396|FG007|Overall Study|Lost to Follow-up|0|||
129824400|NCT02659631|467322397|FG008|Overall Study|Lost to Follow-up|0|||
129824401|NCT02659631|467322398|FG009|Overall Study|Lost to Follow-up|0|||
129824402|NCT02659631|467322389|FG000|Overall Study|Withdrawal prior to treatment|0|||
129824403|NCT02659631|467322390|FG001|Overall Study|Withdrawal prior to treatment|0|||
129824404|NCT02659631|467322391|FG002|Overall Study|Withdrawal prior to treatment|0|||
129824405|NCT02659631|467322392|FG003|Overall Study|Withdrawal prior to treatment|0|||
129824406|NCT02659631|467322393|FG004|Overall Study|Withdrawal prior to treatment|1|||
129824407|NCT02659631|467322394|FG005|Overall Study|Withdrawal prior to treatment|0|||
129824408|NCT02659631|467322395|FG006|Overall Study|Withdrawal prior to treatment|0|||
129824409|NCT02659631|467322396|FG007|Overall Study|Withdrawal prior to treatment|0|||
129824410|NCT02659631|467322397|FG008|Overall Study|Withdrawal prior to treatment|0|||
129824411|NCT02659631|467322398|FG009|Overall Study|Withdrawal prior to treatment|0|||
129824412|NCT02659631|467322389|FG000|Overall Study|Participant refused further follow-up|0|||
129824413|NCT02659631|467322390|FG001|Overall Study|Participant refused further follow-up|0|||
129824414|NCT02659631|467322391|FG002|Overall Study|Participant refused further follow-up|0|||
129824415|NCT02659631|467322392|FG003|Overall Study|Participant refused further follow-up|1|||
129897483|NCT02974010|467584391|FG002|Overall Study|Lack of Efficacy|1|||
129897484|NCT02974010|467584392|FG003|Overall Study|Lack of Efficacy|0|||
129824416|NCT02659631|467322393|FG004|Overall Study|Participant refused further follow-up|0|||
129897485|NCT00320489|467584393|FG000|Overall Study|Adverse Event|26|||
129824417|NCT02659631|467322394|FG005|Overall Study|Participant refused further follow-up|0|||
129824418|NCT02659631|467322395|FG006|Overall Study|Participant refused further follow-up|0|||
129897486|NCT00320489|467584394|FG001|Overall Study|Adverse Event|25|||
129897487|NCT00320489|467584393|FG000|Overall Study|Clinical Relapse|26|||
129824419|NCT02659631|467322396|FG007|Overall Study|Participant refused further follow-up|0|||
129824420|NCT02659631|467322397|FG008|Overall Study|Participant refused further follow-up|1|||
129824421|NCT02659631|467322398|FG009|Overall Study|Participant refused further follow-up|0|||
129824422|NCT02659631|467322389|FG000|Overall Study|Death (follow-up phase)|1|||
129824423|NCT02659631|467322390|FG001|Overall Study|Death (follow-up phase)|2|||
129824424|NCT02659631|467322391|FG002|Overall Study|Death (follow-up phase)|1|||
129824425|NCT02659631|467322392|FG003|Overall Study|Death (follow-up phase)|1|||
129824426|NCT02659631|467322393|FG004|Overall Study|Death (follow-up phase)|3|||
129824427|NCT02659631|467322394|FG005|Overall Study|Death (follow-up phase)|2|||
129824428|NCT02659631|467322395|FG006|Overall Study|Death (follow-up phase)|0|||
129824429|NCT02659631|467322396|FG007|Overall Study|Death (follow-up phase)|3|||
129824430|NCT02659631|467322397|FG008|Overall Study|Death (follow-up phase)|1|||
129824431|NCT02659631|467322398|FG009|Overall Study|Death (follow-up phase)|0|||
129824432|NCT02659631|467322389|FG000|Overall Study|Death (treatment phase)|0|||
129824433|NCT02659631|467322390|FG001|Overall Study|Death (treatment phase)|0|||
129824434|NCT02659631|467322391|FG002|Overall Study|Death (treatment phase)|0|||
129824435|NCT02659631|467322392|FG003|Overall Study|Death (treatment phase)|0|||
129824436|NCT02659631|467322393|FG004|Overall Study|Death (treatment phase)|1|||
129824437|NCT02659631|467322394|FG005|Overall Study|Death (treatment phase)|0|||
129824438|NCT02659631|467322395|FG006|Overall Study|Death (treatment phase)|1|||
129824439|NCT02659631|467322396|FG007|Overall Study|Death (treatment phase)|0|||
129824440|NCT02659631|467322397|FG008|Overall Study|Death (treatment phase)|0|||
129824441|NCT02659631|467322398|FG009|Overall Study|Death (treatment phase)|0|||
129824442|NCT02377466|467322399|FG000|Overall Study|Other: Randomized and not treated|0|||
129824443|NCT02377466|467322400|FG001|Overall Study|Other: Randomized and not treated|2|||
129824444|NCT00495170|467322401|FG000|Overall Study|Lost to Follow-up|9|||
129824445|NCT00495170|467322401|FG000|Overall Study|Withdrawal by Subject|3|||
129824446|NCT00495170|467322401|FG000|Overall Study|Inappropriate staging|8|||
129824447|NCT04210310|467322402|FG000|Overall Study|Lost to Follow-up|32|||
130059756|NCT01606761|468172418|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
130059757|NCT01606761|468172419|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
130059758|NCT01606761|468172415|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
130059759|NCT01606761|468172416|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
130059760|NCT01606761|468172417|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
130059761|NCT01606761|468172418|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
130059762|NCT01606761|468172419|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
130059763|NCT01606761|468172415|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
130059764|NCT01606761|468172416|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
130059765|NCT01606761|468172417|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
130059766|NCT01606761|468172418|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
130059767|NCT01606761|468172419|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
130059768|NCT05086289|468172420|FG000|Overall Study|Adverse Event|4|||
130059769|NCT05086289|468172421|FG001|Overall Study|Adverse Event|2|||
130059770|NCT05086289|468172420|FG000|Overall Study|Lost to Follow-up|2|||
130059771|NCT05086289|468172421|FG001|Overall Study|Lost to Follow-up|0|||
130059772|NCT05086289|468172420|FG000|Overall Study|Non-compliance with study drug|2|||
130059773|NCT05086289|468172421|FG001|Overall Study|Non-compliance with study drug|1|||
130059774|NCT05086289|468172420|FG000|Overall Study|Physician Decision|2|||
130059775|NCT05086289|468172421|FG001|Overall Study|Physician Decision|0|||
130059776|NCT05086289|468172420|FG000|Overall Study|Withdrawal by Subject|5|||
130059777|NCT05086289|468172421|FG001|Overall Study|Withdrawal by Subject|2|||
129824448|NCT04210310|467322403|FG001|Overall Study|Lost to Follow-up|1|||
130059778|NCT01996748|468172422|FG000|Overall Study|Personal reason|1|||
129824449|NCT02049957|467322412|FG000|Overall Study|Progressive Disease|5|||
129824450|NCT02049957|467322413|FG001|Overall Study|Progressive Disease|4|||
129824451|NCT02049957|467322414|FG002|Overall Study|Progressive Disease|2|||
129824452|NCT02049957|467322415|FG003|Overall Study|Progressive Disease|2|||
129824453|NCT02049957|467322416|FG004|Overall Study|Progressive Disease|6|||
129824454|NCT02049957|467322417|FG005|Overall Study|Progressive Disease|35|||
130059779|NCT01996748|468172423|FG001|Overall Study|Personal reason|0|||
129824455|NCT02049957|467322418|FG006|Overall Study|Progressive Disease|7|||
129824456|NCT02049957|467322419|FG007|Overall Study|Progressive Disease|26|||
129824457|NCT02049957|467322420|FG008|Overall Study|Progressive Disease|6|||
129824458|NCT02049957|467322412|FG000|Overall Study|Adverse Event|1|||
129824459|NCT02049957|467322413|FG001|Overall Study|Adverse Event|1|||
129824460|NCT02049957|467322414|FG002|Overall Study|Adverse Event|1|||
129824461|NCT02049957|467322415|FG003|Overall Study|Adverse Event|0|||
129824462|NCT02049957|467322416|FG004|Overall Study|Adverse Event|0|||
129824463|NCT02049957|467322417|FG005|Overall Study|Adverse Event|5|||
129824464|NCT02049957|467322418|FG006|Overall Study|Adverse Event|0|||
129824465|NCT02049957|467322419|FG007|Overall Study|Adverse Event|6|||
130059780|NCT01996748|468172422|FG000|Overall Study|Physician Decision|2|||
130059781|NCT01996748|468172423|FG001|Overall Study|Physician Decision|0|||
130059782|NCT01996748|468172422|FG000|Overall Study|Adverse Event|1|||
130059783|NCT01996748|468172423|FG001|Overall Study|Adverse Event|4|||
130059784|NCT01996748|468172422|FG000|Overall Study|Withdrawal by Subject|0|||
130059785|NCT01996748|468172423|FG001|Overall Study|Withdrawal by Subject|1|||
130059786|NCT01996748|468172422|FG000|Overall Study|Lost to Follow-up|4|||
130059787|NCT01996748|468172423|FG001|Overall Study|Lost to Follow-up|1|||
130059788|NCT03599141|468172429|FG000|Overall Study|Lost to Follow-up|3|||
130059789|NCT03599141|468172430|FG001|Overall Study|Lost to Follow-up|1|||
130059790|NCT01165021|468172431|FG000|Overall Study|Death|1|||
130059791|NCT01419665|468172432|FG000|Combination Treatment|Adverse Event|7|||
130059792|NCT01419665|468172433|FG001|Combination Treatment|Adverse Event|10|||
130059793|NCT01419665|468172432|FG000|Combination Treatment|Physician Decision|5|||
130059794|NCT01419665|468172433|FG001|Combination Treatment|Physician Decision|8|||
130059795|NCT01419665|468172432|FG000|Combination Treatment|Protocol Violation|6|||
130059796|NCT01419665|468172433|FG001|Combination Treatment|Protocol Violation|2|||
130059797|NCT01419665|468172432|FG000|Combination Treatment|disease progression|10|||
130059798|NCT01419665|468172433|FG001|Combination Treatment|disease progression|9|||
130059799|NCT01419665|468172432|FG000|Combination Treatment|Death|5|||
130059800|NCT01419665|468172433|FG001|Combination Treatment|Death|7|||
130059801|NCT01419665|468172432|FG000|Combination Treatment|administrative problems|0|||
129824466|NCT02049957|467322420|FG008|Overall Study|Adverse Event|1|||
129824467|NCT02049957|467322412|FG000|Overall Study|Study Terminated by Sponsor|0|||
129824468|NCT02049957|467322413|FG001|Overall Study|Study Terminated by Sponsor|1|||
129824469|NCT02049957|467322414|FG002|Overall Study|Study Terminated by Sponsor|0|||
129824470|NCT02049957|467322415|FG003|Overall Study|Study Terminated by Sponsor|0|||
129824471|NCT02049957|467322416|FG004|Overall Study|Study Terminated by Sponsor|0|||
129824472|NCT02049957|467322417|FG005|Overall Study|Study Terminated by Sponsor|0|||
130059802|NCT01419665|468172433|FG001|Combination Treatment|administrative problems|1|||
130059803|NCT01419665|468172432|FG000|Combination Treatment|Withdrawal by Subject|5|||
130059804|NCT01419665|468172433|FG001|Combination Treatment|Withdrawal by Subject|4|||
130059805|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
130059806|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
130059807|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
130059808|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
130059809|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
130059810|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
130059811|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
130059812|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
129824473|NCT02049957|467322418|FG006|Overall Study|Study Terminated by Sponsor|1|||
129824474|NCT02049957|467322419|FG007|Overall Study|Study Terminated by Sponsor|0|||
129824475|NCT02049957|467322420|FG008|Overall Study|Study Terminated by Sponsor|0|||
129824476|NCT02049957|467322412|FG000|Overall Study|Withdrawal by Subject|0|||
130059813|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
130059814|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
130059815|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
130059816|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
130059817|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|Death|1|||
130059818|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|Death|2|||
130059819|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
130059820|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
130059821|NCT01419665|468172432|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
130059822|NCT01419665|468172433|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
130059823|NCT01419665|468172432|FG000|Open Label Phase|Death|1|||
130059824|NCT01419665|468172433|FG001|Open Label Phase|Death|0|||
130059825|NCT01419665|468172432|FG000|Open Label Phase|disease progression|0|||
130112638|NCT00606684|468373420|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130112639|NCT00606684|468373421|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130112640|NCT00606684|468373422|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130112641|NCT00606684|468373423|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
130112642|NCT00606684|468373424|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130112643|NCT00606684|468373425|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129824477|NCT02049957|467322413|FG001|Overall Study|Withdrawal by Subject|0|||
129824478|NCT02049957|467322414|FG002|Overall Study|Withdrawal by Subject|0|||
129824479|NCT02049957|467322415|FG003|Overall Study|Withdrawal by Subject|1|||
129824480|NCT02049957|467322416|FG004|Overall Study|Withdrawal by Subject|0|||
129824481|NCT02049957|467322417|FG005|Overall Study|Withdrawal by Subject|2|||
129824482|NCT02049957|467322418|FG006|Overall Study|Withdrawal by Subject|0|||
129897488|NCT00320489|467584394|FG001|Overall Study|Clinical Relapse|20|||
130059826|NCT01419665|468172433|FG001|Open Label Phase|disease progression|1|||
130059827|NCT01655823|468172434|FG000|Overall Study|Lost to Follow-up|0|||
130059828|NCT01655823|468172435|FG001|Overall Study|Lost to Follow-up|1|||
130059829|NCT01655823|468172436|FG002|Overall Study|Lost to Follow-up|0|||
130059830|NCT01655823|468172437|FG003|Overall Study|Lost to Follow-up|0|||
130059831|NCT01655823|468172438|FG004|Overall Study|Lost to Follow-up|1|||
130059832|NCT01655823|468172434|FG000|Overall Study|Withdrawal by Subject|0|||
130059833|NCT01655823|468172435|FG001|Overall Study|Withdrawal by Subject|1|||
130059834|NCT01655823|468172436|FG002|Overall Study|Withdrawal by Subject|0|||
130059835|NCT01655823|468172437|FG003|Overall Study|Withdrawal by Subject|1|||
130059836|NCT01655823|468172438|FG004|Overall Study|Withdrawal by Subject|0|||
130059837|NCT04799405|468172441|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
130059838|NCT02998554|468172448|FG000|Overall Study|Adverse Event|8|||
130059839|NCT02998554|468172449|FG001|Overall Study|Adverse Event|3|||
130059840|NCT02998554|468172448|FG000|Overall Study|Protocol deviation|1|||
130059841|NCT02998554|468172449|FG001|Overall Study|Protocol deviation|0|||
130059842|NCT02998554|468172448|FG000|Overall Study|Withdrawal by Subject|2|||
130059843|NCT02998554|468172449|FG001|Overall Study|Withdrawal by Subject|6|||
130059844|NCT02998554|468172448|FG000|Overall Study|Lost to Follow-up|0|||
130059845|NCT02998554|468172449|FG001|Overall Study|Lost to Follow-up|1|||
130059846|NCT02998554|468172448|FG000|Overall Study|Lack of Efficacy|0|||
129824483|NCT02049957|467322419|FG007|Overall Study|Withdrawal by Subject|3|||
129824484|NCT02049957|467322420|FG008|Overall Study|Withdrawal by Subject|1|||
129824485|NCT02049957|467322412|FG000|Overall Study|Physician Decision|0|||
129824486|NCT02049957|467322413|FG001|Overall Study|Physician Decision|0|||
129824487|NCT02049957|467322414|FG002|Overall Study|Physician Decision|0|||
129824488|NCT02049957|467322415|FG003|Overall Study|Physician Decision|0|||
129824489|NCT02049957|467322416|FG004|Overall Study|Physician Decision|0|||
129824490|NCT02049957|467322417|FG005|Overall Study|Physician Decision|1|||
129824491|NCT02049957|467322418|FG006|Overall Study|Physician Decision|0|||
129824492|NCT02049957|467322419|FG007|Overall Study|Physician Decision|0|||
129824493|NCT02049957|467322420|FG008|Overall Study|Physician Decision|0|||
129824494|NCT02622321|467322421|FG000|Overall Study|Withdrawal by Subject|2|||
129824495|NCT02622321|467322422|FG001|Overall Study|Withdrawal by Subject|0|||
129824496|NCT02622321|467322423|FG002|Overall Study|Withdrawal by Subject|0|||
129824497|NCT02622321|467322424|FG003|Overall Study|Withdrawal by Subject|0|||
129824498|NCT02622321|467322421|FG000|Overall Study|Death|0|||
129824499|NCT02622321|467322422|FG001|Overall Study|Death|0|||
129824500|NCT02622321|467322423|FG002|Overall Study|Death|1|||
129824501|NCT02622321|467322424|FG003|Overall Study|Death|0|||
129824502|NCT02622321|467322421|FG000|Overall Study|Physician Decision|1|||
129824503|NCT02622321|467322422|FG001|Overall Study|Physician Decision|0|||
129824504|NCT02622321|467322423|FG002|Overall Study|Physician Decision|0|||
129824505|NCT02622321|467322424|FG003|Overall Study|Physician Decision|0|||
129824506|NCT00241280|467322426|FG000|Overall Study|Adverse Event|2|||
129824507|NCT00241280|467322427|FG001|Overall Study|Adverse Event|6|||
129824508|NCT00241280|467322426|FG000|Overall Study|Discomfort|11|||
129824509|NCT00241280|467322427|FG001|Overall Study|Discomfort|16|||
129824510|NCT00241280|467322426|FG000|Overall Study|Pregnancy|1|||
129824511|NCT00241280|467322427|FG001|Overall Study|Pregnancy|5|||
129824512|NCT00241280|467322426|FG000|Overall Study|Lost to Follow-up|5|||
129824513|NCT00241280|467322427|FG001|Overall Study|Lost to Follow-up|8|||
129824514|NCT00241280|467322426|FG000|Overall Study|Withdrawal by Subject|7|||
129824515|NCT00241280|467322427|FG001|Overall Study|Withdrawal by Subject|4|||
129824516|NCT00241280|467322426|FG000|Overall Study|Protocol Violation|4|||
129824517|NCT00241280|467322427|FG001|Overall Study|Protocol Violation|10|||
129824518|NCT00241280|467322426|FG000|Overall Study|Relocation|4|||
129824519|NCT00241280|467322427|FG001|Overall Study|Relocation|4|||
129824520|NCT00241280|467322426|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
129824521|NCT00241280|467322427|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
129824522|NCT00241280|467322426|FG000|Overall Study|Unsatisfactory Visual Response|1|||
129824523|NCT00241280|467322427|FG001|Overall Study|Unsatisfactory Visual Response|1|||
129824524|NCT00241280|467322426|FG000|Overall Study|Diabetic|1|||
129824525|NCT00241280|467322427|FG001|Overall Study|Diabetic|0|||
129824526|NCT00241280|467322426|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
129824527|NCT00241280|467322427|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
129824528|NCT00241280|467322426|FG000|Overall Study|Dispensed incorrect test article|1|||
129824529|NCT00241280|467322427|FG001|Overall Study|Dispensed incorrect test article|2|||
129824530|NCT00241280|467322426|FG000|Overall Study|Unacceptable Fit|0|||
130059847|NCT02998554|468172449|FG001|Overall Study|Lack of Efficacy|1|||
129824531|NCT00241280|467322427|FG001|Overall Study|Unacceptable Fit|1|||
129824532|NCT00241280|467322426|FG000|Overall Study|Scheduling Conflict|0|||
129824533|NCT00241280|467322427|FG001|Overall Study|Scheduling Conflict|2|||
129824534|NCT00241280|467322426|FG000|Overall Study|History of Ocular Surgery|0|||
129897489|NCT00320489|467584393|FG000|Overall Study|Death|0|||
130059848|NCT03095521|468172450|FG000|Overall Study|Withdrawal by Subject|0|||
130059849|NCT03095521|468172451|FG001|Overall Study|Withdrawal by Subject|1|||
129824535|NCT00241280|467322427|FG001|Overall Study|History of Ocular Surgery|1|||
129824536|NCT00241280|467322426|FG000|Overall Study|Coating on Lens|1|||
129824537|NCT00241280|467322427|FG001|Overall Study|Coating on Lens|0|||
129824538|NCT00241280|467322426|FG000|Overall Study|Excessive Dryness|0|||
129824539|NCT00241280|467322427|FG001|Overall Study|Excessive Dryness|1|||
129824540|NCT00965718|467322428|FG000|Overall Study|Withdrawal by Subject|4|||
129824541|NCT01958008|467322429|FG000|Overall Study|Worsening of disease under study|0|||
130059850|NCT03095521|468172450|FG000|Overall Study|Lost to Follow-up|0|||
130059851|NCT03095521|468172451|FG001|Overall Study|Lost to Follow-up|1|||
129824542|NCT01958008|467322430|FG001|Overall Study|Worsening of disease under study|0|||
129824543|NCT01958008|467322431|FG002|Overall Study|Worsening of disease under study|1|||
129824544|NCT01958008|467322432|FG003|Overall Study|Worsening of disease under study|0|||
129824545|NCT01958008|467322429|FG000|Overall Study|Other adverse event|1|||
129824546|NCT01958008|467322430|FG001|Overall Study|Other adverse event|0|||
129824547|NCT01958008|467322431|FG002|Overall Study|Other adverse event|0|||
129824548|NCT01958008|467322432|FG003|Overall Study|Other adverse event|0|||
129824549|NCT01634360|467322434|FG000|Overall Study|Adverse Event|10|||
129824550|NCT01634360|467322435|FG001|Overall Study|Adverse Event|34|||
129824551|NCT01634360|467322434|FG000|Overall Study|subject withdrew consent|13|||
129824552|NCT01634360|467322435|FG001|Overall Study|subject withdrew consent|23|||
129824553|NCT01634360|467322434|FG000|Overall Study|Protocol Violation|1|||
129824554|NCT01634360|467322435|FG001|Overall Study|Protocol Violation|1|||
129824555|NCT01634360|467322434|FG000|Overall Study|Lack of Efficacy|4|||
129824556|NCT01634360|467322435|FG001|Overall Study|Lack of Efficacy|14|||
129824557|NCT01634360|467322434|FG000|Overall Study|Other|3|||
129824558|NCT01634360|467322435|FG001|Overall Study|Other|20|||
129824559|NCT01634360|467322434|FG000|Overall Study|Study termination by sponsor|18|||
129824560|NCT01634360|467322435|FG001|Overall Study|Study termination by sponsor|44|||
129824561|NCT02028065|467322438|FG000|Randomization Through Start Treatment|Not treated|1|||
129824562|NCT02028065|467322439|FG001|Randomization Through Start Treatment|Not treated|3|||
129824563|NCT02028065|467322440|FG002|Randomization Through Start Treatment|Not treated|3|||
129824564|NCT02028065|467322438|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
129824565|NCT02028065|467322439|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
129824566|NCT02028065|467322440|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
129824567|NCT02028065|467322438|FG000|Treatment Through Study Completion|Physician Decision|1|||
129824568|NCT02028065|467322439|FG001|Treatment Through Study Completion|Physician Decision|0|||
129824569|NCT02028065|467322440|FG002|Treatment Through Study Completion|Physician Decision|0|||
129824570|NCT02028065|467322438|FG000|Treatment Through Study Completion|Protocol Violation|1|||
129824571|NCT02028065|467322439|FG001|Treatment Through Study Completion|Protocol Violation|4|||
129824572|NCT02028065|467322440|FG002|Treatment Through Study Completion|Protocol Violation|0|||
129824573|NCT02028065|467322438|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
129824574|NCT02028065|467322439|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
129824575|NCT02028065|467322440|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
129824576|NCT02028065|467322438|FG000|Treatment Through Study Completion|Adverse Event|3|||
129824577|NCT02028065|467322439|FG001|Treatment Through Study Completion|Adverse Event|3|||
129824578|NCT02028065|467322440|FG002|Treatment Through Study Completion|Adverse Event|5|||
129824579|NCT01414855|467322441|FG000|Overall Study|Death|17|||
129824580|NCT01414855|467322441|FG000|Overall Study|Lost to Follow-up|5|||
129824581|NCT01414855|467322441|FG000|Overall Study|Withdrawal by Subject|7|||
129824582|NCT00877383|467322445|FG000|Overall Study|Adverse Event|13|||
129824583|NCT00877383|467322446|FG001|Overall Study|Adverse Event|14|||
129824584|NCT00877383|467322445|FG000|Overall Study|Lost to Follow-up|5|||
129824585|NCT00877383|467322446|FG001|Overall Study|Lost to Follow-up|3|||
129824586|NCT00877383|467322445|FG000|Overall Study|Subject withdrew consent|3|||
129824587|NCT00877383|467322446|FG001|Overall Study|Subject withdrew consent|12|||
129824588|NCT00877383|467322445|FG000|Overall Study|Subject no longer requires study drug|2|||
129824589|NCT00877383|467322446|FG001|Overall Study|Subject no longer requires study drug|0|||
129824590|NCT00877383|467322445|FG000|Overall Study|Administrative problems|2|||
129824591|NCT00877383|467322446|FG001|Overall Study|Administrative problems|0|||
129824592|NCT00877383|467322445|FG000|Overall Study|Protocol deviation|2|||
129824593|NCT00877383|467322446|FG001|Overall Study|Protocol deviation|6|||
129824594|NCT00877383|467322445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129824595|NCT00877383|467322446|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129824596|NCT00877383|467322445|FG000|Overall Study|Death|1|||
129824597|NCT00877383|467322446|FG001|Overall Study|Death|2|||
129824598|NCT04851314|467322447|FG000|Overall Study|Unable to complete research set-up procedures|0|||
129824599|NCT04851314|467322448|FG001|Overall Study|Unable to complete research set-up procedures|2|||
129824600|NCT04851314|467322447|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
129824601|NCT04851314|467322448|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
129824602|NCT02107482|467322455|FG000|Overall Study|inconveinence|2|||
129824603|NCT02107482|467322455|FG000|Overall Study|Lost to Follow-up|1|||
129824604|NCT02107482|467322455|FG000|Overall Study|Lack of Efficacy|1|||
130059852|NCT01810042|468172452|FG000|Overall Study|Lost to Follow-up|10|||
129824605|NCT04868890|467322456|FG000|Overall Study|Death|2|||
129824606|NCT04868890|467322457|FG001|Overall Study|Death|1|||
129824607|NCT04868890|467322456|FG000|Overall Study|Withdrawal by Subject|1|||
129824608|NCT04868890|467322457|FG001|Overall Study|Withdrawal by Subject|5|||
129824609|NCT00867009|467322458|FG000|Induction Period|Nonserious Adverse Event|5|||
129824610|NCT00867009|467322458|FG000|Induction Period|Serious Adverse Event|10|||
129824611|NCT00867009|467322458|FG000|Induction Period|Death due to serious adverse event|6|||
129824612|NCT00867009|467322458|FG000|Induction Period|Death due to Study Disease|4|||
129824613|NCT00867009|467322458|FG000|Induction Period|Protocol Violation|1|||
129824614|NCT00867009|467322458|FG000|Induction Period|Withdrawal by Subject|8|||
129824615|NCT00867009|467322458|FG000|Induction Period|Physician Decision|3|||
129824616|NCT00867009|467322458|FG000|Induction Period|Progressive Disease (PD)|25|||
129824617|NCT00867009|467322458|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
129824618|NCT03358290|467322460|FG000|Overall Study|Study discontinued by Sponsor|0|||
129824619|NCT03358290|467322461|FG001|Overall Study|Study discontinued by Sponsor|1|||
129824620|NCT03358290|467322462|FG002|Overall Study|Study discontinued by Sponsor|1|||
129824621|NCT03358290|467322463|FG003|Overall Study|Study discontinued by Sponsor|0|||
129824622|NCT03358290|467322464|FG004|Overall Study|Study discontinued by Sponsor|0|||
129824623|NCT03358290|467322460|FG000|Overall Study|Adverse Event|0|||
129824624|NCT03358290|467322461|FG001|Overall Study|Adverse Event|0|||
129824625|NCT03358290|467322462|FG002|Overall Study|Adverse Event|1|||
129824626|NCT03358290|467322463|FG003|Overall Study|Adverse Event|2|||
129824627|NCT03358290|467322464|FG004|Overall Study|Adverse Event|0|||
129824628|NCT03358290|467322460|FG000|Overall Study|Withdrawal by Subject|0|||
129824629|NCT03358290|467322461|FG001|Overall Study|Withdrawal by Subject|0|||
129824630|NCT03358290|467322462|FG002|Overall Study|Withdrawal by Subject|0|||
129824631|NCT03358290|467322463|FG003|Overall Study|Withdrawal by Subject|0|||
129824632|NCT03358290|467322464|FG004|Overall Study|Withdrawal by Subject|1|||
129824633|NCT01339429|467322465|FG000|Overall Study|Withdrawal by Subject|1|||
129824634|NCT01339429|467322465|FG000|Overall Study|Physician Decision|3|||
129824635|NCT00459667|467322466|FG000|Overall Study|Adverse Event|9|||
129824636|NCT00459667|467322467|FG001|Overall Study|Adverse Event|12|||
129824637|NCT00459667|467322468|FG002|Overall Study|Adverse Event|8|||
129824638|NCT00459667|467322466|FG000|Overall Study|Lost to Follow-up|5|||
129824639|NCT00459667|467322467|FG001|Overall Study|Lost to Follow-up|9|||
129824640|NCT00459667|467322468|FG002|Overall Study|Lost to Follow-up|3|||
129824641|NCT00459667|467322466|FG000|Overall Study|Pregnancy|1|||
129824642|NCT00459667|467322467|FG001|Overall Study|Pregnancy|1|||
129824643|NCT00459667|467322468|FG002|Overall Study|Pregnancy|1|||
129824644|NCT00459667|467322466|FG000|Overall Study|Protocol Violation|1|||
129824645|NCT00459667|467322467|FG001|Overall Study|Protocol Violation|0|||
129824646|NCT00459667|467322468|FG002|Overall Study|Protocol Violation|0|||
129824647|NCT00459667|467322466|FG000|Overall Study|Withdrawal by Subject|3|||
129824648|NCT00459667|467322467|FG001|Overall Study|Withdrawal by Subject|5|||
129824649|NCT00459667|467322468|FG002|Overall Study|Withdrawal by Subject|5|||
129824650|NCT00459667|467322466|FG000|Overall Study|Other disease modifying treatment|1|||
129824651|NCT00459667|467322467|FG001|Overall Study|Other disease modifying treatment|2|||
129824652|NCT00459667|467322468|FG002|Overall Study|Other disease modifying treatment|1|||
129824653|NCT00459667|467322466|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
129824654|NCT00459667|467322467|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
129824655|NCT00459667|467322468|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
129824656|NCT00459667|467322466|FG000|Overall Study|No treatment administered|6|||
129824657|NCT00459667|467322467|FG001|Overall Study|No treatment administered|3|||
129824658|NCT00459667|467322468|FG002|Overall Study|No treatment administered|1|||
129824659|NCT04140292|467322469|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
129824660|NCT04140292|467322470|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
129824661|NCT00556712|467322471|FG000|Overall Study|Adverse Event|7|||
129824662|NCT00556712|467322472|FG001|Overall Study|Adverse Event|19|||
129824663|NCT00556712|467322471|FG000|Overall Study|Death|5|||
129824664|NCT00556712|467322472|FG001|Overall Study|Death|10|||
129824665|NCT00556712|467322471|FG000|Overall Study|Progressive Disease|383|||
129824666|NCT00556712|467322472|FG001|Overall Study|Progressive Disease|320|||
129824667|NCT00556712|467322471|FG000|Overall Study|Protocol Violation|3|||
129824668|NCT00556712|467322472|FG001|Overall Study|Protocol Violation|2|||
129824669|NCT00556712|467322471|FG000|Overall Study|Refused Treatment|17|||
129824670|NCT00556712|467322472|FG001|Overall Study|Refused Treatment|16|||
129824671|NCT00556712|467322471|FG000|Overall Study|Failure to Return|2|||
129824672|NCT00556712|467322472|FG001|Overall Study|Failure to Return|3|||
129824673|NCT00556712|467322471|FG000|Overall Study|Other|2|||
129824674|NCT00556712|467322472|FG001|Overall Study|Other|2|||
129824675|NCT00556712|467322471|FG000|Overall Study|Ongoing at Data Cutoff|32|||
129824676|NCT00556712|467322472|FG001|Overall Study|Ongoing at Data Cutoff|66|||
129824677|NCT04080297|467322474|FG000|Overall Study|Adverse Event|1|||
129824678|NCT04080297|467322475|FG001|Overall Study|Adverse Event|3|||
129824679|NCT04080297|467322474|FG000|Overall Study|concurrent illness|1|||
129824680|NCT04080297|467322475|FG001|Overall Study|concurrent illness|0|||
129824681|NCT02200445|467322476|FG000|Overall Study|Lack of Efficacy|1|||
129824682|NCT02200445|467322477|FG001|Overall Study|Lack of Efficacy|2|||
129824683|NCT02200445|467322478|FG002|Overall Study|Lack of Efficacy|2|||
129824684|NCT02200445|467322476|FG000|Overall Study|Adverse Event|0|||
129824685|NCT02200445|467322477|FG001|Overall Study|Adverse Event|2|||
129824686|NCT02200445|467322478|FG002|Overall Study|Adverse Event|0|||
129897490|NCT00320489|467584394|FG001|Overall Study|Death|2|||
130059853|NCT02773238|468172454|FG000|Overall Study|Lack of Efficacy|4|||
129824687|NCT00353262|467322482|FG000|Overall Study|Adverse Event|8|||
129824688|NCT00353262|467322482|FG000|Overall Study|Withdrawal by Subject|2|||
129824689|NCT00353262|467322482|FG000|Overall Study|Insufficient Therapeutic Response|13|||
129824690|NCT00353262|467322482|FG000|Overall Study|Progression|1|||
129824691|NCT00353262|467322482|FG000|Overall Study|Surgery|4|||
129824692|NCT00353262|467322482|FG000|Overall Study|Break from Chemotherapy|1|||
129824693|NCT01853826|467324703|FG000|Overall Study|Patients who switched to commercial drug|11|||
129824694|NCT01853826|467324703|FG000|Overall Study|Patient refused to continue medication|21|||
129824695|NCT01853826|467324703|FG000|Overall Study|Lost to Follow-up|2|||
129824696|NCT01853826|467324703|FG000|Overall Study|Non-compliant with protocol|4|||
129824697|NCT01853826|467324703|FG000|Overall Study|Other adverse events (AE)|62|||
129824698|NCT01853826|467324703|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
129824699|NCT01853826|467324703|FG000|Overall Study|Progressive disease|342|||
129824700|NCT01853826|467324703|FG000|Overall Study|Other than listed|13|||
130112644|NCT00606684|468373426|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130112645|NCT00910858|468373432|FG000|Pharmacokinetic Phase|Adverse Event|1|||
130112646|NCT00910858|468373433|FG001|Pharmacokinetic Phase|Adverse Event|0|||
129824701|NCT01853826|467324703|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
129824702|NCT00982488|467324707|FG000|Overall Study|Administrative reason by sponsor|81|||
129824703|NCT00982488|467324708|FG001|Overall Study|Administrative reason by sponsor|3|||
129824704|NCT00982488|467324709|FG002|Overall Study|Administrative reason by sponsor|11|||
129824705|NCT00982488|467324710|FG003|Overall Study|Administrative reason by sponsor|0|||
129824706|NCT00982488|467324711|FG004|Overall Study|Administrative reason by sponsor|0|||
129824707|NCT00982488|467324707|FG000|Overall Study|Adverse event unrelated to study drug|5|||
129824708|NCT00982488|467324708|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129824709|NCT00982488|467324709|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129824710|NCT00982488|467324710|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129824711|NCT00982488|467324711|FG004|Overall Study|Adverse event unrelated to study drug|0|||
129824712|NCT00982488|467324707|FG000|Overall Study|Death|11|||
129824713|NCT00982488|467324708|FG001|Overall Study|Death|0|||
129824714|NCT00982488|467324709|FG002|Overall Study|Death|2|||
129824715|NCT00982488|467324710|FG003|Overall Study|Death|0|||
129824716|NCT00982488|467324711|FG004|Overall Study|Death|0|||
129824717|NCT00982488|467324707|FG000|Overall Study|Disease progression|30|||
129824718|NCT00982488|467324708|FG001|Overall Study|Disease progression|5|||
129824719|NCT00982488|467324709|FG002|Overall Study|Disease progression|10|||
129824720|NCT00982488|467324710|FG003|Overall Study|Disease progression|1|||
129824721|NCT00982488|467324711|FG004|Overall Study|Disease progression|1|||
130059854|NCT00487084|468174554|FG000|Overall Study|Did not receive intervention|4|||
130059855|NCT00487084|468174555|FG001|Overall Study|Did not receive intervention|3|||
130059856|NCT00487084|468174556|FG002|Overall Study|Did not receive intervention|5|||
130059857|NCT00356863|468174557|FG000|Overall Study|Death|16|||
130059858|NCT00356863|468174558|FG001|Overall Study|Death|32|||
130059859|NCT00356863|468174557|FG000|Overall Study|Lost to Follow-up|76|||
130059860|NCT00356863|468174558|FG001|Overall Study|Lost to Follow-up|43|||
130059861|NCT02690207|468174565|FG000|Overall Study|Lost to Follow-up|48|||
130059862|NCT02690207|468174565|FG000|Overall Study|Withdrawal by Subject|46|||
130059863|NCT02690207|468174565|FG000|Overall Study|Protocol Violation|2|||
130059864|NCT02690207|468174565|FG000|Overall Study|Serious adverse event|110|||
130059865|NCT02690207|468174565|FG000|Overall Study|Non-serious Adverse Event|18|||
130059866|NCT02690207|468174565|FG000|Overall Study|Migrated/moved from study area|5|||
130059867|NCT02690207|468174565|FG000|Overall Study|Suspected HZ Episode|1|||
130059868|NCT02690207|468174565|FG000|Overall Study|Other reasons for withdrawal|23|||
130059869|NCT03712345|468174568|FG000|Overall Study|Failure to meet randomization criteria|0|||
130059870|NCT03712345|468174569|FG001|Overall Study|Failure to meet randomization criteria|0|||
130059871|NCT03712345|468174570|FG002|Overall Study|Failure to meet randomization criteria|1|||
130059872|NCT02585999|468174571|FG000|Overall Study|Lost to Follow-up|1|||
130059873|NCT02585999|468174571|FG000|Overall Study|Protocol Violation|1|||
129824722|NCT00982488|467324707|FG000|Overall Study|Lost to Follow-up|1|||
129824723|NCT00982488|467324708|FG001|Overall Study|Lost to Follow-up|0|||
129824724|NCT00982488|467324709|FG002|Overall Study|Lost to Follow-up|0|||
129897491|NCT00320489|467584393|FG000|Overall Study|Entry Criteria Exclusion|2|||
129897492|NCT00320489|467584394|FG001|Overall Study|Entry Criteria Exclusion|4|||
130059874|NCT00485589|468174572|FG000|Overall Study|Death|2|||
130059875|NCT00485589|468174573|FG001|Overall Study|Death|2|||
130059876|NCT00485589|468174574|FG002|Overall Study|Death|0|||
130059877|NCT00485589|468174572|FG000|Overall Study|Failure to return|6|||
129824725|NCT00982488|467324710|FG003|Overall Study|Lost to Follow-up|0|||
129824726|NCT00982488|467324711|FG004|Overall Study|Lost to Follow-up|0|||
129824727|NCT00982488|467324707|FG000|Overall Study|Maximum clinical benefit|1|||
129824728|NCT00982488|467324708|FG001|Overall Study|Maximum clinical benefit|1|||
130059878|NCT00485589|468174573|FG001|Overall Study|Failure to return|5|||
130059879|NCT00485589|468174574|FG002|Overall Study|Failure to return|1|||
130059880|NCT00485589|468174572|FG000|Overall Study|Protocol Violation|1|||
130059881|NCT00485589|468174573|FG001|Overall Study|Protocol Violation|0|||
130059882|NCT00485589|468174574|FG002|Overall Study|Protocol Violation|0|||
130059883|NCT00485589|468174572|FG000|Overall Study|Violation of selection criteria at entry|0|||
130059884|NCT00485589|468174573|FG001|Overall Study|Violation of selection criteria at entry|3|||
130059885|NCT00485589|468174574|FG002|Overall Study|Violation of selection criteria at entry|1|||
130059886|NCT00485589|468174572|FG000|Overall Study|Administrative/Other|1|||
130059887|NCT00485589|468174573|FG001|Overall Study|Administrative/Other|2|||
129824729|NCT00982488|467324709|FG002|Overall Study|Maximum clinical benefit|1|||
129824730|NCT00982488|467324710|FG003|Overall Study|Maximum clinical benefit|0|||
129824731|NCT00982488|467324711|FG004|Overall Study|Maximum clinical benefit|0|||
129824732|NCT00982488|467324707|FG000|Overall Study|Other|15|||
129824733|NCT00982488|467324708|FG001|Overall Study|Other|1|||
129824734|NCT00982488|467324709|FG002|Overall Study|Other|3|||
129824735|NCT00982488|467324710|FG003|Overall Study|Other|1|||
129824736|NCT00982488|467324711|FG004|Overall Study|Other|0|||
129824737|NCT00982488|467324707|FG000|Overall Study|Poor compliance/noncompliance|0|||
129824738|NCT00982488|467324708|FG001|Overall Study|Poor compliance/noncompliance|1|||
129824739|NCT00982488|467324709|FG002|Overall Study|Poor compliance/noncompliance|0|||
129824740|NCT00982488|467324710|FG003|Overall Study|Poor compliance/noncompliance|0|||
129824741|NCT00982488|467324711|FG004|Overall Study|Poor compliance/noncompliance|0|||
129824742|NCT00982488|467324707|FG000|Overall Study|Stem cell transplant|2|||
129824743|NCT00982488|467324708|FG001|Overall Study|Stem cell transplant|0|||
129824744|NCT00982488|467324709|FG002|Overall Study|Stem cell transplant|0|||
129824745|NCT00982488|467324710|FG003|Overall Study|Stem cell transplant|1|||
129824746|NCT00982488|467324711|FG004|Overall Study|Stem cell transplant|0|||
129824747|NCT00982488|467324707|FG000|Overall Study|Study drug toxicity|34|||
129824748|NCT00982488|467324708|FG001|Overall Study|Study drug toxicity|1|||
129824749|NCT00982488|467324709|FG002|Overall Study|Study drug toxicity|6|||
129824750|NCT00982488|467324710|FG003|Overall Study|Study drug toxicity|0|||
129824751|NCT00982488|467324711|FG004|Overall Study|Study drug toxicity|0|||
129824752|NCT00982488|467324707|FG000|Overall Study|Withdrawal by Subject|5|||
129824753|NCT00982488|467324708|FG001|Overall Study|Withdrawal by Subject|1|||
129824754|NCT00982488|467324709|FG002|Overall Study|Withdrawal by Subject|1|||
129824755|NCT00982488|467324710|FG003|Overall Study|Withdrawal by Subject|0|||
129824756|NCT00982488|467324711|FG004|Overall Study|Withdrawal by Subject|0|||
129824757|NCT00180414|467324720|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
129824758|NCT00180414|467324721|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
129824759|NCT01572909|467324722|FG000|Overall Study|Adverse Event|7|||
129824760|NCT01572909|467324723|FG001|Overall Study|Adverse Event|2|||
129824761|NCT01572909|467324722|FG000|Overall Study|Death|3|||
129824762|NCT01572909|467324723|FG001|Overall Study|Death|1|||
129824763|NCT01572909|467324722|FG000|Overall Study|Lost to Follow-up|8|||
129824764|NCT01572909|467324723|FG001|Overall Study|Lost to Follow-up|7|||
129824765|NCT01572909|467324722|FG000|Overall Study|Physician Decision|1|||
129824766|NCT01572909|467324723|FG001|Overall Study|Physician Decision|1|||
129824767|NCT01572909|467324722|FG000|Overall Study|Technical Issues|1|||
129824768|NCT01572909|467324723|FG001|Overall Study|Technical Issues|0|||
129824769|NCT01572909|467324722|FG000|Overall Study|Withdrawal by Subject|12|||
129824770|NCT01572909|467324723|FG001|Overall Study|Withdrawal by Subject|11|||
129824771|NCT01572909|467324722|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
129824772|NCT01572909|467324723|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
129824773|NCT03641651|467324724|FG000|Overall Study|organizational issues at one study site|1|||
129824774|NCT04779489|467324725|FG000|Overall Study|Physician Decision|1|||
129824775|NCT00623727|467324726|FG000|Double Blind (DB)|Adverse Event|1|||
129824776|NCT00623727|467324727|FG001|Double Blind (DB)|Adverse Event|3|||
129824777|NCT00623727|467324726|FG000|Double Blind (DB)|Physician Decision|0|||
129824778|NCT00623727|467324727|FG001|Double Blind (DB)|Physician Decision|1|||
129824779|NCT00623727|467324726|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
129824780|NCT00623727|467324727|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
129824781|NCT00623727|467324726|FG000|Double Blind (DB)|Lack of Efficacy|2|||
129824782|NCT00623727|467324727|FG001|Double Blind (DB)|Lack of Efficacy|2|||
129824783|NCT00623727|467324726|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
129824784|NCT00623727|467324727|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
130059888|NCT00485589|468174574|FG002|Overall Study|Administrative/Other|1|||
130059889|NCT00485589|468174572|FG000|Overall Study|Insufficient therapeutic response|10|||
130059890|NCT00485589|468174573|FG001|Overall Study|Insufficient therapeutic response|3|||
129824785|NCT00623727|467324726|FG000|Double Blind (DB)|Lost to Follow-up|1|||
129824786|NCT00623727|467324727|FG001|Double Blind (DB)|Lost to Follow-up|1|||
129824787|NCT00623727|467324726|FG000|Double Blind (DB)|Protocol Violation|2|||
129824788|NCT00623727|467324727|FG001|Double Blind (DB)|Protocol Violation|2|||
129824789|NCT00623727|467324726|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
129824790|NCT00623727|467324727|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
129824791|NCT00623727|467324726|FG000|Open Label Follow-up|Study termination|0|||
129824792|NCT00623727|467324727|FG001|Open Label Follow-up|Study termination|6|||
129824793|NCT00623727|467324726|FG000|Open Label Follow-up|Participant convenience|0|||
129824794|NCT00623727|467324727|FG001|Open Label Follow-up|Participant convenience|1|||
129824795|NCT00951665|467324728|FG000|Phase 1b|Adverse Event|2|||
129824796|NCT00951665|467324729|FG001|Phase 1b|Adverse Event|1|||
130059891|NCT00485589|468174574|FG002|Overall Study|Insufficient therapeutic response|1|||
129824797|NCT00951665|467324730|FG002|Phase 1b|Adverse Event|0|||
129824798|NCT00951665|467324731|FG003|Phase 1b|Adverse Event|1|||
129824799|NCT00951665|467324732|FG004|Phase 1b|Adverse Event|0|||
129824800|NCT00951665|467324733|FG005|Phase 1b|Adverse Event|0|||
129824801|NCT00951665|467324728|FG000|Phase 1b|Death|1|||
129824802|NCT00951665|467324729|FG001|Phase 1b|Death|0|||
129824803|NCT00951665|467324730|FG002|Phase 1b|Death|2|||
129824804|NCT00951665|467324731|FG003|Phase 1b|Death|0|||
129824805|NCT00951665|467324732|FG004|Phase 1b|Death|0|||
129824806|NCT00951665|467324733|FG005|Phase 1b|Death|0|||
129824807|NCT00951665|467324728|FG000|Phase 1b|Physician Decision|4|||
129824808|NCT00951665|467324729|FG001|Phase 1b|Physician Decision|0|||
129824809|NCT00951665|467324730|FG002|Phase 1b|Physician Decision|1|||
129824810|NCT00951665|467324731|FG003|Phase 1b|Physician Decision|0|||
129824811|NCT00951665|467324732|FG004|Phase 1b|Physician Decision|0|||
129824812|NCT00951665|467324733|FG005|Phase 1b|Physician Decision|0|||
129824813|NCT00951665|467324728|FG000|Phase 1b|Withdrawal by Subject|0|||
129824814|NCT00951665|467324729|FG001|Phase 1b|Withdrawal by Subject|1|||
129824815|NCT00951665|467324730|FG002|Phase 1b|Withdrawal by Subject|0|||
129824816|NCT00951665|467324731|FG003|Phase 1b|Withdrawal by Subject|0|||
129824817|NCT00951665|467324732|FG004|Phase 1b|Withdrawal by Subject|0|||
129824818|NCT00951665|467324733|FG005|Phase 1b|Withdrawal by Subject|0|||
129824819|NCT00951665|467324728|FG000|Phase 1b|Disease Progression|13|||
129824820|NCT00951665|467324729|FG001|Phase 1b|Disease Progression|2|||
129824821|NCT00951665|467324730|FG002|Phase 1b|Disease Progression|14|||
129824822|NCT00951665|467324731|FG003|Phase 1b|Disease Progression|0|||
129824823|NCT00951665|467324732|FG004|Phase 1b|Disease Progression|0|||
129824824|NCT00951665|467324733|FG005|Phase 1b|Disease Progression|0|||
129824825|NCT00951665|467324728|FG000|Phase 1b|Protocol Violation|2|||
129824826|NCT00951665|467324729|FG001|Phase 1b|Protocol Violation|0|||
129824827|NCT00951665|467324730|FG002|Phase 1b|Protocol Violation|0|||
129824828|NCT00951665|467324731|FG003|Phase 1b|Protocol Violation|0|||
129824829|NCT00951665|467324732|FG004|Phase 1b|Protocol Violation|0|||
129824830|NCT00951665|467324733|FG005|Phase 1b|Protocol Violation|0|||
129824831|NCT00951665|467324728|FG000|Phase 2a|Adverse Event|0|||
129824832|NCT00951665|467324729|FG001|Phase 2a|Adverse Event|0|||
129824833|NCT00951665|467324730|FG002|Phase 2a|Adverse Event|0|||
129824834|NCT00951665|467324731|FG003|Phase 2a|Adverse Event|0|||
129824835|NCT00951665|467324732|FG004|Phase 2a|Adverse Event|2|||
129824836|NCT00951665|467324733|FG005|Phase 2a|Adverse Event|0|||
129824837|NCT00951665|467324728|FG000|Phase 2a|Death|0|||
129824838|NCT00951665|467324729|FG001|Phase 2a|Death|0|||
129824839|NCT00951665|467324730|FG002|Phase 2a|Death|0|||
129824840|NCT00951665|467324731|FG003|Phase 2a|Death|0|||
129824841|NCT00951665|467324732|FG004|Phase 2a|Death|1|||
129824842|NCT00951665|467324733|FG005|Phase 2a|Death|1|||
129824843|NCT00951665|467324728|FG000|Phase 2a|Lost to Follow-up|0|||
129824844|NCT00951665|467324729|FG001|Phase 2a|Lost to Follow-up|0|||
129824845|NCT00951665|467324730|FG002|Phase 2a|Lost to Follow-up|0|||
129824846|NCT00951665|467324731|FG003|Phase 2a|Lost to Follow-up|0|||
129824847|NCT00951665|467324732|FG004|Phase 2a|Lost to Follow-up|1|||
129824848|NCT00951665|467324733|FG005|Phase 2a|Lost to Follow-up|0|||
129824849|NCT00951665|467324728|FG000|Phase 2a|Physician Decision|0|||
129824850|NCT00951665|467324729|FG001|Phase 2a|Physician Decision|0|||
129824851|NCT00951665|467324730|FG002|Phase 2a|Physician Decision|0|||
129824852|NCT00951665|467324731|FG003|Phase 2a|Physician Decision|0|||
129824853|NCT00951665|467324732|FG004|Phase 2a|Physician Decision|0|||
129824854|NCT00951665|467324733|FG005|Phase 2a|Physician Decision|1|||
129824855|NCT00951665|467324728|FG000|Phase 2a|Withdrawal by Subject|0|||
129824856|NCT00951665|467324729|FG001|Phase 2a|Withdrawal by Subject|0|||
129824857|NCT00951665|467324730|FG002|Phase 2a|Withdrawal by Subject|0|||
129824858|NCT00951665|467324731|FG003|Phase 2a|Withdrawal by Subject|0|||
129824859|NCT00951665|467324732|FG004|Phase 2a|Withdrawal by Subject|2|||
129824860|NCT00951665|467324733|FG005|Phase 2a|Withdrawal by Subject|0|||
129824861|NCT00951665|467324728|FG000|Phase 2a|Disease Progression|0|||
129824862|NCT00951665|467324729|FG001|Phase 2a|Disease Progression|0|||
129824863|NCT00951665|467324730|FG002|Phase 2a|Disease Progression|0|||
129824864|NCT00951665|467324731|FG003|Phase 2a|Disease Progression|0|||
129824865|NCT00951665|467324732|FG004|Phase 2a|Disease Progression|6|||
129824866|NCT00951665|467324733|FG005|Phase 2a|Disease Progression|5|||
129824867|NCT01199289|467324734|FG000|Overall Study|Ineligibility determined|2|||
129824868|NCT01199289|467324735|FG001|Overall Study|Ineligibility determined|1|||
129824869|NCT01199289|467324736|FG002|Overall Study|Ineligibility determined|0|||
129824870|NCT01199289|467324737|FG003|Overall Study|Ineligibility determined|0|||
129824871|NCT01199289|467324734|FG000|Overall Study|Protocol Violation|1|||
129824872|NCT01199289|467324735|FG001|Overall Study|Protocol Violation|0|||
129824873|NCT01199289|467324736|FG002|Overall Study|Protocol Violation|0|||
129824874|NCT01199289|467324737|FG003|Overall Study|Protocol Violation|1|||
129824875|NCT01199289|467324734|FG000|Overall Study|Noncompliance|1|||
129824876|NCT01199289|467324735|FG001|Overall Study|Noncompliance|0|||
129824877|NCT01199289|467324736|FG002|Overall Study|Noncompliance|2|||
129824878|NCT01199289|467324737|FG003|Overall Study|Noncompliance|0|||
129824879|NCT01199289|467324734|FG000|Overall Study|Adverse Event|0|||
129824880|NCT01199289|467324735|FG001|Overall Study|Adverse Event|3|||
129824881|NCT01199289|467324736|FG002|Overall Study|Adverse Event|1|||
129824882|NCT01199289|467324737|FG003|Overall Study|Adverse Event|4|||
129824883|NCT01199289|467324734|FG000|Overall Study|Full consent withdrawn|2|||
129824884|NCT01199289|467324735|FG001|Overall Study|Full consent withdrawn|2|||
129824885|NCT01199289|467324736|FG002|Overall Study|Full consent withdrawn|2|||
129824886|NCT01199289|467324737|FG003|Overall Study|Full consent withdrawn|3|||
129824887|NCT01199289|467324734|FG000|Overall Study|Administrative decision|0|||
129824888|NCT01199289|467324735|FG001|Overall Study|Administrative decision|0|||
129824889|NCT01199289|467324736|FG002|Overall Study|Administrative decision|0|||
129824890|NCT01199289|467324737|FG003|Overall Study|Administrative decision|1|||
129824891|NCT01199289|467324734|FG000|Overall Study|Lost to Follow-up|0|||
129824892|NCT01199289|467324735|FG001|Overall Study|Lost to Follow-up|0|||
129824893|NCT01199289|467324736|FG002|Overall Study|Lost to Follow-up|0|||
129824894|NCT01199289|467324737|FG003|Overall Study|Lost to Follow-up|1|||
129824895|NCT01199289|467324734|FG000|Overall Study|Protocol-specified criteria|3|||
129824896|NCT01199289|467324735|FG001|Overall Study|Protocol-specified criteria|0|||
129824897|NCT01199289|467324736|FG002|Overall Study|Protocol-specified criteria|0|||
129824898|NCT01199289|467324737|FG003|Overall Study|Protocol-specified criteria|1|||
129824899|NCT01199289|467324734|FG000|Overall Study|Pregnancy|0|||
129824900|NCT01199289|467324735|FG001|Overall Study|Pregnancy|1|||
129824901|NCT01199289|467324736|FG002|Overall Study|Pregnancy|0|||
129824902|NCT01199289|467324737|FG003|Overall Study|Pregnancy|1|||
129824903|NCT02723084|467324738|FG000|Overall Study|Withdrawal by Subject|1|||
129824904|NCT02723084|467324739|FG001|Overall Study|Withdrawal by Subject|1|||
129824905|NCT02723084|467324738|FG000|Overall Study|Lost to Follow-up|3|||
129824906|NCT02723084|467324739|FG001|Overall Study|Lost to Follow-up|0|||
129824907|NCT02450903|467324745|FG000|Overall Study|Adverse Event|3|||
129824908|NCT02450903|467324745|FG000|Overall Study|Progressive disease|15|||
129824909|NCT02450903|467324745|FG000|Overall Study|Switched to commercial drug|1|||
129824910|NCT02450903|467324745|FG000|Overall Study|Subject/guardian decision|1|||
129824911|NCT01164956|467324746|FG000|Overall Study|Side Effects|1|||
129824912|NCT01164956|467324747|FG001|Overall Study|Side Effects|0|||
129824913|NCT01164956|467324748|FG002|Overall Study|Side Effects|1|||
129824914|NCT03020407|467324755|FG000|Overall Study|Withdrawal by Subject|2|||
129824915|NCT03020407|467324756|FG001|Overall Study|Withdrawal by Subject|1|||
129824916|NCT03020407|467324755|FG000|Overall Study|Lost to Follow-up|2|||
129824917|NCT03020407|467324756|FG001|Overall Study|Lost to Follow-up|3|||
129824918|NCT03020407|467324755|FG000|Overall Study|Protocol Violation|0|||
129824919|NCT03020407|467324756|FG001|Overall Study|Protocol Violation|1|||
129824920|NCT00708162|467324757|FG000|Randomized Phase|Randomized but Not Treated|7|||
129824921|NCT00708162|467324758|FG001|Randomized Phase|Randomized but Not Treated|5|||
129824922|NCT00708162|467324757|FG000|Randomized Phase|Participant Noncompliance|40|||
129824923|NCT00708162|467324758|FG001|Randomized Phase|Participant Noncompliance|32|||
129824924|NCT00708162|467324757|FG000|Randomized Phase|Lost to Follow-up|34|||
129824925|NCT00708162|467324758|FG001|Randomized Phase|Lost to Follow-up|34|||
129824926|NCT00708162|467324757|FG000|Randomized Phase|Withdrew Consent|31|||
129824927|NCT00708162|467324758|FG001|Randomized Phase|Withdrew Consent|22|||
129824928|NCT00708162|467324757|FG000|Randomized Phase|Lack of Efficacy|14|||
129824929|NCT00708162|467324758|FG001|Randomized Phase|Lack of Efficacy|19|||
129824930|NCT00708162|467324757|FG000|Randomized Phase|Protocol Violation|10|||
129824931|NCT00708162|467324758|FG001|Randomized Phase|Protocol Violation|11|||
129824932|NCT00708162|467324757|FG000|Randomized Phase|Adverse Event|8|||
129824933|NCT00708162|467324758|FG001|Randomized Phase|Adverse Event|12|||
129824934|NCT00708162|467324757|FG000|Randomized Phase|Investigator's Discretion|7|||
129824935|NCT00708162|467324758|FG001|Randomized Phase|Investigator's Discretion|10|||
129824936|NCT00708162|467324757|FG000|Randomized Phase|Death|2|||
129824937|NCT00708162|467324758|FG001|Randomized Phase|Death|9|||
129824938|NCT00708162|467324757|FG000|Randomized Phase|Pregnancy|3|||
129824939|NCT00708162|467324758|FG001|Randomized Phase|Pregnancy|0|||
129824940|NCT00708162|467324757|FG000|Open-Label Phase|Lost to Follow-up|10|||
129824941|NCT00708162|467324758|FG001|Open-Label Phase|Lost to Follow-up|8|||
129824942|NCT00708162|467324757|FG000|Open-Label Phase|Withdrew Consent|12|||
130112647|NCT00910858|468373434|FG002|Pharmacokinetic Phase|Adverse Event|0|||
130112648|NCT00910858|468373432|FG000|Monotherapy Phase|Adverse Event|3|||
130112649|NCT00910858|468373433|FG001|Monotherapy Phase|Adverse Event|2|||
130112650|NCT00910858|468373434|FG002|Monotherapy Phase|Adverse Event|0|||
130112651|NCT00910858|468373432|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
130112652|NCT00910858|468373433|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
129824943|NCT00708162|467324758|FG001|Open-Label Phase|Withdrew Consent|6|||
129824944|NCT00708162|467324757|FG000|Open-Label Phase|Participant Noncompliance|7|||
129824945|NCT00708162|467324758|FG001|Open-Label Phase|Participant Noncompliance|7|||
129824946|NCT00708162|467324757|FG000|Open-Label Phase|Lack of Efficacy|7|||
129824947|NCT00708162|467324758|FG001|Open-Label Phase|Lack of Efficacy|4|||
129824948|NCT00708162|467324757|FG000|Open-Label Phase|Investigator's Discretion|3|||
129824949|NCT00708162|467324758|FG001|Open-Label Phase|Investigator's Discretion|2|||
129824950|NCT00708162|467324757|FG000|Open-Label Phase|Death|3|||
129824951|NCT00708162|467324758|FG001|Open-Label Phase|Death|1|||
129824952|NCT00708162|467324757|FG000|Open-Label Phase|Adverse Event|1|||
130059892|NCT00485589|468174572|FG000|Overall Study|Refused treatment/did not cooperate|1|||
130059893|NCT00485589|468174573|FG001|Overall Study|Refused treatment/did not cooperate|0|||
130059894|NCT00485589|468174574|FG002|Overall Study|Refused treatment/did not cooperate|2|||
130059895|NCT00485589|468174572|FG000|Overall Study|Withdrawal by Subject|3|||
130059896|NCT00485589|468174573|FG001|Overall Study|Withdrawal by Subject|2|||
130059897|NCT00485589|468174574|FG002|Overall Study|Withdrawal by Subject|2|||
130059898|NCT00485589|468174572|FG000|Overall Study|Adverse Event|3|||
130059899|NCT00485589|468174573|FG001|Overall Study|Adverse Event|3|||
130059900|NCT00485589|468174574|FG002|Overall Study|Adverse Event|10|||
130059901|NCT01369849|468174575|FG000|Overall Study|Ineligible prior to treatment|0|||
130059902|NCT01369849|468174576|FG001|Overall Study|Ineligible prior to treatment|0|||
130059903|NCT01369849|468174577|FG002|Overall Study|Ineligible prior to treatment|1|||
130059904|NCT01369849|468174575|FG000|Overall Study|Ineligible after receiving treatment|0|||
130059905|NCT01369849|468174576|FG001|Overall Study|Ineligible after receiving treatment|1|||
130059906|NCT01369849|468174577|FG002|Overall Study|Ineligible after receiving treatment|0|||
130059907|NCT00756886|468174578|FG000|Overall Study|Lost to Follow-up|1|||
130059908|NCT00756886|468174579|FG001|Overall Study|Lost to Follow-up|0|||
130059909|NCT00756886|468174578|FG000|Overall Study|Adverse Event|0|||
130059910|NCT00756886|468174579|FG001|Overall Study|Adverse Event|3|||
129824953|NCT00708162|467324758|FG001|Open-Label Phase|Adverse Event|2|||
129824954|NCT00708162|467324757|FG000|Open-Label Phase|Other|1|||
129824955|NCT00708162|467324758|FG001|Open-Label Phase|Other|0|||
129824956|NCT02699554|467324759|FG000|Overall Study|Lost to Follow-up|9|||
129824957|NCT00708643|467324760|FG000|Overall Study|Adverse Event|0|||
129824958|NCT00708643|467324761|FG001|Overall Study|Adverse Event|1|||
129824959|NCT00788151|467324762|FG000|Overall Study|Other adverse event|0|||
129824960|NCT00788151|467324763|FG001|Overall Study|Other adverse event|2|||
129824961|NCT00788151|467324762|FG000|Overall Study|Protocol Violation|0|||
129824962|NCT00788151|467324763|FG001|Overall Study|Protocol Violation|1|||
129824963|NCT00788151|467324762|FG000|Overall Study|Withdrawal by Subject|13|||
129824964|NCT00788151|467324763|FG001|Overall Study|Withdrawal by Subject|6|||
129824965|NCT00788151|467324762|FG000|Overall Study|Enrolled but not treated|1|||
129824966|NCT00788151|467324763|FG001|Overall Study|Enrolled but not treated|1|||
129824967|NCT00503009|467324764|FG000|Overall Study|Protocol Violation|1|||
129824968|NCT00503009|467324765|FG001|Overall Study|Protocol Violation|0|||
129824969|NCT00503009|467324766|FG002|Overall Study|Protocol Violation|1|||
129824970|NCT00503009|467324764|FG000|Overall Study|Withdrawal by Subject|0|||
129824971|NCT00503009|467324765|FG001|Overall Study|Withdrawal by Subject|1|||
129824972|NCT00503009|467324766|FG002|Overall Study|Withdrawal by Subject|1|||
129824973|NCT00503009|467324764|FG000|Overall Study|Physician Decision|0|||
129824974|NCT00503009|467324765|FG001|Overall Study|Physician Decision|1|||
129824975|NCT00503009|467324766|FG002|Overall Study|Physician Decision|1|||
129824976|NCT01349803|467324767|FG000|Overall Study|Adverse Event|0|||
129824977|NCT01349803|467324768|FG001|Overall Study|Adverse Event|0|||
129824978|NCT01349803|467324769|FG002|Overall Study|Adverse Event|0|||
129824979|NCT01349803|467324770|FG003|Overall Study|Adverse Event|2|||
129824980|NCT01349803|467324767|FG000|Overall Study|Withdrawal by Subject|1|||
129824981|NCT01349803|467324768|FG001|Overall Study|Withdrawal by Subject|0|||
129824982|NCT01349803|467324769|FG002|Overall Study|Withdrawal by Subject|0|||
129824983|NCT01349803|467324770|FG003|Overall Study|Withdrawal by Subject|0|||
129824984|NCT01349803|467324767|FG000|Overall Study|Protocol-specified criteria|0|||
129824985|NCT01349803|467324768|FG001|Overall Study|Protocol-specified criteria|1|||
129824986|NCT01349803|467324769|FG002|Overall Study|Protocol-specified criteria|3|||
129824987|NCT01349803|467324770|FG003|Overall Study|Protocol-specified criteria|0|||
129824988|NCT01710033|467324771|FG000|Stage 2|Adverse Event|0|||
129824989|NCT01710033|467324772|FG001|Stage 2|Adverse Event|0|||
129824990|NCT01710033|467324773|FG002|Stage 2|Adverse Event|0|||
129824991|NCT01710033|467324774|FG003|Stage 2|Adverse Event|0|||
129824992|NCT01710033|467324775|FG004|Stage 2|Adverse Event|1|||
129824993|NCT00100815|467324776|FG000|Overall Study|Progression|24|||
129824994|NCT00100815|467324776|FG000|Overall Study|Adverse Event|18|||
129824995|NCT00100815|467324776|FG000|Overall Study|Death|4|||
129824996|NCT00100815|467324776|FG000|Overall Study|Other|3|||
129824997|NCT01647282|467324778|FG000|Overall Study|Physician Decision|7|||
129897493|NCT00320489|467584393|FG000|Overall Study|Lack of Efficacy|16|||
129897494|NCT00320489|467584394|FG001|Overall Study|Lack of Efficacy|7|||
129824998|NCT01647282|467324779|FG001|Overall Study|Physician Decision|5|||
129824999|NCT01244906|467324781|FG000|Overall Study|Death|2|||
129825000|NCT01244906|467324781|FG000|Overall Study|Progression of disease post treatment|6|||
129825001|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
129825002|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
129897495|NCT00320489|467584393|FG000|Overall Study|Lost to Follow-up|21|||
129825003|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
129825004|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
130059911|NCT00756886|468174578|FG000|Overall Study|Lack of Efficacy|1|||
130059912|NCT00756886|468174579|FG001|Overall Study|Lack of Efficacy|0|||
130059913|NCT00756886|468174578|FG000|Overall Study|Ineligible|9|||
130059914|NCT00756886|468174579|FG001|Overall Study|Ineligible|4|||
129825005|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
129825006|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
129825007|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825008|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825009|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825010|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
129825011|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825012|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
129825013|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
129825014|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
130059915|NCT00174785|468174583|FG000|Overall Study|Adverse Event|293|||
129825015|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
129825016|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
129825017|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
129825018|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
129825019|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825020|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825021|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825022|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825023|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
129825024|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
129825025|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
129825026|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
129825027|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
129825028|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
129825029|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
129825030|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
129825031|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
129825032|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
129825033|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
129825034|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
129825035|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
129825036|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
129825037|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825038|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825039|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825040|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
129825041|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
129825042|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825043|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
129825044|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
129825045|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
129825046|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
129825047|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
129825048|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
129825049|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825050|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825051|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825052|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825053|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825054|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
129825055|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
129825056|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
130059916|NCT00174785|468174584|FG001|Overall Study|Adverse Event|191|||
130059917|NCT00174785|468174583|FG000|Overall Study|Protocol Violation|14|||
129825057|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
129825058|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
129825059|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
129825060|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
129825061|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825062|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
130059918|NCT00174785|468174584|FG001|Overall Study|Protocol Violation|14|||
129825063|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
130059919|NCT00174785|468174583|FG000|Overall Study|Withdrawal by Subject|173|||
130059920|NCT00174785|468174584|FG001|Overall Study|Withdrawal by Subject|175|||
130059921|NCT00174785|468174583|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
130059922|NCT00174785|468174584|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
130059923|NCT00174785|468174583|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
130059924|NCT00174785|468174584|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
130059925|NCT00174785|468174583|FG000|Overall Study|Other prohibited medication|5|||
130059926|NCT00174785|468174584|FG001|Overall Study|Other prohibited medication|3|||
130059927|NCT00174785|468174583|FG000|Overall Study|Family request|6|||
130059928|NCT00174785|468174584|FG001|Overall Study|Family request|8|||
130059929|NCT00174785|468174583|FG000|Overall Study|Not pre-specified/Not coded|56|||
130059930|NCT00174785|468174584|FG001|Overall Study|Not pre-specified/Not coded|70|||
130059931|NCT00120289|468174586|FG000|Overall Study|Death|96|||
130059932|NCT00120289|468174587|FG001|Overall Study|Death|82|||
130059933|NCT00120289|468174586|FG000|Overall Study|Lost to Follow-up|11|||
130059934|NCT00120289|468174587|FG001|Overall Study|Lost to Follow-up|14|||
130059935|NCT00120289|468174586|FG000|Overall Study|Withdrawal by Subject|14|||
130059936|NCT00120289|468174587|FG001|Overall Study|Withdrawal by Subject|13|||
130059937|NCT01944969|468174588|FG000|Overall Study|Adverse Event|1|||
130059938|NCT01944969|468174588|FG000|Overall Study|Lack of Efficacy|1|||
130059939|NCT01944969|468174588|FG000|Overall Study|Non-compliance with IMP|1|||
130059940|NCT01944969|468174588|FG000|Overall Study|Administrative or other reasons|23|||
130059941|NCT02938585|468174597|FG000|Overall Study|Withdrawal by parent or guardian|0|||
130059942|NCT02938585|468174598|FG001|Overall Study|Withdrawal by parent or guardian|1|||
130059943|NCT02938585|468174599|FG002|Overall Study|Withdrawal by parent or guardian|0|||
130059944|NCT02938585|468174600|FG003|Overall Study|Withdrawal by parent or guardian|0|||
130059945|NCT02938585|468174597|FG000|Overall Study|Withdrawal by Subject|0|||
130059946|NCT02938585|468174598|FG001|Overall Study|Withdrawal by Subject|0|||
129825064|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825065|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825066|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825067|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825068|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825069|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825070|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
129825071|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825072|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
129825073|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825074|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825075|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825076|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825077|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825078|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
129825079|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825080|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825081|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
129825082|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825083|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825084|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825085|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
129825086|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
129825087|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
129825088|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
129825089|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
129825090|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
129825091|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Other|0|||
129825092|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Other|1|||
129825093|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Other|0|||
129825094|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Other|2|||
129825095|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Other|1|||
129825096|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Other|0|||
129825097|NCT00453921|467324788|FG000|Overall Study|Withdrawal by Subject|1|||
130112653|NCT00910858|468373434|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
129825098|NCT00453921|467324789|FG001|Overall Study|Withdrawal by Subject|1|||
129825099|NCT00453921|467324790|FG002|Overall Study|Withdrawal by Subject|1|||
129825100|NCT00453921|467324791|FG003|Overall Study|Withdrawal by Subject|1|||
129825101|NCT00453921|467324788|FG000|Overall Study|Lost to Follow-up|0|||
129825102|NCT00453921|467324789|FG001|Overall Study|Lost to Follow-up|0|||
129897496|NCT00320489|467584394|FG001|Overall Study|Lost to Follow-up|22|||
130059947|NCT02938585|468174599|FG002|Overall Study|Withdrawal by Subject|0|||
130059948|NCT02938585|468174600|FG003|Overall Study|Withdrawal by Subject|5|||
130059949|NCT00213980|468174601|FG000|Overall Study|Withdrawal by Subject|3|||
130059950|NCT00213980|468174602|FG001|Overall Study|Withdrawal by Subject|1|||
130059951|NCT00213980|468174601|FG000|Overall Study|Adverse Event|1|||
130059952|NCT00213980|468174602|FG001|Overall Study|Adverse Event|1|||
129825103|NCT00453921|467324790|FG002|Overall Study|Lost to Follow-up|1|||
129825104|NCT00453921|467324791|FG003|Overall Study|Lost to Follow-up|0|||
129825105|NCT00993291|467324795|FG000|Overall Study|Withdrawal by Subject|1|||
129825106|NCT02763189|467324796|FG000|Overall Study|Device failure|0|||
129825107|NCT02763189|467324797|FG001|Overall Study|Device failure|2|||
129825108|NCT00573534|467324802|FG000|Overall Study|oppositional behavior|3|||
129825109|NCT00467259|467324807|FG000|Overall Study|Adverse Event|24|||
129825110|NCT00467259|467324808|FG001|Overall Study|Adverse Event|90|||
129825111|NCT00467259|467324807|FG000|Overall Study|Protocol Violation|1|||
129825112|NCT00467259|467324808|FG001|Overall Study|Protocol Violation|7|||
129825113|NCT00467259|467324807|FG000|Overall Study|Withdrawal by Subject|34|||
129825114|NCT00467259|467324808|FG001|Overall Study|Withdrawal by Subject|108|||
129825115|NCT00467259|467324807|FG000|Overall Study|Physician Decision|0|||
129825116|NCT00467259|467324808|FG001|Overall Study|Physician Decision|2|||
129825117|NCT00467259|467324807|FG000|Overall Study|Lost to Follow-up|14|||
129825118|NCT00467259|467324808|FG001|Overall Study|Lost to Follow-up|34|||
129825119|NCT00467259|467324807|FG000|Overall Study|Site Closed|2|||
129825120|NCT00467259|467324808|FG001|Overall Study|Site Closed|1|||
129825121|NCT01129960|467324816|FG000|Overall Study|Withdrawal by Subject|3|||
129825122|NCT01129960|467324817|FG001|Overall Study|Withdrawal by Subject|0|||
129825123|NCT01129960|467324818|FG002|Overall Study|Withdrawal by Subject|3|||
129825124|NCT01129960|467324819|FG003|Overall Study|Withdrawal by Subject|2|||
129825125|NCT01129960|467324816|FG000|Overall Study|Lack of Efficacy|1|||
129825126|NCT01129960|467324817|FG001|Overall Study|Lack of Efficacy|1|||
129825127|NCT01129960|467324818|FG002|Overall Study|Lack of Efficacy|1|||
129825128|NCT01129960|467324819|FG003|Overall Study|Lack of Efficacy|1|||
129825129|NCT01129960|467324816|FG000|Overall Study|Adverse Event|23|||
129825130|NCT01129960|467324817|FG001|Overall Study|Adverse Event|16|||
129825131|NCT01129960|467324818|FG002|Overall Study|Adverse Event|16|||
129825132|NCT01129960|467324819|FG003|Overall Study|Adverse Event|7|||
129825133|NCT01129960|467324816|FG000|Overall Study|Protocol Violation|1|||
129825134|NCT01129960|467324817|FG001|Overall Study|Protocol Violation|2|||
129825135|NCT01129960|467324818|FG002|Overall Study|Protocol Violation|3|||
129825136|NCT01129960|467324819|FG003|Overall Study|Protocol Violation|0|||
129825137|NCT01129960|467324816|FG000|Overall Study|Lost to Follow-up|0|||
129825138|NCT01129960|467324817|FG001|Overall Study|Lost to Follow-up|2|||
129825139|NCT01129960|467324818|FG002|Overall Study|Lost to Follow-up|3|||
129825140|NCT01129960|467324819|FG003|Overall Study|Lost to Follow-up|3|||
129825141|NCT01129960|467324816|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
129825142|NCT01129960|467324817|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
129825143|NCT01129960|467324818|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
129825144|NCT01129960|467324819|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
129825145|NCT01129960|467324816|FG000|Overall Study|Physician Decision|1|||
129825146|NCT01129960|467324817|FG001|Overall Study|Physician Decision|0|||
129825147|NCT01129960|467324818|FG002|Overall Study|Physician Decision|0|||
129825148|NCT01129960|467324819|FG003|Overall Study|Physician Decision|0|||
129825149|NCT01129960|467324816|FG000|Overall Study|Pregnancy|1|||
129825150|NCT01129960|467324817|FG001|Overall Study|Pregnancy|0|||
129825151|NCT01129960|467324818|FG002|Overall Study|Pregnancy|0|||
129825152|NCT01129960|467324819|FG003|Overall Study|Pregnancy|0|||
129825153|NCT04285879|467324820|FG000|Overall Study|Lost to Follow-up|1|||
129825154|NCT04285879|467324821|FG001|Overall Study|Lost to Follow-up|8|||
129825155|NCT04285879|467324820|FG000|Overall Study|medical/surgical exclusion|16|||
129825156|NCT04285879|467324821|FG001|Overall Study|medical/surgical exclusion|0|||
129825157|NCT02056340|467324823|FG000|Overall Study|Lost to Follow-up|5|||
129825158|NCT02056340|467324824|FG001|Overall Study|Lost to Follow-up|5|||
129825159|NCT02056340|467324823|FG000|Overall Study|Withdrawal by Subject|2|||
129825160|NCT02056340|467324824|FG001|Overall Study|Withdrawal by Subject|6|||
129825161|NCT04900220|467324825|FG000|Overall Study|Lost to Follow-up|1|||
129825162|NCT04900220|467324826|FG001|Overall Study|Lost to Follow-up|1|||
129825163|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
129825164|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
129825165|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
129897497|NCT00320489|467584393|FG000|Overall Study|Physician Decision|8|||
129825166|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
129825167|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Death|7|||
129825168|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Death|5|||
129825169|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
129825170|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
129825171|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
129825172|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
129825173|NCT02999854|467324832|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
129825174|NCT02999854|467324833|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
129825175|NCT02999854|467324832|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
129825176|NCT02999854|467324833|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
129897498|NCT00320489|467584394|FG001|Overall Study|Physician Decision|8|||
129825177|NCT02999854|467324832|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
129825178|NCT02999854|467324833|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
129825179|NCT01085591|467324834|FG000|Overall Study|Adverse Event|0|||
129825180|NCT01085591|467324835|FG001|Overall Study|Adverse Event|1|||
129825181|NCT01085591|467324836|FG002|Overall Study|Adverse Event|3|||
129825182|NCT01085591|467324834|FG000|Overall Study|Physician Decision|1|||
129825183|NCT01085591|467324835|FG001|Overall Study|Physician Decision|0|||
129825184|NCT01085591|467324836|FG002|Overall Study|Physician Decision|1|||
129825185|NCT01085591|467324834|FG000|Overall Study|Withdrawal by Subject|0|||
129825186|NCT01085591|467324835|FG001|Overall Study|Withdrawal by Subject|2|||
129825187|NCT01085591|467324836|FG002|Overall Study|Withdrawal by Subject|1|||
129825188|NCT01085591|467324834|FG000|Overall Study|Lost to Follow-up|0|||
129825189|NCT01085591|467324835|FG001|Overall Study|Lost to Follow-up|1|||
129825190|NCT01085591|467324836|FG002|Overall Study|Lost to Follow-up|1|||
129825191|NCT01085591|467324834|FG000|Overall Study|Protocol Violation|1|||
129825192|NCT01085591|467324835|FG001|Overall Study|Protocol Violation|1|||
129825193|NCT01085591|467324836|FG002|Overall Study|Protocol Violation|1|||
129825194|NCT01085591|467324834|FG000|Overall Study|Other|0|||
129825195|NCT01085591|467324835|FG001|Overall Study|Other|1|||
129825196|NCT01085591|467324836|FG002|Overall Study|Other|0|||
129825197|NCT01085591|467324834|FG000|Overall Study|Not Properly Consented|1|||
129825198|NCT01085591|467324835|FG001|Overall Study|Not Properly Consented|0|||
129825199|NCT01085591|467324836|FG002|Overall Study|Not Properly Consented|0|||
129825200|NCT00847704|467324837|FG000|Overall Study|Withdrawal by Subject|1|||
129825201|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
129825202|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
129825203|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
129825204|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
129825205|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
129825206|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
129825207|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
129825208|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
129825209|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
129825210|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
129825211|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
129825212|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
129825213|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
129825214|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
129825215|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
129825216|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
129825217|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
129825218|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
129825219|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
129825220|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
129825221|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
129825222|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
129825223|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
129825224|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
129825225|NCT03036072|467324844|FG000|Overall Study|Death|0|||
129825226|NCT03036072|467324845|FG001|Overall Study|Death|1|||
129825227|NCT03036072|467324844|FG000|Overall Study|Withdrawal by Subject|0|||
129825228|NCT03036072|467324845|FG001|Overall Study|Withdrawal by Subject|1|||
129825229|NCT03036072|467324844|FG000|Overall Study|Physician Decision|0|||
129825230|NCT03036072|467324845|FG001|Overall Study|Physician Decision|1|||
129825231|NCT02484729|467324846|FG000|Overall Study|Failure of IntelliCap Error|0|||
129825232|NCT02484729|467324847|FG001|Overall Study|Failure of IntelliCap Error|0|||
129825233|NCT02484729|467324848|FG002|Overall Study|Failure of IntelliCap Error|0|||
129825234|NCT02484729|467324849|FG003|Overall Study|Failure of IntelliCap Error|0|||
129825235|NCT02484729|467324850|FG004|Overall Study|Failure of IntelliCap Error|0|||
129825236|NCT02484729|467324851|FG005|Overall Study|Failure of IntelliCap Error|0|||
129825237|NCT02484729|467324852|FG006|Overall Study|Failure of IntelliCap Error|0|||
129825238|NCT02484729|467324853|FG007|Overall Study|Failure of IntelliCap Error|0|||
129825239|NCT02484729|467324854|FG008|Overall Study|Failure of IntelliCap Error|0|||
129825240|NCT02484729|467324855|FG009|Overall Study|Failure of IntelliCap Error|1|||
129825241|NCT02111850|467324858|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825242|NCT02111850|467324859|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825243|NCT02111850|467324860|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825244|NCT02111850|467324861|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825245|NCT02111850|467324862|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
129825246|NCT02111850|467324863|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825247|NCT02111850|467324864|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825248|NCT02111850|467324865|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825249|NCT02111850|467324866|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825250|NCT02111850|467324867|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825251|NCT02111850|467324868|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825252|NCT00665847|467324869|FG000|Overall Study|Adverse Event|8|||
129825253|NCT00665847|467324869|FG000|Overall Study|Withdrawal by Subject|2|||
129825254|NCT00665847|467324869|FG000|Overall Study|Subject non-compliant|8|||
129825255|NCT00665847|467324869|FG000|Overall Study|Subject reached a virologic endpoint|4|||
129825256|NCT00665847|467324869|FG000|Overall Study|Resistance to TMC125|1|||
129825257|NCT00665847|467324869|FG000|Overall Study|Subject ineligible to continue the trial|1|||
129825258|NCT00665847|467324869|FG000|Overall Study|Switch to Commercial Medication|1|||
129825259|NCT03605303|467324870|FG000|Period 1|Study Terminated|2|||
129825260|NCT03605303|467324871|FG001|Period 1|Study Terminated|1|||
129825261|NCT02626520|467324874|FG000|Overall Study|Physician Decision|1|||
129825262|NCT02626520|467324875|FG001|Overall Study|Physician Decision|1|||
129825263|NCT02626520|467324874|FG000|Overall Study|Adverse Event|0|||
129825264|NCT02626520|467324875|FG001|Overall Study|Adverse Event|4|||
129825265|NCT02626520|467324874|FG000|Overall Study|Lack of Efficacy|0|||
129825266|NCT02626520|467324875|FG001|Overall Study|Lack of Efficacy|2|||
129825267|NCT02626520|467324874|FG000|Overall Study|Did not start protocol therapy|0|||
129825268|NCT02626520|467324875|FG001|Overall Study|Did not start protocol therapy|2|||
129825269|NCT02626520|467324874|FG000|Overall Study|Study terminated|0|||
129825270|NCT02626520|467324875|FG001|Overall Study|Study terminated|1|||
129825271|NCT00492115|467324876|FG000|Overall Study|Withdrawal by Subject|3|||
129825272|NCT00492115|467324877|FG001|Overall Study|Withdrawal by Subject|4|||
129825273|NCT03564145|467324880|FG000|Overall Study|Adverse Event|4|||
129825274|NCT03564145|467324880|FG000|Overall Study|Lost to Follow-up|21|||
129825275|NCT03564145|467324880|FG000|Overall Study|Protocol Violation|2|||
129825276|NCT03564145|467324880|FG000|Overall Study|Withdrawal by Subject|48|||
129825277|NCT03564145|467324880|FG000|Overall Study|Study Terminated by Sponsor|146|||
129825278|NCT03564145|467324880|FG000|Overall Study|Physician Decision|1|||
129825279|NCT03564145|467324880|FG000|Overall Study|Other Than Specified|1|||
129825280|NCT03564145|467324880|FG000|Overall Study|Pregnancy|1|||
129825281|NCT03915496|467324881|FG000|Overall Study|Adverse Event|2|||
129825282|NCT03915496|467324882|FG001|Overall Study|Adverse Event|1|||
129825283|NCT03915496|467324883|FG002|Overall Study|Adverse Event|2|||
129825284|NCT01031069|467324884|FG000|Overall Study|Serious Adverse Event|0|||
129825285|NCT01031069|467324885|FG001|Overall Study|Serious Adverse Event|1|||
129825286|NCT01031069|467324886|FG002|Overall Study|Serious Adverse Event|0|||
129825287|NCT01031069|467324887|FG003|Overall Study|Serious Adverse Event|0|||
129825288|NCT01031069|467324884|FG000|Overall Study|Withdrawal by Subject|2|||
129825289|NCT01031069|467324885|FG001|Overall Study|Withdrawal by Subject|3|||
129825290|NCT01031069|467324886|FG002|Overall Study|Withdrawal by Subject|18|||
129825291|NCT01031069|467324887|FG003|Overall Study|Withdrawal by Subject|18|||
129825292|NCT01031069|467324884|FG000|Overall Study|Migrated/moved from study area|1|||
129825293|NCT01031069|467324885|FG001|Overall Study|Migrated/moved from study area|2|||
129825294|NCT01031069|467324886|FG002|Overall Study|Migrated/moved from study area|1|||
129825295|NCT01031069|467324887|FG003|Overall Study|Migrated/moved from study area|1|||
129825296|NCT01031069|467324884|FG000|Overall Study|Lost to Follow-up|9|||
129825297|NCT01031069|467324885|FG001|Overall Study|Lost to Follow-up|5|||
129825298|NCT01031069|467324886|FG002|Overall Study|Lost to Follow-up|21|||
129825299|NCT01031069|467324887|FG003|Overall Study|Lost to Follow-up|15|||
129825300|NCT01031069|467324884|FG000|Overall Study|Other|0|||
129825301|NCT01031069|467324885|FG001|Overall Study|Other|0|||
129825302|NCT01031069|467324886|FG002|Overall Study|Other|1|||
129825303|NCT01031069|467324887|FG003|Overall Study|Other|0|||
129825304|NCT05286307|467324888|FG000|Overall Study|Incomplete outcome assessments|2|||
129825305|NCT05286307|467324889|FG001|Overall Study|Incomplete outcome assessments|1|||
129825306|NCT05286307|467324888|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
130059953|NCT00213980|468174601|FG000|Overall Study|Disease progression|0|||
130059954|NCT00213980|468174602|FG001|Overall Study|Disease progression|2|||
130059955|NCT00213980|468174601|FG000|Overall Study|Developed ovarian cancer|1|||
130059956|NCT00213980|468174602|FG001|Overall Study|Developed ovarian cancer|0|||
130059957|NCT00213980|468174601|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
129825307|NCT05286307|467324889|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
129825308|NCT05286307|467324888|FG000|Overall Study|Lost to follow up at 6 months|25|||
129825309|NCT05286307|467324889|FG001|Overall Study|Lost to follow up at 6 months|35|||
129825310|NCT05286307|467324888|FG000|Overall Study|Study medication not available|1|||
129825311|NCT05286307|467324889|FG001|Overall Study|Study medication not available|1|||
129825312|NCT01103284|467324890|FG000|Overall Study|Death|2|||
129825313|NCT01103284|467324891|FG001|Overall Study|Death|0|||
129825314|NCT01103284|467324890|FG000|Overall Study|Lost to Follow-up|9|||
129825315|NCT01103284|467324891|FG001|Overall Study|Lost to Follow-up|10|||
129825316|NCT01103284|467324890|FG000|Overall Study|Pregnancy|3|||
129825317|NCT01103284|467324891|FG001|Overall Study|Pregnancy|1|||
129825318|NCT01103284|467324890|FG000|Overall Study|Protocol Violation|12|||
129825319|NCT01103284|467324891|FG001|Overall Study|Protocol Violation|5|||
129825320|NCT01103284|467324890|FG000|Overall Study|Adverse Event|0|||
129825321|NCT01103284|467324891|FG001|Overall Study|Adverse Event|5|||
129825322|NCT01103284|467324890|FG000|Overall Study|Withdrawal by Subject|14|||
129825323|NCT01103284|467324891|FG001|Overall Study|Withdrawal by Subject|18|||
129825324|NCT01103284|467324890|FG000|Overall Study|Dermal Hypersensitivity|0|||
129825325|NCT01103284|467324891|FG001|Overall Study|Dermal Hypersensitivity|1|||
129825326|NCT01103284|467324890|FG000|Overall Study|Termination by the Sponsor|0|||
129825327|NCT01103284|467324891|FG001|Overall Study|Termination by the Sponsor|1|||
129825328|NCT01103284|467324890|FG000|Overall Study|Not described|2|||
129825329|NCT01103284|467324891|FG001|Overall Study|Not described|1|||
129825330|NCT01103284|467324890|FG000|Overall Study|Missing CRF entries for study completion|0|||
129825331|NCT01103284|467324891|FG001|Overall Study|Missing CRF entries for study completion|2|||
129825332|NCT05024058|467326499|FG000|Treatment|Study terminated by sponsor|5|||
129825333|NCT05024058|467326500|FG001|Treatment|Study terminated by sponsor|6|||
129825334|NCT05024058|467326501|FG002|Treatment|Study terminated by sponsor|4|||
129825335|NCT05024058|467326502|FG003|Treatment|Study terminated by sponsor|2|||
129825336|NCT05024058|467326503|FG004|Treatment|Study terminated by sponsor|3|||
129825337|NCT05024058|467326504|FG005|Treatment|Study terminated by sponsor|3|||
129825338|NCT05024058|467326505|FG006|Treatment|Study terminated by sponsor|1|||
129825339|NCT05024058|467326506|FG007|Treatment|Study terminated by sponsor|3|||
129825340|NCT05024058|467326507|FG008|Treatment|Study terminated by sponsor|6|||
129825341|NCT05024058|467326508|FG009|Treatment|Study terminated by sponsor|6|||
129825342|NCT05024058|467326499|FG000|Follow-up|Withdrawal by Subject|1|||
129825343|NCT05024058|467326500|FG001|Follow-up|Withdrawal by Subject|0|||
129825344|NCT05024058|467326501|FG002|Follow-up|Withdrawal by Subject|1|||
129825345|NCT05024058|467326502|FG003|Follow-up|Withdrawal by Subject|0|||
129825346|NCT05024058|467326503|FG004|Follow-up|Withdrawal by Subject|0|||
129825347|NCT05024058|467326504|FG005|Follow-up|Withdrawal by Subject|0|||
129825348|NCT05024058|467326505|FG006|Follow-up|Withdrawal by Subject|0|||
129825349|NCT05024058|467326506|FG007|Follow-up|Withdrawal by Subject|1|||
129825350|NCT05024058|467326507|FG008|Follow-up|Withdrawal by Subject|0|||
129825351|NCT05024058|467326508|FG009|Follow-up|Withdrawal by Subject|1|||
129825352|NCT00501293|467326509|FG000|Optimization Period|Enrolled in error|1|||
129825353|NCT00501293|467326510|FG001|Optimization Period|Enrolled in error|0|||
129825354|NCT00501293|467326509|FG000|Maintenance Period|Withdrawal by Subject|14|||
129825355|NCT00501293|467326510|FG001|Maintenance Period|Withdrawal by Subject|13|||
129825356|NCT00501293|467326509|FG000|Maintenance Period|Lost to Follow-up|12|||
129825357|NCT00501293|467326510|FG001|Maintenance Period|Lost to Follow-up|7|||
129825358|NCT00501293|467326509|FG000|Maintenance Period|Adverse Event|6|||
129825359|NCT00501293|467326510|FG001|Maintenance Period|Adverse Event|6|||
129825360|NCT00501293|467326509|FG000|Maintenance Period|Protocol Violation|2|||
129825361|NCT00501293|467326510|FG001|Maintenance Period|Protocol Violation|1|||
129825362|NCT00501293|467326509|FG000|Maintenance Period|Lack of Efficacy|4|||
129825363|NCT00501293|467326510|FG001|Maintenance Period|Lack of Efficacy|1|||
129825364|NCT00501293|467326509|FG000|Maintenance Period|Noncompliant with study medication|5|||
129825365|NCT00501293|467326510|FG001|Maintenance Period|Noncompliant with study medication|0|||
129825366|NCT00501293|467326509|FG000|Maintenance Period|Went into rehabilitation|1|||
129825367|NCT00501293|467326510|FG001|Maintenance Period|Went into rehabilitation|0|||
129825368|NCT00501293|467326509|FG000|Maintenance Period|Would not wear patch|1|||
129825369|NCT00501293|467326510|FG001|Maintenance Period|Would not wear patch|0|||
129825370|NCT00501293|467326509|FG000|Maintenance Period|Application site reaction|1|||
129825371|NCT00501293|467326510|FG001|Maintenance Period|Application site reaction|0|||
129825372|NCT00127712|467326511|FG000|Overall Study|Adverse Event|3|||
129825373|NCT00127712|467326512|FG001|Overall Study|Adverse Event|0|||
129825374|NCT00127712|467326511|FG000|Overall Study|Lack of GI access to continue|2|||
129825375|NCT00127712|467326512|FG001|Overall Study|Lack of GI access to continue|0|||
129825376|NCT02642614|467326513|FG000|Overall Study|Adverse Event|1|||
129825377|NCT02642614|467326514|FG001|Overall Study|Adverse Event|1|||
129825378|NCT02642614|467326515|FG002|Overall Study|Adverse Event|2|||
129825379|NCT02642614|467326516|FG003|Overall Study|Adverse Event|2|||
129825380|NCT02642614|467326513|FG000|Overall Study|Lost to Follow-up|1|||
129825381|NCT02642614|467326514|FG001|Overall Study|Lost to Follow-up|0|||
129825382|NCT02642614|467326515|FG002|Overall Study|Lost to Follow-up|0|||
129825383|NCT02642614|467326516|FG003|Overall Study|Lost to Follow-up|0|||
129825384|NCT02642614|467326513|FG000|Overall Study|Withdrawal by Subject|1|||
129825385|NCT02642614|467326514|FG001|Overall Study|Withdrawal by Subject|1|||
129825386|NCT02642614|467326515|FG002|Overall Study|Withdrawal by Subject|0|||
129825387|NCT02642614|467326516|FG003|Overall Study|Withdrawal by Subject|0|||
129825388|NCT00967798|467326517|FG000|Overall Study|Withdrawal by Subject|5|||
129825389|NCT00967798|467326518|FG001|Overall Study|Withdrawal by Subject|2|||
129825390|NCT00967798|467326517|FG000|Overall Study|Lost to Follow-up|4|||
129825391|NCT00967798|467326518|FG001|Overall Study|Lost to Follow-up|1|||
129825392|NCT01320085|467326519|FG000|Overall Study|Disease Progression|26|||
129825393|NCT01320085|467326520|FG001|Overall Study|Disease Progression|93|||
129825394|NCT01320085|467326521|FG002|Overall Study|Disease Progression|17|||
129825395|NCT01320085|467326519|FG000|Overall Study|Adverse Event|12|||
129825396|NCT01320085|467326520|FG001|Overall Study|Adverse Event|20|||
129825397|NCT01320085|467326521|FG002|Overall Study|Adverse Event|5|||
129825398|NCT01320085|467326519|FG000|Overall Study|Withdrawal by Subject|2|||
129825399|NCT01320085|467326520|FG001|Overall Study|Withdrawal by Subject|4|||
129825400|NCT01320085|467326521|FG002|Overall Study|Withdrawal by Subject|1|||
129825401|NCT01320085|467326519|FG000|Overall Study|Protocol Deviation|1|||
129825402|NCT01320085|467326520|FG001|Overall Study|Protocol Deviation|0|||
129825403|NCT01320085|467326521|FG002|Overall Study|Protocol Deviation|1|||
129825404|NCT01320085|467326519|FG000|Overall Study|Administrative problems|0|||
129825405|NCT01320085|467326520|FG001|Overall Study|Administrative problems|0|||
129825406|NCT01320085|467326521|FG002|Overall Study|Administrative problems|1|||
129825407|NCT03316131|467326522|FG000|Treatment Period 2|Protocol deviation|1|||
129825408|NCT03316131|467326523|FG001|Treatment Period 2|Protocol deviation|0|||
129825409|NCT01409564|467326524|FG000|Overall Study|low medication compliance|4|||
129825410|NCT01409564|467326525|FG001|Overall Study|low medication compliance|3|||
129825411|NCT01409564|467326524|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
129825412|NCT01409564|467326525|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
129825413|NCT01525550|467326531|FG000|Overall Study|Lost to Follow-up|8|||
129825414|NCT01525550|467326532|FG001|Overall Study|Lost to Follow-up|2|||
129825415|NCT01525550|467326531|FG000|Overall Study|Death|19|||
129825416|NCT01525550|467326532|FG001|Overall Study|Death|28|||
129825417|NCT01525550|467326531|FG000|Overall Study|Other|0|||
129825418|NCT01525550|467326532|FG001|Overall Study|Other|4|||
129825419|NCT01525550|467326531|FG000|Overall Study|Sponsor's Decision|30|||
129825420|NCT01525550|467326532|FG001|Overall Study|Sponsor's Decision|11|||
129825421|NCT01525550|467326531|FG000|Overall Study|Withdrawal by Subject|4|||
129825422|NCT01525550|467326532|FG001|Overall Study|Withdrawal by Subject|0|||
129825423|NCT00723892|467326538|FG000|Overall Study|Participant not tracked|33|||
129825424|NCT00723892|467326539|FG001|Overall Study|Participant not tracked|35|||
129825425|NCT00723892|467326538|FG000|Overall Study|Virological criterion|24|||
129825426|NCT00723892|467326539|FG001|Overall Study|Virological criterion|9|||
129825427|NCT00723892|467326538|FG000|Overall Study|Withdrawal by Subject|6|||
129825428|NCT00723892|467326539|FG001|Overall Study|Withdrawal by Subject|9|||
129825429|NCT00723892|467326538|FG000|Overall Study|End planned|11|||
129825430|NCT00723892|467326539|FG001|Overall Study|End planned|7|||
129825431|NCT00723892|467326538|FG000|Overall Study|Bad tolerance|5|||
129825432|NCT00723892|467326539|FG001|Overall Study|Bad tolerance|5|||
129825433|NCT00723892|467326538|FG000|Overall Study|Multiple reasons|17|||
129825434|NCT00723892|467326539|FG001|Overall Study|Multiple reasons|12|||
129825435|NCT00723892|467326538|FG000|Overall Study|Other|6|||
129825436|NCT00723892|467326539|FG001|Overall Study|Other|3|||
129825437|NCT00723892|467326538|FG000|Overall Study|Study end|1|||
129825438|NCT00723892|467326539|FG001|Overall Study|Study end|3|||
129825439|NCT00723892|467326538|FG000|Overall Study|Weight loss|1|||
129825440|NCT00723892|467326539|FG001|Overall Study|Weight loss|3|||
129825441|NCT00723892|467326538|FG000|Overall Study|Alcohol abuse|0|||
129825442|NCT00723892|467326539|FG001|Overall Study|Alcohol abuse|1|||
129825443|NCT00723892|467326538|FG000|Overall Study|Intercurrent infection|2|||
129825444|NCT00723892|467326539|FG001|Overall Study|Intercurrent infection|0|||
129825445|NCT00723892|467326538|FG000|Overall Study|Drug addiction|1|||
129825446|NCT00723892|467326539|FG001|Overall Study|Drug addiction|0|||
129825447|NCT02411292|467326543|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
129825448|NCT02411292|467326543|FG000|Overall Study|Death|2|||
129825449|NCT02411292|467326543|FG000|Overall Study|Lost to Follow-up|3|||
129825450|NCT02232425|467326544|FG000|Overall Study|Lost to Follow-up|6|||
129825451|NCT02232425|467326545|FG001|Overall Study|Lost to Follow-up|2|||
129825452|NCT02232425|467326544|FG000|Overall Study|Adverse Event|2|||
129825453|NCT02232425|467326545|FG001|Overall Study|Adverse Event|0|||
129825454|NCT02232425|467326544|FG000|Overall Study|Withdrawal by Subject|5|||
129825455|NCT02232425|467326545|FG001|Overall Study|Withdrawal by Subject|6|||
129825456|NCT02232425|467326544|FG000|Overall Study|Lack of Efficacy|1|||
129825457|NCT02232425|467326545|FG001|Overall Study|Lack of Efficacy|0|||
129825458|NCT00665353|467326546|FG000|Study Step 1|Adverse Event|1|||
129825459|NCT00665353|467326546|FG000|Study Step 1|Withdrawal by Subject|2|||
129825460|NCT00665353|467326546|FG000|Study Step 2|Lost to Follow-up|2|||
129897499|NCT00320489|467584393|FG000|Overall Study|Protocol Violation|4|||
129825461|NCT00665353|467326546|FG000|Study Step 2|Lack of Efficacy|12|||
129825462|NCT00498602|467326547|FG000|Overall Study|Death|0|||
129825463|NCT00498602|467326548|FG001|Overall Study|Death|0|||
129825464|NCT00498602|467326549|FG002|Overall Study|Death|0|||
129825465|NCT00498602|467326550|FG003|Overall Study|Death|0|||
129825466|NCT00498602|467326551|FG004|Overall Study|Death|0|||
129825467|NCT00498602|467326552|FG005|Overall Study|Death|1|||
129825468|NCT00498602|467326553|FG006|Overall Study|Death|0|||
129825469|NCT00498602|467326547|FG000|Overall Study|Lack of Efficacy|1|||
129825470|NCT00498602|467326548|FG001|Overall Study|Lack of Efficacy|0|||
129825471|NCT00498602|467326549|FG002|Overall Study|Lack of Efficacy|0|||
129825472|NCT00498602|467326550|FG003|Overall Study|Lack of Efficacy|0|||
129825473|NCT00498602|467326551|FG004|Overall Study|Lack of Efficacy|0|||
129825474|NCT00498602|467326552|FG005|Overall Study|Lack of Efficacy|0|||
129825475|NCT00498602|467326553|FG006|Overall Study|Lack of Efficacy|0|||
129825476|NCT00498602|467326547|FG000|Overall Study|Lost to Follow-up|0|||
129825477|NCT00498602|467326548|FG001|Overall Study|Lost to Follow-up|2|||
129825478|NCT00498602|467326549|FG002|Overall Study|Lost to Follow-up|0|||
129825479|NCT00498602|467326550|FG003|Overall Study|Lost to Follow-up|2|||
129825480|NCT00498602|467326551|FG004|Overall Study|Lost to Follow-up|0|||
129825481|NCT00498602|467326552|FG005|Overall Study|Lost to Follow-up|0|||
129825482|NCT00498602|467326553|FG006|Overall Study|Lost to Follow-up|0|||
129825483|NCT00498602|467326547|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129825484|NCT00498602|467326548|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129825485|NCT00498602|467326549|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
129825486|NCT00498602|467326550|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
129825487|NCT00498602|467326551|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129825488|NCT00498602|467326552|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129825489|NCT00498602|467326553|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129825490|NCT00498602|467326547|FG000|Overall Study|AE not related to Study Drug|1|||
129825491|NCT00498602|467326548|FG001|Overall Study|AE not related to Study Drug|3|||
129825492|NCT00498602|467326549|FG002|Overall Study|AE not related to Study Drug|0|||
129825493|NCT00498602|467326550|FG003|Overall Study|AE not related to Study Drug|0|||
129825494|NCT00498602|467326551|FG004|Overall Study|AE not related to Study Drug|2|||
129825495|NCT00498602|467326552|FG005|Overall Study|AE not related to Study Drug|2|||
129825496|NCT00498602|467326553|FG006|Overall Study|AE not related to Study Drug|1|||
129825497|NCT00498602|467326547|FG000|Overall Study|Caregiver Request|2|||
129825498|NCT00498602|467326548|FG001|Overall Study|Caregiver Request|2|||
129825499|NCT00498602|467326549|FG002|Overall Study|Caregiver Request|2|||
129825500|NCT00498602|467326550|FG003|Overall Study|Caregiver Request|0|||
129825501|NCT00498602|467326551|FG004|Overall Study|Caregiver Request|1|||
129825502|NCT00498602|467326552|FG005|Overall Study|Caregiver Request|2|||
129825503|NCT00498602|467326553|FG006|Overall Study|Caregiver Request|0|||
129825504|NCT00498602|467326547|FG000|Overall Study|Investigator Request|0|||
129825505|NCT00498602|467326548|FG001|Overall Study|Investigator Request|0|||
129825506|NCT00498602|467326549|FG002|Overall Study|Investigator Request|1|||
129825507|NCT00498602|467326550|FG003|Overall Study|Investigator Request|0|||
129825508|NCT00498602|467326551|FG004|Overall Study|Investigator Request|0|||
129825509|NCT00498602|467326552|FG005|Overall Study|Investigator Request|0|||
129825510|NCT00498602|467326553|FG006|Overall Study|Investigator Request|0|||
129825511|NCT00498602|467326547|FG000|Overall Study|Subject Request|3|||
129825512|NCT00498602|467326548|FG001|Overall Study|Subject Request|0|||
129825513|NCT00498602|467326549|FG002|Overall Study|Subject Request|1|||
129825514|NCT00498602|467326550|FG003|Overall Study|Subject Request|1|||
129825515|NCT00498602|467326551|FG004|Overall Study|Subject Request|1|||
129825516|NCT00498602|467326552|FG005|Overall Study|Subject Request|4|||
129825517|NCT00498602|467326553|FG006|Overall Study|Subject Request|1|||
129825518|NCT00498602|467326547|FG000|Overall Study|Other|2|||
129825519|NCT00498602|467326548|FG001|Overall Study|Other|3|||
129825520|NCT00498602|467326549|FG002|Overall Study|Other|1|||
129825521|NCT00498602|467326550|FG003|Overall Study|Other|0|||
129825522|NCT00498602|467326551|FG004|Overall Study|Other|0|||
129825523|NCT00498602|467326552|FG005|Overall Study|Other|3|||
129825524|NCT00498602|467326553|FG006|Overall Study|Other|0|||
129825525|NCT03103919|467326557|FG000|Overall Study|Adverse Event|2|||
129825526|NCT03103919|467326558|FG001|Overall Study|Adverse Event|2|||
129825527|NCT01291173|467326559|FG000|Overall Study|Adverse Event|0|||
129825528|NCT01291173|467326560|FG001|Overall Study|Adverse Event|3|||
129825529|NCT01291173|467326561|FG002|Overall Study|Adverse Event|1|||
129825530|NCT01291173|467326562|FG003|Overall Study|Adverse Event|3|||
129825531|NCT01291173|467326559|FG000|Overall Study|Protocol Violation|7|||
129825532|NCT01291173|467326560|FG001|Overall Study|Protocol Violation|2|||
129825533|NCT01291173|467326561|FG002|Overall Study|Protocol Violation|2|||
129825534|NCT01291173|467326562|FG003|Overall Study|Protocol Violation|5|||
129825535|NCT01291173|467326559|FG000|Overall Study|Withdrawal by Subject|6|||
129825536|NCT01291173|467326560|FG001|Overall Study|Withdrawal by Subject|4|||
129825537|NCT01291173|467326561|FG002|Overall Study|Withdrawal by Subject|4|||
129825538|NCT01291173|467326562|FG003|Overall Study|Withdrawal by Subject|2|||
129897500|NCT00320489|467584394|FG001|Overall Study|Protocol Violation|4|||
129897501|NCT00320489|467584393|FG000|Overall Study|Sponsor Decision|3|||
129825539|NCT01291173|467326559|FG000|Overall Study|Lost to Follow-up|4|||
129825540|NCT01291173|467326560|FG001|Overall Study|Lost to Follow-up|6|||
129825541|NCT01291173|467326561|FG002|Overall Study|Lost to Follow-up|3|||
129825542|NCT01291173|467326562|FG003|Overall Study|Lost to Follow-up|2|||
129825543|NCT01291173|467326559|FG000|Overall Study|Unable to meet visit schedule|0|||
129825544|NCT01291173|467326560|FG001|Overall Study|Unable to meet visit schedule|0|||
129825545|NCT01291173|467326561|FG002|Overall Study|Unable to meet visit schedule|1|||
129825546|NCT01291173|467326562|FG003|Overall Study|Unable to meet visit schedule|0|||
129825547|NCT01291173|467326559|FG000|Overall Study|Lack of compliance|0|||
129825548|NCT01291173|467326560|FG001|Overall Study|Lack of compliance|0|||
130059958|NCT00213980|468174602|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
130059959|NCT01397552|468174605|FG000|Overall Study|Adverse Event|1|||
130059960|NCT01397552|468174606|FG001|Overall Study|Adverse Event|0|||
130059961|NCT01397552|468174605|FG000|Overall Study|Withdrawal by Subject|2|||
129825549|NCT01291173|467326561|FG002|Overall Study|Lack of compliance|0|||
129825550|NCT01291173|467326562|FG003|Overall Study|Lack of compliance|1|||
129825551|NCT01291173|467326559|FG000|Overall Study|Subject was unblinded|0|||
129825552|NCT01291173|467326560|FG001|Overall Study|Subject was unblinded|0|||
129825553|NCT01291173|467326561|FG002|Overall Study|Subject was unblinded|1|||
129825554|NCT01291173|467326562|FG003|Overall Study|Subject was unblinded|0|||
129825555|NCT01291173|467326559|FG000|Overall Study|Excluded therapy|0|||
129825556|NCT01291173|467326560|FG001|Overall Study|Excluded therapy|0|||
129825557|NCT01291173|467326561|FG002|Overall Study|Excluded therapy|1|||
129825558|NCT01291173|467326562|FG003|Overall Study|Excluded therapy|0|||
129825559|NCT01846507|467326563|FG000|Overall Study|Lost to Follow-up|4|||
129825560|NCT01846507|467326563|FG000|Overall Study|Protocol Violation|1|||
129825561|NCT01846507|467326563|FG000|Overall Study|Missing data|2|||
129825562|NCT02436356|467326564|FG000|Overall Study|Excluded by MRI Screening|0|||
129825563|NCT02436356|467326565|FG001|Overall Study|Excluded by MRI Screening|0|||
129825564|NCT02436356|467326566|FG002|Overall Study|Excluded by MRI Screening|2|||
129825565|NCT02436356|467326564|FG000|Overall Study|Lost to Follow-up|0|||
129825566|NCT02436356|467326565|FG001|Overall Study|Lost to Follow-up|1|||
129825567|NCT02436356|467326566|FG002|Overall Study|Lost to Follow-up|0|||
129825568|NCT02436356|467326564|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
129825569|NCT02436356|467326565|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
130059962|NCT01397552|468174606|FG001|Overall Study|Withdrawal by Subject|1|||
130059963|NCT02504268|468174608|FG000|Overall Study|Adverse Event|18|||
130059964|NCT02504268|468174609|FG001|Overall Study|Adverse Event|8|||
130059965|NCT02504268|468174610|FG002|Overall Study|Adverse Event|14|||
130059966|NCT02504268|468174611|FG003|Overall Study|Adverse Event|0|||
130059967|NCT02504268|468174612|FG004|Overall Study|Adverse Event|0|||
130059968|NCT02504268|468174613|FG005|Overall Study|Adverse Event|0|||
130059969|NCT02504268|468174614|FG006|Overall Study|Adverse Event|0|||
130059970|NCT02504268|468174615|FG007|Overall Study|Adverse Event|0|||
130059971|NCT02504268|468174616|FG008|Overall Study|Adverse Event|0|||
130059972|NCT02504268|468174608|FG000|Overall Study|Withdrawal of Consent|11|||
130059973|NCT02504268|468174609|FG001|Overall Study|Withdrawal of Consent|10|||
130059974|NCT02504268|468174610|FG002|Overall Study|Withdrawal of Consent|3|||
130059975|NCT02504268|468174611|FG003|Overall Study|Withdrawal of Consent|0|||
130059976|NCT02504268|468174612|FG004|Overall Study|Withdrawal of Consent|0|||
130059977|NCT02504268|468174613|FG005|Overall Study|Withdrawal of Consent|0|||
130059978|NCT02504268|468174614|FG006|Overall Study|Withdrawal of Consent|0|||
130059979|NCT02504268|468174615|FG007|Overall Study|Withdrawal of Consent|0|||
130059980|NCT02504268|468174616|FG008|Overall Study|Withdrawal of Consent|0|||
130059981|NCT02504268|468174608|FG000|Overall Study|Pregnancy|2|||
130059982|NCT02504268|468174609|FG001|Overall Study|Pregnancy|0|||
130059983|NCT02504268|468174610|FG002|Overall Study|Pregnancy|0|||
130059984|NCT02504268|468174611|FG003|Overall Study|Pregnancy|0|||
130059985|NCT02504268|468174612|FG004|Overall Study|Pregnancy|0|||
130059986|NCT02504268|468174613|FG005|Overall Study|Pregnancy|0|||
130059987|NCT02504268|468174614|FG006|Overall Study|Pregnancy|0|||
130059988|NCT02504268|468174615|FG007|Overall Study|Pregnancy|0|||
130059989|NCT02504268|468174616|FG008|Overall Study|Pregnancy|0|||
130059990|NCT02504268|468174608|FG000|Overall Study|Lost to Follow-up|3|||
130059991|NCT02504268|468174609|FG001|Overall Study|Lost to Follow-up|6|||
130059992|NCT02504268|468174610|FG002|Overall Study|Lost to Follow-up|4|||
130059993|NCT02504268|468174611|FG003|Overall Study|Lost to Follow-up|0|||
130059994|NCT02504268|468174612|FG004|Overall Study|Lost to Follow-up|0|||
130059995|NCT02504268|468174613|FG005|Overall Study|Lost to Follow-up|0|||
130059996|NCT02504268|468174614|FG006|Overall Study|Lost to Follow-up|0|||
130059997|NCT02504268|468174615|FG007|Overall Study|Lost to Follow-up|0|||
130059998|NCT02504268|468174616|FG008|Overall Study|Lost to Follow-up|0|||
130059999|NCT02504268|468174608|FG000|Overall Study|Death|1|||
130060000|NCT02504268|468174609|FG001|Overall Study|Death|1|||
130060001|NCT02504268|468174610|FG002|Overall Study|Death|0|||
130060002|NCT02504268|468174611|FG003|Overall Study|Death|0|||
130060003|NCT02504268|468174612|FG004|Overall Study|Death|0|||
130060004|NCT02504268|468174613|FG005|Overall Study|Death|0|||
130060005|NCT02504268|468174614|FG006|Overall Study|Death|0|||
129825570|NCT02436356|467326566|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
129825571|NCT02436356|467326564|FG000|Overall Study|Excluded due to other medical conditions|3|||
129825572|NCT02436356|467326565|FG001|Overall Study|Excluded due to other medical conditions|0|||
129825573|NCT02436356|467326566|FG002|Overall Study|Excluded due to other medical conditions|0|||
130060006|NCT02504268|468174615|FG007|Overall Study|Death|0|||
130060007|NCT02504268|468174616|FG008|Overall Study|Death|0|||
130060008|NCT02504268|468174608|FG000|Overall Study|Subject Request to Discontinue|11|||
130060009|NCT02504268|468174609|FG001|Overall Study|Subject Request to Discontinue|3|||
130060010|NCT02504268|468174610|FG002|Overall Study|Subject Request to Discontinue|6|||
130060011|NCT02504268|468174611|FG003|Overall Study|Subject Request to Discontinue|0|||
130060012|NCT02504268|468174612|FG004|Overall Study|Subject Request to Discontinue|0|||
130060013|NCT02504268|468174613|FG005|Overall Study|Subject Request to Discontinue|0|||
130060014|NCT02504268|468174614|FG006|Overall Study|Subject Request to Discontinue|0|||
129825574|NCT02436356|467326564|FG000|Overall Study|Withdrawal by Subject|1|||
129825575|NCT02436356|467326565|FG001|Overall Study|Withdrawal by Subject|0|||
129825576|NCT02436356|467326566|FG002|Overall Study|Withdrawal by Subject|0|||
129825577|NCT04577118|467326567|FG000|Overall Study|Withdrawal by Subject|4|||
129825578|NCT00674661|467326568|FG000|Overall Study|Other|5|||
129825579|NCT00674661|467326569|FG001|Overall Study|Other|7|||
129825580|NCT00674661|467326568|FG000|Overall Study|Lost to Follow-up|6|||
129825581|NCT00674661|467326569|FG001|Overall Study|Lost to Follow-up|3|||
129825582|NCT00674661|467326568|FG000|Overall Study|Withdrawal by Subject|0|||
129825583|NCT00674661|467326569|FG001|Overall Study|Withdrawal by Subject|5|||
129825584|NCT03108027|467326570|FG000|Period 1|Subject/Guardian Decision|0|||
129825585|NCT03108027|467326571|FG001|Period 1|Subject/Guardian Decision|0|||
129825586|NCT03108027|467326572|FG002|Period 1|Subject/Guardian Decision|0|||
129825587|NCT03108027|467326573|FG003|Period 1|Subject/Guardian Decision|2|||
129825588|NCT03108027|467326574|FG004|Period 1|Subject/Guardian Decision|0|||
129825589|NCT03108027|467326575|FG005|Period 1|Subject/Guardian Decision|0|||
129825590|NCT03108027|467326570|FG000|Period 3|Adverse Event|0|||
129825591|NCT03108027|467326571|FG001|Period 3|Adverse Event|1|||
129825592|NCT03108027|467326572|FG002|Period 3|Adverse Event|0|||
129825593|NCT03108027|467326573|FG003|Period 3|Adverse Event|0|||
129825594|NCT03108027|467326574|FG004|Period 3|Adverse Event|0|||
129825595|NCT03108027|467326575|FG005|Period 3|Adverse Event|0|||
129825596|NCT00268996|467326576|FG000|Overall Study|Adverse Event|11|||
129825597|NCT00268996|467326577|FG001|Overall Study|Adverse Event|7|||
129825598|NCT00268996|467326576|FG000|Overall Study|Lost to Follow-up|3|||
129825599|NCT00268996|467326577|FG001|Overall Study|Lost to Follow-up|1|||
129825600|NCT00268996|467326576|FG000|Overall Study|Withdrawal by Subject|5|||
129825601|NCT00268996|467326577|FG001|Overall Study|Withdrawal by Subject|11|||
129825602|NCT00268996|467326576|FG000|Overall Study|Non-compliance|1|||
129825603|NCT00268996|467326577|FG001|Overall Study|Non-compliance|0|||
129825604|NCT00268996|467326576|FG000|Overall Study|Other|1|||
129825605|NCT00268996|467326577|FG001|Overall Study|Other|1|||
129825606|NCT00451321|467326580|FG000|Overall Study|Lost to Follow-up|3|||
129825607|NCT00451321|467326581|FG001|Overall Study|Lost to Follow-up|3|||
129825608|NCT00451321|467326582|FG002|Overall Study|Lost to Follow-up|1|||
129825609|NCT00451321|467326583|FG003|Overall Study|Lost to Follow-up|3|||
129825610|NCT00451321|467326584|FG004|Overall Study|Lost to Follow-up|0|||
129825611|NCT00451321|467326585|FG005|Overall Study|Lost to Follow-up|1|||
129825612|NCT00451321|467326586|FG006|Overall Study|Lost to Follow-up|0|||
129825613|NCT00451321|467326587|FG007|Overall Study|Lost to Follow-up|0|||
129825614|NCT00451321|467326580|FG000|Overall Study|Withdrawal by Subject|3|||
129825615|NCT00451321|467326581|FG001|Overall Study|Withdrawal by Subject|1|||
129825616|NCT00451321|467326582|FG002|Overall Study|Withdrawal by Subject|0|||
129825617|NCT00451321|467326583|FG003|Overall Study|Withdrawal by Subject|4|||
129825618|NCT00451321|467326584|FG004|Overall Study|Withdrawal by Subject|0|||
129825619|NCT00451321|467326585|FG005|Overall Study|Withdrawal by Subject|0|||
129825620|NCT00451321|467326586|FG006|Overall Study|Withdrawal by Subject|0|||
129825621|NCT00451321|467326587|FG007|Overall Study|Withdrawal by Subject|0|||
129825622|NCT00451321|467326580|FG000|Overall Study|Study closed/terminated|1|||
129825623|NCT00451321|467326581|FG001|Overall Study|Study closed/terminated|1|||
130060015|NCT02504268|468174615|FG007|Overall Study|Subject Request to Discontinue|0|||
130060016|NCT02504268|468174616|FG008|Overall Study|Subject Request to Discontinue|0|||
129825624|NCT00451321|467326582|FG002|Overall Study|Study closed/terminated|17|||
129825625|NCT00451321|467326583|FG003|Overall Study|Study closed/terminated|5|||
129825626|NCT00451321|467326584|FG004|Overall Study|Study closed/terminated|7|||
129825627|NCT00451321|467326585|FG005|Overall Study|Study closed/terminated|7|||
129825628|NCT00451321|467326586|FG006|Overall Study|Study closed/terminated|5|||
129825629|NCT00451321|467326587|FG007|Overall Study|Study closed/terminated|3|||
129825630|NCT00451321|467326580|FG000|Overall Study|Sponsor decision to amend protocol|0|||
129825631|NCT00451321|467326581|FG001|Overall Study|Sponsor decision to amend protocol|0|||
129825632|NCT00451321|467326582|FG002|Overall Study|Sponsor decision to amend protocol|0|||
129825633|NCT00451321|467326583|FG003|Overall Study|Sponsor decision to amend protocol|0|||
130060017|NCT02504268|468174608|FG000|Overall Study|No Longer Meets Study Criteria|2|||
129825634|NCT00451321|467326584|FG004|Overall Study|Sponsor decision to amend protocol|0|||
129825635|NCT00451321|467326585|FG005|Overall Study|Sponsor decision to amend protocol|1|||
129825636|NCT00451321|467326586|FG006|Overall Study|Sponsor decision to amend protocol|1|||
129825637|NCT00451321|467326587|FG007|Overall Study|Sponsor decision to amend protocol|3|||
129825638|NCT01528254|467326590|FG000|Overall Study|Administrative problems|96|||
129825639|NCT01528254|467326591|FG001|Overall Study|Administrative problems|94|||
129825640|NCT01528254|467326590|FG000|Overall Study|Adverse Event|28|||
129825641|NCT01528254|467326591|FG001|Overall Study|Adverse Event|44|||
129825642|NCT01528254|467326590|FG000|Overall Study|Lost to Follow-up|17|||
129825643|NCT01528254|467326591|FG001|Overall Study|Lost to Follow-up|24|||
129825644|NCT01528254|467326590|FG000|Overall Study|Death|13|||
129825645|NCT01528254|467326591|FG001|Overall Study|Death|9|||
129825646|NCT01528254|467326590|FG000|Overall Study|Protocol deviation|9|||
129825647|NCT01528254|467326591|FG001|Overall Study|Protocol deviation|19|||
129825648|NCT01528254|467326590|FG000|Overall Study|New therapy for study indication|8|||
129825649|NCT01528254|467326591|FG001|Overall Study|New therapy for study indication|6|||
129825650|NCT01528254|467326590|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129825651|NCT01528254|467326591|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129825652|NCT01528254|467326590|FG000|Overall Study|Withdrawal by Subject|5|||
129825653|NCT01528254|467326591|FG001|Overall Study|Withdrawal by Subject|4|||
129825654|NCT01528254|467326590|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129825655|NCT01528254|467326591|FG001|Overall Study|Abnormal laboratory value(s)|7|||
129825656|NCT01528254|467326590|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129825657|NCT01528254|467326591|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129825658|NCT01528254|467326590|FG000|Overall Study|No longer requires study drug|1|||
129825659|NCT01528254|467326591|FG001|Overall Study|No longer requires study drug|1|||
129825660|NCT02196558|467326597|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
129825661|NCT02196558|467326598|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
129825662|NCT02196558|467326599|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
129825663|NCT02196558|467326597|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
129825664|NCT02196558|467326598|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
129825665|NCT02196558|467326599|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
129825666|NCT02196558|467326597|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
129825667|NCT02196558|467326598|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
129825668|NCT02196558|467326599|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
129825669|NCT02196558|467326597|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
129825670|NCT02196558|467326598|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
129825671|NCT02196558|467326599|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
129825672|NCT02196558|467326597|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
129897502|NCT00320489|467584394|FG001|Overall Study|Sponsor Decision|3|||
129897503|NCT00320489|467584393|FG000|Overall Study|Withdrawal by Subject|39|||
129897504|NCT00320489|467584394|FG001|Overall Study|Withdrawal by Subject|41|||
129897505|NCT03441984|467584395|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897506|NCT03441984|467584396|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897507|NCT03441984|467584397|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
129897508|NCT03441984|467584398|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897509|NCT03441984|467584399|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897510|NCT03441984|467584400|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897511|NCT03441984|467584401|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897512|NCT03441984|467584402|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897513|NCT03441984|467584403|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897514|NCT03441984|467584404|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897515|NCT03441984|467584405|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897516|NCT03441984|467584406|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897517|NCT00746330|467584408|FG000|Period 1|Abnormal test procedure result|0|||
129897518|NCT00746330|467584409|FG001|Period 1|Abnormal test procedure result|0|||
129897519|NCT00746330|467584410|FG002|Period 1|Abnormal test procedure result|1|||
129897520|NCT00746330|467584411|FG003|Period 1|Abnormal test procedure result|0|||
129897521|NCT01981850|467584412|FG000|Main Phase Stage 1|Death|2|||
129897522|NCT01981850|467584413|FG001|Main Phase Stage 1|Death|0|||
129897523|NCT01981850|467584414|FG002|Main Phase Stage 1|Death|0|||
129897524|NCT01981850|467584415|FG003|Main Phase Stage 1|Death|0|||
129897525|NCT01981850|467584416|FG004|Main Phase Stage 1|Death|0|||
129897526|NCT01981850|467584417|FG005|Main Phase Stage 1|Death|0|||
129897527|NCT01981850|467584418|FG006|Main Phase Stage 1|Death|0|||
129897528|NCT01981850|467584419|FG007|Main Phase Stage 1|Death|0|||
129897529|NCT01981850|467584420|FG008|Main Phase Stage 1|Death|0|||
129897530|NCT01981850|467584421|FG009|Main Phase Stage 1|Death|0|||
129897531|NCT01981850|467584412|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
129897532|NCT01981850|467584413|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897533|NCT01981850|467584414|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897534|NCT01981850|467584415|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130060018|NCT02504268|468174609|FG001|Overall Study|No Longer Meets Study Criteria|3|||
130060019|NCT02504268|468174610|FG002|Overall Study|No Longer Meets Study Criteria|0|||
130060020|NCT02504268|468174611|FG003|Overall Study|No Longer Meets Study Criteria|0|||
129825673|NCT02196558|467326598|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
129825674|NCT02196558|467326599|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
129825675|NCT02669433|467326603|FG000|Overall Study|Protocol Violation|0|||
129825676|NCT02669433|467326604|FG001|Overall Study|Protocol Violation|4|||
129825677|NCT02669433|467326605|FG002|Overall Study|Protocol Violation|1|||
129897535|NCT01981850|467584416|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897536|NCT01981850|467584417|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
130060021|NCT02504268|468174612|FG004|Overall Study|No Longer Meets Study Criteria|0|||
130060022|NCT02504268|468174613|FG005|Overall Study|No Longer Meets Study Criteria|0|||
130060023|NCT02504268|468174614|FG006|Overall Study|No Longer Meets Study Criteria|0|||
130060024|NCT02504268|468174615|FG007|Overall Study|No Longer Meets Study Criteria|0|||
130060025|NCT02504268|468174616|FG008|Overall Study|No Longer Meets Study Criteria|0|||
130060026|NCT02504268|468174608|FG000|Overall Study|Lack of Efficacy|11|||
130060027|NCT02504268|468174609|FG001|Overall Study|Lack of Efficacy|35|||
129825678|NCT02669433|467326603|FG000|Overall Study|Disease Progression|1|||
130060028|NCT02504268|468174610|FG002|Overall Study|Lack of Efficacy|9|||
130060029|NCT02504268|468174611|FG003|Overall Study|Lack of Efficacy|0|||
130060030|NCT02504268|468174612|FG004|Overall Study|Lack of Efficacy|0|||
130060031|NCT02504268|468174613|FG005|Overall Study|Lack of Efficacy|0|||
130060032|NCT02504268|468174614|FG006|Overall Study|Lack of Efficacy|0|||
130060033|NCT02504268|468174615|FG007|Overall Study|Lack of Efficacy|0|||
130060034|NCT02504268|468174616|FG008|Overall Study|Lack of Efficacy|0|||
130060035|NCT02504268|468174608|FG000|Overall Study|Poor/Non-Compliance|3|||
129825679|NCT02669433|467326604|FG001|Overall Study|Disease Progression|0|||
129825680|NCT02669433|467326605|FG002|Overall Study|Disease Progression|0|||
129825681|NCT02669433|467326603|FG000|Overall Study|Physician Decision|1|||
129825682|NCT02669433|467326604|FG001|Overall Study|Physician Decision|1|||
129825683|NCT02669433|467326605|FG002|Overall Study|Physician Decision|0|||
129825684|NCT02669433|467326603|FG000|Overall Study|Adverse Event|6|||
129825685|NCT02669433|467326604|FG001|Overall Study|Adverse Event|7|||
129825686|NCT02669433|467326605|FG002|Overall Study|Adverse Event|10|||
129825687|NCT02669433|467326603|FG000|Overall Study|Sponsor Termination|1|||
129825688|NCT02669433|467326604|FG001|Overall Study|Sponsor Termination|0|||
129825689|NCT02669433|467326605|FG002|Overall Study|Sponsor Termination|1|||
129825690|NCT02669433|467326603|FG000|Overall Study|Withdrawal by Subject|5|||
129825691|NCT02669433|467326604|FG001|Overall Study|Withdrawal by Subject|1|||
129825692|NCT02669433|467326605|FG002|Overall Study|Withdrawal by Subject|0|||
129825693|NCT02669433|467326603|FG000|Overall Study|Withdrawal by Caregiver|1|||
129825694|NCT02669433|467326604|FG001|Overall Study|Withdrawal by Caregiver|0|||
129825695|NCT02669433|467326605|FG002|Overall Study|Withdrawal by Caregiver|2|||
129825696|NCT02669433|467326603|FG000|Overall Study|Death|0|||
129825697|NCT02669433|467326604|FG001|Overall Study|Death|1|||
129825698|NCT02669433|467326605|FG002|Overall Study|Death|1|||
129825699|NCT00576927|467326606|FG000|Clinical Assessment|Lack of Efficacy|24|||
129825700|NCT00576927|467326606|FG000|Clinical Assessment|Death|1|||
129825701|NCT00576927|467326606|FG000|Clinical Assessment|Withdrawal by Subject|10|||
129825702|NCT00576927|467326606|FG000|Clinical Assessment|Physician Decision|1|||
129825703|NCT00576927|467326606|FG000|Baseline|Physician Decision|9|||
129825704|NCT00576927|467326606|FG000|Baseline|Medication Change by PCP of subject|1|||
129825705|NCT00576927|467326606|FG000|Baseline|Withdrawal by Subject|3|||
129825706|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
129825707|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
129825708|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
129825709|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
129825710|NCT00576927|467326606|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
129825711|NCT03266094|467326607|FG000|Overall Study|Lost to Follow-up|1|||
129825712|NCT03266094|467326607|FG000|Overall Study|Withdrawal by Subject|1|||
129825713|NCT03128892|467326608|FG000|Overall Study|Withdrawal by Subject|2|||
129825714|NCT03128892|467326608|FG000|Overall Study|Physician Decision|1|||
129825715|NCT00459108|467326610|FG000|Overall Study|Withdrawal by Subject|5|||
129825716|NCT00459108|467326610|FG000|Overall Study|Adverse Event|3|||
129825717|NCT00459108|467326610|FG000|Overall Study|Death|2|||
129825718|NCT00459108|467326610|FG000|Overall Study|Progression|1|||
129825719|NCT03473808|467326615|FG000|Overall Study|Withdrawal by Subject|1|||
129825720|NCT02157298|467326616|FG000|Overall Study|Adverse Event|1|||
129825721|NCT02157298|467326617|FG001|Overall Study|Adverse Event|0|||
129825722|NCT02157298|467326616|FG000|Overall Study|Subject no longer meets study criteria|1|||
129825723|NCT02157298|467326617|FG001|Overall Study|Subject no longer meets study criteria|2|||
129825724|NCT02157298|467326616|FG000|Overall Study|Poor/Non-compliance|1|||
129825725|NCT02157298|467326617|FG001|Overall Study|Poor/Non-compliance|0|||
129825726|NCT02157298|467326616|FG000|Overall Study|Withdrawal by Subject|1|||
129825727|NCT02157298|467326617|FG001|Overall Study|Withdrawal by Subject|0|||
129825728|NCT03171415|467326618|FG000|Overall Study|Lost to Follow-up|0|||
129825729|NCT03171415|467326619|FG001|Overall Study|Lost to Follow-up|0|||
129825730|NCT03171415|467326620|FG002|Overall Study|Lost to Follow-up|0|||
130060036|NCT02504268|468174609|FG001|Overall Study|Poor/Non-Compliance|2|||
130060037|NCT02504268|468174610|FG002|Overall Study|Poor/Non-Compliance|3|||
130060038|NCT02504268|468174611|FG003|Overall Study|Poor/Non-Compliance|0|||
130060039|NCT02504268|468174612|FG004|Overall Study|Poor/Non-Compliance|0|||
129825731|NCT03171415|467326621|FG003|Overall Study|Lost to Follow-up|0|||
129825732|NCT03171415|467326622|FG004|Overall Study|Lost to Follow-up|2|||
129825733|NCT04059094|467326623|FG000|Overall Study|Adverse Event|0|||
130060040|NCT02504268|468174613|FG005|Overall Study|Poor/Non-Compliance|0|||
130060041|NCT02504268|468174614|FG006|Overall Study|Poor/Non-Compliance|0|||
130060042|NCT02504268|468174615|FG007|Overall Study|Poor/Non-Compliance|0|||
130060043|NCT02504268|468174616|FG008|Overall Study|Poor/Non-Compliance|0|||
130060044|NCT02504268|468174608|FG000|Overall Study|Not Disclosed|1|||
130060045|NCT02504268|468174609|FG001|Overall Study|Not Disclosed|0|||
130060046|NCT02504268|468174610|FG002|Overall Study|Not Disclosed|2|||
130060047|NCT02504268|468174611|FG003|Overall Study|Not Disclosed|0|||
130060048|NCT02504268|468174612|FG004|Overall Study|Not Disclosed|0|||
129825734|NCT04059094|467326624|FG001|Overall Study|Adverse Event|0|||
129825735|NCT04059094|467326625|FG002|Overall Study|Adverse Event|0|||
129825736|NCT04059094|467326626|FG003|Overall Study|Adverse Event|0|||
129825737|NCT04059094|467326627|FG004|Overall Study|Adverse Event|1|||
130060049|NCT02504268|468174613|FG005|Overall Study|Not Disclosed|0|||
129825738|NCT04059094|467326623|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825739|NCT04059094|467326624|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
129825740|NCT04059094|467326625|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825741|NCT04059094|467326626|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825742|NCT04059094|467326627|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825743|NCT00883116|467326632|FG000|Overall Study|Adverse event unrelated to study drug|5|||
129825744|NCT00883116|467326633|FG001|Overall Study|Adverse event unrelated to study drug|10|||
129825745|NCT00883116|467326632|FG000|Overall Study|Death|6|||
129825746|NCT00883116|467326633|FG001|Overall Study|Death|2|||
129825747|NCT00883116|467326632|FG000|Overall Study|Disease progression|130|||
129825748|NCT00883116|467326633|FG001|Overall Study|Disease progression|128|||
129825749|NCT00883116|467326632|FG000|Overall Study|Lost to Follow-up|0|||
129825750|NCT00883116|467326633|FG001|Overall Study|Lost to Follow-up|1|||
129825751|NCT00883116|467326632|FG000|Overall Study|Maximum clinical benefit|13|||
129825752|NCT00883116|467326633|FG001|Overall Study|Maximum clinical benefit|46|||
129825753|NCT00883116|467326632|FG000|Overall Study|Not identified|3|||
129825754|NCT00883116|467326633|FG001|Overall Study|Not identified|6|||
129825755|NCT00883116|467326632|FG000|Overall Study|Study drug toxicity|36|||
129825756|NCT00883116|467326633|FG001|Overall Study|Study drug toxicity|16|||
129825757|NCT00883116|467326632|FG000|Overall Study|Withdrawal by Subject|14|||
129825758|NCT00883116|467326633|FG001|Overall Study|Withdrawal by Subject|8|||
129825759|NCT00883116|467326632|FG000|Overall Study|No longer meets study criteria|2|||
129825760|NCT00883116|467326633|FG001|Overall Study|No longer meets study criteria|2|||
129825761|NCT03715764|467326634|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
129825762|NCT03715764|467326635|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
129825763|NCT03715764|467326634|FG000|3 Month Follow-up|Lost to Follow-up|2|||
129825764|NCT03715764|467326635|FG001|3 Month Follow-up|Lost to Follow-up|2|||
129825765|NCT03715764|467326634|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
129825766|NCT03715764|467326635|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
129825767|NCT03715764|467326634|FG000|6 Month Follow-up|Lost to Follow-up|3|||
129825768|NCT03715764|467326635|FG001|6 Month Follow-up|Lost to Follow-up|0|||
129825769|NCT03715764|467326634|FG000|12 Month Follow-up|Lost to Follow-up|2|||
129825770|NCT03715764|467326635|FG001|12 Month Follow-up|Lost to Follow-up|3|||
129825771|NCT03715764|467326634|FG000|12 Month Follow-up|Pregnancy|0|||
129825772|NCT03715764|467326635|FG001|12 Month Follow-up|Pregnancy|1|||
129825773|NCT03715764|467326634|FG000|12 Month Follow-up|Surgery|2|||
129825774|NCT03715764|467326635|FG001|12 Month Follow-up|Surgery|0|||
129825775|NCT03715764|467326634|FG000|12 Month Follow-up|Wrong address|1|||
129825776|NCT03715764|467326635|FG001|12 Month Follow-up|Wrong address|0|||
129825777|NCT03715764|467326634|FG000|12 Month Follow-up|No symptoms|1|||
129825778|NCT03715764|467326635|FG001|12 Month Follow-up|No symptoms|0|||
129825779|NCT03715764|467326634|FG000|12 Month Follow-up|Changed primary care centre|0|||
129825780|NCT03715764|467326635|FG001|12 Month Follow-up|Changed primary care centre|1|||
129825781|NCT00818662|467326641|FG000|Overall Study|Adverse Event|5|||
129825782|NCT00818662|467326642|FG001|Overall Study|Adverse Event|14|||
129825783|NCT00818662|467326643|FG002|Overall Study|Adverse Event|4|||
129825784|NCT00818662|467326644|FG003|Overall Study|Adverse Event|3|||
129825785|NCT00818662|467326641|FG000|Overall Study|Withdrawal by Subject|5|||
129825786|NCT00818662|467326642|FG001|Overall Study|Withdrawal by Subject|4|||
129825787|NCT00818662|467326643|FG002|Overall Study|Withdrawal by Subject|2|||
129825788|NCT00818662|467326644|FG003|Overall Study|Withdrawal by Subject|2|||
130060050|NCT02504268|468174614|FG006|Overall Study|Not Disclosed|0|||
129825789|NCT00818662|467326641|FG000|Overall Study|Death|1|||
129825790|NCT00818662|467326642|FG001|Overall Study|Death|3|||
129825791|NCT00818662|467326643|FG002|Overall Study|Death|0|||
129825792|NCT00818662|467326644|FG003|Overall Study|Death|0|||
129825793|NCT00818662|467326641|FG000|Overall Study|Physician Decision|1|||
129825794|NCT00818662|467326642|FG001|Overall Study|Physician Decision|0|||
129825795|NCT00818662|467326643|FG002|Overall Study|Physician Decision|0|||
129825796|NCT00818662|467326644|FG003|Overall Study|Physician Decision|0|||
129825797|NCT00818662|467326641|FG000|Overall Study|Lost to Follow-up|0|||
129825798|NCT00818662|467326642|FG001|Overall Study|Lost to Follow-up|0|||
130060051|NCT02504268|468174615|FG007|Overall Study|Not Disclosed|0|||
130060052|NCT02504268|468174616|FG008|Overall Study|Not Disclosed|0|||
130060053|NCT02130427|468174617|FG000|Overall Study|Imaging results not interpretable|30|||
129825799|NCT00818662|467326643|FG002|Overall Study|Lost to Follow-up|0|||
129825800|NCT00818662|467326644|FG003|Overall Study|Lost to Follow-up|1|||
129825801|NCT00818662|467326641|FG000|Overall Study|Unwilling or Unable to Participate|4|||
129825802|NCT00818662|467326642|FG001|Overall Study|Unwilling or Unable to Participate|6|||
129825803|NCT00818662|467326643|FG002|Overall Study|Unwilling or Unable to Participate|2|||
129825804|NCT00818662|467326644|FG003|Overall Study|Unwilling or Unable to Participate|4|||
129825805|NCT00818662|467326641|FG000|Overall Study|Protocol Violation|1|||
129825806|NCT00818662|467326642|FG001|Overall Study|Protocol Violation|1|||
129825807|NCT00818662|467326643|FG002|Overall Study|Protocol Violation|0|||
129825808|NCT00818662|467326644|FG003|Overall Study|Protocol Violation|0|||
129825809|NCT00818662|467326641|FG000|Overall Study|Requires a Prohibited Medication|1|||
129825810|NCT00818662|467326642|FG001|Overall Study|Requires a Prohibited Medication|0|||
129825811|NCT00818662|467326643|FG002|Overall Study|Requires a Prohibited Medication|0|||
129825812|NCT00818662|467326644|FG003|Overall Study|Requires a Prohibited Medication|0|||
129825813|NCT00818662|467326641|FG000|Overall Study|Safety Risk|1|||
129825814|NCT00818662|467326642|FG001|Overall Study|Safety Risk|1|||
129825815|NCT00818662|467326643|FG002|Overall Study|Safety Risk|0|||
129825816|NCT00818662|467326644|FG003|Overall Study|Safety Risk|1|||
129825817|NCT00818662|467326641|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
129825818|NCT00818662|467326642|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
129825819|NCT00818662|467326643|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
129825820|NCT00818662|467326644|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
129825821|NCT00818662|467326641|FG000|Overall Study|Participant's health declined|0|||
129825822|NCT00818662|467326642|FG001|Overall Study|Participant's health declined|0|||
129825823|NCT00818662|467326643|FG002|Overall Study|Participant's health declined|0|||
129825824|NCT00818662|467326644|FG003|Overall Study|Participant's health declined|1|||
129825825|NCT00818662|467326641|FG000|Overall Study|Caregiver to pursue other treatment|0|||
129825826|NCT00818662|467326642|FG001|Overall Study|Caregiver to pursue other treatment|1|||
129825827|NCT00818662|467326643|FG002|Overall Study|Caregiver to pursue other treatment|0|||
129825828|NCT00818662|467326644|FG003|Overall Study|Caregiver to pursue other treatment|0|||
129825829|NCT00818662|467326641|FG000|Overall Study|Moving out of state|0|||
129825830|NCT00818662|467326642|FG001|Overall Study|Moving out of state|0|||
129825831|NCT00818662|467326643|FG002|Overall Study|Moving out of state|0|||
129825832|NCT00818662|467326644|FG003|Overall Study|Moving out of state|1|||
129825833|NCT00818662|467326641|FG000|Overall Study|Declined move to another study site|1|||
129825834|NCT00818662|467326642|FG001|Overall Study|Declined move to another study site|0|||
129825835|NCT00818662|467326643|FG002|Overall Study|Declined move to another study site|0|||
129825836|NCT00818662|467326644|FG003|Overall Study|Declined move to another study site|0|||
129825837|NCT00818662|467326641|FG000|Overall Study|Change in living situation|0|||
129825838|NCT00818662|467326642|FG001|Overall Study|Change in living situation|0|||
129825839|NCT00818662|467326643|FG002|Overall Study|Change in living situation|0|||
129825840|NCT00818662|467326644|FG003|Overall Study|Change in living situation|1|||
129825841|NCT00818662|467326641|FG000|Overall Study|Study partner decision|0|||
129825842|NCT00818662|467326642|FG001|Overall Study|Study partner decision|0|||
129825843|NCT00818662|467326643|FG002|Overall Study|Study partner decision|0|||
129825844|NCT00818662|467326644|FG003|Overall Study|Study partner decision|1|||
129825845|NCT00818662|467326641|FG000|Overall Study|Admitted to long term nursing care|0|||
129825846|NCT00818662|467326642|FG001|Overall Study|Admitted to long term nursing care|1|||
129825847|NCT00818662|467326643|FG002|Overall Study|Admitted to long term nursing care|0|||
129825848|NCT00818662|467326644|FG003|Overall Study|Admitted to long term nursing care|0|||
129825849|NCT01472081|467326645|FG000|Overall Study|Continuing treatment at time of analysis|1|||
129825850|NCT01472081|467326646|FG001|Overall Study|Continuing treatment at time of analysis|4|||
129825851|NCT01472081|467326647|FG002|Overall Study|Continuing treatment at time of analysis|1|||
129825852|NCT01472081|467326648|FG003|Overall Study|Continuing treatment at time of analysis|8|||
129825853|NCT01472081|467326649|FG004|Overall Study|Continuing treatment at time of analysis|9|||
129825854|NCT01472081|467326650|FG005|Overall Study|Continuing treatment at time of analysis|0|||
129825855|NCT01472081|467326645|FG000|Overall Study|Disease Progression|4|||
129825856|NCT01472081|467326646|FG001|Overall Study|Disease Progression|10|||
129825857|NCT01472081|467326647|FG002|Overall Study|Disease Progression|12|||
129825858|NCT01472081|467326648|FG003|Overall Study|Disease Progression|31|||
129825859|NCT01472081|467326649|FG004|Overall Study|Disease Progression|22|||
129825860|NCT01472081|467326650|FG005|Overall Study|Disease Progression|3|||
129825861|NCT01472081|467326645|FG000|Overall Study|Study drug toxicity|2|||
129825862|NCT01472081|467326646|FG001|Overall Study|Study drug toxicity|9|||
129825863|NCT01472081|467326647|FG002|Overall Study|Study drug toxicity|4|||
129825864|NCT01472081|467326648|FG003|Overall Study|Study drug toxicity|6|||
129825865|NCT01472081|467326649|FG004|Overall Study|Study drug toxicity|13|||
129825866|NCT01472081|467326650|FG005|Overall Study|Study drug toxicity|2|||
129825867|NCT01472081|467326645|FG000|Overall Study|Death|0|||
129825868|NCT01472081|467326646|FG001|Overall Study|Death|0|||
129825869|NCT01472081|467326647|FG002|Overall Study|Death|0|||
129825870|NCT01472081|467326648|FG003|Overall Study|Death|0|||
129825871|NCT01472081|467326649|FG004|Overall Study|Death|1|||
129825872|NCT01472081|467326650|FG005|Overall Study|Death|0|||
129897537|NCT01981850|467584418|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129825873|NCT01472081|467326645|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
129825874|NCT01472081|467326646|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
129825875|NCT01472081|467326647|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
129825876|NCT01472081|467326648|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
129825877|NCT01472081|467326649|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
129825878|NCT01472081|467326650|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
129825879|NCT01472081|467326645|FG000|Overall Study|Withdrawal by Subject|0|||
129825880|NCT01472081|467326646|FG001|Overall Study|Withdrawal by Subject|0|||
129825881|NCT01472081|467326647|FG002|Overall Study|Withdrawal by Subject|0|||
129825882|NCT01472081|467326648|FG003|Overall Study|Withdrawal by Subject|0|||
129825883|NCT01472081|467326649|FG004|Overall Study|Withdrawal by Subject|0|||
129825884|NCT01472081|467326650|FG005|Overall Study|Withdrawal by Subject|1|||
129825885|NCT01472081|467326645|FG000|Overall Study|Poor/non-compliance|0|||
129825886|NCT01472081|467326646|FG001|Overall Study|Poor/non-compliance|0|||
129825887|NCT01472081|467326647|FG002|Overall Study|Poor/non-compliance|1|||
129825888|NCT01472081|467326648|FG003|Overall Study|Poor/non-compliance|0|||
129825889|NCT01472081|467326649|FG004|Overall Study|Poor/non-compliance|1|||
129825890|NCT01472081|467326650|FG005|Overall Study|Poor/non-compliance|0|||
129825891|NCT01472081|467326645|FG000|Overall Study|No longer meets study criteria|0|||
129825892|NCT01472081|467326646|FG001|Overall Study|No longer meets study criteria|0|||
129825893|NCT01472081|467326647|FG002|Overall Study|No longer meets study criteria|1|||
129825894|NCT01472081|467326648|FG003|Overall Study|No longer meets study criteria|0|||
129825895|NCT01472081|467326649|FG004|Overall Study|No longer meets study criteria|0|||
129825896|NCT01472081|467326650|FG005|Overall Study|No longer meets study criteria|0|||
129825897|NCT01472081|467326645|FG000|Overall Study|Subject request to discontinue treatment|0|||
129825898|NCT01472081|467326646|FG001|Overall Study|Subject request to discontinue treatment|3|||
129825899|NCT01472081|467326647|FG002|Overall Study|Subject request to discontinue treatment|1|||
129825900|NCT01472081|467326648|FG003|Overall Study|Subject request to discontinue treatment|1|||
129825901|NCT01472081|467326649|FG004|Overall Study|Subject request to discontinue treatment|0|||
129825902|NCT01472081|467326650|FG005|Overall Study|Subject request to discontinue treatment|0|||
129825903|NCT01705652|467326651|FG000|Overall Study|Adverse Event|1|||
129825904|NCT01705652|467326652|FG001|Overall Study|Adverse Event|0|||
129825905|NCT01705652|467326651|FG000|Overall Study|Withdrawal by Subject|1|||
129825906|NCT01705652|467326652|FG001|Overall Study|Withdrawal by Subject|2|||
129825907|NCT01705652|467326651|FG000|Overall Study|non-compliance|1|||
129825908|NCT01705652|467326652|FG001|Overall Study|non-compliance|1|||
129825909|NCT01686633|467326654|FG000|Overall Study|Lack of Efficacy|33|||
129825910|NCT01686633|467326655|FG001|Overall Study|Lack of Efficacy|13|||
129825911|NCT01686633|467326656|FG002|Overall Study|Lack of Efficacy|11|||
129825912|NCT01686633|467326654|FG000|Overall Study|Withdrawal by Subject|8|||
129897538|NCT01981850|467584419|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897539|NCT01981850|467584420|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897540|NCT01981850|467584421|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897541|NCT01981850|467584412|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
129897542|NCT01981850|467584413|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
129825913|NCT01686633|467326655|FG001|Overall Study|Withdrawal by Subject|8|||
129825914|NCT01686633|467326656|FG002|Overall Study|Withdrawal by Subject|5|||
129825915|NCT01686633|467326654|FG000|Overall Study|Physician Decision|3|||
129825916|NCT01686633|467326655|FG001|Overall Study|Physician Decision|4|||
129825917|NCT01686633|467326656|FG002|Overall Study|Physician Decision|4|||
129825918|NCT01686633|467326654|FG000|Overall Study|Adverse Event|4|||
129825919|NCT01686633|467326655|FG001|Overall Study|Adverse Event|3|||
129825920|NCT01686633|467326656|FG002|Overall Study|Adverse Event|3|||
129825921|NCT01686633|467326654|FG000|Overall Study|Protocol Violation|2|||
129825922|NCT01686633|467326655|FG001|Overall Study|Protocol Violation|3|||
129825923|NCT01686633|467326656|FG002|Overall Study|Protocol Violation|0|||
129825924|NCT01686633|467326654|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
129825925|NCT01686633|467326655|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
129825926|NCT01686633|467326656|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
129825927|NCT01686633|467326654|FG000|Overall Study|Lost to Follow-up|0|||
129825928|NCT01686633|467326655|FG001|Overall Study|Lost to Follow-up|1|||
130060054|NCT00862849|468174622|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130060055|NCT00862849|468174623|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
129825929|NCT01686633|467326656|FG002|Overall Study|Lost to Follow-up|1|||
129825930|NCT00397982|467328965|FG000|Overall Study|Withdrawal by Subject|1|||
129825931|NCT00397982|467328965|FG000|Overall Study|Adverse Event|1|||
129825932|NCT00397982|467328965|FG000|Overall Study|noncompliance|1|||
129825933|NCT00397982|467328965|FG000|Overall Study|Unrelated health issues|1|||
129825934|NCT04244786|467328966|FG000|Overall Study|Adverse Event|0|||
129825935|NCT04244786|467328967|FG001|Overall Study|Adverse Event|0|||
129825936|NCT04244786|467328968|FG002|Overall Study|Adverse Event|2|||
129825937|NCT04244786|467328966|FG000|Overall Study|Withdrawal by Subject|0|||
129825938|NCT04244786|467328967|FG001|Overall Study|Withdrawal by Subject|0|||
130060056|NCT00862849|468174624|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129825939|NCT04244786|467328968|FG002|Overall Study|Withdrawal by Subject|5|||
129825940|NCT00613938|467328975|FG000|Overall Study|Withdrawal by Subject|2|||
129825941|NCT00613938|467328976|FG001|Overall Study|Withdrawal by Subject|4|||
129825942|NCT00613938|467328977|FG002|Overall Study|Withdrawal by Subject|9|||
129825943|NCT00613938|467328978|FG003|Overall Study|Withdrawal by Subject|9|||
129825944|NCT00613938|467328975|FG000|Overall Study|Adverse Event|1|||
129825945|NCT00613938|467328976|FG001|Overall Study|Adverse Event|4|||
129825946|NCT00613938|467328977|FG002|Overall Study|Adverse Event|8|||
129825947|NCT00613938|467328978|FG003|Overall Study|Adverse Event|5|||
129825948|NCT00613938|467328975|FG000|Overall Study|Lack of Efficacy|16|||
129825949|NCT00613938|467328976|FG001|Overall Study|Lack of Efficacy|18|||
129825950|NCT00613938|467328977|FG002|Overall Study|Lack of Efficacy|5|||
129825951|NCT00613938|467328978|FG003|Overall Study|Lack of Efficacy|9|||
129825952|NCT00613938|467328975|FG000|Overall Study|Other|1|||
129825953|NCT00613938|467328976|FG001|Overall Study|Other|2|||
129825954|NCT00613938|467328977|FG002|Overall Study|Other|1|||
129825955|NCT00613938|467328978|FG003|Overall Study|Other|3|||
129825956|NCT02636868|467328979|FG000|Overall Study|Death|0|||
129825957|NCT02636868|467328980|FG001|Overall Study|Death|1|||
129825958|NCT02636868|467328981|FG002|Overall Study|Death|2|||
129825959|NCT03220217|467328982|FG000|Overall Study|Withdrawal by Subject|0|||
129825960|NCT03220217|467328983|FG001|Overall Study|Withdrawal by Subject|1|||
129825961|NCT03220217|467328984|FG002|Overall Study|Withdrawal by Subject|0|||
129825962|NCT03220217|467328982|FG000|Overall Study|Subject Missed Procedure|0|||
129825963|NCT03220217|467328983|FG001|Overall Study|Subject Missed Procedure|0|||
129825964|NCT03220217|467328984|FG002|Overall Study|Subject Missed Procedure|1|||
129825965|NCT03025542|467328985|FG000|Overall Study|Adverse Event|0|||
129825966|NCT03025542|467328986|FG001|Overall Study|Adverse Event|2|||
129825967|NCT03025542|467328985|FG000|Overall Study|Lost to Follow-up|1|||
129825968|NCT03025542|467328986|FG001|Overall Study|Lost to Follow-up|0|||
129825969|NCT03025542|467328985|FG000|Overall Study|Withdrawal by Subject|1|||
129825970|NCT03025542|467328986|FG001|Overall Study|Withdrawal by Subject|0|||
129825971|NCT03745937|467328988|FG000|Overall Study|Withdrawal by Subject|0|||
129825972|NCT03745937|467328989|FG001|Overall Study|Withdrawal by Subject|0|||
129825973|NCT03745937|467328990|FG002|Overall Study|Withdrawal by Subject|0|||
129825974|NCT03745937|467328991|FG003|Overall Study|Withdrawal by Subject|1|||
129825975|NCT03745937|467328988|FG000|Overall Study|Not-specifed|0|||
129825976|NCT03745937|467328989|FG001|Overall Study|Not-specifed|1|||
129825977|NCT03745937|467328990|FG002|Overall Study|Not-specifed|0|||
129825978|NCT03745937|467328991|FG003|Overall Study|Not-specifed|1|||
129825979|NCT00696696|467328997|FG000|Overall Study|Adverse Event|5|||
129825980|NCT00696696|467328997|FG000|Overall Study|Withdrawal by Subject|8|||
129825981|NCT00696696|467328997|FG000|Overall Study|Physician Decision|2|||
129825982|NCT00696696|467328997|FG000|Overall Study|Death|3|||
129825983|NCT02507505|467328998|FG000|Overall Study|Withdrawal by Subject|13|||
129825984|NCT02507505|467328999|FG001|Overall Study|Withdrawal by Subject|11|||
129825985|NCT02507505|467328998|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
129825986|NCT02507505|467328999|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
129825987|NCT02507505|467328998|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
129825988|NCT02507505|467328999|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
129825989|NCT02507505|467328998|FG000|Overall Study|Death before receipt of anesthesia|0|||
129825990|NCT02507505|467328999|FG001|Overall Study|Death before receipt of anesthesia|1|||
129825991|NCT03182829|467329000|FG000|Overall Study|Protocol Violation|12|||
129825992|NCT03182829|467329001|FG001|Overall Study|Protocol Violation|12|||
129825993|NCT03182829|467329000|FG000|Overall Study|Other|4|||
129825994|NCT03182829|467329001|FG001|Overall Study|Other|3|||
129825995|NCT00254540|467329002|FG000|Overall Study|Adverse Event|6|||
129825996|NCT00254540|467329003|FG001|Overall Study|Adverse Event|7|||
129825997|NCT00254540|467329002|FG000|Overall Study|Lack of Efficacy|13|||
129825998|NCT00254540|467329003|FG001|Overall Study|Lack of Efficacy|13|||
129825999|NCT00254540|467329002|FG000|Overall Study|Death|0|||
129826000|NCT00254540|467329003|FG001|Overall Study|Death|1|||
129826001|NCT00254540|467329002|FG000|Overall Study|Laboratory Test Abnormality|0|||
129826002|NCT00254540|467329003|FG001|Overall Study|Laboratory Test Abnormality|1|||
129826003|NCT00225251|467329004|FG000|Overall Study|Withdrawal by Subject|1|||
129826004|NCT00225251|467329005|FG001|Overall Study|Withdrawal by Subject|1|||
129826005|NCT03045328|467329006|FG000|Overall Study|Withdrawal by Subject|2|||
129826006|NCT01313767|467329012|FG000|Overall Study|Adverse Event|1|||
129826007|NCT01313767|467329013|FG001|Overall Study|Adverse Event|0|||
129826008|NCT01313767|467329012|FG000|Overall Study|Lost to Follow-up|1|||
129826009|NCT01313767|467329013|FG001|Overall Study|Lost to Follow-up|0|||
129826010|NCT01313767|467329012|FG000|Overall Study|Withdrawal by Subject|2|||
129826011|NCT01313767|467329013|FG001|Overall Study|Withdrawal by Subject|1|||
129826012|NCT01313767|467329012|FG000|Overall Study|Protocol Violation|3|||
129826013|NCT01313767|467329013|FG001|Overall Study|Protocol Violation|1|||
129826014|NCT01287897|467329014|FG000|Overall Study|Adverse Event|5|||
129826015|NCT01287897|467329015|FG001|Overall Study|Adverse Event|3|||
129826016|NCT01287897|467329016|FG002|Overall Study|Adverse Event|6|||
129826017|NCT01287897|467329017|FG003|Overall Study|Adverse Event|4|||
129826018|NCT01287897|467329014|FG000|Overall Study|Lack of Efficacy|2|||
129826019|NCT01287897|467329015|FG001|Overall Study|Lack of Efficacy|0|||
129826020|NCT01287897|467329016|FG002|Overall Study|Lack of Efficacy|0|||
129826021|NCT01287897|467329017|FG003|Overall Study|Lack of Efficacy|0|||
129826022|NCT01287897|467329014|FG000|Overall Study|Protocol Violation|1|||
129826023|NCT01287897|467329015|FG001|Overall Study|Protocol Violation|1|||
129826024|NCT01287897|467329016|FG002|Overall Study|Protocol Violation|0|||
129826025|NCT01287897|467329017|FG003|Overall Study|Protocol Violation|1|||
129826026|NCT01287897|467329014|FG000|Overall Study|Lost to Follow-up|0|||
129826027|NCT01287897|467329015|FG001|Overall Study|Lost to Follow-up|0|||
129826028|NCT01287897|467329016|FG002|Overall Study|Lost to Follow-up|2|||
129826029|NCT01287897|467329017|FG003|Overall Study|Lost to Follow-up|0|||
129826030|NCT01287897|467329014|FG000|Overall Study|Withdrawal by Subject|1|||
129826031|NCT01287897|467329015|FG001|Overall Study|Withdrawal by Subject|5|||
129826032|NCT01287897|467329016|FG002|Overall Study|Withdrawal by Subject|3|||
129826033|NCT01287897|467329017|FG003|Overall Study|Withdrawal by Subject|2|||
129826034|NCT01287897|467329014|FG000|Overall Study|Not consented properly|0|||
129826035|NCT01287897|467329015|FG001|Overall Study|Not consented properly|1|||
129826036|NCT01287897|467329016|FG002|Overall Study|Not consented properly|0|||
129826037|NCT01287897|467329017|FG003|Overall Study|Not consented properly|0|||
129826038|NCT01287897|467329014|FG000|Overall Study|Not meeting entrance criteria|1|||
129826039|NCT01287897|467329015|FG001|Overall Study|Not meeting entrance criteria|1|||
129826040|NCT01287897|467329016|FG002|Overall Study|Not meeting entrance criteria|0|||
129826041|NCT01287897|467329017|FG003|Overall Study|Not meeting entrance criteria|0|||
129826042|NCT01287897|467329014|FG000|Overall Study|Other|1|||
129826043|NCT01287897|467329015|FG001|Overall Study|Other|0|||
129826044|NCT01287897|467329016|FG002|Overall Study|Other|1|||
129826045|NCT01287897|467329017|FG003|Overall Study|Other|0|||
129826046|NCT00065507|467329018|FG000|Overall Study|Death|16|||
129826047|NCT00065507|467329019|FG001|Overall Study|Death|17|||
129826048|NCT00065507|467329018|FG000|Overall Study|Adverse Event|4|||
129826049|NCT00065507|467329019|FG001|Overall Study|Adverse Event|3|||
129826050|NCT00065507|467329018|FG000|Overall Study|Lack of Efficacy|0|||
129826051|NCT00065507|467329019|FG001|Overall Study|Lack of Efficacy|6|||
129826052|NCT00065507|467329018|FG000|Overall Study|Poor/Non-compliance|3|||
129826053|NCT00065507|467329019|FG001|Overall Study|Poor/Non-compliance|2|||
129826054|NCT00065507|467329018|FG000|Overall Study|Lost to Follow-up|3|||
129826055|NCT00065507|467329019|FG001|Overall Study|Lost to Follow-up|0|||
129826056|NCT00065507|467329018|FG000|Overall Study|Subject Withdrew Consent|2|||
129826057|NCT00065507|467329019|FG001|Overall Study|Subject Withdrew Consent|1|||
129826058|NCT00065507|467329018|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
129826059|NCT00065507|467329019|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
129826060|NCT02169739|467329020|FG000|Overall Study|Lost to Follow-up|0|||
129826061|NCT02169739|467329021|FG001|Overall Study|Lost to Follow-up|4|||
129826062|NCT03635957|467329022|FG000|Run-In Period|Lost to Follow-up|1|||
129826063|NCT03635957|467329022|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
129826064|NCT00350636|467329023|FG000|Overall Study|Adverse Event|19|||
129826065|NCT00350636|467329024|FG001|Overall Study|Adverse Event|13|||
129826066|NCT00350636|467329023|FG000|Overall Study|Protocol Violation|1|||
129826067|NCT00350636|467329024|FG001|Overall Study|Protocol Violation|3|||
129826068|NCT00350636|467329023|FG000|Overall Study|Withdrawal by Subject|13|||
129826069|NCT00350636|467329024|FG001|Overall Study|Withdrawal by Subject|17|||
129826070|NCT00350636|467329023|FG000|Overall Study|Lost to Follow-up|9|||
129826071|NCT00350636|467329024|FG001|Overall Study|Lost to Follow-up|8|||
129826072|NCT00350636|467329023|FG000|Overall Study|Physician Decision|0|||
129826073|NCT00350636|467329024|FG001|Overall Study|Physician Decision|2|||
129826074|NCT00350636|467329023|FG000|Overall Study|Other|1|||
129826075|NCT00350636|467329024|FG001|Overall Study|Other|2|||
129826076|NCT01042236|467329029|FG000|Treatment Period 1|Adverse Event|0|||
129826077|NCT01042236|467329030|FG001|Treatment Period 1|Adverse Event|1|||
129826078|NCT01042236|467329031|FG002|Treatment Period 1|Adverse Event|0|||
129826079|NCT01042236|467329032|FG003|Treatment Period 1|Adverse Event|0|||
129826080|NCT01042236|467329033|FG004|Treatment Period 1|Adverse Event|1|||
129826081|NCT01042236|467329034|FG005|Treatment Period 1|Adverse Event|0|||
129826082|NCT01042236|467329029|FG000|Treatment Period 3|Adverse Event|0|||
129826083|NCT01042236|467329030|FG001|Treatment Period 3|Adverse Event|0|||
129826084|NCT01042236|467329031|FG002|Treatment Period 3|Adverse Event|0|||
129826085|NCT01042236|467329032|FG003|Treatment Period 3|Adverse Event|1|||
129826086|NCT01042236|467329033|FG004|Treatment Period 3|Adverse Event|0|||
129826087|NCT01042236|467329034|FG005|Treatment Period 3|Adverse Event|0|||
129826088|NCT01042236|467329029|FG000|Treatment Period 3|Protocol Violation|0|||
129826089|NCT01042236|467329030|FG001|Treatment Period 3|Protocol Violation|0|||
129826090|NCT01042236|467329031|FG002|Treatment Period 3|Protocol Violation|0|||
129826091|NCT01042236|467329032|FG003|Treatment Period 3|Protocol Violation|1|||
129826092|NCT01042236|467329033|FG004|Treatment Period 3|Protocol Violation|0|||
129826093|NCT01042236|467329034|FG005|Treatment Period 3|Protocol Violation|0|||
129826094|NCT00227903|467329035|FG000|Overall Study|Withdrawal by Subject|2|||
129826095|NCT00227903|467329036|FG001|Overall Study|Withdrawal by Subject|5|||
129826096|NCT00227903|467329035|FG000|Overall Study|Subject moved out of area|1|||
129826097|NCT00227903|467329036|FG001|Overall Study|Subject moved out of area|2|||
129826098|NCT00227903|467329035|FG000|Overall Study|Lost to Follow-up|1|||
129826099|NCT00227903|467329036|FG001|Overall Study|Lost to Follow-up|3|||
129826100|NCT00227903|467329035|FG000|Overall Study|Miscarriage|1|||
129826101|NCT00227903|467329036|FG001|Overall Study|Miscarriage|0|||
129826102|NCT01475331|467329037|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
129826103|NCT01475331|467329038|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
129826104|NCT01475331|467329037|FG000|Overall Study|excessive main duct communication|1|||
129826105|NCT01475331|467329038|FG001|Overall Study|excessive main duct communication|1|||
129826106|NCT01475331|467329037|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
129826107|NCT01475331|467329038|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
129826108|NCT01475331|467329037|FG000|Overall Study|Sign of malignancy during the procedure|2|||
129826109|NCT01475331|467329038|FG001|Overall Study|Sign of malignancy during the procedure|0|||
129826110|NCT01475331|467329037|FG000|Overall Study|cyst found to be prohibitively small|0|||
129826111|NCT01475331|467329038|FG001|Overall Study|cyst found to be prohibitively small|1|||
129826112|NCT03683758|467329040|FG000|Overall Study|Non-study commitment conflict|1|||
129826113|NCT03683758|467329041|FG001|Overall Study|Non-study commitment conflict|3|||
129826114|NCT03683758|467329040|FG000|Overall Study|Illness preventing participation|1|||
129826115|NCT03683758|467329041|FG001|Overall Study|Illness preventing participation|0|||
129826116|NCT03683758|467329040|FG000|Overall Study|Adverse Event|1|||
129826117|NCT03683758|467329041|FG001|Overall Study|Adverse Event|0|||
129826118|NCT01172847|467329042|FG000|Overall Study|Withdrawal by Subject|3|||
129826119|NCT01163279|467329043|FG000|Overall Study|Withdrawal by Subject|2|||
129826120|NCT01163279|467329044|FG001|Overall Study|Withdrawal by Subject|0|||
129826121|NCT01601626|467329045|FG000|Overall Study|Death|1|||
129826122|NCT01601626|467329046|FG001|Overall Study|Death|1|||
129826123|NCT01601626|467329047|FG002|Overall Study|Death|1|||
129826124|NCT01601626|467329045|FG000|Overall Study|Lost to Follow-up|1|||
129826125|NCT01601626|467329046|FG001|Overall Study|Lost to Follow-up|2|||
129826126|NCT01601626|467329047|FG002|Overall Study|Lost to Follow-up|0|||
129826127|NCT01601626|467329045|FG000|Overall Study|Unable to Get to Clinic|0|||
129826128|NCT01601626|467329046|FG001|Overall Study|Unable to Get to Clinic|1|||
129826129|NCT01601626|467329047|FG002|Overall Study|Unable to Get to Clinic|0|||
129826130|NCT01601626|467329045|FG000|Overall Study|Withdrawal by Subject|0|||
129826131|NCT01601626|467329046|FG001|Overall Study|Withdrawal by Subject|1|||
129826132|NCT01601626|467329047|FG002|Overall Study|Withdrawal by Subject|1|||
129826133|NCT01601626|467329045|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
129826134|NCT01601626|467329046|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
129826135|NCT01601626|467329047|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
129826136|NCT02632552|467329051|FG000|Overall Study|Lost to Follow-up|14|||
129826137|NCT02632552|467329052|FG001|Overall Study|Lost to Follow-up|8|||
129826138|NCT02632552|467329051|FG000|Overall Study|Withdrawal by Subject|2|||
129826139|NCT02632552|467329052|FG001|Overall Study|Withdrawal by Subject|0|||
129826140|NCT02632552|467329051|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
129826141|NCT02632552|467329052|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
129826142|NCT02728895|467329053|FG000|Overall Study|Other|1|||
129826143|NCT02728895|467329054|FG001|Overall Study|Other|2|||
129826144|NCT02728895|467329053|FG000|Overall Study|Withdrawal by Subject|0|||
129826145|NCT02728895|467329054|FG001|Overall Study|Withdrawal by Subject|3|||
129826146|NCT00810407|467329057|FG000|Overall Study|Protocol Violation|3|||
129826147|NCT00810407|467329057|FG000|Overall Study|No Visit After First Day of Treatment|3|||
129826148|NCT02426892|467329059|FG000|Overall Study|Adverse Event|2|||
129826149|NCT02426892|467329059|FG000|Overall Study|Lack of Efficacy|17|||
129826150|NCT02426892|467329059|FG000|Overall Study|Withdrawal by Subject|1|||
129826151|NCT02574247|467329060|FG000|Overall Study|Withdrawal by Subject|1|||
129826152|NCT02574247|467329061|FG001|Overall Study|Withdrawal by Subject|0|||
129826153|NCT02574247|467329062|FG002|Overall Study|Withdrawal by Subject|0|||
129826154|NCT02574247|467329060|FG000|Overall Study|Did not meet inclusion criteria|4|||
129826155|NCT02574247|467329061|FG001|Overall Study|Did not meet inclusion criteria|3|||
129826156|NCT02574247|467329062|FG002|Overall Study|Did not meet inclusion criteria|5|||
129826157|NCT01382446|467329063|FG000|Overall Study|Withdrawal by Subject|0|||
129826158|NCT01382446|467329064|FG001|Overall Study|Withdrawal by Subject|1|||
129826159|NCT01382446|467329063|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
129826160|NCT01382446|467329064|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
129826161|NCT01166763|467329067|FG000|Overall Study|Withdrawal by Subject|3|||
129826162|NCT04339296|467329068|FG000|Overall Study|Refuse to participate after allocation|1|||
129826163|NCT04339296|467329069|FG001|Overall Study|Refuse to participate after allocation|1|||
129826164|NCT04339296|467329068|FG000|Overall Study|Withdrew after completion of baseline|2|||
129826165|NCT04339296|467329069|FG001|Overall Study|Withdrew after completion of baseline|1|||
129826166|NCT04339296|467329068|FG000|Overall Study|Lost to Follow-up|0|||
129826167|NCT04339296|467329069|FG001|Overall Study|Lost to Follow-up|4|||
129826168|NCT04339296|467329068|FG000|Overall Study|Discontinued intervention|5|||
129826169|NCT04339296|467329069|FG001|Overall Study|Discontinued intervention|3|||
129826170|NCT01909479|467329070|FG000|From Baseline to Week 26|Adverse Event|3|||
129826171|NCT01909479|467329071|FG001|From Baseline to Week 26|Adverse Event|2|||
129826172|NCT01909479|467329070|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
129826173|NCT01909479|467329071|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
129826174|NCT01909479|467329070|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
129826175|NCT01909479|467329071|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
129826176|NCT01909479|467329070|FG000|26 - 52 Weeks|Adverse Event|0|||
129826177|NCT01909479|467329071|FG001|26 - 52 Weeks|Adverse Event|1|||
129826178|NCT01909479|467329070|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
129826179|NCT01909479|467329071|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
129826180|NCT01909479|467329070|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
129826181|NCT01909479|467329071|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
129826182|NCT01909479|467329070|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
129826183|NCT01909479|467329071|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
129826184|NCT01909479|467329070|FG000|52 Weeks to End of Study|Adverse Event|2|||
129826185|NCT01909479|467329071|FG001|52 Weeks to End of Study|Adverse Event|1|||
129826186|NCT01909479|467329070|FG000|52 Weeks to End of Study|Death|0|||
129826187|NCT01909479|467329071|FG001|52 Weeks to End of Study|Death|1|||
129826188|NCT01909479|467329070|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
129826189|NCT01909479|467329071|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
129826190|NCT01909479|467329070|FG000|52 Weeks to End of Study|Protocol Violation|1|||
129826191|NCT01909479|467329071|FG001|52 Weeks to End of Study|Protocol Violation|0|||
129826192|NCT01909479|467329070|FG000|52 Weeks to End of Study|Progressive disease|1|||
129826193|NCT01909479|467329071|FG001|52 Weeks to End of Study|Progressive disease|1|||
129826194|NCT01909479|467329070|FG000|52 Weeks to End of Study|Personal reasons|2|||
129826195|NCT01909479|467329071|FG001|52 Weeks to End of Study|Personal reasons|1|||
129826196|NCT01909479|467329070|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
129826197|NCT01909479|467329071|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
129826198|NCT01909479|467329070|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
129826199|NCT01909479|467329071|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
129826200|NCT01909479|467329070|FG000|52 Weeks to End of Study|Lack of contact|1|||
129826201|NCT01909479|467329071|FG001|52 Weeks to End of Study|Lack of contact|0|||
129826202|NCT01909479|467329070|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
129826203|NCT01909479|467329071|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
129826204|NCT01909479|467329070|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
129826205|NCT01909479|467329071|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
129826206|NCT04446377|467329072|FG000|Overall Study|Withdrawal by Subject|6|||
129826207|NCT04446377|467329073|FG001|Overall Study|Withdrawal by Subject|1|||
129826208|NCT04446377|467329072|FG000|Overall Study|Physician Decision|1|||
129826209|NCT04446377|467329073|FG001|Overall Study|Physician Decision|1|||
129826210|NCT04446377|467329072|FG000|Overall Study|Lost to Follow-up|0|||
129826211|NCT04446377|467329073|FG001|Overall Study|Lost to Follow-up|2|||
129826212|NCT04446377|467329072|FG000|Overall Study|Not eligible|0|||
129826213|NCT04446377|467329073|FG001|Overall Study|Not eligible|1|||
129826214|NCT03557151|467329076|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
129826215|NCT03557151|467329077|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
129826216|NCT03557151|467329076|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
129826217|NCT03557151|467329077|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
129826218|NCT03557151|467329076|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
129826219|NCT03557151|467329077|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
129826220|NCT01414075|467329078|FG000|Overall Study|Adverse Event|1|||
129826221|NCT01414075|467329079|FG001|Overall Study|Adverse Event|0|||
129826222|NCT01414075|467329080|FG002|Overall Study|Adverse Event|1|||
129826223|NCT01414075|467329081|FG003|Overall Study|Adverse Event|0|||
129826224|NCT01414075|467329078|FG000|Overall Study|Death|1|||
129826225|NCT01414075|467329079|FG001|Overall Study|Death|0|||
129826226|NCT01414075|467329080|FG002|Overall Study|Death|0|||
130060057|NCT00862849|468174625|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129826227|NCT01414075|467329081|FG003|Overall Study|Death|1|||
129826228|NCT01414075|467329078|FG000|Overall Study|Withdrawal by Subject|0|||
129826229|NCT01414075|467329079|FG001|Overall Study|Withdrawal by Subject|0|||
129826230|NCT01414075|467329080|FG002|Overall Study|Withdrawal by Subject|0|||
129826231|NCT01414075|467329081|FG003|Overall Study|Withdrawal by Subject|1|||
129826232|NCT01414075|467329078|FG000|Overall Study|Other than specified|1|||
130060058|NCT00862849|468174626|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129826233|NCT01414075|467329079|FG001|Overall Study|Other than specified|0|||
129826234|NCT01414075|467329080|FG002|Overall Study|Other than specified|1|||
129826235|NCT01414075|467329081|FG003|Overall Study|Other than specified|0|||
129826236|NCT01187043|467329083|FG000|Overall Study|Adverse Event|0|||
129826237|NCT01187043|467329084|FG001|Overall Study|Adverse Event|0|||
129826238|NCT01187043|467329085|FG002|Overall Study|Adverse Event|0|||
129826239|NCT01187043|467329086|FG003|Overall Study|Adverse Event|0|||
129826240|NCT01187043|467329087|FG004|Overall Study|Adverse Event|1|||
129897543|NCT01981850|467584414|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
129826241|NCT01187043|467329083|FG000|Overall Study|Unable to make scheduled visits|1|||
129826242|NCT01187043|467329084|FG001|Overall Study|Unable to make scheduled visits|0|||
129826243|NCT01187043|467329085|FG002|Overall Study|Unable to make scheduled visits|4|||
129826244|NCT01187043|467329086|FG003|Overall Study|Unable to make scheduled visits|0|||
129826245|NCT01187043|467329087|FG004|Overall Study|Unable to make scheduled visits|1|||
129826246|NCT03198234|467329089|FG000|Overall Study|Relapse of primary disease|0|||
129826247|NCT03198234|467329090|FG001|Overall Study|Relapse of primary disease|1|||
129826248|NCT03198234|467329091|FG002|Overall Study|Relapse of primary disease|0|||
129826249|NCT01361464|467329092|FG000|Overall Study|Death|1|||
129826250|NCT01361464|467329092|FG000|Overall Study|Withdrawal by Subject|2|||
129826251|NCT01106898|467329096|FG000|Overall Study|Adverse Event|6|||
129826252|NCT01722071|467329097|FG000|Overall Study|Protocol Violation|1|||
129826253|NCT01722071|467329098|FG001|Overall Study|Protocol Violation|0|||
129826254|NCT00541034|467329099|FG000|Overall Study|Non-Compliance|3|||
129826255|NCT01505868|467329100|FG000|Overall Study|Withdrawal by Subject|1|||
129826256|NCT01505868|467329101|FG001|Overall Study|Withdrawal by Subject|0|||
129826257|NCT01505868|467329102|FG002|Overall Study|Withdrawal by Subject|0|||
129826258|NCT01505868|467329103|FG003|Overall Study|Withdrawal by Subject|0|||
129826259|NCT01505868|467329104|FG004|Overall Study|Withdrawal by Subject|0|||
129826260|NCT02062879|467329105|FG000|Overall Study|Withdrawal by Subject|4|||
129826261|NCT02062879|467329106|FG001|Overall Study|Withdrawal by Subject|1|||
129826262|NCT02289079|467329107|FG000|Overall Study|Physician Decision|2|||
129826263|NCT02289079|467329108|FG001|Overall Study|Physician Decision|0|||
129826264|NCT02289079|467329107|FG000|Overall Study|Lost to Follow-up|0|||
129826265|NCT02289079|467329108|FG001|Overall Study|Lost to Follow-up|1|||
129826266|NCT00680043|467329109|FG000|Overall Study|Withdrawal by Subject|1|||
129826267|NCT00680043|467329110|FG001|Overall Study|Withdrawal by Subject|0|||
129826268|NCT00680043|467329111|FG002|Overall Study|Withdrawal by Subject|0|||
129826269|NCT00680043|467329109|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
129826270|NCT00680043|467329110|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
129826271|NCT00680043|467329111|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
129826272|NCT00680043|467329109|FG000|Overall Study|Renal Transplant|1|||
129826273|NCT00680043|467329110|FG001|Overall Study|Renal Transplant|0|||
129826274|NCT00680043|467329111|FG002|Overall Study|Renal Transplant|4|||
129826275|NCT00553150|467329112|FG000|Overall Study|Withdrawal by Subject|0|||
129826276|NCT00553150|467329113|FG001|Overall Study|Withdrawal by Subject|0|||
129826277|NCT00553150|467329114|FG002|Overall Study|Withdrawal by Subject|0|||
129826278|NCT00553150|467329115|FG003|Overall Study|Withdrawal by Subject|2|||
129826279|NCT00553150|467329112|FG000|Overall Study|Protocol Violation|0|||
129826280|NCT00553150|467329113|FG001|Overall Study|Protocol Violation|0|||
129826281|NCT00553150|467329114|FG002|Overall Study|Protocol Violation|0|||
129826282|NCT00553150|467329115|FG003|Overall Study|Protocol Violation|1|||
129826283|NCT00553150|467329112|FG000|Overall Study|Ineligible|0|||
129826284|NCT00553150|467329113|FG001|Overall Study|Ineligible|0|||
129826285|NCT00553150|467329114|FG002|Overall Study|Ineligible|0|||
129826286|NCT00553150|467329115|FG003|Overall Study|Ineligible|1|||
129826287|NCT03061331|467329116|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
129826288|NCT03061331|467329117|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
129826289|NCT02625259|467329118|FG000|First Intervention (Day 1)|Other|0|||
129826290|NCT02625259|467329119|FG001|First Intervention (Day 1)|Other|0|||
129826291|NCT02625259|467329120|FG002|First Intervention (Day 1)|Other|1|||
129826292|NCT02625259|467329121|FG003|First Intervention (Day 1)|Other|0|||
129826293|NCT02625259|467329122|FG004|First Intervention (Day 1)|Other|0|||
129826294|NCT02625259|467329118|FG000|First Intervention (Day 1)|Adverse Event|2|||
129826295|NCT02625259|467329119|FG001|First Intervention (Day 1)|Adverse Event|1|||
129826296|NCT02625259|467329120|FG002|First Intervention (Day 1)|Adverse Event|0|||
129826297|NCT02625259|467329121|FG003|First Intervention (Day 1)|Adverse Event|0|||
129826298|NCT02625259|467329122|FG004|First Intervention (Day 1)|Adverse Event|0|||
129826299|NCT02625259|467329118|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826300|NCT02625259|467329119|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826301|NCT02625259|467329120|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826302|NCT02625259|467329121|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
129826303|NCT02625259|467329122|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826304|NCT01980875|467329123|FG000|Overall Study|Withdrew Consent|1|||
129826305|NCT01980875|467329124|FG001|Overall Study|Withdrew Consent|1|||
129826306|NCT01980875|467329125|FG002|Overall Study|Withdrew Consent|1|||
129826307|NCT01980875|467329123|FG000|Overall Study|Study Terminated by Sponsor|7|||
129897544|NCT01981850|467584415|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
129826308|NCT01980875|467329124|FG001|Overall Study|Study Terminated by Sponsor|24|||
129826309|NCT01980875|467329125|FG002|Overall Study|Study Terminated by Sponsor|22|||
129826310|NCT01980875|467329123|FG000|Overall Study|Lost to Follow-up|0|||
129826311|NCT01980875|467329124|FG001|Overall Study|Lost to Follow-up|0|||
129826312|NCT01980875|467329125|FG002|Overall Study|Lost to Follow-up|1|||
129826313|NCT02998840|467329126|FG000|Overall Study|Lost to Follow-up|1|||
129826314|NCT02998840|467329127|FG001|Overall Study|Lost to Follow-up|1|||
129826315|NCT02998840|467329128|FG002|Overall Study|Lost to Follow-up|2|||
129826316|NCT02998840|467329129|FG003|Overall Study|Lost to Follow-up|3|||
129826317|NCT02998840|467329126|FG000|Overall Study|Withdrawal by Subject|1|||
129826318|NCT02998840|467329127|FG001|Overall Study|Withdrawal by Subject|1|||
129826319|NCT02998840|467329128|FG002|Overall Study|Withdrawal by Subject|0|||
129826320|NCT02998840|467329129|FG003|Overall Study|Withdrawal by Subject|1|||
129826321|NCT02998840|467329126|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
129826322|NCT02998840|467329127|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
129826323|NCT02998840|467329128|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
129826324|NCT02998840|467329129|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
129826325|NCT00513474|467329133|FG000|Overall Study|Death|6|||
129826326|NCT00513474|467329134|FG001|Overall Study|Death|9|||
129826327|NCT00513474|467329133|FG000|Overall Study|Participant Withdrew Consent|1|||
129826328|NCT00513474|467329134|FG001|Overall Study|Participant Withdrew Consent|0|||
129826329|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Adverse Event|82|||
129826330|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Death|6|||
129826331|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
129826332|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
129897545|NCT01981850|467584416|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
129897546|NCT01981850|467584417|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
129897547|NCT01981850|467584418|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
129897548|NCT01981850|467584419|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
129897549|NCT01981850|467584420|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
129897550|NCT01981850|467584421|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
129897551|NCT01981850|467584412|FG000|Main Phase Stage 1|Various reasons|0|||
129897552|NCT01981850|467584413|FG001|Main Phase Stage 1|Various reasons|0|||
129897553|NCT01981850|467584414|FG002|Main Phase Stage 1|Various reasons|2|||
129897554|NCT01981850|467584415|FG003|Main Phase Stage 1|Various reasons|0|||
129897555|NCT01981850|467584416|FG004|Main Phase Stage 1|Various reasons|0|||
129897556|NCT01981850|467584417|FG005|Main Phase Stage 1|Various reasons|0|||
129897557|NCT01981850|467584418|FG006|Main Phase Stage 1|Various reasons|0|||
129897558|NCT01981850|467584419|FG007|Main Phase Stage 1|Various reasons|0|||
129897559|NCT01981850|467584420|FG008|Main Phase Stage 1|Various reasons|0|||
129897560|NCT01981850|467584421|FG009|Main Phase Stage 1|Various reasons|0|||
129897561|NCT01981850|467584412|FG000|Main Phase Stage 2|Adverse Event|0|||
129897562|NCT01981850|467584413|FG001|Main Phase Stage 2|Adverse Event|0|||
129897563|NCT01981850|467584414|FG002|Main Phase Stage 2|Adverse Event|0|||
129897564|NCT01981850|467584415|FG003|Main Phase Stage 2|Adverse Event|0|||
129897565|NCT01981850|467584416|FG004|Main Phase Stage 2|Adverse Event|6|||
129897566|NCT01981850|467584417|FG005|Main Phase Stage 2|Adverse Event|5|||
129897567|NCT01981850|467584418|FG006|Main Phase Stage 2|Adverse Event|7|||
129897568|NCT01981850|467584419|FG007|Main Phase Stage 2|Adverse Event|0|||
129897569|NCT01981850|467584420|FG008|Main Phase Stage 2|Adverse Event|0|||
129897570|NCT01981850|467584421|FG009|Main Phase Stage 2|Adverse Event|0|||
129897571|NCT01981850|467584412|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897572|NCT01981850|467584413|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897573|NCT01981850|467584414|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897574|NCT01981850|467584415|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897575|NCT01981850|467584416|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
129897576|NCT01981850|467584417|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
129897577|NCT01981850|467584418|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
129897578|NCT01981850|467584419|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897579|NCT01981850|467584420|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897580|NCT01981850|467584421|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897581|NCT01981850|467584412|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
129897582|NCT01981850|467584413|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
129897583|NCT01981850|467584414|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
129897584|NCT01981850|467584415|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
129897585|NCT01981850|467584416|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
129897586|NCT01981850|467584417|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
129897587|NCT01981850|467584418|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
129826333|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
129826334|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
129826335|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
129826336|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Other reasons|68|||
129826337|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
129897588|NCT01981850|467584419|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
129897589|NCT01981850|467584420|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
129897590|NCT01981850|467584421|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
129897591|NCT01981850|467584412|FG000|Main Phase Stage 2|Various reasons|0|||
129897592|NCT01981850|467584413|FG001|Main Phase Stage 2|Various reasons|0|||
129897593|NCT01981850|467584414|FG002|Main Phase Stage 2|Various reasons|0|||
129897594|NCT01981850|467584415|FG003|Main Phase Stage 2|Various reasons|0|||
129897595|NCT01981850|467584416|FG004|Main Phase Stage 2|Various reasons|2|||
129897596|NCT01981850|467584417|FG005|Main Phase Stage 2|Various reasons|0|||
129897597|NCT01981850|467584418|FG006|Main Phase Stage 2|Various reasons|1|||
129897598|NCT01981850|467584419|FG007|Main Phase Stage 2|Various reasons|0|||
129897599|NCT01981850|467584420|FG008|Main Phase Stage 2|Various reasons|0|||
129897600|NCT01981850|467584421|FG009|Main Phase Stage 2|Various reasons|0|||
129897601|NCT01981850|467584412|FG000|Main Phase Stage 2|Progressive Disease|0|||
129897602|NCT01981850|467584413|FG001|Main Phase Stage 2|Progressive Disease|0|||
129897603|NCT01981850|467584414|FG002|Main Phase Stage 2|Progressive Disease|0|||
129897604|NCT01981850|467584415|FG003|Main Phase Stage 2|Progressive Disease|0|||
129897605|NCT01981850|467584416|FG004|Main Phase Stage 2|Progressive Disease|0|||
129897606|NCT01981850|467584417|FG005|Main Phase Stage 2|Progressive Disease|6|||
129897607|NCT01981850|467584418|FG006|Main Phase Stage 2|Progressive Disease|6|||
129897608|NCT01981850|467584419|FG007|Main Phase Stage 2|Progressive Disease|0|||
129897609|NCT01981850|467584420|FG008|Main Phase Stage 2|Progressive Disease|0|||
129897610|NCT01981850|467584421|FG009|Main Phase Stage 2|Progressive Disease|0|||
129897611|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Adverse Event|0|||
129897612|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Adverse Event|0|||
129897613|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Adverse Event|0|||
129897614|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Adverse Event|0|||
129897615|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Adverse Event|0|||
129897616|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Adverse Event|0|||
129897617|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Adverse Event|0|||
129897618|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Adverse Event|2|||
129897619|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Adverse Event|1|||
129897620|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Adverse Event|8|||
129897621|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897622|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897623|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897624|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897625|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897626|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897627|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897628|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
129897629|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
129897630|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
129897631|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Various reasons|0|||
129897632|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Various reasons|0|||
129897633|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Various reasons|0|||
129897634|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Various reasons|0|||
129897635|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Various reasons|0|||
129897636|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Various reasons|0|||
129826338|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
129826339|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
129826340|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
129826341|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
129826342|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
129826343|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
129826344|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
129826345|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
129826346|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
129826347|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
129826348|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
129826349|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
129826350|NCT01189812|467329141|FG000|Overall Study|Withdrawal by Subject|2|||
129826351|NCT01189812|467329142|FG001|Overall Study|Withdrawal by Subject|3|||
129826352|NCT01189812|467329141|FG000|Overall Study|Adverse Event|1|||
129826353|NCT01189812|467329142|FG001|Overall Study|Adverse Event|0|||
129826354|NCT01189812|467329141|FG000|Overall Study|Out of Window|4|||
129826355|NCT01189812|467329142|FG001|Overall Study|Out of Window|3|||
129826356|NCT01189812|467329141|FG000|Overall Study|Moved out of State|1|||
129826357|NCT01189812|467329142|FG001|Overall Study|Moved out of State|2|||
129826358|NCT00535223|467329144|FG000|Overall Study|Withdrawal by Subject|4|||
129826359|NCT00535223|467329145|FG001|Overall Study|Withdrawal by Subject|1|||
129826360|NCT02953314|467329146|FG000|Overall Study|Adverse Event|0|||
129826361|NCT02953314|467329147|FG001|Overall Study|Adverse Event|1|||
129826362|NCT02953314|467329146|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129826363|NCT02953314|467329147|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129897637|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Various reasons|0|||
129897638|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Various reasons|3|||
129826364|NCT01765153|467329148|FG000|Training Phase 1|Format of intervention differed|1|||
129826365|NCT01765153|467329149|FG001|Training Phase 1|Format of intervention differed|0|||
129897639|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Various reasons|1|||
129826366|NCT01765153|467329148|FG000|Training Phase 1|Poor participation in intervention|0|||
129826367|NCT01765153|467329149|FG001|Training Phase 1|Poor participation in intervention|1|||
129826368|NCT01765153|467329148|FG000|Rest Phase 1|Withdrawal by Subject|0|||
129826369|NCT01765153|467329149|FG001|Rest Phase 1|Withdrawal by Subject|1|||
129826370|NCT01765153|467329148|FG000|Training Phase 2|Withdrawal by Subject|0|||
129826371|NCT01765153|467329149|FG001|Training Phase 2|Withdrawal by Subject|1|||
129826372|NCT01765153|467329148|FG000|Rest Phase 2|Lost to Follow-up|2|||
129826373|NCT01765153|467329149|FG001|Rest Phase 2|Lost to Follow-up|1|||
129826374|NCT02554812|467329150|FG000|Overall Study|Adverse Event|2|||
129826375|NCT02554812|467329151|FG001|Overall Study|Adverse Event|5|||
129826376|NCT02554812|467329152|FG002|Overall Study|Adverse Event|3|||
129826377|NCT02554812|467329153|FG003|Overall Study|Adverse Event|0|||
129826378|NCT02554812|467329154|FG004|Overall Study|Adverse Event|5|||
129826379|NCT02554812|467329155|FG005|Overall Study|Adverse Event|0|||
129826380|NCT02554812|467329156|FG006|Overall Study|Adverse Event|1|||
129826381|NCT02554812|467329157|FG007|Overall Study|Adverse Event|6|||
129826382|NCT02554812|467329158|FG008|Overall Study|Adverse Event|2|||
129826383|NCT02554812|467329159|FG009|Overall Study|Adverse Event|2|||
129826384|NCT02554812|467329160|FG010|Overall Study|Adverse Event|1|||
129826385|NCT02554812|467329161|FG011|Overall Study|Adverse Event|2|||
129826386|NCT02554812|467329162|FG012|Overall Study|Adverse Event|0|||
129826387|NCT02554812|467329163|FG013|Overall Study|Adverse Event|3|||
129826388|NCT02554812|467329164|FG014|Overall Study|Adverse Event|2|||
129826389|NCT02554812|467329165|FG015|Overall Study|Adverse Event|1|||
129826390|NCT02554812|467329166|FG016|Overall Study|Adverse Event|0|||
129826391|NCT02554812|467329167|FG017|Overall Study|Adverse Event|1|||
129826392|NCT02554812|467329168|FG018|Overall Study|Adverse Event|0|||
129826393|NCT02554812|467329169|FG019|Overall Study|Adverse Event|0|||
129826394|NCT02554812|467329170|FG020|Overall Study|Adverse Event|0|||
129826395|NCT02554812|467329171|FG021|Overall Study|Adverse Event|2|||
129826396|NCT02554812|467329172|FG022|Overall Study|Adverse Event|1|||
129826397|NCT02554812|467329173|FG023|Overall Study|Adverse Event|1|||
129826398|NCT02554812|467329174|FG024|Overall Study|Adverse Event|1|||
129826399|NCT02554812|467329175|FG025|Overall Study|Adverse Event|2|||
129826400|NCT02554812|467329176|FG026|Overall Study|Adverse Event|1|||
129826401|NCT02554812|467329150|FG000|Overall Study|Death|1|||
129826402|NCT02554812|467329151|FG001|Overall Study|Death|2|||
129897640|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Various reasons|3|||
129897641|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
129897642|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
129897643|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
129897644|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
129897645|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
129897646|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
129897647|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
129897648|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
129897649|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
129897650|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
129897651|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897652|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897653|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897654|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897655|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897656|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897657|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129826403|NCT02554812|467329152|FG002|Overall Study|Death|2|||
129826404|NCT02554812|467329153|FG003|Overall Study|Death|2|||
129826405|NCT02554812|467329154|FG004|Overall Study|Death|0|||
129826406|NCT02554812|467329155|FG005|Overall Study|Death|1|||
129826407|NCT02554812|467329156|FG006|Overall Study|Death|1|||
129826408|NCT02554812|467329157|FG007|Overall Study|Death|1|||
129826409|NCT02554812|467329158|FG008|Overall Study|Death|0|||
129826410|NCT02554812|467329159|FG009|Overall Study|Death|0|||
129826411|NCT02554812|467329160|FG010|Overall Study|Death|0|||
129826412|NCT02554812|467329161|FG011|Overall Study|Death|0|||
129826413|NCT02554812|467329162|FG012|Overall Study|Death|0|||
129826414|NCT02554812|467329163|FG013|Overall Study|Death|0|||
129826415|NCT02554812|467329164|FG014|Overall Study|Death|1|||
129826416|NCT02554812|467329165|FG015|Overall Study|Death|1|||
129826417|NCT02554812|467329166|FG016|Overall Study|Death|1|||
129897658|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129826418|NCT02554812|467329167|FG017|Overall Study|Death|0|||
129826419|NCT02554812|467329168|FG018|Overall Study|Death|1|||
129826420|NCT02554812|467329169|FG019|Overall Study|Death|2|||
129826421|NCT02554812|467329170|FG020|Overall Study|Death|0|||
129826422|NCT02554812|467329171|FG021|Overall Study|Death|1|||
129826423|NCT02554812|467329172|FG022|Overall Study|Death|1|||
129826424|NCT02554812|467329173|FG023|Overall Study|Death|0|||
129826425|NCT02554812|467329174|FG024|Overall Study|Death|0|||
129826426|NCT02554812|467329175|FG025|Overall Study|Death|0|||
129826427|NCT02554812|467329176|FG026|Overall Study|Death|0|||
129826428|NCT02554812|467329150|FG000|Overall Study|Lost to Follow-up|0|||
129826429|NCT02554812|467329151|FG001|Overall Study|Lost to Follow-up|1|||
129826430|NCT02554812|467329152|FG002|Overall Study|Lost to Follow-up|0|||
129826431|NCT02554812|467329153|FG003|Overall Study|Lost to Follow-up|0|||
129826432|NCT02554812|467329154|FG004|Overall Study|Lost to Follow-up|0|||
129826433|NCT02554812|467329155|FG005|Overall Study|Lost to Follow-up|0|||
129826434|NCT02554812|467329156|FG006|Overall Study|Lost to Follow-up|0|||
129826435|NCT02554812|467329157|FG007|Overall Study|Lost to Follow-up|0|||
129826436|NCT02554812|467329158|FG008|Overall Study|Lost to Follow-up|0|||
129826437|NCT02554812|467329159|FG009|Overall Study|Lost to Follow-up|0|||
129826438|NCT02554812|467329160|FG010|Overall Study|Lost to Follow-up|0|||
129826439|NCT02554812|467329161|FG011|Overall Study|Lost to Follow-up|0|||
129826440|NCT02554812|467329162|FG012|Overall Study|Lost to Follow-up|0|||
129826441|NCT02554812|467329163|FG013|Overall Study|Lost to Follow-up|0|||
129826442|NCT02554812|467329164|FG014|Overall Study|Lost to Follow-up|0|||
129826443|NCT02554812|467329165|FG015|Overall Study|Lost to Follow-up|0|||
129826444|NCT02554812|467329166|FG016|Overall Study|Lost to Follow-up|0|||
129826445|NCT02554812|467329167|FG017|Overall Study|Lost to Follow-up|0|||
129826446|NCT02554812|467329168|FG018|Overall Study|Lost to Follow-up|0|||
129826447|NCT02554812|467329169|FG019|Overall Study|Lost to Follow-up|0|||
129826448|NCT02554812|467329170|FG020|Overall Study|Lost to Follow-up|0|||
129826449|NCT02554812|467329171|FG021|Overall Study|Lost to Follow-up|0|||
129826450|NCT02554812|467329172|FG022|Overall Study|Lost to Follow-up|0|||
129826451|NCT02554812|467329173|FG023|Overall Study|Lost to Follow-up|0|||
129826452|NCT02554812|467329174|FG024|Overall Study|Lost to Follow-up|0|||
129826453|NCT02554812|467329175|FG025|Overall Study|Lost to Follow-up|0|||
129826454|NCT02554812|467329176|FG026|Overall Study|Lost to Follow-up|0|||
129826455|NCT02554812|467329150|FG000|Overall Study|Global deterioration of health status|4|||
129826456|NCT02554812|467329151|FG001|Overall Study|Global deterioration of health status|3|||
129826457|NCT02554812|467329152|FG002|Overall Study|Global deterioration of health status|3|||
129826458|NCT02554812|467329153|FG003|Overall Study|Global deterioration of health status|2|||
129826459|NCT02554812|467329154|FG004|Overall Study|Global deterioration of health status|5|||
129826460|NCT02554812|467329155|FG005|Overall Study|Global deterioration of health status|0|||
129826461|NCT02554812|467329156|FG006|Overall Study|Global deterioration of health status|2|||
129826462|NCT02554812|467329157|FG007|Overall Study|Global deterioration of health status|1|||
129826463|NCT02554812|467329158|FG008|Overall Study|Global deterioration of health status|1|||
129826464|NCT02554812|467329159|FG009|Overall Study|Global deterioration of health status|1|||
129826465|NCT02554812|467329160|FG010|Overall Study|Global deterioration of health status|2|||
129826466|NCT02554812|467329161|FG011|Overall Study|Global deterioration of health status|1|||
129826467|NCT02554812|467329162|FG012|Overall Study|Global deterioration of health status|0|||
129826468|NCT02554812|467329163|FG013|Overall Study|Global deterioration of health status|0|||
129826469|NCT02554812|467329164|FG014|Overall Study|Global deterioration of health status|0|||
129826470|NCT02554812|467329165|FG015|Overall Study|Global deterioration of health status|1|||
129826471|NCT02554812|467329166|FG016|Overall Study|Global deterioration of health status|0|||
129826472|NCT02554812|467329167|FG017|Overall Study|Global deterioration of health status|0|||
129826473|NCT02554812|467329168|FG018|Overall Study|Global deterioration of health status|0|||
129826474|NCT02554812|467329169|FG019|Overall Study|Global deterioration of health status|0|||
129826475|NCT02554812|467329170|FG020|Overall Study|Global deterioration of health status|0|||
129826476|NCT02554812|467329171|FG021|Overall Study|Global deterioration of health status|0|||
129826477|NCT02554812|467329172|FG022|Overall Study|Global deterioration of health status|0|||
129826478|NCT02554812|467329173|FG023|Overall Study|Global deterioration of health status|0|||
129826479|NCT02554812|467329174|FG024|Overall Study|Global deterioration of health status|0|||
129826480|NCT02554812|467329175|FG025|Overall Study|Global deterioration of health status|0|||
129826481|NCT02554812|467329176|FG026|Overall Study|Global deterioration of health status|0|||
129826482|NCT02554812|467329150|FG000|Overall Study|Progressive disease|20|||
129826483|NCT02554812|467329151|FG001|Overall Study|Progressive disease|16|||
129826484|NCT02554812|467329152|FG002|Overall Study|Progressive disease|19|||
129826485|NCT02554812|467329153|FG003|Overall Study|Progressive disease|18|||
129826486|NCT02554812|467329154|FG004|Overall Study|Progressive disease|21|||
129826487|NCT02554812|467329155|FG005|Overall Study|Progressive disease|15|||
129826488|NCT02554812|467329156|FG006|Overall Study|Progressive disease|6|||
129826489|NCT02554812|467329157|FG007|Overall Study|Progressive disease|13|||
129826490|NCT02554812|467329158|FG008|Overall Study|Progressive disease|6|||
129826491|NCT02554812|467329159|FG009|Overall Study|Progressive disease|6|||
129826492|NCT02554812|467329160|FG010|Overall Study|Progressive disease|8|||
129826493|NCT02554812|467329161|FG011|Overall Study|Progressive disease|8|||
129826494|NCT02554812|467329162|FG012|Overall Study|Progressive disease|6|||
129826495|NCT02554812|467329163|FG013|Overall Study|Progressive disease|10|||
129826496|NCT02554812|467329164|FG014|Overall Study|Progressive disease|20|||
129826497|NCT02554812|467329165|FG015|Overall Study|Progressive disease|6|||
129826498|NCT02554812|467329166|FG016|Overall Study|Progressive disease|3|||
129826499|NCT02554812|467329167|FG017|Overall Study|Progressive disease|3|||
129826500|NCT02554812|467329168|FG018|Overall Study|Progressive disease|11|||
130060059|NCT00862849|468174627|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
130060060|NCT00862849|468174622|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130060061|NCT00862849|468174623|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
130060062|NCT00862849|468174624|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130060063|NCT00862849|468174625|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130060064|NCT00862849|468174626|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130060065|NCT00862849|468174627|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
130060066|NCT04032171|468174635|FG000|Overall Study|Study Termination|1|||
130060067|NCT04032171|468174636|FG001|Overall Study|Study Termination|0|||
130060068|NCT01363713|468174637|FG000|Overall Study|Adverse Event|1|||
129826501|NCT02554812|467329169|FG019|Overall Study|Progressive disease|7|||
130060069|NCT01363713|468174637|FG000|Overall Study|Protocol Violation|3|||
130060070|NCT01363713|468174637|FG000|Overall Study|Withdrawal by Subject|2|||
130060071|NCT02108951|468174641|FG000|Overall Study|Lost to Follow-up|1|||
130060072|NCT02108951|468174641|FG000|Overall Study|Patient's/guardian's decision|1|||
130060073|NCT02108951|468174641|FG000|Overall Study|Study Terminated by Sponsor|14|||
130060074|NCT00718666|468174642|FG000|Booster Phase Year 5|No active participation request|0|||
130060075|NCT00718666|468174643|FG001|Booster Phase Year 5|No active participation request|0|||
130060076|NCT00718666|468174644|FG002|Booster Phase Year 5|No active participation request|1|||
130060077|NCT00718666|468174642|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
130060078|NCT00718666|468174643|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
130060079|NCT00718666|468174644|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
130060080|NCT00718666|468174642|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
130060081|NCT00718666|468174643|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
130060082|NCT00718666|468174644|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
130060083|NCT00718666|468174642|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
130060084|NCT00718666|468174643|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
130060085|NCT00718666|468174644|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
130060086|NCT03471767|468174647|FG000|Overall Study|Withdrawal by Subject|3|||
130060087|NCT03471767|468174648|FG001|Overall Study|Withdrawal by Subject|1|||
130060088|NCT03471767|468174647|FG000|Overall Study|Adverse Event|1|||
130060089|NCT03471767|468174648|FG001|Overall Study|Adverse Event|0|||
130060090|NCT03471767|468174647|FG000|Overall Study|Lost to Follow-up|1|||
130060091|NCT03471767|468174648|FG001|Overall Study|Lost to Follow-up|0|||
130060092|NCT03471767|468174647|FG000|Overall Study|PI Withdrawal|1|||
130060093|NCT03471767|468174648|FG001|Overall Study|PI Withdrawal|3|||
130060094|NCT00678587|468174649|FG000|Overall Study|Adverse Event|3|||
130060095|NCT00678587|468174650|FG001|Overall Study|Adverse Event|3|||
130060096|NCT00678587|468174649|FG000|Overall Study|Lack of Efficacy|1|||
130060097|NCT00678587|468174650|FG001|Overall Study|Lack of Efficacy|0|||
130060098|NCT00678587|468174649|FG000|Overall Study|Protocol Violation|2|||
130060099|NCT00678587|468174650|FG001|Overall Study|Protocol Violation|1|||
130060100|NCT00678587|468174649|FG000|Overall Study|Study Closed/Terminated|1|||
130060101|NCT00678587|468174650|FG001|Overall Study|Study Closed/Terminated|0|||
130060102|NCT00678587|468174649|FG000|Overall Study|Lost to Follow-up|3|||
130060103|NCT00678587|468174650|FG001|Overall Study|Lost to Follow-up|5|||
130060104|NCT00678587|468174649|FG000|Overall Study|Investigator Discretion|2|||
130060105|NCT00678587|468174650|FG001|Overall Study|Investigator Discretion|6|||
130060106|NCT00678587|468174649|FG000|Overall Study|Withdrew Consent|8|||
130060107|NCT00678587|468174650|FG001|Overall Study|Withdrew Consent|3|||
130060108|NCT03806179|468174651|FG000|Overall Study|Progressive disease|0|||
130060109|NCT03806179|468174652|FG001|Overall Study|Progressive disease|2|||
130060110|NCT00608530|468174655|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
130060111|NCT00608530|468174656|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
130060112|NCT00608530|468174657|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
130060113|NCT00608530|468174658|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
130060114|NCT00608530|468174655|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
130060115|NCT00608530|468174656|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
130060116|NCT00608530|468174657|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
130060117|NCT00608530|468174658|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
129826502|NCT02554812|467329170|FG020|Overall Study|Progressive disease|11|||
129826503|NCT02554812|467329171|FG021|Overall Study|Progressive disease|6|||
129826504|NCT02554812|467329172|FG022|Overall Study|Progressive disease|9|||
129826505|NCT02554812|467329173|FG023|Overall Study|Progressive disease|9|||
129826506|NCT02554812|467329174|FG024|Overall Study|Progressive disease|4|||
130060118|NCT00608530|468174655|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
130060119|NCT00608530|468174656|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
130060120|NCT00608530|468174657|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
130060121|NCT00608530|468174658|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
130060122|NCT00608530|468174655|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
130060123|NCT00608530|468174656|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
130060124|NCT00608530|468174657|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
130060125|NCT00608530|468174658|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
129826507|NCT02554812|467329175|FG025|Overall Study|Progressive disease|5|||
129826508|NCT02554812|467329176|FG026|Overall Study|Progressive disease|5|||
129826509|NCT02554812|467329150|FG000|Overall Study|Other|0|||
129826510|NCT02554812|467329151|FG001|Overall Study|Other|0|||
129826511|NCT02554812|467329152|FG002|Overall Study|Other|2|||
129826512|NCT02554812|467329153|FG003|Overall Study|Other|3|||
129826513|NCT02554812|467329154|FG004|Overall Study|Other|2|||
129826514|NCT02554812|467329155|FG005|Overall Study|Other|1|||
129826515|NCT02554812|467329156|FG006|Overall Study|Other|0|||
129826516|NCT02554812|467329157|FG007|Overall Study|Other|0|||
129826517|NCT02554812|467329158|FG008|Overall Study|Other|1|||
129826518|NCT02554812|467329159|FG009|Overall Study|Other|1|||
129826519|NCT02554812|467329160|FG010|Overall Study|Other|0|||
129826520|NCT02554812|467329161|FG011|Overall Study|Other|0|||
129826521|NCT02554812|467329162|FG012|Overall Study|Other|1|||
129826522|NCT02554812|467329163|FG013|Overall Study|Other|0|||
129826523|NCT02554812|467329164|FG014|Overall Study|Other|1|||
129826524|NCT02554812|467329165|FG015|Overall Study|Other|0|||
129826525|NCT02554812|467329166|FG016|Overall Study|Other|0|||
129826526|NCT02554812|467329167|FG017|Overall Study|Other|0|||
129826527|NCT02554812|467329168|FG018|Overall Study|Other|0|||
129826528|NCT02554812|467329169|FG019|Overall Study|Other|0|||
129826529|NCT02554812|467329170|FG020|Overall Study|Other|0|||
129826530|NCT02554812|467329171|FG021|Overall Study|Other|2|||
129826531|NCT02554812|467329172|FG022|Overall Study|Other|0|||
129826532|NCT02554812|467329173|FG023|Overall Study|Other|0|||
129826533|NCT02554812|467329174|FG024|Overall Study|Other|0|||
129826534|NCT02554812|467329175|FG025|Overall Study|Other|0|||
129826535|NCT02554812|467329176|FG026|Overall Study|Other|0|||
129826536|NCT02554812|467329150|FG000|Overall Study|Withdrawal by Subject|1|||
129826537|NCT02554812|467329151|FG001|Overall Study|Withdrawal by Subject|0|||
129826538|NCT02554812|467329152|FG002|Overall Study|Withdrawal by Subject|0|||
129826539|NCT02554812|467329153|FG003|Overall Study|Withdrawal by Subject|2|||
129826540|NCT02554812|467329154|FG004|Overall Study|Withdrawal by Subject|2|||
129826541|NCT02554812|467329155|FG005|Overall Study|Withdrawal by Subject|3|||
129826542|NCT02554812|467329156|FG006|Overall Study|Withdrawal by Subject|0|||
129826543|NCT02554812|467329157|FG007|Overall Study|Withdrawal by Subject|0|||
129826544|NCT02554812|467329158|FG008|Overall Study|Withdrawal by Subject|1|||
129826545|NCT02554812|467329159|FG009|Overall Study|Withdrawal by Subject|1|||
129826546|NCT02554812|467329160|FG010|Overall Study|Withdrawal by Subject|0|||
129826547|NCT02554812|467329161|FG011|Overall Study|Withdrawal by Subject|1|||
129826548|NCT02554812|467329162|FG012|Overall Study|Withdrawal by Subject|1|||
129826549|NCT02554812|467329163|FG013|Overall Study|Withdrawal by Subject|1|||
129826550|NCT02554812|467329164|FG014|Overall Study|Withdrawal by Subject|1|||
129826551|NCT02554812|467329165|FG015|Overall Study|Withdrawal by Subject|1|||
129826552|NCT02554812|467329166|FG016|Overall Study|Withdrawal by Subject|3|||
129826553|NCT02554812|467329167|FG017|Overall Study|Withdrawal by Subject|1|||
129826554|NCT02554812|467329168|FG018|Overall Study|Withdrawal by Subject|0|||
129826555|NCT02554812|467329169|FG019|Overall Study|Withdrawal by Subject|2|||
129826556|NCT02554812|467329170|FG020|Overall Study|Withdrawal by Subject|0|||
129826557|NCT02554812|467329171|FG021|Overall Study|Withdrawal by Subject|1|||
129826558|NCT02554812|467329172|FG022|Overall Study|Withdrawal by Subject|0|||
129826559|NCT02554812|467329173|FG023|Overall Study|Withdrawal by Subject|1|||
129826560|NCT02554812|467329174|FG024|Overall Study|Withdrawal by Subject|0|||
129826561|NCT02554812|467329175|FG025|Overall Study|Withdrawal by Subject|0|||
129826562|NCT02554812|467329176|FG026|Overall Study|Withdrawal by Subject|1|||
129826563|NCT02554812|467329150|FG000|Overall Study|Physician Decision|1|||
129826564|NCT02554812|467329151|FG001|Overall Study|Physician Decision|0|||
129826565|NCT02554812|467329152|FG002|Overall Study|Physician Decision|0|||
129826566|NCT02554812|467329153|FG003|Overall Study|Physician Decision|1|||
129826567|NCT02554812|467329154|FG004|Overall Study|Physician Decision|0|||
129826568|NCT02554812|467329155|FG005|Overall Study|Physician Decision|1|||
129826569|NCT02554812|467329156|FG006|Overall Study|Physician Decision|0|||
130060126|NCT00608530|468174655|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
129826570|NCT02554812|467329157|FG007|Overall Study|Physician Decision|0|||
129826571|NCT02554812|467329158|FG008|Overall Study|Physician Decision|0|||
129826572|NCT02554812|467329159|FG009|Overall Study|Physician Decision|0|||
129826573|NCT02554812|467329160|FG010|Overall Study|Physician Decision|1|||
129826574|NCT02554812|467329161|FG011|Overall Study|Physician Decision|0|||
129826575|NCT02554812|467329162|FG012|Overall Study|Physician Decision|0|||
129826576|NCT02554812|467329163|FG013|Overall Study|Physician Decision|0|||
129826577|NCT02554812|467329164|FG014|Overall Study|Physician Decision|0|||
129826578|NCT02554812|467329165|FG015|Overall Study|Physician Decision|0|||
129826579|NCT02554812|467329166|FG016|Overall Study|Physician Decision|1|||
129826580|NCT02554812|467329167|FG017|Overall Study|Physician Decision|1|||
129826581|NCT02554812|467329168|FG018|Overall Study|Physician Decision|0|||
129826582|NCT02554812|467329169|FG019|Overall Study|Physician Decision|1|||
129826583|NCT02554812|467329170|FG020|Overall Study|Physician Decision|1|||
129826584|NCT02554812|467329171|FG021|Overall Study|Physician Decision|0|||
130060127|NCT00608530|468174656|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
129826585|NCT02554812|467329172|FG022|Overall Study|Physician Decision|1|||
129826586|NCT02554812|467329173|FG023|Overall Study|Physician Decision|0|||
129826587|NCT02554812|467329174|FG024|Overall Study|Physician Decision|0|||
129826588|NCT02554812|467329175|FG025|Overall Study|Physician Decision|0|||
129826589|NCT02554812|467329176|FG026|Overall Study|Physician Decision|0|||
129826590|NCT02554812|467329150|FG000|Overall Study|Study terminated by sponsor|0|||
129826591|NCT02554812|467329151|FG001|Overall Study|Study terminated by sponsor|0|||
129826592|NCT02554812|467329152|FG002|Overall Study|Study terminated by sponsor|0|||
129826593|NCT02554812|467329153|FG003|Overall Study|Study terminated by sponsor|0|||
129826594|NCT02554812|467329154|FG004|Overall Study|Study terminated by sponsor|0|||
129826595|NCT02554812|467329155|FG005|Overall Study|Study terminated by sponsor|0|||
129826596|NCT02554812|467329156|FG006|Overall Study|Study terminated by sponsor|0|||
129826597|NCT02554812|467329157|FG007|Overall Study|Study terminated by sponsor|0|||
129826598|NCT02554812|467329158|FG008|Overall Study|Study terminated by sponsor|0|||
129826599|NCT02554812|467329159|FG009|Overall Study|Study terminated by sponsor|0|||
129826600|NCT02554812|467329160|FG010|Overall Study|Study terminated by sponsor|0|||
129826601|NCT02554812|467329161|FG011|Overall Study|Study terminated by sponsor|0|||
129826602|NCT02554812|467329162|FG012|Overall Study|Study terminated by sponsor|0|||
129826603|NCT02554812|467329163|FG013|Overall Study|Study terminated by sponsor|0|||
129826604|NCT02554812|467329164|FG014|Overall Study|Study terminated by sponsor|0|||
129826605|NCT02554812|467329165|FG015|Overall Study|Study terminated by sponsor|0|||
129826606|NCT02554812|467329166|FG016|Overall Study|Study terminated by sponsor|0|||
129826607|NCT02554812|467329167|FG017|Overall Study|Study terminated by sponsor|0|||
129826608|NCT02554812|467329168|FG018|Overall Study|Study terminated by sponsor|0|||
129826609|NCT02554812|467329169|FG019|Overall Study|Study terminated by sponsor|0|||
129826610|NCT02554812|467329170|FG020|Overall Study|Study terminated by sponsor|0|||
129826611|NCT02554812|467329171|FG021|Overall Study|Study terminated by sponsor|0|||
129826612|NCT02554812|467329172|FG022|Overall Study|Study terminated by sponsor|0|||
129826613|NCT02554812|467329173|FG023|Overall Study|Study terminated by sponsor|0|||
129826614|NCT02554812|467329174|FG024|Overall Study|Study terminated by sponsor|1|||
129826615|NCT02554812|467329175|FG025|Overall Study|Study terminated by sponsor|0|||
129826616|NCT02554812|467329176|FG026|Overall Study|Study terminated by sponsor|0|||
129826617|NCT02554812|467329150|FG000|Overall Study|No longer meets eligibility criteria|0|||
129826618|NCT02554812|467329151|FG001|Overall Study|No longer meets eligibility criteria|1|||
129826619|NCT02554812|467329152|FG002|Overall Study|No longer meets eligibility criteria|0|||
129826620|NCT02554812|467329153|FG003|Overall Study|No longer meets eligibility criteria|0|||
129826621|NCT02554812|467329154|FG004|Overall Study|No longer meets eligibility criteria|0|||
129826622|NCT02554812|467329155|FG005|Overall Study|No longer meets eligibility criteria|0|||
129826623|NCT02554812|467329156|FG006|Overall Study|No longer meets eligibility criteria|0|||
129826624|NCT02554812|467329157|FG007|Overall Study|No longer meets eligibility criteria|0|||
129826625|NCT02554812|467329158|FG008|Overall Study|No longer meets eligibility criteria|0|||
129826626|NCT02554812|467329159|FG009|Overall Study|No longer meets eligibility criteria|0|||
129826627|NCT02554812|467329160|FG010|Overall Study|No longer meets eligibility criteria|0|||
129826628|NCT02554812|467329161|FG011|Overall Study|No longer meets eligibility criteria|0|||
129826629|NCT02554812|467329162|FG012|Overall Study|No longer meets eligibility criteria|0|||
129826630|NCT02554812|467329163|FG013|Overall Study|No longer meets eligibility criteria|0|||
129826631|NCT02554812|467329164|FG014|Overall Study|No longer meets eligibility criteria|0|||
129826632|NCT02554812|467329165|FG015|Overall Study|No longer meets eligibility criteria|0|||
129826633|NCT02554812|467329166|FG016|Overall Study|No longer meets eligibility criteria|0|||
129826634|NCT02554812|467329167|FG017|Overall Study|No longer meets eligibility criteria|0|||
129826635|NCT02554812|467329168|FG018|Overall Study|No longer meets eligibility criteria|0|||
129826636|NCT02554812|467329169|FG019|Overall Study|No longer meets eligibility criteria|0|||
129826637|NCT02554812|467329170|FG020|Overall Study|No longer meets eligibility criteria|0|||
129826638|NCT02554812|467329171|FG021|Overall Study|No longer meets eligibility criteria|0|||
129826639|NCT02554812|467329172|FG022|Overall Study|No longer meets eligibility criteria|0|||
129826640|NCT02554812|467329173|FG023|Overall Study|No longer meets eligibility criteria|0|||
129826641|NCT02554812|467329174|FG024|Overall Study|No longer meets eligibility criteria|0|||
129826642|NCT02554812|467329175|FG025|Overall Study|No longer meets eligibility criteria|0|||
129826643|NCT02554812|467329176|FG026|Overall Study|No longer meets eligibility criteria|0|||
129826644|NCT02081690|467331356|FG000|Overall Study|Death|3|||
129826645|NCT02081690|467331356|FG000|Overall Study|Physician Decision|3|||
129826646|NCT02081690|467331356|FG000|Overall Study|Withdrawal by Subject|1|||
129826647|NCT03204981|467331358|FG000|Overall Study|Physician Decision|2|||
129826648|NCT03204981|467331358|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
129826649|NCT00312494|467331361|FG000|Overall Study|Randomized; not treated with study drug|9|||
129826650|NCT00312494|467331362|FG001|Overall Study|Randomized; not treated with study drug|10|||
129826651|NCT00312494|467331363|FG002|Overall Study|Randomized; not treated with study drug|5|||
129826652|NCT00312494|467331361|FG000|Overall Study|Adverse Event|33|||
129826653|NCT00312494|467331362|FG001|Overall Study|Adverse Event|15|||
129826654|NCT00312494|467331363|FG002|Overall Study|Adverse Event|11|||
129826655|NCT00312494|467331361|FG000|Overall Study|Lack of Efficacy|4|||
129826656|NCT00312494|467331362|FG001|Overall Study|Lack of Efficacy|6|||
130060128|NCT00608530|468174657|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
129826657|NCT00312494|467331363|FG002|Overall Study|Lack of Efficacy|8|||
129826658|NCT00312494|467331361|FG000|Overall Study|Laboratory abnormality|1|||
129826659|NCT00312494|467331362|FG001|Overall Study|Laboratory abnormality|0|||
129826660|NCT00312494|467331363|FG002|Overall Study|Laboratory abnormality|0|||
129826661|NCT00312494|467331361|FG000|Overall Study|Lost to Follow-up|8|||
129826662|NCT00312494|467331362|FG001|Overall Study|Lost to Follow-up|8|||
129826663|NCT00312494|467331363|FG002|Overall Study|Lost to Follow-up|8|||
129826664|NCT00312494|467331361|FG000|Overall Study|Withdrawal by Subject|6|||
129826665|NCT00312494|467331362|FG001|Overall Study|Withdrawal by Subject|9|||
129826666|NCT00312494|467331363|FG002|Overall Study|Withdrawal by Subject|10|||
129826667|NCT00312494|467331361|FG000|Overall Study|Other|10|||
129826668|NCT00312494|467331362|FG001|Overall Study|Other|10|||
129826669|NCT00312494|467331363|FG002|Overall Study|Other|1|||
129826670|NCT02734810|467331366|FG000|Overall Study|Adverse Event|1|||
129826671|NCT02734810|467331367|FG001|Overall Study|Adverse Event|0|||
129826672|NCT02734810|467331366|FG000|Overall Study|Lack of Efficacy|1|||
129826673|NCT02734810|467331367|FG001|Overall Study|Lack of Efficacy|0|||
129826674|NCT00488345|467331368|FG000|Overall Study|Adverse Event|0|||
129826675|NCT00488345|467331369|FG001|Overall Study|Adverse Event|1|||
129826676|NCT00488345|467331370|FG002|Overall Study|Adverse Event|1|||
129826677|NCT00488345|467331368|FG000|Overall Study|Unable to administer antibiotics at home|0|||
129826678|NCT00488345|467331369|FG001|Overall Study|Unable to administer antibiotics at home|1|||
129826679|NCT00488345|467331370|FG002|Overall Study|Unable to administer antibiotics at home|0|||
129826680|NCT00488345|467331368|FG000|Overall Study|Institutional Review Board review|0|||
129826681|NCT00488345|467331369|FG001|Overall Study|Institutional Review Board review|0|||
129826682|NCT00488345|467331370|FG002|Overall Study|Institutional Review Board review|1|||
129826683|NCT00488345|467331368|FG000|Overall Study|Surgical team recommendation|0|||
129826684|NCT00488345|467331369|FG001|Overall Study|Surgical team recommendation|1|||
129826685|NCT00488345|467331370|FG002|Overall Study|Surgical team recommendation|0|||
129826686|NCT00488345|467331368|FG000|Overall Study|Parent/legal guardian request|0|||
129826687|NCT00488345|467331369|FG001|Overall Study|Parent/legal guardian request|1|||
129826688|NCT00488345|467331370|FG002|Overall Study|Parent/legal guardian request|1|||
129826689|NCT00903617|467331376|FG000|Overall Study|Adverse Event|0|||
129826690|NCT00903617|467331377|FG001|Overall Study|Adverse Event|1|||
129826691|NCT00903617|467331378|FG002|Overall Study|Adverse Event|1|||
129826692|NCT00903617|467331379|FG003|Overall Study|Adverse Event|0|||
129826693|NCT00903617|467331376|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129826694|NCT00903617|467331377|FG001|Overall Study|Protocol-defined stopping criteria|2|||
129826695|NCT00903617|467331378|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129826696|NCT00903617|467331379|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129826697|NCT00903617|467331376|FG000|Overall Study|Lost to Follow-up|2|||
129826698|NCT00903617|467331377|FG001|Overall Study|Lost to Follow-up|0|||
129826699|NCT00903617|467331378|FG002|Overall Study|Lost to Follow-up|1|||
129826700|NCT00903617|467331379|FG003|Overall Study|Lost to Follow-up|1|||
129826701|NCT00903617|467331376|FG000|Overall Study|Withdrawal by Subject|1|||
129826702|NCT00903617|467331377|FG001|Overall Study|Withdrawal by Subject|2|||
129826703|NCT00903617|467331378|FG002|Overall Study|Withdrawal by Subject|3|||
129826704|NCT00903617|467331379|FG003|Overall Study|Withdrawal by Subject|0|||
129826705|NCT01104636|467331380|FG000|Overall Study|Lack of Efficacy|43|||
129826706|NCT01104636|467331380|FG000|Overall Study|Lost to Follow-up|24|||
129826707|NCT01104636|467331380|FG000|Overall Study|Withdrawal by Subject|4|||
129826708|NCT01104636|467331380|FG000|Overall Study|Other|43|||
129826709|NCT01104636|467331380|FG000|Overall Study|Study terminated by sponsor|1|||
129826710|NCT01104636|467331380|FG000|Overall Study|Pregnancy|2|||
129826711|NCT01104636|467331380|FG000|Overall Study|Adverse Event|40|||
129826712|NCT01104636|467331380|FG000|Overall Study|Ongoing|21|||
129826713|NCT01706003|467331381|FG000|Overall Study|Withdrawal by Subject|2|||
129826714|NCT01706003|467331382|FG001|Overall Study|Withdrawal by Subject|0|||
129826715|NCT01706003|467331381|FG000|Overall Study|Not scheduled|3|||
129826716|NCT01706003|467331382|FG001|Overall Study|Not scheduled|0|||
129826717|NCT01706003|467331381|FG000|Overall Study|Lost to Follow-up|6|||
130060129|NCT00608530|468174658|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
130060130|NCT00608530|468174655|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
130060131|NCT00608530|468174656|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
129826718|NCT01706003|467331382|FG001|Overall Study|Lost to Follow-up|4|||
129826719|NCT00407563|467331383|FG000|Overall Study|Patient continues on treatment|1|||
129826720|NCT03055260|467331384|FG000|Overall Study|Withdrawal by Subject|1|||
129826721|NCT03055260|467331385|FG001|Overall Study|Withdrawal by Subject|0|||
129826722|NCT00592839|467331386|FG000|Overall Study|Withdrawal by Subject|1|||
129826723|NCT00592839|467331387|FG001|Overall Study|Withdrawal by Subject|1|||
129826724|NCT00592839|467331388|FG002|Overall Study|Withdrawal by Subject|3|||
129826725|NCT00592839|467331386|FG000|Overall Study|Protocol Violation|1|||
129826726|NCT00592839|467331387|FG001|Overall Study|Protocol Violation|1|||
129826727|NCT00592839|467331388|FG002|Overall Study|Protocol Violation|2|||
129826728|NCT00592839|467331386|FG000|Overall Study|Adverse Event|0|||
129826729|NCT00592839|467331387|FG001|Overall Study|Adverse Event|1|||
129826730|NCT00592839|467331388|FG002|Overall Study|Adverse Event|0|||
129826731|NCT00592839|467331386|FG000|Overall Study|Lost to Follow-up|0|||
129826732|NCT00592839|467331387|FG001|Overall Study|Lost to Follow-up|1|||
129826733|NCT00592839|467331388|FG002|Overall Study|Lost to Follow-up|1|||
129826734|NCT00249444|467331394|FG000|Overall Study|Lost to Follow-up|2|||
129826735|NCT00249444|467331395|FG001|Overall Study|Lost to Follow-up|2|||
129826736|NCT00249444|467331394|FG000|Overall Study|non-compliant|9|||
129826737|NCT00249444|467331395|FG001|Overall Study|non-compliant|11|||
129826738|NCT00249444|467331394|FG000|Overall Study|Adverse Event|1|||
129826739|NCT00249444|467331395|FG001|Overall Study|Adverse Event|1|||
129826740|NCT00249444|467331394|FG000|Overall Study|life event|0|||
129826741|NCT00249444|467331395|FG001|Overall Study|life event|1|||
129826742|NCT00936910|467331398|FG000|Overall Study|Lack of Efficacy|3|||
129826743|NCT00412854|467331399|FG000|Overall Study|Withdrawn due to adverse events|1|||
129826744|NCT00412854|467331400|FG001|Overall Study|Withdrawn due to adverse events|5|||
129826745|NCT00412854|467331399|FG000|Overall Study|Withdrawn for other reasons|13|||
129826746|NCT00412854|467331400|FG001|Overall Study|Withdrawn for other reasons|11|||
129826747|NCT04483011|467331404|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
129826748|NCT04483011|467331405|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
129826749|NCT03518073|467331406|FG000|Overall Study|Adverse Event|2|||
129826750|NCT03518073|467331407|FG001|Overall Study|Adverse Event|4|||
129826751|NCT03518073|467331408|FG002|Overall Study|Adverse Event|2|||
129826752|NCT03518073|467331406|FG000|Overall Study|Death|2|||
129826753|NCT03518073|467331407|FG001|Overall Study|Death|1|||
129826754|NCT03518073|467331408|FG002|Overall Study|Death|3|||
129826755|NCT03518073|467331406|FG000|Overall Study|Lost to Follow-up|1|||
129826756|NCT03518073|467331407|FG001|Overall Study|Lost to Follow-up|0|||
129826757|NCT03518073|467331408|FG002|Overall Study|Lost to Follow-up|1|||
129826758|NCT03518073|467331406|FG000|Overall Study|Physician Decision|5|||
129826759|NCT03518073|467331407|FG001|Overall Study|Physician Decision|0|||
129826760|NCT03518073|467331408|FG002|Overall Study|Physician Decision|2|||
129826761|NCT03518073|467331406|FG000|Overall Study|Progressive disease|1|||
129826762|NCT03518073|467331407|FG001|Overall Study|Progressive disease|1|||
129826763|NCT03518073|467331408|FG002|Overall Study|Progressive disease|1|||
129826764|NCT03518073|467331406|FG000|Overall Study|Protocol Violation|1|||
129826765|NCT03518073|467331407|FG001|Overall Study|Protocol Violation|0|||
129826766|NCT03518073|467331408|FG002|Overall Study|Protocol Violation|0|||
129826767|NCT03518073|467331406|FG000|Overall Study|Withdrawal by Subject|30|||
129826768|NCT03518073|467331407|FG001|Overall Study|Withdrawal by Subject|34|||
129826769|NCT03518073|467331408|FG002|Overall Study|Withdrawal by Subject|29|||
129826770|NCT03518073|467331406|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
129826771|NCT03518073|467331407|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
129826772|NCT03518073|467331408|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
129826773|NCT03518073|467331406|FG000|Overall Study|Covid-19|1|||
129826774|NCT03518073|467331407|FG001|Overall Study|Covid-19|2|||
129826775|NCT03518073|467331408|FG002|Overall Study|Covid-19|1|||
129826776|NCT03045081|467331409|FG000|Overall Study|Withdrawal by Subject|6|||
129826777|NCT03045081|467331410|FG001|Overall Study|Withdrawal by Subject|11|||
129826778|NCT01485640|467331411|FG000|Overall Study|Adverse Event|10|||
129826779|NCT01485640|467331411|FG000|Overall Study|Lack of Efficacy|2|||
129826780|NCT01485640|467331411|FG000|Overall Study|Protocol Violation|1|||
129826781|NCT01485640|467331411|FG000|Overall Study|Withdrawal by Subject|14|||
129826782|NCT01485640|467331411|FG000|Overall Study|Terminated by Sponsor|95|||
129826783|NCT01853046|467331412|FG000|Overall Study|Withdrawal by Subject|1|||
129826784|NCT01853046|467331413|FG001|Overall Study|Withdrawal by Subject|1|||
129826785|NCT01853046|467331412|FG000|Overall Study|Adverse Event|4|||
129826786|NCT01853046|467331413|FG001|Overall Study|Adverse Event|2|||
129826787|NCT01853046|467331412|FG000|Overall Study|Disease progression|13|||
129826788|NCT01853046|467331413|FG001|Overall Study|Disease progression|3|||
129826789|NCT02057198|467331421|FG000|Overall Study|Death|0|||
129826790|NCT02057198|467331422|FG001|Overall Study|Death|0|||
129826791|NCT02057198|467331423|FG002|Overall Study|Death|1|||
129826792|NCT02057198|467331421|FG000|Overall Study|Discharged early; lost to followup|0|||
129826793|NCT02057198|467331422|FG001|Overall Study|Discharged early; lost to followup|1|||
129826794|NCT02057198|467331423|FG002|Overall Study|Discharged early; lost to followup|0|||
129826795|NCT02489344|467331426|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
129826796|NCT02489344|467331426|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
129826797|NCT02489344|467331426|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
129826798|NCT02489344|467331426|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
129826799|NCT00546637|467331429|FG000|Overall Study|Adverse Event|46|||
129826800|NCT00546637|467331430|FG001|Overall Study|Adverse Event|20|||
129826801|NCT00546637|467331429|FG000|Overall Study|Lack of Efficacy|5|||
129826802|NCT00546637|467331430|FG001|Overall Study|Lack of Efficacy|5|||
129826803|NCT00546637|467331429|FG000|Overall Study|Lost to Follow-up|2|||
129826804|NCT00546637|467331430|FG001|Overall Study|Lost to Follow-up|2|||
129826805|NCT00546637|467331429|FG000|Overall Study|Other|10|||
129826806|NCT00546637|467331430|FG001|Overall Study|Other|12|||
129826807|NCT00546637|467331429|FG000|Overall Study|Withdrawal by Subject|7|||
129826808|NCT00546637|467331430|FG001|Overall Study|Withdrawal by Subject|9|||
129826809|NCT00546637|467331429|FG000|Overall Study|Randomized, but not treated|3|||
129826810|NCT00546637|467331430|FG001|Overall Study|Randomized, but not treated|1|||
129826811|NCT01074450|467331431|FG000|First Intervention|Emesis in Dosing Interval|0|||
129826812|NCT01074450|467331432|FG001|First Intervention|Emesis in Dosing Interval|2|||
129826813|NCT01074450|467331431|FG000|Second Intervention|Protocol Violation|1|||
129826814|NCT01074450|467331432|FG001|Second Intervention|Protocol Violation|0|||
129826815|NCT01074450|467331431|FG000|Second Intervention|Physician Decision|0|||
129826816|NCT01074450|467331432|FG001|Second Intervention|Physician Decision|1|||
129826817|NCT02968563|467331437|FG000|Overall Study|Adverse Event|0|||
129826818|NCT02968563|467331438|FG001|Overall Study|Adverse Event|6|||
129826819|NCT02968563|467331437|FG000|Overall Study|Death|1|||
129826820|NCT02968563|467331438|FG001|Overall Study|Death|1|||
129826821|NCT02968563|467331437|FG000|Overall Study|Lost to Follow-up|0|||
129826822|NCT02968563|467331438|FG001|Overall Study|Lost to Follow-up|1|||
129826823|NCT03178773|467331439|FG000|Overall Study|Death|0|||
129826824|NCT03178773|467331440|FG001|Overall Study|Death|1|||
129826825|NCT03178773|467331439|FG000|Overall Study|Lost to Follow-up|29|||
129826826|NCT03178773|467331440|FG001|Overall Study|Lost to Follow-up|25|||
129826827|NCT03178773|467331439|FG000|Overall Study|Withdrawal by Subject|10|||
129826828|NCT03178773|467331440|FG001|Overall Study|Withdrawal by Subject|14|||
129826829|NCT02604212|467331447|FG000|Overall Study|Study Terminated by Sponsor|2|||
129826830|NCT02604212|467331448|FG001|Overall Study|Study Terminated by Sponsor|1|||
129826831|NCT02604212|467331449|FG002|Overall Study|Study Terminated by Sponsor|3|||
129826832|NCT02604212|467331450|FG003|Overall Study|Study Terminated by Sponsor|3|||
129826833|NCT02604212|467331447|FG000|Overall Study|Withdrawal by Subject|0|||
129826834|NCT02604212|467331448|FG001|Overall Study|Withdrawal by Subject|0|||
129826835|NCT02604212|467331449|FG002|Overall Study|Withdrawal by Subject|1|||
129826836|NCT02604212|467331450|FG003|Overall Study|Withdrawal by Subject|0|||
129826837|NCT01119131|467331451|FG000|Overall Study|Adverse Event|1|||
129826838|NCT01119131|467331452|FG001|Overall Study|Adverse Event|1|||
129826839|NCT01119131|467331453|FG002|Overall Study|Adverse Event|1|||
129826840|NCT01119131|467331451|FG000|Overall Study|Non-Compliance|1|||
129826841|NCT01119131|467331452|FG001|Overall Study|Non-Compliance|0|||
129826842|NCT01119131|467331453|FG002|Overall Study|Non-Compliance|4|||
129826843|NCT01119131|467331451|FG000|Overall Study|Physician Decision|0|||
129826844|NCT01119131|467331452|FG001|Overall Study|Physician Decision|0|||
129826845|NCT01119131|467331453|FG002|Overall Study|Physician Decision|1|||
129826846|NCT00909389|467331456|FG000|Overall Study|Adverse Event|6|||
129826847|NCT00909389|467331456|FG000|Overall Study|Death|4|||
129826848|NCT00909389|467331456|FG000|Overall Study|Poor Compliance|16|||
129826849|NCT00909389|467331456|FG000|Overall Study|Lost to Follow-up|4|||
129826850|NCT00909389|467331456|FG000|Overall Study|No Information|103|||
129826851|NCT00003492|467331457|FG000|Overall Study|Not evaluable|6|||
129826852|NCT00597766|467331460|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
129826853|NCT00597766|467331461|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
129826854|NCT00597766|467331462|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
129826855|NCT00597766|467331460|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
129826856|NCT00597766|467331461|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
129826857|NCT00597766|467331462|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
129826858|NCT00737282|467331464|FG000|Overall Study|Study prematurely terminated|175|||
129826859|NCT02810392|467331466|FG000|Overall Study|Subject too ill to continue|1|||
129826860|NCT02810392|467331467|FG001|Overall Study|Subject too ill to continue|0|||
129826861|NCT02810392|467331466|FG000|Overall Study|COVID 19 research restrictions|0|||
129826862|NCT02810392|467331467|FG001|Overall Study|COVID 19 research restrictions|1|||
129826863|NCT00840294|467331468|FG000|Overall Study|Withdrawal by Subject|2|||
129826864|NCT00840294|467331469|FG001|Overall Study|Withdrawal by Subject|1|||
129826865|NCT00840294|467331468|FG000|Overall Study|Protocol Violation|1|||
129826866|NCT00840294|467331469|FG001|Overall Study|Protocol Violation|3|||
129826867|NCT00840294|467331468|FG000|Overall Study|Illness|0|||
129826868|NCT00840294|467331469|FG001|Overall Study|Illness|1|||
129826869|NCT00453544|467331472|FG000|Overall Study|Withdrawal by Subject|1|||
129826870|NCT00453544|467331473|FG001|Overall Study|Withdrawal by Subject|0|||
129826871|NCT00453544|467331474|FG002|Overall Study|Withdrawal by Subject|0|||
129826872|NCT00453544|467331475|FG003|Overall Study|Withdrawal by Subject|0|||
129826873|NCT00453544|467331472|FG000|Overall Study|Primary outcome measure not completed|1|||
129826874|NCT00453544|467331473|FG001|Overall Study|Primary outcome measure not completed|1|||
129826875|NCT00453544|467331474|FG002|Overall Study|Primary outcome measure not completed|0|||
129826876|NCT00453544|467331475|FG003|Overall Study|Primary outcome measure not completed|1|||
129826877|NCT02457910|467331476|FG000|Overall Study|Withdrawal by Subject|0|||
129826878|NCT02457910|467331477|FG001|Overall Study|Withdrawal by Subject|0|||
129826879|NCT02457910|467331478|FG002|Overall Study|Withdrawal by Subject|0|||
129826880|NCT02457910|467331479|FG003|Overall Study|Withdrawal by Subject|0|||
129826881|NCT02457910|467331480|FG004|Overall Study|Withdrawal by Subject|0|||
129826882|NCT02457910|467331481|FG005|Overall Study|Withdrawal by Subject|1|||
129826883|NCT02457910|467331476|FG000|Overall Study|Adverse Event|0|||
129826884|NCT02457910|467331477|FG001|Overall Study|Adverse Event|2|||
129826885|NCT02457910|467331478|FG002|Overall Study|Adverse Event|1|||
129826886|NCT02457910|467331479|FG003|Overall Study|Adverse Event|1|||
129826887|NCT02457910|467331480|FG004|Overall Study|Adverse Event|1|||
129826888|NCT02457910|467331481|FG005|Overall Study|Adverse Event|3|||
129826889|NCT02457910|467331476|FG000|Overall Study|Disease progression|3|||
129826890|NCT02457910|467331477|FG001|Overall Study|Disease progression|3|||
129826891|NCT02457910|467331478|FG002|Overall Study|Disease progression|1|||
129826892|NCT02457910|467331479|FG003|Overall Study|Disease progression|1|||
129826893|NCT02457910|467331480|FG004|Overall Study|Disease progression|4|||
129826894|NCT02457910|467331481|FG005|Overall Study|Disease progression|6|||
129826895|NCT02457910|467331476|FG000|Overall Study|Other complicating illness|0|||
129826896|NCT02457910|467331477|FG001|Overall Study|Other complicating illness|0|||
129826897|NCT02457910|467331478|FG002|Overall Study|Other complicating illness|0|||
129826898|NCT02457910|467331479|FG003|Overall Study|Other complicating illness|0|||
129826899|NCT02457910|467331480|FG004|Overall Study|Other complicating illness|0|||
129826900|NCT02457910|467331481|FG005|Overall Study|Other complicating illness|1|||
129826901|NCT02457910|467331476|FG000|Overall Study|Death|0|||
129826902|NCT02457910|467331477|FG001|Overall Study|Death|0|||
129826903|NCT02457910|467331478|FG002|Overall Study|Death|1|||
129826904|NCT02457910|467331479|FG003|Overall Study|Death|0|||
129826905|NCT02457910|467331480|FG004|Overall Study|Death|0|||
129826906|NCT02457910|467331481|FG005|Overall Study|Death|0|||
129826907|NCT00619801|467331482|FG000|Overall Study|Lack of Efficacy|0|||
129826908|NCT00619801|467331483|FG001|Overall Study|Lack of Efficacy|1|||
129826909|NCT00619801|467331482|FG000|Overall Study|Withdrawal by Subject|1|||
129826910|NCT00619801|467331483|FG001|Overall Study|Withdrawal by Subject|1|||
129826911|NCT00619801|467331482|FG000|Overall Study|Loss of efficacy|0|||
129826912|NCT00619801|467331483|FG001|Overall Study|Loss of efficacy|1|||
129826913|NCT03721276|467331486|FG000|Overall Study|Lost to Follow-up|5|||
129826914|NCT03721276|467331487|FG001|Overall Study|Lost to Follow-up|3|||
129826915|NCT03721276|467331486|FG000|Overall Study|Adverse Event|0|||
129826916|NCT03721276|467331487|FG001|Overall Study|Adverse Event|1|||
129826917|NCT01340898|467331488|FG000|Primary Phase|Serious Adverse Events|0|||
129826918|NCT01340898|467331489|FG001|Primary Phase|Serious Adverse Events|0|||
129826919|NCT01340898|467331490|FG002|Primary Phase|Serious Adverse Events|1|||
129826920|NCT01340898|467331488|FG000|Primary Phase|Withdrawal by Subject|8|||
129826921|NCT01340898|467331489|FG001|Primary Phase|Withdrawal by Subject|7|||
129826922|NCT01340898|467331490|FG002|Primary Phase|Withdrawal by Subject|5|||
129826923|NCT01340898|467331488|FG000|Primary Phase|Migrated/moved from study area|4|||
129826924|NCT01340898|467331489|FG001|Primary Phase|Migrated/moved from study area|1|||
129826925|NCT01340898|467331490|FG002|Primary Phase|Migrated/moved from study area|0|||
129826926|NCT01340898|467331488|FG000|Primary Phase|Lost to Follow-up|4|||
129826927|NCT01340898|467331489|FG001|Primary Phase|Lost to Follow-up|1|||
129826928|NCT01340898|467331490|FG002|Primary Phase|Lost to Follow-up|0|||
129826929|NCT01340898|467331488|FG000|Booster Phase|Withdrawal by Subject|3|||
129826930|NCT01340898|467331489|FG001|Booster Phase|Withdrawal by Subject|0|||
129826931|NCT01340898|467331490|FG002|Booster Phase|Withdrawal by Subject|4|||
129826932|NCT01340898|467331488|FG000|Booster Phase|Migrated/moved from study area|3|||
129826933|NCT01340898|467331489|FG001|Booster Phase|Migrated/moved from study area|0|||
129826934|NCT01340898|467331490|FG002|Booster Phase|Migrated/moved from study area|0|||
129826935|NCT01340898|467331488|FG000|Booster Phase|Lost to Follow-up|4|||
129826936|NCT01340898|467331489|FG001|Booster Phase|Lost to Follow-up|2|||
129826937|NCT01340898|467331490|FG002|Booster Phase|Lost to Follow-up|3|||
129826938|NCT01214629|467331492|FG000|Overall Study|Progressive Disease|1|||
129826939|NCT01214629|467331493|FG001|Overall Study|Progressive Disease|1|||
129826940|NCT01214629|467331494|FG002|Overall Study|Progressive Disease|0|||
129826941|NCT01214629|467331495|FG003|Overall Study|Progressive Disease|1|||
129826942|NCT01214629|467331496|FG004|Overall Study|Progressive Disease|2|||
129826943|NCT01214629|467331497|FG005|Overall Study|Progressive Disease|3|||
129826944|NCT01214629|467331498|FG006|Overall Study|Progressive Disease|1|||
129826945|NCT01214629|467331499|FG007|Overall Study|Progressive Disease|1|||
129826946|NCT01214629|467331500|FG008|Overall Study|Progressive Disease|1|||
129826947|NCT01214629|467331501|FG009|Overall Study|Progressive Disease|5|||
129826948|NCT01214629|467331502|FG010|Overall Study|Progressive Disease|1|||
129826949|NCT01214629|467331492|FG000|Overall Study|Adverse Event|0|||
129826950|NCT01214629|467331493|FG001|Overall Study|Adverse Event|0|||
129826951|NCT01214629|467331494|FG002|Overall Study|Adverse Event|0|||
129826952|NCT01214629|467331495|FG003|Overall Study|Adverse Event|1|||
129826953|NCT01214629|467331496|FG004|Overall Study|Adverse Event|0|||
129826954|NCT01214629|467331497|FG005|Overall Study|Adverse Event|1|||
129826955|NCT01214629|467331498|FG006|Overall Study|Adverse Event|0|||
129826956|NCT01214629|467331499|FG007|Overall Study|Adverse Event|0|||
129826957|NCT01214629|467331500|FG008|Overall Study|Adverse Event|0|||
129826958|NCT01214629|467331501|FG009|Overall Study|Adverse Event|1|||
129826959|NCT01214629|467331502|FG010|Overall Study|Adverse Event|0|||
129826960|NCT01214629|467331492|FG000|Overall Study|Physician Decision|0|||
129826961|NCT01214629|467331493|FG001|Overall Study|Physician Decision|0|||
129826962|NCT01214629|467331494|FG002|Overall Study|Physician Decision|0|||
129826963|NCT01214629|467331495|FG003|Overall Study|Physician Decision|0|||
129826964|NCT01214629|467331496|FG004|Overall Study|Physician Decision|0|||
129826965|NCT01214629|467331497|FG005|Overall Study|Physician Decision|0|||
129826966|NCT01214629|467331498|FG006|Overall Study|Physician Decision|0|||
130060132|NCT00608530|468174657|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
130060133|NCT00608530|468174658|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
129826967|NCT01214629|467331499|FG007|Overall Study|Physician Decision|0|||
129826968|NCT01214629|467331500|FG008|Overall Study|Physician Decision|0|||
129826969|NCT01214629|467331501|FG009|Overall Study|Physician Decision|0|||
129826970|NCT01214629|467331502|FG010|Overall Study|Physician Decision|1|||
129826971|NCT01214629|467331492|FG000|Overall Study|Withdrawal by Subject|0|||
129826972|NCT01214629|467331493|FG001|Overall Study|Withdrawal by Subject|0|||
129826973|NCT01214629|467331494|FG002|Overall Study|Withdrawal by Subject|0|||
129826974|NCT01214629|467331495|FG003|Overall Study|Withdrawal by Subject|0|||
129826975|NCT01214629|467331496|FG004|Overall Study|Withdrawal by Subject|0|||
129826976|NCT01214629|467331497|FG005|Overall Study|Withdrawal by Subject|0|||
129826977|NCT01214629|467331498|FG006|Overall Study|Withdrawal by Subject|0|||
129826978|NCT01214629|467331499|FG007|Overall Study|Withdrawal by Subject|0|||
129826979|NCT01214629|467331500|FG008|Overall Study|Withdrawal by Subject|0|||
129826980|NCT01214629|467331501|FG009|Overall Study|Withdrawal by Subject|1|||
129826981|NCT01214629|467331502|FG010|Overall Study|Withdrawal by Subject|0|||
129826982|NCT01829230|467331503|FG000|Overall Study|Protocol Violation|0|||
129826983|NCT01829230|467331504|FG001|Overall Study|Protocol Violation|2|||
129826984|NCT01829230|467331503|FG000|Overall Study|Withdrawal by Subject|0|||
129826985|NCT01829230|467331504|FG001|Overall Study|Withdrawal by Subject|1|||
129826986|NCT01829230|467331503|FG000|Overall Study|Lost to Follow-up|1|||
129826987|NCT01829230|467331504|FG001|Overall Study|Lost to Follow-up|1|||
129826988|NCT04501666|467331505|FG000|Overall Study|Physician Decision|0|||
129826989|NCT04501666|467331506|FG001|Overall Study|Physician Decision|1|||
129826990|NCT04501666|467331505|FG000|Overall Study|Adverse Event|12|||
129826991|NCT04501666|467331506|FG001|Overall Study|Adverse Event|4|||
129826992|NCT04501666|467331505|FG000|Overall Study|Subject's request|10|||
129826993|NCT04501666|467331506|FG001|Overall Study|Subject's request|6|||
129826994|NCT04501666|467331505|FG000|Overall Study|Protocol Deviation|2|||
129826995|NCT04501666|467331506|FG001|Overall Study|Protocol Deviation|1|||
129826996|NCT04501666|467331505|FG000|Overall Study|Other-- site permanently closing|0|||
129826997|NCT04501666|467331506|FG001|Overall Study|Other-- site permanently closing|1|||
129826998|NCT03021265|467331507|FG000|Overall Study|Adverse Event|29|||
129826999|NCT03021265|467331507|FG000|Overall Study|Lack of Efficacy|3|||
129827000|NCT03021265|467331507|FG000|Overall Study|Improved|17|||
129827001|NCT03021265|467331507|FG000|Overall Study|Lost to Follow-up|67|||
129827002|NCT03021265|467331507|FG000|Overall Study|No reason given|2|||
129827003|NCT03021265|467331507|FG000|Overall Study|No visit since the first visit|4|||
129827004|NCT01338493|467331508|FG000|Enrolled|Withdrawal by Subject|1|||
129827005|NCT01338493|467331508|FG000|Enrolled|Patient not implanted|4|||
129827006|NCT01338493|467331508|FG000|Discharge|Death|1|||
129827007|NCT01338493|467331508|FG000|Discharge|Missed visit|1|||
129827008|NCT01338493|467331508|FG000|6 Months Follow up|Lost to Follow-up|11|||
129827009|NCT01338493|467331508|FG000|6 Months Follow up|Missed visit|8|||
129827010|NCT01338493|467331508|FG000|12 Months Follow up|Lost to Follow-up|9|||
129827011|NCT00642941|467331509|FG000|Overall Study|Physician Decision|3|||
129827012|NCT00642941|467331510|FG001|Overall Study|Physician Decision|1|||
129827013|NCT00642941|467331511|FG002|Overall Study|Physician Decision|0|||
130060134|NCT01357915|468174659|FG000|Overall Study|Lost to Follow-up|3|||
130060135|NCT01357915|468174660|FG001|Overall Study|Lost to Follow-up|0|||
130060136|NCT01019486|468174661|FG000|Overall Study|Withdrawal by Subject|1|||
130060137|NCT01019486|468174662|FG001|Overall Study|Withdrawal by Subject|1|||
130060138|NCT01019486|468174663|FG002|Overall Study|Withdrawal by Subject|1|||
130060139|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
130060140|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
130060141|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Death|2|||
130060142|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Death|1|||
130060143|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
130112654|NCT00910858|468373432|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
130112655|NCT00910858|468373433|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
129827014|NCT00642941|467331512|FG003|Overall Study|Physician Decision|0|||
129827015|NCT00642941|467331513|FG004|Overall Study|Physician Decision|0|||
129827016|NCT00642941|467331514|FG005|Overall Study|Physician Decision|0|||
129827017|NCT00642941|467331515|FG006|Overall Study|Physician Decision|1|||
129827018|NCT00642941|467331516|FG007|Overall Study|Physician Decision|0|||
129827019|NCT00642941|467331517|FG008|Overall Study|Physician Decision|0|||
129827020|NCT00642941|467331518|FG009|Overall Study|Physician Decision|1|||
129827021|NCT00642941|467331519|FG010|Overall Study|Physician Decision|0|||
129827022|NCT00642941|467331520|FG011|Overall Study|Physician Decision|1|||
129827023|NCT00642941|467331509|FG000|Overall Study|Death|4|||
129827024|NCT00642941|467331510|FG001|Overall Study|Death|0|||
129827025|NCT00642941|467331511|FG002|Overall Study|Death|1|||
129827026|NCT00642941|467331512|FG003|Overall Study|Death|1|||
129827027|NCT00642941|467331513|FG004|Overall Study|Death|2|||
129827028|NCT00642941|467331514|FG005|Overall Study|Death|1|||
129827029|NCT00642941|467331515|FG006|Overall Study|Death|0|||
129827030|NCT00642941|467331516|FG007|Overall Study|Death|0|||
129827031|NCT00642941|467331517|FG008|Overall Study|Death|0|||
129827032|NCT00642941|467331518|FG009|Overall Study|Death|0|||
129827033|NCT00642941|467331519|FG010|Overall Study|Death|0|||
129827034|NCT00642941|467331520|FG011|Overall Study|Death|1|||
129827035|NCT00642941|467331509|FG000|Overall Study|Study closed by Sponsor|0|||
129827036|NCT00642941|467331510|FG001|Overall Study|Study closed by Sponsor|1|||
129827037|NCT00642941|467331511|FG002|Overall Study|Study closed by Sponsor|0|||
129827038|NCT00642941|467331512|FG003|Overall Study|Study closed by Sponsor|0|||
129827039|NCT00642941|467331513|FG004|Overall Study|Study closed by Sponsor|0|||
129827040|NCT00642941|467331514|FG005|Overall Study|Study closed by Sponsor|0|||
129827041|NCT00642941|467331515|FG006|Overall Study|Study closed by Sponsor|0|||
129827042|NCT00642941|467331516|FG007|Overall Study|Study closed by Sponsor|0|||
129827043|NCT00642941|467331517|FG008|Overall Study|Study closed by Sponsor|0|||
129827044|NCT00642941|467331518|FG009|Overall Study|Study closed by Sponsor|0|||
129827045|NCT00642941|467331519|FG010|Overall Study|Study closed by Sponsor|0|||
129827046|NCT00642941|467331520|FG011|Overall Study|Study closed by Sponsor|0|||
129827047|NCT00642941|467331509|FG000|Overall Study|Withdrawal by Subject|1|||
129827048|NCT00642941|467331510|FG001|Overall Study|Withdrawal by Subject|0|||
129827049|NCT00642941|467331511|FG002|Overall Study|Withdrawal by Subject|0|||
129827050|NCT00642941|467331512|FG003|Overall Study|Withdrawal by Subject|2|||
129827051|NCT00642941|467331513|FG004|Overall Study|Withdrawal by Subject|0|||
129827052|NCT00642941|467331514|FG005|Overall Study|Withdrawal by Subject|0|||
129827053|NCT00642941|467331515|FG006|Overall Study|Withdrawal by Subject|2|||
129827054|NCT00642941|467331516|FG007|Overall Study|Withdrawal by Subject|0|||
129827055|NCT00642941|467331517|FG008|Overall Study|Withdrawal by Subject|1|||
129827056|NCT00642941|467331518|FG009|Overall Study|Withdrawal by Subject|0|||
129827057|NCT00642941|467331519|FG010|Overall Study|Withdrawal by Subject|0|||
129827058|NCT00642941|467331520|FG011|Overall Study|Withdrawal by Subject|1|||
129827059|NCT00642941|467331509|FG000|Overall Study|Protocol Violation|0|||
129827060|NCT00642941|467331510|FG001|Overall Study|Protocol Violation|0|||
129827061|NCT00642941|467331511|FG002|Overall Study|Protocol Violation|0|||
129827062|NCT00642941|467331512|FG003|Overall Study|Protocol Violation|0|||
129827063|NCT00642941|467331513|FG004|Overall Study|Protocol Violation|0|||
129827064|NCT00642941|467331514|FG005|Overall Study|Protocol Violation|0|||
129827065|NCT00642941|467331515|FG006|Overall Study|Protocol Violation|1|||
129827066|NCT00642941|467331516|FG007|Overall Study|Protocol Violation|0|||
129827067|NCT00642941|467331517|FG008|Overall Study|Protocol Violation|0|||
129827068|NCT00642941|467331518|FG009|Overall Study|Protocol Violation|0|||
129827069|NCT00642941|467331519|FG010|Overall Study|Protocol Violation|0|||
129827070|NCT00642941|467331520|FG011|Overall Study|Protocol Violation|0|||
129827071|NCT00642941|467331509|FG000|Overall Study|Adverse Event|1|||
129827072|NCT00642941|467331510|FG001|Overall Study|Adverse Event|1|||
129827073|NCT00642941|467331511|FG002|Overall Study|Adverse Event|0|||
129827074|NCT00642941|467331512|FG003|Overall Study|Adverse Event|0|||
129827075|NCT00642941|467331513|FG004|Overall Study|Adverse Event|0|||
129827076|NCT00642941|467331514|FG005|Overall Study|Adverse Event|0|||
129827077|NCT00642941|467331515|FG006|Overall Study|Adverse Event|1|||
129827078|NCT00642941|467331516|FG007|Overall Study|Adverse Event|1|||
129827079|NCT00642941|467331517|FG008|Overall Study|Adverse Event|0|||
129827080|NCT00642941|467331518|FG009|Overall Study|Adverse Event|1|||
129827081|NCT00642941|467331519|FG010|Overall Study|Adverse Event|0|||
129827082|NCT00642941|467331520|FG011|Overall Study|Adverse Event|0|||
129827083|NCT00642941|467331509|FG000|Overall Study|Other|1|||
129827084|NCT00642941|467331510|FG001|Overall Study|Other|1|||
129827085|NCT00642941|467331511|FG002|Overall Study|Other|1|||
129897659|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897660|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
129897661|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
130112656|NCT00910858|468373434|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
129897662|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
130112657|NCT00910858|468373432|FG000|Monotherapy Phase|Protocol Violation|1|||
130112658|NCT00910858|468373433|FG001|Monotherapy Phase|Protocol Violation|0|||
129827086|NCT00642941|467331512|FG003|Overall Study|Other|1|||
129827087|NCT00642941|467331513|FG004|Overall Study|Other|0|||
129827088|NCT00642941|467331514|FG005|Overall Study|Other|1|||
129827089|NCT00642941|467331515|FG006|Overall Study|Other|0|||
129827090|NCT00642941|467331516|FG007|Overall Study|Other|1|||
129827091|NCT00642941|467331517|FG008|Overall Study|Other|0|||
129827092|NCT00642941|467331518|FG009|Overall Study|Other|0|||
129827093|NCT00642941|467331519|FG010|Overall Study|Other|0|||
129827094|NCT00642941|467331520|FG011|Overall Study|Other|1|||
129827095|NCT00642941|467331509|FG000|Overall Study|Disease progression|60|||
129827096|NCT00642941|467331510|FG001|Overall Study|Disease progression|50|||
129827097|NCT00642941|467331511|FG002|Overall Study|Disease progression|5|||
129827098|NCT00642941|467331512|FG003|Overall Study|Disease progression|36|||
129827099|NCT00642941|467331513|FG004|Overall Study|Disease progression|23|||
129897663|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897664|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897665|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
130060144|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
129827100|NCT00642941|467331514|FG005|Overall Study|Disease progression|39|||
129827101|NCT00642941|467331515|FG006|Overall Study|Disease progression|18|||
129827102|NCT00642941|467331516|FG007|Overall Study|Disease progression|12|||
129827103|NCT00642941|467331517|FG008|Overall Study|Disease progression|10|||
129827104|NCT00642941|467331518|FG009|Overall Study|Disease progression|7|||
129827105|NCT00642941|467331519|FG010|Overall Study|Disease progression|12|||
129827106|NCT00642941|467331520|FG011|Overall Study|Disease progression|7|||
129827107|NCT00656474|467331521|FG000|Overall Study|Other Reason|1|||
129827108|NCT01614067|467331523|FG000|Overall Study|Pregnancy|1|||
129827109|NCT01614067|467331524|FG001|Overall Study|Pregnancy|0|||
129827110|NCT01614067|467331523|FG000|Overall Study|Physician Decision|6|||
129827111|NCT01614067|467331524|FG001|Overall Study|Physician Decision|5|||
129827112|NCT01614067|467331523|FG000|Overall Study|Withdrawal by Subject|0|||
129827113|NCT01614067|467331524|FG001|Overall Study|Withdrawal by Subject|1|||
129827114|NCT01614067|467331523|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
129827115|NCT01614067|467331524|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
129827116|NCT00056407|467331525|FG000|Overall Study|Adverse Event|282|||
129827117|NCT00056407|467331526|FG001|Overall Study|Adverse Event|364|||
129827118|NCT00056407|467331525|FG000|Overall Study|Withdrawal by Subject|377|||
129827119|NCT00056407|467331526|FG001|Overall Study|Withdrawal by Subject|361|||
129827120|NCT00056407|467331525|FG000|Overall Study|Lost to Follow-up|123|||
129827121|NCT00056407|467331526|FG001|Overall Study|Lost to Follow-up|113|||
129827122|NCT00056407|467331525|FG000|Overall Study|Protocol Violation|104|||
129827123|NCT00056407|467331526|FG001|Overall Study|Protocol Violation|95|||
129827124|NCT00056407|467331525|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
129827125|NCT00056407|467331526|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
129827126|NCT00056407|467331525|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
129827127|NCT00056407|467331526|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
129827128|NCT00056407|467331525|FG000|Overall Study|Missing|25|||
129827129|NCT00056407|467331526|FG001|Overall Study|Missing|34|||
129827130|NCT00616655|467331527|FG000|Overall Study|Adverse Event|10|||
129827131|NCT00616655|467331528|FG001|Overall Study|Adverse Event|7|||
129827132|NCT00616655|467331529|FG002|Overall Study|Adverse Event|12|||
129827133|NCT00616655|467331527|FG000|Overall Study|Lack of Efficacy|5|||
129827134|NCT00616655|467331528|FG001|Overall Study|Lack of Efficacy|5|||
129827135|NCT00616655|467331529|FG002|Overall Study|Lack of Efficacy|5|||
129827136|NCT00616655|467331527|FG000|Overall Study|Lost to Follow-up|3|||
129827137|NCT00616655|467331528|FG001|Overall Study|Lost to Follow-up|12|||
129827138|NCT00616655|467331529|FG002|Overall Study|Lost to Follow-up|10|||
129827139|NCT00616655|467331527|FG000|Overall Study|Protocol Violation|2|||
129827140|NCT00616655|467331528|FG001|Overall Study|Protocol Violation|4|||
129827141|NCT00616655|467331529|FG002|Overall Study|Protocol Violation|3|||
129827142|NCT00616655|467331527|FG000|Overall Study|Withdrawal by Subject|9|||
129827143|NCT00616655|467331528|FG001|Overall Study|Withdrawal by Subject|7|||
129827144|NCT00616655|467331529|FG002|Overall Study|Withdrawal by Subject|11|||
129827145|NCT00616655|467331527|FG000|Overall Study|Does not meet in/ex criteria|0|||
129827146|NCT00616655|467331528|FG001|Overall Study|Does not meet in/ex criteria|0|||
129827147|NCT00616655|467331529|FG002|Overall Study|Does not meet in/ex criteria|2|||
129827148|NCT00616655|467331527|FG000|Overall Study|Other|6|||
129827149|NCT00616655|467331528|FG001|Overall Study|Other|6|||
129827150|NCT00616655|467331529|FG002|Overall Study|Other|5|||
129827151|NCT02663674|467331532|FG000|Overall Study|Lost to Follow-up|5|||
129827152|NCT02663674|467331533|FG001|Overall Study|Lost to Follow-up|4|||
129827153|NCT02663674|467331532|FG000|Overall Study|Withdrawal by Subject|1|||
129827154|NCT02663674|467331533|FG001|Overall Study|Withdrawal by Subject|4|||
129827155|NCT02663674|467331532|FG000|Overall Study|Physician Decision|1|||
129827156|NCT02663674|467331533|FG001|Overall Study|Physician Decision|1|||
129827157|NCT02663674|467331532|FG000|Overall Study|Other Event (Health Related)|0|||
129827158|NCT02663674|467331533|FG001|Overall Study|Other Event (Health Related)|1|||
129827159|NCT00415909|467332668|FG000|Overall Study|Withdrawal by Subject|2|||
129827160|NCT00415909|467332668|FG000|Overall Study|Death|1|||
129827161|NCT02355691|467332673|FG000|Overall Study|Loss of Research Personnel|7|||
129827162|NCT02355691|467332674|FG001|Overall Study|Loss of Research Personnel|9|||
129827163|NCT02345811|467332677|FG000|First Intervention|Withdrawal by Subject|1|||
129827164|NCT02345811|467332678|FG001|First Intervention|Withdrawal by Subject|1|||
129827165|NCT00462761|467332679|FG000|Overall Study|Adverse Event|6|||
129827166|NCT00462761|467332679|FG000|Overall Study|Withdrawal by Subject|9|||
129827167|NCT00462761|467332679|FG000|Overall Study|Physician Decision|5|||
129827168|NCT00462761|467332679|FG000|Overall Study|Disease progression|43|||
129827169|NCT00462761|467332679|FG000|Overall Study|Death|12|||
129827170|NCT00462761|467332679|FG000|Overall Study|Other|1|||
129827171|NCT02522286|467332680|FG000|Overall Study|Withdrawal by Subject|3|||
129827172|NCT02522286|467332681|FG001|Overall Study|Withdrawal by Subject|0|||
130060145|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
130060146|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
130060147|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
130060148|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
130060149|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
130060150|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
130060151|NCT03633227|468174664|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
130060152|NCT03633227|468174665|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
129827173|NCT02522286|467332682|FG002|Overall Study|Withdrawal by Subject|0|||
129827174|NCT02522286|467332683|FG003|Overall Study|Withdrawal by Subject|3|||
129827175|NCT02877082|467332684|FG000|Overall Study|Trial was closed early|5|||
129827176|NCT03480750|467332685|FG000|Overall Study|Withdrawal by Subject|0|||
129827177|NCT03480750|467332686|FG001|Overall Study|Withdrawal by Subject|1|||
129827178|NCT03480750|467332687|FG002|Overall Study|Withdrawal by Subject|0|||
129827179|NCT03480750|467332688|FG003|Overall Study|Withdrawal by Subject|0|||
129827180|NCT03480750|467332689|FG004|Overall Study|Withdrawal by Subject|0|||
129827181|NCT03480750|467332690|FG005|Overall Study|Withdrawal by Subject|0|||
129827182|NCT03480750|467332685|FG000|Overall Study|The interruption in Trientine shippment|0|||
129827183|NCT03480750|467332686|FG001|Overall Study|The interruption in Trientine shippment|0|||
129827184|NCT03480750|467332687|FG002|Overall Study|The interruption in Trientine shippment|0|||
129827185|NCT03480750|467332688|FG003|Overall Study|The interruption in Trientine shippment|0|||
129827186|NCT03480750|467332689|FG004|Overall Study|The interruption in Trientine shippment|0|||
129827187|NCT03480750|467332690|FG005|Overall Study|The interruption in Trientine shippment|1|||
129827188|NCT00605813|467332691|FG000|Overall Study|Protocol Violation|25|||
129827189|NCT01132482|467332692|FG000|Overall Study|Adverse Event|1|||
129827190|NCT01132482|467332693|FG001|Overall Study|Adverse Event|0|||
129827191|NCT00174915|467332698|FG000|Overall Study|Lost to Follow-up|19|||
129827192|NCT00174915|467332699|FG001|Overall Study|Lost to Follow-up|17|||
129827193|NCT00174915|467332700|FG002|Overall Study|Lost to Follow-up|9|||
129827194|NCT00174915|467332701|FG003|Overall Study|Lost to Follow-up|17|||
129827195|NCT00174915|467332702|FG004|Overall Study|Lost to Follow-up|10|||
129827196|NCT00174915|467332698|FG000|Overall Study|Adverse Event|18|||
129827197|NCT00174915|467332699|FG001|Overall Study|Adverse Event|16|||
129827198|NCT00174915|467332700|FG002|Overall Study|Adverse Event|11|||
129827199|NCT00174915|467332701|FG003|Overall Study|Adverse Event|18|||
129827200|NCT00174915|467332702|FG004|Overall Study|Adverse Event|5|||
129827201|NCT00174915|467332698|FG000|Overall Study|Personal Reason(s)|16|||
129827202|NCT00174915|467332699|FG001|Overall Study|Personal Reason(s)|16|||
129827203|NCT00174915|467332700|FG002|Overall Study|Personal Reason(s)|9|||
129827204|NCT00174915|467332701|FG003|Overall Study|Personal Reason(s)|9|||
129827205|NCT00174915|467332702|FG004|Overall Study|Personal Reason(s)|9|||
129827206|NCT00174915|467332698|FG000|Overall Study|Other|15|||
129827207|NCT00174915|467332699|FG001|Overall Study|Other|8|||
130060153|NCT03633227|468174664|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
130060154|NCT03633227|468174665|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
130060155|NCT03633227|468174664|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
129827208|NCT00174915|467332700|FG002|Overall Study|Other|6|||
129827209|NCT00174915|467332701|FG003|Overall Study|Other|5|||
129827210|NCT00174915|467332702|FG004|Overall Study|Other|3|||
129827211|NCT00174915|467332698|FG000|Overall Study|Gout Flare|13|||
129827212|NCT00174915|467332699|FG001|Overall Study|Gout Flare|6|||
129827213|NCT00174915|467332700|FG002|Overall Study|Gout Flare|8|||
129827214|NCT00174915|467332701|FG003|Overall Study|Gout Flare|1|||
129827215|NCT00174915|467332702|FG004|Overall Study|Gout Flare|0|||
129827216|NCT00174915|467332698|FG000|Overall Study|Protocol Violation|6|||
130060156|NCT03633227|468174665|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
130060157|NCT03633227|468174664|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
130060158|NCT03633227|468174665|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
130060159|NCT03633227|468174664|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
130112659|NCT00910858|468373434|FG002|Monotherapy Phase|Protocol Violation|0|||
130112660|NCT00910858|468373432|FG000|Monotherapy Phase|Other|3|||
129827217|NCT00174915|467332699|FG001|Overall Study|Protocol Violation|3|||
129827218|NCT00174915|467332700|FG002|Overall Study|Protocol Violation|3|||
129827219|NCT00174915|467332701|FG003|Overall Study|Protocol Violation|6|||
129827220|NCT00174915|467332702|FG004|Overall Study|Protocol Violation|3|||
129827221|NCT00174915|467332698|FG000|Overall Study|Therapeutic Failure|6|||
129827222|NCT00174915|467332699|FG001|Overall Study|Therapeutic Failure|3|||
129827223|NCT00174915|467332700|FG002|Overall Study|Therapeutic Failure|2|||
129827224|NCT00174915|467332701|FG003|Overall Study|Therapeutic Failure|1|||
129827225|NCT00174915|467332702|FG004|Overall Study|Therapeutic Failure|3|||
129827226|NCT03060447|467332707|FG000|Overall Study|Withdrawal by Subject|2|||
129827227|NCT03060447|467332708|FG001|Overall Study|Withdrawal by Subject|0|||
129827228|NCT00573755|467332709|FG000|Overall Study|Still receiving treatment|1|||
129827229|NCT00573755|467332710|FG001|Overall Study|Still receiving treatment|0|||
129827230|NCT03274440|467332714|FG000|Overall Study|Time commitment too great|1|||
130060160|NCT03633227|468174665|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
129827231|NCT03274440|467332715|FG001|Overall Study|Time commitment too great|0|||
129827232|NCT03274440|467332716|FG002|Overall Study|Time commitment too great|0|||
129827233|NCT03274440|467332717|FG003|Overall Study|Time commitment too great|1|||
129827234|NCT03274440|467332718|FG004|Overall Study|Time commitment too great|0|||
129827235|NCT03274440|467332719|FG005|Overall Study|Time commitment too great|0|||
129827236|NCT00450450|467332720|FG000|Overall Study|Death|1|||
129827237|NCT00450450|467332721|FG001|Overall Study|Death|3|||
129827238|NCT00450450|467332720|FG000|Overall Study|Relapse|2|||
129827239|NCT00450450|467332721|FG001|Overall Study|Relapse|0|||
129827240|NCT00450450|467332720|FG000|Overall Study|Missing Data|2|||
129827241|NCT00450450|467332721|FG001|Overall Study|Missing Data|0|||
129827242|NCT04984993|467332722|FG000|Overall Study|Withdrawal by Subject|8|||
129827243|NCT04984993|467332723|FG001|Overall Study|Withdrawal by Subject|2|||
129827244|NCT04984993|467332722|FG000|Overall Study|Lost to Follow-up|2|||
129827245|NCT04984993|467332723|FG001|Overall Study|Lost to Follow-up|2|||
129827246|NCT04984993|467332722|FG000|Overall Study|Both patients moved to another country|4|||
129827247|NCT04984993|467332723|FG001|Overall Study|Both patients moved to another country|0|||
129827248|NCT02865187|467332724|FG000|Overall Study|Lost to Follow-up|12|||
129827249|NCT02865187|467332725|FG001|Overall Study|Lost to Follow-up|7|||
129827250|NCT02865187|467332724|FG000|Overall Study|Adverse Event|1|||
129827251|NCT02865187|467332725|FG001|Overall Study|Adverse Event|0|||
129827252|NCT01110707|467332726|FG000|Overall Study|Protocol Violation|0|||
129827253|NCT01110707|467332727|FG001|Overall Study|Protocol Violation|3|||
129827254|NCT02369341|467332728|FG000|Overall Study|Migrated/moved from study area|1|||
129827255|NCT02369341|467332729|FG001|Overall Study|Migrated/moved from study area|0|||
129827256|NCT03287804|467332730|FG000|Overall Study|Death|1|||
129827257|NCT03287804|467332730|FG000|Overall Study|Physician Decision|2|||
130060161|NCT03633227|468174664|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
130060162|NCT03633227|468174665|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
130060163|NCT02237157|468174666|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
130060164|NCT02237157|468174667|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
130060165|NCT02237157|468174668|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
130060166|NCT02237157|468174669|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
130060167|NCT02237157|468174666|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
130060168|NCT02237157|468174667|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
130060169|NCT02237157|468174668|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
130060170|NCT02237157|468174669|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
130060171|NCT02683525|468174670|FG000|Overall Study|Lost to Follow-up|1|||
130060172|NCT02683525|468174670|FG000|Overall Study|Physician Decision|1|||
130060173|NCT02683525|468174670|FG000|Overall Study|Disease Progression|6|||
130060174|NCT00926796|468174674|FG000|Overall Study|Did not receive randomized treatment|4|||
130060175|NCT00926796|468174675|FG001|Overall Study|Did not receive randomized treatment|7|||
130060176|NCT00926796|468174674|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
130060177|NCT00926796|468174675|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
130060178|NCT00926796|468174674|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
130060179|NCT00926796|468174675|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
130060180|NCT00926796|468174674|FG000|Overall Study|Adverse Event|7|||
130060181|NCT00926796|468174675|FG001|Overall Study|Adverse Event|14|||
130060182|NCT00926796|468174674|FG000|Overall Study|Lost to Follow-up|22|||
130060183|NCT00926796|468174675|FG001|Overall Study|Lost to Follow-up|13|||
130060184|NCT00926796|468174674|FG000|Overall Study|Protocol Violation|15|||
130060185|NCT00926796|468174675|FG001|Overall Study|Protocol Violation|11|||
130060186|NCT00926796|468174674|FG000|Overall Study|Withdrawal by Subject|1|||
130060187|NCT00926796|468174675|FG001|Overall Study|Withdrawal by Subject|0|||
129827258|NCT03287804|467332730|FG000|Overall Study|Progressive disease|8|||
129827259|NCT02710045|467332736|FG000|Overall Study|Death|1|||
129827260|NCT02710045|467332737|FG001|Overall Study|Death|2|||
129827261|NCT02710045|467332738|FG002|Overall Study|Death|0|||
129827262|NCT02710045|467332736|FG000|Overall Study|Withdrawal by Subject|6|||
129827263|NCT02710045|467332737|FG001|Overall Study|Withdrawal by Subject|6|||
129827264|NCT02710045|467332738|FG002|Overall Study|Withdrawal by Subject|2|||
129827265|NCT02710045|467332736|FG000|Overall Study|Protocol Violation|1|||
129827266|NCT02710045|467332737|FG001|Overall Study|Protocol Violation|2|||
129827267|NCT02710045|467332738|FG002|Overall Study|Protocol Violation|3|||
129827268|NCT02710045|467332736|FG000|Overall Study|Lost to Follow-up|3|||
129827269|NCT02710045|467332737|FG001|Overall Study|Lost to Follow-up|6|||
129827270|NCT02710045|467332738|FG002|Overall Study|Lost to Follow-up|7|||
129827271|NCT02710045|467332736|FG000|Overall Study|Physician Decision|0|||
130060188|NCT01341652|468174676|FG000|Overall Study|Incorrect Random Assignment|0|||
130060189|NCT01341652|468174677|FG001|Overall Study|Incorrect Random Assignment|1|||
130060190|NCT01341652|468174676|FG000|Overall Study|ineligible; presence metastatic disease|0|||
130060191|NCT01341652|468174677|FG001|Overall Study|ineligible; presence metastatic disease|1|||
129827272|NCT02710045|467332737|FG001|Overall Study|Physician Decision|0|||
129827273|NCT02710045|467332738|FG002|Overall Study|Physician Decision|1|||
129827274|NCT02710045|467332736|FG000|Overall Study|Poor Attendance|0|||
129827275|NCT02710045|467332737|FG001|Overall Study|Poor Attendance|1|||
129827276|NCT02710045|467332738|FG002|Overall Study|Poor Attendance|0|||
129827277|NCT01275833|467332739|FG000|Overall Study|Study terminated|1|||
129827278|NCT01275833|467332740|FG001|Overall Study|Study terminated|1|||
129827279|NCT02707991|467332742|FG000|Overall Study|Protocol Violation|1|||
129827280|NCT02707991|467332743|FG001|Overall Study|Protocol Violation|0|||
129827281|NCT02707991|467332742|FG000|Overall Study|Became ineligible|0|||
129827282|NCT02707991|467332743|FG001|Overall Study|Became ineligible|1|||
130060192|NCT00586924|468174681|FG000|Overall Study|Adverse event/serious adverse event|0|||
130060193|NCT00586924|468174682|FG001|Overall Study|Adverse event/serious adverse event|0|||
130060194|NCT00586924|468174683|FG002|Overall Study|Adverse event/serious adverse event|0|||
130060195|NCT00586924|468174684|FG003|Overall Study|Adverse event/serious adverse event|1|||
130060196|NCT00586924|468174685|FG004|Overall Study|Adverse event/serious adverse event|0|||
130060197|NCT00586924|468174686|FG005|Overall Study|Adverse event/serious adverse event|2|||
130060198|NCT00586924|468174681|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
130060199|NCT00586924|468174682|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
130060200|NCT00586924|468174683|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
130060201|NCT00586924|468174684|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
130060202|NCT00586924|468174685|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
130060203|NCT00586924|468174686|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
130060204|NCT00586924|468174681|FG000|Overall Study|Disease progression|0|||
130060205|NCT00586924|468174682|FG001|Overall Study|Disease progression|0|||
130060206|NCT00586924|468174683|FG002|Overall Study|Disease progression|0|||
130060207|NCT00586924|468174684|FG003|Overall Study|Disease progression|1|||
129827283|NCT02733991|467332744|FG000|Overall Study|Adverse Event|1|||
129827284|NCT02733991|467332745|FG001|Overall Study|Adverse Event|0|||
129827285|NCT02733991|467332744|FG000|Overall Study|Withdrawal by Subject|0|||
129827286|NCT02733991|467332745|FG001|Overall Study|Withdrawal by Subject|5|||
129827287|NCT04191499|467332746|FG000|Overall Study|Adverse Event|1|||
129827288|NCT04191499|467332747|FG001|Overall Study|Adverse Event|0|||
129827289|NCT04191499|467332746|FG000|Overall Study|Death|42|||
129827290|NCT04191499|467332747|FG001|Overall Study|Death|55|||
129827291|NCT04191499|467332746|FG000|Overall Study|Lost to Follow-up|4|||
129827292|NCT04191499|467332747|FG001|Overall Study|Lost to Follow-up|1|||
129827293|NCT04191499|467332746|FG000|Overall Study|Physician Decision|1|||
129827294|NCT04191499|467332747|FG001|Overall Study|Physician Decision|0|||
129827295|NCT04191499|467332746|FG000|Overall Study|Progressive Disease|1|||
129827296|NCT04191499|467332747|FG001|Overall Study|Progressive Disease|0|||
129827297|NCT04191499|467332746|FG000|Overall Study|Symptomatic Deterioration|1|||
129827298|NCT04191499|467332747|FG001|Overall Study|Symptomatic Deterioration|0|||
129827299|NCT04191499|467332746|FG000|Overall Study|Withdrawal by Subject|7|||
129827300|NCT04191499|467332747|FG001|Overall Study|Withdrawal by Subject|11|||
129827301|NCT04191499|467332746|FG000|Overall Study|Ongoing in the study|104|||
129827302|NCT04191499|467332747|FG001|Overall Study|Ongoing in the study|97|||
129827303|NCT00680745|467332748|FG000|Overall Study|Withdrawal by Subject|8|||
129827304|NCT00680745|467332749|FG001|Overall Study|Withdrawal by Subject|3|||
129827305|NCT00680745|467332750|FG002|Overall Study|Withdrawal by Subject|2|||
129827306|NCT00680745|467332751|FG003|Overall Study|Withdrawal by Subject|8|||
129827307|NCT00680745|467332748|FG000|Overall Study|Lost to Follow-up|0|||
129827308|NCT00680745|467332749|FG001|Overall Study|Lost to Follow-up|1|||
129827309|NCT00680745|467332750|FG002|Overall Study|Lost to Follow-up|1|||
129827310|NCT00680745|467332751|FG003|Overall Study|Lost to Follow-up|0|||
129827311|NCT00680745|467332748|FG000|Overall Study|Death|1|||
129827312|NCT00680745|467332749|FG001|Overall Study|Death|0|||
129827313|NCT00680745|467332750|FG002|Overall Study|Death|1|||
129827314|NCT00680745|467332751|FG003|Overall Study|Death|0|||
129827315|NCT00680745|467332748|FG000|Overall Study|Adverse Event|5|||
129827316|NCT00680745|467332749|FG001|Overall Study|Adverse Event|3|||
129827317|NCT00680745|467332750|FG002|Overall Study|Adverse Event|3|||
129827318|NCT00680745|467332751|FG003|Overall Study|Adverse Event|3|||
129827319|NCT00680745|467332748|FG000|Overall Study|Poor/Non-compliance|0|||
129827320|NCT00680745|467332749|FG001|Overall Study|Poor/Non-compliance|3|||
129827321|NCT00680745|467332750|FG002|Overall Study|Poor/Non-compliance|0|||
129827322|NCT00680745|467332751|FG003|Overall Study|Poor/Non-compliance|0|||
129827323|NCT00680745|467332748|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129827324|NCT00680745|467332749|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
129897666|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
130060208|NCT00586924|468174685|FG004|Overall Study|Disease progression|1|||
129827325|NCT00680745|467332750|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
129827326|NCT00680745|467332751|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
129827327|NCT00680745|467332748|FG000|Overall Study|False Treatment|0|||
129827328|NCT00680745|467332749|FG001|Overall Study|False Treatment|1|||
129827329|NCT00680745|467332750|FG002|Overall Study|False Treatment|3|||
129827330|NCT00680745|467332751|FG003|Overall Study|False Treatment|0|||
129827331|NCT02612428|467332752|FG000|VTL-308|Death|14|||
129827332|NCT02612428|467332753|FG001|VTL-308|Death|16|||
130060209|NCT00586924|468174686|FG005|Overall Study|Disease progression|0|||
130060210|NCT00586924|468174681|FG000|Overall Study|Development of neutralizing antibodies|2|||
130060211|NCT00586924|468174682|FG001|Overall Study|Development of neutralizing antibodies|2|||
129827333|NCT02612428|467332752|FG000|VTL-308|Withdrawal by Subject|0|||
129827334|NCT02612428|467332753|FG001|VTL-308|Withdrawal by Subject|1|||
129827335|NCT02612428|467332752|FG000|VTL-308E|Death|9|||
129827336|NCT02612428|467332753|FG001|VTL-308E|Death|7|||
129827337|NCT02612428|467332752|FG000|VTL-308E|Lost to Follow-up|2|||
129827338|NCT02612428|467332753|FG001|VTL-308E|Lost to Follow-up|0|||
129827339|NCT00742001|467332754|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
129827340|NCT00742001|467332755|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
130060212|NCT00586924|468174683|FG002|Overall Study|Development of neutralizing antibodies|2|||
130060213|NCT00586924|468174684|FG003|Overall Study|Development of neutralizing antibodies|0|||
130060214|NCT00586924|468174685|FG004|Overall Study|Development of neutralizing antibodies|0|||
130060215|NCT00586924|468174686|FG005|Overall Study|Development of neutralizing antibodies|22|||
130060216|NCT00586924|468174681|FG000|Overall Study|Complete response|0|||
130060217|NCT00586924|468174682|FG001|Overall Study|Complete response|1|||
130060218|NCT00586924|468174683|FG002|Overall Study|Complete response|0|||
130060219|NCT00586924|468174684|FG003|Overall Study|Complete response|0|||
130060220|NCT00586924|468174685|FG004|Overall Study|Complete response|2|||
130060221|NCT00586924|468174686|FG005|Overall Study|Complete response|2|||
130060222|NCT00586924|468174681|FG000|Overall Study|Other|1|||
129827341|NCT00742001|467332756|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
129827342|NCT00137423|467332757|FG000|Overall Study|Adverse Event|7|||
129827343|NCT00137423|467332758|FG001|Overall Study|Adverse Event|9|||
129827344|NCT00137423|467332757|FG000|Overall Study|consent withdrawn|1|||
129827345|NCT00137423|467332758|FG001|Overall Study|consent withdrawn|1|||
129827346|NCT00137423|467332757|FG000|Overall Study|Lack of Efficacy|31|||
129827347|NCT00137423|467332758|FG001|Overall Study|Lack of Efficacy|33|||
129827348|NCT00137423|467332757|FG000|Overall Study|Death|0|||
130060223|NCT00586924|468174682|FG001|Overall Study|Other|0|||
130060224|NCT00586924|468174683|FG002|Overall Study|Other|1|||
130060225|NCT00586924|468174684|FG003|Overall Study|Other|1|||
130060226|NCT00586924|468174685|FG004|Overall Study|Other|1|||
130060227|NCT00586924|468174686|FG005|Overall Study|Other|6|||
130060228|NCT03731364|468174688|FG000|Overall Study|Adverse Event|0|||
130060229|NCT03731364|468174689|FG001|Overall Study|Adverse Event|0|||
130060230|NCT03731364|468174690|FG002|Overall Study|Adverse Event|1|||
130060231|NCT03731364|468174691|FG003|Overall Study|Adverse Event|2|||
130060232|NCT03731364|468174692|FG004|Overall Study|Adverse Event|1|||
130060233|NCT01934192|468174693|FG000|Overall Study|Protocol Violation|0|||
130060234|NCT01934192|468174694|FG001|Overall Study|Protocol Violation|0|||
130060235|NCT01934192|468174695|FG002|Overall Study|Protocol Violation|0|||
130060236|NCT01934192|468174696|FG003|Overall Study|Protocol Violation|1|||
130060237|NCT01934192|468174693|FG000|Overall Study|Other: reached stopping criteria|6|||
130060238|NCT01934192|468174694|FG001|Overall Study|Other: reached stopping criteria|5|||
130060239|NCT01934192|468174695|FG002|Overall Study|Other: reached stopping criteria|1|||
130060240|NCT01934192|468174696|FG003|Overall Study|Other: reached stopping criteria|0|||
130060241|NCT01934192|468174693|FG000|Overall Study|Physician Decision|3|||
130060242|NCT01934192|468174694|FG001|Overall Study|Physician Decision|2|||
130060243|NCT01934192|468174695|FG002|Overall Study|Physician Decision|0|||
130060244|NCT01934192|468174696|FG003|Overall Study|Physician Decision|0|||
130060245|NCT01189435|468174697|FG000|Overall Study|Withdrawal by Subject|1|||
130060246|NCT01189435|468174697|FG000|Overall Study|Physician Decision|1|||
130060247|NCT02357849|468174700|FG000|Overall Study|Withdrawal by Subject|2|||
130060248|NCT02357849|468174701|FG001|Overall Study|Withdrawal by Subject|3|||
129827349|NCT00137423|467332758|FG001|Overall Study|Death|1|||
129827350|NCT01928329|467332759|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
129827351|NCT01928329|467332760|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
129827352|NCT01928329|467332759|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
129827353|NCT01928329|467332760|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
129827354|NCT01928329|467332759|FG000|Overall Study|Adverse Event|5|||
129827355|NCT01928329|467332760|FG001|Overall Study|Adverse Event|3|||
130060249|NCT01982773|468174708|FG000|Overall Study|Withdrawal by Subject|1|||
130060250|NCT01982773|468174709|FG001|Overall Study|Withdrawal by Subject|3|||
130060251|NCT01982773|468174708|FG000|Overall Study|Lost to Follow-up|7|||
130060252|NCT01982773|468174709|FG001|Overall Study|Lost to Follow-up|1|||
130060253|NCT01029886|468174710|FG000|Overall Study|Adverse Event|12|||
130060254|NCT01029886|468174711|FG001|Overall Study|Adverse Event|25|||
130060255|NCT01029886|468174710|FG000|Overall Study|Lost to Follow-up|1|||
130060256|NCT01029886|468174711|FG001|Overall Study|Lost to Follow-up|0|||
130060257|NCT01029886|468174710|FG000|Overall Study|Physician Decision|2|||
130060258|NCT01029886|468174711|FG001|Overall Study|Physician Decision|6|||
129827356|NCT01928329|467332759|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
129827357|NCT01928329|467332760|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
129827358|NCT01928329|467332759|FG000|Overall Study|Withdrawal by Subject|1|||
130060259|NCT01029886|468174710|FG000|Overall Study|Protocol Violation|17|||
130060260|NCT01029886|468174711|FG001|Overall Study|Protocol Violation|5|||
129827359|NCT01928329|467332760|FG001|Overall Study|Withdrawal by Subject|5|||
129827360|NCT01928329|467332759|FG000|Overall Study|Physician Decision|1|||
129827361|NCT01928329|467332760|FG001|Overall Study|Physician Decision|1|||
129827362|NCT03187262|467332762|FG000|Induction|Lack of Efficacy|2|||
129827363|NCT03187262|467332762|FG000|Induction|Progressive Disease|4|||
129827364|NCT03187262|467332762|FG000|Consolidation|Progressive Disease|5|||
129827365|NCT02617511|467332763|FG000|Overall Study|Withdrawal by Subject|1|||
129827366|NCT02617511|467332764|FG001|Overall Study|Withdrawal by Subject|0|||
129827367|NCT02141997|467332765|FG000|Overall Study|Adverse Event|0|||
129827368|NCT02141997|467332766|FG001|Overall Study|Adverse Event|2|||
129827369|NCT02141997|467332767|FG002|Overall Study|Adverse Event|0|||
129827370|NCT02141997|467332768|FG003|Overall Study|Adverse Event|1|||
129827371|NCT02141997|467332765|FG000|Overall Study|Participant noncompliance|1|||
129827372|NCT02141997|467332766|FG001|Overall Study|Participant noncompliance|0|||
129827373|NCT02141997|467332767|FG002|Overall Study|Participant noncompliance|0|||
129827374|NCT02141997|467332768|FG003|Overall Study|Participant noncompliance|0|||
129827375|NCT02141997|467332765|FG000|Overall Study|Withdrew consent|1|||
129827376|NCT02141997|467332766|FG001|Overall Study|Withdrew consent|0|||
129827377|NCT02141997|467332767|FG002|Overall Study|Withdrew consent|3|||
129827378|NCT02141997|467332768|FG003|Overall Study|Withdrew consent|0|||
129827379|NCT02141997|467332765|FG000|Overall Study|Other|1|||
129827380|NCT02141997|467332766|FG001|Overall Study|Other|4|||
129827381|NCT02141997|467332767|FG002|Overall Study|Other|0|||
129827382|NCT02141997|467332768|FG003|Overall Study|Other|0|||
129827383|NCT04105998|467332771|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
129827384|NCT04105998|467332772|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
129827385|NCT00450333|467332773|FG000|Overall Study|Study terminated|47|||
129827386|NCT00450333|467332774|FG001|Overall Study|Study terminated|54|||
129827387|NCT00450333|467332775|FG002|Overall Study|Study terminated|16|||
129827388|NCT00450333|467332776|FG003|Overall Study|Study terminated|21|||
129827389|NCT00450333|467332773|FG000|Overall Study|Adverse Event|1|||
129827390|NCT00450333|467332774|FG001|Overall Study|Adverse Event|7|||
129827391|NCT00450333|467332775|FG002|Overall Study|Adverse Event|2|||
129827392|NCT00450333|467332776|FG003|Overall Study|Adverse Event|2|||
129827393|NCT00450333|467332773|FG000|Overall Study|Protocol Violation|1|||
129827394|NCT00450333|467332774|FG001|Overall Study|Protocol Violation|0|||
129827395|NCT00450333|467332775|FG002|Overall Study|Protocol Violation|1|||
129827396|NCT00450333|467332776|FG003|Overall Study|Protocol Violation|0|||
129827397|NCT00450333|467332773|FG000|Overall Study|Withdrawal by Subject|1|||
129827398|NCT00450333|467332774|FG001|Overall Study|Withdrawal by Subject|0|||
129827399|NCT00450333|467332775|FG002|Overall Study|Withdrawal by Subject|3|||
129827400|NCT00450333|467332776|FG003|Overall Study|Withdrawal by Subject|0|||
129827401|NCT00450333|467332773|FG000|Overall Study|Kidney transplant|1|||
129827402|NCT00450333|467332774|FG001|Overall Study|Kidney transplant|0|||
129827403|NCT00450333|467332775|FG002|Overall Study|Kidney transplant|1|||
129827404|NCT00450333|467332776|FG003|Overall Study|Kidney transplant|3|||
129827405|NCT00450333|467332773|FG000|Overall Study|Death|3|||
129827406|NCT00450333|467332774|FG001|Overall Study|Death|2|||
129827407|NCT00450333|467332775|FG002|Overall Study|Death|2|||
129827408|NCT00450333|467332776|FG003|Overall Study|Death|2|||
129827409|NCT00416078|467332777|FG000|Overall Study|Death|3|||
129827410|NCT00416078|467332778|FG001|Overall Study|Death|4|||
129827411|NCT00416078|467332777|FG000|Overall Study|Withdrawal by Subject|3|||
129827412|NCT00416078|467332778|FG001|Overall Study|Withdrawal by Subject|2|||
129827413|NCT00416078|467332777|FG000|Overall Study|Physician Decision|1|||
129827414|NCT00416078|467332778|FG001|Overall Study|Physician Decision|0|||
129827415|NCT00416078|467332777|FG000|Overall Study|Lost to Follow-up|4|||
129827416|NCT00416078|467332778|FG001|Overall Study|Lost to Follow-up|2|||
129827417|NCT00461682|467332782|FG000|Overall Study|Protocol Violation|1|||
129827418|NCT04128267|467332786|FG000|Overall Study|Withdrawal by Subject|6|||
129827419|NCT04128267|467332786|FG000|Overall Study|Death|2|||
129827420|NCT04128267|467332786|FG000|Overall Study|Disease progression|1|||
129827421|NCT04128267|467332786|FG000|Overall Study|Participant had other medical issues|4|||
129827422|NCT04128267|467332786|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
129827423|NCT01698801|467332789|FG000|Treatment Phase|Adverse Event|4|||
129827424|NCT01698801|467332789|FG000|Treatment Phase|Protocol Violation|1|||
129827425|NCT01698801|467332789|FG000|Treatment Phase|Other|4|||
129827426|NCT01698801|467332789|FG000|Treatment Phase|Withdrawal by Subject|1|||
129827427|NCT01698801|467332789|FG000|Treatment Phase|Disease progression|1|||
129827428|NCT01698801|467332789|FG000|Follow Up Phase|Withdrawal by Subject|1|||
129827429|NCT01698801|467332789|FG000|Follow Up Phase|Death|4|||
129827430|NCT03761147|467332790|FG000|Overall Study|Withdrawal by Subject|6|||
129827431|NCT03761147|467332791|FG001|Overall Study|Withdrawal by Subject|1|||
129827432|NCT03761147|467332790|FG000|Overall Study|Adverse Event|1|||
129827433|NCT03761147|467332791|FG001|Overall Study|Adverse Event|3|||
129827434|NCT03232281|467333933|FG000|Overall Study|Adverse Event|1|||
129827435|NCT03232281|467333934|FG001|Overall Study|Adverse Event|1|||
129827436|NCT03232281|467333933|FG000|Overall Study|Withdrawal by Subject|5|||
129827437|NCT03232281|467333934|FG001|Overall Study|Withdrawal by Subject|4|||
129827438|NCT03232281|467333933|FG000|Overall Study|Protocol Deviation|1|||
129827439|NCT03232281|467333934|FG001|Overall Study|Protocol Deviation|1|||
129827440|NCT02132767|467333936|FG000|Overall Study|Death|3|||
129827441|NCT02132767|467333937|FG001|Overall Study|Death|2|||
129827442|NCT02132767|467333936|FG000|Overall Study|Withdrawal by Subject|10|||
129827443|NCT02132767|467333937|FG001|Overall Study|Withdrawal by Subject|9|||
129827444|NCT02132767|467333936|FG000|Overall Study|Lost to Follow-up|4|||
129827445|NCT02132767|467333937|FG001|Overall Study|Lost to Follow-up|4|||
129827446|NCT00778700|467333940|FG000|Overall Study|Adverse Event|6|||
129827447|NCT00778700|467333941|FG001|Overall Study|Adverse Event|1|||
129827448|NCT00778700|467333942|FG002|Overall Study|Adverse Event|3|||
129827449|NCT00778700|467333943|FG003|Overall Study|Adverse Event|5|||
129827450|NCT00778700|467333940|FG000|Overall Study|Protocol Violation|1|||
129827451|NCT00778700|467333941|FG001|Overall Study|Protocol Violation|1|||
129827452|NCT00778700|467333942|FG002|Overall Study|Protocol Violation|0|||
129827453|NCT00778700|467333943|FG003|Overall Study|Protocol Violation|0|||
129827454|NCT00778700|467333940|FG000|Overall Study|Subject Withdrew Consent|6|||
129827455|NCT00778700|467333941|FG001|Overall Study|Subject Withdrew Consent|4|||
129827456|NCT00778700|467333942|FG002|Overall Study|Subject Withdrew Consent|1|||
129827457|NCT00778700|467333943|FG003|Overall Study|Subject Withdrew Consent|4|||
129827458|NCT00778700|467333940|FG000|Overall Study|Lost to Follow-up|3|||
129827459|NCT00778700|467333941|FG001|Overall Study|Lost to Follow-up|1|||
129827460|NCT00778700|467333942|FG002|Overall Study|Lost to Follow-up|0|||
129827461|NCT00778700|467333943|FG003|Overall Study|Lost to Follow-up|1|||
129827462|NCT00778700|467333940|FG000|Overall Study|Reason not Specified|2|||
129827463|NCT00778700|467333941|FG001|Overall Study|Reason not Specified|0|||
129827464|NCT00778700|467333942|FG002|Overall Study|Reason not Specified|1|||
129827465|NCT00778700|467333943|FG003|Overall Study|Reason not Specified|3|||
129827466|NCT00778700|467333940|FG000|Overall Study|Other|0|||
129827467|NCT00778700|467333941|FG001|Overall Study|Other|0|||
129827468|NCT00778700|467333942|FG002|Overall Study|Other|1|||
129827469|NCT00778700|467333943|FG003|Overall Study|Other|0|||
129827470|NCT04267133|467333944|FG000|Overall Study|Withdrawal by Subject|1|||
129827471|NCT04267133|467333944|FG000|Overall Study|Adverse Event|4|||
129827472|NCT04008030|467333946|FG000|Pre-Treatment|Withdrawal by Subject|0|||
129827473|NCT04008030|467333947|FG001|Pre-Treatment|Withdrawal by Subject|0|||
129827474|NCT04008030|467333948|FG002|Pre-Treatment|Withdrawal by Subject|9|||
129827475|NCT04008030|467333946|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129827476|NCT04008030|467333947|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
129827477|NCT04008030|467333948|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
129827478|NCT04008030|467333946|FG000|Pre-Treatment|Other reasons|0|||
129827479|NCT04008030|467333947|FG001|Pre-Treatment|Other reasons|1|||
129827480|NCT04008030|467333948|FG002|Pre-Treatment|Other reasons|6|||
129827481|NCT04008030|467333946|FG000|Treatment|Withdrawal by Subject|1|||
129827482|NCT04008030|467333947|FG001|Treatment|Withdrawal by Subject|1|||
129827483|NCT04008030|467333948|FG002|Treatment|Withdrawal by Subject|1|||
129827484|NCT04008030|467333946|FG000|Treatment|Death|2|||
129827485|NCT04008030|467333947|FG001|Treatment|Death|4|||
129827486|NCT04008030|467333948|FG002|Treatment|Death|0|||
129827487|NCT04008030|467333946|FG000|Treatment|Pregnancy|0|||
129827488|NCT04008030|467333947|FG001|Treatment|Pregnancy|1|||
129827489|NCT04008030|467333948|FG002|Treatment|Pregnancy|0|||
129827490|NCT04008030|467333946|FG000|Treatment|Participant no longer meets study criteria|0|||
129827491|NCT04008030|467333947|FG001|Treatment|Participant no longer meets study criteria|1|||
129827492|NCT04008030|467333948|FG002|Treatment|Participant no longer meets study criteria|0|||
129827493|NCT04008030|467333946|FG000|Treatment|Other reasons|5|||
129827494|NCT04008030|467333947|FG001|Treatment|Other reasons|13|||
129827495|NCT04008030|467333948|FG002|Treatment|Other reasons|6|||
129827496|NCT04008030|467333946|FG000|Treatment|Disease Progression|137|||
129827497|NCT04008030|467333947|FG001|Treatment|Disease Progression|82|||
129827498|NCT04008030|467333948|FG002|Treatment|Disease Progression|85|||
129827499|NCT04008030|467333946|FG000|Treatment|Study drug toxicity|28|||
129827500|NCT04008030|467333947|FG001|Treatment|Study drug toxicity|48|||
129827501|NCT04008030|467333948|FG002|Treatment|Study drug toxicity|8|||
129827502|NCT04008030|467333946|FG000|Treatment|Adverse Event unrelated to study drug|28|||
129827503|NCT04008030|467333947|FG001|Treatment|Adverse Event unrelated to study drug|22|||
129827504|NCT04008030|467333948|FG002|Treatment|Adverse Event unrelated to study drug|6|||
129827505|NCT04008030|467333946|FG000|Treatment|Maximum Clinical Benefit|0|||
129827506|NCT04008030|467333947|FG001|Treatment|Maximum Clinical Benefit|1|||
129827507|NCT04008030|467333948|FG002|Treatment|Maximum Clinical Benefit|9|||
129827508|NCT04008030|467333946|FG000|Treatment|On-going treatment|13|||
129827509|NCT04008030|467333947|FG001|Treatment|On-going treatment|20|||
129827510|NCT04008030|467333948|FG002|Treatment|On-going treatment|0|||
129827511|NCT00003901|467333951|FG000|Overall Study|Adverse Event|1|||
129827512|NCT00003901|467333951|FG000|Overall Study|Withdrawal by Subject|1|||
129827513|NCT00003901|467333951|FG000|Overall Study|Ineligible|6|||
129827514|NCT00003901|467333951|FG000|Overall Study|CT Scan not within protocol requirement|2|||
129827515|NCT00003901|467333951|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
129827516|NCT00003901|467333951|FG000|Overall Study|Medical problems|6|||
129827517|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
129827518|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
129827519|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827520|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827521|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827522|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827523|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
129827524|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
129827525|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827526|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827527|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827528|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827529|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827530|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
129827531|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827532|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827533|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827534|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827535|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
129827536|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
129827537|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827538|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827539|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827540|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827541|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Other|1|||
129827542|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Other|2|||
129827543|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Other|0|||
129827544|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Other|0|||
129827545|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Other|0|||
129827546|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Other|0|||
129827547|NCT01496313|467333958|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827548|NCT01496313|467333959|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827549|NCT01496313|467333960|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827550|NCT01496313|467333961|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827551|NCT01496313|467333962|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827552|NCT01496313|467333963|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
129827553|NCT01496313|467333958|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827554|NCT01496313|467333959|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827555|NCT01496313|467333960|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827556|NCT01496313|467333961|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827557|NCT01496313|467333962|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827558|NCT01496313|467333963|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
129827559|NCT01496313|467333958|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
129827560|NCT01496313|467333959|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
129827561|NCT01496313|467333960|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
129827562|NCT01496313|467333961|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
129827563|NCT01496313|467333962|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
129827564|NCT01496313|467333963|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
129827565|NCT01050257|467333964|FG000|Overall Study|Adverse Event|4|||
129827566|NCT01050257|467333965|FG001|Overall Study|Adverse Event|4|||
129827567|NCT01050257|467333966|FG002|Overall Study|Adverse Event|2|||
129827568|NCT01050257|467333964|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
129827569|NCT01050257|467333965|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
129827570|NCT01050257|467333966|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
129827571|NCT01050257|467333964|FG000|Overall Study|Withdrawal by Subject|0|||
129827572|NCT01050257|467333965|FG001|Overall Study|Withdrawal by Subject|3|||
129827573|NCT01050257|467333966|FG002|Overall Study|Withdrawal by Subject|0|||
129827574|NCT01050257|467333964|FG000|Overall Study|No reason specified|0|||
129827575|NCT01050257|467333965|FG001|Overall Study|No reason specified|0|||
129827576|NCT01050257|467333966|FG002|Overall Study|No reason specified|2|||
129827577|NCT01050257|467333964|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
129827578|NCT01050257|467333965|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
129897667|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897668|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897669|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
129827579|NCT01050257|467333966|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
129827580|NCT01050257|467333964|FG000|Overall Study|Violation criteria|0|||
129827581|NCT01050257|467333965|FG001|Overall Study|Violation criteria|1|||
129827582|NCT01050257|467333966|FG002|Overall Study|Violation criteria|0|||
129827583|NCT01050257|467333964|FG000|Overall Study|Failure to return|0|||
129827584|NCT01050257|467333965|FG001|Overall Study|Failure to return|2|||
129827585|NCT01050257|467333966|FG002|Overall Study|Failure to return|0|||
129827586|NCT01050257|467333964|FG000|Overall Study|Death|0|||
129827587|NCT01050257|467333965|FG001|Overall Study|Death|0|||
129827588|NCT01050257|467333966|FG002|Overall Study|Death|1|||
129827589|NCT00278109|467333968|FG000|Overall Study|Adverse Event|3|||
129827590|NCT00278109|467333968|FG000|Overall Study|social circumstances|1|||
129827591|NCT02580357|467333969|FG000|Overall Study|Lost to Follow-up|2|||
129827592|NCT02580357|467333970|FG001|Overall Study|Lost to Follow-up|0|||
129827593|NCT02580357|467333971|FG002|Overall Study|Lost to Follow-up|0|||
129827594|NCT02580357|467333969|FG000|Overall Study|Protocol Violation|1|||
129827595|NCT02580357|467333970|FG001|Overall Study|Protocol Violation|0|||
129827596|NCT02580357|467333971|FG002|Overall Study|Protocol Violation|0|||
129827597|NCT02064166|467333972|FG000|Overall Study|Adverse Event|1|||
129827598|NCT02064166|467333973|FG001|Overall Study|Adverse Event|0|||
129827599|NCT00383149|467333977|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
129827600|NCT00383149|467333977|FG000|Overall Study|Death|2|||
129827601|NCT00383149|467333977|FG000|Overall Study|Disease Progression|38|||
129827602|NCT00383149|467333977|FG000|Overall Study|Lost to Follow-up|1|||
129827603|NCT00383149|467333977|FG000|Overall Study|Other|1|||
129827604|NCT00383149|467333977|FG000|Overall Study|Study Drug Toxicity|4|||
129827605|NCT00383149|467333977|FG000|Overall Study|Request to Discontinue Treatment|4|||
129827606|NCT00383149|467333977|FG000|Overall Study|Participant Withdrew Consent|1|||
129827607|NCT00969150|467334006|FG000|Overall Study|Adverse Event|4|||
129827608|NCT00969150|467334007|FG001|Overall Study|Adverse Event|14|||
129827609|NCT00969150|467334006|FG000|Overall Study|Lack of Efficacy|1|||
129827610|NCT00969150|467334007|FG001|Overall Study|Lack of Efficacy|1|||
129827611|NCT00969150|467334006|FG000|Overall Study|Protocol Violation|9|||
129827612|NCT00969150|467334007|FG001|Overall Study|Protocol Violation|12|||
129827613|NCT00969150|467334006|FG000|Overall Study|Withdrawal by Subject|13|||
129827614|NCT00969150|467334007|FG001|Overall Study|Withdrawal by Subject|9|||
129827615|NCT00969150|467334006|FG000|Overall Study|Lost to Follow-up|5|||
129827616|NCT00969150|467334007|FG001|Overall Study|Lost to Follow-up|4|||
129827617|NCT00969150|467334006|FG000|Overall Study|Other reasons|1|||
129827618|NCT00969150|467334007|FG001|Overall Study|Other reasons|0|||
129827619|NCT00309842|467334011|FG000|Overall Study|Lost to Follow-up|1|||
129827620|NCT01026792|467334012|FG000|Overall Study|Protocol Violation|1|||
129827621|NCT00423150|467334013|FG000|Overall Study|Adverse Event|11|||
129827622|NCT00423150|467334013|FG000|Overall Study|Progression of disease being studied|69|||
129827623|NCT00423150|467334013|FG000|Overall Study|Withdrawal by Subject|1|||
129827624|NCT00423150|467334013|FG000|Overall Study|Non-compliance with protocol|1|||
129827625|NCT00423150|467334013|FG000|Overall Study|Administrative|4|||
129827626|NCT03204305|467334014|FG000|Overall Study|Lost to Follow-up|6|||
129827627|NCT03204305|467334015|FG001|Overall Study|Lost to Follow-up|4|||
129827628|NCT03204305|467334016|FG002|Overall Study|Lost to Follow-up|0|||
129827629|NCT03204305|467334017|FG003|Overall Study|Lost to Follow-up|0|||
129827630|NCT03204305|467334014|FG000|Overall Study|Physician Decision|1|||
129827631|NCT03204305|467334015|FG001|Overall Study|Physician Decision|0|||
129827632|NCT03204305|467334016|FG002|Overall Study|Physician Decision|0|||
129827633|NCT03204305|467334017|FG003|Overall Study|Physician Decision|0|||
129827634|NCT03204305|467334014|FG000|Overall Study|failure to place arterial line|2|||
129827635|NCT03204305|467334015|FG001|Overall Study|failure to place arterial line|1|||
129827636|NCT03204305|467334016|FG002|Overall Study|failure to place arterial line|0|||
129827637|NCT03204305|467334017|FG003|Overall Study|failure to place arterial line|0|||
129827638|NCT03204305|467334014|FG000|Overall Study|Withdrawal by Subject|2|||
129827639|NCT03204305|467334015|FG001|Overall Study|Withdrawal by Subject|0|||
129827640|NCT03204305|467334016|FG002|Overall Study|Withdrawal by Subject|0|||
129827641|NCT03204305|467334017|FG003|Overall Study|Withdrawal by Subject|0|||
129827642|NCT02045797|467334018|FG000|Overall Study|Adverse Event|3|||
129827643|NCT02045797|467334019|FG001|Overall Study|Adverse Event|1|||
129827644|NCT02045797|467334020|FG002|Overall Study|Adverse Event|0|||
129827645|NCT02045797|467334018|FG000|Overall Study|Lack of Efficacy|1|||
129827646|NCT02045797|467334019|FG001|Overall Study|Lack of Efficacy|0|||
129827647|NCT02045797|467334020|FG002|Overall Study|Lack of Efficacy|0|||
129827648|NCT02045797|467334018|FG000|Overall Study|Lost to Follow-up|2|||
129827649|NCT02045797|467334019|FG001|Overall Study|Lost to Follow-up|3|||
129827650|NCT02045797|467334020|FG002|Overall Study|Lost to Follow-up|1|||
129827651|NCT02045797|467334018|FG000|Overall Study|Physician Decision|0|||
129827652|NCT02045797|467334019|FG001|Overall Study|Physician Decision|1|||
129827653|NCT02045797|467334020|FG002|Overall Study|Physician Decision|0|||
129827654|NCT02045797|467334018|FG000|Overall Study|Withdrawal by Subject|1|||
129827655|NCT02045797|467334019|FG001|Overall Study|Withdrawal by Subject|2|||
129827656|NCT02045797|467334020|FG002|Overall Study|Withdrawal by Subject|0|||
129827657|NCT00101907|467334024|FG000|Overall Study|Adverse Event|1|||
129827658|NCT00101907|467334025|FG001|Overall Study|Adverse Event|0|||
129827659|NCT00101907|467334026|FG002|Overall Study|Adverse Event|0|||
129827660|NCT00101907|467334027|FG003|Overall Study|Adverse Event|0|||
129827661|NCT00101907|467334028|FG004|Overall Study|Adverse Event|0|||
129827662|NCT00101907|467334029|FG005|Overall Study|Adverse Event|0|||
129827663|NCT00101907|467334024|FG000|Overall Study|Death|0|||
129827664|NCT00101907|467334025|FG001|Overall Study|Death|1|||
129827665|NCT00101907|467334026|FG002|Overall Study|Death|0|||
129827666|NCT00101907|467334027|FG003|Overall Study|Death|0|||
129827667|NCT00101907|467334028|FG004|Overall Study|Death|3|||
129827668|NCT00101907|467334029|FG005|Overall Study|Death|0|||
129827669|NCT00101907|467334024|FG000|Overall Study|Physician Decision|0|||
129827670|NCT00101907|467334025|FG001|Overall Study|Physician Decision|0|||
129827671|NCT00101907|467334026|FG002|Overall Study|Physician Decision|0|||
129827672|NCT00101907|467334027|FG003|Overall Study|Physician Decision|1|||
129827673|NCT00101907|467334028|FG004|Overall Study|Physician Decision|1|||
129827674|NCT00101907|467334029|FG005|Overall Study|Physician Decision|0|||
129827675|NCT00101907|467334024|FG000|Overall Study|Withdrawal by Subject|1|||
129827676|NCT00101907|467334025|FG001|Overall Study|Withdrawal by Subject|0|||
129827677|NCT00101907|467334026|FG002|Overall Study|Withdrawal by Subject|1|||
129827678|NCT00101907|467334027|FG003|Overall Study|Withdrawal by Subject|0|||
129827679|NCT00101907|467334028|FG004|Overall Study|Withdrawal by Subject|1|||
129827680|NCT00101907|467334029|FG005|Overall Study|Withdrawal by Subject|0|||
129827681|NCT03279692|467334032|FG000|Overall Study|Withdrawal by Subject|1|||
129827682|NCT04219891|467334036|FG000|Overall Study|Lost to Follow-up|3|||
129827683|NCT04219891|467334036|FG000|Overall Study|Withdrawal by Subject|2|||
129827684|NCT04958785|467335084|FG000|Overall Study|Study Terminated by Sponsor|4|||
129827685|NCT04958785|467335085|FG001|Overall Study|Study Terminated by Sponsor|10|||
129827686|NCT04958785|467335086|FG002|Overall Study|Study Terminated by Sponsor|7|||
129827687|NCT04958785|467335087|FG003|Overall Study|Study Terminated by Sponsor|6|||
129827688|NCT04958785|467335088|FG004|Overall Study|Study Terminated by Sponsor|34|||
129827689|NCT04958785|467335084|FG000|Overall Study|Death|2|||
129827690|NCT04958785|467335085|FG001|Overall Study|Death|3|||
129827691|NCT04958785|467335086|FG002|Overall Study|Death|4|||
129827692|NCT04958785|467335087|FG003|Overall Study|Death|5|||
129827693|NCT04958785|467335088|FG004|Overall Study|Death|5|||
129827694|NCT04958785|467335084|FG000|Overall Study|Withdrew consent|2|||
129827695|NCT04958785|467335085|FG001|Overall Study|Withdrew consent|0|||
129827696|NCT04958785|467335086|FG002|Overall Study|Withdrew consent|3|||
129827697|NCT04958785|467335087|FG003|Overall Study|Withdrew consent|1|||
129827698|NCT04958785|467335088|FG004|Overall Study|Withdrew consent|0|||
129827699|NCT04958785|467335084|FG000|Overall Study|Investigator's discretion|0|||
129827700|NCT04958785|467335085|FG001|Overall Study|Investigator's discretion|1|||
129827701|NCT04958785|467335086|FG002|Overall Study|Investigator's discretion|0|||
129827702|NCT04958785|467335087|FG003|Overall Study|Investigator's discretion|1|||
129827703|NCT04958785|467335088|FG004|Overall Study|Investigator's discretion|2|||
129827704|NCT04958785|467335084|FG000|Overall Study|Adverse Event|0|||
129827705|NCT04958785|467335085|FG001|Overall Study|Adverse Event|0|||
129827706|NCT04958785|467335086|FG002|Overall Study|Adverse Event|0|||
129827707|NCT04958785|467335087|FG003|Overall Study|Adverse Event|0|||
129827708|NCT04958785|467335088|FG004|Overall Study|Adverse Event|1|||
129827709|NCT04958785|467335084|FG000|Overall Study|Lost to Follow-up|0|||
129827710|NCT04958785|467335085|FG001|Overall Study|Lost to Follow-up|0|||
129827711|NCT04958785|467335086|FG002|Overall Study|Lost to Follow-up|0|||
129827712|NCT04958785|467335087|FG003|Overall Study|Lost to Follow-up|0|||
129827713|NCT04958785|467335088|FG004|Overall Study|Lost to Follow-up|1|||
129827714|NCT03274687|467335089|FG000|Overall Study|Protocol Violation|1|||
129827715|NCT03274687|467335090|FG001|Overall Study|Protocol Violation|1|||
129827716|NCT04734652|467335095|FG000|Overall Study|Withdrawal by Subject|2|||
129827717|NCT04734652|467335096|FG001|Overall Study|Withdrawal by Subject|0|||
129827718|NCT04734652|467335095|FG000|Overall Study|Death|0|||
130060261|NCT01029886|468174710|FG000|Overall Study|Withdrawal by Subject|8|||
129827719|NCT04734652|467335096|FG001|Overall Study|Death|1|||
130060262|NCT01029886|468174711|FG001|Overall Study|Withdrawal by Subject|18|||
130060263|NCT01029886|468174710|FG000|Overall Study|Entry Criteria Not Met|13|||
130060264|NCT01029886|468174711|FG001|Overall Study|Entry Criteria Not Met|5|||
130060265|NCT01029886|468174710|FG000|Overall Study|Sponsor Decision|1|||
129827720|NCT05104476|467335106|FG000|Overall Study|Randomized But Not Treated|1|||
129827721|NCT05104476|467335107|FG001|Overall Study|Randomized But Not Treated|2|||
129827722|NCT05104476|467335106|FG000|Overall Study|Adverse Event|2|||
129827723|NCT05104476|467335107|FG001|Overall Study|Adverse Event|2|||
129827724|NCT05104476|467335106|FG000|Overall Study|Withdrawal by Subject|3|||
129827725|NCT05104476|467335107|FG001|Overall Study|Withdrawal by Subject|3|||
129827726|NCT05104476|467335106|FG000|Overall Study|Other Than Specified|0|||
129827727|NCT05104476|467335107|FG001|Overall Study|Other Than Specified|3|||
129827728|NCT04519645|467335109|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
129827729|NCT04519645|467335110|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
129827730|NCT04519645|467335111|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
129827731|NCT04519645|467335109|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
129827732|NCT04519645|467335110|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
129827733|NCT04519645|467335111|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
129827734|NCT04519645|467335109|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
129827735|NCT04519645|467335110|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
129827736|NCT04519645|467335111|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
129827737|NCT04519645|467335109|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
129827738|NCT04519645|467335110|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
129827739|NCT04519645|467335111|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
129827740|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827741|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
129827742|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827743|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827744|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827745|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827746|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827747|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
129827748|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
129827749|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
129827750|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
129827751|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
129827752|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
129827753|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
129827754|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
129827755|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
129827756|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
129827757|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
129827758|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
129827759|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
129827760|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
129827761|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827762|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
129827763|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827764|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827765|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827766|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
129827767|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827768|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
129827769|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
129827770|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
129827771|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
129827772|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
129827773|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
129827774|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
129827775|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827776|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827777|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827778|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827779|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827780|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
129827781|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827782|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
129827783|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
129827784|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
129827785|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
129827786|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
129827787|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
129827788|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
129827789|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827790|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827791|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827792|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827793|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129897670|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
129827794|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827795|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
129827796|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
129827797|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
129827798|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
129827799|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
129827800|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
129827801|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
129827802|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
129827803|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827804|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827805|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
129827806|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
129827807|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827808|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827809|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
129827810|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827811|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
129827812|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
129827813|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827814|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827815|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827816|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827817|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
129827818|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827819|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827820|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827821|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827822|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827823|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
129827824|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
129827825|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
129827826|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
129827827|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
129827828|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
129827829|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
129827830|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
129827831|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
129827832|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827833|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
129827834|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827835|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827836|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827837|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
129827838|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827839|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827840|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
129827841|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827842|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827843|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827844|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827845|NCT04447755|467335119|FG000|Overall Study|Death|9|||
129827846|NCT04447755|467335120|FG001|Overall Study|Death|16|||
129827847|NCT04447755|467335121|FG002|Overall Study|Death|8|||
129827848|NCT04447755|467335122|FG003|Overall Study|Death|9|||
129827849|NCT04447755|467335123|FG004|Overall Study|Death|8|||
129827850|NCT04447755|467335124|FG005|Overall Study|Death|9|||
129827851|NCT04447755|467335125|FG006|Overall Study|Death|55|||
129827852|NCT04447755|467335119|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129827853|NCT04447755|467335120|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129827854|NCT04447755|467335121|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129827855|NCT04447755|467335122|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129827856|NCT04447755|467335123|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129827857|NCT04447755|467335124|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129827858|NCT04447755|467335125|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
129827859|NCT04447755|467335119|FG000|Overall Study|Sponsor Decision|0|||
129827860|NCT04447755|467335120|FG001|Overall Study|Sponsor Decision|0|||
129827861|NCT04447755|467335121|FG002|Overall Study|Sponsor Decision|0|||
129827862|NCT04447755|467335122|FG003|Overall Study|Sponsor Decision|0|||
129827863|NCT04447755|467335123|FG004|Overall Study|Sponsor Decision|1|||
129827864|NCT04447755|467335124|FG005|Overall Study|Sponsor Decision|0|||
129827865|NCT04447755|467335125|FG006|Overall Study|Sponsor Decision|10|||
129827866|NCT04447755|467335119|FG000|Overall Study|Lost to Follow-up|0|||
129827867|NCT04447755|467335120|FG001|Overall Study|Lost to Follow-up|0|||
129827868|NCT04447755|467335121|FG002|Overall Study|Lost to Follow-up|0|||
129827869|NCT04447755|467335122|FG003|Overall Study|Lost to Follow-up|0|||
129827870|NCT04447755|467335123|FG004|Overall Study|Lost to Follow-up|0|||
129827871|NCT04447755|467335124|FG005|Overall Study|Lost to Follow-up|0|||
129827872|NCT04447755|467335125|FG006|Overall Study|Lost to Follow-up|1|||
129827873|NCT02375113|467335128|FG000|Overall Study|Undisclosed Reason(s).|1|||
129827874|NCT02375113|467335129|FG001|Overall Study|Undisclosed Reason(s).|1|||
129827875|NCT02375113|467335128|FG000|Overall Study|Poor adherence (<70%).|1|||
129827876|NCT02375113|467335129|FG001|Overall Study|Poor adherence (<70%).|0|||
129827877|NCT02375113|467335128|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
129827878|NCT02375113|467335129|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
129827879|NCT04387435|467335135|FG000|Overall Study|Physician Decision|1|||
129827880|NCT03855280|467335136|FG000|Treatment Phase|Adverse Event|1|||
129827881|NCT03855280|467335136|FG000|Treatment Phase|Withdrawal by Subject|1|||
129827882|NCT03855280|467335136|FG000|Continuation Phase|Protocol Violation|1|||
129827883|NCT03855280|467335136|FG000|Continuation Phase|Adverse Event|1|||
129827884|NCT03855280|467335136|FG000|Continuation Phase|Sponsor Concluded Study|1|||
129827885|NCT03338855|467335137|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
129827886|NCT03338855|467335138|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
129827887|NCT00511667|467335139|FG000|Overall Study|Adverse Event|1|||
129827888|NCT00511667|467335140|FG001|Overall Study|Adverse Event|0|||
129827889|NCT00511667|467335139|FG000|Overall Study|Protocol Violation|1|||
129827890|NCT00511667|467335140|FG001|Overall Study|Protocol Violation|1|||
129827891|NCT00511667|467335139|FG000|Overall Study|Withdrawal by Subject|2|||
129827892|NCT00511667|467335140|FG001|Overall Study|Withdrawal by Subject|0|||
129827893|NCT00511667|467335139|FG000|Overall Study|Site terminated|6|||
129827894|NCT00511667|467335140|FG001|Overall Study|Site terminated|1|||
129827895|NCT00511667|467335139|FG000|Overall Study|Other|2|||
129827896|NCT00511667|467335140|FG001|Overall Study|Other|1|||
129827897|NCT02335099|467335141|FG000|Treatment|Withdrawal by Subject|1|||
129827898|NCT02335099|467335142|FG001|Treatment|Withdrawal by Subject|3|||
129827899|NCT02335099|467335141|FG000|Treatment|Lost to Follow-up|2|||
129827900|NCT02335099|467335142|FG001|Treatment|Lost to Follow-up|0|||
130060266|NCT01029886|468174711|FG001|Overall Study|Sponsor Decision|0|||
130060267|NCT01029886|468174710|FG000|Overall Study|Loss Glucose Control|7|||
130060268|NCT01029886|468174711|FG001|Overall Study|Loss Glucose Control|1|||
130060269|NCT03294681|468174712|FG000|Overall Study|Withdrawal by Subject|1|||
130060270|NCT01778127|468174713|FG000|Overall Study|Lost to Follow-up|5|||
130060271|NCT01778127|468174714|FG001|Overall Study|Lost to Follow-up|1|||
129827901|NCT02335099|467335141|FG000|Treatment|Death|1|||
129827902|NCT02335099|467335142|FG001|Treatment|Death|0|||
130060272|NCT01778127|468174715|FG002|Overall Study|Lost to Follow-up|2|||
130060273|NCT01778127|468174713|FG000|Overall Study|Withdrawal by Subject|3|||
130060274|NCT01778127|468174714|FG001|Overall Study|Withdrawal by Subject|1|||
130060275|NCT01778127|468174715|FG002|Overall Study|Withdrawal by Subject|4|||
129827903|NCT02335099|467335141|FG000|Treatment|Adverse Event|1|||
129827904|NCT02335099|467335142|FG001|Treatment|Adverse Event|2|||
129827905|NCT02335099|467335141|FG000|Follow-up|Death|0|||
129827906|NCT02335099|467335142|FG001|Follow-up|Death|1|||
129827907|NCT00484939|467335145|FG000|Overall Study|Death|9|||
129827908|NCT00484939|467335146|FG001|Overall Study|Death|13|||
130060276|NCT01348425|468174716|FG000|Overall Study|Imaging was not taken.|1|||
129827909|NCT00484939|467335145|FG000|Overall Study|Adverse Event|22|||
129827910|NCT00484939|467335146|FG001|Overall Study|Adverse Event|12|||
129827911|NCT00484939|467335145|FG000|Overall Study|Patient Withdrew Consent|19|||
129827912|NCT00484939|467335146|FG001|Overall Study|Patient Withdrew Consent|10|||
129827913|NCT00484939|467335145|FG000|Overall Study|Protocol Violation|3|||
129827914|NCT00484939|467335146|FG001|Overall Study|Protocol Violation|3|||
129827915|NCT00484939|467335145|FG000|Overall Study|Lost to Follow-up|0|||
129827916|NCT00484939|467335146|FG001|Overall Study|Lost to Follow-up|3|||
129827917|NCT00484939|467335145|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
129897671|NCT02524288|467584422|FG000|Overall Study|Adverse Event|115|||
130060277|NCT01348425|468174717|FG001|Overall Study|Imaging was not taken.|1|||
130060278|NCT01536119|468174718|FG000|Overall Study|Lost to Follow-up|17|||
129827918|NCT00484939|467335146|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
129827919|NCT00484939|467335145|FG000|Overall Study|Disease progression|67|||
129827920|NCT00484939|467335146|FG001|Overall Study|Disease progression|88|||
129827921|NCT00484939|467335145|FG000|Overall Study|Screen Failure|2|||
129827922|NCT00484939|467335146|FG001|Overall Study|Screen Failure|2|||
129827923|NCT00484939|467335145|FG000|Overall Study|Reason Not Specified|11|||
129827924|NCT00484939|467335146|FG001|Overall Study|Reason Not Specified|6|||
129827925|NCT01474876|467335149|FG000|Overall Study|Adverse Event|11|||
129827926|NCT01474876|467335150|FG001|Overall Study|Adverse Event|5|||
129827927|NCT01474876|467335151|FG002|Overall Study|Adverse Event|0|||
129827928|NCT01474876|467335149|FG000|Overall Study|Serious Adverse Event|2|||
129827929|NCT01474876|467335150|FG001|Overall Study|Serious Adverse Event|3|||
129827930|NCT01474876|467335151|FG002|Overall Study|Serious Adverse Event|0|||
129827931|NCT01474876|467335149|FG000|Overall Study|Lost to Follow-up|5|||
129827932|NCT01474876|467335150|FG001|Overall Study|Lost to Follow-up|4|||
129827933|NCT01474876|467335151|FG002|Overall Study|Lost to Follow-up|0|||
129827934|NCT01474876|467335149|FG000|Overall Study|Investigator's decision|28|||
129827935|NCT01474876|467335150|FG001|Overall Study|Investigator's decision|6|||
129827936|NCT01474876|467335151|FG002|Overall Study|Investigator's decision|0|||
129827937|NCT01474876|467335149|FG000|Overall Study|Patient's request|19|||
129827938|NCT01474876|467335150|FG001|Overall Study|Patient's request|5|||
129827939|NCT01474876|467335151|FG002|Overall Study|Patient's request|0|||
129827940|NCT01474876|467335149|FG000|Overall Study|Investigator's decision and pt request|1|||
129827941|NCT01474876|467335150|FG001|Overall Study|Investigator's decision and pt request|0|||
129827942|NCT01474876|467335151|FG002|Overall Study|Investigator's decision and pt request|0|||
129827943|NCT01523886|467335152|FG000|Overall Study|surgery cancelled|0|||
129827944|NCT01523886|467335153|FG001|Overall Study|surgery cancelled|1|||
129827945|NCT01173718|467335163|FG000|Overall Study|Death|17|||
129827946|NCT01173718|467335163|FG000|Overall Study|Abandonment of study graft|27|||
129827947|NCT01367158|467335164|FG000|Overall Study|Withdrew consent|0|||
129827948|NCT01367158|467335165|FG001|Overall Study|Withdrew consent|2|||
129827949|NCT01367158|467335166|FG002|Overall Study|Withdrew consent|1|||
129827950|NCT01367158|467335167|FG003|Overall Study|Withdrew consent|0|||
129827951|NCT01367158|467335168|FG004|Overall Study|Withdrew consent|2|||
129827952|NCT01367158|467335169|FG005|Overall Study|Withdrew consent|0|||
129827953|NCT01367158|467335170|FG006|Overall Study|Withdrew consent|0|||
129827954|NCT01367158|467335171|FG007|Overall Study|Withdrew consent|1|||
129827955|NCT01367158|467335172|FG008|Overall Study|Withdrew consent|0|||
129827956|NCT01367158|467335173|FG009|Overall Study|Withdrew consent|0|||
129827957|NCT01367158|467335174|FG010|Overall Study|Withdrew consent|0|||
129827958|NCT01367158|467335164|FG000|Overall Study|Lost to Follow-up|0|||
129827959|NCT01367158|467335165|FG001|Overall Study|Lost to Follow-up|0|||
129827960|NCT01367158|467335166|FG002|Overall Study|Lost to Follow-up|0|||
129827961|NCT01367158|467335167|FG003|Overall Study|Lost to Follow-up|1|||
129827962|NCT01367158|467335168|FG004|Overall Study|Lost to Follow-up|0|||
129827963|NCT01367158|467335169|FG005|Overall Study|Lost to Follow-up|2|||
129827964|NCT01367158|467335170|FG006|Overall Study|Lost to Follow-up|0|||
129827965|NCT01367158|467335171|FG007|Overall Study|Lost to Follow-up|1|||
129827966|NCT01367158|467335172|FG008|Overall Study|Lost to Follow-up|0|||
129827967|NCT01367158|467335173|FG009|Overall Study|Lost to Follow-up|0|||
129827968|NCT01367158|467335174|FG010|Overall Study|Lost to Follow-up|1|||
129827969|NCT01367158|467335164|FG000|Overall Study|Protocol Violation|0|||
129827970|NCT01367158|467335165|FG001|Overall Study|Protocol Violation|1|||
129827971|NCT01367158|467335166|FG002|Overall Study|Protocol Violation|0|||
129827972|NCT01367158|467335167|FG003|Overall Study|Protocol Violation|0|||
129827973|NCT01367158|467335168|FG004|Overall Study|Protocol Violation|0|||
129827974|NCT01367158|467335169|FG005|Overall Study|Protocol Violation|0|||
129827975|NCT01367158|467335170|FG006|Overall Study|Protocol Violation|0|||
129827976|NCT01367158|467335171|FG007|Overall Study|Protocol Violation|0|||
129827977|NCT01367158|467335172|FG008|Overall Study|Protocol Violation|0|||
129827978|NCT01367158|467335173|FG009|Overall Study|Protocol Violation|0|||
129827979|NCT01367158|467335174|FG010|Overall Study|Protocol Violation|0|||
129827980|NCT02226003|467335175|FG000|Overall Study|Lost to Follow-up|2|||
129827981|NCT02226003|467335176|FG001|Overall Study|Lost to Follow-up|1|||
129827982|NCT02226003|467335177|FG002|Overall Study|Lost to Follow-up|3|||
129827983|NCT02226003|467335175|FG000|Overall Study|Withdrawal by Subject|0|||
129827984|NCT02226003|467335176|FG001|Overall Study|Withdrawal by Subject|0|||
129827985|NCT02226003|467335177|FG002|Overall Study|Withdrawal by Subject|3|||
129827986|NCT01499563|467335180|FG000|Overall Study|Withdrawal by Subject|10|||
129827987|NCT01499563|467335181|FG001|Overall Study|Withdrawal by Subject|11|||
129827988|NCT01499563|467335182|FG002|Overall Study|Withdrawal by Subject|7|||
129827989|NCT01499563|467335183|FG003|Overall Study|Withdrawal by Subject|8|||
130112661|NCT00910858|468373433|FG001|Monotherapy Phase|Other|4|||
129827990|NCT01499563|467335180|FG000|Overall Study|Physician Decision|2|||
129827991|NCT01499563|467335181|FG001|Overall Study|Physician Decision|1|||
129827992|NCT01499563|467335182|FG002|Overall Study|Physician Decision|3|||
129827993|NCT01499563|467335183|FG003|Overall Study|Physician Decision|0|||
129827994|NCT01499563|467335180|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
129827995|NCT01499563|467335181|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
129827996|NCT01499563|467335182|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
129827997|NCT01499563|467335183|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
129827998|NCT01499563|467335180|FG000|Overall Study|Adverse Event|2|||
129827999|NCT01499563|467335181|FG001|Overall Study|Adverse Event|0|||
129828000|NCT01499563|467335182|FG002|Overall Study|Adverse Event|1|||
129828001|NCT01499563|467335183|FG003|Overall Study|Adverse Event|3|||
129828002|NCT01499563|467335180|FG000|Overall Study|Lack of Efficacy|0|||
129828003|NCT01499563|467335181|FG001|Overall Study|Lack of Efficacy|1|||
129828004|NCT01499563|467335182|FG002|Overall Study|Lack of Efficacy|6|||
129828005|NCT01499563|467335183|FG003|Overall Study|Lack of Efficacy|3|||
129828006|NCT01499563|467335180|FG000|Overall Study|Other|8|||
129828007|NCT01499563|467335181|FG001|Overall Study|Other|6|||
129828008|NCT01499563|467335182|FG002|Overall Study|Other|6|||
129828009|NCT01499563|467335183|FG003|Overall Study|Other|4|||
129828010|NCT00597012|467335188|FG000|Overall Study|Death|1|||
129828011|NCT00597012|467335189|FG001|Overall Study|Death|1|||
129828012|NCT00597012|467335188|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
129828013|NCT00597012|467335189|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
129828014|NCT00597012|467335188|FG000|Overall Study|Withdrawal by Subject|7|||
129828015|NCT00597012|467335189|FG001|Overall Study|Withdrawal by Subject|4|||
129828016|NCT00597012|467335188|FG000|Overall Study|Ineligible|2|||
129828017|NCT00597012|467335189|FG001|Overall Study|Ineligible|0|||
129828018|NCT00597012|467335188|FG000|Overall Study|Lost to Follow-up|0|||
129828019|NCT00597012|467335189|FG001|Overall Study|Lost to Follow-up|2|||
129828020|NCT00587561|467335693|FG000|Overall Study|Lost to Follow-up|6|||
129828021|NCT00587561|467335694|FG001|Overall Study|Lost to Follow-up|4|||
129828022|NCT00410761|467335695|FG000|Randomized Treatment Period|Adverse Event|34|||
129828023|NCT00410761|467335696|FG001|Randomized Treatment Period|Adverse Event|3|||
129828024|NCT00410761|467335695|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
129828025|NCT00410761|467335696|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
129828026|NCT00410761|467335695|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
129828027|NCT00410761|467335696|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
129828028|NCT00410761|467335695|FG000|Randomized Treatment Period|Other|69|||
129828029|NCT00410761|467335696|FG001|Randomized Treatment Period|Other|21|||
129828030|NCT00410761|467335695|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
129828031|NCT00410761|467335696|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
129828032|NCT00410761|467335695|FG000|Open-Label Treatment Period|Adverse Event|13|||
129828033|NCT00410761|467335696|FG001|Open-Label Treatment Period|Adverse Event|15|||
129828034|NCT00410761|467335695|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
129828035|NCT00410761|467335696|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
129828036|NCT00410761|467335695|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
129828037|NCT00410761|467335696|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
129828038|NCT00410761|467335695|FG000|Open-Label Treatment Period|Other|18|||
129828039|NCT00410761|467335696|FG001|Open-Label Treatment Period|Other|9|||
129828040|NCT02926924|467335698|FG000|Overall Study|withdrawal - reason unknown|0|||
129828041|NCT02926924|467335699|FG001|Overall Study|withdrawal - reason unknown|1|||
129828042|NCT04568590|467335702|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
129828043|NCT02268864|467335703|FG000|Overall Study|Withdrawal by Subject|2|||
129828044|NCT02268864|467335704|FG001|Overall Study|Withdrawal by Subject|0|||
129828045|NCT02268864|467335705|FG002|Overall Study|Withdrawal by Subject|0|||
129828046|NCT02268864|467335703|FG000|Overall Study|Death|0|||
129828047|NCT02268864|467335704|FG001|Overall Study|Death|1|||
129828048|NCT02268864|467335705|FG002|Overall Study|Death|0|||
129828049|NCT05407675|467335706|FG000|Overall Study|Withdrawal by Subject|0|||
129828050|NCT05407675|467335707|FG001|Overall Study|Withdrawal by Subject|2|||
129828051|NCT05407675|467335708|FG002|Overall Study|Withdrawal by Subject|3|||
129828052|NCT05407675|467335709|FG003|Overall Study|Withdrawal by Subject|5|||
129828053|NCT05407675|467335710|FG004|Overall Study|Withdrawal by Subject|0|||
129828054|NCT05407675|467335711|FG005|Overall Study|Withdrawal by Subject|2|||
129828055|NCT05407675|467335712|FG006|Overall Study|Withdrawal by Subject|0|||
129828056|NCT05407675|467335713|FG007|Overall Study|Withdrawal by Subject|0|||
129828057|NCT05407675|467335714|FG008|Overall Study|Withdrawal by Subject|2|||
129828058|NCT05407675|467335715|FG009|Overall Study|Withdrawal by Subject|0|||
129828059|NCT05407675|467335716|FG010|Overall Study|Withdrawal by Subject|1|||
129828060|NCT05407675|467335717|FG011|Overall Study|Withdrawal by Subject|0|||
129828061|NCT05407675|467335718|FG012|Overall Study|Withdrawal by Subject|0|||
129828062|NCT05407675|467335706|FG000|Overall Study|Site terminated by sponsor|0|||
129828063|NCT05407675|467335707|FG001|Overall Study|Site terminated by sponsor|0|||
129828064|NCT05407675|467335708|FG002|Overall Study|Site terminated by sponsor|1|||
129828065|NCT05407675|467335709|FG003|Overall Study|Site terminated by sponsor|0|||
129828066|NCT05407675|467335710|FG004|Overall Study|Site terminated by sponsor|2|||
129828067|NCT05407675|467335711|FG005|Overall Study|Site terminated by sponsor|0|||
129828068|NCT05407675|467335712|FG006|Overall Study|Site terminated by sponsor|1|||
129828069|NCT05407675|467335713|FG007|Overall Study|Site terminated by sponsor|0|||
129828070|NCT05407675|467335714|FG008|Overall Study|Site terminated by sponsor|0|||
129828071|NCT05407675|467335715|FG009|Overall Study|Site terminated by sponsor|2|||
129828072|NCT05407675|467335716|FG010|Overall Study|Site terminated by sponsor|2|||
129828073|NCT05407675|467335717|FG011|Overall Study|Site terminated by sponsor|2|||
129828074|NCT05407675|467335718|FG012|Overall Study|Site terminated by sponsor|1|||
129828075|NCT05407675|467335706|FG000|Overall Study|Disease Progression|0|||
129828076|NCT05407675|467335707|FG001|Overall Study|Disease Progression|0|||
129828077|NCT05407675|467335708|FG002|Overall Study|Disease Progression|0|||
129828078|NCT05407675|467335709|FG003|Overall Study|Disease Progression|0|||
129828079|NCT05407675|467335710|FG004|Overall Study|Disease Progression|0|||
129828080|NCT05407675|467335711|FG005|Overall Study|Disease Progression|0|||
129828081|NCT05407675|467335712|FG006|Overall Study|Disease Progression|0|||
129828082|NCT05407675|467335713|FG007|Overall Study|Disease Progression|0|||
129828083|NCT05407675|467335714|FG008|Overall Study|Disease Progression|0|||
129828084|NCT05407675|467335715|FG009|Overall Study|Disease Progression|0|||
129828085|NCT05407675|467335716|FG010|Overall Study|Disease Progression|1|||
129828086|NCT05407675|467335717|FG011|Overall Study|Disease Progression|0|||
129828087|NCT05407675|467335718|FG012|Overall Study|Disease Progression|0|||
129828088|NCT05407675|467335706|FG000|Overall Study|Physician Decision|0|||
129828089|NCT05407675|467335707|FG001|Overall Study|Physician Decision|0|||
129828090|NCT05407675|467335708|FG002|Overall Study|Physician Decision|0|||
129828091|NCT05407675|467335709|FG003|Overall Study|Physician Decision|0|||
129828092|NCT05407675|467335710|FG004|Overall Study|Physician Decision|0|||
129828093|NCT05407675|467335711|FG005|Overall Study|Physician Decision|0|||
129828094|NCT05407675|467335712|FG006|Overall Study|Physician Decision|0|||
129828095|NCT05407675|467335713|FG007|Overall Study|Physician Decision|0|||
129828096|NCT05407675|467335714|FG008|Overall Study|Physician Decision|0|||
129828097|NCT05407675|467335715|FG009|Overall Study|Physician Decision|0|||
129828098|NCT05407675|467335716|FG010|Overall Study|Physician Decision|1|||
129828099|NCT05407675|467335717|FG011|Overall Study|Physician Decision|0|||
129828100|NCT05407675|467335718|FG012|Overall Study|Physician Decision|0|||
129828101|NCT05407675|467335706|FG000|Overall Study|Other reasons|0|||
129828102|NCT05407675|467335707|FG001|Overall Study|Other reasons|0|||
129828103|NCT05407675|467335708|FG002|Overall Study|Other reasons|0|||
129828104|NCT05407675|467335709|FG003|Overall Study|Other reasons|0|||
129828105|NCT05407675|467335710|FG004|Overall Study|Other reasons|0|||
129828106|NCT05407675|467335711|FG005|Overall Study|Other reasons|0|||
129828107|NCT05407675|467335712|FG006|Overall Study|Other reasons|0|||
129828108|NCT05407675|467335713|FG007|Overall Study|Other reasons|0|||
129828109|NCT05407675|467335714|FG008|Overall Study|Other reasons|1|||
129828110|NCT05407675|467335715|FG009|Overall Study|Other reasons|1|||
129828111|NCT05407675|467335716|FG010|Overall Study|Other reasons|1|||
129828112|NCT05407675|467335717|FG011|Overall Study|Other reasons|1|||
129828113|NCT05407675|467335718|FG012|Overall Study|Other reasons|0|||
129828114|NCT05407675|467335706|FG000|Overall Study|Death|3|||
129828115|NCT05407675|467335707|FG001|Overall Study|Death|4|||
129828116|NCT05407675|467335708|FG002|Overall Study|Death|3|||
129828117|NCT05407675|467335709|FG003|Overall Study|Death|6|||
129828118|NCT05407675|467335710|FG004|Overall Study|Death|0|||
129828119|NCT05407675|467335711|FG005|Overall Study|Death|2|||
129828120|NCT05407675|467335712|FG006|Overall Study|Death|4|||
129828121|NCT05407675|467335713|FG007|Overall Study|Death|2|||
129828122|NCT05407675|467335714|FG008|Overall Study|Death|2|||
129828123|NCT05407675|467335715|FG009|Overall Study|Death|4|||
129828124|NCT05407675|467335716|FG010|Overall Study|Death|2|||
129828125|NCT05407675|467335717|FG011|Overall Study|Death|1|||
129828126|NCT05407675|467335718|FG012|Overall Study|Death|0|||
129828127|NCT05407675|467335706|FG000|Overall Study|Adverse Event|0|||
129828128|NCT05407675|467335707|FG001|Overall Study|Adverse Event|0|||
129828129|NCT05407675|467335708|FG002|Overall Study|Adverse Event|0|||
129828130|NCT05407675|467335709|FG003|Overall Study|Adverse Event|0|||
129828131|NCT05407675|467335710|FG004|Overall Study|Adverse Event|1|||
129828132|NCT05407675|467335711|FG005|Overall Study|Adverse Event|0|||
129828133|NCT05407675|467335712|FG006|Overall Study|Adverse Event|0|||
129828134|NCT05407675|467335713|FG007|Overall Study|Adverse Event|0|||
129828135|NCT05407675|467335714|FG008|Overall Study|Adverse Event|0|||
129828136|NCT05407675|467335715|FG009|Overall Study|Adverse Event|0|||
129828137|NCT05407675|467335716|FG010|Overall Study|Adverse Event|0|||
129828138|NCT05407675|467335717|FG011|Overall Study|Adverse Event|1|||
129828139|NCT05407675|467335718|FG012|Overall Study|Adverse Event|0|||
129828140|NCT05407675|467335706|FG000|Overall Study|Ongoing Treatment|0|||
129828141|NCT05407675|467335707|FG001|Overall Study|Ongoing Treatment|0|||
129828142|NCT05407675|467335708|FG002|Overall Study|Ongoing Treatment|0|||
129828143|NCT05407675|467335709|FG003|Overall Study|Ongoing Treatment|0|||
129828144|NCT05407675|467335710|FG004|Overall Study|Ongoing Treatment|0|||
129828145|NCT05407675|467335711|FG005|Overall Study|Ongoing Treatment|0|||
129828146|NCT05407675|467335712|FG006|Overall Study|Ongoing Treatment|0|||
129828147|NCT05407675|467335713|FG007|Overall Study|Ongoing Treatment|0|||
129828148|NCT05407675|467335714|FG008|Overall Study|Ongoing Treatment|1|||
129828149|NCT05407675|467335715|FG009|Overall Study|Ongoing Treatment|0|||
129828150|NCT05407675|467335716|FG010|Overall Study|Ongoing Treatment|0|||
129828151|NCT05407675|467335717|FG011|Overall Study|Ongoing Treatment|0|||
129828152|NCT05407675|467335718|FG012|Overall Study|Ongoing Treatment|0|||
129828153|NCT00857220|467335719|FG000|Overall Study|Adverse Event|35|||
129828154|NCT00857220|467335719|FG000|Overall Study|Death|1|||
129828155|NCT00857220|467335719|FG000|Overall Study|Lack of Efficacy|11|||
129828156|NCT00857220|467335719|FG000|Overall Study|Lost to Follow-up|30|||
130060279|NCT01536119|468174719|FG001|Overall Study|Lost to Follow-up|14|||
130060280|NCT00280150|468176607|FG000|Overall Study|Adverse Event|0|||
130060281|NCT00280150|468176608|FG001|Overall Study|Adverse Event|1|||
129828157|NCT00857220|467335719|FG000|Overall Study|Physician Decision|4|||
129828158|NCT00857220|467335719|FG000|Overall Study|Protocol Violation|16|||
129828159|NCT00857220|467335719|FG000|Overall Study|Withdrawal by Subject|67|||
129828160|NCT00857220|467335719|FG000|Overall Study|Clinical Hold|6|||
129828161|NCT00857220|467335719|FG000|Overall Study|Site Closed|5|||
129828162|NCT00857220|467335719|FG000|Overall Study|Miscellaneous|8|||
129828163|NCT03698994|467335720|FG000|Overall Study|Adverse Event|2|||
129828164|NCT03698994|467335720|FG000|Overall Study|Death|1|||
129828165|NCT03698994|467335720|FG000|Overall Study|Physician Decision|1|||
129828166|NCT03698994|467335720|FG000|Overall Study|Withdrawal by Subject|3|||
129828167|NCT03698994|467335720|FG000|Overall Study|Progressive Disease|12|||
129828168|NCT03251079|467335726|FG000|Overall Study|Withdrawal by Subject|1|||
129828169|NCT02472795|467335733|FG000|Overall Study|Adverse Event|0|||
129828170|NCT02472795|467335734|FG001|Overall Study|Adverse Event|1|||
129828171|NCT02472795|467335735|FG002|Overall Study|Adverse Event|0|||
129828172|NCT02472795|467335736|FG003|Overall Study|Adverse Event|0|||
129828173|NCT02472795|467335737|FG004|Overall Study|Adverse Event|2|||
129828174|NCT02472795|467335733|FG000|Overall Study|Withdrawal by Subject|0|||
129828175|NCT02472795|467335734|FG001|Overall Study|Withdrawal by Subject|0|||
129828176|NCT02472795|467335735|FG002|Overall Study|Withdrawal by Subject|0|||
129828177|NCT02472795|467335736|FG003|Overall Study|Withdrawal by Subject|0|||
129828178|NCT02472795|467335737|FG004|Overall Study|Withdrawal by Subject|1|||
129828179|NCT04166513|467335738|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
129828180|NCT04166513|467335739|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
129828181|NCT04166513|467335740|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
129828182|NCT04166513|467335741|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
129828183|NCT04166513|467335738|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
129828184|NCT04166513|467335739|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
129828185|NCT04166513|467335740|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
129828186|NCT04166513|467335741|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
129828187|NCT04166513|467335738|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
129828188|NCT04166513|467335739|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
129828189|NCT04166513|467335740|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
129828190|NCT04166513|467335741|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
129828191|NCT04166513|467335738|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
129828192|NCT04166513|467335739|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
129828193|NCT04166513|467335740|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
129828194|NCT04166513|467335741|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
129828195|NCT04166513|467335738|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
129828196|NCT04166513|467335739|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
129828197|NCT04166513|467335740|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
129828198|NCT04166513|467335741|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
129828199|NCT00202644|467337254|FG000|Overall Study|Adverse Event|12|||
129828200|NCT00202644|467337255|FG001|Overall Study|Adverse Event|13|||
129828201|NCT00202644|467337254|FG000|Overall Study|Withdrawal by Subject|8|||
129828202|NCT00202644|467337255|FG001|Overall Study|Withdrawal by Subject|6|||
129828203|NCT00202644|467337254|FG000|Overall Study|Lack of Efficacy|6|||
129828204|NCT00202644|467337255|FG001|Overall Study|Lack of Efficacy|6|||
129828205|NCT00202644|467337254|FG000|Overall Study|Lost to Follow-up|0|||
129828206|NCT00202644|467337255|FG001|Overall Study|Lost to Follow-up|1|||
129828207|NCT00202644|467337254|FG000|Overall Study|Other|9|||
129828208|NCT00202644|467337255|FG001|Overall Study|Other|1|||
129828209|NCT03724812|467337262|FG000|Overall Study|Missed Visit|1|||
129828210|NCT03724812|467337262|FG000|Overall Study|Death|2|||
129828211|NCT03724812|467337262|FG000|Overall Study|Withdrawal by Subject|1|||
129828212|NCT01851720|467337263|FG000|Overall Study|Lost to Follow-up|0|||
129828213|NCT01851720|467337264|FG001|Overall Study|Lost to Follow-up|1|||
129828214|NCT01870583|467337267|FG000|Overall Study|Protocol Violation|0|||
129828215|NCT01870583|467337268|FG001|Overall Study|Protocol Violation|5|||
129828216|NCT01870583|467337269|FG002|Overall Study|Protocol Violation|3|||
129828217|NCT01870583|467337267|FG000|Overall Study|Lost to Follow-up|11|||
129828218|NCT01870583|467337268|FG001|Overall Study|Lost to Follow-up|13|||
129828219|NCT01870583|467337269|FG002|Overall Study|Lost to Follow-up|5|||
129828220|NCT04741074|467337270|FG000|Overall Study|Withdrawal by Subject|1|||
129828221|NCT04741074|467337271|FG001|Overall Study|Withdrawal by Subject|1|||
129828222|NCT04741074|467337270|FG000|Overall Study|Study terminated prematurely|1|||
129828223|NCT04741074|467337271|FG001|Overall Study|Study terminated prematurely|0|||
129828224|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Death|3|||
129828225|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Death|2|||
129828226|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Death|4|||
129828227|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Death|3|||
129828228|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Death|0|||
129828229|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Death|0|||
129828230|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828231|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
129897672|NCT02524288|467584422|FG000|Overall Study|Lost to Follow-up|216|||
129897673|NCT02524288|467584422|FG000|Overall Study|Non-Compliance With Protocol|32|||
129828232|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
129828233|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828234|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828235|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828236|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
129828237|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828238|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828239|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828240|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828241|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828242|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
129828243|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
129828244|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
129828245|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
129828246|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
129828247|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
129828248|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828249|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828250|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
129828251|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
129828252|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828253|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828254|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
129828255|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
129828256|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
129828257|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
129828258|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
129828259|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
129828260|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828261|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828262|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
129828263|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828264|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828265|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828266|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
129828267|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
129828268|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
129828269|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
129828270|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
129828271|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
129828272|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828273|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828274|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828275|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828276|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
129828277|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
129828278|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828279|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828280|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828281|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828282|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
129828283|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828284|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828285|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828286|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828287|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828288|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
129828289|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
129828290|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129828291|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129828292|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129828293|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129897674|NCT02524288|467584422|FG000|Overall Study|Non-Compliance With Study Drug|14|||
130060282|NCT00280150|468176609|FG002|Overall Study|Adverse Event|2|||
130060283|NCT00280150|468176610|FG003|Overall Study|Adverse Event|3|||
130060284|NCT00280150|468176607|FG000|Overall Study|Lack of Efficacy|0|||
130060285|NCT00280150|468176608|FG001|Overall Study|Lack of Efficacy|0|||
130060286|NCT00280150|468176609|FG002|Overall Study|Lack of Efficacy|0|||
130060287|NCT00280150|468176610|FG003|Overall Study|Lack of Efficacy|3|||
130060288|NCT00280150|468176607|FG000|Overall Study|Physician Decision|0|||
130060289|NCT00280150|468176608|FG001|Overall Study|Physician Decision|0|||
130060290|NCT00280150|468176609|FG002|Overall Study|Physician Decision|0|||
130060291|NCT00280150|468176610|FG003|Overall Study|Physician Decision|1|||
129828294|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
129828295|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
129828296|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828297|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828298|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828299|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828300|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
129828301|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
129828302|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828303|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828304|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828305|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828306|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
129828307|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828308|NCT01770379|467337278|FG000|Overall Study|Technical issues|1|||
129828309|NCT01770379|467337279|FG001|Overall Study|Technical issues|0|||
129828310|NCT01770379|467337280|FG002|Overall Study|Technical issues|0|||
129828311|NCT01770379|467337278|FG000|Overall Study|Withdrawal by Subject|7|||
129828312|NCT01770379|467337279|FG001|Overall Study|Withdrawal by Subject|10|||
129828313|NCT01770379|467337280|FG002|Overall Study|Withdrawal by Subject|7|||
129828314|NCT01770379|467337278|FG000|Overall Study|study terminated by sponsor|22|||
129828315|NCT01770379|467337279|FG001|Overall Study|study terminated by sponsor|23|||
129828316|NCT01770379|467337280|FG002|Overall Study|study terminated by sponsor|22|||
129828317|NCT01770379|467337278|FG000|Overall Study|Protocol Violation|0|||
129828318|NCT01770379|467337279|FG001|Overall Study|Protocol Violation|1|||
129828319|NCT01770379|467337280|FG002|Overall Study|Protocol Violation|1|||
129828320|NCT01770379|467337278|FG000|Overall Study|Physician Decision|0|||
129828321|NCT01770379|467337279|FG001|Overall Study|Physician Decision|1|||
129828322|NCT01770379|467337280|FG002|Overall Study|Physician Decision|2|||
129828323|NCT01770379|467337278|FG000|Overall Study|Lost to Follow-up|0|||
129828324|NCT01770379|467337279|FG001|Overall Study|Lost to Follow-up|0|||
129828325|NCT01770379|467337280|FG002|Overall Study|Lost to Follow-up|2|||
129828326|NCT01770379|467337278|FG000|Overall Study|Lack of Efficacy|8|||
129828327|NCT01770379|467337279|FG001|Overall Study|Lack of Efficacy|6|||
129828328|NCT01770379|467337280|FG002|Overall Study|Lack of Efficacy|6|||
129828329|NCT01770379|467337278|FG000|Overall Study|Adverse Event|1|||
129828330|NCT01770379|467337279|FG001|Overall Study|Adverse Event|3|||
129828331|NCT01770379|467337280|FG002|Overall Study|Adverse Event|2|||
129828332|NCT03045887|467337281|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
129828333|NCT03045887|467337282|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828334|NCT03045887|467337283|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828335|NCT03045887|467337284|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828336|NCT03045887|467337285|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828337|NCT03045887|467337286|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828338|NCT03045887|467337287|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828339|NCT03045887|467337288|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828340|NCT03045887|467337289|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828341|NCT03045887|467337290|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828342|NCT03045887|467337281|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828343|NCT03045887|467337282|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828344|NCT03045887|467337283|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828345|NCT03045887|467337284|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
129828346|NCT03045887|467337285|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828347|NCT03045887|467337286|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828348|NCT03045887|467337287|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828349|NCT03045887|467337288|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828350|NCT03045887|467337289|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828351|NCT03045887|467337290|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129897675|NCT02524288|467584422|FG000|Overall Study|Pregnancy Wish|6|||
129897676|NCT02524288|467584422|FG000|Overall Study|Protocol Violation|6|||
130060292|NCT00280150|468176607|FG000|Overall Study|Protocol Violation|0|||
130060293|NCT00280150|468176608|FG001|Overall Study|Protocol Violation|0|||
129828352|NCT03045887|467337281|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
129828353|NCT03045887|467337282|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828354|NCT03045887|467337283|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828355|NCT03045887|467337284|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828356|NCT03045887|467337285|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828357|NCT03045887|467337286|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828358|NCT03045887|467337287|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828359|NCT03045887|467337288|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828360|NCT03045887|467337289|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828361|NCT03045887|467337290|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828362|NCT03045887|467337281|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828363|NCT03045887|467337282|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828364|NCT03045887|467337283|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
129828365|NCT03045887|467337284|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
129828366|NCT03045887|467337285|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828367|NCT03045887|467337286|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828368|NCT03045887|467337287|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828369|NCT03045887|467337288|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828370|NCT03045887|467337289|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828371|NCT03045887|467337290|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828372|NCT03045887|467337281|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828373|NCT03045887|467337282|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828374|NCT03045887|467337283|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828375|NCT03045887|467337284|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
129828376|NCT03045887|467337285|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828377|NCT03045887|467337286|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828378|NCT03045887|467337287|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828379|NCT03045887|467337288|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828380|NCT03045887|467337289|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828381|NCT03045887|467337290|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828382|NCT01912287|467337292|FG000|Overall Study|Ineligible|1|||
129828383|NCT01912287|467337293|FG001|Overall Study|Ineligible|0|||
129828384|NCT01912287|467337294|FG002|Overall Study|Ineligible|1|||
129828385|NCT01912287|467337292|FG000|Overall Study|No-show|0|||
129828386|NCT01912287|467337293|FG001|Overall Study|No-show|0|||
129828387|NCT01912287|467337294|FG002|Overall Study|No-show|1|||
129828388|NCT01912287|467337292|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
129828389|NCT01912287|467337293|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
129828390|NCT01912287|467337294|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
129828391|NCT01912287|467337292|FG000|Overall Study|Felt treatment no longer needed|0|||
129828392|NCT01912287|467337293|FG001|Overall Study|Felt treatment no longer needed|1|||
129828393|NCT01912287|467337294|FG002|Overall Study|Felt treatment no longer needed|0|||
129828394|NCT01912287|467337292|FG000|Overall Study|Life circumstances|4|||
129828395|NCT01912287|467337293|FG001|Overall Study|Life circumstances|2|||
129828396|NCT01912287|467337294|FG002|Overall Study|Life circumstances|0|||
129828397|NCT01912287|467337292|FG000|Overall Study|Lost Interest|1|||
129828398|NCT01912287|467337293|FG001|Overall Study|Lost Interest|0|||
129828399|NCT01912287|467337294|FG002|Overall Study|Lost Interest|0|||
129828400|NCT01912287|467337292|FG000|Overall Study|Uknown reason - subject drop out|5|||
129828401|NCT01912287|467337293|FG001|Overall Study|Uknown reason - subject drop out|7|||
129828402|NCT01912287|467337294|FG002|Overall Study|Uknown reason - subject drop out|3|||
129828403|NCT01912287|467337292|FG000|Overall Study|Missed Assesment|1|||
129828404|NCT01912287|467337293|FG001|Overall Study|Missed Assesment|1|||
129828405|NCT01912287|467337294|FG002|Overall Study|Missed Assesment|1|||
129828406|NCT01912287|467337292|FG000|Overall Study|Scheduling/change in availability|17|||
129828407|NCT01912287|467337293|FG001|Overall Study|Scheduling/change in availability|10|||
129828408|NCT01912287|467337294|FG002|Overall Study|Scheduling/change in availability|8|||
129828409|NCT03914326|467337297|FG000|Overall Study|Withdrawal by Subject|27|||
129828410|NCT03914326|467337298|FG001|Overall Study|Withdrawal by Subject|34|||
129828411|NCT03914326|467337297|FG000|Overall Study|Lost to Follow-up|43|||
129828412|NCT03914326|467337298|FG001|Overall Study|Lost to Follow-up|51|||
129828413|NCT03914326|467337297|FG000|Overall Study|Randomised more than once|0|||
129828414|NCT03914326|467337298|FG001|Overall Study|Randomised more than once|1|||
129828415|NCT03226392|467337303|FG000|Overall Study|Protocol Deviation|1|||
129828416|NCT03226392|467337304|FG001|Overall Study|Protocol Deviation|0|||
129828417|NCT03226392|467337303|FG000|Overall Study|Physician Decision|1|||
129828418|NCT03226392|467337304|FG001|Overall Study|Physician Decision|0|||
129828419|NCT03226392|467337303|FG000|Overall Study|Lost to Follow-up|1|||
129828420|NCT03226392|467337304|FG001|Overall Study|Lost to Follow-up|0|||
129828421|NCT03226392|467337303|FG000|Overall Study|Adverse Event|1|||
129828422|NCT03226392|467337304|FG001|Overall Study|Adverse Event|0|||
129828423|NCT03226392|467337303|FG000|Overall Study|Technical Problems|0|||
129828424|NCT03226392|467337304|FG001|Overall Study|Technical Problems|2|||
129828425|NCT03226392|467337303|FG000|Overall Study|Subject/Guardian Decision|7|||
130060294|NCT00280150|468176609|FG002|Overall Study|Protocol Violation|0|||
130060295|NCT00280150|468176610|FG003|Overall Study|Protocol Violation|1|||
130060296|NCT00280150|468176607|FG000|Overall Study|Withdrawal by Subject|0|||
130060297|NCT00280150|468176608|FG001|Overall Study|Withdrawal by Subject|0|||
130060298|NCT00280150|468176609|FG002|Overall Study|Withdrawal by Subject|0|||
130060299|NCT00280150|468176610|FG003|Overall Study|Withdrawal by Subject|1|||
129828426|NCT03226392|467337304|FG001|Overall Study|Subject/Guardian Decision|6|||
129828427|NCT04788953|467337305|FG000|Overall Study|Adverse Event|1|||
129828428|NCT04788953|467337306|FG001|Overall Study|Adverse Event|1|||
129828429|NCT04788953|467337305|FG000|Overall Study|Withdrawal by Subject|1|||
129828430|NCT04788953|467337306|FG001|Overall Study|Withdrawal by Subject|0|||
129828431|NCT04788953|467337305|FG000|Overall Study|Protocol Violation|0|||
129828432|NCT04788953|467337306|FG001|Overall Study|Protocol Violation|1|||
129828433|NCT00937157|467337307|FG000|Overall Study|Pregnancy|1|||
129828434|NCT00937157|467337307|FG000|Overall Study|Lost to Follow-up|3|||
129828435|NCT00469092|467337308|FG000|Overall Study|Adverse Event|5|||
129828436|NCT00469092|467337309|FG001|Overall Study|Adverse Event|4|||
129828437|NCT00469092|467337308|FG000|Overall Study|Lack of Efficacy|1|||
129828438|NCT00469092|467337309|FG001|Overall Study|Lack of Efficacy|0|||
129828439|NCT00469092|467337308|FG000|Overall Study|Lost to Follow-up|1|||
129828440|NCT00469092|467337309|FG001|Overall Study|Lost to Follow-up|2|||
129828441|NCT00469092|467337308|FG000|Overall Study|Protocol Violation|3|||
129828442|NCT00469092|467337309|FG001|Overall Study|Protocol Violation|3|||
129828443|NCT00469092|467337308|FG000|Overall Study|Withdrawal by Subject|4|||
129828444|NCT00469092|467337309|FG001|Overall Study|Withdrawal by Subject|4|||
129828445|NCT00469092|467337308|FG000|Overall Study|Withdrawal Criteria|3|||
129828446|NCT00469092|467337309|FG001|Overall Study|Withdrawal Criteria|4|||
129828447|NCT00469092|467337308|FG000|Overall Study|Incorrectly Randomised|4|||
129828448|NCT00469092|467337309|FG001|Overall Study|Incorrectly Randomised|3|||
129828449|NCT00469092|467337308|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
129828450|NCT00469092|467337309|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
129828451|NCT00469092|467337308|FG000|Overall Study|Use of lipid lowering drug|1|||
129828452|NCT00469092|467337309|FG001|Overall Study|Use of lipid lowering drug|0|||
129828453|NCT00469092|467337308|FG000|Overall Study|Hypoglycaemic Episodes|1|||
129828454|NCT00469092|467337309|FG001|Overall Study|Hypoglycaemic Episodes|1|||
129828455|NCT00469092|467337308|FG000|Overall Study|Abnormal lab value|1|||
129828456|NCT00469092|467337309|FG001|Overall Study|Abnormal lab value|0|||
129828457|NCT00469092|467337308|FG000|Overall Study|Use of Corticosteroid|1|||
129828458|NCT00469092|467337309|FG001|Overall Study|Use of Corticosteroid|0|||
129828459|NCT02024867|467337310|FG000|Overall Study|Protocol Violation|3|||
129828460|NCT02024867|467337311|FG001|Overall Study|Protocol Violation|3|||
129828461|NCT02024867|467337310|FG000|Overall Study|Lost to Follow-up|6|||
129828462|NCT02024867|467337311|FG001|Overall Study|Lost to Follow-up|4|||
129828463|NCT01998633|467337313|FG000|Overall Study|Death|1|||
129828464|NCT00413192|467337314|FG000|Overall Study|Disease progression|26|||
129828465|NCT00413192|467337315|FG001|Overall Study|Disease progression|31|||
129828466|NCT00413192|467337316|FG002|Overall Study|Disease progression|16|||
129828467|NCT00413192|467337317|FG003|Overall Study|Disease progression|25|||
129828468|NCT00413192|467337314|FG000|Overall Study|Toxicity|3|||
129828469|NCT00413192|467337315|FG001|Overall Study|Toxicity|2|||
129828470|NCT00413192|467337316|FG002|Overall Study|Toxicity|2|||
129828471|NCT00413192|467337317|FG003|Overall Study|Toxicity|2|||
129828472|NCT00413192|467337314|FG000|Overall Study|Withdrawal by Subject|3|||
129828473|NCT00413192|467337315|FG001|Overall Study|Withdrawal by Subject|5|||
129828474|NCT00413192|467337316|FG002|Overall Study|Withdrawal by Subject|0|||
129828475|NCT00413192|467337317|FG003|Overall Study|Withdrawal by Subject|1|||
129828476|NCT00413192|467337314|FG000|Overall Study|Intercurrent illness|0|||
129828477|NCT00413192|467337315|FG001|Overall Study|Intercurrent illness|0|||
129828478|NCT00413192|467337316|FG002|Overall Study|Intercurrent illness|0|||
129828479|NCT00413192|467337317|FG003|Overall Study|Intercurrent illness|1|||
129828480|NCT00413192|467337314|FG000|Overall Study|Intercurrent death|0|||
129828481|NCT00413192|467337315|FG001|Overall Study|Intercurrent death|1|||
129828482|NCT00413192|467337316|FG002|Overall Study|Intercurrent death|0|||
129828483|NCT00413192|467337317|FG003|Overall Study|Intercurrent death|0|||
129828484|NCT00413192|467337314|FG000|Overall Study|Other|5|||
130060300|NCT00280150|468176607|FG000|Overall Study|Did not get consolidation therapy|3|||
129828485|NCT00413192|467337315|FG001|Overall Study|Other|1|||
129828486|NCT00413192|467337316|FG002|Overall Study|Other|1|||
129828487|NCT00413192|467337317|FG003|Overall Study|Other|2|||
129828488|NCT00413192|467337314|FG000|Overall Study|Not treated|0|||
129828489|NCT00413192|467337315|FG001|Overall Study|Not treated|0|||
129828490|NCT00413192|467337316|FG002|Overall Study|Not treated|0|||
129828491|NCT00413192|467337317|FG003|Overall Study|Not treated|1|||
129828492|NCT02631850|467337318|FG000|Treatment Period|Lost to Follow-up|0|||
129828493|NCT02631850|467337319|FG001|Treatment Period|Lost to Follow-up|1|||
129828494|NCT02631850|467337320|FG002|Treatment Period|Lost to Follow-up|0|||
129828495|NCT02631850|467337321|FG003|Treatment Period|Lost to Follow-up|0|||
129828496|NCT02631850|467337318|FG000|Treatment Period|Protocol Violation|1|||
129828497|NCT02631850|467337319|FG001|Treatment Period|Protocol Violation|0|||
129828498|NCT02631850|467337320|FG002|Treatment Period|Protocol Violation|0|||
129828499|NCT02631850|467337321|FG003|Treatment Period|Protocol Violation|0|||
129828500|NCT02631850|467337318|FG000|Treatment Period|Withdrawal by Subject|0|||
129828501|NCT02631850|467337319|FG001|Treatment Period|Withdrawal by Subject|5|||
129828502|NCT02631850|467337320|FG002|Treatment Period|Withdrawal by Subject|2|||
129828503|NCT02631850|467337321|FG003|Treatment Period|Withdrawal by Subject|2|||
129828504|NCT02631850|467337318|FG000|Treatment Period|Adverse Event|1|||
129828505|NCT02631850|467337319|FG001|Treatment Period|Adverse Event|0|||
129828506|NCT02631850|467337320|FG002|Treatment Period|Adverse Event|2|||
129828507|NCT02631850|467337321|FG003|Treatment Period|Adverse Event|3|||
129828508|NCT02631850|467337318|FG000|Treatment Period|Family medical issue|1|||
129828509|NCT02631850|467337319|FG001|Treatment Period|Family medical issue|0|||
129828510|NCT02631850|467337320|FG002|Treatment Period|Family medical issue|0|||
129828511|NCT02631850|467337321|FG003|Treatment Period|Family medical issue|0|||
129828512|NCT02631850|467337318|FG000|6 Month Follow up|Lost to Follow-up|5|||
129828513|NCT02631850|467337319|FG001|6 Month Follow up|Lost to Follow-up|8|||
129828514|NCT02631850|467337320|FG002|6 Month Follow up|Lost to Follow-up|3|||
129828515|NCT02631850|467337321|FG003|6 Month Follow up|Lost to Follow-up|5|||
129828516|NCT02631850|467337318|FG000|6 Month Follow up|Withdrawal by Subject|1|||
129828517|NCT02631850|467337319|FG001|6 Month Follow up|Withdrawal by Subject|0|||
129828518|NCT02631850|467337320|FG002|6 Month Follow up|Withdrawal by Subject|0|||
129828519|NCT02631850|467337321|FG003|6 Month Follow up|Withdrawal by Subject|2|||
129828520|NCT02631850|467337318|FG000|6 Month Follow up|Adverse Event|1|||
129828521|NCT02631850|467337319|FG001|6 Month Follow up|Adverse Event|4|||
129828522|NCT02631850|467337320|FG002|6 Month Follow up|Adverse Event|1|||
129828523|NCT02631850|467337321|FG003|6 Month Follow up|Adverse Event|3|||
129828524|NCT02631850|467337318|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
129828525|NCT02631850|467337319|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
129828526|NCT02631850|467337320|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
129828527|NCT02631850|467337321|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
129828528|NCT03992781|467337324|FG000|Overall Study|Lost to Follow-up|5|||
129828529|NCT03992781|467337324|FG000|Overall Study|Adverse Event|1|||
129828530|NCT03992781|467337324|FG000|Overall Study|Lack of Efficacy|5|||
129828531|NCT02118012|467337325|FG000|Overall Study|Adverse Event|0|||
129828532|NCT02118012|467337326|FG001|Overall Study|Adverse Event|1|||
129828533|NCT02118012|467337325|FG000|Overall Study|Physician Decision|0|||
129828534|NCT02118012|467337326|FG001|Overall Study|Physician Decision|1|||
129828535|NCT00171223|467337327|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
129828536|NCT00171223|467337328|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
129828537|NCT00171223|467337329|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
129828538|NCT00171223|467337327|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
129828539|NCT00171223|467337328|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
130112662|NCT00910858|468373434|FG002|Monotherapy Phase|Other|2|||
129828540|NCT00171223|467337329|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
129828541|NCT00171223|467337327|FG000|Overall Study|Abnormal Procedure|1|||
129828542|NCT00171223|467337328|FG001|Overall Study|Abnormal Procedure|0|||
129828543|NCT00171223|467337329|FG002|Overall Study|Abnormal Procedure|0|||
129828544|NCT00171223|467337327|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
129828545|NCT00171223|467337328|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
129828546|NCT00171223|467337329|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
129828547|NCT00171223|467337327|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
129828548|NCT00171223|467337328|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
129828549|NCT00171223|467337329|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
129828550|NCT00171223|467337327|FG000|Overall Study|Protocol Violation|2|||
129828551|NCT00171223|467337328|FG001|Overall Study|Protocol Violation|2|||
129828552|NCT00171223|467337329|FG002|Overall Study|Protocol Violation|3|||
129828553|NCT00171223|467337327|FG000|Overall Study|Participant Withdrew Consent|12|||
129828554|NCT00171223|467337328|FG001|Overall Study|Participant Withdrew Consent|21|||
129828555|NCT00171223|467337329|FG002|Overall Study|Participant Withdrew Consent|15|||
129828556|NCT00171223|467337327|FG000|Overall Study|Lost to Follow-up|5|||
129828557|NCT00171223|467337328|FG001|Overall Study|Lost to Follow-up|2|||
129828558|NCT00171223|467337329|FG002|Overall Study|Lost to Follow-up|3|||
129828559|NCT00171223|467337327|FG000|Overall Study|Administrative Problems|4|||
129828560|NCT00171223|467337328|FG001|Overall Study|Administrative Problems|7|||
129828561|NCT00171223|467337329|FG002|Overall Study|Administrative Problems|6|||
129828562|NCT00171223|467337327|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
130112663|NCT00910858|468373432|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
129828563|NCT00171223|467337328|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
129828564|NCT00171223|467337329|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
129828565|NCT00171223|467337327|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
129828566|NCT00171223|467337328|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
129828567|NCT00171223|467337329|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
129828568|NCT00455429|467337330|FG000|Overall Study|Study Terminated by Sponsor|0|||
129828569|NCT00455429|467337331|FG001|Overall Study|Study Terminated by Sponsor|0|||
129828570|NCT00455429|467337332|FG002|Overall Study|Study Terminated by Sponsor|0|||
129828571|NCT00455429|467337333|FG003|Overall Study|Study Terminated by Sponsor|3|||
129828572|NCT00455429|467337330|FG000|Overall Study|Lost to Follow-up|1|||
129828573|NCT00455429|467337331|FG001|Overall Study|Lost to Follow-up|0|||
129828574|NCT00455429|467337332|FG002|Overall Study|Lost to Follow-up|0|||
129828575|NCT00455429|467337333|FG003|Overall Study|Lost to Follow-up|3|||
129828576|NCT00455429|467337330|FG000|Overall Study|Withdrawal by Subject|0|||
129828577|NCT00455429|467337331|FG001|Overall Study|Withdrawal by Subject|1|||
129828578|NCT00455429|467337332|FG002|Overall Study|Withdrawal by Subject|1|||
129828579|NCT00455429|467337333|FG003|Overall Study|Withdrawal by Subject|0|||
129828580|NCT00455429|467337330|FG000|Overall Study|Lack of Efficacy|0|||
129828581|NCT00455429|467337331|FG001|Overall Study|Lack of Efficacy|1|||
129828582|NCT00455429|467337332|FG002|Overall Study|Lack of Efficacy|0|||
129828583|NCT00455429|467337333|FG003|Overall Study|Lack of Efficacy|1|||
129828584|NCT00455429|467337330|FG000|Overall Study|Adverse Event|0|||
129828585|NCT00455429|467337331|FG001|Overall Study|Adverse Event|1|||
129828586|NCT00455429|467337332|FG002|Overall Study|Adverse Event|0|||
129828587|NCT00455429|467337333|FG003|Overall Study|Adverse Event|3|||
129828588|NCT00455429|467337330|FG000|Overall Study|Randomly assigned but not treated|0|||
129828589|NCT00455429|467337331|FG001|Overall Study|Randomly assigned but not treated|0|||
129828590|NCT00455429|467337332|FG002|Overall Study|Randomly assigned but not treated|0|||
129828591|NCT00455429|467337333|FG003|Overall Study|Randomly assigned but not treated|2|||
129828592|NCT00455429|467337330|FG000|Overall Study|Personal Reason|1|||
129828593|NCT00455429|467337331|FG001|Overall Study|Personal Reason|0|||
129828594|NCT00455429|467337332|FG002|Overall Study|Personal Reason|0|||
129828595|NCT00455429|467337333|FG003|Overall Study|Personal Reason|0|||
129828596|NCT00455429|467337330|FG000|Overall Study|Non-compliance|0|||
129828597|NCT00455429|467337331|FG001|Overall Study|Non-compliance|0|||
129828598|NCT00455429|467337332|FG002|Overall Study|Non-compliance|0|||
129828599|NCT00455429|467337333|FG003|Overall Study|Non-compliance|1|||
129828600|NCT00455429|467337330|FG000|Overall Study|Other|0|||
129828601|NCT00455429|467337331|FG001|Overall Study|Other|2|||
129828602|NCT00455429|467337332|FG002|Overall Study|Other|0|||
129828603|NCT00455429|467337333|FG003|Overall Study|Other|1|||
129828604|NCT01165554|467337334|FG000|Overall Study|Withdrawal by Subject|23|||
129828605|NCT02951156|467337341|FG000|Overall Study|Death|3|||
129828606|NCT02951156|467337342|FG001|Overall Study|Death|8|||
129828607|NCT02951156|467337343|FG002|Overall Study|Death|5|||
129828608|NCT02951156|467337341|FG000|Overall Study|Progressive disease|1|||
129828609|NCT02951156|467337342|FG001|Overall Study|Progressive disease|0|||
129828610|NCT02951156|467337343|FG002|Overall Study|Progressive disease|1|||
129828611|NCT02951156|467337341|FG000|Overall Study|Withdrawal by Subject|0|||
129828612|NCT02951156|467337342|FG001|Overall Study|Withdrawal by Subject|0|||
129828613|NCT02951156|467337343|FG002|Overall Study|Withdrawal by Subject|1|||
129828614|NCT02951156|467337341|FG000|Overall Study|Study terminated by sponsor|0|||
129828615|NCT02951156|467337342|FG001|Overall Study|Study terminated by sponsor|0|||
129828616|NCT02951156|467337343|FG002|Overall Study|Study terminated by sponsor|1|||
129828617|NCT02951156|467337341|FG000|Overall Study|Other|5|||
129828618|NCT02951156|467337342|FG001|Overall Study|Other|1|||
129828619|NCT02951156|467337343|FG002|Overall Study|Other|2|||
129828620|NCT04351087|467337344|FG000|Overall Study|Lost to Follow-up|7|||
129828621|NCT04351087|467337345|FG001|Overall Study|Lost to Follow-up|3|||
129828622|NCT04351087|467337344|FG000|Overall Study|Withdrawal by Subject|3|||
129828623|NCT04351087|467337345|FG001|Overall Study|Withdrawal by Subject|4|||
129828624|NCT04351087|467337344|FG000|Overall Study|Lack of Efficacy|3|||
129828625|NCT04351087|467337345|FG001|Overall Study|Lack of Efficacy|2|||
129828626|NCT01603459|467337348|FG000|Overall Study|Adverse Event|5|||
129828627|NCT01603459|467337348|FG000|Overall Study|Withdrawal by Subject|5|||
129828628|NCT01603459|467337348|FG000|Overall Study|Lost to Follow-up|3|||
129828629|NCT01603459|467337348|FG000|Overall Study|Predefined discontinuation criteria|3|||
129828630|NCT01603459|467337348|FG000|Overall Study|Non-compliance|1|||
129828631|NCT01603459|467337348|FG000|Overall Study|Administrative reason|1|||
129828632|NCT03519347|467337351|FG000|Interventional Crossover Period 1|Death|0|||
129897677|NCT02524288|467584422|FG000|Overall Study|Screen Failure|2|||
129828633|NCT03519347|467337352|FG001|Interventional Crossover Period 1|Death|0|||
129828634|NCT03519347|467337353|FG002|Interventional Crossover Period 1|Death|0|||
129828635|NCT03519347|467337354|FG003|Interventional Crossover Period 1|Death|1|||
129828636|NCT05517382|467337355|FG000|Overall Study|Lost to Follow-up|0|||
129828637|NCT05517382|467337356|FG001|Overall Study|Lost to Follow-up|1|||
129828638|NCT01641692|467337357|FG000|Treatment Period 1|Adverse Event|1|||
129828639|NCT01641692|467337358|FG001|Treatment Period 1|Adverse Event|0|||
129828640|NCT01641692|467337359|FG002|Treatment Period 1|Adverse Event|0|||
129828641|NCT01641692|467337360|FG003|Treatment Period 1|Adverse Event|0|||
129828642|NCT01641692|467337361|FG004|Treatment Period 1|Adverse Event|0|||
129828643|NCT01641692|467337362|FG005|Treatment Period 1|Adverse Event|0|||
129828644|NCT01641692|467337363|FG006|Treatment Period 1|Adverse Event|0|||
129828645|NCT01641692|467337364|FG007|Treatment Period 1|Adverse Event|0|||
129897678|NCT02524288|467584422|FG000|Overall Study|Site Discontinued Study Participation|1|||
129828646|NCT01641692|467337357|FG000|Treatment Period 1|Lack of Efficacy|0|||
129828647|NCT01641692|467337358|FG001|Treatment Period 1|Lack of Efficacy|0|||
129828648|NCT01641692|467337359|FG002|Treatment Period 1|Lack of Efficacy|0|||
129828649|NCT01641692|467337360|FG003|Treatment Period 1|Lack of Efficacy|0|||
129828650|NCT01641692|467337361|FG004|Treatment Period 1|Lack of Efficacy|0|||
129828651|NCT01641692|467337362|FG005|Treatment Period 1|Lack of Efficacy|0|||
129828652|NCT01641692|467337363|FG006|Treatment Period 1|Lack of Efficacy|0|||
129828653|NCT01641692|467337364|FG007|Treatment Period 1|Lack of Efficacy|1|||
129828654|NCT01641692|467337357|FG000|Treatment Period 1|Protocol Violation|1|||
129828655|NCT01641692|467337358|FG001|Treatment Period 1|Protocol Violation|0|||
129828656|NCT01641692|467337359|FG002|Treatment Period 1|Protocol Violation|0|||
129828657|NCT01641692|467337360|FG003|Treatment Period 1|Protocol Violation|0|||
129828658|NCT01641692|467337361|FG004|Treatment Period 1|Protocol Violation|2|||
129828659|NCT01641692|467337362|FG005|Treatment Period 1|Protocol Violation|0|||
129828660|NCT01641692|467337363|FG006|Treatment Period 1|Protocol Violation|0|||
129828661|NCT01641692|467337364|FG007|Treatment Period 1|Protocol Violation|0|||
129828662|NCT01641692|467337357|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828663|NCT01641692|467337358|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828664|NCT01641692|467337359|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828665|NCT01641692|467337360|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828666|NCT01641692|467337361|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
129828667|NCT01641692|467337362|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828668|NCT01641692|467337363|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828669|NCT01641692|467337364|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
129828670|NCT01641692|467337357|FG000|Treatment Period 1|Lost to Follow-up|0|||
129828671|NCT01641692|467337358|FG001|Treatment Period 1|Lost to Follow-up|0|||
129828672|NCT01641692|467337359|FG002|Treatment Period 1|Lost to Follow-up|1|||
129828673|NCT01641692|467337360|FG003|Treatment Period 1|Lost to Follow-up|0|||
129828674|NCT01641692|467337361|FG004|Treatment Period 1|Lost to Follow-up|0|||
129828675|NCT01641692|467337362|FG005|Treatment Period 1|Lost to Follow-up|0|||
129828676|NCT01641692|467337363|FG006|Treatment Period 1|Lost to Follow-up|0|||
129828677|NCT01641692|467337364|FG007|Treatment Period 1|Lost to Follow-up|0|||
129828678|NCT01641692|467337357|FG000|Treatment Period 1|Physician Decision|0|||
129828679|NCT01641692|467337358|FG001|Treatment Period 1|Physician Decision|0|||
129828680|NCT01641692|467337359|FG002|Treatment Period 1|Physician Decision|0|||
129828681|NCT01641692|467337360|FG003|Treatment Period 1|Physician Decision|0|||
129828682|NCT01641692|467337361|FG004|Treatment Period 1|Physician Decision|1|||
129828683|NCT01641692|467337362|FG005|Treatment Period 1|Physician Decision|0|||
129828684|NCT01641692|467337363|FG006|Treatment Period 1|Physician Decision|0|||
129828685|NCT01641692|467337364|FG007|Treatment Period 1|Physician Decision|0|||
129828686|NCT01641692|467337357|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129828687|NCT01641692|467337358|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129828688|NCT01641692|467337359|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129828689|NCT01641692|467337360|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129828690|NCT01641692|467337361|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129828691|NCT01641692|467337362|FG005|Treatment Period 1|Withdrawal by Subject|2|||
129828692|NCT01641692|467337363|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129828693|NCT01641692|467337364|FG007|Treatment Period 1|Withdrawal by Subject|1|||
129828694|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
129828695|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828696|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828697|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828698|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828699|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828700|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828701|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828702|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828703|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828704|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828705|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828706|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828707|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828708|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
129828709|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828710|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828711|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828712|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
129828713|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828714|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
129828715|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828716|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828717|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828718|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828719|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828720|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129828721|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828722|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828723|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129828724|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828725|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129828726|NCT01641692|467337357|FG000|Treatment Period 2|Lack of Efficacy|1|||
129828727|NCT01641692|467337358|FG001|Treatment Period 2|Lack of Efficacy|0|||
129828728|NCT01641692|467337359|FG002|Treatment Period 2|Lack of Efficacy|0|||
129828729|NCT01641692|467337360|FG003|Treatment Period 2|Lack of Efficacy|0|||
129828730|NCT01641692|467337361|FG004|Treatment Period 2|Lack of Efficacy|0|||
129828731|NCT01641692|467337362|FG005|Treatment Period 2|Lack of Efficacy|0|||
129828732|NCT01641692|467337363|FG006|Treatment Period 2|Lack of Efficacy|0|||
129828733|NCT01641692|467337364|FG007|Treatment Period 2|Lack of Efficacy|0|||
129828734|NCT01641692|467337357|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
129828735|NCT01641692|467337358|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828736|NCT01641692|467337359|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828737|NCT01641692|467337360|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828738|NCT01641692|467337361|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828739|NCT01641692|467337362|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828740|NCT01641692|467337363|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828741|NCT01641692|467337364|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828742|NCT01641692|467337357|FG000|Treatment Period 2|Lost to Follow-up|0|||
129828743|NCT01641692|467337358|FG001|Treatment Period 2|Lost to Follow-up|0|||
129828744|NCT01641692|467337359|FG002|Treatment Period 2|Lost to Follow-up|0|||
129828745|NCT01641692|467337360|FG003|Treatment Period 2|Lost to Follow-up|0|||
129828746|NCT01641692|467337361|FG004|Treatment Period 2|Lost to Follow-up|0|||
129828747|NCT01641692|467337362|FG005|Treatment Period 2|Lost to Follow-up|1|||
129828748|NCT01641692|467337363|FG006|Treatment Period 2|Lost to Follow-up|0|||
129828749|NCT01641692|467337364|FG007|Treatment Period 2|Lost to Follow-up|0|||
129828750|NCT01641692|467337357|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129828751|NCT01641692|467337358|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129828752|NCT01641692|467337359|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129828753|NCT01641692|467337360|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129828754|NCT01641692|467337361|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129828755|NCT01641692|467337362|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129828756|NCT01641692|467337363|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129828757|NCT01641692|467337364|FG007|Treatment Period 2|Withdrawal by Subject|1|||
129828758|NCT01641692|467337357|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828759|NCT01641692|467337358|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828760|NCT01641692|467337359|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828761|NCT01641692|467337360|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828762|NCT01641692|467337361|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
129828763|NCT01641692|467337362|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828764|NCT01641692|467337363|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828765|NCT01641692|467337364|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828766|NCT01641692|467337357|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828767|NCT01641692|467337358|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828768|NCT01641692|467337359|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129828769|NCT01641692|467337360|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828770|NCT01641692|467337361|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828771|NCT01641692|467337362|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129828772|NCT01641692|467337363|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828773|NCT01641692|467337364|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129828774|NCT01641692|467337357|FG000|Treatment Period 3|Adverse Event|0|||
129828775|NCT01641692|467337358|FG001|Treatment Period 3|Adverse Event|0|||
129828776|NCT01641692|467337359|FG002|Treatment Period 3|Adverse Event|0|||
129828777|NCT01641692|467337360|FG003|Treatment Period 3|Adverse Event|0|||
129828778|NCT01641692|467337361|FG004|Treatment Period 3|Adverse Event|0|||
129828779|NCT01641692|467337362|FG005|Treatment Period 3|Adverse Event|0|||
129828780|NCT01641692|467337363|FG006|Treatment Period 3|Adverse Event|1|||
129828781|NCT01641692|467337364|FG007|Treatment Period 3|Adverse Event|0|||
129828782|NCT01641692|467337357|FG000|Treatment Period 3|Protocol Violation|0|||
129828783|NCT01641692|467337358|FG001|Treatment Period 3|Protocol Violation|0|||
129828784|NCT01641692|467337359|FG002|Treatment Period 3|Protocol Violation|1|||
129828785|NCT01641692|467337360|FG003|Treatment Period 3|Protocol Violation|0|||
129828786|NCT01641692|467337361|FG004|Treatment Period 3|Protocol Violation|0|||
130060301|NCT00280150|468176608|FG001|Overall Study|Did not get consolidation therapy|0|||
130060302|NCT00280150|468176609|FG002|Overall Study|Did not get consolidation therapy|3|||
130060303|NCT00280150|468176610|FG003|Overall Study|Did not get consolidation therapy|0|||
130060304|NCT00280150|468176607|FG000|Overall Study|Declining Performance Status|0|||
130060305|NCT00280150|468176608|FG001|Overall Study|Declining Performance Status|0|||
130060306|NCT00280150|468176609|FG002|Overall Study|Declining Performance Status|0|||
130060307|NCT00280150|468176610|FG003|Overall Study|Declining Performance Status|1|||
130060308|NCT02871401|468176614|FG000|Overall Study|Adverse Event|1|||
130060309|NCT02871401|468176615|FG001|Overall Study|Adverse Event|0|||
130060310|NCT01120379|468176616|FG000|One Year Timepoint|Withdrawal by Subject|41|||
130060311|NCT01120379|468176616|FG000|One Year Timepoint|Lost to Follow-up|115|||
130060312|NCT01120379|468176616|FG000|One Year Timepoint|Death|108|||
130060313|NCT01120379|468176616|FG000|One Year Timepoint|Physician Decision|9|||
130060314|NCT01120379|468176616|FG000|One Year Timepoint|Any other reason for early termination|5|||
130060315|NCT01120379|468176616|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
130060316|NCT01120379|468176616|FG000|Two Year Timepoint|Lost to Follow-up|87|||
130060317|NCT01120379|468176616|FG000|Two Year Timepoint|Death|123|||
130060318|NCT01120379|468176616|FG000|Two Year Timepoint|Physician Decision|12|||
130060319|NCT01120379|468176616|FG000|Two Year Timepoint|Any other reason for early termination|4|||
130060320|NCT01120379|468176616|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
130060321|NCT01120379|468176616|FG000|Three Year Timepoint|Lost to Follow-up|43|||
130060322|NCT01120379|468176616|FG000|Three Year Timepoint|Death|120|||
130060323|NCT01120379|468176616|FG000|Three Year Timepoint|Physician Decision|9|||
130060324|NCT01120379|468176616|FG000|Three Year Timepoint|Any other reason for early termination|17|||
130060325|NCT01120379|468176616|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
130060326|NCT01120379|468176616|FG000|Four Year Timepoint|Lost to Follow-up|10|||
130060327|NCT01120379|468176616|FG000|Four Year Timepoint|Death|131|||
130060328|NCT01120379|468176616|FG000|Four Year Timepoint|Physician Decision|5|||
130060329|NCT01120379|468176616|FG000|Four Year Timepoint|Any other reason for early termination|217|||
130060330|NCT03162055|468176617|FG000|Overall Study|Adverse Event|6|||
130060331|NCT03162055|468176618|FG001|Overall Study|Adverse Event|5|||
130060332|NCT03162055|468176617|FG000|Overall Study|Death|3|||
130060333|NCT03162055|468176618|FG001|Overall Study|Death|3|||
130060334|NCT03162055|468176617|FG000|Overall Study|Lost to Follow-up|0|||
130060335|NCT03162055|468176618|FG001|Overall Study|Lost to Follow-up|1|||
130060336|NCT03162055|468176617|FG000|Overall Study|Study-specific withdrawal criteria|22|||
130060337|NCT03162055|468176618|FG001|Overall Study|Study-specific withdrawal criteria|14|||
130060338|NCT03162055|468176617|FG000|Overall Study|Withdrawal by Subject|17|||
130060339|NCT03162055|468176618|FG001|Overall Study|Withdrawal by Subject|2|||
130060340|NCT03162055|468176617|FG000|Overall Study|Did not receive treatment|2|||
130060341|NCT03162055|468176618|FG001|Overall Study|Did not receive treatment|0|||
129828787|NCT01641692|467337362|FG005|Treatment Period 3|Protocol Violation|0|||
129828788|NCT01641692|467337363|FG006|Treatment Period 3|Protocol Violation|0|||
129828789|NCT01641692|467337364|FG007|Treatment Period 3|Protocol Violation|0|||
129828790|NCT01641692|467337357|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828791|NCT01641692|467337358|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828792|NCT01641692|467337359|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828793|NCT01641692|467337360|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828794|NCT01641692|467337361|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828795|NCT01641692|467337362|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828796|NCT01641692|467337363|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
129828797|NCT01641692|467337364|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828798|NCT01641692|467337357|FG000|Treatment Period 3|Lost to Follow-up|0|||
129828799|NCT01641692|467337358|FG001|Treatment Period 3|Lost to Follow-up|1|||
129828800|NCT01641692|467337359|FG002|Treatment Period 3|Lost to Follow-up|0|||
129828801|NCT01641692|467337360|FG003|Treatment Period 3|Lost to Follow-up|0|||
129828802|NCT01641692|467337361|FG004|Treatment Period 3|Lost to Follow-up|0|||
129828803|NCT01641692|467337362|FG005|Treatment Period 3|Lost to Follow-up|0|||
129828804|NCT01641692|467337363|FG006|Treatment Period 3|Lost to Follow-up|0|||
129828805|NCT01641692|467337364|FG007|Treatment Period 3|Lost to Follow-up|0|||
129828806|NCT01641692|467337357|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828807|NCT01641692|467337358|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828808|NCT01641692|467337359|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828809|NCT01641692|467337360|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
130060342|NCT03162055|468176617|FG000|Overall Study|Incorrect randomization|4|||
130060343|NCT03162055|468176618|FG001|Overall Study|Incorrect randomization|3|||
130060344|NCT03162055|468176617|FG000|Overall Study|Other|8|||
129828810|NCT01641692|467337361|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828811|NCT01641692|467337362|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
130060345|NCT03162055|468176618|FG001|Overall Study|Other|15|||
130060346|NCT01993615|468176622|FG000|Overall Study|Death|1|||
130060347|NCT01993615|468176623|FG001|Overall Study|Death|0|||
130060348|NCT00310388|468176627|FG000|Primary Reporting Phase|Adverse Event|101|||
130060349|NCT00310388|468176628|FG001|Primary Reporting Phase|Adverse Event|0|||
130060350|NCT00310388|468176627|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
130060351|NCT00310388|468176628|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
130060352|NCT00310388|468176627|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
130060353|NCT00310388|468176628|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
130060354|NCT00310388|468176627|FG000|Primary Reporting Phase|Protocol Violation|10|||
130060355|NCT00310388|468176628|FG001|Primary Reporting Phase|Protocol Violation|0|||
130060356|NCT00310388|468176627|FG000|Primary Reporting Phase|Pregnancy|3|||
130060357|NCT00310388|468176628|FG001|Primary Reporting Phase|Pregnancy|0|||
130060358|NCT00310388|468176627|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
130060359|NCT00310388|468176628|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
130060360|NCT00310388|468176627|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
130060361|NCT00310388|468176628|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
130060362|NCT00310388|468176627|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
130060363|NCT00310388|468176628|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
130060364|NCT00310388|468176627|FG000|Primary Reporting Phase|Physician Decision|2|||
130060365|NCT00310388|468176628|FG001|Primary Reporting Phase|Physician Decision|0|||
130060366|NCT00310388|468176627|FG000|Primary Reporting Phase|Request of the sponsor|19|||
130060367|NCT00310388|468176628|FG001|Primary Reporting Phase|Request of the sponsor|0|||
130060368|NCT00310388|468176627|FG000|Primary Reporting Phase|Failed to return|8|||
130060369|NCT00310388|468176628|FG001|Primary Reporting Phase|Failed to return|0|||
130060370|NCT00310388|468176627|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
130060371|NCT00310388|468176628|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
130060372|NCT00310388|468176627|FG000|Primary Reporting Phase|Participant request|2|||
130060373|NCT00310388|468176628|FG001|Primary Reporting Phase|Participant request|0|||
130060374|NCT00310388|468176627|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
130060375|NCT00310388|468176628|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
130060376|NCT00310388|468176627|FG000|Primary Reporting Phase|Discontinuation of study|1|||
130060377|NCT00310388|468176628|FG001|Primary Reporting Phase|Discontinuation of study|0|||
130060378|NCT00310388|468176627|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
130060379|NCT00310388|468176628|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
130060380|NCT00310388|468176627|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
130060381|NCT00310388|468176628|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
130060382|NCT00310388|468176627|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
130060383|NCT00310388|468176628|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
130060384|NCT00310388|468176627|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
130060385|NCT00310388|468176628|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
129828812|NCT01641692|467337363|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828813|NCT01641692|467337364|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828814|NCT01641692|467337357|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828815|NCT01641692|467337358|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
129828816|NCT01641692|467337359|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828817|NCT01641692|467337360|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828818|NCT01641692|467337361|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
129828819|NCT01641692|467337362|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828820|NCT01641692|467337363|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828821|NCT01641692|467337364|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
129828822|NCT04948450|467337369|FG000|Overall Study|Return home|1|||
129828823|NCT04948450|467337370|FG001|Overall Study|Return home|3|||
129828824|NCT05198843|467337373|FG000|Overall Study|Lack of Efficacy|1|||
129828825|NCT01721330|467337374|FG000|Overall Study|Withdrawal by Subject|0|||
129828826|NCT01721330|467337375|FG001|Overall Study|Withdrawal by Subject|1|||
129828827|NCT00296374|467337376|FG000|Overall Study|Adverse Event|14|||
129828828|NCT00296374|467337377|FG001|Overall Study|Adverse Event|10|||
129828829|NCT00296374|467337378|FG002|Overall Study|Adverse Event|7|||
129828830|NCT00296374|467337376|FG000|Overall Study|Withdrawal by Subject|3|||
129828831|NCT00296374|467337377|FG001|Overall Study|Withdrawal by Subject|5|||
129828832|NCT00296374|467337378|FG002|Overall Study|Withdrawal by Subject|11|||
129828833|NCT00296374|467337376|FG000|Overall Study|Incorrect enrollment|3|||
129828834|NCT00296374|467337377|FG001|Overall Study|Incorrect enrollment|3|||
129828835|NCT00296374|467337378|FG002|Overall Study|Incorrect enrollment|4|||
129828836|NCT00296374|467337376|FG000|Overall Study|Protocol Violation|1|||
129828837|NCT00296374|467337377|FG001|Overall Study|Protocol Violation|2|||
129828838|NCT00296374|467337378|FG002|Overall Study|Protocol Violation|3|||
129828839|NCT00296374|467337376|FG000|Overall Study|Lost to Follow-up|3|||
129828840|NCT00296374|467337377|FG001|Overall Study|Lost to Follow-up|1|||
129828841|NCT00296374|467337378|FG002|Overall Study|Lost to Follow-up|1|||
129828842|NCT00296374|467337376|FG000|Overall Study|Relocated to another state|1|||
129828843|NCT00296374|467337377|FG001|Overall Study|Relocated to another state|0|||
130112664|NCT00910858|468373433|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
130112665|NCT00910858|468373434|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
129828844|NCT00296374|467337378|FG002|Overall Study|Relocated to another state|0|||
129828845|NCT00296374|467337376|FG000|Overall Study|Stopped drug before end of study visit|0|||
129828846|NCT00296374|467337377|FG001|Overall Study|Stopped drug before end of study visit|1|||
129828847|NCT00296374|467337378|FG002|Overall Study|Stopped drug before end of study visit|0|||
129828848|NCT00296374|467337376|FG000|Overall Study|Nephrologist introduced ACE|0|||
129828849|NCT00296374|467337377|FG001|Overall Study|Nephrologist introduced ACE|1|||
129828850|NCT00296374|467337378|FG002|Overall Study|Nephrologist introduced ACE|0|||
129828851|NCT00296374|467337376|FG000|Overall Study|Pregnancy|0|||
129828852|NCT00296374|467337377|FG001|Overall Study|Pregnancy|0|||
129828853|NCT00296374|467337378|FG002|Overall Study|Pregnancy|2|||
129828854|NCT00296374|467337376|FG000|Overall Study|Other|0|||
129828855|NCT00296374|467337377|FG001|Overall Study|Other|0|||
129828856|NCT00296374|467337378|FG002|Overall Study|Other|1|||
129828857|NCT01786629|467338819|FG000|Overall Study|Lack of Efficacy|0|||
129828858|NCT01786629|467338820|FG001|Overall Study|Lack of Efficacy|4|||
129828859|NCT01786629|467338819|FG000|Overall Study|Adverse Event|0|||
129828860|NCT01786629|467338820|FG001|Overall Study|Adverse Event|1|||
129828861|NCT02750592|467338825|FG000|Overall Study|Adverse Event|3|||
129828862|NCT02750592|467338825|FG000|Overall Study|Lack of Efficacy|2|||
129828863|NCT02981342|467338828|FG000|Overall Study|Adverse Event|0|||
129828864|NCT02981342|467338829|FG001|Overall Study|Adverse Event|0|||
129828865|NCT02981342|467338830|FG002|Overall Study|Adverse Event|0|||
129828866|NCT02981342|467338831|FG003|Overall Study|Adverse Event|1|||
129828867|NCT02981342|467338828|FG000|Overall Study|Death|0|||
129828868|NCT02981342|467338829|FG001|Overall Study|Death|9|||
129828869|NCT02981342|467338830|FG002|Overall Study|Death|9|||
129828870|NCT02981342|467338831|FG003|Overall Study|Death|4|||
129828871|NCT02981342|467338828|FG000|Overall Study|Withdrawal by Subject|0|||
129828872|NCT02981342|467338829|FG001|Overall Study|Withdrawal by Subject|0|||
129828873|NCT02981342|467338830|FG002|Overall Study|Withdrawal by Subject|3|||
129828874|NCT02981342|467338831|FG003|Overall Study|Withdrawal by Subject|1|||
129828875|NCT02981342|467338828|FG000|Overall Study|Study closed by sponsor|0|||
129828876|NCT02981342|467338829|FG001|Overall Study|Study closed by sponsor|0|||
129828877|NCT02981342|467338830|FG002|Overall Study|Study closed by sponsor|1|||
129828878|NCT02981342|467338831|FG003|Overall Study|Study closed by sponsor|1|||
129828879|NCT02981342|467338828|FG000|Overall Study|Randomized, Never Treated|0|||
129828880|NCT02981342|467338829|FG001|Overall Study|Randomized, Never Treated|1|||
129828881|NCT02981342|467338830|FG002|Overall Study|Randomized, Never Treated|0|||
129828882|NCT02981342|467338831|FG003|Overall Study|Randomized, Never Treated|7|||
129828883|NCT02981342|467338828|FG000|Overall Study|Lost to Follow-up|0|||
129828884|NCT02981342|467338829|FG001|Overall Study|Lost to Follow-up|1|||
129828885|NCT02981342|467338830|FG002|Overall Study|Lost to Follow-up|0|||
129828886|NCT02981342|467338831|FG003|Overall Study|Lost to Follow-up|0|||
129828887|NCT05333900|467338832|FG000|Overall Study|Protocol Violation|0|||
129828888|NCT05333900|467338833|FG001|Overall Study|Protocol Violation|1|||
129828889|NCT05333900|467338832|FG000|Overall Study|Withdrawal by Subject|0|||
129828890|NCT05333900|467338833|FG001|Overall Study|Withdrawal by Subject|1|||
129828891|NCT05333900|467338832|FG000|Overall Study|COVID-19 Pandemic|1|||
129897679|NCT02524288|467584422|FG000|Overall Study|Study Terminated By Sponsor|1417|||
129828892|NCT05333900|467338833|FG001|Overall Study|COVID-19 Pandemic|1|||
129828893|NCT01394523|467338836|FG000|Overall Study|Unable to place block|1|||
129828894|NCT01394523|467338837|FG001|Overall Study|Unable to place block|0|||
129828895|NCT01394523|467338838|FG002|Overall Study|Unable to place block|0|||
129828896|NCT02389998|467338839|FG000|Overall Study|car accident|1|||
129828897|NCT02389998|467338840|FG001|Overall Study|car accident|0|||
129828898|NCT03525574|467338841|FG000|Overall Study|Adverse Event|15|||
129828899|NCT03525574|467338842|FG001|Overall Study|Adverse Event|0|||
129828900|NCT03525574|467338841|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
129828901|NCT03525574|467338842|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129828902|NCT03525574|467338841|FG000|Overall Study|Lost to Follow-up|4|||
129828903|NCT03525574|467338842|FG001|Overall Study|Lost to Follow-up|0|||
129828904|NCT03525574|467338841|FG000|Overall Study|Commercial drug is Available for participant|48|||
129828905|NCT03525574|467338842|FG001|Overall Study|Commercial drug is Available for participant|0|||
129828906|NCT03525574|467338841|FG000|Overall Study|Death|1|||
129828907|NCT03525574|467338842|FG001|Overall Study|Death|0|||
129828908|NCT03525574|467338841|FG000|Overall Study|Other non-compliance|2|||
129828909|NCT03525574|467338842|FG001|Overall Study|Other non-compliance|0|||
129828910|NCT03525574|467338841|FG000|Overall Study|Physician Decision|6|||
129828911|NCT03525574|467338842|FG001|Overall Study|Physician Decision|0|||
129828912|NCT03525574|467338841|FG000|Overall Study|Other|58|||
129828913|NCT03525574|467338842|FG001|Overall Study|Other|0|||
129828914|NCT03525574|467338841|FG000|Overall Study|Enrolled but never dosed|1|||
129828915|NCT03525574|467338842|FG001|Overall Study|Enrolled but never dosed|0|||
129828916|NCT03525574|467338841|FG000|Overall Study|Not enrolled in 105 study|0|||
129828917|NCT03525574|467338842|FG001|Overall Study|Not enrolled in 105 study|3|||
129828918|NCT02150954|467338845|FG000|Overall Study|Protocol Violation|1|||
129828919|NCT02150954|467338846|FG001|Overall Study|Protocol Violation|0|||
129828920|NCT03814746|467338847|FG000|Overall Study|Participant decision|9|||
129828921|NCT03814746|467338848|FG001|Overall Study|Participant decision|6|||
129828922|NCT03814746|467338849|FG002|Overall Study|Participant decision|15|||
129828923|NCT03814746|467338847|FG000|Overall Study|Physician Decision|2|||
129828924|NCT03814746|467338848|FG001|Overall Study|Physician Decision|2|||
129828925|NCT03814746|467338849|FG002|Overall Study|Physician Decision|4|||
129828926|NCT03814746|467338847|FG000|Overall Study|Death|2|||
130060386|NCT00310388|468176627|FG000|Primary Reporting Phase|Participant passed away|1|||
130060387|NCT00310388|468176628|FG001|Primary Reporting Phase|Participant passed away|0|||
130060388|NCT00310388|468176627|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
130060389|NCT00310388|468176628|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
130060390|NCT00310388|468176627|FG000|Primary Reporting Phase|Missing|1|||
130060391|NCT00310388|468176628|FG001|Primary Reporting Phase|Missing|0|||
130060392|NCT00310388|468176627|FG000|Primary Reporting Phase|Other|1|||
130060393|NCT00310388|468176628|FG001|Primary Reporting Phase|Other|0|||
130060394|NCT00310388|468176627|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
130060395|NCT00310388|468176628|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
130060396|NCT00310388|468176627|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
130060397|NCT00310388|468176628|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
130060398|NCT00310388|468176627|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
130060399|NCT00310388|468176628|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
130060400|NCT00310388|468176627|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
130060401|NCT00310388|468176628|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
129828927|NCT03814746|467338848|FG001|Overall Study|Death|2|||
129828928|NCT03814746|467338849|FG002|Overall Study|Death|2|||
129828929|NCT03814746|467338847|FG000|Overall Study|Adverse Event|2|||
129828930|NCT03814746|467338848|FG001|Overall Study|Adverse Event|2|||
129828931|NCT03814746|467338849|FG002|Overall Study|Adverse Event|1|||
129828932|NCT03814746|467338847|FG000|Overall Study|Lost to Follow-up|2|||
129828933|NCT03814746|467338848|FG001|Overall Study|Lost to Follow-up|1|||
129828934|NCT03814746|467338849|FG002|Overall Study|Lost to Follow-up|2|||
129828935|NCT03814746|467338847|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129828936|NCT03814746|467338848|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129828937|NCT03814746|467338849|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129828938|NCT03814746|467338847|FG000|Overall Study|Pregnancy|0|||
129828939|NCT03814746|467338848|FG001|Overall Study|Pregnancy|1|||
129828940|NCT03814746|467338849|FG002|Overall Study|Pregnancy|1|||
129828941|NCT03814746|467338847|FG000|Overall Study|Protocol Violation|1|||
129828942|NCT03814746|467338848|FG001|Overall Study|Protocol Violation|0|||
129828943|NCT03814746|467338849|FG002|Overall Study|Protocol Violation|0|||
129828944|NCT01086540|467338858|FG000|Overall Study|Death|3|||
129828945|NCT01086540|467338859|FG001|Overall Study|Death|1|||
129828946|NCT01086540|467338858|FG000|Overall Study|Physician Decision|2|||
129828947|NCT01086540|467338859|FG001|Overall Study|Physician Decision|1|||
129828948|NCT01086540|467338858|FG000|Overall Study|Addition of new therapy for PAH|1|||
129828949|NCT01086540|467338859|FG001|Overall Study|Addition of new therapy for PAH|0|||
129828950|NCT00518323|467338860|FG000|Overall Study|Lack of Efficacy|14|||
129828951|NCT00518323|467338861|FG001|Overall Study|Lack of Efficacy|2|||
129828952|NCT00518323|467338862|FG002|Overall Study|Lack of Efficacy|4|||
129828953|NCT00518323|467338863|FG003|Overall Study|Lack of Efficacy|20|||
129828954|NCT00518323|467338860|FG000|Overall Study|Withdrawal by Subject|1|||
129828955|NCT00518323|467338861|FG001|Overall Study|Withdrawal by Subject|2|||
129828956|NCT00518323|467338862|FG002|Overall Study|Withdrawal by Subject|4|||
129828957|NCT00518323|467338863|FG003|Overall Study|Withdrawal by Subject|2|||
129828958|NCT00518323|467338860|FG000|Overall Study|Lost to Follow-up|0|||
129828959|NCT00518323|467338861|FG001|Overall Study|Lost to Follow-up|2|||
129828960|NCT00518323|467338862|FG002|Overall Study|Lost to Follow-up|1|||
129828961|NCT00518323|467338863|FG003|Overall Study|Lost to Follow-up|3|||
129828962|NCT00518323|467338860|FG000|Overall Study|Adverse Event|1|||
129828963|NCT00518323|467338861|FG001|Overall Study|Adverse Event|1|||
129828964|NCT00518323|467338862|FG002|Overall Study|Adverse Event|1|||
129828965|NCT00518323|467338863|FG003|Overall Study|Adverse Event|0|||
129828966|NCT00518323|467338860|FG000|Overall Study|Prohibited medication and others|3|||
129828967|NCT00518323|467338861|FG001|Overall Study|Prohibited medication and others|1|||
129828968|NCT00518323|467338862|FG002|Overall Study|Prohibited medication and others|1|||
129828969|NCT00518323|467338863|FG003|Overall Study|Prohibited medication and others|0|||
129828970|NCT03164928|467338864|FG000|Overall Study|Lost to Follow-up|1|||
129828971|NCT03164928|467338865|FG001|Overall Study|Lost to Follow-up|0|||
129828972|NCT02278263|467338866|FG000|Overall Study|Protocol Violation|7|||
129828973|NCT02278263|467338867|FG001|Overall Study|Protocol Violation|0|||
129828974|NCT02278263|467338868|FG002|Overall Study|Protocol Violation|9|||
129828975|NCT01998737|467338869|FG000|Overall Study|Corrupted database|23|||
129828976|NCT01998737|467338870|FG001|Overall Study|Corrupted database|0|||
129828977|NCT03997383|467338873|FG000|Double-blind Treatment Period|Adverse Event|4|||
129828978|NCT03997383|467338874|FG001|Double-blind Treatment Period|Adverse Event|3|||
129828979|NCT03997383|467338873|FG000|Double-blind Treatment Period|Death|4|||
129828980|NCT03997383|467338874|FG001|Double-blind Treatment Period|Death|4|||
129828981|NCT03997383|467338873|FG000|Double-blind Treatment Period|Physician Decision|2|||
129828982|NCT03997383|467338874|FG001|Double-blind Treatment Period|Physician Decision|0|||
129828983|NCT03997383|467338873|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
129828984|NCT03997383|467338874|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
129828985|NCT03997383|467338873|FG000|Open-label Extension Period|Ongoing|148|||
129828986|NCT03997383|467338874|FG001|Open-label Extension Period|Ongoing|151|||
129828987|NCT03997383|467338873|FG000|Open-label Extension Period|Adverse Event|4|||
129828988|NCT03997383|467338874|FG001|Open-label Extension Period|Adverse Event|1|||
129828989|NCT03997383|467338873|FG000|Open-label Extension Period|Death|8|||
129828990|NCT03997383|467338874|FG001|Open-label Extension Period|Death|9|||
129828991|NCT03997383|467338873|FG000|Open-label Extension Period|Physician Decision|1|||
129828992|NCT03997383|467338874|FG001|Open-label Extension Period|Physician Decision|1|||
129828993|NCT03997383|467338873|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
129828994|NCT03997383|467338874|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
129828995|NCT03997383|467338873|FG000|Open-label Extension Period|Reason Not Specified|2|||
129828996|NCT03997383|467338874|FG001|Open-label Extension Period|Reason Not Specified|0|||
129828997|NCT03880019|467338875|FG000|Overall Study|Competing disease|1|||
129828998|NCT00326950|467338876|FG000|Overall Study|Progressive Disease|1|||
129828999|NCT01266460|467338882|FG000|Overall Study|Adverse Event|3|||
129829000|NCT01266460|467338882|FG000|Overall Study|Withdrawal by Subject|5|||
129829001|NCT01266460|467338882|FG000|Overall Study|Disease Progression|18|||
129829002|NCT01266460|467338882|FG000|Overall Study|Not otherwise specified|8|||
129829003|NCT01132547|467338887|FG000|Overall Study|Withdrawal by Subject|3|||
129829004|NCT01132547|467338888|FG001|Overall Study|Withdrawal by Subject|1|||
129829005|NCT01132547|467338887|FG000|Overall Study|Death|1|||
129829006|NCT01132547|467338888|FG001|Overall Study|Death|0|||
129829007|NCT05811234|467338889|FG000|Overall Study|Loss of Effectiveness|2|||
129829008|NCT05811234|467338889|FG000|Overall Study|Adverse Event|4|||
129829009|NCT05811234|467338889|FG000|Overall Study|Pregnancy|1|||
129829010|NCT05811234|467338889|FG000|Overall Study|Disease progression|1|||
129829011|NCT05811234|467338889|FG000|Overall Study|Withdrawal by Subject|4|||
129829012|NCT05811234|467338889|FG000|Overall Study|Lost to Follow-up|13|||
129829013|NCT05811234|467338889|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
129829014|NCT04499781|467338890|FG000|Overall Study|Lost to Follow-up|2|||
129829015|NCT04499781|467338891|FG001|Overall Study|Lost to Follow-up|3|||
129829016|NCT04499781|467338890|FG000|Overall Study|Withdrawal by Subject|2|||
129829017|NCT04499781|467338891|FG001|Overall Study|Withdrawal by Subject|0|||
129829018|NCT00730912|467338911|FG000|Overall Study|Discontinued|0|||
129829019|NCT00730912|467338912|FG001|Overall Study|Discontinued|0|||
129829020|NCT00730912|467338913|FG002|Overall Study|Discontinued|1|||
129829021|NCT04053023|467338920|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
129829022|NCT04053023|467338921|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
130112666|NCT00910858|468373432|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
130112667|NCT00910858|468373433|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
130112668|NCT00910858|468373434|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
130112669|NCT00910858|468373432|FG000|Combined Treatment Phase|Protocol Violation|1|||
130112670|NCT00910858|468373433|FG001|Combined Treatment Phase|Protocol Violation|0|||
130112671|NCT00910858|468373434|FG002|Combined Treatment Phase|Protocol Violation|0|||
130112672|NCT00910858|468373432|FG000|Combined Treatment Phase|Other|0|||
130112673|NCT00910858|468373433|FG001|Combined Treatment Phase|Other|2|||
130112674|NCT00910858|468373434|FG002|Combined Treatment Phase|Other|1|||
130112675|NCT01703741|468373441|FG000|Overall Study|Withdrawal by Subject|6|||
130112676|NCT01703741|468373441|FG000|Overall Study|Adverse Event|2|||
130112677|NCT01703741|468373441|FG000|Overall Study|Physician Decision|2|||
130112678|NCT01703741|468373441|FG000|Overall Study|Protocol Violation|1|||
129829043|NCT03424265|467338926|FG000|Overall Study|screening failure|1|||
129829044|NCT03424265|467338927|FG001|Overall Study|screening failure|0|||
129829045|NCT03424265|467338926|FG000|Overall Study|Withdrawal by Subject|0|||
129829046|NCT03424265|467338927|FG001|Overall Study|Withdrawal by Subject|2|||
129829047|NCT00894322|467338934|FG000|Overall Study|Withdrawal by Subject|1|||
129829048|NCT00894322|467338935|FG001|Overall Study|Withdrawal by Subject|0|||
129829049|NCT00894322|467338936|FG002|Overall Study|Withdrawal by Subject|0|||
129829050|NCT02738450|467338945|FG000|Overall Study|Withdrawal by Subject|0|||
129829051|NCT02738450|467338946|FG001|Overall Study|Withdrawal by Subject|2|||
129829052|NCT02738450|467338947|FG002|Overall Study|Withdrawal by Subject|0|||
129829053|NCT00399360|467338949|FG000|Overall Study|Lost to Follow-up|2|||
129829054|NCT00399360|467338950|FG001|Overall Study|Lost to Follow-up|1|||
129829055|NCT00399360|467338951|FG002|Overall Study|Lost to Follow-up|2|||
129829056|NCT00399360|467338952|FG003|Overall Study|Lost to Follow-up|4|||
129829057|NCT00399360|467338949|FG000|Overall Study|Adverse Event|0|||
129829058|NCT00399360|467338950|FG001|Overall Study|Adverse Event|0|||
129829059|NCT00399360|467338951|FG002|Overall Study|Adverse Event|1|||
129829060|NCT00399360|467338952|FG003|Overall Study|Adverse Event|0|||
129829061|NCT00399360|467338949|FG000|Overall Study|Withdrawal by Subject|0|||
129829062|NCT00399360|467338950|FG001|Overall Study|Withdrawal by Subject|2|||
129829063|NCT00399360|467338951|FG002|Overall Study|Withdrawal by Subject|0|||
129829064|NCT00399360|467338952|FG003|Overall Study|Withdrawal by Subject|2|||
129829065|NCT01412021|467338954|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
129829066|NCT01412021|467338954|FG000|Overall Study|Treatment Prior to Approval|3|||
129829067|NCT01412021|467338954|FG000|Overall Study|Transferred to Other Hospital|9|||
129829068|NCT01166178|467338955|FG000|Overall Study|Withdrawal by Subject|1|||
129829069|NCT01166178|467338956|FG001|Overall Study|Withdrawal by Subject|0|||
129829070|NCT01166178|467338955|FG000|Overall Study|Study was terminated|20|||
129829071|NCT01166178|467338956|FG001|Overall Study|Study was terminated|8|||
129829072|NCT07114198|467338958|FG000|Overall Study|Protocol Violation|1|||
129829073|NCT07114198|467338959|FG001|Overall Study|Protocol Violation|1|||
129829074|NCT00670800|467340790|FG000|Overall Study|2 controls were insulin resistant|0|||
129829075|NCT00670800|467340791|FG001|Overall Study|2 controls were insulin resistant|2|||
129829076|NCT04736199|467340792|FG000|Overall Study|Adverse Event|28|||
129829077|NCT04736199|467340793|FG001|Overall Study|Adverse Event|22|||
129829078|NCT04736199|467340792|FG000|Overall Study|Death|9|||
129829079|NCT04736199|467340793|FG001|Overall Study|Death|3|||
129829080|NCT04736199|467340792|FG000|Overall Study|Lost to Follow-up|4|||
129829081|NCT04736199|467340793|FG001|Overall Study|Lost to Follow-up|1|||
129829082|NCT04736199|467340792|FG000|Overall Study|Physician Decision|5|||
129829083|NCT04736199|467340793|FG001|Overall Study|Physician Decision|9|||
129829084|NCT04736199|467340792|FG000|Overall Study|Withdrawal by Subject|21|||
129829085|NCT04736199|467340793|FG001|Overall Study|Withdrawal by Subject|9|||
129829086|NCT04736199|467340792|FG000|Overall Study|Progressive disease|120|||
129829087|NCT04736199|467340793|FG001|Overall Study|Progressive disease|101|||
129829088|NCT04736199|467340792|FG000|Overall Study|Subject decision|13|||
129829089|NCT04736199|467340793|FG001|Overall Study|Subject decision|13|||
129829090|NCT04736199|467340792|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
129829091|NCT04736199|467340793|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
129829092|NCT04736199|467340792|FG000|Overall Study|Additional primary malignancy|1|||
129829093|NCT04736199|467340793|FG001|Overall Study|Additional primary malignancy|0|||
129829094|NCT04736199|467340792|FG000|Overall Study|Non-compliance with study drug|0|||
129829095|NCT04736199|467340793|FG001|Overall Study|Non-compliance with study drug|1|||
129829096|NCT04736199|467340792|FG000|Overall Study|Other reason|0|||
129829097|NCT04736199|467340793|FG001|Overall Study|Other reason|1|||
129829098|NCT04736199|467340792|FG000|Overall Study|Ongoing with study drug|240|||
129829099|NCT04736199|467340793|FG001|Overall Study|Ongoing with study drug|63|||
129829100|NCT04736199|467340792|FG000|Overall Study|Study drug never administered|3|||
129829101|NCT04736199|467340793|FG001|Overall Study|Study drug never administered|0|||
129829102|NCT04318080|467340794|FG000|Overall Study|Study closed by sponsor|10|||
129829103|NCT04318080|467340795|FG001|Overall Study|Study closed by sponsor|22|||
129829104|NCT04318080|467340794|FG000|Overall Study|Death|3|||
129829105|NCT04318080|467340795|FG001|Overall Study|Death|9|||
129829106|NCT04318080|467340794|FG000|Overall Study|Withdrawal by Subject|1|||
129829107|NCT04318080|467340795|FG001|Overall Study|Withdrawal by Subject|0|||
129829108|NCT04318080|467340794|FG000|Overall Study|Protocol Deviation|1|||
129829109|NCT04318080|467340795|FG001|Overall Study|Protocol Deviation|0|||
129829110|NCT06308822|467340796|FG000|Overall Study|Mutation Status Not Confirmed|17|||
129829111|NCT06308822|467340796|FG000|Overall Study|Adverse Event|1|||
129829112|NCT06308822|467340796|FG000|Overall Study|Death|5|||
129829113|NCT06308822|467340796|FG000|Overall Study|Disease progression|8|||
129829114|NCT06308822|467340796|FG000|Overall Study|Withdrawal by Subject|1|||
129829115|NCT06308822|467340796|FG000|Overall Study|Physician Decision|3|||
129829116|NCT03712904|467340797|FG000|Overall Study|Death|0|||
129829117|NCT03712904|467340798|FG001|Overall Study|Death|1|||
129829118|NCT03712904|467340797|FG000|Overall Study|Withdrawal by Subject|0|||
129897680|NCT02524288|467584422|FG000|Overall Study|Subject Moved|32|||
129829119|NCT03712904|467340798|FG001|Overall Study|Withdrawal by Subject|1|||
129829120|NCT03712904|467340797|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
129829121|NCT03712904|467340798|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
129829122|NCT01852942|467340799|FG000|Overall Study|Physician Decision|1|||
129829123|NCT01852942|467340800|FG001|Overall Study|Physician Decision|0|||
129829124|NCT01852942|467340799|FG000|Overall Study|Death|1|||
129829125|NCT01852942|467340800|FG001|Overall Study|Death|1|||
129829126|NCT01852942|467340799|FG000|Overall Study|Withdrawal by Subject|2|||
129829127|NCT01852942|467340800|FG001|Overall Study|Withdrawal by Subject|3|||
129829128|NCT01852942|467340799|FG000|Overall Study|Lost to Follow-up|1|||
129829129|NCT01852942|467340800|FG001|Overall Study|Lost to Follow-up|2|||
129829130|NCT01921179|467340801|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
129829131|NCT01921179|467340802|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
129829132|NCT01921179|467340801|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
129829133|NCT01921179|467340802|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
129829134|NCT05608005|467340809|FG000|Overall Study|Adverse Event|2|||
129829135|NCT05608005|467340810|FG001|Overall Study|Adverse Event|1|||
129829136|NCT05608005|467340811|FG002|Overall Study|Adverse Event|3|||
129829137|NCT05608005|467340809|FG000|Overall Study|Protocol Violation|2|||
129829138|NCT05608005|467340810|FG001|Overall Study|Protocol Violation|3|||
129829139|NCT05608005|467340811|FG002|Overall Study|Protocol Violation|0|||
129829140|NCT05608005|467340809|FG000|Overall Study|Withdrawal by Subject|10|||
129829141|NCT05608005|467340810|FG001|Overall Study|Withdrawal by Subject|12|||
129829142|NCT05608005|467340811|FG002|Overall Study|Withdrawal by Subject|4|||
129829143|NCT05608005|467340809|FG000|Overall Study|Lost to Follow-up|25|||
129829144|NCT05608005|467340810|FG001|Overall Study|Lost to Follow-up|27|||
129829145|NCT05608005|467340811|FG002|Overall Study|Lost to Follow-up|15|||
129829146|NCT05608005|467340809|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
129829147|NCT05608005|467340810|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
129829148|NCT05608005|467340811|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
129829149|NCT04708886|467340812|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
129829150|NCT04708886|467340812|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
129829151|NCT01372501|467340813|FG000|Overall Study|Adverse Event|4|||
129829152|NCT01372501|467340813|FG000|Overall Study|Device migration|1|||
129829153|NCT01466348|467340814|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
129829154|NCT01466348|467340815|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
129829155|NCT03989440|467340816|FG000|Overall Study|COVID-19 travel restrictions|0|||
129829156|NCT03989440|467340817|FG001|Overall Study|COVID-19 travel restrictions|0|||
129829157|NCT03989440|467340818|FG002|Overall Study|COVID-19 travel restrictions|1|||
129829158|NCT03989440|467340819|FG003|Overall Study|COVID-19 travel restrictions|0|||
129829159|NCT03989440|467340820|FG004|Overall Study|COVID-19 travel restrictions|0|||
129829160|NCT03989440|467340821|FG005|Overall Study|COVID-19 travel restrictions|0|||
129829161|NCT03989440|467340816|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
129829162|NCT03989440|467340817|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
129829163|NCT03989440|467340818|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
129829164|NCT03989440|467340819|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
129829165|NCT03989440|467340820|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
129829166|NCT03989440|467340821|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
129829167|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
129829168|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
129829169|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
129829170|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
129829171|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
129829172|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
129829173|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
129829174|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
129829175|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
129829176|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
129829177|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
129829178|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
129829179|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
129829180|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
129829181|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
129829182|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Other|1|||
129829183|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Other|1|||
129829184|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Other|0|||
129829185|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Other|0|||
129829186|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Other|0|||
129829187|NCT03970733|467340824|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829188|NCT03970733|467340825|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
130060402|NCT00798694|468176632|FG000|Overall Study|Lost to Follow-up|1|||
129829189|NCT03970733|467340826|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829190|NCT03970733|467340827|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829191|NCT03970733|467340828|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
129829192|NCT02189473|467340832|FG000|Overall Study|Death|22|||
129829193|NCT02189473|467340833|FG001|Overall Study|Death|23|||
129829194|NCT02189473|467340832|FG000|Overall Study|Lost to Follow-up|1|||
129829195|NCT02189473|467340833|FG001|Overall Study|Lost to Follow-up|2|||
129829196|NCT01955161|467340834|FG000|Overall Study|Withdrawal before treatment|2|||
129829197|NCT01955161|467340835|FG001|Overall Study|Withdrawal before treatment|0|||
129829198|NCT01955161|467340836|FG002|Overall Study|Withdrawal before treatment|1|||
129829199|NCT01955161|467340834|FG000|Overall Study|Adverse Event|10|||
129829200|NCT01955161|467340835|FG001|Overall Study|Adverse Event|14|||
129829201|NCT01955161|467340836|FG002|Overall Study|Adverse Event|15|||
129829202|NCT01955161|467340834|FG000|Overall Study|Death|1|||
129829203|NCT01955161|467340835|FG001|Overall Study|Death|1|||
129829204|NCT01955161|467340836|FG002|Overall Study|Death|3|||
129829205|NCT01955161|467340834|FG000|Overall Study|Withdrawal by Subject|9|||
129829206|NCT01955161|467340835|FG001|Overall Study|Withdrawal by Subject|8|||
129829207|NCT01955161|467340836|FG002|Overall Study|Withdrawal by Subject|12|||
129829208|NCT01955161|467340834|FG000|Overall Study|Protocol Violation|2|||
129829209|NCT01955161|467340835|FG001|Overall Study|Protocol Violation|0|||
129829210|NCT01955161|467340836|FG002|Overall Study|Protocol Violation|0|||
129829211|NCT01955161|467340834|FG000|Overall Study|Other reason: physician decision|0|||
129829212|NCT01955161|467340835|FG001|Overall Study|Other reason: physician decision|1|||
129829213|NCT01955161|467340836|FG002|Overall Study|Other reason: physician decision|1|||
129829214|NCT01955161|467340834|FG000|Overall Study|Other reason: disallowed medication|1|||
129829215|NCT01955161|467340835|FG001|Overall Study|Other reason: disallowed medication|0|||
129829216|NCT01955161|467340836|FG002|Overall Study|Other reason: disallowed medication|1|||
129829217|NCT01955161|467340834|FG000|Overall Study|Other reason: caregiver unavailable|1|||
129829218|NCT01955161|467340835|FG001|Overall Study|Other reason: caregiver unavailable|0|||
129829219|NCT01955161|467340836|FG002|Overall Study|Other reason: caregiver unavailable|0|||
129829220|NCT01955161|467340834|FG000|Overall Study|Other reason: moved to nursing home|0|||
129829221|NCT01955161|467340835|FG001|Overall Study|Other reason: moved to nursing home|1|||
129829222|NCT01955161|467340836|FG002|Overall Study|Other reason: moved to nursing home|0|||
129829223|NCT01955161|467340834|FG000|Overall Study|Other reason: insufficient compliance|0|||
129829224|NCT01955161|467340835|FG001|Overall Study|Other reason: insufficient compliance|0|||
129829225|NCT01955161|467340836|FG002|Overall Study|Other reason: insufficient compliance|1|||
129829226|NCT01955161|467340834|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
129829227|NCT01955161|467340835|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
129829228|NCT01955161|467340836|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
129829229|NCT01955161|467340834|FG000|Overall Study|Other reason: patient's will|0|||
129829230|NCT01955161|467340835|FG001|Overall Study|Other reason: patient's will|0|||
129829231|NCT01955161|467340836|FG002|Overall Study|Other reason: patient's will|1|||
129829232|NCT02784821|467340839|FG000|Overall Study|Death|0|||
129829233|NCT02784821|467340840|FG001|Overall Study|Death|5|||
129829234|NCT02784821|467340841|FG002|Overall Study|Death|4|||
129829235|NCT02784821|467340842|FG003|Overall Study|Death|5|||
129829236|NCT01277523|467340843|FG000|Overall Study|Adverse Event|1|||
129829237|NCT01277523|467340844|FG001|Overall Study|Adverse Event|0|||
129829238|NCT01277523|467340845|FG002|Overall Study|Adverse Event|0|||
129829239|NCT01277523|467340843|FG000|Overall Study|Protocol Violation|2|||
129829240|NCT01277523|467340844|FG001|Overall Study|Protocol Violation|0|||
129829241|NCT01277523|467340845|FG002|Overall Study|Protocol Violation|0|||
129829242|NCT01277523|467340843|FG000|Overall Study|Other Reason not Defined|0|||
129829243|NCT01277523|467340844|FG001|Overall Study|Other Reason not Defined|1|||
129829244|NCT01277523|467340845|FG002|Overall Study|Other Reason not Defined|0|||
129829245|NCT01881230|467340851|FG000|Overall Study|Death|2|||
129829246|NCT01881230|467340852|FG001|Overall Study|Death|0|||
129829247|NCT01881230|467340853|FG002|Overall Study|Death|1|||
129829248|NCT01881230|467340851|FG000|Overall Study|Adverse Event|9|||
129829249|NCT01881230|467340852|FG001|Overall Study|Adverse Event|13|||
129829250|NCT01881230|467340853|FG002|Overall Study|Adverse Event|12|||
129829251|NCT01881230|467340851|FG000|Overall Study|Progressive Disease|31|||
129829252|NCT01881230|467340852|FG001|Overall Study|Progressive Disease|35|||
129829253|NCT01881230|467340853|FG002|Overall Study|Progressive Disease|36|||
129829254|NCT01881230|467340851|FG000|Overall Study|Symptomatic Deterioration|3|||
129829255|NCT01881230|467340852|FG001|Overall Study|Symptomatic Deterioration|3|||
129829256|NCT01881230|467340853|FG002|Overall Study|Symptomatic Deterioration|1|||
130112679|NCT01703741|468373441|FG000|Overall Study|Lost to Follow-up|3|||
129829257|NCT01881230|467340851|FG000|Overall Study|Withdrawal by Subject|6|||
129829258|NCT01881230|467340852|FG001|Overall Study|Withdrawal by Subject|4|||
129829259|NCT01881230|467340853|FG002|Overall Study|Withdrawal by Subject|6|||
129829260|NCT01881230|467340851|FG000|Overall Study|Physician Decision|4|||
129897681|NCT02524288|467584422|FG000|Overall Study|Withdrawal by Subject|76|||
130112680|NCT01703741|468373441|FG000|Overall Study|Subject did not want to continue|2|||
130112681|NCT01703741|468373441|FG000|Overall Study|Subject cannot comply with study visits|1|||
130112682|NCT01703741|468373441|FG000|Overall Study|Subject started testosterone injections|1|||
130112683|NCT01170364|468373442|FG000|Overall Study|Protocol Violation|4|||
129829261|NCT01881230|467340852|FG001|Overall Study|Physician Decision|3|||
129829262|NCT01881230|467340853|FG002|Overall Study|Physician Decision|6|||
129829263|NCT01881230|467340851|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129829264|NCT01881230|467340852|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129829265|NCT01881230|467340853|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129829266|NCT01881230|467340851|FG000|Overall Study|Given Commercially Available Drug|0|||
129829267|NCT01881230|467340852|FG001|Overall Study|Given Commercially Available Drug|0|||
129829268|NCT01881230|467340853|FG002|Overall Study|Given Commercially Available Drug|2|||
129829269|NCT01881230|467340851|FG000|Overall Study|Protocol Violation|1|||
129829270|NCT01881230|467340852|FG001|Overall Study|Protocol Violation|1|||
129829271|NCT01881230|467340853|FG002|Overall Study|Protocol Violation|0|||
129829272|NCT01881230|467340851|FG000|Overall Study|Miscellaneous|3|||
129829273|NCT01881230|467340852|FG001|Overall Study|Miscellaneous|3|||
129829274|NCT01881230|467340853|FG002|Overall Study|Miscellaneous|0|||
129829275|NCT01881230|467340851|FG000|Overall Study|Untreated: Other|0|||
129829276|NCT01881230|467340852|FG001|Overall Study|Untreated: Other|0|||
129829277|NCT01881230|467340853|FG002|Overall Study|Untreated: Other|1|||
129829278|NCT01881230|467340851|FG000|Overall Study|Untreated: Death|0|||
129829279|NCT01881230|467340852|FG001|Overall Study|Untreated: Death|0|||
129829280|NCT01881230|467340853|FG002|Overall Study|Untreated: Death|1|||
129829281|NCT01881230|467340851|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
129829282|NCT01881230|467340852|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
129829283|NCT01881230|467340853|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
129829284|NCT00112502|467340854|FG000|Overall Study|Withdrawal by Subject|0|||
129829285|NCT00112502|467340855|FG001|Overall Study|Withdrawal by Subject|1|||
129829286|NCT00112502|467340856|FG002|Overall Study|Withdrawal by Subject|1|||
129829287|NCT00112502|467340857|FG003|Overall Study|Withdrawal by Subject|4|||
129829288|NCT00112502|467340858|FG004|Overall Study|Withdrawal by Subject|2|||
129829289|NCT00112502|467340859|FG005|Overall Study|Withdrawal by Subject|5|||
129829290|NCT00112502|467340860|FG006|Overall Study|Withdrawal by Subject|3|||
129829291|NCT00112502|467340861|FG007|Overall Study|Withdrawal by Subject|7|||
129829292|NCT02385266|467340862|FG000|Overall Study|Withdrawal by Subject|1|||
129829293|NCT02385266|467340863|FG001|Overall Study|Withdrawal by Subject|3|||
129829294|NCT01030523|467340864|FG000|Initial Study (5 Years)|Death|1|||
129829295|NCT01030523|467340865|FG001|Initial Study (5 Years)|Death|0|||
129829296|NCT01030523|467340864|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
129829297|NCT01030523|467340865|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
129829298|NCT01030523|467340864|FG000|Initial Study (5 Years)|Implant failure|1|||
129829299|NCT01030523|467340865|FG001|Initial Study (5 Years)|Implant failure|0|||
129829300|NCT01030523|467340864|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
129829301|NCT01030523|467340865|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
129829302|NCT01030523|467340864|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
129829303|NCT01030523|467340865|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
129829304|NCT01030523|467340864|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
129829305|NCT01030523|467340865|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
129829306|NCT02357901|467340872|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
129829307|NCT02357901|467340873|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
129829308|NCT02357901|467340874|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
129829309|NCT02357901|467340875|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
129829310|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
129829311|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
129829312|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
129829313|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
129829314|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
129829315|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
129829316|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
129829317|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
129829318|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
129829319|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
129829320|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
129829321|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
130112684|NCT01170364|468373443|FG001|Overall Study|Protocol Violation|1|||
129829322|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
129829323|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
129829324|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
129829325|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
129829326|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
130112685|NCT01381900|468373444|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
129897682|NCT02524288|467584422|FG000|Overall Study|Pregnancy|22|||
129897683|NCT02524288|467584422|FG000|Overall Study|Physician Decision|2|||
129829327|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
129829328|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
129829329|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
129829330|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
129829331|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
129829332|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
129829333|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
129829334|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
129829335|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
129829336|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
129829337|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
129829338|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
129829339|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
129829340|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
129829341|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
129829342|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
129829343|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
129829344|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
129829345|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
129829346|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
129829347|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
129829348|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
129829349|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
129829350|NCT00491387|467340881|FG000|Overall Study|study terminated|20|||
129829351|NCT00227305|467340885|FG000|Overall Study|Adverse Event|40|||
129829352|NCT00227305|467340885|FG000|Overall Study|Withdrawal by Subject|42|||
129829353|NCT00227305|467340885|FG000|Overall Study|Lost to Follow-up|33|||
129829354|NCT00227305|467340885|FG000|Overall Study|Study specific discontinuation|13|||
129829355|NCT00227305|467340885|FG000|Overall Study|MOVED OUT OF AREA|3|||
129829356|NCT00227305|467340885|FG000|Overall Study|Lack of Efficacy|7|||
129829357|NCT00227305|467340885|FG000|Overall Study|Physician Decision|3|||
129829358|NCT00227305|467340885|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
129829359|NCT00227305|467340885|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
129829360|NCT00227305|467340885|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
129829361|NCT00483379|467340886|FG000|Treatment Period|Adverse Event|1|||
129829362|NCT00483379|467340887|FG001|Treatment Period|Adverse Event|0|||
129829363|NCT00483379|467340886|FG000|Treatment Period|Withdrawal by Subject|1|||
129829364|NCT00483379|467340887|FG001|Treatment Period|Withdrawal by Subject|0|||
129829365|NCT03311659|467340888|FG000|Overall Study|Protocol Violation|1|||
129829366|NCT00071760|467340889|FG000|Overall Study|Adverse Event|2|||
129829367|NCT00071760|467340890|FG001|Overall Study|Adverse Event|1|||
129829368|NCT00071760|467340889|FG000|Overall Study|Lost to Follow-up|0|||
129829369|NCT00071760|467340890|FG001|Overall Study|Lost to Follow-up|3|||
129829370|NCT00071760|467340889|FG000|Overall Study|Protocol Violation|1|||
129829371|NCT00071760|467340890|FG001|Overall Study|Protocol Violation|0|||
129829372|NCT00071760|467340889|FG000|Overall Study|Withdrawal by Subject|0|||
129829373|NCT00071760|467340890|FG001|Overall Study|Withdrawal by Subject|1|||
129829374|NCT00071760|467340889|FG000|Overall Study|Insufficient Viral Load Response|1|||
129829375|NCT00071760|467340890|FG001|Overall Study|Insufficient Viral Load Response|1|||
129829376|NCT00071760|467340889|FG000|Overall Study|Lack of availability of RTV|1|||
129829377|NCT00071760|467340890|FG001|Overall Study|Lack of availability of RTV|0|||
129829378|NCT00071760|467340889|FG000|Overall Study|Physician Decision|2|||
129829379|NCT00071760|467340890|FG001|Overall Study|Physician Decision|1|||
129829380|NCT00071760|467340889|FG000|Overall Study|Relocation|0|||
129829381|NCT00071760|467340890|FG001|Overall Study|Relocation|1|||
129829382|NCT01994629|467340891|FG000|Overall Study|Withdrawal by Subject|1|||
129829383|NCT01994629|467340892|FG001|Overall Study|Withdrawal by Subject|0|||
129829384|NCT01994629|467340891|FG000|Overall Study|Lost to Follow-up|0|||
129829385|NCT01994629|467340892|FG001|Overall Study|Lost to Follow-up|3|||
129829386|NCT03338062|467340893|FG000|Overall Study|Alternative Therapy|1|||
129829387|NCT03338062|467340894|FG001|Overall Study|Alternative Therapy|0|||
129829388|NCT01558752|467340895|FG000|Overall Study|Physician Decision|2|||
129829389|NCT01558752|467340896|FG001|Overall Study|Physician Decision|0|||
129829390|NCT04340362|467340900|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
129829391|NCT01170091|467340901|FG000|Overall Study|Missing efficacy evaluation|3|||
129829392|NCT01170091|467340901|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
129829393|NCT00391274|467340909|FG000|Overall Study|Death Due to Study Disease|55|||
129829394|NCT00391274|467340910|FG001|Overall Study|Death Due to Study Disease|45|||
129829395|NCT00391274|467340909|FG000|Overall Study|Lost to Follow-up|0|||
129829396|NCT00391274|467340910|FG001|Overall Study|Lost to Follow-up|3|||
129897684|NCT00517933|467584423|FG000|Period 1|Death|2|||
129829397|NCT00391274|467340909|FG000|Overall Study|Physician Decision|4|||
129829398|NCT00391274|467340910|FG001|Overall Study|Physician Decision|2|||
129829399|NCT00391274|467340909|FG000|Overall Study|Withdrawal by Subject|0|||
129829400|NCT00391274|467340910|FG001|Overall Study|Withdrawal by Subject|3|||
129829401|NCT00391274|467340909|FG000|Overall Study|Death Due to Adverse Event|1|||
129829402|NCT00391274|467340910|FG001|Overall Study|Death Due to Adverse Event|3|||
129829403|NCT00391274|467340909|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
129829404|NCT00391274|467340910|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
129829405|NCT00391274|467340909|FG000|Overall Study|Death Not Study Related|0|||
129829406|NCT00391274|467340910|FG001|Overall Study|Death Not Study Related|1|||
129829407|NCT03051607|467340911|FG000|Overall Study|Adverse Event|66|||
129829408|NCT03341533|467340912|FG000|Overall Study|Withdrawal by Subject|1|||
129829409|NCT03341533|467340913|FG001|Overall Study|Withdrawal by Subject|1|||
129829410|NCT03341533|467340912|FG000|Overall Study|Not eligible after randomization|2|||
129829411|NCT03341533|467340913|FG001|Overall Study|Not eligible after randomization|1|||
129829412|NCT03447990|467340914|FG000|Overall Study|Withdrawal by Subject|0|||
129829413|NCT03447990|467340915|FG001|Overall Study|Withdrawal by Subject|0|||
129829414|NCT03447990|467340916|FG002|Overall Study|Withdrawal by Subject|0|||
129829415|NCT03447990|467340917|FG003|Overall Study|Withdrawal by Subject|0|||
129829416|NCT03447990|467340918|FG004|Overall Study|Withdrawal by Subject|0|||
129829417|NCT03447990|467340919|FG005|Overall Study|Withdrawal by Subject|0|||
129829418|NCT03447990|467340920|FG006|Overall Study|Withdrawal by Subject|1|||
129829419|NCT03658538|467340930|FG000|Overall Study|Death|2|||
129829420|NCT03658538|467340931|FG001|Overall Study|Death|1|||
129829421|NCT03658538|467340930|FG000|Overall Study|Cancer diagnosis|1|||
129829422|NCT03658538|467340931|FG001|Overall Study|Cancer diagnosis|0|||
129829423|NCT03658538|467340930|FG000|Overall Study|Change residence|1|||
129829424|NCT03658538|467340931|FG001|Overall Study|Change residence|2|||
129829425|NCT03658538|467340930|FG000|Overall Study|Lost to Follow-up|3|||
129829426|NCT03658538|467340931|FG001|Overall Study|Lost to Follow-up|3|||
129829427|NCT03658538|467340930|FG000|Overall Study|Unblinded|2|||
129829428|NCT03658538|467340931|FG001|Overall Study|Unblinded|3|||
129829429|NCT03658538|467340930|FG000|Overall Study|Physician Decision|0|||
129829430|NCT03658538|467340931|FG001|Overall Study|Physician Decision|1|||
129829431|NCT03658538|467340930|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
129829432|NCT03658538|467340931|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
130112686|NCT01381900|468373445|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
129829433|NCT03658538|467340930|FG000|Overall Study|Evicted from home|1|||
129829434|NCT03658538|467340931|FG001|Overall Study|Evicted from home|0|||
129829435|NCT02446990|467340932|FG000|Overall Study|Death|485|||
129829436|NCT02446990|467340933|FG001|Overall Study|Death|458|||
129829437|NCT02446990|467340932|FG000|Overall Study|Lost to Follow-up|3|||
129829438|NCT02446990|467340933|FG001|Overall Study|Lost to Follow-up|1|||
129829439|NCT02446990|467340932|FG000|Overall Study|Physician Decision|1|||
129829440|NCT02446990|467340933|FG001|Overall Study|Physician Decision|0|||
129829441|NCT02446990|467340932|FG000|Overall Study|Withdrawal by Subject|231|||
129829442|NCT02446990|467340933|FG001|Overall Study|Withdrawal by Subject|199|||
129829443|NCT03333044|467340934|FG000|Overall Study|Pregnancy|1|||
129829444|NCT03333044|467340935|FG001|Overall Study|Pregnancy|0|||
129829445|NCT03333044|467340936|FG002|Overall Study|Pregnancy|0|||
129829446|NCT03333044|467340934|FG000|Overall Study|Lost to Follow-up|0|||
129829447|NCT03333044|467340935|FG001|Overall Study|Lost to Follow-up|14|||
129829448|NCT03333044|467340936|FG002|Overall Study|Lost to Follow-up|6|||
129829449|NCT03649711|467340937|FG000|Overall Study|Adverse Event|0|||
129829450|NCT03649711|467340938|FG001|Overall Study|Adverse Event|1|||
129829451|NCT03649711|467340939|FG002|Overall Study|Adverse Event|0|||
129829452|NCT03649711|467340937|FG000|Overall Study|Kidney Transplant|1|||
129829453|NCT03649711|467340938|FG001|Overall Study|Kidney Transplant|0|||
129829454|NCT03649711|467340939|FG002|Overall Study|Kidney Transplant|0|||
129829455|NCT03188094|467340944|FG000|Overall Study|Screen failure|1|||
129829456|NCT03188094|467340945|FG001|Overall Study|Screen failure|0|||
129829457|NCT03188094|467340946|FG002|Overall Study|Screen failure|0|||
130112687|NCT01381900|468373446|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
129829458|NCT03188094|467340944|FG000|Overall Study|Pregnancy|3|||
129829459|NCT03188094|467340945|FG001|Overall Study|Pregnancy|0|||
129829460|NCT03188094|467340946|FG002|Overall Study|Pregnancy|0|||
129829461|NCT03188094|467340944|FG000|Overall Study|Ineligible|1|||
129829462|NCT03188094|467340945|FG001|Overall Study|Ineligible|0|||
129829463|NCT03188094|467340946|FG002|Overall Study|Ineligible|0|||
129829464|NCT03188094|467340944|FG000|Overall Study|Lost to Follow-up|0|||
129829465|NCT03188094|467340945|FG001|Overall Study|Lost to Follow-up|0|||
129829466|NCT03188094|467340946|FG002|Overall Study|Lost to Follow-up|17|||
129829467|NCT04537234|467340947|FG000|Overall Study|Withdrawal by Subject|2|||
130112688|NCT01381900|468373444|FG000|Overall Study|Adverse Event|4|||
129829468|NCT04537234|467340948|FG001|Overall Study|Withdrawal by Subject|0|||
129829469|NCT05478252|467340949|FG000|Overall Study|Withdrawal by Subject|2|||
129829470|NCT05478252|467340950|FG001|Overall Study|Withdrawal by Subject|3|||
129829471|NCT05478252|467340949|FG000|Overall Study|Lost to Follow-up|4|||
129829472|NCT05478252|467340950|FG001|Overall Study|Lost to Follow-up|2|||
130060403|NCT00798694|468176633|FG001|Overall Study|Lost to Follow-up|1|||
129829473|NCT05478252|467340949|FG000|Overall Study|Physician Decision|1|||
129829474|NCT05478252|467340950|FG001|Overall Study|Physician Decision|1|||
129829475|NCT05478252|467340949|FG000|Overall Study|Death|1|||
129829476|NCT05478252|467340950|FG001|Overall Study|Death|0|||
129829477|NCT00858442|467342783|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
129829478|NCT00858442|467342784|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
129829479|NCT03329690|467342788|FG000|Overall Study|Progressive disease per RECIST|85|||
129829480|NCT03329690|467342789|FG001|Overall Study|Progressive disease per RECIST|44|||
129829481|NCT03329690|467342790|FG002|Overall Study|Progressive disease per RECIST|6|||
129829482|NCT03329690|467342791|FG003|Overall Study|Progressive disease per RECIST|16|||
129829483|NCT03329690|467342792|FG004|Overall Study|Progressive disease per RECIST|20|||
129829484|NCT03329690|467342788|FG000|Overall Study|Clinical progression|7|||
129829485|NCT03329690|467342789|FG001|Overall Study|Clinical progression|4|||
129829486|NCT03329690|467342790|FG002|Overall Study|Clinical progression|1|||
129829487|NCT03329690|467342791|FG003|Overall Study|Clinical progression|1|||
129829488|NCT03329690|467342792|FG004|Overall Study|Clinical progression|1|||
129829489|NCT03329690|467342788|FG000|Overall Study|Adverse Event|22|||
129829490|NCT03329690|467342789|FG001|Overall Study|Adverse Event|4|||
129829491|NCT03329690|467342790|FG002|Overall Study|Adverse Event|0|||
129829492|NCT03329690|467342791|FG003|Overall Study|Adverse Event|1|||
129829493|NCT03329690|467342792|FG004|Overall Study|Adverse Event|2|||
129829494|NCT03329690|467342788|FG000|Overall Study|Death|2|||
129829495|NCT03329690|467342789|FG001|Overall Study|Death|0|||
129829496|NCT03329690|467342790|FG002|Overall Study|Death|0|||
129829497|NCT03329690|467342791|FG003|Overall Study|Death|1|||
129829498|NCT03329690|467342792|FG004|Overall Study|Death|0|||
129829499|NCT03329690|467342788|FG000|Overall Study|Withdrawal by Subject|2|||
129829500|NCT03329690|467342789|FG001|Overall Study|Withdrawal by Subject|3|||
129829501|NCT03329690|467342790|FG002|Overall Study|Withdrawal by Subject|0|||
129829502|NCT03329690|467342791|FG003|Overall Study|Withdrawal by Subject|1|||
129829503|NCT03329690|467342792|FG004|Overall Study|Withdrawal by Subject|0|||
129829504|NCT03329690|467342788|FG000|Overall Study|Physician Decision|1|||
129829505|NCT03329690|467342789|FG001|Overall Study|Physician Decision|0|||
129829506|NCT03329690|467342790|FG002|Overall Study|Physician Decision|0|||
129829507|NCT03329690|467342791|FG003|Overall Study|Physician Decision|0|||
129829508|NCT03329690|467342792|FG004|Overall Study|Physician Decision|1|||
129829509|NCT03329690|467342788|FG000|Overall Study|Miscellaneous|6|||
129829510|NCT03329690|467342789|FG001|Overall Study|Miscellaneous|0|||
129829511|NCT03329690|467342790|FG002|Overall Study|Miscellaneous|0|||
129829512|NCT03329690|467342791|FG003|Overall Study|Miscellaneous|0|||
129829513|NCT03329690|467342792|FG004|Overall Study|Miscellaneous|0|||
129829514|NCT03329690|467342788|FG000|Overall Study|Did not receive treatment|1|||
129829515|NCT03329690|467342789|FG001|Overall Study|Did not receive treatment|0|||
129829516|NCT03329690|467342790|FG002|Overall Study|Did not receive treatment|0|||
129829517|NCT03329690|467342791|FG003|Overall Study|Did not receive treatment|1|||
129829518|NCT03329690|467342792|FG004|Overall Study|Did not receive treatment|0|||
129829519|NCT02337907|467342794|FG000|Overall Study|Other than listed|1|||
129829520|NCT02337907|467342795|FG001|Overall Study|Other than listed|0|||
129829521|NCT02337907|467342796|FG002|Overall Study|Other than listed|0|||
129829522|NCT02337907|467342797|FG003|Overall Study|Other than listed|1|||
129829523|NCT02337907|467342798|FG004|Overall Study|Other than listed|1|||
129829524|NCT02337907|467342799|FG005|Overall Study|Other than listed|0|||
129829525|NCT02337907|467342794|FG000|Overall Study|Withdrawal by Subject|2|||
129829526|NCT02337907|467342795|FG001|Overall Study|Withdrawal by Subject|3|||
129829527|NCT02337907|467342796|FG002|Overall Study|Withdrawal by Subject|0|||
129829528|NCT02337907|467342797|FG003|Overall Study|Withdrawal by Subject|2|||
129829529|NCT02337907|467342798|FG004|Overall Study|Withdrawal by Subject|5|||
129829530|NCT02337907|467342799|FG005|Overall Study|Withdrawal by Subject|0|||
129829531|NCT02337907|467342794|FG000|Overall Study|Lost to Follow-up|0|||
129829532|NCT02337907|467342795|FG001|Overall Study|Lost to Follow-up|0|||
129829533|NCT02337907|467342796|FG002|Overall Study|Lost to Follow-up|0|||
129829534|NCT02337907|467342797|FG003|Overall Study|Lost to Follow-up|0|||
129829535|NCT02337907|467342798|FG004|Overall Study|Lost to Follow-up|0|||
129829536|NCT02337907|467342799|FG005|Overall Study|Lost to Follow-up|1|||
129829537|NCT02337907|467342794|FG000|Overall Study|Adverse Event|1|||
130060404|NCT00798694|468176632|FG000|Overall Study|Physician Decision|1|||
129829538|NCT02337907|467342795|FG001|Overall Study|Adverse Event|1|||
129829539|NCT02337907|467342796|FG002|Overall Study|Adverse Event|1|||
129829540|NCT02337907|467342797|FG003|Overall Study|Adverse Event|1|||
129829541|NCT02337907|467342798|FG004|Overall Study|Adverse Event|4|||
129829542|NCT02337907|467342799|FG005|Overall Study|Adverse Event|0|||
129829543|NCT02488681|467342804|FG000|Overall Study|Implant unsuccessful|7|||
129829544|NCT03165110|467342805|FG000|Overall Study|Anroid phone software incompatibility|1|||
129829545|NCT05533632|467342806|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
129829546|NCT05533632|467342806|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
129829547|NCT05533632|467342806|FG000|Overall Study|Lost to Follow-up|1|||
129897685|NCT00517933|467584424|FG001|Period 1|Death|1|||
129829548|NCT05533632|467342806|FG000|Overall Study|Withdrawal by Subject|4|||
129829549|NCT05533632|467342806|FG000|Overall Study|Adverse Event|4|||
129829550|NCT04327388|467342809|FG000|Overall Study|Adverse Event|17|||
129829551|NCT04327388|467342810|FG001|Overall Study|Adverse Event|18|||
129829552|NCT04327388|467342811|FG002|Overall Study|Adverse Event|9|||
129829553|NCT04327388|467342809|FG000|Overall Study|Other|1|||
129829554|NCT04327388|467342810|FG001|Overall Study|Other|2|||
129829555|NCT04327388|467342811|FG002|Overall Study|Other|0|||
129829556|NCT04327388|467342809|FG000|Overall Study|Randomized and not treated|2|||
129829557|NCT04327388|467342810|FG001|Overall Study|Randomized and not treated|0|||
129829558|NCT04327388|467342811|FG002|Overall Study|Randomized and not treated|2|||
129829559|NCT04120974|467342812|FG000|Overall Study|Death|1|||
129829560|NCT04120974|467342812|FG000|Overall Study|Physician Decision|1|||
129829561|NCT04120974|467342812|FG000|Overall Study|Lost to Follow-up|6|||
129829562|NCT01519960|467342813|FG000|Overall Study|Withdrawal from the study|26|||
129829563|NCT01519960|467342814|FG001|Overall Study|Withdrawal from the study|22|||
129829564|NCT01519960|467342815|FG002|Overall Study|Withdrawal from the study|5|||
129829565|NCT01387347|467342816|FG000|Overall Study|Lost to Follow-up|2|||
129829566|NCT01387347|467342817|FG001|Overall Study|Lost to Follow-up|1|||
129829567|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
129829568|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
129829569|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
129829570|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
129829571|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
129829572|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
129829573|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
129829574|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
129829575|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
129829576|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
129829577|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
129829578|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
129829579|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
129829580|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
129829581|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
129829582|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Other|0|||
129829583|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Other|2|||
129829584|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Other|1|||
129829585|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
129829586|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
129829587|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
129829588|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
129829589|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
129829590|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
129829591|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
129829592|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
129829593|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
129829594|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
129829595|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
129829596|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
129829597|NCT00238121|467342823|FG000|Overall Study|Withdrawal by Subject|1|||
129829598|NCT00238121|467342824|FG001|Overall Study|Withdrawal by Subject|1|||
129829599|NCT00238121|467342823|FG000|Overall Study|Adverse Event|2|||
129829600|NCT00238121|467342824|FG001|Overall Study|Adverse Event|1|||
129829601|NCT03255382|467342825|FG000|Overall Study|Adverse Event|3|||
129829602|NCT03255382|467342826|FG001|Overall Study|Adverse Event|0|||
129829603|NCT03255382|467342825|FG000|Overall Study|Lost to Follow-up|2|||
129829604|NCT03255382|467342826|FG001|Overall Study|Lost to Follow-up|0|||
129829605|NCT03255382|467342825|FG000|Overall Study|Withdrawal by Subject|2|||
129829606|NCT03255382|467342826|FG001|Overall Study|Withdrawal by Subject|0|||
129829607|NCT03255382|467342825|FG000|Overall Study|Other|6|||
129829608|NCT03255382|467342826|FG001|Overall Study|Other|0|||
129897686|NCT00517933|467584423|FG000|Period 1|Adverse Event|4|||
130060405|NCT00798694|468176633|FG001|Overall Study|Physician Decision|0|||
130060406|NCT01774344|468176635|FG000|Overall Study|Withdrawal by Subject|3|||
130060407|NCT01774344|468176636|FG001|Overall Study|Withdrawal by Subject|10|||
130060408|NCT01774344|468176635|FG000|Overall Study|Protocol Violation|0|||
130060409|NCT01774344|468176636|FG001|Overall Study|Protocol Violation|1|||
130060410|NCT01774344|468176635|FG000|Overall Study|Lost to Follow-up|4|||
130060411|NCT01774344|468176636|FG001|Overall Study|Lost to Follow-up|10|||
130060412|NCT01774344|468176635|FG000|Overall Study|End of survival follow-up not available|2|||
130060413|NCT01774344|468176636|FG001|Overall Study|End of survival follow-up not available|2|||
130060414|NCT01774344|468176635|FG000|Overall Study|Data collection finished|4|||
130060415|NCT01774344|468176636|FG001|Overall Study|Data collection finished|14|||
130060416|NCT01774344|468176635|FG000|Overall Study|Other|0|||
129829609|NCT02221284|467342829|FG000|Overall Study|Case Report Forms Uncollected|56|||
129829610|NCT02221284|467342829|FG000|Overall Study|Protocol Deviation|5|||
129829611|NCT03526458|467342832|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
129829612|NCT03526458|467342833|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
129829613|NCT03526458|467342832|FG000|Overall Study|Stone passed, surgery cancelled|2|||
129829614|NCT03526458|467342833|FG001|Overall Study|Stone passed, surgery cancelled|1|||
129829615|NCT03526458|467342832|FG000|Overall Study|Withdrawal by Subject|1|||
129829616|NCT03526458|467342833|FG001|Overall Study|Withdrawal by Subject|0|||
129829617|NCT03526458|467342832|FG000|Overall Study|Physician Decision|2|||
129829618|NCT03526458|467342833|FG001|Overall Study|Physician Decision|1|||
129829619|NCT03526458|467342832|FG000|Overall Study|Lack of equipment|1|||
129829620|NCT03526458|467342833|FG001|Overall Study|Lack of equipment|1|||
129829621|NCT00529542|467342834|FG000|Overall Study|Withdrawal by Subject|1|||
129829622|NCT00529542|467342835|FG001|Overall Study|Withdrawal by Subject|0|||
129829623|NCT00529542|467342834|FG000|Overall Study|Lost to Follow-up|0|||
129829624|NCT00529542|467342835|FG001|Overall Study|Lost to Follow-up|1|||
129829625|NCT02587065|467342837|FG000|Overall Study|Adverse Event|14|||
129829626|NCT02587065|467342837|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
129829627|NCT02587065|467342837|FG000|Overall Study|Non-adherence to the Protocol|3|||
129829628|NCT02587065|467342837|FG000|Overall Study|Discontinuation of Study Medication|2|||
129829629|NCT02587065|467342837|FG000|Overall Study|Reason not Specified|3|||
129829630|NCT05104567|467342839|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829631|NCT05104567|467342840|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
129829632|NCT05104567|467342841|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829633|NCT05104567|467342842|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829634|NCT05104567|467342843|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829635|NCT05104567|467342844|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829636|NCT05104567|467342845|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829637|NCT05104567|467342839|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
129829638|NCT05104567|467342840|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
129829639|NCT05104567|467342841|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
129829640|NCT05104567|467342842|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
129829641|NCT05104567|467342843|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
129829642|NCT05104567|467342844|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
129829643|NCT05104567|467342845|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
129829644|NCT05104567|467342839|FG000|Overall Study|Progressive disease|3|||
129829645|NCT05104567|467342840|FG001|Overall Study|Progressive disease|13|||
129829646|NCT05104567|467342841|FG002|Overall Study|Progressive disease|13|||
129829647|NCT05104567|467342842|FG003|Overall Study|Progressive disease|17|||
129829648|NCT05104567|467342843|FG004|Overall Study|Progressive disease|17|||
129829649|NCT05104567|467342844|FG005|Overall Study|Progressive disease|28|||
129829650|NCT05104567|467342845|FG006|Overall Study|Progressive disease|24|||
129829651|NCT05104567|467342839|FG000|Overall Study|Withdrawal by Subject|1|||
129829652|NCT05104567|467342840|FG001|Overall Study|Withdrawal by Subject|1|||
129829653|NCT05104567|467342841|FG002|Overall Study|Withdrawal by Subject|2|||
129829654|NCT05104567|467342842|FG003|Overall Study|Withdrawal by Subject|0|||
129829655|NCT05104567|467342843|FG004|Overall Study|Withdrawal by Subject|0|||
129829656|NCT05104567|467342844|FG005|Overall Study|Withdrawal by Subject|0|||
129829657|NCT05104567|467342845|FG006|Overall Study|Withdrawal by Subject|0|||
129829658|NCT05104567|467342839|FG000|Overall Study|Other|1|||
129829659|NCT05104567|467342840|FG001|Overall Study|Other|1|||
129829660|NCT05104567|467342841|FG002|Overall Study|Other|1|||
129829661|NCT05104567|467342842|FG003|Overall Study|Other|0|||
129829662|NCT05104567|467342843|FG004|Overall Study|Other|0|||
129829663|NCT05104567|467342844|FG005|Overall Study|Other|0|||
129829664|NCT05104567|467342845|FG006|Overall Study|Other|0|||
129829665|NCT00733746|467342850|FG000|Overall Study|Ineligible|5|||
129829666|NCT05778786|467342851|FG000|Period 1|COVID-19 Related|3|||
129829667|NCT05778786|467342852|FG001|Period 1|COVID-19 Related|3|||
129829668|NCT05778786|467342851|FG000|Period 1|Withdrew Consent during Study|1|||
129829669|NCT05778786|467342852|FG001|Period 1|Withdrew Consent during Study|0|||
129829670|NCT05778786|467342851|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
129829671|NCT05778786|467342852|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
129829672|NCT05778786|467342851|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
129829673|NCT05778786|467342852|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
129829674|NCT02113956|467342856|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
129829675|NCT02113956|467342857|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
129829676|NCT02113956|467342856|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
129829677|NCT02113956|467342857|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
129897687|NCT00517933|467584424|FG001|Period 1|Adverse Event|4|||
129897688|NCT00517933|467584423|FG000|Period 1|Lost to Follow-up|2|||
129897689|NCT00517933|467584424|FG001|Period 1|Lost to Follow-up|0|||
129829678|NCT02113956|467342856|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
129829679|NCT02113956|467342857|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
129829680|NCT01602380|467342858|FG000|Overall Study|Death|147|||
129829681|NCT01602380|467342859|FG001|Overall Study|Death|145|||
129829682|NCT01602380|467342858|FG000|Overall Study|Withdrawal by Subject|39|||
129829683|NCT01602380|467342859|FG001|Overall Study|Withdrawal by Subject|41|||
129829684|NCT01602380|467342858|FG000|Overall Study|Lost to Follow-up|15|||
129829685|NCT01602380|467342859|FG001|Overall Study|Lost to Follow-up|12|||
129829686|NCT01602380|467342858|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129829687|NCT01602380|467342859|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
129829688|NCT01602380|467342858|FG000|Overall Study|Other|2|||
129829689|NCT01602380|467342859|FG001|Overall Study|Other|0|||
129829690|NCT01064401|467342861|FG000|Overall Study|Adverse Event|47|||
129829691|NCT01064401|467342862|FG001|Overall Study|Adverse Event|56|||
129829692|NCT01064401|467342861|FG000|Overall Study|Lack of Efficacy|46|||
129829693|NCT01064401|467342862|FG001|Overall Study|Lack of Efficacy|23|||
129829694|NCT01064401|467342861|FG000|Overall Study|Lost to Follow-up|12|||
129829695|NCT01064401|467342862|FG001|Overall Study|Lost to Follow-up|9|||
129829696|NCT01064401|467342861|FG000|Overall Study|Consent Withdrawn|98|||
129829697|NCT01064401|467342862|FG001|Overall Study|Consent Withdrawn|80|||
129829698|NCT01064401|467342861|FG000|Overall Study|Investigator Decision|4|||
129829699|NCT01064401|467342862|FG001|Overall Study|Investigator Decision|6|||
129829700|NCT01064401|467342861|FG000|Overall Study|Death|4|||
129829701|NCT01064401|467342862|FG001|Overall Study|Death|0|||
129829702|NCT01064401|467342861|FG000|Overall Study|Pregnancy|4|||
129829703|NCT01064401|467342862|FG001|Overall Study|Pregnancy|7|||
129829704|NCT01064401|467342861|FG000|Overall Study|Noncompliance|7|||
129829705|NCT01064401|467342862|FG001|Overall Study|Noncompliance|8|||
129829706|NCT01064401|467342861|FG000|Overall Study|Site Closure|4|||
129829707|NCT01064401|467342862|FG001|Overall Study|Site Closure|5|||
129829708|NCT01064401|467342861|FG000|Overall Study|Other|2|||
129829709|NCT01064401|467342862|FG001|Overall Study|Other|1|||
129829710|NCT03158051|467342863|FG000|Overall Study|Lost to Follow-up|41|||
129829711|NCT03158051|467342864|FG001|Overall Study|Lost to Follow-up|47|||
129829712|NCT03158051|467342863|FG000|Overall Study|Physician Decision|6|||
129829713|NCT03158051|467342864|FG001|Overall Study|Physician Decision|7|||
129829714|NCT03158051|467342863|FG000|Overall Study|Withdrawal by Subject|24|||
129829715|NCT03158051|467342864|FG001|Overall Study|Withdrawal by Subject|15|||
129829716|NCT03158051|467342863|FG000|Overall Study|Death|0|||
129829717|NCT03158051|467342864|FG001|Overall Study|Death|1|||
129829718|NCT02738151|467342865|FG000|Overall Study|Randomized but not treated|4|||
129829719|NCT02738151|467342866|FG001|Overall Study|Randomized but not treated|1|||
129829720|NCT02738151|467342865|FG000|Overall Study|Adverse Event|4|||
129829721|NCT02738151|467342866|FG001|Overall Study|Adverse Event|5|||
129829722|NCT02738151|467342865|FG000|Overall Study|Hypoglycemia|0|||
129829723|NCT02738151|467342866|FG001|Overall Study|Hypoglycemia|1|||
129829724|NCT02738151|467342865|FG000|Overall Study|Poor Compliance to Protocol|4|||
129829725|NCT02738151|467342866|FG001|Overall Study|Poor Compliance to Protocol|3|||
129829726|NCT02738151|467342865|FG000|Overall Study|Other than specified above|11|||
129829727|NCT02738151|467342866|FG001|Overall Study|Other than specified above|21|||
129829728|NCT02005250|467342867|FG000|Overall Study|Lost to Follow-up|15|||
129829729|NCT02005250|467342868|FG001|Overall Study|Lost to Follow-up|5|||
129829730|NCT02588833|467342869|FG000|Part 1|Withdrawal by Subject|1|||
129829731|NCT02588833|467342870|FG001|Part 1|Withdrawal by Subject|0|||
129829732|NCT02588833|467342869|FG000|Part 2A|Physician Decision|0|||
129829733|NCT02588833|467342870|FG001|Part 2A|Physician Decision|1|||
129829734|NCT02588833|467342869|FG000|Part 2A|Withdrawal by Subject|0|||
129829735|NCT02588833|467342870|FG001|Part 2A|Withdrawal by Subject|1|||
129829736|NCT02588833|467342869|FG000|Part 2B|Adverse Event|0|||
129829737|NCT02588833|467342870|FG001|Part 2B|Adverse Event|1|||
129829738|NCT02588833|467342869|FG000|Part 2C|Adverse Event|0|||
129829739|NCT02588833|467342870|FG001|Part 2C|Adverse Event|1|||
129829740|NCT02588833|467342869|FG000|Part 2C|Withdrawal by Subject|0|||
129829741|NCT02588833|467342870|FG001|Part 2C|Withdrawal by Subject|1|||
129829742|NCT02588833|467342869|FG000|Part 3 (Safety Follow-up)|Other|0|||
129829743|NCT02588833|467342870|FG001|Part 3 (Safety Follow-up)|Other|2|||
129829744|NCT04007094|467342876|FG000|Overall Study|Lost to Follow-up|1|||
129829745|NCT04007094|467342877|FG001|Overall Study|Lost to Follow-up|1|||
129829746|NCT02921776|467342878|FG000|Overall Study|patient deterioration, fatigue|2|||
129829747|NCT02921776|467342879|FG001|Overall Study|patient deterioration, fatigue|6|||
129829748|NCT02921776|467342880|FG002|Overall Study|patient deterioration, fatigue|0|||
129829749|NCT02921776|467342881|FG003|Overall Study|patient deterioration, fatigue|0|||
129829750|NCT02921776|467342882|FG004|Overall Study|patient deterioration, fatigue|0|||
129829751|NCT02921776|467342883|FG005|Overall Study|patient deterioration, fatigue|0|||
129829752|NCT02921776|467342884|FG006|Overall Study|patient deterioration, fatigue|0|||
129829753|NCT02921776|467342885|FG007|Overall Study|patient deterioration, fatigue|0|||
129829754|NCT02921776|467342878|FG000|Overall Study|Withdrawal by Subject|0|||
129829755|NCT02921776|467342879|FG001|Overall Study|Withdrawal by Subject|2|||
129829756|NCT02921776|467342880|FG002|Overall Study|Withdrawal by Subject|0|||
129829757|NCT02921776|467342881|FG003|Overall Study|Withdrawal by Subject|1|||
129829758|NCT02921776|467342882|FG004|Overall Study|Withdrawal by Subject|1|||
129829759|NCT02921776|467342883|FG005|Overall Study|Withdrawal by Subject|0|||
129829760|NCT02921776|467342884|FG006|Overall Study|Withdrawal by Subject|8|||
129829761|NCT02921776|467342885|FG007|Overall Study|Withdrawal by Subject|1|||
129829762|NCT02921776|467342878|FG000|Overall Study|Death|0|||
129829763|NCT02921776|467342879|FG001|Overall Study|Death|0|||
129829764|NCT02921776|467342880|FG002|Overall Study|Death|0|||
130060417|NCT01774344|468176636|FG001|Overall Study|Other|1|||
130060418|NCT01774344|468176635|FG000|Overall Study|Did not enter Survival Follow up|49|||
130060419|NCT01774344|468176636|FG001|Overall Study|Did not enter Survival Follow up|83|||
130060420|NCT01089582|468176640|FG000|Overall Study|Death|2|||
130060421|NCT01089582|468176640|FG000|Overall Study|Adverse Event|15|||
129829765|NCT02921776|467342881|FG003|Overall Study|Death|2|||
129829766|NCT02921776|467342882|FG004|Overall Study|Death|0|||
129829767|NCT02921776|467342883|FG005|Overall Study|Death|0|||
129829768|NCT02921776|467342884|FG006|Overall Study|Death|0|||
129829769|NCT02921776|467342885|FG007|Overall Study|Death|0|||
129829770|NCT02921776|467342878|FG000|Overall Study|extubation or early discharge|0|||
129829771|NCT02921776|467342879|FG001|Overall Study|extubation or early discharge|0|||
129829772|NCT02921776|467342880|FG002|Overall Study|extubation or early discharge|0|||
129829773|NCT02921776|467342881|FG003|Overall Study|extubation or early discharge|5|||
129829774|NCT02921776|467342882|FG004|Overall Study|extubation or early discharge|5|||
129829775|NCT02921776|467342883|FG005|Overall Study|extubation or early discharge|0|||
129829776|NCT02921776|467342884|FG006|Overall Study|extubation or early discharge|0|||
129829777|NCT02921776|467342885|FG007|Overall Study|extubation or early discharge|0|||
129829778|NCT02921776|467342878|FG000|Overall Study|Lost to Follow-up|0|||
129829779|NCT02921776|467342879|FG001|Overall Study|Lost to Follow-up|0|||
129829780|NCT02921776|467342880|FG002|Overall Study|Lost to Follow-up|0|||
129829781|NCT02921776|467342881|FG003|Overall Study|Lost to Follow-up|0|||
129829782|NCT02921776|467342882|FG004|Overall Study|Lost to Follow-up|0|||
129829783|NCT02921776|467342883|FG005|Overall Study|Lost to Follow-up|2|||
129829784|NCT02921776|467342884|FG006|Overall Study|Lost to Follow-up|3|||
129829785|NCT02921776|467342885|FG007|Overall Study|Lost to Follow-up|6|||
129829786|NCT02070744|467342891|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829787|NCT02070744|467342892|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829788|NCT02070744|467342893|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829789|NCT02070744|467342894|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
129829790|NCT02070744|467342895|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829791|NCT02070744|467342891|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829792|NCT02070744|467342892|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829793|NCT02070744|467342893|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829794|NCT02070744|467342894|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829795|NCT02070744|467342895|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
129829796|NCT02070744|467342891|FG000|OLE Phase (48 Weeks)|Other|0|||
129829797|NCT02070744|467342892|FG001|OLE Phase (48 Weeks)|Other|0|||
129829798|NCT02070744|467342893|FG002|OLE Phase (48 Weeks)|Other|0|||
129829799|NCT02070744|467342894|FG003|OLE Phase (48 Weeks)|Other|0|||
129829800|NCT02070744|467342895|FG004|OLE Phase (48 Weeks)|Other|1|||
129829801|NCT04199117|467342896|FG000|Overall Study|Withdrawal by Subject|3|||
129829802|NCT04199117|467342897|FG001|Overall Study|Withdrawal by Subject|0|||
129829803|NCT04199117|467342898|FG002|Overall Study|Withdrawal by Subject|0|||
129829804|NCT04199117|467342899|FG003|Overall Study|Withdrawal by Subject|1|||
129829805|NCT04199117|467342900|FG004|Overall Study|Withdrawal by Subject|1|||
129829806|NCT04199117|467342901|FG005|Overall Study|Withdrawal by Subject|0|||
129829807|NCT04199117|467342902|FG006|Overall Study|Withdrawal by Subject|0|||
129829808|NCT04199117|467342903|FG007|Overall Study|Withdrawal by Subject|2|||
129829809|NCT04199117|467342904|FG008|Overall Study|Withdrawal by Subject|0|||
129829810|NCT04199117|467342905|FG009|Overall Study|Withdrawal by Subject|0|||
129829811|NCT04199117|467342906|FG010|Overall Study|Withdrawal by Subject|1|||
129829812|NCT04199117|467342907|FG011|Overall Study|Withdrawal by Subject|1|||
129829813|NCT04199117|467342908|FG012|Overall Study|Withdrawal by Subject|2|||
129829814|NCT04199117|467342909|FG013|Overall Study|Withdrawal by Subject|1|||
129829815|NCT04199117|467342910|FG014|Overall Study|Withdrawal by Subject|1|||
129829816|NCT04199117|467342911|FG015|Overall Study|Withdrawal by Subject|1|||
129829817|NCT04199117|467342896|FG000|Overall Study|Death|1|||
129829818|NCT04199117|467342897|FG001|Overall Study|Death|1|||
129829819|NCT04199117|467342898|FG002|Overall Study|Death|0|||
129829820|NCT04199117|467342899|FG003|Overall Study|Death|0|||
129829821|NCT04199117|467342900|FG004|Overall Study|Death|0|||
129829822|NCT04199117|467342901|FG005|Overall Study|Death|0|||
129829823|NCT04199117|467342902|FG006|Overall Study|Death|0|||
129829824|NCT04199117|467342903|FG007|Overall Study|Death|0|||
129829825|NCT04199117|467342904|FG008|Overall Study|Death|0|||
129829826|NCT04199117|467342905|FG009|Overall Study|Death|0|||
129829827|NCT04199117|467342906|FG010|Overall Study|Death|0|||
130060422|NCT01089582|468176640|FG000|Overall Study|Lost to Follow-up|8|||
129829828|NCT04199117|467342907|FG011|Overall Study|Death|1|||
129829829|NCT04199117|467342908|FG012|Overall Study|Death|0|||
129829830|NCT04199117|467342909|FG013|Overall Study|Death|1|||
129829831|NCT04199117|467342910|FG014|Overall Study|Death|0|||
129829832|NCT04199117|467342911|FG015|Overall Study|Death|0|||
129829833|NCT04199117|467342896|FG000|Overall Study|Withdrawal by PI|0|||
129829834|NCT04199117|467342897|FG001|Overall Study|Withdrawal by PI|0|||
129829835|NCT04199117|467342898|FG002|Overall Study|Withdrawal by PI|0|||
129829836|NCT04199117|467342899|FG003|Overall Study|Withdrawal by PI|0|||
129829837|NCT04199117|467342900|FG004|Overall Study|Withdrawal by PI|0|||
129829838|NCT04199117|467342901|FG005|Overall Study|Withdrawal by PI|0|||
129829839|NCT04199117|467342902|FG006|Overall Study|Withdrawal by PI|0|||
129829840|NCT04199117|467342903|FG007|Overall Study|Withdrawal by PI|0|||
129829841|NCT04199117|467342904|FG008|Overall Study|Withdrawal by PI|0|||
129829842|NCT04199117|467342905|FG009|Overall Study|Withdrawal by PI|0|||
129829843|NCT04199117|467342906|FG010|Overall Study|Withdrawal by PI|0|||
129829844|NCT04199117|467342907|FG011|Overall Study|Withdrawal by PI|0|||
129829845|NCT04199117|467342908|FG012|Overall Study|Withdrawal by PI|1|||
129829846|NCT04199117|467342909|FG013|Overall Study|Withdrawal by PI|0|||
129829847|NCT04199117|467342910|FG014|Overall Study|Withdrawal by PI|0|||
129829848|NCT04199117|467342911|FG015|Overall Study|Withdrawal by PI|0|||
129829849|NCT04439253|467344322|FG000|Overall Study|Adverse Event|1|||
129829850|NCT04439253|467344322|FG000|Overall Study|Disease progression|2|||
129829851|NCT04439253|467344322|FG000|Overall Study|Complicating disease|1|||
129829852|NCT00702403|467344323|FG000|From Consent to Engraftment|Progressive leukemia|6|||
129829853|NCT00702403|467344323|FG000|From Consent to Engraftment|Critically ill|2|||
129829854|NCT00702403|467344323|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
129829855|NCT00702403|467344323|FG000|From Consent to Engraftment|Myocardial infarction|1|||
129829856|NCT00702403|467344323|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
129829857|NCT00702403|467344323|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
129829858|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
129829859|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
129829860|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Non-compliance|2|||
129829861|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
129829862|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
129829863|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Suicide|1|||
129829864|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
129829865|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
129829866|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
129829867|NCT00380978|467344325|FG000|Overall Study|Refused allocated intervention|0|||
129829868|NCT00380978|467344326|FG001|Overall Study|Refused allocated intervention|6|||
129829869|NCT00380978|467344325|FG000|Overall Study|Wrong study envelope|0|||
129829870|NCT00380978|467344326|FG001|Overall Study|Wrong study envelope|2|||
129829871|NCT00380978|467344325|FG000|Overall Study|Allocation prior to analgesia request|1|||
129829872|NCT00380978|467344326|FG001|Overall Study|Allocation prior to analgesia request|2|||
129829873|NCT00380978|467344325|FG000|Overall Study|Parous patient|1|||
129829874|NCT00380978|467344326|FG001|Overall Study|Parous patient|0|||
129829875|NCT04146545|467344327|FG000|Overall Study|deemed ineligible after randomization|1|||
129829876|NCT04146545|467344328|FG001|Overall Study|deemed ineligible after randomization|0|||
129829877|NCT01729754|467344329|FG000|Part 1|Adverse Event|2|||
129829878|NCT01729754|467344330|FG001|Part 1|Adverse Event|0|||
129829879|NCT01729754|467344331|FG002|Part 1|Adverse Event|0|||
129829880|NCT01729754|467344332|FG003|Part 1|Adverse Event|1|||
129829881|NCT01729754|467344333|FG004|Part 1|Adverse Event|0|||
129829882|NCT01729754|467344334|FG005|Part 1|Adverse Event|0|||
129829883|NCT01729754|467344335|FG006|Part 1|Adverse Event|2|||
129829884|NCT01729754|467344336|FG007|Part 1|Adverse Event|0|||
129829885|NCT01729754|467344337|FG008|Part 1|Adverse Event|0|||
129829886|NCT01729754|467344338|FG009|Part 1|Adverse Event|5|||
129829887|NCT01729754|467344329|FG000|Part 1|Lack of Efficacy|1|||
129829888|NCT01729754|467344330|FG001|Part 1|Lack of Efficacy|0|||
129829889|NCT01729754|467344331|FG002|Part 1|Lack of Efficacy|0|||
129829890|NCT01729754|467344332|FG003|Part 1|Lack of Efficacy|0|||
129829891|NCT01729754|467344333|FG004|Part 1|Lack of Efficacy|0|||
129829892|NCT01729754|467344334|FG005|Part 1|Lack of Efficacy|0|||
129829893|NCT01729754|467344335|FG006|Part 1|Lack of Efficacy|2|||
129829894|NCT01729754|467344336|FG007|Part 1|Lack of Efficacy|0|||
130112689|NCT01381900|468373445|FG001|Overall Study|Adverse Event|6|||
129829895|NCT01729754|467344337|FG008|Part 1|Lack of Efficacy|0|||
129829896|NCT01729754|467344338|FG009|Part 1|Lack of Efficacy|0|||
129829897|NCT01729754|467344329|FG000|Part 1|Lost to Follow-up|1|||
129829898|NCT01729754|467344330|FG001|Part 1|Lost to Follow-up|0|||
129829899|NCT01729754|467344331|FG002|Part 1|Lost to Follow-up|0|||
130112690|NCT01381900|468373446|FG002|Overall Study|Adverse Event|7|||
129829900|NCT01729754|467344332|FG003|Part 1|Lost to Follow-up|2|||
129829901|NCT01729754|467344333|FG004|Part 1|Lost to Follow-up|0|||
129829902|NCT01729754|467344334|FG005|Part 1|Lost to Follow-up|0|||
129829903|NCT01729754|467344335|FG006|Part 1|Lost to Follow-up|3|||
129829904|NCT01729754|467344336|FG007|Part 1|Lost to Follow-up|0|||
129829905|NCT01729754|467344337|FG008|Part 1|Lost to Follow-up|0|||
129829906|NCT01729754|467344338|FG009|Part 1|Lost to Follow-up|3|||
129829907|NCT01729754|467344329|FG000|Part 1|Non-compliance with Study Drug|1|||
129829908|NCT01729754|467344330|FG001|Part 1|Non-compliance with Study Drug|0|||
129829909|NCT01729754|467344331|FG002|Part 1|Non-compliance with Study Drug|0|||
129829910|NCT01729754|467344332|FG003|Part 1|Non-compliance with Study Drug|0|||
129829911|NCT01729754|467344333|FG004|Part 1|Non-compliance with Study Drug|0|||
129829912|NCT01729754|467344334|FG005|Part 1|Non-compliance with Study Drug|0|||
129829913|NCT01729754|467344335|FG006|Part 1|Non-compliance with Study Drug|0|||
129829914|NCT01729754|467344336|FG007|Part 1|Non-compliance with Study Drug|0|||
129829915|NCT01729754|467344337|FG008|Part 1|Non-compliance with Study Drug|0|||
129829916|NCT01729754|467344338|FG009|Part 1|Non-compliance with Study Drug|0|||
129829917|NCT01729754|467344329|FG000|Part 1|Physician Decision|0|||
129829918|NCT01729754|467344330|FG001|Part 1|Physician Decision|0|||
129829919|NCT01729754|467344331|FG002|Part 1|Physician Decision|0|||
129829920|NCT01729754|467344332|FG003|Part 1|Physician Decision|0|||
129829921|NCT01729754|467344333|FG004|Part 1|Physician Decision|0|||
129829922|NCT01729754|467344334|FG005|Part 1|Physician Decision|0|||
129829923|NCT01729754|467344335|FG006|Part 1|Physician Decision|0|||
129829924|NCT01729754|467344336|FG007|Part 1|Physician Decision|0|||
129829925|NCT01729754|467344337|FG008|Part 1|Physician Decision|0|||
129829926|NCT01729754|467344338|FG009|Part 1|Physician Decision|4|||
129829927|NCT01729754|467344329|FG000|Part 1|Pregnancy|0|||
129829928|NCT01729754|467344330|FG001|Part 1|Pregnancy|0|||
129829929|NCT01729754|467344331|FG002|Part 1|Pregnancy|0|||
129829930|NCT01729754|467344332|FG003|Part 1|Pregnancy|1|||
129829931|NCT01729754|467344333|FG004|Part 1|Pregnancy|0|||
129829932|NCT01729754|467344334|FG005|Part 1|Pregnancy|0|||
129829933|NCT01729754|467344335|FG006|Part 1|Pregnancy|0|||
129829934|NCT01729754|467344336|FG007|Part 1|Pregnancy|0|||
129829935|NCT01729754|467344337|FG008|Part 1|Pregnancy|0|||
129829936|NCT01729754|467344338|FG009|Part 1|Pregnancy|1|||
129829937|NCT01729754|467344329|FG000|Part 1|Progressive Disease|0|||
129829938|NCT01729754|467344330|FG001|Part 1|Progressive Disease|0|||
129829939|NCT01729754|467344331|FG002|Part 1|Progressive Disease|0|||
129829940|NCT01729754|467344332|FG003|Part 1|Progressive Disease|0|||
129829941|NCT01729754|467344333|FG004|Part 1|Progressive Disease|0|||
129829942|NCT01729754|467344334|FG005|Part 1|Progressive Disease|0|||
129829943|NCT01729754|467344335|FG006|Part 1|Progressive Disease|0|||
129829944|NCT01729754|467344336|FG007|Part 1|Progressive Disease|0|||
129829945|NCT01729754|467344337|FG008|Part 1|Progressive Disease|0|||
129829946|NCT01729754|467344338|FG009|Part 1|Progressive Disease|1|||
129829947|NCT01729754|467344329|FG000|Part 1|Protocol Violation|2|||
129829948|NCT01729754|467344330|FG001|Part 1|Protocol Violation|0|||
129829949|NCT01729754|467344331|FG002|Part 1|Protocol Violation|0|||
129829950|NCT01729754|467344332|FG003|Part 1|Protocol Violation|1|||
129829951|NCT01729754|467344333|FG004|Part 1|Protocol Violation|0|||
129829952|NCT01729754|467344334|FG005|Part 1|Protocol Violation|0|||
129829953|NCT01729754|467344335|FG006|Part 1|Protocol Violation|1|||
129829954|NCT01729754|467344336|FG007|Part 1|Protocol Violation|0|||
129829955|NCT01729754|467344337|FG008|Part 1|Protocol Violation|0|||
129829956|NCT01729754|467344338|FG009|Part 1|Protocol Violation|0|||
129829957|NCT01729754|467344329|FG000|Part 1|Withdrawal by Subject|5|||
129829958|NCT01729754|467344330|FG001|Part 1|Withdrawal by Subject|0|||
129829959|NCT01729754|467344331|FG002|Part 1|Withdrawal by Subject|0|||
129829960|NCT01729754|467344332|FG003|Part 1|Withdrawal by Subject|7|||
129829961|NCT01729754|467344333|FG004|Part 1|Withdrawal by Subject|0|||
129829962|NCT01729754|467344334|FG005|Part 1|Withdrawal by Subject|0|||
129829963|NCT01729754|467344335|FG006|Part 1|Withdrawal by Subject|5|||
129829964|NCT01729754|467344336|FG007|Part 1|Withdrawal by Subject|0|||
129829965|NCT01729754|467344337|FG008|Part 1|Withdrawal by Subject|0|||
129829966|NCT01729754|467344338|FG009|Part 1|Withdrawal by Subject|6|||
129829967|NCT01729754|467344329|FG000|Part 1|Other Protocol Specified Criteria|2|||
129829968|NCT01729754|467344330|FG001|Part 1|Other Protocol Specified Criteria|0|||
129829969|NCT01729754|467344331|FG002|Part 1|Other Protocol Specified Criteria|0|||
129829970|NCT01729754|467344332|FG003|Part 1|Other Protocol Specified Criteria|0|||
129829971|NCT01729754|467344333|FG004|Part 1|Other Protocol Specified Criteria|0|||
129829972|NCT01729754|467344334|FG005|Part 1|Other Protocol Specified Criteria|0|||
129829973|NCT01729754|467344335|FG006|Part 1|Other Protocol Specified Criteria|1|||
129829974|NCT01729754|467344336|FG007|Part 1|Other Protocol Specified Criteria|0|||
129829975|NCT01729754|467344337|FG008|Part 1|Other Protocol Specified Criteria|0|||
129829976|NCT01729754|467344338|FG009|Part 1|Other Protocol Specified Criteria|4|||
129829977|NCT01729754|467344329|FG000|Part 2|Adverse Event|2|||
130060423|NCT01089582|468176640|FG000|Overall Study|Other|4|||
129829978|NCT01729754|467344330|FG001|Part 2|Adverse Event|0|||
129829979|NCT01729754|467344331|FG002|Part 2|Adverse Event|0|||
129829980|NCT01729754|467344332|FG003|Part 2|Adverse Event|0|||
129829981|NCT01729754|467344333|FG004|Part 2|Adverse Event|0|||
129829982|NCT01729754|467344334|FG005|Part 2|Adverse Event|0|||
129829983|NCT01729754|467344335|FG006|Part 2|Adverse Event|0|||
129829984|NCT01729754|467344336|FG007|Part 2|Adverse Event|0|||
129829985|NCT01729754|467344337|FG008|Part 2|Adverse Event|1|||
129829986|NCT01729754|467344338|FG009|Part 2|Adverse Event|2|||
129829987|NCT01729754|467344329|FG000|Part 2|Lack of Efficacy|0|||
130060424|NCT01089582|468176640|FG000|Overall Study|Withdrawal by Subject|1|||
130060425|NCT02108600|468176641|FG000|Overall Study|Withdrawal by Subject|2|||
129829988|NCT01729754|467344330|FG001|Part 2|Lack of Efficacy|0|||
129829989|NCT01729754|467344331|FG002|Part 2|Lack of Efficacy|0|||
129829990|NCT01729754|467344332|FG003|Part 2|Lack of Efficacy|0|||
129829991|NCT01729754|467344333|FG004|Part 2|Lack of Efficacy|0|||
129829992|NCT01729754|467344334|FG005|Part 2|Lack of Efficacy|0|||
129829993|NCT01729754|467344335|FG006|Part 2|Lack of Efficacy|0|||
129829994|NCT01729754|467344336|FG007|Part 2|Lack of Efficacy|0|||
129829995|NCT01729754|467344337|FG008|Part 2|Lack of Efficacy|2|||
129829996|NCT01729754|467344338|FG009|Part 2|Lack of Efficacy|2|||
129829997|NCT01729754|467344329|FG000|Part 2|Lost to Follow-up|0|||
129829998|NCT01729754|467344330|FG001|Part 2|Lost to Follow-up|0|||
129829999|NCT01729754|467344331|FG002|Part 2|Lost to Follow-up|0|||
129830000|NCT01729754|467344332|FG003|Part 2|Lost to Follow-up|2|||
129830001|NCT01729754|467344333|FG004|Part 2|Lost to Follow-up|0|||
129830002|NCT01729754|467344334|FG005|Part 2|Lost to Follow-up|0|||
129830003|NCT01729754|467344335|FG006|Part 2|Lost to Follow-up|0|||
129830004|NCT01729754|467344336|FG007|Part 2|Lost to Follow-up|1|||
129830005|NCT01729754|467344337|FG008|Part 2|Lost to Follow-up|0|||
129830006|NCT01729754|467344338|FG009|Part 2|Lost to Follow-up|2|||
129830007|NCT01729754|467344329|FG000|Part 2|Non-Compliance with Study Drug|0|||
129830008|NCT01729754|467344330|FG001|Part 2|Non-Compliance with Study Drug|0|||
129830009|NCT01729754|467344331|FG002|Part 2|Non-Compliance with Study Drug|0|||
129830010|NCT01729754|467344332|FG003|Part 2|Non-Compliance with Study Drug|0|||
129830011|NCT01729754|467344333|FG004|Part 2|Non-Compliance with Study Drug|0|||
129830012|NCT01729754|467344334|FG005|Part 2|Non-Compliance with Study Drug|0|||
129830013|NCT01729754|467344335|FG006|Part 2|Non-Compliance with Study Drug|0|||
129830014|NCT01729754|467344336|FG007|Part 2|Non-Compliance with Study Drug|0|||
129830015|NCT01729754|467344337|FG008|Part 2|Non-Compliance with Study Drug|0|||
129830016|NCT01729754|467344338|FG009|Part 2|Non-Compliance with Study Drug|1|||
129830017|NCT01729754|467344329|FG000|Part 2|Pregnancy|0|||
129830018|NCT01729754|467344330|FG001|Part 2|Pregnancy|0|||
129830019|NCT01729754|467344331|FG002|Part 2|Pregnancy|0|||
129830020|NCT01729754|467344332|FG003|Part 2|Pregnancy|1|||
129830021|NCT01729754|467344333|FG004|Part 2|Pregnancy|0|||
129830022|NCT01729754|467344334|FG005|Part 2|Pregnancy|0|||
129830023|NCT01729754|467344335|FG006|Part 2|Pregnancy|0|||
129830024|NCT01729754|467344336|FG007|Part 2|Pregnancy|0|||
129830025|NCT01729754|467344337|FG008|Part 2|Pregnancy|0|||
129830026|NCT01729754|467344338|FG009|Part 2|Pregnancy|1|||
129830027|NCT01729754|467344329|FG000|Part 2|Withdrawal by Subject|3|||
129830028|NCT01729754|467344330|FG001|Part 2|Withdrawal by Subject|0|||
129830029|NCT01729754|467344331|FG002|Part 2|Withdrawal by Subject|0|||
129830030|NCT01729754|467344332|FG003|Part 2|Withdrawal by Subject|2|||
129830031|NCT01729754|467344333|FG004|Part 2|Withdrawal by Subject|0|||
129830032|NCT01729754|467344334|FG005|Part 2|Withdrawal by Subject|0|||
129830033|NCT01729754|467344335|FG006|Part 2|Withdrawal by Subject|0|||
129830034|NCT01729754|467344336|FG007|Part 2|Withdrawal by Subject|1|||
129830035|NCT01729754|467344337|FG008|Part 2|Withdrawal by Subject|1|||
129830036|NCT01729754|467344338|FG009|Part 2|Withdrawal by Subject|4|||
129830037|NCT01729754|467344329|FG000|Part 2|Other Protocol Specified Criteria|1|||
129830038|NCT01729754|467344330|FG001|Part 2|Other Protocol Specified Criteria|0|||
129830039|NCT01729754|467344331|FG002|Part 2|Other Protocol Specified Criteria|0|||
129830040|NCT01729754|467344332|FG003|Part 2|Other Protocol Specified Criteria|0|||
129830041|NCT01729754|467344333|FG004|Part 2|Other Protocol Specified Criteria|0|||
129830042|NCT01729754|467344334|FG005|Part 2|Other Protocol Specified Criteria|0|||
129830043|NCT01729754|467344335|FG006|Part 2|Other Protocol Specified Criteria|0|||
129830044|NCT01729754|467344336|FG007|Part 2|Other Protocol Specified Criteria|1|||
129830045|NCT01729754|467344337|FG008|Part 2|Other Protocol Specified Criteria|0|||
129830046|NCT01729754|467344338|FG009|Part 2|Other Protocol Specified Criteria|0|||
129830047|NCT01729754|467344329|FG000|Part 3|Adverse Event|0|||
129830048|NCT01729754|467344330|FG001|Part 3|Adverse Event|0|||
129830049|NCT01729754|467344331|FG002|Part 3|Adverse Event|1|||
129897690|NCT00517933|467584423|FG000|Period 1|Underwent lung transplant|0|||
129830050|NCT01729754|467344332|FG003|Part 3|Adverse Event|0|||
129830051|NCT01729754|467344333|FG004|Part 3|Adverse Event|0|||
129830052|NCT01729754|467344334|FG005|Part 3|Adverse Event|5|||
130060426|NCT02108600|468176642|FG001|Overall Study|Withdrawal by Subject|0|||
130060427|NCT02108600|468176641|FG000|Overall Study|Lost to Follow-up|1|||
129830053|NCT01729754|467344335|FG006|Part 3|Adverse Event|0|||
129830054|NCT01729754|467344336|FG007|Part 3|Adverse Event|0|||
129830055|NCT01729754|467344337|FG008|Part 3|Adverse Event|0|||
129830056|NCT01729754|467344338|FG009|Part 3|Adverse Event|3|||
129830057|NCT01729754|467344329|FG000|Part 3|Death|0|||
129830058|NCT01729754|467344330|FG001|Part 3|Death|0|||
129830059|NCT01729754|467344331|FG002|Part 3|Death|0|||
129830060|NCT01729754|467344332|FG003|Part 3|Death|0|||
129830061|NCT01729754|467344333|FG004|Part 3|Death|0|||
129830062|NCT01729754|467344334|FG005|Part 3|Death|2|||
129830063|NCT01729754|467344335|FG006|Part 3|Death|0|||
129830064|NCT01729754|467344336|FG007|Part 3|Death|0|||
129830065|NCT01729754|467344337|FG008|Part 3|Death|0|||
129830066|NCT01729754|467344338|FG009|Part 3|Death|0|||
129830067|NCT01729754|467344329|FG000|Part 3|Lack of Efficacy|0|||
129830068|NCT01729754|467344330|FG001|Part 3|Lack of Efficacy|0|||
129830069|NCT01729754|467344331|FG002|Part 3|Lack of Efficacy|0|||
129830070|NCT01729754|467344332|FG003|Part 3|Lack of Efficacy|0|||
129830071|NCT01729754|467344333|FG004|Part 3|Lack of Efficacy|2|||
129830072|NCT01729754|467344334|FG005|Part 3|Lack of Efficacy|0|||
129830073|NCT01729754|467344335|FG006|Part 3|Lack of Efficacy|0|||
129830074|NCT01729754|467344336|FG007|Part 3|Lack of Efficacy|0|||
129830075|NCT01729754|467344337|FG008|Part 3|Lack of Efficacy|0|||
129830076|NCT01729754|467344338|FG009|Part 3|Lack of Efficacy|4|||
129830077|NCT01729754|467344329|FG000|Part 3|Lost to Follow-up|0|||
129830078|NCT01729754|467344330|FG001|Part 3|Lost to Follow-up|1|||
129830079|NCT01729754|467344331|FG002|Part 3|Lost to Follow-up|2|||
129830080|NCT01729754|467344332|FG003|Part 3|Lost to Follow-up|0|||
129830081|NCT01729754|467344333|FG004|Part 3|Lost to Follow-up|0|||
129830082|NCT01729754|467344334|FG005|Part 3|Lost to Follow-up|3|||
129830083|NCT01729754|467344335|FG006|Part 3|Lost to Follow-up|0|||
129830084|NCT01729754|467344336|FG007|Part 3|Lost to Follow-up|0|||
129830085|NCT01729754|467344337|FG008|Part 3|Lost to Follow-up|1|||
129830086|NCT01729754|467344338|FG009|Part 3|Lost to Follow-up|0|||
129830087|NCT01729754|467344329|FG000|Part 3|Physician Decision|0|||
129830088|NCT01729754|467344330|FG001|Part 3|Physician Decision|0|||
129830089|NCT01729754|467344331|FG002|Part 3|Physician Decision|1|||
129830090|NCT01729754|467344332|FG003|Part 3|Physician Decision|0|||
129830091|NCT01729754|467344333|FG004|Part 3|Physician Decision|0|||
129830092|NCT01729754|467344334|FG005|Part 3|Physician Decision|0|||
129830093|NCT01729754|467344335|FG006|Part 3|Physician Decision|0|||
129830094|NCT01729754|467344336|FG007|Part 3|Physician Decision|0|||
129830095|NCT01729754|467344337|FG008|Part 3|Physician Decision|0|||
129830096|NCT01729754|467344338|FG009|Part 3|Physician Decision|0|||
129830097|NCT01729754|467344329|FG000|Part 3|Withdrawal by Subject|0|||
129830098|NCT01729754|467344330|FG001|Part 3|Withdrawal by Subject|4|||
129830099|NCT01729754|467344331|FG002|Part 3|Withdrawal by Subject|1|||
129830100|NCT01729754|467344332|FG003|Part 3|Withdrawal by Subject|0|||
129830101|NCT01729754|467344333|FG004|Part 3|Withdrawal by Subject|2|||
129830102|NCT01729754|467344334|FG005|Part 3|Withdrawal by Subject|1|||
129830103|NCT01729754|467344335|FG006|Part 3|Withdrawal by Subject|0|||
129830104|NCT01729754|467344336|FG007|Part 3|Withdrawal by Subject|2|||
129830105|NCT01729754|467344337|FG008|Part 3|Withdrawal by Subject|0|||
129830106|NCT01729754|467344338|FG009|Part 3|Withdrawal by Subject|0|||
129830107|NCT01729754|467344329|FG000|Part 3|Other Protocol Specified Criteria|0|||
129830108|NCT01729754|467344330|FG001|Part 3|Other Protocol Specified Criteria|0|||
129830109|NCT01729754|467344331|FG002|Part 3|Other Protocol Specified Criteria|0|||
129830110|NCT01729754|467344332|FG003|Part 3|Other Protocol Specified Criteria|0|||
129830111|NCT01729754|467344333|FG004|Part 3|Other Protocol Specified Criteria|0|||
129830112|NCT01729754|467344334|FG005|Part 3|Other Protocol Specified Criteria|2|||
129830113|NCT01729754|467344335|FG006|Part 3|Other Protocol Specified Criteria|0|||
129830114|NCT01729754|467344336|FG007|Part 3|Other Protocol Specified Criteria|1|||
129830115|NCT01729754|467344337|FG008|Part 3|Other Protocol Specified Criteria|0|||
129830116|NCT01729754|467344338|FG009|Part 3|Other Protocol Specified Criteria|0|||
129830117|NCT00773292|467344339|FG000|Treatment 48 Weeks|Adverse Event|1|||
129830118|NCT00773292|467344339|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
129830119|NCT02794103|467344340|FG000|Overall Study|Loss to follow up due to high sedation|3|||
129830120|NCT04608500|467344341|FG000|Overall Study|Adverse Event|2|||
129830121|NCT04608500|467344342|FG001|Overall Study|Adverse Event|0|||
129830122|NCT04608500|467344341|FG000|Overall Study|Lost to Follow-up|15|||
129830123|NCT04608500|467344342|FG001|Overall Study|Lost to Follow-up|9|||
129830124|NCT04608500|467344341|FG000|Overall Study|Participant request|11|||
130112691|NCT01381900|468373444|FG000|Overall Study|Noncompliance with study drug|0|||
130112692|NCT01381900|468373445|FG001|Overall Study|Noncompliance with study drug|0|||
130112693|NCT01381900|468373446|FG002|Overall Study|Noncompliance with study drug|1|||
129830125|NCT04608500|467344342|FG001|Overall Study|Participant request|7|||
129830126|NCT04608500|467344341|FG000|Overall Study|Protocol Violation|1|||
129830127|NCT04608500|467344342|FG001|Overall Study|Protocol Violation|0|||
129830128|NCT04608500|467344341|FG000|Overall Study|Other|6|||
129830129|NCT04608500|467344342|FG001|Overall Study|Other|2|||
129830130|NCT00542919|467344343|FG000|Overall Study|Adverse Event|1|||
129830131|NCT00542919|467344344|FG001|Overall Study|Adverse Event|5|||
129830132|NCT00542919|467344345|FG002|Overall Study|Adverse Event|1|||
129830133|NCT00542919|467344343|FG000|Overall Study|Withdrawal by Subject|1|||
129830134|NCT00542919|467344344|FG001|Overall Study|Withdrawal by Subject|0|||
129830135|NCT00542919|467344345|FG002|Overall Study|Withdrawal by Subject|3|||
129830136|NCT00542919|467344343|FG000|Overall Study|Physician Decision|2|||
129830137|NCT00542919|467344344|FG001|Overall Study|Physician Decision|2|||
129830138|NCT00542919|467344345|FG002|Overall Study|Physician Decision|1|||
129830139|NCT00542919|467344343|FG000|Overall Study|Sponsor Decision|1|||
129830140|NCT00542919|467344344|FG001|Overall Study|Sponsor Decision|0|||
129830141|NCT00542919|467344345|FG002|Overall Study|Sponsor Decision|0|||
129830142|NCT00542919|467344343|FG000|Overall Study|Lost to Follow-up|2|||
129830143|NCT00542919|467344344|FG001|Overall Study|Lost to Follow-up|0|||
129830144|NCT00542919|467344345|FG002|Overall Study|Lost to Follow-up|1|||
129830145|NCT02747420|467344346|FG000|Overall Study|Lost to Follow-up|4|||
129830146|NCT02747420|467344347|FG001|Overall Study|Lost to Follow-up|2|||
129830147|NCT02747420|467344346|FG000|Overall Study|Withdrawal by Subject|3|||
129830148|NCT02747420|467344347|FG001|Overall Study|Withdrawal by Subject|2|||
129830149|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
129830150|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830151|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830152|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830153|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830154|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830155|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830156|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830157|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830158|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830159|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
129830160|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830161|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830162|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830163|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830164|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830165|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830166|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830167|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
129830168|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
129830169|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
129830170|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
129830171|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
129830172|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
129830173|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
129830174|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
129830175|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
129830176|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
129830177|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830178|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830179|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830180|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830181|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830182|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830183|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830184|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830185|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830186|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830187|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830188|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830189|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830190|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
129830191|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830192|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830193|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830194|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830195|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830196|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830197|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
129830198|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
129830199|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830200|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830201|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830202|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830203|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830204|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830205|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830206|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
129830207|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
129830208|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
129830209|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830210|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830211|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830212|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129897691|NCT00517933|467584424|FG001|Period 1|Underwent lung transplant|1|||
130060428|NCT02108600|468176642|FG001|Overall Study|Lost to Follow-up|1|||
129897692|NCT00517933|467584423|FG000|Period 2|Death|2|||
129897693|NCT00517933|467584424|FG001|Period 2|Death|4|||
129897694|NCT00517933|467584423|FG000|Period 2|Adverse Event|2|||
130112694|NCT01381900|468373444|FG000|Overall Study|Physician Decision|0|||
129830213|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830214|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830215|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830216|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
129830217|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
129830218|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830219|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830220|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830221|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830222|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830223|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830224|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830225|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830226|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
129830227|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830228|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830229|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830230|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830231|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830232|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830233|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830234|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830235|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830236|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830237|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
129830238|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830239|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830240|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830241|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830242|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830243|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830244|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830245|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
129830246|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830247|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
129830248|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830249|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830250|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830251|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830252|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830253|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830254|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
129830255|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830256|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
129830257|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830258|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830259|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830260|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830261|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830262|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830263|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
129830264|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
129830265|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
129830266|NCT01217060|467344357|FG000|Overall Study|Withdrawal by Subject|1|||
129830267|NCT03388138|467344362|FG000|Overall Study|Protocol Violation|1|||
129830268|NCT03388138|467344363|FG001|Overall Study|Protocol Violation|0|||
129830269|NCT01528072|467344366|FG000|Overall Study|Withdrawal by Subject|5|||
129830270|NCT01528072|467344366|FG000|Overall Study|Physician Decision|1|||
129830271|NCT01528072|467344366|FG000|Overall Study|Determined not eligible by AEAC|1|||
129830272|NCT01528072|467344366|FG000|Overall Study|Missed Visit|2|||
129830273|NCT01528072|467344366|FG000|Overall Study|Lost to Follow-up|5|||
129830274|NCT01528072|467344366|FG000|Overall Study|Explanted|2|||
129830275|NCT01528072|467344366|FG000|Overall Study|Site Closure|4|||
129897695|NCT00517933|467584424|FG001|Period 2|Adverse Event|4|||
130112695|NCT01381900|468373445|FG001|Overall Study|Physician Decision|1|||
129830276|NCT01528072|467344366|FG000|Overall Study|Death|2|||
129830277|NCT01528072|467344366|FG000|Overall Study|Early Termination of Study|52|||
129830278|NCT01859494|467344369|FG000|Overall Study|Adverse Event|1|||
129830279|NCT02769247|467344378|FG000|Overall Study|Withdrawal by Subject|1|||
130112696|NCT01381900|468373446|FG002|Overall Study|Physician Decision|1|||
129830280|NCT02769247|467344379|FG001|Overall Study|Withdrawal by Subject|0|||
129830281|NCT02769247|467344380|FG002|Overall Study|Withdrawal by Subject|0|||
129830282|NCT02769247|467344381|FG003|Overall Study|Withdrawal by Subject|1|||
129830283|NCT02769247|467344378|FG000|Overall Study|Protocol Violation|0|||
129830284|NCT02769247|467344379|FG001|Overall Study|Protocol Violation|0|||
129830285|NCT02769247|467344380|FG002|Overall Study|Protocol Violation|1|||
129830286|NCT02769247|467344381|FG003|Overall Study|Protocol Violation|0|||
129830287|NCT02769247|467344378|FG000|Overall Study|Physician Decision|1|||
129830288|NCT02769247|467344379|FG001|Overall Study|Physician Decision|0|||
129830289|NCT02769247|467344380|FG002|Overall Study|Physician Decision|0|||
129830290|NCT02769247|467344381|FG003|Overall Study|Physician Decision|0|||
129830291|NCT01462084|467344387|FG000|Overall Study|Withdrawal by Subject|1|||
129830292|NCT01462084|467344388|FG001|Overall Study|Withdrawal by Subject|0|||
129830293|NCT01462084|467344387|FG000|Overall Study|Protocol Violation|1|||
129830294|NCT01462084|467344388|FG001|Overall Study|Protocol Violation|1|||
129830295|NCT05089682|467344389|FG000|Overall Study|Withdrawal by Subject|2|||
129830296|NCT01996826|467344390|FG000|Overall Study|Lost to Follow-up|6|||
129830297|NCT01996826|467344391|FG001|Overall Study|Lost to Follow-up|2|||
129830298|NCT01996826|467344390|FG000|Overall Study|Physician Decision|1|||
129830299|NCT01996826|467344391|FG001|Overall Study|Physician Decision|1|||
129830300|NCT00695396|467344392|FG000|Overall Study|Study Closed Prematurely|5|||
129830301|NCT00695396|467344393|FG001|Overall Study|Study Closed Prematurely|6|||
129830302|NCT00695396|467344394|FG002|Overall Study|Study Closed Prematurely|8|||
129830303|NCT00695396|467344392|FG000|Overall Study|Withdrawal by Subject|2|||
129830304|NCT00695396|467344393|FG001|Overall Study|Withdrawal by Subject|2|||
129830305|NCT00695396|467344394|FG002|Overall Study|Withdrawal by Subject|0|||
129830306|NCT01514760|467344396|FG000|Overall Study|Lost to Follow-up|2|||
129830307|NCT02092662|467344397|FG000|Overall Study|Lost to Follow-up|13|||
129830308|NCT02092662|467344398|FG001|Overall Study|Lost to Follow-up|0|||
129830309|NCT02418468|467344399|FG000|Overall Study|Adverse Event|1|||
129830310|NCT02418468|467344400|FG001|Overall Study|Adverse Event|0|||
129830311|NCT02418468|467344399|FG000|Overall Study|Withdrawal of informed consent|1|||
129830312|NCT02418468|467344400|FG001|Overall Study|Withdrawal of informed consent|1|||
129830313|NCT02914769|467344401|FG000|Overall Study|Protocol Violation|3|||
129830314|NCT02914769|467344402|FG001|Overall Study|Protocol Violation|2|||
129830315|NCT02914769|467344401|FG000|Overall Study|Withdrawal by Subject|0|||
129830316|NCT02914769|467344402|FG001|Overall Study|Withdrawal by Subject|1|||
129830317|NCT01592344|467344403|FG000|Overall Study|Adverse Event|1|||
129830318|NCT01592344|467344404|FG001|Overall Study|Adverse Event|1|||
129830319|NCT01592344|467344403|FG000|Overall Study|Lack of Efficacy|1|||
129830320|NCT01592344|467344404|FG001|Overall Study|Lack of Efficacy|0|||
129830321|NCT01592344|467344403|FG000|Overall Study|not available at primary outcome visit|2|||
129830322|NCT01592344|467344404|FG001|Overall Study|not available at primary outcome visit|4|||
129830323|NCT00099437|467344405|FG000|Overall Study|Lost to Follow-up|30|||
129830324|NCT00099437|467344406|FG001|Overall Study|Lost to Follow-up|33|||
129830325|NCT00099437|467344405|FG000|Overall Study|Death|293|||
129830326|NCT00099437|467344406|FG001|Overall Study|Death|261|||
129830327|NCT00099437|467344405|FG000|Overall Study|Withdrawal by Subject|6|||
129830328|NCT00099437|467344406|FG001|Overall Study|Withdrawal by Subject|10|||
129830329|NCT00099437|467344405|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
129830330|NCT00099437|467344406|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
129830331|NCT02809677|467344409|FG000|Overall Study|Withdrawal by Subject|8|||
129830332|NCT04969224|467344410|FG000|Overall Study|Adverse Event|1|||
129830333|NCT04969224|467344410|FG000|Overall Study|Enrolled but never dosed|1|||
129830334|NCT00613015|467344411|FG000|Overall Study|Lost to Follow-up|0|||
129830335|NCT00613015|467344412|FG001|Overall Study|Lost to Follow-up|1|||
129830336|NCT00613015|467344413|FG002|Overall Study|Lost to Follow-up|3|||
129830337|NCT00613015|467344414|FG003|Overall Study|Lost to Follow-up|3|||
129830338|NCT00613015|467344415|FG004|Overall Study|Lost to Follow-up|2|||
129830339|NCT00613015|467344416|FG005|Overall Study|Lost to Follow-up|3|||
129830340|NCT04256785|467344417|FG000|Overall Study|Adverse Event|8|||
129830341|NCT04256785|467344418|FG001|Overall Study|Adverse Event|6|||
129830342|NCT04256785|467344417|FG000|Overall Study|Lack of Efficacy|3|||
129830343|NCT04256785|467344418|FG001|Overall Study|Lack of Efficacy|4|||
129830344|NCT04256785|467344417|FG000|Overall Study|Lost to Follow-up|7|||
129830345|NCT04256785|467344418|FG001|Overall Study|Lost to Follow-up|7|||
129830346|NCT04256785|467344417|FG000|Overall Study|Protocol Violation|1|||
129830347|NCT04256785|467344418|FG001|Overall Study|Protocol Violation|0|||
129830348|NCT04256785|467344417|FG000|Overall Study|Withdrawal by Subject|4|||
129830349|NCT04256785|467344418|FG001|Overall Study|Withdrawal by Subject|1|||
129830350|NCT04256785|467344417|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
129830351|NCT04256785|467344418|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
129830352|NCT03559257|467344424|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
129830353|NCT03559257|467344425|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
129830354|NCT03559257|467344424|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129830355|NCT03559257|467344425|FG001|Double Blind Treatment Period|Protocol Violation|4|||
129830356|NCT03559257|467344424|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
129830357|NCT03559257|467344425|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
129830358|NCT03559257|467344424|FG000|Double Blind Treatment Period|Adverse Event|0|||
129830359|NCT03559257|467344425|FG001|Double Blind Treatment Period|Adverse Event|1|||
129830360|NCT03559257|467344424|FG000|Double Blind Treatment Period|Screen Failure|0|||
129830361|NCT03559257|467344425|FG001|Double Blind Treatment Period|Screen Failure|1|||
129830362|NCT03559257|467344424|FG000|Open-label Treatment Period|Adverse Event|1|||
129830363|NCT03559257|467344425|FG001|Open-label Treatment Period|Adverse Event|4|||
129830364|NCT03559257|467344424|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
129830365|NCT03559257|467344425|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
129830366|NCT03559257|467344424|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
129830367|NCT03559257|467344425|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129830368|NCT03559257|467344424|FG000|Open-label Treatment Period|Protocol Violation|2|||
129830369|NCT03559257|467344425|FG001|Open-label Treatment Period|Protocol Violation|0|||
129830370|NCT03559257|467344424|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
129830371|NCT03559257|467344425|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129830372|NCT03559257|467344424|FG000|Open-label Treatment Period|Physician Decision|0|||
129830373|NCT03559257|467344425|FG001|Open-label Treatment Period|Physician Decision|1|||
129830374|NCT01288287|467344426|FG000|Overall Study|Lost to Follow-up|8|||
129830375|NCT01288287|467344426|FG000|Overall Study|Withdrawal by Subject|4|||
129830376|NCT01288287|467344426|FG000|Overall Study|Lack of Efficacy|13|||
129830377|NCT01288287|467344426|FG000|Overall Study|Other Reason|13|||
129830378|NCT01288287|467344426|FG000|Overall Study|Unknown Reason|1|||
129830379|NCT01288287|467344426|FG000|Overall Study|Unknown Status|7|||
129830380|NCT01092182|467344427|FG000|Overall Study|Death|0|||
129830381|NCT01092182|467344428|FG001|Overall Study|Death|5|||
129830382|NCT01092182|467344429|FG002|Overall Study|Death|3|||
129830383|NCT01092182|467344427|FG000|Overall Study|participant safety|1|||
129830384|NCT01092182|467344428|FG001|Overall Study|participant safety|2|||
129830385|NCT01092182|467344429|FG002|Overall Study|participant safety|0|||
129830386|NCT01092182|467344427|FG000|Overall Study|Physician Decision|0|||
129830387|NCT01092182|467344428|FG001|Overall Study|Physician Decision|6|||
129830388|NCT01092182|467344429|FG002|Overall Study|Physician Decision|0|||
129830389|NCT01092182|467344427|FG000|Overall Study|Did not meet criteria|0|||
129830390|NCT01092182|467344428|FG001|Overall Study|Did not meet criteria|0|||
129830391|NCT01092182|467344429|FG002|Overall Study|Did not meet criteria|25|||
129830392|NCT01092182|467344427|FG000|Overall Study|Non-compliance|0|||
129830393|NCT01092182|467344428|FG001|Overall Study|Non-compliance|3|||
129830394|NCT01092182|467344429|FG002|Overall Study|Non-compliance|0|||
129830395|NCT01092182|467344427|FG000|Overall Study|Participant refused follow-up|0|||
129830396|NCT01092182|467344428|FG001|Overall Study|Participant refused follow-up|2|||
129830397|NCT01092182|467344429|FG002|Overall Study|Participant refused follow-up|0|||
129830398|NCT02515045|467344436|FG000|Overall Study|Adverse Event|0|||
129830399|NCT02515045|467344437|FG001|Overall Study|Adverse Event|3|||
129830400|NCT02515045|467344438|FG002|Overall Study|Adverse Event|3|||
129830401|NCT02515045|467344436|FG000|Overall Study|Lost to Follow-up|0|||
129830402|NCT02515045|467344437|FG001|Overall Study|Lost to Follow-up|1|||
129830403|NCT02515045|467344438|FG002|Overall Study|Lost to Follow-up|1|||
129830404|NCT01675128|467344441|FG000|Overall Study|Disease progression on study|1|||
129830405|NCT01675128|467344442|FG001|Overall Study|Disease progression on study|1|||
129830406|NCT01675128|467344443|FG002|Overall Study|Disease progression on study|1|||
129830407|NCT01675128|467344441|FG000|Overall Study|Refused further treatment|1|||
129830408|NCT01675128|467344442|FG001|Overall Study|Refused further treatment|0|||
129830409|NCT01675128|467344443|FG002|Overall Study|Refused further treatment|0|||
129830410|NCT01675128|467344441|FG000|Overall Study|Pulmonary complication; off study|0|||
129830411|NCT01675128|467344442|FG001|Overall Study|Pulmonary complication; off study|1|||
129830412|NCT01675128|467344443|FG002|Overall Study|Pulmonary complication; off study|0|||
129830413|NCT00832585|467344452|FG000|Overall Study|Withdrawal by Subject|1|||
129830414|NCT00832585|467344452|FG000|Overall Study|Lost to Follow-up|1|||
129830415|NCT01374087|467344458|FG000|Overall Study|Adverse Event|1|||
129830416|NCT01374087|467344459|FG001|Overall Study|Adverse Event|0|||
129830417|NCT01374087|467344458|FG000|Overall Study|Disease progression|2|||
129830418|NCT01374087|467344459|FG001|Overall Study|Disease progression|2|||
129830419|NCT01374087|467344458|FG000|Overall Study|Study discontinued|13|||
129830420|NCT01374087|467344459|FG001|Overall Study|Study discontinued|13|||
129830421|NCT03011307|467344460|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
129830422|NCT03011307|467344461|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
129830423|NCT03011307|467344460|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
129830424|NCT03011307|467344461|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
129830425|NCT03011307|467344460|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
129830426|NCT03011307|467344461|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
129830427|NCT00271947|467344462|FG000|Overall Study|Lost to Follow-up|1|||
129830428|NCT02677987|467344463|FG000|Overall Study|Withdrawal by Subject|3|||
129830429|NCT02677987|467344464|FG001|Overall Study|Withdrawal by Subject|0|||
129830430|NCT02677987|467344463|FG000|Overall Study|Lost to Follow-up|1|||
129830431|NCT02677987|467344464|FG001|Overall Study|Lost to Follow-up|0|||
129830432|NCT01522365|467344467|FG000|Overall Study|Withdrawal by Subject|1|||
129830433|NCT01522365|467344468|FG001|Overall Study|Withdrawal by Subject|1|||
129830434|NCT01522365|467344467|FG000|Overall Study|Lost to Follow-up|1|||
129830435|NCT01522365|467344468|FG001|Overall Study|Lost to Follow-up|1|||
129830436|NCT00673179|467344469|FG000|Overall Study|Toxicity/Complications|3|||
129830437|NCT00673179|467344470|FG001|Overall Study|Toxicity/Complications|0|||
129830438|NCT02466555|467344471|FG000|Overall Study|Lost to Follow-up|2|||
129830439|NCT04170348|467344472|FG000|Overall Study|Lost to Follow-up|2|||
129830440|NCT04170348|467344473|FG001|Overall Study|Lost to Follow-up|2|||
129830441|NCT04170348|467344472|FG000|Overall Study|Withdrawal by Subject|1|||
129830442|NCT04170348|467344473|FG001|Overall Study|Withdrawal by Subject|5|||
129830443|NCT04170348|467344472|FG000|Overall Study|Non-adherence|1|||
129830444|NCT04170348|467344473|FG001|Overall Study|Non-adherence|1|||
129830445|NCT04170348|467344472|FG000|Overall Study|Adverse Event|1|||
129830446|NCT04170348|467344473|FG001|Overall Study|Adverse Event|0|||
129830447|NCT01120756|467344474|FG000|Overall Study|Withdrawal by Subject|1|||
129830448|NCT01120756|467344475|FG001|Overall Study|Withdrawal by Subject|1|||
129830449|NCT03760146|467344481|FG000|Overall Study|Adverse Event|11|||
129830450|NCT03760146|467344482|FG001|Overall Study|Adverse Event|8|||
129830451|NCT03760146|467344483|FG002|Overall Study|Adverse Event|0|||
129830452|NCT03760146|467344484|FG003|Overall Study|Adverse Event|0|||
129830453|NCT03760146|467344485|FG004|Overall Study|Adverse Event|0|||
129830454|NCT03760146|467344486|FG005|Overall Study|Adverse Event|0|||
129830455|NCT03760146|467344481|FG000|Overall Study|Death|1|||
129830456|NCT03760146|467344482|FG001|Overall Study|Death|0|||
129830457|NCT03760146|467344483|FG002|Overall Study|Death|0|||
129830458|NCT03760146|467344484|FG003|Overall Study|Death|0|||
129830459|NCT03760146|467344485|FG004|Overall Study|Death|0|||
129830460|NCT03760146|467344486|FG005|Overall Study|Death|0|||
129830461|NCT03760146|467344481|FG000|Overall Study|Lost to Follow-up|41|||
129830462|NCT03760146|467344482|FG001|Overall Study|Lost to Follow-up|28|||
129830463|NCT03760146|467344483|FG002|Overall Study|Lost to Follow-up|9|||
129830464|NCT03760146|467344484|FG003|Overall Study|Lost to Follow-up|2|||
129830465|NCT03760146|467344485|FG004|Overall Study|Lost to Follow-up|14|||
129830466|NCT03760146|467344486|FG005|Overall Study|Lost to Follow-up|8|||
129830467|NCT03760146|467344481|FG000|Overall Study|No longer met eligibility criteria|3|||
129830468|NCT03760146|467344482|FG001|Overall Study|No longer met eligibility criteria|9|||
129830469|NCT03760146|467344483|FG002|Overall Study|No longer met eligibility criteria|0|||
129830470|NCT03760146|467344484|FG003|Overall Study|No longer met eligibility criteria|0|||
129830471|NCT03760146|467344485|FG004|Overall Study|No longer met eligibility criteria|1|||
129830472|NCT03760146|467344486|FG005|Overall Study|No longer met eligibility criteria|0|||
129830473|NCT03760146|467344481|FG000|Overall Study|Protocol Violation|21|||
129830474|NCT03760146|467344482|FG001|Overall Study|Protocol Violation|13|||
129830475|NCT03760146|467344483|FG002|Overall Study|Protocol Violation|1|||
129830476|NCT03760146|467344484|FG003|Overall Study|Protocol Violation|0|||
129830477|NCT03760146|467344485|FG004|Overall Study|Protocol Violation|1|||
129830478|NCT03760146|467344486|FG005|Overall Study|Protocol Violation|0|||
129830479|NCT03760146|467344481|FG000|Overall Study|Withdrawal by Subject|19|||
129830480|NCT03760146|467344482|FG001|Overall Study|Withdrawal by Subject|20|||
129830481|NCT03760146|467344483|FG002|Overall Study|Withdrawal by Subject|1|||
129830482|NCT03760146|467344484|FG003|Overall Study|Withdrawal by Subject|0|||
129830483|NCT03760146|467344485|FG004|Overall Study|Withdrawal by Subject|1|||
129830484|NCT03760146|467344486|FG005|Overall Study|Withdrawal by Subject|0|||
129830485|NCT01082965|467344487|FG000|Overall Study|Protocol Violation|0|||
129830486|NCT01082965|467344488|FG001|Overall Study|Protocol Violation|1|||
129830487|NCT01082965|467344487|FG000|Overall Study|Other|1|||
129830488|NCT01082965|467344488|FG001|Overall Study|Other|1|||
129830489|NCT03839212|467344490|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
129830490|NCT00445965|467344491|FG000|Overall Study|Adverse Event|2|||
129830491|NCT00445965|467344491|FG000|Overall Study|Physician Decision|1|||
129830492|NCT00445965|467344491|FG000|Overall Study|Enrolled but not treated|1|||
129830493|NCT00445965|467344491|FG000|Overall Study|Removed due to progressive disease|29|||
129830494|NCT00679263|467344492|FG000|Visit 2/Dose 1|Adverse Event|1|||
129830495|NCT00679263|467344493|FG001|Visit 2/Dose 1|Adverse Event|0|||
129830496|NCT00679263|467344494|FG002|Visit 2/Dose 1|Adverse Event|0|||
129830497|NCT00679263|467344492|FG000|Visit 2/Dose 1|subject not compliance|1|||
129830498|NCT00679263|467344493|FG001|Visit 2/Dose 1|subject not compliance|1|||
129830499|NCT00679263|467344494|FG002|Visit 2/Dose 1|subject not compliance|0|||
129830500|NCT01464346|467344498|FG000|Overall Study|Withdrawal by Subject|0|||
129830501|NCT01464346|467344499|FG001|Overall Study|Withdrawal by Subject|0|||
129830502|NCT01464346|467344500|FG002|Overall Study|Withdrawal by Subject|1|||
129830503|NCT03999892|467344501|FG000|Overall Study|Lost to Follow-up|1|||
129830504|NCT02295995|467344502|FG000|Overall Study|Lost to Follow-up|5|||
129830505|NCT02295995|467344503|FG001|Overall Study|Lost to Follow-up|1|||
129830506|NCT02447081|467344504|FG000|Overall Study|Death|161|||
129830507|NCT02447081|467344504|FG000|Overall Study|Lost to Follow-up|36|||
129830508|NCT02447081|467344504|FG000|Overall Study|Visit not completed|17|||
129830509|NCT02447081|467344504|FG000|Overall Study|unsuccessful implant procedure|10|||
129830510|NCT02406651|467344507|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
129830511|NCT02255981|467346026|FG000|Overall Study|Lost to Follow-up|3|||
129830512|NCT02255981|467346026|FG000|Overall Study|Withdrawal by Subject|1|||
129830513|NCT01046682|467346029|FG000|Overall Study|Adverse Event|2|||
129830514|NCT01046682|467346030|FG001|Overall Study|Adverse Event|0|||
129830515|NCT00371254|467346031|FG000|Overall Study|Disease progression|13|||
129830516|NCT00371254|467346032|FG001|Overall Study|Disease progression|13|||
129830517|NCT00371254|467346031|FG000|Overall Study|Study drug toxicity|3|||
129830518|NCT00371254|467346032|FG001|Overall Study|Study drug toxicity|5|||
129830519|NCT00371254|467346031|FG000|Overall Study|Subject request|5|||
129830520|NCT00371254|467346032|FG001|Overall Study|Subject request|0|||
129830521|NCT00371254|467346031|FG000|Overall Study|Investigator Decision|2|||
129830522|NCT00371254|467346032|FG001|Overall Study|Investigator Decision|0|||
129830523|NCT00371254|467346031|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129830524|NCT00371254|467346032|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129830525|NCT00371254|467346031|FG000|Overall Study|Lost to Follow-up|0|||
129830526|NCT00371254|467346032|FG001|Overall Study|Lost to Follow-up|1|||
129830527|NCT00371254|467346031|FG000|Overall Study|Withdrawal by Subject|0|||
129830528|NCT00371254|467346032|FG001|Overall Study|Withdrawal by Subject|1|||
129830529|NCT02246673|467346035|FG000|Overall Study|Sponsor Decision|1|||
129830530|NCT02246673|467346036|FG001|Overall Study|Sponsor Decision|0|||
129830531|NCT02246673|467346037|FG002|Overall Study|Sponsor Decision|0|||
129830532|NCT02246673|467346038|FG003|Overall Study|Sponsor Decision|0|||
129830533|NCT02246673|467346039|FG004|Overall Study|Sponsor Decision|0|||
129830534|NCT02246673|467346035|FG000|Overall Study|Withdrawal by Subject|0|||
129830535|NCT02246673|467346036|FG001|Overall Study|Withdrawal by Subject|0|||
129830536|NCT02246673|467346037|FG002|Overall Study|Withdrawal by Subject|0|||
129830537|NCT02246673|467346038|FG003|Overall Study|Withdrawal by Subject|0|||
129830538|NCT02246673|467346039|FG004|Overall Study|Withdrawal by Subject|1|||
129830539|NCT02246673|467346035|FG000|Overall Study|Lost to Follow-up|0|||
129830540|NCT02246673|467346036|FG001|Overall Study|Lost to Follow-up|0|||
129830541|NCT02246673|467346037|FG002|Overall Study|Lost to Follow-up|0|||
129830542|NCT02246673|467346038|FG003|Overall Study|Lost to Follow-up|1|||
129830543|NCT02246673|467346039|FG004|Overall Study|Lost to Follow-up|0|||
129830544|NCT02246673|467346035|FG000|Overall Study|Protocol Violation|0|||
129830545|NCT02246673|467346036|FG001|Overall Study|Protocol Violation|0|||
129830546|NCT02246673|467346037|FG002|Overall Study|Protocol Violation|0|||
129830547|NCT02246673|467346038|FG003|Overall Study|Protocol Violation|1|||
129830548|NCT02246673|467346039|FG004|Overall Study|Protocol Violation|0|||
129830549|NCT05413369|467346044|FG000|Overall Study|Adverse Event|1|||
129830550|NCT05413369|467346045|FG001|Overall Study|Adverse Event|1|||
129830551|NCT05413369|467346044|FG000|Overall Study|Withdrawal by Subject|13|||
129830552|NCT05413369|467346045|FG001|Overall Study|Withdrawal by Subject|4|||
129830553|NCT05413369|467346044|FG000|Overall Study|Non-compliance with study schedule|2|||
129830554|NCT05413369|467346045|FG001|Overall Study|Non-compliance with study schedule|1|||
129830555|NCT05413369|467346044|FG000|Overall Study|Other|1|||
129830556|NCT05413369|467346045|FG001|Overall Study|Other|1|||
129830557|NCT00720057|467346046|FG000|Overall Study|Lost to Follow-up|0|||
129830558|NCT00720057|467346047|FG001|Overall Study|Lost to Follow-up|2|||
129830559|NCT00720057|467346046|FG000|Overall Study|Protocol Violation|1|||
129830560|NCT00720057|467346047|FG001|Overall Study|Protocol Violation|0|||
129830561|NCT00720057|467346046|FG000|Overall Study|Withdrawal by Subject|0|||
129830562|NCT00720057|467346047|FG001|Overall Study|Withdrawal by Subject|1|||
129830563|NCT02726074|467346051|FG000|Overall Study|Withdrawal by Subject|4|||
129830564|NCT02726074|467346051|FG000|Overall Study|Adverse Event|14|||
129830565|NCT02726074|467346051|FG000|Overall Study|Protocol Violation|3|||
129830566|NCT02726074|467346051|FG000|Overall Study|Lost to Follow-up|2|||
129830567|NCT02726074|467346051|FG000|Overall Study|Others|3|||
129830568|NCT01679002|467346052|FG000|Overall Study|Adverse Event|1|||
129830569|NCT01679002|467346053|FG001|Overall Study|Adverse Event|1|||
129830570|NCT01679002|467346054|FG002|Overall Study|Adverse Event|0|||
129830571|NCT01179477|467346058|FG000|Overall Study|Death|542|||
129830572|NCT01179477|467346058|FG000|Overall Study|Unsuccessful implant|80|||
129830573|NCT01179477|467346058|FG000|Overall Study|Non-death withdrawal|438|||
129830574|NCT01179477|467346058|FG000|Overall Study|Did not complete final visit|27|||
129830575|NCT00975481|467346065|FG000|Second Intervention Period|Adverse Event|2|||
129830576|NCT00975481|467346066|FG001|Second Intervention Period|Adverse Event|1|||
129830577|NCT00975481|467346067|FG002|Second Intervention Period|Adverse Event|0|||
129830578|NCT00975481|467346068|FG003|Second Intervention Period|Adverse Event|0|||
129830579|NCT00975481|467346069|FG004|Second Intervention Period|Adverse Event|0|||
129830580|NCT00975481|467346070|FG005|Second Intervention Period|Adverse Event|0|||
129830581|NCT00975481|467346065|FG000|Second Intervention Period|Withdrawal by Subject|0|||
129830582|NCT00975481|467346066|FG001|Second Intervention Period|Withdrawal by Subject|0|||
129830583|NCT00975481|467346067|FG002|Second Intervention Period|Withdrawal by Subject|1|||
129830584|NCT00975481|467346068|FG003|Second Intervention Period|Withdrawal by Subject|0|||
129897696|NCT00517933|467584423|FG000|Period 2|Physician Decision|1|||
129830585|NCT00975481|467346069|FG004|Second Intervention Period|Withdrawal by Subject|0|||
129830586|NCT00975481|467346070|FG005|Second Intervention Period|Withdrawal by Subject|0|||
129830587|NCT00975481|467346065|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
129830588|NCT00975481|467346066|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
129830589|NCT00975481|467346067|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
129830590|NCT00975481|467346068|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
129830591|NCT00975481|467346069|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
129830592|NCT00975481|467346070|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
129830593|NCT00975481|467346065|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
129830594|NCT00975481|467346066|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
129830595|NCT00975481|467346067|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
129830596|NCT00975481|467346068|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
129830597|NCT00975481|467346069|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
129830598|NCT00975481|467346070|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
129830599|NCT00643682|467346071|FG000|Overall Study|did not keep appointment|522|||
129830600|NCT00643682|467346072|FG001|Overall Study|did not keep appointment|509|||
129830601|NCT03630120|467346076|FG000|Overall Study|Disease progression|0|||
129830602|NCT03630120|467346077|FG001|Overall Study|Disease progression|1|||
129830603|NCT03630120|467346078|FG002|Overall Study|Disease progression|1|||
129830604|NCT03630120|467346079|FG003|Overall Study|Disease progression|1|||
129830605|NCT03755414|467346081|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
129830606|NCT03755414|467346082|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
129830607|NCT03755414|467346083|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
129830608|NCT03755414|467346081|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
129830609|NCT03755414|467346082|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
129830610|NCT03755414|467346083|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
129830611|NCT03755414|467346081|FG000|Overall Study|Non-compliance|0|||
129830612|NCT03755414|467346082|FG001|Overall Study|Non-compliance|1|||
129830613|NCT03755414|467346083|FG002|Overall Study|Non-compliance|0|||
129830614|NCT02153112|467346084|FG000|Overall Study|Adverse Event|0|||
129830615|NCT02153112|467346085|FG001|Overall Study|Adverse Event|0|||
129830616|NCT02153112|467346086|FG002|Overall Study|Adverse Event|1|||
129830617|NCT02153112|467346087|FG003|Overall Study|Adverse Event|0|||
129830618|NCT02153112|467346088|FG004|Overall Study|Adverse Event|0|||
129830619|NCT02153112|467346089|FG005|Overall Study|Adverse Event|0|||
129830620|NCT02153112|467346090|FG006|Overall Study|Adverse Event|0|||
129830621|NCT02153112|467346091|FG007|Overall Study|Adverse Event|0|||
129830622|NCT02153112|467346092|FG008|Overall Study|Adverse Event|0|||
129830623|NCT02153112|467346093|FG009|Overall Study|Adverse Event|0|||
129830624|NCT02153112|467346084|FG000|Overall Study|Lost to Follow-up|1|||
129830625|NCT02153112|467346085|FG001|Overall Study|Lost to Follow-up|1|||
129830626|NCT02153112|467346086|FG002|Overall Study|Lost to Follow-up|0|||
129830627|NCT02153112|467346087|FG003|Overall Study|Lost to Follow-up|0|||
129830628|NCT02153112|467346088|FG004|Overall Study|Lost to Follow-up|2|||
129830629|NCT02153112|467346089|FG005|Overall Study|Lost to Follow-up|1|||
129830630|NCT02153112|467346090|FG006|Overall Study|Lost to Follow-up|1|||
129830631|NCT02153112|467346091|FG007|Overall Study|Lost to Follow-up|0|||
129830632|NCT02153112|467346092|FG008|Overall Study|Lost to Follow-up|1|||
129830633|NCT02153112|467346093|FG009|Overall Study|Lost to Follow-up|1|||
129830634|NCT02153112|467346084|FG000|Overall Study|Withdrawal by Subject|3|||
129830635|NCT02153112|467346085|FG001|Overall Study|Withdrawal by Subject|1|||
129830636|NCT02153112|467346086|FG002|Overall Study|Withdrawal by Subject|2|||
129830637|NCT02153112|467346087|FG003|Overall Study|Withdrawal by Subject|2|||
129830638|NCT02153112|467346088|FG004|Overall Study|Withdrawal by Subject|1|||
129830639|NCT02153112|467346089|FG005|Overall Study|Withdrawal by Subject|1|||
129830640|NCT02153112|467346090|FG006|Overall Study|Withdrawal by Subject|7|||
129830641|NCT02153112|467346091|FG007|Overall Study|Withdrawal by Subject|2|||
129830642|NCT02153112|467346092|FG008|Overall Study|Withdrawal by Subject|13|||
129830643|NCT02153112|467346093|FG009|Overall Study|Withdrawal by Subject|12|||
129830644|NCT02153112|467346084|FG000|Overall Study|Reason not Specified|0|||
129830645|NCT02153112|467346085|FG001|Overall Study|Reason not Specified|0|||
129830646|NCT02153112|467346086|FG002|Overall Study|Reason not Specified|0|||
129830647|NCT02153112|467346087|FG003|Overall Study|Reason not Specified|0|||
129830648|NCT02153112|467346088|FG004|Overall Study|Reason not Specified|0|||
129830649|NCT02153112|467346089|FG005|Overall Study|Reason not Specified|0|||
129830650|NCT02153112|467346090|FG006|Overall Study|Reason not Specified|0|||
129830651|NCT02153112|467346091|FG007|Overall Study|Reason not Specified|0|||
129830652|NCT02153112|467346092|FG008|Overall Study|Reason not Specified|1|||
129830653|NCT02153112|467346093|FG009|Overall Study|Reason not Specified|1|||
129830654|NCT00449644|467346099|FG000|Overall Study|Adverse Event|0|||
129830655|NCT00449644|467346100|FG001|Overall Study|Adverse Event|0|||
129830656|NCT00449644|467346101|FG002|Overall Study|Adverse Event|3|||
129830657|NCT00449644|467346102|FG003|Overall Study|Adverse Event|5|||
129830658|NCT00449644|467346099|FG000|Overall Study|Death|1|||
129830659|NCT00449644|467346100|FG001|Overall Study|Death|0|||
129830660|NCT00449644|467346101|FG002|Overall Study|Death|6|||
129830661|NCT00449644|467346102|FG003|Overall Study|Death|1|||
129830662|NCT00449644|467346099|FG000|Overall Study|Lost to Follow-up|1|||
129830663|NCT00449644|467346100|FG001|Overall Study|Lost to Follow-up|1|||
129830664|NCT00449644|467346101|FG002|Overall Study|Lost to Follow-up|5|||
129830665|NCT00449644|467346102|FG003|Overall Study|Lost to Follow-up|3|||
129830666|NCT00449644|467346099|FG000|Overall Study|Pregnancy|0|||
129830667|NCT00449644|467346100|FG001|Overall Study|Pregnancy|0|||
129830668|NCT00449644|467346101|FG002|Overall Study|Pregnancy|3|||
129830669|NCT00449644|467346102|FG003|Overall Study|Pregnancy|2|||
129830670|NCT00449644|467346099|FG000|Overall Study|Protocol Violation|4|||
129830671|NCT00449644|467346100|FG001|Overall Study|Protocol Violation|4|||
129830672|NCT00449644|467346101|FG002|Overall Study|Protocol Violation|3|||
129830673|NCT00449644|467346102|FG003|Overall Study|Protocol Violation|7|||
129830674|NCT00449644|467346099|FG000|Overall Study|Withdrawal by Subject|3|||
129830675|NCT00449644|467346100|FG001|Overall Study|Withdrawal by Subject|4|||
129830676|NCT00449644|467346101|FG002|Overall Study|Withdrawal by Subject|6|||
129830677|NCT00449644|467346102|FG003|Overall Study|Withdrawal by Subject|7|||
129830678|NCT00449644|467346099|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
129830679|NCT00449644|467346100|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
129830680|NCT00449644|467346101|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
129830681|NCT00449644|467346102|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
129830682|NCT00449644|467346099|FG000|Overall Study|Other|1|||
129830683|NCT00449644|467346100|FG001|Overall Study|Other|4|||
129830684|NCT00449644|467346101|FG002|Overall Study|Other|1|||
129830685|NCT00449644|467346102|FG003|Overall Study|Other|0|||
129830686|NCT00449644|467346099|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
129830687|NCT00449644|467346100|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
129830688|NCT00449644|467346101|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
129830689|NCT00449644|467346102|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
129830690|NCT01559012|467346105|FG000|Overall Study|Withdrawal by Subject|0|||
129830691|NCT01559012|467346106|FG001|Overall Study|Withdrawal by Subject|1|||
129830692|NCT02291055|467346107|FG000|Overall Study|Death|2|||
129830693|NCT02291055|467346108|FG001|Overall Study|Death|2|||
129830694|NCT02291055|467346109|FG002|Overall Study|Death|5|||
129830695|NCT02291055|467346110|FG003|Overall Study|Death|8|||
129830696|NCT02291055|467346111|FG004|Overall Study|Death|12|||
129830697|NCT02291055|467346107|FG000|Overall Study|Lost to Follow-up|0|||
129830698|NCT02291055|467346108|FG001|Overall Study|Lost to Follow-up|0|||
129830699|NCT02291055|467346109|FG002|Overall Study|Lost to Follow-up|0|||
129830700|NCT02291055|467346110|FG003|Overall Study|Lost to Follow-up|1|||
129830701|NCT02291055|467346111|FG004|Overall Study|Lost to Follow-up|2|||
129830702|NCT02291055|467346107|FG000|Overall Study|Withdrawal by Subject|3|||
129830703|NCT02291055|467346108|FG001|Overall Study|Withdrawal by Subject|1|||
129830704|NCT02291055|467346109|FG002|Overall Study|Withdrawal by Subject|1|||
129830705|NCT02291055|467346110|FG003|Overall Study|Withdrawal by Subject|5|||
129830706|NCT02291055|467346111|FG004|Overall Study|Withdrawal by Subject|10|||
129830707|NCT02291055|467346107|FG000|Overall Study|Progressive Disease|0|||
129830708|NCT02291055|467346108|FG001|Overall Study|Progressive Disease|0|||
129830709|NCT02291055|467346109|FG002|Overall Study|Progressive Disease|1|||
129830710|NCT02291055|467346110|FG003|Overall Study|Progressive Disease|4|||
129830711|NCT02291055|467346111|FG004|Overall Study|Progressive Disease|2|||
129830712|NCT02291055|467346107|FG000|Overall Study|Study Terminated by Sponsor|0|||
129830713|NCT02291055|467346108|FG001|Overall Study|Study Terminated by Sponsor|0|||
129830714|NCT02291055|467346109|FG002|Overall Study|Study Terminated by Sponsor|0|||
129830715|NCT02291055|467346110|FG003|Overall Study|Study Terminated by Sponsor|5|||
129830716|NCT02291055|467346111|FG004|Overall Study|Study Terminated by Sponsor|1|||
129830717|NCT02291055|467346107|FG000|Overall Study|Other|0|||
129830718|NCT02291055|467346108|FG001|Overall Study|Other|2|||
129830719|NCT02291055|467346109|FG002|Overall Study|Other|1|||
129830720|NCT02291055|467346110|FG003|Overall Study|Other|4|||
129830721|NCT02291055|467346111|FG004|Overall Study|Other|0|||
129830722|NCT00853723|467346112|FG000|Overall Study|Adverse Event|3|||
129830723|NCT00853723|467346113|FG001|Overall Study|Adverse Event|4|||
129830724|NCT00853723|467346114|FG002|Overall Study|Adverse Event|1|||
129830725|NCT00853723|467346112|FG000|Overall Study|Withdrawal by Subject|2|||
129830726|NCT00853723|467346113|FG001|Overall Study|Withdrawal by Subject|1|||
129830727|NCT00853723|467346114|FG002|Overall Study|Withdrawal by Subject|0|||
129830728|NCT00853723|467346112|FG000|Overall Study|Protocol Violation|1|||
129830729|NCT00853723|467346113|FG001|Overall Study|Protocol Violation|2|||
129830730|NCT00853723|467346114|FG002|Overall Study|Protocol Violation|1|||
129830731|NCT01531387|467346115|FG000|Overall Study|Early termination of study|11|||
129830732|NCT01531387|467346116|FG001|Overall Study|Early termination of study|11|||
129830733|NCT01848756|467346119|FG000|Overall Study|Adverse Event|1|||
129830734|NCT01848756|467346119|FG000|Overall Study|Withdrawal by Subject|1|||
129830735|NCT01848756|467346119|FG000|Overall Study|Enrolled in Error|1|||
129830736|NCT02075658|467346120|FG000|Overall Study|Physician Decision|2|||
129830737|NCT02075658|467346121|FG001|Overall Study|Physician Decision|2|||
129830738|NCT01498458|467346122|FG000|Overall Study|Adverse Event|4|||
129830739|NCT01498458|467346122|FG000|Overall Study|Physician Decision|3|||
129830740|NCT00718328|467346123|FG000|Overall Study|Lost to Follow-up|1|||
129830741|NCT00718328|467346124|FG001|Overall Study|Lost to Follow-up|0|||
129830742|NCT02865915|467346125|FG000|Overall Study|Pregnancy|1|||
129830743|NCT02865915|467346126|FG001|Overall Study|Pregnancy|0|||
129830744|NCT02865915|467346125|FG000|Overall Study|Withdrawal by Subject|1|||
129830745|NCT02865915|467346126|FG001|Overall Study|Withdrawal by Subject|1|||
129830746|NCT02865915|467346125|FG000|Overall Study|Adverse Event|0|||
129830747|NCT02865915|467346126|FG001|Overall Study|Adverse Event|4|||
129830748|NCT02865915|467346125|FG000|Overall Study|Lost to Follow-up|0|||
129830749|NCT02865915|467346126|FG001|Overall Study|Lost to Follow-up|1|||
129830750|NCT02865915|467346125|FG000|Overall Study|Protocol Violation|0|||
129830751|NCT02865915|467346126|FG001|Overall Study|Protocol Violation|1|||
129830752|NCT02865915|467346125|FG000|Overall Study|Study terminated by sponsor|23|||
129830753|NCT02865915|467346126|FG001|Overall Study|Study terminated by sponsor|18|||
129830754|NCT02865915|467346125|FG000|Overall Study|Dosing group discontinued|0|||
129830755|NCT02865915|467346126|FG001|Overall Study|Dosing group discontinued|5|||
129830756|NCT02946047|467346133|FG000|Overall Study|Adverse Event|1|||
129830757|NCT02946047|467346134|FG001|Overall Study|Adverse Event|0|||
129830758|NCT02946047|467346135|FG002|Overall Study|Adverse Event|0|||
129830759|NCT02946047|467346136|FG003|Overall Study|Adverse Event|0|||
129830760|NCT04350788|467346144|FG000|Overall Study|Lost to Follow-up|6|||
129830761|NCT04350788|467346145|FG001|Overall Study|Lost to Follow-up|2|||
129830762|NCT04350788|467346144|FG000|Overall Study|Withdrawal by Subject|2|||
129830763|NCT04350788|467346145|FG001|Overall Study|Withdrawal by Subject|4|||
129830764|NCT04350788|467346144|FG000|Overall Study|Protocol Violation|4|||
129830765|NCT04350788|467346145|FG001|Overall Study|Protocol Violation|0|||
129830766|NCT01581307|467346146|FG000|Overall Study|Withdrawal by Subject|1|||
129830767|NCT00378209|467346149|FG000|Overall Study|Progressive disease|11|||
129830768|NCT00378209|467346149|FG000|Overall Study|Adverse Event|3|||
129830769|NCT00378209|467346149|FG000|Overall Study|Initiation of non-protocol therapy|3|||
129830770|NCT00378209|467346149|FG000|Overall Study|Physician Decision|3|||
129830771|NCT00378209|467346149|FG000|Overall Study|Death|1|||
129830772|NCT00378209|467346149|FG000|Overall Study|Treatment delay|1|||
129830773|NCT01894581|467346152|FG000|Overall Study|Withdrawal by Subject|2|||
129830774|NCT01894581|467346153|FG001|Overall Study|Withdrawal by Subject|3|||
129830775|NCT01894581|467346152|FG000|Overall Study|Screen Failure|3|||
129830776|NCT01894581|467346153|FG001|Overall Study|Screen Failure|4|||
129830777|NCT03313804|467346157|FG000|Treatment|Death|5|||
129830778|NCT03313804|467346157|FG000|Treatment|still on treatment|2|||
129830779|NCT03313804|467346157|FG000|Follow Up|still on follow up|3|||
129830780|NCT03795298|467346158|FG000|Overall Study|Death|34|||
129830781|NCT03795298|467346159|FG001|Overall Study|Death|29|||
129830782|NCT03795298|467346158|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
129830783|NCT03795298|467346159|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
129830784|NCT03795298|467346158|FG000|Overall Study|Lost to Follow-up|28|||
129830785|NCT03795298|467346159|FG001|Overall Study|Lost to Follow-up|17|||
129830786|NCT03795298|467346158|FG000|Overall Study|Physician Decision|5|||
129830787|NCT03795298|467346159|FG001|Overall Study|Physician Decision|4|||
129830788|NCT03795298|467346158|FG000|Overall Study|Withdrawal by Subject|43|||
129830789|NCT03795298|467346159|FG001|Overall Study|Withdrawal by Subject|28|||
129830790|NCT03795298|467346158|FG000|Overall Study|Reason not reported|7|||
129830791|NCT03795298|467346159|FG001|Overall Study|Reason not reported|9|||
129830792|NCT01252940|467346160|FG000|Main Study Phase|Randomized but not treated|4|||
129830793|NCT01252940|467346161|FG001|Main Study Phase|Randomized but not treated|2|||
129830794|NCT01252940|467346160|FG000|Main Study Phase|Adverse Event|3|||
129830795|NCT01252940|467346161|FG001|Main Study Phase|Adverse Event|1|||
129830796|NCT01252940|467346160|FG000|Main Study Phase|Lack of Efficacy|1|||
129830797|NCT01252940|467346161|FG001|Main Study Phase|Lack of Efficacy|0|||
129830798|NCT01252940|467346160|FG000|Main Study Phase|Lost to Follow-up|6|||
129830799|NCT01252940|467346161|FG001|Main Study Phase|Lost to Follow-up|1|||
129830800|NCT01252940|467346160|FG000|Main Study Phase|Physician Decision|1|||
129830801|NCT01252940|467346161|FG001|Main Study Phase|Physician Decision|0|||
129830802|NCT01252940|467346160|FG000|Main Study Phase|Protocol Violation|4|||
129830803|NCT01252940|467346161|FG001|Main Study Phase|Protocol Violation|2|||
129830804|NCT01252940|467346160|FG000|Main Study Phase|Withdrawal by Subject|6|||
129830805|NCT01252940|467346161|FG001|Main Study Phase|Withdrawal by Subject|5|||
129830806|NCT01252940|467346160|FG000|Main Study Phase|Subject Non-compliance|1|||
129830807|NCT01252940|467346161|FG001|Main Study Phase|Subject Non-compliance|1|||
129830808|NCT01252940|467346160|FG000|Extension Phase|Adverse Event|2|||
129830809|NCT01252940|467346161|FG001|Extension Phase|Adverse Event|1|||
129830810|NCT01252940|467346160|FG000|Extension Phase|Lack of Efficacy|1|||
129830811|NCT01252940|467346161|FG001|Extension Phase|Lack of Efficacy|0|||
129830812|NCT01252940|467346160|FG000|Extension Phase|Lost to Follow-up|5|||
129830813|NCT01252940|467346161|FG001|Extension Phase|Lost to Follow-up|0|||
129830814|NCT01252940|467346160|FG000|Extension Phase|Physician Decision|0|||
129830815|NCT01252940|467346161|FG001|Extension Phase|Physician Decision|1|||
129830816|NCT01252940|467346160|FG000|Extension Phase|Subject Non-compliance|1|||
129830817|NCT01252940|467346161|FG001|Extension Phase|Subject Non-compliance|0|||
129830818|NCT01252940|467346160|FG000|Extension Phase|Withdrawal by Subject|1|||
129830819|NCT01252940|467346161|FG001|Extension Phase|Withdrawal by Subject|1|||
129830820|NCT04814433|467346164|FG000|Overall Study|Survey not returned|4|||
129830821|NCT04814433|467346165|FG001|Overall Study|Survey not returned|8|||
129830822|NCT04814433|467346166|FG002|Overall Study|Survey not returned|4|||
129830823|NCT04814433|467346167|FG003|Overall Study|Survey not returned|5|||
129830824|NCT02496533|467346170|FG000|Overall Study|Lack of data on outcome|3|||
129830825|NCT02496533|467346171|FG001|Overall Study|Lack of data on outcome|0|||
129830826|NCT02496533|467346170|FG000|Overall Study|Patient did not complete all measures|0|||
130060429|NCT00992784|468176643|FG000|Overall Study|Adverse Event|2|||
129830827|NCT02496533|467346171|FG001|Overall Study|Patient did not complete all measures|4|||
129830828|NCT02496533|467346170|FG000|Overall Study|Late for radiologic testing|0|||
129830829|NCT02496533|467346171|FG001|Overall Study|Late for radiologic testing|2|||
129830830|NCT01816893|467346174|FG000|Washout Period|Withdrawal by Subject|2|||
129830831|NCT01816893|467346175|FG001|Washout Period|Withdrawal by Subject|0|||
129830832|NCT02016625|467347781|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
129830833|NCT02016625|467347782|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
129830834|NCT02016625|467347781|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
129830835|NCT02016625|467347782|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
129830836|NCT02016625|467347781|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
129830837|NCT02016625|467347782|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
129830838|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
129830839|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
129830840|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
129830841|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
129830842|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
129830843|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
129830844|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
129830845|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
129830846|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
129830847|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
129830848|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
129830849|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
129830850|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
129830851|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
129830852|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
129830853|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
129830854|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
129830855|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
129830856|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
129830857|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
129830858|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
130060430|NCT00992784|468176644|FG001|Overall Study|Adverse Event|1|||
130060431|NCT00992784|468176645|FG002|Overall Study|Adverse Event|0|||
130060432|NCT00992784|468176643|FG000|Overall Study|Withdrawal by Subject|1|||
130060433|NCT00992784|468176644|FG001|Overall Study|Withdrawal by Subject|1|||
130060434|NCT00992784|468176645|FG002|Overall Study|Withdrawal by Subject|1|||
130060435|NCT01658579|468176650|FG000|Treatment Period A|Other|0|||
130060436|NCT01658579|468176651|FG001|Treatment Period A|Other|0|||
130060437|NCT01658579|468176652|FG002|Treatment Period A|Other|1|||
130060438|NCT01658579|468176653|FG003|Treatment Period A|Other|1|||
130060439|NCT01658579|468176650|FG000|Treatment Period A|Adverse Event|1|||
130060440|NCT01658579|468176651|FG001|Treatment Period A|Adverse Event|0|||
130060441|NCT01658579|468176652|FG002|Treatment Period A|Adverse Event|0|||
130060442|NCT01658579|468176653|FG003|Treatment Period A|Adverse Event|0|||
130060443|NCT01658579|468176650|FG000|Treatment Period B|Other|0|||
130060444|NCT01658579|468176651|FG001|Treatment Period B|Other|0|||
130060445|NCT01658579|468176652|FG002|Treatment Period B|Other|0|||
130060446|NCT01658579|468176653|FG003|Treatment Period B|Other|1|||
130060447|NCT01514188|468176654|FG000|Overall Study|Adverse Event|3|||
130060448|NCT01514188|468176655|FG001|Overall Study|Adverse Event|5|||
130112697|NCT01381900|468373444|FG000|Overall Study|Protocol Violation|0|||
130112698|NCT01381900|468373445|FG001|Overall Study|Protocol Violation|1|||
130112699|NCT01381900|468373446|FG002|Overall Study|Protocol Violation|1|||
130112700|NCT01381900|468373444|FG000|Overall Study|Withdrawal by Subject|0|||
129830859|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
129830860|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
130060449|NCT01514188|468176654|FG000|Overall Study|Withdrawal by Subject|2|||
130060450|NCT01514188|468176655|FG001|Overall Study|Withdrawal by Subject|4|||
130060451|NCT01514188|468176654|FG000|Overall Study|Protocol Violation|2|||
130060452|NCT01514188|468176655|FG001|Overall Study|Protocol Violation|4|||
130060453|NCT01514188|468176654|FG000|Overall Study|Physician Decision|0|||
129830861|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
129830862|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
129830863|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
129830864|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
129830865|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
129830866|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
129830867|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
129830868|NCT00914810|467347787|FG000|Overall Study|Withdrawal by Subject|1|||
129830869|NCT00914810|467347788|FG001|Overall Study|Withdrawal by Subject|0|||
129830870|NCT00914810|467347787|FG000|Overall Study|Relocated out of state|1|||
129830871|NCT00914810|467347788|FG001|Overall Study|Relocated out of state|0|||
129830872|NCT00914810|467347787|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
129830873|NCT00914810|467347788|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
129830874|NCT01465022|467347789|FG000|Overall Study|Lost to Follow-up|15|||
129830875|NCT01465022|467347790|FG001|Overall Study|Lost to Follow-up|14|||
129830876|NCT01465022|467347791|FG002|Overall Study|Lost to Follow-up|0|||
129830877|NCT01465022|467347789|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
129830878|NCT01465022|467347790|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
129830879|NCT01465022|467347791|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
129830880|NCT01465022|467347789|FG000|Overall Study|Not Randomized|0|||
129830881|NCT01465022|467347790|FG001|Overall Study|Not Randomized|0|||
129830882|NCT01465022|467347791|FG002|Overall Study|Not Randomized|70|||
129830883|NCT01327300|467347792|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
129830884|NCT01327300|467347793|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
129830885|NCT03257631|467347807|FG000|Overall Study|Death|1|||
129830886|NCT03257631|467347808|FG001|Overall Study|Death|0|||
129830887|NCT03257631|467347809|FG002|Overall Study|Death|1|||
129830888|NCT03257631|467347810|FG003|Overall Study|Death|1|||
129830889|NCT03257631|467347807|FG000|Overall Study|Progressive Disease|10|||
129830890|NCT03257631|467347808|FG001|Overall Study|Progressive Disease|9|||
129830891|NCT03257631|467347809|FG002|Overall Study|Progressive Disease|17|||
129830892|NCT03257631|467347810|FG003|Overall Study|Progressive Disease|8|||
129830893|NCT03257631|467347807|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129830894|NCT03257631|467347808|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129830895|NCT03257631|467347809|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129830896|NCT03257631|467347810|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
129830897|NCT03257631|467347807|FG000|Overall Study|Adverse Event|0|||
129830898|NCT03257631|467347808|FG001|Overall Study|Adverse Event|0|||
129830899|NCT03257631|467347809|FG002|Overall Study|Adverse Event|2|||
129830900|NCT03257631|467347810|FG003|Overall Study|Adverse Event|0|||
129830901|NCT02529137|467347811|FG000|Overall Study|Discontinuation for different reasons|8|||
129830902|NCT01290666|467347815|FG000|Overall Study|Lost to Follow-up|11|||
129830903|NCT01290666|467347815|FG000|Overall Study|Withdrawal by Subject|23|||
129830904|NCT01290666|467347815|FG000|Overall Study|Early Termination of Study|4|||
129830905|NCT03036098|467347816|FG000|Pre-Treatment|Other Reasons|1|||
129830906|NCT03036098|467347817|FG001|Pre-Treatment|Other Reasons|2|||
129830907|NCT03036098|467347818|FG002|Pre-Treatment|Other Reasons|0|||
129830908|NCT03036098|467347819|FG003|Pre-Treatment|Other Reasons|5|||
129830909|NCT03036098|467347816|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
129830910|NCT03036098|467347817|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
129830911|NCT03036098|467347818|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
129830912|NCT03036098|467347819|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
129830913|NCT03036098|467347816|FG000|Pre-Treatment|Withdrawal by Subject|1|||
129830914|NCT03036098|467347817|FG001|Pre-Treatment|Withdrawal by Subject|14|||
129830915|NCT03036098|467347818|FG002|Pre-Treatment|Withdrawal by Subject|0|||
129830916|NCT03036098|467347819|FG003|Pre-Treatment|Withdrawal by Subject|5|||
129830917|NCT03036098|467347816|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
129830918|NCT03036098|467347817|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
129830919|NCT03036098|467347818|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
130060454|NCT01514188|468176655|FG001|Overall Study|Physician Decision|2|||
130060455|NCT01514188|468176654|FG000|Overall Study|Disease Progression|13|||
130060456|NCT01514188|468176655|FG001|Overall Study|Disease Progression|14|||
130060457|NCT01514188|468176654|FG000|Overall Study|Death|1|||
130060458|NCT01514188|468176655|FG001|Overall Study|Death|3|||
130060459|NCT01514188|468176654|FG000|Overall Study|Other|2|||
129830920|NCT03036098|467347819|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
129830921|NCT03036098|467347816|FG000|Treatment|Disease Progression|130|||
129830922|NCT03036098|467347817|FG001|Treatment|Disease Progression|77|||
129830923|NCT03036098|467347818|FG002|Treatment|Disease Progression|168|||
129830924|NCT03036098|467347819|FG003|Treatment|Disease Progression|50|||
129830925|NCT03036098|467347816|FG000|Treatment|Study Drug Toxicity|95|||
129830926|NCT03036098|467347817|FG001|Treatment|Study Drug Toxicity|45|||
129830927|NCT03036098|467347818|FG002|Treatment|Study Drug Toxicity|26|||
130060460|NCT01514188|468176655|FG001|Overall Study|Other|1|||
130060461|NCT02932332|468176660|FG000|Overall Study|Withdrawal by Subject|1|||
129830928|NCT03036098|467347819|FG003|Treatment|Study Drug Toxicity|22|||
129830929|NCT03036098|467347816|FG000|Treatment|Death|9|||
129830930|NCT03036098|467347817|FG001|Treatment|Death|3|||
129830931|NCT03036098|467347818|FG002|Treatment|Death|1|||
129830932|NCT03036098|467347819|FG003|Treatment|Death|2|||
129830933|NCT03036098|467347816|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
129830934|NCT03036098|467347817|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
129830935|NCT03036098|467347818|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
129830936|NCT03036098|467347819|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
129830937|NCT03036098|467347816|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
129830938|NCT03036098|467347817|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
129830939|NCT03036098|467347818|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
129830940|NCT03036098|467347819|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
129830941|NCT03036098|467347816|FG000|Treatment|Withdrawal by Subject|2|||
129830942|NCT03036098|467347817|FG001|Treatment|Withdrawal by Subject|9|||
129830943|NCT03036098|467347818|FG002|Treatment|Withdrawal by Subject|2|||
129830944|NCT03036098|467347819|FG003|Treatment|Withdrawal by Subject|4|||
129830945|NCT03036098|467347816|FG000|Treatment|Maximum Clinical Benefit|6|||
129830946|NCT03036098|467347817|FG001|Treatment|Maximum Clinical Benefit|1|||
129830947|NCT03036098|467347818|FG002|Treatment|Maximum Clinical Benefit|6|||
129830948|NCT03036098|467347819|FG003|Treatment|Maximum Clinical Benefit|10|||
129830949|NCT03036098|467347816|FG000|Treatment|Poor/Non Compliance|1|||
129830950|NCT03036098|467347817|FG001|Treatment|Poor/Non Compliance|2|||
129830951|NCT03036098|467347818|FG002|Treatment|Poor/Non Compliance|0|||
129830952|NCT03036098|467347819|FG003|Treatment|Poor/Non Compliance|1|||
129830953|NCT03036098|467347816|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
129830954|NCT03036098|467347817|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
129830955|NCT03036098|467347818|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
129830956|NCT03036098|467347819|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
129830957|NCT03036098|467347816|FG000|Treatment|Administrative Reason by Sponsor|1|||
129830958|NCT03036098|467347817|FG001|Treatment|Administrative Reason by Sponsor|0|||
129830959|NCT03036098|467347818|FG002|Treatment|Administrative Reason by Sponsor|2|||
129830960|NCT03036098|467347819|FG003|Treatment|Administrative Reason by Sponsor|1|||
129830961|NCT03036098|467347816|FG000|Treatment|Other Reasons|31|||
129830962|NCT03036098|467347817|FG001|Treatment|Other Reasons|5|||
129830963|NCT03036098|467347818|FG002|Treatment|Other Reasons|21|||
129830964|NCT03036098|467347819|FG003|Treatment|Other Reasons|8|||
129830965|NCT03036098|467347816|FG000|Treatment|Ongoing Treatment|0|||
129830966|NCT03036098|467347817|FG001|Treatment|Ongoing Treatment|0|||
129830967|NCT03036098|467347818|FG002|Treatment|Ongoing Treatment|23|||
129830968|NCT03036098|467347819|FG003|Treatment|Ongoing Treatment|0|||
129830969|NCT02063854|467347821|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
129830970|NCT02063854|467347822|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
129830971|NCT02063854|467347823|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
129830972|NCT02063854|467347824|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
129830973|NCT02063854|467347825|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
129830974|NCT02063854|467347826|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
129830975|NCT02063854|467347827|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
129830976|NCT02063854|467347821|FG000|Overall Study|Major Protocol Deviation|0|||
129830977|NCT02063854|467347822|FG001|Overall Study|Major Protocol Deviation|0|||
129830978|NCT02063854|467347823|FG002|Overall Study|Major Protocol Deviation|3|||
129830979|NCT02063854|467347824|FG003|Overall Study|Major Protocol Deviation|0|||
129830980|NCT02063854|467347825|FG004|Overall Study|Major Protocol Deviation|0|||
129830981|NCT02063854|467347826|FG005|Overall Study|Major Protocol Deviation|0|||
129830982|NCT02063854|467347827|FG006|Overall Study|Major Protocol Deviation|0|||
129830983|NCT02063854|467347821|FG000|Overall Study|Voluntary Withdrawal|2|||
129830984|NCT02063854|467347822|FG001|Overall Study|Voluntary Withdrawal|0|||
129830985|NCT02063854|467347823|FG002|Overall Study|Voluntary Withdrawal|8|||
129830986|NCT02063854|467347824|FG003|Overall Study|Voluntary Withdrawal|1|||
129830987|NCT02063854|467347825|FG004|Overall Study|Voluntary Withdrawal|3|||
129830988|NCT02063854|467347826|FG005|Overall Study|Voluntary Withdrawal|6|||
129830989|NCT02063854|467347827|FG006|Overall Study|Voluntary Withdrawal|1|||
129830990|NCT02063854|467347821|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
130112701|NCT01381900|468373445|FG001|Overall Study|Withdrawal by Subject|0|||
129830991|NCT02063854|467347822|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
129830992|NCT02063854|467347823|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
129830993|NCT02063854|467347824|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
129830994|NCT02063854|467347825|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
129830995|NCT02063854|467347826|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
129830996|NCT02063854|467347827|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
129830997|NCT02063854|467347821|FG000|Overall Study|Reason Not Specified|1|||
129830998|NCT02063854|467347822|FG001|Overall Study|Reason Not Specified|0|||
129830999|NCT02063854|467347823|FG002|Overall Study|Reason Not Specified|0|||
129831000|NCT02063854|467347824|FG003|Overall Study|Reason Not Specified|0|||
129831001|NCT02063854|467347825|FG004|Overall Study|Reason Not Specified|0|||
129831002|NCT02063854|467347826|FG005|Overall Study|Reason Not Specified|0|||
129831003|NCT02063854|467347827|FG006|Overall Study|Reason Not Specified|0|||
129831004|NCT02063854|467347821|FG000|Overall Study|Did Not Receive Study Drug|0|||
130112702|NCT01381900|468373446|FG002|Overall Study|Withdrawal by Subject|1|||
130112703|NCT01381900|468373444|FG000|Overall Study|Early withdraw|3|||
130112704|NCT01381900|468373445|FG001|Overall Study|Early withdraw|1|||
130112705|NCT01381900|468373446|FG002|Overall Study|Early withdraw|1|||
130112706|NCT02041494|468373447|FG000|Overall Study|Death|1|||
129831005|NCT02063854|467347822|FG001|Overall Study|Did Not Receive Study Drug|0|||
129831006|NCT02063854|467347823|FG002|Overall Study|Did Not Receive Study Drug|0|||
129831007|NCT02063854|467347824|FG003|Overall Study|Did Not Receive Study Drug|0|||
129831008|NCT02063854|467347825|FG004|Overall Study|Did Not Receive Study Drug|0|||
129831009|NCT02063854|467347826|FG005|Overall Study|Did Not Receive Study Drug|1|||
129831010|NCT02063854|467347827|FG006|Overall Study|Did Not Receive Study Drug|0|||
129831011|NCT03538158|467347828|FG000|Overall Study|Lost to Follow-up|13|||
129831012|NCT03538158|467347829|FG001|Overall Study|Lost to Follow-up|7|||
129831013|NCT03538158|467347828|FG000|Overall Study|Withdrawal by Subject|2|||
129831014|NCT03538158|467347829|FG001|Overall Study|Withdrawal by Subject|1|||
129831015|NCT00772707|467347830|FG000|Overall Study|Withdrawn|3|||
129831016|NCT01454570|467347831|FG000|Overall Study|Withdrawal by Subject|2|||
129831017|NCT01454570|467347831|FG000|Overall Study|Screen Failure|7|||
129831018|NCT04356963|467347833|FG000|First Session|Withdrawal by Subject|1|||
129831019|NCT04356963|467347833|FG000|Second Session|Withdrawal by Subject|3|||
129831020|NCT04356963|467347833|FG000|Second Session|Lost to Follow-up|1|||
129831021|NCT04356963|467347833|FG000|Third Session|Lost to Follow-up|6|||
129831022|NCT04356963|467347833|FG000|Third Session|Withdrawal by Subject|1|||
129831023|NCT01176266|467347840|FG000|Overall Study|Death|6|||
129831024|NCT01176266|467347840|FG000|Overall Study|Withdrawal by Subject|3|||
129831025|NCT05075850|467347841|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
129831026|NCT00271609|467347842|FG000|Overall Study|Adverse Event|11|||
129831027|NCT00271609|467347843|FG001|Overall Study|Adverse Event|3|||
129831028|NCT00271609|467347842|FG000|Overall Study|Withdrawal by Subject|2|||
129831029|NCT00271609|467347843|FG001|Overall Study|Withdrawal by Subject|0|||
129831030|NCT02188589|467347844|FG000|Overall Study|Withdrawal by Subject|5|||
129831031|NCT00741039|467347848|FG000|Overall Study|Patient non-compliance|2|||
129831032|NCT00741039|467347849|FG001|Overall Study|Patient non-compliance|0|||
129831033|NCT00878709|467347850|FG000|Overall Study|Withdrawal by Subject|197|||
129831034|NCT00878709|467347851|FG001|Overall Study|Withdrawal by Subject|120|||
129831035|NCT00878709|467347850|FG000|Overall Study|Lost to Follow-up|35|||
129831036|NCT00878709|467347851|FG001|Overall Study|Lost to Follow-up|33|||
129831037|NCT00878709|467347850|FG000|Overall Study|Other Reasons|93|||
129831038|NCT00878709|467347851|FG001|Overall Study|Other Reasons|84|||
129831039|NCT01712854|467347852|FG000|Overall Study|Physician Decision|1|||
129831040|NCT00768300|467347857|FG000|Overall Study|Randomized but not treated|1|||
129831041|NCT00768300|467347858|FG001|Overall Study|Randomized but not treated|1|||
129831042|NCT00768300|467347857|FG000|Overall Study|Adverse Event|10|||
129831043|NCT00768300|467347858|FG001|Overall Study|Adverse Event|2|||
129831044|NCT00768300|467347857|FG000|Overall Study|Protocol Violation|6|||
129831045|NCT00768300|467347858|FG001|Overall Study|Protocol Violation|1|||
129831046|NCT00768300|467347857|FG000|Overall Study|Withdrawal by Subject|13|||
129831047|NCT00768300|467347858|FG001|Overall Study|Withdrawal by Subject|7|||
129831048|NCT00768300|467347857|FG000|Overall Study|Physician Decision|2|||
129831049|NCT00768300|467347858|FG001|Overall Study|Physician Decision|3|||
129831050|NCT00768300|467347857|FG000|Overall Study|Study discontinued by Sponsor|271|||
129831051|NCT00768300|467347858|FG001|Overall Study|Study discontinued by Sponsor|140|||
129831052|NCT00768300|467347857|FG000|Overall Study|Death|21|||
129831053|NCT00768300|467347858|FG001|Overall Study|Death|5|||
129831054|NCT00768300|467347857|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
129831055|NCT00768300|467347858|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
129831056|NCT00768300|467347857|FG000|Overall Study|Screen failure following randomization|1|||
129831057|NCT00768300|467347858|FG001|Overall Study|Screen failure following randomization|0|||
130112707|NCT02041494|468373448|FG001|Overall Study|Death|3|||
130112708|NCT02041494|468373447|FG000|Overall Study|Lost to Follow-up|2|||
129831058|NCT00768300|467347857|FG000|Overall Study|Received lung transplant|1|||
129831059|NCT00768300|467347858|FG001|Overall Study|Received lung transplant|1|||
129831060|NCT00768300|467347857|FG000|Overall Study|Lost to Follow-up|0|||
129831061|NCT00768300|467347858|FG001|Overall Study|Lost to Follow-up|1|||
129831062|NCT00768300|467347857|FG000|Overall Study|Began prohibited concomitant medication|0|||
129831063|NCT00768300|467347858|FG001|Overall Study|Began prohibited concomitant medication|1|||
129831064|NCT00768300|467347857|FG000|Overall Study|Treated but never dosed with Study drug|1|||
129831065|NCT00768300|467347858|FG001|Overall Study|Treated but never dosed with Study drug|0|||
129831066|NCT00768300|467347857|FG000|Overall Study|Missing data|1|||
129831067|NCT00768300|467347858|FG001|Overall Study|Missing data|0|||
129831068|NCT00322842|467347861|FG000|Overall Study|Withdrawal by Subject|0|||
129831069|NCT00322842|467347862|FG001|Overall Study|Withdrawal by Subject|1|||
130112709|NCT02041494|468373448|FG001|Overall Study|Lost to Follow-up|6|||
129831070|NCT00322842|467347861|FG000|Overall Study|Lost to Follow-up|0|||
129831071|NCT00322842|467347862|FG001|Overall Study|Lost to Follow-up|1|||
129831072|NCT00322842|467347861|FG000|Overall Study|Refused transplant|1|||
129831073|NCT00322842|467347862|FG001|Overall Study|Refused transplant|0|||
129831074|NCT00322842|467347861|FG000|Overall Study|Death|1|||
129831075|NCT00322842|467347862|FG001|Overall Study|Death|0|||
129831076|NCT02068222|467347865|FG000|Overall Study|Lost to Follow-up|1|||
129831077|NCT01782664|467347867|FG000|Overall Study|Adverse Event|2|||
129831078|NCT01782664|467347868|FG001|Overall Study|Adverse Event|2|||
129831079|NCT01782664|467347869|FG002|Overall Study|Adverse Event|2|||
129831080|NCT01782664|467347870|FG003|Overall Study|Adverse Event|2|||
129831081|NCT01782664|467347871|FG004|Overall Study|Adverse Event|0|||
129831082|NCT01782664|467347872|FG005|Overall Study|Adverse Event|0|||
129831083|NCT01782664|467347867|FG000|Overall Study|Lack of Efficacy|2|||
129831084|NCT01782664|467347868|FG001|Overall Study|Lack of Efficacy|0|||
129831085|NCT01782664|467347869|FG002|Overall Study|Lack of Efficacy|2|||
129831086|NCT01782664|467347870|FG003|Overall Study|Lack of Efficacy|2|||
129831087|NCT01782664|467347871|FG004|Overall Study|Lack of Efficacy|0|||
129831088|NCT01782664|467347872|FG005|Overall Study|Lack of Efficacy|0|||
129831089|NCT01782664|467347867|FG000|Overall Study|Protocol Violation|0|||
129831090|NCT01782664|467347868|FG001|Overall Study|Protocol Violation|1|||
129831091|NCT01782664|467347869|FG002|Overall Study|Protocol Violation|0|||
129831092|NCT01782664|467347870|FG003|Overall Study|Protocol Violation|1|||
129831093|NCT01782664|467347871|FG004|Overall Study|Protocol Violation|0|||
129831094|NCT01782664|467347872|FG005|Overall Study|Protocol Violation|0|||
129831095|NCT01782664|467347867|FG000|Overall Study|Withdrawal by Subject|2|||
129831096|NCT01782664|467347868|FG001|Overall Study|Withdrawal by Subject|2|||
129831097|NCT01782664|467347869|FG002|Overall Study|Withdrawal by Subject|0|||
129831098|NCT01782664|467347870|FG003|Overall Study|Withdrawal by Subject|0|||
129831099|NCT01782664|467347871|FG004|Overall Study|Withdrawal by Subject|0|||
129831100|NCT01782664|467347872|FG005|Overall Study|Withdrawal by Subject|0|||
129831101|NCT00651755|467347874|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
129831102|NCT00651755|467347875|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
129831103|NCT00651755|467347874|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
129831104|NCT00651755|467347875|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
129831105|NCT00624052|467347876|FG000|Overall Study|Adverse Event|7|||
129831106|NCT00624052|467347877|FG001|Overall Study|Adverse Event|6|||
129831107|NCT00624052|467347878|FG002|Overall Study|Adverse Event|0|||
129831108|NCT00624052|467347879|FG003|Overall Study|Adverse Event|3|||
129831109|NCT00624052|467347876|FG000|Overall Study|Lack of Efficacy|1|||
129831110|NCT00624052|467347877|FG001|Overall Study|Lack of Efficacy|1|||
129831111|NCT00624052|467347878|FG002|Overall Study|Lack of Efficacy|0|||
129831112|NCT00624052|467347879|FG003|Overall Study|Lack of Efficacy|0|||
129831113|NCT00624052|467347876|FG000|Overall Study|Lost to Follow-up|2|||
129831114|NCT00624052|467347877|FG001|Overall Study|Lost to Follow-up|3|||
129831115|NCT00624052|467347878|FG002|Overall Study|Lost to Follow-up|1|||
129831116|NCT00624052|467347879|FG003|Overall Study|Lost to Follow-up|0|||
129831117|NCT00624052|467347876|FG000|Overall Study|Non compliant with the protocol|2|||
129831118|NCT00624052|467347877|FG001|Overall Study|Non compliant with the protocol|1|||
129831119|NCT00624052|467347878|FG002|Overall Study|Non compliant with the protocol|1|||
129831120|NCT00624052|467347879|FG003|Overall Study|Non compliant with the protocol|1|||
129831121|NCT00624052|467347876|FG000|Overall Study|Consent withdrawn|3|||
129831122|NCT00624052|467347877|FG001|Overall Study|Consent withdrawn|1|||
129831123|NCT00624052|467347878|FG002|Overall Study|Consent withdrawn|1|||
129831124|NCT00624052|467347879|FG003|Overall Study|Consent withdrawn|0|||
129831125|NCT00624052|467347876|FG000|Overall Study|Changed job/ran out if meds|0|||
129831126|NCT00624052|467347877|FG001|Overall Study|Changed job/ran out if meds|2|||
129831127|NCT00624052|467347878|FG002|Overall Study|Changed job/ran out if meds|0|||
129831128|NCT00624052|467347879|FG003|Overall Study|Changed job/ran out if meds|0|||
129831129|NCT00281684|467347882|FG000|Overall Study|Lost to Follow-up|0|||
129831130|NCT00281684|467347883|FG001|Overall Study|Lost to Follow-up|0|||
129831131|NCT00281684|467347884|FG002|Overall Study|Lost to Follow-up|1|||
129831132|NCT00281684|467347885|FG003|Overall Study|Lost to Follow-up|0|||
129831133|NCT00281684|467347882|FG000|Overall Study|Withdrawal by Subject|1|||
129831134|NCT00281684|467347883|FG001|Overall Study|Withdrawal by Subject|0|||
129831135|NCT00281684|467347884|FG002|Overall Study|Withdrawal by Subject|0|||
129831136|NCT00281684|467347885|FG003|Overall Study|Withdrawal by Subject|0|||
129831137|NCT00698581|467347888|FG000|Overall Study|Lack of Efficacy|23|||
129831138|NCT00698581|467347889|FG001|Overall Study|Lack of Efficacy|11|||
129831139|NCT00698581|467347888|FG000|Overall Study|Withdrawal by Subject|6|||
129831140|NCT00698581|467347889|FG001|Overall Study|Withdrawal by Subject|0|||
129831141|NCT00698581|467347888|FG000|Overall Study|Other reason|9|||
129831142|NCT00698581|467347889|FG001|Overall Study|Other reason|1|||
129831143|NCT00698581|467347888|FG000|Overall Study|SAE, non-fatal|1|||
129831144|NCT00698581|467347889|FG001|Overall Study|SAE, non-fatal|0|||
129831145|NCT00698581|467347888|FG000|Overall Study|AE, non-serious non-fatal|4|||
129831146|NCT00698581|467347889|FG001|Overall Study|AE, non-serious non-fatal|0|||
129831147|NCT00698581|467347888|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129897697|NCT00517933|467584424|FG001|Period 2|Physician Decision|0|||
129831148|NCT00698581|467347889|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129831149|NCT00698581|467347888|FG000|Overall Study|AE of unknown type|1|||
129831150|NCT00698581|467347889|FG001|Overall Study|AE of unknown type|0|||
129831151|NCT03642717|467347890|FG000|Overall Study|Lost to Follow-up|2|||
129831152|NCT03642717|467347890|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
129831153|NCT03642717|467347890|FG000|Overall Study|Taken study drug prior to contract date|3|||
129831154|NCT00946712|467347891|FG000|Overall Study|Adverse Event|118|||
129831155|NCT00946712|467347892|FG001|Overall Study|Adverse Event|124|||
129831156|NCT00946712|467347891|FG000|Overall Study|Disease progression|308|||
129831157|NCT00946712|467347892|FG001|Overall Study|Disease progression|404|||
129831158|NCT00946712|467347891|FG000|Overall Study|Death|21|||
129831159|NCT00946712|467347892|FG001|Overall Study|Death|22|||
129831160|NCT00946712|467347891|FG000|Overall Study|No treatment given|25|||
129831161|NCT00946712|467347892|FG001|Overall Study|No treatment given|29|||
129831162|NCT00946712|467347891|FG000|Overall Study|Other reasons|61|||
129831163|NCT00946712|467347892|FG001|Overall Study|Other reasons|73|||
129831164|NCT00946712|467347891|FG000|Overall Study|On Treatment|0|||
129831165|NCT00946712|467347892|FG001|Overall Study|On Treatment|4|||
129831166|NCT00946712|467347891|FG000|Overall Study|Ineligible|14|||
129831167|NCT00946712|467347892|FG001|Overall Study|Ineligible|6|||
129831168|NCT00302458|467347893|FG000|Overall Study|Lost to Follow-up|1|||
129831169|NCT00302458|467347893|FG000|Overall Study|Ineligible after screening|1|||
129831170|NCT00302458|467347893|FG000|Overall Study|Withdrawal by Subject|1|||
129831171|NCT02642432|467347896|FG000|Overall Study|Adverse Event|2|||
129831172|NCT02642432|467347896|FG000|Overall Study|Withdrew Consent|1|||
129831173|NCT02642432|467347896|FG000|Overall Study|Lost to Follow-up|2|||
129831174|NCT02642432|467347896|FG000|Overall Study|Other|3|||
129831175|NCT03245008|467347897|FG000|Overall Study|Adverse Event|15|||
129831176|NCT03245008|467347898|FG001|Overall Study|Adverse Event|18|||
129831177|NCT03245008|467347899|FG002|Overall Study|Adverse Event|15|||
129831178|NCT03245008|467347900|FG003|Overall Study|Adverse Event|0|||
129831179|NCT03245008|467347901|FG004|Overall Study|Adverse Event|1|||
129831180|NCT03245008|467347897|FG000|Overall Study|Lack of Efficacy|0|||
129831181|NCT03245008|467347898|FG001|Overall Study|Lack of Efficacy|1|||
129831182|NCT03245008|467347899|FG002|Overall Study|Lack of Efficacy|0|||
129831183|NCT03245008|467347900|FG003|Overall Study|Lack of Efficacy|0|||
129831184|NCT03245008|467347901|FG004|Overall Study|Lack of Efficacy|0|||
129831185|NCT03245008|467347897|FG000|Overall Study|Lost to Follow-up|4|||
129831186|NCT03245008|467347898|FG001|Overall Study|Lost to Follow-up|1|||
129831187|NCT03245008|467347899|FG002|Overall Study|Lost to Follow-up|0|||
129831188|NCT03245008|467347900|FG003|Overall Study|Lost to Follow-up|0|||
129831189|NCT03245008|467347901|FG004|Overall Study|Lost to Follow-up|1|||
129831190|NCT03245008|467347897|FG000|Overall Study|Physician Decision|1|||
129831191|NCT03245008|467347898|FG001|Overall Study|Physician Decision|3|||
129831192|NCT03245008|467347899|FG002|Overall Study|Physician Decision|4|||
129831193|NCT03245008|467347900|FG003|Overall Study|Physician Decision|0|||
129831194|NCT03245008|467347901|FG004|Overall Study|Physician Decision|0|||
129831195|NCT03245008|467347897|FG000|Overall Study|Protocol Violation|0|||
129831196|NCT03245008|467347898|FG001|Overall Study|Protocol Violation|1|||
129831197|NCT03245008|467347899|FG002|Overall Study|Protocol Violation|0|||
129831198|NCT03245008|467347900|FG003|Overall Study|Protocol Violation|0|||
129831199|NCT03245008|467347901|FG004|Overall Study|Protocol Violation|0|||
129831200|NCT03245008|467347897|FG000|Overall Study|Withdrawal by Subject|20|||
129831201|NCT03245008|467347898|FG001|Overall Study|Withdrawal by Subject|19|||
129831202|NCT03245008|467347899|FG002|Overall Study|Withdrawal by Subject|11|||
129831203|NCT03245008|467347900|FG003|Overall Study|Withdrawal by Subject|0|||
129831204|NCT03245008|467347901|FG004|Overall Study|Withdrawal by Subject|0|||
129831205|NCT03245008|467347897|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129831206|NCT03245008|467347898|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129831207|NCT03245008|467347899|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129831208|NCT03245008|467347900|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
129831209|NCT03245008|467347901|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
129831210|NCT03245008|467347897|FG000|Overall Study|Failure to meet randomization criteria|0|||
129831211|NCT03245008|467347898|FG001|Overall Study|Failure to meet randomization criteria|1|||
129831212|NCT03245008|467347899|FG002|Overall Study|Failure to meet randomization criteria|0|||
129831213|NCT03245008|467347900|FG003|Overall Study|Failure to meet randomization criteria|1|||
129831214|NCT03245008|467347901|FG004|Overall Study|Failure to meet randomization criteria|0|||
129831215|NCT01286012|467347902|FG000|Overall Study|Adverse Event|3|||
129831216|NCT01286012|467347903|FG001|Overall Study|Adverse Event|3|||
129831217|NCT01286012|467347902|FG000|Overall Study|Death|2|||
129831218|NCT01286012|467347903|FG001|Overall Study|Death|3|||
129831219|NCT01286012|467347902|FG000|Overall Study|Protocol Violation|1|||
129831220|NCT01286012|467347903|FG001|Overall Study|Protocol Violation|1|||
129831221|NCT01286012|467347902|FG000|Overall Study|Withdrawal by Subject|4|||
129831222|NCT01286012|467347903|FG001|Overall Study|Withdrawal by Subject|4|||
129831223|NCT01286012|467347902|FG000|Overall Study|Physician Decision|2|||
129831224|NCT01286012|467347903|FG001|Overall Study|Physician Decision|0|||
129897698|NCT00517933|467584423|FG000|Period 2|Withdrawal by Subject|1|||
129831225|NCT01286012|467347902|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
129831226|NCT01286012|467347903|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
129831227|NCT00663052|467347907|FG000|Overall Study|Adverse Event|6|||
129831228|NCT00663052|467347908|FG001|Overall Study|Adverse Event|3|||
129831229|NCT00663052|467347907|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
129831230|NCT00663052|467347908|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129831231|NCT00663052|467347907|FG000|Overall Study|Protocol Violation|1|||
129831232|NCT00663052|467347908|FG001|Overall Study|Protocol Violation|0|||
129831233|NCT00663052|467347907|FG000|Overall Study|Withdrawal by Subject|2|||
129831234|NCT00663052|467347908|FG001|Overall Study|Withdrawal by Subject|5|||
129831235|NCT00663052|467347907|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
129831236|NCT00663052|467347908|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
129831237|NCT00663052|467347907|FG000|Overall Study|Other|0|||
129831238|NCT00663052|467347908|FG001|Overall Study|Other|1|||
129831239|NCT05760300|467347911|FG000|Overall Study|Adverse Event|0|||
129831240|NCT05760300|467347912|FG001|Overall Study|Adverse Event|0|||
129831241|NCT05760300|467347913|FG002|Overall Study|Adverse Event|1|||
129831242|NCT05760300|467347914|FG003|Overall Study|Adverse Event|0|||
129831243|NCT05760300|467347911|FG000|Overall Study|Participant Decision|1|||
129831244|NCT05760300|467347912|FG001|Overall Study|Participant Decision|0|||
129831245|NCT05760300|467347913|FG002|Overall Study|Participant Decision|0|||
129831246|NCT05760300|467347914|FG003|Overall Study|Participant Decision|0|||
129831247|NCT04690751|467347924|FG000|Overall Study|Protocol Violation|0|||
129831248|NCT04690751|467347925|FG001|Overall Study|Protocol Violation|1|||
129831249|NCT04690751|467347926|FG002|Overall Study|Protocol Violation|0|||
129831250|NCT04690751|467347927|FG003|Overall Study|Protocol Violation|1|||
129831251|NCT04690751|467347928|FG004|Overall Study|Protocol Violation|2|||
129831252|NCT04690751|467347929|FG005|Overall Study|Protocol Violation|0|||
129831253|NCT04690751|467347924|FG000|Overall Study|Adverse Event|0|||
129831254|NCT04690751|467347925|FG001|Overall Study|Adverse Event|0|||
129831255|NCT04690751|467347926|FG002|Overall Study|Adverse Event|1|||
129831256|NCT04690751|467347927|FG003|Overall Study|Adverse Event|0|||
129831257|NCT04690751|467347928|FG004|Overall Study|Adverse Event|0|||
129831258|NCT04690751|467347929|FG005|Overall Study|Adverse Event|0|||
129831259|NCT04690751|467347924|FG000|Overall Study|Positive urine drug screen test|0|||
129831260|NCT04690751|467347925|FG001|Overall Study|Positive urine drug screen test|0|||
129831261|NCT04690751|467347926|FG002|Overall Study|Positive urine drug screen test|0|||
129831262|NCT04690751|467347927|FG003|Overall Study|Positive urine drug screen test|0|||
129831263|NCT04690751|467347928|FG004|Overall Study|Positive urine drug screen test|1|||
129831264|NCT04690751|467347929|FG005|Overall Study|Positive urine drug screen test|0|||
129831265|NCT04364620|467347930|FG000|Overall Study|Disease Progression|20|||
129831266|NCT04364620|467347930|FG000|Overall Study|Adverse Event|5|||
129831267|NCT04364620|467347930|FG000|Overall Study|Physician Decision|4|||
129831268|NCT04364620|467347930|FG000|Overall Study|Death|3|||
129831269|NCT04364620|467347930|FG000|Overall Study|Other|2|||
129831270|NCT04364620|467347930|FG000|Overall Study|Withdrawal by Subject|1|||
129831271|NCT03971695|467349113|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831272|NCT03971695|467349114|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831273|NCT03971695|467349115|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831274|NCT03971695|467349116|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
129831275|NCT03971695|467349117|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
129831276|NCT03971695|467349118|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831277|NCT03971695|467349119|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831278|NCT03971695|467349120|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831279|NCT03971695|467349121|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
129831280|NCT03971695|467349122|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831281|NCT03971695|467349123|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
129831282|NCT03971695|467349124|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
129831283|NCT03971695|467349125|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
129831284|NCT02155738|467349133|FG000|Overall Study|Missing critical information|1|||
129831285|NCT02155738|467349134|FG001|Overall Study|Missing critical information|0|||
129831286|NCT02155738|467349135|FG002|Overall Study|Missing critical information|0|||
129831287|NCT02155738|467349136|FG003|Overall Study|Missing critical information|1|||
129831288|NCT01190254|467349137|FG000|Overall Study|Adverse Event|3|||
129831289|NCT01190254|467349138|FG001|Overall Study|Adverse Event|6|||
129831290|NCT01190254|467349139|FG002|Overall Study|Adverse Event|8|||
129831291|NCT01190254|467349137|FG000|Overall Study|Lack of Efficacy|7|||
129831292|NCT01190254|467349138|FG001|Overall Study|Lack of Efficacy|4|||
129831293|NCT01190254|467349139|FG002|Overall Study|Lack of Efficacy|5|||
129831294|NCT01190254|467349137|FG000|Overall Study|Lost to Follow-up|4|||
129831295|NCT01190254|467349138|FG001|Overall Study|Lost to Follow-up|2|||
129831296|NCT01190254|467349139|FG002|Overall Study|Lost to Follow-up|0|||
129831297|NCT01190254|467349137|FG000|Overall Study|Withdrawal by Subject|4|||
129831298|NCT01190254|467349138|FG001|Overall Study|Withdrawal by Subject|5|||
129831299|NCT01190254|467349139|FG002|Overall Study|Withdrawal by Subject|7|||
129831300|NCT01190254|467349137|FG000|Overall Study|Protocol Violation|2|||
129831301|NCT01190254|467349138|FG001|Overall Study|Protocol Violation|0|||
129831302|NCT01190254|467349139|FG002|Overall Study|Protocol Violation|2|||
129831303|NCT01190254|467349137|FG000|Overall Study|Did not meet protocol eligibility|1|||
129831304|NCT01190254|467349138|FG001|Overall Study|Did not meet protocol eligibility|0|||
129831305|NCT01190254|467349139|FG002|Overall Study|Did not meet protocol eligibility|0|||
129831306|NCT02356783|467349140|FG000|Overall Study|Lost to Follow-up|1|||
129831307|NCT02356783|467349141|FG001|Overall Study|Lost to Follow-up|3|||
129831308|NCT02603809|467349142|FG000|Overall Study|Withdrawal by Subject|4|||
129831309|NCT02603809|467349143|FG001|Overall Study|Withdrawal by Subject|1|||
129831310|NCT02603809|467349144|FG002|Overall Study|Withdrawal by Subject|2|||
129831311|NCT02603809|467349145|FG003|Overall Study|Withdrawal by Subject|3|||
129831312|NCT02603809|467349146|FG004|Overall Study|Withdrawal by Subject|3|||
129831313|NCT02603809|467349147|FG005|Overall Study|Withdrawal by Subject|4|||
129831314|NCT02603809|467349142|FG000|Overall Study|Lost to Follow-up|2|||
129831315|NCT02603809|467349143|FG001|Overall Study|Lost to Follow-up|3|||
129831316|NCT02603809|467349144|FG002|Overall Study|Lost to Follow-up|1|||
129831317|NCT02603809|467349145|FG003|Overall Study|Lost to Follow-up|4|||
129831318|NCT02603809|467349146|FG004|Overall Study|Lost to Follow-up|2|||
129831319|NCT02603809|467349147|FG005|Overall Study|Lost to Follow-up|2|||
129831320|NCT02603809|467349142|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
129831321|NCT02603809|467349143|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
129831322|NCT02603809|467349144|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
129831323|NCT02603809|467349145|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
129831324|NCT02603809|467349146|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
129831325|NCT02603809|467349147|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
129831326|NCT02603809|467349142|FG000|Overall Study|Physician Decision|0|||
129831327|NCT02603809|467349143|FG001|Overall Study|Physician Decision|0|||
129831328|NCT02603809|467349144|FG002|Overall Study|Physician Decision|0|||
129831329|NCT02603809|467349145|FG003|Overall Study|Physician Decision|1|||
129831330|NCT02603809|467349146|FG004|Overall Study|Physician Decision|2|||
129831331|NCT02603809|467349147|FG005|Overall Study|Physician Decision|1|||
129831332|NCT02603809|467349142|FG000|Overall Study|Adverse Event|3|||
129831333|NCT02603809|467349143|FG001|Overall Study|Adverse Event|0|||
129831334|NCT02603809|467349144|FG002|Overall Study|Adverse Event|2|||
129831335|NCT02603809|467349145|FG003|Overall Study|Adverse Event|2|||
129831336|NCT02603809|467349146|FG004|Overall Study|Adverse Event|1|||
129831337|NCT02603809|467349147|FG005|Overall Study|Adverse Event|1|||
129831338|NCT02603809|467349142|FG000|Overall Study|Lack of Efficacy|0|||
129831339|NCT02603809|467349143|FG001|Overall Study|Lack of Efficacy|1|||
129831340|NCT02603809|467349144|FG002|Overall Study|Lack of Efficacy|0|||
129831341|NCT02603809|467349145|FG003|Overall Study|Lack of Efficacy|0|||
129831342|NCT02603809|467349146|FG004|Overall Study|Lack of Efficacy|0|||
129831343|NCT02603809|467349147|FG005|Overall Study|Lack of Efficacy|1|||
129831344|NCT04729127|467349148|FG000|Overall Study|Suspended/Terminated EI Services|4|||
129831345|NCT04729127|467349149|FG001|Overall Study|Suspended/Terminated EI Services|0|||
129831346|NCT04729127|467349150|FG002|Overall Study|Suspended/Terminated EI Services|4|||
129831347|NCT04729127|467349151|FG003|Overall Study|Suspended/Terminated EI Services|6|||
129831348|NCT04729127|467349152|FG004|Overall Study|Suspended/Terminated EI Services|0|||
129831349|NCT04729127|467349153|FG005|Overall Study|Suspended/Terminated EI Services|6|||
129831350|NCT04729127|467349154|FG006|Overall Study|Suspended/Terminated EI Services|2|||
129831351|NCT04729127|467349155|FG007|Overall Study|Suspended/Terminated EI Services|0|||
129831352|NCT04729127|467349156|FG008|Overall Study|Suspended/Terminated EI Services|2|||
129831353|NCT04729127|467349148|FG000|Overall Study|Withdrawal by Subject|1|||
129831354|NCT04729127|467349149|FG001|Overall Study|Withdrawal by Subject|0|||
129831355|NCT04729127|467349150|FG002|Overall Study|Withdrawal by Subject|1|||
129831356|NCT04729127|467349151|FG003|Overall Study|Withdrawal by Subject|0|||
129831357|NCT04729127|467349152|FG004|Overall Study|Withdrawal by Subject|0|||
129831358|NCT04729127|467349153|FG005|Overall Study|Withdrawal by Subject|0|||
129831359|NCT04729127|467349154|FG006|Overall Study|Withdrawal by Subject|0|||
129831360|NCT04729127|467349155|FG007|Overall Study|Withdrawal by Subject|0|||
129831361|NCT04729127|467349156|FG008|Overall Study|Withdrawal by Subject|0|||
129831362|NCT04729127|467349148|FG000|Overall Study|Switched Agency/Setting|1|||
129831363|NCT04729127|467349149|FG001|Overall Study|Switched Agency/Setting|0|||
129831364|NCT04729127|467349150|FG002|Overall Study|Switched Agency/Setting|1|||
129831365|NCT04729127|467349151|FG003|Overall Study|Switched Agency/Setting|1|||
129831366|NCT04729127|467349152|FG004|Overall Study|Switched Agency/Setting|0|||
129831367|NCT04729127|467349153|FG005|Overall Study|Switched Agency/Setting|1|||
129831368|NCT04729127|467349154|FG006|Overall Study|Switched Agency/Setting|1|||
129831369|NCT04729127|467349155|FG007|Overall Study|Switched Agency/Setting|0|||
129831370|NCT04729127|467349156|FG008|Overall Study|Switched Agency/Setting|1|||
129831371|NCT01365507|467349157|FG000|Overall Study|Withdrawal Criteria|8|||
129831372|NCT01365507|467349158|FG001|Overall Study|Withdrawal Criteria|5|||
129831373|NCT01365507|467349157|FG000|Overall Study|Unclassified|1|||
129831374|NCT01365507|467349158|FG001|Overall Study|Unclassified|4|||
129831375|NCT00192504|467349161|FG000|Overall Study|Lost to Follow-up|1|||
130060462|NCT02932332|468176661|FG001|Overall Study|Withdrawal by Subject|1|||
130060463|NCT02932332|468176662|FG002|Overall Study|Withdrawal by Subject|0|||
130060464|NCT02932332|468176663|FG003|Overall Study|Withdrawal by Subject|1|||
130060465|NCT02932332|468176660|FG000|Overall Study|Chest pain|0|||
130060466|NCT02932332|468176661|FG001|Overall Study|Chest pain|0|||
130060467|NCT02932332|468176662|FG002|Overall Study|Chest pain|0|||
130060468|NCT02932332|468176663|FG003|Overall Study|Chest pain|1|||
130060469|NCT02932332|468176660|FG000|Overall Study|Not Dyspneic cough|1|||
130060470|NCT02932332|468176661|FG001|Overall Study|Not Dyspneic cough|2|||
130060471|NCT02932332|468176662|FG002|Overall Study|Not Dyspneic cough|1|||
130060472|NCT02932332|468176663|FG003|Overall Study|Not Dyspneic cough|0|||
130060473|NCT02841787|468176664|FG000|Overall Study|Lost to Follow-up|1|||
130060474|NCT02841787|468176665|FG001|Overall Study|Lost to Follow-up|0|||
130060475|NCT02841787|468176666|FG002|Overall Study|Lost to Follow-up|0|||
130060476|NCT02841787|468176664|FG000|Overall Study|Symptoms dropped below threshold|1|||
130060477|NCT02841787|468176665|FG001|Overall Study|Symptoms dropped below threshold|0|||
130060478|NCT02841787|468176666|FG002|Overall Study|Symptoms dropped below threshold|0|||
130060479|NCT02841787|468176664|FG000|Overall Study|Withdrawal by Subject|1|||
130060480|NCT02841787|468176665|FG001|Overall Study|Withdrawal by Subject|4|||
130060481|NCT02841787|468176666|FG002|Overall Study|Withdrawal by Subject|0|||
130060482|NCT03029650|468176671|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
130060483|NCT03029650|468176672|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
130060484|NCT03029650|468176671|FG000|Washout (1 Week)|Physician Decision|0|||
130060485|NCT03029650|468176672|FG001|Washout (1 Week)|Physician Decision|1|||
130060486|NCT01875367|468176673|FG000|Overall Study|Not complete at least 2 questionaries|4|||
130060487|NCT01875367|468176674|FG001|Overall Study|Not complete at least 2 questionaries|2|||
130060488|NCT01875367|468176673|FG000|Overall Study|Not receive study treatment|1|||
130060489|NCT01875367|468176674|FG001|Overall Study|Not receive study treatment|0|||
130060490|NCT04533815|468176677|FG000|Overall Study|Adverse Event|2|||
130060491|NCT04533815|468176677|FG000|Overall Study|Site withdrew|5|||
130060492|NCT02951988|468176680|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
130060493|NCT02951988|468176681|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
129831376|NCT00192504|467349162|FG001|Overall Study|Lost to Follow-up|0|||
129831377|NCT00192504|467349163|FG002|Overall Study|Lost to Follow-up|0|||
129831378|NCT00192504|467349164|FG003|Overall Study|Lost to Follow-up|0|||
129831379|NCT00192504|467349161|FG000|Overall Study|Dosing window missed|0|||
129831380|NCT00192504|467349162|FG001|Overall Study|Dosing window missed|0|||
129831381|NCT00192504|467349163|FG002|Overall Study|Dosing window missed|1|||
129831382|NCT00192504|467349164|FG003|Overall Study|Dosing window missed|0|||
129831383|NCT01139450|467349165|FG000|Overall Study|Withdrawal by Subject|7|||
129831384|NCT01139450|467349166|FG001|Overall Study|Withdrawal by Subject|10|||
129831385|NCT01139450|467349167|FG002|Overall Study|Withdrawal by Subject|13|||
129831386|NCT01139450|467349165|FG000|Overall Study|Lack of Efficacy|3|||
129831387|NCT01139450|467349166|FG001|Overall Study|Lack of Efficacy|1|||
129831388|NCT01139450|467349167|FG002|Overall Study|Lack of Efficacy|8|||
129831389|NCT01139450|467349165|FG000|Overall Study|Protocol Violation|6|||
129831390|NCT01139450|467349166|FG001|Overall Study|Protocol Violation|5|||
129831391|NCT01139450|467349167|FG002|Overall Study|Protocol Violation|2|||
129831392|NCT01139450|467349165|FG000|Overall Study|Lost to Follow-up|9|||
129831393|NCT01139450|467349166|FG001|Overall Study|Lost to Follow-up|7|||
129831394|NCT01139450|467349167|FG002|Overall Study|Lost to Follow-up|11|||
129831395|NCT01139450|467349165|FG000|Overall Study|Administrative|0|||
129831396|NCT01139450|467349166|FG001|Overall Study|Administrative|0|||
129831397|NCT01139450|467349167|FG002|Overall Study|Administrative|1|||
130060494|NCT02951988|468176682|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
130060495|NCT02951988|468176683|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
130060496|NCT02951988|468176680|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
129831398|NCT01139450|467349165|FG000|Overall Study|Adverse Event|2|||
129831399|NCT01139450|467349166|FG001|Overall Study|Adverse Event|2|||
129831400|NCT01139450|467349167|FG002|Overall Study|Adverse Event|3|||
129831401|NCT05129488|467349176|FG000|Overall Study|Protocol Violation|3|||
130060497|NCT02951988|468176681|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
130060498|NCT02951988|468176682|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
129831402|NCT04782856|467349177|FG000|Overall Study|Withdrawal by Subject|0|||
129831403|NCT04782856|467349178|FG001|Overall Study|Withdrawal by Subject|1|||
129831404|NCT03020823|467349179|FG000|Overall Study|Physician Decision|4|||
129831405|NCT03020823|467349179|FG000|Overall Study|Lack of Efficacy|4|||
130060499|NCT02951988|468176683|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
130060500|NCT02951988|468176680|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
129831406|NCT03020823|467349179|FG000|Overall Study|Adverse Event|2|||
129831407|NCT03739112|467349180|FG000|Overall Study|Adverse Event|2|||
129831408|NCT03739112|467349181|FG001|Overall Study|Adverse Event|2|||
129831409|NCT03739112|467349180|FG000|Overall Study|Withdrawal by Subject|38|||
129831410|NCT03739112|467349181|FG001|Overall Study|Withdrawal by Subject|19|||
129831411|NCT03739112|467349180|FG000|Overall Study|Lost to Follow-up|31|||
129831412|NCT03739112|467349181|FG001|Overall Study|Lost to Follow-up|33|||
129831413|NCT03739112|467349180|FG000|Overall Study|Protocol Deviation|12|||
129831414|NCT03739112|467349181|FG001|Overall Study|Protocol Deviation|9|||
129831415|NCT03739112|467349180|FG000|Overall Study|Physician Decision|1|||
129831416|NCT03739112|467349181|FG001|Overall Study|Physician Decision|0|||
129831417|NCT03739112|467349180|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
129831418|NCT03739112|467349181|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
129831419|NCT03739112|467349180|FG000|Overall Study|Site went on hold|65|||
129831420|NCT03739112|467349181|FG001|Overall Study|Site went on hold|67|||
129831421|NCT03739112|467349180|FG000|Overall Study|Other than specified|8|||
129831422|NCT03739112|467349181|FG001|Overall Study|Other than specified|5|||
129831423|NCT03739112|467349180|FG000|Overall Study|Randomized but not vaccinated|31|||
129831424|NCT03739112|467349181|FG001|Overall Study|Randomized but not vaccinated|25|||
129831425|NCT04307446|467349182|FG000|Overall Study|Lost to Follow-up|2|||
129831426|NCT04307446|467349183|FG001|Overall Study|Lost to Follow-up|0|||
129831427|NCT01652664|467349186|FG000|Overall Study|Treatment Failure|5|||
129831428|NCT01652664|467349187|FG001|Overall Study|Treatment Failure|1|||
129831429|NCT01652664|467349186|FG000|Overall Study|Inadequate IOP control|1|||
129831430|NCT01652664|467349187|FG001|Overall Study|Inadequate IOP control|0|||
129831431|NCT00297037|467349188|FG000|Overall Study|Withdrawal by Subject|2|||
129831432|NCT00297037|467349189|FG001|Overall Study|Withdrawal by Subject|0|||
129831433|NCT00405587|467349192|FG000|Overall Study|Death|0|||
129831434|NCT00405587|467349193|FG001|Overall Study|Death|0|||
129831435|NCT00405587|467349194|FG002|Overall Study|Death|0|||
129831436|NCT00405587|467349195|FG003|Overall Study|Death|1|||
129831437|NCT00405587|467349192|FG000|Overall Study|Disease Progression|22|||
129831438|NCT00405587|467349193|FG001|Overall Study|Disease Progression|23|||
129831439|NCT00405587|467349194|FG002|Overall Study|Disease Progression|21|||
129831440|NCT00405587|467349195|FG003|Overall Study|Disease Progression|17|||
129831441|NCT00405587|467349192|FG000|Overall Study|Physician Decision|3|||
129831442|NCT00405587|467349193|FG001|Overall Study|Physician Decision|2|||
129831443|NCT00405587|467349194|FG002|Overall Study|Physician Decision|0|||
129831444|NCT00405587|467349195|FG003|Overall Study|Physician Decision|0|||
129831445|NCT00405587|467349192|FG000|Overall Study|Adverse Event|1|||
129831446|NCT00405587|467349193|FG001|Overall Study|Adverse Event|0|||
129831447|NCT00405587|467349194|FG002|Overall Study|Adverse Event|0|||
129831448|NCT00405587|467349195|FG003|Overall Study|Adverse Event|0|||
129831449|NCT00405587|467349192|FG000|Overall Study|Lost to Follow-up|0|||
129831450|NCT00405587|467349193|FG001|Overall Study|Lost to Follow-up|1|||
129831451|NCT00405587|467349194|FG002|Overall Study|Lost to Follow-up|1|||
129831452|NCT00405587|467349195|FG003|Overall Study|Lost to Follow-up|0|||
129831453|NCT00405587|467349192|FG000|Overall Study|Radiation induced necrosis|0|||
129831454|NCT00405587|467349193|FG001|Overall Study|Radiation induced necrosis|1|||
129831455|NCT00405587|467349194|FG002|Overall Study|Radiation induced necrosis|0|||
129831456|NCT00405587|467349195|FG003|Overall Study|Radiation induced necrosis|0|||
129831457|NCT00405587|467349192|FG000|Overall Study|Withdrawal by Subject|0|||
129831458|NCT00405587|467349193|FG001|Overall Study|Withdrawal by Subject|0|||
129831459|NCT00405587|467349194|FG002|Overall Study|Withdrawal by Subject|0|||
129831460|NCT00405587|467349195|FG003|Overall Study|Withdrawal by Subject|2|||
129831461|NCT00405587|467349192|FG000|Overall Study|Participant not dosed|0|||
129831462|NCT00405587|467349193|FG001|Overall Study|Participant not dosed|1|||
129831463|NCT00405587|467349194|FG002|Overall Study|Participant not dosed|0|||
129831464|NCT00405587|467349195|FG003|Overall Study|Participant not dosed|0|||
129831465|NCT06027866|467349196|FG000|Overall Study|Withdrawal by Subject|2|||
129831466|NCT00507442|467349199|FG000|Overall Study|Adverse Event|8|||
129831467|NCT00507442|467349200|FG001|Overall Study|Adverse Event|11|||
129831468|NCT00507442|467349201|FG002|Overall Study|Adverse Event|4|||
129831469|NCT00507442|467349202|FG003|Overall Study|Adverse Event|1|||
129831470|NCT00507442|467349199|FG000|Overall Study|Protocol Violation|0|||
129831471|NCT00507442|467349200|FG001|Overall Study|Protocol Violation|1|||
129831472|NCT00507442|467349201|FG002|Overall Study|Protocol Violation|0|||
129831473|NCT00507442|467349202|FG003|Overall Study|Protocol Violation|0|||
129831474|NCT00507442|467349199|FG000|Overall Study|Lost to Follow-up|0|||
129831475|NCT00507442|467349200|FG001|Overall Study|Lost to Follow-up|0|||
129831476|NCT00507442|467349201|FG002|Overall Study|Lost to Follow-up|1|||
129831477|NCT00507442|467349202|FG003|Overall Study|Lost to Follow-up|0|||
129831478|NCT00507442|467349199|FG000|Overall Study|Physician Decision|0|||
129831479|NCT00507442|467349200|FG001|Overall Study|Physician Decision|2|||
129831480|NCT00507442|467349201|FG002|Overall Study|Physician Decision|4|||
129831481|NCT00507442|467349202|FG003|Overall Study|Physician Decision|1|||
129831482|NCT00507442|467349199|FG000|Overall Study|Progressive Disease|2|||
129831483|NCT00507442|467349200|FG001|Overall Study|Progressive Disease|4|||
129831484|NCT00507442|467349201|FG002|Overall Study|Progressive Disease|2|||
129831485|NCT00507442|467349202|FG003|Overall Study|Progressive Disease|0|||
129831486|NCT00507442|467349199|FG000|Overall Study|Withdrawal by Subject|4|||
129831487|NCT00507442|467349200|FG001|Overall Study|Withdrawal by Subject|4|||
129831488|NCT00507442|467349201|FG002|Overall Study|Withdrawal by Subject|2|||
129831489|NCT00507442|467349202|FG003|Overall Study|Withdrawal by Subject|1|||
129831490|NCT00507442|467349199|FG000|Overall Study|Other|2|||
129831491|NCT00507442|467349200|FG001|Overall Study|Other|5|||
129831492|NCT00507442|467349201|FG002|Overall Study|Other|2|||
129831493|NCT00507442|467349202|FG003|Overall Study|Other|2|||
129831494|NCT00930579|467349203|FG000|Overall Study|Withdrawal by Subject|1|||
129831495|NCT00930579|467349203|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
129831496|NCT02672423|467349204|FG000|Period 1|Adverse Event|0|||
129831497|NCT02672423|467349205|FG001|Period 1|Adverse Event|0|||
129831498|NCT02672423|467349206|FG002|Period 1|Adverse Event|0|||
129831499|NCT02672423|467349207|FG003|Period 1|Adverse Event|0|||
129831500|NCT02672423|467349208|FG004|Period 1|Adverse Event|1|||
129831501|NCT02672423|467349209|FG005|Period 1|Adverse Event|0|||
129831502|NCT02672423|467349210|FG006|Period 1|Adverse Event|0|||
129831503|NCT02672423|467349211|FG007|Period 1|Adverse Event|0|||
129831504|NCT02672423|467349212|FG008|Period 1|Adverse Event|0|||
129831505|NCT02672423|467349213|FG009|Period 1|Adverse Event|0|||
129831506|NCT02672423|467349204|FG000|Period 2|Withdrawal by Subject|0|||
129831507|NCT02672423|467349205|FG001|Period 2|Withdrawal by Subject|0|||
129831508|NCT02672423|467349206|FG002|Period 2|Withdrawal by Subject|1|||
129831509|NCT02672423|467349207|FG003|Period 2|Withdrawal by Subject|0|||
129831510|NCT02672423|467349208|FG004|Period 2|Withdrawal by Subject|0|||
129831511|NCT02672423|467349209|FG005|Period 2|Withdrawal by Subject|0|||
129831512|NCT02672423|467349210|FG006|Period 2|Withdrawal by Subject|0|||
129831513|NCT02672423|467349211|FG007|Period 2|Withdrawal by Subject|0|||
129831514|NCT02672423|467349212|FG008|Period 2|Withdrawal by Subject|0|||
129831515|NCT02672423|467349213|FG009|Period 2|Withdrawal by Subject|0|||
129831516|NCT02672423|467349204|FG000|Period 3|Withdrawal by Subject|0|||
129831517|NCT02672423|467349205|FG001|Period 3|Withdrawal by Subject|0|||
129831518|NCT02672423|467349206|FG002|Period 3|Withdrawal by Subject|0|||
129831519|NCT02672423|467349207|FG003|Period 3|Withdrawal by Subject|0|||
129831520|NCT02672423|467349208|FG004|Period 3|Withdrawal by Subject|0|||
129831521|NCT02672423|467349209|FG005|Period 3|Withdrawal by Subject|0|||
129831522|NCT02672423|467349210|FG006|Period 3|Withdrawal by Subject|0|||
129831523|NCT02672423|467349211|FG007|Period 3|Withdrawal by Subject|1|||
129831524|NCT02672423|467349212|FG008|Period 3|Withdrawal by Subject|0|||
129831525|NCT02672423|467349213|FG009|Period 3|Withdrawal by Subject|0|||
129831526|NCT02672423|467349204|FG000|Period 3|Physician Decision|0|||
129831527|NCT02672423|467349205|FG001|Period 3|Physician Decision|0|||
129831528|NCT02672423|467349206|FG002|Period 3|Physician Decision|0|||
129831529|NCT02672423|467349207|FG003|Period 3|Physician Decision|0|||
129831530|NCT02672423|467349208|FG004|Period 3|Physician Decision|0|||
129831531|NCT02672423|467349209|FG005|Period 3|Physician Decision|1|||
129831532|NCT02672423|467349210|FG006|Period 3|Physician Decision|0|||
129831533|NCT02672423|467349211|FG007|Period 3|Physician Decision|0|||
129831534|NCT02672423|467349212|FG008|Period 3|Physician Decision|0|||
129831535|NCT02672423|467349213|FG009|Period 3|Physician Decision|0|||
129831536|NCT00536107|467349217|FG000|Overall Study|Death|5|||
129831537|NCT00536107|467349218|FG001|Overall Study|Death|1|||
129831538|NCT00536107|467349217|FG000|Overall Study|Incorrect enrolment|1|||
129831539|NCT00536107|467349218|FG001|Overall Study|Incorrect enrolment|0|||
129831540|NCT00536107|467349217|FG000|Overall Study|Withdrawal by Subject|0|||
129831541|NCT00536107|467349218|FG001|Overall Study|Withdrawal by Subject|1|||
129831542|NCT00536107|467349217|FG000|Overall Study|Study Termination|2|||
129831543|NCT00536107|467349218|FG001|Overall Study|Study Termination|4|||
129831544|NCT04829318|467349219|FG000|Overall Study|Adverse Event|6|||
129831545|NCT04829318|467349219|FG000|Overall Study|Death|1|||
129831546|NCT04829318|467349219|FG000|Overall Study|Lost to Follow-up|1|||
129831547|NCT04829318|467349219|FG000|Overall Study|Physician Decision|1|||
129831548|NCT04829318|467349219|FG000|Overall Study|Withdrawal by Subject|19|||
129831549|NCT04829318|467349219|FG000|Overall Study|Site terminated by sponsor|1|||
129831550|NCT04829318|467349219|FG000|Overall Study|Sponsor decision|5|||
129831551|NCT04829318|467349219|FG000|Overall Study|Other|1|||
129831552|NCT01265849|467349225|FG000|Overall Study|Randomized//Treatment not initiated|1|||
129831553|NCT01265849|467349226|FG001|Overall Study|Randomized//Treatment not initiated|4|||
129831554|NCT01265849|467349227|FG002|Overall Study|Randomized//Treatment not initiated|0|||
129831555|NCT01265849|467349225|FG000|Overall Study|Physician Decision|1|||
129831556|NCT01265849|467349226|FG001|Overall Study|Physician Decision|2|||
129897699|NCT00517933|467584424|FG001|Period 2|Withdrawal by Subject|3|||
129897700|NCT00517933|467584423|FG000|Period 2|Underwent lung transplant|0|||
129831557|NCT01265849|467349227|FG002|Overall Study|Physician Decision|0|||
129831558|NCT01265849|467349225|FG000|Overall Study|Lost to Follow-up|18|||
129831559|NCT01265849|467349226|FG001|Overall Study|Lost to Follow-up|15|||
129831560|NCT01265849|467349227|FG002|Overall Study|Lost to Follow-up|5|||
129831561|NCT01265849|467349225|FG000|Overall Study|Not otherwise specified|1|||
129897701|NCT00517933|467584424|FG001|Period 2|Underwent lung transplant|2|||
129831562|NCT01265849|467349226|FG001|Overall Study|Not otherwise specified|6|||
129831563|NCT01265849|467349227|FG002|Overall Study|Not otherwise specified|1|||
129831564|NCT01265849|467349225|FG000|Overall Study|Withdrawal by Subject|25|||
129831565|NCT01265849|467349226|FG001|Overall Study|Withdrawal by Subject|34|||
129831566|NCT01265849|467349227|FG002|Overall Study|Withdrawal by Subject|13|||
129831567|NCT03194321|467349229|FG000|Overall Study|Withdrawal by Subject|1|||
129831568|NCT03194321|467349229|FG000|Overall Study|Lost to Follow-up|1|||
129831569|NCT03194321|467349229|FG000|Overall Study|Travel for Follow-up|1|||
129831570|NCT03803774|467349230|FG000|Dose Escalation|Withdrawal by Subject|0|||
129831571|NCT03803774|467349231|FG001|Dose Escalation|Withdrawal by Subject|0|||
129831572|NCT03803774|467349232|FG002|Dose Escalation|Withdrawal by Subject|0|||
129831573|NCT03803774|467349233|FG003|Dose Escalation|Withdrawal by Subject|1|||
129831574|NCT03803774|467349234|FG004|Dose Escalation|Withdrawal by Subject|0|||
129831575|NCT00003641|467349236|FG000|Overall Study|Withdrawal by Subject|0|||
129831576|NCT00003641|467349237|FG001|Overall Study|Withdrawal by Subject|100|||
129831577|NCT00003641|467349236|FG000|Overall Study|Adverse Event|0|||
129831578|NCT00003641|467349237|FG001|Overall Study|Adverse Event|38|||
129831579|NCT00003641|467349236|FG000|Overall Study|Disease progression|0|||
130060501|NCT02951988|468176681|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
130060502|NCT02951988|468176682|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
130060503|NCT02951988|468176683|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
130060504|NCT02951988|468176680|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
130060505|NCT02951988|468176681|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
130060506|NCT02951988|468176682|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
130060507|NCT02951988|468176683|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
130060508|NCT02951988|468176680|FG000|Open-Label Treatment Period|Protocol Violation|22|||
130060509|NCT02951988|468176681|FG001|Open-Label Treatment Period|Protocol Violation|0|||
130060510|NCT02951988|468176682|FG002|Open-Label Treatment Period|Protocol Violation|0|||
130060511|NCT02951988|468176683|FG003|Open-Label Treatment Period|Protocol Violation|0|||
130060512|NCT02951988|468176680|FG000|Open-Label Treatment Period|Pregnancy|2|||
130060513|NCT02951988|468176681|FG001|Open-Label Treatment Period|Pregnancy|0|||
130060514|NCT02951988|468176682|FG002|Open-Label Treatment Period|Pregnancy|0|||
130060515|NCT02951988|468176683|FG003|Open-Label Treatment Period|Pregnancy|0|||
130060516|NCT02951988|468176680|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
130060517|NCT02951988|468176681|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
130060518|NCT02951988|468176682|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
130060519|NCT02951988|468176683|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
130060520|NCT02951988|468176680|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
130060521|NCT02951988|468176681|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
130060522|NCT02951988|468176682|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
130060523|NCT02951988|468176683|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
130060524|NCT02951988|468176680|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
130060525|NCT02951988|468176681|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130060526|NCT02951988|468176682|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
130060527|NCT02951988|468176683|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
130060528|NCT02951988|468176680|FG000|Open-Label Treatment Period|Adverse Event|45|||
130060529|NCT02951988|468176681|FG001|Open-Label Treatment Period|Adverse Event|0|||
130060530|NCT02951988|468176682|FG002|Open-Label Treatment Period|Adverse Event|0|||
130060531|NCT02951988|468176683|FG003|Open-Label Treatment Period|Adverse Event|0|||
130060532|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
130060533|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
130060534|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
130060535|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
130060536|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
129831580|NCT00003641|467349237|FG001|Overall Study|Disease progression|2|||
129831581|NCT00003641|467349236|FG000|Overall Study|Unknown/missing|0|||
129831582|NCT00003641|467349237|FG001|Overall Study|Unknown/missing|22|||
129831583|NCT00003641|467349236|FG000|Overall Study|Should not receive interferon therapy|2|||
129831584|NCT00003641|467349237|FG001|Overall Study|Should not receive interferon therapy|0|||
129831585|NCT00003641|467349236|FG000|Overall Study|Never started interferon|567|||
129831586|NCT00003641|467349237|FG001|Overall Study|Never started interferon|12|||
129831587|NCT02154581|467349239|FG000|Overall Study|Lost to Follow-up|7|||
129831588|NCT02154581|467349240|FG001|Overall Study|Lost to Follow-up|8|||
129831589|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
129831590|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
130060537|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
130060538|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
130060539|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
129831591|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
130060540|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
130060541|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
130060542|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
130060543|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
129831592|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
129831593|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
129897702|NCT00121199|467584426|FG000|Overall Study|Adverse Event|11|||
129831594|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
129831595|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
129831596|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
129831597|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
129831598|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
129831599|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
129831600|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
129831601|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Other|1|||
129831602|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Other|3|||
129831603|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Other|9|||
129831604|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
129831605|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
129831606|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
129831607|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
129831608|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
129831609|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
129831610|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
129831611|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
129831612|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
129831613|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
129831614|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
129831615|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
129831616|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
129831617|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
129831618|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
129831619|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
129831620|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
129831621|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
129831622|NCT03886220|467349244|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
129831623|NCT03886220|467349245|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
129831624|NCT03886220|467349244|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
129831625|NCT03886220|467349245|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129831626|NCT03886220|467349244|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
129831627|NCT03886220|467349245|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129831628|NCT03615105|467349248|FG000|Overall Study|Protocol Violation|1|||
129831629|NCT03615105|467349249|FG001|Overall Study|Protocol Violation|0|||
129831630|NCT03615105|467349250|FG002|Overall Study|Protocol Violation|0|||
129831631|NCT03615105|467349248|FG000|Overall Study|Death|0|||
129831632|NCT03615105|467349249|FG001|Overall Study|Death|2|||
129831633|NCT03615105|467349250|FG002|Overall Study|Death|0|||
129831634|NCT03482791|467349251|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
129831635|NCT03482791|467349252|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
129831636|NCT01344161|467349254|FG000|Overall Study|Lost to Follow-up|4|||
129831637|NCT01344161|467349255|FG001|Overall Study|Lost to Follow-up|1|||
129831638|NCT01344161|467349254|FG000|Overall Study|Pregnancy|0|||
129831639|NCT01344161|467349255|FG001|Overall Study|Pregnancy|1|||
129831640|NCT01344161|467349254|FG000|Overall Study|Protocol Violation|1|||
129831641|NCT01344161|467349255|FG001|Overall Study|Protocol Violation|1|||
129831642|NCT03759379|467352097|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
129831643|NCT03759379|467352098|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
129831644|NCT03759379|467352097|FG000|Treatment Period|Death|2|||
129831645|NCT03759379|467352098|FG001|Treatment Period|Death|3|||
129831646|NCT03759379|467352097|FG000|Treatment Period|Lost to Follow-up|1|||
129831647|NCT03759379|467352098|FG001|Treatment Period|Lost to Follow-up|0|||
129831648|NCT03759379|467352097|FG000|Treatment Period|Physician Decision|0|||
129831649|NCT03759379|467352098|FG001|Treatment Period|Physician Decision|1|||
129831650|NCT04579380|467352100|FG000|Overall Study|Death|9|||
129831651|NCT04579380|467352101|FG001|Overall Study|Death|22|||
129831652|NCT04579380|467352102|FG002|Overall Study|Death|22|||
129831653|NCT04579380|467352103|FG003|Overall Study|Death|17|||
129831654|NCT04579380|467352104|FG004|Overall Study|Death|6|||
129831655|NCT04579380|467352105|FG005|Overall Study|Death|21|||
129831656|NCT04579380|467352106|FG006|Overall Study|Death|10|||
129831657|NCT04579380|467352107|FG007|Overall Study|Death|11|||
129831658|NCT04579380|467352108|FG008|Overall Study|Death|25|||
129831659|NCT04579380|467352100|FG000|Overall Study|Withdrawal by Subject|0|||
129831660|NCT04579380|467352101|FG001|Overall Study|Withdrawal by Subject|3|||
129831661|NCT04579380|467352102|FG002|Overall Study|Withdrawal by Subject|4|||
129831662|NCT04579380|467352103|FG003|Overall Study|Withdrawal by Subject|0|||
129831663|NCT04579380|467352104|FG004|Overall Study|Withdrawal by Subject|1|||
129831664|NCT04579380|467352105|FG005|Overall Study|Withdrawal by Subject|2|||
129831665|NCT04579380|467352106|FG006|Overall Study|Withdrawal by Subject|0|||
129831666|NCT04579380|467352107|FG007|Overall Study|Withdrawal by Subject|1|||
129831667|NCT04579380|467352108|FG008|Overall Study|Withdrawal by Subject|2|||
129831668|NCT04579380|467352100|FG000|Overall Study|Ongoing|2|||
129831669|NCT04579380|467352101|FG001|Overall Study|Ongoing|6|||
129831670|NCT04579380|467352102|FG002|Overall Study|Ongoing|4|||
129831671|NCT04579380|467352103|FG003|Overall Study|Ongoing|8|||
129831672|NCT04579380|467352104|FG004|Overall Study|Ongoing|5|||
129831673|NCT04579380|467352105|FG005|Overall Study|Ongoing|8|||
129831674|NCT04579380|467352106|FG006|Overall Study|Ongoing|3|||
129831675|NCT04579380|467352107|FG007|Overall Study|Ongoing|19|||
129831676|NCT04579380|467352108|FG008|Overall Study|Ongoing|6|||
129831677|NCT02967692|467352109|FG000|Overall Study|Progressive disease|3|||
129831678|NCT02967692|467352110|FG001|Overall Study|Progressive disease|15|||
129831679|NCT02967692|467352111|FG002|Overall Study|Progressive disease|114|||
129831680|NCT02967692|467352112|FG003|Overall Study|Progressive disease|151|||
129831681|NCT02967692|467352109|FG000|Overall Study|Subject/guardian decision|1|||
129831682|NCT02967692|467352110|FG001|Overall Study|Subject/guardian decision|1|||
129831683|NCT02967692|467352111|FG002|Overall Study|Subject/guardian decision|14|||
129831684|NCT02967692|467352112|FG003|Overall Study|Subject/guardian decision|22|||
129831685|NCT02967692|467352109|FG000|Overall Study|Death|0|||
129831686|NCT02967692|467352110|FG001|Overall Study|Death|1|||
129831687|NCT02967692|467352111|FG002|Overall Study|Death|13|||
129831688|NCT02967692|467352112|FG003|Overall Study|Death|13|||
129831689|NCT02967692|467352109|FG000|Overall Study|Protocol deviation|1|||
129831690|NCT02967692|467352110|FG001|Overall Study|Protocol deviation|0|||
129831691|NCT02967692|467352111|FG002|Overall Study|Protocol deviation|1|||
129831692|NCT02967692|467352112|FG003|Overall Study|Protocol deviation|1|||
129831693|NCT02967692|467352109|FG000|Overall Study|Lost to Follow-up|0|||
129831694|NCT02967692|467352110|FG001|Overall Study|Lost to Follow-up|0|||
129831695|NCT02967692|467352111|FG002|Overall Study|Lost to Follow-up|1|||
129831696|NCT02967692|467352112|FG003|Overall Study|Lost to Follow-up|0|||
129831697|NCT02967692|467352109|FG000|Overall Study|Physician Decision|0|||
129831698|NCT02967692|467352110|FG001|Overall Study|Physician Decision|0|||
129831699|NCT02967692|467352111|FG002|Overall Study|Physician Decision|22|||
129831700|NCT02967692|467352112|FG003|Overall Study|Physician Decision|13|||
129831701|NCT02967692|467352109|FG000|Overall Study|Adverse Event|2|||
129831702|NCT02967692|467352110|FG001|Overall Study|Adverse Event|9|||
129831703|NCT02967692|467352111|FG002|Overall Study|Adverse Event|60|||
129831704|NCT02967692|467352112|FG003|Overall Study|Adverse Event|28|||
129831705|NCT02967692|467352109|FG000|Overall Study|Study terminated by sponsor|2|||
129831706|NCT02967692|467352110|FG001|Overall Study|Study terminated by sponsor|1|||
129831707|NCT02967692|467352111|FG002|Overall Study|Study terminated by sponsor|42|||
129831708|NCT02967692|467352112|FG003|Overall Study|Study terminated by sponsor|37|||
129831709|NCT01536379|467352113|FG000|Overall Study|Adverse Event|1|||
129831710|NCT01536379|467352114|FG001|Overall Study|Adverse Event|2|||
129831711|NCT01536379|467352113|FG000|Overall Study|Withdrawal by Subject|1|||
129831712|NCT01536379|467352114|FG001|Overall Study|Withdrawal by Subject|1|||
129831713|NCT00939809|467352120|FG000|Overall Study|Adverse Event|2|||
129831714|NCT00939809|467352120|FG000|Overall Study|Death|1|||
129831715|NCT04447417|467352121|FG000|Overall Study|Withdrawal by Subject|1|||
129831716|NCT04447417|467352122|FG001|Overall Study|Withdrawal by Subject|0|||
129831717|NCT04447417|467352121|FG000|Overall Study|Failure to meet inclusion criteria|1|||
129831718|NCT04447417|467352122|FG001|Overall Study|Failure to meet inclusion criteria|0|||
129831719|NCT04447417|467352121|FG000|Overall Study|Lost to Follow-up|1|||
129831720|NCT04447417|467352122|FG001|Overall Study|Lost to Follow-up|0|||
129831721|NCT00066066|467352123|FG000|Overall Study|Lost to Follow-up|6|||
129831722|NCT00066066|467352124|FG001|Overall Study|Lost to Follow-up|4|||
129831723|NCT00066066|467352125|FG002|Overall Study|Lost to Follow-up|7|||
129831724|NCT00066066|467352126|FG003|Overall Study|Lost to Follow-up|4|||
129831725|NCT00066066|467352127|FG004|Overall Study|Lost to Follow-up|3|||
129831726|NCT00066066|467352128|FG005|Overall Study|Lost to Follow-up|5|||
129831727|NCT02268409|467352129|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
129831728|NCT02268409|467352129|FG000|Overall Study|Death|1|||
129831729|NCT02268409|467352129|FG000|Overall Study|Lost to Follow-up|1|||
129831730|NCT02268409|467352129|FG000|Overall Study|Protocol Violation|3|||
129831731|NCT02268409|467352129|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
129831732|NCT02268409|467352129|FG000|Overall Study|Withdrawal by Subject|5|||
129831733|NCT00156533|467352133|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
129831734|NCT00156533|467352134|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
129831735|NCT00156533|467352135|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
129831736|NCT00156533|467352136|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
129831737|NCT00156533|467352133|FG000|Overall Study|Withdrawal by Subject|1|||
129831738|NCT00156533|467352134|FG001|Overall Study|Withdrawal by Subject|0|||
129831739|NCT00156533|467352135|FG002|Overall Study|Withdrawal by Subject|0|||
129831740|NCT00156533|467352136|FG003|Overall Study|Withdrawal by Subject|1|||
129831741|NCT00156533|467352133|FG000|Overall Study|Failed Screening|1|||
129831742|NCT00156533|467352134|FG001|Overall Study|Failed Screening|0|||
129831743|NCT00156533|467352135|FG002|Overall Study|Failed Screening|1|||
129831744|NCT00156533|467352136|FG003|Overall Study|Failed Screening|1|||
129831745|NCT02608268|467352137|FG000|Overall Study|Adverse Event|0|||
129831746|NCT02608268|467352138|FG001|Overall Study|Adverse Event|0|||
129831747|NCT02608268|467352139|FG002|Overall Study|Adverse Event|1|||
129831748|NCT02608268|467352140|FG003|Overall Study|Adverse Event|0|||
129831749|NCT02608268|467352141|FG004|Overall Study|Adverse Event|0|||
129831750|NCT02608268|467352142|FG005|Overall Study|Adverse Event|0|||
129831751|NCT02608268|467352143|FG006|Overall Study|Adverse Event|0|||
129831752|NCT02608268|467352144|FG007|Overall Study|Adverse Event|0|||
129831753|NCT02608268|467352145|FG008|Overall Study|Adverse Event|0|||
129831754|NCT02608268|467352146|FG009|Overall Study|Adverse Event|0|||
129831755|NCT02608268|467352147|FG010|Overall Study|Adverse Event|0|||
129831756|NCT02608268|467352148|FG011|Overall Study|Adverse Event|0|||
129831757|NCT02608268|467352149|FG012|Overall Study|Adverse Event|2|||
129831758|NCT02608268|467352150|FG013|Overall Study|Adverse Event|0|||
129831759|NCT02608268|467352151|FG014|Overall Study|Adverse Event|0|||
129831760|NCT02608268|467352152|FG015|Overall Study|Adverse Event|0|||
129831761|NCT02608268|467352153|FG016|Overall Study|Adverse Event|0|||
129831762|NCT02608268|467352154|FG017|Overall Study|Adverse Event|0|||
129831763|NCT02608268|467352155|FG018|Overall Study|Adverse Event|0|||
129831764|NCT02608268|467352156|FG019|Overall Study|Adverse Event|0|||
129831765|NCT02608268|467352157|FG020|Overall Study|Adverse Event|1|||
129831766|NCT02608268|467352158|FG021|Overall Study|Adverse Event|1|||
129831767|NCT02608268|467352159|FG022|Overall Study|Adverse Event|0|||
129831768|NCT02608268|467352160|FG023|Overall Study|Adverse Event|0|||
129831769|NCT02608268|467352161|FG024|Overall Study|Adverse Event|1|||
129831770|NCT02608268|467352162|FG025|Overall Study|Adverse Event|0|||
129831771|NCT02608268|467352163|FG026|Overall Study|Adverse Event|0|||
129831772|NCT02608268|467352164|FG027|Overall Study|Adverse Event|0|||
129831773|NCT02608268|467352165|FG028|Overall Study|Adverse Event|1|||
129831774|NCT02608268|467352166|FG029|Overall Study|Adverse Event|0|||
129897703|NCT00121199|467584426|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129897704|NCT00121199|467584426|FG000|Overall Study|Progression/Relapse|1|||
129831775|NCT02608268|467352137|FG000|Overall Study|Death|1|||
129831776|NCT02608268|467352138|FG001|Overall Study|Death|0|||
129831777|NCT02608268|467352139|FG002|Overall Study|Death|0|||
129831778|NCT02608268|467352140|FG003|Overall Study|Death|0|||
129831779|NCT02608268|467352141|FG004|Overall Study|Death|0|||
129831780|NCT02608268|467352142|FG005|Overall Study|Death|0|||
129831781|NCT02608268|467352143|FG006|Overall Study|Death|0|||
129831782|NCT02608268|467352144|FG007|Overall Study|Death|0|||
129831783|NCT02608268|467352145|FG008|Overall Study|Death|1|||
129831784|NCT02608268|467352146|FG009|Overall Study|Death|1|||
129831785|NCT02608268|467352147|FG010|Overall Study|Death|0|||
129831786|NCT02608268|467352148|FG011|Overall Study|Death|0|||
129831787|NCT02608268|467352149|FG012|Overall Study|Death|0|||
129831788|NCT02608268|467352150|FG013|Overall Study|Death|0|||
129831789|NCT02608268|467352151|FG014|Overall Study|Death|0|||
129831790|NCT02608268|467352152|FG015|Overall Study|Death|1|||
130060544|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
130060545|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
130060546|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
130060547|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
130060548|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Pregnancy|0|||
130060549|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Pregnancy|1|||
129831791|NCT02608268|467352153|FG016|Overall Study|Death|0|||
129831792|NCT02608268|467352154|FG017|Overall Study|Death|1|||
129831793|NCT02608268|467352155|FG018|Overall Study|Death|0|||
129831794|NCT02608268|467352156|FG019|Overall Study|Death|1|||
129831795|NCT02608268|467352157|FG020|Overall Study|Death|1|||
129831796|NCT02608268|467352158|FG021|Overall Study|Death|0|||
129897705|NCT00121199|467584426|FG000|Overall Study|Death|3|||
129897706|NCT00121199|467584426|FG000|Overall Study|Other - Not Protocol Specified|3|||
130060550|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Pregnancy|1|||
130060551|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Pregnancy|0|||
130060552|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129831797|NCT02608268|467352159|FG022|Overall Study|Death|0|||
129831798|NCT02608268|467352160|FG023|Overall Study|Death|0|||
129831799|NCT02608268|467352161|FG024|Overall Study|Death|1|||
129831800|NCT02608268|467352162|FG025|Overall Study|Death|2|||
129831801|NCT02608268|467352163|FG026|Overall Study|Death|0|||
129831802|NCT02608268|467352164|FG027|Overall Study|Death|1|||
129831803|NCT02608268|467352165|FG028|Overall Study|Death|4|||
129831804|NCT02608268|467352166|FG029|Overall Study|Death|0|||
129831805|NCT02608268|467352137|FG000|Overall Study|Physician Decision|0|||
129831806|NCT02608268|467352138|FG001|Overall Study|Physician Decision|0|||
129831807|NCT02608268|467352139|FG002|Overall Study|Physician Decision|0|||
129831808|NCT02608268|467352140|FG003|Overall Study|Physician Decision|0|||
129831809|NCT02608268|467352141|FG004|Overall Study|Physician Decision|0|||
129831810|NCT02608268|467352142|FG005|Overall Study|Physician Decision|0|||
129831811|NCT02608268|467352143|FG006|Overall Study|Physician Decision|0|||
129831812|NCT02608268|467352144|FG007|Overall Study|Physician Decision|0|||
129831813|NCT02608268|467352145|FG008|Overall Study|Physician Decision|0|||
129831814|NCT02608268|467352146|FG009|Overall Study|Physician Decision|0|||
129831815|NCT02608268|467352147|FG010|Overall Study|Physician Decision|1|||
129831816|NCT02608268|467352148|FG011|Overall Study|Physician Decision|0|||
129831817|NCT02608268|467352149|FG012|Overall Study|Physician Decision|0|||
129831818|NCT02608268|467352150|FG013|Overall Study|Physician Decision|1|||
129831819|NCT02608268|467352151|FG014|Overall Study|Physician Decision|0|||
129831820|NCT02608268|467352152|FG015|Overall Study|Physician Decision|0|||
129831821|NCT02608268|467352153|FG016|Overall Study|Physician Decision|0|||
129831822|NCT02608268|467352154|FG017|Overall Study|Physician Decision|0|||
129831823|NCT02608268|467352155|FG018|Overall Study|Physician Decision|0|||
130060553|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
130060554|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
129831824|NCT02608268|467352156|FG019|Overall Study|Physician Decision|0|||
129831825|NCT02608268|467352157|FG020|Overall Study|Physician Decision|0|||
129831826|NCT02608268|467352158|FG021|Overall Study|Physician Decision|0|||
129831827|NCT02608268|467352159|FG022|Overall Study|Physician Decision|1|||
129831828|NCT02608268|467352160|FG023|Overall Study|Physician Decision|1|||
129831829|NCT02608268|467352161|FG024|Overall Study|Physician Decision|1|||
129831830|NCT02608268|467352162|FG025|Overall Study|Physician Decision|0|||
129831831|NCT02608268|467352163|FG026|Overall Study|Physician Decision|0|||
129831832|NCT02608268|467352164|FG027|Overall Study|Physician Decision|2|||
129831833|NCT02608268|467352165|FG028|Overall Study|Physician Decision|1|||
129831834|NCT02608268|467352166|FG029|Overall Study|Physician Decision|1|||
129831835|NCT02608268|467352137|FG000|Overall Study|Progressive disease|12|||
129831836|NCT02608268|467352138|FG001|Overall Study|Progressive disease|8|||
129831837|NCT02608268|467352139|FG002|Overall Study|Progressive disease|13|||
129831838|NCT02608268|467352140|FG003|Overall Study|Progressive disease|5|||
129831839|NCT02608268|467352141|FG004|Overall Study|Progressive disease|2|||
129831840|NCT02608268|467352142|FG005|Overall Study|Progressive disease|4|||
129831841|NCT02608268|467352143|FG006|Overall Study|Progressive disease|6|||
129831842|NCT02608268|467352144|FG007|Overall Study|Progressive disease|2|||
129831843|NCT02608268|467352145|FG008|Overall Study|Progressive disease|5|||
129831844|NCT02608268|467352146|FG009|Overall Study|Progressive disease|6|||
129831845|NCT02608268|467352147|FG010|Overall Study|Progressive disease|5|||
129831846|NCT02608268|467352148|FG011|Overall Study|Progressive disease|5|||
129831847|NCT02608268|467352149|FG012|Overall Study|Progressive disease|4|||
129831848|NCT02608268|467352150|FG013|Overall Study|Progressive disease|11|||
129831849|NCT02608268|467352151|FG014|Overall Study|Progressive disease|6|||
129831850|NCT02608268|467352152|FG015|Overall Study|Progressive disease|3|||
129831851|NCT02608268|467352153|FG016|Overall Study|Progressive disease|5|||
129831852|NCT02608268|467352154|FG017|Overall Study|Progressive disease|5|||
129831853|NCT02608268|467352155|FG018|Overall Study|Progressive disease|5|||
129831854|NCT02608268|467352156|FG019|Overall Study|Progressive disease|2|||
129831855|NCT02608268|467352157|FG020|Overall Study|Progressive disease|10|||
129831856|NCT02608268|467352158|FG021|Overall Study|Progressive disease|4|||
129831857|NCT02608268|467352159|FG022|Overall Study|Progressive disease|5|||
129831858|NCT02608268|467352160|FG023|Overall Study|Progressive disease|5|||
129831859|NCT02608268|467352161|FG024|Overall Study|Progressive disease|3|||
129831860|NCT02608268|467352162|FG025|Overall Study|Progressive disease|11|||
129831861|NCT02608268|467352163|FG026|Overall Study|Progressive disease|16|||
129831862|NCT02608268|467352164|FG027|Overall Study|Progressive disease|11|||
129831863|NCT02608268|467352165|FG028|Overall Study|Progressive disease|10|||
129831864|NCT02608268|467352166|FG029|Overall Study|Progressive disease|15|||
129831865|NCT02608268|467352137|FG000|Overall Study|Subject/guardian decision|1|||
129831866|NCT02608268|467352138|FG001|Overall Study|Subject/guardian decision|1|||
129831867|NCT02608268|467352139|FG002|Overall Study|Subject/guardian decision|2|||
129831868|NCT02608268|467352140|FG003|Overall Study|Subject/guardian decision|0|||
129831869|NCT02608268|467352141|FG004|Overall Study|Subject/guardian decision|0|||
129831870|NCT02608268|467352142|FG005|Overall Study|Subject/guardian decision|0|||
129831871|NCT02608268|467352143|FG006|Overall Study|Subject/guardian decision|0|||
129831872|NCT02608268|467352144|FG007|Overall Study|Subject/guardian decision|0|||
129831873|NCT02608268|467352145|FG008|Overall Study|Subject/guardian decision|2|||
129831874|NCT02608268|467352146|FG009|Overall Study|Subject/guardian decision|2|||
129831875|NCT02608268|467352147|FG010|Overall Study|Subject/guardian decision|0|||
129831876|NCT02608268|467352148|FG011|Overall Study|Subject/guardian decision|1|||
129831877|NCT02608268|467352149|FG012|Overall Study|Subject/guardian decision|0|||
129831878|NCT02608268|467352150|FG013|Overall Study|Subject/guardian decision|1|||
129831879|NCT02608268|467352151|FG014|Overall Study|Subject/guardian decision|0|||
129831880|NCT02608268|467352152|FG015|Overall Study|Subject/guardian decision|1|||
130060555|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
129831881|NCT02608268|467352153|FG016|Overall Study|Subject/guardian decision|0|||
129831882|NCT02608268|467352154|FG017|Overall Study|Subject/guardian decision|0|||
129831883|NCT02608268|467352155|FG018|Overall Study|Subject/guardian decision|1|||
129831884|NCT02608268|467352156|FG019|Overall Study|Subject/guardian decision|0|||
129831885|NCT02608268|467352157|FG020|Overall Study|Subject/guardian decision|0|||
129831886|NCT02608268|467352158|FG021|Overall Study|Subject/guardian decision|0|||
129831887|NCT02608268|467352159|FG022|Overall Study|Subject/guardian decision|1|||
129831888|NCT02608268|467352160|FG023|Overall Study|Subject/guardian decision|0|||
129831889|NCT02608268|467352161|FG024|Overall Study|Subject/guardian decision|0|||
129831890|NCT02608268|467352162|FG025|Overall Study|Subject/guardian decision|1|||
129831891|NCT02608268|467352163|FG026|Overall Study|Subject/guardian decision|1|||
129831892|NCT02608268|467352164|FG027|Overall Study|Subject/guardian decision|1|||
129831893|NCT02608268|467352165|FG028|Overall Study|Subject/guardian decision|1|||
129831894|NCT02608268|467352166|FG029|Overall Study|Subject/guardian decision|0|||
129831895|NCT03873987|467352167|FG000|Overall Study|Adverse Event|1|||
129831896|NCT03873987|467352168|FG001|Overall Study|Adverse Event|0|||
129831897|NCT03873987|467352167|FG000|Overall Study|staff was unable to start a new IV line|1|||
129831898|NCT03873987|467352168|FG001|Overall Study|staff was unable to start a new IV line|0|||
129831899|NCT03873987|467352167|FG000|Overall Study|Lost to Follow-up|0|||
129831900|NCT03873987|467352168|FG001|Overall Study|Lost to Follow-up|1|||
129831901|NCT02520011|467352170|FG000|Overall Study|Adverse Event|0|||
129831902|NCT02520011|467352171|FG001|Overall Study|Adverse Event|1|||
129831903|NCT02520011|467352172|FG002|Overall Study|Adverse Event|2|||
129831904|NCT02520011|467352170|FG000|Overall Study|Death|0|||
129831905|NCT02520011|467352171|FG001|Overall Study|Death|8|||
129831906|NCT02520011|467352172|FG002|Overall Study|Death|1|||
129831907|NCT02520011|467352170|FG000|Overall Study|Lack of Efficacy|4|||
129831908|NCT02520011|467352171|FG001|Overall Study|Lack of Efficacy|26|||
129831909|NCT02520011|467352172|FG002|Overall Study|Lack of Efficacy|4|||
129831910|NCT02520011|467352170|FG000|Overall Study|Physician Decision|0|||
129831911|NCT02520011|467352171|FG001|Overall Study|Physician Decision|2|||
129831912|NCT02520011|467352172|FG002|Overall Study|Physician Decision|0|||
129831913|NCT02520011|467352170|FG000|Overall Study|Withdrawal by Subject|1|||
129831914|NCT02520011|467352171|FG001|Overall Study|Withdrawal by Subject|3|||
129831915|NCT02520011|467352172|FG002|Overall Study|Withdrawal by Subject|0|||
129831916|NCT02520011|467352170|FG000|Overall Study|Protocol Deviation|0|||
129831917|NCT02520011|467352171|FG001|Overall Study|Protocol Deviation|1|||
129831918|NCT02520011|467352172|FG002|Overall Study|Protocol Deviation|0|||
129831919|NCT02520011|467352170|FG000|Overall Study|Patient went to hospice|0|||
129831920|NCT02520011|467352171|FG001|Overall Study|Patient went to hospice|1|||
129831921|NCT02520011|467352172|FG002|Overall Study|Patient went to hospice|0|||
129831922|NCT02520011|467352170|FG000|Overall Study|Progressive disease following response|0|||
129831923|NCT02520011|467352171|FG001|Overall Study|Progressive disease following response|4|||
129831924|NCT02520011|467352172|FG002|Overall Study|Progressive disease following response|2|||
129831925|NCT01063764|467352173|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
129831926|NCT01063764|467352173|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
129831927|NCT01063764|467352173|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
129831928|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
129831929|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
129831930|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
129831931|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
129831932|NCT00697515|467352174|FG000|Dose Optimization Period|Adverse Event|4|||
129831933|NCT00697515|467352175|FG001|Dose Optimization Period|Adverse Event|0|||
129831934|NCT00697515|467352174|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
129831935|NCT00697515|467352175|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
129831936|NCT00697515|467352174|FG000|Dose Optimization Period|Lost to Follow-up|2|||
129831937|NCT00697515|467352175|FG001|Dose Optimization Period|Lost to Follow-up|0|||
129831938|NCT00697515|467352174|FG000|Dose Optimization Period|sponsor request|2|||
129831939|NCT00697515|467352175|FG001|Dose Optimization Period|sponsor request|0|||
129831940|NCT00697515|467352174|FG000|Dose Optimization Period|called to active duty|1|||
129831941|NCT00697515|467352175|FG001|Dose Optimization Period|called to active duty|0|||
129831942|NCT00697515|467352174|FG000|Dose Optimization Period|elevated QTc|1|||
129897707|NCT00121199|467584426|FG000|Overall Study|Ineligible|9|||
129897708|NCT04109118|467584427|FG000|Overall Study|Lost to Follow-up|3|||
129897709|NCT03235349|467584430|FG000|Overall Study|Adverse Event|1|||
129897710|NCT03235349|467584430|FG000|Overall Study|Other|1|||
129897711|NCT00819910|467584434|FG000|Overall Study|Adverse Event|0|||
129831943|NCT00697515|467352175|FG001|Dose Optimization Period|elevated QTc|0|||
129831944|NCT00697515|467352174|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
129831945|NCT00697515|467352175|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
129831946|NCT00697515|467352174|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
129897712|NCT00819910|467584435|FG001|Overall Study|Adverse Event|0|||
129897713|NCT00819910|467584436|FG002|Overall Study|Adverse Event|2|||
129897714|NCT00819910|467584437|FG003|Overall Study|Adverse Event|1|||
129897715|NCT00819910|467584434|FG000|Overall Study|Withdrawal by Subject|1|||
129897716|NCT00819910|467584435|FG001|Overall Study|Withdrawal by Subject|1|||
129897717|NCT00819910|467584436|FG002|Overall Study|Withdrawal by Subject|1|||
129897718|NCT00819910|467584437|FG003|Overall Study|Withdrawal by Subject|0|||
129897719|NCT00819910|467584434|FG000|Overall Study|Lost to Follow-up|1|||
129831947|NCT00697515|467352175|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
129897720|NCT00819910|467584435|FG001|Overall Study|Lost to Follow-up|0|||
129831948|NCT00697515|467352174|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
129831949|NCT00697515|467352175|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
130060556|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130060557|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
130060558|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
130060559|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
130060560|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130060561|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Adverse Event|8|||
130060562|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Adverse Event|3|||
130060563|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Adverse Event|6|||
130060564|NCT02951988|468176680|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
130060565|NCT02951988|468176681|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
130060566|NCT02951988|468176682|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
130060567|NCT02951988|468176683|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
130060568|NCT00603980|468176685|FG000|Study Qualification|Protocol Violation|3|||
130060569|NCT00603980|468176685|FG000|Study Qualification|Inconsistent data reporting|13|||
130060570|NCT00603980|468176685|FG000|Main Study|14th subject completed trial|1|||
130060571|NCT01627067|468176686|FG000|Overall Study|Screen Failure|1|||
130060572|NCT00632463|468176687|FG000|Overall Study|Adverse Event|0|||
130060573|NCT00632463|468176688|FG001|Overall Study|Adverse Event|1|||
130060574|NCT00632463|468176689|FG002|Overall Study|Adverse Event|0|||
130060575|NCT04167306|468176690|FG000|Overall Study|Lost to Follow-up|2|||
130060576|NCT04167306|468176691|FG001|Overall Study|Lost to Follow-up|2|||
130060577|NCT04167306|468176692|FG002|Overall Study|Lost to Follow-up|5|||
130060578|NCT04167306|468176693|FG003|Overall Study|Lost to Follow-up|5|||
130060579|NCT04167306|468176690|FG000|Overall Study|Adverse Event|13|||
130060580|NCT04167306|468176691|FG001|Overall Study|Adverse Event|14|||
130060581|NCT04167306|468176692|FG002|Overall Study|Adverse Event|5|||
130060582|NCT04167306|468176693|FG003|Overall Study|Adverse Event|4|||
130060583|NCT04167306|468176690|FG000|Overall Study|Withdrawal by Subject|4|||
130060584|NCT04167306|468176691|FG001|Overall Study|Withdrawal by Subject|6|||
130060585|NCT04167306|468176692|FG002|Overall Study|Withdrawal by Subject|8|||
130060586|NCT04167306|468176693|FG003|Overall Study|Withdrawal by Subject|3|||
130060587|NCT04167306|468176690|FG000|Overall Study|covid|1|||
130060588|NCT04167306|468176691|FG001|Overall Study|covid|1|||
130060589|NCT04167306|468176692|FG002|Overall Study|covid|2|||
130060590|NCT04167306|468176693|FG003|Overall Study|covid|1|||
130060591|NCT04167306|468176690|FG000|Overall Study|concomitant medication|0|||
130060592|NCT04167306|468176691|FG001|Overall Study|concomitant medication|0|||
130060593|NCT04167306|468176692|FG002|Overall Study|concomitant medication|0|||
130060594|NCT04167306|468176693|FG003|Overall Study|concomitant medication|1|||
129831950|NCT00697515|467352174|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
129831951|NCT00697515|467352175|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
129831952|NCT01727141|467352177|FG000|Overall Study|Physician Decision|0|||
129831953|NCT01727141|467352178|FG001|Overall Study|Physician Decision|1|||
129831954|NCT01727141|467352179|FG002|Overall Study|Physician Decision|0|||
129831955|NCT01727141|467352180|FG003|Overall Study|Physician Decision|2|||
129831956|NCT01727141|467352177|FG000|Overall Study|Lost to Follow-up|0|||
129831957|NCT01727141|467352178|FG001|Overall Study|Lost to Follow-up|2|||
129831958|NCT01727141|467352179|FG002|Overall Study|Lost to Follow-up|0|||
129831959|NCT01727141|467352180|FG003|Overall Study|Lost to Follow-up|0|||
129831960|NCT01727141|467352177|FG000|Overall Study|Death|0|||
129831961|NCT01727141|467352178|FG001|Overall Study|Death|1|||
129831962|NCT01727141|467352179|FG002|Overall Study|Death|1|||
129831963|NCT01727141|467352180|FG003|Overall Study|Death|1|||
129831964|NCT01727141|467352177|FG000|Overall Study|Protocol deviation|1|||
129831965|NCT01727141|467352178|FG001|Overall Study|Protocol deviation|1|||
129831966|NCT01727141|467352179|FG002|Overall Study|Protocol deviation|0|||
129831967|NCT01727141|467352180|FG003|Overall Study|Protocol deviation|1|||
129831968|NCT01727141|467352177|FG000|Overall Study|Withdrawal by Subject|4|||
129831969|NCT01727141|467352178|FG001|Overall Study|Withdrawal by Subject|4|||
129831970|NCT01727141|467352179|FG002|Overall Study|Withdrawal by Subject|2|||
129831971|NCT01727141|467352180|FG003|Overall Study|Withdrawal by Subject|11|||
129831972|NCT04014075|467352183|FG000|Overall Study|Progressive Disease|53|||
129831973|NCT04014075|467352183|FG000|Overall Study|Adverse Event|15|||
129831974|NCT04014075|467352183|FG000|Overall Study|Clinical Progression|4|||
129831975|NCT04014075|467352183|FG000|Overall Study|Death|2|||
130060595|NCT04167306|468176690|FG000|Overall Study|Alcohol treatment|0|||
130060596|NCT04167306|468176691|FG001|Overall Study|Alcohol treatment|4|||
130060597|NCT04167306|468176692|FG002|Overall Study|Alcohol treatment|3|||
129831976|NCT04014075|467352183|FG000|Overall Study|Withdrawal by Subject|2|||
129831977|NCT04014075|467352183|FG000|Overall Study|Miscellaneous|2|||
129831978|NCT04014075|467352183|FG000|Overall Study|Physician Decision|1|||
130060598|NCT04167306|468176693|FG003|Overall Study|Alcohol treatment|2|||
130060599|NCT04167306|468176690|FG000|Overall Study|non-compliance|0|||
130060600|NCT04167306|468176691|FG001|Overall Study|non-compliance|0|||
129831979|NCT02603432|467352184|FG000|Overall Study|Adverse Event|1|||
129831980|NCT02603432|467352185|FG001|Overall Study|Adverse Event|0|||
129831981|NCT02603432|467352184|FG000|Overall Study|Death|221|||
130060601|NCT04167306|468176692|FG002|Overall Study|non-compliance|1|||
130060602|NCT04167306|468176693|FG003|Overall Study|non-compliance|0|||
130060603|NCT04167306|468176690|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
130060604|NCT04167306|468176691|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
130060605|NCT04167306|468176692|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
130060606|NCT04167306|468176693|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
130060607|NCT04146467|468176697|FG000|Overall Study|Adverse Event|0|||
130060608|NCT04146467|468176698|FG001|Overall Study|Adverse Event|1|||
130060609|NCT04146467|468176697|FG000|Overall Study|Lost to Follow-up|0|||
130060610|NCT04146467|468176698|FG001|Overall Study|Lost to Follow-up|2|||
130060611|NCT03722784|468176701|FG000|Overall Study|Withdrawal by Subject|1|||
130060612|NCT03722784|468176702|FG001|Overall Study|Withdrawal by Subject|0|||
130060613|NCT03722784|468176701|FG000|Overall Study|Physician Decision|1|||
130060614|NCT03722784|468176702|FG001|Overall Study|Physician Decision|1|||
130060615|NCT03722784|468176701|FG000|Overall Study|Protocol Violation|0|||
130060616|NCT03722784|468176702|FG001|Overall Study|Protocol Violation|1|||
130060617|NCT00751114|468176704|FG000|Overall Study|Adverse Event|2|||
130060618|NCT00751114|468176705|FG001|Overall Study|Adverse Event|4|||
130060619|NCT00751114|468176704|FG000|Overall Study|Protocol Violation|8|||
130060620|NCT00751114|468176705|FG001|Overall Study|Protocol Violation|9|||
130060621|NCT00751114|468176704|FG000|Overall Study|Withdrawal by Subject|9|||
130060622|NCT00751114|468176705|FG001|Overall Study|Withdrawal by Subject|4|||
129831982|NCT02603432|467352185|FG001|Overall Study|Death|242|||
129831983|NCT02603432|467352184|FG000|Overall Study|Lost to Follow-up|3|||
129831984|NCT02603432|467352185|FG001|Overall Study|Lost to Follow-up|9|||
129831985|NCT02603432|467352184|FG000|Overall Study|Progressive Disease|7|||
129831986|NCT02603432|467352185|FG001|Overall Study|Progressive Disease|5|||
129831987|NCT02603432|467352184|FG000|Overall Study|Withdrawal by Subject|12|||
129831988|NCT02603432|467352185|FG001|Overall Study|Withdrawal by Subject|18|||
129831989|NCT02603432|467352184|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
129831990|NCT02603432|467352185|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129831991|NCT02603432|467352184|FG000|Overall Study|Study terminated by sponsor|74|||
129831992|NCT02603432|467352185|FG001|Overall Study|Study terminated by sponsor|75|||
129831993|NCT02603432|467352184|FG000|Overall Study|Other|13|||
129831994|NCT02603432|467352185|FG001|Overall Study|Other|0|||
129831995|NCT05954052|467352189|FG000|Overall Study|Adverse Event|1|||
129831996|NCT01957462|467352190|FG000|Test Period 1|Withdrawal by Subject|1|||
129831997|NCT01957462|467352191|FG001|Test Period 1|Withdrawal by Subject|0|||
129831998|NCT01957462|467352190|FG000|Test Period 1|Adverse Event|1|||
129831999|NCT01957462|467352191|FG001|Test Period 1|Adverse Event|0|||
129832000|NCT02584504|467352192|FG000|Double-blind Treatment|Participant withdrew consent|0|||
129832001|NCT02584504|467352193|FG001|Double-blind Treatment|Participant withdrew consent|0|||
129832002|NCT02584504|467352194|FG002|Double-blind Treatment|Participant withdrew consent|1|||
129832003|NCT02584504|467352192|FG000|Double-blind Treatment|Adverse Event|0|||
129832004|NCT02584504|467352193|FG001|Double-blind Treatment|Adverse Event|1|||
129832005|NCT02584504|467352194|FG002|Double-blind Treatment|Adverse Event|0|||
129832006|NCT02584504|467352192|FG000|Double-blind Treatment|Family Matter|0|||
129832007|NCT02584504|467352193|FG001|Double-blind Treatment|Family Matter|1|||
129832008|NCT02584504|467352194|FG002|Double-blind Treatment|Family Matter|0|||
129832009|NCT02584504|467352192|FG000|Open-label Treatment|Participant withdrew consent|0|||
129832010|NCT02584504|467352193|FG001|Open-label Treatment|Participant withdrew consent|0|||
129832011|NCT02584504|467352194|FG002|Open-label Treatment|Participant withdrew consent|4|||
129832012|NCT02584504|467352192|FG000|Open-label Treatment|Adverse Event|2|||
129832013|NCT02584504|467352193|FG001|Open-label Treatment|Adverse Event|2|||
129832014|NCT02584504|467352194|FG002|Open-label Treatment|Adverse Event|3|||
129832015|NCT02584504|467352192|FG000|Open-label Treatment|Physician Decision|0|||
129832016|NCT02584504|467352193|FG001|Open-label Treatment|Physician Decision|1|||
129832017|NCT02584504|467352194|FG002|Open-label Treatment|Physician Decision|0|||
130060623|NCT00751114|468176704|FG000|Overall Study|Lost to Follow-up|4|||
130060624|NCT00751114|468176705|FG001|Overall Study|Lost to Follow-up|7|||
130060625|NCT00751114|468176704|FG000|Overall Study|Lack of Efficacy|0|||
130060626|NCT00751114|468176705|FG001|Overall Study|Lack of Efficacy|7|||
130060627|NCT00751114|468176704|FG000|Overall Study|Not Treated|13|||
130060628|NCT00751114|468176705|FG001|Overall Study|Not Treated|1|||
130060629|NCT00751114|468176704|FG000|Overall Study|Out of country for 2 months|1|||
130060630|NCT00751114|468176705|FG001|Overall Study|Out of country for 2 months|0|||
129832018|NCT02584504|467352192|FG000|Open-label Treatment|Entered but not treated|0|||
129832019|NCT02584504|467352193|FG001|Open-label Treatment|Entered but not treated|1|||
129832020|NCT02584504|467352194|FG002|Open-label Treatment|Entered but not treated|1|||
130060631|NCT00751114|468176704|FG000|Overall Study|Move to another city|1|||
129832021|NCT03102918|467352195|FG000|Overall Study|Protocol Violation|1|||
129832022|NCT03102918|467352196|FG001|Overall Study|Protocol Violation|0|||
129832023|NCT04765358|467352199|FG000|Overall Study|Withdrawal by Subject|1|||
129832024|NCT02731729|467352200|FG000|Overall Study|Death|2|||
129832025|NCT02731729|467352201|FG001|Overall Study|Death|2|||
129832026|NCT02731729|467352200|FG000|Overall Study|Study terminated by Sponsor|6|||
130112710|NCT02041494|468373447|FG000|Overall Study|study terminated|16|||
130112711|NCT02041494|468373448|FG001|Overall Study|study terminated|11|||
130112712|NCT00608205|468373449|FG000|Overall Study|Adverse Event|3|||
130112713|NCT00608205|468373450|FG001|Overall Study|Adverse Event|2|||
130112714|NCT00608205|468373449|FG000|Overall Study|Patient non-compliant|0|||
130112715|NCT00608205|468373450|FG001|Overall Study|Patient non-compliant|1|||
130112716|NCT01797120|468373453|FG000|Overall Study|Disesae progression|37|||
130112717|NCT01797120|468373454|FG001|Overall Study|Disesae progression|49|||
130112718|NCT01797120|468373453|FG000|Overall Study|Adverse Event|13|||
130112719|NCT01797120|468373454|FG001|Overall Study|Adverse Event|5|||
130112720|NCT01797120|468373453|FG000|Overall Study|Withdrawal by Subject|6|||
130112721|NCT01797120|468373454|FG001|Overall Study|Withdrawal by Subject|6|||
129832027|NCT02731729|467352201|FG001|Overall Study|Study terminated by Sponsor|6|||
129832028|NCT02731729|467352200|FG000|Overall Study|Withdrawal by Subject|1|||
129832029|NCT02731729|467352201|FG001|Overall Study|Withdrawal by Subject|0|||
129832030|NCT03446040|467352206|FG000|Overall Study|Disease progression|3|||
129832031|NCT03446040|467352207|FG001|Overall Study|Disease progression|3|||
129832032|NCT03446040|467352208|FG002|Overall Study|Disease progression|3|||
129832033|NCT03446040|467352209|FG003|Overall Study|Disease progression|4|||
129832034|NCT03446040|467352210|FG004|Overall Study|Disease progression|4|||
129832035|NCT03446040|467352211|FG005|Overall Study|Disease progression|6|||
129832036|NCT03446040|467352212|FG006|Overall Study|Disease progression|3|||
129832037|NCT03446040|467352213|FG007|Overall Study|Disease progression|4|||
129832038|NCT03446040|467352214|FG008|Overall Study|Disease progression|2|||
129832039|NCT03446040|467352215|FG009|Overall Study|Disease progression|4|||
129832040|NCT03446040|467352216|FG010|Overall Study|Disease progression|9|||
129832041|NCT03446040|467352217|FG011|Overall Study|Disease progression|3|||
129832042|NCT03446040|467352218|FG012|Overall Study|Disease progression|7|||
129832043|NCT03446040|467352219|FG013|Overall Study|Disease progression|7|||
129832044|NCT03446040|467352206|FG000|Overall Study|Study drug toxicity|0|||
129832045|NCT03446040|467352207|FG001|Overall Study|Study drug toxicity|0|||
129832046|NCT03446040|467352208|FG002|Overall Study|Study drug toxicity|0|||
129832047|NCT03446040|467352209|FG003|Overall Study|Study drug toxicity|0|||
129832048|NCT03446040|467352210|FG004|Overall Study|Study drug toxicity|0|||
129832049|NCT03446040|467352211|FG005|Overall Study|Study drug toxicity|0|||
129832050|NCT03446040|467352212|FG006|Overall Study|Study drug toxicity|0|||
129832051|NCT03446040|467352213|FG007|Overall Study|Study drug toxicity|0|||
129832052|NCT03446040|467352214|FG008|Overall Study|Study drug toxicity|1|||
129832053|NCT03446040|467352215|FG009|Overall Study|Study drug toxicity|0|||
129832054|NCT03446040|467352216|FG010|Overall Study|Study drug toxicity|0|||
129832055|NCT03446040|467352217|FG011|Overall Study|Study drug toxicity|0|||
129832056|NCT03446040|467352218|FG012|Overall Study|Study drug toxicity|0|||
129832057|NCT03446040|467352219|FG013|Overall Study|Study drug toxicity|0|||
129832058|NCT03446040|467352206|FG000|Overall Study|Adverse Event|0|||
129832059|NCT03446040|467352207|FG001|Overall Study|Adverse Event|0|||
129832060|NCT03446040|467352208|FG002|Overall Study|Adverse Event|0|||
129832061|NCT03446040|467352209|FG003|Overall Study|Adverse Event|0|||
129832062|NCT03446040|467352210|FG004|Overall Study|Adverse Event|0|||
129832063|NCT03446040|467352211|FG005|Overall Study|Adverse Event|2|||
129832064|NCT03446040|467352212|FG006|Overall Study|Adverse Event|0|||
129832065|NCT03446040|467352213|FG007|Overall Study|Adverse Event|0|||
129832066|NCT03446040|467352214|FG008|Overall Study|Adverse Event|1|||
129832067|NCT03446040|467352215|FG009|Overall Study|Adverse Event|0|||
129832068|NCT03446040|467352216|FG010|Overall Study|Adverse Event|0|||
129832069|NCT03446040|467352217|FG011|Overall Study|Adverse Event|0|||
129832070|NCT03446040|467352218|FG012|Overall Study|Adverse Event|0|||
129832071|NCT03446040|467352219|FG013|Overall Study|Adverse Event|0|||
129832072|NCT03446040|467352206|FG000|Overall Study|Death|0|||
129832073|NCT03446040|467352207|FG001|Overall Study|Death|0|||
130112722|NCT01797120|468373453|FG000|Overall Study|Symptomatic progression|2|||
130112723|NCT01797120|468373454|FG001|Overall Study|Symptomatic progression|1|||
130112724|NCT01797120|468373453|FG000|Overall Study|Non-compliance|1|||
129832074|NCT03446040|467352208|FG002|Overall Study|Death|0|||
129832075|NCT03446040|467352209|FG003|Overall Study|Death|0|||
129832076|NCT03446040|467352210|FG004|Overall Study|Death|0|||
129832077|NCT03446040|467352211|FG005|Overall Study|Death|0|||
129832078|NCT03446040|467352212|FG006|Overall Study|Death|0|||
129832079|NCT03446040|467352213|FG007|Overall Study|Death|0|||
129832080|NCT03446040|467352214|FG008|Overall Study|Death|0|||
129832081|NCT03446040|467352215|FG009|Overall Study|Death|0|||
129832082|NCT03446040|467352216|FG010|Overall Study|Death|1|||
129832083|NCT03446040|467352217|FG011|Overall Study|Death|0|||
129832084|NCT03446040|467352218|FG012|Overall Study|Death|0|||
129832085|NCT03446040|467352219|FG013|Overall Study|Death|2|||
129832086|NCT03446040|467352206|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
129832087|NCT03446040|467352207|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
129832088|NCT03446040|467352208|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
129832089|NCT03446040|467352209|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
130112725|NCT01797120|468373454|FG001|Overall Study|Non-compliance|0|||
130112726|NCT01797120|468373453|FG000|Overall Study|Physician Decision|3|||
129832090|NCT03446040|467352210|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
129832091|NCT03446040|467352211|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
129832092|NCT03446040|467352212|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
129832093|NCT03446040|467352213|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
129832094|NCT03446040|467352214|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
129832095|NCT03446040|467352215|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
129832096|NCT03446040|467352216|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
129832097|NCT03446040|467352217|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
129832098|NCT03446040|467352218|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
129832099|NCT03446040|467352219|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
129832100|NCT03446040|467352206|FG000|Overall Study|Participant withdrew consent|0|||
129832101|NCT03446040|467352207|FG001|Overall Study|Participant withdrew consent|0|||
129832102|NCT03446040|467352208|FG002|Overall Study|Participant withdrew consent|0|||
129832103|NCT03446040|467352209|FG003|Overall Study|Participant withdrew consent|0|||
129832104|NCT03446040|467352210|FG004|Overall Study|Participant withdrew consent|0|||
129832105|NCT03446040|467352211|FG005|Overall Study|Participant withdrew consent|1|||
129832106|NCT03446040|467352212|FG006|Overall Study|Participant withdrew consent|0|||
129832107|NCT03446040|467352213|FG007|Overall Study|Participant withdrew consent|1|||
129832108|NCT03446040|467352214|FG008|Overall Study|Participant withdrew consent|0|||
129832109|NCT03446040|467352215|FG009|Overall Study|Participant withdrew consent|0|||
129832110|NCT03446040|467352216|FG010|Overall Study|Participant withdrew consent|0|||
129832111|NCT03446040|467352217|FG011|Overall Study|Participant withdrew consent|0|||
129832112|NCT03446040|467352218|FG012|Overall Study|Participant withdrew consent|0|||
129832113|NCT03446040|467352219|FG013|Overall Study|Participant withdrew consent|0|||
129897721|NCT00819910|467584436|FG002|Overall Study|Lost to Follow-up|0|||
129897722|NCT00819910|467584437|FG003|Overall Study|Lost to Follow-up|0|||
129897723|NCT00299702|467584438|FG000|Overall Study|Death|1|||
129897724|NCT00299702|467584439|FG001|Overall Study|Death|0|||
129832114|NCT03446040|467352206|FG000|Overall Study|Not reported|0|||
129832115|NCT03446040|467352207|FG001|Overall Study|Not reported|0|||
129832116|NCT03446040|467352208|FG002|Overall Study|Not reported|1|||
129832117|NCT03446040|467352209|FG003|Overall Study|Not reported|0|||
129832118|NCT03446040|467352210|FG004|Overall Study|Not reported|0|||
129832119|NCT03446040|467352211|FG005|Overall Study|Not reported|0|||
129832120|NCT03446040|467352212|FG006|Overall Study|Not reported|0|||
129832121|NCT03446040|467352213|FG007|Overall Study|Not reported|0|||
129832122|NCT03446040|467352214|FG008|Overall Study|Not reported|0|||
129832123|NCT03446040|467352215|FG009|Overall Study|Not reported|0|||
129832124|NCT03446040|467352216|FG010|Overall Study|Not reported|0|||
129832125|NCT03446040|467352217|FG011|Overall Study|Not reported|0|||
129832126|NCT03446040|467352218|FG012|Overall Study|Not reported|0|||
129832127|NCT03446040|467352219|FG013|Overall Study|Not reported|0|||
129832128|NCT02066467|467352220|FG000|Overall Study|Did not undergo implant procedure|24|||
129832129|NCT02066467|467352220|FG000|Overall Study|Attempted to implant withoput success|43|||
129832130|NCT02066467|467352220|FG000|Overall Study|Consent ineligible|1|||
129832131|NCT02066467|467352220|FG000|Overall Study|Death|54|||
129832132|NCT02066467|467352220|FG000|Overall Study|Lost to Follow-up|51|||
129832133|NCT02066467|467352220|FG000|Overall Study|Adverse Event|20|||
129832134|NCT02066467|467352220|FG000|Overall Study|Withdrawal by Subject|16|||
129832135|NCT02066467|467352220|FG000|Overall Study|Physician Decision|2|||
129832136|NCT02066467|467352220|FG000|Overall Study|Not defined|4|||
129832137|NCT00456521|467352221|FG000|Overall Study|Adverse Event|150|||
129832138|NCT00456521|467352222|FG001|Overall Study|Adverse Event|25|||
129832139|NCT00456521|467352221|FG000|Overall Study|Withdrawal by Subject|43|||
129832140|NCT00456521|467352222|FG001|Overall Study|Withdrawal by Subject|24|||
129832141|NCT00456521|467352221|FG000|Overall Study|Lost to Follow-up|22|||
129832142|NCT00456521|467352222|FG001|Overall Study|Lost to Follow-up|17|||
129832143|NCT00456521|467352221|FG000|Overall Study|Lack of Efficacy|3|||
129832144|NCT00456521|467352222|FG001|Overall Study|Lack of Efficacy|6|||
129832145|NCT00456521|467352221|FG000|Overall Study|Protocol Violation|4|||
129832146|NCT00456521|467352222|FG001|Overall Study|Protocol Violation|0|||
129832147|NCT00456521|467352221|FG000|Overall Study|Pregnancy|1|||
129832148|NCT00456521|467352222|FG001|Overall Study|Pregnancy|1|||
129832149|NCT00456521|467352221|FG000|Overall Study|Drug non-compliance, moved, other|26|||
129832150|NCT00456521|467352222|FG001|Overall Study|Drug non-compliance, moved, other|11|||
130060632|NCT00751114|468176705|FG001|Overall Study|Move to another city|0|||
130060633|NCT03259490|468176706|FG000|Period 1|Withdrawal by Subject|0|||
130060634|NCT03259490|468176707|FG001|Period 1|Withdrawal by Subject|1|||
130060635|NCT03259490|468176706|FG000|Period 2|Protocol Violation|1|||
130060636|NCT03259490|468176707|FG001|Period 2|Protocol Violation|0|||
130060637|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
130060638|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
130060639|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
130060640|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
129832151|NCT01316276|467352223|FG000|Overall Study|Death|1|||
129832152|NCT01316276|467352223|FG000|Overall Study|Adverse Event|19|||
129832153|NCT01316276|467352223|FG000|Overall Study|Withdrawal of consent|24|||
129832154|NCT01316276|467352223|FG000|Overall Study|Lost to Follow-up|1|||
129832155|NCT01316276|467352223|FG000|Overall Study|Other|22|||
129832156|NCT00605475|467352224|FG000|Overall Study|Abnormal Laboratory Values|0|||
129832157|NCT00605475|467352225|FG001|Overall Study|Abnormal Laboratory Values|0|||
129832158|NCT00605475|467352226|FG002|Overall Study|Abnormal Laboratory Values|0|||
129832159|NCT00605475|467352227|FG003|Overall Study|Abnormal Laboratory Values|0|||
129832160|NCT00605475|467352228|FG004|Overall Study|Abnormal Laboratory Values|0|||
129832161|NCT00605475|467352229|FG005|Overall Study|Abnormal Laboratory Values|0|||
129832162|NCT00605475|467352230|FG006|Overall Study|Abnormal Laboratory Values|0|||
129832163|NCT00605475|467352231|FG007|Overall Study|Abnormal Laboratory Values|0|||
129832164|NCT00605475|467352232|FG008|Overall Study|Abnormal Laboratory Values|1|||
129832165|NCT00605475|467352233|FG009|Overall Study|Abnormal Laboratory Values|0|||
129832166|NCT00605475|467352224|FG000|Overall Study|Administrative problems|0|||
129832167|NCT00605475|467352225|FG001|Overall Study|Administrative problems|0|||
129832168|NCT00605475|467352226|FG002|Overall Study|Administrative problems|0|||
129832169|NCT00605475|467352227|FG003|Overall Study|Administrative problems|0|||
129832170|NCT00605475|467352228|FG004|Overall Study|Administrative problems|0|||
129832171|NCT00605475|467352229|FG005|Overall Study|Administrative problems|0|||
129832172|NCT00605475|467352230|FG006|Overall Study|Administrative problems|1|||
129832173|NCT00605475|467352231|FG007|Overall Study|Administrative problems|0|||
129832174|NCT00605475|467352232|FG008|Overall Study|Administrative problems|0|||
129832175|NCT00605475|467352233|FG009|Overall Study|Administrative problems|0|||
129832176|NCT00605475|467352224|FG000|Overall Study|Lost to Follow-up|0|||
129832177|NCT00605475|467352225|FG001|Overall Study|Lost to Follow-up|0|||
129832178|NCT00605475|467352226|FG002|Overall Study|Lost to Follow-up|0|||
129832179|NCT00605475|467352227|FG003|Overall Study|Lost to Follow-up|0|||
129832180|NCT00605475|467352228|FG004|Overall Study|Lost to Follow-up|0|||
129832181|NCT00605475|467352229|FG005|Overall Study|Lost to Follow-up|0|||
129832182|NCT00605475|467352230|FG006|Overall Study|Lost to Follow-up|0|||
129832183|NCT00605475|467352231|FG007|Overall Study|Lost to Follow-up|0|||
129832184|NCT00605475|467352232|FG008|Overall Study|Lost to Follow-up|1|||
129832185|NCT00605475|467352233|FG009|Overall Study|Lost to Follow-up|1|||
129832186|NCT00605475|467352224|FG000|Overall Study|Protocol Violation|0|||
129832187|NCT00605475|467352225|FG001|Overall Study|Protocol Violation|0|||
129832188|NCT00605475|467352226|FG002|Overall Study|Protocol Violation|0|||
129832189|NCT00605475|467352227|FG003|Overall Study|Protocol Violation|0|||
129832190|NCT00605475|467352228|FG004|Overall Study|Protocol Violation|1|||
129832191|NCT00605475|467352229|FG005|Overall Study|Protocol Violation|0|||
129832192|NCT00605475|467352230|FG006|Overall Study|Protocol Violation|0|||
129832193|NCT00605475|467352231|FG007|Overall Study|Protocol Violation|0|||
129832194|NCT00605475|467352232|FG008|Overall Study|Protocol Violation|0|||
129832195|NCT00605475|467352233|FG009|Overall Study|Protocol Violation|0|||
129832196|NCT00605475|467352224|FG000|Overall Study|Withdrawal by Subject|0|||
129832197|NCT00605475|467352225|FG001|Overall Study|Withdrawal by Subject|0|||
129832198|NCT00605475|467352226|FG002|Overall Study|Withdrawal by Subject|0|||
129832199|NCT00605475|467352227|FG003|Overall Study|Withdrawal by Subject|0|||
129832200|NCT00605475|467352228|FG004|Overall Study|Withdrawal by Subject|0|||
129832201|NCT00605475|467352229|FG005|Overall Study|Withdrawal by Subject|2|||
129832202|NCT00605475|467352230|FG006|Overall Study|Withdrawal by Subject|0|||
129832203|NCT00605475|467352231|FG007|Overall Study|Withdrawal by Subject|0|||
129832204|NCT00605475|467352232|FG008|Overall Study|Withdrawal by Subject|0|||
129832205|NCT00605475|467352233|FG009|Overall Study|Withdrawal by Subject|1|||
130060641|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
130060642|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
129832206|NCT02596854|467352234|FG000|Overall Study|Withdrawn|8|||
129832207|NCT00076011|467352235|FG000|Overall Study|Death|1|||
129832208|NCT00076011|467352235|FG000|Overall Study|Adverse Event|10|||
129832209|NCT00076011|467352235|FG000|Overall Study|Lack of Efficacy|25|||
129832210|NCT00076011|467352235|FG000|Overall Study|Withdrawal by Subject|1|||
129832211|NCT00076011|467352235|FG000|Overall Study|Study terminated by sponsor|3|||
129832212|NCT00076011|467352235|FG000|Overall Study|Other|11|||
130060643|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
129832213|NCT00076011|467352235|FG000|Overall Study|Ongoing|1|||
130060644|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
129832214|NCT00581776|467352236|FG000|Overall Study|Disease progression or no response|3|||
129832215|NCT00464568|467352241|FG000|Overall Study|Adverse Event|2|||
129832216|NCT02410954|467352242|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
129832217|NCT02410954|467352243|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
129832218|NCT02410954|467352242|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
129832219|NCT02410954|467352243|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
129832220|NCT00949325|467352244|FG000|Overall Study|Adverse Event|0|||
129832221|NCT00949325|467352245|FG001|Overall Study|Adverse Event|2|||
129832222|NCT00949325|467352246|FG002|Overall Study|Adverse Event|0|||
129832223|NCT00791518|467352247|FG000|Overall Study|Protocol Violation|93|||
129832224|NCT01520363|467352248|FG000|Overall Study|Withdrawal by Subject|2|||
129832225|NCT01520363|467352249|FG001|Overall Study|Withdrawal by Subject|0|||
129832226|NCT05172544|467352254|FG000|Overall Study|Withdrawal by Subject|1|||
129832227|NCT05172544|467352255|FG001|Overall Study|Withdrawal by Subject|0|||
129832228|NCT05172544|467352256|FG002|Overall Study|Withdrawal by Subject|0|||
129832229|NCT05172544|467352254|FG000|Overall Study|Physician Decision|0|||
129832230|NCT05172544|467352255|FG001|Overall Study|Physician Decision|0|||
129832231|NCT05172544|467352256|FG002|Overall Study|Physician Decision|1|||
129832232|NCT00728130|467352257|FG000|Overall Study|Withdrawal by Subject|1|||
129832233|NCT00728130|467352257|FG000|Overall Study|Paperwork not completed in time|1|||
129832234|NCT00728130|467352257|FG000|Overall Study|Physician Decision|1|||
129832235|NCT02073279|467352260|FG000|Double-blind Period|Adverse Event|1|||
129832236|NCT02073279|467352261|FG001|Double-blind Period|Adverse Event|1|||
129832237|NCT02073279|467352260|FG000|Double-blind Period|Switched to another treatment|1|||
129832238|NCT02073279|467352261|FG001|Double-blind Period|Switched to another treatment|2|||
129832239|NCT02073279|467352260|FG000|Double-blind Period|Protocol Violation|0|||
129832240|NCT02073279|467352261|FG001|Double-blind Period|Protocol Violation|1|||
129832241|NCT02073279|467352260|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
129832242|NCT02073279|467352261|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
129832243|NCT02073279|467352260|FG000|Double-blind Period|Withdrawal by Subject|2|||
129832244|NCT02073279|467352261|FG001|Double-blind Period|Withdrawal by Subject|2|||
129832245|NCT02073279|467352260|FG000|Open-label Extension Period|Adverse Event|1|||
129832246|NCT02073279|467352261|FG001|Open-label Extension Period|Adverse Event|0|||
129832247|NCT02073279|467352260|FG000|Open-label Extension Period|Lack of Efficacy|1|||
129832248|NCT02073279|467352261|FG001|Open-label Extension Period|Lack of Efficacy|0|||
129832249|NCT02073279|467352260|FG000|Open-label Extension Period|Lost to Follow-up|0|||
129832250|NCT02073279|467352261|FG001|Open-label Extension Period|Lost to Follow-up|4|||
129832251|NCT02073279|467352260|FG000|Open-label Extension Period|Switched to another treatment|1|||
129832252|NCT02073279|467352261|FG001|Open-label Extension Period|Switched to another treatment|4|||
129832253|NCT02073279|467352260|FG000|Open-label Extension Period|Protocol Violation|0|||
129832254|NCT02073279|467352261|FG001|Open-label Extension Period|Protocol Violation|1|||
129832255|NCT02073279|467352260|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
129832256|NCT02073279|467352261|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
129832257|NCT02073279|467352260|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
129832258|NCT02073279|467352261|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
129832259|NCT00973479|467352262|FG000|Overall Study|Lost to Follow-up|0|||
129832260|NCT00973479|467352263|FG001|Overall Study|Lost to Follow-up|3|||
129832261|NCT00973479|467352262|FG000|Overall Study|Death|2|||
129832262|NCT00973479|467352263|FG001|Overall Study|Death|2|||
129832263|NCT00973479|467352262|FG000|Overall Study|Withdrawal by Subject|15|||
129832264|NCT00973479|467352263|FG001|Overall Study|Withdrawal by Subject|16|||
129832265|NCT00973479|467352262|FG000|Overall Study|Lack of Efficacy|5|||
129832266|NCT00973479|467352263|FG001|Overall Study|Lack of Efficacy|7|||
129832267|NCT00973479|467352262|FG000|Overall Study|Adverse Event|12|||
129832268|NCT00973479|467352263|FG001|Overall Study|Adverse Event|32|||
129832269|NCT00973479|467352262|FG000|Overall Study|Protocol Violation|2|||
129832270|NCT00973479|467352263|FG001|Overall Study|Protocol Violation|2|||
129832271|NCT00973479|467352262|FG000|Overall Study|Other|1|||
129832272|NCT00973479|467352263|FG001|Overall Study|Other|7|||
129832273|NCT00362115|467352264|FG000|Overall Study|Adverse Event|0|||
129832274|NCT00362115|467352265|FG001|Overall Study|Adverse Event|1|||
129832275|NCT00362115|467352266|FG002|Overall Study|Adverse Event|1|||
129832276|NCT00362115|467352267|FG003|Overall Study|Adverse Event|1|||
129832277|NCT00362115|467352268|FG004|Overall Study|Adverse Event|2|||
129832278|NCT00362115|467352269|FG005|Overall Study|Adverse Event|2|||
129832279|NCT00362115|467352270|FG006|Overall Study|Adverse Event|1|||
129832280|NCT00362115|467352264|FG000|Overall Study|Protocol Violation|0|||
129832281|NCT00362115|467352265|FG001|Overall Study|Protocol Violation|0|||
129832282|NCT00362115|467352266|FG002|Overall Study|Protocol Violation|0|||
129832283|NCT00362115|467352267|FG003|Overall Study|Protocol Violation|0|||
129832284|NCT00362115|467352268|FG004|Overall Study|Protocol Violation|0|||
130060645|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
129832285|NCT00362115|467352269|FG005|Overall Study|Protocol Violation|1|||
129832286|NCT00362115|467352270|FG006|Overall Study|Protocol Violation|0|||
129832287|NCT00362115|467352264|FG000|Overall Study|Lost to Follow-up|0|||
129832288|NCT00362115|467352265|FG001|Overall Study|Lost to Follow-up|1|||
129832289|NCT00362115|467352266|FG002|Overall Study|Lost to Follow-up|0|||
129832290|NCT00362115|467352267|FG003|Overall Study|Lost to Follow-up|0|||
129832291|NCT00362115|467352268|FG004|Overall Study|Lost to Follow-up|2|||
129832292|NCT00362115|467352269|FG005|Overall Study|Lost to Follow-up|0|||
129832293|NCT00362115|467352270|FG006|Overall Study|Lost to Follow-up|1|||
129832294|NCT00362115|467352264|FG000|Overall Study|Withdrawal by Subject|1|||
129832295|NCT00362115|467352265|FG001|Overall Study|Withdrawal by Subject|3|||
129832296|NCT00362115|467352266|FG002|Overall Study|Withdrawal by Subject|1|||
129832297|NCT00362115|467352267|FG003|Overall Study|Withdrawal by Subject|0|||
129832298|NCT00362115|467352268|FG004|Overall Study|Withdrawal by Subject|1|||
129832299|NCT00362115|467352269|FG005|Overall Study|Withdrawal by Subject|3|||
129832300|NCT00362115|467352270|FG006|Overall Study|Withdrawal by Subject|4|||
129832301|NCT00362115|467352264|FG000|Overall Study|Lack of Efficacy|1|||
129832302|NCT00362115|467352265|FG001|Overall Study|Lack of Efficacy|0|||
129832303|NCT00362115|467352266|FG002|Overall Study|Lack of Efficacy|5|||
129832304|NCT00362115|467352267|FG003|Overall Study|Lack of Efficacy|2|||
129832305|NCT00362115|467352268|FG004|Overall Study|Lack of Efficacy|2|||
129832306|NCT00362115|467352269|FG005|Overall Study|Lack of Efficacy|0|||
129832307|NCT00362115|467352270|FG006|Overall Study|Lack of Efficacy|3|||
129832308|NCT00362115|467352264|FG000|Overall Study|Physician Decision|0|||
129832309|NCT00362115|467352265|FG001|Overall Study|Physician Decision|0|||
129832310|NCT00362115|467352266|FG002|Overall Study|Physician Decision|0|||
129832311|NCT00362115|467352267|FG003|Overall Study|Physician Decision|0|||
129832312|NCT00362115|467352268|FG004|Overall Study|Physician Decision|0|||
129832313|NCT00362115|467352269|FG005|Overall Study|Physician Decision|0|||
129832314|NCT00362115|467352270|FG006|Overall Study|Physician Decision|3|||
129832315|NCT00362115|467352264|FG000|Overall Study|Other|0|||
129832316|NCT00362115|467352265|FG001|Overall Study|Other|1|||
129832317|NCT00362115|467352266|FG002|Overall Study|Other|0|||
129832318|NCT00362115|467352267|FG003|Overall Study|Other|1|||
130060646|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
129832319|NCT00362115|467352268|FG004|Overall Study|Other|0|||
130060647|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
130060648|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
130060649|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130060650|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130060651|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
130060652|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130060653|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130060654|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
130060655|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130060656|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130060657|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
130060658|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
130060659|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
129832320|NCT00362115|467352269|FG005|Overall Study|Other|1|||
129832321|NCT00362115|467352270|FG006|Overall Study|Other|0|||
129832322|NCT03965962|467352271|FG000|Overall Study|Adverse Event|1|||
129832323|NCT03965962|467352272|FG001|Overall Study|Adverse Event|0|||
130060660|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
130060661|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
130060662|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
129832324|NCT03965962|467352273|FG002|Overall Study|Adverse Event|0|||
129832325|NCT03965962|467352274|FG003|Overall Study|Adverse Event|0|||
129832326|NCT03965962|467352271|FG000|Overall Study|Protocol Violation|21|||
129832327|NCT03965962|467352272|FG001|Overall Study|Protocol Violation|4|||
129832328|NCT03965962|467352273|FG002|Overall Study|Protocol Violation|10|||
129832329|NCT03965962|467352274|FG003|Overall Study|Protocol Violation|5|||
129832330|NCT03965962|467352271|FG000|Overall Study|Lost to Follow-up|0|||
129832331|NCT03965962|467352272|FG001|Overall Study|Lost to Follow-up|1|||
129832332|NCT03965962|467352273|FG002|Overall Study|Lost to Follow-up|0|||
129832333|NCT03965962|467352274|FG003|Overall Study|Lost to Follow-up|0|||
129832334|NCT03965962|467352271|FG000|Overall Study|Withdrawal by Subject|3|||
129832335|NCT03965962|467352272|FG001|Overall Study|Withdrawal by Subject|0|||
129832336|NCT03965962|467352273|FG002|Overall Study|Withdrawal by Subject|0|||
129832337|NCT03965962|467352274|FG003|Overall Study|Withdrawal by Subject|1|||
130060663|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
129832338|NCT01408030|467352279|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
129832339|NCT01408030|467352280|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
129832340|NCT01408030|467352281|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
129832341|NCT01408030|467352282|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
130060664|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
130060665|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
130060666|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
130060667|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129832342|NCT01408030|467352279|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
129832343|NCT01408030|467352280|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
129832344|NCT01408030|467352281|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
129832345|NCT01408030|467352282|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
129832346|NCT01408030|467352279|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
129832347|NCT01408030|467352280|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
129832348|NCT01408030|467352281|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
129832349|NCT01408030|467352282|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
129832350|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
129832351|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
129832352|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
129832353|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
129832354|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
129832355|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
129832356|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
130060668|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130060669|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130060670|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
130060671|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130060672|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
130060673|NCT01963208|468176708|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
129832357|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
129832358|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
129832359|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
129832360|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
129832361|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
129832362|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Other|1|||
129832363|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Other|1|||
129832364|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Other|1|||
129832365|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Other|1|||
129832366|NCT05214768|467352283|FG000|Induction Period|Withdrawal by Subject|1|||
129832367|NCT05214768|467352284|FG001|Induction Period|Withdrawal by Subject|0|||
129832368|NCT05214768|467352285|FG002|Induction Period|Withdrawal by Subject|0|||
129832369|NCT05214768|467352286|FG003|Induction Period|Withdrawal by Subject|0|||
129832370|NCT05214768|467352287|FG004|Induction Period|Withdrawal by Subject|0|||
129832371|NCT05214768|467352288|FG005|Induction Period|Withdrawal by Subject|0|||
129832372|NCT05214768|467352283|FG000|Induction Period|Physician Decision|1|||
129832373|NCT05214768|467352284|FG001|Induction Period|Physician Decision|0|||
129832374|NCT05214768|467352285|FG002|Induction Period|Physician Decision|0|||
129832375|NCT05214768|467352286|FG003|Induction Period|Physician Decision|0|||
129832376|NCT05214768|467352287|FG004|Induction Period|Physician Decision|0|||
129832377|NCT05214768|467352288|FG005|Induction Period|Physician Decision|0|||
129832378|NCT05214768|467352283|FG000|Maintenance Period|Other Reasons|0|||
129832379|NCT05214768|467352284|FG001|Maintenance Period|Other Reasons|0|||
129832380|NCT05214768|467352285|FG002|Maintenance Period|Other Reasons|1|||
129832381|NCT05214768|467352286|FG003|Maintenance Period|Other Reasons|1|||
129832382|NCT05214768|467352287|FG004|Maintenance Period|Other Reasons|0|||
129832383|NCT05214768|467352288|FG005|Maintenance Period|Other Reasons|0|||
129832384|NCT05214768|467352283|FG000|Maintenance Period|Withdrawal by Subject|0|||
129832385|NCT05214768|467352284|FG001|Maintenance Period|Withdrawal by Subject|0|||
129832386|NCT05214768|467352285|FG002|Maintenance Period|Withdrawal by Subject|0|||
129832387|NCT05214768|467352286|FG003|Maintenance Period|Withdrawal by Subject|1|||
129832388|NCT05214768|467352287|FG004|Maintenance Period|Withdrawal by Subject|0|||
129832389|NCT05214768|467352288|FG005|Maintenance Period|Withdrawal by Subject|0|||
129832390|NCT05214768|467352283|FG000|Maintenance Period|Lack of Efficacy|0|||
129832391|NCT05214768|467352284|FG001|Maintenance Period|Lack of Efficacy|0|||
129832392|NCT05214768|467352285|FG002|Maintenance Period|Lack of Efficacy|1|||
129832393|NCT05214768|467352286|FG003|Maintenance Period|Lack of Efficacy|0|||
129832394|NCT05214768|467352287|FG004|Maintenance Period|Lack of Efficacy|1|||
129832395|NCT05214768|467352288|FG005|Maintenance Period|Lack of Efficacy|0|||
129832396|NCT05214768|467352283|FG000|Open Label Extension Period|Physician Decision|0|||
129832397|NCT05214768|467352284|FG001|Open Label Extension Period|Physician Decision|0|||
129832398|NCT05214768|467352285|FG002|Open Label Extension Period|Physician Decision|0|||
129832399|NCT05214768|467352286|FG003|Open Label Extension Period|Physician Decision|0|||
129832400|NCT05214768|467352287|FG004|Open Label Extension Period|Physician Decision|0|||
129832401|NCT05214768|467352288|FG005|Open Label Extension Period|Physician Decision|1|||
129832402|NCT05214768|467352283|FG000|Open Label Extension Period|Lack of Efficacy|0|||
129832403|NCT05214768|467352284|FG001|Open Label Extension Period|Lack of Efficacy|0|||
129832404|NCT05214768|467352285|FG002|Open Label Extension Period|Lack of Efficacy|0|||
129832405|NCT05214768|467352286|FG003|Open Label Extension Period|Lack of Efficacy|0|||
129832406|NCT05214768|467352287|FG004|Open Label Extension Period|Lack of Efficacy|0|||
129832407|NCT05214768|467352288|FG005|Open Label Extension Period|Lack of Efficacy|1|||
129832408|NCT05214768|467352283|FG000|Open Label Extension Period|Ongoing Study|0|||
129832409|NCT05214768|467352284|FG001|Open Label Extension Period|Ongoing Study|0|||
129832410|NCT05214768|467352285|FG002|Open Label Extension Period|Ongoing Study|0|||
129832411|NCT05214768|467352286|FG003|Open Label Extension Period|Ongoing Study|0|||
129832412|NCT05214768|467352287|FG004|Open Label Extension Period|Ongoing Study|0|||
129832413|NCT05214768|467352288|FG005|Open Label Extension Period|Ongoing Study|42|||
130112727|NCT01797120|468373454|FG001|Overall Study|Physician Decision|0|||
129832422|NCT01239368|467353944|FG000|Overall Study|Principal investigator discretion|1|||
129832423|NCT01239368|467353945|FG001|Overall Study|Principal investigator discretion|0|||
129832424|NCT01239368|467353946|FG002|Overall Study|Principal investigator discretion|0|||
129832425|NCT01239368|467353947|FG003|Overall Study|Principal investigator discretion|0|||
129832426|NCT01239368|467353948|FG004|Overall Study|Principal investigator discretion|1|||
129832427|NCT01239368|467353949|FG005|Overall Study|Principal investigator discretion|2|||
129832428|NCT01239368|467353950|FG006|Overall Study|Principal investigator discretion|0|||
129832429|NCT01239368|467353951|FG007|Overall Study|Principal investigator discretion|0|||
129832430|NCT01239368|467353952|FG008|Overall Study|Principal investigator discretion|0|||
129832431|NCT01239368|467353953|FG009|Overall Study|Principal investigator discretion|1|||
129832432|NCT01239368|467353944|FG000|Overall Study|Disease progression on study|1|||
129832433|NCT01239368|467353945|FG001|Overall Study|Disease progression on study|1|||
129832434|NCT01239368|467353946|FG002|Overall Study|Disease progression on study|1|||
129832435|NCT01239368|467353947|FG003|Overall Study|Disease progression on study|1|||
129832436|NCT01239368|467353948|FG004|Overall Study|Disease progression on study|4|||
129832437|NCT01239368|467353949|FG005|Overall Study|Disease progression on study|2|||
129832438|NCT01239368|467353950|FG006|Overall Study|Disease progression on study|5|||
129832439|NCT01239368|467353951|FG007|Overall Study|Disease progression on study|0|||
129832440|NCT01239368|467353952|FG008|Overall Study|Disease progression on study|0|||
129832441|NCT01239368|467353953|FG009|Overall Study|Disease progression on study|2|||
129832442|NCT01239368|467353944|FG000|Overall Study|Refused further treatment|0|||
129832443|NCT01239368|467353945|FG001|Overall Study|Refused further treatment|0|||
129832444|NCT01239368|467353946|FG002|Overall Study|Refused further treatment|0|||
129832445|NCT01239368|467353947|FG003|Overall Study|Refused further treatment|0|||
129832446|NCT01239368|467353948|FG004|Overall Study|Refused further treatment|0|||
129832447|NCT01239368|467353949|FG005|Overall Study|Refused further treatment|0|||
129832448|NCT01239368|467353950|FG006|Overall Study|Refused further treatment|0|||
129832449|NCT01239368|467353951|FG007|Overall Study|Refused further treatment|0|||
129832450|NCT01239368|467353952|FG008|Overall Study|Refused further treatment|0|||
129832451|NCT01239368|467353953|FG009|Overall Study|Refused further treatment|1|||
129832452|NCT01239368|467353944|FG000|Overall Study|Death|0|||
129832453|NCT01239368|467353945|FG001|Overall Study|Death|0|||
129832454|NCT01239368|467353946|FG002|Overall Study|Death|0|||
129832455|NCT01239368|467353947|FG003|Overall Study|Death|0|||
129832456|NCT01239368|467353948|FG004|Overall Study|Death|0|||
129832457|NCT01239368|467353949|FG005|Overall Study|Death|0|||
129832458|NCT01239368|467353950|FG006|Overall Study|Death|1|||
129832459|NCT01239368|467353951|FG007|Overall Study|Death|0|||
129832460|NCT01239368|467353952|FG008|Overall Study|Death|0|||
129832461|NCT01239368|467353953|FG009|Overall Study|Death|0|||
129832462|NCT01254227|467353958|FG000|Overall Study|Withdrawal by Subject|6|||
129832463|NCT01254227|467353958|FG000|Overall Study|Lost to Follow-up|6|||
129832464|NCT01254227|467353958|FG000|Overall Study|Adverse Event|5|||
129832465|NCT01254227|467353958|FG000|Overall Study|Abnormal test procedure result|5|||
129832466|NCT01254227|467353958|FG000|Overall Study|Administrative problems|2|||
129832467|NCT01254227|467353958|FG000|Overall Study|Death|1|||
129832468|NCT01254227|467353958|FG000|Overall Study|Protocol deviation|1|||
129832469|NCT03265249|467353961|FG000|Overall Study|Withdrawal by Subject|0|||
129832470|NCT03265249|467353962|FG001|Overall Study|Withdrawal by Subject|1|||
129832471|NCT01614990|467353963|FG000|Overall Study|Protocol Violation|1|||
129832472|NCT01614990|467353964|FG001|Overall Study|Protocol Violation|1|||
129832473|NCT01012622|467353967|FG000|Overall Study|Withdrawal by Subject|6|||
129832474|NCT01012622|467353967|FG000|Overall Study|Lost to Follow-up|5|||
129832475|NCT01012622|467353967|FG000|Overall Study|Adverse Event|7|||
129832476|NCT01012622|467353967|FG000|Overall Study|non-compliance with the drug|9|||
129832477|NCT01012622|467353967|FG000|Overall Study|Other|1|||
129832478|NCT01012622|467353967|FG000|Overall Study|screening failure|1|||
129832479|NCT01012622|467353967|FG000|Overall Study|withdrawal of consent by a parent|2|||
129832480|NCT00706641|467353969|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
129832481|NCT00706641|467353969|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
129832482|NCT00706641|467353969|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
129832483|NCT02535741|467353972|FG000|Overall Study|Adverse Event|3|||
129832484|NCT02535741|467353972|FG000|Overall Study|Withdrawal by Subject|9|||
129832485|NCT02535741|467353972|FG000|Overall Study|Lost to Follow-up|10|||
129832486|NCT02535741|467353972|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
129832487|NCT02535741|467353972|FG000|Overall Study|Missing data|6|||
129832488|NCT00798369|467353973|FG000|Overall Study|Subject withdrew consent|0|||
129832489|NCT00798369|467353974|FG001|Overall Study|Subject withdrew consent|0|||
129832490|NCT00798369|467353975|FG002|Overall Study|Subject withdrew consent|1|||
129832491|NCT00798369|467353976|FG003|Overall Study|Subject withdrew consent|1|||
130112728|NCT01797120|468373453|FG000|Overall Study|still on treatment|2|||
130060674|NCT01963208|468176709|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130060675|NCT01963208|468176710|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130060676|NCT01963208|468176711|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
129832492|NCT00798369|467353977|FG004|Overall Study|Subject withdrew consent|0|||
129832493|NCT00798369|467353978|FG005|Overall Study|Subject withdrew consent|2|||
129832494|NCT00798369|467353973|FG000|Overall Study|Lost to Follow-up|1|||
129832495|NCT00798369|467353974|FG001|Overall Study|Lost to Follow-up|1|||
129832496|NCT00798369|467353975|FG002|Overall Study|Lost to Follow-up|1|||
129832497|NCT00798369|467353976|FG003|Overall Study|Lost to Follow-up|0|||
129832498|NCT00798369|467353977|FG004|Overall Study|Lost to Follow-up|1|||
129832499|NCT00798369|467353978|FG005|Overall Study|Lost to Follow-up|0|||
129832500|NCT00798369|467353973|FG000|Overall Study|Adminstrative problems|0|||
129832501|NCT00798369|467353974|FG001|Overall Study|Adminstrative problems|0|||
129832502|NCT00798369|467353975|FG002|Overall Study|Adminstrative problems|0|||
129832503|NCT00798369|467353976|FG003|Overall Study|Adminstrative problems|0|||
129832504|NCT00798369|467353977|FG004|Overall Study|Adminstrative problems|0|||
129832505|NCT00798369|467353978|FG005|Overall Study|Adminstrative problems|1|||
129832506|NCT04475588|467353979|FG000|Overall Study|Adverse Event|2|||
129832507|NCT04475588|467353980|FG001|Overall Study|Adverse Event|0|||
129832508|NCT04762680|467353981|FG000|Phase 2|Adverse Event|0|||
129832509|NCT04762680|467353982|FG001|Phase 2|Adverse Event|1|||
129832510|NCT04762680|467353983|FG002|Phase 2|Adverse Event|0|||
129832511|NCT04762680|467353984|FG003|Phase 2|Adverse Event|0|||
129832512|NCT04762680|467353985|FG004|Phase 2|Adverse Event|0|||
129832513|NCT04762680|467353986|FG005|Phase 2|Adverse Event|0|||
129832514|NCT04762680|467353987|FG006|Phase 2|Adverse Event|0|||
129832515|NCT04762680|467353988|FG007|Phase 2|Adverse Event|0|||
129832516|NCT04762680|467353989|FG008|Phase 2|Adverse Event|0|||
129832517|NCT04762680|467353990|FG009|Phase 2|Adverse Event|0|||
129832518|NCT04762680|467353991|FG010|Phase 2|Adverse Event|0|||
129832519|NCT04762680|467353992|FG011|Phase 2|Adverse Event|0|||
129832520|NCT04762680|467353993|FG012|Phase 2|Adverse Event|0|||
129832521|NCT04762680|467353994|FG013|Phase 2|Adverse Event|0|||
129832522|NCT04762680|467353995|FG014|Phase 2|Adverse Event|0|||
129832523|NCT04762680|467353996|FG015|Phase 2|Adverse Event|0|||
129832524|NCT04762680|467353997|FG016|Phase 2|Adverse Event|0|||
129832525|NCT04762680|467353998|FG017|Phase 2|Adverse Event|0|||
129832526|NCT04762680|467353999|FG018|Phase 2|Adverse Event|0|||
129832527|NCT04762680|467354000|FG019|Phase 2|Adverse Event|0|||
129832528|NCT04762680|467354001|FG020|Phase 2|Adverse Event|0|||
129832529|NCT04762680|467354002|FG021|Phase 2|Adverse Event|0|||
129832530|NCT04762680|467353981|FG000|Phase 2|Protocol Violation|5|||
129832531|NCT04762680|467353982|FG001|Phase 2|Protocol Violation|5|||
129832532|NCT04762680|467353983|FG002|Phase 2|Protocol Violation|1|||
129832533|NCT04762680|467353984|FG003|Phase 2|Protocol Violation|0|||
129832534|NCT04762680|467353985|FG004|Phase 2|Protocol Violation|0|||
129832535|NCT04762680|467353986|FG005|Phase 2|Protocol Violation|0|||
129832536|NCT04762680|467353987|FG006|Phase 2|Protocol Violation|0|||
129832537|NCT04762680|467353988|FG007|Phase 2|Protocol Violation|0|||
129832538|NCT04762680|467353989|FG008|Phase 2|Protocol Violation|0|||
129832539|NCT04762680|467353990|FG009|Phase 2|Protocol Violation|0|||
129832540|NCT04762680|467353991|FG010|Phase 2|Protocol Violation|0|||
129832541|NCT04762680|467353992|FG011|Phase 2|Protocol Violation|0|||
129832542|NCT04762680|467353993|FG012|Phase 2|Protocol Violation|0|||
129832543|NCT04762680|467353994|FG013|Phase 2|Protocol Violation|0|||
129832544|NCT04762680|467353995|FG014|Phase 2|Protocol Violation|0|||
129832545|NCT04762680|467353996|FG015|Phase 2|Protocol Violation|0|||
129832546|NCT04762680|467353997|FG016|Phase 2|Protocol Violation|0|||
129832547|NCT04762680|467353998|FG017|Phase 2|Protocol Violation|0|||
129832548|NCT04762680|467353999|FG018|Phase 2|Protocol Violation|0|||
129832549|NCT04762680|467354000|FG019|Phase 2|Protocol Violation|0|||
129832550|NCT04762680|467354001|FG020|Phase 2|Protocol Violation|0|||
129832551|NCT04762680|467354002|FG021|Phase 2|Protocol Violation|0|||
130112729|NCT01797120|468373454|FG001|Overall Study|still on treatment|4|||
129832552|NCT04762680|467353981|FG000|Phase 2|Withdrawal by Subject|23|||
129832553|NCT04762680|467353982|FG001|Phase 2|Withdrawal by Subject|21|||
129832554|NCT04762680|467353983|FG002|Phase 2|Withdrawal by Subject|28|||
129832555|NCT04762680|467353984|FG003|Phase 2|Withdrawal by Subject|0|||
129832556|NCT04762680|467353985|FG004|Phase 2|Withdrawal by Subject|0|||
129832557|NCT04762680|467353986|FG005|Phase 2|Withdrawal by Subject|0|||
129832558|NCT04762680|467353987|FG006|Phase 2|Withdrawal by Subject|0|||
129832559|NCT04762680|467353988|FG007|Phase 2|Withdrawal by Subject|0|||
129832560|NCT04762680|467353989|FG008|Phase 2|Withdrawal by Subject|0|||
129832561|NCT04762680|467353990|FG009|Phase 2|Withdrawal by Subject|0|||
129832562|NCT04762680|467353991|FG010|Phase 2|Withdrawal by Subject|0|||
129832563|NCT04762680|467353992|FG011|Phase 2|Withdrawal by Subject|0|||
129832564|NCT04762680|467353993|FG012|Phase 2|Withdrawal by Subject|0|||
129832565|NCT04762680|467353994|FG013|Phase 2|Withdrawal by Subject|0|||
129832566|NCT04762680|467353995|FG014|Phase 2|Withdrawal by Subject|0|||
129832567|NCT04762680|467353996|FG015|Phase 2|Withdrawal by Subject|0|||
129832568|NCT04762680|467353997|FG016|Phase 2|Withdrawal by Subject|0|||
129832569|NCT04762680|467353998|FG017|Phase 2|Withdrawal by Subject|0|||
129832570|NCT04762680|467353999|FG018|Phase 2|Withdrawal by Subject|0|||
129832571|NCT04762680|467354000|FG019|Phase 2|Withdrawal by Subject|0|||
129832572|NCT04762680|467354001|FG020|Phase 2|Withdrawal by Subject|0|||
129832573|NCT04762680|467354002|FG021|Phase 2|Withdrawal by Subject|0|||
129832574|NCT04762680|467353981|FG000|Phase 2|Lost to Follow-up|14|||
129832575|NCT04762680|467353982|FG001|Phase 2|Lost to Follow-up|8|||
129832576|NCT04762680|467353983|FG002|Phase 2|Lost to Follow-up|9|||
129832577|NCT04762680|467353984|FG003|Phase 2|Lost to Follow-up|0|||
129832578|NCT04762680|467353985|FG004|Phase 2|Lost to Follow-up|0|||
129832579|NCT04762680|467353986|FG005|Phase 2|Lost to Follow-up|0|||
129832580|NCT04762680|467353987|FG006|Phase 2|Lost to Follow-up|0|||
129832581|NCT04762680|467353988|FG007|Phase 2|Lost to Follow-up|0|||
129832582|NCT04762680|467353989|FG008|Phase 2|Lost to Follow-up|0|||
129832583|NCT04762680|467353990|FG009|Phase 2|Lost to Follow-up|0|||
129832584|NCT04762680|467353991|FG010|Phase 2|Lost to Follow-up|0|||
129832585|NCT04762680|467353992|FG011|Phase 2|Lost to Follow-up|0|||
129832586|NCT04762680|467353993|FG012|Phase 2|Lost to Follow-up|0|||
129832587|NCT04762680|467353994|FG013|Phase 2|Lost to Follow-up|0|||
129832588|NCT04762680|467353995|FG014|Phase 2|Lost to Follow-up|0|||
129832589|NCT04762680|467353996|FG015|Phase 2|Lost to Follow-up|0|||
129832590|NCT04762680|467353997|FG016|Phase 2|Lost to Follow-up|0|||
129832591|NCT04762680|467353998|FG017|Phase 2|Lost to Follow-up|0|||
129832592|NCT04762680|467353999|FG018|Phase 2|Lost to Follow-up|0|||
129832593|NCT04762680|467354000|FG019|Phase 2|Lost to Follow-up|0|||
129832594|NCT04762680|467354001|FG020|Phase 2|Lost to Follow-up|0|||
129832595|NCT04762680|467354002|FG021|Phase 2|Lost to Follow-up|0|||
129832596|NCT04762680|467353981|FG000|Phase 3|Adverse Event|0|||
129832597|NCT04762680|467353982|FG001|Phase 3|Adverse Event|0|||
129832598|NCT04762680|467353983|FG002|Phase 3|Adverse Event|0|||
129832599|NCT04762680|467353984|FG003|Phase 3|Adverse Event|1|||
129832600|NCT04762680|467353985|FG004|Phase 3|Adverse Event|0|||
129832601|NCT04762680|467353986|FG005|Phase 3|Adverse Event|0|||
129832602|NCT04762680|467353987|FG006|Phase 3|Adverse Event|0|||
129832603|NCT04762680|467353988|FG007|Phase 3|Adverse Event|0|||
129832604|NCT04762680|467353989|FG008|Phase 3|Adverse Event|0|||
129832605|NCT04762680|467353990|FG009|Phase 3|Adverse Event|0|||
129832606|NCT04762680|467353991|FG010|Phase 3|Adverse Event|0|||
129832607|NCT04762680|467353992|FG011|Phase 3|Adverse Event|0|||
129832608|NCT04762680|467353993|FG012|Phase 3|Adverse Event|0|||
129832609|NCT04762680|467353994|FG013|Phase 3|Adverse Event|0|||
129832610|NCT04762680|467353995|FG014|Phase 3|Adverse Event|0|||
129832611|NCT04762680|467353996|FG015|Phase 3|Adverse Event|0|||
129832612|NCT04762680|467353997|FG016|Phase 3|Adverse Event|0|||
129832613|NCT04762680|467353998|FG017|Phase 3|Adverse Event|3|||
129832614|NCT04762680|467353999|FG018|Phase 3|Adverse Event|0|||
129832615|NCT04762680|467354000|FG019|Phase 3|Adverse Event|0|||
129832616|NCT04762680|467354001|FG020|Phase 3|Adverse Event|0|||
129832617|NCT04762680|467354002|FG021|Phase 3|Adverse Event|0|||
129832618|NCT04762680|467353981|FG000|Phase 3|Protocol Violation|0|||
129832619|NCT04762680|467353982|FG001|Phase 3|Protocol Violation|0|||
129832620|NCT04762680|467353983|FG002|Phase 3|Protocol Violation|0|||
129832621|NCT04762680|467353984|FG003|Phase 3|Protocol Violation|4|||
129832622|NCT04762680|467353985|FG004|Phase 3|Protocol Violation|1|||
129832623|NCT04762680|467353986|FG005|Phase 3|Protocol Violation|5|||
129832624|NCT04762680|467353987|FG006|Phase 3|Protocol Violation|1|||
129832625|NCT04762680|467353988|FG007|Phase 3|Protocol Violation|0|||
129832626|NCT04762680|467353989|FG008|Phase 3|Protocol Violation|0|||
129832627|NCT04762680|467353990|FG009|Phase 3|Protocol Violation|0|||
129832628|NCT04762680|467353991|FG010|Phase 3|Protocol Violation|0|||
129832629|NCT04762680|467353992|FG011|Phase 3|Protocol Violation|2|||
129832630|NCT04762680|467353993|FG012|Phase 3|Protocol Violation|3|||
129832631|NCT04762680|467353994|FG013|Phase 3|Protocol Violation|0|||
129832632|NCT04762680|467353995|FG014|Phase 3|Protocol Violation|0|||
129832633|NCT04762680|467353996|FG015|Phase 3|Protocol Violation|1|||
129832634|NCT04762680|467353997|FG016|Phase 3|Protocol Violation|0|||
129832635|NCT04762680|467353998|FG017|Phase 3|Protocol Violation|10|||
129832636|NCT04762680|467353999|FG018|Phase 3|Protocol Violation|0|||
129832637|NCT04762680|467354000|FG019|Phase 3|Protocol Violation|0|||
129832638|NCT04762680|467354001|FG020|Phase 3|Protocol Violation|0|||
129832639|NCT04762680|467354002|FG021|Phase 3|Protocol Violation|0|||
129832640|NCT04762680|467353981|FG000|Phase 3|Withdrawal by Subject|0|||
129832641|NCT04762680|467353982|FG001|Phase 3|Withdrawal by Subject|0|||
129832642|NCT04762680|467353983|FG002|Phase 3|Withdrawal by Subject|0|||
129832643|NCT04762680|467353984|FG003|Phase 3|Withdrawal by Subject|13|||
129832644|NCT04762680|467353985|FG004|Phase 3|Withdrawal by Subject|17|||
129832645|NCT04762680|467353986|FG005|Phase 3|Withdrawal by Subject|12|||
129832646|NCT04762680|467353987|FG006|Phase 3|Withdrawal by Subject|8|||
129832647|NCT04762680|467353988|FG007|Phase 3|Withdrawal by Subject|3|||
129832648|NCT04762680|467353989|FG008|Phase 3|Withdrawal by Subject|2|||
129832649|NCT04762680|467353990|FG009|Phase 3|Withdrawal by Subject|4|||
129832650|NCT04762680|467353991|FG010|Phase 3|Withdrawal by Subject|3|||
129832651|NCT04762680|467353992|FG011|Phase 3|Withdrawal by Subject|1|||
129832652|NCT04762680|467353993|FG012|Phase 3|Withdrawal by Subject|3|||
129832653|NCT04762680|467353994|FG013|Phase 3|Withdrawal by Subject|2|||
129832654|NCT04762680|467353995|FG014|Phase 3|Withdrawal by Subject|1|||
129832655|NCT04762680|467353996|FG015|Phase 3|Withdrawal by Subject|4|||
129832656|NCT04762680|467353997|FG016|Phase 3|Withdrawal by Subject|6|||
129832657|NCT04762680|467353998|FG017|Phase 3|Withdrawal by Subject|32|||
129832658|NCT04762680|467353999|FG018|Phase 3|Withdrawal by Subject|0|||
129832659|NCT04762680|467354000|FG019|Phase 3|Withdrawal by Subject|0|||
129832660|NCT04762680|467354001|FG020|Phase 3|Withdrawal by Subject|0|||
129832661|NCT04762680|467354002|FG021|Phase 3|Withdrawal by Subject|0|||
129832662|NCT04762680|467353981|FG000|Phase 3|Lost to Follow-up|0|||
129832663|NCT04762680|467353982|FG001|Phase 3|Lost to Follow-up|0|||
129832664|NCT04762680|467353983|FG002|Phase 3|Lost to Follow-up|0|||
129832665|NCT04762680|467353984|FG003|Phase 3|Lost to Follow-up|9|||
129832666|NCT04762680|467353985|FG004|Phase 3|Lost to Follow-up|22|||
129832667|NCT04762680|467353986|FG005|Phase 3|Lost to Follow-up|24|||
129832668|NCT04762680|467353987|FG006|Phase 3|Lost to Follow-up|2|||
129832669|NCT04762680|467353988|FG007|Phase 3|Lost to Follow-up|4|||
129832670|NCT04762680|467353989|FG008|Phase 3|Lost to Follow-up|6|||
129832671|NCT04762680|467353990|FG009|Phase 3|Lost to Follow-up|4|||
129832672|NCT04762680|467353991|FG010|Phase 3|Lost to Follow-up|3|||
129832673|NCT04762680|467353992|FG011|Phase 3|Lost to Follow-up|0|||
129832674|NCT04762680|467353993|FG012|Phase 3|Lost to Follow-up|5|||
129832675|NCT04762680|467353994|FG013|Phase 3|Lost to Follow-up|4|||
129832676|NCT04762680|467353995|FG014|Phase 3|Lost to Follow-up|6|||
129832677|NCT04762680|467353996|FG015|Phase 3|Lost to Follow-up|1|||
129832678|NCT04762680|467353997|FG016|Phase 3|Lost to Follow-up|1|||
129832679|NCT04762680|467353998|FG017|Phase 3|Lost to Follow-up|66|||
129832680|NCT04762680|467353999|FG018|Phase 3|Lost to Follow-up|0|||
129832681|NCT04762680|467354000|FG019|Phase 3|Lost to Follow-up|0|||
129832682|NCT04762680|467354001|FG020|Phase 3|Lost to Follow-up|0|||
129832683|NCT04762680|467354002|FG021|Phase 3|Lost to Follow-up|0|||
129832684|NCT04762680|467353981|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832685|NCT04762680|467353982|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832686|NCT04762680|467353983|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832687|NCT04762680|467353984|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832688|NCT04762680|467353985|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832689|NCT04762680|467353986|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832690|NCT04762680|467353987|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832691|NCT04762680|467353988|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832692|NCT04762680|467353989|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832693|NCT04762680|467353990|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832694|NCT04762680|467353991|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832695|NCT04762680|467353992|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832696|NCT04762680|467353993|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832697|NCT04762680|467353994|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832698|NCT04762680|467353995|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832699|NCT04762680|467353996|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832700|NCT04762680|467353997|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832701|NCT04762680|467353998|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832702|NCT04762680|467353999|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832703|NCT04762680|467354000|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832704|NCT04762680|467354001|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832705|NCT04762680|467354002|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
129832706|NCT04762680|467353981|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832707|NCT04762680|467353982|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832708|NCT04762680|467353983|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832709|NCT04762680|467353984|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832710|NCT04762680|467353985|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832711|NCT04762680|467353986|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832712|NCT04762680|467353987|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832713|NCT04762680|467353988|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832714|NCT04762680|467353989|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832715|NCT04762680|467353990|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832716|NCT04762680|467353991|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832717|NCT04762680|467353992|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832718|NCT04762680|467353993|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832719|NCT04762680|467353994|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832720|NCT04762680|467353995|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832721|NCT04762680|467353996|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832722|NCT04762680|467353997|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832723|NCT04762680|467353998|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832724|NCT04762680|467353999|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832725|NCT04762680|467354000|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
129832726|NCT04762680|467354001|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832727|NCT04762680|467354002|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832728|NCT02082210|467354003|FG000|Overall Study|Death|0|||
129832729|NCT02082210|467354004|FG001|Overall Study|Death|0|||
129832730|NCT02082210|467354005|FG002|Overall Study|Death|1|||
129832731|NCT02082210|467354006|FG003|Overall Study|Death|1|||
129832732|NCT02082210|467354007|FG004|Overall Study|Death|1|||
129832733|NCT02082210|467354008|FG005|Overall Study|Death|0|||
129832734|NCT02082210|467354003|FG000|Overall Study|Withdrawal by Subject|0|||
129832735|NCT02082210|467354004|FG001|Overall Study|Withdrawal by Subject|0|||
129832736|NCT02082210|467354005|FG002|Overall Study|Withdrawal by Subject|0|||
129832737|NCT02082210|467354006|FG003|Overall Study|Withdrawal by Subject|1|||
129832738|NCT02082210|467354007|FG004|Overall Study|Withdrawal by Subject|2|||
129832739|NCT02082210|467354008|FG005|Overall Study|Withdrawal by Subject|2|||
129832740|NCT02082210|467354003|FG000|Overall Study|Clinical Progression|0|||
129832741|NCT02082210|467354004|FG001|Overall Study|Clinical Progression|0|||
129832742|NCT02082210|467354005|FG002|Overall Study|Clinical Progression|0|||
129832743|NCT02082210|467354006|FG003|Overall Study|Clinical Progression|1|||
129832744|NCT02082210|467354007|FG004|Overall Study|Clinical Progression|0|||
129832745|NCT02082210|467354008|FG005|Overall Study|Clinical Progression|0|||
129832746|NCT02082210|467354003|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832747|NCT02082210|467354004|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832748|NCT02082210|467354005|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
129832749|NCT02082210|467354006|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
129832750|NCT02082210|467354007|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832751|NCT02082210|467354008|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832752|NCT02082210|467354003|FG000|Overall Study|Physician Decision|0|||
129832753|NCT02082210|467354004|FG001|Overall Study|Physician Decision|0|||
129832754|NCT02082210|467354005|FG002|Overall Study|Physician Decision|1|||
129832755|NCT02082210|467354006|FG003|Overall Study|Physician Decision|1|||
129832756|NCT02082210|467354007|FG004|Overall Study|Physician Decision|0|||
129832757|NCT02082210|467354008|FG005|Overall Study|Physician Decision|0|||
129832758|NCT04461015|467354022|FG000|Overall Study|IV access lost during the study|0|||
129832759|NCT04461015|467354023|FG001|Overall Study|IV access lost during the study|1|||
129832760|NCT04461015|467354022|FG000|Overall Study|Withdrawal by Subject|0|||
129832761|NCT04461015|467354023|FG001|Overall Study|Withdrawal by Subject|1|||
129832762|NCT03615326|467354025|FG000|Overall Study|Death|266|||
129832763|NCT03615326|467354026|FG001|Overall Study|Death|286|||
129832764|NCT03615326|467354027|FG002|Overall Study|Death|14|||
129832765|NCT03615326|467354028|FG003|Overall Study|Death|17|||
129832766|NCT03615326|467354025|FG000|Overall Study|Lost to Follow-up|0|||
129832767|NCT03615326|467354026|FG001|Overall Study|Lost to Follow-up|1|||
129832768|NCT03615326|467354027|FG002|Overall Study|Lost to Follow-up|0|||
129832769|NCT03615326|467354028|FG003|Overall Study|Lost to Follow-up|0|||
129832770|NCT03615326|467354025|FG000|Overall Study|Withdrawal by Subject|1|||
129832771|NCT03615326|467354026|FG001|Overall Study|Withdrawal by Subject|3|||
129832772|NCT03615326|467354027|FG002|Overall Study|Withdrawal by Subject|0|||
129832773|NCT03615326|467354028|FG003|Overall Study|Withdrawal by Subject|0|||
129832774|NCT03615326|467354025|FG000|Overall Study|Participants Ongoing|83|||
129832775|NCT03615326|467354026|FG001|Overall Study|Participants Ongoing|58|||
129832776|NCT03615326|467354027|FG002|Overall Study|Participants Ongoing|6|||
129832777|NCT03615326|467354028|FG003|Overall Study|Participants Ongoing|3|||
129832778|NCT03425331|467354041|FG000|Overall Study|Withdrawal by Subject|1|||
129832779|NCT03425331|467354041|FG000|Overall Study|Death|1|||
129832780|NCT03425331|467354041|FG000|Overall Study|Adverse Event|1|||
129832781|NCT03425331|467354041|FG000|Overall Study|Disease Progression|2|||
129832782|NCT02864251|467354044|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
129832783|NCT02864251|467354045|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
129832784|NCT02864251|467354046|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
130112730|NCT01797120|468373453|FG000|Overall Study|never start protocol therapy|2|||
130112731|NCT01797120|468373454|FG001|Overall Study|never start protocol therapy|0|||
130112732|NCT00827359|468373460|FG000|Overall Study|Progressive Diseas|19|||
130112733|NCT00827359|468373460|FG000|Overall Study|Unacceptable Toxicity|5|||
130112734|NCT00827359|468373460|FG000|Overall Study|Ineligible|1|||
130112735|NCT03840135|468373461|FG000|Overall Study|Protocol Violation|6|||
130112736|NCT03840135|468373462|FG001|Overall Study|Protocol Violation|1|||
130112737|NCT03840135|468373461|FG000|Overall Study|Withdrawal by Subject|1|||
130112738|NCT03840135|468373462|FG001|Overall Study|Withdrawal by Subject|0|||
130112739|NCT01809314|468373463|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
130112740|NCT01809314|468373463|FG000|Overall Study|Adverse Event|6|||
130112741|NCT01809314|468373463|FG000|Overall Study|Insufficient Therapeutic Response|14|||
130112742|NCT01809314|468373463|FG000|Overall Study|Lost to Follow-up|724|||
130112743|NCT00863057|468373466|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
130112744|NCT00863057|468373467|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
130112745|NCT00863057|468373468|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
130112746|NCT00863057|468373469|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
130112747|NCT00863057|468373466|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129832785|NCT02864251|467354044|FG000|Pre-Treatment|Withdrawal by Participant|0|||
129832786|NCT02864251|467354045|FG001|Pre-Treatment|Withdrawal by Participant|0|||
130112748|NCT00863057|468373467|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
129832787|NCT02864251|467354046|FG002|Pre-Treatment|Withdrawal by Participant|4|||
130060677|NCT01963208|468176712|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130060678|NCT01963208|468176713|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
130060679|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129832788|NCT02864251|467354044|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
129832789|NCT02864251|467354045|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
129832790|NCT02864251|467354046|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
129832791|NCT02864251|467354044|FG000|Pre-Treatment|Other Reasons|0|||
129832792|NCT02864251|467354045|FG001|Pre-Treatment|Other Reasons|1|||
129832793|NCT02864251|467354046|FG002|Pre-Treatment|Other Reasons|1|||
129832794|NCT02864251|467354044|FG000|Treatment|Disease Progression|109|||
129832795|NCT02864251|467354045|FG001|Treatment|Disease Progression|52|||
129832796|NCT02864251|467354046|FG002|Treatment|Disease Progression|101|||
129832797|NCT02864251|467354044|FG000|Treatment|Study Drug Toxicity|9|||
129832798|NCT02864251|467354045|FG001|Treatment|Study Drug Toxicity|4|||
129832799|NCT02864251|467354046|FG002|Treatment|Study Drug Toxicity|10|||
129832800|NCT02864251|467354044|FG000|Treatment|Death|0|||
129832801|NCT02864251|467354045|FG001|Treatment|Death|2|||
129832802|NCT02864251|467354046|FG002|Treatment|Death|3|||
129832803|NCT02864251|467354044|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
129832804|NCT02864251|467354045|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
129832805|NCT02864251|467354046|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
129832806|NCT02864251|467354044|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
129832807|NCT02864251|467354045|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
129832808|NCT02864251|467354046|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
129832809|NCT02864251|467354044|FG000|Treatment|Withdrawal by Participant|8|||
129832810|NCT02864251|467354045|FG001|Treatment|Withdrawal by Participant|5|||
129832811|NCT02864251|467354046|FG002|Treatment|Withdrawal by Participant|13|||
129832812|NCT02864251|467354044|FG000|Treatment|Maximum Clinical Benefit|1|||
129832813|NCT02864251|467354045|FG001|Treatment|Maximum Clinical Benefit|0|||
129832814|NCT02864251|467354046|FG002|Treatment|Maximum Clinical Benefit|1|||
129832815|NCT02864251|467354044|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
129832816|NCT02864251|467354045|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
129832817|NCT02864251|467354046|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
129832818|NCT02864251|467354044|FG000|Treatment|Other Reasons|1|||
129832819|NCT02864251|467354045|FG001|Treatment|Other Reasons|1|||
129832820|NCT02864251|467354046|FG002|Treatment|Other Reasons|4|||
129832821|NCT02864251|467354044|FG000|Treatment|Administrative Reason by Sponsor|1|||
129832822|NCT02864251|467354045|FG001|Treatment|Administrative Reason by Sponsor|0|||
129832823|NCT02864251|467354046|FG002|Treatment|Administrative Reason by Sponsor|0|||
129832824|NCT03506373|467354049|FG000|Overall Study|Adverse Event|6|||
129832825|NCT03506373|467354049|FG000|Overall Study|Withdrawal by Subject|2|||
129832826|NCT03506373|467354049|FG000|Overall Study|Disease progression|5|||
129832827|NCT03506373|467354049|FG000|Overall Study|Other|3|||
129832828|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
129832829|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
129832830|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
129832831|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
129832832|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
129832833|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
129832834|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
129832835|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
129832836|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
129832837|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Death|0|||
129832838|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Death|0|||
129832839|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Death|1|||
129832840|NCT00885755|467354050|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
129832841|NCT00885755|467354051|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
129832842|NCT00885755|467354052|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
129832843|NCT05442554|467354053|FG000|Overall Study|Adverse Event|1|||
129832844|NCT01852812|467354054|FG000|Overall Study|Adverse Event|0|||
129832845|NCT01852812|467354055|FG001|Overall Study|Adverse Event|0|||
129832846|NCT01852812|467354056|FG002|Overall Study|Adverse Event|1|||
129832847|NCT01852812|467354054|FG000|Overall Study|Non-compliance With Study Drug|0|||
129832848|NCT01852812|467354055|FG001|Overall Study|Non-compliance With Study Drug|1|||
129832849|NCT01852812|467354056|FG002|Overall Study|Non-compliance With Study Drug|0|||
129832850|NCT02250443|467354057|FG000|Overall Study|Administrative problems|7|||
129832851|NCT02250443|467354057|FG000|Overall Study|Adverse Event|3|||
129832852|NCT01549964|467354058|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
129832853|NCT01549964|467354059|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
129832854|NCT01549964|467354060|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
129832855|NCT01549964|467354061|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
129832856|NCT01549964|467354058|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
129832857|NCT01549964|467354059|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
129832858|NCT01549964|467354060|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
129832859|NCT01549964|467354061|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
130060680|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
130060681|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
130060682|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129832860|NCT01549964|467354058|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
129832861|NCT01549964|467354059|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
129832862|NCT01549964|467354060|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
129832863|NCT01549964|467354061|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
129832864|NCT01549964|467354058|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
129832865|NCT01549964|467354059|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
129832866|NCT01549964|467354060|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
129832867|NCT01549964|467354061|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
129832868|NCT01549964|467354058|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
129832869|NCT01549964|467354059|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
129832870|NCT01549964|467354060|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
129832871|NCT01549964|467354061|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
129832872|NCT01549964|467354058|FG000|24-Week Treatment Period|Other|1|||
129832873|NCT01549964|467354059|FG001|24-Week Treatment Period|Other|0|||
129832874|NCT01549964|467354060|FG002|24-Week Treatment Period|Other|1|||
129832875|NCT01549964|467354061|FG003|24-Week Treatment Period|Other|0|||
129832876|NCT01549964|467354058|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129832877|NCT01549964|467354059|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129832878|NCT01549964|467354060|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
129832879|NCT01549964|467354061|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129832880|NCT01549964|467354058|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
129832881|NCT01549964|467354059|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
129832882|NCT01549964|467354060|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
129832883|NCT01549964|467354061|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
129832884|NCT01549964|467354058|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
129832885|NCT01549964|467354059|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
129832886|NCT01549964|467354060|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
129832887|NCT01549964|467354061|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
129832888|NCT01549964|467354058|FG000|80-Week Extension Period|Pregnancy|0|||
129832889|NCT01549964|467354059|FG001|80-Week Extension Period|Pregnancy|0|||
129832890|NCT01549964|467354060|FG002|80-Week Extension Period|Pregnancy|1|||
129832891|NCT01549964|467354061|FG003|80-Week Extension Period|Pregnancy|0|||
129832892|NCT01549964|467354058|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
129832893|NCT01549964|467354059|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
129832894|NCT01549964|467354060|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
129832895|NCT01549964|467354061|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
129832896|NCT01549964|467354058|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
129832897|NCT01549964|467354059|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
129832898|NCT01549964|467354060|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
129832899|NCT01549964|467354061|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
129832900|NCT01549964|467354058|FG000|80-Week Extension Period|Lost to Follow-up|1|||
129832901|NCT01549964|467354059|FG001|80-Week Extension Period|Lost to Follow-up|0|||
129832902|NCT01549964|467354060|FG002|80-Week Extension Period|Lost to Follow-up|2|||
129832903|NCT01549964|467354061|FG003|80-Week Extension Period|Lost to Follow-up|1|||
129832904|NCT01549964|467354058|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
129832905|NCT01549964|467354059|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
129832906|NCT01549964|467354060|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
129832907|NCT01549964|467354061|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
129832908|NCT02290821|467354062|FG000|Overall Study|Withdrawal by Subject|1|||
129832909|NCT02290821|467354063|FG001|Overall Study|Withdrawal by Subject|1|||
129832910|NCT02290821|467354062|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
129832911|NCT02290821|467354063|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
129832912|NCT02290821|467354062|FG000|Overall Study|Lost to Follow-up|3|||
129832913|NCT02290821|467354063|FG001|Overall Study|Lost to Follow-up|2|||
129832914|NCT00751348|467354068|FG000|Overall Study|Withdrawal by Subject|5|||
129832915|NCT00751348|467354069|FG001|Overall Study|Withdrawal by Subject|2|||
129832916|NCT00751348|467354068|FG000|Overall Study|Migration from study area|1|||
129832917|NCT00751348|467354069|FG001|Overall Study|Migration from study area|0|||
129832918|NCT02039674|467354072|FG000|Overall Study|Adverse Event|0|||
129832919|NCT02039674|467354073|FG001|Overall Study|Adverse Event|0|||
130060683|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
129832920|NCT02039674|467354074|FG002|Overall Study|Adverse Event|0|||
129832921|NCT02039674|467354075|FG003|Overall Study|Adverse Event|1|||
129832922|NCT02039674|467354076|FG004|Overall Study|Adverse Event|0|||
129832923|NCT02039674|467354077|FG005|Overall Study|Adverse Event|0|||
130060684|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
130060685|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130060686|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130060687|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130060688|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
130060689|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
130060690|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
130060691|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130060692|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130060693|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130060694|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130060695|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
130060696|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
130060697|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130060698|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130060699|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130060700|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130060701|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
130060702|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
130060703|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
130060704|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
130060705|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
130060706|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
130060707|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
130060708|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
130060709|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130060710|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130060711|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130060712|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
130060713|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
130060714|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
130060715|NCT01963208|468176708|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
130060716|NCT01963208|468176709|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
130060717|NCT01963208|468176710|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
130060718|NCT01963208|468176711|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
130060719|NCT01963208|468176712|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
130060720|NCT01963208|468176713|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
130060721|NCT00448916|468176714|FG000|Overall Study|Adverse Event|2|||
130060722|NCT00448916|468176715|FG001|Overall Study|Adverse Event|2|||
130060723|NCT00448916|468176716|FG002|Overall Study|Adverse Event|3|||
130060724|NCT00448916|468176717|FG003|Overall Study|Adverse Event|2|||
130060725|NCT00448916|468176714|FG000|Overall Study|Lack of Efficacy|1|||
130060726|NCT00448916|468176715|FG001|Overall Study|Lack of Efficacy|0|||
130060727|NCT00448916|468176716|FG002|Overall Study|Lack of Efficacy|2|||
130060728|NCT00448916|468176717|FG003|Overall Study|Lack of Efficacy|1|||
130060729|NCT00448916|468176714|FG000|Overall Study|Withdrawal by Subject|3|||
130060730|NCT00448916|468176715|FG001|Overall Study|Withdrawal by Subject|3|||
130060731|NCT00448916|468176716|FG002|Overall Study|Withdrawal by Subject|1|||
130060732|NCT00448916|468176717|FG003|Overall Study|Withdrawal by Subject|1|||
130060733|NCT00448916|468176714|FG000|Overall Study|Other|1|||
130060734|NCT00448916|468176715|FG001|Overall Study|Other|0|||
130060735|NCT00448916|468176716|FG002|Overall Study|Other|0|||
130060736|NCT00448916|468176717|FG003|Overall Study|Other|0|||
130060737|NCT00448916|468176714|FG000|Overall Study|Lost to Follow-up|0|||
130060738|NCT00448916|468176715|FG001|Overall Study|Lost to Follow-up|1|||
129832924|NCT02039674|467354078|FG006|Overall Study|Adverse Event|0|||
130060739|NCT00448916|468176716|FG002|Overall Study|Lost to Follow-up|0|||
130112749|NCT00863057|468373468|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
130112750|NCT00863057|468373469|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129832925|NCT02039674|467354079|FG007|Overall Study|Adverse Event|0|||
129832926|NCT02039674|467354080|FG008|Overall Study|Adverse Event|2|||
130060740|NCT00448916|468176717|FG003|Overall Study|Lost to Follow-up|1|||
130060741|NCT00448916|468176714|FG000|Overall Study|Protocol Violation|0|||
130060742|NCT00448916|468176715|FG001|Overall Study|Protocol Violation|0|||
130060743|NCT00448916|468176716|FG002|Overall Study|Protocol Violation|0|||
130060744|NCT00448916|468176717|FG003|Overall Study|Protocol Violation|1|||
130060745|NCT03521193|468176718|FG000|Overall Study|Withdrawal by Subject|8|||
130112751|NCT00863057|468373466|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
130112752|NCT00863057|468373467|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
130112753|NCT00863057|468373468|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
130060746|NCT03521193|468176719|FG001|Overall Study|Withdrawal by Subject|0|||
130060747|NCT03521193|468176718|FG000|Overall Study|non compliant to ASA treatment|8|||
130112754|NCT00863057|468373469|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
129832927|NCT02039674|467354081|FG009|Overall Study|Adverse Event|1|||
129832928|NCT02039674|467354082|FG010|Overall Study|Adverse Event|0|||
129832929|NCT02039674|467354083|FG011|Overall Study|Adverse Event|2|||
129832930|NCT02039674|467354084|FG012|Overall Study|Adverse Event|3|||
129832931|NCT02039674|467354085|FG013|Overall Study|Adverse Event|1|||
129832932|NCT02039674|467354072|FG000|Overall Study|Death|2|||
129832933|NCT02039674|467354073|FG001|Overall Study|Death|0|||
129832934|NCT02039674|467354074|FG002|Overall Study|Death|2|||
129832935|NCT02039674|467354075|FG003|Overall Study|Death|3|||
129832936|NCT02039674|467354076|FG004|Overall Study|Death|0|||
129832937|NCT02039674|467354077|FG005|Overall Study|Death|0|||
129832938|NCT02039674|467354078|FG006|Overall Study|Death|1|||
129832939|NCT02039674|467354079|FG007|Overall Study|Death|0|||
129832940|NCT02039674|467354080|FG008|Overall Study|Death|2|||
129832941|NCT02039674|467354081|FG009|Overall Study|Death|0|||
129832942|NCT02039674|467354082|FG010|Overall Study|Death|1|||
129832943|NCT02039674|467354083|FG011|Overall Study|Death|3|||
129832944|NCT02039674|467354084|FG012|Overall Study|Death|2|||
129832945|NCT02039674|467354085|FG013|Overall Study|Death|8|||
129832946|NCT02039674|467354072|FG000|Overall Study|Excluded Medication|1|||
129832947|NCT02039674|467354073|FG001|Overall Study|Excluded Medication|1|||
129832948|NCT02039674|467354074|FG002|Overall Study|Excluded Medication|0|||
129832949|NCT02039674|467354075|FG003|Overall Study|Excluded Medication|1|||
129832950|NCT02039674|467354076|FG004|Overall Study|Excluded Medication|0|||
129832951|NCT02039674|467354077|FG005|Overall Study|Excluded Medication|1|||
129832952|NCT02039674|467354078|FG006|Overall Study|Excluded Medication|0|||
129832953|NCT02039674|467354079|FG007|Overall Study|Excluded Medication|0|||
129832954|NCT02039674|467354080|FG008|Overall Study|Excluded Medication|2|||
129832955|NCT02039674|467354081|FG009|Overall Study|Excluded Medication|3|||
129832956|NCT02039674|467354082|FG010|Overall Study|Excluded Medication|5|||
129832957|NCT02039674|467354083|FG011|Overall Study|Excluded Medication|6|||
129832958|NCT02039674|467354084|FG012|Overall Study|Excluded Medication|8|||
129832959|NCT02039674|467354085|FG013|Overall Study|Excluded Medication|3|||
129832960|NCT02039674|467354072|FG000|Overall Study|Lost to Follow-up|0|||
129832961|NCT02039674|467354073|FG001|Overall Study|Lost to Follow-up|0|||
129832962|NCT02039674|467354074|FG002|Overall Study|Lost to Follow-up|0|||
129832963|NCT02039674|467354075|FG003|Overall Study|Lost to Follow-up|0|||
129832964|NCT02039674|467354076|FG004|Overall Study|Lost to Follow-up|1|||
129832965|NCT02039674|467354077|FG005|Overall Study|Lost to Follow-up|1|||
129832966|NCT02039674|467354078|FG006|Overall Study|Lost to Follow-up|0|||
129832967|NCT02039674|467354079|FG007|Overall Study|Lost to Follow-up|0|||
129832968|NCT02039674|467354080|FG008|Overall Study|Lost to Follow-up|0|||
129832969|NCT02039674|467354081|FG009|Overall Study|Lost to Follow-up|0|||
129832970|NCT02039674|467354082|FG010|Overall Study|Lost to Follow-up|0|||
129832971|NCT02039674|467354083|FG011|Overall Study|Lost to Follow-up|2|||
129832972|NCT02039674|467354084|FG012|Overall Study|Lost to Follow-up|2|||
129832973|NCT02039674|467354085|FG013|Overall Study|Lost to Follow-up|1|||
129832974|NCT02039674|467354072|FG000|Overall Study|Physician Decision|0|||
129832975|NCT02039674|467354073|FG001|Overall Study|Physician Decision|0|||
129832976|NCT02039674|467354074|FG002|Overall Study|Physician Decision|0|||
129832977|NCT02039674|467354075|FG003|Overall Study|Physician Decision|0|||
129832978|NCT02039674|467354076|FG004|Overall Study|Physician Decision|0|||
129832979|NCT02039674|467354077|FG005|Overall Study|Physician Decision|0|||
129832980|NCT02039674|467354078|FG006|Overall Study|Physician Decision|0|||
129832981|NCT02039674|467354079|FG007|Overall Study|Physician Decision|0|||
129832982|NCT02039674|467354080|FG008|Overall Study|Physician Decision|0|||
129832983|NCT02039674|467354081|FG009|Overall Study|Physician Decision|0|||
129832984|NCT02039674|467354082|FG010|Overall Study|Physician Decision|0|||
129832985|NCT02039674|467354083|FG011|Overall Study|Physician Decision|1|||
129832986|NCT02039674|467354084|FG012|Overall Study|Physician Decision|1|||
129832987|NCT02039674|467354085|FG013|Overall Study|Physician Decision|0|||
129832988|NCT02039674|467354072|FG000|Overall Study|Progressive Disease|8|||
129832989|NCT02039674|467354073|FG001|Overall Study|Progressive Disease|8|||
129832990|NCT02039674|467354074|FG002|Overall Study|Progressive Disease|6|||
129832991|NCT02039674|467354075|FG003|Overall Study|Progressive Disease|7|||
129832992|NCT02039674|467354076|FG004|Overall Study|Progressive Disease|9|||
129832993|NCT02039674|467354077|FG005|Overall Study|Progressive Disease|10|||
129832994|NCT02039674|467354078|FG006|Overall Study|Progressive Disease|1|||
129832995|NCT02039674|467354079|FG007|Overall Study|Progressive Disease|3|||
129832996|NCT02039674|467354080|FG008|Overall Study|Progressive Disease|6|||
129832997|NCT02039674|467354081|FG009|Overall Study|Progressive Disease|4|||
129832998|NCT02039674|467354082|FG010|Overall Study|Progressive Disease|0|||
129832999|NCT02039674|467354083|FG011|Overall Study|Progressive Disease|34|||
129833000|NCT02039674|467354084|FG012|Overall Study|Progressive Disease|34|||
129833001|NCT02039674|467354085|FG013|Overall Study|Progressive Disease|18|||
129833002|NCT02039674|467354072|FG000|Overall Study|Withdrawal by Subject|1|||
129833003|NCT02039674|467354073|FG001|Overall Study|Withdrawal by Subject|2|||
129833004|NCT02039674|467354074|FG002|Overall Study|Withdrawal by Subject|3|||
129833005|NCT02039674|467354075|FG003|Overall Study|Withdrawal by Subject|0|||
129833006|NCT02039674|467354076|FG004|Overall Study|Withdrawal by Subject|1|||
129833007|NCT02039674|467354077|FG005|Overall Study|Withdrawal by Subject|0|||
129833008|NCT02039674|467354078|FG006|Overall Study|Withdrawal by Subject|0|||
129833009|NCT02039674|467354079|FG007|Overall Study|Withdrawal by Subject|0|||
129833010|NCT02039674|467354080|FG008|Overall Study|Withdrawal by Subject|0|||
129833011|NCT02039674|467354081|FG009|Overall Study|Withdrawal by Subject|1|||
129833012|NCT02039674|467354082|FG010|Overall Study|Withdrawal by Subject|1|||
129833013|NCT02039674|467354083|FG011|Overall Study|Withdrawal by Subject|4|||
129833014|NCT02039674|467354084|FG012|Overall Study|Withdrawal by Subject|6|||
129833015|NCT02039674|467354085|FG013|Overall Study|Withdrawal by Subject|2|||
129833016|NCT02039674|467354072|FG000|Overall Study|Clinical Progression|0|||
129833017|NCT02039674|467354073|FG001|Overall Study|Clinical Progression|0|||
129833018|NCT02039674|467354074|FG002|Overall Study|Clinical Progression|0|||
129833019|NCT02039674|467354075|FG003|Overall Study|Clinical Progression|0|||
129833020|NCT02039674|467354076|FG004|Overall Study|Clinical Progression|0|||
129833021|NCT02039674|467354077|FG005|Overall Study|Clinical Progression|0|||
129833022|NCT02039674|467354078|FG006|Overall Study|Clinical Progression|1|||
129833023|NCT02039674|467354079|FG007|Overall Study|Clinical Progression|0|||
129833024|NCT02039674|467354080|FG008|Overall Study|Clinical Progression|0|||
129833025|NCT02039674|467354081|FG009|Overall Study|Clinical Progression|0|||
129833026|NCT02039674|467354082|FG010|Overall Study|Clinical Progression|0|||
129833027|NCT02039674|467354083|FG011|Overall Study|Clinical Progression|0|||
129833028|NCT02039674|467354084|FG012|Overall Study|Clinical Progression|1|||
129833029|NCT02039674|467354085|FG013|Overall Study|Clinical Progression|0|||
129833030|NCT02039674|467354072|FG000|Overall Study|Sponsor Decision|1|||
129833031|NCT02039674|467354073|FG001|Overall Study|Sponsor Decision|1|||
129833032|NCT02039674|467354074|FG002|Overall Study|Sponsor Decision|1|||
129833033|NCT02039674|467354075|FG003|Overall Study|Sponsor Decision|1|||
129833034|NCT02039674|467354076|FG004|Overall Study|Sponsor Decision|1|||
129833035|NCT02039674|467354077|FG005|Overall Study|Sponsor Decision|0|||
129833036|NCT02039674|467354078|FG006|Overall Study|Sponsor Decision|0|||
129833037|NCT02039674|467354079|FG007|Overall Study|Sponsor Decision|0|||
129833038|NCT02039674|467354080|FG008|Overall Study|Sponsor Decision|0|||
129833039|NCT02039674|467354081|FG009|Overall Study|Sponsor Decision|3|||
129833040|NCT02039674|467354082|FG010|Overall Study|Sponsor Decision|0|||
129833041|NCT02039674|467354083|FG011|Overall Study|Sponsor Decision|8|||
129833042|NCT02039674|467354084|FG012|Overall Study|Sponsor Decision|5|||
129833043|NCT02039674|467354085|FG013|Overall Study|Sponsor Decision|0|||
129833044|NCT02039674|467354072|FG000|Overall Study|Other|0|||
129833045|NCT02039674|467354073|FG001|Overall Study|Other|0|||
129833046|NCT02039674|467354074|FG002|Overall Study|Other|0|||
129833047|NCT02039674|467354075|FG003|Overall Study|Other|0|||
129833048|NCT02039674|467354076|FG004|Overall Study|Other|0|||
129833049|NCT02039674|467354077|FG005|Overall Study|Other|0|||
129833050|NCT02039674|467354078|FG006|Overall Study|Other|0|||
129833051|NCT02039674|467354079|FG007|Overall Study|Other|0|||
129833052|NCT02039674|467354080|FG008|Overall Study|Other|0|||
129833053|NCT02039674|467354081|FG009|Overall Study|Other|0|||
129833054|NCT02039674|467354082|FG010|Overall Study|Other|0|||
129833055|NCT02039674|467354083|FG011|Overall Study|Other|0|||
129833056|NCT02039674|467354084|FG012|Overall Study|Other|1|||
129833057|NCT02039674|467354085|FG013|Overall Study|Other|0|||
129833058|NCT01826487|467354086|FG000|Overall Study|Adverse Event|1|||
129833059|NCT01826487|467354087|FG001|Overall Study|Adverse Event|1|||
129833060|NCT01826487|467354086|FG000|Overall Study|Lost to Follow-up|1|||
129833061|NCT01826487|467354087|FG001|Overall Study|Lost to Follow-up|0|||
129833062|NCT01826487|467354086|FG000|Overall Study|Withdrawal by Subject|1|||
129833063|NCT01826487|467354087|FG001|Overall Study|Withdrawal by Subject|3|||
129833064|NCT01826487|467354086|FG000|Overall Study|Protocol Violation|1|||
129833065|NCT01826487|467354087|FG001|Overall Study|Protocol Violation|1|||
129833066|NCT01358357|467354088|FG000|Open Label Phase|Adverse Event|0|||
129833067|NCT01358357|467354089|FG001|Open Label Phase|Adverse Event|0|||
129833068|NCT01358357|467354090|FG002|Open Label Phase|Adverse Event|59|||
129833069|NCT01358357|467354088|FG000|Open Label Phase|Lack of Efficacy|0|||
129833070|NCT01358357|467354089|FG001|Open Label Phase|Lack of Efficacy|0|||
129833071|NCT01358357|467354090|FG002|Open Label Phase|Lack of Efficacy|107|||
129833072|NCT01358357|467354088|FG000|Open Label Phase|Lost to Follow-up|0|||
129833073|NCT01358357|467354089|FG001|Open Label Phase|Lost to Follow-up|0|||
129833074|NCT01358357|467354090|FG002|Open Label Phase|Lost to Follow-up|76|||
129833075|NCT01358357|467354088|FG000|Open Label Phase|Protocol Violation|0|||
129833076|NCT01358357|467354089|FG001|Open Label Phase|Protocol Violation|0|||
129833077|NCT01358357|467354090|FG002|Open Label Phase|Protocol Violation|45|||
130060748|NCT03521193|468176719|FG001|Overall Study|non compliant to ASA treatment|0|||
130060749|NCT00012012|468176720|FG000|Overall Study|Protocol Violation|1|||
129833078|NCT01358357|467354088|FG000|Open Label Phase|Withdrawal by Subject|0|||
129833079|NCT01358357|467354089|FG001|Open Label Phase|Withdrawal by Subject|0|||
129833080|NCT01358357|467354090|FG002|Open Label Phase|Withdrawal by Subject|112|||
129833081|NCT01358357|467354088|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
129833082|NCT01358357|467354089|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
130060750|NCT00012012|468176721|FG001|Overall Study|Protocol Violation|1|||
129833083|NCT01358357|467354090|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
129833084|NCT01358357|467354088|FG000|Open Label Phase|Terminated at study completion|0|||
130112755|NCT00863057|468373466|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
130112756|NCT00863057|468373467|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
129833085|NCT01358357|467354089|FG001|Open Label Phase|Terminated at study completion|0|||
129833086|NCT01358357|467354090|FG002|Open Label Phase|Terminated at study completion|5|||
129833087|NCT01358357|467354088|FG000|Open Label Phase|Mood episode|0|||
129833088|NCT01358357|467354089|FG001|Open Label Phase|Mood episode|0|||
129833089|NCT01358357|467354090|FG002|Open Label Phase|Mood episode|42|||
129833090|NCT01358357|467354088|FG000|Double-Blind Phase|Adverse Event|8|||
129833091|NCT01358357|467354089|FG001|Double-Blind Phase|Adverse Event|5|||
129833092|NCT01358357|467354090|FG002|Double-Blind Phase|Adverse Event|0|||
129833093|NCT01358357|467354088|FG000|Double-Blind Phase|Lost to Follow-up|5|||
129833094|NCT01358357|467354089|FG001|Double-Blind Phase|Lost to Follow-up|7|||
129833095|NCT01358357|467354090|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129833096|NCT01358357|467354088|FG000|Double-Blind Phase|Protocol Violation|1|||
129833097|NCT01358357|467354089|FG001|Double-Blind Phase|Protocol Violation|11|||
129833098|NCT01358357|467354090|FG002|Double-Blind Phase|Protocol Violation|0|||
129833099|NCT01358357|467354088|FG000|Double-Blind Phase|Protocol Violation|16|||
129833100|NCT01358357|467354089|FG001|Double-Blind Phase|Protocol Violation|12|||
129833101|NCT01358357|467354090|FG002|Double-Blind Phase|Protocol Violation|0|||
129833102|NCT01358357|467354088|FG000|Double-Blind Phase|Terminated at study completion|2|||
129833103|NCT01358357|467354089|FG001|Double-Blind Phase|Terminated at study completion|0|||
129833104|NCT01358357|467354090|FG002|Double-Blind Phase|Terminated at study completion|0|||
129833105|NCT01358357|467354088|FG000|Double-Blind Phase|Recurrence of mood event|48|||
129833106|NCT01358357|467354089|FG001|Double-Blind Phase|Recurrence of mood event|64|||
129833107|NCT01358357|467354090|FG002|Double-Blind Phase|Recurrence of mood event|0|||
129833108|NCT01358357|467354088|FG000|Double-Blind Phase|Administrative|0|||
129833109|NCT01358357|467354089|FG001|Double-Blind Phase|Administrative|1|||
129833110|NCT01358357|467354090|FG002|Double-Blind Phase|Administrative|0|||
129833111|NCT02136576|467354091|FG000|Overall Study|Lost to Follow-up|2|||
129833112|NCT02136576|467354092|FG001|Overall Study|Lost to Follow-up|0|||
129833113|NCT02136576|467354093|FG002|Overall Study|Lost to Follow-up|0|||
129833114|NCT00537381|467354094|FG000|Overall Study|Adverse Event|13|||
129833115|NCT00537381|467354095|FG001|Overall Study|Adverse Event|9|||
129833116|NCT00537381|467354094|FG000|Overall Study|Death|3|||
129833117|NCT00537381|467354095|FG001|Overall Study|Death|3|||
129833118|NCT00537381|467354094|FG000|Overall Study|Withdrawal by Subject|5|||
129833119|NCT00537381|467354095|FG001|Overall Study|Withdrawal by Subject|14|||
129833120|NCT00537381|467354094|FG000|Overall Study|Physician Decision|7|||
129833121|NCT00537381|467354095|FG001|Overall Study|Physician Decision|6|||
129833122|NCT00537381|467354094|FG000|Overall Study|Disease Progression|9|||
129833123|NCT00537381|467354095|FG001|Overall Study|Disease Progression|18|||
129833124|NCT00537381|467354094|FG000|Overall Study|Sponsor decision|14|||
129833125|NCT00537381|467354095|FG001|Overall Study|Sponsor decision|9|||
129833126|NCT00537381|467354094|FG000|Overall Study|Other|5|||
129833127|NCT00537381|467354095|FG001|Overall Study|Other|3|||
129833128|NCT02590939|467354096|FG000|Overall Study|Withdrawal by Subject|3|||
129833129|NCT02590939|467354097|FG001|Overall Study|Withdrawal by Subject|1|||
129833130|NCT02590939|467354096|FG000|Overall Study|Failed the nociceptive test|2|||
129833131|NCT02590939|467354097|FG001|Overall Study|Failed the nociceptive test|1|||
129833132|NCT02081079|467354099|FG000|Overall Study|Lack of Efficacy|3|||
129833133|NCT02081079|467354100|FG001|Overall Study|Lack of Efficacy|2|||
129833134|NCT02081079|467354099|FG000|Overall Study|Lost to Follow-up|1|||
129833135|NCT02081079|467354100|FG001|Overall Study|Lost to Follow-up|0|||
129833136|NCT02225743|467354101|FG000|Overall Study|Withdrawal by Subject|18|||
129833137|NCT00729183|467354106|FG000|Overall Study|Adverse Event|11|||
129833138|NCT00729183|467354107|FG001|Overall Study|Adverse Event|5|||
129833139|NCT00729183|467354106|FG000|Overall Study|Lack of Efficacy|0|||
129833140|NCT00729183|467354107|FG001|Overall Study|Lack of Efficacy|1|||
129833141|NCT00729183|467354106|FG000|Overall Study|Lost to Follow-up|3|||
129833142|NCT00729183|467354107|FG001|Overall Study|Lost to Follow-up|1|||
129833143|NCT00729183|467354106|FG000|Overall Study|Physician Decision|1|||
129833144|NCT00729183|467354107|FG001|Overall Study|Physician Decision|1|||
129833145|NCT00729183|467354106|FG000|Overall Study|Protocol Violation|1|||
129833146|NCT00729183|467354107|FG001|Overall Study|Protocol Violation|0|||
129833147|NCT00729183|467354106|FG000|Overall Study|Withdrawal by Subject|9|||
129833148|NCT00729183|467354107|FG001|Overall Study|Withdrawal by Subject|7|||
129833149|NCT02867709|467354110|FG000|Treatment Period|Adverse Event|1|||
129833150|NCT02867709|467354111|FG001|Treatment Period|Adverse Event|1|||
129833151|NCT02867709|467354112|FG002|Treatment Period|Adverse Event|2|||
129833152|NCT02867709|467354110|FG000|Treatment Period|Withdrawal of Consent|7|||
129833153|NCT02867709|467354111|FG001|Treatment Period|Withdrawal of Consent|9|||
129833154|NCT02867709|467354112|FG002|Treatment Period|Withdrawal of Consent|8|||
129833155|NCT02867709|467354110|FG000|Treatment Period|Lost to Follow-up|17|||
129833156|NCT02867709|467354111|FG001|Treatment Period|Lost to Follow-up|20|||
129833157|NCT02867709|467354112|FG002|Treatment Period|Lost to Follow-up|20|||
130112757|NCT00863057|468373468|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
129833158|NCT02867709|467354110|FG000|Treatment Period|Lack of Qualifying Event|42|||
129833159|NCT02867709|467354111|FG001|Treatment Period|Lack of Qualifying Event|55|||
130060751|NCT00012012|468176720|FG000|Overall Study|Withdrawal by Subject|0|||
130060752|NCT00012012|468176721|FG001|Overall Study|Withdrawal by Subject|2|||
130060753|NCT01391819|468176722|FG000|Overall Study|Withdrawal by Subject|56|||
130060754|NCT01391819|468176722|FG000|Overall Study|Migrated/moved from study area|82|||
130060755|NCT01391819|468176722|FG000|Overall Study|Lost to Follow-up|252|||
129833160|NCT02867709|467354112|FG002|Treatment Period|Lack of Qualifying Event|42|||
129833161|NCT02867709|467354110|FG000|Treatment Period|Protocol Violation|3|||
129833162|NCT02867709|467354111|FG001|Treatment Period|Protocol Violation|2|||
129833163|NCT02867709|467354112|FG002|Treatment Period|Protocol Violation|3|||
129833164|NCT02867709|467354110|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
129833165|NCT02867709|467354111|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
129833166|NCT02867709|467354112|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
129833167|NCT02867709|467354110|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
129833168|NCT02867709|467354111|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
129833169|NCT02867709|467354112|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
129833170|NCT02867709|467354110|FG000|Safety Follow-up Period|Pregnancy|0|||
129833171|NCT02867709|467354111|FG001|Safety Follow-up Period|Pregnancy|1|||
129833172|NCT02867709|467354112|FG002|Safety Follow-up Period|Pregnancy|0|||
129833173|NCT02867709|467354110|FG000|Safety Follow-up Period|Protocol Violation|0|||
129833174|NCT02867709|467354111|FG001|Safety Follow-up Period|Protocol Violation|1|||
129833175|NCT02867709|467354112|FG002|Safety Follow-up Period|Protocol Violation|1|||
129833176|NCT05497284|467354113|FG000|Overall Study|Adverse Event|1|||
129833177|NCT05497284|467354114|FG001|Overall Study|Adverse Event|0|||
129833178|NCT05497284|467354113|FG000|Overall Study|Physician Decision|0|||
129833179|NCT05497284|467354114|FG001|Overall Study|Physician Decision|1|||
129833180|NCT05497284|467354113|FG000|Overall Study|Study terminated by sponsor|7|||
129833181|NCT05497284|467354114|FG001|Overall Study|Study terminated by sponsor|4|||
129833182|NCT05497284|467354113|FG000|Overall Study|Subject Decision|0|||
129833183|NCT05497284|467354114|FG001|Overall Study|Subject Decision|1|||
129833184|NCT03878446|467354115|FG000|Overall Study|Withdrawn by parent or guardian|1|||
129833185|NCT03878446|467354116|FG001|Overall Study|Withdrawn by parent or guardian|0|||
129833186|NCT03878446|467354117|FG002|Overall Study|Withdrawn by parent or guardian|0|||
129833187|NCT03878446|467354118|FG003|Overall Study|Withdrawn by parent or guardian|0|||
129833188|NCT03878446|467354119|FG004|Overall Study|Withdrawn by parent or guardian|0|||
129833189|NCT05041322|467354120|FG000|Baseline|Withdrawal by Subject|1|||
129833190|NCT05041322|467354121|FG001|Baseline|Withdrawal by Subject|0|||
129833191|NCT05041322|467354120|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
129833192|NCT05041322|467354121|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
129833193|NCT05041322|467354120|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
129833194|NCT05041322|467354121|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
129833195|NCT01502423|467354122|FG000|Overall Study|Withdrawal by Subject|0|||
129833196|NCT01502423|467354123|FG001|Overall Study|Withdrawal by Subject|1|||
129833197|NCT00567892|467354124|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833198|NCT00567892|467354125|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833199|NCT00567892|467354126|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
129833200|NCT00567892|467354127|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
129833201|NCT00567892|467354124|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833202|NCT00567892|467354125|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833203|NCT00567892|467354126|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833204|NCT00567892|467354127|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
129833205|NCT04383743|467354128|FG000|Overall Study|Withdrawal by Subject|1|||
129833206|NCT04383743|467354128|FG000|Overall Study|Adverse Event|1|||
129833207|NCT04837131|467354129|FG000|Overall Study|Death|1|||
129833208|NCT04837131|467354129|FG000|Overall Study|Withdrawal by Subject|1|||
129833209|NCT04837131|467354129|FG000|Overall Study|Adverse Event|1|||
129833210|NCT04837131|467354129|FG000|Overall Study|Protocol Violation|1|||
129833211|NCT04709575|467355526|FG000|Overall Study|Withdrawal by Subject|6|||
129833212|NCT04709575|467355527|FG001|Overall Study|Withdrawal by Subject|2|||
129833213|NCT04709575|467355526|FG000|Overall Study|Lost to Follow-up|2|||
129833214|NCT04709575|467355527|FG001|Overall Study|Lost to Follow-up|2|||
129833215|NCT04709575|467355526|FG000|Overall Study|Adverse Event|1|||
130060756|NCT01391819|468176722|FG000|Overall Study|Death|3|||
129833216|NCT04709575|467355527|FG001|Overall Study|Adverse Event|0|||
129833217|NCT04709575|467355526|FG000|Overall Study|Protocol Violation|1|||
129833218|NCT04709575|467355527|FG001|Overall Study|Protocol Violation|1|||
129833219|NCT03181399|467355528|FG000|6 Months on Treatment|Protocol non-compliance|7|||
129833220|NCT03181399|467355528|FG000|6 Months on Treatment|Adverse Event|4|||
129833221|NCT03181399|467355528|FG000|6 Months on Treatment|Tried alternative treatment|2|||
129833222|NCT03181399|467355528|FG000|6 Months on Treatment|Lost to Follow-up|2|||
129833223|NCT03181399|467355528|FG000|6 Months on Treatment|Personal reasons|1|||
129833224|NCT03181399|467355528|FG000|3 Months Off-treatment|Parent unable to travel|1|||
129833225|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
130060757|NCT01391819|468176722|FG000|Overall Study|Other|9|||
130060758|NCT03707158|468176725|FG000|Midtreatment|Lost to Follow-up|16|||
130060759|NCT03707158|468176726|FG001|Midtreatment|Lost to Follow-up|7|||
130112758|NCT00863057|468373469|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
130112759|NCT03652961|468373476|FG000|Overall Study|Lost to Follow-up|3|||
130112760|NCT03652961|468373476|FG000|Overall Study|Screen Failure|1|||
130112761|NCT02741271|468373477|FG000|Overall Study|Lost to Follow-up|2|||
129833226|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
129833227|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
130112762|NCT02741271|468373478|FG001|Overall Study|Lost to Follow-up|0|||
129833228|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
129833229|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
129833230|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
129833231|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
129833232|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
129833233|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
129833234|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
129833235|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
129833236|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
129833237|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
129833238|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
129833239|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
129833240|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
129833241|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
129833242|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
129833243|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
129833244|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
129833245|NCT05123222|467355535|FG000|Overall Study|Lost to Follow-up|2|||
129833246|NCT05123222|467355536|FG001|Overall Study|Lost to Follow-up|0|||
129833247|NCT05123222|467355537|FG002|Overall Study|Lost to Follow-up|0|||
129833248|NCT05123222|467355538|FG003|Overall Study|Lost to Follow-up|0|||
129833249|NCT05123222|467355535|FG000|Overall Study|Protocol Violation|0|||
129833250|NCT05123222|467355536|FG001|Overall Study|Protocol Violation|0|||
129833251|NCT05123222|467355537|FG002|Overall Study|Protocol Violation|1|||
129833252|NCT05123222|467355538|FG003|Overall Study|Protocol Violation|0|||
129833253|NCT02255500|467355543|FG000|Overall Study|Withdrawal by Subject|1|||
129833254|NCT02255500|467355544|FG001|Overall Study|Withdrawal by Subject|0|||
129833255|NCT00265343|467355545|FG000|Overall Study|Adverse Event|10|||
129833256|NCT00265343|467355546|FG001|Overall Study|Adverse Event|7|||
129833257|NCT00265343|467355545|FG000|Overall Study|Withdrawal by Subject|3|||
129833258|NCT00265343|467355546|FG001|Overall Study|Withdrawal by Subject|9|||
129833259|NCT00265343|467355545|FG000|Overall Study|Other|8|||
129833260|NCT00265343|467355546|FG001|Overall Study|Other|3|||
129833261|NCT04865354|467355547|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
129833262|NCT04865354|467355548|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
129833263|NCT04865354|467355547|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
129833264|NCT04865354|467355548|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
129833265|NCT04865354|467355547|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
129833266|NCT04865354|467355548|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
129833267|NCT00588822|467355553|FG000|Overall Study|progression of disease|8|||
129833268|NCT03616912|467355560|FG000|Overall Study|Adverse Event|17|||
129833269|NCT03616912|467355561|FG001|Overall Study|Adverse Event|21|||
129833270|NCT03616912|467355562|FG002|Overall Study|Adverse Event|9|||
129833271|NCT03616912|467355563|FG003|Overall Study|Adverse Event|0|||
129833272|NCT03616912|467355564|FG004|Overall Study|Adverse Event|0|||
129833273|NCT03616912|467355565|FG005|Overall Study|Adverse Event|0|||
129833274|NCT03616912|467355560|FG000|Overall Study|Death|1|||
129833275|NCT03616912|467355561|FG001|Overall Study|Death|1|||
129833276|NCT03616912|467355562|FG002|Overall Study|Death|0|||
129833277|NCT03616912|467355563|FG003|Overall Study|Death|0|||
129833278|NCT03616912|467355564|FG004|Overall Study|Death|0|||
130112763|NCT02741271|468373477|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130112764|NCT02741271|468373478|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129833279|NCT03616912|467355565|FG005|Overall Study|Death|0|||
129833280|NCT03616912|467355560|FG000|Overall Study|Lack of Efficacy|13|||
129833281|NCT03616912|467355561|FG001|Overall Study|Lack of Efficacy|6|||
129833282|NCT03616912|467355562|FG002|Overall Study|Lack of Efficacy|8|||
129833283|NCT03616912|467355563|FG003|Overall Study|Lack of Efficacy|4|||
129833284|NCT03616912|467355564|FG004|Overall Study|Lack of Efficacy|5|||
129833285|NCT03616912|467355565|FG005|Overall Study|Lack of Efficacy|1|||
129833286|NCT03616912|467355560|FG000|Overall Study|Lost to Follow-up|1|||
129833287|NCT03616912|467355561|FG001|Overall Study|Lost to Follow-up|2|||
129897725|NCT00299702|467584438|FG000|Overall Study|Adverse Event|0|||
129833288|NCT03616912|467355562|FG002|Overall Study|Lost to Follow-up|3|||
130112765|NCT01612156|468373479|FG000|Overall Study|Protocol Violation|2|||
129833289|NCT03616912|467355563|FG003|Overall Study|Lost to Follow-up|0|||
129833290|NCT03616912|467355564|FG004|Overall Study|Lost to Follow-up|0|||
129897726|NCT00299702|467584439|FG001|Overall Study|Adverse Event|4|||
129833291|NCT03616912|467355565|FG005|Overall Study|Lost to Follow-up|0|||
129833292|NCT03616912|467355560|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
129833293|NCT03616912|467355561|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
129833294|NCT03616912|467355562|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
129833295|NCT03616912|467355563|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
129833296|NCT03616912|467355564|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
129833297|NCT03616912|467355565|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
130060760|NCT03707158|468176725|FG000|Midtreatment|Withdrawal by Subject|28|||
130060761|NCT03707158|468176726|FG001|Midtreatment|Withdrawal by Subject|19|||
130060762|NCT03707158|468176725|FG000|Posttreatment|Lost to Follow-up|0|||
129833298|NCT03616912|467355560|FG000|Overall Study|Withdrawal by Subject|12|||
129833299|NCT03616912|467355561|FG001|Overall Study|Withdrawal by Subject|12|||
129833300|NCT03616912|467355562|FG002|Overall Study|Withdrawal by Subject|15|||
129833301|NCT03616912|467355563|FG003|Overall Study|Withdrawal by Subject|2|||
129833302|NCT03616912|467355564|FG004|Overall Study|Withdrawal by Subject|0|||
129833303|NCT03616912|467355565|FG005|Overall Study|Withdrawal by Subject|2|||
129833304|NCT03616912|467355560|FG000|Overall Study|Study Terminated by Sponsor|0|||
129833305|NCT03616912|467355561|FG001|Overall Study|Study Terminated by Sponsor|0|||
129833306|NCT03616912|467355562|FG002|Overall Study|Study Terminated by Sponsor|0|||
129833307|NCT03616912|467355563|FG003|Overall Study|Study Terminated by Sponsor|10|||
129833308|NCT03616912|467355564|FG004|Overall Study|Study Terminated by Sponsor|9|||
129833309|NCT03616912|467355565|FG005|Overall Study|Study Terminated by Sponsor|11|||
129833310|NCT03616912|467355560|FG000|Overall Study|Protocol Deviation|1|||
129833311|NCT03616912|467355561|FG001|Overall Study|Protocol Deviation|1|||
129833312|NCT03616912|467355562|FG002|Overall Study|Protocol Deviation|0|||
129833313|NCT03616912|467355563|FG003|Overall Study|Protocol Deviation|0|||
129833314|NCT03616912|467355564|FG004|Overall Study|Protocol Deviation|0|||
129833315|NCT03616912|467355565|FG005|Overall Study|Protocol Deviation|0|||
129833316|NCT03616912|467355560|FG000|Overall Study|Pregnancy|1|||
129833317|NCT03616912|467355561|FG001|Overall Study|Pregnancy|0|||
129833318|NCT03616912|467355562|FG002|Overall Study|Pregnancy|4|||
129833319|NCT03616912|467355563|FG003|Overall Study|Pregnancy|0|||
129833320|NCT03616912|467355564|FG004|Overall Study|Pregnancy|0|||
129833321|NCT03616912|467355565|FG005|Overall Study|Pregnancy|0|||
129833322|NCT03616912|467355560|FG000|Overall Study|Protocol Violation|1|||
129833323|NCT03616912|467355561|FG001|Overall Study|Protocol Violation|0|||
129833324|NCT03616912|467355562|FG002|Overall Study|Protocol Violation|2|||
129833325|NCT03616912|467355563|FG003|Overall Study|Protocol Violation|0|||
129833326|NCT03616912|467355564|FG004|Overall Study|Protocol Violation|0|||
129833327|NCT03616912|467355565|FG005|Overall Study|Protocol Violation|0|||
129833328|NCT03616912|467355560|FG000|Overall Study|Physician Decision|2|||
129833329|NCT03616912|467355561|FG001|Overall Study|Physician Decision|0|||
129833330|NCT03616912|467355562|FG002|Overall Study|Physician Decision|0|||
129833331|NCT03616912|467355563|FG003|Overall Study|Physician Decision|0|||
129833332|NCT03616912|467355564|FG004|Overall Study|Physician Decision|1|||
129833333|NCT03616912|467355565|FG005|Overall Study|Physician Decision|0|||
129833334|NCT03616912|467355560|FG000|Overall Study|Randomized But Never Treated|0|||
129833335|NCT03616912|467355561|FG001|Overall Study|Randomized But Never Treated|2|||
129833336|NCT03616912|467355562|FG002|Overall Study|Randomized But Never Treated|0|||
129833337|NCT03616912|467355563|FG003|Overall Study|Randomized But Never Treated|0|||
129833338|NCT03616912|467355564|FG004|Overall Study|Randomized But Never Treated|0|||
129833339|NCT03616912|467355565|FG005|Overall Study|Randomized But Never Treated|0|||
129833340|NCT01649375|467355566|FG000|Up to Week 16|Adverse Event|2|||
129833341|NCT01649375|467355567|FG001|Up to Week 16|Adverse Event|5|||
129833342|NCT01649375|467355568|FG002|Up to Week 16|Adverse Event|4|||
129833343|NCT01649375|467355569|FG003|Up to Week 16|Adverse Event|0|||
129833344|NCT01649375|467355570|FG004|Up to Week 16|Adverse Event|0|||
129833345|NCT01649375|467355566|FG000|Up to Week 16|Lack of Efficacy|0|||
129833346|NCT01649375|467355567|FG001|Up to Week 16|Lack of Efficacy|0|||
129833347|NCT01649375|467355568|FG002|Up to Week 16|Lack of Efficacy|1|||
129833348|NCT01649375|467355569|FG003|Up to Week 16|Lack of Efficacy|0|||
130060763|NCT03707158|468176726|FG001|Posttreatment|Lost to Follow-up|5|||
130060764|NCT03707158|468176725|FG000|Follow-up|Lost to Follow-up|19|||
129833349|NCT01649375|467355570|FG004|Up to Week 16|Lack of Efficacy|0|||
129833350|NCT01649375|467355566|FG000|Up to Week 16|Physician Decision|0|||
129833351|NCT01649375|467355567|FG001|Up to Week 16|Physician Decision|0|||
129833352|NCT01649375|467355568|FG002|Up to Week 16|Physician Decision|1|||
130060765|NCT03707158|468176726|FG001|Follow-up|Lost to Follow-up|18|||
129833353|NCT01649375|467355569|FG003|Up to Week 16|Physician Decision|0|||
129833354|NCT01649375|467355570|FG004|Up to Week 16|Physician Decision|0|||
129833355|NCT01649375|467355566|FG000|Up to Week 16|Withdrawal by Subject|2|||
129833356|NCT01649375|467355567|FG001|Up to Week 16|Withdrawal by Subject|1|||
129833357|NCT01649375|467355568|FG002|Up to Week 16|Withdrawal by Subject|2|||
129833358|NCT01649375|467355569|FG003|Up to Week 16|Withdrawal by Subject|0|||
129833359|NCT01649375|467355570|FG004|Up to Week 16|Withdrawal by Subject|0|||
129833360|NCT01649375|467355566|FG000|Up to Week 16|Death|1|||
129833361|NCT01649375|467355567|FG001|Up to Week 16|Death|0|||
129833362|NCT01649375|467355568|FG002|Up to Week 16|Death|0|||
129833363|NCT01649375|467355569|FG003|Up to Week 16|Death|0|||
130060766|NCT03707158|468176725|FG000|Follow-up|Withdrawal by Subject|13|||
130060767|NCT03707158|468176726|FG001|Follow-up|Withdrawal by Subject|6|||
130060768|NCT01208038|468176727|FG000|Overall Study|Withdrawal by Subject|1|||
130060769|NCT03260205|468176733|FG000|Overall Study|Adverse Event|2|||
130060770|NCT03260205|468176734|FG001|Overall Study|Adverse Event|0|||
130060771|NCT03260205|468176735|FG002|Overall Study|Adverse Event|2|||
130060772|NCT03260205|468176736|FG003|Overall Study|Adverse Event|2|||
130060773|NCT03260205|468176737|FG004|Overall Study|Adverse Event|4|||
130060774|NCT03260205|468176733|FG000|Overall Study|Lost to Follow-up|2|||
130060775|NCT03260205|468176734|FG001|Overall Study|Lost to Follow-up|2|||
130060776|NCT03260205|468176735|FG002|Overall Study|Lost to Follow-up|1|||
130112766|NCT01612156|468373480|FG001|Overall Study|Protocol Violation|0|||
130112767|NCT00410410|468373481|FG000|Induction Period (IP)|Death|1|||
130112768|NCT00410410|468373482|FG001|Induction Period (IP)|Death|0|||
130112769|NCT00410410|468373483|FG002|Induction Period (IP)|Death|0|||
130112770|NCT00410410|468373484|FG003|Induction Period (IP)|Death|0|||
130112771|NCT00410410|468373485|FG004|Induction Period (IP)|Death|0|||
130112772|NCT00410410|468373486|FG005|Induction Period (IP)|Death|0|||
130112773|NCT00410410|468373487|FG006|Induction Period (IP)|Death|0|||
130112774|NCT00410410|468373488|FG007|Induction Period (IP)|Death|0|||
130112775|NCT00410410|468373489|FG008|Induction Period (IP)|Death|0|||
130112776|NCT00410410|468373481|FG000|Induction Period (IP)|Adverse Event|3|||
130112777|NCT00410410|468373482|FG001|Induction Period (IP)|Adverse Event|4|||
130112778|NCT00410410|468373483|FG002|Induction Period (IP)|Adverse Event|2|||
130112779|NCT00410410|468373484|FG003|Induction Period (IP)|Adverse Event|4|||
130112780|NCT00410410|468373485|FG004|Induction Period (IP)|Adverse Event|1|||
130112781|NCT00410410|468373486|FG005|Induction Period (IP)|Adverse Event|0|||
130112782|NCT00410410|468373487|FG006|Induction Period (IP)|Adverse Event|0|||
130112783|NCT00410410|468373488|FG007|Induction Period (IP)|Adverse Event|0|||
130112784|NCT00410410|468373489|FG008|Induction Period (IP)|Adverse Event|0|||
130112785|NCT00410410|468373481|FG000|Induction Period (IP)|Lack of Efficacy|26|||
130112786|NCT00410410|468373482|FG001|Induction Period (IP)|Lack of Efficacy|24|||
130112787|NCT00410410|468373483|FG002|Induction Period (IP)|Lack of Efficacy|8|||
130112788|NCT00410410|468373484|FG003|Induction Period (IP)|Lack of Efficacy|8|||
130112789|NCT00410410|468373485|FG004|Induction Period (IP)|Lack of Efficacy|7|||
129833364|NCT01649375|467355570|FG004|Up to Week 16|Death|0|||
129833365|NCT01649375|467355566|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
129833366|NCT01649375|467355567|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
129833367|NCT01649375|467355568|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
129833368|NCT01649375|467355569|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
129833369|NCT01649375|467355570|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
129833370|NCT01649375|467355566|FG000|Week 16 up to Week 260|Non-compliance|0|||
130060777|NCT03260205|468176736|FG003|Overall Study|Lost to Follow-up|1|||
129833371|NCT01649375|467355567|FG001|Week 16 up to Week 260|Non-compliance|1|||
129833372|NCT01649375|467355568|FG002|Week 16 up to Week 260|Non-compliance|0|||
129833373|NCT01649375|467355569|FG003|Week 16 up to Week 260|Non-compliance|1|||
129833374|NCT01649375|467355570|FG004|Week 16 up to Week 260|Non-compliance|0|||
129833375|NCT01649375|467355566|FG000|Week 16 up to Week 260|Physician Decision|0|||
129833376|NCT01649375|467355567|FG001|Week 16 up to Week 260|Physician Decision|2|||
129833377|NCT01649375|467355568|FG002|Week 16 up to Week 260|Physician Decision|0|||
129833378|NCT01649375|467355569|FG003|Week 16 up to Week 260|Physician Decision|0|||
129833379|NCT01649375|467355570|FG004|Week 16 up to Week 260|Physician Decision|0|||
129833380|NCT01649375|467355566|FG000|Week 16 up to Week 260|Technical issues|0|||
129833381|NCT01649375|467355567|FG001|Week 16 up to Week 260|Technical issues|1|||
129833382|NCT01649375|467355568|FG002|Week 16 up to Week 260|Technical issues|0|||
129833383|NCT01649375|467355569|FG003|Week 16 up to Week 260|Technical issues|1|||
129833384|NCT01649375|467355570|FG004|Week 16 up to Week 260|Technical issues|0|||
129833385|NCT01649375|467355566|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
130112790|NCT00410410|468373486|FG005|Induction Period (IP)|Lack of Efficacy|7|||
130112791|NCT00410410|468373487|FG006|Induction Period (IP)|Lack of Efficacy|0|||
130112792|NCT00410410|468373488|FG007|Induction Period (IP)|Lack of Efficacy|0|||
130112793|NCT00410410|468373489|FG008|Induction Period (IP)|Lack of Efficacy|0|||
129833386|NCT01649375|467355567|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
129833387|NCT01649375|467355568|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
129833388|NCT01649375|467355569|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
130060778|NCT03260205|468176737|FG004|Overall Study|Lost to Follow-up|5|||
130060779|NCT03260205|468176733|FG000|Overall Study|Protocol Violation|0|||
130060780|NCT03260205|468176734|FG001|Overall Study|Protocol Violation|0|||
130112794|NCT00410410|468373481|FG000|Induction Period (IP)|Lost to Follow-up|2|||
130112795|NCT00410410|468373482|FG001|Induction Period (IP)|Lost to Follow-up|2|||
130112796|NCT00410410|468373483|FG002|Induction Period (IP)|Lost to Follow-up|2|||
129833389|NCT01649375|467355570|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
129833390|NCT01649375|467355566|FG000|Week 16 up to Week 260|Death|1|||
129833391|NCT01649375|467355567|FG001|Week 16 up to Week 260|Death|1|||
129833392|NCT01649375|467355568|FG002|Week 16 up to Week 260|Death|0|||
130112797|NCT00410410|468373484|FG003|Induction Period (IP)|Lost to Follow-up|3|||
130112798|NCT00410410|468373485|FG004|Induction Period (IP)|Lost to Follow-up|0|||
129833393|NCT01649375|467355569|FG003|Week 16 up to Week 260|Death|0|||
129833394|NCT01649375|467355570|FG004|Week 16 up to Week 260|Death|0|||
129833395|NCT01649375|467355566|FG000|Week 16 up to Week 260|Adverse Event|5|||
129833396|NCT01649375|467355567|FG001|Week 16 up to Week 260|Adverse Event|2|||
129833397|NCT01649375|467355568|FG002|Week 16 up to Week 260|Adverse Event|0|||
129833398|NCT01649375|467355569|FG003|Week 16 up to Week 260|Adverse Event|3|||
129833399|NCT01649375|467355570|FG004|Week 16 up to Week 260|Adverse Event|2|||
129833400|NCT01856790|467355571|FG000|Closed Loop Control|Withdrawal by Subject|2|||
129833401|NCT01856790|467355571|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
129833402|NCT04091646|467355572|FG000|Overall Study|Adverse Event|2|||
129833403|NCT04091646|467355573|FG001|Overall Study|Adverse Event|1|||
129833404|NCT04091646|467355572|FG000|Overall Study|Lost to Follow-up|6|||
129833405|NCT04091646|467355573|FG001|Overall Study|Lost to Follow-up|2|||
129833406|NCT04091646|467355572|FG000|Overall Study|Protocol Violation|0|||
129833407|NCT04091646|467355573|FG001|Overall Study|Protocol Violation|1|||
129833408|NCT04091646|467355572|FG000|Overall Study|Withdrawal by Subject|4|||
129833409|NCT04091646|467355573|FG001|Overall Study|Withdrawal by Subject|1|||
129833410|NCT04091646|467355572|FG000|Overall Study|Participant Incarcerated|1|||
129833411|NCT04091646|467355573|FG001|Overall Study|Participant Incarcerated|0|||
129833412|NCT01762943|467355574|FG000|Overall Study|Physician Decision|1|||
129833413|NCT01762943|467355575|FG001|Overall Study|Physician Decision|1|||
130060781|NCT03260205|468176735|FG002|Overall Study|Protocol Violation|2|||
130060782|NCT03260205|468176736|FG003|Overall Study|Protocol Violation|0|||
130060783|NCT03260205|468176737|FG004|Overall Study|Protocol Violation|1|||
130060784|NCT03260205|468176733|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
130060785|NCT03260205|468176734|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
130060786|NCT03260205|468176735|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
130060787|NCT03260205|468176736|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
130060788|NCT03260205|468176737|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
130060789|NCT03260205|468176733|FG000|Overall Study|Other: Unspecified|0|||
130060790|NCT03260205|468176734|FG001|Overall Study|Other: Unspecified|0|||
130060791|NCT03260205|468176735|FG002|Overall Study|Other: Unspecified|3|||
130060792|NCT03260205|468176736|FG003|Overall Study|Other: Unspecified|1|||
130060793|NCT03260205|468176737|FG004|Overall Study|Other: Unspecified|1|||
130060794|NCT03260205|468176733|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
130060795|NCT03260205|468176734|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
130060796|NCT03260205|468176735|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
130060797|NCT03260205|468176736|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
130060798|NCT03260205|468176737|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
130060799|NCT05301322|468176738|FG000|Overall Study|Adverse Event|7|||
130060800|NCT05301322|468176739|FG001|Overall Study|Adverse Event|3|||
130060801|NCT05301322|468176738|FG000|Overall Study|Death|0|||
130060802|NCT05301322|468176739|FG001|Overall Study|Death|1|||
130060803|NCT05301322|468176738|FG000|Overall Study|Lost to Follow-up|2|||
130060804|NCT05301322|468176739|FG001|Overall Study|Lost to Follow-up|1|||
130060805|NCT05301322|468176738|FG000|Overall Study|Protocol Violation|3|||
130060806|NCT05301322|468176739|FG001|Overall Study|Protocol Violation|1|||
130060807|NCT05301322|468176738|FG000|Overall Study|Withdrawal by Subject|3|||
130060808|NCT05301322|468176739|FG001|Overall Study|Withdrawal by Subject|0|||
130060809|NCT05301322|468176738|FG000|Overall Study|Other|4|||
130060810|NCT05301322|468176739|FG001|Overall Study|Other|0|||
130060811|NCT00808249|468176742|FG000|Overall Study|Adverse Event|4|||
130060812|NCT00808249|468176743|FG001|Overall Study|Adverse Event|7|||
130060813|NCT00808249|468176744|FG002|Overall Study|Adverse Event|10|||
130060814|NCT00808249|468176745|FG003|Overall Study|Adverse Event|6|||
130060815|NCT00808249|468176742|FG000|Overall Study|Lost to Follow-up|2|||
130060816|NCT00808249|468176743|FG001|Overall Study|Lost to Follow-up|3|||
130060817|NCT00808249|468176744|FG002|Overall Study|Lost to Follow-up|3|||
130060818|NCT00808249|468176745|FG003|Overall Study|Lost to Follow-up|5|||
130060819|NCT00808249|468176742|FG000|Overall Study|Withdrawal by Subject|4|||
130060820|NCT00808249|468176743|FG001|Overall Study|Withdrawal by Subject|0|||
129833414|NCT01762943|467355574|FG000|Overall Study|Protocol Violation|1|||
129833415|NCT01762943|467355575|FG001|Overall Study|Protocol Violation|0|||
129833416|NCT01762943|467355574|FG000|Overall Study|Withdrawal by Subject|2|||
130060821|NCT00808249|468176744|FG002|Overall Study|Withdrawal by Subject|2|||
130060822|NCT00808249|468176745|FG003|Overall Study|Withdrawal by Subject|4|||
130060823|NCT00808249|468176742|FG000|Overall Study|Protocol Violation|3|||
130060824|NCT00808249|468176743|FG001|Overall Study|Protocol Violation|3|||
130060825|NCT00808249|468176744|FG002|Overall Study|Protocol Violation|3|||
130060826|NCT00808249|468176745|FG003|Overall Study|Protocol Violation|0|||
130060827|NCT00808249|468176742|FG000|Overall Study|Lack of Efficacy|1|||
130060828|NCT00808249|468176743|FG001|Overall Study|Lack of Efficacy|1|||
130060829|NCT00808249|468176744|FG002|Overall Study|Lack of Efficacy|0|||
130060830|NCT00808249|468176745|FG003|Overall Study|Lack of Efficacy|0|||
129833417|NCT01762943|467355575|FG001|Overall Study|Withdrawal by Subject|1|||
129833418|NCT00539838|467355576|FG000|Overall Study|Fail to return|2|||
129833419|NCT00539838|467355577|FG001|Overall Study|Fail to return|0|||
129833420|NCT00539838|467355578|FG002|Overall Study|Fail to return|0|||
129833421|NCT00539838|467355576|FG000|Overall Study|Withdrawal by Subject|0|||
129833422|NCT00539838|467355577|FG001|Overall Study|Withdrawal by Subject|4|||
129833423|NCT00539838|467355578|FG002|Overall Study|Withdrawal by Subject|0|||
129833424|NCT00539838|467355576|FG000|Overall Study|Death|0|||
129833425|NCT00539838|467355577|FG001|Overall Study|Death|2|||
129833426|NCT00539838|467355578|FG002|Overall Study|Death|0|||
129833427|NCT00539838|467355576|FG000|Overall Study|Did not cooperate|1|||
129833428|NCT00539838|467355577|FG001|Overall Study|Did not cooperate|0|||
129833429|NCT00539838|467355578|FG002|Overall Study|Did not cooperate|1|||
129833430|NCT00539838|467355576|FG000|Overall Study|Administrative|4|||
129833431|NCT00539838|467355577|FG001|Overall Study|Administrative|0|||
129833432|NCT00539838|467355578|FG002|Overall Study|Administrative|8|||
129833433|NCT04343521|467355579|FG000|Overall Study|Adverse Event|0|||
129833434|NCT04343521|467355580|FG001|Overall Study|Adverse Event|2|||
129833435|NCT04343521|467355579|FG000|Overall Study|Death|1|||
129833436|NCT04343521|467355580|FG001|Overall Study|Death|2|||
129833437|NCT04343521|467355579|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
129833438|NCT04343521|467355580|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
129833439|NCT04343521|467355579|FG000|Overall Study|Withdrawal by Subject|70|||
129833440|NCT04343521|467355580|FG001|Overall Study|Withdrawal by Subject|95|||
129833441|NCT04343521|467355579|FG000|Overall Study|Withdrawal by study team|6|||
129833442|NCT04343521|467355580|FG001|Overall Study|Withdrawal by study team|12|||
129833443|NCT00107198|467355581|FG000|Overall Study|Lack of Efficacy|28|||
129833444|NCT00107198|467355581|FG000|Overall Study|Lost to Follow-up|12|||
129833445|NCT00107198|467355581|FG000|Overall Study|Protocol Violation|1|||
129833446|NCT00107198|467355581|FG000|Overall Study|Withdrawal by Subject|6|||
129833447|NCT00107198|467355581|FG000|Overall Study|Ineligible|5|||
129833448|NCT02120950|467355582|FG000|Overall Study|Adverse Event|5|||
129833449|NCT02120950|467355583|FG001|Overall Study|Adverse Event|4|||
129833450|NCT02120950|467355584|FG002|Overall Study|Adverse Event|3|||
129833451|NCT02120950|467355582|FG000|Overall Study|Death|3|||
129833452|NCT02120950|467355583|FG001|Overall Study|Death|0|||
129833453|NCT02120950|467355584|FG002|Overall Study|Death|1|||
129833454|NCT02120950|467355582|FG000|Overall Study|Withdrawal by Subject|6|||
129833455|NCT02120950|467355583|FG001|Overall Study|Withdrawal by Subject|3|||
129833456|NCT02120950|467355584|FG002|Overall Study|Withdrawal by Subject|2|||
129833457|NCT02120950|467355582|FG000|Overall Study|Protocol Violation|1|||
129833458|NCT02120950|467355583|FG001|Overall Study|Protocol Violation|1|||
129833459|NCT02120950|467355584|FG002|Overall Study|Protocol Violation|7|||
129833460|NCT02120950|467355582|FG000|Overall Study|Other reasons|5|||
129833461|NCT02120950|467355583|FG001|Overall Study|Other reasons|4|||
129833462|NCT02120950|467355584|FG002|Overall Study|Other reasons|1|||
129833463|NCT02120950|467355582|FG000|Overall Study|Lost to Follow-up|0|||
129833464|NCT02120950|467355583|FG001|Overall Study|Lost to Follow-up|2|||
129833465|NCT02120950|467355584|FG002|Overall Study|Lost to Follow-up|1|||
129833466|NCT02424383|467355585|FG000|Overall Study|Withdrawal by Subject|32|||
129833467|NCT02424383|467355585|FG000|Overall Study|Death|170|||
129833468|NCT02424383|467355585|FG000|Overall Study|Sponsor's decision|3|||
129833469|NCT02424383|467355585|FG000|Overall Study|Investigator's decision|44|||
129833470|NCT02424383|467355585|FG000|Overall Study|Lost to Follow-up|81|||
129833471|NCT02424383|467355585|FG000|Overall Study|Other|7|||
129833472|NCT02424383|467355585|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
129833473|NCT01817725|467355586|FG000|Overall Study|Withdrawal by Subject|1|||
129833474|NCT02438722|467355589|FG000|Overall Study|Adverse Event|12|||
129833475|NCT02438722|467355590|FG001|Overall Study|Adverse Event|9|||
129833476|NCT02438722|467355589|FG000|Overall Study|Refusal unrelated to AE|2|||
129833477|NCT02438722|467355590|FG001|Overall Study|Refusal unrelated to AE|5|||
129833478|NCT02438722|467355589|FG000|Overall Study|Disease progression/relapse|46|||
129833479|NCT02438722|467355590|FG001|Overall Study|Disease progression/relapse|51|||
129833480|NCT02438722|467355589|FG000|Overall Study|Death|0|||
129833481|NCT02438722|467355590|FG001|Overall Study|Death|3|||
129833482|NCT02438722|467355589|FG000|Overall Study|Physician Decision|2|||
129833483|NCT02438722|467355590|FG001|Overall Study|Physician Decision|2|||
129833484|NCT02438722|467355589|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
129833485|NCT02438722|467355590|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
129833486|NCT02438722|467355589|FG000|Overall Study|Withdrawal by Subject|0|||
130112799|NCT00410410|468373486|FG005|Induction Period (IP)|Lost to Follow-up|1|||
129833487|NCT02438722|467355590|FG001|Overall Study|Withdrawal by Subject|1|||
129833488|NCT02438722|467355589|FG000|Overall Study|On protocol treatment|15|||
129833489|NCT02438722|467355590|FG001|Overall Study|On protocol treatment|14|||
129833490|NCT02438722|467355589|FG000|Overall Study|Did not receive protocol treatment|5|||
129833491|NCT02438722|467355590|FG001|Overall Study|Did not receive protocol treatment|0|||
129833492|NCT00909779|467355591|FG000|Overall Study|Adverse Event|53|||
129833493|NCT00909779|467355592|FG001|Overall Study|Adverse Event|55|||
129833494|NCT00909779|467355591|FG000|Overall Study|Lack of Efficacy|7|||
129833495|NCT00909779|467355592|FG001|Overall Study|Lack of Efficacy|4|||
129833496|NCT00909779|467355591|FG000|Overall Study|Lost to Follow-up|19|||
129833497|NCT00909779|467355592|FG001|Overall Study|Lost to Follow-up|15|||
129833498|NCT00909779|467355591|FG000|Overall Study|Physician Decision|8|||
129833499|NCT00909779|467355592|FG001|Overall Study|Physician Decision|2|||
129833500|NCT00909779|467355591|FG000|Overall Study|Protocol Violation|2|||
129833501|NCT00909779|467355592|FG001|Overall Study|Protocol Violation|5|||
129833502|NCT00909779|467355591|FG000|Overall Study|Withdrawal by Subject|116|||
129833503|NCT00909779|467355592|FG001|Overall Study|Withdrawal by Subject|80|||
129833504|NCT00909779|467355591|FG000|Overall Study|Site Ceasing Operation|2|||
129833505|NCT00909779|467355592|FG001|Overall Study|Site Ceasing Operation|2|||
129833506|NCT00909779|467355591|FG000|Overall Study|Medical Monitor Decision|1|||
129833507|NCT00909779|467355592|FG001|Overall Study|Medical Monitor Decision|0|||
129833508|NCT00909779|467355591|FG000|Overall Study|Noncompliance|1|||
129833509|NCT00909779|467355592|FG001|Overall Study|Noncompliance|1|||
129833510|NCT00909779|467355591|FG000|Overall Study|Randomized in error|1|||
129833511|NCT00909779|467355592|FG001|Overall Study|Randomized in error|1|||
129833512|NCT02738333|467355596|FG000|Overall Study|Death|1|||
129833513|NCT02738333|467355597|FG001|Overall Study|Death|0|||
129833514|NCT02738333|467355598|FG002|Overall Study|Death|0|||
129833515|NCT02738333|467355596|FG000|Overall Study|Lost to Follow-up|1|||
129833516|NCT02738333|467355597|FG001|Overall Study|Lost to Follow-up|0|||
129833517|NCT02738333|467355598|FG002|Overall Study|Lost to Follow-up|0|||
129833518|NCT01498952|467355600|FG000|Overall Study|Death|2|||
129833519|NCT01498952|467355601|FG001|Overall Study|Death|2|||
129833520|NCT01498952|467355602|FG002|Overall Study|Death|0|||
129833521|NCT01498952|467355603|FG003|Overall Study|Death|0|||
129833522|NCT01498952|467355604|FG004|Overall Study|Death|0|||
129833523|NCT00579826|467355605|FG000|Overall Study|Withdrawal by Subject|5|||
129833524|NCT00579826|467355606|FG001|Overall Study|Withdrawal by Subject|3|||
129833525|NCT04191382|467355607|FG000|Overall Study|Withdrawal by Subject|1|||
129833526|NCT04191382|467355608|FG001|Overall Study|Withdrawal by Subject|0|||
129833527|NCT04191382|467355609|FG002|Overall Study|Withdrawal by Subject|0|||
129833528|NCT05237206|467355610|FG000|Overall Study|screen failure-did not receive treatment|8|||
129833529|NCT05237206|467355610|FG000|Overall Study|did not receive treatment|3|||
129833530|NCT00454987|467355616|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
129833531|NCT00454987|467355617|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
129833532|NCT00454987|467355618|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
129833533|NCT00454987|467355616|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
129833534|NCT00454987|467355617|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
129833535|NCT00454987|467355618|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
129833536|NCT00454987|467355616|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
129833537|NCT00454987|467355617|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
129833538|NCT00454987|467355618|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
129833539|NCT02205333|467355619|FG000|Overall Study|Death|5|||
129833540|NCT02205333|467355620|FG001|Overall Study|Death|6|||
129833541|NCT02205333|467355621|FG002|Overall Study|Death|2|||
129833542|NCT02205333|467355622|FG003|Overall Study|Death|6|||
129833543|NCT02205333|467355623|FG004|Overall Study|Death|5|||
129833544|NCT02205333|467355624|FG005|Overall Study|Death|3|||
129833545|NCT02205333|467355625|FG006|Overall Study|Death|3|||
129833546|NCT02205333|467355626|FG007|Overall Study|Death|2|||
129833547|NCT02205333|467355627|FG008|Overall Study|Death|0|||
129833548|NCT02205333|467355619|FG000|Overall Study|Withdrawal by Subject|1|||
129833549|NCT02205333|467355620|FG001|Overall Study|Withdrawal by Subject|0|||
129833550|NCT02205333|467355621|FG002|Overall Study|Withdrawal by Subject|0|||
129833551|NCT02205333|467355622|FG003|Overall Study|Withdrawal by Subject|1|||
129833552|NCT02205333|467355623|FG004|Overall Study|Withdrawal by Subject|0|||
129833553|NCT02205333|467355624|FG005|Overall Study|Withdrawal by Subject|0|||
129833554|NCT02205333|467355625|FG006|Overall Study|Withdrawal by Subject|2|||
129833555|NCT02205333|467355626|FG007|Overall Study|Withdrawal by Subject|0|||
129833556|NCT02205333|467355627|FG008|Overall Study|Withdrawal by Subject|0|||
129833557|NCT01476696|467355628|FG000|Overall Study|Sponsor decision|2|||
129833558|NCT01476696|467355629|FG001|Overall Study|Sponsor decision|1|||
130060831|NCT00808249|468176742|FG000|Overall Study|study specific discontinuation criteria|1|||
130060832|NCT00808249|468176743|FG001|Overall Study|study specific discontinuation criteria|0|||
129833559|NCT01476696|467355630|FG002|Overall Study|Sponsor decision|0|||
129833560|NCT01476696|467355628|FG000|Overall Study|Withdrawal by Subject|1|||
129833561|NCT01476696|467355629|FG001|Overall Study|Withdrawal by Subject|0|||
129833562|NCT01476696|467355630|FG002|Overall Study|Withdrawal by Subject|0|||
129833563|NCT02009046|467355631|FG000|Overall Study|Lost to Follow-up|256|||
129833564|NCT02009046|467355632|FG001|Overall Study|Lost to Follow-up|206|||
129833565|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|5|||
129833566|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833567|NCT00304356|467355638|FG000|Nitazoxanide|number is 0|1|||
129833568|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833569|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833570|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833571|NCT01737047|467355639|FG000|Overall Study|Death|10|||
129833572|NCT01737047|467355640|FG001|Overall Study|Death|0|||
129833573|NCT01737047|467355641|FG002|Overall Study|Death|1|||
129833574|NCT01737047|467355639|FG000|Overall Study|Withdrawal by Subject|17|||
129833575|NCT01737047|467355640|FG001|Overall Study|Withdrawal by Subject|11|||
129833576|NCT01737047|467355641|FG002|Overall Study|Withdrawal by Subject|4|||
129833577|NCT00335972|467355642|FG000|Overall Study|not given treatments|0|||
129833578|NCT00335972|467355643|FG001|Overall Study|not given treatments|3|||
129833579|NCT03082599|467355646|FG000|Overall Study|Lost to Follow-up|1|||
129833580|NCT03082599|467355647|FG001|Overall Study|Lost to Follow-up|0|||
129833581|NCT00323115|467355648|FG000|Vaccine Administration|Adverse Event|1|||
129833582|NCT00323115|467355648|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
129833583|NCT00489853|467357803|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
129833584|NCT00489853|467357804|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
129833585|NCT00489853|467357805|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
129833586|NCT00489853|467357803|FG000|Wash-out Period 1|Adverse Event|0|||
129833587|NCT00489853|467357804|FG001|Wash-out Period 1|Adverse Event|1|||
129833588|NCT00489853|467357805|FG002|Wash-out Period 1|Adverse Event|1|||
129833589|NCT00489853|467357803|FG000|Wash-out Period 1|Protocol Violation|0|||
129833590|NCT00489853|467357804|FG001|Wash-out Period 1|Protocol Violation|1|||
129833591|NCT00489853|467357805|FG002|Wash-out Period 1|Protocol Violation|1|||
129833592|NCT00489853|467357803|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
129833593|NCT00489853|467357804|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
129833594|NCT00489853|467357805|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
129833595|NCT00489853|467357803|FG000|Wash-out Period 2|Adverse Event|1|||
129833596|NCT00489853|467357804|FG001|Wash-out Period 2|Adverse Event|1|||
129833597|NCT00489853|467357805|FG002|Wash-out Period 2|Adverse Event|0|||
129833598|NCT00489853|467357803|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
129833599|NCT00489853|467357804|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
129833600|NCT00489853|467357805|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
129833601|NCT00489853|467357803|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
129833602|NCT00489853|467357804|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
129833603|NCT00489853|467357805|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
129833604|NCT04254978|467357808|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
129833605|NCT04254978|467357808|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
129833606|NCT04254978|467357808|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
129833607|NCT04254978|467357808|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
129833608|NCT04254978|467357808|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
129833609|NCT04254978|467357808|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
129833610|NCT02515942|467357809|FG000|Overall Study|Adverse Event|5|||
129833611|NCT02515942|467357810|FG001|Overall Study|Adverse Event|0|||
129833612|NCT02515942|467357811|FG002|Overall Study|Adverse Event|0|||
129833613|NCT02515942|467357809|FG000|Overall Study|Death|0|||
129833614|NCT02515942|467357810|FG001|Overall Study|Death|0|||
129833615|NCT02515942|467357811|FG002|Overall Study|Death|1|||
129833616|NCT02515942|467357809|FG000|Overall Study|Lack of Efficacy|0|||
129833617|NCT02515942|467357810|FG001|Overall Study|Lack of Efficacy|0|||
129833618|NCT02515942|467357811|FG002|Overall Study|Lack of Efficacy|1|||
129833619|NCT02515942|467357809|FG000|Overall Study|Lost to Follow-up|2|||
129833620|NCT02515942|467357810|FG001|Overall Study|Lost to Follow-up|0|||
129833621|NCT02515942|467357811|FG002|Overall Study|Lost to Follow-up|0|||
129833622|NCT02515942|467357809|FG000|Overall Study|Withdrawal by Subject|0|||
129833623|NCT02515942|467357810|FG001|Overall Study|Withdrawal by Subject|3|||
129833624|NCT02515942|467357811|FG002|Overall Study|Withdrawal by Subject|2|||
129833625|NCT02436759|467357812|FG000|Overall Study|Adverse Event|3|||
129833626|NCT02436759|467357813|FG001|Overall Study|Adverse Event|0|||
129833627|NCT02436759|467357812|FG000|Overall Study|Protocol Violation|1|||
129833628|NCT02436759|467357813|FG001|Overall Study|Protocol Violation|0|||
129833629|NCT02436759|467357812|FG000|Overall Study|Withdrawal by Subject|0|||
130060833|NCT00808249|468176744|FG002|Overall Study|study specific discontinuation criteria|1|||
130060834|NCT00808249|468176745|FG003|Overall Study|study specific discontinuation criteria|0|||
130060835|NCT00808249|468176742|FG000|Overall Study|All other reasons|2|||
130060836|NCT00808249|468176743|FG001|Overall Study|All other reasons|1|||
130060837|NCT00808249|468176744|FG002|Overall Study|All other reasons|3|||
129833630|NCT02436759|467357813|FG001|Overall Study|Withdrawal by Subject|1|||
129833631|NCT00902564|467357814|FG000|Overall Study|Withdrawal by Subject|2|||
129833632|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
129833633|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
129833634|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
129833635|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
129833636|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
129833637|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
129833638|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
129833639|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
129833640|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
129897727|NCT00299702|467584438|FG000|Overall Study|Lost to Follow-up|18|||
129833641|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
129833642|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
129833643|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
129833644|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
129833645|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
129833646|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
129833647|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
129833648|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
129833649|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
129833650|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
130112800|NCT00410410|468373487|FG006|Induction Period (IP)|Lost to Follow-up|0|||
130112801|NCT00410410|468373488|FG007|Induction Period (IP)|Lost to Follow-up|0|||
130112802|NCT00410410|468373489|FG008|Induction Period (IP)|Lost to Follow-up|0|||
130112803|NCT00410410|468373481|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
130112804|NCT00410410|468373482|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
130112805|NCT00410410|468373483|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
130112806|NCT00410410|468373484|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
130112807|NCT00410410|468373485|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
130112808|NCT00410410|468373486|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
130112809|NCT00410410|468373487|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
130112810|NCT00410410|468373488|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
130112811|NCT00410410|468373489|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
130112812|NCT00410410|468373481|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112813|NCT00410410|468373482|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112814|NCT00410410|468373483|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
130112815|NCT00410410|468373484|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112816|NCT00410410|468373485|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112817|NCT00410410|468373486|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112818|NCT00410410|468373487|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112819|NCT00410410|468373488|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112820|NCT00410410|468373489|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
130112821|NCT00410410|468373481|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112822|NCT00410410|468373482|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112823|NCT00410410|468373483|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112824|NCT00410410|468373484|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112825|NCT00410410|468373485|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
130112826|NCT00410410|468373486|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
130112827|NCT00410410|468373487|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112828|NCT00410410|468373488|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112829|NCT00410410|468373489|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
130112830|NCT00410410|468373481|FG000|Induction Period (IP)|Other|0|||
130112831|NCT00410410|468373482|FG001|Induction Period (IP)|Other|0|||
130112832|NCT00410410|468373483|FG002|Induction Period (IP)|Other|1|||
130112833|NCT00410410|468373484|FG003|Induction Period (IP)|Other|0|||
130112834|NCT00410410|468373485|FG004|Induction Period (IP)|Other|0|||
130112835|NCT00410410|468373486|FG005|Induction Period (IP)|Other|0|||
130112836|NCT00410410|468373487|FG006|Induction Period (IP)|Other|0|||
129833651|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
129833652|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
129833653|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
129833654|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
129833655|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
129833656|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
129833657|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
129833658|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
129833659|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
129833660|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
129833661|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
129833662|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
129833663|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
129833664|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
129833665|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
129833666|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
129833667|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
130112837|NCT00410410|468373488|FG007|Induction Period (IP)|Other|0|||
130112838|NCT00410410|468373489|FG008|Induction Period (IP)|Other|0|||
130112839|NCT00410410|468373481|FG000|Maintenance Period (MP)|Death|0|||
130112840|NCT00410410|468373482|FG001|Maintenance Period (MP)|Death|0|||
129833668|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
129833669|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
129833670|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
129833671|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
129833672|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
129833673|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
129833674|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
129833675|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
129833676|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
129833677|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
129833678|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
129833679|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
129833680|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
129833681|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
129833682|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
129833683|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
129833684|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
129833685|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
129833686|NCT03336216|467357818|FG000|Randomization|Not reported|2|||
129833687|NCT03336216|467357819|FG001|Randomization|Not reported|0|||
129833688|NCT03336216|467357820|FG002|Randomization|Not reported|1|||
129833689|NCT03336216|467357821|FG003|Randomization|Not reported|0|||
129833690|NCT03336216|467357818|FG000|Randomization|Other reasons|1|||
129833691|NCT03336216|467357819|FG001|Randomization|Other reasons|1|||
129833692|NCT03336216|467357820|FG002|Randomization|Other reasons|1|||
129833693|NCT03336216|467357821|FG003|Randomization|Other reasons|0|||
129833694|NCT03336216|467357818|FG000|Randomization|Participant no longer meets study criteria|0|||
129833695|NCT03336216|467357819|FG001|Randomization|Participant no longer meets study criteria|2|||
129833696|NCT03336216|467357820|FG002|Randomization|Participant no longer meets study criteria|4|||
129833697|NCT03336216|467357821|FG003|Randomization|Participant no longer meets study criteria|1|||
129833698|NCT03336216|467357818|FG000|Randomization|Lost to Follow-up|1|||
129833699|NCT03336216|467357819|FG001|Randomization|Lost to Follow-up|0|||
129833700|NCT03336216|467357820|FG002|Randomization|Lost to Follow-up|0|||
129833701|NCT03336216|467357821|FG003|Randomization|Lost to Follow-up|0|||
129833702|NCT03336216|467357818|FG000|Randomization|Participant withdrew consent|9|||
129833703|NCT03336216|467357819|FG001|Randomization|Participant withdrew consent|1|||
129833704|NCT03336216|467357820|FG002|Randomization|Participant withdrew consent|0|||
129833705|NCT03336216|467357821|FG003|Randomization|Participant withdrew consent|0|||
129833706|NCT03336216|467357818|FG000|Randomization|Adverse Event|1|||
129833707|NCT03336216|467357819|FG001|Randomization|Adverse Event|1|||
129833708|NCT03336216|467357820|FG002|Randomization|Adverse Event|0|||
129833709|NCT03336216|467357821|FG003|Randomization|Adverse Event|0|||
129833710|NCT03336216|467357818|FG000|Treatment|Adverse Event|2|||
129833711|NCT03336216|467357819|FG001|Treatment|Adverse Event|3|||
129833712|NCT03336216|467357820|FG002|Treatment|Adverse Event|4|||
129833713|NCT03336216|467357821|FG003|Treatment|Adverse Event|4|||
129833714|NCT03336216|467357818|FG000|Treatment|Participant request to discontinue treatment|2|||
129833715|NCT03336216|467357819|FG001|Treatment|Participant request to discontinue treatment|1|||
129833716|NCT03336216|467357820|FG002|Treatment|Participant request to discontinue treatment|2|||
129833717|NCT03336216|467357821|FG003|Treatment|Participant request to discontinue treatment|2|||
129833718|NCT03336216|467357818|FG000|Treatment|Participant withdrew consent|7|||
129833719|NCT03336216|467357819|FG001|Treatment|Participant withdrew consent|2|||
129833720|NCT03336216|467357820|FG002|Treatment|Participant withdrew consent|3|||
129833721|NCT03336216|467357821|FG003|Treatment|Participant withdrew consent|2|||
129833722|NCT03336216|467357818|FG000|Treatment|Death|2|||
129833723|NCT03336216|467357819|FG001|Treatment|Death|3|||
129833724|NCT03336216|467357820|FG002|Treatment|Death|3|||
129833725|NCT03336216|467357821|FG003|Treatment|Death|4|||
130060838|NCT00808249|468176745|FG003|Overall Study|All other reasons|1|||
130060839|NCT03829332|468176746|FG000|Overall Study|Death|225|||
130060840|NCT03829332|468176747|FG001|Overall Study|Death|230|||
129833726|NCT03336216|467357818|FG000|Treatment|Participant no longer meets study criteria|0|||
129833727|NCT03336216|467357819|FG001|Treatment|Participant no longer meets study criteria|1|||
129833728|NCT03336216|467357820|FG002|Treatment|Participant no longer meets study criteria|0|||
129833729|NCT03336216|467357821|FG003|Treatment|Participant no longer meets study criteria|0|||
129833730|NCT03336216|467357818|FG000|Treatment|Other reasons|2|||
129833731|NCT03336216|467357819|FG001|Treatment|Other reasons|0|||
129833732|NCT03336216|467357820|FG002|Treatment|Other reasons|0|||
129833733|NCT03336216|467357821|FG003|Treatment|Other reasons|3|||
129833734|NCT03336216|467357818|FG000|Treatment|Disease progression|23|||
129833735|NCT03336216|467357819|FG001|Treatment|Disease progression|34|||
129833736|NCT03336216|467357820|FG002|Treatment|Disease progression|33|||
129833737|NCT03336216|467357821|FG003|Treatment|Disease progression|26|||
130060841|NCT03829332|468176746|FG000|Overall Study|Lost to Follow-up|1|||
129833738|NCT03336216|467357818|FG000|Treatment|Study drug toxicity|0|||
129833739|NCT03336216|467357819|FG001|Treatment|Study drug toxicity|3|||
129833740|NCT03336216|467357820|FG002|Treatment|Study drug toxicity|2|||
129833741|NCT03336216|467357821|FG003|Treatment|Study drug toxicity|0|||
129833742|NCT03336216|467357818|FG000|Treatment|Adverse Event unrelated to study drug|1|||
129833743|NCT03336216|467357819|FG001|Treatment|Adverse Event unrelated to study drug|1|||
129833744|NCT03336216|467357820|FG002|Treatment|Adverse Event unrelated to study drug|1|||
129833745|NCT03336216|467357821|FG003|Treatment|Adverse Event unrelated to study drug|0|||
129833746|NCT03336216|467357818|FG000|Treatment|Disease Recurrence|1|||
129833747|NCT03336216|467357819|FG001|Treatment|Disease Recurrence|0|||
129833748|NCT03336216|467357820|FG002|Treatment|Disease Recurrence|0|||
129833749|NCT03336216|467357821|FG003|Treatment|Disease Recurrence|0|||
129833750|NCT03239470|467357822|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
129833751|NCT03239470|467357823|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
129833752|NCT00922766|467357824|FG000|Overall Study|Death|3|||
129833753|NCT00922766|467357824|FG000|Overall Study|Withdrawal by Subject|2|||
129833754|NCT00922766|467357824|FG000|Overall Study|Other|1|||
129833755|NCT00922766|467357824|FG000|Overall Study|Adverse Event|1|||
129833756|NCT01231581|467357827|FG000|Overall Study|Lost to Follow-up|2|||
129833757|NCT01231581|467357828|FG001|Overall Study|Lost to Follow-up|2|||
129833758|NCT01231581|467357827|FG000|Overall Study|Withdrawal by Subject|6|||
129833759|NCT01231581|467357828|FG001|Overall Study|Withdrawal by Subject|9|||
129833760|NCT01231581|467357827|FG000|Overall Study|Study Closed/Terminated|6|||
129833761|NCT01231581|467357828|FG001|Overall Study|Study Closed/Terminated|5|||
129833762|NCT01231581|467357827|FG000|Overall Study|Death|65|||
129833763|NCT01231581|467357828|FG001|Overall Study|Death|64|||
129833764|NCT01231581|467357827|FG000|Overall Study|Ongoing|1|||
129833765|NCT01231581|467357828|FG001|Overall Study|Ongoing|0|||
129833766|NCT02510794|467357829|FG000|Overall Study|Adverse Event|0|||
129833767|NCT02510794|467357830|FG001|Overall Study|Adverse Event|1|||
129833768|NCT02510794|467357831|FG002|Overall Study|Adverse Event|0|||
129833769|NCT02510794|467357832|FG003|Overall Study|Adverse Event|0|||
129833770|NCT02510794|467357829|FG000|Overall Study|Death|1|||
129833771|NCT02510794|467357830|FG001|Overall Study|Death|2|||
129833772|NCT02510794|467357831|FG002|Overall Study|Death|1|||
129833773|NCT02510794|467357832|FG003|Overall Study|Death|1|||
129833774|NCT02510794|467357829|FG000|Overall Study|Lack of Efficacy|3|||
129833775|NCT02510794|467357830|FG001|Overall Study|Lack of Efficacy|1|||
129833776|NCT02510794|467357831|FG002|Overall Study|Lack of Efficacy|1|||
129833777|NCT02510794|467357832|FG003|Overall Study|Lack of Efficacy|0|||
129833778|NCT02510794|467357829|FG000|Overall Study|Participant moved out of the area|0|||
129833779|NCT02510794|467357830|FG001|Overall Study|Participant moved out of the area|0|||
129833780|NCT02510794|467357831|FG002|Overall Study|Participant moved out of the area|0|||
129833781|NCT02510794|467357832|FG003|Overall Study|Participant moved out of the area|1|||
129833782|NCT02510794|467357829|FG000|Overall Study|Physician Decision|3|||
129833783|NCT02510794|467357830|FG001|Overall Study|Physician Decision|0|||
129833784|NCT02510794|467357831|FG002|Overall Study|Physician Decision|0|||
129833785|NCT02510794|467357832|FG003|Overall Study|Physician Decision|0|||
129833786|NCT02510794|467357829|FG000|Overall Study|Protocol Violation|0|||
130060842|NCT03829332|468176747|FG001|Overall Study|Lost to Follow-up|3|||
130060843|NCT03829332|468176746|FG000|Overall Study|Physician Decision|1|||
130060844|NCT03829332|468176747|FG001|Overall Study|Physician Decision|0|||
130060845|NCT03829332|468176746|FG000|Overall Study|Sponsor Decision|71|||
130060846|NCT03829332|468176747|FG001|Overall Study|Sponsor Decision|72|||
129833787|NCT02510794|467357830|FG001|Overall Study|Protocol Violation|0|||
129897728|NCT00299702|467584439|FG001|Overall Study|Lost to Follow-up|10|||
129897729|NCT00299702|467584438|FG000|Overall Study|Withdrawal by Subject|25|||
129897730|NCT00299702|467584439|FG001|Overall Study|Withdrawal by Subject|23|||
129897731|NCT00299702|467584438|FG000|Overall Study|Pregnancy|0|||
129897732|NCT00299702|467584439|FG001|Overall Study|Pregnancy|1|||
129897733|NCT00299702|467584438|FG000|Overall Study|Insufficient Response|4|||
129897734|NCT00299702|467584439|FG001|Overall Study|Insufficient Response|3|||
129897735|NCT00299702|467584438|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
129897736|NCT00299702|467584439|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
129897737|NCT00751036|467584440|FG000|Overall Study|Disease Progression|28|||
129897738|NCT00751036|467584441|FG001|Overall Study|Disease Progression|29|||
129897739|NCT00751036|467584440|FG000|Overall Study|Adverse Event|6|||
129897740|NCT00751036|467584441|FG001|Overall Study|Adverse Event|4|||
129833788|NCT02510794|467357831|FG002|Overall Study|Protocol Violation|1|||
129833789|NCT02510794|467357832|FG003|Overall Study|Protocol Violation|0|||
129833790|NCT02510794|467357829|FG000|Overall Study|Withdrawal by Subject|1|||
129833791|NCT02510794|467357830|FG001|Overall Study|Withdrawal by Subject|2|||
129833792|NCT02510794|467357831|FG002|Overall Study|Withdrawal by Subject|4|||
129833793|NCT02510794|467357832|FG003|Overall Study|Withdrawal by Subject|3|||
129833794|NCT01124604|467357833|FG000|Overall Study|Adverse Event|10|||
129833795|NCT01124604|467357834|FG001|Overall Study|Adverse Event|1|||
129833796|NCT01124604|467357833|FG000|Overall Study|Lack of Efficacy|1|||
130060847|NCT03829332|468176746|FG000|Overall Study|Withdrawal by Subject|11|||
130060848|NCT03829332|468176747|FG001|Overall Study|Withdrawal by Subject|9|||
130060849|NCT00430521|468176748|FG000|Overall Study|Adverse Event|0|||
130060850|NCT00430521|468176749|FG001|Overall Study|Adverse Event|0|||
130060851|NCT00430521|468176750|FG002|Overall Study|Adverse Event|0|||
130060852|NCT00430521|468176751|FG003|Overall Study|Adverse Event|0|||
130060853|NCT00430521|468176752|FG004|Overall Study|Adverse Event|0|||
130060854|NCT00430521|468176753|FG005|Overall Study|Adverse Event|2|||
130060855|NCT00430521|468176754|FG006|Overall Study|Adverse Event|1|||
130060856|NCT00430521|468176755|FG007|Overall Study|Adverse Event|0|||
130060857|NCT00430521|468176748|FG000|Overall Study|Lost to Follow-up|7|||
130060858|NCT00430521|468176749|FG001|Overall Study|Lost to Follow-up|8|||
130060859|NCT00430521|468176750|FG002|Overall Study|Lost to Follow-up|3|||
130060860|NCT00430521|468176751|FG003|Overall Study|Lost to Follow-up|5|||
129833797|NCT01124604|467357834|FG001|Overall Study|Lack of Efficacy|0|||
129833798|NCT01124604|467357833|FG000|Overall Study|Withdrawal by Subject|4|||
129833799|NCT01124604|467357834|FG001|Overall Study|Withdrawal by Subject|0|||
129897741|NCT00751036|467584440|FG000|Overall Study|Administrative Problems|3|||
129897742|NCT00751036|467584441|FG001|Overall Study|Administrative Problems|4|||
129897743|NCT00751036|467584440|FG000|Overall Study|Withdrawal by Subject|5|||
129897744|NCT00751036|467584441|FG001|Overall Study|Withdrawal by Subject|2|||
129897745|NCT00751036|467584440|FG000|Overall Study|Death|3|||
129897746|NCT00751036|467584441|FG001|Overall Study|Death|3|||
129897747|NCT00751036|467584440|FG000|Overall Study|Lost to Follow-up|0|||
129897748|NCT00751036|467584441|FG001|Overall Study|Lost to Follow-up|1|||
129897749|NCT00751036|467584440|FG000|Overall Study|Protocol Violation|1|||
129897750|NCT00751036|467584441|FG001|Overall Study|Protocol Violation|0|||
129897751|NCT00751036|467584440|FG000|Overall Study|Missing end of Treatment Page|2|||
129897752|NCT00751036|467584441|FG001|Overall Study|Missing end of Treatment Page|3|||
129897753|NCT05460663|467584442|FG000|Overall Study|Withdrawal by Subject|2|||
129897754|NCT05460663|467584443|FG001|Overall Study|Withdrawal by Subject|5|||
129897755|NCT05273801|467584444|FG000|Overall Study|Physician Decision|1|||
129897756|NCT05526911|467586455|FG000|Overall Study|Adverse Event|2|||
129897757|NCT05025449|467586456|FG000|Overall Study|Withdrawal by Subject|1|||
129897758|NCT05025449|467586456|FG000|Overall Study|Patient emergently taken to operating room|1|||
129897759|NCT00613301|467586457|FG000|Overall Study|Adverse Event|49|||
129897760|NCT00613301|467586457|FG000|Overall Study|Lost to Follow-up|88|||
129897761|NCT00613301|467586457|FG000|Overall Study|Withdrawal by Subject|5|||
129897762|NCT00613301|467586457|FG000|Overall Study|Death|6|||
129897763|NCT00613301|467586457|FG000|Overall Study|Lack of Efficacy|13|||
129897764|NCT00613301|467586457|FG000|Overall Study|Physician Decision|2|||
129897765|NCT00613301|467586457|FG000|Overall Study|No data was collected|53|||
129897766|NCT00613301|467586457|FG000|Overall Study|Irregularly enrolled patients|12|||
129897767|NCT00569946|467586458|FG000|Overall Study|Adverse Event|16|||
129897768|NCT00569946|467586458|FG000|Overall Study|Objective Progression or Relapse|42|||
130060861|NCT00430521|468176752|FG004|Overall Study|Lost to Follow-up|5|||
130112841|NCT00410410|468373483|FG002|Maintenance Period (MP)|Death|0|||
129833800|NCT01124604|467357833|FG000|Overall Study|Disease Progression|0|||
130112842|NCT00410410|468373484|FG003|Maintenance Period (MP)|Death|0|||
129833801|NCT01124604|467357834|FG001|Overall Study|Disease Progression|1|||
129833802|NCT02658890|467357840|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833803|NCT02658890|467357841|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833804|NCT02658890|467357842|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833805|NCT02658890|467357843|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833806|NCT02658890|467357844|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833807|NCT02658890|467357845|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833808|NCT02658890|467357846|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833809|NCT02658890|467357847|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833810|NCT02658890|467357848|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129833811|NCT02658890|467357849|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833812|NCT02658890|467357850|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833813|NCT02658890|467357851|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833814|NCT02658890|467357852|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833815|NCT02658890|467357853|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129897769|NCT00569946|467586458|FG000|Overall Study|Global Deterioration of Health Status|1|||
129897770|NCT00762463|467586460|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
129897771|NCT00762463|467586461|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
129897772|NCT00762463|467586462|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
129897773|NCT00762463|467586463|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
130112843|NCT00410410|468373485|FG004|Maintenance Period (MP)|Death|0|||
130060862|NCT00430521|468176753|FG005|Overall Study|Lost to Follow-up|2|||
130060863|NCT00430521|468176754|FG006|Overall Study|Lost to Follow-up|8|||
130060864|NCT00430521|468176755|FG007|Overall Study|Lost to Follow-up|10|||
130060865|NCT00430521|468176748|FG000|Overall Study|Pregnancy|0|||
129833816|NCT02658890|467357854|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833817|NCT02658890|467357855|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833818|NCT02658890|467357856|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833819|NCT02658890|467357857|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833820|NCT02658890|467357858|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833821|NCT02658890|467357859|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833822|NCT02658890|467357860|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833823|NCT02658890|467357861|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833824|NCT02658890|467357862|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833825|NCT02658890|467357863|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833826|NCT02658890|467357864|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833827|NCT02658890|467357865|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833828|NCT02658890|467357866|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833829|NCT02658890|467357840|FG000|Treatment Phase|Adverse Event|0|||
129833830|NCT02658890|467357841|FG001|Treatment Phase|Adverse Event|1|||
129833831|NCT02658890|467357842|FG002|Treatment Phase|Adverse Event|2|||
129833832|NCT02658890|467357843|FG003|Treatment Phase|Adverse Event|2|||
129833833|NCT02658890|467357844|FG004|Treatment Phase|Adverse Event|1|||
129833834|NCT02658890|467357845|FG005|Treatment Phase|Adverse Event|0|||
129833835|NCT02658890|467357846|FG006|Treatment Phase|Adverse Event|0|||
129833836|NCT02658890|467357847|FG007|Treatment Phase|Adverse Event|2|||
129833837|NCT02658890|467357848|FG008|Treatment Phase|Adverse Event|1|||
129833838|NCT02658890|467357849|FG009|Treatment Phase|Adverse Event|2|||
129833839|NCT02658890|467357850|FG010|Treatment Phase|Adverse Event|3|||
129833840|NCT02658890|467357851|FG011|Treatment Phase|Adverse Event|0|||
129833841|NCT02658890|467357852|FG012|Treatment Phase|Adverse Event|1|||
129833842|NCT02658890|467357853|FG013|Treatment Phase|Adverse Event|4|||
129833843|NCT02658890|467357854|FG014|Treatment Phase|Adverse Event|0|||
129833844|NCT02658890|467357855|FG015|Treatment Phase|Adverse Event|0|||
129833845|NCT02658890|467357856|FG016|Treatment Phase|Adverse Event|0|||
129833846|NCT02658890|467357857|FG017|Treatment Phase|Adverse Event|0|||
129833847|NCT02658890|467357858|FG018|Treatment Phase|Adverse Event|5|||
129833848|NCT02658890|467357859|FG019|Treatment Phase|Adverse Event|1|||
129833849|NCT02658890|467357860|FG020|Treatment Phase|Adverse Event|3|||
129833850|NCT02658890|467357861|FG021|Treatment Phase|Adverse Event|0|||
129833851|NCT02658890|467357862|FG022|Treatment Phase|Adverse Event|5|||
129833852|NCT02658890|467357863|FG023|Treatment Phase|Adverse Event|0|||
129833853|NCT02658890|467357864|FG024|Treatment Phase|Adverse Event|0|||
129833854|NCT02658890|467357865|FG025|Treatment Phase|Adverse Event|2|||
129833855|NCT02658890|467357866|FG026|Treatment Phase|Adverse Event|1|||
129833856|NCT02658890|467357840|FG000|Treatment Phase|Death|0|||
129833857|NCT02658890|467357841|FG001|Treatment Phase|Death|0|||
129833858|NCT02658890|467357842|FG002|Treatment Phase|Death|0|||
129833859|NCT02658890|467357843|FG003|Treatment Phase|Death|0|||
129833860|NCT02658890|467357844|FG004|Treatment Phase|Death|0|||
129833861|NCT02658890|467357845|FG005|Treatment Phase|Death|0|||
129833862|NCT02658890|467357846|FG006|Treatment Phase|Death|0|||
129833863|NCT02658890|467357847|FG007|Treatment Phase|Death|0|||
129833864|NCT02658890|467357848|FG008|Treatment Phase|Death|0|||
129833865|NCT02658890|467357849|FG009|Treatment Phase|Death|0|||
129833866|NCT02658890|467357850|FG010|Treatment Phase|Death|0|||
129833867|NCT02658890|467357851|FG011|Treatment Phase|Death|0|||
129833868|NCT02658890|467357852|FG012|Treatment Phase|Death|0|||
129833869|NCT02658890|467357853|FG013|Treatment Phase|Death|0|||
129833870|NCT02658890|467357854|FG014|Treatment Phase|Death|0|||
129833871|NCT02658890|467357855|FG015|Treatment Phase|Death|0|||
129833872|NCT02658890|467357856|FG016|Treatment Phase|Death|0|||
129833873|NCT02658890|467357857|FG017|Treatment Phase|Death|0|||
129833874|NCT02658890|467357858|FG018|Treatment Phase|Death|1|||
129833875|NCT02658890|467357859|FG019|Treatment Phase|Death|0|||
129833876|NCT02658890|467357860|FG020|Treatment Phase|Death|0|||
129833877|NCT02658890|467357861|FG021|Treatment Phase|Death|0|||
129833878|NCT02658890|467357862|FG022|Treatment Phase|Death|0|||
129833879|NCT02658890|467357863|FG023|Treatment Phase|Death|0|||
130060866|NCT00430521|468176749|FG001|Overall Study|Pregnancy|0|||
130060867|NCT00430521|468176750|FG002|Overall Study|Pregnancy|0|||
130060868|NCT00430521|468176751|FG003|Overall Study|Pregnancy|0|||
130060869|NCT00430521|468176752|FG004|Overall Study|Pregnancy|0|||
129833880|NCT02658890|467357864|FG024|Treatment Phase|Death|0|||
129833881|NCT02658890|467357865|FG025|Treatment Phase|Death|0|||
129833882|NCT02658890|467357866|FG026|Treatment Phase|Death|0|||
129833883|NCT02658890|467357840|FG000|Treatment Phase|Lost to Follow-up|0|||
129833884|NCT02658890|467357841|FG001|Treatment Phase|Lost to Follow-up|0|||
129833885|NCT02658890|467357842|FG002|Treatment Phase|Lost to Follow-up|0|||
129833886|NCT02658890|467357843|FG003|Treatment Phase|Lost to Follow-up|0|||
129833887|NCT02658890|467357844|FG004|Treatment Phase|Lost to Follow-up|0|||
129833888|NCT02658890|467357845|FG005|Treatment Phase|Lost to Follow-up|0|||
129833889|NCT02658890|467357846|FG006|Treatment Phase|Lost to Follow-up|1|||
129833890|NCT02658890|467357847|FG007|Treatment Phase|Lost to Follow-up|0|||
130060870|NCT00430521|468176753|FG005|Overall Study|Pregnancy|0|||
129833891|NCT02658890|467357848|FG008|Treatment Phase|Lost to Follow-up|0|||
129833892|NCT02658890|467357849|FG009|Treatment Phase|Lost to Follow-up|0|||
129833893|NCT02658890|467357850|FG010|Treatment Phase|Lost to Follow-up|0|||
129833894|NCT02658890|467357851|FG011|Treatment Phase|Lost to Follow-up|0|||
129833895|NCT02658890|467357852|FG012|Treatment Phase|Lost to Follow-up|0|||
129833896|NCT02658890|467357853|FG013|Treatment Phase|Lost to Follow-up|0|||
129833897|NCT02658890|467357854|FG014|Treatment Phase|Lost to Follow-up|0|||
129833898|NCT02658890|467357855|FG015|Treatment Phase|Lost to Follow-up|0|||
129833899|NCT02658890|467357856|FG016|Treatment Phase|Lost to Follow-up|0|||
129833900|NCT02658890|467357857|FG017|Treatment Phase|Lost to Follow-up|0|||
129833901|NCT02658890|467357858|FG018|Treatment Phase|Lost to Follow-up|0|||
129833902|NCT02658890|467357859|FG019|Treatment Phase|Lost to Follow-up|0|||
129833903|NCT02658890|467357860|FG020|Treatment Phase|Lost to Follow-up|0|||
129833904|NCT02658890|467357861|FG021|Treatment Phase|Lost to Follow-up|0|||
129833905|NCT02658890|467357862|FG022|Treatment Phase|Lost to Follow-up|0|||
129833906|NCT02658890|467357863|FG023|Treatment Phase|Lost to Follow-up|0|||
129833907|NCT02658890|467357864|FG024|Treatment Phase|Lost to Follow-up|0|||
129833908|NCT02658890|467357865|FG025|Treatment Phase|Lost to Follow-up|0|||
129833909|NCT02658890|467357866|FG026|Treatment Phase|Lost to Follow-up|0|||
129833910|NCT02658890|467357840|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
129833911|NCT02658890|467357841|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
129833912|NCT02658890|467357842|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
129833913|NCT02658890|467357843|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
129833914|NCT02658890|467357844|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
129833915|NCT02658890|467357845|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
129833916|NCT02658890|467357846|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
129833917|NCT02658890|467357847|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
129833918|NCT02658890|467357848|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
129833919|NCT02658890|467357849|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
129833920|NCT02658890|467357850|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
129833921|NCT02658890|467357851|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
129833922|NCT02658890|467357852|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
129833923|NCT02658890|467357853|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
129833924|NCT02658890|467357854|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
129833925|NCT02658890|467357855|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
129833926|NCT02658890|467357856|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
129833927|NCT02658890|467357857|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
129833928|NCT02658890|467357858|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
129833929|NCT02658890|467357859|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
129833930|NCT02658890|467357860|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
129833931|NCT02658890|467357861|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
129833932|NCT02658890|467357862|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
129833933|NCT02658890|467357863|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
129833934|NCT02658890|467357864|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
129833935|NCT02658890|467357865|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
129833936|NCT02658890|467357866|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
129833937|NCT02658890|467357840|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
129833938|NCT02658890|467357841|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
129833939|NCT02658890|467357842|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
129833940|NCT02658890|467357843|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
129833941|NCT02658890|467357844|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
129833942|NCT02658890|467357845|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
129833943|NCT02658890|467357846|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
129833944|NCT02658890|467357847|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
129833945|NCT02658890|467357848|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
129833946|NCT02658890|467357849|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
129833947|NCT02658890|467357850|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
129833948|NCT02658890|467357851|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
129833949|NCT02658890|467357852|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
129833950|NCT02658890|467357853|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
129833951|NCT02658890|467357854|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
129833952|NCT02658890|467357855|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
129833953|NCT02658890|467357856|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
129833954|NCT02658890|467357857|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
129833955|NCT02658890|467357858|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
129833956|NCT02658890|467357859|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
129833957|NCT02658890|467357860|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
130060871|NCT00430521|468176754|FG006|Overall Study|Pregnancy|1|||
130060872|NCT00430521|468176755|FG007|Overall Study|Pregnancy|0|||
129833958|NCT02658890|467357861|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
129833959|NCT02658890|467357862|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
129833960|NCT02658890|467357863|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
129833961|NCT02658890|467357864|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
129833962|NCT02658890|467357865|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
129833963|NCT02658890|467357866|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
129833964|NCT02658890|467357840|FG000|Treatment Phase|Other Reasons|0|||
129833965|NCT02658890|467357841|FG001|Treatment Phase|Other Reasons|0|||
129833966|NCT02658890|467357842|FG002|Treatment Phase|Other Reasons|0|||
129833967|NCT02658890|467357843|FG003|Treatment Phase|Other Reasons|0|||
129833968|NCT02658890|467357844|FG004|Treatment Phase|Other Reasons|0|||
129833969|NCT02658890|467357845|FG005|Treatment Phase|Other Reasons|0|||
129833970|NCT02658890|467357846|FG006|Treatment Phase|Other Reasons|1|||
129833971|NCT02658890|467357847|FG007|Treatment Phase|Other Reasons|0|||
129833972|NCT02658890|467357848|FG008|Treatment Phase|Other Reasons|1|||
129833973|NCT02658890|467357849|FG009|Treatment Phase|Other Reasons|0|||
129833974|NCT02658890|467357850|FG010|Treatment Phase|Other Reasons|0|||
129833975|NCT02658890|467357851|FG011|Treatment Phase|Other Reasons|0|||
129833976|NCT02658890|467357852|FG012|Treatment Phase|Other Reasons|0|||
129833977|NCT02658890|467357853|FG013|Treatment Phase|Other Reasons|2|||
129833978|NCT02658890|467357854|FG014|Treatment Phase|Other Reasons|0|||
129833979|NCT02658890|467357855|FG015|Treatment Phase|Other Reasons|0|||
129833980|NCT02658890|467357856|FG016|Treatment Phase|Other Reasons|0|||
129833981|NCT02658890|467357857|FG017|Treatment Phase|Other Reasons|0|||
129833982|NCT02658890|467357858|FG018|Treatment Phase|Other Reasons|1|||
129833983|NCT02658890|467357859|FG019|Treatment Phase|Other Reasons|0|||
129833984|NCT02658890|467357860|FG020|Treatment Phase|Other Reasons|0|||
129833985|NCT02658890|467357861|FG021|Treatment Phase|Other Reasons|0|||
129833986|NCT02658890|467357862|FG022|Treatment Phase|Other Reasons|0|||
129833987|NCT02658890|467357863|FG023|Treatment Phase|Other Reasons|0|||
129833988|NCT02658890|467357864|FG024|Treatment Phase|Other Reasons|1|||
129833989|NCT02658890|467357865|FG025|Treatment Phase|Other Reasons|0|||
129833990|NCT02658890|467357866|FG026|Treatment Phase|Other Reasons|1|||
129833991|NCT02658890|467357840|FG000|Treatment Phase|Progressive Disease|6|||
129833992|NCT02658890|467357841|FG001|Treatment Phase|Progressive Disease|7|||
129833993|NCT02658890|467357842|FG002|Treatment Phase|Progressive Disease|6|||
129833994|NCT02658890|467357843|FG003|Treatment Phase|Progressive Disease|12|||
129833995|NCT02658890|467357844|FG004|Treatment Phase|Progressive Disease|6|||
129833996|NCT02658890|467357845|FG005|Treatment Phase|Progressive Disease|18|||
129833997|NCT02658890|467357846|FG006|Treatment Phase|Progressive Disease|12|||
129833998|NCT02658890|467357847|FG007|Treatment Phase|Progressive Disease|19|||
129833999|NCT02658890|467357848|FG008|Treatment Phase|Progressive Disease|26|||
129834000|NCT02658890|467357849|FG009|Treatment Phase|Progressive Disease|8|||
129834001|NCT02658890|467357850|FG010|Treatment Phase|Progressive Disease|7|||
129834002|NCT02658890|467357851|FG011|Treatment Phase|Progressive Disease|9|||
129834003|NCT02658890|467357852|FG012|Treatment Phase|Progressive Disease|8|||
129834004|NCT02658890|467357853|FG013|Treatment Phase|Progressive Disease|29|||
129834005|NCT02658890|467357854|FG014|Treatment Phase|Progressive Disease|6|||
129834006|NCT02658890|467357855|FG015|Treatment Phase|Progressive Disease|2|||
129834007|NCT02658890|467357856|FG016|Treatment Phase|Progressive Disease|32|||
129834008|NCT02658890|467357857|FG017|Treatment Phase|Progressive Disease|14|||
129834009|NCT02658890|467357858|FG018|Treatment Phase|Progressive Disease|40|||
129834010|NCT02658890|467357859|FG019|Treatment Phase|Progressive Disease|32|||
129834011|NCT02658890|467357860|FG020|Treatment Phase|Progressive Disease|19|||
129834012|NCT02658890|467357861|FG021|Treatment Phase|Progressive Disease|30|||
129834013|NCT02658890|467357862|FG022|Treatment Phase|Progressive Disease|15|||
129834014|NCT02658890|467357863|FG023|Treatment Phase|Progressive Disease|0|||
129834015|NCT02658890|467357864|FG024|Treatment Phase|Progressive Disease|0|||
129834016|NCT02658890|467357865|FG025|Treatment Phase|Progressive Disease|14|||
129834017|NCT02658890|467357866|FG026|Treatment Phase|Progressive Disease|11|||
129834018|NCT02658890|467357840|FG000|Treatment Phase|Study Drug Toxicity|0|||
129834019|NCT02658890|467357841|FG001|Treatment Phase|Study Drug Toxicity|0|||
129834020|NCT02658890|467357842|FG002|Treatment Phase|Study Drug Toxicity|2|||
129897774|NCT00762463|467586460|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
129979658|NCT00403767|467889417|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
129834021|NCT02658890|467357843|FG003|Treatment Phase|Study Drug Toxicity|0|||
129834022|NCT02658890|467357844|FG004|Treatment Phase|Study Drug Toxicity|0|||
129834023|NCT02658890|467357845|FG005|Treatment Phase|Study Drug Toxicity|0|||
129834024|NCT02658890|467357846|FG006|Treatment Phase|Study Drug Toxicity|0|||
129834025|NCT02658890|467357847|FG007|Treatment Phase|Study Drug Toxicity|0|||
129834026|NCT02658890|467357848|FG008|Treatment Phase|Study Drug Toxicity|3|||
129834027|NCT02658890|467357849|FG009|Treatment Phase|Study Drug Toxicity|0|||
129834028|NCT02658890|467357850|FG010|Treatment Phase|Study Drug Toxicity|1|||
129834029|NCT02658890|467357851|FG011|Treatment Phase|Study Drug Toxicity|1|||
129834030|NCT02658890|467357852|FG012|Treatment Phase|Study Drug Toxicity|2|||
129834031|NCT02658890|467357853|FG013|Treatment Phase|Study Drug Toxicity|9|||
129834032|NCT02658890|467357854|FG014|Treatment Phase|Study Drug Toxicity|0|||
130112844|NCT00410410|468373486|FG005|Maintenance Period (MP)|Death|0|||
129834033|NCT02658890|467357855|FG015|Treatment Phase|Study Drug Toxicity|1|||
129834034|NCT02658890|467357856|FG016|Treatment Phase|Study Drug Toxicity|1|||
129834035|NCT02658890|467357857|FG017|Treatment Phase|Study Drug Toxicity|0|||
129834036|NCT02658890|467357858|FG018|Treatment Phase|Study Drug Toxicity|8|||
129834037|NCT02658890|467357859|FG019|Treatment Phase|Study Drug Toxicity|3|||
129897775|NCT00762463|467586461|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
129897776|NCT00762463|467586462|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
129897777|NCT00762463|467586463|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
129897778|NCT00762463|467586460|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
129897779|NCT00762463|467586461|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
129897780|NCT00762463|467586462|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
129897781|NCT00762463|467586463|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
129897782|NCT00762463|467586460|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
129897783|NCT00762463|467586461|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
130112845|NCT00410410|468373487|FG006|Maintenance Period (MP)|Death|1|||
130112846|NCT00410410|468373488|FG007|Maintenance Period (MP)|Death|0|||
130112847|NCT00410410|468373489|FG008|Maintenance Period (MP)|Death|0|||
129834038|NCT02658890|467357860|FG020|Treatment Phase|Study Drug Toxicity|2|||
129834039|NCT02658890|467357861|FG021|Treatment Phase|Study Drug Toxicity|0|||
129834040|NCT02658890|467357862|FG022|Treatment Phase|Study Drug Toxicity|8|||
129834041|NCT02658890|467357863|FG023|Treatment Phase|Study Drug Toxicity|0|||
129834042|NCT02658890|467357864|FG024|Treatment Phase|Study Drug Toxicity|0|||
129834043|NCT02658890|467357865|FG025|Treatment Phase|Study Drug Toxicity|2|||
129834044|NCT02658890|467357866|FG026|Treatment Phase|Study Drug Toxicity|0|||
129834045|NCT02658890|467357840|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834046|NCT02658890|467357841|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834047|NCT02658890|467357842|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834048|NCT02658890|467357843|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834049|NCT02658890|467357844|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834050|NCT02658890|467357845|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834051|NCT02658890|467357846|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834052|NCT02658890|467357847|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834053|NCT02658890|467357848|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834054|NCT02658890|467357849|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834055|NCT02658890|467357850|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834056|NCT02658890|467357851|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834057|NCT02658890|467357852|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834058|NCT02658890|467357853|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834059|NCT02658890|467357854|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834060|NCT02658890|467357855|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834061|NCT02658890|467357856|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834062|NCT02658890|467357857|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834063|NCT02658890|467357858|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834064|NCT02658890|467357859|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834065|NCT02658890|467357860|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834066|NCT02658890|467357861|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834067|NCT02658890|467357862|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834068|NCT02658890|467357863|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834069|NCT02658890|467357864|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834070|NCT02658890|467357865|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834071|NCT02658890|467357866|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834072|NCT02658890|467357840|FG000|Treatment Phase|Withdrawal by Subject|0|||
129834073|NCT02658890|467357841|FG001|Treatment Phase|Withdrawal by Subject|1|||
129834074|NCT02658890|467357842|FG002|Treatment Phase|Withdrawal by Subject|0|||
129834075|NCT02658890|467357843|FG003|Treatment Phase|Withdrawal by Subject|0|||
129834076|NCT02658890|467357844|FG004|Treatment Phase|Withdrawal by Subject|0|||
129834077|NCT02658890|467357845|FG005|Treatment Phase|Withdrawal by Subject|0|||
129834078|NCT02658890|467357846|FG006|Treatment Phase|Withdrawal by Subject|1|||
129834079|NCT02658890|467357847|FG007|Treatment Phase|Withdrawal by Subject|0|||
129834080|NCT02658890|467357848|FG008|Treatment Phase|Withdrawal by Subject|0|||
129834081|NCT02658890|467357849|FG009|Treatment Phase|Withdrawal by Subject|1|||
129834082|NCT02658890|467357850|FG010|Treatment Phase|Withdrawal by Subject|0|||
129834083|NCT02658890|467357851|FG011|Treatment Phase|Withdrawal by Subject|0|||
129834084|NCT02658890|467357852|FG012|Treatment Phase|Withdrawal by Subject|1|||
129834085|NCT02658890|467357853|FG013|Treatment Phase|Withdrawal by Subject|3|||
129834086|NCT02658890|467357854|FG014|Treatment Phase|Withdrawal by Subject|0|||
129834087|NCT02658890|467357855|FG015|Treatment Phase|Withdrawal by Subject|0|||
129834088|NCT02658890|467357856|FG016|Treatment Phase|Withdrawal by Subject|1|||
129834089|NCT02658890|467357857|FG017|Treatment Phase|Withdrawal by Subject|0|||
129834090|NCT02658890|467357858|FG018|Treatment Phase|Withdrawal by Subject|4|||
129834091|NCT02658890|467357859|FG019|Treatment Phase|Withdrawal by Subject|3|||
129834092|NCT02658890|467357860|FG020|Treatment Phase|Withdrawal by Subject|0|||
129834093|NCT02658890|467357861|FG021|Treatment Phase|Withdrawal by Subject|4|||
129834094|NCT02658890|467357862|FG022|Treatment Phase|Withdrawal by Subject|1|||
129834095|NCT02658890|467357863|FG023|Treatment Phase|Withdrawal by Subject|1|||
129834096|NCT02658890|467357864|FG024|Treatment Phase|Withdrawal by Subject|0|||
129834097|NCT02658890|467357865|FG025|Treatment Phase|Withdrawal by Subject|0|||
129834098|NCT02658890|467357866|FG026|Treatment Phase|Withdrawal by Subject|0|||
129834099|NCT02474199|467357867|FG000|Overall Study|Lost to Follow-up|1|||
129834100|NCT02474199|467357868|FG001|Overall Study|Lost to Follow-up|0|||
129834101|NCT02474199|467357869|FG002|Overall Study|Lost to Follow-up|0|||
129834102|NCT02474199|467357870|FG003|Overall Study|Lost to Follow-up|0|||
129834103|NCT02474199|467357867|FG000|Overall Study|Withdrawal by Subject|1|||
129834104|NCT02474199|467357868|FG001|Overall Study|Withdrawal by Subject|2|||
129834105|NCT02474199|467357869|FG002|Overall Study|Withdrawal by Subject|0|||
129834106|NCT02474199|467357870|FG003|Overall Study|Withdrawal by Subject|1|||
129834107|NCT02474199|467357867|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
129834108|NCT02474199|467357868|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
129834109|NCT02474199|467357869|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
129834110|NCT02474199|467357870|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
129834111|NCT02474199|467357867|FG000|Overall Study|Did not meet eligibility criteria|0|||
129834112|NCT02474199|467357868|FG001|Overall Study|Did not meet eligibility criteria|0|||
129834113|NCT02474199|467357869|FG002|Overall Study|Did not meet eligibility criteria|2|||
129834114|NCT02474199|467357870|FG003|Overall Study|Did not meet eligibility criteria|2|||
129834115|NCT03090100|467357871|FG000|Overall Study|Adverse Event|9|||
129834116|NCT03090100|467357872|FG001|Overall Study|Adverse Event|11|||
129834117|NCT03090100|467357871|FG000|Overall Study|Pregnancy|1|||
129834118|NCT03090100|467357872|FG001|Overall Study|Pregnancy|1|||
129834119|NCT03090100|467357871|FG000|Overall Study|Lack of Efficacy|2|||
129834120|NCT03090100|467357872|FG001|Overall Study|Lack of Efficacy|7|||
129834121|NCT03090100|467357871|FG000|Overall Study|Lost to Follow-up|2|||
129834122|NCT03090100|467357872|FG001|Overall Study|Lost to Follow-up|2|||
129834123|NCT03090100|467357871|FG000|Overall Study|Withdrawal by Subject|7|||
129834124|NCT03090100|467357872|FG001|Overall Study|Withdrawal by Subject|19|||
129834125|NCT03090100|467357871|FG000|Overall Study|Protocol Violation|2|||
129834126|NCT03090100|467357872|FG001|Overall Study|Protocol Violation|6|||
129834127|NCT03090100|467357871|FG000|Overall Study|Non-compliance|2|||
129834128|NCT03090100|467357872|FG001|Overall Study|Non-compliance|0|||
129834129|NCT03090100|467357871|FG000|Overall Study|Other|2|||
129834130|NCT03090100|467357872|FG001|Overall Study|Other|2|||
129834131|NCT00159588|467357873|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
129834132|NCT00159588|467357874|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
129834133|NCT00159588|467357875|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
129834134|NCT01660711|467357876|FG000|Overall Study|Adverse Event|7|||
129834135|NCT01660711|467357876|FG000|Overall Study|Withdrawal by Subject|1|||
129834136|NCT03253848|467357878|FG000|Overall Study|Adverse Event|7|||
129834137|NCT03253848|467357878|FG000|Overall Study|Death|5|||
129834138|NCT03253848|467357878|FG000|Overall Study|initiation of other treatments|3|||
129834139|NCT03253848|467357878|FG000|Overall Study|Other complicating disease|1|||
129834140|NCT03253848|467357878|FG000|Overall Study|Withdrawal by Subject|1|||
129834141|NCT03253848|467357878|FG000|Overall Study|Declining health|1|||
129834142|NCT05352815|467357879|FG000|Overall Study|Withdrawal by Subject|28|||
129834143|NCT05352815|467357880|FG001|Overall Study|Withdrawal by Subject|24|||
129834144|NCT05352815|467357879|FG000|Overall Study|Lost to Follow-up|4|||
129834145|NCT05352815|467357880|FG001|Overall Study|Lost to Follow-up|7|||
129834146|NCT05352815|467357879|FG000|Overall Study|Death|2|||
129834147|NCT05352815|467357880|FG001|Overall Study|Death|3|||
129834148|NCT05352815|467357879|FG000|Overall Study|Site closure|1|||
129834149|NCT05352815|467357880|FG001|Overall Study|Site closure|0|||
129834150|NCT02759120|467357881|FG000|Overall Study|Death|34|||
129834151|NCT02759120|467357882|FG001|Overall Study|Death|36|||
129834152|NCT02759120|467357881|FG000|Overall Study|Lost to Follow-up|4|||
129834153|NCT02759120|467357882|FG001|Overall Study|Lost to Follow-up|7|||
129834154|NCT02759120|467357881|FG000|Overall Study|Physician Decision|3|||
129834155|NCT02759120|467357882|FG001|Overall Study|Physician Decision|0|||
129834156|NCT02759120|467357881|FG000|Overall Study|Withdrawal by Subject|28|||
129834157|NCT02759120|467357882|FG001|Overall Study|Withdrawal by Subject|15|||
129897784|NCT00762463|467586462|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
130060873|NCT00430521|468176748|FG000|Overall Study|Vaccine Expired|0|||
129834158|NCT02759120|467357881|FG000|Overall Study|Moved out of area|3|||
129834159|NCT02759120|467357882|FG001|Overall Study|Moved out of area|4|||
129834160|NCT02759120|467357881|FG000|Overall Study|Lung transplant|3|||
129834161|NCT02759120|467357882|FG001|Overall Study|Lung transplant|5|||
129834162|NCT02759120|467357881|FG000|Overall Study|Other reason not completed|10|||
129834163|NCT02759120|467357882|FG001|Overall Study|Other reason not completed|12|||
129834164|NCT03056755|467357884|FG000|Treatment- Core Phase|Progressive disease|89|||
129834165|NCT03056755|467357885|FG001|Treatment- Core Phase|Progressive disease|88|||
129834166|NCT03056755|467357886|FG002|Treatment- Core Phase|Progressive disease|90|||
130060874|NCT00430521|468176749|FG001|Overall Study|Vaccine Expired|0|||
130112848|NCT00410410|468373481|FG000|Maintenance Period (MP)|Adverse Event|0|||
130112849|NCT00410410|468373482|FG001|Maintenance Period (MP)|Adverse Event|0|||
130112850|NCT00410410|468373483|FG002|Maintenance Period (MP)|Adverse Event|0|||
130112851|NCT00410410|468373484|FG003|Maintenance Period (MP)|Adverse Event|0|||
130112852|NCT00410410|468373485|FG004|Maintenance Period (MP)|Adverse Event|0|||
130112853|NCT00410410|468373486|FG005|Maintenance Period (MP)|Adverse Event|0|||
130112854|NCT00410410|468373487|FG006|Maintenance Period (MP)|Adverse Event|1|||
130112855|NCT00410410|468373488|FG007|Maintenance Period (MP)|Adverse Event|3|||
130112856|NCT00410410|468373489|FG008|Maintenance Period (MP)|Adverse Event|0|||
130112857|NCT00410410|468373481|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
130112858|NCT00410410|468373482|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
130112859|NCT00410410|468373483|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
130112860|NCT00410410|468373484|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
130112861|NCT00410410|468373485|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
130112862|NCT00410410|468373486|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
130112863|NCT00410410|468373487|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
130112864|NCT00410410|468373488|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
130112865|NCT00410410|468373489|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
130112866|NCT00410410|468373481|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
130112867|NCT00410410|468373482|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
130112868|NCT00410410|468373483|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
130112869|NCT00410410|468373484|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
130112870|NCT00410410|468373485|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
130112871|NCT00410410|468373486|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
130112872|NCT00410410|468373487|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
130112873|NCT00410410|468373488|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
130112874|NCT00410410|468373489|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
130112875|NCT00410410|468373481|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112876|NCT00410410|468373482|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112877|NCT00410410|468373483|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112878|NCT00410410|468373484|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112879|NCT00410410|468373485|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112880|NCT00410410|468373486|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112881|NCT00410410|468373487|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
130112882|NCT00410410|468373488|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
130112883|NCT00410410|468373489|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
130112884|NCT00410410|468373481|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112885|NCT00410410|468373482|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112886|NCT00410410|468373483|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112887|NCT00410410|468373484|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112888|NCT00410410|468373485|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112889|NCT00410410|468373486|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112890|NCT00410410|468373487|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
130112891|NCT00410410|468373488|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
129834167|NCT03056755|467357884|FG000|Treatment- Core Phase|Adverse Event|20|||
129834168|NCT03056755|467357885|FG001|Treatment- Core Phase|Adverse Event|14|||
129834169|NCT03056755|467357886|FG002|Treatment- Core Phase|Adverse Event|13|||
129834170|NCT03056755|467357884|FG000|Treatment- Core Phase|Physician Decision|7|||
129834171|NCT03056755|467357885|FG001|Treatment- Core Phase|Physician Decision|13|||
129834172|NCT03056755|467357886|FG002|Treatment- Core Phase|Physician Decision|5|||
129834173|NCT03056755|467357884|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
129834174|NCT03056755|467357885|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
129834175|NCT03056755|467357886|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
129834176|NCT03056755|467357884|FG000|Treatment- Core Phase|Death|3|||
129834177|NCT03056755|467357885|FG001|Treatment- Core Phase|Death|2|||
129834178|NCT03056755|467357886|FG002|Treatment- Core Phase|Death|4|||
129834179|NCT03056755|467357884|FG000|Treatment- Core Phase|Protocol deviation|1|||
129834180|NCT03056755|467357885|FG001|Treatment- Core Phase|Protocol deviation|1|||
129834181|NCT03056755|467357886|FG002|Treatment- Core Phase|Protocol deviation|0|||
129834182|NCT03056755|467357884|FG000|Treatment- Core Phase|Technical problems|1|||
129834183|NCT03056755|467357885|FG001|Treatment- Core Phase|Technical problems|0|||
129834184|NCT03056755|467357886|FG002|Treatment- Core Phase|Technical problems|0|||
129834185|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
129979659|NCT00403767|467889418|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
130112892|NCT00410410|468373489|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
130112893|NCT00410410|468373481|FG000|Open-Label Period (OL)|Death|0|||
130112894|NCT00410410|468373482|FG001|Open-Label Period (OL)|Death|0|||
130112895|NCT00410410|468373483|FG002|Open-Label Period (OL)|Death|0|||
130112896|NCT00410410|468373484|FG003|Open-Label Period (OL)|Death|0|||
130112897|NCT00410410|468373485|FG004|Open-Label Period (OL)|Death|0|||
130112898|NCT00410410|468373486|FG005|Open-Label Period (OL)|Death|0|||
130112899|NCT00410410|468373487|FG006|Open-Label Period (OL)|Death|0|||
130112900|NCT00410410|468373488|FG007|Open-Label Period (OL)|Death|0|||
129834186|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
129834187|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
129834188|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
129834189|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
129834190|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
129834191|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
129834192|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
129834193|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
129834194|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
129834195|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
129834196|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
129834197|NCT03406858|467357887|FG000|Overall Study|Failure to receive treatment drug.|1|||
129834198|NCT03406858|467357887|FG000|Overall Study|ineligible|1|||
129834199|NCT02419742|467357888|FG000|Overall Study|Adverse Event|2|||
129834200|NCT02419742|467357889|FG001|Overall Study|Adverse Event|0|||
129834201|NCT02419742|467357888|FG000|Overall Study|Disease Progression|0|||
129834202|NCT02419742|467357889|FG001|Overall Study|Disease Progression|1|||
129834203|NCT02419742|467357888|FG000|Overall Study|Withdrew Consent|2|||
129834204|NCT02419742|467357889|FG001|Overall Study|Withdrew Consent|1|||
129834205|NCT02419742|467357888|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
129834206|NCT02419742|467357889|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
129834207|NCT05071183|467357898|FG000|Overall Study|Death|1|||
129834208|NCT05071183|467357899|FG001|Overall Study|Death|2|||
129834209|NCT05071183|467357900|FG002|Overall Study|Death|0|||
129834210|NCT05071183|467357898|FG000|Overall Study|Other Reasons|1|||
129834211|NCT05071183|467357899|FG001|Overall Study|Other Reasons|3|||
129834212|NCT05071183|467357900|FG002|Overall Study|Other Reasons|2|||
129834213|NCT02532647|467357908|FG000|Overall Study|Did not receive trial medication|1|||
129834214|NCT02532647|467357909|FG001|Overall Study|Did not receive trial medication|0|||
129834215|NCT02532647|467357910|FG002|Overall Study|Did not receive trial medication|1|||
129834216|NCT02211131|467357911|FG000|Overall Study|Death|26|||
129834217|NCT02211131|467357912|FG001|Overall Study|Death|16|||
129834218|NCT02211131|467357911|FG000|Overall Study|Lost to Follow-up|4|||
129834219|NCT02211131|467357912|FG001|Overall Study|Lost to Follow-up|3|||
129834220|NCT02211131|467357911|FG000|Overall Study|Decision by Sponsor|1|||
129834221|NCT02211131|467357912|FG001|Overall Study|Decision by Sponsor|1|||
129834222|NCT02211131|467357911|FG000|Overall Study|Withdrawal by Subject|3|||
129834223|NCT02211131|467357912|FG001|Overall Study|Withdrawal by Subject|8|||
129834224|NCT02939560|467357914|FG000|Overall Study|Withdrawal by Subject|2|||
129834225|NCT02939560|467357914|FG000|Overall Study|Protocol Violation|1|||
129834226|NCT03340025|467357915|FG000|Overall Study|Lost to Follow-up|2|||
129834227|NCT03340025|467357916|FG001|Overall Study|Lost to Follow-up|2|||
129834228|NCT03897179|467357924|FG000|Overall Study|Withdrawal by Subject|1|||
129834229|NCT00704535|467357925|FG000|Overall Study|Adverse Event|2|||
129834230|NCT00704535|467357925|FG000|Overall Study|Death|2|||
129834231|NCT00704535|467357925|FG000|Overall Study|Lost to Follow-up|8|||
129834232|NCT00704535|467357925|FG000|Overall Study|Protocol Violation|10|||
129897785|NCT00762463|467586463|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
129897786|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
129897787|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
129897788|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
129897789|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
129897790|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
129897791|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
129834233|NCT00704535|467357925|FG000|Overall Study|Completed status not on Case Report Form|124|||
129834234|NCT01480076|467357926|FG000|Overall Study|Run-in Failure|52|||
129834235|NCT01480076|467357926|FG000|Overall Study|Adverse Event|39|||
129834236|NCT01480076|467357926|FG000|Overall Study|Death|2|||
129834237|NCT01480076|467357926|FG000|Overall Study|Disease Progression|5|||
129834238|NCT01480076|467357926|FG000|Overall Study|Non-compliance With Study Protocol|15|||
129834239|NCT01480076|467357926|FG000|Overall Study|Withdrawal by Subject|105|||
129834240|NCT01480076|467357926|FG000|Overall Study|Lost to Follow-up|7|||
129834241|NCT01480076|467357926|FG000|Overall Study|Investigator Decision|13|||
129897792|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
129834242|NCT01480076|467357926|FG000|Overall Study|Other|52|||
130060875|NCT00430521|468176750|FG002|Overall Study|Vaccine Expired|0|||
129834243|NCT02625090|467357933|FG000|Overall Study|Participant wants to be pregnant|2|||
129834244|NCT02625090|467357933|FG000|Overall Study|For the Promoter|1|||
129834245|NCT02625090|467357933|FG000|Overall Study|Sponsor's Decision|9|||
129834246|NCT02625090|467357933|FG000|Overall Study|Somnolence|1|||
129834247|NCT02625090|467357933|FG000|Overall Study|Study terminated by Sponsor|7|||
129834248|NCT02625090|467357933|FG000|Overall Study|Negative Benefit/Risk|1|||
130060876|NCT00430521|468176751|FG003|Overall Study|Vaccine Expired|0|||
130112901|NCT00410410|468373489|FG008|Open-Label Period (OL)|Death|1|||
130112902|NCT00410410|468373481|FG000|Open-Label Period (OL)|Adverse Event|0|||
130112903|NCT00410410|468373482|FG001|Open-Label Period (OL)|Adverse Event|0|||
130112904|NCT00410410|468373483|FG002|Open-Label Period (OL)|Adverse Event|0|||
130112905|NCT00410410|468373484|FG003|Open-Label Period (OL)|Adverse Event|0|||
130112906|NCT00410410|468373485|FG004|Open-Label Period (OL)|Adverse Event|0|||
130112907|NCT00410410|468373486|FG005|Open-Label Period (OL)|Adverse Event|0|||
130112908|NCT00410410|468373487|FG006|Open-Label Period (OL)|Adverse Event|0|||
130112909|NCT00410410|468373488|FG007|Open-Label Period (OL)|Adverse Event|0|||
130112910|NCT00410410|468373489|FG008|Open-Label Period (OL)|Adverse Event|10|||
130112911|NCT00410410|468373481|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
130112912|NCT00410410|468373482|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
130112913|NCT00410410|468373483|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
130112914|NCT00410410|468373484|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
130112915|NCT00410410|468373485|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
130112916|NCT00410410|468373486|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
130112917|NCT00410410|468373487|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
130112918|NCT00410410|468373488|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
130112919|NCT00410410|468373489|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
130112920|NCT00410410|468373481|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
130112921|NCT00410410|468373482|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
130112922|NCT00410410|468373483|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
130112923|NCT00410410|468373484|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
130112924|NCT00410410|468373485|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
130112925|NCT00410410|468373486|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
130112926|NCT00410410|468373487|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
130112927|NCT00410410|468373488|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
130112928|NCT00410410|468373489|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
130112929|NCT00410410|468373481|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112930|NCT00410410|468373482|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112931|NCT00410410|468373483|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112932|NCT00410410|468373484|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112933|NCT00410410|468373485|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112934|NCT00410410|468373486|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
129834249|NCT02625090|467357933|FG000|Overall Study|Protocol Deviation|2|||
129834250|NCT02625090|467357933|FG000|Overall Study|Lack of Efficacy|16|||
129834251|NCT02625090|467357933|FG000|Overall Study|Adverse Event|3|||
129834252|NCT02439320|467357934|FG000|Overall Study|Adverse Event|0|||
129834253|NCT02439320|467357935|FG001|Overall Study|Adverse Event|2|||
129834254|NCT02439320|467357936|FG002|Overall Study|Adverse Event|0|||
129834255|NCT02439320|467357934|FG000|Overall Study|Lost to Follow-up|37|||
129834256|NCT02439320|467357935|FG001|Overall Study|Lost to Follow-up|34|||
129834257|NCT02439320|467357936|FG002|Overall Study|Lost to Follow-up|42|||
129834258|NCT02439320|467357934|FG000|Overall Study|Death|0|||
129834259|NCT02439320|467357935|FG001|Overall Study|Death|1|||
129834260|NCT02439320|467357936|FG002|Overall Study|Death|0|||
129834261|NCT02439320|467357934|FG000|Overall Study|Noncompliance with Protocol|10|||
129834262|NCT02439320|467357935|FG001|Overall Study|Noncompliance with Protocol|11|||
129834263|NCT02439320|467357936|FG002|Overall Study|Noncompliance with Protocol|7|||
129834264|NCT02439320|467357934|FG000|Overall Study|Pregnancy|0|||
129834265|NCT02439320|467357935|FG001|Overall Study|Pregnancy|1|||
129834266|NCT02439320|467357936|FG002|Overall Study|Pregnancy|1|||
129834267|NCT02439320|467357934|FG000|Overall Study|Withdrawal by Subject|12|||
129834268|NCT02439320|467357935|FG001|Overall Study|Withdrawal by Subject|16|||
129834269|NCT02439320|467357936|FG002|Overall Study|Withdrawal by Subject|14|||
129834270|NCT02439320|467357934|FG000|Overall Study|Physician Decision|2|||
129834271|NCT02439320|467357935|FG001|Overall Study|Physician Decision|1|||
129834272|NCT02439320|467357936|FG002|Overall Study|Physician Decision|0|||
129834273|NCT02439320|467357934|FG000|Overall Study|Sponsor Request|0|||
129834274|NCT02439320|467357935|FG001|Overall Study|Sponsor Request|2|||
129834275|NCT02439320|467357936|FG002|Overall Study|Sponsor Request|1|||
129834276|NCT02439320|467357934|FG000|Overall Study|Randomization Failure|35|||
129834277|NCT02439320|467357935|FG001|Overall Study|Randomization Failure|46|||
129834278|NCT02439320|467357936|FG002|Overall Study|Randomization Failure|34|||
129834279|NCT02972632|467357937|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129834280|NCT02972632|467357937|FG000|Overall Study|Lost to Follow-up|4|||
129834281|NCT02972632|467357937|FG000|Overall Study|Voluntary Withdrawal|10|||
129834282|NCT01251380|467357942|FG000|Overall Study|Other (Not otherwise specified)|12|||
129834283|NCT01251380|467357942|FG000|Overall Study|Withdrawal by Subject|6|||
129834284|NCT01251380|467357942|FG000|Overall Study|Lack of Efficacy|1|||
129834285|NCT01251380|467357942|FG000|Overall Study|Adverse Event|1|||
130112935|NCT00410410|468373487|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112936|NCT00410410|468373488|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
130112937|NCT00410410|468373489|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
130112938|NCT00410410|468373481|FG000|Open-Label Period (OL)|Pregnancy|0|||
130112939|NCT00410410|468373482|FG001|Open-Label Period (OL)|Pregnancy|0|||
130112940|NCT00410410|468373483|FG002|Open-Label Period (OL)|Pregnancy|0|||
129834286|NCT01251380|467357942|FG000|Overall Study|Lost to Follow-up|2|||
129834287|NCT03054870|467357946|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
129834288|NCT03054870|467357946|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
129834289|NCT01154218|467357947|FG000|Third Intervention Period|Adverse Event|0|||
129834290|NCT01154218|467357948|FG001|Third Intervention Period|Adverse Event|1|||
129834291|NCT01154218|467357949|FG002|Third Intervention Period|Adverse Event|0|||
129834292|NCT01154218|467357950|FG003|Third Intervention Period|Adverse Event|0|||
129834293|NCT01154218|467357947|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129834294|NCT01154218|467357948|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129834295|NCT01154218|467357949|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129834296|NCT01154218|467357950|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
129834297|NCT01154218|467357947|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
129834298|NCT01154218|467357948|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
129834299|NCT01154218|467357949|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
129834300|NCT01154218|467357950|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
129834301|NCT00129129|467357951|FG000|Primary Phase|Adverse Event|2|||
129834302|NCT00129129|467357952|FG001|Primary Phase|Adverse Event|1|||
129834303|NCT00129129|467357953|FG002|Primary Phase|Adverse Event|0|||
129834304|NCT00129129|467357954|FG003|Primary Phase|Adverse Event|0|||
129834305|NCT00129129|467357955|FG004|Primary Phase|Adverse Event|0|||
129834306|NCT00129129|467357951|FG000|Primary Phase|Withdrawal by Subject|12|||
129834307|NCT00129129|467357952|FG001|Primary Phase|Withdrawal by Subject|10|||
129834308|NCT00129129|467357953|FG002|Primary Phase|Withdrawal by Subject|0|||
129834309|NCT00129129|467357954|FG003|Primary Phase|Withdrawal by Subject|0|||
129834310|NCT00129129|467357955|FG004|Primary Phase|Withdrawal by Subject|0|||
129834311|NCT00129129|467357951|FG000|Primary Phase|Migration from study area|1|||
129834312|NCT00129129|467357952|FG001|Primary Phase|Migration from study area|3|||
129834313|NCT00129129|467357953|FG002|Primary Phase|Migration from study area|0|||
129834314|NCT00129129|467357954|FG003|Primary Phase|Migration from study area|0|||
129834315|NCT00129129|467357955|FG004|Primary Phase|Migration from study area|0|||
129834316|NCT00129129|467357951|FG000|Primary Phase|Lost to Follow-up|8|||
129834317|NCT00129129|467357952|FG001|Primary Phase|Lost to Follow-up|6|||
129834318|NCT00129129|467357953|FG002|Primary Phase|Lost to Follow-up|0|||
129834319|NCT00129129|467357954|FG003|Primary Phase|Lost to Follow-up|0|||
129834320|NCT00129129|467357955|FG004|Primary Phase|Lost to Follow-up|0|||
129834321|NCT00129129|467357951|FG000|Primary Phase|Other|2|||
129834322|NCT00129129|467357952|FG001|Primary Phase|Other|5|||
129834323|NCT00129129|467357953|FG002|Primary Phase|Other|0|||
129834324|NCT00129129|467357954|FG003|Primary Phase|Other|0|||
129834325|NCT00129129|467357955|FG004|Primary Phase|Other|0|||
129834326|NCT00129129|467357951|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
129834327|NCT00129129|467357952|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
129834328|NCT00129129|467357953|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
129834329|NCT00129129|467357954|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
129834330|NCT00129129|467357955|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
129834331|NCT00129129|467357951|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
129834332|NCT00129129|467357952|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
129834333|NCT00129129|467357953|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
129834334|NCT00129129|467357954|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
129834335|NCT00129129|467357955|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
129834336|NCT00129129|467357951|FG000|Fourth Dose Phase|Migration from study area|0|||
129834337|NCT00129129|467357952|FG001|Fourth Dose Phase|Migration from study area|0|||
129834338|NCT00129129|467357953|FG002|Fourth Dose Phase|Migration from study area|0|||
129834339|NCT00129129|467357954|FG003|Fourth Dose Phase|Migration from study area|0|||
129834340|NCT00129129|467357955|FG004|Fourth Dose Phase|Migration from study area|2|||
129834341|NCT00129129|467357951|FG000|Fourth Dose Phase|Other|0|||
129834342|NCT00129129|467357952|FG001|Fourth Dose Phase|Other|0|||
129834343|NCT00129129|467357953|FG002|Fourth Dose Phase|Other|0|||
129834344|NCT00129129|467357954|FG003|Fourth Dose Phase|Other|1|||
129834345|NCT00129129|467357955|FG004|Fourth Dose Phase|Other|1|||
129834346|NCT00129129|467357951|FG000|Fourth Dose Phase|Protocol Violation|0|||
129834347|NCT00129129|467357952|FG001|Fourth Dose Phase|Protocol Violation|0|||
129834348|NCT00129129|467357953|FG002|Fourth Dose Phase|Protocol Violation|0|||
129834349|NCT00129129|467357954|FG003|Fourth Dose Phase|Protocol Violation|1|||
129834350|NCT00129129|467357955|FG004|Fourth Dose Phase|Protocol Violation|0|||
129834351|NCT02140567|467357958|FG000|Overall Study|Problems with recording equipment|6|||
129834352|NCT02882854|467357959|FG000|Overall Study|Lost to Follow-up|1|||
129834353|NCT02882854|467357960|FG001|Overall Study|Lost to Follow-up|2|||
129834354|NCT02882854|467357959|FG000|Overall Study|Physician Decision|0|||
129834355|NCT02882854|467357960|FG001|Overall Study|Physician Decision|1|||
129834356|NCT03774433|467357966|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
129834357|NCT00108160|467357967|FG000|Overall Study|Lost to Follow-up|25|||
129834358|NCT00108160|467357968|FG001|Overall Study|Lost to Follow-up|12|||
129834359|NCT00108160|467357967|FG000|Overall Study|Death|1|||
129834360|NCT00108160|467357968|FG001|Overall Study|Death|2|||
130060877|NCT00430521|468176752|FG004|Overall Study|Vaccine Expired|0|||
129834361|NCT00108160|467357967|FG000|Overall Study|Withdrawal by Subject|4|||
129834362|NCT00108160|467357968|FG001|Overall Study|Withdrawal by Subject|2|||
129834363|NCT00108160|467357967|FG000|Overall Study|Protocol Violation|9|||
129834364|NCT00108160|467357968|FG001|Overall Study|Protocol Violation|5|||
129834365|NCT00004888|467359461|FG000|Overall Study|Adverse Event|5|||
129834366|NCT00004888|467359462|FG001|Overall Study|Adverse Event|10|||
129834367|NCT00004888|467359461|FG000|Overall Study|Withdrawal by Subject|0|||
129834368|NCT00004888|467359462|FG001|Overall Study|Withdrawal by Subject|3|||
129834369|NCT00004888|467359461|FG000|Overall Study|Physician Decision|1|||
129834370|NCT00004888|467359462|FG001|Overall Study|Physician Decision|1|||
129834371|NCT00004888|467359461|FG000|Overall Study|Progressive Disease|4|||
129834372|NCT00004888|467359462|FG001|Overall Study|Progressive Disease|9|||
129834373|NCT00004888|467359461|FG000|Overall Study|Death without progressive disease|0|||
129834374|NCT00004888|467359462|FG001|Overall Study|Death without progressive disease|1|||
129834375|NCT00004888|467359461|FG000|Overall Study|Toxic death|1|||
129834376|NCT00004888|467359462|FG001|Overall Study|Toxic death|0|||
129834377|NCT02579265|467359463|FG000|Overall Study|Weaned off earlier than 28 days|44|||
129834378|NCT02579265|467359464|FG001|Overall Study|Weaned off earlier than 28 days|43|||
129834379|NCT02579265|467359463|FG000|Overall Study|Adverse Event|2|||
129834380|NCT02579265|467359464|FG001|Overall Study|Adverse Event|0|||
129834381|NCT02579265|467359463|FG000|Overall Study|Any other reason not specified|0|||
129834382|NCT02579265|467359464|FG001|Overall Study|Any other reason not specified|2|||
129834383|NCT02579265|467359463|FG000|Overall Study|Withdrawal by Subject|2|||
129834384|NCT02579265|467359464|FG001|Overall Study|Withdrawal by Subject|0|||
129834385|NCT02579265|467359463|FG000|Overall Study|Physician Decision|1|||
130112941|NCT00410410|468373484|FG003|Open-Label Period (OL)|Pregnancy|0|||
130112942|NCT00410410|468373485|FG004|Open-Label Period (OL)|Pregnancy|0|||
130112943|NCT00410410|468373486|FG005|Open-Label Period (OL)|Pregnancy|0|||
130112944|NCT00410410|468373487|FG006|Open-Label Period (OL)|Pregnancy|0|||
130112945|NCT00410410|468373488|FG007|Open-Label Period (OL)|Pregnancy|0|||
129834386|NCT02579265|467359464|FG001|Overall Study|Physician Decision|0|||
129834387|NCT02579265|467359463|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
129834388|NCT02579265|467359464|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
129834389|NCT02174848|467359465|FG000|Overall Study|Adverse Event|2|||
129834390|NCT02174848|467359466|FG001|Overall Study|Adverse Event|1|||
129834391|NCT02174848|467359465|FG000|Overall Study|Withdrawal by Subject|3|||
129834392|NCT02174848|467359466|FG001|Overall Study|Withdrawal by Subject|3|||
129834393|NCT02174848|467359465|FG000|Overall Study|Lost to Follow-up|0|||
129834394|NCT02174848|467359466|FG001|Overall Study|Lost to Follow-up|1|||
129834395|NCT02174848|467359465|FG000|Overall Study|Worsening of disease|1|||
129834396|NCT02174848|467359466|FG001|Overall Study|Worsening of disease|1|||
129834397|NCT02174848|467359465|FG000|Overall Study|Unable to comply with study requirements|1|||
129834398|NCT02174848|467359466|FG001|Overall Study|Unable to comply with study requirements|0|||
129834399|NCT00644969|467359470|FG000|Treatment Phase|Randomized, not treated|1|||
129834400|NCT00644969|467359471|FG001|Treatment Phase|Randomized, not treated|0|||
129834401|NCT00644969|467359470|FG000|Treatment Phase|Adverse Event|3|||
129834402|NCT00644969|467359471|FG001|Treatment Phase|Adverse Event|0|||
129897793|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
129897794|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
129897795|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
129897796|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
129897797|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
129897798|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
129897799|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
129897800|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
129897801|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
129897802|NCT01306331|467586466|FG000|Overall Study|Adverse Event|28|||
129897803|NCT01306331|467586467|FG001|Overall Study|Adverse Event|25|||
129897804|NCT01306331|467586466|FG000|Overall Study|Lost to Follow-up|321|||
129897805|NCT01306331|467586467|FG001|Overall Study|Lost to Follow-up|323|||
129897806|NCT01306331|467586466|FG000|Overall Study|Physician Decision|26|||
130112946|NCT00410410|468373489|FG008|Open-Label Period (OL)|Pregnancy|1|||
129834403|NCT00644969|467359470|FG000|Treatment Phase|Withdrawal by Subject|4|||
129834404|NCT00644969|467359471|FG001|Treatment Phase|Withdrawal by Subject|0|||
129834405|NCT00644969|467359470|FG000|Treatment Phase|Lost to Follow-up|2|||
129834406|NCT00644969|467359471|FG001|Treatment Phase|Lost to Follow-up|2|||
129834407|NCT00644969|467359470|FG000|Treatment Phase|Other|4|||
129834408|NCT00644969|467359471|FG001|Treatment Phase|Other|1|||
129834409|NCT00644969|467359470|FG000|Post Treatment Phase|Death|1|||
129834410|NCT00644969|467359471|FG001|Post Treatment Phase|Death|0|||
129834411|NCT00644969|467359470|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
129834412|NCT00644969|467359471|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
129834413|NCT00644969|467359470|FG000|Post Treatment Phase|Lost to Follow-up|4|||
129897807|NCT01306331|467586467|FG001|Overall Study|Physician Decision|22|||
129897808|NCT01306331|467586466|FG000|Overall Study|Pregnancy|136|||
129834414|NCT00644969|467359471|FG001|Post Treatment Phase|Lost to Follow-up|1|||
129834415|NCT00644969|467359470|FG000|Post Treatment Phase|Other|1|||
129834416|NCT00644969|467359471|FG001|Post Treatment Phase|Other|0|||
129834417|NCT00666757|467359479|FG000|Overall Study|Lost to Follow-up|39|||
129834418|NCT00666757|467359480|FG001|Overall Study|Lost to Follow-up|35|||
129834419|NCT00666757|467359479|FG000|Overall Study|Protocol Violation|23|||
129834420|NCT00666757|467359480|FG001|Overall Study|Protocol Violation|24|||
129834421|NCT00666757|467359479|FG000|Overall Study|Adverse Event|22|||
129834422|NCT00666757|467359480|FG001|Overall Study|Adverse Event|12|||
129834423|NCT00666757|467359479|FG000|Overall Study|Withdrawal by Subject|13|||
129834424|NCT00666757|467359480|FG001|Overall Study|Withdrawal by Subject|17|||
129834425|NCT00666757|467359479|FG000|Overall Study|Lack of Efficacy|3|||
129834426|NCT00666757|467359480|FG001|Overall Study|Lack of Efficacy|6|||
129834427|NCT00666757|467359479|FG000|Overall Study|Physician Decision|0|||
129834428|NCT00666757|467359480|FG001|Overall Study|Physician Decision|2|||
129834429|NCT00666757|467359479|FG000|Overall Study|Sponsor decision|0|||
129834430|NCT00666757|467359480|FG001|Overall Study|Sponsor decision|1|||
129834431|NCT00952341|467359485|FG000|Cycle 1|Adverse Event|4|||
129834432|NCT00952341|467359486|FG001|Cycle 1|Adverse Event|1|||
129834433|NCT00952341|467359485|FG000|Cycle 1|Withdrawal by Subject|3|||
129834434|NCT00952341|467359486|FG001|Cycle 1|Withdrawal by Subject|8|||
129834435|NCT00952341|467359485|FG000|Cycle 1|Protocol Violation|2|||
129834436|NCT00952341|467359486|FG001|Cycle 1|Protocol Violation|1|||
129834437|NCT00952341|467359485|FG000|Cycle 1|Lost to Follow-up|11|||
129834438|NCT00952341|467359486|FG001|Cycle 1|Lost to Follow-up|2|||
129834439|NCT00952341|467359485|FG000|Cycle 1|Physician Decision|0|||
129834440|NCT00952341|467359486|FG001|Cycle 1|Physician Decision|1|||
129834441|NCT00952341|467359485|FG000|Cycle 2|Withdrawal by Subject|1|||
129834442|NCT00952341|467359486|FG001|Cycle 2|Withdrawal by Subject|1|||
129834443|NCT00952341|467359485|FG000|Cycle 2|Protocol Violation|1|||
129834444|NCT00952341|467359486|FG001|Cycle 2|Protocol Violation|0|||
129834445|NCT00952341|467359485|FG000|Cycle 2|Lost to Follow-up|6|||
129834446|NCT00952341|467359486|FG001|Cycle 2|Lost to Follow-up|9|||
129834447|NCT00952341|467359485|FG000|Cycle 2|Physician Decision|1|||
129834448|NCT00952341|467359486|FG001|Cycle 2|Physician Decision|1|||
129834449|NCT00952341|467359485|FG000|Cycle 2|Progressive Disease|0|||
129834450|NCT00952341|467359486|FG001|Cycle 2|Progressive Disease|1|||
129834451|NCT04920123|467359487|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
129834452|NCT04920123|467359488|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129834453|NCT04920123|467359489|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
129834454|NCT00278954|467359492|FG000|Overall Study|Adverse Event|3|||
129834455|NCT00278954|467359492|FG000|Overall Study|Lost to Follow-up|1|||
129834456|NCT00278954|467359492|FG000|Overall Study|Withdrawal by Subject|1|||
129834457|NCT02420691|467359498|FG000|Overall Study|Adverse Event|3|||
129834458|NCT02420691|467359498|FG000|Overall Study|Withdrawal by Subject|3|||
129834459|NCT02503332|467359501|FG000|Overall Study|Adverse Event|17|||
129834460|NCT02503332|467359502|FG001|Overall Study|Adverse Event|5|||
129834461|NCT02503332|467359503|FG002|Overall Study|Adverse Event|3|||
129834462|NCT02503332|467359504|FG003|Overall Study|Adverse Event|1|||
129834463|NCT02503332|467359501|FG000|Overall Study|Investigator's Decision|5|||
129834464|NCT02503332|467359502|FG001|Overall Study|Investigator's Decision|1|||
129834465|NCT02503332|467359503|FG002|Overall Study|Investigator's Decision|0|||
129834466|NCT02503332|467359504|FG003|Overall Study|Investigator's Decision|0|||
129834467|NCT02503332|467359501|FG000|Overall Study|Sponsor's Decision|1|||
129834468|NCT02503332|467359502|FG001|Overall Study|Sponsor's Decision|0|||
129834469|NCT02503332|467359503|FG002|Overall Study|Sponsor's Decision|0|||
129834470|NCT02503332|467359504|FG003|Overall Study|Sponsor's Decision|1|||
129834471|NCT02503332|467359501|FG000|Overall Study|Subject Request|6|||
129834472|NCT02503332|467359502|FG001|Overall Study|Subject Request|5|||
129834473|NCT02503332|467359503|FG002|Overall Study|Subject Request|2|||
129834474|NCT02503332|467359504|FG003|Overall Study|Subject Request|1|||
129834475|NCT02503332|467359501|FG000|Overall Study|Death|0|||
129834476|NCT02503332|467359502|FG001|Overall Study|Death|2|||
129834477|NCT02503332|467359503|FG002|Overall Study|Death|2|||
129834478|NCT02503332|467359504|FG003|Overall Study|Death|0|||
129834479|NCT02503332|467359501|FG000|Overall Study|Other|5|||
129834480|NCT02503332|467359502|FG001|Overall Study|Other|6|||
129834481|NCT02503332|467359503|FG002|Overall Study|Other|1|||
129834482|NCT02503332|467359504|FG003|Overall Study|Other|1|||
129834483|NCT01413360|467359505|FG000|Overall Study|Lost to Follow-up|2|||
129834484|NCT01413360|467359505|FG000|Overall Study|Adverse Event|1|||
129834485|NCT05694546|467359508|FG000|Overall Study|Lost to Follow-up|11|||
129834486|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
129834487|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
129834488|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
129834489|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
129834490|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
129834491|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
129834492|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
129897809|NCT01306331|467586467|FG001|Overall Study|Pregnancy|151|||
129834493|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
129834494|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
129834495|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
129834496|NCT01488097|467359521|FG000|Overall Study|Lost to Follow-up|1|||
129834497|NCT02016482|467359525|FG000|Period A|Adverse Event|3|||
129834498|NCT02016482|467359526|FG001|Period A|Adverse Event|5|||
129834499|NCT02016482|467359525|FG000|Period A|Withdrawal by Subject|3|||
129834500|NCT02016482|467359526|FG001|Period A|Withdrawal by Subject|4|||
129834501|NCT02016482|467359525|FG000|Period A|Lost to Follow-up|3|||
129834502|NCT02016482|467359526|FG001|Period A|Lost to Follow-up|3|||
129834503|NCT02016482|467359525|FG000|Period A|Lack of Efficacy|2|||
129834504|NCT02016482|467359526|FG001|Period A|Lack of Efficacy|1|||
129834505|NCT02016482|467359525|FG000|Period A|Other|3|||
129834506|NCT02016482|467359526|FG001|Period A|Other|0|||
129834507|NCT02016482|467359525|FG000|Period A|Protocol Violation|0|||
129834508|NCT02016482|467359526|FG001|Period A|Protocol Violation|1|||
129834509|NCT02016482|467359525|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
129834510|NCT02016482|467359526|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
129834511|NCT02016482|467359525|FG000|Period B|Withdrawal by Subject|1|||
129834512|NCT02016482|467359526|FG001|Period B|Withdrawal by Subject|1|||
129834513|NCT02016482|467359525|FG000|Period B|Lost to Follow-up|2|||
129834514|NCT02016482|467359526|FG001|Period B|Lost to Follow-up|0|||
129834515|NCT02016482|467359525|FG000|Period B|Lack of Efficacy|6|||
129834516|NCT02016482|467359526|FG001|Period B|Lack of Efficacy|4|||
129834517|NCT02016482|467359525|FG000|Period B|Other|4|||
129834518|NCT02016482|467359526|FG001|Period B|Other|0|||
129834519|NCT02016482|467359525|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
129834520|NCT02016482|467359526|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
129834521|NCT03089606|467359540|FG000|Overall Study|Progression after Cycle 1|1|||
129834522|NCT01709695|467359544|FG000|Overall Study|Withdrawal by Subject|1|||
129834523|NCT01709695|467359545|FG001|Overall Study|Withdrawal by Subject|1|||
129834524|NCT02802592|467359546|FG000|Overall Study|Study terminated due to loss of funding|4|||
129834525|NCT01150123|467359548|FG000|Overall Study|Withdrawal by Subject|1|||
129834526|NCT01150123|467359549|FG001|Overall Study|Withdrawal by Subject|1|||
129834527|NCT01150123|467359550|FG002|Overall Study|Withdrawal by Subject|2|||
129834528|NCT01150123|467359551|FG003|Overall Study|Withdrawal by Subject|1|||
129834529|NCT01150123|467359552|FG004|Overall Study|Withdrawal by Subject|1|||
129834530|NCT01150123|467359553|FG005|Overall Study|Withdrawal by Subject|1|||
129834531|NCT01150123|467359554|FG006|Overall Study|Withdrawal by Subject|0|||
129834532|NCT01150123|467359555|FG007|Overall Study|Withdrawal by Subject|3|||
129834533|NCT01150123|467359556|FG008|Overall Study|Withdrawal by Subject|2|||
129834534|NCT01150123|467359557|FG009|Overall Study|Withdrawal by Subject|0|||
129834535|NCT01150123|467359558|FG010|Overall Study|Withdrawal by Subject|1|||
129834536|NCT01150123|467359559|FG011|Overall Study|Withdrawal by Subject|0|||
129834537|NCT01150123|467359560|FG012|Overall Study|Withdrawal by Subject|1|||
129834538|NCT01150123|467359561|FG013|Overall Study|Withdrawal by Subject|0|||
129834539|NCT01150123|467359562|FG014|Overall Study|Withdrawal by Subject|0|||
129834540|NCT01150123|467359563|FG015|Overall Study|Withdrawal by Subject|1|||
129834541|NCT01150123|467359564|FG016|Overall Study|Withdrawal by Subject|0|||
129834542|NCT01150123|467359565|FG017|Overall Study|Withdrawal by Subject|1|||
129834543|NCT01150123|467359548|FG000|Overall Study|Lost to Follow-up|2|||
129834544|NCT01150123|467359549|FG001|Overall Study|Lost to Follow-up|1|||
129834545|NCT01150123|467359550|FG002|Overall Study|Lost to Follow-up|2|||
129834546|NCT01150123|467359551|FG003|Overall Study|Lost to Follow-up|2|||
129834547|NCT01150123|467359552|FG004|Overall Study|Lost to Follow-up|2|||
129834548|NCT01150123|467359553|FG005|Overall Study|Lost to Follow-up|5|||
129834549|NCT01150123|467359554|FG006|Overall Study|Lost to Follow-up|0|||
129834550|NCT01150123|467359555|FG007|Overall Study|Lost to Follow-up|0|||
129834551|NCT01150123|467359556|FG008|Overall Study|Lost to Follow-up|3|||
129834552|NCT01150123|467359557|FG009|Overall Study|Lost to Follow-up|1|||
129834553|NCT01150123|467359558|FG010|Overall Study|Lost to Follow-up|1|||
129834554|NCT01150123|467359559|FG011|Overall Study|Lost to Follow-up|1|||
129834555|NCT01150123|467359560|FG012|Overall Study|Lost to Follow-up|2|||
129834556|NCT01150123|467359561|FG013|Overall Study|Lost to Follow-up|0|||
129834557|NCT01150123|467359562|FG014|Overall Study|Lost to Follow-up|0|||
129834558|NCT01150123|467359563|FG015|Overall Study|Lost to Follow-up|0|||
129834559|NCT01150123|467359564|FG016|Overall Study|Lost to Follow-up|0|||
129834560|NCT01150123|467359565|FG017|Overall Study|Lost to Follow-up|0|||
129834561|NCT02347189|467359568|FG000|Overall Study|No implant attempted of study device|9|||
129834562|NCT02347189|467359568|FG000|Overall Study|No primary outcome data available|2|||
129834563|NCT00735878|467359569|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
129834564|NCT00735878|467359570|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
129834565|NCT00735878|467359571|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
129834566|NCT00994240|467359572|FG000|Overall Study|Lost to Follow-up|3|||
129834567|NCT00994240|467359573|FG001|Overall Study|Lost to Follow-up|2|||
129834568|NCT00994240|467359572|FG000|Overall Study|Withdrawal by Subject|1|||
129834569|NCT00994240|467359573|FG001|Overall Study|Withdrawal by Subject|0|||
129834570|NCT00994240|467359572|FG000|Overall Study|study termination|2|||
129834571|NCT00994240|467359573|FG001|Overall Study|study termination|3|||
129834572|NCT00352846|467359574|FG000|Overall Study|Disease progression|0|||
129834573|NCT00352846|467359575|FG001|Overall Study|Disease progression|2|||
129834574|NCT00352846|467359574|FG000|Overall Study|Withdrawal by Subject|3|||
129834575|NCT00352846|467359575|FG001|Overall Study|Withdrawal by Subject|8|||
129834576|NCT00352846|467359574|FG000|Overall Study|Ineligible|3|||
129834577|NCT00352846|467359575|FG001|Overall Study|Ineligible|2|||
129834578|NCT00352846|467359574|FG000|Overall Study|Non-compliance|2|||
129834579|NCT00352846|467359575|FG001|Overall Study|Non-compliance|0|||
129834580|NCT00352846|467359574|FG000|Overall Study|Death|0|||
129834581|NCT00352846|467359575|FG001|Overall Study|Death|1|||
129834582|NCT00788827|467359576|FG000|Overall Study|Lack of Efficacy|2|||
129834583|NCT01527682|467359583|FG000|Overall Study|Protocol Violation|8|||
129834584|NCT01586819|467359584|FG000|Overall Study|Withdrawal by Subject|1|||
129834585|NCT01586819|467359585|FG001|Overall Study|Withdrawal by Subject|0|||
129834586|NCT01359254|467359586|FG000|Overall Study|Death|1|||
129834587|NCT01359254|467359587|FG001|Overall Study|Death|0|||
129834588|NCT03979638|467359589|FG000|Period 1|Physician Decision|1|||
129834589|NCT03979638|467359590|FG001|Period 1|Physician Decision|1|||
129834590|NCT03979638|467359589|FG000|Period 1|Withdrawal by Subject|4|||
129834591|NCT03979638|467359590|FG001|Period 1|Withdrawal by Subject|3|||
129834592|NCT03979638|467359589|FG000|Period 1|Study terminated by Sponsor|1|||
129834593|NCT03979638|467359590|FG001|Period 1|Study terminated by Sponsor|3|||
129834594|NCT03979638|467359589|FG000|Period 1|Protocol Violation|1|||
129834595|NCT03979638|467359590|FG001|Period 1|Protocol Violation|0|||
129834596|NCT03979638|467359589|FG000|Period 2|Study terminated by Sponsor|1|||
129834597|NCT03979638|467359590|FG001|Period 2|Study terminated by Sponsor|1|||
129834598|NCT04248933|467359593|FG000|Overall Study|Lost to Follow-up|9|||
129834599|NCT04248933|467359593|FG000|Overall Study|Withdrawal by Subject|2|||
129834600|NCT00578942|467359594|FG000|Overall Study|Lost to Follow-up|1|||
129834601|NCT00600938|467359605|FG000|Core Study|Abnormal test procedure result(s)|3|||
129834602|NCT00600938|467359606|FG001|Core Study|Abnormal test procedure result(s)|2|||
129834603|NCT00600938|467359607|FG002|Core Study|Abnormal test procedure result(s)|0|||
129834604|NCT00600938|467359608|FG003|Core Study|Abnormal test procedure result(s)|0|||
129834605|NCT00600938|467359605|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
129834606|NCT00600938|467359606|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
129834607|NCT00600938|467359607|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
129834608|NCT00600938|467359608|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
129834609|NCT00600938|467359605|FG000|Core Study|Patient withdrew consent|7|||
129834610|NCT00600938|467359606|FG001|Core Study|Patient withdrew consent|12|||
129834611|NCT00600938|467359607|FG002|Core Study|Patient withdrew consent|0|||
129834612|NCT00600938|467359608|FG003|Core Study|Patient withdrew consent|0|||
129834613|NCT00600938|467359605|FG000|Core Study|Lost to Follow-up|3|||
129834614|NCT00600938|467359606|FG001|Core Study|Lost to Follow-up|2|||
129834615|NCT00600938|467359607|FG002|Core Study|Lost to Follow-up|0|||
129834616|NCT00600938|467359608|FG003|Core Study|Lost to Follow-up|0|||
129834617|NCT00600938|467359605|FG000|Core Study|Death|1|||
129834618|NCT00600938|467359606|FG001|Core Study|Death|1|||
129834619|NCT00600938|467359607|FG002|Core Study|Death|0|||
129834620|NCT00600938|467359608|FG003|Core Study|Death|0|||
129834621|NCT00600938|467359605|FG000|Core Study|Protocol Violation|1|||
129834622|NCT00600938|467359606|FG001|Core Study|Protocol Violation|2|||
130112947|NCT00410410|468373481|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130112948|NCT00410410|468373482|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130112949|NCT00410410|468373483|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130112950|NCT00410410|468373484|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130112951|NCT00410410|468373485|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129834623|NCT00600938|467359607|FG002|Core Study|Protocol Violation|0|||
129834624|NCT00600938|467359608|FG003|Core Study|Protocol Violation|0|||
129834625|NCT00600938|467359605|FG000|Extension Study|Adverse Event|1|||
129834626|NCT00600938|467359606|FG001|Extension Study|Adverse Event|0|||
129834627|NCT00600938|467359607|FG002|Extension Study|Adverse Event|2|||
129834628|NCT00600938|467359608|FG003|Extension Study|Adverse Event|0|||
129834629|NCT00600938|467359605|FG000|Extension Study|Abnormal test procedure results|0|||
129834630|NCT00600938|467359606|FG001|Extension Study|Abnormal test procedure results|1|||
129834631|NCT00600938|467359607|FG002|Extension Study|Abnormal test procedure results|1|||
129834632|NCT00600938|467359608|FG003|Extension Study|Abnormal test procedure results|1|||
129834633|NCT00600938|467359605|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
129834634|NCT00600938|467359606|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
129834635|NCT00600938|467359607|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
129834636|NCT00600938|467359608|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
129834637|NCT00600938|467359605|FG000|Extension Study|Withdrawal by Subject|2|||
129834638|NCT00600938|467359606|FG001|Extension Study|Withdrawal by Subject|2|||
130112952|NCT00410410|468373486|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130112953|NCT00410410|468373487|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129834639|NCT00600938|467359607|FG002|Extension Study|Withdrawal by Subject|3|||
129834640|NCT00600938|467359608|FG003|Extension Study|Withdrawal by Subject|0|||
129897810|NCT01306331|467586466|FG000|Overall Study|Protocol Violation|154|||
130060878|NCT00430521|468176753|FG005|Overall Study|Vaccine Expired|1|||
129834641|NCT00600938|467359605|FG000|Extension Study|Lost to Follow-up|1|||
129834642|NCT00600938|467359606|FG001|Extension Study|Lost to Follow-up|1|||
129834643|NCT00600938|467359607|FG002|Extension Study|Lost to Follow-up|2|||
129834644|NCT00600938|467359608|FG003|Extension Study|Lost to Follow-up|0|||
129834645|NCT00600938|467359605|FG000|Extension Study|Death|1|||
129834646|NCT00600938|467359606|FG001|Extension Study|Death|0|||
129834647|NCT00600938|467359607|FG002|Extension Study|Death|0|||
129834648|NCT00600938|467359608|FG003|Extension Study|Death|0|||
129834649|NCT04056195|467359609|FG000|Overall Study|Adverse Event|1|||
129834650|NCT04056195|467359610|FG001|Overall Study|Adverse Event|0|||
129834651|NCT04056195|467359611|FG002|Overall Study|Adverse Event|0|||
129834652|NCT04056195|467359609|FG000|Overall Study|Withdrawal by Subject|0|||
129834653|NCT04056195|467359610|FG001|Overall Study|Withdrawal by Subject|1|||
129834654|NCT04056195|467359611|FG002|Overall Study|Withdrawal by Subject|1|||
129834655|NCT04056195|467359609|FG000|Overall Study|Physician Decision|1|||
129834656|NCT04056195|467359610|FG001|Overall Study|Physician Decision|1|||
129834657|NCT04056195|467359611|FG002|Overall Study|Physician Decision|1|||
129834658|NCT00549562|467359612|FG000|Overall Study|Adverse Event|1|||
129834659|NCT00549562|467359612|FG000|Overall Study|Lack of Efficacy|1|||
129834660|NCT04365556|467359615|FG000|Overall Study|No longer eligible due to treatment plan|1|||
129834661|NCT04365556|467359616|FG001|Overall Study|No longer eligible due to treatment plan|0|||
129834662|NCT04365556|467359615|FG000|Overall Study|Lost to Follow-up|3|||
129834663|NCT04365556|467359616|FG001|Overall Study|Lost to Follow-up|2|||
129834664|NCT04439318|467359619|FG000|Overall Study|Ineligible|1|||
129834665|NCT04439318|467359619|FG000|Overall Study|Never Started Treatment|3|||
129834666|NCT04439318|467359619|FG000|Overall Study|Adverse Event|10|||
129834667|NCT04439318|467359619|FG000|Overall Study|Death|2|||
129834668|NCT04439318|467359619|FG000|Overall Study|Disease Progression|25|||
129834669|NCT04439318|467359619|FG000|Overall Study|Other Complicating Disease|2|||
129834670|NCT04439318|467359619|FG000|Overall Study|Withdrawal by Subject|4|||
129834671|NCT04439318|467359619|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
129834672|NCT04439318|467359619|FG000|Overall Study|Non-Compliance|1|||
129834673|NCT04439318|467359619|FG000|Overall Study|Still on Treatment|1|||
129834674|NCT00699972|467360981|FG000|Overall Study|Adverse Event|7|||
129834675|NCT00699972|467360982|FG001|Overall Study|Adverse Event|9|||
129834676|NCT00699972|467360983|FG002|Overall Study|Adverse Event|24|||
129834677|NCT00699972|467360981|FG000|Overall Study|Lost to Follow-up|0|||
129834678|NCT00699972|467360982|FG001|Overall Study|Lost to Follow-up|2|||
129834679|NCT00699972|467360983|FG002|Overall Study|Lost to Follow-up|0|||
129834680|NCT00699972|467360981|FG000|Overall Study|Withdrawal by Subject|3|||
129834681|NCT00699972|467360982|FG001|Overall Study|Withdrawal by Subject|7|||
129834682|NCT00699972|467360983|FG002|Overall Study|Withdrawal by Subject|4|||
129834683|NCT00699972|467360981|FG000|Overall Study|Lack of Efficacy|2|||
129834684|NCT00699972|467360982|FG001|Overall Study|Lack of Efficacy|0|||
129834685|NCT00699972|467360983|FG002|Overall Study|Lack of Efficacy|2|||
129834686|NCT00699972|467360981|FG000|Overall Study|Administrative/Other|3|||
129834687|NCT00699972|467360982|FG001|Overall Study|Administrative/Other|1|||
129834688|NCT00699972|467360983|FG002|Overall Study|Administrative/Other|4|||
129834689|NCT00699972|467360981|FG000|Overall Study|Randomized, Not Treated|1|||
129834690|NCT00699972|467360982|FG001|Overall Study|Randomized, Not Treated|0|||
129834691|NCT00699972|467360983|FG002|Overall Study|Randomized, Not Treated|1|||
129834692|NCT03509675|467360988|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
129834693|NCT03509675|467360989|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
129834694|NCT03509675|467360988|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
129834695|NCT03509675|467360989|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
129834696|NCT03509675|467360988|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
129834697|NCT03509675|467360989|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
129834698|NCT03509675|467360988|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
129834699|NCT03509675|467360989|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
129834700|NCT01023581|467360992|FG000|Overall Study|Adverse Event|4|||
130060879|NCT00430521|468176754|FG006|Overall Study|Vaccine Expired|0|||
130060880|NCT00430521|468176755|FG007|Overall Study|Vaccine Expired|0|||
130060881|NCT00430521|468176748|FG000|Overall Study|Protocol Violation|1|||
130060882|NCT00430521|468176749|FG001|Overall Study|Protocol Violation|0|||
130060883|NCT00430521|468176750|FG002|Overall Study|Protocol Violation|0|||
130060884|NCT00430521|468176751|FG003|Overall Study|Protocol Violation|0|||
130060885|NCT00430521|468176752|FG004|Overall Study|Protocol Violation|0|||
129834701|NCT01023581|467360993|FG001|Overall Study|Adverse Event|4|||
129897811|NCT01306331|467586467|FG001|Overall Study|Protocol Violation|124|||
129897812|NCT01306331|467586466|FG000|Overall Study|Withdrawal by Subject|163|||
129834702|NCT01023581|467360994|FG002|Overall Study|Adverse Event|7|||
129897813|NCT01306331|467586467|FG001|Overall Study|Withdrawal by Subject|152|||
130060886|NCT00430521|468176753|FG005|Overall Study|Protocol Violation|0|||
130060887|NCT00430521|468176754|FG006|Overall Study|Protocol Violation|0|||
129834703|NCT01023581|467360995|FG003|Overall Study|Adverse Event|3|||
129834704|NCT01023581|467360996|FG004|Overall Study|Adverse Event|2|||
129834705|NCT01023581|467360997|FG005|Overall Study|Adverse Event|5|||
129834706|NCT01023581|467360998|FG006|Overall Study|Adverse Event|11|||
129834707|NCT01023581|467360992|FG000|Overall Study|Major protocol deviation|2|||
129834708|NCT01023581|467360993|FG001|Overall Study|Major protocol deviation|0|||
129834709|NCT01023581|467360994|FG002|Overall Study|Major protocol deviation|3|||
129834710|NCT01023581|467360995|FG003|Overall Study|Major protocol deviation|0|||
129834711|NCT01023581|467360996|FG004|Overall Study|Major protocol deviation|0|||
129834712|NCT01023581|467360997|FG005|Overall Study|Major protocol deviation|0|||
129834713|NCT01023581|467360998|FG006|Overall Study|Major protocol deviation|0|||
129834714|NCT01023581|467360992|FG000|Overall Study|Lost to Follow-up|4|||
129834715|NCT01023581|467360993|FG001|Overall Study|Lost to Follow-up|8|||
129834716|NCT01023581|467360994|FG002|Overall Study|Lost to Follow-up|7|||
129834717|NCT01023581|467360995|FG003|Overall Study|Lost to Follow-up|2|||
129834718|NCT01023581|467360996|FG004|Overall Study|Lost to Follow-up|5|||
129834719|NCT01023581|467360997|FG005|Overall Study|Lost to Follow-up|2|||
129834720|NCT01023581|467360998|FG006|Overall Study|Lost to Follow-up|2|||
129834721|NCT01023581|467360992|FG000|Overall Study|Withdrawal by Subject|13|||
129834722|NCT01023581|467360993|FG001|Overall Study|Withdrawal by Subject|8|||
129834723|NCT01023581|467360994|FG002|Overall Study|Withdrawal by Subject|16|||
129834724|NCT01023581|467360995|FG003|Overall Study|Withdrawal by Subject|10|||
129834725|NCT01023581|467360996|FG004|Overall Study|Withdrawal by Subject|6|||
129834726|NCT01023581|467360997|FG005|Overall Study|Withdrawal by Subject|8|||
129834727|NCT01023581|467360998|FG006|Overall Study|Withdrawal by Subject|5|||
129834728|NCT01023581|467360992|FG000|Overall Study|Pregnancy|0|||
129834729|NCT01023581|467360993|FG001|Overall Study|Pregnancy|0|||
129834730|NCT01023581|467360994|FG002|Overall Study|Pregnancy|0|||
129834731|NCT01023581|467360995|FG003|Overall Study|Pregnancy|2|||
129834732|NCT01023581|467360996|FG004|Overall Study|Pregnancy|0|||
129834733|NCT01023581|467360997|FG005|Overall Study|Pregnancy|1|||
129834734|NCT01023581|467360998|FG006|Overall Study|Pregnancy|0|||
129834735|NCT01023581|467360992|FG000|Overall Study|Lack of Efficacy|9|||
129834736|NCT01023581|467360993|FG001|Overall Study|Lack of Efficacy|3|||
129834737|NCT01023581|467360994|FG002|Overall Study|Lack of Efficacy|6|||
129834738|NCT01023581|467360995|FG003|Overall Study|Lack of Efficacy|2|||
129834739|NCT01023581|467360996|FG004|Overall Study|Lack of Efficacy|1|||
129834740|NCT01023581|467360997|FG005|Overall Study|Lack of Efficacy|2|||
129834741|NCT01023581|467360998|FG006|Overall Study|Lack of Efficacy|1|||
129834742|NCT01023581|467360992|FG000|Overall Study|Physician Decision|2|||
129834743|NCT01023581|467360993|FG001|Overall Study|Physician Decision|0|||
129834744|NCT01023581|467360994|FG002|Overall Study|Physician Decision|2|||
129834745|NCT01023581|467360995|FG003|Overall Study|Physician Decision|1|||
129834746|NCT01023581|467360996|FG004|Overall Study|Physician Decision|1|||
129834747|NCT01023581|467360997|FG005|Overall Study|Physician Decision|1|||
129834748|NCT01023581|467360998|FG006|Overall Study|Physician Decision|1|||
129834749|NCT01023581|467360992|FG000|Overall Study|Other|1|||
129897814|NCT01306331|467586466|FG000|Overall Study|Not sexually active|29|||
129897815|NCT01306331|467586467|FG001|Overall Study|Not sexually active|28|||
129897816|NCT01306331|467586466|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
129897817|NCT01306331|467586467|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
129897818|NCT01306331|467586466|FG000|Overall Study|Other|34|||
129897819|NCT01306331|467586467|FG001|Overall Study|Other|32|||
129897820|NCT04048135|467586470|FG000|Overall Study|Withdrawal by Subject|1|||
129897821|NCT04048135|467586471|FG001|Overall Study|Withdrawal by Subject|1|||
129897822|NCT04048135|467586472|FG002|Overall Study|Withdrawal by Subject|1|||
129897823|NCT04048135|467586473|FG003|Overall Study|Withdrawal by Subject|2|||
129897824|NCT04048135|467586474|FG004|Overall Study|Withdrawal by Subject|0|||
129897825|NCT04048135|467586475|FG005|Overall Study|Withdrawal by Subject|0|||
129897826|NCT04048135|467586476|FG006|Overall Study|Withdrawal by Subject|1|||
129834750|NCT01023581|467360993|FG001|Overall Study|Other|0|||
129834751|NCT01023581|467360994|FG002|Overall Study|Other|1|||
129834752|NCT01023581|467360995|FG003|Overall Study|Other|0|||
129834753|NCT01023581|467360996|FG004|Overall Study|Other|1|||
129834754|NCT01023581|467360997|FG005|Overall Study|Other|0|||
130060888|NCT00430521|468176755|FG007|Overall Study|Protocol Violation|0|||
129834755|NCT01023581|467360998|FG006|Overall Study|Other|0|||
129897827|NCT04048135|467586477|FG007|Overall Study|Withdrawal by Subject|1|||
130060889|NCT00430521|468176748|FG000|Overall Study|Withdrawal by Subject|3|||
129834756|NCT01723163|467360999|FG000|Treatment Phase|Withdrawal by Subject|14|||
129834757|NCT01723163|467361000|FG001|Treatment Phase|Withdrawal by Subject|6|||
129834758|NCT01723163|467360999|FG000|Treatment Phase|Withdrawal by PI|5|||
129834759|NCT01723163|467361000|FG001|Treatment Phase|Withdrawal by PI|1|||
129834760|NCT01723163|467360999|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
129834761|NCT01723163|467361000|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
129897828|NCT04048135|467586470|FG000|Overall Study|Adverse Event|0|||
129897829|NCT04048135|467586471|FG001|Overall Study|Adverse Event|0|||
129897830|NCT04048135|467586472|FG002|Overall Study|Adverse Event|0|||
129834762|NCT01723163|467360999|FG000|3-Month Follow-up|Unable to Contact|12|||
129834763|NCT01723163|467361000|FG001|3-Month Follow-up|Unable to Contact|19|||
129834764|NCT01723163|467360999|FG000|6-Month Follow-up|Death|1|||
129834765|NCT01723163|467361000|FG001|6-Month Follow-up|Death|0|||
129834766|NCT01723163|467360999|FG000|6-Month Follow-up|Unable to Contact|17|||
129834767|NCT01723163|467361000|FG001|6-Month Follow-up|Unable to Contact|15|||
129834768|NCT01723163|467360999|FG000|12-Month Follow-up|Death|1|||
129834769|NCT01723163|467361000|FG001|12-Month Follow-up|Death|0|||
129834770|NCT01723163|467360999|FG000|12-Month Follow-up|Unable to Contact|23|||
129834771|NCT01723163|467361000|FG001|12-Month Follow-up|Unable to Contact|28|||
129834772|NCT05664490|467361008|FG000|Overall Study|Withdrawal by Subject|0|||
129834773|NCT05664490|467361009|FG001|Overall Study|Withdrawal by Subject|1|||
129834774|NCT05664490|467361008|FG000|Overall Study|Lost to Follow-up|14|||
129834775|NCT05664490|467361009|FG001|Overall Study|Lost to Follow-up|22|||
129834776|NCT00325754|467361010|FG000|Overall Study|Adverse Event|4|||
129834777|NCT00325754|467361011|FG001|Overall Study|Adverse Event|1|||
129834778|NCT03412084|467361014|FG000|Overall Study|Withdrawal by Subject|2|||
129834779|NCT03412084|467361015|FG001|Overall Study|Withdrawal by Subject|0|||
129834780|NCT03412084|467361014|FG000|Overall Study|Participant moved|1|||
129834781|NCT03412084|467361015|FG001|Overall Study|Participant moved|0|||
129834782|NCT03412084|467361014|FG000|Overall Study|Lost to Follow-up|1|||
129834783|NCT03412084|467361015|FG001|Overall Study|Lost to Follow-up|1|||
129834784|NCT01289847|467361022|FG000|Overall Study|Patient could not comply with visits|1|||
129834785|NCT02872116|467361025|FG000|Pre-Treatment|Disease Progression|0|||
129834786|NCT02872116|467361026|FG001|Pre-Treatment|Disease Progression|1|||
129834787|NCT02872116|467361027|FG002|Pre-Treatment|Disease Progression|0|||
129834788|NCT02872116|467361025|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
129834789|NCT02872116|467361026|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
129834790|NCT02872116|467361027|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
129834791|NCT02872116|467361025|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
129834792|NCT02872116|467361026|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
130060890|NCT00430521|468176749|FG001|Overall Study|Withdrawal by Subject|1|||
130060891|NCT00430521|468176750|FG002|Overall Study|Withdrawal by Subject|0|||
130060892|NCT00430521|468176751|FG003|Overall Study|Withdrawal by Subject|3|||
130060893|NCT00430521|468176752|FG004|Overall Study|Withdrawal by Subject|0|||
130060894|NCT00430521|468176753|FG005|Overall Study|Withdrawal by Subject|0|||
130060895|NCT00430521|468176754|FG006|Overall Study|Withdrawal by Subject|0|||
130060896|NCT00430521|468176755|FG007|Overall Study|Withdrawal by Subject|2|||
130060897|NCT05108805|468176756|FG000|Overall Study|T-cell expansion was not successful.|5|||
130060898|NCT00479557|468176757|FG000|Overall Study|Death|0|||
130060899|NCT00479557|468176758|FG001|Overall Study|Death|0|||
130060900|NCT00479557|468176759|FG002|Overall Study|Death|0|||
130060901|NCT00479557|468176760|FG003|Overall Study|Death|0|||
130060902|NCT00479557|468176761|FG004|Overall Study|Death|0|||
130060903|NCT00479557|468176762|FG005|Overall Study|Death|1|||
130060904|NCT00479557|468176763|FG006|Overall Study|Death|0|||
130060905|NCT00479557|468176757|FG000|Overall Study|Lack of Efficacy|1|||
130060906|NCT00479557|468176758|FG001|Overall Study|Lack of Efficacy|0|||
130060907|NCT00479557|468176759|FG002|Overall Study|Lack of Efficacy|0|||
130060908|NCT00479557|468176760|FG003|Overall Study|Lack of Efficacy|0|||
130060909|NCT00479557|468176761|FG004|Overall Study|Lack of Efficacy|0|||
130060910|NCT00479557|468176762|FG005|Overall Study|Lack of Efficacy|0|||
130060911|NCT00479557|468176763|FG006|Overall Study|Lack of Efficacy|0|||
130060912|NCT00479557|468176757|FG000|Overall Study|Lost to Follow-up|0|||
130060913|NCT00479557|468176758|FG001|Overall Study|Lost to Follow-up|2|||
130060914|NCT00479557|468176759|FG002|Overall Study|Lost to Follow-up|0|||
130060915|NCT00479557|468176760|FG003|Overall Study|Lost to Follow-up|2|||
130060916|NCT00479557|468176761|FG004|Overall Study|Lost to Follow-up|0|||
130060917|NCT00479557|468176762|FG005|Overall Study|Lost to Follow-up|0|||
130060918|NCT00479557|468176763|FG006|Overall Study|Lost to Follow-up|0|||
130060919|NCT00479557|468176757|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130060920|NCT00479557|468176758|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130060921|NCT00479557|468176759|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
130060922|NCT00479557|468176760|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
130060923|NCT00479557|468176761|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130060924|NCT00479557|468176762|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
130060925|NCT00479557|468176763|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
130060926|NCT00479557|468176757|FG000|Overall Study|AE not related to Study Drug|1|||
129834793|NCT02872116|467361027|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
129834794|NCT02872116|467361025|FG000|Pre-Treatment|Participant withdrew consent|2|||
129834795|NCT02872116|467361026|FG001|Pre-Treatment|Participant withdrew consent|20|||
129834796|NCT02872116|467361027|FG002|Pre-Treatment|Participant withdrew consent|3|||
129834797|NCT02872116|467361025|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
130060927|NCT00479557|468176758|FG001|Overall Study|AE not related to Study Drug|3|||
130060928|NCT00479557|468176759|FG002|Overall Study|AE not related to Study Drug|0|||
130060929|NCT00479557|468176760|FG003|Overall Study|AE not related to Study Drug|0|||
130060930|NCT00479557|468176761|FG004|Overall Study|AE not related to Study Drug|2|||
130060931|NCT00479557|468176762|FG005|Overall Study|AE not related to Study Drug|2|||
130060932|NCT00479557|468176763|FG006|Overall Study|AE not related to Study Drug|1|||
129897831|NCT04048135|467586473|FG003|Overall Study|Adverse Event|1|||
129897832|NCT04048135|467586474|FG004|Overall Study|Adverse Event|1|||
129897833|NCT04048135|467586475|FG005|Overall Study|Adverse Event|0|||
129897834|NCT04048135|467586476|FG006|Overall Study|Adverse Event|0|||
129897835|NCT04048135|467586477|FG007|Overall Study|Adverse Event|0|||
129897836|NCT04048135|467586470|FG000|Overall Study|Protocol Violation|0|||
129897837|NCT04048135|467586471|FG001|Overall Study|Protocol Violation|0|||
129834798|NCT02872116|467361026|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
129834799|NCT02872116|467361027|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
129834800|NCT02872116|467361025|FG000|Pre-Treatment|Other reasons|1|||
129834801|NCT02872116|467361026|FG001|Pre-Treatment|Other reasons|2|||
129834802|NCT02872116|467361027|FG002|Pre-Treatment|Other reasons|2|||
129834803|NCT02872116|467361025|FG000|Treatment|Death|121|||
129834804|NCT02872116|467361026|FG001|Treatment|Death|94|||
129834805|NCT02872116|467361027|FG002|Treatment|Death|68|||
129834806|NCT02872116|467361025|FG000|Treatment|Lost to Follow-up|5|||
129834807|NCT02872116|467361026|FG001|Treatment|Lost to Follow-up|7|||
129834808|NCT02872116|467361027|FG002|Treatment|Lost to Follow-up|3|||
129834809|NCT02872116|467361025|FG000|Treatment|Participant withdrew consent|20|||
129834810|NCT02872116|467361026|FG001|Treatment|Participant withdrew consent|40|||
129834811|NCT02872116|467361027|FG002|Treatment|Participant withdrew consent|8|||
129834812|NCT02872116|467361025|FG000|Treatment|Other reasons|13|||
129834813|NCT02872116|467361026|FG001|Treatment|Other reasons|12|||
129834814|NCT02872116|467361027|FG002|Treatment|Other reasons|5|||
129834815|NCT01324388|467361032|FG000|Part 1 of Study|Adverse Event|2|||
129834816|NCT01324388|467361033|FG001|Part 1 of Study|Adverse Event|0|||
129834817|NCT01324388|467361034|FG002|Part 1 of Study|Adverse Event|0|||
129834818|NCT01324388|467361035|FG003|Part 1 of Study|Adverse Event|0|||
129834819|NCT01324388|467361032|FG000|Part 1 of Study|Protocol Violation|1|||
129834820|NCT01324388|467361033|FG001|Part 1 of Study|Protocol Violation|2|||
129834821|NCT01324388|467361034|FG002|Part 1 of Study|Protocol Violation|0|||
129834822|NCT01324388|467361035|FG003|Part 1 of Study|Protocol Violation|0|||
129834823|NCT01324388|467361032|FG000|Part 1 of Study|Physician Decision|1|||
129834824|NCT01324388|467361033|FG001|Part 1 of Study|Physician Decision|0|||
129834825|NCT01324388|467361034|FG002|Part 1 of Study|Physician Decision|0|||
129834826|NCT01324388|467361035|FG003|Part 1 of Study|Physician Decision|0|||
129834827|NCT01324388|467361032|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
129834828|NCT01324388|467361033|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
129834829|NCT01324388|467361034|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
129834830|NCT01324388|467361035|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
129834831|NCT01324388|467361032|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129834832|NCT01324388|467361033|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129834833|NCT01324388|467361034|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
129834834|NCT01324388|467361035|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129834835|NCT02171260|467361039|FG000|Overall Study|Death|0|||
129834836|NCT02171260|467361040|FG001|Overall Study|Death|0|||
129834837|NCT02171260|467361041|FG002|Overall Study|Death|0|||
129834838|NCT02171260|467361042|FG003|Overall Study|Death|1|||
129834839|NCT02171260|467361039|FG000|Overall Study|Physician Decision|1|||
129834840|NCT02171260|467361040|FG001|Overall Study|Physician Decision|0|||
129834841|NCT02171260|467361041|FG002|Overall Study|Physician Decision|1|||
129834842|NCT02171260|467361042|FG003|Overall Study|Physician Decision|0|||
129834843|NCT02171260|467361039|FG000|Overall Study|Withdrawal by Subject|1|||
129834844|NCT02171260|467361040|FG001|Overall Study|Withdrawal by Subject|0|||
129834845|NCT02171260|467361041|FG002|Overall Study|Withdrawal by Subject|0|||
129834846|NCT02171260|467361042|FG003|Overall Study|Withdrawal by Subject|0|||
129834847|NCT02171260|467361039|FG000|Overall Study|Evidence of progressive disease|4|||
129834848|NCT02171260|467361040|FG001|Overall Study|Evidence of progressive disease|6|||
129834849|NCT02171260|467361041|FG002|Overall Study|Evidence of progressive disease|4|||
129834850|NCT02171260|467361042|FG003|Overall Study|Evidence of progressive disease|4|||
129834851|NCT00323492|467361043|FG000|Study Phase 1|Adverse Event|2|||
129834852|NCT00323492|467361044|FG001|Study Phase 1|Adverse Event|0|||
129834853|NCT00323492|467361045|FG002|Study Phase 1|Adverse Event|0|||
129834854|NCT00323492|467361043|FG000|Study Phase 2|Adverse Event|1|||
129834855|NCT00323492|467361044|FG001|Study Phase 2|Adverse Event|0|||
129834856|NCT00323492|467361045|FG002|Study Phase 2|Adverse Event|0|||
129834857|NCT00323492|467361043|FG000|Study Phase 2|Physician Decision|1|||
129834858|NCT00323492|467361044|FG001|Study Phase 2|Physician Decision|0|||
129834859|NCT00323492|467361045|FG002|Study Phase 2|Physician Decision|0|||
129834860|NCT00323492|467361043|FG000|Study Phase 2|Lost to Follow-up|1|||
129834861|NCT00323492|467361044|FG001|Study Phase 2|Lost to Follow-up|0|||
129834862|NCT00323492|467361045|FG002|Study Phase 2|Lost to Follow-up|0|||
129834863|NCT00323492|467361043|FG000|Study Phase 2|Withdrawal by Subject|0|||
129834864|NCT00323492|467361044|FG001|Study Phase 2|Withdrawal by Subject|1|||
129897838|NCT04048135|467586472|FG002|Overall Study|Protocol Violation|0|||
129897839|NCT04048135|467586473|FG003|Overall Study|Protocol Violation|0|||
129897840|NCT04048135|467586474|FG004|Overall Study|Protocol Violation|0|||
130112954|NCT00410410|468373488|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
130112955|NCT00410410|468373489|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
130112956|NCT00410410|468373481|FG000|Open-Label Period (OL)|Other|0|||
130112957|NCT00410410|468373482|FG001|Open-Label Period (OL)|Other|0|||
130112958|NCT00410410|468373483|FG002|Open-Label Period (OL)|Other|0|||
130112959|NCT00410410|468373484|FG003|Open-Label Period (OL)|Other|0|||
130112960|NCT00410410|468373485|FG004|Open-Label Period (OL)|Other|0|||
130112961|NCT00410410|468373486|FG005|Open-Label Period (OL)|Other|0|||
130112962|NCT00410410|468373487|FG006|Open-Label Period (OL)|Other|0|||
130112963|NCT00410410|468373488|FG007|Open-Label Period (OL)|Other|0|||
130112964|NCT00410410|468373489|FG008|Open-Label Period (OL)|Other|7|||
130112965|NCT01783496|468373490|FG000|Overall Study|Lost to Follow-up|0|||
130112966|NCT01783496|468373491|FG001|Overall Study|Lost to Follow-up|0|||
130112967|NCT01783496|468373492|FG002|Overall Study|Lost to Follow-up|0|||
130112968|NCT01783496|468373493|FG003|Overall Study|Lost to Follow-up|2|||
130112969|NCT01783496|468373494|FG004|Overall Study|Lost to Follow-up|0|||
130112970|NCT01783496|468373495|FG005|Overall Study|Lost to Follow-up|1|||
130112971|NCT01783496|468373490|FG000|Overall Study|Withdrawal by Subject|1|||
130112972|NCT01783496|468373491|FG001|Overall Study|Withdrawal by Subject|0|||
130112973|NCT01783496|468373492|FG002|Overall Study|Withdrawal by Subject|0|||
130112974|NCT01783496|468373493|FG003|Overall Study|Withdrawal by Subject|0|||
130112975|NCT01783496|468373494|FG004|Overall Study|Withdrawal by Subject|0|||
130112976|NCT01783496|468373495|FG005|Overall Study|Withdrawal by Subject|0|||
130112977|NCT01023269|468373496|FG000|Overall Study|early termination of the study|2|||
130112978|NCT01023269|468373497|FG001|Overall Study|early termination of the study|0|||
130112979|NCT00947011|468373500|FG000|Overall Study|Study was terminated,PI left institution|12|||
130112980|NCT00814658|468373501|FG000|Overall Study|Lost to Follow-up|0|||
130112981|NCT00814658|468373502|FG001|Overall Study|Lost to Follow-up|1|||
130112982|NCT00814658|468373501|FG000|Overall Study|Physician Decision|1|||
130112983|NCT00814658|468373502|FG001|Overall Study|Physician Decision|0|||
130112984|NCT00814658|468373501|FG000|Overall Study|Adverse Event|3|||
130112985|NCT00814658|468373502|FG001|Overall Study|Adverse Event|3|||
130112986|NCT05266456|468373503|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
130112987|NCT05266456|468373504|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
130112988|NCT05266456|468373505|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
130112989|NCT05266456|468373506|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
130112990|NCT05266456|468373503|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
130112991|NCT05266456|468373504|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
130112992|NCT05266456|468373505|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
130112993|NCT05266456|468373506|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
130112994|NCT05266456|468373503|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
130112995|NCT05266456|468373504|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
130112996|NCT05266456|468373505|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
129834865|NCT00323492|467361045|FG002|Study Phase 2|Withdrawal by Subject|0|||
129834866|NCT00323492|467361043|FG000|Study Phase 2|Noncompliance with study schedule|0|||
129834867|NCT00323492|467361044|FG001|Study Phase 2|Noncompliance with study schedule|0|||
129834868|NCT00323492|467361045|FG002|Study Phase 2|Noncompliance with study schedule|1|||
129834869|NCT00323492|467361043|FG000|Study Phase 2|Protocol Violation|1|||
129834870|NCT00323492|467361044|FG001|Study Phase 2|Protocol Violation|0|||
129834871|NCT00323492|467361045|FG002|Study Phase 2|Protocol Violation|0|||
129834872|NCT02486042|467361046|FG000|Overall Study|Physician Decision|1|||
129834873|NCT02486042|467361047|FG001|Overall Study|Physician Decision|7|||
129834874|NCT02486042|467361046|FG000|Overall Study|Hospital transfer|2|||
129834875|NCT02486042|467361047|FG001|Overall Study|Hospital transfer|2|||
129834876|NCT02486042|467361046|FG000|Overall Study|Withdrawal by Subject|0|||
129834877|NCT02486042|467361047|FG001|Overall Study|Withdrawal by Subject|2|||
129834878|NCT01466387|467361048|FG000|Overall Study|Adverse Event|0|||
129834879|NCT01466387|467361049|FG001|Overall Study|Adverse Event|0|||
129834880|NCT01466387|467361050|FG002|Overall Study|Adverse Event|1|||
129834881|NCT01466387|467361051|FG003|Overall Study|Adverse Event|1|||
129834882|NCT01466387|467361052|FG004|Overall Study|Adverse Event|0|||
129834883|NCT01466387|467361053|FG005|Overall Study|Adverse Event|0|||
129834884|NCT01466387|467361048|FG000|Overall Study|Lost to Follow-up|0|||
129834885|NCT01466387|467361049|FG001|Overall Study|Lost to Follow-up|0|||
129834886|NCT01466387|467361050|FG002|Overall Study|Lost to Follow-up|0|||
129897841|NCT04048135|467586475|FG005|Overall Study|Protocol Violation|1|||
130112997|NCT05266456|468373506|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
130112998|NCT05266456|468373503|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
130112999|NCT05266456|468373504|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
130113000|NCT05266456|468373505|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
130113001|NCT05266456|468373506|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
130113002|NCT05266456|468373503|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
129834887|NCT01466387|467361051|FG003|Overall Study|Lost to Follow-up|0|||
129834888|NCT01466387|467361052|FG004|Overall Study|Lost to Follow-up|0|||
129834889|NCT01466387|467361053|FG005|Overall Study|Lost to Follow-up|1|||
129834890|NCT01466387|467361048|FG000|Overall Study|Protocol Violation|1|||
129834891|NCT01466387|467361049|FG001|Overall Study|Protocol Violation|0|||
129834892|NCT01466387|467361050|FG002|Overall Study|Protocol Violation|0|||
129834893|NCT01466387|467361051|FG003|Overall Study|Protocol Violation|1|||
129834894|NCT01466387|467361052|FG004|Overall Study|Protocol Violation|0|||
129834895|NCT01466387|467361053|FG005|Overall Study|Protocol Violation|0|||
129834896|NCT04404855|467361057|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
129834897|NCT04404855|467361058|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
129834898|NCT03320564|467361059|FG000|Overall Study|Protocol Violation|1|||
129834899|NCT01124643|467361060|FG000|Overall Study|Death|1|||
129834900|NCT04220411|467361061|FG000|Overall Study|Adverse Event|0|||
129834901|NCT04220411|467361062|FG001|Overall Study|Adverse Event|0|||
129834902|NCT04220411|467361063|FG002|Overall Study|Adverse Event|0|||
129834903|NCT04220411|467361064|FG003|Overall Study|Adverse Event|1|||
129834904|NCT02028988|467361065|FG000|Overall Study|Withdrawal by Subject|2|||
129834905|NCT02680639|467361068|FG000|Screening Period|Screen Failure|7|||
129834906|NCT02680639|467361069|FG001|Screening Period|Screen Failure|0|||
129834907|NCT02680639|467361070|FG002|Screening Period|Screen Failure|0|||
129834908|NCT01063595|467361071|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
129834909|NCT01063595|467361072|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
129834910|NCT01063595|467361071|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
129834911|NCT01063595|467361072|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
129834912|NCT01063595|467361071|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
129834913|NCT01063595|467361072|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
129834914|NCT01063595|467361071|FG000|First Intervention|Adverse Event|1|||
129834915|NCT01063595|467361072|FG001|First Intervention|Adverse Event|4|||
129834916|NCT01063595|467361071|FG000|First Intervention|Withdrawal by Subject|1|||
129834917|NCT01063595|467361072|FG001|First Intervention|Withdrawal by Subject|0|||
129834918|NCT01063595|467361071|FG000|First Intervention|Reason not Specified|0|||
129834919|NCT01063595|467361072|FG001|First Intervention|Reason not Specified|1|||
129834920|NCT02678676|467361073|FG000|Overall Study|Death|619|||
129834921|NCT02678676|467361074|FG001|Overall Study|Death|649|||
129834922|NCT02678676|467361073|FG000|Overall Study|Withdrawal by Subject|13|||
129834923|NCT02678676|467361074|FG001|Overall Study|Withdrawal by Subject|5|||
129834924|NCT02678676|467361073|FG000|Overall Study|Lost to Follow-up|171|||
129834925|NCT02678676|467361074|FG001|Overall Study|Lost to Follow-up|151|||
129834926|NCT02678676|467361073|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
129834927|NCT02678676|467361074|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
129834928|NCT00747435|467361075|FG000|Overall Study|Lost to Follow-up|2|||
129834929|NCT00747435|467361075|FG000|Overall Study|Withdrawal by Subject|3|||
129834930|NCT00747435|467361075|FG000|Overall Study|Still undergoing follow up|1|||
129834931|NCT00851799|467361076|FG000|Overall Study|Death|1|||
129834932|NCT00851799|467361077|FG001|Overall Study|Death|0|||
129834933|NCT00851799|467361078|FG002|Overall Study|Death|1|||
129834934|NCT00851799|467361076|FG000|Overall Study|Lost to Follow-up|5|||
129834935|NCT00851799|467361077|FG001|Overall Study|Lost to Follow-up|3|||
129834936|NCT00851799|467361078|FG002|Overall Study|Lost to Follow-up|10|||
129834937|NCT00851799|467361076|FG000|Overall Study|Not able to get to clinic|8|||
129834938|NCT00851799|467361077|FG001|Overall Study|Not able to get to clinic|5|||
129834939|NCT00851799|467361078|FG002|Overall Study|Not able to get to clinic|9|||
129834940|NCT00851799|467361076|FG000|Overall Study|Not willing to adhere to requirements|1|||
129834941|NCT00851799|467361077|FG001|Overall Study|Not willing to adhere to requirements|2|||
129834942|NCT00851799|467361078|FG002|Overall Study|Not willing to adhere to requirements|2|||
129834943|NCT00851799|467361076|FG000|Overall Study|Withdrew consent prior study completion|1|||
129834944|NCT00851799|467361077|FG001|Overall Study|Withdrew consent prior study completion|2|||
129834945|NCT00851799|467361078|FG002|Overall Study|Withdrew consent prior study completion|1|||
129834946|NCT00851799|467361076|FG000|Overall Study|Severe Debilitation|0|||
129834947|NCT00851799|467361077|FG001|Overall Study|Severe Debilitation|1|||
129834948|NCT00851799|467361078|FG002|Overall Study|Severe Debilitation|0|||
129834949|NCT00851799|467361076|FG000|Overall Study|Completed protocol due to pregnancy|0|||
129834950|NCT00851799|467361077|FG001|Overall Study|Completed protocol due to pregnancy|0|||
129834951|NCT00851799|467361078|FG002|Overall Study|Completed protocol due to pregnancy|1|||
129834952|NCT01342510|467361092|FG000|Overall Study|Protocol Violation|12|||
129834953|NCT01342510|467361093|FG001|Overall Study|Protocol Violation|6|||
129834954|NCT01342510|467361094|FG002|Overall Study|Protocol Violation|13|||
129834955|NCT01342510|467361095|FG003|Overall Study|Protocol Violation|11|||
129834956|NCT01449526|467361096|FG000|Overall Study|Lost to Follow-up|1|||
129834957|NCT01449526|467361097|FG001|Overall Study|Lost to Follow-up|2|||
129834958|NCT01449526|467361096|FG000|Overall Study|Withdrawal by Subject|1|||
129834959|NCT01449526|467361097|FG001|Overall Study|Withdrawal by Subject|1|||
129834960|NCT01449526|467361096|FG000|Overall Study|Symptoms/complaints|0|||
129834961|NCT01449526|467361097|FG001|Overall Study|Symptoms/complaints|1|||
129834962|NCT01449526|467361096|FG000|Overall Study|Lack of Motivation|0|||
129834963|NCT01449526|467361097|FG001|Overall Study|Lack of Motivation|1|||
129834964|NCT01449526|467361096|FG000|Overall Study|Cannot maintain visits|0|||
130113003|NCT05266456|468373504|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
130113004|NCT05266456|468373505|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
130113005|NCT05266456|468373506|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
130113006|NCT01141283|468373507|FG000|Overall Study|Adverse Event|56|||
130113007|NCT01141283|468373507|FG000|Overall Study|Lost to Follow-up|4|||
130113008|NCT01141283|468373507|FG000|Overall Study|Withdrawal by Subject|14|||
130113009|NCT01141283|468373507|FG000|Overall Study|Administrative|4|||
130113010|NCT01141283|468373507|FG000|Overall Study|Lack of Efficacy|10|||
130113011|NCT02868281|468373508|FG000|Overall Study|Adverse Event|2|||
130113012|NCT02868281|468373509|FG001|Overall Study|Adverse Event|2|||
130113013|NCT02868281|468373508|FG000|Overall Study|Protocol Violation|13|||
130113014|NCT02868281|468373509|FG001|Overall Study|Protocol Violation|10|||
130113015|NCT02868281|468373508|FG000|Overall Study|Lost to Follow-up|3|||
130113016|NCT02868281|468373509|FG001|Overall Study|Lost to Follow-up|6|||
130113017|NCT02868281|468373508|FG000|Overall Study|Withdrawal by Subject|11|||
130113018|NCT02868281|468373509|FG001|Overall Study|Withdrawal by Subject|15|||
130113019|NCT02868281|468373508|FG000|Overall Study|Physician Decision|2|||
130113020|NCT02868281|468373509|FG001|Overall Study|Physician Decision|0|||
130113021|NCT02868281|468373508|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
130113022|NCT02868281|468373509|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
130113023|NCT02868281|468373508|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
130113024|NCT02868281|468373509|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
130113025|NCT02868281|468373508|FG000|Overall Study|Long journey/moving away|1|||
130113026|NCT02868281|468373509|FG001|Overall Study|Long journey/moving away|1|||
130113027|NCT03124381|468373510|FG000|Overall Study|Lost to Follow-up|1|||
130113028|NCT03124381|468373511|FG001|Overall Study|Lost to Follow-up|1|||
130113029|NCT03124381|468373510|FG000|Overall Study|Withdrawal by Subject|6|||
130113030|NCT03124381|468373511|FG001|Overall Study|Withdrawal by Subject|3|||
130113031|NCT03124381|468373510|FG000|Overall Study|Protocol Violation|0|||
130113032|NCT03124381|468373511|FG001|Overall Study|Protocol Violation|1|||
130113033|NCT03124381|468373510|FG000|Overall Study|Adverse Event|1|||
130113034|NCT03124381|468373511|FG001|Overall Study|Adverse Event|1|||
130113035|NCT03124381|468373510|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
130113036|NCT03124381|468373511|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
130113037|NCT02168270|468373512|FG000|Overall Study|Lack of Efficacy|4|||
130113038|NCT02533999|468373513|FG000|Overall Study|Lost to Follow-up|3|||
130113039|NCT02533999|468373514|FG001|Overall Study|Lost to Follow-up|5|||
130113040|NCT02533999|468373513|FG000|Overall Study|Protocol Violation|3|||
130113041|NCT02533999|468373514|FG001|Overall Study|Protocol Violation|0|||
130113042|NCT02533999|468373513|FG000|Overall Study|Adverse Event|0|||
130113043|NCT02533999|468373514|FG001|Overall Study|Adverse Event|1|||
130113044|NCT02533999|468373513|FG000|Overall Study|Randomized but intervention not received|0|||
130113045|NCT02533999|468373514|FG001|Overall Study|Randomized but intervention not received|1|||
130113046|NCT01102777|468373515|FG000|Overall Study|Death|2|||
130113047|NCT01102777|468373516|FG001|Overall Study|Death|6|||
130113048|NCT01102777|468373515|FG000|Overall Study|Lost to Follow-up|7|||
130113049|NCT01102777|468373516|FG001|Overall Study|Lost to Follow-up|10|||
129834965|NCT01449526|467361097|FG001|Overall Study|Cannot maintain visits|1|||
129834966|NCT01400516|467361099|FG000|Primary Trial|Withdrawal by Subject|0|||
129834967|NCT01400516|467361100|FG001|Primary Trial|Withdrawal by Subject|2|||
129834968|NCT01132495|467361103|FG000|Overall Study|Various reasons|40|||
129834969|NCT01132495|467361104|FG001|Overall Study|Various reasons|38|||
129834970|NCT01132495|467361105|FG002|Overall Study|Various reasons|20|||
129834971|NCT01132495|467361106|FG003|Overall Study|Various reasons|12|||
129834972|NCT00082433|467361113|FG000|Overall Study|Adverse Event|12|||
129834973|NCT00082433|467361114|FG001|Overall Study|Adverse Event|17|||
129834974|NCT00082433|467361113|FG000|Overall Study|Death|8|||
129834975|NCT00082433|467361114|FG001|Overall Study|Death|18|||
129834976|NCT00082433|467361113|FG000|Overall Study|Disease Progression/Relapse|270|||
129834977|NCT00082433|467361114|FG001|Overall Study|Disease Progression/Relapse|388|||
129834978|NCT00082433|467361113|FG000|Overall Study|Physician Decision|50|||
129834979|NCT00082433|467361114|FG001|Overall Study|Physician Decision|61|||
129834980|NCT00082433|467361113|FG000|Overall Study|Lost to Follow-up|1|||
129834981|NCT00082433|467361114|FG001|Overall Study|Lost to Follow-up|2|||
129897842|NCT04048135|467586476|FG006|Overall Study|Protocol Violation|0|||
130113050|NCT01875445|468373517|FG000|Overall Study|Lost to Follow-up|5|||
130113051|NCT01875445|468373518|FG001|Overall Study|Lost to Follow-up|0|||
130113052|NCT01875445|468373517|FG000|Overall Study|Withdrawal by Subject|2|||
130113053|NCT01875445|468373518|FG001|Overall Study|Withdrawal by Subject|0|||
130113054|NCT00706706|468373519|FG000|Overall Study|Death|53|||
130113055|NCT00706706|468373519|FG000|Overall Study|Lost to Follow-up|7|||
130113056|NCT00706706|468373519|FG000|Overall Study|Study endpoint had reached|45|||
130113057|NCT05017493|468373520|FG000|Overall Study|Withdrawal by Subject|26|||
129834982|NCT00082433|467361113|FG000|Overall Study|Study Drug Toxicity|179|||
129834983|NCT00082433|467361114|FG001|Overall Study|Study Drug Toxicity|66|||
129834984|NCT00082433|467361113|FG000|Overall Study|Withdrawal by Subject|55|||
129834985|NCT00082433|467361114|FG001|Overall Study|Withdrawal by Subject|30|||
130113058|NCT05017493|468373521|FG001|Overall Study|Withdrawal by Subject|0|||
129834986|NCT00082433|467361113|FG000|Overall Study|Still On Treatment|2|||
129834987|NCT00082433|467361114|FG001|Overall Study|Still On Treatment|1|||
129834988|NCT00082433|467361113|FG000|Overall Study|Not Treated|12|||
129834989|NCT00082433|467361114|FG001|Overall Study|Not Treated|11|||
129834990|NCT00082433|467361113|FG000|Overall Study|Ineligible|2|||
129834991|NCT00082433|467361114|FG001|Overall Study|Ineligible|1|||
129834992|NCT00082433|467361113|FG000|Overall Study|Noncompliance|2|||
129834993|NCT00082433|467361114|FG001|Overall Study|Noncompliance|1|||
129834994|NCT00082433|467361113|FG000|Overall Study|New primary cancer|1|||
129834995|NCT00082433|467361114|FG001|Overall Study|New primary cancer|0|||
129834996|NCT00082433|467361113|FG000|Overall Study|Impending surgery|0|||
129834997|NCT00082433|467361114|FG001|Overall Study|Impending surgery|1|||
129834998|NCT01796197|467361117|FG000|Overall Study|Lost to Follow-up|1|||
129834999|NCT01796197|467361117|FG000|Overall Study|Lack of Efficacy|1|||
129835000|NCT01380184|467361118|FG000|Part 1 (19 Days)|Adverse Event|1|||
129835001|NCT01380184|467361118|FG000|Part 2|Adverse Event|5|||
129835002|NCT01380184|467361118|FG000|Part 2|Disease Progression|8|||
129835003|NCT01380184|467361118|FG000|Part 2|Lost to Follow-up|1|||
129835004|NCT04097821|467361119|FG000|Overall Study|Subject Decision|0|||
129835005|NCT04097821|467361120|FG001|Overall Study|Subject Decision|0|||
129835006|NCT04097821|467361121|FG002|Overall Study|Subject Decision|0|||
129835007|NCT04097821|467361122|FG003|Overall Study|Subject Decision|1|||
129835008|NCT04097821|467361123|FG004|Overall Study|Subject Decision|2|||
129835009|NCT04097821|467361124|FG005|Overall Study|Subject Decision|2|||
129835010|NCT04097821|467361125|FG006|Overall Study|Subject Decision|0|||
129835011|NCT04097821|467361126|FG007|Overall Study|Subject Decision|1|||
129835012|NCT04097821|467361119|FG000|Overall Study|Death|0|||
129835013|NCT04097821|467361120|FG001|Overall Study|Death|0|||
129835014|NCT04097821|467361121|FG002|Overall Study|Death|3|||
129835015|NCT04097821|467361122|FG003|Overall Study|Death|1|||
129835016|NCT04097821|467361123|FG004|Overall Study|Death|0|||
129835017|NCT04097821|467361124|FG005|Overall Study|Death|0|||
129835018|NCT04097821|467361125|FG006|Overall Study|Death|0|||
129835019|NCT04097821|467361126|FG007|Overall Study|Death|0|||
129835020|NCT04097821|467361119|FG000|Overall Study|Physician Decision|1|||
129835021|NCT04097821|467361120|FG001|Overall Study|Physician Decision|2|||
129835022|NCT04097821|467361121|FG002|Overall Study|Physician Decision|0|||
129835023|NCT04097821|467361122|FG003|Overall Study|Physician Decision|0|||
129835024|NCT04097821|467361123|FG004|Overall Study|Physician Decision|0|||
129835025|NCT04097821|467361124|FG005|Overall Study|Physician Decision|0|||
129835026|NCT04097821|467361125|FG006|Overall Study|Physician Decision|0|||
129835027|NCT04097821|467361126|FG007|Overall Study|Physician Decision|0|||
129835028|NCT04097821|467361119|FG000|Overall Study|Adverse Event|0|||
129835029|NCT04097821|467361120|FG001|Overall Study|Adverse Event|0|||
129835030|NCT04097821|467361121|FG002|Overall Study|Adverse Event|1|||
129835031|NCT04097821|467361122|FG003|Overall Study|Adverse Event|1|||
129835032|NCT04097821|467361123|FG004|Overall Study|Adverse Event|0|||
129835033|NCT04097821|467361124|FG005|Overall Study|Adverse Event|0|||
129835034|NCT04097821|467361125|FG006|Overall Study|Adverse Event|0|||
129835035|NCT04097821|467361126|FG007|Overall Study|Adverse Event|0|||
129835036|NCT04097821|467361119|FG000|Overall Study|New Therapy For Study Indication|0|||
129835037|NCT04097821|467361120|FG001|Overall Study|New Therapy For Study Indication|0|||
129835038|NCT04097821|467361121|FG002|Overall Study|New Therapy For Study Indication|0|||
129835039|NCT04097821|467361122|FG003|Overall Study|New Therapy For Study Indication|0|||
129835040|NCT04097821|467361123|FG004|Overall Study|New Therapy For Study Indication|0|||
129835041|NCT04097821|467361124|FG005|Overall Study|New Therapy For Study Indication|0|||
129835042|NCT04097821|467361125|FG006|Overall Study|New Therapy For Study Indication|1|||
129835043|NCT04097821|467361126|FG007|Overall Study|New Therapy For Study Indication|0|||
129835044|NCT04243538|467361127|FG000|Overall Study|Withdrawal by Subject|0|||
129835045|NCT04243538|467361128|FG001|Overall Study|Withdrawal by Subject|2|||
129835046|NCT04243538|467361127|FG000|Overall Study|Lost to Follow-up|0|||
129835047|NCT04243538|467361128|FG001|Overall Study|Lost to Follow-up|3|||
129835048|NCT03532295|467361129|FG000|Overall Study|Did not start treatment|0|||
129835049|NCT03532295|467361130|FG001|Overall Study|Did not start treatment|2|||
129835050|NCT02776917|467361131|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
129835051|NCT02449239|467362730|FG000|Induction Phase|Lack of Efficacy|64|||
129835052|NCT02449239|467362730|FG000|Induction Phase|Adverse Event|1|||
129835053|NCT02449239|467362730|FG000|Induction Phase|Lost to Follow-up|1|||
129835054|NCT02449239|467362730|FG000|Induction Phase|Protocol Violation|1|||
129835055|NCT02449239|467362730|FG000|Induction Phase|Physician Decision|1|||
129835056|NCT02449239|467362730|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
129835057|NCT02449239|467362730|FG000|Induction Phase|Withdrawal by Subject|1|||
129835058|NCT02449239|467362730|FG000|Maintenance Month 3|Lack of Efficacy|14|||
129835059|NCT02449239|467362730|FG000|Maintenance Month 6|Lack of Efficacy|10|||
129835060|NCT02449239|467362730|FG000|Maintenance Month 6|Adverse Event|2|||
129835061|NCT02449239|467362730|FG000|Maintenance Month 6|Physician Decision|1|||
129835062|NCT02449239|467362730|FG000|Maintenance Month 9|Lack of Efficacy|2|||
129835063|NCT02449239|467362730|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
129835064|NCT02449239|467362730|FG000|Maintenance Month 12|Lack of Efficacy|5|||
129897843|NCT04048135|467586477|FG007|Overall Study|Protocol Violation|0|||
129897844|NCT00172185|467586478|FG000|Overall Study|Adverse Event|0|||
129897845|NCT00172185|467586479|FG001|Overall Study|Adverse Event|1|||
129897846|NCT00172185|467586480|FG002|Overall Study|Adverse Event|3|||
129897847|NCT00172185|467586481|FG003|Overall Study|Adverse Event|4|||
129897848|NCT00172185|467586478|FG000|Overall Study|Physician Decision|0|||
129897849|NCT00172185|467586479|FG001|Overall Study|Physician Decision|0|||
129897850|NCT00172185|467586480|FG002|Overall Study|Physician Decision|1|||
129897851|NCT00172185|467586481|FG003|Overall Study|Physician Decision|0|||
129897852|NCT00172185|467586478|FG000|Overall Study|SPONSOR Decision|0|||
129897853|NCT00172185|467586479|FG001|Overall Study|SPONSOR Decision|1|||
129897854|NCT00172185|467586480|FG002|Overall Study|SPONSOR Decision|0|||
129897855|NCT00172185|467586481|FG003|Overall Study|SPONSOR Decision|0|||
129897856|NCT00172185|467586478|FG000|Overall Study|Withdrawal by Subject|0|||
129897857|NCT00172185|467586479|FG001|Overall Study|Withdrawal by Subject|0|||
129897858|NCT00172185|467586480|FG002|Overall Study|Withdrawal by Subject|1|||
129897859|NCT00172185|467586481|FG003|Overall Study|Withdrawal by Subject|0|||
129897860|NCT01677936|467586482|FG000|Overall Study|Lost to Follow-up|4|||
129897861|NCT01677936|467586483|FG001|Overall Study|Lost to Follow-up|1|||
129897862|NCT01677936|467586482|FG000|Overall Study|Protocol Violation|3|||
129897863|NCT01677936|467586483|FG001|Overall Study|Protocol Violation|0|||
129897864|NCT01677936|467586482|FG000|Overall Study|Adverse Event|1|||
129897865|NCT01677936|467586483|FG001|Overall Study|Adverse Event|0|||
129897866|NCT01677936|467586482|FG000|Overall Study|Lost to Follow-up|1|||
129897867|NCT01677936|467586483|FG001|Overall Study|Lost to Follow-up|0|||
129897868|NCT01677936|467586482|FG000|Overall Study|Protocol Violation|0|||
129897869|NCT01677936|467586483|FG001|Overall Study|Protocol Violation|4|||
129897870|NCT00349908|467586492|FG000|Overall Study|Withdrawal by Subject|0|||
129897871|NCT00349908|467586493|FG001|Overall Study|Withdrawal by Subject|4|||
129897872|NCT04565249|467586494|FG000|Overall Study|Death|0|||
129897873|NCT04565249|467586495|FG001|Overall Study|Death|0|||
129897874|NCT04565249|467586496|FG002|Overall Study|Death|0|||
129897875|NCT04565249|467586497|FG003|Overall Study|Death|1|||
129897876|NCT00151996|467586498|FG000|Overall Study|Adverse Event|3|||
129897877|NCT00151996|467586499|FG001|Overall Study|Adverse Event|2|||
129897878|NCT00151996|467586498|FG000|Overall Study|Withdrawal by Subject|1|||
129897879|NCT00151996|467586499|FG001|Overall Study|Withdrawal by Subject|1|||
129897880|NCT00151996|467586498|FG000|Overall Study|Protocol Violation|1|||
130060933|NCT00479557|468176757|FG000|Overall Study|Caregiver Request|2|||
129835065|NCT02449239|467362730|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
129835066|NCT02449239|467362730|FG000|Maintenance Month 12|Subject moved from area|1|||
129835067|NCT02449239|467362730|FG000|Maintenance Month 15|Lack of Efficacy|1|||
129835068|NCT02449239|467362730|FG000|Maintenance Month 21|Lack of Efficacy|1|||
129835069|NCT02449239|467362730|FG000|Maintenance Month 21|Sponsor decision|1|||
129835070|NCT03314584|467362737|FG000|Overall Study|Withdrawal by Subject|3|||
129835071|NCT03314584|467362738|FG001|Overall Study|Withdrawal by Subject|3|||
129835072|NCT03314584|467362737|FG000|Overall Study|Lost to Follow-up|4|||
129835073|NCT03314584|467362738|FG001|Overall Study|Lost to Follow-up|0|||
129835074|NCT06134817|467362739|FG000|Overall Study|Physician Departure - termination of study|1|||
129835075|NCT02053753|467362751|FG000|Overall Study|Withdrawal by Subject|2|||
129835076|NCT02053753|467362752|FG001|Overall Study|Withdrawal by Subject|4|||
129835077|NCT02053753|467362751|FG000|Overall Study|Decision by Sponsor|1|||
129835078|NCT02053753|467362752|FG001|Overall Study|Decision by Sponsor|1|||
129835079|NCT02053753|467362751|FG000|Overall Study|Lost to Follow-up|4|||
130060934|NCT00479557|468176758|FG001|Overall Study|Caregiver Request|2|||
130060935|NCT00479557|468176759|FG002|Overall Study|Caregiver Request|2|||
130060936|NCT00479557|468176760|FG003|Overall Study|Caregiver Request|0|||
130060937|NCT00479557|468176761|FG004|Overall Study|Caregiver Request|1|||
129835080|NCT02053753|467362752|FG001|Overall Study|Lost to Follow-up|3|||
130060938|NCT00479557|468176762|FG005|Overall Study|Caregiver Request|2|||
130060939|NCT00479557|468176763|FG006|Overall Study|Caregiver Request|0|||
130060940|NCT00479557|468176757|FG000|Overall Study|Investigator Request|0|||
130060941|NCT00479557|468176758|FG001|Overall Study|Investigator Request|0|||
130060942|NCT00479557|468176759|FG002|Overall Study|Investigator Request|1|||
130060943|NCT00479557|468176760|FG003|Overall Study|Investigator Request|0|||
130060944|NCT00479557|468176761|FG004|Overall Study|Investigator Request|0|||
129835081|NCT02023151|467362757|FG000|Overall Study|Lost to Follow-up|4|||
129835082|NCT04064294|467362758|FG000|Overall Study|Adverse Event|1|||
129897881|NCT00151996|467586499|FG001|Overall Study|Protocol Violation|2|||
129897882|NCT00151996|467586498|FG000|Overall Study|Sponsor's decision|0|||
129835083|NCT04064294|467362759|FG001|Overall Study|Adverse Event|0|||
129835084|NCT04064294|467362760|FG002|Overall Study|Adverse Event|0|||
129897883|NCT00151996|467586499|FG001|Overall Study|Sponsor's decision|2|||
129897884|NCT01649791|467586506|FG000|Overall Study|Disease Progression|2|||
129897885|NCT01649791|467586506|FG000|Overall Study|Adverse Event|1|||
129897886|NCT01801930|467586507|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
130060945|NCT00479557|468176762|FG005|Overall Study|Investigator Request|0|||
130060946|NCT00479557|468176763|FG006|Overall Study|Investigator Request|0|||
130060947|NCT00479557|468176757|FG000|Overall Study|Subject Request|3|||
130060948|NCT00479557|468176758|FG001|Overall Study|Subject Request|0|||
130060949|NCT00479557|468176759|FG002|Overall Study|Subject Request|1|||
130060950|NCT00479557|468176760|FG003|Overall Study|Subject Request|1|||
130060951|NCT00479557|468176761|FG004|Overall Study|Subject Request|1|||
130060952|NCT00479557|468176762|FG005|Overall Study|Subject Request|4|||
130060953|NCT00479557|468176763|FG006|Overall Study|Subject Request|1|||
130060954|NCT00479557|468176757|FG000|Overall Study|Other|2|||
130060955|NCT00479557|468176758|FG001|Overall Study|Other|3|||
130060956|NCT00479557|468176759|FG002|Overall Study|Other|1|||
130060957|NCT00479557|468176760|FG003|Overall Study|Other|0|||
130060958|NCT00479557|468176761|FG004|Overall Study|Other|0|||
130060959|NCT00479557|468176762|FG005|Overall Study|Other|3|||
130060960|NCT00479557|468176763|FG006|Overall Study|Other|0|||
130060961|NCT04752189|468176764|FG000|Overall Study|Withdrawal by Subject|0|||
130060962|NCT04752189|468176765|FG001|Overall Study|Withdrawal by Subject|150|||
130060963|NCT04752189|468176764|FG000|Overall Study|Lost to Follow-up|261|||
130060964|NCT04752189|468176765|FG001|Overall Study|Lost to Follow-up|126|||
130060965|NCT03422133|468176766|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
130060966|NCT03422133|468176767|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
130060967|NCT03003403|468176768|FG000|Overall Study|Ineligible|8|||
130060968|NCT03003403|468176769|FG001|Overall Study|Ineligible|7|||
130060969|NCT03003403|468176768|FG000|Overall Study|Withdrawal by Subject|3|||
130060970|NCT03003403|468176769|FG001|Overall Study|Withdrawal by Subject|1|||
130060971|NCT02198651|468178755|FG000|Lead-in Period|Withdrew consent|13|||
130060972|NCT02198651|468178756|FG001|Lead-in Period|Withdrew consent|0|||
130060973|NCT02198651|468178757|FG002|Lead-in Period|Withdrew consent|0|||
130060974|NCT02198651|468178758|FG003|Lead-in Period|Withdrew consent|0|||
130060975|NCT02198651|468178759|FG004|Lead-in Period|Withdrew consent|0|||
130060976|NCT02198651|468178755|FG000|Lead-in Period|Adverse Event|2|||
130060977|NCT02198651|468178756|FG001|Lead-in Period|Adverse Event|0|||
130060978|NCT02198651|468178757|FG002|Lead-in Period|Adverse Event|0|||
130060979|NCT02198651|468178758|FG003|Lead-in Period|Adverse Event|0|||
130060980|NCT02198651|468178759|FG004|Lead-in Period|Adverse Event|0|||
130060981|NCT02198651|468178755|FG000|Lead-in Period|Other, not specified|22|||
130060982|NCT02198651|468178756|FG001|Lead-in Period|Other, not specified|0|||
130060983|NCT02198651|468178757|FG002|Lead-in Period|Other, not specified|0|||
130060984|NCT02198651|468178758|FG003|Lead-in Period|Other, not specified|0|||
130060985|NCT02198651|468178759|FG004|Lead-in Period|Other, not specified|0|||
130060986|NCT02198651|468178755|FG000|Double-blind Period|Withdrew consent|0|||
130060987|NCT02198651|468178756|FG001|Double-blind Period|Withdrew consent|4|||
130060988|NCT02198651|468178757|FG002|Double-blind Period|Withdrew consent|0|||
130060989|NCT02198651|468178758|FG003|Double-blind Period|Withdrew consent|0|||
130060990|NCT02198651|468178759|FG004|Double-blind Period|Withdrew consent|0|||
130060991|NCT02198651|468178755|FG000|Double-blind Period|Adverse Event|0|||
130060992|NCT02198651|468178756|FG001|Double-blind Period|Adverse Event|1|||
130060993|NCT02198651|468178757|FG002|Double-blind Period|Adverse Event|0|||
130060994|NCT02198651|468178758|FG003|Double-blind Period|Adverse Event|0|||
130060995|NCT02198651|468178759|FG004|Double-blind Period|Adverse Event|0|||
130060996|NCT02198651|468178755|FG000|Double-blind Period|Other, not specified|0|||
130060997|NCT02198651|468178756|FG001|Double-blind Period|Other, not specified|4|||
130060998|NCT02198651|468178757|FG002|Double-blind Period|Other, not specified|1|||
130060999|NCT02198651|468178758|FG003|Double-blind Period|Other, not specified|0|||
130061000|NCT02198651|468178759|FG004|Double-blind Period|Other, not specified|0|||
130061001|NCT02198651|468178755|FG000|Open-label Rescue Period|Withdrew consent|0|||
130061002|NCT02198651|468178756|FG001|Open-label Rescue Period|Withdrew consent|0|||
130061003|NCT02198651|468178757|FG002|Open-label Rescue Period|Withdrew consent|0|||
130061004|NCT02198651|468178758|FG003|Open-label Rescue Period|Withdrew consent|2|||
130061005|NCT02198651|468178759|FG004|Open-label Rescue Period|Withdrew consent|0|||
130061006|NCT02198651|468178755|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130061007|NCT02198651|468178756|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130061008|NCT02198651|468178757|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130061009|NCT02198651|468178758|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
130061010|NCT02198651|468178759|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
130061011|NCT00696436|468178767|FG000|Overall Study|Adverse Event|7|||
130061012|NCT00696436|468178768|FG001|Overall Study|Adverse Event|9|||
130061013|NCT00696436|468178769|FG002|Overall Study|Adverse Event|8|||
130061014|NCT00696436|468178770|FG003|Overall Study|Adverse Event|6|||
130061015|NCT00696436|468178771|FG004|Overall Study|Adverse Event|4|||
129835085|NCT03450707|467362761|FG000|Overall Study|Outside enrollment window|4|||
130061016|NCT00696436|468178767|FG000|Overall Study|Protocol Violation|3|||
130061017|NCT00696436|468178768|FG001|Overall Study|Protocol Violation|2|||
130061018|NCT00696436|468178769|FG002|Overall Study|Protocol Violation|2|||
130061019|NCT00696436|468178770|FG003|Overall Study|Protocol Violation|0|||
130061020|NCT00696436|468178771|FG004|Overall Study|Protocol Violation|1|||
130061021|NCT00696436|468178767|FG000|Overall Study|Lost to Follow-up|1|||
130061022|NCT00696436|468178768|FG001|Overall Study|Lost to Follow-up|6|||
130061023|NCT00696436|468178769|FG002|Overall Study|Lost to Follow-up|2|||
129835086|NCT03450707|467362762|FG001|Overall Study|Outside enrollment window|1|||
129835087|NCT03450707|467362761|FG000|Overall Study|Death|1|||
129835088|NCT03450707|467362762|FG001|Overall Study|Death|0|||
130113059|NCT05017493|468373520|FG000|Overall Study|Physician Decision|15|||
130113060|NCT05017493|468373521|FG001|Overall Study|Physician Decision|0|||
130113061|NCT05017493|468373520|FG000|Overall Study|Protocol Violation|81|||
130113062|NCT05017493|468373521|FG001|Overall Study|Protocol Violation|0|||
130113063|NCT01154153|468373528|FG000|Overall Study|Poor compliance to protocol|2|||
130113064|NCT01154153|468373529|FG001|Overall Study|Poor compliance to protocol|0|||
130113065|NCT01154153|468373528|FG000|Overall Study|Unable to use labs|2|||
130113066|NCT01154153|468373529|FG001|Overall Study|Unable to use labs|3|||
130113067|NCT01154153|468373528|FG000|Overall Study|Withdrew consent|1|||
130113068|NCT01154153|468373529|FG001|Overall Study|Withdrew consent|0|||
130113069|NCT00771901|468373530|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
130113070|NCT00771901|468373531|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
130113071|NCT00771901|468373532|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
130113072|NCT01965652|468373533|FG000|Overall Study|Adverse Event|40|||
130113073|NCT01965652|468373534|FG001|Overall Study|Adverse Event|37|||
130113074|NCT01965652|468373533|FG000|Overall Study|Withdrawal by Subject|62|||
130113075|NCT01965652|468373534|FG001|Overall Study|Withdrawal by Subject|69|||
130113076|NCT01965652|468373533|FG000|Overall Study|Lost to Follow-up|53|||
130113077|NCT01965652|468373534|FG001|Overall Study|Lost to Follow-up|40|||
130113078|NCT01965652|468373533|FG000|Overall Study|Protocol Violation|34|||
130113079|NCT01965652|468373534|FG001|Overall Study|Protocol Violation|38|||
130113080|NCT01965652|468373533|FG000|Overall Study|Death|3|||
130113081|NCT01965652|468373534|FG001|Overall Study|Death|4|||
130113082|NCT01965652|468373533|FG000|Overall Study|Other - Miscellaneous|18|||
129835089|NCT03450707|467362761|FG000|Overall Study|Indication for thiamine|1|||
129835090|NCT03450707|467362762|FG001|Overall Study|Indication for thiamine|1|||
129835091|NCT03450707|467362761|FG000|Overall Study|Evidence of traumatic brain injury|1|||
129835092|NCT03450707|467362762|FG001|Overall Study|Evidence of traumatic brain injury|0|||
129835093|NCT03450707|467362761|FG000|Overall Study|Following commands|0|||
129835094|NCT03450707|467362762|FG001|Overall Study|Following commands|3|||
129835095|NCT03450707|467362761|FG000|Overall Study|Lactate < 3.5|0|||
130061024|NCT00696436|468178770|FG003|Overall Study|Lost to Follow-up|4|||
130061025|NCT00696436|468178771|FG004|Overall Study|Lost to Follow-up|3|||
130061026|NCT00696436|468178767|FG000|Overall Study|Withdrawal by Subject|4|||
130061027|NCT00696436|468178768|FG001|Overall Study|Withdrawal by Subject|11|||
130061028|NCT00696436|468178769|FG002|Overall Study|Withdrawal by Subject|5|||
130061029|NCT00696436|468178770|FG003|Overall Study|Withdrawal by Subject|7|||
130061030|NCT00696436|468178771|FG004|Overall Study|Withdrawal by Subject|1|||
130061031|NCT00696436|468178767|FG000|Overall Study|Lack of Efficacy|3|||
130061032|NCT00696436|468178768|FG001|Overall Study|Lack of Efficacy|1|||
130061033|NCT00696436|468178769|FG002|Overall Study|Lack of Efficacy|5|||
130061034|NCT00696436|468178770|FG003|Overall Study|Lack of Efficacy|2|||
130061035|NCT00696436|468178771|FG004|Overall Study|Lack of Efficacy|4|||
130061036|NCT00696436|468178767|FG000|Overall Study|Participant Unavailability|2|||
130061037|NCT00696436|468178768|FG001|Overall Study|Participant Unavailability|0|||
130061038|NCT00696436|468178769|FG002|Overall Study|Participant Unavailability|2|||
130061039|NCT00696436|468178770|FG003|Overall Study|Participant Unavailability|1|||
130061040|NCT00696436|468178771|FG004|Overall Study|Participant Unavailability|0|||
130061041|NCT00696436|468178767|FG000|Overall Study|Administrative Error|2|||
130061042|NCT00696436|468178768|FG001|Overall Study|Administrative Error|0|||
130061043|NCT00696436|468178769|FG002|Overall Study|Administrative Error|2|||
130061044|NCT00696436|468178770|FG003|Overall Study|Administrative Error|0|||
130061045|NCT00696436|468178771|FG004|Overall Study|Administrative Error|0|||
130061046|NCT00696436|468178767|FG000|Overall Study|Participant Non-compliance|0|||
130061047|NCT00696436|468178768|FG001|Overall Study|Participant Non-compliance|0|||
130061048|NCT00696436|468178769|FG002|Overall Study|Participant Non-compliance|1|||
130061049|NCT00696436|468178770|FG003|Overall Study|Participant Non-compliance|2|||
130061050|NCT00696436|468178771|FG004|Overall Study|Participant Non-compliance|0|||
130061051|NCT00696436|468178767|FG000|Overall Study|Administrative Decision|1|||
130061052|NCT00696436|468178768|FG001|Overall Study|Administrative Decision|0|||
130061053|NCT00696436|468178769|FG002|Overall Study|Administrative Decision|0|||
130113083|NCT01965652|468373534|FG001|Overall Study|Other - Miscellaneous|21|||
130113084|NCT01965652|468373533|FG000|Overall Study|Pregnancy|0|||
129835096|NCT03450707|467362762|FG001|Overall Study|Lactate < 3.5|2|||
129835097|NCT03450707|467362761|FG000|Overall Study|Rearrest with ECMO|0|||
129835098|NCT03450707|467362762|FG001|Overall Study|Rearrest with ECMO|1|||
130061054|NCT00696436|468178770|FG003|Overall Study|Administrative Decision|0|||
130113085|NCT01965652|468373534|FG001|Overall Study|Pregnancy|1|||
130113086|NCT01121900|468373537|FG000|First Intervention Period|Adverse Event|1|||
130061055|NCT00696436|468178771|FG004|Overall Study|Administrative Decision|0|||
130061056|NCT00696436|468178767|FG000|Overall Study|Missing|0|||
130061057|NCT00696436|468178768|FG001|Overall Study|Missing|1|||
130061058|NCT00696436|468178769|FG002|Overall Study|Missing|1|||
130061059|NCT00696436|468178770|FG003|Overall Study|Missing|0|||
130061060|NCT00696436|468178771|FG004|Overall Study|Missing|0|||
130113087|NCT01121900|468373538|FG001|First Intervention Period|Adverse Event|1|||
130113088|NCT01121900|468373537|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130113089|NCT01121900|468373538|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130113090|NCT01328054|468373539|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
130113091|NCT01328054|468373540|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
130113092|NCT01328054|468373539|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
130113093|NCT01328054|468373540|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
130113094|NCT01328054|468373539|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
130113095|NCT01328054|468373540|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
130113096|NCT05478603|468373541|FG000|Overall Study|Withdrawal by Subject|0|||
130113097|NCT05478603|468373542|FG001|Overall Study|Withdrawal by Subject|1|||
130113098|NCT05478603|468373543|FG002|Overall Study|Withdrawal by Subject|0|||
130113099|NCT05478603|468373544|FG003|Overall Study|Withdrawal by Subject|0|||
129835099|NCT03450707|467362761|FG000|Overall Study|Indication for thiamine + head CT results|0|||
130113100|NCT00291330|468373547|FG000|Overall Study|Adverse Event|47|||
130113101|NCT00291330|468373548|FG001|Overall Study|Adverse Event|40|||
130113102|NCT00291330|468373547|FG000|Overall Study|Protocol Violation|13|||
130113103|NCT00291330|468373548|FG001|Overall Study|Protocol Violation|20|||
130113104|NCT00291330|468373547|FG000|Overall Study|Lost to Follow-up|16|||
130113105|NCT00291330|468373548|FG001|Overall Study|Lost to Follow-up|11|||
130113106|NCT00291330|468373547|FG000|Overall Study|Withdrawal by Subject|22|||
130113107|NCT00291330|468373548|FG001|Overall Study|Withdrawal by Subject|25|||
130113108|NCT00291330|468373547|FG000|Overall Study|Other|3|||
130113109|NCT00291330|468373548|FG001|Overall Study|Other|1|||
130113110|NCT02378506|468373553|FG000|Overall Study|Lack of Efficacy|3|||
130113111|NCT02378506|468373553|FG000|Overall Study|Withdrawal by Subject|4|||
130113112|NCT02378506|468373553|FG000|Overall Study|Protocol Violation|2|||
130113113|NCT02378506|468373553|FG000|Overall Study|Death|1|||
130113114|NCT02378506|468373553|FG000|Overall Study|Adverse Event|14|||
130113115|NCT02378506|468373553|FG000|Overall Study|Randomized But Not Treated|1|||
130113116|NCT01606137|468373554|FG000|Overall Study|Adverse Event|85|||
130113117|NCT01606137|468373554|FG000|Overall Study|Withdrawal by Subject|74|||
130113118|NCT01606137|468373554|FG000|Overall Study|Lack of Efficacy|56|||
130113119|NCT01606137|468373554|FG000|Overall Study|Lost to Follow-up|15|||
130113120|NCT01606137|468373554|FG000|Overall Study|Protocol Violation|1|||
130113121|NCT01606137|468373554|FG000|Overall Study|Patient non-compliance|9|||
130113122|NCT01606137|468373554|FG000|Overall Study|Death|1|||
130113123|NCT01606137|468373554|FG000|Overall Study|Decreased/no pain|4|||
130113124|NCT01606137|468373554|FG000|Overall Study|Issues with driving|4|||
130113125|NCT01606137|468373554|FG000|Overall Study|multiple sclerosis less stable|1|||
130113126|NCT01606137|468373554|FG000|Overall Study|Increased bilirubin|1|||
130113127|NCT01606137|468373554|FG000|Overall Study|Spray causes nausea|1|||
130113128|NCT01606137|468373554|FG000|Overall Study|Not enough improvement|4|||
130113129|NCT01606137|468373554|FG000|Overall Study|Wanted to try another treatment|1|||
130113130|NCT01606137|468373554|FG000|Overall Study|Patient leaving country|1|||
130113131|NCT01606137|468373554|FG000|Overall Study|Personal reasons|1|||
130113132|NCT01606137|468373554|FG000|Overall Study|Unable to tolerate study med. taste|1|||
130113133|NCT01606137|468373554|FG000|Overall Study|Patient moving|1|||
130113134|NCT01606137|468373554|FG000|Overall Study|Unable to collect consistent data|1|||
130113135|NCT00720798|468375338|FG000|Overall Study|Adverse Event|304|||
130113136|NCT00720798|468375338|FG000|Overall Study|Death|39|||
130113137|NCT00720798|468375338|FG000|Overall Study|Insufficient Therapeutic Response|129|||
130113138|NCT00720798|468375338|FG000|Overall Study|Protocol Violation|4|||
130113139|NCT00720798|468375338|FG000|Overall Study|Refused Treatment|151|||
130113140|NCT00720798|468375338|FG000|Overall Study|Failure to Return|46|||
130113141|NCT00720798|468375338|FG000|Overall Study|Reason not Specified|83|||
130113142|NCT00433381|468375339|FG000|Overall Study|Ineligible / no protocol treatment|3|||
130113143|NCT00433381|468375340|FG001|Overall Study|Ineligible / no protocol treatment|3|||
130113144|NCT00598559|468375342|FG000|Overall Study|Adverse Event|11|||
130113145|NCT00598559|468375343|FG001|Overall Study|Adverse Event|7|||
130113146|NCT00598559|468375344|FG002|Overall Study|Adverse Event|0|||
129835100|NCT03450707|467362762|FG001|Overall Study|Indication for thiamine + head CT results|1|||
130113147|NCT00598559|468375342|FG000|Overall Study|Withdrawal by Subject|2|||
130113148|NCT00598559|468375343|FG001|Overall Study|Withdrawal by Subject|2|||
129835101|NCT03450707|467362761|FG000|Overall Study|Family/patient goals of care|0|||
130113149|NCT00598559|468375344|FG002|Overall Study|Withdrawal by Subject|0|||
130113150|NCT00598559|468375342|FG000|Overall Study|Protocol Non-compliance|1|||
130113151|NCT00598559|468375343|FG001|Overall Study|Protocol Non-compliance|0|||
130113152|NCT00598559|468375344|FG002|Overall Study|Protocol Non-compliance|0|||
130113153|NCT00598559|468375342|FG000|Overall Study|Early discharge from hospital|9|||
130113154|NCT00598559|468375343|FG001|Overall Study|Early discharge from hospital|12|||
130113155|NCT00598559|468375344|FG002|Overall Study|Early discharge from hospital|3|||
130113156|NCT00598559|468375342|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
130113157|NCT00598559|468375343|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
130113158|NCT00598559|468375344|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
129897887|NCT01801930|467586508|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
129897888|NCT01801930|467586509|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
129897889|NCT01801930|467586510|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
129897890|NCT01801930|467586507|FG000|Overall Study|DLT occurs|0|||
129897891|NCT01801930|467586508|FG001|Overall Study|DLT occurs|1|||
129897892|NCT01801930|467586509|FG002|Overall Study|DLT occurs|0|||
129897893|NCT01801930|467586510|FG003|Overall Study|DLT occurs|0|||
129897894|NCT00930813|467586520|FG000|Overall Study|Death|4|||
129897895|NCT00930813|467586521|FG001|Overall Study|Death|5|||
129897896|NCT00930813|467586520|FG000|Overall Study|Withdrawal by Subject|2|||
129897897|NCT00930813|467586521|FG001|Overall Study|Withdrawal by Subject|5|||
129897898|NCT00930813|467586520|FG000|Overall Study|Lost to Follow-up|2|||
129897899|NCT00930813|467586521|FG001|Overall Study|Lost to Follow-up|4|||
129897900|NCT03999554|467586523|FG000|Overall Study|Lost to Follow-up|4|||
129897901|NCT03999554|467586524|FG001|Overall Study|Lost to Follow-up|5|||
129897902|NCT03999554|467586525|FG002|Overall Study|Lost to Follow-up|4|||
129897903|NCT03999554|467586526|FG003|Overall Study|Lost to Follow-up|5|||
129897904|NCT03999554|467586527|FG004|Overall Study|Lost to Follow-up|8|||
129897905|NCT03999554|467586523|FG000|Overall Study|Protocol Violation|0|||
129897906|NCT03999554|467586524|FG001|Overall Study|Protocol Violation|0|||
129897907|NCT03999554|467586525|FG002|Overall Study|Protocol Violation|5|||
129897908|NCT03999554|467586526|FG003|Overall Study|Protocol Violation|0|||
129897909|NCT03999554|467586527|FG004|Overall Study|Protocol Violation|0|||
129897910|NCT03999554|467586523|FG000|Overall Study|Pregnancy|0|||
129897911|NCT03999554|467586524|FG001|Overall Study|Pregnancy|0|||
129897912|NCT03999554|467586525|FG002|Overall Study|Pregnancy|1|||
129897913|NCT03999554|467586526|FG003|Overall Study|Pregnancy|0|||
129897914|NCT03999554|467586527|FG004|Overall Study|Pregnancy|0|||
129897915|NCT03999554|467586523|FG000|Overall Study|Withdrawal by Subject|2|||
129897916|NCT03999554|467586524|FG001|Overall Study|Withdrawal by Subject|2|||
129897917|NCT03999554|467586525|FG002|Overall Study|Withdrawal by Subject|2|||
129897918|NCT03999554|467586526|FG003|Overall Study|Withdrawal by Subject|1|||
129897919|NCT03999554|467586527|FG004|Overall Study|Withdrawal by Subject|1|||
129897920|NCT03999554|467586523|FG000|Overall Study|failure to comply with protocol requirements|0|||
129897921|NCT03999554|467586524|FG001|Overall Study|failure to comply with protocol requirements|0|||
129897922|NCT03999554|467586525|FG002|Overall Study|failure to comply with protocol requirements|0|||
129897923|NCT03999554|467586526|FG003|Overall Study|failure to comply with protocol requirements|1|||
129897924|NCT03999554|467586527|FG004|Overall Study|failure to comply with protocol requirements|0|||
129897925|NCT03102710|467586528|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
129897926|NCT03102710|467586529|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
129897927|NCT03102710|467586530|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
129897928|NCT03102710|467586528|FG000|Overall Study|Technical issues during final MRI scan|0|||
129897929|NCT03102710|467586529|FG001|Overall Study|Technical issues during final MRI scan|1|||
129897930|NCT03102710|467586530|FG002|Overall Study|Technical issues during final MRI scan|0|||
129897931|NCT03102710|467586528|FG000|Overall Study|Nausea during MRI scan|0|||
129897932|NCT03102710|467586529|FG001|Overall Study|Nausea during MRI scan|1|||
129897933|NCT03102710|467586530|FG002|Overall Study|Nausea during MRI scan|0|||
129897934|NCT03102710|467586528|FG000|Overall Study|Subject unable to attend final session|0|||
129835102|NCT03450707|467362762|FG001|Overall Study|Family/patient goals of care|1|||
129835103|NCT00481195|467362763|FG000|Overall Study|Adverse Event|16|||
129835104|NCT00481195|467362764|FG001|Overall Study|Adverse Event|11|||
129835105|NCT00481195|467362763|FG000|Overall Study|Lack of Efficacy|1|||
129835106|NCT00481195|467362764|FG001|Overall Study|Lack of Efficacy|3|||
129835107|NCT00481195|467362763|FG000|Overall Study|Lost to Follow-up|4|||
129835108|NCT00481195|467362764|FG001|Overall Study|Lost to Follow-up|6|||
129835109|NCT00481195|467362763|FG000|Overall Study|Physician Decision|3|||
129835110|NCT00481195|467362764|FG001|Overall Study|Physician Decision|1|||
129835111|NCT00481195|467362763|FG000|Overall Study|Protocol Violation|10|||
129835112|NCT00481195|467362764|FG001|Overall Study|Protocol Violation|7|||
129835113|NCT00481195|467362763|FG000|Overall Study|Withdrawal by Subject|3|||
129835114|NCT00481195|467362764|FG001|Overall Study|Withdrawal by Subject|9|||
129835115|NCT00481195|467362763|FG000|Overall Study|Miscellaneous|2|||
129835116|NCT00481195|467362764|FG001|Overall Study|Miscellaneous|2|||
129835117|NCT03343483|467362765|FG000|Overall Study|Death|0|||
129835118|NCT03343483|467362766|FG001|Overall Study|Death|3|||
129835119|NCT03343483|467362765|FG000|Overall Study|Lost to Follow-up|9|||
129835120|NCT03343483|467362766|FG001|Overall Study|Lost to Follow-up|13|||
129835121|NCT03343483|467362765|FG000|Overall Study|Withdrawal by Subject|8|||
129835122|NCT03343483|467362766|FG001|Overall Study|Withdrawal by Subject|17|||
129897935|NCT03102710|467586529|FG001|Overall Study|Subject unable to attend final session|1|||
129897936|NCT03102710|467586530|FG002|Overall Study|Subject unable to attend final session|0|||
129835123|NCT01505608|467362767|FG000|Phase I|Lack of Efficacy|0|||
129835124|NCT01505608|467362768|FG001|Phase I|Lack of Efficacy|4|||
129835125|NCT01505608|467362767|FG000|Phase I|Adverse Event|0|||
129835126|NCT01505608|467362768|FG001|Phase I|Adverse Event|1|||
129835127|NCT01505608|467362767|FG000|Phase I|Withdrawal by Subject|0|||
130061061|NCT02282982|468178772|FG000|Overall Study|Lost to Follow-up|15|||
130061062|NCT02282982|468178772|FG000|Overall Study|Withdrew consent|2|||
130061063|NCT02282982|468178772|FG000|Overall Study|Death|4|||
130061064|NCT02282982|468178772|FG000|Overall Study|Lack of product|156|||
130061065|NCT02282982|468178772|FG000|Overall Study|Palivizumab is ended|11|||
130061066|NCT02282982|468178772|FG000|Overall Study|Other, not specified|18|||
130061067|NCT02370498|468178775|FG000|Overall Study|Adverse Event|10|||
130061068|NCT02370498|468178776|FG001|Overall Study|Adverse Event|8|||
130061069|NCT02370498|468178775|FG000|Overall Study|Death|263|||
130061070|NCT02370498|468178776|FG001|Overall Study|Death|265|||
129835128|NCT01505608|467362768|FG001|Phase I|Withdrawal by Subject|1|||
129835129|NCT01505608|467362767|FG000|Phase II|Lack of Efficacy|2|||
129835130|NCT01505608|467362768|FG001|Phase II|Lack of Efficacy|1|||
129835131|NCT01505608|467362767|FG000|Phase II|Protocol Violation|0|||
129835132|NCT01505608|467362768|FG001|Phase II|Protocol Violation|1|||
129835133|NCT03975647|467362769|FG000|Overall Study|Death|71|||
129835134|NCT03975647|467362770|FG001|Overall Study|Death|63|||
129835135|NCT03975647|467362769|FG000|Overall Study|Lost to Follow-up|2|||
129835136|NCT03975647|467362770|FG001|Overall Study|Lost to Follow-up|2|||
129835137|NCT03975647|467362769|FG000|Overall Study|Subject withdrawal of consent|7|||
129835138|NCT03975647|467362770|FG001|Overall Study|Subject withdrawal of consent|11|||
129835139|NCT02404350|467362771|FG000|Overall Study|Adverse Event|2|||
129835140|NCT02404350|467362772|FG001|Overall Study|Adverse Event|2|||
129835141|NCT02404350|467362773|FG002|Overall Study|Adverse Event|3|||
129835142|NCT02404350|467362774|FG003|Overall Study|Adverse Event|9|||
129835143|NCT02404350|467362771|FG000|Overall Study|Lack of Efficacy|3|||
129835144|NCT02404350|467362772|FG001|Overall Study|Lack of Efficacy|1|||
129835145|NCT02404350|467362773|FG002|Overall Study|Lack of Efficacy|0|||
129835146|NCT02404350|467362774|FG003|Overall Study|Lack of Efficacy|3|||
129835147|NCT02404350|467362771|FG000|Overall Study|Lost to Follow-up|2|||
129835148|NCT02404350|467362772|FG001|Overall Study|Lost to Follow-up|0|||
129835149|NCT02404350|467362773|FG002|Overall Study|Lost to Follow-up|0|||
129835150|NCT02404350|467362774|FG003|Overall Study|Lost to Follow-up|1|||
129897937|NCT01101165|467586531|FG000|Period 1|Adverse Event|1|||
129897938|NCT01101165|467586532|FG001|Period 1|Adverse Event|2|||
129897939|NCT01101165|467586531|FG000|Period 1|Withdrawal by Subject|0|||
129897940|NCT01101165|467586532|FG001|Period 1|Withdrawal by Subject|2|||
129897941|NCT01101165|467586531|FG000|Period 1|Positive Drug Screen|0|||
129897942|NCT01101165|467586532|FG001|Period 1|Positive Drug Screen|1|||
129897943|NCT01101165|467586531|FG000|Period 1|Lost to Follow-up|1|||
129897944|NCT01101165|467586532|FG001|Period 1|Lost to Follow-up|0|||
129897945|NCT01101165|467586531|FG000|Period 2|Withdrawal by Subject|3|||
129897946|NCT01101165|467586532|FG001|Period 2|Withdrawal by Subject|1|||
129897947|NCT01101165|467586531|FG000|Period 2|Adverse Event|1|||
129897948|NCT01101165|467586532|FG001|Period 2|Adverse Event|0|||
129897949|NCT00015457|467586533|FG000|First Intervention|Adverse Event|0|||
129897950|NCT00015457|467586534|FG001|First Intervention|Adverse Event|2|||
129897951|NCT00015457|467586533|FG000|First Intervention|Lack of Efficacy|0|||
129897952|NCT00015457|467586534|FG001|First Intervention|Lack of Efficacy|1|||
129897953|NCT00015457|467586533|FG000|Second Intervention|Withdrawal by Subject|1|||
129897954|NCT00015457|467586534|FG001|Second Intervention|Withdrawal by Subject|0|||
129897955|NCT02317705|467586535|FG000|Overall Study|Withdrawal by Subject|3|||
129897956|NCT02317705|467586535|FG000|Overall Study|Physician Decision|1|||
129897957|NCT02317705|467586535|FG000|Overall Study|Drug not usable|1|||
129897958|NCT02219490|467586536|FG000|Overall Study|Adverse Event|24|||
129897959|NCT02219490|467586536|FG000|Overall Study|Withdrew consent|96|||
129897960|NCT02219490|467586536|FG000|Overall Study|Lost to Follow-up|126|||
129897961|NCT02219490|467586536|FG000|Overall Study|COVID-19 infection|2|||
129897962|NCT02219490|467586536|FG000|Overall Study|COVID-19 logistical restrictions|33|||
129897963|NCT02219490|467586536|FG000|Overall Study|Other, not specified|57|||
129897964|NCT01599325|467586537|FG000|Primary Parent Phase|Adverse Event|5|||
130061071|NCT02370498|468178775|FG000|Overall Study|Protocol Violation|1|||
130061072|NCT02370498|468178776|FG001|Overall Study|Protocol Violation|2|||
129835151|NCT02404350|467362771|FG000|Overall Study|Physician Decision|1|||
129835152|NCT02404350|467362772|FG001|Overall Study|Physician Decision|0|||
129835153|NCT02404350|467362773|FG002|Overall Study|Physician Decision|0|||
129897965|NCT01599325|467586537|FG000|Primary Parent Phase|Disease Progression|7|||
129897966|NCT01599325|467586537|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
129897967|NCT01599325|467586537|FG000|Primary Parent Phase|Death|13|||
129897968|NCT01599325|467586537|FG000|Primary Parent Phase|Protocol Violation|1|||
129897969|NCT01599325|467586537|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
129897970|NCT01599325|467586537|FG000|Primary Parent Phase|Other|2|||
129897971|NCT01599325|467586537|FG000|Extension Phase|Study Closure|1|||
129897972|NCT01599325|467586537|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
129897973|NCT01599325|467586537|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
130061073|NCT02370498|468178775|FG000|Overall Study|Withdrawal by Subject|7|||
130061074|NCT02370498|468178776|FG001|Overall Study|Withdrawal by Subject|12|||
129835154|NCT02404350|467362774|FG003|Overall Study|Physician Decision|2|||
129835155|NCT02404350|467362771|FG000|Overall Study|Pregnancy|0|||
129897974|NCT01599325|467586537|FG000|Extension Phase|Disease Progression|1|||
130113159|NCT01059071|468375345|FG000|Overall Study|Lack of Efficacy|1|||
130113160|NCT01059071|468375346|FG001|Overall Study|Lack of Efficacy|4|||
130113161|NCT01059071|468375347|FG002|Overall Study|Lack of Efficacy|2|||
130113162|NCT01059071|468375348|FG003|Overall Study|Lack of Efficacy|3|||
130113163|NCT01059071|468375345|FG000|Overall Study|Withdrawal by Subject|1|||
130113164|NCT01059071|468375346|FG001|Overall Study|Withdrawal by Subject|0|||
130113165|NCT01059071|468375347|FG002|Overall Study|Withdrawal by Subject|0|||
130113166|NCT01059071|468375348|FG003|Overall Study|Withdrawal by Subject|2|||
130113167|NCT01059071|468375345|FG000|Overall Study|Physician Decision|0|||
130113168|NCT01059071|468375346|FG001|Overall Study|Physician Decision|0|||
130113169|NCT01059071|468375347|FG002|Overall Study|Physician Decision|0|||
130113170|NCT01059071|468375348|FG003|Overall Study|Physician Decision|1|||
130113171|NCT00936884|468375353|FG000|Double-blind|Withdrawal by Subject|6|||
130113172|NCT00936884|468375354|FG001|Double-blind|Withdrawal by Subject|4|||
130113173|NCT00936884|468375355|FG002|Double-blind|Withdrawal by Subject|0|||
130113174|NCT00936884|468375353|FG000|Double-blind|Death|2|||
130113175|NCT00936884|468375354|FG001|Double-blind|Death|1|||
130113176|NCT00936884|468375355|FG002|Double-blind|Death|0|||
130113177|NCT00936884|468375353|FG000|Double-blind|Lack of Efficacy|1|||
130113178|NCT00936884|468375354|FG001|Double-blind|Lack of Efficacy|1|||
130113179|NCT00936884|468375355|FG002|Double-blind|Lack of Efficacy|0|||
130113180|NCT00936884|468375353|FG000|Double-blind|Adverse Event|1|||
130113181|NCT00936884|468375354|FG001|Double-blind|Adverse Event|0|||
130113182|NCT00936884|468375355|FG002|Double-blind|Adverse Event|0|||
130113183|NCT00936884|468375353|FG000|Double-blind|Physician Decision|1|||
130113184|NCT00936884|468375354|FG001|Double-blind|Physician Decision|0|||
130113185|NCT00936884|468375355|FG002|Double-blind|Physician Decision|0|||
130113186|NCT00936884|468375353|FG000|Double-blind|No post baseline diary entry|1|||
130113187|NCT00936884|468375354|FG001|Double-blind|No post baseline diary entry|0|||
130113188|NCT00936884|468375355|FG002|Double-blind|No post baseline diary entry|0|||
130113189|NCT00936884|468375353|FG000|Double-blind|Did not receive study drug|0|||
130113190|NCT00936884|468375354|FG001|Double-blind|Did not receive study drug|1|||
130113191|NCT00936884|468375355|FG002|Double-blind|Did not receive study drug|0|||
130113192|NCT01034137|468375360|FG000|Overall Study|Adverse Event|9|||
130113193|NCT01034137|468375361|FG001|Overall Study|Adverse Event|10|||
130113194|NCT01034137|468375362|FG002|Overall Study|Adverse Event|8|||
130113195|NCT01034137|468375360|FG000|Overall Study|Withdrawal by Subject|4|||
130113196|NCT01034137|468375361|FG001|Overall Study|Withdrawal by Subject|3|||
130113197|NCT01034137|468375362|FG002|Overall Study|Withdrawal by Subject|3|||
130113198|NCT01034137|468375360|FG000|Overall Study|Lack of Efficacy|9|||
130113199|NCT01034137|468375361|FG001|Overall Study|Lack of Efficacy|4|||
130113200|NCT01034137|468375362|FG002|Overall Study|Lack of Efficacy|13|||
130113201|NCT01034137|468375360|FG000|Overall Study|Protocol Violation|2|||
130113202|NCT01034137|468375361|FG001|Overall Study|Protocol Violation|2|||
130113203|NCT01034137|468375362|FG002|Overall Study|Protocol Violation|1|||
130113204|NCT01034137|468375360|FG000|Overall Study|Refused treatment or did not cooperate|2|||
130113205|NCT01034137|468375361|FG001|Overall Study|Refused treatment or did not cooperate|0|||
130113206|NCT01034137|468375362|FG002|Overall Study|Refused treatment or did not cooperate|1|||
130113207|NCT01034137|468375360|FG000|Overall Study|Administrative or other|2|||
130113208|NCT01034137|468375361|FG001|Overall Study|Administrative or other|3|||
130113209|NCT01034137|468375362|FG002|Overall Study|Administrative or other|4|||
130113210|NCT01764854|468375366|FG000|Overall Study|Adverse Event|0|||
130113211|NCT01764854|468375367|FG001|Overall Study|Adverse Event|0|||
129835156|NCT02404350|467362772|FG001|Overall Study|Pregnancy|0|||
129835157|NCT02404350|467362773|FG002|Overall Study|Pregnancy|0|||
129835158|NCT02404350|467362774|FG003|Overall Study|Pregnancy|1|||
129835159|NCT02404350|467362771|FG000|Overall Study|Withdrawal by Subject|7|||
129835160|NCT02404350|467362772|FG001|Overall Study|Withdrawal by Subject|3|||
129835161|NCT02404350|467362773|FG002|Overall Study|Withdrawal by Subject|3|||
129835162|NCT02404350|467362774|FG003|Overall Study|Withdrawal by Subject|19|||
129835163|NCT02404350|467362771|FG000|Overall Study|Due to Non-compliance with treatment|0|||
129835164|NCT02404350|467362772|FG001|Overall Study|Due to Non-compliance with treatment|0|||
129835165|NCT02404350|467362773|FG002|Overall Study|Due to Non-compliance with treatment|0|||
129835166|NCT02404350|467362774|FG003|Overall Study|Due to Non-compliance with treatment|1|||
130113212|NCT01764854|468375368|FG002|Overall Study|Adverse Event|2|||
130113213|NCT01764854|468375369|FG003|Overall Study|Adverse Event|0|||
130113214|NCT01764854|468375366|FG000|Overall Study|Withdrawal by Subject|0|||
130113215|NCT01764854|468375367|FG001|Overall Study|Withdrawal by Subject|0|||
130113216|NCT01764854|468375368|FG002|Overall Study|Withdrawal by Subject|1|||
130113217|NCT01764854|468375369|FG003|Overall Study|Withdrawal by Subject|0|||
130113218|NCT01764854|468375366|FG000|Overall Study|relocation|0|||
130113219|NCT01764854|468375367|FG001|Overall Study|relocation|0|||
130113220|NCT01764854|468375368|FG002|Overall Study|relocation|2|||
130113221|NCT01764854|468375369|FG003|Overall Study|relocation|0|||
130113222|NCT01764854|468375366|FG000|Overall Study|Protocol Violation|0|||
130113223|NCT01764854|468375367|FG001|Overall Study|Protocol Violation|0|||
130113224|NCT01764854|468375368|FG002|Overall Study|Protocol Violation|1|||
130113225|NCT01764854|468375369|FG003|Overall Study|Protocol Violation|2|||
130061075|NCT02370498|468178775|FG000|Overall Study|Sponsor's decision|15|||
130061076|NCT02370498|468178776|FG001|Overall Study|Sponsor's decision|9|||
130061077|NCT00289185|468178777|FG000|Overall Study|Withdrawal by Subject|4|||
129835167|NCT02404350|467362771|FG000|Overall Study|Due to Technical problems|0|||
129835168|NCT02404350|467362772|FG001|Overall Study|Due to Technical problems|0|||
129835169|NCT02404350|467362773|FG002|Overall Study|Due to Technical problems|0|||
129835170|NCT02404350|467362774|FG003|Overall Study|Due to Technical problems|1|||
129835171|NCT02319031|467362775|FG000|Treatment Period|Death|1|||
129835172|NCT02319031|467362776|FG001|Treatment Period|Death|0|||
129835173|NCT02871739|467362777|FG000|Overall Study|Lost to Follow-up|3|||
129835174|NCT02871739|467362778|FG001|Overall Study|Lost to Follow-up|2|||
129835175|NCT02871739|467362779|FG002|Overall Study|Lost to Follow-up|0|||
129835176|NCT02871739|467362780|FG003|Overall Study|Lost to Follow-up|2|||
129835177|NCT00439556|467362781|FG000|Overall Study|Patient was taken off study for non-comp|0|||
129835178|NCT00439556|467362782|FG001|Overall Study|Patient was taken off study for non-comp|1|||
129835179|NCT00439556|467362783|FG002|Overall Study|Patient was taken off study for non-comp|0|||
129835180|NCT01405963|467362786|FG000|Overall Study|Moved Away|2|||
129835181|NCT01405963|467362787|FG001|Overall Study|Moved Away|0|||
129835182|NCT01405963|467362786|FG000|Overall Study|Adverse Event|0|||
129835183|NCT01405963|467362787|FG001|Overall Study|Adverse Event|1|||
129835184|NCT01405963|467362786|FG000|Overall Study|Lost to Follow-up|0|||
129835185|NCT01405963|467362787|FG001|Overall Study|Lost to Follow-up|1|||
129835186|NCT01085097|467362788|FG000|Overall Study|Adverse Event|0|||
129835187|NCT01085097|467362789|FG001|Overall Study|Adverse Event|0|||
129835188|NCT01085097|467362790|FG002|Overall Study|Adverse Event|2|||
129835189|NCT01085097|467362788|FG000|Overall Study|Treatment failure|2|||
129835190|NCT01085097|467362789|FG001|Overall Study|Treatment failure|0|||
129835191|NCT01085097|467362790|FG002|Overall Study|Treatment failure|0|||
129835192|NCT01498640|467362793|FG000|Overall Study|Lost to Follow-up|1|||
129835193|NCT01498640|467362793|FG000|Overall Study|Death|1|||
129835194|NCT01498640|467362793|FG000|Overall Study|Other|3|||
129835195|NCT01524692|467362798|FG000|Overall Study|Withdrawal by Subject|3|||
129835196|NCT04007523|467362800|FG000|Overall Study|Withdrawal by Subject|0|||
129835197|NCT04007523|467362801|FG001|Overall Study|Withdrawal by Subject|1|||
129835198|NCT04007523|467362802|FG002|Overall Study|Withdrawal by Subject|1|||
129835199|NCT04007523|467362803|FG003|Overall Study|Withdrawal by Subject|0|||
129835200|NCT04007523|467362800|FG000|Overall Study|ICU Transfer|0|||
129835201|NCT04007523|467362801|FG001|Overall Study|ICU Transfer|1|||
129835202|NCT04007523|467362802|FG002|Overall Study|ICU Transfer|0|||
129835203|NCT04007523|467362803|FG003|Overall Study|ICU Transfer|0|||
129835204|NCT04007523|467362800|FG000|Overall Study|COVID hospital closure|0|||
129835205|NCT04007523|467362801|FG001|Overall Study|COVID hospital closure|0|||
129835206|NCT04007523|467362802|FG002|Overall Study|COVID hospital closure|1|||
129835207|NCT04007523|467362803|FG003|Overall Study|COVID hospital closure|2|||
129835208|NCT04007523|467362800|FG000|Overall Study|Surgery cancelled|0|||
129835209|NCT04007523|467362801|FG001|Overall Study|Surgery cancelled|0|||
129835210|NCT04007523|467362802|FG002|Overall Study|Surgery cancelled|1|||
129835211|NCT04007523|467362803|FG003|Overall Study|Surgery cancelled|1|||
129835212|NCT02197806|467362807|FG000|Overall Study|Adverse Event|0|||
129835213|NCT02197806|467362808|FG001|Overall Study|Adverse Event|1|||
129835214|NCT02197806|467362809|FG002|Overall Study|Adverse Event|0|||
129835215|NCT02197806|467362810|FG003|Overall Study|Adverse Event|1|||
129835216|NCT03065244|467362818|FG000|Overall Study|Lost to Follow-up|1|||
129835217|NCT03065244|467362819|FG001|Overall Study|Lost to Follow-up|1|||
129835218|NCT03065244|467362818|FG000|Overall Study|Diagnosed with a different disease|1|||
129835219|NCT03065244|467362819|FG001|Overall Study|Diagnosed with a different disease|1|||
129835220|NCT03065244|467362818|FG000|Overall Study|Protocol Violation|0|||
129835221|NCT03065244|467362819|FG001|Overall Study|Protocol Violation|1|||
129835222|NCT03065244|467362818|FG000|Overall Study|Withdrawal by Subject|1|||
129835223|NCT03065244|467362819|FG001|Overall Study|Withdrawal by Subject|1|||
129835224|NCT03717480|467362820|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
129835225|NCT01708174|467362823|FG000|Treatment Period|Withdrawal by Subject|1|||
129835226|NCT01708174|467362824|FG001|Treatment Period|Withdrawal by Subject|0|||
129835227|NCT01708174|467362825|FG002|Treatment Period|Withdrawal by Subject|0|||
129835228|NCT01708174|467362823|FG000|Treatment Period|Progressive disease|0|||
129835229|NCT01708174|467362824|FG001|Treatment Period|Progressive disease|1|||
129835230|NCT01708174|467362825|FG002|Treatment Period|Progressive disease|0|||
129835231|NCT01708174|467362823|FG000|Treatment Period|Death|0|||
130061078|NCT00289185|468178778|FG001|Overall Study|Withdrawal by Subject|8|||
129835232|NCT01708174|467362824|FG001|Treatment Period|Death|0|||
130061079|NCT00289185|468178777|FG000|Overall Study|Lost to Follow-up|23|||
129835233|NCT01708174|467362825|FG002|Treatment Period|Death|1|||
129835234|NCT01708174|467362823|FG000|Treatment Period|Adverse Event|0|||
129835235|NCT01708174|467362824|FG001|Treatment Period|Adverse Event|1|||
129835236|NCT01708174|467362825|FG002|Treatment Period|Adverse Event|0|||
129835237|NCT01894152|467362826|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
129835238|NCT01774786|467362827|FG000|Overall Study|Death|300|||
130061080|NCT00289185|468178778|FG001|Overall Study|Lost to Follow-up|17|||
129835239|NCT01774786|467362828|FG001|Overall Study|Death|319|||
129835240|NCT01774786|467362827|FG000|Overall Study|Lost to Follow-up|6|||
129835241|NCT01774786|467362828|FG001|Overall Study|Lost to Follow-up|7|||
129835242|NCT01774786|467362827|FG000|Overall Study|Withdrawal by Subject|18|||
129835243|NCT01774786|467362828|FG001|Overall Study|Withdrawal by Subject|14|||
129835244|NCT01774786|467362827|FG000|Overall Study|Physician Decision|2|||
129835245|NCT01774786|467362828|FG001|Overall Study|Physician Decision|0|||
129835246|NCT01774786|467362827|FG000|Overall Study|Non-compliance|0|||
129835247|NCT01774786|467362828|FG001|Overall Study|Non-compliance|1|||
129835248|NCT01774786|467362827|FG000|Overall Study|Reason Not Specified|2|||
129835249|NCT01774786|467362828|FG001|Overall Study|Reason Not Specified|5|||
129835250|NCT00075582|467362829|FG000|Overall Study|Adverse Event|3|||
129835251|NCT00075582|467362830|FG001|Overall Study|Adverse Event|1|||
129835252|NCT00075582|467362829|FG000|Overall Study|Lack of Efficacy|4|||
129835253|NCT00075582|467362830|FG001|Overall Study|Lack of Efficacy|8|||
129835254|NCT00075582|467362829|FG000|Overall Study|Physician Decision|5|||
129835255|NCT00075582|467362830|FG001|Overall Study|Physician Decision|8|||
129835256|NCT00075582|467362829|FG000|Overall Study|Withdrawal by Subject|2|||
129835257|NCT00075582|467362830|FG001|Overall Study|Withdrawal by Subject|2|||
129835258|NCT00075582|467362829|FG000|Overall Study|Ineligible for study|36|||
129835259|NCT00075582|467362830|FG001|Overall Study|Ineligible for study|16|||
129835260|NCT02268812|467362831|FG000|Overall Study|Adverse Event|8|||
129835261|NCT02268812|467362832|FG001|Overall Study|Adverse Event|26|||
129835262|NCT02268812|467362833|FG002|Overall Study|Adverse Event|7|||
129835263|NCT02268812|467362834|FG003|Overall Study|Adverse Event|10|||
129835264|NCT02268812|467362831|FG000|Overall Study|Protocol deviation|0|||
129835265|NCT02268812|467362832|FG001|Overall Study|Protocol deviation|0|||
129835266|NCT02268812|467362833|FG002|Overall Study|Protocol deviation|1|||
129835267|NCT02268812|467362834|FG003|Overall Study|Protocol deviation|0|||
129835268|NCT02268812|467362831|FG000|Overall Study|Withdrawal by Subject|0|||
129835269|NCT02268812|467362832|FG001|Overall Study|Withdrawal by Subject|1|||
129835270|NCT02268812|467362833|FG002|Overall Study|Withdrawal by Subject|0|||
129835271|NCT02268812|467362834|FG003|Overall Study|Withdrawal by Subject|0|||
129835272|NCT02268812|467362831|FG000|Overall Study|Physician Decision|3|||
129835273|NCT02268812|467362832|FG001|Overall Study|Physician Decision|1|||
129835274|NCT02268812|467362833|FG002|Overall Study|Physician Decision|0|||
129835275|NCT02268812|467362834|FG003|Overall Study|Physician Decision|1|||
129835276|NCT02268812|467362831|FG000|Overall Study|Other|5|||
129835277|NCT02268812|467362832|FG001|Overall Study|Other|4|||
129835278|NCT02268812|467362833|FG002|Overall Study|Other|1|||
129835279|NCT02268812|467362834|FG003|Overall Study|Other|3|||
129835280|NCT02385084|467362835|FG000|Period 2|Protocol Violation|0|||
129835281|NCT02385084|467362836|FG001|Period 2|Protocol Violation|0|||
129835282|NCT02385084|467362837|FG002|Period 2|Protocol Violation|1|||
129835283|NCT02385084|467362838|FG003|Period 2|Protocol Violation|0|||
129835284|NCT02385084|467362839|FG004|Period 2|Protocol Violation|0|||
129835285|NCT02385084|467362840|FG005|Period 2|Protocol Violation|0|||
129835286|NCT05045144|467362841|FG000|Overall Study|Lost to Follow-up|3|||
129835287|NCT05045144|467362842|FG001|Overall Study|Lost to Follow-up|2|||
129835288|NCT05045144|467362843|FG002|Overall Study|Lost to Follow-up|3|||
129835289|NCT05045144|467362844|FG003|Overall Study|Lost to Follow-up|5|||
129835290|NCT05045144|467362845|FG004|Overall Study|Lost to Follow-up|13|||
129835291|NCT05045144|467362841|FG000|Overall Study|Withdrawal by Subject|0|||
129835292|NCT05045144|467362842|FG001|Overall Study|Withdrawal by Subject|1|||
129835293|NCT05045144|467362843|FG002|Overall Study|Withdrawal by Subject|0|||
129835294|NCT05045144|467362844|FG003|Overall Study|Withdrawal by Subject|0|||
129835295|NCT05045144|467362845|FG004|Overall Study|Withdrawal by Subject|0|||
129835296|NCT05045144|467362841|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835297|NCT05045144|467362842|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835298|NCT05045144|467362843|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129835299|NCT05045144|467362844|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835300|NCT05045144|467362845|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835301|NCT02965703|467362850|FG000|Overall Study|Withdrawal by Subject|6|||
129835302|NCT02965703|467362851|FG001|Overall Study|Withdrawal by Subject|3|||
129835303|NCT02965703|467362852|FG002|Overall Study|Withdrawal by Subject|1|||
129835304|NCT02965703|467362850|FG000|Overall Study|Protocol Violation|1|||
129835305|NCT02965703|467362851|FG001|Overall Study|Protocol Violation|0|||
129835306|NCT02965703|467362852|FG002|Overall Study|Protocol Violation|0|||
129835307|NCT02965703|467362850|FG000|Overall Study|Adverse Event|1|||
129835308|NCT02965703|467362851|FG001|Overall Study|Adverse Event|1|||
129835309|NCT02965703|467362852|FG002|Overall Study|Adverse Event|0|||
129835310|NCT02965703|467362850|FG000|Overall Study|Lost to Follow-up|2|||
130061081|NCT00289185|468178777|FG000|Overall Study|Death|1|||
129835311|NCT02965703|467362851|FG001|Overall Study|Lost to Follow-up|1|||
129835312|NCT02965703|467362852|FG002|Overall Study|Lost to Follow-up|1|||
129835313|NCT00744627|467362853|FG000|Overall Study|Adverse Event|6|||
129835314|NCT00744627|467362854|FG001|Overall Study|Adverse Event|9|||
129835315|NCT00744627|467362853|FG000|Overall Study|Lack of Efficacy|7|||
129835316|NCT00744627|467362854|FG001|Overall Study|Lack of Efficacy|3|||
130061082|NCT00289185|468178778|FG001|Overall Study|Death|1|||
129835317|NCT00744627|467362853|FG000|Overall Study|Noncompliance|0|||
129835318|NCT00744627|467362854|FG001|Overall Study|Noncompliance|1|||
129835319|NCT00744627|467362853|FG000|Overall Study|Protocol Deviations|0|||
129835320|NCT00744627|467362854|FG001|Overall Study|Protocol Deviations|2|||
129835321|NCT00744627|467362853|FG000|Overall Study|Voluntary Withdrawal|9|||
129835322|NCT00744627|467362854|FG001|Overall Study|Voluntary Withdrawal|6|||
129835323|NCT00744627|467362853|FG000|Overall Study|Lost to Follow-up|2|||
129835324|NCT00744627|467362854|FG001|Overall Study|Lost to Follow-up|1|||
129835325|NCT00744627|467362853|FG000|Overall Study|Other|1|||
129835326|NCT00744627|467362854|FG001|Overall Study|Other|0|||
129835327|NCT00768144|467362855|FG000|Overall Study|Adverse Event|13|||
129835328|NCT00768144|467362855|FG000|Overall Study|Progressive Disease|21|||
129835329|NCT00768144|467362855|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
129835330|NCT00768144|467362855|FG000|Overall Study|Pt Withdrew Consent|1|||
129835331|NCT02268786|467362856|FG000|Overall Study|No Euploid Embryos available|42|||
129835332|NCT02268786|467362857|FG001|Overall Study|No Euploid Embryos available|0|||
129835333|NCT02268786|467362856|FG000|Overall Study|Withdrawal by Subject|7|||
129835334|NCT02268786|467362857|FG001|Overall Study|Withdrawal by Subject|14|||
129835335|NCT02268786|467362856|FG000|Overall Study|Thaw Failure|6|||
129835336|NCT02268786|467362857|FG001|Overall Study|Thaw Failure|4|||
129835337|NCT02268786|467362856|FG000|Overall Study|Protocol Violation|1|||
129835338|NCT02268786|467362857|FG001|Overall Study|Protocol Violation|0|||
129835339|NCT04251221|467362858|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
129835340|NCT04251221|467362859|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
129835341|NCT01319877|467362860|FG000|Overall Study|Lost to Follow-up|100|||
129835342|NCT01319877|467362861|FG001|Overall Study|Lost to Follow-up|37|||
129835343|NCT01319877|467362860|FG000|Overall Study|Physician Decision|2|||
129835344|NCT01319877|467362861|FG001|Overall Study|Physician Decision|0|||
129835345|NCT01319877|467362860|FG000|Overall Study|Disease Progression|2|||
129835346|NCT01319877|467362861|FG001|Overall Study|Disease Progression|2|||
129835347|NCT01319877|467362860|FG000|Overall Study|Withdrawal by Subject|0|||
129835348|NCT01319877|467362861|FG001|Overall Study|Withdrawal by Subject|1|||
129835349|NCT01319877|467362860|FG000|Overall Study|Reason Not Specified|4|||
129835350|NCT01319877|467362861|FG001|Overall Study|Reason Not Specified|5|||
129835351|NCT02968979|467362862|FG000|Overall Study|Protocol Violation|7|||
129835352|NCT02968979|467362862|FG000|Overall Study|Withdrawal by Subject|1|||
129835353|NCT03745144|467362863|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
129835354|NCT03745144|467362864|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
129835355|NCT03745144|467362865|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
129835356|NCT03745144|467362863|FG000|Period 1|Other|0|||
129835357|NCT03745144|467362864|FG001|Period 1|Other|0|||
129835358|NCT03745144|467362865|FG002|Period 1|Other|1|||
129835359|NCT00896337|467362866|FG000|Overall Study|Death|7|||
129835360|NCT00896337|467362866|FG000|Overall Study|Withdrawal by Subject|7|||
129835361|NCT00896337|467362866|FG000|Overall Study|Lost to Follow-up|11|||
129835362|NCT04668950|467362867|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
129835363|NCT04668950|467362868|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
129835364|NCT04668950|467362867|FG000|Overall Study|Could not confirm started study medication|15|||
129835365|NCT04668950|467362868|FG001|Overall Study|Could not confirm started study medication|15|||
129835366|NCT04668950|467362867|FG000|Overall Study|Could not confirm baseline status|6|||
129835367|NCT04668950|467362868|FG001|Overall Study|Could not confirm baseline status|2|||
129835368|NCT04668950|467362867|FG000|Overall Study|Drop out and did not start medication|15|||
129835369|NCT04668950|467362868|FG001|Overall Study|Drop out and did not start medication|17|||
129835370|NCT04668950|467362867|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
129835371|NCT04668950|467362868|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
129835372|NCT04668950|467362867|FG000|Overall Study|Other|2|||
129835373|NCT04668950|467362868|FG001|Overall Study|Other|4|||
129835374|NCT04059146|467362874|FG000|Overall Study|Withdrawal by Subject|0|||
129835375|NCT04059146|467362875|FG001|Overall Study|Withdrawal by Subject|1|||
129835376|NCT05756790|467362881|FG000|Overall Study|Withdrawal by Subject|1|||
129835377|NCT05756790|467362882|FG001|Overall Study|Withdrawal by Subject|1|||
129835378|NCT05756790|467362883|FG002|Overall Study|Withdrawal by Subject|1|||
129835379|NCT05756790|467362884|FG003|Overall Study|Withdrawal by Subject|1|||
129835380|NCT05756790|467362885|FG004|Overall Study|Withdrawal by Subject|0|||
129835381|NCT05756790|467362886|FG005|Overall Study|Withdrawal by Subject|0|||
129835382|NCT05756790|467362881|FG000|Overall Study|Protocol Violation|0|||
129835383|NCT05756790|467362882|FG001|Overall Study|Protocol Violation|0|||
129835384|NCT05756790|467362883|FG002|Overall Study|Protocol Violation|1|||
129835385|NCT05756790|467362884|FG003|Overall Study|Protocol Violation|1|||
129897975|NCT01599325|467586537|FG000|Extension Phase|Withdrawal by Subject|8|||
129835386|NCT05756790|467362885|FG004|Overall Study|Protocol Violation|0|||
129897976|NCT03404843|467586539|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
130061083|NCT02432040|468178781|FG000|Overall Study|Lack of Efficacy|3|||
129835387|NCT05756790|467362886|FG005|Overall Study|Protocol Violation|0|||
129835388|NCT05756790|467362881|FG000|Overall Study|Ineligible|0|||
129835389|NCT05756790|467362882|FG001|Overall Study|Ineligible|0|||
129835390|NCT05756790|467362883|FG002|Overall Study|Ineligible|0|||
129835391|NCT05756790|467362884|FG003|Overall Study|Ineligible|0|||
129835392|NCT05756790|467362885|FG004|Overall Study|Ineligible|2|||
129835393|NCT05756790|467362886|FG005|Overall Study|Ineligible|2|||
129835394|NCT00502697|467364158|FG000|Overall Study|Withdrawal by Subject|3|||
130061084|NCT02432040|468178782|FG001|Overall Study|Lack of Efficacy|0|||
130061085|NCT02432040|468178781|FG000|Overall Study|Lost to Follow-up|4|||
130061086|NCT02432040|468178782|FG001|Overall Study|Lost to Follow-up|5|||
130061087|NCT02432040|468178781|FG000|Overall Study|Physician Decision|1|||
129835395|NCT00502697|467364159|FG001|Overall Study|Withdrawal by Subject|1|||
129835396|NCT00502697|467364158|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
129835397|NCT00502697|467364159|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
129835398|NCT00502697|467364158|FG000|Overall Study|found not to meet eligibility criteria|3|||
130061088|NCT02432040|468178782|FG001|Overall Study|Physician Decision|1|||
130061089|NCT00488592|468178785|FG000|Overall Study|Withdrawal by Subject|1|||
130061090|NCT00488592|468178785|FG000|Overall Study|Disease progression|1|||
130061091|NCT00488592|468178785|FG000|Overall Study|Enrolled but not treated|1|||
130061092|NCT05836818|468178786|FG000|Overall Study|Physician Decision|1|||
130061093|NCT05836818|468178787|FG001|Overall Study|Physician Decision|1|||
130061094|NCT05836818|468178788|FG002|Overall Study|Physician Decision|0|||
130061095|NCT05836818|468178786|FG000|Overall Study|Withdrawal by Subject|0|||
130061096|NCT05836818|468178787|FG001|Overall Study|Withdrawal by Subject|0|||
130061097|NCT05836818|468178788|FG002|Overall Study|Withdrawal by Subject|1|||
130061098|NCT05836818|468178786|FG000|Overall Study|Later found to be previously vaccinated|0|||
130061099|NCT05836818|468178787|FG001|Overall Study|Later found to be previously vaccinated|1|||
130061100|NCT05836818|468178788|FG002|Overall Study|Later found to be previously vaccinated|3|||
130061101|NCT05836818|468178786|FG000|Overall Study|Pregnancy|0|||
130061102|NCT05836818|468178787|FG001|Overall Study|Pregnancy|1|||
130061103|NCT05836818|468178788|FG002|Overall Study|Pregnancy|0|||
130061104|NCT05836818|468178786|FG000|Overall Study|Allergic to vaccines|0|||
130061105|NCT05836818|468178787|FG001|Overall Study|Allergic to vaccines|1|||
130061106|NCT05836818|468178788|FG002|Overall Study|Allergic to vaccines|0|||
130061107|NCT03977727|468178789|FG000|Second Treatment|Lost to Follow-up|0|||
130061108|NCT03977727|468178790|FG001|Second Treatment|Lost to Follow-up|3|||
130061109|NCT00621855|468178803|FG000|Overall Study|Adverse Event|32|||
130061110|NCT00621855|468178804|FG001|Overall Study|Adverse Event|31|||
130061111|NCT00621855|468178805|FG002|Overall Study|Adverse Event|48|||
130061112|NCT00621855|468178806|FG003|Overall Study|Adverse Event|34|||
130061113|NCT00621855|468178807|FG004|Overall Study|Adverse Event|31|||
130061114|NCT00621855|468178803|FG000|Overall Study|Lost to Follow-up|0|||
129835399|NCT00502697|467364159|FG001|Overall Study|found not to meet eligibility criteria|4|||
129835400|NCT00502697|467364158|FG000|Overall Study|did not meet assignment criteria|4|||
129835401|NCT00502697|467364159|FG001|Overall Study|did not meet assignment criteria|2|||
129835402|NCT01545817|467364161|FG000|Pazopanib|Disease progression|51|||
129835403|NCT01545817|467364162|FG001|Pazopanib|Disease progression|0|||
129835404|NCT01545817|467364161|FG000|Pazopanib|Adverse Event|19|||
129835405|NCT01545817|467364162|FG001|Pazopanib|Adverse Event|0|||
129835406|NCT01545817|467364161|FG000|Pazopanib|Other reason|4|||
129835407|NCT01545817|467364162|FG001|Pazopanib|Other reason|0|||
129835408|NCT01545817|467364161|FG000|Everolimus|Other reason|0|||
129835409|NCT01545817|467364162|FG001|Everolimus|Other reason|7|||
129835410|NCT01545817|467364161|FG000|Everolimus|Disease progression|0|||
129835411|NCT01545817|467364162|FG001|Everolimus|Disease progression|25|||
129835412|NCT01545817|467364161|FG000|Everolimus|Adverse Event|0|||
129835413|NCT01545817|467364162|FG001|Everolimus|Adverse Event|6|||
129835414|NCT00589108|467364168|FG000|Overall Study|Lost to Follow-up|1|||
129835415|NCT00589108|467364169|FG001|Overall Study|Lost to Follow-up|1|||
129835416|NCT00589108|467364170|FG002|Overall Study|Lost to Follow-up|1|||
129835417|NCT00589108|467364168|FG000|Overall Study|Death|3|||
129835418|NCT00589108|467364169|FG001|Overall Study|Death|3|||
129835419|NCT00589108|467364170|FG002|Overall Study|Death|4|||
129835420|NCT03026257|467364175|FG000|Overall Study|Adverse Event|3|||
130061115|NCT00621855|468178804|FG001|Overall Study|Lost to Follow-up|1|||
130113226|NCT03377556|468375378|FG000|Overall Study|Adverse Event|5|||
129835421|NCT03026257|467364176|FG001|Overall Study|Adverse Event|0|||
129835422|NCT03026257|467364177|FG002|Overall Study|Adverse Event|0|||
129835423|NCT03026257|467364178|FG003|Overall Study|Adverse Event|0|||
130061116|NCT00621855|468178805|FG002|Overall Study|Lost to Follow-up|3|||
130061117|NCT00621855|468178806|FG003|Overall Study|Lost to Follow-up|4|||
130061118|NCT00621855|468178807|FG004|Overall Study|Lost to Follow-up|1|||
129835424|NCT03026257|467364179|FG004|Overall Study|Adverse Event|0|||
129835425|NCT03026257|467364180|FG005|Overall Study|Adverse Event|0|||
129835426|NCT03026257|467364175|FG000|Overall Study|Lost to Follow-up|1|||
130061119|NCT00621855|468178803|FG000|Overall Study|Protocol Violation|16|||
130061120|NCT00621855|468178804|FG001|Overall Study|Protocol Violation|8|||
129835427|NCT03026257|467364176|FG001|Overall Study|Lost to Follow-up|0|||
129835428|NCT03026257|467364177|FG002|Overall Study|Lost to Follow-up|0|||
130061121|NCT00621855|468178805|FG002|Overall Study|Protocol Violation|6|||
130061122|NCT00621855|468178806|FG003|Overall Study|Protocol Violation|7|||
129835429|NCT03026257|467364178|FG003|Overall Study|Lost to Follow-up|0|||
129835430|NCT03026257|467364179|FG004|Overall Study|Lost to Follow-up|0|||
129835431|NCT03026257|467364180|FG005|Overall Study|Lost to Follow-up|0|||
129835432|NCT03026257|467364175|FG000|Overall Study|Protocol Violation|1|||
129835433|NCT03026257|467364176|FG001|Overall Study|Protocol Violation|0|||
129835434|NCT03026257|467364177|FG002|Overall Study|Protocol Violation|0|||
129835435|NCT03026257|467364178|FG003|Overall Study|Protocol Violation|1|||
129835436|NCT03026257|467364179|FG004|Overall Study|Protocol Violation|1|||
129835437|NCT03026257|467364180|FG005|Overall Study|Protocol Violation|0|||
129835438|NCT03026257|467364175|FG000|Overall Study|Withdrawal by Subject|1|||
129835439|NCT03026257|467364176|FG001|Overall Study|Withdrawal by Subject|1|||
129835440|NCT03026257|467364177|FG002|Overall Study|Withdrawal by Subject|0|||
129835441|NCT03026257|467364178|FG003|Overall Study|Withdrawal by Subject|0|||
129835442|NCT03026257|467364179|FG004|Overall Study|Withdrawal by Subject|0|||
129835443|NCT03026257|467364180|FG005|Overall Study|Withdrawal by Subject|0|||
129835444|NCT04380857|467364181|FG000|Overall Study|Lost to Follow-up|3|||
129835445|NCT04380857|467364182|FG001|Overall Study|Lost to Follow-up|3|||
129835446|NCT00838201|467364183|FG000|Overall Study|Investigator decision, or other reasons|2|||
129835447|NCT00838201|467364184|FG001|Overall Study|Investigator decision, or other reasons|3|||
129835448|NCT00838201|467364183|FG000|Overall Study|Noncompliance|0|||
129835449|NCT00838201|467364184|FG001|Overall Study|Noncompliance|1|||
129835450|NCT00838201|467364183|FG000|Overall Study|Administrative decision|1|||
129835451|NCT00838201|467364184|FG001|Overall Study|Administrative decision|2|||
129835452|NCT00838201|467364183|FG000|Overall Study|Disease progression|3|||
129835453|NCT00838201|467364184|FG001|Overall Study|Disease progression|3|||
129835454|NCT00838201|467364183|FG000|Overall Study|Consent withdrawn|16|||
129835455|NCT00838201|467364184|FG001|Overall Study|Consent withdrawn|19|||
129835456|NCT00838201|467364183|FG000|Overall Study|Lost to Follow-up|4|||
129835457|NCT00838201|467364184|FG001|Overall Study|Lost to Follow-up|3|||
129835458|NCT00838201|467364183|FG000|Overall Study|Adverse Event|5|||
129835459|NCT00838201|467364184|FG001|Overall Study|Adverse Event|9|||
129835460|NCT00838201|467364183|FG000|Overall Study|Death|11|||
129835461|NCT00838201|467364184|FG001|Overall Study|Death|13|||
129835462|NCT02558790|467364185|FG000|Overall Study|Lost to Follow-up|2|||
129835463|NCT02558790|467364185|FG000|Overall Study|Physician Decision|1|||
129835464|NCT02558790|467364185|FG000|Overall Study|Withdrawal by Subject|1|||
129835465|NCT02558790|467364185|FG000|Overall Study|Screen Fail|3|||
129835466|NCT05228470|467364186|FG000|Overall Study|Death|6|||
129835467|NCT05228470|467364187|FG001|Overall Study|Death|11|||
129835468|NCT05228470|467364186|FG000|Overall Study|Withdrawal by Subject|1|||
129835469|NCT05228470|467364187|FG001|Overall Study|Withdrawal by Subject|8|||
129835470|NCT05228470|467364186|FG000|Overall Study|Ongoing|1|||
129835471|NCT05228470|467364187|FG001|Overall Study|Ongoing|11|||
129835472|NCT05620576|467364188|FG000|Overall Study|Adverse Event|1|||
129835473|NCT05620576|467364189|FG001|Overall Study|Adverse Event|1|||
129835474|NCT05620576|467364188|FG000|Overall Study|Lost to Follow-up|3|||
129835475|NCT05620576|467364189|FG001|Overall Study|Lost to Follow-up|1|||
129835476|NCT05620576|467364188|FG000|Overall Study|Physician Decision|0|||
129835477|NCT05620576|467364189|FG001|Overall Study|Physician Decision|1|||
129835478|NCT05620576|467364188|FG000|Overall Study|Protocol Deviation|1|||
129835479|NCT05620576|467364189|FG001|Overall Study|Protocol Deviation|1|||
129835480|NCT05620576|467364188|FG000|Overall Study|Withdrawal by Subject|2|||
129835481|NCT05620576|467364189|FG001|Overall Study|Withdrawal by Subject|3|||
129835482|NCT02622828|467364190|FG000|Overall Study|participant withdrew|3|||
129835483|NCT02780804|467364193|FG000|Overall Study|Death|1|||
129835484|NCT02780804|467364194|FG001|Overall Study|Death|0|||
129835485|NCT02780804|467364195|FG002|Overall Study|Death|0|||
129835486|NCT02780804|467364193|FG000|Overall Study|Lack of Efficacy|5|||
129835487|NCT02780804|467364194|FG001|Overall Study|Lack of Efficacy|8|||
129835488|NCT02780804|467364195|FG002|Overall Study|Lack of Efficacy|4|||
129835489|NCT02780804|467364193|FG000|Overall Study|Physician Decision|0|||
129835490|NCT02780804|467364194|FG001|Overall Study|Physician Decision|0|||
129835491|NCT02780804|467364195|FG002|Overall Study|Physician Decision|2|||
129835492|NCT02780804|467364193|FG000|Overall Study|Withdrawal by Subject|0|||
129835493|NCT02780804|467364194|FG001|Overall Study|Withdrawal by Subject|1|||
129835494|NCT02780804|467364195|FG002|Overall Study|Withdrawal by Subject|0|||
129897977|NCT03404843|467586540|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
129835495|NCT01921829|467364198|FG000|Overall Study|Withdrawal by Subject|0|||
129835496|NCT01921829|467364199|FG001|Overall Study|Withdrawal by Subject|1|||
129835497|NCT04476030|467364200|FG000|Overall Study|Withdrawal by Subject|20|||
129835498|NCT04476030|467364201|FG001|Overall Study|Withdrawal by Subject|16|||
129835499|NCT04476030|467364200|FG000|Overall Study|Adverse Event|10|||
129835500|NCT04476030|467364201|FG001|Overall Study|Adverse Event|11|||
129835501|NCT04476030|467364200|FG000|Overall Study|Lost to Follow-up|7|||
129835502|NCT04476030|467364201|FG001|Overall Study|Lost to Follow-up|4|||
129897978|NCT00567164|467586541|FG000|Overall Study|Withdrawal by Subject|171|||
129835503|NCT04476030|467364200|FG000|Overall Study|Physician Decision|1|||
129835504|NCT04476030|467364201|FG001|Overall Study|Physician Decision|1|||
129835505|NCT04476030|467364200|FG000|Overall Study|Protocol Deviation|2|||
129835506|NCT04476030|467364201|FG001|Overall Study|Protocol Deviation|0|||
130113227|NCT03377556|468375378|FG000|Overall Study|Refusal unrelated to adverse events|1|||
130113228|NCT03377556|468375378|FG000|Overall Study|Progression/relapse|38|||
130113229|NCT03377556|468375378|FG000|Overall Study|Death|3|||
130113230|NCT00472446|468375379|FG000|Overall Study|Protocol Violation|0|||
130113231|NCT00472446|468375380|FG001|Overall Study|Protocol Violation|0|||
130113232|NCT00472446|468375381|FG002|Overall Study|Protocol Violation|0|||
130113233|NCT00472446|468375382|FG003|Overall Study|Protocol Violation|1|||
130113234|NCT00472446|468375379|FG000|Overall Study|Reintervention|0|||
130113235|NCT00472446|468375380|FG001|Overall Study|Reintervention|0|||
130113236|NCT00472446|468375381|FG002|Overall Study|Reintervention|1|||
130113237|NCT00472446|468375382|FG003|Overall Study|Reintervention|1|||
130113238|NCT00472446|468375379|FG000|Overall Study|Questionnaires not returned|5|||
130113239|NCT00472446|468375380|FG001|Overall Study|Questionnaires not returned|6|||
130113240|NCT00472446|468375381|FG002|Overall Study|Questionnaires not returned|6|||
130113241|NCT00472446|468375382|FG003|Overall Study|Questionnaires not returned|4|||
130113242|NCT00827827|468375383|FG000|Overall Study|Lost to Follow-up|3|||
130113243|NCT00827827|468375384|FG001|Overall Study|Lost to Follow-up|0|||
130113244|NCT00827827|468375383|FG000|Overall Study|Fall at home- hospitalization|1|||
130113245|NCT00827827|468375384|FG001|Overall Study|Fall at home- hospitalization|0|||
130113246|NCT00827827|468375383|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
130113247|NCT00827827|468375384|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
130113248|NCT00827827|468375383|FG000|Overall Study|Gout|1|||
130113249|NCT00827827|468375384|FG001|Overall Study|Gout|0|||
130113250|NCT00827827|468375383|FG000|Overall Study|Transportation issues|1|||
130113251|NCT00827827|468375384|FG001|Overall Study|Transportation issues|0|||
130113252|NCT00827827|468375383|FG000|Overall Study|Burned with water at home|1|||
130113253|NCT00827827|468375384|FG001|Overall Study|Burned with water at home|0|||
130113254|NCT01165684|468375387|FG000|Overall Study|Adverse Event|1|||
130113255|NCT01165684|468375388|FG001|Overall Study|Adverse Event|1|||
130113256|NCT01165684|468375387|FG000|Overall Study|Lack of Efficacy|2|||
130113257|NCT01165684|468375388|FG001|Overall Study|Lack of Efficacy|1|||
130113258|NCT01165684|468375387|FG000|Overall Study|Protocol Violation|7|||
130113259|NCT01165684|468375388|FG001|Overall Study|Protocol Violation|15|||
130113260|NCT01165684|468375387|FG000|Overall Study|Withdrawal Criteria|2|||
130113261|NCT01165684|468375388|FG001|Overall Study|Withdrawal Criteria|13|||
130113262|NCT01165684|468375387|FG000|Overall Study|Unclassified|16|||
130113263|NCT01165684|468375388|FG001|Overall Study|Unclassified|22|||
130113264|NCT00671879|468375391|FG000|Overall Study|Withdrawal by Subject|0|||
130113265|NCT00671879|468375392|FG001|Overall Study|Withdrawal by Subject|4|||
130113266|NCT00671879|468375393|FG002|Overall Study|Withdrawal by Subject|6|||
130113267|NCT04633837|468375394|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
130113268|NCT04633837|468375395|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
130113269|NCT00901628|468375396|FG000|Overall Study|disconnection of catheter|4|||
130113270|NCT00901628|468375397|FG001|Overall Study|disconnection of catheter|8|||
130113271|NCT00901628|468375396|FG000|Overall Study|disconnection of drain|0|||
130113272|NCT00901628|468375397|FG001|Overall Study|disconnection of drain|1|||
130113273|NCT00901628|468375396|FG000|Overall Study|peroneal nerve palsy|0|||
130113274|NCT00901628|468375397|FG001|Overall Study|peroneal nerve palsy|1|||
130113275|NCT01909466|468375405|FG000|Overall Study|Lost to Follow-up|5|||
130113276|NCT01909466|468375406|FG001|Overall Study|Lost to Follow-up|7|||
130113277|NCT01909466|468375405|FG000|Overall Study|Adverse Event|3|||
130113278|NCT01909466|468375406|FG001|Overall Study|Adverse Event|4|||
130113279|NCT01909466|468375405|FG000|Overall Study|Met Withdrawal Criteria|0|||
130113280|NCT01909466|468375406|FG001|Overall Study|Met Withdrawal Criteria|3|||
130113281|NCT01909466|468375405|FG000|Overall Study|Physician Decision|2|||
130113282|NCT01909466|468375406|FG001|Overall Study|Physician Decision|0|||
130113283|NCT01909466|468375405|FG000|Overall Study|Withdrawal by Subject|11|||
130113284|NCT01909466|468375406|FG001|Overall Study|Withdrawal by Subject|9|||
130113285|NCT01909466|468375405|FG000|Overall Study|Lack of Efficacy|1|||
130113286|NCT01909466|468375406|FG001|Overall Study|Lack of Efficacy|0|||
129835507|NCT04476030|467364200|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
129835508|NCT04476030|467364201|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
129835509|NCT04476030|467364200|FG000|Overall Study|Randomized but not Dosed|2|||
129835510|NCT04476030|467364201|FG001|Overall Study|Randomized but not Dosed|8|||
129835511|NCT02256891|467364208|FG000|Overall Study|Death|0|||
130113287|NCT01339910|468375407|FG000|Overall Study|Withdrawal by Subject|1|||
130113288|NCT01339910|468375408|FG001|Overall Study|Withdrawal by Subject|0|||
130113289|NCT01339910|468375407|FG000|Overall Study|Physician Decision|1|||
130113290|NCT01339910|468375408|FG001|Overall Study|Physician Decision|0|||
130113291|NCT01339910|468375407|FG000|Overall Study|Disease relapse|1|||
130113292|NCT01339910|468375408|FG001|Overall Study|Disease relapse|4|||
130113293|NCT01567306|468375412|FG000|Overall Study|Protocol Violation|2|||
130113294|NCT01567306|468375413|FG001|Overall Study|Protocol Violation|2|||
130113295|NCT01567306|468375414|FG002|Overall Study|Protocol Violation|0|||
130113296|NCT01567306|468375415|FG003|Overall Study|Protocol Violation|3|||
130113297|NCT01567306|468375416|FG004|Overall Study|Protocol Violation|1|||
130113298|NCT01567306|468375417|FG005|Overall Study|Protocol Violation|1|||
130113299|NCT01567306|468375412|FG000|Overall Study|Change site living|1|||
130113300|NCT01567306|468375413|FG001|Overall Study|Change site living|0|||
130113301|NCT01567306|468375414|FG002|Overall Study|Change site living|0|||
130113302|NCT01567306|468375415|FG003|Overall Study|Change site living|0|||
130113303|NCT01567306|468375416|FG004|Overall Study|Change site living|0|||
130113304|NCT01567306|468375417|FG005|Overall Study|Change site living|0|||
130113305|NCT01567306|468375412|FG000|Overall Study|Adverse Event|0|||
130113306|NCT01567306|468375413|FG001|Overall Study|Adverse Event|0|||
130113307|NCT01567306|468375414|FG002|Overall Study|Adverse Event|0|||
130113308|NCT01567306|468375415|FG003|Overall Study|Adverse Event|2|||
130113309|NCT01567306|468375416|FG004|Overall Study|Adverse Event|4|||
130113310|NCT01567306|468375417|FG005|Overall Study|Adverse Event|1|||
130113311|NCT01567306|468375412|FG000|Overall Study|Lost to Follow-up|0|||
130113312|NCT01567306|468375413|FG001|Overall Study|Lost to Follow-up|0|||
130113313|NCT01567306|468375414|FG002|Overall Study|Lost to Follow-up|0|||
130113314|NCT01567306|468375415|FG003|Overall Study|Lost to Follow-up|0|||
130113315|NCT01567306|468375416|FG004|Overall Study|Lost to Follow-up|2|||
130113316|NCT01567306|468375417|FG005|Overall Study|Lost to Follow-up|0|||
130113317|NCT01567306|468375412|FG000|Overall Study|Withdrawal by Subject|0|||
130113318|NCT01567306|468375413|FG001|Overall Study|Withdrawal by Subject|0|||
130113319|NCT01567306|468375414|FG002|Overall Study|Withdrawal by Subject|0|||
130113320|NCT01567306|468375415|FG003|Overall Study|Withdrawal by Subject|0|||
130113321|NCT01567306|468375416|FG004|Overall Study|Withdrawal by Subject|0|||
130113322|NCT01567306|468375417|FG005|Overall Study|Withdrawal by Subject|1|||
130113323|NCT00738673|468375420|FG000|Overall Study|Adverse Event|1|||
130113324|NCT00738673|468375421|FG001|Overall Study|Adverse Event|0|||
130113325|NCT00738673|468375420|FG000|Overall Study|Lack of Efficacy|19|||
130113326|NCT00738673|468375421|FG001|Overall Study|Lack of Efficacy|8|||
130113327|NCT00738673|468375420|FG000|Overall Study|Protocol Violation|1|||
130113328|NCT00738673|468375421|FG001|Overall Study|Protocol Violation|2|||
130113329|NCT00738673|468375420|FG000|Overall Study|Withdrawal by Subject|3|||
130113330|NCT00738673|468375421|FG001|Overall Study|Withdrawal by Subject|1|||
130113331|NCT02736227|468375424|FG000|Overall Study|Withdrawal by Subject|0|||
130113332|NCT02736227|468375425|FG001|Overall Study|Withdrawal by Subject|0|||
130113333|NCT02736227|468375426|FG002|Overall Study|Withdrawal by Subject|1|||
130113334|NCT02736227|468375424|FG000|Overall Study|Physician Decision|0|||
130113335|NCT02736227|468375425|FG001|Overall Study|Physician Decision|0|||
130113336|NCT02736227|468375426|FG002|Overall Study|Physician Decision|5|||
130113337|NCT02736227|468375424|FG000|Overall Study|Non Compliant|0|||
130113338|NCT02736227|468375425|FG001|Overall Study|Non Compliant|0|||
130113339|NCT02736227|468375426|FG002|Overall Study|Non Compliant|2|||
130113340|NCT04120194|468375427|FG000|Overall Study|Lost to Follow-up|11|||
130113341|NCT04120194|468375428|FG001|Overall Study|Lost to Follow-up|8|||
130113342|NCT04120194|468375427|FG000|Overall Study|Adverse Event|4|||
130113343|NCT04120194|468375428|FG001|Overall Study|Adverse Event|5|||
130113344|NCT04120194|468375427|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
130113345|NCT04120194|468375428|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
130113346|NCT04120194|468375427|FG000|Overall Study|Miscellaneous|4|||
130113347|NCT04120194|468375428|FG001|Overall Study|Miscellaneous|5|||
130113348|NCT01159769|468375429|FG000|Overall Study|Adverse Event|1|||
130113349|NCT02555618|468375430|FG000|Overall Study|Sponsor's Circumstances|1|||
130113350|NCT02555618|468375431|FG001|Overall Study|Sponsor's Circumstances|0|||
130113351|NCT02063698|468375432|FG000|Overall Study|did not complete booklet for days 2-8|1|||
130113352|NCT02063698|468375433|FG001|Overall Study|did not complete booklet for days 2-8|2|||
130113353|NCT01953783|468375434|FG000|Overall Study|Progressive disease|2|||
130113354|NCT00686920|468375435|FG000|Overall Study|Death|45|||
129835512|NCT02256891|467364209|FG001|Overall Study|Death|2|||
129835513|NCT02256891|467364208|FG000|Overall Study|Lost to Follow-up|0|||
129835514|NCT02256891|467364209|FG001|Overall Study|Lost to Follow-up|3|||
130113355|NCT00686920|468375436|FG001|Overall Study|Death|14|||
130113356|NCT00686920|468375435|FG000|Overall Study|Liver Transplant|23|||
130113357|NCT00686920|468375436|FG001|Overall Study|Liver Transplant|8|||
130113358|NCT00686920|468375435|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
130113359|NCT00686920|468375436|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
130113360|NCT00686920|468375435|FG000|Overall Study|Withdrawal by Subject|23|||
130113361|NCT00686920|468375436|FG001|Overall Study|Withdrawal by Subject|5|||
130113362|NCT00686920|468375435|FG000|Overall Study|Protocol Violation|2|||
130113363|NCT00686920|468375436|FG001|Overall Study|Protocol Violation|1|||
130113364|NCT00686920|468375435|FG000|Overall Study|Adverse Event|10|||
130113365|NCT00686920|468375436|FG001|Overall Study|Adverse Event|2|||
130113366|NCT00686920|468375435|FG000|Overall Study|Personal Reason|0|||
130113367|NCT00686920|468375436|FG001|Overall Study|Personal Reason|1|||
130113368|NCT00686920|468375435|FG000|Overall Study|Lost to Follow-up|15|||
130113369|NCT00686920|468375436|FG001|Overall Study|Lost to Follow-up|3|||
130113370|NCT00686920|468375435|FG000|Overall Study|Moved to Another State|1|||
130113371|NCT00686920|468375436|FG001|Overall Study|Moved to Another State|0|||
130113372|NCT00686920|468375435|FG000|Overall Study|Transferred to Nursing Home|1|||
130113373|NCT00686920|468375436|FG001|Overall Study|Transferred to Nursing Home|0|||
130113374|NCT00686920|468375435|FG000|Overall Study|Noncompliance|9|||
130113375|NCT00686920|468375436|FG001|Overall Study|Noncompliance|0|||
130113376|NCT00686920|468375435|FG000|Overall Study|Principal Investigator Decision|2|||
130113377|NCT00686920|468375436|FG001|Overall Study|Principal Investigator Decision|0|||
130113378|NCT00591253|468375439|FG000|Overall Study|Adverse Event|3|||
130113379|NCT00591253|468375440|FG001|Overall Study|Adverse Event|3|||
130113380|NCT00591253|468375441|FG002|Overall Study|Adverse Event|1|||
130113381|NCT00591253|468375439|FG000|Overall Study|Protocol Violation|2|||
130113382|NCT00591253|468375440|FG001|Overall Study|Protocol Violation|2|||
130113383|NCT00591253|468375441|FG002|Overall Study|Protocol Violation|2|||
130113384|NCT00591253|468375439|FG000|Overall Study|Lost to Follow-up|2|||
130113385|NCT00591253|468375440|FG001|Overall Study|Lost to Follow-up|4|||
129835515|NCT02256891|467364208|FG000|Overall Study|Physician Decision|7|||
129835516|NCT02256891|467364209|FG001|Overall Study|Physician Decision|3|||
129835517|NCT02256891|467364208|FG000|Overall Study|Screen Fail|5|||
129835518|NCT02256891|467364209|FG001|Overall Study|Screen Fail|4|||
129835519|NCT02256891|467364208|FG000|Overall Study|Equipment Malfunction|0|||
129835520|NCT02256891|467364209|FG001|Overall Study|Equipment Malfunction|1|||
129835521|NCT01344447|467364210|FG000|Overall Study|Adverse Event|1|||
129835522|NCT01344447|467364210|FG000|Overall Study|Protocol Violation|1|||
129835523|NCT01344447|467364210|FG000|Overall Study|Withdrawal by Subject|1|||
129835524|NCT01344447|467364210|FG000|Overall Study|The contrast was not seen|1|||
129835525|NCT01344447|467364210|FG000|Overall Study|Physician Decision|1|||
129835526|NCT01344447|467364210|FG000|Overall Study|MRA unsuccessful|1|||
129835527|NCT01344447|467364210|FG000|Overall Study|Bolus tracking failed|1|||
129835528|NCT01344447|467364210|FG000|Overall Study|Error of power injector|1|||
129835529|NCT04214288|467364219|FG000|Overall Study|Ongoing in the study|41|||
129835530|NCT04214288|467364220|FG001|Overall Study|Ongoing in the study|51|||
129835531|NCT04214288|467364221|FG002|Overall Study|Ongoing in the study|12|||
129835532|NCT04214288|467364222|FG003|Overall Study|Ongoing in the study|39|||
129835533|NCT04214288|467364219|FG000|Overall Study|Adverse Event|1|||
129835534|NCT04214288|467364220|FG001|Overall Study|Adverse Event|0|||
129835535|NCT04214288|467364221|FG002|Overall Study|Adverse Event|0|||
129835536|NCT04214288|467364222|FG003|Overall Study|Adverse Event|0|||
129835537|NCT04214288|467364219|FG000|Overall Study|Death|22|||
129835538|NCT04214288|467364220|FG001|Overall Study|Death|13|||
129835539|NCT04214288|467364221|FG002|Overall Study|Death|7|||
129835540|NCT04214288|467364222|FG003|Overall Study|Death|19|||
129835541|NCT04214288|467364219|FG000|Overall Study|Lost to Follow-up|1|||
129835542|NCT04214288|467364220|FG001|Overall Study|Lost to Follow-up|2|||
129835543|NCT04214288|467364221|FG002|Overall Study|Lost to Follow-up|1|||
129835544|NCT04214288|467364222|FG003|Overall Study|Lost to Follow-up|0|||
129835545|NCT04214288|467364219|FG000|Overall Study|Other|1|||
129835546|NCT04214288|467364220|FG001|Overall Study|Other|2|||
129835547|NCT04214288|467364221|FG002|Overall Study|Other|0|||
129835548|NCT04214288|467364222|FG003|Overall Study|Other|6|||
129835549|NCT04214288|467364219|FG000|Overall Study|Protocol Violation|0|||
129835550|NCT04214288|467364220|FG001|Overall Study|Protocol Violation|1|||
129835551|NCT04214288|467364221|FG002|Overall Study|Protocol Violation|0|||
129897979|NCT00567164|467586542|FG001|Overall Study|Withdrawal by Subject|21|||
129897980|NCT00567164|467586543|FG002|Overall Study|Withdrawal by Subject|17|||
129897981|NCT00567164|467586541|FG000|Overall Study|Protocol Violation|23|||
129897982|NCT00567164|467586542|FG001|Overall Study|Protocol Violation|4|||
129897983|NCT00567164|467586543|FG002|Overall Study|Protocol Violation|2|||
129897984|NCT00567164|467586541|FG000|Overall Study|Adverse Event|92|||
129897985|NCT00567164|467586542|FG001|Overall Study|Adverse Event|13|||
129897986|NCT00567164|467586543|FG002|Overall Study|Adverse Event|9|||
129897987|NCT00567164|467586541|FG000|Overall Study|Death|0|||
129897988|NCT00567164|467586542|FG001|Overall Study|Death|0|||
129897989|NCT00567164|467586543|FG002|Overall Study|Death|1|||
129897990|NCT00567164|467586541|FG000|Overall Study|Lost to Follow-up|202|||
129897991|NCT00567164|467586542|FG001|Overall Study|Lost to Follow-up|23|||
129897992|NCT00567164|467586543|FG002|Overall Study|Lost to Follow-up|21|||
129835552|NCT04214288|467364222|FG003|Overall Study|Protocol Violation|0|||
129897993|NCT00567164|467586541|FG000|Overall Study|Pregnancy|20|||
129897994|NCT00567164|467586542|FG001|Overall Study|Pregnancy|4|||
129897995|NCT00567164|467586543|FG002|Overall Study|Pregnancy|6|||
129897996|NCT00567164|467586541|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
129835553|NCT04214288|467364219|FG000|Overall Study|Withdrawal by Subject|8|||
129835554|NCT04214288|467364220|FG001|Overall Study|Withdrawal by Subject|4|||
129835555|NCT04214288|467364221|FG002|Overall Study|Withdrawal by Subject|0|||
129835556|NCT04214288|467364222|FG003|Overall Study|Withdrawal by Subject|9|||
129835557|NCT01990495|467364229|FG000|Overall Study|Physician Decision|5|||
129835558|NCT01990495|467364230|FG001|Overall Study|Physician Decision|4|||
129835559|NCT01928862|467364231|FG000|Overall Study|Lost to Follow-up|1|||
129835560|NCT01928862|467364232|FG001|Overall Study|Lost to Follow-up|0|||
129835561|NCT01928862|467364233|FG002|Overall Study|Lost to Follow-up|0|||
129897997|NCT00567164|467586542|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
130113386|NCT00591253|468375441|FG002|Overall Study|Lost to Follow-up|0|||
130113387|NCT00591253|468375439|FG000|Overall Study|Withdrawal by Subject|1|||
129835562|NCT01928862|467364234|FG003|Overall Study|Lost to Follow-up|0|||
129835563|NCT01928862|467364235|FG004|Overall Study|Lost to Follow-up|1|||
129835564|NCT04649164|467364236|FG000|Overall Study|Withdrawal by Subject|1|||
129835565|NCT04649164|467364237|FG001|Overall Study|Withdrawal by Subject|1|||
129835566|NCT04649164|467364238|FG002|Overall Study|Withdrawal by Subject|2|||
130061123|NCT00621855|468178807|FG004|Overall Study|Protocol Violation|8|||
130061124|NCT00621855|468178803|FG000|Overall Study|Withdrawal by Subject|16|||
130061125|NCT00621855|468178804|FG001|Overall Study|Withdrawal by Subject|11|||
130061126|NCT00621855|468178805|FG002|Overall Study|Withdrawal by Subject|13|||
130061127|NCT00621855|468178806|FG003|Overall Study|Withdrawal by Subject|13|||
130061128|NCT00621855|468178807|FG004|Overall Study|Withdrawal by Subject|9|||
130061129|NCT00621855|468178803|FG000|Overall Study|Other|9|||
130061130|NCT00621855|468178804|FG001|Overall Study|Other|7|||
130061131|NCT00621855|468178805|FG002|Overall Study|Other|6|||
130061132|NCT00621855|468178806|FG003|Overall Study|Other|5|||
130061133|NCT00621855|468178807|FG004|Overall Study|Other|4|||
130061134|NCT00621855|468178803|FG000|Overall Study|Patients did not receive study drug|3|||
130061135|NCT00621855|468178804|FG001|Overall Study|Patients did not receive study drug|3|||
130061136|NCT00621855|468178805|FG002|Overall Study|Patients did not receive study drug|5|||
130061137|NCT00621855|468178806|FG003|Overall Study|Patients did not receive study drug|4|||
130061138|NCT00621855|468178807|FG004|Overall Study|Patients did not receive study drug|2|||
130061139|NCT02953782|468178808|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
130061140|NCT02953782|468178809|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
130061141|NCT02953782|468178810|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
130061142|NCT02953782|468178811|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
130061143|NCT02953782|468178812|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
130061144|NCT02953782|468178813|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
130061145|NCT02953782|468178814|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
130061146|NCT02953782|468178815|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
130061147|NCT02953782|468178808|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
130061148|NCT02953782|468178809|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130061149|NCT02953782|468178810|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
130061150|NCT02953782|468178811|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130061151|NCT02953782|468178812|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
130061152|NCT02953782|468178813|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130061153|NCT02953782|468178814|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130061154|NCT02953782|468178815|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
130061155|NCT02953782|468178808|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130061156|NCT02953782|468178809|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
130061157|NCT02953782|468178810|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130061158|NCT02953782|468178811|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
130061159|NCT02953782|468178812|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
130061160|NCT02953782|468178813|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130061161|NCT02953782|468178814|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130061162|NCT02953782|468178815|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
130061163|NCT02953782|468178808|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130061164|NCT02953782|468178809|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130061165|NCT02953782|468178810|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
130061166|NCT02953782|468178811|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
130061167|NCT02953782|468178812|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130061168|NCT02953782|468178813|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130061169|NCT02953782|468178814|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130061170|NCT02953782|468178815|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
130061171|NCT02953782|468178808|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130061172|NCT02953782|468178809|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130061173|NCT02953782|468178810|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130061174|NCT02953782|468178811|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130061175|NCT02953782|468178812|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
130061176|NCT02953782|468178813|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
130061177|NCT02953782|468178814|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
130061178|NCT02953782|468178815|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
130061179|NCT02953782|468178808|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130113388|NCT00591253|468375440|FG001|Overall Study|Withdrawal by Subject|7|||
130113389|NCT00591253|468375441|FG002|Overall Study|Withdrawal by Subject|6|||
129835567|NCT04649164|467364236|FG000|Overall Study|Participant's care recipient expired|0|||
129835568|NCT04649164|467364237|FG001|Overall Study|Participant's care recipient expired|0|||
129835569|NCT04649164|467364238|FG002|Overall Study|Participant's care recipient expired|2|||
129835570|NCT03168464|467364239|FG000|Overall Study|Death|9|||
129835571|NCT03168464|467364239|FG000|Overall Study|Progression of disease|6|||
129835572|NCT02286193|467364244|FG000|Overall Study|Referred: CRS unable to make contact|62|||
129835573|NCT02286193|467364244|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
129835574|NCT02286193|467364244|FG000|Overall Study|Referred: Declined service|38|||
129835575|NCT02932904|467364245|FG000|Overall Study|Reason not Specified|1|||
129835576|NCT02932904|467364246|FG001|Overall Study|Reason not Specified|0|||
129835577|NCT02932904|467364247|FG002|Overall Study|Reason not Specified|2|||
129835578|NCT02932904|467364248|FG003|Overall Study|Reason not Specified|2|||
129835579|NCT02932904|467364245|FG000|Overall Study|Noncompliance with Study Drug|2|||
129835580|NCT02932904|467364246|FG001|Overall Study|Noncompliance with Study Drug|3|||
129835581|NCT02932904|467364247|FG002|Overall Study|Noncompliance with Study Drug|3|||
129835582|NCT02932904|467364248|FG003|Overall Study|Noncompliance with Study Drug|4|||
129835583|NCT02932904|467364245|FG000|Overall Study|Pregnancy|0|||
129835584|NCT02932904|467364246|FG001|Overall Study|Pregnancy|1|||
129835585|NCT02932904|467364247|FG002|Overall Study|Pregnancy|1|||
129835586|NCT02932904|467364248|FG003|Overall Study|Pregnancy|0|||
129835587|NCT02932904|467364245|FG000|Overall Study|Study Termination|0|||
129835588|NCT02932904|467364246|FG001|Overall Study|Study Termination|1|||
129835589|NCT02932904|467364247|FG002|Overall Study|Study Termination|0|||
129835590|NCT02932904|467364248|FG003|Overall Study|Study Termination|0|||
129835591|NCT02932904|467364245|FG000|Overall Study|Voluntary Withdrawal|2|||
129835592|NCT02932904|467364246|FG001|Overall Study|Voluntary Withdrawal|1|||
129835593|NCT02932904|467364247|FG002|Overall Study|Voluntary Withdrawal|4|||
129835594|NCT02932904|467364248|FG003|Overall Study|Voluntary Withdrawal|2|||
129835595|NCT02932904|467364245|FG000|Overall Study|Lost to Follow-up|5|||
129835596|NCT02932904|467364246|FG001|Overall Study|Lost to Follow-up|3|||
129835597|NCT02932904|467364247|FG002|Overall Study|Lost to Follow-up|6|||
129835598|NCT02932904|467364248|FG003|Overall Study|Lost to Follow-up|0|||
129835599|NCT02932904|467364245|FG000|Overall Study|Significant Protocol Deviation|2|||
129835600|NCT02932904|467364246|FG001|Overall Study|Significant Protocol Deviation|3|||
129835601|NCT02932904|467364247|FG002|Overall Study|Significant Protocol Deviation|6|||
129835602|NCT02932904|467364248|FG003|Overall Study|Significant Protocol Deviation|1|||
129835603|NCT02932904|467364245|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129835604|NCT02932904|467364246|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
129835605|NCT02932904|467364247|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129835606|NCT02932904|467364248|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
129835607|NCT02932904|467364245|FG000|Overall Study|Randomized But Not Treated|1|||
129835608|NCT02932904|467364246|FG001|Overall Study|Randomized But Not Treated|1|||
129835609|NCT02932904|467364247|FG002|Overall Study|Randomized But Not Treated|0|||
129835610|NCT02932904|467364248|FG003|Overall Study|Randomized But Not Treated|2|||
129835611|NCT00337103|467364249|FG000|Overall Study|Progressive Disease|414|||
129835612|NCT00337103|467364250|FG001|Overall Study|Progressive Disease|410|||
129835613|NCT00337103|467364249|FG000|Overall Study|Adverse Event|45|||
129835614|NCT00337103|467364250|FG001|Overall Study|Adverse Event|59|||
129835615|NCT00337103|467364249|FG000|Overall Study|Subject Choice|34|||
129835616|NCT00337103|467364250|FG001|Overall Study|Subject Choice|27|||
129835617|NCT00337103|467364249|FG000|Overall Study|Clinical Progression|27|||
129835618|NCT00337103|467364250|FG001|Overall Study|Clinical Progression|24|||
129835619|NCT00337103|467364249|FG000|Overall Study|Physician Decision|15|||
129835620|NCT00337103|467364250|FG001|Overall Study|Physician Decision|14|||
129835621|NCT00337103|467364249|FG000|Overall Study|Withdrawal by Subject|8|||
129835622|NCT00337103|467364250|FG001|Overall Study|Withdrawal by Subject|5|||
129835623|NCT00337103|467364249|FG000|Overall Study|Other|5|||
129835624|NCT00337103|467364250|FG001|Overall Study|Other|6|||
129835625|NCT00337103|467364249|FG000|Overall Study|Entry Criteria Not Met|4|||
129835626|NCT00337103|467364250|FG001|Overall Study|Entry Criteria Not Met|1|||
129835627|NCT00337103|467364249|FG000|Overall Study|Lost to Follow-up|1|||
129835628|NCT00337103|467364250|FG001|Overall Study|Lost to Follow-up|2|||
129835629|NCT00337103|467364249|FG000|Overall Study|Death|1|||
129835630|NCT00337103|467364250|FG001|Overall Study|Death|0|||
129835631|NCT01577758|467364251|FG000|Dose Escalation Phase|Adverse Event|0|||
129835632|NCT01577758|467364252|FG001|Dose Escalation Phase|Adverse Event|0|||
129835633|NCT01577758|467364253|FG002|Dose Escalation Phase|Adverse Event|0|||
129835634|NCT01577758|467364254|FG003|Dose Escalation Phase|Adverse Event|0|||
129835635|NCT01577758|467364255|FG004|Dose Escalation Phase|Adverse Event|0|||
129835636|NCT01577758|467364256|FG005|Dose Escalation Phase|Adverse Event|2|||
129835637|NCT01577758|467364257|FG006|Dose Escalation Phase|Adverse Event|1|||
129835638|NCT01577758|467364258|FG007|Dose Escalation Phase|Adverse Event|0|||
129835639|NCT01577758|467364251|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835640|NCT01577758|467364252|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835641|NCT01577758|467364253|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
129835642|NCT01577758|467364254|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835643|NCT01577758|467364255|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
129835644|NCT01577758|467364256|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
129835645|NCT01577758|467364257|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835646|NCT01577758|467364258|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835647|NCT01577758|467364251|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129835648|NCT01577758|467364252|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129835649|NCT01577758|467364253|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129835650|NCT01577758|467364254|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129835651|NCT01577758|467364255|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
129835652|NCT01577758|467364256|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
129835653|NCT01577758|467364257|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
130061180|NCT02953782|468178809|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130061181|NCT02953782|468178810|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130061182|NCT02953782|468178811|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130061183|NCT02953782|468178812|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
130061184|NCT02953782|468178813|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
130061185|NCT02953782|468178814|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
130061186|NCT02953782|468178815|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
130061187|NCT02953782|468178808|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130061188|NCT02953782|468178809|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130061189|NCT02953782|468178810|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130061190|NCT02953782|468178811|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130061191|NCT02953782|468178812|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
130061192|NCT02953782|468178813|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
130061193|NCT02953782|468178814|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
130061194|NCT02953782|468178815|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
130061195|NCT02953782|468178808|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061196|NCT02953782|468178809|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061197|NCT02953782|468178810|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061198|NCT02953782|468178811|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061199|NCT02953782|468178812|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061200|NCT02953782|468178813|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061201|NCT02953782|468178814|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
130061202|NCT02953782|468178815|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
130061203|NCT01737840|468178816|FG000|Overall Study|Diagnosed with an other pathology|2|||
130061204|NCT01737840|468178817|FG001|Overall Study|Diagnosed with an other pathology|2|||
130061205|NCT03105700|468178820|FG000|Overall Study|screen fail|3|||
130061206|NCT03105700|468178820|FG000|Overall Study|Lost to Follow-up|4|||
130061207|NCT00403559|468178821|FG000|Overall Study|Adverse Event|0|||
130061208|NCT00403559|468178822|FG001|Overall Study|Adverse Event|1|||
130061209|NCT00403559|468178821|FG000|Overall Study|Lost to Follow-up|3|||
130061210|NCT00403559|468178822|FG001|Overall Study|Lost to Follow-up|3|||
130061211|NCT00403559|468178821|FG000|Overall Study|Withdrawal by Subject|1|||
130061212|NCT00403559|468178822|FG001|Overall Study|Withdrawal by Subject|0|||
130061213|NCT01253421|468178823|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
130061214|NCT01253421|468178824|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
130061215|NCT01253421|468178825|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
130061216|NCT01253421|468178826|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
130113390|NCT00591253|468375439|FG000|Overall Study|Lack of Efficacy|1|||
130113391|NCT00591253|468375440|FG001|Overall Study|Lack of Efficacy|0|||
130113392|NCT00591253|468375441|FG002|Overall Study|Lack of Efficacy|3|||
130113393|NCT00591253|468375439|FG000|Overall Study|Other|5|||
130113394|NCT00591253|468375440|FG001|Overall Study|Other|5|||
130113395|NCT00591253|468375441|FG002|Overall Study|Other|3|||
130113396|NCT03811249|468375442|FG000|Overall Study|Withdrawal by Subject|44|||
130113397|NCT03811249|468375442|FG000|Overall Study|Missed Visit|24|||
130113398|NCT01783730|468375443|FG000|Overall Study|Failed to meet inclusion criteria|6|||
130113399|NCT01841359|468375444|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
130113400|NCT01841359|468375444|FG000|Overall Study|Concommitant medical issues|2|||
130113401|NCT01841359|468375444|FG000|Overall Study|Adverse Event|3|||
130113402|NCT01841359|468375444|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
130113403|NCT02151461|468375445|FG000|Overall Study|Adverse Event|5|||
130113404|NCT02151461|468375446|FG001|Overall Study|Adverse Event|1|||
130113405|NCT02151461|468375447|FG002|Overall Study|Adverse Event|0|||
130113406|NCT02151461|468375448|FG003|Overall Study|Adverse Event|2|||
129835654|NCT01577758|467364258|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
129835655|NCT01577758|467364251|FG000|Dose Escalation Phase|Progression Disease|2|||
130061217|NCT01253421|468178827|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
130113407|NCT02151461|468375445|FG000|Overall Study|Lost to Follow-up|0|||
130113408|NCT02151461|468375446|FG001|Overall Study|Lost to Follow-up|0|||
130113409|NCT02151461|468375447|FG002|Overall Study|Lost to Follow-up|1|||
130113410|NCT02151461|468375448|FG003|Overall Study|Lost to Follow-up|1|||
129835656|NCT01577758|467364252|FG001|Dose Escalation Phase|Progression Disease|2|||
129835657|NCT01577758|467364253|FG002|Dose Escalation Phase|Progression Disease|1|||
129835658|NCT01577758|467364254|FG003|Dose Escalation Phase|Progression Disease|2|||
129835659|NCT01577758|467364255|FG004|Dose Escalation Phase|Progression Disease|5|||
129835660|NCT01577758|467364256|FG005|Dose Escalation Phase|Progression Disease|0|||
129835661|NCT01577758|467364257|FG006|Dose Escalation Phase|Progression Disease|0|||
129835662|NCT01577758|467364258|FG007|Dose Escalation Phase|Progression Disease|0|||
129835663|NCT01577758|467364251|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835664|NCT01577758|467364252|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835665|NCT01577758|467364253|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835666|NCT01577758|467364254|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835667|NCT01577758|467364255|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835668|NCT01577758|467364256|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
130061218|NCT01253421|468178823|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
130061219|NCT01253421|468178824|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
130061220|NCT01253421|468178825|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
130061221|NCT01253421|468178826|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
130061222|NCT01253421|468178827|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
130061223|NCT01253421|468178823|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
130061224|NCT01253421|468178824|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
130061225|NCT01253421|468178825|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
130061226|NCT01253421|468178826|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
130061227|NCT01253421|468178827|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
130061228|NCT01253421|468178823|FG000|Assessment and Scheduling|Physician Decision|1|||
130061229|NCT01253421|468178824|FG001|Assessment and Scheduling|Physician Decision|0|||
130061230|NCT01253421|468178825|FG002|Assessment and Scheduling|Physician Decision|0|||
130061231|NCT01253421|468178826|FG003|Assessment and Scheduling|Physician Decision|0|||
130061232|NCT01253421|468178827|FG004|Assessment and Scheduling|Physician Decision|0|||
130061233|NCT01253421|468178823|FG000|Drug+Scanning Visit|Physician Decision|0|||
130061234|NCT01253421|468178824|FG001|Drug+Scanning Visit|Physician Decision|0|||
130061235|NCT01253421|468178825|FG002|Drug+Scanning Visit|Physician Decision|0|||
130061236|NCT01253421|468178826|FG003|Drug+Scanning Visit|Physician Decision|0|||
130061237|NCT01253421|468178827|FG004|Drug+Scanning Visit|Physician Decision|1|||
130061238|NCT00929734|468178828|FG000|Overall Study|Lost to Follow-up|2|||
130061239|NCT00929734|468178829|FG001|Overall Study|Lost to Follow-up|1|||
130061240|NCT00929734|468178828|FG000|Overall Study|Withdrawal by Subject|0|||
130061241|NCT00929734|468178829|FG001|Overall Study|Withdrawal by Subject|2|||
130061242|NCT00980980|468178831|FG000|Overall Study|Withdrawal by Hospital|0|||
130061243|NCT00980980|468178832|FG001|Overall Study|Withdrawal by Hospital|1|||
130061244|NCT00980980|468178833|FG002|Overall Study|Withdrawal by Hospital|0|||
130061245|NCT00121992|468178834|FG000|Overall Study|Treatment not received|2|||
130061246|NCT00121992|468178835|FG001|Overall Study|Treatment not received|11|||
130061247|NCT01449682|468178836|FG000|Overall Study|Death|0|||
130061248|NCT01449682|468178837|FG001|Overall Study|Death|1|||
130061249|NCT01449682|468178836|FG000|Overall Study|Adverse Event|1|||
130061250|NCT01449682|468178837|FG001|Overall Study|Adverse Event|0|||
130061251|NCT04863014|468178838|FG000|Overall Study|Lost to Follow-up|3|||
130061252|NCT04863014|468178839|FG001|Overall Study|Lost to Follow-up|2|||
130061253|NCT04863014|468178838|FG000|Overall Study|Subject Decision|0|||
130061254|NCT04863014|468178839|FG001|Overall Study|Subject Decision|4|||
130061255|NCT04633473|468178840|FG000|Overall Study|Withdrawal by Subject|6|||
130061256|NCT00264849|468178841|FG000|Overall Study|Adverse Event|7|||
130061257|NCT00264849|468178842|FG001|Overall Study|Adverse Event|2|||
130061258|NCT00264849|468178841|FG000|Overall Study|Withdrawal by Subject|7|||
130061259|NCT00264849|468178842|FG001|Overall Study|Withdrawal by Subject|11|||
130061260|NCT00264849|468178841|FG000|Overall Study|Protocol Violation|5|||
130061261|NCT00264849|468178842|FG001|Overall Study|Protocol Violation|3|||
130061262|NCT00264849|468178841|FG000|Overall Study|Lack of Efficacy|1|||
130061263|NCT00264849|468178842|FG001|Overall Study|Lack of Efficacy|6|||
130061264|NCT00264849|468178841|FG000|Overall Study|Lost to Follow-up|0|||
129835669|NCT01577758|467364257|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835670|NCT01577758|467364258|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
129835671|NCT01577758|467364251|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835672|NCT01577758|467364252|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835673|NCT01577758|467364253|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835674|NCT01577758|467364254|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835675|NCT01577758|467364255|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835676|NCT01577758|467364256|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835677|NCT01577758|467364257|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835678|NCT01577758|467364258|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
130061265|NCT00264849|468178842|FG001|Overall Study|Lost to Follow-up|2|||
129835679|NCT01577758|467364251|FG000|mCRC Expansion Phase|Progression Disease|0|||
130061266|NCT00264849|468178841|FG000|Overall Study|Death|0|||
130061267|NCT00264849|468178842|FG001|Overall Study|Death|1|||
130061268|NCT00264849|468178841|FG000|Overall Study|Administrative Problems|2|||
130061269|NCT00264849|468178842|FG001|Overall Study|Administrative Problems|0|||
130061270|NCT00099359|468178845|FG000|Overall Study|Death|11|||
130113411|NCT02151461|468375445|FG000|Overall Study|Withdrawal by Subject|1|||
130113412|NCT02151461|468375446|FG001|Overall Study|Withdrawal by Subject|0|||
130113413|NCT02151461|468375447|FG002|Overall Study|Withdrawal by Subject|1|||
130113414|NCT02151461|468375448|FG003|Overall Study|Withdrawal by Subject|1|||
130113415|NCT02151461|468375445|FG000|Overall Study|Treatment discontinuation|0|||
130113416|NCT02151461|468375446|FG001|Overall Study|Treatment discontinuation|0|||
130113417|NCT02151461|468375447|FG002|Overall Study|Treatment discontinuation|1|||
129835680|NCT01577758|467364252|FG001|mCRC Expansion Phase|Progression Disease|0|||
129835681|NCT01577758|467364253|FG002|mCRC Expansion Phase|Progression Disease|0|||
129835682|NCT01577758|467364254|FG003|mCRC Expansion Phase|Progression Disease|0|||
129835683|NCT01577758|467364255|FG004|mCRC Expansion Phase|Progression Disease|0|||
129835684|NCT01577758|467364256|FG005|mCRC Expansion Phase|Progression Disease|0|||
129835685|NCT01577758|467364257|FG006|mCRC Expansion Phase|Progression Disease|0|||
129835686|NCT01577758|467364258|FG007|mCRC Expansion Phase|Progression Disease|19|||
129835687|NCT00600756|467364262|FG000|Analysis After 6 Months|Adverse Event|43|||
129835688|NCT00600756|467364263|FG001|Analysis After 6 Months|Adverse Event|33|||
129835689|NCT00600756|467364262|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
129835690|NCT00600756|467364263|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
130061271|NCT00099359|468178846|FG001|Overall Study|Death|15|||
130061272|NCT00099359|468178847|FG002|Overall Study|Death|17|||
130061273|NCT00099359|468178845|FG000|Overall Study|Withdrawal by Subject|19|||
130061274|NCT00099359|468178846|FG001|Overall Study|Withdrawal by Subject|19|||
130061275|NCT00099359|468178847|FG002|Overall Study|Withdrawal by Subject|23|||
130061276|NCT00099359|468178845|FG000|Overall Study|Lost to Follow-up|15|||
130061277|NCT00099359|468178846|FG001|Overall Study|Lost to Follow-up|24|||
130061278|NCT00099359|468178847|FG002|Overall Study|Lost to Follow-up|24|||
130061279|NCT00099359|468178845|FG000|Overall Study|moved out of area|9|||
130061280|NCT00099359|468178846|FG001|Overall Study|moved out of area|7|||
130061281|NCT00099359|468178847|FG002|Overall Study|moved out of area|4|||
130061282|NCT01822691|468178848|FG000|Overall Study|Withdrawal by Subject|2|||
130061283|NCT02756650|468178849|FG000|Overall Study|Physician Decision|1|||
130061284|NCT02756650|468178849|FG000|Overall Study|Adverse Event|1|||
130061285|NCT01553916|468178850|FG000|Overall Study|Withdrawal by Subject|2|||
130061286|NCT01553916|468178850|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
129835691|NCT00600756|467364262|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
129835692|NCT00600756|467364263|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
129835693|NCT00600756|467364262|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
129835694|NCT00600756|467364263|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
129835695|NCT00600756|467364262|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
129835696|NCT00600756|467364263|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
129835697|NCT00600756|467364262|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
129835698|NCT00600756|467364263|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
129835699|NCT00600756|467364262|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
129835700|NCT00600756|467364263|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
129835701|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
129835702|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
129835703|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
129835704|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
129835705|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
129835706|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
129835707|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
129835708|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
129835709|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
129835710|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
129835711|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
129835712|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
129835713|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
129835714|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
129835715|NCT01256593|467364264|FG000|Overall Study|Protocol Violation|26|||
129835716|NCT01256593|467364264|FG000|Overall Study|No Drug Administration Information|2|||
129835717|NCT01256593|467364264|FG000|Overall Study|No Visit After Treatment|186|||
129835718|NCT04414553|467364265|FG000|Overall Study|Lost to Follow-up|20|||
129835719|NCT03519971|467364273|FG000|Overall Study|Death|142|||
129835720|NCT03519971|467364274|FG001|Overall Study|Death|69|||
129835721|NCT03519971|467364273|FG000|Overall Study|Lost to Follow-up|0|||
129835722|NCT03519971|467364274|FG001|Overall Study|Lost to Follow-up|1|||
130061287|NCT03089216|468178853|FG000|Overall Study|Adverse Event|0|||
130061288|NCT03089216|468178854|FG001|Overall Study|Adverse Event|0|||
130061289|NCT03089216|468178855|FG002|Overall Study|Adverse Event|0|||
130113418|NCT02151461|468375448|FG003|Overall Study|Treatment discontinuation|0|||
130113419|NCT01086215|468375449|FG000|Overall Study|Death|14|||
130061290|NCT03089216|468178856|FG003|Overall Study|Adverse Event|1|||
130113420|NCT01086215|468375450|FG001|Overall Study|Death|8|||
130113421|NCT01086215|468375451|FG002|Overall Study|Death|8|||
130113422|NCT01086215|468375452|FG003|Overall Study|Death|1|||
130113423|NCT01086215|468375449|FG000|Overall Study|Lost to Follow-up|22|||
130113424|NCT01086215|468375450|FG001|Overall Study|Lost to Follow-up|39|||
130113425|NCT01086215|468375451|FG002|Overall Study|Lost to Follow-up|18|||
130113426|NCT01086215|468375452|FG003|Overall Study|Lost to Follow-up|2|||
130113427|NCT03469271|468375453|FG000|Overall Study|Withdrawal by Subject|2|||
130113428|NCT03469271|468375454|FG001|Overall Study|Withdrawal by Subject|0|||
130113429|NCT03469271|468375455|FG002|Overall Study|Withdrawal by Subject|0|||
130113430|NCT03469271|468375456|FG003|Overall Study|Withdrawal by Subject|1|||
130113431|NCT03493698|468375457|FG000|Treatment Period C|Adverse Event|1|||
130113432|NCT03493698|468375457|FG000|Treatment Period C|Withdrawal by Subject|1|||
130113433|NCT00408876|468375458|FG000|Overall Study|Adverse Event|9|||
130113434|NCT00408876|468375459|FG001|Overall Study|Adverse Event|17|||
130113435|NCT00408876|468375460|FG002|Overall Study|Adverse Event|27|||
130113436|NCT00408876|468375461|FG003|Overall Study|Adverse Event|10|||
130113437|NCT00408876|468375458|FG000|Overall Study|Withdrawal by Subject|3|||
130113438|NCT00408876|468375459|FG001|Overall Study|Withdrawal by Subject|6|||
130113439|NCT00408876|468375460|FG002|Overall Study|Withdrawal by Subject|6|||
130113440|NCT00408876|468375461|FG003|Overall Study|Withdrawal by Subject|14|||
130113441|NCT00408876|468375458|FG000|Overall Study|Lack of Efficacy|2|||
130113442|NCT00408876|468375459|FG001|Overall Study|Lack of Efficacy|4|||
130113443|NCT00408876|468375460|FG002|Overall Study|Lack of Efficacy|5|||
130113444|NCT00408876|468375461|FG003|Overall Study|Lack of Efficacy|6|||
130113445|NCT00408876|468375458|FG000|Overall Study|Lost to Follow-up|1|||
130113446|NCT00408876|468375459|FG001|Overall Study|Lost to Follow-up|6|||
130113447|NCT00408876|468375460|FG002|Overall Study|Lost to Follow-up|5|||
130113448|NCT00408876|468375461|FG003|Overall Study|Lost to Follow-up|2|||
130113449|NCT00408876|468375458|FG000|Overall Study|Protocol Violation|0|||
130113450|NCT00408876|468375459|FG001|Overall Study|Protocol Violation|3|||
130113451|NCT00408876|468375460|FG002|Overall Study|Protocol Violation|4|||
130113452|NCT00408876|468375461|FG003|Overall Study|Protocol Violation|3|||
130113453|NCT00408876|468375458|FG000|Overall Study|Physician Decision|1|||
130113454|NCT00408876|468375459|FG001|Overall Study|Physician Decision|0|||
130113455|NCT00408876|468375460|FG002|Overall Study|Physician Decision|3|||
130113456|NCT00408876|468375461|FG003|Overall Study|Physician Decision|0|||
130113457|NCT02006147|468375462|FG000|Overall Study|Protocol Violation|1|||
130113458|NCT02006147|468375463|FG001|Overall Study|Protocol Violation|1|||
130113459|NCT02006147|468375464|FG002|Overall Study|Protocol Violation|0|||
130113460|NCT02006147|468375465|FG003|Overall Study|Protocol Violation|0|||
130113461|NCT02006147|468375462|FG000|Overall Study|Withdrawal by Subject|0|||
129835723|NCT03519971|467364273|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
129835724|NCT03519971|467364274|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
129835725|NCT03519971|467364273|FG000|Overall Study|Withdrawal by Subject|3|||
129835726|NCT03519971|467364274|FG001|Overall Study|Withdrawal by Subject|2|||
129835727|NCT03519971|467364273|FG000|Overall Study|Other|1|||
129835728|NCT03519971|467364274|FG001|Overall Study|Other|0|||
129835729|NCT04544293|467364276|FG000|Double-blind|Adverse Event|2|||
129835730|NCT04544293|467364277|FG001|Double-blind|Adverse Event|1|||
129835731|NCT04544293|467364276|FG000|Double-blind|Pregnancy|0|||
129835732|NCT04544293|467364277|FG001|Double-blind|Pregnancy|1|||
129835733|NCT04544293|467364276|FG000|Double-blind|Lost to Follow-up|0|||
129835734|NCT04544293|467364277|FG001|Double-blind|Lost to Follow-up|1|||
129835735|NCT04544293|467364276|FG000|Open-Label Extension|Study ongoing|79|||
129835736|NCT04544293|467364277|FG001|Open-Label Extension|Study ongoing|81|||
129835737|NCT00642668|467364283|FG000|Overall Study|Lost to Follow-up|1|||
129835738|NCT00642668|467364283|FG000|Overall Study|Adverse Event|2|||
129835739|NCT00642668|467364283|FG000|Overall Study|Death|2|||
129835740|NCT00642668|467364283|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129835741|NCT00642668|467364283|FG000|Overall Study|Failure to Return|1|||
129835742|NCT00642668|467364283|FG000|Overall Study|Dialysis Initiation|5|||
129835743|NCT00642668|467364283|FG000|Overall Study|Blood Transfusion|2|||
129835744|NCT03608774|467364284|FG000|Overall Study|Lost to Follow-up|5|||
129835745|NCT03608774|467364285|FG001|Overall Study|Lost to Follow-up|5|||
129835746|NCT03608774|467364284|FG000|Overall Study|Withdrawal by Subject|1|||
129835747|NCT03608774|467364285|FG001|Overall Study|Withdrawal by Subject|0|||
129835748|NCT03608774|467364284|FG000|Overall Study|Protocol Violation|1|||
129835749|NCT03608774|467364285|FG001|Overall Study|Protocol Violation|0|||
130113462|NCT02006147|468375463|FG001|Overall Study|Withdrawal by Subject|1|||
130113463|NCT02006147|468375464|FG002|Overall Study|Withdrawal by Subject|0|||
130113464|NCT02006147|468375465|FG003|Overall Study|Withdrawal by Subject|0|||
130113465|NCT02006147|468375462|FG000|Overall Study|Withdrawal by Sponsor|1|||
130113466|NCT02006147|468375463|FG001|Overall Study|Withdrawal by Sponsor|0|||
130113467|NCT02006147|468375464|FG002|Overall Study|Withdrawal by Sponsor|0|||
129835750|NCT03608774|467364284|FG000|Overall Study|Not eligible at enrollment|0|||
129835751|NCT03608774|467364285|FG001|Overall Study|Not eligible at enrollment|1|||
130113468|NCT02006147|468375465|FG003|Overall Study|Withdrawal by Sponsor|0|||
130113469|NCT03361956|468375466|FG000|Overall Study|Adverse Event|1|||
129897998|NCT00567164|467586543|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
129897999|NCT00567164|467586541|FG000|Overall Study|Missing|1|||
130061291|NCT04348591|468178859|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
130061292|NCT04348591|468178860|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
130061293|NCT04348591|468178859|FG000|Imaging Session (120 Min)|Physician Decision|0|||
130061294|NCT04348591|468178860|FG001|Imaging Session (120 Min)|Physician Decision|1|||
130061295|NCT04348591|468178859|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
130061296|NCT04348591|468178860|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
130061297|NCT00417976|468178862|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
130061298|NCT00417976|468178862|FG000|Overall Study|Treatment -related toxicity|2|||
130061299|NCT02104804|468178867|FG000|Overall Study|Did not take study medication|0|||
130061300|NCT02104804|468178868|FG001|Overall Study|Did not take study medication|1|||
130061301|NCT02104804|468178867|FG000|Overall Study|Study specific discontinuation criteria|6|||
130061302|NCT02104804|468178868|FG001|Overall Study|Study specific discontinuation criteria|1|||
130061303|NCT02104804|468178867|FG000|Overall Study|Other listed|2|||
130061304|NCT02104804|468178868|FG001|Overall Study|Other listed|1|||
130061305|NCT02104804|468178867|FG000|Overall Study|Protocol Violation|0|||
130061306|NCT02104804|468178868|FG001|Overall Study|Protocol Violation|1|||
130061307|NCT02104804|468178867|FG000|Overall Study|Adverse Event|4|||
130061308|NCT02104804|468178868|FG001|Overall Study|Adverse Event|3|||
130061309|NCT02104804|468178867|FG000|Overall Study|Withdrawal by Subject|4|||
130061310|NCT02104804|468178868|FG001|Overall Study|Withdrawal by Subject|12|||
130061311|NCT02720016|468178872|FG000|Overall Study|Separation of couple|6|||
130061312|NCT02720016|468178873|FG001|Overall Study|Separation of couple|8|||
130061313|NCT02720016|468178874|FG002|Overall Study|Separation of couple|2|||
130061314|NCT02720016|468178872|FG000|Overall Study|Withdrawal by Subject|6|||
130061315|NCT02720016|468178873|FG001|Overall Study|Withdrawal by Subject|6|||
130061316|NCT02720016|468178874|FG002|Overall Study|Withdrawal by Subject|4|||
130061317|NCT02720016|468178872|FG000|Overall Study|Scheduling issues|2|||
130061318|NCT02720016|468178873|FG001|Overall Study|Scheduling issues|4|||
130061319|NCT02720016|468178874|FG002|Overall Study|Scheduling issues|7|||
130061320|NCT02720016|468178872|FG000|Overall Study|Childcare|2|||
130061321|NCT02720016|468178873|FG001|Overall Study|Childcare|0|||
130061322|NCT02720016|468178874|FG002|Overall Study|Childcare|2|||
130061323|NCT02720016|468178872|FG000|Overall Study|Withdrawal by PI|2|||
130061324|NCT02720016|468178873|FG001|Overall Study|Withdrawal by PI|2|||
130061325|NCT02720016|468178874|FG002|Overall Study|Withdrawal by PI|0|||
130061326|NCT02720016|468178872|FG000|Overall Study|Moved away|2|||
130061327|NCT02720016|468178873|FG001|Overall Study|Moved away|0|||
130061328|NCT02720016|468178874|FG002|Overall Study|Moved away|0|||
130061329|NCT02720016|468178872|FG000|Overall Study|Not Primary Health Concern|0|||
130061330|NCT02720016|468178873|FG001|Overall Study|Not Primary Health Concern|0|||
130061331|NCT02720016|468178874|FG002|Overall Study|Not Primary Health Concern|2|||
130061332|NCT02720016|468178872|FG000|Overall Study|Transportation issues|0|||
130061333|NCT02720016|468178873|FG001|Overall Study|Transportation issues|0|||
130061334|NCT02720016|468178874|FG002|Overall Study|Transportation issues|1|||
130061335|NCT02720016|468178872|FG000|Overall Study|Other|0|||
130061336|NCT02720016|468178873|FG001|Overall Study|Other|0|||
130061337|NCT02720016|468178874|FG002|Overall Study|Other|2|||
130061338|NCT04501679|468178879|FG000|Overall Study|Pregnancy|0|||
130061339|NCT04501679|468178880|FG001|Overall Study|Pregnancy|1|||
130061340|NCT04501679|468178879|FG000|Overall Study|Adverse Event|4|||
130061341|NCT04501679|468178880|FG001|Overall Study|Adverse Event|2|||
130061342|NCT04501679|468178879|FG000|Overall Study|Withdrawal by Subject|2|||
130061343|NCT04501679|468178880|FG001|Overall Study|Withdrawal by Subject|0|||
130061344|NCT04501679|468178879|FG000|Overall Study|Physician Decision|1|||
130061345|NCT04501679|468178880|FG001|Overall Study|Physician Decision|0|||
130061346|NCT04501679|468178879|FG000|Overall Study|Lost to Follow-up|2|||
130061347|NCT04501679|468178880|FG001|Overall Study|Lost to Follow-up|0|||
130061348|NCT01968954|468178888|FG000|Overall Study|Adverse Event|6|||
130061349|NCT01968954|468178889|FG001|Overall Study|Adverse Event|3|||
130061350|NCT01968954|468178888|FG000|Overall Study|Death|1|||
130061351|NCT01968954|468178889|FG001|Overall Study|Death|2|||
130061352|NCT01968954|468178888|FG000|Overall Study|Lost to Follow-up|6|||
130061353|NCT01968954|468178889|FG001|Overall Study|Lost to Follow-up|4|||
130061354|NCT01968954|468178888|FG000|Overall Study|Withdrawal by Subject|20|||
130061355|NCT01968954|468178889|FG001|Overall Study|Withdrawal by Subject|23|||
130061356|NCT01968954|468178888|FG000|Overall Study|Other|7|||
130061357|NCT01968954|468178889|FG001|Overall Study|Other|8|||
130061358|NCT01968954|468178888|FG000|Overall Study|Protocol Violation|0|||
130061359|NCT01968954|468178889|FG001|Overall Study|Protocol Violation|1|||
130061360|NCT01968954|468178888|FG000|Overall Study|Did not met inclusion criteria|0|||
130061361|NCT01968954|468178889|FG001|Overall Study|Did not met inclusion criteria|2|||
130061362|NCT05319080|468178890|FG000|Overall Study|Withdrawal by Subject|2|||
130061363|NCT05319080|468178890|FG000|Overall Study|Physician Decision|4|||
130061364|NCT02358369|468178893|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
130061365|NCT02358369|468178894|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130113470|NCT03361956|468375467|FG001|Overall Study|Adverse Event|0|||
129898000|NCT00567164|467586542|FG001|Overall Study|Missing|0|||
129898001|NCT00567164|467586543|FG002|Overall Study|Missing|0|||
129835752|NCT03608774|467364284|FG000|Overall Study|Health related event|0|||
129835753|NCT03608774|467364285|FG001|Overall Study|Health related event|1|||
129835754|NCT01177540|467364286|FG000|Overall Study|Adverse Event|1|||
129835755|NCT01177540|467364287|FG001|Overall Study|Adverse Event|0|||
129835756|NCT02910167|467364288|FG000|Overall Study|Adverse Event|1|||
129835757|NCT02910167|467364288|FG000|Overall Study|Lost to Follow-up|18|||
129835758|NCT03913091|467364289|FG000|Overall Study|Lost to Follow-up|18|||
129835759|NCT03913091|467364290|FG001|Overall Study|Lost to Follow-up|11|||
129835760|NCT03913091|467364289|FG000|Overall Study|Required additional meds/surgery|1|||
129835761|NCT03913091|467364290|FG001|Overall Study|Required additional meds/surgery|2|||
129835762|NCT03913091|467364289|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
129835763|NCT03913091|467364290|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
129835764|NCT04477304|467364291|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
129835765|NCT04477304|467364292|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
129835766|NCT03256552|467366054|FG000|Overall Study|Protocol Violation|1|||
129835767|NCT03256552|467366054|FG000|Overall Study|Physician Decision|1|||
129835768|NCT03256552|467366054|FG000|Overall Study|Adverse Event|1|||
129835769|NCT03256552|467366054|FG000|Overall Study|Withdrawal by Subject|2|||
129835770|NCT05083442|467366055|FG000|Overall Study|Lost to Follow-up|1|||
129835771|NCT05083442|467366056|FG001|Overall Study|Lost to Follow-up|0|||
129835772|NCT05083442|467366055|FG000|Overall Study|Lack of Efficacy|0|||
129835773|NCT05083442|467366056|FG001|Overall Study|Lack of Efficacy|1|||
129835774|NCT05083442|467366055|FG000|Overall Study|Withdrawal by Subject|1|||
129835775|NCT05083442|467366056|FG001|Overall Study|Withdrawal by Subject|3|||
129835776|NCT05083442|467366055|FG000|Overall Study|scheduling difficulties|1|||
129835777|NCT05083442|467366056|FG001|Overall Study|scheduling difficulties|2|||
129835778|NCT03387813|467366066|FG000|Overall Study|Death|40|||
129835779|NCT03387813|467366067|FG001|Overall Study|Death|37|||
129835780|NCT03387813|467366068|FG002|Overall Study|Death|190|||
129835781|NCT03387813|467366066|FG000|Overall Study|Withdrawal by Subject|9|||
129835782|NCT03387813|467366067|FG001|Overall Study|Withdrawal by Subject|19|||
129835783|NCT03387813|467366068|FG002|Overall Study|Withdrawal by Subject|32|||
129835784|NCT03387813|467366066|FG000|Overall Study|Lost to Follow-up|3|||
129835785|NCT03387813|467366067|FG001|Overall Study|Lost to Follow-up|9|||
129835786|NCT03387813|467366068|FG002|Overall Study|Lost to Follow-up|15|||
129835787|NCT03387813|467366066|FG000|Overall Study|Non-Compliance|6|||
129835788|NCT03387813|467366067|FG001|Overall Study|Non-Compliance|6|||
129835789|NCT03387813|467366068|FG002|Overall Study|Non-Compliance|31|||
129835790|NCT03387813|467366066|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
129835791|NCT03387813|467366067|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
129835792|NCT03387813|467366068|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
129835793|NCT04327999|467366069|FG000|Overall Study|Protocol Violation|1|||
129835794|NCT03792672|467366070|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
129835795|NCT03792672|467366071|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835796|NCT03792672|467366072|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835797|NCT03792672|467366073|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
129835798|NCT03792672|467366074|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835799|NCT03792672|467366075|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835800|NCT03792672|467366070|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
129835801|NCT03792672|467366071|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
129835802|NCT03792672|467366072|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
129835803|NCT03792672|467366073|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
129835804|NCT03792672|467366074|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
129835805|NCT03792672|467366075|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
129835806|NCT03792672|467366070|FG000|Treatment Period 4 (2 Days)|Other|1|||
129835807|NCT03792672|467366071|FG001|Treatment Period 4 (2 Days)|Other|0|||
129835808|NCT03792672|467366072|FG002|Treatment Period 4 (2 Days)|Other|0|||
129835809|NCT03792672|467366073|FG003|Treatment Period 4 (2 Days)|Other|0|||
129835810|NCT03792672|467366074|FG004|Treatment Period 4 (2 Days)|Other|0|||
129835811|NCT03792672|467366075|FG005|Treatment Period 4 (2 Days)|Other|0|||
129835812|NCT00006478|467366077|FG000|Overall Study|Vaccine could not be produced|1|||
129835813|NCT00006478|467366077|FG000|Overall Study|Physician Decision|6|||
129835814|NCT03161483|467366083|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
129835815|NCT03161483|467366084|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
129898002|NCT02430532|467586550|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
129835816|NCT03161483|467366085|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
129835817|NCT03161483|467366086|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
129835818|NCT03161483|467366083|FG000|Treatment Period|Death|1|||
129835819|NCT03161483|467366084|FG001|Treatment Period|Death|0|||
129835820|NCT03161483|467366085|FG002|Treatment Period|Death|0|||
129898003|NCT02430532|467586551|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
129898004|NCT02430532|467586550|FG000|Overall Study|Consent Withdrawn|0|||
130113471|NCT03361956|468375468|FG002|Overall Study|Adverse Event|1|||
130113472|NCT03361956|468375469|FG003|Overall Study|Adverse Event|1|||
130113473|NCT03361956|468375470|FG004|Overall Study|Adverse Event|0|||
130113474|NCT03361956|468375466|FG000|Overall Study|Other|0|||
130113475|NCT03361956|468375467|FG001|Overall Study|Other|0|||
130113476|NCT03361956|468375468|FG002|Overall Study|Other|0|||
130113477|NCT03361956|468375469|FG003|Overall Study|Other|1|||
130113478|NCT03361956|468375470|FG004|Overall Study|Other|0|||
130113479|NCT03361956|468375466|FG000|Overall Study|Withdrawal by Subject|2|||
130113480|NCT03361956|468375467|FG001|Overall Study|Withdrawal by Subject|2|||
130113481|NCT03361956|468375468|FG002|Overall Study|Withdrawal by Subject|2|||
130113482|NCT03361956|468375469|FG003|Overall Study|Withdrawal by Subject|0|||
130113483|NCT03361956|468375470|FG004|Overall Study|Withdrawal by Subject|3|||
130113484|NCT03361956|468375466|FG000|Overall Study|Disease Relapse|0|||
130113485|NCT03361956|468375467|FG001|Overall Study|Disease Relapse|0|||
130113486|NCT03361956|468375468|FG002|Overall Study|Disease Relapse|1|||
130113487|NCT03361956|468375469|FG003|Overall Study|Disease Relapse|0|||
130113488|NCT03361956|468375470|FG004|Overall Study|Disease Relapse|0|||
130113489|NCT03361956|468375466|FG000|Overall Study|Physician Decision|0|||
130113490|NCT03361956|468375467|FG001|Overall Study|Physician Decision|2|||
130113491|NCT03361956|468375468|FG002|Overall Study|Physician Decision|0|||
130113492|NCT03361956|468375469|FG003|Overall Study|Physician Decision|1|||
130113493|NCT03361956|468375470|FG004|Overall Study|Physician Decision|0|||
130113494|NCT03361956|468375466|FG000|Overall Study|Lost to Follow-up|0|||
130113495|NCT03361956|468375467|FG001|Overall Study|Lost to Follow-up|0|||
130113496|NCT03361956|468375468|FG002|Overall Study|Lost to Follow-up|1|||
130113497|NCT03361956|468375469|FG003|Overall Study|Lost to Follow-up|1|||
130113498|NCT03361956|468375470|FG004|Overall Study|Lost to Follow-up|2|||
129835821|NCT03161483|467366086|FG003|Treatment Period|Death|0|||
129835822|NCT03161483|467366083|FG000|Treatment Period|Adverse Event|5|||
129835823|NCT03161483|467366084|FG001|Treatment Period|Adverse Event|2|||
129835824|NCT03161483|467366085|FG002|Treatment Period|Adverse Event|1|||
129835825|NCT03161483|467366086|FG003|Treatment Period|Adverse Event|11|||
129835826|NCT03161483|467366083|FG000|Treatment Period|Pregnancy|1|||
129835827|NCT03161483|467366084|FG001|Treatment Period|Pregnancy|0|||
129835828|NCT03161483|467366085|FG002|Treatment Period|Pregnancy|0|||
129835829|NCT03161483|467366086|FG003|Treatment Period|Pregnancy|0|||
129835830|NCT03161483|467366083|FG000|Treatment Period|Lack of Efficacy|0|||
129835831|NCT03161483|467366084|FG001|Treatment Period|Lack of Efficacy|0|||
129835832|NCT03161483|467366085|FG002|Treatment Period|Lack of Efficacy|0|||
129835833|NCT03161483|467366086|FG003|Treatment Period|Lack of Efficacy|1|||
129835834|NCT03161483|467366083|FG000|Treatment Period|Withdrawal by Subject|2|||
129835835|NCT03161483|467366084|FG001|Treatment Period|Withdrawal by Subject|5|||
129835836|NCT03161483|467366085|FG002|Treatment Period|Withdrawal by Subject|2|||
129835837|NCT03161483|467366086|FG003|Treatment Period|Withdrawal by Subject|6|||
129835838|NCT03161483|467366083|FG000|Treatment Period|Lost to Follow-up|0|||
129835839|NCT03161483|467366084|FG001|Treatment Period|Lost to Follow-up|0|||
129835840|NCT03161483|467366085|FG002|Treatment Period|Lost to Follow-up|0|||
129835841|NCT03161483|467366086|FG003|Treatment Period|Lost to Follow-up|1|||
129835842|NCT03161483|467366083|FG000|Treatment Period|Protocol Violation|0|||
129835843|NCT03161483|467366084|FG001|Treatment Period|Protocol Violation|0|||
129835844|NCT03161483|467366085|FG002|Treatment Period|Protocol Violation|0|||
129835845|NCT03161483|467366086|FG003|Treatment Period|Protocol Violation|1|||
129835846|NCT03161483|467366083|FG000|Treatment Period|Other reasons|1|||
130113499|NCT03760510|468375475|FG000|Overall Study|Not ventilated for 24 hours|105|||
130113500|NCT03760510|468375476|FG001|Overall Study|Not ventilated for 24 hours|97|||
130113501|NCT00566709|468375478|FG000|Overall Study|Protocol Violation|5|||
129835847|NCT03161483|467366084|FG001|Treatment Period|Other reasons|1|||
129835848|NCT03161483|467366085|FG002|Treatment Period|Other reasons|0|||
129835849|NCT03161483|467366086|FG003|Treatment Period|Other reasons|0|||
129835850|NCT04238728|467366097|FG000|Overall Study|Withdrawal by Subject|1|||
129835851|NCT04238728|467366097|FG000|Overall Study|Lost to Follow-up|2|||
129835852|NCT05389657|467366099|FG000|Overall Study|Lost to Follow-up|7|||
129835853|NCT05389657|467366100|FG001|Overall Study|Lost to Follow-up|8|||
129835854|NCT01907828|467366101|FG000|Overall Study|Exclusion criteria not met|0|||
129835855|NCT01907828|467366102|FG001|Overall Study|Exclusion criteria not met|1|||
129835856|NCT01907828|467366101|FG000|Overall Study|Withdrawal by Subject|3|||
129835857|NCT01907828|467366102|FG001|Overall Study|Withdrawal by Subject|4|||
129835858|NCT01907828|467366101|FG000|Overall Study|Lost to Follow-up|3|||
130113502|NCT00566709|468375479|FG001|Overall Study|Protocol Violation|0|||
129835859|NCT01907828|467366102|FG001|Overall Study|Lost to Follow-up|0|||
129835860|NCT01907828|467366101|FG000|Overall Study|Participant refused 24-month follow-up|1|||
129835861|NCT01907828|467366102|FG001|Overall Study|Participant refused 24-month follow-up|0|||
129898005|NCT02430532|467586551|FG001|Overall Study|Consent Withdrawn|2|||
129835862|NCT01907828|467366101|FG000|Overall Study|Participant met exclusion criteria|0|||
129835863|NCT01907828|467366102|FG001|Overall Study|Participant met exclusion criteria|1|||
130113503|NCT03443869|468375480|FG000|Overall Study|Death|3|||
130113504|NCT03443869|468375481|FG001|Overall Study|Death|3|||
130113505|NCT03443869|468375480|FG000|Overall Study|Withdrawal by Subject|34|||
129835864|NCT01073865|467366108|FG000|Overall Study|Reasons other than below|19|||
130061366|NCT02358369|468178895|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130061367|NCT02358369|468178896|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130061368|NCT02358369|468178897|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
130061369|NCT02358369|468178893|FG000|Treatment Period A/B|Adverse Event|0|||
130061370|NCT02358369|468178894|FG001|Treatment Period A/B|Adverse Event|0|||
130061371|NCT02358369|468178895|FG002|Treatment Period A/B|Adverse Event|1|||
130061372|NCT02358369|468178896|FG003|Treatment Period A/B|Adverse Event|2|||
130061373|NCT02358369|468178897|FG004|Treatment Period A/B|Adverse Event|0|||
130061374|NCT02358369|468178893|FG000|Treatment Period A/B|Death|0|||
130061375|NCT02358369|468178894|FG001|Treatment Period A/B|Death|0|||
130061376|NCT02358369|468178895|FG002|Treatment Period A/B|Death|1|||
130061377|NCT02358369|468178896|FG003|Treatment Period A/B|Death|0|||
130061378|NCT02358369|468178897|FG004|Treatment Period A/B|Death|0|||
129835865|NCT01073865|467366109|FG001|Overall Study|Reasons other than below|31|||
129835866|NCT01073865|467366108|FG000|Overall Study|Lost to Follow-up|1|||
129835867|NCT01073865|467366109|FG001|Overall Study|Lost to Follow-up|1|||
129835868|NCT01073865|467366108|FG000|Overall Study|Death|3|||
129835869|NCT01073865|467366109|FG001|Overall Study|Death|2|||
129835870|NCT01073865|467366108|FG000|Overall Study|Withdrawal by Subject|5|||
129835871|NCT01073865|467366109|FG001|Overall Study|Withdrawal by Subject|5|||
129835872|NCT03261947|467366115|FG000|Overall Study|Death|10|||
129835873|NCT03261947|467366116|FG001|Overall Study|Death|13|||
129835874|NCT03261947|467366117|FG002|Overall Study|Death|17|||
129835875|NCT03261947|467366118|FG003|Overall Study|Death|12|||
129835876|NCT03261947|467366119|FG004|Overall Study|Death|8|||
129835877|NCT03261947|467366115|FG000|Overall Study|Lost to Follow-up|0|||
129835878|NCT03261947|467366116|FG001|Overall Study|Lost to Follow-up|0|||
129835879|NCT03261947|467366117|FG002|Overall Study|Lost to Follow-up|2|||
129835880|NCT03261947|467366118|FG003|Overall Study|Lost to Follow-up|1|||
129835881|NCT03261947|467366119|FG004|Overall Study|Lost to Follow-up|0|||
129835882|NCT03261947|467366115|FG000|Overall Study|Withdrawal by Subject|0|||
129835883|NCT03261947|467366116|FG001|Overall Study|Withdrawal by Subject|0|||
129835884|NCT03261947|467366117|FG002|Overall Study|Withdrawal by Subject|3|||
129835885|NCT03261947|467366118|FG003|Overall Study|Withdrawal by Subject|0|||
129835886|NCT03261947|467366119|FG004|Overall Study|Withdrawal by Subject|1|||
129835887|NCT03261947|467366115|FG000|Overall Study|Site Terminated by Sponsor|0|||
129835888|NCT03261947|467366116|FG001|Overall Study|Site Terminated by Sponsor|0|||
129835889|NCT03261947|467366117|FG002|Overall Study|Site Terminated by Sponsor|4|||
129835890|NCT03261947|467366118|FG003|Overall Study|Site Terminated by Sponsor|7|||
129835891|NCT03261947|467366119|FG004|Overall Study|Site Terminated by Sponsor|5|||
129835892|NCT03261947|467366115|FG000|Overall Study|Reason not Specified|2|||
129835893|NCT03261947|467366116|FG001|Overall Study|Reason not Specified|0|||
129835894|NCT03261947|467366117|FG002|Overall Study|Reason not Specified|4|||
129835895|NCT03261947|467366118|FG003|Overall Study|Reason not Specified|1|||
129835896|NCT03261947|467366119|FG004|Overall Study|Reason not Specified|3|||
129835897|NCT03969992|467366120|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
129835898|NCT03969992|467366121|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
129835899|NCT03969992|467366122|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
129835900|NCT03969992|467366120|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
129835901|NCT03969992|467366121|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
129835902|NCT03969992|467366122|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
129835903|NCT03969992|467366120|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
129835904|NCT03969992|467366121|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
129835905|NCT03969992|467366122|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
129835906|NCT03969992|467366120|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
129835907|NCT03969992|467366121|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
129835908|NCT03969992|467366122|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
129835909|NCT03969992|467366120|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
129835910|NCT03969992|467366121|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
129835911|NCT03969992|467366122|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
129835912|NCT00228917|467366127|FG000|Overall Study|Migrated/moved from study area|0|||
129835913|NCT00228917|467366128|FG001|Overall Study|Migrated/moved from study area|0|||
129898006|NCT02430532|467586550|FG000|Overall Study|Adverse Event|0|||
129898007|NCT02430532|467586551|FG001|Overall Study|Adverse Event|1|||
130061379|NCT02358369|468178893|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
130061380|NCT02358369|468178894|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
130061381|NCT02358369|468178895|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
130061382|NCT02358369|468178896|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
130061383|NCT02358369|468178897|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
129835914|NCT00228917|467366129|FG002|Overall Study|Migrated/moved from study area|0|||
129835915|NCT00228917|467366130|FG003|Overall Study|Migrated/moved from study area|0|||
129898008|NCT03256344|467586552|FG000|Overall Study|Death|6|||
129898009|NCT03256344|467586553|FG001|Overall Study|Death|22|||
130113506|NCT03443869|468375481|FG001|Overall Study|Withdrawal by Subject|22|||
130113507|NCT03443869|468375480|FG000|Overall Study|Lost to Follow-up|1|||
130113508|NCT03443869|468375481|FG001|Overall Study|Lost to Follow-up|2|||
130113509|NCT03443869|468375480|FG000|Overall Study|Physician Decision|3|||
130113510|NCT03443869|468375481|FG001|Overall Study|Physician Decision|3|||
130113511|NCT03443869|468375480|FG000|Overall Study|Other|4|||
130113512|NCT03443869|468375481|FG001|Overall Study|Other|4|||
130113513|NCT00299728|468375482|FG000|Overall Study|Lost to Follow-up|0|||
130113514|NCT00299728|468375483|FG001|Overall Study|Lost to Follow-up|1|||
130113515|NCT00299728|468375482|FG000|Overall Study|Withdrawal by Subject|0|||
130113516|NCT00299728|468375483|FG001|Overall Study|Withdrawal by Subject|1|||
130113517|NCT00299728|468375482|FG000|Overall Study|Progressive disease|0|||
130113518|NCT00299728|468375483|FG001|Overall Study|Progressive disease|1|||
130113519|NCT03558997|468375484|FG000|Overall Study|Adverse Event|0|||
130113520|NCT03558997|468375485|FG001|Overall Study|Adverse Event|2|||
130113521|NCT03558997|468375486|FG002|Overall Study|Adverse Event|5|||
130113522|NCT03558997|468375487|FG003|Overall Study|Adverse Event|1|||
130113523|NCT03558997|468375484|FG000|Overall Study|Physician Decision|0|||
130113524|NCT03558997|468375485|FG001|Overall Study|Physician Decision|0|||
130113525|NCT03558997|468375486|FG002|Overall Study|Physician Decision|1|||
130113526|NCT03558997|468375487|FG003|Overall Study|Physician Decision|0|||
130113527|NCT03558997|468375484|FG000|Overall Study|Withdrawal by Subject|1|||
130113528|NCT03558997|468375485|FG001|Overall Study|Withdrawal by Subject|0|||
130113529|NCT03558997|468375486|FG002|Overall Study|Withdrawal by Subject|1|||
130113530|NCT03558997|468375487|FG003|Overall Study|Withdrawal by Subject|1|||
130113531|NCT03558997|468375484|FG000|Overall Study|Lost to Follow-up|0|||
130113532|NCT03558997|468375485|FG001|Overall Study|Lost to Follow-up|0|||
130113533|NCT03558997|468375486|FG002|Overall Study|Lost to Follow-up|1|||
130113534|NCT03558997|468375487|FG003|Overall Study|Lost to Follow-up|0|||
130113535|NCT02230085|468375490|FG000|Overall Study|Physician Decision|1|||
130113536|NCT02230085|468375490|FG000|Overall Study|Withdrawal by Subject|3|||
130113537|NCT03572933|468377316|FG000|Overall Study|Adverse Event|4|||
130113538|NCT03572933|468377317|FG001|Overall Study|Adverse Event|1|||
130113539|NCT03572933|468377316|FG000|Overall Study|Withdrawal by Subject|0|||
130113540|NCT03572933|468377317|FG001|Overall Study|Withdrawal by Subject|1|||
130113541|NCT01907737|468377318|FG000|Overall Study|Withdrawal by Subject|1|||
130113542|NCT00678392|468377320|FG000|Overall Study|Adverse Event|0|||
130113543|NCT00678392|468377321|FG001|Overall Study|Adverse Event|6|||
130113544|NCT00678392|468377320|FG000|Overall Study|Death|280|||
130113545|NCT00678392|468377321|FG001|Overall Study|Death|269|||
130113546|NCT00678392|468377320|FG000|Overall Study|Lost to Follow-up|15|||
130113547|NCT00678392|468377321|FG001|Overall Study|Lost to Follow-up|13|||
130113548|NCT00678392|468377320|FG000|Overall Study|Objective Progression or Relapse|3|||
130113549|NCT00678392|468377321|FG001|Overall Study|Objective Progression or Relapse|8|||
130113550|NCT00678392|468377320|FG000|Overall Study|Sponsor's Decision|1|||
130113551|NCT00678392|468377321|FG001|Overall Study|Sponsor's Decision|2|||
130113552|NCT00678392|468377320|FG000|Overall Study|Withdrawal by Subject|4|||
130113553|NCT00678392|468377321|FG001|Overall Study|Withdrawal by Subject|4|||
130113554|NCT00678392|468377320|FG000|Overall Study|Randomized But Not Treated|2|||
130113555|NCT00678392|468377321|FG001|Overall Study|Randomized But Not Treated|7|||
130113556|NCT00678392|468377320|FG000|Overall Study|Other|56|||
130113557|NCT00678392|468377321|FG001|Overall Study|Other|53|||
130113558|NCT01405820|468377324|FG000|Randomized Treatment Period|Adverse Event|3|||
130113559|NCT01405820|468377325|FG001|Randomized Treatment Period|Adverse Event|3|||
130113560|NCT01405820|468377326|FG002|Randomized Treatment Period|Adverse Event|3|||
130113561|NCT01405820|468377327|FG003|Randomized Treatment Period|Adverse Event|0|||
130113562|NCT01405820|468377328|FG004|Randomized Treatment Period|Adverse Event|2|||
130113563|NCT01405820|468377329|FG005|Randomized Treatment Period|Adverse Event|1|||
130113564|NCT01405820|468377324|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
130113565|NCT01405820|468377325|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
130113566|NCT01405820|468377326|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
130113567|NCT01405820|468377327|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
129835916|NCT00228917|467366131|FG004|Overall Study|Migrated/moved from study area|0|||
129835917|NCT00228917|467366132|FG005|Overall Study|Migrated/moved from study area|2|||
129835918|NCT00228917|467366133|FG006|Overall Study|Migrated/moved from study area|0|||
129835919|NCT00228917|467366134|FG007|Overall Study|Migrated/moved from study area|0|||
129835920|NCT00409617|467366135|FG000|Overall Study|Adverse Event|57|||
129835921|NCT00409617|467366135|FG000|Overall Study|Lack of Efficacy|54|||
129835922|NCT00409617|467366135|FG000|Overall Study|Lost to Follow-up|2|||
129835923|NCT00409617|467366135|FG000|Overall Study|Protocol Violation|24|||
130113568|NCT01405820|468377328|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
130113569|NCT01405820|468377329|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
129835924|NCT00409617|467366135|FG000|Overall Study|Withdrawal by Subject|8|||
129835925|NCT00409617|467366135|FG000|Overall Study|Administrative reasons|1|||
129898010|NCT03256344|467586552|FG000|Overall Study|Withdrawal by Subject|3|||
130113570|NCT01405820|468377324|FG000|Randomized Treatment Period|Other|2|||
130113571|NCT01405820|468377325|FG001|Randomized Treatment Period|Other|2|||
130113572|NCT01405820|468377326|FG002|Randomized Treatment Period|Other|1|||
130113573|NCT01405820|468377327|FG003|Randomized Treatment Period|Other|1|||
130113574|NCT01405820|468377328|FG004|Randomized Treatment Period|Other|0|||
130113575|NCT01405820|468377329|FG005|Randomized Treatment Period|Other|0|||
129835926|NCT00409617|467366135|FG000|Overall Study|Not described|14|||
129835927|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
130113576|NCT01405820|468377324|FG000|Randomized Treatment Period|Physician Decision|0|||
130113577|NCT01405820|468377325|FG001|Randomized Treatment Period|Physician Decision|2|||
130113578|NCT01405820|468377326|FG002|Randomized Treatment Period|Physician Decision|1|||
130113579|NCT01405820|468377327|FG003|Randomized Treatment Period|Physician Decision|0|||
130113580|NCT01405820|468377328|FG004|Randomized Treatment Period|Physician Decision|0|||
130113581|NCT01405820|468377329|FG005|Randomized Treatment Period|Physician Decision|0|||
130113582|NCT01405820|468377324|FG000|Randomized Treatment Period|Rescue|0|||
130113583|NCT01405820|468377325|FG001|Randomized Treatment Period|Rescue|1|||
130113584|NCT01405820|468377326|FG002|Randomized Treatment Period|Rescue|13|||
130113585|NCT01405820|468377327|FG003|Randomized Treatment Period|Rescue|10|||
130113586|NCT01405820|468377328|FG004|Randomized Treatment Period|Rescue|8|||
130113587|NCT01405820|468377329|FG005|Randomized Treatment Period|Rescue|8|||
130113588|NCT01405820|468377324|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
130113589|NCT01405820|468377325|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
130113590|NCT01405820|468377326|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
130113591|NCT01405820|468377327|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
130113592|NCT01405820|468377328|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
130113593|NCT01405820|468377329|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
130113594|NCT01405820|468377324|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
130113595|NCT01405820|468377325|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
130113596|NCT01405820|468377326|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
130113597|NCT01405820|468377327|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
130113598|NCT01405820|468377328|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
130113599|NCT01405820|468377329|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
130113600|NCT01405820|468377324|FG000|Randomized Treatment Period|Death|0|||
130113601|NCT01405820|468377325|FG001|Randomized Treatment Period|Death|0|||
130113602|NCT01405820|468377326|FG002|Randomized Treatment Period|Death|0|||
130113603|NCT01405820|468377327|FG003|Randomized Treatment Period|Death|1|||
130113604|NCT01405820|468377328|FG004|Randomized Treatment Period|Death|0|||
130113605|NCT01405820|468377329|FG005|Randomized Treatment Period|Death|0|||
130113606|NCT01405820|468377324|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130113607|NCT01405820|468377325|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130113608|NCT01405820|468377326|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130113609|NCT01405820|468377327|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
130113610|NCT01405820|468377328|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130113611|NCT01405820|468377329|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
130113612|NCT01405820|468377324|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
130113613|NCT01405820|468377325|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
130113614|NCT01405820|468377326|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
130113615|NCT01405820|468377327|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
130113616|NCT01405820|468377328|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
130113617|NCT01405820|468377329|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
130113618|NCT01405820|468377324|FG000|Open-Label Treatment Period|Other|1|||
130113619|NCT01405820|468377325|FG001|Open-Label Treatment Period|Other|1|||
130113620|NCT01405820|468377326|FG002|Open-Label Treatment Period|Other|1|||
130113621|NCT01405820|468377327|FG003|Open-Label Treatment Period|Other|1|||
130113622|NCT01405820|468377328|FG004|Open-Label Treatment Period|Other|1|||
129835928|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
129835929|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
129835930|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
129835931|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
129835932|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
129835933|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
129835934|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129835935|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
130113623|NCT01405820|468377329|FG005|Open-Label Treatment Period|Other|1|||
129835936|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129835937|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
129835938|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
129835939|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
130113624|NCT01405820|468377324|FG000|Open-Label Treatment Period|Physician Decision|0|||
130113625|NCT01405820|468377325|FG001|Open-Label Treatment Period|Physician Decision|0|||
130113626|NCT01405820|468377326|FG002|Open-Label Treatment Period|Physician Decision|1|||
130113627|NCT01405820|468377327|FG003|Open-Label Treatment Period|Physician Decision|2|||
130113628|NCT01405820|468377328|FG004|Open-Label Treatment Period|Physician Decision|1|||
130113629|NCT01405820|468377329|FG005|Open-Label Treatment Period|Physician Decision|0|||
130113630|NCT01405820|468377324|FG000|Open-Label Treatment Period|Adverse Event|0|||
130113631|NCT01405820|468377325|FG001|Open-Label Treatment Period|Adverse Event|0|||
129835940|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
129835941|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
129835942|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
129835943|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835944|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835945|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835946|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835947|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
129835948|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
129835949|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
129835950|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
129835951|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
129835952|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835953|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
129835954|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835955|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835956|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835957|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835958|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835959|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835960|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
129835961|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835962|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
129835963|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
129835964|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
129835965|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
129835966|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
129835967|NCT03373383|467366144|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
129835968|NCT03373383|467366145|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835969|NCT03373383|467366146|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835970|NCT03373383|467366147|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835971|NCT03373383|467366148|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835972|NCT03818516|467366150|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
129835973|NCT04372602|467366151|FG000|Overall Study|Withdrawal by Subject|1|||
129835974|NCT04372602|467366152|FG001|Overall Study|Withdrawal by Subject|1|||
129835975|NCT04372602|467366151|FG000|Overall Study|Adverse Event|0|||
129835976|NCT04372602|467366152|FG001|Overall Study|Adverse Event|1|||
129835977|NCT04372602|467366151|FG000|Overall Study|Transitioned to comfort care|0|||
129835978|NCT04372602|467366152|FG001|Overall Study|Transitioned to comfort care|1|||
130061384|NCT02358369|468178893|FG000|Treatment Period C|Adverse Event|0|||
130061385|NCT02358369|468178894|FG001|Treatment Period C|Adverse Event|0|||
130061386|NCT02358369|468178895|FG002|Treatment Period C|Adverse Event|0|||
130061387|NCT02358369|468178896|FG003|Treatment Period C|Adverse Event|0|||
130061388|NCT02358369|468178897|FG004|Treatment Period C|Adverse Event|7|||
130061389|NCT04465396|468178898|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
130061390|NCT04465396|468178899|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
130061391|NCT04465396|468178900|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
130061392|NCT04465396|468178901|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
130061393|NCT02648724|468178904|FG000|Overall Study|Withdrawal by Subject|0|||
130061394|NCT02648724|468178905|FG001|Overall Study|Withdrawal by Subject|1|||
130061395|NCT02648724|468178906|FG002|Overall Study|Withdrawal by Subject|1|||
130061396|NCT02648724|468178907|FG003|Overall Study|Withdrawal by Subject|0|||
130061397|NCT02648724|468178908|FG004|Overall Study|Withdrawal by Subject|1|||
130061398|NCT02648724|468178909|FG005|Overall Study|Withdrawal by Subject|0|||
130061399|NCT02648724|468178910|FG006|Overall Study|Withdrawal by Subject|0|||
130061400|NCT02648724|468178904|FG000|Overall Study|Progressive disease|2|||
130061401|NCT02648724|468178905|FG001|Overall Study|Progressive disease|2|||
130061402|NCT02648724|468178906|FG002|Overall Study|Progressive disease|2|||
130061403|NCT02648724|468178907|FG003|Overall Study|Progressive disease|3|||
130061404|NCT02648724|468178908|FG004|Overall Study|Progressive disease|22|||
130061405|NCT02648724|468178909|FG005|Overall Study|Progressive disease|7|||
130061406|NCT02648724|468178910|FG006|Overall Study|Progressive disease|8|||
130061407|NCT02648724|468178904|FG000|Overall Study|Other reason (unknown)|1|||
130061408|NCT02648724|468178905|FG001|Overall Study|Other reason (unknown)|0|||
130061409|NCT02648724|468178906|FG002|Overall Study|Other reason (unknown)|0|||
129835979|NCT02907359|467366153|FG000|Overall Study|Death|234|||
129835980|NCT02907359|467366154|FG001|Overall Study|Death|117|||
129835981|NCT02907359|467366153|FG000|Overall Study|Withdrawal by Subject|6|||
129835982|NCT02907359|467366154|FG001|Overall Study|Withdrawal by Subject|11|||
129835983|NCT02907359|467366153|FG000|Overall Study|Lost to Follow-up|1|||
129835984|NCT02907359|467366154|FG001|Overall Study|Lost to Follow-up|0|||
129835985|NCT02739269|467366159|FG000|Overall Study|Protocol Violation|5|||
129898011|NCT03256344|467586553|FG001|Overall Study|Withdrawal by Subject|3|||
129898012|NCT03256344|467586552|FG000|Overall Study|Sponsor Decision|1|||
129898013|NCT03256344|467586553|FG001|Overall Study|Sponsor Decision|0|||
130061410|NCT02648724|468178907|FG003|Overall Study|Other reason (unknown)|0|||
130061411|NCT02648724|468178908|FG004|Overall Study|Other reason (unknown)|0|||
130061412|NCT02648724|468178909|FG005|Overall Study|Other reason (unknown)|0|||
130061413|NCT02648724|468178910|FG006|Overall Study|Other reason (unknown)|0|||
130061414|NCT02648724|468178904|FG000|Overall Study|Protocol Violation|0|||
130061415|NCT02648724|468178905|FG001|Overall Study|Protocol Violation|0|||
130061416|NCT02648724|468178906|FG002|Overall Study|Protocol Violation|0|||
130061417|NCT02648724|468178907|FG003|Overall Study|Protocol Violation|0|||
130061418|NCT02648724|468178908|FG004|Overall Study|Protocol Violation|1|||
130061419|NCT02648724|468178909|FG005|Overall Study|Protocol Violation|0|||
130061420|NCT02648724|468178910|FG006|Overall Study|Protocol Violation|0|||
130061421|NCT02648724|468178904|FG000|Overall Study|Death|0|||
130061422|NCT02648724|468178905|FG001|Overall Study|Death|0|||
130061423|NCT02648724|468178906|FG002|Overall Study|Death|0|||
130061424|NCT02648724|468178907|FG003|Overall Study|Death|0|||
130061425|NCT02648724|468178908|FG004|Overall Study|Death|0|||
130061426|NCT02648724|468178909|FG005|Overall Study|Death|0|||
130061427|NCT02648724|468178910|FG006|Overall Study|Death|3|||
130061428|NCT02648724|468178904|FG000|Overall Study|Physician Decision|0|||
130061429|NCT02648724|468178905|FG001|Overall Study|Physician Decision|0|||
130061430|NCT02648724|468178906|FG002|Overall Study|Physician Decision|0|||
130061431|NCT02648724|468178907|FG003|Overall Study|Physician Decision|0|||
130061432|NCT02648724|468178908|FG004|Overall Study|Physician Decision|1|||
130061433|NCT02648724|468178909|FG005|Overall Study|Physician Decision|0|||
130061434|NCT02648724|468178910|FG006|Overall Study|Physician Decision|1|||
130061435|NCT02648724|468178904|FG000|Overall Study|Transferred to named patient program|0|||
130061436|NCT02648724|468178905|FG001|Overall Study|Transferred to named patient program|0|||
130061437|NCT02648724|468178906|FG002|Overall Study|Transferred to named patient program|0|||
130061438|NCT02648724|468178907|FG003|Overall Study|Transferred to named patient program|0|||
130061439|NCT02648724|468178908|FG004|Overall Study|Transferred to named patient program|0|||
130061440|NCT02648724|468178909|FG005|Overall Study|Transferred to named patient program|1|||
130061441|NCT02648724|468178910|FG006|Overall Study|Transferred to named patient program|0|||
130061442|NCT03076190|468178912|FG000|Overall Study|Lost to Follow-up|9|||
130061443|NCT03076190|468178913|FG001|Overall Study|Lost to Follow-up|34|||
130061444|NCT03076190|468178912|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
130061445|NCT03076190|468178913|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
130061446|NCT00434122|468178914|FG000|Overall Study|Non-compliance with protocol|0|||
130061447|NCT00434122|468178915|FG001|Overall Study|Non-compliance with protocol|1|||
130061448|NCT00434122|468178914|FG000|Overall Study|loss of subject contact|1|||
130061449|NCT00434122|468178915|FG001|Overall Study|loss of subject contact|1|||
130061450|NCT00434122|468178914|FG000|Overall Study|Personal reasons|1|||
130061451|NCT00434122|468178915|FG001|Overall Study|Personal reasons|1|||
130061452|NCT00434122|468178914|FG000|Overall Study|Large follicle size|2|||
130061453|NCT00434122|468178915|FG001|Overall Study|Large follicle size|2|||
130061454|NCT00434122|468178914|FG000|Overall Study|Low follicular response.|1|||
130061455|NCT00434122|468178915|FG001|Overall Study|Low follicular response.|2|||
130061456|NCT00434122|468178914|FG000|Overall Study|Travelling of subject.|1|||
130061457|NCT00434122|468178915|FG001|Overall Study|Travelling of subject.|0|||
130061458|NCT04191577|468178919|FG000|Overall Study|Withdrawal by Subject|2|||
130061459|NCT04191577|468178920|FG001|Overall Study|Withdrawal by Subject|2|||
130061460|NCT04191577|468178921|FG002|Overall Study|Withdrawal by Subject|1|||
130113632|NCT01405820|468377326|FG002|Open-Label Treatment Period|Adverse Event|0|||
130113633|NCT01405820|468377327|FG003|Open-Label Treatment Period|Adverse Event|1|||
130113634|NCT01405820|468377328|FG004|Open-Label Treatment Period|Adverse Event|0|||
130113635|NCT01405820|468377329|FG005|Open-Label Treatment Period|Adverse Event|0|||
130113636|NCT01418352|468377336|FG000|Overall Study|Lost to Follow-up|2|||
130113637|NCT01418352|468377337|FG001|Overall Study|Lost to Follow-up|0|||
130113638|NCT01418352|468377338|FG002|Overall Study|Lost to Follow-up|0|||
130113639|NCT01418352|468377339|FG003|Overall Study|Lost to Follow-up|0|||
130113640|NCT01418352|468377336|FG000|Overall Study|Adverse Event|0|||
130113641|NCT01418352|468377337|FG001|Overall Study|Adverse Event|1|||
130113642|NCT01418352|468377338|FG002|Overall Study|Adverse Event|0|||
130113643|NCT01418352|468377339|FG003|Overall Study|Adverse Event|0|||
130113644|NCT01418352|468377336|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
130113645|NCT01418352|468377337|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
130113646|NCT01418352|468377338|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
130113647|NCT01418352|468377339|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
130113648|NCT01418352|468377336|FG000|Overall Study|Subject Withdrew Consent|0|||
130113649|NCT01418352|468377337|FG001|Overall Study|Subject Withdrew Consent|1|||
130113650|NCT01418352|468377338|FG002|Overall Study|Subject Withdrew Consent|2|||
129898014|NCT01670019|467586562|FG000|Overall Study|Adverse Event|3|||
130061461|NCT04191577|468178919|FG000|Overall Study|Physician Decision|1|||
130061462|NCT04191577|468178920|FG001|Overall Study|Physician Decision|1|||
130061463|NCT04191577|468178921|FG002|Overall Study|Physician Decision|0|||
130113651|NCT01418352|468377339|FG003|Overall Study|Subject Withdrew Consent|1|||
130113652|NCT01418352|468377336|FG000|Overall Study|Protocol Deviation|0|||
130113653|NCT01418352|468377337|FG001|Overall Study|Protocol Deviation|0|||
130113654|NCT01418352|468377338|FG002|Overall Study|Protocol Deviation|1|||
130113655|NCT01418352|468377339|FG003|Overall Study|Protocol Deviation|0|||
130113656|NCT01418352|468377336|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
130113657|NCT01418352|468377337|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
130113658|NCT01418352|468377338|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
130113659|NCT01418352|468377339|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
130113660|NCT00619619|468377340|FG000|Overall Study|Physician Decision|0|||
130113661|NCT00619619|468377341|FG001|Overall Study|Physician Decision|0|||
130113662|NCT00619619|468377342|FG002|Overall Study|Physician Decision|1|||
130113663|NCT00619619|468377343|FG003|Overall Study|Physician Decision|0|||
130113664|NCT00619619|468377344|FG004|Overall Study|Physician Decision|0|||
130113665|NCT00619619|468377345|FG005|Overall Study|Physician Decision|0|||
130113666|NCT00619619|468377346|FG006|Overall Study|Physician Decision|0|||
130113667|NCT00619619|468377347|FG007|Overall Study|Physician Decision|0|||
130113668|NCT00619619|468377340|FG000|Overall Study|Protocol Violation|0|||
130113669|NCT00619619|468377341|FG001|Overall Study|Protocol Violation|0|||
130113670|NCT00619619|468377342|FG002|Overall Study|Protocol Violation|0|||
130113671|NCT00619619|468377343|FG003|Overall Study|Protocol Violation|1|||
130113672|NCT00619619|468377344|FG004|Overall Study|Protocol Violation|0|||
130113673|NCT00619619|468377345|FG005|Overall Study|Protocol Violation|0|||
130113674|NCT00619619|468377346|FG006|Overall Study|Protocol Violation|1|||
130113675|NCT00619619|468377347|FG007|Overall Study|Protocol Violation|1|||
130113676|NCT00619619|468377340|FG000|Overall Study|Adverse Event|0|||
130113677|NCT00619619|468377341|FG001|Overall Study|Adverse Event|0|||
130113678|NCT00619619|468377342|FG002|Overall Study|Adverse Event|0|||
130113679|NCT00619619|468377343|FG003|Overall Study|Adverse Event|0|||
130113680|NCT00619619|468377344|FG004|Overall Study|Adverse Event|2|||
130113681|NCT00619619|468377345|FG005|Overall Study|Adverse Event|0|||
130113682|NCT00619619|468377346|FG006|Overall Study|Adverse Event|0|||
130113683|NCT00619619|468377347|FG007|Overall Study|Adverse Event|2|||
130113684|NCT01092702|468377348|FG000|Overall Study|Withdrawal by Subject|7|||
130113685|NCT01092702|468377348|FG000|Overall Study|Lost to Follow-up|2|||
130113686|NCT03263819|468377349|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
130113687|NCT03263819|468377350|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
130113688|NCT01271933|468377359|FG000|Single-Blind Phase|Lack of Efficacy|37|||
130113689|NCT01271933|468377360|FG001|Single-Blind Phase|Lack of Efficacy|0|||
130113690|NCT01271933|468377361|FG002|Single-Blind Phase|Lack of Efficacy|0|||
130113691|NCT01271933|468377359|FG000|Single-Blind Phase|Lost to Follow-up|10|||
130113692|NCT01271933|468377360|FG001|Single-Blind Phase|Lost to Follow-up|0|||
130113693|NCT01271933|468377361|FG002|Single-Blind Phase|Lost to Follow-up|0|||
130113694|NCT01271933|468377359|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
130113695|NCT01271933|468377360|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
130113696|NCT01271933|468377361|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
130113697|NCT01271933|468377359|FG000|Single-Blind Phase|Protocol Violation|3|||
130113698|NCT01271933|468377360|FG001|Single-Blind Phase|Protocol Violation|0|||
130113699|NCT01271933|468377361|FG002|Single-Blind Phase|Protocol Violation|0|||
130113700|NCT01271933|468377359|FG000|Single-Blind Phase|Adverse Event|52|||
130113701|NCT01271933|468377360|FG001|Single-Blind Phase|Adverse Event|0|||
130113702|NCT01271933|468377361|FG002|Single-Blind Phase|Adverse Event|0|||
130113703|NCT01271933|468377359|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
130113704|NCT01271933|468377360|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
130113705|NCT01271933|468377361|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
130113706|NCT01271933|468377359|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
130113707|NCT01271933|468377360|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
130113708|NCT01271933|468377361|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
130113709|NCT01271933|468377359|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
130113710|NCT01271933|468377360|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
130113711|NCT01271933|468377361|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
130113712|NCT01271933|468377359|FG000|Double-Blind Phase|Randomized but not treated|0|||
130113713|NCT01271933|468377360|FG001|Double-Blind Phase|Randomized but not treated|0|||
130113714|NCT01271933|468377361|FG002|Double-Blind Phase|Randomized but not treated|1|||
130113715|NCT01271933|468377359|FG000|Double-Blind Phase|Lack of Efficacy|0|||
130113716|NCT01271933|468377360|FG001|Double-Blind Phase|Lack of Efficacy|6|||
130113717|NCT01271933|468377361|FG002|Double-Blind Phase|Lack of Efficacy|9|||
130113718|NCT01271933|468377359|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130113719|NCT01271933|468377360|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130113720|NCT01271933|468377361|FG002|Double-Blind Phase|Lost to Follow-up|1|||
130113721|NCT01271933|468377359|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130113722|NCT01271933|468377360|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
130113723|NCT01271933|468377361|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
130113724|NCT01271933|468377359|FG000|Double-Blind Phase|Adverse Event|0|||
129898015|NCT01670019|467586563|FG001|Overall Study|Adverse Event|0|||
129898016|NCT01670019|467586562|FG000|Overall Study|Withdrawal by Subject|6|||
129898017|NCT01670019|467586563|FG001|Overall Study|Withdrawal by Subject|0|||
129898018|NCT00580801|467586564|FG000|Overall Study|Physician Decision|1|||
129898019|NCT00580801|467586565|FG001|Overall Study|Physician Decision|0|||
129898020|NCT00580801|467586566|FG002|Overall Study|Physician Decision|0|||
129898021|NCT00580801|467586564|FG000|Overall Study|Adverse Event|2|||
129898022|NCT00580801|467586565|FG001|Overall Study|Adverse Event|0|||
129898023|NCT00580801|467586566|FG002|Overall Study|Adverse Event|0|||
129898024|NCT00580801|467586564|FG000|Overall Study|Lost to Follow-up|2|||
129898025|NCT00580801|467586565|FG001|Overall Study|Lost to Follow-up|0|||
129898026|NCT00580801|467586566|FG002|Overall Study|Lost to Follow-up|0|||
129898027|NCT00580801|467586564|FG000|Overall Study|Reached a virologic endpoint|0|||
129898028|NCT00580801|467586565|FG001|Overall Study|Reached a virologic endpoint|1|||
129898029|NCT00580801|467586566|FG002|Overall Study|Reached a virologic endpoint|2|||
129898030|NCT00580801|467586564|FG000|Overall Study|Participant non-compliant|0|||
129898031|NCT00580801|467586565|FG001|Overall Study|Participant non-compliant|0|||
129898032|NCT00580801|467586566|FG002|Overall Study|Participant non-compliant|1|||
129898033|NCT00580801|467586564|FG000|Overall Study|Travel|1|||
129898034|NCT00580801|467586565|FG001|Overall Study|Travel|0|||
129898035|NCT00580801|467586566|FG002|Overall Study|Travel|0|||
129898036|NCT00502593|467586567|FG000|Overall Study|Withdrawn unspecified reason|1|||
129898037|NCT00502593|467586568|FG001|Overall Study|Withdrawn unspecified reason|1|||
129898038|NCT00502593|467586569|FG002|Overall Study|Withdrawn unspecified reason|3|||
129898039|NCT00502593|467586570|FG003|Overall Study|Withdrawn unspecified reason|1|||
129898040|NCT00502593|467586571|FG004|Overall Study|Withdrawn unspecified reason|2|||
129898041|NCT00502593|467586572|FG005|Overall Study|Withdrawn unspecified reason|0|||
129898042|NCT00502593|467586573|FG006|Overall Study|Withdrawn unspecified reason|2|||
129898043|NCT00502593|467586574|FG007|Overall Study|Withdrawn unspecified reason|0|||
129898044|NCT00502593|467586575|FG008|Overall Study|Withdrawn unspecified reason|0|||
129898045|NCT00502593|467586576|FG009|Overall Study|Withdrawn unspecified reason|0|||
129898046|NCT00502593|467586577|FG010|Overall Study|Withdrawn unspecified reason|0|||
129898047|NCT00502593|467586578|FG011|Overall Study|Withdrawn unspecified reason|0|||
129898048|NCT00502593|467586567|FG000|Overall Study|Withdrawal by Subject|0|||
129898049|NCT00502593|467586568|FG001|Overall Study|Withdrawal by Subject|0|||
129898050|NCT00502593|467586569|FG002|Overall Study|Withdrawal by Subject|6|||
129898051|NCT00502593|467586570|FG003|Overall Study|Withdrawal by Subject|2|||
129898052|NCT00502593|467586571|FG004|Overall Study|Withdrawal by Subject|2|||
129898053|NCT00502593|467586572|FG005|Overall Study|Withdrawal by Subject|0|||
129898054|NCT00502593|467586573|FG006|Overall Study|Withdrawal by Subject|3|||
129898055|NCT00502593|467586574|FG007|Overall Study|Withdrawal by Subject|0|||
129898056|NCT00502593|467586575|FG008|Overall Study|Withdrawal by Subject|3|||
129898057|NCT00502593|467586576|FG009|Overall Study|Withdrawal by Subject|0|||
129898058|NCT00502593|467586577|FG010|Overall Study|Withdrawal by Subject|1|||
129898059|NCT00502593|467586578|FG011|Overall Study|Withdrawal by Subject|0|||
129898060|NCT00502593|467586567|FG000|Overall Study|Lost to Follow-up|2|||
129898061|NCT00502593|467586568|FG001|Overall Study|Lost to Follow-up|1|||
129898062|NCT00502593|467586569|FG002|Overall Study|Lost to Follow-up|1|||
129898063|NCT00502593|467586570|FG003|Overall Study|Lost to Follow-up|1|||
129898064|NCT00502593|467586571|FG004|Overall Study|Lost to Follow-up|0|||
129898065|NCT00502593|467586572|FG005|Overall Study|Lost to Follow-up|0|||
129898066|NCT00502593|467586573|FG006|Overall Study|Lost to Follow-up|0|||
129898067|NCT00502593|467586574|FG007|Overall Study|Lost to Follow-up|0|||
130061464|NCT04191577|468178919|FG000|Overall Study|Adverse Event|0|||
130061465|NCT04191577|468178920|FG001|Overall Study|Adverse Event|0|||
130061466|NCT04191577|468178921|FG002|Overall Study|Adverse Event|1|||
130061467|NCT04191577|468178919|FG000|Overall Study|Death|0|||
130061468|NCT04191577|468178920|FG001|Overall Study|Death|0|||
130061469|NCT04191577|468178921|FG002|Overall Study|Death|1|||
130061470|NCT03655717|468178922|FG000|Overall Study|Withdrawal by Subject|4|||
130061471|NCT03655717|468178923|FG001|Overall Study|Withdrawal by Subject|8|||
130061472|NCT03655717|468178924|FG002|Overall Study|Withdrawal by Subject|1|||
130061473|NCT03655717|468178925|FG003|Overall Study|Withdrawal by Subject|0|||
130061474|NCT03655717|468178926|FG004|Overall Study|Withdrawal by Subject|0|||
130061475|NCT03655717|468178927|FG005|Overall Study|Withdrawal by Subject|1|||
129898068|NCT00502593|467586575|FG008|Overall Study|Lost to Follow-up|3|||
129898069|NCT00502593|467586576|FG009|Overall Study|Lost to Follow-up|0|||
129898070|NCT00502593|467586577|FG010|Overall Study|Lost to Follow-up|1|||
129898071|NCT00502593|467586578|FG011|Overall Study|Lost to Follow-up|0|||
129898072|NCT01664104|467586579|FG000|Overall Study|Adverse Event|6|||
129898073|NCT01664104|467586579|FG000|Overall Study|Lack of Efficacy|2|||
129898074|NCT01664104|467586579|FG000|Overall Study|Withdrawal by Subject|1|||
129898075|NCT01664104|467586579|FG000|Overall Study|Lost to Follow-up|4|||
129898076|NCT01664104|467586579|FG000|Overall Study|Other|1|||
130061476|NCT03655717|468178928|FG006|Overall Study|Withdrawal by Subject|3|||
130061477|NCT03655717|468178929|FG007|Overall Study|Withdrawal by Subject|1|||
130061478|NCT03655717|468178930|FG008|Overall Study|Withdrawal by Subject|2|||
129835986|NCT02739269|467366160|FG001|Overall Study|Protocol Violation|0|||
129835987|NCT02739269|467366159|FG000|Overall Study|Cycle cancellation|2|||
129835988|NCT02739269|467366160|FG001|Overall Study|Cycle cancellation|2|||
129835989|NCT02739269|467366159|FG000|Overall Study|Withdrawal by Subject|0|||
129835990|NCT02739269|467366160|FG001|Overall Study|Withdrawal by Subject|2|||
129835991|NCT00923559|467366161|FG000|Overall Study|Lost to Follow-up|2|||
129835992|NCT00923559|467366162|FG001|Overall Study|Lost to Follow-up|3|||
129835993|NCT01951157|467366163|FG000|Overall Study|Progressive Disease|12|||
129835994|NCT01951157|467366164|FG001|Overall Study|Progressive Disease|13|||
129835995|NCT01951157|467366165|FG002|Overall Study|Progressive Disease|10|||
129835996|NCT01951157|467366163|FG000|Overall Study|Treatment-unrelated AE|1|||
129835997|NCT01951157|467366164|FG001|Overall Study|Treatment-unrelated AE|0|||
129835998|NCT01951157|467366165|FG002|Overall Study|Treatment-unrelated AE|3|||
129835999|NCT01951157|467366163|FG000|Overall Study|Study Termination|0|||
129836000|NCT01951157|467366164|FG001|Overall Study|Study Termination|0|||
129836001|NCT01951157|467366165|FG002|Overall Study|Study Termination|1|||
129836002|NCT01951157|467366163|FG000|Overall Study|Physician Decision|5|||
129836003|NCT01951157|467366164|FG001|Overall Study|Physician Decision|3|||
129836004|NCT01951157|467366165|FG002|Overall Study|Physician Decision|2|||
129836005|NCT01951157|467366163|FG000|Overall Study|Non-treatmentrelated death|2|||
129836006|NCT01951157|467366164|FG001|Overall Study|Non-treatmentrelated death|2|||
129836007|NCT01951157|467366165|FG002|Overall Study|Non-treatmentrelated death|2|||
129836008|NCT01951157|467366163|FG000|Overall Study|No treated|0|||
129836009|NCT01951157|467366164|FG001|Overall Study|No treated|1|||
129836010|NCT01951157|467366165|FG002|Overall Study|No treated|0|||
129836011|NCT01951157|467366163|FG000|Overall Study|Treatment-related AE|2|||
129836012|NCT01951157|467366164|FG001|Overall Study|Treatment-related AE|0|||
129836013|NCT01951157|467366165|FG002|Overall Study|Treatment-related AE|4|||
129836014|NCT01951157|467366163|FG000|Overall Study|Consent withdrawn by subject|0|||
129836015|NCT01951157|467366164|FG001|Overall Study|Consent withdrawn by subject|1|||
129836016|NCT01951157|467366165|FG002|Overall Study|Consent withdrawn by subject|3|||
129836017|NCT01951157|467366163|FG000|Overall Study|Treatment-related death|0|||
129836018|NCT01951157|467366164|FG001|Overall Study|Treatment-related death|2|||
129836019|NCT01951157|467366165|FG002|Overall Study|Treatment-related death|0|||
129836020|NCT00329407|467366171|FG000|Overall Study|Withdrawal by Subject|1|||
129836021|NCT00978068|467366172|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
129836022|NCT00978068|467366173|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
129836023|NCT00978068|467366172|FG000|Overall Study|Death|1|||
129836024|NCT00978068|467366173|FG001|Overall Study|Death|2|||
129836025|NCT00978068|467366172|FG000|Overall Study|Lost to Follow-up|1|||
129836026|NCT00978068|467366173|FG001|Overall Study|Lost to Follow-up|2|||
129836027|NCT00978068|467366172|FG000|Overall Study|Physician Decision|0|||
129836028|NCT00978068|467366173|FG001|Overall Study|Physician Decision|1|||
129836029|NCT00978068|467366172|FG000|Overall Study|Unable to Comply with Study|0|||
129836030|NCT00978068|467366173|FG001|Overall Study|Unable to Comply with Study|2|||
129836031|NCT03560531|467366174|FG000|Overall Study|Death|4|||
129836032|NCT03560531|467366175|FG001|Overall Study|Death|1|||
129836033|NCT03560531|467366176|FG002|Overall Study|Death|1|||
129836034|NCT03560531|467366177|FG003|Overall Study|Death|2|||
129836035|NCT03560531|467366178|FG004|Overall Study|Death|6|||
129836036|NCT03560531|467366179|FG005|Overall Study|Death|1|||
129836037|NCT03560531|467366180|FG006|Overall Study|Death|4|||
129836038|NCT03560531|467366181|FG007|Overall Study|Death|8|||
130061479|NCT03655717|468178931|FG009|Overall Study|Withdrawal by Subject|0|||
130061480|NCT03655717|468178932|FG010|Overall Study|Withdrawal by Subject|0|||
130061481|NCT03655717|468178933|FG011|Overall Study|Withdrawal by Subject|1|||
130061482|NCT03655717|468178934|FG012|Overall Study|Withdrawal by Subject|0|||
130061483|NCT03655717|468178935|FG013|Overall Study|Withdrawal by Subject|3|||
130061484|NCT03655717|468178936|FG014|Overall Study|Withdrawal by Subject|0|||
130061485|NCT03655717|468178937|FG015|Overall Study|Withdrawal by Subject|1|||
130061486|NCT03655717|468178938|FG016|Overall Study|Withdrawal by Subject|0|||
130061487|NCT03655717|468178939|FG017|Overall Study|Withdrawal by Subject|0|||
129898077|NCT01664104|467586579|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
130061488|NCT03655717|468178940|FG018|Overall Study|Withdrawal by Subject|1|||
129836039|NCT03560531|467366182|FG008|Overall Study|Death|1|||
129836040|NCT03560531|467366183|FG009|Overall Study|Death|3|||
129836041|NCT03560531|467366184|FG010|Overall Study|Death|2|||
129836042|NCT03560531|467366185|FG011|Overall Study|Death|0|||
129836043|NCT03560531|467366186|FG012|Overall Study|Death|4|||
129836044|NCT03560531|467366187|FG013|Overall Study|Death|1|||
129836045|NCT03560531|467366174|FG000|Overall Study|Lost to Follow-up|1|||
129836046|NCT03560531|467366175|FG001|Overall Study|Lost to Follow-up|1|||
129836047|NCT03560531|467366176|FG002|Overall Study|Lost to Follow-up|0|||
129836048|NCT03560531|467366177|FG003|Overall Study|Lost to Follow-up|0|||
129836049|NCT03560531|467366178|FG004|Overall Study|Lost to Follow-up|0|||
129836050|NCT03560531|467366179|FG005|Overall Study|Lost to Follow-up|0|||
129836051|NCT03560531|467366180|FG006|Overall Study|Lost to Follow-up|1|||
129836052|NCT03560531|467366181|FG007|Overall Study|Lost to Follow-up|0|||
129836053|NCT03560531|467366182|FG008|Overall Study|Lost to Follow-up|0|||
129836054|NCT03560531|467366183|FG009|Overall Study|Lost to Follow-up|0|||
129836055|NCT03560531|467366184|FG010|Overall Study|Lost to Follow-up|0|||
129836056|NCT03560531|467366185|FG011|Overall Study|Lost to Follow-up|0|||
130061489|NCT03655717|468178941|FG019|Overall Study|Withdrawal by Subject|0|||
130061490|NCT03655717|468178942|FG020|Overall Study|Withdrawal by Subject|0|||
130061491|NCT03655717|468178943|FG021|Overall Study|Withdrawal by Subject|1|||
130061492|NCT03655717|468178944|FG022|Overall Study|Withdrawal by Subject|2|||
130061493|NCT03655717|468178945|FG023|Overall Study|Withdrawal by Subject|1|||
130061494|NCT03655717|468178946|FG024|Overall Study|Withdrawal by Subject|1|||
130061495|NCT03655717|468178947|FG025|Overall Study|Withdrawal by Subject|0|||
130061496|NCT03655717|468178922|FG000|Overall Study|Physician Decision|3|||
130061497|NCT03655717|468178923|FG001|Overall Study|Physician Decision|3|||
130061498|NCT03655717|468178924|FG002|Overall Study|Physician Decision|0|||
130061499|NCT03655717|468178925|FG003|Overall Study|Physician Decision|0|||
130061500|NCT03655717|468178926|FG004|Overall Study|Physician Decision|0|||
130061501|NCT03655717|468178927|FG005|Overall Study|Physician Decision|0|||
130061502|NCT03655717|468178928|FG006|Overall Study|Physician Decision|0|||
130061503|NCT03655717|468178929|FG007|Overall Study|Physician Decision|0|||
130061504|NCT03655717|468178930|FG008|Overall Study|Physician Decision|0|||
130061505|NCT03655717|468178931|FG009|Overall Study|Physician Decision|1|||
130061506|NCT03655717|468178932|FG010|Overall Study|Physician Decision|0|||
130061507|NCT03655717|468178933|FG011|Overall Study|Physician Decision|0|||
130061508|NCT03655717|468178934|FG012|Overall Study|Physician Decision|0|||
130061509|NCT03655717|468178935|FG013|Overall Study|Physician Decision|0|||
130061510|NCT03655717|468178936|FG014|Overall Study|Physician Decision|0|||
130061511|NCT03655717|468178937|FG015|Overall Study|Physician Decision|0|||
130061512|NCT03655717|468178938|FG016|Overall Study|Physician Decision|0|||
130061513|NCT03655717|468178939|FG017|Overall Study|Physician Decision|0|||
130061514|NCT03655717|468178940|FG018|Overall Study|Physician Decision|0|||
130061515|NCT03655717|468178941|FG019|Overall Study|Physician Decision|1|||
130061516|NCT03655717|468178942|FG020|Overall Study|Physician Decision|0|||
130061517|NCT03655717|468178943|FG021|Overall Study|Physician Decision|0|||
130061518|NCT03655717|468178944|FG022|Overall Study|Physician Decision|0|||
130061519|NCT03655717|468178945|FG023|Overall Study|Physician Decision|1|||
130061520|NCT03655717|468178946|FG024|Overall Study|Physician Decision|0|||
130061521|NCT03655717|468178947|FG025|Overall Study|Physician Decision|0|||
130061522|NCT03655717|468178922|FG000|Overall Study|Lost to Follow-up|3|||
130061523|NCT03655717|468178923|FG001|Overall Study|Lost to Follow-up|1|||
130061524|NCT03655717|468178924|FG002|Overall Study|Lost to Follow-up|0|||
130061525|NCT03655717|468178925|FG003|Overall Study|Lost to Follow-up|1|||
130061526|NCT03655717|468178926|FG004|Overall Study|Lost to Follow-up|0|||
130061527|NCT03655717|468178927|FG005|Overall Study|Lost to Follow-up|1|||
130061528|NCT03655717|468178928|FG006|Overall Study|Lost to Follow-up|0|||
130061529|NCT03655717|468178929|FG007|Overall Study|Lost to Follow-up|0|||
130061530|NCT03655717|468178930|FG008|Overall Study|Lost to Follow-up|0|||
130061531|NCT03655717|468178931|FG009|Overall Study|Lost to Follow-up|0|||
130061532|NCT03655717|468178932|FG010|Overall Study|Lost to Follow-up|0|||
130061533|NCT03655717|468178933|FG011|Overall Study|Lost to Follow-up|1|||
130061534|NCT03655717|468178934|FG012|Overall Study|Lost to Follow-up|0|||
130061535|NCT03655717|468178935|FG013|Overall Study|Lost to Follow-up|0|||
130061536|NCT03655717|468178936|FG014|Overall Study|Lost to Follow-up|0|||
130061537|NCT03655717|468178937|FG015|Overall Study|Lost to Follow-up|0|||
130061538|NCT03655717|468178938|FG016|Overall Study|Lost to Follow-up|0|||
130061539|NCT03655717|468178939|FG017|Overall Study|Lost to Follow-up|0|||
130061540|NCT03655717|468178940|FG018|Overall Study|Lost to Follow-up|0|||
130061541|NCT03655717|468178941|FG019|Overall Study|Lost to Follow-up|0|||
130061542|NCT03655717|468178942|FG020|Overall Study|Lost to Follow-up|0|||
130061543|NCT03655717|468178943|FG021|Overall Study|Lost to Follow-up|0|||
130061544|NCT03655717|468178944|FG022|Overall Study|Lost to Follow-up|0|||
130061545|NCT03655717|468178945|FG023|Overall Study|Lost to Follow-up|0|||
130061546|NCT03655717|468178946|FG024|Overall Study|Lost to Follow-up|0|||
130061547|NCT03655717|468178947|FG025|Overall Study|Lost to Follow-up|0|||
130061548|NCT01185249|468178948|FG000|Overall Study|Patients discharged or change in status|42|||
130061549|NCT00406783|468178951|FG000|Overall Study|Adverse Event|4|||
130061550|NCT00406783|468178952|FG001|Overall Study|Adverse Event|4|||
130061551|NCT00406783|468178951|FG000|Overall Study|Treatment Failure|2|||
130061552|NCT00406783|468178952|FG001|Overall Study|Treatment Failure|3|||
130061553|NCT00406783|468178951|FG000|Overall Study|Lost to Follow-up|3|||
130061554|NCT00406783|468178952|FG001|Overall Study|Lost to Follow-up|0|||
130061555|NCT00406783|468178951|FG000|Overall Study|Withdrawal by Subject|1|||
130061556|NCT00406783|468178952|FG001|Overall Study|Withdrawal by Subject|4|||
130061557|NCT00406783|468178951|FG000|Overall Study|Protocol Violation|4|||
130061558|NCT00406783|468178952|FG001|Overall Study|Protocol Violation|4|||
129836057|NCT03560531|467366186|FG012|Overall Study|Lost to Follow-up|0|||
130061559|NCT03073213|468180580|FG000|Multiple Dose Period|Protocol Violation|0|||
130061560|NCT03073213|468180581|FG001|Multiple Dose Period|Protocol Violation|0|||
130061561|NCT03073213|468180582|FG002|Multiple Dose Period|Protocol Violation|1|||
130061562|NCT01617655|468180586|FG000|Overall Study|Adverse Event|2|||
130061563|NCT01617655|468180587|FG001|Overall Study|Adverse Event|3|||
130061564|NCT01617655|468180586|FG000|Overall Study|Poor compliance to protocol|1|||
130061565|NCT01617655|468180587|FG001|Overall Study|Poor compliance to protocol|4|||
129836058|NCT03560531|467366187|FG013|Overall Study|Lost to Follow-up|0|||
129836059|NCT03560531|467366174|FG000|Overall Study|Withdrawal by Subject|1|||
129836060|NCT03560531|467366175|FG001|Overall Study|Withdrawal by Subject|0|||
129836061|NCT03560531|467366176|FG002|Overall Study|Withdrawal by Subject|0|||
129836062|NCT03560531|467366177|FG003|Overall Study|Withdrawal by Subject|0|||
129836063|NCT03560531|467366178|FG004|Overall Study|Withdrawal by Subject|0|||
129836064|NCT03560531|467366179|FG005|Overall Study|Withdrawal by Subject|0|||
129836065|NCT03560531|467366180|FG006|Overall Study|Withdrawal by Subject|0|||
129836066|NCT03560531|467366181|FG007|Overall Study|Withdrawal by Subject|3|||
129836067|NCT03560531|467366182|FG008|Overall Study|Withdrawal by Subject|2|||
129836068|NCT03560531|467366183|FG009|Overall Study|Withdrawal by Subject|0|||
129836069|NCT03560531|467366184|FG010|Overall Study|Withdrawal by Subject|0|||
129836070|NCT03560531|467366185|FG011|Overall Study|Withdrawal by Subject|0|||
129836071|NCT03560531|467366186|FG012|Overall Study|Withdrawal by Subject|2|||
129836072|NCT03560531|467366187|FG013|Overall Study|Withdrawal by Subject|0|||
129836073|NCT03560531|467366174|FG000|Overall Study|Study end per-protocol|1|||
129836074|NCT03560531|467366175|FG001|Overall Study|Study end per-protocol|1|||
129836075|NCT03560531|467366176|FG002|Overall Study|Study end per-protocol|2|||
129836076|NCT03560531|467366177|FG003|Overall Study|Study end per-protocol|0|||
129836077|NCT03560531|467366178|FG004|Overall Study|Study end per-protocol|1|||
129836078|NCT03560531|467366179|FG005|Overall Study|Study end per-protocol|0|||
129836079|NCT03560531|467366180|FG006|Overall Study|Study end per-protocol|0|||
129836080|NCT03560531|467366181|FG007|Overall Study|Study end per-protocol|0|||
129836081|NCT03560531|467366182|FG008|Overall Study|Study end per-protocol|0|||
129836082|NCT03560531|467366183|FG009|Overall Study|Study end per-protocol|0|||
129836083|NCT03560531|467366184|FG010|Overall Study|Study end per-protocol|0|||
129836084|NCT03560531|467366185|FG011|Overall Study|Study end per-protocol|0|||
130061566|NCT01617655|468180586|FG000|Overall Study|Participants moved|0|||
130061567|NCT01617655|468180587|FG001|Overall Study|Participants moved|4|||
130061568|NCT01617655|468180586|FG000|Overall Study|Consent withdrawn by participant|1|||
130061569|NCT01617655|468180587|FG001|Overall Study|Consent withdrawn by participant|1|||
130061570|NCT01617655|468180586|FG000|Overall Study|Last visit outside protocol visit window|1|||
130061571|NCT01617655|468180587|FG001|Overall Study|Last visit outside protocol visit window|10|||
130061572|NCT01617655|468180586|FG000|Overall Study|Site closure|3|||
130061573|NCT01617655|468180587|FG001|Overall Study|Site closure|5|||
130061574|NCT01617655|468180586|FG000|Overall Study|Other than specified above|1|||
130061575|NCT01617655|468180587|FG001|Overall Study|Other than specified above|2|||
130061576|NCT01175213|468180588|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
130061577|NCT01175213|468180589|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
130061578|NCT01175213|468180588|FG000|IGSC, 10%/rHuPH20|Death|1|||
130061579|NCT01175213|468180589|FG001|IGSC, 10%/rHuPH20|Death|0|||
130061580|NCT01175213|468180588|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
130061581|NCT01175213|468180589|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
130061582|NCT01175213|468180588|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
130061583|NCT01175213|468180589|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
130061584|NCT01175213|468180588|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
130061585|NCT01175213|468180589|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
130061586|NCT01175213|468180588|FG000|Safety Follow-up|Adverse Event|1|||
130061587|NCT01175213|468180589|FG001|Safety Follow-up|Adverse Event|0|||
130061588|NCT01245764|468180593|FG000|Study Phase A|Other|3|||
130061589|NCT01245764|468180594|FG001|Study Phase A|Other|2|||
130061590|NCT01245764|468180595|FG002|Study Phase A|Other|3|||
130061591|NCT01245764|468180596|FG003|Study Phase A|Other|1|||
130061592|NCT01245764|468180593|FG000|Study Phase A|Protocol Violation|6|||
130061593|NCT01245764|468180594|FG001|Study Phase A|Protocol Violation|3|||
130061594|NCT01245764|468180595|FG002|Study Phase A|Protocol Violation|2|||
130061595|NCT01245764|468180596|FG003|Study Phase A|Protocol Violation|2|||
130061596|NCT01245764|468180593|FG000|Study Phase A|Lost to Follow-up|0|||
130061597|NCT01245764|468180594|FG001|Study Phase A|Lost to Follow-up|0|||
130061598|NCT01245764|468180595|FG002|Study Phase A|Lost to Follow-up|5|||
130061599|NCT01245764|468180596|FG003|Study Phase A|Lost to Follow-up|0|||
130061600|NCT00003476|468180597|FG000|Overall Study|Not evaluable|1|||
130061601|NCT00781963|468180600|FG000|Overall Study|Death|3|||
130061602|NCT00781963|468180601|FG001|Overall Study|Death|0|||
130061603|NCT00781963|468180600|FG000|Overall Study|Lost to Follow-up|2|||
130061604|NCT00781963|468180601|FG001|Overall Study|Lost to Follow-up|1|||
129836085|NCT03560531|467366186|FG012|Overall Study|Study end per-protocol|0|||
130061605|NCT00781963|468180600|FG000|Overall Study|Withdrawal by Subject|3|||
130061606|NCT00781963|468180601|FG001|Overall Study|Withdrawal by Subject|1|||
130061607|NCT00781963|468180600|FG000|Overall Study|Refused follow-up|9|||
130061608|NCT00781963|468180601|FG001|Overall Study|Refused follow-up|0|||
130113725|NCT01271933|468377360|FG001|Double-Blind Phase|Adverse Event|3|||
129836086|NCT03560531|467366187|FG013|Overall Study|Study end per-protocol|0|||
129836087|NCT03560531|467366174|FG000|Overall Study|Early study termination by sponsor|9|||
129836088|NCT03560531|467366175|FG001|Overall Study|Early study termination by sponsor|0|||
130061609|NCT03057951|468180605|FG000|Overall Study|Adverse Event|553|||
130061610|NCT03057951|468180606|FG001|Overall Study|Adverse Event|575|||
130113726|NCT01271933|468377361|FG002|Double-Blind Phase|Adverse Event|0|||
130113727|NCT01271933|468377359|FG000|Double-Blind Phase|Participant request-personal reason|0|||
130113728|NCT01271933|468377360|FG001|Double-Blind Phase|Participant request-personal reason|1|||
130113729|NCT01271933|468377361|FG002|Double-Blind Phase|Participant request-personal reason|0|||
130113730|NCT01138150|468377362|FG000|Overall Study|blood unable to be processed|0|||
130113731|NCT01138150|468377363|FG001|Overall Study|blood unable to be processed|1|||
130113732|NCT01138150|468377362|FG000|Overall Study|Physician Decision|1|||
130113733|NCT01138150|468377363|FG001|Overall Study|Physician Decision|0|||
130113734|NCT01620983|468377364|FG000|Overall Study|Lost to Follow-up|8|||
130113735|NCT01620983|468377365|FG001|Overall Study|Lost to Follow-up|4|||
130113736|NCT01620983|468377366|FG002|Overall Study|Lost to Follow-up|9|||
130113737|NCT01620983|468377364|FG000|Overall Study|Withdrawal by Subject|6|||
130113738|NCT01620983|468377365|FG001|Overall Study|Withdrawal by Subject|8|||
130113739|NCT01620983|468377366|FG002|Overall Study|Withdrawal by Subject|1|||
130113740|NCT01620983|468377364|FG000|Overall Study|Death|2|||
130113741|NCT01620983|468377365|FG001|Overall Study|Death|0|||
130113742|NCT01620983|468377366|FG002|Overall Study|Death|0|||
130113743|NCT01620983|468377364|FG000|Overall Study|Physician Decision|3|||
130113744|NCT01620983|468377365|FG001|Overall Study|Physician Decision|10|||
130113745|NCT01620983|468377366|FG002|Overall Study|Physician Decision|5|||
130113746|NCT05085964|468377368|FG000|Overall Study|Premature termination of study|21|||
130113747|NCT05085964|468377369|FG001|Overall Study|Premature termination of study|0|||
130113748|NCT00545233|468377370|FG000|Overall Study|Adverse Event|10|||
130113749|NCT00545233|468377371|FG001|Overall Study|Adverse Event|5|||
130113750|NCT00545233|468377370|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
130113751|NCT00545233|468377371|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130113752|NCT00545233|468377370|FG000|Overall Study|Protocol Violation|2|||
129898078|NCT01467700|467586581|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
129898079|NCT01467700|467586582|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
129898080|NCT01467700|467586583|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
129898081|NCT01467700|467586584|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
129898082|NCT01467700|467586581|FG000|Overall Study|Major Protocol Deviation|3|||
129898083|NCT01467700|467586582|FG001|Overall Study|Major Protocol Deviation|3|||
129898084|NCT01467700|467586583|FG002|Overall Study|Major Protocol Deviation|2|||
129898085|NCT01467700|467586584|FG003|Overall Study|Major Protocol Deviation|3|||
129898086|NCT01467700|467586581|FG000|Overall Study|Lost to Follow-up|6|||
129898087|NCT01467700|467586582|FG001|Overall Study|Lost to Follow-up|5|||
129898088|NCT01467700|467586583|FG002|Overall Study|Lost to Follow-up|2|||
129898089|NCT01467700|467586584|FG003|Overall Study|Lost to Follow-up|3|||
129898090|NCT01467700|467586581|FG000|Overall Study|Voluntary Withdrawal|5|||
129898091|NCT01467700|467586582|FG001|Overall Study|Voluntary Withdrawal|7|||
129898092|NCT01467700|467586583|FG002|Overall Study|Voluntary Withdrawal|6|||
129898093|NCT01467700|467586584|FG003|Overall Study|Voluntary Withdrawal|2|||
129898094|NCT01467700|467586581|FG000|Overall Study|Study Termination|6|||
129898095|NCT01467700|467586582|FG001|Overall Study|Study Termination|5|||
129898096|NCT01467700|467586583|FG002|Overall Study|Study Termination|10|||
129898097|NCT01467700|467586584|FG003|Overall Study|Study Termination|7|||
129898098|NCT01467700|467586581|FG000|Overall Study|Pregnancy|0|||
129898099|NCT01467700|467586582|FG001|Overall Study|Pregnancy|1|||
130061611|NCT03057951|468180605|FG000|Overall Study|Protocol Violation|30|||
130061612|NCT03057951|468180606|FG001|Overall Study|Protocol Violation|24|||
130061613|NCT03057951|468180605|FG000|Overall Study|Lost to Follow-up|6|||
130061614|NCT03057951|468180606|FG001|Overall Study|Lost to Follow-up|16|||
130061615|NCT03057951|468180605|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
130061616|NCT03057951|468180606|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
130061617|NCT03057951|468180605|FG000|Overall Study|Study drug stopped, reason missing|6|||
130061618|NCT03057951|468180606|FG001|Overall Study|Study drug stopped, reason missing|1|||
130061619|NCT03057951|468180605|FG000|Overall Study|Medical advice|6|||
130061620|NCT03057951|468180606|FG001|Overall Study|Medical advice|2|||
130061621|NCT03057951|468180605|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
130061622|NCT03057951|468180606|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
130061623|NCT03057951|468180605|FG000|Overall Study|Investigator decision|2|||
130061624|NCT03057951|468180606|FG001|Overall Study|Investigator decision|0|||
130061625|NCT03057951|468180605|FG000|Overall Study|Patient decision|5|||
130061626|NCT03057951|468180606|FG001|Overall Study|Patient decision|2|||
130061627|NCT03057951|468180605|FG000|Overall Study|Not attending study visits|3|||
130061628|NCT03057951|468180606|FG001|Overall Study|Not attending study visits|0|||
130061629|NCT03057951|468180605|FG000|Overall Study|Patient moved away|3|||
130061630|NCT03057951|468180606|FG001|Overall Study|Patient moved away|4|||
130061631|NCT03057951|468180605|FG000|Overall Study|Other reason than stated above|23|||
130061632|NCT03057951|468180606|FG001|Overall Study|Other reason than stated above|29|||
130061633|NCT03057951|468180605|FG000|Overall Study|Not treated|2|||
129898100|NCT01467700|467586583|FG002|Overall Study|Pregnancy|1|||
129898101|NCT01467700|467586584|FG003|Overall Study|Pregnancy|0|||
129898102|NCT01467700|467586581|FG000|Overall Study|Lack of Efficacy|2|||
130113753|NCT00545233|468377371|FG001|Overall Study|Protocol Violation|0|||
130061634|NCT03057951|468180606|FG001|Overall Study|Not treated|1|||
130061635|NCT02064205|468180607|FG000|Overall Study|Withdrawal by Subject|1|||
130061636|NCT02062463|468180608|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
130061637|NCT02062463|468180609|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
130061638|NCT02062463|468180610|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
130061639|NCT02062463|468180611|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
130061640|NCT02062463|468180608|FG000|Stage 2|Adverse Event|0|||
130061641|NCT02062463|468180609|FG001|Stage 2|Adverse Event|0|||
130061642|NCT02062463|468180610|FG002|Stage 2|Adverse Event|12|||
130061643|NCT02062463|468180611|FG003|Stage 2|Adverse Event|20|||
130061644|NCT02062463|468180608|FG000|Stage 2|Lack of Efficacy|0|||
130061645|NCT02062463|468180609|FG001|Stage 2|Lack of Efficacy|0|||
130061646|NCT02062463|468180610|FG002|Stage 2|Lack of Efficacy|3|||
130061647|NCT02062463|468180611|FG003|Stage 2|Lack of Efficacy|4|||
130061648|NCT02062463|468180608|FG000|Stage 2|Lost to Follow-up|0|||
130061649|NCT02062463|468180609|FG001|Stage 2|Lost to Follow-up|0|||
130061650|NCT02062463|468180610|FG002|Stage 2|Lost to Follow-up|20|||
130061651|NCT02062463|468180611|FG003|Stage 2|Lost to Follow-up|20|||
130061652|NCT02062463|468180608|FG000|Stage 2|Non-Compliance|0|||
130061653|NCT02062463|468180609|FG001|Stage 2|Non-Compliance|0|||
130061654|NCT02062463|468180610|FG002|Stage 2|Non-Compliance|0|||
130061655|NCT02062463|468180611|FG003|Stage 2|Non-Compliance|1|||
130061656|NCT02062463|468180608|FG000|Stage 2|Other than specified|0|||
130061657|NCT02062463|468180609|FG001|Stage 2|Other than specified|0|||
130061658|NCT02062463|468180610|FG002|Stage 2|Other than specified|3|||
130061659|NCT02062463|468180611|FG003|Stage 2|Other than specified|1|||
130061660|NCT02062463|468180608|FG000|Stage 2|Withdrawal by Subject|0|||
130061661|NCT02062463|468180609|FG001|Stage 2|Withdrawal by Subject|0|||
130061662|NCT02062463|468180610|FG002|Stage 2|Withdrawal by Subject|15|||
130061663|NCT02062463|468180611|FG003|Stage 2|Withdrawal by Subject|10|||
130061664|NCT04124692|468180612|FG000|Overall Study|Medical reason|0|||
130061665|NCT04124692|468180613|FG001|Overall Study|Medical reason|1|||
130061666|NCT04124692|468180612|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
130061667|NCT04124692|468180613|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
130061668|NCT04124692|468180612|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
130061669|NCT04124692|468180613|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
130061670|NCT04124692|468180612|FG000|Overall Study|Lost to Follow-up|2|||
130061671|NCT04124692|468180613|FG001|Overall Study|Lost to Follow-up|4|||
130061672|NCT04124692|468180612|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
130061673|NCT04124692|468180613|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
130061674|NCT02924688|468180614|FG000|Overall Study|Adverse Event|9|||
130061675|NCT02924688|468180615|FG001|Overall Study|Adverse Event|3|||
130061676|NCT02924688|468180616|FG002|Overall Study|Adverse Event|2|||
130061677|NCT02924688|468180617|FG003|Overall Study|Adverse Event|2|||
130061678|NCT02924688|468180618|FG004|Overall Study|Adverse Event|3|||
130061679|NCT02924688|468180619|FG005|Overall Study|Adverse Event|2|||
130061680|NCT02924688|468180614|FG000|Overall Study|Lack of Efficacy|2|||
130061681|NCT02924688|468180615|FG001|Overall Study|Lack of Efficacy|3|||
130061682|NCT02924688|468180616|FG002|Overall Study|Lack of Efficacy|4|||
130061683|NCT02924688|468180617|FG003|Overall Study|Lack of Efficacy|2|||
130061684|NCT02924688|468180618|FG004|Overall Study|Lack of Efficacy|1|||
130061685|NCT02924688|468180619|FG005|Overall Study|Lack of Efficacy|1|||
130061686|NCT02924688|468180614|FG000|Overall Study|Protocol Violation|3|||
130061687|NCT02924688|468180615|FG001|Overall Study|Protocol Violation|7|||
130061688|NCT02924688|468180616|FG002|Overall Study|Protocol Violation|5|||
130061689|NCT02924688|468180617|FG003|Overall Study|Protocol Violation|6|||
130061690|NCT02924688|468180618|FG004|Overall Study|Protocol Violation|2|||
130061691|NCT02924688|468180619|FG005|Overall Study|Protocol Violation|2|||
130061692|NCT02924688|468180614|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
130061693|NCT02924688|468180615|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
130061694|NCT02924688|468180616|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
130061695|NCT02924688|468180617|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
130113754|NCT00545233|468377370|FG000|Overall Study|Refused Treatment|9|||
130113755|NCT00545233|468377371|FG001|Overall Study|Refused Treatment|7|||
130061696|NCT02924688|468180618|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
130061697|NCT02924688|468180619|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
130061698|NCT02924688|468180614|FG000|Overall Study|Lost to Follow-up|2|||
130061699|NCT02924688|468180615|FG001|Overall Study|Lost to Follow-up|4|||
130061700|NCT02924688|468180616|FG002|Overall Study|Lost to Follow-up|2|||
130061701|NCT02924688|468180617|FG003|Overall Study|Lost to Follow-up|4|||
130061702|NCT02924688|468180618|FG004|Overall Study|Lost to Follow-up|2|||
130061703|NCT02924688|468180619|FG005|Overall Study|Lost to Follow-up|4|||
130061704|NCT02924688|468180614|FG000|Overall Study|Physician Decision|2|||
130061705|NCT02924688|468180615|FG001|Overall Study|Physician Decision|1|||
130061706|NCT02924688|468180616|FG002|Overall Study|Physician Decision|0|||
130061707|NCT02924688|468180617|FG003|Overall Study|Physician Decision|1|||
130061708|NCT02924688|468180618|FG004|Overall Study|Physician Decision|1|||
130061709|NCT02924688|468180619|FG005|Overall Study|Physician Decision|1|||
129898103|NCT01467700|467586582|FG001|Overall Study|Lack of Efficacy|0|||
129898104|NCT01467700|467586583|FG002|Overall Study|Lack of Efficacy|2|||
129898105|NCT01467700|467586584|FG003|Overall Study|Lack of Efficacy|1|||
129898106|NCT01467700|467586581|FG000|Overall Study|Reason not Specified|1|||
129898107|NCT01467700|467586582|FG001|Overall Study|Reason not Specified|3|||
129898108|NCT01467700|467586583|FG002|Overall Study|Reason not Specified|2|||
129898109|NCT01467700|467586584|FG003|Overall Study|Reason not Specified|8|||
129898110|NCT03396913|467586587|FG000|Overall Study|Lost to Follow-up|0|||
129898111|NCT03396913|467586588|FG001|Overall Study|Lost to Follow-up|6|||
129898112|NCT00813488|467586589|FG000|Titration Period 1|Adverse Event|6|||
129898113|NCT00813488|467586590|FG001|Titration Period 1|Adverse Event|1|||
129898114|NCT00813488|467586589|FG000|Titration Period 1|Lack of Efficacy|9|||
129898115|NCT00813488|467586590|FG001|Titration Period 1|Lack of Efficacy|7|||
129898116|NCT00813488|467586589|FG000|Titration Period 1|Withdrawal by Subject|2|||
129898117|NCT00813488|467586590|FG001|Titration Period 1|Withdrawal by Subject|2|||
129898118|NCT00813488|467586589|FG000|Titration Period 1|Protocol Violation|4|||
129898119|NCT00813488|467586590|FG001|Titration Period 1|Protocol Violation|3|||
129898120|NCT00813488|467586589|FG000|Titration Period 1|Non-compliance to study medication|4|||
129898121|NCT00813488|467586590|FG001|Titration Period 1|Non-compliance to study medication|1|||
129898122|NCT00813488|467586589|FG000|Titration Period 1|Non-compliance to study procedures|2|||
129898123|NCT00813488|467586590|FG001|Titration Period 1|Non-compliance to study procedures|2|||
129898124|NCT00813488|467586589|FG000|Titration Period 1|Technical Difficulties|0|||
129898125|NCT00813488|467586590|FG001|Titration Period 1|Technical Difficulties|1|||
129898126|NCT00813488|467586589|FG000|Titration Period 2|Adverse Event|2|||
129898127|NCT00813488|467586590|FG001|Titration Period 2|Adverse Event|3|||
129898128|NCT00813488|467586589|FG000|Titration Period 2|Lack of Efficacy|8|||
129898129|NCT00813488|467586590|FG001|Titration Period 2|Lack of Efficacy|4|||
129898130|NCT00813488|467586589|FG000|Titration Period 2|Protocol Violation|3|||
129898131|NCT00813488|467586590|FG001|Titration Period 2|Protocol Violation|2|||
130061710|NCT02924688|468180614|FG000|Overall Study|Withdrawal by Subject|14|||
130061711|NCT02924688|468180615|FG001|Overall Study|Withdrawal by Subject|13|||
130061712|NCT02924688|468180616|FG002|Overall Study|Withdrawal by Subject|9|||
130061713|NCT02924688|468180617|FG003|Overall Study|Withdrawal by Subject|12|||
130061714|NCT02924688|468180618|FG004|Overall Study|Withdrawal by Subject|13|||
130061715|NCT02924688|468180619|FG005|Overall Study|Withdrawal by Subject|14|||
130061716|NCT01754922|468180620|FG000|Overall Study|Adverse Event|0|||
130061717|NCT01754922|468180621|FG001|Overall Study|Adverse Event|1|||
130061718|NCT00848250|468180622|FG000|Overall Study|surgery was completed without cardiopulm|0|||
130061719|NCT00848250|468180623|FG001|Overall Study|surgery was completed without cardiopulm|1|||
130061720|NCT00571688|468180634|FG000|Overall Study|Lost to Follow-up|3|||
130061721|NCT00571688|468180635|FG001|Overall Study|Lost to Follow-up|6|||
130061722|NCT00571688|468180634|FG000|Overall Study|subject did not tolerate Consta|1|||
130061723|NCT00571688|468180635|FG001|Overall Study|subject did not tolerate Consta|0|||
130061724|NCT00571688|468180634|FG000|Overall Study|subject moved out of the area|1|||
130061725|NCT00571688|468180635|FG001|Overall Study|subject moved out of the area|0|||
130061726|NCT03457103|468180636|FG000|Overall Study|illness/hospitalization|4|||
130061727|NCT03457103|468180637|FG001|Overall Study|illness/hospitalization|2|||
130061728|NCT03457103|468180636|FG000|Overall Study|Lost to Follow-up|2|||
130061729|NCT03457103|468180637|FG001|Overall Study|Lost to Follow-up|1|||
130061730|NCT03457103|468180636|FG000|Overall Study|Withdrawal by Subject|1|||
130061731|NCT03457103|468180637|FG001|Overall Study|Withdrawal by Subject|2|||
130061732|NCT03457103|468180636|FG000|Overall Study|financial/ insurance issues|1|||
130061733|NCT03457103|468180637|FG001|Overall Study|financial/ insurance issues|1|||
130061734|NCT00502320|468180638|FG000|Overall Study|Lost to Follow-up|1|||
130061735|NCT00502320|468180639|FG001|Overall Study|Lost to Follow-up|1|||
130061736|NCT00502320|468180638|FG000|Overall Study|Withdrew Consent|1|||
130061737|NCT00502320|468180639|FG001|Overall Study|Withdrew Consent|0|||
130061738|NCT00502320|468180638|FG000|Overall Study|No longer met criteria|1|||
130061739|NCT00502320|468180639|FG001|Overall Study|No longer met criteria|0|||
130061740|NCT00502320|468180638|FG000|Overall Study|Screen Failure|0|||
130061741|NCT00502320|468180639|FG001|Overall Study|Screen Failure|1|||
130061742|NCT00502320|468180638|FG000|Overall Study|Adverse Event|3|||
130061743|NCT00502320|468180639|FG001|Overall Study|Adverse Event|5|||
130061744|NCT03654755|468180645|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
130113756|NCT00545233|468377370|FG000|Overall Study|Failure to Return|4|||
130061745|NCT03654755|468180646|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
130061746|NCT03654755|468180647|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
130061747|NCT03654755|468180645|FG000|Overall Study|Withdrawal by Subject|2|||
130061748|NCT03654755|468180646|FG001|Overall Study|Withdrawal by Subject|4|||
130113757|NCT00545233|468377371|FG001|Overall Study|Failure to Return|6|||
130113758|NCT00545233|468377370|FG000|Overall Study|Insufficient response|14|||
129898132|NCT00813488|467586589|FG000|Titration Period 2|Lost to Follow-up|1|||
129898133|NCT00813488|467586590|FG001|Titration Period 2|Lost to Follow-up|0|||
129898134|NCT00813488|467586589|FG000|Titration Period 2|Non-compliance with study procedures|2|||
129898135|NCT00813488|467586590|FG001|Titration Period 2|Non-compliance with study procedures|1|||
130113759|NCT00545233|468377371|FG001|Overall Study|Insufficient response|15|||
130113760|NCT00545233|468377370|FG000|Overall Study|Physician Decision|2|||
130113761|NCT00545233|468377371|FG001|Overall Study|Physician Decision|1|||
130113762|NCT01208402|468377374|FG000|Overall Study|Withdrawal by Subject|1|||
129836089|NCT03560531|467366176|FG002|Overall Study|Early study termination by sponsor|0|||
129836090|NCT03560531|467366177|FG003|Overall Study|Early study termination by sponsor|4|||
130061749|NCT03654755|468180647|FG002|Overall Study|Withdrawal by Subject|8|||
130061750|NCT03654755|468180645|FG000|Overall Study|Lost to Follow-up|1|||
130061751|NCT03654755|468180646|FG001|Overall Study|Lost to Follow-up|3|||
130061752|NCT03654755|468180647|FG002|Overall Study|Lost to Follow-up|7|||
130061753|NCT03654755|468180645|FG000|Overall Study|Physician Decision|0|||
130061754|NCT03654755|468180646|FG001|Overall Study|Physician Decision|1|||
130061755|NCT03654755|468180647|FG002|Overall Study|Physician Decision|0|||
129836091|NCT03560531|467366178|FG004|Overall Study|Early study termination by sponsor|8|||
130061756|NCT03654755|468180645|FG000|Overall Study|Adverse Event|0|||
130061757|NCT03654755|468180646|FG001|Overall Study|Adverse Event|0|||
130061758|NCT03654755|468180647|FG002|Overall Study|Adverse Event|4|||
130061759|NCT03654755|468180645|FG000|Overall Study|Lack of Efficacy|0|||
130061760|NCT03654755|468180646|FG001|Overall Study|Lack of Efficacy|0|||
130061761|NCT03654755|468180647|FG002|Overall Study|Lack of Efficacy|1|||
130061762|NCT02394808|468180648|FG000|Period 1|Unsatisfactory lens fitting|0|||
130061763|NCT02394808|468180649|FG001|Period 1|Unsatisfactory lens fitting|1|||
130061764|NCT02394808|468180648|FG000|Period 2|Lost to Follow-up|1|||
130061765|NCT02394808|468180649|FG001|Period 2|Lost to Follow-up|0|||
130061766|NCT03943953|468180652|FG000|Trial of ITG 1|Lost to Follow-up|19|||
130061767|NCT03943953|468180653|FG001|Trial of ITG 1|Lost to Follow-up|1|||
130061768|NCT03943953|468180652|FG000|Trial of ITG 2|Lost to Follow-up|8|||
130061769|NCT03943953|468180653|FG001|Trial of ITG 2|Lost to Follow-up|0|||
130061770|NCT03943953|468180652|FG000|Trial of ITG 3|Lost to Follow-up|2|||
130061771|NCT03943953|468180653|FG001|Trial of ITG 3|Lost to Follow-up|0|||
130061772|NCT03943953|468180652|FG000|Trial of ITG 4|Lost to Follow-up|2|||
130061773|NCT03943953|468180653|FG001|Trial of ITG 4|Lost to Follow-up|0|||
130061774|NCT01199055|468180654|FG000|Overall Study|Death|0|||
130061775|NCT01199055|468180655|FG001|Overall Study|Death|1|||
130061776|NCT01199055|468180656|FG002|Overall Study|Death|0|||
130061777|NCT01199055|468180654|FG000|Overall Study|Physician Decision|0|||
130061778|NCT01199055|468180655|FG001|Overall Study|Physician Decision|1|||
130061779|NCT01199055|468180656|FG002|Overall Study|Physician Decision|1|||
130061780|NCT01199055|468180654|FG000|Overall Study|Progressive disease|2|||
130061781|NCT01199055|468180655|FG001|Overall Study|Progressive disease|1|||
130061782|NCT01199055|468180656|FG002|Overall Study|Progressive disease|2|||
130061783|NCT01199055|468180654|FG000|Overall Study|Withdrawal by Subject|0|||
130061784|NCT01199055|468180655|FG001|Overall Study|Withdrawal by Subject|0|||
130061785|NCT01199055|468180656|FG002|Overall Study|Withdrawal by Subject|1|||
130061786|NCT04580394|468180657|FG000|First Intervention|Incorrectly Randomized|1|||
130061787|NCT04580394|468180657|FG000|First Intervention|Physician Decision|1|||
130061788|NCT04580394|468180657|FG000|First Intervention|Lost to Follow-up|1|||
130061789|NCT04580394|468180657|FG000|Washout (One Week)|Withdrawal by Subject|1|||
130061790|NCT04580394|468180657|FG000|Washout (One Week)|Adverse Event|1|||
130061791|NCT04580394|468180657|FG000|Washout (One Week)|Withdrawal by Subject|2|||
130061792|NCT04580394|468180657|FG000|Third Intervention|Adverse Event|1|||
130061793|NCT04580394|468180657|FG000|Third Intervention|Withdrawal by Subject|1|||
130061794|NCT04580394|468180657|FG000|Washout (One Week)|Withdrawal by Subject|2|||
130061795|NCT00642746|468180659|FG000|Overall Study|Patient unevaluable|1|||
130061796|NCT00642746|468180660|FG001|Overall Study|Patient unevaluable|0|||
130061797|NCT03337152|468180663|FG000|Overall Study|Physician Decision|1|||
130061798|NCT03337152|468180664|FG001|Overall Study|Physician Decision|0|||
130061799|NCT03337152|468180663|FG000|Overall Study|Lost to Follow-up|1|||
130061800|NCT03337152|468180664|FG001|Overall Study|Lost to Follow-up|3|||
130061801|NCT03337152|468180663|FG000|Overall Study|Adverse Event|3|||
129836092|NCT03560531|467366179|FG005|Overall Study|Early study termination by sponsor|2|||
129836093|NCT03560531|467366180|FG006|Overall Study|Early study termination by sponsor|5|||
129836094|NCT03560531|467366181|FG007|Overall Study|Early study termination by sponsor|64|||
129836095|NCT03560531|467366182|FG008|Overall Study|Early study termination by sponsor|7|||
130061802|NCT03337152|468180664|FG001|Overall Study|Adverse Event|1|||
130061803|NCT03337152|468180663|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
130061804|NCT03337152|468180664|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
130113763|NCT01208402|468377375|FG001|Overall Study|Withdrawal by Subject|0|||
130061805|NCT01069523|468180665|FG000|Overall Study|Withdrawal by Subject|4|||
130061806|NCT01069523|468180666|FG001|Overall Study|Withdrawal by Subject|7|||
130061807|NCT01551758|468180677|FG000|Overall Study|Adverse Event|29|||
130061808|NCT01551758|468180678|FG001|Overall Study|Adverse Event|43|||
129836096|NCT03560531|467366183|FG009|Overall Study|Early study termination by sponsor|2|||
130061809|NCT01551758|468180677|FG000|Overall Study|Lack of Efficacy|0|||
130061810|NCT01551758|468180678|FG001|Overall Study|Lack of Efficacy|1|||
130061811|NCT01551758|468180677|FG000|Overall Study|Protocol Violation|5|||
130061812|NCT01551758|468180678|FG001|Overall Study|Protocol Violation|6|||
130061813|NCT01551758|468180677|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
130061814|NCT01551758|468180678|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
130061815|NCT01551758|468180677|FG000|Overall Study|Lost to Follow-up|29|||
130061816|NCT01551758|468180678|FG001|Overall Study|Lost to Follow-up|25|||
130061817|NCT01551758|468180677|FG000|Overall Study|Physician Decision|9|||
130061818|NCT01551758|468180678|FG001|Overall Study|Physician Decision|3|||
130061819|NCT01551758|468180677|FG000|Overall Study|Withdrawal by Subject|14|||
130061820|NCT01551758|468180678|FG001|Overall Study|Withdrawal by Subject|17|||
130061821|NCT03670641|468180679|FG000|Overall Study|Lost to Follow-up|3|||
130061822|NCT01096849|468180680|FG000|Overall Study|Consent Withdrawn|1|||
130061823|NCT01096849|468180681|FG001|Overall Study|Consent Withdrawn|4|||
130061824|NCT01096849|468180682|FG002|Overall Study|Consent Withdrawn|2|||
130061825|NCT01096849|468180680|FG000|Overall Study|Lack of Efficacy|0|||
130061826|NCT01096849|468180681|FG001|Overall Study|Lack of Efficacy|2|||
130061827|NCT01096849|468180682|FG002|Overall Study|Lack of Efficacy|0|||
130061828|NCT01096849|468180680|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
130061829|NCT01096849|468180681|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
130061830|NCT01096849|468180682|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
130061831|NCT01096849|468180680|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
130061832|NCT01096849|468180681|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
130061833|NCT01096849|468180682|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
130061834|NCT01096849|468180680|FG000|Overall Study|Administrative Reasons|0|||
130061835|NCT01096849|468180681|FG001|Overall Study|Administrative Reasons|1|||
130061836|NCT01096849|468180682|FG002|Overall Study|Administrative Reasons|2|||
130061837|NCT01096849|468180680|FG000|Overall Study|Lost to Follow-up|1|||
130061838|NCT01096849|468180681|FG001|Overall Study|Lost to Follow-up|3|||
130061839|NCT01096849|468180682|FG002|Overall Study|Lost to Follow-up|1|||
130061840|NCT00118482|468180684|FG000|Overall Study|Lost to Follow-up|7|||
130061841|NCT00118482|468180685|FG001|Overall Study|Lost to Follow-up|7|||
130061842|NCT00118482|468180684|FG000|Overall Study|Withdrawal by Subject|23|||
130061843|NCT00118482|468180685|FG001|Overall Study|Withdrawal by Subject|22|||
130061844|NCT00242580|468180686|FG000|Overall Study|Adverse Event|3|||
130061845|NCT00242580|468180687|FG001|Overall Study|Adverse Event|0|||
130061846|NCT00242580|468180688|FG002|Overall Study|Adverse Event|2|||
130061847|NCT00242580|468180686|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130061848|NCT00242580|468180687|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130061849|NCT00242580|468180688|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
130061850|NCT00242580|468180686|FG000|Overall Study|Protocol Violation|0|||
130061851|NCT00242580|468180687|FG001|Overall Study|Protocol Violation|0|||
130061852|NCT00242580|468180688|FG002|Overall Study|Protocol Violation|1|||
130061853|NCT00242580|468180686|FG000|Overall Study|Subject withdrew consent|2|||
130061854|NCT00242580|468180687|FG001|Overall Study|Subject withdrew consent|2|||
130061855|NCT00242580|468180688|FG002|Overall Study|Subject withdrew consent|5|||
130061856|NCT00242580|468180686|FG000|Overall Study|Lost to Follow-up|0|||
130061857|NCT00242580|468180687|FG001|Overall Study|Lost to Follow-up|3|||
130061858|NCT00242580|468180688|FG002|Overall Study|Lost to Follow-up|0|||
130061859|NCT00242580|468180686|FG000|Overall Study|Death|1|||
130061860|NCT00242580|468180687|FG001|Overall Study|Death|2|||
130061861|NCT00242580|468180688|FG002|Overall Study|Death|1|||
130061862|NCT01232894|468180689|FG000|Overall Study|Lost to Follow-up|0|||
130061863|NCT01232894|468180690|FG001|Overall Study|Lost to Follow-up|1|||
130061864|NCT01232894|468180689|FG000|Overall Study|Death|1|||
130061865|NCT01232894|468180690|FG001|Overall Study|Death|0|||
130061866|NCT01232894|468180689|FG000|Overall Study|Protocol Violation|1|||
130061867|NCT01232894|468180690|FG001|Overall Study|Protocol Violation|1|||
130061868|NCT01232894|468180689|FG000|Overall Study|Withdrawal by Subject|8|||
130061869|NCT01232894|468180690|FG001|Overall Study|Withdrawal by Subject|5|||
130061870|NCT01232894|468180689|FG000|Overall Study|Physician Decision|2|||
130061871|NCT01232894|468180690|FG001|Overall Study|Physician Decision|1|||
130061872|NCT03970395|468180693|FG000|Overall Study|Withdrawal by Subject|3|||
130061873|NCT03970395|468180694|FG001|Overall Study|Withdrawal by Subject|4|||
130061874|NCT03970395|468180693|FG000|Overall Study|Lost to Follow-up|4|||
130061875|NCT03970395|468180694|FG001|Overall Study|Lost to Follow-up|8|||
130061876|NCT00125190|468180696|FG000|Overall Study|Subject/Parent Decision|7|||
129836097|NCT03560531|467366184|FG010|Overall Study|Early study termination by sponsor|16|||
129836098|NCT03560531|467366185|FG011|Overall Study|Early study termination by sponsor|2|||
129836099|NCT03560531|467366186|FG012|Overall Study|Early study termination by sponsor|6|||
129836100|NCT03560531|467366187|FG013|Overall Study|Early study termination by sponsor|2|||
129836101|NCT01200797|467366190|FG000|Overall Study|symptomatic deterioration|2|||
130061877|NCT00125190|468180696|FG000|Overall Study|Non-compliance|2|||
130061878|NCT00125190|468180696|FG000|Overall Study|Adverse Event|1|||
130113764|NCT01335464|468377378|FG000|Overall Study|Adverse Event|15|||
129836102|NCT01200797|467366190|FG000|Overall Study|Adverse Event|4|||
129836103|NCT01200797|467366190|FG000|Overall Study|Disease Progression|13|||
130061879|NCT00125190|468180696|FG000|Overall Study|Other|1|||
130061880|NCT00125190|468180696|FG000|Overall Study|Lost to Follow-up|4|||
130061881|NCT02128763|468180697|FG000|Overall Study|Death|1|||
130061882|NCT02128763|468180698|FG001|Overall Study|Death|0|||
130061883|NCT02128763|468180697|FG000|Overall Study|Lost to Follow-up|19|||
129836104|NCT02818777|467366194|FG000|Overall Study|Adverse Event|3|||
129836105|NCT01623596|467366196|FG000|Overall Study|Abnormal laboratory values|2|||
129836106|NCT01623596|467366197|FG001|Overall Study|Abnormal laboratory values|0|||
129836107|NCT01623596|467366196|FG000|Overall Study|Administrative problems|9|||
129836108|NCT01623596|467366197|FG001|Overall Study|Administrative problems|13|||
130061884|NCT02128763|468180698|FG001|Overall Study|Lost to Follow-up|16|||
130061885|NCT03666858|468180701|FG000|Cohort 1|Adverse Event|1|||
130061886|NCT03666858|468180702|FG001|Cohort 1|Adverse Event|0|||
130061887|NCT03666858|468180701|FG000|Cohort 2|Adverse Event|0|||
130061888|NCT03666858|468180702|FG001|Cohort 2|Adverse Event|1|||
130061889|NCT02921919|468180703|FG000|Overall Study|Other|5|||
130061890|NCT02921919|468180704|FG001|Overall Study|Other|6|||
130061891|NCT02921919|468180703|FG000|Overall Study|Lost to Follow-up|0|||
130061892|NCT02921919|468180704|FG001|Overall Study|Lost to Follow-up|1|||
130061893|NCT02921919|468180703|FG000|Overall Study|Withdrawal by Subject|5|||
130061894|NCT02921919|468180704|FG001|Overall Study|Withdrawal by Subject|1|||
130061895|NCT02921919|468180703|FG000|Overall Study|Disease Progression|47|||
130061896|NCT02921919|468180704|FG001|Overall Study|Disease Progression|38|||
130061897|NCT02921919|468180703|FG000|Overall Study|Physician Decision|3|||
130061898|NCT02921919|468180704|FG001|Overall Study|Physician Decision|2|||
130061899|NCT02921919|468180703|FG000|Overall Study|Adverse Event|6|||
130061900|NCT02921919|468180704|FG001|Overall Study|Adverse Event|4|||
130061901|NCT03282357|468180705|FG000|Overall Study|Lost to Follow-up|3|||
130061902|NCT03282357|468180705|FG000|Overall Study|Withdrawal by Subject|4|||
130061903|NCT03282357|468180705|FG000|Overall Study|Adverse Event|1|||
130061904|NCT03282357|468180705|FG000|Overall Study|Other|9|||
130061905|NCT01586156|468180706|FG000|Overall Study|Pregnancy|0|||
130061906|NCT01586156|468180707|FG001|Overall Study|Pregnancy|1|||
130061907|NCT01586156|468180708|FG002|Overall Study|Pregnancy|0|||
130061908|NCT00547378|468180709|FG000|Randomized Cohort|Withdrawal by Subject|7|||
130061909|NCT00547378|468180710|FG001|Randomized Cohort|Withdrawal by Subject|5|||
130061910|NCT00547378|468180711|FG002|Randomized Cohort|Withdrawal by Subject|0|||
130061911|NCT00547378|468180709|FG000|Randomized Cohort|Death|0|||
130061912|NCT00547378|468180710|FG001|Randomized Cohort|Death|1|||
130061913|NCT00547378|468180711|FG002|Randomized Cohort|Death|0|||
130061914|NCT00547378|468180709|FG000|Randomized Cohort|Lost to Follow-up|1|||
130061915|NCT00547378|468180710|FG001|Randomized Cohort|Lost to Follow-up|0|||
130061916|NCT00547378|468180711|FG002|Randomized Cohort|Lost to Follow-up|0|||
130061917|NCT00547378|468180709|FG000|Randomized Cohort|Adverse Event|1|||
130061918|NCT00547378|468180710|FG001|Randomized Cohort|Adverse Event|0|||
130061919|NCT00547378|468180711|FG002|Randomized Cohort|Adverse Event|0|||
130061920|NCT00547378|468180709|FG000|Randomized Cohort|Other reasons|2|||
130061921|NCT00547378|468180710|FG001|Randomized Cohort|Other reasons|0|||
130061922|NCT00547378|468180711|FG002|Randomized Cohort|Other reasons|0|||
130061923|NCT00547378|468180709|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
129836109|NCT01623596|467366196|FG000|Overall Study|Adverse Event|20|||
129836110|NCT01623596|467366197|FG001|Overall Study|Adverse Event|29|||
129836111|NCT01623596|467366196|FG000|Overall Study|Death|0|||
129836112|NCT01623596|467366197|FG001|Overall Study|Death|2|||
129836113|NCT01623596|467366196|FG000|Overall Study|Lost to Follow-up|12|||
129836114|NCT01623596|467366197|FG001|Overall Study|Lost to Follow-up|16|||
129836115|NCT01623596|467366196|FG000|Overall Study|Withdrawal by Subject|13|||
129836116|NCT01623596|467366197|FG001|Overall Study|Withdrawal by Subject|31|||
129836117|NCT01623596|467366196|FG000|Overall Study|Patient no longer requires study drug|1|||
129836118|NCT01623596|467366197|FG001|Overall Study|Patient no longer requires study drug|0|||
129836119|NCT01623596|467366196|FG000|Overall Study|Protocol Violation|0|||
129836120|NCT01623596|467366197|FG001|Overall Study|Protocol Violation|6|||
129836121|NCT01623596|467366196|FG000|Overall Study|Lack of Efficacy|5|||
129836122|NCT01623596|467366197|FG001|Overall Study|Lack of Efficacy|3|||
129836123|NCT01324349|467366201|FG000|Overall Study|Death|1|||
129836124|NCT01324349|467366202|FG001|Overall Study|Death|1|||
129836125|NCT01324349|467366201|FG000|Overall Study|Withdrawal by Subject|0|||
129836126|NCT01324349|467366202|FG001|Overall Study|Withdrawal by Subject|1|||
129836127|NCT00748215|467366203|FG000|Overall Study|Withdrawal by Subject|7|||
129836128|NCT00748215|467366204|FG001|Overall Study|Withdrawal by Subject|7|||
129836129|NCT00748215|467366203|FG000|Overall Study|Treatment change|2|||
130061924|NCT00547378|468180710|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
130113765|NCT01335464|468377379|FG001|Overall Study|Adverse Event|25|||
129836130|NCT00748215|467366204|FG001|Overall Study|Treatment change|1|||
129836131|NCT00748215|467366203|FG000|Overall Study|Change in patient condition|0|||
130061925|NCT00547378|468180711|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
130061926|NCT00547378|468180709|FG000|All Implanted Cohort|Adverse Event|4|||
130061927|NCT00547378|468180710|FG001|All Implanted Cohort|Adverse Event|10|||
130061928|NCT00547378|468180711|FG002|All Implanted Cohort|Adverse Event|17|||
130061929|NCT00547378|468180709|FG000|All Implanted Cohort|Lost to Follow-up|0|||
130061930|NCT00547378|468180710|FG001|All Implanted Cohort|Lost to Follow-up|1|||
129836132|NCT00748215|467366204|FG001|Overall Study|Change in patient condition|3|||
129836133|NCT00748215|467366203|FG000|Overall Study|Non-compliant|0|||
129836134|NCT00748215|467366204|FG001|Overall Study|Non-compliant|2|||
130061931|NCT00547378|468180711|FG002|All Implanted Cohort|Lost to Follow-up|14|||
130061932|NCT00547378|468180709|FG000|All Implanted Cohort|Death|3|||
130061933|NCT00547378|468180710|FG001|All Implanted Cohort|Death|1|||
130061934|NCT00547378|468180711|FG002|All Implanted Cohort|Death|4|||
130061935|NCT00547378|468180709|FG000|All Implanted Cohort|Physician Decision|0|||
130061936|NCT00547378|468180710|FG001|All Implanted Cohort|Physician Decision|2|||
130061937|NCT00547378|468180711|FG002|All Implanted Cohort|Physician Decision|6|||
130061938|NCT00547378|468180709|FG000|All Implanted Cohort|Site closure|2|||
130061939|NCT00547378|468180710|FG001|All Implanted Cohort|Site closure|0|||
130061940|NCT00547378|468180711|FG002|All Implanted Cohort|Site closure|1|||
130061941|NCT00547378|468180709|FG000|All Implanted Cohort|Other reasons|1|||
130061942|NCT00547378|468180710|FG001|All Implanted Cohort|Other reasons|0|||
130061943|NCT00547378|468180711|FG002|All Implanted Cohort|Other reasons|1|||
130061944|NCT02112994|468180712|FG000|Overall Study|Progressive Disease|0|||
130061945|NCT02112994|468180713|FG001|Overall Study|Progressive Disease|0|||
130061946|NCT02112994|468180714|FG002|Overall Study|Progressive Disease|1|||
130061947|NCT02112994|468180712|FG000|Overall Study|Pregnancy|0|||
130061948|NCT02112994|468180713|FG001|Overall Study|Pregnancy|1|||
130061949|NCT02112994|468180714|FG002|Overall Study|Pregnancy|1|||
130061950|NCT02112994|468180712|FG000|Overall Study|Liver Transplant|0|||
130061951|NCT02112994|468180713|FG001|Overall Study|Liver Transplant|1|||
130061952|NCT02112994|468180714|FG002|Overall Study|Liver Transplant|0|||
130061953|NCT02112994|468180712|FG000|Overall Study|Withdrawal by Subject|0|||
130061954|NCT02112994|468180713|FG001|Overall Study|Withdrawal by Subject|0|||
130061955|NCT02112994|468180714|FG002|Overall Study|Withdrawal by Subject|1|||
130061956|NCT04105244|468180716|FG000|Overall Study|Withdrawal by Subject|10|||
130061957|NCT04105244|468180717|FG001|Overall Study|Withdrawal by Subject|12|||
130061958|NCT04105244|468180716|FG000|Overall Study|Lost to Follow-up|20|||
130061959|NCT04105244|468180717|FG001|Overall Study|Lost to Follow-up|15|||
130061960|NCT04105244|468180716|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
130061961|NCT04105244|468180717|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
130113766|NCT01335464|468377378|FG000|Overall Study|Non compliant with protocol|2|||
129836135|NCT00748215|467366203|FG000|Overall Study|Adverse Event|0|||
129836136|NCT00748215|467366204|FG001|Overall Study|Adverse Event|5|||
129836137|NCT03200899|467366211|FG000|Overall Study|Lost to Follow-up|10|||
129836138|NCT03200899|467366212|FG001|Overall Study|Lost to Follow-up|23|||
129836139|NCT00026793|467366214|FG000|Overall Study|Death on study due to underlying disease|4|||
129836140|NCT00026793|467366214|FG000|Overall Study|Physician Decision|2|||
129836141|NCT00026793|467366214|FG000|Overall Study|Off study|2|||
129836142|NCT04151290|467366215|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
129836143|NCT00969553|467366216|FG000|Overall Study|Progressive disease (PD)|2|||
129836144|NCT00969553|467366217|FG001|Overall Study|Progressive disease (PD)|2|||
129836145|NCT00969553|467366218|FG002|Overall Study|Progressive disease (PD)|6|||
129836146|NCT00969553|467366219|FG003|Overall Study|Progressive disease (PD)|9|||
129836147|NCT00969553|467366220|FG004|Overall Study|Progressive disease (PD)|2|||
129836148|NCT00969553|467366221|FG005|Overall Study|Progressive disease (PD)|4|||
129836149|NCT00969553|467366222|FG006|Overall Study|Progressive disease (PD)|2|||
129836150|NCT00969553|467366223|FG007|Overall Study|Progressive disease (PD)|12|||
129836151|NCT00969553|467366224|FG008|Overall Study|Progressive disease (PD)|3|||
129836152|NCT00969553|467366216|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836153|NCT00969553|467366217|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836154|NCT00969553|467366218|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836155|NCT00969553|467366219|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836156|NCT00969553|467366220|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
129836157|NCT00969553|467366221|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836158|NCT00969553|467366222|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836159|NCT00969553|467366223|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836160|NCT00969553|467366224|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836161|NCT00969553|467366216|FG000|Overall Study|Other Adverse Event|0|||
129836162|NCT00969553|467366217|FG001|Overall Study|Other Adverse Event|0|||
129836163|NCT00969553|467366218|FG002|Overall Study|Other Adverse Event|0|||
129836164|NCT00969553|467366219|FG003|Overall Study|Other Adverse Event|1|||
129836165|NCT00969553|467366220|FG004|Overall Study|Other Adverse Event|0|||
129836166|NCT00969553|467366221|FG005|Overall Study|Other Adverse Event|0|||
129836167|NCT00969553|467366222|FG006|Overall Study|Other Adverse Event|1|||
129836168|NCT00969553|467366223|FG007|Overall Study|Other Adverse Event|0|||
129836169|NCT00969553|467366224|FG008|Overall Study|Other Adverse Event|0|||
129836170|NCT00969553|467366216|FG000|Overall Study|Refused cont. medication|1|||
130061962|NCT04105244|468180716|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
130061963|NCT04105244|468180717|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
130061964|NCT00414960|468180718|FG000|Overall Study|Adverse Event|4|||
130061965|NCT00414960|468180719|FG001|Overall Study|Adverse Event|0|||
130061966|NCT00414960|468180718|FG000|Overall Study|Withdrawal by Subject|3|||
130061967|NCT00414960|468180719|FG001|Overall Study|Withdrawal by Subject|0|||
130113767|NCT01335464|468377379|FG001|Overall Study|Non compliant with protocol|0|||
130113768|NCT01335464|468377378|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
129898136|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
129898137|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
129898138|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
129898139|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
129898140|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
129898141|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
129898142|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
129898143|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
129898144|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
129898145|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
129898146|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
129898147|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
129898148|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
129898149|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
129898150|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Other|1|||
129898151|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Other|0|||
129898152|NCT00813488|467586589|FG000|Open-label Extension|Adverse Event|1|||
129898153|NCT00813488|467586590|FG001|Open-label Extension|Adverse Event|2|||
129898154|NCT00813488|467586589|FG000|Open-label Extension|Lack of Efficacy|3|||
129898155|NCT00813488|467586590|FG001|Open-label Extension|Lack of Efficacy|0|||
129898156|NCT00813488|467586589|FG000|Open-label Extension|Withdrawal by Subject|0|||
129898157|NCT00813488|467586590|FG001|Open-label Extension|Withdrawal by Subject|2|||
129898158|NCT00813488|467586589|FG000|Open-label Extension|Protocol Violation|1|||
129898159|NCT00813488|467586590|FG001|Open-label Extension|Protocol Violation|2|||
129898160|NCT00813488|467586589|FG000|Open-label Extension|Non-compliance study medication|4|||
129898161|NCT00813488|467586590|FG001|Open-label Extension|Non-compliance study medication|0|||
129898162|NCT00813488|467586589|FG000|Open-label Extension|Non-compliance study procedures|2|||
129898163|NCT00813488|467586590|FG001|Open-label Extension|Non-compliance study procedures|1|||
129898164|NCT00813488|467586589|FG000|Open-label Extension|Other|1|||
129898165|NCT00813488|467586590|FG001|Open-label Extension|Other|0|||
129898166|NCT01729871|467586592|FG000|Overall Study|Adverse Event|7|||
129898167|NCT01729871|467586593|FG001|Overall Study|Adverse Event|7|||
129898168|NCT01729871|467586592|FG000|Overall Study|Death|0|||
129898169|NCT01729871|467586593|FG001|Overall Study|Death|1|||
129898170|NCT01729871|467586592|FG000|Overall Study|Lack of Efficacy|0|||
129898171|NCT01729871|467586593|FG001|Overall Study|Lack of Efficacy|1|||
129898172|NCT01729871|467586592|FG000|Overall Study|Physician Decision|0|||
129898173|NCT01729871|467586593|FG001|Overall Study|Physician Decision|2|||
129898174|NCT01729871|467586592|FG000|Overall Study|Protocol Violation|1|||
129898175|NCT01729871|467586593|FG001|Overall Study|Protocol Violation|0|||
129898176|NCT01729871|467586592|FG000|Overall Study|Withdrawal by Subject|0|||
129898177|NCT01729871|467586593|FG001|Overall Study|Withdrawal by Subject|3|||
129898178|NCT01729871|467586592|FG000|Overall Study|Other|4|||
129898179|NCT01729871|467586593|FG001|Overall Study|Other|9|||
129898180|NCT01143077|467586594|FG000|Overall Study|Lack of Efficacy|0|||
129898181|NCT01143077|467586595|FG001|Overall Study|Lack of Efficacy|2|||
129898182|NCT01143077|467586596|FG002|Overall Study|Lack of Efficacy|1|||
129898183|NCT01143077|467586594|FG000|Overall Study|Adverse Event|5|||
129898184|NCT01143077|467586595|FG001|Overall Study|Adverse Event|6|||
129898185|NCT01143077|467586596|FG002|Overall Study|Adverse Event|5|||
129898186|NCT01143077|467586594|FG000|Overall Study|Lost to Follow-up|2|||
130061968|NCT00414960|468180718|FG000|Overall Study|Physician Decision|0|||
130061969|NCT00414960|468180719|FG001|Overall Study|Physician Decision|1|||
130061970|NCT02768194|468180720|FG000|Period 1|Adverse Event|0|||
130061971|NCT02768194|468180721|FG001|Period 1|Adverse Event|0|||
130061972|NCT02768194|468180722|FG002|Period 1|Adverse Event|0|||
130061973|NCT02768194|468180723|FG003|Period 1|Adverse Event|1|||
130061974|NCT02768194|468180724|FG004|Period 1|Adverse Event|0|||
130061975|NCT02768194|468180725|FG005|Period 1|Adverse Event|0|||
130061976|NCT02768194|468180720|FG000|Period 2|Other (Reason not specified)|1|||
130061977|NCT02768194|468180721|FG001|Period 2|Other (Reason not specified)|0|||
130061978|NCT02768194|468180722|FG002|Period 2|Other (Reason not specified)|0|||
130061979|NCT02768194|468180723|FG003|Period 2|Other (Reason not specified)|0|||
130061980|NCT02768194|468180724|FG004|Period 2|Other (Reason not specified)|0|||
129898187|NCT01143077|467586595|FG001|Overall Study|Lost to Follow-up|3|||
129898188|NCT01143077|467586596|FG002|Overall Study|Lost to Follow-up|4|||
129898189|NCT01143077|467586594|FG000|Overall Study|Protocol Violation|2|||
129898190|NCT01143077|467586595|FG001|Overall Study|Protocol Violation|0|||
129898191|NCT01143077|467586596|FG002|Overall Study|Protocol Violation|0|||
129898192|NCT01143077|467586594|FG000|Overall Study|Withdrawal by Subject|4|||
129898193|NCT01143077|467586595|FG001|Overall Study|Withdrawal by Subject|3|||
129898194|NCT01143077|467586596|FG002|Overall Study|Withdrawal by Subject|3|||
130061981|NCT02768194|468180725|FG005|Period 2|Other (Reason not specified)|0|||
129898195|NCT01143077|467586594|FG000|Overall Study|Non-compliance with study drug|0|||
129898196|NCT01143077|467586595|FG001|Overall Study|Non-compliance with study drug|1|||
130061982|NCT02768194|468180720|FG000|Period 3|Other (Reason not specified)|0|||
130113769|NCT01335464|468377379|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
130113770|NCT01335464|468377378|FG000|Overall Study|Not treated|2|||
130113771|NCT01335464|468377379|FG001|Overall Study|Not treated|0|||
130113772|NCT01335464|468377378|FG000|Overall Study|Reason other than those stated above|1|||
130113773|NCT01335464|468377379|FG001|Overall Study|Reason other than those stated above|1|||
130113774|NCT03156270|468377380|FG000|Overall Study|Failed pre-treatment screening|1|||
130113775|NCT03156270|468377380|FG000|Overall Study|Lost to Follow-up|1|||
130113776|NCT00446654|468377381|FG000|Overall Study|Withdrawal by Subject|1|||
129836171|NCT00969553|467366217|FG001|Overall Study|Refused cont. medication|1|||
129836172|NCT00969553|467366218|FG002|Overall Study|Refused cont. medication|0|||
129836173|NCT00969553|467366219|FG003|Overall Study|Refused cont. medication|2|||
129836174|NCT00969553|467366220|FG004|Overall Study|Refused cont. medication|0|||
129836175|NCT00969553|467366221|FG005|Overall Study|Refused cont. medication|0|||
129836176|NCT00969553|467366222|FG006|Overall Study|Refused cont. medication|0|||
129836177|NCT00969553|467366223|FG007|Overall Study|Refused cont. medication|1|||
129836178|NCT00969553|467366224|FG008|Overall Study|Refused cont. medication|0|||
129836179|NCT00969553|467366216|FG000|Overall Study|Not specified above|0|||
129836180|NCT00969553|467366217|FG001|Overall Study|Not specified above|0|||
129836181|NCT00969553|467366218|FG002|Overall Study|Not specified above|0|||
129836182|NCT00969553|467366219|FG003|Overall Study|Not specified above|4|||
129836183|NCT00969553|467366220|FG004|Overall Study|Not specified above|0|||
129836184|NCT00969553|467366221|FG005|Overall Study|Not specified above|0|||
129836185|NCT00969553|467366222|FG006|Overall Study|Not specified above|1|||
129836186|NCT00969553|467366223|FG007|Overall Study|Not specified above|1|||
129836187|NCT00969553|467366224|FG008|Overall Study|Not specified above|0|||
129836188|NCT01077804|467366226|FG000|Overall Study|Unreachable|102|||
129836189|NCT01077804|467366226|FG000|Overall Study|Refused to continue|79|||
129836190|NCT01077804|467366226|FG000|Overall Study|Other|18|||
129836191|NCT00136084|467368104|FG000|Overall Study|Death|12|||
129836192|NCT00136084|467368105|FG001|Overall Study|Death|5|||
129836193|NCT00136084|467368104|FG000|Overall Study|Unacceptable toxicity|8|||
129836194|NCT00136084|467368105|FG001|Overall Study|Unacceptable toxicity|11|||
129836195|NCT00136084|467368104|FG000|Overall Study|Relapse|20|||
129836196|NCT00136084|467368105|FG001|Overall Study|Relapse|23|||
129836197|NCT00136084|467368104|FG000|Overall Study|Lost to Follow-up|2|||
129836198|NCT00136084|467368105|FG001|Overall Study|Lost to Follow-up|0|||
129836199|NCT00136084|467368104|FG000|Overall Study|No Response|1|||
129836200|NCT00136084|467368105|FG001|Overall Study|No Response|2|||
129836201|NCT00136084|467368104|FG000|Overall Study|Withdrawal by Subject|5|||
129836202|NCT00136084|467368105|FG001|Overall Study|Withdrawal by Subject|1|||
129836203|NCT00997503|467368106|FG000|Overall Study|Death|53|||
129836204|NCT00997503|467368106|FG000|Overall Study|Withdrawal by Subject|76|||
129836205|NCT00997503|467368106|FG000|Overall Study|Lost to Follow-up|33|||
129836206|NCT00997503|467368106|FG000|Overall Study|Adverse Event|3|||
129836207|NCT00997503|467368106|FG000|Overall Study|Physician Decision|10|||
129836208|NCT00997503|467368106|FG000|Overall Study|Missed 12-month follow-up|85|||
129836209|NCT00997503|467368106|FG000|Overall Study|Other reason|13|||
129836210|NCT00116831|467368107|FG000|Overall Study|Adverse Event|14|||
129836211|NCT00116831|467368108|FG001|Overall Study|Adverse Event|16|||
129836212|NCT00116831|467368107|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
129836213|NCT00116831|467368108|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
129836214|NCT00116831|467368107|FG000|Overall Study|Lost to Follow-up|8|||
129836215|NCT00116831|467368108|FG001|Overall Study|Lost to Follow-up|6|||
129836216|NCT00116831|467368107|FG000|Overall Study|Protocol Violation|3|||
129836217|NCT00116831|467368108|FG001|Overall Study|Protocol Violation|6|||
129836218|NCT00116831|467368107|FG000|Overall Study|Hypoglycaemic events|1|||
129836219|NCT00116831|467368108|FG001|Overall Study|Hypoglycaemic events|0|||
129836220|NCT00116831|467368107|FG000|Overall Study|Low haemoglobin on screening|1|||
129836221|NCT00116831|467368108|FG001|Overall Study|Low haemoglobin on screening|0|||
129836222|NCT00116831|467368107|FG000|Overall Study|Withdrawn investigational product|1|||
129836223|NCT00116831|467368108|FG001|Overall Study|Withdrawn investigational product|0|||
129836224|NCT00116831|467368107|FG000|Overall Study|Withdrawal by Subject|32|||
129836225|NCT00116831|467368108|FG001|Overall Study|Withdrawal by Subject|32|||
129836226|NCT00116831|467368107|FG000|Overall Study|Insufficient therapeutic effect|0|||
129836227|NCT00116831|467368108|FG001|Overall Study|Insufficient therapeutic effect|1|||
129836228|NCT00116831|467368107|FG000|Overall Study|Missing data for participant|1|||
129836229|NCT00116831|467368108|FG001|Overall Study|Missing data for participant|0|||
129836230|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
129836231|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
129836232|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
129836233|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
129836234|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
129836235|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
129836236|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
129836237|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
129836238|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
130113777|NCT00446654|468377382|FG001|Overall Study|Withdrawal by Subject|0|||
129836239|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
129836240|NCT00380393|467368109|FG000|Month 14|Withdrawal by Subject|9|||
129836241|NCT00380393|467368110|FG001|Month 14|Withdrawal by Subject|7|||
129836242|NCT00380393|467368109|FG000|Month 14|Death|1|||
130061983|NCT02768194|468180721|FG001|Period 3|Other (Reason not specified)|1|||
130061984|NCT02768194|468180722|FG002|Period 3|Other (Reason not specified)|0|||
130061985|NCT02768194|468180723|FG003|Period 3|Other (Reason not specified)|0|||
130061986|NCT02768194|468180724|FG004|Period 3|Other (Reason not specified)|0|||
130061987|NCT02768194|468180725|FG005|Period 3|Other (Reason not specified)|0|||
130061988|NCT00975195|468180726|FG000|Overall Study|Adverse Event|108|||
130061989|NCT00975195|468180727|FG001|Overall Study|Adverse Event|101|||
130061990|NCT00975195|468180726|FG000|Overall Study|Lack of Efficacy|6|||
130061991|NCT00975195|468180727|FG001|Overall Study|Lack of Efficacy|6|||
130061992|NCT00975195|468180726|FG000|Overall Study|Protocol Violation|27|||
130061993|NCT00975195|468180727|FG001|Overall Study|Protocol Violation|23|||
130061994|NCT00975195|468180726|FG000|Overall Study|Lost to Follow-up|9|||
130061995|NCT00975195|468180727|FG001|Overall Study|Lost to Follow-up|7|||
130061996|NCT00975195|468180726|FG000|Overall Study|Withdrawal by Subject|48|||
130061997|NCT00975195|468180727|FG001|Overall Study|Withdrawal by Subject|61|||
130061998|NCT00975195|468180726|FG000|Overall Study|Other reason not defined above|29|||
130061999|NCT00975195|468180727|FG001|Overall Study|Other reason not defined above|33|||
130062000|NCT00975195|468180726|FG000|Overall Study|Not treated|1|||
130062001|NCT00975195|468180727|FG001|Overall Study|Not treated|2|||
130062002|NCT01608724|468180728|FG000|Overall Study|Withdrawal by Subject|131|||
130062003|NCT01608724|468180728|FG000|Overall Study|Lost to Follow-up|41|||
130062004|NCT01608724|468180728|FG000|Overall Study|Study-specific discontinuation criteria|32|||
130062005|NCT01608724|468180728|FG000|Overall Study|Adverse Event|29|||
130062006|NCT01608724|468180728|FG000|Overall Study|Protocol Violation|6|||
130062007|NCT01608724|468180728|FG000|Overall Study|bood sugar too high, etc.|3|||
130062008|NCT01608724|468180728|FG000|Overall Study|Safety reasons|1|||
130062009|NCT00363246|468180733|FG000|Overall Study|Death|40|||
130062010|NCT00363246|468180733|FG000|Overall Study|Withdrawal by Subject|19|||
130062011|NCT00363246|468180733|FG000|Overall Study|Lost to Follow-up|14|||
130062012|NCT00363246|468180733|FG000|Overall Study|Bad health|6|||
130062013|NCT00363246|468180733|FG000|Overall Study|Stopped using wheelchair|11|||
130062014|NCT00363246|468180733|FG000|Overall Study|Subject expressed security concerns|2|||
130062015|NCT00363246|468180733|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
130062016|NCT04387136|468180734|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
130062017|NCT04387136|468180735|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
130062018|NCT00717366|468180736|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
130062019|NCT00717366|468180737|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
130062020|NCT00717366|468180736|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
130062021|NCT00717366|468180737|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
130062022|NCT00717366|468180736|FG000|Core Study Period (20 Weeks)|Death|0|||
130062023|NCT00717366|468180737|FG001|Core Study Period (20 Weeks)|Death|1|||
130062024|NCT00717366|468180736|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
130062025|NCT00717366|468180737|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
130062026|NCT00717366|468180736|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
130062027|NCT00717366|468180737|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
130062028|NCT00717366|468180736|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
130062029|NCT00717366|468180737|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
130062030|NCT00717366|468180736|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
130062031|NCT00717366|468180737|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
130062032|NCT00910429|468180740|FG000|Overall Study|Death|18|||
130062033|NCT00910429|468180741|FG001|Overall Study|Death|12|||
130062034|NCT00910429|468180740|FG000|Overall Study|Withdrawal by Subject|3|||
130062035|NCT00910429|468180741|FG001|Overall Study|Withdrawal by Subject|2|||
130062036|NCT00910429|468180740|FG000|Overall Study|Protocol Violation|1|||
130062037|NCT00910429|468180741|FG001|Overall Study|Protocol Violation|0|||
130062038|NCT00910429|468180740|FG000|Overall Study|Lost to Follow-up|2|||
130062039|NCT00910429|468180741|FG001|Overall Study|Lost to Follow-up|1|||
130062040|NCT00910429|468180740|FG000|Overall Study|Adverse Event|10|||
130062041|NCT00910429|468180741|FG001|Overall Study|Adverse Event|5|||
130062042|NCT00910429|468180740|FG000|Overall Study|Drug non-compliance|1|||
130062043|NCT00910429|468180741|FG001|Overall Study|Drug non-compliance|0|||
130062044|NCT00910429|468180740|FG000|Overall Study|Lack of Efficacy|4|||
130062045|NCT00910429|468180741|FG001|Overall Study|Lack of Efficacy|1|||
130062046|NCT02164513|468180742|FG000|Overall Study|Adverse Event|162|||
130062047|NCT02164513|468180743|FG001|Overall Study|Adverse Event|180|||
130062048|NCT02164513|468180744|FG002|Overall Study|Adverse Event|111|||
130062049|NCT02164513|468180742|FG000|Overall Study|Other: Study Closed or terminated|5|||
130062050|NCT02164513|468180743|FG001|Overall Study|Other: Study Closed or terminated|2|||
130062051|NCT02164513|468180744|FG002|Overall Study|Other: Study Closed or terminated|4|||
130062052|NCT02164513|468180742|FG000|Overall Study|Lost to Follow-up|30|||
130062053|NCT02164513|468180743|FG001|Overall Study|Lost to Follow-up|36|||
130062054|NCT02164513|468180744|FG002|Overall Study|Lost to Follow-up|22|||
130062055|NCT02164513|468180742|FG000|Overall Study|Physician Decision|47|||
130062056|NCT02164513|468180743|FG001|Overall Study|Physician Decision|57|||
129836243|NCT00380393|467368110|FG001|Month 14|Death|0|||
129836244|NCT00380393|467368109|FG000|Month 14|Lost to Follow-up|0|||
129836245|NCT00380393|467368110|FG001|Month 14|Lost to Follow-up|1|||
129836246|NCT00380393|467368109|FG000|Month 14|Migrated/moved from study area|39|||
129836247|NCT00380393|467368110|FG001|Month 14|Migrated/moved from study area|42|||
129836248|NCT00380393|467368109|FG000|Month 14|Protocol Violation|2|||
129836249|NCT00380393|467368110|FG001|Month 14|Protocol Violation|0|||
129836250|NCT00380393|467368109|FG000|Month 14|Others|6|||
129836251|NCT00380393|467368110|FG001|Month 14|Others|6|||
129836252|NCT01933048|467368111|FG000|Overall Study|Lost to Follow-up|15|||
129836253|NCT01933048|467368112|FG001|Overall Study|Lost to Follow-up|18|||
129836254|NCT01933048|467368111|FG000|Overall Study|personal reasons|1|||
129836255|NCT01933048|467368112|FG001|Overall Study|personal reasons|1|||
129836256|NCT01933048|467368111|FG000|Overall Study|Protocol Violation|7|||
129836257|NCT01933048|467368112|FG001|Overall Study|Protocol Violation|8|||
129836258|NCT01933048|467368111|FG000|Overall Study|Physician Decision|1|||
129836259|NCT01933048|467368112|FG001|Overall Study|Physician Decision|0|||
129836260|NCT01933048|467368111|FG000|Overall Study|unknown reasons|1|||
129836261|NCT01933048|467368112|FG001|Overall Study|unknown reasons|1|||
129836262|NCT02476968|467368113|FG000|Overall Study|Other|0|||
129836263|NCT02476968|467368114|FG001|Overall Study|Other|2|||
129836264|NCT02476968|467368115|FG002|Overall Study|Other|0|||
129836265|NCT02476968|467368113|FG000|Overall Study|Lost to Follow-up|10|||
129836266|NCT02476968|467368114|FG001|Overall Study|Lost to Follow-up|0|||
129836267|NCT02476968|467368115|FG002|Overall Study|Lost to Follow-up|1|||
129836268|NCT02476968|467368113|FG000|Overall Study|Death|48|||
129836269|NCT02476968|467368114|FG001|Overall Study|Death|8|||
129836270|NCT02476968|467368115|FG002|Overall Study|Death|1|||
129836271|NCT02476968|467368113|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129836272|NCT02476968|467368114|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129836273|NCT02476968|467368115|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129836274|NCT02476968|467368113|FG000|Overall Study|Patient decision|37|||
129836275|NCT02476968|467368114|FG001|Overall Study|Patient decision|8|||
129836276|NCT02476968|467368115|FG002|Overall Study|Patient decision|0|||
129836277|NCT01859507|467368116|FG000|Overall Study|left the country|4|||
129836278|NCT02404311|467368117|FG000|Part A: Month 0-18|Death|2|||
129836279|NCT02404311|467368118|FG001|Part A: Month 0-18|Death|0|||
129836280|NCT02404311|467368119|FG002|Part A: Month 0-18|Death|0|||
129836281|NCT02404311|467368120|FG003|Part A: Month 0-18|Death|0|||
129836282|NCT02404311|467368121|FG004|Part A: Month 0-18|Death|0|||
129836283|NCT02404311|467368117|FG000|Part A: Month 0-18|Physician Decision|1|||
129836284|NCT02404311|467368118|FG001|Part A: Month 0-18|Physician Decision|0|||
129836285|NCT02404311|467368119|FG002|Part A: Month 0-18|Physician Decision|0|||
129836286|NCT02404311|467368120|FG003|Part A: Month 0-18|Physician Decision|0|||
129836287|NCT02404311|467368121|FG004|Part A: Month 0-18|Physician Decision|0|||
129836288|NCT02404311|467368117|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
129836289|NCT02404311|467368118|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
130062057|NCT02164513|468180744|FG002|Overall Study|Physician Decision|28|||
130062058|NCT02164513|468180742|FG000|Overall Study|Withdrawal by Subject|192|||
130062059|NCT02164513|468180743|FG001|Overall Study|Withdrawal by Subject|261|||
130062060|NCT02164513|468180744|FG002|Overall Study|Withdrawal by Subject|130|||
130062061|NCT02164513|468180742|FG000|Overall Study|Other: Reason not provided by site|1|||
130062062|NCT02164513|468180743|FG001|Overall Study|Other: Reason not provided by site|0|||
130062063|NCT02164513|468180744|FG002|Overall Study|Other: Reason not provided by site|0|||
130062064|NCT01179347|468182082|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
130062065|NCT01179347|468182083|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
130062066|NCT01179347|468182082|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
129836290|NCT02404311|467368119|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
129836291|NCT02404311|467368120|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
129836292|NCT02404311|467368121|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
129836293|NCT02404311|467368117|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
129836294|NCT02404311|467368118|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
129836295|NCT02404311|467368119|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
129836296|NCT02404311|467368120|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
129836297|NCT02404311|467368121|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
129836298|NCT02404311|467368117|FG000|Part A: Month 0-18|HIV Infection|6|||
129836299|NCT02404311|467368118|FG001|Part A: Month 0-18|HIV Infection|2|||
129836300|NCT02404311|467368119|FG002|Part A: Month 0-18|HIV Infection|0|||
129836301|NCT02404311|467368120|FG003|Part A: Month 0-18|HIV Infection|0|||
129836302|NCT02404311|467368121|FG004|Part A: Month 0-18|HIV Infection|0|||
130062067|NCT01179347|468182083|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
130062068|NCT01179347|468182082|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
130062069|NCT01179347|468182083|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
130113778|NCT00446654|468377381|FG000|Overall Study|Adverse Event|1|||
129836303|NCT02404311|467368117|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
129836304|NCT02404311|467368118|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
130062070|NCT01179347|468182082|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
130062071|NCT01179347|468182083|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
130062072|NCT01179347|468182082|FG000|Double-blind Period (12 Weeks)|Other|2|||
130062073|NCT01179347|468182083|FG001|Double-blind Period (12 Weeks)|Other|4|||
130062074|NCT01179347|468182082|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
130062075|NCT01179347|468182083|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
130062076|NCT01179347|468182082|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
130062077|NCT01179347|468182083|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
130062078|NCT01179347|468182082|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
130062079|NCT01179347|468182083|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
130062080|NCT01179347|468182082|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
130062081|NCT01179347|468182083|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
130062082|NCT01179347|468182082|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
130062083|NCT01179347|468182083|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
130062084|NCT01179347|468182082|FG000|Open-label Period (12 Weeks)|Other|7|||
130062085|NCT01179347|468182083|FG001|Open-label Period (12 Weeks)|Other|4|||
130062086|NCT02586077|468182084|FG000|Overall Study|Withdrawal by Subject|1|||
130062087|NCT02586077|468182084|FG000|Overall Study|Physician Decision|4|||
130062088|NCT02586077|468182084|FG000|Overall Study|Lost to Follow-up|3|||
130062089|NCT00205699|468182087|FG000|Overall Study|Lost to Follow-up|1|||
130062090|NCT00205699|468182088|FG001|Overall Study|Lost to Follow-up|3|||
130062091|NCT00205699|468182089|FG002|Overall Study|Lost to Follow-up|5|||
130062092|NCT00205699|468182087|FG000|Overall Study|Adverse Event|1|||
130062093|NCT00205699|468182088|FG001|Overall Study|Adverse Event|0|||
130062094|NCT00205699|468182089|FG002|Overall Study|Adverse Event|0|||
130062095|NCT00205699|468182087|FG000|Overall Study|Withdrawal by Subject|1|||
130062096|NCT00205699|468182088|FG001|Overall Study|Withdrawal by Subject|2|||
130062097|NCT00205699|468182089|FG002|Overall Study|Withdrawal by Subject|1|||
130062098|NCT00205699|468182087|FG000|Overall Study|Lack of Efficacy|0|||
130062099|NCT00205699|468182088|FG001|Overall Study|Lack of Efficacy|1|||
130062100|NCT00205699|468182089|FG002|Overall Study|Lack of Efficacy|0|||
130062101|NCT03225716|468182095|FG000|Overall Study|Withdrawal by Subject|2|||
130062102|NCT03225716|468182096|FG001|Overall Study|Withdrawal by Subject|2|||
130062103|NCT03225716|468182097|FG002|Overall Study|Withdrawal by Subject|0|||
130062104|NCT03225716|468182095|FG000|Overall Study|Lack of Efficacy|1|||
130062105|NCT03225716|468182096|FG001|Overall Study|Lack of Efficacy|0|||
130062106|NCT03225716|468182097|FG002|Overall Study|Lack of Efficacy|0|||
130062107|NCT03225716|468182095|FG000|Overall Study|Adverse Event|2|||
130062108|NCT03225716|468182096|FG001|Overall Study|Adverse Event|0|||
130062109|NCT03225716|468182097|FG002|Overall Study|Adverse Event|1|||
130062110|NCT03225716|468182095|FG000|Overall Study|Study early termination by Sponsor|0|||
130062111|NCT03225716|468182096|FG001|Overall Study|Study early termination by Sponsor|0|||
130062112|NCT03225716|468182097|FG002|Overall Study|Study early termination by Sponsor|2|||
130062113|NCT00190983|468182098|FG000|Overall Study|Inevaluable (never treated)|2|||
130062114|NCT01453998|468182099|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
130062115|NCT01453998|468182100|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
130062116|NCT01453998|468182101|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
130062117|NCT03247413|468182103|FG000|Overall Study|Lost to Follow-up|28|||
130062118|NCT00091026|468182106|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
130062119|NCT00091026|468182107|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
130062120|NCT00091026|468182106|FG000|Overall Study|Patient withdrew and never received trea|0|||
130062121|NCT00091026|468182107|FG001|Overall Study|Patient withdrew and never received trea|2|||
130062122|NCT00091026|468182106|FG000|Overall Study|Unknown-never received treatment|0|||
130062123|NCT00091026|468182107|FG001|Overall Study|Unknown-never received treatment|1|||
130062124|NCT00077610|468182108|FG000|Overall Study|Adverse Event|9|||
130062125|NCT00077610|468182109|FG001|Overall Study|Adverse Event|7|||
130062126|NCT00077610|468182110|FG002|Overall Study|Adverse Event|1|||
130062127|NCT00077610|468182108|FG000|Overall Study|Lost to Follow-up|0|||
130062128|NCT00077610|468182109|FG001|Overall Study|Lost to Follow-up|1|||
130062129|NCT00077610|468182110|FG002|Overall Study|Lost to Follow-up|2|||
130062130|NCT00077610|468182108|FG000|Overall Study|Withdrawal by Subject|4|||
129836305|NCT02404311|467368119|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
129836306|NCT02404311|467368120|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
130062131|NCT00077610|468182109|FG001|Overall Study|Withdrawal by Subject|10|||
130062132|NCT00077610|468182110|FG002|Overall Study|Withdrawal by Subject|6|||
130062133|NCT00077610|468182108|FG000|Overall Study|Death|17|||
130062134|NCT00077610|468182109|FG001|Overall Study|Death|13|||
130062135|NCT00077610|468182110|FG002|Overall Study|Death|13|||
130062136|NCT00077610|468182108|FG000|Overall Study|Renal transplant|12|||
130062137|NCT00077610|468182109|FG001|Overall Study|Renal transplant|15|||
130062138|NCT00077610|468182110|FG002|Overall Study|Renal transplant|11|||
130062139|NCT00077610|468182108|FG000|Overall Study|Withdrew from dialysis care|5|||
130062140|NCT00077610|468182109|FG001|Overall Study|Withdrew from dialysis care|0|||
130062141|NCT00077610|468182110|FG002|Overall Study|Withdrew from dialysis care|3|||
130062142|NCT00077610|468182108|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130062143|NCT00077610|468182109|FG001|Overall Study|Insufficient Therapeutic Response|0|||
130062144|NCT00077610|468182110|FG002|Overall Study|Insufficient Therapeutic Response|0|||
130062145|NCT00077610|468182108|FG000|Overall Study|Multiple blood transfusions|0|||
130062146|NCT00077610|468182109|FG001|Overall Study|Multiple blood transfusions|0|||
130062147|NCT00077610|468182110|FG002|Overall Study|Multiple blood transfusions|1|||
130062148|NCT00077610|468182108|FG000|Overall Study|Principal Investigator's decision|1|||
130062149|NCT00077610|468182109|FG001|Overall Study|Principal Investigator's decision|0|||
130062150|NCT00077610|468182110|FG002|Overall Study|Principal Investigator's decision|1|||
130062151|NCT00077610|468182108|FG000|Overall Study|Worsening of health condition|1|||
130062152|NCT00077610|468182109|FG001|Overall Study|Worsening of health condition|1|||
130062153|NCT00077610|468182110|FG002|Overall Study|Worsening of health condition|0|||
130062154|NCT00077610|468182108|FG000|Overall Study|Given Epogen in hospital|1|||
130062155|NCT00077610|468182109|FG001|Overall Study|Given Epogen in hospital|0|||
130062156|NCT00077610|468182110|FG002|Overall Study|Given Epogen in hospital|0|||
130062157|NCT00077610|468182108|FG000|Overall Study|Transferred to other unit|0|||
130062158|NCT00077610|468182109|FG001|Overall Study|Transferred to other unit|0|||
130062159|NCT00077610|468182110|FG002|Overall Study|Transferred to other unit|1|||
130062160|NCT00077610|468182108|FG000|Overall Study|Transferred to nursing home|0|||
130062161|NCT00077610|468182109|FG001|Overall Study|Transferred to nursing home|0|||
130062162|NCT00077610|468182110|FG002|Overall Study|Transferred to nursing home|1|||
130062163|NCT00077610|468182108|FG000|Overall Study|Transfer to satellite unit|1|||
130062164|NCT00077610|468182109|FG001|Overall Study|Transfer to satellite unit|0|||
130062165|NCT00077610|468182110|FG002|Overall Study|Transfer to satellite unit|0|||
130062166|NCT00077610|468182108|FG000|Overall Study|Transfer to other center for surgery|1|||
130062167|NCT00077610|468182109|FG001|Overall Study|Transfer to other center for surgery|0|||
130062168|NCT00077610|468182110|FG002|Overall Study|Transfer to other center for surgery|0|||
130062169|NCT00077610|468182108|FG000|Overall Study|Change in dialysis modality|1|||
130062170|NCT00077610|468182109|FG001|Overall Study|Change in dialysis modality|0|||
130062171|NCT00077610|468182110|FG002|Overall Study|Change in dialysis modality|0|||
130062172|NCT00077610|468182108|FG000|Overall Study|Relocation|0|||
130062173|NCT00077610|468182109|FG001|Overall Study|Relocation|8|||
130062174|NCT00077610|468182110|FG002|Overall Study|Relocation|5|||
130062175|NCT00077610|468182108|FG000|Overall Study|Financial issues|0|||
130062176|NCT00077610|468182109|FG001|Overall Study|Financial issues|1|||
130062177|NCT00077610|468182110|FG002|Overall Study|Financial issues|0|||
130062178|NCT00077610|468182108|FG000|Overall Study|Sponsors decision to withdraw|0|||
130062179|NCT00077610|468182109|FG001|Overall Study|Sponsors decision to withdraw|0|||
130062180|NCT00077610|468182110|FG002|Overall Study|Sponsors decision to withdraw|1|||
130062181|NCT00976950|468182111|FG000|Overall Study|Adverse Event|3|||
130062182|NCT00976950|468182111|FG000|Overall Study|Events with no relationship to Aptivus|3|||
130062183|NCT00304915|468182112|FG000|Overall Study|Lost to Follow-up|11|||
130062184|NCT00304915|468182113|FG001|Overall Study|Lost to Follow-up|11|||
130062185|NCT00304915|468182112|FG000|Overall Study|Death|4|||
130062186|NCT00304915|468182113|FG001|Overall Study|Death|5|||
130062187|NCT00304915|468182112|FG000|Overall Study|Withdrawal by Subject|3|||
130062188|NCT00304915|468182113|FG001|Overall Study|Withdrawal by Subject|0|||
130062189|NCT02662985|468182122|FG000|Treatment Period 1|Adverse Event|0|||
130062190|NCT02662985|468182123|FG001|Treatment Period 1|Adverse Event|2|||
130062191|NCT02662985|468182122|FG000|Treatment Period 1|Protocol Violation|0|||
130062192|NCT02662985|468182123|FG001|Treatment Period 1|Protocol Violation|1|||
130062193|NCT02662985|468182122|FG000|Treatment Period 1|Physician Decision|1|||
130062194|NCT02662985|468182123|FG001|Treatment Period 1|Physician Decision|0|||
130062195|NCT02662985|468182122|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130062196|NCT02662985|468182123|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130062197|NCT02662985|468182122|FG000|Treatment Period 2|Lack of Efficacy|0|||
130062198|NCT02662985|468182123|FG001|Treatment Period 2|Lack of Efficacy|1|||
130062199|NCT02662985|468182122|FG000|Treatment Period 2|Lost to Follow-up|1|||
130062200|NCT02662985|468182123|FG001|Treatment Period 2|Lost to Follow-up|0|||
130062201|NCT02662985|468182122|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
130062202|NCT02662985|468182123|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
130062203|NCT02662985|468182122|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
130062204|NCT02662985|468182123|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
130062205|NCT02662985|468182122|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
130062206|NCT02662985|468182123|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
130062207|NCT02662985|468182122|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
130062208|NCT02662985|468182123|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
130062209|NCT02662985|468182122|FG000|Treatment Period 3 (Extension Period)|Death|0|||
130062210|NCT02662985|468182123|FG001|Treatment Period 3 (Extension Period)|Death|1|||
130062211|NCT03442829|468182124|FG000|Overall Study|Scheduling clash|3|||
130113779|NCT00446654|468377382|FG001|Overall Study|Adverse Event|0|||
130113780|NCT01504867|468377386|FG000|Overall Study|Inclusion criteria not met|2|||
130113781|NCT01504867|468377387|FG001|Overall Study|Inclusion criteria not met|2|||
130113782|NCT01504867|468377386|FG000|Overall Study|Consent revoked|5|||
130113783|NCT01504867|468377387|FG001|Overall Study|Consent revoked|1|||
130062212|NCT03442829|468182125|FG001|Overall Study|Scheduling clash|1|||
130062213|NCT03442829|468182124|FG000|Overall Study|Illness unrelated to study|1|||
130062214|NCT03442829|468182125|FG001|Overall Study|Illness unrelated to study|1|||
130062215|NCT01486784|468182126|FG000|Overall Study|Withdrawal by Subject|0|||
130062216|NCT01486784|468182127|FG001|Overall Study|Withdrawal by Subject|0|||
130062217|NCT01486784|468182128|FG002|Overall Study|Withdrawal by Subject|1|||
130062218|NCT01486784|468182129|FG003|Overall Study|Withdrawal by Subject|0|||
130062219|NCT01486784|468182130|FG004|Overall Study|Withdrawal by Subject|1|||
130062220|NCT01486784|468182131|FG005|Overall Study|Withdrawal by Subject|2|||
130062221|NCT01486784|468182126|FG000|Overall Study|Subject did not meet entry criteria|0|||
130062222|NCT01486784|468182127|FG001|Overall Study|Subject did not meet entry criteria|0|||
130062223|NCT01486784|468182128|FG002|Overall Study|Subject did not meet entry criteria|0|||
130062224|NCT01486784|468182129|FG003|Overall Study|Subject did not meet entry criteria|0|||
130062225|NCT01486784|468182130|FG004|Overall Study|Subject did not meet entry criteria|1|||
130062226|NCT01486784|468182131|FG005|Overall Study|Subject did not meet entry criteria|0|||
130062227|NCT01486784|468182126|FG000|Overall Study|Death|0|||
130062228|NCT01486784|468182127|FG001|Overall Study|Death|0|||
130062229|NCT01486784|468182128|FG002|Overall Study|Death|0|||
130062230|NCT01486784|468182129|FG003|Overall Study|Death|0|||
130062231|NCT01486784|468182130|FG004|Overall Study|Death|0|||
130062232|NCT01486784|468182131|FG005|Overall Study|Death|1|||
130062233|NCT01021852|468182134|FG000|Treatment Period 1|Adverse Event|3|||
130062234|NCT01021852|468182135|FG001|Treatment Period 1|Adverse Event|1|||
130062235|NCT01021852|468182136|FG002|Treatment Period 1|Adverse Event|1|||
130062236|NCT01021852|468182137|FG003|Treatment Period 1|Adverse Event|0|||
130062237|NCT01021852|468182138|FG004|Treatment Period 1|Adverse Event|2|||
130062238|NCT01021852|468182139|FG005|Treatment Period 1|Adverse Event|2|||
130062239|NCT01021852|468182140|FG006|Treatment Period 1|Adverse Event|0|||
130062240|NCT01021852|468182141|FG007|Treatment Period 1|Adverse Event|0|||
130062241|NCT01021852|468182134|FG000|Treatment Period 1|Pregnancy|0|||
130062242|NCT01021852|468182135|FG001|Treatment Period 1|Pregnancy|0|||
130062243|NCT01021852|468182136|FG002|Treatment Period 1|Pregnancy|1|||
130062244|NCT01021852|468182137|FG003|Treatment Period 1|Pregnancy|0|||
130062245|NCT01021852|468182138|FG004|Treatment Period 1|Pregnancy|0|||
130062246|NCT01021852|468182139|FG005|Treatment Period 1|Pregnancy|0|||
130062247|NCT01021852|468182140|FG006|Treatment Period 1|Pregnancy|0|||
130062248|NCT01021852|468182141|FG007|Treatment Period 1|Pregnancy|0|||
130062249|NCT01021852|468182134|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130062250|NCT01021852|468182135|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130062251|NCT01021852|468182136|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130062252|NCT01021852|468182137|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130062253|NCT01021852|468182138|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130062254|NCT01021852|468182139|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130062255|NCT01021852|468182140|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130062256|NCT01021852|468182141|FG007|Treatment Period 1|Withdrawal by Subject|1|||
130062257|NCT01021852|468182134|FG000|Treatment Period 1|Not Treated|0|||
130062258|NCT01021852|468182135|FG001|Treatment Period 1|Not Treated|0|||
130062259|NCT01021852|468182136|FG002|Treatment Period 1|Not Treated|0|||
130062260|NCT01021852|468182137|FG003|Treatment Period 1|Not Treated|2|||
130062261|NCT01021852|468182138|FG004|Treatment Period 1|Not Treated|0|||
130062262|NCT01021852|468182139|FG005|Treatment Period 1|Not Treated|0|||
130062263|NCT01021852|468182140|FG006|Treatment Period 1|Not Treated|0|||
130062264|NCT01021852|468182141|FG007|Treatment Period 1|Not Treated|0|||
130062265|NCT01021852|468182134|FG000|Washout Period-Placebo|Adverse Event|0|||
130062266|NCT01021852|468182135|FG001|Washout Period-Placebo|Adverse Event|0|||
130062267|NCT01021852|468182136|FG002|Washout Period-Placebo|Adverse Event|0|||
130062268|NCT01021852|468182137|FG003|Washout Period-Placebo|Adverse Event|1|||
130062269|NCT01021852|468182138|FG004|Washout Period-Placebo|Adverse Event|0|||
130062270|NCT01021852|468182139|FG005|Washout Period-Placebo|Adverse Event|1|||
130062271|NCT01021852|468182140|FG006|Washout Period-Placebo|Adverse Event|0|||
130062272|NCT01021852|468182141|FG007|Washout Period-Placebo|Adverse Event|0|||
130062273|NCT01021852|468182134|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
130062274|NCT01021852|468182135|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
130062275|NCT01021852|468182136|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
130062276|NCT01021852|468182137|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
130062277|NCT01021852|468182138|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
130062278|NCT01021852|468182139|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
130062279|NCT01021852|468182140|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
130062280|NCT01021852|468182141|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
130062281|NCT01021852|468182134|FG000|Washout Period-Placebo|Protocol Violation|0|||
130062282|NCT01021852|468182135|FG001|Washout Period-Placebo|Protocol Violation|0|||
130062283|NCT01021852|468182136|FG002|Washout Period-Placebo|Protocol Violation|0|||
130062284|NCT01021852|468182137|FG003|Washout Period-Placebo|Protocol Violation|0|||
130062285|NCT01021852|468182138|FG004|Washout Period-Placebo|Protocol Violation|0|||
130062286|NCT01021852|468182139|FG005|Washout Period-Placebo|Protocol Violation|0|||
130062287|NCT01021852|468182140|FG006|Washout Period-Placebo|Protocol Violation|1|||
130062288|NCT01021852|468182141|FG007|Washout Period-Placebo|Protocol Violation|0|||
130113784|NCT00871169|468377388|FG000|Overall Study|Protocol Violation|1|||
130113785|NCT00871169|468377388|FG000|Overall Study|Patient did not receive study treatment|2|||
130113786|NCT02110706|468377392|FG000|Overall Study|Adverse Event|2|||
130113787|NCT02110706|468377393|FG001|Overall Study|Adverse Event|3|||
130113788|NCT02110706|468377392|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
130113789|NCT02110706|468377393|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
130113790|NCT03210259|468377394|FG000|12-Week Run-in Period|Adverse Event|1|||
130113791|NCT03210259|468377395|FG001|12-Week Run-in Period|Adverse Event|0|||
130113792|NCT03210259|468377396|FG002|12-Week Run-in Period|Adverse Event|0|||
130113793|NCT03210259|468377394|FG000|12-Week Run-in Period|Death|1|||
130113794|NCT03210259|468377395|FG001|12-Week Run-in Period|Death|0|||
130113795|NCT03210259|468377396|FG002|12-Week Run-in Period|Death|0|||
130113796|NCT03210259|468377394|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
130113797|NCT03210259|468377395|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
130113798|NCT03210259|468377396|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
130113799|NCT03210259|468377394|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
130113800|NCT03210259|468377395|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
130113801|NCT03210259|468377396|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
130113802|NCT03210259|468377394|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
130113803|NCT03210259|468377395|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
130113804|NCT03210259|468377396|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
130113805|NCT03210259|468377394|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
130113806|NCT03210259|468377395|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
130113807|NCT03210259|468377396|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
130113808|NCT03210259|468377394|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
130113809|NCT03210259|468377395|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
130113810|NCT03210259|468377396|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
130113811|NCT03210259|468377394|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
130113812|NCT03210259|468377395|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
129836307|NCT02404311|467368121|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
129836308|NCT00218296|467368129|FG000|Overall Study|Lost to Follow-up|9|||
129836309|NCT00218296|467368130|FG001|Overall Study|Lost to Follow-up|7|||
129836310|NCT00218296|467368129|FG000|Overall Study|Withdrawal by Subject|36|||
129836311|NCT00218296|467368130|FG001|Overall Study|Withdrawal by Subject|47|||
129836312|NCT00218296|467368129|FG000|Overall Study|Randomized but did not enter treatment|66|||
129836313|NCT00218296|467368130|FG001|Overall Study|Randomized but did not enter treatment|67|||
129836314|NCT00097721|467368131|FG000|Overall Study|Adverse Event|8|||
129836315|NCT00097721|467368132|FG001|Overall Study|Adverse Event|1|||
129836316|NCT00097721|467368131|FG000|Overall Study|Withdrawal by Subject|6|||
129836317|NCT00097721|467368132|FG001|Overall Study|Withdrawal by Subject|1|||
129836318|NCT00097721|467368131|FG000|Overall Study|Progressive Disease|55|||
129836319|NCT00097721|467368132|FG001|Overall Study|Progressive Disease|27|||
129836320|NCT00097721|467368131|FG000|Overall Study|Physician Decision|1|||
129836321|NCT00097721|467368132|FG001|Overall Study|Physician Decision|3|||
129836322|NCT00097721|467368131|FG000|Overall Study|Reason not given|1|||
129836323|NCT00097721|467368132|FG001|Overall Study|Reason not given|1|||
129836324|NCT01752855|467368136|FG000|Overall Study|Adverse Event|1|||
129836325|NCT01752855|467368137|FG001|Overall Study|Adverse Event|0|||
129836326|NCT01752855|467368136|FG000|Overall Study|Withdrew Consent|0|||
129836327|NCT01752855|467368137|FG001|Overall Study|Withdrew Consent|2|||
129836328|NCT01752855|467368136|FG000|Overall Study|Lack of Efficacy|0|||
129836329|NCT01752855|467368137|FG001|Overall Study|Lack of Efficacy|2|||
129836330|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
129836331|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
129836332|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
129836333|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
130113813|NCT03210259|468377396|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
129836334|NCT01478321|467368138|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
129836335|NCT01478321|467368138|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
129836336|NCT01478321|467368138|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
129836337|NCT01478321|467368138|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
129836338|NCT00634088|467368141|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
129836339|NCT00634088|467368142|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
129836340|NCT00634088|467368143|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
130113814|NCT03210259|468377394|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
130113815|NCT03210259|468377395|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
130113816|NCT03210259|468377396|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
129836341|NCT00634088|467368144|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
129836342|NCT00634088|467368141|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
129836343|NCT00634088|467368142|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
130113817|NCT03210259|468377394|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
129836344|NCT00634088|467368143|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
129836345|NCT00634088|467368144|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
130113818|NCT03210259|468377395|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
130113819|NCT03210259|468377396|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
130113820|NCT03210259|468377394|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
130113821|NCT03210259|468377395|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
130113822|NCT03210259|468377396|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
129898197|NCT01143077|467586596|FG002|Overall Study|Non-compliance with study drug|1|||
129898198|NCT01143077|467586594|FG000|Overall Study|Administrative|1|||
129898199|NCT01143077|467586595|FG001|Overall Study|Administrative|0|||
129898200|NCT01143077|467586596|FG002|Overall Study|Administrative|0|||
129898201|NCT01143077|467586594|FG000|Overall Study|Principal Investigator Decision|2|||
129898202|NCT01143077|467586595|FG001|Overall Study|Principal Investigator Decision|0|||
129898203|NCT01143077|467586596|FG002|Overall Study|Principal Investigator Decision|1|||
129898204|NCT00871429|467586602|FG000|Overall Study|Lost to Follow-up|6|||
129898205|NCT00871429|467586602|FG000|Overall Study|Withdrawal by Subject|17|||
129898206|NCT00871429|467586602|FG000|Overall Study|Questionnaire not completed|1|||
129898207|NCT01772719|467586605|FG000|Overall Study|Withdrawal by Subject|3|||
129898208|NCT01772719|467586605|FG000|Overall Study|Adverse Event|2|||
129898209|NCT01772719|467586605|FG000|Overall Study|Protocol Violation|1|||
129898210|NCT01772719|467586605|FG000|Overall Study|Lost to Follow-up|1|||
129898211|NCT00477412|467586606|FG000|Overall Study|Death|0|||
129898212|NCT00477412|467586607|FG001|Overall Study|Death|0|||
129898213|NCT00477412|467586608|FG002|Overall Study|Death|0|||
129898214|NCT00477412|467586609|FG003|Overall Study|Death|4|||
129898215|NCT00477412|467586606|FG000|Overall Study|Lost to Follow-up|0|||
129898216|NCT00477412|467586607|FG001|Overall Study|Lost to Follow-up|0|||
129898217|NCT00477412|467586608|FG002|Overall Study|Lost to Follow-up|0|||
129898218|NCT00477412|467586609|FG003|Overall Study|Lost to Follow-up|1|||
129898219|NCT00477412|467586606|FG000|Overall Study|Withdrawal by Subject|0|||
129898220|NCT00477412|467586607|FG001|Overall Study|Withdrawal by Subject|0|||
129898221|NCT00477412|467586608|FG002|Overall Study|Withdrawal by Subject|0|||
129898222|NCT00477412|467586609|FG003|Overall Study|Withdrawal by Subject|2|||
129898223|NCT00477412|467586606|FG000|Overall Study|Second Malignancy|0|||
129898224|NCT00477412|467586607|FG001|Overall Study|Second Malignancy|0|||
129898225|NCT00477412|467586608|FG002|Overall Study|Second Malignancy|0|||
129898226|NCT00477412|467586609|FG003|Overall Study|Second Malignancy|1|||
129898227|NCT00477412|467586606|FG000|Overall Study|Adverse Event|1|||
129898228|NCT00477412|467586607|FG001|Overall Study|Adverse Event|0|||
129898229|NCT00477412|467586608|FG002|Overall Study|Adverse Event|1|||
129898230|NCT00477412|467586609|FG003|Overall Study|Adverse Event|0|||
129898231|NCT03820986|467586611|FG000|Overall Study|Death|177|||
129898232|NCT03820986|467586612|FG001|Overall Study|Death|156|||
129898233|NCT03820986|467586611|FG000|Overall Study|Lost to Follow-up|0|||
129898234|NCT03820986|467586612|FG001|Overall Study|Lost to Follow-up|1|||
129898235|NCT03820986|467586611|FG000|Overall Study|Withdrawal by Subject|8|||
129898236|NCT03820986|467586612|FG001|Overall Study|Withdrawal by Subject|3|||
129898237|NCT03820986|467586611|FG000|Overall Study|Ongoing|149|||
129898238|NCT03820986|467586612|FG001|Overall Study|Ongoing|180|||
129898239|NCT05790408|467588280|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
129898240|NCT02145182|467588281|FG000|Overall Study|Adverse Event|4|||
129898241|NCT02145182|467588282|FG001|Overall Study|Adverse Event|1|||
129898242|NCT02145182|467588281|FG000|Overall Study|Death|7|||
129898243|NCT02145182|467588282|FG001|Overall Study|Death|7|||
129898244|NCT02145182|467588281|FG000|Overall Study|Lost to Follow-up|2|||
129898245|NCT02145182|467588282|FG001|Overall Study|Lost to Follow-up|2|||
129898246|NCT02145182|467588281|FG000|Overall Study|Pre-transplant Withdrawal|0|||
129898247|NCT02145182|467588282|FG001|Overall Study|Pre-transplant Withdrawal|2|||
129898248|NCT02145182|467588281|FG000|Overall Study|Withdrawal by Subject|5|||
130113823|NCT02087059|468377397|FG000|Overall Study|Disease Progression|1|||
130113824|NCT02087059|468377397|FG000|Overall Study|Adverse Event|5|||
130113825|NCT02087059|468377397|FG000|Overall Study|Lost to Follow-up|1|||
130113826|NCT00252187|468377398|FG000|Overall Study|Adverse Event|3|||
130113827|NCT00252187|468377399|FG001|Overall Study|Adverse Event|1|||
129898249|NCT02145182|467588282|FG001|Overall Study|Withdrawal by Subject|4|||
129898250|NCT02274493|467588283|FG000|Overall Study|Withdrawal by Subject|1|||
129898251|NCT00558363|467588284|FG000|Overall Study|Physician Decision|18|||
129898252|NCT00558363|467588285|FG001|Overall Study|Physician Decision|4|||
129898253|NCT00558363|467588284|FG000|Overall Study|Withdrawal by Subject|11|||
129898254|NCT00558363|467588285|FG001|Overall Study|Withdrawal by Subject|4|||
129898255|NCT00558363|467588284|FG000|Overall Study|Adverse Event|5|||
130113828|NCT00252187|468377398|FG000|Overall Study|Withdrawal by Subject|1|||
129898256|NCT00558363|467588285|FG001|Overall Study|Adverse Event|5|||
129898257|NCT00558363|467588284|FG000|Overall Study|Lack of Efficacy|2|||
130113829|NCT00252187|468377399|FG001|Overall Study|Withdrawal by Subject|0|||
129898258|NCT00558363|467588285|FG001|Overall Study|Lack of Efficacy|2|||
129898259|NCT00558363|467588284|FG000|Overall Study|Protocol Violation|2|||
129898260|NCT00558363|467588285|FG001|Overall Study|Protocol Violation|1|||
129898261|NCT00558363|467588284|FG000|Overall Study|Lost to Follow-up|0|||
129898262|NCT00558363|467588285|FG001|Overall Study|Lost to Follow-up|1|||
130062289|NCT01021852|468182134|FG000|Washout Period-No Drug|Adverse Event|1|||
130062290|NCT01021852|468182135|FG001|Washout Period-No Drug|Adverse Event|0|||
130062291|NCT01021852|468182136|FG002|Washout Period-No Drug|Adverse Event|0|||
130062292|NCT01021852|468182137|FG003|Washout Period-No Drug|Adverse Event|0|||
130062293|NCT01021852|468182138|FG004|Washout Period-No Drug|Adverse Event|0|||
130062294|NCT01021852|468182139|FG005|Washout Period-No Drug|Adverse Event|1|||
130062295|NCT01021852|468182140|FG006|Washout Period-No Drug|Adverse Event|0|||
130062296|NCT01021852|468182141|FG007|Washout Period-No Drug|Adverse Event|0|||
130062297|NCT01021852|468182134|FG000|Treatment Period 2|Adverse Event|0|||
130062298|NCT01021852|468182135|FG001|Treatment Period 2|Adverse Event|1|||
130062299|NCT01021852|468182136|FG002|Treatment Period 2|Adverse Event|0|||
130062300|NCT01021852|468182137|FG003|Treatment Period 2|Adverse Event|0|||
130062301|NCT01021852|468182138|FG004|Treatment Period 2|Adverse Event|1|||
129898263|NCT00558363|467588284|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
129898264|NCT00558363|467588285|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
129898265|NCT00558363|467588284|FG000|Overall Study|Randomized in Error|1|||
129898266|NCT00558363|467588285|FG001|Overall Study|Randomized in Error|2|||
129898267|NCT00558363|467588284|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
129898268|NCT00558363|467588285|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
129898269|NCT03736785|467588296|FG000|Overall Study|Adverse Event|1|||
129898270|NCT03736785|467588297|FG001|Overall Study|Adverse Event|1|||
130062302|NCT01021852|468182139|FG005|Treatment Period 2|Adverse Event|0|||
129836346|NCT00634088|467368141|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
129836347|NCT00634088|467368142|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
129836348|NCT00634088|467368143|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
129836349|NCT00634088|467368144|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
129836350|NCT00634088|467368141|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
129836351|NCT00634088|467368142|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
129836352|NCT00634088|467368143|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
129836353|NCT00634088|467368144|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
129836354|NCT00634088|467368141|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
129836355|NCT00634088|467368142|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
129836356|NCT00634088|467368143|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
129836357|NCT00634088|467368144|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
129836358|NCT00634088|467368141|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
129836359|NCT00634088|467368142|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
129836360|NCT00634088|467368143|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
129836361|NCT00634088|467368144|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
129836362|NCT01203072|467368147|FG000|Overall Study|Adverse Event|5|||
129836363|NCT01203072|467368148|FG001|Overall Study|Adverse Event|3|||
129836364|NCT01203072|467368149|FG002|Overall Study|Adverse Event|2|||
129836365|NCT01203072|467368150|FG003|Overall Study|Adverse Event|4|||
129836366|NCT01203072|467368151|FG004|Overall Study|Adverse Event|2|||
129836367|NCT01203072|467368147|FG000|Overall Study|Lack of Efficacy|1|||
129836368|NCT01203072|467368148|FG001|Overall Study|Lack of Efficacy|0|||
129898271|NCT03736785|467588298|FG002|Overall Study|Adverse Event|1|||
129898272|NCT03736785|467588296|FG000|Overall Study|Death|1|||
129898273|NCT03736785|467588297|FG001|Overall Study|Death|0|||
129898274|NCT03736785|467588298|FG002|Overall Study|Death|1|||
130062303|NCT01021852|468182140|FG006|Treatment Period 2|Adverse Event|1|||
130062304|NCT01021852|468182141|FG007|Treatment Period 2|Adverse Event|0|||
130062305|NCT01021852|468182134|FG000|Treatment Period 2|Lack of Efficacy|0|||
130062306|NCT01021852|468182135|FG001|Treatment Period 2|Lack of Efficacy|0|||
130062307|NCT01021852|468182136|FG002|Treatment Period 2|Lack of Efficacy|0|||
130062308|NCT01021852|468182137|FG003|Treatment Period 2|Lack of Efficacy|0|||
130062309|NCT01021852|468182138|FG004|Treatment Period 2|Lack of Efficacy|0|||
130062310|NCT01021852|468182139|FG005|Treatment Period 2|Lack of Efficacy|1|||
130062311|NCT01021852|468182140|FG006|Treatment Period 2|Lack of Efficacy|0|||
130062312|NCT01021852|468182141|FG007|Treatment Period 2|Lack of Efficacy|0|||
130062313|NCT01021852|468182134|FG000|Treatment Period 2|Physician Decision|0|||
130062314|NCT01021852|468182135|FG001|Treatment Period 2|Physician Decision|0|||
130062315|NCT01021852|468182136|FG002|Treatment Period 2|Physician Decision|1|||
130062316|NCT01021852|468182137|FG003|Treatment Period 2|Physician Decision|0|||
130062317|NCT01021852|468182138|FG004|Treatment Period 2|Physician Decision|0|||
129836369|NCT01203072|467368149|FG002|Overall Study|Lack of Efficacy|0|||
129836370|NCT01203072|467368150|FG003|Overall Study|Lack of Efficacy|0|||
129836371|NCT01203072|467368151|FG004|Overall Study|Lack of Efficacy|0|||
129836372|NCT01203072|467368147|FG000|Overall Study|Lost to Follow-up|0|||
129836373|NCT01203072|467368148|FG001|Overall Study|Lost to Follow-up|1|||
129836374|NCT01203072|467368149|FG002|Overall Study|Lost to Follow-up|0|||
129836375|NCT01203072|467368150|FG003|Overall Study|Lost to Follow-up|0|||
130062318|NCT01021852|468182139|FG005|Treatment Period 2|Physician Decision|0|||
130062319|NCT01021852|468182140|FG006|Treatment Period 2|Physician Decision|0|||
130062320|NCT01021852|468182141|FG007|Treatment Period 2|Physician Decision|0|||
130062321|NCT01021852|468182134|FG000|Treatment Period 2|Protocol Violation|0|||
130062322|NCT01021852|468182135|FG001|Treatment Period 2|Protocol Violation|0|||
130062323|NCT01021852|468182136|FG002|Treatment Period 2|Protocol Violation|0|||
130062324|NCT01021852|468182137|FG003|Treatment Period 2|Protocol Violation|0|||
130062325|NCT01021852|468182138|FG004|Treatment Period 2|Protocol Violation|1|||
130062326|NCT01021852|468182139|FG005|Treatment Period 2|Protocol Violation|0|||
130062327|NCT01021852|468182140|FG006|Treatment Period 2|Protocol Violation|1|||
130062328|NCT01021852|468182141|FG007|Treatment Period 2|Protocol Violation|0|||
130062329|NCT01021852|468182134|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130062330|NCT01021852|468182135|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130062331|NCT01021852|468182136|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130062332|NCT01021852|468182137|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130062333|NCT01021852|468182138|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130062334|NCT01021852|468182139|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130062335|NCT01021852|468182140|FG006|Treatment Period 2|Withdrawal by Subject|1|||
130062336|NCT01021852|468182141|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130062337|NCT02493426|468182142|FG000|Overall Study|Withdrawal by Subject|0|||
130113830|NCT02175966|468377402|FG000|Follow-up Period|Lack of Efficacy|10|||
129836376|NCT01203072|467368151|FG004|Overall Study|Lost to Follow-up|0|||
129836377|NCT01203072|467368147|FG000|Overall Study|Protocol Violation|2|||
129836378|NCT01203072|467368148|FG001|Overall Study|Protocol Violation|0|||
129836379|NCT01203072|467368149|FG002|Overall Study|Protocol Violation|0|||
129836380|NCT01203072|467368150|FG003|Overall Study|Protocol Violation|0|||
129836381|NCT01203072|467368151|FG004|Overall Study|Protocol Violation|1|||
129836382|NCT01203072|467368147|FG000|Overall Study|Withdrawal by Subject|2|||
129836383|NCT01203072|467368148|FG001|Overall Study|Withdrawal by Subject|2|||
129836384|NCT01203072|467368149|FG002|Overall Study|Withdrawal by Subject|1|||
129836385|NCT01203072|467368150|FG003|Overall Study|Withdrawal by Subject|2|||
129836386|NCT01203072|467368151|FG004|Overall Study|Withdrawal by Subject|3|||
129836387|NCT01293240|467368162|FG000|Overall Study|Noncompliance|2|||
129836388|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
129836389|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
129836390|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
129836391|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
129836392|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
129836393|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
129836394|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
129836395|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
129836396|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
129836397|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
129836398|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
129836399|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
129836400|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
129836401|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
129836402|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
129836403|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
129836404|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
129836405|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
129836406|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
129836407|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
129836408|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
129836409|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
129836410|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
129836411|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
129836412|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
129836413|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
129836414|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
129836415|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
129836416|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
129836417|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
129836418|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
129836419|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
129836420|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
129836421|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
129836422|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
129836423|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
129836424|NCT01987427|467368169|FG000|Overall Study|Adverse Event|4|||
129836425|NCT01987427|467368170|FG001|Overall Study|Adverse Event|2|||
130062338|NCT02493426|468182143|FG001|Overall Study|Withdrawal by Subject|1|||
129836426|NCT01987427|467368171|FG002|Overall Study|Adverse Event|8|||
129836427|NCT01987427|467368169|FG000|Overall Study|Lost to Follow-up|6|||
129836428|NCT01987427|467368170|FG001|Overall Study|Lost to Follow-up|6|||
129836429|NCT01987427|467368171|FG002|Overall Study|Lost to Follow-up|9|||
129836430|NCT01987427|467368169|FG000|Overall Study|Withdrawal by Subject|2|||
129836431|NCT01987427|467368170|FG001|Overall Study|Withdrawal by Subject|1|||
129898275|NCT03736785|467588296|FG000|Overall Study|Lost to Follow-up|0|||
129898276|NCT03736785|467588297|FG001|Overall Study|Lost to Follow-up|2|||
129898277|NCT03736785|467588298|FG002|Overall Study|Lost to Follow-up|3|||
129898278|NCT03736785|467588296|FG000|Overall Study|Non compliance with study drug|1|||
129898279|NCT03736785|467588297|FG001|Overall Study|Non compliance with study drug|1|||
129898280|NCT03736785|467588298|FG002|Overall Study|Non compliance with study drug|0|||
129898281|NCT03736785|467588296|FG000|Overall Study|Physician Decision|0|||
129898282|NCT03736785|467588297|FG001|Overall Study|Physician Decision|1|||
129898283|NCT03736785|467588298|FG002|Overall Study|Physician Decision|1|||
129898284|NCT03736785|467588296|FG000|Overall Study|Protocol Violation|1|||
129898285|NCT03736785|467588297|FG001|Overall Study|Protocol Violation|4|||
129898286|NCT03736785|467588298|FG002|Overall Study|Protocol Violation|3|||
129898287|NCT03736785|467588296|FG000|Overall Study|Sponsor Decision|1|||
129898288|NCT03736785|467588297|FG001|Overall Study|Sponsor Decision|0|||
129898289|NCT03736785|467588298|FG002|Overall Study|Sponsor Decision|0|||
129898290|NCT03736785|467588296|FG000|Overall Study|Unknown/Missing data|3|||
129898291|NCT03736785|467588297|FG001|Overall Study|Unknown/Missing data|2|||
129898292|NCT03736785|467588298|FG002|Overall Study|Unknown/Missing data|1|||
129898293|NCT03736785|467588296|FG000|Overall Study|Withdrawal by Subject|9|||
129898294|NCT03736785|467588297|FG001|Overall Study|Withdrawal by Subject|6|||
129898295|NCT03736785|467588298|FG002|Overall Study|Withdrawal by Subject|4|||
129898296|NCT01744691|467588300|FG000|Overall Study|Progressive Disease|18|||
129898297|NCT01744691|467588300|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
129898298|NCT01744691|467588300|FG000|Overall Study|Withdrawal of consent for treatment|3|||
129898299|NCT01744691|467588300|FG000|Overall Study|Physician Decision|4|||
129898300|NCT02701361|467588302|FG000|Overall Study|Lost to Follow-up|5|||
129898301|NCT02701361|467588303|FG001|Overall Study|Lost to Follow-up|2|||
129898302|NCT02701361|467588304|FG002|Overall Study|Lost to Follow-up|1|||
129898303|NCT02701361|467588302|FG000|Overall Study|Withdrawal by Subject|4|||
129898304|NCT02701361|467588303|FG001|Overall Study|Withdrawal by Subject|0|||
129898305|NCT02701361|467588304|FG002|Overall Study|Withdrawal by Subject|0|||
129898306|NCT02701361|467588302|FG000|Overall Study|timed out in rehab center|0|||
129898307|NCT02701361|467588303|FG001|Overall Study|timed out in rehab center|1|||
129898308|NCT02701361|467588304|FG002|Overall Study|timed out in rehab center|0|||
129898309|NCT02701361|467588302|FG000|Overall Study|incarceration|0|||
129898310|NCT02701361|467588303|FG001|Overall Study|incarceration|0|||
129898311|NCT02701361|467588304|FG002|Overall Study|incarceration|1|||
129898312|NCT04588480|467588305|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
129898313|NCT04588480|467588306|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
129898314|NCT04588480|467588307|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
129898315|NCT04588480|467588305|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
129898316|NCT04588480|467588306|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
129898317|NCT04588480|467588307|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
129898318|NCT01190150|467588312|FG000|First Treatment|Withdrawal by Subject|1|||
129898319|NCT01190150|467588313|FG001|First Treatment|Withdrawal by Subject|0|||
129898320|NCT01190150|467588312|FG000|Washout|Withdrawal by Subject|0|||
129898321|NCT01190150|467588313|FG001|Washout|Withdrawal by Subject|1|||
129898322|NCT01190150|467588312|FG000|Washout|Difficulty in adherence|0|||
129898323|NCT01190150|467588313|FG001|Washout|Difficulty in adherence|1|||
129898324|NCT00843193|467588319|FG000|Overall Study|Adverse Event|2|||
129898325|NCT00843193|467588320|FG001|Overall Study|Adverse Event|4|||
130062339|NCT03491553|468182144|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
130062340|NCT03491553|468182145|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
130062341|NCT03491553|468182146|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
130062342|NCT03491553|468182147|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
130062343|NCT03491553|468182148|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
130062344|NCT03491553|468182149|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
130062345|NCT03491553|468182144|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
130062346|NCT03491553|468182145|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
130062347|NCT03491553|468182146|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
130062348|NCT03491553|468182147|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
130062349|NCT03491553|468182148|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
130062350|NCT03491553|468182149|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
130062351|NCT01025817|468182152|FG000|Completed Study Medication|Adverse Event|66|||
130062352|NCT01025817|468182153|FG001|Completed Study Medication|Adverse Event|39|||
130062353|NCT01025817|468182152|FG000|Completed Study Medication|Protocol Deviation|9|||
130062354|NCT01025817|468182153|FG001|Completed Study Medication|Protocol Deviation|8|||
130062355|NCT01025817|468182152|FG000|Completed Study Medication|Withdrawal by Subject|8|||
130062356|NCT01025817|468182153|FG001|Completed Study Medication|Withdrawal by Subject|9|||
130062357|NCT01025817|468182152|FG000|Completed Study Medication|Administrative problems|7|||
130062358|NCT01025817|468182153|FG001|Completed Study Medication|Administrative problems|5|||
130062359|NCT01025817|468182152|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
130062360|NCT01025817|468182153|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
129898326|NCT00843193|467588319|FG000|Overall Study|Lack of Efficacy|1|||
129898327|NCT00843193|467588320|FG001|Overall Study|Lack of Efficacy|1|||
130113831|NCT02175966|468377403|FG001|Follow-up Period|Lack of Efficacy|6|||
130113832|NCT00210626|468377408|FG000|Overall Study|Adverse Event|1|||
130113833|NCT00210626|468377409|FG001|Overall Study|Adverse Event|2|||
130113834|NCT00210626|468377408|FG000|Overall Study|Protocol Violation|1|||
130113835|NCT00210626|468377409|FG001|Overall Study|Protocol Violation|5|||
130113836|NCT00210626|468377408|FG000|Overall Study|Lost to Follow-up|11|||
130113837|NCT00210626|468377409|FG001|Overall Study|Lost to Follow-up|11|||
130113838|NCT00210626|468377408|FG000|Overall Study|Death|1|||
130113839|NCT00210626|468377409|FG001|Overall Study|Death|0|||
130113840|NCT00210626|468377408|FG000|Overall Study|Withdrawal by Subject|29|||
130113841|NCT00210626|468377409|FG001|Overall Study|Withdrawal by Subject|20|||
130113842|NCT00210626|468377408|FG000|Overall Study|Physician Decision|0|||
130113843|NCT00210626|468377409|FG001|Overall Study|Physician Decision|2|||
130113844|NCT00210626|468377408|FG000|Overall Study|Sponser Request|1|||
130113845|NCT00210626|468377409|FG001|Overall Study|Sponser Request|0|||
130113846|NCT00210626|468377408|FG000|Overall Study|Other|4|||
130113847|NCT00210626|468377409|FG001|Overall Study|Other|5|||
130113848|NCT02473510|468377410|FG000|Overall Study|Lost to Follow-up|1|||
130113849|NCT02473510|468377411|FG001|Overall Study|Lost to Follow-up|2|||
130113850|NCT01306253|468377412|FG000|Overall Study|Lost to Follow-up|1|||
130113851|NCT01306253|468377413|FG001|Overall Study|Lost to Follow-up|1|||
130113852|NCT01261325|468377414|FG000|Overall Study|Lack of Efficacy|1|||
130113853|NCT01261325|468377415|FG001|Overall Study|Lack of Efficacy|1|||
130113854|NCT01261325|468377416|FG002|Overall Study|Lack of Efficacy|0|||
130113855|NCT01261325|468377414|FG000|Overall Study|Withdrawal by Subject|2|||
130113856|NCT01261325|468377415|FG001|Overall Study|Withdrawal by Subject|2|||
130113857|NCT01261325|468377416|FG002|Overall Study|Withdrawal by Subject|4|||
130113858|NCT01261325|468377414|FG000|Overall Study|SAE, non-fatal|1|||
130113859|NCT01261325|468377415|FG001|Overall Study|SAE, non-fatal|5|||
130113860|NCT01261325|468377416|FG002|Overall Study|SAE, non-fatal|1|||
130113861|NCT01261325|468377414|FG000|Overall Study|AE, non-serious non-fatal|9|||
130113862|NCT01261325|468377415|FG001|Overall Study|AE, non-serious non-fatal|15|||
130113863|NCT01261325|468377416|FG002|Overall Study|AE, non-serious non-fatal|13|||
130113864|NCT01261325|468377414|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130113865|NCT01261325|468377415|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130113866|NCT01261325|468377416|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130113867|NCT01261325|468377414|FG000|Overall Study|Non Compliance|2|||
130113868|NCT01261325|468377415|FG001|Overall Study|Non Compliance|0|||
130113869|NCT01261325|468377416|FG002|Overall Study|Non Compliance|0|||
130113870|NCT01261325|468377414|FG000|Overall Study|Patient Randomized by Mistake|0|||
130113871|NCT01261325|468377415|FG001|Overall Study|Patient Randomized by Mistake|1|||
130113872|NCT01261325|468377416|FG002|Overall Study|Patient Randomized by Mistake|0|||
130113873|NCT01261325|468377414|FG000|Overall Study|Erroneously Randomized|1|||
130113874|NCT01261325|468377415|FG001|Overall Study|Erroneously Randomized|0|||
130113875|NCT01261325|468377416|FG002|Overall Study|Erroneously Randomized|0|||
130113876|NCT01261325|468377414|FG000|Overall Study|Screen Failure|1|||
130113877|NCT01261325|468377415|FG001|Overall Study|Screen Failure|0|||
130113878|NCT01261325|468377416|FG002|Overall Study|Screen Failure|0|||
130113879|NCT01261325|468377414|FG000|Overall Study|Randomized in Error|0|||
130113880|NCT01261325|468377415|FG001|Overall Study|Randomized in Error|0|||
130113881|NCT01261325|468377416|FG002|Overall Study|Randomized in Error|1|||
130113882|NCT01261325|468377414|FG000|Overall Study|Protocol Violation|0|||
130113883|NCT01261325|468377415|FG001|Overall Study|Protocol Violation|3|||
130113884|NCT01261325|468377416|FG002|Overall Study|Protocol Violation|1|||
130113885|NCT01261325|468377414|FG000|Overall Study|Lost to Follow-up|0|||
130113886|NCT01261325|468377415|FG001|Overall Study|Lost to Follow-up|1|||
130113887|NCT01261325|468377416|FG002|Overall Study|Lost to Follow-up|3|||
130113888|NCT01261325|468377414|FG000|Overall Study|AE, serious fatal|0|||
130113889|NCT01261325|468377415|FG001|Overall Study|AE, serious fatal|0|||
130113890|NCT01261325|468377416|FG002|Overall Study|AE, serious fatal|2|||
130113891|NCT02280356|468377420|FG000|Overall Study|Not Treated|2|||
130113892|NCT02280356|468377420|FG000|Overall Study|Withdrawal by Subject|1|||
129836432|NCT01987427|467368171|FG002|Overall Study|Withdrawal by Subject|3|||
129836433|NCT01987427|467368169|FG000|Overall Study|Lack of Efficacy|1|||
129836434|NCT01987427|467368170|FG001|Overall Study|Lack of Efficacy|0|||
130113893|NCT02280356|468377420|FG000|Overall Study|Not evaluable|2|||
130113894|NCT00871728|468377427|FG000|Overall Study|Adverse Event|1|||
130113895|NCT00871728|468377427|FG000|Overall Study|Protocol Violation|7|||
130113896|NCT00871728|468377427|FG000|Overall Study|Lost to Follow-up|2|||
130113897|NCT00871728|468377427|FG000|Overall Study|Failed to Visit Hospital|4|||
130113898|NCT00871728|468377427|FG000|Overall Study|Participant Non-compliance|1|||
130113899|NCT00871728|468377427|FG000|Overall Study|Withdrawal of Informed Consent|5|||
130113900|NCT04147715|468377428|FG000|Overall Study|Adverse Event|0|||
130113901|NCT04147715|468377429|FG001|Overall Study|Adverse Event|0|||
130113902|NCT04147715|468377430|FG002|Overall Study|Adverse Event|0|||
130113903|NCT04147715|468377431|FG003|Overall Study|Adverse Event|0|||
130113904|NCT04147715|468377432|FG004|Overall Study|Adverse Event|0|||
129836435|NCT01987427|467368171|FG002|Overall Study|Lack of Efficacy|0|||
130113905|NCT04147715|468377433|FG005|Overall Study|Adverse Event|0|||
129898328|NCT00843193|467588319|FG000|Overall Study|Protocol Violation|1|||
129898329|NCT00843193|467588320|FG001|Overall Study|Protocol Violation|2|||
129898330|NCT00843193|467588319|FG000|Overall Study|Lost to Follow-up|1|||
129898331|NCT00843193|467588320|FG001|Overall Study|Lost to Follow-up|0|||
129898332|NCT00843193|467588319|FG000|Overall Study|Physician Decision|0|||
129898333|NCT00843193|467588320|FG001|Overall Study|Physician Decision|1|||
129898334|NCT00843193|467588319|FG000|Overall Study|Withdrawal by Subject|3|||
129898335|NCT00843193|467588320|FG001|Overall Study|Withdrawal by Subject|3|||
129898336|NCT04511650|467588321|FG000|Overall Study|Lost to Follow-up|1|||
129898337|NCT04511650|467588322|FG001|Overall Study|Lost to Follow-up|0|||
129898338|NCT04511650|467588323|FG002|Overall Study|Lost to Follow-up|0|||
129898339|NCT04511650|467588321|FG000|Overall Study|Withdrawal by Subject|1|||
129898340|NCT04511650|467588322|FG001|Overall Study|Withdrawal by Subject|0|||
129898341|NCT04511650|467588323|FG002|Overall Study|Withdrawal by Subject|0|||
129898342|NCT04511650|467588321|FG000|Overall Study|reason not provided|0|||
129898343|NCT04511650|467588322|FG001|Overall Study|reason not provided|0|||
129898344|NCT04511650|467588323|FG002|Overall Study|reason not provided|1|||
129898345|NCT04511650|467588321|FG000|Overall Study|Death|1|||
129898346|NCT04511650|467588322|FG001|Overall Study|Death|1|||
129898347|NCT04511650|467588323|FG002|Overall Study|Death|1|||
129898348|NCT00544440|467588325|FG000|Overall Study|Other|1|||
129898349|NCT00544440|467588325|FG000|Overall Study|Adverse Event|1|||
129898350|NCT00544440|467588325|FG000|Overall Study|Withdrawal by Subject|2|||
129898351|NCT00544440|467588325|FG000|Overall Study|Subject Non-compliance|1|||
129898352|NCT00544440|467588325|FG000|Overall Study|Progressive Disease|47|||
129898353|NCT00544440|467588325|FG000|Overall Study|Other|5|||
129898354|NCT03586167|467588327|FG000|Overall Study|Other|1|||
129898355|NCT03586167|467588328|FG001|Overall Study|Other|0|||
129898356|NCT00591838|467588329|FG000|Overall Study|Withdrawal by Subject|0|||
129898357|NCT00591838|467588330|FG001|Overall Study|Withdrawal by Subject|0|||
129898358|NCT00591838|467588331|FG002|Overall Study|Withdrawal by Subject|0|||
129898359|NCT00591838|467588332|FG003|Overall Study|Withdrawal by Subject|1|||
129898360|NCT00591838|467588333|FG004|Overall Study|Withdrawal by Subject|0|||
129898361|NCT04163458|467588336|FG000|Overall Study|Protocol Deviation|7|||
129898362|NCT04163458|467588337|FG001|Overall Study|Protocol Deviation|13|||
129898363|NCT04163458|467588336|FG000|Overall Study|Adverse Event|5|||
129898364|NCT04163458|467588337|FG001|Overall Study|Adverse Event|8|||
129898365|NCT04163458|467588336|FG000|Overall Study|Due to COVID-19 pandemic|4|||
129898366|NCT04163458|467588337|FG001|Overall Study|Due to COVID-19 pandemic|2|||
129898367|NCT04163458|467588336|FG000|Overall Study|Participant withdrew consent|2|||
129898368|NCT04163458|467588337|FG001|Overall Study|Participant withdrew consent|3|||
129898369|NCT04163458|467588336|FG000|Overall Study|Randomization failure|2|||
129898370|NCT04163458|467588337|FG001|Overall Study|Randomization failure|2|||
129898371|NCT04163458|467588336|FG000|Overall Study|Other|4|||
129898372|NCT04163458|467588337|FG001|Overall Study|Other|2|||
129898373|NCT03523962|467588339|FG000|Closed Fractures|Death|86|||
129898374|NCT03523962|467588340|FG001|Closed Fractures|Death|71|||
129898375|NCT03523962|467588341|FG002|Closed Fractures|Death|0|||
129898376|NCT03523962|467588342|FG003|Closed Fractures|Death|0|||
129898377|NCT03523962|467588339|FG000|Closed Fractures|Lost to Follow-up|62|||
129898378|NCT03523962|467588340|FG001|Closed Fractures|Lost to Follow-up|36|||
129898379|NCT03523962|467588341|FG002|Closed Fractures|Lost to Follow-up|0|||
129898380|NCT03523962|467588342|FG003|Closed Fractures|Lost to Follow-up|0|||
129898381|NCT03523962|467588339|FG000|Closed Fractures|Withdrawal by Subject|19|||
129898382|NCT03523962|467588340|FG001|Closed Fractures|Withdrawal by Subject|29|||
129898383|NCT03523962|467588341|FG002|Closed Fractures|Withdrawal by Subject|0|||
129898384|NCT03523962|467588342|FG003|Closed Fractures|Withdrawal by Subject|0|||
129898385|NCT03523962|467588339|FG000|Closed Fractures|Incarceration|1|||
129898386|NCT03523962|467588340|FG001|Closed Fractures|Incarceration|4|||
129898387|NCT03523962|467588341|FG002|Closed Fractures|Incarceration|0|||
129898388|NCT03523962|467588342|FG003|Closed Fractures|Incarceration|0|||
129898389|NCT03523962|467588339|FG000|Open Fractures|Death|0|||
129898390|NCT03523962|467588340|FG001|Open Fractures|Death|0|||
129898391|NCT03523962|467588341|FG002|Open Fractures|Death|11|||
129898392|NCT03523962|467588342|FG003|Open Fractures|Death|6|||
129898393|NCT03523962|467588339|FG000|Open Fractures|Lost to Follow-up|0|||
129898394|NCT03523962|467588340|FG001|Open Fractures|Lost to Follow-up|0|||
129898395|NCT03523962|467588341|FG002|Open Fractures|Lost to Follow-up|15|||
129898396|NCT03523962|467588342|FG003|Open Fractures|Lost to Follow-up|8|||
129898397|NCT03523962|467588339|FG000|Open Fractures|Withdrawal by Subject|0|||
129898398|NCT03523962|467588340|FG001|Open Fractures|Withdrawal by Subject|0|||
129898399|NCT03523962|467588341|FG002|Open Fractures|Withdrawal by Subject|6|||
129898400|NCT03523962|467588342|FG003|Open Fractures|Withdrawal by Subject|2|||
129898401|NCT03523962|467588339|FG000|Open Fractures|Incarceration|0|||
129898402|NCT03523962|467588340|FG001|Open Fractures|Incarceration|0|||
129898403|NCT03523962|467588341|FG002|Open Fractures|Incarceration|1|||
129898404|NCT03523962|467588342|FG003|Open Fractures|Incarceration|0|||
129898405|NCT01081145|467588346|FG000|Open-Label Phase|Lack of Efficacy|56|||
129898406|NCT01081145|467588347|FG001|Open-Label Phase|Lack of Efficacy|0|||
129898407|NCT01081145|467588346|FG000|Open-Label Phase|Response criteria not met|46|||
129836436|NCT01987427|467368169|FG000|Overall Study|Other|1|||
129836437|NCT01987427|467368170|FG001|Overall Study|Other|1|||
129836438|NCT01987427|467368171|FG002|Overall Study|Other|0|||
129836439|NCT02547129|467368175|FG000|Overall Study|Difficulty with ongoing infection|1|||
129836440|NCT02547129|467368176|FG001|Overall Study|Difficulty with ongoing infection|0|||
129836441|NCT03925324|467368177|FG000|Overall Study|Death|1|||
129836442|NCT03925324|467368178|FG001|Overall Study|Death|1|||
129836443|NCT00805766|467368179|FG000|Screening Period|Adverse Event|1|||
129836444|NCT00805766|467368179|FG000|Screening Period|Lack of Efficacy|2|||
129836445|NCT00805766|467368179|FG000|Screening Period|Pregnancy|1|||
129836446|NCT00805766|467368179|FG000|Screening Period|Responder|2|||
129836447|NCT00805766|467368179|FG000|Increased Dose Period|Adverse Event|4|||
129836448|NCT00805766|467368179|FG000|Increased Dose Period|Lack of Efficacy|7|||
129836449|NCT00805766|467368179|FG000|Increased Dose Period|Pregnancy|1|||
129836450|NCT00805766|467368179|FG000|Increased Dose Period|Withdrawal by Subject|1|||
129836451|NCT02063737|467368182|FG000|Overall Study|Lost to Follow-up|11|||
129836452|NCT02063737|467368183|FG001|Overall Study|Lost to Follow-up|4|||
129836453|NCT02159521|467368184|FG000|Overall Study|Enrolled but not treated|3|||
129836454|NCT02159521|467368184|FG000|Overall Study|Withdrawal by Subject|7|||
129836455|NCT02159521|467368184|FG000|Overall Study|Lost to Follow-up|6|||
129836456|NCT02159521|467368184|FG000|Overall Study|Death|1|||
129836457|NCT02159521|467368184|FG000|Overall Study|Other than specified|1|||
129836458|NCT00694369|467368187|FG000|Overall Study|Adverse Event|0|||
129836459|NCT00694369|467368188|FG001|Overall Study|Adverse Event|1|||
129836460|NCT00694369|467368189|FG002|Overall Study|Adverse Event|0|||
129836461|NCT00694369|467368190|FG003|Overall Study|Adverse Event|1|||
129836462|NCT00694369|467368191|FG004|Overall Study|Adverse Event|3|||
129836463|NCT00694369|467368187|FG000|Overall Study|Lost to Follow-up|0|||
129836464|NCT00694369|467368188|FG001|Overall Study|Lost to Follow-up|0|||
129836465|NCT00694369|467368189|FG002|Overall Study|Lost to Follow-up|1|||
129836466|NCT00694369|467368190|FG003|Overall Study|Lost to Follow-up|1|||
129836467|NCT00694369|467368191|FG004|Overall Study|Lost to Follow-up|0|||
129836468|NCT00694369|467368187|FG000|Overall Study|Physician Decision|0|||
129836469|NCT00694369|467368188|FG001|Overall Study|Physician Decision|0|||
129836470|NCT00694369|467368189|FG002|Overall Study|Physician Decision|0|||
129836471|NCT00694369|467368190|FG003|Overall Study|Physician Decision|0|||
129836472|NCT00694369|467368191|FG004|Overall Study|Physician Decision|1|||
129836473|NCT00694369|467368187|FG000|Overall Study|Protocol Violation|0|||
129836474|NCT00694369|467368188|FG001|Overall Study|Protocol Violation|1|||
129836475|NCT00694369|467368189|FG002|Overall Study|Protocol Violation|0|||
129836476|NCT00694369|467368190|FG003|Overall Study|Protocol Violation|0|||
129836477|NCT00694369|467368191|FG004|Overall Study|Protocol Violation|0|||
129836478|NCT00694369|467368187|FG000|Overall Study|Withdrawal by Subject|1|||
129836479|NCT00694369|467368188|FG001|Overall Study|Withdrawal by Subject|1|||
129836480|NCT00694369|467368189|FG002|Overall Study|Withdrawal by Subject|1|||
129836481|NCT00694369|467368190|FG003|Overall Study|Withdrawal by Subject|1|||
129836482|NCT00694369|467368191|FG004|Overall Study|Withdrawal by Subject|2|||
129836483|NCT00907374|467368194|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
129836484|NCT00907374|467368195|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
129836485|NCT00594464|467368198|FG000|Overall Study|Withdrawal by Subject|1|||
129836486|NCT00594464|467368198|FG000|Overall Study|Delay in operation|2|||
129836487|NCT00775437|467368199|FG000|Overall Study|Loss of efficacy|2|||
129836488|NCT00775437|467368199|FG000|Overall Study|Withdrawal by Subject|3|||
129836489|NCT00775437|467368199|FG000|Overall Study|Lost to Follow-up|1|||
129836490|NCT03131440|467368200|FG000|Overall Study|Withdrawal by Subject|1|||
129836491|NCT03131440|467368201|FG001|Overall Study|Withdrawal by Subject|3|||
129836492|NCT03131440|467368202|FG002|Overall Study|Withdrawal by Subject|0|||
129836493|NCT03131440|467368203|FG003|Overall Study|Withdrawal by Subject|0|||
129836494|NCT03131440|467368204|FG004|Overall Study|Withdrawal by Subject|1|||
129836495|NCT03131440|467368205|FG005|Overall Study|Withdrawal by Subject|0|||
129836496|NCT03131440|467368206|FG006|Overall Study|Withdrawal by Subject|0|||
129836497|NCT03131440|467368207|FG007|Overall Study|Withdrawal by Subject|1|||
129836498|NCT03131440|467368208|FG008|Overall Study|Withdrawal by Subject|1|||
129836499|NCT03131440|467368209|FG009|Overall Study|Withdrawal by Subject|1|||
129836500|NCT03131440|467368210|FG010|Overall Study|Withdrawal by Subject|0|||
129836501|NCT03131440|467368211|FG011|Overall Study|Withdrawal by Subject|1|||
129836502|NCT03131440|467368212|FG012|Overall Study|Withdrawal by Subject|1|||
129836503|NCT03131440|467368213|FG013|Overall Study|Withdrawal by Subject|0|||
129836504|NCT03131440|467368214|FG014|Overall Study|Withdrawal by Subject|1|||
129836505|NCT03131440|467368215|FG015|Overall Study|Withdrawal by Subject|0|||
129836506|NCT03131440|467368216|FG016|Overall Study|Withdrawal by Subject|0|||
129836507|NCT03131440|467368217|FG017|Overall Study|Withdrawal by Subject|0|||
129836508|NCT03131440|467368218|FG018|Overall Study|Withdrawal by Subject|1|||
129836509|NCT03131440|467368219|FG019|Overall Study|Withdrawal by Subject|0|||
129836510|NCT03131440|467368220|FG020|Overall Study|Withdrawal by Subject|1|||
129836511|NCT03131440|467368221|FG021|Overall Study|Withdrawal by Subject|1|||
129836512|NCT03131440|467368222|FG022|Overall Study|Withdrawal by Subject|1|||
129836513|NCT03131440|467368223|FG023|Overall Study|Withdrawal by Subject|0|||
130113906|NCT04147715|468377434|FG006|Overall Study|Adverse Event|0|||
130113907|NCT04147715|468377435|FG007|Overall Study|Adverse Event|2|||
130113908|NCT04147715|468377436|FG008|Overall Study|Adverse Event|1|||
130113909|NCT04147715|468377437|FG009|Overall Study|Adverse Event|0|||
130113910|NCT04147715|468377438|FG010|Overall Study|Adverse Event|0|||
130113911|NCT04147715|468377439|FG011|Overall Study|Adverse Event|0|||
130113912|NCT01829295|468377440|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
130113913|NCT01829295|468377441|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
130113914|NCT01829295|468377442|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
130113915|NCT01829295|468377443|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
130113916|NCT01829295|468377440|FG000|6-12 Months|Adverse Event|0|||
130113917|NCT01829295|468377441|FG001|6-12 Months|Adverse Event|0|||
130113918|NCT01829295|468377442|FG002|6-12 Months|Adverse Event|3|||
130113919|NCT01829295|468377443|FG003|6-12 Months|Adverse Event|2|||
130113920|NCT01829295|468377440|FG000|6-12 Months|Lost to Follow-up|2|||
130113921|NCT01829295|468377441|FG001|6-12 Months|Lost to Follow-up|0|||
130113922|NCT01829295|468377442|FG002|6-12 Months|Lost to Follow-up|0|||
130113923|NCT01829295|468377443|FG003|6-12 Months|Lost to Follow-up|0|||
130113924|NCT01829295|468377440|FG000|6-12 Months|Withdrawal by Subject|2|||
130113925|NCT01829295|468377441|FG001|6-12 Months|Withdrawal by Subject|2|||
130113926|NCT01829295|468377442|FG002|6-12 Months|Withdrawal by Subject|0|||
130113927|NCT01829295|468377443|FG003|6-12 Months|Withdrawal by Subject|0|||
130113928|NCT01626859|468377444|FG000|Overall Study|Adverse Event|1|||
130113929|NCT01626859|468377445|FG001|Overall Study|Adverse Event|3|||
130113930|NCT01626859|468377446|FG002|Overall Study|Adverse Event|2|||
130113931|NCT01626859|468377444|FG000|Overall Study|Physician Decision|0|||
130113932|NCT01626859|468377445|FG001|Overall Study|Physician Decision|1|||
130113933|NCT01626859|468377446|FG002|Overall Study|Physician Decision|0|||
130113934|NCT01626859|468377444|FG000|Overall Study|Withdrawal by Subject|1|||
130113935|NCT01626859|468377445|FG001|Overall Study|Withdrawal by Subject|4|||
130113936|NCT01626859|468377446|FG002|Overall Study|Withdrawal by Subject|2|||
130113937|NCT02629965|468377447|FG000|Period 1|Adverse Event|1|||
130113938|NCT02629965|468377448|FG001|Period 1|Adverse Event|0|||
130113939|NCT02629965|468377447|FG000|Period 1|Unexpected worsening of disease|2|||
130113940|NCT02629965|468377448|FG001|Period 1|Unexpected worsening of disease|0|||
130113941|NCT02629965|468377447|FG000|Period 1|Other than listed above|1|||
130113942|NCT02629965|468377448|FG001|Period 1|Other than listed above|2|||
130113943|NCT02629965|468377447|FG000|Period 2|Adverse Event|1|||
130113944|NCT02629965|468377448|FG001|Period 2|Adverse Event|0|||
130113945|NCT02330081|468377449|FG000|Overall Study|Adverse Event|1|||
130113946|NCT02330081|468377449|FG000|Overall Study|Donation did not meet criteria|1|||
130113947|NCT02330081|468377449|FG000|Overall Study|Protocol Violation|6|||
130113948|NCT02826603|468377450|FG000|Overall Study|Adverse Event|17|||
130113949|NCT02826603|468377451|FG001|Overall Study|Adverse Event|9|||
130113950|NCT02826603|468377450|FG000|Overall Study|Lack of Efficacy|4|||
130113951|NCT02826603|468377451|FG001|Overall Study|Lack of Efficacy|9|||
130113952|NCT02826603|468377450|FG000|Overall Study|Lost to Follow-up|13|||
130113953|NCT02826603|468377451|FG001|Overall Study|Lost to Follow-up|12|||
130113954|NCT02826603|468377450|FG000|Overall Study|Noncompliance with treatment|0|||
130113955|NCT02826603|468377451|FG001|Overall Study|Noncompliance with treatment|2|||
130113956|NCT02826603|468377450|FG000|Overall Study|Physician Decision|1|||
130113957|NCT02826603|468377451|FG001|Overall Study|Physician Decision|7|||
130113958|NCT02826603|468377450|FG000|Overall Study|Pregnancy|1|||
130113959|NCT02826603|468377451|FG001|Overall Study|Pregnancy|2|||
130113960|NCT02826603|468377450|FG000|Overall Study|Protocol Violation|3|||
130113961|NCT02826603|468377451|FG001|Overall Study|Protocol Violation|3|||
130113962|NCT02826603|468377450|FG000|Overall Study|Withdrawal by Subject|20|||
130113963|NCT02826603|468377451|FG001|Overall Study|Withdrawal by Subject|19|||
130113964|NCT02826603|468377450|FG000|Overall Study|Death|2|||
130113965|NCT02826603|468377451|FG001|Overall Study|Death|0|||
130113966|NCT02826603|468377450|FG000|Overall Study|New therapy for study indication|0|||
130113967|NCT02826603|468377451|FG001|Overall Study|New therapy for study indication|1|||
130113968|NCT01337050|468377455|FG000|Overall Study|Death|0|||
130113969|NCT01337050|468377456|FG001|Overall Study|Death|0|||
130113970|NCT01337050|468377457|FG002|Overall Study|Death|4|||
130113971|NCT01337050|468377455|FG000|Overall Study|Other|4|||
130113972|NCT01337050|468377456|FG001|Overall Study|Other|6|||
130113973|NCT01337050|468377457|FG002|Overall Study|Other|8|||
130113974|NCT01337050|468377455|FG000|Overall Study|Participants refused further follow-up|0|||
130113975|NCT01337050|468377456|FG001|Overall Study|Participants refused further follow-up|7|||
130113976|NCT01337050|468377457|FG002|Overall Study|Participants refused further follow-up|7|||
130113977|NCT00003102|468377458|FG000|Overall Study|Physician Decision|1|||
130113978|NCT00003102|468377459|FG001|Overall Study|Physician Decision|1|||
130113979|NCT00003102|468377460|FG002|Overall Study|Physician Decision|0|||
130113980|NCT00003102|468377458|FG000|Overall Study|Progressive Disease|0|||
130113981|NCT00003102|468377459|FG001|Overall Study|Progressive Disease|1|||
130113982|NCT00003102|468377460|FG002|Overall Study|Progressive Disease|0|||
130113983|NCT00003102|468377458|FG000|Overall Study|Adverse Event|0|||
130113984|NCT00003102|468377459|FG001|Overall Study|Adverse Event|1|||
130113985|NCT00003102|468377460|FG002|Overall Study|Adverse Event|1|||
129836514|NCT03131440|467368224|FG024|Overall Study|Withdrawal by Subject|0|||
129836515|NCT03131440|467368225|FG025|Overall Study|Withdrawal by Subject|0|||
129836516|NCT03131440|467368226|FG026|Overall Study|Withdrawal by Subject|0|||
129836517|NCT03131440|467368227|FG027|Overall Study|Withdrawal by Subject|0|||
129836518|NCT03131440|467368228|FG028|Overall Study|Withdrawal by Subject|0|||
129836519|NCT03131440|467368229|FG029|Overall Study|Withdrawal by Subject|0|||
129836520|NCT03131440|467368230|FG030|Overall Study|Withdrawal by Subject|1|||
129836521|NCT03131440|467368231|FG031|Overall Study|Withdrawal by Subject|0|||
129836522|NCT03131440|467368200|FG000|Overall Study|Lost to Follow-up|0|||
129836523|NCT03131440|467368201|FG001|Overall Study|Lost to Follow-up|0|||
129836524|NCT03131440|467368202|FG002|Overall Study|Lost to Follow-up|0|||
129836525|NCT03131440|467368203|FG003|Overall Study|Lost to Follow-up|0|||
129836526|NCT03131440|467368204|FG004|Overall Study|Lost to Follow-up|0|||
129836527|NCT03131440|467368205|FG005|Overall Study|Lost to Follow-up|1|||
129836528|NCT03131440|467368206|FG006|Overall Study|Lost to Follow-up|0|||
129836529|NCT03131440|467368207|FG007|Overall Study|Lost to Follow-up|0|||
130113986|NCT00003102|468377458|FG000|Overall Study|Death|0|||
129836530|NCT03131440|467368208|FG008|Overall Study|Lost to Follow-up|0|||
129836531|NCT03131440|467368209|FG009|Overall Study|Lost to Follow-up|0|||
129836532|NCT03131440|467368210|FG010|Overall Study|Lost to Follow-up|0|||
129898408|NCT01081145|467588347|FG001|Open-Label Phase|Response criteria not met|0|||
129898409|NCT01081145|467588346|FG000|Open-Label Phase|Adverse Event|42|||
129898410|NCT01081145|467588347|FG001|Open-Label Phase|Adverse Event|0|||
129898411|NCT01081145|467588346|FG000|Open-Label Phase|Withdrawal by Subject|41|||
129898412|NCT01081145|467588347|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129898413|NCT01081145|467588346|FG000|Open-Label Phase|Other|12|||
129898414|NCT01081145|467588347|FG001|Open-Label Phase|Other|0|||
129898415|NCT01081145|467588346|FG000|Open-Label Phase|Lost to Follow-up|11|||
129898416|NCT01081145|467588347|FG001|Open-Label Phase|Lost to Follow-up|0|||
129898417|NCT01081145|467588346|FG000|Open-Label Phase|Protocol Violation|4|||
129898418|NCT01081145|467588347|FG001|Open-Label Phase|Protocol Violation|0|||
129898419|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
129898420|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
129898421|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
129898422|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
129898423|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
129898424|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
129898425|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
129898426|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
129898427|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
129898428|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
129898429|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
129898430|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
129898431|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
129898432|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
129898433|NCT03394027|467588351|FG000|Overall Study|Ineligible|3|||
129898434|NCT03394027|467588352|FG001|Overall Study|Ineligible|1|||
129898435|NCT03394027|467588353|FG002|Overall Study|Ineligible|3|||
129898436|NCT03394027|467588351|FG000|Overall Study|Participant declined to participate before treatment started|0|||
129898437|NCT03394027|467588352|FG001|Overall Study|Participant declined to participate before treatment started|0|||
129898438|NCT03394027|467588353|FG002|Overall Study|Participant declined to participate before treatment started|1|||
129898439|NCT01018511|467588355|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
129898440|NCT01018511|467588356|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
129898441|NCT01018511|467588357|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
129898442|NCT01018511|467588358|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
129898443|NCT01018511|467588355|FG000|Overall Study|Adverse Event|5|||
129898444|NCT01018511|467588356|FG001|Overall Study|Adverse Event|9|||
129898445|NCT01018511|467588357|FG002|Overall Study|Adverse Event|13|||
129898446|NCT01018511|467588358|FG003|Overall Study|Adverse Event|10|||
129898447|NCT01018511|467588355|FG000|Overall Study|Lack of Efficacy|4|||
129898448|NCT01018511|467588356|FG001|Overall Study|Lack of Efficacy|1|||
129898449|NCT01018511|467588357|FG002|Overall Study|Lack of Efficacy|1|||
129898450|NCT01018511|467588358|FG003|Overall Study|Lack of Efficacy|2|||
129898451|NCT01018511|467588355|FG000|Overall Study|Withdrawal by Subject|6|||
129898452|NCT01018511|467588356|FG001|Overall Study|Withdrawal by Subject|5|||
129898453|NCT01018511|467588357|FG002|Overall Study|Withdrawal by Subject|11|||
129898454|NCT01018511|467588358|FG003|Overall Study|Withdrawal by Subject|9|||
129898455|NCT01018511|467588355|FG000|Overall Study|Lost to Follow-up|0|||
129898456|NCT01018511|467588356|FG001|Overall Study|Lost to Follow-up|0|||
129898457|NCT01018511|467588357|FG002|Overall Study|Lost to Follow-up|1|||
129898458|NCT01018511|467588358|FG003|Overall Study|Lost to Follow-up|0|||
129898459|NCT01018511|467588355|FG000|Overall Study|Protocol Violation|5|||
129898460|NCT01018511|467588356|FG001|Overall Study|Protocol Violation|8|||
129836533|NCT03131440|467368211|FG011|Overall Study|Lost to Follow-up|0|||
130113987|NCT00003102|468377459|FG001|Overall Study|Death|0|||
130113988|NCT00003102|468377460|FG002|Overall Study|Death|1|||
130113989|NCT00583596|468377461|FG000|Overall Study|Lost to Follow-up|110|||
130113990|NCT00583596|468377461|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
130113991|NCT00583596|468377461|FG000|Overall Study|Death|2|||
130113992|NCT00583596|468377461|FG000|Overall Study|Withdrawal by Subject|6|||
130113993|NCT00583596|468377461|FG000|Overall Study|Lost to Follow-up|94|||
130113994|NCT00583596|468377461|FG000|Overall Study|Data not complete|1|||
130113995|NCT00583596|468377461|FG000|Overall Study|Not consented|15|||
130113996|NCT00583596|468377461|FG000|Overall Study|Outside f-up window|26|||
130113997|NCT00656019|468377462|FG000|Overall Study|Not Eligible|10|||
130113998|NCT00656019|468377463|FG001|Overall Study|Not Eligible|0|||
129836534|NCT03131440|467368212|FG012|Overall Study|Lost to Follow-up|0|||
129836535|NCT03131440|467368213|FG013|Overall Study|Lost to Follow-up|0|||
129836536|NCT03131440|467368214|FG014|Overall Study|Lost to Follow-up|0|||
129836537|NCT03131440|467368215|FG015|Overall Study|Lost to Follow-up|0|||
129836538|NCT03131440|467368216|FG016|Overall Study|Lost to Follow-up|0|||
129836539|NCT03131440|467368217|FG017|Overall Study|Lost to Follow-up|0|||
129836540|NCT03131440|467368218|FG018|Overall Study|Lost to Follow-up|0|||
129836541|NCT03131440|467368219|FG019|Overall Study|Lost to Follow-up|2|||
129836542|NCT03131440|467368220|FG020|Overall Study|Lost to Follow-up|1|||
129836543|NCT03131440|467368221|FG021|Overall Study|Lost to Follow-up|0|||
129836544|NCT03131440|467368222|FG022|Overall Study|Lost to Follow-up|1|||
129836545|NCT03131440|467368223|FG023|Overall Study|Lost to Follow-up|0|||
129836546|NCT03131440|467368224|FG024|Overall Study|Lost to Follow-up|1|||
129836547|NCT03131440|467368225|FG025|Overall Study|Lost to Follow-up|0|||
129836548|NCT03131440|467368226|FG026|Overall Study|Lost to Follow-up|0|||
129836549|NCT03131440|467368227|FG027|Overall Study|Lost to Follow-up|2|||
129836550|NCT03131440|467368228|FG028|Overall Study|Lost to Follow-up|0|||
129836551|NCT03131440|467368229|FG029|Overall Study|Lost to Follow-up|2|||
129836552|NCT03131440|467368230|FG030|Overall Study|Lost to Follow-up|0|||
129836553|NCT03131440|467368231|FG031|Overall Study|Lost to Follow-up|0|||
129836554|NCT03131440|467368200|FG000|Overall Study|Death|0|||
129836555|NCT03131440|467368201|FG001|Overall Study|Death|0|||
129836556|NCT03131440|467368202|FG002|Overall Study|Death|0|||
129836557|NCT03131440|467368203|FG003|Overall Study|Death|0|||
129836558|NCT03131440|467368204|FG004|Overall Study|Death|0|||
129836559|NCT03131440|467368205|FG005|Overall Study|Death|0|||
129836560|NCT03131440|467368206|FG006|Overall Study|Death|0|||
129836561|NCT03131440|467368207|FG007|Overall Study|Death|0|||
129836562|NCT03131440|467368208|FG008|Overall Study|Death|0|||
129836563|NCT03131440|467368209|FG009|Overall Study|Death|0|||
129836564|NCT03131440|467368210|FG010|Overall Study|Death|0|||
129836565|NCT03131440|467368211|FG011|Overall Study|Death|0|||
129836566|NCT03131440|467368212|FG012|Overall Study|Death|0|||
129836567|NCT03131440|467368213|FG013|Overall Study|Death|0|||
129836568|NCT03131440|467368214|FG014|Overall Study|Death|0|||
129836569|NCT03131440|467368215|FG015|Overall Study|Death|0|||
129836570|NCT03131440|467368216|FG016|Overall Study|Death|0|||
129836571|NCT03131440|467368217|FG017|Overall Study|Death|0|||
129836572|NCT03131440|467368218|FG018|Overall Study|Death|0|||
129836573|NCT03131440|467368219|FG019|Overall Study|Death|0|||
129836574|NCT03131440|467368220|FG020|Overall Study|Death|0|||
129836575|NCT03131440|467368221|FG021|Overall Study|Death|0|||
129836576|NCT03131440|467368222|FG022|Overall Study|Death|0|||
130113999|NCT00656019|468377464|FG002|Overall Study|Not Eligible|0|||
130114000|NCT00656019|468377465|FG003|Overall Study|Not Eligible|0|||
129836577|NCT03131440|467368223|FG023|Overall Study|Death|0|||
129836578|NCT03131440|467368224|FG024|Overall Study|Death|0|||
129836579|NCT03131440|467368225|FG025|Overall Study|Death|1|||
129836580|NCT03131440|467368226|FG026|Overall Study|Death|0|||
129836581|NCT03131440|467368227|FG027|Overall Study|Death|0|||
129836582|NCT03131440|467368228|FG028|Overall Study|Death|0|||
129836583|NCT03131440|467368229|FG029|Overall Study|Death|0|||
129836584|NCT03131440|467368230|FG030|Overall Study|Death|0|||
129836585|NCT03131440|467368231|FG031|Overall Study|Death|0|||
129836586|NCT00746941|467368234|FG000|Overall Study|Death|2|||
130114001|NCT00656019|468377462|FG000|Overall Study|Withdrawal by Subject|2|||
129836587|NCT00746941|467368235|FG001|Overall Study|Death|0|||
129836588|NCT00746941|467368236|FG002|Overall Study|Death|0|||
129836589|NCT00746941|467368237|FG003|Overall Study|Death|6|||
129836590|NCT00746941|467368234|FG000|Overall Study|Physician Decision|0|||
130114002|NCT00656019|468377463|FG001|Overall Study|Withdrawal by Subject|0|||
130114003|NCT00656019|468377464|FG002|Overall Study|Withdrawal by Subject|0|||
130114004|NCT00656019|468377465|FG003|Overall Study|Withdrawal by Subject|0|||
129836591|NCT00746941|467368235|FG001|Overall Study|Physician Decision|0|||
129836592|NCT00746941|467368236|FG002|Overall Study|Physician Decision|2|||
129836593|NCT00746941|467368237|FG003|Overall Study|Physician Decision|0|||
129836594|NCT00746941|467368234|FG000|Overall Study|Withdrawal by Subject|3|||
129836595|NCT00746941|467368235|FG001|Overall Study|Withdrawal by Subject|0|||
129836596|NCT00746941|467368236|FG002|Overall Study|Withdrawal by Subject|0|||
129836597|NCT00746941|467368237|FG003|Overall Study|Withdrawal by Subject|2|||
129836598|NCT00746941|467368234|FG000|Overall Study|Other, reason not provided|2|||
129836599|NCT00746941|467368235|FG001|Overall Study|Other, reason not provided|4|||
129836600|NCT00746941|467368236|FG002|Overall Study|Other, reason not provided|0|||
129836601|NCT00746941|467368237|FG003|Overall Study|Other, reason not provided|4|||
129836602|NCT00746941|467368234|FG000|Overall Study|Adverse Event|0|||
129836603|NCT00746941|467368235|FG001|Overall Study|Adverse Event|0|||
129836604|NCT00746941|467368236|FG002|Overall Study|Adverse Event|0|||
129836605|NCT00746941|467368237|FG003|Overall Study|Adverse Event|1|||
129836606|NCT03316885|467368238|FG000|Overall Study|Adverse Event|1|||
129836607|NCT03316885|467368238|FG000|Overall Study|Death|10|||
129836608|NCT03316885|467368238|FG000|Overall Study|Lost to Follow-up|4|||
129836609|NCT03316885|467368238|FG000|Overall Study|Withdrawal by Subject|9|||
129836610|NCT03316885|467368238|FG000|Overall Study|COVID related|8|||
129836611|NCT04371380|467368239|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
129836612|NCT04371380|467368240|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
129836613|NCT04371380|467368241|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
129836614|NCT00680901|467368250|FG000|Overall Study|Ongoing: On Study Treatment|1|||
129836615|NCT00680901|467368251|FG001|Overall Study|Ongoing: On Study Treatment|0|||
129836616|NCT00680901|467368250|FG000|Overall Study|Ongoing: In Follow Up|1|||
129836617|NCT00680901|467368251|FG001|Overall Study|Ongoing: In Follow Up|0|||
129836618|NCT00680901|467368250|FG000|Overall Study|Adverse Event|1|||
129836619|NCT00680901|467368251|FG001|Overall Study|Adverse Event|1|||
129836620|NCT00680901|467368250|FG000|Overall Study|Lost to Follow-up|3|||
129836621|NCT00680901|467368251|FG001|Overall Study|Lost to Follow-up|5|||
129836622|NCT00680901|467368250|FG000|Overall Study|Subject decided to withdraw from the study|4|||
129836623|NCT00680901|467368251|FG001|Overall Study|Subject decided to withdraw from the study|15|||
129836624|NCT00680901|467368250|FG000|Overall Study|Sponsor decision|1|||
129836625|NCT00680901|467368251|FG001|Overall Study|Sponsor decision|0|||
129836626|NCT00680901|467368250|FG000|Overall Study|Physician Decision|0|||
129836627|NCT00680901|467368251|FG001|Overall Study|Physician Decision|2|||
129836628|NCT00680901|467368250|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
129836629|NCT00680901|467368251|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
129836630|NCT00680901|467368250|FG000|Overall Study|Other protocol defined stopping criteria|17|||
129836631|NCT00680901|467368251|FG001|Overall Study|Other protocol defined stopping criteria|17|||
129836632|NCT04809220|467368254|FG000|Overall Study|Adverse Event|4|||
129836633|NCT04809220|467368255|FG001|Overall Study|Adverse Event|0|||
129836634|NCT04809220|467368254|FG000|Overall Study|Death|1|||
129836635|NCT04809220|467368255|FG001|Overall Study|Death|0|||
129836636|NCT04809220|467368254|FG000|Overall Study|Lost to Follow-up|3|||
129836637|NCT04809220|467368255|FG001|Overall Study|Lost to Follow-up|0|||
129836638|NCT04809220|467368254|FG000|Overall Study|Physician Decision|0|||
129836639|NCT04809220|467368255|FG001|Overall Study|Physician Decision|1|||
129836640|NCT04809220|467368254|FG000|Overall Study|Withdrawal by Subject|9|||
129836641|NCT04809220|467368255|FG001|Overall Study|Withdrawal by Subject|5|||
129836642|NCT04809220|467368254|FG000|Overall Study|Due to long-term overseas business trips|1|||
129836643|NCT04809220|467368255|FG001|Overall Study|Due to long-term overseas business trips|0|||
129836644|NCT01062555|467368256|FG000|Phase 1|Death|10|||
129836645|NCT01062555|467368257|FG001|Phase 1|Death|17|||
129836646|NCT01062555|467368258|FG002|Phase 1|Death|0|||
129836647|NCT01062555|467368259|FG003|Phase 1|Death|0|||
129836648|NCT01062555|467368256|FG000|Phase 1|Graft Failure|12|||
129836649|NCT01062555|467368257|FG001|Phase 1|Graft Failure|8|||
129836650|NCT01062555|467368258|FG002|Phase 1|Graft Failure|0|||
129836651|NCT01062555|467368259|FG003|Phase 1|Graft Failure|0|||
129836652|NCT01062555|467368256|FG000|Phase 1|Withdrawal by Subject|1|||
129836653|NCT01062555|467368257|FG001|Phase 1|Withdrawal by Subject|1|||
129836654|NCT01062555|467368258|FG002|Phase 1|Withdrawal by Subject|0|||
129836655|NCT01062555|467368259|FG003|Phase 1|Withdrawal by Subject|0|||
129836656|NCT01062555|467368256|FG000|Phase 2|Death|0|||
129836657|NCT01062555|467368257|FG001|Phase 2|Death|0|||
129836658|NCT01062555|467368258|FG002|Phase 2|Death|8|||
129836659|NCT01062555|467368259|FG003|Phase 2|Death|3|||
129836660|NCT01062555|467368256|FG000|Phase 2|Graft failure|0|||
129836661|NCT01062555|467368257|FG001|Phase 2|Graft failure|0|||
129836662|NCT01062555|467368258|FG002|Phase 2|Graft failure|7|||
129836663|NCT01062555|467368259|FG003|Phase 2|Graft failure|4|||
129836664|NCT01062555|467368256|FG000|Phase 2|Withdrawal by Subject|0|||
129836665|NCT01062555|467368257|FG001|Phase 2|Withdrawal by Subject|0|||
129836666|NCT01062555|467368258|FG002|Phase 2|Withdrawal by Subject|0|||
129836667|NCT01062555|467368259|FG003|Phase 2|Withdrawal by Subject|7|||
129836668|NCT01062555|467368256|FG000|Phase 2|Protocol Violation|0|||
129836669|NCT01062555|467368257|FG001|Phase 2|Protocol Violation|0|||
129836670|NCT01062555|467368258|FG002|Phase 2|Protocol Violation|0|||
129836671|NCT01062555|467368259|FG003|Phase 2|Protocol Violation|3|||
129836672|NCT01062555|467368256|FG000|Phase 2|Physician Decision|0|||
129836673|NCT01062555|467368257|FG001|Phase 2|Physician Decision|0|||
129836674|NCT01062555|467368258|FG002|Phase 2|Physician Decision|0|||
129836675|NCT01062555|467368259|FG003|Phase 2|Physician Decision|17|||
129836676|NCT02641379|467368262|FG000|Overall Study|Exclusion criterion during screening|1|||
129898461|NCT01018511|467588357|FG002|Overall Study|Protocol Violation|7|||
129836677|NCT02641379|467368263|FG001|Overall Study|Exclusion criterion during screening|0|||
129836678|NCT02641379|467368264|FG002|Overall Study|Exclusion criterion during screening|0|||
129836679|NCT02641379|467368265|FG003|Overall Study|Exclusion criterion during screening|1|||
129836680|NCT02641379|467368266|FG004|Overall Study|Exclusion criterion during screening|2|||
129836681|NCT02641379|467368267|FG005|Overall Study|Exclusion criterion during screening|0|||
129836682|NCT02641379|467368268|FG006|Overall Study|Exclusion criterion during screening|0|||
129836683|NCT02641379|467368269|FG007|Overall Study|Exclusion criterion during screening|0|||
129836684|NCT02641379|467368270|FG008|Overall Study|Exclusion criterion during screening|0|||
129836685|NCT02641379|467368271|FG009|Overall Study|Exclusion criterion during screening|0|||
129836686|NCT02641379|467368272|FG010|Overall Study|Exclusion criterion during screening|0|||
129836687|NCT02641379|467368262|FG000|Overall Study|Withdrawal of informed consent|0|||
129836688|NCT02641379|467368263|FG001|Overall Study|Withdrawal of informed consent|1|||
129836689|NCT02641379|467368264|FG002|Overall Study|Withdrawal of informed consent|0|||
129836690|NCT02641379|467368265|FG003|Overall Study|Withdrawal of informed consent|0|||
129836691|NCT02641379|467368266|FG004|Overall Study|Withdrawal of informed consent|0|||
129836692|NCT02641379|467368267|FG005|Overall Study|Withdrawal of informed consent|0|||
129836693|NCT02641379|467368268|FG006|Overall Study|Withdrawal of informed consent|0|||
129836694|NCT02641379|467368269|FG007|Overall Study|Withdrawal of informed consent|1|||
129836695|NCT02641379|467368270|FG008|Overall Study|Withdrawal of informed consent|0|||
129836696|NCT02641379|467368271|FG009|Overall Study|Withdrawal of informed consent|0|||
129836697|NCT02641379|467368272|FG010|Overall Study|Withdrawal of informed consent|0|||
129836698|NCT02641379|467368262|FG000|Overall Study|Adverse Event|7|||
129836699|NCT02641379|467368263|FG001|Overall Study|Adverse Event|8|||
129836700|NCT02641379|467368264|FG002|Overall Study|Adverse Event|2|||
129836701|NCT02641379|467368265|FG003|Overall Study|Adverse Event|2|||
129836702|NCT02641379|467368266|FG004|Overall Study|Adverse Event|5|||
129836703|NCT02641379|467368267|FG005|Overall Study|Adverse Event|1|||
129836704|NCT02641379|467368268|FG006|Overall Study|Adverse Event|5|||
129836705|NCT02641379|467368269|FG007|Overall Study|Adverse Event|0|||
129836706|NCT02641379|467368270|FG008|Overall Study|Adverse Event|1|||
129836707|NCT02641379|467368271|FG009|Overall Study|Adverse Event|1|||
129836708|NCT02641379|467368272|FG010|Overall Study|Adverse Event|5|||
129836709|NCT02641379|467368262|FG000|Overall Study|Lack of Efficacy|0|||
129836710|NCT02641379|467368263|FG001|Overall Study|Lack of Efficacy|0|||
129836711|NCT02641379|467368264|FG002|Overall Study|Lack of Efficacy|2|||
129836712|NCT02641379|467368265|FG003|Overall Study|Lack of Efficacy|0|||
129836713|NCT02641379|467368266|FG004|Overall Study|Lack of Efficacy|0|||
129836714|NCT02641379|467368267|FG005|Overall Study|Lack of Efficacy|2|||
129836715|NCT02641379|467368268|FG006|Overall Study|Lack of Efficacy|0|||
129836716|NCT02641379|467368269|FG007|Overall Study|Lack of Efficacy|5|||
129836717|NCT02641379|467368270|FG008|Overall Study|Lack of Efficacy|0|||
129836718|NCT02641379|467368271|FG009|Overall Study|Lack of Efficacy|0|||
129836719|NCT02641379|467368272|FG010|Overall Study|Lack of Efficacy|0|||
129836720|NCT02641379|467368262|FG000|Overall Study|Participant unable to attend study visit|4|||
129836721|NCT02641379|467368263|FG001|Overall Study|Participant unable to attend study visit|10|||
129836722|NCT02641379|467368264|FG002|Overall Study|Participant unable to attend study visit|1|||
129836723|NCT02641379|467368265|FG003|Overall Study|Participant unable to attend study visit|2|||
129836724|NCT02641379|467368266|FG004|Overall Study|Participant unable to attend study visit|5|||
129836725|NCT02641379|467368267|FG005|Overall Study|Participant unable to attend study visit|1|||
129836726|NCT02641379|467368268|FG006|Overall Study|Participant unable to attend study visit|1|||
130062361|NCT01025817|468182152|FG000|Completed Study Medication|Abnormal test procedure|4|||
130062362|NCT01025817|468182153|FG001|Completed Study Medication|Abnormal test procedure|0|||
130062363|NCT01025817|468182152|FG000|Completed Study Medication|Graft loss|2|||
130062364|NCT01025817|468182153|FG001|Completed Study Medication|Graft loss|5|||
130062365|NCT01025817|468182152|FG000|Completed Study Medication|Death|2|||
130062366|NCT01025817|468182153|FG001|Completed Study Medication|Death|2|||
130062367|NCT01025817|468182152|FG000|Completed Study Medication|Abnormal lab values|0|||
130062368|NCT01025817|468182153|FG001|Completed Study Medication|Abnormal lab values|2|||
130062369|NCT01025817|468182152|FG000|Completed Study Medication|Subject no longer required study drug|0|||
130062370|NCT01025817|468182153|FG001|Completed Study Medication|Subject no longer required study drug|1|||
130062371|NCT01025817|468182152|FG000|Completed Study Medication|Lost to Follow-up|0|||
130114005|NCT00656019|468377462|FG000|Overall Study|Lost to Follow-up|2|||
129836727|NCT02641379|467368269|FG007|Overall Study|Participant unable to attend study visit|1|||
129836728|NCT02641379|467368270|FG008|Overall Study|Participant unable to attend study visit|0|||
129836729|NCT02641379|467368271|FG009|Overall Study|Participant unable to attend study visit|2|||
129836730|NCT02641379|467368272|FG010|Overall Study|Participant unable to attend study visit|0|||
129836731|NCT02641379|467368262|FG000|Overall Study|Participant's compliance|0|||
129836732|NCT02641379|467368263|FG001|Overall Study|Participant's compliance|1|||
129836733|NCT02641379|467368264|FG002|Overall Study|Participant's compliance|0|||
129836734|NCT02641379|467368265|FG003|Overall Study|Participant's compliance|1|||
129836735|NCT02641379|467368266|FG004|Overall Study|Participant's compliance|0|||
130062372|NCT01025817|468182153|FG001|Completed Study Medication|Lost to Follow-up|1|||
129836736|NCT02641379|467368267|FG005|Overall Study|Participant's compliance|2|||
129836737|NCT02641379|467368268|FG006|Overall Study|Participant's compliance|0|||
129836738|NCT02641379|467368269|FG007|Overall Study|Participant's compliance|0|||
129836739|NCT02641379|467368270|FG008|Overall Study|Participant's compliance|1|||
129836740|NCT02641379|467368271|FG009|Overall Study|Participant's compliance|1|||
129836741|NCT02641379|467368272|FG010|Overall Study|Participant's compliance|1|||
129836742|NCT02641379|467368262|FG000|Overall Study|Participant cannot be reached|4|||
129836743|NCT02641379|467368263|FG001|Overall Study|Participant cannot be reached|4|||
129836744|NCT02641379|467368264|FG002|Overall Study|Participant cannot be reached|0|||
129836745|NCT02641379|467368265|FG003|Overall Study|Participant cannot be reached|8|||
129898462|NCT01018511|467588358|FG003|Overall Study|Protocol Violation|9|||
129836746|NCT02641379|467368266|FG004|Overall Study|Participant cannot be reached|2|||
129836747|NCT02641379|467368267|FG005|Overall Study|Participant cannot be reached|1|||
129836748|NCT02641379|467368268|FG006|Overall Study|Participant cannot be reached|0|||
129898463|NCT01018511|467588355|FG000|Overall Study|Miscellaneous|0|||
129898464|NCT01018511|467588356|FG001|Overall Study|Miscellaneous|2|||
129898465|NCT01018511|467588357|FG002|Overall Study|Miscellaneous|0|||
129898466|NCT01018511|467588358|FG003|Overall Study|Miscellaneous|0|||
129898467|NCT04523181|467588359|FG000|Overall Study|Withdrawal by Subject|4|||
129898468|NCT04523181|467588360|FG001|Overall Study|Withdrawal by Subject|5|||
129898469|NCT04523181|467588359|FG000|Overall Study|Lost to Follow-up|2|||
129898470|NCT04523181|467588360|FG001|Overall Study|Lost to Follow-up|3|||
129898471|NCT04523181|467588359|FG000|Overall Study|Physician Decision|1|||
129898472|NCT04523181|467588360|FG001|Overall Study|Physician Decision|0|||
129898473|NCT04523181|467588359|FG000|Overall Study|Transferred to external facility.|1|||
129898474|NCT04523181|467588360|FG001|Overall Study|Transferred to external facility.|1|||
129898475|NCT04550039|467588361|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
129898476|NCT04550039|467588362|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
129898477|NCT04550039|467588361|FG000|Overall Study|patient self-withdrew from study|0|||
129898478|NCT04550039|467588362|FG001|Overall Study|patient self-withdrew from study|1|||
129898479|NCT04391309|467588363|FG000|Overall Study|Death|1|||
129898480|NCT04391309|467588364|FG001|Overall Study|Death|1|||
129898481|NCT04391309|467588363|FG000|Overall Study|Lost to Follow-up|3|||
129898482|NCT04391309|467588364|FG001|Overall Study|Lost to Follow-up|2|||
129898483|NCT04391309|467588363|FG000|Overall Study|Withdrawal by Subject|2|||
129898484|NCT04391309|467588364|FG001|Overall Study|Withdrawal by Subject|2|||
129898485|NCT00881335|467588371|FG000|Overall Study|Lost to Follow-up|3|||
129898486|NCT00881335|467588372|FG001|Overall Study|Lost to Follow-up|2|||
129898487|NCT05824351|467588375|FG000|Overall Study|Adverse Event|6|||
129898488|NCT00828945|467588376|FG000|Overall Study|Death|4|||
129898489|NCT00828945|467588376|FG000|Overall Study|Participant was missing|1|||
129898490|NCT00828945|467588376|FG000|Overall Study|Other|36|||
129898491|NCT02482233|467588381|FG000|Overall Study|Lost to Follow-up|1|||
129898492|NCT02482233|467588382|FG001|Overall Study|Lost to Follow-up|1|||
129898493|NCT03822351|467588383|FG000|Overall Study|Death|27|||
129898494|NCT03822351|467588384|FG001|Overall Study|Death|23|||
129898495|NCT03822351|467588385|FG002|Overall Study|Death|24|||
129898496|NCT03822351|467588383|FG000|Overall Study|Lost to Follow-up|6|||
129898497|NCT03822351|467588384|FG001|Overall Study|Lost to Follow-up|2|||
129898498|NCT03822351|467588385|FG002|Overall Study|Lost to Follow-up|1|||
129898499|NCT03822351|467588383|FG000|Overall Study|Withdrawal by Subject|10|||
129898500|NCT03822351|467588384|FG001|Overall Study|Withdrawal by Subject|4|||
129898501|NCT03822351|467588385|FG002|Overall Study|Withdrawal by Subject|6|||
129898502|NCT03822351|467588383|FG000|Overall Study|Progressive Disease|2|||
129898503|NCT03822351|467588384|FG001|Overall Study|Progressive Disease|1|||
129898504|NCT03822351|467588385|FG002|Overall Study|Progressive Disease|0|||
129898505|NCT03822351|467588383|FG000|Overall Study|Not Treated|1|||
129898506|NCT03822351|467588384|FG001|Overall Study|Not Treated|1|||
129898507|NCT03822351|467588385|FG002|Overall Study|Not Treated|1|||
129898508|NCT00462943|467588386|FG000|Overall Study|Failure to achieve a response|5|||
129898509|NCT00462943|467588387|FG001|Overall Study|Failure to achieve a response|5|||
129898510|NCT00462943|467588388|FG002|Overall Study|Failure to achieve a response|1|||
129898511|NCT00462943|467588386|FG000|Overall Study|Adverse Event|6|||
129898512|NCT00462943|467588387|FG001|Overall Study|Adverse Event|4|||
129898513|NCT00462943|467588388|FG002|Overall Study|Adverse Event|1|||
129898514|NCT00462943|467588386|FG000|Overall Study|Protocol Violation|1|||
129898515|NCT00462943|467588387|FG001|Overall Study|Protocol Violation|0|||
129898516|NCT00462943|467588388|FG002|Overall Study|Protocol Violation|0|||
129898517|NCT00462943|467588386|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
129898518|NCT00462943|467588387|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
129898519|NCT00462943|467588388|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
129898520|NCT00462943|467588386|FG000|Overall Study|Disease Progression|15|||
129898521|NCT00462943|467588387|FG001|Overall Study|Disease Progression|15|||
129898522|NCT00462943|467588388|FG002|Overall Study|Disease Progression|9|||
129898523|NCT00462943|467588386|FG000|Overall Study|Death|5|||
129898524|NCT00462943|467588387|FG001|Overall Study|Death|2|||
129898525|NCT00462943|467588388|FG002|Overall Study|Death|7|||
129836749|NCT02641379|467368269|FG007|Overall Study|Participant cannot be reached|1|||
129836750|NCT02641379|467368270|FG008|Overall Study|Participant cannot be reached|0|||
129836751|NCT02641379|467368271|FG009|Overall Study|Participant cannot be reached|2|||
129836752|NCT02641379|467368272|FG010|Overall Study|Participant cannot be reached|1|||
129836753|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 24|15|||
129836754|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 24|21|||
129836755|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 24|62|||
129836756|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 24|0|||
129836757|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 24|0|||
129836758|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 24|6|||
129836759|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 24|3|||
129836760|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 24|8|||
129836761|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 24|0|||
129836762|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 24|1|||
129836763|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 24|0|||
129836764|NCT02641379|467368262|FG000|Overall Study|PCR positive at follow up 2|1|||
129836765|NCT02641379|467368263|FG001|Overall Study|PCR positive at follow up 2|0|||
129836766|NCT02641379|467368264|FG002|Overall Study|PCR positive at follow up 2|0|||
129836767|NCT02641379|467368265|FG003|Overall Study|PCR positive at follow up 2|0|||
129836768|NCT02641379|467368266|FG004|Overall Study|PCR positive at follow up 2|0|||
129836769|NCT02641379|467368267|FG005|Overall Study|PCR positive at follow up 2|0|||
129836770|NCT02641379|467368268|FG006|Overall Study|PCR positive at follow up 2|0|||
129836771|NCT02641379|467368269|FG007|Overall Study|PCR positive at follow up 2|0|||
129836772|NCT02641379|467368270|FG008|Overall Study|PCR positive at follow up 2|0|||
129836773|NCT02641379|467368271|FG009|Overall Study|PCR positive at follow up 2|0|||
129836774|NCT02641379|467368272|FG010|Overall Study|PCR positive at follow up 2|0|||
129836775|NCT02641379|467368262|FG000|Overall Study|Participant showed relapse|1|||
129836776|NCT02641379|467368263|FG001|Overall Study|Participant showed relapse|0|||
129836777|NCT02641379|467368264|FG002|Overall Study|Participant showed relapse|0|||
129836778|NCT02641379|467368265|FG003|Overall Study|Participant showed relapse|0|||
129836779|NCT02641379|467368266|FG004|Overall Study|Participant showed relapse|0|||
129836780|NCT02641379|467368267|FG005|Overall Study|Participant showed relapse|0|||
129836781|NCT02641379|467368268|FG006|Overall Study|Participant showed relapse|1|||
129836782|NCT02641379|467368269|FG007|Overall Study|Participant showed relapse|0|||
129836783|NCT02641379|467368270|FG008|Overall Study|Participant showed relapse|0|||
129836784|NCT02641379|467368271|FG009|Overall Study|Participant showed relapse|0|||
129836785|NCT02641379|467368272|FG010|Overall Study|Participant showed relapse|0|||
129836786|NCT02641379|467368262|FG000|Overall Study|Participant stopped study/treatment|1|||
129836787|NCT02641379|467368263|FG001|Overall Study|Participant stopped study/treatment|3|||
129836788|NCT02641379|467368264|FG002|Overall Study|Participant stopped study/treatment|1|||
129836789|NCT02641379|467368265|FG003|Overall Study|Participant stopped study/treatment|0|||
129836790|NCT02641379|467368266|FG004|Overall Study|Participant stopped study/treatment|0|||
129836791|NCT02641379|467368267|FG005|Overall Study|Participant stopped study/treatment|1|||
129836792|NCT02641379|467368268|FG006|Overall Study|Participant stopped study/treatment|2|||
130062373|NCT01025817|468182152|FG000|Completed Study|Withdrawal by Subject|8|||
130062374|NCT01025817|468182153|FG001|Completed Study|Withdrawal by Subject|16|||
130062375|NCT01025817|468182152|FG000|Completed Study|Death|6|||
130062376|NCT01025817|468182153|FG001|Completed Study|Death|5|||
130062377|NCT01025817|468182152|FG000|Completed Study|Missing|2|||
130062378|NCT01025817|468182153|FG001|Completed Study|Missing|0|||
130062379|NCT01025817|468182152|FG000|Completed Study|Lost to Follow-up|0|||
130062380|NCT01025817|468182153|FG001|Completed Study|Lost to Follow-up|1|||
130062381|NCT01354431|468182156|FG000|Pre-Treatment Period|Not reported|1|||
130062382|NCT01354431|468182157|FG001|Pre-Treatment Period|Not reported|0|||
130062383|NCT01354431|468182158|FG002|Pre-Treatment Period|Not reported|0|||
130062384|NCT01354431|468182156|FG000|Treatment Period|Disease Progression|50|||
130062385|NCT01354431|468182157|FG001|Treatment Period|Disease Progression|40|||
130062386|NCT01354431|468182158|FG002|Treatment Period|Disease Progression|44|||
130062387|NCT01354431|468182156|FG000|Treatment Period|Study Drug Toxicity|5|||
130062388|NCT01354431|468182157|FG001|Treatment Period|Study Drug Toxicity|8|||
130062389|NCT01354431|468182158|FG002|Treatment Period|Study Drug Toxicity|4|||
130062390|NCT01354431|468182156|FG000|Treatment Period|Death|0|||
130062391|NCT01354431|468182157|FG001|Treatment Period|Death|1|||
130062392|NCT01354431|468182158|FG002|Treatment Period|Death|0|||
129836793|NCT02641379|467368269|FG007|Overall Study|Participant stopped study/treatment|0|||
129836794|NCT02641379|467368270|FG008|Overall Study|Participant stopped study/treatment|1|||
129836795|NCT02641379|467368271|FG009|Overall Study|Participant stopped study/treatment|0|||
129836796|NCT02641379|467368272|FG010|Overall Study|Participant stopped study/treatment|0|||
129836797|NCT02641379|467368262|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
129836798|NCT02641379|467368263|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
129836799|NCT02641379|467368264|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
129836800|NCT02641379|467368265|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
130062393|NCT01354431|468182156|FG000|Treatment Period|AE unrelated to study drug|1|||
130062394|NCT01354431|468182157|FG001|Treatment Period|AE unrelated to study drug|2|||
130062395|NCT01354431|468182158|FG002|Treatment Period|AE unrelated to study drug|5|||
129836801|NCT02641379|467368266|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
129836802|NCT02641379|467368267|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
129836803|NCT02641379|467368268|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
129836804|NCT02641379|467368269|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
129836805|NCT02641379|467368270|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
129836806|NCT02641379|467368271|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
129836807|NCT02641379|467368272|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
129836808|NCT02641379|467368262|FG000|Overall Study|Financial problems|0|||
129836809|NCT02641379|467368263|FG001|Overall Study|Financial problems|1|||
129836810|NCT02641379|467368264|FG002|Overall Study|Financial problems|0|||
129836811|NCT02641379|467368265|FG003|Overall Study|Financial problems|0|||
129836812|NCT02641379|467368266|FG004|Overall Study|Financial problems|0|||
129836813|NCT02641379|467368267|FG005|Overall Study|Financial problems|0|||
129836814|NCT02641379|467368268|FG006|Overall Study|Financial problems|0|||
129836815|NCT02641379|467368269|FG007|Overall Study|Financial problems|0|||
129836816|NCT02641379|467368270|FG008|Overall Study|Financial problems|0|||
129836817|NCT02641379|467368271|FG009|Overall Study|Financial problems|0|||
129836818|NCT02641379|467368272|FG010|Overall Study|Financial problems|0|||
129836819|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 68|0|||
129836820|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 68|1|||
129836821|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 68|0|||
129836822|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 68|0|||
129836823|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 68|0|||
129836824|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 68|0|||
129836825|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 68|0|||
129836826|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 68|0|||
129836827|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 68|0|||
129836828|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 68|0|||
129836829|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 68|0|||
129836830|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 48|0|||
129836831|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 48|1|||
129836832|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 48|0|||
129836833|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 48|0|||
129836834|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 48|0|||
129836835|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 48|0|||
129836836|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 48|0|||
129836837|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 48|0|||
129836838|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 48|0|||
129836839|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 48|0|||
129836840|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 48|0|||
129836841|NCT02641379|467368262|FG000|Overall Study|PCR not performed at Week 12|0|||
129836842|NCT02641379|467368263|FG001|Overall Study|PCR not performed at Week 12|0|||
129836843|NCT02641379|467368264|FG002|Overall Study|PCR not performed at Week 12|1|||
129836844|NCT02641379|467368265|FG003|Overall Study|PCR not performed at Week 12|0|||
129836845|NCT02641379|467368266|FG004|Overall Study|PCR not performed at Week 12|0|||
129836846|NCT02641379|467368267|FG005|Overall Study|PCR not performed at Week 12|0|||
129836847|NCT02641379|467368268|FG006|Overall Study|PCR not performed at Week 12|0|||
129836848|NCT02641379|467368269|FG007|Overall Study|PCR not performed at Week 12|0|||
129836849|NCT02641379|467368270|FG008|Overall Study|PCR not performed at Week 12|0|||
129836850|NCT02641379|467368271|FG009|Overall Study|PCR not performed at Week 12|0|||
129836851|NCT02641379|467368272|FG010|Overall Study|PCR not performed at Week 12|0|||
129836852|NCT02641379|467368262|FG000|Overall Study|No PCR at baseline|0|||
129836853|NCT02641379|467368263|FG001|Overall Study|No PCR at baseline|0|||
129836854|NCT02641379|467368264|FG002|Overall Study|No PCR at baseline|1|||
129836855|NCT02641379|467368265|FG003|Overall Study|No PCR at baseline|0|||
129836856|NCT02641379|467368266|FG004|Overall Study|No PCR at baseline|0|||
129836857|NCT02641379|467368267|FG005|Overall Study|No PCR at baseline|0|||
129836858|NCT02641379|467368268|FG006|Overall Study|No PCR at baseline|0|||
129836859|NCT02641379|467368269|FG007|Overall Study|No PCR at baseline|0|||
129836860|NCT02641379|467368270|FG008|Overall Study|No PCR at baseline|0|||
129836861|NCT02641379|467368271|FG009|Overall Study|No PCR at baseline|0|||
129836862|NCT02641379|467368272|FG010|Overall Study|No PCR at baseline|0|||
129836863|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 28|0|||
129836864|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 28|0|||
129836865|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 28|1|||
129836866|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 28|0|||
129836867|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 28|0|||
129836868|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 28|0|||
129836869|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 28|0|||
129836870|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 28|0|||
129836871|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 28|0|||
129836872|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 28|0|||
129836873|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 28|0|||
129836874|NCT02641379|467368262|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
129836875|NCT02641379|467368263|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
129836876|NCT02641379|467368264|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
129836877|NCT02641379|467368265|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
129836878|NCT02641379|467368266|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
129836879|NCT02641379|467368267|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
129836880|NCT02641379|467368268|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
129836881|NCT02641379|467368269|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
129836882|NCT02641379|467368270|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
129836883|NCT02641379|467368271|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
129836884|NCT02641379|467368272|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
129836885|NCT02641379|467368262|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
129836886|NCT02641379|467368263|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
129836887|NCT02641379|467368264|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
129836888|NCT02641379|467368265|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
129836889|NCT02641379|467368266|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
129836890|NCT02641379|467368267|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
129836891|NCT02641379|467368268|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
129836892|NCT02641379|467368269|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
129836893|NCT02641379|467368270|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
129836894|NCT02641379|467368271|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
129836895|NCT02641379|467368272|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
129836896|NCT02641379|467368262|FG000|Overall Study|Baseline viral load unavailable|0|||
129836897|NCT02641379|467368263|FG001|Overall Study|Baseline viral load unavailable|0|||
129836898|NCT02641379|467368264|FG002|Overall Study|Baseline viral load unavailable|0|||
129836899|NCT02641379|467368265|FG003|Overall Study|Baseline viral load unavailable|1|||
129836900|NCT02641379|467368266|FG004|Overall Study|Baseline viral load unavailable|0|||
129836901|NCT02641379|467368267|FG005|Overall Study|Baseline viral load unavailable|0|||
129836902|NCT02641379|467368268|FG006|Overall Study|Baseline viral load unavailable|0|||
129836903|NCT02641379|467368269|FG007|Overall Study|Baseline viral load unavailable|0|||
129836904|NCT02641379|467368270|FG008|Overall Study|Baseline viral load unavailable|0|||
129836905|NCT02641379|467368271|FG009|Overall Study|Baseline viral load unavailable|0|||
129836906|NCT02641379|467368272|FG010|Overall Study|Baseline viral load unavailable|0|||
129836907|NCT02641379|467368262|FG000|Overall Study|Blood could not be drawn|0|||
129836908|NCT02641379|467368263|FG001|Overall Study|Blood could not be drawn|0|||
129836909|NCT02641379|467368264|FG002|Overall Study|Blood could not be drawn|0|||
129836910|NCT02641379|467368265|FG003|Overall Study|Blood could not be drawn|0|||
129836911|NCT02641379|467368266|FG004|Overall Study|Blood could not be drawn|1|||
129836912|NCT02641379|467368267|FG005|Overall Study|Blood could not be drawn|0|||
129836913|NCT02641379|467368268|FG006|Overall Study|Blood could not be drawn|0|||
129836914|NCT02641379|467368269|FG007|Overall Study|Blood could not be drawn|0|||
129836915|NCT02641379|467368270|FG008|Overall Study|Blood could not be drawn|0|||
129836916|NCT02641379|467368271|FG009|Overall Study|Blood could not be drawn|0|||
129836917|NCT02641379|467368272|FG010|Overall Study|Blood could not be drawn|0|||
129836918|NCT02641379|467368262|FG000|Overall Study|Protocol Violation|0|||
129836919|NCT02641379|467368263|FG001|Overall Study|Protocol Violation|0|||
129836920|NCT02641379|467368264|FG002|Overall Study|Protocol Violation|0|||
129836921|NCT02641379|467368265|FG003|Overall Study|Protocol Violation|0|||
129836922|NCT02641379|467368266|FG004|Overall Study|Protocol Violation|2|||
129836923|NCT02641379|467368267|FG005|Overall Study|Protocol Violation|0|||
129836924|NCT02641379|467368268|FG006|Overall Study|Protocol Violation|0|||
129836925|NCT02641379|467368269|FG007|Overall Study|Protocol Violation|0|||
129836926|NCT02641379|467368270|FG008|Overall Study|Protocol Violation|1|||
129836927|NCT02641379|467368271|FG009|Overall Study|Protocol Violation|0|||
129836928|NCT02641379|467368272|FG010|Overall Study|Protocol Violation|0|||
129836929|NCT02641379|467368262|FG000|Overall Study|Participation in sili rescue study|0|||
129836930|NCT02641379|467368263|FG001|Overall Study|Participation in sili rescue study|0|||
129836931|NCT02641379|467368264|FG002|Overall Study|Participation in sili rescue study|0|||
129836932|NCT02641379|467368265|FG003|Overall Study|Participation in sili rescue study|0|||
129836933|NCT02641379|467368266|FG004|Overall Study|Participation in sili rescue study|0|||
129898526|NCT00462943|467588386|FG000|Overall Study|Stem Cell Transplant|1|||
129898527|NCT00462943|467588387|FG001|Overall Study|Stem Cell Transplant|1|||
130062396|NCT01354431|468182156|FG000|Treatment Period|Participant request to discontinue|2|||
130062397|NCT01354431|468182157|FG001|Treatment Period|Participant request to discontinue|2|||
130062398|NCT01354431|468182158|FG002|Treatment Period|Participant request to discontinue|1|||
130062399|NCT01354431|468182156|FG000|Treatment Period|Participant withdrew consent|0|||
130062400|NCT01354431|468182157|FG001|Treatment Period|Participant withdrew consent|1|||
130062401|NCT01354431|468182158|FG002|Treatment Period|Participant withdrew consent|0|||
130062402|NCT01354431|468182156|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
130062403|NCT01354431|468182157|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
130062404|NCT01354431|468182158|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
130062405|NCT02802878|468182159|FG000|Overall Study|Withdrawal by Subject|3|||
130062406|NCT02802878|468182160|FG001|Overall Study|Withdrawal by Subject|3|||
130062407|NCT02802878|468182159|FG000|Overall Study|Protocol Violation|1|||
129898528|NCT00462943|467588388|FG002|Overall Study|Stem Cell Transplant|0|||
129898529|NCT00462943|467588386|FG000|Overall Study|Bone Marrow Transplant|1|||
129898530|NCT00462943|467588387|FG001|Overall Study|Bone Marrow Transplant|0|||
129898531|NCT00462943|467588388|FG002|Overall Study|Bone Marrow Transplant|0|||
129898532|NCT00462943|467588386|FG000|Overall Study|Required Lymphocyte Infusion|1|||
129898533|NCT00462943|467588387|FG001|Overall Study|Required Lymphocyte Infusion|0|||
129898534|NCT00462943|467588388|FG002|Overall Study|Required Lymphocyte Infusion|0|||
129898535|NCT00462943|467588386|FG000|Overall Study|Transplant - not specified|1|||
129898536|NCT00462943|467588387|FG001|Overall Study|Transplant - not specified|0|||
129898537|NCT00462943|467588388|FG002|Overall Study|Transplant - not specified|1|||
129898538|NCT00462943|467588386|FG000|Overall Study|Physician Decision|1|||
129898539|NCT00462943|467588387|FG001|Overall Study|Physician Decision|0|||
129898540|NCT00462943|467588388|FG002|Overall Study|Physician Decision|0|||
129898541|NCT00462943|467588386|FG000|Overall Study|Withdrawal by Subject|0|||
129898542|NCT00462943|467588387|FG001|Overall Study|Withdrawal by Subject|1|||
129898543|NCT00462943|467588388|FG002|Overall Study|Withdrawal by Subject|0|||
129898544|NCT00708097|467588394|FG000|Period 1|Protocol Violation|0|||
129898545|NCT00708097|467588395|FG001|Period 1|Protocol Violation|1|||
129898546|NCT00708097|467588396|FG002|Period 1|Protocol Violation|0|||
129898547|NCT00708097|467588397|FG003|Period 1|Protocol Violation|2|||
129898548|NCT00708097|467588398|FG004|Period 1|Protocol Violation|0|||
129898549|NCT00708097|467588394|FG000|Period 1|Other Reason|0|||
129898550|NCT00708097|467588395|FG001|Period 1|Other Reason|0|||
129898551|NCT00708097|467588396|FG002|Period 1|Other Reason|0|||
130062408|NCT02802878|468182160|FG001|Overall Study|Protocol Violation|0|||
130062409|NCT01029002|468182161|FG000|Overall Study|Lost to Follow-up|2|||
129836934|NCT02641379|467368267|FG005|Overall Study|Participation in sili rescue study|1|||
129836935|NCT02641379|467368268|FG006|Overall Study|Participation in sili rescue study|0|||
129836936|NCT02641379|467368269|FG007|Overall Study|Participation in sili rescue study|0|||
129836937|NCT02641379|467368270|FG008|Overall Study|Participation in sili rescue study|0|||
129836938|NCT02641379|467368271|FG009|Overall Study|Participation in sili rescue study|0|||
129836939|NCT02641379|467368272|FG010|Overall Study|Participation in sili rescue study|0|||
129836940|NCT02641379|467368262|FG000|Overall Study|Lost to Follow-up|0|||
129836941|NCT02641379|467368263|FG001|Overall Study|Lost to Follow-up|0|||
129836942|NCT02641379|467368264|FG002|Overall Study|Lost to Follow-up|0|||
129836943|NCT02641379|467368265|FG003|Overall Study|Lost to Follow-up|0|||
129836944|NCT02641379|467368266|FG004|Overall Study|Lost to Follow-up|0|||
129836945|NCT02641379|467368267|FG005|Overall Study|Lost to Follow-up|0|||
129836946|NCT02641379|467368268|FG006|Overall Study|Lost to Follow-up|0|||
129836947|NCT02641379|467368269|FG007|Overall Study|Lost to Follow-up|0|||
129836948|NCT02641379|467368270|FG008|Overall Study|Lost to Follow-up|1|||
129836949|NCT02641379|467368271|FG009|Overall Study|Lost to Follow-up|0|||
129836950|NCT02641379|467368272|FG010|Overall Study|Lost to Follow-up|0|||
129836951|NCT02641379|467368262|FG000|Overall Study|Source data not found|0|||
129836952|NCT02641379|467368263|FG001|Overall Study|Source data not found|0|||
129836953|NCT02641379|467368264|FG002|Overall Study|Source data not found|0|||
129836954|NCT02641379|467368265|FG003|Overall Study|Source data not found|0|||
129836955|NCT02641379|467368266|FG004|Overall Study|Source data not found|0|||
129836956|NCT02641379|467368267|FG005|Overall Study|Source data not found|1|||
129836957|NCT02641379|467368268|FG006|Overall Study|Source data not found|0|||
129836958|NCT02641379|467368269|FG007|Overall Study|Source data not found|0|||
129836959|NCT02641379|467368270|FG008|Overall Study|Source data not found|0|||
129836960|NCT02641379|467368271|FG009|Overall Study|Source data not found|0|||
129836961|NCT02641379|467368272|FG010|Overall Study|Source data not found|0|||
129836962|NCT02641379|467368262|FG000|Overall Study|Participant showed weight reduction|0|||
129836963|NCT02641379|467368263|FG001|Overall Study|Participant showed weight reduction|0|||
129836964|NCT02641379|467368264|FG002|Overall Study|Participant showed weight reduction|0|||
129836965|NCT02641379|467368265|FG003|Overall Study|Participant showed weight reduction|0|||
129836966|NCT02641379|467368266|FG004|Overall Study|Participant showed weight reduction|0|||
129836967|NCT02641379|467368267|FG005|Overall Study|Participant showed weight reduction|0|||
129836968|NCT02641379|467368268|FG006|Overall Study|Participant showed weight reduction|0|||
129836969|NCT02641379|467368269|FG007|Overall Study|Participant showed weight reduction|1|||
129836970|NCT02641379|467368270|FG008|Overall Study|Participant showed weight reduction|0|||
129836971|NCT02641379|467368271|FG009|Overall Study|Participant showed weight reduction|0|||
129836972|NCT02641379|467368272|FG010|Overall Study|Participant showed weight reduction|0|||
129836973|NCT02641379|467368262|FG000|Overall Study|Non-response Week 12|0|||
129836974|NCT02641379|467368263|FG001|Overall Study|Non-response Week 12|0|||
129836975|NCT02641379|467368264|FG002|Overall Study|Non-response Week 12|0|||
129898552|NCT00708097|467588397|FG003|Period 1|Other Reason|0|||
129898553|NCT00708097|467588398|FG004|Period 1|Other Reason|1|||
129898554|NCT00708097|467588394|FG000|Period 2|Protocol Violation|0|||
129898555|NCT00708097|467588395|FG001|Period 2|Protocol Violation|1|||
129898556|NCT00708097|467588396|FG002|Period 2|Protocol Violation|1|||
129836976|NCT02641379|467368265|FG003|Overall Study|Non-response Week 12|0|||
129898557|NCT00708097|467588397|FG003|Period 2|Protocol Violation|1|||
129898558|NCT00708097|467588398|FG004|Period 2|Protocol Violation|0|||
129836977|NCT02641379|467368266|FG004|Overall Study|Non-response Week 12|0|||
129836978|NCT02641379|467368267|FG005|Overall Study|Non-response Week 12|0|||
129836979|NCT02641379|467368268|FG006|Overall Study|Non-response Week 12|0|||
129836980|NCT02641379|467368269|FG007|Overall Study|Non-response Week 12|1|||
129836981|NCT02641379|467368270|FG008|Overall Study|Non-response Week 12|0|||
129836982|NCT02641379|467368271|FG009|Overall Study|Non-response Week 12|0|||
129836983|NCT02641379|467368272|FG010|Overall Study|Non-response Week 12|0|||
129836984|NCT02641379|467368262|FG000|Overall Study|No 2 Log drop at Week 12|0|||
129836985|NCT02641379|467368263|FG001|Overall Study|No 2 Log drop at Week 12|0|||
129836986|NCT02641379|467368264|FG002|Overall Study|No 2 Log drop at Week 12|0|||
129836987|NCT02641379|467368265|FG003|Overall Study|No 2 Log drop at Week 12|0|||
129836988|NCT02641379|467368266|FG004|Overall Study|No 2 Log drop at Week 12|0|||
129836989|NCT02641379|467368267|FG005|Overall Study|No 2 Log drop at Week 12|0|||
129836990|NCT02641379|467368268|FG006|Overall Study|No 2 Log drop at Week 12|0|||
129836991|NCT02641379|467368269|FG007|Overall Study|No 2 Log drop at Week 12|0|||
129836992|NCT02641379|467368270|FG008|Overall Study|No 2 Log drop at Week 12|0|||
129836993|NCT02641379|467368271|FG009|Overall Study|No 2 Log drop at Week 12|0|||
129836994|NCT02641379|467368272|FG010|Overall Study|No 2 Log drop at Week 12|1|||
129836995|NCT02641379|467368262|FG000|Overall Study|Negative PCR result|0|||
129836996|NCT02641379|467368263|FG001|Overall Study|Negative PCR result|0|||
129836997|NCT02641379|467368264|FG002|Overall Study|Negative PCR result|0|||
129836998|NCT02641379|467368265|FG003|Overall Study|Negative PCR result|0|||
129836999|NCT02641379|467368266|FG004|Overall Study|Negative PCR result|0|||
129837000|NCT02641379|467368267|FG005|Overall Study|Negative PCR result|0|||
129837001|NCT02641379|467368268|FG006|Overall Study|Negative PCR result|0|||
129837002|NCT02641379|467368269|FG007|Overall Study|Negative PCR result|0|||
129837003|NCT02641379|467368270|FG008|Overall Study|Negative PCR result|0|||
129837004|NCT02641379|467368271|FG009|Overall Study|Negative PCR result|1|||
129837005|NCT02641379|467368272|FG010|Overall Study|Negative PCR result|0|||
129837006|NCT02641379|467368262|FG000|Overall Study|Participant's PCR high|0|||
130062410|NCT01029002|468182162|FG001|Overall Study|Lost to Follow-up|4|||
129837007|NCT02641379|467368263|FG001|Overall Study|Participant's PCR high|0|||
129837008|NCT02641379|467368264|FG002|Overall Study|Participant's PCR high|0|||
129837009|NCT02641379|467368265|FG003|Overall Study|Participant's PCR high|0|||
129837010|NCT02641379|467368266|FG004|Overall Study|Participant's PCR high|0|||
129837011|NCT02641379|467368267|FG005|Overall Study|Participant's PCR high|0|||
129837012|NCT02641379|467368268|FG006|Overall Study|Participant's PCR high|0|||
129837013|NCT02641379|467368269|FG007|Overall Study|Participant's PCR high|1|||
129837014|NCT02641379|467368270|FG008|Overall Study|Participant's PCR high|0|||
129837015|NCT02641379|467368271|FG009|Overall Study|Participant's PCR high|0|||
129837016|NCT02641379|467368272|FG010|Overall Study|Participant's PCR high|0|||
129837017|NCT02641379|467368262|FG000|Overall Study|Participant treated after Week 24|0|||
129837018|NCT02641379|467368263|FG001|Overall Study|Participant treated after Week 24|0|||
129837019|NCT02641379|467368264|FG002|Overall Study|Participant treated after Week 24|0|||
129837020|NCT02641379|467368265|FG003|Overall Study|Participant treated after Week 24|0|||
129837021|NCT02641379|467368266|FG004|Overall Study|Participant treated after Week 24|0|||
129837022|NCT02641379|467368267|FG005|Overall Study|Participant treated after Week 24|0|||
129837023|NCT02641379|467368268|FG006|Overall Study|Participant treated after Week 24|0|||
129837024|NCT02641379|467368269|FG007|Overall Study|Participant treated after Week 24|0|||
129837025|NCT02641379|467368270|FG008|Overall Study|Participant treated after Week 24|1|||
129837026|NCT02641379|467368271|FG009|Overall Study|Participant treated after Week 24|0|||
129837027|NCT02641379|467368272|FG010|Overall Study|Participant treated after Week 24|0|||
129837028|NCT02641379|467368262|FG000|Overall Study|Missing PCR result at Week 8|0|||
129837029|NCT02641379|467368263|FG001|Overall Study|Missing PCR result at Week 8|0|||
129837030|NCT02641379|467368264|FG002|Overall Study|Missing PCR result at Week 8|0|||
129837031|NCT02641379|467368265|FG003|Overall Study|Missing PCR result at Week 8|0|||
129837032|NCT02641379|467368266|FG004|Overall Study|Missing PCR result at Week 8|0|||
129837033|NCT02641379|467368267|FG005|Overall Study|Missing PCR result at Week 8|0|||
129837034|NCT02641379|467368268|FG006|Overall Study|Missing PCR result at Week 8|0|||
129837035|NCT02641379|467368269|FG007|Overall Study|Missing PCR result at Week 8|0|||
130062411|NCT00702052|468182163|FG000|Overall Study|Adverse Event|23|||
130062412|NCT00702052|468182163|FG000|Overall Study|Disease Progression|30|||
130062413|NCT00702052|468182163|FG000|Overall Study|Withdrawal by Subject|5|||
129837036|NCT02641379|467368270|FG008|Overall Study|Missing PCR result at Week 8|0|||
129837037|NCT02641379|467368271|FG009|Overall Study|Missing PCR result at Week 8|1|||
129837038|NCT02641379|467368272|FG010|Overall Study|Missing PCR result at Week 8|0|||
130062414|NCT01577160|468182164|FG000|Overall Study|Adverse Event|9|||
129837039|NCT02641379|467368262|FG000|Overall Study|PCR positive|0|||
129837040|NCT02641379|467368263|FG001|Overall Study|PCR positive|0|||
129837041|NCT02641379|467368264|FG002|Overall Study|PCR positive|0|||
129837042|NCT02641379|467368265|FG003|Overall Study|PCR positive|0|||
129837043|NCT02641379|467368266|FG004|Overall Study|PCR positive|0|||
129837044|NCT02641379|467368267|FG005|Overall Study|PCR positive|0|||
129837045|NCT02641379|467368268|FG006|Overall Study|PCR positive|1|||
129837046|NCT02641379|467368269|FG007|Overall Study|PCR positive|0|||
130062415|NCT01577160|468182164|FG000|Overall Study|Lack of Efficacy|15|||
130062416|NCT01577160|468182164|FG000|Overall Study|Lost to Follow-up|40|||
129837047|NCT02641379|467368270|FG008|Overall Study|PCR positive|0|||
129837048|NCT02641379|467368271|FG009|Overall Study|PCR positive|0|||
129837049|NCT02641379|467368272|FG010|Overall Study|PCR positive|0|||
129837050|NCT04964128|467368273|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
129837051|NCT04964128|467368273|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
129837052|NCT01471379|467368274|FG000|Overall Study|Adverse Event|1|||
129837053|NCT01471379|467368275|FG001|Overall Study|Adverse Event|0|||
129837054|NCT01471379|467368276|FG002|Overall Study|Adverse Event|0|||
129837055|NCT01471379|467368274|FG000|Overall Study|Study terminated|0|||
129837056|NCT01471379|467368275|FG001|Overall Study|Study terminated|1|||
129837057|NCT01471379|467368276|FG002|Overall Study|Study terminated|0|||
129837058|NCT02120794|467368277|FG000|Overall Study|Withdrawal by Subject|43|||
129837059|NCT02120794|467368277|FG000|Overall Study|Adverse Event|10|||
129837060|NCT02120794|467368277|FG000|Overall Study|Physician Decision|4|||
129837061|NCT02120794|467368277|FG000|Overall Study|Due to insurance coverage|1|||
129837062|NCT01644175|467368280|FG000|Overall Study|Randomized But Not Treated|0|||
129837063|NCT01644175|467368281|FG001|Overall Study|Randomized But Not Treated|2|||
129837064|NCT01644175|467368280|FG000|Overall Study|Adverse Event|8|||
129837065|NCT01644175|467368281|FG001|Overall Study|Adverse Event|13|||
129837066|NCT01644175|467368280|FG000|Overall Study|Death|1|||
129837067|NCT01644175|467368281|FG001|Overall Study|Death|2|||
129837068|NCT01644175|467368280|FG000|Overall Study|Poor compliance to protocol|9|||
129837069|NCT01644175|467368281|FG001|Overall Study|Poor compliance to protocol|10|||
129837070|NCT01644175|467368280|FG000|Overall Study|Physician Decision|1|||
129837071|NCT01644175|467368281|FG001|Overall Study|Physician Decision|2|||
129837072|NCT01644175|467368280|FG000|Overall Study|Participant Moved|1|||
129837073|NCT01644175|467368281|FG001|Overall Study|Participant Moved|2|||
129837074|NCT01644175|467368280|FG000|Overall Study|Consent withdrawn by participant|3|||
129837075|NCT01644175|467368281|FG001|Overall Study|Consent withdrawn by participant|4|||
129837076|NCT01644175|467368280|FG000|Overall Study|Related to Autoinjector Administration|2|||
129837077|NCT01644175|467368281|FG001|Overall Study|Related to Autoinjector Administration|1|||
129837078|NCT01644175|467368280|FG000|Overall Study|Last visit outside protocol visit window|4|||
129837079|NCT01644175|467368281|FG001|Overall Study|Last visit outside protocol visit window|11|||
129837080|NCT01644175|467368280|FG000|Overall Study|Selection criteria finally not met|0|||
129837081|NCT01644175|467368281|FG001|Overall Study|Selection criteria finally not met|1|||
129837082|NCT01644175|467368280|FG000|Overall Study|Site closure|2|||
129837083|NCT01644175|467368281|FG001|Overall Study|Site closure|2|||
129837084|NCT01644175|467368280|FG000|Overall Study|Lost to Follow-up|1|||
129837085|NCT01644175|467368281|FG001|Overall Study|Lost to Follow-up|0|||
129837086|NCT01644175|467368280|FG000|Overall Study|Other than specified above|0|||
129837087|NCT01644175|467368281|FG001|Overall Study|Other than specified above|3|||
129837088|NCT01070316|467368299|FG000|Extension Phase|Lack of Efficacy|3|||
129837089|NCT01070316|467368299|FG000|Extension Phase|Withdrawal by Subject|1|||
129837090|NCT00692770|467368302|FG000|Overall Study|Protocol Violation|2|||
129837091|NCT00692770|467368303|FG001|Overall Study|Protocol Violation|7|||
129837092|NCT00692770|467368302|FG000|Overall Study|Withdrawal by Subject|97|||
129837093|NCT00692770|467368303|FG001|Overall Study|Withdrawal by Subject|36|||
129837094|NCT00692770|467368302|FG000|Overall Study|Adverse Event|136|||
129837095|NCT00692770|467368303|FG001|Overall Study|Adverse Event|41|||
129837096|NCT00692770|467368302|FG000|Overall Study|Death|10|||
129837097|NCT00692770|467368303|FG001|Overall Study|Death|5|||
129837098|NCT00692770|467368302|FG000|Overall Study|Lost to Follow-up|7|||
129837099|NCT00692770|467368303|FG001|Overall Study|Lost to Follow-up|3|||
129837100|NCT00692770|467368302|FG000|Overall Study|Non-compliant with study medication|11|||
129837101|NCT00692770|467368303|FG001|Overall Study|Non-compliant with study medication|5|||
129837102|NCT00692770|467368302|FG000|Overall Study|Progression by clinical judgment|2|||
129837103|NCT00692770|467368303|FG001|Overall Study|Progression by clinical judgment|3|||
129837104|NCT00692770|467368302|FG000|Overall Study|Physician decision not protocol driven|10|||
129837105|NCT00692770|467368303|FG001|Overall Study|Physician decision not protocol driven|14|||
129837106|NCT00692770|467368302|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
129837107|NCT00692770|467368303|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
129837108|NCT00692770|467368302|FG000|Overall Study|Protocol driven decision point|3|||
129837109|NCT00692770|467368303|FG001|Overall Study|Protocol driven decision point|7|||
129837110|NCT00692770|467368302|FG000|Overall Study|Completed all planned assessments|79|||
129837111|NCT00692770|467368303|FG001|Overall Study|Completed all planned assessments|101|||
129837112|NCT00692770|467368302|FG000|Overall Study|Radiological and clinical progression|8|||
129837113|NCT00692770|467368303|FG001|Overall Study|Radiological and clinical progression|8|||
129837114|NCT00692770|467368302|FG000|Overall Study|Clinical endpoint reached|16|||
129837115|NCT00692770|467368303|FG001|Overall Study|Clinical endpoint reached|43|||
129837116|NCT00692770|467368302|FG000|Overall Study|Study terminated by sponsor|2|||
129837117|NCT00692770|467368303|FG001|Overall Study|Study terminated by sponsor|2|||
129837118|NCT00692770|467368302|FG000|Overall Study|Randomized but not treated|3|||
130062417|NCT01577160|468182164|FG000|Overall Study|Withdrawal by Subject|18|||
129837119|NCT00692770|467368303|FG001|Overall Study|Randomized but not treated|4|||
129837120|NCT04248816|467368304|FG000|Overall Study|Ineligible post-randomization|7|||
129837121|NCT04248816|467368305|FG001|Overall Study|Ineligible post-randomization|21|||
129837122|NCT04248816|467368306|FG002|Overall Study|Ineligible post-randomization|25|||
129837123|NCT02620046|467368309|FG000|Overall Study|Adverse Event|22|||
129837124|NCT02620046|467368310|FG001|Overall Study|Adverse Event|42|||
129837125|NCT02620046|467368309|FG000|Overall Study|Lost to Follow-up|4|||
129837126|NCT02620046|467368310|FG001|Overall Study|Lost to Follow-up|10|||
129837127|NCT02620046|467368309|FG000|Overall Study|Withdrawal by Subject|36|||
129837128|NCT02620046|467368310|FG001|Overall Study|Withdrawal by Subject|66|||
129837129|NCT02620046|467368309|FG000|Overall Study|Site Termination|3|||
129837130|NCT02620046|467368310|FG001|Overall Study|Site Termination|3|||
129837131|NCT02620046|467368309|FG000|Overall Study|Pregnancy|3|||
129837132|NCT02620046|467368310|FG001|Overall Study|Pregnancy|7|||
129837133|NCT02620046|467368309|FG000|Overall Study|Lack of Efficacy|81|||
129837134|NCT02620046|467368310|FG001|Overall Study|Lack of Efficacy|146|||
129837135|NCT02620046|467368309|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
129837136|NCT02620046|467368310|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
129837137|NCT02620046|467368309|FG000|Overall Study|Reason Not Specified|13|||
129837138|NCT02620046|467368310|FG001|Overall Study|Reason Not Specified|21|||
129837139|NCT02620046|467368309|FG000|Overall Study|Significant Protocol Deviation|0|||
129837140|NCT02620046|467368310|FG001|Overall Study|Significant Protocol Deviation|1|||
129837141|NCT00427635|467369552|FG000|Treatment Phase|Withdrawal by Subject|1|||
129837142|NCT00427635|467369553|FG001|Treatment Phase|Withdrawal by Subject|0|||
129837143|NCT00427635|467369552|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
129837144|NCT00427635|467369553|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
129837145|NCT03711162|467369556|FG000|Overall Study|Adverse Event|5|||
129837146|NCT03711162|467369557|FG001|Overall Study|Adverse Event|2|||
129837147|NCT03711162|467369558|FG002|Overall Study|Adverse Event|4|||
129837148|NCT03711162|467369556|FG000|Overall Study|Death|11|||
129837149|NCT03711162|467369557|FG001|Overall Study|Death|7|||
129837150|NCT03711162|467369558|FG002|Overall Study|Death|8|||
129837151|NCT03711162|467369556|FG000|Overall Study|Lost to Follow-up|1|||
129837152|NCT03711162|467369557|FG001|Overall Study|Lost to Follow-up|0|||
129837153|NCT03711162|467369558|FG002|Overall Study|Lost to Follow-up|1|||
129837154|NCT03711162|467369556|FG000|Overall Study|Study Terminated by Sponsor|139|||
129837155|NCT03711162|467369557|FG001|Overall Study|Study Terminated by Sponsor|152|||
129837156|NCT03711162|467369558|FG002|Overall Study|Study Terminated by Sponsor|146|||
129837157|NCT03711162|467369556|FG000|Overall Study|Withdrawal by Subject|17|||
129837158|NCT03711162|467369557|FG001|Overall Study|Withdrawal by Subject|10|||
129837159|NCT03711162|467369558|FG002|Overall Study|Withdrawal by Subject|10|||
129837160|NCT03711162|467369556|FG000|Overall Study|Miscellaneous|1|||
129837161|NCT03711162|467369557|FG001|Overall Study|Miscellaneous|2|||
129837162|NCT03711162|467369558|FG002|Overall Study|Miscellaneous|2|||
129837163|NCT03711162|467369556|FG000|Overall Study|Not Treated|1|||
129837164|NCT03711162|467369557|FG001|Overall Study|Not Treated|0|||
129837165|NCT03711162|467369558|FG002|Overall Study|Not Treated|1|||
129837166|NCT03711162|467369556|FG000|Overall Study|Physician Decision|0|||
129837167|NCT03711162|467369557|FG001|Overall Study|Physician Decision|2|||
129837168|NCT03711162|467369558|FG002|Overall Study|Physician Decision|0|||
129837169|NCT03711162|467369556|FG000|Overall Study|Lack of Efficacy|0|||
129837170|NCT03711162|467369557|FG001|Overall Study|Lack of Efficacy|0|||
129837171|NCT03711162|467369558|FG002|Overall Study|Lack of Efficacy|2|||
129837172|NCT03711162|467369556|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
129837173|NCT03711162|467369557|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
129837174|NCT03711162|467369558|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
129837175|NCT00394212|467369561|FG000|Overall Study|Lost to Follow-up|3|||
129837176|NCT00394212|467369562|FG001|Overall Study|Lost to Follow-up|0|||
129837177|NCT00394212|467369561|FG000|Overall Study|Withdrawal by Subject|4|||
130062418|NCT01577160|468182164|FG000|Overall Study|Subject Uncooperative|7|||
130062419|NCT01577160|468182164|FG000|Overall Study|Other|9|||
129837178|NCT00394212|467369562|FG001|Overall Study|Withdrawal by Subject|1|||
129837179|NCT00588445|467369563|FG000|Overall Study|Protocol Violation|1|||
129837180|NCT00588445|467369563|FG000|Overall Study|Withdrawal by Subject|3|||
129837181|NCT00588445|467369563|FG000|Overall Study|Disease Progression|1|||
129837182|NCT00588445|467369563|FG000|Overall Study|Not Treated|10|||
129837183|NCT03240133|467369564|FG000|Overall Study|Withdrawal by Subject|0|||
129837184|NCT03240133|467369565|FG001|Overall Study|Withdrawal by Subject|1|||
129837185|NCT03240133|467369566|FG002|Overall Study|Withdrawal by Subject|0|||
129837186|NCT03240133|467369564|FG000|Overall Study|Adverse Event|1|||
129837187|NCT03240133|467369565|FG001|Overall Study|Adverse Event|1|||
129837188|NCT03240133|467369566|FG002|Overall Study|Adverse Event|0|||
129837189|NCT03240133|467369564|FG000|Overall Study|Rash|1|||
129837190|NCT03240133|467369565|FG001|Overall Study|Rash|0|||
129837191|NCT03240133|467369566|FG002|Overall Study|Rash|0|||
129837192|NCT03240133|467369564|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
129837193|NCT03240133|467369565|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
129898559|NCT04358549|467589998|FG000|Overall Study|Adverse Event|0|||
129898560|NCT04358549|467589999|FG001|Overall Study|Adverse Event|1|||
129898561|NCT04358549|467589998|FG000|Overall Study|Death|1|||
129898562|NCT04358549|467589999|FG001|Overall Study|Death|0|||
129898563|NCT04358549|467589998|FG000|Overall Study|Lost to Follow-up|2|||
129898564|NCT04358549|467589999|FG001|Overall Study|Lost to Follow-up|1|||
129898565|NCT04358549|467589998|FG000|Overall Study|Withdrawal by Subject|6|||
129898566|NCT04358549|467589999|FG001|Overall Study|Withdrawal by Subject|6|||
129898567|NCT04358549|467589998|FG000|Overall Study|Start remdesivir|1|||
129898568|NCT04358549|467589999|FG001|Overall Study|Start remdesivir|0|||
129898569|NCT01118377|467590000|FG000|Overall Study|Did Not Receive Study Medication|1|||
129898570|NCT01118377|467590000|FG000|Overall Study|Death|38|||
129898571|NCT01118377|467590000|FG000|Overall Study|Failure to Return|3|||
129898572|NCT03837028|467590001|FG000|Overall Study|Lost to Follow-up|4|||
130062420|NCT00101192|468182165|FG000|Overall Study|Ineligible|6|||
130062421|NCT00101192|468182165|FG000|Overall Study|Inevaluable|1|||
130062422|NCT02121756|468182169|FG000|Overall Study|Adverse Event|3|||
130062423|NCT02121756|468182170|FG001|Overall Study|Adverse Event|0|||
130062424|NCT02121756|468182169|FG000|Overall Study|Protocol Violation|1|||
130062425|NCT02121756|468182170|FG001|Overall Study|Protocol Violation|1|||
130062426|NCT02121756|468182169|FG000|Overall Study|Physician Decision|2|||
130062427|NCT02121756|468182170|FG001|Overall Study|Physician Decision|1|||
130062428|NCT00255086|468182173|FG000|Overall Study|Adverse Event|1|||
130062429|NCT00255086|468182174|FG001|Overall Study|Adverse Event|1|||
130062430|NCT00255086|468182173|FG000|Overall Study|Protocol Violation|1|||
130062431|NCT00255086|468182174|FG001|Overall Study|Protocol Violation|1|||
130062432|NCT02365584|468182176|FG000|Overall Study|Adverse Event|2|||
130062433|NCT02365584|468182177|FG001|Overall Study|Adverse Event|2|||
130062434|NCT02365584|468182176|FG000|Overall Study|Withdrawal by Subject|1|||
130062435|NCT02365584|468182177|FG001|Overall Study|Withdrawal by Subject|0|||
130062436|NCT02365584|468182176|FG000|Overall Study|Disease Progression|9|||
130062437|NCT02365584|468182177|FG001|Overall Study|Disease Progression|12|||
130062438|NCT00349752|468182178|FG000|Overall Study|Adverse Event|8|||
130062439|NCT00349752|468182179|FG001|Overall Study|Adverse Event|12|||
130062440|NCT00349752|468182178|FG000|Overall Study|Lack of Efficacy|37|||
130062441|NCT00349752|468182179|FG001|Overall Study|Lack of Efficacy|42|||
130062442|NCT00349752|468182178|FG000|Overall Study|Lost to Follow-up|4|||
130062443|NCT00349752|468182179|FG001|Overall Study|Lost to Follow-up|2|||
130062444|NCT00349752|468182178|FG000|Overall Study|Personal reasons|6|||
130062445|NCT00349752|468182179|FG001|Overall Study|Personal reasons|5|||
130062446|NCT00349752|468182178|FG000|Overall Study|Other: Required exclusionary medication|0|||
130062447|NCT00349752|468182179|FG001|Overall Study|Other: Required exclusionary medication|1|||
130062448|NCT00349752|468182178|FG000|Overall Study|Other: Non compliance|0|||
130062449|NCT00349752|468182179|FG001|Overall Study|Other: Non compliance|1|||
130062450|NCT00349752|468182178|FG000|Overall Study|Other: Patient stopped steroids|0|||
129898573|NCT03837028|467590002|FG001|Overall Study|Lost to Follow-up|0|||
129898574|NCT03837028|467590003|FG002|Overall Study|Lost to Follow-up|2|||
129898575|NCT03837028|467590004|FG003|Overall Study|Lost to Follow-up|0|||
129898576|NCT03837028|467590001|FG000|Overall Study|Withdrawal by Subject|12|||
129898577|NCT03837028|467590002|FG001|Overall Study|Withdrawal by Subject|11|||
129898578|NCT03837028|467590003|FG002|Overall Study|Withdrawal by Subject|11|||
129898579|NCT03837028|467590004|FG003|Overall Study|Withdrawal by Subject|7|||
129898580|NCT04867902|467590005|FG000|Overall Study|Lost to Follow-up|1|||
129898581|NCT04867902|467590005|FG000|Overall Study|Withdrawal by Subject|2|||
129898582|NCT04867902|467590005|FG000|Overall Study|Protocol Violation|1|||
129898583|NCT05355116|467590006|FG000|Overall Study|Withdrawal by Subject|2|||
129898584|NCT01090024|467590007|FG000|Period 1|Met exclusion criteria|0|||
129898585|NCT01090024|467590008|FG001|Period 1|Met exclusion criteria|0|||
129898586|NCT01090024|467590009|FG002|Period 1|Met exclusion criteria|0|||
129898587|NCT01090024|467590010|FG003|Period 1|Met exclusion criteria|0|||
129898588|NCT01090024|467590011|FG004|Period 1|Met exclusion criteria|0|||
129898589|NCT01090024|467590012|FG005|Period 1|Met exclusion criteria|0|||
129898590|NCT01090024|467590013|FG006|Period 1|Met exclusion criteria|0|||
129898591|NCT01090024|467590014|FG007|Period 1|Met exclusion criteria|0|||
129898592|NCT01090024|467590015|FG008|Period 1|Met exclusion criteria|0|||
129898593|NCT01090024|467590016|FG009|Period 1|Met exclusion criteria|0|||
129898594|NCT01090024|467590017|FG010|Period 1|Met exclusion criteria|0|||
129898595|NCT01090024|467590018|FG011|Period 1|Met exclusion criteria|0|||
129898596|NCT01090024|467590019|FG012|Period 1|Met exclusion criteria|0|||
129898597|NCT01090024|467590020|FG013|Period 1|Met exclusion criteria|0|||
129898598|NCT01090024|467590021|FG014|Period 1|Met exclusion criteria|1|||
129898599|NCT01090024|467590022|FG015|Period 1|Met exclusion criteria|0|||
129898600|NCT01090024|467590023|FG016|Period 1|Met exclusion criteria|0|||
129898601|NCT01090024|467590024|FG017|Period 1|Met exclusion criteria|0|||
129898602|NCT01090024|467590007|FG000|Period 1|Adverse Event|0|||
130062451|NCT00349752|468182179|FG001|Overall Study|Other: Patient stopped steroids|1|||
130062452|NCT00349752|468182178|FG000|Overall Study|Other: Patient's steroid use|1|||
130062453|NCT00349752|468182179|FG001|Overall Study|Other: Patient's steroid use|0|||
130062454|NCT00349752|468182178|FG000|Overall Study|Other: Ineligible|1|||
130062455|NCT00349752|468182179|FG001|Overall Study|Other: Ineligible|0|||
129837194|NCT03240133|467369566|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
129837195|NCT03240133|467369564|FG000|Overall Study|Intercurrent illness.|0|||
129837196|NCT03240133|467369565|FG001|Overall Study|Intercurrent illness.|1|||
129837197|NCT03240133|467369566|FG002|Overall Study|Intercurrent illness.|0|||
129837198|NCT03240133|467369564|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
129837199|NCT03240133|467369565|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
129837200|NCT03240133|467369566|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
129837201|NCT01176292|467369570|FG000|Overall Study|Lost to Follow-up|2|||
129837202|NCT01176292|467369571|FG001|Overall Study|Lost to Follow-up|4|||
129837203|NCT01176292|467369570|FG000|Overall Study|Adverse Event|1|||
129837204|NCT01176292|467369571|FG001|Overall Study|Adverse Event|1|||
129837205|NCT01176292|467369570|FG000|Overall Study|Physician Decision|0|||
129837206|NCT01176292|467369571|FG001|Overall Study|Physician Decision|2|||
129837207|NCT01176292|467369570|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
129837208|NCT01176292|467369571|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
129837209|NCT00110812|467369572|FG000|Main Study|Death|0|||
129837210|NCT00110812|467369573|FG001|Main Study|Death|0|||
129837211|NCT00110812|467369574|FG002|Main Study|Death|2|||
129837212|NCT00110812|467369572|FG000|Main Study|Withdrawal by Subject|0|||
129837213|NCT00110812|467369573|FG001|Main Study|Withdrawal by Subject|0|||
129837214|NCT00110812|467369574|FG002|Main Study|Withdrawal by Subject|1|||
129837215|NCT00110812|467369572|FG000|Main Study|Lost to Follow-up|8|||
129837216|NCT00110812|467369573|FG001|Main Study|Lost to Follow-up|11|||
129837217|NCT00110812|467369574|FG002|Main Study|Lost to Follow-up|10|||
129837218|NCT00110812|467369572|FG000|Extended Follow-up|Death|1|||
129837219|NCT00110812|467369573|FG001|Extended Follow-up|Death|0|||
129837220|NCT00110812|467369574|FG002|Extended Follow-up|Death|3|||
129837221|NCT00110812|467369572|FG000|Extended Follow-up|Withdrawal by Subject|0|||
129837222|NCT00110812|467369573|FG001|Extended Follow-up|Withdrawal by Subject|1|||
129837223|NCT00110812|467369574|FG002|Extended Follow-up|Withdrawal by Subject|0|||
129837224|NCT00110812|467369572|FG000|Extended Follow-up|Lost to Follow-up|1|||
129837225|NCT00110812|467369573|FG001|Extended Follow-up|Lost to Follow-up|3|||
129837226|NCT00110812|467369574|FG002|Extended Follow-up|Lost to Follow-up|1|||
129837227|NCT01446965|467369576|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
129837228|NCT01446965|467369577|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
129837229|NCT01446965|467369576|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
129837230|NCT01446965|467369577|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
129837231|NCT02852265|467369578|FG000|3-month Follow-up|Lost to Follow-up|1|||
129837232|NCT02852265|467369579|FG001|3-month Follow-up|Lost to Follow-up|1|||
129837233|NCT01828034|467369582|FG000|Overall Study|Withdrawal by Subject|0|||
129837234|NCT01828034|467369583|FG001|Overall Study|Withdrawal by Subject|0|||
129837235|NCT01828034|467369584|FG002|Overall Study|Withdrawal by Subject|0|||
129837236|NCT01828034|467369585|FG003|Overall Study|Withdrawal by Subject|1|||
129837237|NCT02871375|467369586|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
129837238|NCT02871375|467369587|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
129837239|NCT01988571|467369590|FG000|Overall Study|Death|3|||
129837240|NCT01988571|467369591|FG001|Overall Study|Death|1|||
129837241|NCT01988571|467369590|FG000|Overall Study|Physician Decision|2|||
129837242|NCT01988571|467369591|FG001|Overall Study|Physician Decision|1|||
129837243|NCT01988571|467369590|FG000|Overall Study|Lost to Follow-up|3|||
129898603|NCT01090024|467590008|FG001|Period 1|Adverse Event|0|||
129837244|NCT01988571|467369591|FG001|Overall Study|Lost to Follow-up|0|||
129837245|NCT01988571|467369590|FG000|Overall Study|Withdrawal by Subject|31|||
129837246|NCT01988571|467369591|FG001|Overall Study|Withdrawal by Subject|33|||
129837247|NCT00004412|467369592|FG000|Randomized Period|Moved to Crossover Period|3|||
129837248|NCT00004412|467369593|FG001|Randomized Period|Moved to Crossover Period|0|||
129898604|NCT01090024|467590009|FG002|Period 1|Adverse Event|0|||
129837249|NCT00004412|467369594|FG002|Randomized Period|Moved to Crossover Period|0|||
129837250|NCT01364428|467369597|FG000|Overall Study|Adverse Event|1|||
129837251|NCT01364428|467369598|FG001|Overall Study|Adverse Event|2|||
129837252|NCT01364428|467369597|FG000|Overall Study|Protocol Violation|2|||
129837253|NCT01364428|467369598|FG001|Overall Study|Protocol Violation|0|||
129837254|NCT01364428|467369597|FG000|Overall Study|Withdrawal Criteria|14|||
129837255|NCT01364428|467369598|FG001|Overall Study|Withdrawal Criteria|10|||
129837256|NCT01364428|467369597|FG000|Overall Study|Other|3|||
129837257|NCT01364428|467369598|FG001|Overall Study|Other|3|||
129837258|NCT00743652|467369599|FG000|Overall Study|Parent/Legal Guardian Request|3|||
129837259|NCT00743652|467369600|FG001|Overall Study|Parent/Legal Guardian Request|2|||
129898605|NCT01090024|467590010|FG003|Period 1|Adverse Event|0|||
129837260|NCT00743652|467369601|FG002|Overall Study|Parent/Legal Guardian Request|2|||
129837261|NCT00743652|467369602|FG003|Overall Study|Parent/Legal Guardian Request|2|||
129837262|NCT00743652|467369603|FG004|Overall Study|Parent/Legal Guardian Request|0|||
129837263|NCT00743652|467369599|FG000|Overall Study|Adverse Event|3|||
129898606|NCT01090024|467590011|FG004|Period 1|Adverse Event|0|||
129898607|NCT01090024|467590012|FG005|Period 1|Adverse Event|0|||
129898608|NCT01090024|467590013|FG006|Period 1|Adverse Event|0|||
129898609|NCT01090024|467590014|FG007|Period 1|Adverse Event|0|||
129898610|NCT01090024|467590015|FG008|Period 1|Adverse Event|0|||
129898611|NCT01090024|467590016|FG009|Period 1|Adverse Event|1|||
129898612|NCT01090024|467590017|FG010|Period 1|Adverse Event|0|||
129898613|NCT01090024|467590018|FG011|Period 1|Adverse Event|1|||
129898614|NCT01090024|467590019|FG012|Period 1|Adverse Event|0|||
129898615|NCT01090024|467590020|FG013|Period 1|Adverse Event|0|||
129898616|NCT01090024|467590021|FG014|Period 1|Adverse Event|0|||
129898617|NCT01090024|467590022|FG015|Period 1|Adverse Event|0|||
129898618|NCT01090024|467590023|FG016|Period 1|Adverse Event|0|||
129898619|NCT01090024|467590024|FG017|Period 1|Adverse Event|1|||
129898620|NCT01090024|467590007|FG000|Period 1|Withdrawal by Subject|0|||
129898621|NCT01090024|467590008|FG001|Period 1|Withdrawal by Subject|0|||
129898622|NCT01090024|467590009|FG002|Period 1|Withdrawal by Subject|0|||
129837264|NCT00743652|467369600|FG001|Overall Study|Adverse Event|0|||
129837265|NCT00743652|467369601|FG002|Overall Study|Adverse Event|0|||
129837266|NCT00743652|467369602|FG003|Overall Study|Adverse Event|0|||
129837267|NCT00743652|467369603|FG004|Overall Study|Adverse Event|0|||
129837268|NCT00743652|467369599|FG000|Overall Study|Death|2|||
129837269|NCT00743652|467369600|FG001|Overall Study|Death|0|||
129837270|NCT00743652|467369601|FG002|Overall Study|Death|0|||
129837271|NCT00743652|467369602|FG003|Overall Study|Death|0|||
129837272|NCT00743652|467369603|FG004|Overall Study|Death|0|||
129837273|NCT00743652|467369599|FG000|Overall Study|Investigator Request|0|||
129837274|NCT00743652|467369600|FG001|Overall Study|Investigator Request|0|||
129837275|NCT00743652|467369601|FG002|Overall Study|Investigator Request|0|||
129837276|NCT00743652|467369602|FG003|Overall Study|Investigator Request|2|||
129837277|NCT00743652|467369603|FG004|Overall Study|Investigator Request|0|||
129837278|NCT00743652|467369599|FG000|Overall Study|Other|1|||
129837279|NCT00743652|467369600|FG001|Overall Study|Other|1|||
129837280|NCT00743652|467369601|FG002|Overall Study|Other|0|||
129898623|NCT01090024|467590010|FG003|Period 1|Withdrawal by Subject|1|||
129898624|NCT01090024|467590011|FG004|Period 1|Withdrawal by Subject|0|||
129898625|NCT01090024|467590012|FG005|Period 1|Withdrawal by Subject|0|||
130062456|NCT00349752|468182178|FG000|Overall Study|Other: Inadvertently unblinded|1|||
130062457|NCT00349752|468182179|FG001|Overall Study|Other: Inadvertently unblinded|0|||
130062458|NCT00349752|468182178|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
130062459|NCT00349752|468182179|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
130062460|NCT01973452|468182184|FG000|Overall Study|Lack of Efficacy|0|||
130062461|NCT01973452|468182185|FG001|Overall Study|Lack of Efficacy|1|||
130062462|NCT01973452|468182184|FG000|Overall Study|Lost to Follow-up|1|||
130062463|NCT01973452|468182185|FG001|Overall Study|Lost to Follow-up|0|||
130062464|NCT01973452|468182184|FG000|Overall Study|Withdrawal by Subject|10|||
130062465|NCT01973452|468182185|FG001|Overall Study|Withdrawal by Subject|9|||
130062466|NCT01973452|468182184|FG000|Overall Study|Ineligible|1|||
130062467|NCT01973452|468182185|FG001|Overall Study|Ineligible|1|||
130062468|NCT01973452|468182184|FG000|Overall Study|Surgery canceled by participant|5|||
130062469|NCT01973452|468182185|FG001|Overall Study|Surgery canceled by participant|3|||
130062470|NCT05294211|468182187|FG000|Overall Study|Withdrawal by Subject|3|||
130062471|NCT05294211|468182187|FG000|Overall Study|Physician Decision|2|||
130062472|NCT05294211|468182187|FG000|Overall Study|Progressed to active labor|1|||
130062473|NCT05294211|468182187|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
130062474|NCT05294211|468182187|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
130062475|NCT00064350|468182188|FG000|Induction Treatment|Disease Progression|5|||
130062476|NCT00064350|468182189|FG001|Induction Treatment|Disease Progression|1|||
130062477|NCT00064350|468182190|FG002|Induction Treatment|Disease Progression|110|||
130062478|NCT00064350|468182188|FG000|Induction Treatment|Adverse Event|0|||
130062479|NCT00064350|468182189|FG001|Induction Treatment|Adverse Event|2|||
130062480|NCT00064350|468182190|FG002|Induction Treatment|Adverse Event|49|||
130062481|NCT00064350|468182188|FG000|Induction Treatment|Death|0|||
130062482|NCT00064350|468182189|FG001|Induction Treatment|Death|0|||
130062483|NCT00064350|468182190|FG002|Induction Treatment|Death|9|||
130062484|NCT00064350|468182188|FG000|Induction Treatment|Withdrawal by Subject|0|||
130062485|NCT00064350|468182189|FG001|Induction Treatment|Withdrawal by Subject|0|||
130062486|NCT00064350|468182190|FG002|Induction Treatment|Withdrawal by Subject|21|||
129837281|NCT00743652|467369602|FG003|Overall Study|Other|0|||
129837282|NCT00743652|467369603|FG004|Overall Study|Other|0|||
129837283|NCT00743652|467369599|FG000|Overall Study|Lost to Follow-up|1|||
129898626|NCT01090024|467590013|FG006|Period 1|Withdrawal by Subject|0|||
129837284|NCT00743652|467369600|FG001|Overall Study|Lost to Follow-up|0|||
129837285|NCT00743652|467369601|FG002|Overall Study|Lost to Follow-up|0|||
129837286|NCT00743652|467369602|FG003|Overall Study|Lost to Follow-up|0|||
129837287|NCT00743652|467369603|FG004|Overall Study|Lost to Follow-up|0|||
129898627|NCT01090024|467590014|FG007|Period 1|Withdrawal by Subject|0|||
129898628|NCT01090024|467590015|FG008|Period 1|Withdrawal by Subject|0|||
129898629|NCT01090024|467590016|FG009|Period 1|Withdrawal by Subject|0|||
129898630|NCT01090024|467590017|FG010|Period 1|Withdrawal by Subject|0|||
129898631|NCT01090024|467590018|FG011|Period 1|Withdrawal by Subject|0|||
130062487|NCT00064350|468182188|FG000|Induction Treatment|Ineligible or never started treatment|3|||
130062488|NCT00064350|468182189|FG001|Induction Treatment|Ineligible or never started treatment|6|||
130062489|NCT00064350|468182190|FG002|Induction Treatment|Ineligible or never started treatment|34|||
129837288|NCT02689258|467369604|FG000|Overall Study|Subject Non-Compliance|0|||
129837289|NCT02689258|467369605|FG001|Overall Study|Subject Non-Compliance|1|||
130062490|NCT00064350|468182188|FG000|Induction Treatment|Other|0|||
130062491|NCT00064350|468182189|FG001|Induction Treatment|Other|0|||
130062492|NCT00064350|468182190|FG002|Induction Treatment|Other|13|||
130062493|NCT00064350|468182188|FG000|Randomization|Adverse Event|8|||
130062494|NCT00064350|468182189|FG001|Randomization|Adverse Event|3|||
130062495|NCT00064350|468182190|FG002|Randomization|Adverse Event|0|||
130062496|NCT00064350|468182188|FG000|Randomization|Death|3|||
130062497|NCT00064350|468182189|FG001|Randomization|Death|0|||
130062498|NCT00064350|468182190|FG002|Randomization|Death|0|||
130062499|NCT00064350|468182188|FG000|Randomization|Withdrawal by Subject|1|||
130062500|NCT00064350|468182189|FG001|Randomization|Withdrawal by Subject|0|||
130062501|NCT00064350|468182190|FG002|Randomization|Withdrawal by Subject|0|||
130062502|NCT00064350|468182188|FG000|Randomization|Ineligible or never started treatment|9|||
130062503|NCT00064350|468182189|FG001|Randomization|Ineligible or never started treatment|15|||
130062504|NCT00064350|468182190|FG002|Randomization|Ineligible or never started treatment|0|||
130062505|NCT00064350|468182188|FG000|Randomization|Other|5|||
130062506|NCT00064350|468182189|FG001|Randomization|Other|0|||
130062507|NCT00064350|468182190|FG002|Randomization|Other|0|||
130062508|NCT00064350|468182188|FG000|Cross-Over|Adverse Event|0|||
130062509|NCT00064350|468182189|FG001|Cross-Over|Adverse Event|1|||
130062510|NCT00064350|468182190|FG002|Cross-Over|Adverse Event|0|||
130062511|NCT00064350|468182188|FG000|Cross-Over|Death|1|||
130062512|NCT00064350|468182189|FG001|Cross-Over|Death|3|||
130062513|NCT00064350|468182190|FG002|Cross-Over|Death|0|||
130062514|NCT00064350|468182188|FG000|Cross-Over|Withdrawal by Subject|2|||
130062515|NCT00064350|468182189|FG001|Cross-Over|Withdrawal by Subject|2|||
130062516|NCT00064350|468182190|FG002|Cross-Over|Withdrawal by Subject|0|||
130062517|NCT00064350|468182188|FG000|Cross-Over|Ineligible or never started treatment|3|||
130062518|NCT00064350|468182189|FG001|Cross-Over|Ineligible or never started treatment|6|||
130062519|NCT00064350|468182190|FG002|Cross-Over|Ineligible or never started treatment|0|||
130062520|NCT00064350|468182188|FG000|Cross-Over|Other|0|||
130062521|NCT00064350|468182189|FG001|Cross-Over|Other|2|||
130062522|NCT00064350|468182190|FG002|Cross-Over|Other|0|||
130062523|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
130062524|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
130062525|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
130062526|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
130062527|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
130062528|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
130062529|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
130062530|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130062531|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
130062532|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
130062533|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
130062534|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
130062535|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
130062536|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
130062537|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
130062538|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
130062539|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Missing|3|||
130062540|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Missing|1|||
130062541|NCT00838916|468182191|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
130062542|NCT00838916|468182192|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130062543|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
130062544|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
130062545|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
130062546|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
130062547|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
130062548|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
130062549|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
130062550|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
130062551|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
130062552|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
130062553|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
130062554|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
130062555|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
130062556|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
130062557|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130062558|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
130062559|NCT00838916|468182191|FG000|Follow-up Period (8 Weeks)|Missing|3|||
130062560|NCT00838916|468182192|FG001|Follow-up Period (8 Weeks)|Missing|0|||
130062561|NCT01842607|468182193|FG000|Overall Study|Adverse Event|11|||
130062562|NCT01842607|468182193|FG000|Overall Study|Lack of Efficacy|19|||
129837290|NCT02689258|467369606|FG002|Overall Study|Subject Non-Compliance|0|||
129837291|NCT02689258|467369607|FG003|Overall Study|Subject Non-Compliance|0|||
129837292|NCT02689258|467369608|FG004|Overall Study|Subject Non-Compliance|0|||
129837293|NCT02689258|467369609|FG005|Overall Study|Subject Non-Compliance|0|||
129837294|NCT02689258|467369610|FG006|Overall Study|Subject Non-Compliance|0|||
129837295|NCT02689258|467369611|FG007|Overall Study|Subject Non-Compliance|0|||
129837296|NCT02689258|467369612|FG008|Overall Study|Subject Non-Compliance|0|||
129837297|NCT02689258|467369613|FG009|Overall Study|Subject Non-Compliance|0|||
129837298|NCT02689258|467369614|FG010|Overall Study|Subject Non-Compliance|0|||
129837299|NCT02689258|467369615|FG011|Overall Study|Subject Non-Compliance|0|||
129837300|NCT02689258|467369604|FG000|Overall Study|Subject Refusal to Continue|0|||
129837301|NCT02689258|467369605|FG001|Overall Study|Subject Refusal to Continue|1|||
129837302|NCT02689258|467369606|FG002|Overall Study|Subject Refusal to Continue|0|||
129837303|NCT02689258|467369607|FG003|Overall Study|Subject Refusal to Continue|0|||
129837304|NCT02689258|467369608|FG004|Overall Study|Subject Refusal to Continue|0|||
129837305|NCT02689258|467369609|FG005|Overall Study|Subject Refusal to Continue|0|||
129837306|NCT02689258|467369610|FG006|Overall Study|Subject Refusal to Continue|0|||
129837307|NCT02689258|467369611|FG007|Overall Study|Subject Refusal to Continue|0|||
129837308|NCT02689258|467369612|FG008|Overall Study|Subject Refusal to Continue|1|||
129837309|NCT02689258|467369613|FG009|Overall Study|Subject Refusal to Continue|0|||
129837310|NCT02689258|467369614|FG010|Overall Study|Subject Refusal to Continue|0|||
129837311|NCT02689258|467369615|FG011|Overall Study|Subject Refusal to Continue|1|||
129837312|NCT02689258|467369604|FG000|Overall Study|Other|0|||
129837313|NCT02689258|467369605|FG001|Overall Study|Other|2|||
129837314|NCT02689258|467369606|FG002|Overall Study|Other|0|||
129837315|NCT02689258|467369607|FG003|Overall Study|Other|0|||
129837316|NCT02689258|467369608|FG004|Overall Study|Other|1|||
129837317|NCT02689258|467369609|FG005|Overall Study|Other|0|||
129837318|NCT02689258|467369610|FG006|Overall Study|Other|0|||
129837319|NCT02689258|467369611|FG007|Overall Study|Other|0|||
129837320|NCT02689258|467369612|FG008|Overall Study|Other|1|||
129837321|NCT02689258|467369613|FG009|Overall Study|Other|0|||
129837322|NCT02689258|467369614|FG010|Overall Study|Other|0|||
129837323|NCT02689258|467369615|FG011|Overall Study|Other|0|||
129837324|NCT06049043|467369625|FG000|Overall Study|Lost to Follow-up|11|||
129837325|NCT06049043|467369626|FG001|Overall Study|Lost to Follow-up|9|||
129837326|NCT01354496|467369630|FG000|Period 1|Adverse Event|0|||
129837327|NCT01354496|467369631|FG001|Period 1|Adverse Event|0|||
129837328|NCT01354496|467369632|FG002|Period 1|Adverse Event|1|||
129837329|NCT01354496|467369633|FG003|Period 1|Adverse Event|0|||
129837330|NCT01354496|467369634|FG004|Period 1|Adverse Event|0|||
129837331|NCT01354496|467369635|FG005|Period 1|Adverse Event|0|||
129837332|NCT01354496|467369630|FG000|Period 1|Physician Decision|0|||
129837333|NCT01354496|467369631|FG001|Period 1|Physician Decision|0|||
129837334|NCT01354496|467369632|FG002|Period 1|Physician Decision|1|||
129837335|NCT01354496|467369633|FG003|Period 1|Physician Decision|0|||
129837336|NCT01354496|467369634|FG004|Period 1|Physician Decision|0|||
129837337|NCT01354496|467369635|FG005|Period 1|Physician Decision|0|||
129837338|NCT01354496|467369630|FG000|Period 2|Adverse Event|0|||
129837339|NCT01354496|467369631|FG001|Period 2|Adverse Event|0|||
129837340|NCT01354496|467369632|FG002|Period 2|Adverse Event|0|||
129837341|NCT01354496|467369633|FG003|Period 2|Adverse Event|1|||
129837342|NCT01354496|467369634|FG004|Period 2|Adverse Event|0|||
129837343|NCT01354496|467369635|FG005|Period 2|Adverse Event|0|||
129837344|NCT01354496|467369630|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837345|NCT01354496|467369631|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
129837346|NCT01354496|467369632|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837347|NCT01354496|467369633|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
129837348|NCT01354496|467369634|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837349|NCT01354496|467369635|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837350|NCT03216850|467369636|FG000|Overall Study|Pre-analytical error|6|||
129837351|NCT03190889|467369637|FG000|Overall Study|Lost to Follow-up|7|||
129837352|NCT03190889|467369638|FG001|Overall Study|Lost to Follow-up|7|||
129837353|NCT03190889|467369639|FG002|Overall Study|Lost to Follow-up|3|||
129898632|NCT01090024|467590019|FG012|Period 1|Withdrawal by Subject|0|||
129837354|NCT03190889|467369637|FG000|Overall Study|Withdrawal by Subject|1|||
129837355|NCT03190889|467369638|FG001|Overall Study|Withdrawal by Subject|1|||
129837356|NCT03190889|467369639|FG002|Overall Study|Withdrawal by Subject|2|||
129837357|NCT03190889|467369637|FG000|Overall Study|Did not complete protocol|4|||
129837358|NCT03190889|467369638|FG001|Overall Study|Did not complete protocol|9|||
129837359|NCT03190889|467369639|FG002|Overall Study|Did not complete protocol|0|||
129837360|NCT03190889|467369637|FG000|Overall Study|COVID-19|1|||
129837361|NCT03190889|467369638|FG001|Overall Study|COVID-19|0|||
129837362|NCT03190889|467369639|FG002|Overall Study|COVID-19|2|||
129837363|NCT01228747|467369640|FG000|Overall Study|Adverse Event|8|||
129837364|NCT01228747|467369641|FG001|Overall Study|Adverse Event|4|||
129837365|NCT01228747|467369640|FG000|Overall Study|Lack of Efficacy|40|||
129837366|NCT01228747|467369641|FG001|Overall Study|Lack of Efficacy|27|||
129837367|NCT01228747|467369640|FG000|Overall Study|Protocol Violation|6|||
129837368|NCT01228747|467369641|FG001|Overall Study|Protocol Violation|5|||
130114006|NCT00656019|468377463|FG001|Overall Study|Lost to Follow-up|1|||
130114007|NCT00656019|468377464|FG002|Overall Study|Lost to Follow-up|0|||
130114008|NCT00656019|468377465|FG003|Overall Study|Lost to Follow-up|0|||
130114009|NCT00096486|468377466|FG000|Overall Study|Withdrawal by Subject|0|||
130114010|NCT00096486|468377467|FG001|Overall Study|Withdrawal by Subject|0|||
130114011|NCT00096486|468377468|FG002|Overall Study|Withdrawal by Subject|1|||
130114012|NCT00096486|468377469|FG003|Overall Study|Withdrawal by Subject|1|||
130114013|NCT00096486|468377466|FG000|Overall Study|Not Treated|0|||
130114014|NCT00096486|468377467|FG001|Overall Study|Not Treated|0|||
130114015|NCT00096486|468377468|FG002|Overall Study|Not Treated|1|||
130114016|NCT00096486|468377469|FG003|Overall Study|Not Treated|1|||
130114017|NCT01360632|468377475|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
130114018|NCT01360632|468377476|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
130114019|NCT01360632|468377477|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
130114020|NCT01360632|468377478|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
130114021|NCT01360632|468377479|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
130114022|NCT01360632|468377475|FG000|Phase A (8 Weeks)|Adverse Event|60|||
129837369|NCT01228747|467369640|FG000|Overall Study|Lost to Follow-up|4|||
129837370|NCT01228747|467369641|FG001|Overall Study|Lost to Follow-up|3|||
129837371|NCT01228747|467369640|FG000|Overall Study|Withdrawal by Subject|5|||
129837372|NCT01228747|467369641|FG001|Overall Study|Withdrawal by Subject|1|||
129837373|NCT01228747|467369640|FG000|Overall Study|Other Reason|2|||
129837374|NCT01228747|467369641|FG001|Overall Study|Other Reason|5|||
129837375|NCT00500292|467369645|FG000|Overall Study|Adverse Event|3|||
129837376|NCT00500292|467369646|FG001|Overall Study|Adverse Event|6|||
129837377|NCT00500292|467369647|FG002|Overall Study|Adverse Event|4|||
129837378|NCT00500292|467369645|FG000|Overall Study|Condition under investigation worsened|21|||
129837379|NCT00500292|467369646|FG001|Overall Study|Condition under investigation worsened|23|||
129837380|NCT00500292|467369647|FG002|Overall Study|Condition under investigation worsened|19|||
129837381|NCT00500292|467369645|FG000|Overall Study|Withdrawal by Subject|0|||
129837382|NCT00500292|467369646|FG001|Overall Study|Withdrawal by Subject|1|||
129837383|NCT00500292|467369647|FG002|Overall Study|Withdrawal by Subject|0|||
129837384|NCT00500292|467369645|FG000|Overall Study|Other|1|||
129837385|NCT00500292|467369646|FG001|Overall Study|Other|1|||
129837386|NCT00500292|467369647|FG002|Overall Study|Other|4|||
129837387|NCT04982250|467369650|FG000|Overall Study|Lost to Follow-up|0|||
129837388|NCT04982250|467369651|FG001|Overall Study|Lost to Follow-up|26|||
129837389|NCT04982250|467369652|FG002|Overall Study|Lost to Follow-up|0|||
129837390|NCT04982250|467369653|FG003|Overall Study|Lost to Follow-up|0|||
129837391|NCT04982250|467369654|FG004|Overall Study|Lost to Follow-up|72|||
129837392|NCT04982250|467369655|FG005|Overall Study|Lost to Follow-up|69|||
129837393|NCT04982250|467369650|FG000|Overall Study|Not Eligible to Enroll|0|||
129837394|NCT04982250|467369651|FG001|Overall Study|Not Eligible to Enroll|0|||
129837395|NCT04982250|467369652|FG002|Overall Study|Not Eligible to Enroll|0|||
129837396|NCT04982250|467369653|FG003|Overall Study|Not Eligible to Enroll|0|||
129837397|NCT04982250|467369654|FG004|Overall Study|Not Eligible to Enroll|10|||
129837398|NCT04982250|467369655|FG005|Overall Study|Not Eligible to Enroll|7|||
129837399|NCT01148511|467369657|FG000|Exposed to Study Drug|Protocol Violation|2|||
129837400|NCT01148511|467369658|FG001|Exposed to Study Drug|Protocol Violation|0|||
129837401|NCT01148511|467369659|FG002|Exposed to Study Drug|Protocol Violation|0|||
129837402|NCT01148511|467369657|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
129837403|NCT01148511|467369658|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
129837404|NCT01148511|467369659|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
129837405|NCT01148511|467369657|FG000|Randomized|Adverse Event|0|||
129837406|NCT01148511|467369658|FG001|Randomized|Adverse Event|1|||
129837407|NCT01148511|467369659|FG002|Randomized|Adverse Event|0|||
129837408|NCT01148511|467369657|FG000|Randomized|Protocol Violation|0|||
129837409|NCT01148511|467369658|FG001|Randomized|Protocol Violation|2|||
129837410|NCT01148511|467369659|FG002|Randomized|Protocol Violation|1|||
129837411|NCT01148511|467369657|FG000|Randomized|Lost to Follow-up|0|||
129837412|NCT01148511|467369658|FG001|Randomized|Lost to Follow-up|1|||
129837413|NCT01148511|467369659|FG002|Randomized|Lost to Follow-up|1|||
129837414|NCT01148511|467369657|FG000|Randomized|Consent withdrawal|0|||
130114023|NCT01360632|468377476|FG001|Phase A (8 Weeks)|Adverse Event|0|||
129837415|NCT01148511|467369658|FG001|Randomized|Consent withdrawal|5|||
129837416|NCT01148511|467369659|FG002|Randomized|Consent withdrawal|3|||
129837417|NCT01148511|467369657|FG000|Randomized|Other|0|||
129837418|NCT01148511|467369658|FG001|Randomized|Other|1|||
129837419|NCT01148511|467369659|FG002|Randomized|Other|1|||
129837420|NCT04258605|467369661|FG000|Overall Study|Death|1|||
129837421|NCT04258605|467369662|FG001|Overall Study|Death|0|||
129837422|NCT04258605|467369661|FG000|Overall Study|Early study termination|21|||
129837423|NCT04258605|467369662|FG001|Overall Study|Early study termination|2|||
129837424|NCT00856908|467369679|FG000|Overall Study|Lost to Follow-up|1|||
130114024|NCT01360632|468377477|FG002|Phase A (8 Weeks)|Adverse Event|0|||
130114025|NCT01360632|468377478|FG003|Phase A (8 Weeks)|Adverse Event|0|||
130114026|NCT01360632|468377479|FG004|Phase A (8 Weeks)|Adverse Event|0|||
130114027|NCT01360632|468377475|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
129837425|NCT00856908|467369680|FG001|Overall Study|Lost to Follow-up|0|||
130114028|NCT01360632|468377476|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130062563|NCT01842607|468182193|FG000|Overall Study|Protocol Violation|8|||
130062564|NCT01842607|468182193|FG000|Overall Study|Protocol defined stopping criteria|2|||
130062565|NCT01842607|468182193|FG000|Overall Study|Lost to Follow-up|3|||
130062566|NCT01842607|468182193|FG000|Overall Study|Physician Decision|9|||
130062567|NCT01842607|468182193|FG000|Overall Study|Withdrawal by Subject|14|||
130062568|NCT02034474|468182194|FG000|Overall Study|Adverse Event|3|||
130062569|NCT02034474|468182195|FG001|Overall Study|Adverse Event|2|||
130062570|NCT02034474|468182194|FG000|Overall Study|Withdrawal by Subject|1|||
130062571|NCT02034474|468182195|FG001|Overall Study|Withdrawal by Subject|2|||
130062572|NCT03600714|468182196|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
130062573|NCT00675103|468182197|FG000|Overall Study|Lack of Efficacy|2|||
130062574|NCT00675103|468182197|FG000|Overall Study|Adverse Event|1|||
130062575|NCT01244191|468182200|FG000|Overall Study|Progressive disease|295|||
130062576|NCT01244191|468182201|FG001|Overall Study|Progressive disease|350|||
130062577|NCT01244191|468182200|FG000|Overall Study|Clinical disease progression|54|||
130062578|NCT01244191|468182201|FG001|Overall Study|Clinical disease progression|36|||
130062579|NCT01244191|468182200|FG000|Overall Study|Adverse Event|65|||
130062580|NCT01244191|468182201|FG001|Overall Study|Adverse Event|48|||
130062581|NCT01244191|468182200|FG000|Overall Study|Death|22|||
130062582|NCT01244191|468182201|FG001|Overall Study|Death|29|||
130062583|NCT01244191|468182200|FG000|Overall Study|Lost to Follow-up|0|||
130062584|NCT01244191|468182201|FG001|Overall Study|Lost to Follow-up|2|||
130062585|NCT01244191|468182200|FG000|Overall Study|Protocol Violation|1|||
130062586|NCT01244191|468182201|FG001|Overall Study|Protocol Violation|2|||
130062587|NCT01244191|468182200|FG000|Overall Study|Withdrawal by Subject|31|||
130062588|NCT01244191|468182201|FG001|Overall Study|Withdrawal by Subject|23|||
130062589|NCT01244191|468182200|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
130062590|NCT01244191|468182201|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
130062591|NCT02509494|468182209|FG000|Overall Study|Lost to Follow-up|8|||
130062592|NCT02509494|468182210|FG001|Overall Study|Lost to Follow-up|47|||
130062593|NCT02509494|468182211|FG002|Overall Study|Lost to Follow-up|19|||
130062594|NCT02509494|468182212|FG003|Overall Study|Lost to Follow-up|6|||
130062595|NCT02509494|468182213|FG004|Overall Study|Lost to Follow-up|3|||
130062596|NCT02509494|468182214|FG005|Overall Study|Lost to Follow-up|3|||
130062597|NCT02509494|468182215|FG006|Overall Study|Lost to Follow-up|1|||
130062598|NCT02509494|468182216|FG007|Overall Study|Lost to Follow-up|3|||
130062599|NCT02509494|468182217|FG008|Overall Study|Lost to Follow-up|1|||
130062600|NCT02509494|468182209|FG000|Overall Study|Physician Decision|2|||
130062601|NCT02509494|468182210|FG001|Overall Study|Physician Decision|1|||
130062602|NCT02509494|468182211|FG002|Overall Study|Physician Decision|0|||
130062603|NCT02509494|468182212|FG003|Overall Study|Physician Decision|0|||
130062604|NCT02509494|468182213|FG004|Overall Study|Physician Decision|0|||
130062605|NCT02509494|468182214|FG005|Overall Study|Physician Decision|0|||
130062606|NCT02509494|468182215|FG006|Overall Study|Physician Decision|0|||
130062607|NCT02509494|468182216|FG007|Overall Study|Physician Decision|0|||
130062608|NCT02509494|468182217|FG008|Overall Study|Physician Decision|0|||
130062609|NCT02509494|468182209|FG000|Overall Study|Withdrawal by Subject|4|||
130062610|NCT02509494|468182210|FG001|Overall Study|Withdrawal by Subject|17|||
130062611|NCT02509494|468182211|FG002|Overall Study|Withdrawal by Subject|7|||
130062612|NCT02509494|468182212|FG003|Overall Study|Withdrawal by Subject|5|||
130062613|NCT02509494|468182213|FG004|Overall Study|Withdrawal by Subject|0|||
130062614|NCT02509494|468182214|FG005|Overall Study|Withdrawal by Subject|6|||
130062615|NCT02509494|468182215|FG006|Overall Study|Withdrawal by Subject|1|||
130062616|NCT02509494|468182216|FG007|Overall Study|Withdrawal by Subject|2|||
130062617|NCT02509494|468182217|FG008|Overall Study|Withdrawal by Subject|1|||
130062618|NCT02509494|468182209|FG000|Overall Study|Death|0|||
130062619|NCT02509494|468182210|FG001|Overall Study|Death|1|||
130114029|NCT01360632|468377477|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129837426|NCT01712256|467369683|FG000|Overall Study|Lost to Follow-up|1|||
129837427|NCT02196324|467369686|FG000|Overall Study|Withdrawal by Subject|8|||
129837428|NCT02196324|467369687|FG001|Overall Study|Withdrawal by Subject|4|||
129837429|NCT02196324|467369686|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
129837430|NCT02196324|467369687|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
129837431|NCT02196324|467369686|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
129837432|NCT02196324|467369687|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
130062620|NCT02509494|468182211|FG002|Overall Study|Death|0|||
130062621|NCT02509494|468182212|FG003|Overall Study|Death|0|||
130062622|NCT02509494|468182213|FG004|Overall Study|Death|1|||
130062623|NCT02509494|468182214|FG005|Overall Study|Death|0|||
130062624|NCT02509494|468182215|FG006|Overall Study|Death|0|||
130062625|NCT02509494|468182216|FG007|Overall Study|Death|1|||
130062626|NCT02509494|468182217|FG008|Overall Study|Death|0|||
130062627|NCT02509494|468182209|FG000|Overall Study|Other|0|||
130062628|NCT02509494|468182210|FG001|Overall Study|Other|4|||
130062629|NCT02509494|468182211|FG002|Overall Study|Other|5|||
130062630|NCT02509494|468182212|FG003|Overall Study|Other|0|||
130114030|NCT01360632|468377478|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130062631|NCT02509494|468182213|FG004|Overall Study|Other|0|||
130062632|NCT02509494|468182214|FG005|Overall Study|Other|0|||
129837433|NCT02196324|467369686|FG000|Overall Study|Other|1|||
129837434|NCT02196324|467369687|FG001|Overall Study|Other|0|||
129837435|NCT04327986|467369688|FG000|Overall Study|Physician Decision|2|||
129837436|NCT04327986|467369689|FG001|Overall Study|Physician Decision|0|||
129837437|NCT04327986|467369690|FG002|Overall Study|Physician Decision|0|||
129837438|NCT04327986|467369688|FG000|Overall Study|Death|1|||
129837439|NCT04327986|467369689|FG001|Overall Study|Death|0|||
129837440|NCT04327986|467369690|FG002|Overall Study|Death|0|||
129837441|NCT00655564|467369691|FG000|Overall Study|Adverse Event|1|||
129837442|NCT00655564|467369691|FG000|Overall Study|Lost to Follow-up|1|||
129837443|NCT00655564|467369691|FG000|Overall Study|Desired Alternate Therapy|1|||
129837444|NCT00560950|467369693|FG000|Overall Study|Lost to Follow-up|1|||
129837445|NCT00560950|467369694|FG001|Overall Study|Lost to Follow-up|0|||
129837446|NCT02917031|467369695|FG000|Overall Study|Reason not specified|7|||
129837447|NCT02917031|467369696|FG001|Overall Study|Reason not specified|5|||
129837448|NCT02917031|467369697|FG002|Overall Study|Reason not specified|6|||
129837449|NCT02917031|467369695|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
129837450|NCT02917031|467369696|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
129837451|NCT02917031|467369697|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
129837452|NCT02917031|467369695|FG000|Overall Study|Withdrawal by Subject|3|||
129837453|NCT02917031|467369696|FG001|Overall Study|Withdrawal by Subject|3|||
129837454|NCT02917031|467369697|FG002|Overall Study|Withdrawal by Subject|0|||
129837455|NCT02917031|467369695|FG000|Overall Study|Physician Decision|1|||
129837456|NCT02917031|467369696|FG001|Overall Study|Physician Decision|0|||
129837457|NCT02917031|467369697|FG002|Overall Study|Physician Decision|0|||
129837458|NCT02917031|467369695|FG000|Overall Study|Adverse Event|4|||
129837459|NCT02917031|467369696|FG001|Overall Study|Adverse Event|1|||
129837460|NCT02917031|467369697|FG002|Overall Study|Adverse Event|5|||
129837461|NCT02917031|467369695|FG000|Overall Study|Death|2|||
129837462|NCT02917031|467369696|FG001|Overall Study|Death|3|||
129837463|NCT02917031|467369697|FG002|Overall Study|Death|4|||
129837464|NCT02181556|467371601|FG000|Overall Study|Withdrawal by Subject|1|||
129837465|NCT01940120|467371602|FG000|Overall Study|Death|40|||
129837466|NCT01940120|467371602|FG000|Overall Study|Withdrawal by Subject|8|||
129837467|NCT01572038|467371604|FG000|Overall Study|Death|648|||
129837468|NCT01572038|467371604|FG000|Overall Study|Withdrawal by Subject|204|||
129837469|NCT01572038|467371604|FG000|Overall Study|Lost to Follow-up|81|||
129837470|NCT01572038|467371604|FG000|Overall Study|Physician Decision|20|||
129837471|NCT01572038|467371604|FG000|Overall Study|Patient Decision|14|||
129837472|NCT01572038|467371604|FG000|Overall Study|Progressive Disease|8|||
129837473|NCT01572038|467371604|FG000|Overall Study|Site Closed Before Completing Form|6|||
129837474|NCT01572038|467371604|FG000|Overall Study|Enrolled into Another Trial|3|||
129837475|NCT01572038|467371604|FG000|Overall Study|Participated in Another Trial|3|||
129837476|NCT01572038|467371604|FG000|Overall Study|Termination by Sponsor|2|||
129837477|NCT01572038|467371604|FG000|Overall Study|Patient Deterioration|1|||
129837478|NCT01572038|467371604|FG000|Overall Study|Sponsor Decision|1|||
129837479|NCT01888497|467371605|FG000|Washout Period 1|Withdrawal by Subject|0|||
129837480|NCT01888497|467371606|FG001|Washout Period 1|Withdrawal by Subject|0|||
129837481|NCT01888497|467371607|FG002|Washout Period 1|Withdrawal by Subject|1|||
129837482|NCT01888497|467371608|FG003|Washout Period 1|Withdrawal by Subject|1|||
129837483|NCT01888497|467371605|FG000|Washout Period 2|Adverse Event|0|||
129837484|NCT01888497|467371606|FG001|Washout Period 2|Adverse Event|0|||
129837485|NCT01888497|467371607|FG002|Washout Period 2|Adverse Event|0|||
129837486|NCT01888497|467371608|FG003|Washout Period 2|Adverse Event|1|||
129837487|NCT01888497|467371605|FG000|Washout Period 2|Withdrawal by Subject|0|||
129837488|NCT01888497|467371606|FG001|Washout Period 2|Withdrawal by Subject|0|||
129837489|NCT01888497|467371607|FG002|Washout Period 2|Withdrawal by Subject|0|||
129837490|NCT01888497|467371608|FG003|Washout Period 2|Withdrawal by Subject|1|||
129837491|NCT04152447|467371609|FG000|Overall Study|Lost to Follow-up|1|||
129837492|NCT04152447|467371610|FG001|Overall Study|Lost to Follow-up|0|||
129837493|NCT04152447|467371609|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
129837494|NCT04152447|467371610|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
129837495|NCT04152447|467371609|FG000|Overall Study|Withdrawal by Subject|0|||
129837496|NCT04152447|467371610|FG001|Overall Study|Withdrawal by Subject|1|||
129837497|NCT04152447|467371609|FG000|Overall Study|Found ineligible after enrolling|1|||
129837498|NCT04152447|467371610|FG001|Overall Study|Found ineligible after enrolling|1|||
129837499|NCT04152447|467371609|FG000|Overall Study|Did not receive VR headset in time.|0|||
129837500|NCT04152447|467371610|FG001|Overall Study|Did not receive VR headset in time.|2|||
129837501|NCT03034954|467371611|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
129837502|NCT03034954|467371612|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
129837503|NCT04200248|467371617|FG000|Overall Study|Personal reasons|0|||
129837504|NCT04200248|467371618|FG001|Overall Study|Personal reasons|0|||
129837505|NCT04200248|467371619|FG002|Overall Study|Personal reasons|1|||
129837506|NCT04200248|467371617|FG000|Overall Study|Discontinued prior to treatment|3|||
129837507|NCT04200248|467371618|FG001|Overall Study|Discontinued prior to treatment|3|||
129837508|NCT04200248|467371619|FG002|Overall Study|Discontinued prior to treatment|2|||
129898633|NCT01090024|467590020|FG013|Period 1|Withdrawal by Subject|0|||
130114031|NCT01360632|468377479|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
130114032|NCT01360632|468377475|FG000|Phase A (8 Weeks)|Physician Decision|10|||
130114033|NCT01360632|468377476|FG001|Phase A (8 Weeks)|Physician Decision|0|||
130114034|NCT01360632|468377477|FG002|Phase A (8 Weeks)|Physician Decision|0|||
130114035|NCT01360632|468377478|FG003|Phase A (8 Weeks)|Physician Decision|0|||
130114036|NCT01360632|468377479|FG004|Phase A (8 Weeks)|Physician Decision|0|||
129837509|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
129837510|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
129837511|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
129837512|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
129837513|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
129837514|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
129837515|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
129837516|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
129837517|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
129837518|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
129837519|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
129837520|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
129837521|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
129837522|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
129837523|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
129837524|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
129837525|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
129837526|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
129837527|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
129837528|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
129837529|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
129837530|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
129837531|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
129837532|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
129837533|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
129837534|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
129837535|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
129837536|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
129837537|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
129837538|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
129837539|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
129837540|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
129837541|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
129837542|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
129837543|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
129837544|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
129837545|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
129837546|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
129837547|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
129837548|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
129837549|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
129837550|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
129837551|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
129837552|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
129837553|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
129837554|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
129837555|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
129837556|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
129837557|NCT04171414|467371626|FG000|Overall Study|Death|1|||
129837558|NCT04171414|467371626|FG000|Overall Study|Withdrawal by Subject|1|||
129837559|NCT01714310|467371627|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
129837560|NCT01714310|467371628|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
130114037|NCT01360632|468377475|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
130114038|NCT01360632|468377476|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130114039|NCT01360632|468377477|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130114040|NCT01360632|468377478|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130114041|NCT01360632|468377479|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
130114042|NCT01360632|468377475|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
129898634|NCT01090024|467590021|FG014|Period 1|Withdrawal by Subject|0|||
129837561|NCT01714310|467371629|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
129837562|NCT01714310|467371627|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
129837563|NCT01714310|467371628|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
129837564|NCT01714310|467371629|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
129837565|NCT01714310|467371627|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
129837566|NCT01714310|467371628|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
129837567|NCT01714310|467371629|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
129837568|NCT01714310|467371627|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
129837569|NCT01714310|467371628|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
129837570|NCT01714310|467371629|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
129837571|NCT02586493|467371634|FG000|Overall Study|Adverse Event|4|||
129837572|NCT02586493|467371634|FG000|Overall Study|Protocol Violation|6|||
129837573|NCT02586493|467371634|FG000|Overall Study|Lost to Follow-up|1|||
129837574|NCT02586493|467371634|FG000|Overall Study|Withdrawal by Subject|1|||
129837575|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
129837576|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
129837577|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
129837578|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
129837579|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
129837580|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
129898635|NCT01090024|467590022|FG015|Period 1|Withdrawal by Subject|0|||
129898636|NCT01090024|467590023|FG016|Period 1|Withdrawal by Subject|0|||
129898637|NCT01090024|467590024|FG017|Period 1|Withdrawal by Subject|0|||
129898638|NCT01090024|467590007|FG000|Period 1|Lost to Follow-up|0|||
129898639|NCT01090024|467590008|FG001|Period 1|Lost to Follow-up|1|||
129898640|NCT01090024|467590009|FG002|Period 1|Lost to Follow-up|0|||
129898641|NCT01090024|467590010|FG003|Period 1|Lost to Follow-up|0|||
129898642|NCT01090024|467590011|FG004|Period 1|Lost to Follow-up|0|||
129898643|NCT01090024|467590012|FG005|Period 1|Lost to Follow-up|0|||
129898644|NCT01090024|467590013|FG006|Period 1|Lost to Follow-up|0|||
129898645|NCT01090024|467590014|FG007|Period 1|Lost to Follow-up|0|||
129898646|NCT01090024|467590015|FG008|Period 1|Lost to Follow-up|0|||
129898647|NCT01090024|467590016|FG009|Period 1|Lost to Follow-up|0|||
129898648|NCT01090024|467590017|FG010|Period 1|Lost to Follow-up|0|||
129898649|NCT01090024|467590018|FG011|Period 1|Lost to Follow-up|0|||
129898650|NCT01090024|467590019|FG012|Period 1|Lost to Follow-up|0|||
129898651|NCT01090024|467590020|FG013|Period 1|Lost to Follow-up|0|||
129898652|NCT01090024|467590021|FG014|Period 1|Lost to Follow-up|0|||
129898653|NCT01090024|467590022|FG015|Period 1|Lost to Follow-up|0|||
129898654|NCT01090024|467590023|FG016|Period 1|Lost to Follow-up|0|||
129898655|NCT01090024|467590024|FG017|Period 1|Lost to Follow-up|0|||
129898656|NCT01090024|467590007|FG000|Period 2|Lost to Follow-up|0|||
129898657|NCT01090024|467590008|FG001|Period 2|Lost to Follow-up|0|||
129898658|NCT01090024|467590009|FG002|Period 2|Lost to Follow-up|0|||
129898659|NCT01090024|467590010|FG003|Period 2|Lost to Follow-up|1|||
129898660|NCT01090024|467590011|FG004|Period 2|Lost to Follow-up|0|||
129898661|NCT01090024|467590012|FG005|Period 2|Lost to Follow-up|0|||
129898662|NCT01090024|467590013|FG006|Period 2|Lost to Follow-up|0|||
129898663|NCT01090024|467590014|FG007|Period 2|Lost to Follow-up|0|||
129898664|NCT01090024|467590015|FG008|Period 2|Lost to Follow-up|0|||
129898665|NCT01090024|467590016|FG009|Period 2|Lost to Follow-up|0|||
129898666|NCT01090024|467590017|FG010|Period 2|Lost to Follow-up|0|||
129898667|NCT01090024|467590018|FG011|Period 2|Lost to Follow-up|0|||
129898668|NCT01090024|467590019|FG012|Period 2|Lost to Follow-up|0|||
129898669|NCT01090024|467590020|FG013|Period 2|Lost to Follow-up|0|||
129898670|NCT01090024|467590021|FG014|Period 2|Lost to Follow-up|0|||
129898671|NCT01090024|467590022|FG015|Period 2|Lost to Follow-up|0|||
129898672|NCT01090024|467590023|FG016|Period 2|Lost to Follow-up|0|||
129898673|NCT01090024|467590024|FG017|Period 2|Lost to Follow-up|0|||
129898674|NCT01090024|467590007|FG000|Period 2|Adverse Event|1|||
129898675|NCT01090024|467590008|FG001|Period 2|Adverse Event|0|||
129898676|NCT01090024|467590009|FG002|Period 2|Adverse Event|0|||
129898677|NCT01090024|467590010|FG003|Period 2|Adverse Event|0|||
129898678|NCT01090024|467590011|FG004|Period 2|Adverse Event|0|||
129898679|NCT01090024|467590012|FG005|Period 2|Adverse Event|0|||
130062633|NCT02509494|468182215|FG006|Overall Study|Other|0|||
130062634|NCT02509494|468182216|FG007|Overall Study|Other|0|||
129898680|NCT01090024|467590013|FG006|Period 2|Adverse Event|0|||
129898681|NCT01090024|467590014|FG007|Period 2|Adverse Event|0|||
130062635|NCT02509494|468182217|FG008|Overall Study|Other|0|||
130062636|NCT02509494|468182209|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129898682|NCT01090024|467590015|FG008|Period 2|Adverse Event|0|||
129898683|NCT01090024|467590016|FG009|Period 2|Adverse Event|0|||
129898684|NCT01090024|467590017|FG010|Period 2|Adverse Event|0|||
129898685|NCT01090024|467590018|FG011|Period 2|Adverse Event|0|||
129898686|NCT01090024|467590019|FG012|Period 2|Adverse Event|0|||
129898687|NCT01090024|467590020|FG013|Period 2|Adverse Event|0|||
129898688|NCT01090024|467590021|FG014|Period 2|Adverse Event|0|||
130114043|NCT01360632|468377476|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
130114044|NCT01360632|468377477|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
130114045|NCT01360632|468377478|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
130114046|NCT01360632|468377479|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
130114047|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
130114048|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
130114049|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
130114050|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
130114051|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
130114052|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Adverse Event|0|||
130114053|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Adverse Event|3|||
130114054|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Adverse Event|9|||
130114055|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Adverse Event|3|||
130114056|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Adverse Event|0|||
130114057|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130114058|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130114059|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
130114060|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
130114061|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
130114062|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Physician Decision|0|||
130114063|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Physician Decision|0|||
130114064|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Physician Decision|0|||
130114065|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Physician Decision|1|||
130114066|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Physician Decision|0|||
129837581|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
129837582|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
129837583|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
129837584|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
129837585|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
129837586|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
129837587|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
129837588|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
129837589|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
129837590|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Death|5|||
129837591|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Death|0|||
129837592|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Death|2|||
129837593|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Death|0|||
129837594|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Death|4|||
129837595|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
129837596|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
129837597|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
129837598|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
129837599|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
129837600|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
129837601|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
129837602|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
129837603|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
129837604|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
129837605|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
129837606|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
129837607|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
129837608|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
129837609|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
129837610|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Other|15|||
129837611|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Other|0|||
129837612|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Other|10|||
129837613|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Other|0|||
129837614|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Other|6|||
129837615|NCT01604343|467371638|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
129837616|NCT01604343|467371639|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
129837617|NCT01604343|467371640|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
129837618|NCT01604343|467371641|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
129837619|NCT01604343|467371642|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
129837620|NCT01604343|467371638|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
129837621|NCT01604343|467371639|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
129837622|NCT01604343|467371640|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
129837623|NCT01604343|467371641|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
130114067|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130114068|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
130114069|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
130114070|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
130114071|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
130114072|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
130114073|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
130114074|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
130114075|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
130114076|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
130114077|NCT01360632|468377475|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
130114078|NCT01360632|468377476|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
130114079|NCT01360632|468377477|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
130114080|NCT01360632|468377478|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
130114081|NCT01360632|468377479|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
130114082|NCT01360632|468377475|FG000|Phase A+|Lost to Follow-up|0|||
130114083|NCT01360632|468377476|FG001|Phase A+|Lost to Follow-up|0|||
130114084|NCT01360632|468377477|FG002|Phase A+|Lost to Follow-up|0|||
130114085|NCT01360632|468377478|FG003|Phase A+|Lost to Follow-up|0|||
130114086|NCT01360632|468377479|FG004|Phase A+|Lost to Follow-up|2|||
130114087|NCT01360632|468377475|FG000|Phase A+|Adverse Event|0|||
130114088|NCT01360632|468377476|FG001|Phase A+|Adverse Event|0|||
130114089|NCT01360632|468377477|FG002|Phase A+|Adverse Event|0|||
130114090|NCT01360632|468377478|FG003|Phase A+|Adverse Event|0|||
130114091|NCT01360632|468377479|FG004|Phase A+|Adverse Event|2|||
129898689|NCT01090024|467590022|FG015|Period 2|Adverse Event|0|||
130062637|NCT02509494|468182210|FG001|Overall Study|Non-Compliance With Study Drug|11|||
130062638|NCT02509494|468182211|FG002|Overall Study|Non-Compliance With Study Drug|7|||
130062639|NCT02509494|468182212|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130062640|NCT02509494|468182213|FG004|Overall Study|Non-Compliance With Study Drug|1|||
130062641|NCT02509494|468182214|FG005|Overall Study|Non-Compliance With Study Drug|2|||
130062642|NCT02509494|468182215|FG006|Overall Study|Non-Compliance With Study Drug|1|||
130062643|NCT02509494|468182216|FG007|Overall Study|Non-Compliance With Study Drug|1|||
130062644|NCT02509494|468182217|FG008|Overall Study|Non-Compliance With Study Drug|0|||
130062645|NCT01511107|468182218|FG000|Overall Study|Ineligible|3|||
130062646|NCT01511107|468182219|FG001|Overall Study|Ineligible|2|||
130062647|NCT01511107|468182218|FG000|Overall Study|Lost to Follow-up|10|||
130062648|NCT01511107|468182219|FG001|Overall Study|Lost to Follow-up|19|||
130062649|NCT01511107|468182218|FG000|Overall Study|Withdrawal by Subject|9|||
130062650|NCT01511107|468182219|FG001|Overall Study|Withdrawal by Subject|20|||
130062651|NCT00369967|468184127|FG000|Overall Study|Lost to Follow-up|23|||
130062652|NCT00369967|468184128|FG001|Overall Study|Lost to Follow-up|12|||
130062653|NCT01830816|468184136|FG000|Overall Study|Progressive Disease|12|||
130062654|NCT01830816|468184137|FG001|Overall Study|Progressive Disease|7|||
130062655|NCT01830816|468184138|FG002|Overall Study|Progressive Disease|7|||
130062656|NCT01830816|468184136|FG000|Overall Study|Adverse Event|3|||
130062657|NCT01830816|468184137|FG001|Overall Study|Adverse Event|4|||
130062658|NCT01830816|468184138|FG002|Overall Study|Adverse Event|0|||
130062659|NCT01830816|468184136|FG000|Overall Study|Study Terminated by Sponsor|1|||
130062660|NCT01830816|468184137|FG001|Overall Study|Study Terminated by Sponsor|1|||
130062661|NCT01830816|468184138|FG002|Overall Study|Study Terminated by Sponsor|0|||
130062662|NCT01830816|468184136|FG000|Overall Study|Withdrawal by Subject|1|||
130062663|NCT01830816|468184137|FG001|Overall Study|Withdrawal by Subject|1|||
130062664|NCT01830816|468184138|FG002|Overall Study|Withdrawal by Subject|0|||
130062665|NCT01830816|468184136|FG000|Overall Study|Lost to Follow-up|0|||
130062666|NCT01830816|468184137|FG001|Overall Study|Lost to Follow-up|1|||
130114092|NCT01360632|468377475|FG000|Phase A+|Met Withdrawal Criteria|0|||
130114093|NCT01360632|468377476|FG001|Phase A+|Met Withdrawal Criteria|0|||
130114094|NCT01360632|468377477|FG002|Phase A+|Met Withdrawal Criteria|0|||
130114095|NCT01360632|468377478|FG003|Phase A+|Met Withdrawal Criteria|0|||
130114096|NCT01360632|468377479|FG004|Phase A+|Met Withdrawal Criteria|7|||
130114097|NCT01360632|468377475|FG000|Phase A+|Physician Decision|0|||
129898690|NCT01090024|467590023|FG016|Period 2|Adverse Event|0|||
130062667|NCT01830816|468184138|FG002|Overall Study|Lost to Follow-up|0|||
130062668|NCT01830816|468184136|FG000|Overall Study|Symptomatic Deterioration|1|||
130062669|NCT01830816|468184137|FG001|Overall Study|Symptomatic Deterioration|0|||
130062670|NCT01830816|468184138|FG002|Overall Study|Symptomatic Deterioration|0|||
130062671|NCT01830816|468184136|FG000|Overall Study|Reason not Specified|2|||
130062672|NCT01830816|468184137|FG001|Overall Study|Reason not Specified|0|||
130062673|NCT01830816|468184138|FG002|Overall Study|Reason not Specified|0|||
130062674|NCT04019795|468184142|FG000|Overall Study|Withdrawal by Subject|1|||
130062675|NCT04019795|468184143|FG001|Overall Study|Withdrawal by Subject|2|||
130062676|NCT04019795|468184144|FG002|Overall Study|Withdrawal by Subject|2|||
130062677|NCT04019795|468184145|FG003|Overall Study|Withdrawal by Subject|1|||
130114098|NCT01360632|468377476|FG001|Phase A+|Physician Decision|0|||
130062678|NCT04019795|468184142|FG000|Overall Study|Lost to Follow-up|0|||
130062679|NCT04019795|468184143|FG001|Overall Study|Lost to Follow-up|1|||
130062680|NCT04019795|468184144|FG002|Overall Study|Lost to Follow-up|1|||
130114099|NCT01360632|468377477|FG002|Phase A+|Physician Decision|0|||
130114100|NCT01360632|468377478|FG003|Phase A+|Physician Decision|0|||
130114101|NCT01360632|468377479|FG004|Phase A+|Physician Decision|3|||
129898691|NCT01090024|467590024|FG017|Period 2|Adverse Event|0|||
129898692|NCT01090024|467590007|FG000|Period 3|Withdrawal by Subject|0|||
129898693|NCT01090024|467590008|FG001|Period 3|Withdrawal by Subject|0|||
129898694|NCT01090024|467590009|FG002|Period 3|Withdrawal by Subject|0|||
129898695|NCT01090024|467590010|FG003|Period 3|Withdrawal by Subject|0|||
129898696|NCT01090024|467590011|FG004|Period 3|Withdrawal by Subject|0|||
129898697|NCT01090024|467590012|FG005|Period 3|Withdrawal by Subject|0|||
129898698|NCT01090024|467590013|FG006|Period 3|Withdrawal by Subject|0|||
129898699|NCT01090024|467590014|FG007|Period 3|Withdrawal by Subject|0|||
129898700|NCT01090024|467590015|FG008|Period 3|Withdrawal by Subject|0|||
129898701|NCT01090024|467590016|FG009|Period 3|Withdrawal by Subject|0|||
129898702|NCT01090024|467590017|FG010|Period 3|Withdrawal by Subject|0|||
129898703|NCT01090024|467590018|FG011|Period 3|Withdrawal by Subject|0|||
129898704|NCT01090024|467590019|FG012|Period 3|Withdrawal by Subject|0|||
129898705|NCT01090024|467590020|FG013|Period 3|Withdrawal by Subject|0|||
129898706|NCT01090024|467590021|FG014|Period 3|Withdrawal by Subject|0|||
129898707|NCT01090024|467590022|FG015|Period 3|Withdrawal by Subject|1|||
129898708|NCT01090024|467590023|FG016|Period 3|Withdrawal by Subject|0|||
129898709|NCT01090024|467590024|FG017|Period 3|Withdrawal by Subject|0|||
129898710|NCT01090024|467590007|FG000|Period 3|Protocol Violation|0|||
129898711|NCT01090024|467590008|FG001|Period 3|Protocol Violation|0|||
129898712|NCT01090024|467590009|FG002|Period 3|Protocol Violation|0|||
129898713|NCT01090024|467590010|FG003|Period 3|Protocol Violation|0|||
129898714|NCT01090024|467590011|FG004|Period 3|Protocol Violation|0|||
129898715|NCT01090024|467590012|FG005|Period 3|Protocol Violation|0|||
129898716|NCT01090024|467590013|FG006|Period 3|Protocol Violation|0|||
129898717|NCT01090024|467590014|FG007|Period 3|Protocol Violation|0|||
129898718|NCT01090024|467590015|FG008|Period 3|Protocol Violation|1|||
129898719|NCT01090024|467590016|FG009|Period 3|Protocol Violation|0|||
129898720|NCT01090024|467590017|FG010|Period 3|Protocol Violation|0|||
129898721|NCT01090024|467590018|FG011|Period 3|Protocol Violation|0|||
129898722|NCT01090024|467590019|FG012|Period 3|Protocol Violation|0|||
129898723|NCT01090024|467590020|FG013|Period 3|Protocol Violation|0|||
129898724|NCT01090024|467590021|FG014|Period 3|Protocol Violation|0|||
129898725|NCT01090024|467590022|FG015|Period 3|Protocol Violation|0|||
129898726|NCT01090024|467590023|FG016|Period 3|Protocol Violation|0|||
129898727|NCT01090024|467590024|FG017|Period 3|Protocol Violation|0|||
129898728|NCT01090024|467590007|FG000|Period 3|Adverse Event|0|||
129898729|NCT01090024|467590008|FG001|Period 3|Adverse Event|0|||
129898730|NCT01090024|467590009|FG002|Period 3|Adverse Event|0|||
129837624|NCT01604343|467371642|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
129837625|NCT01604343|467371638|FG000|Week 52 to Week 104|Adverse Event|0|||
129837626|NCT01604343|467371639|FG001|Week 52 to Week 104|Adverse Event|12|||
129837627|NCT01604343|467371640|FG002|Week 52 to Week 104|Adverse Event|26|||
129837628|NCT01604343|467371641|FG003|Week 52 to Week 104|Adverse Event|21|||
129837629|NCT01604343|467371642|FG004|Week 52 to Week 104|Adverse Event|27|||
129837630|NCT01604343|467371638|FG000|Week 52 to Week 104|Death|0|||
129837631|NCT01604343|467371639|FG001|Week 52 to Week 104|Death|4|||
129837632|NCT01604343|467371640|FG002|Week 52 to Week 104|Death|2|||
129837633|NCT01604343|467371641|FG003|Week 52 to Week 104|Death|5|||
129837634|NCT01604343|467371642|FG004|Week 52 to Week 104|Death|0|||
129837635|NCT01604343|467371638|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
129837636|NCT01604343|467371639|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
129837637|NCT01604343|467371640|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
129837638|NCT01604343|467371641|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
129837639|NCT01604343|467371642|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
129837640|NCT01604343|467371638|FG000|Week 52 to Week 104|Physician Decision|0|||
129837641|NCT01604343|467371639|FG001|Week 52 to Week 104|Physician Decision|1|||
129898731|NCT01090024|467590010|FG003|Period 3|Adverse Event|0|||
129898732|NCT01090024|467590011|FG004|Period 3|Adverse Event|0|||
129898733|NCT01090024|467590012|FG005|Period 3|Adverse Event|1|||
129898734|NCT01090024|467590013|FG006|Period 3|Adverse Event|0|||
129898735|NCT01090024|467590014|FG007|Period 3|Adverse Event|0|||
129898736|NCT01090024|467590015|FG008|Period 3|Adverse Event|0|||
129898737|NCT01090024|467590016|FG009|Period 3|Adverse Event|0|||
129898738|NCT01090024|467590017|FG010|Period 3|Adverse Event|0|||
129837642|NCT01604343|467371640|FG002|Week 52 to Week 104|Physician Decision|0|||
129898739|NCT01090024|467590018|FG011|Period 3|Adverse Event|0|||
129898740|NCT01090024|467590019|FG012|Period 3|Adverse Event|0|||
129898741|NCT01090024|467590020|FG013|Period 3|Adverse Event|0|||
129898742|NCT01090024|467590021|FG014|Period 3|Adverse Event|0|||
129837643|NCT01604343|467371641|FG003|Week 52 to Week 104|Physician Decision|0|||
129837644|NCT01604343|467371642|FG004|Week 52 to Week 104|Physician Decision|2|||
129837645|NCT01604343|467371638|FG000|Week 52 to Week 104|Pregnancy|0|||
129837646|NCT01604343|467371639|FG001|Week 52 to Week 104|Pregnancy|0|||
129898743|NCT01090024|467590022|FG015|Period 3|Adverse Event|0|||
129898744|NCT01090024|467590023|FG016|Period 3|Adverse Event|0|||
129898745|NCT01090024|467590024|FG017|Period 3|Adverse Event|0|||
129898746|NCT00567879|467590029|FG000|Overall Study|Adverse Event|2|||
129898747|NCT00567879|467590030|FG001|Overall Study|Adverse Event|0|||
129898748|NCT00567879|467590031|FG002|Overall Study|Adverse Event|1|||
129898749|NCT00567879|467590032|FG003|Overall Study|Adverse Event|0|||
129898750|NCT00567879|467590033|FG004|Overall Study|Adverse Event|1|||
129898751|NCT00567879|467590034|FG005|Overall Study|Adverse Event|0|||
129898752|NCT00567879|467590029|FG000|Overall Study|Abnormal test procedure(s)|0|||
129898753|NCT00567879|467590030|FG001|Overall Study|Abnormal test procedure(s)|0|||
129898754|NCT00567879|467590031|FG002|Overall Study|Abnormal test procedure(s)|1|||
129898755|NCT00567879|467590032|FG003|Overall Study|Abnormal test procedure(s)|0|||
129837647|NCT01604343|467371640|FG002|Week 52 to Week 104|Pregnancy|1|||
129837648|NCT01604343|467371641|FG003|Week 52 to Week 104|Pregnancy|2|||
129837649|NCT01604343|467371642|FG004|Week 52 to Week 104|Pregnancy|1|||
129837650|NCT01604343|467371638|FG000|Week 52 to Week 104|Other|0|||
129837651|NCT01604343|467371639|FG001|Week 52 to Week 104|Other|11|||
129837652|NCT01604343|467371640|FG002|Week 52 to Week 104|Other|11|||
129837653|NCT01604343|467371641|FG003|Week 52 to Week 104|Other|6|||
129837654|NCT01604343|467371642|FG004|Week 52 to Week 104|Other|3|||
129837655|NCT01604343|467371638|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
129837656|NCT01604343|467371639|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
129837657|NCT01604343|467371640|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
129837658|NCT01604343|467371641|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
129837659|NCT01604343|467371642|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
129837660|NCT01604343|467371638|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
129837661|NCT01604343|467371639|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
129837662|NCT01604343|467371640|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
129837663|NCT01604343|467371641|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
129837664|NCT01604343|467371642|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
129837665|NCT01604343|467371638|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
129837666|NCT01604343|467371639|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
129837667|NCT01604343|467371640|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
129837668|NCT01604343|467371641|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
129837669|NCT01604343|467371642|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
129837670|NCT02346136|467371659|FG000|Overall Study|Withdrawal by Subject|7|||
129837671|NCT02346136|467371660|FG001|Overall Study|Withdrawal by Subject|5|||
129837672|NCT02346136|467371659|FG000|Overall Study|Death|1|||
129837673|NCT02346136|467371660|FG001|Overall Study|Death|0|||
129837674|NCT02346136|467371659|FG000|Overall Study|Study termination|14|||
129837675|NCT02346136|467371660|FG001|Overall Study|Study termination|18|||
129837676|NCT00453999|467371664|FG000|Overall Study|Adverse Event|1|||
129837677|NCT00453999|467371665|FG001|Overall Study|Adverse Event|2|||
129837678|NCT00453999|467371666|FG002|Overall Study|Adverse Event|1|||
129837679|NCT00453999|467371664|FG000|Overall Study|Lost to Follow-up|0|||
129837680|NCT00453999|467371665|FG001|Overall Study|Lost to Follow-up|1|||
129837681|NCT00453999|467371666|FG002|Overall Study|Lost to Follow-up|1|||
129837682|NCT00453999|467371664|FG000|Overall Study|Withdrawal by Subject|2|||
129837683|NCT00453999|467371665|FG001|Overall Study|Withdrawal by Subject|1|||
129837684|NCT00453999|467371666|FG002|Overall Study|Withdrawal by Subject|1|||
129837685|NCT00453999|467371664|FG000|Overall Study|Subject Request|2|||
129837686|NCT00453999|467371665|FG001|Overall Study|Subject Request|1|||
129837687|NCT00453999|467371666|FG002|Overall Study|Subject Request|0|||
129837688|NCT04960228|467371680|FG000|Overall Study|Withdrawal by Subject|216|||
129837689|NCT04960228|467371681|FG001|Overall Study|Withdrawal by Subject|35|||
129837690|NCT04960228|467371680|FG000|Overall Study|Failed attention check|69|||
129837691|NCT04960228|467371681|FG001|Overall Study|Failed attention check|148|||
129837692|NCT04960228|467371680|FG000|Overall Study|Flagged for response quality by Dynata|3|||
129837693|NCT04960228|467371681|FG001|Overall Study|Flagged for response quality by Dynata|3|||
129837694|NCT02129803|467371685|FG000|Overall Study|Protocol Violation|4|||
129837695|NCT02129803|467371686|FG001|Overall Study|Protocol Violation|0|||
129837696|NCT02129803|467371685|FG000|Overall Study|Physician Decision|0|||
129837697|NCT02129803|467371686|FG001|Overall Study|Physician Decision|1|||
129837698|NCT02129803|467371685|FG000|Overall Study|Difficulty sleeping|1|||
129837699|NCT02129803|467371686|FG001|Overall Study|Difficulty sleeping|0|||
129837700|NCT02129803|467371685|FG000|Overall Study|Morning headache|0|||
129837701|NCT02129803|467371686|FG001|Overall Study|Morning headache|1|||
130062681|NCT04019795|468184145|FG003|Overall Study|Lost to Follow-up|2|||
130062682|NCT04019795|468184142|FG000|Overall Study|Treatment non-compliance|3|||
130062683|NCT04019795|468184143|FG001|Overall Study|Treatment non-compliance|1|||
130062684|NCT04019795|468184144|FG002|Overall Study|Treatment non-compliance|2|||
130062685|NCT04019795|468184145|FG003|Overall Study|Treatment non-compliance|0|||
130062686|NCT04019795|468184142|FG000|Overall Study|Physician Decision|0|||
130062687|NCT04019795|468184143|FG001|Overall Study|Physician Decision|0|||
130062688|NCT04019795|468184144|FG002|Overall Study|Physician Decision|1|||
130062689|NCT04019795|468184145|FG003|Overall Study|Physician Decision|0|||
130062690|NCT04019795|468184142|FG000|Overall Study|Adverse Event|1|||
129837702|NCT02129803|467371685|FG000|Overall Study|Withdrawal by Subject|1|||
129837703|NCT02129803|467371686|FG001|Overall Study|Withdrawal by Subject|1|||
129837704|NCT00149747|467371687|FG000|Overall Study|Death|1|||
129837705|NCT00149747|467371688|FG001|Overall Study|Death|0|||
130062691|NCT04019795|468184143|FG001|Overall Study|Adverse Event|0|||
129837706|NCT00149747|467371687|FG000|Overall Study|Withdrawal by Subject|3|||
129837707|NCT00149747|467371688|FG001|Overall Study|Withdrawal by Subject|3|||
129837708|NCT04753164|467371689|FG000|Overall Study|Adverse Event|0|||
129837709|NCT04753164|467371690|FG001|Overall Study|Adverse Event|2|||
129837710|NCT04753164|467371689|FG000|Overall Study|Withdrawal by Subject|9|||
129837711|NCT04753164|467371690|FG001|Overall Study|Withdrawal by Subject|7|||
129837712|NCT04753164|467371689|FG000|Overall Study|Lost to Follow-up|6|||
129837713|NCT04753164|467371690|FG001|Overall Study|Lost to Follow-up|6|||
129837714|NCT04753164|467371689|FG000|Overall Study|Other|12|||
129837715|NCT04753164|467371690|FG001|Overall Study|Other|5|||
129837716|NCT01183975|467371696|FG000|Overall Study|Lost to Follow-up|73|||
129837717|NCT03742141|467371700|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
129837718|NCT04180020|467371701|FG000|Overall Study|missed visit|18|||
129837719|NCT04180020|467371702|FG001|Overall Study|missed visit|16|||
129837720|NCT04180020|467371701|FG000|Overall Study|Death|2|||
129837721|NCT04180020|467371702|FG001|Overall Study|Death|3|||
129837722|NCT04180020|467371701|FG000|Overall Study|Withdrawal by Subject|1|||
129837723|NCT04180020|467371702|FG001|Overall Study|Withdrawal by Subject|5|||
129837724|NCT04180020|467371701|FG000|Overall Study|incarcerated|1|||
129837725|NCT04180020|467371702|FG001|Overall Study|incarcerated|1|||
129837726|NCT04180020|467371701|FG000|Overall Study|Physician Decision|0|||
129837727|NCT04180020|467371702|FG001|Overall Study|Physician Decision|2|||
129837728|NCT00405548|467371703|FG000|Overall Study|Cognitive Memory problems on study day|1|||
129837729|NCT00405548|467371704|FG001|Overall Study|Cognitive Memory problems on study day|0|||
129837730|NCT00405548|467371703|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
129837731|NCT00405548|467371704|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
129837732|NCT00405548|467371703|FG000|Overall Study|Unable to self-administer shots|1|||
129837733|NCT00405548|467371704|FG001|Overall Study|Unable to self-administer shots|0|||
129837734|NCT00405548|467371703|FG000|Overall Study|Venous access failed during study day|1|||
129837735|NCT00405548|467371704|FG001|Overall Study|Venous access failed during study day|0|||
129837736|NCT00405548|467371703|FG000|Overall Study|Withdrawal by Subject|1|||
129837737|NCT00405548|467371704|FG001|Overall Study|Withdrawal by Subject|0|||
129837738|NCT03554291|467371705|FG000|Overall Study|Death|2|||
129837739|NCT03554291|467371706|FG001|Overall Study|Death|1|||
129837740|NCT03554291|467371705|FG000|Overall Study|Lost to Follow-up|1|||
129837741|NCT03554291|467371706|FG001|Overall Study|Lost to Follow-up|0|||
129837742|NCT03554291|467371705|FG000|Overall Study|Withdrawal by Subject|1|||
129837743|NCT03554291|467371706|FG001|Overall Study|Withdrawal by Subject|0|||
129837744|NCT03554291|467371705|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
129837745|NCT03554291|467371706|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
129837746|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Death|3|||
129837747|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Death|2|||
129837748|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Death|0|||
129837749|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Death|0|||
129837750|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Death|0|||
129837751|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Death|0|||
129837752|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Death|0|||
130062692|NCT04019795|468184144|FG002|Overall Study|Adverse Event|0|||
130062693|NCT04019795|468184145|FG003|Overall Study|Adverse Event|0|||
130062694|NCT01107405|468184146|FG000|Overall Study|Adverse Event|1|||
130062695|NCT01107405|468184147|FG001|Overall Study|Adverse Event|1|||
130062696|NCT01107405|468184148|FG002|Overall Study|Adverse Event|0|||
130062697|NCT01107405|468184149|FG003|Overall Study|Adverse Event|0|||
130062698|NCT01107405|468184150|FG004|Overall Study|Adverse Event|2|||
130062699|NCT01107405|468184146|FG000|Overall Study|Withdrawal by Subject|1|||
130062700|NCT01107405|468184147|FG001|Overall Study|Withdrawal by Subject|0|||
130062701|NCT01107405|468184148|FG002|Overall Study|Withdrawal by Subject|1|||
130062702|NCT01107405|468184149|FG003|Overall Study|Withdrawal by Subject|2|||
130062703|NCT01107405|468184150|FG004|Overall Study|Withdrawal by Subject|1|||
130062704|NCT01107405|468184146|FG000|Overall Study|Protocol Violation|0|||
130062705|NCT01107405|468184147|FG001|Overall Study|Protocol Violation|0|||
130062706|NCT01107405|468184148|FG002|Overall Study|Protocol Violation|1|||
130062707|NCT01107405|468184149|FG003|Overall Study|Protocol Violation|1|||
130062708|NCT01107405|468184150|FG004|Overall Study|Protocol Violation|0|||
130062709|NCT01895452|468184154|FG000|Overall Study|Adverse Event|1|||
130062710|NCT01895452|468184155|FG001|Overall Study|Adverse Event|4|||
130062711|NCT01895452|468184154|FG000|Overall Study|Lost to Follow-up|1|||
130062712|NCT01895452|468184155|FG001|Overall Study|Lost to Follow-up|5|||
129837753|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Death|0|||
129837754|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
129837755|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
130062713|NCT01895452|468184154|FG000|Overall Study|Pregnancy|0|||
130062714|NCT01895452|468184155|FG001|Overall Study|Pregnancy|1|||
130062715|NCT01895452|468184154|FG000|Overall Study|Withdrawal by Subject|2|||
130062716|NCT01895452|468184155|FG001|Overall Study|Withdrawal by Subject|14|||
130062717|NCT01895452|468184154|FG000|Overall Study|Underlying disease|0|||
129837756|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837757|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837758|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837759|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837760|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837761|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837762|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837763|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
129837764|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837765|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837766|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837767|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837768|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837769|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837770|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
129837771|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
129837772|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
129837773|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
129837774|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
129837775|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
129837776|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
129837777|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
129837778|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837779|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837780|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
129837781|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
129837782|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
129837783|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
130114102|NCT01360632|468377475|FG000|Phase A+|Withdrawal by Subject|0|||
130114103|NCT01360632|468377476|FG001|Phase A+|Withdrawal by Subject|0|||
130114104|NCT01360632|468377477|FG002|Phase A+|Withdrawal by Subject|0|||
130114105|NCT01360632|468377478|FG003|Phase A+|Withdrawal by Subject|0|||
130114106|NCT01360632|468377479|FG004|Phase A+|Withdrawal by Subject|8|||
130114107|NCT01360632|468377475|FG000|Phase A+|Protocol Deviation|0|||
130114108|NCT01360632|468377476|FG001|Phase A+|Protocol Deviation|0|||
130114109|NCT01360632|468377477|FG002|Phase A+|Protocol Deviation|0|||
130114110|NCT01360632|468377478|FG003|Phase A+|Protocol Deviation|0|||
130114111|NCT01360632|468377479|FG004|Phase A+|Protocol Deviation|3|||
130114112|NCT02173301|468377480|FG000|Overall Study|Adverse Event|7|||
130114113|NCT02173301|468377481|FG001|Overall Study|Adverse Event|8|||
130114114|NCT02173301|468377482|FG002|Overall Study|Adverse Event|13|||
130114115|NCT02173301|468377483|FG003|Overall Study|Adverse Event|5|||
130114116|NCT02173301|468377480|FG000|Overall Study|Withdrawal by Subject|8|||
130114117|NCT02173301|468377481|FG001|Overall Study|Withdrawal by Subject|10|||
130114118|NCT02173301|468377482|FG002|Overall Study|Withdrawal by Subject|4|||
130114119|NCT02173301|468377483|FG003|Overall Study|Withdrawal by Subject|8|||
130114120|NCT02173301|468377480|FG000|Overall Study|Lost to Follow-up|4|||
130114121|NCT02173301|468377481|FG001|Overall Study|Lost to Follow-up|4|||
130114122|NCT02173301|468377482|FG002|Overall Study|Lost to Follow-up|2|||
130114123|NCT02173301|468377483|FG003|Overall Study|Lost to Follow-up|2|||
129837784|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837785|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837786|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837787|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837788|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
129837789|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837790|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837791|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837792|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837793|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837794|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Death|0|||
129837795|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Death|0|||
129837796|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Death|1|||
129837797|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Death|0|||
129837798|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Death|0|||
129837799|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Death|0|||
130114124|NCT02173301|468377480|FG000|Overall Study|Protocol Violation|0|||
130114125|NCT02173301|468377481|FG001|Overall Study|Protocol Violation|1|||
130114126|NCT02173301|468377482|FG002|Overall Study|Protocol Violation|0|||
130114127|NCT02173301|468377483|FG003|Overall Study|Protocol Violation|0|||
130114128|NCT02173301|468377480|FG000|Overall Study|Physician Decision|0|||
130114129|NCT02173301|468377481|FG001|Overall Study|Physician Decision|0|||
130114130|NCT02173301|468377482|FG002|Overall Study|Physician Decision|1|||
130114131|NCT02173301|468377483|FG003|Overall Study|Physician Decision|0|||
130114132|NCT02173301|468377480|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
129837800|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Death|0|||
129837801|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Death|0|||
129837802|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Not treated|0|||
129837803|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Not treated|0|||
129837804|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Not treated|0|||
129837805|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Not treated|1|||
129837806|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Not treated|0|||
129837807|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Not treated|0|||
129837808|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Not treated|0|||
129837809|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Not treated|0|||
129837810|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Adverse Event|0|||
129837811|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Adverse Event|0|||
129837812|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Adverse Event|0|||
129837813|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Adverse Event|0|||
129837814|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Adverse Event|0|||
129837815|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Adverse Event|4|||
129837816|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Adverse Event|0|||
129837817|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Adverse Event|2|||
129837818|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Death|0|||
129837819|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Death|0|||
129837820|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Death|0|||
129837821|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Death|0|||
129837822|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Death|0|||
129837823|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Death|24|||
129837824|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Death|0|||
129837825|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Death|3|||
129837826|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837827|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837828|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837829|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837830|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837831|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837832|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837833|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
129837834|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Physician Decision|0|||
129837835|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Physician Decision|0|||
129837836|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Physician Decision|0|||
129837837|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Physician Decision|0|||
129837838|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Physician Decision|0|||
129837839|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Physician Decision|1|||
129837840|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Physician Decision|0|||
129837841|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Physician Decision|0|||
129837842|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
129837843|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
129837844|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
129837845|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
129837846|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
129837847|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
129837848|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
129837849|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
129837850|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837851|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837852|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
130114133|NCT02173301|468377481|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
130114134|NCT02173301|468377482|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
130114135|NCT02173301|468377483|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
130114136|NCT03016078|468377484|FG000|Overall Study|Protocol Violation|1|||
130114137|NCT03016078|468377484|FG000|Overall Study|Protocol Violation|1|||
130114138|NCT01715415|468377490|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
130114139|NCT01715415|468377491|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
130114140|NCT01715415|468377490|FG000|Double-blind Treatment|Adverse Event|3|||
130114141|NCT01715415|468377491|FG001|Double-blind Treatment|Adverse Event|0|||
129837853|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837854|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837855|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
129837856|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837857|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
129837858|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837859|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837860|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837861|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837862|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837863|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
129837864|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
129837865|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
129837866|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Not Treated|0|||
129837867|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Not Treated|0|||
129837868|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Not Treated|0|||
129837869|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Not Treated|0|||
129837870|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Not Treated|0|||
129837871|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Not Treated|2|||
129837872|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Not Treated|0|||
129837873|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Not Treated|0|||
129837874|NCT02741700|467371715|FG000|Overall Study|Lost to Follow-up|17|||
129837875|NCT02741700|467371716|FG001|Overall Study|Lost to Follow-up|8|||
129837876|NCT02741700|467371715|FG000|Overall Study|Withdrawal by Subject|2|||
129837877|NCT02741700|467371716|FG001|Overall Study|Withdrawal by Subject|5|||
129837878|NCT02741700|467371715|FG000|Overall Study|Physician Decision|3|||
129837879|NCT02741700|467371716|FG001|Overall Study|Physician Decision|0|||
129837880|NCT02741700|467371715|FG000|Overall Study|Moved out of State|0|||
129837881|NCT02741700|467371716|FG001|Overall Study|Moved out of State|1|||
129837882|NCT02741700|467371715|FG000|Overall Study|Death|4|||
129837883|NCT02741700|467371716|FG001|Overall Study|Death|5|||
129837884|NCT00811577|467371717|FG000|Overall Study|Lost to Follow-up|7|||
129837885|NCT00811577|467371718|FG001|Overall Study|Lost to Follow-up|1|||
129837886|NCT00811577|467371717|FG000|Overall Study|Withdrawal by Subject|3|||
129837887|NCT00811577|467371718|FG001|Overall Study|Withdrawal by Subject|0|||
129837888|NCT01068509|467371719|FG000|Overall Study|Death|0|||
129837889|NCT01068509|467371720|FG001|Overall Study|Death|0|||
129837890|NCT01068509|467371721|FG002|Overall Study|Death|1|||
129837891|NCT01068509|467371719|FG000|Overall Study|Disease Progression|5|||
129837892|NCT01068509|467371720|FG001|Overall Study|Disease Progression|20|||
129837893|NCT01068509|467371721|FG002|Overall Study|Disease Progression|18|||
129837894|NCT01068509|467371719|FG000|Overall Study|Lost to Follow-up|1|||
130062718|NCT01895452|468184155|FG001|Overall Study|Underlying disease|3|||
130062719|NCT01895452|468184154|FG000|Overall Study|Noncompliance with study drug|0|||
130062720|NCT01895452|468184155|FG001|Overall Study|Noncompliance with study drug|1|||
130062721|NCT01653158|468184156|FG000|Overall Study|Death|0|||
130062722|NCT01653158|468184157|FG001|Overall Study|Death|0|||
130062723|NCT01653158|468184158|FG002|Overall Study|Death|0|||
130062724|NCT01653158|468184159|FG003|Overall Study|Death|1|||
130062725|NCT01653158|468184160|FG004|Overall Study|Death|0|||
130062726|NCT01653158|468184161|FG005|Overall Study|Death|0|||
130062727|NCT01653158|468184162|FG006|Overall Study|Death|0|||
130062728|NCT01653158|468184163|FG007|Overall Study|Death|2|||
130062729|NCT01653158|468184156|FG000|Overall Study|Adverse Event|0|||
130062730|NCT01653158|468184157|FG001|Overall Study|Adverse Event|0|||
130062731|NCT01653158|468184158|FG002|Overall Study|Adverse Event|0|||
130062732|NCT01653158|468184159|FG003|Overall Study|Adverse Event|1|||
130062733|NCT01653158|468184160|FG004|Overall Study|Adverse Event|0|||
130062734|NCT01653158|468184161|FG005|Overall Study|Adverse Event|0|||
130062735|NCT01653158|468184162|FG006|Overall Study|Adverse Event|0|||
130062736|NCT01653158|468184163|FG007|Overall Study|Adverse Event|3|||
130062737|NCT01653158|468184156|FG000|Overall Study|Other|0|||
130062738|NCT01653158|468184157|FG001|Overall Study|Other|0|||
130062739|NCT01653158|468184158|FG002|Overall Study|Other|0|||
130062740|NCT01653158|468184159|FG003|Overall Study|Other|0|||
130062741|NCT01653158|468184160|FG004|Overall Study|Other|0|||
130062742|NCT01653158|468184161|FG005|Overall Study|Other|0|||
130062743|NCT01653158|468184162|FG006|Overall Study|Other|0|||
130062744|NCT01653158|468184163|FG007|Overall Study|Other|1|||
130062745|NCT01653158|468184156|FG000|Overall Study|Progressive disease|0|||
130062746|NCT01653158|468184157|FG001|Overall Study|Progressive disease|0|||
130062747|NCT01653158|468184158|FG002|Overall Study|Progressive disease|0|||
130062748|NCT01653158|468184159|FG003|Overall Study|Progressive disease|0|||
129837895|NCT01068509|467371720|FG001|Overall Study|Lost to Follow-up|0|||
129837896|NCT01068509|467371721|FG002|Overall Study|Lost to Follow-up|0|||
129837897|NCT01068509|467371719|FG000|Overall Study|Withdrew Consent|0|||
129837898|NCT01068509|467371720|FG001|Overall Study|Withdrew Consent|1|||
130062749|NCT01653158|468184160|FG004|Overall Study|Progressive disease|1|||
130062750|NCT01653158|468184161|FG005|Overall Study|Progressive disease|1|||
130062751|NCT01653158|468184162|FG006|Overall Study|Progressive disease|2|||
129837899|NCT01068509|467371721|FG002|Overall Study|Withdrew Consent|2|||
130062752|NCT01653158|468184163|FG007|Overall Study|Progressive disease|9|||
130062753|NCT01653158|468184156|FG000|Overall Study|Withdrawal by Subject|1|||
129837900|NCT01068509|467371719|FG000|Overall Study|Reason Not Specified|0|||
130062754|NCT01653158|468184157|FG001|Overall Study|Withdrawal by Subject|0|||
130062755|NCT01653158|468184158|FG002|Overall Study|Withdrawal by Subject|0|||
130062756|NCT01653158|468184159|FG003|Overall Study|Withdrawal by Subject|0|||
130062757|NCT01653158|468184160|FG004|Overall Study|Withdrawal by Subject|0|||
130062758|NCT01653158|468184161|FG005|Overall Study|Withdrawal by Subject|0|||
130114142|NCT01715415|468377490|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
130114143|NCT01715415|468377491|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
130114144|NCT01715415|468377490|FG000|Double-blind Treatment|Other|1|||
130114145|NCT01715415|468377491|FG001|Double-blind Treatment|Other|0|||
130114146|NCT01715415|468377490|FG000|Open-label Treatment|Adverse Event|0|||
130114147|NCT01715415|468377491|FG001|Open-label Treatment|Adverse Event|1|||
130114148|NCT01715415|468377490|FG000|Open-label Treatment|Subject Noncompliant|0|||
130114149|NCT01715415|468377491|FG001|Open-label Treatment|Subject Noncompliant|1|||
130114150|NCT05028751|468377492|FG000|Overall Study|Study Terminated by Sponsor|3|||
130114151|NCT05028751|468377493|FG001|Overall Study|Study Terminated by Sponsor|0|||
130114152|NCT05028751|468377494|FG002|Overall Study|Study Terminated by Sponsor|0|||
130114153|NCT05028751|468377495|FG003|Overall Study|Study Terminated by Sponsor|0|||
130114154|NCT05028751|468377492|FG000|Overall Study|Death|9|||
130114155|NCT05028751|468377493|FG001|Overall Study|Death|3|||
130114156|NCT05028751|468377494|FG002|Overall Study|Death|2|||
130114157|NCT05028751|468377495|FG003|Overall Study|Death|4|||
130114158|NCT05028751|468377492|FG000|Overall Study|Withdrawal by Subject|0|||
130114159|NCT05028751|468377493|FG001|Overall Study|Withdrawal by Subject|0|||
130114160|NCT05028751|468377494|FG002|Overall Study|Withdrawal by Subject|1|||
130114161|NCT05028751|468377495|FG003|Overall Study|Withdrawal by Subject|0|||
130114162|NCT05028751|468377492|FG000|Overall Study|Miscellaneous|2|||
130114163|NCT05028751|468377493|FG001|Overall Study|Miscellaneous|0|||
130114164|NCT05028751|468377494|FG002|Overall Study|Miscellaneous|0|||
130114165|NCT05028751|468377495|FG003|Overall Study|Miscellaneous|0|||
130114166|NCT00395083|468377498|FG000|Overall Study|Withdrawal by Subject|6|||
130114167|NCT00395083|468377499|FG001|Overall Study|Withdrawal by Subject|5|||
130114168|NCT00395083|468377498|FG000|Overall Study|Developed another disease|4|||
130114169|NCT00395083|468377499|FG001|Overall Study|Developed another disease|3|||
130114170|NCT00972153|468377500|FG000|Overall Study|Equipment malfunction during case|0|||
130114171|NCT00972153|468377501|FG001|Overall Study|Equipment malfunction during case|1|||
130114172|NCT00972153|468377502|FG002|Overall Study|Equipment malfunction during case|0|||
130114173|NCT04136626|468377503|FG000|Treatment Phase|Withdrawal by Subject|1|||
130114174|NCT04136626|468377504|FG001|Treatment Phase|Withdrawal by Subject|9|||
130114175|NCT04136626|468377503|FG000|Treatment Phase|Adverse Event|1|||
130114176|NCT04136626|468377504|FG001|Treatment Phase|Adverse Event|0|||
130114177|NCT04136626|468377503|FG000|Treatment Phase|Lost to Follow-up|1|||
130114178|NCT04136626|468377504|FG001|Treatment Phase|Lost to Follow-up|5|||
130114179|NCT04136626|468377503|FG000|12-month Follow-up|Lost to Follow-up|8|||
130114180|NCT04136626|468377504|FG001|12-month Follow-up|Lost to Follow-up|7|||
130114181|NCT01405950|468379574|FG000|Overall Study|Withdrawal by Subject|1|||
130114182|NCT01405950|468379575|FG001|Overall Study|Withdrawal by Subject|0|||
130114183|NCT01405950|468379576|FG002|Overall Study|Withdrawal by Subject|0|||
130114184|NCT01405950|468379577|FG003|Overall Study|Withdrawal by Subject|0|||
130114185|NCT02410252|468379578|FG000|Overall Study|Withdrawal by Subject|4|||
130114186|NCT02410252|468379578|FG000|Overall Study|Physician Decision|2|||
130114187|NCT00387712|468379581|FG000|Overall Study|Physician Decision|6|||
130114188|NCT00387712|468379582|FG001|Overall Study|Physician Decision|4|||
130114189|NCT00387712|468379581|FG000|Overall Study|Lost to Follow-up|17|||
130114190|NCT00387712|468379582|FG001|Overall Study|Lost to Follow-up|20|||
130114191|NCT00387712|468379581|FG000|Overall Study|Withdrawal by Subject|6|||
130114192|NCT00387712|468379582|FG001|Overall Study|Withdrawal by Subject|12|||
130114193|NCT01772368|468379589|FG000|Overall Study|Adverse Event|1|||
130114194|NCT01772368|468379589|FG000|Overall Study|Withdrawal by Subject|3|||
130114195|NCT01772368|468379589|FG000|Overall Study|Protocol Violation|2|||
130114196|NCT01772368|468379589|FG000|Overall Study|Other|1|||
130114197|NCT01452529|468379590|FG000|Run-in Period|Adverse Event|96|||
130114198|NCT01452529|468379591|FG001|Run-in Period|Adverse Event|0|||
130114199|NCT01452529|468379592|FG002|Run-in Period|Adverse Event|0|||
130114200|NCT01452529|468379590|FG000|Run-in Period|Withdrawal by Subject|49|||
130114201|NCT01452529|468379591|FG001|Run-in Period|Withdrawal by Subject|0|||
130114202|NCT01452529|468379592|FG002|Run-in Period|Withdrawal by Subject|0|||
130114203|NCT01452529|468379590|FG000|Run-in Period|Lost to Follow-up|19|||
130114204|NCT01452529|468379591|FG001|Run-in Period|Lost to Follow-up|0|||
130114205|NCT01452529|468379592|FG002|Run-in Period|Lost to Follow-up|0|||
129837901|NCT01068509|467371720|FG001|Overall Study|Reason Not Specified|1|||
129837902|NCT01068509|467371721|FG002|Overall Study|Reason Not Specified|0|||
129837903|NCT02442778|467371722|FG000|Overall Study|Adverse Event|2|||
130114206|NCT01452529|468379590|FG000|Run-in Period|Lack of Efficacy|46|||
130114207|NCT01452529|468379591|FG001|Run-in Period|Lack of Efficacy|0|||
130114208|NCT01452529|468379592|FG002|Run-in Period|Lack of Efficacy|0|||
130114209|NCT01452529|468379590|FG000|Run-in Period|Confirmed or suspected diversion|23|||
130114210|NCT01452529|468379591|FG001|Run-in Period|Confirmed or suspected diversion|0|||
130114211|NCT01452529|468379592|FG002|Run-in Period|Confirmed or suspected diversion|0|||
130114212|NCT01452529|468379590|FG000|Run-in Period|Administrative|21|||
130114213|NCT01452529|468379591|FG001|Run-in Period|Administrative|0|||
130114214|NCT01452529|468379592|FG002|Run-in Period|Administrative|0|||
130114215|NCT01452529|468379590|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
129898756|NCT00567879|467590033|FG004|Overall Study|Abnormal test procedure(s)|0|||
129837904|NCT02442778|467371723|FG001|Overall Study|Adverse Event|6|||
129837905|NCT02442778|467371724|FG002|Overall Study|Adverse Event|6|||
129837906|NCT02442778|467371722|FG000|Overall Study|Death|0|||
129837907|NCT02442778|467371723|FG001|Overall Study|Death|2|||
129837908|NCT02442778|467371724|FG002|Overall Study|Death|0|||
129837909|NCT02442778|467371722|FG000|Overall Study|Lack of Efficacy|1|||
129837910|NCT02442778|467371723|FG001|Overall Study|Lack of Efficacy|0|||
129837911|NCT02442778|467371724|FG002|Overall Study|Lack of Efficacy|0|||
129837912|NCT02442778|467371722|FG000|Overall Study|Lost to Follow-up|1|||
129837913|NCT02442778|467371723|FG001|Overall Study|Lost to Follow-up|1|||
129837914|NCT02442778|467371724|FG002|Overall Study|Lost to Follow-up|1|||
129837915|NCT02442778|467371722|FG000|Overall Study|Non-compliance with study drug|2|||
129837916|NCT02442778|467371723|FG001|Overall Study|Non-compliance with study drug|0|||
129837917|NCT02442778|467371724|FG002|Overall Study|Non-compliance with study drug|1|||
129837918|NCT02442778|467371722|FG000|Overall Study|Physician Decision|1|||
129837919|NCT02442778|467371723|FG001|Overall Study|Physician Decision|1|||
129837920|NCT02442778|467371724|FG002|Overall Study|Physician Decision|1|||
129837921|NCT02442778|467371722|FG000|Overall Study|Protocol Deviation|3|||
129837922|NCT02442778|467371723|FG001|Overall Study|Protocol Deviation|0|||
129837923|NCT02442778|467371724|FG002|Overall Study|Protocol Deviation|1|||
129837924|NCT02442778|467371722|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
129837925|NCT02442778|467371723|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
129837926|NCT02442778|467371724|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
129837927|NCT02442778|467371722|FG000|Overall Study|Withdrawal by Subject|4|||
129837928|NCT02442778|467371723|FG001|Overall Study|Withdrawal by Subject|4|||
129837929|NCT02442778|467371724|FG002|Overall Study|Withdrawal by Subject|3|||
129837930|NCT02442778|467371722|FG000|Overall Study|Reason not specified|1|||
129837931|NCT02442778|467371723|FG001|Overall Study|Reason not specified|4|||
129837932|NCT02442778|467371724|FG002|Overall Study|Reason not specified|0|||
129837933|NCT01165138|467371725|FG000|Overall Study|Adverse Event|0|||
129837934|NCT01165138|467371726|FG001|Overall Study|Adverse Event|1|||
129837935|NCT01165138|467371727|FG002|Overall Study|Adverse Event|0|||
129837936|NCT01165138|467371728|FG003|Overall Study|Adverse Event|2|||
129837937|NCT01165138|467371725|FG000|Overall Study|Lack of Efficacy|0|||
129837938|NCT01165138|467371726|FG001|Overall Study|Lack of Efficacy|32|||
129837939|NCT01165138|467371727|FG002|Overall Study|Lack of Efficacy|6|||
129837940|NCT01165138|467371728|FG003|Overall Study|Lack of Efficacy|7|||
129837941|NCT01165138|467371725|FG000|Overall Study|Protocol Violation|0|||
129837942|NCT01165138|467371726|FG001|Overall Study|Protocol Violation|7|||
129837943|NCT01165138|467371727|FG002|Overall Study|Protocol Violation|0|||
129837944|NCT01165138|467371728|FG003|Overall Study|Protocol Violation|2|||
129837945|NCT01165138|467371725|FG000|Overall Study|Lost to Follow-up|0|||
129837946|NCT01165138|467371726|FG001|Overall Study|Lost to Follow-up|0|||
129837947|NCT01165138|467371727|FG002|Overall Study|Lost to Follow-up|1|||
129837948|NCT01165138|467371728|FG003|Overall Study|Lost to Follow-up|2|||
129837949|NCT01165138|467371725|FG000|Overall Study|Physician Decision|0|||
129837950|NCT01165138|467371726|FG001|Overall Study|Physician Decision|6|||
129837951|NCT01165138|467371727|FG002|Overall Study|Physician Decision|7|||
129837952|NCT01165138|467371728|FG003|Overall Study|Physician Decision|6|||
129837953|NCT01165138|467371725|FG000|Overall Study|Withdrawal by Subject|0|||
129837954|NCT01165138|467371726|FG001|Overall Study|Withdrawal by Subject|6|||
129837955|NCT01165138|467371727|FG002|Overall Study|Withdrawal by Subject|6|||
129837956|NCT01165138|467371728|FG003|Overall Study|Withdrawal by Subject|3|||
129837957|NCT01418937|467371729|FG000|Overall Study|Lost to Follow-up|5|||
129837958|NCT01418937|467371729|FG000|Overall Study|Protocol Violation|1|||
129837959|NCT01418937|467371729|FG000|Overall Study|Pregnancy|1|||
129837960|NCT01418937|467371729|FG000|Overall Study|Withdrawal by Subject|1|||
129837961|NCT00962104|467371730|FG000|Overall Study|Adverse Event|10|||
129837962|NCT00962104|467371731|FG001|Overall Study|Adverse Event|3|||
129837963|NCT00962104|467371730|FG000|Overall Study|Entry Criteria Not Met|1|||
129837964|NCT00962104|467371731|FG001|Overall Study|Entry Criteria Not Met|2|||
129837965|NCT00962104|467371730|FG000|Overall Study|Lack of Efficacy|0|||
129837966|NCT00962104|467371731|FG001|Overall Study|Lack of Efficacy|1|||
129837967|NCT00962104|467371730|FG000|Overall Study|Lost to Follow-up|10|||
129837968|NCT00962104|467371731|FG001|Overall Study|Lost to Follow-up|4|||
129837969|NCT00962104|467371730|FG000|Overall Study|Physician Decision|1|||
129837970|NCT00962104|467371731|FG001|Overall Study|Physician Decision|0|||
129837971|NCT00962104|467371730|FG000|Overall Study|Protocol Violation|6|||
129837972|NCT00962104|467371731|FG001|Overall Study|Protocol Violation|8|||
129837973|NCT00962104|467371730|FG000|Overall Study|Sponsor Decision|0|||
129837974|NCT00962104|467371731|FG001|Overall Study|Sponsor Decision|1|||
129837975|NCT00962104|467371730|FG000|Overall Study|Withdrawal by Subject|10|||
129837976|NCT00962104|467371731|FG001|Overall Study|Withdrawal by Subject|6|||
129837977|NCT00962104|467371730|FG000|Overall Study|Other|2|||
129837978|NCT00962104|467371731|FG001|Overall Study|Other|0|||
129837979|NCT02013167|467371732|FG000|Overall Study|Withdrawal by Subject|15|||
129837980|NCT02013167|467371733|FG001|Overall Study|Withdrawal by Subject|14|||
129837981|NCT02013167|467371732|FG000|Overall Study|Sponsor Decision|1|||
129837982|NCT02013167|467371733|FG001|Overall Study|Sponsor Decision|3|||
129837983|NCT02013167|467371732|FG000|Overall Study|Lost to Follow-up|0|||
129837984|NCT02013167|467371733|FG001|Overall Study|Lost to Follow-up|1|||
129837985|NCT02013167|467371732|FG000|Overall Study|Death|85|||
129837986|NCT02013167|467371733|FG001|Overall Study|Death|160|||
129837987|NCT00603746|467371734|FG000|Overall Study|Adverse Event|2|||
129837988|NCT00603746|467371735|FG001|Overall Study|Adverse Event|3|||
129837989|NCT00603746|467371736|FG002|Overall Study|Adverse Event|0|||
129837990|NCT00603746|467371737|FG003|Overall Study|Adverse Event|1|||
129837991|NCT00603746|467371738|FG004|Overall Study|Adverse Event|0|||
129837992|NCT00603746|467371739|FG005|Overall Study|Adverse Event|4|||
129837993|NCT00603746|467371734|FG000|Overall Study|Lack of Efficacy|34|||
129837994|NCT00603746|467371735|FG001|Overall Study|Lack of Efficacy|11|||
129837995|NCT00603746|467371736|FG002|Overall Study|Lack of Efficacy|6|||
129837996|NCT00603746|467371737|FG003|Overall Study|Lack of Efficacy|11|||
129837997|NCT00603746|467371738|FG004|Overall Study|Lack of Efficacy|12|||
129837998|NCT00603746|467371739|FG005|Overall Study|Lack of Efficacy|8|||
129837999|NCT00603746|467371734|FG000|Overall Study|Protocol Violation|0|||
129838000|NCT00603746|467371735|FG001|Overall Study|Protocol Violation|3|||
129838001|NCT00603746|467371736|FG002|Overall Study|Protocol Violation|1|||
129838002|NCT00603746|467371737|FG003|Overall Study|Protocol Violation|0|||
129838003|NCT00603746|467371738|FG004|Overall Study|Protocol Violation|1|||
129838004|NCT00603746|467371739|FG005|Overall Study|Protocol Violation|0|||
129838005|NCT00603746|467371734|FG000|Overall Study|Lost to Follow-up|0|||
129838006|NCT00603746|467371735|FG001|Overall Study|Lost to Follow-up|1|||
129838007|NCT00603746|467371736|FG002|Overall Study|Lost to Follow-up|1|||
129838008|NCT00603746|467371737|FG003|Overall Study|Lost to Follow-up|0|||
129838009|NCT00603746|467371738|FG004|Overall Study|Lost to Follow-up|0|||
129838010|NCT00603746|467371739|FG005|Overall Study|Lost to Follow-up|0|||
129838011|NCT00603746|467371734|FG000|Overall Study|Physician Decision|1|||
130062759|NCT01653158|468184162|FG006|Overall Study|Withdrawal by Subject|0|||
130062760|NCT01653158|468184163|FG007|Overall Study|Withdrawal by Subject|0|||
130062761|NCT00980343|468184164|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
130062762|NCT00980343|468184165|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
130062763|NCT01194869|468184172|FG000|Overall Study|Disease Progression|2|||
130062764|NCT01194869|468184172|FG000|Overall Study|Toxicity|2|||
130062765|NCT04321252|468184175|FG000|Overall Study|Withdrawal by Subject|0|||
130062766|NCT04321252|468184176|FG001|Overall Study|Withdrawal by Subject|0|||
130062767|NCT04321252|468184177|FG002|Overall Study|Withdrawal by Subject|0|||
130062768|NCT04321252|468184178|FG003|Overall Study|Withdrawal by Subject|0|||
130062769|NCT04321252|468184179|FG004|Overall Study|Withdrawal by Subject|0|||
130062770|NCT04321252|468184180|FG005|Overall Study|Withdrawal by Subject|1|||
130062771|NCT04321252|468184181|FG006|Overall Study|Withdrawal by Subject|0|||
130062772|NCT04321252|468184182|FG007|Overall Study|Withdrawal by Subject|0|||
130062773|NCT04321252|468184183|FG008|Overall Study|Withdrawal by Subject|0|||
130062774|NCT03004469|468184184|FG000|Overall Study|Adverse Event|6|||
130062775|NCT03004469|468184185|FG001|Overall Study|Adverse Event|4|||
130062776|NCT03004469|468184186|FG002|Overall Study|Adverse Event|6|||
130062777|NCT03004469|468184184|FG000|Overall Study|Lack of Efficacy|1|||
130062778|NCT03004469|468184185|FG001|Overall Study|Lack of Efficacy|0|||
130062779|NCT03004469|468184186|FG002|Overall Study|Lack of Efficacy|1|||
130062780|NCT03004469|468184184|FG000|Overall Study|Lost to Follow-up|23|||
130062781|NCT03004469|468184185|FG001|Overall Study|Lost to Follow-up|14|||
130062782|NCT03004469|468184186|FG002|Overall Study|Lost to Follow-up|6|||
130062783|NCT03004469|468184184|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130062784|NCT03004469|468184185|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130062785|NCT03004469|468184186|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130062786|NCT03004469|468184184|FG000|Overall Study|Protocol Violation|0|||
130062787|NCT03004469|468184185|FG001|Overall Study|Protocol Violation|0|||
130062788|NCT03004469|468184186|FG002|Overall Study|Protocol Violation|1|||
130062789|NCT03004469|468184184|FG000|Overall Study|Withdrawal by Subject|29|||
130062790|NCT03004469|468184185|FG001|Overall Study|Withdrawal by Subject|27|||
129838012|NCT00603746|467371735|FG001|Overall Study|Physician Decision|0|||
129838013|NCT00603746|467371736|FG002|Overall Study|Physician Decision|0|||
129838014|NCT00603746|467371737|FG003|Overall Study|Physician Decision|0|||
130062791|NCT03004469|468184186|FG002|Overall Study|Withdrawal by Subject|10|||
130062792|NCT03004469|468184184|FG000|Overall Study|Other unspecified reason|0|||
130062793|NCT03004469|468184185|FG001|Overall Study|Other unspecified reason|4|||
130062794|NCT03004469|468184186|FG002|Overall Study|Other unspecified reason|1|||
130062795|NCT00259740|468184187|FG000|Overall Study|Physician Decision|1|||
130062796|NCT00259740|468184188|FG001|Overall Study|Physician Decision|1|||
130062797|NCT00259740|468184187|FG000|Overall Study|Adverse Event|0|||
129838015|NCT00603746|467371738|FG004|Overall Study|Physician Decision|1|||
129838016|NCT00603746|467371739|FG005|Overall Study|Physician Decision|0|||
129838017|NCT00603746|467371734|FG000|Overall Study|Withdrawal by Subject|1|||
129838018|NCT00603746|467371735|FG001|Overall Study|Withdrawal by Subject|0|||
129838019|NCT00603746|467371736|FG002|Overall Study|Withdrawal by Subject|0|||
129838020|NCT00603746|467371737|FG003|Overall Study|Withdrawal by Subject|1|||
129838021|NCT00603746|467371738|FG004|Overall Study|Withdrawal by Subject|3|||
129838022|NCT00603746|467371739|FG005|Overall Study|Withdrawal by Subject|1|||
129838023|NCT01113879|467371742|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
129838024|NCT01113879|467371743|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
129838025|NCT03323658|467371745|FG000|Overall Study|Adverse Event|0|||
129838026|NCT03323658|467371746|FG001|Overall Study|Adverse Event|1|||
129838027|NCT03323658|467371747|FG002|Overall Study|Adverse Event|0|||
130114216|NCT01452529|468379591|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
130114217|NCT01452529|468379592|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
130114218|NCT01452529|468379590|FG000|Double-blind (DB) Period|Adverse Event|0|||
130114219|NCT01452529|468379591|FG001|Double-blind (DB) Period|Adverse Event|18|||
130114220|NCT01452529|468379592|FG002|Double-blind (DB) Period|Adverse Event|11|||
130114221|NCT01452529|468379590|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
130114222|NCT01452529|468379591|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
130114223|NCT01452529|468379592|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
129838028|NCT00615056|467371748|FG000|Overall Study|Death|31|||
129838029|NCT00615056|467371749|FG001|Overall Study|Death|31|||
129838030|NCT00615056|467371750|FG002|Overall Study|Death|21|||
129838031|NCT00615056|467371751|FG003|Overall Study|Death|23|||
129838032|NCT00615056|467371748|FG000|Overall Study|Lost to Follow-up|1|||
129838033|NCT00615056|467371749|FG001|Overall Study|Lost to Follow-up|2|||
129838034|NCT00615056|467371750|FG002|Overall Study|Lost to Follow-up|4|||
129838035|NCT00615056|467371751|FG003|Overall Study|Lost to Follow-up|5|||
129838036|NCT00615056|467371748|FG000|Overall Study|Other|13|||
129838037|NCT00615056|467371749|FG001|Overall Study|Other|15|||
129838038|NCT00615056|467371750|FG002|Overall Study|Other|10|||
129838039|NCT00615056|467371751|FG003|Overall Study|Other|7|||
129838040|NCT00615056|467371748|FG000|Overall Study|Objective progression or relapse|0|||
129838041|NCT00615056|467371749|FG001|Overall Study|Objective progression or relapse|2|||
129838042|NCT00615056|467371750|FG002|Overall Study|Objective progression or relapse|0|||
129838043|NCT00615056|467371751|FG003|Overall Study|Objective progression or relapse|0|||
129838044|NCT00615056|467371748|FG000|Overall Study|Withdrawal by Subject|0|||
129838045|NCT00615056|467371749|FG001|Overall Study|Withdrawal by Subject|1|||
129838046|NCT00615056|467371750|FG002|Overall Study|Withdrawal by Subject|1|||
129838047|NCT00615056|467371751|FG003|Overall Study|Withdrawal by Subject|0|||
129838048|NCT00615056|467371748|FG000|Overall Study|Discontinued by Sponsor|1|||
129838049|NCT00615056|467371749|FG001|Overall Study|Discontinued by Sponsor|0|||
129838050|NCT00615056|467371750|FG002|Overall Study|Discontinued by Sponsor|0|||
129838051|NCT00615056|467371751|FG003|Overall Study|Discontinued by Sponsor|0|||
129838052|NCT00615056|467371748|FG000|Overall Study|Randomized but not treated|3|||
129838053|NCT00615056|467371749|FG001|Overall Study|Randomized but not treated|0|||
129838054|NCT00615056|467371750|FG002|Overall Study|Randomized but not treated|0|||
129838055|NCT00615056|467371751|FG003|Overall Study|Randomized but not treated|0|||
129838056|NCT00717769|467371752|FG000|Overall Study|Adverse Event|9|||
129838057|NCT00717769|467371753|FG001|Overall Study|Adverse Event|6|||
129838058|NCT00717769|467371754|FG002|Overall Study|Adverse Event|1|||
129838059|NCT00717769|467371752|FG000|Overall Study|Lack of compliance|0|||
129838060|NCT00717769|467371753|FG001|Overall Study|Lack of compliance|2|||
129838061|NCT00717769|467371754|FG002|Overall Study|Lack of compliance|0|||
129838062|NCT00717769|467371752|FG000|Overall Study|Lost to Follow-up|3|||
129838063|NCT00717769|467371753|FG001|Overall Study|Lost to Follow-up|4|||
129838064|NCT00717769|467371754|FG002|Overall Study|Lost to Follow-up|0|||
129838065|NCT00717769|467371752|FG000|Overall Study|Lack of Efficacy|1|||
129838066|NCT00717769|467371753|FG001|Overall Study|Lack of Efficacy|2|||
129838067|NCT00717769|467371754|FG002|Overall Study|Lack of Efficacy|0|||
129838068|NCT00717769|467371752|FG000|Overall Study|Protocol Violation|0|||
129838069|NCT00717769|467371753|FG001|Overall Study|Protocol Violation|2|||
129838070|NCT00717769|467371754|FG002|Overall Study|Protocol Violation|0|||
129838071|NCT00717769|467371752|FG000|Overall Study|Sponsor decision|1|||
129838072|NCT00717769|467371753|FG001|Overall Study|Sponsor decision|0|||
129838073|NCT00717769|467371754|FG002|Overall Study|Sponsor decision|10|||
129838074|NCT00717769|467371752|FG000|Overall Study|Withdrew consent|2|||
129838075|NCT00717769|467371753|FG001|Overall Study|Withdrew consent|2|||
129838076|NCT00717769|467371754|FG002|Overall Study|Withdrew consent|0|||
129838077|NCT02276612|467371755|FG000|Overall Study|Death|1|||
129838078|NCT02276612|467371756|FG001|Overall Study|Death|0|||
129838079|NCT02276612|467371755|FG000|Overall Study|Pregnancy|1|||
129838080|NCT02276612|467371756|FG001|Overall Study|Pregnancy|0|||
129838081|NCT02276612|467371755|FG000|Overall Study|Withdrew Consent|1|||
129838082|NCT02276612|467371756|FG001|Overall Study|Withdrew Consent|0|||
129838083|NCT02276612|467371755|FG000|Overall Study|Lost to Follow-up|1|||
129838084|NCT02276612|467371756|FG001|Overall Study|Lost to Follow-up|0|||
129838085|NCT00262067|467371757|FG000|Overall Study|Death|190|||
129838086|NCT00262067|467371758|FG001|Overall Study|Death|89|||
129838087|NCT00262067|467371759|FG002|Overall Study|Death|186|||
129838088|NCT00262067|467371760|FG003|Overall Study|Death|99|||
129838089|NCT00262067|467371757|FG000|Overall Study|Lost to Follow-up|5|||
129838090|NCT00262067|467371758|FG001|Overall Study|Lost to Follow-up|4|||
129838091|NCT00262067|467371759|FG002|Overall Study|Lost to Follow-up|7|||
129838092|NCT00262067|467371760|FG003|Overall Study|Lost to Follow-up|5|||
129838093|NCT00262067|467371757|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
129838094|NCT00262067|467371758|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
129838095|NCT00262067|467371759|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
129838096|NCT00262067|467371760|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
129838097|NCT00262067|467371757|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
129838098|NCT00262067|467371758|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
129838099|NCT00262067|467371759|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
129838100|NCT00262067|467371760|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
129838101|NCT02849548|467371761|FG000|Overall Study|Lost to Follow-up|1|||
129838102|NCT02849548|467371762|FG001|Overall Study|Lost to Follow-up|2|||
129838103|NCT02849548|467371761|FG000|Overall Study|Protocol Violation|1|||
129838104|NCT02849548|467371762|FG001|Overall Study|Protocol Violation|0|||
129838105|NCT02357147|467371764|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
129838106|NCT02357147|467371765|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
129838107|NCT02357147|467371764|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
129838108|NCT02357147|467371765|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
129838109|NCT02357147|467371764|FG000|Combination Treatment Phase|Investigator Discretion|1|||
129838110|NCT02357147|467371765|FG001|Combination Treatment Phase|Investigator Discretion|1|||
129838111|NCT02357147|467371764|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
129838112|NCT02357147|467371765|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
129838113|NCT02357147|467371764|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
129838114|NCT02357147|467371765|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
129838115|NCT02357147|467371764|FG000|Combination Treatment Phase|Adverse Event|12|||
129838116|NCT02357147|467371765|FG001|Combination Treatment Phase|Adverse Event|4|||
129838117|NCT02357147|467371764|FG000|Combination Treatment Phase|Death|1|||
129838118|NCT02357147|467371765|FG001|Combination Treatment Phase|Death|1|||
129838119|NCT02357147|467371764|FG000|Combination Treatment Phase|Sponsor Decision|0|||
129838120|NCT02357147|467371765|FG001|Combination Treatment Phase|Sponsor Decision|12|||
129838121|NCT02357147|467371764|FG000|Combination Treatment Phase|Other|1|||
129838122|NCT02357147|467371765|FG001|Combination Treatment Phase|Other|0|||
129838123|NCT02357147|467371764|FG000|Combination Treatment Phase|Not treated|0|||
129838124|NCT02357147|467371765|FG001|Combination Treatment Phase|Not treated|2|||
129838125|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
129838126|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
129838127|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129838128|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
129838129|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
129838130|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
129838131|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Adverse Event|0|||
130062798|NCT00259740|468184188|FG001|Overall Study|Adverse Event|2|||
130062799|NCT00259740|468184187|FG000|Overall Study|Withdrawal by Subject|2|||
130062800|NCT00259740|468184188|FG001|Overall Study|Withdrawal by Subject|6|||
130062801|NCT00259740|468184187|FG000|Overall Study|Death|1|||
130062802|NCT00259740|468184188|FG001|Overall Study|Death|1|||
130062803|NCT00259740|468184187|FG000|Overall Study|Disease progression|19|||
130062804|NCT00259740|468184188|FG001|Overall Study|Disease progression|36|||
130062805|NCT00259740|468184187|FG000|Overall Study|Ongoing|17|||
130062806|NCT00259740|468184188|FG001|Overall Study|Ongoing|3|||
130062807|NCT00259740|468184187|FG000|Overall Study|Other|3|||
130062808|NCT00259740|468184188|FG001|Overall Study|Other|0|||
130062809|NCT00259740|468184187|FG000|Overall Study|Requirement for alternative therapy|0|||
130062810|NCT00259740|468184188|FG001|Overall Study|Requirement for alternative therapy|4|||
130062811|NCT02287402|468184189|FG000|Treatment Period|Adverse Event|17|||
130062812|NCT02287402|468184189|FG000|Treatment Period|Voluntary Withdrawal|10|||
130062813|NCT02287402|468184189|FG000|Follow-up|Lost to Follow-up|1|||
130062814|NCT02287402|468184189|FG000|Follow-up|Voluntary Withdrawal|2|||
130062815|NCT01844830|468184190|FG000|Overall Study|Withdrawal by Subject|1|||
130062816|NCT01844830|468184191|FG001|Overall Study|Withdrawal by Subject|0|||
130062817|NCT04247815|468184192|FG000|Overall Study|Adverse Event|1|||
130062818|NCT04247815|468184193|FG001|Overall Study|Adverse Event|0|||
130062819|NCT04247815|468184192|FG000|Overall Study|Withdrawal by Subject|1|||
130062820|NCT04247815|468184193|FG001|Overall Study|Withdrawal by Subject|0|||
130062821|NCT04247815|468184192|FG000|Overall Study|Protocol Violation|0|||
130062822|NCT04247815|468184193|FG001|Overall Study|Protocol Violation|1|||
130062823|NCT03495453|468184201|FG000|Overall Study|Withdrawal by Subject|0|||
130062824|NCT03495453|468184202|FG001|Overall Study|Withdrawal by Subject|1|||
130062825|NCT03084718|468184205|FG000|Overall Study|Withdrawal by Subject|4|||
130062826|NCT03084718|468184206|FG001|Overall Study|Withdrawal by Subject|3|||
130062827|NCT03084718|468184207|FG002|Overall Study|Withdrawal by Subject|4|||
130062828|NCT03084718|468184208|FG003|Overall Study|Withdrawal by Subject|0|||
130062829|NCT03084718|468184209|FG004|Overall Study|Withdrawal by Subject|0|||
130062830|NCT03084718|468184205|FG000|Overall Study|Physician Decision|1|||
129838132|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Adverse Event|3|||
129838133|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
129838134|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
129838135|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Not Treated|1|||
129838136|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Not Treated|0|||
129838137|NCT00256698|467371766|FG000|Overall Study|Withdrawal by Subject|7|||
129838138|NCT00256698|467371767|FG001|Overall Study|Withdrawal by Subject|7|||
129838139|NCT00256698|467371766|FG000|Overall Study|Adverse Event|13|||
129838140|NCT00256698|467371767|FG001|Overall Study|Adverse Event|6|||
129838141|NCT00256698|467371766|FG000|Overall Study|Protocol Violation|6|||
129838142|NCT00256698|467371767|FG001|Overall Study|Protocol Violation|5|||
129838143|NCT00256698|467371766|FG000|Overall Study|Lost to Follow-up|1|||
129838144|NCT00256698|467371767|FG001|Overall Study|Lost to Follow-up|3|||
129838145|NCT00256698|467371766|FG000|Overall Study|disease progression|97|||
129838146|NCT00256698|467371767|FG001|Overall Study|disease progression|105|||
129838147|NCT00256698|467371766|FG000|Overall Study|still ongoing at data cut-off|41|||
129838148|NCT00256698|467371767|FG001|Overall Study|still ongoing at data cut-off|46|||
129838149|NCT00256698|467371766|FG000|Overall Study|withdrawn due to osteoporosis|1|||
129838150|NCT00256698|467371767|FG001|Overall Study|withdrawn due to osteoporosis|0|||
129838151|NCT00256698|467371766|FG000|Overall Study|Prematurely Discontinued|1|||
129838152|NCT00256698|467371767|FG001|Overall Study|Prematurely Discontinued|0|||
129838153|NCT03962543|467371768|FG000|Treatment Phase|Death|0|||
129838154|NCT03962543|467371769|FG001|Treatment Phase|Death|1|||
129838155|NCT03962543|467371768|FG000|Treatment Phase|Withdrawal by Subject|3|||
129838156|NCT03962543|467371769|FG001|Treatment Phase|Withdrawal by Subject|0|||
129838157|NCT03962543|467371768|FG000|Treatment Phase|Adverse Event|3|||
129838158|NCT03962543|467371769|FG001|Treatment Phase|Adverse Event|12|||
129838159|NCT03962543|467371768|FG000|Treatment Phase|Lost to Follow-up|1|||
129838160|NCT03962543|467371769|FG001|Treatment Phase|Lost to Follow-up|2|||
129838161|NCT03962543|467371768|FG000|Treatment Phase|Radiographic PD|9|||
129838162|NCT03962543|467371769|FG001|Treatment Phase|Radiographic PD|3|||
129838163|NCT03962543|467371768|FG000|Treatment Phase|Participant Decision|3|||
129838164|NCT03962543|467371769|FG001|Treatment Phase|Participant Decision|8|||
129838165|NCT03962543|467371768|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
129838166|NCT03962543|467371769|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
129838167|NCT03962543|467371768|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
129838168|NCT03962543|467371769|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
129838169|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
129838170|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
129838171|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
129838172|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
129838173|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
129838174|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
129838175|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
129838176|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
129838177|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
129838178|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
129838179|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
129838180|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
129838181|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
129838182|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
129838183|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
129838184|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
129838185|NCT03264404|467373206|FG000|Overall Study|Death|2|||
129838186|NCT03264404|467373206|FG000|Overall Study|Physician Decision|1|||
129838187|NCT03264404|467373206|FG000|Overall Study|Disease Progression|28|||
129838188|NCT03264404|467373206|FG000|Overall Study|Adverse Event|1|||
129838189|NCT03264404|467373206|FG000|Overall Study|Off study prior to treatment|2|||
129838190|NCT03036566|467373209|FG000|Overall Study|Lost to Follow-up|3|||
129838191|NCT01852292|467373213|FG000|Overall Study|Untreated - did not receive study drug|3|||
129838192|NCT01852292|467373214|FG001|Overall Study|Untreated - did not receive study drug|1|||
129838193|NCT01852292|467373213|FG000|Overall Study|Death|9|||
129838194|NCT01852292|467373214|FG001|Overall Study|Death|8|||
129838195|NCT01852292|467373213|FG000|Overall Study|Patient/guardian decision|8|||
129838196|NCT01852292|467373214|FG001|Overall Study|Patient/guardian decision|4|||
129838197|NCT01852292|467373213|FG000|Overall Study|Adverse Event|8|||
129838198|NCT01852292|467373214|FG001|Overall Study|Adverse Event|11|||
129838199|NCT01852292|467373213|FG000|Overall Study|Physician Decision|6|||
129838200|NCT01852292|467373214|FG001|Overall Study|Physician Decision|2|||
129838201|NCT01852292|467373213|FG000|Overall Study|Protocol Violation|2|||
129838202|NCT01852292|467373214|FG001|Overall Study|Protocol Violation|0|||
129838203|NCT01852292|467373213|FG000|Overall Study|Non-compliance with study treatment|1|||
129838204|NCT01852292|467373214|FG001|Overall Study|Non-compliance with study treatment|0|||
129838205|NCT01852292|467373213|FG000|Overall Study|Study terminated by Sponsor|0|||
129838206|NCT01852292|467373214|FG001|Overall Study|Study terminated by Sponsor|1|||
129838207|NCT01852292|467373213|FG000|Overall Study|Progressive disease|42|||
130062831|NCT03084718|468184206|FG001|Overall Study|Physician Decision|0|||
130062832|NCT03084718|468184207|FG002|Overall Study|Physician Decision|0|||
130062833|NCT03084718|468184208|FG003|Overall Study|Physician Decision|0|||
130062834|NCT03084718|468184209|FG004|Overall Study|Physician Decision|0|||
130062835|NCT03084718|468184205|FG000|Overall Study|Adverse Event|3|||
130062836|NCT03084718|468184206|FG001|Overall Study|Adverse Event|5|||
130062837|NCT03084718|468184207|FG002|Overall Study|Adverse Event|5|||
130062838|NCT03084718|468184208|FG003|Overall Study|Adverse Event|8|||
130062839|NCT03084718|468184209|FG004|Overall Study|Adverse Event|2|||
130062840|NCT03084718|468184205|FG000|Overall Study|Lack of Efficacy|2|||
130062841|NCT03084718|468184206|FG001|Overall Study|Lack of Efficacy|0|||
130062842|NCT03084718|468184207|FG002|Overall Study|Lack of Efficacy|1|||
130062843|NCT03084718|468184208|FG003|Overall Study|Lack of Efficacy|4|||
130062844|NCT03084718|468184209|FG004|Overall Study|Lack of Efficacy|0|||
130062845|NCT03084718|468184205|FG000|Overall Study|Lost to Follow-up|0|||
130062846|NCT03084718|468184206|FG001|Overall Study|Lost to Follow-up|1|||
130062847|NCT03084718|468184207|FG002|Overall Study|Lost to Follow-up|0|||
130062848|NCT03084718|468184208|FG003|Overall Study|Lost to Follow-up|0|||
130062849|NCT03084718|468184209|FG004|Overall Study|Lost to Follow-up|2|||
130062850|NCT03084718|468184205|FG000|Overall Study|Protocol Violation|0|||
130062851|NCT03084718|468184206|FG001|Overall Study|Protocol Violation|0|||
130062852|NCT03084718|468184207|FG002|Overall Study|Protocol Violation|1|||
130062853|NCT03084718|468184208|FG003|Overall Study|Protocol Violation|0|||
130062854|NCT03084718|468184209|FG004|Overall Study|Protocol Violation|0|||
130062855|NCT03084718|468184205|FG000|Overall Study|Death|0|||
130062856|NCT03084718|468184206|FG001|Overall Study|Death|1|||
130062857|NCT03084718|468184207|FG002|Overall Study|Death|0|||
130062858|NCT03084718|468184208|FG003|Overall Study|Death|0|||
130062859|NCT03084718|468184209|FG004|Overall Study|Death|0|||
130062860|NCT03084718|468184205|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
130062861|NCT03084718|468184206|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
130062862|NCT03084718|468184207|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
130062863|NCT03084718|468184208|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
130062864|NCT03084718|468184209|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
130062865|NCT03341923|468184210|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
130062866|NCT03341923|468184211|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
130062867|NCT04929613|468184212|FG000|Overall Study|Withdrawal by Subject|12|||
130062868|NCT01742078|468184213|FG000|Overall Study|Withdrawal by Subject|0|||
130062869|NCT01742078|468184214|FG001|Overall Study|Withdrawal by Subject|0|||
130062870|NCT01742078|468184215|FG002|Overall Study|Withdrawal by Subject|0|||
130062871|NCT01742078|468184216|FG003|Overall Study|Withdrawal by Subject|1|||
130062872|NCT01742078|468184217|FG004|Overall Study|Withdrawal by Subject|0|||
130062873|NCT01742078|468184218|FG005|Overall Study|Withdrawal by Subject|0|||
130062874|NCT01742078|468184219|FG006|Overall Study|Withdrawal by Subject|0|||
130062875|NCT01742078|468184220|FG007|Overall Study|Withdrawal by Subject|0|||
130062876|NCT01742078|468184221|FG008|Overall Study|Withdrawal by Subject|0|||
130062877|NCT02767856|468184224|FG000|Overall Study|Lost to Follow-up|9|||
130062878|NCT02767856|468184225|FG001|Overall Study|Lost to Follow-up|1|||
130062879|NCT02767856|468184224|FG000|Overall Study|Withdrawal by Subject|2|||
130062880|NCT02767856|468184225|FG001|Overall Study|Withdrawal by Subject|1|||
130062881|NCT00424294|468184226|FG000|Overall Study|Adverse Event|4|||
130062882|NCT00424294|468184227|FG001|Overall Study|Adverse Event|10|||
130062883|NCT00424294|468184226|FG000|Overall Study|Lack of Efficacy|2|||
130062884|NCT00424294|468184227|FG001|Overall Study|Lack of Efficacy|1|||
130062885|NCT00424294|468184226|FG000|Overall Study|Withdrawal by Subject|1|||
130062886|NCT00424294|468184227|FG001|Overall Study|Withdrawal by Subject|2|||
130062887|NCT00424294|468184226|FG000|Overall Study|Other|0|||
130062888|NCT00424294|468184227|FG001|Overall Study|Other|2|||
130062889|NCT00424294|468184226|FG000|Overall Study|Randomized but not Treated|1|||
130062890|NCT00424294|468184227|FG001|Overall Study|Randomized but not Treated|0|||
130062891|NCT01464788|468184228|FG000|Overall Study|Lost to Follow-up|0|||
130062892|NCT01464788|468184229|FG001|Overall Study|Lost to Follow-up|1|||
130062893|NCT01464788|468184230|FG002|Overall Study|Lost to Follow-up|0|||
130062894|NCT01464788|468184228|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
130062895|NCT01464788|468184229|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
130062896|NCT01464788|468184230|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
130062897|NCT04397718|468184231|FG000|Overall Study|Death|7|||
130062898|NCT04397718|468184232|FG001|Overall Study|Death|11|||
130062899|NCT04397718|468184231|FG000|Overall Study|Lost to Follow-up|0|||
130062900|NCT04397718|468184232|FG001|Overall Study|Lost to Follow-up|4|||
130062901|NCT01797965|468184233|FG000|Overall Study|Adverse Event|104|||
130062902|NCT01797965|468184234|FG001|Overall Study|Adverse Event|129|||
130062903|NCT01797965|468184235|FG002|Overall Study|Adverse Event|4|||
130062904|NCT01797965|468184236|FG003|Overall Study|Adverse Event|21|||
130062905|NCT01797965|468184233|FG000|Overall Study|Lost to Follow-up|9|||
129838208|NCT01852292|467373214|FG001|Overall Study|Progressive disease|52|||
130114224|NCT01452529|468379590|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
130114225|NCT01452529|468379591|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
130114226|NCT01452529|468379592|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
130114227|NCT01452529|468379590|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
130114228|NCT01452529|468379591|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
130114229|NCT01452529|468379592|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
130114230|NCT01452529|468379590|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
130114231|NCT01452529|468379591|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
130114232|NCT01452529|468379592|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
130114233|NCT01452529|468379590|FG000|Double-blind (DB) Period|Administrative|0|||
130114234|NCT01452529|468379591|FG001|Double-blind (DB) Period|Administrative|11|||
130114235|NCT01452529|468379592|FG002|Double-blind (DB) Period|Administrative|7|||
130114236|NCT03347695|468379599|FG000|Overall Study|Death|0|||
130114237|NCT03347695|468379600|FG001|Overall Study|Death|4|||
130114238|NCT03347695|468379599|FG000|Overall Study|Lost to Follow-up|0|||
130114239|NCT03347695|468379600|FG001|Overall Study|Lost to Follow-up|1|||
130114240|NCT02668783|468379621|FG000|Overall Study|Pregnancy|0|||
130114241|NCT02668783|468379622|FG001|Overall Study|Pregnancy|1|||
130114242|NCT02668783|468379621|FG000|Overall Study|Protocol Violation|2|||
130114243|NCT02668783|468379622|FG001|Overall Study|Protocol Violation|1|||
130114244|NCT02668783|468379621|FG000|Overall Study|Study terminated by sponsor|9|||
130114245|NCT02668783|468379622|FG001|Overall Study|Study terminated by sponsor|10|||
130114246|NCT02668783|468379621|FG000|Overall Study|Subject moved|1|||
130114247|NCT02668783|468379622|FG001|Overall Study|Subject moved|0|||
130114248|NCT02668783|468379621|FG000|Overall Study|Withdrawal by Subject|1|||
130114249|NCT02668783|468379622|FG001|Overall Study|Withdrawal by Subject|0|||
130114250|NCT02884206|468379623|FG000|Valsartan Run-in Period|Death|1|||
130114251|NCT02884206|468379624|FG001|Valsartan Run-in Period|Death|0|||
130114252|NCT02884206|468379625|FG002|Valsartan Run-in Period|Death|0|||
130114253|NCT02884206|468379623|FG000|Valsartan Run-in Period|Adverse Event|31|||
130114254|NCT02884206|468379624|FG001|Valsartan Run-in Period|Adverse Event|0|||
130114255|NCT02884206|468379625|FG002|Valsartan Run-in Period|Adverse Event|0|||
130114256|NCT02884206|468379623|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
130114257|NCT02884206|468379624|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
130114258|NCT02884206|468379625|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
130114259|NCT02884206|468379623|FG000|Valsartan Run-in Period|Protocol deviation|4|||
130114260|NCT02884206|468379624|FG001|Valsartan Run-in Period|Protocol deviation|0|||
130114261|NCT02884206|468379625|FG002|Valsartan Run-in Period|Protocol deviation|0|||
130114262|NCT02884206|468379623|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
130114263|NCT02884206|468379624|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
130114264|NCT02884206|468379625|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
130114265|NCT02884206|468379623|FG000|Valsartan Run-in Period|Physician Decision|1|||
129838209|NCT01914666|467373217|FG000|Treatment Period|Lack of Efficacy|0|||
129838210|NCT01914666|467373218|FG001|Treatment Period|Lack of Efficacy|0|||
129838211|NCT01914666|467373219|FG002|Treatment Period|Lack of Efficacy|2|||
129838212|NCT01914666|467373217|FG000|Treatment Period|Adverse Event|10|||
129838213|NCT01914666|467373218|FG001|Treatment Period|Adverse Event|4|||
129838214|NCT01914666|467373219|FG002|Treatment Period|Adverse Event|2|||
129838215|NCT01914666|467373217|FG000|Treatment Period|Withdrawal by Subject|3|||
129838216|NCT01914666|467373218|FG001|Treatment Period|Withdrawal by Subject|2|||
130062906|NCT01797965|468184234|FG001|Overall Study|Lost to Follow-up|8|||
130062907|NCT01797965|468184235|FG002|Overall Study|Lost to Follow-up|1|||
130062908|NCT01797965|468184236|FG003|Overall Study|Lost to Follow-up|2|||
130062909|NCT01797965|468184233|FG000|Overall Study|Consent withdrawn|130|||
130062910|NCT01797965|468184234|FG001|Overall Study|Consent withdrawn|117|||
130062911|NCT01797965|468184235|FG002|Overall Study|Consent withdrawn|3|||
130062912|NCT01797965|468184236|FG003|Overall Study|Consent withdrawn|35|||
130062913|NCT01797965|468184233|FG000|Overall Study|Investigator decision|21|||
130062914|NCT01797965|468184234|FG001|Overall Study|Investigator decision|15|||
130062915|NCT01797965|468184235|FG002|Overall Study|Investigator decision|0|||
130062916|NCT01797965|468184236|FG003|Overall Study|Investigator decision|0|||
130062917|NCT01797965|468184233|FG000|Overall Study|Death|2|||
130062918|NCT01797965|468184234|FG001|Overall Study|Death|4|||
130062919|NCT01797965|468184235|FG002|Overall Study|Death|0|||
130062920|NCT01797965|468184236|FG003|Overall Study|Death|0|||
130062921|NCT01797965|468184233|FG000|Overall Study|Disease progression, defined by protocol|3|||
130062922|NCT01797965|468184234|FG001|Overall Study|Disease progression, defined by protocol|1|||
130114266|NCT02884206|468379624|FG001|Valsartan Run-in Period|Physician Decision|0|||
130114267|NCT02884206|468379625|FG002|Valsartan Run-in Period|Physician Decision|0|||
130114268|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Adverse Event|38|||
130114269|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Adverse Event|0|||
130114270|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Adverse Event|0|||
129838217|NCT01914666|467373219|FG002|Treatment Period|Withdrawal by Subject|2|||
129838218|NCT01914666|467373217|FG000|Treatment Period|Physician Decision|0|||
130062923|NCT01797965|468184235|FG002|Overall Study|Disease progression, defined by protocol|0|||
130114271|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Death|2|||
129838219|NCT01914666|467373218|FG001|Treatment Period|Physician Decision|0|||
129838220|NCT01914666|467373219|FG002|Treatment Period|Physician Decision|2|||
129838221|NCT02586012|467373220|FG000|Overall Study|Withdrawal by Subject|1|||
129838222|NCT02586012|467373221|FG001|Overall Study|Withdrawal by Subject|1|||
129838223|NCT02586012|467373222|FG002|Overall Study|Withdrawal by Subject|0|||
129838224|NCT02586012|467373223|FG003|Overall Study|Withdrawal by Subject|1|||
129838225|NCT02586012|467373224|FG004|Overall Study|Withdrawal by Subject|0|||
129838226|NCT02586012|467373225|FG005|Overall Study|Withdrawal by Subject|2|||
129838227|NCT02586012|467373220|FG000|Overall Study|Protocol Violation|0|||
129838228|NCT02586012|467373221|FG001|Overall Study|Protocol Violation|0|||
129838229|NCT02586012|467373222|FG002|Overall Study|Protocol Violation|0|||
129838230|NCT02586012|467373223|FG003|Overall Study|Protocol Violation|0|||
129838231|NCT02586012|467373224|FG004|Overall Study|Protocol Violation|0|||
129838232|NCT02586012|467373225|FG005|Overall Study|Protocol Violation|1|||
129838233|NCT02586012|467373220|FG000|Overall Study|study terminated|0|||
129838234|NCT02586012|467373221|FG001|Overall Study|study terminated|2|||
129838235|NCT02586012|467373222|FG002|Overall Study|study terminated|1|||
129898757|NCT00567879|467590034|FG005|Overall Study|Abnormal test procedure(s)|0|||
129898758|NCT00567879|467590029|FG000|Overall Study|Withdrawal by Subject|0|||
129898759|NCT00567879|467590030|FG001|Overall Study|Withdrawal by Subject|0|||
129898760|NCT00567879|467590031|FG002|Overall Study|Withdrawal by Subject|3|||
129898761|NCT00567879|467590032|FG003|Overall Study|Withdrawal by Subject|1|||
129898762|NCT00567879|467590033|FG004|Overall Study|Withdrawal by Subject|0|||
129898763|NCT00567879|467590034|FG005|Overall Study|Withdrawal by Subject|0|||
129898764|NCT00567879|467590029|FG000|Overall Study|New cancer therapy|0|||
129898765|NCT00567879|467590030|FG001|Overall Study|New cancer therapy|0|||
129898766|NCT00567879|467590031|FG002|Overall Study|New cancer therapy|1|||
129838236|NCT02586012|467373223|FG003|Overall Study|study terminated|1|||
129838237|NCT02586012|467373224|FG004|Overall Study|study terminated|1|||
129838238|NCT02586012|467373225|FG005|Overall Study|study terminated|0|||
129838239|NCT03277846|467373226|FG000|Overall Study|Inpatient stay too brief|12|||
129898767|NCT00567879|467590032|FG003|Overall Study|New cancer therapy|0|||
129898768|NCT00567879|467590033|FG004|Overall Study|New cancer therapy|0|||
129838240|NCT03277846|467373227|FG001|Overall Study|Inpatient stay too brief|11|||
129838241|NCT04013191|467373228|FG000|Overall Study|Adverse Event|1|||
129838242|NCT04013191|467373229|FG001|Overall Study|Adverse Event|0|||
129838243|NCT01275066|467373238|FG000|Overall Study|Withdrawal by Subject|0|||
129838244|NCT01275066|467373239|FG001|Overall Study|Withdrawal by Subject|0|||
129838245|NCT01275066|467373240|FG002|Overall Study|Withdrawal by Subject|1|||
129838246|NCT01275066|467373238|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
129838247|NCT01275066|467373239|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
129838248|NCT01275066|467373240|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
129838249|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
129838250|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
129838251|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
129838252|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
129838253|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
129838254|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
129838255|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
129838256|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
129838257|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
129838258|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
129838259|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
129838260|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
129838261|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
129898769|NCT00567879|467590034|FG005|Overall Study|New cancer therapy|0|||
129898770|NCT00567879|467590029|FG000|Overall Study|Disease progression|5|||
129898771|NCT00567879|467590030|FG001|Overall Study|Disease progression|7|||
129898772|NCT00567879|467590031|FG002|Overall Study|Disease progression|15|||
129898773|NCT00567879|467590032|FG003|Overall Study|Disease progression|5|||
129898774|NCT00567879|467590033|FG004|Overall Study|Disease progression|11|||
129898775|NCT00567879|467590034|FG005|Overall Study|Disease progression|3|||
129838262|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
129898776|NCT00470626|467590035|FG000|Overall Study|Lost to Follow-up|10|||
129838263|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
129898777|NCT00470626|467590035|FG000|Overall Study|Withdrawal by Subject|7|||
129898778|NCT00777556|467590036|FG000|Overall Study|Inappropriate self-selection|34|||
129838264|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
129838265|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
129838266|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
129898779|NCT00777556|467590036|FG000|Overall Study|Dispensed but did not use product|12|||
129898780|NCT00777556|467590036|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
129898781|NCT01729819|467590041|FG000|Overall Study|Adverse Event|2|||
129898782|NCT01729819|467590042|FG001|Overall Study|Adverse Event|4|||
129898783|NCT01729819|467590041|FG000|Overall Study|Lack of Efficacy|1|||
130114272|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Death|0|||
130114273|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Death|0|||
130114274|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
130114275|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
130114276|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
130114277|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
130114278|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
130114279|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
130114280|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
130114281|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
130114282|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
130114283|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Physician Decision|1|||
130114284|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Physician Decision|0|||
130114285|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Physician Decision|0|||
130114286|NCT02884206|468379623|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
130114287|NCT02884206|468379624|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
130114288|NCT02884206|468379625|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
130114289|NCT02884206|468379623|FG000|Double-Blind Period|Death|0|||
130114290|NCT02884206|468379624|FG001|Double-Blind Period|Death|28|||
130114291|NCT02884206|468379625|FG002|Double-Blind Period|Death|39|||
130114292|NCT02884206|468379623|FG000|Double-Blind Period|Patient/guardian decision|0|||
130114293|NCT02884206|468379624|FG001|Double-Blind Period|Patient/guardian decision|10|||
130114294|NCT02884206|468379625|FG002|Double-Blind Period|Patient/guardian decision|13|||
130114295|NCT02884206|468379623|FG000|Double-Blind Period|Lost to Follow-up|0|||
130114296|NCT02884206|468379624|FG001|Double-Blind Period|Lost to Follow-up|4|||
130114297|NCT02884206|468379625|FG002|Double-Blind Period|Lost to Follow-up|4|||
130114298|NCT02884206|468379623|FG000|Double-Blind Period|Physician Decision|0|||
130114299|NCT02884206|468379624|FG001|Double-Blind Period|Physician Decision|2|||
130114300|NCT02884206|468379625|FG002|Double-Blind Period|Physician Decision|0|||
130114301|NCT02884206|468379623|FG000|Double-Blind Period|Adverse Event|0|||
130114302|NCT02884206|468379624|FG001|Double-Blind Period|Adverse Event|0|||
130114303|NCT02884206|468379625|FG002|Double-Blind Period|Adverse Event|3|||
130114304|NCT02884206|468379623|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
130114305|NCT02884206|468379624|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
130114306|NCT02884206|468379625|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
130114307|NCT00112489|468379628|FG000|Overall Study|Refused further treatment|8|||
130114308|NCT00112489|468379628|FG000|Overall Study|Adverse Event|12|||
130114309|NCT00112489|468379628|FG000|Overall Study|Death|2|||
130114310|NCT00112489|468379628|FG000|Overall Study|Other, Not Specified|9|||
130114311|NCT00112489|468379628|FG000|Overall Study|Patient never treated|2|||
130114312|NCT00112489|468379628|FG000|Overall Study|Ineligible|7|||
130114313|NCT01003886|468379629|FG000|Overall Study|Lack of Efficacy|5|||
130114314|NCT01003886|468379629|FG000|Overall Study|Lost to Follow-up|169|||
130114315|NCT01003886|468379629|FG000|Overall Study|Withdrawal by Subject|39|||
130114316|NCT01003886|468379629|FG000|Overall Study|Other|14|||
130114317|NCT01003886|468379629|FG000|Overall Study|Adverse Event|3|||
130114318|NCT00909727|468379630|FG000|Overall Study|Adverse Event|1|||
130114319|NCT00909727|468379631|FG001|Overall Study|Adverse Event|0|||
130114320|NCT00909727|468379630|FG000|Overall Study|Wrong Genotype|1|||
129838267|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
129838268|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
129838269|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
129838270|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
129838271|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
129838272|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
129838273|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
129838274|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
129898784|NCT01729819|467590042|FG001|Overall Study|Lack of Efficacy|0|||
129898785|NCT01729819|467590041|FG000|Overall Study|Lost to Follow-up|2|||
129898786|NCT01729819|467590042|FG001|Overall Study|Lost to Follow-up|0|||
130114321|NCT00909727|468379631|FG001|Overall Study|Wrong Genotype|0|||
130114322|NCT00909727|468379630|FG000|Overall Study|Withdrawal of Consent|1|||
130114323|NCT00909727|468379631|FG001|Overall Study|Withdrawal of Consent|0|||
130114324|NCT00909727|468379630|FG000|Overall Study|Prohibited Medication|1|||
130114325|NCT00909727|468379631|FG001|Overall Study|Prohibited Medication|0|||
130114326|NCT05751629|468379632|FG000|Overall Study|Withdrawal by Subject|6|||
130114327|NCT05751629|468379632|FG000|Overall Study|Death|25|||
130114328|NCT05751629|468379632|FG000|Overall Study|Study Site Closed|9|||
130114329|NCT05751629|468379632|FG000|Overall Study|Physician Decision|1|||
130114330|NCT00295854|468379637|FG000|Overall Study|Adverse Event|7|||
130114331|NCT00295854|468379638|FG001|Overall Study|Adverse Event|7|||
130114332|NCT00295854|468379639|FG002|Overall Study|Adverse Event|6|||
130114333|NCT00295854|468379637|FG000|Overall Study|Protocol Violation|1|||
130114334|NCT00295854|468379638|FG001|Overall Study|Protocol Violation|1|||
129838275|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
130114335|NCT00295854|468379639|FG002|Overall Study|Protocol Violation|1|||
130114336|NCT00295854|468379637|FG000|Overall Study|Lost to Follow-up|2|||
130114337|NCT00295854|468379638|FG001|Overall Study|Lost to Follow-up|0|||
130114338|NCT00295854|468379639|FG002|Overall Study|Lost to Follow-up|1|||
130114339|NCT00295854|468379637|FG000|Overall Study|Withdrawal by Subject|3|||
130114340|NCT00295854|468379638|FG001|Overall Study|Withdrawal by Subject|7|||
130114341|NCT00295854|468379639|FG002|Overall Study|Withdrawal by Subject|4|||
130114342|NCT00295854|468379637|FG000|Overall Study|did not continue to meet criteria|1|||
130114343|NCT00295854|468379638|FG001|Overall Study|did not continue to meet criteria|1|||
130114344|NCT00295854|468379639|FG002|Overall Study|did not continue to meet criteria|2|||
130114345|NCT00295854|468379637|FG000|Overall Study|required a prohibited medication|1|||
130114346|NCT00295854|468379638|FG001|Overall Study|required a prohibited medication|0|||
130114347|NCT00295854|468379639|FG002|Overall Study|required a prohibited medication|0|||
130114348|NCT00295854|468379637|FG000|Overall Study|Other|3|||
130114349|NCT00295854|468379638|FG001|Overall Study|Other|5|||
130114350|NCT00295854|468379639|FG002|Overall Study|Other|1|||
130114351|NCT00772577|468379640|FG000|Overall Study|Adverse Event|6|||
130114352|NCT00772577|468379641|FG001|Overall Study|Adverse Event|3|||
130114353|NCT00772577|468379640|FG000|Overall Study|Abnormal laboratory values|0|||
130114354|NCT00772577|468379641|FG001|Overall Study|Abnormal laboratory values|1|||
130114355|NCT00772577|468379640|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130114356|NCT00772577|468379641|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129838276|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
129838277|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
129838278|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
129838279|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
129838280|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
129838281|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
129838282|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
129838283|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
129838284|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
129838285|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
129838286|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
129838287|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
129838288|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
129838289|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
129838290|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
129838291|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
129838292|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
129838293|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
129838294|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
129838295|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
129838296|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
129838297|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
129838298|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
129838299|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
129838300|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
129838301|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
129838302|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
129838303|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
129838304|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
129838305|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
129838306|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
129838307|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
129838308|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
129838309|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
129838310|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
129838311|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
129838312|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
129838313|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
130114357|NCT00772577|468379640|FG000|Overall Study|Patient withdrew consent|8|||
130114358|NCT00772577|468379641|FG001|Overall Study|Patient withdrew consent|5|||
130114359|NCT00772577|468379640|FG000|Overall Study|Lost to Follow-up|4|||
130114360|NCT00772577|468379641|FG001|Overall Study|Lost to Follow-up|3|||
130114361|NCT00772577|468379640|FG000|Overall Study|Administrative problems|2|||
130114362|NCT00772577|468379641|FG001|Overall Study|Administrative problems|1|||
130114363|NCT00772577|468379640|FG000|Overall Study|Protocol Deviation|3|||
129838314|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
129838315|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
129838316|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
129838317|NCT04033003|467373250|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
129838318|NCT04033003|467373251|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
129838319|NCT04033003|467373250|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
129838320|NCT04033003|467373251|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
129838321|NCT04033003|467373250|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
129838322|NCT04033003|467373251|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
129838323|NCT02487394|467373252|FG000|Phase 1|Withdrawal by Subject|0|||
129838324|NCT02487394|467373253|FG001|Phase 1|Withdrawal by Subject|1|||
129838325|NCT00782210|467373254|FG000|Overall Study|Adverse Event|21|||
129838326|NCT00782210|467373255|FG001|Overall Study|Adverse Event|17|||
129838327|NCT00782210|467373256|FG002|Overall Study|Adverse Event|16|||
129838328|NCT00782210|467373254|FG000|Overall Study|Lost to Follow-up|2|||
129838329|NCT00782210|467373255|FG001|Overall Study|Lost to Follow-up|1|||
129838330|NCT00782210|467373256|FG002|Overall Study|Lost to Follow-up|2|||
129838331|NCT00782210|467373254|FG000|Overall Study|Withdrawal by Subject|11|||
129838332|NCT00782210|467373255|FG001|Overall Study|Withdrawal by Subject|8|||
129838333|NCT00782210|467373256|FG002|Overall Study|Withdrawal by Subject|11|||
129838334|NCT00782210|467373254|FG000|Overall Study|Non compliance with protocol|0|||
129838335|NCT00782210|467373255|FG001|Overall Study|Non compliance with protocol|3|||
129838336|NCT00782210|467373256|FG002|Overall Study|Non compliance with protocol|2|||
129838337|NCT00782210|467373254|FG000|Overall Study|Lack of Efficacy|13|||
129838338|NCT00782210|467373255|FG001|Overall Study|Lack of Efficacy|4|||
129838339|NCT00782210|467373256|FG002|Overall Study|Lack of Efficacy|1|||
129838340|NCT00782210|467373254|FG000|Overall Study|Other reason not described above|3|||
129838341|NCT00782210|467373255|FG001|Overall Study|Other reason not described above|2|||
129838342|NCT00782210|467373256|FG002|Overall Study|Other reason not described above|3|||
129838343|NCT00735371|467373257|FG000|Overall Study|Adverse Event|3|||
129838344|NCT00735371|467373258|FG001|Overall Study|Adverse Event|3|||
129838345|NCT00735371|467373259|FG002|Overall Study|Adverse Event|4|||
129838346|NCT00735371|467373260|FG003|Overall Study|Adverse Event|1|||
129838347|NCT00735371|467373257|FG000|Overall Study|Protocol Violation|2|||
129838348|NCT00735371|467373258|FG001|Overall Study|Protocol Violation|2|||
129838349|NCT00735371|467373259|FG002|Overall Study|Protocol Violation|0|||
129838350|NCT00735371|467373260|FG003|Overall Study|Protocol Violation|3|||
129838351|NCT00735371|467373257|FG000|Overall Study|Withdrawal by Subject|0|||
129838352|NCT00735371|467373258|FG001|Overall Study|Withdrawal by Subject|2|||
129838353|NCT00735371|467373259|FG002|Overall Study|Withdrawal by Subject|2|||
129838354|NCT00735371|467373260|FG003|Overall Study|Withdrawal by Subject|0|||
129838355|NCT00735371|467373257|FG000|Overall Study|Lost to Follow-up|1|||
129838356|NCT00735371|467373258|FG001|Overall Study|Lost to Follow-up|1|||
129838357|NCT00735371|467373259|FG002|Overall Study|Lost to Follow-up|3|||
129838358|NCT00735371|467373260|FG003|Overall Study|Lost to Follow-up|1|||
129838359|NCT00735371|467373257|FG000|Overall Study|Lack of Efficacy|4|||
129838360|NCT00735371|467373258|FG001|Overall Study|Lack of Efficacy|2|||
129838361|NCT00735371|467373259|FG002|Overall Study|Lack of Efficacy|0|||
129838362|NCT00735371|467373260|FG003|Overall Study|Lack of Efficacy|4|||
129838363|NCT00735371|467373257|FG000|Overall Study|Sponsor Decision|3|||
129838364|NCT00735371|467373258|FG001|Overall Study|Sponsor Decision|1|||
129838365|NCT00735371|467373259|FG002|Overall Study|Sponsor Decision|0|||
129838366|NCT00735371|467373260|FG003|Overall Study|Sponsor Decision|1|||
129838367|NCT00735371|467373257|FG000|Overall Study|Protocol Violation|0|||
129838368|NCT00735371|467373258|FG001|Overall Study|Protocol Violation|1|||
129838369|NCT00735371|467373259|FG002|Overall Study|Protocol Violation|2|||
129838370|NCT00735371|467373260|FG003|Overall Study|Protocol Violation|0|||
129838371|NCT00735371|467373257|FG000|Overall Study|Prior Vyvanse Exposure|1|||
129838372|NCT00735371|467373258|FG001|Overall Study|Prior Vyvanse Exposure|1|||
129838373|NCT00735371|467373259|FG002|Overall Study|Prior Vyvanse Exposure|0|||
129838374|NCT00735371|467373260|FG003|Overall Study|Prior Vyvanse Exposure|0|||
129838375|NCT00735371|467373257|FG000|Overall Study|Exclusion criteria|1|||
129838376|NCT00735371|467373258|FG001|Overall Study|Exclusion criteria|0|||
129838377|NCT00735371|467373259|FG002|Overall Study|Exclusion criteria|0|||
129838378|NCT00735371|467373260|FG003|Overall Study|Exclusion criteria|0|||
129838379|NCT00994448|467373261|FG000|Overall Study|Adverse Event|1|||
129838380|NCT00994448|467373262|FG001|Overall Study|Adverse Event|0|||
129838381|NCT00994448|467373261|FG000|Overall Study|Lost to Follow-up|5|||
129838382|NCT00994448|467373262|FG001|Overall Study|Lost to Follow-up|1|||
129838383|NCT00994448|467373261|FG000|Overall Study|Withdrawal by Subject|1|||
129838384|NCT00994448|467373262|FG001|Overall Study|Withdrawal by Subject|1|||
129838385|NCT00994448|467373261|FG000|Overall Study|Physician Decision|1|||
129838386|NCT00994448|467373262|FG001|Overall Study|Physician Decision|0|||
129838387|NCT00436748|467373267|FG000|Overall Study|Ineligibility Determined|1|||
129838388|NCT00436748|467373268|FG001|Overall Study|Ineligibility Determined|1|||
129838389|NCT00436748|467373267|FG000|Overall Study|Adverse Event|0|||
129838390|NCT00436748|467373268|FG001|Overall Study|Adverse Event|2|||
129838391|NCT00436748|467373267|FG000|Overall Study|Consent Withdrawn|1|||
130114364|NCT00772577|468379641|FG001|Overall Study|Protocol Deviation|2|||
130114365|NCT00672620|468379642|FG000|Overall Study|Adverse Event|7|||
130114366|NCT00672620|468379643|FG001|Overall Study|Adverse Event|7|||
130114367|NCT00672620|468379644|FG002|Overall Study|Adverse Event|12|||
130114368|NCT00672620|468379645|FG003|Overall Study|Adverse Event|17|||
130114369|NCT00672620|468379642|FG000|Overall Study|Lack of Efficacy|1|||
130114370|NCT00672620|468379643|FG001|Overall Study|Lack of Efficacy|2|||
130114371|NCT00672620|468379644|FG002|Overall Study|Lack of Efficacy|2|||
130114372|NCT00672620|468379645|FG003|Overall Study|Lack of Efficacy|0|||
130114373|NCT00672620|468379642|FG000|Overall Study|Noncompliance with Study Drug|3|||
130114374|NCT00672620|468379643|FG001|Overall Study|Noncompliance with Study Drug|4|||
130114375|NCT00672620|468379644|FG002|Overall Study|Noncompliance with Study Drug|0|||
130114376|NCT00672620|468379645|FG003|Overall Study|Noncompliance with Study Drug|2|||
130114377|NCT00672620|468379642|FG000|Overall Study|Protocol Deviations|5|||
130114378|NCT00672620|468379643|FG001|Overall Study|Protocol Deviations|7|||
130114379|NCT00672620|468379644|FG002|Overall Study|Protocol Deviations|2|||
130114380|NCT00672620|468379645|FG003|Overall Study|Protocol Deviations|5|||
130114381|NCT00672620|468379642|FG000|Overall Study|Withdrawal of Consent|6|||
130114382|NCT00672620|468379643|FG001|Overall Study|Withdrawal of Consent|12|||
130114383|NCT00672620|468379644|FG002|Overall Study|Withdrawal of Consent|5|||
130114384|NCT00672620|468379645|FG003|Overall Study|Withdrawal of Consent|6|||
130114385|NCT00672620|468379642|FG000|Overall Study|Lost to Follow-up|8|||
130114386|NCT00672620|468379643|FG001|Overall Study|Lost to Follow-up|19|||
130114387|NCT00672620|468379644|FG002|Overall Study|Lost to Follow-up|8|||
130114388|NCT00672620|468379645|FG003|Overall Study|Lost to Follow-up|11|||
130114389|NCT00672620|468379642|FG000|Overall Study|Reason not Specified|3|||
130114390|NCT00672620|468379643|FG001|Overall Study|Reason not Specified|3|||
130114391|NCT00672620|468379644|FG002|Overall Study|Reason not Specified|2|||
130114392|NCT00672620|468379645|FG003|Overall Study|Reason not Specified|1|||
130114393|NCT03211156|468379646|FG000|Overall Study|Withdrawal by Subject|0|||
130114394|NCT03211156|468379647|FG001|Overall Study|Withdrawal by Subject|2|||
130114395|NCT03211156|468379646|FG000|Overall Study|Lost to Follow-up|1|||
130114396|NCT03211156|468379647|FG001|Overall Study|Lost to Follow-up|1|||
130114397|NCT03211156|468379646|FG000|Overall Study|Adverse Event|1|||
130114398|NCT03211156|468379647|FG001|Overall Study|Adverse Event|0|||
130114399|NCT00829413|468379650|FG000|Overall Study|No study drug admimnistered|13|||
130114400|NCT00829413|468379650|FG000|Overall Study|Training Patients|67|||
130114401|NCT00829413|468379650|FG000|Overall Study|No truth standard procedure available|9|||
129838392|NCT00436748|467373268|FG001|Overall Study|Consent Withdrawn|4|||
129838393|NCT00436748|467373267|FG000|Overall Study|Administrative Decision|1|||
129838394|NCT00436748|467373268|FG001|Overall Study|Administrative Decision|0|||
129838395|NCT00436748|467373267|FG000|Overall Study|Lost to Follow-up|0|||
129838396|NCT00436748|467373268|FG001|Overall Study|Lost to Follow-up|1|||
129838397|NCT00436748|467373267|FG000|Overall Study|Protocol-specified Criteria|5|||
129838398|NCT00436748|467373268|FG001|Overall Study|Protocol-specified Criteria|4|||
129838399|NCT00436748|467373267|FG000|Overall Study|Other|3|||
129838400|NCT00436748|467373268|FG001|Overall Study|Other|0|||
129838401|NCT01610791|467373269|FG000|Overall Study|Lost to Follow-up|7|||
129838402|NCT01610791|467373269|FG000|Overall Study|Adverse Event|6|||
129838403|NCT01610791|467373269|FG000|Overall Study|Physician Decision|1|||
129838404|NCT01610791|467373269|FG000|Overall Study|Adverse event and Investigator decision|1|||
129838405|NCT01610791|467373269|FG000|Overall Study|Death|1|||
129838406|NCT01610791|467373269|FG000|Overall Study|Not determined|5|||
129838407|NCT00850200|467373272|FG000|Overall Study|Physician Decision|2|||
129838408|NCT00850200|467373272|FG000|Overall Study|Did not recieve treatment|2|||
129838409|NCT00850200|467373272|FG000|Overall Study|Withdrawal by Subject|1|||
129838410|NCT02711800|467373273|FG000|Overall Study|Lost to Follow-up|1|||
129838411|NCT02711800|467373273|FG000|Overall Study|Withdrawal by Subject|1|||
129838412|NCT04164901|467373277|FG000|Overall Study|Withdrawal by Subject|4|||
129838413|NCT04164901|467373278|FG001|Overall Study|Withdrawal by Subject|4|||
129838414|NCT05040152|467373283|FG000|Overall Study|Withdrawal by Subject|5|||
129838415|NCT05040152|467373284|FG001|Overall Study|Withdrawal by Subject|0|||
129838416|NCT05040152|467373283|FG000|Overall Study|Lost to Follow-up|0|||
129838417|NCT05040152|467373284|FG001|Overall Study|Lost to Follow-up|2|||
129838418|NCT02046148|467373292|FG000|Overall Study|Lost to Follow-up|1|||
129838419|NCT02046148|467373293|FG001|Overall Study|Lost to Follow-up|1|||
129838420|NCT02046148|467373292|FG000|Overall Study|Withdrawal by Subject|0|||
129838421|NCT02046148|467373293|FG001|Overall Study|Withdrawal by Subject|2|||
129838422|NCT00314574|467373294|FG000|Overall Study|Death|3|||
130114402|NCT00829413|468379650|FG000|Overall Study|Technically inadequate truth standard|2|||
130114403|NCT00829413|468379650|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
130114404|NCT03487796|468379652|FG000|Overall Study|Lost to Follow-up|18|||
130114405|NCT03487796|468379653|FG001|Overall Study|Lost to Follow-up|6|||
129838423|NCT00314574|467373295|FG001|Overall Study|Death|0|||
129838424|NCT00314574|467373294|FG000|Overall Study|Adverse Event|11|||
130114406|NCT04272775|468379654|FG000|Overall Study|Study Terminated by Sponsor|1|||
130114407|NCT04272775|468379655|FG001|Overall Study|Study Terminated by Sponsor|0|||
129838425|NCT00314574|467373295|FG001|Overall Study|Adverse Event|16|||
129838426|NCT00314574|467373294|FG000|Overall Study|Lost to Follow-up|19|||
129838427|NCT00314574|467373295|FG001|Overall Study|Lost to Follow-up|25|||
129838428|NCT00314574|467373294|FG000|Overall Study|Withdrawal by Subject|33|||
129838429|NCT00314574|467373295|FG001|Overall Study|Withdrawal by Subject|22|||
129838430|NCT00314574|467373294|FG000|Overall Study|Physician Decision|22|||
129838431|NCT00314574|467373295|FG001|Overall Study|Physician Decision|15|||
129838432|NCT00314574|467373294|FG000|Overall Study|Pregnancy|6|||
129838433|NCT00314574|467373295|FG001|Overall Study|Pregnancy|4|||
129838434|NCT00314574|467373294|FG000|Overall Study|Data unknown at database lock|0|||
129838435|NCT00314574|467373295|FG001|Overall Study|Data unknown at database lock|1|||
129838436|NCT00449956|467373296|FG000|Overall Study|Adverse Event|7|||
129838437|NCT00449956|467373297|FG001|Overall Study|Adverse Event|1|||
129838438|NCT00449956|467373298|FG002|Overall Study|Adverse Event|6|||
129838439|NCT00449956|467373296|FG000|Overall Study|Lack of Efficacy|0|||
129838440|NCT00449956|467373297|FG001|Overall Study|Lack of Efficacy|0|||
129838441|NCT00449956|467373298|FG002|Overall Study|Lack of Efficacy|1|||
129838442|NCT00449956|467373296|FG000|Overall Study|Protocol Violation|1|||
129838443|NCT00449956|467373297|FG001|Overall Study|Protocol Violation|1|||
129838444|NCT00449956|467373298|FG002|Overall Study|Protocol Violation|1|||
129838445|NCT00449956|467373296|FG000|Overall Study|Withdrawal by Subject|0|||
129838446|NCT00449956|467373297|FG001|Overall Study|Withdrawal by Subject|1|||
129838447|NCT00449956|467373298|FG002|Overall Study|Withdrawal by Subject|0|||
129898787|NCT01729819|467590041|FG000|Overall Study|Other reason|1|||
129898788|NCT01729819|467590042|FG001|Overall Study|Other reason|0|||
129898789|NCT01729819|467590041|FG000|Overall Study|Protocol Violation|0|||
129898790|NCT01729819|467590042|FG001|Overall Study|Protocol Violation|1|||
129898791|NCT01729819|467590041|FG000|Overall Study|Withdrawal by Subject|0|||
129898792|NCT01729819|467590042|FG001|Overall Study|Withdrawal by Subject|2|||
129898793|NCT03646669|467590043|FG000|Overall Study|Withdrawal by Subject|5|||
129898794|NCT03646669|467590044|FG001|Overall Study|Withdrawal by Subject|0|||
129898795|NCT03439124|467590049|FG000|Overall Study|Adverse Event|2|||
129898796|NCT03439124|467590050|FG001|Overall Study|Adverse Event|0|||
129898797|NCT03439124|467590049|FG000|Overall Study|Lost to Follow-up|1|||
129898798|NCT03439124|467590050|FG001|Overall Study|Lost to Follow-up|0|||
129898799|NCT03439124|467590049|FG000|Overall Study|Other reasons|1|||
129898800|NCT03439124|467590050|FG001|Overall Study|Other reasons|0|||
129898801|NCT01451814|467590051|FG000|Overall Study|Withdrawal by Subject|1|||
129898802|NCT01451814|467590052|FG001|Overall Study|Withdrawal by Subject|1|||
129898803|NCT01451814|467590051|FG000|Overall Study|Lost to Follow-up|5|||
129898804|NCT01451814|467590052|FG001|Overall Study|Lost to Follow-up|4|||
129898805|NCT02049866|467590053|FG000|Overall Study|Withdrawal by Subject|1|||
129898806|NCT01117480|467590054|FG000|Overall Study|Protocol Violation|8|||
129898807|NCT01117480|467590054|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
129898808|NCT02955069|467590056|FG000|Overall Study|Adverse Event|7|||
129898809|NCT02955069|467590057|FG001|Overall Study|Adverse Event|2|||
129898810|NCT02955069|467590056|FG000|Overall Study|Death|7|||
129898811|NCT02955069|467590057|FG001|Overall Study|Death|3|||
129898812|NCT02955069|467590056|FG000|Overall Study|Physician Decision|10|||
129898813|NCT02955069|467590057|FG001|Overall Study|Physician Decision|2|||
129898814|NCT02955069|467590056|FG000|Overall Study|Progressive disease|64|||
129898815|NCT02955069|467590057|FG001|Overall Study|Progressive disease|13|||
129898816|NCT02955069|467590056|FG000|Overall Study|Study terminated by sponsor|4|||
129898817|NCT02955069|467590057|FG001|Overall Study|Study terminated by sponsor|0|||
129898818|NCT02955069|467590056|FG000|Overall Study|Subject/Guardian decision|3|||
129898819|NCT02955069|467590057|FG001|Overall Study|Subject/Guardian decision|1|||
129898820|NCT00943605|467590059|FG000|Overall Study|Study termination|30|||
129898821|NCT00943605|467590060|FG001|Overall Study|Study termination|30|||
129838448|NCT00449956|467373296|FG000|Overall Study|Physician Decision|2|||
129838449|NCT00449956|467373297|FG001|Overall Study|Physician Decision|1|||
129898822|NCT04148937|467590063|FG000|Overall Study|Withdrawal by Subject|0|||
130114408|NCT04272775|468379654|FG000|Overall Study|Protocol Violation|0|||
129838450|NCT00449956|467373298|FG002|Overall Study|Physician Decision|1|||
129838451|NCT02086110|467373299|FG000|Overall Study|Withdrawal by Subject|1|||
129838452|NCT02086110|467373300|FG001|Overall Study|Withdrawal by Subject|1|||
129838453|NCT00235872|467373305|FG000|Overall Study|Adverse Event|34|||
129838454|NCT00235872|467373305|FG000|Overall Study|Death|1|||
129838455|NCT00235872|467373305|FG000|Overall Study|Lost to Follow-up|1|||
129838456|NCT00235872|467373305|FG000|Overall Study|Withdrawal by Subject|50|||
129838457|NCT00235872|467373305|FG000|Overall Study|Administrative reason|61|||
129838458|NCT02272413|467373306|FG000|Randomized Through Treatment Start|Not treated|3|||
129838459|NCT02272413|467373307|FG001|Randomized Through Treatment Start|Not treated|5|||
129838460|NCT02272413|467373306|FG000|Pre-switch Period|Adverse Event|38|||
129838461|NCT02272413|467373307|FG001|Pre-switch Period|Adverse Event|37|||
129898823|NCT04148937|467590064|FG001|Overall Study|Withdrawal by Subject|0|||
129898824|NCT04148937|467590065|FG002|Overall Study|Withdrawal by Subject|0|||
129898825|NCT04148937|467590066|FG003|Overall Study|Withdrawal by Subject|1|||
129898826|NCT04148937|467590067|FG004|Overall Study|Withdrawal by Subject|0|||
129898827|NCT04148937|467590068|FG005|Overall Study|Withdrawal by Subject|1|||
130114409|NCT04272775|468379655|FG001|Overall Study|Protocol Violation|1|||
129838462|NCT02272413|467373306|FG000|Pre-switch Period|Death|26|||
129838463|NCT02272413|467373307|FG001|Pre-switch Period|Death|26|||
129838464|NCT02272413|467373306|FG000|Pre-switch Period|Withdrawal by Subject|27|||
129838465|NCT02272413|467373307|FG001|Pre-switch Period|Withdrawal by Subject|15|||
129838466|NCT02272413|467373306|FG000|Pre-switch Period|Physician Decision|6|||
129838467|NCT02272413|467373307|FG001|Pre-switch Period|Physician Decision|18|||
129838468|NCT02272413|467373306|FG000|Pre-switch Period|Progressive disease|185|||
129838469|NCT02272413|467373307|FG001|Pre-switch Period|Progressive disease|173|||
129838470|NCT02272413|467373306|FG000|Pre-switch Period|Lost to Follow-up|0|||
129838471|NCT02272413|467373307|FG001|Pre-switch Period|Lost to Follow-up|2|||
129838472|NCT02272413|467373306|FG000|Pre-switch Period|Protocol Violation|1|||
129838473|NCT02272413|467373307|FG001|Pre-switch Period|Protocol Violation|0|||
129838474|NCT02272413|467373306|FG000|Pre-switch Period|Other than listed|10|||
129838475|NCT02272413|467373307|FG001|Pre-switch Period|Other than listed|11|||
129838476|NCT02272413|467373306|FG000|Post-switch Period|Adverse Event|4|||
129838477|NCT02272413|467373307|FG001|Post-switch Period|Adverse Event|4|||
129838478|NCT02272413|467373306|FG000|Post-switch Period|Death|3|||
129838479|NCT02272413|467373307|FG001|Post-switch Period|Death|2|||
129838480|NCT02272413|467373306|FG000|Post-switch Period|Withdrawal by Subject|1|||
129838481|NCT02272413|467373307|FG001|Post-switch Period|Withdrawal by Subject|2|||
129838482|NCT02272413|467373306|FG000|Post-switch Period|Physician Decision|1|||
129838483|NCT02272413|467373307|FG001|Post-switch Period|Physician Decision|1|||
129838484|NCT02272413|467373306|FG000|Post-switch Period|Progressive disease|21|||
129838485|NCT02272413|467373307|FG001|Post-switch Period|Progressive disease|21|||
129838486|NCT02272413|467373306|FG000|Post-switch Period|Study terminated by sponsor|8|||
129838487|NCT02272413|467373307|FG001|Post-switch Period|Study terminated by sponsor|11|||
129838488|NCT02272413|467373306|FG000|Post-switch Period|Other than listed|4|||
129838489|NCT02272413|467373307|FG001|Post-switch Period|Other than listed|5|||
129838490|NCT03144180|467373316|FG000|Overall Study|STAT Delivery|1|||
129838491|NCT03144180|467373317|FG001|Overall Study|STAT Delivery|1|||
129838492|NCT03144180|467373316|FG000|Overall Study|Provider forgot to fill out forms|1|||
129838493|NCT03144180|467373317|FG001|Overall Study|Provider forgot to fill out forms|3|||
129838494|NCT03144180|467373316|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
129838495|NCT03144180|467373317|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
129838496|NCT03144180|467373316|FG000|Overall Study|Scrub tech removed tube cap|0|||
129838497|NCT03144180|467373317|FG001|Overall Study|Scrub tech removed tube cap|1|||
129838498|NCT02308735|467373318|FG000|Overall Study|Physician Decision|2|||
129838499|NCT02308735|467373319|FG001|Overall Study|Physician Decision|0|||
129898828|NCT04148937|467590069|FG006|Overall Study|Withdrawal by Subject|1|||
129898829|NCT04148937|467590070|FG007|Overall Study|Withdrawal by Subject|0|||
129898830|NCT04148937|467590063|FG000|Overall Study|Lost to Follow-up|0|||
129898831|NCT04148937|467590064|FG001|Overall Study|Lost to Follow-up|0|||
129898832|NCT04148937|467590065|FG002|Overall Study|Lost to Follow-up|1|||
129898833|NCT04148937|467590066|FG003|Overall Study|Lost to Follow-up|0|||
129898834|NCT04148937|467590067|FG004|Overall Study|Lost to Follow-up|0|||
129898835|NCT04148937|467590068|FG005|Overall Study|Lost to Follow-up|2|||
129898836|NCT04148937|467590069|FG006|Overall Study|Lost to Follow-up|0|||
129898837|NCT04148937|467590070|FG007|Overall Study|Lost to Follow-up|0|||
129898838|NCT03107611|467590072|FG000|Overall Study|Adverse Event|1|||
129898839|NCT03107611|467590073|FG001|Overall Study|Adverse Event|0|||
129898840|NCT03107611|467590074|FG002|Overall Study|Adverse Event|2|||
129838500|NCT02308735|467373320|FG002|Overall Study|Physician Decision|0|||
129838501|NCT02308735|467373321|FG003|Overall Study|Physician Decision|2|||
129838502|NCT00606892|467373322|FG000|First Intervention|Protocol Violation|1|||
129838503|NCT00606892|467373323|FG001|First Intervention|Protocol Violation|4|||
129838504|NCT00794196|467373324|FG000|Overall Study|Lost to Follow-up|5|||
129838505|NCT00794196|467373325|FG001|Overall Study|Lost to Follow-up|23|||
129838506|NCT00850395|467373331|FG000|Overall Study|Death|1|||
129838507|NCT00850395|467373331|FG000|Overall Study|Adverse Event|1|||
129898841|NCT03107611|467590072|FG000|Overall Study|Lost to Follow-up|3|||
129898842|NCT03107611|467590073|FG001|Overall Study|Lost to Follow-up|3|||
129898843|NCT03107611|467590074|FG002|Overall Study|Lost to Follow-up|3|||
130062924|NCT01797965|468184236|FG003|Overall Study|Disease progression, defined by protocol|0|||
129898844|NCT03107611|467590072|FG000|Overall Study|Protocol Violation|0|||
130062925|NCT01797965|468184233|FG000|Overall Study|Reason Not Specified|280|||
130062926|NCT01797965|468184234|FG001|Overall Study|Reason Not Specified|295|||
130062927|NCT01797965|468184235|FG002|Overall Study|Reason Not Specified|0|||
130062928|NCT01797965|468184236|FG003|Overall Study|Reason Not Specified|15|||
130062929|NCT00973921|468184237|FG000|Overall Study|IVUS results were not available|9|||
130062930|NCT04404010|468184241|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
130062931|NCT04404010|468184242|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
130062932|NCT02120157|468184243|FG000|Overall Study|Death|8|||
130062933|NCT00441103|468184248|FG000|Overall Study|Adverse Event|2|||
130062934|NCT00441103|468184249|FG001|Overall Study|Adverse Event|1|||
130062935|NCT00441103|468184248|FG000|Overall Study|Death|1|||
130062936|NCT00441103|468184249|FG001|Overall Study|Death|0|||
130062937|NCT00441103|468184248|FG000|Overall Study|Disease Progression|2|||
130062938|NCT00441103|468184249|FG001|Overall Study|Disease Progression|0|||
130062939|NCT00441103|468184248|FG000|Overall Study|Lost to Follow-up|1|||
130062940|NCT00441103|468184249|FG001|Overall Study|Lost to Follow-up|0|||
130062941|NCT00441103|468184248|FG000|Overall Study|Protocol Violation|1|||
130062942|NCT00441103|468184249|FG001|Overall Study|Protocol Violation|0|||
129838508|NCT00850395|467373331|FG000|Overall Study|Insufficient clinical response|3|||
129838509|NCT00850395|467373331|FG000|Overall Study|Other|5|||
129838510|NCT02376166|467373332|FG000|Overall Study|Adverse Event|1|||
129838511|NCT02376166|467373332|FG000|Overall Study|Discontinued metformin early|2|||
129838512|NCT00842348|467373334|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
129838513|NCT00842348|467373335|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
129838514|NCT00842348|467373334|FG000|Study 729|Disease progression/death|19|||
129838515|NCT00842348|467373335|FG001|Study 729|Disease progression/death|30|||
129838516|NCT00842348|467373334|FG000|Study 729|Adverse Event|1|||
129838517|NCT00842348|467373335|FG001|Study 729|Adverse Event|1|||
129838518|NCT00842348|467373334|FG000|Study 729|Protocol Violation|1|||
129838519|NCT00842348|467373335|FG001|Study 729|Protocol Violation|1|||
129838520|NCT00842348|467373334|FG000|Study 729|Withdrawal by Subject|2|||
129838521|NCT00842348|467373335|FG001|Study 729|Withdrawal by Subject|4|||
129838522|NCT00842348|467373334|FG000|Study 729|Due to Sponsor stopping the study|1|||
129838523|NCT00842348|467373335|FG001|Study 729|Due to Sponsor stopping the study|1|||
129838524|NCT00842348|467373334|FG000|Study 729|Due to non-availability of IP|0|||
129838525|NCT00842348|467373335|FG001|Study 729|Due to non-availability of IP|1|||
129838526|NCT00842348|467373334|FG000|Study 729|Sponsor's decision|1|||
129838527|NCT00842348|467373335|FG001|Study 729|Sponsor's decision|0|||
129838528|NCT00842348|467373334|FG000|Study 729|Surgical resection|1|||
129838529|NCT00842348|467373335|FG001|Study 729|Surgical resection|0|||
129838530|NCT01524627|467373338|FG000|Overall Study|Physician Decision|0|||
129838531|NCT01524627|467373339|FG001|Overall Study|Physician Decision|1|||
129838532|NCT01524627|467373338|FG000|Overall Study|Lost to Follow-up|1|||
129838533|NCT01524627|467373339|FG001|Overall Study|Lost to Follow-up|1|||
129838534|NCT02388737|467375280|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
129838535|NCT02388737|467375281|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
129838536|NCT02388737|467375282|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
129838537|NCT02388737|467375280|FG000|Overall Study|Major Protocol Deviation|18|||
129838538|NCT02388737|467375281|FG001|Overall Study|Major Protocol Deviation|25|||
129838539|NCT02388737|467375282|FG002|Overall Study|Major Protocol Deviation|22|||
129838540|NCT02388737|467375280|FG000|Overall Study|Lost to Follow-up|5|||
129838541|NCT02388737|467375281|FG001|Overall Study|Lost to Follow-up|1|||
129838542|NCT02388737|467375282|FG002|Overall Study|Lost to Follow-up|4|||
129838543|NCT02388737|467375280|FG000|Overall Study|Voluntary Withdrawal|10|||
129838544|NCT02388737|467375281|FG001|Overall Study|Voluntary Withdrawal|18|||
129838545|NCT02388737|467375282|FG002|Overall Study|Voluntary Withdrawal|17|||
129838546|NCT02388737|467375280|FG000|Overall Study|Lack of Efficacy|3|||
129838547|NCT02388737|467375281|FG001|Overall Study|Lack of Efficacy|0|||
129838548|NCT02388737|467375282|FG002|Overall Study|Lack of Efficacy|3|||
129838549|NCT02388737|467375280|FG000|Overall Study|Reason Not Specified|5|||
129838550|NCT02388737|467375281|FG001|Overall Study|Reason Not Specified|5|||
129838551|NCT02388737|467375282|FG002|Overall Study|Reason Not Specified|4|||
129838552|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
129838553|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
129838554|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
129838555|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
129838556|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
129838557|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
129838558|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
129838559|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
129838560|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
129838561|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
129838562|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
129838563|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
129838564|NCT03252522|467375283|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
129838565|NCT03252522|467375284|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
129838566|NCT03252522|467375285|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
129838567|NCT03252522|467375283|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
129838568|NCT03252522|467375284|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
129838569|NCT03252522|467375285|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
129838570|NCT03252522|467375283|FG000|Phase 2: Open Label|Adverse Event|0|||
129838571|NCT03252522|467375284|FG001|Phase 2: Open Label|Adverse Event|0|||
129838572|NCT03252522|467375285|FG002|Phase 2: Open Label|Adverse Event|2|||
129838573|NCT03252522|467375283|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
129838574|NCT03252522|467375284|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
129838575|NCT03252522|467375285|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
129838576|NCT03299842|467375287|FG000|Overall Study|Caregiver withdrew consent|2|||
129838577|NCT03299842|467375287|FG000|Overall Study|Child would not keep the watch on|3|||
129838578|NCT01344369|467375288|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
129838579|NCT01344369|467375289|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
129838580|NCT01344369|467375288|FG000|Washout of 28 Days|Physician Decision|0|||
129838581|NCT01344369|467375289|FG001|Washout of 28 Days|Physician Decision|1|||
129838582|NCT01344369|467375288|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
129838583|NCT01344369|467375289|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
129838584|NCT01454726|467375295|FG000|Overall Study|Withdrawal by Subject|0|||
129838585|NCT01454726|467375296|FG001|Overall Study|Withdrawal by Subject|1|||
129838586|NCT01886833|467375297|FG000|Overall Study|IgA not available from both periods|204|||
129838587|NCT03848845|467375298|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
129838588|NCT03848845|467375299|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
129838589|NCT03848845|467375300|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
129838590|NCT03848845|467375301|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
129838591|NCT03848845|467375298|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
129838592|NCT03848845|467375299|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
129838593|NCT03848845|467375300|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
129838594|NCT03848845|467375301|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
129838595|NCT03848845|467375298|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
129838596|NCT03848845|467375299|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
129838597|NCT03848845|467375300|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
129838598|NCT03848845|467375301|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
129838599|NCT03848845|467375298|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129838600|NCT03848845|467375299|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129838601|NCT03848845|467375300|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129838602|NCT03848845|467375301|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
129838603|NCT02223767|467375307|FG000|Overall Study|Withdrawal by Subject|4|||
129838604|NCT02223767|467375308|FG001|Overall Study|Withdrawal by Subject|4|||
129838605|NCT02342704|467375309|FG000|Overall Study|Physician Decision|0|||
129838606|NCT02342704|467375310|FG001|Overall Study|Physician Decision|3|||
129838607|NCT02342704|467375309|FG000|Overall Study|Sponsor Termination|49|||
129838608|NCT02342704|467375310|FG001|Overall Study|Sponsor Termination|43|||
129838609|NCT02342704|467375309|FG000|Overall Study|Other|0|||
129838610|NCT02342704|467375310|FG001|Overall Study|Other|1|||
129838611|NCT02342704|467375309|FG000|Overall Study|Withdrawal by Subject|1|||
129838612|NCT02342704|467375310|FG001|Overall Study|Withdrawal by Subject|0|||
129838613|NCT02342704|467375309|FG000|Overall Study|Lost to Follow-up|2|||
129838614|NCT02342704|467375310|FG001|Overall Study|Lost to Follow-up|1|||
129838615|NCT02342704|467375309|FG000|Overall Study|Adverse Event|1|||
129838616|NCT02342704|467375310|FG001|Overall Study|Adverse Event|3|||
129838617|NCT02347527|467375311|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
129838618|NCT02347527|467375312|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
129838619|NCT02347527|467375313|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
129838620|NCT02347527|467375314|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
129838621|NCT02347527|467375311|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
129838622|NCT02347527|467375312|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
129838623|NCT02347527|467375313|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
129838624|NCT02347527|467375314|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
129838625|NCT02347527|467375311|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
129838626|NCT02347527|467375312|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
129838627|NCT02347527|467375313|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
129838628|NCT02347527|467375314|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
129838629|NCT02347527|467375311|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
129838630|NCT02347527|467375312|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
129838631|NCT02347527|467375313|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
129838632|NCT02347527|467375314|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
129838633|NCT02347527|467375311|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
129838634|NCT02347527|467375312|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
129838635|NCT02347527|467375313|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
129838636|NCT02347527|467375314|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
129838637|NCT00302003|467375316|FG000|Overall Study|Lack of Efficacy|62|||
129838638|NCT00302003|467375316|FG000|Overall Study|Lost to Follow-up|1|||
129838639|NCT00302003|467375316|FG000|Overall Study|Physician Decision|2|||
129838640|NCT00302003|467375316|FG000|Overall Study|Withdrawal by Subject|5|||
129838641|NCT00302003|467375316|FG000|Overall Study|Ineligible|9|||
129838642|NCT00302003|467375316|FG000|Overall Study|Protocol Violation|1|||
130114410|NCT04272775|468379654|FG000|Overall Study|Symptomatic Deterioration|1|||
130114411|NCT04272775|468379655|FG001|Overall Study|Symptomatic Deterioration|1|||
130114412|NCT04272775|468379654|FG000|Overall Study|Withdrawal by Subject|1|||
130114413|NCT04272775|468379655|FG001|Overall Study|Withdrawal by Subject|2|||
130114414|NCT04272775|468379654|FG000|Overall Study|Adverse Event|1|||
130114415|NCT04272775|468379655|FG001|Overall Study|Adverse Event|2|||
130114416|NCT04272775|468379654|FG000|Overall Study|Progressive Disease|3|||
130114417|NCT04272775|468379655|FG001|Overall Study|Progressive Disease|1|||
130114418|NCT00124020|468379656|FG000|Overall Study|Death|67|||
130114419|NCT00124020|468379657|FG001|Overall Study|Death|71|||
130114420|NCT00124020|468379656|FG000|Overall Study|Withdrawal by Subject|13|||
130114421|NCT00124020|468379657|FG001|Overall Study|Withdrawal by Subject|11|||
130114422|NCT00124020|468379656|FG000|Overall Study|Lost to Follow-up|5|||
130114423|NCT00124020|468379657|FG001|Overall Study|Lost to Follow-up|8|||
130114424|NCT00124020|468379656|FG000|Overall Study|Other|1|||
130114425|NCT00124020|468379657|FG001|Overall Study|Other|1|||
130114426|NCT00124020|468379656|FG000|Overall Study|Transfer to another hospital|2|||
130114427|NCT00124020|468379657|FG001|Overall Study|Transfer to another hospital|0|||
130114428|NCT02043366|468379658|FG000|Overall Study|Lost to Follow-up|2|||
130114429|NCT02043366|468379659|FG001|Overall Study|Lost to Follow-up|2|||
130114430|NCT02043366|468379660|FG002|Overall Study|Lost to Follow-up|2|||
129838643|NCT00283439|467375317|FG000|Overall Study|Adverse Event|0|||
129838644|NCT00283439|467375318|FG001|Overall Study|Adverse Event|0|||
129838645|NCT00283439|467375319|FG002|Overall Study|Adverse Event|0|||
129838646|NCT00283439|467375320|FG003|Overall Study|Adverse Event|1|||
129838647|NCT00283439|467375317|FG000|Overall Study|Death|0|||
129838648|NCT00283439|467375318|FG001|Overall Study|Death|0|||
129838649|NCT00283439|467375319|FG002|Overall Study|Death|1|||
129838650|NCT00283439|467375320|FG003|Overall Study|Death|0|||
129838651|NCT00283439|467375317|FG000|Overall Study|Disease progression|0|||
129838652|NCT00283439|467375318|FG001|Overall Study|Disease progression|1|||
129838653|NCT00283439|467375319|FG002|Overall Study|Disease progression|0|||
129838654|NCT00283439|467375320|FG003|Overall Study|Disease progression|0|||
130114431|NCT02043366|468379661|FG003|Overall Study|Lost to Follow-up|2|||
130114432|NCT02043366|468379662|FG004|Overall Study|Lost to Follow-up|2|||
129838655|NCT00283439|467375317|FG000|Overall Study|Requirement for alternative therapy|1|||
129838656|NCT00283439|467375318|FG001|Overall Study|Requirement for alternative therapy|2|||
129838657|NCT00283439|467375319|FG002|Overall Study|Requirement for alternative therapy|5|||
129838658|NCT00283439|467375320|FG003|Overall Study|Requirement for alternative therapy|2|||
129838659|NCT00283439|467375317|FG000|Overall Study|Stem cell transplant|6|||
129838660|NCT00283439|467375318|FG001|Overall Study|Stem cell transplant|6|||
129838661|NCT00283439|467375319|FG002|Overall Study|Stem cell transplant|4|||
129838662|NCT00283439|467375320|FG003|Overall Study|Stem cell transplant|3|||
129838663|NCT00283439|467375317|FG000|Overall Study|Treatment discontinued|0|||
129838664|NCT00283439|467375318|FG001|Overall Study|Treatment discontinued|2|||
129838665|NCT00283439|467375319|FG002|Overall Study|Treatment discontinued|1|||
129838666|NCT00283439|467375320|FG003|Overall Study|Treatment discontinued|3|||
129838667|NCT00283439|467375317|FG000|Overall Study|Other|1|||
129838668|NCT00283439|467375318|FG001|Overall Study|Other|0|||
129838669|NCT00283439|467375319|FG002|Overall Study|Other|0|||
129838670|NCT00283439|467375320|FG003|Overall Study|Other|0|||
129838671|NCT02042924|467375321|FG000|Overall Study|Early Death|1|||
129838672|NCT01632891|467375322|FG000|Overall Study|Lost to Follow-up|0|||
129838673|NCT01632891|467375323|FG001|Overall Study|Lost to Follow-up|1|||
129838674|NCT01632891|467375322|FG000|Overall Study|Withdrawal by Subject|1|||
129838675|NCT01632891|467375323|FG001|Overall Study|Withdrawal by Subject|0|||
129838676|NCT02919670|467375324|FG000|Overall Study|Only 17 participants met compliance|43|||
129838677|NCT02919670|467375325|FG001|Overall Study|Only 17 participants met compliance|39|||
129838678|NCT00240071|467375326|FG000|Overall Study|Withdrawal by Subject|3|||
129838679|NCT01466270|467375327|FG000|Overall Study|Withdrawal by Subject|4|||
129838680|NCT01466270|467375328|FG001|Overall Study|Withdrawal by Subject|1|||
129838681|NCT01466270|467375327|FG000|Overall Study|Physician Decision|1|||
129838682|NCT01466270|467375328|FG001|Overall Study|Physician Decision|0|||
129838683|NCT01466270|467375327|FG000|Overall Study|Lost to Follow-up|1|||
129838684|NCT01466270|467375328|FG001|Overall Study|Lost to Follow-up|3|||
129838685|NCT01466270|467375327|FG000|Overall Study|Progression|1|||
130114433|NCT02043366|468379663|FG005|Overall Study|Lost to Follow-up|2|||
130114434|NCT00891774|468379666|FG000|Overall Study|Lost to Follow-up|5|||
130114435|NCT00891774|468379666|FG000|Overall Study|Illness (Self/Mother)|3|||
130114436|NCT00891774|468379666|FG000|Overall Study|Withdrawal by Subject|2|||
129838686|NCT01466270|467375328|FG001|Overall Study|Progression|0|||
129838687|NCT01466270|467375327|FG000|Overall Study|Toxicity|4|||
129838688|NCT01466270|467375328|FG001|Overall Study|Toxicity|1|||
129838689|NCT01466270|467375327|FG000|Overall Study|Multiple|1|||
129838690|NCT01466270|467375328|FG001|Overall Study|Multiple|1|||
129838691|NCT04206293|467375333|FG000|Overall Study|Consent withdrawal|1|||
129838692|NCT01454934|467375336|FG000|Overall Study|Clinical progression|28|||
129838693|NCT01454934|467375337|FG001|Overall Study|Clinical progression|25|||
129838694|NCT01454934|467375336|FG000|Overall Study|Other|6|||
130114437|NCT00891774|468379666|FG000|Overall Study|Protocol Violation|4|||
129838695|NCT01454934|467375337|FG001|Overall Study|Other|17|||
129838696|NCT01454934|467375336|FG000|Overall Study|Adverse Event|28|||
129838697|NCT01454934|467375337|FG001|Overall Study|Adverse Event|24|||
129838698|NCT01454934|467375336|FG000|Overall Study|Withdrawn consent|2|||
129838699|NCT01454934|467375337|FG001|Overall Study|Withdrawn consent|5|||
129838700|NCT01454934|467375336|FG000|Overall Study|Withdrawal by Subject|11|||
129838701|NCT01454934|467375337|FG001|Overall Study|Withdrawal by Subject|15|||
129838702|NCT01454934|467375336|FG000|Overall Study|Disease progression|194|||
129838703|NCT01454934|467375337|FG001|Overall Study|Disease progression|181|||
129838704|NCT01454934|467375336|FG000|Overall Study|Lost to Follow-up|0|||
129838705|NCT01454934|467375337|FG001|Overall Study|Lost to Follow-up|1|||
129838706|NCT01454934|467375336|FG000|Overall Study|Not treated|1|||
129838707|NCT01454934|467375337|FG001|Overall Study|Not treated|2|||
129838708|NCT00430092|467375340|FG000|Overall Study|Adverse Event|0|||
129838709|NCT00430092|467375341|FG001|Overall Study|Adverse Event|0|||
129838710|NCT00430092|467375342|FG002|Overall Study|Adverse Event|1|||
129838711|NCT00430092|467375340|FG000|Overall Study|Lack of Efficacy|5|||
129838712|NCT00430092|467375341|FG001|Overall Study|Lack of Efficacy|2|||
129838713|NCT00430092|467375342|FG002|Overall Study|Lack of Efficacy|54|||
129838714|NCT00430092|467375340|FG000|Overall Study|Lost to Follow-up|1|||
129838715|NCT00430092|467375341|FG001|Overall Study|Lost to Follow-up|0|||
129838716|NCT00430092|467375342|FG002|Overall Study|Lost to Follow-up|0|||
129838717|NCT00430092|467375340|FG000|Overall Study|Protocol Violation|0|||
129838718|NCT00430092|467375341|FG001|Overall Study|Protocol Violation|1|||
129838719|NCT00430092|467375342|FG002|Overall Study|Protocol Violation|1|||
129838720|NCT00430092|467375340|FG000|Overall Study|Withdrawal by Subject|0|||
129838721|NCT00430092|467375341|FG001|Overall Study|Withdrawal by Subject|1|||
129838722|NCT00430092|467375342|FG002|Overall Study|Withdrawal by Subject|1|||
129838723|NCT00706966|467375347|FG000|Overall Study|Adverse Event|1|||
129838724|NCT02884089|467375355|FG000|Period 1|Dosing error|2|||
129838725|NCT02884089|467375356|FG001|Period 1|Dosing error|2|||
129838726|NCT02884089|467375357|FG002|Period 1|Dosing error|0|||
129838727|NCT02884089|467375358|FG003|Period 1|Dosing error|0|||
129838728|NCT02884089|467375355|FG000|Washout Period 1|Lost to Follow-up|0|||
129838729|NCT02884089|467375356|FG001|Washout Period 1|Lost to Follow-up|1|||
129838730|NCT02884089|467375357|FG002|Washout Period 1|Lost to Follow-up|0|||
129838731|NCT02884089|467375358|FG003|Washout Period 1|Lost to Follow-up|1|||
129838732|NCT02884089|467375355|FG000|Washout Period 1|Withdrawal by Subject|0|||
129838733|NCT02884089|467375356|FG001|Washout Period 1|Withdrawal by Subject|1|||
129838734|NCT02884089|467375357|FG002|Washout Period 1|Withdrawal by Subject|0|||
129838735|NCT02884089|467375358|FG003|Washout Period 1|Withdrawal by Subject|0|||
129838736|NCT02884089|467375355|FG000|Period 2|Adverse Event|1|||
129838737|NCT02884089|467375356|FG001|Period 2|Adverse Event|0|||
129838738|NCT02884089|467375357|FG002|Period 2|Adverse Event|0|||
129838739|NCT02884089|467375358|FG003|Period 2|Adverse Event|0|||
129838740|NCT02884089|467375355|FG000|Period 3|Withdrawal by Subject|0|||
129838741|NCT02884089|467375356|FG001|Period 3|Withdrawal by Subject|0|||
129838742|NCT02884089|467375357|FG002|Period 3|Withdrawal by Subject|1|||
129838743|NCT02884089|467375358|FG003|Period 3|Withdrawal by Subject|0|||
129838744|NCT02884089|467375355|FG000|Washout Period 3|Withdrawal by Subject|0|||
129838745|NCT02884089|467375356|FG001|Washout Period 3|Withdrawal by Subject|0|||
129838746|NCT02884089|467375357|FG002|Washout Period 3|Withdrawal by Subject|1|||
129838747|NCT02884089|467375358|FG003|Washout Period 3|Withdrawal by Subject|0|||
129838748|NCT02884089|467375355|FG000|Washout Period 3|Lost to Follow-up|0|||
129838749|NCT02884089|467375356|FG001|Washout Period 3|Lost to Follow-up|0|||
129838750|NCT02884089|467375357|FG002|Washout Period 3|Lost to Follow-up|0|||
129838751|NCT02884089|467375358|FG003|Washout Period 3|Lost to Follow-up|1|||
129838752|NCT02884089|467375355|FG000|Period 4|Withdrawal by Subject|0|||
129838753|NCT02884089|467375356|FG001|Period 4|Withdrawal by Subject|1|||
129838754|NCT02884089|467375357|FG002|Period 4|Withdrawal by Subject|0|||
129838755|NCT02884089|467375358|FG003|Period 4|Withdrawal by Subject|0|||
129838756|NCT02884089|467375355|FG000|Period 4|Lost to Follow-up|1|||
129838757|NCT02884089|467375356|FG001|Period 4|Lost to Follow-up|0|||
130062943|NCT00441103|468184248|FG000|Overall Study|Participant unable to use Rebiject II|1|||
129838758|NCT02884089|467375357|FG002|Period 4|Lost to Follow-up|0|||
129838759|NCT02884089|467375358|FG003|Period 4|Lost to Follow-up|0|||
129838760|NCT02884089|467375355|FG000|Follow-up Visit|Withdrawal by Subject|1|||
129838761|NCT02884089|467375356|FG001|Follow-up Visit|Withdrawal by Subject|0|||
129838762|NCT02884089|467375357|FG002|Follow-up Visit|Withdrawal by Subject|0|||
129838763|NCT02884089|467375358|FG003|Follow-up Visit|Withdrawal by Subject|1|||
129838764|NCT01631474|467375359|FG000|Overall Study|Lost to Follow-up|8|||
129838765|NCT01631474|467375360|FG001|Overall Study|Lost to Follow-up|5|||
129838766|NCT01631474|467375361|FG002|Overall Study|Lost to Follow-up|7|||
129838767|NCT01631474|467375362|FG003|Overall Study|Lost to Follow-up|5|||
129838768|NCT01631474|467375363|FG004|Overall Study|Lost to Follow-up|5|||
129838769|NCT01631474|467375359|FG000|Overall Study|Withdrawal by Subject|4|||
129838770|NCT01631474|467375360|FG001|Overall Study|Withdrawal by Subject|4|||
129838771|NCT01631474|467375361|FG002|Overall Study|Withdrawal by Subject|2|||
129838772|NCT01631474|467375362|FG003|Overall Study|Withdrawal by Subject|6|||
129838773|NCT01631474|467375363|FG004|Overall Study|Withdrawal by Subject|5|||
129838774|NCT01631474|467375359|FG000|Overall Study|Lack of Efficacy|2|||
129838775|NCT01631474|467375360|FG001|Overall Study|Lack of Efficacy|2|||
129838776|NCT01631474|467375361|FG002|Overall Study|Lack of Efficacy|0|||
129838777|NCT01631474|467375362|FG003|Overall Study|Lack of Efficacy|0|||
129838778|NCT01631474|467375363|FG004|Overall Study|Lack of Efficacy|2|||
129838779|NCT01631474|467375359|FG000|Overall Study|Noncompliance with Study Drug|0|||
129838780|NCT01631474|467375360|FG001|Overall Study|Noncompliance with Study Drug|0|||
129838781|NCT01631474|467375361|FG002|Overall Study|Noncompliance with Study Drug|0|||
129838782|NCT01631474|467375362|FG003|Overall Study|Noncompliance with Study Drug|0|||
129838783|NCT01631474|467375363|FG004|Overall Study|Noncompliance with Study Drug|1|||
129838784|NCT01631474|467375359|FG000|Overall Study|Adverse Event|0|||
129838785|NCT01631474|467375360|FG001|Overall Study|Adverse Event|1|||
129838786|NCT01631474|467375361|FG002|Overall Study|Adverse Event|0|||
129838787|NCT01631474|467375362|FG003|Overall Study|Adverse Event|0|||
129838788|NCT01631474|467375363|FG004|Overall Study|Adverse Event|0|||
129838789|NCT02624284|467375364|FG000|Overall Study|Withdrawal by Subject|3|||
129838790|NCT02624284|467375365|FG001|Overall Study|Withdrawal by Subject|6|||
129838791|NCT02624284|467375366|FG002|Overall Study|Withdrawal by Subject|3|||
129838792|NCT02624284|467375364|FG000|Overall Study|Protocol Violation|9|||
129838793|NCT02624284|467375365|FG001|Overall Study|Protocol Violation|10|||
129838794|NCT02624284|467375366|FG002|Overall Study|Protocol Violation|7|||
129838795|NCT02624284|467375364|FG000|Overall Study|Revealed exclusionary condition|2|||
129838796|NCT02624284|467375365|FG001|Overall Study|Revealed exclusionary condition|2|||
129838797|NCT02624284|467375366|FG002|Overall Study|Revealed exclusionary condition|0|||
129838798|NCT02624284|467375364|FG000|Overall Study|Adverse Event|0|||
129838799|NCT02624284|467375365|FG001|Overall Study|Adverse Event|0|||
129838800|NCT02624284|467375366|FG002|Overall Study|Adverse Event|1|||
129838801|NCT01641367|467375377|FG000|Cohorts|Death|18|||
129838802|NCT01641367|467375378|FG001|Cohorts|Death|1|||
129838803|NCT01641367|467375379|FG002|Cohorts|Death|2|||
129838804|NCT01641367|467375380|FG003|Cohorts|Death|0|||
129838805|NCT01641367|467375381|FG004|Cohorts|Death|1|||
129838806|NCT01641367|467375382|FG005|Cohorts|Death|1|||
129838807|NCT01641367|467375383|FG006|Cohorts|Death|0|||
129838808|NCT01641367|467375384|FG007|Cohorts|Death|0|||
129838809|NCT01641367|467375377|FG000|Cohorts|Lost to Follow-up|16|||
129838810|NCT01641367|467375378|FG001|Cohorts|Lost to Follow-up|0|||
129838811|NCT01641367|467375379|FG002|Cohorts|Lost to Follow-up|2|||
129838812|NCT01641367|467375380|FG003|Cohorts|Lost to Follow-up|0|||
129838813|NCT01641367|467375381|FG004|Cohorts|Lost to Follow-up|2|||
129838814|NCT01641367|467375382|FG005|Cohorts|Lost to Follow-up|0|||
129838815|NCT01641367|467375383|FG006|Cohorts|Lost to Follow-up|0|||
129838816|NCT01641367|467375384|FG007|Cohorts|Lost to Follow-up|0|||
129838817|NCT01641367|467375377|FG000|Randomized Adherence Intervention|Death|0|||
130062944|NCT00441103|468184249|FG001|Overall Study|Participant unable to use Rebiject II|0|||
130062945|NCT00441103|468184248|FG000|Overall Study|Participant refused MRI|1|||
130062946|NCT00441103|468184249|FG001|Overall Study|Participant refused MRI|0|||
130062947|NCT00441103|468184248|FG000|Overall Study|Inclusion criteria absent|1|||
130062948|NCT00441103|468184249|FG001|Overall Study|Inclusion criteria absent|0|||
130062949|NCT00441103|468184248|FG000|Overall Study|Non-compliant|0|||
130062950|NCT00441103|468184249|FG001|Overall Study|Non-compliant|1|||
130062951|NCT00441103|468184248|FG000|Overall Study|Participant decided to withdraw|1|||
130062952|NCT00441103|468184249|FG001|Overall Study|Participant decided to withdraw|0|||
130062953|NCT00441103|468184248|FG000|Overall Study|Participant's reason|0|||
130062954|NCT00441103|468184249|FG001|Overall Study|Participant's reason|1|||
130062955|NCT00441103|468184248|FG000|Overall Study|Participant decided to stop|0|||
130062956|NCT00441103|468184249|FG001|Overall Study|Participant decided to stop|1|||
130114438|NCT03175120|468379668|FG000|Overall Study|Adverse Event|2|||
130114439|NCT03175120|468379669|FG001|Overall Study|Adverse Event|2|||
130114440|NCT03175120|468379668|FG000|Overall Study|Protocol Violation|5|||
129838818|NCT01641367|467375378|FG001|Randomized Adherence Intervention|Death|0|||
129838819|NCT01641367|467375379|FG002|Randomized Adherence Intervention|Death|0|||
129838820|NCT01641367|467375380|FG003|Randomized Adherence Intervention|Death|0|||
129838821|NCT01641367|467375381|FG004|Randomized Adherence Intervention|Death|0|||
129838822|NCT01641367|467375382|FG005|Randomized Adherence Intervention|Death|0|||
129838823|NCT01641367|467375383|FG006|Randomized Adherence Intervention|Death|11|||
129838824|NCT01641367|467375384|FG007|Randomized Adherence Intervention|Death|12|||
129838825|NCT01641367|467375377|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838826|NCT01641367|467375378|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838827|NCT01641367|467375379|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
129898845|NCT03107611|467590073|FG001|Overall Study|Protocol Violation|0|||
129838828|NCT01641367|467375380|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838829|NCT01641367|467375381|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838830|NCT01641367|467375382|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
130114441|NCT03175120|468379669|FG001|Overall Study|Protocol Violation|2|||
129838831|NCT01641367|467375383|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
130062957|NCT01599754|468184250|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
129838832|NCT01641367|467375384|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
129838833|NCT00654381|467375389|FG000|1st Stage|Adverse Event|3|||
129838834|NCT00654381|467375390|FG001|1st Stage|Adverse Event|3|||
129838835|NCT00654381|467375391|FG002|1st Stage|Adverse Event|3|||
129838836|NCT00654381|467375392|FG003|1st Stage|Adverse Event|3|||
129838837|NCT00654381|467375393|FG004|1st Stage|Adverse Event|2|||
129838838|NCT00654381|467375394|FG005|1st Stage|Adverse Event|1|||
129838839|NCT00654381|467375389|FG000|1st Stage|Withdrawal by Subject|0|||
129838840|NCT00654381|467375390|FG001|1st Stage|Withdrawal by Subject|0|||
129838841|NCT00654381|467375391|FG002|1st Stage|Withdrawal by Subject|0|||
129838842|NCT00654381|467375392|FG003|1st Stage|Withdrawal by Subject|1|||
129838843|NCT00654381|467375393|FG004|1st Stage|Withdrawal by Subject|0|||
129838844|NCT00654381|467375394|FG005|1st Stage|Withdrawal by Subject|1|||
129838845|NCT00654381|467375389|FG000|1st Stage|Investigator's decision|0|||
129838846|NCT00654381|467375390|FG001|1st Stage|Investigator's decision|0|||
129838847|NCT00654381|467375391|FG002|1st Stage|Investigator's decision|0|||
129838848|NCT00654381|467375392|FG003|1st Stage|Investigator's decision|1|||
129838849|NCT00654381|467375393|FG004|1st Stage|Investigator's decision|0|||
129838850|NCT00654381|467375394|FG005|1st Stage|Investigator's decision|0|||
129838851|NCT00654381|467375389|FG000|2nd Stage|Adverse Event|2|||
129838852|NCT00654381|467375390|FG001|2nd Stage|Adverse Event|0|||
129838853|NCT00654381|467375391|FG002|2nd Stage|Adverse Event|2|||
129838854|NCT00654381|467375392|FG003|2nd Stage|Adverse Event|3|||
129838855|NCT00654381|467375393|FG004|2nd Stage|Adverse Event|7|||
129838856|NCT00654381|467375394|FG005|2nd Stage|Adverse Event|2|||
129838857|NCT00654381|467375389|FG000|2nd Stage|Withdrawal by Subject|0|||
129838858|NCT00654381|467375390|FG001|2nd Stage|Withdrawal by Subject|0|||
129838859|NCT00654381|467375391|FG002|2nd Stage|Withdrawal by Subject|0|||
129838860|NCT00654381|467375392|FG003|2nd Stage|Withdrawal by Subject|0|||
129838861|NCT00654381|467375393|FG004|2nd Stage|Withdrawal by Subject|1|||
129838862|NCT00654381|467375394|FG005|2nd Stage|Withdrawal by Subject|1|||
129838863|NCT00654381|467375389|FG000|2nd Stage|Investigator's decision|0|||
129838864|NCT00654381|467375390|FG001|2nd Stage|Investigator's decision|0|||
129838865|NCT00654381|467375391|FG002|2nd Stage|Investigator's decision|1|||
129838866|NCT00654381|467375392|FG003|2nd Stage|Investigator's decision|1|||
129838867|NCT00654381|467375393|FG004|2nd Stage|Investigator's decision|0|||
129838868|NCT00654381|467375394|FG005|2nd Stage|Investigator's decision|0|||
129838869|NCT00654381|467375389|FG000|Extension Stage|Adverse Event|1|||
129838870|NCT00654381|467375390|FG001|Extension Stage|Adverse Event|2|||
129838871|NCT00654381|467375391|FG002|Extension Stage|Adverse Event|9|||
129838872|NCT00654381|467375392|FG003|Extension Stage|Adverse Event|7|||
129838873|NCT00654381|467375393|FG004|Extension Stage|Adverse Event|1|||
129838874|NCT00654381|467375394|FG005|Extension Stage|Adverse Event|1|||
129838875|NCT00654381|467375389|FG000|Extension Stage|Protocol Violation|0|||
129838876|NCT00654381|467375390|FG001|Extension Stage|Protocol Violation|0|||
129838877|NCT00654381|467375391|FG002|Extension Stage|Protocol Violation|0|||
129838878|NCT00654381|467375392|FG003|Extension Stage|Protocol Violation|1|||
129838879|NCT00654381|467375393|FG004|Extension Stage|Protocol Violation|0|||
129838880|NCT00654381|467375394|FG005|Extension Stage|Protocol Violation|0|||
129838881|NCT00654381|467375389|FG000|Extension Stage|Lack of Efficacy|0|||
129838882|NCT00654381|467375390|FG001|Extension Stage|Lack of Efficacy|0|||
129838883|NCT00654381|467375391|FG002|Extension Stage|Lack of Efficacy|1|||
129838884|NCT00654381|467375392|FG003|Extension Stage|Lack of Efficacy|0|||
129838885|NCT00654381|467375393|FG004|Extension Stage|Lack of Efficacy|0|||
129838886|NCT00654381|467375394|FG005|Extension Stage|Lack of Efficacy|0|||
129838887|NCT00654381|467375389|FG000|Extension Stage|Withdrawal by Subject|0|||
129838888|NCT00654381|467375390|FG001|Extension Stage|Withdrawal by Subject|0|||
129838889|NCT00654381|467375391|FG002|Extension Stage|Withdrawal by Subject|1|||
129838890|NCT00654381|467375392|FG003|Extension Stage|Withdrawal by Subject|1|||
129838891|NCT00654381|467375393|FG004|Extension Stage|Withdrawal by Subject|1|||
129838892|NCT00654381|467375394|FG005|Extension Stage|Withdrawal by Subject|1|||
129838893|NCT00654381|467375389|FG000|Extension Stage|Closure of the trial site|0|||
129838894|NCT00654381|467375390|FG001|Extension Stage|Closure of the trial site|0|||
129838895|NCT00654381|467375391|FG002|Extension Stage|Closure of the trial site|0|||
129838896|NCT00654381|467375392|FG003|Extension Stage|Closure of the trial site|0|||
129838897|NCT00654381|467375393|FG004|Extension Stage|Closure of the trial site|1|||
129838898|NCT00654381|467375394|FG005|Extension Stage|Closure of the trial site|1|||
129838899|NCT00826267|467375397|FG000|Overall Study|Other Adverse Event|1|||
129838900|NCT00826267|467375398|FG001|Overall Study|Other Adverse Event|0|||
129838901|NCT00826267|467375399|FG002|Overall Study|Other Adverse Event|0|||
129838902|NCT01675882|467375412|FG000|Overall Study|Adverse Event|0|||
129838903|NCT01675882|467375413|FG001|Overall Study|Adverse Event|2|||
129838904|NCT01675882|467375414|FG002|Overall Study|Adverse Event|1|||
129838905|NCT01675882|467375415|FG003|Overall Study|Adverse Event|0|||
129838906|NCT01675882|467375412|FG000|Overall Study|Participant unwilling to continue|2|||
129838907|NCT01675882|467375413|FG001|Overall Study|Participant unwilling to continue|4|||
129838908|NCT01675882|467375414|FG002|Overall Study|Participant unwilling to continue|2|||
129838909|NCT01675882|467375415|FG003|Overall Study|Participant unwilling to continue|1|||
129838910|NCT01675882|467375412|FG000|Overall Study|Lost to Follow-up|0|||
129838911|NCT01675882|467375413|FG001|Overall Study|Lost to Follow-up|1|||
129898846|NCT03107611|467590074|FG002|Overall Study|Protocol Violation|1|||
130062958|NCT01599754|468184251|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
130062959|NCT01599754|468184250|FG000|Overall Study|Participant noncompliance|4|||
130062960|NCT01599754|468184251|FG001|Overall Study|Participant noncompliance|4|||
130062961|NCT01599754|468184250|FG000|Overall Study|Lost to Follow-up|13|||
130062962|NCT01599754|468184251|FG001|Overall Study|Lost to Follow-up|6|||
130062963|NCT01599754|468184250|FG000|Overall Study|Death|31|||
130062964|NCT01599754|468184251|FG001|Overall Study|Death|33|||
130062965|NCT01599754|468184250|FG000|Overall Study|Adverse Event|3|||
130062966|NCT01599754|468184251|FG001|Overall Study|Adverse Event|2|||
130062967|NCT01599754|468184250|FG000|Overall Study|Investigator decision|1|||
130062968|NCT01599754|468184251|FG001|Overall Study|Investigator decision|3|||
130062969|NCT01599754|468184250|FG000|Overall Study|Withdrawal by Subject|24|||
130062970|NCT01599754|468184251|FG001|Overall Study|Withdrawal by Subject|25|||
130062971|NCT01599754|468184250|FG000|Overall Study|Study terminated by sponsor|282|||
130062972|NCT01599754|468184251|FG001|Overall Study|Study terminated by sponsor|285|||
130062973|NCT02618928|468184252|FG000|Overall Study|Failure to Return|28|||
130062974|NCT02618928|468184252|FG000|Overall Study|Insufficient Virological Response|1|||
130062975|NCT02618928|468184252|FG000|Overall Study|Withdrawal by Subject|2|||
130062976|NCT02618928|468184252|FG000|Overall Study|Death|3|||
130062977|NCT02618928|468184252|FG000|Overall Study|Other|11|||
130062978|NCT02618928|468184252|FG000|Overall Study|Missing|6|||
130062979|NCT02618928|468184252|FG000|Overall Study|Treatment Never Started|7|||
130062980|NCT00916370|468184255|FG000|Overall Study|Death|3|||
130062981|NCT00916370|468184256|FG001|Overall Study|Death|1|||
130062982|NCT00916370|468184255|FG000|Overall Study|Withdrawal by Subject|2|||
130062983|NCT00916370|468184256|FG001|Overall Study|Withdrawal by Subject|0|||
130062984|NCT00916370|468184255|FG000|Overall Study|Physician Decision|0|||
130062985|NCT00916370|468184256|FG001|Overall Study|Physician Decision|1|||
130062986|NCT01317615|468184257|FG000|Overall Study|Disease progression|25|||
130062987|NCT01317615|468184257|FG000|Overall Study|New cancer therapy|5|||
130062988|NCT01317615|468184257|FG000|Overall Study|Death|6|||
130062989|NCT01317615|468184257|FG000|Overall Study|Withdrawal by Subject|5|||
130062990|NCT01317615|468184257|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130062991|NCT01317615|468184257|FG000|Overall Study|Adverse Event|7|||
130062992|NCT00438399|468184260|FG000|Overall Study|Lost to Follow-up|2|||
130062993|NCT00438399|468184261|FG001|Overall Study|Lost to Follow-up|2|||
130062994|NCT00438399|468184262|FG002|Overall Study|Lost to Follow-up|1|||
130062995|NCT00438399|468184263|FG003|Overall Study|Lost to Follow-up|1|||
130062996|NCT00438399|468184264|FG004|Overall Study|Lost to Follow-up|1|||
130062997|NCT00438399|468184265|FG005|Overall Study|Lost to Follow-up|1|||
130062998|NCT00438399|468184260|FG000|Overall Study|Adverse Event|0|||
130062999|NCT00438399|468184261|FG001|Overall Study|Adverse Event|0|||
130063000|NCT00438399|468184262|FG002|Overall Study|Adverse Event|1|||
130063001|NCT00438399|468184263|FG003|Overall Study|Adverse Event|1|||
130063002|NCT00438399|468184264|FG004|Overall Study|Adverse Event|0|||
129838912|NCT01675882|467375414|FG002|Overall Study|Lost to Follow-up|0|||
129838913|NCT01675882|467375415|FG003|Overall Study|Lost to Follow-up|0|||
129838914|NCT01675882|467375412|FG000|Overall Study|Non-compliance|0|||
129838915|NCT01675882|467375413|FG001|Overall Study|Non-compliance|0|||
129838916|NCT01675882|467375414|FG002|Overall Study|Non-compliance|0|||
129838917|NCT01675882|467375415|FG003|Overall Study|Non-compliance|1|||
129838918|NCT04116710|467375425|FG000|Overall Study|Death|4|||
129838919|NCT04116710|467375426|FG001|Overall Study|Death|6|||
129838920|NCT04116710|467375427|FG002|Overall Study|Death|3|||
129838921|NCT04116710|467375428|FG003|Overall Study|Death|1|||
129838922|NCT04116710|467375425|FG000|Overall Study|Withdrawal by Subject|0|||
129838923|NCT04116710|467375426|FG001|Overall Study|Withdrawal by Subject|0|||
129838924|NCT04116710|467375427|FG002|Overall Study|Withdrawal by Subject|0|||
129838925|NCT04116710|467375428|FG003|Overall Study|Withdrawal by Subject|1|||
129838926|NCT00582933|467375429|FG000|Overall Study|Physician Decision|3|||
129838927|NCT00696137|467375431|FG000|Overall Study|Withdrawal by Subject|2|||
130063003|NCT00438399|468184265|FG005|Overall Study|Adverse Event|1|||
130063004|NCT00438399|468184260|FG000|Overall Study|Withdrawal by Subject|5|||
129838928|NCT00785486|467375435|FG000|Midazolam Alone|Withdrawal by Subject|1|||
130063005|NCT00438399|468184261|FG001|Overall Study|Withdrawal by Subject|6|||
130063006|NCT00438399|468184262|FG002|Overall Study|Withdrawal by Subject|3|||
130063007|NCT00438399|468184263|FG003|Overall Study|Withdrawal by Subject|2|||
130063008|NCT00438399|468184264|FG004|Overall Study|Withdrawal by Subject|2|||
130063009|NCT00438399|468184265|FG005|Overall Study|Withdrawal by Subject|2|||
130063010|NCT00438399|468184260|FG000|Overall Study|Protocol Violation|0|||
130063011|NCT00438399|468184261|FG001|Overall Study|Protocol Violation|0|||
129838929|NCT01640366|467375439|FG000|Overall Study|Withdrawal by Subject|1|||
130063012|NCT00438399|468184262|FG002|Overall Study|Protocol Violation|1|||
129838930|NCT01640366|467375439|FG000|Overall Study|Protocol Violation|16|||
129898847|NCT03107611|467590072|FG000|Overall Study|Withdrawal by Subject|1|||
129838931|NCT01640366|467375439|FG000|Overall Study|Lost to Follow-up|5|||
129838932|NCT01116232|467375442|FG000|Overall Study|Progressive diease|4|||
129838933|NCT02357940|467375445|FG000|Overall Study|Adverse Event|0|||
129838934|NCT02357940|467375446|FG001|Overall Study|Adverse Event|1|||
129838935|NCT02357940|467375445|FG000|Overall Study|Investigator's judgement|0|||
129838936|NCT02357940|467375446|FG001|Overall Study|Investigator's judgement|1|||
129838937|NCT02275481|467375447|FG000|Overall Study|Death|2|||
129838938|NCT02275481|467375448|FG001|Overall Study|Death|1|||
129838939|NCT02275481|467375447|FG000|Overall Study|Lost to Follow-up|2|||
129838940|NCT02275481|467375448|FG001|Overall Study|Lost to Follow-up|0|||
129838941|NCT02275481|467375447|FG000|Overall Study|Withdrawal by Subject|3|||
129838942|NCT02275481|467375448|FG001|Overall Study|Withdrawal by Subject|0|||
129838943|NCT02275481|467375447|FG000|Overall Study|all other reasons combined|2|||
129838944|NCT02275481|467375448|FG001|Overall Study|all other reasons combined|1|||
129838945|NCT02275481|467375447|FG000|Overall Study|Physician Decision|0|||
129838946|NCT02275481|467375448|FG001|Overall Study|Physician Decision|1|||
129838947|NCT03274986|467375449|FG000|Overall Study|Withdrawal by Subject|0|||
129838948|NCT03274986|467375450|FG001|Overall Study|Withdrawal by Subject|1|||
129838949|NCT03274986|467375449|FG000|Overall Study|Lost to Follow-up|0|||
129838950|NCT03274986|467375450|FG001|Overall Study|Lost to Follow-up|1|||
129838951|NCT00344773|467375459|FG000|Overall Study|Adverse Event|2|||
129838952|NCT00344773|467375459|FG000|Overall Study|Objective Disease Progression|16|||
129838953|NCT00344773|467375459|FG000|Overall Study|Withdrawal by Subject|1|||
129838954|NCT00344773|467375459|FG000|Overall Study|Not Eligible for the study|2|||
129838955|NCT00714259|467375461|FG000|Overall Study|Death|2|||
129838956|NCT02141074|467375462|FG000|Pre-prophylaxis|Adverse Event|3|||
129838957|NCT02141074|467375463|FG001|Pre-prophylaxis|Adverse Event|0|||
129838958|NCT02141074|467375462|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
129838959|NCT02141074|467375463|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
129838960|NCT02141074|467375462|FG000|Prophylaxis|Adverse Event|0|||
129838961|NCT02141074|467375463|FG001|Prophylaxis|Adverse Event|4|||
129838962|NCT02141074|467375462|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
129838963|NCT02141074|467375463|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
129838964|NCT02141074|467375462|FG000|Prophylaxis|Withdrawal by Subject|0|||
129838965|NCT02141074|467375463|FG001|Prophylaxis|Withdrawal by Subject|1|||
129838966|NCT01336738|467377461|FG000|Overall Study|Adverse Event|0|||
129838967|NCT01336738|467377462|FG001|Overall Study|Adverse Event|3|||
129838968|NCT01336738|467377463|FG002|Overall Study|Adverse Event|2|||
129838969|NCT01336738|467377464|FG003|Overall Study|Adverse Event|1|||
129838970|NCT01336738|467377465|FG004|Overall Study|Adverse Event|3|||
129838971|NCT01336738|467377461|FG000|Overall Study|Lost to Follow-up|2|||
129838972|NCT01336738|467377462|FG001|Overall Study|Lost to Follow-up|1|||
129838973|NCT01336738|467377463|FG002|Overall Study|Lost to Follow-up|2|||
129838974|NCT01336738|467377464|FG003|Overall Study|Lost to Follow-up|2|||
129838975|NCT01336738|467377465|FG004|Overall Study|Lost to Follow-up|2|||
129838976|NCT01336738|467377461|FG000|Overall Study|Did not meet entrance criteria|0|||
129838977|NCT01336738|467377462|FG001|Overall Study|Did not meet entrance criteria|1|||
129838978|NCT01336738|467377463|FG002|Overall Study|Did not meet entrance criteria|0|||
129838979|NCT01336738|467377464|FG003|Overall Study|Did not meet entrance criteria|0|||
129838980|NCT01336738|467377465|FG004|Overall Study|Did not meet entrance criteria|0|||
129838981|NCT01336738|467377461|FG000|Overall Study|Protocol Violation|0|||
129838982|NCT01336738|467377462|FG001|Overall Study|Protocol Violation|1|||
129838983|NCT01336738|467377463|FG002|Overall Study|Protocol Violation|0|||
129838984|NCT01336738|467377464|FG003|Overall Study|Protocol Violation|0|||
129898848|NCT03107611|467590073|FG001|Overall Study|Withdrawal by Subject|0|||
129898849|NCT03107611|467590074|FG002|Overall Study|Withdrawal by Subject|1|||
129898850|NCT03107611|467590072|FG000|Overall Study|Worsening signs/symptoms|2|||
129898851|NCT03107611|467590073|FG001|Overall Study|Worsening signs/symptoms|1|||
129898852|NCT03107611|467590074|FG002|Overall Study|Worsening signs/symptoms|2|||
129898853|NCT01720446|467590075|FG000|Overall Study|Lost to Follow-up|12|||
129898854|NCT01720446|467590076|FG001|Overall Study|Lost to Follow-up|6|||
129898855|NCT01720446|467590077|FG002|Overall Study|Lost to Follow-up|16|||
130063013|NCT00438399|468184263|FG003|Overall Study|Protocol Violation|0|||
130063014|NCT00438399|468184264|FG004|Overall Study|Protocol Violation|0|||
130063015|NCT00438399|468184265|FG005|Overall Study|Protocol Violation|1|||
129838985|NCT01336738|467377465|FG004|Overall Study|Protocol Violation|0|||
129838986|NCT01336738|467377461|FG000|Overall Study|Withdrawal by Subject|2|||
130063016|NCT00438399|468184260|FG000|Overall Study|Subje stopped study|0|||
130063017|NCT00438399|468184261|FG001|Overall Study|Subje stopped study|0|||
129838987|NCT01336738|467377462|FG001|Overall Study|Withdrawal by Subject|0|||
129838988|NCT01336738|467377463|FG002|Overall Study|Withdrawal by Subject|2|||
129838989|NCT01336738|467377464|FG003|Overall Study|Withdrawal by Subject|1|||
129838990|NCT01336738|467377465|FG004|Overall Study|Withdrawal by Subject|1|||
129838991|NCT01336738|467377461|FG000|Overall Study|Other|3|||
129838992|NCT01336738|467377462|FG001|Overall Study|Other|3|||
129838993|NCT01336738|467377463|FG002|Overall Study|Other|2|||
129838994|NCT01336738|467377464|FG003|Overall Study|Other|3|||
129838995|NCT01336738|467377465|FG004|Overall Study|Other|4|||
129838996|NCT03003520|467377466|FG000|Overall Study|Adverse Event|9|||
129838997|NCT03003520|467377467|FG001|Overall Study|Adverse Event|0|||
129838998|NCT03003520|467377466|FG000|Overall Study|Death|1|||
129898856|NCT01720446|467590078|FG003|Overall Study|Lost to Follow-up|16|||
130063018|NCT00438399|468184262|FG002|Overall Study|Subje stopped study|1|||
130063019|NCT00438399|468184263|FG003|Overall Study|Subje stopped study|0|||
130063020|NCT00438399|468184264|FG004|Overall Study|Subje stopped study|0|||
130063021|NCT00438399|468184265|FG005|Overall Study|Subje stopped study|0|||
130063022|NCT00438399|468184260|FG000|Overall Study|Pregnancy|0|||
130063023|NCT00438399|468184261|FG001|Overall Study|Pregnancy|0|||
130063024|NCT00438399|468184262|FG002|Overall Study|Pregnancy|0|||
130063025|NCT00438399|468184263|FG003|Overall Study|Pregnancy|0|||
130063026|NCT00438399|468184264|FG004|Overall Study|Pregnancy|0|||
130063027|NCT00438399|468184265|FG005|Overall Study|Pregnancy|1|||
130063028|NCT00438399|468184260|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
130063029|NCT00438399|468184261|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
130063030|NCT00438399|468184262|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
130063031|NCT00438399|468184263|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
130063032|NCT00438399|468184264|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
130063033|NCT00438399|468184265|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
130063034|NCT00632541|468184268|FG000|Overall Study|Adverse Event|7|||
130063035|NCT00393913|468184270|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
130063036|NCT00393913|468184270|FG000|Initial Assessment|Withdrawal by Subject|16|||
130063037|NCT00393913|468184270|FG000|CPAP|Withdrawal by Subject|3|||
130063038|NCT00393913|468184270|FG000|CPAP|Physician Decision|1|||
130063039|NCT00393913|468184270|FG000|CPAP|TEchnical problem with CPAP|3|||
130063040|NCT01927419|468184271|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
130063041|NCT01927419|468184272|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
130063042|NCT01927419|468184271|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
130063043|NCT01927419|468184272|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
130063044|NCT01927419|468184271|FG000|Treatment Period|Disease progression|17|||
130063045|NCT01927419|468184272|FG001|Treatment Period|Disease progression|20|||
130063046|NCT01927419|468184271|FG000|Treatment Period|Study drug toxicity|48|||
130063047|NCT01927419|468184272|FG001|Treatment Period|Study drug toxicity|10|||
130063048|NCT01927419|468184271|FG000|Treatment Period|Death|0|||
130063049|NCT01927419|468184272|FG001|Treatment Period|Death|1|||
130063050|NCT01927419|468184271|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
130063051|NCT01927419|468184272|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
130063052|NCT01927419|468184271|FG000|Treatment Period|Participant request to discontinue|12|||
130063053|NCT01927419|468184272|FG001|Treatment Period|Participant request to discontinue|4|||
130063054|NCT01927419|468184271|FG000|Treatment Period|Withdrawal by Subject|1|||
130063055|NCT01927419|468184272|FG001|Treatment Period|Withdrawal by Subject|1|||
130063056|NCT01927419|468184271|FG000|Treatment Period|Maximum Clinical Benefit|6|||
130063057|NCT01927419|468184272|FG001|Treatment Period|Maximum Clinical Benefit|2|||
130063058|NCT01927419|468184271|FG000|Treatment Period|Other reasons|3|||
130063059|NCT01927419|468184272|FG001|Treatment Period|Other reasons|4|||
130063060|NCT01927419|468184271|FG000|Treatment Period|Not Reported|1|||
130063061|NCT01927419|468184272|FG001|Treatment Period|Not Reported|1|||
130063062|NCT03488251|468184273|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
130063063|NCT03488251|468184274|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
130063064|NCT03488251|468184275|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
130063065|NCT03488251|468184276|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
130063066|NCT03488251|468184273|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
130063067|NCT03488251|468184274|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
130063068|NCT03488251|468184275|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
130063069|NCT03488251|468184276|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
130063070|NCT03488251|468184273|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
130063071|NCT03488251|468184274|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
130063072|NCT03488251|468184275|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
130063073|NCT03488251|468184276|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
130063074|NCT03488251|468184273|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
130063075|NCT03488251|468184274|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
130063076|NCT03488251|468184275|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
130063077|NCT03488251|468184276|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
130063078|NCT03488251|468184273|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
130063079|NCT03488251|468184274|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
130063080|NCT03488251|468184275|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
130063081|NCT03488251|468184276|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
130063082|NCT00592553|468184282|FG000|Overall Study|Protocol Noncompliance|1|||
130063083|NCT00592553|468184283|FG001|Overall Study|Protocol Noncompliance|0|||
130063084|NCT00592553|468184284|FG002|Overall Study|Protocol Noncompliance|0|||
130063085|NCT02379390|468184285|FG000|Overall Study|Adverse Event|1|||
130063086|NCT02379390|468184286|FG001|Overall Study|Adverse Event|1|||
130063087|NCT02379390|468184285|FG000|Overall Study|Investigator's decision|1|||
129898857|NCT01720446|467590075|FG000|Overall Study|Withdrawal by Subject|2|||
129898858|NCT01720446|467590076|FG001|Overall Study|Withdrawal by Subject|5|||
129898859|NCT01720446|467590077|FG002|Overall Study|Withdrawal by Subject|4|||
129898860|NCT01720446|467590078|FG003|Overall Study|Withdrawal by Subject|4|||
129898861|NCT04464421|467590079|FG000|Overall Study|Lost to Follow-up|2|||
129898862|NCT04464421|467590080|FG001|Overall Study|Lost to Follow-up|2|||
129898863|NCT01956669|467590081|FG000|Overall Study|Disease Progression|12|||
129898864|NCT01956669|467590082|FG001|Overall Study|Disease Progression|7|||
129898865|NCT01956669|467590083|FG002|Overall Study|Disease Progression|7|||
129898866|NCT01956669|467590084|FG003|Overall Study|Disease Progression|8|||
129898867|NCT01956669|467590085|FG004|Overall Study|Disease Progression|4|||
129898868|NCT01956669|467590086|FG005|Overall Study|Disease Progression|3|||
129898869|NCT01956669|467590087|FG006|Overall Study|Disease Progression|5|||
129898870|NCT01956669|467590081|FG000|Overall Study|Adverse Event|0|||
129898871|NCT01956669|467590082|FG001|Overall Study|Adverse Event|2|||
129898872|NCT01956669|467590083|FG002|Overall Study|Adverse Event|2|||
129898873|NCT01956669|467590084|FG003|Overall Study|Adverse Event|1|||
129898874|NCT01956669|467590085|FG004|Overall Study|Adverse Event|0|||
129898875|NCT01956669|467590086|FG005|Overall Study|Adverse Event|0|||
129898876|NCT01956669|467590087|FG006|Overall Study|Adverse Event|0|||
129898877|NCT01956669|467590081|FG000|Overall Study|Physician Decision|0|||
129898878|NCT01956669|467590082|FG001|Overall Study|Physician Decision|2|||
129898879|NCT01956669|467590083|FG002|Overall Study|Physician Decision|0|||
129898880|NCT01956669|467590084|FG003|Overall Study|Physician Decision|0|||
129898881|NCT01956669|467590085|FG004|Overall Study|Physician Decision|0|||
129898882|NCT01956669|467590086|FG005|Overall Study|Physician Decision|1|||
129898883|NCT01956669|467590087|FG006|Overall Study|Physician Decision|0|||
129898884|NCT01956669|467590081|FG000|Overall Study|Withdrawal by Subject|0|||
129898885|NCT01956669|467590082|FG001|Overall Study|Withdrawal by Subject|0|||
129898886|NCT01956669|467590083|FG002|Overall Study|Withdrawal by Subject|1|||
129898887|NCT01956669|467590084|FG003|Overall Study|Withdrawal by Subject|1|||
129898888|NCT01956669|467590085|FG004|Overall Study|Withdrawal by Subject|0|||
129898889|NCT01956669|467590086|FG005|Overall Study|Withdrawal by Subject|0|||
129898890|NCT01956669|467590087|FG006|Overall Study|Withdrawal by Subject|1|||
129898891|NCT01072357|467590090|FG000|Overall Study|Lost to Follow-up|0|||
129898892|NCT01072357|467590091|FG001|Overall Study|Lost to Follow-up|1|||
129898893|NCT02131324|467590092|FG000|Overall Study|Withdrawal by Subject|1|||
129898894|NCT02131324|467590093|FG001|Overall Study|Withdrawal by Subject|2|||
129898895|NCT02131324|467590092|FG000|Overall Study|Lost to Follow-up|1|||
129898896|NCT02131324|467590093|FG001|Overall Study|Lost to Follow-up|1|||
129898897|NCT00891618|467590094|FG000|Overall Study|Withdrawal by Subject|1|||
129898898|NCT01693614|467590095|FG000|Overall Study|Adverse Event|7|||
130114442|NCT03175120|468379668|FG000|Overall Study|Lost to Follow-up|1|||
130114443|NCT03175120|468379669|FG001|Overall Study|Lost to Follow-up|0|||
129838999|NCT03003520|467377467|FG001|Overall Study|Death|0|||
129839000|NCT03003520|467377466|FG000|Overall Study|Other reasons|4|||
129839001|NCT03003520|467377467|FG001|Overall Study|Other reasons|0|||
129839002|NCT03003520|467377466|FG000|Overall Study|Withdrawal by Subject|6|||
129839003|NCT03003520|467377467|FG001|Overall Study|Withdrawal by Subject|0|||
129839004|NCT03003520|467377466|FG000|Overall Study|Progressive disease|9|||
129839005|NCT03003520|467377467|FG001|Overall Study|Progressive disease|1|||
129839006|NCT01920932|467377469|FG000|Overall Study|Death|1|||
129839007|NCT01920932|467377469|FG000|Overall Study|Withdrawal of consent|1|||
129839008|NCT01816139|467377470|FG000|Overall Study|Adverse Event|6|||
129839009|NCT01816139|467377471|FG001|Overall Study|Adverse Event|8|||
129839010|NCT01816139|467377470|FG000|Overall Study|Lack of Efficacy|1|||
129839011|NCT01816139|467377471|FG001|Overall Study|Lack of Efficacy|2|||
129839012|NCT01816139|467377470|FG000|Overall Study|Lost to Follow-up|5|||
129839013|NCT01816139|467377471|FG001|Overall Study|Lost to Follow-up|3|||
129839014|NCT01816139|467377470|FG000|Overall Study|Withdrew Consent|6|||
129839015|NCT01816139|467377471|FG001|Overall Study|Withdrew Consent|4|||
129839016|NCT01816139|467377470|FG000|Overall Study|Protocol Violation|6|||
129839017|NCT01816139|467377471|FG001|Overall Study|Protocol Violation|3|||
129839018|NCT01816139|467377470|FG000|Overall Study|Reason not Specified|4|||
129839019|NCT01816139|467377471|FG001|Overall Study|Reason not Specified|2|||
129898899|NCT01693614|467590096|FG001|Overall Study|Adverse Event|11|||
130114444|NCT03175120|468379668|FG000|Overall Study|Withdrawal by Subject|2|||
129839020|NCT03240575|467377474|FG000|Overall Study|Adverse Event|0|||
129839021|NCT03240575|467377475|FG001|Overall Study|Adverse Event|2|||
129839022|NCT03240575|467377476|FG002|Overall Study|Adverse Event|0|||
129839023|NCT03240575|467377477|FG003|Overall Study|Adverse Event|1|||
129898900|NCT01693614|467590097|FG002|Overall Study|Adverse Event|5|||
129898901|NCT01693614|467590095|FG000|Overall Study|Disease progression|11|||
129898902|NCT01693614|467590096|FG001|Overall Study|Disease progression|8|||
129898903|NCT01693614|467590097|FG002|Overall Study|Disease progression|7|||
129898904|NCT01693614|467590095|FG000|Overall Study|Protocol Violation|5|||
129898905|NCT01693614|467590096|FG001|Overall Study|Protocol Violation|2|||
129898906|NCT01693614|467590097|FG002|Overall Study|Protocol Violation|1|||
129898907|NCT01693614|467590095|FG000|Overall Study|Death|1|||
129898908|NCT01693614|467590096|FG001|Overall Study|Death|0|||
130114445|NCT03175120|468379669|FG001|Overall Study|Withdrawal by Subject|5|||
130114446|NCT03175120|468379668|FG000|Overall Study|Other|2|||
130114447|NCT03175120|468379669|FG001|Overall Study|Other|3|||
130114448|NCT01977092|468379670|FG000|Overall Study|Death|3|||
130114449|NCT01977092|468379671|FG001|Overall Study|Death|4|||
130114450|NCT01977092|468379670|FG000|Overall Study|Lost to Follow-up|23|||
130114451|NCT01977092|468379671|FG001|Overall Study|Lost to Follow-up|14|||
130114452|NCT01977092|468379670|FG000|Overall Study|Withdrawal by Subject|2|||
130114453|NCT01977092|468379671|FG001|Overall Study|Withdrawal by Subject|1|||
130114454|NCT01977092|468379670|FG000|Overall Study|In prison|3|||
130114455|NCT01977092|468379671|FG001|Overall Study|In prison|11|||
130114456|NCT03038113|468379672|FG000|Overall Study|Withdrawal by Subject|0|||
130114457|NCT03038113|468379673|FG001|Overall Study|Withdrawal by Subject|0|||
130114458|NCT03038113|468379674|FG002|Overall Study|Withdrawal by Subject|1|||
130114459|NCT03038113|468379675|FG003|Overall Study|Withdrawal by Subject|0|||
130114460|NCT03038113|468379676|FG004|Overall Study|Withdrawal by Subject|0|||
130114461|NCT03038113|468379677|FG005|Overall Study|Withdrawal by Subject|0|||
130114462|NCT03038113|468379678|FG006|Overall Study|Withdrawal by Subject|0|||
130114463|NCT03038113|468379679|FG007|Overall Study|Withdrawal by Subject|0|||
130114464|NCT03038113|468379680|FG008|Overall Study|Withdrawal by Subject|0|||
130114465|NCT03038113|468379681|FG009|Overall Study|Withdrawal by Subject|0|||
130114466|NCT03038113|468379682|FG010|Overall Study|Withdrawal by Subject|0|||
130114467|NCT03038113|468379683|FG011|Overall Study|Withdrawal by Subject|0|||
130114468|NCT03038113|468379684|FG012|Overall Study|Withdrawal by Subject|0|||
130114469|NCT03038113|468379685|FG013|Overall Study|Withdrawal by Subject|1|||
130114470|NCT03038113|468379672|FG000|Overall Study|Lost to Follow-up|0|||
130114471|NCT03038113|468379673|FG001|Overall Study|Lost to Follow-up|0|||
130114472|NCT03038113|468379674|FG002|Overall Study|Lost to Follow-up|0|||
130114473|NCT03038113|468379675|FG003|Overall Study|Lost to Follow-up|0|||
130114474|NCT03038113|468379676|FG004|Overall Study|Lost to Follow-up|0|||
130114475|NCT03038113|468379677|FG005|Overall Study|Lost to Follow-up|0|||
130114476|NCT03038113|468379678|FG006|Overall Study|Lost to Follow-up|1|||
130114477|NCT03038113|468379679|FG007|Overall Study|Lost to Follow-up|0|||
130114478|NCT03038113|468379680|FG008|Overall Study|Lost to Follow-up|0|||
130114479|NCT03038113|468379681|FG009|Overall Study|Lost to Follow-up|0|||
130114480|NCT03038113|468379682|FG010|Overall Study|Lost to Follow-up|0|||
130114481|NCT03038113|468379683|FG011|Overall Study|Lost to Follow-up|0|||
130114482|NCT03038113|468379684|FG012|Overall Study|Lost to Follow-up|0|||
130114483|NCT03038113|468379685|FG013|Overall Study|Lost to Follow-up|0|||
130114484|NCT03341507|468379687|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
130114485|NCT02927847|468379688|FG000|Overall Study|Lost to Follow-up|1|||
130114486|NCT02927847|468379689|FG001|Overall Study|Lost to Follow-up|0|||
130114487|NCT02927847|468379688|FG000|Overall Study|Withdrawal by Subject|4|||
130114488|NCT02927847|468379689|FG001|Overall Study|Withdrawal by Subject|2|||
130114489|NCT02927847|468379688|FG000|Overall Study|PI withdrawn due to missed visits|1|||
130114490|NCT02927847|468379689|FG001|Overall Study|PI withdrawn due to missed visits|1|||
130114491|NCT00723554|468379690|FG000|Overall Study|Adverse Event|12|||
130114492|NCT00723554|468379690|FG000|Overall Study|Investigator's judgement|5|||
130063088|NCT02379390|468184286|FG001|Overall Study|Investigator's decision|0|||
130063089|NCT02379390|468184285|FG000|Overall Study|Study Termination|0|||
130063090|NCT02379390|468184286|FG001|Overall Study|Study Termination|1|||
130063091|NCT00363051|468186224|FG000|Overall Study|Adminstrative problems|1|||
130063092|NCT00363051|468186225|FG001|Overall Study|Adminstrative problems|1|||
130063093|NCT00363051|468186224|FG000|Overall Study|Adverse Event|21|||
130063094|NCT00363051|468186225|FG001|Overall Study|Adverse Event|12|||
130063095|NCT00363051|468186224|FG000|Overall Study|New Cancer Therapy|2|||
130063096|NCT00363051|468186225|FG001|Overall Study|New Cancer Therapy|1|||
130063097|NCT00363051|468186224|FG000|Overall Study|Withdrawal by Subject|11|||
130063098|NCT00363051|468186225|FG001|Overall Study|Withdrawal by Subject|3|||
130063099|NCT00363051|468186224|FG000|Overall Study|Lost to Follow-up|0|||
130063100|NCT00363051|468186225|FG001|Overall Study|Lost to Follow-up|1|||
130063101|NCT00363051|468186224|FG000|Overall Study|Protocol Violation|0|||
130063102|NCT00363051|468186225|FG001|Overall Study|Protocol Violation|2|||
130063103|NCT00363051|468186224|FG000|Overall Study|Death|3|||
130063104|NCT00363051|468186225|FG001|Overall Study|Death|2|||
130063105|NCT00830115|468186228|FG000|Overall Study|Adverse Event|2|||
130114493|NCT00723554|468379690|FG000|Overall Study|Inhaled medication other than iloprost|4|||
130114494|NCT00723554|468379690|FG000|Overall Study|Withdrawal of consent|3|||
130063106|NCT00830115|468186228|FG000|Overall Study|Improvement/recovery|1|||
130063107|NCT01207388|468186236|FG000|Overall Study|Death|67|||
130114495|NCT00723554|468379690|FG000|Overall Study|Other|3|||
130114496|NCT00723554|468379690|FG000|Overall Study|Lost to Follow-up|1|||
130114497|NCT00723554|468379690|FG000|Overall Study|Non-compliance|1|||
130114498|NCT01698320|468379691|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
130063108|NCT01207388|468186236|FG000|Overall Study|Withdrawal by Subject|1|||
130114499|NCT01698320|468379692|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
130114500|NCT01698320|468379693|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
130063109|NCT01885078|468186237|FG000|Treatment Period|Adverse Event|52|||
129839024|NCT03240575|467377474|FG000|Overall Study|Withdrawal by Subject|2|||
129839025|NCT03240575|467377475|FG001|Overall Study|Withdrawal by Subject|11|||
129839026|NCT03240575|467377476|FG002|Overall Study|Withdrawal by Subject|0|||
129839027|NCT03240575|467377477|FG003|Overall Study|Withdrawal by Subject|1|||
129839028|NCT03240575|467377474|FG000|Overall Study|Other|0|||
129839029|NCT03240575|467377475|FG001|Overall Study|Other|1|||
129839030|NCT03240575|467377476|FG002|Overall Study|Other|0|||
129839031|NCT03240575|467377477|FG003|Overall Study|Other|0|||
129898909|NCT01693614|467590097|FG002|Overall Study|Death|0|||
129898910|NCT01693614|467590095|FG000|Overall Study|Physician Decision|1|||
129898911|NCT01693614|467590096|FG001|Overall Study|Physician Decision|1|||
129898912|NCT01693614|467590097|FG002|Overall Study|Physician Decision|4|||
129898913|NCT01693614|467590095|FG000|Overall Study|Withdrawal by subject/guardian|0|||
129898914|NCT01693614|467590096|FG001|Overall Study|Withdrawal by subject/guardian|0|||
129898915|NCT01693614|467590097|FG002|Overall Study|Withdrawal by subject/guardian|2|||
129898916|NCT01693614|467590095|FG000|Overall Study|Withdrawal by Subject|1|||
129898917|NCT01693614|467590096|FG001|Overall Study|Withdrawal by Subject|0|||
129898918|NCT01693614|467590097|FG002|Overall Study|Withdrawal by Subject|5|||
129898919|NCT00420316|467590098|FG000|Overall Study|Withdrawal by Subject|0|||
129898920|NCT00420316|467590099|FG001|Overall Study|Withdrawal by Subject|1|||
129898921|NCT00420316|467590098|FG000|Overall Study|Lost to Follow-up|12|||
129898922|NCT00420316|467590099|FG001|Overall Study|Lost to Follow-up|8|||
129898923|NCT01196988|467590100|FG000|Overall Study|Adverse Event|1|||
129898924|NCT01196988|467590101|FG001|Overall Study|Adverse Event|2|||
129898925|NCT01196988|467590102|FG002|Overall Study|Adverse Event|0|||
129898926|NCT01196988|467590103|FG003|Overall Study|Adverse Event|0|||
129898927|NCT01196988|467590100|FG000|Overall Study|Withdrawal by Subject|5|||
129898928|NCT01196988|467590101|FG001|Overall Study|Withdrawal by Subject|1|||
129898929|NCT01196988|467590102|FG002|Overall Study|Withdrawal by Subject|4|||
129898930|NCT01196988|467590103|FG003|Overall Study|Withdrawal by Subject|0|||
129898931|NCT01196988|467590100|FG000|Overall Study|Lost to Follow-up|16|||
129898932|NCT01196988|467590101|FG001|Overall Study|Lost to Follow-up|29|||
129898933|NCT01196988|467590102|FG002|Overall Study|Lost to Follow-up|21|||
129898934|NCT01196988|467590103|FG003|Overall Study|Lost to Follow-up|1|||
129898935|NCT01196988|467590100|FG000|Overall Study|Other|2|||
129898936|NCT01196988|467590101|FG001|Overall Study|Other|0|||
129898937|NCT01196988|467590102|FG002|Overall Study|Other|0|||
129898938|NCT01196988|467590103|FG003|Overall Study|Other|0|||
129898939|NCT05419557|467590104|FG000|Overall Study|Lost to Follow-up|11|||
129898940|NCT05419557|467590105|FG001|Overall Study|Lost to Follow-up|4|||
129898941|NCT01313182|467590107|FG000|Overall Study|Protocol Violation|66|||
129898942|NCT01313182|467590108|FG001|Overall Study|Protocol Violation|92|||
129898943|NCT01695317|467590109|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
129898944|NCT01695317|467590110|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
129898945|NCT01695317|467590109|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
129898946|NCT01695317|467590110|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
129898947|NCT00464672|467590111|FG000|Overall Study|withdrawal of consent|0|||
129898948|NCT00464672|467590112|FG001|Overall Study|withdrawal of consent|0|||
129898949|NCT00464672|467590113|FG002|Overall Study|withdrawal of consent|0|||
129898950|NCT00464672|467590114|FG003|Overall Study|withdrawal of consent|1|||
129898951|NCT00464672|467590115|FG004|Overall Study|withdrawal of consent|9|||
129898952|NCT00464672|467590116|FG005|Overall Study|withdrawal of consent|4|||
129898953|NCT00464672|467590111|FG000|Overall Study|Lost to Follow-up|25|||
129898954|NCT00464672|467590112|FG001|Overall Study|Lost to Follow-up|10|||
129898955|NCT00464672|467590113|FG002|Overall Study|Lost to Follow-up|0|||
129898956|NCT00464672|467590114|FG003|Overall Study|Lost to Follow-up|0|||
129898957|NCT00464672|467590115|FG004|Overall Study|Lost to Follow-up|1|||
129898958|NCT00464672|467590116|FG005|Overall Study|Lost to Follow-up|0|||
129898959|NCT00957229|467590118|FG000|Study Start|Adverse Event|0|||
129898960|NCT00957229|467590119|FG001|Study Start|Adverse Event|3|||
129898961|NCT00957229|467590118|FG000|Study Start|Disease Progression|1|||
129898962|NCT00957229|467590119|FG001|Study Start|Disease Progression|0|||
129898963|NCT00957229|467590118|FG000|Reallocated to or Continued Vismodegib|Death|1|||
130063110|NCT01885078|468186238|FG001|Treatment Period|Adverse Event|136|||
130063111|NCT01885078|468186239|FG002|Treatment Period|Adverse Event|30|||
129898964|NCT00957229|467590119|FG001|Reallocated to or Continued Vismodegib|Death|1|||
129898965|NCT00957229|467590118|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
130063112|NCT01885078|468186240|FG003|Treatment Period|Adverse Event|73|||
130063113|NCT01885078|468186241|FG004|Treatment Period|Adverse Event|17|||
130063114|NCT01885078|468186242|FG005|Treatment Period|Adverse Event|72|||
129839032|NCT00697346|467377478|FG000|Overall Study|Adverse Event|4|||
129839033|NCT00697346|467377479|FG001|Overall Study|Adverse Event|5|||
129898966|NCT00957229|467590119|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
129898967|NCT00606580|467590120|FG000|Overall Study|Lost to Follow-up|1|||
129898968|NCT00606580|467590121|FG001|Overall Study|Lost to Follow-up|1|||
129898969|NCT00606580|467590122|FG002|Overall Study|Lost to Follow-up|4|||
129898970|NCT00606580|467590120|FG000|Overall Study|Clinical failures|1|||
129898971|NCT00606580|467590121|FG001|Overall Study|Clinical failures|0|||
129839034|NCT00697346|467377480|FG002|Overall Study|Adverse Event|0|||
129898972|NCT00606580|467590122|FG002|Overall Study|Clinical failures|12|||
129898973|NCT00606580|467590120|FG000|Overall Study|Withdrawal by investigator|0|||
129898974|NCT00606580|467590121|FG001|Overall Study|Withdrawal by investigator|1|||
129898975|NCT00606580|467590122|FG002|Overall Study|Withdrawal by investigator|6|||
129898976|NCT00606580|467590120|FG000|Overall Study|Withdrawal by Subject|0|||
129898977|NCT00606580|467590121|FG001|Overall Study|Withdrawal by Subject|1|||
129898978|NCT00606580|467590122|FG002|Overall Study|Withdrawal by Subject|0|||
129898979|NCT00927823|467590125|FG000|Continuous Dosing Period|Death|0|||
129839035|NCT00697346|467377478|FG000|Overall Study|Progressive Disease|19|||
129839036|NCT00697346|467377479|FG001|Overall Study|Progressive Disease|18|||
130114501|NCT01698320|468379691|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
130114502|NCT01698320|468379692|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
129839037|NCT00697346|467377480|FG002|Overall Study|Progressive Disease|0|||
129839038|NCT00697346|467377478|FG000|Overall Study|Symptomatic Deterioration|0|||
129839039|NCT00697346|467377479|FG001|Overall Study|Symptomatic Deterioration|1|||
129839040|NCT00697346|467377480|FG002|Overall Study|Symptomatic Deterioration|0|||
129839041|NCT00697346|467377478|FG000|Overall Study|Withdrawal by Subject|2|||
129839042|NCT00697346|467377479|FG001|Overall Study|Withdrawal by Subject|2|||
129839043|NCT00697346|467377480|FG002|Overall Study|Withdrawal by Subject|0|||
129839044|NCT00697346|467377478|FG000|Overall Study|Reason not Specified|3|||
129839045|NCT00697346|467377479|FG001|Overall Study|Reason not Specified|0|||
129839046|NCT00697346|467377480|FG002|Overall Study|Reason not Specified|1|||
129839047|NCT03643562|467377482|FG000|Overall Study|Adverse Event|1|||
129898980|NCT00927823|467590126|FG001|Continuous Dosing Period|Death|0|||
129898981|NCT00927823|467590127|FG002|Continuous Dosing Period|Death|6|||
130114503|NCT01698320|468379693|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
129839048|NCT03643562|467377483|FG001|Overall Study|Adverse Event|0|||
130114504|NCT01698320|468379691|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
130114505|NCT01698320|468379692|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
130114506|NCT01698320|468379693|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
130114507|NCT01698320|468379691|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
130114508|NCT01698320|468379692|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
130114509|NCT01698320|468379693|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
130114510|NCT01698320|468379691|FG000|12-Week Double-Blind Period|Adverse Event|0|||
130114511|NCT01698320|468379692|FG001|12-Week Double-Blind Period|Adverse Event|1|||
130114512|NCT01698320|468379693|FG002|12-Week Double-Blind Period|Adverse Event|1|||
130114513|NCT01698320|468379691|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
130114514|NCT01698320|468379692|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
130114515|NCT01698320|468379693|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
130114516|NCT01698320|468379691|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
130114517|NCT01698320|468379692|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
130114518|NCT01698320|468379693|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
130114519|NCT01698320|468379691|FG000|12-Week Double-Blind Period|Pregnancy|0|||
130114520|NCT01698320|468379692|FG001|12-Week Double-Blind Period|Pregnancy|1|||
130114521|NCT01698320|468379693|FG002|12-Week Double-Blind Period|Pregnancy|1|||
130114522|NCT01698320|468379691|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
130114523|NCT01698320|468379692|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
130114524|NCT01698320|468379693|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
130114525|NCT01698320|468379691|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
130114526|NCT01698320|468379692|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
130114527|NCT01698320|468379693|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
130114528|NCT01698320|468379691|FG000|40-Week Open-Label Period|Adverse Event|0|||
130114529|NCT01698320|468379692|FG001|40-Week Open-Label Period|Adverse Event|3|||
130114530|NCT01698320|468379693|FG002|40-Week Open-Label Period|Adverse Event|2|||
130114531|NCT01698320|468379691|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
130114532|NCT01698320|468379692|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
130114533|NCT01698320|468379693|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
130114534|NCT01698320|468379691|FG000|40-Week Open-Label Period|Pregnancy|0|||
130114535|NCT01698320|468379692|FG001|40-Week Open-Label Period|Pregnancy|2|||
129839049|NCT03643562|467377482|FG000|Overall Study|Lack of Efficacy|0|||
129898982|NCT00927823|467590128|FG003|Continuous Dosing Period|Death|0|||
129898983|NCT00927823|467590125|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
129898984|NCT00927823|467590126|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
130114536|NCT01698320|468379693|FG002|40-Week Open-Label Period|Pregnancy|1|||
130114537|NCT01698320|468379691|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
129839050|NCT03643562|467377483|FG001|Overall Study|Lack of Efficacy|1|||
129839051|NCT03643562|467377482|FG000|Overall Study|Physician Decision|0|||
129839052|NCT03643562|467377483|FG001|Overall Study|Physician Decision|1|||
129839053|NCT03643562|467377482|FG000|Overall Study|Study Terminated by Sponsor|2|||
129898985|NCT00927823|467590127|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
129898986|NCT00927823|467590128|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
129898987|NCT00927823|467590125|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
130114538|NCT01698320|468379692|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
130114539|NCT01698320|468379693|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
130114540|NCT01698320|468379691|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
130114541|NCT01698320|468379692|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
130114542|NCT01698320|468379693|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
130114543|NCT01952574|468379694|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
130114544|NCT01952574|468379695|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
130114545|NCT01952574|468379696|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
130114546|NCT01952574|468379697|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
130114547|NCT01952574|468379698|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130114548|NCT01952574|468379699|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130114549|NCT01952574|468379700|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
130114550|NCT01952574|468379694|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
130114551|NCT01952574|468379695|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
130114552|NCT01952574|468379696|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
130114553|NCT01952574|468379697|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
130114554|NCT01952574|468379698|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
130114555|NCT01952574|468379699|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
130114556|NCT01952574|468379700|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
130114557|NCT01952574|468379694|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
130114558|NCT01952574|468379695|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
130114559|NCT01952574|468379696|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
130114560|NCT01952574|468379697|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
130114561|NCT01952574|468379698|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
130114562|NCT01952574|468379699|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
130114563|NCT01952574|468379700|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
130114564|NCT01952574|468379694|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
130114565|NCT01952574|468379695|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
130114566|NCT01952574|468379696|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
130114567|NCT01952574|468379697|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
130114568|NCT01952574|468379698|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
130114569|NCT01952574|468379699|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
130114570|NCT01952574|468379700|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
130114571|NCT01952574|468379694|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
130114572|NCT01952574|468379695|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
130114573|NCT01952574|468379696|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
130114574|NCT01952574|468379697|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
130114575|NCT01952574|468379698|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
130114576|NCT01952574|468379699|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
130114577|NCT01952574|468379700|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
130114578|NCT01952574|468379694|FG000|Open-label Treatment Phase|Missing|0|||
130114579|NCT01952574|468379695|FG001|Open-label Treatment Phase|Missing|0|||
130114580|NCT01952574|468379696|FG002|Open-label Treatment Phase|Missing|0|||
130114581|NCT01952574|468379697|FG003|Open-label Treatment Phase|Missing|0|||
130114582|NCT01952574|468379698|FG004|Open-label Treatment Phase|Missing|4|||
130114583|NCT01952574|468379699|FG005|Open-label Treatment Phase|Missing|0|||
130114584|NCT01952574|468379700|FG006|Open-label Treatment Phase|Missing|0|||
130114585|NCT01952574|468379694|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
130114586|NCT01952574|468379695|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130114587|NCT01952574|468379696|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
130114588|NCT01952574|468379697|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
130114589|NCT01952574|468379698|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
130114590|NCT01952574|468379699|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
130114591|NCT01952574|468379700|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
129839054|NCT03643562|467377483|FG001|Overall Study|Study Terminated by Sponsor|10|||
129839055|NCT03643562|467377482|FG000|Overall Study|Withdrawal by Subject|2|||
129839056|NCT03643562|467377483|FG001|Overall Study|Withdrawal by Subject|2|||
129839057|NCT03643562|467377482|FG000|Overall Study|Other than specified|3|||
129839058|NCT03643562|467377483|FG001|Overall Study|Other than specified|2|||
129839059|NCT01982253|467377486|FG000|Overall Study|Withdrawal by Subject|1|||
129839060|NCT01982253|467377487|FG001|Overall Study|Withdrawal by Subject|0|||
129839061|NCT01982253|467377488|FG002|Overall Study|Withdrawal by Subject|0|||
129839062|NCT01982253|467377486|FG000|Overall Study|Study terminated by sponsor|1|||
130114592|NCT01952574|468379694|FG000|Open-label Treatment Phase|Death|0|||
130114593|NCT01952574|468379695|FG001|Open-label Treatment Phase|Death|0|||
130114594|NCT01952574|468379696|FG002|Open-label Treatment Phase|Death|0|||
130114595|NCT01952574|468379697|FG003|Open-label Treatment Phase|Death|0|||
130114596|NCT01952574|468379698|FG004|Open-label Treatment Phase|Death|1|||
130114597|NCT01952574|468379699|FG005|Open-label Treatment Phase|Death|0|||
129839063|NCT01982253|467377487|FG001|Overall Study|Study terminated by sponsor|4|||
129839064|NCT01982253|467377488|FG002|Overall Study|Study terminated by sponsor|4|||
130114598|NCT01952574|468379700|FG006|Open-label Treatment Phase|Death|0|||
130114599|NCT01952574|468379694|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130114600|NCT01952574|468379695|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130114601|NCT01952574|468379696|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130114602|NCT01952574|468379697|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130114603|NCT01952574|468379698|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130114604|NCT01952574|468379699|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
130114605|NCT01952574|468379700|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
130114606|NCT01952574|468379694|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
130114607|NCT01952574|468379695|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
130114608|NCT01952574|468379696|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
130114609|NCT01952574|468379697|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
130114610|NCT01952574|468379698|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
130114611|NCT01952574|468379699|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
130114612|NCT01952574|468379700|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
130114613|NCT00770991|468379710|FG000|Overall Study|Physician Decision|2|||
130114614|NCT00770991|468379711|FG001|Overall Study|Physician Decision|0|||
130114615|NCT00770991|468379710|FG000|Overall Study|Withdrawal by Subject|1|||
130114616|NCT00770991|468379711|FG001|Overall Study|Withdrawal by Subject|0|||
130114617|NCT00770991|468379710|FG000|Overall Study|Adverse Event|1|||
130114618|NCT00770991|468379711|FG001|Overall Study|Adverse Event|5|||
130114619|NCT00770991|468379710|FG000|Overall Study|Pregnancy|1|||
130114620|NCT00770991|468379711|FG001|Overall Study|Pregnancy|0|||
130114621|NCT03404206|468379720|FG000|Overall Study|Withdrawal by Subject|1|||
130114622|NCT03404206|468379721|FG001|Overall Study|Withdrawal by Subject|1|||
130114623|NCT03404206|468379722|FG002|Overall Study|Withdrawal by Subject|0|||
130114624|NCT03404206|468379720|FG000|Overall Study|Lost to Follow-up|3|||
130114625|NCT03404206|468379721|FG001|Overall Study|Lost to Follow-up|1|||
130114626|NCT03404206|468379722|FG002|Overall Study|Lost to Follow-up|0|||
130114627|NCT00905489|468379733|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
130114628|NCT00905489|468379733|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
130114629|NCT00905489|468379733|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
130114630|NCT02668302|468379737|FG000|Overall Study|Withdrawal by Subject|1|||
130114631|NCT02668302|468379738|FG001|Overall Study|Withdrawal by Subject|0|||
130114632|NCT00895583|468379743|FG000|Overall Study|Adverse Event|28|||
130114633|NCT00895583|468379744|FG001|Overall Study|Adverse Event|4|||
130114634|NCT00895583|468379743|FG000|Overall Study|Death|2|||
130114635|NCT00895583|468379744|FG001|Overall Study|Death|1|||
130114636|NCT00895583|468379743|FG000|Overall Study|Physician Decision|3|||
130114637|NCT00895583|468379744|FG001|Overall Study|Physician Decision|1|||
130114638|NCT00895583|468379743|FG000|Overall Study|Lost to Follow-up|1|||
130114639|NCT00895583|468379744|FG001|Overall Study|Lost to Follow-up|3|||
130114640|NCT00895583|468379743|FG000|Overall Study|Protocol Violation|1|||
130114641|NCT00895583|468379744|FG001|Overall Study|Protocol Violation|0|||
130114642|NCT00895583|468379743|FG000|Overall Study|Withdrawal by Subject|4|||
130114643|NCT00895583|468379744|FG001|Overall Study|Withdrawal by Subject|2|||
130114644|NCT00895583|468379743|FG000|Overall Study|Lack of Efficacy|5|||
130114645|NCT00895583|468379744|FG001|Overall Study|Lack of Efficacy|0|||
130114646|NCT00895583|468379743|FG000|Overall Study|Other|0|||
130114647|NCT00895583|468379744|FG001|Overall Study|Other|1|||
130114648|NCT00616928|468379745|FG000|Overall Study|Adverse Event|6|||
130114649|NCT00616928|468379746|FG001|Overall Study|Adverse Event|3|||
130114650|NCT00616928|468379747|FG002|Overall Study|Adverse Event|2|||
130114651|NCT00616928|468379748|FG003|Overall Study|Adverse Event|2|||
130114652|NCT00616928|468379745|FG000|Overall Study|Other|51|||
130114653|NCT00616928|468379746|FG001|Overall Study|Other|8|||
130114654|NCT00616928|468379747|FG002|Overall Study|Other|15|||
130114655|NCT00616928|468379748|FG003|Overall Study|Other|5|||
129839065|NCT00913744|467377490|FG000|Overall Study|Adverse Event|2|||
129839066|NCT00913744|467377491|FG001|Overall Study|Adverse Event|0|||
129839067|NCT00913744|467377490|FG000|Overall Study|Withdrawal by Subject|2|||
129839068|NCT00913744|467377491|FG001|Overall Study|Withdrawal by Subject|1|||
129839069|NCT00913744|467377490|FG000|Overall Study|Death|1|||
129839070|NCT00913744|467377491|FG001|Overall Study|Death|0|||
129839071|NCT02945410|467377492|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839072|NCT02945410|467377493|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
130114656|NCT00616928|468379745|FG000|Overall Study|Lost to Follow-up|5|||
129898988|NCT00927823|467590126|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
130114657|NCT00616928|468379746|FG001|Overall Study|Lost to Follow-up|7|||
130114658|NCT00616928|468379747|FG002|Overall Study|Lost to Follow-up|0|||
130114659|NCT00616928|468379748|FG003|Overall Study|Lost to Follow-up|0|||
130114660|NCT04535583|468379749|FG000|Overall Study|Lost to Follow-up|1|||
129839073|NCT02945410|467377494|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839074|NCT02945410|467377495|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
130114661|NCT04535583|468379749|FG000|Overall Study|Physician Decision|1|||
130114662|NCT04535583|468379749|FG000|Overall Study|Withdrawal by Subject|1|||
130114663|NCT01078090|468379750|FG000|Overall Study|Lost to Follow-up|2363|||
130114664|NCT01078090|468379750|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
130114665|NCT01078090|468379750|FG000|Overall Study|Lack of Efficacy|1193|||
130114666|NCT01078090|468379750|FG000|Overall Study|ADR and lack of efficacy|61|||
130114667|NCT01078090|468379750|FG000|Overall Study|Other|523|||
130114668|NCT04049552|468379752|FG000|Overall Study|Lost to Follow-up|1|||
130114669|NCT02123459|468379755|FG000|Washout Period (1 Day)|Adverse Event|1|||
130114670|NCT02123459|468379756|FG001|Washout Period (1 Day)|Adverse Event|0|||
130114671|NCT02196506|468379761|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
130114672|NCT02196506|468379762|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
130114673|NCT02196506|468379763|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
130114674|NCT02196506|468379764|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
130114675|NCT02196506|468379761|FG000|Phase A|Withdrawal by Subject|34|||
130114676|NCT02196506|468379762|FG001|Phase A|Withdrawal by Subject|0|||
130114677|NCT02196506|468379763|FG002|Phase A|Withdrawal by Subject|0|||
130114678|NCT02196506|468379764|FG003|Phase A|Withdrawal by Subject|0|||
130114679|NCT02196506|468379761|FG000|Phase A|Adverse Event|22|||
130114680|NCT02196506|468379762|FG001|Phase A|Adverse Event|0|||
130114681|NCT02196506|468379763|FG002|Phase A|Adverse Event|0|||
130114682|NCT02196506|468379764|FG003|Phase A|Adverse Event|0|||
130114683|NCT02196506|468379761|FG000|Phase A|Lost to Follow-up|9|||
130114684|NCT02196506|468379762|FG001|Phase A|Lost to Follow-up|0|||
130114685|NCT02196506|468379763|FG002|Phase A|Lost to Follow-up|0|||
130114686|NCT02196506|468379764|FG003|Phase A|Lost to Follow-up|0|||
130114687|NCT02196506|468379761|FG000|Phase A|Protocol deviation|12|||
130114688|NCT02196506|468379762|FG001|Phase A|Protocol deviation|0|||
130114689|NCT02196506|468379763|FG002|Phase A|Protocol deviation|0|||
130114690|NCT02196506|468379764|FG003|Phase A|Protocol deviation|0|||
129839075|NCT02945410|467377496|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839076|NCT02945410|467377497|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839077|NCT02945410|467377492|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
129839078|NCT02945410|467377493|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
129839079|NCT02945410|467377494|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
129839080|NCT02945410|467377495|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
129839081|NCT02945410|467377496|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
129839082|NCT02945410|467377497|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
129839083|NCT02945410|467377492|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839084|NCT02945410|467377493|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839085|NCT02945410|467377494|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
129839086|NCT02945410|467377495|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839087|NCT02945410|467377496|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
129839088|NCT02945410|467377497|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839089|NCT02118428|467377504|FG000|Overall Study|Physician Decision|0|||
129839090|NCT02118428|467377505|FG001|Overall Study|Physician Decision|1|||
129839091|NCT02118428|467377506|FG002|Overall Study|Physician Decision|0|||
129839092|NCT02118428|467377504|FG000|Overall Study|Withdrawal by Subject|2|||
129839093|NCT02118428|467377505|FG001|Overall Study|Withdrawal by Subject|2|||
129839094|NCT02118428|467377506|FG002|Overall Study|Withdrawal by Subject|0|||
129839095|NCT02118428|467377504|FG000|Overall Study|Death|7|||
129839096|NCT02118428|467377505|FG001|Overall Study|Death|5|||
129839097|NCT02118428|467377506|FG002|Overall Study|Death|0|||
129839098|NCT02118428|467377504|FG000|Overall Study|Lost to Follow-up|3|||
129839099|NCT02118428|467377505|FG001|Overall Study|Lost to Follow-up|1|||
129839100|NCT02118428|467377506|FG002|Overall Study|Lost to Follow-up|0|||
129839101|NCT02118428|467377504|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
129839102|NCT02118428|467377505|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
129839103|NCT02118428|467377506|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
129839104|NCT03100825|467377507|FG000|Overall Study|Participant/Guardian Decision|7|||
129839105|NCT03100825|467377507|FG000|Overall Study|Physician Decision|1|||
129839106|NCT00048542|467377516|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129839107|NCT00048542|467377517|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
129839108|NCT00048542|467377518|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129839109|NCT00048542|467377519|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129839110|NCT00048542|467377520|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129839111|NCT00048542|467377521|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
129839112|NCT00048542|467377522|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
130114691|NCT02196506|468379761|FG000|Phase A|Participant withdrawn by investigator|10|||
130114692|NCT02196506|468379762|FG001|Phase A|Participant withdrawn by investigator|0|||
130114693|NCT02196506|468379763|FG002|Phase A|Participant withdrawn by investigator|0|||
129839113|NCT00048542|467377523|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
129839114|NCT00048542|467377516|FG000|Double-Blind Phase|Protocol Violation|0|||
129839115|NCT00048542|467377517|FG001|Double-Blind Phase|Protocol Violation|0|||
129839116|NCT00048542|467377518|FG002|Double-Blind Phase|Protocol Violation|1|||
129839117|NCT00048542|467377519|FG003|Double-Blind Phase|Protocol Violation|0|||
129839118|NCT00048542|467377520|FG004|Double-Blind Phase|Protocol Violation|0|||
129839119|NCT00048542|467377521|FG005|Double-Blind Phase|Protocol Violation|0|||
130114694|NCT02196506|468379764|FG003|Phase A|Participant withdrawn by investigator|0|||
130114695|NCT02196506|468379761|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
129839120|NCT00048542|467377522|FG006|Double-Blind Phase|Protocol Violation|0|||
129839121|NCT00048542|467377523|FG007|Double-Blind Phase|Protocol Violation|0|||
129839122|NCT00048542|467377516|FG000|Double-Blind Phase|Sponsor request or decision|2|||
129839123|NCT00048542|467377517|FG001|Double-Blind Phase|Sponsor request or decision|0|||
129839124|NCT00048542|467377518|FG002|Double-Blind Phase|Sponsor request or decision|0|||
129839125|NCT00048542|467377519|FG003|Double-Blind Phase|Sponsor request or decision|0|||
129839126|NCT00048542|467377520|FG004|Double-Blind Phase|Sponsor request or decision|0|||
129839127|NCT00048542|467377521|FG005|Double-Blind Phase|Sponsor request or decision|0|||
130063115|NCT01885078|468186243|FG006|Treatment Period|Adverse Event|24|||
130063116|NCT01885078|468186244|FG007|Treatment Period|Adverse Event|5|||
130063117|NCT01885078|468186245|FG008|Treatment Period|Adverse Event|0|||
130063118|NCT01885078|468186246|FG009|Treatment Period|Adverse Event|0|||
130063119|NCT01885078|468186237|FG000|Treatment Period|Death|13|||
130063120|NCT01885078|468186238|FG001|Treatment Period|Death|33|||
130063121|NCT01885078|468186239|FG002|Treatment Period|Death|5|||
130063122|NCT01885078|468186240|FG003|Treatment Period|Death|9|||
130063123|NCT01885078|468186241|FG004|Treatment Period|Death|2|||
130063124|NCT01885078|468186242|FG005|Treatment Period|Death|10|||
130063125|NCT01885078|468186243|FG006|Treatment Period|Death|3|||
130063126|NCT01885078|468186244|FG007|Treatment Period|Death|2|||
130063127|NCT01885078|468186245|FG008|Treatment Period|Death|0|||
130063128|NCT01885078|468186246|FG009|Treatment Period|Death|0|||
130063129|NCT01885078|468186237|FG000|Treatment Period|Lack of Efficacy|12|||
130063130|NCT01885078|468186238|FG001|Treatment Period|Lack of Efficacy|33|||
130063131|NCT01885078|468186239|FG002|Treatment Period|Lack of Efficacy|10|||
130063132|NCT01885078|468186240|FG003|Treatment Period|Lack of Efficacy|23|||
130063133|NCT01885078|468186241|FG004|Treatment Period|Lack of Efficacy|24|||
130063134|NCT01885078|468186242|FG005|Treatment Period|Lack of Efficacy|58|||
130063135|NCT01885078|468186243|FG006|Treatment Period|Lack of Efficacy|9|||
130063136|NCT01885078|468186244|FG007|Treatment Period|Lack of Efficacy|5|||
130063137|NCT01885078|468186245|FG008|Treatment Period|Lack of Efficacy|0|||
130063138|NCT01885078|468186246|FG009|Treatment Period|Lack of Efficacy|0|||
130063139|NCT01885078|468186237|FG000|Treatment Period|Lost to Follow-up|16|||
130063140|NCT01885078|468186238|FG001|Treatment Period|Lost to Follow-up|19|||
130063141|NCT01885078|468186239|FG002|Treatment Period|Lost to Follow-up|7|||
130063142|NCT01885078|468186240|FG003|Treatment Period|Lost to Follow-up|9|||
130063143|NCT01885078|468186241|FG004|Treatment Period|Lost to Follow-up|2|||
130063144|NCT01885078|468186242|FG005|Treatment Period|Lost to Follow-up|8|||
130063145|NCT01885078|468186243|FG006|Treatment Period|Lost to Follow-up|2|||
130063146|NCT01885078|468186244|FG007|Treatment Period|Lost to Follow-up|0|||
130063147|NCT01885078|468186245|FG008|Treatment Period|Lost to Follow-up|0|||
130063148|NCT01885078|468186246|FG009|Treatment Period|Lost to Follow-up|0|||
130063149|NCT01885078|468186237|FG000|Treatment Period|Physician Decision|19|||
130063150|NCT01885078|468186238|FG001|Treatment Period|Physician Decision|21|||
130063151|NCT01885078|468186239|FG002|Treatment Period|Physician Decision|5|||
130063152|NCT01885078|468186240|FG003|Treatment Period|Physician Decision|12|||
130063153|NCT01885078|468186241|FG004|Treatment Period|Physician Decision|9|||
130063154|NCT01885078|468186242|FG005|Treatment Period|Physician Decision|24|||
130063155|NCT01885078|468186243|FG006|Treatment Period|Physician Decision|4|||
130063156|NCT01885078|468186244|FG007|Treatment Period|Physician Decision|3|||
130063157|NCT01885078|468186245|FG008|Treatment Period|Physician Decision|0|||
130063158|NCT01885078|468186246|FG009|Treatment Period|Physician Decision|0|||
130063159|NCT01885078|468186237|FG000|Treatment Period|Protocol Violation|3|||
130063160|NCT01885078|468186238|FG001|Treatment Period|Protocol Violation|5|||
130063161|NCT01885078|468186239|FG002|Treatment Period|Protocol Violation|0|||
130063162|NCT01885078|468186240|FG003|Treatment Period|Protocol Violation|3|||
130063163|NCT01885078|468186241|FG004|Treatment Period|Protocol Violation|1|||
130063164|NCT01885078|468186242|FG005|Treatment Period|Protocol Violation|6|||
130063165|NCT01885078|468186243|FG006|Treatment Period|Protocol Violation|0|||
130063166|NCT01885078|468186244|FG007|Treatment Period|Protocol Violation|0|||
130063167|NCT01885078|468186245|FG008|Treatment Period|Protocol Violation|0|||
130063168|NCT01885078|468186246|FG009|Treatment Period|Protocol Violation|0|||
130063169|NCT01885078|468186237|FG000|Treatment Period|Sponsor Decision|245|||
130063170|NCT01885078|468186238|FG001|Treatment Period|Sponsor Decision|648|||
130063171|NCT01885078|468186239|FG002|Treatment Period|Sponsor Decision|49|||
129839128|NCT00048542|467377522|FG006|Double-Blind Phase|Sponsor request or decision|0|||
130114696|NCT02196506|468379762|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
130063172|NCT01885078|468186240|FG003|Treatment Period|Sponsor Decision|90|||
130063173|NCT01885078|468186241|FG004|Treatment Period|Sponsor Decision|20|||
130063174|NCT01885078|468186242|FG005|Treatment Period|Sponsor Decision|38|||
130063175|NCT01885078|468186243|FG006|Treatment Period|Sponsor Decision|162|||
130063176|NCT01885078|468186244|FG007|Treatment Period|Sponsor Decision|3|||
130063177|NCT01885078|468186245|FG008|Treatment Period|Sponsor Decision|0|||
130063178|NCT01885078|468186246|FG009|Treatment Period|Sponsor Decision|0|||
130063179|NCT01885078|468186237|FG000|Treatment Period|Withdrawal by Subject|72|||
130063180|NCT01885078|468186238|FG001|Treatment Period|Withdrawal by Subject|132|||
130063181|NCT01885078|468186239|FG002|Treatment Period|Withdrawal by Subject|25|||
130063182|NCT01885078|468186240|FG003|Treatment Period|Withdrawal by Subject|63|||
129839129|NCT00048542|467377523|FG007|Double-Blind Phase|Sponsor request or decision|0|||
129839130|NCT00048542|467377516|FG000|Double-Blind Phase|Randomized in error|1|||
129839131|NCT00048542|467377517|FG001|Double-Blind Phase|Randomized in error|0|||
129839132|NCT00048542|467377518|FG002|Double-Blind Phase|Randomized in error|0|||
129839133|NCT00048542|467377519|FG003|Double-Blind Phase|Randomized in error|0|||
129839134|NCT00048542|467377520|FG004|Double-Blind Phase|Randomized in error|0|||
129839135|NCT00048542|467377521|FG005|Double-Blind Phase|Randomized in error|0|||
129839136|NCT00048542|467377522|FG006|Double-Blind Phase|Randomized in error|0|||
129839137|NCT00048542|467377523|FG007|Double-Blind Phase|Randomized in error|0|||
129839138|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839139|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839140|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839141|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839142|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
129839143|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
129839144|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839145|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839146|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839147|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839148|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839149|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839150|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839151|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
129839152|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839153|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839154|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839155|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839156|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
130063183|NCT01885078|468186241|FG004|Treatment Period|Withdrawal by Subject|15|||
130063184|NCT01885078|468186242|FG005|Treatment Period|Withdrawal by Subject|34|||
130063185|NCT01885078|468186243|FG006|Treatment Period|Withdrawal by Subject|17|||
130063186|NCT01885078|468186244|FG007|Treatment Period|Withdrawal by Subject|10|||
130063187|NCT01885078|468186245|FG008|Treatment Period|Withdrawal by Subject|0|||
130063188|NCT01885078|468186246|FG009|Treatment Period|Withdrawal by Subject|0|||
130063189|NCT01885078|468186237|FG000|Treatment Period|Other|0|||
130063190|NCT01885078|468186238|FG001|Treatment Period|Other|0|||
130063191|NCT01885078|468186239|FG002|Treatment Period|Other|0|||
130063192|NCT01885078|468186240|FG003|Treatment Period|Other|1|||
130063193|NCT01885078|468186241|FG004|Treatment Period|Other|0|||
130063194|NCT01885078|468186242|FG005|Treatment Period|Other|0|||
130063195|NCT01885078|468186243|FG006|Treatment Period|Other|0|||
130063196|NCT01885078|468186244|FG007|Treatment Period|Other|0|||
130063197|NCT01885078|468186245|FG008|Treatment Period|Other|0|||
130063198|NCT01885078|468186246|FG009|Treatment Period|Other|0|||
130063199|NCT01885078|468186237|FG000|Step-down Period|Sponsor Decision|0|||
130063200|NCT01885078|468186238|FG001|Step-down Period|Sponsor Decision|0|||
130063201|NCT01885078|468186239|FG002|Step-down Period|Sponsor Decision|0|||
130063202|NCT01885078|468186240|FG003|Step-down Period|Sponsor Decision|0|||
130063203|NCT01885078|468186241|FG004|Step-down Period|Sponsor Decision|0|||
130063204|NCT01885078|468186242|FG005|Step-down Period|Sponsor Decision|0|||
130063205|NCT01885078|468186243|FG006|Step-down Period|Sponsor Decision|0|||
130063206|NCT01885078|468186244|FG007|Step-down Period|Sponsor Decision|0|||
130063207|NCT01885078|468186245|FG008|Step-down Period|Sponsor Decision|1|||
130063208|NCT01885078|468186246|FG009|Step-down Period|Sponsor Decision|1|||
130063209|NCT01885078|468186237|FG000|Step-down Period|Adverse Event|0|||
130063210|NCT01885078|468186238|FG001|Step-down Period|Adverse Event|0|||
130063211|NCT01885078|468186239|FG002|Step-down Period|Adverse Event|0|||
130063212|NCT01885078|468186240|FG003|Step-down Period|Adverse Event|0|||
130063213|NCT01885078|468186241|FG004|Step-down Period|Adverse Event|0|||
130063214|NCT01885078|468186242|FG005|Step-down Period|Adverse Event|0|||
130063215|NCT01885078|468186243|FG006|Step-down Period|Adverse Event|0|||
130063216|NCT01885078|468186244|FG007|Step-down Period|Adverse Event|0|||
130063217|NCT01885078|468186245|FG008|Step-down Period|Adverse Event|29|||
130063218|NCT01885078|468186246|FG009|Step-down Period|Adverse Event|38|||
130063219|NCT01885078|468186237|FG000|Step-down Period|Withdrawal by Subject|0|||
130063220|NCT01885078|468186238|FG001|Step-down Period|Withdrawal by Subject|0|||
130063221|NCT01885078|468186239|FG002|Step-down Period|Withdrawal by Subject|0|||
130063222|NCT01885078|468186240|FG003|Step-down Period|Withdrawal by Subject|0|||
130063223|NCT01885078|468186241|FG004|Step-down Period|Withdrawal by Subject|0|||
130063224|NCT01885078|468186242|FG005|Step-down Period|Withdrawal by Subject|0|||
130063225|NCT01885078|468186243|FG006|Step-down Period|Withdrawal by Subject|0|||
130063226|NCT01885078|468186244|FG007|Step-down Period|Withdrawal by Subject|0|||
130063227|NCT01885078|468186245|FG008|Step-down Period|Withdrawal by Subject|25|||
130063228|NCT01885078|468186246|FG009|Step-down Period|Withdrawal by Subject|15|||
130063229|NCT01885078|468186237|FG000|Step-down Period|Physician Decision|0|||
130114697|NCT02196506|468379763|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
130114698|NCT02196506|468379764|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
130114699|NCT02196506|468379761|FG000|Phase B|Lack of Efficacy|0|||
130114700|NCT02196506|468379762|FG001|Phase B|Lack of Efficacy|1|||
130114701|NCT02196506|468379763|FG002|Phase B|Lack of Efficacy|2|||
130114702|NCT02196506|468379764|FG003|Phase B|Lack of Efficacy|0|||
130114703|NCT02196506|468379761|FG000|Phase B|Withdrawal by Participant|0|||
130114704|NCT02196506|468379762|FG001|Phase B|Withdrawal by Participant|8|||
130114705|NCT02196506|468379763|FG002|Phase B|Withdrawal by Participant|1|||
130114706|NCT02196506|468379764|FG003|Phase B|Withdrawal by Participant|0|||
130114707|NCT02196506|468379761|FG000|Phase B|Adverse Event|0|||
130114708|NCT02196506|468379762|FG001|Phase B|Adverse Event|4|||
130114709|NCT02196506|468379763|FG002|Phase B|Adverse Event|1|||
130114710|NCT02196506|468379764|FG003|Phase B|Adverse Event|0|||
130114711|NCT02196506|468379761|FG000|Phase B|Lost to Follow-up|0|||
130114712|NCT02196506|468379762|FG001|Phase B|Lost to Follow-up|2|||
130114713|NCT02196506|468379763|FG002|Phase B|Lost to Follow-up|1|||
130114714|NCT02196506|468379764|FG003|Phase B|Lost to Follow-up|0|||
130114715|NCT02196506|468379761|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
130114716|NCT02196506|468379762|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
130114717|NCT02196506|468379763|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
130114718|NCT02196506|468379764|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
130114719|NCT02196506|468379761|FG000|Phase A+|Withdrawal by Participant|0|||
130114720|NCT02196506|468379762|FG001|Phase A+|Withdrawal by Participant|0|||
130114721|NCT02196506|468379763|FG002|Phase A+|Withdrawal by Participant|0|||
130114722|NCT02196506|468379764|FG003|Phase A+|Withdrawal by Participant|5|||
130114723|NCT02196506|468379761|FG000|Phase A+|Adverse Event|0|||
130114724|NCT02196506|468379762|FG001|Phase A+|Adverse Event|0|||
130114725|NCT02196506|468379763|FG002|Phase A+|Adverse Event|0|||
130114726|NCT02196506|468379764|FG003|Phase A+|Adverse Event|1|||
130114727|NCT02196506|468379761|FG000|Phase A+|Lost to Follow-up|0|||
130114728|NCT02196506|468379762|FG001|Phase A+|Lost to Follow-up|0|||
130114729|NCT02196506|468379763|FG002|Phase A+|Lost to Follow-up|0|||
130114730|NCT02196506|468379764|FG003|Phase A+|Lost to Follow-up|6|||
130114731|NCT02196506|468379761|FG000|Phase A+|Participant withdrawn by investigator|0|||
130114732|NCT02196506|468379762|FG001|Phase A+|Participant withdrawn by investigator|0|||
129898989|NCT00927823|467590127|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
129898990|NCT00927823|467590128|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
129898991|NCT00927823|467590125|FG000|Continuous Dosing Period|Other|1|||
129898992|NCT00927823|467590126|FG001|Continuous Dosing Period|Other|2|||
129898993|NCT00927823|467590127|FG002|Continuous Dosing Period|Other|9|||
129898994|NCT00927823|467590128|FG003|Continuous Dosing Period|Other|3|||
129898995|NCT00828672|467590129|FG000|Study Treatment|Lost to Follow-up|1|||
129898996|NCT00828672|467590130|FG001|Study Treatment|Lost to Follow-up|0|||
129898997|NCT00828672|467590129|FG000|Study Treatment|Adverse Event|0|||
129898998|NCT00828672|467590130|FG001|Study Treatment|Adverse Event|1|||
129898999|NCT00828672|467590129|FG000|Study Treatment|Complete response, no surgery|1|||
129899000|NCT00828672|467590130|FG001|Study Treatment|Complete response, no surgery|1|||
130114733|NCT02196506|468379763|FG002|Phase A+|Participant withdrawn by investigator|0|||
130114734|NCT02196506|468379764|FG003|Phase A+|Participant withdrawn by investigator|1|||
130114735|NCT00254397|468379765|FG000|Overall Study|Disease Progression|4|||
130114736|NCT00254397|468379766|FG001|Overall Study|Disease Progression|1|||
129839157|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839158|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
129839159|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
129839160|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839161|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839162|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
129839163|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
129839164|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
129839165|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
129839166|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
129839167|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
129839168|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
129839169|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
129899001|NCT00828672|467590129|FG000|Post-surgery (<30 Days)|No central review materials|0|||
129899002|NCT00828672|467590130|FG001|Post-surgery (<30 Days)|No central review materials|1|||
130114737|NCT00254397|468379767|FG002|Overall Study|Disease Progression|16|||
130114738|NCT00254397|468379768|FG003|Overall Study|Disease Progression|23|||
130114739|NCT00254397|468379765|FG000|Overall Study|Non-Compliant|0|||
130114740|NCT00254397|468379766|FG001|Overall Study|Non-Compliant|0|||
130114741|NCT00254397|468379767|FG002|Overall Study|Non-Compliant|0|||
130114742|NCT00254397|468379768|FG003|Overall Study|Non-Compliant|1|||
130114743|NCT00254397|468379765|FG000|Overall Study|Adverse Event|2|||
130114744|NCT00254397|468379766|FG001|Overall Study|Adverse Event|0|||
130114745|NCT00254397|468379767|FG002|Overall Study|Adverse Event|3|||
130114746|NCT00254397|468379768|FG003|Overall Study|Adverse Event|1|||
129839170|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839171|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839172|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839173|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839174|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
129839175|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
129839176|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839177|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839178|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839179|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839180|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839181|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839182|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839183|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839184|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
129839185|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
129839186|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839187|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839188|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
130063230|NCT01885078|468186238|FG001|Step-down Period|Physician Decision|0|||
130063231|NCT01885078|468186239|FG002|Step-down Period|Physician Decision|0|||
130063232|NCT01885078|468186240|FG003|Step-down Period|Physician Decision|0|||
130063233|NCT01885078|468186241|FG004|Step-down Period|Physician Decision|0|||
130063234|NCT01885078|468186242|FG005|Step-down Period|Physician Decision|0|||
130063235|NCT01885078|468186243|FG006|Step-down Period|Physician Decision|0|||
130063236|NCT01885078|468186244|FG007|Step-down Period|Physician Decision|0|||
130063237|NCT01885078|468186245|FG008|Step-down Period|Physician Decision|7|||
130063238|NCT01885078|468186246|FG009|Step-down Period|Physician Decision|2|||
130063239|NCT01885078|468186237|FG000|Step-down Period|Death|0|||
130063240|NCT01885078|468186238|FG001|Step-down Period|Death|0|||
130063241|NCT01885078|468186239|FG002|Step-down Period|Death|0|||
130063242|NCT01885078|468186240|FG003|Step-down Period|Death|0|||
130063243|NCT01885078|468186241|FG004|Step-down Period|Death|0|||
130063244|NCT01885078|468186242|FG005|Step-down Period|Death|0|||
130063245|NCT01885078|468186243|FG006|Step-down Period|Death|0|||
130063246|NCT01885078|468186244|FG007|Step-down Period|Death|0|||
130063247|NCT01885078|468186245|FG008|Step-down Period|Death|4|||
130063248|NCT01885078|468186246|FG009|Step-down Period|Death|3|||
130063249|NCT01885078|468186237|FG000|Step-down Period|Lost to Follow-up|0|||
130063250|NCT01885078|468186238|FG001|Step-down Period|Lost to Follow-up|0|||
130063251|NCT01885078|468186239|FG002|Step-down Period|Lost to Follow-up|0|||
130063252|NCT01885078|468186240|FG003|Step-down Period|Lost to Follow-up|0|||
130063253|NCT01885078|468186241|FG004|Step-down Period|Lost to Follow-up|0|||
130063254|NCT01885078|468186242|FG005|Step-down Period|Lost to Follow-up|0|||
130063255|NCT01885078|468186243|FG006|Step-down Period|Lost to Follow-up|0|||
130063256|NCT01885078|468186244|FG007|Step-down Period|Lost to Follow-up|0|||
130063257|NCT01885078|468186245|FG008|Step-down Period|Lost to Follow-up|1|||
130063258|NCT01885078|468186246|FG009|Step-down Period|Lost to Follow-up|1|||
130063259|NCT01885078|468186237|FG000|Step-down Period|Lack of Efficacy|0|||
130063260|NCT01885078|468186238|FG001|Step-down Period|Lack of Efficacy|0|||
130063261|NCT01885078|468186239|FG002|Step-down Period|Lack of Efficacy|0|||
130063262|NCT01885078|468186240|FG003|Step-down Period|Lack of Efficacy|0|||
130063263|NCT01885078|468186241|FG004|Step-down Period|Lack of Efficacy|0|||
130063264|NCT01885078|468186242|FG005|Step-down Period|Lack of Efficacy|0|||
130063265|NCT01885078|468186243|FG006|Step-down Period|Lack of Efficacy|0|||
130063266|NCT01885078|468186244|FG007|Step-down Period|Lack of Efficacy|0|||
130063267|NCT01885078|468186245|FG008|Step-down Period|Lack of Efficacy|1|||
130063268|NCT01885078|468186246|FG009|Step-down Period|Lack of Efficacy|0|||
130063269|NCT01885078|468186237|FG000|Step-down Period|Protocol Violation|0|||
130063270|NCT01885078|468186238|FG001|Step-down Period|Protocol Violation|0|||
130063271|NCT01885078|468186239|FG002|Step-down Period|Protocol Violation|0|||
130063272|NCT01885078|468186240|FG003|Step-down Period|Protocol Violation|0|||
130063273|NCT01885078|468186241|FG004|Step-down Period|Protocol Violation|0|||
130063274|NCT01885078|468186242|FG005|Step-down Period|Protocol Violation|0|||
130063275|NCT01885078|468186243|FG006|Step-down Period|Protocol Violation|0|||
130063276|NCT01885078|468186244|FG007|Step-down Period|Protocol Violation|0|||
130063277|NCT01885078|468186245|FG008|Step-down Period|Protocol Violation|1|||
130063278|NCT01885078|468186246|FG009|Step-down Period|Protocol Violation|1|||
130063279|NCT03115112|468186247|FG000|Overall Study|Adverse Event|5|||
130063280|NCT03115112|468186248|FG001|Overall Study|Adverse Event|1|||
130063281|NCT03115112|468186247|FG000|Overall Study|Withdrawal by Subject|4|||
130063282|NCT03115112|468186248|FG001|Overall Study|Withdrawal by Subject|2|||
130063283|NCT03115112|468186247|FG000|Overall Study|Lost to Follow-up|0|||
130063284|NCT03115112|468186248|FG001|Overall Study|Lost to Follow-up|1|||
130063285|NCT03115112|468186247|FG000|Overall Study|Death|1|||
130063286|NCT03115112|468186248|FG001|Overall Study|Death|0|||
130063287|NCT03115112|468186247|FG000|Overall Study|Pregnancy|1|||
130063288|NCT03115112|468186248|FG001|Overall Study|Pregnancy|0|||
130063289|NCT03115112|468186247|FG000|Overall Study|Site closure|1|||
130063290|NCT03115112|468186248|FG001|Overall Study|Site closure|1|||
130063291|NCT01204697|468186249|FG000|Overall Study|Death|26|||
130063292|NCT01204697|468186250|FG001|Overall Study|Death|27|||
130063293|NCT01204697|468186249|FG000|Overall Study|Lost to Follow-up|3|||
130063294|NCT01204697|468186250|FG001|Overall Study|Lost to Follow-up|4|||
130063295|NCT01204697|468186249|FG000|Overall Study|Withdrawal by Subject|2|||
130063296|NCT01204697|468186250|FG001|Overall Study|Withdrawal by Subject|4|||
130063297|NCT01204697|468186249|FG000|Overall Study|Randomized, but not treated|0|||
130063298|NCT01204697|468186250|FG001|Overall Study|Randomized, but not treated|1|||
130063299|NCT01170702|468186251|FG000|Overall Study|Exclusion criteria met after consent|1|||
130063300|NCT01170702|468186252|FG001|Overall Study|Exclusion criteria met after consent|2|||
130063301|NCT01170702|468186253|FG002|Overall Study|Exclusion criteria met after consent|0|||
130063302|NCT01170702|468186254|FG003|Overall Study|Exclusion criteria met after consent|2|||
130063303|NCT01205451|468186255|FG000|Overall Study|Lost to Follow-up|1|||
130063304|NCT01205451|468186256|FG001|Overall Study|Lost to Follow-up|1|||
130063305|NCT01205451|468186255|FG000|Overall Study|Withdrawal by Subject|5|||
130063306|NCT01205451|468186256|FG001|Overall Study|Withdrawal by Subject|9|||
130063307|NCT01677507|468186257|FG000|Initial Assignment|Adverse Event|0|||
130063308|NCT01677507|468186258|FG001|Initial Assignment|Adverse Event|1|||
130063309|NCT01677507|468186257|FG000|Initial Assignment|Protocol Violation|0|||
130063310|NCT01677507|468186258|FG001|Initial Assignment|Protocol Violation|1|||
130063311|NCT01677507|468186257|FG000|Second Assigment|Withdrawal by Subject|2|||
130063312|NCT01677507|468186258|FG001|Second Assigment|Withdrawal by Subject|2|||
130063313|NCT01677507|468186257|FG000|Second Assigment|Adverse Event|1|||
130063314|NCT01677507|468186258|FG001|Second Assigment|Adverse Event|3|||
130063315|NCT00712933|468186265|FG000|Overall Study|Adverse Event|69|||
130063316|NCT00712933|468186265|FG000|Overall Study|Lack of Efficacy|6|||
130063317|NCT00712933|468186265|FG000|Overall Study|Lost to Follow-up|22|||
130063318|NCT00712933|468186265|FG000|Overall Study|Non-compliance with study drug|13|||
130063319|NCT00712933|468186265|FG000|Overall Study|Other Pregnancy|37|||
130063320|NCT00712933|468186265|FG000|Overall Study|Sponsor decision|14|||
130063321|NCT00712933|468186265|FG000|Overall Study|Withdrew consent|4|||
130063322|NCT00712933|468186265|FG000|Overall Study|Hip replacement surgery|1|||
130063323|NCT00712933|468186265|FG000|Overall Study|Involved in Clinical research|3|||
130063324|NCT00712933|468186265|FG000|Overall Study|Participant hospitalized|1|||
130063325|NCT00712933|468186265|FG000|Overall Study|Participant travelled overseas|2|||
130063326|NCT00712933|468186265|FG000|Overall Study|Death of patient|1|||
130063327|NCT00712933|468186265|FG000|Overall Study|Other Physician decision|1|||
130063328|NCT00712933|468186265|FG000|Overall Study|Not committed to contraception|1|||
130063329|NCT00712933|468186265|FG000|Overall Study|Participant received medication|1|||
130063330|NCT00712933|468186265|FG000|Overall Study|Physician Decision|36|||
130063331|NCT00712933|468186265|FG000|Overall Study|Protocol Violation|4|||
130063332|NCT00712933|468186265|FG000|Overall Study|Withdrawal by Subject|151|||
130063333|NCT01295580|468186269|FG000|Overall Study|Protocol Violation|4|||
130063334|NCT01295580|468186270|FG001|Overall Study|Protocol Violation|2|||
130063335|NCT01295580|468186269|FG000|Overall Study|Withdrawal by Subject|1|||
130063336|NCT01295580|468186270|FG001|Overall Study|Withdrawal by Subject|4|||
130063337|NCT01295580|468186269|FG000|Overall Study|Adverse Event|2|||
130063338|NCT01295580|468186270|FG001|Overall Study|Adverse Event|1|||
130063339|NCT01295580|468186269|FG000|Overall Study|Lost to Follow-up|1|||
130063340|NCT01295580|468186270|FG001|Overall Study|Lost to Follow-up|0|||
130063341|NCT01295580|468186269|FG000|Overall Study|Lack of Efficacy|1|||
130063342|NCT01295580|468186270|FG001|Overall Study|Lack of Efficacy|0|||
130063343|NCT01295580|468186269|FG000|Overall Study|Other: inconvenience|1|||
130063344|NCT01295580|468186270|FG001|Overall Study|Other: inconvenience|0|||
129839189|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839190|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839191|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839192|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
130063345|NCT01295580|468186269|FG000|Overall Study|Other: family objection|0|||
130063346|NCT01295580|468186270|FG001|Overall Study|Other: family objection|1|||
130063347|NCT01879319|468186275|FG000|Overall Study|Withdrawal by Subject|1|||
130063348|NCT01879319|468186276|FG001|Overall Study|Withdrawal by Subject|0|||
130063349|NCT01879319|468186275|FG000|Overall Study|Lost to Follow-up|1|||
130063350|NCT01879319|468186276|FG001|Overall Study|Lost to Follow-up|5|||
130063351|NCT03986190|468186277|FG000|Overall Study|Withdrawal by Subject|12|||
130063352|NCT03986190|468186278|FG001|Overall Study|Withdrawal by Subject|0|||
130063353|NCT04511819|468186279|FG000|Overall Study|Non-compliance with study drug|5|||
130063354|NCT04511819|468186280|FG001|Overall Study|Non-compliance with study drug|1|||
130063355|NCT04511819|468186279|FG000|Overall Study|Withdrawal by Subject|0|||
130063356|NCT04511819|468186280|FG001|Overall Study|Withdrawal by Subject|3|||
130063357|NCT04511819|468186279|FG000|Overall Study|Adverse Event|0|||
129899003|NCT01250002|467590138|FG000|Overall Study|Change to open surgical procedure|4|||
129899004|NCT01250002|467590139|FG001|Overall Study|Change to open surgical procedure|3|||
129899005|NCT04044664|467590144|FG000|Stage 1|Adverse Event|3|||
129899006|NCT04044664|467590145|FG001|Stage 1|Adverse Event|3|||
129899007|NCT04044664|467590146|FG002|Stage 1|Adverse Event|1|||
129899008|NCT04044664|467590144|FG000|Stage 1|Lost to Follow-up|3|||
129899009|NCT04044664|467590145|FG001|Stage 1|Lost to Follow-up|2|||
129899010|NCT04044664|467590146|FG002|Stage 1|Lost to Follow-up|2|||
129899011|NCT04044664|467590144|FG000|Stage 1|Withdrawal by Subject|9|||
129899012|NCT04044664|467590145|FG001|Stage 1|Withdrawal by Subject|1|||
129899013|NCT04044664|467590146|FG002|Stage 1|Withdrawal by Subject|0|||
129899014|NCT04044664|467590144|FG000|Stage 1|noncompliance, personal reason|2|||
129899015|NCT04044664|467590145|FG001|Stage 1|noncompliance, personal reason|0|||
129899016|NCT04044664|467590146|FG002|Stage 1|noncompliance, personal reason|0|||
129899017|NCT04044664|467590144|FG000|Stage 1|randomization error|0|||
129899018|NCT04044664|467590145|FG001|Stage 1|randomization error|1|||
129899019|NCT04044664|467590146|FG002|Stage 1|randomization error|0|||
129899020|NCT04044664|467590144|FG000|Stage 2|Adverse Event|2|||
129899021|NCT04044664|467590145|FG001|Stage 2|Adverse Event|0|||
129899022|NCT04044664|467590146|FG002|Stage 2|Adverse Event|0|||
129899023|NCT04044664|467590144|FG000|Stage 2|Lost to Follow-up|3|||
129899024|NCT04044664|467590145|FG001|Stage 2|Lost to Follow-up|2|||
129899025|NCT04044664|467590146|FG002|Stage 2|Lost to Follow-up|1|||
129899026|NCT04044664|467590144|FG000|Stage 2|Withdrawal by Subject|3|||
129899027|NCT04044664|467590145|FG001|Stage 2|Withdrawal by Subject|0|||
129899028|NCT04044664|467590146|FG002|Stage 2|Withdrawal by Subject|0|||
129899029|NCT04044664|467590144|FG000|Stage 2|protocol deviation|1|||
129899030|NCT04044664|467590145|FG001|Stage 2|protocol deviation|0|||
129899031|NCT04044664|467590146|FG002|Stage 2|protocol deviation|0|||
129899032|NCT00001575|467590150|FG000|Overall Study|Screening failures-Ph I portion|22|||
129899033|NCT00001575|467590150|FG000|Overall Study|Withdrawn/deaths|23|||
129899034|NCT00290732|467590157|FG000|Overall Study|Inability to instill drug intraductally.|0|||
129899035|NCT00290732|467590158|FG001|Overall Study|Inability to instill drug intraductally.|1|||
129899036|NCT00290732|467590159|FG002|Overall Study|Inability to instill drug intraductally.|1|||
129899037|NCT00290732|467590160|FG003|Overall Study|Inability to instill drug intraductally.|0|||
129899038|NCT00290732|467590161|FG004|Overall Study|Inability to instill drug intraductally.|0|||
129899039|NCT00542386|467590162|FG000|Overall Study|Adverse Event|1|||
129899040|NCT00542386|467590163|FG001|Overall Study|Adverse Event|7|||
129899041|NCT00542386|467590164|FG002|Overall Study|Adverse Event|7|||
129899042|NCT00542386|467590165|FG003|Overall Study|Adverse Event|8|||
129839193|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
129839194|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839195|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839196|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839197|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839198|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839199|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839200|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
129839201|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
129839202|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839203|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839204|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839205|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839206|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839207|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839208|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
129839209|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
129839210|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839211|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839212|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839213|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839214|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839215|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839216|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
129899043|NCT00542386|467590166|FG004|Overall Study|Adverse Event|13|||
129899044|NCT00542386|467590167|FG005|Overall Study|Adverse Event|4|||
129899045|NCT00542386|467590162|FG000|Overall Study|Death|0|||
129899046|NCT00542386|467590163|FG001|Overall Study|Death|0|||
129899047|NCT00542386|467590164|FG002|Overall Study|Death|1|||
129899048|NCT00542386|467590165|FG003|Overall Study|Death|2|||
129899049|NCT00542386|467590166|FG004|Overall Study|Death|1|||
129899050|NCT00542386|467590167|FG005|Overall Study|Death|2|||
129899051|NCT00542386|467590162|FG000|Overall Study|Lack of Efficacy|32|||
129899052|NCT00542386|467590163|FG001|Overall Study|Lack of Efficacy|12|||
129839217|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
129839218|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839219|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839220|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839221|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839222|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839223|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839224|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
129839225|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
129839226|NCT00578175|467377524|FG000|Overall Study|Adverse Event|0|||
129839227|NCT00578175|467377525|FG001|Overall Study|Adverse Event|1|||
129839228|NCT00578175|467377526|FG002|Overall Study|Adverse Event|1|||
129839229|NCT00578175|467377524|FG000|Overall Study|Other reasons|70|||
129839230|NCT00578175|467377525|FG001|Overall Study|Other reasons|42|||
129839231|NCT00578175|467377526|FG002|Overall Study|Other reasons|23|||
129839232|NCT01869192|467377527|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
129839233|NCT01869192|467377528|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
129839234|NCT01869192|467377527|FG000|Postoperative Chemotherapy|Physician Decision|0|||
129839235|NCT01869192|467377528|FG001|Postoperative Chemotherapy|Physician Decision|2|||
129839236|NCT02126969|467377533|FG000|Overall Study|Withdrawal by Subject|1|||
129839237|NCT02126969|467377534|FG001|Overall Study|Withdrawal by Subject|2|||
129839238|NCT00423891|467377535|FG000|Enrolled|Withdrawal by Subject|0|||
129839239|NCT00423891|467377536|FG001|Enrolled|Withdrawal by Subject|0|||
129839240|NCT00423891|467377537|FG002|Enrolled|Withdrawal by Subject|1|||
129839241|NCT00423891|467377535|FG000|Enrolled|Lost to Follow-up|0|||
129839242|NCT00423891|467377536|FG001|Enrolled|Lost to Follow-up|0|||
129839243|NCT00423891|467377537|FG002|Enrolled|Lost to Follow-up|1|||
129839244|NCT00423891|467377535|FG000|Enrolled|No longer met criteria|11|||
129839245|NCT00423891|467377536|FG001|Enrolled|No longer met criteria|2|||
129839246|NCT00423891|467377537|FG002|Enrolled|No longer met criteria|1|||
129839247|NCT00423891|467377535|FG000|Treatment|Withdrawal by Subject|1|||
129839248|NCT00423891|467377536|FG001|Treatment|Withdrawal by Subject|0|||
129839249|NCT00423891|467377537|FG002|Treatment|Withdrawal by Subject|0|||
129839250|NCT00423891|467377535|FG000|Treatment|Lost to Follow-up|1|||
129839251|NCT00423891|467377536|FG001|Treatment|Lost to Follow-up|0|||
129839252|NCT00423891|467377537|FG002|Treatment|Lost to Follow-up|0|||
129839253|NCT00423891|467377535|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
129839254|NCT00423891|467377536|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
130063358|NCT04511819|468186280|FG001|Overall Study|Adverse Event|1|||
130063359|NCT04511819|468186279|FG000|Overall Study|Protocol deviation|1|||
130063360|NCT04511819|468186280|FG001|Overall Study|Protocol deviation|0|||
130063361|NCT00084929|468186281|FG000|Overall Study|ineligible - medical contraindication|1|||
130063362|NCT00084929|468186281|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
130063363|NCT00084929|468186281|FG000|Overall Study|Ineligible - Medical history|6|||
130063364|NCT00084929|468186281|FG000|Overall Study|Withdrawal by Subject|10|||
130063365|NCT00084929|468186281|FG000|Overall Study|Missing/incomplete CTC exam|9|||
130063366|NCT00084929|468186281|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
130063367|NCT00589979|468186282|FG000|Run-In Period|Adverse Event|5|||
130063368|NCT00589979|468186283|FG001|Run-In Period|Adverse Event|0|||
130063369|NCT00589979|468186284|FG002|Run-In Period|Adverse Event|0|||
129839255|NCT00423891|467377537|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
129839256|NCT00423891|467377535|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
129839257|NCT00423891|467377536|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
129839258|NCT00423891|467377537|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
129839259|NCT00414661|467377538|FG000|Overall Study|Death|2|||
129839260|NCT00414661|467377539|FG001|Overall Study|Death|5|||
129839261|NCT00414661|467377540|FG002|Overall Study|Death|0|||
129839262|NCT00414661|467377541|FG003|Overall Study|Death|0|||
129839263|NCT00414661|467377538|FG000|Overall Study|Lost to Follow-up|1|||
129839264|NCT00414661|467377539|FG001|Overall Study|Lost to Follow-up|4|||
129839265|NCT00414661|467377540|FG002|Overall Study|Lost to Follow-up|0|||
129839266|NCT00414661|467377541|FG003|Overall Study|Lost to Follow-up|1|||
129839267|NCT00414661|467377538|FG000|Overall Study|Withdrawal by Subject|5|||
129839268|NCT00414661|467377539|FG001|Overall Study|Withdrawal by Subject|2|||
129899053|NCT00542386|467590164|FG002|Overall Study|Lack of Efficacy|10|||
129899054|NCT00542386|467590165|FG003|Overall Study|Lack of Efficacy|13|||
130063370|NCT00589979|468186282|FG000|Run-In Period|Protocol Violation|3|||
130063371|NCT00589979|468186283|FG001|Run-In Period|Protocol Violation|0|||
130063372|NCT00589979|468186284|FG002|Run-In Period|Protocol Violation|0|||
130063373|NCT00589979|468186282|FG000|Run-In Period|Did not qualify for randomization|54|||
130063374|NCT00589979|468186283|FG001|Run-In Period|Did not qualify for randomization|0|||
130063375|NCT00589979|468186284|FG002|Run-In Period|Did not qualify for randomization|0|||
130063376|NCT00589979|468186282|FG000|Run-In Period|Withdrawal by Subject|10|||
130063377|NCT00589979|468186283|FG001|Run-In Period|Withdrawal by Subject|0|||
129839269|NCT00414661|467377540|FG002|Overall Study|Withdrawal by Subject|2|||
129839270|NCT00414661|467377541|FG003|Overall Study|Withdrawal by Subject|2|||
129899055|NCT00542386|467590166|FG004|Overall Study|Lack of Efficacy|7|||
129899056|NCT00542386|467590167|FG005|Overall Study|Lack of Efficacy|31|||
129899057|NCT00542386|467590162|FG000|Overall Study|Physician Decision|1|||
129899058|NCT00542386|467590163|FG001|Overall Study|Physician Decision|0|||
129899059|NCT00542386|467590164|FG002|Overall Study|Physician Decision|0|||
129899060|NCT00542386|467590165|FG003|Overall Study|Physician Decision|1|||
129899061|NCT00542386|467590166|FG004|Overall Study|Physician Decision|0|||
129899062|NCT00542386|467590167|FG005|Overall Study|Physician Decision|0|||
129899063|NCT00542386|467590162|FG000|Overall Study|Protocol Violation|0|||
129899064|NCT00542386|467590163|FG001|Overall Study|Protocol Violation|0|||
129899065|NCT00542386|467590164|FG002|Overall Study|Protocol Violation|1|||
129899066|NCT00542386|467590165|FG003|Overall Study|Protocol Violation|0|||
129899067|NCT00542386|467590166|FG004|Overall Study|Protocol Violation|0|||
129899068|NCT00542386|467590167|FG005|Overall Study|Protocol Violation|4|||
129899069|NCT00542386|467590162|FG000|Overall Study|Withdrawal by Subject|5|||
129899070|NCT00542386|467590163|FG001|Overall Study|Withdrawal by Subject|8|||
129899071|NCT00542386|467590164|FG002|Overall Study|Withdrawal by Subject|10|||
129899072|NCT00542386|467590165|FG003|Overall Study|Withdrawal by Subject|11|||
129899073|NCT00542386|467590166|FG004|Overall Study|Withdrawal by Subject|15|||
129899074|NCT00542386|467590167|FG005|Overall Study|Withdrawal by Subject|7|||
129839271|NCT00414661|467377538|FG000|Overall Study|Other|6|||
129839272|NCT00414661|467377539|FG001|Overall Study|Other|3|||
129839273|NCT00414661|467377540|FG002|Overall Study|Other|0|||
129839274|NCT00414661|467377541|FG003|Overall Study|Other|0|||
129839275|NCT00357370|467377542|FG000|Cohort 2|Lack of Efficacy|0|||
129839276|NCT00357370|467377543|FG001|Cohort 2|Lack of Efficacy|2|||
129839277|NCT00357370|467377544|FG002|Cohort 2|Lack of Efficacy|1|||
129839278|NCT00357370|467377542|FG000|Cohort 2|Adverse Event|1|||
129839279|NCT00357370|467377543|FG001|Cohort 2|Adverse Event|1|||
129839280|NCT00357370|467377544|FG002|Cohort 2|Adverse Event|1|||
129839281|NCT00357370|467377542|FG000|Cohort 2|Lost to Follow-up|0|||
129839282|NCT00357370|467377543|FG001|Cohort 2|Lost to Follow-up|1|||
129839283|NCT00357370|467377544|FG002|Cohort 2|Lost to Follow-up|0|||
129839284|NCT00357370|467377542|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
129839285|NCT00357370|467377543|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
129839286|NCT00357370|467377544|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
129839287|NCT00357370|467377542|FG000|Cohort 2|Withdrawal by Subject|0|||
129839288|NCT00357370|467377543|FG001|Cohort 2|Withdrawal by Subject|2|||
129839289|NCT00357370|467377544|FG002|Cohort 2|Withdrawal by Subject|0|||
129839290|NCT01143090|467377545|FG000|Overall Study|Lack of Efficacy|2|||
129839291|NCT01143090|467377545|FG000|Overall Study|Adverse Event|17|||
129839292|NCT01143090|467377545|FG000|Overall Study|Lost to Follow-up|9|||
129839293|NCT01143090|467377545|FG000|Overall Study|Protocol Violation|2|||
129839294|NCT01143090|467377545|FG000|Overall Study|Withdrawal by Subject|18|||
129839295|NCT01143090|467377545|FG000|Overall Study|Non-compliance with study drug|1|||
129839296|NCT01143090|467377545|FG000|Overall Study|Failure to meet eligibility criteria|1|||
129839297|NCT01143090|467377545|FG000|Overall Study|Administrative|1|||
129839298|NCT01232296|467377546|FG000|Overall Study|Adverse Event|24|||
129839299|NCT01232296|467377547|FG001|Overall Study|Adverse Event|12|||
129839300|NCT01232296|467377546|FG000|Overall Study|Physician Decision|1|||
129839301|NCT01232296|467377547|FG001|Overall Study|Physician Decision|1|||
129839302|NCT01232296|467377546|FG000|Overall Study|Progressive disease|43|||
129839303|NCT01232296|467377547|FG001|Overall Study|Progressive disease|61|||
129839304|NCT01232296|467377546|FG000|Overall Study|Study terminated by sponsor|0|||
129839305|NCT01232296|467377547|FG001|Overall Study|Study terminated by sponsor|1|||
129839306|NCT01232296|467377546|FG000|Overall Study|Technical problems|3|||
129839307|NCT01232296|467377547|FG001|Overall Study|Technical problems|0|||
129839308|NCT01232296|467377546|FG000|Overall Study|Subject/guardian decision|10|||
129839309|NCT01232296|467377547|FG001|Overall Study|Subject/guardian decision|2|||
129839310|NCT01232296|467377546|FG000|Overall Study|Death|1|||
129839311|NCT01232296|467377547|FG001|Overall Study|Death|6|||
129839312|NCT00727714|467377550|FG000|Overall Study|Lost to Follow-up|2|||
129839313|NCT00937547|467377551|FG000|Overall Study|misdiagnosis|1|||
129839314|NCT00937547|467377552|FG001|Overall Study|misdiagnosis|6|||
129839315|NCT00937547|467377553|FG002|Overall Study|misdiagnosis|7|||
129839316|NCT00325234|467377554|FG000|Overall Study|Adverse Event|10|||
129839317|NCT00325234|467377555|FG001|Overall Study|Adverse Event|7|||
129899075|NCT00542386|467590162|FG000|Overall Study|Other Reasons|4|||
129899076|NCT00542386|467590163|FG001|Overall Study|Other Reasons|1|||
129839318|NCT00325234|467377554|FG000|Overall Study|Death due to Study Disease|1|||
129839319|NCT00325234|467377555|FG001|Overall Study|Death due to Study Disease|0|||
129839320|NCT00325234|467377554|FG000|Overall Study|Entry Criteria Not Met|1|||
129839321|NCT00325234|467377555|FG001|Overall Study|Entry Criteria Not Met|2|||
129839322|NCT00325234|467377554|FG000|Overall Study|Subject Decision|6|||
129839323|NCT00325234|467377555|FG001|Overall Study|Subject Decision|8|||
129839324|NCT00325234|467377554|FG000|Overall Study|Physician Decision|17|||
129839325|NCT00325234|467377555|FG001|Overall Study|Physician Decision|12|||
129839326|NCT00325234|467377554|FG000|Overall Study|Progressive Disease|34|||
129899077|NCT00542386|467590164|FG002|Overall Study|Other Reasons|4|||
129839327|NCT00325234|467377555|FG001|Overall Study|Progressive Disease|37|||
129899078|NCT00542386|467590165|FG003|Overall Study|Other Reasons|3|||
130114747|NCT01015612|468379775|FG000|Overall Study|Death|113|||
130114748|NCT01015612|468379775|FG000|Overall Study|Withdrawal by Subject|40|||
130114749|NCT00066807|468379776|FG000|Overall Study|Study was terminated early|14|||
130114750|NCT00066807|468379777|FG001|Overall Study|Study was terminated early|15|||
130114751|NCT03586830|468379779|FG000|Overall Study|Site terminated by Sponsor|1|||
130114752|NCT03586830|468379780|FG001|Overall Study|Site terminated by Sponsor|4|||
130114753|NCT03586830|468379781|FG002|Overall Study|Site terminated by Sponsor|3|||
130114754|NCT03586830|468379782|FG003|Overall Study|Site terminated by Sponsor|3|||
130114755|NCT03586830|468379779|FG000|Overall Study|Lost to Follow-up|0|||
130114756|NCT03586830|468379780|FG001|Overall Study|Lost to Follow-up|2|||
130114757|NCT03586830|468379781|FG002|Overall Study|Lost to Follow-up|2|||
130114758|NCT03586830|468379782|FG003|Overall Study|Lost to Follow-up|1|||
130114759|NCT03586830|468379779|FG000|Overall Study|Withdrawal by Subject|1|||
130114760|NCT03586830|468379780|FG001|Overall Study|Withdrawal by Subject|0|||
130114761|NCT03586830|468379781|FG002|Overall Study|Withdrawal by Subject|3|||
130114762|NCT03586830|468379782|FG003|Overall Study|Withdrawal by Subject|1|||
130114763|NCT04578548|468379783|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
130114764|NCT04578548|468379784|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
130114765|NCT04578548|468379783|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
129839328|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
129839329|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
129839330|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
129839331|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
129839332|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
129839333|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
129839334|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
129839335|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
129839336|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
129839337|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
129839338|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
129839339|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
129839340|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
129839341|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
129839342|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
129839343|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
129839344|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
129839345|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
129839346|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Death|0|||
129839347|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Death|0|||
129839348|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Death|1|||
129839349|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Death|0|||
129839350|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Death|0|||
129839351|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Death|0|||
129839352|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Death|0|||
129839353|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Death|0|||
129839354|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Death|0|||
129839355|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
129839356|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
129839357|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
129899079|NCT00542386|467590166|FG004|Overall Study|Other Reasons|4|||
129899080|NCT00542386|467590167|FG005|Overall Study|Other Reasons|2|||
129899081|NCT01549652|467590168|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
130063378|NCT00589979|468186284|FG002|Run-In Period|Withdrawal by Subject|0|||
130063379|NCT00589979|468186282|FG000|Run-In Period|Informed Consent Withdrawn|4|||
130063380|NCT00589979|468186283|FG001|Run-In Period|Informed Consent Withdrawn|0|||
130063381|NCT00589979|468186284|FG002|Run-In Period|Informed Consent Withdrawn|0|||
130063382|NCT00589979|468186282|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
130063383|NCT00589979|468186283|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
130063384|NCT00589979|468186284|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
130063385|NCT00589979|468186282|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
130063386|NCT00589979|468186283|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
130063387|NCT00589979|468186284|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
130063388|NCT00589979|468186282|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
130063389|NCT00589979|468186283|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
130063390|NCT00589979|468186284|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
130063391|NCT00589979|468186282|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
130063392|NCT00589979|468186283|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
130063393|NCT00589979|468186284|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
130063394|NCT00589979|468186282|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130063395|NCT00589979|468186283|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130114766|NCT04578548|468379784|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
130114767|NCT04578548|468379783|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
130114768|NCT04578548|468379784|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
130114769|NCT04578548|468379783|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
130114770|NCT04578548|468379784|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
130114771|NCT04578548|468379783|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
130114772|NCT04578548|468379784|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
130114773|NCT04578548|468379783|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
130114774|NCT04578548|468379784|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
130114775|NCT00628745|468379785|FG000|Overall Study|Withdrawal by Subject|63|||
130114776|NCT00628745|468379786|FG001|Overall Study|Withdrawal by Subject|3|||
130114777|NCT00628745|468379787|FG002|Overall Study|Withdrawal by Subject|9|||
130114778|NCT00628745|468379788|FG003|Overall Study|Withdrawal by Subject|2|||
130114779|NCT00628745|468379789|FG004|Overall Study|Withdrawal by Subject|69|||
130114780|NCT00628745|468379785|FG000|Overall Study|Does not meet inclusion criteria|0|||
130114781|NCT00628745|468379786|FG001|Overall Study|Does not meet inclusion criteria|12|||
130114782|NCT00628745|468379787|FG002|Overall Study|Does not meet inclusion criteria|0|||
130114783|NCT00628745|468379788|FG003|Overall Study|Does not meet inclusion criteria|0|||
130114784|NCT00628745|468379789|FG004|Overall Study|Does not meet inclusion criteria|18|||
130114785|NCT00628745|468379785|FG000|Overall Study|Participation in an interventional clinical trial|81|||
130114786|NCT00628745|468379786|FG001|Overall Study|Participation in an interventional clinical trial|4|||
130114787|NCT00628745|468379787|FG002|Overall Study|Participation in an interventional clinical trial|7|||
130114788|NCT00628745|468379788|FG003|Overall Study|Participation in an interventional clinical trial|0|||
130114789|NCT00628745|468379789|FG004|Overall Study|Participation in an interventional clinical trial|63|||
130114790|NCT00628745|468379785|FG000|Overall Study|Physician Decision|8|||
130114791|NCT00628745|468379786|FG001|Overall Study|Physician Decision|4|||
130114792|NCT00628745|468379787|FG002|Overall Study|Physician Decision|3|||
130114793|NCT00628745|468379788|FG003|Overall Study|Physician Decision|0|||
130114794|NCT00628745|468379789|FG004|Overall Study|Physician Decision|30|||
130114795|NCT00628745|468379785|FG000|Overall Study|Lost to Follow-up|109|||
130114796|NCT00628745|468379786|FG001|Overall Study|Lost to Follow-up|7|||
130114797|NCT00628745|468379787|FG002|Overall Study|Lost to Follow-up|7|||
130114798|NCT00628745|468379788|FG003|Overall Study|Lost to Follow-up|0|||
129839358|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130063396|NCT00589979|468186284|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
130063397|NCT00589979|468186282|FG000|Double-Blind Treatment Period 2|Other|0|||
130063398|NCT00589979|468186283|FG001|Double-Blind Treatment Period 2|Other|0|||
130063399|NCT00589979|468186284|FG002|Double-Blind Treatment Period 2|Other|1|||
130063400|NCT00589979|468186282|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
130063401|NCT00589979|468186283|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
130063402|NCT00589979|468186284|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
130063403|NCT00589979|468186282|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
130063404|NCT00589979|468186283|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
130063405|NCT00589979|468186284|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
130063406|NCT00712322|468186285|FG000|Overall Study|Protocol deviation|0|||
130063407|NCT00712322|468186286|FG001|Overall Study|Protocol deviation|1|||
130063408|NCT00712322|468186287|FG002|Overall Study|Protocol deviation|0|||
130063409|NCT02670330|468186289|FG000|Overall Study|Protocol Deviation|1|||
130063410|NCT02670330|468186290|FG001|Overall Study|Protocol Deviation|0|||
130063411|NCT02670330|468186289|FG000|Overall Study|Study Terminated By Sponsor|36|||
130063412|NCT02670330|468186290|FG001|Overall Study|Study Terminated By Sponsor|43|||
130063413|NCT02670330|468186289|FG000|Overall Study|Adverse Event|1|||
130063414|NCT02670330|468186290|FG001|Overall Study|Adverse Event|3|||
130063415|NCT02670330|468186289|FG000|Overall Study|Withdrawal by Subject|34|||
130063416|NCT02670330|468186290|FG001|Overall Study|Withdrawal by Subject|29|||
130063417|NCT02670330|468186289|FG000|Overall Study|Lost to Follow-up|3|||
130063418|NCT02670330|468186290|FG001|Overall Study|Lost to Follow-up|2|||
130063419|NCT02180217|468186293|FG000|Overall Study|Adverse Event|3|||
130063420|NCT02180217|468186294|FG001|Overall Study|Adverse Event|2|||
130063421|NCT02180217|468186295|FG002|Overall Study|Adverse Event|22|||
130063422|NCT02180217|468186293|FG000|Overall Study|Death|1|||
130063423|NCT02180217|468186294|FG001|Overall Study|Death|1|||
130114799|NCT00628745|468379789|FG004|Overall Study|Lost to Follow-up|498|||
129839359|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839360|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839361|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
130063424|NCT02180217|468186295|FG002|Overall Study|Death|0|||
130063425|NCT02180217|468186293|FG000|Overall Study|Withdrawal by Subject|1|||
130063426|NCT02180217|468186294|FG001|Overall Study|Withdrawal by Subject|1|||
130063427|NCT02180217|468186295|FG002|Overall Study|Withdrawal by Subject|4|||
130114800|NCT00628745|468379785|FG000|Overall Study|Death|197|||
130114801|NCT00628745|468379786|FG001|Overall Study|Death|81|||
130063428|NCT02180217|468186293|FG000|Overall Study|Subject/Guardian decision|5|||
130063429|NCT02180217|468186294|FG001|Overall Study|Subject/Guardian decision|3|||
130114802|NCT00628745|468379787|FG002|Overall Study|Death|12|||
130114803|NCT00628745|468379788|FG003|Overall Study|Death|4|||
130114804|NCT00628745|468379789|FG004|Overall Study|Death|939|||
130114805|NCT00628745|468379785|FG000|Overall Study|Participant transferred to another THAOS site|6|||
130114806|NCT00628745|468379786|FG001|Overall Study|Participant transferred to another THAOS site|0|||
130114807|NCT00628745|468379787|FG002|Overall Study|Participant transferred to another THAOS site|0|||
130114808|NCT00628745|468379788|FG003|Overall Study|Participant transferred to another THAOS site|0|||
130114809|NCT00628745|468379789|FG004|Overall Study|Participant transferred to another THAOS site|7|||
130114810|NCT00628745|468379785|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
130114811|NCT00628745|468379786|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
130114812|NCT00628745|468379787|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
130114813|NCT00628745|468379788|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
130114814|NCT00628745|468379789|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
130114815|NCT00628745|468379785|FG000|Overall Study|Site closure|152|||
130114816|NCT00628745|468379786|FG001|Overall Study|Site closure|146|||
130114817|NCT00628745|468379787|FG002|Overall Study|Site closure|6|||
130114818|NCT00628745|468379788|FG003|Overall Study|Site closure|8|||
130114819|NCT00628745|468379789|FG004|Overall Study|Site closure|691|||
130114820|NCT00628745|468379785|FG000|Overall Study|Duplicate participant|0|||
130114821|NCT00628745|468379786|FG001|Overall Study|Duplicate participant|0|||
130114822|NCT00628745|468379787|FG002|Overall Study|Duplicate participant|0|||
130114823|NCT00628745|468379788|FG003|Overall Study|Duplicate participant|0|||
130114824|NCT00628745|468379789|FG004|Overall Study|Duplicate participant|1|||
130114825|NCT00628745|468379785|FG000|Overall Study|Missing|4|||
129839362|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839363|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839364|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
129839365|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
129839366|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
129839367|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839368|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839369|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839370|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839371|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839372|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839373|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
129839374|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
129839375|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
129839376|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
129839377|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
129839378|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
129839379|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
129839380|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
129839381|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
129839382|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
129839383|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
129839384|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
129839385|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
129839386|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
129839387|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
129839388|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
129839389|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
129839390|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
129839391|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
129839392|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
129839393|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
129839394|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129899082|NCT01549652|467590169|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
129899083|NCT01549652|467590170|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
129899084|NCT01549652|467590171|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
129899085|NCT01549652|467590168|FG000|Overall Study|Study Drug Titration Failure|5|||
129899086|NCT01549652|467590169|FG001|Overall Study|Study Drug Titration Failure|6|||
129899087|NCT01549652|467590170|FG002|Overall Study|Study Drug Titration Failure|0|||
129899088|NCT01549652|467590171|FG003|Overall Study|Study Drug Titration Failure|0|||
129839395|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
130114826|NCT00628745|468379786|FG001|Overall Study|Missing|3|||
130114827|NCT00628745|468379787|FG002|Overall Study|Missing|0|||
130114828|NCT00628745|468379788|FG003|Overall Study|Missing|0|||
129839396|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839397|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839398|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839399|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839400|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839401|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
129839402|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839403|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839404|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839405|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839406|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129899089|NCT01549652|467590168|FG000|Overall Study|Withdrawal Effect|0|||
129899090|NCT01549652|467590169|FG001|Overall Study|Withdrawal Effect|2|||
129899091|NCT01549652|467590170|FG002|Overall Study|Withdrawal Effect|0|||
130063430|NCT02180217|468186295|FG002|Overall Study|Subject/Guardian decision|6|||
130063431|NCT02180217|468186293|FG000|Overall Study|Physician Decision|1|||
130063432|NCT02180217|468186294|FG001|Overall Study|Physician Decision|1|||
130063433|NCT02180217|468186295|FG002|Overall Study|Physician Decision|6|||
130063434|NCT02180217|468186293|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130063435|NCT02180217|468186294|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130063436|NCT02180217|468186295|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
130063437|NCT00239837|468186296|FG000|Overall Study|Lost to Follow-up|3|||
130063438|NCT00239837|468186297|FG001|Overall Study|Lost to Follow-up|7|||
130063439|NCT01153893|468186298|FG000|Overall Study|Adverse Event|1|||
130063440|NCT01153893|468186299|FG001|Overall Study|Adverse Event|0|||
130063441|NCT01838590|468186300|FG000|Overall Study|Lack of Efficacy|12|||
130063442|NCT01838590|468186301|FG001|Overall Study|Lack of Efficacy|4|||
130063443|NCT01838590|468186300|FG000|Overall Study|Lost to Follow-up|0|||
130063444|NCT01838590|468186301|FG001|Overall Study|Lost to Follow-up|1|||
130063445|NCT00536978|468186302|FG000|Overall Study|Not eligible for Adback Infusion|22|||
130063446|NCT03550131|468186304|FG000|Overall Study|Lost to Follow-up|16|||
130063447|NCT03550131|468186305|FG001|Overall Study|Lost to Follow-up|24|||
130063448|NCT03550131|468186304|FG000|Overall Study|Withdrawal by Subject|36|||
130063449|NCT03550131|468186305|FG001|Overall Study|Withdrawal by Subject|28|||
130063450|NCT03550131|468186304|FG000|Overall Study|Illness of dyad member|10|||
130063451|NCT03550131|468186305|FG001|Overall Study|Illness of dyad member|2|||
130063452|NCT03550131|468186304|FG000|Overall Study|Death of person with dementia|4|||
130063453|NCT03550131|468186305|FG001|Overall Study|Death of person with dementia|8|||
130063454|NCT01318512|468186306|FG000|Maintenance Period (6 Months)|Death|2|||
130063455|NCT01318512|468186306|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
129839407|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839408|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839409|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
129839410|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
129839411|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
129839412|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
129839413|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
129839414|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
129839415|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
129839416|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
129839417|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
129839418|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Other|0|||
129839419|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Other|1|||
129839420|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Other|0|||
129839421|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Other|0|||
129839422|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Other|0|||
129839423|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Other|0|||
129839424|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Other|0|||
129839425|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Other|0|||
129839426|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Other|0|||
129839427|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
129839428|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
129839429|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
129839430|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
129839431|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
129839432|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
129839433|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
129839434|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
129839435|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
129839436|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
130063456|NCT01364233|468186308|FG000|Overall Study|Lost to Follow-up|1|||
130063457|NCT00878215|468186309|FG000|Overall Study|Determined to be ineligible|0|||
130063458|NCT00878215|468186310|FG001|Overall Study|Determined to be ineligible|10|||
129839437|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
129839438|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
129839439|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
129839440|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
129839441|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
129839442|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
129839443|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
129839444|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
129839445|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839446|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839447|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839448|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839449|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
129839450|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839451|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839452|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839453|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839454|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839455|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839456|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839457|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839458|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839459|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
129839460|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839461|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839462|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839463|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Disease progression|0|||
129839464|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Disease progression|0|||
129839465|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Disease progression|0|||
129839466|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Disease progression|1|||
129839467|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Disease progression|0|||
129839468|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Disease progression|0|||
129839469|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Disease progression|0|||
129839470|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Disease progression|0|||
129839471|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Disease progression|0|||
129839472|NCT00404352|467377556|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839473|NCT00404352|467377557|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839474|NCT00404352|467377558|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839475|NCT00404352|467377559|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839476|NCT00404352|467377560|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839477|NCT00404352|467377561|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839478|NCT00404352|467377562|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
129839479|NCT00404352|467377563|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
129839480|NCT00404352|467377564|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839481|NCT00404352|467377556|FG000|Open Label Extension (up to 36 Months)|Other|0|||
129839482|NCT00404352|467377557|FG001|Open Label Extension (up to 36 Months)|Other|0|||
129839483|NCT00404352|467377558|FG002|Open Label Extension (up to 36 Months)|Other|0|||
129839484|NCT00404352|467377559|FG003|Open Label Extension (up to 36 Months)|Other|0|||
129839485|NCT00404352|467377560|FG004|Open Label Extension (up to 36 Months)|Other|0|||
129839486|NCT00404352|467377561|FG005|Open Label Extension (up to 36 Months)|Other|0|||
129839487|NCT00404352|467377562|FG006|Open Label Extension (up to 36 Months)|Other|0|||
129839488|NCT00404352|467377563|FG007|Open Label Extension (up to 36 Months)|Other|0|||
129839489|NCT00404352|467377564|FG008|Open Label Extension (up to 36 Months)|Other|2|||
129839490|NCT04370691|467377565|FG000|Overall Study|Pending visit|48|||
129839491|NCT04370691|467377565|FG000|Overall Study|Have Not Reached Lower Window|15|||
129839492|NCT04370691|467377565|FG000|Overall Study|Termination|14|||
129839493|NCT04370691|467377565|FG000|Overall Study|Missed or Overdue|10|||
129839494|NCT00486265|467377566|FG000|Overall Study|Adverse Event|1|||
129839495|NCT00486265|467377566|FG000|Overall Study|Lack of Efficacy|8|||
129839496|NCT04225923|467377570|FG000|Overall Study|Protocol Violation|1|||
129839497|NCT04225923|467377571|FG001|Overall Study|Protocol Violation|0|||
129839498|NCT04225923|467377572|FG002|Overall Study|Protocol Violation|1|||
129839499|NCT04225923|467377570|FG000|Overall Study|Withdrawal by Subject|4|||
129839500|NCT04225923|467377571|FG001|Overall Study|Withdrawal by Subject|1|||
129839501|NCT04225923|467377572|FG002|Overall Study|Withdrawal by Subject|3|||
129839502|NCT04225923|467377570|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
129839503|NCT04225923|467377571|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
129839504|NCT04225923|467377572|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
129839505|NCT00855309|467377573|FG000|Overall Study|patient never recieved drug|1|||
129839506|NCT00855309|467377574|FG001|Overall Study|patient never recieved drug|0|||
130114829|NCT00628745|468379789|FG004|Overall Study|Missing|10|||
130114830|NCT00628745|468379785|FG000|Overall Study|Othe reasons|987|||
130114831|NCT00628745|468379786|FG001|Overall Study|Othe reasons|373|||
130114832|NCT00628745|468379787|FG002|Overall Study|Othe reasons|105|||
130114833|NCT00628745|468379788|FG003|Overall Study|Othe reasons|1|||
130114834|NCT00628745|468379789|FG004|Overall Study|Othe reasons|1772|||
130114835|NCT02468557|468381216|FG000|Overall Study|Adverse Event|1|||
130114836|NCT02468557|468381216|FG000|Overall Study|Death|1|||
129839507|NCT01417481|467377575|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129839508|NCT01417481|467377576|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129839509|NCT00829296|467377577|FG000|Overall Study|Adverse Event|5|||
129839510|NCT00829296|467377578|FG001|Overall Study|Adverse Event|4|||
129839511|NCT03029624|467377579|FG000|Overall Study|Adverse Event|1|||
129839512|NCT03029624|467377579|FG000|Overall Study|Withdrawal by Subject|1|||
129839513|NCT03029624|467377579|FG000|Overall Study|Lack of Efficacy|1|||
129839514|NCT03029624|467377579|FG000|Overall Study|MRI need|2|||
129839515|NCT01077960|467377583|FG000|Overall Study|Adverse Event|6|||
129839516|NCT01077960|467377583|FG000|Overall Study|Protocol Violation|3|||
129839517|NCT01077960|467377583|FG000|Overall Study|Lost to Follow-up|5|||
129839518|NCT01077960|467377583|FG000|Overall Study|Subject decision|1|||
129839519|NCT01077960|467377583|FG000|Overall Study|Reason unspecified|1|||
129839520|NCT03837899|467377584|FG000|Overall Study|Death|6|||
129839521|NCT03837899|467377585|FG001|Overall Study|Death|8|||
129839522|NCT03837899|467377586|FG002|Overall Study|Death|3|||
129839523|NCT03837899|467377587|FG003|Overall Study|Death|7|||
129839524|NCT03837899|467377588|FG004|Overall Study|Death|8|||
129839525|NCT03837899|467377589|FG005|Overall Study|Death|7|||
129839526|NCT03837899|467377584|FG000|Overall Study|Moved to post-trial access program|0|||
129839527|NCT03837899|467377585|FG001|Overall Study|Moved to post-trial access program|1|||
129839528|NCT03837899|467377586|FG002|Overall Study|Moved to post-trial access program|0|||
129839529|NCT03837899|467377587|FG003|Overall Study|Moved to post-trial access program|0|||
129839530|NCT03837899|467377588|FG004|Overall Study|Moved to post-trial access program|0|||
129839531|NCT03837899|467377589|FG005|Overall Study|Moved to post-trial access program|0|||
129839532|NCT03837899|467377584|FG000|Overall Study|Other|0|||
129839533|NCT03837899|467377585|FG001|Overall Study|Other|0|||
129839534|NCT03837899|467377586|FG002|Overall Study|Other|0|||
129839535|NCT03837899|467377587|FG003|Overall Study|Other|0|||
129839536|NCT03837899|467377588|FG004|Overall Study|Other|0|||
129839537|NCT03837899|467377589|FG005|Overall Study|Other|2|||
129839538|NCT03837899|467377584|FG000|Overall Study|Lost to Follow-up|0|||
129839539|NCT03837899|467377585|FG001|Overall Study|Lost to Follow-up|1|||
129839540|NCT03837899|467377586|FG002|Overall Study|Lost to Follow-up|0|||
129839541|NCT03837899|467377587|FG003|Overall Study|Lost to Follow-up|0|||
129839542|NCT03837899|467377588|FG004|Overall Study|Lost to Follow-up|0|||
129839543|NCT03837899|467377589|FG005|Overall Study|Lost to Follow-up|0|||
129839544|NCT03837899|467377584|FG000|Overall Study|Withdrawal by Subject|0|||
129839545|NCT03837899|467377585|FG001|Overall Study|Withdrawal by Subject|0|||
129839546|NCT03837899|467377586|FG002|Overall Study|Withdrawal by Subject|0|||
129839547|NCT03837899|467377587|FG003|Overall Study|Withdrawal by Subject|1|||
129839548|NCT03837899|467377588|FG004|Overall Study|Withdrawal by Subject|0|||
129839549|NCT03837899|467377589|FG005|Overall Study|Withdrawal by Subject|0|||
129839550|NCT03837899|467377584|FG000|Overall Study|Study specific discontinuation criteria|0|||
129839551|NCT03837899|467377585|FG001|Overall Study|Study specific discontinuation criteria|1|||
129839552|NCT03837899|467377586|FG002|Overall Study|Study specific discontinuation criteria|0|||
129839553|NCT03837899|467377587|FG003|Overall Study|Study specific discontinuation criteria|0|||
129839554|NCT03837899|467377588|FG004|Overall Study|Study specific discontinuation criteria|3|||
129839555|NCT03837899|467377589|FG005|Overall Study|Study specific discontinuation criteria|1|||
129839556|NCT01371656|467377590|FG000|Overall Study|Death|7|||
129839557|NCT01371656|467377591|FG001|Overall Study|Death|4|||
129839558|NCT01371656|467377590|FG000|Overall Study|Physician Decision|46|||
129839559|NCT01371656|467377591|FG001|Overall Study|Physician Decision|7|||
129839560|NCT01371656|467377590|FG000|Overall Study|Withdrawal by Subject|7|||
129839561|NCT01371656|467377591|FG001|Overall Study|Withdrawal by Subject|0|||
129839562|NCT01371656|467377590|FG000|Overall Study|Ineligible|4|||
129839563|NCT01371656|467377591|FG001|Overall Study|Ineligible|3|||
129839564|NCT01465464|467377592|FG000|Overall Study|Adverse Event|96|||
129839565|NCT01465464|467377593|FG001|Overall Study|Adverse Event|49|||
129839566|NCT01465464|467377592|FG000|Overall Study|Lack of Efficacy|139|||
129839567|NCT01465464|467377593|FG001|Overall Study|Lack of Efficacy|190|||
129839568|NCT01465464|467377592|FG000|Overall Study|Physician Decision|13|||
129839569|NCT01465464|467377593|FG001|Overall Study|Physician Decision|5|||
130114837|NCT02468557|468381216|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
130114838|NCT02468557|468381216|FG000|Overall Study|All Enrolled but Never Dosed|4|||
130114839|NCT00982410|468381217|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
129839570|NCT01465464|467377592|FG000|Overall Study|Protocol Violation|1|||
129839571|NCT01465464|467377593|FG001|Overall Study|Protocol Violation|1|||
129839572|NCT01465464|467377592|FG000|Overall Study|Withdrawal by Subject|46|||
129839573|NCT01465464|467377593|FG001|Overall Study|Withdrawal by Subject|30|||
129899092|NCT01549652|467590171|FG003|Overall Study|Withdrawal Effect|0|||
129899093|NCT01549652|467590168|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
130114840|NCT00982410|468381218|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
130114841|NCT00982410|468381217|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
130114842|NCT00982410|468381218|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
130114843|NCT00982410|468381217|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
130114844|NCT00982410|468381218|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
130114845|NCT00982410|468381217|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
130114846|NCT00982410|468381218|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
130114847|NCT00982410|468381217|FG000|6-month Follow-up Assessment|participant no transportation|1|||
130114848|NCT00982410|468381218|FG001|6-month Follow-up Assessment|participant no transportation|0|||
130114849|NCT00982410|468381217|FG000|6-month Follow-up Assessment|incarceration|0|||
130114850|NCT00982410|468381218|FG001|6-month Follow-up Assessment|incarceration|2|||
130114851|NCT00982410|468381217|FG000|6-month Follow-up Assessment|patent surgery|0|||
130114852|NCT00982410|468381218|FG001|6-month Follow-up Assessment|patent surgery|1|||
130114853|NCT00982410|468381217|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
130114854|NCT00982410|468381218|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
130114855|NCT00982410|468381217|FG000|12-month Follow-up Assessment|Death|0|||
130114856|NCT00982410|468381218|FG001|12-month Follow-up Assessment|Death|2|||
130114857|NCT00982410|468381217|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
130114858|NCT00982410|468381218|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
130114859|NCT00982410|468381217|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
130114860|NCT00982410|468381218|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
130114861|NCT00982410|468381217|FG000|12-month Follow-up Assessment|incarceration|2|||
130114862|NCT00982410|468381218|FG001|12-month Follow-up Assessment|incarceration|1|||
130114863|NCT00982410|468381217|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
130114864|NCT00982410|468381218|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
130114865|NCT03322462|468381219|FG000|Overall Study|Technical difficulties|2|||
130114866|NCT03322462|468381219|FG000|Overall Study|Other|1|||
130114867|NCT02004847|468381223|FG000|Overall Study|Protocol Violation|1|||
130114868|NCT02004847|468381224|FG001|Overall Study|Protocol Violation|1|||
130114869|NCT02034799|468381225|FG000|Overall Study|Withdrawal by Subject|0|||
130114870|NCT02034799|468381226|FG001|Overall Study|Withdrawal by Subject|2|||
130114871|NCT02034799|468381225|FG000|Overall Study|Lost to Follow-up|0|||
129839574|NCT01465464|467377592|FG000|Overall Study|Other|9|||
129839575|NCT01465464|467377593|FG001|Overall Study|Other|3|||
129839576|NCT01465464|467377592|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
129839577|NCT01465464|467377593|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
129899094|NCT01549652|467590169|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
129839578|NCT01554618|467377594|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
129839579|NCT01554618|467377595|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
129839580|NCT01554618|467377594|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
129839581|NCT01554618|467377595|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
129839582|NCT01554618|467377594|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
129839583|NCT01554618|467377595|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
129839584|NCT01554618|467377594|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
129839585|NCT01554618|467377595|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
129839586|NCT01554618|467377594|FG000|Open-Label Extension Period|Physician Decision|0|||
129839587|NCT01554618|467377595|FG001|Open-Label Extension Period|Physician Decision|1|||
129839588|NCT01554618|467377594|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
129839589|NCT01554618|467377595|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
129839590|NCT02244580|467377597|FG000|Overall Study|No cancer tissues available|241|||
129839591|NCT04011410|467377598|FG000|Overall Study|Withdrawal by Subject|1|||
129839592|NCT00291668|467377604|FG000|Overall Study|Lack of Efficacy|1|||
129839593|NCT00291668|467377605|FG001|Overall Study|Lack of Efficacy|0|||
129839594|NCT00291668|467377606|FG002|Overall Study|Lack of Efficacy|0|||
129839595|NCT00291668|467377604|FG000|Overall Study|SAE, non-fatal|1|||
129839596|NCT00291668|467377605|FG001|Overall Study|SAE, non-fatal|1|||
129839597|NCT00291668|467377606|FG002|Overall Study|SAE, non-fatal|1|||
129839598|NCT00291668|467377604|FG000|Overall Study|AE, non-serious non-fatal|1|||
129839599|NCT00291668|467377605|FG001|Overall Study|AE, non-serious non-fatal|0|||
129839600|NCT00291668|467377606|FG002|Overall Study|AE, non-serious non-fatal|0|||
129839601|NCT00291668|467377604|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129839602|NCT00291668|467377605|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129839603|NCT00291668|467377606|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130114872|NCT02034799|468381226|FG001|Overall Study|Lost to Follow-up|1|||
130114873|NCT02034799|468381225|FG000|Overall Study|Death|2|||
129839604|NCT00313612|467377609|FG000|Overall Study|Patient never received treatment|0|||
129839605|NCT00313612|467377610|FG001|Overall Study|Patient never received treatment|1|||
129839606|NCT00451035|467377611|FG000|Overall Study|Disease progression|11|||
130114874|NCT02034799|468381226|FG001|Overall Study|Death|1|||
130114875|NCT00759148|468381235|FG000|Overall Study|Adverse Event|1|||
129899095|NCT01549652|467590170|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
129899096|NCT01549652|467590171|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
129899097|NCT01549652|467590168|FG000|Overall Study|Problem with Infusion|1|||
129899098|NCT01549652|467590169|FG001|Overall Study|Problem with Infusion|0|||
129899099|NCT01549652|467590170|FG002|Overall Study|Problem with Infusion|0|||
129899100|NCT01549652|467590171|FG003|Overall Study|Problem with Infusion|0|||
129899101|NCT01549652|467590168|FG000|Overall Study|Titration Non-Compliance|1|||
129899102|NCT01549652|467590169|FG001|Overall Study|Titration Non-Compliance|3|||
129899103|NCT01549652|467590170|FG002|Overall Study|Titration Non-Compliance|4|||
129899104|NCT01549652|467590171|FG003|Overall Study|Titration Non-Compliance|5|||
129899105|NCT01549652|467590168|FG000|Overall Study|Titration Side Effects|0|||
129899106|NCT01549652|467590169|FG001|Overall Study|Titration Side Effects|0|||
129899107|NCT01549652|467590170|FG002|Overall Study|Titration Side Effects|6|||
129899108|NCT01549652|467590171|FG003|Overall Study|Titration Side Effects|3|||
129899109|NCT01549652|467590168|FG000|Overall Study|Withdrawal by Subject|0|||
129899110|NCT01549652|467590169|FG001|Overall Study|Withdrawal by Subject|0|||
129899111|NCT01549652|467590170|FG002|Overall Study|Withdrawal by Subject|5|||
129899112|NCT01549652|467590171|FG003|Overall Study|Withdrawal by Subject|3|||
129899113|NCT00988637|467590183|FG000|Overall Study|Lost to Follow-up|2|||
129899114|NCT00988637|467590184|FG001|Overall Study|Lost to Follow-up|1|||
129899115|NCT00988637|467590183|FG000|Overall Study|Withdrawal by Subject|1|||
129899116|NCT00988637|467590184|FG001|Overall Study|Withdrawal by Subject|1|||
129899117|NCT00988637|467590183|FG000|Overall Study|non-compliance with study drug|0|||
129899118|NCT00988637|467590184|FG001|Overall Study|non-compliance with study drug|1|||
129899119|NCT03593070|467590185|FG000|Overall Study|administrative withdrawal|1|||
129899120|NCT03593070|467590186|FG001|Overall Study|administrative withdrawal|1|||
129899121|NCT01582945|467590187|FG000|Overall Study|Intolerable side-effects|1|||
129899122|NCT01582945|467590187|FG000|Overall Study|Scheduling conflicts|1|||
129899123|NCT02197234|467590188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
129899124|NCT02197234|467590188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
129899125|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
129899126|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
129899127|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
129899128|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
129839607|NCT00451035|467377611|FG000|Overall Study|Death|3|||
129839608|NCT00451035|467377611|FG000|Overall Study|New anti-neoplastic therapy|3|||
129839609|NCT01393405|467377614|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
129839610|NCT01393405|467377615|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
129839611|NCT01393405|467377616|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
129839612|NCT01393405|467377614|FG000|Induction Period (week1-16)|Adverse Event|16|||
129839613|NCT01393405|467377615|FG001|Induction Period (week1-16)|Adverse Event|0|||
129839614|NCT01393405|467377616|FG002|Induction Period (week1-16)|Adverse Event|0|||
129899129|NCT01543685|467590189|FG000|Overall Study|Lack of Efficacy|1|||
129899130|NCT01543685|467590190|FG001|Overall Study|Lack of Efficacy|2|||
129899131|NCT01543685|467590191|FG002|Overall Study|Lack of Efficacy|2|||
129839615|NCT01393405|467377614|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
129839616|NCT01393405|467377615|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
129839617|NCT01393405|467377616|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
129839618|NCT01393405|467377614|FG000|Maintenance Period Week|Lack of Efficacy|0|||
129839619|NCT01393405|467377615|FG001|Maintenance Period Week|Lack of Efficacy|22|||
129839620|NCT01393405|467377616|FG002|Maintenance Period Week|Lack of Efficacy|22|||
129839621|NCT01393405|467377614|FG000|Maintenance Period Week|Adverse Event|0|||
129839622|NCT01393405|467377615|FG001|Maintenance Period Week|Adverse Event|5|||
129839623|NCT01393405|467377616|FG002|Maintenance Period Week|Adverse Event|2|||
129839624|NCT01393405|467377614|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
130114876|NCT00759148|468381236|FG001|Overall Study|Adverse Event|6|||
129839625|NCT01393405|467377615|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
129899132|NCT01543685|467590192|FG003|Overall Study|Lack of Efficacy|0|||
129899133|NCT01543685|467590193|FG004|Overall Study|Lack of Efficacy|2|||
129899134|NCT01543685|467590189|FG000|Overall Study|Adverse Event|2|||
130114877|NCT00759148|468381235|FG000|Overall Study|Withdrawal by Subject|3|||
129839626|NCT01393405|467377616|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
129839627|NCT01393405|467377614|FG000|Maintenance Period Week|Lost to Follow-up|0|||
129899135|NCT01543685|467590190|FG001|Overall Study|Adverse Event|1|||
129899136|NCT01543685|467590191|FG002|Overall Study|Adverse Event|0|||
130114878|NCT00759148|468381236|FG001|Overall Study|Withdrawal by Subject|7|||
129839628|NCT01393405|467377615|FG001|Maintenance Period Week|Lost to Follow-up|1|||
129839629|NCT01393405|467377616|FG002|Maintenance Period Week|Lost to Follow-up|0|||
129839630|NCT03350503|467377620|FG000|Overall Study|Adverse Event|5|||
129899137|NCT01543685|467590192|FG003|Overall Study|Adverse Event|0|||
129899138|NCT01543685|467590193|FG004|Overall Study|Adverse Event|2|||
129899139|NCT02163915|467590194|FG000|Overall Study|Withdrawal by Subject|2|||
129899140|NCT02163915|467590195|FG001|Overall Study|Withdrawal by Subject|0|||
129899141|NCT02163915|467590196|FG002|Overall Study|Withdrawal by Subject|2|||
129839631|NCT03350503|467377620|FG000|Overall Study|Withdrawal by Subject|5|||
129839632|NCT03350503|467377620|FG000|Overall Study|Continuation impossible due to move|4|||
129839633|NCT03350503|467377620|FG000|Overall Study|Physician Decision|3|||
129839634|NCT04536727|467377621|FG000|Overall Study|Lost to Follow-up|1|||
129839635|NCT04536727|467377622|FG001|Overall Study|Lost to Follow-up|1|||
129839636|NCT04536727|467377621|FG000|Overall Study|Death|0|||
129839637|NCT04536727|467377622|FG001|Overall Study|Death|1|||
129839638|NCT01399593|467377623|FG000|Overall Study|Physician Decision|1|||
129839639|NCT01399593|467377624|FG001|Overall Study|Physician Decision|0|||
129839640|NCT01399593|467377623|FG000|Overall Study|Adverse Event|1|||
129839641|NCT01399593|467377624|FG001|Overall Study|Adverse Event|0|||
129839642|NCT01399593|467377623|FG000|Overall Study|Death|1|||
129839643|NCT01399593|467377624|FG001|Overall Study|Death|1|||
129839644|NCT01399593|467377623|FG000|Overall Study|Transplantectomy|0|||
129839645|NCT01399593|467377624|FG001|Overall Study|Transplantectomy|1|||
129839646|NCT05627518|467377625|FG000|Treatment Period 1|Adverse Event|0|||
129839647|NCT05627518|467377626|FG001|Treatment Period 1|Adverse Event|0|||
129839648|NCT05627518|467377627|FG002|Treatment Period 1|Adverse Event|1|||
129839649|NCT05627518|467377628|FG003|Treatment Period 1|Adverse Event|0|||
129839650|NCT05627518|467377629|FG004|Treatment Period 1|Adverse Event|0|||
129839651|NCT05627518|467377630|FG005|Treatment Period 1|Adverse Event|0|||
129839652|NCT05627518|467377631|FG006|Treatment Period 1|Adverse Event|0|||
129839653|NCT05627518|467377632|FG007|Treatment Period 1|Adverse Event|1|||
129839654|NCT05627518|467377625|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129839655|NCT05627518|467377626|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129839656|NCT05627518|467377627|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129839657|NCT05627518|467377628|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129839658|NCT05627518|467377629|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129839659|NCT05627518|467377630|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129839660|NCT05627518|467377631|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129839661|NCT05627518|467377632|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129839662|NCT05627518|467377625|FG000|Treatment Period 1|Protocol Violation|0|||
129839663|NCT05627518|467377626|FG001|Treatment Period 1|Protocol Violation|0|||
129839664|NCT05627518|467377627|FG002|Treatment Period 1|Protocol Violation|0|||
129839665|NCT05627518|467377628|FG003|Treatment Period 1|Protocol Violation|0|||
129839666|NCT05627518|467377629|FG004|Treatment Period 1|Protocol Violation|0|||
129839667|NCT05627518|467377630|FG005|Treatment Period 1|Protocol Violation|0|||
129839668|NCT05627518|467377631|FG006|Treatment Period 1|Protocol Violation|6|||
129839669|NCT05627518|467377632|FG007|Treatment Period 1|Protocol Violation|6|||
129839670|NCT05627518|467377625|FG000|Treatment Period 2|Adverse Event|1|||
129839671|NCT05627518|467377626|FG001|Treatment Period 2|Adverse Event|0|||
129839672|NCT05627518|467377627|FG002|Treatment Period 2|Adverse Event|0|||
129839673|NCT05627518|467377628|FG003|Treatment Period 2|Adverse Event|0|||
129839674|NCT05627518|467377629|FG004|Treatment Period 2|Adverse Event|0|||
130063459|NCT00878215|468186311|FG002|Overall Study|Determined to be ineligible|0|||
130063460|NCT00878215|468186312|FG003|Overall Study|Determined to be ineligible|0|||
130063461|NCT00302718|468186314|FG000|Overall Study|Participant left the hospital|1|||
130063462|NCT00302718|468186315|FG001|Overall Study|Participant left the hospital|0|||
130063463|NCT00302718|468186316|FG002|Overall Study|Participant left the hospital|0|||
130063464|NCT00302718|468186317|FG003|Overall Study|Participant left the hospital|1|||
130063465|NCT00302718|468186314|FG000|Overall Study|Withdrawal by Subject|0|||
130063466|NCT00302718|468186315|FG001|Overall Study|Withdrawal by Subject|1|||
130063467|NCT00302718|468186316|FG002|Overall Study|Withdrawal by Subject|0|||
130063468|NCT00302718|468186317|FG003|Overall Study|Withdrawal by Subject|0|||
130063469|NCT00302718|468186314|FG000|Overall Study|Participant left primary care setting|0|||
130063470|NCT00302718|468186315|FG001|Overall Study|Participant left primary care setting|0|||
130063471|NCT00302718|468186316|FG002|Overall Study|Participant left primary care setting|2|||
130063472|NCT00302718|468186317|FG003|Overall Study|Participant left primary care setting|1|||
130063473|NCT00819585|468186318|FG000|Core Study|Adverse Event|2|||
130063474|NCT00819585|468186319|FG001|Core Study|Adverse Event|1|||
130063475|NCT00819585|468186320|FG002|Core Study|Adverse Event|1|||
130063476|NCT00819585|468186321|FG003|Core Study|Adverse Event|4|||
130063477|NCT00819585|468186322|FG004|Core Study|Adverse Event|1|||
130063478|NCT00819585|468186323|FG005|Core Study|Adverse Event|0|||
130063479|NCT00819585|468186324|FG006|Core Study|Adverse Event|2|||
130063480|NCT00819585|468186325|FG007|Core Study|Adverse Event|0|||
130063481|NCT00819585|468186326|FG008|Core Study|Adverse Event|0|||
130063482|NCT00819585|468186327|FG009|Core Study|Adverse Event|0|||
130063483|NCT00819585|468186328|FG010|Core Study|Adverse Event|0|||
130063484|NCT00819585|468186318|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
130063485|NCT00819585|468186319|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
130063486|NCT00819585|468186320|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
130063487|NCT00819585|468186321|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
130063488|NCT00819585|468186322|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
130063489|NCT00819585|468186323|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
130063490|NCT00819585|468186324|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
129839675|NCT05627518|467377630|FG005|Treatment Period 2|Adverse Event|0|||
129839676|NCT05627518|467377631|FG006|Treatment Period 2|Adverse Event|0|||
129839677|NCT05627518|467377632|FG007|Treatment Period 2|Adverse Event|0|||
129839678|NCT05627518|467377625|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129839679|NCT05627518|467377626|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129839680|NCT05627518|467377627|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129839681|NCT05627518|467377628|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129839682|NCT05627518|467377629|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129839683|NCT05627518|467377630|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129839684|NCT05627518|467377631|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129899142|NCT02163915|467590197|FG003|Overall Study|Withdrawal by Subject|2|||
129899143|NCT02163915|467590198|FG004|Overall Study|Withdrawal by Subject|2|||
129899144|NCT02163915|467590194|FG000|Overall Study|Study termination|1|||
129899145|NCT02163915|467590195|FG001|Overall Study|Study termination|0|||
129899146|NCT02163915|467590196|FG002|Overall Study|Study termination|0|||
129899147|NCT02163915|467590197|FG003|Overall Study|Study termination|0|||
129899148|NCT02163915|467590198|FG004|Overall Study|Study termination|2|||
129899149|NCT02163915|467590194|FG000|Overall Study|Physician Decision|0|||
129899150|NCT02163915|467590195|FG001|Overall Study|Physician Decision|0|||
129899151|NCT02163915|467590196|FG002|Overall Study|Physician Decision|0|||
129899152|NCT02163915|467590197|FG003|Overall Study|Physician Decision|1|||
129899153|NCT02163915|467590198|FG004|Overall Study|Physician Decision|0|||
130114879|NCT00759148|468381235|FG000|Overall Study|Lost to Follow-up|3|||
130114880|NCT00759148|468381236|FG001|Overall Study|Lost to Follow-up|9|||
129839685|NCT05627518|467377632|FG007|Treatment Period 2|Withdrawal by Subject|0|||
129839686|NCT00403273|467379006|FG000|Overall Study|Lost to Follow-up|3|||
129839687|NCT00403273|467379007|FG001|Overall Study|Lost to Follow-up|2|||
129839688|NCT00403273|467379006|FG000|Overall Study|Physician Decision|0|||
129839689|NCT00403273|467379007|FG001|Overall Study|Physician Decision|1|||
129839690|NCT00403273|467379006|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
129839691|NCT00403273|467379007|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
129839692|NCT00574405|467379009|FG000|Overall Study|Withdrawal by Subject|3|||
129839693|NCT00574405|467379010|FG001|Overall Study|Withdrawal by Subject|2|||
129839694|NCT01332149|467379012|FG000|Overall Study|Adverse Event|11|||
129839695|NCT01332149|467379013|FG001|Overall Study|Adverse Event|9|||
129839696|NCT01332149|467379012|FG000|Overall Study|Other unspecified|5|||
129839697|NCT01332149|467379013|FG001|Overall Study|Other unspecified|7|||
129839698|NCT01332149|467379012|FG000|Overall Study|Protocol Violation|1|||
129839699|NCT01332149|467379013|FG001|Overall Study|Protocol Violation|3|||
129839700|NCT01332149|467379012|FG000|Overall Study|Withdrawal by Subject|4|||
129839701|NCT01332149|467379013|FG001|Overall Study|Withdrawal by Subject|5|||
129839702|NCT01332149|467379012|FG000|Overall Study|Lost to Follow-up|1|||
129839703|NCT01332149|467379013|FG001|Overall Study|Lost to Follow-up|1|||
129839704|NCT01332149|467379012|FG000|Overall Study|Insufficient clinical response|4|||
129839705|NCT01332149|467379013|FG001|Overall Study|Insufficient clinical response|7|||
129839706|NCT01332149|467379012|FG000|Overall Study|Did not meet entrance criteria|3|||
129839707|NCT01332149|467379013|FG001|Overall Study|Did not meet entrance criteria|4|||
129839708|NCT01332149|467379012|FG000|Overall Study|Randomized but not treated|1|||
129839709|NCT01332149|467379013|FG001|Overall Study|Randomized but not treated|2|||
129839710|NCT02565381|467379014|FG000|Overall Study|Lost to Follow-up|1|||
129839711|NCT02565381|467379015|FG001|Overall Study|Lost to Follow-up|0|||
129839712|NCT02565381|467379016|FG002|Overall Study|Lost to Follow-up|1|||
129839713|NCT04615949|467379019|FG000|Overall Study|Withdrawal by Subject|2|||
129839714|NCT04615949|467379020|FG001|Overall Study|Withdrawal by Subject|4|||
129839715|NCT04615949|467379019|FG000|Overall Study|Lost to Follow-up|2|||
129839716|NCT04615949|467379020|FG001|Overall Study|Lost to Follow-up|2|||
129839717|NCT04615949|467379019|FG000|Overall Study|Death|0|||
129839718|NCT04615949|467379020|FG001|Overall Study|Death|2|||
129839719|NCT05084053|467379021|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
129839720|NCT05084053|467379022|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
129839721|NCT05084053|467379023|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
129839722|NCT05084053|467379024|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
129839723|NCT05084053|467379021|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
129839724|NCT05084053|467379022|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
129839725|NCT05084053|467379023|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
129839726|NCT05084053|467379024|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
129839727|NCT05084053|467379021|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
129839728|NCT05084053|467379022|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
129839729|NCT05084053|467379023|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
129839730|NCT05084053|467379024|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
129839731|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Adverse Event|2|||
129839732|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Adverse Event|3|||
129839733|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Adverse Event|4|||
129839734|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Adverse Event|4|||
129839735|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
129899154|NCT02931396|467590199|FG000|Overall Study|Lost to Follow-up|3|||
129899155|NCT02931396|467590200|FG001|Overall Study|Lost to Follow-up|0|||
129899156|NCT02931396|467590199|FG000|Overall Study|Withdrawal by Subject|2|||
130114881|NCT00759148|468381235|FG000|Overall Study|Treatment Failure|6|||
130114882|NCT00759148|468381236|FG001|Overall Study|Treatment Failure|10|||
130114883|NCT00759148|468381235|FG000|Overall Study|Reason not given|1|||
130114884|NCT00759148|468381236|FG001|Overall Study|Reason not given|0|||
130114885|NCT03381248|468381237|FG000|0-6 Months|Withdrawal by Subject|4|||
130114886|NCT03381248|468381238|FG001|0-6 Months|Withdrawal by Subject|1|||
130114887|NCT03381248|468381237|FG000|0-6 Months|Lost to Follow-up|3|||
130114888|NCT03381248|468381238|FG001|0-6 Months|Lost to Follow-up|2|||
130114889|NCT03381248|468381237|FG000|0-6 Months|Lack of Efficacy|1|||
130114890|NCT03381248|468381238|FG001|0-6 Months|Lack of Efficacy|0|||
130114891|NCT03381248|468381237|FG000|0-6 Months|Adverse Event|1|||
130114892|NCT03381248|468381238|FG001|0-6 Months|Adverse Event|0|||
130114893|NCT03381248|468381237|FG000|0-6 Months|Protocol Violation|2|||
130114894|NCT03381248|468381238|FG001|0-6 Months|Protocol Violation|1|||
130114895|NCT03381248|468381237|FG000|0-6 Months|Physician Decision|1|||
130114896|NCT03381248|468381238|FG001|0-6 Months|Physician Decision|0|||
130114897|NCT03381248|468381237|FG000|0-6 Months|Planning another procedure|1|||
129839736|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
129839737|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
129839738|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
129839739|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
129839740|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
129839741|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
129839742|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
129839743|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
129839744|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
129839745|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
129839746|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
129839747|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
129839748|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
129839749|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
129839750|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
129839751|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
129839752|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
129839753|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
129839754|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
129839755|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129839756|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129839757|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129839758|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
129839759|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129839760|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129839761|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129839762|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
129839763|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129839764|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129839765|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129839766|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
129839767|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129839768|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129839769|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
129839770|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
129839771|NCT02554656|467379029|FG000|Overall Study|Protocol Violation|3|||
129839772|NCT00749463|467379034|FG000|Overall Study|Adverse Event|0|||
129839773|NCT00749463|467379035|FG001|Overall Study|Adverse Event|4|||
129839774|NCT00749463|467379036|FG002|Overall Study|Adverse Event|1|||
129839775|NCT00749463|467379034|FG000|Overall Study|Withdrawal by Subject|1|||
129839776|NCT00749463|467379035|FG001|Overall Study|Withdrawal by Subject|0|||
129839777|NCT00749463|467379036|FG002|Overall Study|Withdrawal by Subject|0|||
129839778|NCT00805935|467379041|FG000|Overall Study|Stimulation Failure|1|||
130114898|NCT03381248|468381238|FG001|0-6 Months|Planning another procedure|2|||
130114899|NCT03381248|468381237|FG000|6-12 Months|Withdrawal by Subject|1|||
130114900|NCT03381248|468381238|FG001|6-12 Months|Withdrawal by Subject|3|||
130114901|NCT03381248|468381237|FG000|6-12 Months|Lost to Follow-up|0|||
129839779|NCT00805935|467379042|FG001|Overall Study|Stimulation Failure|5|||
129839780|NCT00805935|467379043|FG002|Overall Study|Stimulation Failure|2|||
129839781|NCT00805935|467379044|FG003|Overall Study|Stimulation Failure|2|||
129839782|NCT00805935|467379041|FG000|Overall Study|Cycle cancelled|0|||
129899157|NCT02931396|467590200|FG001|Overall Study|Withdrawal by Subject|0|||
129899158|NCT03895034|467591767|FG000|Overall Study|Lost to Follow-up|2|||
130114902|NCT03381248|468381238|FG001|6-12 Months|Lost to Follow-up|2|||
130114903|NCT03381248|468381237|FG000|6-12 Months|Protocol Violation|3|||
130114904|NCT03381248|468381238|FG001|6-12 Months|Protocol Violation|2|||
130114905|NCT03381248|468381237|FG000|6-12 Months|Planning another procedure|6|||
129839783|NCT00805935|467379042|FG001|Overall Study|Cycle cancelled|0|||
129839784|NCT00805935|467379043|FG002|Overall Study|Cycle cancelled|2|||
129839785|NCT00805935|467379044|FG003|Overall Study|Cycle cancelled|0|||
129899159|NCT03784963|467591768|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
129899160|NCT03784963|467591769|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
129899161|NCT03784963|467591770|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
129839786|NCT00805935|467379041|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
129839787|NCT00805935|467379042|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
129839788|NCT00805935|467379043|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
129839789|NCT00805935|467379044|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
129839790|NCT00805935|467379041|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
129839791|NCT00805935|467379042|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
129839792|NCT00805935|467379043|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
129839793|NCT00805935|467379044|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
129839794|NCT00805935|467379041|FG000|Overall Study|Lost to Follow-up|1|||
129839795|NCT00805935|467379042|FG001|Overall Study|Lost to Follow-up|0|||
129839796|NCT00805935|467379043|FG002|Overall Study|Lost to Follow-up|0|||
129839797|NCT00805935|467379044|FG003|Overall Study|Lost to Follow-up|0|||
129899162|NCT03784963|467591771|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
129899163|NCT00157014|467591772|FG000|Overall Study|Death|4|||
129899164|NCT00157014|467591773|FG001|Overall Study|Death|2|||
129899165|NCT00157014|467591774|FG002|Overall Study|Death|1|||
129899166|NCT00157014|467591775|FG003|Overall Study|Death|1|||
129899167|NCT00157014|467591772|FG000|Overall Study|Physician Decision|0|||
129899168|NCT00157014|467591773|FG001|Overall Study|Physician Decision|1|||
129899169|NCT00157014|467591774|FG002|Overall Study|Physician Decision|0|||
129899170|NCT00157014|467591775|FG003|Overall Study|Physician Decision|0|||
129899171|NCT00157014|467591772|FG000|Overall Study|Medications withdrawn on family request|0|||
129899172|NCT00157014|467591773|FG001|Overall Study|Medications withdrawn on family request|1|||
129899173|NCT00157014|467591774|FG002|Overall Study|Medications withdrawn on family request|0|||
129839798|NCT00805935|467379041|FG000|Overall Study|No positive serum pregnancy|8|||
129839799|NCT00805935|467379042|FG001|Overall Study|No positive serum pregnancy|7|||
129839800|NCT00805935|467379043|FG002|Overall Study|No positive serum pregnancy|6|||
129839801|NCT00805935|467379044|FG003|Overall Study|No positive serum pregnancy|5|||
129839802|NCT00805935|467379041|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129839803|NCT00805935|467379042|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129839804|NCT00805935|467379043|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129839805|NCT00805935|467379044|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
129839806|NCT00805935|467379041|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
129839807|NCT00805935|467379042|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
129839808|NCT00805935|467379043|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
129839809|NCT00805935|467379044|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
129839810|NCT00805935|467379041|FG000|Overall Study|Biochemical pregnancy|0|||
129839811|NCT00805935|467379042|FG001|Overall Study|Biochemical pregnancy|1|||
129839812|NCT00805935|467379043|FG002|Overall Study|Biochemical pregnancy|0|||
129839813|NCT00805935|467379044|FG003|Overall Study|Biochemical pregnancy|0|||
129839814|NCT00805935|467379041|FG000|Overall Study|Chemical pregnancy|0|||
129839815|NCT00805935|467379042|FG001|Overall Study|Chemical pregnancy|5|||
129839816|NCT00805935|467379043|FG002|Overall Study|Chemical pregnancy|3|||
129839817|NCT00805935|467379044|FG003|Overall Study|Chemical pregnancy|2|||
129839818|NCT00805935|467379041|FG000|Overall Study|Ectopic pregnancy|0|||
129839819|NCT00805935|467379042|FG001|Overall Study|Ectopic pregnancy|0|||
129839820|NCT00805935|467379043|FG002|Overall Study|Ectopic pregnancy|1|||
129839821|NCT00805935|467379044|FG003|Overall Study|Ectopic pregnancy|0|||
129839822|NCT00805935|467379041|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
129839823|NCT00805935|467379042|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
129839824|NCT00805935|467379043|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
129839825|NCT00805935|467379044|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
129839826|NCT01539226|467379045|FG000|Overall Study|Withdrawal by Subject|24|||
129839827|NCT01539226|467379046|FG001|Overall Study|Withdrawal by Subject|54|||
129839828|NCT01539226|467379045|FG000|Overall Study|Lost to Follow-up|20|||
129839829|NCT01539226|467379046|FG001|Overall Study|Lost to Follow-up|54|||
129839830|NCT01539226|467379045|FG000|Overall Study|Death|1|||
129839831|NCT01539226|467379046|FG001|Overall Study|Death|2|||
129839832|NCT01539226|467379045|FG000|Overall Study|Adverse Event|2|||
129839833|NCT01539226|467379046|FG001|Overall Study|Adverse Event|0|||
129839834|NCT01539226|467379045|FG000|Overall Study|Pregnancy|13|||
129839835|NCT01539226|467379046|FG001|Overall Study|Pregnancy|29|||
129839836|NCT01539226|467379045|FG000|Overall Study|inappropriate enrollment|0|||
129839837|NCT01539226|467379046|FG001|Overall Study|inappropriate enrollment|1|||
129839838|NCT01539226|467379045|FG000|Overall Study|Multiple Reasons|3|||
129839839|NCT01539226|467379046|FG001|Overall Study|Multiple Reasons|1|||
129839840|NCT01539226|467379045|FG000|Overall Study|not HIV seroconversion-related|93|||
130114906|NCT03381248|468381238|FG001|6-12 Months|Planning another procedure|2|||
130114907|NCT03381248|468381237|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
130114908|NCT03381248|468381238|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
130114909|NCT03381248|468381237|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
130114910|NCT03381248|468381238|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
130114911|NCT03381248|468381237|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
130114912|NCT03381248|468381238|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
129839841|NCT01539226|467379046|FG001|Overall Study|not HIV seroconversion-related|176|||
129899174|NCT00157014|467591775|FG003|Overall Study|Medications withdrawn on family request|0|||
130114913|NCT01133821|468381239|FG000|Overall Study|Lost to Follow-up|8|||
130114914|NCT01133821|468381240|FG001|Overall Study|Lost to Follow-up|11|||
130114915|NCT01133821|468381239|FG000|Overall Study|Withdrawal by Subject|8|||
130114916|NCT01133821|468381240|FG001|Overall Study|Withdrawal by Subject|3|||
130114917|NCT01133821|468381239|FG000|Overall Study|preferred other treatment|1|||
130114918|NCT01133821|468381240|FG001|Overall Study|preferred other treatment|1|||
130114919|NCT01133821|468381239|FG000|Overall Study|Protocol Violation|0|||
130114920|NCT01133821|468381240|FG001|Overall Study|Protocol Violation|1|||
130114921|NCT01133821|468381239|FG000|Overall Study|Refused participation|1|||
130114922|NCT01133821|468381240|FG001|Overall Study|Refused participation|3|||
130114923|NCT00434161|468381241|FG000|Overall Study|Adverse Event|5|||
130114924|NCT00434161|468381242|FG001|Overall Study|Adverse Event|1|||
130114925|NCT00434161|468381243|FG002|Overall Study|Adverse Event|4|||
130114926|NCT00434161|468381241|FG000|Overall Study|Lost to Follow-up|0|||
130114927|NCT00434161|468381242|FG001|Overall Study|Lost to Follow-up|1|||
130114928|NCT00434161|468381243|FG002|Overall Study|Lost to Follow-up|0|||
130114929|NCT00434161|468381241|FG000|Overall Study|Death|1|||
130114930|NCT00434161|468381242|FG001|Overall Study|Death|0|||
130114931|NCT00434161|468381243|FG002|Overall Study|Death|1|||
130114932|NCT00434161|468381241|FG000|Overall Study|Non-Compliance|1|||
130114933|NCT00434161|468381242|FG001|Overall Study|Non-Compliance|1|||
130114934|NCT00434161|468381243|FG002|Overall Study|Non-Compliance|0|||
130114935|NCT00434161|468381241|FG000|Overall Study|Withdrawal by Subject|2|||
130114936|NCT00434161|468381242|FG001|Overall Study|Withdrawal by Subject|0|||
130114937|NCT00434161|468381243|FG002|Overall Study|Withdrawal by Subject|3|||
130114938|NCT00434161|468381241|FG000|Overall Study|Logistical error study assessments|1|||
130114939|NCT00434161|468381242|FG001|Overall Study|Logistical error study assessments|0|||
130114940|NCT00434161|468381243|FG002|Overall Study|Logistical error study assessments|3|||
130114941|NCT03342898|468381244|FG000|Overall Study|Adverse Event|3|||
130114942|NCT03342898|468381245|FG001|Overall Study|Adverse Event|1|||
130114943|NCT03342898|468381246|FG002|Overall Study|Adverse Event|0|||
130114944|NCT03342898|468381244|FG000|Overall Study|Lost to Follow-up|44|||
130114945|NCT03342898|468381245|FG001|Overall Study|Lost to Follow-up|40|||
130114946|NCT03342898|468381246|FG002|Overall Study|Lost to Follow-up|42|||
129839842|NCT01539226|467379045|FG000|Overall Study|HIV seroconversion-related|55|||
129839843|NCT01539226|467379046|FG001|Overall Study|HIV seroconversion-related|80|||
129839844|NCT01539226|467379045|FG000|Overall Study|Non-compliance|6|||
129839845|NCT01539226|467379046|FG001|Overall Study|Non-compliance|8|||
129839846|NCT05288556|467379054|FG000|Overall Study|Protocol Violation|1|||
129839847|NCT05288556|467379054|FG000|Overall Study|Withdrawal by Subject|1|||
129839848|NCT02775344|467379055|FG000|Overall Study|No ovarian cyst identified|3|||
129839849|NCT02775344|467379056|FG001|Overall Study|No ovarian cyst identified|2|||
129839850|NCT04627064|467379057|FG000|Overall Study|Progressive disease|8|||
129839851|NCT04627064|467379058|FG001|Overall Study|Progressive disease|0|||
129839852|NCT04627064|467379057|FG000|Overall Study|Withdrawal by Subject|2|||
129839853|NCT04627064|467379058|FG001|Overall Study|Withdrawal by Subject|0|||
129839854|NCT04627064|467379057|FG000|Overall Study|Physician Decision|1|||
129839855|NCT04627064|467379058|FG001|Overall Study|Physician Decision|0|||
129839856|NCT01800916|467379059|FG000|Test Period 1 (1 Week)|Convex product user|0|||
129839857|NCT01800916|467379060|FG001|Test Period 1 (1 Week)|Convex product user|0|||
129839858|NCT01800916|467379061|FG002|Test Period 1 (1 Week)|Convex product user|0|||
129839859|NCT01800916|467379062|FG003|Test Period 1 (1 Week)|Convex product user|1|||
129899175|NCT00157014|467591772|FG000|Overall Study|Patient withdrawn by investigator|1|||
130114947|NCT03342898|468381244|FG000|Overall Study|Withdrawal of Consent|5|||
130114948|NCT03342898|468381245|FG001|Overall Study|Withdrawal of Consent|9|||
130114949|NCT03342898|468381246|FG002|Overall Study|Withdrawal of Consent|11|||
130114950|NCT03342898|468381244|FG000|Overall Study|Death|0|||
130114951|NCT03342898|468381245|FG001|Overall Study|Death|1|||
129839860|NCT01800916|467379063|FG004|Test Period 1 (1 Week)|Convex product user|0|||
129839861|NCT01800916|467379064|FG005|Test Period 1 (1 Week)|Convex product user|0|||
129839862|NCT01800916|467379065|FG006|Test Period 1 (1 Week)|Convex product user|0|||
129839863|NCT01800916|467379066|FG007|Test Period 1 (1 Week)|Convex product user|0|||
129839864|NCT01800916|467379067|FG008|Test Period 1 (1 Week)|Convex product user|0|||
130114952|NCT03342898|468381246|FG002|Overall Study|Death|1|||
130114953|NCT03342898|468381244|FG000|Overall Study|Reason not Specified|2|||
130114954|NCT03342898|468381245|FG001|Overall Study|Reason not Specified|2|||
129839865|NCT01800916|467379059|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
129839866|NCT01800916|467379060|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
129839867|NCT01800916|467379061|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
129839868|NCT01800916|467379062|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
129839869|NCT01800916|467379063|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
129839870|NCT01800916|467379064|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
129839871|NCT01800916|467379065|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
129839872|NCT01800916|467379066|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
129839873|NCT01800916|467379067|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
129839874|NCT01234467|467379070|FG000|Overall Study|Adverse Event|3|||
129839875|NCT01234467|467379070|FG000|Overall Study|Death|2|||
129839876|NCT01234467|467379070|FG000|Overall Study|Withdrawal by Subject|2|||
129839877|NCT01234467|467379070|FG000|Overall Study|Disease Progression|2|||
129839878|NCT01234467|467379070|FG000|Overall Study|Clinical deterioration|1|||
129839879|NCT01234467|467379070|FG000|Overall Study|Physician Decision|1|||
129839880|NCT01234467|467379070|FG000|Overall Study|Other complicating disease (stroke)|1|||
129839881|NCT00559962|467379073|FG000|Overall Study|Adverse Event|1|||
129839882|NCT00559962|467379074|FG001|Overall Study|Adverse Event|7|||
129839883|NCT00559962|467379075|FG002|Overall Study|Adverse Event|8|||
129839884|NCT00559962|467379076|FG003|Overall Study|Adverse Event|5|||
129839885|NCT00559962|467379077|FG004|Overall Study|Adverse Event|11|||
129839886|NCT00559962|467379078|FG005|Overall Study|Adverse Event|4|||
129839887|NCT00559962|467379079|FG006|Overall Study|Adverse Event|4|||
129839888|NCT00559962|467379080|FG007|Overall Study|Adverse Event|2|||
129839889|NCT00559962|467379073|FG000|Overall Study|Lost to Follow-up|0|||
129839890|NCT00559962|467379074|FG001|Overall Study|Lost to Follow-up|1|||
129839891|NCT00559962|467379075|FG002|Overall Study|Lost to Follow-up|0|||
129839892|NCT00559962|467379076|FG003|Overall Study|Lost to Follow-up|0|||
129839893|NCT00559962|467379077|FG004|Overall Study|Lost to Follow-up|0|||
129839894|NCT00559962|467379078|FG005|Overall Study|Lost to Follow-up|0|||
129839895|NCT00559962|467379079|FG006|Overall Study|Lost to Follow-up|0|||
129839896|NCT00559962|467379080|FG007|Overall Study|Lost to Follow-up|0|||
129839897|NCT00559962|467379073|FG000|Overall Study|Withdrawal by Subject|1|||
129839898|NCT00559962|467379074|FG001|Overall Study|Withdrawal by Subject|1|||
129839899|NCT00559962|467379075|FG002|Overall Study|Withdrawal by Subject|2|||
129839900|NCT00559962|467379076|FG003|Overall Study|Withdrawal by Subject|0|||
129839901|NCT00559962|467379077|FG004|Overall Study|Withdrawal by Subject|3|||
129839902|NCT00559962|467379078|FG005|Overall Study|Withdrawal by Subject|1|||
129839903|NCT00559962|467379079|FG006|Overall Study|Withdrawal by Subject|0|||
129839904|NCT00559962|467379080|FG007|Overall Study|Withdrawal by Subject|2|||
129839905|NCT00559962|467379073|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
129839906|NCT00559962|467379074|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
129839907|NCT00559962|467379075|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
129839908|NCT00559962|467379076|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
129839909|NCT00559962|467379077|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
129839910|NCT00559962|467379078|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
129839911|NCT00559962|467379079|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
129839912|NCT00559962|467379080|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
129839913|NCT01461096|467379081|FG000|Overall Study|Death|3|||
129839914|NCT01461096|467379082|FG001|Overall Study|Death|6|||
129839915|NCT01461096|467379081|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129839916|NCT01461096|467379082|FG001|Overall Study|Severe debilitation, unable to continue|1|||
129839917|NCT01461096|467379081|FG000|Overall Study|Subj not able to get to clinic|15|||
129839918|NCT01461096|467379082|FG001|Overall Study|Subj not able to get to clinic|13|||
129839919|NCT01461096|467379081|FG000|Overall Study|Site is closing|27|||
129839920|NCT01461096|467379082|FG001|Overall Study|Site is closing|30|||
129839921|NCT01461096|467379081|FG000|Overall Study|Withdrawal by Subject|5|||
129839922|NCT01461096|467379082|FG001|Overall Study|Withdrawal by Subject|3|||
129839923|NCT01461096|467379081|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
129839924|NCT01461096|467379082|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
129839925|NCT01461096|467379081|FG000|Overall Study|Lost to Follow-up|8|||
129839926|NCT01461096|467379082|FG001|Overall Study|Lost to Follow-up|4|||
129839927|NCT01452412|467379088|FG000|Overall Study|Withdrawal by Subject|15|||
129839928|NCT01452412|467379089|FG001|Overall Study|Withdrawal by Subject|11|||
129839929|NCT01452412|467379088|FG000|Overall Study|Adverse Event|4|||
129839930|NCT01452412|467379089|FG001|Overall Study|Adverse Event|3|||
129839931|NCT01452412|467379088|FG000|Overall Study|Lost to Follow-up|5|||
129839932|NCT01452412|467379089|FG001|Overall Study|Lost to Follow-up|3|||
129839933|NCT01452412|467379088|FG000|Overall Study|Death|1|||
129839934|NCT01452412|467379089|FG001|Overall Study|Death|0|||
129839935|NCT01452412|467379088|FG000|Overall Study|Initiated dialysis|1|||
129839936|NCT01452412|467379089|FG001|Overall Study|Initiated dialysis|0|||
129839937|NCT01452412|467379088|FG000|Overall Study|Other|2|||
129839938|NCT01452412|467379089|FG001|Overall Study|Other|0|||
129839939|NCT03047135|467379090|FG000|Overall Study|Still being treated|3|||
129839940|NCT03013543|467379091|FG000|Overall Study|Withdrawal by Subject|0|||
129839941|NCT03013543|467379092|FG001|Overall Study|Withdrawal by Subject|2|||
129839942|NCT03013543|467379093|FG002|Overall Study|Withdrawal by Subject|0|||
130114955|NCT03342898|468381246|FG002|Overall Study|Reason not Specified|0|||
130114956|NCT01387282|468381247|FG000|Overall Study|Death|47|||
130114957|NCT01387282|468381248|FG001|Overall Study|Death|16|||
130114958|NCT01387282|468381247|FG000|Overall Study|Other|5|||
130114959|NCT01387282|468381248|FG001|Overall Study|Other|1|||
130114960|NCT01387282|468381247|FG000|Overall Study|Unrelated AE|6|||
130114961|NCT01387282|468381248|FG001|Overall Study|Unrelated AE|4|||
130114962|NCT01387282|468381247|FG000|Overall Study|Withdrawal by patient|33|||
130114963|NCT01387282|468381248|FG001|Overall Study|Withdrawal by patient|23|||
130114964|NCT01387282|468381247|FG000|Overall Study|Study drug-related AE|2|||
130114965|NCT01387282|468381248|FG001|Overall Study|Study drug-related AE|2|||
130114966|NCT01387282|468381247|FG000|Overall Study|Lost to Follow-up|4|||
130114967|NCT01387282|468381248|FG001|Overall Study|Lost to Follow-up|1|||
130114968|NCT01267266|468381249|FG000|Enrollment Phase|Withdrawal by Subject|2|||
130114969|NCT01267266|468381250|FG001|Enrollment Phase|Withdrawal by Subject|0|||
130114970|NCT01267266|468381249|FG000|Lead-in Phase|Lack of Efficacy|20|||
130114971|NCT01267266|468381250|FG001|Lead-in Phase|Lack of Efficacy|0|||
130114972|NCT01267266|468381249|FG000|Lead-in Phase|Adverse Event|2|||
130114973|NCT01267266|468381250|FG001|Lead-in Phase|Adverse Event|0|||
130114974|NCT01267266|468381249|FG000|Lead-in Phase|Withdrawal by Subject|1|||
130114975|NCT01267266|468381250|FG001|Lead-in Phase|Withdrawal by Subject|0|||
130114976|NCT01466686|468381262|FG000|Overall Study|Withdrawal by Subject|1|||
130114977|NCT02049359|468381264|FG000|Overall Study|Lost to Follow-up|26|||
130114978|NCT02049359|468381265|FG001|Overall Study|Lost to Follow-up|19|||
130114979|NCT01907087|468381266|FG000|Overall Study|Withdrawal by Subject|1|||
130114980|NCT03273387|468381267|FG000|Overall Study|Death|2|||
130114981|NCT03273387|468381268|FG001|Overall Study|Death|2|||
130114982|NCT03273387|468381267|FG000|Overall Study|Withdrawal by Subject|1|||
130114983|NCT03273387|468381268|FG001|Overall Study|Withdrawal by Subject|1|||
130114984|NCT05216978|468381269|FG000|Overall Study|Withdrawal by Subject|3|||
130114985|NCT05216978|468381269|FG000|Overall Study|Lost to Follow-up|5|||
130114986|NCT00658320|468381273|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
130114987|NCT00658320|468381274|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
130114988|NCT00658320|468381273|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
130114989|NCT00658320|468381274|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
130114990|NCT00658320|468381273|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
130114991|NCT00658320|468381274|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
130114992|NCT00658320|468381273|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
130114993|NCT00658320|468381274|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
130114994|NCT03551730|468381277|FG000|Overall Study|Adverse Event|1|||
130114995|NCT03551730|468381278|FG001|Overall Study|Adverse Event|0|||
130114996|NCT03551730|468381279|FG002|Overall Study|Adverse Event|0|||
130114997|NCT03551730|468381280|FG003|Overall Study|Adverse Event|0|||
130114998|NCT04467697|468381281|FG000|Overall Study|Adverse Event|2|||
130114999|NCT04467697|468381281|FG000|Overall Study|Lost to Follow-up|6|||
130115000|NCT04467697|468381281|FG000|Overall Study|Withdrawal by Subject|9|||
130115001|NCT04467697|468381281|FG000|Overall Study|Protocol Violation|3|||
130115002|NCT02231710|468381284|FG000|Overall Study|Physician Decision|1|||
130115003|NCT04081337|468381285|FG000|Overall Study|Adverse Event|0|||
130115004|NCT04081337|468381286|FG001|Overall Study|Adverse Event|1|||
130115005|NCT04081337|468381285|FG000|Overall Study|Withdrawal by Subject|2|||
130115006|NCT04081337|468381286|FG001|Overall Study|Withdrawal by Subject|0|||
130115007|NCT04081337|468381285|FG000|Overall Study|Physician Decision|1|||
130115008|NCT04081337|468381286|FG001|Overall Study|Physician Decision|2|||
130115009|NCT04081337|468381285|FG000|Overall Study|Lost to Follow-up|1|||
130115010|NCT04081337|468381286|FG001|Overall Study|Lost to Follow-up|0|||
130115011|NCT00673361|468381287|FG000|Overall Study|Screen Failure|2|||
130115012|NCT01799590|468381290|FG000|Overall Study|Adverse Event|13|||
130115013|NCT01799590|468381291|FG001|Overall Study|Adverse Event|7|||
130115014|NCT01799590|468381292|FG002|Overall Study|Adverse Event|5|||
130115015|NCT01799590|468381290|FG000|Overall Study|Pregnancy|2|||
130115016|NCT01799590|468381291|FG001|Overall Study|Pregnancy|0|||
130115017|NCT01799590|468381292|FG002|Overall Study|Pregnancy|0|||
130115018|NCT01799590|468381290|FG000|Overall Study|Lack of Efficacy|3|||
130115019|NCT01799590|468381291|FG001|Overall Study|Lack of Efficacy|1|||
129899176|NCT00157014|467591773|FG001|Overall Study|Patient withdrawn by investigator|0|||
129899177|NCT00157014|467591774|FG002|Overall Study|Patient withdrawn by investigator|0|||
130115020|NCT01799590|468381292|FG002|Overall Study|Lack of Efficacy|3|||
130115021|NCT01799590|468381290|FG000|Overall Study|Participants convenience|4|||
130115022|NCT01799590|468381291|FG001|Overall Study|Participants convenience|4|||
130115023|NCT01799590|468381292|FG002|Overall Study|Participants convenience|2|||
129899178|NCT00157014|467591775|FG003|Overall Study|Patient withdrawn by investigator|0|||
130115024|NCT01799590|468381290|FG000|Overall Study|Aggravation of complications|0|||
130115025|NCT01799590|468381291|FG001|Overall Study|Aggravation of complications|1|||
130115026|NCT01799590|468381292|FG002|Overall Study|Aggravation of complications|1|||
130115027|NCT01799590|468381290|FG000|Overall Study|Using drugs with restricted days of use|0|||
129899179|NCT00157014|467591772|FG000|Overall Study|Patient unable to return in nursing home|1|||
129899180|NCT00157014|467591773|FG001|Overall Study|Patient unable to return in nursing home|0|||
129899181|NCT00157014|467591774|FG002|Overall Study|Patient unable to return in nursing home|0|||
129899182|NCT00157014|467591775|FG003|Overall Study|Patient unable to return in nursing home|0|||
129899183|NCT00157014|467591772|FG000|Overall Study|Patient would not receive transplant|0|||
129899184|NCT00157014|467591773|FG001|Overall Study|Patient would not receive transplant|1|||
129899185|NCT00157014|467591774|FG002|Overall Study|Patient would not receive transplant|0|||
129899186|NCT00157014|467591775|FG003|Overall Study|Patient would not receive transplant|0|||
129899187|NCT00157014|467591772|FG000|Overall Study|Withdrawal by Subject|1|||
129899188|NCT00157014|467591773|FG001|Overall Study|Withdrawal by Subject|0|||
129899189|NCT00157014|467591774|FG002|Overall Study|Withdrawal by Subject|0|||
129899190|NCT00157014|467591775|FG003|Overall Study|Withdrawal by Subject|0|||
129899191|NCT01362491|467591776|FG000|Overall Study|Ineligible|1|||
129899192|NCT01362491|467591777|FG001|Overall Study|Ineligible|0|||
129899193|NCT01362491|467591778|FG002|Overall Study|Ineligible|0|||
129899194|NCT03181958|467591779|FG000|Overall Study|Lost to Follow-up|17|||
129899195|NCT03181958|467591780|FG001|Overall Study|Lost to Follow-up|21|||
129899196|NCT03181958|467591781|FG002|Overall Study|Lost to Follow-up|15|||
129899197|NCT01257503|467591782|FG000|Overall Study|Lost to Follow-up|7|||
129899198|NCT01257503|467591783|FG001|Overall Study|Lost to Follow-up|10|||
129899199|NCT01257503|467591782|FG000|Overall Study|Over 5 years old at enrollment|0|||
129899200|NCT01257503|467591783|FG001|Overall Study|Over 5 years old at enrollment|1|||
129899201|NCT01257503|467591782|FG000|Overall Study|strep culture positive at enrollment|1|||
129899202|NCT01257503|467591783|FG001|Overall Study|strep culture positive at enrollment|0|||
129899203|NCT02987543|467591786|FG000|Overall Study|Ongoing study at data cut off|49|||
129899204|NCT02987543|467591787|FG001|Overall Study|Ongoing study at data cut off|21|||
129899205|NCT02987543|467591788|FG002|Overall Study|Ongoing study at data cut off|19|||
129899206|NCT02987543|467591789|FG003|Overall Study|Ongoing study at data cut off|12|||
129899207|NCT02987543|467591786|FG000|Overall Study|Death|88|||
129899208|NCT02987543|467591787|FG001|Overall Study|Death|54|||
129899209|NCT02987543|467591788|FG002|Overall Study|Death|67|||
129899210|NCT02987543|467591789|FG003|Overall Study|Death|28|||
129899211|NCT02987543|467591786|FG000|Overall Study|Lost to Follow-up|3|||
129899212|NCT02987543|467591787|FG001|Overall Study|Lost to Follow-up|0|||
129899213|NCT02987543|467591788|FG002|Overall Study|Lost to Follow-up|1|||
129899214|NCT02987543|467591789|FG003|Overall Study|Lost to Follow-up|0|||
129899215|NCT02987543|467591786|FG000|Overall Study|Screen failure|0|||
129899216|NCT02987543|467591787|FG001|Overall Study|Screen failure|0|||
129899217|NCT02987543|467591788|FG002|Overall Study|Screen failure|0|||
129899218|NCT02987543|467591789|FG003|Overall Study|Screen failure|1|||
129899219|NCT02987543|467591786|FG000|Overall Study|Withdrawal by Subject|21|||
129899220|NCT02987543|467591787|FG001|Overall Study|Withdrawal by Subject|7|||
129899221|NCT02987543|467591788|FG002|Overall Study|Withdrawal by Subject|7|||
129899222|NCT02987543|467591789|FG003|Overall Study|Withdrawal by Subject|6|||
129899223|NCT02987543|467591786|FG000|Overall Study|Study terminated by sponsor|1|||
129899224|NCT02987543|467591787|FG001|Overall Study|Study terminated by sponsor|0|||
129899225|NCT02987543|467591788|FG002|Overall Study|Study terminated by sponsor|0|||
129899226|NCT02987543|467591789|FG003|Overall Study|Study terminated by sponsor|0|||
129899227|NCT02987543|467591786|FG000|Overall Study|Investigator decision|0|||
129899228|NCT02987543|467591787|FG001|Overall Study|Investigator decision|1|||
129899229|NCT02987543|467591788|FG002|Overall Study|Investigator decision|0|||
129899230|NCT02987543|467591789|FG003|Overall Study|Investigator decision|0|||
129899231|NCT02987543|467591786|FG000|Overall Study|Disease progression|0|||
129899232|NCT02987543|467591787|FG001|Overall Study|Disease progression|0|||
129899233|NCT02987543|467591788|FG002|Overall Study|Disease progression|0|||
129899234|NCT02987543|467591789|FG003|Overall Study|Disease progression|1|||
129899235|NCT01977612|467591792|FG000|Overall Study|Lost to Follow-up|1|||
129899236|NCT01977612|467591793|FG001|Overall Study|Lost to Follow-up|1|||
129899237|NCT01883492|467591795|FG000|Overall Study|Lost to Follow-up|3|||
129899238|NCT01883492|467591796|FG001|Overall Study|Lost to Follow-up|4|||
129899239|NCT01883492|467591795|FG000|Overall Study|Surgery on contra-lateral hip|0|||
129899240|NCT01883492|467591796|FG001|Overall Study|Surgery on contra-lateral hip|1|||
129899241|NCT01883492|467591795|FG000|Overall Study|Poor X-ray quality|7|||
129899242|NCT01883492|467591796|FG001|Overall Study|Poor X-ray quality|4|||
129899243|NCT01883492|467591795|FG000|Overall Study|Withdrawal by Subject|1|||
129899244|NCT01883492|467591796|FG001|Overall Study|Withdrawal by Subject|0|||
129899245|NCT01883492|467591795|FG000|Overall Study|inappropriate implant used|1|||
129899246|NCT01883492|467591796|FG001|Overall Study|inappropriate implant used|1|||
129899247|NCT01883492|467591795|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
129899248|NCT01883492|467591796|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
129899249|NCT01259102|467591797|FG000|Overall Study|Adverse Event|1|||
129899250|NCT01259102|467591798|FG001|Overall Study|Adverse Event|0|||
129899251|NCT01259102|467591799|FG002|Overall Study|Adverse Event|1|||
129899252|NCT01259102|467591800|FG003|Overall Study|Adverse Event|1|||
129899253|NCT01259102|467591801|FG004|Overall Study|Adverse Event|0|||
129899254|NCT01259102|467591797|FG000|Overall Study|Other|0|||
129899255|NCT01259102|467591798|FG001|Overall Study|Other|0|||
129899256|NCT01259102|467591799|FG002|Overall Study|Other|1|||
129899257|NCT01259102|467591800|FG003|Overall Study|Other|1|||
129899258|NCT01259102|467591801|FG004|Overall Study|Other|1|||
129899259|NCT01876511|467591803|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
129899260|NCT01876511|467591804|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
129899261|NCT01876511|467591805|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
129899262|NCT01876511|467591803|FG000|Overall Study|Death (unrelated)|3|||
129899263|NCT01876511|467591804|FG001|Overall Study|Death (unrelated)|0|||
129899264|NCT01876511|467591805|FG002|Overall Study|Death (unrelated)|2|||
129899265|NCT01876511|467591803|FG000|Overall Study|Drug-related Toxicity|5|||
129899266|NCT01876511|467591804|FG001|Overall Study|Drug-related Toxicity|1|||
129899267|NCT01876511|467591805|FG002|Overall Study|Drug-related Toxicity|6|||
129899268|NCT01876511|467591803|FG000|Overall Study|Patient Decision|3|||
129899269|NCT01876511|467591804|FG001|Overall Study|Patient Decision|0|||
129899270|NCT01876511|467591805|FG002|Overall Study|Patient Decision|6|||
129899271|NCT01876511|467591803|FG000|Overall Study|Physician Decision|1|||
129899272|NCT01876511|467591804|FG001|Overall Study|Physician Decision|0|||
129899273|NCT01876511|467591805|FG002|Overall Study|Physician Decision|1|||
129899274|NCT01048788|467591806|FG000|Overall Study|Adverse Event|5|||
129899275|NCT01048788|467591807|FG001|Overall Study|Adverse Event|1|||
129899276|NCT01048788|467591808|FG002|Overall Study|Adverse Event|1|||
129899277|NCT01048788|467591806|FG000|Overall Study|Lack of Efficacy|0|||
129899278|NCT01048788|467591807|FG001|Overall Study|Lack of Efficacy|0|||
129899279|NCT01048788|467591808|FG002|Overall Study|Lack of Efficacy|1|||
129899280|NCT01048788|467591806|FG000|Overall Study|Withdrawal by Subject|0|||
129899281|NCT01048788|467591807|FG001|Overall Study|Withdrawal by Subject|1|||
129899282|NCT01048788|467591808|FG002|Overall Study|Withdrawal by Subject|0|||
129899283|NCT01233050|467591809|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
129899284|NCT01233050|467591810|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
129899285|NCT01064817|467591811|FG000|Study Completion|Physician Decision|1|||
129899286|NCT01064817|467591812|FG001|Study Completion|Physician Decision|0|||
129899287|NCT01064817|467591811|FG000|Study Completion|Withdrawal by Subject|1|||
129899288|NCT01064817|467591812|FG001|Study Completion|Withdrawal by Subject|0|||
129899289|NCT00920686|467591813|FG000|Overall Study|Lost to Follow-up|2|||
129899290|NCT00920686|467591814|FG001|Overall Study|Lost to Follow-up|3|||
129899291|NCT00920686|467591815|FG002|Overall Study|Lost to Follow-up|1|||
129899292|NCT00920686|467591813|FG000|Overall Study|Study drug dosing criteria not met|17|||
129899293|NCT00920686|467591814|FG001|Overall Study|Study drug dosing criteria not met|19|||
129899294|NCT00920686|467591815|FG002|Overall Study|Study drug dosing criteria not met|12|||
129899295|NCT00868192|467591816|FG000|Overall Study|Ineligible|4|||
129899296|NCT04304534|467591817|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
129899297|NCT04304534|467591818|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
129899298|NCT04304534|467591819|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
129899299|NCT04304534|467591820|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
129899300|NCT04304534|467591817|FG000|Overall Study|Non-Compliance with study drug|0|||
129899301|NCT04304534|467591818|FG001|Overall Study|Non-Compliance with study drug|1|||
129899302|NCT04304534|467591819|FG002|Overall Study|Non-Compliance with study drug|1|||
129839943|NCT03013543|467379094|FG003|Overall Study|Withdrawal by Subject|5|||
129839944|NCT03013543|467379095|FG004|Overall Study|Withdrawal by Subject|6|||
129839945|NCT03013543|467379096|FG005|Overall Study|Withdrawal by Subject|2|||
129839946|NCT03013543|467379097|FG006|Overall Study|Withdrawal by Subject|3|||
129839947|NCT03013543|467379098|FG007|Overall Study|Withdrawal by Subject|1|||
129839948|NCT03013543|467379099|FG008|Overall Study|Withdrawal by Subject|0|||
129839949|NCT03013543|467379100|FG009|Overall Study|Withdrawal by Subject|4|||
129839950|NCT03013543|467379091|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129839951|NCT03013543|467379092|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129839952|NCT03013543|467379093|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
129839953|NCT03013543|467379094|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
129839954|NCT03013543|467379095|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
129839955|NCT03013543|467379096|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
130063491|NCT00819585|468186325|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
129839956|NCT03013543|467379097|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
129839957|NCT03013543|467379098|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
129899303|NCT04304534|467591820|FG003|Overall Study|Non-Compliance with study drug|1|||
129899304|NCT04304534|467591817|FG000|Overall Study|Lost to Follow-up|0|||
129899305|NCT04304534|467591818|FG001|Overall Study|Lost to Follow-up|1|||
129899306|NCT04304534|467591819|FG002|Overall Study|Lost to Follow-up|2|||
129899307|NCT04304534|467591820|FG003|Overall Study|Lost to Follow-up|3|||
129899308|NCT04304534|467591817|FG000|Overall Study|Unspecific|4|||
129899309|NCT04304534|467591818|FG001|Overall Study|Unspecific|2|||
130063492|NCT00819585|468186326|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
129899310|NCT04304534|467591819|FG002|Overall Study|Unspecific|2|||
129899311|NCT04304534|467591820|FG003|Overall Study|Unspecific|2|||
129899312|NCT04304534|467591817|FG000|Overall Study|Technical Problems|2|||
129899313|NCT04304534|467591818|FG001|Overall Study|Technical Problems|2|||
130115028|NCT01799590|468381291|FG001|Overall Study|Using drugs with restricted days of use|3|||
130115029|NCT01799590|468381292|FG002|Overall Study|Using drugs with restricted days of use|2|||
130115030|NCT01799590|468381290|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
130115031|NCT01799590|468381291|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
130115032|NCT01799590|468381292|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
130115033|NCT01799590|468381290|FG000|Overall Study|Other|3|||
130115034|NCT01799590|468381291|FG001|Overall Study|Other|0|||
130115035|NCT01799590|468381292|FG002|Overall Study|Other|1|||
130115036|NCT01489956|468381293|FG000|Overall Study|Lost to Follow-up|1|||
130115037|NCT01489956|468381294|FG001|Overall Study|Lost to Follow-up|0|||
130115038|NCT01489956|468381295|FG002|Overall Study|Lost to Follow-up|0|||
130115039|NCT01489956|468381293|FG000|Overall Study|Withdrawal by Subject|0|||
130115040|NCT01489956|468381294|FG001|Overall Study|Withdrawal by Subject|0|||
130115041|NCT01489956|468381295|FG002|Overall Study|Withdrawal by Subject|1|||
130115042|NCT03255031|468381298|FG000|Overall Study|Adverse Event|5|||
130115043|NCT03255031|468381299|FG001|Overall Study|Adverse Event|3|||
130115044|NCT03255031|468381298|FG000|Overall Study|Physician Decision|2|||
130115045|NCT03255031|468381299|FG001|Overall Study|Physician Decision|1|||
130115046|NCT03255031|468381298|FG000|Overall Study|Withdrawal by Subject|9|||
130115047|NCT03255031|468381299|FG001|Overall Study|Withdrawal by Subject|3|||
130115048|NCT01689974|468381301|FG000|Overall Study|Termination of Study|5|||
130115049|NCT01689974|468381302|FG001|Overall Study|Termination of Study|5|||
130115050|NCT00415532|468381306|FG000|Treatment Period|Adverse Event|2|||
130115051|NCT00415532|468381307|FG001|Treatment Period|Adverse Event|3|||
130115052|NCT00415532|468381306|FG000|Treatment Period|Death|2|||
130115053|NCT00415532|468381307|FG001|Treatment Period|Death|1|||
130115054|NCT00415532|468381306|FG000|Treatment Period|Lost to Follow-up|1|||
130115055|NCT00415532|468381307|FG001|Treatment Period|Lost to Follow-up|1|||
130115056|NCT00415532|468381306|FG000|Treatment Period|Protocol Violation|1|||
130115057|NCT00415532|468381307|FG001|Treatment Period|Protocol Violation|0|||
129839958|NCT03013543|467379099|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
129839959|NCT03013543|467379100|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
129839960|NCT03013543|467379091|FG000|Overall Study|Other|0|||
129839961|NCT03013543|467379092|FG001|Overall Study|Other|0|||
129839962|NCT03013543|467379093|FG002|Overall Study|Other|2|||
129839963|NCT03013543|467379094|FG003|Overall Study|Other|0|||
129839964|NCT03013543|467379095|FG004|Overall Study|Other|2|||
129839965|NCT03013543|467379096|FG005|Overall Study|Other|0|||
129839966|NCT03013543|467379097|FG006|Overall Study|Other|0|||
129839967|NCT03013543|467379098|FG007|Overall Study|Other|0|||
129839968|NCT03013543|467379099|FG008|Overall Study|Other|1|||
129839969|NCT03013543|467379100|FG009|Overall Study|Other|0|||
129839970|NCT03013543|467379091|FG000|Overall Study|Adverse Event|0|||
129839971|NCT03013543|467379092|FG001|Overall Study|Adverse Event|0|||
129839972|NCT03013543|467379093|FG002|Overall Study|Adverse Event|0|||
129839973|NCT03013543|467379094|FG003|Overall Study|Adverse Event|3|||
129839974|NCT03013543|467379095|FG004|Overall Study|Adverse Event|2|||
129839975|NCT03013543|467379096|FG005|Overall Study|Adverse Event|1|||
129839976|NCT03013543|467379097|FG006|Overall Study|Adverse Event|3|||
129839977|NCT03013543|467379098|FG007|Overall Study|Adverse Event|8|||
129839978|NCT03013543|467379099|FG008|Overall Study|Adverse Event|0|||
129839979|NCT03013543|467379100|FG009|Overall Study|Adverse Event|2|||
129839980|NCT03013543|467379091|FG000|Overall Study|Death|0|||
129839981|NCT03013543|467379092|FG001|Overall Study|Death|0|||
129839982|NCT03013543|467379093|FG002|Overall Study|Death|0|||
129839983|NCT03013543|467379094|FG003|Overall Study|Death|1|||
129839984|NCT03013543|467379095|FG004|Overall Study|Death|0|||
129839985|NCT03013543|467379096|FG005|Overall Study|Death|0|||
129839986|NCT03013543|467379097|FG006|Overall Study|Death|0|||
129839987|NCT03013543|467379098|FG007|Overall Study|Death|0|||
129839988|NCT03013543|467379099|FG008|Overall Study|Death|0|||
129839989|NCT03013543|467379100|FG009|Overall Study|Death|0|||
129839990|NCT03013543|467379091|FG000|Overall Study|Lack of Efficacy|0|||
129839991|NCT03013543|467379092|FG001|Overall Study|Lack of Efficacy|0|||
129839992|NCT03013543|467379093|FG002|Overall Study|Lack of Efficacy|0|||
129839993|NCT03013543|467379094|FG003|Overall Study|Lack of Efficacy|1|||
129839994|NCT03013543|467379095|FG004|Overall Study|Lack of Efficacy|0|||
129839995|NCT03013543|467379096|FG005|Overall Study|Lack of Efficacy|0|||
130115058|NCT00415532|468381306|FG000|Treatment Period|Withdrawal by Subject|6|||
130115059|NCT00415532|468381307|FG001|Treatment Period|Withdrawal by Subject|6|||
129839996|NCT03013543|467379097|FG006|Overall Study|Lack of Efficacy|0|||
129839997|NCT03013543|467379098|FG007|Overall Study|Lack of Efficacy|0|||
130115060|NCT00415532|468381306|FG000|Treatment Period|Other|2|||
130115061|NCT00415532|468381307|FG001|Treatment Period|Other|2|||
129839998|NCT03013543|467379099|FG008|Overall Study|Lack of Efficacy|0|||
129839999|NCT03013543|467379100|FG009|Overall Study|Lack of Efficacy|0|||
129840000|NCT03013543|467379091|FG000|Overall Study|Lost to Follow-up|0|||
129840001|NCT03013543|467379092|FG001|Overall Study|Lost to Follow-up|0|||
130115062|NCT00415532|468381306|FG000|Treatment Period|Ineligibility determined|1|||
130115063|NCT00415532|468381307|FG001|Treatment Period|Ineligibility determined|1|||
130115064|NCT00415532|468381306|FG000|Treatment Period|Noncompliance|1|||
129840002|NCT03013543|467379093|FG002|Overall Study|Lost to Follow-up|0|||
129840003|NCT03013543|467379094|FG003|Overall Study|Lost to Follow-up|1|||
129840004|NCT03013543|467379095|FG004|Overall Study|Lost to Follow-up|0|||
129840005|NCT03013543|467379096|FG005|Overall Study|Lost to Follow-up|0|||
129840006|NCT03013543|467379097|FG006|Overall Study|Lost to Follow-up|1|||
129840007|NCT03013543|467379098|FG007|Overall Study|Lost to Follow-up|0|||
129840008|NCT03013543|467379099|FG008|Overall Study|Lost to Follow-up|0|||
129840009|NCT03013543|467379100|FG009|Overall Study|Lost to Follow-up|2|||
129840010|NCT03013543|467379091|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129840011|NCT03013543|467379092|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129840012|NCT03013543|467379093|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129840013|NCT03013543|467379094|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129840014|NCT03013543|467379095|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129840015|NCT03013543|467379096|FG005|Overall Study|Non-Compliance With Study Drug|0|||
129840016|NCT03013543|467379097|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129840017|NCT03013543|467379098|FG007|Overall Study|Non-Compliance With Study Drug|0|||
129840018|NCT03013543|467379099|FG008|Overall Study|Non-Compliance With Study Drug|1|||
129840019|NCT03013543|467379100|FG009|Overall Study|Non-Compliance With Study Drug|0|||
129840020|NCT03013543|467379091|FG000|Overall Study|Physician Decision|0|||
129840021|NCT03013543|467379092|FG001|Overall Study|Physician Decision|0|||
129840022|NCT03013543|467379093|FG002|Overall Study|Physician Decision|0|||
129840023|NCT03013543|467379094|FG003|Overall Study|Physician Decision|0|||
129840024|NCT03013543|467379095|FG004|Overall Study|Physician Decision|1|||
129840025|NCT03013543|467379096|FG005|Overall Study|Physician Decision|0|||
129840026|NCT03013543|467379097|FG006|Overall Study|Physician Decision|0|||
129840027|NCT03013543|467379098|FG007|Overall Study|Physician Decision|0|||
129840028|NCT03013543|467379099|FG008|Overall Study|Physician Decision|0|||
129840029|NCT03013543|467379100|FG009|Overall Study|Physician Decision|0|||
129840030|NCT03013543|467379091|FG000|Overall Study|Protocol Violation|0|||
129840031|NCT03013543|467379092|FG001|Overall Study|Protocol Violation|0|||
129840032|NCT03013543|467379093|FG002|Overall Study|Protocol Violation|0|||
129840033|NCT03013543|467379094|FG003|Overall Study|Protocol Violation|0|||
129840034|NCT03013543|467379095|FG004|Overall Study|Protocol Violation|0|||
129840035|NCT03013543|467379096|FG005|Overall Study|Protocol Violation|0|||
129840036|NCT03013543|467379097|FG006|Overall Study|Protocol Violation|0|||
129840037|NCT03013543|467379098|FG007|Overall Study|Protocol Violation|0|||
129840038|NCT03013543|467379099|FG008|Overall Study|Protocol Violation|0|||
129840039|NCT03013543|467379100|FG009|Overall Study|Protocol Violation|1|||
129840040|NCT01537783|467379107|FG000|Overall Study|Lost to Follow-up|11|||
129840041|NCT01537783|467379108|FG001|Overall Study|Lost to Follow-up|2|||
129840042|NCT02722928|467379111|FG000|Overall Study|Standard CT was not as required per prot|5|||
129840043|NCT02722928|467379112|FG001|Overall Study|Standard CT was not as required per prot|13|||
129840044|NCT02722928|467379111|FG000|Overall Study|Required Intraoperative MRI|5|||
129840045|NCT02722928|467379112|FG001|Overall Study|Required Intraoperative MRI|7|||
129840046|NCT01838642|467379113|FG000|Overall Study|Died on study|1|||
129840047|NCT01398956|467379114|FG000|Overall Study|Withdrawal by Subject|4|||
129840048|NCT01398956|467379114|FG000|Overall Study|AE, non-serious non-fatal|4|||
129840049|NCT01398956|467379114|FG000|Overall Study|Withdrawal Criteria No.3|1|||
129840050|NCT01398956|467379114|FG000|Overall Study|Subject moved a long distance|1|||
129840051|NCT01557400|467379115|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
129840052|NCT01557400|467379115|FG000|Overall Study|Adverse Event|3|||
129840053|NCT01557400|467379115|FG000|Overall Study|Lost to Follow-up|5|||
129840054|NCT01557400|467379115|FG000|Overall Study|Withdrawal by Subject|9|||
129840055|NCT02281552|467379118|FG000|Overall Study|Medication error|1|||
129840056|NCT02281552|467379119|FG001|Overall Study|Medication error|0|||
129840057|NCT02281552|467379118|FG000|Overall Study|Insufficient clinical response|0|||
129840058|NCT02281552|467379119|FG001|Overall Study|Insufficient clinical response|1|||
129840059|NCT02281552|467379118|FG000|Overall Study|Adverse Event|3|||
129840060|NCT02281552|467379119|FG001|Overall Study|Adverse Event|9|||
129840061|NCT01224639|467379120|FG000|Overall Study|Withdrawal by Subject|0|||
129840062|NCT01224639|467379121|FG001|Overall Study|Withdrawal by Subject|0|||
129840063|NCT01224639|467379122|FG002|Overall Study|Withdrawal by Subject|0|||
129840064|NCT01224639|467379123|FG003|Overall Study|Withdrawal by Subject|0|||
129840065|NCT01224639|467379124|FG004|Overall Study|Withdrawal by Subject|2|||
129840066|NCT01224639|467379125|FG005|Overall Study|Withdrawal by Subject|0|||
129840067|NCT01224639|467379126|FG006|Overall Study|Withdrawal by Subject|1|||
129840068|NCT01224639|467379127|FG007|Overall Study|Withdrawal by Subject|1|||
129840069|NCT01224639|467379120|FG000|Overall Study|Adverse Event|0|||
129840070|NCT01224639|467379121|FG001|Overall Study|Adverse Event|0|||
129840071|NCT01224639|467379122|FG002|Overall Study|Adverse Event|0|||
129840072|NCT01224639|467379123|FG003|Overall Study|Adverse Event|0|||
129840073|NCT01224639|467379124|FG004|Overall Study|Adverse Event|0|||
129840074|NCT01224639|467379125|FG005|Overall Study|Adverse Event|0|||
129840075|NCT01224639|467379126|FG006|Overall Study|Adverse Event|0|||
129840076|NCT01224639|467379127|FG007|Overall Study|Adverse Event|1|||
129840077|NCT03465878|467379128|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
129840078|NCT03465878|467379129|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
129840079|NCT03465878|467379130|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
129840080|NCT03465878|467379131|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
129840081|NCT03465878|467379128|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
129840082|NCT03465878|467379129|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
129840083|NCT03465878|467379130|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
129840084|NCT03465878|467379131|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
129840085|NCT03465878|467379128|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
129840086|NCT03465878|467379129|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
129840087|NCT03465878|467379130|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
129840088|NCT03465878|467379131|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
129840089|NCT04656132|467379132|FG000|Overall Study|Lost to Follow-up|4|||
129840090|NCT04656132|467379132|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
129840091|NCT04365699|467379133|FG000|Overall Study|Death|2|||
129840092|NCT04365699|467379134|FG001|Overall Study|Death|5|||
129840093|NCT04365699|467379135|FG002|Overall Study|Death|15|||
129840094|NCT02540954|467379136|FG000|Overall Study|Physician Decision|3|||
129840095|NCT02540954|467379137|FG001|Overall Study|Physician Decision|1|||
129840096|NCT02540954|467379136|FG000|Overall Study|Withdrawal by Subject|6|||
129840097|NCT02540954|467379137|FG001|Overall Study|Withdrawal by Subject|5|||
129840098|NCT02540954|467379136|FG000|Overall Study|Lost to Follow-up|1|||
129840099|NCT02540954|467379137|FG001|Overall Study|Lost to Follow-up|1|||
129840100|NCT02540954|467379136|FG000|Overall Study|Adverse Event|4|||
129840101|NCT02540954|467379137|FG001|Overall Study|Adverse Event|2|||
129840102|NCT02540954|467379136|FG000|Overall Study|Death|0|||
129840103|NCT02540954|467379137|FG001|Overall Study|Death|3|||
129840104|NCT02540954|467379136|FG000|Overall Study|Treatment failure|1|||
129840105|NCT02540954|467379137|FG001|Overall Study|Treatment failure|0|||
129840106|NCT02540954|467379136|FG000|Overall Study|Other reason|4|||
129840107|NCT02540954|467379137|FG001|Overall Study|Other reason|2|||
129840108|NCT00834912|467379140|FG000|Treatment Period 1|Adverse Event|0|||
129840109|NCT00834912|467379141|FG001|Treatment Period 1|Adverse Event|1|||
129840110|NCT00834912|467379142|FG002|Treatment Period 1|Adverse Event|0|||
129840111|NCT00834912|467379143|FG003|Treatment Period 1|Adverse Event|1|||
129840112|NCT00834912|467379144|FG004|Treatment Period 1|Adverse Event|0|||
129840113|NCT00834912|467379145|FG005|Treatment Period 1|Adverse Event|0|||
129840114|NCT00834912|467379140|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129840115|NCT00834912|467379141|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129840116|NCT00834912|467379142|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129840117|NCT00834912|467379143|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129840118|NCT00834912|467379144|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129840119|NCT00834912|467379145|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129840120|NCT03829046|467379146|FG000|Overall Study|Withdrawal by Subject|1|||
129840121|NCT03829046|467379147|FG001|Overall Study|Withdrawal by Subject|0|||
129840122|NCT00244712|467379150|FG000|Overall Study|Adverse Event|20|||
129840123|NCT00244712|467379151|FG001|Overall Study|Adverse Event|21|||
129840124|NCT00244712|467379150|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
129840125|NCT00244712|467379151|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
129840126|NCT00244712|467379150|FG000|Overall Study|Lack of Compliance|10|||
129840127|NCT00244712|467379151|FG001|Overall Study|Lack of Compliance|11|||
129840128|NCT00244712|467379150|FG000|Overall Study|Lost to Follow-up|45|||
129840129|NCT00244712|467379151|FG001|Overall Study|Lost to Follow-up|52|||
129840130|NCT00244712|467379150|FG000|Overall Study|Withdrawal by Subject|13|||
129840131|NCT00244712|467379151|FG001|Overall Study|Withdrawal by Subject|23|||
129840132|NCT00244712|467379150|FG000|Overall Study|Protocol Violation, disease progression|13|||
129840133|NCT00244712|467379151|FG001|Overall Study|Protocol Violation, disease progression|11|||
129840134|NCT00500370|467379162|FG000|Overall Study|Adverse Event|9|||
129840135|NCT00500370|467379163|FG001|Overall Study|Adverse Event|3|||
129840136|NCT00500370|467379162|FG000|Overall Study|Lost to Follow-up|10|||
129840137|NCT00500370|467379163|FG001|Overall Study|Lost to Follow-up|10|||
129840138|NCT00500370|467379162|FG000|Overall Study|Protocol Violation|2|||
129840139|NCT00500370|467379163|FG001|Overall Study|Protocol Violation|4|||
129840140|NCT00500370|467379162|FG000|Overall Study|Sponsor Decision|2|||
129840141|NCT00500370|467379163|FG001|Overall Study|Sponsor Decision|0|||
129840142|NCT00500370|467379162|FG000|Overall Study|Subject Decision|10|||
129840143|NCT00500370|467379163|FG001|Overall Study|Subject Decision|17|||
129840144|NCT04804813|467379164|FG000|Overall Study|Protocol Violation|2|||
129840145|NCT04804813|467379165|FG001|Overall Study|Protocol Violation|0|||
129840146|NCT04804813|467379164|FG000|Overall Study|Withdrawal by Subject|1|||
130063493|NCT00819585|468186327|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
129840147|NCT04804813|467379165|FG001|Overall Study|Withdrawal by Subject|0|||
130063494|NCT00819585|468186328|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
130063495|NCT00819585|468186318|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
129840148|NCT02777125|467379168|FG000|Overall Study|Consent form violation|14|||
129840149|NCT02777125|467379169|FG001|Overall Study|Consent form violation|12|||
129840150|NCT02777125|467379168|FG000|Overall Study|Assent form violation|21|||
130115065|NCT00415532|468381307|FG001|Treatment Period|Noncompliance|1|||
130115066|NCT00415532|468381306|FG000|Treatment Period|Requirement for alternative therapy|1|||
130115067|NCT00415532|468381307|FG001|Treatment Period|Requirement for alternative therapy|0|||
130115068|NCT00415532|468381306|FG000|Safety Follow Up Period|Adverse Event|1|||
130115069|NCT00415532|468381307|FG001|Safety Follow Up Period|Adverse Event|3|||
130115070|NCT00415532|468381306|FG000|Safety Follow Up Period|Death|3|||
130115071|NCT00415532|468381307|FG001|Safety Follow Up Period|Death|0|||
130115072|NCT00415532|468381306|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
130115073|NCT00415532|468381307|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
130115074|NCT00415532|468381306|FG000|Safety Follow Up Period|Other|1|||
130115075|NCT00415532|468381307|FG001|Safety Follow Up Period|Other|4|||
130115076|NCT00415532|468381306|FG000|Safety Follow Up Period|Ineligibility determined|1|||
130115077|NCT00415532|468381307|FG001|Safety Follow Up Period|Ineligibility determined|1|||
130115078|NCT00415532|468381306|FG000|Safety Follow Up Period|Noncompliance|1|||
130115079|NCT00415532|468381307|FG001|Safety Follow Up Period|Noncompliance|0|||
130115080|NCT00415532|468381306|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
130115081|NCT00415532|468381307|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
130115082|NCT02040766|468381308|FG000|Overall Study|Adverse Event|1|||
129840151|NCT02777125|467379169|FG001|Overall Study|Assent form violation|23|||
129840152|NCT02777125|467379168|FG000|Overall Study|Protocol Violation|8|||
129840153|NCT02777125|467379169|FG001|Overall Study|Protocol Violation|12|||
129840154|NCT06023394|467379170|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
129840155|NCT06023394|467379171|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
129840156|NCT06023394|467379170|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
130063496|NCT00819585|468186319|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
130063497|NCT00819585|468186320|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063498|NCT00819585|468186321|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063499|NCT00819585|468186322|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063500|NCT00819585|468186323|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063501|NCT00819585|468186324|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
130063502|NCT00819585|468186325|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063503|NCT00819585|468186326|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063504|NCT00819585|468186327|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063505|NCT00819585|468186328|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
130063506|NCT00819585|468186318|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
130063507|NCT00819585|468186319|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
130063508|NCT00819585|468186320|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
130063509|NCT00819585|468186321|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
130063510|NCT00819585|468186322|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
130063511|NCT00819585|468186323|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
130063512|NCT00819585|468186324|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
130063513|NCT00819585|468186325|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
130063514|NCT00819585|468186326|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
130063515|NCT00819585|468186327|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
130063516|NCT00819585|468186328|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
130063517|NCT00819585|468186318|FG000|Core Study|Subject Withdrew Consent|0|||
130063518|NCT00819585|468186319|FG001|Core Study|Subject Withdrew Consent|3|||
130063519|NCT00819585|468186320|FG002|Core Study|Subject Withdrew Consent|2|||
130063520|NCT00819585|468186321|FG003|Core Study|Subject Withdrew Consent|1|||
130063521|NCT00819585|468186322|FG004|Core Study|Subject Withdrew Consent|0|||
130063522|NCT00819585|468186323|FG005|Core Study|Subject Withdrew Consent|0|||
130063523|NCT00819585|468186324|FG006|Core Study|Subject Withdrew Consent|3|||
130063524|NCT00819585|468186325|FG007|Core Study|Subject Withdrew Consent|0|||
130063525|NCT00819585|468186326|FG008|Core Study|Subject Withdrew Consent|0|||
130063526|NCT00819585|468186327|FG009|Core Study|Subject Withdrew Consent|0|||
130063527|NCT00819585|468186328|FG010|Core Study|Subject Withdrew Consent|0|||
130063528|NCT00819585|468186318|FG000|Core Study|Lost to Follow-up|2|||
130063529|NCT00819585|468186319|FG001|Core Study|Lost to Follow-up|1|||
130063530|NCT00819585|468186320|FG002|Core Study|Lost to Follow-up|2|||
130063531|NCT00819585|468186321|FG003|Core Study|Lost to Follow-up|0|||
130063532|NCT00819585|468186322|FG004|Core Study|Lost to Follow-up|1|||
130063533|NCT00819585|468186323|FG005|Core Study|Lost to Follow-up|1|||
130063534|NCT00819585|468186324|FG006|Core Study|Lost to Follow-up|1|||
130063535|NCT00819585|468186325|FG007|Core Study|Lost to Follow-up|0|||
130063536|NCT00819585|468186326|FG008|Core Study|Lost to Follow-up|0|||
130063537|NCT00819585|468186327|FG009|Core Study|Lost to Follow-up|0|||
130063538|NCT00819585|468186328|FG010|Core Study|Lost to Follow-up|0|||
130063539|NCT00819585|468186318|FG000|Core Study|Administrative Problems|0|||
130063540|NCT00819585|468186319|FG001|Core Study|Administrative Problems|0|||
130115083|NCT02040766|468381309|FG001|Overall Study|Adverse Event|1|||
130115084|NCT02040766|468381310|FG002|Overall Study|Adverse Event|1|||
130115085|NCT02040766|468381311|FG003|Overall Study|Adverse Event|0|||
130063541|NCT00819585|468186320|FG002|Core Study|Administrative Problems|0|||
130063542|NCT00819585|468186321|FG003|Core Study|Administrative Problems|0|||
129899314|NCT04304534|467591819|FG002|Overall Study|Technical Problems|3|||
129899315|NCT04304534|467591820|FG003|Overall Study|Technical Problems|4|||
129899316|NCT04304534|467591817|FG000|Overall Study|Death|7|||
129899317|NCT04304534|467591818|FG001|Overall Study|Death|2|||
129899318|NCT04304534|467591819|FG002|Overall Study|Death|4|||
129899319|NCT04304534|467591820|FG003|Overall Study|Death|3|||
129899320|NCT04304534|467591817|FG000|Overall Study|Withdrawal by Subject|7|||
129899321|NCT04304534|467591818|FG001|Overall Study|Withdrawal by Subject|2|||
129899322|NCT04304534|467591819|FG002|Overall Study|Withdrawal by Subject|7|||
129899323|NCT04304534|467591820|FG003|Overall Study|Withdrawal by Subject|4|||
129899324|NCT04304534|467591817|FG000|Overall Study|Physician Decision|4|||
129899325|NCT04304534|467591818|FG001|Overall Study|Physician Decision|9|||
129899326|NCT04304534|467591819|FG002|Overall Study|Physician Decision|9|||
129899327|NCT04304534|467591820|FG003|Overall Study|Physician Decision|5|||
129899328|NCT04304534|467591817|FG000|Overall Study|Subject Decision|34|||
129899329|NCT04304534|467591818|FG001|Overall Study|Subject Decision|25|||
129899330|NCT04304534|467591819|FG002|Overall Study|Subject Decision|25|||
129899331|NCT04304534|467591820|FG003|Overall Study|Subject Decision|26|||
129899332|NCT04304534|467591817|FG000|Overall Study|Adverse Event|35|||
129899333|NCT04304534|467591818|FG001|Overall Study|Adverse Event|40|||
129899334|NCT04304534|467591819|FG002|Overall Study|Adverse Event|39|||
129899335|NCT04304534|467591820|FG003|Overall Study|Adverse Event|44|||
129899336|NCT04580303|467591821|FG000|Overall Study|Adverse Event|0|||
129899337|NCT04580303|467591822|FG001|Overall Study|Adverse Event|1|||
129899338|NCT04580303|467591823|FG002|Overall Study|Adverse Event|0|||
129899339|NCT04580303|467591824|FG003|Overall Study|Adverse Event|0|||
129899340|NCT04580303|467591821|FG000|Overall Study|Withdrawal by Subject|0|||
129840157|NCT06023394|467379171|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
129840158|NCT06023394|467379170|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
129840159|NCT06023394|467379171|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
129840160|NCT06023394|467379170|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
129840161|NCT06023394|467379171|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
129840162|NCT01581593|467380712|FG000|Overall Study|Withdrawal by Subject|1|||
129840163|NCT02970968|467380713|FG000|Overall Study|Withdrawal by Subject|3|||
129840164|NCT02970968|467380714|FG001|Overall Study|Withdrawal by Subject|3|||
129840165|NCT02970968|467380713|FG000|Overall Study|Adverse Event|1|||
129840166|NCT02970968|467380714|FG001|Overall Study|Adverse Event|2|||
129840167|NCT02970968|467380713|FG000|Overall Study|Lost to Follow-up|1|||
129840168|NCT02970968|467380714|FG001|Overall Study|Lost to Follow-up|1|||
129840169|NCT02970968|467380713|FG000|Overall Study|Non-Compliance|0|||
129840170|NCT02970968|467380714|FG001|Overall Study|Non-Compliance|1|||
129840171|NCT04127786|467380719|FG000|Primary Series|Adverse Event|1|||
129840172|NCT04127786|467380720|FG001|Primary Series|Adverse Event|0|||
129840173|NCT04127786|467380721|FG002|Primary Series|Adverse Event|0|||
129840174|NCT04127786|467380722|FG003|Primary Series|Adverse Event|1|||
129840175|NCT04127786|467380723|FG004|Primary Series|Adverse Event|0|||
129840176|NCT04127786|467380724|FG005|Primary Series|Adverse Event|1|||
129840177|NCT04127786|467380719|FG000|Primary Series|Protocol Violation|5|||
129840178|NCT04127786|467380720|FG001|Primary Series|Protocol Violation|3|||
129840179|NCT04127786|467380721|FG002|Primary Series|Protocol Violation|4|||
129840180|NCT04127786|467380722|FG003|Primary Series|Protocol Violation|3|||
129840181|NCT04127786|467380723|FG004|Primary Series|Protocol Violation|2|||
129840182|NCT04127786|467380724|FG005|Primary Series|Protocol Violation|0|||
129840183|NCT04127786|467380719|FG000|Primary Series|Withdrawal by Subject|0|||
129840184|NCT04127786|467380720|FG001|Primary Series|Withdrawal by Subject|0|||
129840185|NCT04127786|467380721|FG002|Primary Series|Withdrawal by Subject|0|||
129840186|NCT04127786|467380722|FG003|Primary Series|Withdrawal by Subject|1|||
129840187|NCT04127786|467380723|FG004|Primary Series|Withdrawal by Subject|0|||
129840188|NCT04127786|467380724|FG005|Primary Series|Withdrawal by Subject|0|||
129840189|NCT04127786|467380719|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
129840190|NCT04127786|467380720|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
129840191|NCT04127786|467380721|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
129840192|NCT04127786|467380722|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
129840193|NCT04127786|467380723|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
129840194|NCT04127786|467380724|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
129899341|NCT04580303|467591822|FG001|Overall Study|Withdrawal by Subject|0|||
129899342|NCT04580303|467591823|FG002|Overall Study|Withdrawal by Subject|1|||
129899343|NCT04580303|467591824|FG003|Overall Study|Withdrawal by Subject|0|||
129899344|NCT02299635|467591826|FG000|Overall Study|Adverse Event|2|||
129899345|NCT02299635|467591826|FG000|Overall Study|Death|1|||
130115086|NCT02040766|468381312|FG004|Overall Study|Adverse Event|2|||
129899346|NCT02299635|467591826|FG000|Overall Study|Global deterioration of health status|1|||
129899347|NCT02299635|467591826|FG000|Overall Study|Objective progression or relapse|10|||
129840195|NCT04127786|467380719|FG000|Booster Phase|Withdrawal by Subject|2|||
129840196|NCT04127786|467380720|FG001|Booster Phase|Withdrawal by Subject|0|||
129840197|NCT04127786|467380721|FG002|Booster Phase|Withdrawal by Subject|0|||
130115087|NCT02040766|468381308|FG000|Overall Study|Withdrawal by Subject|4|||
130115088|NCT02040766|468381309|FG001|Overall Study|Withdrawal by Subject|3|||
130115089|NCT02040766|468381310|FG002|Overall Study|Withdrawal by Subject|2|||
130115090|NCT02040766|468381311|FG003|Overall Study|Withdrawal by Subject|3|||
130115091|NCT02040766|468381312|FG004|Overall Study|Withdrawal by Subject|2|||
130115092|NCT02040766|468381308|FG000|Overall Study|Non-compliance|0|||
130115093|NCT02040766|468381309|FG001|Overall Study|Non-compliance|1|||
130115094|NCT02040766|468381310|FG002|Overall Study|Non-compliance|0|||
130115095|NCT02040766|468381311|FG003|Overall Study|Non-compliance|0|||
130115096|NCT02040766|468381312|FG004|Overall Study|Non-compliance|0|||
130115097|NCT02040766|468381308|FG000|Overall Study|Protocol Violation|2|||
130115098|NCT02040766|468381309|FG001|Overall Study|Protocol Violation|1|||
130115099|NCT02040766|468381310|FG002|Overall Study|Protocol Violation|2|||
130115100|NCT02040766|468381311|FG003|Overall Study|Protocol Violation|3|||
130115101|NCT02040766|468381312|FG004|Overall Study|Protocol Violation|0|||
130115102|NCT02040766|468381308|FG000|Overall Study|Lost to Follow-up|4|||
130115103|NCT02040766|468381309|FG001|Overall Study|Lost to Follow-up|1|||
130115104|NCT02040766|468381310|FG002|Overall Study|Lost to Follow-up|3|||
130115105|NCT02040766|468381311|FG003|Overall Study|Lost to Follow-up|1|||
130115106|NCT02040766|468381312|FG004|Overall Study|Lost to Follow-up|4|||
130115107|NCT02040766|468381308|FG000|Overall Study|Not reported|1|||
130115108|NCT02040766|468381309|FG001|Overall Study|Not reported|0|||
130115109|NCT02040766|468381310|FG002|Overall Study|Not reported|0|||
130115110|NCT02040766|468381311|FG003|Overall Study|Not reported|0|||
130115111|NCT02040766|468381312|FG004|Overall Study|Not reported|0|||
130115112|NCT02040766|468381308|FG000|Overall Study|Lack of Efficacy|6|||
130115113|NCT02040766|468381309|FG001|Overall Study|Lack of Efficacy|3|||
130115114|NCT02040766|468381310|FG002|Overall Study|Lack of Efficacy|4|||
130115115|NCT02040766|468381311|FG003|Overall Study|Lack of Efficacy|6|||
130115116|NCT02040766|468381312|FG004|Overall Study|Lack of Efficacy|5|||
130115117|NCT02974114|468381313|FG000|Overall Study|Other (Not specified)|0|||
130115118|NCT02974114|468381314|FG001|Overall Study|Other (Not specified)|1|||
130115119|NCT02974114|468381315|FG002|Overall Study|Other (Not specified)|2|||
130115120|NCT01580020|468381316|FG000|Overall Study|Lack of Efficacy|0|||
130115121|NCT01580020|468381317|FG001|Overall Study|Lack of Efficacy|5|||
130115122|NCT01580020|468381318|FG002|Overall Study|Lack of Efficacy|0|||
130115123|NCT01580020|468381319|FG003|Overall Study|Lack of Efficacy|1|||
130115124|NCT01580020|468381316|FG000|Overall Study|Withdrawal by Subject|0|||
130115125|NCT01580020|468381317|FG001|Overall Study|Withdrawal by Subject|1|||
130115126|NCT01580020|468381318|FG002|Overall Study|Withdrawal by Subject|1|||
130115127|NCT01580020|468381319|FG003|Overall Study|Withdrawal by Subject|0|||
130115128|NCT01580020|468381316|FG000|Overall Study|Adverse Event|1|||
130115129|NCT01580020|468381317|FG001|Overall Study|Adverse Event|1|||
130115130|NCT01580020|468381318|FG002|Overall Study|Adverse Event|1|||
130115131|NCT01580020|468381319|FG003|Overall Study|Adverse Event|1|||
130115132|NCT01580020|468381316|FG000|Overall Study|Administrative Problems|0|||
130115133|NCT01580020|468381317|FG001|Overall Study|Administrative Problems|0|||
130115134|NCT01580020|468381318|FG002|Overall Study|Administrative Problems|1|||
130115135|NCT01580020|468381319|FG003|Overall Study|Administrative Problems|0|||
130115136|NCT01580020|468381316|FG000|Overall Study|Lost to Follow-up|0|||
130115137|NCT01580020|468381317|FG001|Overall Study|Lost to Follow-up|0|||
130115138|NCT01580020|468381318|FG002|Overall Study|Lost to Follow-up|1|||
130115139|NCT01580020|468381319|FG003|Overall Study|Lost to Follow-up|0|||
130115140|NCT01724359|468381320|FG000|Overall Study|Adverse Event|10|||
130115141|NCT01724359|468381320|FG000|Overall Study|Death|1|||
130115142|NCT01724359|468381320|FG000|Overall Study|Other|20|||
130115143|NCT00593333|468381322|FG000|Overall Study|Lost to Follow-up|10|||
130115144|NCT00593333|468381323|FG001|Overall Study|Lost to Follow-up|11|||
130115145|NCT01752920|468381324|FG000|Overall Study|Adverse Event|1|||
130115146|NCT01752920|468381325|FG001|Overall Study|Adverse Event|0|||
130115147|NCT01752920|468381326|FG002|Overall Study|Adverse Event|5|||
130115148|NCT01752920|468381327|FG003|Overall Study|Adverse Event|10|||
130115149|NCT01752920|468381324|FG000|Overall Study|Clinical Disease Progression|6|||
130115150|NCT01752920|468381325|FG001|Overall Study|Clinical Disease Progression|4|||
130115151|NCT01752920|468381326|FG002|Overall Study|Clinical Disease Progression|1|||
130115152|NCT01752920|468381327|FG003|Overall Study|Clinical Disease Progression|13|||
130115153|NCT01752920|468381324|FG000|Overall Study|Physician Decision|1|||
130115154|NCT01752920|468381325|FG001|Overall Study|Physician Decision|0|||
130115155|NCT01752920|468381326|FG002|Overall Study|Physician Decision|0|||
130115156|NCT01752920|468381327|FG003|Overall Study|Physician Decision|3|||
130115157|NCT01752920|468381324|FG000|Overall Study|Radiographic Disease Progression|20|||
130115158|NCT01752920|468381325|FG001|Overall Study|Radiographic Disease Progression|7|||
130115159|NCT01752920|468381326|FG002|Overall Study|Radiographic Disease Progression|12|||
130115160|NCT01752920|468381327|FG003|Overall Study|Radiographic Disease Progression|29|||
130115161|NCT01752920|468381324|FG000|Overall Study|Study Terminated by Sponsor|0|||
130115162|NCT01752920|468381325|FG001|Overall Study|Study Terminated by Sponsor|0|||
130115163|NCT01752920|468381326|FG002|Overall Study|Study Terminated by Sponsor|0|||
130115164|NCT01752920|468381327|FG003|Overall Study|Study Terminated by Sponsor|1|||
129840198|NCT04127786|467380722|FG003|Booster Phase|Withdrawal by Subject|0|||
129840199|NCT04127786|467380723|FG004|Booster Phase|Withdrawal by Subject|0|||
129840200|NCT04127786|467380724|FG005|Booster Phase|Withdrawal by Subject|0|||
129840201|NCT03568942|467380725|FG000|Overall Study|Family emergency|1|||
129840202|NCT03568942|467380725|FG000|Overall Study|Lost to Follow-up|1|||
129840203|NCT01945489|467380726|FG000|Cycle 1|Adverse Event|2|||
129840204|NCT01945489|467380727|FG001|Cycle 1|Adverse Event|0|||
129840205|NCT01945489|467380726|FG000|Cycle 1|Lost to Follow-up|4|||
129840206|NCT01945489|467380727|FG001|Cycle 1|Lost to Follow-up|0|||
129840207|NCT01945489|467380726|FG000|Cycle 1|Personal Reasons|4|||
129840208|NCT01945489|467380727|FG001|Cycle 1|Personal Reasons|2|||
129840209|NCT01945489|467380726|FG000|Cycle 1|Protocol Violation|0|||
129840210|NCT01945489|467380727|FG001|Cycle 1|Protocol Violation|1|||
129840211|NCT01945489|467380726|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
129840212|NCT01945489|467380727|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
129840213|NCT01945489|467380726|FG000|Cycle 2|Adverse Event|1|||
129840214|NCT01945489|467380727|FG001|Cycle 2|Adverse Event|0|||
129840215|NCT01945489|467380726|FG000|Cycle 2|Lost to Follow-up|0|||
129840216|NCT01945489|467380727|FG001|Cycle 2|Lost to Follow-up|1|||
129840217|NCT00358527|467380728|FG000|Overall Study|Adverse Event|4|||
129840218|NCT00358527|467380729|FG001|Overall Study|Adverse Event|0|||
129840219|NCT00358527|467380728|FG000|Overall Study|Withdrawal by Subject|1|||
129840220|NCT00358527|467380729|FG001|Overall Study|Withdrawal by Subject|1|||
129840221|NCT00358527|467380728|FG000|Overall Study|Non-compliance with protocol|6|||
129840222|NCT00358527|467380729|FG001|Overall Study|Non-compliance with protocol|1|||
129840223|NCT00358527|467380728|FG000|Overall Study|Administrative|2|||
129840224|NCT00358527|467380729|FG001|Overall Study|Administrative|1|||
129840225|NCT04144166|467380730|FG000|Overall Study|Discharged before study start|1|||
129840226|NCT04144166|467380730|FG000|Overall Study|Pregnancy|1|||
129840227|NCT04144166|467380730|FG000|Overall Study|Nail polish could not be removed from finger|1|||
129840228|NCT03569371|467380731|FG000|Overall Study|Lack of Efficacy|1|||
129840229|NCT03569371|467380731|FG000|Overall Study|Lost to Follow-up|1|||
129840230|NCT03569371|467380731|FG000|Overall Study|Adverse Event|1|||
129840231|NCT04145895|467380732|FG000|Overall Study|Physician Decision|2|||
129840232|NCT04145895|467380733|FG001|Overall Study|Physician Decision|0|||
129840233|NCT04145895|467380732|FG000|Overall Study|Withdrawal by Subject|0|||
129840234|NCT04145895|467380733|FG001|Overall Study|Withdrawal by Subject|2|||
129840235|NCT01236755|467380734|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
129840236|NCT01236755|467380734|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
129840237|NCT01236755|467380734|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
129840238|NCT01236755|467380734|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
129840239|NCT04904185|467380735|FG000|Overall Study|Expansion failure|1|||
129840240|NCT04904185|467380736|FG001|Overall Study|Expansion failure|0|||
129840241|NCT04904185|467380735|FG000|Overall Study|Late response on prior treatment|1|||
129840242|NCT04904185|467380736|FG001|Overall Study|Late response on prior treatment|0|||
129840243|NCT02433834|467380740|FG000|Overall Study|Protocol-specified criteria|7|||
129840244|NCT02433834|467380740|FG000|Overall Study|Protocol Violation|3|||
129840245|NCT02433834|467380740|FG000|Overall Study|Lost to Follow-up|6|||
129840246|NCT02433834|467380740|FG000|Overall Study|Withdrawal by Subject|14|||
129840247|NCT02433834|467380740|FG000|Overall Study|Adverse Event|6|||
129840248|NCT02433834|467380740|FG000|Overall Study|Physician Decision|1|||
129840249|NCT02643251|467380741|FG000|Overall Study|Adverse Event|3|||
130063543|NCT00819585|468186322|FG004|Core Study|Administrative Problems|0|||
130063544|NCT00819585|468186323|FG005|Core Study|Administrative Problems|0|||
130063545|NCT00819585|468186324|FG006|Core Study|Administrative Problems|2|||
130063546|NCT00819585|468186325|FG007|Core Study|Administrative Problems|0|||
130063547|NCT00819585|468186326|FG008|Core Study|Administrative Problems|0|||
130063548|NCT00819585|468186327|FG009|Core Study|Administrative Problems|0|||
130063549|NCT00819585|468186328|FG010|Core Study|Administrative Problems|0|||
130063550|NCT00819585|468186318|FG000|Core Study|Death|0|||
130063551|NCT00819585|468186319|FG001|Core Study|Death|0|||
130063552|NCT00819585|468186320|FG002|Core Study|Death|0|||
130063553|NCT00819585|468186321|FG003|Core Study|Death|0|||
130063554|NCT00819585|468186322|FG004|Core Study|Death|0|||
130063555|NCT00819585|468186323|FG005|Core Study|Death|0|||
130063556|NCT00819585|468186324|FG006|Core Study|Death|1|||
130063557|NCT00819585|468186325|FG007|Core Study|Death|0|||
130063558|NCT00819585|468186326|FG008|Core Study|Death|0|||
130063559|NCT00819585|468186327|FG009|Core Study|Death|0|||
129840250|NCT02643251|467380742|FG001|Overall Study|Adverse Event|1|||
129840251|NCT02643251|467380741|FG000|Overall Study|Withdrawal by Subject|2|||
129840252|NCT02643251|467380742|FG001|Overall Study|Withdrawal by Subject|0|||
129840253|NCT02643251|467380741|FG000|Overall Study|Lost to Follow-up|4|||
129840254|NCT02643251|467380742|FG001|Overall Study|Lost to Follow-up|1|||
129899348|NCT02299635|467591826|FG000|Overall Study|Withdrawal by Subject|2|||
129840255|NCT02643251|467380741|FG000|Overall Study|Protocol Violation|1|||
129840256|NCT02643251|467380742|FG001|Overall Study|Protocol Violation|0|||
130063560|NCT00819585|468186328|FG010|Core Study|Death|0|||
130063561|NCT00819585|468186318|FG000|Core Study|Protocol Violation|0|||
130063562|NCT00819585|468186319|FG001|Core Study|Protocol Violation|0|||
129840257|NCT02643251|467380741|FG000|Overall Study|PI Decision to terminate patient|1|||
129840258|NCT02643251|467380742|FG001|Overall Study|PI Decision to terminate patient|0|||
129840259|NCT00333229|467380743|FG000|Overall Study|Lack of Efficacy|0|||
129840260|NCT00333229|467380744|FG001|Overall Study|Lack of Efficacy|1|||
129840261|NCT00348556|467380747|FG000|Overall Study|Adverse Event|1|||
129840262|NCT01944059|467380748|FG000|Overall Study|Lost to Follow-up|1|||
129840263|NCT01944059|467380748|FG000|Overall Study|Physician Decision|3|||
129840264|NCT01944059|467380748|FG000|Overall Study|Withdrawal by Subject|1|||
129840265|NCT01944059|467380748|FG000|Overall Study|Adverse Event|2|||
129840266|NCT02365636|467380749|FG000|Overall Study|Adverse Event|3|||
129840267|NCT02365636|467380750|FG001|Overall Study|Adverse Event|3|||
129840268|NCT02365636|467380751|FG002|Overall Study|Adverse Event|2|||
129840269|NCT02365636|467380749|FG000|Overall Study|Protocol Violation|1|||
129840270|NCT02365636|467380750|FG001|Overall Study|Protocol Violation|4|||
129840271|NCT02365636|467380751|FG002|Overall Study|Protocol Violation|0|||
129840272|NCT02365636|467380749|FG000|Overall Study|Lost to Follow-up|0|||
129840273|NCT02365636|467380750|FG001|Overall Study|Lost to Follow-up|0|||
129840274|NCT02365636|467380751|FG002|Overall Study|Lost to Follow-up|1|||
129840275|NCT02365636|467380749|FG000|Overall Study|Other|2|||
129840276|NCT02365636|467380750|FG001|Overall Study|Other|0|||
129840277|NCT02365636|467380751|FG002|Overall Study|Other|0|||
130063563|NCT00819585|468186320|FG002|Core Study|Protocol Violation|1|||
130063564|NCT00819585|468186321|FG003|Core Study|Protocol Violation|0|||
130063565|NCT00819585|468186322|FG004|Core Study|Protocol Violation|0|||
130063566|NCT00819585|468186323|FG005|Core Study|Protocol Violation|1|||
130063567|NCT00819585|468186324|FG006|Core Study|Protocol Violation|3|||
130063568|NCT00819585|468186325|FG007|Core Study|Protocol Violation|0|||
129840278|NCT00463060|467380754|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
129840279|NCT00463060|467380754|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
129840280|NCT01802775|467380757|FG000|Overall Study|Death|0|||
129840281|NCT01802775|467380758|FG001|Overall Study|Death|3|||
129840282|NCT01802775|467380757|FG000|Overall Study|Reason not provided|0|||
129840283|NCT01802775|467380758|FG001|Overall Study|Reason not provided|1|||
129840284|NCT01802775|467380757|FG000|Overall Study|Physician Decision|1|||
129840285|NCT01802775|467380758|FG001|Overall Study|Physician Decision|0|||
129840286|NCT01802775|467380757|FG000|Overall Study|Adverse Event|1|||
129840287|NCT01802775|467380758|FG001|Overall Study|Adverse Event|1|||
129840288|NCT01802775|467380757|FG000|Overall Study|Withdrawal by Subject|3|||
129840289|NCT01802775|467380758|FG001|Overall Study|Withdrawal by Subject|5|||
129840290|NCT01802775|467380757|FG000|Overall Study|Lost to Follow-up|1|||
129840291|NCT01802775|467380758|FG001|Overall Study|Lost to Follow-up|2|||
129840292|NCT01067352|467380763|FG000|Overall Study|Withdrawal by Subject|1|||
129840293|NCT01067352|467380764|FG001|Overall Study|Withdrawal by Subject|2|||
129840294|NCT01067352|467380765|FG002|Overall Study|Withdrawal by Subject|1|||
129840295|NCT01067352|467380763|FG000|Overall Study|Physician Decision|0|||
129840296|NCT01067352|467380764|FG001|Overall Study|Physician Decision|1|||
129840297|NCT01067352|467380765|FG002|Overall Study|Physician Decision|0|||
129840298|NCT01096784|467380766|FG000|Overall Study|Withdrawal by Subject|2|||
129840299|NCT01096784|467380767|FG001|Overall Study|Withdrawal by Subject|1|||
129840300|NCT01096784|467380766|FG000|Overall Study|Adverse Event|11|||
129840301|NCT01096784|467380767|FG001|Overall Study|Adverse Event|9|||
129840302|NCT01096784|467380766|FG000|Overall Study|Protocol Deviation|2|||
129840303|NCT01096784|467380767|FG001|Overall Study|Protocol Deviation|2|||
129840304|NCT01096784|467380766|FG000|Overall Study|Administrative Decision|0|||
129840305|NCT01096784|467380767|FG001|Overall Study|Administrative Decision|1|||
129840306|NCT01096784|467380766|FG000|Overall Study|Other Unspecified|0|||
129840307|NCT01096784|467380767|FG001|Overall Study|Other Unspecified|1|||
129840308|NCT05923229|467380768|FG000|Overall Study|Withdrawal by Subject|3|||
129840309|NCT05923229|467380769|FG001|Overall Study|Withdrawal by Subject|0|||
129840310|NCT05923229|467380768|FG000|Overall Study|Health related|2|||
129840311|NCT05923229|467380769|FG001|Overall Study|Health related|1|||
129840312|NCT03064126|467380770|FG000|Overall Study|Death|40|||
129840313|NCT03064126|467380771|FG001|Overall Study|Death|16|||
129840314|NCT03064126|467380772|FG002|Overall Study|Death|4|||
129840315|NCT03064126|467380773|FG003|Overall Study|Death|2|||
129840316|NCT03064126|467380770|FG000|Overall Study|Withdrawal by Subject|17|||
129840317|NCT03064126|467380771|FG001|Overall Study|Withdrawal by Subject|9|||
130063569|NCT00819585|468186326|FG008|Core Study|Protocol Violation|0|||
130063570|NCT00819585|468186327|FG009|Core Study|Protocol Violation|0|||
130063571|NCT00819585|468186328|FG010|Core Study|Protocol Violation|0|||
130063572|NCT00819585|468186318|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
129840318|NCT03064126|467380772|FG002|Overall Study|Withdrawal by Subject|0|||
129840319|NCT03064126|467380773|FG003|Overall Study|Withdrawal by Subject|2|||
129840320|NCT03064126|467380770|FG000|Overall Study|Lost to Follow-up|7|||
129840321|NCT03064126|467380771|FG001|Overall Study|Lost to Follow-up|3|||
129840322|NCT03064126|467380772|FG002|Overall Study|Lost to Follow-up|0|||
129840323|NCT03064126|467380773|FG003|Overall Study|Lost to Follow-up|0|||
129840324|NCT03064126|467380770|FG000|Overall Study|Adverse Event|2|||
129840325|NCT03064126|467380771|FG001|Overall Study|Adverse Event|0|||
130063573|NCT00819585|468186319|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
130063574|NCT00819585|468186320|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
130063575|NCT00819585|468186321|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
130063576|NCT00819585|468186322|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
130063577|NCT00819585|468186323|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
130063578|NCT00819585|468186324|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
130063579|NCT00819585|468186325|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
130063580|NCT00819585|468186326|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
130063581|NCT00819585|468186327|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
130063582|NCT00819585|468186328|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
130063583|NCT00819585|468186318|FG000|Extension Study|Subject Withdrew Consent|0|||
130063584|NCT00819585|468186319|FG001|Extension Study|Subject Withdrew Consent|0|||
130063585|NCT00819585|468186320|FG002|Extension Study|Subject Withdrew Consent|0|||
130063586|NCT00819585|468186321|FG003|Extension Study|Subject Withdrew Consent|0|||
130063587|NCT00819585|468186322|FG004|Extension Study|Subject Withdrew Consent|0|||
130115165|NCT01752920|468381324|FG000|Overall Study|Withdrawal by Subject|0|||
130115166|NCT01752920|468381325|FG001|Overall Study|Withdrawal by Subject|1|||
130115167|NCT01752920|468381326|FG002|Overall Study|Withdrawal by Subject|0|||
130115168|NCT01752920|468381327|FG003|Overall Study|Withdrawal by Subject|1|||
130115169|NCT01752920|468381324|FG000|Overall Study|Lack of clinical benefit|1|||
130115170|NCT01752920|468381325|FG001|Overall Study|Lack of clinical benefit|1|||
130115171|NCT01752920|468381326|FG002|Overall Study|Lack of clinical benefit|1|||
130115172|NCT01752920|468381327|FG003|Overall Study|Lack of clinical benefit|1|||
130115173|NCT01186978|468381328|FG000|Overall Study|Withdrawal by Subject|1|||
129840326|NCT03064126|467380772|FG002|Overall Study|Adverse Event|0|||
129840327|NCT03064126|467380773|FG003|Overall Study|Adverse Event|0|||
129840328|NCT03064126|467380770|FG000|Overall Study|Physician Decision|3|||
129840329|NCT03064126|467380771|FG001|Overall Study|Physician Decision|0|||
129840330|NCT03064126|467380772|FG002|Overall Study|Physician Decision|0|||
129840331|NCT03064126|467380773|FG003|Overall Study|Physician Decision|0|||
129840332|NCT03064126|467380770|FG000|Overall Study|Other reason for early termination|3|||
129840333|NCT03064126|467380771|FG001|Overall Study|Other reason for early termination|2|||
129840334|NCT03064126|467380772|FG002|Overall Study|Other reason for early termination|0|||
129840335|NCT03064126|467380773|FG003|Overall Study|Other reason for early termination|0|||
129840336|NCT03064126|467380770|FG000|Overall Study|Missed Visit|3|||
129840337|NCT03064126|467380771|FG001|Overall Study|Missed Visit|1|||
129840338|NCT03064126|467380772|FG002|Overall Study|Missed Visit|0|||
129840339|NCT03064126|467380773|FG003|Overall Study|Missed Visit|0|||
129840340|NCT02465528|467380774|FG000|Overall Study|Progressive disease|0|||
129840341|NCT02465528|467380775|FG001|Overall Study|Progressive disease|2|||
129840342|NCT02465528|467380776|FG002|Overall Study|Progressive disease|9|||
129840343|NCT02465528|467380777|FG003|Overall Study|Progressive disease|4|||
129840344|NCT02465528|467380774|FG000|Overall Study|Study terminated by sponsor|1|||
129840345|NCT02465528|467380775|FG001|Overall Study|Study terminated by sponsor|2|||
129840346|NCT02465528|467380776|FG002|Overall Study|Study terminated by sponsor|0|||
129840347|NCT02465528|467380777|FG003|Overall Study|Study terminated by sponsor|0|||
129840348|NCT02465528|467380774|FG000|Overall Study|Withdrawal by Subject|0|||
129840349|NCT02465528|467380775|FG001|Overall Study|Withdrawal by Subject|0|||
129840350|NCT02465528|467380776|FG002|Overall Study|Withdrawal by Subject|2|||
129840351|NCT02465528|467380777|FG003|Overall Study|Withdrawal by Subject|0|||
129840352|NCT02465528|467380774|FG000|Overall Study|Adverse Event|0|||
129840353|NCT02465528|467380775|FG001|Overall Study|Adverse Event|0|||
129840354|NCT02465528|467380776|FG002|Overall Study|Adverse Event|0|||
129840355|NCT02465528|467380777|FG003|Overall Study|Adverse Event|1|||
129840356|NCT02465528|467380774|FG000|Overall Study|Physician Decision|0|||
129840357|NCT02465528|467380775|FG001|Overall Study|Physician Decision|0|||
129840358|NCT02465528|467380776|FG002|Overall Study|Physician Decision|1|||
129840359|NCT02465528|467380777|FG003|Overall Study|Physician Decision|0|||
129840360|NCT00846742|467380780|FG000|Overall Study|Withdrawal by Subject|1|||
129840361|NCT03795610|467380782|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
129840362|NCT03795610|467380782|FG000|Overall Study|Withdrawal by Subject|1|||
129840363|NCT03795610|467380782|FG000|Overall Study|Screen Failure (Unknown)|1|||
129840364|NCT03909165|467380787|FG000|Overall Study|Physician Decision|0|||
129840365|NCT03909165|467380788|FG001|Overall Study|Physician Decision|1|||
129840366|NCT03909165|467380789|FG002|Overall Study|Physician Decision|0|||
129840367|NCT03909165|467380790|FG003|Overall Study|Physician Decision|0|||
129840368|NCT03909165|467380791|FG004|Overall Study|Physician Decision|0|||
129840369|NCT03909165|467380787|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129840370|NCT03909165|467380788|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129840371|NCT03909165|467380789|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130063588|NCT00819585|468186323|FG005|Extension Study|Subject Withdrew Consent|0|||
130063589|NCT00819585|468186324|FG006|Extension Study|Subject Withdrew Consent|0|||
130063590|NCT00819585|468186325|FG007|Extension Study|Subject Withdrew Consent|0|||
129840372|NCT03909165|467380790|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130063591|NCT00819585|468186326|FG008|Extension Study|Subject Withdrew Consent|3|||
129840373|NCT03909165|467380791|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129840374|NCT03909165|467380787|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129840375|NCT03909165|467380788|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
129840376|NCT03909165|467380789|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
129840377|NCT03909165|467380790|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
129840378|NCT03909165|467380791|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
129840379|NCT03909165|467380787|FG000|Overall Study|Previous Drug Exposure|0|||
129840380|NCT03909165|467380788|FG001|Overall Study|Previous Drug Exposure|0|||
129840381|NCT03909165|467380789|FG002|Overall Study|Previous Drug Exposure|1|||
129840382|NCT03909165|467380790|FG003|Overall Study|Previous Drug Exposure|0|||
129840383|NCT03909165|467380791|FG004|Overall Study|Previous Drug Exposure|0|||
129840384|NCT03909165|467380787|FG000|Overall Study|Early Discharge|1|||
129840385|NCT03909165|467380788|FG001|Overall Study|Early Discharge|0|||
129840386|NCT03909165|467380789|FG002|Overall Study|Early Discharge|0|||
129840387|NCT03909165|467380790|FG003|Overall Study|Early Discharge|0|||
129840388|NCT03909165|467380791|FG004|Overall Study|Early Discharge|0|||
129840389|NCT01533246|467380793|FG000|Overall Study|Adverse Event|1|||
129840390|NCT01533246|467380793|FG000|Overall Study|Withdrawal by Subject|1|||
129840391|NCT03491150|467380794|FG000|Overall Study|Adverse Event|1|||
129840392|NCT03491150|467380795|FG001|Overall Study|Adverse Event|0|||
129840393|NCT03491150|467380794|FG000|Overall Study|Study Terminated by Sponsor|74|||
129840394|NCT03491150|467380795|FG001|Overall Study|Study Terminated by Sponsor|70|||
129840395|NCT03491150|467380794|FG000|Overall Study|Other|0|||
129840396|NCT03491150|467380795|FG001|Overall Study|Other|1|||
129840397|NCT03491150|467380794|FG000|Overall Study|Withdrawal by Subject|1|||
129840398|NCT03491150|467380795|FG001|Overall Study|Withdrawal by Subject|2|||
129840399|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
129840400|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840401|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840402|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840403|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840404|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840405|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840406|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
129840407|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840408|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840409|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840410|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840411|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840412|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840413|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
129840414|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840415|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840416|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840417|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840418|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840419|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840420|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
129840421|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840422|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840423|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840424|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840425|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840426|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840427|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
129840428|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840429|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840430|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840431|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840432|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840433|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840434|NCT01479621|467380796|FG000|Treatment Period|Adverse Event|0|||
129840435|NCT01479621|467380797|FG001|Treatment Period|Adverse Event|0|||
129840436|NCT01479621|467380798|FG002|Treatment Period|Adverse Event|0|||
129840437|NCT01479621|467380799|FG003|Treatment Period|Adverse Event|0|||
129840438|NCT01479621|467380800|FG004|Treatment Period|Adverse Event|1|||
129840439|NCT01479621|467380801|FG005|Treatment Period|Adverse Event|2|||
129840440|NCT01479621|467380802|FG006|Treatment Period|Adverse Event|2|||
129840441|NCT01479621|467380796|FG000|Treatment Period|Withdrawal by Subject|0|||
129899349|NCT02299635|467591826|FG000|Overall Study|Other|3|||
129899350|NCT01456936|467591830|FG000|Overall Study|Other reason|41|||
129899351|NCT01456936|467591831|FG001|Overall Study|Other reason|30|||
129899352|NCT01456936|467591832|FG002|Overall Study|Other reason|36|||
129899353|NCT01456936|467591833|FG003|Overall Study|Other reason|33|||
129899354|NCT01456936|467591830|FG000|Overall Study|No longer meets eligibility criteria|4|||
129899355|NCT01456936|467591831|FG001|Overall Study|No longer meets eligibility criteria|8|||
129899356|NCT01456936|467591832|FG002|Overall Study|No longer meets eligibility criteria|6|||
129899357|NCT01456936|467591833|FG003|Overall Study|No longer meets eligibility criteria|5|||
129899358|NCT01456936|467591830|FG000|Overall Study|Protocol Violation|4|||
129899359|NCT01456936|467591831|FG001|Overall Study|Protocol Violation|2|||
129899360|NCT01456936|467591832|FG002|Overall Study|Protocol Violation|5|||
129899361|NCT01456936|467591833|FG003|Overall Study|Protocol Violation|5|||
129899362|NCT01456936|467591830|FG000|Overall Study|Pregnancy|1|||
129899363|NCT01456936|467591831|FG001|Overall Study|Pregnancy|0|||
129899364|NCT01456936|467591832|FG002|Overall Study|Pregnancy|0|||
129899365|NCT01456936|467591833|FG003|Overall Study|Pregnancy|1|||
129899366|NCT01456936|467591830|FG000|Overall Study|Insufficient clinical response|4|||
129899367|NCT01456936|467591831|FG001|Overall Study|Insufficient clinical response|4|||
129899368|NCT01456936|467591832|FG002|Overall Study|Insufficient clinical response|14|||
129899369|NCT01456936|467591833|FG003|Overall Study|Insufficient clinical response|13|||
129899370|NCT01456936|467591830|FG000|Overall Study|No longer willing to participate|195|||
129899371|NCT01456936|467591831|FG001|Overall Study|No longer willing to participate|218|||
129899372|NCT01456936|467591832|FG002|Overall Study|No longer willing to participate|224|||
129899373|NCT01456936|467591833|FG003|Overall Study|No longer willing to participate|248|||
129899374|NCT01456936|467591830|FG000|Overall Study|Lost to Follow-up|135|||
129899375|NCT01456936|467591831|FG001|Overall Study|Lost to Follow-up|126|||
129899376|NCT01456936|467591832|FG002|Overall Study|Lost to Follow-up|144|||
129899377|NCT01456936|467591833|FG003|Overall Study|Lost to Follow-up|127|||
129899378|NCT01456936|467591830|FG000|Overall Study|Medication error|0|||
129899379|NCT01456936|467591831|FG001|Overall Study|Medication error|1|||
129899380|NCT01456936|467591832|FG002|Overall Study|Medication error|0|||
129899381|NCT01456936|467591833|FG003|Overall Study|Medication error|1|||
129899382|NCT01456936|467591830|FG000|Overall Study|Adverse event (study drug)|25|||
129899383|NCT01456936|467591831|FG001|Overall Study|Adverse event (study drug)|21|||
129899384|NCT01456936|467591832|FG002|Overall Study|Adverse event (study drug)|26|||
129899385|NCT01456936|467591833|FG003|Overall Study|Adverse event (study drug)|17|||
129899386|NCT01456936|467591830|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
129899387|NCT01456936|467591831|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
129899388|NCT01456936|467591832|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
129899389|NCT01456936|467591833|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
129899390|NCT01456936|467591830|FG000|Overall Study|Death|0|||
129899391|NCT01456936|467591831|FG001|Overall Study|Death|3|||
129899392|NCT01456936|467591832|FG002|Overall Study|Death|1|||
129899393|NCT01456936|467591833|FG003|Overall Study|Death|3|||
129899394|NCT01456936|467591830|FG000|Overall Study|Randomized but not treated|21|||
129899395|NCT01456936|467591831|FG001|Overall Study|Randomized but not treated|28|||
129899396|NCT01456936|467591832|FG002|Overall Study|Randomized but not treated|16|||
129899397|NCT01456936|467591833|FG003|Overall Study|Randomized but not treated|21|||
129899398|NCT01710514|467591834|FG000|Overall Study|Adverse Event|6|||
129899399|NCT01710514|467591835|FG001|Overall Study|Adverse Event|7|||
129899400|NCT01710514|467591834|FG000|Overall Study|Withdrawal by Subject|1|||
129899401|NCT01710514|467591835|FG001|Overall Study|Withdrawal by Subject|0|||
129899402|NCT02750709|467591839|FG000|Treatment Period 1|Adverse Event|0|||
129899403|NCT02750709|467591840|FG001|Treatment Period 1|Adverse Event|0|||
129899404|NCT02750709|467591841|FG002|Treatment Period 1|Adverse Event|0|||
129899405|NCT02750709|467591842|FG003|Treatment Period 1|Adverse Event|0|||
129899406|NCT02750709|467591843|FG004|Treatment Period 1|Adverse Event|0|||
130115174|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
130115175|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
130115176|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
129899407|NCT02750709|467591844|FG005|Treatment Period 1|Adverse Event|1|||
129899408|NCT02595398|467591846|FG000|Overall Study|Non-compliance|1|||
129899409|NCT02595398|467591847|FG001|Overall Study|Non-compliance|0|||
129899410|NCT02595398|467591846|FG000|Overall Study|Withdrawal by Subject|2|||
129899411|NCT02595398|467591847|FG001|Overall Study|Withdrawal by Subject|1|||
129899412|NCT02595398|467591846|FG000|Overall Study|Lost to Follow-up|1|||
129899413|NCT02595398|467591847|FG001|Overall Study|Lost to Follow-up|0|||
129899414|NCT00197015|467591848|FG000|Overall Study|Adverse Event|3|||
129899415|NCT00197015|467591849|FG001|Overall Study|Adverse Event|0|||
129899416|NCT00197015|467591850|FG002|Overall Study|Adverse Event|1|||
129899417|NCT00197015|467591848|FG000|Overall Study|Protocol Violation|0|||
129899418|NCT00197015|467591849|FG001|Overall Study|Protocol Violation|3|||
129899419|NCT00197015|467591850|FG002|Overall Study|Protocol Violation|3|||
129899420|NCT00197015|467591848|FG000|Overall Study|Withdrawal by Subject|17|||
129899421|NCT00197015|467591849|FG001|Overall Study|Withdrawal by Subject|37|||
130115177|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
129840442|NCT01479621|467380797|FG001|Treatment Period|Withdrawal by Subject|4|||
129840443|NCT01479621|467380798|FG002|Treatment Period|Withdrawal by Subject|2|||
129840444|NCT01479621|467380799|FG003|Treatment Period|Withdrawal by Subject|2|||
129840445|NCT01479621|467380800|FG004|Treatment Period|Withdrawal by Subject|5|||
129840446|NCT01479621|467380801|FG005|Treatment Period|Withdrawal by Subject|5|||
129840447|NCT01479621|467380802|FG006|Treatment Period|Withdrawal by Subject|1|||
129840448|NCT01479621|467380796|FG000|Treatment Period|Physician Decision|0|||
129840449|NCT01479621|467380797|FG001|Treatment Period|Physician Decision|0|||
129840450|NCT01479621|467380798|FG002|Treatment Period|Physician Decision|0|||
129840451|NCT01479621|467380799|FG003|Treatment Period|Physician Decision|0|||
129840452|NCT01479621|467380800|FG004|Treatment Period|Physician Decision|1|||
129840453|NCT01479621|467380801|FG005|Treatment Period|Physician Decision|1|||
129840454|NCT01479621|467380802|FG006|Treatment Period|Physician Decision|0|||
129840455|NCT01479621|467380796|FG000|Treatment Period|Non-compliance to study drug|0|||
129840456|NCT01479621|467380797|FG001|Treatment Period|Non-compliance to study drug|1|||
129840457|NCT01479621|467380798|FG002|Treatment Period|Non-compliance to study drug|0|||
129840458|NCT01479621|467380799|FG003|Treatment Period|Non-compliance to study drug|0|||
129840459|NCT01479621|467380800|FG004|Treatment Period|Non-compliance to study drug|0|||
129840460|NCT01479621|467380801|FG005|Treatment Period|Non-compliance to study drug|0|||
129840461|NCT01479621|467380802|FG006|Treatment Period|Non-compliance to study drug|1|||
129840462|NCT01479621|467380796|FG000|Treatment Period|Protocol Violation|0|||
129840463|NCT01479621|467380797|FG001|Treatment Period|Protocol Violation|9|||
129840464|NCT01479621|467380798|FG002|Treatment Period|Protocol Violation|6|||
129840465|NCT01479621|467380799|FG003|Treatment Period|Protocol Violation|5|||
129840466|NCT01479621|467380800|FG004|Treatment Period|Protocol Violation|2|||
129840467|NCT01479621|467380801|FG005|Treatment Period|Protocol Violation|10|||
129840468|NCT01479621|467380802|FG006|Treatment Period|Protocol Violation|6|||
129840469|NCT01479621|467380796|FG000|Treatment Period|Pregnancy|0|||
129840470|NCT01479621|467380797|FG001|Treatment Period|Pregnancy|0|||
129840471|NCT01479621|467380798|FG002|Treatment Period|Pregnancy|2|||
129840472|NCT01479621|467380799|FG003|Treatment Period|Pregnancy|0|||
129840473|NCT01479621|467380800|FG004|Treatment Period|Pregnancy|0|||
129840474|NCT01479621|467380801|FG005|Treatment Period|Pregnancy|0|||
129840475|NCT01479621|467380802|FG006|Treatment Period|Pregnancy|0|||
129840476|NCT01479621|467380796|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
129840477|NCT01479621|467380797|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
129840478|NCT01479621|467380798|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
129840479|NCT01479621|467380799|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
129840480|NCT01479621|467380800|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
129840481|NCT01479621|467380801|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
129840482|NCT01479621|467380802|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
129840483|NCT01479621|467380796|FG000|Treatment Period|Lost to Follow-up|0|||
129840484|NCT01479621|467380797|FG001|Treatment Period|Lost to Follow-up|0|||
129840485|NCT01479621|467380798|FG002|Treatment Period|Lost to Follow-up|1|||
129840486|NCT01479621|467380799|FG003|Treatment Period|Lost to Follow-up|0|||
130063592|NCT00819585|468186327|FG009|Extension Study|Subject Withdrew Consent|0|||
130063593|NCT00819585|468186328|FG010|Extension Study|Subject Withdrew Consent|1|||
130063594|NCT00819585|468186318|FG000|Extension Study|Lost to Follow-up|0|||
130063595|NCT00819585|468186319|FG001|Extension Study|Lost to Follow-up|0|||
130063596|NCT00819585|468186320|FG002|Extension Study|Lost to Follow-up|0|||
130063597|NCT00819585|468186321|FG003|Extension Study|Lost to Follow-up|0|||
130063598|NCT00819585|468186322|FG004|Extension Study|Lost to Follow-up|0|||
130063599|NCT00819585|468186323|FG005|Extension Study|Lost to Follow-up|0|||
130063600|NCT00819585|468186324|FG006|Extension Study|Lost to Follow-up|0|||
130063601|NCT00819585|468186325|FG007|Extension Study|Lost to Follow-up|0|||
130063602|NCT00819585|468186326|FG008|Extension Study|Lost to Follow-up|2|||
130063603|NCT00819585|468186327|FG009|Extension Study|Lost to Follow-up|1|||
130063604|NCT00819585|468186328|FG010|Extension Study|Lost to Follow-up|1|||
130063605|NCT00819585|468186318|FG000|Extension Study|Death|0|||
130063606|NCT00819585|468186319|FG001|Extension Study|Death|0|||
130063607|NCT00819585|468186320|FG002|Extension Study|Death|0|||
130063608|NCT00819585|468186321|FG003|Extension Study|Death|0|||
130063609|NCT00819585|468186322|FG004|Extension Study|Death|0|||
130063610|NCT00819585|468186323|FG005|Extension Study|Death|0|||
130063611|NCT00819585|468186324|FG006|Extension Study|Death|0|||
130063612|NCT00819585|468186325|FG007|Extension Study|Death|0|||
130063613|NCT00819585|468186326|FG008|Extension Study|Death|2|||
130063614|NCT00819585|468186327|FG009|Extension Study|Death|0|||
130063615|NCT00819585|468186328|FG010|Extension Study|Death|0|||
130063616|NCT00738374|468186329|FG000|Induction Treatment Phase|Adverse Event|14|||
130063617|NCT00738374|468186330|FG001|Induction Treatment Phase|Adverse Event|0|||
130063618|NCT00738374|468186331|FG002|Induction Treatment Phase|Adverse Event|0|||
130063619|NCT00738374|468186332|FG003|Induction Treatment Phase|Adverse Event|0|||
130063620|NCT00738374|468186329|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
130063621|NCT00738374|468186330|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
130063622|NCT00738374|468186331|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
129840487|NCT01479621|467380800|FG004|Treatment Period|Lost to Follow-up|2|||
129840488|NCT01479621|467380801|FG005|Treatment Period|Lost to Follow-up|2|||
129840489|NCT01479621|467380802|FG006|Treatment Period|Lost to Follow-up|1|||
129840490|NCT01479621|467380796|FG000|Treatment Period|Met stopping criteria|0|||
129840491|NCT01479621|467380797|FG001|Treatment Period|Met stopping criteria|8|||
129840492|NCT01479621|467380798|FG002|Treatment Period|Met stopping criteria|7|||
129840493|NCT01479621|467380799|FG003|Treatment Period|Met stopping criteria|4|||
129840494|NCT01479621|467380800|FG004|Treatment Period|Met stopping criteria|9|||
129840495|NCT01479621|467380801|FG005|Treatment Period|Met stopping criteria|20|||
129840496|NCT01479621|467380802|FG006|Treatment Period|Met stopping criteria|6|||
129840497|NCT00677807|467380816|FG000|Overall Study|Adverse Event|4|||
129840498|NCT00677807|467380817|FG001|Overall Study|Adverse Event|1|||
129840499|NCT00677807|467380818|FG002|Overall Study|Adverse Event|6|||
129840500|NCT00677807|467380816|FG000|Overall Study|Lack of Efficacy|0|||
129840501|NCT00677807|467380817|FG001|Overall Study|Lack of Efficacy|0|||
129840502|NCT00677807|467380818|FG002|Overall Study|Lack of Efficacy|2|||
129840503|NCT00677807|467380816|FG000|Overall Study|Participant no longer needs study drug|0|||
129840504|NCT00677807|467380817|FG001|Overall Study|Participant no longer needs study drug|0|||
129840505|NCT00677807|467380818|FG002|Overall Study|Participant no longer needs study drug|1|||
129840506|NCT00677807|467380816|FG000|Overall Study|Withdrawal by Subject|10|||
129840507|NCT00677807|467380817|FG001|Overall Study|Withdrawal by Subject|3|||
129840508|NCT00677807|467380818|FG002|Overall Study|Withdrawal by Subject|6|||
129840509|NCT00677807|467380816|FG000|Overall Study|Lost to Follow-up|2|||
129840510|NCT00677807|467380817|FG001|Overall Study|Lost to Follow-up|2|||
129840511|NCT00677807|467380818|FG002|Overall Study|Lost to Follow-up|2|||
129840512|NCT00677807|467380816|FG000|Overall Study|Administrative problems|1|||
129840513|NCT00677807|467380817|FG001|Overall Study|Administrative problems|1|||
129840514|NCT00677807|467380818|FG002|Overall Study|Administrative problems|2|||
129840515|NCT00677807|467380816|FG000|Overall Study|Death|0|||
129840516|NCT00677807|467380817|FG001|Overall Study|Death|1|||
129840517|NCT00677807|467380818|FG002|Overall Study|Death|1|||
129840518|NCT00677807|467380816|FG000|Overall Study|Protocol Deviation|1|||
129840519|NCT00677807|467380817|FG001|Overall Study|Protocol Deviation|3|||
129840520|NCT00677807|467380818|FG002|Overall Study|Protocol Deviation|0|||
129840521|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
129840522|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
129840523|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
129840524|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129840525|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129840526|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129840527|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840528|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840529|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
129840530|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840531|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840532|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840533|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
129840534|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
129840535|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
129840536|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129840537|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129840538|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129840539|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840540|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840541|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
129840542|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840543|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840544|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840545|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129840546|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129840547|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129840548|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
129840549|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
129840550|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
129840551|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840552|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840553|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
130063623|NCT00738374|468186332|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
130063624|NCT00738374|468186329|FG000|Induction Treatment Phase|Physician Decision|2|||
129899422|NCT00197015|467591850|FG002|Overall Study|Withdrawal by Subject|34|||
129899423|NCT00197015|467591848|FG000|Overall Study|Lost to Follow-up|28|||
129899424|NCT00197015|467591849|FG001|Overall Study|Lost to Follow-up|46|||
130063625|NCT00738374|468186330|FG001|Induction Treatment Phase|Physician Decision|0|||
129840554|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
129840555|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840556|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840557|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840558|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840559|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840560|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840561|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
129840562|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840563|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129840564|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129840565|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129840566|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
129840567|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
129840568|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
129840569|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840570|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840571|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840572|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840573|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
129840574|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
129840575|NCT03925727|467380825|FG000|Overall Study|Adverse Event|4|||
129840576|NCT03925727|467380826|FG001|Overall Study|Adverse Event|0|||
129840577|NCT03925727|467380827|FG002|Overall Study|Adverse Event|3|||
129840578|NCT03925727|467380825|FG000|Overall Study|Protocol Violation|1|||
129840579|NCT03925727|467380826|FG001|Overall Study|Protocol Violation|2|||
129840580|NCT03925727|467380827|FG002|Overall Study|Protocol Violation|2|||
129840581|NCT03925727|467380825|FG000|Overall Study|Withdrawal by Subject|3|||
129840582|NCT03925727|467380826|FG001|Overall Study|Withdrawal by Subject|2|||
129840583|NCT03925727|467380827|FG002|Overall Study|Withdrawal by Subject|4|||
129840584|NCT03925727|467380825|FG000|Overall Study|Administrative Reasons|3|||
129840585|NCT03925727|467380826|FG001|Overall Study|Administrative Reasons|1|||
129840586|NCT03925727|467380827|FG002|Overall Study|Administrative Reasons|2|||
129840587|NCT03925727|467380825|FG000|Overall Study|Randomized in error or Disqualified|8|||
129840588|NCT03925727|467380826|FG001|Overall Study|Randomized in error or Disqualified|1|||
129840589|NCT03925727|467380827|FG002|Overall Study|Randomized in error or Disqualified|7|||
129840590|NCT01393743|467380828|FG000|Core Study|Adverse Event|5|||
129840591|NCT01393743|467380829|FG001|Core Study|Adverse Event|9|||
129840592|NCT01393743|467380830|FG002|Core Study|Adverse Event|0|||
129840593|NCT01393743|467380828|FG000|Core Study|Lost to Follow-up|1|||
129840594|NCT01393743|467380829|FG001|Core Study|Lost to Follow-up|1|||
129840595|NCT01393743|467380830|FG002|Core Study|Lost to Follow-up|0|||
129840596|NCT01393743|467380828|FG000|Core Study|Participant's Choice|2|||
129840597|NCT01393743|467380829|FG001|Core Study|Participant's Choice|3|||
129840598|NCT01393743|467380830|FG002|Core Study|Participant's Choice|0|||
129840599|NCT01393743|467380828|FG000|Core Study|Inadequate therapeutic effect|2|||
129840600|NCT01393743|467380829|FG001|Core Study|Inadequate therapeutic effect|0|||
129840601|NCT01393743|467380830|FG002|Core Study|Inadequate therapeutic effect|0|||
129840602|NCT01393743|467380828|FG000|Extension Phase|Adverse Event|0|||
129840603|NCT01393743|467380829|FG001|Extension Phase|Adverse Event|0|||
129840604|NCT01393743|467380830|FG002|Extension Phase|Adverse Event|12|||
129840605|NCT01393743|467380828|FG000|Extension Phase|Lost to Follow-up|0|||
129840606|NCT01393743|467380829|FG001|Extension Phase|Lost to Follow-up|0|||
129840607|NCT01393743|467380830|FG002|Extension Phase|Lost to Follow-up|2|||
129840608|NCT01393743|467380828|FG000|Extension Phase|Participant choice|0|||
129840609|NCT01393743|467380829|FG001|Extension Phase|Participant choice|0|||
129840610|NCT01393743|467380830|FG002|Extension Phase|Participant choice|16|||
129840611|NCT01393743|467380828|FG000|Extension Phase|Inadequate therapeutic effect|0|||
129840612|NCT01393743|467380829|FG001|Extension Phase|Inadequate therapeutic effect|0|||
129840613|NCT01393743|467380830|FG002|Extension Phase|Inadequate therapeutic effect|7|||
129840614|NCT01393743|467380828|FG000|Extension Phase|Withdrawal by Subject|0|||
129840615|NCT01393743|467380829|FG001|Extension Phase|Withdrawal by Subject|0|||
129840616|NCT01393743|467380830|FG002|Extension Phase|Withdrawal by Subject|8|||
129840617|NCT01393743|467380828|FG000|Extension Phase|Pregnancy|0|||
129840618|NCT01393743|467380829|FG001|Extension Phase|Pregnancy|0|||
129840619|NCT01393743|467380830|FG002|Extension Phase|Pregnancy|1|||
129840620|NCT01393743|467380828|FG000|Extension Phase|Other|0|||
129840621|NCT01393743|467380829|FG001|Extension Phase|Other|0|||
129840622|NCT01393743|467380830|FG002|Extension Phase|Other|14|||
129899425|NCT00197015|467591850|FG002|Overall Study|Lost to Follow-up|37|||
129899426|NCT00197015|467591848|FG000|Overall Study|Other|2|||
129840623|NCT00314366|467380831|FG000|Overall Study|not treated due to patient medical condi|1|||
129840624|NCT00314366|467380832|FG001|Overall Study|not treated due to patient medical condi|0|||
129840625|NCT02321462|467380836|FG000|Overall Study|Withdrawal by Subject|5|||
129840626|NCT02321462|467380837|FG001|Overall Study|Withdrawal by Subject|2|||
129840627|NCT02321462|467380836|FG000|Overall Study|Subject withdrawn before any treatment|1|||
129840628|NCT02321462|467380837|FG001|Overall Study|Subject withdrawn before any treatment|1|||
129840629|NCT01574352|467380850|FG000|Overall Study|Withdrawal by Subject|6|||
129840630|NCT01574352|467380851|FG001|Overall Study|Withdrawal by Subject|13|||
129840631|NCT01574352|467380850|FG000|Overall Study|Injury in non-camp related sport|1|||
129840632|NCT01574352|467380851|FG001|Overall Study|Injury in non-camp related sport|0|||
129840633|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
129840634|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
129840635|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
129840636|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
129840637|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
129840638|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
129840639|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
129840640|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
129840641|NCT02283788|467380858|FG000|Overall Study|Adverse Event|1|||
129840642|NCT02283788|467380859|FG001|Overall Study|Adverse Event|3|||
129840643|NCT02283788|467380860|FG002|Overall Study|Adverse Event|5|||
129840644|NCT02283788|467380861|FG003|Overall Study|Adverse Event|1|||
129840645|NCT02283788|467380858|FG000|Overall Study|Withdrawal by Subject|0|||
129840646|NCT02283788|467380859|FG001|Overall Study|Withdrawal by Subject|1|||
129840647|NCT02283788|467380860|FG002|Overall Study|Withdrawal by Subject|0|||
129840648|NCT02283788|467380861|FG003|Overall Study|Withdrawal by Subject|1|||
129840649|NCT01083433|467382680|FG000|Overall Study|Lost to Follow-up|2|||
129840650|NCT01083433|467382681|FG001|Overall Study|Lost to Follow-up|1|||
129840651|NCT01083433|467382682|FG002|Overall Study|Lost to Follow-up|1|||
129840652|NCT01083433|467382680|FG000|Overall Study|Withdrawal by Subject|0|||
129840653|NCT01083433|467382681|FG001|Overall Study|Withdrawal by Subject|5|||
129840654|NCT01083433|467382682|FG002|Overall Study|Withdrawal by Subject|3|||
129840655|NCT01083433|467382680|FG000|Overall Study|Pregnancy|0|||
129840656|NCT01083433|467382681|FG001|Overall Study|Pregnancy|0|||
129840657|NCT01083433|467382682|FG002|Overall Study|Pregnancy|1|||
129840658|NCT04982029|467382683|FG000|Overall Study|Lost to Follow-up|2|||
129840659|NCT04982029|467382684|FG001|Overall Study|Lost to Follow-up|3|||
129840660|NCT05458856|467382685|FG000|Overall Study|Withdrawal by Subject|5|||
129840661|NCT05458856|467382685|FG000|Overall Study|Death|4|||
129840662|NCT05458856|467382685|FG000|Overall Study|Protocol Deviation|3|||
129840663|NCT05458856|467382685|FG000|Overall Study|Physician Decision|1|||
129840664|NCT05168475|467382686|FG000|Period 1|Protocol Violation|1|||
129840665|NCT05168475|467382686|FG000|Period 1|IMP shortage|2|||
129840666|NCT05168475|467382686|FG000|Period 1|Not randomised|2|||
129840667|NCT05168475|467382686|FG000|Period 2|IMP shortage|1|||
129840668|NCT01589822|467382687|FG000|Overall Study|Withdrawal by Subject|1|||
129840669|NCT01589822|467382688|FG001|Overall Study|Withdrawal by Subject|2|||
129840670|NCT01589822|467382689|FG002|Overall Study|Withdrawal by Subject|0|||
129840671|NCT01589822|467382687|FG000|Overall Study|Death|1|||
129840672|NCT01589822|467382688|FG001|Overall Study|Death|0|||
129840673|NCT01589822|467382689|FG002|Overall Study|Death|0|||
129840674|NCT01589822|467382687|FG000|Overall Study|Missed 90 day visit|2|||
129840675|NCT01589822|467382688|FG001|Overall Study|Missed 90 day visit|1|||
129840676|NCT01589822|467382689|FG002|Overall Study|Missed 90 day visit|1|||
129840677|NCT01140477|467382690|FG000|Overall Study|Lost to Follow-up|4|||
129840678|NCT01140477|467382691|FG001|Overall Study|Lost to Follow-up|0|||
129840679|NCT01140477|467382690|FG000|Overall Study|Withdrawal by Subject|1|||
129840680|NCT01140477|467382691|FG001|Overall Study|Withdrawal by Subject|4|||
129840681|NCT01140477|467382690|FG000|Overall Study|Surgical complication preventing implant|2|||
129840682|NCT01140477|467382691|FG001|Overall Study|Surgical complication preventing implant|0|||
129840683|NCT01140477|467382690|FG000|Overall Study|Death|1|||
129840684|NCT01140477|467382691|FG001|Overall Study|Death|1|||
129840685|NCT01140477|467382690|FG000|Overall Study|Subject explanted|0|||
129840686|NCT01140477|467382691|FG001|Overall Study|Subject explanted|1|||
129840687|NCT00773175|467382692|FG000|Overall Study|Adverse Event|2|||
129840688|NCT00773175|467382693|FG001|Overall Study|Adverse Event|0|||
129840689|NCT00773175|467382692|FG000|Overall Study|Consent Withdrawn|0|||
129840690|NCT00773175|467382693|FG001|Overall Study|Consent Withdrawn|2|||
129840691|NCT01904604|467382700|FG000|Overall Study|Withdrew before receiving dosing|0|||
129840692|NCT01904604|467382701|FG001|Overall Study|Withdrew before receiving dosing|1|||
129840693|NCT01904604|467382702|FG002|Overall Study|Withdrew before receiving dosing|0|||
129840694|NCT01904604|467382700|FG000|Overall Study|Non-compliance|1|||
129840695|NCT01904604|467382701|FG001|Overall Study|Non-compliance|0|||
129840696|NCT01904604|467382702|FG002|Overall Study|Non-compliance|0|||
129840697|NCT01904604|467382700|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
129840698|NCT01904604|467382701|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
129899427|NCT00197015|467591849|FG001|Overall Study|Other|3|||
129840699|NCT01904604|467382702|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
129840700|NCT01904604|467382700|FG000|Overall Study|Patch site reactions|1|||
129840701|NCT01904604|467382701|FG001|Overall Study|Patch site reactions|1|||
129840702|NCT01904604|467382702|FG002|Overall Study|Patch site reactions|0|||
129840703|NCT01904604|467382700|FG000|Overall Study|Increased syncope|0|||
129840704|NCT01904604|467382701|FG001|Overall Study|Increased syncope|1|||
129840705|NCT01904604|467382702|FG002|Overall Study|Increased syncope|0|||
130063626|NCT00738374|468186331|FG002|Induction Treatment Phase|Physician Decision|0|||
130063627|NCT00738374|468186332|FG003|Induction Treatment Phase|Physician Decision|0|||
130063628|NCT00738374|468186329|FG000|Induction Treatment Phase|Protocol Violation|2|||
130063629|NCT00738374|468186330|FG001|Induction Treatment Phase|Protocol Violation|0|||
130063630|NCT00738374|468186331|FG002|Induction Treatment Phase|Protocol Violation|0|||
130063631|NCT00738374|468186332|FG003|Induction Treatment Phase|Protocol Violation|0|||
130063632|NCT00738374|468186329|FG000|Induction Treatment Phase|Non-compliance|1|||
130063633|NCT00738374|468186330|FG001|Induction Treatment Phase|Non-compliance|0|||
130063634|NCT00738374|468186331|FG002|Induction Treatment Phase|Non-compliance|0|||
130063635|NCT00738374|468186332|FG003|Induction Treatment Phase|Non-compliance|0|||
130063636|NCT00738374|468186329|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
130063637|NCT00738374|468186330|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
130063638|NCT00738374|468186331|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
130063639|NCT00738374|468186332|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
130063640|NCT00738374|468186329|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
130063641|NCT00738374|468186330|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
130063642|NCT00738374|468186331|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
130063643|NCT00738374|468186332|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
130063644|NCT00738374|468186329|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
130063645|NCT00738374|468186330|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
130063646|NCT00738374|468186331|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
130063647|NCT00738374|468186332|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
130063648|NCT00738374|468186329|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
130063649|NCT00738374|468186330|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
130063650|NCT00738374|468186331|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
130063651|NCT00738374|468186332|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
130063652|NCT00738374|468186329|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
130063653|NCT00738374|468186330|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
130063654|NCT00738374|468186331|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
130063655|NCT00738374|468186332|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
130063656|NCT00738374|468186329|FG000|Maintenance Treatment/Observation Phase|Other|0|||
130063657|NCT00738374|468186330|FG001|Maintenance Treatment/Observation Phase|Other|1|||
130063658|NCT00738374|468186331|FG002|Maintenance Treatment/Observation Phase|Other|0|||
130063659|NCT00738374|468186332|FG003|Maintenance Treatment/Observation Phase|Other|0|||
130063660|NCT03334396|468186333|FG000|Overall Study|Adverse Event|1|||
130063661|NCT03334396|468186334|FG001|Overall Study|Adverse Event|0|||
130063662|NCT03334396|468186335|FG002|Overall Study|Adverse Event|1|||
130063663|NCT03334396|468186336|FG003|Overall Study|Adverse Event|0|||
130063664|NCT03334396|468186337|FG004|Overall Study|Adverse Event|0|||
130063665|NCT03334396|468186338|FG005|Overall Study|Adverse Event|0|||
130063666|NCT03334396|468186339|FG006|Overall Study|Adverse Event|0|||
130063667|NCT03334396|468186340|FG007|Overall Study|Adverse Event|0|||
130063668|NCT03334396|468186333|FG000|Overall Study|Lack of Efficacy|10|||
130063669|NCT03334396|468186334|FG001|Overall Study|Lack of Efficacy|4|||
130063670|NCT03334396|468186335|FG002|Overall Study|Lack of Efficacy|1|||
130063671|NCT03334396|468186336|FG003|Overall Study|Lack of Efficacy|3|||
130063672|NCT03334396|468186337|FG004|Overall Study|Lack of Efficacy|1|||
130063673|NCT03334396|468186338|FG005|Overall Study|Lack of Efficacy|0|||
130063674|NCT03334396|468186339|FG006|Overall Study|Lack of Efficacy|0|||
130063675|NCT03334396|468186340|FG007|Overall Study|Lack of Efficacy|1|||
130063676|NCT03334396|468186333|FG000|Overall Study|Lost to Follow-up|0|||
130063677|NCT03334396|468186334|FG001|Overall Study|Lost to Follow-up|0|||
130063678|NCT03334396|468186335|FG002|Overall Study|Lost to Follow-up|1|||
130063679|NCT03334396|468186336|FG003|Overall Study|Lost to Follow-up|0|||
130063680|NCT03334396|468186337|FG004|Overall Study|Lost to Follow-up|0|||
130063681|NCT03334396|468186338|FG005|Overall Study|Lost to Follow-up|0|||
130063682|NCT03334396|468186339|FG006|Overall Study|Lost to Follow-up|1|||
130063683|NCT03334396|468186340|FG007|Overall Study|Lost to Follow-up|0|||
130063684|NCT03334396|468186333|FG000|Overall Study|Physician Decision|1|||
130063685|NCT03334396|468186334|FG001|Overall Study|Physician Decision|0|||
130063686|NCT03334396|468186335|FG002|Overall Study|Physician Decision|0|||
130063687|NCT03334396|468186336|FG003|Overall Study|Physician Decision|0|||
130063688|NCT03334396|468186337|FG004|Overall Study|Physician Decision|0|||
130063689|NCT03334396|468186338|FG005|Overall Study|Physician Decision|0|||
129840706|NCT01904604|467382700|FG000|Overall Study|Unrelated illness|0|||
129840707|NCT01904604|467382701|FG001|Overall Study|Unrelated illness|1|||
130115178|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
130115179|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
130115180|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
130115181|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
130115182|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
130115183|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
130115184|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
130115185|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
130115186|NCT01227668|468381329|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
130115187|NCT01227668|468381330|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
130115188|NCT01227668|468381329|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
130115189|NCT01227668|468381330|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
130115190|NCT01227668|468381329|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
130115191|NCT01227668|468381330|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
130115192|NCT01227668|468381329|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
130115193|NCT01227668|468381330|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
130115194|NCT01227668|468381329|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
130115195|NCT01227668|468381330|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
130115196|NCT01227668|468381329|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
130115197|NCT01227668|468381330|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
130115198|NCT01709383|468381336|FG000|Overall Study|Lost to Follow-up|1|||
130115199|NCT01709383|468381337|FG001|Overall Study|Lost to Follow-up|0|||
130115200|NCT03264066|468381338|FG000|Overall Study|Adverse Event|1|||
130115201|NCT03264066|468381339|FG001|Overall Study|Adverse Event|1|||
130115202|NCT03264066|468381340|FG002|Overall Study|Adverse Event|0|||
130115203|NCT03264066|468381341|FG003|Overall Study|Adverse Event|0|||
130115204|NCT03264066|468381342|FG004|Overall Study|Adverse Event|0|||
130115205|NCT03264066|468381343|FG005|Overall Study|Adverse Event|0|||
130115206|NCT03264066|468381338|FG000|Overall Study|Death|12|||
130115207|NCT03264066|468381339|FG001|Overall Study|Death|12|||
130115208|NCT03264066|468381340|FG002|Overall Study|Death|8|||
129840708|NCT01904604|467382702|FG002|Overall Study|Unrelated illness|0|||
129840709|NCT01904604|467382700|FG000|Overall Study|Passed Week 52 OFC|1|||
129840710|NCT01904604|467382701|FG001|Overall Study|Passed Week 52 OFC|0|||
129840711|NCT01904604|467382702|FG002|Overall Study|Passed Week 52 OFC|0|||
129840712|NCT01904604|467382700|FG000|Overall Study|Withdrawal by Subject|1|||
129840713|NCT01904604|467382701|FG001|Overall Study|Withdrawal by Subject|2|||
129840714|NCT01904604|467382702|FG002|Overall Study|Withdrawal by Subject|0|||
129840715|NCT01904604|467382700|FG000|Overall Study|Participant Relocated|1|||
129840716|NCT01904604|467382701|FG001|Overall Study|Participant Relocated|1|||
129840717|NCT01904604|467382702|FG002|Overall Study|Participant Relocated|1|||
129840718|NCT01904604|467382700|FG000|Overall Study|Lost to Follow-up|0|||
129840719|NCT01904604|467382701|FG001|Overall Study|Lost to Follow-up|0|||
129840720|NCT01904604|467382702|FG002|Overall Study|Lost to Follow-up|1|||
129840721|NCT01481116|467382707|FG000|Overall Study|Adverse Event|26|||
129840722|NCT01481116|467382708|FG001|Overall Study|Adverse Event|26|||
129840723|NCT01481116|467382709|FG002|Overall Study|Adverse Event|42|||
129840724|NCT01481116|467382707|FG000|Overall Study|Major Protocol Deviation|3|||
129840725|NCT01481116|467382708|FG001|Overall Study|Major Protocol Deviation|7|||
129840726|NCT01481116|467382709|FG002|Overall Study|Major Protocol Deviation|1|||
129840727|NCT01481116|467382707|FG000|Overall Study|Lost to Follow-up|8|||
129840728|NCT01481116|467382708|FG001|Overall Study|Lost to Follow-up|12|||
129840729|NCT01481116|467382709|FG002|Overall Study|Lost to Follow-up|11|||
129840730|NCT01481116|467382707|FG000|Overall Study|Withdrawal by Subject|37|||
129840731|NCT01481116|467382708|FG001|Overall Study|Withdrawal by Subject|33|||
129840732|NCT01481116|467382709|FG002|Overall Study|Withdrawal by Subject|37|||
129840733|NCT01481116|467382707|FG000|Overall Study|Study Termination|730|||
129840734|NCT01481116|467382708|FG001|Overall Study|Study Termination|729|||
129840735|NCT01481116|467382709|FG002|Overall Study|Study Termination|713|||
129840736|NCT01481116|467382707|FG000|Overall Study|Pregnancy|0|||
129840737|NCT01481116|467382708|FG001|Overall Study|Pregnancy|0|||
129840738|NCT01481116|467382709|FG002|Overall Study|Pregnancy|1|||
129840739|NCT01481116|467382707|FG000|Overall Study|Lack of Efficacy|3|||
129840740|NCT01481116|467382708|FG001|Overall Study|Lack of Efficacy|3|||
129840741|NCT01481116|467382709|FG002|Overall Study|Lack of Efficacy|1|||
129840742|NCT01481116|467382707|FG000|Overall Study|Contraindications|1|||
129840743|NCT01481116|467382708|FG001|Overall Study|Contraindications|1|||
129840744|NCT01481116|467382709|FG002|Overall Study|Contraindications|0|||
129840745|NCT01481116|467382707|FG000|Overall Study|Other|1|||
129840746|NCT01481116|467382708|FG001|Overall Study|Other|1|||
129840747|NCT01481116|467382709|FG002|Overall Study|Other|0|||
129840748|NCT01481116|467382707|FG000|Overall Study|Participant Started Taking Glipizide|1|||
129840749|NCT01481116|467382708|FG001|Overall Study|Participant Started Taking Glipizide|0|||
129840750|NCT01481116|467382709|FG002|Overall Study|Participant Started Taking Glipizide|0|||
130115209|NCT03264066|468381341|FG003|Overall Study|Death|10|||
130115210|NCT03264066|468381342|FG004|Overall Study|Death|6|||
129899428|NCT00197015|467591850|FG002|Overall Study|Other|2|||
129899429|NCT02982213|467591853|FG000|Overall Study|Did not complete follow up questionnaire|5|||
129899430|NCT02982213|467591854|FG001|Overall Study|Did not complete follow up questionnaire|1|||
129899431|NCT01972152|467591855|FG000|First Treatment Visit|Lost to Follow-up|0|||
129899432|NCT01972152|467591856|FG001|First Treatment Visit|Lost to Follow-up|1|||
129899433|NCT01972152|467591857|FG002|First Treatment Visit|Lost to Follow-up|0|||
129899434|NCT01972152|467591858|FG003|First Treatment Visit|Lost to Follow-up|0|||
129899435|NCT01972152|467591859|FG004|First Treatment Visit|Lost to Follow-up|0|||
129899436|NCT01972152|467591860|FG005|First Treatment Visit|Lost to Follow-up|0|||
129899437|NCT01972152|467591855|FG000|Second Treatment Visit|Protocol Violation|0|||
129899438|NCT01972152|467591856|FG001|Second Treatment Visit|Protocol Violation|1|||
129899439|NCT01972152|467591857|FG002|Second Treatment Visit|Protocol Violation|0|||
129899440|NCT01972152|467591858|FG003|Second Treatment Visit|Protocol Violation|0|||
129899441|NCT01972152|467591859|FG004|Second Treatment Visit|Protocol Violation|0|||
129899442|NCT01972152|467591860|FG005|Second Treatment Visit|Protocol Violation|0|||
129899443|NCT02512042|467591861|FG000|Overall Study|Adverse Event|0|||
129899444|NCT02512042|467591862|FG001|Overall Study|Adverse Event|4|||
129899445|NCT02512042|467591861|FG000|Overall Study|Withdrawal by Subject|6|||
129899446|NCT02512042|467591862|FG001|Overall Study|Withdrawal by Subject|6|||
129899447|NCT02512042|467591861|FG000|Overall Study|Non-compliance with study drug|1|||
129899448|NCT02512042|467591862|FG001|Overall Study|Non-compliance with study drug|2|||
129899449|NCT02512042|467591861|FG000|Overall Study|Lost to Follow-up|5|||
129899450|NCT02512042|467591862|FG001|Overall Study|Lost to Follow-up|2|||
129899451|NCT02512042|467591861|FG000|Overall Study|Other|11|||
129899452|NCT02512042|467591862|FG001|Overall Study|Other|11|||
129899453|NCT01194258|467591863|FG000|Titration Period|Withdrawal by Subject|6|||
129899454|NCT01194258|467591864|FG001|Titration Period|Withdrawal by Subject|0|||
129899455|NCT01194258|467591865|FG002|Titration Period|Withdrawal by Subject|0|||
129899456|NCT01194258|467591866|FG003|Titration Period|Withdrawal by Subject|0|||
129899457|NCT01194258|467591867|FG004|Titration Period|Withdrawal by Subject|0|||
129899458|NCT01194258|467591863|FG000|Titration Period|Lost to Follow-up|2|||
129899459|NCT01194258|467591864|FG001|Titration Period|Lost to Follow-up|0|||
129899460|NCT01194258|467591865|FG002|Titration Period|Lost to Follow-up|0|||
129899461|NCT01194258|467591866|FG003|Titration Period|Lost to Follow-up|0|||
129899462|NCT01194258|467591867|FG004|Titration Period|Lost to Follow-up|0|||
129899463|NCT01194258|467591863|FG000|Titration Period|Titration failure|3|||
129899464|NCT01194258|467591864|FG001|Titration Period|Titration failure|0|||
129899465|NCT01194258|467591865|FG002|Titration Period|Titration failure|0|||
129899466|NCT01194258|467591866|FG003|Titration Period|Titration failure|0|||
129899467|NCT01194258|467591867|FG004|Titration Period|Titration failure|0|||
129899468|NCT01194258|467591863|FG000|Period 1 (12 Weeks)|Death|0|||
129899469|NCT01194258|467591864|FG001|Period 1 (12 Weeks)|Death|0|||
129899470|NCT01194258|467591865|FG002|Period 1 (12 Weeks)|Death|0|||
129899471|NCT01194258|467591866|FG003|Period 1 (12 Weeks)|Death|0|||
129899472|NCT01194258|467591867|FG004|Period 1 (12 Weeks)|Death|1|||
129899473|NCT01194258|467591863|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899474|NCT01194258|467591864|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899475|NCT01194258|467591865|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899476|NCT01194258|467591866|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899477|NCT01194258|467591867|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
129899478|NCT01194258|467591863|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
129899479|NCT01194258|467591864|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
129899480|NCT01194258|467591865|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
129899481|NCT01194258|467591866|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
129899482|NCT01194258|467591867|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
129899483|NCT01194258|467591863|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129899484|NCT01194258|467591864|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129899485|NCT01194258|467591865|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129899486|NCT01194258|467591866|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129899487|NCT01194258|467591867|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129899488|NCT01253226|467591868|FG000|Overall Study|Adverse Event|0|||
129899489|NCT01253226|467591869|FG001|Overall Study|Adverse Event|0|||
129899490|NCT01253226|467591870|FG002|Overall Study|Adverse Event|1|||
129899491|NCT01253226|467591871|FG003|Overall Study|Adverse Event|0|||
129899492|NCT01253226|467591872|FG004|Overall Study|Adverse Event|0|||
129899493|NCT01253226|467591868|FG000|Overall Study|Death|0|||
129899494|NCT01253226|467591869|FG001|Overall Study|Death|1|||
129899495|NCT01253226|467591870|FG002|Overall Study|Death|0|||
129899496|NCT01253226|467591871|FG003|Overall Study|Death|0|||
129899497|NCT01253226|467591872|FG004|Overall Study|Death|0|||
129899498|NCT01253226|467591868|FG000|Overall Study|Physician Decision|0|||
129899499|NCT01253226|467591869|FG001|Overall Study|Physician Decision|0|||
129899500|NCT01253226|467591870|FG002|Overall Study|Physician Decision|0|||
129899501|NCT01253226|467591871|FG003|Overall Study|Physician Decision|0|||
129899502|NCT01253226|467591872|FG004|Overall Study|Physician Decision|2|||
129899503|NCT01253226|467591868|FG000|Overall Study|Withdrawal by Subject|0|||
129899504|NCT01253226|467591869|FG001|Overall Study|Withdrawal by Subject|0|||
129899505|NCT01253226|467591870|FG002|Overall Study|Withdrawal by Subject|0|||
129840751|NCT01481116|467382707|FG000|Overall Study|Participant Moved Out of Area|2|||
129840752|NCT01481116|467382708|FG001|Overall Study|Participant Moved Out of Area|0|||
129840753|NCT01481116|467382709|FG002|Overall Study|Participant Moved Out of Area|1|||
129840754|NCT01481116|467382707|FG000|Overall Study|Participant Moved Out of Country|1|||
129840755|NCT01481116|467382708|FG001|Overall Study|Participant Moved Out of Country|0|||
129840756|NCT01481116|467382709|FG002|Overall Study|Participant Moved Out of Country|1|||
129840757|NCT01481116|467382707|FG000|Overall Study|Investigator Decision|3|||
129840758|NCT01481116|467382708|FG001|Overall Study|Investigator Decision|2|||
129840759|NCT01481116|467382709|FG002|Overall Study|Investigator Decision|1|||
129840760|NCT01481116|467382707|FG000|Overall Study|Sponsor Decision|0|||
129840761|NCT01481116|467382708|FG001|Overall Study|Sponsor Decision|1|||
129840762|NCT01481116|467382709|FG002|Overall Study|Sponsor Decision|3|||
129840763|NCT01481116|467382707|FG000|Overall Study|Non-Compliant With Study Drug|0|||
129840764|NCT01481116|467382708|FG001|Overall Study|Non-Compliant With Study Drug|1|||
129840765|NCT01481116|467382709|FG002|Overall Study|Non-Compliant With Study Drug|1|||
129840766|NCT01481116|467382707|FG000|Overall Study|Investigator's Discretion|2|||
129840767|NCT01481116|467382708|FG001|Overall Study|Investigator's Discretion|0|||
129840768|NCT01481116|467382709|FG002|Overall Study|Investigator's Discretion|0|||
129840769|NCT01481116|467382707|FG000|Overall Study|Death|2|||
129840770|NCT01481116|467382708|FG001|Overall Study|Death|1|||
129840771|NCT01481116|467382709|FG002|Overall Study|Death|0|||
129840772|NCT01481116|467382707|FG000|Overall Study|Hypoglycemic Event|4|||
129840773|NCT01481116|467382708|FG001|Overall Study|Hypoglycemic Event|0|||
129840774|NCT01481116|467382709|FG002|Overall Study|Hypoglycemic Event|0|||
129840775|NCT01782313|467382727|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
129840776|NCT01782313|467382727|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
129840777|NCT01782313|467382727|FG000|Treated Cycle 3|Progressive Disease|21|||
129840778|NCT01782313|467382727|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
129840779|NCT01782313|467382727|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
129840780|NCT01782313|467382727|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
129840781|NCT01782313|467382727|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
129840782|NCT01782313|467382727|FG000|Survival Follow up|Lost to Follow-up|1|||
129840783|NCT04476017|467382731|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
129840784|NCT04476017|467382732|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
129840785|NCT02704364|467382733|FG000|Overall Study|Adverse Event|1|||
129840786|NCT02704364|467382734|FG001|Overall Study|Adverse Event|1|||
129840787|NCT02704364|467382735|FG002|Overall Study|Adverse Event|0|||
129840788|NCT02704364|467382733|FG000|Overall Study|Noncompliance with study drug|1|||
129840789|NCT02704364|467382734|FG001|Overall Study|Noncompliance with study drug|1|||
129840790|NCT02704364|467382735|FG002|Overall Study|Noncompliance with study drug|0|||
129840791|NCT02704364|467382733|FG000|Overall Study|Other|0|||
129840792|NCT02704364|467382734|FG001|Overall Study|Other|1|||
129840793|NCT02704364|467382735|FG002|Overall Study|Other|1|||
129840794|NCT02975934|467382736|FG000|Treatment Phase|Never initiated study drug|0|||
129840795|NCT02975934|467382737|FG001|Treatment Phase|Never initiated study drug|5|||
129840796|NCT02975934|467382738|FG002|Treatment Phase|Never initiated study drug|0|||
129840797|NCT03362502|467382739|FG000|Overall Study|Death|0|||
129840798|NCT03362502|467382740|FG001|Overall Study|Death|0|||
129840799|NCT03362502|467382741|FG002|Overall Study|Death|1|||
129840800|NCT02075840|467382742|FG000|Overall Study|Withdrawal by Subject|13|||
129840801|NCT02075840|467382743|FG001|Overall Study|Withdrawal by Subject|22|||
129840802|NCT02075840|467382742|FG000|Overall Study|Reason not specified|1|||
129840803|NCT02075840|467382743|FG001|Overall Study|Reason not specified|0|||
129840804|NCT02075840|467382742|FG000|Overall Study|Adverse Event|0|||
129840805|NCT02075840|467382743|FG001|Overall Study|Adverse Event|2|||
129840806|NCT02075840|467382742|FG000|Overall Study|Death|35|||
129840807|NCT02075840|467382743|FG001|Overall Study|Death|40|||
129840808|NCT02075840|467382742|FG000|Overall Study|Lost to Follow-up|3|||
129840809|NCT02075840|467382743|FG001|Overall Study|Lost to Follow-up|2|||
129840810|NCT02075840|467382742|FG000|Overall Study|Physician Decision|1|||
129840811|NCT02075840|467382743|FG001|Overall Study|Physician Decision|3|||
129840812|NCT02075840|467382742|FG000|Overall Study|Ongoing at CCOD|99|||
129840813|NCT02075840|467382743|FG001|Overall Study|Ongoing at CCOD|82|||
129840814|NCT04098458|467382748|FG000|Overall Study|Death|1|||
129840815|NCT04098458|467382748|FG000|Overall Study|did not meet study inclusion criteria|3|||
129840816|NCT00006489|467382751|FG000|Overall Study|Adverse Event|3|||
129840817|NCT00006489|467382752|FG001|Overall Study|Adverse Event|2|||
129840818|NCT00006489|467382753|FG002|Overall Study|Adverse Event|4|||
129840819|NCT00006489|467382754|FG003|Overall Study|Adverse Event|3|||
129840820|NCT00006489|467382751|FG000|Overall Study|Withdrawal by Subject|10|||
129840821|NCT00006489|467382752|FG001|Overall Study|Withdrawal by Subject|9|||
129840822|NCT00006489|467382753|FG002|Overall Study|Withdrawal by Subject|9|||
129840823|NCT00006489|467382754|FG003|Overall Study|Withdrawal by Subject|6|||
129840824|NCT00006489|467382751|FG000|Overall Study|Scheduling Conflict|0|||
129840825|NCT00006489|467382752|FG001|Overall Study|Scheduling Conflict|3|||
129840826|NCT00006489|467382753|FG002|Overall Study|Scheduling Conflict|2|||
129840827|NCT00006489|467382754|FG003|Overall Study|Scheduling Conflict|1|||
129840828|NCT00006489|467382751|FG000|Overall Study|Death|0|||
129840829|NCT00006489|467382752|FG001|Overall Study|Death|0|||
129840830|NCT00006489|467382753|FG002|Overall Study|Death|0|||
129840831|NCT00006489|467382754|FG003|Overall Study|Death|1|||
129840832|NCT05179421|467382765|FG000|First Infusion Day|Adverse Event|1|||
129840833|NCT05179421|467382766|FG001|First Infusion Day|Adverse Event|0|||
129840834|NCT04889625|467382767|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
129840835|NCT04889625|467382768|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
129840836|NCT04889625|467382767|FG000|Period 1|Subject out of window|0|||
129840837|NCT04889625|467382768|FG001|Period 1|Subject out of window|1|||
129840838|NCT04889625|467382767|FG000|Period 1|Wrong add power dispensed|0|||
129840839|NCT04889625|467382768|FG001|Period 1|Wrong add power dispensed|1|||
129840840|NCT04889625|467382767|FG000|Period 1|Discontinued due to fitting guide error|1|||
129840841|NCT04889625|467382768|FG001|Period 1|Discontinued due to fitting guide error|1|||
129840842|NCT04889625|467382767|FG000|Period 2|Test article no longer available|1|||
129840843|NCT04889625|467382768|FG001|Period 2|Test article no longer available|0|||
130063690|NCT03334396|468186339|FG006|Overall Study|Physician Decision|0|||
130063691|NCT03334396|468186340|FG007|Overall Study|Physician Decision|0|||
130063692|NCT03334396|468186333|FG000|Overall Study|Withdrawal by Subject|10|||
130063693|NCT03334396|468186334|FG001|Overall Study|Withdrawal by Subject|5|||
130063694|NCT03334396|468186335|FG002|Overall Study|Withdrawal by Subject|7|||
130063695|NCT03334396|468186336|FG003|Overall Study|Withdrawal by Subject|2|||
130063696|NCT03334396|468186337|FG004|Overall Study|Withdrawal by Subject|2|||
130063697|NCT03334396|468186338|FG005|Overall Study|Withdrawal by Subject|1|||
130063698|NCT03334396|468186339|FG006|Overall Study|Withdrawal by Subject|2|||
130063699|NCT03334396|468186340|FG007|Overall Study|Withdrawal by Subject|0|||
130063700|NCT03334396|468186333|FG000|Overall Study|Pregnancy|0|||
130063701|NCT03334396|468186334|FG001|Overall Study|Pregnancy|1|||
130063702|NCT03334396|468186335|FG002|Overall Study|Pregnancy|0|||
130063703|NCT03334396|468186336|FG003|Overall Study|Pregnancy|0|||
130063704|NCT03334396|468186337|FG004|Overall Study|Pregnancy|0|||
130063705|NCT03334396|468186338|FG005|Overall Study|Pregnancy|0|||
130063706|NCT03334396|468186339|FG006|Overall Study|Pregnancy|0|||
130063707|NCT03334396|468186340|FG007|Overall Study|Pregnancy|0|||
130063708|NCT03334396|468186333|FG000|Overall Study|Ineligible|0|||
130063709|NCT03334396|468186334|FG001|Overall Study|Ineligible|1|||
130063710|NCT03334396|468186335|FG002|Overall Study|Ineligible|0|||
130063711|NCT03334396|468186336|FG003|Overall Study|Ineligible|0|||
130063712|NCT03334396|468186337|FG004|Overall Study|Ineligible|0|||
130063713|NCT03334396|468186338|FG005|Overall Study|Ineligible|0|||
130063714|NCT03334396|468186339|FG006|Overall Study|Ineligible|0|||
130063715|NCT03334396|468186340|FG007|Overall Study|Ineligible|0|||
130063716|NCT03334396|468186333|FG000|Overall Study|Started New Job|1|||
130063717|NCT03334396|468186334|FG001|Overall Study|Started New Job|0|||
130063718|NCT03334396|468186335|FG002|Overall Study|Started New Job|0|||
130063719|NCT03334396|468186336|FG003|Overall Study|Started New Job|0|||
130063720|NCT03334396|468186337|FG004|Overall Study|Started New Job|0|||
130063721|NCT03334396|468186338|FG005|Overall Study|Started New Job|0|||
130063722|NCT03334396|468186339|FG006|Overall Study|Started New Job|0|||
130063723|NCT03334396|468186340|FG007|Overall Study|Started New Job|0|||
130063724|NCT02927873|468186343|FG000|Overall Study|Lost to Follow-up|0|||
130063725|NCT02927873|468186344|FG001|Overall Study|Lost to Follow-up|1|||
130063726|NCT02927873|468186345|FG002|Overall Study|Lost to Follow-up|0|||
130063727|NCT02927873|468186346|FG003|Overall Study|Lost to Follow-up|0|||
130063728|NCT02927873|468186347|FG004|Overall Study|Lost to Follow-up|0|||
130063729|NCT02927873|468186348|FG005|Overall Study|Lost to Follow-up|0|||
130063730|NCT02927873|468186343|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130063731|NCT02927873|468186344|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130063732|NCT02927873|468186345|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130063733|NCT02927873|468186346|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130063734|NCT02927873|468186347|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130063735|NCT02927873|468186348|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130063736|NCT02927873|468186343|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130063737|NCT02927873|468186344|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130063738|NCT02927873|468186345|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130063739|NCT02927873|468186346|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130063740|NCT02927873|468186347|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130063741|NCT02927873|468186348|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130063742|NCT02927873|468186343|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130063743|NCT02927873|468186344|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
130063744|NCT02927873|468186345|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130063745|NCT02927873|468186346|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130063746|NCT02927873|468186347|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130063747|NCT02927873|468186348|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
130063748|NCT02927873|468186343|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
130115211|NCT03264066|468381343|FG005|Overall Study|Death|1|||
130115212|NCT03264066|468381338|FG000|Overall Study|Lost to Follow-up|1|||
130115213|NCT03264066|468381339|FG001|Overall Study|Lost to Follow-up|0|||
130115214|NCT03264066|468381340|FG002|Overall Study|Lost to Follow-up|0|||
130115215|NCT03264066|468381341|FG003|Overall Study|Lost to Follow-up|0|||
130115216|NCT03264066|468381342|FG004|Overall Study|Lost to Follow-up|0|||
130115217|NCT03264066|468381343|FG005|Overall Study|Lost to Follow-up|0|||
130115218|NCT03264066|468381338|FG000|Overall Study|Progressive Disease|0|||
130115219|NCT03264066|468381339|FG001|Overall Study|Progressive Disease|2|||
130115220|NCT03264066|468381340|FG002|Overall Study|Progressive Disease|1|||
130115221|NCT03264066|468381341|FG003|Overall Study|Progressive Disease|0|||
130115222|NCT03264066|468381342|FG004|Overall Study|Progressive Disease|0|||
130115223|NCT03264066|468381343|FG005|Overall Study|Progressive Disease|0|||
130115224|NCT03264066|468381338|FG000|Overall Study|Study Terminated by Sponsor|5|||
130115225|NCT03264066|468381339|FG001|Overall Study|Study Terminated by Sponsor|5|||
130115226|NCT03264066|468381340|FG002|Overall Study|Study Terminated by Sponsor|8|||
130115227|NCT03264066|468381341|FG003|Overall Study|Study Terminated by Sponsor|5|||
130115228|NCT03264066|468381342|FG004|Overall Study|Study Terminated by Sponsor|1|||
130115229|NCT03264066|468381343|FG005|Overall Study|Study Terminated by Sponsor|2|||
130115230|NCT03264066|468381338|FG000|Overall Study|Withdrawal by Subject|1|||
130115231|NCT03264066|468381339|FG001|Overall Study|Withdrawal by Subject|0|||
130115232|NCT03264066|468381340|FG002|Overall Study|Withdrawal by Subject|0|||
130115233|NCT03264066|468381341|FG003|Overall Study|Withdrawal by Subject|5|||
130115234|NCT03264066|468381342|FG004|Overall Study|Withdrawal by Subject|0|||
130115235|NCT03264066|468381343|FG005|Overall Study|Withdrawal by Subject|0|||
130115236|NCT01193517|468381349|FG000|Overall Study|Early Progression|1|||
130115237|NCT01193517|468381350|FG001|Overall Study|Early Progression|0|||
130115238|NCT01193517|468381351|FG002|Overall Study|Early Progression|0|||
130115239|NCT02115256|468381352|FG000|Overall Study|Withdrawal by Subject|0|||
130115240|NCT02115256|468381353|FG001|Overall Study|Withdrawal by Subject|1|||
130115241|NCT03775681|468381356|FG000|Overall Study|Physician Decision|3|||
130115242|NCT01512979|468381361|FG000|Overall Study|Adverse Event|2|||
130115243|NCT01512979|468381362|FG001|Overall Study|Adverse Event|2|||
130115244|NCT01512979|468381361|FG000|Overall Study|Protocol Violation|1|||
130115245|NCT01512979|468381362|FG001|Overall Study|Protocol Violation|4|||
130115246|NCT01512979|468381361|FG000|Overall Study|Lost to Follow-up|2|||
130115247|NCT01512979|468381362|FG001|Overall Study|Lost to Follow-up|5|||
130115248|NCT01512979|468381361|FG000|Overall Study|Withdrawal by Subject|1|||
130115249|NCT01512979|468381362|FG001|Overall Study|Withdrawal by Subject|2|||
130115250|NCT01512979|468381361|FG000|Overall Study|Reason other than stated above|13|||
130115251|NCT01512979|468381362|FG001|Overall Study|Reason other than stated above|9|||
130115252|NCT00526890|468381366|FG000|Overall Study|Adverse Event|2|||
130115253|NCT03529955|468381367|FG000|Overall Study|Adverse Event|1|||
130115254|NCT03529955|468381367|FG000|Overall Study|Lack of Efficacy|1|||
130115255|NCT00580983|468381368|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
130115256|NCT03907280|468382872|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
130115257|NCT03907280|468382873|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
130115258|NCT03907280|468382874|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
130115259|NCT01464827|468382877|FG000|Overall Study|Adverse Event|0|||
130115260|NCT01464827|468382878|FG001|Overall Study|Adverse Event|0|||
130115261|NCT01464827|468382879|FG002|Overall Study|Adverse Event|0|||
130115262|NCT01464827|468382880|FG003|Overall Study|Adverse Event|0|||
130115263|NCT01464827|468382881|FG004|Overall Study|Adverse Event|0|||
130115264|NCT01464827|468382882|FG005|Overall Study|Adverse Event|0|||
130115265|NCT01464827|468382883|FG006|Overall Study|Adverse Event|0|||
130115266|NCT01464827|468382884|FG007|Overall Study|Adverse Event|0|||
130115267|NCT01464827|468382885|FG008|Overall Study|Adverse Event|0|||
130115268|NCT01464827|468382886|FG009|Overall Study|Adverse Event|0|||
130115269|NCT01464827|468382887|FG010|Overall Study|Adverse Event|0|||
130115270|NCT01464827|468382888|FG011|Overall Study|Adverse Event|0|||
130115271|NCT01464827|468382889|FG012|Overall Study|Adverse Event|1|||
130115272|NCT01464827|468382890|FG013|Overall Study|Adverse Event|0|||
130115273|NCT01464827|468382877|FG000|Overall Study|Withdrawal by Subject|1|||
130115274|NCT01464827|468382878|FG001|Overall Study|Withdrawal by Subject|0|||
130115275|NCT01464827|468382879|FG002|Overall Study|Withdrawal by Subject|0|||
130115276|NCT01464827|468382880|FG003|Overall Study|Withdrawal by Subject|0|||
130115277|NCT01464827|468382881|FG004|Overall Study|Withdrawal by Subject|1|||
130115278|NCT01464827|468382882|FG005|Overall Study|Withdrawal by Subject|0|||
130115279|NCT01464827|468382883|FG006|Overall Study|Withdrawal by Subject|0|||
130115280|NCT01464827|468382884|FG007|Overall Study|Withdrawal by Subject|1|||
130115281|NCT01464827|468382885|FG008|Overall Study|Withdrawal by Subject|0|||
130115282|NCT01464827|468382886|FG009|Overall Study|Withdrawal by Subject|0|||
130115283|NCT01464827|468382887|FG010|Overall Study|Withdrawal by Subject|0|||
130115284|NCT01464827|468382888|FG011|Overall Study|Withdrawal by Subject|0|||
130115285|NCT01464827|468382889|FG012|Overall Study|Withdrawal by Subject|0|||
130115286|NCT01464827|468382890|FG013|Overall Study|Withdrawal by Subject|0|||
130115287|NCT01464827|468382877|FG000|Overall Study|Lost to Follow-up|0|||
130115288|NCT01464827|468382878|FG001|Overall Study|Lost to Follow-up|2|||
130115289|NCT01464827|468382879|FG002|Overall Study|Lost to Follow-up|0|||
130115290|NCT01464827|468382880|FG003|Overall Study|Lost to Follow-up|2|||
130115291|NCT01464827|468382881|FG004|Overall Study|Lost to Follow-up|3|||
130115292|NCT01464827|468382882|FG005|Overall Study|Lost to Follow-up|1|||
130115293|NCT01464827|468382883|FG006|Overall Study|Lost to Follow-up|2|||
130115294|NCT01464827|468382884|FG007|Overall Study|Lost to Follow-up|2|||
130115295|NCT01464827|468382885|FG008|Overall Study|Lost to Follow-up|0|||
130115296|NCT01464827|468382886|FG009|Overall Study|Lost to Follow-up|0|||
130115297|NCT01464827|468382887|FG010|Overall Study|Lost to Follow-up|0|||
130115298|NCT01464827|468382888|FG011|Overall Study|Lost to Follow-up|1|||
130115299|NCT01464827|468382889|FG012|Overall Study|Lost to Follow-up|0|||
130115300|NCT01464827|468382890|FG013|Overall Study|Lost to Follow-up|1|||
130115301|NCT01464827|468382877|FG000|Overall Study|Other|2|||
130115302|NCT01464827|468382878|FG001|Overall Study|Other|3|||
130115303|NCT01464827|468382879|FG002|Overall Study|Other|0|||
130115304|NCT01464827|468382880|FG003|Overall Study|Other|2|||
130115305|NCT01464827|468382881|FG004|Overall Study|Other|3|||
130115306|NCT01464827|468382882|FG005|Overall Study|Other|0|||
130115307|NCT01464827|468382883|FG006|Overall Study|Other|1|||
130115308|NCT01464827|468382884|FG007|Overall Study|Other|0|||
130115309|NCT01464827|468382885|FG008|Overall Study|Other|3|||
130115310|NCT01464827|468382886|FG009|Overall Study|Other|1|||
130115311|NCT01464827|468382887|FG010|Overall Study|Other|2|||
130115312|NCT01464827|468382888|FG011|Overall Study|Other|0|||
130115313|NCT01464827|468382889|FG012|Overall Study|Other|1|||
130115314|NCT01464827|468382890|FG013|Overall Study|Other|0|||
130115315|NCT01464827|468382877|FG000|Overall Study|Not Treated|0|||
130115316|NCT01464827|468382878|FG001|Overall Study|Not Treated|2|||
130115317|NCT01464827|468382879|FG002|Overall Study|Not Treated|0|||
130115318|NCT01464827|468382880|FG003|Overall Study|Not Treated|0|||
130115319|NCT01464827|468382881|FG004|Overall Study|Not Treated|1|||
130115320|NCT01464827|468382882|FG005|Overall Study|Not Treated|0|||
130115321|NCT01464827|468382883|FG006|Overall Study|Not Treated|1|||
129840844|NCT04889625|467382767|FG000|Period 2|Incorrect lens dispensed|1|||
129840845|NCT04889625|467382768|FG001|Period 2|Incorrect lens dispensed|0|||
129840846|NCT04889625|467382767|FG000|Period 2|Wrong add power dispensed|0|||
129840847|NCT04889625|467382768|FG001|Period 2|Wrong add power dispensed|1|||
129840848|NCT03746522|467382778|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
129840849|NCT03746522|467382779|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
129840850|NCT03746522|467382780|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
129840851|NCT03746522|467382778|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
129840852|NCT03746522|467382779|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
129840853|NCT03746522|467382780|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
129840854|NCT03746522|467382778|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
129840855|NCT03746522|467382779|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
129840856|NCT03746522|467382780|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
129840857|NCT03746522|467382778|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
129840858|NCT03746522|467382779|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
129840859|NCT03746522|467382780|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
129840860|NCT03746522|467382778|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
129840861|NCT03746522|467382779|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
129840862|NCT03746522|467382780|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
129840863|NCT00323414|467382783|FG000|Overall Study|Withdrawal by Subject|0|||
129840864|NCT00323414|467382784|FG001|Overall Study|Withdrawal by Subject|1|||
129840865|NCT02552316|467382786|FG000|Overall Study|Withdrawal by Subject|1|||
129840866|NCT02552316|467382786|FG000|Overall Study|Withdrawal due to non-compliance|1|||
129840867|NCT02659020|467382787|FG000|Overall Study|Adverse Event|0|||
129840868|NCT02659020|467382788|FG001|Overall Study|Adverse Event|0|||
129840869|NCT02659020|467382789|FG002|Overall Study|Adverse Event|0|||
129840870|NCT02659020|467382790|FG003|Overall Study|Adverse Event|2|||
129840871|NCT02659020|467382791|FG004|Overall Study|Adverse Event|0|||
129840872|NCT02659020|467382792|FG005|Overall Study|Adverse Event|0|||
130115322|NCT01464827|468382884|FG007|Overall Study|Not Treated|0|||
129840873|NCT02659020|467382793|FG006|Overall Study|Adverse Event|2|||
129840874|NCT02659020|467382787|FG000|Overall Study|Lost to Follow-up|1|||
129840875|NCT02659020|467382788|FG001|Overall Study|Lost to Follow-up|2|||
129840876|NCT02659020|467382789|FG002|Overall Study|Lost to Follow-up|1|||
129840877|NCT02659020|467382790|FG003|Overall Study|Lost to Follow-up|6|||
130115323|NCT01464827|468382885|FG008|Overall Study|Not Treated|0|||
130115324|NCT01464827|468382886|FG009|Overall Study|Not Treated|2|||
130115325|NCT01464827|468382887|FG010|Overall Study|Not Treated|0|||
130115326|NCT01464827|468382888|FG011|Overall Study|Not Treated|1|||
130115327|NCT01464827|468382889|FG012|Overall Study|Not Treated|0|||
130115328|NCT01464827|468382890|FG013|Overall Study|Not Treated|2|||
130115329|NCT05487456|468382891|FG000|Overall Study|Withdrawal by Subject|0|||
130115330|NCT05487456|468382892|FG001|Overall Study|Withdrawal by Subject|0|||
130115331|NCT05487456|468382893|FG002|Overall Study|Withdrawal by Subject|1|||
130115332|NCT05487456|468382894|FG003|Overall Study|Withdrawal by Subject|0|||
130115333|NCT03882047|468382897|FG000|Overall Study|Adverse Event|0|||
130115334|NCT03882047|468382898|FG001|Overall Study|Adverse Event|2|||
130115335|NCT03882047|468382899|FG002|Overall Study|Adverse Event|2|||
130115336|NCT03882047|468382897|FG000|Overall Study|Treatment Failure|3|||
130115337|NCT03882047|468382898|FG001|Overall Study|Treatment Failure|3|||
130115338|NCT03882047|468382899|FG002|Overall Study|Treatment Failure|12|||
130115339|NCT03882047|468382897|FG000|Overall Study|Lost to Follow-up|0|||
130115340|NCT03882047|468382898|FG001|Overall Study|Lost to Follow-up|1|||
130115341|NCT03882047|468382899|FG002|Overall Study|Lost to Follow-up|0|||
130115342|NCT03882047|468382897|FG000|Overall Study|Did Not Wish to Continue|1|||
130115343|NCT03882047|468382898|FG001|Overall Study|Did Not Wish to Continue|4|||
130115344|NCT03882047|468382899|FG002|Overall Study|Did Not Wish to Continue|1|||
130115345|NCT03882047|468382897|FG000|Overall Study|Noncompliance With Protocol|2|||
130115346|NCT03882047|468382898|FG001|Overall Study|Noncompliance With Protocol|0|||
130115347|NCT03882047|468382899|FG002|Overall Study|Noncompliance With Protocol|0|||
130115348|NCT03882047|468382897|FG000|Overall Study|Did Not Meet Eligibility|0|||
130115349|NCT03882047|468382898|FG001|Overall Study|Did Not Meet Eligibility|0|||
130115350|NCT03882047|468382899|FG002|Overall Study|Did Not Meet Eligibility|1|||
130115351|NCT00441584|468382900|FG000|Overall Study|Lack of Efficacy|79|||
129840878|NCT02659020|467382791|FG004|Overall Study|Lost to Follow-up|1|||
130115352|NCT00441584|468382900|FG000|Overall Study|Withdrawal by Subject|8|||
130115353|NCT00441584|468382900|FG000|Overall Study|Adverse Event|6|||
130115354|NCT00441584|468382900|FG000|Overall Study|Protocol Violation|5|||
130115355|NCT00441584|468382900|FG000|Overall Study|Lost to Follow-up|4|||
130115356|NCT00441584|468382900|FG000|Overall Study|Failure to meet eligibility criteria|3|||
130115357|NCT01333033|468382903|FG000|Overall Study|Ineligible|0|||
130115358|NCT01333033|468382904|FG001|Overall Study|Ineligible|0|||
130115359|NCT01333033|468382905|FG002|Overall Study|Ineligible|0|||
130115360|NCT01333033|468382906|FG003|Overall Study|Ineligible|0|||
130115361|NCT01333033|468382907|FG004|Overall Study|Ineligible|6|||
130115362|NCT01333033|468382908|FG005|Overall Study|Ineligible|8|||
130115363|NCT01333033|468382903|FG000|Overall Study|Withdrawal by Subject|0|||
130115364|NCT01333033|468382904|FG001|Overall Study|Withdrawal by Subject|0|||
130115365|NCT01333033|468382905|FG002|Overall Study|Withdrawal by Subject|0|||
130115366|NCT01333033|468382906|FG003|Overall Study|Withdrawal by Subject|0|||
130115367|NCT01333033|468382907|FG004|Overall Study|Withdrawal by Subject|4|||
130115368|NCT01333033|468382908|FG005|Overall Study|Withdrawal by Subject|2|||
130115369|NCT01333033|468382903|FG000|Overall Study|PET inevaluable|0|||
130115370|NCT01333033|468382904|FG001|Overall Study|PET inevaluable|0|||
130115371|NCT01333033|468382905|FG002|Overall Study|PET inevaluable|0|||
130115372|NCT01333033|468382906|FG003|Overall Study|PET inevaluable|0|||
130115373|NCT01333033|468382907|FG004|Overall Study|PET inevaluable|2|||
130115374|NCT01333033|468382908|FG005|Overall Study|PET inevaluable|4|||
130115375|NCT01333033|468382903|FG000|Overall Study|Adverse Event|0|||
130115376|NCT01333033|468382904|FG001|Overall Study|Adverse Event|0|||
130115377|NCT01333033|468382905|FG002|Overall Study|Adverse Event|0|||
130115378|NCT01333033|468382906|FG003|Overall Study|Adverse Event|0|||
130115379|NCT01333033|468382907|FG004|Overall Study|Adverse Event|2|||
130115380|NCT01333033|468382908|FG005|Overall Study|Adverse Event|1|||
130115381|NCT01333033|468382903|FG000|Overall Study|Progression|0|||
130115382|NCT01333033|468382904|FG001|Overall Study|Progression|0|||
130115383|NCT01333033|468382905|FG002|Overall Study|Progression|0|||
130115384|NCT01333033|468382906|FG003|Overall Study|Progression|0|||
130115385|NCT01333033|468382907|FG004|Overall Study|Progression|0|||
130115386|NCT01333033|468382908|FG005|Overall Study|Progression|1|||
130115387|NCT01333033|468382903|FG000|Overall Study|MD Decision|0|||
130115388|NCT01333033|468382904|FG001|Overall Study|MD Decision|0|||
130115389|NCT01333033|468382905|FG002|Overall Study|MD Decision|0|||
130115390|NCT01333033|468382906|FG003|Overall Study|MD Decision|0|||
130115391|NCT01333033|468382907|FG004|Overall Study|MD Decision|0|||
130115392|NCT01333033|468382908|FG005|Overall Study|MD Decision|2|||
130115393|NCT03687125|468382909|FG000|Overall Study|Progressive Disease|2|||
130115394|NCT03687125|468382910|FG001|Overall Study|Progressive Disease|1|||
130115395|NCT03687125|468382909|FG000|Overall Study|Protocol Violation|1|||
130115396|NCT03687125|468382910|FG001|Overall Study|Protocol Violation|0|||
130115397|NCT01992107|468382913|FG000|Overall Study|Administrative reasons|2|||
130115398|NCT01992107|468382914|FG001|Overall Study|Administrative reasons|0|||
130115399|NCT01992107|468382915|FG002|Overall Study|Administrative reasons|0|||
130115400|NCT01992107|468382913|FG000|Overall Study|Adverse Event|0|||
129840879|NCT02659020|467382792|FG005|Overall Study|Lost to Follow-up|5|||
129840880|NCT02659020|467382793|FG006|Overall Study|Lost to Follow-up|0|||
130115401|NCT01992107|468382914|FG001|Overall Study|Adverse Event|1|||
130115402|NCT01992107|468382915|FG002|Overall Study|Adverse Event|0|||
130115403|NCT01992107|468382913|FG000|Overall Study|Lost to Follow-up|46|||
130115404|NCT01992107|468382914|FG001|Overall Study|Lost to Follow-up|22|||
130115405|NCT01992107|468382915|FG002|Overall Study|Lost to Follow-up|26|||
130115406|NCT01992107|468382913|FG000|Overall Study|noncompliance and were unavailable|7|||
130115407|NCT01992107|468382914|FG001|Overall Study|noncompliance and were unavailable|3|||
130115408|NCT01992107|468382915|FG002|Overall Study|noncompliance and were unavailable|2|||
130115409|NCT01992107|468382913|FG000|Overall Study|Withdrawal by Subject|13|||
130115410|NCT01992107|468382914|FG001|Overall Study|Withdrawal by Subject|7|||
130115411|NCT01992107|468382915|FG002|Overall Study|Withdrawal by Subject|8|||
130115412|NCT02022007|468382916|FG000|Overall Study|Withdrawal by Subject|1|||
130115413|NCT02022007|468382917|FG001|Overall Study|Withdrawal by Subject|1|||
130115414|NCT02022007|468382918|FG002|Overall Study|Withdrawal by Subject|1|||
130115415|NCT02022007|468382916|FG000|Overall Study|Noncompliant|0|||
130115416|NCT02022007|468382917|FG001|Overall Study|Noncompliant|0|||
130115417|NCT02022007|468382918|FG002|Overall Study|Noncompliant|1|||
130115418|NCT02087046|468382919|FG000|Overall Study|Adverse Event|4|||
130115419|NCT02087046|468382919|FG000|Overall Study|Death|1|||
130115420|NCT02087046|468382919|FG000|Overall Study|Lost to Follow-up|3|||
130115421|NCT02087046|468382919|FG000|Overall Study|Withdrawal by Subject|2|||
130115422|NCT02087046|468382919|FG000|Overall Study|Physician Decision|1|||
130115423|NCT01107535|468382920|FG000|Overall Study|Death|5|||
130115424|NCT01214603|468382921|FG000|Overall Study|Adverse Event|0|||
130115425|NCT01214603|468382922|FG001|Overall Study|Adverse Event|0|||
130115426|NCT01214603|468382923|FG002|Overall Study|Adverse Event|1|||
130115427|NCT01214603|468382921|FG000|Overall Study|Death|1|||
130115428|NCT01214603|468382922|FG001|Overall Study|Death|0|||
130115429|NCT01214603|468382923|FG002|Overall Study|Death|0|||
130115430|NCT01214603|468382921|FG000|Overall Study|Progressive Disease|4|||
130115431|NCT01214603|468382922|FG001|Overall Study|Progressive Disease|1|||
130115432|NCT01214603|468382923|FG002|Overall Study|Progressive Disease|3|||
130115433|NCT02444533|468382924|FG000|Overall Study|Not able to complete forms|0|||
130115434|NCT02444533|468382925|FG001|Overall Study|Not able to complete forms|2|||
130115435|NCT02444533|468382924|FG000|Overall Study|Only gave post-procedure complications|2|||
130115436|NCT02444533|468382925|FG001|Overall Study|Only gave post-procedure complications|2|||
130115437|NCT01388647|468382926|FG000|Overall Study|Adverse Event|1|||
130115438|NCT01388647|468382927|FG001|Overall Study|Adverse Event|2|||
130115439|NCT03567057|468382928|FG000|Overall Study|Adverse Event|56|||
130115440|NCT03567057|468382929|FG001|Overall Study|Adverse Event|53|||
130115441|NCT03567057|468382930|FG002|Overall Study|Adverse Event|28|||
130115442|NCT03567057|468382928|FG000|Overall Study|Withdrawal by Subject|22|||
130115443|NCT03567057|468382929|FG001|Overall Study|Withdrawal by Subject|24|||
130115444|NCT03567057|468382930|FG002|Overall Study|Withdrawal by Subject|13|||
130115445|NCT03567057|468382928|FG000|Overall Study|Lost to Follow-up|3|||
130115446|NCT03567057|468382929|FG001|Overall Study|Lost to Follow-up|5|||
130115447|NCT03567057|468382930|FG002|Overall Study|Lost to Follow-up|2|||
130115448|NCT03567057|468382928|FG000|Overall Study|COVID-19 pandemic|4|||
130115449|NCT03567057|468382929|FG001|Overall Study|COVID-19 pandemic|3|||
130115450|NCT03567057|468382930|FG002|Overall Study|COVID-19 pandemic|0|||
130115451|NCT03567057|468382928|FG000|Overall Study|Non-compliance with study drug|4|||
130115452|NCT03567057|468382929|FG001|Overall Study|Non-compliance with study drug|2|||
130115453|NCT03567057|468382930|FG002|Overall Study|Non-compliance with study drug|0|||
130115454|NCT03567057|468382928|FG000|Overall Study|Lack of Efficacy|3|||
130115455|NCT03567057|468382929|FG001|Overall Study|Lack of Efficacy|0|||
130115456|NCT03567057|468382930|FG002|Overall Study|Lack of Efficacy|1|||
130115457|NCT03567057|468382928|FG000|Overall Study|Death|1|||
130115458|NCT03567057|468382929|FG001|Overall Study|Death|0|||
130115459|NCT03567057|468382930|FG002|Overall Study|Death|0|||
130115460|NCT03567057|468382928|FG000|Overall Study|Physician Decision|1|||
130115461|NCT03567057|468382929|FG001|Overall Study|Physician Decision|0|||
130115462|NCT03567057|468382930|FG002|Overall Study|Physician Decision|0|||
130115463|NCT03567057|468382928|FG000|Overall Study|Unstable medical condition|1|||
130115464|NCT03567057|468382929|FG001|Overall Study|Unstable medical condition|0|||
130115465|NCT03567057|468382930|FG002|Overall Study|Unstable medical condition|0|||
130115466|NCT03567057|468382928|FG000|Overall Study|Medical history event|0|||
130115467|NCT03567057|468382929|FG001|Overall Study|Medical history event|0|||
130115468|NCT03567057|468382930|FG002|Overall Study|Medical history event|1|||
130115469|NCT03567057|468382928|FG000|Overall Study|Other|0|||
130115470|NCT03567057|468382929|FG001|Overall Study|Other|0|||
130115471|NCT03567057|468382930|FG002|Overall Study|Other|1|||
130115472|NCT00490061|468382931|FG000|Overall Study|Physician Decision|1|||
130115473|NCT01155583|468382932|FG000|Phase I|Screen failure - did not start treatment|0|||
130115474|NCT01155583|468382933|FG001|Phase I|Screen failure - did not start treatment|0|||
130115475|NCT01155583|468382934|FG002|Phase I|Screen failure - did not start treatment|0|||
130115476|NCT01155583|468382935|FG003|Phase I|Screen failure - did not start treatment|0|||
130115477|NCT01155583|468382936|FG004|Phase I|Screen failure - did not start treatment|1|||
129840881|NCT02659020|467382787|FG000|Overall Study|Physician Decision|0|||
129840882|NCT02659020|467382788|FG001|Overall Study|Physician Decision|0|||
130115478|NCT01155583|468382937|FG005|Phase I|Screen failure - did not start treatment|0|||
130115479|NCT01155583|468382938|FG006|Phase I|Screen failure - did not start treatment|0|||
130115480|NCT01155583|468382939|FG007|Phase I|Screen failure - did not start treatment|2|||
130115481|NCT01155583|468382940|FG008|Phase I|Screen failure - did not start treatment|0|||
130115482|NCT01155583|468382932|FG000|Phase I|Withdrawal by Subject|0|||
130115483|NCT01155583|468382933|FG001|Phase I|Withdrawal by Subject|0|||
129840883|NCT02659020|467382789|FG002|Overall Study|Physician Decision|0|||
129840884|NCT02659020|467382790|FG003|Overall Study|Physician Decision|1|||
129840885|NCT02659020|467382791|FG004|Overall Study|Physician Decision|1|||
129840886|NCT02659020|467382792|FG005|Overall Study|Physician Decision|0|||
129840887|NCT02659020|467382793|FG006|Overall Study|Physician Decision|1|||
129840888|NCT02659020|467382787|FG000|Overall Study|Withdrawal by Subject|2|||
129840889|NCT02659020|467382788|FG001|Overall Study|Withdrawal by Subject|1|||
129840890|NCT02659020|467382789|FG002|Overall Study|Withdrawal by Subject|0|||
129840891|NCT02659020|467382790|FG003|Overall Study|Withdrawal by Subject|3|||
129840892|NCT02659020|467382791|FG004|Overall Study|Withdrawal by Subject|3|||
129840893|NCT02659020|467382792|FG005|Overall Study|Withdrawal by Subject|6|||
129840894|NCT02659020|467382793|FG006|Overall Study|Withdrawal by Subject|3|||
129840895|NCT02659020|467382787|FG000|Overall Study|Progressive Disease|0|||
129840896|NCT02659020|467382788|FG001|Overall Study|Progressive Disease|0|||
129840897|NCT02659020|467382789|FG002|Overall Study|Progressive Disease|0|||
129840898|NCT02659020|467382790|FG003|Overall Study|Progressive Disease|4|||
129840899|NCT02659020|467382791|FG004|Overall Study|Progressive Disease|1|||
129840900|NCT02659020|467382792|FG005|Overall Study|Progressive Disease|0|||
129840901|NCT02659020|467382793|FG006|Overall Study|Progressive Disease|2|||
129840902|NCT04382911|467382794|FG000|Overall Study|unable to be imaged prior to surgery|2|||
129840903|NCT01585766|467382798|FG000|Overall Study|Withdrawal by Subject|0|||
129840904|NCT01585766|467382799|FG001|Overall Study|Withdrawal by Subject|1|||
129840905|NCT01585766|467382800|FG002|Overall Study|Withdrawal by Subject|1|||
129840906|NCT01585766|467382801|FG003|Overall Study|Withdrawal by Subject|0|||
129840907|NCT01585766|467382802|FG004|Overall Study|Withdrawal by Subject|0|||
129840908|NCT01585766|467382803|FG005|Overall Study|Withdrawal by Subject|0|||
129840909|NCT01585766|467382798|FG000|Overall Study|Death|0|||
129840910|NCT01585766|467382799|FG001|Overall Study|Death|1|||
129840911|NCT01585766|467382800|FG002|Overall Study|Death|0|||
129840912|NCT01585766|467382801|FG003|Overall Study|Death|0|||
129840913|NCT01585766|467382802|FG004|Overall Study|Death|0|||
129840914|NCT01585766|467382803|FG005|Overall Study|Death|0|||
129840915|NCT01585766|467382798|FG000|Overall Study|Physician Decision|0|||
129840916|NCT01585766|467382799|FG001|Overall Study|Physician Decision|0|||
129840917|NCT01585766|467382800|FG002|Overall Study|Physician Decision|1|||
129840918|NCT01585766|467382801|FG003|Overall Study|Physician Decision|0|||
129840919|NCT01585766|467382802|FG004|Overall Study|Physician Decision|0|||
129840920|NCT01585766|467382803|FG005|Overall Study|Physician Decision|0|||
129840921|NCT01120210|467382804|FG000|MAIN INFUSION|Adverse Event|1|||
129840922|NCT01120210|467382805|FG001|MAIN INFUSION|Adverse Event|0|||
129840923|NCT01120210|467382804|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
129840924|NCT01120210|467382805|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
129840925|NCT00477672|467382818|FG000|Overall Study|Adverse Event|3|||
129840926|NCT00477672|467382819|FG001|Overall Study|Adverse Event|5|||
129840927|NCT00477672|467382820|FG002|Overall Study|Adverse Event|6|||
129840928|NCT00477672|467382818|FG000|Overall Study|Death|0|||
129840929|NCT00477672|467382819|FG001|Overall Study|Death|1|||
129840930|NCT00477672|467382820|FG002|Overall Study|Death|0|||
129840931|NCT00477672|467382818|FG000|Overall Study|Disease progression|0|||
129840932|NCT00477672|467382819|FG001|Overall Study|Disease progression|1|||
129840933|NCT00477672|467382820|FG002|Overall Study|Disease progression|0|||
130063749|NCT02927873|468186344|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130063750|NCT02927873|468186345|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130063751|NCT02927873|468186346|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130063752|NCT02927873|468186347|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130063753|NCT02927873|468186348|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
130063754|NCT02927873|468186343|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
130063755|NCT02927873|468186344|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130063756|NCT02927873|468186345|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130063757|NCT02927873|468186346|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130063758|NCT02927873|468186347|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130063759|NCT02927873|468186348|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
130063760|NCT02159469|468186349|FG000|Overall Study|Missing Completion status|1|||
130063761|NCT02159469|468186349|FG000|Overall Study|Adverse Event|5|||
130063762|NCT02159469|468186349|FG000|Overall Study|Non-compliance|2|||
130063763|NCT02159469|468186349|FG000|Overall Study|Withdrawal by Subject|9|||
130063764|NCT02159469|468186349|FG000|Overall Study|Lost to Follow-up|1|||
130063765|NCT02159469|468186349|FG000|Overall Study|Sponsor's request|2|||
130063766|NCT02159469|468186349|FG000|Overall Study|Met Stopping Criteria|3|||
130063767|NCT02159469|468186349|FG000|Overall Study|Other|1|||
130063768|NCT02159469|468186349|FG000|Overall Study|Multiple|29|||
130063769|NCT03629041|468186355|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
129840934|NCT00477672|467382818|FG000|Overall Study|Physician Decision|1|||
129840935|NCT00477672|467382819|FG001|Overall Study|Physician Decision|0|||
129840936|NCT00477672|467382820|FG002|Overall Study|Physician Decision|0|||
129840937|NCT00477672|467382818|FG000|Overall Study|Protocol noncompliance|0|||
130115484|NCT01155583|468382934|FG002|Phase I|Withdrawal by Subject|0|||
130115485|NCT01155583|468382935|FG003|Phase I|Withdrawal by Subject|0|||
130115486|NCT01155583|468382936|FG004|Phase I|Withdrawal by Subject|0|||
130115487|NCT01155583|468382937|FG005|Phase I|Withdrawal by Subject|0|||
130115488|NCT01155583|468382938|FG006|Phase I|Withdrawal by Subject|0|||
130115489|NCT01155583|468382939|FG007|Phase I|Withdrawal by Subject|1|||
130115490|NCT01155583|468382940|FG008|Phase I|Withdrawal by Subject|0|||
130115491|NCT00952484|468382941|FG000|Overall Study|Withdrawal by Subject|0|||
130115492|NCT00952484|468382942|FG001|Overall Study|Withdrawal by Subject|1|||
130115493|NCT00952484|468382943|FG002|Overall Study|Withdrawal by Subject|0|||
130115494|NCT00886483|468382954|FG000|Overall Study|Lost to Follow-up|0|||
130115495|NCT00886483|468382955|FG001|Overall Study|Lost to Follow-up|1|||
130115496|NCT00886483|468382954|FG000|Overall Study|Pursue medications|1|||
130115497|NCT00886483|468382955|FG001|Overall Study|Pursue medications|2|||
130115498|NCT00886483|468382954|FG000|Overall Study|Distance to center, poor grades|1|||
130115499|NCT00886483|468382955|FG001|Overall Study|Distance to center, poor grades|0|||
130115500|NCT00192296|468382958|FG000|Overall Study|Withdrawal by Subject|0|||
130115501|NCT00192296|468382959|FG001|Overall Study|Withdrawal by Subject|1|||
129840938|NCT00477672|467382819|FG001|Overall Study|Protocol noncompliance|2|||
129840939|NCT00477672|467382820|FG002|Overall Study|Protocol noncompliance|0|||
130063770|NCT03629041|468186356|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
130063771|NCT03629041|468186357|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
130063772|NCT03629041|468186358|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
130063773|NCT00995670|468186360|FG000|Overall Study|Failed arterial cannulation|1|||
130063774|NCT00995670|468186361|FG001|Overall Study|Failed arterial cannulation|0|||
130063775|NCT00995670|468186362|FG002|Overall Study|Failed arterial cannulation|3|||
130063776|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
130063777|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
130063778|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
130063779|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
130063780|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
129840940|NCT00477672|467382818|FG000|Overall Study|Consent withdrawn|2|||
129840941|NCT00477672|467382819|FG001|Overall Study|Consent withdrawn|5|||
129840942|NCT00477672|467382820|FG002|Overall Study|Consent withdrawn|10|||
129840943|NCT00477672|467382818|FG000|Overall Study|Discretion of Sponsor|1|||
129840944|NCT00477672|467382819|FG001|Overall Study|Discretion of Sponsor|2|||
129840945|NCT00477672|467382820|FG002|Overall Study|Discretion of Sponsor|0|||
129840946|NCT03571516|467382821|FG000|Overall Study|Severe diarrhea|1|||
130063781|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
130063782|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130063783|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
130063784|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
130063785|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
130063786|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
130063787|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
130063788|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
130063789|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
130063790|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
130063791|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
130063792|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
130063793|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
130063794|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
130063795|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
130063796|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
129840947|NCT03571516|467382822|FG001|Overall Study|Severe diarrhea|0|||
129840948|NCT03571516|467382821|FG000|Overall Study|Withdrawal by Subject|0|||
129840949|NCT03571516|467382822|FG001|Overall Study|Withdrawal by Subject|1|||
129840950|NCT03044197|467382825|FG000|Overall Study|Withdrawal by Subject|3|||
129840951|NCT03044197|467382826|FG001|Overall Study|Withdrawal by Subject|1|||
129840952|NCT00989833|467382831|FG000|Overall Study|Lost to Follow-up|0|||
129840953|NCT00989833|467382832|FG001|Overall Study|Lost to Follow-up|1|||
129840954|NCT00989833|467382833|FG002|Overall Study|Lost to Follow-up|0|||
130063797|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130063798|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
130115502|NCT00192296|468382960|FG002|Overall Study|Withdrawal by Subject|0|||
130115503|NCT00192296|468382961|FG003|Overall Study|Withdrawal by Subject|0|||
130115504|NCT03465891|468382962|FG000|Overall Study|Withdrawal by Subject|0|||
130115505|NCT03465891|468382963|FG001|Overall Study|Withdrawal by Subject|1|||
129840955|NCT00989833|467382831|FG000|Overall Study|Protocol Violation|1|||
129840956|NCT00989833|467382832|FG001|Overall Study|Protocol Violation|2|||
130115506|NCT03465891|468382962|FG000|Overall Study|Disease progression|1|||
130115507|NCT03465891|468382963|FG001|Overall Study|Disease progression|0|||
130115508|NCT01001169|468382964|FG000|Overall Study|Withdrawal by Subject|2|||
130115509|NCT01001169|468382965|FG001|Overall Study|Withdrawal by Subject|1|||
130115510|NCT02536378|468382970|FG000|Overall Study|Physician Decision|0|||
130115511|NCT02536378|468382971|FG001|Overall Study|Physician Decision|2|||
130115512|NCT02536378|468382970|FG000|Overall Study|Withdrawal by Subject|0|||
130115513|NCT02536378|468382971|FG001|Overall Study|Withdrawal by Subject|1|||
130115514|NCT02536378|468382970|FG000|Overall Study|Death|1|||
130115515|NCT02536378|468382971|FG001|Overall Study|Death|2|||
130115516|NCT02536378|468382970|FG000|Overall Study|Patient refused further follow up|6|||
129899506|NCT01253226|467591871|FG003|Overall Study|Withdrawal by Subject|1|||
129899507|NCT01253226|467591872|FG004|Overall Study|Withdrawal by Subject|0|||
129899508|NCT03310983|467591873|FG000|Overall Study|Lost to Follow-up|15|||
129899509|NCT03310983|467591874|FG001|Overall Study|Lost to Follow-up|17|||
130115517|NCT02536378|468382971|FG001|Overall Study|Patient refused further follow up|2|||
130115518|NCT00798889|468382972|FG000|Overall Study|Adverse Event|53|||
129840957|NCT00989833|467382833|FG002|Overall Study|Protocol Violation|1|||
129840958|NCT00989833|467382831|FG000|Overall Study|Withdrawal by Subject|0|||
129840959|NCT00989833|467382832|FG001|Overall Study|Withdrawal by Subject|0|||
129840960|NCT00989833|467382833|FG002|Overall Study|Withdrawal by Subject|1|||
129840961|NCT00989833|467382831|FG000|Overall Study|Incorrectly randomized|1|||
129840962|NCT00989833|467382832|FG001|Overall Study|Incorrectly randomized|0|||
129840963|NCT00989833|467382833|FG002|Overall Study|Incorrectly randomized|0|||
129840964|NCT02469610|467382834|FG000|Overall Study|Death|1|||
129840965|NCT02469610|467382835|FG001|Overall Study|Death|0|||
129840966|NCT02469610|467382834|FG000|Overall Study|Lost to Follow-up|1|||
129840967|NCT02469610|467382835|FG001|Overall Study|Lost to Follow-up|0|||
129840968|NCT02469610|467382834|FG000|Overall Study|exclusion criteria|2|||
129840969|NCT02469610|467382835|FG001|Overall Study|exclusion criteria|1|||
129840970|NCT01806896|467382836|FG000|Overall Study|Adverse Event|2|||
129840971|NCT01806896|467382837|FG001|Overall Study|Adverse Event|0|||
129840972|NCT01806896|467382836|FG000|Overall Study|Other|1|||
129840973|NCT01806896|467382837|FG001|Overall Study|Other|0|||
129840974|NCT02434770|467382838|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
129840975|NCT02434770|467382839|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
129840976|NCT02434770|467382840|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
129840977|NCT02434770|467382838|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
129840978|NCT02434770|467382839|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
129840979|NCT02434770|467382840|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
129840980|NCT02434770|467382838|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
129840981|NCT02434770|467382839|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
129840982|NCT02434770|467382840|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
129840983|NCT02434770|467382838|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
129840984|NCT02434770|467382839|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
129840985|NCT02434770|467382840|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
129840986|NCT02434770|467382838|FG000|Week 1 to Week 18|Death|1|||
129840987|NCT02434770|467382839|FG001|Week 1 to Week 18|Death|0|||
129840988|NCT02434770|467382840|FG002|Week 1 to Week 18|Death|0|||
129840989|NCT02434770|467382838|FG000|Week 18 to Week|Lost to Follow-up|2|||
129840990|NCT02434770|467382839|FG001|Week 18 to Week|Lost to Follow-up|2|||
129840991|NCT02434770|467382840|FG002|Week 18 to Week|Lost to Follow-up|1|||
129840992|NCT02434770|467382838|FG000|Week 18 to Week|Withdrawal by Subject|0|||
129840993|NCT02434770|467382839|FG001|Week 18 to Week|Withdrawal by Subject|0|||
129840994|NCT02434770|467382840|FG002|Week 18 to Week|Withdrawal by Subject|2|||
129840995|NCT02434770|467382838|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
129840996|NCT02434770|467382839|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
129840997|NCT02434770|467382840|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
129840998|NCT00245765|467382841|FG000|Overall Study|Adverse Event|1|||
129840999|NCT00245765|467382842|FG001|Overall Study|Adverse Event|1|||
129841000|NCT00245765|467382843|FG002|Overall Study|Adverse Event|0|||
129841001|NCT00245765|467382841|FG000|Overall Study|Lack of Efficacy|14|||
129841002|NCT00245765|467382842|FG001|Overall Study|Lack of Efficacy|7|||
129841003|NCT00245765|467382843|FG002|Overall Study|Lack of Efficacy|0|||
129841004|NCT00245765|467382841|FG000|Overall Study|Lost to Follow-up|1|||
129841005|NCT00245765|467382842|FG001|Overall Study|Lost to Follow-up|2|||
129841006|NCT00245765|467382843|FG002|Overall Study|Lost to Follow-up|0|||
129841007|NCT00245765|467382841|FG000|Overall Study|Withdrawal by Subject|1|||
129841008|NCT00245765|467382842|FG001|Overall Study|Withdrawal by Subject|0|||
129841009|NCT00245765|467382843|FG002|Overall Study|Withdrawal by Subject|3|||
129841010|NCT00245765|467382841|FG000|Overall Study|Other reason|2|||
129841011|NCT00245765|467382842|FG001|Overall Study|Other reason|0|||
129841012|NCT00245765|467382843|FG002|Overall Study|Other reason|1|||
129841013|NCT00245765|467382841|FG000|Overall Study|Other|13|||
129899510|NCT01656304|467591880|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
130115519|NCT00798889|468382972|FG000|Overall Study|Protocol Violation|2|||
130115520|NCT00798889|468382972|FG000|Overall Study|Withdrawal by Subject|31|||
129841014|NCT00245765|467382842|FG001|Overall Study|Other|4|||
129841015|NCT00245765|467382843|FG002|Overall Study|Other|4|||
130115521|NCT00798889|468382972|FG000|Overall Study|Lost to Follow-up|1|||
130115522|NCT00798889|468382972|FG000|Overall Study|Lack of Efficacy|213|||
130115523|NCT00798889|468382972|FG000|Overall Study|Decision of Sponsor|11|||
130115524|NCT00798889|468382972|FG000|Overall Study|Enrolled, Not treated|3|||
130115525|NCT00617461|468382973|FG000|First Treatment Intervention Period|Adverse Event|2|||
130115526|NCT00617461|468382974|FG001|First Treatment Intervention Period|Adverse Event|0|||
130115527|NCT00617461|468382973|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
130115528|NCT00617461|468382974|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
130115529|NCT00617461|468382973|FG000|First Treatment Intervention Period|Protocol Violation|2|||
130115530|NCT00617461|468382974|FG001|First Treatment Intervention Period|Protocol Violation|1|||
130115531|NCT00617461|468382973|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
130115532|NCT00617461|468382974|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
130115533|NCT00617461|468382973|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
130115534|NCT00617461|468382974|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
130115535|NCT00617461|468382973|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
130115536|NCT00617461|468382974|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
130115537|NCT00617461|468382973|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
130115538|NCT00617461|468382974|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
130115539|NCT00617461|468382973|FG000|Second Treatment Intervention Period|Adverse Event|0|||
130115540|NCT00617461|468382974|FG001|Second Treatment Intervention Period|Adverse Event|1|||
130115541|NCT00617461|468382973|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
130115542|NCT00617461|468382974|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
130115543|NCT00617461|468382973|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
130115544|NCT00617461|468382974|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
130115545|NCT00617461|468382973|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
130115546|NCT00617461|468382974|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
130115547|NCT00358826|468382975|FG000|Core Study|Adverse Event|1|||
130115548|NCT00358826|468382976|FG001|Core Study|Adverse Event|3|||
130115549|NCT00358826|468382977|FG002|Core Study|Adverse Event|1|||
130115550|NCT00358826|468382978|FG003|Core Study|Adverse Event|1|||
130115551|NCT00358826|468382979|FG004|Core Study|Adverse Event|0|||
130115552|NCT00358826|468382980|FG005|Core Study|Adverse Event|0|||
130115553|NCT00358826|468382981|FG006|Core Study|Adverse Event|0|||
130115554|NCT00358826|468382982|FG007|Core Study|Adverse Event|0|||
130115555|NCT00358826|468382975|FG000|Core Study|Withdrawal by Subject|2|||
130115556|NCT00358826|468382976|FG001|Core Study|Withdrawal by Subject|2|||
130115557|NCT00358826|468382977|FG002|Core Study|Withdrawal by Subject|0|||
130115558|NCT00358826|468382978|FG003|Core Study|Withdrawal by Subject|0|||
130115559|NCT00358826|468382979|FG004|Core Study|Withdrawal by Subject|0|||
130115560|NCT00358826|468382980|FG005|Core Study|Withdrawal by Subject|0|||
130115561|NCT00358826|468382981|FG006|Core Study|Withdrawal by Subject|0|||
130115562|NCT00358826|468382982|FG007|Core Study|Withdrawal by Subject|0|||
130115563|NCT00358826|468382975|FG000|Core Study|Lost to Follow-up|0|||
130115564|NCT00358826|468382976|FG001|Core Study|Lost to Follow-up|0|||
130115565|NCT00358826|468382977|FG002|Core Study|Lost to Follow-up|0|||
130115566|NCT00358826|468382978|FG003|Core Study|Lost to Follow-up|1|||
130115567|NCT00358826|468382979|FG004|Core Study|Lost to Follow-up|0|||
130115568|NCT00358826|468382980|FG005|Core Study|Lost to Follow-up|0|||
130115569|NCT00358826|468382981|FG006|Core Study|Lost to Follow-up|0|||
130115570|NCT00358826|468382982|FG007|Core Study|Lost to Follow-up|0|||
130115571|NCT00358826|468382975|FG000|Core Study|Physician Decision|0|||
130115572|NCT00358826|468382976|FG001|Core Study|Physician Decision|0|||
130115573|NCT00358826|468382977|FG002|Core Study|Physician Decision|1|||
130115574|NCT00358826|468382978|FG003|Core Study|Physician Decision|0|||
130115575|NCT00358826|468382979|FG004|Core Study|Physician Decision|0|||
130115576|NCT00358826|468382980|FG005|Core Study|Physician Decision|0|||
130115577|NCT00358826|468382981|FG006|Core Study|Physician Decision|0|||
130115578|NCT00358826|468382982|FG007|Core Study|Physician Decision|0|||
130115579|NCT00358826|468382975|FG000|MDCT Substudy|Adverse Event|0|||
130115580|NCT00358826|468382976|FG001|MDCT Substudy|Adverse Event|0|||
130115581|NCT00358826|468382977|FG002|MDCT Substudy|Adverse Event|0|||
130115582|NCT00358826|468382978|FG003|MDCT Substudy|Adverse Event|0|||
130115583|NCT00358826|468382979|FG004|MDCT Substudy|Adverse Event|1|||
130115584|NCT00358826|468382980|FG005|MDCT Substudy|Adverse Event|0|||
130115585|NCT00358826|468382981|FG006|MDCT Substudy|Adverse Event|0|||
130115586|NCT00358826|468382982|FG007|MDCT Substudy|Adverse Event|0|||
130115587|NCT00358826|468382975|FG000|MDCT Substudy|Lost to Follow-up|0|||
129841016|NCT00660348|467382844|FG000|Overall Study|Withdrawal by Subject|1|||
129841017|NCT00660348|467382845|FG001|Overall Study|Withdrawal by Subject|0|||
129841018|NCT03316872|467382849|FG000|Overall Study|Death|1|||
130115588|NCT00358826|468382976|FG001|MDCT Substudy|Lost to Follow-up|0|||
130115589|NCT00358826|468382977|FG002|MDCT Substudy|Lost to Follow-up|0|||
130115590|NCT00358826|468382978|FG003|MDCT Substudy|Lost to Follow-up|0|||
130115591|NCT00358826|468382979|FG004|MDCT Substudy|Lost to Follow-up|0|||
130115592|NCT00358826|468382980|FG005|MDCT Substudy|Lost to Follow-up|1|||
129841019|NCT04074317|467382853|FG000|Third Period|Withdrawal by Subject|0|||
129841020|NCT04074317|467382854|FG001|Third Period|Withdrawal by Subject|0|||
130063799|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
130063800|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
130063801|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
130063802|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
130063803|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
130063804|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
130063805|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
130063806|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
130063807|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
130063808|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
130063809|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
130063810|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
130063811|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
130063812|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
130063813|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
130063814|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
130063815|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
130063816|NCT00383721|468186363|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
130063817|NCT00383721|468186364|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
130063818|NCT00383721|468186365|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
130063819|NCT00383721|468186366|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
130063820|NCT00383721|468186367|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
130063821|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
130063822|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
130063823|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
130063824|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
130063825|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
130063826|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130063827|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
130063828|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
130063829|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
130063830|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
130063831|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
130063832|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130063833|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130063834|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
130063835|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
130063836|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
130063837|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
130063838|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
130063839|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
130063840|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
130063841|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130063842|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130063843|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130063844|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
130063845|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
130063846|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
130063847|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130063848|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
130063849|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
130063850|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
130063851|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130063852|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130063853|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130063854|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
130063855|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
130063856|NCT00383721|468186363|FG000|26-Week Treatment Safety Extension|Administrative|1|||
130063857|NCT00383721|468186364|FG001|26-Week Treatment Safety Extension|Administrative|2|||
130063858|NCT00383721|468186365|FG002|26-Week Treatment Safety Extension|Administrative|3|||
130063859|NCT00383721|468186366|FG003|26-Week Treatment Safety Extension|Administrative|1|||
129841021|NCT04074317|467382855|FG002|Third Period|Withdrawal by Subject|0|||
129899511|NCT01155869|467591881|FG000|Overall Study|Lost to Follow-up|3|||
129899512|NCT01155869|467591882|FG001|Overall Study|Lost to Follow-up|1|||
129899513|NCT02824432|467591883|FG000|Overall Study|Major Protocol Deviation|1|||
129899514|NCT02824432|467591884|FG001|Overall Study|Major Protocol Deviation|0|||
129899515|NCT05826431|467591886|FG000|Overall Study|Withdrawal by Subject|1|||
129899516|NCT04771273|467591887|FG000|Dose Escalation Period|Not treated with trial medication|0|||
129899517|NCT04771273|467591888|FG001|Dose Escalation Period|Not treated with trial medication|1|||
129899518|NCT04771273|467591889|FG002|Dose Escalation Period|Not treated with trial medication|1|||
129899519|NCT04771273|467591890|FG003|Dose Escalation Period|Not treated with trial medication|0|||
129899520|NCT04771273|467591887|FG000|Dose Escalation Period|Other reasons than listed|2|||
129899521|NCT04771273|467591888|FG001|Dose Escalation Period|Other reasons than listed|0|||
129899522|NCT04771273|467591889|FG002|Dose Escalation Period|Other reasons than listed|2|||
129899523|NCT04771273|467591890|FG003|Dose Escalation Period|Other reasons than listed|1|||
129899524|NCT04771273|467591887|FG000|Dose Escalation Period|Protocol Violation|0|||
129899525|NCT04771273|467591888|FG001|Dose Escalation Period|Protocol Violation|0|||
129899526|NCT04771273|467591889|FG002|Dose Escalation Period|Protocol Violation|3|||
129899527|NCT04771273|467591890|FG003|Dose Escalation Period|Protocol Violation|1|||
129899528|NCT04771273|467591887|FG000|Dose Escalation Period|Burden of study procedures|1|||
129899529|NCT04771273|467591888|FG001|Dose Escalation Period|Burden of study procedures|0|||
129899530|NCT04771273|467591889|FG002|Dose Escalation Period|Burden of study procedures|0|||
129899531|NCT04771273|467591890|FG003|Dose Escalation Period|Burden of study procedures|0|||
129841022|NCT04074317|467382856|FG003|Third Period|Withdrawal by Subject|1|||
129841023|NCT04074317|467382857|FG004|Third Period|Withdrawal by Subject|0|||
129841024|NCT04074317|467382858|FG005|Third Period|Withdrawal by Subject|0|||
129841025|NCT00355238|467385025|FG000|Overall Study|Adverse event unrelated to study drug|2|||
129841026|NCT00355238|467385026|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129841027|NCT00355238|467385027|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129841028|NCT00355238|467385028|FG003|Overall Study|Adverse event unrelated to study drug|1|||
129841029|NCT00355238|467385025|FG000|Overall Study|Death|1|||
129841030|NCT00355238|467385026|FG001|Overall Study|Death|0|||
129841031|NCT00355238|467385027|FG002|Overall Study|Death|0|||
129841032|NCT00355238|467385028|FG003|Overall Study|Death|0|||
129841033|NCT00355238|467385025|FG000|Overall Study|Disease progression|37|||
129841034|NCT00355238|467385026|FG001|Overall Study|Disease progression|36|||
129841035|NCT00355238|467385027|FG002|Overall Study|Disease progression|16|||
129841036|NCT00355238|467385028|FG003|Overall Study|Disease progression|11|||
129841037|NCT00355238|467385025|FG000|Overall Study|Study drug toxicity|11|||
129841038|NCT00355238|467385026|FG001|Overall Study|Study drug toxicity|7|||
129841039|NCT00355238|467385027|FG002|Overall Study|Study drug toxicity|5|||
129841040|NCT00355238|467385028|FG003|Overall Study|Study drug toxicity|2|||
129841041|NCT00355238|467385025|FG000|Overall Study|Participant withdrew consent|3|||
129841042|NCT00355238|467385026|FG001|Overall Study|Participant withdrew consent|1|||
129841043|NCT00355238|467385027|FG002|Overall Study|Participant withdrew consent|0|||
129841044|NCT00355238|467385028|FG003|Overall Study|Participant withdrew consent|0|||
129841045|NCT00355238|467385025|FG000|Overall Study|Participant request to discontinue study treatment|1|||
129841046|NCT00355238|467385026|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129841047|NCT00355238|467385027|FG002|Overall Study|Participant request to discontinue study treatment|1|||
129841048|NCT00355238|467385028|FG003|Overall Study|Participant request to discontinue study treatment|0|||
129841049|NCT01956110|467385029|FG000|Overall Study|Protocol Violation|25|||
129841050|NCT01956110|467385030|FG001|Overall Study|Protocol Violation|11|||
129841051|NCT01956110|467385029|FG000|Overall Study|Adverse Event|9|||
129841052|NCT01956110|467385030|FG001|Overall Study|Adverse Event|10|||
129841053|NCT01956110|467385029|FG000|Overall Study|Personal reasons|1|||
129841054|NCT01956110|467385030|FG001|Overall Study|Personal reasons|1|||
129841055|NCT00910715|467385037|FG000|Overall Study|Lost to Follow-up|22|||
129841056|NCT00910715|467385038|FG001|Overall Study|Lost to Follow-up|26|||
129841057|NCT00910715|467385039|FG002|Overall Study|Lost to Follow-up|0|||
129841058|NCT01467076|467385040|FG000|Overall Study|Lost to Follow-up|1|||
129841059|NCT01467076|467385041|FG001|Overall Study|Lost to Follow-up|0|||
129841060|NCT01467076|467385042|FG002|Overall Study|Lost to Follow-up|0|||
129841061|NCT03761628|467385044|FG000|Overall Study|Withdrawal by Subject|3|||
129899532|NCT04771273|467591887|FG000|Dose Escalation Period|Change of residence|0|||
129841062|NCT03761628|467385044|FG000|Overall Study|Physician Decision|1|||
129841063|NCT03761628|467385044|FG000|Overall Study|Pregnancy|1|||
129841064|NCT03761628|467385044|FG000|Overall Study|Lost to Follow-up|1|||
129841065|NCT05358821|467385047|FG000|Overall Study|Withdrawal by Subject|0|||
129841066|NCT05358821|467385048|FG001|Overall Study|Withdrawal by Subject|1|||
129841067|NCT05358821|467385049|FG002|Overall Study|Withdrawal by Subject|0|||
129841068|NCT05358821|467385047|FG000|Overall Study|Withdrawal of Consent|0|||
129841069|NCT05358821|467385048|FG001|Overall Study|Withdrawal of Consent|0|||
129899533|NCT04771273|467591888|FG001|Dose Escalation Period|Change of residence|0|||
129899534|NCT04771273|467591889|FG002|Dose Escalation Period|Change of residence|0|||
130115593|NCT00358826|468382981|FG006|MDCT Substudy|Lost to Follow-up|0|||
129841070|NCT05358821|467385049|FG002|Overall Study|Withdrawal of Consent|1|||
129841071|NCT04649151|467385050|FG000|Overall Study|Pregnancy|0|||
129899535|NCT04771273|467591890|FG003|Dose Escalation Period|Change of residence|1|||
129899536|NCT04771273|467591887|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
129841072|NCT04649151|467385051|FG001|Overall Study|Pregnancy|0|||
129841073|NCT04649151|467385052|FG002|Overall Study|Pregnancy|0|||
129841074|NCT04649151|467385053|FG003|Overall Study|Pregnancy|0|||
129841075|NCT04649151|467385054|FG004|Overall Study|Pregnancy|3|||
129841076|NCT04649151|467385050|FG000|Overall Study|Physician Decision|10|||
129841077|NCT04649151|467385051|FG001|Overall Study|Physician Decision|0|||
129841078|NCT04649151|467385052|FG002|Overall Study|Physician Decision|0|||
129841079|NCT04649151|467385053|FG003|Overall Study|Physician Decision|1|||
129841080|NCT04649151|467385054|FG004|Overall Study|Physician Decision|1|||
129841081|NCT04649151|467385050|FG000|Overall Study|Protocol Deviation|25|||
129841082|NCT04649151|467385051|FG001|Overall Study|Protocol Deviation|3|||
129841083|NCT04649151|467385052|FG002|Overall Study|Protocol Deviation|0|||
129841084|NCT04649151|467385053|FG003|Overall Study|Protocol Deviation|0|||
129841085|NCT04649151|467385054|FG004|Overall Study|Protocol Deviation|0|||
129841086|NCT04649151|467385050|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
129841087|NCT04649151|467385051|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
129841088|NCT04649151|467385052|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
129841089|NCT04649151|467385053|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
129841090|NCT04649151|467385054|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
129841091|NCT04649151|467385050|FG000|Overall Study|Withdrawal by Subject|370|||
129841092|NCT04649151|467385051|FG001|Overall Study|Withdrawal by Subject|113|||
129841093|NCT04649151|467385052|FG002|Overall Study|Withdrawal by Subject|2|||
129841094|NCT04649151|467385053|FG003|Overall Study|Withdrawal by Subject|7|||
129841095|NCT04649151|467385054|FG004|Overall Study|Withdrawal by Subject|15|||
129841096|NCT04649151|467385050|FG000|Overall Study|Adverse Event|1|||
129841097|NCT04649151|467385051|FG001|Overall Study|Adverse Event|0|||
129841098|NCT04649151|467385052|FG002|Overall Study|Adverse Event|0|||
129841099|NCT04649151|467385053|FG003|Overall Study|Adverse Event|0|||
129841100|NCT04649151|467385054|FG004|Overall Study|Adverse Event|0|||
129841101|NCT04649151|467385050|FG000|Overall Study|Lost to Follow-up|256|||
129841102|NCT04649151|467385051|FG001|Overall Study|Lost to Follow-up|29|||
129841103|NCT04649151|467385052|FG002|Overall Study|Lost to Follow-up|10|||
129841104|NCT04649151|467385053|FG003|Overall Study|Lost to Follow-up|3|||
129841105|NCT04649151|467385054|FG004|Overall Study|Lost to Follow-up|6|||
129841106|NCT04649151|467385050|FG000|Overall Study|Other than specified|59|||
129841107|NCT04649151|467385051|FG001|Overall Study|Other than specified|294|||
129841108|NCT04649151|467385052|FG002|Overall Study|Other than specified|0|||
129841109|NCT04649151|467385053|FG003|Overall Study|Other than specified|0|||
129841110|NCT04649151|467385054|FG004|Overall Study|Other than specified|4|||
129841111|NCT04649151|467385050|FG000|Overall Study|Death|0|||
129841112|NCT04649151|467385051|FG001|Overall Study|Death|0|||
129841113|NCT04649151|467385052|FG002|Overall Study|Death|0|||
129841114|NCT04649151|467385053|FG003|Overall Study|Death|0|||
129841115|NCT04649151|467385054|FG004|Overall Study|Death|1|||
129841116|NCT03752619|467385055|FG000|Overall Study|Lost to Follow-up|2|||
129841117|NCT03752619|467385056|FG001|Overall Study|Lost to Follow-up|1|||
129841118|NCT03752619|467385055|FG000|Overall Study|Withdrawal by Subject|1|||
129841119|NCT03752619|467385056|FG001|Overall Study|Withdrawal by Subject|1|||
129841120|NCT03752619|467385055|FG000|Overall Study|Adverse Event|0|||
129841121|NCT03752619|467385056|FG001|Overall Study|Adverse Event|1|||
129841122|NCT03907683|467385057|FG000|Overall Study|Pregnancy|1|||
129841123|NCT03907683|467385057|FG000|Overall Study|Withdrawal by Subject|1|||
129841124|NCT03400332|467385058|FG000|Pre-Treatment|Other reasons|0|||
129841125|NCT03400332|467385059|FG001|Pre-Treatment|Other reasons|0|||
129841126|NCT03400332|467385060|FG002|Pre-Treatment|Other reasons|0|||
129841127|NCT03400332|467385061|FG003|Pre-Treatment|Other reasons|0|||
129841128|NCT03400332|467385062|FG004|Pre-Treatment|Other reasons|0|||
129841129|NCT03400332|467385063|FG005|Pre-Treatment|Other reasons|0|||
129841130|NCT03400332|467385064|FG006|Pre-Treatment|Other reasons|0|||
129841131|NCT03400332|467385065|FG007|Pre-Treatment|Other reasons|0|||
129899537|NCT04771273|467591888|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
130115594|NCT00358826|468382982|FG007|MDCT Substudy|Lost to Follow-up|0|||
129841132|NCT03400332|467385066|FG008|Pre-Treatment|Other reasons|1|||
129841133|NCT03400332|467385058|FG000|Pre-Treatment|No longer met study criteria|0|||
129841134|NCT03400332|467385059|FG001|Pre-Treatment|No longer met study criteria|0|||
129841135|NCT03400332|467385060|FG002|Pre-Treatment|No longer met study criteria|0|||
129841136|NCT03400332|467385061|FG003|Pre-Treatment|No longer met study criteria|0|||
129841137|NCT03400332|467385062|FG004|Pre-Treatment|No longer met study criteria|0|||
129841138|NCT03400332|467385063|FG005|Pre-Treatment|No longer met study criteria|0|||
129841139|NCT03400332|467385064|FG006|Pre-Treatment|No longer met study criteria|0|||
129841140|NCT03400332|467385065|FG007|Pre-Treatment|No longer met study criteria|0|||
129841141|NCT03400332|467385066|FG008|Pre-Treatment|No longer met study criteria|1|||
129841142|NCT03400332|467385058|FG000|Pre-Treatment|Withdrawal by Subject|0|||
129841143|NCT03400332|467385059|FG001|Pre-Treatment|Withdrawal by Subject|0|||
129841144|NCT03400332|467385060|FG002|Pre-Treatment|Withdrawal by Subject|0|||
130115595|NCT00358826|468382975|FG000|MDCT Substudy|Withdrawal by Subject|0|||
130063860|NCT00383721|468186367|FG004|26-Week Treatment Safety Extension|Administrative|0|||
130063861|NCT03519516|468186369|FG000|Overall Study|Adverse Event|0|||
130063862|NCT03519516|468186370|FG001|Overall Study|Adverse Event|1|||
130063863|NCT01935336|468186371|FG000|Overall Study|Adverse Event|1|||
130063864|NCT01935336|468186372|FG001|Overall Study|Adverse Event|0|||
130063865|NCT01935336|468186373|FG002|Overall Study|Adverse Event|0|||
130063866|NCT01935336|468186374|FG003|Overall Study|Adverse Event|0|||
130063867|NCT01935336|468186371|FG000|Overall Study|Progressive disease|5|||
130063868|NCT01935336|468186372|FG001|Overall Study|Progressive disease|3|||
130063869|NCT01935336|468186373|FG002|Overall Study|Progressive disease|47|||
130063870|NCT01935336|468186374|FG003|Overall Study|Progressive disease|66|||
130063871|NCT01146951|468187787|FG000|Overall Study|Adverse Event|4|||
130063872|NCT01146951|468187788|FG001|Overall Study|Adverse Event|1|||
130063873|NCT01747811|468187789|FG000|Overall Study|Lack of Efficacy|2|||
130063874|NCT01747811|468187790|FG001|Overall Study|Lack of Efficacy|4|||
130063875|NCT01337167|468187794|FG000|Infant Series|Adverse Event|1|||
130063876|NCT01337167|468187795|FG001|Infant Series|Adverse Event|1|||
130063877|NCT01337167|468187794|FG000|Infant Series|Death|1|||
130063878|NCT01337167|468187795|FG001|Infant Series|Death|1|||
130063879|NCT01337167|468187794|FG000|Infant Series|Lost to Follow-up|13|||
130063880|NCT01337167|468187795|FG001|Infant Series|Lost to Follow-up|7|||
130063881|NCT01337167|468187794|FG000|Infant Series|Non-compliance with study drug|2|||
130063882|NCT01337167|468187795|FG001|Infant Series|Non-compliance with study drug|1|||
130063883|NCT01337167|468187794|FG000|Infant Series|Physician Decision|3|||
130063884|NCT01337167|468187795|FG001|Infant Series|Physician Decision|1|||
130063885|NCT01337167|468187794|FG000|Infant Series|Protocol Violation|22|||
130063886|NCT01337167|468187795|FG001|Infant Series|Protocol Violation|9|||
130063887|NCT01337167|468187794|FG000|Infant Series|Withdrawal by Subject|15|||
130063888|NCT01337167|468187795|FG001|Infant Series|Withdrawal by Subject|4|||
130063889|NCT01337167|468187794|FG000|Infant Series|Randomized but not vaccinated|5|||
130063890|NCT01337167|468187795|FG001|Infant Series|Randomized but not vaccinated|3|||
130063891|NCT01337167|468187794|FG000|Interim Period|Lost to Follow-up|51|||
130063892|NCT01337167|468187795|FG001|Interim Period|Lost to Follow-up|23|||
130063893|NCT01337167|468187794|FG000|Interim Period|Non-compliance with study drug|1|||
130063894|NCT01337167|468187795|FG001|Interim Period|Non-compliance with study drug|0|||
130063895|NCT01337167|468187794|FG000|Interim Period|Physician Decision|6|||
130063896|NCT01337167|468187795|FG001|Interim Period|Physician Decision|3|||
130063897|NCT01337167|468187794|FG000|Interim Period|Protocol Violation|5|||
130063898|NCT01337167|468187795|FG001|Interim Period|Protocol Violation|3|||
130063899|NCT01337167|468187794|FG000|Interim Period|Withdrawal by Subject|18|||
130063900|NCT01337167|468187795|FG001|Interim Period|Withdrawal by Subject|10|||
130063901|NCT01337167|468187794|FG000|Interim Period|Other protocol criterion not met|0|||
130063902|NCT01337167|468187795|FG001|Interim Period|Other protocol criterion not met|1|||
130063903|NCT01337167|468187794|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
130063904|NCT01337167|468187795|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
130063905|NCT01337167|468187794|FG000|Toddler Vaccinations|Protocol Violation|0|||
130063906|NCT01337167|468187795|FG001|Toddler Vaccinations|Protocol Violation|1|||
130063907|NCT01337167|468187794|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
130063908|NCT01337167|468187795|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
130063909|NCT03833817|468187796|FG000|Overall Study|Withdrawal by Subject|3|||
130063910|NCT03833817|468187797|FG001|Overall Study|Withdrawal by Subject|3|||
130063911|NCT03833817|468187796|FG000|Overall Study|Lost to Follow-up|3|||
130063912|NCT03833817|468187797|FG001|Overall Study|Lost to Follow-up|3|||
130063913|NCT02126670|468187802|FG000|Overall Study|Withdrawal by Subject|1|||
130063914|NCT02126670|468187803|FG001|Overall Study|Withdrawal by Subject|0|||
130063915|NCT02126670|468187804|FG002|Overall Study|Withdrawal by Subject|0|||
130063916|NCT02126670|468187805|FG003|Overall Study|Withdrawal by Subject|1|||
129841145|NCT03400332|467385061|FG003|Pre-Treatment|Withdrawal by Subject|0|||
129841146|NCT03400332|467385062|FG004|Pre-Treatment|Withdrawal by Subject|0|||
129841147|NCT03400332|467385063|FG005|Pre-Treatment|Withdrawal by Subject|0|||
130063917|NCT03363919|468187808|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
130115596|NCT00358826|468382976|FG001|MDCT Substudy|Withdrawal by Subject|0|||
129841148|NCT03400332|467385064|FG006|Pre-Treatment|Withdrawal by Subject|0|||
129841149|NCT03400332|467385065|FG007|Pre-Treatment|Withdrawal by Subject|0|||
130063918|NCT03363919|468187809|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
130063919|NCT03363919|468187808|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
130063920|NCT03363919|468187809|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
130063921|NCT01646398|468187810|FG000|Overall Study|Withdrawal by Subject|1|||
130063922|NCT01646398|468187811|FG001|Overall Study|Withdrawal by Subject|0|||
130063923|NCT00255034|468187812|FG000|Overall Study|Withdrawal by Subject|15|||
130063924|NCT00255034|468187813|FG001|Overall Study|Withdrawal by Subject|38|||
130063925|NCT01827319|468187814|FG000|Overall Study|Lost to Follow-up|3|||
130063926|NCT03947255|468187818|FG000|Overall Study|Study Closure by Sponsor|2|||
130063927|NCT03947255|468187819|FG001|Overall Study|Study Closure by Sponsor|2|||
130063928|NCT03947255|468187818|FG000|Overall Study|Withdrawal by Subject|2|||
130063929|NCT03947255|468187819|FG001|Overall Study|Withdrawal by Subject|2|||
130063930|NCT03947255|468187818|FG000|Overall Study|Lost to Follow-up|2|||
130063931|NCT03947255|468187819|FG001|Overall Study|Lost to Follow-up|0|||
130063932|NCT03947255|468187818|FG000|Overall Study|Death|0|||
130063933|NCT03947255|468187819|FG001|Overall Study|Death|2|||
129841150|NCT03400332|467385066|FG008|Pre-Treatment|Withdrawal by Subject|1|||
129841151|NCT03400332|467385058|FG000|Treatment|Participant withdrew consent|2|||
129841152|NCT03400332|467385059|FG001|Treatment|Participant withdrew consent|2|||
129841153|NCT03400332|467385060|FG002|Treatment|Participant withdrew consent|0|||
129841154|NCT03400332|467385061|FG003|Treatment|Participant withdrew consent|0|||
129841155|NCT03400332|467385062|FG004|Treatment|Participant withdrew consent|3|||
129841156|NCT03400332|467385063|FG005|Treatment|Participant withdrew consent|3|||
129841157|NCT03400332|467385064|FG006|Treatment|Participant withdrew consent|1|||
129841158|NCT03400332|467385065|FG007|Treatment|Participant withdrew consent|1|||
129841159|NCT03400332|467385066|FG008|Treatment|Participant withdrew consent|1|||
129841160|NCT03400332|467385058|FG000|Treatment|Other reasons|0|||
129841161|NCT03400332|467385059|FG001|Treatment|Other reasons|1|||
129841162|NCT03400332|467385060|FG002|Treatment|Other reasons|1|||
129841163|NCT03400332|467385061|FG003|Treatment|Other reasons|0|||
129841164|NCT03400332|467385062|FG004|Treatment|Other reasons|3|||
129841165|NCT03400332|467385063|FG005|Treatment|Other reasons|1|||
129841166|NCT03400332|467385064|FG006|Treatment|Other reasons|2|||
129841167|NCT03400332|467385065|FG007|Treatment|Other reasons|0|||
129841168|NCT03400332|467385066|FG008|Treatment|Other reasons|1|||
129841169|NCT03400332|467385058|FG000|Treatment|Lost to Follow-up|0|||
129841170|NCT03400332|467385059|FG001|Treatment|Lost to Follow-up|1|||
129841171|NCT03400332|467385060|FG002|Treatment|Lost to Follow-up|0|||
129841172|NCT03400332|467385061|FG003|Treatment|Lost to Follow-up|0|||
129841173|NCT03400332|467385062|FG004|Treatment|Lost to Follow-up|0|||
129841174|NCT03400332|467385063|FG005|Treatment|Lost to Follow-up|0|||
129841175|NCT03400332|467385064|FG006|Treatment|Lost to Follow-up|0|||
129841176|NCT03400332|467385065|FG007|Treatment|Lost to Follow-up|0|||
129841177|NCT03400332|467385066|FG008|Treatment|Lost to Follow-up|0|||
129841178|NCT03400332|467385058|FG000|Treatment|Death|3|||
129841179|NCT03400332|467385059|FG001|Treatment|Death|1|||
129841180|NCT03400332|467385060|FG002|Treatment|Death|2|||
129841181|NCT03400332|467385061|FG003|Treatment|Death|3|||
129841182|NCT03400332|467385062|FG004|Treatment|Death|6|||
129841183|NCT03400332|467385063|FG005|Treatment|Death|2|||
129841184|NCT03400332|467385064|FG006|Treatment|Death|1|||
129841185|NCT03400332|467385065|FG007|Treatment|Death|3|||
129841186|NCT03400332|467385066|FG008|Treatment|Death|6|||
129841187|NCT03901963|467385067|FG000|Overall Study|Lost to Follow-up|1|||
129841188|NCT03901963|467385068|FG001|Overall Study|Lost to Follow-up|1|||
129841189|NCT03901963|467385067|FG000|Overall Study|Physician Decision|1|||
129841190|NCT03901963|467385068|FG001|Overall Study|Physician Decision|2|||
129841191|NCT03901963|467385067|FG000|Overall Study|Protocol Violation|1|||
129841192|NCT03901963|467385068|FG001|Overall Study|Protocol Violation|1|||
129841193|NCT03901963|467385067|FG000|Overall Study|Withdrawal by Subject|4|||
129841194|NCT03901963|467385068|FG001|Overall Study|Withdrawal by Subject|11|||
129841195|NCT03901963|467385067|FG000|Overall Study|Ongoing|84|||
129841196|NCT03901963|467385068|FG001|Overall Study|Ongoing|73|||
129841197|NCT03901963|467385067|FG000|Overall Study|Randomized but not treated|3|||
129841198|NCT03901963|467385068|FG001|Overall Study|Randomized but not treated|3|||
129841199|NCT02018458|467385075|FG000|Overall Study|Death|4|||
129841200|NCT04033159|467385099|FG000|Washout Period|Physician Decision|0|||
129841201|NCT04033159|467385100|FG001|Washout Period|Physician Decision|1|||
129841202|NCT04033159|467385101|FG002|Washout Period|Physician Decision|0|||
129841203|NCT04033159|467385099|FG000|Washout Period|Study terminated by Sponsor|0|||
129841204|NCT04033159|467385100|FG001|Washout Period|Study terminated by Sponsor|7|||
129841205|NCT04033159|467385101|FG002|Washout Period|Study terminated by Sponsor|0|||
129841206|NCT04033159|467385099|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
129841207|NCT04033159|467385100|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
130063934|NCT02499575|468187820|FG000|Overall Study|Protocol Violation|0|||
130063935|NCT02499575|468187821|FG001|Overall Study|Protocol Violation|1|||
130063936|NCT00574119|468187822|FG000|Overall Study|Adverse Event|1|||
129841208|NCT04033159|467385101|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
129841209|NCT00116558|467385102|FG000|Overall Study|Death|11|||
129841210|NCT00116558|467385103|FG001|Overall Study|Death|5|||
129841211|NCT00116558|467385104|FG002|Overall Study|Death|3|||
129841212|NCT00116558|467385102|FG000|Overall Study|Withdrawal by Subject|17|||
129841213|NCT00116558|467385103|FG001|Overall Study|Withdrawal by Subject|3|||
129841214|NCT00116558|467385104|FG002|Overall Study|Withdrawal by Subject|12|||
129841215|NCT00116558|467385102|FG000|Overall Study|disease progression|3|||
129841216|NCT00116558|467385103|FG001|Overall Study|disease progression|7|||
129841217|NCT00116558|467385104|FG002|Overall Study|disease progression|18|||
129841218|NCT02027844|467385105|FG000|Overall Study|Withdrawal by Subject|3|||
129841219|NCT02027844|467385106|FG001|Overall Study|Withdrawal by Subject|2|||
129841220|NCT02027844|467385107|FG002|Overall Study|Withdrawal by Subject|1|||
130063937|NCT00574119|468187822|FG000|Overall Study|Protocol Violation|1|||
130063938|NCT00574119|468187822|FG000|Overall Study|Withdrawal by Subject|1|||
130063939|NCT00574119|468187822|FG000|Overall Study|Physician Decision|1|||
130063940|NCT02667457|468187827|FG000|Overall Study|Withdrawal by Subject|1|||
130063941|NCT02667457|468187828|FG001|Overall Study|Withdrawal by Subject|0|||
130063942|NCT02667457|468187827|FG000|Overall Study|Other Reason|0|||
130063943|NCT02667457|468187828|FG001|Overall Study|Other Reason|2|||
130063944|NCT02475850|468187829|FG000|Overall Study|Death|155|||
130063945|NCT02475850|468187830|FG001|Overall Study|Death|141|||
130063946|NCT02475850|468187829|FG000|Overall Study|Lost to Follow-up|217|||
130063947|NCT02475850|468187830|FG001|Overall Study|Lost to Follow-up|188|||
130063948|NCT02475850|468187829|FG000|Overall Study|Withdrawal by Subject|221|||
130063949|NCT02475850|468187830|FG001|Overall Study|Withdrawal by Subject|155|||
130063950|NCT03297216|468187835|FG000|Overall Study|Death|0|||
130063951|NCT03297216|468187836|FG001|Overall Study|Death|1|||
130063952|NCT03297216|468187835|FG000|Overall Study|Miscarriage|0|||
130063953|NCT03297216|468187836|FG001|Overall Study|Miscarriage|2|||
130063954|NCT03297216|468187835|FG000|Overall Study|Lost to Follow-up|3|||
130063955|NCT03297216|468187836|FG001|Overall Study|Lost to Follow-up|2|||
130063956|NCT02700919|468187837|FG000|Overall Study|Physician Decision|1|||
130063957|NCT02700919|468187838|FG001|Overall Study|Physician Decision|0|||
130063958|NCT02700919|468187839|FG002|Overall Study|Physician Decision|0|||
130063959|NCT02700919|468187837|FG000|Overall Study|Protocol Violation|1|||
130063960|NCT02700919|468187838|FG001|Overall Study|Protocol Violation|0|||
130063961|NCT02700919|468187839|FG002|Overall Study|Protocol Violation|0|||
130063962|NCT02700919|468187837|FG000|Overall Study|Adverse Event|1|||
130063963|NCT02700919|468187838|FG001|Overall Study|Adverse Event|3|||
130063964|NCT02700919|468187839|FG002|Overall Study|Adverse Event|1|||
130063965|NCT02700919|468187837|FG000|Overall Study|Withdrawal by Subject|5|||
130063966|NCT02700919|468187838|FG001|Overall Study|Withdrawal by Subject|8|||
130063967|NCT02700919|468187839|FG002|Overall Study|Withdrawal by Subject|2|||
129841221|NCT02027844|467385105|FG000|Overall Study|Lost to Follow-up|0|||
130063968|NCT02700919|468187837|FG000|Overall Study|Lost to Follow-up|2|||
129841222|NCT02027844|467385106|FG001|Overall Study|Lost to Follow-up|2|||
129841223|NCT02027844|467385107|FG002|Overall Study|Lost to Follow-up|1|||
129841224|NCT02027844|467385105|FG000|Overall Study|Protocol Violation|0|||
129841225|NCT02027844|467385106|FG001|Overall Study|Protocol Violation|2|||
129841226|NCT02027844|467385107|FG002|Overall Study|Protocol Violation|0|||
129841227|NCT02027844|467385105|FG000|Overall Study|Incomlete data|2|||
129841228|NCT02027844|467385106|FG001|Overall Study|Incomlete data|0|||
129841229|NCT02027844|467385107|FG002|Overall Study|Incomlete data|0|||
129841230|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
129841231|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
129841232|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Graft loss|1|||
129841233|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Graft loss|2|||
129841234|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Death|5|||
129841235|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Death|3|||
129841236|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
129841237|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
129841238|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
129841239|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
129841240|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
129841241|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
130063969|NCT02700919|468187838|FG001|Overall Study|Lost to Follow-up|0|||
130063970|NCT02700919|468187839|FG002|Overall Study|Lost to Follow-up|0|||
130063971|NCT02700919|468187837|FG000|Overall Study|Other|2|||
130063972|NCT02700919|468187838|FG001|Overall Study|Other|1|||
130063973|NCT02700919|468187839|FG002|Overall Study|Other|1|||
130063974|NCT03434418|468187840|FG000|Overall Study|Disease Progression|11|||
130063975|NCT03434418|468187840|FG000|Overall Study|Adverse Event|2|||
130063976|NCT03434418|468187840|FG000|Overall Study|Physician Decision|1|||
130063977|NCT03434418|468187840|FG000|Overall Study|Decline in Performance Status (PS)|1|||
130063978|NCT00912340|468187844|FG000|Overall Study|Adverse Event|2|||
130063979|NCT00912340|468187845|FG001|Overall Study|Adverse Event|4|||
130063980|NCT00912340|468187846|FG002|Overall Study|Adverse Event|0|||
130063981|NCT00912340|468187844|FG000|Overall Study|Protocol revised to remove arm|0|||
130063982|NCT00912340|468187845|FG001|Overall Study|Protocol revised to remove arm|0|||
129841242|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
129841243|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
129841244|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
130063983|NCT00912340|468187846|FG002|Overall Study|Protocol revised to remove arm|4|||
130063984|NCT01517412|468187849|FG000|Overall Study|Adverse Event|10|||
130063985|NCT01517412|468187850|FG001|Overall Study|Adverse Event|11|||
130063986|NCT01517412|468187849|FG000|Overall Study|Lack of Efficacy|10|||
130063987|NCT01517412|468187850|FG001|Overall Study|Lack of Efficacy|5|||
130063988|NCT01517412|468187849|FG000|Overall Study|Poor compliance to protocol|8|||
130063989|NCT01517412|468187850|FG001|Overall Study|Poor compliance to protocol|3|||
130063990|NCT01517412|468187849|FG000|Overall Study|Other than specified above|8|||
130063991|NCT01517412|468187850|FG001|Overall Study|Other than specified above|5|||
130063992|NCT01253187|468187851|FG000|Period 2|Withdrawal by Subject|0|||
130115597|NCT00358826|468382977|FG002|MDCT Substudy|Withdrawal by Subject|0|||
130115598|NCT00358826|468382978|FG003|MDCT Substudy|Withdrawal by Subject|0|||
130115599|NCT00358826|468382979|FG004|MDCT Substudy|Withdrawal by Subject|0|||
130115600|NCT00358826|468382980|FG005|MDCT Substudy|Withdrawal by Subject|1|||
130115601|NCT00358826|468382981|FG006|MDCT Substudy|Withdrawal by Subject|0|||
130115602|NCT00358826|468382982|FG007|MDCT Substudy|Withdrawal by Subject|0|||
130115603|NCT00903383|468382986|FG000|Overall Study|Adverse Event|1|||
130115604|NCT00903383|468382987|FG001|Overall Study|Adverse Event|2|||
130115605|NCT00903383|468382988|FG002|Overall Study|Adverse Event|3|||
130115606|NCT00903383|468382989|FG003|Overall Study|Adverse Event|1|||
130115607|NCT00903383|468382986|FG000|Overall Study|Physician Decision|1|||
130115608|NCT00903383|468382987|FG001|Overall Study|Physician Decision|2|||
130115609|NCT00903383|468382988|FG002|Overall Study|Physician Decision|0|||
130115610|NCT00903383|468382989|FG003|Overall Study|Physician Decision|0|||
130115611|NCT00903383|468382986|FG000|Overall Study|Lost to Follow-up|0|||
130115612|NCT00903383|468382987|FG001|Overall Study|Lost to Follow-up|0|||
130115613|NCT00903383|468382988|FG002|Overall Study|Lost to Follow-up|0|||
130115614|NCT00903383|468382989|FG003|Overall Study|Lost to Follow-up|1|||
130115615|NCT00903383|468382986|FG000|Overall Study|Decision of Sponsor|1|||
130115616|NCT00903383|468382987|FG001|Overall Study|Decision of Sponsor|0|||
130115617|NCT00903383|468382988|FG002|Overall Study|Decision of Sponsor|0|||
130115618|NCT00903383|468382989|FG003|Overall Study|Decision of Sponsor|0|||
130115619|NCT00903383|468382986|FG000|Overall Study|Withdrawal by Subject|4|||
130115620|NCT00903383|468382987|FG001|Overall Study|Withdrawal by Subject|1|||
130115621|NCT00903383|468382988|FG002|Overall Study|Withdrawal by Subject|0|||
130115622|NCT00903383|468382989|FG003|Overall Study|Withdrawal by Subject|2|||
130115623|NCT00903383|468382986|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
130115624|NCT00903383|468382987|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
130115625|NCT00903383|468382988|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
130115626|NCT00903383|468382989|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
130115627|NCT00903383|468382986|FG000|Overall Study|Patient Decision|0|||
130115628|NCT00903383|468382987|FG001|Overall Study|Patient Decision|0|||
130115629|NCT00903383|468382988|FG002|Overall Study|Patient Decision|0|||
130115630|NCT00903383|468382989|FG003|Overall Study|Patient Decision|1|||
130115631|NCT01821625|468382992|FG000|Overall Study|Withdrawal by Subject|2|||
130115632|NCT01821625|468382992|FG000|Overall Study|Lack of Efficacy|2|||
130115633|NCT01821625|468382992|FG000|Overall Study|Adverse Event|1|||
130115634|NCT01821625|468382992|FG000|Overall Study|Medical contraindication|1|||
130115635|NCT00320593|468382993|FG000|Overall Study|Lost to Follow-up|3|||
130115636|NCT00320593|468382994|FG001|Overall Study|Lost to Follow-up|0|||
130115637|NCT00320593|468382993|FG000|Overall Study|Moved to another state|1|||
130115638|NCT00320593|468382994|FG001|Overall Study|Moved to another state|0|||
130115639|NCT00320593|468382993|FG000|Overall Study|Withdrawal by Subject|2|||
130115640|NCT00320593|468382994|FG001|Overall Study|Withdrawal by Subject|1|||
130115641|NCT00320593|468382993|FG000|Overall Study|Withdrawal by clinical center|1|||
130115642|NCT00320593|468382994|FG001|Overall Study|Withdrawal by clinical center|0|||
130115643|NCT00457665|468382997|FG000|12 Months|Drug allergy|1|||
130115644|NCT00457665|468382998|FG001|12 Months|Drug allergy|1|||
130115645|NCT00457665|468382997|FG000|12 Months|High HIV viral load|5|||
130115646|NCT00457665|468382998|FG001|12 Months|High HIV viral load|1|||
130115647|NCT00457665|468382997|FG000|12 Months|Lipodystrophy|2|||
130115648|NCT00457665|468382998|FG001|12 Months|Lipodystrophy|0|||
130115649|NCT00457665|468382997|FG000|12 Months|Withdrawal by Subject|0|||
130115650|NCT00457665|468382998|FG001|12 Months|Withdrawal by Subject|2|||
130115651|NCT00457665|468382997|FG000|12 Months|Abnormal Liver function tests|0|||
129899538|NCT04771273|467591889|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
129899539|NCT04771273|467591890|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
129899540|NCT04771273|467591887|FG000|Dose Escalation Period|Adverse Event|8|||
129899541|NCT04771273|467591888|FG001|Dose Escalation Period|Adverse Event|9|||
129899542|NCT04771273|467591889|FG002|Dose Escalation Period|Adverse Event|12|||
129899543|NCT04771273|467591890|FG003|Dose Escalation Period|Adverse Event|2|||
129899544|NCT04771273|467591887|FG000|Maintenance Period|Other than listed|4|||
129899545|NCT04771273|467591888|FG001|Maintenance Period|Other than listed|2|||
129899546|NCT04771273|467591889|FG002|Maintenance Period|Other than listed|0|||
130115652|NCT00457665|468382998|FG001|12 Months|Abnormal Liver function tests|5|||
130115653|NCT00457665|468382997|FG000|24 Months|Withdrawal by Subject|3|||
130115654|NCT00457665|468382998|FG001|24 Months|Withdrawal by Subject|2|||
130115655|NCT00457665|468382997|FG000|24 Months|Lipodystrophy|1|||
130115656|NCT00457665|468382998|FG001|24 Months|Lipodystrophy|1|||
130115657|NCT00457665|468382997|FG000|24 Months|Abnormal liver function tests|1|||
130115658|NCT00457665|468382998|FG001|24 Months|Abnormal liver function tests|5|||
130115659|NCT01716754|468383001|FG000|Overall Study|Death|0|||
129899547|NCT04771273|467591890|FG003|Maintenance Period|Other than listed|3|||
129899548|NCT04771273|467591887|FG000|Maintenance Period|Burden of study procedures|1|||
130115660|NCT01716754|468383002|FG001|Overall Study|Death|0|||
130115661|NCT01716754|468383003|FG002|Overall Study|Death|0|||
130115662|NCT01716754|468383004|FG003|Overall Study|Death|1|||
130115663|NCT01716754|468383001|FG000|Overall Study|Protocol deviation|0|||
129899549|NCT04771273|467591888|FG001|Maintenance Period|Burden of study procedures|0|||
129899550|NCT04771273|467591889|FG002|Maintenance Period|Burden of study procedures|0|||
129899551|NCT04771273|467591890|FG003|Maintenance Period|Burden of study procedures|0|||
129899552|NCT04771273|467591887|FG000|Maintenance Period|Change of residence|0|||
129899553|NCT04771273|467591888|FG001|Maintenance Period|Change of residence|1|||
129899554|NCT04771273|467591889|FG002|Maintenance Period|Change of residence|3|||
129899555|NCT04771273|467591890|FG003|Maintenance Period|Change of residence|0|||
129899556|NCT04771273|467591887|FG000|Maintenance Period|Perceived lack of efficacy|0|||
129899557|NCT04771273|467591888|FG001|Maintenance Period|Perceived lack of efficacy|0|||
129899558|NCT04771273|467591889|FG002|Maintenance Period|Perceived lack of efficacy|0|||
129899559|NCT04771273|467591890|FG003|Maintenance Period|Perceived lack of efficacy|1|||
129899560|NCT04771273|467591887|FG000|Maintenance Period|Adverse Event|4|||
129899561|NCT04771273|467591888|FG001|Maintenance Period|Adverse Event|5|||
129899562|NCT04771273|467591889|FG002|Maintenance Period|Adverse Event|5|||
129899563|NCT04771273|467591890|FG003|Maintenance Period|Adverse Event|0|||
129899564|NCT02465359|467591891|FG000|Overall Study|Lack of Efficacy|1|||
129899565|NCT02465359|467591891|FG000|Overall Study|Withdrawal by Subject|1|||
129899566|NCT02465359|467591891|FG000|Overall Study|Adverse Event|1|||
129899567|NCT01304147|467591892|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
129899568|NCT01304147|467591893|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
129899569|NCT01244828|467591894|FG000|Overall Study|Adverse Event|37|||
129899570|NCT01244828|467591894|FG000|Overall Study|Withdrawal by Subject|31|||
129899571|NCT01244828|467591894|FG000|Overall Study|Lack of Efficacy|7|||
129899572|NCT01244828|467591894|FG000|Overall Study|Lost to Follow-up|2|||
129899573|NCT01244828|467591894|FG000|Overall Study|Other reason (not specified)|1|||
129899574|NCT01278862|467591895|FG000|Overall Study|Lost to Follow-up|1|||
129899575|NCT01278862|467591896|FG001|Overall Study|Lost to Follow-up|1|||
129899576|NCT00603447|467591898|FG000|Overall Study|Adverse Event|0|||
129899577|NCT00603447|467591899|FG001|Overall Study|Adverse Event|1|||
129899578|NCT00603447|467591900|FG002|Overall Study|Adverse Event|1|||
129899579|NCT00603447|467591901|FG003|Overall Study|Adverse Event|2|||
129899580|NCT00603447|467591902|FG004|Overall Study|Adverse Event|1|||
129899581|NCT00603447|467591903|FG005|Overall Study|Adverse Event|2|||
129899582|NCT00603447|467591904|FG006|Overall Study|Adverse Event|10|||
129899583|NCT00603447|467591898|FG000|Overall Study|Other|0|||
129899584|NCT00603447|467591899|FG001|Overall Study|Other|0|||
129899585|NCT00603447|467591900|FG002|Overall Study|Other|1|||
129899586|NCT00603447|467591901|FG003|Overall Study|Other|0|||
129899587|NCT00603447|467591902|FG004|Overall Study|Other|3|||
129899588|NCT00603447|467591903|FG005|Overall Study|Other|0|||
129899589|NCT00603447|467591904|FG006|Overall Study|Other|13|||
129899590|NCT00603447|467591898|FG000|Overall Study|Withdrew Consent|0|||
129899591|NCT00603447|467591899|FG001|Overall Study|Withdrew Consent|2|||
129899592|NCT00603447|467591900|FG002|Overall Study|Withdrew Consent|0|||
129899593|NCT00603447|467591901|FG003|Overall Study|Withdrew Consent|0|||
129899594|NCT00603447|467591902|FG004|Overall Study|Withdrew Consent|1|||
129899595|NCT00603447|467591903|FG005|Overall Study|Withdrew Consent|0|||
129899596|NCT00603447|467591904|FG006|Overall Study|Withdrew Consent|1|||
129899597|NCT05233085|467591905|FG000|Overall Study|Adverse Event|1|||
129899598|NCT05233085|467591906|FG001|Overall Study|Adverse Event|0|||
129899599|NCT05233085|467591907|FG002|Overall Study|Adverse Event|0|||
129899600|NCT05233085|467591908|FG003|Overall Study|Adverse Event|0|||
129899601|NCT00798265|467591909|FG000|Overall Study|Lost to Follow-up|1|||
129899602|NCT00798265|467591910|FG001|Overall Study|Lost to Follow-up|10|||
129899603|NCT00798265|467591909|FG000|Overall Study|Study closing|7|||
129899604|NCT00798265|467591910|FG001|Overall Study|Study closing|6|||
129899605|NCT00798265|467591909|FG000|Overall Study|Withdrawal by Subject|0|||
129899606|NCT00798265|467591910|FG001|Overall Study|Withdrawal by Subject|1|||
129899607|NCT00798265|467591909|FG000|Overall Study|Screen failure|0|||
129899608|NCT00798265|467591910|FG001|Overall Study|Screen failure|1|||
129899609|NCT01838200|467591913|FG000|Overall Study|Adverse Event|0|||
129899610|NCT01838200|467591914|FG001|Overall Study|Adverse Event|2|||
130063993|NCT01253187|468187852|FG001|Period 2|Withdrawal by Subject|0|||
130063994|NCT01253187|468187853|FG002|Period 2|Withdrawal by Subject|0|||
130063995|NCT01253187|468187854|FG003|Period 2|Withdrawal by Subject|0|||
129899611|NCT01838200|467591913|FG000|Overall Study|Progressive disease|3|||
129899612|NCT01838200|467591914|FG001|Overall Study|Progressive disease|0|||
129899613|NCT02738840|467593704|FG000|Overall Study|MRI Scan not Performed|5|||
129899614|NCT02738840|467593704|FG000|Overall Study|Lost to Follow-up|1|||
129899615|NCT02738840|467593704|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
129899616|NCT02738840|467593704|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
129899617|NCT01311648|467593706|FG000|Main Study|Protocol Violation|0|||
129899618|NCT01311648|467593707|FG001|Main Study|Protocol Violation|1|||
129899619|NCT01311648|467593706|FG000|Main Study|Adverse Event|0|||
129899620|NCT01311648|467593707|FG001|Main Study|Adverse Event|1|||
129899621|NCT01311648|467593706|FG000|Main Study|Inhibitor management|0|||
129899622|NCT01311648|467593707|FG001|Main Study|Inhibitor management|17|||
129899623|NCT01311648|467593706|FG000|Main Study|Withdrawal by Subject|0|||
130063996|NCT01253187|468187855|FG004|Period 2|Withdrawal by Subject|1|||
129899624|NCT01311648|467593707|FG001|Main Study|Withdrawal by Subject|2|||
129899625|NCT01311648|467593706|FG000|Extension Study|Physician Decision|0|||
129899626|NCT01311648|467593707|FG001|Extension Study|Physician Decision|1|||
129899627|NCT01311648|467593706|FG000|Extension Study|ITI therapy with marketed product|0|||
129899628|NCT01311648|467593707|FG001|Extension Study|ITI therapy with marketed product|1|||
129899629|NCT01311648|467593706|FG000|Extension Study|Incorrect visit planning|0|||
129899630|NCT01311648|467593707|FG001|Extension Study|Incorrect visit planning|1|||
129899631|NCT01311648|467593706|FG000|Extension Study|Family's decision|0|||
129899632|NCT01311648|467593707|FG001|Extension Study|Family's decision|1|||
129899633|NCT01311648|467593706|FG000|Extension Study|Failure of ITI therapy|0|||
129899634|NCT01311648|467593707|FG001|Extension Study|Failure of ITI therapy|3|||
129899635|NCT01311648|467593706|FG000|Extension Study|Long travel|0|||
129899636|NCT01311648|467593707|FG001|Extension Study|Long travel|1|||
129899637|NCT01311648|467593706|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
129899638|NCT01311648|467593707|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
129899639|NCT01311648|467593706|FG000|Extension Study|Withdrawal by Subject|0|||
129899640|NCT01311648|467593707|FG001|Extension Study|Withdrawal by Subject|1|||
129899641|NCT01311648|467593706|FG000|Extension Study|Inhibitor management|0|||
129899642|NCT01311648|467593707|FG001|Extension Study|Inhibitor management|2|||
129899643|NCT04057196|467593708|FG000|Overall Study|Withdrawal by Subject|3|||
129899644|NCT04057196|467593708|FG000|Overall Study|Death|3|||
129899645|NCT02466516|467593710|FG000|Overall Study|Adverse Event|1|||
129899646|NCT02466516|467593711|FG001|Overall Study|Adverse Event|1|||
129899647|NCT02466516|467593712|FG002|Overall Study|Adverse Event|0|||
129899648|NCT02466516|467593713|FG003|Overall Study|Adverse Event|0|||
129899649|NCT02466516|467593714|FG004|Overall Study|Adverse Event|0|||
129899650|NCT02466516|467593710|FG000|Overall Study|Withdrew Consent|1|||
129899651|NCT02466516|467593711|FG001|Overall Study|Withdrew Consent|0|||
129899652|NCT02466516|467593712|FG002|Overall Study|Withdrew Consent|0|||
129899653|NCT02466516|467593713|FG003|Overall Study|Withdrew Consent|0|||
129899654|NCT02466516|467593714|FG004|Overall Study|Withdrew Consent|0|||
129899655|NCT02466516|467593710|FG000|Overall Study|Lost to Follow-up|2|||
129899656|NCT02466516|467593711|FG001|Overall Study|Lost to Follow-up|0|||
129899657|NCT02466516|467593712|FG002|Overall Study|Lost to Follow-up|1|||
129899658|NCT02466516|467593713|FG003|Overall Study|Lost to Follow-up|0|||
129899659|NCT02466516|467593714|FG004|Overall Study|Lost to Follow-up|0|||
129899660|NCT03712930|467593715|FG000|Overall Study|Death|7|||
129899661|NCT03712930|467593715|FG000|Overall Study|Physician Decision|1|||
129899662|NCT03712930|467593715|FG000|Overall Study|Study Terminated by Sponsor|3|||
129899663|NCT03712930|467593715|FG000|Overall Study|Progressive Disease|2|||
129899664|NCT00739102|467593720|FG000|Overall Study|Death|5|||
129899665|NCT00739102|467593720|FG000|Overall Study|Withdrawal by Subject|10|||
129899666|NCT01331824|467593721|FG000|Overall Study|Adverse Event|2|||
129899667|NCT01331824|467593721|FG000|Overall Study|Death|1|||
129899668|NCT01331824|467593721|FG000|Overall Study|Disease Progression|9|||
129899669|NCT01331824|467593721|FG000|Overall Study|Withdrawal by Subject|1|||
129899670|NCT01091454|467593722|FG000|Overall Study|Ineligible|1|||
129899671|NCT01510912|467593725|FG000|Overall Study|Adverse Event|99|||
129899672|NCT01510912|467593725|FG000|Overall Study|Lack of Efficacy|12|||
129899673|NCT01510912|467593725|FG000|Overall Study|Non-compliance with trial drug|23|||
129899674|NCT01510912|467593725|FG000|Overall Study|Withdrawal by Subject|49|||
129899675|NCT01510912|467593725|FG000|Overall Study|Physician Decision|1|||
129899676|NCT01510912|467593725|FG000|Overall Study|Protocol Violation|27|||
129899677|NCT01510912|467593725|FG000|Overall Study|Lost to Follow-up|26|||
129899678|NCT01510912|467593725|FG000|Overall Study|Other, including joint replacement|5|||
129899679|NCT03179787|467593726|FG000|Overall Study|Lost to Follow-up|15|||
129899680|NCT03179787|467593726|FG000|Overall Study|Case report failures|2|||
129899681|NCT03179787|467593726|FG000|Overall Study|Treatment not administered|1|||
129899682|NCT02030028|467593727|FG000|Overall Study|Withdrawal by Subject|4|||
129899683|NCT02030028|467593727|FG000|Overall Study|lack of transportation|1|||
129899684|NCT02380742|467593729|FG000|Overall Study|Withdrawal by Subject|1|||
129899685|NCT02380742|467593730|FG001|Overall Study|Withdrawal by Subject|0|||
129899686|NCT02930343|467593732|FG000|Overall Study|Lost to Follow-up|9|||
129899687|NCT02930343|467593733|FG001|Overall Study|Lost to Follow-up|7|||
129899688|NCT01280591|467593736|FG000|Overall Study|Withdrawal by Subject|0|||
129899689|NCT01280591|467593737|FG001|Overall Study|Withdrawal by Subject|0|||
129899690|NCT01280591|467593738|FG002|Overall Study|Withdrawal by Subject|0|||
129899691|NCT01280591|467593739|FG003|Overall Study|Withdrawal by Subject|2|||
129899692|NCT01280591|467593736|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
129899693|NCT01280591|467593737|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
129899694|NCT01280591|467593738|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
129899695|NCT01280591|467593739|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
129899696|NCT01803646|467593745|FG000|Overall Study|Protocol Violation|1|||
129899697|NCT01803646|467593746|FG001|Overall Study|Protocol Violation|0|||
129899698|NCT01803646|467593745|FG000|Overall Study|Adverse Event|1|||
129899699|NCT01803646|467593746|FG001|Overall Study|Adverse Event|1|||
129899700|NCT01803646|467593745|FG000|Overall Study|Withdrawal by Subject|9|||
129899701|NCT01803646|467593746|FG001|Overall Study|Withdrawal by Subject|6|||
129899702|NCT01803646|467593745|FG000|Overall Study|Randomization error|1|||
129899703|NCT01803646|467593746|FG001|Overall Study|Randomization error|2|||
129899704|NCT01803646|467593745|FG000|Overall Study|Lost to Follow-up|5|||
129899705|NCT01803646|467593746|FG001|Overall Study|Lost to Follow-up|1|||
129899706|NCT01131494|467593747|FG000|Overall Study|Withdrawal by Subject|2|||
129899707|NCT01368406|467593752|FG000|Overall Study|Lost to Follow-up|8|||
129899708|NCT01368406|467593753|FG001|Overall Study|Lost to Follow-up|4|||
129899709|NCT01368406|467593752|FG000|Overall Study|Withdrawal by Subject|8|||
129899710|NCT01368406|467593753|FG001|Overall Study|Withdrawal by Subject|4|||
129899711|NCT01368406|467593752|FG000|Overall Study|relapse of the disease|3|||
129899712|NCT01368406|467593753|FG001|Overall Study|relapse of the disease|2|||
129899713|NCT01368406|467593752|FG000|Overall Study|started working|2|||
129899714|NCT01368406|467593753|FG001|Overall Study|started working|3|||
129899715|NCT01466881|467593759|FG000|Overall Study|Ineligible|5|||
129899716|NCT01466881|467593759|FG000|Overall Study|Adverse Event|6|||
129899717|NCT01466881|467593759|FG000|Overall Study|Progression/relapse|20|||
129899718|NCT01466881|467593759|FG000|Overall Study|Death|4|||
129899719|NCT01466881|467593759|FG000|Overall Study|Other reason not protocol specified|5|||
129899720|NCT03670602|467593763|FG000|Overall Study|Lost to Follow-up|1|||
129899721|NCT03670602|467593764|FG001|Overall Study|Lost to Follow-up|0|||
129899722|NCT03670602|467593763|FG000|Overall Study|Withdrawal by Subject|0|||
129899723|NCT03670602|467593764|FG001|Overall Study|Withdrawal by Subject|3|||
129899724|NCT00906698|467593765|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899725|NCT00906698|467593766|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
129899726|NCT00906698|467593767|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899727|NCT00906698|467593768|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899728|NCT00906698|467593769|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
129899729|NCT00906698|467593770|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899730|NCT00906698|467593765|FG000|Overall Study|Adverse Event|0|||
129899731|NCT00906698|467593766|FG001|Overall Study|Adverse Event|0|||
129899732|NCT00906698|467593767|FG002|Overall Study|Adverse Event|2|||
129899733|NCT00906698|467593768|FG003|Overall Study|Adverse Event|0|||
129899734|NCT00906698|467593769|FG004|Overall Study|Adverse Event|4|||
129899735|NCT00906698|467593770|FG005|Overall Study|Adverse Event|1|||
129899736|NCT00906698|467593765|FG000|Overall Study|Disease progression|3|||
129899737|NCT00906698|467593766|FG001|Overall Study|Disease progression|12|||
129899738|NCT00906698|467593767|FG002|Overall Study|Disease progression|4|||
129899739|NCT00906698|467593768|FG003|Overall Study|Disease progression|4|||
129899740|NCT00906698|467593769|FG004|Overall Study|Disease progression|12|||
129899741|NCT00906698|467593770|FG005|Overall Study|Disease progression|4|||
129899742|NCT00906698|467593765|FG000|Overall Study|Withdrawal by Subject|0|||
129899743|NCT00906698|467593766|FG001|Overall Study|Withdrawal by Subject|0|||
129899744|NCT00906698|467593767|FG002|Overall Study|Withdrawal by Subject|0|||
129899745|NCT00906698|467593768|FG003|Overall Study|Withdrawal by Subject|0|||
129899746|NCT00906698|467593769|FG004|Overall Study|Withdrawal by Subject|1|||
129899747|NCT00906698|467593770|FG005|Overall Study|Withdrawal by Subject|0|||
129899748|NCT00906698|467593765|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
129899749|NCT00906698|467593766|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
129899750|NCT00906698|467593767|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
129899751|NCT00906698|467593768|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
129899752|NCT00906698|467593769|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
129899753|NCT00906698|467593770|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
129899754|NCT03095508|467593771|FG000|Overall Study|Adverse Event|0|||
129899755|NCT03095508|467593772|FG001|Overall Study|Adverse Event|1|||
129899756|NCT02846415|467593773|FG000|Overall Study|Lost to Follow-up|2|||
129899757|NCT02846415|467593774|FG001|Overall Study|Lost to Follow-up|0|||
129899758|NCT02846415|467593773|FG000|Overall Study|Withdrawal by Subject|1|||
129899759|NCT02846415|467593774|FG001|Overall Study|Withdrawal by Subject|1|||
129899760|NCT03383887|467593775|FG000|Overall Study|Lost to Follow-up|0|||
129899761|NCT03383887|467593776|FG001|Overall Study|Lost to Follow-up|1|||
129899762|NCT00831792|467593777|FG000|Overall Study|Not Eligible|3|||
129899763|NCT00831792|467593777|FG000|Overall Study|Adverse Event|1|||
129899764|NCT00831792|467593777|FG000|Overall Study|Death|1|||
129899765|NCT00831792|467593777|FG000|Overall Study|Lack of Efficacy|1|||
129899766|NCT02469064|467593782|FG000|Overall Study|Request not to receive intervention.|1|||
129899767|NCT02469064|467593783|FG001|Overall Study|Request not to receive intervention.|3|||
130063997|NCT01253187|468187856|FG005|Period 2|Withdrawal by Subject|0|||
129899768|NCT00678795|467593784|FG000|Overall Study|Adverse Event|7|||
130063998|NCT01253187|468187851|FG000|Period 3|Pregnancy|1|||
129899769|NCT00678795|467593785|FG001|Overall Study|Adverse Event|3|||
129899770|NCT00678795|467593784|FG000|Overall Study|Withdrawal by Subject|3|||
129899771|NCT00678795|467593785|FG001|Overall Study|Withdrawal by Subject|0|||
129899772|NCT00678795|467593784|FG000|Overall Study|Protocol Violation|0|||
129899773|NCT00678795|467593785|FG001|Overall Study|Protocol Violation|1|||
129899774|NCT00678795|467593784|FG000|Overall Study|Lost to Follow-up|0|||
130063999|NCT01253187|468187852|FG001|Period 3|Pregnancy|0|||
129899775|NCT00678795|467593785|FG001|Overall Study|Lost to Follow-up|1|||
129899776|NCT00678795|467593784|FG000|Overall Study|Lack of Efficacy|1|||
129899777|NCT00678795|467593785|FG001|Overall Study|Lack of Efficacy|1|||
129899778|NCT00404079|467593786|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
129899779|NCT00404079|467593787|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
129899780|NCT01120275|467593788|FG000|Overall Study|Adverse Event|3|||
129899781|NCT01120275|467593788|FG000|Overall Study|Progression|27|||
129899782|NCT01120275|467593788|FG000|Overall Study|Ineligible|3|||
129899783|NCT01120275|467593788|FG000|Overall Study|Withdrawal by Subject|1|||
129899784|NCT01120275|467593788|FG000|Overall Study|Refusal|1|||
129899785|NCT01120275|467593788|FG000|Overall Study|Not specific|1|||
129899786|NCT00880906|467593789|FG000|Overall Study|Lost to Follow-up|0|||
129899787|NCT00880906|467593790|FG001|Overall Study|Lost to Follow-up|1|||
129899788|NCT00880906|467593789|FG000|Overall Study|Did not meet criteria following patholog|12|||
129899789|NCT00880906|467593790|FG001|Overall Study|Did not meet criteria following patholog|6|||
129899790|NCT00559949|467593793|FG000|Overall Study|Progressive Disease during cycle 1|1|||
129899791|NCT00559949|467593793|FG000|Overall Study|Adverse Event|1|||
129899792|NCT00559949|467593793|FG000|Overall Study|Withdrawal by Subject|4|||
129899793|NCT00559949|467593793|FG000|Overall Study|No disease evaluation per protocol|1|||
129899794|NCT01235949|467593796|FG000|Primary Phase|Migrated/moved from study area|1|||
129899795|NCT01235949|467593797|FG001|Primary Phase|Migrated/moved from study area|1|||
129899796|NCT01235949|467593798|FG002|Primary Phase|Migrated/moved from study area|0|||
129899797|NCT01235949|467593799|FG003|Primary Phase|Migrated/moved from study area|0|||
129899798|NCT01235949|467593800|FG004|Primary Phase|Migrated/moved from study area|1|||
129899799|NCT01235949|467593801|FG005|Primary Phase|Migrated/moved from study area|2|||
129899800|NCT01235949|467593802|FG006|Primary Phase|Migrated/moved from study area|0|||
129899801|NCT01235949|467593803|FG007|Primary Phase|Migrated/moved from study area|0|||
129899802|NCT01235949|467593804|FG008|Primary Phase|Migrated/moved from study area|0|||
129899803|NCT01235949|467593805|FG009|Primary Phase|Migrated/moved from study area|0|||
129899804|NCT01235949|467593806|FG010|Primary Phase|Migrated/moved from study area|0|||
129899805|NCT01235949|467593807|FG011|Primary Phase|Migrated/moved from study area|0|||
129899806|NCT01235949|467593808|FG012|Primary Phase|Migrated/moved from study area|0|||
129899807|NCT01235949|467593809|FG013|Primary Phase|Migrated/moved from study area|0|||
129899808|NCT01235949|467593810|FG014|Primary Phase|Migrated/moved from study area|0|||
129899809|NCT01235949|467593811|FG015|Primary Phase|Migrated/moved from study area|0|||
129899810|NCT01235949|467593812|FG016|Primary Phase|Migrated/moved from study area|0|||
129899811|NCT01235949|467593813|FG017|Primary Phase|Migrated/moved from study area|0|||
129899812|NCT01235949|467593796|FG000|Primary Phase|Adverse Event|0|||
129899813|NCT01235949|467593797|FG001|Primary Phase|Adverse Event|0|||
129899814|NCT01235949|467593798|FG002|Primary Phase|Adverse Event|0|||
129899815|NCT01235949|467593799|FG003|Primary Phase|Adverse Event|1|||
129899816|NCT01235949|467593800|FG004|Primary Phase|Adverse Event|0|||
129899817|NCT01235949|467593801|FG005|Primary Phase|Adverse Event|0|||
129899818|NCT01235949|467593802|FG006|Primary Phase|Adverse Event|0|||
129899819|NCT01235949|467593803|FG007|Primary Phase|Adverse Event|0|||
129899820|NCT01235949|467593804|FG008|Primary Phase|Adverse Event|0|||
129899821|NCT01235949|467593805|FG009|Primary Phase|Adverse Event|0|||
129899822|NCT01235949|467593806|FG010|Primary Phase|Adverse Event|0|||
129899823|NCT01235949|467593807|FG011|Primary Phase|Adverse Event|0|||
129899824|NCT01235949|467593808|FG012|Primary Phase|Adverse Event|0|||
129899825|NCT01235949|467593809|FG013|Primary Phase|Adverse Event|0|||
129899826|NCT01235949|467593810|FG014|Primary Phase|Adverse Event|0|||
129899827|NCT01235949|467593811|FG015|Primary Phase|Adverse Event|0|||
129899828|NCT01235949|467593812|FG016|Primary Phase|Adverse Event|0|||
129899829|NCT01235949|467593813|FG017|Primary Phase|Adverse Event|0|||
129899830|NCT01235949|467593796|FG000|Primary Phase|Withdrawal by Subject|3|||
129899831|NCT01235949|467593797|FG001|Primary Phase|Withdrawal by Subject|2|||
129899832|NCT01235949|467593798|FG002|Primary Phase|Withdrawal by Subject|2|||
129899833|NCT01235949|467593799|FG003|Primary Phase|Withdrawal by Subject|0|||
129899834|NCT01235949|467593800|FG004|Primary Phase|Withdrawal by Subject|0|||
129899835|NCT01235949|467593801|FG005|Primary Phase|Withdrawal by Subject|3|||
130064000|NCT01253187|468187853|FG002|Period 3|Pregnancy|0|||
130064001|NCT01253187|468187854|FG003|Period 3|Pregnancy|0|||
130064002|NCT01253187|468187855|FG004|Period 3|Pregnancy|0|||
130064003|NCT01253187|468187856|FG005|Period 3|Pregnancy|0|||
130064004|NCT01253187|468187851|FG000|Period 3|difficulty with blood sampling|0|||
130064005|NCT01253187|468187852|FG001|Period 3|difficulty with blood sampling|1|||
130115664|NCT01716754|468383002|FG001|Overall Study|Protocol deviation|2|||
129899836|NCT01235949|467593802|FG006|Primary Phase|Withdrawal by Subject|0|||
129899837|NCT01235949|467593803|FG007|Primary Phase|Withdrawal by Subject|0|||
129899838|NCT01235949|467593804|FG008|Primary Phase|Withdrawal by Subject|0|||
129899839|NCT01235949|467593805|FG009|Primary Phase|Withdrawal by Subject|0|||
129899840|NCT01235949|467593806|FG010|Primary Phase|Withdrawal by Subject|0|||
129899841|NCT01235949|467593807|FG011|Primary Phase|Withdrawal by Subject|0|||
130064006|NCT01253187|468187853|FG002|Period 3|difficulty with blood sampling|0|||
130064007|NCT01253187|468187854|FG003|Period 3|difficulty with blood sampling|0|||
129899842|NCT01235949|467593808|FG012|Primary Phase|Withdrawal by Subject|0|||
129899843|NCT01235949|467593809|FG013|Primary Phase|Withdrawal by Subject|0|||
129899844|NCT01235949|467593810|FG014|Primary Phase|Withdrawal by Subject|0|||
129899845|NCT01235949|467593811|FG015|Primary Phase|Withdrawal by Subject|0|||
129899846|NCT01235949|467593812|FG016|Primary Phase|Withdrawal by Subject|0|||
129899847|NCT01235949|467593813|FG017|Primary Phase|Withdrawal by Subject|0|||
129899848|NCT01235949|467593796|FG000|Primary Phase|Lost to Follow-up|0|||
129899849|NCT01235949|467593797|FG001|Primary Phase|Lost to Follow-up|0|||
129899850|NCT01235949|467593798|FG002|Primary Phase|Lost to Follow-up|1|||
129899851|NCT01235949|467593799|FG003|Primary Phase|Lost to Follow-up|1|||
129899852|NCT01235949|467593800|FG004|Primary Phase|Lost to Follow-up|0|||
129899853|NCT01235949|467593801|FG005|Primary Phase|Lost to Follow-up|2|||
129899854|NCT01235949|467593802|FG006|Primary Phase|Lost to Follow-up|0|||
129899855|NCT01235949|467593803|FG007|Primary Phase|Lost to Follow-up|0|||
129899856|NCT01235949|467593804|FG008|Primary Phase|Lost to Follow-up|0|||
129899857|NCT01235949|467593805|FG009|Primary Phase|Lost to Follow-up|0|||
129899858|NCT01235949|467593806|FG010|Primary Phase|Lost to Follow-up|0|||
129899859|NCT01235949|467593807|FG011|Primary Phase|Lost to Follow-up|0|||
129899860|NCT01235949|467593808|FG012|Primary Phase|Lost to Follow-up|0|||
129899861|NCT01235949|467593809|FG013|Primary Phase|Lost to Follow-up|0|||
129899862|NCT01235949|467593810|FG014|Primary Phase|Lost to Follow-up|0|||
129899863|NCT01235949|467593811|FG015|Primary Phase|Lost to Follow-up|0|||
129899864|NCT01235949|467593812|FG016|Primary Phase|Lost to Follow-up|0|||
129899865|NCT01235949|467593813|FG017|Primary Phase|Lost to Follow-up|0|||
129899866|NCT01235949|467593796|FG000|Booster Phase|Migrated/moved from study area|0|||
129899867|NCT01235949|467593797|FG001|Booster Phase|Migrated/moved from study area|0|||
129899868|NCT01235949|467593798|FG002|Booster Phase|Migrated/moved from study area|0|||
129899869|NCT01235949|467593799|FG003|Booster Phase|Migrated/moved from study area|0|||
129899870|NCT01235949|467593800|FG004|Booster Phase|Migrated/moved from study area|0|||
129899871|NCT01235949|467593801|FG005|Booster Phase|Migrated/moved from study area|0|||
129899872|NCT01235949|467593802|FG006|Booster Phase|Migrated/moved from study area|0|||
129899873|NCT01235949|467593803|FG007|Booster Phase|Migrated/moved from study area|0|||
129899874|NCT01235949|467593804|FG008|Booster Phase|Migrated/moved from study area|0|||
129899875|NCT01235949|467593805|FG009|Booster Phase|Migrated/moved from study area|0|||
129899876|NCT01235949|467593806|FG010|Booster Phase|Migrated/moved from study area|0|||
129899877|NCT01235949|467593807|FG011|Booster Phase|Migrated/moved from study area|1|||
129899878|NCT01235949|467593808|FG012|Booster Phase|Migrated/moved from study area|1|||
129899879|NCT01235949|467593809|FG013|Booster Phase|Migrated/moved from study area|0|||
129899880|NCT01235949|467593810|FG014|Booster Phase|Migrated/moved from study area|0|||
129899881|NCT01235949|467593811|FG015|Booster Phase|Migrated/moved from study area|0|||
129899882|NCT01235949|467593812|FG016|Booster Phase|Migrated/moved from study area|0|||
129899883|NCT01235949|467593813|FG017|Booster Phase|Migrated/moved from study area|1|||
129899884|NCT01235949|467593796|FG000|Booster Phase|Adverse Event|0|||
129899885|NCT01235949|467593797|FG001|Booster Phase|Adverse Event|0|||
129899886|NCT01235949|467593798|FG002|Booster Phase|Adverse Event|0|||
129899887|NCT01235949|467593799|FG003|Booster Phase|Adverse Event|0|||
129899888|NCT01235949|467593800|FG004|Booster Phase|Adverse Event|0|||
129899889|NCT01235949|467593801|FG005|Booster Phase|Adverse Event|0|||
129899890|NCT01235949|467593802|FG006|Booster Phase|Adverse Event|0|||
129899891|NCT01235949|467593803|FG007|Booster Phase|Adverse Event|0|||
129899892|NCT01235949|467593804|FG008|Booster Phase|Adverse Event|0|||
129899893|NCT01235949|467593805|FG009|Booster Phase|Adverse Event|0|||
129899894|NCT01235949|467593806|FG010|Booster Phase|Adverse Event|0|||
129899895|NCT01235949|467593807|FG011|Booster Phase|Adverse Event|0|||
129899896|NCT01235949|467593808|FG012|Booster Phase|Adverse Event|0|||
129899897|NCT01235949|467593809|FG013|Booster Phase|Adverse Event|0|||
129899898|NCT01235949|467593810|FG014|Booster Phase|Adverse Event|0|||
129899899|NCT01235949|467593811|FG015|Booster Phase|Adverse Event|1|||
129899900|NCT01235949|467593812|FG016|Booster Phase|Adverse Event|0|||
129899901|NCT01235949|467593813|FG017|Booster Phase|Adverse Event|0|||
129899902|NCT01235949|467593796|FG000|Booster Phase|Withdrawal by Subject|0|||
129899903|NCT01235949|467593797|FG001|Booster Phase|Withdrawal by Subject|0|||
129899904|NCT01235949|467593798|FG002|Booster Phase|Withdrawal by Subject|0|||
129899905|NCT01235949|467593799|FG003|Booster Phase|Withdrawal by Subject|0|||
129899906|NCT01235949|467593800|FG004|Booster Phase|Withdrawal by Subject|0|||
129899907|NCT01235949|467593801|FG005|Booster Phase|Withdrawal by Subject|0|||
129899908|NCT01235949|467593802|FG006|Booster Phase|Withdrawal by Subject|0|||
129899909|NCT01235949|467593803|FG007|Booster Phase|Withdrawal by Subject|1|||
129899910|NCT01235949|467593804|FG008|Booster Phase|Withdrawal by Subject|1|||
130064008|NCT01253187|468187855|FG004|Period 3|difficulty with blood sampling|0|||
130064009|NCT01253187|468187856|FG005|Period 3|difficulty with blood sampling|0|||
130064010|NCT01253187|468187851|FG000|Period 3|non-compliance|0|||
130064011|NCT01253187|468187852|FG001|Period 3|non-compliance|0|||
129899911|NCT01235949|467593805|FG009|Booster Phase|Withdrawal by Subject|0|||
129899912|NCT01235949|467593806|FG010|Booster Phase|Withdrawal by Subject|1|||
129899913|NCT01235949|467593807|FG011|Booster Phase|Withdrawal by Subject|1|||
130064012|NCT01253187|468187853|FG002|Period 3|non-compliance|0|||
130115665|NCT01716754|468383003|FG002|Overall Study|Protocol deviation|7|||
130115666|NCT01716754|468383004|FG003|Overall Study|Protocol deviation|2|||
130115667|NCT01716754|468383001|FG000|Overall Study|Non-compliance with study treatment|0|||
130115668|NCT01716754|468383002|FG001|Overall Study|Non-compliance with study treatment|0|||
130115669|NCT01716754|468383003|FG002|Overall Study|Non-compliance with study treatment|1|||
130115670|NCT01716754|468383004|FG003|Overall Study|Non-compliance with study treatment|0|||
130115671|NCT01716754|468383001|FG000|Overall Study|Physician Decision|1|||
130115672|NCT01716754|468383002|FG001|Overall Study|Physician Decision|0|||
130115673|NCT01716754|468383003|FG002|Overall Study|Physician Decision|0|||
130115674|NCT01716754|468383004|FG003|Overall Study|Physician Decision|0|||
130115675|NCT01716754|468383001|FG000|Overall Study|Lost to Follow-up|1|||
130115676|NCT01716754|468383002|FG001|Overall Study|Lost to Follow-up|0|||
130115677|NCT01716754|468383003|FG002|Overall Study|Lost to Follow-up|0|||
130115678|NCT01716754|468383004|FG003|Overall Study|Lost to Follow-up|1|||
130115679|NCT01716754|468383001|FG000|Overall Study|Adverse Event|4|||
130115680|NCT01716754|468383002|FG001|Overall Study|Adverse Event|2|||
130115681|NCT01716754|468383003|FG002|Overall Study|Adverse Event|2|||
130115682|NCT01716754|468383004|FG003|Overall Study|Adverse Event|1|||
130115683|NCT01716754|468383001|FG000|Overall Study|Withdrawal by Subject|5|||
130115684|NCT01716754|468383002|FG001|Overall Study|Withdrawal by Subject|0|||
130115685|NCT01716754|468383003|FG002|Overall Study|Withdrawal by Subject|4|||
130115686|NCT01716754|468383004|FG003|Overall Study|Withdrawal by Subject|3|||
130115687|NCT00481247|468383005|FG000|Overall Study|Death|0|||
130115688|NCT00481247|468383006|FG001|Overall Study|Death|1|||
130115689|NCT00481247|468383005|FG000|Overall Study|Disease progression|18|||
130115690|NCT00481247|468383006|FG001|Overall Study|Disease progression|22|||
130115691|NCT00481247|468383005|FG000|Overall Study|Intolerance|42|||
130115692|NCT00481247|468383006|FG001|Overall Study|Intolerance|17|||
130115693|NCT00481247|468383005|FG000|Overall Study|Treatment failure|10|||
130115694|NCT00481247|468383006|FG001|Overall Study|Treatment failure|14|||
130115695|NCT00481247|468383005|FG000|Overall Study|AE unrelated to study drug|13|||
130115696|NCT00481247|468383006|FG001|Overall Study|AE unrelated to study drug|4|||
130115697|NCT00481247|468383005|FG000|Overall Study|Withdrawal by Subject|8|||
130115698|NCT00481247|468383006|FG001|Overall Study|Withdrawal by Subject|13|||
130115699|NCT00481247|468383005|FG000|Overall Study|Pregnancy|2|||
130115700|NCT00481247|468383006|FG001|Overall Study|Pregnancy|1|||
130115701|NCT00481247|468383005|FG000|Overall Study|Lost to Follow-up|1|||
130115702|NCT00481247|468383006|FG001|Overall Study|Lost to Follow-up|2|||
130115703|NCT00481247|468383005|FG000|Overall Study|Poor compliance/noncompliance|1|||
130115704|NCT00481247|468383006|FG001|Overall Study|Poor compliance/noncompliance|7|||
130115705|NCT00481247|468383005|FG000|Overall Study|Administrative reason by sponsor|157|||
130115706|NCT00481247|468383006|FG001|Overall Study|Administrative reason by sponsor|162|||
130115707|NCT00481247|468383005|FG000|Overall Study|Varied|6|||
130115708|NCT00481247|468383006|FG001|Overall Study|Varied|15|||
130115709|NCT00481247|468383005|FG000|Overall Study|Did not receive treatment|1|||
130115710|NCT00481247|468383006|FG001|Overall Study|Did not receive treatment|2|||
130115711|NCT02535000|468383008|FG000|Overall Study|Cancellation of surgery.|1|||
130115712|NCT02535000|468383009|FG001|Overall Study|Cancellation of surgery.|2|||
130115713|NCT04317781|468383010|FG000|Overall Study|Adverse Event|1|||
130115714|NCT04317781|468383010|FG000|Overall Study|Disease relapse|1|||
130115715|NCT04317781|468383010|FG000|Overall Study|Withdrawal by Subject|1|||
130115716|NCT01620489|468383011|FG000|Overall Study|Adverse Event|17|||
130115717|NCT01620489|468383012|FG001|Overall Study|Adverse Event|4|||
130115718|NCT01620489|468383011|FG000|Overall Study|Protocol Violation|0|||
130115719|NCT01620489|468383012|FG001|Overall Study|Protocol Violation|3|||
130115720|NCT01620489|468383011|FG000|Overall Study|Withdrawal Criteria|17|||
130115721|NCT01620489|468383012|FG001|Overall Study|Withdrawal Criteria|25|||
130115722|NCT01620489|468383011|FG000|Overall Study|Unclassified|1|||
130115723|NCT01620489|468383012|FG001|Overall Study|Unclassified|2|||
130115724|NCT02649231|468383013|FG000|Overall Study|Adverse Event|0|||
129841245|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
129841246|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
129841247|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
130115725|NCT02649231|468383014|FG001|Overall Study|Adverse Event|0|||
130115726|NCT02649231|468383015|FG002|Overall Study|Adverse Event|0|||
130115727|NCT02649231|468383016|FG003|Overall Study|Adverse Event|1|||
130115728|NCT02649231|468383013|FG000|Overall Study|Lost to Follow-up|2|||
130115729|NCT02649231|468383014|FG001|Overall Study|Lost to Follow-up|1|||
130115730|NCT02649231|468383015|FG002|Overall Study|Lost to Follow-up|1|||
130115731|NCT02649231|468383016|FG003|Overall Study|Lost to Follow-up|0|||
130115732|NCT02649231|468383013|FG000|Overall Study|Withdrawal by Subject|0|||
130115733|NCT02649231|468383014|FG001|Overall Study|Withdrawal by Subject|1|||
130115734|NCT02649231|468383015|FG002|Overall Study|Withdrawal by Subject|0|||
130115735|NCT02649231|468383016|FG003|Overall Study|Withdrawal by Subject|1|||
130115736|NCT02649231|468383013|FG000|Overall Study|Protocol Violation|2|||
130115737|NCT02649231|468383014|FG001|Overall Study|Protocol Violation|1|||
130115738|NCT02649231|468383015|FG002|Overall Study|Protocol Violation|1|||
130115739|NCT02649231|468383016|FG003|Overall Study|Protocol Violation|0|||
130115740|NCT01738581|468383017|FG000|Overall Study|Lost to Follow-up|1|||
129899914|NCT01235949|467593808|FG012|Booster Phase|Withdrawal by Subject|2|||
129899915|NCT01235949|467593809|FG013|Booster Phase|Withdrawal by Subject|0|||
129899916|NCT01235949|467593810|FG014|Booster Phase|Withdrawal by Subject|2|||
129899917|NCT01235949|467593811|FG015|Booster Phase|Withdrawal by Subject|0|||
129899918|NCT01235949|467593812|FG016|Booster Phase|Withdrawal by Subject|0|||
129899919|NCT01235949|467593813|FG017|Booster Phase|Withdrawal by Subject|0|||
129899920|NCT01235949|467593796|FG000|Booster Phase|Lost to Follow-up|0|||
129899921|NCT01235949|467593797|FG001|Booster Phase|Lost to Follow-up|0|||
129899922|NCT01235949|467593798|FG002|Booster Phase|Lost to Follow-up|0|||
129899923|NCT01235949|467593799|FG003|Booster Phase|Lost to Follow-up|0|||
129899924|NCT01235949|467593800|FG004|Booster Phase|Lost to Follow-up|0|||
129899925|NCT01235949|467593801|FG005|Booster Phase|Lost to Follow-up|0|||
129899926|NCT01235949|467593802|FG006|Booster Phase|Lost to Follow-up|0|||
129899927|NCT01235949|467593803|FG007|Booster Phase|Lost to Follow-up|0|||
129899928|NCT01235949|467593804|FG008|Booster Phase|Lost to Follow-up|1|||
129899929|NCT01235949|467593805|FG009|Booster Phase|Lost to Follow-up|1|||
129899930|NCT01235949|467593806|FG010|Booster Phase|Lost to Follow-up|1|||
129899931|NCT01235949|467593807|FG011|Booster Phase|Lost to Follow-up|1|||
129899932|NCT01235949|467593808|FG012|Booster Phase|Lost to Follow-up|0|||
129899933|NCT01235949|467593809|FG013|Booster Phase|Lost to Follow-up|0|||
129899934|NCT01235949|467593810|FG014|Booster Phase|Lost to Follow-up|0|||
129899935|NCT01235949|467593811|FG015|Booster Phase|Lost to Follow-up|0|||
129899936|NCT01235949|467593812|FG016|Booster Phase|Lost to Follow-up|0|||
129899937|NCT01235949|467593813|FG017|Booster Phase|Lost to Follow-up|1|||
129899938|NCT00383188|467593814|FG000|Overall Study|Adverse Event|4|||
129899939|NCT00383188|467593815|FG001|Overall Study|Adverse Event|7|||
129899940|NCT00383188|467593816|FG002|Overall Study|Adverse Event|9|||
129899941|NCT00383188|467593817|FG003|Overall Study|Adverse Event|8|||
129899942|NCT00383188|467593818|FG004|Overall Study|Adverse Event|8|||
129899943|NCT00383188|467593814|FG000|Overall Study|Lack of Efficacy|9|||
129899944|NCT00383188|467593815|FG001|Overall Study|Lack of Efficacy|3|||
129899945|NCT00383188|467593816|FG002|Overall Study|Lack of Efficacy|3|||
129899946|NCT00383188|467593817|FG003|Overall Study|Lack of Efficacy|2|||
129899947|NCT00383188|467593818|FG004|Overall Study|Lack of Efficacy|6|||
129899948|NCT00383188|467593814|FG000|Overall Study|Other|3|||
129899949|NCT00383188|467593815|FG001|Overall Study|Other|1|||
129899950|NCT00383188|467593816|FG002|Overall Study|Other|0|||
129899951|NCT00383188|467593817|FG003|Overall Study|Other|2|||
129899952|NCT00383188|467593818|FG004|Overall Study|Other|6|||
129899953|NCT00383188|467593814|FG000|Overall Study|No longer willing to participate|1|||
129899954|NCT00383188|467593815|FG001|Overall Study|No longer willing to participate|0|||
129899955|NCT00383188|467593816|FG002|Overall Study|No longer willing to participate|1|||
129899956|NCT00383188|467593817|FG003|Overall Study|No longer willing to participate|0|||
129899957|NCT00383188|467593818|FG004|Overall Study|No longer willing to participate|2|||
129899958|NCT00383188|467593814|FG000|Overall Study|Lost to Follow-up|0|||
129899959|NCT00383188|467593815|FG001|Overall Study|Lost to Follow-up|0|||
129899960|NCT00383188|467593816|FG002|Overall Study|Lost to Follow-up|0|||
129899961|NCT00383188|467593817|FG003|Overall Study|Lost to Follow-up|0|||
129899962|NCT00383188|467593818|FG004|Overall Study|Lost to Follow-up|1|||
129899963|NCT02341625|467593823|FG000|Overall Study|Disease Progression|2|||
129899964|NCT02341625|467593824|FG001|Overall Study|Disease Progression|2|||
129899965|NCT02341625|467593825|FG002|Overall Study|Disease Progression|3|||
129899966|NCT02341625|467593826|FG003|Overall Study|Disease Progression|6|||
129899967|NCT02341625|467593827|FG004|Overall Study|Disease Progression|7|||
129899968|NCT02341625|467593828|FG005|Overall Study|Disease Progression|7|||
129899969|NCT02341625|467593829|FG006|Overall Study|Disease Progression|28|||
129899970|NCT02341625|467593830|FG007|Overall Study|Disease Progression|5|||
129899971|NCT02341625|467593831|FG008|Overall Study|Disease Progression|4|||
129899972|NCT02341625|467593832|FG009|Overall Study|Disease Progression|19|||
129899973|NCT02341625|467593823|FG000|Overall Study|Study Drug Toxicity|0|||
129899974|NCT02341625|467593824|FG001|Overall Study|Study Drug Toxicity|0|||
129899975|NCT02341625|467593825|FG002|Overall Study|Study Drug Toxicity|0|||
129899976|NCT02341625|467593826|FG003|Overall Study|Study Drug Toxicity|1|||
129899977|NCT02341625|467593827|FG004|Overall Study|Study Drug Toxicity|0|||
129899978|NCT02341625|467593828|FG005|Overall Study|Study Drug Toxicity|3|||
129899979|NCT02341625|467593829|FG006|Overall Study|Study Drug Toxicity|10|||
129899980|NCT02341625|467593830|FG007|Overall Study|Study Drug Toxicity|0|||
129899981|NCT02341625|467593831|FG008|Overall Study|Study Drug Toxicity|0|||
129899982|NCT02341625|467593832|FG009|Overall Study|Study Drug Toxicity|3|||
130064013|NCT01253187|468187854|FG003|Period 3|non-compliance|0|||
129899983|NCT02341625|467593823|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899984|NCT02341625|467593824|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899985|NCT02341625|467593825|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899986|NCT02341625|467593826|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899987|NCT02341625|467593827|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899988|NCT02341625|467593828|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899989|NCT02341625|467593829|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129899990|NCT02341625|467593830|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130064014|NCT01253187|468187855|FG004|Period 3|non-compliance|1|||
129841248|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Death|1|||
129841249|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Death|2|||
129841250|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
129841251|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
129841252|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
129841253|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
129841254|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
129841255|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
129841256|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
129841257|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
129841258|NCT00354172|467385110|FG000|Overall Study|Did not receive transplant|1|||
129841259|NCT02287896|467385116|FG000|Second Injection Visit|Withdrawal by Subject|0|||
129841260|NCT02287896|467385117|FG001|Second Injection Visit|Withdrawal by Subject|1|||
129841261|NCT01639040|467385119|FG000|Overall Study|Adverse Event|1|||
129841262|NCT01639040|467385120|FG001|Overall Study|Adverse Event|0|||
129841263|NCT03473743|467385121|FG000|Overall Study|Withdrawal by Subject|0|||
129841264|NCT03473743|467385122|FG001|Overall Study|Withdrawal by Subject|0|||
129841265|NCT03473743|467385123|FG002|Overall Study|Withdrawal by Subject|0|||
129841266|NCT03473743|467385124|FG003|Overall Study|Withdrawal by Subject|0|||
129841267|NCT03473743|467385125|FG004|Overall Study|Withdrawal by Subject|0|||
129841268|NCT03473743|467385126|FG005|Overall Study|Withdrawal by Subject|0|||
129841269|NCT03473743|467385127|FG006|Overall Study|Withdrawal by Subject|0|||
129841270|NCT03473743|467385128|FG007|Overall Study|Withdrawal by Subject|3|||
129841271|NCT03473743|467385121|FG000|Overall Study|Other|0|||
129841272|NCT03473743|467385122|FG001|Overall Study|Other|0|||
129841273|NCT03473743|467385123|FG002|Overall Study|Other|0|||
129841274|NCT03473743|467385124|FG003|Overall Study|Other|1|||
129841275|NCT03473743|467385125|FG004|Overall Study|Other|0|||
129841276|NCT03473743|467385126|FG005|Overall Study|Other|0|||
129841277|NCT03473743|467385127|FG006|Overall Study|Other|0|||
129841278|NCT03473743|467385128|FG007|Overall Study|Other|0|||
129841279|NCT03473743|467385121|FG000|Overall Study|Ongoing|0|||
129841280|NCT03473743|467385122|FG001|Overall Study|Ongoing|0|||
129841281|NCT03473743|467385123|FG002|Overall Study|Ongoing|6|||
129841282|NCT03473743|467385124|FG003|Overall Study|Ongoing|8|||
129841283|NCT03473743|467385125|FG004|Overall Study|Ongoing|1|||
129841284|NCT03473743|467385126|FG005|Overall Study|Ongoing|1|||
129841285|NCT03473743|467385127|FG006|Overall Study|Ongoing|22|||
129841286|NCT03473743|467385128|FG007|Overall Study|Ongoing|24|||
129841287|NCT03473743|467385121|FG000|Overall Study|Randomized but not treated|0|||
129841288|NCT03473743|467385122|FG001|Overall Study|Randomized but not treated|0|||
129841289|NCT03473743|467385123|FG002|Overall Study|Randomized but not treated|0|||
129841290|NCT03473743|467385124|FG003|Overall Study|Randomized but not treated|0|||
129841291|NCT03473743|467385125|FG004|Overall Study|Randomized but not treated|0|||
129841292|NCT03473743|467385126|FG005|Overall Study|Randomized but not treated|0|||
129841293|NCT03473743|467385127|FG006|Overall Study|Randomized but not treated|1|||
129841294|NCT03473743|467385128|FG007|Overall Study|Randomized but not treated|1|||
129841295|NCT02052739|467385131|FG000|Overall Study|Withdrew due to Adverse Event|3|||
129841296|NCT02052739|467385132|FG001|Overall Study|Withdrew due to Adverse Event|0|||
129841297|NCT02052739|467385131|FG000|Overall Study|Participant Died|2|||
129841298|NCT02052739|467385132|FG001|Overall Study|Participant Died|1|||
129841299|NCT02043015|467385135|FG000|Overall Study|Lost to Follow-up|4|||
129841300|NCT02043015|467385135|FG000|Overall Study|Withdrawal by Subject|4|||
129841301|NCT02043015|467385135|FG000|Overall Study|Removed once target enrollment reached|15|||
129841302|NCT02043015|467385135|FG000|Overall Study|Participant moved away from study city|4|||
129841303|NCT02043015|467385135|FG000|Overall Study|Incarceration|1|||
129841304|NCT05619692|467385136|FG000|Overall Study|Adverse Event|2|||
129841305|NCT05619692|467385137|FG001|Overall Study|Adverse Event|2|||
129841306|NCT05619692|467385136|FG000|Overall Study|Withdrawal by Participant|3|||
129841307|NCT05619692|467385137|FG001|Overall Study|Withdrawal by Participant|4|||
129841308|NCT05619692|467385136|FG000|Overall Study|Lost to Follow-up|2|||
129841309|NCT05619692|467385137|FG001|Overall Study|Lost to Follow-up|1|||
129841310|NCT05619692|467385136|FG000|Overall Study|Randomized but not treated|1|||
129841311|NCT05619692|467385137|FG001|Overall Study|Randomized but not treated|3|||
129841312|NCT05267054|467385139|FG000|Overall Study|Death|13|||
129899991|NCT02341625|467593831|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129841313|NCT05267054|467385140|FG001|Overall Study|Death|14|||
129841314|NCT05267054|467385139|FG000|Overall Study|Study Ended by Sponsor|9|||
129841315|NCT05267054|467385140|FG001|Overall Study|Study Ended by Sponsor|13|||
129841316|NCT05267054|467385139|FG000|Overall Study|Lost to Follow-up|1|||
129841317|NCT05267054|467385140|FG001|Overall Study|Lost to Follow-up|1|||
129841318|NCT05267054|467385139|FG000|Overall Study|Withdrawal by Subject|1|||
129841319|NCT05267054|467385140|FG001|Overall Study|Withdrawal by Subject|1|||
130115741|NCT01738581|468383018|FG001|Overall Study|Lost to Follow-up|0|||
129841320|NCT04049760|467385141|FG000|Overall Study|Withdrawal by Subject|1|||
129841321|NCT02457598|467385142|FG000|Overall Study|Progressive Disease|2|||
129841322|NCT02457598|467385143|FG001|Overall Study|Progressive Disease|2|||
129899992|NCT02341625|467593832|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129899993|NCT02341625|467593823|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899994|NCT02341625|467593824|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899995|NCT02341625|467593825|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899996|NCT02341625|467593826|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899997|NCT02341625|467593827|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899998|NCT02341625|467593828|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899999|NCT02341625|467593829|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
129900000|NCT02341625|467593830|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
129900001|NCT02341625|467593831|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129900002|NCT02341625|467593832|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129900003|NCT02341625|467593823|FG000|Overall Study|Participant Withdrew Consent|0|||
129900004|NCT02341625|467593824|FG001|Overall Study|Participant Withdrew Consent|0|||
129900005|NCT02341625|467593825|FG002|Overall Study|Participant Withdrew Consent|0|||
129900006|NCT02341625|467593826|FG003|Overall Study|Participant Withdrew Consent|1|||
129900007|NCT02341625|467593827|FG004|Overall Study|Participant Withdrew Consent|0|||
129900008|NCT02341625|467593828|FG005|Overall Study|Participant Withdrew Consent|0|||
129900009|NCT02341625|467593829|FG006|Overall Study|Participant Withdrew Consent|0|||
129900010|NCT02341625|467593830|FG007|Overall Study|Participant Withdrew Consent|0|||
129900011|NCT02341625|467593831|FG008|Overall Study|Participant Withdrew Consent|0|||
129900012|NCT02341625|467593832|FG009|Overall Study|Participant Withdrew Consent|0|||
129900013|NCT02341625|467593823|FG000|Overall Study|Completed Treatment as per Protocol|0|||
129900014|NCT02341625|467593824|FG001|Overall Study|Completed Treatment as per Protocol|0|||
129900015|NCT02341625|467593825|FG002|Overall Study|Completed Treatment as per Protocol|0|||
129900016|NCT02341625|467593826|FG003|Overall Study|Completed Treatment as per Protocol|0|||
129900017|NCT02341625|467593827|FG004|Overall Study|Completed Treatment as per Protocol|0|||
129900018|NCT02341625|467593828|FG005|Overall Study|Completed Treatment as per Protocol|0|||
129900019|NCT02341625|467593829|FG006|Overall Study|Completed Treatment as per Protocol|0|||
129900020|NCT02341625|467593830|FG007|Overall Study|Completed Treatment as per Protocol|0|||
129900021|NCT02341625|467593831|FG008|Overall Study|Completed Treatment as per Protocol|0|||
129900022|NCT02341625|467593832|FG009|Overall Study|Completed Treatment as per Protocol|1|||
129900023|NCT02341625|467593823|FG000|Overall Study|Other Reasons|0|||
129900024|NCT02341625|467593824|FG001|Overall Study|Other Reasons|0|||
129900025|NCT02341625|467593825|FG002|Overall Study|Other Reasons|0|||
129900026|NCT02341625|467593826|FG003|Overall Study|Other Reasons|0|||
129900027|NCT02341625|467593827|FG004|Overall Study|Other Reasons|1|||
129900028|NCT02341625|467593828|FG005|Overall Study|Other Reasons|0|||
129900029|NCT02341625|467593829|FG006|Overall Study|Other Reasons|5|||
129900030|NCT02341625|467593830|FG007|Overall Study|Other Reasons|0|||
129900031|NCT02341625|467593831|FG008|Overall Study|Other Reasons|0|||
129900032|NCT02341625|467593832|FG009|Overall Study|Other Reasons|2|||
129900033|NCT02341625|467593823|FG000|Overall Study|Not Reported|0|||
129900034|NCT02341625|467593824|FG001|Overall Study|Not Reported|0|||
129900035|NCT02341625|467593825|FG002|Overall Study|Not Reported|0|||
129900036|NCT02341625|467593826|FG003|Overall Study|Not Reported|0|||
129900037|NCT02341625|467593827|FG004|Overall Study|Not Reported|0|||
129900038|NCT02341625|467593828|FG005|Overall Study|Not Reported|0|||
129900039|NCT02341625|467593829|FG006|Overall Study|Not Reported|0|||
129900040|NCT02341625|467593830|FG007|Overall Study|Not Reported|0|||
129900041|NCT02341625|467593831|FG008|Overall Study|Not Reported|0|||
129900042|NCT02341625|467593832|FG009|Overall Study|Not Reported|3|||
129900043|NCT01726023|467593834|FG000|Overall Study|Death|1|||
129900044|NCT01726023|467593835|FG001|Overall Study|Death|1|||
129900045|NCT01726023|467593834|FG000|Overall Study|Lost to Follow-up|5|||
129900046|NCT01726023|467593835|FG001|Overall Study|Lost to Follow-up|10|||
129900047|NCT01726023|467593834|FG000|Overall Study|Other Eligibility criteria|7|||
129900048|NCT01726023|467593835|FG001|Overall Study|Other Eligibility criteria|7|||
129900049|NCT01726023|467593834|FG000|Overall Study|Withdrawal by Subject|16|||
129900050|NCT01726023|467593835|FG001|Overall Study|Withdrawal by Subject|8|||
129900051|NCT04858425|467593839|FG000|Overall Study|Adverse Event|2|||
129900052|NCT04858425|467593840|FG001|Overall Study|Adverse Event|2|||
130064015|NCT01253187|468187856|FG005|Period 3|non-compliance|0|||
130064016|NCT01956240|468187859|FG000|Overall Study|Lost to Follow-up|6|||
130064017|NCT01956240|468187860|FG001|Overall Study|Lost to Follow-up|20|||
130064018|NCT01956240|468187859|FG000|Overall Study|Adverse Event|17|||
130064019|NCT01956240|468187860|FG001|Overall Study|Adverse Event|4|||
129900053|NCT04858425|467593839|FG000|Overall Study|Withdrawal by Subject|3|||
129900054|NCT04858425|467593840|FG001|Overall Study|Withdrawal by Subject|1|||
129900055|NCT04858425|467593839|FG000|Overall Study|Lost to Follow-up|4|||
129900056|NCT04858425|467593840|FG001|Overall Study|Lost to Follow-up|2|||
129900057|NCT04858425|467593839|FG000|Overall Study|Lost to Follow-up|1|||
129900058|NCT04858425|467593840|FG001|Overall Study|Lost to Follow-up|0|||
129900059|NCT04536077|467593842|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
130064020|NCT00600028|468187863|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129900060|NCT04536077|467593843|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
129900061|NCT04536077|467593842|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
129900062|NCT04536077|467593843|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
129900063|NCT02698241|467593849|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
129900064|NCT02698241|467593849|FG000|Overall Study|Screening not met|7|||
129900065|NCT02698241|467593849|FG000|Overall Study|Withdrawal by Subject|7|||
129900066|NCT02698241|467593849|FG000|Overall Study|Physician Decision|2|||
129900067|NCT02698241|467593849|FG000|Overall Study|Subject underwent system modification|2|||
129900068|NCT02698241|467593849|FG000|Overall Study|Lost to Follow-up|3|||
129900069|NCT02698241|467593849|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
129900070|NCT02698241|467593849|FG000|Overall Study|geographic and licensing issue|1|||
129900071|NCT02698241|467593849|FG000|Overall Study|Death|2|||
129900072|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
129900073|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
129900074|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Progressive disease|6|||
129900075|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Toxicity|1|||
129900076|NCT02540213|467593853|FG000|Overall Study|Death/adverse event|18|||
129900077|NCT02540213|467593853|FG000|Overall Study|Administrative reasons|3|||
129900078|NCT02540213|467593853|FG000|Overall Study|Kidney transplant|3|||
129900079|NCT02540213|467593853|FG000|Overall Study|Lack of Efficacy|6|||
129900080|NCT02540213|467593853|FG000|Overall Study|Consent withdrawn|7|||
129900081|NCT02540213|467593853|FG000|Overall Study|Enrolled but not treated|2|||
129900082|NCT00290706|467593860|FG000|Overall Study|Withdrawal by Subject|2|||
129900083|NCT00290706|467593861|FG001|Overall Study|Withdrawal by Subject|0|||
129900084|NCT00290706|467593862|FG002|Overall Study|Withdrawal by Subject|0|||
129900085|NCT00290706|467593863|FG003|Overall Study|Withdrawal by Subject|0|||
129900086|NCT00290706|467593860|FG000|Overall Study|Progressive Disease|3|||
129900087|NCT00290706|467593861|FG001|Overall Study|Progressive Disease|5|||
129900088|NCT00290706|467593862|FG002|Overall Study|Progressive Disease|4|||
129900089|NCT00290706|467593863|FG003|Overall Study|Progressive Disease|10|||
129900090|NCT00290706|467593860|FG000|Overall Study|Adverse Event|0|||
129900091|NCT00290706|467593861|FG001|Overall Study|Adverse Event|1|||
129900092|NCT00290706|467593862|FG002|Overall Study|Adverse Event|2|||
129900093|NCT00290706|467593863|FG003|Overall Study|Adverse Event|0|||
129900094|NCT00290706|467593860|FG000|Overall Study|Receive auto transplant or radiation|0|||
129900095|NCT00290706|467593861|FG001|Overall Study|Receive auto transplant or radiation|0|||
129900096|NCT00290706|467593862|FG002|Overall Study|Receive auto transplant or radiation|0|||
129900097|NCT00290706|467593863|FG003|Overall Study|Receive auto transplant or radiation|1|||
129900098|NCT00290706|467593860|FG000|Overall Study|Physician Decision|0|||
129900099|NCT00290706|467593861|FG001|Overall Study|Physician Decision|0|||
129900100|NCT00290706|467593862|FG002|Overall Study|Physician Decision|0|||
129900101|NCT00290706|467593863|FG003|Overall Study|Physician Decision|1|||
129900102|NCT02952261|467593866|FG000|Overall Study|Withdrawal by Subject|4|||
129900103|NCT02952261|467593867|FG001|Overall Study|Withdrawal by Subject|5|||
129900104|NCT02952261|467593866|FG000|Overall Study|Protocol Violation|1|||
129900105|NCT02952261|467593867|FG001|Overall Study|Protocol Violation|0|||
129900106|NCT02960659|467594986|FG000|Overall Study|Withdrawal by Subject|1|||
129900107|NCT02960659|467594987|FG001|Overall Study|Withdrawal by Subject|0|||
129900108|NCT02960659|467594986|FG000|Overall Study|Poor compliance|0|||
129900109|NCT02960659|467594987|FG001|Overall Study|Poor compliance|1|||
129900110|NCT01645111|467594989|FG000|Overall Study|Did not require Clevidipine|15|||
129900111|NCT03068468|467594993|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
129900112|NCT03068468|467594994|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
129900113|NCT03068468|467594995|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
129900114|NCT03068468|467594996|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
129900115|NCT03068468|467594993|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
129900116|NCT03068468|467594994|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
129900117|NCT03068468|467594995|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
129900118|NCT03068468|467594996|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
129900119|NCT03068468|467594993|FG000|Placebo-Controlled Period|Adverse Event|16|||
129900120|NCT03068468|467594994|FG001|Placebo-Controlled Period|Adverse Event|21|||
129900121|NCT03068468|467594995|FG002|Placebo-Controlled Period|Adverse Event|0|||
129900122|NCT03068468|467594996|FG003|Placebo-Controlled Period|Adverse Event|0|||
129900123|NCT03068468|467594993|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
129900124|NCT03068468|467594994|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
129900125|NCT03068468|467594995|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
129900126|NCT03068468|467594996|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
129900127|NCT03068468|467594993|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129900128|NCT03068468|467594994|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
129900129|NCT03068468|467594995|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129900130|NCT03068468|467594996|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129900131|NCT03068468|467594993|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
129900132|NCT03068468|467594994|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
129900133|NCT03068468|467594995|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
129900134|NCT03068468|467594996|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
129900135|NCT03068468|467594993|FG000|Placebo-Controlled Period|Death|0|||
129900136|NCT03068468|467594994|FG001|Placebo-Controlled Period|Death|1|||
129900137|NCT03068468|467594995|FG002|Placebo-Controlled Period|Death|0|||
129900138|NCT03068468|467594996|FG003|Placebo-Controlled Period|Death|0|||
129900139|NCT03068468|467594993|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
129900140|NCT03068468|467594994|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
129900141|NCT03068468|467594995|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
129900142|NCT03068468|467594996|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
129900143|NCT03068468|467594993|FG000|Open-Label Extension Period|Adverse Event|0|||
129900144|NCT03068468|467594994|FG001|Open-Label Extension Period|Adverse Event|0|||
129900145|NCT03068468|467594995|FG002|Open-Label Extension Period|Adverse Event|13|||
129900146|NCT03068468|467594996|FG003|Open-Label Extension Period|Adverse Event|17|||
129900147|NCT03068468|467594993|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
129900148|NCT03068468|467594994|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
129900149|NCT03068468|467594995|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
129900150|NCT03068468|467594996|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
129900151|NCT03068468|467594993|FG000|Open-Label Extension Period|Death|0|||
129900152|NCT03068468|467594994|FG001|Open-Label Extension Period|Death|0|||
129900153|NCT03068468|467594995|FG002|Open-Label Extension Period|Death|0|||
129900154|NCT03068468|467594996|FG003|Open-Label Extension Period|Death|1|||
129900155|NCT03068468|467594993|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
129900156|NCT03068468|467594994|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
129900157|NCT03068468|467594995|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
129900158|NCT03068468|467594996|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
129900159|NCT03068468|467594993|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
129900160|NCT03068468|467594994|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
129900161|NCT03068468|467594995|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
129900162|NCT03068468|467594996|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
129900163|NCT03068468|467594993|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
129900164|NCT03068468|467594994|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
129900165|NCT03068468|467594995|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
129900166|NCT03068468|467594996|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
129900167|NCT03068468|467594993|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
129900168|NCT03068468|467594994|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
129900169|NCT03068468|467594995|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
129900170|NCT03068468|467594996|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
129900171|NCT03068468|467594993|FG000|Open-Label Extension Period|Reason not Specified|0|||
129900172|NCT03068468|467594994|FG001|Open-Label Extension Period|Reason not Specified|0|||
129900173|NCT03068468|467594995|FG002|Open-Label Extension Period|Reason not Specified|1|||
129900174|NCT03068468|467594996|FG003|Open-Label Extension Period|Reason not Specified|4|||
129900175|NCT01062126|467594998|FG000|Overall Study|Death|209|||
129900176|NCT01062126|467594998|FG000|Overall Study|All Withdrawals|324|||
129900177|NCT00646451|467594999|FG000|Overall Study|Adverse Event|3|||
129900178|NCT00646451|467595000|FG001|Overall Study|Adverse Event|0|||
129900179|NCT00646451|467594999|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
129900180|NCT00646451|467595000|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
129900181|NCT01249092|467595004|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
129900182|NCT01249092|467595004|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
129900183|NCT00486759|467595005|FG000|Treatment|Adverse event/intercurrent illness|86|||
129900184|NCT00486759|467595006|FG001|Treatment|Adverse event/intercurrent illness|39|||
129900185|NCT00486759|467595005|FG000|Treatment|Insufficient therapeutic response|37|||
129900186|NCT00486759|467595006|FG001|Treatment|Insufficient therapeutic response|39|||
129900187|NCT00486759|467595005|FG000|Treatment|Death|17|||
129900188|NCT00486759|467595006|FG001|Treatment|Death|10|||
129900189|NCT00486759|467595005|FG000|Treatment|Withdrew consent|15|||
129900190|NCT00486759|467595006|FG001|Treatment|Withdrew consent|12|||
129900191|NCT00486759|467595005|FG000|Treatment|Administrative/reason not specified|17|||
129900192|NCT00486759|467595006|FG001|Treatment|Administrative/reason not specified|21|||
129900193|NCT00486759|467595005|FG000|Treatment|Refused treatment|10|||
129900194|NCT00486759|467595006|FG001|Treatment|Refused treatment|7|||
130064021|NCT00600028|468187864|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129900195|NCT00486759|467595005|FG000|Treatment|Violation of selection criteria at entry|3|||
129900196|NCT00486759|467595006|FG001|Treatment|Violation of selection criteria at entry|3|||
129900197|NCT00486759|467595005|FG000|Treatment|Other protocol violation|1|||
129900198|NCT00486759|467595006|FG001|Treatment|Other protocol violation|5|||
130064022|NCT00600028|468187863|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
129900199|NCT00486759|467595005|FG000|Treatment|Failure to return|1|||
129900200|NCT00486759|467595006|FG001|Treatment|Failure to return|1|||
129900201|NCT00486759|467595005|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
130115742|NCT00696709|468383019|FG000|Overall Study|Withdrawal by Subject|1|||
130115743|NCT00696709|468383020|FG001|Overall Study|Withdrawal by Subject|2|||
130115744|NCT00696709|468383021|FG002|Overall Study|Withdrawal by Subject|1|||
130115745|NCT00696709|468383022|FG003|Overall Study|Withdrawal by Subject|4|||
130115746|NCT00696709|468383023|FG004|Overall Study|Withdrawal by Subject|3|||
130115747|NCT00696709|468383019|FG000|Overall Study|Protocol Violation|1|||
130115748|NCT00696709|468383020|FG001|Overall Study|Protocol Violation|0|||
130115749|NCT00696709|468383021|FG002|Overall Study|Protocol Violation|0|||
130115750|NCT00696709|468383022|FG003|Overall Study|Protocol Violation|0|||
130115751|NCT00696709|468383023|FG004|Overall Study|Protocol Violation|0|||
130115752|NCT00696709|468383019|FG000|Overall Study|Lost to Follow-up|1|||
130115753|NCT00696709|468383020|FG001|Overall Study|Lost to Follow-up|1|||
130115754|NCT00696709|468383021|FG002|Overall Study|Lost to Follow-up|0|||
130115755|NCT00696709|468383022|FG003|Overall Study|Lost to Follow-up|0|||
130115756|NCT00696709|468383023|FG004|Overall Study|Lost to Follow-up|0|||
130115757|NCT00696709|468383019|FG000|Overall Study|Adverse Event|0|||
130115758|NCT00696709|468383020|FG001|Overall Study|Adverse Event|0|||
130115759|NCT00696709|468383021|FG002|Overall Study|Adverse Event|0|||
130115760|NCT00696709|468383022|FG003|Overall Study|Adverse Event|1|||
130115761|NCT00696709|468383023|FG004|Overall Study|Adverse Event|0|||
130115762|NCT00321711|468383024|FG000|Part A|Adverse Event|3|||
130115763|NCT00321711|468383025|FG001|Part A|Adverse Event|3|||
130115764|NCT00321711|468383026|FG002|Part A|Adverse Event|2|||
130115765|NCT00321711|468383027|FG003|Part A|Adverse Event|0|||
130115766|NCT00321711|468383028|FG004|Part A|Adverse Event|0|||
130115767|NCT00321711|468383024|FG000|Part A|Withdrawal by Subject|1|||
130115768|NCT00321711|468383025|FG001|Part A|Withdrawal by Subject|1|||
130115769|NCT00321711|468383026|FG002|Part A|Withdrawal by Subject|1|||
130115770|NCT00321711|468383027|FG003|Part A|Withdrawal by Subject|0|||
130115771|NCT00321711|468383028|FG004|Part A|Withdrawal by Subject|0|||
130115772|NCT00321711|468383024|FG000|Part A|Disease progression|0|||
130115773|NCT00321711|468383025|FG001|Part A|Disease progression|1|||
130115774|NCT00321711|468383026|FG002|Part A|Disease progression|0|||
130115775|NCT00321711|468383027|FG003|Part A|Disease progression|0|||
130115776|NCT00321711|468383028|FG004|Part A|Disease progression|0|||
130115777|NCT00321711|468383024|FG000|Part A|Requirement for alternative therapy|0|||
130115778|NCT00321711|468383025|FG001|Part A|Requirement for alternative therapy|2|||
130115779|NCT00321711|468383026|FG002|Part A|Requirement for alternative therapy|1|||
130115780|NCT00321711|468383027|FG003|Part A|Requirement for alternative therapy|0|||
130115781|NCT00321711|468383028|FG004|Part A|Requirement for alternative therapy|0|||
130115782|NCT00321711|468383024|FG000|Part A|Physician Decision|0|||
130115783|NCT00321711|468383025|FG001|Part A|Physician Decision|1|||
130115784|NCT00321711|468383026|FG002|Part A|Physician Decision|3|||
130115785|NCT00321711|468383027|FG003|Part A|Physician Decision|0|||
130115786|NCT00321711|468383028|FG004|Part A|Physician Decision|0|||
130115787|NCT00321711|468383024|FG000|Part A|Other|1|||
130115788|NCT00321711|468383025|FG001|Part A|Other|2|||
130115789|NCT00321711|468383026|FG002|Part A|Other|3|||
130115790|NCT00321711|468383027|FG003|Part A|Other|0|||
130115791|NCT00321711|468383028|FG004|Part A|Other|0|||
130115792|NCT00321711|468383024|FG000|Part A|Protocol deviation|0|||
130115793|NCT00321711|468383025|FG001|Part A|Protocol deviation|0|||
130115794|NCT00321711|468383026|FG002|Part A|Protocol deviation|1|||
130115795|NCT00321711|468383027|FG003|Part A|Protocol deviation|0|||
130115796|NCT00321711|468383028|FG004|Part A|Protocol deviation|0|||
130115797|NCT00321711|468383024|FG000|Part B|Noncompliance|0|||
130115798|NCT00321711|468383025|FG001|Part B|Noncompliance|0|||
130115799|NCT00321711|468383026|FG002|Part B|Noncompliance|0|||
130115800|NCT00321711|468383027|FG003|Part B|Noncompliance|0|||
130115801|NCT00321711|468383028|FG004|Part B|Noncompliance|1|||
130115802|NCT00321711|468383024|FG000|Part B|Adverse Event|0|||
130115803|NCT00321711|468383025|FG001|Part B|Adverse Event|0|||
130115804|NCT00321711|468383026|FG002|Part B|Adverse Event|0|||
130115805|NCT00321711|468383027|FG003|Part B|Adverse Event|2|||
130115806|NCT00321711|468383028|FG004|Part B|Adverse Event|1|||
130115807|NCT00321711|468383024|FG000|Part B|Disease progression|0|||
130115808|NCT00321711|468383025|FG001|Part B|Disease progression|0|||
130115809|NCT00321711|468383026|FG002|Part B|Disease progression|0|||
130115810|NCT00321711|468383027|FG003|Part B|Disease progression|1|||
130115811|NCT00321711|468383028|FG004|Part B|Disease progression|0|||
130115812|NCT00321711|468383024|FG000|Part B|Physician Decision|0|||
130115813|NCT00321711|468383025|FG001|Part B|Physician Decision|0|||
130115814|NCT00321711|468383026|FG002|Part B|Physician Decision|0|||
130115815|NCT00321711|468383027|FG003|Part B|Physician Decision|1|||
130115816|NCT00321711|468383028|FG004|Part B|Physician Decision|2|||
130115817|NCT00321711|468383024|FG000|Part B|Death|0|||
130115818|NCT00321711|468383025|FG001|Part B|Death|0|||
130115819|NCT00321711|468383026|FG002|Part B|Death|0|||
130115820|NCT00321711|468383027|FG003|Part B|Death|2|||
130115821|NCT00321711|468383028|FG004|Part B|Death|1|||
130115822|NCT01484028|468383033|FG000|Period 1|Lost to Follow-up|0|||
130115823|NCT01484028|468383034|FG001|Period 1|Lost to Follow-up|1|||
130115824|NCT01484028|468383035|FG002|Period 1|Lost to Follow-up|0|||
130115825|NCT01484028|468383036|FG003|Period 1|Lost to Follow-up|0|||
129841323|NCT02457598|467385144|FG002|Overall Study|Progressive Disease|1|||
129841324|NCT02457598|467385145|FG003|Overall Study|Progressive Disease|11|||
129841325|NCT02457598|467385146|FG004|Overall Study|Progressive Disease|7|||
129841326|NCT02457598|467385147|FG005|Overall Study|Progressive Disease|3|||
129841327|NCT02457598|467385148|FG006|Overall Study|Progressive Disease|2|||
129841328|NCT02457598|467385149|FG007|Overall Study|Progressive Disease|1|||
129841329|NCT02457598|467385150|FG008|Overall Study|Progressive Disease|1|||
129841330|NCT02457598|467385151|FG009|Overall Study|Progressive Disease|2|||
129841331|NCT02457598|467385152|FG010|Overall Study|Progressive Disease|45|||
129841332|NCT02457598|467385153|FG011|Overall Study|Progressive Disease|6|||
129841333|NCT02457598|467385154|FG012|Overall Study|Progressive Disease|2|||
129841334|NCT02457598|467385155|FG013|Overall Study|Progressive Disease|2|||
129841335|NCT02457598|467385156|FG014|Overall Study|Progressive Disease|10|||
129841336|NCT02457598|467385157|FG015|Overall Study|Progressive Disease|1|||
129841337|NCT02457598|467385158|FG016|Overall Study|Progressive Disease|1|||
129841338|NCT02457598|467385142|FG000|Overall Study|Investigator's Discretion|0|||
129841339|NCT02457598|467385143|FG001|Overall Study|Investigator's Discretion|2|||
129841340|NCT02457598|467385144|FG002|Overall Study|Investigator's Discretion|2|||
129841341|NCT02457598|467385145|FG003|Overall Study|Investigator's Discretion|2|||
129841342|NCT02457598|467385146|FG004|Overall Study|Investigator's Discretion|0|||
129841343|NCT02457598|467385147|FG005|Overall Study|Investigator's Discretion|0|||
129841344|NCT02457598|467385148|FG006|Overall Study|Investigator's Discretion|0|||
129841345|NCT02457598|467385149|FG007|Overall Study|Investigator's Discretion|1|||
129841346|NCT02457598|467385150|FG008|Overall Study|Investigator's Discretion|2|||
129841347|NCT02457598|467385151|FG009|Overall Study|Investigator's Discretion|0|||
129841348|NCT02457598|467385152|FG010|Overall Study|Investigator's Discretion|10|||
129841349|NCT02457598|467385153|FG011|Overall Study|Investigator's Discretion|2|||
129841350|NCT02457598|467385154|FG012|Overall Study|Investigator's Discretion|2|||
129841351|NCT02457598|467385155|FG013|Overall Study|Investigator's Discretion|1|||
129841352|NCT02457598|467385156|FG014|Overall Study|Investigator's Discretion|5|||
129841353|NCT02457598|467385157|FG015|Overall Study|Investigator's Discretion|0|||
129841354|NCT02457598|467385158|FG016|Overall Study|Investigator's Discretion|0|||
129841355|NCT02457598|467385142|FG000|Overall Study|Study Terminated by Sponsor|0|||
129841356|NCT02457598|467385143|FG001|Overall Study|Study Terminated by Sponsor|1|||
129841357|NCT02457598|467385144|FG002|Overall Study|Study Terminated by Sponsor|0|||
129841358|NCT02457598|467385145|FG003|Overall Study|Study Terminated by Sponsor|4|||
129841359|NCT02457598|467385146|FG004|Overall Study|Study Terminated by Sponsor|1|||
129841360|NCT02457598|467385147|FG005|Overall Study|Study Terminated by Sponsor|0|||
129841361|NCT02457598|467385148|FG006|Overall Study|Study Terminated by Sponsor|1|||
129841362|NCT02457598|467385149|FG007|Overall Study|Study Terminated by Sponsor|0|||
129841363|NCT02457598|467385150|FG008|Overall Study|Study Terminated by Sponsor|0|||
129841364|NCT02457598|467385151|FG009|Overall Study|Study Terminated by Sponsor|0|||
129841365|NCT02457598|467385152|FG010|Overall Study|Study Terminated by Sponsor|4|||
129841366|NCT02457598|467385153|FG011|Overall Study|Study Terminated by Sponsor|0|||
129841367|NCT02457598|467385154|FG012|Overall Study|Study Terminated by Sponsor|1|||
129841368|NCT02457598|467385155|FG013|Overall Study|Study Terminated by Sponsor|0|||
129841369|NCT02457598|467385156|FG014|Overall Study|Study Terminated by Sponsor|8|||
129841370|NCT02457598|467385157|FG015|Overall Study|Study Terminated by Sponsor|1|||
129841371|NCT02457598|467385158|FG016|Overall Study|Study Terminated by Sponsor|0|||
129841372|NCT02457598|467385142|FG000|Overall Study|Adverse Event|0|||
129841373|NCT02457598|467385143|FG001|Overall Study|Adverse Event|1|||
129841374|NCT02457598|467385144|FG002|Overall Study|Adverse Event|1|||
129841375|NCT02457598|467385145|FG003|Overall Study|Adverse Event|4|||
129841376|NCT02457598|467385146|FG004|Overall Study|Adverse Event|1|||
129841377|NCT02457598|467385147|FG005|Overall Study|Adverse Event|0|||
129841378|NCT02457598|467385148|FG006|Overall Study|Adverse Event|0|||
129841379|NCT02457598|467385149|FG007|Overall Study|Adverse Event|1|||
129841380|NCT02457598|467385150|FG008|Overall Study|Adverse Event|0|||
129841381|NCT02457598|467385151|FG009|Overall Study|Adverse Event|1|||
129841382|NCT02457598|467385152|FG010|Overall Study|Adverse Event|6|||
129841383|NCT02457598|467385153|FG011|Overall Study|Adverse Event|0|||
129841384|NCT02457598|467385154|FG012|Overall Study|Adverse Event|0|||
129841385|NCT02457598|467385155|FG013|Overall Study|Adverse Event|1|||
129841386|NCT02457598|467385156|FG014|Overall Study|Adverse Event|2|||
129841387|NCT02457598|467385157|FG015|Overall Study|Adverse Event|0|||
129841388|NCT02457598|467385158|FG016|Overall Study|Adverse Event|0|||
129841389|NCT02457598|467385142|FG000|Overall Study|Death|0|||
129841390|NCT02457598|467385143|FG001|Overall Study|Death|0|||
129841391|NCT02457598|467385144|FG002|Overall Study|Death|0|||
129841392|NCT02457598|467385145|FG003|Overall Study|Death|3|||
129841393|NCT02457598|467385146|FG004|Overall Study|Death|0|||
129841394|NCT02457598|467385147|FG005|Overall Study|Death|1|||
129841395|NCT02457598|467385148|FG006|Overall Study|Death|0|||
129841396|NCT02457598|467385149|FG007|Overall Study|Death|0|||
129841397|NCT02457598|467385150|FG008|Overall Study|Death|0|||
129841398|NCT02457598|467385151|FG009|Overall Study|Death|0|||
129841399|NCT02457598|467385152|FG010|Overall Study|Death|3|||
129841400|NCT02457598|467385153|FG011|Overall Study|Death|0|||
129841401|NCT02457598|467385154|FG012|Overall Study|Death|0|||
129841402|NCT02457598|467385155|FG013|Overall Study|Death|1|||
129841403|NCT02457598|467385156|FG014|Overall Study|Death|2|||
129841404|NCT02457598|467385157|FG015|Overall Study|Death|0|||
129841405|NCT02457598|467385158|FG016|Overall Study|Death|1|||
129841406|NCT02457598|467385142|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841407|NCT02457598|467385143|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
129841408|NCT02457598|467385144|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841409|NCT02457598|467385145|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841410|NCT02457598|467385146|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841411|NCT02457598|467385147|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841412|NCT02457598|467385148|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841413|NCT02457598|467385149|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841414|NCT02457598|467385150|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841415|NCT02457598|467385151|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
130064023|NCT00600028|468187864|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
130064024|NCT00600028|468187863|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
130064025|NCT00600028|468187864|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
130064026|NCT03172481|468187868|FG000|Double-blind|Withdrawal by Subject|1|||
130064027|NCT03172481|468187869|FG001|Double-blind|Withdrawal by Subject|0|||
130064028|NCT01061736|468187876|FG000|Overall Study|Dose regimen not selected|0|||
130064029|NCT01061736|468187877|FG001|Overall Study|Dose regimen not selected|0|||
130064030|NCT01061736|468187878|FG002|Overall Study|Dose regimen not selected|0|||
130064031|NCT01061736|468187879|FG003|Overall Study|Dose regimen not selected|0|||
130064032|NCT01061736|468187880|FG004|Overall Study|Dose regimen not selected|0|||
130064033|NCT01061736|468187881|FG005|Overall Study|Dose regimen not selected|0|||
130064034|NCT01061736|468187882|FG006|Overall Study|Dose regimen not selected|79|||
130064035|NCT01061736|468187883|FG007|Overall Study|Dose regimen not selected|0|||
130064036|NCT01061736|468187884|FG008|Overall Study|Dose regimen not selected|0|||
130064037|NCT01061736|468187885|FG009|Overall Study|Dose regimen not selected|0|||
130064038|NCT01061736|468187876|FG000|Overall Study|Adverse Event|13|||
130064039|NCT01061736|468187877|FG001|Overall Study|Adverse Event|1|||
130064040|NCT01061736|468187878|FG002|Overall Study|Adverse Event|3|||
130064041|NCT01061736|468187879|FG003|Overall Study|Adverse Event|2|||
130064042|NCT01061736|468187880|FG004|Overall Study|Adverse Event|4|||
130064043|NCT01061736|468187881|FG005|Overall Study|Adverse Event|1|||
130064044|NCT01061736|468187882|FG006|Overall Study|Adverse Event|4|||
130064045|NCT01061736|468187883|FG007|Overall Study|Adverse Event|63|||
130064046|NCT01061736|468187884|FG008|Overall Study|Adverse Event|67|||
130064047|NCT01061736|468187885|FG009|Overall Study|Adverse Event|34|||
130064048|NCT01061736|468187876|FG000|Overall Study|Lack of Efficacy|0|||
130064049|NCT01061736|468187877|FG001|Overall Study|Lack of Efficacy|2|||
130064050|NCT01061736|468187878|FG002|Overall Study|Lack of Efficacy|1|||
130064051|NCT01061736|468187879|FG003|Overall Study|Lack of Efficacy|1|||
130064052|NCT01061736|468187880|FG004|Overall Study|Lack of Efficacy|1|||
130064053|NCT01061736|468187881|FG005|Overall Study|Lack of Efficacy|2|||
130064054|NCT01061736|468187882|FG006|Overall Study|Lack of Efficacy|1|||
130064055|NCT01061736|468187883|FG007|Overall Study|Lack of Efficacy|9|||
130064056|NCT01061736|468187884|FG008|Overall Study|Lack of Efficacy|9|||
130064057|NCT01061736|468187885|FG009|Overall Study|Lack of Efficacy|10|||
130064058|NCT01061736|468187876|FG000|Overall Study|Poor compliance to protocol|0|||
130064059|NCT01061736|468187877|FG001|Overall Study|Poor compliance to protocol|0|||
130064060|NCT01061736|468187878|FG002|Overall Study|Poor compliance to protocol|0|||
130064061|NCT01061736|468187879|FG003|Overall Study|Poor compliance to protocol|0|||
130064062|NCT01061736|468187880|FG004|Overall Study|Poor compliance to protocol|0|||
130064063|NCT01061736|468187881|FG005|Overall Study|Poor compliance to protocol|0|||
130064064|NCT01061736|468187882|FG006|Overall Study|Poor compliance to protocol|0|||
130064065|NCT01061736|468187883|FG007|Overall Study|Poor compliance to protocol|2|||
130064066|NCT01061736|468187884|FG008|Overall Study|Poor compliance to protocol|5|||
130064067|NCT01061736|468187885|FG009|Overall Study|Poor compliance to protocol|9|||
130064068|NCT01061736|468187876|FG000|Overall Study|Not treated|0|||
130064069|NCT01061736|468187877|FG001|Overall Study|Not treated|0|||
130064070|NCT01061736|468187878|FG002|Overall Study|Not treated|0|||
130064071|NCT01061736|468187879|FG003|Overall Study|Not treated|0|||
130064072|NCT01061736|468187880|FG004|Overall Study|Not treated|1|||
130064073|NCT01061736|468187881|FG005|Overall Study|Not treated|0|||
130064074|NCT01061736|468187882|FG006|Overall Study|Not treated|0|||
130064075|NCT01061736|468187883|FG007|Overall Study|Not treated|2|||
130064076|NCT01061736|468187884|FG008|Overall Study|Not treated|1|||
129841416|NCT02457598|467385152|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
129841417|NCT02457598|467385153|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
130064077|NCT01061736|468187885|FG009|Overall Study|Not treated|0|||
130064078|NCT01061736|468187876|FG000|Overall Study|Other than specified above|0|||
130064079|NCT01061736|468187877|FG001|Overall Study|Other than specified above|1|||
130064080|NCT01061736|468187878|FG002|Overall Study|Other than specified above|2|||
130064081|NCT01061736|468187879|FG003|Overall Study|Other than specified above|0|||
130064082|NCT01061736|468187880|FG004|Overall Study|Other than specified above|1|||
130064083|NCT01061736|468187881|FG005|Overall Study|Other than specified above|0|||
130064084|NCT01061736|468187882|FG006|Overall Study|Other than specified above|0|||
129900202|NCT00486759|467595006|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
129900203|NCT00486759|467595005|FG000|Safety Follow-up|Death|40|||
129900204|NCT00486759|467595006|FG001|Safety Follow-up|Death|29|||
129900205|NCT00486759|467595005|FG000|Safety Follow-up|Withdrew consent|32|||
129900206|NCT00486759|467595006|FG001|Safety Follow-up|Withdrew consent|23|||
129900207|NCT00486759|467595005|FG000|Safety Follow-up|Failure to return|9|||
129900208|NCT00486759|467595006|FG001|Safety Follow-up|Failure to return|6|||
129900209|NCT00486759|467595005|FG000|Safety Follow-up|Administrative/not specified|8|||
129900210|NCT00486759|467595006|FG001|Safety Follow-up|Administrative/not specified|6|||
129900211|NCT00486759|467595005|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
129900212|NCT00486759|467595006|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
129900213|NCT00486759|467595005|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
129900214|NCT00486759|467595006|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
129900215|NCT01185522|467595007|FG000|Overall Study|Lack of Efficacy|28|||
129900216|NCT01185522|467595007|FG000|Overall Study|Lost to Follow-up|19|||
129900217|NCT01185522|467595007|FG000|Overall Study|Withdrawal by Subject|10|||
129900218|NCT01185522|467595007|FG000|Overall Study|Poor tolerance|39|||
129900219|NCT01185522|467595007|FG000|Overall Study|Other reasons|12|||
129900220|NCT00109967|467595008|FG000|Overall Study|Cancel Prior to Treatment|2|||
129900221|NCT00109967|467595009|FG001|Overall Study|Cancel Prior to Treatment|0|||
129900222|NCT00109967|467595008|FG000|Overall Study|Adverse Event|12|||
129900223|NCT00109967|467595009|FG001|Overall Study|Adverse Event|1|||
129900224|NCT00109967|467595008|FG000|Overall Study|Withdrawal by Subject|5|||
129900225|NCT00109967|467595009|FG001|Overall Study|Withdrawal by Subject|0|||
129900226|NCT00109967|467595008|FG000|Overall Study|Physician Decision|1|||
129900227|NCT00109967|467595009|FG001|Overall Study|Physician Decision|3|||
129900228|NCT00109967|467595008|FG000|Overall Study|Death|0|||
129900229|NCT00109967|467595009|FG001|Overall Study|Death|2|||
129900230|NCT03357341|467595016|FG000|Overall Study|Withdrawal by Subject|3|||
129900231|NCT03357341|467595017|FG001|Overall Study|Withdrawal by Subject|6|||
129900232|NCT03357341|467595016|FG000|Overall Study|Lost to Follow-up|4|||
129900233|NCT03357341|467595017|FG001|Overall Study|Lost to Follow-up|5|||
129900234|NCT03357341|467595016|FG000|Overall Study|Death|0|||
129900235|NCT03357341|467595017|FG001|Overall Study|Death|1|||
129900236|NCT00918957|467595018|FG000|Overall Study|Adverse Event|2|||
129900237|NCT00918957|467595019|FG001|Overall Study|Adverse Event|0|||
129900238|NCT00918957|467595018|FG000|Overall Study|Withdrawal by Subject|1|||
129900239|NCT00918957|467595019|FG001|Overall Study|Withdrawal by Subject|0|||
129900240|NCT00543725|467595020|FG000|Overall Study|Adverse Event|18|||
129900241|NCT00543725|467595021|FG001|Overall Study|Adverse Event|27|||
129900242|NCT00543725|467595020|FG000|Overall Study|Sponsor's Decision|0|||
129900243|NCT00543725|467595021|FG001|Overall Study|Sponsor's Decision|1|||
129900244|NCT00543725|467595020|FG000|Overall Study|Subject Non-Compliant|4|||
129900245|NCT00543725|467595021|FG001|Overall Study|Subject Non-Compliant|4|||
129900246|NCT00543725|467595020|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
129900247|NCT00543725|467595021|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
129900248|NCT00543725|467595020|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
129900249|NCT00543725|467595021|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
129900250|NCT00543725|467595020|FG000|Overall Study|Protocol Violation|0|||
129900251|NCT00543725|467595021|FG001|Overall Study|Protocol Violation|1|||
129900252|NCT00543725|467595020|FG000|Overall Study|Withdrawal by Subject|4|||
129900253|NCT00543725|467595021|FG001|Overall Study|Withdrawal by Subject|13|||
129900254|NCT00543725|467595020|FG000|Overall Study|Lost to Follow-up|15|||
129900255|NCT00543725|467595021|FG001|Overall Study|Lost to Follow-up|11|||
129900256|NCT00543725|467595020|FG000|Overall Study|Other|3|||
129900257|NCT00543725|467595021|FG001|Overall Study|Other|3|||
129900258|NCT01242085|467595023|FG000|Overall Study|Withdrawal by Subject|4|||
129900259|NCT01242085|467595024|FG001|Overall Study|Withdrawal by Subject|2|||
129900260|NCT01242085|467595025|FG002|Overall Study|Withdrawal by Subject|0|||
129900261|NCT01242085|467595023|FG000|Overall Study|medically unable to have surgery|4|||
129900262|NCT01242085|467595024|FG001|Overall Study|medically unable to have surgery|5|||
129900263|NCT01242085|467595025|FG002|Overall Study|medically unable to have surgery|0|||
129900264|NCT01178762|467595026|FG000|Overall Study|Lost to Follow-up|15|||
129900265|NCT01651949|467595032|FG000|Overall Study|Unknown status|4|||
129900266|NCT01651949|467595033|FG001|Overall Study|Unknown status|4|||
129900267|NCT01651949|467595034|FG002|Overall Study|Unknown status|0|||
130115826|NCT01484028|468383033|FG000|Period 1|Non-Compliance to Protocol|0|||
129900268|NCT01651949|467595032|FG000|Overall Study|Lost to Follow-up|30|||
129900269|NCT01651949|467595033|FG001|Overall Study|Lost to Follow-up|56|||
129900270|NCT01651949|467595034|FG002|Overall Study|Lost to Follow-up|20|||
129900271|NCT01651949|467595032|FG000|Overall Study|Protocol Violation|0|||
129900272|NCT01651949|467595033|FG001|Overall Study|Protocol Violation|2|||
129900273|NCT01651949|467595034|FG002|Overall Study|Protocol Violation|1|||
129900274|NCT01651949|467595032|FG000|Overall Study|Physician Decision|0|||
129900275|NCT01651949|467595033|FG001|Overall Study|Physician Decision|2|||
129900276|NCT01651949|467595034|FG002|Overall Study|Physician Decision|0|||
129900277|NCT01651949|467595032|FG000|Overall Study|Adverse Event|0|||
129841418|NCT02457598|467385154|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841419|NCT02457598|467385155|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841420|NCT02457598|467385156|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
130064085|NCT01061736|468187883|FG007|Overall Study|Other than specified above|18|||
130064086|NCT01061736|468187884|FG008|Overall Study|Other than specified above|15|||
130064087|NCT01061736|468187885|FG009|Overall Study|Other than specified above|21|||
129841421|NCT02457598|467385157|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841422|NCT02457598|467385158|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841423|NCT02457598|467385142|FG000|Overall Study|Withdrew Consent|0|||
129841424|NCT02457598|467385143|FG001|Overall Study|Withdrew Consent|0|||
129841425|NCT02457598|467385144|FG002|Overall Study|Withdrew Consent|0|||
129841426|NCT02457598|467385145|FG003|Overall Study|Withdrew Consent|0|||
129841427|NCT02457598|467385146|FG004|Overall Study|Withdrew Consent|0|||
129841428|NCT02457598|467385147|FG005|Overall Study|Withdrew Consent|0|||
129841429|NCT02457598|467385148|FG006|Overall Study|Withdrew Consent|0|||
129841430|NCT02457598|467385149|FG007|Overall Study|Withdrew Consent|2|||
130064088|NCT02168803|468187886|FG000|Overall Study|Lost to Follow-up|1|||
130064089|NCT02168803|468187887|FG001|Overall Study|Lost to Follow-up|0|||
130064090|NCT02168803|468187888|FG002|Overall Study|Lost to Follow-up|1|||
130064091|NCT02168803|468187886|FG000|Overall Study|Withdrawal by Subject|1|||
130064092|NCT02168803|468187887|FG001|Overall Study|Withdrawal by Subject|1|||
130064093|NCT02168803|468187888|FG002|Overall Study|Withdrawal by Subject|2|||
130064094|NCT02168803|468187886|FG000|Overall Study|Physician Decision|0|||
130064095|NCT02168803|468187887|FG001|Overall Study|Physician Decision|1|||
130064096|NCT02168803|468187888|FG002|Overall Study|Physician Decision|0|||
130064097|NCT02168803|468187886|FG000|Overall Study|Adverse Event|0|||
130064098|NCT02168803|468187887|FG001|Overall Study|Adverse Event|1|||
130064099|NCT02168803|468187888|FG002|Overall Study|Adverse Event|1|||
130064100|NCT02168803|468187886|FG000|Overall Study|Death|0|||
130064101|NCT02168803|468187887|FG001|Overall Study|Death|0|||
130064102|NCT02168803|468187888|FG002|Overall Study|Death|1|||
130064103|NCT02168803|468187886|FG000|Overall Study|Sponsor Decision|0|||
130064104|NCT02168803|468187887|FG001|Overall Study|Sponsor Decision|0|||
130064105|NCT02168803|468187888|FG002|Overall Study|Sponsor Decision|1|||
130064106|NCT01114373|468187893|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
130064107|NCT01114373|468187894|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
130064108|NCT01114373|468187893|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
130064109|NCT01114373|468187894|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
130064110|NCT01114373|468187893|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
130064111|NCT01114373|468187894|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
130064112|NCT01114373|468187893|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
130064113|NCT01114373|468187894|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
130064114|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130064115|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130064116|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
130064117|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
130064118|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130064119|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
130064120|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
130064121|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
130064122|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
130064123|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
130064124|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
130064125|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
130064126|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
130064127|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
130064128|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
130064129|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130064130|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130064131|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
130064132|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
130064133|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
130064134|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130064135|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130064136|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130064137|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
130064138|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
130064139|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
130064140|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
129841431|NCT02457598|467385150|FG008|Overall Study|Withdrew Consent|0|||
129841432|NCT02457598|467385151|FG009|Overall Study|Withdrew Consent|0|||
130115827|NCT01484028|468383034|FG001|Period 1|Non-Compliance to Protocol|1|||
129841433|NCT02457598|467385152|FG010|Overall Study|Withdrew Consent|3|||
129841434|NCT02457598|467385153|FG011|Overall Study|Withdrew Consent|0|||
129841435|NCT02457598|467385154|FG012|Overall Study|Withdrew Consent|0|||
129841436|NCT02457598|467385155|FG013|Overall Study|Withdrew Consent|1|||
129841437|NCT02457598|467385156|FG014|Overall Study|Withdrew Consent|0|||
129841438|NCT02457598|467385157|FG015|Overall Study|Withdrew Consent|0|||
129841439|NCT02457598|467385158|FG016|Overall Study|Withdrew Consent|0|||
129841440|NCT02457598|467385142|FG000|Overall Study|Unacceptable Toxicity|0|||
129841441|NCT02457598|467385143|FG001|Overall Study|Unacceptable Toxicity|0|||
129841442|NCT02457598|467385144|FG002|Overall Study|Unacceptable Toxicity|0|||
129841443|NCT02457598|467385145|FG003|Overall Study|Unacceptable Toxicity|0|||
129841444|NCT02457598|467385146|FG004|Overall Study|Unacceptable Toxicity|0|||
129841445|NCT02457598|467385147|FG005|Overall Study|Unacceptable Toxicity|0|||
129841446|NCT02457598|467385148|FG006|Overall Study|Unacceptable Toxicity|0|||
129841447|NCT02457598|467385149|FG007|Overall Study|Unacceptable Toxicity|0|||
129841448|NCT02457598|467385150|FG008|Overall Study|Unacceptable Toxicity|0|||
129841449|NCT02457598|467385151|FG009|Overall Study|Unacceptable Toxicity|0|||
129841450|NCT02457598|467385152|FG010|Overall Study|Unacceptable Toxicity|1|||
129841451|NCT02457598|467385153|FG011|Overall Study|Unacceptable Toxicity|0|||
129841452|NCT02457598|467385154|FG012|Overall Study|Unacceptable Toxicity|1|||
129841453|NCT02457598|467385155|FG013|Overall Study|Unacceptable Toxicity|1|||
129841454|NCT02457598|467385156|FG014|Overall Study|Unacceptable Toxicity|1|||
129841455|NCT02457598|467385157|FG015|Overall Study|Unacceptable Toxicity|0|||
129841456|NCT02457598|467385158|FG016|Overall Study|Unacceptable Toxicity|0|||
129841457|NCT02457598|467385142|FG000|Overall Study|Intercurrent Illness|0|||
129841458|NCT02457598|467385143|FG001|Overall Study|Intercurrent Illness|0|||
129841459|NCT02457598|467385144|FG002|Overall Study|Intercurrent Illness|0|||
129841460|NCT02457598|467385145|FG003|Overall Study|Intercurrent Illness|0|||
129841461|NCT02457598|467385146|FG004|Overall Study|Intercurrent Illness|0|||
129841462|NCT02457598|467385147|FG005|Overall Study|Intercurrent Illness|0|||
129841463|NCT02457598|467385148|FG006|Overall Study|Intercurrent Illness|0|||
129841464|NCT02457598|467385149|FG007|Overall Study|Intercurrent Illness|0|||
129841465|NCT02457598|467385150|FG008|Overall Study|Intercurrent Illness|0|||
129841466|NCT02457598|467385151|FG009|Overall Study|Intercurrent Illness|0|||
129841467|NCT02457598|467385152|FG010|Overall Study|Intercurrent Illness|1|||
129841468|NCT02457598|467385153|FG011|Overall Study|Intercurrent Illness|0|||
129841469|NCT02457598|467385154|FG012|Overall Study|Intercurrent Illness|0|||
129841470|NCT02457598|467385155|FG013|Overall Study|Intercurrent Illness|0|||
129841471|NCT02457598|467385156|FG014|Overall Study|Intercurrent Illness|0|||
129841472|NCT02457598|467385157|FG015|Overall Study|Intercurrent Illness|0|||
129841473|NCT02457598|467385158|FG016|Overall Study|Intercurrent Illness|0|||
129841474|NCT02457598|467385142|FG000|Overall Study|Protocol Violation|0|||
129841475|NCT02457598|467385143|FG001|Overall Study|Protocol Violation|0|||
129841476|NCT02457598|467385144|FG002|Overall Study|Protocol Violation|0|||
129841477|NCT02457598|467385145|FG003|Overall Study|Protocol Violation|0|||
129841478|NCT02457598|467385146|FG004|Overall Study|Protocol Violation|0|||
129841479|NCT02457598|467385147|FG005|Overall Study|Protocol Violation|0|||
129841480|NCT02457598|467385148|FG006|Overall Study|Protocol Violation|0|||
129841481|NCT02457598|467385149|FG007|Overall Study|Protocol Violation|0|||
129841482|NCT02457598|467385150|FG008|Overall Study|Protocol Violation|0|||
129841483|NCT02457598|467385151|FG009|Overall Study|Protocol Violation|0|||
129841484|NCT02457598|467385152|FG010|Overall Study|Protocol Violation|1|||
129841485|NCT02457598|467385153|FG011|Overall Study|Protocol Violation|0|||
129841486|NCT02457598|467385154|FG012|Overall Study|Protocol Violation|0|||
129841487|NCT02457598|467385155|FG013|Overall Study|Protocol Violation|0|||
129841488|NCT02457598|467385156|FG014|Overall Study|Protocol Violation|0|||
129841489|NCT02457598|467385157|FG015|Overall Study|Protocol Violation|0|||
129841490|NCT02457598|467385158|FG016|Overall Study|Protocol Violation|0|||
129841491|NCT01403974|467385159|FG000|Overall Study|Progressive disease according to RECIST|3|||
129841492|NCT01403974|467385160|FG001|Overall Study|Progressive disease according to RECIST|3|||
129841493|NCT01403974|467385161|FG002|Overall Study|Progressive disease according to RECIST|2|||
129841494|NCT01403974|467385162|FG003|Overall Study|Progressive disease according to RECIST|3|||
129841495|NCT01403974|467385163|FG004|Overall Study|Progressive disease according to RECIST|3|||
129841496|NCT01403974|467385164|FG005|Overall Study|Progressive disease according to RECIST|2|||
129841497|NCT01403974|467385165|FG006|Overall Study|Progressive disease according to RECIST|3|||
129841498|NCT01403974|467385166|FG007|Overall Study|Progressive disease according to RECIST|2|||
129841499|NCT01403974|467385167|FG008|Overall Study|Progressive disease according to RECIST|6|||
129841500|NCT01403974|467385168|FG009|Overall Study|Progressive disease according to RECIST|2|||
129841501|NCT01403974|467385169|FG010|Overall Study|Progressive disease according to RECIST|3|||
129841502|NCT01403974|467385170|FG011|Overall Study|Progressive disease according to RECIST|2|||
129841503|NCT01403974|467385171|FG012|Overall Study|Progressive disease according to RECIST|2|||
129841504|NCT01403974|467385172|FG013|Overall Study|Progressive disease according to RECIST|3|||
129841505|NCT01403974|467385173|FG014|Overall Study|Progressive disease according to RECIST|1|||
129900278|NCT01651949|467595033|FG001|Overall Study|Adverse Event|2|||
129900279|NCT01651949|467595034|FG002|Overall Study|Adverse Event|1|||
129900280|NCT01651949|467595032|FG000|Overall Study|Screen failure|2|||
129900281|NCT01651949|467595033|FG001|Overall Study|Screen failure|2|||
129900282|NCT01651949|467595034|FG002|Overall Study|Screen failure|0|||
129900283|NCT01651949|467595032|FG000|Overall Study|Withdrawal by Subject|17|||
129900284|NCT01651949|467595033|FG001|Overall Study|Withdrawal by Subject|18|||
129900285|NCT01651949|467595034|FG002|Overall Study|Withdrawal by Subject|9|||
129900286|NCT01806714|467595037|FG000|Overall Study|No functioning phone number|200|||
129900287|NCT01806714|467595038|FG001|Overall Study|No functioning phone number|170|||
129900288|NCT02155829|467595039|FG000|Overall Study|Adverse Event|1|||
129900289|NCT02155829|467595040|FG001|Overall Study|Adverse Event|0|||
129900290|NCT02155829|467595039|FG000|Overall Study|Withdrawal by Subject|3|||
129900291|NCT02155829|467595040|FG001|Overall Study|Withdrawal by Subject|3|||
129900292|NCT02155829|467595039|FG000|Overall Study|Protocol Violation|2|||
129900293|NCT02155829|467595040|FG001|Overall Study|Protocol Violation|0|||
129900294|NCT01585038|467595041|FG000|Overall Study|Adverse Event|2|||
129900295|NCT01585038|467595042|FG001|Overall Study|Adverse Event|2|||
129900296|NCT04107805|467595045|FG000|Overall Study|Adverse Event|0|||
129900297|NCT04107805|467595046|FG001|Overall Study|Adverse Event|0|||
129900298|NCT04107805|467595047|FG002|Overall Study|Adverse Event|0|||
129900299|NCT04107805|467595048|FG003|Overall Study|Adverse Event|1|||
129900300|NCT04107805|467595049|FG004|Overall Study|Adverse Event|0|||
129900301|NCT04107805|467595050|FG005|Overall Study|Adverse Event|1|||
129900302|NCT04107805|467595051|FG006|Overall Study|Adverse Event|0|||
129900303|NCT04107805|467595052|FG007|Overall Study|Adverse Event|0|||
129900304|NCT04107805|467595053|FG008|Overall Study|Adverse Event|1|||
129900305|NCT02596035|467595062|FG000|Overall Study|Disease Progression|64|||
129900306|NCT02596035|467595063|FG001|Overall Study|Disease Progression|32|||
129900307|NCT02596035|467595064|FG002|Overall Study|Disease Progression|1|||
129900308|NCT02596035|467595062|FG000|Overall Study|study drug toxicity|12|||
129900309|NCT02596035|467595063|FG001|Overall Study|study drug toxicity|3|||
129900310|NCT02596035|467595064|FG002|Overall Study|study drug toxicity|0|||
129900311|NCT02596035|467595062|FG000|Overall Study|AE unrelated to study drug|5|||
129900312|NCT02596035|467595063|FG001|Overall Study|AE unrelated to study drug|2|||
129900313|NCT02596035|467595064|FG002|Overall Study|AE unrelated to study drug|0|||
129900314|NCT02596035|467595062|FG000|Overall Study|participant request to discontinue study treatment|2|||
129900315|NCT02596035|467595063|FG001|Overall Study|participant request to discontinue study treatment|0|||
129900316|NCT02596035|467595064|FG002|Overall Study|participant request to discontinue study treatment|0|||
129900317|NCT02596035|467595062|FG000|Overall Study|participant withdrew consent|2|||
129900318|NCT02596035|467595063|FG001|Overall Study|participant withdrew consent|2|||
129900319|NCT02596035|467595064|FG002|Overall Study|participant withdrew consent|0|||
129900320|NCT02596035|467595062|FG000|Overall Study|Poor/Non Comlpiance|0|||
129900321|NCT02596035|467595063|FG001|Overall Study|Poor/Non Comlpiance|1|||
129900322|NCT02596035|467595064|FG002|Overall Study|Poor/Non Comlpiance|0|||
129900323|NCT02596035|467595062|FG000|Overall Study|participant no longer meets study criteria|1|||
129900324|NCT02596035|467595063|FG001|Overall Study|participant no longer meets study criteria|0|||
129900325|NCT02596035|467595064|FG002|Overall Study|participant no longer meets study criteria|0|||
129900326|NCT02596035|467595062|FG000|Overall Study|other reasons|11|||
129900327|NCT02596035|467595063|FG001|Overall Study|other reasons|4|||
129900328|NCT02596035|467595064|FG002|Overall Study|other reasons|0|||
129900329|NCT00414648|467595065|FG000|Overall Study|Adverse Event|5|||
130064141|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130064142|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130064143|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
130064144|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
130064145|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130064146|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130064147|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130064148|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129841506|NCT01403974|467385174|FG015|Overall Study|Progressive disease according to RECIST|8|||
129841507|NCT01403974|467385159|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
129841508|NCT01403974|467385160|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
129841509|NCT01403974|467385161|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
129841510|NCT01403974|467385162|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
129841511|NCT01403974|467385163|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
129841512|NCT01403974|467385164|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
129841513|NCT01403974|467385165|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
129841514|NCT01403974|467385166|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
129841515|NCT01403974|467385167|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
129841516|NCT01403974|467385168|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
129900330|NCT00414648|467595066|FG001|Overall Study|Adverse Event|5|||
129900331|NCT00414648|467595065|FG000|Overall Study|Death|0|||
129900332|NCT00414648|467595066|FG001|Overall Study|Death|1|||
129900333|NCT00414648|467595065|FG000|Overall Study|Lack of Efficacy|0|||
129900334|NCT00414648|467595066|FG001|Overall Study|Lack of Efficacy|2|||
129841517|NCT01403974|467385169|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
129841518|NCT01403974|467385170|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
129841519|NCT01403974|467385171|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
129841520|NCT01403974|467385172|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
129841521|NCT01403974|467385173|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
129841522|NCT01403974|467385174|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
129841523|NCT01403974|467385159|FG000|Overall Study|Refused to continue study medication|0|||
129841524|NCT01403974|467385160|FG001|Overall Study|Refused to continue study medication|0|||
129841525|NCT01403974|467385161|FG002|Overall Study|Refused to continue study medication|0|||
129841526|NCT01403974|467385162|FG003|Overall Study|Refused to continue study medication|0|||
129841527|NCT01403974|467385163|FG004|Overall Study|Refused to continue study medication|0|||
129841528|NCT01403974|467385164|FG005|Overall Study|Refused to continue study medication|1|||
129841529|NCT01403974|467385165|FG006|Overall Study|Refused to continue study medication|0|||
129841530|NCT01403974|467385166|FG007|Overall Study|Refused to continue study medication|0|||
129841531|NCT01403974|467385167|FG008|Overall Study|Refused to continue study medication|1|||
129841532|NCT01403974|467385168|FG009|Overall Study|Refused to continue study medication|0|||
129841533|NCT01403974|467385169|FG010|Overall Study|Refused to continue study medication|1|||
129841534|NCT01403974|467385170|FG011|Overall Study|Refused to continue study medication|0|||
129841535|NCT01403974|467385171|FG012|Overall Study|Refused to continue study medication|0|||
129841536|NCT01403974|467385172|FG013|Overall Study|Refused to continue study medication|0|||
129841537|NCT01403974|467385173|FG014|Overall Study|Refused to continue study medication|0|||
129841538|NCT01403974|467385174|FG015|Overall Study|Refused to continue study medication|4|||
129841539|NCT01403974|467385159|FG000|Overall Study|Adverse Event|0|||
129841540|NCT01403974|467385160|FG001|Overall Study|Adverse Event|0|||
129841541|NCT01403974|467385161|FG002|Overall Study|Adverse Event|1|||
129841542|NCT01403974|467385162|FG003|Overall Study|Adverse Event|0|||
129841543|NCT01403974|467385163|FG004|Overall Study|Adverse Event|0|||
129841544|NCT01403974|467385164|FG005|Overall Study|Adverse Event|0|||
129841545|NCT01403974|467385165|FG006|Overall Study|Adverse Event|0|||
129841546|NCT01403974|467385166|FG007|Overall Study|Adverse Event|1|||
129841547|NCT01403974|467385167|FG008|Overall Study|Adverse Event|0|||
129841548|NCT01403974|467385168|FG009|Overall Study|Adverse Event|0|||
129841549|NCT01403974|467385169|FG010|Overall Study|Adverse Event|0|||
129841550|NCT01403974|467385170|FG011|Overall Study|Adverse Event|0|||
129841551|NCT01403974|467385171|FG012|Overall Study|Adverse Event|1|||
129841552|NCT01403974|467385172|FG013|Overall Study|Adverse Event|0|||
129841553|NCT01403974|467385173|FG014|Overall Study|Adverse Event|0|||
129841554|NCT01403974|467385174|FG015|Overall Study|Adverse Event|0|||
129841555|NCT01403974|467385159|FG000|Overall Study|Other than specified|0|||
129841556|NCT01403974|467385160|FG001|Overall Study|Other than specified|0|||
129841557|NCT01403974|467385161|FG002|Overall Study|Other than specified|0|||
129841558|NCT01403974|467385162|FG003|Overall Study|Other than specified|0|||
129841559|NCT01403974|467385163|FG004|Overall Study|Other than specified|0|||
129841560|NCT01403974|467385164|FG005|Overall Study|Other than specified|0|||
129841561|NCT01403974|467385165|FG006|Overall Study|Other than specified|0|||
129841562|NCT01403974|467385166|FG007|Overall Study|Other than specified|0|||
129841563|NCT01403974|467385167|FG008|Overall Study|Other than specified|0|||
129841564|NCT01403974|467385168|FG009|Overall Study|Other than specified|1|||
129841565|NCT01403974|467385169|FG010|Overall Study|Other than specified|0|||
129841566|NCT01403974|467385170|FG011|Overall Study|Other than specified|1|||
129841567|NCT01403974|467385171|FG012|Overall Study|Other than specified|0|||
129841568|NCT01403974|467385172|FG013|Overall Study|Other than specified|0|||
129841569|NCT01403974|467385173|FG014|Overall Study|Other than specified|0|||
129841570|NCT01403974|467385174|FG015|Overall Study|Other than specified|0|||
129841571|NCT01526889|467385175|FG000|Treatment Period|Adverse Event|2|||
129841572|NCT01526889|467385176|FG001|Treatment Period|Adverse Event|0|||
129841573|NCT01526889|467385175|FG000|Treatment Extension Period|Administrative problems|1|||
129841574|NCT01526889|467385176|FG001|Treatment Extension Period|Administrative problems|0|||
129841575|NCT00974571|467385179|FG000|Overall Study|Adverse Event|31|||
129841576|NCT00974571|467385180|FG001|Overall Study|Adverse Event|4|||
129841577|NCT00974571|467385181|FG002|Overall Study|Adverse Event|27|||
129841578|NCT00974571|467385179|FG000|Overall Study|Lack of Efficacy|3|||
129841579|NCT00974571|467385180|FG001|Overall Study|Lack of Efficacy|2|||
129841580|NCT00974571|467385181|FG002|Overall Study|Lack of Efficacy|9|||
129841581|NCT00974571|467385179|FG000|Overall Study|Lost to Follow-up|2|||
129841582|NCT00974571|467385180|FG001|Overall Study|Lost to Follow-up|1|||
129841583|NCT00974571|467385181|FG002|Overall Study|Lost to Follow-up|2|||
129841584|NCT00974571|467385179|FG000|Overall Study|Protocol Violation|13|||
129841585|NCT00974571|467385180|FG001|Overall Study|Protocol Violation|4|||
129841586|NCT00974571|467385181|FG002|Overall Study|Protocol Violation|18|||
129841587|NCT00974571|467385179|FG000|Overall Study|Withdrawal by Subject|14|||
129841588|NCT00974571|467385180|FG001|Overall Study|Withdrawal by Subject|5|||
129841589|NCT00974571|467385181|FG002|Overall Study|Withdrawal by Subject|16|||
129841590|NCT00974571|467385179|FG000|Overall Study|Patient Moved|1|||
130115828|NCT01484028|468383035|FG002|Period 1|Non-Compliance to Protocol|0|||
130115829|NCT01484028|468383036|FG003|Period 1|Non-Compliance to Protocol|1|||
130115830|NCT01484028|468383033|FG000|Period 1|Lens Discomfort|0|||
130115831|NCT01484028|468383034|FG001|Period 1|Lens Discomfort|1|||
130115832|NCT01484028|468383035|FG002|Period 1|Lens Discomfort|0|||
130115833|NCT01484028|468383036|FG003|Period 1|Lens Discomfort|0|||
129900335|NCT00414648|467595065|FG000|Overall Study|Withdrawal by Subject|0|||
129900336|NCT00414648|467595066|FG001|Overall Study|Withdrawal by Subject|1|||
129900337|NCT04173572|467595069|FG000|Overall Study|Withdrawal by Subject|1|||
129900338|NCT04173572|467595070|FG001|Overall Study|Withdrawal by Subject|5|||
129900339|NCT04173572|467595069|FG000|Overall Study|Lost to Follow-up|3|||
129900340|NCT04173572|467595070|FG001|Overall Study|Lost to Follow-up|1|||
129900341|NCT00835380|467595075|FG000|Overall Study|Withdrawal by Subject|2|||
129900342|NCT03247543|467595076|FG000|Overall Study|Adverse Event|3|||
129900343|NCT03247543|467595077|FG001|Overall Study|Adverse Event|6|||
129900344|NCT03247543|467595078|FG002|Overall Study|Adverse Event|4|||
129900345|NCT03247543|467595076|FG000|Overall Study|Lost to Follow-up|10|||
129900346|NCT03247543|467595077|FG001|Overall Study|Lost to Follow-up|7|||
129900347|NCT03247543|467595078|FG002|Overall Study|Lost to Follow-up|8|||
129900348|NCT03247543|467595076|FG000|Overall Study|Consent withdrawn by caregiver|2|||
129900349|NCT03247543|467595077|FG001|Overall Study|Consent withdrawn by caregiver|2|||
129900350|NCT03247543|467595078|FG002|Overall Study|Consent withdrawn by caregiver|9|||
129900351|NCT03247543|467595076|FG000|Overall Study|Withdrawal by Subject|0|||
129900352|NCT03247543|467595077|FG001|Overall Study|Withdrawal by Subject|0|||
129900353|NCT03247543|467595078|FG002|Overall Study|Withdrawal by Subject|1|||
129900354|NCT03247543|467595076|FG000|Overall Study|Failure to Follow study procedures|1|||
129900355|NCT03247543|467595077|FG001|Overall Study|Failure to Follow study procedures|3|||
129900356|NCT03247543|467595078|FG002|Overall Study|Failure to Follow study procedures|1|||
129900357|NCT03247543|467595076|FG000|Overall Study|Lack of Efficacy|1|||
129900358|NCT03247543|467595077|FG001|Overall Study|Lack of Efficacy|0|||
129900359|NCT03247543|467595078|FG002|Overall Study|Lack of Efficacy|0|||
129900360|NCT03247543|467595076|FG000|Overall Study|Non-compliance with study visits|0|||
129900361|NCT03247543|467595077|FG001|Overall Study|Non-compliance with study visits|1|||
129900362|NCT03247543|467595078|FG002|Overall Study|Non-compliance with study visits|0|||
129900363|NCT02059980|467595081|FG000|Overall Study|Lost to Follow-up|2|||
129900364|NCT02059980|467595082|FG001|Overall Study|Lost to Follow-up|1|||
129900365|NCT01104415|467595083|FG000|Core Phase|Consent withdrawn by subjects|1|||
129900366|NCT01104415|467595084|FG001|Core Phase|Consent withdrawn by subjects|0|||
129900367|NCT01104415|467595083|FG000|Extension Period|Progressive disease|0|||
129900368|NCT01104415|467595084|FG001|Extension Period|Progressive disease|4|||
129900369|NCT01104415|467595083|FG000|Extension Period|Death|0|||
129900370|NCT01104415|467595084|FG001|Extension Period|Death|1|||
129900371|NCT01104415|467595083|FG000|Extension Period|Physician Decision|0|||
129900372|NCT01104415|467595084|FG001|Extension Period|Physician Decision|1|||
129900373|NCT01104415|467595083|FG000|Extension Period|Transition to Study LX1606.302|0|||
129900374|NCT01104415|467595084|FG001|Extension Period|Transition to Study LX1606.302|4|||
129900375|NCT01104415|467595083|FG000|Extension Period|Heart surgery/feeling miserable|0|||
129900376|NCT01104415|467595084|FG001|Extension Period|Heart surgery/feeling miserable|1|||
129900377|NCT01839877|467595087|FG000|Overall Study|Protocol Violation|1|||
129900378|NCT03098030|467595088|FG000|Overall Study|Death|10|||
129900379|NCT03098030|467595089|FG001|Overall Study|Death|156|||
129900380|NCT03098030|467595090|FG002|Overall Study|Death|156|||
129900381|NCT03098030|467595091|FG003|Overall Study|Death|82|||
129900382|NCT03098030|467595088|FG000|Overall Study|Withdrawal by Subject|0|||
129900383|NCT03098030|467595089|FG001|Overall Study|Withdrawal by Subject|7|||
129900384|NCT03098030|467595090|FG002|Overall Study|Withdrawal by Subject|8|||
129900385|NCT03098030|467595091|FG003|Overall Study|Withdrawal by Subject|2|||
129900386|NCT03098030|467595088|FG000|Overall Study|Lost to Follow-up|0|||
129900387|NCT03098030|467595089|FG001|Overall Study|Lost to Follow-up|0|||
129900388|NCT03098030|467595090|FG002|Overall Study|Lost to Follow-up|2|||
130115834|NCT01855126|468383045|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
130115835|NCT01855126|468383046|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
129900389|NCT03098030|467595091|FG003|Overall Study|Lost to Follow-up|1|||
129900390|NCT03643211|467595092|FG000|Overall Study|Contract violation/deficiency|12|||
129900391|NCT03643211|467595092|FG000|Overall Study|Invalid registration|3|||
129900392|NCT03643211|467595092|FG000|Overall Study|No treatment information|2|||
129900393|NCT03643211|467595092|FG000|Overall Study|No adverse event information - No revisit|4|||
129900394|NCT03368001|467595093|FG000|Allocation|Lost to Pretest|16|||
129900395|NCT03368001|467595094|FG001|Allocation|Lost to Pretest|25|||
129900396|NCT03368001|467595093|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
129900397|NCT03368001|467595094|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
129900398|NCT03368001|467595093|FG000|Posttest|Lost to Posttest|7|||
129900399|NCT03368001|467595094|FG001|Posttest|Lost to Posttest|11|||
129900400|NCT03368001|467595093|FG000|Posttest|Discontinued Intervention|6|||
129900401|NCT03368001|467595094|FG001|Posttest|Discontinued Intervention|19|||
129900402|NCT03368001|467595093|FG000|Follow-up|Lost to Follow-up|6|||
130115836|NCT01855126|468383045|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129841591|NCT00974571|467385180|FG001|Overall Study|Patient Moved|0|||
129841592|NCT00974571|467385181|FG002|Overall Study|Patient Moved|1|||
129841593|NCT00974571|467385179|FG000|Overall Study|Other|4|||
129841594|NCT00974571|467385180|FG001|Overall Study|Other|0|||
129841595|NCT00974571|467385181|FG002|Overall Study|Other|10|||
129841596|NCT01494610|467385198|FG000|Period 1|Withdrawal by Subject|1|||
129841597|NCT01494610|467385199|FG001|Period 1|Withdrawal by Subject|1|||
129841598|NCT01494610|467385198|FG000|Period 3|Adverse Event|1|||
129841599|NCT01494610|467385199|FG001|Period 3|Adverse Event|0|||
129841600|NCT01494610|467385198|FG000|Period 3|Withdrawal by Subject|1|||
129841601|NCT01494610|467385199|FG001|Period 3|Withdrawal by Subject|0|||
129841602|NCT01494610|467385198|FG000|Period 4|Protocol Violation|1|||
129841603|NCT01494610|467385199|FG001|Period 4|Protocol Violation|0|||
129841604|NCT04334460|467385200|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
129841605|NCT04334460|467385201|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
129841606|NCT04334460|467385200|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
129841607|NCT04334460|467385201|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
129841608|NCT02385799|467385202|FG000|Overall Study|Lost to Follow-up|1|||
129841609|NCT02385799|467385203|FG001|Overall Study|Lost to Follow-up|2|||
129841610|NCT02385799|467385202|FG000|Overall Study|Adverse Event|4|||
129841611|NCT02385799|467385203|FG001|Overall Study|Adverse Event|2|||
129841612|NCT02385799|467385202|FG000|Overall Study|Withdrawal by Subject|0|||
129841613|NCT02385799|467385203|FG001|Overall Study|Withdrawal by Subject|4|||
129841614|NCT00547703|467385206|FG000|Overall Study|Lost to Follow-up|1|||
129841615|NCT00547703|467385207|FG001|Overall Study|Lost to Follow-up|0|||
129841616|NCT03995953|467385210|FG000|Overall Study|Death|3|||
129841617|NCT03995953|467385211|FG001|Overall Study|Death|0|||
129841618|NCT03995953|467385212|FG002|Overall Study|Death|3|||
130064149|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
130064150|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
130064151|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
130064152|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
130064153|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
130064154|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
130064155|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
130064156|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
130064157|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
130064158|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130064159|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130064160|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130064161|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
130064162|NCT03444870|468187897|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
130064163|NCT03444870|468187898|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130064164|NCT03444870|468187899|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130064165|NCT03444870|468187900|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130064166|NCT03444870|468187901|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130064167|NCT03444870|468187902|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
130064168|NCT03444870|468187897|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130064169|NCT03444870|468187898|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130064170|NCT03444870|468187899|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130064171|NCT03444870|468187900|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
130064172|NCT03444870|468187901|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
130064173|NCT03444870|468187902|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
130064174|NCT03444870|468187897|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
130064175|NCT03444870|468187898|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
130064176|NCT03444870|468187899|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
130064177|NCT03444870|468187900|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
130064178|NCT03444870|468187901|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
130064179|NCT03444870|468187902|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
130064180|NCT03444870|468187897|FG000|Open-Label Extension (OLE) Period|Death|0|||
130064181|NCT03444870|468187898|FG001|Open-Label Extension (OLE) Period|Death|0|||
130064182|NCT03444870|468187899|FG002|Open-Label Extension (OLE) Period|Death|0|||
130064183|NCT03444870|468187900|FG003|Open-Label Extension (OLE) Period|Death|0|||
130064184|NCT03444870|468187901|FG004|Open-Label Extension (OLE) Period|Death|1|||
130064185|NCT03444870|468187902|FG005|Open-Label Extension (OLE) Period|Death|0|||
130064186|NCT02310906|468187905|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
130064187|NCT02310906|468187906|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
130064188|NCT02310906|468187907|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
130064189|NCT02310906|468187908|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
129900403|NCT03368001|467595094|FG001|Follow-up|Lost to Follow-up|3|||
129900404|NCT00554801|467595095|FG000|Overall Study|left area before completion|5|||
129900405|NCT00554801|467595096|FG001|Overall Study|left area before completion|0|||
129900406|NCT00554801|467595095|FG000|Overall Study|Withdrawal by Subject|14|||
129900407|NCT00554801|467595096|FG001|Overall Study|Withdrawal by Subject|0|||
129900408|NCT04436120|467595097|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900409|NCT04436120|467595098|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900410|NCT04436120|467595099|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900411|NCT04436120|467595100|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
129900412|NCT04436120|467595101|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900413|NCT04436120|467595102|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
129900414|NCT04436120|467595103|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900415|NCT02357784|467595104|FG000|Overall Study|Withdrawal by Subject|1|||
129900416|NCT04776213|467595106|FG000|Overall Study|Other|1|||
129900417|NCT04776213|467595106|FG000|Overall Study|Withdrawal by Subject|7|||
129900418|NCT04776213|467595106|FG000|Overall Study|Protocol Violation|1|||
129900419|NCT04776213|467595106|FG000|Overall Study|Lost to Follow-up|2|||
129900420|NCT01838551|467595107|FG000|Overall Study|Adverse Event|16|||
129900421|NCT01838551|467595107|FG000|Overall Study|Death|1|||
130064190|NCT02310906|468187905|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
130064191|NCT02310906|468187906|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
130064192|NCT02310906|468187907|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
130064193|NCT02310906|468187908|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
130064194|NCT02310906|468187905|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
130064195|NCT02310906|468187906|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
130064196|NCT02310906|468187907|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
130064197|NCT02310906|468187908|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
130064198|NCT02310906|468187905|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
130064199|NCT02310906|468187906|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
130064200|NCT02310906|468187907|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
130064201|NCT02310906|468187908|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
130064202|NCT02680587|468187909|FG000|Overall Study|Withdrawal by Subject|1|||
130064203|NCT02680587|468187910|FG001|Overall Study|Withdrawal by Subject|0|||
130064204|NCT00098020|468187914|FG000|Overall Study|Adverse Event|2|||
130064205|NCT00098020|468187914|FG000|Overall Study|Lost to Follow-up|1|||
130064206|NCT00098020|468187914|FG000|Overall Study|elevated liver enzymes|1|||
130064207|NCT00098020|468187914|FG000|Overall Study|Low urine PCR|1|||
130064208|NCT00098020|468187914|FG000|Overall Study|Low epidermal growth factor receptor|1|||
130064209|NCT01840228|468187916|FG000|Overall Study|Lost to Follow-up|1|||
130064210|NCT01840228|468187917|FG001|Overall Study|Lost to Follow-up|1|||
130064211|NCT02022033|468187923|FG000|Overall Study|Physician Decision|1|||
130064212|NCT01360762|468187924|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
130064213|NCT01360762|468187924|FG000|Main Study Period (12-month Treatment)|Death|5|||
130064214|NCT01360762|468187924|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
130064215|NCT01360762|468187924|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
130064216|NCT01360762|468187924|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
130064217|NCT01360762|468187924|FG000|Whole Study Period|Lost to Follow-up|10|||
130064218|NCT01360762|468187924|FG000|Whole Study Period|Death|7|||
130064219|NCT01360762|468187924|FG000|Whole Study Period|Patient relapsed|18|||
130064220|NCT01360762|468187924|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
130064221|NCT01103778|468187925|FG000|Overall Study|Lost to Follow-up|1|||
130064222|NCT01103778|468187925|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
130064223|NCT01103778|468187925|FG000|Overall Study|Screen failure|1|||
130064224|NCT04724733|468187926|FG000|Overall Study|Lost to Follow-up|1|||
130064225|NCT04724733|468187927|FG001|Overall Study|Lost to Follow-up|1|||
130064226|NCT04724733|468187928|FG002|Overall Study|Lost to Follow-up|1|||
130064227|NCT00844649|468187929|FG000|Overall Study|Progressive Disease|196|||
130064228|NCT00844649|468187930|FG001|Overall Study|Progressive Disease|245|||
130064229|NCT00844649|468187929|FG000|Overall Study|Adverse Event|128|||
130064230|NCT00844649|468187930|FG001|Overall Study|Adverse Event|73|||
130064231|NCT00844649|468187929|FG000|Overall Study|Physician Decision|25|||
130064232|NCT00844649|468187930|FG001|Overall Study|Physician Decision|18|||
130064233|NCT00844649|468187929|FG000|Overall Study|Protocol Violation|10|||
130064234|NCT00844649|468187930|FG001|Overall Study|Protocol Violation|6|||
130064235|NCT00844649|468187929|FG000|Overall Study|Withdrawal by Subject|28|||
129900422|NCT01838551|467595107|FG000|Overall Study|Lack of Efficacy|10|||
130064236|NCT00844649|468187930|FG001|Overall Study|Withdrawal by Subject|39|||
130064237|NCT00844649|468187929|FG000|Overall Study|Other|7|||
130064238|NCT00844649|468187930|FG001|Overall Study|Other|10|||
130064239|NCT00844649|468187929|FG000|Overall Study|Withdrew prior to starting treatment|11|||
130064240|NCT00844649|468187930|FG001|Overall Study|Withdrew prior to starting treatment|27|||
130064241|NCT00664209|468187931|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
130115837|NCT01855126|468383046|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
130115838|NCT01748890|468383057|FG000|Overall Study|Insufficient recruitment for analysis|4|||
130115839|NCT03740100|468383058|FG000|Overall Study|Adverse Event|1|||
130115840|NCT03740100|468383058|FG000|Overall Study|Death|1|||
130115841|NCT03387059|468383060|FG000|Overall Study|Study termination|5|||
130115842|NCT03387059|468383061|FG001|Overall Study|Study termination|4|||
130115843|NCT02995837|468383063|FG000|Overall Study|Lost to Follow-up|9|||
130115844|NCT02995837|468383064|FG001|Overall Study|Lost to Follow-up|8|||
130115845|NCT01859702|468383065|FG000|Overall Study|Protocol deviation|3|||
130115846|NCT01859702|468383065|FG000|Overall Study|Adverse Event|2|||
130115847|NCT01077713|468383070|FG000|Overall Study|Withdrawal by Subject|1|||
130115848|NCT01077713|468383071|FG001|Overall Study|Withdrawal by Subject|2|||
130115849|NCT01077713|468383070|FG000|Overall Study|Progressive Disease (PD)|0|||
130115850|NCT01077713|468383071|FG001|Overall Study|Progressive Disease (PD)|1|||
130115851|NCT01077713|468383070|FG000|Overall Study|Death|28|||
130115852|NCT01077713|468383071|FG001|Overall Study|Death|29|||
130115853|NCT01077713|468383070|FG000|Overall Study|Lost to Follow-up|1|||
130115854|NCT01077713|468383071|FG001|Overall Study|Lost to Follow-up|1|||
130115855|NCT01077713|468383070|FG000|Overall Study|Adverse Event|2|||
130115856|NCT01077713|468383071|FG001|Overall Study|Adverse Event|1|||
130115857|NCT01077713|468383070|FG000|Overall Study|Other|4|||
130115858|NCT01077713|468383071|FG001|Overall Study|Other|2|||
130115859|NCT00289458|468383072|FG000|Overall Study|Death|1|||
130115860|NCT00289458|468383073|FG001|Overall Study|Death|0|||
130115861|NCT00289458|468383074|FG002|Overall Study|Death|0|||
130115862|NCT00289458|468383072|FG000|Overall Study|Physician Decision|3|||
130115863|NCT00289458|468383073|FG001|Overall Study|Physician Decision|4|||
130115864|NCT00289458|468383074|FG002|Overall Study|Physician Decision|2|||
130115865|NCT00289458|468383072|FG000|Overall Study|Withdrawal by Subject|2|||
130115866|NCT00289458|468383073|FG001|Overall Study|Withdrawal by Subject|2|||
130115867|NCT00289458|468383074|FG002|Overall Study|Withdrawal by Subject|4|||
130115868|NCT00874757|468383075|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
130115869|NCT04014959|468385052|FG000|Baseline MRI and Assessments|Physician Decision|2|||
130115870|NCT04014959|468385052|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
130115871|NCT04014959|468385052|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
130115872|NCT03997448|468385059|FG000|Study Treatment|Disease Progression|1|||
130115873|NCT03997448|468385059|FG000|Study Treatment|Symptomatic Deterioration|1|||
130115874|NCT03997448|468385059|FG000|Follow up|Death|2|||
130115875|NCT03997448|468385059|FG000|Follow up|study terminated|1|||
129841619|NCT03995953|467385213|FG003|Overall Study|Death|0|||
129841620|NCT03995953|467385214|FG004|Overall Study|Death|3|||
129841621|NCT03995953|467385215|FG005|Overall Study|Death|0|||
129841622|NCT03995953|467385216|FG006|Overall Study|Death|0|||
129841623|NCT03995953|467385217|FG007|Overall Study|Death|0|||
129841624|NCT03995953|467385218|FG008|Overall Study|Death|1|||
129841625|NCT03995953|467385219|FG009|Overall Study|Death|0|||
129841626|NCT03995953|467385220|FG010|Overall Study|Death|0|||
129841627|NCT03995953|467385221|FG011|Overall Study|Death|0|||
129841628|NCT03995953|467385210|FG000|Overall Study|Lost to Follow-up|6|||
129841629|NCT03995953|467385211|FG001|Overall Study|Lost to Follow-up|54|||
129841630|NCT03995953|467385212|FG002|Overall Study|Lost to Follow-up|3|||
129841631|NCT03995953|467385213|FG003|Overall Study|Lost to Follow-up|32|||
129841632|NCT03995953|467385214|FG004|Overall Study|Lost to Follow-up|5|||
129841633|NCT03995953|467385215|FG005|Overall Study|Lost to Follow-up|44|||
129841634|NCT03995953|467385216|FG006|Overall Study|Lost to Follow-up|0|||
129900423|NCT01838551|467595107|FG000|Overall Study|Physician Decision|4|||
129900424|NCT01838551|467595107|FG000|Overall Study|Withdrawal by Subject|10|||
129900425|NCT01838551|467595107|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
129900426|NCT02289560|467595108|FG000|Overall Study|Lost to Follow-up|6|||
130115876|NCT02482805|468385060|FG000|Overall Study|Lost to Follow-up|4|||
129841635|NCT03995953|467385217|FG007|Overall Study|Lost to Follow-up|31|||
129841636|NCT03995953|467385218|FG008|Overall Study|Lost to Follow-up|8|||
130115877|NCT02482805|468385061|FG001|Overall Study|Lost to Follow-up|4|||
130115878|NCT02482805|468385062|FG002|Overall Study|Lost to Follow-up|0|||
130115879|NCT01144663|468385065|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
130115880|NCT01144663|468385066|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
130115881|NCT01144663|468385067|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
130115882|NCT01144663|468385068|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
130115883|NCT01144663|468385065|FG000|Primary Vaccination Phase|Adverse Event|1|||
130115884|NCT01144663|468385066|FG001|Primary Vaccination Phase|Adverse Event|0|||
130115885|NCT01144663|468385067|FG002|Primary Vaccination Phase|Adverse Event|0|||
129841637|NCT03995953|467385219|FG009|Overall Study|Lost to Follow-up|36|||
130115886|NCT01144663|468385068|FG003|Primary Vaccination Phase|Adverse Event|1|||
130115887|NCT01144663|468385065|FG000|Primary Vaccination Phase|Protocol Violation|2|||
129841638|NCT03995953|467385220|FG010|Overall Study|Lost to Follow-up|5|||
129841639|NCT03995953|467385221|FG011|Overall Study|Lost to Follow-up|41|||
129841640|NCT03995953|467385210|FG000|Overall Study|Withdrawal by Subject|4|||
129841641|NCT03995953|467385211|FG001|Overall Study|Withdrawal by Subject|0|||
129841642|NCT03995953|467385212|FG002|Overall Study|Withdrawal by Subject|1|||
129841643|NCT03995953|467385213|FG003|Overall Study|Withdrawal by Subject|0|||
129841644|NCT03995953|467385214|FG004|Overall Study|Withdrawal by Subject|1|||
129841645|NCT03995953|467385215|FG005|Overall Study|Withdrawal by Subject|0|||
129841646|NCT03995953|467385216|FG006|Overall Study|Withdrawal by Subject|1|||
130115888|NCT01144663|468385066|FG001|Primary Vaccination Phase|Protocol Violation|0|||
130115889|NCT01144663|468385067|FG002|Primary Vaccination Phase|Protocol Violation|1|||
130115890|NCT01144663|468385068|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130115891|NCT01144663|468385065|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
130115892|NCT01144663|468385066|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
130115893|NCT01144663|468385067|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
129900427|NCT02289560|467595108|FG000|Overall Study|Alternative Treatment|4|||
129900428|NCT02289560|467595108|FG000|Overall Study|Inadequate Treatment|2|||
129900429|NCT02289560|467595108|FG000|Overall Study|Withdrawal by Subject|23|||
129900430|NCT01981356|467595111|FG000|Overall Study|Lost to Follow-up|4|||
129900431|NCT01981356|467595112|FG001|Overall Study|Lost to Follow-up|1|||
129900432|NCT01981356|467595111|FG000|Overall Study|Withdrawal by Subject|1|||
129900433|NCT01981356|467595112|FG001|Overall Study|Withdrawal by Subject|1|||
129900434|NCT01981356|467595111|FG000|Overall Study|Protocol Violation|2|||
129900435|NCT01981356|467595112|FG001|Overall Study|Protocol Violation|0|||
129900436|NCT02685033|467595113|FG000|Overall Study|Withdrawal of Consent|0|||
129900437|NCT02685033|467595114|FG001|Overall Study|Withdrawal of Consent|1|||
129900438|NCT02685033|467595113|FG000|Overall Study|Lost to Follow-up|2|||
129900439|NCT02685033|467595114|FG001|Overall Study|Lost to Follow-up|1|||
129900440|NCT02685033|467595113|FG000|Overall Study|Adverse Event|1|||
129900441|NCT02685033|467595114|FG001|Overall Study|Adverse Event|0|||
129900442|NCT02013037|467595115|FG000|Overall Study|Death|6|||
129900443|NCT02013037|467595115|FG000|Overall Study|Withdrawal by Subject|1|||
129900444|NCT02013037|467595115|FG000|Overall Study|Awaiting Transplantation|7|||
129900445|NCT02013037|467595115|FG000|Overall Study|Transplanted without DSA|2|||
129900446|NCT03227757|467597081|FG000|Overall Study|Death|25|||
129900447|NCT03227757|467597081|FG000|Overall Study|Withdrawal|10|||
129900448|NCT03227757|467597081|FG000|Overall Study|Missed visits|1|||
129900449|NCT03227757|467597081|FG000|Overall Study|Lost to Follow-up|2|||
129900450|NCT03140176|467597084|FG000|Overall Study|Reason missing|23|||
129900451|NCT03140176|467597084|FG000|Overall Study|Death|33|||
129900452|NCT03140176|467597084|FG000|Overall Study|Disease progression|1|||
129900453|NCT03140176|467597084|FG000|Overall Study|Physician Decision|1|||
129900454|NCT03140176|467597084|FG000|Overall Study|Withdrawal by Subject|1|||
129900455|NCT03140176|467597084|FG000|Overall Study|Lost to Follow-up|15|||
129900456|NCT00954707|467597088|FG000|Overall Study|Death|34|||
129900457|NCT00954707|467597088|FG000|Overall Study|Withdrawal by Subject|100|||
129900458|NCT00954707|467597088|FG000|Overall Study|Lost to Follow-up|33|||
129900459|NCT02001623|467597089|FG000|Overall Study|Disease Progression|2|||
129900460|NCT02001623|467597090|FG001|Overall Study|Disease Progression|2|||
129900461|NCT02001623|467597091|FG002|Overall Study|Disease Progression|3|||
129900462|NCT02001623|467597092|FG003|Overall Study|Disease Progression|2|||
129900463|NCT02001623|467597093|FG004|Overall Study|Disease Progression|3|||
130115894|NCT01144663|468385068|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
130115895|NCT01144663|468385065|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
130115896|NCT01144663|468385066|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
129841647|NCT03995953|467385217|FG007|Overall Study|Withdrawal by Subject|0|||
129841648|NCT03995953|467385218|FG008|Overall Study|Withdrawal by Subject|3|||
129841649|NCT03995953|467385219|FG009|Overall Study|Withdrawal by Subject|0|||
129841650|NCT03995953|467385220|FG010|Overall Study|Withdrawal by Subject|3|||
129841651|NCT03995953|467385221|FG011|Overall Study|Withdrawal by Subject|0|||
129841652|NCT03995953|467385210|FG000|Overall Study|Health Issues|0|||
129841653|NCT03995953|467385211|FG001|Overall Study|Health Issues|0|||
129841654|NCT03995953|467385212|FG002|Overall Study|Health Issues|0|||
129841655|NCT03995953|467385213|FG003|Overall Study|Health Issues|0|||
129841656|NCT03995953|467385214|FG004|Overall Study|Health Issues|1|||
129841657|NCT03995953|467385215|FG005|Overall Study|Health Issues|0|||
129841658|NCT03995953|467385216|FG006|Overall Study|Health Issues|0|||
129841659|NCT03995953|467385217|FG007|Overall Study|Health Issues|0|||
129841660|NCT03995953|467385218|FG008|Overall Study|Health Issues|4|||
129841661|NCT03995953|467385219|FG009|Overall Study|Health Issues|0|||
129841662|NCT03995953|467385220|FG010|Overall Study|Health Issues|0|||
129841663|NCT03995953|467385221|FG011|Overall Study|Health Issues|0|||
129841664|NCT03995953|467385210|FG000|Overall Study|Relocated|11|||
129900464|NCT02001623|467597094|FG005|Overall Study|Disease Progression|2|||
129900465|NCT02001623|467597095|FG006|Overall Study|Disease Progression|3|||
129900466|NCT02001623|467597096|FG007|Overall Study|Disease Progression|3|||
129841665|NCT03995953|467385211|FG001|Overall Study|Relocated|0|||
129900467|NCT02001623|467597097|FG008|Overall Study|Disease Progression|7|||
129900468|NCT02001623|467597098|FG009|Overall Study|Disease Progression|40|||
129900469|NCT02001623|467597099|FG010|Overall Study|Disease Progression|5|||
129900470|NCT02001623|467597100|FG011|Overall Study|Disease Progression|9|||
129900471|NCT02001623|467597101|FG012|Overall Study|Disease Progression|9|||
129841666|NCT03995953|467385212|FG002|Overall Study|Relocated|16|||
129841667|NCT03995953|467385213|FG003|Overall Study|Relocated|0|||
129841668|NCT03995953|467385214|FG004|Overall Study|Relocated|14|||
129841669|NCT03995953|467385215|FG005|Overall Study|Relocated|0|||
129841670|NCT03995953|467385216|FG006|Overall Study|Relocated|16|||
129841671|NCT03995953|467385217|FG007|Overall Study|Relocated|0|||
129841672|NCT03995953|467385218|FG008|Overall Study|Relocated|14|||
129841673|NCT03995953|467385219|FG009|Overall Study|Relocated|0|||
129841674|NCT03995953|467385220|FG010|Overall Study|Relocated|15|||
129841675|NCT03995953|467385221|FG011|Overall Study|Relocated|0|||
129841676|NCT02130765|467385222|FG000|Overall Study|Did not receive treatment|4|||
129841677|NCT02130765|467385223|FG001|Overall Study|Did not receive treatment|0|||
129841678|NCT02130765|467385224|FG002|Overall Study|Did not receive treatment|0|||
129841679|NCT02130765|467385225|FG003|Overall Study|Did not receive treatment|0|||
129841680|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
129841681|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
129841682|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
129841683|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
129841684|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
129841685|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
129841686|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
129841687|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129841688|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129841689|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129841690|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
129841691|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
129841692|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
129841693|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
129841694|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
129841695|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841696|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
129841697|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841698|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841699|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841700|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
129841701|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
129841702|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
129841703|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
129841704|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
129841705|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841706|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
129841707|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841708|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841709|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841710|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
129841711|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841712|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841713|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841714|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841715|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
129841716|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841717|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841718|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841719|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841720|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
129841721|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841722|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841723|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841724|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841725|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841726|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
129841727|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841728|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841729|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841730|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
129841731|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129841732|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129841733|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129841734|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129900472|NCT02001623|467597102|FG013|Overall Study|Disease Progression|20|||
129841735|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841736|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
129841737|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841738|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841739|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841740|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129841741|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129841742|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
129841743|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129900473|NCT02001623|467597103|FG014|Overall Study|Disease Progression|9|||
129900474|NCT02001623|467597089|FG000|Overall Study|Physician Decision|0|||
129900475|NCT02001623|467597090|FG001|Overall Study|Physician Decision|0|||
129900476|NCT02001623|467597091|FG002|Overall Study|Physician Decision|0|||
129900477|NCT02001623|467597092|FG003|Overall Study|Physician Decision|0|||
129900478|NCT02001623|467597093|FG004|Overall Study|Physician Decision|0|||
129900479|NCT02001623|467597094|FG005|Overall Study|Physician Decision|0|||
129900480|NCT02001623|467597095|FG006|Overall Study|Physician Decision|0|||
129900481|NCT02001623|467597096|FG007|Overall Study|Physician Decision|0|||
129900482|NCT02001623|467597097|FG008|Overall Study|Physician Decision|3|||
129900483|NCT02001623|467597098|FG009|Overall Study|Physician Decision|2|||
129900484|NCT02001623|467597099|FG010|Overall Study|Physician Decision|3|||
129900485|NCT02001623|467597100|FG011|Overall Study|Physician Decision|3|||
129900486|NCT02001623|467597101|FG012|Overall Study|Physician Decision|1|||
129900487|NCT02001623|467597102|FG013|Overall Study|Physician Decision|2|||
129900488|NCT02001623|467597103|FG014|Overall Study|Physician Decision|1|||
129900489|NCT02001623|467597089|FG000|Overall Study|Death|0|||
129900490|NCT02001623|467597090|FG001|Overall Study|Death|1|||
129900491|NCT02001623|467597091|FG002|Overall Study|Death|0|||
129900492|NCT02001623|467597092|FG003|Overall Study|Death|0|||
129900493|NCT02001623|467597093|FG004|Overall Study|Death|0|||
129900494|NCT02001623|467597094|FG005|Overall Study|Death|0|||
129900495|NCT02001623|467597095|FG006|Overall Study|Death|0|||
129900496|NCT02001623|467597096|FG007|Overall Study|Death|0|||
129900497|NCT02001623|467597097|FG008|Overall Study|Death|0|||
129900498|NCT02001623|467597098|FG009|Overall Study|Death|0|||
129900499|NCT02001623|467597099|FG010|Overall Study|Death|0|||
129900500|NCT02001623|467597100|FG011|Overall Study|Death|0|||
129900501|NCT02001623|467597101|FG012|Overall Study|Death|0|||
129900502|NCT02001623|467597102|FG013|Overall Study|Death|0|||
129900503|NCT02001623|467597103|FG014|Overall Study|Death|0|||
129900504|NCT02001623|467597089|FG000|Overall Study|Adverse Event|0|||
129900505|NCT02001623|467597090|FG001|Overall Study|Adverse Event|0|||
129900506|NCT02001623|467597091|FG002|Overall Study|Adverse Event|0|||
129900507|NCT02001623|467597092|FG003|Overall Study|Adverse Event|0|||
129900508|NCT02001623|467597093|FG004|Overall Study|Adverse Event|0|||
129900509|NCT02001623|467597094|FG005|Overall Study|Adverse Event|1|||
129900510|NCT02001623|467597095|FG006|Overall Study|Adverse Event|0|||
129900511|NCT02001623|467597096|FG007|Overall Study|Adverse Event|3|||
129900512|NCT02001623|467597097|FG008|Overall Study|Adverse Event|4|||
129900513|NCT02001623|467597098|FG009|Overall Study|Adverse Event|6|||
129900514|NCT02001623|467597099|FG010|Overall Study|Adverse Event|4|||
129900515|NCT02001623|467597100|FG011|Overall Study|Adverse Event|0|||
129900516|NCT02001623|467597101|FG012|Overall Study|Adverse Event|3|||
129900517|NCT02001623|467597102|FG013|Overall Study|Adverse Event|5|||
129900518|NCT02001623|467597103|FG014|Overall Study|Adverse Event|6|||
129900519|NCT02001623|467597089|FG000|Overall Study|Other - Miscellaneous|0|||
129900520|NCT02001623|467597090|FG001|Overall Study|Other - Miscellaneous|0|||
129900521|NCT02001623|467597091|FG002|Overall Study|Other - Miscellaneous|0|||
129900522|NCT02001623|467597092|FG003|Overall Study|Other - Miscellaneous|0|||
129900523|NCT02001623|467597093|FG004|Overall Study|Other - Miscellaneous|0|||
129900524|NCT02001623|467597094|FG005|Overall Study|Other - Miscellaneous|0|||
129900525|NCT02001623|467597095|FG006|Overall Study|Other - Miscellaneous|0|||
129900526|NCT02001623|467597096|FG007|Overall Study|Other - Miscellaneous|0|||
129900527|NCT02001623|467597097|FG008|Overall Study|Other - Miscellaneous|0|||
129900528|NCT02001623|467597098|FG009|Overall Study|Other - Miscellaneous|1|||
130115897|NCT01144663|468385067|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
129900529|NCT02001623|467597099|FG010|Overall Study|Other - Miscellaneous|0|||
129900530|NCT02001623|467597100|FG011|Overall Study|Other - Miscellaneous|0|||
129900531|NCT02001623|467597101|FG012|Overall Study|Other - Miscellaneous|0|||
129900532|NCT02001623|467597102|FG013|Overall Study|Other - Miscellaneous|1|||
129900533|NCT02001623|467597103|FG014|Overall Study|Other - Miscellaneous|0|||
129900534|NCT02001623|467597089|FG000|Overall Study|Withdrawal by Subject|1|||
129900535|NCT02001623|467597090|FG001|Overall Study|Withdrawal by Subject|0|||
129900536|NCT02001623|467597091|FG002|Overall Study|Withdrawal by Subject|0|||
129900537|NCT02001623|467597092|FG003|Overall Study|Withdrawal by Subject|0|||
129900538|NCT02001623|467597093|FG004|Overall Study|Withdrawal by Subject|0|||
129900539|NCT02001623|467597094|FG005|Overall Study|Withdrawal by Subject|0|||
129900540|NCT02001623|467597095|FG006|Overall Study|Withdrawal by Subject|0|||
129900541|NCT02001623|467597096|FG007|Overall Study|Withdrawal by Subject|0|||
129900542|NCT02001623|467597097|FG008|Overall Study|Withdrawal by Subject|1|||
129900543|NCT02001623|467597098|FG009|Overall Study|Withdrawal by Subject|3|||
129900544|NCT02001623|467597099|FG010|Overall Study|Withdrawal by Subject|2|||
129900545|NCT02001623|467597100|FG011|Overall Study|Withdrawal by Subject|2|||
129900546|NCT02001623|467597101|FG012|Overall Study|Withdrawal by Subject|1|||
129900547|NCT02001623|467597102|FG013|Overall Study|Withdrawal by Subject|5|||
129900548|NCT02001623|467597103|FG014|Overall Study|Withdrawal by Subject|2|||
129900549|NCT02001623|467597089|FG000|Overall Study|Lost to Follow-up|0|||
129900550|NCT02001623|467597090|FG001|Overall Study|Lost to Follow-up|0|||
129900551|NCT02001623|467597091|FG002|Overall Study|Lost to Follow-up|0|||
129900552|NCT02001623|467597092|FG003|Overall Study|Lost to Follow-up|0|||
129900553|NCT02001623|467597093|FG004|Overall Study|Lost to Follow-up|0|||
129900554|NCT02001623|467597094|FG005|Overall Study|Lost to Follow-up|0|||
129900555|NCT02001623|467597095|FG006|Overall Study|Lost to Follow-up|0|||
129900556|NCT02001623|467597096|FG007|Overall Study|Lost to Follow-up|0|||
129900557|NCT02001623|467597097|FG008|Overall Study|Lost to Follow-up|0|||
129900558|NCT02001623|467597098|FG009|Overall Study|Lost to Follow-up|1|||
129900559|NCT02001623|467597099|FG010|Overall Study|Lost to Follow-up|0|||
129900560|NCT02001623|467597100|FG011|Overall Study|Lost to Follow-up|0|||
129900561|NCT02001623|467597101|FG012|Overall Study|Lost to Follow-up|0|||
129900562|NCT02001623|467597102|FG013|Overall Study|Lost to Follow-up|0|||
129900563|NCT02001623|467597103|FG014|Overall Study|Lost to Follow-up|0|||
129900564|NCT02001623|467597089|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
129900565|NCT02001623|467597090|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
129900566|NCT02001623|467597091|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
129900567|NCT02001623|467597092|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
129900568|NCT02001623|467597093|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
129900569|NCT02001623|467597094|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
129900570|NCT02001623|467597095|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
129900571|NCT02001623|467597096|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
129900572|NCT02001623|467597097|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
129900573|NCT02001623|467597098|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
129900574|NCT02001623|467597099|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
129900575|NCT02001623|467597100|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
129900576|NCT02001623|467597101|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
129900577|NCT02001623|467597102|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
129900578|NCT02001623|467597103|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
129900579|NCT02001623|467597089|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
129900580|NCT02001623|467597090|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
129900581|NCT02001623|467597091|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
129900582|NCT02001623|467597092|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
129900583|NCT02001623|467597093|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
129900584|NCT02001623|467597094|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
129900585|NCT02001623|467597095|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
129900586|NCT02001623|467597096|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
129900587|NCT02001623|467597097|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
129900588|NCT02001623|467597098|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
129900589|NCT02001623|467597099|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
129900590|NCT02001623|467597100|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
129900591|NCT02001623|467597101|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
129900592|NCT02001623|467597102|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
129900593|NCT02001623|467597103|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
129900594|NCT00309452|467597104|FG000|Overall Study|Withdrawal by Subject|3|||
129900595|NCT00309452|467597105|FG001|Overall Study|Withdrawal by Subject|0|||
129900596|NCT00771667|467597106|FG000|Induction Phase|Adverse Event|5|||
130064242|NCT00664209|468187931|FG000|Study Treatment Period|Physician Decision|4|||
130064243|NCT00664209|468187931|FG000|Study Treatment Period|Withdrawal by Subject|2|||
130064244|NCT00065442|468187942|FG000|Overall Study|Lost to Follow-up|1|||
130064245|NCT00065442|468187943|FG001|Overall Study|Lost to Follow-up|1|||
130064246|NCT00065442|468187942|FG000|Overall Study|Death|121|||
130064247|NCT00065442|468187943|FG001|Overall Study|Death|210|||
130064248|NCT00065442|468187942|FG000|Overall Study|Withdrawal by Subject|3|||
129900597|NCT00771667|467597107|FG001|Induction Phase|Adverse Event|2|||
129900598|NCT00771667|467597108|FG002|Induction Phase|Adverse Event|4|||
129900599|NCT00771667|467597109|FG003|Induction Phase|Adverse Event|1|||
129900600|NCT00771667|467597110|FG004|Induction Phase|Adverse Event|0|||
129900601|NCT00771667|467597111|FG005|Induction Phase|Adverse Event|0|||
129900602|NCT00771667|467597112|FG006|Induction Phase|Adverse Event|0|||
129900603|NCT00771667|467597113|FG007|Induction Phase|Adverse Event|0|||
129900604|NCT00771667|467597114|FG008|Induction Phase|Adverse Event|0|||
129900605|NCT00771667|467597115|FG009|Induction Phase|Adverse Event|0|||
129900606|NCT00771667|467597106|FG000|Induction Phase|Lack of Efficacy|9|||
129900607|NCT00771667|467597107|FG001|Induction Phase|Lack of Efficacy|2|||
130064249|NCT00065442|468187943|FG001|Overall Study|Withdrawal by Subject|9|||
130064250|NCT01594333|468187944|FG000|Overall Study|Death|96|||
129841744|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
129841745|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
129841746|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
129841747|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
129841748|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
129841749|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
129841750|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
129841751|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
129841752|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
129841753|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
129841754|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
129841755|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
129841756|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
129841757|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
129841758|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
129841759|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
129841760|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841761|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841762|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
129841763|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841764|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841765|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
129841766|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
129841767|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
129841768|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
129841769|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
129841770|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
129841771|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
129841772|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
129841773|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
129841774|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
129841775|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841776|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841777|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841778|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841779|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
129841780|NCT01455012|467385244|FG000|Overall Study|Adverse Event|0|||
129841781|NCT01455012|467385245|FG001|Overall Study|Adverse Event|2|||
129841782|NCT01455012|467385244|FG000|Overall Study|Lack of Efficacy|6|||
129841783|NCT01455012|467385245|FG001|Overall Study|Lack of Efficacy|1|||
129841784|NCT01455012|467385244|FG000|Overall Study|Withdrawal by Subject|3|||
129841785|NCT01455012|467385245|FG001|Overall Study|Withdrawal by Subject|1|||
129841786|NCT01455012|467385244|FG000|Overall Study|Unknown reason|2|||
129841787|NCT01455012|467385245|FG001|Overall Study|Unknown reason|0|||
129841788|NCT01215227|467385246|FG000|Overall Study|Adverse Event|11|||
129841789|NCT01215227|467385247|FG001|Overall Study|Adverse Event|11|||
129841790|NCT01215227|467385248|FG002|Overall Study|Adverse Event|4|||
129841791|NCT01215227|467385249|FG003|Overall Study|Adverse Event|8|||
129841792|NCT01215227|467385250|FG004|Overall Study|Adverse Event|7|||
129841793|NCT01215227|467385251|FG005|Overall Study|Adverse Event|6|||
129841794|NCT01215227|467385246|FG000|Overall Study|Treatment Failure|8|||
129841795|NCT01215227|467385247|FG001|Overall Study|Treatment Failure|4|||
129841796|NCT01215227|467385248|FG002|Overall Study|Treatment Failure|1|||
129841797|NCT01215227|467385249|FG003|Overall Study|Treatment Failure|5|||
129841798|NCT01215227|467385250|FG004|Overall Study|Treatment Failure|1|||
129841799|NCT01215227|467385251|FG005|Overall Study|Treatment Failure|1|||
129841800|NCT01215227|467385246|FG000|Overall Study|Lost to Follow-up|1|||
129841801|NCT01215227|467385247|FG001|Overall Study|Lost to Follow-up|4|||
129841802|NCT01215227|467385248|FG002|Overall Study|Lost to Follow-up|1|||
129841803|NCT01215227|467385249|FG003|Overall Study|Lost to Follow-up|1|||
129841804|NCT01215227|467385250|FG004|Overall Study|Lost to Follow-up|1|||
129841805|NCT01215227|467385251|FG005|Overall Study|Lost to Follow-up|2|||
129841806|NCT01215227|467385246|FG000|Overall Study|Subject Withdrew Consent|16|||
129841807|NCT01215227|467385247|FG001|Overall Study|Subject Withdrew Consent|20|||
129841808|NCT01215227|467385248|FG002|Overall Study|Subject Withdrew Consent|7|||
129841809|NCT01215227|467385249|FG003|Overall Study|Subject Withdrew Consent|10|||
130064251|NCT01594333|468187945|FG001|Overall Study|Death|83|||
130064252|NCT01594333|468187944|FG000|Overall Study|Lost to Follow-up|5|||
130064253|NCT01594333|468187945|FG001|Overall Study|Lost to Follow-up|5|||
129900608|NCT00771667|467597108|FG002|Induction Phase|Lack of Efficacy|4|||
129900609|NCT00771667|467597109|FG003|Induction Phase|Lack of Efficacy|3|||
129900610|NCT00771667|467597110|FG004|Induction Phase|Lack of Efficacy|0|||
129900611|NCT00771667|467597111|FG005|Induction Phase|Lack of Efficacy|0|||
129900612|NCT00771667|467597112|FG006|Induction Phase|Lack of Efficacy|0|||
129900613|NCT00771667|467597113|FG007|Induction Phase|Lack of Efficacy|0|||
129900614|NCT00771667|467597114|FG008|Induction Phase|Lack of Efficacy|0|||
129900615|NCT00771667|467597115|FG009|Induction Phase|Lack of Efficacy|0|||
129900616|NCT00771667|467597106|FG000|Induction Phase|Lost to Follow-up|1|||
129900617|NCT00771667|467597107|FG001|Induction Phase|Lost to Follow-up|0|||
129900618|NCT00771667|467597108|FG002|Induction Phase|Lost to Follow-up|1|||
129900619|NCT00771667|467597109|FG003|Induction Phase|Lost to Follow-up|0|||
129900620|NCT00771667|467597110|FG004|Induction Phase|Lost to Follow-up|0|||
129900621|NCT00771667|467597111|FG005|Induction Phase|Lost to Follow-up|0|||
129900622|NCT00771667|467597112|FG006|Induction Phase|Lost to Follow-up|0|||
129900623|NCT00771667|467597113|FG007|Induction Phase|Lost to Follow-up|0|||
129900624|NCT00771667|467597114|FG008|Induction Phase|Lost to Follow-up|0|||
129900625|NCT00771667|467597115|FG009|Induction Phase|Lost to Follow-up|0|||
129900626|NCT00771667|467597106|FG000|Induction Phase|Other|4|||
129900627|NCT00771667|467597107|FG001|Induction Phase|Other|6|||
129900628|NCT00771667|467597108|FG002|Induction Phase|Other|3|||
129900629|NCT00771667|467597109|FG003|Induction Phase|Other|4|||
129900630|NCT00771667|467597110|FG004|Induction Phase|Other|0|||
129900631|NCT00771667|467597111|FG005|Induction Phase|Other|0|||
129900632|NCT00771667|467597112|FG006|Induction Phase|Other|0|||
129900633|NCT00771667|467597113|FG007|Induction Phase|Other|0|||
129900634|NCT00771667|467597114|FG008|Induction Phase|Other|0|||
129900635|NCT00771667|467597115|FG009|Induction Phase|Other|0|||
129900636|NCT00771667|467597106|FG000|Maintenance Phase|Adverse Event|0|||
129900637|NCT00771667|467597107|FG001|Maintenance Phase|Adverse Event|0|||
129900638|NCT00771667|467597108|FG002|Maintenance Phase|Adverse Event|0|||
129900639|NCT00771667|467597109|FG003|Maintenance Phase|Adverse Event|0|||
129900640|NCT00771667|467597110|FG004|Maintenance Phase|Adverse Event|1|||
129900641|NCT00771667|467597111|FG005|Maintenance Phase|Adverse Event|3|||
129900642|NCT00771667|467597112|FG006|Maintenance Phase|Adverse Event|5|||
129900643|NCT00771667|467597113|FG007|Maintenance Phase|Adverse Event|1|||
129900644|NCT00771667|467597114|FG008|Maintenance Phase|Adverse Event|8|||
129900645|NCT00771667|467597115|FG009|Maintenance Phase|Adverse Event|7|||
129900646|NCT00771667|467597106|FG000|Maintenance Phase|Lack of Efficacy|0|||
129900647|NCT00771667|467597107|FG001|Maintenance Phase|Lack of Efficacy|0|||
129841810|NCT01215227|467385250|FG004|Overall Study|Subject Withdrew Consent|11|||
129841811|NCT01215227|467385251|FG005|Overall Study|Subject Withdrew Consent|8|||
129841812|NCT01215227|467385246|FG000|Overall Study|Non-Compliance With Protocol|2|||
129841813|NCT01215227|467385247|FG001|Overall Study|Non-Compliance With Protocol|6|||
129841814|NCT01215227|467385248|FG002|Overall Study|Non-Compliance With Protocol|1|||
129841815|NCT01215227|467385249|FG003|Overall Study|Non-Compliance With Protocol|0|||
129841816|NCT01215227|467385250|FG004|Overall Study|Non-Compliance With Protocol|0|||
129841817|NCT01215227|467385251|FG005|Overall Study|Non-Compliance With Protocol|0|||
129841818|NCT01215227|467385246|FG000|Overall Study|Administrative|83|||
129841819|NCT01215227|467385247|FG001|Overall Study|Administrative|73|||
129841820|NCT01215227|467385248|FG002|Overall Study|Administrative|42|||
129841821|NCT01215227|467385249|FG003|Overall Study|Administrative|24|||
129841822|NCT01215227|467385250|FG004|Overall Study|Administrative|28|||
129841823|NCT01215227|467385251|FG005|Overall Study|Administrative|40|||
129841824|NCT01215227|467385246|FG000|Overall Study|Missing Status|0|||
129841825|NCT01215227|467385247|FG001|Overall Study|Missing Status|1|||
129841826|NCT01215227|467385248|FG002|Overall Study|Missing Status|0|||
129841827|NCT01215227|467385249|FG003|Overall Study|Missing Status|0|||
129841828|NCT01215227|467385250|FG004|Overall Study|Missing Status|0|||
129841829|NCT01215227|467385251|FG005|Overall Study|Missing Status|0|||
129841830|NCT01215227|467385246|FG000|Overall Study|Randomized but not treated|0|||
129841831|NCT01215227|467385247|FG001|Overall Study|Randomized but not treated|0|||
129841832|NCT01215227|467385248|FG002|Overall Study|Randomized but not treated|1|||
129841833|NCT01215227|467385249|FG003|Overall Study|Randomized but not treated|1|||
129841834|NCT01215227|467385250|FG004|Overall Study|Randomized but not treated|0|||
129841835|NCT01215227|467385251|FG005|Overall Study|Randomized but not treated|1|||
129841836|NCT02253810|467385252|FG000|Overall Study|Withdrawal by Subject|2|||
129841837|NCT02253810|467385253|FG001|Overall Study|Withdrawal by Subject|1|||
129900648|NCT00771667|467597108|FG002|Maintenance Phase|Lack of Efficacy|0|||
129900649|NCT00771667|467597109|FG003|Maintenance Phase|Lack of Efficacy|0|||
129900650|NCT00771667|467597110|FG004|Maintenance Phase|Lack of Efficacy|1|||
129900651|NCT00771667|467597111|FG005|Maintenance Phase|Lack of Efficacy|3|||
129900652|NCT00771667|467597112|FG006|Maintenance Phase|Lack of Efficacy|3|||
129841838|NCT02253810|467385252|FG000|Overall Study|Unknown concomitant procedure|3|||
129900653|NCT00771667|467597113|FG007|Maintenance Phase|Lack of Efficacy|2|||
129900654|NCT00771667|467597114|FG008|Maintenance Phase|Lack of Efficacy|11|||
129900655|NCT00771667|467597115|FG009|Maintenance Phase|Lack of Efficacy|7|||
129900656|NCT00771667|467597106|FG000|Maintenance Phase|Other|0|||
129900657|NCT00771667|467597107|FG001|Maintenance Phase|Other|0|||
129900658|NCT00771667|467597108|FG002|Maintenance Phase|Other|0|||
129841839|NCT02253810|467385253|FG001|Overall Study|Unknown concomitant procedure|2|||
129841840|NCT01434290|467385254|FG000|Overall Study|Protocol Violation|6|||
129841841|NCT01434290|467385255|FG001|Overall Study|Protocol Violation|3|||
129841842|NCT01434290|467385254|FG000|Overall Study|No protocol treatment|2|||
129841843|NCT01434290|467385255|FG001|Overall Study|No protocol treatment|4|||
129841844|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
129841845|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
129841846|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
129841847|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
129841848|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
129841849|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
129841850|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
129841851|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
129841852|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
129841853|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
129841854|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
129841855|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
129841856|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
129841857|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
129900659|NCT00771667|467597109|FG003|Maintenance Phase|Other|0|||
129841858|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
129841859|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
129841860|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
129841861|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
129841862|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
129900660|NCT00771667|467597110|FG004|Maintenance Phase|Other|0|||
129900661|NCT00771667|467597111|FG005|Maintenance Phase|Other|1|||
129900662|NCT00771667|467597112|FG006|Maintenance Phase|Other|2|||
130064254|NCT01594333|468187944|FG000|Overall Study|Withdrawal by Subject|60|||
130064255|NCT01594333|468187945|FG001|Overall Study|Withdrawal by Subject|63|||
129841863|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
129841864|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Other|3|||
129841865|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Other|0|||
129841866|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Other|2|||
129841867|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Other|2|||
129900663|NCT00771667|467597113|FG007|Maintenance Phase|Other|2|||
129900664|NCT00771667|467597114|FG008|Maintenance Phase|Other|3|||
130064256|NCT00565058|468187946|FG000|Overall Study|Adverse Event|1|||
130064257|NCT00565058|468187947|FG001|Overall Study|Adverse Event|0|||
130064258|NCT01397448|468187950|FG000|Overall Study|Adverse Event|4|||
130064259|NCT01397448|468187951|FG001|Overall Study|Adverse Event|4|||
130064260|NCT01397448|468187952|FG002|Overall Study|Adverse Event|6|||
130064261|NCT01397448|468187950|FG000|Overall Study|Withdrawal by Subject|4|||
130064262|NCT01397448|468187951|FG001|Overall Study|Withdrawal by Subject|4|||
130064263|NCT01397448|468187952|FG002|Overall Study|Withdrawal by Subject|3|||
130064264|NCT01397448|468187950|FG000|Overall Study|Lack of Efficacy|2|||
130064265|NCT01397448|468187951|FG001|Overall Study|Lack of Efficacy|0|||
130064266|NCT01397448|468187952|FG002|Overall Study|Lack of Efficacy|5|||
130064267|NCT01397448|468187950|FG000|Overall Study|Other|8|||
130064268|NCT01397448|468187951|FG001|Overall Study|Other|7|||
130064269|NCT01397448|468187952|FG002|Overall Study|Other|4|||
130064270|NCT01969799|468187957|FG000|Overall Study|Adverse Event|0|||
130064271|NCT01969799|468187958|FG001|Overall Study|Adverse Event|1|||
130064272|NCT01969799|468187957|FG000|Overall Study|Death|16|||
130064273|NCT01969799|468187958|FG001|Overall Study|Death|11|||
130064274|NCT01969799|468187957|FG000|Overall Study|Lost to Follow-up|0|||
130064275|NCT01969799|468187958|FG001|Overall Study|Lost to Follow-up|2|||
130064276|NCT01969799|468187957|FG000|Overall Study|Physician Decision|1|||
130064277|NCT01969799|468187958|FG001|Overall Study|Physician Decision|0|||
130064278|NCT01255306|468190092|FG000|Overall Study|Physician Decision|1|||
130064279|NCT01255306|468190093|FG001|Overall Study|Physician Decision|1|||
130064280|NCT01283997|468190094|FG000|Overall Study|Physician Decision|8|||
130064281|NCT01283997|468190095|FG001|Overall Study|Physician Decision|10|||
130115898|NCT01144663|468385068|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
129841868|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Other|7|||
129841869|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841870|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841871|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841872|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
129841873|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841874|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841875|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
130064282|NCT01283997|468190094|FG000|Overall Study|Withdrawal by Subject|3|||
130064283|NCT01283997|468190095|FG001|Overall Study|Withdrawal by Subject|2|||
130064284|NCT01283997|468190094|FG000|Overall Study|Physically unable to continue|0|||
130064285|NCT01283997|468190095|FG001|Overall Study|Physically unable to continue|1|||
130064286|NCT01283997|468190094|FG000|Overall Study|Progressive disease|1|||
130064287|NCT01283997|468190095|FG001|Overall Study|Progressive disease|0|||
130064288|NCT01283997|468190094|FG000|Overall Study|Other|4|||
129841876|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841877|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841878|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
129841879|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
129841880|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
129841881|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
129841882|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
129841883|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
129841884|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
129841885|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
129841886|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
129841887|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
129841888|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
129841889|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
129841890|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
129841891|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
129841892|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
129841893|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
129841894|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Other|2|||
129841895|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Other|1|||
129841896|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Other|2|||
129841897|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Other|8|||
129841898|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Other|7|||
129841899|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841900|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
129841901|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841902|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841903|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841904|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
129841905|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841906|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841907|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841908|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841909|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
129841910|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
129841911|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
129841912|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
129841913|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
129841914|NCT00213148|467385257|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
129841915|NCT00213148|467385258|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
129841916|NCT00213148|467385259|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
129841917|NCT00213148|467385260|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
129841918|NCT00213148|467385261|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
129841919|NCT00213148|467385257|FG000|Cycle 3 (1 Month)|Other|0|||
129841920|NCT00213148|467385258|FG001|Cycle 3 (1 Month)|Other|0|||
129841921|NCT00213148|467385259|FG002|Cycle 3 (1 Month)|Other|1|||
129841922|NCT00213148|467385260|FG003|Cycle 3 (1 Month)|Other|1|||
129841923|NCT00213148|467385261|FG004|Cycle 3 (1 Month)|Other|0|||
129841924|NCT00558103|467385262|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
129841925|NCT00558103|467385263|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
129841926|NCT00558103|467385264|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
129841927|NCT00558103|467385265|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
129841928|NCT00558103|467385266|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
129841929|NCT00558103|467385267|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
129841930|NCT00558103|467385262|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
129841931|NCT00558103|467385263|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
129841932|NCT00558103|467385264|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
129841933|NCT00558103|467385265|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
129841934|NCT00558103|467385266|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
129841935|NCT00558103|467385267|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
129841936|NCT00558103|467385262|FG000|Randomized Treatment Phase|Disease Progression|1|||
129841937|NCT00558103|467385263|FG001|Randomized Treatment Phase|Disease Progression|0|||
129841938|NCT00558103|467385264|FG002|Randomized Treatment Phase|Disease Progression|1|||
129841939|NCT00558103|467385265|FG003|Randomized Treatment Phase|Disease Progression|0|||
129841940|NCT00558103|467385266|FG004|Randomized Treatment Phase|Disease Progression|0|||
129841941|NCT00558103|467385267|FG005|Randomized Treatment Phase|Disease Progression|0|||
129841942|NCT00558103|467385262|FG000|Randomized Treatment Phase|Adverse Event|0|||
129841943|NCT00558103|467385263|FG001|Randomized Treatment Phase|Adverse Event|0|||
129841944|NCT00558103|467385264|FG002|Randomized Treatment Phase|Adverse Event|0|||
129841945|NCT00558103|467385265|FG003|Randomized Treatment Phase|Adverse Event|1|||
129841946|NCT00558103|467385266|FG004|Randomized Treatment Phase|Adverse Event|1|||
129841947|NCT00558103|467385267|FG005|Randomized Treatment Phase|Adverse Event|0|||
129841948|NCT00558103|467385262|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
130115899|NCT01144663|468385065|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
130115900|NCT01144663|468385066|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
130115901|NCT01144663|468385067|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
130115902|NCT01144663|468385068|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
130115903|NCT01144663|468385065|FG000|Primary Vaccination Phase|Other|0|||
130115904|NCT01144663|468385066|FG001|Primary Vaccination Phase|Other|1|||
130115905|NCT01144663|468385067|FG002|Primary Vaccination Phase|Other|0|||
130115906|NCT01144663|468385068|FG003|Primary Vaccination Phase|Other|2|||
130115907|NCT01144663|468385065|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
130115908|NCT01144663|468385066|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
130115909|NCT01144663|468385067|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
130115910|NCT01144663|468385068|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
130115911|NCT01144663|468385065|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
130115912|NCT01144663|468385066|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
130115913|NCT01144663|468385067|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
130115914|NCT01144663|468385068|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
130115915|NCT01144663|468385065|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
130115916|NCT01144663|468385066|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
130115917|NCT01144663|468385067|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
130115918|NCT01144663|468385068|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
130115919|NCT01144663|468385065|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
130115920|NCT01144663|468385066|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
130115921|NCT01144663|468385067|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
130115922|NCT01144663|468385068|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
130115923|NCT01144663|468385065|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
130115924|NCT01144663|468385066|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
130115925|NCT01144663|468385067|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
130115926|NCT01144663|468385068|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
130115927|NCT01144663|468385065|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
130115928|NCT01144663|468385066|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
130115929|NCT01144663|468385067|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
130115930|NCT01144663|468385068|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
130115931|NCT02497391|468385070|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
130115932|NCT02497391|468385071|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
130115933|NCT02497391|468385072|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
130115934|NCT02497391|468385073|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
130115935|NCT02497391|468385074|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
130115936|NCT02497391|468385075|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
130115937|NCT02497391|468385070|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
130115938|NCT02497391|468385071|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
130115939|NCT02497391|468385072|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
130115940|NCT02497391|468385073|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
130115941|NCT02497391|468385074|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
130115942|NCT02497391|468385075|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
130115943|NCT02497391|468385070|FG000|Period 3 (14 Days)|Adverse Event|0|||
130115944|NCT02497391|468385071|FG001|Period 3 (14 Days)|Adverse Event|1|||
130115945|NCT02497391|468385072|FG002|Period 3 (14 Days)|Adverse Event|0|||
130115946|NCT02497391|468385073|FG003|Period 3 (14 Days)|Adverse Event|0|||
130115947|NCT02497391|468385074|FG004|Period 3 (14 Days)|Adverse Event|0|||
130115948|NCT02497391|468385075|FG005|Period 3 (14 Days)|Adverse Event|0|||
130115949|NCT02497391|468385070|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
130115950|NCT02497391|468385071|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
129900665|NCT00771667|467597115|FG009|Maintenance Phase|Other|3|||
129900666|NCT00628862|467597116|FG000|Overall Study|Adverse Event|6|||
129900667|NCT00628862|467597117|FG001|Overall Study|Adverse Event|8|||
129900668|NCT00628862|467597118|FG002|Overall Study|Adverse Event|10|||
129900669|NCT00628862|467597116|FG000|Overall Study|Withdrawal by Subject|4|||
129900670|NCT00628862|467597117|FG001|Overall Study|Withdrawal by Subject|6|||
129900671|NCT00628862|467597118|FG002|Overall Study|Withdrawal by Subject|11|||
129900672|NCT00628862|467597116|FG000|Overall Study|Lost to Follow-up|0|||
129900673|NCT00628862|467597117|FG001|Overall Study|Lost to Follow-up|2|||
130115951|NCT02497391|468385072|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
130115952|NCT02497391|468385073|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
130115953|NCT02497391|468385074|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
130115954|NCT02497391|468385075|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
130115955|NCT02497391|468385070|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
130115956|NCT02497391|468385071|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
130115957|NCT02497391|468385072|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
130115958|NCT02497391|468385073|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
130115959|NCT02497391|468385074|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
129900674|NCT00628862|467597118|FG002|Overall Study|Lost to Follow-up|1|||
129900675|NCT00628862|467597116|FG000|Overall Study|Protocol Violation|1|||
129900676|NCT00628862|467597117|FG001|Overall Study|Protocol Violation|0|||
130115960|NCT02497391|468385075|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
130115961|NCT00633152|468385086|FG000|Overall Study|Adverse Event|1|||
130115962|NCT00633152|468385087|FG001|Overall Study|Adverse Event|0|||
130115963|NCT00633152|468385086|FG000|Overall Study|Randomized, did not receive study drug|5|||
130115964|NCT00633152|468385087|FG001|Overall Study|Randomized, did not receive study drug|2|||
130115965|NCT00633152|468385086|FG000|Overall Study|Withdrawal by Subject|1|||
130115966|NCT00633152|468385087|FG001|Overall Study|Withdrawal by Subject|1|||
130115967|NCT00633152|468385086|FG000|Overall Study|Lost to Follow-up|4|||
130115968|NCT00633152|468385087|FG001|Overall Study|Lost to Follow-up|1|||
130115969|NCT00633152|468385086|FG000|Overall Study|Miscellaneous Other|3|||
130115970|NCT00633152|468385087|FG001|Overall Study|Miscellaneous Other|2|||
130115971|NCT02180061|468385088|FG000|Overall Study|Adverse Event|4|||
130115972|NCT02180061|468385089|FG001|Overall Study|Adverse Event|2|||
130115973|NCT02180061|468385088|FG000|Overall Study|Clinical Progression|5|||
130115974|NCT02180061|468385089|FG001|Overall Study|Clinical Progression|1|||
130115975|NCT02180061|468385088|FG000|Overall Study|Progressive Disease|15|||
130115976|NCT02180061|468385089|FG001|Overall Study|Progressive Disease|5|||
130115977|NCT02180061|468385088|FG000|Overall Study|Physician Decision|1|||
130115978|NCT02180061|468385089|FG001|Overall Study|Physician Decision|0|||
130115979|NCT01469364|468385090|FG000|Overall Study|Adverse Event|1|||
130115980|NCT01469364|468385090|FG000|Overall Study|Withdrawal by Subject|1|||
130115981|NCT03433001|468385109|FG000|Overall Study|Lack of Efficacy|109|||
130115982|NCT03433001|468385109|FG000|Overall Study|Adverse Event|69|||
130115983|NCT03433001|468385109|FG000|Overall Study|Withdrawal by Subject|10|||
130115984|NCT03433001|468385109|FG000|Overall Study|Death|12|||
130115985|NCT03433001|468385109|FG000|Overall Study|Lost to Follow-up|4|||
130115986|NCT03433001|468385109|FG000|Overall Study|Other|25|||
130115987|NCT01007916|468385110|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
130115988|NCT01007916|468385111|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
130115989|NCT01007916|468385110|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
130115990|NCT01007916|468385111|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
130115991|NCT02040428|468385115|FG000|Overall Study|Death|4|||
130115992|NCT02040428|468385116|FG001|Overall Study|Death|3|||
130115993|NCT02040428|468385115|FG000|Overall Study|Withdrawal by Subject|1|||
130115994|NCT02040428|468385116|FG001|Overall Study|Withdrawal by Subject|1|||
130115995|NCT01165996|468385130|FG000|Overall Study|Death|1|||
130115996|NCT01165996|468385130|FG000|Overall Study|Physician Decision|1|||
130115997|NCT01927757|468385147|FG000|Overall Study|Withdrawal by Subject|14|||
130115998|NCT01927757|468385147|FG000|Overall Study|Lost to Follow-up|2|||
130115999|NCT01927757|468385147|FG000|Overall Study|Decision by Sponsor|2|||
130116000|NCT01927757|468385147|FG000|Overall Study|Other|1|||
130116001|NCT01927757|468385147|FG000|Overall Study|Ethical Reasons|4|||
130116002|NCT01399723|468385148|FG000|Overall Study|Lost to Follow-up|0|||
130116003|NCT01399723|468385149|FG001|Overall Study|Lost to Follow-up|1|||
130116004|NCT00268346|468385153|FG000|Overall Study|Adverse Event|0|||
130116005|NCT00268346|468385154|FG001|Overall Study|Adverse Event|1|||
130116006|NCT00268346|468385153|FG000|Overall Study|Death|0|||
130116007|NCT00268346|468385154|FG001|Overall Study|Death|1|||
130116008|NCT00268346|468385153|FG000|Overall Study|Withdrawal by Subject|0|||
129900677|NCT00628862|467597118|FG002|Overall Study|Protocol Violation|0|||
129900678|NCT00628862|467597116|FG000|Overall Study|COPD Exacerbation|0|||
129900679|NCT00628862|467597117|FG001|Overall Study|COPD Exacerbation|1|||
129900680|NCT00628862|467597118|FG002|Overall Study|COPD Exacerbation|0|||
129900681|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Adverse Event|1|||
129900682|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
129900683|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
129900684|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
129900685|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Pregnancy|1|||
129900686|NCT01063036|467597119|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
129900687|NCT01063036|467597119|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
129900688|NCT01063036|467597119|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
130116009|NCT00268346|468385154|FG001|Overall Study|Withdrawal by Subject|1|||
130116010|NCT00294723|468385155|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
129900689|NCT02715258|467597120|FG000|Overall Study|Withdrawal by Subject|6|||
129900690|NCT02715258|467597121|FG001|Overall Study|Withdrawal by Subject|1|||
129900691|NCT02715258|467597120|FG000|Overall Study|Lost to Follow-up|7|||
129900692|NCT02715258|467597121|FG001|Overall Study|Lost to Follow-up|1|||
130116011|NCT00294723|468385156|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
130116012|NCT00294723|468385157|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
130116013|NCT00294723|468385155|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
130116014|NCT00294723|468385156|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
130116015|NCT00294723|468385157|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
130116016|NCT00294723|468385155|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
130116017|NCT00294723|468385156|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
130116018|NCT00294723|468385157|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
130116019|NCT00294723|468385155|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
130116020|NCT00294723|468385156|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
130116021|NCT00294723|468385157|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
130116022|NCT00294723|468385155|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
130116023|NCT00294723|468385156|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
130116024|NCT00294723|468385157|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
130116025|NCT00294723|468385155|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
130116026|NCT00294723|468385156|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
130116027|NCT00294723|468385157|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
130116028|NCT00294723|468385155|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
130116029|NCT00294723|468385156|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
130116030|NCT00294723|468385157|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
130116031|NCT00294723|468385155|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
130116032|NCT00294723|468385156|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
130116033|NCT00294723|468385157|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
130116034|NCT00294723|468385155|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
130116035|NCT00294723|468385156|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
130116036|NCT00294723|468385157|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
130116037|NCT00294723|468385155|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
130116038|NCT00294723|468385156|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
130116039|NCT00294723|468385157|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
130116040|NCT00294723|468385155|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
130116041|NCT00294723|468385156|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
130116042|NCT00294723|468385157|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
130116043|NCT00294723|468385155|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
130116044|NCT00294723|468385156|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
130116045|NCT00294723|468385157|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
130116046|NCT00752791|468385158|FG000|Overall Study|Adverse Event|7|||
130116047|NCT00752791|468385158|FG000|Overall Study|Withdrawal by Subject|1|||
130116048|NCT00752791|468385158|FG000|Overall Study|Physician Decision|1|||
130116049|NCT00752791|468385158|FG000|Overall Study|Death|1|||
130116050|NCT00752791|468385158|FG000|Overall Study|Renal transplant|3|||
130116051|NCT00752791|468385158|FG000|Overall Study|Switched to hemodialysis|2|||
130116052|NCT00752791|468385158|FG000|Overall Study|Protocol deviation|1|||
130116053|NCT01958281|468385159|FG000|Overall Study|Lack of Efficacy|5|||
130116054|NCT01958281|468385160|FG001|Overall Study|Lack of Efficacy|2|||
130116055|NCT01958281|468385161|FG002|Overall Study|Lack of Efficacy|0|||
130116056|NCT01958281|468385159|FG000|Overall Study|Adverse Event|0|||
130116057|NCT01958281|468385160|FG001|Overall Study|Adverse Event|2|||
130116058|NCT01958281|468385161|FG002|Overall Study|Adverse Event|0|||
129841949|NCT00558103|467385263|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
129841950|NCT00558103|467385264|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
129841951|NCT00558103|467385265|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
129841952|NCT00558103|467385266|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
129841953|NCT00558103|467385267|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
129841954|NCT00558103|467385262|FG000|Monotherapy Extension Phase|Disease Progression|0|||
129841955|NCT00558103|467385263|FG001|Monotherapy Extension Phase|Disease Progression|0|||
129841956|NCT00558103|467385264|FG002|Monotherapy Extension Phase|Disease Progression|0|||
129841957|NCT00558103|467385265|FG003|Monotherapy Extension Phase|Disease Progression|0|||
129841958|NCT00558103|467385266|FG004|Monotherapy Extension Phase|Disease Progression|0|||
129841959|NCT00558103|467385267|FG005|Monotherapy Extension Phase|Disease Progression|8|||
129841960|NCT03548584|467387429|FG000|Overall Study|Lost to Follow-up|0|||
129841961|NCT03548584|467387430|FG001|Overall Study|Lost to Follow-up|0|||
129841962|NCT03548584|467387431|FG002|Overall Study|Lost to Follow-up|1|||
129841963|NCT03548584|467387429|FG000|Overall Study|Adverse Event|1|||
129841964|NCT03548584|467387430|FG001|Overall Study|Adverse Event|11|||
129841965|NCT03548584|467387431|FG002|Overall Study|Adverse Event|5|||
129841966|NCT03548584|467387429|FG000|Overall Study|Site Terminated by Sponsor|1|||
129841967|NCT03548584|467387430|FG001|Overall Study|Site Terminated by Sponsor|3|||
129841968|NCT03548584|467387431|FG002|Overall Study|Site Terminated by Sponsor|2|||
129841969|NCT03548584|467387429|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
129841970|NCT03548584|467387430|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
130116059|NCT01958281|468385159|FG000|Overall Study|Withdrew Consent|1|||
130116060|NCT01958281|468385160|FG001|Overall Study|Withdrew Consent|0|||
130116061|NCT01958281|468385161|FG002|Overall Study|Withdrew Consent|0|||
130116062|NCT02784106|468385162|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
130116063|NCT02784106|468385163|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
129841971|NCT03548584|467387431|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
129841972|NCT03548584|467387429|FG000|Overall Study|Lack of Efficacy|0|||
129841973|NCT03548584|467387430|FG001|Overall Study|Lack of Efficacy|1|||
130116064|NCT02784106|468385164|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
130116065|NCT02784106|468385165|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129841974|NCT03548584|467387431|FG002|Overall Study|Lack of Efficacy|0|||
129841975|NCT03548584|467387429|FG000|Overall Study|Non-compliance with Study Drug|0|||
129841976|NCT03548584|467387430|FG001|Overall Study|Non-compliance with Study Drug|1|||
129841977|NCT03548584|467387431|FG002|Overall Study|Non-compliance with Study Drug|0|||
129841978|NCT03548584|467387429|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
129841979|NCT03548584|467387430|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
129841980|NCT03548584|467387431|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
129841981|NCT01101841|467387436|FG000|Overall Study|Adverse Event|15|||
129841982|NCT01101841|467387437|FG001|Overall Study|Adverse Event|15|||
129841983|NCT01101841|467387436|FG000|Overall Study|Lost to Follow-up|9|||
129841984|NCT01101841|467387437|FG001|Overall Study|Lost to Follow-up|3|||
129841985|NCT01101841|467387436|FG000|Overall Study|Withdrawal by Subject|21|||
129841986|NCT01101841|467387437|FG001|Overall Study|Withdrawal by Subject|40|||
129841987|NCT01101841|467387436|FG000|Overall Study|Protocol Violation|1|||
129841988|NCT01101841|467387437|FG001|Overall Study|Protocol Violation|1|||
129841989|NCT01101841|467387436|FG000|Overall Study|Physician Decision|0|||
129841990|NCT01101841|467387437|FG001|Overall Study|Physician Decision|2|||
129841991|NCT01101841|467387436|FG000|Overall Study|Lack of Efficacy|0|||
129841992|NCT01101841|467387437|FG001|Overall Study|Lack of Efficacy|2|||
129841993|NCT01101841|467387436|FG000|Overall Study|Other|0|||
129841994|NCT01101841|467387437|FG001|Overall Study|Other|1|||
129841995|NCT01101841|467387436|FG000|Overall Study|Suicidality Tracking Scale|3|||
129841996|NCT01101841|467387437|FG001|Overall Study|Suicidality Tracking Scale|1|||
129841997|NCT01101841|467387436|FG000|Overall Study|Eligibility Criteria|1|||
129841998|NCT01101841|467387437|FG001|Overall Study|Eligibility Criteria|2|||
129841999|NCT00653224|467387442|FG000|Overall Study|Adverse Event|2|||
129842000|NCT00653224|467387443|FG001|Overall Study|Adverse Event|1|||
129842001|NCT00653224|467387442|FG000|Overall Study|Lack of Efficacy|1|||
129842002|NCT00653224|467387443|FG001|Overall Study|Lack of Efficacy|2|||
129842003|NCT00653224|467387442|FG000|Overall Study|Loss of efficacy|1|||
129842004|NCT00653224|467387443|FG001|Overall Study|Loss of efficacy|0|||
129842005|NCT00653224|467387442|FG000|Overall Study|Lost to Follow-up|1|||
129842006|NCT00653224|467387443|FG001|Overall Study|Lost to Follow-up|0|||
129842007|NCT00653224|467387442|FG000|Overall Study|Other|2|||
129842008|NCT00653224|467387443|FG001|Overall Study|Other|4|||
129842009|NCT03633396|467387448|FG000|Overall Study|Withdrawal by Subject|4|||
130064289|NCT01283997|468190095|FG001|Overall Study|Other|4|||
129842010|NCT03633396|467387449|FG001|Overall Study|Withdrawal by Subject|4|||
129842011|NCT03633396|467387448|FG000|Overall Study|Adverse Event|1|||
130064290|NCT02017899|468190096|FG000|Overall Study|Withdrawal by Subject|0|||
130064291|NCT02017899|468190097|FG001|Overall Study|Withdrawal by Subject|0|||
130064292|NCT02017899|468190098|FG002|Overall Study|Withdrawal by Subject|0|||
130064293|NCT02017899|468190099|FG003|Overall Study|Withdrawal by Subject|1|||
130064294|NCT02017899|468190100|FG004|Overall Study|Withdrawal by Subject|1|||
130064295|NCT02017899|468190101|FG005|Overall Study|Withdrawal by Subject|0|||
130064296|NCT01677624|468190105|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
130064297|NCT00804843|468190106|FG000|Overall Study|Protocol Violation|1|||
130064298|NCT00804843|468190107|FG001|Overall Study|Protocol Violation|0|||
130064299|NCT00804843|468190106|FG000|Overall Study|Adverse Event|8|||
130064300|NCT00804843|468190107|FG001|Overall Study|Adverse Event|5|||
130064301|NCT00804843|468190106|FG000|Overall Study|Withdrawal by Subject|1|||
130064302|NCT00804843|468190107|FG001|Overall Study|Withdrawal by Subject|2|||
130064303|NCT00884221|468190112|FG000|Overall Study|Withdrawal by Subject|0|||
130064304|NCT00884221|468190113|FG001|Overall Study|Withdrawal by Subject|3|||
130064305|NCT00884221|468190112|FG000|Overall Study|Adverse Event|6|||
130064306|NCT00884221|468190113|FG001|Overall Study|Adverse Event|3|||
130064307|NCT00884221|468190112|FG000|Overall Study|Protocol Violation|16|||
130064308|NCT00884221|468190113|FG001|Overall Study|Protocol Violation|13|||
129842012|NCT03633396|467387449|FG001|Overall Study|Adverse Event|1|||
129842013|NCT03633396|467387448|FG000|Overall Study|Lack of Efficacy|1|||
129842014|NCT03633396|467387449|FG001|Overall Study|Lack of Efficacy|0|||
129842015|NCT03633396|467387448|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
129842016|NCT03633396|467387449|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
129842017|NCT01012817|467387450|FG000|Overall Study|Withdrawal by Subject|0|||
129842018|NCT01012817|467387451|FG001|Overall Study|Withdrawal by Subject|0|||
129842019|NCT01012817|467387452|FG002|Overall Study|Withdrawal by Subject|0|||
129842020|NCT01012817|467387453|FG003|Overall Study|Withdrawal by Subject|1|||
129842021|NCT01012817|467387454|FG004|Overall Study|Withdrawal by Subject|0|||
129842022|NCT01012817|467387455|FG005|Overall Study|Withdrawal by Subject|0|||
129842023|NCT01012817|467387456|FG006|Overall Study|Withdrawal by Subject|0|||
129842024|NCT01012817|467387457|FG007|Overall Study|Withdrawal by Subject|1|||
129842025|NCT01012817|467387458|FG008|Overall Study|Withdrawal by Subject|0|||
129842026|NCT01012817|467387459|FG009|Overall Study|Withdrawal by Subject|0|||
130064309|NCT00884221|468190112|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
130064310|NCT00884221|468190113|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
130064311|NCT01975246|468190116|FG000|Overall Study|Adverse Event|2|||
129842027|NCT01012817|467387460|FG010|Overall Study|Withdrawal by Subject|1|||
129842028|NCT01012817|467387461|FG011|Overall Study|Withdrawal by Subject|1|||
129842029|NCT01012817|467387462|FG012|Overall Study|Withdrawal by Subject|0|||
129842030|NCT01012817|467387463|FG013|Overall Study|Withdrawal by Subject|1|||
129842031|NCT01012817|467387450|FG000|Overall Study|Adverse Event|0|||
129842032|NCT01012817|467387451|FG001|Overall Study|Adverse Event|0|||
129842033|NCT01012817|467387452|FG002|Overall Study|Adverse Event|0|||
129842034|NCT01012817|467387453|FG003|Overall Study|Adverse Event|0|||
129842035|NCT01012817|467387454|FG004|Overall Study|Adverse Event|0|||
129842036|NCT01012817|467387455|FG005|Overall Study|Adverse Event|1|||
129842037|NCT01012817|467387456|FG006|Overall Study|Adverse Event|0|||
129842038|NCT01012817|467387457|FG007|Overall Study|Adverse Event|0|||
129842039|NCT01012817|467387458|FG008|Overall Study|Adverse Event|0|||
129842040|NCT01012817|467387459|FG009|Overall Study|Adverse Event|0|||
129842041|NCT01012817|467387460|FG010|Overall Study|Adverse Event|1|||
129842042|NCT01012817|467387461|FG011|Overall Study|Adverse Event|0|||
129842043|NCT01012817|467387462|FG012|Overall Study|Adverse Event|0|||
129842044|NCT01012817|467387463|FG013|Overall Study|Adverse Event|1|||
129842045|NCT03756558|467387464|FG000|Overall Study|Death|1|||
129842046|NCT03756558|467387464|FG000|Overall Study|Lost to Follow-up|2|||
129842047|NCT03756558|467387464|FG000|Overall Study|Withdrawal by Subject|2|||
129842048|NCT05308901|467387465|FG000|Overall Study|Death|6|||
129842049|NCT00978731|467387466|FG000|Overall Study|Death|4|||
129842050|NCT00978731|467387467|FG001|Overall Study|Death|1|||
129842051|NCT00978731|467387468|FG002|Overall Study|Death|1|||
129842052|NCT00978731|467387469|FG003|Overall Study|Death|0|||
129842053|NCT00978731|467387466|FG000|Overall Study|Lost to Follow-up|0|||
129842054|NCT00978731|467387467|FG001|Overall Study|Lost to Follow-up|0|||
129842055|NCT00978731|467387468|FG002|Overall Study|Lost to Follow-up|0|||
129842056|NCT00978731|467387469|FG003|Overall Study|Lost to Follow-up|1|||
129842057|NCT00978731|467387466|FG000|Overall Study|Adverse Event|5|||
129842058|NCT00978731|467387467|FG001|Overall Study|Adverse Event|2|||
129842059|NCT00978731|467387468|FG002|Overall Study|Adverse Event|0|||
129842060|NCT00978731|467387469|FG003|Overall Study|Adverse Event|0|||
129842061|NCT00978731|467387466|FG000|Overall Study|Participant's request|1|||
129842062|NCT00978731|467387467|FG001|Overall Study|Participant's request|0|||
129842063|NCT00978731|467387468|FG002|Overall Study|Participant's request|0|||
129842064|NCT00978731|467387469|FG003|Overall Study|Participant's request|0|||
129842065|NCT00978731|467387466|FG000|Overall Study|Administrative reason|3|||
129842066|NCT00978731|467387467|FG001|Overall Study|Administrative reason|3|||
129842067|NCT00978731|467387468|FG002|Overall Study|Administrative reason|1|||
129842068|NCT00978731|467387469|FG003|Overall Study|Administrative reason|0|||
129842069|NCT00978731|467387466|FG000|Overall Study|Deterioration without progression|0|||
129842070|NCT00978731|467387467|FG001|Overall Study|Deterioration without progression|1|||
129842071|NCT00978731|467387468|FG002|Overall Study|Deterioration without progression|0|||
129842072|NCT00978731|467387469|FG003|Overall Study|Deterioration without progression|0|||
129842073|NCT00978731|467387466|FG000|Overall Study|Disease progression/relapse|5|||
129842074|NCT00978731|467387467|FG001|Overall Study|Disease progression/relapse|4|||
129842075|NCT00978731|467387468|FG002|Overall Study|Disease progression/relapse|2|||
129842076|NCT00978731|467387469|FG003|Overall Study|Disease progression/relapse|2|||
129842077|NCT00978731|467387466|FG000|Overall Study|Study closure|3|||
129842078|NCT00978731|467387467|FG001|Overall Study|Study closure|4|||
129842079|NCT00978731|467387468|FG002|Overall Study|Study closure|1|||
129842080|NCT00978731|467387469|FG003|Overall Study|Study closure|1|||
129842081|NCT00978731|467387466|FG000|Overall Study|No response|1|||
129842082|NCT00978731|467387467|FG001|Overall Study|No response|0|||
129842083|NCT00978731|467387468|FG002|Overall Study|No response|0|||
129842084|NCT00978731|467387469|FG003|Overall Study|No response|0|||
129842085|NCT01896895|467387472|FG000|Double-blind MP|Physician Decision|0|||
129842086|NCT01896895|467387473|FG001|Double-blind MP|Physician Decision|0|||
129842087|NCT01896895|467387474|FG002|Double-blind MP|Physician Decision|1|||
129842088|NCT01896895|467387475|FG003|Double-blind MP|Physician Decision|0|||
129842089|NCT01896895|467387472|FG000|Double-blind MP|Withdrawal by Subject|0|||
129842090|NCT01896895|467387473|FG001|Double-blind MP|Withdrawal by Subject|2|||
129842091|NCT01896895|467387474|FG002|Double-blind MP|Withdrawal by Subject|1|||
129842092|NCT01896895|467387475|FG003|Double-blind MP|Withdrawal by Subject|0|||
129842093|NCT01896895|467387472|FG000|Double-blind MP|Lost to Follow-up|1|||
129842094|NCT01896895|467387473|FG001|Double-blind MP|Lost to Follow-up|0|||
129842095|NCT01896895|467387474|FG002|Double-blind MP|Lost to Follow-up|1|||
129842096|NCT01896895|467387475|FG003|Double-blind MP|Lost to Follow-up|0|||
129842097|NCT00293384|467387476|FG000|Overall Study|Non-compliance|2|||
129842098|NCT00293384|467387476|FG000|Overall Study|Missed dosage/study drug|1|||
129842099|NCT00293384|467387476|FG000|Overall Study|Ineligible|2|||
129842100|NCT04482179|467387477|FG000|Overall Study|Death|1|||
129842101|NCT04482179|467387478|FG001|Overall Study|Death|0|||
129842102|NCT04482179|467387477|FG000|Overall Study|Withdrawal by Subject|1|||
129842103|NCT04482179|467387478|FG001|Overall Study|Withdrawal by Subject|0|||
129842104|NCT00145509|467387479|FG000|Overall Study|Adverse Event|10|||
129842105|NCT00145509|467387480|FG001|Overall Study|Adverse Event|3|||
129842106|NCT00145509|467387479|FG000|Overall Study|Lack of Efficacy|3|||
129842107|NCT00145509|467387480|FG001|Overall Study|Lack of Efficacy|1|||
129842108|NCT00145509|467387479|FG000|Overall Study|Lost to Follow-up|5|||
129842109|NCT00145509|467387480|FG001|Overall Study|Lost to Follow-up|9|||
129842110|NCT00145509|467387479|FG000|Overall Study|Withdrew Consent|2|||
129842111|NCT00145509|467387480|FG001|Overall Study|Withdrew Consent|7|||
129842112|NCT00145509|467387479|FG000|Overall Study|Reason not provided|2|||
129842113|NCT00145509|467387480|FG001|Overall Study|Reason not provided|1|||
129842114|NCT00419562|467387481|FG000|Overall Study|Lost to Follow-up|12|||
129842115|NCT00419562|467387482|FG001|Overall Study|Lost to Follow-up|13|||
129842116|NCT00419562|467387481|FG000|Overall Study|Withdrawal by Subject|20|||
129842117|NCT00419562|467387482|FG001|Overall Study|Withdrawal by Subject|18|||
129842118|NCT00419562|467387481|FG000|Overall Study|Participant Institutionalized|1|||
129842119|NCT00419562|467387482|FG001|Overall Study|Participant Institutionalized|0|||
129842120|NCT02789176|467387483|FG000|Overall Study|Death|0|||
129842121|NCT02789176|467387484|FG001|Overall Study|Death|0|||
129842122|NCT02789176|467387485|FG002|Overall Study|Death|3|||
129842123|NCT02789176|467387486|FG003|Overall Study|Death|0|||
129842124|NCT02789176|467387483|FG000|Overall Study|Withdrawal by Subject|0|||
129842125|NCT02789176|467387484|FG001|Overall Study|Withdrawal by Subject|0|||
129842126|NCT02789176|467387485|FG002|Overall Study|Withdrawal by Subject|1|||
129842127|NCT02789176|467387486|FG003|Overall Study|Withdrawal by Subject|0|||
129842128|NCT02789176|467387483|FG000|Overall Study|Lost to Follow-up|8|||
129842129|NCT02789176|467387484|FG001|Overall Study|Lost to Follow-up|2|||
129842130|NCT02789176|467387485|FG002|Overall Study|Lost to Follow-up|6|||
129842131|NCT02789176|467387486|FG003|Overall Study|Lost to Follow-up|1|||
129842132|NCT00640510|467387487|FG000|Overall Study|Lack of Efficacy|0|||
129842133|NCT00640510|467387488|FG001|Overall Study|Lack of Efficacy|1|||
129842134|NCT00640510|467387487|FG000|Overall Study|Protocol Violation|1|||
129842135|NCT00640510|467387488|FG001|Overall Study|Protocol Violation|0|||
129842136|NCT00640510|467387487|FG000|Overall Study|Physician Decision|0|||
129842137|NCT00640510|467387488|FG001|Overall Study|Physician Decision|1|||
129842138|NCT00596011|467387489|FG000|Overall Study|Withdrawal by Subject|2|||
129842139|NCT00596011|467387490|FG001|Overall Study|Withdrawal by Subject|3|||
129842140|NCT00596011|467387489|FG000|Overall Study|Adverse Event|11|||
129842141|NCT00596011|467387490|FG001|Overall Study|Adverse Event|7|||
129842142|NCT00192075|467387491|FG000|Overall Study|Disease Progression|23|||
129842143|NCT00192075|467387492|FG001|Overall Study|Disease Progression|6|||
129842144|NCT00192075|467387491|FG000|Overall Study|Adverse Event|1|||
129842145|NCT00192075|467387492|FG001|Overall Study|Adverse Event|3|||
129842146|NCT00192075|467387491|FG000|Overall Study|Death|0|||
129842147|NCT00192075|467387492|FG001|Overall Study|Death|1|||
129842148|NCT00192075|467387491|FG000|Overall Study|Lack of Efficacy|0|||
129842149|NCT00192075|467387492|FG001|Overall Study|Lack of Efficacy|0|||
129842150|NCT00192075|467387491|FG000|Overall Study|Physician Decision|3|||
129842151|NCT00192075|467387492|FG001|Overall Study|Physician Decision|0|||
129842152|NCT00192075|467387491|FG000|Overall Study|Withdrawal by Subject|5|||
129842153|NCT00192075|467387492|FG001|Overall Study|Withdrawal by Subject|5|||
129842154|NCT00192075|467387491|FG000|Overall Study|Patient Non-Compliance|0|||
129842155|NCT00192075|467387492|FG001|Overall Study|Patient Non-Compliance|1|||
129842156|NCT00192075|467387491|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
129842157|NCT00192075|467387492|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
129842158|NCT00192075|467387491|FG000|Overall Study|Other|5|||
129842159|NCT00192075|467387492|FG001|Overall Study|Other|2|||
129842160|NCT03325166|467387493|FG000|Overall Study|Adverse Event|1|||
129842161|NCT01400841|467387495|FG000|Initial Study Phase (6 Months)|Death|1|||
129842162|NCT01400841|467387495|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
129842163|NCT00770120|467387498|FG000|Overall Study|Progression|31|||
129842164|NCT00770120|467387498|FG000|Overall Study|Adverse Event|11|||
129842165|NCT00770120|467387498|FG000|Overall Study|Not Protocol Specified|11|||
129842166|NCT00770120|467387498|FG000|Overall Study|Death|3|||
129842167|NCT00770120|467387498|FG000|Overall Study|Withdrawal by Subject|2|||
129842168|NCT00770120|467387498|FG000|Overall Study|Ineligible|1|||
129842169|NCT00770120|467387498|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
129842170|NCT00770120|467387498|FG000|Overall Study|Reason under Review|1|||
129842171|NCT02583256|467387499|FG000|Overall Study|Withdrawal by Subject|0|||
129842172|NCT02583256|467387500|FG001|Overall Study|Withdrawal by Subject|1|||
129900693|NCT02715258|467597120|FG000|Overall Study|Terminated by Sponsor|0|||
129842173|NCT02583256|467387501|FG002|Overall Study|Withdrawal by Subject|1|||
129842174|NCT02583256|467387502|FG003|Overall Study|Withdrawal by Subject|0|||
129842175|NCT02583256|467387499|FG000|Overall Study|Lost to Follow-up|1|||
129842176|NCT02583256|467387500|FG001|Overall Study|Lost to Follow-up|1|||
129842177|NCT02583256|467387501|FG002|Overall Study|Lost to Follow-up|0|||
129842178|NCT02583256|467387502|FG003|Overall Study|Lost to Follow-up|1|||
129842179|NCT02583256|467387499|FG000|Overall Study|Administrative/Other|2|||
129842180|NCT02583256|467387500|FG001|Overall Study|Administrative/Other|0|||
130064312|NCT01975246|468190117|FG001|Overall Study|Adverse Event|1|||
130064313|NCT01975246|468190116|FG000|Overall Study|Lack of Efficacy|1|||
130064314|NCT01975246|468190117|FG001|Overall Study|Lack of Efficacy|0|||
129900694|NCT02715258|467597121|FG001|Overall Study|Terminated by Sponsor|1|||
129900695|NCT02715258|467597120|FG000|Overall Study|Death|0|||
129900696|NCT02715258|467597121|FG001|Overall Study|Death|1|||
129900697|NCT02715258|467597120|FG000|Overall Study|Subject non-compliant|1|||
129900698|NCT02715258|467597121|FG001|Overall Study|Subject non-compliant|1|||
129900699|NCT02715258|467597120|FG000|Overall Study|GCP violation|2|||
129900700|NCT02715258|467597121|FG001|Overall Study|GCP violation|1|||
129900701|NCT02814643|467597122|FG000|Overall Study|Lost to Follow-up|0|||
129900702|NCT02814643|467597123|FG001|Overall Study|Lost to Follow-up|1|||
129900703|NCT02814643|467597122|FG000|Overall Study|Withdrawal by Subject|1|||
129900704|NCT02814643|467597123|FG001|Overall Study|Withdrawal by Subject|2|||
129900705|NCT02263508|467597124|FG000|Overall Study|Withdrawal by Subject|1|||
129900706|NCT02263508|467597125|FG001|Overall Study|Withdrawal by Subject|23|||
129900707|NCT02263508|467597126|FG002|Overall Study|Withdrawal by Subject|17|||
129900708|NCT02263508|467597124|FG000|Overall Study|Sponsor Decision|12|||
129900709|NCT02263508|467597125|FG001|Overall Study|Sponsor Decision|165|||
129900710|NCT02263508|467597126|FG002|Overall Study|Sponsor Decision|182|||
129900711|NCT02263508|467597124|FG000|Overall Study|Lost to Follow-up|2|||
129900712|NCT02263508|467597125|FG001|Overall Study|Lost to Follow-up|7|||
129900713|NCT02263508|467597126|FG002|Overall Study|Lost to Follow-up|7|||
129900714|NCT02263508|467597124|FG000|Overall Study|Death|6|||
129900715|NCT02263508|467597125|FG001|Overall Study|Death|151|||
129900716|NCT02263508|467597126|FG002|Overall Study|Death|140|||
129900717|NCT03265210|467597129|FG000|Overall Study|Withdrawal by Subject|7|||
129900718|NCT03265210|467597130|FG001|Overall Study|Withdrawal by Subject|9|||
129900719|NCT03265210|467597129|FG000|Overall Study|Lost to Follow-up|2|||
129900720|NCT03265210|467597130|FG001|Overall Study|Lost to Follow-up|0|||
129900721|NCT03265210|467597129|FG000|Overall Study|Physician Decision|2|||
129900722|NCT03265210|467597130|FG001|Overall Study|Physician Decision|0|||
129900723|NCT03265210|467597129|FG000|Overall Study|Adverse Event|1|||
129900724|NCT03265210|467597130|FG001|Overall Study|Adverse Event|0|||
129900725|NCT00686517|467597131|FG000|Treatment|Serious Adverse Event|1|||
129900726|NCT00686517|467597132|FG001|Treatment|Serious Adverse Event|2|||
129900727|NCT00686517|467597133|FG002|Treatment|Serious Adverse Event|1|||
129900728|NCT00686517|467597131|FG000|Treatment|Adverse Event|2|||
129900729|NCT00686517|467597132|FG001|Treatment|Adverse Event|0|||
129900730|NCT00686517|467597133|FG002|Treatment|Adverse Event|0|||
129900731|NCT00686517|467597131|FG000|Treatment|Poor Protocol Compliance|1|||
129900732|NCT00686517|467597132|FG001|Treatment|Poor Protocol Compliance|0|||
129900733|NCT00686517|467597133|FG002|Treatment|Poor Protocol Compliance|0|||
129900734|NCT00686517|467597131|FG000|Treatment|Protocol Violation|2|||
129900735|NCT00686517|467597132|FG001|Treatment|Protocol Violation|1|||
129900736|NCT00686517|467597133|FG002|Treatment|Protocol Violation|0|||
129900737|NCT02281318|467597134|FG000|Overall Study|Adverse Event|2|||
129900738|NCT02281318|467597135|FG001|Overall Study|Adverse Event|2|||
129900739|NCT02281318|467597134|FG000|Overall Study|Lack of Efficacy|2|||
129900740|NCT02281318|467597135|FG001|Overall Study|Lack of Efficacy|0|||
129900741|NCT02281318|467597134|FG000|Overall Study|Lost to Follow-up|2|||
129900742|NCT02281318|467597135|FG001|Overall Study|Lost to Follow-up|1|||
129900743|NCT02281318|467597134|FG000|Overall Study|Physician Decision|2|||
129900744|NCT02281318|467597135|FG001|Overall Study|Physician Decision|0|||
129900745|NCT02281318|467597134|FG000|Overall Study|Withdrawal by Subject|6|||
129900746|NCT02281318|467597135|FG001|Overall Study|Withdrawal by Subject|2|||
129900747|NCT02614560|467597138|FG000|Overall Study|Death|6|||
129900748|NCT02614560|467597139|FG001|Overall Study|Death|2|||
129900749|NCT00703911|467597142|FG000|Overall Study|Death|1|||
129900750|NCT00703911|467597142|FG000|Overall Study|Physician Decision|6|||
129900751|NCT00703911|467597142|FG000|Overall Study|Lost to Follow-up|1|||
129900752|NCT00703911|467597142|FG000|Overall Study|Withdrawal by Subject|2|||
129900753|NCT05193318|467597145|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
129900754|NCT05193318|467597145|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
129900755|NCT00798096|467597146|FG000|Overall Study|Ongoing|2|||
129900756|NCT01833065|467597147|FG000|Overall Study|Adverse Event|6|||
129900757|NCT01833065|467597148|FG001|Overall Study|Adverse Event|1|||
130064315|NCT01975246|468190116|FG000|Overall Study|Protocol Violation|1|||
129900758|NCT01833065|467597149|FG002|Overall Study|Adverse Event|0|||
129900759|NCT01833065|467597150|FG003|Overall Study|Adverse Event|2|||
129900760|NCT01833065|467597151|FG004|Overall Study|Adverse Event|3|||
129900761|NCT01833065|467597147|FG000|Overall Study|Protocol Violation|1|||
129900762|NCT01833065|467597148|FG001|Overall Study|Protocol Violation|0|||
129900763|NCT01833065|467597149|FG002|Overall Study|Protocol Violation|0|||
129900764|NCT01833065|467597150|FG003|Overall Study|Protocol Violation|0|||
129900765|NCT01833065|467597151|FG004|Overall Study|Protocol Violation|2|||
129900766|NCT01833065|467597147|FG000|Overall Study|Lost to Follow-up|1|||
129900767|NCT01833065|467597148|FG001|Overall Study|Lost to Follow-up|0|||
129900768|NCT01833065|467597149|FG002|Overall Study|Lost to Follow-up|0|||
129900769|NCT01833065|467597150|FG003|Overall Study|Lost to Follow-up|0|||
129900770|NCT01833065|467597151|FG004|Overall Study|Lost to Follow-up|3|||
129900771|NCT01833065|467597147|FG000|Overall Study|Withdrawal by Subject|6|||
129900772|NCT01833065|467597148|FG001|Overall Study|Withdrawal by Subject|2|||
130116066|NCT02784106|468385162|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129842181|NCT02583256|467387501|FG002|Overall Study|Administrative/Other|1|||
129842182|NCT02583256|467387502|FG003|Overall Study|Administrative/Other|2|||
129842183|NCT02506816|467387511|FG000|Overall Study|Adverse Event|3|||
129842184|NCT03364049|467387512|FG000|Overall Study|Death|6|||
129842185|NCT03364049|467387513|FG001|Overall Study|Death|4|||
129842186|NCT03364049|467387514|FG002|Overall Study|Death|5|||
129842187|NCT03364049|467387515|FG003|Overall Study|Death|14|||
129842188|NCT03364049|467387512|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
129842189|NCT03364049|467387513|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
129842190|NCT03364049|467387514|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
129842191|NCT03364049|467387515|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
129842192|NCT03364049|467387512|FG000|Overall Study|Withdrawal by Subject|0|||
129842193|NCT03364049|467387513|FG001|Overall Study|Withdrawal by Subject|1|||
129842194|NCT03364049|467387514|FG002|Overall Study|Withdrawal by Subject|1|||
130116067|NCT02784106|468385163|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
130116068|NCT02784106|468385164|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130116069|NCT02784106|468385165|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
130116070|NCT02784106|468385162|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
130116071|NCT02784106|468385163|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130116072|NCT02784106|468385164|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130116073|NCT02784106|468385165|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
130116074|NCT02784106|468385162|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
130116075|NCT02784106|468385163|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130116076|NCT02784106|468385164|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130116077|NCT02784106|468385165|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
130116078|NCT02784106|468385162|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
130116079|NCT02784106|468385163|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
130116080|NCT02784106|468385164|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
130116081|NCT02784106|468385165|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
130116082|NCT02784106|468385162|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
130116083|NCT02784106|468385163|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
130116084|NCT02784106|468385164|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
130116085|NCT02784106|468385165|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
129842195|NCT03364049|467387515|FG003|Overall Study|Withdrawal by Subject|1|||
129842196|NCT00418691|467387516|FG000|Overall Study|Lost to Follow-up|1|||
129842197|NCT00418691|467387517|FG001|Overall Study|Lost to Follow-up|2|||
129842198|NCT00418691|467387518|FG002|Overall Study|Lost to Follow-up|3|||
129842199|NCT00418691|467387516|FG000|Overall Study|Started new medication voiding entry|0|||
129842200|NCT00418691|467387517|FG001|Overall Study|Started new medication voiding entry|0|||
129842201|NCT00418691|467387518|FG002|Overall Study|Started new medication voiding entry|1|||
129842202|NCT00418691|467387516|FG000|Overall Study|Progressive Disease|1|||
129842203|NCT00418691|467387517|FG001|Overall Study|Progressive Disease|0|||
129842204|NCT00418691|467387518|FG002|Overall Study|Progressive Disease|1|||
129842205|NCT02103478|467387519|FG000|Overall Study|Adverse Event|0|||
129842206|NCT02103478|467387520|FG001|Overall Study|Adverse Event|0|||
129842207|NCT02103478|467387521|FG002|Overall Study|Adverse Event|1|||
129842208|NCT02103478|467387522|FG003|Overall Study|Adverse Event|1|||
129842209|NCT02103478|467387523|FG004|Overall Study|Adverse Event|2|||
129842210|NCT02103478|467387524|FG005|Overall Study|Adverse Event|1|||
129842211|NCT02103478|467387525|FG006|Overall Study|Adverse Event|0|||
129842212|NCT02103478|467387526|FG007|Overall Study|Adverse Event|0|||
129842213|NCT02103478|467387527|FG008|Overall Study|Adverse Event|0|||
129842214|NCT02103478|467387519|FG000|Overall Study|Death|2|||
129842215|NCT02103478|467387520|FG001|Overall Study|Death|2|||
129842216|NCT02103478|467387521|FG002|Overall Study|Death|1|||
129842217|NCT02103478|467387522|FG003|Overall Study|Death|1|||
129842218|NCT02103478|467387523|FG004|Overall Study|Death|5|||
129842219|NCT02103478|467387524|FG005|Overall Study|Death|15|||
129842220|NCT02103478|467387525|FG006|Overall Study|Death|14|||
129842221|NCT02103478|467387526|FG007|Overall Study|Death|10|||
129842222|NCT02103478|467387527|FG008|Overall Study|Death|11|||
129842223|NCT02103478|467387519|FG000|Overall Study|Progressive Disease|2|||
129842224|NCT02103478|467387520|FG001|Overall Study|Progressive Disease|1|||
129842225|NCT02103478|467387521|FG002|Overall Study|Progressive Disease|2|||
129842226|NCT02103478|467387522|FG003|Overall Study|Progressive Disease|0|||
129842227|NCT02103478|467387523|FG004|Overall Study|Progressive Disease|9|||
129842228|NCT02103478|467387524|FG005|Overall Study|Progressive Disease|1|||
129842229|NCT02103478|467387525|FG006|Overall Study|Progressive Disease|2|||
129842230|NCT02103478|467387526|FG007|Overall Study|Progressive Disease|0|||
129842231|NCT02103478|467387527|FG008|Overall Study|Progressive Disease|1|||
129842232|NCT02103478|467387519|FG000|Overall Study|Withdrawal by Subject|2|||
130116086|NCT03222141|468385168|FG000|Overall Study|Death|15|||
129842233|NCT02103478|467387520|FG001|Overall Study|Withdrawal by Subject|0|||
129842234|NCT02103478|467387521|FG002|Overall Study|Withdrawal by Subject|0|||
129842235|NCT02103478|467387522|FG003|Overall Study|Withdrawal by Subject|4|||
129842236|NCT02103478|467387523|FG004|Overall Study|Withdrawal by Subject|0|||
129842237|NCT02103478|467387524|FG005|Overall Study|Withdrawal by Subject|0|||
129842238|NCT02103478|467387525|FG006|Overall Study|Withdrawal by Subject|1|||
129842239|NCT02103478|467387526|FG007|Overall Study|Withdrawal by Subject|1|||
129842240|NCT02103478|467387527|FG008|Overall Study|Withdrawal by Subject|0|||
129842241|NCT02103478|467387519|FG000|Overall Study|Lost to Follow-up|0|||
129842242|NCT02103478|467387520|FG001|Overall Study|Lost to Follow-up|0|||
129842243|NCT02103478|467387521|FG002|Overall Study|Lost to Follow-up|0|||
129842244|NCT02103478|467387522|FG003|Overall Study|Lost to Follow-up|0|||
129842245|NCT02103478|467387523|FG004|Overall Study|Lost to Follow-up|0|||
129842246|NCT02103478|467387524|FG005|Overall Study|Lost to Follow-up|0|||
129842247|NCT02103478|467387525|FG006|Overall Study|Lost to Follow-up|0|||
129842248|NCT02103478|467387526|FG007|Overall Study|Lost to Follow-up|1|||
129842249|NCT02103478|467387527|FG008|Overall Study|Lost to Follow-up|0|||
129842250|NCT02103478|467387519|FG000|Overall Study|Other|1|||
129842251|NCT02103478|467387520|FG001|Overall Study|Other|3|||
129842252|NCT02103478|467387521|FG002|Overall Study|Other|2|||
129842253|NCT02103478|467387522|FG003|Overall Study|Other|0|||
129842254|NCT02103478|467387523|FG004|Overall Study|Other|3|||
129842255|NCT02103478|467387524|FG005|Overall Study|Other|8|||
129842256|NCT02103478|467387525|FG006|Overall Study|Other|8|||
129842257|NCT02103478|467387526|FG007|Overall Study|Other|4|||
129842258|NCT02103478|467387527|FG008|Overall Study|Other|2|||
129842259|NCT04182100|467387528|FG000|Overall Study|Adverse Event|1|||
129842260|NCT04182100|467387528|FG000|Overall Study|Withdrawal by Subject|1|||
129842261|NCT04988295|467387529|FG000|Overall Study|Withdrawal by Subject|9|||
129842262|NCT04988295|467387530|FG001|Overall Study|Withdrawal by Subject|29|||
129842263|NCT04988295|467387531|FG002|Overall Study|Withdrawal by Subject|6|||
129842264|NCT04988295|467387532|FG003|Overall Study|Withdrawal by Subject|0|||
129842265|NCT04988295|467387529|FG000|Overall Study|Lost to Follow-up|1|||
129842266|NCT04988295|467387530|FG001|Overall Study|Lost to Follow-up|0|||
129842267|NCT04988295|467387531|FG002|Overall Study|Lost to Follow-up|0|||
129842268|NCT04988295|467387532|FG003|Overall Study|Lost to Follow-up|0|||
129842269|NCT04988295|467387529|FG000|Overall Study|Study participation ongoing|186|||
129842270|NCT04988295|467387530|FG001|Overall Study|Study participation ongoing|169|||
129842271|NCT04988295|467387531|FG002|Overall Study|Study participation ongoing|99|||
129842272|NCT04988295|467387532|FG003|Overall Study|Study participation ongoing|119|||
129842273|NCT00433654|467387533|FG000|Overall Study|Death|4|||
129842274|NCT00433654|467387534|FG001|Overall Study|Death|0|||
129842275|NCT00433654|467387533|FG000|Overall Study|Missed visit|6|||
129842276|NCT00433654|467387534|FG001|Overall Study|Missed visit|3|||
129842277|NCT00433654|467387533|FG000|Overall Study|Subject not yet due for visit|4|||
129842278|NCT00433654|467387534|FG001|Overall Study|Subject not yet due for visit|0|||
129842279|NCT00433654|467387533|FG000|Overall Study|Withdrawal by Subject|1|||
129842280|NCT00433654|467387534|FG001|Overall Study|Withdrawal by Subject|2|||
129842281|NCT03762083|467387535|FG000|Overall Study|Withdrawal by Subject|2|||
129842282|NCT03762083|467387535|FG000|Overall Study|Physician Decision|1|||
129842283|NCT04108208|467387536|FG000|Overall Study|Withdrawal by Subject|2|||
129842284|NCT04108208|467387537|FG001|Overall Study|Withdrawal by Subject|6|||
129842285|NCT04108208|467387536|FG000|Overall Study|other-ongoing|20|||
129842286|NCT04108208|467387537|FG001|Overall Study|other-ongoing|40|||
129842287|NCT04108208|467387536|FG000|Overall Study|Death|1|||
129842288|NCT04108208|467387537|FG001|Overall Study|Death|4|||
129842289|NCT04108208|467387536|FG000|Overall Study|Lost to Follow-up|2|||
129842290|NCT04108208|467387537|FG001|Overall Study|Lost to Follow-up|0|||
129842291|NCT02948842|467387539|FG000|Overall Study|Withdrawal by Subject|4|||
129842292|NCT02350309|467387541|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
129900773|NCT01833065|467597149|FG002|Overall Study|Withdrawal by Subject|4|||
129900774|NCT01833065|467597150|FG003|Overall Study|Withdrawal by Subject|3|||
129900775|NCT01833065|467597151|FG004|Overall Study|Withdrawal by Subject|11|||
129900776|NCT01833065|467597147|FG000|Overall Study|Subject's substantial non-compliance|0|||
129900777|NCT01833065|467597148|FG001|Overall Study|Subject's substantial non-compliance|1|||
130064316|NCT01975246|468190117|FG001|Overall Study|Protocol Violation|0|||
129842293|NCT02350309|467387542|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842294|NCT02350309|467387543|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
129842295|NCT02350309|467387544|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842296|NCT02350309|467387545|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842297|NCT02350309|467387546|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842298|NCT02350309|467387541|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842299|NCT02350309|467387542|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842300|NCT02350309|467387543|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842301|NCT02350309|467387544|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842302|NCT02350309|467387545|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842303|NCT02350309|467387546|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
130116087|NCT03222141|468385168|FG000|Overall Study|Lost to Follow-up|3|||
130116088|NCT01851590|468385181|FG000|Overall Study|Withdrawal by Subject|0|||
130116089|NCT01851590|468385182|FG001|Overall Study|Withdrawal by Subject|0|||
130116090|NCT01851590|468385183|FG002|Overall Study|Withdrawal by Subject|1|||
130116091|NCT01851590|468385181|FG000|Overall Study|Adverse Event|0|||
130116092|NCT01851590|468385182|FG001|Overall Study|Adverse Event|0|||
130116093|NCT01851590|468385183|FG002|Overall Study|Adverse Event|2|||
130116094|NCT01851590|468385181|FG000|Overall Study|Lack of Efficacy|0|||
130116095|NCT01851590|468385182|FG001|Overall Study|Lack of Efficacy|1|||
130116096|NCT01851590|468385183|FG002|Overall Study|Lack of Efficacy|0|||
130116097|NCT00310856|468385186|FG000|Overall Study|Withdrawal by Subject|2|||
130116098|NCT00310856|468385187|FG001|Overall Study|Withdrawal by Subject|2|||
130116099|NCT00310856|468385188|FG002|Overall Study|Withdrawal by Subject|2|||
130116100|NCT00310856|468385186|FG000|Overall Study|Lost to Follow-up|1|||
130116101|NCT00310856|468385187|FG001|Overall Study|Lost to Follow-up|2|||
130116102|NCT00310856|468385188|FG002|Overall Study|Lost to Follow-up|6|||
130116103|NCT00310856|468385186|FG000|Overall Study|Inappropriate enrollment|1|||
130116104|NCT00310856|468385187|FG001|Overall Study|Inappropriate enrollment|1|||
130116105|NCT00310856|468385188|FG002|Overall Study|Inappropriate enrollment|0|||
130116106|NCT00310856|468385186|FG000|Overall Study|Unable to classify|1|||
130116107|NCT00310856|468385187|FG001|Overall Study|Unable to classify|0|||
130116108|NCT00310856|468385188|FG002|Overall Study|Unable to classify|0|||
130116109|NCT02611752|468385189|FG000|Overall Study|Adverse Event|0|||
130116110|NCT02611752|468385190|FG001|Overall Study|Adverse Event|1|||
130116111|NCT00947856|468385196|FG000|Treatment Period|Progressive Disease|33|||
130116112|NCT00947856|468385197|FG001|Treatment Period|Progressive Disease|12|||
130116113|NCT00947856|468385196|FG000|Treatment Period|Adverse Event|15|||
130116114|NCT00947856|468385197|FG001|Treatment Period|Adverse Event|9|||
130116115|NCT00947856|468385196|FG000|Treatment Period|Physician Decision|14|||
130116116|NCT00947856|468385197|FG001|Treatment Period|Physician Decision|6|||
130116117|NCT00947856|468385196|FG000|Treatment Period|Study Stopped by Sponsor|4|||
130116118|NCT00947856|468385197|FG001|Treatment Period|Study Stopped by Sponsor|4|||
130116119|NCT00947856|468385196|FG000|Treatment Period|Withdrawal by Subject|12|||
129842304|NCT01256710|467387547|FG000|Overall Study|Death|449|||
129842305|NCT01256710|467387547|FG000|Overall Study|System Explant|67|||
129842306|NCT01256710|467387547|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
129842307|NCT01256710|467387547|FG000|Overall Study|Lost to Follow-up|67|||
129842308|NCT01256710|467387547|FG000|Overall Study|Withdrawal by Subject|29|||
129842309|NCT01256710|467387547|FG000|Overall Study|Physician Decision|9|||
129842310|NCT01256710|467387547|FG000|Overall Study|Subject Noncompliance|2|||
130064317|NCT01975246|468190116|FG000|Overall Study|Other than stated|0|||
130064318|NCT01975246|468190117|FG001|Overall Study|Other than stated|1|||
130064319|NCT01263093|468190118|FG000|Washout|Physician Decision|1|||
130064320|NCT01263093|468190119|FG001|Washout|Physician Decision|0|||
130064321|NCT01263093|468190118|FG000|Period 2|Adverse Event|1|||
130064322|NCT01263093|468190119|FG001|Period 2|Adverse Event|0|||
130064323|NCT00424346|468190120|FG000|Core Study|Adverse Event|5|||
130064324|NCT00424346|468190121|FG001|Core Study|Adverse Event|3|||
130064325|NCT00424346|468190122|FG002|Core Study|Adverse Event|1|||
130064326|NCT00424346|468190123|FG003|Core Study|Adverse Event|1|||
130064327|NCT00424346|468190120|FG000|Core Study|Abnormal Laboratory Values|0|||
130064328|NCT00424346|468190121|FG001|Core Study|Abnormal Laboratory Values|1|||
130064329|NCT00424346|468190122|FG002|Core Study|Abnormal Laboratory Values|0|||
130064330|NCT00424346|468190123|FG003|Core Study|Abnormal Laboratory Values|0|||
130064331|NCT00424346|468190120|FG000|Core Study|Lack of Efficacy|1|||
130064332|NCT00424346|468190121|FG001|Core Study|Lack of Efficacy|3|||
130064333|NCT00424346|468190122|FG002|Core Study|Lack of Efficacy|0|||
130064334|NCT00424346|468190123|FG003|Core Study|Lack of Efficacy|4|||
130064335|NCT00424346|468190120|FG000|Core Study|Withdrawal by Subject|1|||
130064336|NCT00424346|468190121|FG001|Core Study|Withdrawal by Subject|0|||
130064337|NCT00424346|468190122|FG002|Core Study|Withdrawal by Subject|0|||
130064338|NCT00424346|468190123|FG003|Core Study|Withdrawal by Subject|2|||
130064339|NCT00424346|468190120|FG000|Core Study|Lost to Follow-up|1|||
130064340|NCT00424346|468190121|FG001|Core Study|Lost to Follow-up|1|||
130064341|NCT00424346|468190122|FG002|Core Study|Lost to Follow-up|0|||
130064342|NCT00424346|468190123|FG003|Core Study|Lost to Follow-up|0|||
130064343|NCT00424346|468190120|FG000|Core Study|Administrative Problems|1|||
130064344|NCT00424346|468190121|FG001|Core Study|Administrative Problems|0|||
130064345|NCT00424346|468190122|FG002|Core Study|Administrative Problems|1|||
130064346|NCT00424346|468190123|FG003|Core Study|Administrative Problems|0|||
130064347|NCT00424346|468190120|FG000|Core Study|Protocol Violation|0|||
130064348|NCT00424346|468190121|FG001|Core Study|Protocol Violation|0|||
130064349|NCT00424346|468190122|FG002|Core Study|Protocol Violation|2|||
130064350|NCT00424346|468190123|FG003|Core Study|Protocol Violation|0|||
130064351|NCT00424346|468190120|FG000|Extension Phase|Adverse Event|0|||
130064352|NCT00424346|468190121|FG001|Extension Phase|Adverse Event|9|||
130064353|NCT00424346|468190122|FG002|Extension Phase|Adverse Event|5|||
130064354|NCT00424346|468190123|FG003|Extension Phase|Adverse Event|4|||
129842311|NCT01256710|467387547|FG000|Overall Study|Study Terminated by Sponsor|273|||
129842312|NCT00058825|467387548|FG000|Overall Study|Relapse|9|||
129842313|NCT00058825|467387548|FG000|Overall Study|Progressive Disease|5|||
129842314|NCT00058825|467387548|FG000|Overall Study|Graft Failure|5|||
129842315|NCT00058825|467387548|FG000|Overall Study|Death|3|||
129842316|NCT01205165|467387549|FG000|Overall Study|Lost to Follow-up|2|||
129842317|NCT02942017|467387550|FG000|Overall Study|Adverse Event|0|||
129842318|NCT02942017|467387551|FG001|Overall Study|Adverse Event|1|||
129842319|NCT02942017|467387550|FG000|Overall Study|Withdrawal by Subject|0|||
129842320|NCT02942017|467387551|FG001|Overall Study|Withdrawal by Subject|1|||
129842321|NCT02942017|467387550|FG000|Overall Study|Lost to Follow-up|1|||
129842322|NCT02942017|467387551|FG001|Overall Study|Lost to Follow-up|1|||
129842323|NCT02942017|467387550|FG000|Overall Study|Randomized but not dosed|1|||
129842324|NCT02942017|467387551|FG001|Overall Study|Randomized but not dosed|3|||
129842325|NCT04399161|467387552|FG000|Overall Study|Withdrawal by Subject|1|||
129842326|NCT04399161|467387553|FG001|Overall Study|Withdrawal by Subject|0|||
129842327|NCT04399161|467387554|FG002|Overall Study|Withdrawal by Subject|2|||
129842328|NCT04399161|467387552|FG000|Overall Study|Protocol Violation|1|||
129842329|NCT04399161|467387553|FG001|Overall Study|Protocol Violation|2|||
129842330|NCT04399161|467387554|FG002|Overall Study|Protocol Violation|0|||
129842331|NCT01736696|467387557|FG000|Overall Study|Withdrawal by Subject|0|||
129842332|NCT01736696|467387558|FG001|Overall Study|Withdrawal by Subject|0|||
129842333|NCT01736696|467387559|FG002|Overall Study|Withdrawal by Subject|1|||
129842334|NCT01736696|467387560|FG003|Overall Study|Withdrawal by Subject|0|||
129842335|NCT01736696|467387561|FG004|Overall Study|Withdrawal by Subject|0|||
129842336|NCT01736696|467387562|FG005|Overall Study|Withdrawal by Subject|0|||
129842337|NCT01736696|467387563|FG006|Overall Study|Withdrawal by Subject|0|||
129842338|NCT00838565|467387564|FG000|Overall Study|Withdrawal by Subject|0|||
129842339|NCT00838565|467387565|FG001|Overall Study|Withdrawal by Subject|0|||
129842340|NCT00838565|467387566|FG002|Overall Study|Withdrawal by Subject|1|||
129842341|NCT00838565|467387567|FG003|Overall Study|Withdrawal by Subject|0|||
129842342|NCT00838565|467387568|FG004|Overall Study|Withdrawal by Subject|0|||
129842343|NCT00838565|467387569|FG005|Overall Study|Withdrawal by Subject|2|||
129842344|NCT00838565|467387564|FG000|Overall Study|Other|0|||
129842345|NCT00838565|467387565|FG001|Overall Study|Other|2|||
129842346|NCT00838565|467387566|FG002|Overall Study|Other|0|||
129842347|NCT00838565|467387567|FG003|Overall Study|Other|0|||
129842348|NCT00838565|467387568|FG004|Overall Study|Other|0|||
129842349|NCT00838565|467387569|FG005|Overall Study|Other|0|||
129842350|NCT00838565|467387564|FG000|Overall Study|Randomized but not Treated|0|||
129842351|NCT00838565|467387565|FG001|Overall Study|Randomized but not Treated|1|||
129842352|NCT00838565|467387566|FG002|Overall Study|Randomized but not Treated|0|||
129842353|NCT00838565|467387567|FG003|Overall Study|Randomized but not Treated|0|||
129842354|NCT00838565|467387568|FG004|Overall Study|Randomized but not Treated|0|||
129842355|NCT00838565|467387569|FG005|Overall Study|Randomized but not Treated|0|||
129842356|NCT02114879|467387570|FG000|Overall Study|Withdrawal by Subject|9|||
129842357|NCT02114879|467387571|FG001|Overall Study|Withdrawal by Subject|5|||
129842358|NCT02114879|467387570|FG000|Overall Study|Death|6|||
129842359|NCT02114879|467387571|FG001|Overall Study|Death|11|||
129842360|NCT02114879|467387570|FG000|Overall Study|Lost to Follow-up|4|||
129842361|NCT02114879|467387571|FG001|Overall Study|Lost to Follow-up|6|||
129842362|NCT02114879|467387570|FG000|Overall Study|Physician Decision|0|||
129842363|NCT02114879|467387571|FG001|Overall Study|Physician Decision|2|||
129842364|NCT00458484|467387572|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
129842365|NCT00458484|467387573|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
129842366|NCT00458484|467387574|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
129842367|NCT00458484|467387575|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
129842368|NCT00458484|467387576|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
129842369|NCT00458484|467387577|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
129842370|NCT00458484|467387578|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
129842371|NCT05059600|467387579|FG000|Overall Study|Enrolled but not Treated|10|||
129842372|NCT04538664|467387580|FG000|Overall Study|Withdrawal by Subject|5|||
129842373|NCT04538664|467387581|FG001|Overall Study|Withdrawal by Subject|9|||
129842374|NCT04538664|467387580|FG000|Overall Study|Lost to Follow-up|2|||
129842375|NCT04538664|467387581|FG001|Overall Study|Lost to Follow-up|1|||
129842376|NCT04538664|467387580|FG000|Overall Study|Ongoing|106|||
129842377|NCT04538664|467387581|FG001|Overall Study|Ongoing|115|||
129842378|NCT04552587|467387582|FG000|Overall Study|Lost to Follow-up|4|||
129842379|NCT03400033|467387585|FG000|Overall Study|Withdrawal by Subject|1|||
129842380|NCT03400033|467387586|FG001|Overall Study|Withdrawal by Subject|2|||
129842381|NCT02741115|467387592|FG000|Overall Study|Adverse Event|1|||
129842382|NCT02741115|467387593|FG001|Overall Study|Adverse Event|0|||
129842383|NCT02741115|467387592|FG000|Overall Study|Lost to Follow-up|7|||
129842384|NCT02741115|467387593|FG001|Overall Study|Lost to Follow-up|4|||
129842385|NCT02741115|467387592|FG000|Overall Study|Withdrawal by Subject|4|||
129842386|NCT02741115|467387593|FG001|Overall Study|Withdrawal by Subject|2|||
129842387|NCT06425458|467387594|FG000|Overall Study|Removed by study team|2|||
129842388|NCT06425458|467387594|FG000|Overall Study|Lost to Follow-up|5|||
129842389|NCT00445328|467387595|FG000|Overall Study|Death|0|||
129842390|NCT00445328|467387596|FG001|Overall Study|Death|1|||
129842391|NCT00445328|467387595|FG000|Overall Study|Adverse Event|0|||
129842392|NCT00445328|467387596|FG001|Overall Study|Adverse Event|3|||
129842393|NCT00445328|467387595|FG000|Overall Study|Other|0|||
129842394|NCT00445328|467387596|FG001|Overall Study|Other|2|||
129842395|NCT00445328|467387595|FG000|Overall Study|Withdrawal by Subject|2|||
129842396|NCT00445328|467387596|FG001|Overall Study|Withdrawal by Subject|0|||
129842397|NCT00445328|467387595|FG000|Overall Study|Protocol Violation|1|||
129842398|NCT00445328|467387596|FG001|Overall Study|Protocol Violation|0|||
129842399|NCT02782949|467387600|FG000|Overall Study|Protocol Violation|1|||
129842400|NCT02782949|467387601|FG001|Overall Study|Protocol Violation|0|||
129842401|NCT02782949|467387600|FG000|Overall Study|Withdrawal by Subject|0|||
129842402|NCT02782949|467387601|FG001|Overall Study|Withdrawal by Subject|1|||
129842403|NCT01433263|467388724|FG000|Overall Study|Adverse Event|3|||
129842404|NCT01433263|467388725|FG001|Overall Study|Adverse Event|1|||
129842405|NCT01433263|467388724|FG000|Overall Study|Death|5|||
129842406|NCT01433263|467388725|FG001|Overall Study|Death|3|||
129842407|NCT01433263|467388724|FG000|Overall Study|Lost to Follow-up|0|||
129842408|NCT01433263|467388725|FG001|Overall Study|Lost to Follow-up|1|||
129842409|NCT01433263|467388724|FG000|Overall Study|Protocol Deviation|1|||
129842410|NCT01433263|467388725|FG001|Overall Study|Protocol Deviation|0|||
129842411|NCT01433263|467388724|FG000|Overall Study|Withdrawal by Subject|10|||
129842412|NCT01433263|467388725|FG001|Overall Study|Withdrawal by Subject|7|||
129842413|NCT04709237|467388726|FG000|Overall Study|Lost to Follow-up|1|||
129842414|NCT04709237|467388727|FG001|Overall Study|Lost to Follow-up|0|||
129842415|NCT04709237|467388728|FG002|Overall Study|Lost to Follow-up|0|||
129842416|NCT01302964|467388730|FG000|Overall Study|Adverse Event|1|||
129842417|NCT01302964|467388731|FG001|Overall Study|Adverse Event|0|||
129842418|NCT02489318|467388732|FG000|Randomized|Withdrawal by Subject|0|||
129842419|NCT02489318|467388733|FG001|Randomized|Withdrawal by Subject|1|||
129842420|NCT02489318|467388732|FG000|Treated|Adverse Event|19|||
129842421|NCT02489318|467388733|FG001|Treated|Adverse Event|62|||
129842422|NCT02489318|467388732|FG000|Treated|Death|13|||
129842423|NCT02489318|467388733|FG001|Treated|Death|11|||
129842424|NCT02489318|467388732|FG000|Treated|Physician Decision|4|||
129842425|NCT02489318|467388733|FG001|Treated|Physician Decision|6|||
129842426|NCT02489318|467388732|FG000|Treated|Protocol Violation|1|||
129842427|NCT02489318|467388733|FG001|Treated|Protocol Violation|2|||
129842428|NCT02489318|467388732|FG000|Treated|Withdrawal by Subject|37|||
129842429|NCT02489318|467388733|FG001|Treated|Withdrawal by Subject|36|||
129842430|NCT02489318|467388732|FG000|Treated|Other: Progressive Disease|245|||
129842431|NCT02489318|467388733|FG001|Treated|Other: Progressive Disease|138|||
129842432|NCT02489318|467388732|FG000|Treated|Other|0|||
129842433|NCT02489318|467388733|FG001|Treated|Other|2|||
129842434|NCT02489318|467388732|FG000|Treated|Ongoing|0|||
129842435|NCT02489318|467388733|FG001|Treated|Ongoing|267|||
129842436|NCT05723770|467388734|FG000|Overall Study|Lost to Follow-up|4|||
129842437|NCT05723770|467388734|FG000|Overall Study|Withdrawal by Subject|2|||
129842438|NCT01171898|467388735|FG000|Overall Study|Death|0|||
129842439|NCT01171898|467388736|FG001|Overall Study|Death|0|||
129842440|NCT01171898|467388737|FG002|Overall Study|Death|2|||
129842441|NCT01171898|467388738|FG003|Overall Study|Death|0|||
129842442|NCT01171898|467388735|FG000|Overall Study|Lost to Follow-up|0|||
129842443|NCT01171898|467388736|FG001|Overall Study|Lost to Follow-up|1|||
129842444|NCT01171898|467388737|FG002|Overall Study|Lost to Follow-up|1|||
129842445|NCT01171898|467388738|FG003|Overall Study|Lost to Follow-up|1|||
129842446|NCT01171898|467388735|FG000|Overall Study|Withdrawal by Subject|1|||
129842447|NCT01171898|467388736|FG001|Overall Study|Withdrawal by Subject|4|||
129842448|NCT01171898|467388737|FG002|Overall Study|Withdrawal by Subject|6|||
129842449|NCT01171898|467388738|FG003|Overall Study|Withdrawal by Subject|3|||
129842450|NCT01171898|467388735|FG000|Overall Study|Terminated by Sponsor|1|||
129842451|NCT01171898|467388736|FG001|Overall Study|Terminated by Sponsor|0|||
129842452|NCT01171898|467388737|FG002|Overall Study|Terminated by Sponsor|0|||
129842453|NCT01171898|467388738|FG003|Overall Study|Terminated by Sponsor|0|||
129842454|NCT01171898|467388735|FG000|Overall Study|Ongoing|1|||
129842455|NCT01171898|467388736|FG001|Overall Study|Ongoing|9|||
129842456|NCT01171898|467388737|FG002|Overall Study|Ongoing|3|||
129842457|NCT01171898|467388738|FG003|Overall Study|Ongoing|0|||
129842458|NCT01171898|467388735|FG000|Overall Study|Other|1|||
129842459|NCT01171898|467388736|FG001|Overall Study|Other|5|||
129842460|NCT01171898|467388737|FG002|Overall Study|Other|0|||
129842461|NCT01171898|467388738|FG003|Overall Study|Other|2|||
129842462|NCT01359592|467388742|FG000|Initial Registration|Adverse Event|1|||
129842463|NCT01359592|467388743|FG001|Initial Registration|Adverse Event|0|||
129842464|NCT01359592|467388744|FG002|Initial Registration|Adverse Event|0|||
129842465|NCT01359592|467388745|FG003|Initial Registration|Adverse Event|0|||
129842466|NCT01359592|467388742|FG000|Initial Registration|Death|1|||
129842467|NCT01359592|467388743|FG001|Initial Registration|Death|0|||
129842468|NCT01359592|467388744|FG002|Initial Registration|Death|0|||
129842469|NCT01359592|467388745|FG003|Initial Registration|Death|0|||
129842470|NCT01359592|467388742|FG000|Initial Registration|Other reason not protocol specified|1|||
129900778|NCT01833065|467597149|FG002|Overall Study|Subject's substantial non-compliance|0|||
129900779|NCT01833065|467597150|FG003|Overall Study|Subject's substantial non-compliance|0|||
129900780|NCT01833065|467597151|FG004|Overall Study|Subject's substantial non-compliance|0|||
129900781|NCT01833065|467597147|FG000|Overall Study|Trial terminated by sponsor|8|||
129900782|NCT01833065|467597148|FG001|Overall Study|Trial terminated by sponsor|8|||
129900783|NCT01833065|467597149|FG002|Overall Study|Trial terminated by sponsor|7|||
129900784|NCT01833065|467597150|FG003|Overall Study|Trial terminated by sponsor|3|||
129900785|NCT01833065|467597151|FG004|Overall Study|Trial terminated by sponsor|13|||
129900786|NCT01833065|467597147|FG000|Overall Study|Others|2|||
129900787|NCT01833065|467597148|FG001|Overall Study|Others|1|||
129900788|NCT01833065|467597149|FG002|Overall Study|Others|1|||
129900789|NCT01833065|467597150|FG003|Overall Study|Others|1|||
129900790|NCT01833065|467597151|FG004|Overall Study|Others|4|||
129900791|NCT03201809|467597155|FG000|Overall Study|Lost to Follow-up|2|||
129900792|NCT03201809|467597156|FG001|Overall Study|Lost to Follow-up|0|||
129900793|NCT00246012|467597158|FG000|Overall Study|Adverse Event|0|||
129900794|NCT00246012|467597159|FG001|Overall Study|Adverse Event|0|||
129842471|NCT01359592|467388743|FG001|Initial Registration|Other reason not protocol specified|0|||
129842472|NCT01359592|467388744|FG002|Initial Registration|Other reason not protocol specified|0|||
129842473|NCT01359592|467388745|FG003|Initial Registration|Other reason not protocol specified|0|||
129842474|NCT01359592|467388742|FG000|Initial Registration|Ineligible|26|||
129842475|NCT01359592|467388743|FG001|Initial Registration|Ineligible|0|||
129842476|NCT01359592|467388744|FG002|Initial Registration|Ineligible|0|||
129842477|NCT01359592|467388745|FG003|Initial Registration|Ineligible|0|||
129842478|NCT01359592|467388742|FG000|PET-Directed Therapy|Adverse Event|0|||
129842479|NCT01359592|467388743|FG001|PET-Directed Therapy|Adverse Event|0|||
129842480|NCT01359592|467388744|FG002|PET-Directed Therapy|Adverse Event|1|||
129842481|NCT01359592|467388745|FG003|PET-Directed Therapy|Adverse Event|0|||
129842482|NCT01359592|467388742|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129842483|NCT01359592|467388743|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129842484|NCT01359592|467388744|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
129842485|NCT01359592|467388745|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129842486|NCT01359592|467388742|FG000|PET-Directed Therapy|Ineligible|0|||
129842487|NCT01359592|467388743|FG001|PET-Directed Therapy|Ineligible|0|||
129842488|NCT01359592|467388744|FG002|PET-Directed Therapy|Ineligible|24|||
129842489|NCT01359592|467388745|FG003|PET-Directed Therapy|Ineligible|0|||
129842490|NCT00779675|467388755|FG000|Treatment Period|Adverse Event|87|||
129842491|NCT00779675|467388755|FG000|Treatment Period|Treatment Failure|80|||
129842492|NCT00779675|467388755|FG000|Treatment Period|Transferred to Another Study|38|||
129842493|NCT00779675|467388755|FG000|Treatment Period|Lost to Follow-up|23|||
129842494|NCT00779675|467388755|FG000|Treatment Period|Withdrawal by Subject|46|||
129842495|NCT00779675|467388755|FG000|Treatment Period|Protocol Violation|54|||
129842496|NCT00779675|467388755|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
129842497|NCT00779675|467388755|FG000|Treatment Period|Administrative|3|||
129842498|NCT00779675|467388755|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
129842499|NCT00779675|467388755|FG000|Extended Treatment Period|Protocol Violation|13|||
129842500|NCT00779675|467388755|FG000|Extended Treatment Period|Adverse Event|6|||
129842501|NCT00779675|467388755|FG000|Extended Treatment Period|Treatment Failure|11|||
129842502|NCT00779675|467388755|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
129842503|NCT00779675|467388755|FG000|Extended Treatment Period|Lost to Follow-up|6|||
129842504|NCT00749775|467388758|FG000|Overall Study|Protocol Violation|24|||
129842505|NCT00749775|467388758|FG000|Overall Study|Lost to Follow-up|36|||
129842506|NCT00749775|467388758|FG000|Overall Study|No visit after first day of treatment|44|||
129842507|NCT00749775|467388758|FG000|Overall Study|No drug administration|3|||
129842508|NCT04300296|467388759|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
129842509|NCT04300296|467388760|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842510|NCT04300296|467388761|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842511|NCT04300296|467388762|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842512|NCT04300296|467388763|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842513|NCT04300296|467388764|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842514|NCT04300296|467388759|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842515|NCT04300296|467388760|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842516|NCT04300296|467388761|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842517|NCT04300296|467388762|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842518|NCT04300296|467388763|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
129842519|NCT04300296|467388764|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129900795|NCT00246012|467597160|FG002|Overall Study|Adverse Event|0|||
129900796|NCT00246012|467597161|FG003|Overall Study|Adverse Event|0|||
129900797|NCT00246012|467597162|FG004|Overall Study|Adverse Event|0|||
129900798|NCT00246012|467597163|FG005|Overall Study|Adverse Event|1|||
129900799|NCT00246012|467597164|FG006|Overall Study|Adverse Event|0|||
129900800|NCT00246012|467597165|FG007|Overall Study|Adverse Event|0|||
129900801|NCT00246012|467597166|FG008|Overall Study|Adverse Event|2|||
129842520|NCT04300296|467388759|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
129842521|NCT04300296|467388760|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
129842522|NCT04300296|467388761|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129842523|NCT04300296|467388762|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129842524|NCT04300296|467388763|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129842525|NCT04300296|467388764|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
129842526|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
129842527|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129842528|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
129842529|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129842530|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
129842531|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129842532|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
129842533|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129842534|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
129842535|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129842536|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
129842537|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129842538|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842539|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
129842540|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842541|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842542|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842543|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842544|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
129842545|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
129842546|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
129842547|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
129842548|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
129842549|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
129842550|NCT01633944|467388765|FG000|Open-label Titration Phase|Adverse Event|109|||
129842551|NCT01633944|467388766|FG001|Open-label Titration Phase|Adverse Event|0|||
129842552|NCT01633944|467388767|FG002|Open-label Titration Phase|Adverse Event|0|||
129842553|NCT01633944|467388765|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
129842554|NCT01633944|467388766|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
129842555|NCT01633944|467388767|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
129842556|NCT01633944|467388765|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
129842557|NCT01633944|467388766|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
129842558|NCT01633944|467388767|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
129842559|NCT01633944|467388765|FG000|Open-label Titration Phase|Protocol Violation|24|||
129842560|NCT01633944|467388766|FG001|Open-label Titration Phase|Protocol Violation|0|||
129842561|NCT01633944|467388767|FG002|Open-label Titration Phase|Protocol Violation|0|||
129842562|NCT01633944|467388765|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
129842563|NCT01633944|467388766|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
129842564|NCT01633944|467388767|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
129842565|NCT01633944|467388765|FG000|Open-label Titration Phase|Other|68|||
129842566|NCT01633944|467388766|FG001|Open-label Titration Phase|Other|0|||
129842567|NCT01633944|467388767|FG002|Open-label Titration Phase|Other|0|||
129842568|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129842569|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Adverse Event|13|||
129842570|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Adverse Event|7|||
129842571|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
129842572|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
129842573|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
129842574|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129842575|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
129842576|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
129842577|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
129842578|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
129842579|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
129842580|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129842581|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
129842582|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
129842583|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
129842584|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
129842585|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
129900802|NCT00246012|467597158|FG000|Overall Study|Withdrawal by Subject|0|||
130116120|NCT00947856|468385197|FG001|Treatment Period|Withdrawal by Subject|1|||
129900803|NCT00246012|467597159|FG001|Overall Study|Withdrawal by Subject|0|||
130064355|NCT00424346|468190120|FG000|Extension Phase|Lack of Efficacy|0|||
130064356|NCT00424346|468190121|FG001|Extension Phase|Lack of Efficacy|16|||
130064357|NCT00424346|468190122|FG002|Extension Phase|Lack of Efficacy|14|||
130064358|NCT00424346|468190123|FG003|Extension Phase|Lack of Efficacy|11|||
130064359|NCT00424346|468190120|FG000|Extension Phase|Withdrawal by Subject|0|||
130064360|NCT00424346|468190121|FG001|Extension Phase|Withdrawal by Subject|5|||
130064361|NCT00424346|468190122|FG002|Extension Phase|Withdrawal by Subject|3|||
130064362|NCT00424346|468190123|FG003|Extension Phase|Withdrawal by Subject|4|||
130064363|NCT00424346|468190120|FG000|Extension Phase|Lost to Follow-up|0|||
130064364|NCT00424346|468190121|FG001|Extension Phase|Lost to Follow-up|2|||
130064365|NCT00424346|468190122|FG002|Extension Phase|Lost to Follow-up|0|||
130064366|NCT00424346|468190123|FG003|Extension Phase|Lost to Follow-up|0|||
130064367|NCT00424346|468190120|FG000|Extension Phase|Administrative Problems|0|||
130064368|NCT00424346|468190121|FG001|Extension Phase|Administrative Problems|69|||
130064369|NCT00424346|468190122|FG002|Extension Phase|Administrative Problems|32|||
130064370|NCT00424346|468190123|FG003|Extension Phase|Administrative Problems|35|||
130064371|NCT00424346|468190120|FG000|Extension Phase|Death|0|||
130064372|NCT00424346|468190121|FG001|Extension Phase|Death|0|||
130064373|NCT00424346|468190122|FG002|Extension Phase|Death|0|||
130064374|NCT00424346|468190123|FG003|Extension Phase|Death|1|||
130064375|NCT00424346|468190120|FG000|Extension Phase|Protocol Violation|0|||
130064376|NCT00424346|468190121|FG001|Extension Phase|Protocol Violation|1|||
130064377|NCT00424346|468190122|FG002|Extension Phase|Protocol Violation|1|||
130064378|NCT00424346|468190123|FG003|Extension Phase|Protocol Violation|0|||
130064379|NCT00571519|468190124|FG000|Overall Study|Subject withdrew consent|0|||
130064380|NCT00571519|468190125|FG001|Overall Study|Subject withdrew consent|1|||
130064381|NCT00571519|468190126|FG002|Overall Study|Subject withdrew consent|0|||
130064382|NCT00571519|468190127|FG003|Overall Study|Subject withdrew consent|2|||
130064383|NCT00571519|468190128|FG004|Overall Study|Subject withdrew consent|1|||
130064384|NCT00571519|468190129|FG005|Overall Study|Subject withdrew consent|1|||
130064385|NCT00571519|468190130|FG006|Overall Study|Subject withdrew consent|2|||
130064386|NCT00571519|468190124|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
130064387|NCT00571519|468190125|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130064388|NCT00571519|468190126|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
130064389|NCT00571519|468190127|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
130064390|NCT00571519|468190128|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130064391|NCT00571519|468190129|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130064392|NCT00571519|468190130|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
130064393|NCT00571519|468190124|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
130064394|NCT00571519|468190125|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
130064395|NCT00571519|468190126|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
130064396|NCT00571519|468190127|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
130064397|NCT00571519|468190128|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
130064398|NCT00571519|468190129|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
130064399|NCT00571519|468190130|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
130064400|NCT00571519|468190124|FG000|Overall Study|Termination of study by Sponsor|2|||
130064401|NCT00571519|468190125|FG001|Overall Study|Termination of study by Sponsor|7|||
130064402|NCT00571519|468190126|FG002|Overall Study|Termination of study by Sponsor|10|||
130064403|NCT00571519|468190127|FG003|Overall Study|Termination of study by Sponsor|24|||
130064404|NCT00571519|468190128|FG004|Overall Study|Termination of study by Sponsor|8|||
130064405|NCT00571519|468190129|FG005|Overall Study|Termination of study by Sponsor|9|||
130064406|NCT00571519|468190130|FG006|Overall Study|Termination of study by Sponsor|22|||
130064407|NCT00571519|468190124|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130064408|NCT00571519|468190125|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130064409|NCT00571519|468190126|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
130064410|NCT00571519|468190127|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130064411|NCT00571519|468190128|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130064412|NCT00571519|468190129|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130064413|NCT00571519|468190130|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
130064414|NCT02658968|468190131|FG000|Received Rituximab|Adverse Event|0|||
130064415|NCT02658968|468190132|FG001|Received Rituximab|Adverse Event|0|||
130064416|NCT02658968|468190133|FG002|Received Rituximab|Adverse Event|0|||
130064417|NCT02658968|468190134|FG003|Received Rituximab|Adverse Event|0|||
130064418|NCT02658968|468190135|FG004|Received Rituximab|Adverse Event|1|||
130064419|NCT02658968|468190131|FG000|Received Rituximab|Progressive disease|0|||
130064420|NCT02658968|468190132|FG001|Received Rituximab|Progressive disease|0|||
130064421|NCT02658968|468190133|FG002|Received Rituximab|Progressive disease|0|||
130064422|NCT02658968|468190134|FG003|Received Rituximab|Progressive disease|0|||
130064423|NCT02658968|468190135|FG004|Received Rituximab|Progressive disease|1|||
130116121|NCT00947856|468385196|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
130116122|NCT00947856|468385197|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
130116123|NCT00947856|468385196|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
130116124|NCT00947856|468385197|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
130116125|NCT00947856|468385196|FG000|Follow-up Period|Lost to Follow-up|7|||
130116126|NCT00947856|468385197|FG001|Follow-up Period|Lost to Follow-up|0|||
130116127|NCT00947856|468385196|FG000|Follow-up Period|Patient unavailable for site visits|1|||
130116128|NCT00947856|468385197|FG001|Follow-up Period|Patient unavailable for site visits|0|||
130116129|NCT00947856|468385196|FG000|Follow-up Period|Withdrawal by Subject|1|||
130116130|NCT00947856|468385197|FG001|Follow-up Period|Withdrawal by Subject|0|||
130116131|NCT00543439|468385198|FG000|Period 1|Adverse Event|0|||
130116132|NCT00543439|468385199|FG001|Period 1|Adverse Event|2|||
130116133|NCT00543439|468385200|FG002|Period 1|Adverse Event|1|||
130116134|NCT00543439|468385198|FG000|Period 1|Withdrawal by Subject|1|||
129900804|NCT00246012|467597160|FG002|Overall Study|Withdrawal by Subject|0|||
129900805|NCT00246012|467597161|FG003|Overall Study|Withdrawal by Subject|0|||
129900806|NCT00246012|467597162|FG004|Overall Study|Withdrawal by Subject|0|||
129900807|NCT00246012|467597163|FG005|Overall Study|Withdrawal by Subject|1|||
129900808|NCT00246012|467597164|FG006|Overall Study|Withdrawal by Subject|0|||
129900809|NCT00246012|467597165|FG007|Overall Study|Withdrawal by Subject|0|||
129900810|NCT00246012|467597166|FG008|Overall Study|Withdrawal by Subject|0|||
129900811|NCT00246012|467597158|FG000|Overall Study|Disease progression|3|||
129900812|NCT00246012|467597159|FG001|Overall Study|Disease progression|1|||
129900813|NCT00246012|467597160|FG002|Overall Study|Disease progression|2|||
129900814|NCT00246012|467597161|FG003|Overall Study|Disease progression|3|||
129900815|NCT00246012|467597162|FG004|Overall Study|Disease progression|3|||
129900816|NCT00246012|467597163|FG005|Overall Study|Disease progression|25|||
129900817|NCT00246012|467597164|FG006|Overall Study|Disease progression|30|||
129900818|NCT00246012|467597165|FG007|Overall Study|Disease progression|27|||
129900819|NCT00246012|467597166|FG008|Overall Study|Disease progression|26|||
129900820|NCT00246012|467597158|FG000|Overall Study|Other|0|||
129900821|NCT00246012|467597159|FG001|Overall Study|Other|0|||
129900822|NCT00246012|467597160|FG002|Overall Study|Other|0|||
129900823|NCT00246012|467597161|FG003|Overall Study|Other|0|||
129900824|NCT00246012|467597162|FG004|Overall Study|Other|0|||
129900825|NCT00246012|467597163|FG005|Overall Study|Other|0|||
129900826|NCT00246012|467597164|FG006|Overall Study|Other|0|||
129900827|NCT00246012|467597165|FG007|Overall Study|Other|1|||
129900828|NCT00246012|467597166|FG008|Overall Study|Other|0|||
129900829|NCT00246012|467597158|FG000|Overall Study|Randomly assigned but not treated|0|||
129900830|NCT00246012|467597159|FG001|Overall Study|Randomly assigned but not treated|0|||
129900831|NCT00246012|467597160|FG002|Overall Study|Randomly assigned but not treated|0|||
129900832|NCT00246012|467597161|FG003|Overall Study|Randomly assigned but not treated|0|||
129900833|NCT00246012|467597162|FG004|Overall Study|Randomly assigned but not treated|0|||
129842586|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
129842587|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
129842588|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
129842589|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Other|0|||
129842590|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Other|7|||
129842591|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Other|0|||
129842592|NCT00701129|467388768|FG000|Overall Study|Death|2|||
129842593|NCT02412631|467388769|FG000|Overall Study|Adverse Event|1|||
129842594|NCT02412631|467388770|FG001|Overall Study|Adverse Event|2|||
129842595|NCT02412631|467388769|FG000|Overall Study|Lost to Follow-up|5|||
129842596|NCT02412631|467388770|FG001|Overall Study|Lost to Follow-up|9|||
129842597|NCT02412631|467388769|FG000|Overall Study|Withdrawal by Subject|9|||
129842598|NCT02412631|467388770|FG001|Overall Study|Withdrawal by Subject|3|||
129842599|NCT02412631|467388769|FG000|Overall Study|Early stop by FDA|5|||
129842600|NCT02412631|467388770|FG001|Overall Study|Early stop by FDA|2|||
129842601|NCT02412631|467388769|FG000|Overall Study|Unspecified reason|6|||
129842602|NCT02412631|467388770|FG001|Overall Study|Unspecified reason|8|||
129900834|NCT00246012|467597163|FG005|Overall Study|Randomly assigned but not treated|1|||
129900835|NCT00246012|467597164|FG006|Overall Study|Randomly assigned but not treated|1|||
130116135|NCT00543439|468385199|FG001|Period 1|Withdrawal by Subject|1|||
129842603|NCT00958776|467388771|FG000|Overall Study|Adverse Event|0|||
129900836|NCT00246012|467597165|FG007|Overall Study|Randomly assigned but not treated|0|||
129900837|NCT00246012|467597166|FG008|Overall Study|Randomly assigned but not treated|0|||
129900838|NCT02377362|467597167|FG000|Part A Second Treatment|Protocol Violation|0|||
129900839|NCT02377362|467597168|FG001|Part A Second Treatment|Protocol Violation|0|||
129842604|NCT00958776|467388772|FG001|Overall Study|Adverse Event|1|||
129842605|NCT00958776|467388771|FG000|Overall Study|Physician Decision|1|||
129842606|NCT00958776|467388772|FG001|Overall Study|Physician Decision|0|||
129842607|NCT00958776|467388771|FG000|Overall Study|Lost to Follow-up|2|||
129842608|NCT00958776|467388772|FG001|Overall Study|Lost to Follow-up|6|||
129900840|NCT02377362|467597169|FG002|Part A Second Treatment|Protocol Violation|0|||
129900841|NCT02377362|467597170|FG003|Part A Second Treatment|Protocol Violation|0|||
130116136|NCT00543439|468385200|FG002|Period 1|Withdrawal by Subject|0|||
129900842|NCT02377362|467597171|FG004|Part A Second Treatment|Protocol Violation|1|||
129900843|NCT02377362|467597172|FG005|Part A Second Treatment|Protocol Violation|0|||
129900844|NCT02377362|467597173|FG006|Part A Second Treatment|Protocol Violation|0|||
129900845|NCT02377362|467597174|FG007|Part A Second Treatment|Protocol Violation|0|||
129900846|NCT02377362|467597175|FG008|Part A Second Treatment|Protocol Violation|0|||
129900847|NCT02377362|467597176|FG009|Part A Second Treatment|Protocol Violation|0|||
129900848|NCT02377362|467597177|FG010|Part A Second Treatment|Protocol Violation|0|||
129900849|NCT02377362|467597178|FG011|Part A Second Treatment|Protocol Violation|0|||
129900850|NCT02377362|467597179|FG012|Part A Second Treatment|Protocol Violation|0|||
129900851|NCT02377362|467597167|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900852|NCT02377362|467597168|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900853|NCT02377362|467597169|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900854|NCT02377362|467597170|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
129900855|NCT02377362|467597171|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
129900856|NCT02377362|467597172|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
129900857|NCT02377362|467597173|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900858|NCT02377362|467597174|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900859|NCT02377362|467597175|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900860|NCT02377362|467597176|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900861|NCT02377362|467597177|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900862|NCT02377362|467597178|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900863|NCT02377362|467597179|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900864|NCT02377362|467597167|FG000|Part B Overall|Protocol Violation|0|||
129900865|NCT02377362|467597168|FG001|Part B Overall|Protocol Violation|0|||
129900866|NCT02377362|467597169|FG002|Part B Overall|Protocol Violation|0|||
129900867|NCT02377362|467597170|FG003|Part B Overall|Protocol Violation|0|||
129900868|NCT02377362|467597171|FG004|Part B Overall|Protocol Violation|0|||
129900869|NCT02377362|467597172|FG005|Part B Overall|Protocol Violation|0|||
129900870|NCT02377362|467597173|FG006|Part B Overall|Protocol Violation|0|||
129900871|NCT02377362|467597174|FG007|Part B Overall|Protocol Violation|0|||
129900872|NCT02377362|467597175|FG008|Part B Overall|Protocol Violation|0|||
129900873|NCT02377362|467597176|FG009|Part B Overall|Protocol Violation|1|||
129900874|NCT02377362|467597177|FG010|Part B Overall|Protocol Violation|0|||
129900875|NCT02377362|467597178|FG011|Part B Overall|Protocol Violation|0|||
129900876|NCT02377362|467597179|FG012|Part B Overall|Protocol Violation|0|||
129900877|NCT02377362|467597167|FG000|Part B Overall|Adverse Event|0|||
129900878|NCT02377362|467597168|FG001|Part B Overall|Adverse Event|0|||
129900879|NCT02377362|467597169|FG002|Part B Overall|Adverse Event|0|||
129900880|NCT02377362|467597170|FG003|Part B Overall|Adverse Event|0|||
129900881|NCT02377362|467597171|FG004|Part B Overall|Adverse Event|0|||
129900882|NCT02377362|467597172|FG005|Part B Overall|Adverse Event|0|||
129900883|NCT02377362|467597173|FG006|Part B Overall|Adverse Event|1|||
129900884|NCT02377362|467597174|FG007|Part B Overall|Adverse Event|1|||
129900885|NCT02377362|467597175|FG008|Part B Overall|Adverse Event|0|||
129900886|NCT02377362|467597176|FG009|Part B Overall|Adverse Event|0|||
129900887|NCT02377362|467597177|FG010|Part B Overall|Adverse Event|0|||
129900888|NCT02377362|467597178|FG011|Part B Overall|Adverse Event|0|||
129900889|NCT02377362|467597179|FG012|Part B Overall|Adverse Event|0|||
129900890|NCT02377362|467597167|FG000|Part B Overall|Withdrawal by Subject|0|||
129900891|NCT02377362|467597168|FG001|Part B Overall|Withdrawal by Subject|0|||
129900892|NCT02377362|467597169|FG002|Part B Overall|Withdrawal by Subject|0|||
129900893|NCT02377362|467597170|FG003|Part B Overall|Withdrawal by Subject|0|||
129900894|NCT02377362|467597171|FG004|Part B Overall|Withdrawal by Subject|0|||
129900895|NCT02377362|467597172|FG005|Part B Overall|Withdrawal by Subject|0|||
129900896|NCT02377362|467597173|FG006|Part B Overall|Withdrawal by Subject|1|||
129900897|NCT02377362|467597174|FG007|Part B Overall|Withdrawal by Subject|0|||
129900898|NCT02377362|467597175|FG008|Part B Overall|Withdrawal by Subject|0|||
129900899|NCT02377362|467597176|FG009|Part B Overall|Withdrawal by Subject|0|||
129900900|NCT02377362|467597177|FG010|Part B Overall|Withdrawal by Subject|0|||
129900901|NCT02377362|467597178|FG011|Part B Overall|Withdrawal by Subject|1|||
129900902|NCT02377362|467597179|FG012|Part B Overall|Withdrawal by Subject|0|||
129900903|NCT04889664|467597180|FG000|Screen|Lost to Follow-up|1|||
129900904|NCT04889664|467597180|FG000|Screen|Failed to meet screening criteria|1|||
129900905|NCT04889664|467597180|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
129900906|NCT02322216|467597181|FG000|Overall Study|Adverse Event|1|||
129900907|NCT02322216|467597182|FG001|Overall Study|Adverse Event|0|||
129900908|NCT02322216|467597181|FG000|Overall Study|Withdrawal by Subject|1|||
129900909|NCT02322216|467597182|FG001|Overall Study|Withdrawal by Subject|4|||
129900910|NCT01191086|467597194|FG000|Overall Study|Adverse Event|20|||
129900911|NCT01191086|467597194|FG000|Overall Study|Lack of Efficacy|10|||
129900912|NCT01191086|467597194|FG000|Overall Study|Lost to Follow-up|4|||
129900913|NCT01191086|467597194|FG000|Overall Study|Physician Decision|2|||
129900914|NCT01191086|467597194|FG000|Overall Study|Withdrawal by Subject|24|||
129900915|NCT01191086|467597194|FG000|Overall Study|Discontinuation criterion met|1|||
129900916|NCT01191086|467597194|FG000|Overall Study|Other|1|||
130116137|NCT00543439|468385198|FG000|Period 1|Physician Decision|0|||
130116138|NCT00543439|468385199|FG001|Period 1|Physician Decision|0|||
130116139|NCT00543439|468385200|FG002|Period 1|Physician Decision|1|||
130116140|NCT00543439|468385198|FG000|Period 2|Protocol Violation|1|||
130116141|NCT00543439|468385199|FG001|Period 2|Protocol Violation|0|||
130116142|NCT00543439|468385200|FG002|Period 2|Protocol Violation|1|||
130116143|NCT00543439|468385198|FG000|Period 2|Adverse Event|0|||
130116144|NCT00543439|468385199|FG001|Period 2|Adverse Event|1|||
130116145|NCT00543439|468385200|FG002|Period 2|Adverse Event|1|||
130116146|NCT01211769|468385201|FG000|Overall Study|Lost to Follow-up|7|||
130116147|NCT01211769|468385202|FG001|Overall Study|Lost to Follow-up|9|||
130116148|NCT01211769|468385203|FG002|Overall Study|Lost to Follow-up|5|||
130116149|NCT01211769|468385204|FG003|Overall Study|Lost to Follow-up|9|||
130116150|NCT01211769|468385201|FG000|Overall Study|Physician Decision|2|||
130116151|NCT01211769|468385202|FG001|Overall Study|Physician Decision|0|||
130116152|NCT01211769|468385203|FG002|Overall Study|Physician Decision|2|||
130116153|NCT01211769|468385204|FG003|Overall Study|Physician Decision|1|||
130116154|NCT01211769|468385201|FG000|Overall Study|Adverse Event|0|||
130116155|NCT01211769|468385202|FG001|Overall Study|Adverse Event|1|||
130116156|NCT01211769|468385203|FG002|Overall Study|Adverse Event|1|||
130116157|NCT01211769|468385204|FG003|Overall Study|Adverse Event|1|||
130116158|NCT01214330|468385205|FG000|Overall Study|Withdrawal by Subject|2|||
130116159|NCT01214330|468385205|FG000|Overall Study|Withdrawal by Subject|2|||
130116160|NCT01348542|468385207|FG000|Overall Study|Withdrawal by Subject|3|||
130116161|NCT01348542|468385208|FG001|Overall Study|Withdrawal by Subject|0|||
130116162|NCT03402893|468385209|FG000|Overall Study|Withdrawal by Subject|1|||
130116163|NCT00686036|468385210|FG000|Overall Study|Adverse Event|3|||
130116164|NCT00686036|468385211|FG001|Overall Study|Adverse Event|0|||
130116165|NCT00686036|468385210|FG000|Overall Study|Withdrawal by Subject|3|||
130116166|NCT00686036|468385211|FG001|Overall Study|Withdrawal by Subject|1|||
130116167|NCT00686036|468385210|FG000|Overall Study|Study terminated by AstraZeneca|2|||
130116168|NCT00686036|468385211|FG001|Overall Study|Study terminated by AstraZeneca|1|||
130116169|NCT00686036|468385210|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
130116170|NCT00686036|468385211|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
130116171|NCT00686036|468385210|FG000|Overall Study|Other reasons not identified|0|||
130116172|NCT00686036|468385211|FG001|Overall Study|Other reasons not identified|4|||
130116173|NCT00926289|468385212|FG000|Overall Study|Adverse Event|9|||
130116174|NCT00926289|468385213|FG001|Overall Study|Adverse Event|11|||
130116175|NCT00926289|468385212|FG000|Overall Study|Protocol Violation|8|||
130116176|NCT00926289|468385213|FG001|Overall Study|Protocol Violation|12|||
130116177|NCT00926289|468385212|FG000|Overall Study|Lost to Follow-up|3|||
130116178|NCT00926289|468385213|FG001|Overall Study|Lost to Follow-up|6|||
130116179|NCT00926289|468385212|FG000|Overall Study|Withdrawal by Subject|4|||
130116180|NCT00926289|468385213|FG001|Overall Study|Withdrawal by Subject|4|||
130116181|NCT00926289|468385212|FG000|Overall Study|Other|1|||
130116182|NCT00926289|468385213|FG001|Overall Study|Other|3|||
130116183|NCT00146770|468385215|FG000|Overall Study|Adverse Event|2|||
130116184|NCT00146770|468385216|FG001|Overall Study|Adverse Event|0|||
129900917|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Other|4|||
129900918|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Other|0|||
129900919|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
129900920|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
129900921|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
129900922|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
129900923|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
129900924|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
129900925|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
130116185|NCT00146770|468385215|FG000|Overall Study|Pregnancy|1|||
130116186|NCT00146770|468385216|FG001|Overall Study|Pregnancy|0|||
130116187|NCT00146770|468385215|FG000|Overall Study|Withdrawal by Subject|2|||
129900926|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
129900927|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
130116188|NCT00146770|468385216|FG001|Overall Study|Withdrawal by Subject|0|||
130116189|NCT01070394|468385217|FG000|Overall Study|Adverse Event|6|||
130116190|NCT01070394|468385217|FG000|Overall Study|Withdrawal by Subject|1|||
130116191|NCT01098240|468385218|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
130116192|NCT01098240|468385219|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
130116193|NCT01098240|468385220|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
130116194|NCT01098240|468385218|FG000|Open-Label Phase|Protocol Violation|4|||
130116195|NCT01098240|468385219|FG001|Open-Label Phase|Protocol Violation|0|||
130116196|NCT01098240|468385220|FG002|Open-Label Phase|Protocol Violation|0|||
130116197|NCT01098240|468385218|FG000|Open-Label Phase|Lost to Follow-up|13|||
130116198|NCT01098240|468385219|FG001|Open-Label Phase|Lost to Follow-up|0|||
130116199|NCT01098240|468385220|FG002|Open-Label Phase|Lost to Follow-up|0|||
130116200|NCT01098240|468385218|FG000|Open-Label Phase|Other|19|||
130116201|NCT01098240|468385219|FG001|Open-Label Phase|Other|0|||
130116202|NCT01098240|468385220|FG002|Open-Label Phase|Other|0|||
129842609|NCT00958776|467388771|FG000|Overall Study|Withdrawal by Subject|7|||
129842610|NCT00958776|467388772|FG001|Overall Study|Withdrawal by Subject|16|||
129842611|NCT00958776|467388771|FG000|Overall Study|Protocol Violation|1|||
129842612|NCT00958776|467388772|FG001|Overall Study|Protocol Violation|1|||
129842613|NCT00958776|467388771|FG000|Overall Study|Death|2|||
129842614|NCT00958776|467388772|FG001|Overall Study|Death|1|||
129842615|NCT00958776|467388771|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
129842616|NCT00958776|467388772|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
129842617|NCT00958776|467388771|FG000|Overall Study|Missing|1|||
129842618|NCT00958776|467388772|FG001|Overall Study|Missing|1|||
129842619|NCT00480636|467388773|FG000|Overall Study|Death|12|||
129842620|NCT00480636|467388773|FG000|Overall Study|Lost to Follow-up|4|||
129842621|NCT00480636|467388773|FG000|Overall Study|Other|2|||
129842622|NCT00480636|467388773|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
129842623|NCT00326911|467388776|FG000|Overall Study|Hospitalization prior to treatment|0|||
129842624|NCT00326911|467388777|FG001|Overall Study|Hospitalization prior to treatment|1|||
129842625|NCT00326911|467388776|FG000|Overall Study|Physician decision prior to treatment|1|||
129842626|NCT00326911|467388777|FG001|Overall Study|Physician decision prior to treatment|0|||
129842627|NCT00326911|467388776|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
129842628|NCT00326911|467388777|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
129842629|NCT04537806|467388781|FG000|Overall Study|Randomized but not treated|1|||
129842630|NCT04537806|467388782|FG001|Overall Study|Randomized but not treated|0|||
129842631|NCT04537806|467388781|FG000|Overall Study|Adverse Event|1|||
129842632|NCT04537806|467388782|FG001|Overall Study|Adverse Event|1|||
129842633|NCT03019627|467388783|FG000|Overall Study|Adverse Event|8|||
129842634|NCT03019627|467388784|FG001|Overall Study|Adverse Event|0|||
129842635|NCT03019627|467388783|FG000|Overall Study|Unrelated to adverse event|1|||
129842636|NCT03019627|467388784|FG001|Overall Study|Unrelated to adverse event|3|||
129842637|NCT03019627|467388783|FG000|Overall Study|Lost to Follow-up|2|||
129842638|NCT03019627|467388784|FG001|Overall Study|Lost to Follow-up|1|||
129842639|NCT03019627|467388783|FG000|Overall Study|not compliance|2|||
129842640|NCT03019627|467388784|FG001|Overall Study|not compliance|2|||
129842641|NCT03019627|467388783|FG000|Overall Study|Other|2|||
129842642|NCT03019627|467388784|FG001|Overall Study|Other|2|||
129842643|NCT02953821|467388785|FG000|Overall Study|Adverse Event|0|||
129842644|NCT02953821|467388786|FG001|Overall Study|Adverse Event|4|||
129842645|NCT02953821|467388785|FG000|Overall Study|Death|1|||
129842646|NCT02953821|467388786|FG001|Overall Study|Death|0|||
129842647|NCT02953821|467388785|FG000|Overall Study|Progressive Disease|5|||
129842648|NCT02953821|467388786|FG001|Overall Study|Progressive Disease|1|||
129842649|NCT02953821|467388785|FG000|Overall Study|Lost to Follow-up|2|||
129842650|NCT02953821|467388786|FG001|Overall Study|Lost to Follow-up|0|||
129842651|NCT02953821|467388785|FG000|Overall Study|Physician Decision|1|||
129842652|NCT02953821|467388786|FG001|Overall Study|Physician Decision|1|||
129842653|NCT02953821|467388785|FG000|Overall Study|Withdrawal by Subject|3|||
129842654|NCT02953821|467388786|FG001|Overall Study|Withdrawal by Subject|3|||
129842655|NCT02953821|467388785|FG000|Overall Study|Change of address|0|||
129842656|NCT02953821|467388786|FG001|Overall Study|Change of address|1|||
129842657|NCT02953821|467388785|FG000|Overall Study|Lack of Efficacy|1|||
129842658|NCT02953821|467388786|FG001|Overall Study|Lack of Efficacy|0|||
129842659|NCT02953821|467388785|FG000|Overall Study|Out of state for indeterminate time|0|||
129842660|NCT02953821|467388786|FG001|Overall Study|Out of state for indeterminate time|1|||
129842661|NCT02953821|467388785|FG000|Overall Study|No improvement|0|||
129842662|NCT02953821|467388786|FG001|Overall Study|No improvement|1|||
129842663|NCT02953821|467388785|FG000|Overall Study|Refused follow-up visit|2|||
129842664|NCT02953821|467388786|FG001|Overall Study|Refused follow-up visit|1|||
129842665|NCT03219333|467388787|FG000|Overall Study|Withdrawal by Subject|9|||
129842666|NCT03219333|467388788|FG001|Overall Study|Withdrawal by Subject|4|||
129842667|NCT03219333|467388787|FG000|Overall Study|Lost to Follow-up|1|||
129842668|NCT03219333|467388788|FG001|Overall Study|Lost to Follow-up|1|||
129842669|NCT03219333|467388787|FG000|Overall Study|Death|104|||
129842670|NCT03219333|467388788|FG001|Overall Study|Death|72|||
129842671|NCT03219333|467388787|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
129842672|NCT03219333|467388788|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
129842673|NCT03219333|467388787|FG000|Overall Study|Other|2|||
129842674|NCT03219333|467388788|FG001|Overall Study|Other|2|||
129842675|NCT01470469|467388789|FG000|Overall Study|Withdrawal by Subject|4|||
129842676|NCT01470469|467388790|FG001|Overall Study|Withdrawal by Subject|6|||
129842677|NCT01470469|467388789|FG000|Overall Study|Lack of Efficacy|1|||
129842678|NCT01470469|467388790|FG001|Overall Study|Lack of Efficacy|7|||
129842679|NCT01470469|467388789|FG000|Overall Study|Adverse Event|0|||
129842680|NCT01470469|467388790|FG001|Overall Study|Adverse Event|7|||
129842681|NCT01470469|467388789|FG000|Overall Study|Lost to Follow-up|2|||
129842682|NCT01470469|467388790|FG001|Overall Study|Lost to Follow-up|2|||
129842683|NCT01470469|467388789|FG000|Overall Study|Protocol Violation|1|||
129842684|NCT01470469|467388790|FG001|Overall Study|Protocol Violation|1|||
129842685|NCT01470469|467388789|FG000|Overall Study|Other|2|||
129842686|NCT01470469|467388790|FG001|Overall Study|Other|1|||
129842687|NCT04083976|467388791|FG000|Overall Study|Lost to Follow-up|3|||
129842688|NCT04083976|467388792|FG001|Overall Study|Lost to Follow-up|0|||
129842689|NCT04083976|467388793|FG002|Overall Study|Lost to Follow-up|0|||
129842690|NCT04083976|467388794|FG003|Overall Study|Lost to Follow-up|1|||
129842691|NCT04083976|467388791|FG000|Overall Study|Withdrawal by Subject|16|||
129842692|NCT04083976|467388792|FG001|Overall Study|Withdrawal by Subject|1|||
129842693|NCT04083976|467388793|FG002|Overall Study|Withdrawal by Subject|9|||
129842694|NCT04083976|467388794|FG003|Overall Study|Withdrawal by Subject|0|||
129842695|NCT04083976|467388791|FG000|Overall Study|Sponsor Decision|14|||
129842696|NCT04083976|467388792|FG001|Overall Study|Sponsor Decision|0|||
129842697|NCT04083976|467388793|FG002|Overall Study|Sponsor Decision|0|||
129842698|NCT04083976|467388794|FG003|Overall Study|Sponsor Decision|7|||
129842699|NCT04083976|467388791|FG000|Overall Study|Other|1|||
129842700|NCT04083976|467388792|FG001|Overall Study|Other|0|||
129842701|NCT04083976|467388793|FG002|Overall Study|Other|1|||
129842702|NCT04083976|467388794|FG003|Overall Study|Other|0|||
129842703|NCT02504372|467388795|FG000|Overall Study|Death|136|||
129842704|NCT02504372|467388796|FG001|Overall Study|Death|154|||
129842705|NCT02504372|467388795|FG000|Overall Study|Lost to Follow-up|0|||
129842706|NCT02504372|467388796|FG001|Overall Study|Lost to Follow-up|2|||
129842707|NCT02504372|467388795|FG000|Overall Study|Withdrawal of consent|25|||
129842708|NCT02504372|467388796|FG001|Overall Study|Withdrawal of consent|16|||
129842709|NCT02504372|467388795|FG000|Overall Study|Participants ongoing|429|||
129842710|NCT02504372|467388796|FG001|Overall Study|Participants ongoing|415|||
129842711|NCT03748641|467388804|FG000|Overall Study|Ongoing|155|||
129842712|NCT03748641|467388805|FG001|Overall Study|Ongoing|148|||
129842713|NCT03748641|467388806|FG002|Overall Study|Ongoing|66|||
129842714|NCT03748641|467388807|FG003|Overall Study|Ongoing|79|||
129842715|NCT03748641|467388808|FG004|Overall Study|Ongoing|84|||
129842716|NCT03748641|467388804|FG000|Overall Study|Death|54|||
129842717|NCT03748641|467388805|FG001|Overall Study|Death|59|||
129842718|NCT03748641|467388806|FG002|Overall Study|Death|51|||
129842719|NCT03748641|467388807|FG003|Overall Study|Death|42|||
129842720|NCT03748641|467388808|FG004|Overall Study|Death|9|||
129842721|NCT03748641|467388804|FG000|Overall Study|Lost to Follow-up|0|||
129842722|NCT03748641|467388805|FG001|Overall Study|Lost to Follow-up|2|||
129842723|NCT03748641|467388806|FG002|Overall Study|Lost to Follow-up|1|||
129842724|NCT03748641|467388807|FG003|Overall Study|Lost to Follow-up|0|||
129842725|NCT03748641|467388808|FG004|Overall Study|Lost to Follow-up|0|||
129842726|NCT03748641|467388804|FG000|Overall Study|Withdrawal by Subject|3|||
129842727|NCT03748641|467388805|FG001|Overall Study|Withdrawal by Subject|2|||
129842728|NCT03748641|467388806|FG002|Overall Study|Withdrawal by Subject|5|||
129842729|NCT03748641|467388807|FG003|Overall Study|Withdrawal by Subject|3|||
129842730|NCT03748641|467388808|FG004|Overall Study|Withdrawal by Subject|2|||
129842731|NCT04397263|467388809|FG000|Overall Study|Withdrawal by Subject|2|||
129842732|NCT01428193|467388810|FG000|Overall Study|Physician Decision|1|||
129842733|NCT01428193|467388810|FG000|Overall Study|Elevated screening liver enzymes|1|||
129842734|NCT04697628|467388811|FG000|Overall Study|Withdrawal by Subject|17|||
129842735|NCT04697628|467388812|FG001|Overall Study|Withdrawal by Subject|23|||
129842736|NCT04697628|467388811|FG000|Overall Study|Lost to Follow-up|0|||
129842737|NCT04697628|467388812|FG001|Overall Study|Lost to Follow-up|4|||
129842738|NCT04697628|467388811|FG000|Overall Study|On-going in study|122|||
129842739|NCT04697628|467388812|FG001|Overall Study|On-going in study|91|||
129842740|NCT02703636|467388813|FG000|Overall Study|Adverse Event|14|||
129842741|NCT02703636|467388813|FG000|Overall Study|Study stopped by sponsor|1|||
130064424|NCT02658968|468190131|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
130064425|NCT02658968|468190132|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
130064426|NCT02658968|468190133|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
130064427|NCT02658968|468190134|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
129842742|NCT02703636|467388813|FG000|Overall Study|Withdrawal by Subject|1|||
129842743|NCT00393939|467388814|FG000|Overall Study|Protocol Violation|1|||
129842744|NCT00393939|467388815|FG001|Overall Study|Protocol Violation|1|||
129842745|NCT00393939|467388814|FG000|Overall Study|Lost to Follow-up|2|||
129842746|NCT00393939|467388815|FG001|Overall Study|Lost to Follow-up|4|||
129842747|NCT00393939|467388814|FG000|Overall Study|Death|10|||
129842748|NCT00393939|467388815|FG001|Overall Study|Death|4|||
129842749|NCT00393939|467388814|FG000|Overall Study|Sponsor|5|||
129842750|NCT00393939|467388815|FG001|Overall Study|Sponsor|13|||
129842751|NCT00393939|467388814|FG000|Overall Study|Objective progression or relapse|239|||
130064428|NCT02658968|468190135|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
129842752|NCT00393939|467388815|FG001|Overall Study|Objective progression or relapse|223|||
129842753|NCT00393939|467388814|FG000|Overall Study|Withdrawal by Subject|2|||
129842754|NCT00393939|467388815|FG001|Overall Study|Withdrawal by Subject|7|||
129842755|NCT00393939|467388814|FG000|Overall Study|Other|37|||
129842756|NCT00393939|467388815|FG001|Overall Study|Other|45|||
129842757|NCT03778931|467388816|FG000|Overall Study|Withdrawal by Subject|12|||
129842758|NCT03778931|467388817|FG001|Overall Study|Withdrawal by Subject|25|||
129900928|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
129900929|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
129900930|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
129900931|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
129900932|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
129900933|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
129900934|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
129900935|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
129900936|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
129900937|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
129900938|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
129900939|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
129900940|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
129900941|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
129900942|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
129900943|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
129900944|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
129900945|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
129900946|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
129900947|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Death|1|||
129900948|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Death|6|||
129900949|NCT02046616|467597202|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
129900950|NCT02046616|467597202|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
129900951|NCT02046616|467597202|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
129900952|NCT02046616|467597202|FG000|24-Week Treatment Period|Physician Decision|3|||
129900953|NCT02046616|467597202|FG000|24-Week Treatment Period|Other|1|||
129900954|NCT02046616|467597202|FG000|8-Week FU Period|Lost to Follow-up|1|||
129900955|NCT02736799|467597203|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
129900956|NCT02736799|467597204|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
129900957|NCT02736799|467597205|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
129900958|NCT02736799|467597206|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
129900959|NCT01833832|467597208|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
129900960|NCT01156116|467597210|FG000|Overall Study|Withdrawal by Subject|3|||
129900961|NCT01156116|467597211|FG001|Overall Study|Withdrawal by Subject|1|||
129900962|NCT01156116|467597210|FG000|Overall Study|CPAP intolerance|2|||
129900963|NCT01156116|467597211|FG001|Overall Study|CPAP intolerance|0|||
129900964|NCT00344019|467597212|FG000|Overall Study|did not meet final inclusion criteria|0|||
129900965|NCT00344019|467597213|FG001|Overall Study|did not meet final inclusion criteria|0|||
129900966|NCT00344019|467597214|FG002|Overall Study|did not meet final inclusion criteria|74|||
129900967|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
129900968|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
129900969|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
129900970|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
129900971|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
129900972|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
129900973|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
129900974|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
129900975|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
129900976|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
129900977|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
129900978|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
129900979|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
129842759|NCT03778931|467388816|FG000|Overall Study|Physician Decision|1|||
129842760|NCT03778931|467388817|FG001|Overall Study|Physician Decision|3|||
129842761|NCT03778931|467388816|FG000|Overall Study|Participant Noncompliance|1|||
129842762|NCT03778931|467388817|FG001|Overall Study|Participant Noncompliance|1|||
129842763|NCT03778931|467388816|FG000|Overall Study|Lost to Follow-up|4|||
129842764|NCT03778931|467388817|FG001|Overall Study|Lost to Follow-up|1|||
129842765|NCT03778931|467388816|FG000|Overall Study|Death|69|||
129842766|NCT03778931|467388817|FG001|Overall Study|Death|79|||
129842767|NCT00006184|467388818|FG000|Overall Study|Death|1|||
129842768|NCT00006184|467388819|FG001|Overall Study|Death|0|||
129842769|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
129900980|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
129842770|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
129842771|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
129842772|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
130116203|NCT01098240|468385218|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
130116204|NCT01098240|468385219|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130116205|NCT01098240|468385220|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130116206|NCT01098240|468385218|FG000|Open-Label Phase|Pregnancy|1|||
130116207|NCT01098240|468385219|FG001|Open-Label Phase|Pregnancy|0|||
130116208|NCT01098240|468385220|FG002|Open-Label Phase|Pregnancy|0|||
130116209|NCT01098240|468385218|FG000|Open-Label Phase|Withdrawal by Subject|9|||
130116210|NCT01098240|468385219|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129842773|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
129900981|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
129900982|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
129900983|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
129900984|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
129900985|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
129900986|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
129900987|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
129900988|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
129900989|NCT01191788|467597217|FG000|Overall Study|Lost to Follow-up|21|||
129900990|NCT01191788|467597218|FG001|Overall Study|Lost to Follow-up|22|||
129900991|NCT05046132|467597220|FG000|Overall Study|Adverse Event|4|||
129900992|NCT05046132|467597221|FG001|Overall Study|Adverse Event|0|||
129900993|NCT05046132|467597222|FG002|Overall Study|Adverse Event|0|||
129900994|NCT05046132|467597220|FG000|Overall Study|Withdrawal by Subject|3|||
129900995|NCT05046132|467597221|FG001|Overall Study|Withdrawal by Subject|0|||
129900996|NCT05046132|467597222|FG002|Overall Study|Withdrawal by Subject|0|||
129900997|NCT05046132|467597220|FG000|Overall Study|Positive Covid19 Result.|0|||
129900998|NCT05046132|467597221|FG001|Overall Study|Positive Covid19 Result.|1|||
129900999|NCT05046132|467597222|FG002|Overall Study|Positive Covid19 Result.|0|||
129901000|NCT01959412|467597223|FG000|Overall Study|Protocol deviation|1|||
129901001|NCT01959412|467597224|FG001|Overall Study|Protocol deviation|1|||
129901002|NCT01959412|467597225|FG002|Overall Study|Protocol deviation|0|||
129901003|NCT01959412|467597226|FG003|Overall Study|Protocol deviation|1|||
129901004|NCT01959412|467597227|FG004|Overall Study|Protocol deviation|3|||
129901005|NCT01959412|467597228|FG005|Overall Study|Protocol deviation|0|||
129901006|NCT01959412|467597223|FG000|Overall Study|Adverse Event|0|||
129901007|NCT01959412|467597224|FG001|Overall Study|Adverse Event|0|||
129842774|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
129842775|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
129842776|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
129842777|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
129842778|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
129842779|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
129842780|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
129842781|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
129842782|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
129842783|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
129842784|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
129842785|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
129842786|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
129842787|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
129842788|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
129842789|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
129842790|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
129842791|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
129842792|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
129842793|NCT02161718|467388824|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
129842794|NCT02161718|467388825|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
129842795|NCT02161718|467388826|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
129842796|NCT02161718|467388824|FG000|Post- Randomization Period|Lost to Follow-up|0|||
129842797|NCT02161718|467388825|FG001|Post- Randomization Period|Lost to Follow-up|9|||
129901008|NCT01959412|467597225|FG002|Overall Study|Adverse Event|0|||
129901009|NCT01959412|467597226|FG003|Overall Study|Adverse Event|1|||
129901010|NCT01959412|467597227|FG004|Overall Study|Adverse Event|0|||
129901011|NCT01959412|467597228|FG005|Overall Study|Adverse Event|0|||
129901012|NCT00509769|467597231|FG000|Overall Study|Progressive disease|77|||
129901013|NCT00509769|467597231|FG000|Overall Study|Adverse Event|4|||
129901014|NCT00509769|467597231|FG000|Overall Study|Patient's decision|1|||
129901015|NCT00509769|467597231|FG000|Overall Study|Physician Decision|8|||
129901016|NCT00509769|467597231|FG000|Overall Study|Use of prohibited therapies during study|1|||
129901017|NCT00754936|467597232|FG000|Overall Study|Lost to Follow-up|3|||
130116211|NCT01098240|468385220|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130116212|NCT01098240|468385218|FG000|Open-Label Phase|Adverse Event|12|||
130116213|NCT01098240|468385219|FG001|Open-Label Phase|Adverse Event|0|||
130116214|NCT01098240|468385220|FG002|Open-Label Phase|Adverse Event|0|||
130116215|NCT01098240|468385218|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
130116216|NCT01098240|468385219|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
130116217|NCT01098240|468385220|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
130116218|NCT01098240|468385218|FG000|Double-Blind Phase|Protocol Violation|0|||
130116219|NCT01098240|468385219|FG001|Double-Blind Phase|Protocol Violation|2|||
130116220|NCT01098240|468385220|FG002|Double-Blind Phase|Protocol Violation|4|||
130116221|NCT01098240|468385218|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130116222|NCT01098240|468385219|FG001|Double-Blind Phase|Lost to Follow-up|2|||
130116223|NCT01098240|468385220|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130116224|NCT01098240|468385218|FG000|Double-Blind Phase|Other|0|||
130116225|NCT01098240|468385219|FG001|Double-Blind Phase|Other|2|||
130116226|NCT01098240|468385220|FG002|Double-Blind Phase|Other|2|||
130116227|NCT01098240|468385218|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
130116228|NCT01098240|468385219|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
130116229|NCT01098240|468385220|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
130116230|NCT01098240|468385218|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
130116231|NCT01098240|468385219|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
130116232|NCT01098240|468385220|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
130116233|NCT01098240|468385218|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130116234|NCT01098240|468385219|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
130116235|NCT01098240|468385220|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
130116236|NCT01098240|468385218|FG000|Double-Blind Phase|Adverse Event|0|||
130116237|NCT01098240|468385219|FG001|Double-Blind Phase|Adverse Event|3|||
130116238|NCT01098240|468385220|FG002|Double-Blind Phase|Adverse Event|3|||
130116239|NCT03280537|468385221|FG000|Overall Study|Withdrawal by Subject|2|||
130116240|NCT03280537|468385222|FG001|Overall Study|Withdrawal by Subject|4|||
130116241|NCT01588106|468385223|FG000|Overall Study|Withdrawal by Subject|5|||
130116242|NCT01588106|468385224|FG001|Overall Study|Withdrawal by Subject|4|||
130116243|NCT03083132|468385225|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
130116244|NCT03083132|468385226|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
130116245|NCT03083132|468385225|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
130116246|NCT03083132|468385226|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
130116247|NCT03083132|468385225|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
130116248|NCT03083132|468385226|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
130116249|NCT03118739|468385227|FG000|Overall Study|Physician Decision|0|||
130116250|NCT03118739|468385228|FG001|Overall Study|Physician Decision|1|||
130116251|NCT03118739|468385227|FG000|Overall Study|Withdrawal by Subject|5|||
130116252|NCT03118739|468385228|FG001|Overall Study|Withdrawal by Subject|3|||
129842798|NCT02161718|467388826|FG002|Post- Randomization Period|Lost to Follow-up|15|||
129842799|NCT02161718|467388824|FG000|Post- Randomization Period|Adverse Event|0|||
129842800|NCT02161718|467388825|FG001|Post- Randomization Period|Adverse Event|9|||
129842801|NCT02161718|467388826|FG002|Post- Randomization Period|Adverse Event|10|||
129842802|NCT02161718|467388824|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
129842803|NCT02161718|467388825|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
129842804|NCT02161718|467388826|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
129842805|NCT02161718|467388824|FG000|Post- Randomization Period|Physician Decision|0|||
129842806|NCT02161718|467388825|FG001|Post- Randomization Period|Physician Decision|2|||
129842807|NCT02161718|467388826|FG002|Post- Randomization Period|Physician Decision|4|||
129842808|NCT02161718|467388824|FG000|Post- Randomization Period|Protocol Violation|0|||
129842809|NCT02161718|467388825|FG001|Post- Randomization Period|Protocol Violation|2|||
129842810|NCT02161718|467388826|FG002|Post- Randomization Period|Protocol Violation|3|||
129842811|NCT02161718|467388824|FG000|Post- Randomization Period|Lack of Efficacy|0|||
129842812|NCT02161718|467388825|FG001|Post- Randomization Period|Lack of Efficacy|0|||
129842813|NCT02161718|467388826|FG002|Post- Randomization Period|Lack of Efficacy|1|||
129842814|NCT02161718|467388824|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
129842815|NCT02161718|467388825|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
129842816|NCT02161718|467388826|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
129842817|NCT02161718|467388824|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
129842818|NCT02161718|467388825|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
129842819|NCT02161718|467388826|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
129842820|NCT02161718|467388824|FG000|Post- Randomization Period|Relocation|0|||
129842821|NCT02161718|467388825|FG001|Post- Randomization Period|Relocation|3|||
129842822|NCT02161718|467388826|FG002|Post- Randomization Period|Relocation|0|||
129842823|NCT00376168|467388832|FG000|Overall Study|Adverse Event|1|||
129842824|NCT00376168|467388833|FG001|Overall Study|Adverse Event|1|||
130116253|NCT03118739|468385227|FG000|Overall Study|Lost to Follow-up|2|||
130116254|NCT03118739|468385228|FG001|Overall Study|Lost to Follow-up|0|||
130116255|NCT00669955|468385229|FG000|Overall Study|Adverse Event|3|||
130116256|NCT00669955|468385230|FG001|Overall Study|Adverse Event|5|||
130116257|NCT00669955|468385229|FG000|Overall Study|Death|0|||
129842825|NCT00376168|467388832|FG000|Overall Study|Pregnancy|1|||
129842826|NCT00376168|467388833|FG001|Overall Study|Pregnancy|0|||
129842827|NCT04181827|467388834|FG000|Overall Study|Ongoing|124|||
129842828|NCT04181827|467388835|FG001|Overall Study|Ongoing|157|||
129842829|NCT04181827|467388834|FG000|Overall Study|Death|82|||
129842830|NCT04181827|467388835|FG001|Overall Study|Death|50|||
129842831|NCT04181827|467388834|FG000|Overall Study|Lost to Follow-up|0|||
129842832|NCT04181827|467388835|FG001|Overall Study|Lost to Follow-up|1|||
129842833|NCT04181827|467388834|FG000|Overall Study|Withdrawal by Subject|5|||
129842834|NCT04181827|467388835|FG001|Overall Study|Withdrawal by Subject|0|||
129901018|NCT00754936|467597232|FG000|Overall Study|Physician Decision|1|||
129901019|NCT00754936|467597232|FG000|Overall Study|Withdrawal by Subject|2|||
129901020|NCT00754936|467597232|FG000|Overall Study|Side Effects|3|||
129901021|NCT00754936|467597232|FG000|Overall Study|Inter-current medical events|3|||
129901022|NCT00604721|467597238|FG000|Overall Study|Physician Decision|1|||
129901023|NCT00604721|467597238|FG000|Overall Study|Withdrawal by Subject|1|||
129901024|NCT01144182|467597243|FG000|Overall Study|Death|5|||
129901025|NCT01144182|467597244|FG001|Overall Study|Death|6|||
129901026|NCT01144182|467597243|FG000|Overall Study|Withdrawal by Subject|3|||
129901027|NCT01144182|467597244|FG001|Overall Study|Withdrawal by Subject|6|||
129901028|NCT01144182|467597243|FG000|Overall Study|Lost to Follow-up|9|||
129901029|NCT01144182|467597244|FG001|Overall Study|Lost to Follow-up|9|||
129901030|NCT02317016|467597245|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
129901031|NCT02317016|467597245|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
129901032|NCT02317016|467597245|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
129901033|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
129901034|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
129901035|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
129901036|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
129901037|NCT00536380|467597246|FG000|Overall Study|Adverse Event|0|||
129901038|NCT00536380|467597247|FG001|Overall Study|Adverse Event|2|||
129901039|NCT00536380|467597248|FG002|Overall Study|Adverse Event|2|||
129842835|NCT05091528|467388836|FG000|Overall Study|Study Termination by Sponsor|0|||
129842836|NCT05091528|467388837|FG001|Overall Study|Study Termination by Sponsor|1|||
129842837|NCT05091528|467388838|FG002|Overall Study|Study Termination by Sponsor|0|||
129842838|NCT05091528|467388839|FG003|Overall Study|Study Termination by Sponsor|1|||
129842839|NCT01857063|467388840|FG000|Period 1 (7 Days)|Adverse Event|0|||
129842840|NCT01857063|467388841|FG001|Period 1 (7 Days)|Adverse Event|1|||
129842841|NCT01857063|467388840|FG000|Period 1 (7 Days)|Physician Decision|1|||
129842842|NCT01857063|467388841|FG001|Period 1 (7 Days)|Physician Decision|0|||
129842843|NCT01857063|467388840|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
129842844|NCT01857063|467388841|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
129842845|NCT01857063|467388840|FG000|Period 2 (7 Days)|Adverse Event|2|||
129842846|NCT01857063|467388841|FG001|Period 2 (7 Days)|Adverse Event|1|||
129842847|NCT01857063|467388840|FG000|Period 2 (7 Days)|Physician Decision|1|||
129842848|NCT01857063|467388841|FG001|Period 2 (7 Days)|Physician Decision|1|||
129842849|NCT01857063|467388840|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
129842850|NCT01857063|467388841|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
129842851|NCT02448875|467388842|FG000|Overall Study|Adverse Event|2|||
129842852|NCT02448875|467388843|FG001|Overall Study|Adverse Event|1|||
129842853|NCT02448875|467388844|FG002|Overall Study|Adverse Event|0|||
129842854|NCT02448875|467388842|FG000|Overall Study|Lost to Follow-up|1|||
129842855|NCT02448875|467388843|FG001|Overall Study|Lost to Follow-up|0|||
129842856|NCT02448875|467388844|FG002|Overall Study|Lost to Follow-up|0|||
129842857|NCT02448875|467388842|FG000|Overall Study|Investigator Decision|3|||
129842858|NCT02448875|467388843|FG001|Overall Study|Investigator Decision|0|||
129901040|NCT00536380|467597246|FG000|Overall Study|Lost to Follow-up|0|||
129842859|NCT02448875|467388844|FG002|Overall Study|Investigator Decision|1|||
129842860|NCT02448875|467388842|FG000|Overall Study|Withdrawal by Subject|1|||
129842861|NCT02448875|467388843|FG001|Overall Study|Withdrawal by Subject|0|||
129842862|NCT02448875|467388844|FG002|Overall Study|Withdrawal by Subject|0|||
129842863|NCT00689481|467388845|FG000|Overall Study|Adverse Event|7|||
129842864|NCT00689481|467388846|FG001|Overall Study|Adverse Event|1|||
129842865|NCT00689481|467388845|FG000|Overall Study|Lost to Follow-up|4|||
129842866|NCT00689481|467388846|FG001|Overall Study|Lost to Follow-up|3|||
129842867|NCT00689481|467388845|FG000|Overall Study|Lack of Efficacy|4|||
129842868|NCT00689481|467388846|FG001|Overall Study|Lack of Efficacy|3|||
129842869|NCT00689481|467388845|FG000|Overall Study|Non-compliance with study treatment|1|||
129901041|NCT00536380|467597247|FG001|Overall Study|Lost to Follow-up|0|||
129842870|NCT00689481|467388846|FG001|Overall Study|Non-compliance with study treatment|1|||
129842871|NCT00689481|467388845|FG000|Overall Study|Withdrawal by Subject|8|||
129901042|NCT00536380|467597248|FG002|Overall Study|Lost to Follow-up|1|||
129901043|NCT00536380|467597246|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
129901044|NCT00536380|467597247|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
129842872|NCT00689481|467388846|FG001|Overall Study|Withdrawal by Subject|4|||
129842873|NCT00689481|467388845|FG000|Overall Study|Excluded medication started during study|0|||
129842874|NCT00689481|467388846|FG001|Overall Study|Excluded medication started during study|1|||
129842875|NCT00689481|467388845|FG000|Overall Study|Subject early term, left on vacation|0|||
129842876|NCT00689481|467388846|FG001|Overall Study|Subject early term, left on vacation|1|||
129842877|NCT00316199|467388847|FG000|Overall Study|Adverse Event|2|||
129901045|NCT00536380|467597248|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
129901046|NCT00536380|467597246|FG000|Overall Study|Withdrawal related to study drug|7|||
129901047|NCT00536380|467597247|FG001|Overall Study|Withdrawal related to study drug|5|||
129842878|NCT00316199|467388847|FG000|Overall Study|Death|8|||
129842879|NCT00316199|467388847|FG000|Overall Study|Lost to Follow-up|2|||
129842880|NCT00590954|467388848|FG000|Overall Study|Inevaluable|2|||
129842881|NCT02821962|467390151|FG000|Overall Study|Lost to Follow-up|2|||
129842882|NCT02821962|467390152|FG001|Overall Study|Lost to Follow-up|0|||
129901048|NCT00536380|467597248|FG002|Overall Study|Withdrawal related to study drug|2|||
129901049|NCT00536380|467597246|FG000|Overall Study|Noncompliance with protocol|3|||
129901050|NCT00536380|467597247|FG001|Overall Study|Noncompliance with protocol|2|||
129901051|NCT00536380|467597248|FG002|Overall Study|Noncompliance with protocol|2|||
129842883|NCT00723606|467390155|FG000|Overall Study|Adverse Event|2|||
129842884|NCT00723606|467390156|FG001|Overall Study|Adverse Event|5|||
129842885|NCT00723606|467390155|FG000|Overall Study|Other|2|||
129842886|NCT00723606|467390156|FG001|Overall Study|Other|0|||
129842887|NCT00723606|467390155|FG000|Overall Study|Withdrawal by Subject|0|||
129842888|NCT00723606|467390156|FG001|Overall Study|Withdrawal by Subject|2|||
129842889|NCT00976898|467390157|FG000|Overall Study|Protocol Violation|1|||
129901052|NCT00536380|467597246|FG000|Overall Study|Did not meet protocol eligibility|0|||
129901053|NCT00536380|467597247|FG001|Overall Study|Did not meet protocol eligibility|0|||
129901054|NCT00536380|467597248|FG002|Overall Study|Did not meet protocol eligibility|1|||
129901055|NCT00536380|467597246|FG000|Overall Study|Administrative|0|||
129901056|NCT00536380|467597247|FG001|Overall Study|Administrative|0|||
129901057|NCT00536380|467597248|FG002|Overall Study|Administrative|1|||
129901058|NCT01768676|467597253|FG000|Overall Study|Adverse Event|3|||
129901059|NCT01768676|467597254|FG001|Overall Study|Adverse Event|3|||
129901060|NCT01768676|467597253|FG000|Overall Study|Lost to Follow-up|13|||
129901061|NCT01768676|467597254|FG001|Overall Study|Lost to Follow-up|16|||
129901062|NCT01768676|467597253|FG000|Overall Study|Protocol Violation|1|||
129901063|NCT01768676|467597254|FG001|Overall Study|Protocol Violation|1|||
129901064|NCT01768676|467597253|FG000|Overall Study|Physician Decision|4|||
129901065|NCT01768676|467597254|FG001|Overall Study|Physician Decision|1|||
129901066|NCT01768676|467597253|FG000|Overall Study|Withdrawal by Subject|3|||
129901067|NCT01768676|467597254|FG001|Overall Study|Withdrawal by Subject|10|||
129901068|NCT03395353|467597256|FG000|Overall Study|Adverse Event|20|||
129901069|NCT03395353|467597256|FG000|Overall Study|Protocol Violation|1|||
130064429|NCT02658968|468190131|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
130064430|NCT02658968|468190132|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
130064431|NCT02658968|468190133|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
130064432|NCT02658968|468190134|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
130064433|NCT02658968|468190135|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
130064434|NCT02658968|468190131|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
130064435|NCT02658968|468190132|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
130064436|NCT02658968|468190133|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
130064437|NCT02658968|468190134|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
129842890|NCT00976898|467390157|FG000|Overall Study|Adverse Event|1|||
129842891|NCT00976898|467390157|FG000|Overall Study|Physician Decision|1|||
129842892|NCT00976898|467390157|FG000|Overall Study|Liver Transplant|1|||
129842893|NCT00976898|467390157|FG000|Overall Study|Progressive Disease|1|||
129842894|NCT05107128|467390158|FG000|Overall Study|Adverse Event|2|||
129842895|NCT05107128|467390159|FG001|Overall Study|Adverse Event|0|||
129842896|NCT05107128|467390158|FG000|Overall Study|Withdrawal by Subject|3|||
129842897|NCT05107128|467390159|FG001|Overall Study|Withdrawal by Subject|3|||
129842898|NCT05107128|467390158|FG000|Overall Study|Withdrawal of Consent|0|||
129842899|NCT05107128|467390159|FG001|Overall Study|Withdrawal of Consent|1|||
129842900|NCT05107128|467390158|FG000|Overall Study|Reason Not Specified|2|||
129901070|NCT03395353|467597256|FG000|Overall Study|Lack of Efficacy|3|||
130064438|NCT02658968|468190135|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
130116258|NCT00669955|468385230|FG001|Overall Study|Death|1|||
129901071|NCT03395353|467597256|FG000|Overall Study|Withdrawal by Subject|24|||
129901072|NCT03395353|467597256|FG000|Overall Study|Discontinued visit|1|||
129901073|NCT03395353|467597256|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
129901074|NCT03395353|467597256|FG000|Overall Study|Physician Decision|4|||
129901075|NCT03395353|467597256|FG000|Overall Study|Early termination of overall study|33|||
129842901|NCT05107128|467390159|FG001|Overall Study|Reason Not Specified|0|||
129901076|NCT01196429|467597257|FG000|Overall Study|Ineligible - inadequate pathology|1|||
129901077|NCT01196429|467597258|FG001|Overall Study|Ineligible - inadequate pathology|0|||
129901078|NCT01196429|467597257|FG000|Overall Study|Ineligible - wrong cell type|1|||
129901079|NCT01196429|467597258|FG001|Overall Study|Ineligible - wrong cell type|0|||
129842902|NCT05459129|467390160|FG000|Overall Study|Death|1|||
129842903|NCT05459129|467390161|FG001|Overall Study|Death|0|||
129842904|NCT05459129|467390160|FG000|Overall Study|Study Terminated By Sponsor|5|||
129842905|NCT05459129|467390161|FG001|Overall Study|Study Terminated By Sponsor|6|||
129842906|NCT04530552|467390163|FG000|Overall Study|Physician Decision|0|||
129842907|NCT04530552|467390164|FG001|Overall Study|Physician Decision|1|||
129842908|NCT04530552|467390163|FG000|Overall Study|Withdrawal by Subject|0|||
129842909|NCT04530552|467390164|FG001|Overall Study|Withdrawal by Subject|1|||
129842910|NCT04530552|467390163|FG000|Overall Study|Adverse Event|0|||
129842911|NCT04530552|467390164|FG001|Overall Study|Adverse Event|1|||
129842912|NCT04530552|467390163|FG000|Overall Study|No surgery|0|||
129842913|NCT04530552|467390164|FG001|Overall Study|No surgery|1|||
129842914|NCT06034496|467390165|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
129842915|NCT06034496|467390166|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
129842916|NCT06034496|467390165|FG000|Overall Study|Withdrawal by Subject|5|||
129842917|NCT06034496|467390166|FG001|Overall Study|Withdrawal by Subject|4|||
129842918|NCT03277261|467390173|FG000|Overall Study|Adverse Event|17|||
129842919|NCT03277261|467390174|FG001|Overall Study|Adverse Event|1|||
129842920|NCT03277261|467390173|FG000|Overall Study|Participant Withdrawal of Consent|6|||
129842921|NCT03277261|467390174|FG001|Overall Study|Participant Withdrawal of Consent|15|||
129842922|NCT03277261|467390173|FG000|Overall Study|Investigator / Sponsor Decision|4|||
129842923|NCT03277261|467390174|FG001|Overall Study|Investigator / Sponsor Decision|2|||
129842924|NCT03277261|467390173|FG000|Overall Study|Pregnancy|2|||
129842925|NCT03277261|467390174|FG001|Overall Study|Pregnancy|0|||
129842926|NCT03277261|467390173|FG000|Overall Study|Lost to Follow-up|2|||
129842927|NCT03277261|467390174|FG001|Overall Study|Lost to Follow-up|2|||
129842928|NCT03277261|467390173|FG000|Overall Study|Lack of Efficacy|2|||
129842929|NCT03277261|467390174|FG001|Overall Study|Lack of Efficacy|2|||
129842930|NCT03277261|467390173|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
129842931|NCT03277261|467390174|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
129842932|NCT02365597|467390178|FG000|Overall Study|Lost to Follow-up|0|||
129842933|NCT02365597|467390179|FG001|Overall Study|Lost to Follow-up|1|||
129842934|NCT02365597|467390180|FG002|Overall Study|Lost to Follow-up|0|||
129842935|NCT02365597|467390181|FG003|Overall Study|Lost to Follow-up|1|||
129842936|NCT02365597|467390178|FG000|Overall Study|Withdrawal by Subject|1|||
129842937|NCT02365597|467390179|FG001|Overall Study|Withdrawal by Subject|8|||
129842938|NCT02365597|467390180|FG002|Overall Study|Withdrawal by Subject|5|||
129842939|NCT02365597|467390181|FG003|Overall Study|Withdrawal by Subject|1|||
129842940|NCT02365597|467390178|FG000|Overall Study|Sponsor's decision|1|||
129842941|NCT02365597|467390179|FG001|Overall Study|Sponsor's decision|3|||
129842942|NCT02365597|467390180|FG002|Overall Study|Sponsor's decision|13|||
129842943|NCT02365597|467390181|FG003|Overall Study|Sponsor's decision|0|||
129842944|NCT02365597|467390178|FG000|Overall Study|Other|0|||
129842945|NCT02365597|467390179|FG001|Overall Study|Other|4|||
129842946|NCT02365597|467390180|FG002|Overall Study|Other|0|||
129842947|NCT02365597|467390181|FG003|Overall Study|Other|0|||
129842948|NCT02365597|467390178|FG000|Overall Study|Enrolled but not treated|0|||
129842949|NCT02365597|467390179|FG001|Overall Study|Enrolled but not treated|1|||
129842950|NCT02365597|467390180|FG002|Overall Study|Enrolled but not treated|1|||
129842951|NCT02365597|467390181|FG003|Overall Study|Enrolled but not treated|0|||
129842952|NCT02365597|467390178|FG000|Overall Study|Ongoing|0|||
129842953|NCT02365597|467390179|FG001|Overall Study|Ongoing|0|||
129842954|NCT02365597|467390180|FG002|Overall Study|Ongoing|0|||
129842955|NCT02365597|467390181|FG003|Overall Study|Ongoing|17|||
129842956|NCT00499603|467390182|FG000|Overall Study|Adverse Event|0|||
129842957|NCT00499603|467390183|FG001|Overall Study|Adverse Event|1|||
129842958|NCT03323099|467390184|FG000|Overall Study|Withdrawal by Subject|6|||
129842959|NCT03323099|467390185|FG001|Overall Study|Withdrawal by Subject|12|||
129842960|NCT03323099|467390184|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
129842961|NCT03323099|467390185|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
129842962|NCT05132127|467390188|FG000|Overall Study|Adverse Event|1|||
129842963|NCT05220397|467390189|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842964|NCT05220397|467390190|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842965|NCT05220397|467390191|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
129842966|NCT05220397|467390192|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842967|NCT05220397|467390193|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842968|NCT03604692|467390196|FG000|Overall Study|Investigator's Decision|0|||
129842969|NCT03604692|467390197|FG001|Overall Study|Investigator's Decision|0|||
129842970|NCT03604692|467390198|FG002|Overall Study|Investigator's Decision|0|||
129842971|NCT03604692|467390199|FG003|Overall Study|Investigator's Decision|1|||
129842972|NCT03604692|467390200|FG004|Overall Study|Investigator's Decision|0|||
129842973|NCT03604692|467390201|FG005|Overall Study|Investigator's Decision|7|||
129842974|NCT03604692|467390196|FG000|Overall Study|Withdrawal by Subject|0|||
129842975|NCT03604692|467390197|FG001|Overall Study|Withdrawal by Subject|0|||
129842976|NCT03604692|467390198|FG002|Overall Study|Withdrawal by Subject|0|||
129842977|NCT03604692|467390199|FG003|Overall Study|Withdrawal by Subject|0|||
129842978|NCT03604692|467390200|FG004|Overall Study|Withdrawal by Subject|0|||
129842979|NCT03604692|467390201|FG005|Overall Study|Withdrawal by Subject|2|||
129842980|NCT03604692|467390196|FG000|Overall Study|Progressive Disease|1|||
129842981|NCT03604692|467390197|FG001|Overall Study|Progressive Disease|0|||
129842982|NCT03604692|467390198|FG002|Overall Study|Progressive Disease|1|||
129842983|NCT03604692|467390199|FG003|Overall Study|Progressive Disease|0|||
129842984|NCT03604692|467390200|FG004|Overall Study|Progressive Disease|3|||
129842985|NCT03604692|467390201|FG005|Overall Study|Progressive Disease|4|||
129842986|NCT03604692|467390196|FG000|Overall Study|Difficulty Coming into Site|0|||
129842987|NCT03604692|467390197|FG001|Overall Study|Difficulty Coming into Site|0|||
129842988|NCT03604692|467390198|FG002|Overall Study|Difficulty Coming into Site|0|||
129842989|NCT03604692|467390199|FG003|Overall Study|Difficulty Coming into Site|0|||
129842990|NCT03604692|467390200|FG004|Overall Study|Difficulty Coming into Site|0|||
129842991|NCT03604692|467390201|FG005|Overall Study|Difficulty Coming into Site|1|||
129842992|NCT03604692|467390196|FG000|Overall Study|Death|0|||
129842993|NCT03604692|467390197|FG001|Overall Study|Death|0|||
129842994|NCT03604692|467390198|FG002|Overall Study|Death|1|||
129842995|NCT03604692|467390199|FG003|Overall Study|Death|0|||
129842996|NCT03604692|467390200|FG004|Overall Study|Death|0|||
129842997|NCT03604692|467390201|FG005|Overall Study|Death|0|||
129842998|NCT03604692|467390196|FG000|Overall Study|Drug Intolerance|0|||
129842999|NCT03604692|467390197|FG001|Overall Study|Drug Intolerance|0|||
129843000|NCT03604692|467390198|FG002|Overall Study|Drug Intolerance|0|||
129843001|NCT03604692|467390199|FG003|Overall Study|Drug Intolerance|1|||
129843002|NCT03604692|467390200|FG004|Overall Study|Drug Intolerance|0|||
129843003|NCT03604692|467390201|FG005|Overall Study|Drug Intolerance|0|||
129843004|NCT03604692|467390196|FG000|Overall Study|Noncompliance with follow-up visit|0|||
129843005|NCT03604692|467390197|FG001|Overall Study|Noncompliance with follow-up visit|0|||
129843006|NCT03604692|467390198|FG002|Overall Study|Noncompliance with follow-up visit|0|||
129843007|NCT03604692|467390199|FG003|Overall Study|Noncompliance with follow-up visit|1|||
129843008|NCT03604692|467390200|FG004|Overall Study|Noncompliance with follow-up visit|0|||
129843009|NCT03604692|467390201|FG005|Overall Study|Noncompliance with follow-up visit|0|||
129843010|NCT03604692|467390196|FG000|Overall Study|Not Treated|0|||
129843011|NCT03604692|467390197|FG001|Overall Study|Not Treated|0|||
129843012|NCT03604692|467390198|FG002|Overall Study|Not Treated|0|||
129843013|NCT03604692|467390199|FG003|Overall Study|Not Treated|0|||
129843014|NCT03604692|467390200|FG004|Overall Study|Not Treated|1|||
129843015|NCT03604692|467390201|FG005|Overall Study|Not Treated|0|||
129843016|NCT01946204|467390202|FG000|Overall Study|Death|38|||
129843017|NCT01946204|467390203|FG001|Overall Study|Death|59|||
129843018|NCT01946204|467390202|FG000|Overall Study|Withdrawal by Subject|37|||
129843019|NCT01946204|467390203|FG001|Overall Study|Withdrawal by Subject|50|||
129843020|NCT01946204|467390202|FG000|Overall Study|Lost to Follow-up|3|||
129843021|NCT01946204|467390203|FG001|Overall Study|Lost to Follow-up|7|||
129843022|NCT01946204|467390202|FG000|Overall Study|Ongoing|316|||
129843023|NCT01946204|467390203|FG001|Overall Study|Ongoing|687|||
129843024|NCT01946204|467390202|FG000|Overall Study|Other|7|||
129843025|NCT01946204|467390203|FG001|Overall Study|Other|3|||
129843026|NCT03466411|467390204|FG000|Overall Study|Lost to Follow-up|0|||
129843027|NCT03466411|467390205|FG001|Overall Study|Lost to Follow-up|1|||
129843028|NCT03466411|467390206|FG002|Overall Study|Lost to Follow-up|1|||
129843029|NCT03466411|467390207|FG003|Overall Study|Lost to Follow-up|0|||
129843030|NCT03466411|467390208|FG004|Overall Study|Lost to Follow-up|0|||
129843031|NCT03466411|467390209|FG005|Overall Study|Lost to Follow-up|0|||
129843032|NCT03466411|467390210|FG006|Overall Study|Lost to Follow-up|1|||
129843033|NCT03466411|467390211|FG007|Overall Study|Lost to Follow-up|1|||
129843034|NCT03466411|467390212|FG008|Overall Study|Lost to Follow-up|0|||
129843035|NCT03466411|467390213|FG009|Overall Study|Lost to Follow-up|1|||
129843036|NCT03466411|467390214|FG010|Overall Study|Lost to Follow-up|1|||
129843037|NCT03466411|467390215|FG011|Overall Study|Lost to Follow-up|1|||
129843038|NCT03466411|467390216|FG012|Overall Study|Lost to Follow-up|0|||
129843039|NCT03466411|467390204|FG000|Overall Study|Withdrawal by Subject|14|||
129843040|NCT03466411|467390205|FG001|Overall Study|Withdrawal by Subject|7|||
129843041|NCT03466411|467390206|FG002|Overall Study|Withdrawal by Subject|8|||
129843042|NCT03466411|467390207|FG003|Overall Study|Withdrawal by Subject|4|||
129843043|NCT03466411|467390208|FG004|Overall Study|Withdrawal by Subject|6|||
129843044|NCT03466411|467390209|FG005|Overall Study|Withdrawal by Subject|3|||
129843045|NCT03466411|467390210|FG006|Overall Study|Withdrawal by Subject|6|||
129843046|NCT03466411|467390211|FG007|Overall Study|Withdrawal by Subject|9|||
129843047|NCT03466411|467390212|FG008|Overall Study|Withdrawal by Subject|6|||
129843048|NCT03466411|467390213|FG009|Overall Study|Withdrawal by Subject|11|||
129843049|NCT03466411|467390214|FG010|Overall Study|Withdrawal by Subject|14|||
129843050|NCT03466411|467390215|FG011|Overall Study|Withdrawal by Subject|12|||
129843051|NCT03466411|467390216|FG012|Overall Study|Withdrawal by Subject|7|||
129843052|NCT03466411|467390204|FG000|Overall Study|Other|1|||
129843053|NCT03466411|467390205|FG001|Overall Study|Other|1|||
129843054|NCT03466411|467390206|FG002|Overall Study|Other|0|||
129843055|NCT03466411|467390207|FG003|Overall Study|Other|1|||
129843056|NCT03466411|467390208|FG004|Overall Study|Other|2|||
129843057|NCT03466411|467390209|FG005|Overall Study|Other|0|||
129843058|NCT03466411|467390210|FG006|Overall Study|Other|0|||
129843059|NCT03466411|467390211|FG007|Overall Study|Other|0|||
129843060|NCT03466411|467390212|FG008|Overall Study|Other|0|||
129843061|NCT03466411|467390213|FG009|Overall Study|Other|1|||
129843062|NCT03466411|467390214|FG010|Overall Study|Other|2|||
129843063|NCT03466411|467390215|FG011|Overall Study|Other|0|||
129843064|NCT03466411|467390216|FG012|Overall Study|Other|0|||
129843065|NCT03466411|467390204|FG000|Overall Study|Randomized but not Treated|0|||
129843066|NCT03466411|467390205|FG001|Overall Study|Randomized but not Treated|0|||
129843067|NCT03466411|467390206|FG002|Overall Study|Randomized but not Treated|0|||
129843068|NCT03466411|467390207|FG003|Overall Study|Randomized but not Treated|0|||
129843069|NCT03466411|467390208|FG004|Overall Study|Randomized but not Treated|0|||
129843070|NCT03466411|467390209|FG005|Overall Study|Randomized but not Treated|0|||
129843071|NCT03466411|467390210|FG006|Overall Study|Randomized but not Treated|1|||
129843072|NCT03466411|467390211|FG007|Overall Study|Randomized but not Treated|0|||
129843073|NCT03466411|467390212|FG008|Overall Study|Randomized but not Treated|0|||
129843074|NCT03466411|467390213|FG009|Overall Study|Randomized but not Treated|0|||
129843075|NCT03466411|467390214|FG010|Overall Study|Randomized but not Treated|0|||
129843076|NCT03466411|467390215|FG011|Overall Study|Randomized but not Treated|0|||
129843077|NCT03466411|467390216|FG012|Overall Study|Randomized but not Treated|0|||
129843078|NCT04115358|467390219|FG000|Overall Study|exfoliation|0|||
129843079|NCT04115358|467390220|FG001|Overall Study|exfoliation|0|||
129843080|NCT04115358|467390221|FG002|Overall Study|exfoliation|1|||
129843081|NCT02681302|467390224|FG000|Overall Study|Withdrawal by Subject|1|||
129843082|NCT02681302|467390225|FG001|Overall Study|Withdrawal by Subject|1|||
129843083|NCT02681302|467390226|FG002|Overall Study|Withdrawal by Subject|0|||
129843084|NCT02681302|467390227|FG003|Overall Study|Withdrawal by Subject|0|||
129843085|NCT02681302|467390228|FG004|Overall Study|Withdrawal by Subject|1|||
129843086|NCT02681302|467390229|FG005|Overall Study|Withdrawal by Subject|0|||
129843087|NCT02681302|467390224|FG000|Overall Study|Screen Failure|2|||
129843088|NCT02681302|467390225|FG001|Overall Study|Screen Failure|4|||
129843089|NCT02681302|467390226|FG002|Overall Study|Screen Failure|2|||
129843090|NCT02681302|467390227|FG003|Overall Study|Screen Failure|0|||
129843091|NCT02681302|467390228|FG004|Overall Study|Screen Failure|1|||
129843092|NCT02681302|467390229|FG005|Overall Study|Screen Failure|1|||
129843093|NCT02681302|467390224|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843094|NCT02681302|467390225|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843095|NCT02681302|467390226|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843096|NCT02681302|467390227|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843097|NCT02681302|467390228|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843098|NCT02681302|467390229|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
129843099|NCT02115282|467390230|FG000|Overall Study|Disease progression during treatment|216|||
129843100|NCT02115282|467390231|FG001|Overall Study|Disease progression during treatment|229|||
129843101|NCT02115282|467390230|FG000|Overall Study|Adverse Event|49|||
129843102|NCT02115282|467390231|FG001|Overall Study|Adverse Event|23|||
129843103|NCT02115282|467390230|FG000|Overall Study|Death|1|||
129843104|NCT02115282|467390231|FG001|Overall Study|Death|3|||
129843105|NCT02115282|467390230|FG000|Overall Study|Alternative therapy|1|||
129843106|NCT02115282|467390231|FG001|Overall Study|Alternative therapy|1|||
129843107|NCT02115282|467390230|FG000|Overall Study|Complicating disease|0|||
129843108|NCT02115282|467390231|FG001|Overall Study|Complicating disease|3|||
129843109|NCT02115282|467390230|FG000|Overall Study|Withdrawal by Subject|12|||
129843110|NCT02115282|467390231|FG001|Overall Study|Withdrawal by Subject|10|||
129843111|NCT02115282|467390230|FG000|Overall Study|Symptomatic progression/deterioration|7|||
129843112|NCT02115282|467390231|FG001|Overall Study|Symptomatic progression/deterioration|18|||
129843113|NCT02115282|467390230|FG000|Overall Study|Non-compliance|5|||
129843114|NCT02115282|467390231|FG001|Overall Study|Non-compliance|1|||
129843115|NCT02115282|467390230|FG000|Overall Study|Protocol Violation|2|||
129843116|NCT02115282|467390231|FG001|Overall Study|Protocol Violation|2|||
129843117|NCT02115282|467390230|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
129843118|NCT02115282|467390231|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
129843119|NCT02115282|467390230|FG000|Overall Study|Not start protocol therapy|9|||
129843120|NCT02115282|467390231|FG001|Overall Study|Not start protocol therapy|10|||
129843121|NCT02152995|467390234|FG000|Overall Study|Withdrawal by Subject|1|||
129843122|NCT02152995|467390235|FG001|Overall Study|Withdrawal by Subject|0|||
129843123|NCT00480779|467390237|FG000|Overall Study|Other|2|||
129843124|NCT00480779|467390238|FG001|Overall Study|Other|0|||
129843125|NCT00480779|467390237|FG000|Overall Study|Job and Health-related|0|||
129843126|NCT00480779|467390238|FG001|Overall Study|Job and Health-related|3|||
129843127|NCT04907032|467390239|FG000|Overall Study|Withdrawal by Subject|7|||
129843128|NCT04907032|467390240|FG001|Overall Study|Withdrawal by Subject|1|||
129843129|NCT00613509|467390241|FG000|Cycle 1|Adverse Event|2|||
129843130|NCT00613509|467390242|FG001|Cycle 1|Adverse Event|1|||
129843131|NCT00613509|467390241|FG000|Cycle 1|Disease Progression|2|||
129843132|NCT00613509|467390242|FG001|Cycle 1|Disease Progression|6|||
129843133|NCT00613509|467390241|FG000|Cycle 1|Unacceptable Toxicity|1|||
129843134|NCT00613509|467390242|FG001|Cycle 1|Unacceptable Toxicity|0|||
129843135|NCT00613509|467390241|FG000|Cycle 1|Other administrative reason|0|||
129843136|NCT00613509|467390242|FG001|Cycle 1|Other administrative reason|1|||
129843137|NCT01723228|467390258|FG000|Overall Study|Adverse Event|2|||
129843138|NCT01723228|467390259|FG001|Overall Study|Adverse Event|6|||
129843139|NCT01723228|467390258|FG000|Overall Study|Withdrawal by Subject|2|||
129843140|NCT01723228|467390259|FG001|Overall Study|Withdrawal by Subject|1|||
129843141|NCT01723228|467390258|FG000|Overall Study|Protocol Violation|0|||
129843142|NCT01723228|467390259|FG001|Overall Study|Protocol Violation|2|||
129843143|NCT01723228|467390258|FG000|Overall Study|Lost to Follow-up|2|||
129843144|NCT01723228|467390259|FG001|Overall Study|Lost to Follow-up|1|||
129843145|NCT01723228|467390258|FG000|Overall Study|Other|2|||
129843146|NCT01723228|467390259|FG001|Overall Study|Other|1|||
129843147|NCT01451424|467390262|FG000|Overall Study|Withdrawal by Subject|1|||
129843148|NCT01451424|467390263|FG001|Overall Study|Withdrawal by Subject|1|||
129843149|NCT01451424|467390264|FG002|Overall Study|Withdrawal by Subject|0|||
129843150|NCT01451424|467390265|FG003|Overall Study|Withdrawal by Subject|2|||
129843151|NCT01451424|467390262|FG000|Overall Study|Lost to Follow-up|0|||
129843152|NCT01451424|467390263|FG001|Overall Study|Lost to Follow-up|1|||
129843153|NCT01451424|467390264|FG002|Overall Study|Lost to Follow-up|0|||
129843154|NCT01451424|467390265|FG003|Overall Study|Lost to Follow-up|1|||
129843155|NCT01451424|467390262|FG000|Overall Study|Physician Decision|0|||
129843156|NCT01451424|467390263|FG001|Overall Study|Physician Decision|0|||
129843157|NCT01451424|467390264|FG002|Overall Study|Physician Decision|1|||
129843158|NCT01451424|467390265|FG003|Overall Study|Physician Decision|1|||
129843159|NCT01451424|467390262|FG000|Overall Study|Adverse Event|0|||
129843160|NCT01451424|467390263|FG001|Overall Study|Adverse Event|0|||
129843161|NCT01451424|467390264|FG002|Overall Study|Adverse Event|0|||
129843162|NCT01451424|467390265|FG003|Overall Study|Adverse Event|1|||
129843163|NCT00528528|467390267|FG000|Overall Study|Lost to Follow-up|0|||
129843164|NCT00528528|467390268|FG001|Overall Study|Lost to Follow-up|0|||
129843165|NCT00528528|467390269|FG002|Overall Study|Lost to Follow-up|1|||
129843166|NCT00528528|467390270|FG003|Overall Study|Lost to Follow-up|1|||
129843167|NCT00528528|467390267|FG000|Overall Study|Ineligible to continue the trial|0|||
129843168|NCT00528528|467390268|FG001|Overall Study|Ineligible to continue the trial|0|||
129843169|NCT00528528|467390269|FG002|Overall Study|Ineligible to continue the trial|0|||
129843170|NCT00528528|467390270|FG003|Overall Study|Ineligible to continue the trial|1|||
129843171|NCT00528528|467390267|FG000|Overall Study|Other|0|||
129843172|NCT00528528|467390268|FG001|Overall Study|Other|1|||
129843173|NCT00528528|467390269|FG002|Overall Study|Other|0|||
129843174|NCT00528528|467390270|FG003|Overall Study|Other|0|||
129843175|NCT00528528|467390267|FG000|Overall Study|Withdrawal by Subject|3|||
129843176|NCT00528528|467390268|FG001|Overall Study|Withdrawal by Subject|2|||
129843177|NCT00528528|467390269|FG002|Overall Study|Withdrawal by Subject|1|||
129843178|NCT00528528|467390270|FG003|Overall Study|Withdrawal by Subject|1|||
129843179|NCT00528528|467390267|FG000|Overall Study|Ongoing participant|0|||
129843180|NCT00528528|467390268|FG001|Overall Study|Ongoing participant|0|||
129843181|NCT00528528|467390269|FG002|Overall Study|Ongoing participant|1|||
129843182|NCT00528528|467390270|FG003|Overall Study|Ongoing participant|0|||
129843183|NCT04325828|467390271|FG000|Overall Study|Ongoing|26|||
129843184|NCT03508219|467390272|FG000|Overall Study|Death|2|||
129843185|NCT03508219|467390272|FG000|Overall Study|Withdrawal by Subject|1|||
129843186|NCT03508219|467390272|FG000|Overall Study|Lost to Follow-up|4|||
129843187|NCT03508219|467390272|FG000|Overall Study|Missed visit|2|||
129843188|NCT03945981|467390273|FG000|Overall Study|Lost to Follow-up|12|||
129843189|NCT03945981|467390273|FG000|Overall Study|Physician Decision|4|||
129843190|NCT03945981|467390273|FG000|Overall Study|Withdrawal by Subject|6|||
129843191|NCT03945981|467390273|FG000|Overall Study|Protocol Violation|1|||
129843192|NCT04466891|467390274|FG000|Overall Study|Death|60|||
129843193|NCT04466891|467390275|FG001|Overall Study|Death|6|||
129843194|NCT04466891|467390274|FG000|Overall Study|Withdrawal by Subject|8|||
129843195|NCT04466891|467390275|FG001|Overall Study|Withdrawal by Subject|1|||
129843196|NCT04466891|467390274|FG000|Overall Study|Study terminated by sponsor|5|||
129843197|NCT04466891|467390275|FG001|Overall Study|Study terminated by sponsor|0|||
129843198|NCT04466891|467390274|FG000|Overall Study|Lost to Follow-up|2|||
129843199|NCT04466891|467390275|FG001|Overall Study|Lost to Follow-up|0|||
129843200|NCT04466891|467390274|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
129843201|NCT04466891|467390275|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
129843202|NCT03091192|467390276|FG000|Overall Study|Study terminated by sponsor|21|||
129843203|NCT03091192|467390277|FG001|Overall Study|Study terminated by sponsor|14|||
129843204|NCT03091192|467390276|FG000|Overall Study|Death|9|||
129843205|NCT03091192|467390277|FG001|Overall Study|Death|13|||
129843206|NCT03091192|467390276|FG000|Overall Study|Withdrawal by Subject|2|||
129843207|NCT03091192|467390277|FG001|Overall Study|Withdrawal by Subject|0|||
129843208|NCT03091192|467390276|FG000|Overall Study|Lost to Follow-up|1|||
129843209|NCT03091192|467390277|FG001|Overall Study|Lost to Follow-up|0|||
129843210|NCT04487080|467390280|FG000|Overall Study|Withdrawal by Subject|19|||
130064439|NCT02658968|468190131|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
129843211|NCT04487080|467390281|FG001|Overall Study|Withdrawal by Subject|18|||
129843212|NCT04487080|467390282|FG002|Overall Study|Withdrawal by Subject|13|||
130064440|NCT02658968|468190132|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
130116259|NCT00669955|468385229|FG000|Overall Study|Withdrawal by Subject|2|||
130116260|NCT00669955|468385230|FG001|Overall Study|Withdrawal by Subject|3|||
130116261|NCT00669955|468385229|FG000|Overall Study|Lost to Follow-up|5|||
130116262|NCT00669955|468385230|FG001|Overall Study|Lost to Follow-up|7|||
130116263|NCT00669955|468385229|FG000|Overall Study|Protocol Violation|2|||
130116264|NCT00669955|468385230|FG001|Overall Study|Protocol Violation|7|||
130116265|NCT00669955|468385229|FG000|Overall Study|Investigator Sponsor Judgement|0|||
129901080|NCT01196429|467597257|FG000|Overall Study|Refused - Never Treated|1|||
129901081|NCT01196429|467597258|FG001|Overall Study|Refused - Never Treated|0|||
129901082|NCT02486588|467597259|FG000|Overall Study|Randomized in error- ineligible|738|||
129901083|NCT02486588|467597260|FG001|Overall Study|Randomized in error- ineligible|750|||
129901084|NCT02486588|467597261|FG002|Overall Study|Randomized in error- ineligible|755|||
130116266|NCT00669955|468385230|FG001|Overall Study|Investigator Sponsor Judgement|1|||
130116267|NCT00669955|468385229|FG000|Overall Study|not compliant with study drug/visit|2|||
130116268|NCT00669955|468385230|FG001|Overall Study|not compliant with study drug/visit|3|||
130116269|NCT04274192|468385234|FG000|Overall Study|Protocol Violation|1|||
130116270|NCT04274192|468385235|FG001|Overall Study|Protocol Violation|0|||
130116271|NCT03507439|468385236|FG000|Overall Study|Other|2|||
130116272|NCT03507439|468385237|FG001|Overall Study|Other|1|||
130116273|NCT03507439|468385236|FG000|Overall Study|Withdrawal by Subject|1|||
130116274|NCT03507439|468385237|FG001|Overall Study|Withdrawal by Subject|0|||
130116275|NCT03507439|468385236|FG000|Overall Study|Death|1|||
130116276|NCT03507439|468385237|FG001|Overall Study|Death|1|||
130116277|NCT02806232|468387053|FG000|Overall Study|Lost to Follow-up|1|||
130116278|NCT02806232|468387054|FG001|Overall Study|Lost to Follow-up|2|||
130116279|NCT02806232|468387055|FG002|Overall Study|Lost to Follow-up|1|||
130116280|NCT02806232|468387056|FG003|Overall Study|Lost to Follow-up|0|||
130116281|NCT02806232|468387057|FG004|Overall Study|Lost to Follow-up|0|||
130116282|NCT02806232|468387058|FG005|Overall Study|Lost to Follow-up|1|||
130116283|NCT02806232|468387059|FG006|Overall Study|Lost to Follow-up|0|||
130116284|NCT02806232|468387060|FG007|Overall Study|Lost to Follow-up|0|||
130116285|NCT02806232|468387061|FG008|Overall Study|Lost to Follow-up|0|||
130116286|NCT02806232|468387053|FG000|Overall Study|Withdrawal by Subject|0|||
130116287|NCT02806232|468387054|FG001|Overall Study|Withdrawal by Subject|2|||
130116288|NCT02806232|468387055|FG002|Overall Study|Withdrawal by Subject|0|||
130116289|NCT02806232|468387056|FG003|Overall Study|Withdrawal by Subject|0|||
130116290|NCT02806232|468387057|FG004|Overall Study|Withdrawal by Subject|2|||
130116291|NCT02806232|468387058|FG005|Overall Study|Withdrawal by Subject|1|||
130116292|NCT02806232|468387059|FG006|Overall Study|Withdrawal by Subject|0|||
130116293|NCT02806232|468387060|FG007|Overall Study|Withdrawal by Subject|0|||
130116294|NCT02806232|468387061|FG008|Overall Study|Withdrawal by Subject|0|||
130116295|NCT01621490|468387066|FG000|Overall Study|Subject no longer meets study criteria|0|||
130116296|NCT01621490|468387067|FG001|Overall Study|Subject no longer meets study criteria|0|||
130116297|NCT01621490|468387068|FG002|Overall Study|Subject no longer meets study criteria|0|||
130116298|NCT01621490|468387069|FG003|Overall Study|Subject no longer meets study criteria|0|||
130116299|NCT01621490|468387070|FG004|Overall Study|Subject no longer meets study criteria|1|||
130116300|NCT01621490|468387071|FG005|Overall Study|Subject no longer meets study criteria|0|||
130116301|NCT01621490|468387072|FG006|Overall Study|Subject no longer meets study criteria|0|||
130116302|NCT01621490|468387073|FG007|Overall Study|Subject no longer meets study criteria|0|||
130116303|NCT01621490|468387074|FG008|Overall Study|Subject no longer meets study criteria|0|||
130116304|NCT01621490|468387075|FG009|Overall Study|Subject no longer meets study criteria|0|||
130116305|NCT01621490|468387076|FG010|Overall Study|Subject no longer meets study criteria|0|||
130116306|NCT01621490|468387066|FG000|Overall Study|Maximum clinical benefit|3|||
130116307|NCT01621490|468387067|FG001|Overall Study|Maximum clinical benefit|2|||
130116308|NCT01621490|468387068|FG002|Overall Study|Maximum clinical benefit|0|||
129901085|NCT02486588|467597262|FG003|Overall Study|Randomized in error- ineligible|738|||
129901086|NCT02486588|467597263|FG004|Overall Study|Randomized in error- ineligible|746|||
129901087|NCT02486588|467597264|FG005|Overall Study|Randomized in error- ineligible|746|||
129901088|NCT04248829|467597265|FG000|Overall Study|Disease progression|44|||
129901089|NCT04248829|467597266|FG001|Overall Study|Disease progression|109|||
130116309|NCT01621490|468387069|FG003|Overall Study|Maximum clinical benefit|0|||
130116310|NCT01621490|468387070|FG004|Overall Study|Maximum clinical benefit|0|||
129901090|NCT04248829|467597265|FG000|Overall Study|Adverse Event|19|||
129901091|NCT04248829|467597266|FG001|Overall Study|Adverse Event|18|||
130116311|NCT01621490|468387071|FG005|Overall Study|Maximum clinical benefit|0|||
130116312|NCT01621490|468387072|FG006|Overall Study|Maximum clinical benefit|1|||
130116313|NCT01621490|468387073|FG007|Overall Study|Maximum clinical benefit|2|||
130116314|NCT01621490|468387074|FG008|Overall Study|Maximum clinical benefit|2|||
130116315|NCT01621490|468387075|FG009|Overall Study|Maximum clinical benefit|0|||
130116316|NCT01621490|468387076|FG010|Overall Study|Maximum clinical benefit|0|||
130116317|NCT01621490|468387066|FG000|Overall Study|Withdrawal by Subject|1|||
130116318|NCT01621490|468387067|FG001|Overall Study|Withdrawal by Subject|0|||
130116319|NCT01621490|468387068|FG002|Overall Study|Withdrawal by Subject|0|||
130116320|NCT01621490|468387069|FG003|Overall Study|Withdrawal by Subject|0|||
130116321|NCT01621490|468387070|FG004|Overall Study|Withdrawal by Subject|0|||
129843213|NCT04487080|467390280|FG000|Overall Study|Lost to Follow-up|3|||
129843214|NCT04487080|467390281|FG001|Overall Study|Lost to Follow-up|1|||
129843215|NCT04487080|467390282|FG002|Overall Study|Lost to Follow-up|0|||
129843216|NCT04487080|467390280|FG000|Overall Study|Ongoing|313|||
129843217|NCT04487080|467390281|FG001|Overall Study|Ongoing|297|||
129843218|NCT04487080|467390282|FG002|Overall Study|Ongoing|149|||
129843219|NCT05645432|467390283|FG000|Overall Study|Withdrawal by Subject|1|||
129843220|NCT03195478|467390284|FG000|Overall Study|Disease Progression|5|||
129843221|NCT03195478|467390285|FG001|Overall Study|Disease Progression|4|||
129843222|NCT03195478|467390286|FG002|Overall Study|Disease Progression|6|||
129843223|NCT03195478|467390287|FG003|Overall Study|Disease Progression|1|||
129843224|NCT03195478|467390284|FG000|Overall Study|Study Drug Toxicity|2|||
129843225|NCT03195478|467390285|FG001|Overall Study|Study Drug Toxicity|0|||
129843226|NCT03195478|467390286|FG002|Overall Study|Study Drug Toxicity|0|||
129843227|NCT03195478|467390287|FG003|Overall Study|Study Drug Toxicity|1|||
129843228|NCT03195478|467390284|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
129843229|NCT03195478|467390285|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
129843230|NCT03195478|467390286|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
129843231|NCT03195478|467390287|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
129843232|NCT03195478|467390284|FG000|Overall Study|Participant Withdrew Consent|1|||
129843233|NCT03195478|467390285|FG001|Overall Study|Participant Withdrew Consent|0|||
129843234|NCT03195478|467390286|FG002|Overall Study|Participant Withdrew Consent|0|||
129843235|NCT03195478|467390287|FG003|Overall Study|Participant Withdrew Consent|0|||
129843236|NCT03195478|467390284|FG000|Overall Study|Maximum Clinical benefit|0|||
129843237|NCT03195478|467390285|FG001|Overall Study|Maximum Clinical benefit|0|||
129843238|NCT03195478|467390286|FG002|Overall Study|Maximum Clinical benefit|1|||
129843239|NCT03195478|467390287|FG003|Overall Study|Maximum Clinical benefit|0|||
129843240|NCT03195478|467390284|FG000|Overall Study|Other Reasons|0|||
129843241|NCT03195478|467390285|FG001|Overall Study|Other Reasons|0|||
129843242|NCT03195478|467390286|FG002|Overall Study|Other Reasons|1|||
129843243|NCT03195478|467390287|FG003|Overall Study|Other Reasons|0|||
129843244|NCT03890367|467390288|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129843245|NCT03890367|467390289|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129843246|NCT03890367|467390290|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129843247|NCT03890367|467390288|FG000|Overall Study|Protocol deviation|2|||
129843248|NCT03890367|467390289|FG001|Overall Study|Protocol deviation|2|||
129843249|NCT03890367|467390290|FG002|Overall Study|Protocol deviation|1|||
129843250|NCT03890367|467390288|FG000|Overall Study|Lost to Follow-up|1|||
129843251|NCT03890367|467390289|FG001|Overall Study|Lost to Follow-up|1|||
129843252|NCT03890367|467390290|FG002|Overall Study|Lost to Follow-up|0|||
129843253|NCT03370341|467391928|FG000|Overall Study|Lost to Follow-up|0|||
129843254|NCT03370341|467391929|FG001|Overall Study|Lost to Follow-up|1|||
129843255|NCT01707004|467391932|FG000|Overall Study|Physician Decision|3|||
129843256|NCT00533949|467391933|FG000|Overall Study|Protocol Violation|12|||
129843257|NCT00533949|467391934|FG001|Overall Study|Protocol Violation|12|||
129843258|NCT00533949|467391935|FG002|Overall Study|Protocol Violation|9|||
129843259|NCT00533949|467391936|FG003|Overall Study|Protocol Violation|9|||
129843260|NCT00533949|467391933|FG000|Overall Study|Withdrawal by Subject|3|||
129843261|NCT00533949|467391934|FG001|Overall Study|Withdrawal by Subject|2|||
129843262|NCT00533949|467391935|FG002|Overall Study|Withdrawal by Subject|1|||
129843263|NCT00533949|467391936|FG003|Overall Study|Withdrawal by Subject|1|||
129843264|NCT00727194|467391937|FG000|Screening Period|Low QMG scores|0|||
129843265|NCT00727194|467391938|FG001|Screening Period|Low QMG scores|0|||
129843266|NCT00727194|467391939|FG002|Screening Period|Low QMG scores|6|||
129843267|NCT00727194|467391937|FG000|Screening Period|Lacked AChR antibodies|0|||
129843268|NCT00727194|467391938|FG001|Screening Period|Lacked AChR antibodies|0|||
129843269|NCT00727194|467391939|FG002|Screening Period|Lacked AChR antibodies|5|||
129843270|NCT00727194|467391937|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
129843271|NCT00727194|467391938|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
129843272|NCT00727194|467391939|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
129843273|NCT00727194|467391937|FG000|Screening Period|Severe infections|0|||
129843274|NCT00727194|467391938|FG001|Screening Period|Severe infections|0|||
129843275|NCT00727194|467391939|FG002|Screening Period|Severe infections|2|||
129843276|NCT00727194|467391937|FG000|Screening Period|History of thymoma|0|||
129843277|NCT00727194|467391938|FG001|Screening Period|History of thymoma|0|||
129843278|NCT00727194|467391939|FG002|Screening Period|History of thymoma|1|||
129843279|NCT00727194|467391937|FG000|Treatment Period 2|Lack of Efficacy|0|||
129843280|NCT00727194|467391938|FG001|Treatment Period 2|Lack of Efficacy|1|||
129843281|NCT00727194|467391939|FG002|Treatment Period 2|Lack of Efficacy|0|||
129843282|NCT04269161|467391945|FG000|Overall Study|Change of modality and no longer eligible|3|||
129843283|NCT04269161|467391946|FG001|Overall Study|Change of modality and no longer eligible|3|||
129843284|NCT04269161|467391945|FG000|Overall Study|Required procedure outside of NICU|1|||
129843285|NCT04269161|467391946|FG001|Overall Study|Required procedure outside of NICU|0|||
129843286|NCT04269161|467391945|FG000|Overall Study|Equipment issue|1|||
129843287|NCT04269161|467391946|FG001|Overall Study|Equipment issue|1|||
129843288|NCT01677195|467391947|FG000|Overall Study|Lost to Follow-up|14|||
129901092|NCT04248829|467597265|FG000|Overall Study|Withdrawal by Subject|11|||
129901093|NCT04248829|467597266|FG001|Overall Study|Withdrawal by Subject|2|||
129901094|NCT04248829|467597265|FG000|Overall Study|Lost to Follow-up|0|||
129901095|NCT04248829|467597266|FG001|Overall Study|Lost to Follow-up|1|||
129901096|NCT04248829|467597265|FG000|Overall Study|Death|12|||
129901097|NCT04248829|467597266|FG001|Overall Study|Death|14|||
129901098|NCT04248829|467597265|FG000|Overall Study|Physician Decision|2|||
129901099|NCT04248829|467597266|FG001|Overall Study|Physician Decision|4|||
129901100|NCT04248829|467597265|FG000|Overall Study|Any reason not specifically recorded|0|||
129901101|NCT04248829|467597266|FG001|Overall Study|Any reason not specifically recorded|2|||
129901102|NCT02132702|467597267|FG000|Overall Study|Protocol Violation|2|||
129901103|NCT02132702|467597267|FG000|Overall Study|Adverse Event|3|||
129901104|NCT02132702|467597267|FG000|Overall Study|Withdrawal by Subject|3|||
129901105|NCT03354390|467597268|FG000|Level 1|Death|2|||
129901106|NCT03354390|467597269|FG001|Level 1|Death|0|||
129901107|NCT03354390|467597270|FG002|Level 1|Death|0|||
129901108|NCT03354390|467597271|FG003|Level 1|Death|0|||
129901109|NCT03354390|467597268|FG000|Level 1|Physician Decision|1|||
129901110|NCT03354390|467597269|FG001|Level 1|Physician Decision|0|||
129901111|NCT03354390|467597270|FG002|Level 1|Physician Decision|0|||
129901112|NCT03354390|467597271|FG003|Level 1|Physician Decision|0|||
129901113|NCT03354390|467597268|FG000|Level 2|Physician Decision|0|||
129901114|NCT03354390|467597269|FG001|Level 2|Physician Decision|2|||
129901115|NCT03354390|467597270|FG002|Level 2|Physician Decision|0|||
129901116|NCT03354390|467597271|FG003|Level 2|Physician Decision|0|||
129901117|NCT03354390|467597268|FG000|Level 2|Lack of Efficacy|0|||
129901118|NCT03354390|467597269|FG001|Level 2|Lack of Efficacy|1|||
129901119|NCT03354390|467597270|FG002|Level 2|Lack of Efficacy|0|||
129901120|NCT03354390|467597271|FG003|Level 2|Lack of Efficacy|0|||
129901121|NCT03354390|467597268|FG000|Level 2|Lost to Follow-up|0|||
129901122|NCT03354390|467597269|FG001|Level 2|Lost to Follow-up|1|||
129901123|NCT03354390|467597270|FG002|Level 2|Lost to Follow-up|0|||
129901124|NCT03354390|467597271|FG003|Level 2|Lost to Follow-up|0|||
129901125|NCT03354390|467597268|FG000|Level 3|Death|0|||
129901126|NCT03354390|467597269|FG001|Level 3|Death|0|||
129901127|NCT03354390|467597270|FG002|Level 3|Death|1|||
129901128|NCT03354390|467597271|FG003|Level 3|Death|0|||
129901129|NCT03354390|467597268|FG000|Level 3|Physician Decision|0|||
129901130|NCT03354390|467597269|FG001|Level 3|Physician Decision|0|||
129901131|NCT03354390|467597270|FG002|Level 3|Physician Decision|2|||
129901132|NCT03354390|467597271|FG003|Level 3|Physician Decision|0|||
129901133|NCT03354390|467597268|FG000|Level 4|Death|0|||
129901134|NCT03354390|467597269|FG001|Level 4|Death|0|||
129901135|NCT03354390|467597270|FG002|Level 4|Death|0|||
129901136|NCT03354390|467597271|FG003|Level 4|Death|3|||
129901137|NCT01066923|467597272|FG000|Overall Study|Withdrawal by Subject|3|||
129901138|NCT01066923|467597273|FG001|Overall Study|Withdrawal by Subject|3|||
129901139|NCT01066923|467597274|FG002|Overall Study|Withdrawal by Subject|8|||
129901140|NCT01066923|467597275|FG003|Overall Study|Withdrawal by Subject|8|||
129979660|NCT00403767|467889417|FG000|Overall Study|Study terminated by sponsor|82|||
129979661|NCT00403767|467889418|FG001|Overall Study|Study terminated by sponsor|69|||
129979662|NCT00403767|467889417|FG000|Overall Study|Missing/incomplete data|1|||
129979663|NCT00403767|467889418|FG001|Overall Study|Missing/incomplete data|1|||
129979664|NCT01696955|467889419|FG000|Main Study|Protocol Violation|1|||
129979665|NCT01696955|467889420|FG001|Main Study|Protocol Violation|0|||
129979666|NCT01696955|467889419|FG000|Main Study|Withdrawal by Subject|1|||
129979667|NCT01696955|467889420|FG001|Main Study|Withdrawal by Subject|1|||
129979668|NCT03192475|467889421|FG000|Overall Study|Death|0|||
129979669|NCT03192475|467889422|FG001|Overall Study|Death|1|||
129979670|NCT03192475|467889421|FG000|Overall Study|Lost to Follow-up|13|||
129979671|NCT03192475|467889422|FG001|Overall Study|Lost to Follow-up|8|||
130116322|NCT01621490|468387071|FG005|Overall Study|Withdrawal by Subject|1|||
130116323|NCT01621490|468387072|FG006|Overall Study|Withdrawal by Subject|0|||
130116324|NCT01621490|468387073|FG007|Overall Study|Withdrawal by Subject|0|||
130116325|NCT01621490|468387074|FG008|Overall Study|Withdrawal by Subject|0|||
130116326|NCT01621490|468387075|FG009|Overall Study|Withdrawal by Subject|0|||
129979672|NCT03653208|467889425|FG000|Overall Study|Withdrawal by Subject|0|||
129979673|NCT03653208|467889426|FG001|Overall Study|Withdrawal by Subject|0|||
129979674|NCT03653208|467889427|FG002|Overall Study|Withdrawal by Subject|0|||
129979675|NCT03653208|467889428|FG003|Overall Study|Withdrawal by Subject|0|||
129979676|NCT03653208|467889429|FG004|Overall Study|Withdrawal by Subject|1|||
129979677|NCT03653208|467889430|FG005|Overall Study|Withdrawal by Subject|0|||
130116327|NCT01621490|468387076|FG010|Overall Study|Withdrawal by Subject|0|||
130116328|NCT01621490|468387066|FG000|Overall Study|Subject request to discontinue study|1|||
129979678|NCT03653208|467889431|FG006|Overall Study|Withdrawal by Subject|0|||
129979679|NCT03653208|467889432|FG007|Overall Study|Withdrawal by Subject|1|||
129979680|NCT03653208|467889433|FG008|Overall Study|Withdrawal by Subject|1|||
129979681|NCT00436605|467889434|FG000|Overall Study|Protocol Violation|3|||
129979682|NCT03752970|467889435|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
129979683|NCT03752970|467889436|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
129979684|NCT03752970|467889437|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
129901141|NCT01144468|467598776|FG000|Overall Study|Lost to Follow-up|4|||
129901142|NCT01144468|467598777|FG001|Overall Study|Lost to Follow-up|7|||
129901143|NCT01144468|467598776|FG000|Overall Study|Adverse Event|3|||
129901144|NCT01144468|467598777|FG001|Overall Study|Adverse Event|2|||
129901145|NCT01144468|467598776|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
129901146|NCT01144468|467598777|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
129901147|NCT01875250|467598778|FG000|Overall Study|Adverse Event|2|||
129901148|NCT01875250|467598779|FG001|Overall Study|Adverse Event|0|||
129901149|NCT00149630|467598785|FG000|Overall Study|Incarceration|2|||
129901150|NCT00149630|467598786|FG001|Overall Study|Incarceration|0|||
129901151|NCT00149630|467598785|FG000|Overall Study|Treatment Programs|4|||
129901152|NCT00149630|467598786|FG001|Overall Study|Treatment Programs|5|||
129901153|NCT00149630|467598785|FG000|Overall Study|Adverse Event|2|||
129901154|NCT00149630|467598786|FG001|Overall Study|Adverse Event|0|||
129901155|NCT05298111|467598788|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
129901156|NCT05298111|467598789|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
129901157|NCT02689349|467598790|FG000|Overall Study|Not implanted|4|||
129901158|NCT02689349|467598791|FG001|Overall Study|Not implanted|0|||
129901159|NCT02689349|467598790|FG000|Overall Study|Withdrawal by Subject|9|||
129901160|NCT02689349|467598791|FG001|Overall Study|Withdrawal by Subject|0|||
129901161|NCT03518112|467598792|FG000|Overall Study|Withdrawal by Subject|1|||
129901162|NCT01546155|467598793|FG000|Overall Study|could not tolerate long scan duration|3|||
129901163|NCT00377455|467598794|FG000|Overall Study|Withdrawal by Subject|1|||
129901164|NCT02034916|467598797|FG000|Overall Study|Death|39|||
129901165|NCT02034916|467598798|FG001|Overall Study|Death|28|||
129901166|NCT02034916|467598797|FG000|Overall Study|Withdrawal by Subject|2|||
129901167|NCT02034916|467598798|FG001|Overall Study|Withdrawal by Subject|1|||
129901168|NCT02034916|467598797|FG000|Overall Study|Lost to Follow-up|4|||
129901169|NCT02034916|467598798|FG001|Overall Study|Lost to Follow-up|1|||
129901170|NCT02034916|467598797|FG000|Overall Study|Study terminated by sponsor|4|||
129901171|NCT02034916|467598798|FG001|Overall Study|Study terminated by sponsor|5|||
129901172|NCT01616654|467598803|FG000|Overall Study|Lack of Efficacy|1|||
129901173|NCT01616654|467598804|FG001|Overall Study|Lack of Efficacy|0|||
129901174|NCT01616654|467598805|FG002|Overall Study|Lack of Efficacy|0|||
129901175|NCT01616654|467598806|FG003|Overall Study|Lack of Efficacy|0|||
129901176|NCT01616654|467598807|FG004|Overall Study|Lack of Efficacy|1|||
129901177|NCT01616654|467598803|FG000|Overall Study|Adverse Event|0|||
129901178|NCT01616654|467598804|FG001|Overall Study|Adverse Event|1|||
129901179|NCT01616654|467598805|FG002|Overall Study|Adverse Event|2|||
129901180|NCT01616654|467598806|FG003|Overall Study|Adverse Event|1|||
129901181|NCT01616654|467598807|FG004|Overall Study|Adverse Event|0|||
129901182|NCT01616654|467598803|FG000|Overall Study|Withdrawal by Subject|2|||
129901183|NCT01616654|467598804|FG001|Overall Study|Withdrawal by Subject|2|||
129901184|NCT01616654|467598805|FG002|Overall Study|Withdrawal by Subject|3|||
129901185|NCT01616654|467598806|FG003|Overall Study|Withdrawal by Subject|1|||
129901186|NCT01616654|467598807|FG004|Overall Study|Withdrawal by Subject|5|||
129901187|NCT01616654|467598803|FG000|Overall Study|Protocol Violation|0|||
129901188|NCT01616654|467598804|FG001|Overall Study|Protocol Violation|5|||
129901189|NCT01616654|467598805|FG002|Overall Study|Protocol Violation|2|||
129901190|NCT01616654|467598806|FG003|Overall Study|Protocol Violation|4|||
129901191|NCT01616654|467598807|FG004|Overall Study|Protocol Violation|4|||
129901192|NCT01616654|467598803|FG000|Overall Study|Lost to Follow-up|1|||
129901193|NCT01616654|467598804|FG001|Overall Study|Lost to Follow-up|0|||
129901194|NCT01616654|467598805|FG002|Overall Study|Lost to Follow-up|3|||
129901195|NCT01616654|467598806|FG003|Overall Study|Lost to Follow-up|2|||
129901196|NCT01616654|467598807|FG004|Overall Study|Lost to Follow-up|1|||
129901197|NCT01616654|467598803|FG000|Overall Study|Pregnancy|1|||
129901198|NCT01616654|467598804|FG001|Overall Study|Pregnancy|0|||
129901199|NCT01616654|467598805|FG002|Overall Study|Pregnancy|0|||
129901200|NCT01616654|467598806|FG003|Overall Study|Pregnancy|0|||
129901201|NCT01616654|467598807|FG004|Overall Study|Pregnancy|1|||
129901202|NCT02057692|467598811|FG000|Overall Study|Adverse Event|1|||
129901203|NCT02057692|467598812|FG001|Overall Study|Adverse Event|0|||
129901204|NCT02057692|467598813|FG002|Overall Study|Adverse Event|0|||
129901205|NCT02057692|467598814|FG003|Overall Study|Adverse Event|0|||
129901206|NCT02057692|467598811|FG000|Overall Study|Lost to Follow-up|0|||
129901207|NCT02057692|467598812|FG001|Overall Study|Lost to Follow-up|0|||
129901208|NCT02057692|467598813|FG002|Overall Study|Lost to Follow-up|0|||
129901209|NCT02057692|467598814|FG003|Overall Study|Lost to Follow-up|1|||
129901210|NCT02174562|467598815|FG000|Overall Study|Withdrawal by Subject|7|||
129901211|NCT02174562|467598816|FG001|Overall Study|Withdrawal by Subject|2|||
129901212|NCT02174562|467598815|FG000|Overall Study|Death|2|||
129901213|NCT02174562|467598816|FG001|Overall Study|Death|0|||
129901214|NCT02174562|467598815|FG000|Overall Study|Lost to Follow-up|0|||
129901215|NCT02174562|467598816|FG001|Overall Study|Lost to Follow-up|3|||
129901216|NCT00864682|467598817|FG000|Overall Study|Protocol Violation|2|||
129901217|NCT00864682|467598818|FG001|Overall Study|Protocol Violation|1|||
129901218|NCT00864682|467598819|FG002|Overall Study|Protocol Violation|2|||
129901219|NCT00545844|467598820|FG000|Overall Study|Lost to Follow-up|9|||
129843289|NCT01677195|467391948|FG001|Overall Study|Lost to Follow-up|22|||
129843290|NCT01677195|467391949|FG002|Overall Study|Lost to Follow-up|22|||
129843291|NCT01677195|467391947|FG000|Overall Study|Withdrawal by Subject|1|||
129843292|NCT01677195|467391948|FG001|Overall Study|Withdrawal by Subject|0|||
129843293|NCT01677195|467391949|FG002|Overall Study|Withdrawal by Subject|1|||
129843294|NCT01677195|467391947|FG000|Overall Study|Adverse Event|6|||
129843295|NCT01677195|467391948|FG001|Overall Study|Adverse Event|4|||
129843296|NCT01677195|467391949|FG002|Overall Study|Adverse Event|1|||
129843297|NCT01677195|467391947|FG000|Overall Study|Physician Decision|1|||
129843298|NCT01677195|467391948|FG001|Overall Study|Physician Decision|2|||
129843299|NCT01677195|467391949|FG002|Overall Study|Physician Decision|2|||
129843300|NCT01677195|467391947|FG000|Overall Study|Pregnancy|0|||
129843301|NCT01677195|467391948|FG001|Overall Study|Pregnancy|1|||
129843302|NCT01677195|467391949|FG002|Overall Study|Pregnancy|0|||
129843303|NCT01677195|467391947|FG000|Overall Study|Protocol Violation|7|||
129843304|NCT01677195|467391948|FG001|Overall Study|Protocol Violation|3|||
129843305|NCT01677195|467391949|FG002|Overall Study|Protocol Violation|4|||
129843306|NCT02143414|467391951|FG000|Induction|Adverse Event|1|||
129843307|NCT02143414|467391952|FG001|Induction|Adverse Event|2|||
129843308|NCT02143414|467391951|FG000|Induction|Death|1|||
129843309|NCT02143414|467391952|FG001|Induction|Death|2|||
129843310|NCT02143414|467391951|FG000|Induction|Patient refusal|1|||
129843311|NCT02143414|467391952|FG001|Induction|Patient refusal|1|||
129843312|NCT02143414|467391951|FG000|Induction|Refractory|1|||
129843313|NCT02143414|467391952|FG001|Induction|Refractory|0|||
129843314|NCT02143414|467391951|FG000|Induction|Began alternative treatment|1|||
129843315|NCT02143414|467391952|FG001|Induction|Began alternative treatment|0|||
129843316|NCT02143414|467391951|FG000|Induction|Ineligible for postremission|5|||
129843317|NCT02143414|467391952|FG001|Induction|Ineligible for postremission|1|||
129843318|NCT02143414|467391951|FG000|Post-remission|Adverse Event|0|||
129843319|NCT02143414|467391952|FG001|Post-remission|Adverse Event|2|||
129843320|NCT02143414|467391951|FG000|Post-remission|Disease progression/relapse|5|||
129843321|NCT02143414|467391952|FG001|Post-remission|Disease progression/relapse|0|||
129843322|NCT02143414|467391951|FG000|Maintenance|Adverse Event|4|||
129843323|NCT02143414|467391952|FG001|Maintenance|Adverse Event|6|||
129843324|NCT02143414|467391951|FG000|Maintenance|Disease progression/relapse|3|||
129843325|NCT02143414|467391952|FG001|Maintenance|Disease progression/relapse|2|||
129843326|NCT02143414|467391951|FG000|Maintenance|Patient refusal|2|||
129843327|NCT02143414|467391952|FG001|Maintenance|Patient refusal|1|||
129843328|NCT02143414|467391951|FG000|Maintenance|Physician Decision|1|||
129843329|NCT02143414|467391952|FG001|Maintenance|Physician Decision|0|||
129843330|NCT02143414|467391951|FG000|Maintenance|Death|0|||
129843331|NCT02143414|467391952|FG001|Maintenance|Death|1|||
129843332|NCT02143414|467391951|FG000|Maintenance|On protocol treatment|0|||
129843333|NCT02143414|467391952|FG001|Maintenance|On protocol treatment|6|||
129843334|NCT00634647|467391956|FG000|Overall Study|death on study|3|||
129843335|NCT00634647|467391956|FG000|Overall Study|refused further treatment|3|||
129843336|NCT00634647|467391956|FG000|Overall Study|declined to participate before treatment|1|||
129843337|NCT02984020|467391957|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
129843338|NCT02984020|467391957|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
129843339|NCT02984020|467391957|FG000|Overall Study|Other significant protocol violation|2|||
129843340|NCT00646204|467391960|FG000|Overall Study|Adverse Event|3|||
129843341|NCT00646204|467391961|FG001|Overall Study|Adverse Event|0|||
129843342|NCT00646204|467391960|FG000|Overall Study|Withdrawal by Subject|1|||
129843343|NCT00646204|467391961|FG001|Overall Study|Withdrawal by Subject|0|||
129843344|NCT03107988|467391965|FG000|Overall Study|Adverse Event|0|||
129843345|NCT03107988|467391966|FG001|Overall Study|Adverse Event|0|||
129843346|NCT03107988|467391967|FG002|Overall Study|Adverse Event|0|||
129843347|NCT03107988|467391968|FG003|Overall Study|Adverse Event|1|||
129843348|NCT03107988|467391969|FG004|Overall Study|Adverse Event|0|||
129843349|NCT03107988|467391970|FG005|Overall Study|Adverse Event|1|||
129843350|NCT03107988|467391971|FG006|Overall Study|Adverse Event|0|||
129843351|NCT03107988|467391972|FG007|Overall Study|Adverse Event|1|||
129843352|NCT03107988|467391973|FG008|Overall Study|Adverse Event|0|||
129843353|NCT03107988|467391974|FG009|Overall Study|Adverse Event|0|||
129843354|NCT03107988|467391975|FG010|Overall Study|Adverse Event|0|||
129843355|NCT03107988|467391976|FG011|Overall Study|Adverse Event|0|||
129843356|NCT03107988|467391977|FG012|Overall Study|Adverse Event|0|||
129843357|NCT03107988|467391965|FG000|Overall Study|Disease Progression or Relapse|1|||
129901220|NCT00545844|467598820|FG000|Overall Study|Protocol Violation|1|||
129843358|NCT03107988|467391966|FG001|Overall Study|Disease Progression or Relapse|2|||
129901221|NCT00545844|467598820|FG000|Overall Study|Withdrawal by Subject|2|||
129843359|NCT03107988|467391967|FG002|Overall Study|Disease Progression or Relapse|2|||
129843360|NCT03107988|467391968|FG003|Overall Study|Disease Progression or Relapse|5|||
129843361|NCT03107988|467391969|FG004|Overall Study|Disease Progression or Relapse|1|||
129843362|NCT03107988|467391970|FG005|Overall Study|Disease Progression or Relapse|1|||
129843363|NCT03107988|467391971|FG006|Overall Study|Disease Progression or Relapse|0|||
129843364|NCT03107988|467391972|FG007|Overall Study|Disease Progression or Relapse|0|||
129901222|NCT00957658|467598821|FG000|Overall Study|Death|1|||
129901223|NCT00957658|467598821|FG000|Overall Study|Lost to Follow-up|4|||
129901224|NCT00957658|467598821|FG000|Overall Study|Withdrawal by Subject|12|||
129901225|NCT00957658|467598821|FG000|Overall Study|Revision|1|||
129901226|NCT00957658|467598821|FG000|Overall Study|Incomplete 2 yr data|28|||
129901227|NCT00957658|467598821|FG000|Overall Study|Site termination|10|||
129901228|NCT00957658|467598821|FG000|Overall Study|unwilling/unable to return|2|||
129901229|NCT00957658|467598821|FG000|Overall Study|surgery cancelled|2|||
129901230|NCT00957658|467598821|FG000|Overall Study|Protocol Violation|5|||
129901231|NCT00975806|467598823|FG000|Overall Study|Adverse Event|2|||
129901232|NCT00975806|467598824|FG001|Overall Study|Adverse Event|1|||
129901233|NCT00975806|467598825|FG002|Overall Study|Adverse Event|2|||
129901234|NCT00975806|467598823|FG000|Overall Study|Disease Progression|1|||
129901235|NCT00975806|467598824|FG001|Overall Study|Disease Progression|5|||
129901236|NCT00975806|467598825|FG002|Overall Study|Disease Progression|1|||
129901237|NCT00975806|467598823|FG000|Overall Study|Withdrawal by Subject|1|||
129901238|NCT00975806|467598824|FG001|Overall Study|Withdrawal by Subject|0|||
129901239|NCT00975806|467598825|FG002|Overall Study|Withdrawal by Subject|0|||
129901240|NCT00975806|467598823|FG000|Overall Study|Death|0|||
129901241|NCT00975806|467598824|FG001|Overall Study|Death|1|||
129901242|NCT00975806|467598825|FG002|Overall Study|Death|0|||
129901243|NCT00975806|467598823|FG000|Overall Study|Physician decision and disease related|1|||
129901244|NCT00975806|467598824|FG001|Overall Study|Physician decision and disease related|0|||
129901245|NCT00975806|467598825|FG002|Overall Study|Physician decision and disease related|1|||
129901246|NCT00094809|467598826|FG000|Overall Study|Protocol deviation|2|||
129901247|NCT00094809|467598827|FG001|Overall Study|Protocol deviation|2|||
129901248|NCT00094809|467598826|FG000|Overall Study|Noncompliance|1|||
129901249|NCT00094809|467598827|FG001|Overall Study|Noncompliance|0|||
129901250|NCT00094809|467598826|FG000|Overall Study|Adverse Event|3|||
129901251|NCT00094809|467598827|FG001|Overall Study|Adverse Event|1|||
129901252|NCT00094809|467598826|FG000|Overall Study|Withdrawal by Subject|8|||
129901253|NCT00094809|467598827|FG001|Overall Study|Withdrawal by Subject|9|||
129901254|NCT00094809|467598826|FG000|Overall Study|Disease progression|3|||
129901255|NCT00094809|467598827|FG001|Overall Study|Disease progression|3|||
129901256|NCT00094809|467598826|FG000|Overall Study|Physician Decision|3|||
129901257|NCT00094809|467598827|FG001|Overall Study|Physician Decision|5|||
129901258|NCT00094809|467598826|FG000|Overall Study|Lost to Follow-up|6|||
129901259|NCT00094809|467598827|FG001|Overall Study|Lost to Follow-up|6|||
129901260|NCT00094809|467598826|FG000|Overall Study|Death|19|||
129901261|NCT00094809|467598827|FG001|Overall Study|Death|25|||
129901262|NCT00094809|467598826|FG000|Overall Study|Protocol-specified criteria|1|||
129901263|NCT00094809|467598827|FG001|Overall Study|Protocol-specified criteria|1|||
129901264|NCT00094809|467598826|FG000|Overall Study|Other|2|||
129901265|NCT00094809|467598827|FG001|Overall Study|Other|4|||
129901266|NCT00094809|467598826|FG000|Overall Study|Informed consent signed after treatment|1|||
129901267|NCT00094809|467598827|FG001|Overall Study|Informed consent signed after treatment|0|||
129901268|NCT00094809|467598826|FG000|Overall Study|Study drug not received|2|||
129901269|NCT00094809|467598827|FG001|Overall Study|Study drug not received|8|||
129901270|NCT00094809|467598826|FG000|Overall Study|Other|1|||
129901271|NCT00094809|467598827|FG001|Overall Study|Other|1|||
129901272|NCT00771849|467598829|FG000|Overall Study|Lost to Follow-up|1|||
129901273|NCT00771849|467598830|FG001|Overall Study|Lost to Follow-up|2|||
129901274|NCT00771849|467598829|FG000|Overall Study|Withdrawal by Subject|1|||
129901275|NCT00771849|467598830|FG001|Overall Study|Withdrawal by Subject|1|||
129901276|NCT00771849|467598829|FG000|Overall Study|Not vaccinated|0|||
129901277|NCT00771849|467598830|FG001|Overall Study|Not vaccinated|1|||
129901278|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Death|1|||
129901279|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Death|1|||
129901280|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Death|0|||
129843365|NCT03107988|467391973|FG008|Overall Study|Disease Progression or Relapse|0|||
129843366|NCT03107988|467391974|FG009|Overall Study|Disease Progression or Relapse|1|||
129843367|NCT03107988|467391975|FG010|Overall Study|Disease Progression or Relapse|4|||
129843368|NCT03107988|467391976|FG011|Overall Study|Disease Progression or Relapse|0|||
129843369|NCT03107988|467391977|FG012|Overall Study|Disease Progression or Relapse|0|||
129843370|NCT03107988|467391965|FG000|Overall Study|Ineligible|0|||
129843371|NCT03107988|467391966|FG001|Overall Study|Ineligible|0|||
129843372|NCT03107988|467391967|FG002|Overall Study|Ineligible|0|||
129901281|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Death|0|||
129901282|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Death|0|||
129843373|NCT03107988|467391968|FG003|Overall Study|Ineligible|0|||
129901283|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
129901284|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
129901285|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
129901286|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
129901287|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
130064441|NCT02658968|468190133|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
129843374|NCT03107988|467391969|FG004|Overall Study|Ineligible|0|||
129901288|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Physician Decision|0|||
129901289|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Physician Decision|0|||
129843375|NCT03107988|467391970|FG005|Overall Study|Ineligible|0|||
129843376|NCT03107988|467391971|FG006|Overall Study|Ineligible|0|||
129843377|NCT03107988|467391972|FG007|Overall Study|Ineligible|0|||
129843378|NCT03107988|467391973|FG008|Overall Study|Ineligible|1|||
129843379|NCT03107988|467391974|FG009|Overall Study|Ineligible|0|||
129843380|NCT03107988|467391975|FG010|Overall Study|Ineligible|0|||
129843381|NCT03107988|467391976|FG011|Overall Study|Ineligible|0|||
129843382|NCT03107988|467391977|FG012|Overall Study|Ineligible|0|||
129843383|NCT02610192|467391979|FG000|Overall Study|Received other treatment|8|||
129843384|NCT02610192|467391979|FG000|Overall Study|Physician Decision|1|||
129843385|NCT00503841|467391980|FG000|Overall Study|All screen failures|44|||
129843386|NCT00326612|467391981|FG000|Overall Study|They did not have a seizure requiring tx|129|||
129843387|NCT00326612|467391982|FG001|Overall Study|They did not have a seizure requiring tx|137|||
129843388|NCT00548808|467391984|FG000|Overall Study|Lost to Follow-up|9|||
129843389|NCT00548808|467391985|FG001|Overall Study|Lost to Follow-up|3|||
129843390|NCT00548808|467391984|FG000|Overall Study|Protocol Violation|8|||
129843391|NCT00548808|467391985|FG001|Overall Study|Protocol Violation|8|||
129843392|NCT00548808|467391984|FG000|Overall Study|Withdrawal by Subject|8|||
129843393|NCT00548808|467391985|FG001|Overall Study|Withdrawal by Subject|4|||
129843394|NCT00548808|467391984|FG000|Overall Study|Physician Decision|6|||
129843395|NCT00548808|467391985|FG001|Overall Study|Physician Decision|3|||
129843396|NCT00548808|467391984|FG000|Overall Study|Adverse Event|4|||
129843397|NCT00548808|467391985|FG001|Overall Study|Adverse Event|5|||
129843398|NCT00548808|467391984|FG000|Overall Study|Death|2|||
129843399|NCT00548808|467391985|FG001|Overall Study|Death|0|||
129843400|NCT00548808|467391984|FG000|Overall Study|Entry Criteria Not Met|2|||
129843401|NCT00548808|467391985|FG001|Overall Study|Entry Criteria Not Met|2|||
129843402|NCT00548808|467391984|FG000|Overall Study|Lack of Efficacy|2|||
129843403|NCT00548808|467391985|FG001|Overall Study|Lack of Efficacy|0|||
129843404|NCT00548808|467391984|FG000|Overall Study|Sponsor Decision|1|||
129843405|NCT00548808|467391985|FG001|Overall Study|Sponsor Decision|1|||
129843406|NCT02177266|467391986|FG000|Overall Study|Adverse Event|0|||
129843407|NCT02177266|467391987|FG001|Overall Study|Adverse Event|1|||
129843408|NCT02177266|467391986|FG000|Overall Study|Withdrawal by Subject|1|||
129843409|NCT02177266|467391987|FG001|Overall Study|Withdrawal by Subject|0|||
129843410|NCT00546715|467391989|FG000|Overall Study|Withdrawal by Subject|0|||
129843411|NCT00546715|467391990|FG001|Overall Study|Withdrawal by Subject|1|||
129843412|NCT00546715|467391991|FG002|Overall Study|Withdrawal by Subject|0|||
129843413|NCT00546715|467391992|FG003|Overall Study|Withdrawal by Subject|0|||
129843414|NCT02331446|467391993|FG000|Overall Study|Lost to Follow-up|2|||
129843415|NCT02331446|467391994|FG001|Overall Study|Lost to Follow-up|1|||
129843416|NCT02331446|467391995|FG002|Overall Study|Lost to Follow-up|0|||
129843417|NCT02331446|467391996|FG003|Overall Study|Lost to Follow-up|1|||
129843418|NCT02331446|467391993|FG000|Overall Study|Personal Problem|2|||
129843419|NCT02331446|467391994|FG001|Overall Study|Personal Problem|0|||
129843420|NCT02331446|467391995|FG002|Overall Study|Personal Problem|0|||
129843421|NCT02331446|467391996|FG003|Overall Study|Personal Problem|0|||
129843422|NCT02331446|467391993|FG000|Overall Study|Disease|0|||
129843423|NCT02331446|467391994|FG001|Overall Study|Disease|2|||
129843424|NCT02331446|467391995|FG002|Overall Study|Disease|2|||
129843425|NCT02331446|467391996|FG003|Overall Study|Disease|1|||
129843426|NCT02331446|467391993|FG000|Overall Study|Physician Decision|0|||
129843427|NCT02331446|467391994|FG001|Overall Study|Physician Decision|1|||
129843428|NCT02331446|467391995|FG002|Overall Study|Physician Decision|0|||
129843429|NCT02331446|467391996|FG003|Overall Study|Physician Decision|1|||
129843430|NCT02331446|467391993|FG000|Overall Study|Lost before baseline analysis|0|||
129843431|NCT02331446|467391994|FG001|Overall Study|Lost before baseline analysis|1|||
129843432|NCT02331446|467391995|FG002|Overall Study|Lost before baseline analysis|1|||
129843433|NCT02331446|467391996|FG003|Overall Study|Lost before baseline analysis|0|||
129843434|NCT03670810|467392005|FG000|Main Study|Adverse Event|37|||
129843435|NCT03670810|467392006|FG001|Main Study|Adverse Event|38|||
129843436|NCT03670810|467392007|FG002|Main Study|Adverse Event|3|||
129843437|NCT03670810|467392008|FG003|Main Study|Adverse Event|4|||
129843438|NCT03670810|467392009|FG004|Main Study|Adverse Event|4|||
129843439|NCT03670810|467392010|FG005|Main Study|Adverse Event|5|||
129843440|NCT03670810|467392011|FG006|Main Study|Adverse Event|0|||
129843441|NCT03670810|467392012|FG007|Main Study|Adverse Event|0|||
129843442|NCT03670810|467392013|FG008|Main Study|Adverse Event|0|||
129843443|NCT03670810|467392005|FG000|Main Study|Lack of Efficacy|8|||
129843444|NCT03670810|467392006|FG001|Main Study|Lack of Efficacy|9|||
129843445|NCT03670810|467392007|FG002|Main Study|Lack of Efficacy|3|||
129843446|NCT03670810|467392008|FG003|Main Study|Lack of Efficacy|4|||
129843447|NCT03670810|467392009|FG004|Main Study|Lack of Efficacy|0|||
129843448|NCT03670810|467392010|FG005|Main Study|Lack of Efficacy|0|||
129843449|NCT03670810|467392011|FG006|Main Study|Lack of Efficacy|0|||
129843450|NCT03670810|467392012|FG007|Main Study|Lack of Efficacy|0|||
129843451|NCT03670810|467392013|FG008|Main Study|Lack of Efficacy|0|||
129843452|NCT03670810|467392005|FG000|Main Study|Lost to Follow-up|9|||
129843453|NCT03670810|467392006|FG001|Main Study|Lost to Follow-up|7|||
129843454|NCT03670810|467392007|FG002|Main Study|Lost to Follow-up|4|||
129843455|NCT03670810|467392008|FG003|Main Study|Lost to Follow-up|6|||
130116329|NCT01621490|468387067|FG001|Overall Study|Subject request to discontinue study|3|||
130116330|NCT01621490|468387068|FG002|Overall Study|Subject request to discontinue study|1|||
130116331|NCT01621490|468387069|FG003|Overall Study|Subject request to discontinue study|1|||
130116332|NCT01621490|468387070|FG004|Overall Study|Subject request to discontinue study|0|||
130116333|NCT01621490|468387071|FG005|Overall Study|Subject request to discontinue study|2|||
130116334|NCT01621490|468387072|FG006|Overall Study|Subject request to discontinue study|1|||
130116335|NCT01621490|468387073|FG007|Overall Study|Subject request to discontinue study|0|||
130116336|NCT01621490|468387074|FG008|Overall Study|Subject request to discontinue study|1|||
130116337|NCT01621490|468387075|FG009|Overall Study|Subject request to discontinue study|0|||
130116338|NCT01621490|468387076|FG010|Overall Study|Subject request to discontinue study|0|||
130116339|NCT01621490|468387066|FG000|Overall Study|Adverse event unrelated to study drug|1|||
130116340|NCT01621490|468387067|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130116341|NCT01621490|468387068|FG002|Overall Study|Adverse event unrelated to study drug|0|||
130116342|NCT01621490|468387069|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130116343|NCT01621490|468387070|FG004|Overall Study|Adverse event unrelated to study drug|0|||
130116344|NCT01621490|468387071|FG005|Overall Study|Adverse event unrelated to study drug|0|||
130116345|NCT01621490|468387072|FG006|Overall Study|Adverse event unrelated to study drug|0|||
130116346|NCT01621490|468387073|FG007|Overall Study|Adverse event unrelated to study drug|2|||
130116347|NCT01621490|468387074|FG008|Overall Study|Adverse event unrelated to study drug|0|||
130116348|NCT01621490|468387075|FG009|Overall Study|Adverse event unrelated to study drug|0|||
130116349|NCT01621490|468387076|FG010|Overall Study|Adverse event unrelated to study drug|0|||
130116350|NCT01621490|468387066|FG000|Overall Study|Disease progression|27|||
130116351|NCT01621490|468387067|FG001|Overall Study|Disease progression|28|||
130116352|NCT01621490|468387068|FG002|Overall Study|Disease progression|1|||
130116353|NCT01621490|468387069|FG003|Overall Study|Disease progression|5|||
130116354|NCT01621490|468387070|FG004|Overall Study|Disease progression|3|||
130116355|NCT01621490|468387071|FG005|Overall Study|Disease progression|8|||
130116356|NCT01621490|468387072|FG006|Overall Study|Disease progression|7|||
130116357|NCT01621490|468387073|FG007|Overall Study|Disease progression|1|||
130116358|NCT01621490|468387074|FG008|Overall Study|Disease progression|4|||
130116359|NCT01621490|468387075|FG009|Overall Study|Disease progression|1|||
130116360|NCT01621490|468387076|FG010|Overall Study|Disease progression|1|||
130116361|NCT01621490|468387066|FG000|Overall Study|Study drug toxicity|1|||
130116362|NCT01621490|468387067|FG001|Overall Study|Study drug toxicity|4|||
130116363|NCT01621490|468387068|FG002|Overall Study|Study drug toxicity|5|||
130116364|NCT01621490|468387069|FG003|Overall Study|Study drug toxicity|3|||
130116365|NCT01621490|468387070|FG004|Overall Study|Study drug toxicity|1|||
130116366|NCT01621490|468387071|FG005|Overall Study|Study drug toxicity|10|||
130116367|NCT01621490|468387072|FG006|Overall Study|Study drug toxicity|1|||
130116368|NCT01621490|468387073|FG007|Overall Study|Study drug toxicity|4|||
130116369|NCT01621490|468387074|FG008|Overall Study|Study drug toxicity|1|||
130116370|NCT01621490|468387075|FG009|Overall Study|Study drug toxicity|0|||
130116371|NCT01621490|468387076|FG010|Overall Study|Study drug toxicity|0|||
130116372|NCT01621490|468387066|FG000|Overall Study|Death|0|||
130116373|NCT01621490|468387067|FG001|Overall Study|Death|0|||
130116374|NCT01621490|468387068|FG002|Overall Study|Death|0|||
130116375|NCT01621490|468387069|FG003|Overall Study|Death|0|||
130116376|NCT01621490|468387070|FG004|Overall Study|Death|0|||
130116377|NCT01621490|468387071|FG005|Overall Study|Death|0|||
130116378|NCT01621490|468387072|FG006|Overall Study|Death|0|||
130116379|NCT01621490|468387073|FG007|Overall Study|Death|0|||
130116380|NCT01621490|468387074|FG008|Overall Study|Death|1|||
130116381|NCT01621490|468387075|FG009|Overall Study|Death|0|||
130116382|NCT01621490|468387076|FG010|Overall Study|Death|0|||
130116383|NCT01621490|468387066|FG000|Overall Study|Other reasons|7|||
130116384|NCT01621490|468387067|FG001|Overall Study|Other reasons|6|||
130116385|NCT01621490|468387068|FG002|Overall Study|Other reasons|4|||
130116386|NCT01621490|468387069|FG003|Overall Study|Other reasons|1|||
130116387|NCT01621490|468387070|FG004|Overall Study|Other reasons|1|||
130116388|NCT01621490|468387071|FG005|Overall Study|Other reasons|3|||
130116389|NCT01621490|468387072|FG006|Overall Study|Other reasons|1|||
130116390|NCT01621490|468387073|FG007|Overall Study|Other reasons|1|||
130116391|NCT01621490|468387074|FG008|Overall Study|Other reasons|1|||
130116392|NCT01621490|468387075|FG009|Overall Study|Other reasons|0|||
130116393|NCT01621490|468387076|FG010|Overall Study|Other reasons|0|||
130116394|NCT00506753|468387077|FG000|Overall Study|Lost to Follow-up|21|||
130116395|NCT00506753|468387078|FG001|Overall Study|Lost to Follow-up|15|||
130116396|NCT00125359|468387079|FG000|Overall Study|Death|4|||
130116397|NCT00125359|468387079|FG000|Overall Study|Adverse Event|5|||
130116398|NCT00125359|468387079|FG000|Overall Study|Physician Decision|14|||
130116399|NCT02451670|468387080|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
130116400|NCT02451670|468387081|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
130116401|NCT00461500|468387082|FG000|Overall Study|Adverse Event|1|||
130116402|NCT00461500|468387083|FG001|Overall Study|Adverse Event|0|||
130116403|NCT00461500|468387082|FG000|Overall Study|Lack of Efficacy|0|||
130116404|NCT00461500|468387083|FG001|Overall Study|Lack of Efficacy|1|||
130116405|NCT00461500|468387082|FG000|Overall Study|Expired Drug Treatment|1|||
129901290|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Physician Decision|0|||
130116406|NCT00461500|468387083|FG001|Overall Study|Expired Drug Treatment|1|||
130116407|NCT00461500|468387082|FG000|Overall Study|Study Stopped|1|||
130116408|NCT00461500|468387083|FG001|Overall Study|Study Stopped|2|||
130116409|NCT00461500|468387082|FG000|Overall Study|Drug Treatment Misuse|1|||
130116410|NCT00461500|468387083|FG001|Overall Study|Drug Treatment Misuse|0|||
130116411|NCT00461500|468387082|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
130116412|NCT00461500|468387083|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
130116413|NCT00461500|468387082|FG000|Overall Study|Lost to Follow-up|2|||
130116414|NCT00461500|468387083|FG001|Overall Study|Lost to Follow-up|2|||
130116415|NCT01513551|468387088|FG000|Overall Study|Death|0|||
130116416|NCT01513551|468387089|FG001|Overall Study|Death|1|||
130116417|NCT01513551|468387090|FG002|Overall Study|Death|0|||
130116418|NCT01513551|468387088|FG000|Overall Study|Lost to Follow-up|3|||
130116419|NCT01513551|468387089|FG001|Overall Study|Lost to Follow-up|5|||
130116420|NCT01513551|468387090|FG002|Overall Study|Lost to Follow-up|2|||
130116421|NCT01513551|468387088|FG000|Overall Study|Withdrawal by Subject|1|||
130116422|NCT01513551|468387089|FG001|Overall Study|Withdrawal by Subject|0|||
130116423|NCT01513551|468387090|FG002|Overall Study|Withdrawal by Subject|2|||
130116424|NCT01513551|468387088|FG000|Overall Study|Randomized but not vaccinated|0|||
130116425|NCT01513551|468387089|FG001|Overall Study|Randomized but not vaccinated|0|||
130116426|NCT01513551|468387090|FG002|Overall Study|Randomized but not vaccinated|1|||
130116427|NCT01806597|468387091|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
130116428|NCT01806597|468387092|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
130116429|NCT01806597|468387093|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
130116430|NCT01806597|468387094|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
130116431|NCT01806597|468387095|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
130116432|NCT01806597|468387096|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
130116433|NCT01806597|468387091|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
130116434|NCT01806597|468387092|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130116435|NCT01806597|468387093|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129843456|NCT03670810|467392009|FG004|Main Study|Lost to Follow-up|1|||
129843457|NCT03670810|467392010|FG005|Main Study|Lost to Follow-up|0|||
129843458|NCT03670810|467392011|FG006|Main Study|Lost to Follow-up|0|||
129843459|NCT03670810|467392012|FG007|Main Study|Lost to Follow-up|0|||
129843460|NCT03670810|467392013|FG008|Main Study|Lost to Follow-up|0|||
129843461|NCT03670810|467392005|FG000|Main Study|Non-compliance with Study Drug|0|||
129843462|NCT03670810|467392006|FG001|Main Study|Non-compliance with Study Drug|2|||
129843463|NCT03670810|467392007|FG002|Main Study|Non-compliance with Study Drug|3|||
129843464|NCT03670810|467392008|FG003|Main Study|Non-compliance with Study Drug|0|||
129843465|NCT03670810|467392009|FG004|Main Study|Non-compliance with Study Drug|0|||
129843466|NCT03670810|467392010|FG005|Main Study|Non-compliance with Study Drug|0|||
129843467|NCT03670810|467392011|FG006|Main Study|Non-compliance with Study Drug|0|||
129843468|NCT03670810|467392012|FG007|Main Study|Non-compliance with Study Drug|1|||
129843469|NCT03670810|467392013|FG008|Main Study|Non-compliance with Study Drug|0|||
129843470|NCT03670810|467392005|FG000|Main Study|Physician Decision|3|||
129843471|NCT03670810|467392006|FG001|Main Study|Physician Decision|0|||
129843472|NCT03670810|467392007|FG002|Main Study|Physician Decision|1|||
129843473|NCT03670810|467392008|FG003|Main Study|Physician Decision|0|||
129843474|NCT03670810|467392009|FG004|Main Study|Physician Decision|0|||
129843475|NCT03670810|467392010|FG005|Main Study|Physician Decision|0|||
129843476|NCT03670810|467392011|FG006|Main Study|Physician Decision|1|||
129843477|NCT03670810|467392012|FG007|Main Study|Physician Decision|1|||
129843478|NCT03670810|467392013|FG008|Main Study|Physician Decision|0|||
129843479|NCT03670810|467392005|FG000|Main Study|Pregnancy|1|||
129843480|NCT03670810|467392006|FG001|Main Study|Pregnancy|2|||
129843481|NCT03670810|467392007|FG002|Main Study|Pregnancy|0|||
129843482|NCT03670810|467392008|FG003|Main Study|Pregnancy|0|||
129843483|NCT03670810|467392009|FG004|Main Study|Pregnancy|0|||
129843484|NCT03670810|467392010|FG005|Main Study|Pregnancy|0|||
129843485|NCT03670810|467392011|FG006|Main Study|Pregnancy|0|||
129901291|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Physician Decision|0|||
129901292|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Physician Decision|1|||
130116436|NCT01806597|468387094|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130116437|NCT01806597|468387095|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
130116438|NCT01806597|468387096|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
130116439|NCT01806597|468387091|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129843486|NCT03670810|467392012|FG007|Main Study|Pregnancy|0|||
129843487|NCT03670810|467392013|FG008|Main Study|Pregnancy|0|||
129843488|NCT03670810|467392005|FG000|Main Study|Protocol Deviation|2|||
129843489|NCT03670810|467392006|FG001|Main Study|Protocol Deviation|12|||
130116440|NCT01806597|468387092|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
130116441|NCT01806597|468387093|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129843490|NCT03670810|467392007|FG002|Main Study|Protocol Deviation|8|||
129843491|NCT03670810|467392008|FG003|Main Study|Protocol Deviation|4|||
129843492|NCT03670810|467392009|FG004|Main Study|Protocol Deviation|0|||
129843493|NCT03670810|467392010|FG005|Main Study|Protocol Deviation|0|||
129843494|NCT03670810|467392011|FG006|Main Study|Protocol Deviation|0|||
129843495|NCT03670810|467392012|FG007|Main Study|Protocol Deviation|0|||
129843496|NCT03670810|467392013|FG008|Main Study|Protocol Deviation|0|||
129843497|NCT03670810|467392005|FG000|Main Study|Withdrawal by Subject|21|||
129843498|NCT03670810|467392006|FG001|Main Study|Withdrawal by Subject|21|||
129843499|NCT03670810|467392007|FG002|Main Study|Withdrawal by Subject|8|||
129843500|NCT03670810|467392008|FG003|Main Study|Withdrawal by Subject|9|||
129843501|NCT03670810|467392009|FG004|Main Study|Withdrawal by Subject|5|||
129843502|NCT03670810|467392010|FG005|Main Study|Withdrawal by Subject|2|||
129843503|NCT03670810|467392011|FG006|Main Study|Withdrawal by Subject|1|||
129843504|NCT03670810|467392012|FG007|Main Study|Withdrawal by Subject|1|||
129843505|NCT03670810|467392013|FG008|Main Study|Withdrawal by Subject|0|||
129843506|NCT03670810|467392005|FG000|Main Study|Participant did not want to take the three other treatments|1|||
129843507|NCT03670810|467392006|FG001|Main Study|Participant did not want to take the three other treatments|0|||
129843508|NCT03670810|467392007|FG002|Main Study|Participant did not want to take the three other treatments|0|||
129843509|NCT03670810|467392008|FG003|Main Study|Participant did not want to take the three other treatments|0|||
129843510|NCT03670810|467392009|FG004|Main Study|Participant did not want to take the three other treatments|0|||
129843511|NCT03670810|467392010|FG005|Main Study|Participant did not want to take the three other treatments|0|||
129843512|NCT03670810|467392011|FG006|Main Study|Participant did not want to take the three other treatments|0|||
129843513|NCT03670810|467392012|FG007|Main Study|Participant did not want to take the three other treatments|0|||
129843514|NCT03670810|467392013|FG008|Main Study|Participant did not want to take the three other treatments|0|||
129843515|NCT03670810|467392005|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843516|NCT03670810|467392006|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
129843517|NCT03670810|467392007|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843518|NCT03670810|467392008|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843519|NCT03670810|467392009|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843520|NCT03670810|467392010|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843521|NCT03670810|467392011|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843522|NCT03670810|467392012|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843523|NCT03670810|467392013|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843524|NCT03670810|467392005|FG000|Main Study|Travel and Coronavirus issues|0|||
129843525|NCT03670810|467392006|FG001|Main Study|Travel and Coronavirus issues|0|||
129843526|NCT03670810|467392007|FG002|Main Study|Travel and Coronavirus issues|0|||
129843527|NCT03670810|467392008|FG003|Main Study|Travel and Coronavirus issues|1|||
129843528|NCT03670810|467392009|FG004|Main Study|Travel and Coronavirus issues|0|||
129843529|NCT03670810|467392010|FG005|Main Study|Travel and Coronavirus issues|0|||
129843530|NCT03670810|467392011|FG006|Main Study|Travel and Coronavirus issues|0|||
129843531|NCT03670810|467392012|FG007|Main Study|Travel and Coronavirus issues|0|||
129843532|NCT03670810|467392013|FG008|Main Study|Travel and Coronavirus issues|0|||
129843533|NCT03670810|467392005|FG000|Open Label Extension|Protocol Deviation|0|||
129843534|NCT03670810|467392006|FG001|Open Label Extension|Protocol Deviation|0|||
129843535|NCT03670810|467392007|FG002|Open Label Extension|Protocol Deviation|0|||
129843536|NCT03670810|467392008|FG003|Open Label Extension|Protocol Deviation|0|||
129843537|NCT03670810|467392009|FG004|Open Label Extension|Protocol Deviation|0|||
129843538|NCT03670810|467392010|FG005|Open Label Extension|Protocol Deviation|0|||
129843539|NCT03670810|467392011|FG006|Open Label Extension|Protocol Deviation|0|||
129843540|NCT03670810|467392012|FG007|Open Label Extension|Protocol Deviation|0|||
129843541|NCT03670810|467392013|FG008|Open Label Extension|Protocol Deviation|5|||
129843542|NCT03670810|467392005|FG000|Open Label Extension|Death|0|||
129843543|NCT03670810|467392006|FG001|Open Label Extension|Death|0|||
129843544|NCT03670810|467392007|FG002|Open Label Extension|Death|0|||
130064442|NCT02658968|468190134|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
130064443|NCT02658968|468190135|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
130064444|NCT02658968|468190131|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
130064445|NCT02658968|468190132|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
130064446|NCT02658968|468190133|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
130064447|NCT02658968|468190134|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
130064448|NCT02658968|468190135|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
130064449|NCT03039738|468190141|FG000|Overall Study|Incomplete data sets|54|||
130064450|NCT03039738|468190142|FG001|Overall Study|Incomplete data sets|0|||
130064451|NCT02716194|468190146|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
130064452|NCT02716194|468190147|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
130064453|NCT02716194|468190148|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
130064454|NCT01957709|468190152|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
130064455|NCT01610076|468190153|FG000|Overall Study|Technical issue with video|0|||
130064456|NCT01610076|468190154|FG001|Overall Study|Technical issue with video|1|||
130064457|NCT01610076|468190153|FG000|Overall Study|Lost to Follow-up|3|||
130064458|NCT01610076|468190154|FG001|Overall Study|Lost to Follow-up|4|||
130116442|NCT01806597|468387094|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130064459|NCT02899377|468190157|FG000|Overall Study|Adverse Event|1|||
129843545|NCT03670810|467392008|FG003|Open Label Extension|Death|0|||
129843546|NCT03670810|467392009|FG004|Open Label Extension|Death|0|||
129843547|NCT03670810|467392010|FG005|Open Label Extension|Death|0|||
129843548|NCT03670810|467392011|FG006|Open Label Extension|Death|0|||
129843549|NCT03670810|467392012|FG007|Open Label Extension|Death|0|||
129843550|NCT03670810|467392013|FG008|Open Label Extension|Death|1|||
129843551|NCT03670810|467392005|FG000|Open Label Extension|COVID-19|0|||
129843552|NCT03670810|467392006|FG001|Open Label Extension|COVID-19|0|||
129843553|NCT03670810|467392007|FG002|Open Label Extension|COVID-19|0|||
129843554|NCT03670810|467392008|FG003|Open Label Extension|COVID-19|0|||
129843555|NCT03670810|467392009|FG004|Open Label Extension|COVID-19|0|||
129843556|NCT03670810|467392010|FG005|Open Label Extension|COVID-19|0|||
129843557|NCT03670810|467392011|FG006|Open Label Extension|COVID-19|0|||
129843558|NCT03670810|467392012|FG007|Open Label Extension|COVID-19|0|||
129843559|NCT03670810|467392013|FG008|Open Label Extension|COVID-19|1|||
129843560|NCT03670810|467392005|FG000|Open Label Extension|Lack of Efficacy|0|||
129843561|NCT03670810|467392006|FG001|Open Label Extension|Lack of Efficacy|0|||
129843562|NCT03670810|467392007|FG002|Open Label Extension|Lack of Efficacy|0|||
129843563|NCT03670810|467392008|FG003|Open Label Extension|Lack of Efficacy|0|||
129843564|NCT03670810|467392009|FG004|Open Label Extension|Lack of Efficacy|0|||
129843565|NCT03670810|467392010|FG005|Open Label Extension|Lack of Efficacy|0|||
129843566|NCT03670810|467392011|FG006|Open Label Extension|Lack of Efficacy|0|||
129843567|NCT03670810|467392012|FG007|Open Label Extension|Lack of Efficacy|0|||
129843568|NCT03670810|467392013|FG008|Open Label Extension|Lack of Efficacy|39|||
129843569|NCT03670810|467392005|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
129843570|NCT03670810|467392006|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
129843571|NCT03670810|467392007|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
129843572|NCT03670810|467392008|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
129843573|NCT03670810|467392009|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
129843574|NCT03670810|467392010|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
129843575|NCT03670810|467392011|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
129843576|NCT03670810|467392012|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
129843577|NCT03670810|467392013|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
129843578|NCT03670810|467392005|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843579|NCT03670810|467392006|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843580|NCT03670810|467392007|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843581|NCT03670810|467392008|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843582|NCT03670810|467392009|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843583|NCT03670810|467392010|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843584|NCT03670810|467392011|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843585|NCT03670810|467392012|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843586|NCT03670810|467392013|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
129843587|NCT03670810|467392005|FG000|Open Label Extension|Withdrawal by Subject|0|||
129843588|NCT03670810|467392006|FG001|Open Label Extension|Withdrawal by Subject|0|||
129843589|NCT03670810|467392007|FG002|Open Label Extension|Withdrawal by Subject|0|||
129843590|NCT03670810|467392008|FG003|Open Label Extension|Withdrawal by Subject|0|||
129843591|NCT03670810|467392009|FG004|Open Label Extension|Withdrawal by Subject|0|||
129843592|NCT03670810|467392010|FG005|Open Label Extension|Withdrawal by Subject|0|||
129843593|NCT03670810|467392011|FG006|Open Label Extension|Withdrawal by Subject|0|||
129843594|NCT03670810|467392012|FG007|Open Label Extension|Withdrawal by Subject|0|||
129843595|NCT03670810|467392013|FG008|Open Label Extension|Withdrawal by Subject|46|||
129843596|NCT03670810|467392005|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843597|NCT03670810|467392006|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843598|NCT03670810|467392007|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843599|NCT03670810|467392008|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843600|NCT03670810|467392009|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843601|NCT03670810|467392010|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843602|NCT03670810|467392011|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843603|NCT03670810|467392012|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843604|NCT03670810|467392013|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
129843605|NCT03670810|467392005|FG000|Open Label Extension|Physician Decision|0|||
129843606|NCT03670810|467392006|FG001|Open Label Extension|Physician Decision|0|||
129843607|NCT03670810|467392007|FG002|Open Label Extension|Physician Decision|0|||
129843608|NCT03670810|467392008|FG003|Open Label Extension|Physician Decision|0|||
129843609|NCT03670810|467392009|FG004|Open Label Extension|Physician Decision|0|||
129843610|NCT03670810|467392010|FG005|Open Label Extension|Physician Decision|0|||
129843611|NCT03670810|467392011|FG006|Open Label Extension|Physician Decision|0|||
129843612|NCT03670810|467392012|FG007|Open Label Extension|Physician Decision|0|||
130116443|NCT01806597|468387095|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130116444|NCT01806597|468387096|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
130116445|NCT01806597|468387091|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
130116446|NCT01806597|468387092|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
130116447|NCT01806597|468387093|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
130116448|NCT01806597|468387094|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
130116449|NCT01806597|468387095|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
130116450|NCT01806597|468387096|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
130116451|NCT01806597|468387091|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130116452|NCT01806597|468387092|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
130116453|NCT01806597|468387093|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130116454|NCT01806597|468387094|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130116455|NCT01806597|468387095|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130116456|NCT01806597|468387096|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
130116457|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
130116458|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
130116459|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
130116460|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
130116461|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
130116462|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
130116463|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
130116464|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
130116465|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
130116466|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
130116467|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
130116468|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
130116469|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
130116470|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130116471|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130116472|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130116473|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130116474|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
130116475|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
129901293|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
130116476|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
130116477|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129843613|NCT03670810|467392013|FG008|Open Label Extension|Physician Decision|2|||
129843614|NCT03670810|467392005|FG000|Open Label Extension|Non-compliance with study drug|0|||
129843615|NCT03670810|467392006|FG001|Open Label Extension|Non-compliance with study drug|0|||
129843616|NCT03670810|467392007|FG002|Open Label Extension|Non-compliance with study drug|0|||
129843617|NCT03670810|467392008|FG003|Open Label Extension|Non-compliance with study drug|0|||
129843618|NCT03670810|467392009|FG004|Open Label Extension|Non-compliance with study drug|0|||
129843619|NCT03670810|467392010|FG005|Open Label Extension|Non-compliance with study drug|0|||
129843620|NCT03670810|467392011|FG006|Open Label Extension|Non-compliance with study drug|0|||
129843621|NCT03670810|467392012|FG007|Open Label Extension|Non-compliance with study drug|0|||
129843622|NCT03670810|467392013|FG008|Open Label Extension|Non-compliance with study drug|5|||
129843623|NCT03670810|467392005|FG000|Open Label Extension|Pregnancy|0|||
129843624|NCT03670810|467392006|FG001|Open Label Extension|Pregnancy|0|||
129843625|NCT03670810|467392007|FG002|Open Label Extension|Pregnancy|0|||
129843626|NCT03670810|467392008|FG003|Open Label Extension|Pregnancy|0|||
129843627|NCT03670810|467392009|FG004|Open Label Extension|Pregnancy|0|||
129843628|NCT03670810|467392010|FG005|Open Label Extension|Pregnancy|0|||
129843629|NCT03670810|467392011|FG006|Open Label Extension|Pregnancy|0|||
129843630|NCT03670810|467392012|FG007|Open Label Extension|Pregnancy|0|||
129843631|NCT03670810|467392013|FG008|Open Label Extension|Pregnancy|3|||
129843632|NCT03670810|467392005|FG000|Open Label Extension|Adverse Event|0|||
129843633|NCT03670810|467392006|FG001|Open Label Extension|Adverse Event|0|||
129843634|NCT03670810|467392007|FG002|Open Label Extension|Adverse Event|0|||
129843635|NCT03670810|467392008|FG003|Open Label Extension|Adverse Event|0|||
129843636|NCT03670810|467392009|FG004|Open Label Extension|Adverse Event|0|||
129843637|NCT03670810|467392010|FG005|Open Label Extension|Adverse Event|0|||
129843638|NCT03670810|467392011|FG006|Open Label Extension|Adverse Event|0|||
129843639|NCT03670810|467392012|FG007|Open Label Extension|Adverse Event|0|||
129901294|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
129843640|NCT03670810|467392013|FG008|Open Label Extension|Adverse Event|24|||
129843641|NCT03670810|467392005|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
129843642|NCT03670810|467392006|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
129901295|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
129901296|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
129901297|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
129901298|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
129901299|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
129901300|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
129901301|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
129901302|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
129901303|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
129901304|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
129901305|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
129901306|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
129901307|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
129901308|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Death|1|||
129901309|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Death|0|||
129901310|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Death|0|||
129901311|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Death|0|||
129901312|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Death|0|||
129901313|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
129901314|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
129901315|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
129901316|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
129901317|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
129901318|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Physician Decision|1|||
129901319|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Physician Decision|0|||
129901320|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Physician Decision|1|||
129901321|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Physician Decision|3|||
129901322|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Physician Decision|0|||
129901323|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
129901324|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
129901325|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
129901326|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
129901327|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
129901328|NCT00608907|467598840|FG000|Overall Study|Adverse Event|6|||
129901329|NCT00608907|467598841|FG001|Overall Study|Adverse Event|0|||
129901330|NCT00608907|467598842|FG002|Overall Study|Adverse Event|1|||
129901331|NCT00608907|467598840|FG000|Overall Study|Death|1|||
129901332|NCT00608907|467598841|FG001|Overall Study|Death|0|||
129901333|NCT00608907|467598842|FG002|Overall Study|Death|0|||
129901334|NCT00608907|467598840|FG000|Overall Study|Withdrawal by Subject|4|||
129901335|NCT00608907|467598841|FG001|Overall Study|Withdrawal by Subject|0|||
129901336|NCT00608907|467598842|FG002|Overall Study|Withdrawal by Subject|0|||
129901337|NCT00608907|467598840|FG000|Overall Study|Progressive Disease|1|||
129901338|NCT00608907|467598841|FG001|Overall Study|Progressive Disease|0|||
129901339|NCT00608907|467598842|FG002|Overall Study|Progressive Disease|0|||
129901340|NCT00906035|467598846|FG000|Overall Study|Withdrawal by Subject|2|||
129901341|NCT00906035|467598847|FG001|Overall Study|Withdrawal by Subject|3|||
129901342|NCT00906035|467598848|FG002|Overall Study|Withdrawal by Subject|0|||
129901343|NCT03058991|467598851|FG000|Overall Study|Lost to Follow-up|17|||
129901344|NCT03058991|467598852|FG001|Overall Study|Lost to Follow-up|12|||
129901345|NCT03058991|467598853|FG002|Overall Study|Lost to Follow-up|12|||
129901346|NCT03058991|467598851|FG000|Overall Study|Withdrawal by Subject|1|||
129901347|NCT03058991|467598852|FG001|Overall Study|Withdrawal by Subject|0|||
129901348|NCT03058991|467598853|FG002|Overall Study|Withdrawal by Subject|0|||
129901349|NCT00130637|467598854|FG000|Overall Study|Adverse Event|2|||
129901350|NCT00130637|467598854|FG000|Overall Study|Withdrawal by Subject|1|||
129901351|NCT01460342|467598856|FG000|Overall Study|Adverse Event|5|||
129901352|NCT01460342|467598857|FG001|Overall Study|Adverse Event|4|||
129901353|NCT01460342|467598856|FG000|Overall Study|Lost to Follow-up|1|||
129901354|NCT01460342|467598857|FG001|Overall Study|Lost to Follow-up|2|||
129901355|NCT01460342|467598856|FG000|Overall Study|Protocol Violation|0|||
129901356|NCT01460342|467598857|FG001|Overall Study|Protocol Violation|1|||
129901357|NCT01460342|467598856|FG000|Overall Study|Withdrawal by Subject|3|||
129901358|NCT01460342|467598857|FG001|Overall Study|Withdrawal by Subject|4|||
129901359|NCT01460342|467598856|FG000|Overall Study|Physician Decision|1|||
129901360|NCT01460342|467598857|FG001|Overall Study|Physician Decision|3|||
129901361|NCT01460342|467598856|FG000|Overall Study|Lack of Efficacy|1|||
129901362|NCT01460342|467598857|FG001|Overall Study|Lack of Efficacy|0|||
129901363|NCT01689519|467598858|FG000|Intent to Treat|Death|157|||
129901364|NCT01689519|467598859|FG001|Intent to Treat|Death|167|||
129901365|NCT01689519|467598858|FG000|Intent to Treat|Lost to Follow-up|4|||
129901366|NCT01689519|467598859|FG001|Intent to Treat|Lost to Follow-up|8|||
129901367|NCT01689519|467598858|FG000|Intent to Treat|Other|2|||
129901368|NCT01689519|467598859|FG001|Intent to Treat|Other|4|||
129901369|NCT01689519|467598858|FG000|Intent to Treat|Physician Decision|4|||
129901370|NCT01689519|467598859|FG001|Intent to Treat|Physician Decision|1|||
129901371|NCT01689519|467598858|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
130116478|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130116479|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130116480|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
130116481|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
130116482|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130116483|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130116484|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130116485|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130116486|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
130116487|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130116488|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
129901372|NCT01689519|467598859|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
129901373|NCT01689519|467598858|FG000|Intent to Treat|Withdrawal by Subject|21|||
129901374|NCT01689519|467598859|FG001|Intent to Treat|Withdrawal by Subject|20|||
129901375|NCT01689519|467598858|FG000|Safety Population|Death|158|||
129901376|NCT01689519|467598859|FG001|Safety Population|Death|165|||
129901377|NCT01689519|467598858|FG000|Safety Population|Lost to Follow-up|4|||
129901378|NCT01689519|467598859|FG001|Safety Population|Lost to Follow-up|8|||
129901379|NCT01689519|467598858|FG000|Safety Population|Other|2|||
129901380|NCT01689519|467598859|FG001|Safety Population|Other|4|||
129901381|NCT01689519|467598858|FG000|Safety Population|Physician Decision|4|||
129901382|NCT01689519|467598859|FG001|Safety Population|Physician Decision|1|||
129901383|NCT01689519|467598858|FG000|Safety Population|Study Terminated By Sponsor|60|||
129901384|NCT01689519|467598859|FG001|Safety Population|Study Terminated By Sponsor|47|||
129901385|NCT01689519|467598858|FG000|Safety Population|Withdrawal by Subject|20|||
129901386|NCT01689519|467598859|FG001|Safety Population|Withdrawal by Subject|20|||
129901387|NCT03525119|467598863|FG000|Overall Study|Adverse Event|0|||
129901388|NCT03525119|467598864|FG001|Overall Study|Adverse Event|1|||
129901389|NCT03525119|467598865|FG002|Overall Study|Adverse Event|0|||
129901390|NCT03525119|467598863|FG000|Overall Study|Lost to Follow-up|32|||
129901391|NCT03525119|467598864|FG001|Overall Study|Lost to Follow-up|33|||
129901392|NCT03525119|467598865|FG002|Overall Study|Lost to Follow-up|37|||
129901393|NCT03525119|467598863|FG000|Overall Study|Withdrawal by Subject|5|||
129901394|NCT03525119|467598864|FG001|Overall Study|Withdrawal by Subject|4|||
129901395|NCT03525119|467598865|FG002|Overall Study|Withdrawal by Subject|2|||
129901396|NCT03525119|467598863|FG000|Overall Study|Reason not Specified|2|||
129901397|NCT03525119|467598864|FG001|Overall Study|Reason not Specified|1|||
129901398|NCT03525119|467598865|FG002|Overall Study|Reason not Specified|2|||
130116489|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130116490|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
130116491|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129843643|NCT03670810|467392007|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
129843644|NCT03670810|467392008|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
129843645|NCT03670810|467392009|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
129843646|NCT03670810|467392010|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
129843647|NCT03670810|467392011|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
129843648|NCT03670810|467392012|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
129843649|NCT03670810|467392013|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
129843650|NCT03670810|467392005|FG000|Open Label Extension|Lost to Follow-up|0|||
129843651|NCT03670810|467392006|FG001|Open Label Extension|Lost to Follow-up|0|||
129843652|NCT03670810|467392007|FG002|Open Label Extension|Lost to Follow-up|0|||
129843653|NCT03670810|467392008|FG003|Open Label Extension|Lost to Follow-up|0|||
129843654|NCT03670810|467392009|FG004|Open Label Extension|Lost to Follow-up|0|||
129843655|NCT03670810|467392010|FG005|Open Label Extension|Lost to Follow-up|0|||
129843656|NCT03670810|467392011|FG006|Open Label Extension|Lost to Follow-up|0|||
129843657|NCT03670810|467392012|FG007|Open Label Extension|Lost to Follow-up|0|||
129843658|NCT03670810|467392013|FG008|Open Label Extension|Lost to Follow-up|23|||
129843659|NCT02644967|467392015|FG000|Overall Study|Death|26|||
129843660|NCT02644967|467392015|FG000|Overall Study|Physician Decision|1|||
129843661|NCT02644967|467392015|FG000|Overall Study|Withdrawal by Subject|2|||
129843662|NCT02644967|467392015|FG000|Overall Study|Protocol Violation|1|||
129843663|NCT02644967|467392015|FG000|Overall Study|Progressive Disease|1|||
129843664|NCT02644967|467392015|FG000|Overall Study|Study Terminated by Sponsor|4|||
129843665|NCT01502644|467392016|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
129843666|NCT01502644|467392017|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
129901399|NCT03525119|467598863|FG000|Overall Study|Randomized but not Vaccinated|1|||
129901400|NCT03525119|467598864|FG001|Overall Study|Randomized but not Vaccinated|0|||
129901401|NCT03525119|467598865|FG002|Overall Study|Randomized but not Vaccinated|2|||
129901402|NCT01713530|467598866|FG000|Overall Study|Adverse Event|0|||
129901403|NCT01713530|467598867|FG001|Overall Study|Adverse Event|5|||
129843667|NCT01502644|467392018|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
129843668|NCT01502644|467392019|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
129843669|NCT01502644|467392016|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
129843670|NCT01502644|467392017|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129843671|NCT01502644|467392018|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129843672|NCT01502644|467392019|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129843673|NCT01502644|467392016|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
129843674|NCT01502644|467392017|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129843675|NCT01502644|467392018|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129843676|NCT01502644|467392019|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129843677|NCT01502644|467392016|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
129843678|NCT01502644|467392017|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
129843679|NCT01502644|467392018|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
129843680|NCT01502644|467392019|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
129843681|NCT01502644|467392016|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
129843682|NCT01502644|467392017|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
129843683|NCT01502644|467392018|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
129843684|NCT01502644|467392019|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
129843685|NCT01552226|467392020|FG000|Overall Study|Withdrawal by Subject|4|||
129843686|NCT01552226|467392021|FG001|Overall Study|Withdrawal by Subject|4|||
129843687|NCT00637195|467392022|FG000|Overall Study|Lost to Follow-up|1|||
129843688|NCT00637195|467392023|FG001|Overall Study|Lost to Follow-up|0|||
129843689|NCT00637195|467392022|FG000|Overall Study|Other|2|||
129843690|NCT00637195|467392023|FG001|Overall Study|Other|0|||
129843691|NCT00637195|467392022|FG000|Overall Study|Withdrawal by Subject|0|||
129843692|NCT00637195|467392023|FG001|Overall Study|Withdrawal by Subject|1|||
129843693|NCT02388997|467392024|FG000|Overall Study|Adverse Event|1|||
129843694|NCT02388997|467392025|FG001|Overall Study|Adverse Event|2|||
129843695|NCT02388997|467392024|FG000|Overall Study|Withdrawal by Subject|2|||
129843696|NCT02388997|467392025|FG001|Overall Study|Withdrawal by Subject|1|||
129843697|NCT02388997|467392024|FG000|Overall Study|Lung function exclusion criteria|0|||
129843698|NCT02388997|467392025|FG001|Overall Study|Lung function exclusion criteria|2|||
129843699|NCT02388997|467392024|FG000|Overall Study|Tested positive for virus during run-in|0|||
129843700|NCT02388997|467392025|FG001|Overall Study|Tested positive for virus during run-in|1|||
129843701|NCT01110915|467392026|FG000|Overall Study|Death|2|||
129843702|NCT01110915|467392027|FG001|Overall Study|Death|1|||
129843703|NCT01110915|467392026|FG000|Overall Study|Lost to Follow-up|1|||
129843704|NCT01110915|467392027|FG001|Overall Study|Lost to Follow-up|0|||
129843705|NCT01110915|467392026|FG000|Overall Study|Withdrawal by Subject|7|||
129843706|NCT01110915|467392027|FG001|Overall Study|Withdrawal by Subject|1|||
129843707|NCT00207142|467392028|FG000|Induction Phase|Adverse Event|9|||
129843708|NCT00207142|467392029|FG001|Induction Phase|Adverse Event|0|||
129843709|NCT00207142|467392030|FG002|Induction Phase|Adverse Event|0|||
129843710|NCT00207142|467392031|FG003|Induction Phase|Adverse Event|0|||
129843711|NCT00207142|467392028|FG000|Induction Phase|Death|1|||
129843712|NCT00207142|467392029|FG001|Induction Phase|Death|0|||
129843713|NCT00207142|467392030|FG002|Induction Phase|Death|0|||
129901404|NCT01713530|467598866|FG000|Overall Study|Withdrawal criteria|21|||
129843714|NCT00207142|467392031|FG003|Induction Phase|Death|0|||
129843715|NCT00207142|467392028|FG000|Induction Phase|Lack of Efficacy|1|||
129843716|NCT00207142|467392029|FG001|Induction Phase|Lack of Efficacy|0|||
129843717|NCT00207142|467392030|FG002|Induction Phase|Lack of Efficacy|0|||
129843718|NCT00207142|467392031|FG003|Induction Phase|Lack of Efficacy|0|||
129843719|NCT00207142|467392028|FG000|Induction Phase|Lost to Follow-up|5|||
129843720|NCT00207142|467392029|FG001|Induction Phase|Lost to Follow-up|0|||
129843721|NCT00207142|467392030|FG002|Induction Phase|Lost to Follow-up|0|||
129843722|NCT00207142|467392031|FG003|Induction Phase|Lost to Follow-up|0|||
129843723|NCT00207142|467392028|FG000|Induction Phase|Physician Decision|2|||
129843724|NCT00207142|467392029|FG001|Induction Phase|Physician Decision|0|||
129843725|NCT00207142|467392030|FG002|Induction Phase|Physician Decision|0|||
129843726|NCT00207142|467392031|FG003|Induction Phase|Physician Decision|0|||
129843727|NCT00207142|467392028|FG000|Induction Phase|Poor/noncompliance|2|||
129843728|NCT00207142|467392029|FG001|Induction Phase|Poor/noncompliance|0|||
129843729|NCT00207142|467392030|FG002|Induction Phase|Poor/noncompliance|0|||
129843730|NCT00207142|467392031|FG003|Induction Phase|Poor/noncompliance|0|||
129843731|NCT00207142|467392028|FG000|Induction Phase|Pregnancy|1|||
129843732|NCT00207142|467392029|FG001|Induction Phase|Pregnancy|0|||
129843733|NCT00207142|467392030|FG002|Induction Phase|Pregnancy|0|||
129843734|NCT00207142|467392031|FG003|Induction Phase|Pregnancy|0|||
129843735|NCT00207142|467392028|FG000|Induction Phase|Subject no longer meets study criteria|3|||
129843736|NCT00207142|467392029|FG001|Induction Phase|Subject no longer meets study criteria|0|||
129843737|NCT00207142|467392030|FG002|Induction Phase|Subject no longer meets study criteria|0|||
129901405|NCT01713530|467598867|FG001|Overall Study|Withdrawal criteria|12|||
129843738|NCT00207142|467392031|FG003|Induction Phase|Subject no longer meets study criteria|0|||
129843739|NCT00207142|467392028|FG000|Induction Phase|Withdrawal by Subject|4|||
129843740|NCT00207142|467392029|FG001|Induction Phase|Withdrawal by Subject|0|||
129843741|NCT00207142|467392030|FG002|Induction Phase|Withdrawal by Subject|0|||
129843742|NCT00207142|467392031|FG003|Induction Phase|Withdrawal by Subject|0|||
129843743|NCT00207142|467392028|FG000|Induction Phase|Incarceration|1|||
129843744|NCT00207142|467392029|FG001|Induction Phase|Incarceration|0|||
129843745|NCT00207142|467392030|FG002|Induction Phase|Incarceration|0|||
129843746|NCT00207142|467392031|FG003|Induction Phase|Incarceration|0|||
129843747|NCT00207142|467392028|FG000|Induction Phase|Missing lab data|1|||
129843748|NCT00207142|467392029|FG001|Induction Phase|Missing lab data|0|||
129843749|NCT00207142|467392030|FG002|Induction Phase|Missing lab data|0|||
129843750|NCT00207142|467392031|FG003|Induction Phase|Missing lab data|0|||
129843751|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
129843752|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
129843753|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
129843754|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
129843755|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
129843756|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
129843757|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
129843758|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
129843759|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
129843760|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
129843761|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
129843762|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
129843763|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
129843764|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
129843765|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
129843766|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
129843767|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
129843768|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
129843769|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
129843770|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
129843771|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
129843772|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
129843773|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
129843774|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
129843775|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
129843776|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
129843777|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
129843778|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
129843779|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Death|0|||
129843780|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Death|0|||
129843781|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Death|0|||
129843782|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Death|1|||
129843783|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
129843784|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
129843785|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
129843786|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
129843787|NCT02375672|467392032|FG000|Overall Study|remain on follow up|20|||
129843788|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843789|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
129843790|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
129843791|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
129843792|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843793|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843794|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843795|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843796|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843797|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843798|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843799|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843800|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843801|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843802|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843803|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843804|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843805|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843806|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
130116492|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
130116493|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
130116494|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
130116495|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
130116496|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
130116497|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
130116498|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
130116499|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
130116500|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
130116501|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
130116502|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
130116503|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
130116504|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
130116505|NCT01806597|468387091|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
130116506|NCT01806597|468387092|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130116507|NCT01806597|468387093|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130116508|NCT01806597|468387094|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130116509|NCT01806597|468387095|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130116510|NCT01806597|468387096|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
130116511|NCT01806597|468387091|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130116512|NCT01806597|468387092|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130116513|NCT01806597|468387093|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130116514|NCT01806597|468387094|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130116515|NCT01806597|468387095|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
130116516|NCT01806597|468387096|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
130116517|NCT01806597|468387091|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130116518|NCT01806597|468387092|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130116519|NCT01806597|468387093|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130116520|NCT01806597|468387094|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130116521|NCT01806597|468387095|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
130116522|NCT01806597|468387096|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
130116523|NCT01806597|468387091|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130116524|NCT01806597|468387092|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130116525|NCT01806597|468387093|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130116526|NCT01806597|468387094|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130116527|NCT01806597|468387095|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
130116528|NCT01806597|468387096|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
130116529|NCT01806597|468387091|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130116530|NCT01806597|468387092|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130116531|NCT01806597|468387093|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130116532|NCT01806597|468387094|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130116533|NCT01806597|468387095|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
130116534|NCT01806597|468387096|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
129843807|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843808|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843809|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843810|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843811|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843812|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843813|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
129843814|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843815|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129901406|NCT01713530|467598866|FG000|Overall Study|Unclassified|4|||
129901407|NCT01713530|467598867|FG001|Overall Study|Unclassified|2|||
129901408|NCT01186848|467598868|FG000|Overall Study|Lost to Follow-up|4|||
129901409|NCT01186848|467598868|FG000|Overall Study|Withdrawal by Subject|2|||
130116535|NCT01806597|468387091|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130116536|NCT01806597|468387092|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130116537|NCT01806597|468387093|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129901410|NCT01186848|467598868|FG000|Overall Study|Adverse Event|2|||
129901411|NCT02148133|467598881|FG000|Overall Study|Investigator discretion|1|||
130116538|NCT01806597|468387094|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129843816|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843817|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843818|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843819|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843820|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843821|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843822|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843823|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843824|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843825|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843826|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843827|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843828|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843829|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843830|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843831|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843832|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843833|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843834|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843835|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843836|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843837|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
129843838|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843839|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843840|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843841|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843842|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843843|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843844|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843845|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843846|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843847|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843848|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843849|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843850|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843851|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843852|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843853|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843854|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843855|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843856|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843857|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843858|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843859|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843860|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
129843861|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
129843862|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
129843863|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
129843864|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843865|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843866|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
130064460|NCT02899377|468190158|FG001|Overall Study|Adverse Event|0|||
130064461|NCT00469209|468190160|FG000|Overall Study|Adverse Event|1|||
130064462|NCT00469209|468190161|FG001|Overall Study|Adverse Event|0|||
130064463|NCT00469209|468190162|FG002|Overall Study|Adverse Event|1|||
130064464|NCT00865189|468190163|FG000|Overall Study|Other|1|||
130064465|NCT00865189|468190164|FG001|Overall Study|Other|2|||
130064466|NCT00865189|468190163|FG000|Overall Study|Death|4|||
129843867|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843868|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843869|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843870|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843871|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843872|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843873|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843874|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843875|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843876|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843877|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843878|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843879|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843880|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843881|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843882|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843883|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843884|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
130064467|NCT00865189|468190164|FG001|Overall Study|Death|11|||
130064468|NCT00865189|468190163|FG000|Overall Study|Lost to Follow-up|6|||
130064469|NCT00865189|468190164|FG001|Overall Study|Lost to Follow-up|6|||
130064470|NCT00865189|468190163|FG000|Overall Study|Withdrawal by Subject|1|||
130064471|NCT00865189|468190164|FG001|Overall Study|Withdrawal by Subject|0|||
130064472|NCT00418379|468190173|FG000|Year 1|Adverse Event|9|||
130064473|NCT00418379|468190174|FG001|Year 1|Adverse Event|15|||
130064474|NCT00418379|468190175|FG002|Year 1|Adverse Event|3|||
130064475|NCT00418379|468190173|FG000|Year 1|Withdrawal by Subject|7|||
130064476|NCT00418379|468190174|FG001|Year 1|Withdrawal by Subject|8|||
130064477|NCT00418379|468190175|FG002|Year 1|Withdrawal by Subject|5|||
130064478|NCT00418379|468190173|FG000|Year 1|Any other reason not above-mentioned|2|||
130064479|NCT00418379|468190174|FG001|Year 1|Any other reason not above-mentioned|5|||
130064480|NCT00418379|468190175|FG002|Year 1|Any other reason not above-mentioned|7|||
130064481|NCT00418379|468190173|FG000|Year 2|Adverse Event|5|||
130064482|NCT00418379|468190174|FG001|Year 2|Adverse Event|2|||
130064483|NCT00418379|468190175|FG002|Year 2|Adverse Event|1|||
130064484|NCT00418379|468190173|FG000|Year 2|Withdrawal by Subject|1|||
130064485|NCT00418379|468190174|FG001|Year 2|Withdrawal by Subject|1|||
130064486|NCT00418379|468190175|FG002|Year 2|Withdrawal by Subject|3|||
130064487|NCT00418379|468190173|FG000|Year 2|Any other reason not above-mentioned|2|||
130064488|NCT00418379|468190174|FG001|Year 2|Any other reason not above-mentioned|1|||
130064489|NCT00418379|468190175|FG002|Year 2|Any other reason not above-mentioned|6|||
130064490|NCT00418379|468190173|FG000|Year 3|Withdrawal by Subject|1|||
130064491|NCT00418379|468190174|FG001|Year 3|Withdrawal by Subject|1|||
130064492|NCT00418379|468190175|FG002|Year 3|Withdrawal by Subject|2|||
130064493|NCT00418379|468190173|FG000|Year 3|Any other reason not above-mentioned|2|||
130064494|NCT00418379|468190174|FG001|Year 3|Any other reason not above-mentioned|1|||
130064495|NCT00418379|468190175|FG002|Year 3|Any other reason not above-mentioned|1|||
130064496|NCT00418379|468190173|FG000|Year 4|Adverse Event|0|||
130064497|NCT00418379|468190174|FG001|Year 4|Adverse Event|1|||
130064498|NCT00418379|468190175|FG002|Year 4|Adverse Event|0|||
130064499|NCT00418379|468190173|FG000|Year 4|Withdrawal by Subject|2|||
130064500|NCT00418379|468190174|FG001|Year 4|Withdrawal by Subject|3|||
130064501|NCT00418379|468190175|FG002|Year 4|Withdrawal by Subject|2|||
130064502|NCT00418379|468190173|FG000|Year 4|Any other reason not above-mentioned|1|||
130064503|NCT00418379|468190174|FG001|Year 4|Any other reason not above-mentioned|1|||
130064504|NCT00418379|468190175|FG002|Year 4|Any other reason not above-mentioned|0|||
130064505|NCT00418379|468190173|FG000|Year 5|Adverse Event|0|||
130064506|NCT00418379|468190174|FG001|Year 5|Adverse Event|1|||
130064507|NCT00418379|468190175|FG002|Year 5|Adverse Event|0|||
130064508|NCT00418379|468190173|FG000|Year 5|Any other reason not above-mentioned|2|||
130064509|NCT00418379|468190174|FG001|Year 5|Any other reason not above-mentioned|4|||
130064510|NCT00418379|468190175|FG002|Year 5|Any other reason not above-mentioned|3|||
130064511|NCT00843843|468190176|FG000|Overall Study|Physician Decision|1|||
130064512|NCT00843843|468190177|FG001|Overall Study|Physician Decision|1|||
130064513|NCT00843843|468190176|FG000|Overall Study|Protocol Violation|1|||
130064514|NCT00843843|468190177|FG001|Overall Study|Protocol Violation|1|||
130064515|NCT00830804|468190180|FG000|Overall Study|Lost to Follow-up|4|||
130064516|NCT00830804|468190180|FG000|Overall Study|Death|1|||
130064517|NCT00830804|468190180|FG000|Overall Study|Unable to get to clinic|7|||
130064518|NCT00830804|468190180|FG000|Overall Study|Consent withdrawn|2|||
130064519|NCT00830804|468190180|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
130064520|NCT03428997|468190188|FG000|Overall Study|Sponsor decision.|1|||
130064521|NCT03428997|468190188|FG000|Overall Study|Withdrawal by Subject|3|||
130064522|NCT03428997|468190188|FG000|Overall Study|Lost to Follow-up|4|||
130064523|NCT00510068|468190192|FG000|Double-blind Period|Disease progression|98|||
130064524|NCT00510068|468190193|FG001|Double-blind Period|Disease progression|169|||
130064525|NCT00510068|468190192|FG000|Double-blind Period|Final primary analysis|52|||
130064526|NCT00510068|468190193|FG001|Double-blind Period|Final primary analysis|18|||
130064527|NCT00510068|468190192|FG000|Double-blind Period|Adverse Event|37|||
130064528|NCT00510068|468190193|FG001|Double-blind Period|Adverse Event|7|||
130064529|NCT00510068|468190192|FG000|Double-blind Period|Withdrawal by Subject|8|||
130064530|NCT00510068|468190193|FG001|Double-blind Period|Withdrawal by Subject|6|||
130064531|NCT00510068|468190192|FG000|Double-blind Period|Death|4|||
130064532|NCT00510068|468190193|FG001|Double-blind Period|Death|3|||
130064533|NCT00510068|468190192|FG000|Double-blind Period|Abnormal test result (s)|1|||
129843885|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
129843886|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
129901412|NCT02148133|467598881|FG000|Overall Study|Lack of Efficacy|1|||
129901413|NCT02148133|467598881|FG000|Overall Study|Protocol deviation|1|||
129843887|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
129843888|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843889|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843890|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843891|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843892|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843893|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843894|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843895|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843896|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843897|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843898|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843899|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843900|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843901|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843902|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843903|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843904|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843905|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843906|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843907|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843908|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843909|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
129843910|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843911|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
129843912|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843913|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843914|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843915|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843916|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843917|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843918|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843919|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843920|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843921|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843922|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843923|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843924|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843925|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843926|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843927|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843928|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843929|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843930|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843931|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843932|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843933|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843934|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
129843935|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843936|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843937|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843938|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843939|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843940|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843941|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843942|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843943|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129901414|NCT02148133|467598881|FG000|Overall Study|Protocol-defined stopping criteria|2|||
129901415|NCT00079183|467598882|FG000|Overall Study|Withdrawal by Subject|4|||
129843944|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129901416|NCT00079183|467598882|FG000|Overall Study|Study medication non-compliance|2|||
129901417|NCT00079183|467598882|FG000|Overall Study|Specimen collection non-compliance|1|||
130116539|NCT01806597|468387095|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
130116540|NCT01806597|468387096|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
130116541|NCT02247479|468387100|FG000|Overall Study|Adverse Event|8|||
130116542|NCT02247479|468387101|FG001|Overall Study|Adverse Event|9|||
130116543|NCT02247479|468387102|FG002|Overall Study|Adverse Event|8|||
130116544|NCT02247479|468387100|FG000|Overall Study|Death|5|||
129843945|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843946|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843947|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843948|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843949|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843950|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843951|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843952|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843953|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843954|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843955|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843956|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843957|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843958|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843959|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843960|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843961|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843962|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843963|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129843964|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129843965|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843966|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843967|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843968|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843969|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129843970|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
129843971|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129843972|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129843973|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843974|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843975|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843976|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843977|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843978|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843979|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843980|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843981|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843982|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843983|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843984|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843985|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843986|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843987|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843988|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843989|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843990|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843991|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843992|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843993|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129843994|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843995|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
129901418|NCT00619645|467598883|FG000|Overall Study|Adverse Event|1|||
130116545|NCT02247479|468387101|FG001|Overall Study|Death|4|||
129843996|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843997|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843998|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843999|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844000|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844001|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129901419|NCT04364269|467598884|FG000|Overall Study|Adverse Event|1|||
129844002|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844003|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844004|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844005|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844006|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844007|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844008|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844009|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844010|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844011|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844012|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844013|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844014|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844015|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844016|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844017|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844018|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
129844019|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844020|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844021|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844022|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844023|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844024|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844025|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844026|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844027|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844028|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844029|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844030|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844031|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844032|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844033|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844034|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844035|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844036|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844037|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844038|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844039|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
129844040|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844041|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
129844042|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
129844043|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
129844044|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844045|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844046|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844047|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844048|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844049|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844050|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844051|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844052|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844053|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844054|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129901420|NCT04364269|467598885|FG001|Overall Study|Adverse Event|0|||
129844055|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844056|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844057|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844058|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844059|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844060|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844061|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844062|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844063|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129901421|NCT04364269|467598886|FG002|Overall Study|Adverse Event|0|||
129901422|NCT04364269|467598884|FG000|Overall Study|Withdrawal by Subject|0|||
129901423|NCT04364269|467598885|FG001|Overall Study|Withdrawal by Subject|1|||
129901424|NCT04364269|467598886|FG002|Overall Study|Withdrawal by Subject|0|||
129901425|NCT00371566|467598887|FG000|Treatment Phase|Withdrawal by Subject|0|||
129901426|NCT00371566|467598888|FG001|Treatment Phase|Withdrawal by Subject|1|||
129901427|NCT00371566|467598887|FG000|Treatment Phase|Adverse Event|0|||
129901428|NCT00371566|467598888|FG001|Treatment Phase|Adverse Event|1|||
129901429|NCT00371566|467598887|FG000|Treatment Phase|Protocol Violation|0|||
129901430|NCT00371566|467598888|FG001|Treatment Phase|Protocol Violation|1|||
129901431|NCT00371566|467598887|FG000|Chemoradiation Phase|Physician Decision|2|||
129901432|NCT00371566|467598888|FG001|Chemoradiation Phase|Physician Decision|0|||
129901433|NCT00371566|467598887|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
129844064|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844065|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
129844066|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
129844067|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
129844068|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
129844069|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844070|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844071|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844072|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844073|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844074|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844075|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844076|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844077|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844078|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844079|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844080|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844081|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844082|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
129844083|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844084|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844085|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844086|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844087|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844088|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844089|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844090|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844091|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844092|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844093|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844094|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844095|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844096|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844097|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844098|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844099|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844100|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844101|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844102|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844103|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844104|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844105|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844106|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844107|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844108|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129901434|NCT00371566|467598888|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
129901435|NCT00371566|467598887|FG000|Chemoradiation Phase|Non compliant|0|||
129901436|NCT00371566|467598888|FG001|Chemoradiation Phase|Non compliant|1|||
129901437|NCT00371566|467598887|FG000|Chemoradiation Phase|Progressive Disease|1|||
129901438|NCT00371566|467598888|FG001|Chemoradiation Phase|Progressive Disease|1|||
129901439|NCT00371566|467598887|FG000|Chemoradiation Phase|Death|2|||
129901440|NCT00371566|467598888|FG001|Chemoradiation Phase|Death|0|||
129901441|NCT00371566|467598887|FG000|Follow Up Phase|Death|0|||
129901442|NCT00371566|467598888|FG001|Follow Up Phase|Death|5|||
129901443|NCT00371566|467598887|FG000|Follow Up Phase|Disease progression|1|||
129844109|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844110|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844111|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129844112|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129901444|NCT00371566|467598888|FG001|Follow Up Phase|Disease progression|0|||
129901445|NCT00371566|467598887|FG000|Follow Up Phase|Withdrawal by Subject|0|||
129901446|NCT00371566|467598888|FG001|Follow Up Phase|Withdrawal by Subject|1|||
129901447|NCT00371566|467598887|FG000|Follow Up Phase|Physician Decision|1|||
129901448|NCT00371566|467598888|FG001|Follow Up Phase|Physician Decision|1|||
129901449|NCT00371566|467598887|FG000|Follow Up Phase|Lost to Follow-up|1|||
129901450|NCT00371566|467598888|FG001|Follow Up Phase|Lost to Follow-up|0|||
129901451|NCT00972504|467598889|FG000|Overall Study|Adverse Event|2|||
129901452|NCT00972504|467598889|FG000|Overall Study|Investigator discretion|1|||
129901453|NCT04246762|467598890|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
129901454|NCT00597519|467598891|FG000|Overall Study|Death|1|||
129901455|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
129901456|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
129901457|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
129901458|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
129901459|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
129901460|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
129901461|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
129901462|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
129901463|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
129901464|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
129901465|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
129901466|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
129901467|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Death|7|||
129901468|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Death|4|||
129901469|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
129901470|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
129901471|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
129901472|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
129901473|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
129901474|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
129901475|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
129844113|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129844114|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129844115|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844116|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844117|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844118|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844119|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844120|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844121|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844122|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844123|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844124|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844125|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129901476|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
129901477|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
129901478|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
129901479|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
129901480|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
129901481|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
129901482|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
129901483|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
129901484|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
129901485|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
129901486|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
129901487|NCT01227707|467598894|FG000|Overall Study|Adverse Event|10|||
129901488|NCT01227707|467598894|FG000|Overall Study|Progression of disease|3|||
129901489|NCT01227707|467598894|FG000|Overall Study|Withdrawal by Subject|1|||
129901490|NCT01227707|467598894|FG000|Overall Study|Patient non-compliance|3|||
129901491|NCT01227707|467598894|FG000|Overall Study|Medical decision|6|||
129901492|NCT01227707|467598894|FG000|Overall Study|Death|1|||
129901493|NCT05484726|467598897|FG000|Overall Study|Protocol Violation|3|||
129901494|NCT05484726|467598898|FG001|Overall Study|Protocol Violation|3|||
129901495|NCT05484726|467598897|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
129901496|NCT05484726|467598898|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
129901497|NCT05484726|467598897|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
129901498|NCT05484726|467598898|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
129901499|NCT05484726|467598897|FG000|Overall Study|continued need of mechanical ventilation|2|||
129901500|NCT05484726|467598898|FG001|Overall Study|continued need of mechanical ventilation|3|||
129901501|NCT05484726|467598897|FG000|Overall Study|Withdrawal by Subject|2|||
129844126|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844127|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844128|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844129|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844130|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844131|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844132|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844133|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
129844134|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844135|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844136|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844137|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844138|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844139|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844140|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844141|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844142|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844143|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844144|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844145|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844146|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844147|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844148|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844149|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844150|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844151|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844152|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844153|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844154|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844155|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844156|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844157|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844158|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
129844159|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844160|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844161|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844162|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844163|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844164|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844165|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844166|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844167|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129901502|NCT05484726|467598898|FG001|Overall Study|Withdrawal by Subject|3|||
129901503|NCT05484726|467598897|FG000|Overall Study|IVH (G III & IV)|2|||
129901504|NCT05484726|467598898|FG001|Overall Study|IVH (G III & IV)|1|||
129901505|NCT05484726|467598897|FG000|Overall Study|NEC (stage II & III)|2|||
129901506|NCT05484726|467598898|FG001|Overall Study|NEC (stage II & III)|3|||
129844168|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844169|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844170|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844171|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844172|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844173|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844174|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844175|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844176|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844177|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844178|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844179|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844180|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844181|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844182|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844183|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844184|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844185|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844186|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
129844187|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844188|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844189|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844190|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844191|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844192|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844193|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844194|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844195|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844196|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844197|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844198|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844199|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844200|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844201|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844202|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844203|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844204|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844205|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844206|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844207|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844208|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844209|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844210|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
129844211|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844212|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844213|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844214|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844215|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844216|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844217|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844218|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844219|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844220|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844221|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844222|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844223|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844224|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844225|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844226|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844227|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844228|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844229|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844230|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844231|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844232|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844233|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844234|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
129844235|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844236|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844237|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844238|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844239|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844240|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844241|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844242|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844243|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844244|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844245|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844246|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844247|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844248|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844249|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844250|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844251|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844252|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844253|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844254|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844255|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844256|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844257|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844258|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844259|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844260|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844261|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
129844262|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
129844263|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
129844264|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129844265|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
129844266|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129844267|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129844268|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844269|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844270|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844271|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844272|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844273|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844274|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844275|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844276|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844277|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844278|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844279|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844280|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844281|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844282|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844283|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844284|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844285|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844286|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
129844287|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
129844288|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844289|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
129844290|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844291|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844292|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844293|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844294|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844295|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844296|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844297|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844298|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844299|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844300|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844301|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844302|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844303|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844304|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844305|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844306|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844307|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844308|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844309|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844310|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129844311|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844312|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844313|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129844314|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844315|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844316|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844317|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844318|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844319|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844320|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844321|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844322|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844323|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844324|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844325|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844326|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844327|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844328|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844329|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844330|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844331|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844332|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844333|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844334|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844335|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844336|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844337|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
129844338|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844339|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844340|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844341|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844342|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844343|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844344|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844345|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844346|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844347|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844348|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844349|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844350|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844351|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844352|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844353|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844354|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844355|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844356|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844357|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
129844358|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
129844359|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
129844360|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844361|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129844362|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129844363|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129844364|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844365|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844366|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844367|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844368|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844369|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844370|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844371|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844372|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844373|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844374|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844375|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844376|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844377|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844378|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844379|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844380|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844381|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844382|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
129844383|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129844384|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844385|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
129844386|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129844387|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129844388|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844389|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844390|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844391|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844392|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844393|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844394|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844395|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844396|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844397|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844398|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844399|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844400|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844401|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844402|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844403|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844404|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844405|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844406|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
129844407|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844408|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844409|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
129844410|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
129844411|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
129844412|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844413|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844414|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844415|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844416|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844417|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844418|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844419|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844420|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844421|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844422|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844423|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844424|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844425|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844426|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844427|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844428|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844429|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844430|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
129844431|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844432|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844433|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844434|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844435|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844436|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844437|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844438|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
129844439|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844440|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844441|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
129844442|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844443|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
129844444|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
129844445|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
129844446|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129844447|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
129844448|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129844449|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129844450|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
129844451|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844452|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844453|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844454|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844455|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844456|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844457|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129844458|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844459|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129844460|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844461|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844462|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
129844463|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844464|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
129844465|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
129844466|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844467|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844468|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
129844469|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844470|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844471|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844472|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129901507|NCT01093534|467598901|FG000|Overall Study|Adverse Event|2|||
129901508|NCT01093534|467598902|FG001|Overall Study|Adverse Event|5|||
129901509|NCT01093534|467598903|FG002|Overall Study|Adverse Event|2|||
129844473|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844474|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844475|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844476|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
129844477|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844478|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844479|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
129844480|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844481|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
129844482|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844483|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844484|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
129844485|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
129844486|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844487|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
129844488|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
129844489|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844490|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844491|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844492|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844493|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844494|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844495|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844496|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844497|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
129844498|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844499|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844500|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844501|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844502|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
129844503|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844504|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844505|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129844506|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844507|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844508|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844509|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844510|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844511|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844512|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844513|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
129844514|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
129844515|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
129844516|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
129844517|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
129844518|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
129901510|NCT01093534|467598901|FG000|Overall Study|Lack of Efficacy|2|||
129901511|NCT01093534|467598902|FG001|Overall Study|Lack of Efficacy|1|||
129901512|NCT01093534|467598903|FG002|Overall Study|Lack of Efficacy|1|||
129901513|NCT01093534|467598901|FG000|Overall Study|Withdrawal by Subject|5|||
129901514|NCT01093534|467598902|FG001|Overall Study|Withdrawal by Subject|7|||
129901515|NCT01093534|467598903|FG002|Overall Study|Withdrawal by Subject|2|||
129901516|NCT01093534|467598901|FG000|Overall Study|Other|1|||
129844519|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
129844520|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844521|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
129844522|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844523|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844524|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844525|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
129844526|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129901517|NCT01093534|467598902|FG001|Overall Study|Other|3|||
129901518|NCT01093534|467598903|FG002|Overall Study|Other|4|||
129901519|NCT01837641|467598910|FG000|Overall Study|Sponsor decision|1|||
129901520|NCT01837641|467598911|FG001|Overall Study|Sponsor decision|0|||
129901521|NCT01837641|467598912|FG002|Overall Study|Sponsor decision|0|||
129901522|NCT01837641|467598913|FG003|Overall Study|Sponsor decision|0|||
129901523|NCT01837641|467598914|FG004|Overall Study|Sponsor decision|0|||
129901524|NCT01837641|467598915|FG005|Overall Study|Sponsor decision|1|||
129901525|NCT01837641|467598916|FG006|Overall Study|Sponsor decision|0|||
129901526|NCT01837641|467598917|FG007|Overall Study|Sponsor decision|0|||
129901527|NCT01837641|467598910|FG000|Overall Study|Adverse Event|0|||
129901528|NCT01837641|467598911|FG001|Overall Study|Adverse Event|0|||
129901529|NCT01837641|467598912|FG002|Overall Study|Adverse Event|0|||
129901530|NCT01837641|467598913|FG003|Overall Study|Adverse Event|0|||
129901531|NCT01837641|467598914|FG004|Overall Study|Adverse Event|0|||
129901532|NCT01837641|467598915|FG005|Overall Study|Adverse Event|1|||
129901533|NCT01837641|467598916|FG006|Overall Study|Adverse Event|0|||
129901534|NCT01837641|467598917|FG007|Overall Study|Adverse Event|0|||
129901535|NCT01837641|467598910|FG000|Overall Study|Withdrawal by Subject|0|||
129901536|NCT01837641|467598911|FG001|Overall Study|Withdrawal by Subject|0|||
129901537|NCT01837641|467598912|FG002|Overall Study|Withdrawal by Subject|0|||
129901538|NCT01837641|467598913|FG003|Overall Study|Withdrawal by Subject|0|||
129901539|NCT01837641|467598914|FG004|Overall Study|Withdrawal by Subject|1|||
129901540|NCT01837641|467598915|FG005|Overall Study|Withdrawal by Subject|0|||
129901541|NCT01837641|467598916|FG006|Overall Study|Withdrawal by Subject|1|||
129901542|NCT01837641|467598917|FG007|Overall Study|Withdrawal by Subject|0|||
129901543|NCT01769391|467598922|FG000|Overall Study|Death|10|||
129901544|NCT01769391|467598923|FG001|Overall Study|Death|1|||
129901545|NCT01769391|467598922|FG000|Overall Study|Adverse Event|0|||
129901546|NCT01769391|467598923|FG001|Overall Study|Adverse Event|3|||
129901547|NCT01769391|467598922|FG000|Overall Study|Progressive Disease|1|||
129901548|NCT01769391|467598923|FG001|Overall Study|Progressive Disease|2|||
129901549|NCT01769391|467598922|FG000|Overall Study|Withdrawal by Subject|4|||
129901550|NCT01769391|467598923|FG001|Overall Study|Withdrawal by Subject|3|||
129901551|NCT01769391|467598922|FG000|Overall Study|Investigator Decision|2|||
129901552|NCT01769391|467598923|FG001|Overall Study|Investigator Decision|0|||
129901553|NCT02351180|467598926|FG000|Overall Study|Withdrawal by Subject|1|||
129901554|NCT02351180|467598927|FG001|Overall Study|Withdrawal by Subject|0|||
129901555|NCT01123083|467598928|FG000|Overall Study|Investigator recommendation|1|||
130116546|NCT02247479|468387102|FG002|Overall Study|Death|6|||
130116547|NCT02247479|468387100|FG000|Overall Study|Lost to Follow-up|3|||
130116548|NCT02247479|468387101|FG001|Overall Study|Lost to Follow-up|3|||
129844527|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
129844528|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844529|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844530|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844531|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844532|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844533|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844534|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844535|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129844536|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129844537|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844538|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844539|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129844540|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844541|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
129844542|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844543|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844544|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844545|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844546|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844547|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844548|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
129901556|NCT01123083|467598929|FG001|Overall Study|Investigator recommendation|1|||
129901557|NCT01123083|467598928|FG000|Overall Study|Administrative reasons|0|||
129901558|NCT01123083|467598929|FG001|Overall Study|Administrative reasons|4|||
129901559|NCT01123083|467598928|FG000|Overall Study|Lost to Follow-up|2|||
129901560|NCT01123083|467598929|FG001|Overall Study|Lost to Follow-up|6|||
129901561|NCT01123083|467598928|FG000|Overall Study|Adverse Event|1|||
129901562|NCT01123083|467598929|FG001|Overall Study|Adverse Event|0|||
129901563|NCT01123083|467598928|FG000|Overall Study|Withdrew for another reason not covered|0|||
130116549|NCT02247479|468387102|FG002|Overall Study|Lost to Follow-up|1|||
130116550|NCT02247479|468387100|FG000|Overall Study|Non-compliance|0|||
130116551|NCT02247479|468387101|FG001|Overall Study|Non-compliance|0|||
129844549|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844550|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844551|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844552|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844553|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844554|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
129844555|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
129844556|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844557|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844558|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844559|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844560|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
129844561|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844562|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844563|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
129844564|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844565|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844566|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844567|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844568|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844569|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844570|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
129844571|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844572|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844573|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844574|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844575|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844576|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844577|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844578|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844579|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844580|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844581|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129844582|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129844583|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844584|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844585|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844586|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844587|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844588|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844589|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844590|NCT01573624|467392058|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
129844591|NCT01573624|467392059|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129844592|NCT01573624|467392060|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129844593|NCT01573624|467392061|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129844594|NCT01573624|467392062|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
129844595|NCT01573624|467392063|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
129844596|NCT01573624|467392064|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
129844597|NCT01573624|467392058|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844598|NCT01573624|467392059|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
129844599|NCT01573624|467392060|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844600|NCT01573624|467392061|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844601|NCT01573624|467392062|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844602|NCT01573624|467392063|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
129844603|NCT01573624|467392064|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844604|NCT01573624|467392058|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
129844605|NCT01573624|467392059|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844606|NCT01573624|467392060|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844607|NCT01573624|467392061|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844608|NCT01573624|467392062|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844609|NCT01573624|467392063|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844610|NCT01573624|467392064|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129901564|NCT01123083|467598929|FG001|Overall Study|Withdrew for another reason not covered|1|||
129901565|NCT01123083|467598928|FG000|Overall Study|Participant/legal representative request|7|||
129901566|NCT01123083|467598929|FG001|Overall Study|Participant/legal representative request|3|||
129901567|NCT01751724|467598930|FG000|Overall Study|extubated bef.start assigned treatment|1|||
129901568|NCT01751724|467598931|FG001|Overall Study|extubated bef.start assigned treatment|0|||
129901569|NCT01751724|467598930|FG000|Overall Study|withdrawn by parent|0|||
129901570|NCT01751724|467598931|FG001|Overall Study|withdrawn by parent|2|||
129901571|NCT00605033|467598932|FG000|Overall Study|Adverse Event|2|||
129901572|NCT00605033|467598933|FG001|Overall Study|Adverse Event|2|||
129901573|NCT00605033|467598932|FG000|Overall Study|Lost to Follow-up|1|||
129901574|NCT00605033|467598933|FG001|Overall Study|Lost to Follow-up|1|||
129901575|NCT00605033|467598932|FG000|Overall Study|Withdrawal by Subject|3|||
129901576|NCT00605033|467598933|FG001|Overall Study|Withdrawal by Subject|4|||
129901577|NCT00605033|467598932|FG000|Overall Study|Protocol Violation|1|||
129901578|NCT00605033|467598933|FG001|Overall Study|Protocol Violation|1|||
129901579|NCT03121950|467598935|FG000|Overall Study|Withdrawal by Subject|11|||
129901580|NCT03121950|467598936|FG001|Overall Study|Withdrawal by Subject|2|||
129901581|NCT01867580|467598937|FG000|Overall Study|Withdrawal by Subject|2|||
129901582|NCT01867580|467598938|FG001|Overall Study|Withdrawal by Subject|3|||
129901583|NCT01867580|467598937|FG000|Overall Study|Physician Decision|17|||
129901584|NCT01867580|467598938|FG001|Overall Study|Physician Decision|12|||
129901585|NCT01867580|467598937|FG000|Overall Study|Lost to Follow-up|3|||
129901586|NCT01867580|467598938|FG001|Overall Study|Lost to Follow-up|5|||
129901587|NCT01867580|467598937|FG000|Overall Study|Sponsor terminated study|1|||
129901588|NCT01867580|467598938|FG001|Overall Study|Sponsor terminated study|0|||
129901589|NCT01867580|467598937|FG000|Overall Study|Missed follow-up assessment|2|||
129901590|NCT01867580|467598938|FG001|Overall Study|Missed follow-up assessment|1|||
129901591|NCT01867580|467598937|FG000|Overall Study|Interruption to therapy|3|||
129901592|NCT01867580|467598938|FG001|Overall Study|Interruption to therapy|0|||
129901593|NCT01867580|467598937|FG000|Overall Study|Osteomyelitis|0|||
129901594|NCT01867580|467598938|FG001|Overall Study|Osteomyelitis|1|||
129901595|NCT01867580|467598937|FG000|Overall Study|Continuation of therapy|0|||
129901596|NCT01867580|467598938|FG001|Overall Study|Continuation of therapy|1|||
129901597|NCT01867580|467598937|FG000|Overall Study|Wound recurrence|0|||
129901598|NCT01867580|467598938|FG001|Overall Study|Wound recurrence|1|||
129901599|NCT03141788|467598939|FG000|Overall Study|Lost to Follow-up|1|||
129901600|NCT03141788|467598939|FG000|Overall Study|Protocol Violation|3|||
129901601|NCT03141788|467598939|FG000|Overall Study|Withdrawal by Subject|4|||
129901602|NCT01025843|467600519|FG000|Washout 4|Withdrawal by Subject|0|||
129901603|NCT01025843|467600520|FG001|Washout 4|Withdrawal by Subject|0|||
129901604|NCT01025843|467600521|FG002|Washout 4|Withdrawal by Subject|1|||
129901605|NCT01025843|467600522|FG003|Washout 4|Withdrawal by Subject|1|||
129901606|NCT01025843|467600523|FG004|Washout 4|Withdrawal by Subject|0|||
129901607|NCT01025843|467600524|FG005|Washout 4|Withdrawal by Subject|0|||
129901608|NCT01025843|467600525|FG006|Washout 4|Withdrawal by Subject|0|||
129901609|NCT01025843|467600526|FG007|Washout 4|Withdrawal by Subject|0|||
129901610|NCT01025843|467600527|FG008|Washout 4|Withdrawal by Subject|0|||
129901611|NCT01025843|467600528|FG009|Washout 4|Withdrawal by Subject|0|||
129901612|NCT01897233|467600531|FG000|Part B (24 Weeks)|Adverse Event|1|||
129901613|NCT01897233|467600531|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
129901614|NCT01897233|467600531|FG000|Part B (24 Weeks)|Physician Decision|1|||
129901615|NCT01281813|467600540|FG000|Overall Study|Adverse Event|0|||
129901616|NCT01281813|467600541|FG001|Overall Study|Adverse Event|0|||
129901617|NCT01281813|467600542|FG002|Overall Study|Adverse Event|10|||
129901618|NCT01281813|467600540|FG000|Overall Study|Lost to Follow-up|0|||
129901619|NCT01281813|467600541|FG001|Overall Study|Lost to Follow-up|0|||
129901620|NCT01281813|467600542|FG002|Overall Study|Lost to Follow-up|31|||
129901621|NCT01281813|467600540|FG000|Overall Study|Withdrawal by Subject|0|||
129901622|NCT01281813|467600541|FG001|Overall Study|Withdrawal by Subject|0|||
129901623|NCT01281813|467600542|FG002|Overall Study|Withdrawal by Subject|13|||
129901624|NCT01281813|467600540|FG000|Overall Study|Subject Non-Compliant|0|||
129901625|NCT01281813|467600541|FG001|Overall Study|Subject Non-Compliant|0|||
129901626|NCT01281813|467600542|FG002|Overall Study|Subject Non-Compliant|6|||
129901627|NCT01281813|467600540|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
129901628|NCT01281813|467600541|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
129901629|NCT01281813|467600542|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
129901630|NCT01281813|467600540|FG000|Overall Study|Sponsor's Decision|4|||
129901631|NCT01281813|467600541|FG001|Overall Study|Sponsor's Decision|3|||
129901632|NCT01281813|467600542|FG002|Overall Study|Sponsor's Decision|7|||
129901633|NCT01281813|467600540|FG000|Overall Study|Switched to Commercially Available Medication|0|||
130116552|NCT02247479|468387102|FG002|Overall Study|Non-compliance|1|||
129901634|NCT01281813|467600541|FG001|Overall Study|Switched to Commercially Available Medication|0|||
129901635|NCT01281813|467600542|FG002|Overall Study|Switched to Commercially Available Medication|26|||
129901636|NCT01281813|467600540|FG000|Overall Study|Other|0|||
129901637|NCT01281813|467600541|FG001|Overall Study|Other|1|||
129901638|NCT01281813|467600542|FG002|Overall Study|Other|39|||
129901639|NCT03546907|467600543|FG000|Overall Study|Lack of Efficacy|1|||
129844611|NCT01573624|467392058|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844612|NCT01573624|467392059|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844613|NCT01573624|467392060|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844614|NCT01573624|467392061|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844615|NCT01573624|467392062|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
129844616|NCT01573624|467392063|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
129844617|NCT01573624|467392064|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844618|NCT01573624|467392058|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
129844619|NCT01573624|467392059|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844620|NCT01573624|467392060|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844621|NCT01573624|467392061|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844622|NCT01573624|467392062|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844623|NCT01573624|467392063|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844624|NCT01573624|467392064|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844625|NCT03306264|467392065|FG000|Overall Study|Death|33|||
129844626|NCT03306264|467392066|FG001|Overall Study|Death|25|||
129844627|NCT03306264|467392067|FG002|Overall Study|Death|34|||
129844628|NCT03306264|467392068|FG003|Overall Study|Death|34|||
129901640|NCT03546907|467600544|FG001|Overall Study|Lack of Efficacy|1|||
129901641|NCT03546907|467600543|FG000|Overall Study|Withdrawal by Subject|8|||
129901642|NCT03546907|467600544|FG001|Overall Study|Withdrawal by Subject|9|||
129901643|NCT03546907|467600543|FG000|Overall Study|Adverse events (AEs)|7|||
129901644|NCT03546907|467600544|FG001|Overall Study|Adverse events (AEs)|10|||
129901645|NCT03546907|467600543|FG000|Overall Study|Other-unspecified|1|||
129901646|NCT03546907|467600544|FG001|Overall Study|Other-unspecified|1|||
129901647|NCT02810080|467600551|FG000|Overall Study|Adverse Event|3|||
129901648|NCT02810080|467600552|FG001|Overall Study|Adverse Event|0|||
129901649|NCT02810080|467600551|FG000|Overall Study|Death|0|||
129901650|NCT02810080|467600552|FG001|Overall Study|Death|2|||
129901651|NCT02810080|467600551|FG000|Overall Study|Physician Decision|4|||
129901652|NCT02810080|467600552|FG001|Overall Study|Physician Decision|0|||
129901653|NCT02810080|467600551|FG000|Overall Study|Withdrawal by Subject|0|||
129901654|NCT02810080|467600552|FG001|Overall Study|Withdrawal by Subject|2|||
129901655|NCT03808883|467600556|FG000|Overall Study|Withdrawal by Subject|2|||
129901656|NCT03808883|467600557|FG001|Overall Study|Withdrawal by Subject|0|||
129901657|NCT03808883|467600556|FG000|Overall Study|Did not complete pre test or post test survey|4|||
129901658|NCT03808883|467600557|FG001|Overall Study|Did not complete pre test or post test survey|3|||
129901659|NCT00158054|467600559|FG000|Overall Study|Refused to continue|3|||
129901660|NCT00158054|467600560|FG001|Overall Study|Refused to continue|0|||
129901661|NCT00158054|467600559|FG000|Overall Study|Unavailable for follow up|7|||
129901662|NCT00158054|467600560|FG001|Overall Study|Unavailable for follow up|3|||
129901663|NCT00855465|467600563|FG000|Treatment Period|Adverse Event|4|||
129901664|NCT00855465|467600564|FG001|Treatment Period|Adverse Event|2|||
129901665|NCT00855465|467600563|FG000|Treatment Period|Death|2|||
129901666|NCT00855465|467600564|FG001|Treatment Period|Death|2|||
129901667|NCT00855465|467600563|FG000|Treatment Period|Lack of Efficacy|2|||
129901668|NCT00855465|467600564|FG001|Treatment Period|Lack of Efficacy|1|||
129901669|NCT00855465|467600563|FG000|Treatment Period|Non-compliance|1|||
129901670|NCT00855465|467600564|FG001|Treatment Period|Non-compliance|0|||
129901671|NCT00855465|467600563|FG000|Treatment Period|Protocol Violation|2|||
129901672|NCT00855465|467600564|FG001|Treatment Period|Protocol Violation|0|||
129901673|NCT00855465|467600563|FG000|Treatment Period|Withdrawal by Subject|2|||
129901674|NCT00855465|467600564|FG001|Treatment Period|Withdrawal by Subject|0|||
129901675|NCT00855465|467600563|FG000|Treatment Period|Not treated|1|||
129901676|NCT00855465|467600564|FG001|Treatment Period|Not treated|0|||
129901677|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Adverse Event|0|||
129901678|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Adverse Event|1|||
129901679|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Death|0|||
129901680|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Death|1|||
129901681|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
129901682|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
129901683|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
129844629|NCT03306264|467392065|FG000|Overall Study|Complete Consent Withdrawal|4|||
129901684|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
129901685|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Missing|1|||
129901686|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Missing|0|||
129901687|NCT04567888|467600578|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
129901688|NCT04567888|467600579|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
129901689|NCT04567888|467600578|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
129901690|NCT04567888|467600579|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
129901691|NCT04567888|467600578|FG000|Overall Study|Reported Unusual Birth Year|2|||
129901692|NCT04567888|467600579|FG001|Overall Study|Reported Unusual Birth Year|3|||
129901693|NCT04567888|467600578|FG000|Overall Study|Duplicate Responses|0|||
129901694|NCT04567888|467600579|FG001|Overall Study|Duplicate Responses|1|||
129901695|NCT02371746|467600580|FG000|Overall Study|Consent withdrawn|0|||
129901696|NCT02371746|467600581|FG001|Overall Study|Consent withdrawn|0|||
129844630|NCT03306264|467392066|FG001|Overall Study|Complete Consent Withdrawal|4|||
129844631|NCT03306264|467392067|FG002|Overall Study|Complete Consent Withdrawal|1|||
129844632|NCT03306264|467392068|FG003|Overall Study|Complete Consent Withdrawal|8|||
129844633|NCT03306264|467392065|FG000|Overall Study|Lost to Follow-up|1|||
129844634|NCT03306264|467392066|FG001|Overall Study|Lost to Follow-up|0|||
129844635|NCT03306264|467392067|FG002|Overall Study|Lost to Follow-up|1|||
129844636|NCT03306264|467392068|FG003|Overall Study|Lost to Follow-up|0|||
129844637|NCT03306264|467392065|FG000|Overall Study|Rollover to ASTX727-06|10|||
129844638|NCT03306264|467392066|FG001|Overall Study|Rollover to ASTX727-06|18|||
129844639|NCT03306264|467392067|FG002|Overall Study|Rollover to ASTX727-06|4|||
129844640|NCT03306264|467392068|FG003|Overall Study|Rollover to ASTX727-06|2|||
129844641|NCT03306264|467392065|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
129844642|NCT03306264|467392066|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
129844643|NCT03306264|467392067|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
129844644|NCT03306264|467392068|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
129844645|NCT02257736|467392072|FG000|Overall Study|Progressive disease|365|||
129844646|NCT02257736|467392073|FG001|Overall Study|Progressive disease|327|||
129844647|NCT02257736|467392072|FG000|Overall Study|Adverse Event|45|||
129844648|NCT02257736|467392073|FG001|Overall Study|Adverse Event|56|||
129844649|NCT02257736|467392072|FG000|Overall Study|Withdrawal by Subject|21|||
129844650|NCT02257736|467392073|FG001|Overall Study|Withdrawal by Subject|38|||
129844651|NCT02257736|467392072|FG000|Overall Study|Death|11|||
129844652|NCT02257736|467392073|FG001|Overall Study|Death|6|||
129844653|NCT02257736|467392072|FG000|Overall Study|Physician Decision|5|||
129844654|NCT02257736|467392073|FG001|Overall Study|Physician Decision|9|||
129844655|NCT02257736|467392072|FG000|Overall Study|Non-Compliance with study drug|1|||
129844656|NCT02257736|467392073|FG001|Overall Study|Non-Compliance with study drug|2|||
129844657|NCT02257736|467392072|FG000|Overall Study|Protocol Violation|1|||
129844658|NCT02257736|467392073|FG001|Overall Study|Protocol Violation|0|||
129844659|NCT02257736|467392072|FG000|Overall Study|Other|1|||
129844660|NCT02257736|467392073|FG001|Overall Study|Other|7|||
129844661|NCT02257736|467392072|FG000|Overall Study|Randomized, not treated|1|||
129844662|NCT02257736|467392073|FG001|Overall Study|Randomized, not treated|2|||
129844663|NCT00308711|467392076|FG000|Overall Study|Withdrawal by Subject|1|||
129844664|NCT00308711|467392077|FG001|Overall Study|Withdrawal by Subject|0|||
129844665|NCT00308711|467392078|FG002|Overall Study|Withdrawal by Subject|1|||
129844666|NCT00308711|467392076|FG000|Overall Study|Protocol Violation|0|||
129844667|NCT00308711|467392077|FG001|Overall Study|Protocol Violation|1|||
129844668|NCT00308711|467392078|FG002|Overall Study|Protocol Violation|1|||
129844669|NCT00308711|467392076|FG000|Overall Study|Lost to Follow-up|0|||
129844670|NCT00308711|467392077|FG001|Overall Study|Lost to Follow-up|1|||
129844671|NCT00308711|467392078|FG002|Overall Study|Lost to Follow-up|0|||
129844672|NCT00308711|467392076|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
129844673|NCT00308711|467392077|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
129844674|NCT00308711|467392078|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
129844675|NCT00308711|467392076|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
129844676|NCT00308711|467392077|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
129844677|NCT00308711|467392078|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
129844678|NCT02167256|467392079|FG000|Overall Study|Adverse Event|13|||
129844679|NCT02167256|467392080|FG001|Overall Study|Adverse Event|6|||
129844680|NCT02167256|467392079|FG000|Overall Study|Withdrawal by Subject|4|||
129844681|NCT02167256|467392080|FG001|Overall Study|Withdrawal by Subject|4|||
129844682|NCT02167256|467392079|FG000|Overall Study|non-compliance|3|||
129844683|NCT02167256|467392080|FG001|Overall Study|non-compliance|0|||
129844684|NCT02167256|467392079|FG000|Overall Study|Study partner unable to participate|1|||
129844685|NCT02167256|467392080|FG001|Overall Study|Study partner unable to participate|0|||
129844686|NCT01420081|467392081|FG000|Overall Study|Death|1|||
129844687|NCT01420081|467392082|FG001|Overall Study|Death|0|||
129901697|NCT02371746|467600582|FG002|Overall Study|Consent withdrawn|0|||
129901698|NCT02371746|467600583|FG003|Overall Study|Consent withdrawn|0|||
129901699|NCT02371746|467600584|FG004|Overall Study|Consent withdrawn|0|||
129901700|NCT02371746|467600585|FG005|Overall Study|Consent withdrawn|0|||
129844688|NCT01420081|467392083|FG002|Overall Study|Death|8|||
129844689|NCT01420081|467392084|FG003|Overall Study|Death|0|||
129844690|NCT01420081|467392085|FG004|Overall Study|Death|7|||
129844691|NCT01420081|467392086|FG005|Overall Study|Death|12|||
129844692|NCT01420081|467392087|FG006|Overall Study|Death|0|||
129844693|NCT01420081|467392088|FG007|Overall Study|Death|1|||
129844694|NCT01420081|467392089|FG008|Overall Study|Death|1|||
129844695|NCT01420081|467392081|FG000|Overall Study|Lost to Follow-up|0|||
129844696|NCT01420081|467392082|FG001|Overall Study|Lost to Follow-up|0|||
129844697|NCT01420081|467392083|FG002|Overall Study|Lost to Follow-up|0|||
129844698|NCT01420081|467392084|FG003|Overall Study|Lost to Follow-up|0|||
129844699|NCT01420081|467392085|FG004|Overall Study|Lost to Follow-up|1|||
129844700|NCT01420081|467392086|FG005|Overall Study|Lost to Follow-up|1|||
129844701|NCT01420081|467392087|FG006|Overall Study|Lost to Follow-up|0|||
129901701|NCT02371746|467600586|FG006|Overall Study|Consent withdrawn|1|||
129844702|NCT01420081|467392088|FG007|Overall Study|Lost to Follow-up|0|||
129844703|NCT01420081|467392089|FG008|Overall Study|Lost to Follow-up|0|||
129844704|NCT01420081|467392081|FG000|Overall Study|Study Terminated by Sponsor|2|||
129844705|NCT01420081|467392082|FG001|Overall Study|Study Terminated by Sponsor|1|||
129844706|NCT01420081|467392083|FG002|Overall Study|Study Terminated by Sponsor|1|||
129844707|NCT01420081|467392084|FG003|Overall Study|Study Terminated by Sponsor|3|||
129844708|NCT01420081|467392085|FG004|Overall Study|Study Terminated by Sponsor|11|||
129844709|NCT01420081|467392086|FG005|Overall Study|Study Terminated by Sponsor|7|||
129844710|NCT01420081|467392087|FG006|Overall Study|Study Terminated by Sponsor|3|||
129844711|NCT01420081|467392088|FG007|Overall Study|Study Terminated by Sponsor|2|||
129844712|NCT01420081|467392089|FG008|Overall Study|Study Terminated by Sponsor|2|||
129844713|NCT01420081|467392081|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
129844714|NCT01420081|467392082|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
129844715|NCT01420081|467392083|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
129844716|NCT01420081|467392084|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
129844717|NCT01420081|467392085|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
129844718|NCT01420081|467392086|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
129844719|NCT01420081|467392087|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
129844720|NCT01420081|467392088|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
129844721|NCT01420081|467392089|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
129844722|NCT01420081|467392081|FG000|Overall Study|Other Reasons|0|||
129844723|NCT01420081|467392082|FG001|Overall Study|Other Reasons|0|||
129844724|NCT01420081|467392083|FG002|Overall Study|Other Reasons|1|||
129844725|NCT01420081|467392084|FG003|Overall Study|Other Reasons|0|||
129844726|NCT01420081|467392085|FG004|Overall Study|Other Reasons|0|||
129844727|NCT01420081|467392086|FG005|Overall Study|Other Reasons|0|||
129844728|NCT01420081|467392087|FG006|Overall Study|Other Reasons|0|||
129844729|NCT01420081|467392088|FG007|Overall Study|Other Reasons|0|||
129844730|NCT01420081|467392089|FG008|Overall Study|Other Reasons|0|||
129844731|NCT03431350|467392092|FG000|Overall Study|ONGOING|0|||
129844732|NCT03431350|467392093|FG001|Overall Study|ONGOING|0|||
129844733|NCT03431350|467392094|FG002|Overall Study|ONGOING|2|||
129844734|NCT03431350|467392095|FG003|Overall Study|ONGOING|0|||
129844735|NCT03431350|467392096|FG004|Overall Study|ONGOING|1|||
129844736|NCT03431350|467392097|FG005|Overall Study|ONGOING|3|||
129844737|NCT03431350|467392098|FG006|Overall Study|ONGOING|0|||
129844738|NCT03431350|467392099|FG007|Overall Study|ONGOING|1|||
129844739|NCT03431350|467392100|FG008|Overall Study|ONGOING|3|||
129844740|NCT03431350|467392101|FG009|Overall Study|ONGOING|4|||
129844741|NCT03431350|467392102|FG010|Overall Study|ONGOING|2|||
129844742|NCT03431350|467392103|FG011|Overall Study|ONGOING|1|||
129844743|NCT03431350|467392092|FG000|Overall Study|Death|6|||
129844744|NCT03431350|467392093|FG001|Overall Study|Death|5|||
129844745|NCT03431350|467392094|FG002|Overall Study|Death|18|||
129844746|NCT03431350|467392095|FG003|Overall Study|Death|7|||
129844747|NCT03431350|467392096|FG004|Overall Study|Death|4|||
129844748|NCT03431350|467392097|FG005|Overall Study|Death|3|||
129844749|NCT03431350|467392098|FG006|Overall Study|Death|2|||
129844750|NCT03431350|467392099|FG007|Overall Study|Death|0|||
129844751|NCT03431350|467392100|FG008|Overall Study|Death|0|||
129844752|NCT03431350|467392101|FG009|Overall Study|Death|0|||
129844753|NCT03431350|467392102|FG010|Overall Study|Death|4|||
129844754|NCT03431350|467392103|FG011|Overall Study|Death|0|||
129844755|NCT03431350|467392092|FG000|Overall Study|Lost to Follow-up|0|||
129844756|NCT03431350|467392093|FG001|Overall Study|Lost to Follow-up|1|||
129844757|NCT03431350|467392094|FG002|Overall Study|Lost to Follow-up|0|||
129844758|NCT03431350|467392095|FG003|Overall Study|Lost to Follow-up|0|||
129844759|NCT03431350|467392096|FG004|Overall Study|Lost to Follow-up|0|||
129844760|NCT03431350|467392097|FG005|Overall Study|Lost to Follow-up|0|||
129844761|NCT03431350|467392098|FG006|Overall Study|Lost to Follow-up|0|||
129844762|NCT03431350|467392099|FG007|Overall Study|Lost to Follow-up|0|||
129844763|NCT03431350|467392100|FG008|Overall Study|Lost to Follow-up|0|||
129844764|NCT03431350|467392101|FG009|Overall Study|Lost to Follow-up|0|||
129844765|NCT03431350|467392102|FG010|Overall Study|Lost to Follow-up|0|||
129844766|NCT03431350|467392103|FG011|Overall Study|Lost to Follow-up|0|||
129844767|NCT03431350|467392092|FG000|Overall Study|Withdrawal by Subject|0|||
129844768|NCT03431350|467392093|FG001|Overall Study|Withdrawal by Subject|0|||
129844769|NCT03431350|467392094|FG002|Overall Study|Withdrawal by Subject|0|||
129844770|NCT03431350|467392095|FG003|Overall Study|Withdrawal by Subject|1|||
129844771|NCT03431350|467392096|FG004|Overall Study|Withdrawal by Subject|1|||
129844772|NCT03431350|467392097|FG005|Overall Study|Withdrawal by Subject|1|||
129844773|NCT03431350|467392098|FG006|Overall Study|Withdrawal by Subject|0|||
129844774|NCT03431350|467392099|FG007|Overall Study|Withdrawal by Subject|0|||
129844775|NCT03431350|467392100|FG008|Overall Study|Withdrawal by Subject|0|||
129844776|NCT03431350|467392101|FG009|Overall Study|Withdrawal by Subject|2|||
129844777|NCT03431350|467392102|FG010|Overall Study|Withdrawal by Subject|0|||
129844778|NCT03431350|467392103|FG011|Overall Study|Withdrawal by Subject|1|||
129844779|NCT03431350|467392092|FG000|Overall Study|Other|0|||
129844780|NCT03431350|467392093|FG001|Overall Study|Other|0|||
129844781|NCT03431350|467392094|FG002|Overall Study|Other|1|||
129901702|NCT00436644|467600588|FG000|Overall Study|Adverse Event|2|||
129901703|NCT00436644|467600588|FG000|Overall Study|Death|1|||
129901704|NCT01490580|467600589|FG000|Overall Study|Parents withdrew consent|0|||
129901705|NCT01490580|467600590|FG001|Overall Study|Parents withdrew consent|2|||
129901706|NCT00878722|467600591|FG000|Overall Study|Progressive disease|3|||
129901707|NCT00878722|467600592|FG001|Overall Study|Progressive disease|3|||
129901708|NCT00878722|467600593|FG002|Overall Study|Progressive disease|3|||
129901709|NCT00878722|467600594|FG003|Overall Study|Progressive disease|7|||
129901710|NCT00878722|467600595|FG004|Overall Study|Progressive disease|7|||
129901711|NCT00878722|467600596|FG005|Overall Study|Progressive disease|1|||
129901712|NCT00878722|467600597|FG006|Overall Study|Progressive disease|4|||
129901713|NCT00878722|467600598|FG007|Overall Study|Progressive disease|3|||
129901714|NCT00878722|467600591|FG000|Overall Study|Death|0|||
129901715|NCT00878722|467600592|FG001|Overall Study|Death|0|||
129901716|NCT00878722|467600593|FG002|Overall Study|Death|0|||
129901717|NCT00878722|467600594|FG003|Overall Study|Death|1|||
129901718|NCT00878722|467600595|FG004|Overall Study|Death|0|||
129901719|NCT00878722|467600596|FG005|Overall Study|Death|1|||
129901720|NCT00878722|467600597|FG006|Overall Study|Death|0|||
129901721|NCT00878722|467600598|FG007|Overall Study|Death|2|||
129901722|NCT00878722|467600591|FG000|Overall Study|Adverse Event|0|||
129901723|NCT00878722|467600592|FG001|Overall Study|Adverse Event|0|||
129901724|NCT00878722|467600593|FG002|Overall Study|Adverse Event|0|||
129901725|NCT00878722|467600594|FG003|Overall Study|Adverse Event|0|||
129901726|NCT00878722|467600595|FG004|Overall Study|Adverse Event|0|||
129901727|NCT00878722|467600596|FG005|Overall Study|Adverse Event|0|||
129901728|NCT00878722|467600597|FG006|Overall Study|Adverse Event|2|||
129901729|NCT00878722|467600598|FG007|Overall Study|Adverse Event|0|||
129901730|NCT00878722|467600591|FG000|Overall Study|Withdrawal by Subject|0|||
129901731|NCT00878722|467600592|FG001|Overall Study|Withdrawal by Subject|0|||
129901732|NCT00878722|467600593|FG002|Overall Study|Withdrawal by Subject|0|||
129901733|NCT00878722|467600594|FG003|Overall Study|Withdrawal by Subject|0|||
129901734|NCT00878722|467600595|FG004|Overall Study|Withdrawal by Subject|0|||
129901735|NCT00878722|467600596|FG005|Overall Study|Withdrawal by Subject|0|||
129901736|NCT00878722|467600597|FG006|Overall Study|Withdrawal by Subject|0|||
129901737|NCT00878722|467600598|FG007|Overall Study|Withdrawal by Subject|2|||
129901738|NCT00878722|467600591|FG000|Overall Study|Relapse|0|||
129901739|NCT00878722|467600592|FG001|Overall Study|Relapse|0|||
129901740|NCT00878722|467600593|FG002|Overall Study|Relapse|0|||
129901741|NCT00878722|467600594|FG003|Overall Study|Relapse|1|||
129901742|NCT00878722|467600595|FG004|Overall Study|Relapse|0|||
129901743|NCT00878722|467600596|FG005|Overall Study|Relapse|0|||
129901744|NCT00878722|467600597|FG006|Overall Study|Relapse|0|||
129901745|NCT00878722|467600598|FG007|Overall Study|Relapse|0|||
129901746|NCT02873754|467600599|FG000|Overall Study|Lost to Follow-up|5|||
129901747|NCT02873754|467600599|FG000|Overall Study|Couldn't complete study procedures|1|||
129901748|NCT02807493|467600604|FG000|Overall Study|Adverse Event|5|||
129901749|NCT02807493|467600605|FG001|Overall Study|Adverse Event|2|||
129901750|NCT02807493|467600604|FG000|Overall Study|Lost to Follow-up|6|||
129901751|NCT02807493|467600605|FG001|Overall Study|Lost to Follow-up|0|||
129901752|NCT02807493|467600604|FG000|Overall Study|Physician Decision|4|||
129901753|NCT02807493|467600605|FG001|Overall Study|Physician Decision|1|||
129844782|NCT03431350|467392095|FG003|Overall Study|Other|3|||
129844783|NCT03431350|467392096|FG004|Overall Study|Other|2|||
129844784|NCT03431350|467392097|FG005|Overall Study|Other|2|||
129844785|NCT03431350|467392098|FG006|Overall Study|Other|4|||
129844786|NCT03431350|467392099|FG007|Overall Study|Other|0|||
129844787|NCT03431350|467392100|FG008|Overall Study|Other|14|||
129844788|NCT03431350|467392101|FG009|Overall Study|Other|11|||
129844789|NCT03431350|467392102|FG010|Overall Study|Other|11|||
129844790|NCT03431350|467392103|FG011|Overall Study|Other|15|||
129844791|NCT00414388|467392104|FG000|Overall Study|Adverse Event|1|||
129844792|NCT03591575|467392106|FG000|Overall Study|Adverse Event|2|||
129844793|NCT03591575|467392107|FG001|Overall Study|Adverse Event|0|||
129844794|NCT03591575|467392106|FG000|Overall Study|Withdrawal by Subject|4|||
129844795|NCT03591575|467392107|FG001|Overall Study|Withdrawal by Subject|1|||
129844796|NCT00218543|467392108|FG000|Overall Study|Lost to Follow-up|8|||
129844797|NCT00218543|467392108|FG000|Overall Study|relocated|1|||
129844798|NCT00218543|467392108|FG000|Overall Study|Withdrawal by Subject|1|||
129844799|NCT00218543|467392108|FG000|Overall Study|Physician Decision|3|||
129844800|NCT00218543|467392108|FG000|Overall Study|Adverse Event|2|||
129844801|NCT01864291|467392109|FG000|Overall Study|need for revision surgery|2|||
129844802|NCT01387607|467392110|FG000|Overall Study|Adverse Event|23|||
129844803|NCT01387607|467392111|FG001|Overall Study|Adverse Event|11|||
129844804|NCT01387607|467392110|FG000|Overall Study|Lack of Efficacy|8|||
129844805|NCT01387607|467392111|FG001|Overall Study|Lack of Efficacy|6|||
129844806|NCT01387607|467392110|FG000|Overall Study|Lost to Follow-up|2|||
129844807|NCT01387607|467392111|FG001|Overall Study|Lost to Follow-up|1|||
129844808|NCT01387607|467392110|FG000|Overall Study|No longer meets eligibility criteria|0|||
129844809|NCT01387607|467392111|FG001|Overall Study|No longer meets eligibility criteria|1|||
129844810|NCT01387607|467392110|FG000|Overall Study|Protocol Violation|1|||
129844811|NCT01387607|467392111|FG001|Overall Study|Protocol Violation|5|||
129844812|NCT01387607|467392110|FG000|Overall Study|Withdrawal by Subject|13|||
129844813|NCT01387607|467392111|FG001|Overall Study|Withdrawal by Subject|14|||
129844814|NCT01387607|467392110|FG000|Overall Study|Other|1|||
129844815|NCT01387607|467392111|FG001|Overall Study|Other|1|||
129844816|NCT01387607|467392110|FG000|Overall Study|Randomized, not treated|3|||
129844817|NCT01387607|467392111|FG001|Overall Study|Randomized, not treated|6|||
129844818|NCT03080961|467392112|FG000|Overall Study|Withdrawal by Subject|3|||
129844819|NCT04602624|467392117|FG000|Overall Study|Protocol Deviation|1|||
129844820|NCT04602624|467392117|FG000|Overall Study|Withdrawal by Participant|1|||
129844821|NCT04084769|467392118|FG000|Overall Study|Protocol Violation|1|||
129844822|NCT04084769|467392119|FG001|Overall Study|Protocol Violation|3|||
129844823|NCT04084769|467392120|FG002|Overall Study|Protocol Violation|0|||
129844824|NCT04084769|467392121|FG003|Overall Study|Protocol Violation|1|||
129844825|NCT04084769|467392118|FG000|Overall Study|Withdrawal by Subject|0|||
129844826|NCT04084769|467392119|FG001|Overall Study|Withdrawal by Subject|1|||
129844827|NCT04084769|467392120|FG002|Overall Study|Withdrawal by Subject|0|||
129844828|NCT04084769|467392121|FG003|Overall Study|Withdrawal by Subject|0|||
129844829|NCT04084769|467392118|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129901754|NCT02807493|467600604|FG000|Overall Study|Protocol Violation|7|||
129844830|NCT04084769|467392119|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129844831|NCT04084769|467392120|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129844832|NCT04084769|467392121|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129844833|NCT04084769|467392118|FG000|Overall Study|Lost to Follow-up|2|||
129844834|NCT04084769|467392119|FG001|Overall Study|Lost to Follow-up|0|||
129844835|NCT04084769|467392120|FG002|Overall Study|Lost to Follow-up|0|||
129844836|NCT04084769|467392121|FG003|Overall Study|Lost to Follow-up|0|||
129844837|NCT03390504|467392122|FG000|Overall Study|Lost to Follow-up|2|||
129844838|NCT03390504|467392123|FG001|Overall Study|Lost to Follow-up|4|||
129844839|NCT03390504|467392124|FG002|Overall Study|Lost to Follow-up|0|||
129844840|NCT03390504|467392125|FG003|Overall Study|Lost to Follow-up|1|||
129844841|NCT03390504|467392122|FG000|Overall Study|Withdrawal by Subject|3|||
129844842|NCT03390504|467392123|FG001|Overall Study|Withdrawal by Subject|15|||
129844843|NCT03390504|467392124|FG002|Overall Study|Withdrawal by Subject|5|||
129844844|NCT03390504|467392125|FG003|Overall Study|Withdrawal by Subject|2|||
129901755|NCT02807493|467600605|FG001|Overall Study|Protocol Violation|0|||
129901756|NCT02807493|467600604|FG000|Overall Study|Withdrawal by Subject|17|||
129901757|NCT02807493|467600605|FG001|Overall Study|Withdrawal by Subject|10|||
129901758|NCT02807493|467600604|FG000|Overall Study|Other withdrawal|17|||
129901759|NCT02807493|467600605|FG001|Overall Study|Other withdrawal|0|||
129901760|NCT02807493|467600604|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
129901761|NCT02807493|467600605|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
129901762|NCT03612804|467600607|FG000|Overall Study|Death|0|||
129901763|NCT03612804|467600608|FG001|Overall Study|Death|7|||
129844845|NCT03390504|467392122|FG000|Overall Study|Other|1|||
129844846|NCT03390504|467392123|FG001|Overall Study|Other|2|||
129844847|NCT03390504|467392124|FG002|Overall Study|Other|2|||
129844848|NCT03390504|467392125|FG003|Overall Study|Other|6|||
129844849|NCT03665038|467392128|FG000|Overall Study|Lost to Follow-up|0|||
129844850|NCT03665038|467392129|FG001|Overall Study|Lost to Follow-up|0|||
129844851|NCT03665038|467392130|FG002|Overall Study|Lost to Follow-up|1|||
129844852|NCT04579679|467392131|FG000|Overall Study|New Antitumor Therapy|6|||
129844853|NCT04579679|467392132|FG001|Overall Study|New Antitumor Therapy|4|||
129901764|NCT03612804|467600609|FG002|Overall Study|Death|0|||
129901765|NCT03612804|467600610|FG003|Overall Study|Death|8|||
129901766|NCT03612804|467600607|FG000|Overall Study|Medication copay coverage issues|0|||
130064534|NCT00510068|468190193|FG001|Double-blind Period|Abnormal test result (s)|0|||
130064535|NCT00510068|468190192|FG000|Double-blind Period|Lost to Follow-up|1|||
129844854|NCT04579679|467392133|FG002|Overall Study|New Antitumor Therapy|7|||
129844855|NCT04579679|467392134|FG003|Overall Study|New Antitumor Therapy|0|||
129844856|NCT04579679|467392131|FG000|Overall Study|Withdrawal of Consent|1|||
129844857|NCT04579679|467392132|FG001|Overall Study|Withdrawal of Consent|1|||
129844858|NCT04579679|467392133|FG002|Overall Study|Withdrawal of Consent|2|||
129844859|NCT04579679|467392134|FG003|Overall Study|Withdrawal of Consent|4|||
129844860|NCT04579679|467392131|FG000|Overall Study|Death|2|||
129844861|NCT04579679|467392132|FG001|Overall Study|Death|2|||
129844862|NCT04579679|467392133|FG002|Overall Study|Death|2|||
129844863|NCT04579679|467392134|FG003|Overall Study|Death|0|||
129844864|NCT04579679|467392131|FG000|Overall Study|Adverse Event|0|||
129844865|NCT04579679|467392132|FG001|Overall Study|Adverse Event|4|||
129844866|NCT04579679|467392133|FG002|Overall Study|Adverse Event|0|||
129844867|NCT04579679|467392134|FG003|Overall Study|Adverse Event|0|||
129844868|NCT04579679|467392131|FG000|Overall Study|Disease Progression|9|||
129844869|NCT04579679|467392132|FG001|Overall Study|Disease Progression|13|||
129844870|NCT04579679|467392133|FG002|Overall Study|Disease Progression|7|||
129844871|NCT04579679|467392134|FG003|Overall Study|Disease Progression|0|||
129844872|NCT04579679|467392131|FG000|Overall Study|Physician Decision|0|||
130064536|NCT00510068|468190193|FG001|Double-blind Period|Lost to Follow-up|0|||
129901767|NCT03612804|467600608|FG001|Overall Study|Medication copay coverage issues|0|||
129844873|NCT04579679|467392132|FG001|Overall Study|Physician Decision|0|||
129844874|NCT04579679|467392133|FG002|Overall Study|Physician Decision|1|||
129844875|NCT04579679|467392134|FG003|Overall Study|Physician Decision|0|||
129844876|NCT04579679|467392131|FG000|Overall Study|Study Terminated by Sponsor|2|||
129844877|NCT04579679|467392132|FG001|Overall Study|Study Terminated by Sponsor|7|||
129844878|NCT04579679|467392133|FG002|Overall Study|Study Terminated by Sponsor|1|||
129844879|NCT04579679|467392134|FG003|Overall Study|Study Terminated by Sponsor|0|||
129844880|NCT04346615|467393353|FG000|Overall Study|Lost to Follow-up|0|||
129844881|NCT04346615|467393354|FG001|Overall Study|Lost to Follow-up|2|||
129844882|NCT04346615|467393353|FG000|Overall Study|Withdrawal by Subject|1|||
129844883|NCT04346615|467393354|FG001|Overall Study|Withdrawal by Subject|0|||
129844884|NCT04346615|467393353|FG000|Overall Study|Death|5|||
129844885|NCT04346615|467393354|FG001|Overall Study|Death|1|||
129844886|NCT04346615|467393353|FG000|Overall Study|Other|0|||
129844887|NCT04346615|467393354|FG001|Overall Study|Other|2|||
129844888|NCT04346615|467393353|FG000|Overall Study|Randomized not treated|1|||
129844889|NCT04346615|467393354|FG001|Overall Study|Randomized not treated|0|||
129844890|NCT04368429|467393355|FG000|Overall Study|Adverse Event|1|||
129844891|NCT04368429|467393356|FG001|Overall Study|Adverse Event|0|||
129844892|NCT02472756|467393357|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
129844893|NCT02472756|467393357|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
129844894|NCT02472756|467393357|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
129844895|NCT02472756|467393357|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
129844896|NCT02472756|467393357|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
129844897|NCT00110266|467393359|FG000|Overall Study|Adverse Event|27|||
129844898|NCT00110266|467393359|FG000|Overall Study|Abnormal laboratory value|15|||
129844899|NCT00110266|467393359|FG000|Overall Study|Withdrawal by Subject|16|||
129844900|NCT00110266|467393359|FG000|Overall Study|Death|17|||
129844901|NCT00110266|467393359|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129844902|NCT00110266|467393359|FG000|Overall Study|Participant condition no longer requires study drug|1|||
129844903|NCT02896400|467393360|FG000|1 Month Follow-up|Lost to Follow-up|7|||
129844904|NCT02896400|467393361|FG001|1 Month Follow-up|Lost to Follow-up|7|||
129844905|NCT02896400|467393362|FG002|1 Month Follow-up|Lost to Follow-up|5|||
129844906|NCT02896400|467393363|FG003|1 Month Follow-up|Lost to Follow-up|8|||
129844907|NCT02896400|467393364|FG004|1 Month Follow-up|Lost to Follow-up|9|||
129844908|NCT02896400|467393365|FG005|1 Month Follow-up|Lost to Follow-up|6|||
129844909|NCT02896400|467393366|FG006|1 Month Follow-up|Lost to Follow-up|5|||
129844910|NCT02896400|467393367|FG007|1 Month Follow-up|Lost to Follow-up|6|||
129844911|NCT02896400|467393368|FG008|1 Month Follow-up|Lost to Follow-up|4|||
129844912|NCT02896400|467393369|FG009|1 Month Follow-up|Lost to Follow-up|7|||
129844913|NCT02896400|467393370|FG010|1 Month Follow-up|Lost to Follow-up|5|||
129844914|NCT02896400|467393371|FG011|1 Month Follow-up|Lost to Follow-up|5|||
129844915|NCT02896400|467393372|FG012|1 Month Follow-up|Lost to Follow-up|3|||
129844916|NCT02896400|467393373|FG013|1 Month Follow-up|Lost to Follow-up|4|||
129844917|NCT02896400|467393374|FG014|1 Month Follow-up|Lost to Follow-up|1|||
129844918|NCT02896400|467393375|FG015|1 Month Follow-up|Lost to Follow-up|2|||
129844919|NCT02896400|467393360|FG000|1 Month Follow-up|Death|0|||
129844920|NCT02896400|467393361|FG001|1 Month Follow-up|Death|0|||
129844921|NCT02896400|467393362|FG002|1 Month Follow-up|Death|0|||
129844922|NCT02896400|467393363|FG003|1 Month Follow-up|Death|0|||
129844923|NCT02896400|467393364|FG004|1 Month Follow-up|Death|0|||
129844924|NCT02896400|467393365|FG005|1 Month Follow-up|Death|0|||
129844925|NCT02896400|467393366|FG006|1 Month Follow-up|Death|0|||
129844926|NCT02896400|467393367|FG007|1 Month Follow-up|Death|0|||
129844927|NCT02896400|467393368|FG008|1 Month Follow-up|Death|0|||
129844928|NCT02896400|467393369|FG009|1 Month Follow-up|Death|0|||
129844929|NCT02896400|467393370|FG010|1 Month Follow-up|Death|0|||
129844930|NCT02896400|467393371|FG011|1 Month Follow-up|Death|0|||
129844931|NCT02896400|467393372|FG012|1 Month Follow-up|Death|0|||
129844932|NCT02896400|467393373|FG013|1 Month Follow-up|Death|0|||
129844933|NCT02896400|467393374|FG014|1 Month Follow-up|Death|0|||
129844934|NCT02896400|467393375|FG015|1 Month Follow-up|Death|1|||
129844935|NCT02896400|467393360|FG000|3 Month Follow-up|Lost to Follow-up|6|||
129844936|NCT02896400|467393361|FG001|3 Month Follow-up|Lost to Follow-up|3|||
129844937|NCT02896400|467393362|FG002|3 Month Follow-up|Lost to Follow-up|6|||
129844938|NCT02896400|467393363|FG003|3 Month Follow-up|Lost to Follow-up|11|||
129844939|NCT02896400|467393364|FG004|3 Month Follow-up|Lost to Follow-up|12|||
129844940|NCT02896400|467393365|FG005|3 Month Follow-up|Lost to Follow-up|6|||
129844941|NCT02896400|467393366|FG006|3 Month Follow-up|Lost to Follow-up|4|||
129844942|NCT02896400|467393367|FG007|3 Month Follow-up|Lost to Follow-up|3|||
129844943|NCT02896400|467393368|FG008|3 Month Follow-up|Lost to Follow-up|6|||
129844944|NCT02896400|467393369|FG009|3 Month Follow-up|Lost to Follow-up|5|||
129844945|NCT02896400|467393370|FG010|3 Month Follow-up|Lost to Follow-up|6|||
129844946|NCT02896400|467393371|FG011|3 Month Follow-up|Lost to Follow-up|6|||
129844947|NCT02896400|467393372|FG012|3 Month Follow-up|Lost to Follow-up|3|||
129844948|NCT02896400|467393373|FG013|3 Month Follow-up|Lost to Follow-up|5|||
129844949|NCT02896400|467393374|FG014|3 Month Follow-up|Lost to Follow-up|3|||
129844950|NCT02896400|467393375|FG015|3 Month Follow-up|Lost to Follow-up|2|||
129844951|NCT02896400|467393360|FG000|3 Month Follow-up|Death|0|||
129844952|NCT02896400|467393361|FG001|3 Month Follow-up|Death|0|||
129844953|NCT02896400|467393362|FG002|3 Month Follow-up|Death|0|||
129844954|NCT02896400|467393363|FG003|3 Month Follow-up|Death|0|||
129844955|NCT02896400|467393364|FG004|3 Month Follow-up|Death|0|||
129844956|NCT02896400|467393365|FG005|3 Month Follow-up|Death|0|||
129844957|NCT02896400|467393366|FG006|3 Month Follow-up|Death|0|||
129844958|NCT02896400|467393367|FG007|3 Month Follow-up|Death|0|||
129844959|NCT02896400|467393368|FG008|3 Month Follow-up|Death|0|||
129844960|NCT02896400|467393369|FG009|3 Month Follow-up|Death|0|||
129844961|NCT02896400|467393370|FG010|3 Month Follow-up|Death|0|||
129844962|NCT02896400|467393371|FG011|3 Month Follow-up|Death|0|||
129844963|NCT02896400|467393372|FG012|3 Month Follow-up|Death|0|||
129844964|NCT02896400|467393373|FG013|3 Month Follow-up|Death|1|||
129844965|NCT02896400|467393374|FG014|3 Month Follow-up|Death|1|||
129844966|NCT02896400|467393375|FG015|3 Month Follow-up|Death|0|||
129844967|NCT02896400|467393360|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844968|NCT02896400|467393361|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844969|NCT02896400|467393362|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844970|NCT02896400|467393363|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844971|NCT02896400|467393364|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844972|NCT02896400|467393365|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844973|NCT02896400|467393366|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
129844974|NCT02896400|467393367|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
129844975|NCT02896400|467393368|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844976|NCT02896400|467393369|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844977|NCT02896400|467393370|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844978|NCT02896400|467393371|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844979|NCT02896400|467393372|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844980|NCT02896400|467393373|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844981|NCT02896400|467393374|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
129844982|NCT02896400|467393375|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844983|NCT02896400|467393360|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
129844984|NCT02896400|467393361|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844985|NCT02896400|467393362|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
129844986|NCT02896400|467393363|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
129844987|NCT02896400|467393364|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
129844988|NCT02896400|467393365|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844989|NCT02896400|467393366|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844990|NCT02896400|467393367|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
129844991|NCT02896400|467393368|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
129844992|NCT02896400|467393369|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
129844993|NCT02896400|467393370|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
129844994|NCT02896400|467393371|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
129844995|NCT02896400|467393372|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
129844996|NCT02896400|467393373|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844997|NCT02896400|467393374|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
129844998|NCT02896400|467393375|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
129844999|NCT01700179|467393377|FG000|Overall Study|Physician Decision|2|||
129845000|NCT00679341|467393378|FG000|Overall Study|Disease progression|42|||
129845001|NCT00679341|467393379|FG001|Overall Study|Disease progression|36|||
129845002|NCT00679341|467393378|FG000|Overall Study|Adverse Event|5|||
129845003|NCT00679341|467393379|FG001|Overall Study|Adverse Event|6|||
129845004|NCT00679341|467393378|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
129845005|NCT00679341|467393379|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
129845006|NCT00679341|467393378|FG000|Overall Study|Death|1|||
129845007|NCT00679341|467393379|FG001|Overall Study|Death|1|||
129845008|NCT00679341|467393378|FG000|Overall Study|Other|1|||
129845009|NCT00679341|467393379|FG001|Overall Study|Other|0|||
129845010|NCT00679341|467393378|FG000|Overall Study|Physician Decision|1|||
129845011|NCT00679341|467393379|FG001|Overall Study|Physician Decision|0|||
129845012|NCT00679341|467393378|FG000|Overall Study|Not treated|0|||
129845013|NCT00679341|467393379|FG001|Overall Study|Not treated|2|||
129845014|NCT00679341|467393378|FG000|Overall Study|Physician/patient decision to withdraw|0|||
129845015|NCT00679341|467393379|FG001|Overall Study|Physician/patient decision to withdraw|6|||
129845016|NCT00667342|467393380|FG000|Overall Study|Protocol Violation|1|||
129845017|NCT00667342|467393381|FG001|Overall Study|Protocol Violation|0|||
129845018|NCT00667342|467393382|FG002|Overall Study|Protocol Violation|0|||
129845019|NCT00667342|467393380|FG000|Overall Study|Withdrawal by Subject|1|||
129845020|NCT00667342|467393381|FG001|Overall Study|Withdrawal by Subject|0|||
129845021|NCT00667342|467393382|FG002|Overall Study|Withdrawal by Subject|0|||
129845022|NCT00667342|467393380|FG000|Overall Study|Physician Decision|3|||
129845023|NCT00667342|467393381|FG001|Overall Study|Physician Decision|0|||
129845024|NCT00667342|467393382|FG002|Overall Study|Physician Decision|0|||
129845025|NCT00667342|467393380|FG000|Overall Study|Relapse or tumor progression|9|||
129845026|NCT00667342|467393381|FG001|Overall Study|Relapse or tumor progression|0|||
129845027|NCT00667342|467393382|FG002|Overall Study|Relapse or tumor progression|7|||
129901768|NCT03612804|467600609|FG002|Overall Study|Medication copay coverage issues|0|||
129901769|NCT03612804|467600610|FG003|Overall Study|Medication copay coverage issues|17|||
129901770|NCT03612804|467600607|FG000|Overall Study|Not current smoker at time of screening|0|||
129901771|NCT03612804|467600608|FG001|Overall Study|Not current smoker at time of screening|1|||
129845028|NCT00667342|467393380|FG000|Overall Study|Adverse Event|0|||
129845029|NCT00667342|467393381|FG001|Overall Study|Adverse Event|0|||
129845030|NCT00667342|467393382|FG002|Overall Study|Adverse Event|1|||
129845031|NCT00667342|467393380|FG000|Overall Study|Ineligible|0|||
129845032|NCT00667342|467393381|FG001|Overall Study|Ineligible|0|||
129845033|NCT00667342|467393382|FG002|Overall Study|Ineligible|1|||
129845034|NCT01207778|467393383|FG000|Overall Study|Lost to Follow-up|0|||
129845035|NCT01207778|467393384|FG001|Overall Study|Lost to Follow-up|3|||
129845036|NCT01207778|467393385|FG002|Overall Study|Lost to Follow-up|3|||
129845037|NCT01440322|467393388|FG000|Overall Study|Discomfort|2|||
129845038|NCT01440322|467393389|FG001|Overall Study|Discomfort|0|||
129845039|NCT01440322|467393388|FG000|Overall Study|Biomicroscopy|1|||
129845040|NCT01440322|467393389|FG001|Overall Study|Biomicroscopy|0|||
129845041|NCT01440322|467393388|FG000|Overall Study|Symptoms and Problems|1|||
129845042|NCT01440322|467393389|FG001|Overall Study|Symptoms and Problems|0|||
129845043|NCT01440322|467393388|FG000|Overall Study|Unacceptable Subjective Vision|1|||
129845044|NCT01440322|467393389|FG001|Overall Study|Unacceptable Subjective Vision|0|||
129845045|NCT01440322|467393388|FG000|Overall Study|Other Product Related|1|||
129845046|NCT01440322|467393389|FG001|Overall Study|Other Product Related|0|||
129845047|NCT01440322|467393388|FG000|Overall Study|Unrelated Medical Problem|0|||
129845048|NCT01440322|467393389|FG001|Overall Study|Unrelated Medical Problem|1|||
129845049|NCT01440322|467393388|FG000|Overall Study|Other Non-Product Related|1|||
129845050|NCT01440322|467393389|FG001|Overall Study|Other Non-Product Related|0|||
129845051|NCT05044234|467393391|FG000|Overall Study|Lost to Follow-up|2|||
129845052|NCT05044234|467393392|FG001|Overall Study|Lost to Follow-up|1|||
129845053|NCT05044234|467393393|FG002|Overall Study|Lost to Follow-up|1|||
129845054|NCT05044234|467393394|FG003|Overall Study|Lost to Follow-up|2|||
129845055|NCT05044234|467393391|FG000|Overall Study|Withdrawal by Subject|6|||
129845056|NCT05044234|467393392|FG001|Overall Study|Withdrawal by Subject|4|||
129845057|NCT05044234|467393393|FG002|Overall Study|Withdrawal by Subject|5|||
129845058|NCT05044234|467393394|FG003|Overall Study|Withdrawal by Subject|8|||
129845059|NCT05044234|467393391|FG000|Overall Study|Study terminated by Sponsor|21|||
129845060|NCT05044234|467393392|FG001|Overall Study|Study terminated by Sponsor|21|||
129845061|NCT05044234|467393393|FG002|Overall Study|Study terminated by Sponsor|20|||
129845062|NCT05044234|467393394|FG003|Overall Study|Study terminated by Sponsor|14|||
129845063|NCT05044234|467393391|FG000|Overall Study|Other, not specified|0|||
129845064|NCT05044234|467393392|FG001|Overall Study|Other, not specified|0|||
129845065|NCT05044234|467393393|FG002|Overall Study|Other, not specified|1|||
129901772|NCT03612804|467600609|FG002|Overall Study|Not current smoker at time of screening|0|||
129901773|NCT03612804|467600610|FG003|Overall Study|Not current smoker at time of screening|3|||
129901774|NCT03612804|467600607|FG000|Overall Study|Non-veteran status|0|||
129901775|NCT03612804|467600608|FG001|Overall Study|Non-veteran status|1|||
129901776|NCT03612804|467600609|FG002|Overall Study|Non-veteran status|0|||
129901777|NCT03612804|467600610|FG003|Overall Study|Non-veteran status|0|||
129901778|NCT03612804|467600607|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
129901779|NCT03612804|467600608|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
129901780|NCT03612804|467600609|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
129901781|NCT03612804|467600610|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
129845066|NCT05044234|467393394|FG003|Overall Study|Other, not specified|2|||
129845067|NCT05044234|467393391|FG000|Overall Study|Delayed data entry|0|||
129845068|NCT05044234|467393392|FG001|Overall Study|Delayed data entry|0|||
129845069|NCT05044234|467393393|FG002|Overall Study|Delayed data entry|0|||
130064537|NCT00510068|468190192|FG000|Double-blind Period|Protocol Violation|6|||
129845070|NCT05044234|467393394|FG003|Overall Study|Delayed data entry|1|||
129845071|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Adverse Event|9|||
129845072|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Adverse Event|2|||
129845073|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
129845074|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
129845075|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
129845076|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
129845077|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Physician Decision|1|||
130064538|NCT00510068|468190193|FG001|Double-blind Period|Protocol Violation|0|||
129845078|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Physician Decision|1|||
129845079|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Pregnancy|2|||
129845080|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Pregnancy|0|||
129845081|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
129845082|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
129845083|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Technical problems|1|||
129845084|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Technical problems|0|||
129845085|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
129845086|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
129845087|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
129845088|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
129845089|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
129845090|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
129845091|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
129845092|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
129845093|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
129845094|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
129845095|NCT00279708|467393397|FG000|Overall Study|Withdrawal by Subject|2|||
129845096|NCT00279708|467393398|FG001|Overall Study|Withdrawal by Subject|3|||
129845097|NCT00279708|467393397|FG000|Overall Study|Adverse Event|1|||
129845098|NCT00279708|467393398|FG001|Overall Study|Adverse Event|1|||
129845099|NCT03354429|467393399|FG000|Overall Study|Withdrawal by Subject|8|||
129845100|NCT03354429|467393400|FG001|Overall Study|Withdrawal by Subject|7|||
129845101|NCT03354429|467393399|FG000|Overall Study|Lost to Follow-up|1|||
129845102|NCT03354429|467393400|FG001|Overall Study|Lost to Follow-up|0|||
129845103|NCT02488629|467393401|FG000|Overall Study|Lack of Efficacy|3|||
129845104|NCT02488629|467393402|FG001|Overall Study|Lack of Efficacy|1|||
129845105|NCT02488629|467393403|FG002|Overall Study|Lack of Efficacy|0|||
129845106|NCT02488629|467393404|FG003|Overall Study|Lack of Efficacy|0|||
129845107|NCT02488629|467393401|FG000|Overall Study|Withdrawal by Subject|0|||
129845108|NCT02488629|467393402|FG001|Overall Study|Withdrawal by Subject|1|||
129845109|NCT02488629|467393403|FG002|Overall Study|Withdrawal by Subject|0|||
129845110|NCT02488629|467393404|FG003|Overall Study|Withdrawal by Subject|0|||
129845111|NCT02940691|467393405|FG000|Overall Study|Lost to Follow-up|5|||
129845112|NCT02940691|467393405|FG000|Overall Study|Incarceration|1|||
129845113|NCT03912233|467393406|FG000|Overall Study|Adverse Event|1|||
129845114|NCT03912233|467393407|FG001|Overall Study|Adverse Event|0|||
129845115|NCT03912233|467393408|FG002|Overall Study|Adverse Event|0|||
129845116|NCT03912233|467393409|FG003|Overall Study|Adverse Event|0|||
129845117|NCT03912233|467393410|FG004|Overall Study|Adverse Event|0|||
129845118|NCT03912233|467393411|FG005|Overall Study|Adverse Event|0|||
129845119|NCT03912233|467393406|FG000|Overall Study|Physician Decision|1|||
129845120|NCT03912233|467393407|FG001|Overall Study|Physician Decision|0|||
129845121|NCT03912233|467393408|FG002|Overall Study|Physician Decision|0|||
129845122|NCT03912233|467393409|FG003|Overall Study|Physician Decision|0|||
129845123|NCT03912233|467393410|FG004|Overall Study|Physician Decision|0|||
129845124|NCT03912233|467393411|FG005|Overall Study|Physician Decision|0|||
129845125|NCT03912233|467393406|FG000|Overall Study|Other|0|||
129845126|NCT03912233|467393407|FG001|Overall Study|Other|0|||
129845127|NCT03912233|467393408|FG002|Overall Study|Other|0|||
129845128|NCT03912233|467393409|FG003|Overall Study|Other|0|||
129845129|NCT03912233|467393410|FG004|Overall Study|Other|7|||
129845130|NCT03912233|467393411|FG005|Overall Study|Other|12|||
129845131|NCT00654628|467393412|FG000|6-week Active Treatment Period|Adverse Event|9|||
129845132|NCT00654628|467393412|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
129845133|NCT00654628|467393412|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
129845134|NCT00654628|467393412|FG000|6-week Active Treatment Period|Out of window period|1|||
129845135|NCT00654628|467393412|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
129845136|NCT00654628|467393412|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
129845137|NCT00953329|467393417|FG000|Overall Study|Lack of Efficacy|1|||
129845138|NCT02477020|467393420|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
129845139|NCT02477020|467393421|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
129845140|NCT02477020|467393420|FG000|Overall Study|Voluntary Withdrawal|7|||
129845141|NCT02477020|467393421|FG001|Overall Study|Voluntary Withdrawal|16|||
129845142|NCT02477020|467393420|FG000|Overall Study|Reason not Specified|3|||
129845143|NCT02477020|467393421|FG001|Overall Study|Reason not Specified|1|||
129845144|NCT02477020|467393420|FG000|Overall Study|Lack of Efficacy|14|||
129845145|NCT02477020|467393421|FG001|Overall Study|Lack of Efficacy|5|||
129845146|NCT01465802|467393423|FG000|Overall Study|Study terminated by sponsor|1|||
129845147|NCT01465802|467393424|FG001|Overall Study|Study terminated by sponsor|0|||
129845148|NCT01465802|467393425|FG002|Overall Study|Study terminated by sponsor|0|||
129845149|NCT01465802|467393426|FG003|Overall Study|Study terminated by sponsor|1|||
129845150|NCT01465802|467393427|FG004|Overall Study|Study terminated by sponsor|7|||
129845151|NCT01465802|467393423|FG000|Overall Study|Withdrawal by Subject|7|||
129845152|NCT01465802|467393424|FG001|Overall Study|Withdrawal by Subject|7|||
129845153|NCT01465802|467393425|FG002|Overall Study|Withdrawal by Subject|0|||
129845154|NCT01465802|467393426|FG003|Overall Study|Withdrawal by Subject|8|||
129845155|NCT01465802|467393427|FG004|Overall Study|Withdrawal by Subject|1|||
129845156|NCT01465802|467393423|FG000|Overall Study|Lost to Follow-up|1|||
129901782|NCT03612804|467600607|FG000|Overall Study|Provider retired from VA|0|||
129901783|NCT03612804|467600608|FG001|Overall Study|Provider retired from VA|0|||
129901784|NCT03612804|467600609|FG002|Overall Study|Provider retired from VA|2|||
129901785|NCT03612804|467600610|FG003|Overall Study|Provider retired from VA|0|||
129901786|NCT03612804|467600607|FG000|Overall Study|Withdrawal by Subject|0|||
129901787|NCT03612804|467600608|FG001|Overall Study|Withdrawal by Subject|0|||
129901788|NCT03612804|467600609|FG002|Overall Study|Withdrawal by Subject|7|||
129901789|NCT03612804|467600610|FG003|Overall Study|Withdrawal by Subject|0|||
129901790|NCT03612804|467600607|FG000|Overall Study|Provider involved with study activities|1|||
129901791|NCT03612804|467600608|FG001|Overall Study|Provider involved with study activities|0|||
129901792|NCT03612804|467600609|FG002|Overall Study|Provider involved with study activities|0|||
129901793|NCT03612804|467600610|FG003|Overall Study|Provider involved with study activities|0|||
129901794|NCT00741988|467600618|FG000|Overall Study|Adverse Event|2|||
129901795|NCT00741988|467600619|FG001|Overall Study|Adverse Event|4|||
129901796|NCT00741988|467600618|FG000|Overall Study|Lack of Efficacy|2|||
129901797|NCT00741988|467600619|FG001|Overall Study|Lack of Efficacy|0|||
129901798|NCT00811057|467600620|FG000|Overall Study|Protocol Violation|5|||
129901799|NCT00811057|467600621|FG001|Overall Study|Protocol Violation|10|||
129901800|NCT00811057|467600622|FG002|Overall Study|Protocol Violation|10|||
129901801|NCT00768651|467600627|FG000|Overall Study|Withdrawal by Subject|1|||
129901802|NCT02104765|467600628|FG000|Overall Study|Lost to Follow-up|0|||
129901803|NCT02104765|467600629|FG001|Overall Study|Lost to Follow-up|0|||
129901804|NCT02104765|467600630|FG002|Overall Study|Lost to Follow-up|1|||
129901805|NCT02104765|467600631|FG003|Overall Study|Lost to Follow-up|0|||
129901806|NCT02104765|467600632|FG004|Overall Study|Lost to Follow-up|0|||
129901807|NCT02104765|467600633|FG005|Overall Study|Lost to Follow-up|0|||
129901808|NCT02104765|467600634|FG006|Overall Study|Lost to Follow-up|0|||
129901809|NCT02104765|467600628|FG000|Overall Study|Withdrawal by Subject|0|||
129901810|NCT02104765|467600629|FG001|Overall Study|Withdrawal by Subject|0|||
129901811|NCT02104765|467600630|FG002|Overall Study|Withdrawal by Subject|0|||
129901812|NCT02104765|467600631|FG003|Overall Study|Withdrawal by Subject|1|||
129901813|NCT02104765|467600632|FG004|Overall Study|Withdrawal by Subject|1|||
129901814|NCT02104765|467600633|FG005|Overall Study|Withdrawal by Subject|0|||
129901815|NCT02104765|467600634|FG006|Overall Study|Withdrawal by Subject|1|||
129901816|NCT00995709|467600639|FG000|Overall Study|Adverse Event|4|||
129901817|NCT00995709|467600640|FG001|Overall Study|Adverse Event|2|||
129901818|NCT00995709|467600641|FG002|Overall Study|Adverse Event|0|||
129901819|NCT00995709|467600639|FG000|Overall Study|Lack of Efficacy|0|||
129901820|NCT00995709|467600640|FG001|Overall Study|Lack of Efficacy|1|||
129901821|NCT00995709|467600641|FG002|Overall Study|Lack of Efficacy|4|||
129901822|NCT00995709|467600639|FG000|Overall Study|Withdrawal by Subject|0|||
129901823|NCT00995709|467600640|FG001|Overall Study|Withdrawal by Subject|4|||
129901824|NCT00995709|467600641|FG002|Overall Study|Withdrawal by Subject|1|||
129901825|NCT00995709|467600639|FG000|Overall Study|Lost to Follow-up|1|||
129901826|NCT00995709|467600640|FG001|Overall Study|Lost to Follow-up|0|||
129901827|NCT00995709|467600641|FG002|Overall Study|Lost to Follow-up|0|||
129901828|NCT00995709|467600639|FG000|Overall Study|Death|0|||
129901829|NCT00995709|467600640|FG001|Overall Study|Death|1|||
129901830|NCT00995709|467600641|FG002|Overall Study|Death|0|||
129901831|NCT00995709|467600639|FG000|Overall Study|Protocol Violation|2|||
129901832|NCT00995709|467600640|FG001|Overall Study|Protocol Violation|1|||
129901833|NCT00995709|467600641|FG002|Overall Study|Protocol Violation|0|||
129901834|NCT01697319|467600642|FG000|Primary Phase|Withdrawal by Subject|1|||
129901835|NCT01697319|467600642|FG000|Extension Phase|Terminated by Sponsor|15|||
129901836|NCT04222959|467600643|FG000|Overall Study|Lost to Follow-up|76|||
129901837|NCT04222959|467600644|FG001|Overall Study|Lost to Follow-up|28|||
129901838|NCT03008915|467600645|FG000|Treatment 1|Withdrawal by Subject|0|||
129901839|NCT03008915|467600646|FG001|Treatment 1|Withdrawal by Subject|1|||
129901840|NCT00712166|467600649|FG000|Overall Study|Noncompliance|0|||
129901841|NCT00712166|467600650|FG001|Overall Study|Noncompliance|1|||
129901842|NCT01773122|467600651|FG000|Overall Study|Due to amended age eligibility criteria|3|||
129901843|NCT01773122|467600652|FG001|Overall Study|Due to amended age eligibility criteria|1|||
129901844|NCT01773122|467600653|FG002|Overall Study|Due to amended age eligibility criteria|0|||
129901845|NCT01773122|467600654|FG003|Overall Study|Due to amended age eligibility criteria|1|||
129901846|NCT01264718|467600655|FG000|Overall Study|Lost to Follow-up|3|||
129901847|NCT01264718|467600656|FG001|Overall Study|Lost to Follow-up|2|||
129901848|NCT01264718|467600655|FG000|Overall Study|Withdrawal by Subject|9|||
129901849|NCT01264718|467600656|FG001|Overall Study|Withdrawal by Subject|15|||
129901850|NCT01264718|467600655|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
129901851|NCT01264718|467600656|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
129901852|NCT03386929|467600659|FG000|Overall Study|Death|0|||
129901853|NCT03386929|467600660|FG001|Overall Study|Death|0|||
129901854|NCT03386929|467600661|FG002|Overall Study|Death|1|||
129901855|NCT03386929|467600659|FG000|Overall Study|Withdrawal by Subject|0|||
129901856|NCT03386929|467600660|FG001|Overall Study|Withdrawal by Subject|1|||
129901857|NCT03386929|467600661|FG002|Overall Study|Withdrawal by Subject|0|||
129901858|NCT03386929|467600659|FG000|Overall Study|Physician Decision|0|||
129901859|NCT03386929|467600660|FG001|Overall Study|Physician Decision|0|||
129901860|NCT03386929|467600661|FG002|Overall Study|Physician Decision|1|||
129901861|NCT03386929|467600659|FG000|Overall Study|Progression|4|||
129901862|NCT03386929|467600660|FG001|Overall Study|Progression|4|||
129901863|NCT03386929|467600661|FG002|Overall Study|Progression|0|||
129901864|NCT03386929|467600659|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
129901865|NCT03386929|467600660|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
129901866|NCT03386929|467600661|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
129901867|NCT03386929|467600659|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
129901868|NCT03386929|467600660|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
129901869|NCT03386929|467600661|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
129901870|NCT03264456|467600668|FG000|Overall Study|Withdrawal by Subject|3|||
129901871|NCT03264456|467600668|FG000|Overall Study|Lost to Follow-up|1|||
129901872|NCT03538054|467600669|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
129901873|NCT03538054|467600669|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
129901874|NCT03538054|467600669|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
129901875|NCT03254394|467600670|FG000|Overall Study|Withdrawal by Subject|0|||
129901876|NCT03254394|467600671|FG001|Overall Study|Withdrawal by Subject|2|||
129901877|NCT00387465|467600678|FG000|Overall Study|Withdrawal by Subject|0|||
129901878|NCT00387465|467600679|FG001|Overall Study|Withdrawal by Subject|1|||
129901879|NCT00387465|467600680|FG002|Overall Study|Withdrawal by Subject|0|||
129901880|NCT03418324|467600681|FG000|Overall Study|Death|0|||
129901881|NCT03418324|467600682|FG001|Overall Study|Death|1|||
129901882|NCT03418324|467600681|FG000|Overall Study|Physician Decision|1|||
129901883|NCT03418324|467600682|FG001|Overall Study|Physician Decision|1|||
129901884|NCT04257058|467602208|FG000|Overall Study|Lost to Follow-up|31|||
129901885|NCT00661778|467602218|FG000|Overall Study|Disease Progression|23|||
129901886|NCT00661778|467602218|FG000|Overall Study|Adverse Event|18|||
129901887|NCT00661778|467602218|FG000|Overall Study|Reason not Specified|6|||
129901888|NCT00661778|467602218|FG000|Overall Study|Protocol Violation|2|||
129901889|NCT00661778|467602218|FG000|Overall Study|Withdrawal of Consent|1|||
129901890|NCT00487578|467602222|FG000|Overall Study|Adverse Event|1|||
129901891|NCT00487578|467602223|FG001|Overall Study|Adverse Event|2|||
129901892|NCT00487578|467602222|FG000|Overall Study|Lack of Efficacy|0|||
129901893|NCT00487578|467602223|FG001|Overall Study|Lack of Efficacy|1|||
129901894|NCT00487578|467602222|FG000|Overall Study|Lost to Follow-up|0|||
129901895|NCT00487578|467602223|FG001|Overall Study|Lost to Follow-up|1|||
129901896|NCT02525796|467602228|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
129901897|NCT02525796|467602229|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
129901898|NCT02525796|467602230|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
129901899|NCT02525796|467602228|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
129901900|NCT02525796|467602229|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
129901901|NCT02525796|467602230|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
129901902|NCT02525796|467602228|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
129901903|NCT02525796|467602229|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
129901904|NCT02525796|467602230|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
129901905|NCT02525796|467602228|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
129901906|NCT02525796|467602229|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
129901907|NCT02525796|467602230|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
129901908|NCT02525796|467602228|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
129901909|NCT02525796|467602229|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
129901910|NCT02525796|467602230|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
129901911|NCT01499134|467602231|FG000|Overall Study|Withdrawal by Subject|0|||
129901912|NCT01499134|467602232|FG001|Overall Study|Withdrawal by Subject|1|||
129901913|NCT01198275|467602233|FG000|Overall Study|Adverse Event|2|||
129901914|NCT01198275|467602234|FG001|Overall Study|Adverse Event|3|||
129901915|NCT01198275|467602233|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
129901916|NCT01198275|467602234|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
129901917|NCT02385669|467602238|FG000|Overall Study|Adverse Event|2|||
129901918|NCT00970307|467602239|FG000|Overall Study|Serious Adverse Event|1|||
129901919|NCT00970307|467602240|FG001|Overall Study|Serious Adverse Event|0|||
129901920|NCT00970307|467602241|FG002|Overall Study|Serious Adverse Event|0|||
129901921|NCT00970307|467602239|FG000|Overall Study|Withdrawal by Subject|2|||
130064539|NCT00510068|468190192|FG000|Open-label Period|Disease Progression|124|||
129901922|NCT00970307|467602240|FG001|Overall Study|Withdrawal by Subject|3|||
129901923|NCT00970307|467602241|FG002|Overall Study|Withdrawal by Subject|2|||
129901924|NCT05257798|467602242|FG000|Follow-up Phase|Lost to Follow-up|1|||
129901925|NCT05257798|467602243|FG001|Follow-up Phase|Lost to Follow-up|0|||
129901926|NCT04033432|467602246|FG000|Overall Study|Progressive Disease|8|||
129901927|NCT04033432|467602246|FG000|Overall Study|Adverse Event|4|||
129901928|NCT04033432|467602246|FG000|Overall Study|Death|1|||
129901929|NCT00393848|467602247|FG000|Overall Study|Surgical schedule|0|||
129901930|NCT00393848|467602248|FG001|Overall Study|Surgical schedule|0|||
129901931|NCT00393848|467602249|FG002|Overall Study|Surgical schedule|0|||
129901932|NCT00393848|467602250|FG003|Overall Study|Surgical schedule|1|||
129901933|NCT00393848|467602247|FG000|Overall Study|Personal reasons|0|||
129901934|NCT00393848|467602248|FG001|Overall Study|Personal reasons|0|||
129901935|NCT00393848|467602249|FG002|Overall Study|Personal reasons|2|||
129901936|NCT00393848|467602250|FG003|Overall Study|Personal reasons|0|||
129901937|NCT02192606|467602256|FG000|Overall Study|surgery type was changed|1|||
129901938|NCT02192606|467602257|FG001|Overall Study|surgery type was changed|1|||
129901939|NCT02192606|467602256|FG000|Overall Study|Physician Decision|1|||
129901940|NCT02192606|467602257|FG001|Overall Study|Physician Decision|2|||
129901941|NCT02192606|467602256|FG000|Overall Study|3D equipment rep unable to join|0|||
129901942|NCT02192606|467602257|FG001|Overall Study|3D equipment rep unable to join|1|||
129901943|NCT01458210|467602258|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
129901944|NCT01458210|467602258|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
129901945|NCT01458210|467602258|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
129901946|NCT01458210|467602258|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
129901947|NCT03923491|467602259|FG000|Overall Study|Lost to Follow-up|5|||
129901948|NCT03923491|467602260|FG001|Overall Study|Lost to Follow-up|8|||
129901949|NCT03923491|467602259|FG000|Overall Study|Withdrawal by Subject|4|||
129901950|NCT03923491|467602260|FG001|Overall Study|Withdrawal by Subject|6|||
129901951|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
129901952|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
129901953|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
129901954|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
129901955|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
129901956|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
129901957|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
129901958|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
129901959|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
129901960|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
129901961|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
129901962|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
129901963|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
129901964|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
129901965|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
129901966|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
129901967|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
129901968|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
129901969|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
129901970|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
129901971|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
129901972|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
129901973|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
129901974|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
129901975|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
129901976|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
129901977|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
129901978|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
129901979|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
129901980|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
129901981|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
129901982|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
129901983|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
129901984|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
129901985|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
129901986|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
129901987|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
129901988|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
129901989|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
129901990|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
129901991|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
129901992|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
129901993|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
129901994|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
130064540|NCT00510068|468190193|FG001|Open-label Period|Disease Progression|0|||
129901995|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
129901996|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
129901997|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
129845157|NCT01465802|467393424|FG001|Overall Study|Lost to Follow-up|1|||
129845158|NCT01465802|467393425|FG002|Overall Study|Lost to Follow-up|0|||
129845159|NCT01465802|467393426|FG003|Overall Study|Lost to Follow-up|0|||
129845160|NCT01465802|467393427|FG004|Overall Study|Lost to Follow-up|0|||
129845161|NCT01465802|467393423|FG000|Overall Study|Reason not specified|9|||
129845162|NCT01465802|467393424|FG001|Overall Study|Reason not specified|4|||
129845163|NCT01465802|467393425|FG002|Overall Study|Reason not specified|0|||
129845164|NCT01465802|467393426|FG003|Overall Study|Reason not specified|10|||
129845165|NCT01465802|467393427|FG004|Overall Study|Reason not specified|2|||
129845166|NCT01465802|467393423|FG000|Overall Study|Death|15|||
129845167|NCT01465802|467393424|FG001|Overall Study|Death|12|||
129845168|NCT01465802|467393425|FG002|Overall Study|Death|0|||
129845169|NCT01465802|467393426|FG003|Overall Study|Death|10|||
129845170|NCT01465802|467393427|FG004|Overall Study|Death|2|||
129845171|NCT01340976|467393428|FG000|Overall Study|Physician Decision|2|||
129845172|NCT01340976|467393429|FG001|Overall Study|Physician Decision|0|||
129845173|NCT01340976|467393430|FG002|Overall Study|Physician Decision|1|||
129845174|NCT01340976|467393431|FG003|Overall Study|Physician Decision|1|||
129845175|NCT01340976|467393432|FG004|Overall Study|Physician Decision|1|||
129845176|NCT01340976|467393433|FG005|Overall Study|Physician Decision|0|||
129845177|NCT01340976|467393428|FG000|Overall Study|Death|0|||
129845178|NCT01340976|467393429|FG001|Overall Study|Death|1|||
129845179|NCT01340976|467393430|FG002|Overall Study|Death|0|||
129845180|NCT01340976|467393431|FG003|Overall Study|Death|0|||
129845181|NCT01340976|467393432|FG004|Overall Study|Death|0|||
129845182|NCT01340976|467393433|FG005|Overall Study|Death|0|||
129845183|NCT01340976|467393428|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
129901998|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
129901999|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
129902000|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
129902001|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
129902002|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
129902003|NCT01027286|467602268|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
129902004|NCT01027286|467602269|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
129902005|NCT01027286|467602268|FG000|Overall Study|Lost to Follow-up|0|||
129902006|NCT01027286|467602269|FG001|Overall Study|Lost to Follow-up|1|||
129902007|NCT01563354|467602274|FG000|Core Phase|Adverse Event|5|||
129902008|NCT01563354|467602275|FG001|Core Phase|Adverse Event|15|||
129902009|NCT01563354|467602276|FG002|Core Phase|Adverse Event|13|||
129902010|NCT01563354|467602274|FG000|Core Phase|Withdrawal by Subject|1|||
129902011|NCT01563354|467602275|FG001|Core Phase|Withdrawal by Subject|0|||
129902012|NCT01563354|467602276|FG002|Core Phase|Withdrawal by Subject|3|||
129902013|NCT01563354|467602274|FG000|Core Phase|Lost to Follow-up|1|||
129902014|NCT01563354|467602275|FG001|Core Phase|Lost to Follow-up|0|||
129902015|NCT01563354|467602276|FG002|Core Phase|Lost to Follow-up|0|||
129902016|NCT01563354|467602274|FG000|Core Phase|Death|1|||
129902017|NCT01563354|467602275|FG001|Core Phase|Death|5|||
129902018|NCT01563354|467602276|FG002|Core Phase|Death|2|||
129902019|NCT01563354|467602274|FG000|Core Phase|Diseasse progression|18|||
129902020|NCT01563354|467602275|FG001|Core Phase|Diseasse progression|7|||
129902021|NCT01563354|467602276|FG002|Core Phase|Diseasse progression|8|||
129902022|NCT01563354|467602274|FG000|Core Phase|Protocol deviation|2|||
129902023|NCT01563354|467602275|FG001|Core Phase|Protocol deviation|0|||
129902024|NCT01563354|467602276|FG002|Core Phase|Protocol deviation|0|||
129902025|NCT01563354|467602274|FG000|Core Phase|PI decision - did not enter extension|0|||
129902026|NCT01563354|467602275|FG001|Core Phase|PI decision - did not enter extension|1|||
129902027|NCT01563354|467602276|FG002|Core Phase|PI decision - did not enter extension|0|||
129902028|NCT01563354|467602274|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
129902029|NCT01563354|467602275|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
129902030|NCT01563354|467602276|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
129902031|NCT01563354|467602274|FG000|Extension Phase|Adverse Event|0|||
129902032|NCT01563354|467602275|FG001|Extension Phase|Adverse Event|3|||
129902033|NCT01563354|467602276|FG002|Extension Phase|Adverse Event|2|||
129902034|NCT01563354|467602274|FG000|Extension Phase|Withdrawal by Subject|0|||
129902035|NCT01563354|467602275|FG001|Extension Phase|Withdrawal by Subject|1|||
129902036|NCT01563354|467602276|FG002|Extension Phase|Withdrawal by Subject|0|||
129902037|NCT01563354|467602274|FG000|Extension Phase|Administration problems|3|||
129902038|NCT01563354|467602275|FG001|Extension Phase|Administration problems|2|||
129902039|NCT01563354|467602276|FG002|Extension Phase|Administration problems|3|||
129902040|NCT01563354|467602274|FG000|Extension Phase|Disease progression|9|||
129902041|NCT01563354|467602275|FG001|Extension Phase|Disease progression|8|||
129902042|NCT01563354|467602276|FG002|Extension Phase|Disease progression|10|||
129845184|NCT01340976|467393429|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845185|NCT01340976|467393430|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129902043|NCT01565928|467602277|FG000|Overall Study|Adverse Event|3|||
129902044|NCT01565928|467602277|FG000|Overall Study|Other|3|||
129902045|NCT01565928|467602277|FG000|Overall Study|Progressive Disease|13|||
129902046|NCT01565928|467602277|FG000|Overall Study|Withdrawal by Subject|1|||
129902047|NCT01565928|467602277|FG000|Overall Study|Death|2|||
129902048|NCT01119950|467602278|FG000|Overall Study|Adverse Event|25|||
129902049|NCT01119950|467602278|FG000|Overall Study|Withdrawal by Subject|9|||
129902050|NCT01119950|467602278|FG000|Overall Study|Protocol Violation|5|||
129902051|NCT01119950|467602278|FG000|Overall Study|Lost to Follow-up|4|||
129902052|NCT01119950|467602278|FG000|Overall Study|Administrative|2|||
129902053|NCT01119950|467602278|FG000|Overall Study|Abnormal lab value|1|||
129902054|NCT01119950|467602278|FG000|Overall Study|Death|1|||
129902055|NCT01988233|467602283|FG000|Overall Study|Lost to Follow-up|64|||
129902056|NCT01988233|467602284|FG001|Overall Study|Lost to Follow-up|51|||
129902057|NCT03621761|467602289|FG000|Overall Study|Lost to Follow-up|1|||
129902058|NCT03621761|467602290|FG001|Overall Study|Lost to Follow-up|1|||
129902059|NCT03621761|467602291|FG002|Overall Study|Lost to Follow-up|2|||
129902060|NCT03621761|467602289|FG000|Overall Study|Withdrawal by Subject|2|||
129902061|NCT03621761|467602290|FG001|Overall Study|Withdrawal by Subject|1|||
129902062|NCT03621761|467602291|FG002|Overall Study|Withdrawal by Subject|1|||
129902063|NCT03621761|467602289|FG000|Overall Study|Became Ineligible|0|||
129902064|NCT03621761|467602290|FG001|Overall Study|Became Ineligible|2|||
129902065|NCT03621761|467602291|FG002|Overall Study|Became Ineligible|0|||
129902066|NCT00217672|467602292|FG000|Allocation|Ineligible|2|||
129902067|NCT00217672|467602293|FG001|Allocation|Ineligible|0|||
129902068|NCT00217672|467602292|FG000|Treatment|disease progression|33|||
129902069|NCT00217672|467602293|FG001|Treatment|disease progression|4|||
129902070|NCT00217672|467602292|FG000|Treatment|Adverse Event|18|||
129902071|NCT00217672|467602293|FG001|Treatment|Adverse Event|2|||
129902072|NCT00217672|467602292|FG000|Treatment|reqd treatment not permitted by protocol|6|||
129902073|NCT00217672|467602293|FG001|Treatment|reqd treatment not permitted by protocol|0|||
129902074|NCT00217672|467602292|FG000|Treatment|Physician Decision|6|||
129902075|NCT00217672|467602293|FG001|Treatment|Physician Decision|0|||
129902076|NCT00217672|467602292|FG000|Treatment|insurance issues|1|||
129902077|NCT00217672|467602293|FG001|Treatment|insurance issues|1|||
129902078|NCT00217672|467602292|FG000|Treatment|Death|2|||
129902079|NCT00217672|467602293|FG001|Treatment|Death|0|||
129902080|NCT00217672|467602292|FG000|Treatment|secondary malignancy|1|||
129902081|NCT00217672|467602293|FG001|Treatment|secondary malignancy|0|||
129902082|NCT00217672|467602292|FG000|Follow-up|Withdrawal by Subject|4|||
129902083|NCT00217672|467602293|FG001|Follow-up|Withdrawal by Subject|0|||
129902084|NCT00217672|467602292|FG000|Follow-up|Lost to Follow-up|1|||
129902085|NCT00217672|467602293|FG001|Follow-up|Lost to Follow-up|0|||
129902086|NCT01050569|467602294|FG000|Overall Study|Lost to Follow-up|20|||
129902087|NCT01050569|467602295|FG001|Overall Study|Lost to Follow-up|14|||
129902088|NCT01050569|467602296|FG002|Overall Study|Lost to Follow-up|16|||
129902089|NCT01050569|467602294|FG000|Overall Study|Withdrawal by Subject|9|||
129902090|NCT01050569|467602295|FG001|Overall Study|Withdrawal by Subject|3|||
129902091|NCT01050569|467602296|FG002|Overall Study|Withdrawal by Subject|11|||
129902092|NCT01050569|467602294|FG000|Overall Study|Lack of Efficacy|5|||
129902093|NCT01050569|467602295|FG001|Overall Study|Lack of Efficacy|4|||
129902094|NCT01050569|467602296|FG002|Overall Study|Lack of Efficacy|3|||
129902095|NCT01050569|467602294|FG000|Overall Study|Adverse Event|1|||
129902096|NCT01050569|467602295|FG001|Overall Study|Adverse Event|0|||
129902097|NCT01050569|467602296|FG002|Overall Study|Adverse Event|0|||
129902098|NCT01050569|467602294|FG000|Overall Study|Physician Decision|3|||
129902099|NCT01050569|467602295|FG001|Overall Study|Physician Decision|3|||
129902100|NCT01050569|467602296|FG002|Overall Study|Physician Decision|3|||
129902101|NCT01591616|467602301|FG000|Overall Study|Withdrawal by Subject|1|||
129902102|NCT00758602|467602302|FG000|Overall Study|Adverse Event|11|||
129902103|NCT00758602|467602303|FG001|Overall Study|Adverse Event|10|||
129902104|NCT00758602|467602302|FG000|Overall Study|Lost to Follow-up|4|||
129902105|NCT00758602|467602303|FG001|Overall Study|Lost to Follow-up|3|||
129902106|NCT00758602|467602302|FG000|Overall Study|Withdrawal by Subject|1|||
129902107|NCT00758602|467602303|FG001|Overall Study|Withdrawal by Subject|3|||
129902108|NCT00758602|467602302|FG000|Overall Study|Protocol Violation|0|||
129902109|NCT00758602|467602303|FG001|Overall Study|Protocol Violation|2|||
129902110|NCT00758602|467602302|FG000|Overall Study|Death|0|||
129902111|NCT00758602|467602303|FG001|Overall Study|Death|1|||
129902112|NCT00758602|467602302|FG000|Overall Study|Reason not specified|3|||
129902113|NCT00758602|467602303|FG001|Overall Study|Reason not specified|3|||
129902114|NCT03939819|467602304|FG000|Overall Study|Death|2|||
129902115|NCT03939819|467602305|FG001|Overall Study|Death|0|||
129902116|NCT01183780|467602306|FG000|Overall Study|Withdrawal by Subject|25|||
129902117|NCT01183780|467602307|FG001|Overall Study|Withdrawal by Subject|14|||
129902118|NCT01183780|467602306|FG000|Overall Study|Lost to Follow-up|6|||
129902119|NCT01183780|467602307|FG001|Overall Study|Lost to Follow-up|11|||
129902120|NCT04379713|467602308|FG000|Overall Study|Adverse Event|2|||
129902121|NCT04379713|467602309|FG001|Overall Study|Adverse Event|0|||
129902122|NCT04379713|467602308|FG000|Overall Study|Physician Decision|2|||
129902123|NCT04379713|467602309|FG001|Overall Study|Physician Decision|1|||
129902124|NCT04379713|467602308|FG000|Overall Study|Protocol Violation|11|||
129902125|NCT04379713|467602309|FG001|Overall Study|Protocol Violation|6|||
130064541|NCT00510068|468190192|FG000|Open-label Period|Adverse Event|46|||
129902126|NCT04379713|467602308|FG000|Overall Study|No longer met eligibility criteria|14|||
129902127|NCT04379713|467602309|FG001|Overall Study|No longer met eligibility criteria|11|||
129902128|NCT04379713|467602308|FG000|Overall Study|Withdrawal by parent/guardian|36|||
129902129|NCT04379713|467602309|FG001|Overall Study|Withdrawal by parent/guardian|15|||
129902130|NCT04379713|467602308|FG000|Overall Study|Lost to Follow-up|31|||
129902131|NCT04379713|467602309|FG001|Overall Study|Lost to Follow-up|21|||
129902132|NCT02613364|467602310|FG000|Overall Study|Other|19|||
129902133|NCT02613364|467602311|FG001|Overall Study|Other|29|||
129902134|NCT02613364|467602312|FG002|Overall Study|Other|17|||
129902135|NCT02613364|467602310|FG000|Overall Study|Too time consuming|21|||
129902136|NCT02613364|467602311|FG001|Overall Study|Too time consuming|26|||
129902137|NCT02613364|467602312|FG002|Overall Study|Too time consuming|26|||
129902138|NCT02613364|467602310|FG000|Overall Study|Withdrawal by Subject|13|||
129902139|NCT02613364|467602311|FG001|Overall Study|Withdrawal by Subject|18|||
129902140|NCT02613364|467602312|FG002|Overall Study|Withdrawal by Subject|17|||
129902141|NCT02613364|467602310|FG000|Overall Study|Medical|12|||
129902142|NCT02613364|467602311|FG001|Overall Study|Medical|13|||
129902143|NCT02613364|467602312|FG002|Overall Study|Medical|9|||
129902144|NCT02613364|467602310|FG000|Overall Study|Disliked Study Procedure|1|||
129902145|NCT02613364|467602311|FG001|Overall Study|Disliked Study Procedure|1|||
129902146|NCT02613364|467602312|FG002|Overall Study|Disliked Study Procedure|4|||
129902147|NCT02613364|467602310|FG000|Overall Study|Disliked Intervention|0|||
129902148|NCT02613364|467602311|FG001|Overall Study|Disliked Intervention|3|||
129902149|NCT02613364|467602312|FG002|Overall Study|Disliked Intervention|3|||
129902150|NCT00082810|467602320|FG000|Overall Study|Adverse Event|3|||
129902151|NCT00082810|467602320|FG000|Overall Study|Progressive disease|24|||
129845186|NCT01340976|467393431|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845187|NCT01340976|467393432|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845188|NCT01340976|467393433|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845189|NCT01340976|467393428|FG000|Overall Study|Withdrawal by Subject|0|||
129845190|NCT01340976|467393429|FG001|Overall Study|Withdrawal by Subject|0|||
129845191|NCT01340976|467393430|FG002|Overall Study|Withdrawal by Subject|0|||
129845192|NCT01340976|467393431|FG003|Overall Study|Withdrawal by Subject|1|||
129845193|NCT01340976|467393432|FG004|Overall Study|Withdrawal by Subject|1|||
129845194|NCT01340976|467393433|FG005|Overall Study|Withdrawal by Subject|0|||
129845195|NCT01340976|467393428|FG000|Overall Study|Other anemia treatment|1|||
129845196|NCT01340976|467393429|FG001|Overall Study|Other anemia treatment|0|||
129845197|NCT01340976|467393430|FG002|Overall Study|Other anemia treatment|2|||
129845198|NCT01340976|467393431|FG003|Overall Study|Other anemia treatment|1|||
129845199|NCT01340976|467393432|FG004|Overall Study|Other anemia treatment|0|||
129845200|NCT01340976|467393433|FG005|Overall Study|Other anemia treatment|1|||
129845201|NCT01340976|467393428|FG000|Overall Study|Adverse Event|0|||
129845202|NCT01340976|467393429|FG001|Overall Study|Adverse Event|1|||
129845203|NCT01340976|467393430|FG002|Overall Study|Adverse Event|0|||
129845204|NCT01340976|467393431|FG003|Overall Study|Adverse Event|0|||
129845205|NCT01340976|467393432|FG004|Overall Study|Adverse Event|0|||
129845206|NCT01340976|467393433|FG005|Overall Study|Adverse Event|0|||
129845207|NCT01358981|467393434|FG000|Period 1|Withdrawal by Subject|0|||
129845208|NCT01358981|467393435|FG001|Period 1|Withdrawal by Subject|0|||
129845209|NCT01358981|467393436|FG002|Period 1|Withdrawal by Subject|0|||
129845210|NCT01358981|467393437|FG003|Period 1|Withdrawal by Subject|1|||
129845211|NCT01358981|467393438|FG004|Period 1|Withdrawal by Subject|0|||
129845212|NCT01358981|467393439|FG005|Period 1|Withdrawal by Subject|0|||
129845213|NCT01358981|467393440|FG006|Period 1|Withdrawal by Subject|0|||
129845214|NCT03417141|467393449|FG000|Overall Study|Withdrawal by Subject|1|||
129845215|NCT03417141|467393449|FG000|Overall Study|Protocol Violation|3|||
129845216|NCT03706690|467393450|FG000|Overall Study|Withdrawal by Subject|8|||
129845217|NCT03706690|467393451|FG001|Overall Study|Withdrawal by Subject|8|||
129845218|NCT03706690|467393450|FG000|Overall Study|Death|143|||
129845219|NCT03706690|467393451|FG001|Overall Study|Death|75|||
129845220|NCT03706690|467393450|FG000|Overall Study|Ongoing at DCO|121|||
129845221|NCT03706690|467393451|FG001|Overall Study|Ongoing at DCO|52|||
129845222|NCT02098109|467393452|FG000|Overall Study|Protocol Violation|3|||
129845223|NCT02098109|467393453|FG001|Overall Study|Protocol Violation|0|||
129845224|NCT01822132|467393454|FG000|Overall Study|Lost to Follow-up|4|||
129845225|NCT01822132|467393455|FG001|Overall Study|Lost to Follow-up|2|||
129845226|NCT02519712|467393458|FG000|Overall Study|Disease Relapse|1|||
129845227|NCT02519712|467393458|FG000|Overall Study|Disease Progression|1|||
129845228|NCT02519712|467393458|FG000|Overall Study|Accruals are donors|2|||
129845229|NCT01247090|467393461|FG000|Overall Study|Physician Decision|1|||
129845230|NCT01247090|467393462|FG001|Overall Study|Physician Decision|0|||
129845231|NCT01247090|467393463|FG002|Overall Study|Physician Decision|0|||
129845232|NCT01247090|467393461|FG000|Overall Study|Withdrawal by Subject|0|||
129902152|NCT00082810|467602320|FG000|Overall Study|Withdrawal by Subject|4|||
129902153|NCT05052983|467602326|FG000|Overall Study|Lack of Efficacy|3|||
129902154|NCT05052983|467602327|FG001|Overall Study|Lack of Efficacy|12|||
129902155|NCT05052983|467602326|FG000|Overall Study|Adverse Event|1|||
129845233|NCT01247090|467393462|FG001|Overall Study|Withdrawal by Subject|1|||
129902156|NCT05052983|467602327|FG001|Overall Study|Adverse Event|0|||
129902157|NCT03425643|467602328|FG000|Overall Study|Withdrawal by Subject|10|||
129902158|NCT03425643|467602329|FG001|Overall Study|Withdrawal by Subject|12|||
129902159|NCT03425643|467602328|FG000|Overall Study|Lost to Follow-up|2|||
129902160|NCT03425643|467602329|FG001|Overall Study|Lost to Follow-up|0|||
129902161|NCT03425643|467602328|FG000|Overall Study|Death|109|||
129902162|NCT03425643|467602329|FG001|Overall Study|Death|141|||
129902163|NCT03425643|467602328|FG000|Overall Study|Ongoing in study|276|||
129902164|NCT03425643|467602329|FG001|Overall Study|Ongoing in study|247|||
129902165|NCT04133363|467602330|FG000|Overall Study|Lost to Follow-up|2|||
129902166|NCT04133363|467602331|FG001|Overall Study|Lost to Follow-up|1|||
129902167|NCT04133363|467602332|FG002|Overall Study|Lost to Follow-up|4|||
129902168|NCT00849147|467602336|FG000|Overall Study|Withdrawal by Subject|1|||
129845234|NCT01247090|467393463|FG002|Overall Study|Withdrawal by Subject|0|||
129845235|NCT00006916|467393465|FG000|Overall Study|Device not inserted|4|||
129845236|NCT00006916|467393465|FG000|Overall Study|Complication of device insertion|1|||
129845237|NCT03385239|467393470|FG000|Overall Study|Voluntary Withdrawal|2|||
129845238|NCT03385239|467393471|FG001|Overall Study|Voluntary Withdrawal|3|||
129845239|NCT03385239|467393472|FG002|Overall Study|Voluntary Withdrawal|2|||
129845240|NCT03385239|467393473|FG003|Overall Study|Voluntary Withdrawal|3|||
129845241|NCT03385239|467393474|FG004|Overall Study|Voluntary Withdrawal|0|||
129845242|NCT03385239|467393470|FG000|Overall Study|Adverse Event|0|||
129845243|NCT03385239|467393471|FG001|Overall Study|Adverse Event|0|||
129845244|NCT03385239|467393472|FG002|Overall Study|Adverse Event|1|||
129845245|NCT03385239|467393473|FG003|Overall Study|Adverse Event|0|||
129845246|NCT03385239|467393474|FG004|Overall Study|Adverse Event|0|||
129845247|NCT03385239|467393470|FG000|Overall Study|Other|0|||
129845248|NCT03385239|467393471|FG001|Overall Study|Other|0|||
129845249|NCT03385239|467393472|FG002|Overall Study|Other|0|||
129845250|NCT03385239|467393473|FG003|Overall Study|Other|1|||
129845251|NCT03385239|467393474|FG004|Overall Study|Other|0|||
129845252|NCT01574703|467393475|FG000|Overall Study|Adverse Event|0|||
129845253|NCT01574703|467393476|FG001|Overall Study|Adverse Event|2|||
129845254|NCT01574703|467393477|FG002|Overall Study|Adverse Event|1|||
129845255|NCT01574703|467393478|FG003|Overall Study|Adverse Event|1|||
129845256|NCT01574703|467393475|FG000|Overall Study|Protocol Violation|0|||
129902169|NCT00849147|467602336|FG000|Overall Study|Protocol Violation|2|||
129902170|NCT00849147|467602336|FG000|Overall Study|Disease Relapse/Progression|2|||
129902171|NCT04199728|467604056|FG000|Overall Study|Adverse Event|1|||
129902172|NCT04199728|467604057|FG001|Overall Study|Adverse Event|0|||
129902173|NCT04199728|467604056|FG000|Overall Study|Withdrawal by Subject|8|||
129902174|NCT04199728|467604057|FG001|Overall Study|Withdrawal by Subject|3|||
129902175|NCT04199728|467604056|FG000|Overall Study|Screen fail after consent|0|||
129902176|NCT04199728|467604057|FG001|Overall Study|Screen fail after consent|1|||
129902177|NCT04199728|467604056|FG000|Overall Study|Early withdraw criteria met|0|||
129902178|NCT04199728|467604057|FG001|Overall Study|Early withdraw criteria met|1|||
129902179|NCT04199728|467604056|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
129902180|NCT04199728|467604057|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
129902181|NCT00482729|467604058|FG000|Overall Study|Adverse Event|29|||
129902182|NCT00482729|467604059|FG001|Overall Study|Adverse Event|33|||
129902183|NCT00482729|467604058|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
129902184|NCT00482729|467604059|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
129902185|NCT00482729|467604058|FG000|Overall Study|Hyperglycemia Criteria|7|||
129902186|NCT00482729|467604059|FG001|Overall Study|Hyperglycemia Criteria|5|||
129902187|NCT00482729|467604058|FG000|Overall Study|Lack of Efficacy|4|||
129902188|NCT00482729|467604059|FG001|Overall Study|Lack of Efficacy|16|||
129902189|NCT00482729|467604058|FG000|Overall Study|Lost to Follow-up|86|||
129902190|NCT00482729|467604059|FG001|Overall Study|Lost to Follow-up|66|||
129902191|NCT00482729|467604058|FG000|Overall Study|Physician Decision|10|||
129902192|NCT00482729|467604059|FG001|Overall Study|Physician Decision|7|||
129902193|NCT00482729|467604058|FG000|Overall Study|Pregnancy|4|||
129902194|NCT00482729|467604059|FG001|Overall Study|Pregnancy|2|||
129902195|NCT00482729|467604058|FG000|Overall Study|Protocol Violation|10|||
129902196|NCT00482729|467604059|FG001|Overall Study|Protocol Violation|18|||
129902197|NCT00482729|467604058|FG000|Overall Study|Withdrawal by Subject|67|||
129902198|NCT00482729|467604059|FG001|Overall Study|Withdrawal by Subject|69|||
129902199|NCT01070888|467604062|FG000|First Intervention (14 Days)|Adverse Event|0|||
129902200|NCT01070888|467604063|FG001|First Intervention (14 Days)|Adverse Event|1|||
129902201|NCT01070888|467604062|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
129902202|NCT01070888|467604063|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
129902203|NCT01070888|467604062|FG000|Washout (14 Days)|Physician Decision|1|||
129902204|NCT01070888|467604063|FG001|Washout (14 Days)|Physician Decision|0|||
129902205|NCT02577523|467604064|FG000|Overall Study|Adverse Event|1|||
129902206|NCT02577523|467604065|FG001|Overall Study|Adverse Event|1|||
129845257|NCT01574703|467393476|FG001|Overall Study|Protocol Violation|0|||
129902207|NCT02577523|467604064|FG000|Overall Study|Lack of Efficacy|1|||
129902208|NCT02577523|467604065|FG001|Overall Study|Lack of Efficacy|1|||
129845258|NCT01574703|467393477|FG002|Overall Study|Protocol Violation|0|||
129902209|NCT02577523|467604064|FG000|Overall Study|Withdrawal by Subject|1|||
129902210|NCT02577523|467604065|FG001|Overall Study|Withdrawal by Subject|0|||
129902211|NCT02631148|467604066|FG000|Overall Study|8 were ineligible|8|||
129902212|NCT02631148|467604067|FG001|Overall Study|8 were ineligible|0|||
129902213|NCT02631148|467604066|FG000|Overall Study|Withdrawal by Subject|1|||
129902214|NCT02631148|467604067|FG001|Overall Study|Withdrawal by Subject|0|||
129902215|NCT02631148|467604066|FG000|Overall Study|PAH not available to study participant|1|||
129902216|NCT02631148|467604067|FG001|Overall Study|PAH not available to study participant|0|||
129902217|NCT00955825|467604069|FG000|Overall Study|Adverse Event|15|||
129902218|NCT00955825|467604070|FG001|Overall Study|Adverse Event|2|||
129902219|NCT00955825|467604069|FG000|Overall Study|Withdrawal by Subject|4|||
129902220|NCT00955825|467604070|FG001|Overall Study|Withdrawal by Subject|6|||
129902221|NCT00955825|467604069|FG000|Overall Study|Any other reason not above-mentioned|7|||
129902222|NCT00955825|467604070|FG001|Overall Study|Any other reason not above-mentioned|9|||
129902223|NCT02488980|467604071|FG000|Overall Study|Protocol Violation|2|||
129902224|NCT02488980|467604072|FG001|Overall Study|Protocol Violation|2|||
129902225|NCT02488980|467604073|FG002|Overall Study|Protocol Violation|2|||
129902226|NCT00150176|467604074|FG000|Overall Study|Adverse Event|16|||
129902227|NCT00150176|467604075|FG001|Overall Study|Adverse Event|53|||
129902228|NCT00150176|467604074|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
129902229|NCT00150176|467604075|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
129902230|NCT00150176|467604074|FG000|Overall Study|Withdrawal by Subject|19|||
129902231|NCT00150176|467604075|FG001|Overall Study|Withdrawal by Subject|12|||
129902232|NCT00150176|467604074|FG000|Overall Study|Lost to Follow-up|3|||
129902233|NCT00150176|467604075|FG001|Overall Study|Lost to Follow-up|3|||
129902234|NCT00150176|467604074|FG000|Overall Study|OTHER|11|||
129902235|NCT00150176|467604075|FG001|Overall Study|OTHER|13|||
129902236|NCT02082158|467604077|FG000|Overall Study|Withdrawal by Subject|0|||
129902237|NCT02082158|467604078|FG001|Overall Study|Withdrawal by Subject|0|||
129902238|NCT02082158|467604079|FG002|Overall Study|Withdrawal by Subject|0|||
129902239|NCT02082158|467604080|FG003|Overall Study|Withdrawal by Subject|0|||
129902240|NCT02082158|467604081|FG004|Overall Study|Withdrawal by Subject|1|||
129902241|NCT02082158|467604082|FG005|Overall Study|Withdrawal by Subject|0|||
129902242|NCT02082158|467604077|FG000|Overall Study|Failed Fit-testing|8|||
129902243|NCT02082158|467604078|FG001|Overall Study|Failed Fit-testing|8|||
129902244|NCT02082158|467604079|FG002|Overall Study|Failed Fit-testing|14|||
129902245|NCT02082158|467604080|FG003|Overall Study|Failed Fit-testing|4|||
129902246|NCT02082158|467604081|FG004|Overall Study|Failed Fit-testing|3|||
129902247|NCT02082158|467604082|FG005|Overall Study|Failed Fit-testing|7|||
129902248|NCT00738699|467604083|FG000|Overall Study|Withdrawal by Subject|5|||
129902249|NCT00738699|467604084|FG001|Overall Study|Withdrawal by Subject|0|||
129902250|NCT00738699|467604083|FG000|Overall Study|Lost to Follow-up|1|||
129902251|NCT00738699|467604084|FG001|Overall Study|Lost to Follow-up|0|||
129902252|NCT00738699|467604083|FG000|Overall Study|Death|144|||
129902253|NCT00738699|467604084|FG001|Overall Study|Death|68|||
129902254|NCT00738699|467604083|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
129902255|NCT00738699|467604084|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
129902256|NCT00738699|467604083|FG000|Overall Study|Other|2|||
129902257|NCT00738699|467604084|FG001|Overall Study|Other|0|||
129902258|NCT00549848|467604089|FG000|Overall Study|Death|1|||
129902259|NCT00549848|467604090|FG001|Overall Study|Death|4|||
129902260|NCT00549848|467604091|FG002|Overall Study|Death|13|||
129902261|NCT00549848|467604089|FG000|Overall Study|Physician Decision|0|||
129902262|NCT00549848|467604090|FG001|Overall Study|Physician Decision|0|||
129902263|NCT00549848|467604091|FG002|Overall Study|Physician Decision|4|||
129902264|NCT00549848|467604089|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
129902265|NCT00549848|467604090|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
129902266|NCT00549848|467604091|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
129902267|NCT00549848|467604089|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
129902268|NCT00549848|467604090|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
129902269|NCT00549848|467604091|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
129902270|NCT00549848|467604089|FG000|Overall Study|Participant/Family Withdraw|2|||
129902271|NCT00549848|467604090|FG001|Overall Study|Participant/Family Withdraw|3|||
129902272|NCT00549848|467604091|FG002|Overall Study|Participant/Family Withdraw|5|||
129902273|NCT00549848|467604089|FG000|Overall Study|Second Malignancy|1|||
129902274|NCT00549848|467604090|FG001|Overall Study|Second Malignancy|0|||
129902275|NCT00549848|467604091|FG002|Overall Study|Second Malignancy|0|||
129902276|NCT00549848|467604089|FG000|Overall Study|Transplant|3|||
129902277|NCT00549848|467604090|FG001|Overall Study|Transplant|3|||
129902278|NCT00549848|467604091|FG002|Overall Study|Transplant|18|||
129902279|NCT00549848|467604089|FG000|Overall Study|Unacceptable Toxicity|1|||
129902280|NCT00549848|467604090|FG001|Overall Study|Unacceptable Toxicity|6|||
129902281|NCT00549848|467604091|FG002|Overall Study|Unacceptable Toxicity|6|||
129902282|NCT03262935|467604092|FG000|Overall Study|Withdrawal by Subject|6|||
129902283|NCT03262935|467604093|FG001|Overall Study|Withdrawal by Subject|7|||
129902284|NCT03262935|467604092|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
129902285|NCT03262935|467604093|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
129902286|NCT03262935|467604092|FG000|Overall Study|Death|181|||
129902287|NCT03262935|467604093|FG001|Overall Study|Death|94|||
129902288|NCT03262935|467604092|FG000|Overall Study|Lost to Follow-up|9|||
129902289|NCT03262935|467604093|FG001|Overall Study|Lost to Follow-up|4|||
129902290|NCT03262935|467604092|FG000|Overall Study|Other reason|5|||
129845259|NCT01574703|467393478|FG003|Overall Study|Protocol Violation|1|||
129845260|NCT01574703|467393475|FG000|Overall Study|Unspecified Reason|27|||
129845261|NCT01574703|467393476|FG001|Overall Study|Unspecified Reason|15|||
129845262|NCT01574703|467393477|FG002|Overall Study|Unspecified Reason|20|||
129845263|NCT01574703|467393478|FG003|Overall Study|Unspecified Reason|16|||
129845264|NCT01574703|467393475|FG000|Overall Study|Withdrawal by Subject|53|||
129845265|NCT01574703|467393476|FG001|Overall Study|Withdrawal by Subject|52|||
129845266|NCT01574703|467393477|FG002|Overall Study|Withdrawal by Subject|36|||
129845267|NCT01574703|467393478|FG003|Overall Study|Withdrawal by Subject|61|||
129845268|NCT01574703|467393475|FG000|Overall Study|Met Withdrawal Criteria|0|||
129845269|NCT01574703|467393476|FG001|Overall Study|Met Withdrawal Criteria|1|||
129845270|NCT01574703|467393477|FG002|Overall Study|Met Withdrawal Criteria|1|||
129845271|NCT01574703|467393478|FG003|Overall Study|Met Withdrawal Criteria|0|||
129845272|NCT01574703|467393475|FG000|Overall Study|Lost to Follow-up|43|||
129845273|NCT01574703|467393476|FG001|Overall Study|Lost to Follow-up|41|||
129845274|NCT01574703|467393477|FG002|Overall Study|Lost to Follow-up|46|||
129845275|NCT01574703|467393478|FG003|Overall Study|Lost to Follow-up|35|||
129845276|NCT01574703|467393475|FG000|Overall Study|Death|2|||
129845277|NCT01574703|467393476|FG001|Overall Study|Death|1|||
129845278|NCT01574703|467393477|FG002|Overall Study|Death|1|||
129845279|NCT01574703|467393478|FG003|Overall Study|Death|0|||
129845280|NCT01524770|467393479|FG000|First Intervention|Withdrawal by Subject|1|||
129845281|NCT01524770|467393480|FG001|First Intervention|Withdrawal by Subject|0|||
129845282|NCT01524770|467393479|FG000|First Intervention|Adverse Event|1|||
129845283|NCT01524770|467393480|FG001|First Intervention|Adverse Event|1|||
129845284|NCT01524770|467393479|FG000|First Intervention|Protocol Violation|1|||
129845285|NCT01524770|467393480|FG001|First Intervention|Protocol Violation|0|||
129845286|NCT03467425|467393482|FG000|Overall Study|Adverse Event|9|||
129845287|NCT03467425|467393483|FG001|Overall Study|Adverse Event|9|||
129845288|NCT03467425|467393482|FG000|Overall Study|Lack of Efficacy|3|||
129845289|NCT03467425|467393483|FG001|Overall Study|Lack of Efficacy|1|||
129845290|NCT03467425|467393482|FG000|Overall Study|Protocol Violation|0|||
129845291|NCT03467425|467393483|FG001|Overall Study|Protocol Violation|1|||
129845292|NCT03467425|467393482|FG000|Overall Study|Lost to Follow-up|18|||
129845293|NCT03467425|467393483|FG001|Overall Study|Lost to Follow-up|25|||
129845294|NCT03467425|467393482|FG000|Overall Study|Physician Decision|2|||
129845295|NCT03467425|467393483|FG001|Overall Study|Physician Decision|1|||
129845296|NCT03467425|467393482|FG000|Overall Study|Withdrawal by Subject|15|||
129845297|NCT03467425|467393483|FG001|Overall Study|Withdrawal by Subject|17|||
129845298|NCT02318693|467393484|FG000|Overall Study|Protocol Violation|0|||
129845299|NCT02318693|467393485|FG001|Overall Study|Protocol Violation|1|||
129845300|NCT01282216|467393486|FG000|Overall Study|Graft failure|0|||
129845301|NCT01282216|467393487|FG001|Overall Study|Graft failure|0|||
129845302|NCT01282216|467393488|FG002|Overall Study|Graft failure|3|||
129845303|NCT01282216|467393489|FG003|Overall Study|Graft failure|2|||
129845304|NCT01282216|467393486|FG000|Overall Study|Physician Decision|0|||
129845305|NCT01282216|467393487|FG001|Overall Study|Physician Decision|0|||
129845306|NCT01282216|467393488|FG002|Overall Study|Physician Decision|11|||
129845307|NCT01282216|467393489|FG003|Overall Study|Physician Decision|0|||
129845308|NCT01282216|467393486|FG000|Overall Study|Relapse|0|||
129845309|NCT01282216|467393487|FG001|Overall Study|Relapse|0|||
129845310|NCT01282216|467393488|FG002|Overall Study|Relapse|17|||
129845311|NCT01282216|467393489|FG003|Overall Study|Relapse|6|||
129845312|NCT01282216|467393486|FG000|Overall Study|Death|0|||
129845313|NCT01282216|467393487|FG001|Overall Study|Death|0|||
129845314|NCT01282216|467393488|FG002|Overall Study|Death|2|||
129845315|NCT01282216|467393489|FG003|Overall Study|Death|0|||
129845316|NCT03492177|467393494|FG000|Overall Study|Adverse Event|1|||
129902291|NCT03262935|467604093|FG001|Overall Study|Other reason|0|||
129902292|NCT00419094|467604094|FG000|Overall Study|Adverse Event|3|||
129902293|NCT00419094|467604095|FG001|Overall Study|Adverse Event|7|||
129902294|NCT00419094|467604094|FG000|Overall Study|Lack of Efficacy|1|||
129902295|NCT00419094|467604095|FG001|Overall Study|Lack of Efficacy|0|||
129845317|NCT03492177|467393495|FG001|Overall Study|Adverse Event|0|||
129902296|NCT00419094|467604094|FG000|Overall Study|Lost to Follow-up|0|||
129902297|NCT00419094|467604095|FG001|Overall Study|Lost to Follow-up|2|||
129902298|NCT00419094|467604094|FG000|Overall Study|Protocol Violation|1|||
129902299|NCT00419094|467604095|FG001|Overall Study|Protocol Violation|14|||
129845318|NCT03492177|467393496|FG002|Overall Study|Adverse Event|0|||
129845319|NCT03492177|467393494|FG000|Overall Study|Death|3|||
129845320|NCT03492177|467393495|FG001|Overall Study|Death|0|||
129845321|NCT03492177|467393496|FG002|Overall Study|Death|3|||
129845322|NCT03492177|467393494|FG000|Overall Study|Lack of Efficacy|1|||
129845323|NCT03492177|467393495|FG001|Overall Study|Lack of Efficacy|2|||
129845324|NCT03492177|467393496|FG002|Overall Study|Lack of Efficacy|0|||
129902300|NCT00419094|467604094|FG000|Overall Study|Withdrawal of consent|1|||
129845325|NCT03492177|467393494|FG000|Overall Study|Other|1|||
129845326|NCT03492177|467393495|FG001|Overall Study|Other|0|||
129845327|NCT03492177|467393496|FG002|Overall Study|Other|0|||
129845328|NCT03492177|467393494|FG000|Overall Study|Ongoing|16|||
129845329|NCT03492177|467393495|FG001|Overall Study|Ongoing|19|||
129845330|NCT03492177|467393496|FG002|Overall Study|Ongoing|17|||
129845331|NCT04745689|467393497|FG000|Overall Study|Death|9|||
129845332|NCT04745689|467393498|FG001|Overall Study|Death|6|||
129845333|NCT04745689|467393497|FG000|Overall Study|Lost to Follow-up|1|||
129845334|NCT04745689|467393498|FG001|Overall Study|Lost to Follow-up|0|||
129845335|NCT04745689|467393497|FG000|Overall Study|Withdrawal by Subject|2|||
129845336|NCT04745689|467393498|FG001|Overall Study|Withdrawal by Subject|0|||
129845337|NCT04745689|467393497|FG000|Overall Study|Study terminated by sponsor|10|||
129845338|NCT04745689|467393498|FG001|Overall Study|Study terminated by sponsor|3|||
129902301|NCT00419094|467604095|FG001|Overall Study|Withdrawal of consent|5|||
129902302|NCT00419094|467604094|FG000|Overall Study|Other: Error determining exit criteria|1|||
129902303|NCT00419094|467604095|FG001|Overall Study|Other: Error determining exit criteria|0|||
129902304|NCT00419094|467604094|FG000|Overall Study|Other: Patient non-compliant|0|||
129902305|NCT00419094|467604095|FG001|Overall Study|Other: Patient non-compliant|1|||
129902306|NCT00419094|467604094|FG000|Overall Study|Other: No contact for extended period|0|||
129902307|NCT00419094|467604095|FG001|Overall Study|Other: No contact for extended period|1|||
129902308|NCT01811706|467604096|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
129902309|NCT01811706|467604097|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
129902310|NCT02224924|467604098|FG000|Overall Study|Withdrawal by Subject|7|||
129902311|NCT02224924|467604099|FG001|Overall Study|Withdrawal by Subject|6|||
129902312|NCT02224924|467604098|FG000|Overall Study|Biopsy cancelled|20|||
129902313|NCT02224924|467604099|FG001|Overall Study|Biopsy cancelled|14|||
129902314|NCT02224924|467604098|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
129902315|NCT02224924|467604099|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
129902316|NCT02224924|467604098|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
129902317|NCT02224924|467604099|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
129902318|NCT03020745|467604100|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902319|NCT03020745|467604101|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902320|NCT03020745|467604102|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902321|NCT03020745|467604103|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902322|NCT03020745|467604104|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902323|NCT03020745|467604105|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902324|NCT03020745|467604106|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902325|NCT03020745|467604107|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902326|NCT03020745|467604108|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
129902327|NCT03020745|467604109|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902328|NCT03020745|467604100|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902329|NCT03020745|467604101|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902330|NCT03020745|467604102|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902331|NCT03020745|467604103|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902332|NCT03020745|467604104|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902333|NCT03020745|467604105|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902334|NCT03020745|467604106|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902335|NCT03020745|467604107|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
129902336|NCT03020745|467604108|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902337|NCT03020745|467604109|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902338|NCT03020745|467604100|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902339|NCT03020745|467604101|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902340|NCT03020745|467604102|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902341|NCT03020745|467604103|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902342|NCT03020745|467604104|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902343|NCT03020745|467604105|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
129902344|NCT03020745|467604106|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902345|NCT03020745|467604107|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902346|NCT03020745|467604108|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
129902347|NCT03020745|467604109|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902348|NCT03020745|467604100|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902349|NCT03020745|467604101|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902350|NCT03020745|467604102|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902351|NCT03020745|467604103|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902352|NCT03020745|467604104|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902353|NCT03020745|467604105|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902354|NCT03020745|467604106|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902355|NCT03020745|467604107|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902356|NCT03020745|467604108|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
129902357|NCT03020745|467604109|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129845339|NCT03285646|467395166|FG000|Overall Study|Adverse Event|1|||
129845340|NCT03285646|467395167|FG001|Overall Study|Adverse Event|0|||
129845341|NCT03285646|467395166|FG000|Overall Study|Withdrawal by Subject|10|||
129845342|NCT03285646|467395167|FG001|Overall Study|Withdrawal by Subject|2|||
129845343|NCT03285646|467395166|FG000|Overall Study|Lost to Follow-up|2|||
129845344|NCT03285646|467395167|FG001|Overall Study|Lost to Follow-up|1|||
129845345|NCT03285646|467395166|FG000|Overall Study|Investigator/Sponsor Decision|0|||
129845346|NCT03285646|467395167|FG001|Overall Study|Investigator/Sponsor Decision|1|||
129845347|NCT01344057|467395168|FG000|Overall Study|Premature Withdrawal|1|||
129845348|NCT00306592|467395169|FG000|Overall Study|Adverse Event|8|||
129845349|NCT00306592|467395170|FG001|Overall Study|Adverse Event|15|||
129845350|NCT00306592|467395169|FG000|Overall Study|Lost to Follow-up|1|||
129845351|NCT00306592|467395170|FG001|Overall Study|Lost to Follow-up|0|||
129845352|NCT00306592|467395169|FG000|Overall Study|Noncompliance|0|||
129845353|NCT00306592|467395170|FG001|Overall Study|Noncompliance|2|||
129845354|NCT00306592|467395169|FG000|Overall Study|Persistent Antibodies|6|||
129845355|NCT00306592|467395170|FG001|Overall Study|Persistent Antibodies|3|||
129845356|NCT00306592|467395169|FG000|Overall Study|Voluntary|10|||
129845357|NCT00306592|467395170|FG001|Overall Study|Voluntary|6|||
129845358|NCT00306592|467395169|FG000|Overall Study|Other|5|||
129845359|NCT00306592|467395170|FG001|Overall Study|Other|10|||
129845360|NCT00306592|467395169|FG000|Overall Study|Other|1|||
129845361|NCT00306592|467395170|FG001|Overall Study|Other|2|||
129845362|NCT00306592|467395169|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
129845363|NCT00306592|467395170|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
129845364|NCT02566759|467395171|FG000|All Parts|Withdrawal by Subject|0|||
129845365|NCT02566759|467395172|FG001|All Parts|Withdrawal by Subject|1|||
129845366|NCT02566759|467395173|FG002|All Parts|Withdrawal by Subject|0|||
129845367|NCT02566759|467395174|FG003|All Parts|Withdrawal by Subject|0|||
129845368|NCT02566759|467395175|FG004|All Parts|Withdrawal by Subject|0|||
129845369|NCT02566759|467395176|FG005|All Parts|Withdrawal by Subject|0|||
129845370|NCT02566759|467395177|FG006|All Parts|Withdrawal by Subject|0|||
129845371|NCT02566759|467395178|FG007|All Parts|Withdrawal by Subject|0|||
129845372|NCT02566759|467395179|FG008|All Parts|Withdrawal by Subject|0|||
129845373|NCT02566759|467395180|FG009|All Parts|Withdrawal by Subject|0|||
129845374|NCT02566759|467395181|FG010|All Parts|Withdrawal by Subject|0|||
129845375|NCT02566759|467395182|FG011|All Parts|Withdrawal by Subject|0|||
129845376|NCT02566759|467395183|FG012|All Parts|Withdrawal by Subject|0|||
129845377|NCT02566759|467395184|FG013|All Parts|Withdrawal by Subject|0|||
129845378|NCT02566759|467395185|FG014|All Parts|Withdrawal by Subject|0|||
129845379|NCT02566759|467395186|FG015|All Parts|Withdrawal by Subject|0|||
129845380|NCT02566759|467395187|FG016|All Parts|Withdrawal by Subject|0|||
129845381|NCT02566759|467395171|FG000|All Parts|Adverse Event|0|||
129845382|NCT02566759|467395172|FG001|All Parts|Adverse Event|0|||
129845383|NCT02566759|467395173|FG002|All Parts|Adverse Event|0|||
129845384|NCT02566759|467395174|FG003|All Parts|Adverse Event|0|||
129845385|NCT02566759|467395175|FG004|All Parts|Adverse Event|0|||
129845386|NCT02566759|467395176|FG005|All Parts|Adverse Event|0|||
129845387|NCT02566759|467395177|FG006|All Parts|Adverse Event|0|||
129845388|NCT02566759|467395178|FG007|All Parts|Adverse Event|0|||
129845389|NCT02566759|467395179|FG008|All Parts|Adverse Event|0|||
129845390|NCT02566759|467395180|FG009|All Parts|Adverse Event|0|||
129845391|NCT02566759|467395181|FG010|All Parts|Adverse Event|0|||
129845392|NCT02566759|467395182|FG011|All Parts|Adverse Event|0|||
129845393|NCT02566759|467395183|FG012|All Parts|Adverse Event|1|||
129845394|NCT02566759|467395184|FG013|All Parts|Adverse Event|3|||
129845395|NCT02566759|467395185|FG014|All Parts|Adverse Event|0|||
129845396|NCT02566759|467395186|FG015|All Parts|Adverse Event|0|||
129845397|NCT02566759|467395187|FG016|All Parts|Adverse Event|0|||
129845398|NCT02566759|467395171|FG000|All Parts|Other|0|||
129845399|NCT02566759|467395172|FG001|All Parts|Other|0|||
129845400|NCT02566759|467395173|FG002|All Parts|Other|0|||
129845401|NCT02566759|467395174|FG003|All Parts|Other|0|||
129845402|NCT02566759|467395175|FG004|All Parts|Other|0|||
129845403|NCT02566759|467395176|FG005|All Parts|Other|0|||
129845404|NCT02566759|467395177|FG006|All Parts|Other|0|||
129845405|NCT02566759|467395178|FG007|All Parts|Other|0|||
129845406|NCT02566759|467395179|FG008|All Parts|Other|0|||
129845407|NCT02566759|467395180|FG009|All Parts|Other|0|||
129845408|NCT02566759|467395181|FG010|All Parts|Other|0|||
129845409|NCT02566759|467395182|FG011|All Parts|Other|0|||
129845410|NCT02566759|467395183|FG012|All Parts|Other|0|||
129845411|NCT02566759|467395184|FG013|All Parts|Other|2|||
129845412|NCT02566759|467395185|FG014|All Parts|Other|0|||
129845413|NCT02566759|467395186|FG015|All Parts|Other|0|||
129845414|NCT02566759|467395187|FG016|All Parts|Other|0|||
129845415|NCT02566759|467395171|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845416|NCT02566759|467395172|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845417|NCT02566759|467395173|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845418|NCT02566759|467395174|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845419|NCT02566759|467395175|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845420|NCT02566759|467395176|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845421|NCT02566759|467395177|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129902358|NCT00753012|467604114|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
129902359|NCT00753012|467604115|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
129902360|NCT00753012|467604114|FG000|Overall Study|Adverse Event|2|||
129902361|NCT00753012|467604115|FG001|Overall Study|Adverse Event|0|||
129902362|NCT00753012|467604114|FG000|Overall Study|Withdrawal by Subject|0|||
129902363|NCT00753012|467604115|FG001|Overall Study|Withdrawal by Subject|1|||
129902364|NCT00753012|467604114|FG000|Overall Study|Lost to Follow-up|4|||
129902365|NCT00753012|467604115|FG001|Overall Study|Lost to Follow-up|0|||
129902366|NCT00753012|467604114|FG000|Overall Study|Confounded endpoint data|1|||
129902367|NCT00753012|467604115|FG001|Overall Study|Confounded endpoint data|0|||
129902368|NCT00943735|467604118|FG000|Overall Study|Adverse Event|12|||
129902369|NCT00943735|467604118|FG000|Overall Study|Withdrawal by Subject|8|||
129902370|NCT00943735|467604118|FG000|Overall Study|Death|1|||
129902371|NCT00943735|467604118|FG000|Overall Study|Other|8|||
129902372|NCT00943735|467604118|FG000|Overall Study|Other|3|||
129902373|NCT03804918|467604119|FG000|Overall Study|Participant did not use the app|1|||
129902374|NCT01329328|467604120|FG000|Overall Study|Withdrawal by Subject|2|||
129902375|NCT01329328|467604121|FG001|Overall Study|Withdrawal by Subject|4|||
129902376|NCT01329328|467604122|FG002|Overall Study|Withdrawal by Subject|3|||
129902377|NCT04842604|467604125|FG000|Overall Study|Death|1|||
129902378|NCT04842604|467604126|FG001|Overall Study|Death|0|||
129902379|NCT04842604|467604125|FG000|Overall Study|Other|4|||
129902380|NCT04842604|467604126|FG001|Overall Study|Other|4|||
129902381|NCT04842604|467604125|FG000|Overall Study|Randomized but not treated|1|||
129902382|NCT04842604|467604126|FG001|Overall Study|Randomized but not treated|0|||
129902383|NCT01193153|467604127|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
129845422|NCT02566759|467395178|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845423|NCT02566759|467395179|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845424|NCT02566759|467395180|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845425|NCT02566759|467395181|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845426|NCT02566759|467395182|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845427|NCT02566759|467395183|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845428|NCT02566759|467395184|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845429|NCT02566759|467395185|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845430|NCT02566759|467395186|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845431|NCT02566759|467395187|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
129845432|NCT01126541|467395188|FG000|Overall Study|Adverse Event|0|||
129845433|NCT01126541|467395189|FG001|Overall Study|Adverse Event|2|||
129845434|NCT01126541|467395190|FG002|Overall Study|Adverse Event|4|||
129845435|NCT01126541|467395188|FG000|Overall Study|Death|0|||
129845436|NCT01126541|467395189|FG001|Overall Study|Death|1|||
129845437|NCT01126541|467395190|FG002|Overall Study|Death|0|||
129845438|NCT01126541|467395188|FG000|Overall Study|Lack of Efficacy|6|||
129845439|NCT01126541|467395189|FG001|Overall Study|Lack of Efficacy|1|||
129845440|NCT01126541|467395190|FG002|Overall Study|Lack of Efficacy|11|||
129845441|NCT01126541|467395188|FG000|Overall Study|Lost to Follow-up|1|||
129845442|NCT01126541|467395189|FG001|Overall Study|Lost to Follow-up|2|||
129845443|NCT01126541|467395190|FG002|Overall Study|Lost to Follow-up|2|||
129845444|NCT01126541|467395188|FG000|Overall Study|Withdrawal by Subject|2|||
129845445|NCT01126541|467395189|FG001|Overall Study|Withdrawal by Subject|5|||
129845446|NCT01126541|467395190|FG002|Overall Study|Withdrawal by Subject|6|||
129845447|NCT01126541|467395188|FG000|Overall Study|Protocol Violation|0|||
129845448|NCT01126541|467395189|FG001|Overall Study|Protocol Violation|0|||
129845449|NCT01126541|467395190|FG002|Overall Study|Protocol Violation|1|||
129845450|NCT01126541|467395188|FG000|Overall Study|Administrative reason or other|1|||
129845451|NCT01126541|467395189|FG001|Overall Study|Administrative reason or other|1|||
129845452|NCT01126541|467395190|FG002|Overall Study|Administrative reason or other|2|||
129845453|NCT01532687|467395191|FG000|Overall Study|Death|2|||
129845454|NCT01532687|467395192|FG001|Overall Study|Death|0|||
129845455|NCT01532687|467395191|FG000|Overall Study|Adverse Event|6|||
129845456|NCT01532687|467395192|FG001|Overall Study|Adverse Event|1|||
129845457|NCT01532687|467395191|FG000|Overall Study|Withdrawal by Subject|1|||
129902384|NCT01193153|467604128|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
129902385|NCT01193153|467604127|FG000|Open-label Lead in Period|Pregnancy|1|||
129902386|NCT01193153|467604128|FG001|Open-label Lead in Period|Pregnancy|0|||
129902387|NCT01193153|467604127|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
129902388|NCT01193153|467604128|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
129845458|NCT01532687|467395192|FG001|Overall Study|Withdrawal by Subject|0|||
129845459|NCT01532687|467395191|FG000|Overall Study|Physician Decision|2|||
129845460|NCT01532687|467395192|FG001|Overall Study|Physician Decision|1|||
129845461|NCT01532687|467395191|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
129845462|NCT01532687|467395192|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
129845463|NCT03160703|467395193|FG000|Overall Study|Withdrawal by Subject|0|||
129845464|NCT03160703|467395194|FG001|Overall Study|Withdrawal by Subject|0|||
129902389|NCT01193153|467604127|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
129902390|NCT01193153|467604128|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
129845465|NCT03160703|467395195|FG002|Overall Study|Withdrawal by Subject|0|||
129845466|NCT03160703|467395196|FG003|Overall Study|Withdrawal by Subject|1|||
129845467|NCT00226941|467395197|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
129845468|NCT00226941|467395198|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
129845469|NCT00226941|467395199|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
129845470|NCT00226941|467395200|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
129845471|NCT00226941|467395197|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
129845472|NCT00226941|467395198|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
129845473|NCT00226941|467395199|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
129845474|NCT00226941|467395200|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
129845475|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
129845476|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
129845477|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
129845478|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
129845479|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
129845480|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
129845481|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
129845482|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
129845483|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
129845484|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
129845485|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
129845486|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
129845487|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
129845488|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
129845489|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
129845490|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
129845491|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
129845492|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
129845493|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
129845494|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
129845495|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
129845496|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
129845497|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
129845498|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
129845499|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
129845500|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
129845501|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
129845502|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
129845503|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
129845504|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
129845505|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
129845506|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
129845507|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
129845508|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
129845509|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
129845510|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
129845511|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
129845512|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
129845513|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
129845514|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
129845515|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
129845516|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
129845517|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
129845518|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
129845519|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
129845520|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
129845521|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
129845522|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
129845523|NCT03728582|467395203|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
129845524|NCT03728582|467395204|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
129845525|NCT03728582|467395203|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
129845526|NCT03728582|467395204|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
129845527|NCT01034397|467395205|FG000|Overall Study|Lack of compliance|0|||
129845528|NCT01034397|467395206|FG001|Overall Study|Lack of compliance|1|||
129845529|NCT01034397|467395205|FG000|Overall Study|Lack of Efficacy|3|||
129845530|NCT01034397|467395206|FG001|Overall Study|Lack of Efficacy|0|||
129845531|NCT01034397|467395205|FG000|Overall Study|Adverse Event|4|||
129845532|NCT01034397|467395206|FG001|Overall Study|Adverse Event|0|||
129902391|NCT01193153|467604127|FG000|Open-label Lead in Period|Other|14|||
129902392|NCT01193153|467604128|FG001|Open-label Lead in Period|Other|0|||
129845533|NCT01034397|467395205|FG000|Overall Study|Other|0|||
129845534|NCT01034397|467395206|FG001|Overall Study|Other|1|||
129845535|NCT01018264|467395207|FG000|Overall Study|Withdrawal by Subject|1|||
129845536|NCT01018264|467395208|FG001|Overall Study|Withdrawal by Subject|0|||
129845537|NCT01018264|467395207|FG000|Overall Study|Lost to Follow-up|0|||
129845538|NCT01018264|467395208|FG001|Overall Study|Lost to Follow-up|1|||
129845539|NCT01785524|467395209|FG000|Overall Study|Withdrawal by Subject|2|||
129845540|NCT01785524|467395210|FG001|Overall Study|Withdrawal by Subject|2|||
129845541|NCT00767676|467395215|FG000|Overall Study|Investigator error|54|||
129845542|NCT00617240|467395216|FG000|Overall Study|Lack of Efficacy|1|||
129845543|NCT00617240|467395217|FG001|Overall Study|Lack of Efficacy|0|||
129845544|NCT01611259|467395218|FG000|Overall Study|Physician Decision|1|||
129845545|NCT01611259|467395218|FG000|Overall Study|Lack of Efficacy|2|||
129845546|NCT01611259|467395218|FG000|Overall Study|Adverse Event|4|||
129845547|NCT01611259|467395218|FG000|Overall Study|Withdrawal by Subject|7|||
129845548|NCT04936685|467395219|FG000|Overall Study|Protocol Violation|1|||
129845549|NCT04936685|467395220|FG001|Overall Study|Protocol Violation|0|||
129845550|NCT03969212|467395223|FG000|Overall Study|Adverse Event|1|||
129845551|NCT03969212|467395224|FG001|Overall Study|Adverse Event|0|||
129845552|NCT03969212|467395225|FG002|Overall Study|Adverse Event|0|||
129845553|NCT03969212|467395226|FG003|Overall Study|Adverse Event|0|||
129845554|NCT03969212|467395223|FG000|Overall Study|Lost to Follow-up|2|||
129845555|NCT03969212|467395224|FG001|Overall Study|Lost to Follow-up|2|||
129845556|NCT03969212|467395225|FG002|Overall Study|Lost to Follow-up|2|||
129845557|NCT03969212|467395226|FG003|Overall Study|Lost to Follow-up|2|||
129845558|NCT03969212|467395223|FG000|Overall Study|Protocol Violation|0|||
129845559|NCT03969212|467395224|FG001|Overall Study|Protocol Violation|0|||
129845560|NCT03969212|467395225|FG002|Overall Study|Protocol Violation|0|||
129845561|NCT03969212|467395226|FG003|Overall Study|Protocol Violation|1|||
129845562|NCT03969212|467395223|FG000|Overall Study|Withdrawal by Subject|7|||
129845563|NCT03969212|467395224|FG001|Overall Study|Withdrawal by Subject|13|||
129845564|NCT03969212|467395225|FG002|Overall Study|Withdrawal by Subject|5|||
129845565|NCT03969212|467395226|FG003|Overall Study|Withdrawal by Subject|11|||
129845566|NCT03969212|467395223|FG000|Overall Study|Physician Decision|0|||
129845567|NCT03969212|467395224|FG001|Overall Study|Physician Decision|0|||
129845568|NCT03969212|467395225|FG002|Overall Study|Physician Decision|1|||
129845569|NCT03969212|467395226|FG003|Overall Study|Physician Decision|0|||
129845570|NCT03969212|467395223|FG000|Overall Study|Reason not Specified|22|||
129845571|NCT03969212|467395224|FG001|Overall Study|Reason not Specified|23|||
129845572|NCT03969212|467395225|FG002|Overall Study|Reason not Specified|28|||
129845573|NCT03969212|467395226|FG003|Overall Study|Reason not Specified|26|||
129845574|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
129845575|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
129845576|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
129845577|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
129845578|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
129845579|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
129845580|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
129845581|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
129845582|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
129845583|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
129845584|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
129845585|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
129845586|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
129845587|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
129845588|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
129845589|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
129902393|NCT01193153|467604127|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
129902394|NCT01193153|467604128|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
129902395|NCT01193153|467604127|FG000|Open-label Lead in Period|Adverse Event|41|||
129902396|NCT01193153|467604128|FG001|Open-label Lead in Period|Adverse Event|0|||
129845590|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
129845591|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
129845592|NCT00280566|467395229|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
129845593|NCT00280566|467395230|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
129845594|NCT00280566|467395231|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
129845595|NCT00280566|467395229|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
129845596|NCT00280566|467395230|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
129845597|NCT00280566|467395231|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
129845598|NCT00280566|467395229|FG000|Period 2 Double Blind|Adverse Event|0|||
129845599|NCT00280566|467395230|FG001|Period 2 Double Blind|Adverse Event|11|||
129845600|NCT00280566|467395231|FG002|Period 2 Double Blind|Adverse Event|15|||
129902397|NCT01193153|467604127|FG000|Open-label Lead in Period|Death|1|||
129902398|NCT01193153|467604128|FG001|Open-label Lead in Period|Death|0|||
129845601|NCT00280566|467395229|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
129845602|NCT00280566|467395230|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
129845603|NCT00280566|467395231|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
129845604|NCT00280566|467395229|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
129845605|NCT00280566|467395230|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
129845606|NCT00280566|467395231|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
129845607|NCT00280566|467395229|FG000|Period 2 Double Blind|miscellaneous|0|||
129845608|NCT00280566|467395230|FG001|Period 2 Double Blind|miscellaneous|10|||
129845609|NCT00280566|467395231|FG002|Period 2 Double Blind|miscellaneous|5|||
129845610|NCT00353366|467395232|FG000|Overall Study|Adverse Event|8|||
129845611|NCT00353366|467395232|FG000|Overall Study|Protocol Violation|12|||
129845612|NCT00353366|467395232|FG000|Overall Study|Withdrawal by Subject|12|||
129845613|NCT00353366|467395232|FG000|Overall Study|Lost to Follow-up|92|||
129845614|NCT00353366|467395232|FG000|Overall Study|Other|19|||
129845615|NCT01302392|467395235|FG000|Overall Study|Lost to Follow-up|1|||
129845616|NCT01302392|467395236|FG001|Overall Study|Lost to Follow-up|0|||
129845617|NCT01302392|467395235|FG000|Overall Study|Withdrawal by Subject|6|||
129845618|NCT01302392|467395236|FG001|Overall Study|Withdrawal by Subject|1|||
129845619|NCT00259857|467395237|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
129845620|NCT00259857|467395238|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
129845621|NCT00259857|467395237|FG000|24 Months Treatment|Lost to Follow-up|0|||
129845622|NCT00259857|467395238|FG001|24 Months Treatment|Lost to Follow-up|3|||
129845623|NCT01813019|467395243|FG000|Overall Study|Adverse Event|0|||
129845624|NCT01813019|467395244|FG001|Overall Study|Adverse Event|3|||
129845625|NCT01813019|467395243|FG000|Overall Study|Withdrawal by Subject|3|||
129845626|NCT01813019|467395244|FG001|Overall Study|Withdrawal by Subject|2|||
129845627|NCT01813019|467395243|FG000|Overall Study|administrative problems|2|||
129845628|NCT01813019|467395244|FG001|Overall Study|administrative problems|0|||
129845629|NCT01813019|467395243|FG000|Overall Study|Protocol Deviation|2|||
129845630|NCT01813019|467395244|FG001|Overall Study|Protocol Deviation|1|||
129845631|NCT03025828|467395249|FG000|Overall Study|Lost to Follow-up|1|||
129845632|NCT01020019|467395250|FG000|Overall Study|Lost to Follow-up|21|||
129845633|NCT01020019|467395251|FG001|Overall Study|Lost to Follow-up|18|||
129845634|NCT01020019|467395250|FG000|Overall Study|Adverse Event|1|||
129845635|NCT01020019|467395251|FG001|Overall Study|Adverse Event|5|||
129845636|NCT01020019|467395250|FG000|Overall Study|not interested in treatment|4|||
129845637|NCT01020019|467395251|FG001|Overall Study|not interested in treatment|4|||
129902399|NCT01193153|467604127|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
129902400|NCT01193153|467604128|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
129845638|NCT01020019|467395250|FG000|Overall Study|moving|0|||
129845639|NCT01020019|467395251|FG001|Overall Study|moving|2|||
129845640|NCT04958109|467395252|FG000|Overall Study|Withdrawal by Subject|0|||
129902401|NCT01193153|467604127|FG000|Open-label Stabilization Period|Adverse Event|9|||
129902402|NCT01193153|467604128|FG001|Open-label Stabilization Period|Adverse Event|0|||
129902403|NCT01193153|467604127|FG000|Open-label Stabilization Period|Death|2|||
129902404|NCT01193153|467604128|FG001|Open-label Stabilization Period|Death|0|||
129902405|NCT01193153|467604127|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
129902406|NCT01193153|467604128|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
129902407|NCT01193153|467604127|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
129902408|NCT01193153|467604128|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
129902409|NCT01193153|467604127|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
129902410|NCT01193153|467604128|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
129845641|NCT04958109|467395253|FG001|Overall Study|Withdrawal by Subject|1|||
129845642|NCT04958109|467395252|FG000|Overall Study|Lost to Follow-up|0|||
129845643|NCT04958109|467395253|FG001|Overall Study|Lost to Follow-up|1|||
129845644|NCT02214121|467395254|FG000|Part A|Patient decision|2|||
129845645|NCT02214121|467395255|FG001|Part A|Patient decision|0|||
129845646|NCT02214121|467395256|FG002|Part A|Patient decision|0|||
129845647|NCT02214121|467395254|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
129845648|NCT02214121|467395255|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
129845649|NCT02214121|467395256|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
129845650|NCT02214121|467395254|FG000|Part A|Other|1|||
129845651|NCT02214121|467395255|FG001|Part A|Other|0|||
129845652|NCT02214121|467395256|FG002|Part A|Other|0|||
129845653|NCT02214121|467395254|FG000|Part B|Patient decision|0|||
129902411|NCT01193153|467604127|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
129845654|NCT02214121|467395255|FG001|Part B|Patient decision|1|||
129845655|NCT02214121|467395256|FG002|Part B|Patient decision|0|||
129845656|NCT02214121|467395254|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
129845657|NCT02214121|467395255|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
129845658|NCT02214121|467395256|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
129845659|NCT02214121|467395254|FG000|Part B|Lost to Follow-up|0|||
129902412|NCT01193153|467604128|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
129845660|NCT02214121|467395255|FG001|Part B|Lost to Follow-up|0|||
129845661|NCT02214121|467395256|FG002|Part B|Lost to Follow-up|1|||
129902413|NCT01193153|467604127|FG000|Open-label Stabilization Period|Other|8|||
129902414|NCT01193153|467604128|FG001|Open-label Stabilization Period|Other|0|||
129845662|NCT00715793|467395257|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
129845663|NCT00715793|467395258|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
129845664|NCT00715793|467395257|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
129845665|NCT00715793|467395258|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
129845666|NCT01559311|467395259|FG000|Overall Study|Protocol Violation|0|||
129845667|NCT01559311|467395260|FG001|Overall Study|Protocol Violation|0|||
129845668|NCT01559311|467395261|FG002|Overall Study|Protocol Violation|2|||
129845669|NCT01559311|467395259|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
129845670|NCT01559311|467395260|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
129845671|NCT01559311|467395261|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
129845672|NCT01559311|467395259|FG000|Overall Study|Withdrawal by Subject|2|||
129845673|NCT01559311|467395260|FG001|Overall Study|Withdrawal by Subject|1|||
129845674|NCT01559311|467395261|FG002|Overall Study|Withdrawal by Subject|0|||
129845675|NCT01559311|467395259|FG000|Overall Study|Death|0|||
129845676|NCT01559311|467395260|FG001|Overall Study|Death|2|||
129845677|NCT01559311|467395261|FG002|Overall Study|Death|3|||
129845678|NCT01559311|467395259|FG000|Overall Study|Lost to Follow-up|0|||
129845679|NCT01559311|467395260|FG001|Overall Study|Lost to Follow-up|3|||
129845680|NCT01559311|467395261|FG002|Overall Study|Lost to Follow-up|2|||
129845681|NCT01559311|467395259|FG000|Overall Study|Adverse Event|0|||
129845682|NCT01559311|467395260|FG001|Overall Study|Adverse Event|0|||
129845683|NCT01559311|467395261|FG002|Overall Study|Adverse Event|1|||
129845684|NCT01849588|467395262|FG000|Overall Study|Lack of Efficacy|3|||
129845685|NCT02143843|467395264|FG000|Overall Study|Adverse Event|8|||
129845686|NCT02143843|467395264|FG000|Overall Study|Lack of Efficacy|2|||
129845687|NCT02143843|467395264|FG000|Overall Study|Withdrawal by Subject|2|||
129845688|NCT01462357|467395268|FG000|Overall Study|Death|0|||
129845689|NCT01462357|467395269|FG001|Overall Study|Death|0|||
129845690|NCT01462357|467395270|FG002|Overall Study|Death|1|||
129845691|NCT01462357|467395268|FG000|Overall Study|Withdrawal by Subject|3|||
129845692|NCT01462357|467395269|FG001|Overall Study|Withdrawal by Subject|11|||
129845693|NCT01462357|467395270|FG002|Overall Study|Withdrawal by Subject|3|||
129845694|NCT01462357|467395268|FG000|Overall Study|Migrated/moved from study area|2|||
129845695|NCT01462357|467395269|FG001|Overall Study|Migrated/moved from study area|3|||
129845696|NCT01462357|467395270|FG002|Overall Study|Migrated/moved from study area|1|||
129845697|NCT01462357|467395268|FG000|Overall Study|Lost to Follow-up|3|||
129845698|NCT01462357|467395269|FG001|Overall Study|Lost to Follow-up|5|||
129845699|NCT01462357|467395270|FG002|Overall Study|Lost to Follow-up|7|||
129845700|NCT01482767|467395272|FG000|Overall Study|Death|1|||
129845701|NCT01482767|467395273|FG001|Overall Study|Death|1|||
129845702|NCT01482767|467395272|FG000|Overall Study|Withdrawal by Subject|7|||
129845703|NCT01482767|467395273|FG001|Overall Study|Withdrawal by Subject|5|||
129845704|NCT01482767|467395272|FG000|Overall Study|Lost to Follow-up|12|||
129845705|NCT01482767|467395273|FG001|Overall Study|Lost to Follow-up|6|||
129845706|NCT01482767|467395272|FG000|Overall Study|Adverse Event|0|||
129845707|NCT01482767|467395273|FG001|Overall Study|Adverse Event|3|||
129845708|NCT01482767|467395272|FG000|Overall Study|Site closure|22|||
129845709|NCT01482767|467395273|FG001|Overall Study|Site closure|14|||
129845710|NCT01482767|467395272|FG000|Overall Study|Non-adherence to study requirements|4|||
129845711|NCT01482767|467395273|FG001|Overall Study|Non-adherence to study requirements|7|||
129845712|NCT01482767|467395272|FG000|Overall Study|Alternate HCV treatment|7|||
129845713|NCT01482767|467395273|FG001|Overall Study|Alternate HCV treatment|8|||
129845714|NCT01482767|467395272|FG000|Overall Study|Ineligible|0|||
129845715|NCT01482767|467395273|FG001|Overall Study|Ineligible|5|||
129845716|NCT01482767|467395272|FG000|Overall Study|Nurse error|1|||
129845717|NCT01482767|467395273|FG001|Overall Study|Nurse error|0|||
129845718|NCT00025883|467395274|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
129845719|NCT00025883|467395274|FG000|Overall Study|no baseline data|1|||
129845720|NCT00025883|467395274|FG000|Overall Study|Death|1|||
129845721|NCT00025883|467395274|FG000|Overall Study|Adverse Event|1|||
129845722|NCT00025883|467395274|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
129845723|NCT02908529|467395276|FG000|Overall Study|Lost to Follow-up|0|||
129845724|NCT02908529|467395277|FG001|Overall Study|Lost to Follow-up|2|||
129845725|NCT02553421|467395278|FG000|Overall Study|Lost to Follow-up|21|||
129845726|NCT02553421|467395279|FG001|Overall Study|Lost to Follow-up|1|||
129845727|NCT02553421|467395278|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
129845728|NCT02553421|467395279|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
129845729|NCT02553421|467395278|FG000|Overall Study|Improper Device Placement|3|||
129845730|NCT02553421|467395279|FG001|Overall Study|Improper Device Placement|0|||
129845731|NCT04197713|467395282|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
129845732|NCT04197713|467395283|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
129845733|NCT05569954|467395284|FG000|Overall Study|Lost to Follow-up|3|||
129845734|NCT05569954|467395285|FG001|Overall Study|Lost to Follow-up|4|||
129845735|NCT05569954|467395284|FG000|Overall Study|Protocol Violation|1|||
129845736|NCT05569954|467395285|FG001|Overall Study|Protocol Violation|2|||
129845737|NCT05569954|467395284|FG000|Overall Study|Withdrawal by Subject|4|||
129845738|NCT05569954|467395285|FG001|Overall Study|Withdrawal by Subject|2|||
129902415|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Other|2|||
129902416|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Other|3|||
129902417|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
129902418|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
129902419|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Death|2|||
129902420|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Death|0|||
129902421|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
129902422|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
129902423|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
129902424|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
129902425|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
129902426|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
129902427|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
129902428|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
129902429|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
129902430|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
129902431|NCT01648140|467604129|FG000|Overall Study|Physician Decision|1|||
129902432|NCT01648140|467604130|FG001|Overall Study|Physician Decision|0|||
129902433|NCT01648140|467604131|FG002|Overall Study|Physician Decision|0|||
129902434|NCT01648140|467604132|FG003|Overall Study|Physician Decision|0|||
130116553|NCT02247479|468387100|FG000|Overall Study|Withdrawal by Subject|25|||
130116554|NCT02247479|468387101|FG001|Overall Study|Withdrawal by Subject|29|||
130116555|NCT02247479|468387102|FG002|Overall Study|Withdrawal by Subject|24|||
130116556|NCT02247479|468387100|FG000|Overall Study|Study Terminated by Sponsor|98|||
130116557|NCT02247479|468387101|FG001|Overall Study|Study Terminated by Sponsor|88|||
129845739|NCT01660412|467395286|FG000|Overall Study|Protocol Violation|0|||
129845740|NCT01660412|467395287|FG001|Overall Study|Protocol Violation|3|||
129845741|NCT03013491|467395288|FG000|Main Study|Death|2|||
129902435|NCT01648140|467604129|FG000|Overall Study|Lack of Efficacy|4|||
129902436|NCT01648140|467604130|FG001|Overall Study|Lack of Efficacy|7|||
129902437|NCT01648140|467604131|FG002|Overall Study|Lack of Efficacy|1|||
129902438|NCT01648140|467604132|FG003|Overall Study|Lack of Efficacy|0|||
129902439|NCT01648140|467604129|FG000|Overall Study|Adverse Event|3|||
129902440|NCT01648140|467604130|FG001|Overall Study|Adverse Event|1|||
129902441|NCT01648140|467604131|FG002|Overall Study|Adverse Event|2|||
129902442|NCT01648140|467604132|FG003|Overall Study|Adverse Event|0|||
129902443|NCT01648140|467604129|FG000|Overall Study|Withdrawal by Subject|2|||
129902444|NCT01648140|467604130|FG001|Overall Study|Withdrawal by Subject|3|||
129845742|NCT03013491|467395289|FG001|Main Study|Death|2|||
129845743|NCT03013491|467395290|FG002|Main Study|Death|5|||
129845744|NCT03013491|467395291|FG003|Main Study|Death|3|||
129845745|NCT03013491|467395292|FG004|Main Study|Death|9|||
129845746|NCT03013491|467395293|FG005|Main Study|Death|12|||
129845747|NCT03013491|467395294|FG006|Main Study|Death|3|||
129845748|NCT03013491|467395295|FG007|Main Study|Death|5|||
129845749|NCT03013491|467395296|FG008|Main Study|Death|1|||
129845750|NCT03013491|467395297|FG009|Main Study|Death|2|||
129845751|NCT03013491|467395298|FG010|Main Study|Death|4|||
129845752|NCT03013491|467395299|FG011|Main Study|Death|1|||
129845753|NCT03013491|467395300|FG012|Main Study|Death|1|||
129845754|NCT03013491|467395301|FG013|Main Study|Death|4|||
129845755|NCT03013491|467395302|FG014|Main Study|Death|0|||
129845756|NCT03013491|467395303|FG015|Main Study|Death|3|||
129845757|NCT03013491|467395304|FG016|Main Study|Death|5|||
129845758|NCT03013491|467395305|FG017|Main Study|Death|1|||
129845759|NCT03013491|467395306|FG018|Main Study|Death|47|||
129845760|NCT03013491|467395288|FG000|Main Study|Lost to Follow-up|0|||
129845761|NCT03013491|467395289|FG001|Main Study|Lost to Follow-up|0|||
129845762|NCT03013491|467395290|FG002|Main Study|Lost to Follow-up|1|||
129845763|NCT03013491|467395291|FG003|Main Study|Lost to Follow-up|0|||
129845764|NCT03013491|467395292|FG004|Main Study|Lost to Follow-up|1|||
129845765|NCT03013491|467395293|FG005|Main Study|Lost to Follow-up|0|||
129902445|NCT01648140|467604131|FG002|Overall Study|Withdrawal by Subject|3|||
129902446|NCT01648140|467604132|FG003|Overall Study|Withdrawal by Subject|2|||
129902447|NCT01648140|467604129|FG000|Overall Study|Lost to Follow-up|2|||
129902448|NCT01648140|467604130|FG001|Overall Study|Lost to Follow-up|1|||
129902449|NCT01648140|467604131|FG002|Overall Study|Lost to Follow-up|2|||
129902450|NCT01648140|467604132|FG003|Overall Study|Lost to Follow-up|0|||
129902451|NCT00716144|467604137|FG000|Overall Study|Withdrawal by Subject|4|||
129902452|NCT00716144|467604138|FG001|Overall Study|Withdrawal by Subject|2|||
129902453|NCT00716144|467604139|FG002|Overall Study|Withdrawal by Subject|6|||
130116558|NCT02247479|468387102|FG002|Overall Study|Study Terminated by Sponsor|94|||
129845766|NCT03013491|467395294|FG006|Main Study|Lost to Follow-up|0|||
129845767|NCT03013491|467395295|FG007|Main Study|Lost to Follow-up|0|||
129845768|NCT03013491|467395296|FG008|Main Study|Lost to Follow-up|0|||
129845769|NCT03013491|467395297|FG009|Main Study|Lost to Follow-up|0|||
129845770|NCT03013491|467395298|FG010|Main Study|Lost to Follow-up|0|||
129845771|NCT03013491|467395299|FG011|Main Study|Lost to Follow-up|0|||
129845772|NCT03013491|467395300|FG012|Main Study|Lost to Follow-up|0|||
129845773|NCT03013491|467395301|FG013|Main Study|Lost to Follow-up|0|||
129845774|NCT03013491|467395302|FG014|Main Study|Lost to Follow-up|0|||
129845775|NCT03013491|467395303|FG015|Main Study|Lost to Follow-up|0|||
129845776|NCT03013491|467395304|FG016|Main Study|Lost to Follow-up|0|||
129845777|NCT03013491|467395305|FG017|Main Study|Lost to Follow-up|0|||
129845778|NCT03013491|467395306|FG018|Main Study|Lost to Follow-up|3|||
129845779|NCT03013491|467395288|FG000|Main Study|Termination of the study by Sponsor|0|||
129845780|NCT03013491|467395289|FG001|Main Study|Termination of the study by Sponsor|0|||
129845781|NCT03013491|467395290|FG002|Main Study|Termination of the study by Sponsor|2|||
129845782|NCT03013491|467395291|FG003|Main Study|Termination of the study by Sponsor|0|||
129845783|NCT03013491|467395292|FG004|Main Study|Termination of the study by Sponsor|1|||
129845784|NCT03013491|467395293|FG005|Main Study|Termination of the study by Sponsor|2|||
129845785|NCT03013491|467395294|FG006|Main Study|Termination of the study by Sponsor|0|||
129845786|NCT03013491|467395295|FG007|Main Study|Termination of the study by Sponsor|0|||
129845787|NCT03013491|467395296|FG008|Main Study|Termination of the study by Sponsor|1|||
129845788|NCT03013491|467395297|FG009|Main Study|Termination of the study by Sponsor|1|||
129845789|NCT03013491|467395298|FG010|Main Study|Termination of the study by Sponsor|1|||
129845790|NCT03013491|467395299|FG011|Main Study|Termination of the study by Sponsor|2|||
129845791|NCT03013491|467395300|FG012|Main Study|Termination of the study by Sponsor|0|||
129845792|NCT03013491|467395301|FG013|Main Study|Termination of the study by Sponsor|0|||
129845793|NCT03013491|467395302|FG014|Main Study|Termination of the study by Sponsor|0|||
129845794|NCT03013491|467395303|FG015|Main Study|Termination of the study by Sponsor|0|||
129845795|NCT03013491|467395304|FG016|Main Study|Termination of the study by Sponsor|0|||
129845796|NCT03013491|467395305|FG017|Main Study|Termination of the study by Sponsor|1|||
129845797|NCT03013491|467395306|FG018|Main Study|Termination of the study by Sponsor|13|||
129845798|NCT03013491|467395288|FG000|Main Study|Withdrawal by Subject|0|||
129845799|NCT03013491|467395289|FG001|Main Study|Withdrawal by Subject|0|||
129845800|NCT03013491|467395290|FG002|Main Study|Withdrawal by Subject|0|||
129845801|NCT03013491|467395291|FG003|Main Study|Withdrawal by Subject|4|||
129845802|NCT03013491|467395292|FG004|Main Study|Withdrawal by Subject|2|||
129845803|NCT03013491|467395293|FG005|Main Study|Withdrawal by Subject|1|||
129845804|NCT03013491|467395294|FG006|Main Study|Withdrawal by Subject|0|||
129845805|NCT03013491|467395295|FG007|Main Study|Withdrawal by Subject|0|||
129845806|NCT03013491|467395296|FG008|Main Study|Withdrawal by Subject|0|||
129845807|NCT03013491|467395297|FG009|Main Study|Withdrawal by Subject|0|||
129845808|NCT03013491|467395298|FG010|Main Study|Withdrawal by Subject|1|||
129845809|NCT03013491|467395299|FG011|Main Study|Withdrawal by Subject|2|||
129845810|NCT03013491|467395300|FG012|Main Study|Withdrawal by Subject|0|||
129845811|NCT03013491|467395301|FG013|Main Study|Withdrawal by Subject|2|||
129845812|NCT03013491|467395302|FG014|Main Study|Withdrawal by Subject|0|||
129845813|NCT03013491|467395303|FG015|Main Study|Withdrawal by Subject|0|||
129845814|NCT03013491|467395304|FG016|Main Study|Withdrawal by Subject|0|||
129845815|NCT03013491|467395305|FG017|Main Study|Withdrawal by Subject|0|||
129845816|NCT03013491|467395306|FG018|Main Study|Withdrawal by Subject|18|||
129845817|NCT03013491|467395288|FG000|Main Study|Disease progression|0|||
129845818|NCT03013491|467395289|FG001|Main Study|Disease progression|0|||
129845819|NCT03013491|467395290|FG002|Main Study|Disease progression|0|||
129845820|NCT03013491|467395291|FG003|Main Study|Disease progression|1|||
129845821|NCT03013491|467395292|FG004|Main Study|Disease progression|0|||
129845822|NCT03013491|467395293|FG005|Main Study|Disease progression|0|||
129845823|NCT03013491|467395294|FG006|Main Study|Disease progression|0|||
129845824|NCT03013491|467395295|FG007|Main Study|Disease progression|0|||
129845825|NCT03013491|467395296|FG008|Main Study|Disease progression|1|||
129845826|NCT03013491|467395297|FG009|Main Study|Disease progression|0|||
129845827|NCT03013491|467395298|FG010|Main Study|Disease progression|1|||
129845828|NCT03013491|467395299|FG011|Main Study|Disease progression|0|||
129845829|NCT03013491|467395300|FG012|Main Study|Disease progression|0|||
129845830|NCT03013491|467395301|FG013|Main Study|Disease progression|0|||
129845831|NCT03013491|467395302|FG014|Main Study|Disease progression|0|||
129845832|NCT03013491|467395303|FG015|Main Study|Disease progression|0|||
129845833|NCT03013491|467395304|FG016|Main Study|Disease progression|0|||
129845834|NCT03013491|467395305|FG017|Main Study|Disease progression|0|||
129845835|NCT03013491|467395306|FG018|Main Study|Disease progression|4|||
129845836|NCT03013491|467395288|FG000|Main Study|Symptomatic deterioration|0|||
129845837|NCT03013491|467395289|FG001|Main Study|Symptomatic deterioration|0|||
129845838|NCT03013491|467395290|FG002|Main Study|Symptomatic deterioration|0|||
129845839|NCT03013491|467395291|FG003|Main Study|Symptomatic deterioration|0|||
129845840|NCT03013491|467395292|FG004|Main Study|Symptomatic deterioration|0|||
129845841|NCT03013491|467395293|FG005|Main Study|Symptomatic deterioration|1|||
129845842|NCT03013491|467395294|FG006|Main Study|Symptomatic deterioration|0|||
129845843|NCT03013491|467395295|FG007|Main Study|Symptomatic deterioration|0|||
129845844|NCT03013491|467395296|FG008|Main Study|Symptomatic deterioration|0|||
129845845|NCT03013491|467395297|FG009|Main Study|Symptomatic deterioration|0|||
129845846|NCT03013491|467395298|FG010|Main Study|Symptomatic deterioration|0|||
129845847|NCT03013491|467395299|FG011|Main Study|Symptomatic deterioration|0|||
129845848|NCT03013491|467395300|FG012|Main Study|Symptomatic deterioration|0|||
129845849|NCT03013491|467395301|FG013|Main Study|Symptomatic deterioration|0|||
129845850|NCT03013491|467395302|FG014|Main Study|Symptomatic deterioration|0|||
129845851|NCT03013491|467395303|FG015|Main Study|Symptomatic deterioration|0|||
129845852|NCT03013491|467395304|FG016|Main Study|Symptomatic deterioration|0|||
129845853|NCT03013491|467395305|FG017|Main Study|Symptomatic deterioration|0|||
129845854|NCT03013491|467395306|FG018|Main Study|Symptomatic deterioration|0|||
129845855|NCT03013491|467395288|FG000|Main Study|Protocol version 8.0 approval|0|||
129845856|NCT03013491|467395289|FG001|Main Study|Protocol version 8.0 approval|0|||
129845857|NCT03013491|467395290|FG002|Main Study|Protocol version 8.0 approval|0|||
129845858|NCT03013491|467395291|FG003|Main Study|Protocol version 8.0 approval|0|||
129845859|NCT03013491|467395292|FG004|Main Study|Protocol version 8.0 approval|0|||
129845860|NCT03013491|467395293|FG005|Main Study|Protocol version 8.0 approval|0|||
129845861|NCT03013491|467395294|FG006|Main Study|Protocol version 8.0 approval|0|||
129845862|NCT03013491|467395295|FG007|Main Study|Protocol version 8.0 approval|0|||
129845863|NCT03013491|467395296|FG008|Main Study|Protocol version 8.0 approval|0|||
129845864|NCT03013491|467395297|FG009|Main Study|Protocol version 8.0 approval|0|||
129845865|NCT03013491|467395298|FG010|Main Study|Protocol version 8.0 approval|1|||
129845866|NCT03013491|467395299|FG011|Main Study|Protocol version 8.0 approval|0|||
129845867|NCT03013491|467395300|FG012|Main Study|Protocol version 8.0 approval|0|||
129845868|NCT03013491|467395301|FG013|Main Study|Protocol version 8.0 approval|0|||
129845869|NCT03013491|467395302|FG014|Main Study|Protocol version 8.0 approval|0|||
129845870|NCT03013491|467395303|FG015|Main Study|Protocol version 8.0 approval|0|||
129902454|NCT00716144|467604140|FG003|Overall Study|Withdrawal by Subject|6|||
129845871|NCT03013491|467395304|FG016|Main Study|Protocol version 8.0 approval|0|||
129845872|NCT03013491|467395305|FG017|Main Study|Protocol version 8.0 approval|0|||
129845873|NCT03013491|467395306|FG018|Main Study|Protocol version 8.0 approval|0|||
129845874|NCT03013491|467395288|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
129845875|NCT03013491|467395289|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
129845876|NCT03013491|467395290|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
129845877|NCT03013491|467395291|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
129845878|NCT03013491|467395292|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
129845879|NCT03013491|467395293|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
129845880|NCT03013491|467395294|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
129845881|NCT03013491|467395295|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
129845882|NCT03013491|467395296|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
129845883|NCT03013491|467395297|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
129845884|NCT03013491|467395298|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
129845885|NCT03013491|467395299|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
129845886|NCT03013491|467395300|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
129845887|NCT03013491|467395301|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
129845888|NCT03013491|467395302|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
129845889|NCT03013491|467395303|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
129845890|NCT03013491|467395304|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
129845891|NCT03013491|467395305|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
129902455|NCT00716144|467604137|FG000|Overall Study|Lost to Follow-up|2|||
129902456|NCT00716144|467604138|FG001|Overall Study|Lost to Follow-up|2|||
129902457|NCT00716144|467604139|FG002|Overall Study|Lost to Follow-up|1|||
129902458|NCT00716144|467604140|FG003|Overall Study|Lost to Follow-up|2|||
129902459|NCT00716144|467604137|FG000|Overall Study|Adverse Event|0|||
129902460|NCT00716144|467604138|FG001|Overall Study|Adverse Event|0|||
129902461|NCT00716144|467604139|FG002|Overall Study|Adverse Event|0|||
129902462|NCT00716144|467604140|FG003|Overall Study|Adverse Event|2|||
129902463|NCT00716144|467604137|FG000|Overall Study|Non-compliance|1|||
129902464|NCT00716144|467604138|FG001|Overall Study|Non-compliance|0|||
129902465|NCT00716144|467604139|FG002|Overall Study|Non-compliance|0|||
129902466|NCT00716144|467604140|FG003|Overall Study|Non-compliance|0|||
129845892|NCT03013491|467395306|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
129845893|NCT03013491|467395288|FG000|Main Study|Start of new anticancer therapy|0|||
129845894|NCT03013491|467395289|FG001|Main Study|Start of new anticancer therapy|0|||
129845895|NCT03013491|467395290|FG002|Main Study|Start of new anticancer therapy|0|||
129845896|NCT03013491|467395291|FG003|Main Study|Start of new anticancer therapy|0|||
129845897|NCT03013491|467395292|FG004|Main Study|Start of new anticancer therapy|0|||
129902467|NCT00716144|467604137|FG000|Overall Study|Protocol Violation|2|||
129902468|NCT00716144|467604138|FG001|Overall Study|Protocol Violation|0|||
129902469|NCT00716144|467604139|FG002|Overall Study|Protocol Violation|1|||
129902470|NCT00716144|467604140|FG003|Overall Study|Protocol Violation|0|||
129902471|NCT00716144|467604137|FG000|Overall Study|Physician Decision|0|||
129902472|NCT00716144|467604138|FG001|Overall Study|Physician Decision|1|||
129902473|NCT00716144|467604139|FG002|Overall Study|Physician Decision|2|||
129902474|NCT00716144|467604140|FG003|Overall Study|Physician Decision|2|||
129902475|NCT00716144|467604137|FG000|Overall Study|Intercurrent illness|0|||
129902476|NCT00716144|467604138|FG001|Overall Study|Intercurrent illness|0|||
129902477|NCT00716144|467604139|FG002|Overall Study|Intercurrent illness|1|||
129902478|NCT00716144|467604140|FG003|Overall Study|Intercurrent illness|0|||
129902479|NCT00716144|467604137|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
129902480|NCT00716144|467604138|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
129902481|NCT00716144|467604139|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
129902482|NCT00716144|467604140|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
129845898|NCT03013491|467395293|FG005|Main Study|Start of new anticancer therapy|0|||
129845899|NCT03013491|467395294|FG006|Main Study|Start of new anticancer therapy|0|||
129845900|NCT03013491|467395295|FG007|Main Study|Start of new anticancer therapy|0|||
129845901|NCT03013491|467395296|FG008|Main Study|Start of new anticancer therapy|0|||
129845902|NCT03013491|467395297|FG009|Main Study|Start of new anticancer therapy|0|||
129845903|NCT03013491|467395298|FG010|Main Study|Start of new anticancer therapy|0|||
129845904|NCT03013491|467395299|FG011|Main Study|Start of new anticancer therapy|0|||
129845905|NCT03013491|467395300|FG012|Main Study|Start of new anticancer therapy|0|||
129845906|NCT03013491|467395301|FG013|Main Study|Start of new anticancer therapy|0|||
129845907|NCT03013491|467395302|FG014|Main Study|Start of new anticancer therapy|0|||
129845908|NCT03013491|467395303|FG015|Main Study|Start of new anticancer therapy|0|||
129845909|NCT03013491|467395304|FG016|Main Study|Start of new anticancer therapy|0|||
129845910|NCT03013491|467395305|FG017|Main Study|Start of new anticancer therapy|0|||
129845911|NCT03013491|467395306|FG018|Main Study|Start of new anticancer therapy|2|||
129845912|NCT03013491|467395288|FG000|Long-term Extension|Disease progression|0|||
129845913|NCT03013491|467395289|FG001|Long-term Extension|Disease progression|0|||
129845914|NCT03013491|467395290|FG002|Long-term Extension|Disease progression|0|||
129845915|NCT03013491|467395291|FG003|Long-term Extension|Disease progression|1|||
129845916|NCT03013491|467395292|FG004|Long-term Extension|Disease progression|0|||
129845917|NCT03013491|467395293|FG005|Long-term Extension|Disease progression|0|||
129845918|NCT03013491|467395294|FG006|Long-term Extension|Disease progression|0|||
129845919|NCT03013491|467395295|FG007|Long-term Extension|Disease progression|0|||
129845920|NCT03013491|467395296|FG008|Long-term Extension|Disease progression|0|||
129845921|NCT03013491|467395297|FG009|Long-term Extension|Disease progression|0|||
129845922|NCT03013491|467395298|FG010|Long-term Extension|Disease progression|0|||
129845923|NCT03013491|467395299|FG011|Long-term Extension|Disease progression|0|||
129845924|NCT03013491|467395300|FG012|Long-term Extension|Disease progression|0|||
129845925|NCT03013491|467395301|FG013|Long-term Extension|Disease progression|0|||
129845926|NCT03013491|467395302|FG014|Long-term Extension|Disease progression|0|||
129902483|NCT00716144|467604137|FG000|Overall Study|Adverse event: left foot pain|0|||
129902484|NCT00716144|467604138|FG001|Overall Study|Adverse event: left foot pain|1|||
129902485|NCT00716144|467604139|FG002|Overall Study|Adverse event: left foot pain|0|||
129902486|NCT00716144|467604140|FG003|Overall Study|Adverse event: left foot pain|0|||
129902487|NCT00716144|467604137|FG000|Overall Study|Clinical Depression|0|||
129902488|NCT00716144|467604138|FG001|Overall Study|Clinical Depression|1|||
129902489|NCT00716144|467604139|FG002|Overall Study|Clinical Depression|0|||
129902490|NCT00716144|467604140|FG003|Overall Study|Clinical Depression|0|||
129902491|NCT02950558|467604141|FG000|Overall Study|Lost to Follow-up|2|||
129902492|NCT02950558|467604142|FG001|Overall Study|Lost to Follow-up|0|||
129902493|NCT01321606|467604145|FG000|Overall Study|Lost to Follow-up|0|||
129902494|NCT01321606|467604146|FG001|Overall Study|Lost to Follow-up|0|||
129902495|NCT01321606|467604147|FG002|Overall Study|Lost to Follow-up|0|||
129902496|NCT01321606|467604148|FG003|Overall Study|Lost to Follow-up|1|||
129902497|NCT00756730|467604153|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
129902498|NCT00756730|467604154|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
129902499|NCT00756730|467604153|FG000|Overall Study|persistent low-level viremmia|0|||
129902500|NCT00756730|467604154|FG001|Overall Study|persistent low-level viremmia|1|||
129902501|NCT01161498|467604156|FG000|Overall Study|Disease Progression|0|||
129902502|NCT01161498|467604157|FG001|Overall Study|Disease Progression|1|||
129902503|NCT05686421|467604158|FG000|Overall Study|Screen failure|22|||
129902504|NCT05686421|467604159|FG001|Overall Study|Screen failure|0|||
129902505|NCT05686421|467604160|FG002|Overall Study|Screen failure|0|||
129902506|NCT05686421|467604161|FG003|Overall Study|Screen failure|0|||
129902507|NCT00367055|467604165|FG000|Overall Study|Adverse Event|6|||
129902508|NCT00367055|467604166|FG001|Overall Study|Adverse Event|3|||
130064542|NCT00510068|468190193|FG001|Open-label Period|Adverse Event|0|||
129845927|NCT03013491|467395303|FG015|Long-term Extension|Disease progression|0|||
129845928|NCT03013491|467395304|FG016|Long-term Extension|Disease progression|0|||
129845929|NCT03013491|467395305|FG017|Long-term Extension|Disease progression|0|||
129845930|NCT03013491|467395306|FG018|Long-term Extension|Disease progression|1|||
129845931|NCT03013491|467395288|FG000|Long-term Extension|Withdrawal by Subject|0|||
129902509|NCT00367055|467604165|FG000|Overall Study|Patient's Willing|3|||
129845932|NCT03013491|467395289|FG001|Long-term Extension|Withdrawal by Subject|0|||
129902510|NCT00367055|467604166|FG001|Overall Study|Patient's Willing|2|||
129902511|NCT00367055|467604165|FG000|Overall Study|Lack of Efficacy|1|||
129902512|NCT00367055|467604166|FG001|Overall Study|Lack of Efficacy|2|||
129902513|NCT00367055|467604165|FG000|Overall Study|Lost to Follow-up|1|||
129902514|NCT00367055|467604166|FG001|Overall Study|Lost to Follow-up|1|||
129902515|NCT00367055|467604165|FG000|Overall Study|Protocol Violation|0|||
129902516|NCT00367055|467604166|FG001|Overall Study|Protocol Violation|1|||
129902517|NCT00367055|467604165|FG000|Overall Study|Stopping Criterion Met|0|||
129902518|NCT00367055|467604166|FG001|Overall Study|Stopping Criterion Met|1|||
129902519|NCT00367055|467604165|FG000|Overall Study|Participant Living too Far from Hospital|0|||
129902520|NCT00367055|467604166|FG001|Overall Study|Participant Living too Far from Hospital|1|||
129845933|NCT03013491|467395290|FG002|Long-term Extension|Withdrawal by Subject|0|||
129845934|NCT03013491|467395291|FG003|Long-term Extension|Withdrawal by Subject|0|||
129845935|NCT03013491|467395292|FG004|Long-term Extension|Withdrawal by Subject|0|||
129845936|NCT03013491|467395293|FG005|Long-term Extension|Withdrawal by Subject|0|||
129845937|NCT03013491|467395294|FG006|Long-term Extension|Withdrawal by Subject|0|||
129845938|NCT03013491|467395295|FG007|Long-term Extension|Withdrawal by Subject|1|||
129845939|NCT03013491|467395296|FG008|Long-term Extension|Withdrawal by Subject|0|||
129845940|NCT03013491|467395297|FG009|Long-term Extension|Withdrawal by Subject|0|||
129845941|NCT03013491|467395298|FG010|Long-term Extension|Withdrawal by Subject|0|||
129845942|NCT03013491|467395299|FG011|Long-term Extension|Withdrawal by Subject|0|||
129845943|NCT03013491|467395300|FG012|Long-term Extension|Withdrawal by Subject|0|||
129845944|NCT03013491|467395301|FG013|Long-term Extension|Withdrawal by Subject|0|||
129845945|NCT03013491|467395302|FG014|Long-term Extension|Withdrawal by Subject|0|||
129845946|NCT03013491|467395303|FG015|Long-term Extension|Withdrawal by Subject|0|||
129845947|NCT03013491|467395304|FG016|Long-term Extension|Withdrawal by Subject|0|||
129845948|NCT03013491|467395305|FG017|Long-term Extension|Withdrawal by Subject|0|||
129845949|NCT03013491|467395306|FG018|Long-term Extension|Withdrawal by Subject|0|||
129845950|NCT03013491|467395288|FG000|Long-term Extension|Adverse Event|0|||
129845951|NCT03013491|467395289|FG001|Long-term Extension|Adverse Event|0|||
129845952|NCT03013491|467395290|FG002|Long-term Extension|Adverse Event|0|||
129845953|NCT03013491|467395291|FG003|Long-term Extension|Adverse Event|0|||
129845954|NCT03013491|467395292|FG004|Long-term Extension|Adverse Event|0|||
129845955|NCT03013491|467395293|FG005|Long-term Extension|Adverse Event|0|||
129845956|NCT03013491|467395294|FG006|Long-term Extension|Adverse Event|0|||
129845957|NCT03013491|467395295|FG007|Long-term Extension|Adverse Event|0|||
129845958|NCT03013491|467395296|FG008|Long-term Extension|Adverse Event|0|||
129845959|NCT03013491|467395297|FG009|Long-term Extension|Adverse Event|0|||
129845960|NCT03013491|467395298|FG010|Long-term Extension|Adverse Event|0|||
129902521|NCT02517307|467604181|FG000|Overall Study|Withdrawal by Subject|1|||
129902522|NCT02517307|467604182|FG001|Overall Study|Withdrawal by Subject|0|||
129902523|NCT02517307|467604183|FG002|Overall Study|Withdrawal by Subject|1|||
129902524|NCT02517307|467604184|FG003|Overall Study|Withdrawal by Subject|0|||
129902525|NCT02517307|467604181|FG000|Overall Study|Protocol Violation|0|||
129902526|NCT02517307|467604182|FG001|Overall Study|Protocol Violation|0|||
129902527|NCT02517307|467604183|FG002|Overall Study|Protocol Violation|1|||
129902528|NCT02517307|467604184|FG003|Overall Study|Protocol Violation|1|||
129902529|NCT00823979|467604185|FG000|Overall Study|Lack of Efficacy|13|||
129902530|NCT00823979|467604186|FG001|Overall Study|Lack of Efficacy|16|||
129902531|NCT00823979|467604187|FG002|Overall Study|Lack of Efficacy|9|||
129902532|NCT00823979|467604185|FG000|Overall Study|Lost to Follow-up|2|||
129902533|NCT00823979|467604186|FG001|Overall Study|Lost to Follow-up|1|||
129902534|NCT00823979|467604187|FG002|Overall Study|Lost to Follow-up|0|||
129902535|NCT00823979|467604185|FG000|Overall Study|Withdrawal by Subject|2|||
129902536|NCT00823979|467604186|FG001|Overall Study|Withdrawal by Subject|3|||
129902537|NCT00823979|467604187|FG002|Overall Study|Withdrawal by Subject|2|||
129902538|NCT00823979|467604185|FG000|Overall Study|Protocol Violation|1|||
129902539|NCT00823979|467604186|FG001|Overall Study|Protocol Violation|1|||
129902540|NCT00823979|467604187|FG002|Overall Study|Protocol Violation|0|||
129902541|NCT00823979|467604185|FG000|Overall Study|Pregnancy|0|||
129902542|NCT00823979|467604186|FG001|Overall Study|Pregnancy|1|||
129902543|NCT00823979|467604187|FG002|Overall Study|Pregnancy|0|||
129902544|NCT00823979|467604185|FG000|Overall Study|Adverse Event|0|||
129902545|NCT00823979|467604186|FG001|Overall Study|Adverse Event|2|||
129902546|NCT00823979|467604187|FG002|Overall Study|Adverse Event|4|||
129902547|NCT00823979|467604185|FG000|Overall Study|Other|2|||
129902548|NCT00823979|467604186|FG001|Overall Study|Other|0|||
129902549|NCT00823979|467604187|FG002|Overall Study|Other|1|||
129902550|NCT00823979|467604185|FG000|Overall Study|Randomized but not Treated|4|||
129902551|NCT00823979|467604186|FG001|Overall Study|Randomized but not Treated|3|||
129902552|NCT00823979|467604187|FG002|Overall Study|Randomized but not Treated|1|||
129902553|NCT00823979|467604185|FG000|Overall Study|Study Terminated by Sponsor|5|||
129902554|NCT00823979|467604186|FG001|Overall Study|Study Terminated by Sponsor|5|||
129902555|NCT00823979|467604187|FG002|Overall Study|Study Terminated by Sponsor|7|||
129902556|NCT02781584|467604188|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
129902557|NCT02781584|467604189|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
129902558|NCT02781584|467604190|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
129845961|NCT03013491|467395299|FG011|Long-term Extension|Adverse Event|0|||
129845962|NCT03013491|467395300|FG012|Long-term Extension|Adverse Event|0|||
129845963|NCT03013491|467395301|FG013|Long-term Extension|Adverse Event|0|||
129845964|NCT03013491|467395302|FG014|Long-term Extension|Adverse Event|0|||
129845965|NCT03013491|467395303|FG015|Long-term Extension|Adverse Event|0|||
129902559|NCT02781584|467604191|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
129902560|NCT02781584|467604192|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
129902561|NCT02781584|467604193|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
129902562|NCT02781584|467604194|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
129902563|NCT02781584|467604195|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
129902564|NCT02781584|467604196|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
129902565|NCT02781584|467604197|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
129902566|NCT02781584|467604198|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
129902567|NCT02781584|467604199|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
129902568|NCT02781584|467604200|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
129902569|NCT02781584|467604188|FG000|Pre-treatment Phase|Adverse Event|0|||
129902570|NCT02781584|467604189|FG001|Pre-treatment Phase|Adverse Event|0|||
129902571|NCT02781584|467604190|FG002|Pre-treatment Phase|Adverse Event|0|||
129902572|NCT02781584|467604191|FG003|Pre-treatment Phase|Adverse Event|0|||
129902573|NCT02781584|467604192|FG004|Pre-treatment Phase|Adverse Event|0|||
129902574|NCT02781584|467604193|FG005|Pre-treatment Phase|Adverse Event|0|||
129902575|NCT02781584|467604194|FG006|Pre-treatment Phase|Adverse Event|0|||
129902576|NCT02781584|467604195|FG007|Pre-treatment Phase|Adverse Event|0|||
129902577|NCT02781584|467604196|FG008|Pre-treatment Phase|Adverse Event|0|||
129902578|NCT02781584|467604197|FG009|Pre-treatment Phase|Adverse Event|0|||
129902579|NCT02781584|467604198|FG010|Pre-treatment Phase|Adverse Event|0|||
129902580|NCT02781584|467604199|FG011|Pre-treatment Phase|Adverse Event|1|||
129902581|NCT02781584|467604200|FG012|Pre-treatment Phase|Adverse Event|0|||
129902582|NCT02781584|467604188|FG000|Treatment Phase|Withdrew Consent|0|||
129902583|NCT02781584|467604189|FG001|Treatment Phase|Withdrew Consent|0|||
129902584|NCT02781584|467604190|FG002|Treatment Phase|Withdrew Consent|0|||
129902585|NCT02781584|467604191|FG003|Treatment Phase|Withdrew Consent|0|||
129902586|NCT02781584|467604192|FG004|Treatment Phase|Withdrew Consent|0|||
129902587|NCT02781584|467604193|FG005|Treatment Phase|Withdrew Consent|1|||
129902588|NCT02781584|467604194|FG006|Treatment Phase|Withdrew Consent|0|||
129902589|NCT02781584|467604195|FG007|Treatment Phase|Withdrew Consent|0|||
129902590|NCT02781584|467604196|FG008|Treatment Phase|Withdrew Consent|0|||
129902591|NCT02781584|467604197|FG009|Treatment Phase|Withdrew Consent|0|||
129902592|NCT02781584|467604198|FG010|Treatment Phase|Withdrew Consent|1|||
129902593|NCT02781584|467604199|FG011|Treatment Phase|Withdrew Consent|2|||
129902594|NCT02781584|467604200|FG012|Treatment Phase|Withdrew Consent|0|||
129902595|NCT02781584|467604188|FG000|Treatment Phase|Adverse Event|0|||
129902596|NCT02781584|467604189|FG001|Treatment Phase|Adverse Event|0|||
129902597|NCT02781584|467604190|FG002|Treatment Phase|Adverse Event|0|||
129902598|NCT02781584|467604191|FG003|Treatment Phase|Adverse Event|0|||
129902599|NCT02781584|467604192|FG004|Treatment Phase|Adverse Event|0|||
129902600|NCT02781584|467604193|FG005|Treatment Phase|Adverse Event|0|||
129902601|NCT02781584|467604194|FG006|Treatment Phase|Adverse Event|0|||
129902602|NCT02781584|467604195|FG007|Treatment Phase|Adverse Event|1|||
129902603|NCT02781584|467604196|FG008|Treatment Phase|Adverse Event|0|||
129902604|NCT02781584|467604197|FG009|Treatment Phase|Adverse Event|0|||
129902605|NCT02781584|467604198|FG010|Treatment Phase|Adverse Event|0|||
129902606|NCT02781584|467604199|FG011|Treatment Phase|Adverse Event|0|||
129902607|NCT02781584|467604200|FG012|Treatment Phase|Adverse Event|0|||
129902608|NCT00038103|467604205|FG000|Overall Study|Adverse Event|5|||
129902609|NCT00038103|467604206|FG001|Overall Study|Adverse Event|6|||
129902610|NCT00038103|467604205|FG000|Overall Study|Lack of Efficacy|48|||
129902611|NCT00038103|467604206|FG001|Overall Study|Lack of Efficacy|41|||
129902612|NCT00038103|467604205|FG000|Overall Study|Withdrawal by Subject|0|||
129902613|NCT00038103|467604206|FG001|Overall Study|Withdrawal by Subject|3|||
129902614|NCT00038103|467604205|FG000|Overall Study|Lost to Follow-up|0|||
129902615|NCT00038103|467604206|FG001|Overall Study|Lost to Follow-up|3|||
129902616|NCT00038103|467604205|FG000|Overall Study|Protocol Violation|0|||
129902617|NCT00038103|467604206|FG001|Overall Study|Protocol Violation|2|||
129902618|NCT00038103|467604205|FG000|Overall Study|Sponsor Decision|0|||
129902619|NCT00038103|467604206|FG001|Overall Study|Sponsor Decision|1|||
129902620|NCT00038103|467604205|FG000|Overall Study|Randomized/never treated|2|||
129902621|NCT00038103|467604206|FG001|Overall Study|Randomized/never treated|0|||
129902622|NCT00208767|467604209|FG000|Overall Study|Adverse Event|9|||
129902623|NCT00208767|467604210|FG001|Overall Study|Adverse Event|1|||
129902624|NCT00208767|467604209|FG000|Overall Study|Withdrawal by Subject|14|||
129902625|NCT00208767|467604210|FG001|Overall Study|Withdrawal by Subject|3|||
129902626|NCT00208767|467604209|FG000|Overall Study|Death|1|||
129902627|NCT00208767|467604210|FG001|Overall Study|Death|0|||
129902628|NCT00208767|467604209|FG000|Overall Study|Lost to Follow-up|3|||
129902629|NCT00208767|467604210|FG001|Overall Study|Lost to Follow-up|3|||
129902630|NCT03545984|467604211|FG000|Overall Study|CSF cases not present during rotation|11|||
129902631|NCT03545984|467604212|FG001|Overall Study|CSF cases not present during rotation|9|||
129902632|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
129902633|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
129902634|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
129902635|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902636|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902637|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
130116559|NCT02247479|468387100|FG000|Overall Study|Physician Decision|1|||
129845966|NCT03013491|467395304|FG016|Long-term Extension|Adverse Event|0|||
129845967|NCT03013491|467395305|FG017|Long-term Extension|Adverse Event|0|||
129845968|NCT03013491|467395306|FG018|Long-term Extension|Adverse Event|1|||
129845969|NCT03013491|467395288|FG000|Long-term Extension|Death|0|||
129845970|NCT03013491|467395289|FG001|Long-term Extension|Death|0|||
129845971|NCT03013491|467395290|FG002|Long-term Extension|Death|0|||
129845972|NCT03013491|467395291|FG003|Long-term Extension|Death|0|||
129845973|NCT03013491|467395292|FG004|Long-term Extension|Death|0|||
129845974|NCT03013491|467395293|FG005|Long-term Extension|Death|0|||
129845975|NCT03013491|467395294|FG006|Long-term Extension|Death|0|||
129845976|NCT03013491|467395295|FG007|Long-term Extension|Death|0|||
129845977|NCT03013491|467395296|FG008|Long-term Extension|Death|0|||
129845978|NCT03013491|467395297|FG009|Long-term Extension|Death|0|||
129845979|NCT03013491|467395298|FG010|Long-term Extension|Death|0|||
129845980|NCT03013491|467395299|FG011|Long-term Extension|Death|0|||
129845981|NCT03013491|467395300|FG012|Long-term Extension|Death|0|||
129845982|NCT03013491|467395301|FG013|Long-term Extension|Death|0|||
129845983|NCT03013491|467395302|FG014|Long-term Extension|Death|0|||
129845984|NCT03013491|467395303|FG015|Long-term Extension|Death|0|||
129845985|NCT03013491|467395304|FG016|Long-term Extension|Death|0|||
129845986|NCT03013491|467395305|FG017|Long-term Extension|Death|0|||
129845987|NCT03013491|467395306|FG018|Long-term Extension|Death|1|||
129845988|NCT03238911|467395309|FG000|Overall Study|Withdrawal by Subject|1|||
129845989|NCT03238911|467395310|FG001|Overall Study|Withdrawal by Subject|2|||
129845990|NCT03238911|467395309|FG000|Overall Study|Lost to Follow-up|2|||
129845991|NCT03238911|467395310|FG001|Overall Study|Lost to Follow-up|1|||
129845992|NCT02239536|467395311|FG000|Overall Study|Non-neoplastic polyp|23|||
129845993|NCT02239536|467395312|FG001|Overall Study|Non-neoplastic polyp|17|||
129845994|NCT01038778|467395316|FG000|Overall Study|Withdrawal by Subject|0|||
129845995|NCT01038778|467395317|FG001|Overall Study|Withdrawal by Subject|2|||
129845996|NCT01038778|467395318|FG002|Overall Study|Withdrawal by Subject|3|||
129845997|NCT04740034|467395319|FG000|Overall Study|Death|0|||
129845998|NCT04740034|467395320|FG001|Overall Study|Death|1|||
129845999|NCT04740034|467395321|FG002|Overall Study|Death|2|||
129846000|NCT04740034|467395322|FG003|Overall Study|Death|3|||
129846001|NCT04740034|467395323|FG004|Overall Study|Death|4|||
129846002|NCT04740034|467395324|FG005|Overall Study|Death|4|||
129846003|NCT04740034|467395325|FG006|Overall Study|Death|2|||
129846004|NCT04740034|467395326|FG007|Overall Study|Death|2|||
129846005|NCT04740034|467395327|FG008|Overall Study|Death|2|||
129902638|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902639|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902640|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902641|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
129902642|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
129902643|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
129902644|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902645|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902646|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902647|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902648|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902649|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902650|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
129902651|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
129902652|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
129902653|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902654|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902655|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902656|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902657|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902658|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902659|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
129902660|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902661|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
129846006|NCT04740034|467395328|FG009|Overall Study|Death|4|||
129846007|NCT04740034|467395329|FG010|Overall Study|Death|0|||
129846008|NCT04740034|467395319|FG000|Overall Study|Lost to Follow-up|0|||
129846009|NCT04740034|467395320|FG001|Overall Study|Lost to Follow-up|0|||
129846010|NCT04740034|467395321|FG002|Overall Study|Lost to Follow-up|0|||
129846011|NCT04740034|467395322|FG003|Overall Study|Lost to Follow-up|1|||
129846012|NCT04740034|467395323|FG004|Overall Study|Lost to Follow-up|2|||
129846013|NCT04740034|467395324|FG005|Overall Study|Lost to Follow-up|2|||
129846014|NCT04740034|467395325|FG006|Overall Study|Lost to Follow-up|0|||
129846015|NCT04740034|467395326|FG007|Overall Study|Lost to Follow-up|0|||
129846016|NCT04740034|467395327|FG008|Overall Study|Lost to Follow-up|0|||
129846017|NCT04740034|467395328|FG009|Overall Study|Lost to Follow-up|1|||
129902662|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902663|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902664|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902665|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902666|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902667|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902668|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129902669|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129902670|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
129902671|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902672|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902673|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902674|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902675|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902676|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902677|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902678|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129902679|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129902680|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902681|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902682|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902683|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902684|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902685|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902686|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
129902687|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
129902688|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902689|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902690|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902691|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902692|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902693|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902694|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902695|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902696|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
129902697|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
129902698|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
129902699|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902700|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
129902701|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902702|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902703|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902704|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902705|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
129902706|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
129902707|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
129902708|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902709|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
129902710|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902711|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902712|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902713|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902714|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902715|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
129902716|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902717|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902718|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902719|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902720|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902721|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902722|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902723|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
129902724|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
129902725|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
129846018|NCT04740034|467395329|FG010|Overall Study|Lost to Follow-up|0|||
129846019|NCT04740034|467395319|FG000|Overall Study|Withdrawal by Subject|1|||
129846020|NCT04740034|467395320|FG001|Overall Study|Withdrawal by Subject|0|||
129846021|NCT04740034|467395321|FG002|Overall Study|Withdrawal by Subject|0|||
129846022|NCT04740034|467395322|FG003|Overall Study|Withdrawal by Subject|0|||
129846023|NCT04740034|467395323|FG004|Overall Study|Withdrawal by Subject|0|||
129846024|NCT04740034|467395324|FG005|Overall Study|Withdrawal by Subject|0|||
129846025|NCT04740034|467395325|FG006|Overall Study|Withdrawal by Subject|0|||
129846026|NCT04740034|467395326|FG007|Overall Study|Withdrawal by Subject|1|||
129846027|NCT04740034|467395327|FG008|Overall Study|Withdrawal by Subject|0|||
129846028|NCT04740034|467395328|FG009|Overall Study|Withdrawal by Subject|1|||
129846029|NCT04740034|467395329|FG010|Overall Study|Withdrawal by Subject|0|||
129846030|NCT04740034|467395319|FG000|Overall Study|Decision by sponsor|0|||
129846031|NCT04740034|467395320|FG001|Overall Study|Decision by sponsor|0|||
129846032|NCT04740034|467395321|FG002|Overall Study|Decision by sponsor|1|||
129846033|NCT04740034|467395322|FG003|Overall Study|Decision by sponsor|0|||
129846034|NCT04740034|467395323|FG004|Overall Study|Decision by sponsor|0|||
129846035|NCT04740034|467395324|FG005|Overall Study|Decision by sponsor|0|||
129846036|NCT04740034|467395325|FG006|Overall Study|Decision by sponsor|1|||
129846037|NCT04740034|467395326|FG007|Overall Study|Decision by sponsor|2|||
129846038|NCT04740034|467395327|FG008|Overall Study|Decision by sponsor|1|||
129846039|NCT04740034|467395328|FG009|Overall Study|Decision by sponsor|1|||
129846040|NCT04740034|467395329|FG010|Overall Study|Decision by sponsor|2|||
129846041|NCT04524403|467396922|FG000|Overall Study|Withdrawal by Subject|10|||
129846042|NCT04524403|467396923|FG001|Overall Study|Withdrawal by Subject|3|||
129846043|NCT04524403|467396924|FG002|Overall Study|Withdrawal by Subject|8|||
129846044|NCT04524403|467396922|FG000|Overall Study|Lost to Follow-up|3|||
129846045|NCT04524403|467396923|FG001|Overall Study|Lost to Follow-up|4|||
129846046|NCT04524403|467396924|FG002|Overall Study|Lost to Follow-up|3|||
129846047|NCT04524403|467396922|FG000|Overall Study|Adverse Event|3|||
129846048|NCT04524403|467396923|FG001|Overall Study|Adverse Event|1|||
129846049|NCT04524403|467396924|FG002|Overall Study|Adverse Event|4|||
129846050|NCT04524403|467396922|FG000|Overall Study|Non-compliant with study drug|1|||
129846051|NCT04524403|467396923|FG001|Overall Study|Non-compliant with study drug|2|||
129846052|NCT04524403|467396924|FG002|Overall Study|Non-compliant with study drug|3|||
129846053|NCT04524403|467396922|FG000|Overall Study|Moved|0|||
129846054|NCT04524403|467396923|FG001|Overall Study|Moved|1|||
129846055|NCT04524403|467396924|FG002|Overall Study|Moved|0|||
129846056|NCT02649972|467396932|FG000|Overall Study|Not treated|1|||
129846057|NCT03394391|467396933|FG000|Overall Study|Lost to Follow-up|1|||
129846058|NCT03394391|467396934|FG001|Overall Study|Lost to Follow-up|2|||
129846059|NCT00519649|467396935|FG000|Overall Study|Withdrawal by Subject|1|||
129846060|NCT04879745|467396936|FG000|Overall Study|Lost to Follow-up|4|||
129846061|NCT04879745|467396937|FG001|Overall Study|Lost to Follow-up|1|||
129846062|NCT03592641|467396940|FG000|Overall Study|Withdrawal by Subject|1|||
129846063|NCT00436280|467396941|FG000|Period 1: Induction|Adverse Event|8|||
129846064|NCT00436280|467396941|FG000|Period 1: Induction|Progressive Disease|12|||
129846065|NCT00436280|467396941|FG000|Period 1: Induction|Stable Disease|6|||
129846066|NCT00436280|467396941|FG000|Period 1: Induction|Withdrawal by Subject|1|||
129846067|NCT00436280|467396941|FG000|Period 1: Induction|Death|1|||
129846068|NCT00436280|467396941|FG000|Period 2: Consolidation|Adverse Event|1|||
129846069|NCT00436280|467396941|FG000|Period 2: Consolidation|Progressive Disease|10|||
129846070|NCT00436280|467396941|FG000|Period 2: Consolidation|Stable Disease|1|||
129846071|NCT00436280|467396941|FG000|Period 2: Consolidation|Physician Decision|2|||
129846072|NCT00436280|467396941|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
129846073|NCT00436280|467396941|FG000|Period 2: Consolidation|Death|1|||
129846074|NCT00436280|467396941|FG000|Period 3: Maintenance|Adverse Event|6|||
129846075|NCT00436280|467396941|FG000|Period 3: Maintenance|Progressive Disease|12|||
129846076|NCT01049919|467396944|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
129846077|NCT01049919|467396945|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
129846078|NCT01049919|467396944|FG000|Overall Study|Withdrawal by Subject|5|||
129846079|NCT01049919|467396945|FG001|Overall Study|Withdrawal by Subject|0|||
129846080|NCT01049919|467396944|FG000|Overall Study|Lost to Follow-up|6|||
129846081|NCT01049919|467396945|FG001|Overall Study|Lost to Follow-up|1|||
130064543|NCT00510068|468190192|FG000|Open-label Period|Withdrawal by Subject|21|||
129846082|NCT01049919|467396944|FG000|Overall Study|Physician Decision|2|||
129846083|NCT01049919|467396945|FG001|Overall Study|Physician Decision|0|||
129846084|NCT01049919|467396944|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
129846085|NCT01049919|467396945|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
129846086|NCT01049919|467396944|FG000|Overall Study|Early study termination by sponsor.|2|||
129846087|NCT01049919|467396945|FG001|Overall Study|Early study termination by sponsor.|0|||
129846088|NCT01513291|467396950|FG000|Treatment Period|Adverse Event|8|||
129846089|NCT01513291|467396951|FG001|Treatment Period|Adverse Event|4|||
129846090|NCT01513291|467396952|FG002|Treatment Period|Adverse Event|0|||
129846091|NCT01513291|467396953|FG003|Treatment Period|Adverse Event|0|||
129846092|NCT01513291|467396954|FG004|Treatment Period|Adverse Event|0|||
129846093|NCT01513291|467396950|FG000|Treatment Period|Lack of Efficacy|3|||
129846094|NCT01513291|467396951|FG001|Treatment Period|Lack of Efficacy|0|||
129846095|NCT01513291|467396952|FG002|Treatment Period|Lack of Efficacy|0|||
129846096|NCT01513291|467396953|FG003|Treatment Period|Lack of Efficacy|0|||
129846097|NCT01513291|467396954|FG004|Treatment Period|Lack of Efficacy|0|||
129846098|NCT01513291|467396950|FG000|Treatment Period|Lost to Follow-up|2|||
129846099|NCT01513291|467396951|FG001|Treatment Period|Lost to Follow-up|3|||
129846100|NCT01513291|467396952|FG002|Treatment Period|Lost to Follow-up|0|||
129846101|NCT01513291|467396953|FG003|Treatment Period|Lost to Follow-up|0|||
129846102|NCT01513291|467396954|FG004|Treatment Period|Lost to Follow-up|0|||
129846103|NCT01513291|467396950|FG000|Treatment Period|Physician Decision|1|||
129846104|NCT01513291|467396951|FG001|Treatment Period|Physician Decision|0|||
129846105|NCT01513291|467396952|FG002|Treatment Period|Physician Decision|0|||
129846106|NCT01513291|467396953|FG003|Treatment Period|Physician Decision|0|||
129846107|NCT01513291|467396954|FG004|Treatment Period|Physician Decision|0|||
129846108|NCT01513291|467396950|FG000|Treatment Period|Protocol Violation|1|||
129846109|NCT01513291|467396951|FG001|Treatment Period|Protocol Violation|2|||
129846110|NCT01513291|467396952|FG002|Treatment Period|Protocol Violation|0|||
129846111|NCT01513291|467396953|FG003|Treatment Period|Protocol Violation|0|||
129846112|NCT01513291|467396954|FG004|Treatment Period|Protocol Violation|0|||
129846113|NCT01513291|467396950|FG000|Treatment Period|Withdrawal by Subject|8|||
129846114|NCT01513291|467396951|FG001|Treatment Period|Withdrawal by Subject|5|||
129846115|NCT01513291|467396952|FG002|Treatment Period|Withdrawal by Subject|0|||
129846116|NCT01513291|467396953|FG003|Treatment Period|Withdrawal by Subject|0|||
129846117|NCT01513291|467396954|FG004|Treatment Period|Withdrawal by Subject|0|||
129846118|NCT01513291|467396950|FG000|Treatment Period|Randomized not treated|0|||
129846119|NCT01513291|467396951|FG001|Treatment Period|Randomized not treated|2|||
129846120|NCT01513291|467396952|FG002|Treatment Period|Randomized not treated|0|||
129846121|NCT01513291|467396953|FG003|Treatment Period|Randomized not treated|0|||
129846122|NCT01513291|467396954|FG004|Treatment Period|Randomized not treated|0|||
129846123|NCT01513291|467396950|FG000|Run-out Period|Lost to Follow-up|0|||
129846124|NCT01513291|467396951|FG001|Run-out Period|Lost to Follow-up|0|||
129846125|NCT01513291|467396952|FG002|Run-out Period|Lost to Follow-up|0|||
129846126|NCT01513291|467396953|FG003|Run-out Period|Lost to Follow-up|1|||
129846127|NCT01513291|467396954|FG004|Run-out Period|Lost to Follow-up|0|||
129846128|NCT01513291|467396950|FG000|Run-out Period|Withdrawal by Subject|0|||
129846129|NCT01513291|467396951|FG001|Run-out Period|Withdrawal by Subject|0|||
129846130|NCT01513291|467396952|FG002|Run-out Period|Withdrawal by Subject|0|||
129846131|NCT01513291|467396953|FG003|Run-out Period|Withdrawal by Subject|1|||
129846132|NCT01513291|467396954|FG004|Run-out Period|Withdrawal by Subject|0|||
129846133|NCT03217136|467396955|FG000|Overall Study|Lost to Follow-up|2|||
129846134|NCT03217136|467396956|FG001|Overall Study|Lost to Follow-up|1|||
129846135|NCT03217136|467396955|FG000|Overall Study|Site Randomized Participant in Error|0|||
129846136|NCT03217136|467396956|FG001|Overall Study|Site Randomized Participant in Error|1|||
129846137|NCT03217136|467396955|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
129846138|NCT03217136|467396956|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
129846139|NCT03217136|467396955|FG000|Overall Study|Dispensing Error|1|||
129846140|NCT03217136|467396956|FG001|Overall Study|Dispensing Error|0|||
129846141|NCT03217136|467396955|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129846142|NCT03217136|467396956|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129846143|NCT03192150|467396957|FG000|Overall Study|Adverse Event|14|||
129846144|NCT03192150|467396958|FG001|Overall Study|Adverse Event|12|||
129846145|NCT03192150|467396957|FG000|Overall Study|Lack of Efficacy|23|||
129846146|NCT03192150|467396958|FG001|Overall Study|Lack of Efficacy|30|||
129846147|NCT03192150|467396957|FG000|Overall Study|Lost to Follow-up|1|||
129846148|NCT03192150|467396958|FG001|Overall Study|Lost to Follow-up|1|||
129846149|NCT03192150|467396957|FG000|Overall Study|Withdrawal by Subject|4|||
129846150|NCT03192150|467396958|FG001|Overall Study|Withdrawal by Subject|2|||
129846151|NCT03192150|467396957|FG000|Overall Study|Protocol Violation|5|||
129846152|NCT03192150|467396958|FG001|Overall Study|Protocol Violation|2|||
129846153|NCT03192150|467396957|FG000|Overall Study|Surgery Canceled|6|||
129846154|NCT03192150|467396958|FG001|Overall Study|Surgery Canceled|2|||
129846155|NCT03192150|467396957|FG000|Overall Study|Other-Various Administrative Reasons|2|||
129846156|NCT03192150|467396958|FG001|Overall Study|Other-Various Administrative Reasons|5|||
129846157|NCT02579616|467396959|FG000|Overall Study|Participants did not receive treatment|3|||
129846158|NCT00482391|467396960|FG000|Overall Study|Withdrawal by Subject|1|||
129846159|NCT00482391|467396960|FG000|Overall Study|Adverse Event|1|||
129846160|NCT00482391|467396960|FG000|Overall Study|Death|1|||
129846161|NCT01448850|467396961|FG000|Overall Study|Death|3|||
129846162|NCT01448850|467396962|FG001|Overall Study|Death|6|||
129846163|NCT01448850|467396961|FG000|Overall Study|Withdrawal by Subject|13|||
129846164|NCT01448850|467396962|FG001|Overall Study|Withdrawal by Subject|21|||
129846165|NCT01448850|467396961|FG000|Overall Study|Lost to Follow-up|3|||
129846166|NCT01448850|467396962|FG001|Overall Study|Lost to Follow-up|1|||
129846167|NCT01448850|467396961|FG000|Overall Study|Other|15|||
129846168|NCT01448850|467396962|FG001|Overall Study|Other|12|||
129846169|NCT02939404|467396965|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
130116560|NCT02247479|468387101|FG001|Overall Study|Physician Decision|0|||
129902726|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
129902727|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
129902728|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902729|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902730|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902731|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902732|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
129902733|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902734|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902735|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
129902736|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902737|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902738|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902739|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902740|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902741|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
129902742|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
129902743|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902744|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902745|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902746|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902747|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902748|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902749|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902750|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902751|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902752|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902753|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902754|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902755|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902756|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902757|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
129902758|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902759|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
129902760|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
129902761|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902762|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902763|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902764|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902765|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
129902766|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
129902767|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902768|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
129902769|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
129902770|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902771|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902772|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902773|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902774|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
129902775|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902776|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902777|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
129902778|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
129902779|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902780|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902781|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902782|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902783|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
129902784|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
129902785|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902786|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902787|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
129902788|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902789|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902790|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902791|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
130064544|NCT00510068|468190193|FG001|Open-label Period|Withdrawal by Subject|0|||
129902792|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902793|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902794|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902795|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
129902796|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
129902797|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902798|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902799|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902800|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902801|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
129902802|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902803|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902804|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
129902805|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
129902806|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902807|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902808|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902809|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902810|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
129902811|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
129902812|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902813|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902814|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
129902815|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902816|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902817|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902818|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902819|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902820|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902821|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902822|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
129902823|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129902824|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902825|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902826|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902827|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902828|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129902829|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129902830|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902831|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902832|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902833|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902834|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902835|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902836|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902837|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902838|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
129902839|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902840|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
129902841|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902842|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902843|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902844|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129846170|NCT02939404|467396966|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
129846171|NCT02939404|467396965|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
129846172|NCT02939404|467396966|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
129846173|NCT06640829|467396976|FG000|Overall Study|Withdrawal by Subject|1|||
129846174|NCT06640829|467396976|FG000|Overall Study|Lost to Follow-up|1|||
129846175|NCT01350128|467396986|FG000|Overall Study|Withdrawal by Subject|3|||
129846176|NCT01350128|467396986|FG000|Overall Study|Protocol discontinuation criteria|8|||
129846177|NCT01350128|467396986|FG000|Overall Study|Physician Decision|1|||
129846178|NCT01350128|467396986|FG000|Overall Study|Lost to Follow-up|2|||
129846179|NCT00261716|467396988|FG000|Overall Study|Withdrawal by Subject|6|||
129846180|NCT00261716|467396989|FG001|Overall Study|Withdrawal by Subject|8|||
129846181|NCT00261716|467396988|FG000|Overall Study|Lost to Follow-up|0|||
129846182|NCT00261716|467396989|FG001|Overall Study|Lost to Follow-up|2|||
129846183|NCT01147653|467396990|FG000|Year 2|Withdrawal by Subject|2|||
129846184|NCT01147653|467396991|FG001|Year 2|Withdrawal by Subject|3|||
129846185|NCT01109316|467396992|FG000|Study Period 1|Adverse Event|0|||
129846186|NCT01109316|467396993|FG001|Study Period 1|Adverse Event|0|||
129902845|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902846|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902847|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902848|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902849|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902850|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
129902851|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902852|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902853|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902854|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902855|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902856|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
129902857|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902858|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
129902859|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902860|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902861|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902862|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902863|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902864|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902865|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
129902866|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902867|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
129902868|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
129902869|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902870|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902871|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902872|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902873|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
129902874|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
129902875|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902876|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
129902877|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
129902878|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902879|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902880|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902881|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902882|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
129902883|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
129902884|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902885|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
129902886|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
129902887|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129846187|NCT01109316|467396994|FG002|Study Period 1|Adverse Event|1|||
129846188|NCT01109316|467396995|FG003|Study Period 1|Adverse Event|0|||
129846189|NCT01109316|467396996|FG004|Study Period 1|Adverse Event|0|||
129846190|NCT01109316|467396997|FG005|Study Period 1|Adverse Event|0|||
129846191|NCT01109316|467396992|FG000|Study Period 1|Lost to Follow-up|0|||
129846192|NCT01109316|467396993|FG001|Study Period 1|Lost to Follow-up|0|||
129846193|NCT01109316|467396994|FG002|Study Period 1|Lost to Follow-up|1|||
129846194|NCT01109316|467396995|FG003|Study Period 1|Lost to Follow-up|1|||
129846195|NCT01109316|467396996|FG004|Study Period 1|Lost to Follow-up|0|||
129846196|NCT01109316|467396997|FG005|Study Period 1|Lost to Follow-up|0|||
129846197|NCT01109316|467396992|FG000|Study Period 1|Withdrawal by Subject|0|||
129846198|NCT01109316|467396993|FG001|Study Period 1|Withdrawal by Subject|0|||
129846199|NCT01109316|467396994|FG002|Study Period 1|Withdrawal by Subject|1|||
129846200|NCT01109316|467396995|FG003|Study Period 1|Withdrawal by Subject|0|||
129846201|NCT01109316|467396996|FG004|Study Period 1|Withdrawal by Subject|2|||
129846202|NCT01109316|467396997|FG005|Study Period 1|Withdrawal by Subject|0|||
129846203|NCT01109316|467396992|FG000|Study Period 1|Sponsor Decision|0|||
129846204|NCT01109316|467396993|FG001|Study Period 1|Sponsor Decision|0|||
129846205|NCT01109316|467396994|FG002|Study Period 1|Sponsor Decision|0|||
129846206|NCT01109316|467396995|FG003|Study Period 1|Sponsor Decision|0|||
129846207|NCT01109316|467396996|FG004|Study Period 1|Sponsor Decision|0|||
129846208|NCT01109316|467396997|FG005|Study Period 1|Sponsor Decision|2|||
129846209|NCT01109316|467396992|FG000|Study Period 2|Entry Criteria Not Met|0|||
129846210|NCT01109316|467396993|FG001|Study Period 2|Entry Criteria Not Met|1|||
129846211|NCT01109316|467396994|FG002|Study Period 2|Entry Criteria Not Met|0|||
129846212|NCT01109316|467396995|FG003|Study Period 2|Entry Criteria Not Met|0|||
129846213|NCT01109316|467396996|FG004|Study Period 2|Entry Criteria Not Met|0|||
129846214|NCT01109316|467396997|FG005|Study Period 2|Entry Criteria Not Met|0|||
129846215|NCT01109316|467396992|FG000|Study Period 2|Physician Decision|0|||
129846216|NCT01109316|467396993|FG001|Study Period 2|Physician Decision|0|||
129902888|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902889|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902890|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902891|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
129902892|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
129902893|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
129902894|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
130116561|NCT02247479|468387102|FG002|Overall Study|Physician Decision|2|||
130116562|NCT02247479|468387100|FG000|Overall Study|Unspecified Reason|2|||
130116563|NCT02247479|468387101|FG001|Overall Study|Unspecified Reason|5|||
130116564|NCT02247479|468387102|FG002|Overall Study|Unspecified Reason|2|||
129846217|NCT01109316|467396994|FG002|Study Period 2|Physician Decision|0|||
129846218|NCT01109316|467396995|FG003|Study Period 2|Physician Decision|1|||
129902895|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
129902896|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
129902897|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
129902898|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
129902899|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
129902900|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
129902901|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
129902902|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902903|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902904|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902905|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902906|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902907|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902908|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902909|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
129902910|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902911|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902912|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
129902913|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
129902914|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902915|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902916|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902917|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902918|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129902919|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129902920|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902921|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
129902922|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
129902923|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902924|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902925|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902926|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902927|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
129902928|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902929|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902930|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
129902931|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
129902932|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902933|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902934|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902935|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902936|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
129846219|NCT01109316|467396996|FG004|Study Period 2|Physician Decision|0|||
129846220|NCT01109316|467396997|FG005|Study Period 2|Physician Decision|0|||
129846221|NCT01109316|467396992|FG000|Study Period 2|Protocol Violation|1|||
129846222|NCT01109316|467396993|FG001|Study Period 2|Protocol Violation|0|||
129846223|NCT01109316|467396994|FG002|Study Period 2|Protocol Violation|0|||
129846224|NCT01109316|467396995|FG003|Study Period 2|Protocol Violation|0|||
129902937|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
129902938|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902939|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
129902940|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902941|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902942|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902943|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129846225|NCT01109316|467396996|FG004|Study Period 2|Protocol Violation|0|||
129846226|NCT01109316|467396997|FG005|Study Period 2|Protocol Violation|0|||
129846227|NCT01109316|467396992|FG000|Study Period 2|Withdrawal by Subject|0|||
129846228|NCT01109316|467396993|FG001|Study Period 2|Withdrawal by Subject|0|||
129846229|NCT01109316|467396994|FG002|Study Period 2|Withdrawal by Subject|1|||
129846230|NCT01109316|467396995|FG003|Study Period 2|Withdrawal by Subject|0|||
129846231|NCT01109316|467396996|FG004|Study Period 2|Withdrawal by Subject|0|||
129846232|NCT01109316|467396997|FG005|Study Period 2|Withdrawal by Subject|1|||
129846233|NCT01109316|467396992|FG000|Study Period 3|Lost to Follow-up|0|||
129846234|NCT01109316|467396993|FG001|Study Period 3|Lost to Follow-up|0|||
129846235|NCT01109316|467396994|FG002|Study Period 3|Lost to Follow-up|0|||
129902944|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902945|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902946|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902947|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902948|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
129902949|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
129902950|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902951|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902952|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902953|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902954|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902955|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902956|NCT02812966|467604223|FG000|Overall Study|Death|1|||
129902957|NCT02812966|467604224|FG001|Overall Study|Death|0|||
129902958|NCT05147233|467606290|FG000|Overall Study|Adverse Event|0|||
129902959|NCT05147233|467606291|FG001|Overall Study|Adverse Event|1|||
129902960|NCT05147233|467606290|FG000|Overall Study|Lost to Follow-up|1|||
129902961|NCT05147233|467606291|FG001|Overall Study|Lost to Follow-up|1|||
129902962|NCT05147233|467606290|FG000|Overall Study|Protocol Violation|0|||
129902963|NCT05147233|467606291|FG001|Overall Study|Protocol Violation|1|||
129846236|NCT01109316|467396995|FG003|Study Period 3|Lost to Follow-up|0|||
129846237|NCT01109316|467396996|FG004|Study Period 3|Lost to Follow-up|1|||
129846238|NCT01109316|467396997|FG005|Study Period 3|Lost to Follow-up|0|||
129846239|NCT01109316|467396992|FG000|Study Period 3|Withdrawal by Subject|1|||
129846240|NCT01109316|467396993|FG001|Study Period 3|Withdrawal by Subject|0|||
129846241|NCT01109316|467396994|FG002|Study Period 3|Withdrawal by Subject|0|||
129846242|NCT01109316|467396995|FG003|Study Period 3|Withdrawal by Subject|0|||
129846243|NCT01109316|467396996|FG004|Study Period 3|Withdrawal by Subject|1|||
129846244|NCT01109316|467396997|FG005|Study Period 3|Withdrawal by Subject|0|||
129846245|NCT00670228|467396998|FG000|Overall Study|Adverse Event|1|||
129846246|NCT00670228|467396999|FG001|Overall Study|Adverse Event|0|||
129846247|NCT00670228|467396998|FG000|Overall Study|Death or MACE|0|||
129846248|NCT00670228|467396999|FG001|Overall Study|Death or MACE|1|||
129846249|NCT00670228|467396998|FG000|Overall Study|Not treated|2|||
129846250|NCT00670228|467396999|FG001|Overall Study|Not treated|2|||
129846251|NCT00670228|467396998|FG000|Overall Study|Not meeting the selection criteria|2|||
129846252|NCT00670228|467396999|FG001|Overall Study|Not meeting the selection criteria|0|||
129846253|NCT00094653|467397012|FG000|Overall Study|Death|306|||
129846254|NCT00094653|467397013|FG001|Overall Study|Death|100|||
129846255|NCT00094653|467397014|FG002|Overall Study|Death|119|||
129846256|NCT00094653|467397012|FG000|Overall Study|Subject Withdrew Consent|10|||
129846257|NCT00094653|467397013|FG001|Overall Study|Subject Withdrew Consent|2|||
129846258|NCT00094653|467397014|FG002|Overall Study|Subject Withdrew Consent|3|||
129846259|NCT00094653|467397012|FG000|Overall Study|Other|2|||
129846260|NCT00094653|467397013|FG001|Overall Study|Other|2|||
129846261|NCT00094653|467397014|FG002|Overall Study|Other|2|||
129846262|NCT00094653|467397012|FG000|Overall Study|Lost to Follow-up|3|||
129846263|NCT00094653|467397013|FG001|Overall Study|Lost to Follow-up|2|||
129846264|NCT00094653|467397014|FG002|Overall Study|Lost to Follow-up|1|||
129846265|NCT00094653|467397012|FG000|Overall Study|Protocol Violation|0|||
129846266|NCT00094653|467397013|FG001|Overall Study|Protocol Violation|0|||
129846267|NCT00094653|467397014|FG002|Overall Study|Protocol Violation|1|||
129846268|NCT03921411|467397015|FG000|Overall Study|Withdrawal by Subject|1|||
129846269|NCT03921411|467397015|FG000|Overall Study|Protocol Deviation|2|||
129846270|NCT03921411|467397015|FG000|Overall Study|Enrolled, but never treated|2|||
129846271|NCT01541826|467397018|FG000|Overall Study|Lost to Follow-up|2|||
129846272|NCT01541826|467397019|FG001|Overall Study|Lost to Follow-up|3|||
129846273|NCT01541826|467397020|FG002|Overall Study|Lost to Follow-up|0|||
129846274|NCT01541826|467397018|FG000|Overall Study|Withdrawal by Subject|2|||
129846275|NCT01541826|467397019|FG001|Overall Study|Withdrawal by Subject|0|||
129846276|NCT01541826|467397020|FG002|Overall Study|Withdrawal by Subject|0|||
129846277|NCT01365273|467397023|FG000|Overall Study|Lost to Follow-up|1|||
129846278|NCT01365273|467397024|FG001|Overall Study|Lost to Follow-up|0|||
129846279|NCT01365273|467397023|FG000|Overall Study|Protocol Violation|0|||
129846280|NCT01365273|467397024|FG001|Overall Study|Protocol Violation|1|||
129846281|NCT01365273|467397023|FG000|Overall Study|Physician Decision|1|||
129846282|NCT01365273|467397024|FG001|Overall Study|Physician Decision|0|||
129846283|NCT00854581|467397027|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
129846284|NCT00854581|467397027|FG000|Induction (Up to Day 21)|Death|1|||
129846285|NCT00854581|467397027|FG000|Induction (Up to Day 21)|Physician Decision|1|||
129846286|NCT00854581|467397027|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
129846287|NCT01339390|467397028|FG000|Overall Study|Death|32|||
129846288|NCT01339390|467397029|FG001|Overall Study|Death|29|||
129846289|NCT01339390|467397028|FG000|Overall Study|Lost to Follow-up|125|||
129846290|NCT01339390|467397029|FG001|Overall Study|Lost to Follow-up|127|||
129846291|NCT04847674|467397030|FG000|Overall Study|Withdrawal by Subject|0|||
129846292|NCT04847674|467397031|FG001|Overall Study|Withdrawal by Subject|1|||
129846293|NCT04847674|467397032|FG002|Overall Study|Withdrawal by Subject|0|||
129846294|NCT04847674|467397030|FG000|Overall Study|Lost to Follow-up|0|||
129846295|NCT04847674|467397031|FG001|Overall Study|Lost to Follow-up|0|||
129846296|NCT04847674|467397032|FG002|Overall Study|Lost to Follow-up|2|||
129846297|NCT04847674|467397030|FG000|Overall Study|Other than specified|21|||
129846298|NCT04847674|467397031|FG001|Overall Study|Other than specified|20|||
129846299|NCT04847674|467397032|FG002|Overall Study|Other than specified|20|||
129846300|NCT03254134|467397034|FG000|Overall Study|Not eligible patients|599|||
129846301|NCT03254134|467397035|FG001|Overall Study|Not eligible patients|3630|||
129846302|NCT02563028|467397036|FG000|Overall Study|Lack of equipment|1|||
129846303|NCT02563028|467397036|FG000|Overall Study|Unable to elicit VEP post induction|1|||
129846304|NCT00378703|467397037|FG000|Overall Study|Disease progression|59|||
129846305|NCT00378703|467397038|FG001|Overall Study|Disease progression|43|||
129846306|NCT00378703|467397039|FG002|Overall Study|Disease progression|48|||
129846307|NCT00378703|467397040|FG003|Overall Study|Disease progression|49|||
129846308|NCT00378703|467397037|FG000|Overall Study|Adverse Event|11|||
129846309|NCT00378703|467397038|FG001|Overall Study|Adverse Event|17|||
129846310|NCT00378703|467397039|FG002|Overall Study|Adverse Event|20|||
129846311|NCT00378703|467397040|FG003|Overall Study|Adverse Event|18|||
129846312|NCT00378703|467397037|FG000|Overall Study|Death|2|||
129846313|NCT00378703|467397038|FG001|Overall Study|Death|2|||
129846314|NCT00378703|467397039|FG002|Overall Study|Death|4|||
129846315|NCT00378703|467397040|FG003|Overall Study|Death|3|||
129846316|NCT00378703|467397037|FG000|Overall Study|Withdrawal by Subject|4|||
129846317|NCT00378703|467397038|FG001|Overall Study|Withdrawal by Subject|8|||
129846318|NCT00378703|467397039|FG002|Overall Study|Withdrawal by Subject|5|||
129846319|NCT00378703|467397040|FG003|Overall Study|Withdrawal by Subject|7|||
129846320|NCT00378703|467397037|FG000|Overall Study|Physician Decision|1|||
129846321|NCT00378703|467397038|FG001|Overall Study|Physician Decision|4|||
129846322|NCT00378703|467397039|FG002|Overall Study|Physician Decision|1|||
129846323|NCT00378703|467397040|FG003|Overall Study|Physician Decision|0|||
129846324|NCT00378703|467397037|FG000|Overall Study|Alternative therapy|4|||
129846325|NCT00378703|467397038|FG001|Overall Study|Alternative therapy|2|||
129846326|NCT00378703|467397039|FG002|Overall Study|Alternative therapy|0|||
129846327|NCT00378703|467397040|FG003|Overall Study|Alternative therapy|0|||
129846328|NCT00378703|467397037|FG000|Overall Study|Other complicated disease|0|||
129846329|NCT00378703|467397038|FG001|Overall Study|Other complicated disease|2|||
129846330|NCT00378703|467397039|FG002|Overall Study|Other complicated disease|2|||
129846331|NCT00378703|467397040|FG003|Overall Study|Other complicated disease|0|||
129846332|NCT00378703|467397037|FG000|Overall Study|Symptomatic deterioration|0|||
129846333|NCT00378703|467397038|FG001|Overall Study|Symptomatic deterioration|1|||
129846334|NCT00378703|467397039|FG002|Overall Study|Symptomatic deterioration|0|||
129846335|NCT00378703|467397040|FG003|Overall Study|Symptomatic deterioration|2|||
129846336|NCT00378703|467397037|FG000|Overall Study|Surgery|1|||
129846337|NCT00378703|467397038|FG001|Overall Study|Surgery|0|||
129846338|NCT00378703|467397039|FG002|Overall Study|Surgery|0|||
129846339|NCT00378703|467397040|FG003|Overall Study|Surgery|1|||
129846340|NCT00378703|467397037|FG000|Overall Study|Joint decision of physician and patient|1|||
129846341|NCT00378703|467397038|FG001|Overall Study|Joint decision of physician and patient|0|||
129846342|NCT00378703|467397039|FG002|Overall Study|Joint decision of physician and patient|0|||
129846343|NCT00378703|467397040|FG003|Overall Study|Joint decision of physician and patient|0|||
129846344|NCT00378703|467397037|FG000|Overall Study|Adverse events and progressive disease|0|||
129846345|NCT00378703|467397038|FG001|Overall Study|Adverse events and progressive disease|0|||
129846346|NCT00378703|467397039|FG002|Overall Study|Adverse events and progressive disease|0|||
129846347|NCT00378703|467397040|FG003|Overall Study|Adverse events and progressive disease|1|||
129846348|NCT00378703|467397037|FG000|Overall Study|Relocation|0|||
129846349|NCT00378703|467397038|FG001|Overall Study|Relocation|0|||
129846350|NCT00378703|467397039|FG002|Overall Study|Relocation|1|||
129846351|NCT00378703|467397040|FG003|Overall Study|Relocation|0|||
129846352|NCT00378703|467397037|FG000|Overall Study|Ineligible|4|||
129846353|NCT00378703|467397038|FG001|Overall Study|Ineligible|7|||
129846354|NCT00378703|467397039|FG002|Overall Study|Ineligible|7|||
129846355|NCT00378703|467397040|FG003|Overall Study|Ineligible|7|||
129846356|NCT00378703|467397037|FG000|Overall Study|Never started treatment|1|||
129846357|NCT00378703|467397038|FG001|Overall Study|Never started treatment|4|||
129846358|NCT00378703|467397039|FG002|Overall Study|Never started treatment|0|||
129846359|NCT00378703|467397040|FG003|Overall Study|Never started treatment|0|||
129846360|NCT00378703|467397037|FG000|Overall Study|Other|1|||
129846361|NCT00378703|467397038|FG001|Overall Study|Other|1|||
129846362|NCT00378703|467397039|FG002|Overall Study|Other|2|||
129846363|NCT00378703|467397040|FG003|Overall Study|Other|3|||
129846364|NCT04292730|467397047|FG000|Overall Study|Lost to Follow-up|8|||
129846365|NCT04292730|467397048|FG001|Overall Study|Lost to Follow-up|12|||
129846366|NCT04292730|467397049|FG002|Overall Study|Lost to Follow-up|12|||
129846367|NCT04292730|467397050|FG003|Overall Study|Lost to Follow-up|48|||
129846368|NCT04292730|467397047|FG000|Overall Study|Death|2|||
129846369|NCT04292730|467397048|FG001|Overall Study|Death|2|||
129846370|NCT04292730|467397049|FG002|Overall Study|Death|4|||
129846371|NCT04292730|467397050|FG003|Overall Study|Death|12|||
129846372|NCT04292730|467397047|FG000|Overall Study|Withdrew Consent|2|||
129846373|NCT04292730|467397048|FG001|Overall Study|Withdrew Consent|2|||
129846374|NCT04292730|467397049|FG002|Overall Study|Withdrew Consent|5|||
129846375|NCT04292730|467397050|FG003|Overall Study|Withdrew Consent|6|||
129846376|NCT04292730|467397047|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129846377|NCT04292730|467397048|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129846378|NCT04292730|467397049|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129846379|NCT04292730|467397050|FG003|Overall Study|Non-Compliance with Study Drug|0|||
129846380|NCT04292730|467397047|FG000|Overall Study|Protocol Violation|0|||
129846381|NCT04292730|467397048|FG001|Overall Study|Protocol Violation|0|||
129846382|NCT04292730|467397049|FG002|Overall Study|Protocol Violation|1|||
129846383|NCT04292730|467397050|FG003|Overall Study|Protocol Violation|0|||
129846384|NCT04292730|467397047|FG000|Overall Study|Randomized but not Treated|8|||
129846385|NCT04292730|467397048|FG001|Overall Study|Randomized but not Treated|4|||
129846386|NCT04292730|467397049|FG002|Overall Study|Randomized but not Treated|0|||
129846387|NCT04292730|467397050|FG003|Overall Study|Randomized but not Treated|14|||
129846388|NCT01527292|467397051|FG000|Overall Study|Physician Decision|0|||
129846389|NCT01527292|467397052|FG001|Overall Study|Physician Decision|3|||
129846390|NCT00806546|467397053|FG000|Overall Study|Enrolled, not treated|35|||
129846391|NCT00806546|467397053|FG000|Overall Study|Lost to Follow-up|32|||
129846392|NCT00806546|467397053|FG000|Overall Study|Adverse Event|74|||
129846393|NCT00806546|467397053|FG000|Overall Study|Withdrawal by Subject|75|||
129846394|NCT00806546|467397053|FG000|Overall Study|Protocol Violation|49|||
129846395|NCT00806546|467397053|FG000|Overall Study|Various|42|||
129846396|NCT02751983|467397054|FG000|Treatment|Stopped ACT, but Remained in study|2|||
129846397|NCT02751983|467397055|FG001|Treatment|Stopped ACT, but Remained in study|0|||
129846398|NCT02751983|467397054|FG000|Treatment|Discharged prior to beginning ACT|2|||
129846399|NCT02751983|467397055|FG001|Treatment|Discharged prior to beginning ACT|0|||
129846400|NCT02751983|467397054|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
129846401|NCT02751983|467397055|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
129846402|NCT02751983|467397054|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
129846403|NCT02751983|467397055|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
129846404|NCT02751983|467397054|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
129846405|NCT02751983|467397055|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
129846406|NCT00096044|467397056|FG000|Overall Study|Withdrawal by Subject|9|||
129846407|NCT00096044|467397056|FG000|Overall Study|Adverse Event|21|||
129846408|NCT00096044|467397056|FG000|Overall Study|Disease Progression|4|||
129846409|NCT03139916|467397057|FG000|Overall Study|Withdrawal by Subject|2|||
129846410|NCT03139916|467397057|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
129846411|NCT00813358|467397058|FG000|Overall Study|Death|32|||
129846412|NCT00813358|467397058|FG000|Overall Study|Lost to Follow-up|12|||
129846413|NCT00813358|467397058|FG000|Overall Study|other endpoints|5|||
129846414|NCT00813358|467397058|FG000|Overall Study|Withdrawal by Subject|20|||
129846415|NCT00004031|467397059|FG000|Overall Study|Adverse Event|5|||
129846416|NCT00004031|467397060|FG001|Overall Study|Adverse Event|0|||
129846417|NCT00004031|467397059|FG000|Overall Study|Refusal unrelated to adverse events|2|||
129846418|NCT00004031|467397060|FG001|Overall Study|Refusal unrelated to adverse events|11|||
129846419|NCT00004031|467397059|FG000|Overall Study|Progression/relapse|9|||
129846420|NCT00004031|467397060|FG001|Overall Study|Progression/relapse|4|||
129846421|NCT00004031|467397059|FG000|Overall Study|Death|3|||
129846422|NCT00004031|467397060|FG001|Overall Study|Death|1|||
129846423|NCT00004031|467397059|FG000|Overall Study|Other- not protocol specified|3|||
129846424|NCT00004031|467397060|FG001|Overall Study|Other- not protocol specified|3|||
129846425|NCT00004031|467397059|FG000|Overall Study|Reason under review|3|||
129846426|NCT00004031|467397060|FG001|Overall Study|Reason under review|2|||
129846427|NCT03851016|467397063|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129846428|NCT03851016|467397064|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
129846429|NCT00586469|467397065|FG000|Overall Study|Adverse Event|0|||
129846430|NCT00586469|467397066|FG001|Overall Study|Adverse Event|1|||
129846431|NCT03337724|467397073|FG000|Overall Study|Reason not Specified|12|||
129846432|NCT03337724|467397074|FG001|Overall Study|Reason not Specified|21|||
129846433|NCT03337724|467397075|FG002|Overall Study|Reason not Specified|9|||
129846434|NCT03337724|467397076|FG003|Overall Study|Reason not Specified|9|||
129846435|NCT03337724|467397077|FG004|Overall Study|Reason not Specified|29|||
129846436|NCT03337724|467397073|FG000|Overall Study|Withdrawal by Subject|13|||
129846437|NCT03337724|467397074|FG001|Overall Study|Withdrawal by Subject|15|||
129846438|NCT03337724|467397075|FG002|Overall Study|Withdrawal by Subject|4|||
129846439|NCT03337724|467397076|FG003|Overall Study|Withdrawal by Subject|15|||
129902964|NCT05147233|467606290|FG000|Overall Study|Withdrawal by Subject|2|||
129902965|NCT05147233|467606291|FG001|Overall Study|Withdrawal by Subject|1|||
129902966|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Adverse Event|1|||
129902967|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Adverse Event|0|||
129902968|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Adverse Event|0|||
129846440|NCT03337724|467397077|FG004|Overall Study|Withdrawal by Subject|6|||
129846441|NCT03337724|467397073|FG000|Overall Study|Protocol Deviation|0|||
129846442|NCT03337724|467397074|FG001|Overall Study|Protocol Deviation|1|||
129846443|NCT03337724|467397075|FG002|Overall Study|Protocol Deviation|1|||
129846444|NCT03337724|467397076|FG003|Overall Study|Protocol Deviation|1|||
129846445|NCT03337724|467397077|FG004|Overall Study|Protocol Deviation|0|||
129846446|NCT03337724|467397073|FG000|Overall Study|Adverse Event|1|||
129846447|NCT03337724|467397074|FG001|Overall Study|Adverse Event|1|||
129846448|NCT03337724|467397075|FG002|Overall Study|Adverse Event|0|||
129846449|NCT03337724|467397076|FG003|Overall Study|Adverse Event|1|||
129846450|NCT03337724|467397077|FG004|Overall Study|Adverse Event|0|||
129846451|NCT03337724|467397073|FG000|Overall Study|Death|40|||
129846452|NCT03337724|467397074|FG001|Overall Study|Death|89|||
129846453|NCT03337724|467397075|FG002|Overall Study|Death|43|||
129846454|NCT03337724|467397076|FG003|Overall Study|Death|76|||
129846455|NCT03337724|467397077|FG004|Overall Study|Death|50|||
129846456|NCT03337724|467397073|FG000|Overall Study|Lost to Follow-up|5|||
129846457|NCT03337724|467397074|FG001|Overall Study|Lost to Follow-up|5|||
129846458|NCT03337724|467397075|FG002|Overall Study|Lost to Follow-up|4|||
129846459|NCT03337724|467397076|FG003|Overall Study|Lost to Follow-up|7|||
129846460|NCT03337724|467397077|FG004|Overall Study|Lost to Follow-up|4|||
129846461|NCT03337724|467397073|FG000|Overall Study|Physician Decision|16|||
129846462|NCT03337724|467397074|FG001|Overall Study|Physician Decision|34|||
129846463|NCT03337724|467397075|FG002|Overall Study|Physician Decision|14|||
129846464|NCT03337724|467397076|FG003|Overall Study|Physician Decision|34|||
129846465|NCT03337724|467397077|FG004|Overall Study|Physician Decision|13|||
129846466|NCT03337724|467397073|FG000|Overall Study|Progressive Disease|0|||
129846467|NCT03337724|467397074|FG001|Overall Study|Progressive Disease|2|||
129846468|NCT03337724|467397075|FG002|Overall Study|Progressive Disease|1|||
129846469|NCT03337724|467397076|FG003|Overall Study|Progressive Disease|2|||
129846470|NCT03337724|467397077|FG004|Overall Study|Progressive Disease|0|||
129846471|NCT03337724|467397073|FG000|Overall Study|Symptomatic Deterioration|0|||
129846472|NCT03337724|467397074|FG001|Overall Study|Symptomatic Deterioration|0|||
129846473|NCT03337724|467397075|FG002|Overall Study|Symptomatic Deterioration|0|||
129846474|NCT03337724|467397076|FG003|Overall Study|Symptomatic Deterioration|1|||
129846475|NCT03337724|467397077|FG004|Overall Study|Symptomatic Deterioration|0|||
129846476|NCT03551210|467397079|FG000|Overall Study|Adverse Event|5|||
129846477|NCT03551210|467397080|FG001|Overall Study|Adverse Event|6|||
129846478|NCT03551210|467397079|FG000|Overall Study|Withdrawal by Subject|1|||
129846479|NCT03551210|467397080|FG001|Overall Study|Withdrawal by Subject|7|||
129846480|NCT03551210|467397079|FG000|Overall Study|Needed in other antibiotic treatment|2|||
129846481|NCT03551210|467397080|FG001|Overall Study|Needed in other antibiotic treatment|5|||
129846482|NCT03551210|467397079|FG000|Overall Study|Lost to Follow-up|1|||
129902969|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
129846483|NCT03551210|467397080|FG001|Overall Study|Lost to Follow-up|1|||
129902970|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
129902971|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
129902972|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
129902973|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
129902974|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
129902975|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
129902976|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
129902977|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
129902978|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Adverse Event|1|||
129902979|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Adverse Event|0|||
129902980|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Adverse Event|0|||
129902981|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
129902982|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
129902983|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
129846484|NCT03551210|467397079|FG000|Overall Study|Absence of visit 4 and 5|1|||
129846485|NCT03551210|467397080|FG001|Overall Study|Absence of visit 4 and 5|0|||
129846486|NCT03551210|467397079|FG000|Overall Study|No drug for dispensing|0|||
129846487|NCT03551210|467397080|FG001|Overall Study|No drug for dispensing|1|||
129846488|NCT03265119|467397081|FG000|Overall Study|Adverse Event|2|||
129846489|NCT03265119|467397082|FG001|Overall Study|Adverse Event|1|||
129846490|NCT03265119|467397081|FG000|Overall Study|Lack of Efficacy|3|||
129846491|NCT03265119|467397082|FG001|Overall Study|Lack of Efficacy|0|||
129846492|NCT03265119|467397081|FG000|Overall Study|Protocol Violation|1|||
129846493|NCT03265119|467397082|FG001|Overall Study|Protocol Violation|2|||
129846494|NCT03265119|467397081|FG000|Overall Study|Withdrawal by Subject|2|||
129846495|NCT03265119|467397082|FG001|Overall Study|Withdrawal by Subject|4|||
129846496|NCT03265119|467397081|FG000|Overall Study|Lost to Follow-up|1|||
129902984|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
129902985|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
129902986|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
129902987|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Physician Decision|1|||
129902988|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Physician Decision|0|||
129902989|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Physician Decision|0|||
129902990|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
129902991|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
129902992|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
129902993|NCT04517864|467606294|FG000|Extension Phase|Adverse Event|0|||
129902994|NCT04517864|467606295|FG001|Extension Phase|Adverse Event|0|||
129902995|NCT04517864|467606296|FG002|Extension Phase|Adverse Event|1|||
129902996|NCT04517864|467606294|FG000|Extension Phase|Lack of Efficacy|0|||
129902997|NCT04517864|467606295|FG001|Extension Phase|Lack of Efficacy|0|||
129902998|NCT04517864|467606296|FG002|Extension Phase|Lack of Efficacy|2|||
129902999|NCT04517864|467606294|FG000|Extension Phase|Study Terminated By Sponsor|0|||
129903000|NCT04517864|467606295|FG001|Extension Phase|Study Terminated By Sponsor|0|||
129903001|NCT04517864|467606296|FG002|Extension Phase|Study Terminated By Sponsor|32|||
129903002|NCT04517864|467606294|FG000|Extension Phase|Withdrawal by Subject|0|||
129903003|NCT04517864|467606295|FG001|Extension Phase|Withdrawal by Subject|0|||
129903004|NCT04517864|467606296|FG002|Extension Phase|Withdrawal by Subject|3|||
129903005|NCT04517864|467606294|FG000|Extension Phase|Approved Drug Available for Indication|0|||
129903006|NCT04517864|467606295|FG001|Extension Phase|Approved Drug Available for Indication|0|||
129903007|NCT04517864|467606296|FG002|Extension Phase|Approved Drug Available for Indication|7|||
129903008|NCT04722003|467606297|FG000|Overall Study|Lost to Follow-up|2|||
129903009|NCT04722003|467606298|FG001|Overall Study|Lost to Follow-up|0|||
129903010|NCT04722003|467606297|FG000|Overall Study|Physician Decision|1|||
129903011|NCT04722003|467606298|FG001|Overall Study|Physician Decision|0|||
129903012|NCT04860258|467606305|FG000|Overall Study|Withdrawal by Subject|0|||
129903013|NCT04860258|467606306|FG001|Overall Study|Withdrawal by Subject|0|||
129903014|NCT04860258|467606307|FG002|Overall Study|Withdrawal by Subject|4|||
129903015|NCT04860258|467606308|FG003|Overall Study|Withdrawal by Subject|1|||
129903016|NCT04860258|467606309|FG004|Overall Study|Withdrawal by Subject|4|||
129903017|NCT04860258|467606310|FG005|Overall Study|Withdrawal by Subject|1|||
129903018|NCT04860258|467606311|FG006|Overall Study|Withdrawal by Subject|0|||
129903019|NCT00726999|467606314|FG000|Overall Study|Physician Decision|0|||
129903020|NCT00726999|467606315|FG001|Overall Study|Physician Decision|1|||
129846497|NCT03265119|467397082|FG001|Overall Study|Lost to Follow-up|0|||
129846498|NCT03265119|467397081|FG000|Overall Study|Lack of Compliance|1|||
129846499|NCT03265119|467397082|FG001|Overall Study|Lack of Compliance|0|||
129846500|NCT00991302|467398489|FG000|Overall Study|Death|0|||
129846501|NCT00991302|467398490|FG001|Overall Study|Death|1|||
129846502|NCT00991302|467398489|FG000|Overall Study|Lost to Follow-up|14|||
129846503|NCT00991302|467398490|FG001|Overall Study|Lost to Follow-up|12|||
129846504|NCT03085927|467398491|FG000|Overall Study|Withdrawal by Subject|1|||
129846505|NCT03085927|467398492|FG001|Overall Study|Withdrawal by Subject|4|||
129903021|NCT00726999|467606314|FG000|Overall Study|Withdrawal by Subject|2|||
129903022|NCT00726999|467606315|FG001|Overall Study|Withdrawal by Subject|0|||
129903023|NCT00726999|467606314|FG000|Overall Study|Protocol Violation|1|||
129903024|NCT00726999|467606315|FG001|Overall Study|Protocol Violation|0|||
129903025|NCT00391846|467606316|FG000|Overall Study|Adverse Event|4|||
129903026|NCT00391846|467606317|FG001|Overall Study|Adverse Event|1|||
129903027|NCT00391846|467606316|FG000|Overall Study|Did not meet the required elig. crit|2|||
129903028|NCT00391846|467606317|FG001|Overall Study|Did not meet the required elig. crit|2|||
129903029|NCT00391846|467606316|FG000|Overall Study|Withdrawal by Subject|2|||
129903030|NCT00391846|467606317|FG001|Overall Study|Withdrawal by Subject|3|||
129903031|NCT00391846|467606316|FG000|Overall Study|Developed study specific DC criteria|0|||
129903032|NCT00391846|467606317|FG001|Overall Study|Developed study specific DC criteria|1|||
129903033|NCT03823300|467606321|FG000|Overall Study|Withdrawal by Subject|16|||
129903034|NCT03823300|467606322|FG001|Overall Study|Withdrawal by Subject|22|||
129903035|NCT03823300|467606321|FG000|Overall Study|Death|10|||
129903036|NCT03823300|467606322|FG001|Overall Study|Death|14|||
129903037|NCT03823300|467606321|FG000|Overall Study|Adverse Event|3|||
129903038|NCT03823300|467606322|FG001|Overall Study|Adverse Event|5|||
129903039|NCT03823300|467606321|FG000|Overall Study|Physician Decision|1|||
129903040|NCT03823300|467606322|FG001|Overall Study|Physician Decision|7|||
129903041|NCT03823300|467606321|FG000|Overall Study|Lost to Follow-up|1|||
129903042|NCT03823300|467606322|FG001|Overall Study|Lost to Follow-up|3|||
129903043|NCT03823300|467606321|FG000|Overall Study|Protocol Violation|1|||
129903044|NCT03823300|467606322|FG001|Overall Study|Protocol Violation|1|||
129903045|NCT03823300|467606321|FG000|Overall Study|Lack of Efficacy|1|||
129903046|NCT03823300|467606322|FG001|Overall Study|Lack of Efficacy|1|||
129903047|NCT03823300|467606321|FG000|Overall Study|Not Eligible|0|||
130064545|NCT00510068|468190192|FG000|Open-label Period|Administrative problems|17|||
129846506|NCT03085927|467398491|FG000|Overall Study|Lost to Follow-up|3|||
129846507|NCT03085927|467398492|FG001|Overall Study|Lost to Follow-up|1|||
129846508|NCT03085927|467398491|FG000|Overall Study|Death|1|||
129846509|NCT03085927|467398492|FG001|Overall Study|Death|0|||
129846510|NCT03085927|467398491|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
129846511|NCT03085927|467398492|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
129846512|NCT03085927|467398491|FG000|Overall Study|Dyad Became Ineligible|0|||
129846513|NCT03085927|467398492|FG001|Overall Study|Dyad Became Ineligible|1|||
129846514|NCT02349711|467398494|FG000|Overall Study|Withdrawal by Subject|2|||
129903048|NCT03823300|467606322|FG001|Overall Study|Not Eligible|1|||
129903049|NCT03823300|467606321|FG000|Overall Study|Other|1|||
129903050|NCT03823300|467606322|FG001|Overall Study|Other|0|||
129903051|NCT00964366|467606323|FG000|Overall Study|Did not qualify at Day 1|1|||
129903052|NCT00964366|467606324|FG001|Overall Study|Did not qualify at Day 1|0|||
129903053|NCT00964366|467606323|FG000|Overall Study|Withdrawal by Subject|0|||
129903054|NCT00964366|467606324|FG001|Overall Study|Withdrawal by Subject|1|||
129903055|NCT01370694|467606325|FG000|Overall Study|Switched to rituximab|4|||
129903056|NCT01370694|467606325|FG000|Overall Study|Progressive disease|2|||
129903057|NCT02393716|467606326|FG000|Overall Study|Death|29|||
129903058|NCT02393716|467606326|FG000|Overall Study|Withdrawal by Subject|8|||
129903059|NCT02393716|467606326|FG000|Overall Study|Device Explanted|8|||
129903060|NCT02393716|467606326|FG000|Overall Study|Missed visit|16|||
129903061|NCT02957539|467606327|FG000|Baseline to Week 16|Lost to Follow-up|8|||
129903062|NCT02957539|467606328|FG001|Baseline to Week 16|Lost to Follow-up|10|||
129903063|NCT02957539|467606329|FG002|Baseline to Week 16|Lost to Follow-up|16|||
129903064|NCT02957539|467606327|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
129903065|NCT02957539|467606328|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
129903066|NCT02957539|467606329|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
129903067|NCT02957539|467606327|FG000|Week 16 to 32|Withdrawal by Subject|3|||
129903068|NCT02957539|467606328|FG001|Week 16 to 32|Withdrawal by Subject|3|||
129903069|NCT02957539|467606329|FG002|Week 16 to 32|Withdrawal by Subject|1|||
129903070|NCT02957539|467606327|FG000|Week 16 to 32|Lost to Follow-up|8|||
129903071|NCT02957539|467606328|FG001|Week 16 to 32|Lost to Follow-up|7|||
129903072|NCT02957539|467606329|FG002|Week 16 to 32|Lost to Follow-up|5|||
129903073|NCT02957539|467606327|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
129903074|NCT02957539|467606328|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
129903075|NCT02957539|467606329|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
129903076|NCT02957539|467606327|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
129903077|NCT02957539|467606328|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
129903078|NCT02957539|467606329|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
129903079|NCT01909336|467606334|FG000|Overall Study|Lost to Follow-up|4|||
129903080|NCT01909336|467606335|FG001|Overall Study|Lost to Follow-up|2|||
129903081|NCT01909336|467606336|FG002|Overall Study|Lost to Follow-up|2|||
129903082|NCT01909336|467606334|FG000|Overall Study|Physician Decision|0|||
129903083|NCT01909336|467606335|FG001|Overall Study|Physician Decision|1|||
129903084|NCT01909336|467606336|FG002|Overall Study|Physician Decision|1|||
129903085|NCT01157182|467606337|FG000|Washout of 28 Days|Adverse Event|2|||
129903086|NCT01157182|467606338|FG001|Washout of 28 Days|Adverse Event|0|||
129903087|NCT03743246|467606339|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
129903088|NCT03743246|467606340|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
129903089|NCT03743246|467606341|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
129903090|NCT03743246|467606342|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
129903091|NCT03743246|467606339|FG000|Pre-Treatment Period|Death|0|||
129903092|NCT03743246|467606340|FG001|Pre-Treatment Period|Death|1|||
129903093|NCT03743246|467606341|FG002|Pre-Treatment Period|Death|0|||
129903094|NCT03743246|467606342|FG003|Pre-Treatment Period|Death|1|||
129903095|NCT03743246|467606339|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
129903096|NCT03743246|467606340|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
129903097|NCT03743246|467606341|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
129903098|NCT03743246|467606342|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
129903099|NCT03743246|467606339|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
129903100|NCT03743246|467606340|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
129903101|NCT03743246|467606341|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
129903102|NCT03743246|467606342|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
129903103|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
129903104|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
129903105|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
129903106|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
129903107|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
129903108|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
129846515|NCT02349711|467398495|FG001|Overall Study|Withdrawal by Subject|1|||
129846516|NCT02349711|467398494|FG000|Overall Study|Lost to Follow-up|1|||
129846517|NCT02349711|467398495|FG001|Overall Study|Lost to Follow-up|1|||
129846518|NCT00194012|467398496|FG000|Randomized Phase|Lack of Efficacy|8|||
129846519|NCT00194012|467398497|FG001|Randomized Phase|Lack of Efficacy|18|||
129846520|NCT00194012|467398496|FG000|Randomized Phase|Study nonadherence|2|||
129846521|NCT00194012|467398497|FG001|Randomized Phase|Study nonadherence|1|||
129903109|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
129903110|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
129903111|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
129903112|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
129903113|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
129903114|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
129903115|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
129903116|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
129903117|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
129903118|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
129846522|NCT00194012|467398496|FG000|Randomized Phase|Withdrawal by Subject|3|||
129846523|NCT00194012|467398497|FG001|Randomized Phase|Withdrawal by Subject|3|||
129846524|NCT00194012|467398496|FG000|Randomized Phase|Adverse Event|2|||
129846525|NCT00194012|467398497|FG001|Randomized Phase|Adverse Event|1|||
129846526|NCT00194012|467398496|FG000|Randomized Phase|Participant reported having a rash|1|||
129846527|NCT00194012|467398497|FG001|Randomized Phase|Participant reported having a rash|0|||
129846528|NCT00194012|467398496|FG000|Randomized Phase|Emesis and enuresis|0|||
129846529|NCT00194012|467398497|FG001|Randomized Phase|Emesis and enuresis|1|||
129846530|NCT00194012|467398496|FG000|Randomized Phase|Oral/nasal twitching|0|||
129846531|NCT00194012|467398497|FG001|Randomized Phase|Oral/nasal twitching|1|||
129846532|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Weight Gain|1|||
129846533|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Weight Gain|0|||
129846534|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
129846535|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
129846536|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
129846537|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
129846538|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
129846539|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
129846540|NCT01513317|467398503|FG000|Overall Study|Withdrawal by Subject|15|||
129846541|NCT01513317|467398504|FG001|Overall Study|Withdrawal by Subject|4|||
129846542|NCT01513317|467398503|FG000|Overall Study|Death|1|||
129846543|NCT01513317|467398504|FG001|Overall Study|Death|1|||
129846544|NCT01513317|467398503|FG000|Overall Study|Study terminated by sponsor|18|||
129846545|NCT01513317|467398504|FG001|Overall Study|Study terminated by sponsor|18|||
129846546|NCT01513317|467398503|FG000|Overall Study|Other|0|||
129846547|NCT01513317|467398504|FG001|Overall Study|Other|1|||
129846548|NCT02564198|467398505|FG000|Overall Study|Withdrawal by Subject|2|||
129846549|NCT02564198|467398506|FG001|Overall Study|Withdrawal by Subject|4|||
129846550|NCT02564198|467398507|FG002|Overall Study|Withdrawal by Subject|0|||
129846551|NCT02564198|467398505|FG000|Overall Study|Adverse Event|0|||
129846552|NCT02564198|467398506|FG001|Overall Study|Adverse Event|1|||
129846553|NCT02564198|467398507|FG002|Overall Study|Adverse Event|0|||
129846554|NCT02200042|467398508|FG000|Overall Study|Withdrawal by Subject|0|||
129846555|NCT02200042|467398509|FG001|Overall Study|Withdrawal by Subject|1|||
129846556|NCT02097134|467398510|FG000|Overall Study|Physician Decision|4|||
129846557|NCT02097134|467398510|FG000|Overall Study|Non-Protocol Therapy|1|||
129846558|NCT02097134|467398510|FG000|Overall Study|Progressive Disease|3|||
129846559|NCT02097134|467398510|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
129846560|NCT00298896|467398515|FG000|Overall Study|Death|3|||
129846561|NCT00298896|467398515|FG000|Overall Study|Physician Decision|2|||
129846562|NCT00298896|467398515|FG000|Overall Study|Intercurrent Illness|1|||
129846563|NCT00298896|467398515|FG000|Overall Study|Disease Progression|41|||
129846564|NCT00298896|467398515|FG000|Overall Study|Withdrawal by Subject|2|||
129846565|NCT00298896|467398515|FG000|Overall Study|Assigned to treatment in error|1|||
129846566|NCT02652624|467398518|FG000|Randomized Phase|Pregnancy|3|||
129846567|NCT02652624|467398519|FG001|Randomized Phase|Pregnancy|1|||
129846568|NCT02652624|467398518|FG000|Randomized Phase|Investigator's Discretion|0|||
129846569|NCT02652624|467398519|FG001|Randomized Phase|Investigator's Discretion|2|||
129846570|NCT02652624|467398518|FG000|Randomized Phase|Death|0|||
129846571|NCT02652624|467398519|FG001|Randomized Phase|Death|1|||
129846572|NCT02652624|467398518|FG000|Randomized Phase|Lost to Follow-up|0|||
129846573|NCT02652624|467398519|FG001|Randomized Phase|Lost to Follow-up|1|||
129846574|NCT02652624|467398518|FG000|Extension Phase|Lost to Follow-up|3|||
129846575|NCT02652624|467398519|FG001|Extension Phase|Lost to Follow-up|1|||
129846576|NCT02652624|467398518|FG000|Extension Phase|Pregnancy|1|||
129846577|NCT02652624|467398519|FG001|Extension Phase|Pregnancy|1|||
129846578|NCT02652624|467398518|FG000|Extension Phase|Adverse Event|0|||
129903119|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
129846579|NCT02652624|467398519|FG001|Extension Phase|Adverse Event|1|||
129846580|NCT02652624|467398518|FG000|Extension Phase|Withdrew Consent|0|||
129846581|NCT02652624|467398519|FG001|Extension Phase|Withdrew Consent|1|||
129903120|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
129846582|NCT01023659|467398520|FG000|Overall Study|Lost to Follow-up|73|||
129846583|NCT01023659|467398521|FG001|Overall Study|Lost to Follow-up|228|||
129846584|NCT01023659|467398522|FG002|Overall Study|Lost to Follow-up|99|||
129846585|NCT00912405|467398525|FG000|Overall Study|Lost to Follow-up|5|||
129903121|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
129903122|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
129903123|NCT01596504|467606343|FG000|Overall Study|Participant's Private Reason|0|||
129903124|NCT01596504|467606344|FG001|Overall Study|Participant's Private Reason|1|||
129903125|NCT01596504|467606345|FG002|Overall Study|Participant's Private Reason|0|||
129903126|NCT01596504|467606343|FG000|Overall Study|Adverse Event|1|||
129903127|NCT01596504|467606344|FG001|Overall Study|Adverse Event|2|||
129903128|NCT01596504|467606345|FG002|Overall Study|Adverse Event|1|||
129903129|NCT01596504|467606343|FG000|Overall Study|Withdrawal by Subject|1|||
129903130|NCT01596504|467606344|FG001|Overall Study|Withdrawal by Subject|0|||
129903131|NCT01596504|467606345|FG002|Overall Study|Withdrawal by Subject|0|||
129903132|NCT01901276|467606346|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
129903133|NCT01901276|467606347|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
129903134|NCT02026258|467606348|FG000|Randomized|Did not start treatment|2|||
129903135|NCT02026258|467606349|FG001|Randomized|Did not start treatment|1|||
129903136|NCT02026258|467606348|FG000|Randomized|Change in treatment plan|1|||
129903137|NCT02026258|467606349|FG001|Randomized|Change in treatment plan|0|||
129903138|NCT02026258|467606348|FG000|Randomized|Presence of periodontal disease|1|||
129903139|NCT02026258|467606349|FG001|Randomized|Presence of periodontal disease|1|||
129903140|NCT02026258|467606348|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
129903141|NCT02026258|467606349|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
129903142|NCT02026258|467606348|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
129903143|NCT02026258|467606349|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
129903144|NCT00530842|467606350|FG000|Overall Study|Adverse Event|10|||
129903145|NCT00530842|467606351|FG001|Overall Study|Adverse Event|6|||
129903146|NCT00530842|467606350|FG000|Overall Study|Lack of Efficacy|2|||
129903147|NCT00530842|467606351|FG001|Overall Study|Lack of Efficacy|1|||
129903148|NCT00530842|467606350|FG000|Overall Study|Lost to Follow-up|0|||
129903149|NCT00530842|467606351|FG001|Overall Study|Lost to Follow-up|4|||
129903150|NCT00530842|467606350|FG000|Overall Study|Protocol Violation|3|||
129903151|NCT00530842|467606351|FG001|Overall Study|Protocol Violation|2|||
129903152|NCT00530842|467606350|FG000|Overall Study|Withdrawal by Subject|4|||
129903153|NCT00530842|467606351|FG001|Overall Study|Withdrawal by Subject|5|||
129903154|NCT00530842|467606350|FG000|Overall Study|Individual different reasons|4|||
129903155|NCT00530842|467606351|FG001|Overall Study|Individual different reasons|3|||
129903156|NCT00530842|467606350|FG000|Period 1|Adverse Event|7|||
129903157|NCT00530842|467606351|FG001|Period 1|Adverse Event|3|||
129903158|NCT00530842|467606350|FG000|Period 1|Lack of Efficacy|1|||
129903159|NCT00530842|467606351|FG001|Period 1|Lack of Efficacy|1|||
129903160|NCT00530842|467606350|FG000|Period 1|Protocol Violation|2|||
129903161|NCT00530842|467606351|FG001|Period 1|Protocol Violation|1|||
129903162|NCT00530842|467606350|FG000|Period 1|Withdrawal by Subject|2|||
129903163|NCT00530842|467606351|FG001|Period 1|Withdrawal by Subject|3|||
129903164|NCT00530842|467606350|FG000|Period 1|Individual different reasons|2|||
129903165|NCT00530842|467606351|FG001|Period 1|Individual different reasons|3|||
129903166|NCT00530842|467606350|FG000|Period 2|Adverse Event|3|||
129903167|NCT00530842|467606351|FG001|Period 2|Adverse Event|3|||
129846586|NCT01434823|467398526|FG000|Overall Study|Incomplete data in medical record|4|||
129846587|NCT01434823|467398527|FG001|Overall Study|Incomplete data in medical record|7|||
129846588|NCT00501540|467398528|FG000|Overall Study|Death|5|||
129846589|NCT01797536|467398529|FG000|Overall Study|Adverse Event|0|||
129846590|NCT01797536|467398530|FG001|Overall Study|Adverse Event|1|||
129846591|NCT01797536|467398531|FG002|Overall Study|Adverse Event|0|||
129846592|NCT01797536|467398532|FG003|Overall Study|Adverse Event|0|||
129846593|NCT00120042|467398533|FG000|Overall Study|all completed protocl|0|||
129846594|NCT00120042|467398534|FG001|Overall Study|all completed protocl|0|||
129846595|NCT00120042|467398535|FG002|Overall Study|all completed protocl|0|||
129846596|NCT02984995|467398537|FG000|Overall Study|Required stem cell transplant|13|||
129846597|NCT02984995|467398538|FG001|Overall Study|Required stem cell transplant|2|||
129846598|NCT02984995|467398537|FG000|Overall Study|Progressive disease|11|||
129846599|NCT02984995|467398538|FG001|Overall Study|Progressive disease|1|||
129846600|NCT02984995|467398537|FG000|Overall Study|Adverse Event|1|||
129846601|NCT02984995|467398538|FG001|Overall Study|Adverse Event|0|||
129846602|NCT04304001|467398543|FG000|Overall Study|Lost to Follow-up|13|||
129846603|NCT04304001|467398544|FG001|Overall Study|Lost to Follow-up|9|||
129846604|NCT02664038|467398548|FG000|13 Week|Lost to Follow-up|7|||
129903168|NCT00530842|467606350|FG000|Period 2|Lack of Efficacy|1|||
129903169|NCT00530842|467606351|FG001|Period 2|Lack of Efficacy|0|||
129903170|NCT00530842|467606350|FG000|Period 2|Lost to Follow-up|0|||
129903171|NCT00530842|467606351|FG001|Period 2|Lost to Follow-up|4|||
129903172|NCT00530842|467606350|FG000|Period 2|Protocol Violation|1|||
129903173|NCT00530842|467606351|FG001|Period 2|Protocol Violation|0|||
129903174|NCT00530842|467606350|FG000|Period 2|Withdrawal by Subject|1|||
129903175|NCT00530842|467606351|FG001|Period 2|Withdrawal by Subject|2|||
129903176|NCT00530842|467606350|FG000|Period 2|Individual different reasons|2|||
129903177|NCT00530842|467606351|FG001|Period 2|Individual different reasons|0|||
129903178|NCT00949975|467606352|FG000|Overall Study|Voluntary discontinuation|6|||
129846605|NCT02664038|467398549|FG001|13 Week|Lost to Follow-up|14|||
129846606|NCT02664038|467398548|FG000|13 Week|Withdrawal by Subject|1|||
129846607|NCT02664038|467398549|FG001|13 Week|Withdrawal by Subject|0|||
129846608|NCT02664038|467398548|FG000|26 Week|Lost to Follow-up|5|||
129846609|NCT02664038|467398549|FG001|26 Week|Lost to Follow-up|4|||
129846610|NCT02606136|467398554|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
129846611|NCT02606136|467398554|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
129846612|NCT02606136|467398554|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
129846613|NCT02606136|467398554|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
129846614|NCT03296696|467398555|FG000|Overall Study|Started Other Antitumor Therapy|1|||
129846615|NCT03296696|467398556|FG001|Overall Study|Started Other Antitumor Therapy|2|||
129846616|NCT03296696|467398557|FG002|Overall Study|Started Other Antitumor Therapy|1|||
129846617|NCT03296696|467398558|FG003|Overall Study|Started Other Antitumor Therapy|2|||
129846618|NCT03296696|467398559|FG004|Overall Study|Started Other Antitumor Therapy|1|||
129846619|NCT03296696|467398560|FG005|Overall Study|Started Other Antitumor Therapy|1|||
129846620|NCT03296696|467398561|FG006|Overall Study|Started Other Antitumor Therapy|2|||
129846621|NCT03296696|467398562|FG007|Overall Study|Started Other Antitumor Therapy|3|||
129846622|NCT03296696|467398563|FG008|Overall Study|Started Other Antitumor Therapy|1|||
129846623|NCT03296696|467398564|FG009|Overall Study|Started Other Antitumor Therapy|0|||
129846624|NCT03296696|467398555|FG000|Overall Study|Death|0|||
129846625|NCT03296696|467398556|FG001|Overall Study|Death|1|||
129846626|NCT03296696|467398557|FG002|Overall Study|Death|1|||
129846627|NCT03296696|467398558|FG003|Overall Study|Death|2|||
129846628|NCT03296696|467398559|FG004|Overall Study|Death|2|||
129846629|NCT03296696|467398560|FG005|Overall Study|Death|3|||
129846630|NCT03296696|467398561|FG006|Overall Study|Death|1|||
129846631|NCT03296696|467398562|FG007|Overall Study|Death|2|||
129846632|NCT03296696|467398563|FG008|Overall Study|Death|0|||
129846633|NCT03296696|467398564|FG009|Overall Study|Death|0|||
129846634|NCT03296696|467398555|FG000|Overall Study|Withdrawal by Subject|0|||
129846635|NCT03296696|467398556|FG001|Overall Study|Withdrawal by Subject|0|||
129846636|NCT03296696|467398557|FG002|Overall Study|Withdrawal by Subject|1|||
129846637|NCT03296696|467398558|FG003|Overall Study|Withdrawal by Subject|0|||
129846638|NCT03296696|467398559|FG004|Overall Study|Withdrawal by Subject|1|||
129846639|NCT03296696|467398560|FG005|Overall Study|Withdrawal by Subject|0|||
129846640|NCT03296696|467398561|FG006|Overall Study|Withdrawal by Subject|0|||
129846641|NCT03296696|467398562|FG007|Overall Study|Withdrawal by Subject|0|||
129846642|NCT03296696|467398563|FG008|Overall Study|Withdrawal by Subject|0|||
129846643|NCT03296696|467398564|FG009|Overall Study|Withdrawal by Subject|1|||
129846644|NCT02075437|467398569|FG000|Overall Study|Withdrawal by Subject|5|||
129846645|NCT02075437|467398569|FG000|Overall Study|Lost to Follow-up|1|||
129846646|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
129846647|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
129846648|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
129846649|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
129846650|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
129846651|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
129846652|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
129846653|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
129846654|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
129846655|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
129846656|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
129846657|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
129846658|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
129846659|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
129846660|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
129846661|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
129846662|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
129846663|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
129846664|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
129846665|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
129846666|NCT02047110|467398570|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
129846667|NCT02047110|467398571|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
129846668|NCT02047110|467398572|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
129846669|NCT02047110|467398573|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
129846670|NCT02047110|467398570|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
129846671|NCT02047110|467398571|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
129846672|NCT02047110|467398572|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
129846673|NCT02047110|467398573|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
129846674|NCT02047110|467398570|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
129846675|NCT02047110|467398571|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
129846676|NCT02047110|467398572|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
129846677|NCT02047110|467398573|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
129846678|NCT02047110|467398570|FG000|Escape Treatment Period|Adverse Event|1|||
129846679|NCT02047110|467398571|FG001|Escape Treatment Period|Adverse Event|2|||
129846680|NCT02047110|467398572|FG002|Escape Treatment Period|Adverse Event|2|||
129846681|NCT02047110|467398573|FG003|Escape Treatment Period|Adverse Event|0|||
129846682|NCT02047110|467398570|FG000|Escape Treatment Period|Other than specified|1|||
129846683|NCT02047110|467398571|FG001|Escape Treatment Period|Other than specified|2|||
129846684|NCT02047110|467398572|FG002|Escape Treatment Period|Other than specified|0|||
129846685|NCT02047110|467398573|FG003|Escape Treatment Period|Other than specified|1|||
129846686|NCT02047110|467398570|FG000|OLE Treatment Period|Other than specified|0|||
129846687|NCT02047110|467398571|FG001|OLE Treatment Period|Other than specified|0|||
129846688|NCT02047110|467398572|FG002|OLE Treatment Period|Other than specified|1|||
129846689|NCT02047110|467398573|FG003|OLE Treatment Period|Other than specified|0|||
129846690|NCT04439240|467398574|FG000|Overall Study|Ineligible|2|||
129846691|NCT04439240|467398574|FG000|Overall Study|Never started treatment|2|||
129846692|NCT04439240|467398574|FG000|Overall Study|Adverse Event|12|||
129846693|NCT04439240|467398574|FG000|Overall Study|Death|2|||
129846694|NCT04439240|467398574|FG000|Overall Study|Disease progression|25|||
129846695|NCT04439240|467398574|FG000|Overall Study|Other diseases|2|||
129846696|NCT04439240|467398574|FG000|Overall Study|Withdrawal by Subject|3|||
129846697|NCT04439240|467398574|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
129846698|NCT04439240|467398574|FG000|Overall Study|Symptomatic decline|1|||
129846699|NCT04439240|467398574|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
129846700|NCT04439240|467398574|FG000|Overall Study|Clinical progression|1|||
129846701|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Adverse Event|41|||
129846702|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Adverse Event|24|||
129846703|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
129846704|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
129846705|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
129846706|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
129846707|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Physician Decision|0|||
129846708|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Physician Decision|6|||
129846709|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
129846710|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
129846711|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
129846712|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
129846713|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
129846714|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
129846715|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
129846716|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
129846717|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
129846718|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
129846719|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
129846720|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
129846721|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
129846722|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
129846723|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
129846724|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
129846725|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
129846726|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
129846727|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
129846728|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
129846729|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
129846730|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
129846731|NCT00813124|467398577|FG000|Overall Study|Death|2|||
129846732|NCT00813124|467398577|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
129846733|NCT00813124|467398577|FG000|Overall Study|Withdrawal by Subject|1|||
129846734|NCT00079274|467398582|FG000|Overall Study|Withdrawal by Subject|111|||
129846735|NCT00079274|467398583|FG001|Overall Study|Withdrawal by Subject|10|||
129846736|NCT00079274|467398584|FG002|Overall Study|Withdrawal by Subject|12|||
129846737|NCT00079274|467398585|FG003|Overall Study|Withdrawal by Subject|163|||
129846738|NCT00079274|467398586|FG004|Overall Study|Withdrawal by Subject|7|||
129846739|NCT00079274|467398587|FG005|Overall Study|Withdrawal by Subject|8|||
129846740|NCT00079274|467398588|FG006|Overall Study|Withdrawal by Subject|0|||
129846741|NCT00079274|467398582|FG000|Overall Study|Adverse Event|130|||
129846742|NCT00079274|467398583|FG001|Overall Study|Adverse Event|8|||
129846743|NCT00079274|467398584|FG002|Overall Study|Adverse Event|8|||
129846744|NCT00079274|467398585|FG003|Overall Study|Adverse Event|184|||
129846745|NCT00079274|467398586|FG004|Overall Study|Adverse Event|7|||
129903179|NCT00949975|467606353|FG001|Overall Study|Voluntary discontinuation|5|||
129903180|NCT00949975|467606354|FG002|Overall Study|Voluntary discontinuation|3|||
129903181|NCT00949975|467606355|FG003|Overall Study|Voluntary discontinuation|6|||
129846746|NCT00079274|467398587|FG005|Overall Study|Adverse Event|8|||
129846747|NCT00079274|467398588|FG006|Overall Study|Adverse Event|0|||
129846748|NCT00079274|467398582|FG000|Overall Study|Recurrence|21|||
129846749|NCT00079274|467398583|FG001|Overall Study|Recurrence|0|||
129846750|NCT00079274|467398584|FG002|Overall Study|Recurrence|1|||
129846751|NCT00079274|467398585|FG003|Overall Study|Recurrence|15|||
129846752|NCT00079274|467398586|FG004|Overall Study|Recurrence|0|||
129846753|NCT00079274|467398587|FG005|Overall Study|Recurrence|2|||
129846754|NCT00079274|467398588|FG006|Overall Study|Recurrence|0|||
129846755|NCT00079274|467398582|FG000|Overall Study|Alternate Treatment|6|||
129846756|NCT00079274|467398583|FG001|Overall Study|Alternate Treatment|1|||
129846757|NCT00079274|467398584|FG002|Overall Study|Alternate Treatment|0|||
129846758|NCT00079274|467398585|FG003|Overall Study|Alternate Treatment|3|||
129846759|NCT00079274|467398586|FG004|Overall Study|Alternate Treatment|0|||
129903182|NCT00949975|467606352|FG000|Overall Study|Adverse Event|11|||
129903183|NCT00949975|467606353|FG001|Overall Study|Adverse Event|11|||
129903184|NCT00949975|467606354|FG002|Overall Study|Adverse Event|10|||
129903185|NCT00949975|467606355|FG003|Overall Study|Adverse Event|10|||
129903186|NCT00949975|467606352|FG000|Overall Study|Safety reason|0|||
129903187|NCT00949975|467606353|FG001|Overall Study|Safety reason|1|||
129903188|NCT00949975|467606354|FG002|Overall Study|Safety reason|0|||
129903189|NCT00949975|467606355|FG003|Overall Study|Safety reason|0|||
129903190|NCT00949975|467606352|FG000|Overall Study|Study-specific criteria|0|||
129903191|NCT00949975|467606353|FG001|Overall Study|Study-specific criteria|1|||
129903192|NCT00949975|467606354|FG002|Overall Study|Study-specific criteria|1|||
129903193|NCT00949975|467606355|FG003|Overall Study|Study-specific criteria|0|||
129903194|NCT00949975|467606352|FG000|Overall Study|Incorrect enrolment|5|||
129903195|NCT00949975|467606353|FG001|Overall Study|Incorrect enrolment|10|||
129903196|NCT00949975|467606354|FG002|Overall Study|Incorrect enrolment|4|||
129903197|NCT00949975|467606355|FG003|Overall Study|Incorrect enrolment|7|||
129903198|NCT00949975|467606352|FG000|Overall Study|Severe non-compliance|3|||
129903199|NCT00949975|467606353|FG001|Overall Study|Severe non-compliance|1|||
129903200|NCT00949975|467606354|FG002|Overall Study|Severe non-compliance|0|||
129903201|NCT00949975|467606355|FG003|Overall Study|Severe non-compliance|2|||
129903202|NCT00949975|467606352|FG000|Overall Study|Lost to Follow-up|1|||
129903203|NCT00949975|467606353|FG001|Overall Study|Lost to Follow-up|0|||
129903204|NCT00949975|467606354|FG002|Overall Study|Lost to Follow-up|1|||
129903205|NCT00949975|467606355|FG003|Overall Study|Lost to Follow-up|3|||
129903206|NCT00949975|467606352|FG000|Overall Study|Other|1|||
129903207|NCT00949975|467606353|FG001|Overall Study|Other|0|||
129903208|NCT00949975|467606354|FG002|Overall Study|Other|0|||
129903209|NCT00949975|467606355|FG003|Overall Study|Other|0|||
129903210|NCT04347954|467606356|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
129903211|NCT04347954|467606357|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
129903212|NCT04347954|467606358|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
129903213|NCT04347954|467606356|FG000|Overall Study|Lost to Follow-up|0|||
129903214|NCT04347954|467606357|FG001|Overall Study|Lost to Follow-up|1|||
129903215|NCT04347954|467606358|FG002|Overall Study|Lost to Follow-up|0|||
129903216|NCT02534350|467606359|FG000|Overall Study|Randomized But Not Treated|1|||
129903217|NCT02534350|467606360|FG001|Overall Study|Randomized But Not Treated|0|||
129903218|NCT02534350|467606359|FG000|Overall Study|Protocol Violation|1|||
129903219|NCT02534350|467606360|FG001|Overall Study|Protocol Violation|0|||
129903220|NCT02534350|467606359|FG000|Overall Study|Withdrew Consent|2|||
129903221|NCT02534350|467606360|FG001|Overall Study|Withdrew Consent|0|||
129903222|NCT03257813|467606376|FG000|Overall Study|Protocol Violation|6|||
129903223|NCT03257813|467606377|FG001|Overall Study|Protocol Violation|3|||
129903224|NCT02878330|467606378|FG000|Overall Study|Death|3|||
129903225|NCT02878330|467606379|FG001|Overall Study|Death|2|||
129903226|NCT02878330|467606378|FG000|Overall Study|Lost to Follow-up|11|||
129903227|NCT02878330|467606379|FG001|Overall Study|Lost to Follow-up|26|||
129903228|NCT02878330|467606378|FG000|Overall Study|Withdrawal by Subject|11|||
130064546|NCT00510068|468190193|FG001|Open-label Period|Administrative problems|0|||
129846760|NCT00079274|467398587|FG005|Overall Study|Alternate Treatment|0|||
129846761|NCT00079274|467398588|FG006|Overall Study|Alternate Treatment|0|||
129846762|NCT00079274|467398582|FG000|Overall Study|Other Medical Problems|6|||
129903229|NCT02878330|467606379|FG001|Overall Study|Withdrawal by Subject|21|||
129903230|NCT02878330|467606378|FG000|Overall Study|Other|4|||
129903231|NCT02878330|467606379|FG001|Overall Study|Other|7|||
129903232|NCT05641311|467606384|FG000|Dosing Period 1|Adverse Event|1|||
129903233|NCT05641311|467606385|FG001|Dosing Period 1|Adverse Event|0|||
129903234|NCT00909363|467606386|FG000|Overall Study|Withdrawal by Subject|1|||
129903235|NCT00909363|467606387|FG001|Overall Study|Withdrawal by Subject|0|||
129903236|NCT00909363|467606388|FG002|Overall Study|Withdrawal by Subject|0|||
129903237|NCT00909363|467606386|FG000|Overall Study|Lack of Efficacy|1|||
129903238|NCT00909363|467606387|FG001|Overall Study|Lack of Efficacy|0|||
129903239|NCT00909363|467606388|FG002|Overall Study|Lack of Efficacy|0|||
129903240|NCT00922207|467606391|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
129903241|NCT00922207|467606392|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
129846763|NCT00079274|467398583|FG001|Overall Study|Other Medical Problems|1|||
129846764|NCT00079274|467398584|FG002|Overall Study|Other Medical Problems|0|||
129846765|NCT00079274|467398585|FG003|Overall Study|Other Medical Problems|7|||
129846766|NCT00079274|467398586|FG004|Overall Study|Other Medical Problems|0|||
129846767|NCT00079274|467398587|FG005|Overall Study|Other Medical Problems|0|||
129846768|NCT00079274|467398588|FG006|Overall Study|Other Medical Problems|0|||
129846769|NCT00079274|467398582|FG000|Overall Study|Death|4|||
129846770|NCT00079274|467398583|FG001|Overall Study|Death|0|||
129846771|NCT00079274|467398584|FG002|Overall Study|Death|1|||
129846772|NCT00079274|467398585|FG003|Overall Study|Death|15|||
129846773|NCT00079274|467398586|FG004|Overall Study|Death|0|||
129846774|NCT00079274|467398587|FG005|Overall Study|Death|0|||
129846775|NCT00079274|467398588|FG006|Overall Study|Death|0|||
129846776|NCT00079274|467398582|FG000|Overall Study|Cytogenetic resistance|0|||
129846777|NCT00079274|467398583|FG001|Overall Study|Cytogenetic resistance|0|||
129846778|NCT00079274|467398584|FG002|Overall Study|Cytogenetic resistance|0|||
129846779|NCT00079274|467398585|FG003|Overall Study|Cytogenetic resistance|2|||
129846780|NCT00079274|467398586|FG004|Overall Study|Cytogenetic resistance|0|||
129846781|NCT00079274|467398587|FG005|Overall Study|Cytogenetic resistance|0|||
129846782|NCT00079274|467398588|FG006|Overall Study|Cytogenetic resistance|0|||
129846783|NCT00079274|467398582|FG000|Overall Study|Other|43|||
129846784|NCT00079274|467398583|FG001|Overall Study|Other|7|||
129846785|NCT00079274|467398584|FG002|Overall Study|Other|5|||
129846786|NCT00079274|467398585|FG003|Overall Study|Other|55|||
129846787|NCT00079274|467398586|FG004|Overall Study|Other|1|||
129846788|NCT00079274|467398587|FG005|Overall Study|Other|2|||
129846789|NCT00079274|467398588|FG006|Overall Study|Other|0|||
129846790|NCT02075320|467398589|FG000|Overall Study|Withdrawal by Subject|2|||
129846791|NCT03773757|467398591|FG000|Overall Study|Withdrawal by Subject|2|||
129846792|NCT03773757|467398592|FG001|Overall Study|Withdrawal by Subject|4|||
129846793|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
129846794|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
129846795|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
129846796|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
129846797|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
129846798|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
129846799|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
129846800|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
129846801|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
129846802|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
129846803|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
129846804|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
129846805|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
129846806|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
129846807|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
129846808|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
129846809|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
129903242|NCT00922207|467606393|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
129903243|NCT00922207|467606391|FG000|Overall Study|Insufficient Therapeutic Response|0|||
129903244|NCT00922207|467606392|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129903245|NCT00922207|467606393|FG002|Overall Study|Insufficient Therapeutic Response|1|||
129903246|NCT00922207|467606391|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129903247|NCT00922207|467606392|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129903248|NCT00922207|467606393|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
129903249|NCT00922207|467606391|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
129903250|NCT00922207|467606392|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129903251|NCT00922207|467606393|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129903252|NCT00922207|467606391|FG000|Overall Study|Withdrew Consent|2|||
129903253|NCT00922207|467606392|FG001|Overall Study|Withdrew Consent|5|||
129903254|NCT00922207|467606393|FG002|Overall Study|Withdrew Consent|2|||
129903255|NCT00922207|467606391|FG000|Overall Study|Abnormality of Laboratory Test|0|||
129903256|NCT00922207|467606392|FG001|Overall Study|Abnormality of Laboratory Test|1|||
129903257|NCT00922207|467606393|FG002|Overall Study|Abnormality of Laboratory Test|1|||
129903258|NCT00319436|467606397|FG000|Overall Study|Withdrawal by Subject|6|||
129903259|NCT00319436|467606398|FG001|Overall Study|Withdrawal by Subject|7|||
129903260|NCT02194933|467606409|FG000|Overall Study|Lost to Follow-up|1|||
129903261|NCT02194933|467606410|FG001|Overall Study|Lost to Follow-up|2|||
129903262|NCT02194933|467606409|FG000|Overall Study|Participant met withdrawal criteria|1|||
129846810|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
129846811|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
129846812|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
129846813|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
129903263|NCT02194933|467606410|FG001|Overall Study|Participant met withdrawal criteria|3|||
129903264|NCT02194933|467606409|FG000|Overall Study|Withdrawal by Subject|0|||
129846814|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
129846815|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
129846816|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
129846817|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
129846818|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
129846819|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
129846820|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
129846821|NCT04542070|467398593|FG000|Maintenance + Extension Period|Adverse Event|10|||
129846822|NCT04542070|467398594|FG001|Maintenance + Extension Period|Adverse Event|2|||
129846823|NCT04542070|467398595|FG002|Maintenance + Extension Period|Adverse Event|0|||
129846824|NCT04542070|467398596|FG003|Maintenance + Extension Period|Adverse Event|0|||
129846825|NCT04542070|467398593|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
129846826|NCT04542070|467398594|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
129846827|NCT04542070|467398595|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
129846828|NCT04542070|467398596|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
129846829|NCT04542070|467398593|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
129846830|NCT04542070|467398594|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
129846831|NCT04542070|467398595|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
129846832|NCT04542070|467398596|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
129846833|NCT04542070|467398593|FG000|Maintenance + Extension Period|Physician Decision|1|||
129846834|NCT04542070|467398594|FG001|Maintenance + Extension Period|Physician Decision|1|||
129846835|NCT04542070|467398595|FG002|Maintenance + Extension Period|Physician Decision|0|||
129846836|NCT04542070|467398596|FG003|Maintenance + Extension Period|Physician Decision|0|||
129846837|NCT04542070|467398593|FG000|Maintenance + Extension Period|Protocol Violation|2|||
129846838|NCT04542070|467398594|FG001|Maintenance + Extension Period|Protocol Violation|5|||
129846839|NCT04542070|467398595|FG002|Maintenance + Extension Period|Protocol Violation|0|||
129846840|NCT04542070|467398596|FG003|Maintenance + Extension Period|Protocol Violation|0|||
129846841|NCT04542070|467398593|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
129846842|NCT04542070|467398594|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
129846843|NCT04542070|467398595|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
129846844|NCT04542070|467398596|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
129846845|NCT04542070|467398593|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
129846846|NCT04542070|467398594|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
129846847|NCT04542070|467398595|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
129846848|NCT04542070|467398596|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
129846849|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
129846850|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
129846851|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
129846852|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
129846853|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
129846854|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
129846855|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
129846856|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
129846857|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
129846858|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
129846859|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
129846860|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
129846861|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
129846862|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
129846863|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
129846864|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
129846865|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
129846866|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
129846867|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
129846868|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
129846869|NCT03049813|467398598|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
129846870|NCT03049813|467398599|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
129846871|NCT03049813|467398600|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
129846872|NCT03049813|467398601|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
129846873|NCT03049813|467398598|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
129846874|NCT03049813|467398599|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
129846875|NCT03049813|467398600|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
129846876|NCT03049813|467398601|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
129846877|NCT03049813|467398598|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
129903265|NCT02194933|467606410|FG001|Overall Study|Withdrawal by Subject|2|||
129846878|NCT03049813|467398599|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
129846879|NCT03049813|467398600|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
129846880|NCT03049813|467398601|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
129846881|NCT03049813|467398598|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
129846882|NCT03049813|467398599|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
129846883|NCT03049813|467398600|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
129846884|NCT03049813|467398601|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
129846885|NCT00550836|467398602|FG000|Overall Study|Withdrawal by Subject|3|||
129846886|NCT00550836|467398603|FG001|Overall Study|Withdrawal by Subject|9|||
129846887|NCT03120013|467398604|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129846888|NCT03120013|467398605|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129846889|NCT02705820|467398606|FG000|Overall Study|Death|2|||
129846890|NCT02705820|467398606|FG000|Overall Study|Disease Progression|34|||
129846891|NCT02705820|467398606|FG000|Overall Study|Clinical Deterioration|3|||
129846892|NCT02702401|467398607|FG000|Overall Study|Death|242|||
129846893|NCT02702401|467398608|FG001|Overall Study|Death|125|||
129846894|NCT02702401|467398607|FG000|Overall Study|Withdrawal by Subject|15|||
129846895|NCT02702401|467398608|FG001|Overall Study|Withdrawal by Subject|5|||
129846896|NCT02702401|467398607|FG000|Overall Study|Sponsor Decision|19|||
129903266|NCT02194933|467606409|FG000|Overall Study|Lack of Efficacy|1|||
129846897|NCT02702401|467398608|FG001|Overall Study|Sponsor Decision|3|||
129846898|NCT02702401|467398607|FG000|Overall Study|Physician Decision|1|||
129846899|NCT02702401|467398608|FG001|Overall Study|Physician Decision|2|||
129846900|NCT02702401|467398607|FG000|Overall Study|Lost to Follow-up|1|||
129846901|NCT02702401|467398608|FG001|Overall Study|Lost to Follow-up|0|||
129903267|NCT02194933|467606410|FG001|Overall Study|Lack of Efficacy|2|||
129903268|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
129903269|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
129903270|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
129903271|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
129903272|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
129903273|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
129846902|NCT01856543|467398613|FG000|Overall Study|Treatment discontinued|6|||
129846903|NCT01856543|467398614|FG001|Overall Study|Treatment discontinued|3|||
129846904|NCT01856543|467398613|FG000|Overall Study|Withdrawn before start|7|||
129846905|NCT01856543|467398614|FG001|Overall Study|Withdrawn before start|3|||
129846906|NCT02457325|467398619|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
129846907|NCT02457325|467398620|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
129846908|NCT01541930|467398621|FG000|Overall Study|Withdrawal by Subject|1|||
129846909|NCT04187196|467398622|FG000|Overall Study|Screen Failure|2|||
129846910|NCT04187196|467398623|FG001|Overall Study|Screen Failure|0|||
129846911|NCT01957475|467398626|FG000|Test Period 1|Withdrawal by Subject|1|||
129846912|NCT01957475|467398627|FG001|Test Period 1|Withdrawal by Subject|0|||
129846913|NCT01957475|467398626|FG000|Test Period 1|Other|1|||
129846914|NCT01957475|467398627|FG001|Test Period 1|Other|0|||
129846915|NCT01957475|467398626|FG000|Test Period 1|Lack of Efficacy|0|||
129846916|NCT01957475|467398627|FG001|Test Period 1|Lack of Efficacy|1|||
129846917|NCT01957475|467398626|FG000|Test Period 2|Adverse Event|1|||
129846918|NCT01957475|467398627|FG001|Test Period 2|Adverse Event|0|||
129846919|NCT04587193|467398628|FG000|Overall Study|Screen failure after consent|3|||
129846920|NCT04587193|467398629|FG001|Overall Study|Screen failure after consent|0|||
129846921|NCT04587193|467398628|FG000|Overall Study|Device broke during study|3|||
129846922|NCT04587193|467398629|FG001|Overall Study|Device broke during study|2|||
129846923|NCT01552772|467398630|FG000|Overall Study|Lost to Follow-up|2|||
129846924|NCT01552772|467398630|FG000|Overall Study|Adverse Event|1|||
129846925|NCT01552772|467398630|FG000|Overall Study|Protocol Deviation|1|||
129846926|NCT02920983|467398633|FG000|Dispense 1|Unacceptable Lens Fit|0|||
129846927|NCT02920983|467398634|FG001|Dispense 1|Unacceptable Lens Fit|0|||
129903274|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
129846928|NCT02920983|467398635|FG002|Dispense 1|Unacceptable Lens Fit|0|||
129846929|NCT02920983|467398636|FG003|Dispense 1|Unacceptable Lens Fit|0|||
129846930|NCT02920983|467398637|FG004|Dispense 1|Unacceptable Lens Fit|1|||
129903275|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
129903276|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
129846931|NCT02920983|467398638|FG005|Dispense 1|Unacceptable Lens Fit|0|||
129846932|NCT02920983|467398633|FG000|Dispense 2|Unscceptable lens fit|1|||
129846933|NCT02920983|467398634|FG001|Dispense 2|Unscceptable lens fit|0|||
129846934|NCT02920983|467398635|FG002|Dispense 2|Unscceptable lens fit|0|||
129846935|NCT02920983|467398636|FG003|Dispense 2|Unscceptable lens fit|0|||
129903277|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
130064547|NCT00510068|468190192|FG000|Open-label Period|Death|7|||
129846936|NCT02920983|467398637|FG004|Dispense 2|Unscceptable lens fit|1|||
129846937|NCT02920983|467398638|FG005|Dispense 2|Unscceptable lens fit|0|||
129846938|NCT02920983|467398633|FG000|Dispense 3|Unacceptable Lens Fit|1|||
129846939|NCT02920983|467398634|FG001|Dispense 3|Unacceptable Lens Fit|1|||
129846940|NCT02920983|467398635|FG002|Dispense 3|Unacceptable Lens Fit|0|||
129846941|NCT02920983|467398636|FG003|Dispense 3|Unacceptable Lens Fit|0|||
129846942|NCT02920983|467398637|FG004|Dispense 3|Unacceptable Lens Fit|1|||
129846943|NCT02920983|467398638|FG005|Dispense 3|Unacceptable Lens Fit|0|||
129846944|NCT03878134|467398639|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
129846945|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
129846946|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
129846947|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
129846948|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Death|1|||
129903278|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
129903279|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
129903280|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
129903281|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
129903282|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
129903283|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
129903284|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
129903285|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903286|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903287|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903288|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903289|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903290|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
129903291|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
129903292|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
129903293|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
129903294|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
129903295|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
129903296|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
129903297|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
129903298|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
129903299|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
129903300|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
129903301|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903302|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
129903303|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
129903304|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
129903305|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903306|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903307|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903308|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903309|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903310|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903311|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903312|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903313|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903314|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903315|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903316|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
129903317|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903318|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903319|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903320|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903321|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903322|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903323|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
129903324|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903325|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903326|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903327|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903328|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903329|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903330|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903331|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903332|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903333|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903334|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
129903335|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
129903336|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
129903337|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
129846949|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Death|0|||
129846950|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Death|0|||
129846951|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
129846952|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
129846953|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
129846954|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
129846955|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
129846956|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
129846957|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
129846958|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
129846959|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
129846960|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
129846961|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
129846962|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
129846963|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
129846964|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
129846965|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
129846966|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
129846967|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
129846968|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
129846969|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
129846970|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
129846971|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
129846972|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
129846973|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
129846974|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
129846975|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
129846976|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
129846977|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
129846978|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Other|0|||
129846979|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Other|2|||
129846980|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Other|2|||
129846981|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
129846982|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
129846983|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
129846984|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
129846985|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
129846986|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
129846987|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
129846988|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
129846989|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
129846990|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
129846991|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
129846992|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
129846993|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
129846994|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
129846995|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
129846996|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
129846997|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
129846998|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
129846999|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
129847000|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
129847001|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
129847002|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
129847003|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
129847004|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
129847005|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Other|1|||
129847006|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Other|0|||
129903338|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
129903339|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
130116565|NCT01073020|468387103|FG000|Overall Study|Withdrawal by Subject|6|||
130116566|NCT01073020|468387104|FG001|Overall Study|Withdrawal by Subject|4|||
130116567|NCT01073020|468387105|FG002|Overall Study|Withdrawal by Subject|1|||
130116568|NCT01073020|468387106|FG003|Overall Study|Withdrawal by Subject|2|||
129903340|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
129903341|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
129903342|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
129903343|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
129903344|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
129903345|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903346|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
129903347|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903348|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903349|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
129903350|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
129903351|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903352|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903353|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903354|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903355|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903356|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903357|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903358|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903359|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903360|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903361|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903362|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
129847007|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Other|0|||
129847008|NCT01709318|467400328|FG000|Overall Study|Adverse Event|3|||
129903363|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
129903364|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
129903365|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
129903366|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
129903367|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903368|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903369|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903370|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903371|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903372|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903373|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
129903374|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
129903375|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
129903376|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
129903377|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
129903378|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903379|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903380|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903381|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129847009|NCT01709318|467400329|FG001|Overall Study|Adverse Event|4|||
129847010|NCT01709318|467400330|FG002|Overall Study|Adverse Event|2|||
129847011|NCT01709318|467400331|FG003|Overall Study|Adverse Event|2|||
129847012|NCT01709318|467400332|FG004|Overall Study|Adverse Event|0|||
129847013|NCT01709318|467400333|FG005|Overall Study|Adverse Event|1|||
129847014|NCT01709318|467400334|FG006|Overall Study|Adverse Event|2|||
129847015|NCT01709318|467400328|FG000|Overall Study|Lost to Follow-up|2|||
129847016|NCT01709318|467400329|FG001|Overall Study|Lost to Follow-up|0|||
129847017|NCT01709318|467400330|FG002|Overall Study|Lost to Follow-up|0|||
129847018|NCT01709318|467400331|FG003|Overall Study|Lost to Follow-up|0|||
129847019|NCT01709318|467400332|FG004|Overall Study|Lost to Follow-up|1|||
129903382|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903383|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903384|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
129903385|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
129903386|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
130064548|NCT00510068|468190193|FG001|Open-label Period|Death|0|||
130064549|NCT00510068|468190192|FG000|Open-label Period|New cancer therapy|7|||
130064550|NCT00510068|468190193|FG001|Open-label Period|New cancer therapy|0|||
130064551|NCT00510068|468190192|FG000|Open-label Period|Protocol Violation|2|||
129847020|NCT01709318|467400333|FG005|Overall Study|Lost to Follow-up|1|||
129847021|NCT01709318|467400334|FG006|Overall Study|Lost to Follow-up|1|||
129847022|NCT01709318|467400328|FG000|Overall Study|Non-compliance with Study Drug|0|||
129847023|NCT01709318|467400329|FG001|Overall Study|Non-compliance with Study Drug|2|||
129847024|NCT01709318|467400330|FG002|Overall Study|Non-compliance with Study Drug|1|||
129847025|NCT01709318|467400331|FG003|Overall Study|Non-compliance with Study Drug|1|||
129847026|NCT01709318|467400332|FG004|Overall Study|Non-compliance with Study Drug|0|||
129847027|NCT01709318|467400333|FG005|Overall Study|Non-compliance with Study Drug|0|||
129847028|NCT01709318|467400334|FG006|Overall Study|Non-compliance with Study Drug|2|||
129847029|NCT01709318|467400328|FG000|Overall Study|Physician Decision|0|||
129847030|NCT01709318|467400329|FG001|Overall Study|Physician Decision|0|||
129847031|NCT01709318|467400330|FG002|Overall Study|Physician Decision|0|||
129847032|NCT01709318|467400331|FG003|Overall Study|Physician Decision|0|||
129847033|NCT01709318|467400332|FG004|Overall Study|Physician Decision|0|||
129847034|NCT01709318|467400333|FG005|Overall Study|Physician Decision|0|||
129847035|NCT01709318|467400334|FG006|Overall Study|Physician Decision|1|||
129847036|NCT01709318|467400328|FG000|Overall Study|Pregnancy|0|||
129847037|NCT01709318|467400329|FG001|Overall Study|Pregnancy|0|||
129847038|NCT01709318|467400330|FG002|Overall Study|Pregnancy|0|||
129847039|NCT01709318|467400331|FG003|Overall Study|Pregnancy|0|||
129847040|NCT01709318|467400332|FG004|Overall Study|Pregnancy|1|||
129847041|NCT01709318|467400333|FG005|Overall Study|Pregnancy|0|||
129847042|NCT01709318|467400334|FG006|Overall Study|Pregnancy|0|||
129847043|NCT01709318|467400328|FG000|Overall Study|Protocol Violation|0|||
129847044|NCT01709318|467400329|FG001|Overall Study|Protocol Violation|0|||
129847045|NCT01709318|467400330|FG002|Overall Study|Protocol Violation|0|||
129847046|NCT01709318|467400331|FG003|Overall Study|Protocol Violation|0|||
129847047|NCT01709318|467400332|FG004|Overall Study|Protocol Violation|2|||
129847048|NCT01709318|467400333|FG005|Overall Study|Protocol Violation|0|||
129847049|NCT01709318|467400334|FG006|Overall Study|Protocol Violation|1|||
129847050|NCT01709318|467400328|FG000|Overall Study|Technical Problems|1|||
129847051|NCT01709318|467400329|FG001|Overall Study|Technical Problems|0|||
129847052|NCT01709318|467400330|FG002|Overall Study|Technical Problems|0|||
129847053|NCT01709318|467400331|FG003|Overall Study|Technical Problems|0|||
129847054|NCT01709318|467400332|FG004|Overall Study|Technical Problems|0|||
129847055|NCT01709318|467400333|FG005|Overall Study|Technical Problems|0|||
129847056|NCT01709318|467400334|FG006|Overall Study|Technical Problems|0|||
129847057|NCT01709318|467400328|FG000|Overall Study|Withdrawal by Subject|3|||
129847058|NCT01709318|467400329|FG001|Overall Study|Withdrawal by Subject|0|||
129847059|NCT01709318|467400330|FG002|Overall Study|Withdrawal by Subject|3|||
129847060|NCT01709318|467400331|FG003|Overall Study|Withdrawal by Subject|3|||
129847061|NCT01709318|467400332|FG004|Overall Study|Withdrawal by Subject|0|||
129847062|NCT01709318|467400333|FG005|Overall Study|Withdrawal by Subject|2|||
129847063|NCT01709318|467400334|FG006|Overall Study|Withdrawal by Subject|4|||
129847064|NCT01709318|467400328|FG000|Overall Study|Other Protocol Specified Criteria|0|||
129847065|NCT01709318|467400329|FG001|Overall Study|Other Protocol Specified Criteria|1|||
129847066|NCT01709318|467400330|FG002|Overall Study|Other Protocol Specified Criteria|0|||
129847067|NCT01709318|467400331|FG003|Overall Study|Other Protocol Specified Criteria|0|||
129847068|NCT01709318|467400332|FG004|Overall Study|Other Protocol Specified Criteria|0|||
129847069|NCT01709318|467400333|FG005|Overall Study|Other Protocol Specified Criteria|0|||
129847070|NCT01709318|467400334|FG006|Overall Study|Other Protocol Specified Criteria|0|||
129903387|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903388|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
129903389|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903390|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903391|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903392|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903393|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903394|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903395|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
129903396|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
129903397|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
129903398|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
129903399|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
129903400|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
129903401|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
129903402|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
129903403|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
130064552|NCT00510068|468190193|FG001|Open-label Period|Protocol Violation|0|||
129847071|NCT02383758|467400335|FG000|Overall Study|Withdrawal by Subject|0|||
129847072|NCT02383758|467400336|FG001|Overall Study|Withdrawal by Subject|2|||
129847073|NCT00600821|467400339|FG000|Overall Study|Death|45|||
129847074|NCT00600821|467400340|FG001|Overall Study|Death|46|||
129847075|NCT00600821|467400339|FG000|Overall Study|Lost to Follow-up|2|||
129847076|NCT00600821|467400340|FG001|Overall Study|Lost to Follow-up|2|||
129847077|NCT00600821|467400339|FG000|Overall Study|Withdrawal by Subject|1|||
129847078|NCT00600821|467400340|FG001|Overall Study|Withdrawal by Subject|1|||
129847079|NCT00600821|467400339|FG000|Overall Study|Terminated by sponsor|8|||
129847080|NCT00600821|467400340|FG001|Overall Study|Terminated by sponsor|6|||
129847081|NCT00600821|467400339|FG000|Overall Study|Objective progression or relapse|0|||
129847082|NCT00600821|467400340|FG001|Overall Study|Objective progression or relapse|1|||
129847083|NCT00600821|467400339|FG000|Overall Study|Randomized but not treated|0|||
129847084|NCT00600821|467400340|FG001|Overall Study|Randomized but not treated|1|||
129847085|NCT00600821|467400339|FG000|Overall Study|Other|2|||
129847086|NCT00600821|467400340|FG001|Overall Study|Other|3|||
129847087|NCT04101526|467400350|FG000|Overall Study|Did not complete all sleep diary entries|0|||
129847088|NCT04101526|467400351|FG001|Overall Study|Did not complete all sleep diary entries|1|||
129903404|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
129903405|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
129903406|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
129903407|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
129903408|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
129903409|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
129903410|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
129903411|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903412|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903413|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903414|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903415|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903416|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903417|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903418|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
129903419|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
129903420|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903421|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903422|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903423|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903424|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903425|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903426|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903427|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903428|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903429|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903430|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
129903431|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
129903432|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903433|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903434|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903435|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903436|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903437|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903438|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903439|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129847089|NCT00424372|467400352|FG000|Overall Study|Death|1|||
129847090|NCT00424372|467400352|FG000|Overall Study|Adverse Event|18|||
129847091|NCT00424372|467400352|FG000|Overall Study|Lack of Efficacy|6|||
129847092|NCT00424372|467400352|FG000|Overall Study|Withdrawal by Subject|4|||
129847093|NCT00424372|467400352|FG000|Overall Study|Protocol Violation|1|||
129847094|NCT00424372|467400352|FG000|Overall Study|Health deterioration|1|||
129847095|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847096|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
129847097|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847098|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847099|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847100|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847101|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
129847102|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
129847103|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
129847104|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129847105|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129847106|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129847107|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
129847108|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847109|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847110|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847111|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847112|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847113|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847114|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
129847115|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
129847116|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847117|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847118|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847119|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847120|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847121|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847122|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
129847123|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847124|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847125|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847126|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847127|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847128|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
129847129|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847130|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
129847131|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847132|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847133|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847134|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
129847135|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847136|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847137|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847138|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847139|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847140|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
129847141|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847142|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847143|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129847144|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129847145|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129847146|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
129847147|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
129847148|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
129847149|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129847150|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129847151|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129847152|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
129847153|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
129847154|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
129847155|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
129847156|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
129847157|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
129847158|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
129847159|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
129847160|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
129847161|NCT00098839|467400361|FG000|Overall Study|Adverse Event|5|||
129847162|NCT00098839|467400362|FG001|Overall Study|Adverse Event|2|||
129847163|NCT00098839|467400361|FG000|Overall Study|Death|1|||
129847164|NCT00098839|467400362|FG001|Overall Study|Death|2|||
129847165|NCT00098839|467400361|FG000|Overall Study|Physician Decision|4|||
129847166|NCT00098839|467400362|FG001|Overall Study|Physician Decision|14|||
129847167|NCT00098839|467400361|FG000|Overall Study|Withdrawal by Subject|1|||
129847168|NCT00098839|467400362|FG001|Overall Study|Withdrawal by Subject|0|||
129847169|NCT00098839|467400361|FG000|Overall Study|Refusal of further protocol therapy|3|||
129847170|NCT00098839|467400362|FG001|Overall Study|Refusal of further protocol therapy|1|||
129847171|NCT00098839|467400361|FG000|Overall Study|Relapse|6|||
129847172|NCT00098839|467400362|FG001|Overall Study|Relapse|3|||
129847173|NCT00098839|467400361|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
129847174|NCT00098839|467400362|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
129847175|NCT00098839|467400361|FG000|Overall Study|Ineligible|2|||
129847176|NCT00098839|467400362|FG001|Overall Study|Ineligible|0|||
129847177|NCT03228680|467400364|FG000|Overall Study|Adverse Event|13|||
129847178|NCT03228680|467400365|FG001|Overall Study|Adverse Event|18|||
129847179|NCT03228680|467400364|FG000|Overall Study|Randomization failure|0|||
129847180|NCT03228680|467400365|FG001|Overall Study|Randomization failure|1|||
129847181|NCT03228680|467400364|FG000|Overall Study|Withdrawal by Subject|1|||
129847182|NCT03228680|467400365|FG001|Overall Study|Withdrawal by Subject|0|||
129847183|NCT03228680|467400364|FG000|Overall Study|Other|9|||
129847184|NCT03228680|467400365|FG001|Overall Study|Other|16|||
129847185|NCT02167035|467400366|FG000|Overall Study|Adverse Event|2|||
129847186|NCT02167035|467400367|FG001|Overall Study|Adverse Event|2|||
129847187|NCT02167035|467400366|FG000|Overall Study|Lost to Follow-up|3|||
129847188|NCT02167035|467400367|FG001|Overall Study|Lost to Follow-up|3|||
129847189|NCT02167035|467400366|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
129847190|NCT02167035|467400367|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
129847191|NCT02148003|467400368|FG000|Overall Study|Failed inclusion criteria|1|||
129847192|NCT02148003|467400369|FG001|Overall Study|Failed inclusion criteria|0|||
129847193|NCT02148003|467400368|FG000|Overall Study|Met exclusion criteria|0|||
129847194|NCT02148003|467400369|FG001|Overall Study|Met exclusion criteria|1|||
129847195|NCT02148003|467400368|FG000|Overall Study|Withdrawal by Subject|0|||
129847196|NCT02148003|467400369|FG001|Overall Study|Withdrawal by Subject|1|||
129847197|NCT02489981|467400370|FG000|Overall Study|Adverse Event|21|||
129847198|NCT02489981|467400370|FG000|Overall Study|Insufficient effectiveness|16|||
129847199|NCT02489981|467400370|FG000|Overall Study|Improved|31|||
129847200|NCT02489981|467400370|FG000|Overall Study|Lost to Follow-up|31|||
129847201|NCT02489981|467400370|FG000|Overall Study|Other than listed|28|||
129847202|NCT00796861|467400371|FG000|Overall Study|Withdrawal by Subject|2|||
129847203|NCT00796861|467400371|FG000|Overall Study|Death|2|||
129847204|NCT03852316|467400374|FG000|Overall Study|Protocol Violation|1|||
129847205|NCT03852316|467400374|FG000|Overall Study|Withdrawal by Subject|2|||
129847206|NCT03852316|467400374|FG000|Overall Study|Enrolled but Device not Utilized|1|||
129847207|NCT01263873|467400375|FG000|Overall Study|One provider unable to complete numbers|1|||
129847208|NCT01263873|467400376|FG001|Overall Study|One provider unable to complete numbers|1|||
129847209|NCT00047463|467400377|FG000|Overall Study|Withdrawal by Subject|0|||
129847210|NCT00047463|467400378|FG001|Overall Study|Withdrawal by Subject|3|||
129847211|NCT01401530|467400380|FG000|Overall Study|Disease Progression|1|||
129847212|NCT01401530|467400381|FG001|Overall Study|Disease Progression|2|||
129847213|NCT01401530|467400382|FG002|Overall Study|Disease Progression|1|||
129847214|NCT01401530|467400380|FG000|Overall Study|Adverse Event|1|||
129847215|NCT01401530|467400381|FG001|Overall Study|Adverse Event|1|||
129847216|NCT01401530|467400382|FG002|Overall Study|Adverse Event|1|||
129847217|NCT01401530|467400380|FG000|Overall Study|Participant Choice|1|||
129847218|NCT01401530|467400381|FG001|Overall Study|Participant Choice|2|||
129847219|NCT01401530|467400382|FG002|Overall Study|Participant Choice|1|||
129847220|NCT01401530|467400380|FG000|Overall Study|Physician Decision|0|||
129847221|NCT01401530|467400381|FG001|Overall Study|Physician Decision|1|||
129847222|NCT01401530|467400382|FG002|Overall Study|Physician Decision|0|||
129847223|NCT04694131|467400389|FG000|Overall Study|Withdrawal by Subject|7|||
129847224|NCT04694131|467400389|FG000|Overall Study|Screen Failure|1|||
129847225|NCT04694131|467400389|FG000|Overall Study|High stimulation threshold|3|||
129847226|NCT04456699|467400390|FG000|Overall Study|Death|48|||
129847227|NCT04456699|467400391|FG001|Overall Study|Death|50|||
129847228|NCT04456699|467400392|FG002|Overall Study|Death|52|||
129847229|NCT04456699|467400390|FG000|Overall Study|Physician Decision|0|||
129847230|NCT04456699|467400391|FG001|Overall Study|Physician Decision|0|||
129847231|NCT04456699|467400392|FG002|Overall Study|Physician Decision|2|||
129847232|NCT04456699|467400390|FG000|Overall Study|Sponsor Decision|55|||
129847233|NCT04456699|467400391|FG001|Overall Study|Sponsor Decision|61|||
129847234|NCT04456699|467400392|FG002|Overall Study|Sponsor Decision|50|||
129847235|NCT04456699|467400390|FG000|Overall Study|Withdrawal by Subject|8|||
129847236|NCT04456699|467400391|FG001|Overall Study|Withdrawal by Subject|4|||
129847237|NCT04456699|467400392|FG002|Overall Study|Withdrawal by Subject|5|||
129847238|NCT04112810|467400393|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
129847239|NCT01859715|467400398|FG000|Overall Study|No 2nd VAS|16|||
129847240|NCT01859715|467400399|FG001|Overall Study|No 2nd VAS|8|||
129847241|NCT01859715|467400400|FG002|Overall Study|No 2nd VAS|23|||
129847242|NCT01252290|467400401|FG000|Overall Study|Withdrawal by Subject|1|||
129847243|NCT00086580|467400402|FG000|Treatment Period|Disease progression|9|||
129847244|NCT00086580|467400403|FG001|Treatment Period|Disease progression|8|||
129847245|NCT00086580|467400402|FG000|Treatment Period|Unable to comply with protocol|3|||
129847246|NCT00086580|467400403|FG001|Treatment Period|Unable to comply with protocol|1|||
129847247|NCT00086580|467400402|FG000|Treatment Period|Withdrawal by Subject|7|||
129847248|NCT00086580|467400403|FG001|Treatment Period|Withdrawal by Subject|8|||
129847249|NCT00086580|467400402|FG000|Treatment Period|Physician Decision|13|||
129847250|NCT00086580|467400403|FG001|Treatment Period|Physician Decision|7|||
129847251|NCT00086580|467400402|FG000|Treatment Period|AE - not treatment related|7|||
129847252|NCT00086580|467400403|FG001|Treatment Period|AE - not treatment related|7|||
129847253|NCT00086580|467400402|FG000|Treatment Period|Toxicity - treatment related|15|||
129847254|NCT00086580|467400403|FG001|Treatment Period|Toxicity - treatment related|15|||
129847255|NCT00086580|467400402|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
129847256|NCT00086580|467400403|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
129847257|NCT00086580|467400402|FG000|Treatment Period|Death|5|||
129847258|NCT00086580|467400403|FG001|Treatment Period|Death|7|||
129847259|NCT00086580|467400402|FG000|Treatment Period|Other|5|||
129847260|NCT00086580|467400403|FG001|Treatment Period|Other|3|||
129847261|NCT00086580|467400402|FG000|Follow-up Period|Disease progression|72|||
129847262|NCT00086580|467400403|FG001|Follow-up Period|Disease progression|99|||
129847263|NCT00086580|467400402|FG000|Follow-up Period|Unable to comply with protocol|5|||
129847264|NCT00086580|467400403|FG001|Follow-up Period|Unable to comply with protocol|0|||
129847265|NCT00086580|467400402|FG000|Follow-up Period|Withdrawal by Subject|6|||
129847266|NCT00086580|467400403|FG001|Follow-up Period|Withdrawal by Subject|6|||
129847267|NCT00086580|467400402|FG000|Follow-up Period|Physician Decision|0|||
129847268|NCT00086580|467400403|FG001|Follow-up Period|Physician Decision|1|||
129847269|NCT00086580|467400402|FG000|Follow-up Period|AE - not related|1|||
129847270|NCT00086580|467400403|FG001|Follow-up Period|AE - not related|0|||
129847271|NCT00086580|467400402|FG000|Follow-up Period|Death|13|||
129847272|NCT00086580|467400403|FG001|Follow-up Period|Death|7|||
129847273|NCT00086580|467400402|FG000|Follow-up Period|Other|7|||
129847274|NCT00086580|467400403|FG001|Follow-up Period|Other|6|||
129847275|NCT00086580|467400402|FG000|Observation Period|Unable to comply with protocol|1|||
129847276|NCT00086580|467400403|FG001|Observation Period|Unable to comply with protocol|1|||
129847277|NCT00086580|467400402|FG000|Observation Period|Withdrawal by Subject|4|||
129847278|NCT00086580|467400403|FG001|Observation Period|Withdrawal by Subject|2|||
129847279|NCT00086580|467400402|FG000|Observation Period|Death|33|||
129847280|NCT00086580|467400403|FG001|Observation Period|Death|55|||
129979685|NCT03752970|467889435|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
129847281|NCT00086580|467400402|FG000|Observation Period|Other|8|||
129847282|NCT00086580|467400403|FG001|Observation Period|Other|7|||
129847283|NCT01000051|467400407|FG000|Overall Study|Withdrawal by Subject|1|||
129847284|NCT01000051|467400408|FG001|Overall Study|Withdrawal by Subject|1|||
129847285|NCT01000051|467400407|FG000|Overall Study|Disease Progression|1|||
129847286|NCT01000051|467400408|FG001|Overall Study|Disease Progression|0|||
129847287|NCT01000051|467400407|FG000|Overall Study|Serious noncompliance|1|||
129847288|NCT01000051|467400408|FG001|Overall Study|Serious noncompliance|0|||
129847289|NCT02247349|467400409|FG000|Overall Study|Disease Progression|7|||
129847290|NCT02247349|467400410|FG001|Overall Study|Disease Progression|4|||
129847291|NCT02247349|467400411|FG002|Overall Study|Disease Progression|26|||
129847292|NCT02247349|467400412|FG003|Overall Study|Disease Progression|31|||
129847293|NCT02247349|467400413|FG004|Overall Study|Disease Progression|16|||
129847294|NCT02247349|467400414|FG005|Overall Study|Disease Progression|6|||
129847295|NCT02247349|467400409|FG000|Overall Study|Study drug toxicity|0|||
129847296|NCT02247349|467400410|FG001|Overall Study|Study drug toxicity|1|||
129847297|NCT02247349|467400411|FG002|Overall Study|Study drug toxicity|1|||
129847298|NCT02247349|467400412|FG003|Overall Study|Study drug toxicity|1|||
129847299|NCT02247349|467400413|FG004|Overall Study|Study drug toxicity|2|||
129847300|NCT02247349|467400414|FG005|Overall Study|Study drug toxicity|2|||
129847301|NCT02247349|467400409|FG000|Overall Study|Death|0|||
129847302|NCT02247349|467400410|FG001|Overall Study|Death|0|||
129847303|NCT02247349|467400411|FG002|Overall Study|Death|0|||
129847304|NCT02247349|467400412|FG003|Overall Study|Death|1|||
129847305|NCT02247349|467400413|FG004|Overall Study|Death|0|||
129847306|NCT02247349|467400414|FG005|Overall Study|Death|0|||
129847307|NCT02247349|467400409|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
129847308|NCT02247349|467400410|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
129847309|NCT02247349|467400411|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
129847310|NCT02247349|467400412|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
129847311|NCT02247349|467400413|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
129847312|NCT02247349|467400414|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
129847313|NCT02247349|467400409|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129847314|NCT02247349|467400410|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129847315|NCT02247349|467400411|FG002|Overall Study|Participant request to discontinue study treatment|1|||
129847316|NCT02247349|467400412|FG003|Overall Study|Participant request to discontinue study treatment|2|||
129847317|NCT02247349|467400413|FG004|Overall Study|Participant request to discontinue study treatment|1|||
129847318|NCT02247349|467400414|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129847319|NCT02247349|467400409|FG000|Overall Study|Withdrawal by Subject|0|||
129847320|NCT02247349|467400410|FG001|Overall Study|Withdrawal by Subject|1|||
129847321|NCT02247349|467400411|FG002|Overall Study|Withdrawal by Subject|0|||
129847322|NCT02247349|467400412|FG003|Overall Study|Withdrawal by Subject|0|||
129847323|NCT02247349|467400413|FG004|Overall Study|Withdrawal by Subject|0|||
129847324|NCT02247349|467400414|FG005|Overall Study|Withdrawal by Subject|0|||
129847325|NCT02247349|467400409|FG000|Overall Study|Administrative reason by sponsor|0|||
129847326|NCT02247349|467400410|FG001|Overall Study|Administrative reason by sponsor|0|||
129847327|NCT02247349|467400411|FG002|Overall Study|Administrative reason by sponsor|0|||
129847328|NCT02247349|467400412|FG003|Overall Study|Administrative reason by sponsor|0|||
129847329|NCT02247349|467400413|FG004|Overall Study|Administrative reason by sponsor|1|||
129847330|NCT02247349|467400414|FG005|Overall Study|Administrative reason by sponsor|0|||
129847331|NCT02247349|467400409|FG000|Overall Study|Other reasons|0|||
129847332|NCT02247349|467400410|FG001|Overall Study|Other reasons|0|||
129847333|NCT02247349|467400411|FG002|Overall Study|Other reasons|1|||
129847334|NCT02247349|467400412|FG003|Overall Study|Other reasons|0|||
129847335|NCT02247349|467400413|FG004|Overall Study|Other reasons|0|||
129903440|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903441|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903442|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
129903443|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903444|NCT03383146|467606422|FG000|Overall Study|Screen Failure|1|||
129847336|NCT02247349|467400414|FG005|Overall Study|Other reasons|0|||
129847337|NCT01959581|467400415|FG000|Overall Study|Lost to Follow-up|5|||
129847338|NCT00179413|467400417|FG000|Overall Study|Adverse Event|38|||
129847339|NCT00179413|467400418|FG001|Overall Study|Adverse Event|20|||
129847340|NCT00179413|467400417|FG000|Overall Study|Withdrawal by Subject|87|||
129847341|NCT00179413|467400418|FG001|Overall Study|Withdrawal by Subject|95|||
129847342|NCT01458171|467400421|FG000|Overall Study|Adverse Event|1|||
129847343|NCT01696032|467400422|FG000|Overall Study|Withdrawal by Subject|0|||
129847344|NCT01696032|467400423|FG001|Overall Study|Withdrawal by Subject|0|||
129847345|NCT01696032|467400424|FG002|Overall Study|Withdrawal by Subject|1|||
129847346|NCT01696032|467400425|FG003|Overall Study|Withdrawal by Subject|2|||
129847347|NCT01696032|467400422|FG000|Overall Study|Death|14|||
129847348|NCT01696032|467400423|FG001|Overall Study|Death|4|||
129847349|NCT01696032|467400424|FG002|Overall Study|Death|43|||
129847350|NCT01696032|467400425|FG003|Overall Study|Death|18|||
129847351|NCT01696032|467400422|FG000|Overall Study|Lost to Follow-up|0|||
129847352|NCT01696032|467400423|FG001|Overall Study|Lost to Follow-up|1|||
129847353|NCT01696032|467400424|FG002|Overall Study|Lost to Follow-up|0|||
129847354|NCT01696032|467400425|FG003|Overall Study|Lost to Follow-up|0|||
129847355|NCT01696032|467400422|FG000|Overall Study|Database lock|0|||
129847356|NCT01696032|467400423|FG001|Overall Study|Database lock|1|||
129847357|NCT01696032|467400424|FG002|Overall Study|Database lock|7|||
129847358|NCT01696032|467400425|FG003|Overall Study|Database lock|2|||
129847359|NCT02203591|467400429|FG000|Overall Study|Did not meet treatment day baseline|147|||
129847360|NCT02203591|467400430|FG001|Overall Study|Did not meet treatment day baseline|141|||
129847361|NCT02203591|467400431|FG002|Overall Study|Did not meet treatment day baseline|150|||
129847362|NCT02203591|467400432|FG003|Overall Study|Did not meet treatment day baseline|45|||
129847363|NCT02203591|467400433|FG004|Overall Study|Did not meet treatment day baseline|33|||
129847364|NCT02203591|467400434|FG005|Overall Study|Did not meet treatment day baseline|35|||
129847365|NCT02203591|467400435|FG006|Overall Study|Did not meet treatment day baseline|29|||
129847366|NCT02203591|467400436|FG007|Overall Study|Did not meet treatment day baseline|12|||
129847367|NCT02203591|467400429|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
129847368|NCT02203591|467400430|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
129847369|NCT02203591|467400431|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
129847370|NCT02203591|467400432|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
129847371|NCT02203591|467400433|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
129847372|NCT02203591|467400434|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
129847373|NCT02203591|467400435|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
129847374|NCT02203591|467400436|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
129847375|NCT00515827|467400439|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
129847376|NCT00515827|467400440|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
129847377|NCT00515827|467400439|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
129847378|NCT00515827|467400440|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
129847379|NCT05402995|467400443|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
129847380|NCT05402995|467400444|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
129847381|NCT05402995|467400445|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
129847382|NCT05402995|467400446|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
129847383|NCT01009099|467400447|FG000|Overall Study|Lost to Follow-up|1|||
129903445|NCT03383146|467606423|FG001|Overall Study|Screen Failure|0|||
129903446|NCT03383146|467606422|FG000|Overall Study|Adverse Event|6|||
129903447|NCT03383146|467606423|FG001|Overall Study|Adverse Event|18|||
129903448|NCT03383146|467606422|FG000|Overall Study|Lack of Efficacy|0|||
129903449|NCT03383146|467606423|FG001|Overall Study|Lack of Efficacy|3|||
129903450|NCT03383146|467606422|FG000|Overall Study|Withdrawal by Subject|20|||
129903451|NCT03383146|467606423|FG001|Overall Study|Withdrawal by Subject|36|||
129903452|NCT03383146|467606422|FG000|Overall Study|Lost to Follow-up|5|||
129903453|NCT03383146|467606423|FG001|Overall Study|Lost to Follow-up|15|||
130064553|NCT00510068|468190192|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
130116569|NCT01073020|468387103|FG000|Overall Study|Physician Decision|1|||
129847384|NCT01009099|467400448|FG001|Overall Study|Lost to Follow-up|0|||
129847385|NCT01009099|467400447|FG000|Overall Study|Physician Decision|3|||
129847386|NCT01009099|467400448|FG001|Overall Study|Physician Decision|2|||
129847387|NCT01009099|467400447|FG000|Overall Study|Withdrawal by Subject|1|||
129847388|NCT01009099|467400448|FG001|Overall Study|Withdrawal by Subject|1|||
129847389|NCT01009099|467400447|FG000|Overall Study|Death|0|||
129903454|NCT03383146|467606422|FG000|Overall Study|Death|0|||
129903455|NCT03383146|467606423|FG001|Overall Study|Death|2|||
129903456|NCT03383146|467606422|FG000|Overall Study|Physician Decision|0|||
129847390|NCT01009099|467400448|FG001|Overall Study|Death|1|||
129847391|NCT02501096|467400460|FG000|Overall Study|Lost to Follow-up|0|||
129847392|NCT02501096|467400461|FG001|Overall Study|Lost to Follow-up|0|||
129847393|NCT02501096|467400462|FG002|Overall Study|Lost to Follow-up|0|||
129847394|NCT02501096|467400463|FG003|Overall Study|Lost to Follow-up|0|||
129847395|NCT02501096|467400464|FG004|Overall Study|Lost to Follow-up|1|||
129847396|NCT02501096|467400465|FG005|Overall Study|Lost to Follow-up|1|||
129847397|NCT02501096|467400466|FG006|Overall Study|Lost to Follow-up|3|||
129847398|NCT02501096|467400467|FG007|Overall Study|Lost to Follow-up|0|||
129847399|NCT02501096|467400468|FG008|Overall Study|Lost to Follow-up|0|||
129847400|NCT02501096|467400460|FG000|Overall Study|Withdrawal by Subject|1|||
129847401|NCT02501096|467400461|FG001|Overall Study|Withdrawal by Subject|0|||
129847402|NCT02501096|467400462|FG002|Overall Study|Withdrawal by Subject|7|||
129847403|NCT02501096|467400463|FG003|Overall Study|Withdrawal by Subject|13|||
129847404|NCT02501096|467400464|FG004|Overall Study|Withdrawal by Subject|2|||
129847405|NCT02501096|467400465|FG005|Overall Study|Withdrawal by Subject|2|||
129847406|NCT02501096|467400466|FG006|Overall Study|Withdrawal by Subject|2|||
129847407|NCT02501096|467400467|FG007|Overall Study|Withdrawal by Subject|3|||
129847408|NCT02501096|467400468|FG008|Overall Study|Withdrawal by Subject|0|||
129847409|NCT02501096|467400460|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
129847410|NCT02501096|467400461|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
129847411|NCT02501096|467400462|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
129847412|NCT02501096|467400463|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
129847413|NCT02501096|467400464|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
129847414|NCT02501096|467400465|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
129847415|NCT02501096|467400466|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
129847416|NCT02501096|467400467|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
129847417|NCT02501096|467400468|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
129847418|NCT02501096|467400460|FG000|Overall Study|Death|1|||
129847419|NCT02501096|467400461|FG001|Overall Study|Death|1|||
129847420|NCT02501096|467400462|FG002|Overall Study|Death|88|||
129847421|NCT02501096|467400463|FG003|Overall Study|Death|74|||
129847422|NCT02501096|467400464|FG004|Overall Study|Death|15|||
129847423|NCT02501096|467400465|FG005|Overall Study|Death|16|||
129847424|NCT02501096|467400466|FG006|Overall Study|Death|15|||
129847425|NCT02501096|467400467|FG007|Overall Study|Death|16|||
129847426|NCT02501096|467400468|FG008|Overall Study|Death|1|||
129847427|NCT00512096|467400472|FG000|Overall Study|Adverse Event|2|||
129847428|NCT00512096|467400472|FG000|Overall Study|Withdrawal by Subject|2|||
129847429|NCT00512096|467400472|FG000|Overall Study|Lack of Efficacy|3|||
129847430|NCT01069289|467400473|FG000|Overall Study|Withdrawal by Subject|15|||
129847431|NCT01069289|467400474|FG001|Overall Study|Withdrawal by Subject|26|||
129847432|NCT01069289|467400473|FG000|Overall Study|Adverse Event|21|||
129847433|NCT01069289|467400474|FG001|Overall Study|Adverse Event|28|||
129847434|NCT01069289|467400473|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129847435|NCT01069289|467400474|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129847436|NCT01069289|467400473|FG000|Overall Study|Severe non-compliance to protocol|3|||
129847437|NCT01069289|467400474|FG001|Overall Study|Severe non-compliance to protocol|2|||
129847438|NCT01069289|467400473|FG000|Overall Study|Due to deteriorating health condition|1|||
129847439|NCT01069289|467400474|FG001|Overall Study|Due to deteriorating health condition|0|||
129847440|NCT02696096|467400475|FG000|Overall Study|ruled out at screening|1|||
129847441|NCT02696096|467400475|FG000|Overall Study|did not attend second fMRI|1|||
129847442|NCT02047604|467400476|FG000|Overall Study|Withdrawal by Subject|0|||
129847443|NCT02047604|467400477|FG001|Overall Study|Withdrawal by Subject|0|||
129847444|NCT02047604|467400478|FG002|Overall Study|Withdrawal by Subject|0|||
129847445|NCT02047604|467400479|FG003|Overall Study|Withdrawal by Subject|0|||
129847446|NCT02047604|467400480|FG004|Overall Study|Withdrawal by Subject|1|||
129847447|NCT02047604|467400481|FG005|Overall Study|Withdrawal by Subject|1|||
129847448|NCT00773097|467400482|FG000|Overall Study|Withdrawal by Subject|1|||
129847449|NCT00773097|467400482|FG000|Overall Study|Physician Decision|6|||
129847450|NCT01755416|467400484|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
129847451|NCT01755416|467400485|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
129847452|NCT02742103|467402290|FG000|Overall Study|Protocol Violation|1|||
129847453|NCT02742103|467402291|FG001|Overall Study|Protocol Violation|0|||
129847454|NCT02742103|467402290|FG000|Overall Study|Death|2|||
129847455|NCT02742103|467402291|FG001|Overall Study|Death|2|||
129847456|NCT02742103|467402290|FG000|Overall Study|Adverse Event|1|||
129847457|NCT02742103|467402291|FG001|Overall Study|Adverse Event|0|||
129847458|NCT02742103|467402290|FG000|Overall Study|Moved to another town|0|||
129847459|NCT02742103|467402291|FG001|Overall Study|Moved to another town|1|||
129847460|NCT02742103|467402290|FG000|Overall Study|Withdrawal by Subject|5|||
129847461|NCT02742103|467402291|FG001|Overall Study|Withdrawal by Subject|2|||
129847462|NCT03042312|467402292|FG000|Overall Study|Administrative Reason|1|||
129847463|NCT03042312|467402293|FG001|Overall Study|Administrative Reason|1|||
129847464|NCT03042312|467402292|FG000|Overall Study|Adverse Event|0|||
129847465|NCT03042312|467402293|FG001|Overall Study|Adverse Event|1|||
129847466|NCT03042312|467402292|FG000|Overall Study|Lost to Follow-up|1|||
129847467|NCT03042312|467402293|FG001|Overall Study|Lost to Follow-up|3|||
129847468|NCT03042312|467402292|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
129847469|NCT03042312|467402293|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
129847470|NCT03042312|467402292|FG000|Overall Study|Withdrawal by Subject|4|||
129847471|NCT03042312|467402293|FG001|Overall Study|Withdrawal by Subject|5|||
129847472|NCT00646958|467402296|FG000|Overall Study|Lack of Efficacy|1|||
129847473|NCT00646958|467402297|FG001|Overall Study|Lack of Efficacy|0|||
129847474|NCT00646958|467402298|FG002|Overall Study|Lack of Efficacy|0|||
129847475|NCT00646958|467402296|FG000|Overall Study|Adverse Event|4|||
129847476|NCT00646958|467402297|FG001|Overall Study|Adverse Event|0|||
129847477|NCT00646958|467402298|FG002|Overall Study|Adverse Event|0|||
129847478|NCT00646958|467402296|FG000|Overall Study|Lost to Follow-up|1|||
129847479|NCT00646958|467402297|FG001|Overall Study|Lost to Follow-up|5|||
129847480|NCT00646958|467402298|FG002|Overall Study|Lost to Follow-up|7|||
129847481|NCT00646958|467402296|FG000|Overall Study|Protocol Violation|1|||
129847482|NCT00646958|467402297|FG001|Overall Study|Protocol Violation|1|||
129847483|NCT00646958|467402298|FG002|Overall Study|Protocol Violation|0|||
129847484|NCT00646958|467402296|FG000|Overall Study|Abnormal screening lab tests|1|||
129847485|NCT00646958|467402297|FG001|Overall Study|Abnormal screening lab tests|1|||
129847486|NCT00646958|467402298|FG002|Overall Study|Abnormal screening lab tests|0|||
129847487|NCT00646958|467402296|FG000|Overall Study|Withdrawal by Subject|1|||
129847488|NCT00646958|467402297|FG001|Overall Study|Withdrawal by Subject|2|||
129847489|NCT00646958|467402298|FG002|Overall Study|Withdrawal by Subject|0|||
129847490|NCT00646958|467402296|FG000|Overall Study|Did not receive study drug|2|||
129847491|NCT00646958|467402297|FG001|Overall Study|Did not receive study drug|0|||
129847492|NCT00646958|467402298|FG002|Overall Study|Did not receive study drug|2|||
129847493|NCT02573324|467402300|FG000|Overall Study|Withdrawal by Subject|26|||
129847494|NCT02573324|467402301|FG001|Overall Study|Withdrawal by Subject|23|||
129847495|NCT02573324|467402302|FG002|Overall Study|Withdrawal by Subject|3|||
129847496|NCT02573324|467402300|FG000|Overall Study|Lost to Follow-up|4|||
129847497|NCT02573324|467402301|FG001|Overall Study|Lost to Follow-up|5|||
129847498|NCT02573324|467402302|FG002|Overall Study|Lost to Follow-up|0|||
129847499|NCT02573324|467402300|FG000|Overall Study|Study Terminated by Sponsor|107|||
129847500|NCT02573324|467402301|FG001|Overall Study|Study Terminated by Sponsor|89|||
129847501|NCT02573324|467402302|FG002|Overall Study|Study Terminated by Sponsor|2|||
129847502|NCT02573324|467402300|FG000|Overall Study|Death|182|||
129847503|NCT02573324|467402301|FG001|Overall Study|Death|200|||
129847504|NCT02573324|467402302|FG002|Overall Study|Death|1|||
129847505|NCT02573324|467402300|FG000|Overall Study|Other, Not Specified|20|||
129847506|NCT02573324|467402301|FG001|Overall Study|Other, Not Specified|27|||
129847507|NCT02573324|467402302|FG002|Overall Study|Other, Not Specified|0|||
129847508|NCT02573324|467402300|FG000|Overall Study|Unknown Reason|2|||
129847509|NCT02573324|467402301|FG001|Overall Study|Unknown Reason|0|||
129847510|NCT02573324|467402302|FG002|Overall Study|Unknown Reason|0|||
129847511|NCT01105533|467402303|FG000|Overall Study|Death|0|||
129847512|NCT01105533|467402304|FG001|Overall Study|Death|0|||
129847513|NCT01105533|467402305|FG002|Overall Study|Death|0|||
129847514|NCT01105533|467402306|FG003|Overall Study|Death|0|||
129847515|NCT01105533|467402307|FG004|Overall Study|Death|1|||
129847516|NCT01105533|467402308|FG005|Overall Study|Death|0|||
129847517|NCT01105533|467402309|FG006|Overall Study|Death|0|||
129847518|NCT01105533|467402310|FG007|Overall Study|Death|0|||
129847519|NCT01105533|467402311|FG008|Overall Study|Death|0|||
129847520|NCT01105533|467402303|FG000|Overall Study|Lack of Efficacy|1|||
129847521|NCT01105533|467402304|FG001|Overall Study|Lack of Efficacy|1|||
129847522|NCT01105533|467402305|FG002|Overall Study|Lack of Efficacy|3|||
129847523|NCT01105533|467402306|FG003|Overall Study|Lack of Efficacy|3|||
129847524|NCT01105533|467402307|FG004|Overall Study|Lack of Efficacy|4|||
129847525|NCT01105533|467402308|FG005|Overall Study|Lack of Efficacy|5|||
129847526|NCT01105533|467402309|FG006|Overall Study|Lack of Efficacy|3|||
129847527|NCT01105533|467402310|FG007|Overall Study|Lack of Efficacy|2|||
129847528|NCT01105533|467402311|FG008|Overall Study|Lack of Efficacy|9|||
129847529|NCT01105533|467402303|FG000|Overall Study|Adverse Event|0|||
129847530|NCT01105533|467402304|FG001|Overall Study|Adverse Event|0|||
130064554|NCT00510068|468190193|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
129847531|NCT01105533|467402305|FG002|Overall Study|Adverse Event|0|||
129847532|NCT01105533|467402306|FG003|Overall Study|Adverse Event|0|||
129847533|NCT01105533|467402307|FG004|Overall Study|Adverse Event|1|||
129847534|NCT01105533|467402308|FG005|Overall Study|Adverse Event|2|||
129847535|NCT01105533|467402309|FG006|Overall Study|Adverse Event|2|||
129847536|NCT01105533|467402310|FG007|Overall Study|Adverse Event|0|||
129847537|NCT01105533|467402311|FG008|Overall Study|Adverse Event|1|||
129847538|NCT01105533|467402303|FG000|Overall Study|Other|0|||
129847539|NCT01105533|467402304|FG001|Overall Study|Other|0|||
129847540|NCT01105533|467402305|FG002|Overall Study|Other|0|||
129847541|NCT01105533|467402306|FG003|Overall Study|Other|0|||
129847542|NCT01105533|467402307|FG004|Overall Study|Other|1|||
129847543|NCT01105533|467402308|FG005|Overall Study|Other|0|||
129847544|NCT01105533|467402309|FG006|Overall Study|Other|3|||
129847545|NCT01105533|467402310|FG007|Overall Study|Other|1|||
129847546|NCT01105533|467402311|FG008|Overall Study|Other|2|||
129847547|NCT01105533|467402303|FG000|Overall Study|Physician Decision|0|||
129847548|NCT01105533|467402304|FG001|Overall Study|Physician Decision|0|||
129847549|NCT01105533|467402305|FG002|Overall Study|Physician Decision|0|||
129847550|NCT01105533|467402306|FG003|Overall Study|Physician Decision|0|||
129847551|NCT01105533|467402307|FG004|Overall Study|Physician Decision|0|||
129847552|NCT01105533|467402308|FG005|Overall Study|Physician Decision|0|||
129847553|NCT01105533|467402309|FG006|Overall Study|Physician Decision|0|||
129847554|NCT01105533|467402310|FG007|Overall Study|Physician Decision|1|||
129847555|NCT01105533|467402311|FG008|Overall Study|Physician Decision|0|||
129847556|NCT02096835|467402313|FG000|Overall Study|Withdrawal by Subject|1|||
129847557|NCT02096835|467402314|FG001|Overall Study|Withdrawal by Subject|0|||
129847558|NCT02096835|467402315|FG002|Overall Study|Withdrawal by Subject|0|||
129847559|NCT02096835|467402313|FG000|Overall Study|converted to open procedures|1|||
129847560|NCT02096835|467402314|FG001|Overall Study|converted to open procedures|0|||
129847561|NCT02096835|467402315|FG002|Overall Study|converted to open procedures|0|||
129847562|NCT02096835|467402313|FG000|Overall Study|Lost to Follow-up|1|||
129847563|NCT02096835|467402314|FG001|Overall Study|Lost to Follow-up|0|||
129847564|NCT02096835|467402315|FG002|Overall Study|Lost to Follow-up|1|||
129847565|NCT03892889|467402316|FG000|Overall Study|Adverse Event|17|||
129847566|NCT03892889|467402316|FG000|Overall Study|Lack of Efficacy|1|||
129847567|NCT03892889|467402316|FG000|Overall Study|Lost to Follow-up|46|||
129847568|NCT03892889|467402316|FG000|Overall Study|Non-compliance with study drug|22|||
129847569|NCT03892889|467402316|FG000|Overall Study|Pregnancy|1|||
129847570|NCT03892889|467402316|FG000|Overall Study|Protocol Deviation|3|||
129847571|NCT03892889|467402316|FG000|Overall Study|Withdrawal by Subject|50|||
129847572|NCT03892889|467402316|FG000|Overall Study|Withdrawal by Caregiver|1|||
129847573|NCT03892889|467402316|FG000|Overall Study|Study Terminated by Sponsor|50|||
129847574|NCT03892889|467402316|FG000|Overall Study|Physician Decision|8|||
129847575|NCT03892889|467402316|FG000|Overall Study|Reason not Specified|5|||
129847576|NCT04260191|467402317|FG000|Overall Study|Decision by Sponsor|0|||
129847577|NCT04260191|467402318|FG001|Overall Study|Decision by Sponsor|1|||
129847578|NCT04260191|467402319|FG002|Overall Study|Decision by Sponsor|0|||
129847579|NCT04260191|467402317|FG000|Overall Study|Withdrawal by Subject|1|||
129847580|NCT04260191|467402318|FG001|Overall Study|Withdrawal by Subject|0|||
129847581|NCT04260191|467402319|FG002|Overall Study|Withdrawal by Subject|3|||
129847582|NCT04260191|467402317|FG000|Overall Study|Death|4|||
129847583|NCT04260191|467402318|FG001|Overall Study|Death|3|||
129847584|NCT04260191|467402319|FG002|Overall Study|Death|2|||
129847585|NCT00023673|467402322|FG000|Overall Study|Ineligible / no protocol treatment|0|||
129847586|NCT00023673|467402323|FG001|Overall Study|Ineligible / no protocol treatment|0|||
129847587|NCT00023673|467402324|FG002|Overall Study|Ineligible / no protocol treatment|0|||
129847588|NCT00023673|467402325|FG003|Overall Study|Ineligible / no protocol treatment|1|||
129847589|NCT00023673|467402322|FG000|Overall Study|Patient withdrew consent|0|||
129847590|NCT00023673|467402323|FG001|Overall Study|Patient withdrew consent|0|||
129847591|NCT00023673|467402324|FG002|Overall Study|Patient withdrew consent|0|||
129847592|NCT00023673|467402325|FG003|Overall Study|Patient withdrew consent|1|||
129847593|NCT02453594|467402326|FG000|Overall Study|Protocol Violation|0|||
129847594|NCT02453594|467402327|FG001|Overall Study|Protocol Violation|0|||
129847595|NCT02453594|467402328|FG002|Overall Study|Protocol Violation|1|||
129847596|NCT02453594|467402326|FG000|Overall Study|Cohort Was Closed|17|||
129847597|NCT02453594|467402327|FG001|Overall Study|Cohort Was Closed|21|||
129847598|NCT02453594|467402328|FG002|Overall Study|Cohort Was Closed|14|||
129847599|NCT02453594|467402326|FG000|Overall Study|Death|20|||
129847600|NCT02453594|467402327|FG001|Overall Study|Death|24|||
129847601|NCT02453594|467402328|FG002|Overall Study|Death|16|||
129847602|NCT02453594|467402326|FG000|Overall Study|Lost to Follow-up|6|||
129847603|NCT02453594|467402327|FG001|Overall Study|Lost to Follow-up|14|||
129847604|NCT02453594|467402328|FG002|Overall Study|Lost to Follow-up|2|||
129847605|NCT02453594|467402326|FG000|Overall Study|Physician Decision|2|||
129847606|NCT02453594|467402327|FG001|Overall Study|Physician Decision|4|||
129847607|NCT02453594|467402328|FG002|Overall Study|Physician Decision|0|||
129847608|NCT02453594|467402326|FG000|Overall Study|Site Terminated by Sponsor|1|||
129847609|NCT02453594|467402327|FG001|Overall Study|Site Terminated by Sponsor|0|||
129847610|NCT02453594|467402328|FG002|Overall Study|Site Terminated by Sponsor|1|||
129903457|NCT03383146|467606423|FG001|Overall Study|Physician Decision|1|||
129847611|NCT02453594|467402326|FG000|Overall Study|Transitioned to Extension Study|16|||
129847612|NCT02453594|467402327|FG001|Overall Study|Transitioned to Extension Study|9|||
129847613|NCT02453594|467402328|FG002|Overall Study|Transitioned to Extension Study|16|||
129847614|NCT02453594|467402326|FG000|Overall Study|Withdrawal by Subject|7|||
129847615|NCT02453594|467402327|FG001|Overall Study|Withdrawal by Subject|9|||
129847616|NCT02453594|467402328|FG002|Overall Study|Withdrawal by Subject|11|||
129847617|NCT02086591|467402329|FG000|Overall Study|Adverse Event|1|||
129847618|NCT02086591|467402329|FG000|Overall Study|Withdrawal by Subject|1|||
129847619|NCT02086591|467402329|FG000|Overall Study|protocol terminated|3|||
129847620|NCT02660359|467402330|FG000|Overall Study|Protocol Deviation|0|||
129847621|NCT02660359|467402331|FG001|Overall Study|Protocol Deviation|0|||
129847622|NCT02660359|467402332|FG002|Overall Study|Protocol Deviation|1|||
129847623|NCT02660359|467402330|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
129847624|NCT02660359|467402331|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
129847625|NCT02660359|467402332|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
129847626|NCT02660359|467402330|FG000|Overall Study|Lack of Efficacy|1|||
129847627|NCT02660359|467402331|FG001|Overall Study|Lack of Efficacy|1|||
129847628|NCT02660359|467402332|FG002|Overall Study|Lack of Efficacy|1|||
129847629|NCT02660359|467402330|FG000|Overall Study|Adverse Event|0|||
129847630|NCT02660359|467402331|FG001|Overall Study|Adverse Event|1|||
129847631|NCT02660359|467402332|FG002|Overall Study|Adverse Event|0|||
129847632|NCT02660359|467402330|FG000|Overall Study|Other|2|||
129847633|NCT02660359|467402331|FG001|Overall Study|Other|1|||
129847634|NCT02660359|467402332|FG002|Overall Study|Other|3|||
129847635|NCT02660359|467402330|FG000|Overall Study|Withdrawal by Subject|7|||
129847636|NCT02660359|467402331|FG001|Overall Study|Withdrawal by Subject|5|||
129847637|NCT02660359|467402332|FG002|Overall Study|Withdrawal by Subject|8|||
129847638|NCT02660359|467402330|FG000|Overall Study|Lost to Follow-up|3|||
129847639|NCT02660359|467402331|FG001|Overall Study|Lost to Follow-up|3|||
129847640|NCT02660359|467402332|FG002|Overall Study|Lost to Follow-up|0|||
129847641|NCT03348904|467402334|FG000|Overall Study|Administrative reason by the sponsor|0|||
129847642|NCT03348904|467402335|FG001|Overall Study|Administrative reason by the sponsor|1|||
129847643|NCT03348904|467402336|FG002|Overall Study|Administrative reason by the sponsor|0|||
129847644|NCT04086472|467402337|FG000|Overall Study|Lost to Follow-up|1|||
129847645|NCT04086472|467402338|FG001|Overall Study|Lost to Follow-up|0|||
129847646|NCT04086472|467402339|FG002|Overall Study|Lost to Follow-up|0|||
129847647|NCT04086472|467402340|FG003|Overall Study|Lost to Follow-up|0|||
129847648|NCT04086472|467402341|FG004|Overall Study|Lost to Follow-up|1|||
129847649|NCT04086472|467402337|FG000|Overall Study|Physician Decision|0|||
129847650|NCT04086472|467402338|FG001|Overall Study|Physician Decision|1|||
129847651|NCT04086472|467402339|FG002|Overall Study|Physician Decision|1|||
129847652|NCT04086472|467402340|FG003|Overall Study|Physician Decision|0|||
129847653|NCT04086472|467402341|FG004|Overall Study|Physician Decision|0|||
129847654|NCT04086472|467402337|FG000|Overall Study|Withdrawal by Subject|1|||
129847655|NCT04086472|467402338|FG001|Overall Study|Withdrawal by Subject|1|||
129847656|NCT04086472|467402339|FG002|Overall Study|Withdrawal by Subject|1|||
129847657|NCT04086472|467402340|FG003|Overall Study|Withdrawal by Subject|0|||
129847658|NCT04086472|467402341|FG004|Overall Study|Withdrawal by Subject|0|||
129847659|NCT04086472|467402337|FG000|Overall Study|Various reasons|2|||
129847660|NCT04086472|467402338|FG001|Overall Study|Various reasons|0|||
129847661|NCT04086472|467402339|FG002|Overall Study|Various reasons|0|||
129847662|NCT04086472|467402340|FG003|Overall Study|Various reasons|3|||
129847663|NCT04086472|467402341|FG004|Overall Study|Various reasons|1|||
129847664|NCT00048724|467402347|FG000|Overall Study|Adverse Event|53|||
129847665|NCT00048724|467402348|FG001|Overall Study|Adverse Event|12|||
129847666|NCT00048724|467402347|FG000|Overall Study|Withdrawal by Subject|34|||
129847667|NCT00048724|467402348|FG001|Overall Study|Withdrawal by Subject|54|||
129847668|NCT00048724|467402347|FG000|Overall Study|Lost to Follow-up|5|||
129903458|NCT03383146|467606422|FG000|Overall Study|Protocol Deviation|1|||
129903459|NCT03383146|467606423|FG001|Overall Study|Protocol Deviation|8|||
129903460|NCT03383146|467606422|FG000|Overall Study|Study Terminated by the Sponsor|48|||
129903461|NCT03383146|467606423|FG001|Overall Study|Study Terminated by the Sponsor|95|||
129903462|NCT03383146|467606422|FG000|Overall Study|Reason not Specified|4|||
129903463|NCT03383146|467606423|FG001|Overall Study|Reason not Specified|6|||
129903464|NCT00639002|467606426|FG000|Overall Study|Death|1|||
129903465|NCT00639002|467606426|FG000|Overall Study|Adverse Event|1|||
129903466|NCT00639002|467606426|FG000|Overall Study|Protocol Violation|1|||
129903467|NCT00639002|467606426|FG000|Overall Study|Disease progression|3|||
129903468|NCT00639002|467606426|FG000|Overall Study|Physician Decision|6|||
129903469|NCT00639002|467606426|FG000|Overall Study|Lack of Efficacy|1|||
129903470|NCT05382104|467606427|FG000|Period 2 (2 Days)|Adverse Event|0|||
129903471|NCT05382104|467606428|FG001|Period 2 (2 Days)|Adverse Event|1|||
129903472|NCT05382104|467606429|FG002|Period 2 (2 Days)|Adverse Event|0|||
129903473|NCT05382104|467606430|FG003|Period 2 (2 Days)|Adverse Event|0|||
129847669|NCT00048724|467402348|FG001|Overall Study|Lost to Follow-up|5|||
129847670|NCT00048724|467402347|FG000|Overall Study|Protocol-defined Clinical Event|17|||
129903474|NCT05382104|467606431|FG004|Period 2 (2 Days)|Adverse Event|0|||
129903475|NCT05382104|467606432|FG005|Period 2 (2 Days)|Adverse Event|0|||
129903476|NCT00940992|467606440|FG000|Overall Study|Adverse Event|2|||
129903477|NCT00940992|467606441|FG001|Overall Study|Adverse Event|0|||
129903478|NCT00940992|467606442|FG002|Overall Study|Adverse Event|1|||
129903479|NCT00940992|467606440|FG000|Overall Study|subject request|2|||
129903480|NCT00940992|467606441|FG001|Overall Study|subject request|1|||
129847671|NCT00048724|467402348|FG001|Overall Study|Protocol-defined Clinical Event|32|||
129847672|NCT00048724|467402347|FG000|Overall Study|Noncompliance With Protocol|4|||
129847673|NCT00048724|467402348|FG001|Overall Study|Noncompliance With Protocol|12|||
129847674|NCT00048724|467402347|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
129847675|NCT00048724|467402348|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
129847676|NCT00048724|467402347|FG000|Overall Study|Administrative|1|||
129847677|NCT00048724|467402348|FG001|Overall Study|Administrative|1|||
129847678|NCT00844545|467402349|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
129847679|NCT00844545|467402349|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
129847680|NCT00844545|467402349|FG000|Extension Treatment Period|Adverse Event|2|||
129847681|NCT00844545|467402349|FG000|Post Treatment Period|Withdrawal by Subject|1|||
129847682|NCT02039427|467402350|FG000|Overall Study|Duration of surgery > 3h|1|||
129847683|NCT02039427|467402351|FG001|Overall Study|Duration of surgery > 3h|1|||
129847684|NCT02039427|467402352|FG002|Overall Study|Duration of surgery > 3h|0|||
129847685|NCT02039427|467402353|FG003|Overall Study|Duration of surgery > 3h|0|||
129847686|NCT02039427|467402350|FG000|Overall Study|Withdrawal on concent|0|||
129847687|NCT02039427|467402351|FG001|Overall Study|Withdrawal on concent|0|||
129847688|NCT02039427|467402352|FG002|Overall Study|Withdrawal on concent|0|||
129847689|NCT02039427|467402353|FG003|Overall Study|Withdrawal on concent|1|||
129847690|NCT02039427|467402350|FG000|Overall Study|Cancellation of surgery|0|||
129847691|NCT02039427|467402351|FG001|Overall Study|Cancellation of surgery|0|||
129847692|NCT02039427|467402352|FG002|Overall Study|Cancellation of surgery|1|||
129847693|NCT02039427|467402353|FG003|Overall Study|Cancellation of surgery|0|||
129847694|NCT02039427|467402350|FG000|Overall Study|Loss of follow - up|1|||
129847695|NCT02039427|467402351|FG001|Overall Study|Loss of follow - up|0|||
129847696|NCT02039427|467402352|FG002|Overall Study|Loss of follow - up|2|||
129847697|NCT02039427|467402353|FG003|Overall Study|Loss of follow - up|4|||
129847698|NCT02039427|467402350|FG000|Overall Study|Steroid Use|1|||
129847699|NCT02039427|467402351|FG001|Overall Study|Steroid Use|0|||
129847700|NCT02039427|467402352|FG002|Overall Study|Steroid Use|0|||
129847701|NCT02039427|467402353|FG003|Overall Study|Steroid Use|0|||
129847702|NCT01743092|467402354|FG000|Overall Study|Lost to Follow-up|14|||
129847703|NCT01743092|467402355|FG001|Overall Study|Lost to Follow-up|15|||
129847704|NCT03586869|467402361|FG000|Overall Study|Progressive Disease|3|||
129847705|NCT00403455|467402362|FG000|Overall Study|Withdrawal by Subject|1|||
129847706|NCT00087568|467402371|FG000|Overall Study|Adverse Event|4|||
129847707|NCT00087568|467402372|FG001|Overall Study|Adverse Event|0|||
129847708|NCT00087568|467402371|FG000|Overall Study|Withdrawal by Subject|1|||
129847709|NCT00087568|467402372|FG001|Overall Study|Withdrawal by Subject|1|||
129847710|NCT00087568|467402371|FG000|Overall Study|Lost to Follow-up|1|||
129847711|NCT00087568|467402372|FG001|Overall Study|Lost to Follow-up|0|||
129847712|NCT00087568|467402371|FG000|Overall Study|Lack of Efficacy|24|||
129847713|NCT00087568|467402372|FG001|Overall Study|Lack of Efficacy|1|||
129847714|NCT04394351|467402373|FG000|Part A (16 Weeks)|Adverse Event|1|||
129847715|NCT04394351|467402374|FG001|Part A (16 Weeks)|Adverse Event|0|||
129847716|NCT04394351|467402375|FG002|Part A (16 Weeks)|Adverse Event|0|||
129847717|NCT04394351|467402376|FG003|Part A (16 Weeks)|Adverse Event|0|||
129847718|NCT04394351|467402377|FG004|Part A (16 Weeks)|Adverse Event|0|||
129847719|NCT04394351|467402378|FG005|Part A (16 Weeks)|Adverse Event|0|||
129847720|NCT04394351|467402379|FG006|Part A (16 Weeks)|Adverse Event|0|||
129847721|NCT04394351|467402380|FG007|Part A (16 Weeks)|Adverse Event|0|||
129847722|NCT04394351|467402373|FG000|Part A (16 Weeks)|Physician Decision|0|||
129847723|NCT04394351|467402374|FG001|Part A (16 Weeks)|Physician Decision|1|||
129847724|NCT04394351|467402375|FG002|Part A (16 Weeks)|Physician Decision|0|||
129847725|NCT04394351|467402376|FG003|Part A (16 Weeks)|Physician Decision|0|||
129847726|NCT04394351|467402377|FG004|Part A (16 Weeks)|Physician Decision|0|||
129847727|NCT04394351|467402378|FG005|Part A (16 Weeks)|Physician Decision|0|||
129847728|NCT04394351|467402379|FG006|Part A (16 Weeks)|Physician Decision|0|||
129847729|NCT04394351|467402380|FG007|Part A (16 Weeks)|Physician Decision|0|||
129847730|NCT04394351|467402373|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847731|NCT04394351|467402374|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
129847732|NCT04394351|467402375|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847733|NCT04394351|467402376|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847734|NCT04394351|467402377|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847735|NCT04394351|467402378|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847736|NCT04394351|467402379|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847737|NCT04394351|467402380|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847738|NCT04394351|467402373|FG000|Part B (36 Weeks)|Adverse Event|0|||
129847739|NCT04394351|467402374|FG001|Part B (36 Weeks)|Adverse Event|0|||
129847740|NCT04394351|467402375|FG002|Part B (36 Weeks)|Adverse Event|0|||
130064555|NCT03691610|468190195|FG000|Overall Study|Adverse Event|0|||
129847741|NCT04394351|467402376|FG003|Part B (36 Weeks)|Adverse Event|0|||
129847742|NCT04394351|467402377|FG004|Part B (36 Weeks)|Adverse Event|0|||
129847743|NCT04394351|467402378|FG005|Part B (36 Weeks)|Adverse Event|0|||
129847744|NCT04394351|467402379|FG006|Part B (36 Weeks)|Adverse Event|1|||
129847745|NCT04394351|467402380|FG007|Part B (36 Weeks)|Adverse Event|0|||
129847746|NCT04354831|467402385|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
129847747|NCT04354831|467402386|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
129847748|NCT02732847|467402387|FG000|Overall Study|some filled early|42|||
129847749|NCT02732847|467402388|FG001|Overall Study|some filled early|42|||
129847750|NCT01430585|467402393|FG000|Overall Study|Death|1|||
129847751|NCT01430585|467402393|FG000|Overall Study|Objective Progression or Relapse|3|||
129847752|NCT01430585|467402393|FG000|Overall Study|Study Terminated by Sponsor|3|||
129847753|NCT01430585|467402393|FG000|Overall Study|Other|7|||
129847754|NCT02357576|467402394|FG000|Treatment Period|Withdrawal by Subject|0|||
129847755|NCT02357576|467402395|FG001|Treatment Period|Withdrawal by Subject|1|||
129847756|NCT02357576|467402394|FG000|Treatment Period|Physician Decision|0|||
129847757|NCT02357576|467402395|FG001|Treatment Period|Physician Decision|1|||
129847758|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
129847759|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
129847760|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
129847761|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
129847762|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
129847763|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
129847764|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
129847765|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
129847766|NCT00699699|467402398|FG000|Overall Study|Adverse Event|36|||
129847767|NCT00699699|467402398|FG000|Overall Study|Individual different reasons|21|||
129847768|NCT01632800|467402401|FG000|Overall Study|Subject did not fit in apparatus|1|||
129847769|NCT00057746|467402405|FG000|Overall Study|Withdrawal by Subject|0|||
129847770|NCT00057746|467402406|FG001|Overall Study|Withdrawal by Subject|0|||
129847771|NCT00057746|467402407|FG002|Overall Study|Withdrawal by Subject|1|||
130116570|NCT01073020|468387104|FG001|Overall Study|Physician Decision|0|||
130116571|NCT01073020|468387105|FG002|Overall Study|Physician Decision|2|||
130116572|NCT01073020|468387106|FG003|Overall Study|Physician Decision|0|||
130116573|NCT01073020|468387103|FG000|Overall Study|Death|0|||
130116574|NCT01073020|468387104|FG001|Overall Study|Death|1|||
130116575|NCT01073020|468387105|FG002|Overall Study|Death|0|||
130116576|NCT01073020|468387106|FG003|Overall Study|Death|0|||
130116577|NCT01335477|468387107|FG000|Overall Study|Adverse Event|30|||
129847772|NCT01469065|467402414|FG000|Overall Study|Lack of Efficacy|0|||
129847773|NCT01469065|467402415|FG001|Overall Study|Lack of Efficacy|0|||
129847774|NCT01469065|467402416|FG002|Overall Study|Lack of Efficacy|0|||
129847775|NCT01469065|467402417|FG003|Overall Study|Lack of Efficacy|0|||
129847776|NCT01469065|467402418|FG004|Overall Study|Lack of Efficacy|1|||
129847777|NCT01469065|467402414|FG000|Overall Study|Other|0|||
129847778|NCT01469065|467402415|FG001|Overall Study|Other|1|||
129847779|NCT01469065|467402416|FG002|Overall Study|Other|0|||
129847780|NCT01469065|467402417|FG003|Overall Study|Other|0|||
129847781|NCT01469065|467402418|FG004|Overall Study|Other|0|||
129847782|NCT03075644|467402419|FG000|Overall Study|Withdrawal by Subject|1|||
129847783|NCT03075644|467402420|FG001|Overall Study|Withdrawal by Subject|1|||
129847784|NCT00578565|467402421|FG000|Overall Study|Adverse Event|3|||
129847785|NCT01192152|467402422|FG000|Period 1|left prematurely (while on treatment B)|0|||
129847786|NCT01192152|467402423|FG001|Period 1|left prematurely (while on treatment B)|1|||
129847787|NCT01192152|467402422|FG000|Period 3|family emergency|1|||
129847788|NCT01192152|467402423|FG001|Period 3|family emergency|0|||
129847789|NCT05013905|467402424|FG000|Overall Study|Adverse Event|1|||
129847790|NCT05013905|467402424|FG000|Overall Study|Lack of Efficacy|1|||
129847791|NCT03286140|467402426|FG000|Overall Study|Withdrawal by Subject|10|||
129847792|NCT03286140|467402427|FG001|Overall Study|Withdrawal by Subject|5|||
129847793|NCT03286140|467402426|FG000|Overall Study|Lost to Follow-up|5|||
129847794|NCT03286140|467402427|FG001|Overall Study|Lost to Follow-up|10|||
129847795|NCT03286140|467402426|FG000|Overall Study|Failure to comply|0|||
129847796|NCT03286140|467402427|FG001|Overall Study|Failure to comply|1|||
129847797|NCT04666259|467402428|FG000|Treatment Phase|Physician Decision|9|||
129847798|NCT04666259|467402429|FG001|Treatment Phase|Physician Decision|3|||
129847799|NCT04666259|467402430|FG002|Treatment Phase|Physician Decision|3|||
129847800|NCT04666259|467402428|FG000|Treatment Phase|Adverse Event|3|||
129847801|NCT04666259|467402429|FG001|Treatment Phase|Adverse Event|1|||
129847802|NCT04666259|467402430|FG002|Treatment Phase|Adverse Event|0|||
129847803|NCT04666259|467402428|FG000|Treatment Phase|Subject decision|1|||
129903481|NCT00940992|467606442|FG002|Overall Study|subject request|0|||
129903482|NCT00940992|467606440|FG000|Overall Study|Lost to Follow-up|0|||
129903483|NCT00940992|467606441|FG001|Overall Study|Lost to Follow-up|1|||
129903484|NCT00940992|467606442|FG002|Overall Study|Lost to Follow-up|1|||
129903485|NCT03210402|467606443|FG000|Overall Study|Withdrawal by Subject|0|||
129903486|NCT03210402|467606444|FG001|Overall Study|Withdrawal by Subject|1|||
129903487|NCT03586544|467606447|FG000|First Intervention|Adverse Event|0|||
129903488|NCT03586544|467606448|FG001|First Intervention|Adverse Event|1|||
129903489|NCT03586544|467606447|FG000|Second Intervention|Withdrawal by Subject|0|||
130116578|NCT01335477|468387108|FG001|Overall Study|Adverse Event|42|||
129847804|NCT04666259|467402429|FG001|Treatment Phase|Subject decision|2|||
129847805|NCT04666259|467402430|FG002|Treatment Phase|Subject decision|0|||
129847806|NCT04666259|467402428|FG000|Treatment Phase|Progressive disease|0|||
129847807|NCT04666259|467402429|FG001|Treatment Phase|Progressive disease|1|||
129847808|NCT04666259|467402430|FG002|Treatment Phase|Progressive disease|0|||
129847809|NCT04666259|467402428|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
129903490|NCT03586544|467606448|FG001|Second Intervention|Withdrawal by Subject|1|||
130116579|NCT01335477|468387107|FG000|Overall Study|Non compliant with protocol|0|||
130116580|NCT01335477|468387108|FG001|Overall Study|Non compliant with protocol|2|||
129847810|NCT04666259|467402429|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
129847811|NCT04666259|467402430|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
129847812|NCT04666259|467402428|FG000|Safety Follow-up Phase|Physician Decision|2|||
129847813|NCT04666259|467402429|FG001|Safety Follow-up Phase|Physician Decision|0|||
129847814|NCT04666259|467402430|FG002|Safety Follow-up Phase|Physician Decision|0|||
129847815|NCT04666259|467402428|FG000|Safety Follow-up Phase|Subject decision|1|||
129847816|NCT04666259|467402429|FG001|Safety Follow-up Phase|Subject decision|0|||
129847817|NCT04666259|467402430|FG002|Safety Follow-up Phase|Subject decision|0|||
129847818|NCT04666259|467402428|FG000|Safety Follow-up Phase|Death|0|||
129847819|NCT04666259|467402429|FG001|Safety Follow-up Phase|Death|1|||
129847820|NCT04666259|467402430|FG002|Safety Follow-up Phase|Death|0|||
129847821|NCT01565291|467402431|FG000|Overall Study|Withdrawal by Subject|1|||
129847822|NCT01565291|467402432|FG001|Overall Study|Withdrawal by Subject|0|||
129847823|NCT02188485|467402437|FG000|Overall Study|Withdrawal by Subject|2|||
129847824|NCT02188485|467402438|FG001|Overall Study|Withdrawal by Subject|1|||
129847825|NCT02188485|467402437|FG000|Overall Study|PI withdrew, lack of capacity|0|||
129847826|NCT02188485|467402438|FG001|Overall Study|PI withdrew, lack of capacity|2|||
129847827|NCT03149237|467402441|FG000|Overall Study|Withdrawal by Subject|4|||
129847828|NCT03149237|467402442|FG001|Overall Study|Withdrawal by Subject|5|||
129847829|NCT01466192|467402443|FG000|Overall Study|Physician Decision|1|||
129847830|NCT01466192|467402443|FG000|Overall Study|Withdrawal by Subject|3|||
129847831|NCT01227512|467402446|FG000|Overall Study|Physician Decision|6|||
129847832|NCT01227512|467402447|FG001|Overall Study|Physician Decision|6|||
129847833|NCT01227512|467402446|FG000|Overall Study|Adverse Event|4|||
129847834|NCT01227512|467402447|FG001|Overall Study|Adverse Event|3|||
129847835|NCT01227512|467402446|FG000|Overall Study|Withdrawal by Subject|3|||
129847836|NCT01227512|467402447|FG001|Overall Study|Withdrawal by Subject|0|||
129847837|NCT01227512|467402446|FG000|Overall Study|Participant met withdrawal criteria|0|||
129847838|NCT01227512|467402447|FG001|Overall Study|Participant met withdrawal criteria|1|||
129847839|NCT04055116|467402448|FG000|First Intervention|Physician Decision|2|||
129847840|NCT04055116|467402449|FG001|First Intervention|Physician Decision|7|||
129847841|NCT02774681|467402456|FG000|Treatment on Study|Progressive Disease|7|||
129847842|NCT02774681|467402456|FG000|Follow-Up for 3 Years|Death|11|||
129847843|NCT02774681|467402456|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
129847844|NCT04497987|467402457|FG000|Overall Study|Adverse Event|1|||
129847845|NCT04497987|467402458|FG001|Overall Study|Adverse Event|0|||
129847846|NCT04497987|467402457|FG000|Overall Study|Death|21|||
129847847|NCT04497987|467402458|FG001|Overall Study|Death|13|||
129847848|NCT04497987|467402457|FG000|Overall Study|Lost to Follow-up|19|||
129847849|NCT04497987|467402458|FG001|Overall Study|Lost to Follow-up|17|||
129847850|NCT04497987|467402457|FG000|Overall Study|Other - as reported by the investigator|22|||
129847851|NCT04497987|467402458|FG001|Overall Study|Other - as reported by the investigator|16|||
129847852|NCT04497987|467402457|FG000|Overall Study|Physician Decision|1|||
129847853|NCT04497987|467402458|FG001|Overall Study|Physician Decision|0|||
129847854|NCT04497987|467402457|FG000|Overall Study|Withdrawal by Subject|35|||
129847855|NCT04497987|467402458|FG001|Overall Study|Withdrawal by Subject|21|||
129847856|NCT00298038|467402459|FG000|Overall Study|Lost to Follow-up|0|||
129847857|NCT00298038|467402460|FG001|Overall Study|Lost to Follow-up|1|||
129847858|NCT00298038|467402459|FG000|Overall Study|Liver Transplant|0|||
129847859|NCT00298038|467402460|FG001|Overall Study|Liver Transplant|1|||
129847860|NCT00298038|467402459|FG000|Overall Study|Protocol Violation|1|||
129847861|NCT00298038|467402460|FG001|Overall Study|Protocol Violation|3|||
129847862|NCT00298038|467402459|FG000|Overall Study|Death|6|||
129847863|NCT00298038|467402460|FG001|Overall Study|Death|3|||
129847864|NCT00298038|467402459|FG000|Overall Study|Withdrawal by Subject|6|||
129847865|NCT00298038|467402460|FG001|Overall Study|Withdrawal by Subject|9|||
129847866|NCT00298038|467402459|FG000|Overall Study|Adverse Event|8|||
129847867|NCT00298038|467402460|FG001|Overall Study|Adverse Event|7|||
129847868|NCT00298038|467402459|FG000|Overall Study|Breakthrough overt HE episode|28|||
129847869|NCT00298038|467402460|FG001|Overall Study|Breakthrough overt HE episode|69|||
129847870|NCT00298038|467402459|FG000|Overall Study|Noncompliance|1|||
129847871|NCT00298038|467402460|FG001|Overall Study|Noncompliance|0|||
129847872|NCT00298038|467402459|FG000|Overall Study|Cocaine Abuse|1|||
129847873|NCT00298038|467402460|FG001|Overall Study|Cocaine Abuse|0|||
129847874|NCT00298038|467402459|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
130064556|NCT03691610|468190196|FG001|Overall Study|Adverse Event|1|||
129847875|NCT00298038|467402460|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
129847876|NCT02707640|467402461|FG000|Overall Study|Adverse Event|4|||
129847877|NCT02707640|467402462|FG001|Overall Study|Adverse Event|2|||
129847878|NCT02707640|467402461|FG000|Overall Study|Death|1|||
129847879|NCT02707640|467402462|FG001|Overall Study|Death|2|||
129847880|NCT02707640|467402461|FG000|Overall Study|Physician Decision|2|||
129847881|NCT02707640|467402462|FG001|Overall Study|Physician Decision|0|||
129847882|NCT02707640|467402461|FG000|Overall Study|Withdrawal by Subject|0|||
129847883|NCT02707640|467402462|FG001|Overall Study|Withdrawal by Subject|1|||
129847884|NCT02707640|467402461|FG000|Overall Study|Participant's Personal Decision|1|||
129847885|NCT02707640|467402462|FG001|Overall Study|Participant's Personal Decision|2|||
129847886|NCT02707640|467402461|FG000|Overall Study|Sponsor Discretion|1|||
129847887|NCT02707640|467402462|FG001|Overall Study|Sponsor Discretion|0|||
129847888|NCT02517905|467402463|FG000|Overall Study|Lost to Follow-up|4|||
129847889|NCT02517905|467402464|FG001|Overall Study|Lost to Follow-up|0|||
129847890|NCT02517905|467402463|FG000|Overall Study|Withdrawal by Subject|4|||
129847891|NCT02517905|467402464|FG001|Overall Study|Withdrawal by Subject|0|||
129847892|NCT02517905|467402463|FG000|Overall Study|Screen failure|2|||
129847893|NCT02517905|467402464|FG001|Overall Study|Screen failure|2|||
129847894|NCT01607905|467404311|FG000|Overall Study|Withdrawal by participant|7|||
129847895|NCT01607905|467404312|FG001|Overall Study|Withdrawal by participant|2|||
129847896|NCT01607905|467404313|FG002|Overall Study|Withdrawal by participant|4|||
129903491|NCT03523091|467606449|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
129903492|NCT03523091|467606450|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
129903493|NCT03523091|467606449|FG000|Overall Study|Withdrawal by Subject|0|||
129903494|NCT03523091|467606450|FG001|Overall Study|Withdrawal by Subject|3|||
129903495|NCT03523091|467606449|FG000|Overall Study|Increase Botox dose|0|||
129847897|NCT01607905|467404314|FG003|Overall Study|Withdrawal by participant|6|||
129847898|NCT01607905|467404315|FG004|Overall Study|Withdrawal by participant|0|||
129847899|NCT01607905|467404316|FG005|Overall Study|Withdrawal by participant|4|||
129847900|NCT01607905|467404317|FG006|Overall Study|Withdrawal by participant|12|||
129847901|NCT01607905|467404311|FG000|Overall Study|Incidence or severity of AEs|5|||
129847902|NCT01607905|467404312|FG001|Overall Study|Incidence or severity of AEs|1|||
129847903|NCT01607905|467404313|FG002|Overall Study|Incidence or severity of AEs|1|||
129847904|NCT01607905|467404314|FG003|Overall Study|Incidence or severity of AEs|3|||
129847905|NCT01607905|467404315|FG004|Overall Study|Incidence or severity of AEs|0|||
129847906|NCT01607905|467404316|FG005|Overall Study|Incidence or severity of AEs|2|||
129847907|NCT01607905|467404317|FG006|Overall Study|Incidence or severity of AEs|8|||
129847908|NCT01607905|467404311|FG000|Overall Study|Disease progression|44|||
129847909|NCT01607905|467404312|FG001|Overall Study|Disease progression|16|||
129847910|NCT01607905|467404313|FG002|Overall Study|Disease progression|15|||
129847911|NCT01607905|467404314|FG003|Overall Study|Disease progression|11|||
129847912|NCT01607905|467404315|FG004|Overall Study|Disease progression|6|||
129847913|NCT01607905|467404316|FG005|Overall Study|Disease progression|7|||
129847914|NCT01607905|467404317|FG006|Overall Study|Disease progression|21|||
129847915|NCT01607905|467404311|FG000|Overall Study|Non-compliance with study procedures|0|||
129847916|NCT01607905|467404312|FG001|Overall Study|Non-compliance with study procedures|0|||
129847917|NCT01607905|467404313|FG002|Overall Study|Non-compliance with study procedures|0|||
129847918|NCT01607905|467404314|FG003|Overall Study|Non-compliance with study procedures|0|||
129847919|NCT01607905|467404315|FG004|Overall Study|Non-compliance with study procedures|0|||
129847920|NCT01607905|467404316|FG005|Overall Study|Non-compliance with study procedures|0|||
129847921|NCT01607905|467404317|FG006|Overall Study|Non-compliance with study procedures|1|||
129847922|NCT01607905|467404311|FG000|Overall Study|Death|1|||
129847923|NCT01607905|467404312|FG001|Overall Study|Death|1|||
129847924|NCT01607905|467404313|FG002|Overall Study|Death|1|||
129847925|NCT01607905|467404314|FG003|Overall Study|Death|1|||
129847926|NCT01607905|467404315|FG004|Overall Study|Death|0|||
129847927|NCT01607905|467404316|FG005|Overall Study|Death|0|||
129847928|NCT01607905|467404317|FG006|Overall Study|Death|3|||
129847929|NCT01607905|467404311|FG000|Overall Study|Other treatments become available|1|||
129847930|NCT01607905|467404312|FG001|Overall Study|Other treatments become available|0|||
129847931|NCT01607905|467404313|FG002|Overall Study|Other treatments become available|0|||
129847932|NCT01607905|467404314|FG003|Overall Study|Other treatments become available|0|||
129847933|NCT01607905|467404315|FG004|Overall Study|Other treatments become available|0|||
129847934|NCT01607905|467404316|FG005|Overall Study|Other treatments become available|0|||
129847935|NCT01607905|467404317|FG006|Overall Study|Other treatments become available|1|||
129847936|NCT01607905|467404311|FG000|Overall Study|Investigator discretion|0|||
129847937|NCT01607905|467404312|FG001|Overall Study|Investigator discretion|0|||
129847938|NCT01607905|467404313|FG002|Overall Study|Investigator discretion|0|||
129847939|NCT01607905|467404314|FG003|Overall Study|Investigator discretion|0|||
129847940|NCT01607905|467404315|FG004|Overall Study|Investigator discretion|0|||
129903496|NCT03523091|467606450|FG001|Overall Study|Increase Botox dose|1|||
129903497|NCT03863834|467606456|FG000|Overall Study|Lost to Follow-up|3|||
129903498|NCT02685488|467606457|FG000|Overall Study|Withdrawal by Subject|0|||
129903499|NCT02685488|467606458|FG001|Overall Study|Withdrawal by Subject|1|||
129903500|NCT05019729|467606459|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903501|NCT05019729|467606460|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903502|NCT05019729|467606461|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
130064557|NCT03691610|468190197|FG002|Overall Study|Adverse Event|0|||
130064558|NCT03691610|468190198|FG003|Overall Study|Adverse Event|0|||
129847941|NCT01607905|467404316|FG005|Overall Study|Investigator discretion|1|||
129847942|NCT01607905|467404317|FG006|Overall Study|Investigator discretion|0|||
129847943|NCT01607905|467404311|FG000|Overall Study|Other|1|||
129847944|NCT01607905|467404312|FG001|Overall Study|Other|0|||
129847945|NCT01607905|467404313|FG002|Overall Study|Other|0|||
129847946|NCT01607905|467404314|FG003|Overall Study|Other|0|||
129847947|NCT01607905|467404315|FG004|Overall Study|Other|0|||
129847948|NCT01607905|467404316|FG005|Overall Study|Other|0|||
129847949|NCT01607905|467404317|FG006|Overall Study|Other|1|||
129847950|NCT01607905|467404311|FG000|Overall Study|Randomized but not treated|1|||
129847951|NCT01607905|467404312|FG001|Overall Study|Randomized but not treated|0|||
129847952|NCT01607905|467404313|FG002|Overall Study|Randomized but not treated|0|||
129847953|NCT01607905|467404314|FG003|Overall Study|Randomized but not treated|0|||
129847954|NCT01607905|467404315|FG004|Overall Study|Randomized but not treated|1|||
129847955|NCT01607905|467404316|FG005|Overall Study|Randomized but not treated|1|||
129847956|NCT01607905|467404317|FG006|Overall Study|Randomized but not treated|0|||
129847957|NCT00659646|467404320|FG000|Overall Study|Protocol Violation|12|||
129847958|NCT00659646|467404321|FG001|Overall Study|Protocol Violation|8|||
129847959|NCT00659646|467404320|FG000|Overall Study|Adverse Event|1|||
129847960|NCT00659646|467404321|FG001|Overall Study|Adverse Event|0|||
129847961|NCT00659646|467404320|FG000|Overall Study|Lost to Follow-up|1|||
129847962|NCT00659646|467404321|FG001|Overall Study|Lost to Follow-up|0|||
129847963|NCT00659646|467404320|FG000|Overall Study|protocol noncompliance after randomized|1|||
129847964|NCT00659646|467404321|FG001|Overall Study|protocol noncompliance after randomized|0|||
129847965|NCT02212730|467404327|FG000|Overall Study|Tumor not of the required cell histology|1|||
129847966|NCT02212730|467404328|FG001|Overall Study|Tumor not of the required cell histology|0|||
129847967|NCT02212730|467404327|FG000|Overall Study|Withdrawal by Subject|1|||
129847968|NCT02212730|467404328|FG001|Overall Study|Withdrawal by Subject|0|||
129847969|NCT02212730|467404327|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
129847970|NCT02212730|467404328|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
129847971|NCT02932891|467404329|FG000|Overall Study|Lost to Follow-up|2|||
129847972|NCT02932891|467404329|FG000|Overall Study|HPA Suppress|2|||
129847973|NCT00451282|467404330|FG000|Overall Study|Lost to Follow-up|6|||
129847974|NCT00451282|467404331|FG001|Overall Study|Lost to Follow-up|5|||
129847975|NCT00577122|467404332|FG000|Overall Study|Adverse Event|0|||
129847976|NCT00577122|467404333|FG001|Overall Study|Adverse Event|2|||
129847977|NCT00577122|467404332|FG000|Overall Study|Progression, relapse during active trt|6|||
129847978|NCT00577122|467404333|FG001|Overall Study|Progression, relapse during active trt|8|||
129847979|NCT00577122|467404332|FG000|Overall Study|Prog, refract disease during active trt|8|||
129847980|NCT00577122|467404333|FG001|Overall Study|Prog, refract disease during active trt|5|||
129847981|NCT00577122|467404332|FG000|Overall Study|Alternative Therapy|0|||
129847982|NCT00577122|467404333|FG001|Overall Study|Alternative Therapy|1|||
129847983|NCT04532112|467404342|FG000|Overall Study|Adverse Event|3|||
129847984|NCT04532112|467404343|FG001|Overall Study|Adverse Event|0|||
129847985|NCT00529386|467404344|FG000|Overall Study|Lost to Follow-up|1|||
129847986|NCT02738775|467404345|FG000|Overall Study|Withdrawal by Subject|0|||
129847987|NCT02738775|467404346|FG001|Overall Study|Withdrawal by Subject|1|||
129847988|NCT02738775|467404347|FG002|Overall Study|Withdrawal by Subject|0|||
129847989|NCT02738775|467404348|FG003|Overall Study|Withdrawal by Subject|0|||
129847990|NCT02738775|467404349|FG004|Overall Study|Withdrawal by Subject|0|||
129847991|NCT02738775|467404350|FG005|Overall Study|Withdrawal by Subject|0|||
129847992|NCT02738775|467404345|FG000|Overall Study|Adverse Event|0|||
129847993|NCT02738775|467404346|FG001|Overall Study|Adverse Event|0|||
129847994|NCT02738775|467404347|FG002|Overall Study|Adverse Event|0|||
129847995|NCT02738775|467404348|FG003|Overall Study|Adverse Event|1|||
129847996|NCT02738775|467404349|FG004|Overall Study|Adverse Event|0|||
129847997|NCT02738775|467404350|FG005|Overall Study|Adverse Event|0|||
129847998|NCT02738775|467404345|FG000|Overall Study|Pregnancy|0|||
129847999|NCT02738775|467404346|FG001|Overall Study|Pregnancy|1|||
129848000|NCT02738775|467404347|FG002|Overall Study|Pregnancy|0|||
129848001|NCT02738775|467404348|FG003|Overall Study|Pregnancy|0|||
129848002|NCT02738775|467404349|FG004|Overall Study|Pregnancy|0|||
129848003|NCT02738775|467404350|FG005|Overall Study|Pregnancy|0|||
129848004|NCT02738775|467404345|FG000|Overall Study|Missing|0|||
129848005|NCT02738775|467404346|FG001|Overall Study|Missing|0|||
129848006|NCT02738775|467404347|FG002|Overall Study|Missing|0|||
129848007|NCT02738775|467404348|FG003|Overall Study|Missing|0|||
129848008|NCT02738775|467404349|FG004|Overall Study|Missing|0|||
129848009|NCT02738775|467404350|FG005|Overall Study|Missing|1|||
129848010|NCT02992899|467404351|FG000|Overall Study|Withdrawal by Subject|1|||
129848011|NCT02992899|467404352|FG001|Overall Study|Withdrawal by Subject|0|||
129848012|NCT02992899|467404351|FG000|Overall Study|Lost to Follow-up|1|||
129848013|NCT02992899|467404352|FG001|Overall Study|Lost to Follow-up|3|||
129848014|NCT02370888|467404353|FG000|Overall Study|disease progression|2|||
129848015|NCT02370888|467404353|FG000|Overall Study|did not meet chimerism criteria|6|||
129848016|NCT04574362|467404354|FG000|Overall Study|Other|0|||
129848017|NCT04574362|467404355|FG001|Overall Study|Other|5|||
129848018|NCT04574362|467404354|FG000|Overall Study|COVID-19|0|||
129848019|NCT04574362|467404355|FG001|Overall Study|COVID-19|1|||
129848020|NCT04574362|467404354|FG000|Overall Study|Adverse Event|1|||
129848021|NCT04574362|467404355|FG001|Overall Study|Adverse Event|1|||
129848022|NCT04574362|467404354|FG000|Overall Study|Withdrawal by Subject|2|||
129848023|NCT04574362|467404355|FG001|Overall Study|Withdrawal by Subject|4|||
130064559|NCT03691610|468190195|FG000|Overall Study|Protocol Deviation|15|||
129848024|NCT04574362|467404354|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
129848025|NCT04574362|467404355|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
129848026|NCT04574362|467404354|FG000|Overall Study|Participant refused to come to the hospital|1|||
129848027|NCT04574362|467404355|FG001|Overall Study|Participant refused to come to the hospital|0|||
129848028|NCT04574362|467404354|FG000|Overall Study|Participant refused the visit|1|||
129848029|NCT04574362|467404355|FG001|Overall Study|Participant refused the visit|0|||
129848030|NCT04574362|467404354|FG000|Overall Study|Participant quit early because of business trip|1|||
129848031|NCT04574362|467404355|FG001|Overall Study|Participant quit early because of business trip|0|||
129848032|NCT01060384|467404356|FG000|Overall Study|Withdrawal by Subject|0|||
129848033|NCT01060384|467404357|FG001|Overall Study|Withdrawal by Subject|1|||
129848034|NCT01060384|467404358|FG002|Overall Study|Withdrawal by Subject|0|||
129848035|NCT01060384|467404359|FG003|Overall Study|Withdrawal by Subject|0|||
129848036|NCT01060384|467404360|FG004|Overall Study|Withdrawal by Subject|0|||
129848037|NCT01060384|467404356|FG000|Overall Study|Death|0|||
129848038|NCT01060384|467404357|FG001|Overall Study|Death|0|||
129848039|NCT01060384|467404358|FG002|Overall Study|Death|0|||
129848040|NCT01060384|467404359|FG003|Overall Study|Death|0|||
129848041|NCT01060384|467404360|FG004|Overall Study|Death|1|||
129848042|NCT01060384|467404356|FG000|Overall Study|Intercurrent illness|0|||
129848043|NCT01060384|467404357|FG001|Overall Study|Intercurrent illness|0|||
129848044|NCT01060384|467404358|FG002|Overall Study|Intercurrent illness|0|||
129848045|NCT01060384|467404359|FG003|Overall Study|Intercurrent illness|0|||
129848046|NCT01060384|467404360|FG004|Overall Study|Intercurrent illness|1|||
129848047|NCT00812929|467404363|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
129848048|NCT00812929|467404364|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
129848049|NCT00812929|467404365|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
129848050|NCT00812929|467404366|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
129848051|NCT00812929|467404367|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
129848052|NCT00812929|467404368|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
129848053|NCT00812929|467404369|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
129848054|NCT00812929|467404370|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
129848055|NCT00812929|467404371|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
129848056|NCT00812929|467404372|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
129848057|NCT00812929|467404363|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
129848058|NCT00812929|467404364|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
129848059|NCT00812929|467404365|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
129848060|NCT00812929|467404366|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
129848061|NCT00812929|467404367|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
129848062|NCT00812929|467404368|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
129848063|NCT00812929|467404369|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
129848064|NCT00812929|467404370|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
129848065|NCT00812929|467404371|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
129848066|NCT00812929|467404372|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
129848067|NCT00812929|467404363|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
129848068|NCT00812929|467404364|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
129848069|NCT00812929|467404365|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
129848070|NCT00812929|467404366|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
129848071|NCT00812929|467404367|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
129848072|NCT00812929|467404368|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
129848073|NCT00812929|467404369|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
129848074|NCT00812929|467404370|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
129848075|NCT00812929|467404371|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
129848076|NCT00812929|467404372|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
129848077|NCT00211081|467404374|FG000|Overall Study|Withdrawal by Subject|2|||
129848078|NCT01332305|467404375|FG000|Overall Study|Adverse Event|1|||
129848079|NCT01332305|467404376|FG001|Overall Study|Adverse Event|4|||
129848080|NCT01332305|467404377|FG002|Overall Study|Adverse Event|6|||
129848081|NCT01332305|467404378|FG003|Overall Study|Adverse Event|3|||
129848082|NCT01332305|467404379|FG004|Overall Study|Adverse Event|5|||
129848083|NCT01332305|467404375|FG000|Overall Study|Withdrawal by Subject|6|||
129848084|NCT01332305|467404376|FG001|Overall Study|Withdrawal by Subject|5|||
129848085|NCT01332305|467404377|FG002|Overall Study|Withdrawal by Subject|4|||
129848086|NCT01332305|467404378|FG003|Overall Study|Withdrawal by Subject|1|||
129848087|NCT01332305|467404379|FG004|Overall Study|Withdrawal by Subject|0|||
129848088|NCT01332305|467404375|FG000|Overall Study|Lost to Follow-up|0|||
129848089|NCT01332305|467404376|FG001|Overall Study|Lost to Follow-up|2|||
129848090|NCT01332305|467404377|FG002|Overall Study|Lost to Follow-up|3|||
129848091|NCT01332305|467404378|FG003|Overall Study|Lost to Follow-up|2|||
129848092|NCT01332305|467404379|FG004|Overall Study|Lost to Follow-up|3|||
129848093|NCT01332305|467404375|FG000|Overall Study|Protocol Violation|1|||
129848094|NCT01332305|467404376|FG001|Overall Study|Protocol Violation|2|||
129848095|NCT01332305|467404377|FG002|Overall Study|Protocol Violation|1|||
129848096|NCT01332305|467404378|FG003|Overall Study|Protocol Violation|0|||
129848097|NCT01332305|467404379|FG004|Overall Study|Protocol Violation|3|||
129848098|NCT01332305|467404375|FG000|Overall Study|Withdrawal by Sponsor|1|||
129848099|NCT01332305|467404376|FG001|Overall Study|Withdrawal by Sponsor|0|||
129848100|NCT01332305|467404377|FG002|Overall Study|Withdrawal by Sponsor|0|||
129848101|NCT01332305|467404378|FG003|Overall Study|Withdrawal by Sponsor|1|||
129848102|NCT01332305|467404379|FG004|Overall Study|Withdrawal by Sponsor|1|||
129848103|NCT01332305|467404375|FG000|Overall Study|Treatment Failure|1|||
129848104|NCT01332305|467404376|FG001|Overall Study|Treatment Failure|1|||
129848105|NCT01332305|467404377|FG002|Overall Study|Treatment Failure|0|||
129848106|NCT01332305|467404378|FG003|Overall Study|Treatment Failure|0|||
129848107|NCT01332305|467404379|FG004|Overall Study|Treatment Failure|0|||
129848108|NCT01332305|467404375|FG000|Overall Study|Physician Decision|0|||
129848109|NCT01332305|467404376|FG001|Overall Study|Physician Decision|0|||
129848110|NCT01332305|467404377|FG002|Overall Study|Physician Decision|0|||
129848111|NCT01332305|467404378|FG003|Overall Study|Physician Decision|1|||
129848112|NCT01332305|467404379|FG004|Overall Study|Physician Decision|0|||
129848113|NCT01600040|467404380|FG000|Overall Study|Withdrawal by Subject|1|||
129848114|NCT04027686|467404381|FG000|Overall Study|Lost to Follow-up|2|||
129848115|NCT04027686|467404382|FG001|Overall Study|Lost to Follow-up|0|||
129848116|NCT04027686|467404381|FG000|Overall Study|Withdrawal by Subject|0|||
129848117|NCT04027686|467404382|FG001|Overall Study|Withdrawal by Subject|1|||
129848118|NCT03755765|467404388|FG000|Overall Study|Withdrawal by Subject|2|||
129848119|NCT03755765|467404389|FG001|Overall Study|Withdrawal by Subject|4|||
129848120|NCT03755765|467404390|FG002|Overall Study|Withdrawal by Subject|4|||
129848121|NCT02104557|467404391|FG000|Overall Study|Adverse Event|24|||
129848122|NCT02104557|467404391|FG000|Overall Study|Lost to Follow-up|34|||
129848123|NCT02104557|467404391|FG000|Overall Study|Violated the usage and dosage|14|||
129848124|NCT02104557|467404391|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
129848125|NCT02104557|467404391|FG000|Overall Study|Administered Sayana prior to the contract|1|||
129848126|NCT02104557|467404391|FG000|Overall Study|Other|17|||
129848127|NCT02104557|467404391|FG000|Overall Study|Change to other contraception methods|5|||
129848128|NCT02104557|467404391|FG000|Overall Study|Discontinuation due to no pain|1|||
129848129|NCT02104557|467404391|FG000|Overall Study|Withdrawal consent|2|||
129848130|NCT02104557|467404391|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
129848131|NCT02104557|467404391|FG000|Overall Study|Discontinuation of contraception|9|||
129848132|NCT00111228|467404395|FG000|Overall Study|Withdrawal by Subject|5|||
129848133|NCT00111228|467404396|FG001|Overall Study|Withdrawal by Subject|1|||
129848134|NCT00111228|467404397|FG002|Overall Study|Withdrawal by Subject|0|||
129848135|NCT00678691|467404398|FG000|Overall Study|Adverse Event|6|||
129848136|NCT00678691|467404399|FG001|Overall Study|Adverse Event|4|||
129848137|NCT02178475|467404406|FG000|Overall Study|Withdrawal by Subject|7|||
129848138|NCT02178475|467404406|FG000|Overall Study|Lost to Follow-up|10|||
129848139|NCT02178475|467404406|FG000|Overall Study|Death|13|||
129848140|NCT02178475|467404406|FG000|Overall Study|Protocol-specified Criteria|99|||
129848141|NCT00779766|467404407|FG000|Month 24|Serious Adverse Event|2|||
129848142|NCT00779766|467404408|FG001|Month 24|Serious Adverse Event|3|||
129848143|NCT00779766|467404407|FG000|Month 24|Adverse Event|3|||
129848144|NCT00779766|467404408|FG001|Month 24|Adverse Event|3|||
129848145|NCT00779766|467404407|FG000|Month 24|Protocol Violation|3|||
129903503|NCT05019729|467606462|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903504|NCT05019729|467606463|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
129903505|NCT05019729|467606464|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903506|NCT00361283|467606473|FG000|Overall Study|Lost to Follow-up|27|||
129903507|NCT01049503|467608307|FG000|Overall Study|Lost to Follow-up|11|||
129903508|NCT01049503|467608308|FG001|Overall Study|Lost to Follow-up|12|||
129903509|NCT01049503|467608309|FG002|Overall Study|Lost to Follow-up|24|||
129848146|NCT00779766|467404408|FG001|Month 24|Protocol Violation|1|||
129848147|NCT00779766|467404407|FG000|Month 24|Withdrawal by Subject|159|||
129848148|NCT00779766|467404408|FG001|Month 24|Withdrawal by Subject|127|||
129848149|NCT00779766|467404407|FG000|Month 24|Migrated/moved from study area|138|||
129848150|NCT00779766|467404408|FG001|Month 24|Migrated/moved from study area|162|||
129903510|NCT01049503|467608310|FG003|Overall Study|Lost to Follow-up|26|||
130064560|NCT03691610|468190196|FG001|Overall Study|Protocol Deviation|8|||
129848151|NCT00779766|467404407|FG000|Month 24|Lost to Follow-up|9|||
129848152|NCT00779766|467404408|FG001|Month 24|Lost to Follow-up|9|||
129848153|NCT00779766|467404407|FG000|Month 24|Other|18|||
129848154|NCT00779766|467404408|FG001|Month 24|Other|27|||
129848155|NCT00779766|467404407|FG000|Month 48|Withdrawal by Subject|68|||
129848156|NCT00779766|467404408|FG001|Month 48|Withdrawal by Subject|63|||
129848157|NCT00779766|467404407|FG000|Month 48|Migrated/moved from study area|76|||
129848158|NCT00779766|467404408|FG001|Month 48|Migrated/moved from study area|75|||
129848159|NCT00779766|467404407|FG000|Month 48|Lost to Follow-up|29|||
129848160|NCT00779766|467404408|FG001|Month 48|Lost to Follow-up|30|||
129848161|NCT00779766|467404407|FG000|Month 48|Other|1|||
130064561|NCT03691610|468190197|FG002|Overall Study|Protocol Deviation|1|||
129848162|NCT00779766|467404408|FG001|Month 48|Other|0|||
129848163|NCT00779766|467404407|FG000|Month 72|Withdrawal by Subject|55|||
129848164|NCT00779766|467404408|FG001|Month 72|Withdrawal by Subject|71|||
129848165|NCT00779766|467404407|FG000|Month 72|Migrated/moved from study area|124|||
129848166|NCT00779766|467404408|FG001|Month 72|Migrated/moved from study area|109|||
129848167|NCT00779766|467404407|FG000|Month 72|Lost to Follow-up|6|||
129848168|NCT00779766|467404408|FG001|Month 72|Lost to Follow-up|8|||
129848169|NCT00779766|467404407|FG000|Month 72|Other|0|||
129848170|NCT00779766|467404408|FG001|Month 72|Other|1|||
129848171|NCT01412424|467404411|FG000|Core Treatment Period|Treatment Failure|24|||
129848172|NCT01412424|467404411|FG000|Core Treatment Period|Adverse Event|21|||
129848173|NCT01412424|467404411|FG000|Core Treatment Period|Patient Request|5|||
129848174|NCT01412424|467404411|FG000|Core Treatment Period|Lost to Follow-up|2|||
129848175|NCT01412424|467404411|FG000|Core Treatment Period|Sponsor Request|1|||
129848176|NCT01412424|467404411|FG000|Extension Treatment Period|Adverse Event|2|||
129848177|NCT01412424|467404411|FG000|Extension Treatment Period|Treatment Failure|2|||
129848178|NCT01412424|467404411|FG000|Extension Treatment Period|Patient Request|2|||
129848179|NCT01274637|467404412|FG000|Overall Study|Withdrawal by Subject|0|||
129848180|NCT01274637|467404413|FG001|Overall Study|Withdrawal by Subject|1|||
129848181|NCT01274637|467404412|FG000|Overall Study|Lost to Follow-up|0|||
129848182|NCT01274637|467404413|FG001|Overall Study|Lost to Follow-up|1|||
129848183|NCT00414050|467404421|FG000|Overall Study|Adverse Event|1|||
129848184|NCT00414050|467404422|FG001|Overall Study|Adverse Event|1|||
129848185|NCT00414050|467404423|FG002|Overall Study|Adverse Event|1|||
129848186|NCT00414050|467404424|FG003|Overall Study|Adverse Event|1|||
129848187|NCT00414050|467404421|FG000|Overall Study|Lost to Follow-up|2|||
129848188|NCT00414050|467404422|FG001|Overall Study|Lost to Follow-up|2|||
129848189|NCT00414050|467404423|FG002|Overall Study|Lost to Follow-up|1|||
129848190|NCT00414050|467404424|FG003|Overall Study|Lost to Follow-up|1|||
129848191|NCT00414050|467404421|FG000|Overall Study|Withdrawal by Subject|5|||
129848192|NCT00414050|467404422|FG001|Overall Study|Withdrawal by Subject|3|||
129848193|NCT00414050|467404423|FG002|Overall Study|Withdrawal by Subject|2|||
129848194|NCT00414050|467404424|FG003|Overall Study|Withdrawal by Subject|4|||
129848195|NCT00414050|467404421|FG000|Overall Study|Subject discontinued for other reason|1|||
129848196|NCT00414050|467404422|FG001|Overall Study|Subject discontinued for other reason|2|||
129848197|NCT00414050|467404423|FG002|Overall Study|Subject discontinued for other reason|2|||
129848198|NCT00414050|467404424|FG003|Overall Study|Subject discontinued for other reason|1|||
129848199|NCT00414050|467404421|FG000|Overall Study|Subject Moved|0|||
129848200|NCT00414050|467404422|FG001|Overall Study|Subject Moved|0|||
129848201|NCT00414050|467404423|FG002|Overall Study|Subject Moved|0|||
129848202|NCT00414050|467404424|FG003|Overall Study|Subject Moved|1|||
129848203|NCT00720876|467404425|FG000|Overall Study|found to be ineligible after starting tx|2|||
129848204|NCT03495908|467404427|FG000|Overall Study|Withdrawal by Subject|3|||
129848205|NCT03495908|467404428|FG001|Overall Study|Withdrawal by Subject|1|||
129848206|NCT03495908|467404427|FG000|Overall Study|Lost to Follow-up|1|||
129848207|NCT03495908|467404428|FG001|Overall Study|Lost to Follow-up|4|||
129848208|NCT03495908|467404427|FG000|Overall Study|Adverse Event|0|||
129848209|NCT03495908|467404428|FG001|Overall Study|Adverse Event|2|||
129848210|NCT03495908|467404427|FG000|Overall Study|Death|1|||
129848211|NCT03495908|467404428|FG001|Overall Study|Death|0|||
129848212|NCT03495908|467404427|FG000|Overall Study|Physician Decision|5|||
129848213|NCT03495908|467404428|FG001|Overall Study|Physician Decision|4|||
129848214|NCT03495908|467404427|FG000|Overall Study|No documented reason|0|||
129848215|NCT03495908|467404428|FG001|Overall Study|No documented reason|2|||
129848216|NCT03511560|467404433|FG000|Overall Study|Death|0|||
129848217|NCT03511560|467404434|FG001|Overall Study|Death|1|||
129848218|NCT03511560|467404433|FG000|Overall Study|Adverse Event|0|||
129848219|NCT03511560|467404434|FG001|Overall Study|Adverse Event|2|||
129848220|NCT03511560|467404433|FG000|Overall Study|Transplant cancelled|0|||
129848221|NCT03511560|467404434|FG001|Overall Study|Transplant cancelled|1|||
129848222|NCT03511560|467404433|FG000|Overall Study|Patient switched to another drug|1|||
129848223|NCT03511560|467404434|FG001|Overall Study|Patient switched to another drug|0|||
129848224|NCT02985736|467404439|FG000|Overall Study|Lost to Follow-up|3|||
129848225|NCT00382733|467404440|FG000|Overall Study|Withdrawal by Subject|0|||
129848226|NCT00382733|467404441|FG001|Overall Study|Withdrawal by Subject|1|||
129848227|NCT00382733|467404442|FG002|Overall Study|Withdrawal by Subject|0|||
129848228|NCT00382733|467404443|FG003|Overall Study|Withdrawal by Subject|0|||
129848229|NCT00382733|467404444|FG004|Overall Study|Withdrawal by Subject|0|||
129848230|NCT00439140|467404447|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
129848231|NCT00439140|467404448|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
129848232|NCT00439140|467404449|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
129848233|NCT00439140|467404447|FG000|Treatment Cycle 1|Personal reasons|0|||
129848234|NCT00439140|467404448|FG001|Treatment Cycle 1|Personal reasons|2|||
129848235|NCT00439140|467404449|FG002|Treatment Cycle 1|Personal reasons|0|||
129848236|NCT00439140|467404447|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
129848237|NCT00439140|467404448|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
129848238|NCT00439140|467404449|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
129848239|NCT00439140|467404447|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
129848240|NCT00439140|467404448|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
129848241|NCT00439140|467404449|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
129848242|NCT00439140|467404447|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
129848243|NCT00439140|467404448|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
129848244|NCT00439140|467404449|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
129848245|NCT01193556|467404450|FG000|Overall Study|Study termination|26|||
129848246|NCT01193556|467404451|FG001|Overall Study|Study termination|25|||
129848247|NCT01752933|467404452|FG000|Treatment|Disease Progression|3|||
129848248|NCT01752933|467404453|FG001|Treatment|Disease Progression|29|||
129848249|NCT01752933|467404452|FG000|Treatment|Withdrawal by Subject|0|||
129848250|NCT01752933|467404453|FG001|Treatment|Withdrawal by Subject|5|||
129848251|NCT01752933|467404452|FG000|Treatment|Adverse Event|1|||
129848252|NCT01752933|467404453|FG001|Treatment|Adverse Event|4|||
129848253|NCT01752933|467404452|FG000|Treatment|Physician Decision|0|||
129848254|NCT01752933|467404453|FG001|Treatment|Physician Decision|3|||
129848255|NCT01752933|467404452|FG000|Treatment|Death|0|||
129848256|NCT01752933|467404453|FG001|Treatment|Death|2|||
129848257|NCT01752933|467404452|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
129848258|NCT01752933|467404453|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
129848259|NCT01752933|467404452|FG000|Treatment|Patient noncompliant|0|||
129848260|NCT01752933|467404453|FG001|Treatment|Patient noncompliant|1|||
129848261|NCT01752933|467404452|FG000|Treatment|Patient unable to travel to appointments|0|||
129848262|NCT01752933|467404453|FG001|Treatment|Patient unable to travel to appointments|1|||
129848263|NCT01752933|467404452|FG000|Overall Study and Follow-up|Death|4|||
129848264|NCT01752933|467404453|FG001|Overall Study and Follow-up|Death|34|||
129848265|NCT01752933|467404452|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
129848266|NCT01752933|467404453|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
129848267|NCT01752933|467404452|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
129848268|NCT01752933|467404453|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
129848269|NCT01752933|467404452|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
129848270|NCT01752933|467404453|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
129848271|NCT00835406|467404454|FG000|Period: First Intervention|Adverse Event|0|||
129848272|NCT00835406|467404455|FG001|Period: First Intervention|Adverse Event|1|||
129848273|NCT00835406|467404454|FG000|Period: First Intervention|Withdrawal by Subject|2|||
129848274|NCT00835406|467404455|FG001|Period: First Intervention|Withdrawal by Subject|0|||
129848275|NCT00835406|467404454|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
129848276|NCT00835406|467404455|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
129848277|NCT00799617|467404456|FG000|Main Testosterone Trial|Randomized in error|1|||
129848278|NCT00799617|467404457|FG001|Main Testosterone Trial|Randomized in error|1|||
129848279|NCT00799617|467404456|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
129848280|NCT00799617|467404457|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
129848281|NCT00799617|467404456|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
129848282|NCT00799617|467404457|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
129848283|NCT00799617|467404456|FG000|Sexual Funtion Trial|No Baseline Data|4|||
129848284|NCT00799617|467404457|FG001|Sexual Funtion Trial|No Baseline Data|7|||
129848285|NCT00799617|467404456|FG000|Physical Function Trial|Lost to Follow-up|6|||
129848286|NCT00799617|467404457|FG001|Physical Function Trial|Lost to Follow-up|11|||
129848287|NCT00799617|467404456|FG000|Vitality Trial|Lost to Follow-up|7|||
129848288|NCT00799617|467404457|FG001|Vitality Trial|Lost to Follow-up|22|||
129848289|NCT00799617|467404456|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
129848290|NCT00799617|467404457|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
129848291|NCT00799617|467404456|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
129848292|NCT00799617|467404457|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
129848293|NCT00799617|467404456|FG000|Bone Trial|Month 12 scan not available|6|||
129848294|NCT00799617|467404457|FG001|Bone Trial|Month 12 scan not available|16|||
129848295|NCT00799617|467404456|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
129848296|NCT00799617|467404457|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
129848297|NCT00799617|467404456|FG000|Anemia Trial|Withdrawal by Subject|3|||
129848298|NCT00799617|467404457|FG001|Anemia Trial|Withdrawal by Subject|3|||
129848299|NCT04545515|467404458|FG000|Overall Study|Adverse Event|1|||
129848300|NCT04545515|467404458|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
129848301|NCT04545515|467404458|FG000|Overall Study|Commercial drug is available for participant|7|||
129848302|NCT00958880|467404459|FG000|Overall Study|Lost to Follow-up|2|||
129848303|NCT00958880|467404460|FG001|Overall Study|Lost to Follow-up|2|||
129848304|NCT01848990|467404461|FG000|Overall Study|Adverse Event|6|||
129848305|NCT01848990|467404462|FG001|Overall Study|Adverse Event|2|||
129848306|NCT01848990|467404463|FG002|Overall Study|Adverse Event|0|||
129848307|NCT01848990|467404461|FG000|Overall Study|Lost to Follow-up|6|||
129848308|NCT01848990|467404462|FG001|Overall Study|Lost to Follow-up|2|||
129848309|NCT01848990|467404463|FG002|Overall Study|Lost to Follow-up|2|||
129848310|NCT01848990|467404461|FG000|Overall Study|Protocol Violation|1|||
129848311|NCT01848990|467404462|FG001|Overall Study|Protocol Violation|1|||
129848312|NCT01848990|467404463|FG002|Overall Study|Protocol Violation|0|||
129848313|NCT01848990|467404461|FG000|Overall Study|Withdrawal by Subject|29|||
129848314|NCT01848990|467404462|FG001|Overall Study|Withdrawal by Subject|10|||
129848315|NCT01848990|467404463|FG002|Overall Study|Withdrawal by Subject|11|||
129848316|NCT01848990|467404461|FG000|Overall Study|Physician Decision|1|||
129848317|NCT01848990|467404462|FG001|Overall Study|Physician Decision|1|||
129848318|NCT01848990|467404463|FG002|Overall Study|Physician Decision|0|||
129848319|NCT01848990|467404461|FG000|Overall Study|Non Compliance|1|||
129848320|NCT01848990|467404462|FG001|Overall Study|Non Compliance|0|||
129848321|NCT01848990|467404463|FG002|Overall Study|Non Compliance|0|||
129848322|NCT01848990|467404461|FG000|Overall Study|Death|1|||
129848323|NCT01848990|467404462|FG001|Overall Study|Death|0|||
129848324|NCT01848990|467404463|FG002|Overall Study|Death|1|||
129848325|NCT01848990|467404461|FG000|Overall Study|Other|1|||
129848326|NCT01848990|467404462|FG001|Overall Study|Other|4|||
129848327|NCT01848990|467404463|FG002|Overall Study|Other|2|||
129848328|NCT01712984|467404466|FG000|Overall Study|Adverse Event|0|||
129848329|NCT01712984|467404467|FG001|Overall Study|Adverse Event|0|||
129848330|NCT01712984|467404468|FG002|Overall Study|Adverse Event|1|||
129848331|NCT01712984|467404466|FG000|Overall Study|Protocol Violation|2|||
129848332|NCT01712984|467404467|FG001|Overall Study|Protocol Violation|0|||
129848333|NCT01712984|467404468|FG002|Overall Study|Protocol Violation|1|||
129848334|NCT01712984|467404466|FG000|Overall Study|Lost to Follow-up|8|||
129848335|NCT01712984|467404467|FG001|Overall Study|Lost to Follow-up|10|||
129848336|NCT01712984|467404468|FG002|Overall Study|Lost to Follow-up|1|||
129848337|NCT01712984|467404466|FG000|Overall Study|Withdrawal by Subject|6|||
129848338|NCT01712984|467404467|FG001|Overall Study|Withdrawal by Subject|6|||
129848339|NCT01712984|467404468|FG002|Overall Study|Withdrawal by Subject|7|||
129848340|NCT00678561|467404473|FG000|Overall Study|Adverse Event|0|||
129848341|NCT00678561|467404474|FG001|Overall Study|Adverse Event|1|||
129848342|NCT00678561|467404475|FG002|Overall Study|Adverse Event|1|||
129848343|NCT00678561|467404476|FG003|Overall Study|Adverse Event|0|||
129848344|NCT00678561|467404477|FG004|Overall Study|Adverse Event|1|||
129848345|NCT00678561|467404478|FG005|Overall Study|Adverse Event|0|||
129848346|NCT00678561|467404479|FG006|Overall Study|Adverse Event|0|||
129848347|NCT00678561|467404480|FG007|Overall Study|Adverse Event|0|||
129848348|NCT00678561|467404473|FG000|Overall Study|Protocol Violation|0|||
129848349|NCT00678561|467404474|FG001|Overall Study|Protocol Violation|0|||
129848350|NCT00678561|467404475|FG002|Overall Study|Protocol Violation|0|||
129848351|NCT00678561|467404476|FG003|Overall Study|Protocol Violation|0|||
129848352|NCT00678561|467404477|FG004|Overall Study|Protocol Violation|1|||
129848353|NCT00678561|467404478|FG005|Overall Study|Protocol Violation|1|||
129848354|NCT00678561|467404479|FG006|Overall Study|Protocol Violation|0|||
129848355|NCT00678561|467404480|FG007|Overall Study|Protocol Violation|0|||
129848356|NCT00678561|467404473|FG000|Overall Study|Withdrawal by Subject|0|||
129848357|NCT00678561|467404474|FG001|Overall Study|Withdrawal by Subject|0|||
129848358|NCT00678561|467404475|FG002|Overall Study|Withdrawal by Subject|0|||
129848359|NCT00678561|467404476|FG003|Overall Study|Withdrawal by Subject|0|||
129848360|NCT00678561|467404477|FG004|Overall Study|Withdrawal by Subject|0|||
129848361|NCT00678561|467404478|FG005|Overall Study|Withdrawal by Subject|0|||
129848362|NCT00678561|467404479|FG006|Overall Study|Withdrawal by Subject|0|||
129848363|NCT00678561|467404480|FG007|Overall Study|Withdrawal by Subject|1|||
129848364|NCT00437034|467404481|FG000|Overall Study|Adverse Event|1|||
129848365|NCT00437034|467404481|FG000|Overall Study|Disease progression during treatment|5|||
129848366|NCT02556710|467406757|FG000|Overall Study|Surgical treatment|3|||
129848367|NCT02556710|467406758|FG001|Overall Study|Surgical treatment|0|||
129848368|NCT02556710|467406757|FG000|Overall Study|Required proscribed pain medication|2|||
129848369|NCT02556710|467406758|FG001|Overall Study|Required proscribed pain medication|1|||
129848370|NCT02556710|467406757|FG000|Overall Study|Lack of Efficacy|1|||
129848371|NCT02556710|467406758|FG001|Overall Study|Lack of Efficacy|0|||
129848372|NCT02556710|467406757|FG000|Overall Study|Worsening osteoarthritis|1|||
129848373|NCT02556710|467406758|FG001|Overall Study|Worsening osteoarthritis|0|||
129848374|NCT02556710|467406757|FG000|Overall Study|Moved out of state|1|||
129848375|NCT02556710|467406758|FG001|Overall Study|Moved out of state|0|||
129848376|NCT02556710|467406757|FG000|Overall Study|Missing reason|3|||
129848377|NCT02556710|467406758|FG001|Overall Study|Missing reason|1|||
129848378|NCT02556710|467406757|FG000|Overall Study|Pain as lack of efficacy|0|||
129848379|NCT02556710|467406758|FG001|Overall Study|Pain as lack of efficacy|4|||
129848380|NCT04258839|467406761|FG000|Overall Study|Adverse Event|2|||
129848381|NCT04258839|467406762|FG001|Overall Study|Adverse Event|4|||
129848382|NCT04258839|467406761|FG000|Overall Study|Lack of Efficacy|0|||
129848383|NCT04258839|467406762|FG001|Overall Study|Lack of Efficacy|2|||
129848384|NCT04258839|467406761|FG000|Overall Study|Lost to Follow-up|2|||
129848385|NCT04258839|467406762|FG001|Overall Study|Lost to Follow-up|0|||
129848386|NCT04258839|467406761|FG000|Overall Study|Withdrawal by Subject|1|||
129848387|NCT04258839|467406762|FG001|Overall Study|Withdrawal by Subject|2|||
129848388|NCT04258839|467406761|FG000|Overall Study|Withdrawal by Caregiver|5|||
129848389|NCT04258839|467406762|FG001|Overall Study|Withdrawal by Caregiver|6|||
129848390|NCT04258839|467406761|FG000|Overall Study|Reason not Specified|0|||
129848391|NCT04258839|467406762|FG001|Overall Study|Reason not Specified|1|||
129848392|NCT01519518|467406763|FG000|Overall Study|Consent not available|7|||
129848393|NCT01519518|467406764|FG001|Overall Study|Consent not available|10|||
129848394|NCT01312909|467406766|FG000|Overall Study|Randomized but not treated|1|||
129848395|NCT01312909|467406767|FG001|Overall Study|Randomized but not treated|3|||
129848396|NCT01312909|467406768|FG002|Overall Study|Randomized but not treated|1|||
129848397|NCT01312909|467406766|FG000|Overall Study|Adverse Event|1|||
129848398|NCT01312909|467406767|FG001|Overall Study|Adverse Event|0|||
129848399|NCT01312909|467406768|FG002|Overall Study|Adverse Event|3|||
129848400|NCT01312909|467406766|FG000|Overall Study|Protocol Violation|2|||
129848401|NCT01312909|467406767|FG001|Overall Study|Protocol Violation|0|||
129848402|NCT01312909|467406768|FG002|Overall Study|Protocol Violation|2|||
129848403|NCT01312909|467406766|FG000|Overall Study|Other|9|||
129848404|NCT01312909|467406767|FG001|Overall Study|Other|6|||
129848405|NCT01312909|467406768|FG002|Overall Study|Other|11|||
129848406|NCT01312909|467406766|FG000|Overall Study|Withdrawal by Subject|8|||
129848407|NCT01312909|467406767|FG001|Overall Study|Withdrawal by Subject|10|||
129848408|NCT01312909|467406768|FG002|Overall Study|Withdrawal by Subject|7|||
129848409|NCT01312909|467406766|FG000|Overall Study|Lost to Follow-up|21|||
129848410|NCT01312909|467406767|FG001|Overall Study|Lost to Follow-up|17|||
129848411|NCT01312909|467406768|FG002|Overall Study|Lost to Follow-up|20|||
129848412|NCT01312909|467406766|FG000|Overall Study|Insufficient clinical response|0|||
129848413|NCT01312909|467406767|FG001|Overall Study|Insufficient clinical response|0|||
129848414|NCT01312909|467406768|FG002|Overall Study|Insufficient clinical response|1|||
129848415|NCT01312909|467406766|FG000|Overall Study|Entrance criteria not met|0|||
129848416|NCT01312909|467406767|FG001|Overall Study|Entrance criteria not met|0|||
129848417|NCT01312909|467406768|FG002|Overall Study|Entrance criteria not met|2|||
129848418|NCT00938431|467406772|FG000|Overall Study|Adverse Event|5|||
129848419|NCT00938431|467406773|FG001|Overall Study|Adverse Event|8|||
129848420|NCT00938431|467406774|FG002|Overall Study|Adverse Event|6|||
129848421|NCT00938431|467406772|FG000|Overall Study|Lack of Efficacy|0|||
129848422|NCT00938431|467406773|FG001|Overall Study|Lack of Efficacy|1|||
129848423|NCT00938431|467406774|FG002|Overall Study|Lack of Efficacy|0|||
129848424|NCT00938431|467406772|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
129848425|NCT00938431|467406773|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
129848426|NCT00938431|467406774|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
129848427|NCT00938431|467406772|FG000|Overall Study|Dosing compliance issue|0|||
129848428|NCT00938431|467406773|FG001|Overall Study|Dosing compliance issue|0|||
129848429|NCT00938431|467406774|FG002|Overall Study|Dosing compliance issue|1|||
129848430|NCT00938431|467406772|FG000|Overall Study|Reached maximum dose early|0|||
129848431|NCT00938431|467406773|FG001|Overall Study|Reached maximum dose early|0|||
129848432|NCT00938431|467406774|FG002|Overall Study|Reached maximum dose early|1|||
129848433|NCT01529645|467406775|FG000|Overall Study|Lost to Follow-up|0|||
129848434|NCT01529645|467406776|FG001|Overall Study|Lost to Follow-up|1|||
129848435|NCT01529645|467406777|FG002|Overall Study|Lost to Follow-up|1|||
129848436|NCT01529645|467406778|FG003|Overall Study|Lost to Follow-up|1|||
129848437|NCT01529645|467406779|FG004|Overall Study|Lost to Follow-up|1|||
129848438|NCT01529645|467406780|FG005|Overall Study|Lost to Follow-up|0|||
129848439|NCT01529645|467406781|FG006|Overall Study|Lost to Follow-up|2|||
129848440|NCT01529645|467406782|FG007|Overall Study|Lost to Follow-up|0|||
129848441|NCT01529645|467406783|FG008|Overall Study|Lost to Follow-up|1|||
129848442|NCT01529645|467406784|FG009|Overall Study|Lost to Follow-up|0|||
129848443|NCT01529645|467406775|FG000|Overall Study|SAE - Premature contractions|0|||
129848444|NCT01529645|467406776|FG001|Overall Study|SAE - Premature contractions|0|||
129848445|NCT01529645|467406777|FG002|Overall Study|SAE - Premature contractions|1|||
129848446|NCT01529645|467406778|FG003|Overall Study|SAE - Premature contractions|0|||
129848447|NCT01529645|467406779|FG004|Overall Study|SAE - Premature contractions|0|||
129848448|NCT01529645|467406780|FG005|Overall Study|SAE - Premature contractions|0|||
129848449|NCT01529645|467406781|FG006|Overall Study|SAE - Premature contractions|0|||
129848450|NCT01529645|467406782|FG007|Overall Study|SAE - Premature contractions|0|||
129848451|NCT01529645|467406783|FG008|Overall Study|SAE - Premature contractions|0|||
129848452|NCT01529645|467406784|FG009|Overall Study|SAE - Premature contractions|0|||
129848453|NCT01529645|467406775|FG000|Overall Study|Withdrawal by Subject|2|||
129848454|NCT01529645|467406776|FG001|Overall Study|Withdrawal by Subject|0|||
129848455|NCT01529645|467406777|FG002|Overall Study|Withdrawal by Subject|0|||
129848456|NCT01529645|467406778|FG003|Overall Study|Withdrawal by Subject|1|||
129848457|NCT01529645|467406779|FG004|Overall Study|Withdrawal by Subject|1|||
129848458|NCT01529645|467406780|FG005|Overall Study|Withdrawal by Subject|1|||
129848459|NCT01529645|467406781|FG006|Overall Study|Withdrawal by Subject|0|||
129848460|NCT01529645|467406782|FG007|Overall Study|Withdrawal by Subject|0|||
129848461|NCT01529645|467406783|FG008|Overall Study|Withdrawal by Subject|0|||
129848462|NCT01529645|467406784|FG009|Overall Study|Withdrawal by Subject|0|||
129848463|NCT01774903|467406785|FG000|Overall Study|Adverse Event|7|||
129848464|NCT01774903|467406785|FG000|Overall Study|Withdrawal by Subject|2|||
129848465|NCT01774903|467406785|FG000|Overall Study|Lack of Efficacy|1|||
129848466|NCT01774903|467406785|FG000|Overall Study|Ineligible to continue the trial|1|||
129848467|NCT01602315|467406786|FG000|Overall Study|Protocol Violation|0|||
129848468|NCT01602315|467406787|FG001|Overall Study|Protocol Violation|0|||
129848469|NCT01602315|467406788|FG002|Overall Study|Protocol Violation|0|||
129848470|NCT01602315|467406789|FG003|Overall Study|Protocol Violation|0|||
129848471|NCT01602315|467406790|FG004|Overall Study|Protocol Violation|0|||
129848472|NCT01602315|467406791|FG005|Overall Study|Protocol Violation|1|||
129848473|NCT01602315|467406792|FG006|Overall Study|Protocol Violation|0|||
129848474|NCT01602315|467406786|FG000|Overall Study|Physician Decision|2|||
129848475|NCT01602315|467406787|FG001|Overall Study|Physician Decision|0|||
129848476|NCT01602315|467406788|FG002|Overall Study|Physician Decision|0|||
129848477|NCT01602315|467406789|FG003|Overall Study|Physician Decision|0|||
129848478|NCT01602315|467406790|FG004|Overall Study|Physician Decision|2|||
129848479|NCT01602315|467406791|FG005|Overall Study|Physician Decision|1|||
129848480|NCT01602315|467406792|FG006|Overall Study|Physician Decision|1|||
129848481|NCT01602315|467406786|FG000|Overall Study|Disease progression|6|||
129848482|NCT01602315|467406787|FG001|Overall Study|Disease progression|3|||
129848483|NCT01602315|467406788|FG002|Overall Study|Disease progression|10|||
129848484|NCT01602315|467406789|FG003|Overall Study|Disease progression|1|||
129848485|NCT01602315|467406790|FG004|Overall Study|Disease progression|41|||
129848486|NCT01602315|467406791|FG005|Overall Study|Disease progression|12|||
129848487|NCT01602315|467406792|FG006|Overall Study|Disease progression|15|||
129848488|NCT01602315|467406786|FG000|Overall Study|Death|1|||
129848489|NCT01602315|467406787|FG001|Overall Study|Death|1|||
129848490|NCT01602315|467406788|FG002|Overall Study|Death|1|||
129848491|NCT01602315|467406789|FG003|Overall Study|Death|1|||
129848492|NCT01602315|467406790|FG004|Overall Study|Death|7|||
129848493|NCT01602315|467406791|FG005|Overall Study|Death|2|||
129848494|NCT01602315|467406792|FG006|Overall Study|Death|2|||
129848495|NCT01602315|467406786|FG000|Overall Study|Withdrawal by Subject|2|||
129848496|NCT01602315|467406787|FG001|Overall Study|Withdrawal by Subject|0|||
129848497|NCT01602315|467406788|FG002|Overall Study|Withdrawal by Subject|2|||
129848498|NCT01602315|467406789|FG003|Overall Study|Withdrawal by Subject|0|||
129848499|NCT01602315|467406790|FG004|Overall Study|Withdrawal by Subject|6|||
129848500|NCT01602315|467406791|FG005|Overall Study|Withdrawal by Subject|0|||
129848501|NCT01602315|467406792|FG006|Overall Study|Withdrawal by Subject|1|||
129848502|NCT01602315|467406786|FG000|Overall Study|Adverse Event|5|||
129848503|NCT01602315|467406787|FG001|Overall Study|Adverse Event|1|||
129848504|NCT01602315|467406788|FG002|Overall Study|Adverse Event|5|||
129848505|NCT01602315|467406789|FG003|Overall Study|Adverse Event|4|||
129848506|NCT01602315|467406790|FG004|Overall Study|Adverse Event|15|||
129848507|NCT01602315|467406791|FG005|Overall Study|Adverse Event|3|||
129848508|NCT01602315|467406792|FG006|Overall Study|Adverse Event|9|||
129848509|NCT01602315|467406786|FG000|Overall Study|Subject/guardian decision|0|||
129848510|NCT01602315|467406787|FG001|Overall Study|Subject/guardian decision|0|||
129848511|NCT01602315|467406788|FG002|Overall Study|Subject/guardian decision|0|||
129848512|NCT01602315|467406789|FG003|Overall Study|Subject/guardian decision|0|||
129848513|NCT01602315|467406790|FG004|Overall Study|Subject/guardian decision|0|||
129848514|NCT01602315|467406791|FG005|Overall Study|Subject/guardian decision|0|||
129848515|NCT01602315|467406792|FG006|Overall Study|Subject/guardian decision|1|||
129848516|NCT01602315|467406786|FG000|Overall Study|Cross-over patients to combo treatment|0|||
129848517|NCT01602315|467406787|FG001|Overall Study|Cross-over patients to combo treatment|0|||
129848518|NCT01602315|467406788|FG002|Overall Study|Cross-over patients to combo treatment|0|||
129848519|NCT01602315|467406789|FG003|Overall Study|Cross-over patients to combo treatment|0|||
129848520|NCT01602315|467406790|FG004|Overall Study|Cross-over patients to combo treatment|0|||
129848521|NCT01602315|467406791|FG005|Overall Study|Cross-over patients to combo treatment|16|||
129848522|NCT01602315|467406792|FG006|Overall Study|Cross-over patients to combo treatment|0|||
129848523|NCT02880371|467406793|FG000|Phase 1b|Lost to Follow-up|1|||
129848524|NCT02880371|467406794|FG001|Phase 1b|Lost to Follow-up|0|||
129848525|NCT02880371|467406795|FG002|Phase 1b|Lost to Follow-up|0|||
129848526|NCT02880371|467406796|FG003|Phase 1b|Lost to Follow-up|0|||
129848527|NCT02880371|467406797|FG004|Phase 1b|Lost to Follow-up|0|||
129848528|NCT02880371|467406798|FG005|Phase 1b|Lost to Follow-up|0|||
129848529|NCT02880371|467406799|FG006|Phase 1b|Lost to Follow-up|0|||
129848530|NCT02880371|467406800|FG007|Phase 1b|Lost to Follow-up|0|||
129848531|NCT02880371|467406793|FG000|Phase 1b|Participants terminated by Sponsor|1|||
129848532|NCT02880371|467406794|FG001|Phase 1b|Participants terminated by Sponsor|0|||
129848533|NCT02880371|467406795|FG002|Phase 1b|Participants terminated by Sponsor|0|||
129848534|NCT02880371|467406796|FG003|Phase 1b|Participants terminated by Sponsor|0|||
129848535|NCT02880371|467406797|FG004|Phase 1b|Participants terminated by Sponsor|0|||
129848536|NCT02880371|467406798|FG005|Phase 1b|Participants terminated by Sponsor|0|||
129848537|NCT02880371|467406799|FG006|Phase 1b|Participants terminated by Sponsor|0|||
129848538|NCT02880371|467406800|FG007|Phase 1b|Participants terminated by Sponsor|0|||
129848539|NCT02880371|467406793|FG000|Phase 1b|Withdrawal by Subject|0|||
129848540|NCT02880371|467406794|FG001|Phase 1b|Withdrawal by Subject|0|||
129848541|NCT02880371|467406795|FG002|Phase 1b|Withdrawal by Subject|1|||
129848542|NCT02880371|467406796|FG003|Phase 1b|Withdrawal by Subject|0|||
129848543|NCT02880371|467406797|FG004|Phase 1b|Withdrawal by Subject|0|||
129848544|NCT02880371|467406798|FG005|Phase 1b|Withdrawal by Subject|0|||
129848545|NCT02880371|467406799|FG006|Phase 1b|Withdrawal by Subject|0|||
129848546|NCT02880371|467406800|FG007|Phase 1b|Withdrawal by Subject|0|||
129848547|NCT02880371|467406793|FG000|Phase 1b|Death|4|||
129848548|NCT02880371|467406794|FG001|Phase 1b|Death|6|||
129848549|NCT02880371|467406795|FG002|Phase 1b|Death|5|||
129848550|NCT02880371|467406796|FG003|Phase 1b|Death|1|||
129848551|NCT02880371|467406797|FG004|Phase 1b|Death|0|||
129848552|NCT02880371|467406798|FG005|Phase 1b|Death|0|||
129848553|NCT02880371|467406799|FG006|Phase 1b|Death|0|||
129848554|NCT02880371|467406800|FG007|Phase 1b|Death|0|||
129848555|NCT02880371|467406793|FG000|Phase 1b|Enrolled but not Treated|0|||
129848556|NCT02880371|467406794|FG001|Phase 1b|Enrolled but not Treated|1|||
129848557|NCT02880371|467406795|FG002|Phase 1b|Enrolled but not Treated|0|||
129848558|NCT02880371|467406796|FG003|Phase 1b|Enrolled but not Treated|0|||
129848559|NCT02880371|467406797|FG004|Phase 1b|Enrolled but not Treated|0|||
129848560|NCT02880371|467406798|FG005|Phase 1b|Enrolled but not Treated|0|||
129848561|NCT02880371|467406799|FG006|Phase 1b|Enrolled but not Treated|0|||
129848562|NCT02880371|467406800|FG007|Phase 1b|Enrolled but not Treated|0|||
129848563|NCT02880371|467406793|FG000|Phase 2|Enrolled but not Treated|0|||
129848564|NCT02880371|467406794|FG001|Phase 2|Enrolled but not Treated|0|||
129848565|NCT02880371|467406795|FG002|Phase 2|Enrolled but not Treated|0|||
129848566|NCT02880371|467406796|FG003|Phase 2|Enrolled but not Treated|0|||
129848567|NCT02880371|467406797|FG004|Phase 2|Enrolled but not Treated|0|||
129848568|NCT02880371|467406798|FG005|Phase 2|Enrolled but not Treated|1|||
129848569|NCT02880371|467406799|FG006|Phase 2|Enrolled but not Treated|1|||
129848570|NCT02880371|467406800|FG007|Phase 2|Enrolled but not Treated|0|||
129848571|NCT02880371|467406793|FG000|Phase 2|Other|0|||
129848572|NCT02880371|467406794|FG001|Phase 2|Other|0|||
129848573|NCT02880371|467406795|FG002|Phase 2|Other|0|||
129848574|NCT02880371|467406796|FG003|Phase 2|Other|0|||
129848575|NCT02880371|467406797|FG004|Phase 2|Other|0|||
129848576|NCT02880371|467406798|FG005|Phase 2|Other|1|||
129848577|NCT02880371|467406799|FG006|Phase 2|Other|2|||
129848578|NCT02880371|467406800|FG007|Phase 2|Other|1|||
129848579|NCT02880371|467406793|FG000|Phase 2|Participants terminated by Sponsor|0|||
129848580|NCT02880371|467406794|FG001|Phase 2|Participants terminated by Sponsor|0|||
129848581|NCT02880371|467406795|FG002|Phase 2|Participants terminated by Sponsor|0|||
129848582|NCT02880371|467406796|FG003|Phase 2|Participants terminated by Sponsor|0|||
129848583|NCT02880371|467406797|FG004|Phase 2|Participants terminated by Sponsor|1|||
129848584|NCT02880371|467406798|FG005|Phase 2|Participants terminated by Sponsor|6|||
129848585|NCT02880371|467406799|FG006|Phase 2|Participants terminated by Sponsor|1|||
129848586|NCT02880371|467406800|FG007|Phase 2|Participants terminated by Sponsor|5|||
129848587|NCT02880371|467406793|FG000|Phase 2|Death|0|||
129848588|NCT02880371|467406794|FG001|Phase 2|Death|0|||
129848589|NCT02880371|467406795|FG002|Phase 2|Death|0|||
129848590|NCT02880371|467406796|FG003|Phase 2|Death|0|||
129848591|NCT02880371|467406797|FG004|Phase 2|Death|1|||
129848592|NCT02880371|467406798|FG005|Phase 2|Death|10|||
129848593|NCT02880371|467406799|FG006|Phase 2|Death|20|||
129848594|NCT02880371|467406800|FG007|Phase 2|Death|5|||
129848595|NCT02880371|467406793|FG000|Phase 2|Lost to Follow-up|0|||
129848596|NCT02880371|467406794|FG001|Phase 2|Lost to Follow-up|0|||
129848597|NCT02880371|467406795|FG002|Phase 2|Lost to Follow-up|0|||
129848598|NCT02880371|467406796|FG003|Phase 2|Lost to Follow-up|0|||
129848599|NCT02880371|467406797|FG004|Phase 2|Lost to Follow-up|0|||
129848600|NCT02880371|467406798|FG005|Phase 2|Lost to Follow-up|0|||
129848601|NCT02880371|467406799|FG006|Phase 2|Lost to Follow-up|3|||
129848602|NCT02880371|467406800|FG007|Phase 2|Lost to Follow-up|0|||
129848603|NCT02880371|467406793|FG000|Phase 2|Withdrawal by Subject|0|||
129848604|NCT02880371|467406794|FG001|Phase 2|Withdrawal by Subject|0|||
129848605|NCT02880371|467406795|FG002|Phase 2|Withdrawal by Subject|0|||
129848606|NCT02880371|467406796|FG003|Phase 2|Withdrawal by Subject|0|||
129848607|NCT02880371|467406797|FG004|Phase 2|Withdrawal by Subject|0|||
129848608|NCT02880371|467406798|FG005|Phase 2|Withdrawal by Subject|1|||
129848609|NCT02880371|467406799|FG006|Phase 2|Withdrawal by Subject|1|||
129848610|NCT02880371|467406800|FG007|Phase 2|Withdrawal by Subject|0|||
129848611|NCT02880371|467406793|FG000|Phase 2|End of Study page not completed by error|0|||
129848612|NCT02880371|467406794|FG001|Phase 2|End of Study page not completed by error|0|||
129848613|NCT02880371|467406795|FG002|Phase 2|End of Study page not completed by error|0|||
129848614|NCT02880371|467406796|FG003|Phase 2|End of Study page not completed by error|0|||
129848615|NCT02880371|467406797|FG004|Phase 2|End of Study page not completed by error|0|||
129848616|NCT02880371|467406798|FG005|Phase 2|End of Study page not completed by error|1|||
129848617|NCT02880371|467406799|FG006|Phase 2|End of Study page not completed by error|0|||
129848618|NCT02880371|467406800|FG007|Phase 2|End of Study page not completed by error|0|||
129848619|NCT01777997|467406803|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
129848620|NCT01777997|467406803|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
129848621|NCT01777997|467406803|FG000|Weeks 48 to 72/96 on ART|Death|1|||
129848622|NCT01777997|467406803|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
129848623|NCT00440271|467406812|FG000|Overall Study|Protocol Violation|1|||
129848624|NCT00440271|467406813|FG001|Overall Study|Protocol Violation|1|||
129848625|NCT00440271|467406812|FG000|Overall Study|Adverse Event|0|||
129848626|NCT00440271|467406813|FG001|Overall Study|Adverse Event|1|||
129848627|NCT00440271|467406812|FG000|Overall Study|Lost to Follow-up|1|||
129848628|NCT00440271|467406813|FG001|Overall Study|Lost to Follow-up|0|||
129848629|NCT00440271|467406812|FG000|Overall Study|Withdrawal by Subject|0|||
129848630|NCT00440271|467406813|FG001|Overall Study|Withdrawal by Subject|2|||
129848631|NCT00440271|467406812|FG000|Overall Study|Lack of Efficacy|0|||
129848632|NCT00440271|467406813|FG001|Overall Study|Lack of Efficacy|1|||
129848633|NCT00440271|467406812|FG000|Overall Study|Due to closure of trial|8|||
129848634|NCT00440271|467406813|FG001|Overall Study|Due to closure of trial|10|||
129848635|NCT00440271|467406812|FG000|Overall Study|Other|2|||
129848636|NCT00440271|467406813|FG001|Overall Study|Other|0|||
129848637|NCT00723801|467406814|FG000|Overall Study|Lost to Follow-up|1|||
129848638|NCT00723801|467406815|FG001|Overall Study|Lost to Follow-up|2|||
129848639|NCT00723801|467406814|FG000|Overall Study|Protocol Violation|2|||
129848640|NCT00723801|467406815|FG001|Overall Study|Protocol Violation|1|||
129848641|NCT01565993|467406823|FG000|Overall Study|Physician Decision|0|||
129848642|NCT01565993|467406824|FG001|Overall Study|Physician Decision|3|||
129848643|NCT01824303|467406825|FG000|Randomized Study|Withdrawal by Subject|1|||
129848644|NCT01824303|467406826|FG001|Randomized Study|Withdrawal by Subject|1|||
129848645|NCT01824303|467406825|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
129848646|NCT01824303|467406826|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
129848647|NCT02809976|467406827|FG000|Overall Study|Lost to Follow-up|1|||
129848648|NCT02809976|467406827|FG000|Overall Study|Withdrawal by Subject|1|||
129848649|NCT00113516|467406828|FG000|Part 1|Adverse Event|6|||
129848650|NCT00113516|467406829|FG001|Part 1|Adverse Event|0|||
129848651|NCT00113516|467406828|FG000|Part 1|Death|3|||
129848652|NCT00113516|467406829|FG001|Part 1|Death|0|||
129848653|NCT00113516|467406828|FG000|Part 1|Other|3|||
129848654|NCT00113516|467406829|FG001|Part 1|Other|0|||
129848655|NCT00113516|467406828|FG000|Part 1|Withdrawal by Subject|2|||
129848656|NCT00113516|467406829|FG001|Part 1|Withdrawal by Subject|0|||
129848657|NCT00113516|467406828|FG000|Part 1|Lack of Efficacy|2|||
129848658|NCT00113516|467406829|FG001|Part 1|Lack of Efficacy|0|||
129848659|NCT00113516|467406828|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
129848660|NCT00113516|467406829|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
129848661|NCT00113516|467406828|FG000|Part 1|Laboratory Abnormality|1|||
129848662|NCT00113516|467406829|FG001|Part 1|Laboratory Abnormality|0|||
129848663|NCT00113516|467406828|FG000|Part 1|Ongoing|1|||
129848664|NCT00113516|467406829|FG001|Part 1|Ongoing|0|||
129848665|NCT00113516|467406828|FG000|Part 1|Missing|65|||
129848666|NCT00113516|467406829|FG001|Part 1|Missing|0|||
129848667|NCT00113516|467406828|FG000|Part 2|Adverse Event|0|||
129848668|NCT00113516|467406829|FG001|Part 2|Adverse Event|16|||
129848669|NCT00113516|467406828|FG000|Part 2|Death|0|||
129848670|NCT00113516|467406829|FG001|Part 2|Death|5|||
129903511|NCT01049503|467608311|FG004|Overall Study|Lost to Follow-up|27|||
129903512|NCT01049503|467608312|FG005|Overall Study|Lost to Follow-up|8|||
129903513|NCT00726596|467608313|FG000|Overall Study|Adverse Event|2|||
129903514|NCT00726596|467608314|FG001|Overall Study|Adverse Event|1|||
129903515|NCT00726596|467608313|FG000|Overall Study|Withdrawal by Subject|3|||
129903516|NCT00726596|467608314|FG001|Overall Study|Withdrawal by Subject|3|||
129903517|NCT02974634|467608315|FG000|Overall Study|Advanced disease|12|||
129903518|NCT02974634|467608316|FG001|Overall Study|Advanced disease|3|||
129903519|NCT02974634|467608315|FG000|Overall Study|Noncompliance|3|||
129903520|NCT02974634|467608316|FG001|Overall Study|Noncompliance|7|||
129903521|NCT02974634|467608315|FG000|Overall Study|intervention technology related issues|5|||
129903522|NCT02974634|467608316|FG001|Overall Study|intervention technology related issues|0|||
129848671|NCT00113516|467406828|FG000|Part 2|Lack of Efficacy|0|||
129848672|NCT00113516|467406829|FG001|Part 2|Lack of Efficacy|37|||
129848673|NCT00113516|467406828|FG000|Part 2|Withdrawal by Subject|0|||
129848674|NCT00113516|467406829|FG001|Part 2|Withdrawal by Subject|3|||
129848675|NCT00113516|467406828|FG000|Part 2|Other|0|||
129848676|NCT00113516|467406829|FG001|Part 2|Other|3|||
129848677|NCT00113516|467406828|FG000|Part 2|Laboratory Abnormality|0|||
129848678|NCT00113516|467406829|FG001|Part 2|Laboratory Abnormality|1|||
129848679|NCT00113516|467406828|FG000|Part 2|Ongoing|0|||
129848680|NCT00113516|467406829|FG001|Part 2|Ongoing|1|||
129848681|NCT00642304|467406830|FG000|Overall Study|Adverse Event|1|||
129848682|NCT00642304|467406830|FG000|Overall Study|Death|1|||
129848683|NCT00642304|467406830|FG000|Overall Study|Blood transfusion|2|||
129848684|NCT00642304|467406830|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
129848685|NCT00642304|467406830|FG000|Overall Study|Transplantation|1|||
129848686|NCT00812812|467406831|FG000|Overall Study|Adverse Event|2|||
129848687|NCT00812812|467406832|FG001|Overall Study|Adverse Event|1|||
129848688|NCT00812812|467406831|FG000|Overall Study|Lack of Efficacy|1|||
129848689|NCT00812812|467406832|FG001|Overall Study|Lack of Efficacy|0|||
129848690|NCT00812812|467406831|FG000|Overall Study|Lost to Follow-up|0|||
129903523|NCT02974634|467608315|FG000|Overall Study|Death|8|||
129903524|NCT02974634|467608316|FG001|Overall Study|Death|11|||
129848691|NCT00812812|467406832|FG001|Overall Study|Lost to Follow-up|1|||
129848692|NCT00812812|467406831|FG000|Overall Study|Withdrawal by Subject|0|||
129848693|NCT00812812|467406832|FG001|Overall Study|Withdrawal by Subject|2|||
129848694|NCT02863354|467406836|FG000|Year 1|Lost to Follow-up|1|||
129848695|NCT02863354|467406837|FG001|Year 1|Lost to Follow-up|1|||
129979686|NCT03752970|467889436|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
129848696|NCT02863354|467406836|FG000|Year 1|Withdrawal by Subject|3|||
129848697|NCT02863354|467406837|FG001|Year 1|Withdrawal by Subject|0|||
129848698|NCT02863354|467406836|FG000|Year 1|Death|0|||
129848699|NCT02863354|467406837|FG001|Year 1|Death|1|||
129848700|NCT02863354|467406836|FG000|Year 2|Lost to Follow-up|2|||
129848701|NCT02863354|467406837|FG001|Year 2|Lost to Follow-up|2|||
129848702|NCT03235024|467406838|FG000|Overall Study|Adverse Event|2|||
129848703|NCT03235024|467406839|FG001|Overall Study|Adverse Event|2|||
129848704|NCT03235024|467406838|FG000|Overall Study|Death|1|||
129848705|NCT03235024|467406839|FG001|Overall Study|Death|0|||
129848706|NCT03235024|467406838|FG000|Overall Study|Lost to Follow-up|2|||
129848707|NCT03235024|467406839|FG001|Overall Study|Lost to Follow-up|5|||
129848708|NCT03235024|467406838|FG000|Overall Study|Protocol Violation|1|||
129848709|NCT03235024|467406839|FG001|Overall Study|Protocol Violation|0|||
129848710|NCT03235024|467406838|FG000|Overall Study|Withdrawal by Subject|0|||
129848711|NCT03235024|467406839|FG001|Overall Study|Withdrawal by Subject|3|||
129848712|NCT00705575|467406840|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129848713|NCT00705575|467406841|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129848714|NCT00705575|467406840|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129848715|NCT00705575|467406841|FG001|Overall Study|Abnormal test procedure result(s)|12|||
129848716|NCT00705575|467406840|FG000|Overall Study|Adverse Event|11|||
129848717|NCT00705575|467406841|FG001|Overall Study|Adverse Event|15|||
129848718|NCT00705575|467406840|FG000|Overall Study|Lost to Follow-up|3|||
129848719|NCT00705575|467406841|FG001|Overall Study|Lost to Follow-up|4|||
129848720|NCT00705575|467406840|FG000|Overall Study|Protocol Violation|2|||
129848721|NCT00705575|467406841|FG001|Overall Study|Protocol Violation|2|||
129848722|NCT00705575|467406840|FG000|Overall Study|Withdrawal by Subject|5|||
129848723|NCT00705575|467406841|FG001|Overall Study|Withdrawal by Subject|10|||
129848724|NCT03304379|467406842|FG000|Overall Study|Protocol Violation|8|||
129848725|NCT03304379|467406843|FG001|Overall Study|Protocol Violation|10|||
129848726|NCT03304379|467406844|FG002|Overall Study|Protocol Violation|5|||
129848727|NCT03304379|467406845|FG003|Overall Study|Protocol Violation|0|||
129848728|NCT03304379|467406846|FG004|Overall Study|Protocol Violation|2|||
129848729|NCT03304379|467406842|FG000|Overall Study|Adverse Event|4|||
129848730|NCT03304379|467406843|FG001|Overall Study|Adverse Event|20|||
129848731|NCT03304379|467406844|FG002|Overall Study|Adverse Event|17|||
129848732|NCT03304379|467406845|FG003|Overall Study|Adverse Event|1|||
129848733|NCT03304379|467406846|FG004|Overall Study|Adverse Event|0|||
129848734|NCT03304379|467406842|FG000|Overall Study|Lack of Efficacy|17|||
129848735|NCT03304379|467406843|FG001|Overall Study|Lack of Efficacy|16|||
129848736|NCT03304379|467406844|FG002|Overall Study|Lack of Efficacy|20|||
129848737|NCT03304379|467406845|FG003|Overall Study|Lack of Efficacy|0|||
129848738|NCT03304379|467406846|FG004|Overall Study|Lack of Efficacy|0|||
129848739|NCT03304379|467406842|FG000|Overall Study|Physician Decision|6|||
129848740|NCT03304379|467406843|FG001|Overall Study|Physician Decision|10|||
129848741|NCT03304379|467406844|FG002|Overall Study|Physician Decision|6|||
129848742|NCT03304379|467406845|FG003|Overall Study|Physician Decision|9|||
129848743|NCT03304379|467406846|FG004|Overall Study|Physician Decision|10|||
129848744|NCT03304379|467406842|FG000|Overall Study|Withdrawal by Subject|26|||
129848745|NCT03304379|467406843|FG001|Overall Study|Withdrawal by Subject|58|||
129848746|NCT03304379|467406844|FG002|Overall Study|Withdrawal by Subject|66|||
129848747|NCT03304379|467406845|FG003|Overall Study|Withdrawal by Subject|3|||
129848748|NCT03304379|467406846|FG004|Overall Study|Withdrawal by Subject|5|||
129848749|NCT03304379|467406842|FG000|Overall Study|Lost to Follow-up|8|||
129848750|NCT03304379|467406843|FG001|Overall Study|Lost to Follow-up|24|||
129848751|NCT03304379|467406844|FG002|Overall Study|Lost to Follow-up|35|||
129848752|NCT03304379|467406845|FG003|Overall Study|Lost to Follow-up|4|||
129848753|NCT03304379|467406846|FG004|Overall Study|Lost to Follow-up|0|||
129848754|NCT03304379|467406842|FG000|Overall Study|Death|1|||
129848755|NCT03304379|467406843|FG001|Overall Study|Death|2|||
129848756|NCT03304379|467406844|FG002|Overall Study|Death|0|||
129848757|NCT03304379|467406845|FG003|Overall Study|Death|0|||
129848758|NCT03304379|467406846|FG004|Overall Study|Death|0|||
129848759|NCT03304379|467406842|FG000|Overall Study|Other|0|||
129848760|NCT03304379|467406843|FG001|Overall Study|Other|1|||
129848761|NCT03304379|467406844|FG002|Overall Study|Other|0|||
129848762|NCT03304379|467406845|FG003|Overall Study|Other|0|||
129848763|NCT03304379|467406846|FG004|Overall Study|Other|0|||
129903525|NCT02962674|467608325|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
129903526|NCT00364286|467608326|FG000|Overall Study|Withdrawal by Subject|1|||
129848764|NCT00684424|467406858|FG000|Overall Study|Adverse Event|1|||
129848765|NCT00684424|467406858|FG000|Overall Study|Lost to Follow-up|2|||
129848766|NCT00684424|467406858|FG000|Overall Study|Other|2|||
129848767|NCT02410811|467406859|FG000|Overall Study|Withdrawal by Subject|0|||
129848768|NCT02410811|467406860|FG001|Overall Study|Withdrawal by Subject|0|||
130116581|NCT01335477|468387107|FG000|Overall Study|Lost to Follow-up|1|||
129848769|NCT02410811|467406861|FG002|Overall Study|Withdrawal by Subject|1|||
129848770|NCT02410811|467406862|FG003|Overall Study|Withdrawal by Subject|0|||
129848771|NCT02550652|467406868|FG000|Overall Study|Death|1|||
129848772|NCT02550652|467406869|FG001|Overall Study|Death|4|||
129848773|NCT02550652|467406868|FG000|Overall Study|Lack of Efficacy|1|||
129848774|NCT02550652|467406869|FG001|Overall Study|Lack of Efficacy|0|||
129848775|NCT02550652|467406868|FG000|Overall Study|Withdrawal by Subject|4|||
129848776|NCT02550652|467406869|FG001|Overall Study|Withdrawal by Subject|7|||
129848777|NCT02550652|467406868|FG000|Overall Study|Post Trial Access|1|||
129903527|NCT00364286|467608326|FG000|Overall Study|Adverse Event|2|||
129903528|NCT01134562|467608327|FG000|Overall Study|Adverse Event|0|||
129903529|NCT01134562|467608328|FG001|Overall Study|Adverse Event|1|||
129903530|NCT01134562|467608329|FG002|Overall Study|Adverse Event|0|||
129903531|NCT01134562|467608330|FG003|Overall Study|Adverse Event|0|||
129903532|NCT01134562|467608331|FG004|Overall Study|Adverse Event|0|||
129903533|NCT00357396|467608332|FG000|Overall Study|Adverse Event|1|||
129903534|NCT00357396|467608333|FG001|Overall Study|Adverse Event|0|||
129903535|NCT02496702|467608334|FG000|Overall Study|Lost to Follow-up|8|||
129903536|NCT02496702|467608335|FG001|Overall Study|Lost to Follow-up|6|||
129903537|NCT02496702|467608334|FG000|Overall Study|Only partially tested|0|||
129903538|NCT02496702|467608335|FG001|Overall Study|Only partially tested|2|||
129903539|NCT01227278|467608338|FG000|Overall Study|Withdrawal by Subject|4|||
129903540|NCT01227278|467608339|FG001|Overall Study|Withdrawal by Subject|4|||
129903541|NCT01227278|467608338|FG000|Overall Study|Death|0|||
129903542|NCT01227278|467608339|FG001|Overall Study|Death|2|||
129903543|NCT01227278|467608338|FG000|Overall Study|Other|1|||
129903544|NCT01227278|467608339|FG001|Overall Study|Other|2|||
129903545|NCT04035668|467608340|FG000|Overall Study|Adverse Event|3|||
129903546|NCT04035668|467608341|FG001|Overall Study|Adverse Event|4|||
129903547|NCT04035668|467608342|FG002|Overall Study|Adverse Event|2|||
129903548|NCT04035668|467608340|FG000|Overall Study|Lost to Follow-up|0|||
129903549|NCT04035668|467608341|FG001|Overall Study|Lost to Follow-up|1|||
129903550|NCT04035668|467608342|FG002|Overall Study|Lost to Follow-up|0|||
129903551|NCT04035668|467608340|FG000|Overall Study|Physician Decision|2|||
129903552|NCT04035668|467608341|FG001|Overall Study|Physician Decision|1|||
129903553|NCT04035668|467608342|FG002|Overall Study|Physician Decision|1|||
129903554|NCT04035668|467608340|FG000|Overall Study|Subject Decision|2|||
129903555|NCT04035668|467608341|FG001|Overall Study|Subject Decision|2|||
129903556|NCT04035668|467608342|FG002|Overall Study|Subject Decision|0|||
129903557|NCT02320123|467608343|FG000|Overall Study|Lost to Follow-up|4|||
129903558|NCT02320123|467608344|FG001|Overall Study|Lost to Follow-up|6|||
129903559|NCT02320123|467608343|FG000|Overall Study|Death|6|||
129903560|NCT02320123|467608344|FG001|Overall Study|Death|5|||
129903561|NCT00516386|467608355|FG000|Overall Study|not interested in the study|4|||
129903562|NCT00516386|467608355|FG000|Overall Study|Lost to Follow-up|2|||
129903563|NCT01376089|467608360|FG000|Overall Study|Patient received no contrast media|3|||
129903564|NCT01376089|467608361|FG001|Overall Study|Patient received no contrast media|4|||
129903565|NCT03287622|467608364|FG000|Overall Study|Withdrawal by Subject|1|||
129903566|NCT03287622|467608365|FG001|Overall Study|Withdrawal by Subject|0|||
129903567|NCT03287622|467608364|FG000|Overall Study|Lost to Follow-up|27|||
129903568|NCT03287622|467608365|FG001|Overall Study|Lost to Follow-up|15|||
129903569|NCT03287622|467608364|FG000|Overall Study|No prescripion after surgery|28|||
129903570|NCT03287622|467608365|FG001|Overall Study|No prescripion after surgery|31|||
129903571|NCT03287622|467608364|FG000|Overall Study|prolonged Length of stay|2|||
129903572|NCT03287622|467608365|FG001|Overall Study|prolonged Length of stay|0|||
129903573|NCT03287622|467608364|FG000|Overall Study|surgery related|0|||
129903574|NCT03287622|467608365|FG001|Overall Study|surgery related|2|||
129903575|NCT01786564|467608368|FG000|Overall Study|Lost to Follow-up|47|||
129903576|NCT01786564|467608368|FG000|Overall Study|Ineligible|17|||
129903577|NCT02506257|467608369|FG000|Overall Study|Adverse Event|0|||
129903578|NCT02506257|467608370|FG001|Overall Study|Adverse Event|2|||
129903579|NCT02506257|467608371|FG002|Overall Study|Adverse Event|3|||
129903580|NCT02506257|467608372|FG003|Overall Study|Adverse Event|0|||
129903581|NCT02506257|467608369|FG000|Overall Study|Protocol Violation|0|||
129903582|NCT02506257|467608370|FG001|Overall Study|Protocol Violation|0|||
129903583|NCT02506257|467608371|FG002|Overall Study|Protocol Violation|1|||
129903584|NCT02506257|467608372|FG003|Overall Study|Protocol Violation|0|||
129903585|NCT00139737|467608380|FG000|Overall Study|Withdrawal by Subject|190|||
129903586|NCT00139737|467608380|FG000|Overall Study|Adverse Event|58|||
129903587|NCT00139737|467608380|FG000|Overall Study|Lack of Efficacy|40|||
129903588|NCT00139737|467608380|FG000|Overall Study|Lost to Follow-up|8|||
129903589|NCT00139737|467608380|FG000|Overall Study|Death|3|||
129903590|NCT00139737|467608380|FG000|Overall Study|Laboratory Abnormality|2|||
129903591|NCT00139737|467608380|FG000|Overall Study|Protocol Violation|18|||
129903592|NCT00139737|467608380|FG000|Overall Study|Withdrew During Screening Phase|8|||
129903593|NCT00139737|467608380|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129903594|NCT00139737|467608380|FG000|Overall Study|Screened, Not Treated|13|||
129903595|NCT03781336|467608381|FG000|Overall Study|Withdrawal by Subject|2|||
129903596|NCT03781336|467608382|FG001|Overall Study|Withdrawal by Subject|2|||
129903597|NCT03460756|467608383|FG000|Overall Study|Adverse Event|0|||
129903598|NCT03460756|467608384|FG001|Overall Study|Adverse Event|0|||
129903599|NCT03460756|467608385|FG002|Overall Study|Adverse Event|0|||
129903600|NCT03460756|467608386|FG003|Overall Study|Adverse Event|1|||
129903601|NCT03460756|467608383|FG000|Overall Study|Lack of Efficacy|0|||
129903602|NCT03460756|467608384|FG001|Overall Study|Lack of Efficacy|0|||
129903603|NCT03460756|467608385|FG002|Overall Study|Lack of Efficacy|0|||
129903604|NCT03460756|467608386|FG003|Overall Study|Lack of Efficacy|2|||
129903605|NCT03460756|467608383|FG000|Overall Study|Lost to Follow-up|0|||
129903606|NCT03460756|467608384|FG001|Overall Study|Lost to Follow-up|1|||
129903607|NCT03460756|467608385|FG002|Overall Study|Lost to Follow-up|2|||
129903608|NCT03460756|467608386|FG003|Overall Study|Lost to Follow-up|1|||
129903609|NCT03460756|467608383|FG000|Overall Study|Pregnancy|0|||
129903610|NCT03460756|467608384|FG001|Overall Study|Pregnancy|0|||
129903611|NCT03460756|467608385|FG002|Overall Study|Pregnancy|0|||
129903612|NCT03460756|467608386|FG003|Overall Study|Pregnancy|1|||
129903613|NCT03460756|467608383|FG000|Overall Study|Protocol Violation|0|||
129903614|NCT03460756|467608384|FG001|Overall Study|Protocol Violation|0|||
129903615|NCT03460756|467608385|FG002|Overall Study|Protocol Violation|0|||
129903616|NCT03460756|467608386|FG003|Overall Study|Protocol Violation|1|||
129903617|NCT03460756|467608383|FG000|Overall Study|Withdrawal by Subject|0|||
129903618|NCT03460756|467608384|FG001|Overall Study|Withdrawal by Subject|4|||
129903619|NCT03460756|467608385|FG002|Overall Study|Withdrawal by Subject|7|||
129903620|NCT03460756|467608386|FG003|Overall Study|Withdrawal by Subject|3|||
129903621|NCT03987451|467608387|FG000|Overall Study|Lost to Follow-up|1|||
129903622|NCT03987451|467608388|FG001|Overall Study|Lost to Follow-up|0|||
129903623|NCT03987451|467608387|FG000|Overall Study|Withdrawal by Subject|1|||
129903624|NCT03987451|467608388|FG001|Overall Study|Withdrawal by Subject|1|||
129903625|NCT02441036|467608390|FG000|Overall Study|No tissue resected|0|||
129903626|NCT02441036|467608391|FG001|Overall Study|No tissue resected|1|||
129903627|NCT02441036|467608392|FG002|Overall Study|No tissue resected|0|||
129903628|NCT02441036|467608393|FG003|Overall Study|No tissue resected|1|||
129903629|NCT02441036|467608394|FG004|Overall Study|No tissue resected|0|||
129903630|NCT00612586|467608395|FG000|Overall Study|Adverse Event|6|||
129903631|NCT00612586|467608396|FG001|Overall Study|Adverse Event|2|||
129903632|NCT00612586|467608395|FG000|Overall Study|Death|1|||
129903633|NCT00612586|467608396|FG001|Overall Study|Death|0|||
129903634|NCT00612586|467608395|FG000|Overall Study|Entry Criteria Not Met|0|||
129848778|NCT02550652|467406869|FG001|Overall Study|Post Trial Access|0|||
129848779|NCT02550652|467406868|FG000|Overall Study|Lost to Follow-up|1|||
129848780|NCT02550652|467406869|FG001|Overall Study|Lost to Follow-up|3|||
129848781|NCT02550652|467406868|FG000|Overall Study|Physician Decision|0|||
129848782|NCT02550652|467406869|FG001|Overall Study|Physician Decision|2|||
129848783|NCT02550652|467406868|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
129848784|NCT02550652|467406869|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
129848785|NCT01706250|467406870|FG000|Overall Study|Lost to Follow-up|2|||
129848786|NCT02486406|467406871|FG000|Overall Study|Withdrew consent|1|||
129848787|NCT02486406|467406872|FG001|Overall Study|Withdrew consent|0|||
129848788|NCT02486406|467406873|FG002|Overall Study|Withdrew consent|0|||
129848789|NCT02486406|467406874|FG003|Overall Study|Withdrew consent|1|||
129848790|NCT02486406|467406871|FG000|Overall Study|Lost to Follow-up|1|||
129848791|NCT02486406|467406872|FG001|Overall Study|Lost to Follow-up|3|||
129848792|NCT02486406|467406873|FG002|Overall Study|Lost to Follow-up|1|||
129848793|NCT02486406|467406874|FG003|Overall Study|Lost to Follow-up|3|||
129848794|NCT02486406|467406871|FG000|Overall Study|Other, not specified|0|||
129848795|NCT02486406|467406872|FG001|Overall Study|Other, not specified|0|||
129848796|NCT02486406|467406873|FG002|Overall Study|Other, not specified|1|||
129848797|NCT02486406|467406874|FG003|Overall Study|Other, not specified|0|||
129848798|NCT01826825|467406875|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
129848799|NCT01826825|467406876|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
129848800|NCT01858194|467406877|FG000|Overall Study|Total Artificial Heart Implant|0|||
129848801|NCT01858194|467406878|FG001|Overall Study|Total Artificial Heart Implant|1|||
129848802|NCT01858194|467406877|FG000|Overall Study|Lost to Follow-up|0|||
129848803|NCT01858194|467406878|FG001|Overall Study|Lost to Follow-up|1|||
129848804|NCT03181542|467406882|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
129848805|NCT03181542|467406883|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
129848806|NCT01071512|467406884|FG000|Overall Study|Adverse Event|1|||
129848807|NCT01071512|467406884|FG000|Overall Study|Development of antibodies to drug|2|||
129848808|NCT01071512|467406884|FG000|Overall Study|positive anti-JC virus antibody test|2|||
129848809|NCT02460224|467406895|FG000|Overall Study|Adverse Event|0|||
129848810|NCT02460224|467406896|FG001|Overall Study|Adverse Event|0|||
129848811|NCT02460224|467406897|FG002|Overall Study|Adverse Event|0|||
129903635|NCT00612586|467608396|FG001|Overall Study|Entry Criteria Not Met|2|||
129903636|NCT00612586|467608395|FG000|Overall Study|Withdrawal by Subject|7|||
129903637|NCT00612586|467608396|FG001|Overall Study|Withdrawal by Subject|9|||
129903638|NCT00612586|467608395|FG000|Overall Study|Physician Decision|1|||
129903639|NCT00612586|467608396|FG001|Overall Study|Physician Decision|2|||
129903640|NCT00612586|467608395|FG000|Overall Study|Sponsor Decision|1|||
129903641|NCT00612586|467608396|FG001|Overall Study|Sponsor Decision|1|||
129903642|NCT00612586|467608395|FG000|Overall Study|Progressive Disease|26|||
129903643|NCT00612586|467608396|FG001|Overall Study|Progressive Disease|24|||
129903644|NCT00612586|467608395|FG000|Overall Study|Randomized and Not Treated|1|||
129903645|NCT00612586|467608396|FG001|Overall Study|Randomized and Not Treated|1|||
129903646|NCT01069341|467608397|FG000|Overall Study|Lost to Follow-up|1|||
129848812|NCT02460224|467406898|FG003|Overall Study|Adverse Event|0|||
129848813|NCT02460224|467406899|FG004|Overall Study|Adverse Event|0|||
129848814|NCT02460224|467406900|FG005|Overall Study|Adverse Event|0|||
129848815|NCT02460224|467406901|FG006|Overall Study|Adverse Event|1|||
129848816|NCT02460224|467406902|FG007|Overall Study|Adverse Event|0|||
129848817|NCT02460224|467406903|FG008|Overall Study|Adverse Event|0|||
129848818|NCT02460224|467406904|FG009|Overall Study|Adverse Event|0|||
129848819|NCT02460224|467406905|FG010|Overall Study|Adverse Event|0|||
129848820|NCT02460224|467406906|FG011|Overall Study|Adverse Event|0|||
129848821|NCT02460224|467406907|FG012|Overall Study|Adverse Event|1|||
129848822|NCT02460224|467406908|FG013|Overall Study|Adverse Event|0|||
129848823|NCT02460224|467406909|FG014|Overall Study|Adverse Event|0|||
129848824|NCT02460224|467406910|FG015|Overall Study|Adverse Event|0|||
129848825|NCT02460224|467406911|FG016|Overall Study|Adverse Event|1|||
129848826|NCT02460224|467406912|FG017|Overall Study|Adverse Event|0|||
129848827|NCT02460224|467406913|FG018|Overall Study|Adverse Event|1|||
129848828|NCT02460224|467406914|FG019|Overall Study|Adverse Event|0|||
129848829|NCT02460224|467406915|FG020|Overall Study|Adverse Event|1|||
129848830|NCT02460224|467406916|FG021|Overall Study|Adverse Event|1|||
129848831|NCT02460224|467406917|FG022|Overall Study|Adverse Event|1|||
129848832|NCT02460224|467406918|FG023|Overall Study|Adverse Event|0|||
129848833|NCT02460224|467406919|FG024|Overall Study|Adverse Event|0|||
129848834|NCT02460224|467406920|FG025|Overall Study|Adverse Event|0|||
129848835|NCT02460224|467406921|FG026|Overall Study|Adverse Event|11|||
129848836|NCT02460224|467406922|FG027|Overall Study|Adverse Event|1|||
129848837|NCT02460224|467406923|FG028|Overall Study|Adverse Event|6|||
129848838|NCT02460224|467406895|FG000|Overall Study|Death|0|||
129848839|NCT02460224|467406896|FG001|Overall Study|Death|0|||
129848840|NCT02460224|467406897|FG002|Overall Study|Death|0|||
129848841|NCT02460224|467406898|FG003|Overall Study|Death|0|||
129848842|NCT02460224|467406899|FG004|Overall Study|Death|0|||
129848843|NCT02460224|467406900|FG005|Overall Study|Death|2|||
129848844|NCT02460224|467406901|FG006|Overall Study|Death|1|||
129848845|NCT02460224|467406902|FG007|Overall Study|Death|0|||
129848846|NCT02460224|467406903|FG008|Overall Study|Death|0|||
129848847|NCT02460224|467406904|FG009|Overall Study|Death|1|||
129848848|NCT02460224|467406905|FG010|Overall Study|Death|0|||
129848849|NCT02460224|467406906|FG011|Overall Study|Death|0|||
129848850|NCT02460224|467406907|FG012|Overall Study|Death|0|||
129848851|NCT02460224|467406908|FG013|Overall Study|Death|1|||
129848852|NCT02460224|467406909|FG014|Overall Study|Death|0|||
129848853|NCT02460224|467406910|FG015|Overall Study|Death|0|||
129848854|NCT02460224|467406911|FG016|Overall Study|Death|2|||
129848855|NCT02460224|467406912|FG017|Overall Study|Death|1|||
129848856|NCT02460224|467406913|FG018|Overall Study|Death|0|||
129848857|NCT02460224|467406914|FG019|Overall Study|Death|2|||
129848858|NCT02460224|467406915|FG020|Overall Study|Death|0|||
129848859|NCT02460224|467406916|FG021|Overall Study|Death|0|||
129848860|NCT02460224|467406917|FG022|Overall Study|Death|0|||
129848861|NCT02460224|467406918|FG023|Overall Study|Death|0|||
129848862|NCT02460224|467406919|FG024|Overall Study|Death|1|||
129848863|NCT02460224|467406920|FG025|Overall Study|Death|1|||
129848864|NCT02460224|467406921|FG026|Overall Study|Death|5|||
129848865|NCT02460224|467406922|FG027|Overall Study|Death|0|||
129848866|NCT02460224|467406923|FG028|Overall Study|Death|1|||
129848867|NCT02460224|467406895|FG000|Overall Study|Lost to Follow-up|0|||
129848868|NCT02460224|467406896|FG001|Overall Study|Lost to Follow-up|0|||
129848869|NCT02460224|467406897|FG002|Overall Study|Lost to Follow-up|0|||
129848870|NCT02460224|467406898|FG003|Overall Study|Lost to Follow-up|0|||
129848871|NCT02460224|467406899|FG004|Overall Study|Lost to Follow-up|0|||
129848872|NCT02460224|467406900|FG005|Overall Study|Lost to Follow-up|0|||
129848873|NCT02460224|467406901|FG006|Overall Study|Lost to Follow-up|0|||
129848874|NCT02460224|467406902|FG007|Overall Study|Lost to Follow-up|0|||
129848875|NCT02460224|467406903|FG008|Overall Study|Lost to Follow-up|0|||
129848876|NCT02460224|467406904|FG009|Overall Study|Lost to Follow-up|0|||
129848877|NCT02460224|467406905|FG010|Overall Study|Lost to Follow-up|0|||
129848878|NCT02460224|467406906|FG011|Overall Study|Lost to Follow-up|0|||
129848879|NCT02460224|467406907|FG012|Overall Study|Lost to Follow-up|0|||
129848880|NCT02460224|467406908|FG013|Overall Study|Lost to Follow-up|0|||
129848881|NCT02460224|467406909|FG014|Overall Study|Lost to Follow-up|0|||
129848882|NCT02460224|467406910|FG015|Overall Study|Lost to Follow-up|0|||
129848883|NCT02460224|467406911|FG016|Overall Study|Lost to Follow-up|0|||
129848884|NCT02460224|467406912|FG017|Overall Study|Lost to Follow-up|0|||
129848885|NCT02460224|467406913|FG018|Overall Study|Lost to Follow-up|0|||
129848886|NCT02460224|467406914|FG019|Overall Study|Lost to Follow-up|0|||
129848887|NCT02460224|467406915|FG020|Overall Study|Lost to Follow-up|0|||
129848888|NCT02460224|467406916|FG021|Overall Study|Lost to Follow-up|0|||
129848889|NCT02460224|467406917|FG022|Overall Study|Lost to Follow-up|1|||
129848890|NCT02460224|467406918|FG023|Overall Study|Lost to Follow-up|0|||
129848891|NCT02460224|467406919|FG024|Overall Study|Lost to Follow-up|0|||
129848892|NCT02460224|467406920|FG025|Overall Study|Lost to Follow-up|0|||
129848893|NCT02460224|467406921|FG026|Overall Study|Lost to Follow-up|0|||
129848894|NCT02460224|467406922|FG027|Overall Study|Lost to Follow-up|0|||
129848895|NCT02460224|467406923|FG028|Overall Study|Lost to Follow-up|0|||
129848896|NCT02460224|467406895|FG000|Overall Study|Physician Decision|0|||
129848897|NCT02460224|467406896|FG001|Overall Study|Physician Decision|1|||
129848898|NCT02460224|467406897|FG002|Overall Study|Physician Decision|0|||
129848899|NCT02460224|467406898|FG003|Overall Study|Physician Decision|0|||
129848900|NCT02460224|467406899|FG004|Overall Study|Physician Decision|1|||
129848901|NCT02460224|467406900|FG005|Overall Study|Physician Decision|0|||
129848902|NCT02460224|467406901|FG006|Overall Study|Physician Decision|0|||
129848903|NCT02460224|467406902|FG007|Overall Study|Physician Decision|1|||
129848904|NCT02460224|467406903|FG008|Overall Study|Physician Decision|0|||
129848905|NCT02460224|467406904|FG009|Overall Study|Physician Decision|0|||
129848906|NCT02460224|467406905|FG010|Overall Study|Physician Decision|0|||
129848907|NCT02460224|467406906|FG011|Overall Study|Physician Decision|1|||
129848908|NCT02460224|467406907|FG012|Overall Study|Physician Decision|0|||
129848909|NCT02460224|467406908|FG013|Overall Study|Physician Decision|1|||
129848910|NCT02460224|467406909|FG014|Overall Study|Physician Decision|0|||
129848911|NCT02460224|467406910|FG015|Overall Study|Physician Decision|0|||
129848912|NCT02460224|467406911|FG016|Overall Study|Physician Decision|2|||
129848913|NCT02460224|467406912|FG017|Overall Study|Physician Decision|1|||
129848914|NCT02460224|467406913|FG018|Overall Study|Physician Decision|1|||
129848915|NCT02460224|467406914|FG019|Overall Study|Physician Decision|2|||
129848916|NCT02460224|467406915|FG020|Overall Study|Physician Decision|1|||
129848917|NCT02460224|467406916|FG021|Overall Study|Physician Decision|1|||
129848918|NCT02460224|467406917|FG022|Overall Study|Physician Decision|0|||
129848919|NCT02460224|467406918|FG023|Overall Study|Physician Decision|0|||
129848920|NCT02460224|467406919|FG024|Overall Study|Physician Decision|1|||
129848921|NCT02460224|467406920|FG025|Overall Study|Physician Decision|0|||
129848922|NCT02460224|467406921|FG026|Overall Study|Physician Decision|14|||
129848923|NCT02460224|467406922|FG027|Overall Study|Physician Decision|1|||
129848924|NCT02460224|467406923|FG028|Overall Study|Physician Decision|6|||
129848925|NCT02460224|467406895|FG000|Overall Study|Progressive disease|15|||
129848926|NCT02460224|467406896|FG001|Overall Study|Progressive disease|11|||
129848927|NCT02460224|467406897|FG002|Overall Study|Progressive disease|5|||
129848928|NCT02460224|467406898|FG003|Overall Study|Progressive disease|6|||
129848929|NCT02460224|467406899|FG004|Overall Study|Progressive disease|3|||
129848930|NCT02460224|467406900|FG005|Overall Study|Progressive disease|26|||
129848931|NCT02460224|467406901|FG006|Overall Study|Progressive disease|28|||
129848932|NCT02460224|467406902|FG007|Overall Study|Progressive disease|4|||
129848933|NCT02460224|467406903|FG008|Overall Study|Progressive disease|5|||
129848934|NCT02460224|467406904|FG009|Overall Study|Progressive disease|9|||
129848935|NCT02460224|467406905|FG010|Overall Study|Progressive disease|5|||
129848936|NCT02460224|467406906|FG011|Overall Study|Progressive disease|4|||
129848937|NCT02460224|467406907|FG012|Overall Study|Progressive disease|5|||
129848938|NCT02460224|467406908|FG013|Overall Study|Progressive disease|4|||
129848939|NCT02460224|467406909|FG014|Overall Study|Progressive disease|5|||
129848940|NCT02460224|467406910|FG015|Overall Study|Progressive disease|5|||
129848941|NCT02460224|467406911|FG016|Overall Study|Progressive disease|15|||
129848942|NCT02460224|467406912|FG017|Overall Study|Progressive disease|3|||
129848943|NCT02460224|467406913|FG018|Overall Study|Progressive disease|8|||
129848944|NCT02460224|467406914|FG019|Overall Study|Progressive disease|3|||
129848945|NCT02460224|467406915|FG020|Overall Study|Progressive disease|4|||
129848946|NCT02460224|467406916|FG021|Overall Study|Progressive disease|9|||
129848947|NCT02460224|467406917|FG022|Overall Study|Progressive disease|4|||
129848948|NCT02460224|467406918|FG023|Overall Study|Progressive disease|11|||
129848949|NCT02460224|467406919|FG024|Overall Study|Progressive disease|4|||
129848950|NCT02460224|467406920|FG025|Overall Study|Progressive disease|5|||
129848951|NCT02460224|467406921|FG026|Overall Study|Progressive disease|85|||
129848952|NCT02460224|467406922|FG027|Overall Study|Progressive disease|17|||
129848953|NCT02460224|467406923|FG028|Overall Study|Progressive disease|77|||
129848954|NCT02460224|467406895|FG000|Overall Study|Subject/guardian decision|2|||
129848955|NCT02460224|467406896|FG001|Overall Study|Subject/guardian decision|0|||
129848956|NCT02460224|467406897|FG002|Overall Study|Subject/guardian decision|1|||
129848957|NCT02460224|467406898|FG003|Overall Study|Subject/guardian decision|0|||
129848958|NCT02460224|467406899|FG004|Overall Study|Subject/guardian decision|2|||
129848959|NCT02460224|467406900|FG005|Overall Study|Subject/guardian decision|2|||
129848960|NCT02460224|467406901|FG006|Overall Study|Subject/guardian decision|0|||
129848961|NCT02460224|467406902|FG007|Overall Study|Subject/guardian decision|0|||
129848962|NCT02460224|467406903|FG008|Overall Study|Subject/guardian decision|1|||
129848963|NCT02460224|467406904|FG009|Overall Study|Subject/guardian decision|1|||
129848964|NCT02460224|467406905|FG010|Overall Study|Subject/guardian decision|0|||
129848965|NCT02460224|467406906|FG011|Overall Study|Subject/guardian decision|1|||
129848966|NCT02460224|467406907|FG012|Overall Study|Subject/guardian decision|0|||
129848967|NCT02460224|467406908|FG013|Overall Study|Subject/guardian decision|0|||
129848968|NCT02460224|467406909|FG014|Overall Study|Subject/guardian decision|0|||
129848969|NCT02460224|467406910|FG015|Overall Study|Subject/guardian decision|1|||
129848970|NCT02460224|467406911|FG016|Overall Study|Subject/guardian decision|0|||
129848971|NCT02460224|467406912|FG017|Overall Study|Subject/guardian decision|1|||
129848972|NCT02460224|467406913|FG018|Overall Study|Subject/guardian decision|2|||
129848973|NCT02460224|467406914|FG019|Overall Study|Subject/guardian decision|0|||
129848974|NCT02460224|467406915|FG020|Overall Study|Subject/guardian decision|0|||
129848975|NCT02460224|467406916|FG021|Overall Study|Subject/guardian decision|1|||
129903647|NCT01802632|467608398|FG000|Overall Study|Death|28|||
129848976|NCT02460224|467406917|FG022|Overall Study|Subject/guardian decision|0|||
129848977|NCT02460224|467406918|FG023|Overall Study|Subject/guardian decision|0|||
129848978|NCT02460224|467406919|FG024|Overall Study|Subject/guardian decision|0|||
129848979|NCT02460224|467406920|FG025|Overall Study|Subject/guardian decision|0|||
129848980|NCT02460224|467406921|FG026|Overall Study|Subject/guardian decision|6|||
129848981|NCT02460224|467406922|FG027|Overall Study|Subject/guardian decision|2|||
129848982|NCT02460224|467406923|FG028|Overall Study|Subject/guardian decision|3|||
129848983|NCT00853658|467406924|FG000|Overall Study|Death|713|||
129848984|NCT00853658|467406925|FG001|Overall Study|Death|768|||
129848985|NCT00853658|467406926|FG002|Overall Study|Death|753|||
129848986|NCT00853658|467406924|FG000|Overall Study|Lost to Follow-up|11|||
129848987|NCT00853658|467406925|FG001|Overall Study|Lost to Follow-up|6|||
129848988|NCT00853658|467406926|FG002|Overall Study|Lost to Follow-up|11|||
129848989|NCT00853658|467406924|FG000|Overall Study|H.A. Request|26|||
129848990|NCT00853658|467406925|FG001|Overall Study|H.A. Request|23|||
129848991|NCT00853658|467406926|FG002|Overall Study|H.A. Request|19|||
129848992|NCT00853658|467406924|FG000|Overall Study|IRB request|0|||
129848993|NCT00853658|467406925|FG001|Overall Study|IRB request|0|||
129848994|NCT00853658|467406926|FG002|Overall Study|IRB request|2|||
129848995|NCT00853658|467406924|FG000|Overall Study|Vital Status known (alive) at study end|2|||
129848996|NCT00853658|467406925|FG001|Overall Study|Vital Status known (alive) at study end|3|||
129848997|NCT00853658|467406926|FG002|Overall Study|Vital Status known (alive) at study end|3|||
129848998|NCT00853658|467406924|FG000|Overall Study|Vital Status unknown at study end|1|||
129848999|NCT00853658|467406925|FG001|Overall Study|Vital Status unknown at study end|1|||
129849000|NCT00853658|467406926|FG002|Overall Study|Vital Status unknown at study end|0|||
129849001|NCT00853658|467406924|FG000|Overall Study|Vital Status at study end N/A|8|||
129849002|NCT00853658|467406925|FG001|Overall Study|Vital Status at study end N/A|10|||
129849003|NCT00853658|467406926|FG002|Overall Study|Vital Status at study end N/A|10|||
129849004|NCT00853658|467406924|FG000|Overall Study|Patient's request|21|||
129849005|NCT00853658|467406925|FG001|Overall Study|Patient's request|17|||
129849006|NCT00853658|467406926|FG002|Overall Study|Patient's request|11|||
129849007|NCT00853658|467406924|FG000|Overall Study|Missing study completion information|5|||
129849008|NCT00853658|467406925|FG001|Overall Study|Missing study completion information|4|||
129849009|NCT00853658|467406926|FG002|Overall Study|Missing study completion information|6|||
129849010|NCT03146650|467406928|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
129849011|NCT03146650|467406928|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
129849012|NCT03146650|467406928|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
129849013|NCT03146650|467406928|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
129849014|NCT03146650|467406928|FG000|2 Year Follow-up|Death|11|||
129849015|NCT03146650|467406928|FG000|2 Year Follow-up|Still in follow-up|7|||
129849016|NCT03146650|467406928|FG000|2 Year Follow-up|Lost to Follow-up|1|||
129849017|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
129849018|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
129849019|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
129849020|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
129849021|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
129849022|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
129849023|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
129849024|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
129849025|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
129849026|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
129849027|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
129849028|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
129849029|NCT00983814|467406931|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
129849030|NCT00983814|467406932|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
129849031|NCT00983814|467406933|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
129849032|NCT03333486|467406934|FG000|Overall Study|Withdrawal by Subject|1|||
129849033|NCT03333486|467406934|FG000|Overall Study|Lost to Follow-up|1|||
129849034|NCT01976845|467406937|FG000|Overall Study|Physician Decision|8|||
129849035|NCT01976845|467406938|FG001|Overall Study|Physician Decision|8|||
129903648|NCT01802632|467608399|FG001|Overall Study|Death|1|||
129849036|NCT01976845|467406939|FG002|Overall Study|Physician Decision|3|||
129849037|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
129849038|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
129903649|NCT01802632|467608400|FG002|Overall Study|Death|38|||
129903650|NCT01802632|467608401|FG003|Overall Study|Death|0|||
129849039|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
129849040|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
129849041|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
129849042|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
129903651|NCT01802632|467608402|FG004|Overall Study|Death|2|||
129903652|NCT01802632|467608403|FG005|Overall Study|Death|0|||
130116582|NCT01335477|468387108|FG001|Overall Study|Lost to Follow-up|2|||
129849043|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
129903653|NCT01802632|467608398|FG000|Overall Study|Withdrawal by Subject|4|||
129903654|NCT01802632|467608399|FG001|Overall Study|Withdrawal by Subject|2|||
129903655|NCT01802632|467608400|FG002|Overall Study|Withdrawal by Subject|7|||
129903656|NCT01802632|467608401|FG003|Overall Study|Withdrawal by Subject|3|||
129903657|NCT01802632|467608402|FG004|Overall Study|Withdrawal by Subject|0|||
129903658|NCT01802632|467608403|FG005|Overall Study|Withdrawal by Subject|1|||
129903659|NCT01802632|467608398|FG000|Overall Study|Objective Disease Progression|1|||
129903660|NCT01802632|467608399|FG001|Overall Study|Objective Disease Progression|12|||
129903661|NCT01802632|467608400|FG002|Overall Study|Objective Disease Progression|104|||
129903662|NCT01802632|467608401|FG003|Overall Study|Objective Disease Progression|6|||
129903663|NCT01802632|467608402|FG004|Overall Study|Objective Disease Progression|4|||
129903664|NCT01802632|467608403|FG005|Overall Study|Objective Disease Progression|4|||
129903665|NCT01802632|467608398|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
129903666|NCT01802632|467608399|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
129903667|NCT01802632|467608400|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
129903668|NCT01802632|467608401|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
129903669|NCT01802632|467608402|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
129903670|NCT01802632|467608403|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
129903671|NCT01802632|467608398|FG000|Overall Study|Other (not specified)|0|||
129903672|NCT01802632|467608399|FG001|Overall Study|Other (not specified)|0|||
129903673|NCT01802632|467608400|FG002|Overall Study|Other (not specified)|7|||
129903674|NCT01802632|467608401|FG003|Overall Study|Other (not specified)|1|||
129903675|NCT01802632|467608402|FG004|Overall Study|Other (not specified)|0|||
129903676|NCT01802632|467608403|FG005|Overall Study|Other (not specified)|1|||
129903677|NCT02880241|467608404|FG000|Overall Study|Lack of Efficacy|1|||
129903678|NCT02880241|467608405|FG001|Overall Study|Lack of Efficacy|0|||
129903679|NCT02880241|467608406|FG002|Overall Study|Lack of Efficacy|0|||
129903680|NCT02880241|467608407|FG003|Overall Study|Lack of Efficacy|0|||
129903681|NCT02880241|467608408|FG004|Overall Study|Lack of Efficacy|0|||
129903682|NCT02880241|467608409|FG005|Overall Study|Lack of Efficacy|0|||
129903683|NCT02705586|467608410|FG000|Overall Study|Health Issues|2|||
129903684|NCT02705586|467608410|FG000|Overall Study|Transportation Difficulties|5|||
129903685|NCT02705586|467608410|FG000|Overall Study|Vacation/Planned Absence|1|||
129903686|NCT02045836|467608414|FG000|Overall Study|Adverse Event|4|||
129849044|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
129849045|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
129849046|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
129849047|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
129849048|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
129849049|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
129849050|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
129849051|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
129849052|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
129849053|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
129849054|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
129849055|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
129849056|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
129849057|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
129849058|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
129849059|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
129849060|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
129849061|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
129849062|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
129849063|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
129849064|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
129849065|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849066|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849067|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849068|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849069|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849070|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
129903687|NCT02045836|467608415|FG001|Overall Study|Adverse Event|4|||
129903688|NCT02045836|467608414|FG000|Overall Study|Withdrawal by Subject|1|||
129903689|NCT02045836|467608415|FG001|Overall Study|Withdrawal by Subject|1|||
129903690|NCT02045836|467608414|FG000|Overall Study|Lost to Follow-up|4|||
129903691|NCT02045836|467608415|FG001|Overall Study|Lost to Follow-up|7|||
129903692|NCT02045836|467608414|FG000|Overall Study|Migrated from study area|0|||
129849071|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130064562|NCT03691610|468190198|FG003|Overall Study|Protocol Deviation|2|||
129903693|NCT02045836|467608415|FG001|Overall Study|Migrated from study area|2|||
129903694|NCT03920215|467608418|FG000|Overall Study|Lost to Follow-up|1|||
129903695|NCT03920215|467608419|FG001|Overall Study|Lost to Follow-up|2|||
129903696|NCT03920215|467608420|FG002|Overall Study|Lost to Follow-up|0|||
129903697|NCT03920215|467608421|FG003|Overall Study|Lost to Follow-up|0|||
129903698|NCT03920215|467608418|FG000|Overall Study|Death|0|||
129903699|NCT03920215|467608419|FG001|Overall Study|Death|0|||
129903700|NCT03920215|467608420|FG002|Overall Study|Death|0|||
129903701|NCT03920215|467608421|FG003|Overall Study|Death|1|||
129903702|NCT02000817|467608422|FG000|Overall Study|Withdrawal by Subject|2|||
129903703|NCT02000817|467608423|FG001|Overall Study|Withdrawal by Subject|0|||
129903704|NCT02000817|467608424|FG002|Overall Study|Withdrawal by Subject|0|||
129903705|NCT02000817|467608425|FG003|Overall Study|Withdrawal by Subject|0|||
129903706|NCT02000817|467608422|FG000|Overall Study|Adverse Event|0|||
129903707|NCT02000817|467608423|FG001|Overall Study|Adverse Event|1|||
129903708|NCT02000817|467608424|FG002|Overall Study|Adverse Event|0|||
129903709|NCT02000817|467608425|FG003|Overall Study|Adverse Event|0|||
129903710|NCT02000817|467608422|FG000|Overall Study|Lost to Follow-up|0|||
129903711|NCT02000817|467608423|FG001|Overall Study|Lost to Follow-up|0|||
129903712|NCT02000817|467608424|FG002|Overall Study|Lost to Follow-up|1|||
129903713|NCT02000817|467608425|FG003|Overall Study|Lost to Follow-up|0|||
129903714|NCT00177216|467608426|FG000|Overall Study|Withdrawal by Subject|6|||
129903715|NCT00177216|467608427|FG001|Overall Study|Withdrawal by Subject|3|||
129903716|NCT00177216|467608428|FG002|Overall Study|Withdrawal by Subject|1|||
129903717|NCT02459899|467608429|FG000|Overall Study|Adverse Event|1|||
129903718|NCT02459899|467608430|FG001|Overall Study|Adverse Event|1|||
129903719|NCT02459899|467608431|FG002|Overall Study|Adverse Event|0|||
129903720|NCT02459899|467608432|FG003|Overall Study|Adverse Event|0|||
129903721|NCT02459899|467608429|FG000|Overall Study|Lost to Follow-up|1|||
129903722|NCT02459899|467608430|FG001|Overall Study|Lost to Follow-up|2|||
129903723|NCT02459899|467608431|FG002|Overall Study|Lost to Follow-up|0|||
129903724|NCT02459899|467608432|FG003|Overall Study|Lost to Follow-up|1|||
129903725|NCT02459899|467608429|FG000|Overall Study|Non-compliance with the treatment|0|||
129903726|NCT02459899|467608430|FG001|Overall Study|Non-compliance with the treatment|0|||
129903727|NCT02459899|467608431|FG002|Overall Study|Non-compliance with the treatment|0|||
129903728|NCT02459899|467608432|FG003|Overall Study|Non-compliance with the treatment|1|||
129903729|NCT02459899|467608429|FG000|Overall Study|Withdrawal by Subject|1|||
129903730|NCT02459899|467608430|FG001|Overall Study|Withdrawal by Subject|3|||
129903731|NCT02459899|467608431|FG002|Overall Study|Withdrawal by Subject|0|||
129903732|NCT02459899|467608432|FG003|Overall Study|Withdrawal by Subject|0|||
129903733|NCT02739035|467608435|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
129903734|NCT02739035|467608436|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
129903735|NCT02739035|467608435|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
129903736|NCT02739035|467608436|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
129903737|NCT02739035|467608435|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
129903738|NCT02739035|467608436|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
129903739|NCT02739035|467608435|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
129903740|NCT02739035|467608436|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
129903741|NCT02770248|467608437|FG000|Overall Study|Adverse Event|0|||
129903742|NCT02770248|467608438|FG001|Overall Study|Adverse Event|1|||
129903743|NCT02770248|467608437|FG000|Overall Study|Randomized in error, prior to treatment|0|||
129903744|NCT02770248|467608438|FG001|Overall Study|Randomized in error, prior to treatment|1|||
129903745|NCT03768206|467608441|FG000|Overall Study|Lost to Follow-up|2|||
129903746|NCT03768206|467608442|FG001|Overall Study|Lost to Follow-up|1|||
129903747|NCT03768206|467608441|FG000|Overall Study|Withdrawal by Subject|0|||
129903748|NCT03768206|467608442|FG001|Overall Study|Withdrawal by Subject|1|||
129903749|NCT02551055|467608445|FG000|Overall Study|Death|2|||
129903750|NCT02551055|467608446|FG001|Overall Study|Death|4|||
129903751|NCT02551055|467608447|FG002|Overall Study|Death|2|||
129903752|NCT02551055|467608448|FG003|Overall Study|Death|2|||
129903753|NCT02551055|467608449|FG004|Overall Study|Death|2|||
129903754|NCT02551055|467608450|FG005|Overall Study|Death|1|||
129903755|NCT02551055|467608451|FG006|Overall Study|Death|2|||
129903756|NCT02551055|467608452|FG007|Overall Study|Death|0|||
129903757|NCT02551055|467608445|FG000|Overall Study|Study Terminated by Sponsor|1|||
129903758|NCT02551055|467608446|FG001|Overall Study|Study Terminated by Sponsor|1|||
129903759|NCT02551055|467608447|FG002|Overall Study|Study Terminated by Sponsor|0|||
129903760|NCT02551055|467608448|FG003|Overall Study|Study Terminated by Sponsor|2|||
129903761|NCT02551055|467608449|FG004|Overall Study|Study Terminated by Sponsor|2|||
129903762|NCT02551055|467608450|FG005|Overall Study|Study Terminated by Sponsor|0|||
129903763|NCT02551055|467608451|FG006|Overall Study|Study Terminated by Sponsor|0|||
129903764|NCT02551055|467608452|FG007|Overall Study|Study Terminated by Sponsor|0|||
129903765|NCT02551055|467608445|FG000|Overall Study|Withdrawal by Subject|1|||
129903766|NCT02551055|467608446|FG001|Overall Study|Withdrawal by Subject|1|||
129903767|NCT02551055|467608447|FG002|Overall Study|Withdrawal by Subject|0|||
129903768|NCT02551055|467608448|FG003|Overall Study|Withdrawal by Subject|1|||
129903769|NCT02551055|467608449|FG004|Overall Study|Withdrawal by Subject|2|||
129903770|NCT02551055|467608450|FG005|Overall Study|Withdrawal by Subject|0|||
129849072|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849073|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849074|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849075|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849076|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
129849077|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849078|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849079|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849080|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849081|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849082|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
129849083|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849084|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849085|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849086|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849087|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849088|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
129849089|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849090|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849091|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849092|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849093|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849094|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
129849095|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849096|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849097|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849098|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849099|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849100|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Other|6|||
129849101|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Other|0|||
129849102|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Other|0|||
129849103|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Other|0|||
129849104|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Other|0|||
129849105|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Other|0|||
129849106|NCT02139644|467408729|FG000|Treatment Period|Adverse Event|0|||
129849107|NCT02139644|467408730|FG001|Treatment Period|Adverse Event|0|||
129849108|NCT02139644|467408731|FG002|Treatment Period|Adverse Event|3|||
129849109|NCT02139644|467408732|FG003|Treatment Period|Adverse Event|2|||
129849110|NCT02139644|467408733|FG004|Treatment Period|Adverse Event|1|||
129849111|NCT02139644|467408734|FG005|Treatment Period|Adverse Event|6|||
129849112|NCT02139644|467408729|FG000|Treatment Period|Withdrawal by Subject|0|||
129849113|NCT02139644|467408730|FG001|Treatment Period|Withdrawal by Subject|0|||
129849114|NCT02139644|467408731|FG002|Treatment Period|Withdrawal by Subject|2|||
129849115|NCT02139644|467408732|FG003|Treatment Period|Withdrawal by Subject|2|||
129849116|NCT02139644|467408733|FG004|Treatment Period|Withdrawal by Subject|3|||
129849117|NCT02139644|467408734|FG005|Treatment Period|Withdrawal by Subject|2|||
129849118|NCT02139644|467408729|FG000|Treatment Period|Non-compliance|0|||
129849119|NCT02139644|467408730|FG001|Treatment Period|Non-compliance|0|||
129849120|NCT02139644|467408731|FG002|Treatment Period|Non-compliance|0|||
129849121|NCT02139644|467408732|FG003|Treatment Period|Non-compliance|1|||
129849122|NCT02139644|467408733|FG004|Treatment Period|Non-compliance|0|||
129849123|NCT02139644|467408734|FG005|Treatment Period|Non-compliance|0|||
129849124|NCT02139644|467408729|FG000|Treatment Period|Protocol Violation|0|||
129849125|NCT02139644|467408730|FG001|Treatment Period|Protocol Violation|0|||
129849126|NCT02139644|467408731|FG002|Treatment Period|Protocol Violation|0|||
129849127|NCT02139644|467408732|FG003|Treatment Period|Protocol Violation|1|||
129849128|NCT02139644|467408733|FG004|Treatment Period|Protocol Violation|1|||
129849129|NCT02139644|467408734|FG005|Treatment Period|Protocol Violation|1|||
129849130|NCT02139644|467408729|FG000|Treatment Period|Disease progression|0|||
129849131|NCT02139644|467408730|FG001|Treatment Period|Disease progression|0|||
129849132|NCT02139644|467408731|FG002|Treatment Period|Disease progression|0|||
129849133|NCT02139644|467408732|FG003|Treatment Period|Disease progression|1|||
129849134|NCT02139644|467408733|FG004|Treatment Period|Disease progression|1|||
129849135|NCT02139644|467408734|FG005|Treatment Period|Disease progression|2|||
129849136|NCT02139644|467408729|FG000|Treatment Period|Lost to Follow-up|0|||
129849137|NCT02139644|467408730|FG001|Treatment Period|Lost to Follow-up|0|||
129849138|NCT02139644|467408731|FG002|Treatment Period|Lost to Follow-up|1|||
129849139|NCT02139644|467408732|FG003|Treatment Period|Lost to Follow-up|1|||
129849140|NCT02139644|467408733|FG004|Treatment Period|Lost to Follow-up|1|||
129849141|NCT02139644|467408734|FG005|Treatment Period|Lost to Follow-up|1|||
129849142|NCT02139644|467408729|FG000|Treatment Period|Lack of Efficacy|0|||
129849143|NCT02139644|467408730|FG001|Treatment Period|Lack of Efficacy|0|||
129849144|NCT02139644|467408731|FG002|Treatment Period|Lack of Efficacy|1|||
129849145|NCT02139644|467408732|FG003|Treatment Period|Lack of Efficacy|0|||
129849146|NCT02139644|467408733|FG004|Treatment Period|Lack of Efficacy|1|||
129849147|NCT02139644|467408734|FG005|Treatment Period|Lack of Efficacy|4|||
129849148|NCT02139644|467408729|FG000|Treatment Period|Other|0|||
129849149|NCT02139644|467408730|FG001|Treatment Period|Other|3|||
129849150|NCT02139644|467408731|FG002|Treatment Period|Other|1|||
129849151|NCT02139644|467408732|FG003|Treatment Period|Other|1|||
129849152|NCT02139644|467408733|FG004|Treatment Period|Other|0|||
129849153|NCT02139644|467408734|FG005|Treatment Period|Other|1|||
129849154|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Adverse Event|4|||
129849155|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Adverse Event|1|||
129849156|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Adverse Event|1|||
129849157|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
129849158|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
129849159|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
129849160|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Pregnancy|3|||
129849161|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Pregnancy|0|||
129849162|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Pregnancy|0|||
129849163|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
129849164|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
129849165|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
129849166|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
129849167|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
129849168|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
129849169|NCT03328897|467408739|FG000|Follow-up Epoch|Adverse Event|4|||
129849170|NCT03328897|467408740|FG001|Follow-up Epoch|Adverse Event|0|||
129849171|NCT03328897|467408741|FG002|Follow-up Epoch|Adverse Event|1|||
129849172|NCT03328897|467408739|FG000|Follow-up Epoch|Lack of Efficacy|1|||
129849173|NCT03328897|467408740|FG001|Follow-up Epoch|Lack of Efficacy|1|||
129849174|NCT03328897|467408741|FG002|Follow-up Epoch|Lack of Efficacy|1|||
129849175|NCT03328897|467408739|FG000|Follow-up Epoch|Lost to Follow-up|0|||
129849176|NCT03328897|467408740|FG001|Follow-up Epoch|Lost to Follow-up|1|||
129849177|NCT03328897|467408741|FG002|Follow-up Epoch|Lost to Follow-up|0|||
129849178|NCT03328897|467408739|FG000|Follow-up Epoch|Pregnancy|1|||
129849179|NCT03328897|467408740|FG001|Follow-up Epoch|Pregnancy|0|||
129849180|NCT03328897|467408741|FG002|Follow-up Epoch|Pregnancy|0|||
129849181|NCT03328897|467408739|FG000|Follow-up Epoch|Patient/guardian decision|2|||
129849182|NCT03328897|467408740|FG001|Follow-up Epoch|Patient/guardian decision|1|||
129849183|NCT03328897|467408741|FG002|Follow-up Epoch|Patient/guardian decision|0|||
129849184|NCT02602288|467408742|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
129849185|NCT02602288|467408743|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
129849186|NCT02602288|467408742|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
129849187|NCT02602288|467408743|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
129849188|NCT02602288|467408742|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
129849189|NCT02602288|467408743|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
129849190|NCT02602288|467408742|FG000|12 Month Follow-up|Lost to Follow-up|0|||
129849191|NCT02602288|467408743|FG001|12 Month Follow-up|Lost to Follow-up|4|||
129849192|NCT02602288|467408742|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
129849193|NCT02602288|467408743|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
129849194|NCT01310413|467408744|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
129849195|NCT01310413|467408745|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
129849196|NCT01310413|467408746|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
129849197|NCT01310413|467408747|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
129849198|NCT01310413|467408748|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
129849199|NCT01310413|467408749|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
129849200|NCT01310413|467408750|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
129849201|NCT01310413|467408744|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
129849202|NCT01310413|467408745|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
129849203|NCT01310413|467408746|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
129849204|NCT01310413|467408747|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
129849205|NCT01310413|467408748|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
129849206|NCT01310413|467408749|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
129849207|NCT01310413|467408750|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
129849208|NCT01310413|467408744|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
129849209|NCT01310413|467408745|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
129849210|NCT01310413|467408746|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
129849211|NCT01310413|467408747|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
129849212|NCT01310413|467408748|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
129849213|NCT01310413|467408749|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
129849214|NCT01310413|467408750|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
129849215|NCT01310413|467408744|FG000|Day 0 to Day 385|Other|1|||
129849216|NCT01310413|467408745|FG001|Day 0 to Day 385|Other|0|||
129849217|NCT01310413|467408746|FG002|Day 0 to Day 385|Other|3|||
129849218|NCT01310413|467408747|FG003|Day 0 to Day 385|Other|0|||
129849219|NCT01310413|467408748|FG004|Day 0 to Day 385|Other|0|||
129903771|NCT02551055|467608451|FG006|Overall Study|Withdrawal by Subject|0|||
129903772|NCT02551055|467608452|FG007|Overall Study|Withdrawal by Subject|0|||
129903773|NCT02551055|467608445|FG000|Overall Study|Reason not specified|0|||
129903774|NCT02551055|467608446|FG001|Overall Study|Reason not specified|0|||
129903775|NCT02551055|467608447|FG002|Overall Study|Reason not specified|0|||
129903776|NCT02551055|467608448|FG003|Overall Study|Reason not specified|0|||
129903777|NCT02551055|467608449|FG004|Overall Study|Reason not specified|1|||
129903778|NCT02551055|467608450|FG005|Overall Study|Reason not specified|0|||
129903779|NCT02551055|467608451|FG006|Overall Study|Reason not specified|1|||
129903780|NCT02551055|467608452|FG007|Overall Study|Reason not specified|0|||
129903781|NCT00430300|467608453|FG000|Overall Study|Adverse Event|0|||
129903782|NCT00430300|467608454|FG001|Overall Study|Adverse Event|2|||
129903783|NCT00430300|467608455|FG002|Overall Study|Adverse Event|1|||
129903784|NCT00430300|467608456|FG003|Overall Study|Adverse Event|1|||
129903785|NCT00430300|467608453|FG000|Overall Study|Withdrawal by Subject|1|||
129903786|NCT00430300|467608454|FG001|Overall Study|Withdrawal by Subject|0|||
129903787|NCT00430300|467608455|FG002|Overall Study|Withdrawal by Subject|5|||
129903788|NCT00430300|467608456|FG003|Overall Study|Withdrawal by Subject|0|||
129903789|NCT00430300|467608453|FG000|Overall Study|Laboratory abnormality|1|||
129903790|NCT00430300|467608454|FG001|Overall Study|Laboratory abnormality|0|||
129903791|NCT00430300|467608455|FG002|Overall Study|Laboratory abnormality|0|||
129903792|NCT00430300|467608456|FG003|Overall Study|Laboratory abnormality|0|||
129903793|NCT00430300|467608453|FG000|Overall Study|Other|0|||
129903794|NCT00430300|467608454|FG001|Overall Study|Other|0|||
129903795|NCT00430300|467608455|FG002|Overall Study|Other|0|||
129903796|NCT00430300|467608456|FG003|Overall Study|Other|1|||
129903797|NCT02754479|467608460|FG000|Overall Study|Lost to Follow-up|1|||
129903798|NCT01063517|467608465|FG000|Overall Study|Consent withdrawal|1|||
129903799|NCT01063517|467608466|FG001|Overall Study|Consent withdrawal|0|||
129903800|NCT01063517|467608465|FG000|Overall Study|Study reached data cut-off|19|||
129903801|NCT01063517|467608466|FG001|Overall Study|Study reached data cut-off|7|||
129903802|NCT01063517|467608465|FG000|Overall Study|Lost to Follow-up|4|||
129903803|NCT01063517|467608466|FG001|Overall Study|Lost to Follow-up|3|||
129903804|NCT01063517|467608465|FG000|Overall Study|Withdrawal by Subject|1|||
129903805|NCT01063517|467608466|FG001|Overall Study|Withdrawal by Subject|2|||
129903806|NCT01063517|467608465|FG000|Overall Study|Death|33|||
129903807|NCT01063517|467608466|FG001|Overall Study|Death|48|||
129903808|NCT02041104|467608467|FG000|Overall Study|Lost to Follow-up|1|||
129903809|NCT02041104|467608468|FG001|Overall Study|Lost to Follow-up|4|||
129903810|NCT02041104|467608467|FG000|Overall Study|discomfort during OGTT|0|||
129903811|NCT02041104|467608468|FG001|Overall Study|discomfort during OGTT|3|||
129903812|NCT00617201|467608471|FG000|Overall Study|Lost to Follow-up|9|||
129903813|NCT00617201|467608472|FG001|Overall Study|Lost to Follow-up|13|||
129903814|NCT00546871|467608473|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
129903815|NCT00546871|467608474|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
129903816|NCT00546871|467608473|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
129903817|NCT00546871|467608474|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
129903818|NCT00546871|467608473|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
129903819|NCT00546871|467608474|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
129903820|NCT00546871|467608473|FG000|Study Extension Period|Protocol Violation|1|||
129903821|NCT00546871|467608474|FG001|Study Extension Period|Protocol Violation|0|||
129903822|NCT00546871|467608473|FG000|Study Extension Period|Withdrawal by Subject|0|||
129903823|NCT00546871|467608474|FG001|Study Extension Period|Withdrawal by Subject|1|||
129903824|NCT01713946|467608475|FG000|Overall Study|Death|0|||
129903825|NCT01713946|467608476|FG001|Overall Study|Death|2|||
129903826|NCT01713946|467608477|FG002|Overall Study|Death|2|||
129903827|NCT01713946|467608475|FG000|Overall Study|Adverse Event|19|||
129903828|NCT01713946|467608476|FG001|Overall Study|Adverse Event|14|||
129903829|NCT01713946|467608477|FG002|Overall Study|Adverse Event|13|||
129903830|NCT01713946|467608475|FG000|Overall Study|Withdrawal by Subject|12|||
129903831|NCT01713946|467608476|FG001|Overall Study|Withdrawal by Subject|12|||
129903832|NCT01713946|467608477|FG002|Overall Study|Withdrawal by Subject|8|||
129903833|NCT01713946|467608475|FG000|Overall Study|Lack of Efficacy|8|||
129903834|NCT01713946|467608476|FG001|Overall Study|Lack of Efficacy|8|||
129903835|NCT01713946|467608477|FG002|Overall Study|Lack of Efficacy|14|||
129903836|NCT01713946|467608475|FG000|Overall Study|Protocol Violation|2|||
129903837|NCT01713946|467608476|FG001|Overall Study|Protocol Violation|4|||
129903838|NCT01713946|467608477|FG002|Overall Study|Protocol Violation|1|||
129903839|NCT01713946|467608475|FG000|Overall Study|Lost to Follow-up|0|||
129903840|NCT01713946|467608476|FG001|Overall Study|Lost to Follow-up|0|||
129903841|NCT01713946|467608477|FG002|Overall Study|Lost to Follow-up|1|||
129903842|NCT01713946|467608475|FG000|Overall Study|Administrative problems|1|||
129903843|NCT01713946|467608476|FG001|Overall Study|Administrative problems|0|||
129903844|NCT01713946|467608477|FG002|Overall Study|Administrative problems|0|||
129903845|NCT01713946|467608475|FG000|Overall Study|Did not continue in Ext|0|||
129903846|NCT01713946|467608476|FG001|Overall Study|Did not continue in Ext|3|||
130064563|NCT03691610|468190195|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
129903847|NCT01713946|467608477|FG002|Overall Study|Did not continue in Ext|0|||
129903848|NCT01713946|467608475|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
129903849|NCT01713946|467608476|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
129903850|NCT01713946|467608477|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
129903851|NCT01713946|467608475|FG000|Overall Study|Patients never switched to everolimus|0|||
129903852|NCT01713946|467608476|FG001|Overall Study|Patients never switched to everolimus|0|||
129903853|NCT01713946|467608477|FG002|Overall Study|Patients never switched to everolimus|5|||
129903854|NCT03183518|467608478|FG000|Overall Study|Other (Not specified)|2|||
129903855|NCT03183518|467608478|FG000|Overall Study|Other (Withdrawal of consent)|1|||
129903856|NCT04493242|467608481|FG000|Overall Study|Death|10|||
129903857|NCT04493242|467608482|FG001|Overall Study|Death|14|||
129903858|NCT04493242|467608483|FG002|Overall Study|Death|16|||
129903859|NCT04493242|467608481|FG000|Overall Study|Lost to Follow-up|1|||
129903860|NCT04493242|467608482|FG001|Overall Study|Lost to Follow-up|1|||
129903861|NCT04493242|467608483|FG002|Overall Study|Lost to Follow-up|0|||
129903862|NCT04493242|467608481|FG000|Overall Study|Withdrawal by Subject|1|||
129903863|NCT04493242|467608482|FG001|Overall Study|Withdrawal by Subject|0|||
129903864|NCT04493242|467608483|FG002|Overall Study|Withdrawal by Subject|0|||
129903865|NCT04493242|467608481|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
129903866|NCT04493242|467608482|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
129903867|NCT04493242|467608483|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
129903868|NCT04493242|467608481|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
129903869|NCT04493242|467608482|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
129903870|NCT04493242|467608483|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
129903871|NCT04513522|467610902|FG000|Overall Study|Other reasons|1|||
129903872|NCT04513522|467610902|FG000|Overall Study|Adverse event unrelated to study drug|9|||
129903873|NCT04513522|467610902|FG000|Overall Study|Study drug toxicity|14|||
129903874|NCT04513522|467610902|FG000|Overall Study|Disease progression|39|||
129903875|NCT04513522|467610902|FG000|Overall Study|Participants withdrew consent|2|||
129903876|NCT00589667|467610903|FG000|Overall Study|Adverse Event|2|||
129903877|NCT00589667|467610903|FG000|Overall Study|Withdrawal by Subject|1|||
129903878|NCT03538041|467610906|FG000|12-Week Treatment Period|Adverse Event|1|||
129903879|NCT03538041|467610907|FG001|12-Week Treatment Period|Adverse Event|1|||
129903880|NCT03538041|467610906|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
129903881|NCT03538041|467610907|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
129903882|NCT03538041|467610906|FG000|Treatment Extension Period|Adverse Event|4|||
129903883|NCT03538041|467610907|FG001|Treatment Extension Period|Adverse Event|1|||
129903884|NCT03538041|467610906|FG000|Treatment Extension Period|Physician Decision|1|||
129903885|NCT03538041|467610907|FG001|Treatment Extension Period|Physician Decision|1|||
129903886|NCT03538041|467610906|FG000|Treatment Extension Period|Lack of Efficacy|1|||
129903887|NCT03538041|467610907|FG001|Treatment Extension Period|Lack of Efficacy|4|||
129903888|NCT03538041|467610906|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
129903889|NCT03538041|467610907|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
129903890|NCT03538041|467610906|FG000|Treatment Extension Period|Death|0|||
129903891|NCT03538041|467610907|FG001|Treatment Extension Period|Death|1|||
129903892|NCT01266265|467610908|FG000|Overall Study|Death|95|||
129903893|NCT01266265|467610909|FG001|Overall Study|Death|73|||
129903894|NCT01266265|467610908|FG000|Overall Study|Lost to Follow-up|23|||
129903895|NCT01266265|467610909|FG001|Overall Study|Lost to Follow-up|28|||
129903896|NCT01266265|467610908|FG000|Overall Study|Withdrawal by Subject|13|||
129903897|NCT01266265|467610909|FG001|Overall Study|Withdrawal by Subject|11|||
129903898|NCT01266265|467610908|FG000|Overall Study|Respiratory-related adverse event|2|||
129903899|NCT01266265|467610909|FG001|Overall Study|Respiratory-related adverse event|1|||
129903900|NCT01266265|467610908|FG000|Overall Study|Transferred care to another provider|22|||
129903901|NCT01266265|467610909|FG001|Overall Study|Transferred care to another provider|28|||
129903902|NCT01266265|467610908|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
129903903|NCT01266265|467610909|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
129903904|NCT01266265|467610908|FG000|Overall Study|Enrolled in another clinical study|15|||
129849220|NCT01310413|467408749|FG005|Day 0 to Day 385|Other|0|||
129849221|NCT01310413|467408750|FG006|Day 0 to Day 385|Other|0|||
129849222|NCT01310413|467408744|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849223|NCT01310413|467408745|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849224|NCT01310413|467408746|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849225|NCT01310413|467408747|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849226|NCT01310413|467408748|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849227|NCT01310413|467408749|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849228|NCT01310413|467408750|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
129849229|NCT01310413|467408744|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
129903905|NCT01266265|467610909|FG001|Overall Study|Enrolled in another clinical study|26|||
129903906|NCT01266265|467610908|FG000|Overall Study|Non-compliance|8|||
129849230|NCT01310413|467408745|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
129849231|NCT01310413|467408746|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
129849232|NCT01310413|467408747|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
129849233|NCT01310413|467408748|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
129849234|NCT01310413|467408749|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
129849235|NCT01310413|467408750|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
129849236|NCT00941733|467408751|FG000|Overall Study|Death|24|||
129849237|NCT00941733|467408752|FG001|Overall Study|Death|10|||
129849238|NCT00941733|467408751|FG000|Overall Study|Withdrawal by Subject|14|||
129849239|NCT00941733|467408752|FG001|Overall Study|Withdrawal by Subject|6|||
129849240|NCT00941733|467408751|FG000|Overall Study|Adverse Event|20|||
129849241|NCT00941733|467408752|FG001|Overall Study|Adverse Event|4|||
129849242|NCT00941733|467408751|FG000|Overall Study|Lost to Follow-up|1|||
129849243|NCT00941733|467408752|FG001|Overall Study|Lost to Follow-up|2|||
129849244|NCT00941733|467408751|FG000|Overall Study|Protocol Violation|15|||
129849245|NCT00941733|467408752|FG001|Overall Study|Protocol Violation|6|||
129849246|NCT00612066|467408755|FG000|Overall Study|Adverse Event|1|||
129849247|NCT00630877|467408756|FG000|Overall Study|Adverse Event|11|||
129849248|NCT00630877|467408757|FG001|Overall Study|Adverse Event|8|||
129849249|NCT00630877|467408758|FG002|Overall Study|Adverse Event|7|||
129849250|NCT00630877|467408756|FG000|Overall Study|Withdrawal by Subject|3|||
129849251|NCT00630877|467408757|FG001|Overall Study|Withdrawal by Subject|4|||
129849252|NCT00630877|467408758|FG002|Overall Study|Withdrawal by Subject|0|||
129849253|NCT00630877|467408756|FG000|Overall Study|Lost to Follow-up|2|||
129849254|NCT00630877|467408757|FG001|Overall Study|Lost to Follow-up|0|||
129849255|NCT00630877|467408758|FG002|Overall Study|Lost to Follow-up|0|||
129903907|NCT01266265|467610909|FG001|Overall Study|Non-compliance|5|||
129903908|NCT01266265|467610908|FG000|Overall Study|Lung transplant|6|||
129903909|NCT01266265|467610909|FG001|Overall Study|Lung transplant|5|||
129903910|NCT01266265|467610908|FG000|Overall Study|Site closed early|4|||
129903911|NCT01266265|467610909|FG001|Overall Study|Site closed early|3|||
129903912|NCT01266265|467610908|FG000|Overall Study|Clinical worsening|1|||
129903913|NCT01266265|467610909|FG001|Overall Study|Clinical worsening|1|||
129903914|NCT01580293|467610912|FG000|Part A_Main Trial|Adverse Event|0|||
129903915|NCT01580293|467610913|FG001|Part A_Main Trial|Adverse Event|2|||
129903916|NCT01580293|467610914|FG002|Part A_Main Trial|Adverse Event|0|||
129903917|NCT01580293|467610912|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
129903918|NCT01580293|467610913|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
129903919|NCT01580293|467610914|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
129903920|NCT01580293|467610912|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
129849256|NCT00630877|467408756|FG000|Overall Study|Noncompliance|2|||
129849257|NCT00630877|467408757|FG001|Overall Study|Noncompliance|3|||
129849258|NCT00630877|467408758|FG002|Overall Study|Noncompliance|1|||
129849259|NCT00630877|467408756|FG000|Overall Study|Protocol violation|1|||
129849260|NCT00630877|467408757|FG001|Overall Study|Protocol violation|0|||
129849261|NCT00630877|467408758|FG002|Overall Study|Protocol violation|1|||
129849262|NCT00630877|467408756|FG000|Overall Study|Personal reasons|0|||
129849263|NCT00630877|467408757|FG001|Overall Study|Personal reasons|0|||
129903921|NCT01580293|467610913|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
129903922|NCT01580293|467610914|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
129849264|NCT00630877|467408758|FG002|Overall Study|Personal reasons|1|||
129849265|NCT01643473|467408759|FG000|Overall Study|Lost to Follow-up|1|||
129849266|NCT01643473|467408760|FG001|Overall Study|Lost to Follow-up|0|||
129849267|NCT02033889|467408762|FG000|Overall Study|Adverse Event|3|||
129849268|NCT02033889|467408763|FG001|Overall Study|Adverse Event|1|||
129849269|NCT02033889|467408764|FG002|Overall Study|Adverse Event|3|||
129849270|NCT02033889|467408762|FG000|Overall Study|Death|3|||
129849271|NCT02033889|467408763|FG001|Overall Study|Death|1|||
129849272|NCT02033889|467408764|FG002|Overall Study|Death|2|||
129849273|NCT02033889|467408762|FG000|Overall Study|Excluded Medication|1|||
129849274|NCT02033889|467408763|FG001|Overall Study|Excluded Medication|1|||
129849275|NCT02033889|467408764|FG002|Overall Study|Excluded Medication|0|||
129849276|NCT02033889|467408762|FG000|Overall Study|Lost to Follow-up|8|||
129849277|NCT02033889|467408763|FG001|Overall Study|Lost to Follow-up|5|||
129903923|NCT01580293|467610912|FG000|Part A_Extension|Adverse Event|0|||
129903924|NCT01580293|467610913|FG001|Part A_Extension|Adverse Event|2|||
129903925|NCT01580293|467610914|FG002|Part A_Extension|Adverse Event|0|||
129849278|NCT02033889|467408764|FG002|Overall Study|Lost to Follow-up|6|||
129849279|NCT02033889|467408762|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129849280|NCT02033889|467408763|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129849281|NCT02033889|467408764|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129849282|NCT02033889|467408762|FG000|Overall Study|Physician Decision|0|||
129849283|NCT02033889|467408763|FG001|Overall Study|Physician Decision|1|||
129849284|NCT02033889|467408764|FG002|Overall Study|Physician Decision|1|||
129903926|NCT01580293|467610912|FG000|Part A_Extension|Withdrawal by Subject|0|||
129849285|NCT02033889|467408762|FG000|Overall Study|Participant moved|0|||
129849286|NCT02033889|467408763|FG001|Overall Study|Participant moved|1|||
129849287|NCT02033889|467408764|FG002|Overall Study|Participant moved|0|||
129849288|NCT02033889|467408762|FG000|Overall Study|Withdrawal by Subject|18|||
129849289|NCT02033889|467408763|FG001|Overall Study|Withdrawal by Subject|10|||
129903927|NCT01580293|467610913|FG001|Part A_Extension|Withdrawal by Subject|3|||
129849290|NCT02033889|467408764|FG002|Overall Study|Withdrawal by Subject|13|||
129849291|NCT01913041|467408765|FG000|Overall Study|Protocol Violation|35|||
129849292|NCT01913041|467408765|FG000|Overall Study|Withdrawal by Subject|3|||
129849293|NCT01913041|467408765|FG000|Overall Study|Physician Decision|1|||
129849294|NCT01265953|467408767|FG000|Overall Study|Non compliance|5|||
129849295|NCT01265953|467408768|FG001|Overall Study|Non compliance|3|||
129903928|NCT01580293|467610914|FG002|Part A_Extension|Withdrawal by Subject|0|||
129903929|NCT01580293|467610912|FG000|Part A_Extension|Lost to Follow-up|0|||
129903930|NCT01580293|467610913|FG001|Part A_Extension|Lost to Follow-up|1|||
129903931|NCT01580293|467610914|FG002|Part A_Extension|Lost to Follow-up|0|||
129903932|NCT01580293|467610912|FG000|Part A_Extension|Other Reason|0|||
129903933|NCT01580293|467610913|FG001|Part A_Extension|Other Reason|1|||
129903934|NCT01580293|467610914|FG002|Part A_Extension|Other Reason|0|||
129903935|NCT01580293|467610912|FG000|Part A_Extension|Completed Japan only|0|||
129903936|NCT01580293|467610913|FG001|Part A_Extension|Completed Japan only|5|||
129903937|NCT01580293|467610914|FG002|Part A_Extension|Completed Japan only|0|||
129903938|NCT01580293|467610912|FG000|Part B|Withdrawal by Subject|0|||
129903939|NCT01580293|467610913|FG001|Part B|Withdrawal by Subject|0|||
129903940|NCT01580293|467610914|FG002|Part B|Withdrawal by Subject|1|||
129903941|NCT01580293|467610912|FG000|Part B|Other reason|0|||
129903942|NCT01580293|467610913|FG001|Part B|Other reason|0|||
129903943|NCT01580293|467610914|FG002|Part B|Other reason|1|||
129903944|NCT00028769|467610915|FG000|Overall Study|Adverse Event|2|||
129903945|NCT00028769|467610915|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
129903946|NCT00028769|467610915|FG000|Overall Study|Progression or Death|31|||
129903947|NCT00028769|467610915|FG000|Overall Study|Other - Not Protocol Specified|1|||
129903948|NCT00028769|467610915|FG000|Overall Study|Ineligible|5|||
129903949|NCT00028769|467610915|FG000|Overall Study|Not Analyzable|1|||
129903950|NCT00768664|467610918|FG000|Overall Study|Death|57|||
129903951|NCT00768664|467610918|FG000|Overall Study|Lost to Follow-up|2|||
129903952|NCT00768664|467610918|FG000|Overall Study|Other|9|||
129903953|NCT00768664|467610918|FG000|Overall Study|Participant refused|1|||
129903954|NCT00708032|467610919|FG000|Overall Study|Adverse Event|0|||
129903955|NCT00708032|467610920|FG001|Overall Study|Adverse Event|2|||
129903956|NCT00708032|467610919|FG000|Overall Study|Lost to Follow-up|1|||
129903957|NCT00708032|467610920|FG001|Overall Study|Lost to Follow-up|2|||
129903958|NCT00708032|467610919|FG000|Overall Study|Pregnancy|0|||
129903959|NCT00708032|467610920|FG001|Overall Study|Pregnancy|1|||
129903960|NCT00708032|467610919|FG000|Overall Study|Poor vision|0|||
129903961|NCT00708032|467610920|FG001|Overall Study|Poor vision|6|||
129903962|NCT00708032|467610919|FG000|Overall Study|Visit out of range at month 12|4|||
129903963|NCT00708032|467610920|FG001|Overall Study|Visit out of range at month 12|1|||
129903964|NCT00708032|467610919|FG000|Overall Study|Did not meet protocol criteria|1|||
129903965|NCT00708032|467610920|FG001|Overall Study|Did not meet protocol criteria|2|||
129849296|NCT01610700|467408770|FG000|Overall Study|Adverse Event|3|||
129849297|NCT01610700|467408771|FG001|Overall Study|Adverse Event|1|||
129849298|NCT01610700|467408770|FG000|Overall Study|Withdrawal by Subject|0|||
129849299|NCT01610700|467408771|FG001|Overall Study|Withdrawal by Subject|1|||
129849300|NCT01610700|467408770|FG000|Overall Study|subject took one dose of street cannabis|0|||
129849301|NCT01610700|467408771|FG001|Overall Study|subject took one dose of street cannabis|1|||
129849302|NCT02648698|467408772|FG000|Overall Study|Protocol Violation|1|||
129849303|NCT02648698|467408773|FG001|Overall Study|Protocol Violation|5|||
129849304|NCT01640301|467408774|FG000|Overall Study|Death|0|||
129849305|NCT01640301|467408775|FG001|Overall Study|Death|8|||
129849306|NCT02391948|467408780|FG000|6-month Assessment|Death|0|||
129849307|NCT02391948|467408781|FG001|6-month Assessment|Death|0|||
129849308|NCT02391948|467408782|FG002|6-month Assessment|Death|0|||
129849309|NCT02391948|467408783|FG003|6-month Assessment|Death|0|||
129849310|NCT02391948|467408784|FG004|6-month Assessment|Death|1|||
129849311|NCT02391948|467408780|FG000|6-month Assessment|Withdrawal by Subject|0|||
129849312|NCT02391948|467408781|FG001|6-month Assessment|Withdrawal by Subject|0|||
129849313|NCT02391948|467408782|FG002|6-month Assessment|Withdrawal by Subject|1|||
129903966|NCT00708032|467610919|FG000|Overall Study|Protocol Violation|4|||
129903967|NCT00708032|467610920|FG001|Overall Study|Protocol Violation|1|||
129903968|NCT00708032|467610919|FG000|Overall Study|Withdrawal by Subject|0|||
129903969|NCT00708032|467610920|FG001|Overall Study|Withdrawal by Subject|1|||
129849314|NCT02391948|467408783|FG003|6-month Assessment|Withdrawal by Subject|2|||
129849315|NCT02391948|467408784|FG004|6-month Assessment|Withdrawal by Subject|0|||
129849316|NCT02391948|467408780|FG000|6-month Assessment|Lost to Follow-up|4|||
129849317|NCT02391948|467408781|FG001|6-month Assessment|Lost to Follow-up|5|||
129849318|NCT02391948|467408782|FG002|6-month Assessment|Lost to Follow-up|2|||
129849319|NCT02391948|467408783|FG003|6-month Assessment|Lost to Follow-up|3|||
129849320|NCT02391948|467408784|FG004|6-month Assessment|Lost to Follow-up|1|||
129849321|NCT02391948|467408780|FG000|6-month Assessment|Medical issue/illness|1|||
129903970|NCT01400776|467610921|FG000|Overall Study|Adverse Event|7|||
129903971|NCT01400776|467610922|FG001|Overall Study|Adverse Event|2|||
129903972|NCT01400776|467610923|FG002|Overall Study|Adverse Event|9|||
129903973|NCT01400776|467610924|FG003|Overall Study|Adverse Event|2|||
129903974|NCT01400776|467610921|FG000|Overall Study|Lost to Follow-up|1|||
129903975|NCT01400776|467610922|FG001|Overall Study|Lost to Follow-up|0|||
129903976|NCT01400776|467610923|FG002|Overall Study|Lost to Follow-up|4|||
129903977|NCT01400776|467610924|FG003|Overall Study|Lost to Follow-up|1|||
129903978|NCT01400776|467610921|FG000|Overall Study|Withdrew Consent|4|||
129903979|NCT01400776|467610922|FG001|Overall Study|Withdrew Consent|2|||
129903980|NCT01400776|467610923|FG002|Overall Study|Withdrew Consent|6|||
129903981|NCT01400776|467610924|FG003|Overall Study|Withdrew Consent|1|||
129903982|NCT01400776|467610921|FG000|Overall Study|Protocol Deviation|6|||
129903983|NCT01400776|467610922|FG001|Overall Study|Protocol Deviation|1|||
129903984|NCT01400776|467610923|FG002|Overall Study|Protocol Deviation|5|||
129903985|NCT01400776|467610924|FG003|Overall Study|Protocol Deviation|2|||
129903986|NCT01400776|467610921|FG000|Overall Study|Reason not Specified|3|||
129903987|NCT01400776|467610922|FG001|Overall Study|Reason not Specified|0|||
129903988|NCT01400776|467610923|FG002|Overall Study|Reason not Specified|4|||
129903989|NCT01400776|467610924|FG003|Overall Study|Reason not Specified|3|||
129903990|NCT00423098|467610925|FG000|Overall Study|Adverse Event|1|||
129903991|NCT00423098|467610926|FG001|Overall Study|Adverse Event|2|||
129903992|NCT00423098|467610925|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129903993|NCT00423098|467610926|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129903994|NCT00423098|467610925|FG000|Overall Study|Administrative problems|0|||
129903995|NCT00423098|467610926|FG001|Overall Study|Administrative problems|1|||
129903996|NCT00423098|467610925|FG000|Overall Study|Death|2|||
129903997|NCT00423098|467610926|FG001|Overall Study|Death|0|||
129903998|NCT04480827|467610928|FG000|Overall Study|Adverse Event|0|||
129903999|NCT04480827|467610929|FG001|Overall Study|Adverse Event|0|||
129904000|NCT04480827|467610930|FG002|Overall Study|Adverse Event|0|||
129904001|NCT04480827|467610931|FG003|Overall Study|Adverse Event|0|||
129904002|NCT04480827|467610932|FG004|Overall Study|Adverse Event|0|||
129904003|NCT04480827|467610933|FG005|Overall Study|Adverse Event|1|||
129904004|NCT04480827|467610934|FG006|Overall Study|Adverse Event|0|||
129904005|NCT00941655|467610935|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
129904006|NCT00941655|467610936|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
129904007|NCT00941655|467610935|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
129904008|NCT00941655|467610936|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
129904009|NCT00941655|467610935|FG000|Overall Study|progressed while on chemo|0|||
129904010|NCT00941655|467610936|FG001|Overall Study|progressed while on chemo|2|||
129904011|NCT00941655|467610935|FG000|Overall Study|refused further treatment|0|||
129904012|NCT00941655|467610936|FG001|Overall Study|refused further treatment|1|||
129904013|NCT00941655|467610935|FG000|Overall Study|withdrew consent|0|||
129904014|NCT00941655|467610936|FG001|Overall Study|withdrew consent|1|||
129904015|NCT00941655|467610935|FG000|Overall Study|non-compliant|0|||
129904016|NCT00941655|467610936|FG001|Overall Study|non-compliant|1|||
129904017|NCT02477670|467610942|FG000|Stage 1|Adverse Event|2|||
129904018|NCT02477670|467610943|FG001|Stage 1|Adverse Event|7|||
129904019|NCT02477670|467610944|FG002|Stage 1|Adverse Event|0|||
129904020|NCT02477670|467610945|FG003|Stage 1|Adverse Event|0|||
129904021|NCT02477670|467610946|FG004|Stage 1|Adverse Event|0|||
129904022|NCT02477670|467610947|FG005|Stage 1|Adverse Event|0|||
129904023|NCT02477670|467610948|FG006|Stage 1|Adverse Event|0|||
129904024|NCT02477670|467610942|FG000|Stage 1|Lost to Follow-up|0|||
129904025|NCT02477670|467610943|FG001|Stage 1|Lost to Follow-up|2|||
129904026|NCT02477670|467610944|FG002|Stage 1|Lost to Follow-up|0|||
129904027|NCT02477670|467610945|FG003|Stage 1|Lost to Follow-up|0|||
129904028|NCT02477670|467610946|FG004|Stage 1|Lost to Follow-up|0|||
129904029|NCT02477670|467610947|FG005|Stage 1|Lost to Follow-up|0|||
129904030|NCT02477670|467610948|FG006|Stage 1|Lost to Follow-up|0|||
129904031|NCT02477670|467610942|FG000|Stage 1|Withdrawal by Subject|1|||
129904032|NCT02477670|467610943|FG001|Stage 1|Withdrawal by Subject|2|||
129904033|NCT02477670|467610944|FG002|Stage 1|Withdrawal by Subject|0|||
129904034|NCT02477670|467610945|FG003|Stage 1|Withdrawal by Subject|0|||
129904035|NCT02477670|467610946|FG004|Stage 1|Withdrawal by Subject|0|||
129904036|NCT02477670|467610947|FG005|Stage 1|Withdrawal by Subject|0|||
129904037|NCT02477670|467610948|FG006|Stage 1|Withdrawal by Subject|0|||
129904038|NCT02477670|467610942|FG000|Stage 1|Non-compliance with Study Drug|1|||
129904039|NCT02477670|467610943|FG001|Stage 1|Non-compliance with Study Drug|2|||
129904040|NCT02477670|467610944|FG002|Stage 1|Non-compliance with Study Drug|0|||
129904041|NCT02477670|467610945|FG003|Stage 1|Non-compliance with Study Drug|0|||
129904042|NCT02477670|467610946|FG004|Stage 1|Non-compliance with Study Drug|0|||
129904043|NCT02477670|467610947|FG005|Stage 1|Non-compliance with Study Drug|0|||
129904044|NCT02477670|467610948|FG006|Stage 1|Non-compliance with Study Drug|0|||
129904045|NCT02477670|467610942|FG000|Stage 2|Adverse Event|0|||
129904046|NCT02477670|467610943|FG001|Stage 2|Adverse Event|0|||
129904047|NCT02477670|467610944|FG002|Stage 2|Adverse Event|1|||
129904048|NCT02477670|467610945|FG003|Stage 2|Adverse Event|0|||
129904049|NCT02477670|467610946|FG004|Stage 2|Adverse Event|0|||
129904050|NCT02477670|467610947|FG005|Stage 2|Adverse Event|0|||
129904051|NCT02477670|467610948|FG006|Stage 2|Adverse Event|0|||
130064564|NCT03691610|468190196|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
129904052|NCT02477670|467610942|FG000|Stage 2|Antipsychotic Medication Changed|0|||
129904053|NCT02477670|467610943|FG001|Stage 2|Antipsychotic Medication Changed|0|||
129849322|NCT02391948|467408781|FG001|6-month Assessment|Medical issue/illness|1|||
129849323|NCT02391948|467408782|FG002|6-month Assessment|Medical issue/illness|0|||
129849324|NCT02391948|467408783|FG003|6-month Assessment|Medical issue/illness|0|||
129849325|NCT02391948|467408784|FG004|6-month Assessment|Medical issue/illness|0|||
129904054|NCT02477670|467610944|FG002|Stage 2|Antipsychotic Medication Changed|1|||
129904055|NCT02477670|467610945|FG003|Stage 2|Antipsychotic Medication Changed|0|||
129904056|NCT02477670|467610946|FG004|Stage 2|Antipsychotic Medication Changed|0|||
129904057|NCT02477670|467610947|FG005|Stage 2|Antipsychotic Medication Changed|0|||
129904058|NCT02477670|467610948|FG006|Stage 2|Antipsychotic Medication Changed|0|||
129904059|NCT02477670|467610942|FG000|Stage 2|Withdrawal by Subject|0|||
129904060|NCT02477670|467610943|FG001|Stage 2|Withdrawal by Subject|0|||
129904061|NCT02477670|467610944|FG002|Stage 2|Withdrawal by Subject|0|||
129904062|NCT02477670|467610945|FG003|Stage 2|Withdrawal by Subject|1|||
129904063|NCT02477670|467610946|FG004|Stage 2|Withdrawal by Subject|0|||
129904064|NCT02477670|467610947|FG005|Stage 2|Withdrawal by Subject|0|||
129904065|NCT02477670|467610948|FG006|Stage 2|Withdrawal by Subject|0|||
129904066|NCT00446550|467610950|FG000|Overall Study|Adverse Event|1|||
129904067|NCT00446550|467610951|FG001|Overall Study|Adverse Event|0|||
129904068|NCT02937831|467610952|FG000|Overall Study|Protocol Violation|4|||
129904069|NCT02983617|467610955|FG000|Overall Study|Adverse Event|0|||
129904070|NCT02983617|467610956|FG001|Overall Study|Adverse Event|7|||
129904071|NCT02983617|467610955|FG000|Overall Study|Death|0|||
129904072|NCT02983617|467610956|FG001|Overall Study|Death|1|||
129904073|NCT02983617|467610955|FG000|Overall Study|Investigator's Discretion|0|||
129904074|NCT02983617|467610956|FG001|Overall Study|Investigator's Discretion|1|||
129904075|NCT02027558|467610957|FG000|Overall Study|Death|0|||
129904076|NCT02027558|467610958|FG001|Overall Study|Death|1|||
129904077|NCT02027558|467610957|FG000|Overall Study|Withdrawal by Subject|2|||
129904078|NCT02027558|467610958|FG001|Overall Study|Withdrawal by Subject|0|||
129904079|NCT02027558|467610957|FG000|Overall Study|Lost to Follow-up|4|||
129904080|NCT02027558|467610958|FG001|Overall Study|Lost to Follow-up|1|||
129904081|NCT02027558|467610957|FG000|Overall Study|Refused assessment|3|||
129904082|NCT02027558|467610958|FG001|Overall Study|Refused assessment|0|||
129849326|NCT02391948|467408780|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
129849327|NCT02391948|467408781|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
129849328|NCT02391948|467408782|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
129849329|NCT02391948|467408783|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
129849330|NCT02391948|467408784|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
129849331|NCT02391948|467408780|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
129849332|NCT02391948|467408781|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
129849333|NCT02391948|467408782|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
129849334|NCT02391948|467408783|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
129849335|NCT02391948|467408784|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
129849336|NCT02391948|467408780|FG000|12-month Assessment|Death|0|||
129849337|NCT02391948|467408781|FG001|12-month Assessment|Death|0|||
129849338|NCT02391948|467408782|FG002|12-month Assessment|Death|0|||
129849339|NCT02391948|467408783|FG003|12-month Assessment|Death|1|||
129849340|NCT02391948|467408784|FG004|12-month Assessment|Death|0|||
129849341|NCT02391948|467408780|FG000|12-month Assessment|Withdrawal by Subject|1|||
129849342|NCT02391948|467408781|FG001|12-month Assessment|Withdrawal by Subject|0|||
129849343|NCT02391948|467408782|FG002|12-month Assessment|Withdrawal by Subject|0|||
129849344|NCT02391948|467408783|FG003|12-month Assessment|Withdrawal by Subject|1|||
129849345|NCT02391948|467408784|FG004|12-month Assessment|Withdrawal by Subject|0|||
129849346|NCT02391948|467408780|FG000|12-month Assessment|Lost to Follow-up|5|||
129849347|NCT02391948|467408781|FG001|12-month Assessment|Lost to Follow-up|4|||
129849348|NCT02391948|467408782|FG002|12-month Assessment|Lost to Follow-up|4|||
129849349|NCT02391948|467408783|FG003|12-month Assessment|Lost to Follow-up|4|||
129849350|NCT02391948|467408784|FG004|12-month Assessment|Lost to Follow-up|5|||
129849351|NCT02391948|467408780|FG000|12-month Assessment|Medical issue/illness|0|||
129849352|NCT02391948|467408781|FG001|12-month Assessment|Medical issue/illness|1|||
129904083|NCT03720210|467610959|FG000|Overall Study|Lost to Follow-up|1|||
129904084|NCT00114244|467610960|FG000|Overall Study|Adverse Event|2|||
129904085|NCT00114244|467610961|FG001|Overall Study|Adverse Event|5|||
129904086|NCT00114244|467610960|FG000|Overall Study|Withdrawal by Subject|0|||
129904087|NCT00114244|467610961|FG001|Overall Study|Withdrawal by Subject|2|||
129904088|NCT02698891|467610962|FG000|Overall Study|Withdrawal by Subject|2|||
129904089|NCT02698891|467610962|FG000|Overall Study|deemed ineligible|1|||
129849353|NCT02391948|467408782|FG002|12-month Assessment|Medical issue/illness|0|||
129849354|NCT02391948|467408783|FG003|12-month Assessment|Medical issue/illness|1|||
129849355|NCT02391948|467408784|FG004|12-month Assessment|Medical issue/illness|0|||
129849356|NCT02391948|467408780|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
129849357|NCT02391948|467408781|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
129849358|NCT02391948|467408782|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
129904090|NCT02698891|467610962|FG000|Overall Study|Adverse Event|9|||
129904091|NCT00711958|467610963|FG000|Overall Study|Withdrawal by Subject|6|||
130064565|NCT03691610|468190197|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
129849359|NCT02391948|467408783|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
129849360|NCT02391948|467408784|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
129849361|NCT02391948|467408780|FG000|18-month Assessment|Death|0|||
129849362|NCT02391948|467408781|FG001|18-month Assessment|Death|0|||
129849363|NCT02391948|467408782|FG002|18-month Assessment|Death|0|||
129849364|NCT02391948|467408783|FG003|18-month Assessment|Death|1|||
129849365|NCT02391948|467408784|FG004|18-month Assessment|Death|1|||
129849366|NCT02391948|467408780|FG000|18-month Assessment|Withdrawal by Subject|1|||
129849367|NCT02391948|467408781|FG001|18-month Assessment|Withdrawal by Subject|0|||
129849368|NCT02391948|467408782|FG002|18-month Assessment|Withdrawal by Subject|0|||
129849369|NCT02391948|467408783|FG003|18-month Assessment|Withdrawal by Subject|1|||
129849370|NCT02391948|467408784|FG004|18-month Assessment|Withdrawal by Subject|0|||
129849371|NCT02391948|467408780|FG000|18-month Assessment|Lost to Follow-up|2|||
129849372|NCT02391948|467408781|FG001|18-month Assessment|Lost to Follow-up|6|||
129849373|NCT02391948|467408782|FG002|18-month Assessment|Lost to Follow-up|2|||
129849374|NCT02391948|467408783|FG003|18-month Assessment|Lost to Follow-up|2|||
129849375|NCT02391948|467408784|FG004|18-month Assessment|Lost to Follow-up|3|||
129849376|NCT02391948|467408780|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
129849377|NCT02391948|467408781|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
129849378|NCT02391948|467408782|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
129849379|NCT02391948|467408783|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
129849380|NCT02391948|467408784|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
129849381|NCT02391948|467408780|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
129849382|NCT02391948|467408781|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
129849383|NCT02391948|467408782|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
129849384|NCT02391948|467408783|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
129849385|NCT02391948|467408784|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
129849386|NCT02391948|467408780|FG000|24-month Assessment|Death|0|||
129849387|NCT02391948|467408781|FG001|24-month Assessment|Death|0|||
129849388|NCT02391948|467408782|FG002|24-month Assessment|Death|0|||
129849389|NCT02391948|467408783|FG003|24-month Assessment|Death|0|||
129849390|NCT02391948|467408784|FG004|24-month Assessment|Death|1|||
129849391|NCT02391948|467408780|FG000|24-month Assessment|Withdrawal by Subject|1|||
129849392|NCT02391948|467408781|FG001|24-month Assessment|Withdrawal by Subject|1|||
129849393|NCT02391948|467408782|FG002|24-month Assessment|Withdrawal by Subject|0|||
129849394|NCT02391948|467408783|FG003|24-month Assessment|Withdrawal by Subject|0|||
129849395|NCT02391948|467408784|FG004|24-month Assessment|Withdrawal by Subject|1|||
129849396|NCT02391948|467408780|FG000|24-month Assessment|Lost to Follow-up|5|||
129849397|NCT02391948|467408781|FG001|24-month Assessment|Lost to Follow-up|4|||
129849398|NCT02391948|467408782|FG002|24-month Assessment|Lost to Follow-up|0|||
129904092|NCT00711958|467610964|FG001|Overall Study|Withdrawal by Subject|8|||
129904093|NCT00711958|467610963|FG000|Overall Study|Lack of Efficacy|3|||
129904094|NCT00711958|467610964|FG001|Overall Study|Lack of Efficacy|1|||
129904095|NCT00711958|467610963|FG000|Overall Study|Clinical deterioration|1|||
129904096|NCT00711958|467610964|FG001|Overall Study|Clinical deterioration|0|||
129904097|NCT00711958|467610963|FG000|Overall Study|Adverse Event|9|||
129904098|NCT00711958|467610964|FG001|Overall Study|Adverse Event|7|||
129904099|NCT00711958|467610963|FG000|Overall Study|Protocol Violation|1|||
129904100|NCT00711958|467610964|FG001|Overall Study|Protocol Violation|0|||
129904101|NCT00711958|467610963|FG000|Overall Study|Lost to Follow-up|2|||
129904102|NCT00711958|467610964|FG001|Overall Study|Lost to Follow-up|2|||
129904103|NCT00711958|467610963|FG000|Overall Study|Death|10|||
129904104|NCT00711958|467610964|FG001|Overall Study|Death|5|||
129904105|NCT00711958|467610963|FG000|Overall Study|Progression of disease|1|||
129904106|NCT00711958|467610964|FG001|Overall Study|Progression of disease|0|||
129904107|NCT01111526|467610965|FG000|Overall Study|GVHD Disease Progression|0|||
129904108|NCT01111526|467610966|FG001|Overall Study|GVHD Disease Progression|1|||
129849399|NCT02391948|467408783|FG003|24-month Assessment|Lost to Follow-up|0|||
129849400|NCT02391948|467408784|FG004|24-month Assessment|Lost to Follow-up|0|||
129849401|NCT02391948|467408780|FG000|24-month Assessment|Medical issue/illness|0|||
129904109|NCT01111526|467610967|FG002|Overall Study|GVHD Disease Progression|2|||
129904110|NCT04424641|467610968|FG000|Overall Study|Death|1|||
129904111|NCT04424641|467610969|FG001|Overall Study|Death|2|||
129904112|NCT04424641|467610970|FG002|Overall Study|Death|3|||
129904113|NCT04424641|467610971|FG003|Overall Study|Death|0|||
129904114|NCT04424641|467610972|FG004|Overall Study|Death|3|||
129849402|NCT02391948|467408781|FG001|24-month Assessment|Medical issue/illness|0|||
129849403|NCT02391948|467408782|FG002|24-month Assessment|Medical issue/illness|1|||
129849404|NCT02391948|467408783|FG003|24-month Assessment|Medical issue/illness|0|||
129849405|NCT02391948|467408784|FG004|24-month Assessment|Medical issue/illness|0|||
129849406|NCT02391948|467408780|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
129849407|NCT02391948|467408781|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
129849408|NCT02391948|467408782|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
129904115|NCT04424641|467610973|FG005|Overall Study|Death|0|||
129904116|NCT04424641|467610974|FG006|Overall Study|Death|1|||
129849409|NCT02391948|467408783|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
129849410|NCT02391948|467408784|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
129849411|NCT01639001|467408785|FG000|Overall Study|Refused further follow-up|9|||
129849412|NCT01639001|467408786|FG001|Overall Study|Refused further follow-up|12|||
129849413|NCT01639001|467408785|FG000|Overall Study|Lost to Follow-up|3|||
129849414|NCT01639001|467408786|FG001|Overall Study|Lost to Follow-up|0|||
129849415|NCT01639001|467408785|FG000|Overall Study|Death|62|||
129849416|NCT01639001|467408786|FG001|Overall Study|Death|61|||
129849417|NCT01639001|467408785|FG000|Overall Study|Randomized but not treated|0|||
129849418|NCT01639001|467408786|FG001|Overall Study|Randomized but not treated|2|||
129849419|NCT01639001|467408785|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
129849420|NCT01639001|467408786|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
129849421|NCT01969838|467408787|FG000|Double-blind Phase|Adverse Event|10|||
129849422|NCT01969838|467408788|FG001|Double-blind Phase|Adverse Event|4|||
129849423|NCT01969838|467408789|FG002|Double-blind Phase|Adverse Event|0|||
129849424|NCT01969838|467408790|FG003|Double-blind Phase|Adverse Event|0|||
129849425|NCT01969838|467408787|FG000|Double-blind Phase|Death|5|||
129849426|NCT01969838|467408788|FG001|Double-blind Phase|Death|2|||
129849427|NCT01969838|467408789|FG002|Double-blind Phase|Death|0|||
129849428|NCT01969838|467408790|FG003|Double-blind Phase|Death|0|||
129849429|NCT01969838|467408787|FG000|Double-blind Phase|Physician Decision|5|||
129849430|NCT01969838|467408788|FG001|Double-blind Phase|Physician Decision|1|||
129849431|NCT01969838|467408789|FG002|Double-blind Phase|Physician Decision|0|||
129849432|NCT01969838|467408790|FG003|Double-blind Phase|Physician Decision|0|||
129849433|NCT01969838|467408787|FG000|Double-blind Phase|Subject Decision|4|||
129849434|NCT01969838|467408788|FG001|Double-blind Phase|Subject Decision|2|||
129849435|NCT01969838|467408789|FG002|Double-blind Phase|Subject Decision|0|||
129849436|NCT01969838|467408790|FG003|Double-blind Phase|Subject Decision|0|||
129849437|NCT01969838|467408787|FG000|Double-blind Phase|Disease Progression|2|||
129849438|NCT01969838|467408788|FG001|Double-blind Phase|Disease Progression|0|||
129849439|NCT01969838|467408789|FG002|Double-blind Phase|Disease Progression|0|||
129849440|NCT01969838|467408790|FG003|Double-blind Phase|Disease Progression|0|||
129849441|NCT01969838|467408787|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
129849442|NCT01969838|467408788|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
129849443|NCT01969838|467408789|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
129849444|NCT01969838|467408790|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
129849445|NCT01969838|467408787|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
129849446|NCT01969838|467408788|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
129849447|NCT01969838|467408789|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
129849448|NCT01969838|467408790|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
129849449|NCT01969838|467408787|FG000|Open-label Phase|Adverse Event|0|||
129849450|NCT01969838|467408788|FG001|Open-label Phase|Adverse Event|0|||
129849451|NCT01969838|467408789|FG002|Open-label Phase|Adverse Event|37|||
129849452|NCT01969838|467408790|FG003|Open-label Phase|Adverse Event|49|||
129849453|NCT01969838|467408787|FG000|Open-label Phase|Disease Progression|0|||
129849454|NCT01969838|467408788|FG001|Open-label Phase|Disease Progression|0|||
129849455|NCT01969838|467408789|FG002|Open-label Phase|Disease Progression|26|||
129849456|NCT01969838|467408790|FG003|Open-label Phase|Disease Progression|27|||
129849457|NCT01969838|467408787|FG000|Open-label Phase|Lack of Efficacy|0|||
129849458|NCT01969838|467408788|FG001|Open-label Phase|Lack of Efficacy|0|||
129849459|NCT01969838|467408789|FG002|Open-label Phase|Lack of Efficacy|17|||
129849460|NCT01969838|467408790|FG003|Open-label Phase|Lack of Efficacy|19|||
129849461|NCT01969838|467408787|FG000|Open-label Phase|Subject Decision|0|||
129849462|NCT01969838|467408788|FG001|Open-label Phase|Subject Decision|0|||
129849463|NCT01969838|467408789|FG002|Open-label Phase|Subject Decision|14|||
129849464|NCT01969838|467408790|FG003|Open-label Phase|Subject Decision|15|||
129849465|NCT01969838|467408787|FG000|Open-label Phase|Death|0|||
129849466|NCT01969838|467408788|FG001|Open-label Phase|Death|0|||
129849467|NCT01969838|467408789|FG002|Open-label Phase|Death|13|||
129849468|NCT01969838|467408790|FG003|Open-label Phase|Death|11|||
129849469|NCT01969838|467408787|FG000|Open-label Phase|Physician Decision|0|||
129849470|NCT01969838|467408788|FG001|Open-label Phase|Physician Decision|0|||
129849471|NCT01969838|467408789|FG002|Open-label Phase|Physician Decision|9|||
129849472|NCT01969838|467408790|FG003|Open-label Phase|Physician Decision|14|||
129849473|NCT01969838|467408787|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
129849474|NCT01969838|467408788|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
129849475|NCT01969838|467408789|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
129849476|NCT01969838|467408790|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
129849477|NCT02944578|467408793|FG000|Overall Study|Physician Decision|1|||
129849478|NCT02944578|467408794|FG001|Overall Study|Physician Decision|0|||
129849479|NCT00807092|467408795|FG000|Overall Study|Adverse Event|0|||
129849480|NCT00807092|467408796|FG001|Overall Study|Adverse Event|1|||
129849481|NCT00807092|467408795|FG000|Overall Study|Protocol Violation|0|||
129849482|NCT00807092|467408796|FG001|Overall Study|Protocol Violation|2|||
129904117|NCT04424641|467610975|FG007|Overall Study|Death|2|||
129849483|NCT00807092|467408795|FG000|Overall Study|Withdrawal by Subject|1|||
129849484|NCT00807092|467408796|FG001|Overall Study|Withdrawal by Subject|0|||
129849485|NCT00807092|467408795|FG000|Overall Study|CGMS data collection failed|0|||
129849486|NCT00807092|467408796|FG001|Overall Study|CGMS data collection failed|1|||
129849487|NCT04116229|467408797|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
129849488|NCT04116229|467408798|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
129849489|NCT04116229|467408797|FG000|Overall Study|Scheduling not possible.|0|||
129849490|NCT04116229|467408798|FG001|Overall Study|Scheduling not possible.|1|||
129849491|NCT02170727|467408807|FG000|Overall Study|Lost to Follow-up|1|||
129849492|NCT02170727|467408808|FG001|Overall Study|Lost to Follow-up|0|||
129849493|NCT02170727|467408807|FG000|Overall Study|Withdrawal by Subject|2|||
129849494|NCT02170727|467408808|FG001|Overall Study|Withdrawal by Subject|0|||
129849495|NCT01599650|467408809|FG000|Overall Study|Administrative issue|1|||
129849496|NCT01599650|467408810|FG001|Overall Study|Administrative issue|0|||
129849497|NCT01599650|467408811|FG002|Overall Study|Administrative issue|1|||
129849498|NCT01599650|467408809|FG000|Overall Study|Physician Decision|2|||
129849499|NCT01599650|467408810|FG001|Overall Study|Physician Decision|0|||
129849500|NCT01599650|467408811|FG002|Overall Study|Physician Decision|7|||
129849501|NCT01599650|467408809|FG000|Overall Study|Protocol Violation|0|||
129849502|NCT01599650|467408810|FG001|Overall Study|Protocol Violation|3|||
129849503|NCT01599650|467408811|FG002|Overall Study|Protocol Violation|0|||
129849504|NCT01599650|467408809|FG000|Overall Study|Death|2|||
129849505|NCT01599650|467408810|FG001|Overall Study|Death|1|||
129849506|NCT01599650|467408811|FG002|Overall Study|Death|2|||
129849507|NCT01599650|467408809|FG000|Overall Study|Lost to Follow-up|3|||
129849508|NCT01599650|467408810|FG001|Overall Study|Lost to Follow-up|3|||
129849509|NCT01599650|467408811|FG002|Overall Study|Lost to Follow-up|3|||
129849510|NCT01599650|467408809|FG000|Overall Study|Withdrawal by Subject|11|||
129849511|NCT01599650|467408810|FG001|Overall Study|Withdrawal by Subject|11|||
129849512|NCT01599650|467408811|FG002|Overall Study|Withdrawal by Subject|10|||
129849513|NCT01599650|467408809|FG000|Overall Study|Adverse Event|3|||
129849514|NCT01599650|467408810|FG001|Overall Study|Adverse Event|8|||
129849515|NCT01599650|467408811|FG002|Overall Study|Adverse Event|4|||
129849516|NCT00179647|467408819|FG000|Overall Study|Adverse Event|294|||
129849517|NCT00179647|467408819|FG000|Overall Study|Lack of Efficacy|478|||
129849518|NCT00179647|467408819|FG000|Overall Study|Withdrawal by Subject|83|||
129849519|NCT00179647|467408819|FG000|Overall Study|Lost to Follow-up|4|||
129849520|NCT00179647|467408819|FG000|Overall Study|Death|94|||
129849521|NCT00179647|467408819|FG000|Overall Study|Other|960|||
129849522|NCT04154631|467408820|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
129849523|NCT04154631|467408821|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
129849524|NCT02138214|467408824|FG000|Overall Study|Withdrawal by Subject|0|||
129849525|NCT02138214|467408825|FG001|Overall Study|Withdrawal by Subject|1|||
129849526|NCT02138214|467408826|FG002|Overall Study|Withdrawal by Subject|0|||
129849527|NCT02138214|467408824|FG000|Overall Study|Lost to Follow-up|0|||
129849528|NCT02138214|467408825|FG001|Overall Study|Lost to Follow-up|2|||
129849529|NCT02138214|467408826|FG002|Overall Study|Lost to Follow-up|4|||
129849530|NCT02138214|467408824|FG000|Overall Study|Screen Failure|0|||
129849531|NCT02138214|467408825|FG001|Overall Study|Screen Failure|1|||
129849532|NCT02138214|467408826|FG002|Overall Study|Screen Failure|0|||
129849533|NCT02185768|467408827|FG000|Overall Study|Patients were not treated|2|||
129849534|NCT02158039|467408834|FG000|Overall Study|Withdrawal by Subject|1|||
129849535|NCT02158039|467408834|FG000|Overall Study|Screen Failure|9|||
129849536|NCT02127307|467408841|FG000|Overall Study|Protocol Violation|36|||
129849537|NCT02127307|467408841|FG000|Overall Study|Lost to Follow-up|2|||
129849538|NCT02127307|467408841|FG000|Overall Study|Death|101|||
129849539|NCT02127307|467408841|FG000|Overall Study|Other than specified above|169|||
129849540|NCT03509948|467408842|FG000|Overall Study|Protocol Violation|0|||
129849541|NCT03509948|467408843|FG001|Overall Study|Protocol Violation|1|||
129849542|NCT03221257|467408844|FG000|Overall Study|Lost to Follow-up|0|||
129849543|NCT03221257|467408845|FG001|Overall Study|Lost to Follow-up|1|||
129849544|NCT03221257|467408844|FG000|Overall Study|Withdrawal by Subject|1|||
129849545|NCT03221257|467408845|FG001|Overall Study|Withdrawal by Subject|1|||
129849546|NCT01334866|467408849|FG000|Overall Study|Withdrawal by Subject|10|||
129849547|NCT01334866|467408849|FG000|Overall Study|Lost to Follow-up|3|||
129849548|NCT01334866|467408849|FG000|Overall Study|Physician Decision|3|||
129849549|NCT01334866|467408849|FG000|Overall Study|medically necessary prior to procedure|2|||
129849550|NCT01334866|467408849|FG000|Overall Study|medically necessary post-procedure|1|||
129849551|NCT02755831|467408858|FG000|Overall Study|Lost to Follow-up|3|||
129849552|NCT02755831|467408859|FG001|Overall Study|Lost to Follow-up|3|||
129849553|NCT02296112|467408860|FG000|Overall Study|Disease progression|7|||
129849554|NCT02296112|467408860|FG000|Overall Study|Toxicity|1|||
129849555|NCT02296112|467408860|FG000|Overall Study|Began an alternate therapy|1|||
129849556|NCT02442830|467408861|FG000|Overall Study|Technical Failure|0|||
129849557|NCT02442830|467408862|FG001|Overall Study|Technical Failure|1|||
129849558|NCT00183872|467408863|FG000|Overall Study|Death|3|||
129849559|NCT00183872|467408863|FG000|Overall Study|Adverse Event|9|||
129849560|NCT00183872|467408863|FG000|Overall Study|Withdrawal by Subject|2|||
129849561|NCT00183872|467408863|FG000|Overall Study|Drug delayed more than 28 days|2|||
129849562|NCT01720069|467408864|FG000|Overall Study|Could not use e-diary correctly|0|||
129849563|NCT01720069|467408865|FG001|Overall Study|Could not use e-diary correctly|1|||
129849564|NCT01720069|467408866|FG002|Overall Study|Could not use e-diary correctly|1|||
129849565|NCT01720069|467408864|FG000|Overall Study|Randomised without baseline values|0|||
129849566|NCT01720069|467408865|FG001|Overall Study|Randomised without baseline values|0|||
129849567|NCT01720069|467408866|FG002|Overall Study|Randomised without baseline values|1|||
129849568|NCT01720069|467408864|FG000|Overall Study|Adverse Event|0|||
129849569|NCT01720069|467408865|FG001|Overall Study|Adverse Event|0|||
129849570|NCT01720069|467408866|FG002|Overall Study|Adverse Event|1|||
129849571|NCT01720069|467408864|FG000|Overall Study|Lack of Efficacy|0|||
129849572|NCT01720069|467408865|FG001|Overall Study|Lack of Efficacy|4|||
129849573|NCT01720069|467408866|FG002|Overall Study|Lack of Efficacy|0|||
129849574|NCT01720069|467408864|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
129849575|NCT01720069|467408865|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
129849576|NCT01720069|467408866|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
129849577|NCT01720069|467408864|FG000|Overall Study|Withdrawal by Subject|0|||
129849578|NCT01720069|467408865|FG001|Overall Study|Withdrawal by Subject|2|||
129849579|NCT01720069|467408866|FG002|Overall Study|Withdrawal by Subject|1|||
129849580|NCT01720069|467408864|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
129849581|NCT01720069|467408865|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
129849582|NCT01720069|467408866|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
129849583|NCT01720069|467408864|FG000|Overall Study|Non-compliance on using e-diary|0|||
129849584|NCT01720069|467408865|FG001|Overall Study|Non-compliance on using e-diary|0|||
129849585|NCT01720069|467408866|FG002|Overall Study|Non-compliance on using e-diary|1|||
129849586|NCT01720069|467408864|FG000|Overall Study|Lost to Follow-up|0|||
129849587|NCT01720069|467408865|FG001|Overall Study|Lost to Follow-up|0|||
129849588|NCT01720069|467408866|FG002|Overall Study|Lost to Follow-up|1|||
129849589|NCT00508742|467408867|FG000|Period 1: Infant Series|Adverse Event|5|||
129849590|NCT00508742|467408868|FG001|Period 1: Infant Series|Adverse Event|4|||
129849591|NCT00508742|467408867|FG000|Period 1: Infant Series|Protocol Violation|1|||
129849592|NCT00508742|467408868|FG001|Period 1: Infant Series|Protocol Violation|0|||
129849593|NCT00508742|467408867|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
129849594|NCT00508742|467408868|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
129849595|NCT00508742|467408867|FG000|Period 1: Infant Series|Physician Decision|1|||
129849596|NCT00508742|467408868|FG001|Period 1: Infant Series|Physician Decision|0|||
129849597|NCT00508742|467408867|FG000|Period 1: Infant Series|Other|4|||
129849598|NCT00508742|467408868|FG001|Period 1: Infant Series|Other|1|||
129849599|NCT00508742|467408867|FG000|Period 2: After Infant Series|Adverse Event|2|||
129849600|NCT00508742|467408868|FG001|Period 2: After Infant Series|Adverse Event|6|||
129849601|NCT00508742|467408867|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
129849602|NCT00508742|467408868|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
129849603|NCT00508742|467408867|FG000|Period 2: After Infant Series|Protocol Violation|1|||
129849604|NCT00508742|467408868|FG001|Period 2: After Infant Series|Protocol Violation|0|||
129849605|NCT00508742|467408867|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
129849606|NCT00508742|467408868|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
129849607|NCT00508742|467408867|FG000|Period 2: After Infant Series|Failed to Return|1|||
129849608|NCT00508742|467408868|FG001|Period 2: After Infant Series|Failed to Return|0|||
129849609|NCT00508742|467408867|FG000|Period 2: After Infant Series|Other|2|||
129849610|NCT00508742|467408868|FG001|Period 2: After Infant Series|Other|1|||
129849611|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Adverse Event|1|||
129849612|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Adverse Event|0|||
129849613|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
129849614|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
129904118|NCT04424641|467610968|FG000|Overall Study|Sponsor decision|0|||
129904119|NCT04424641|467610969|FG001|Overall Study|Sponsor decision|2|||
129904120|NCT04424641|467610970|FG002|Overall Study|Sponsor decision|3|||
129904121|NCT04424641|467610971|FG003|Overall Study|Sponsor decision|7|||
129849615|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
129849616|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
129849617|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Other|5|||
129849618|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Other|4|||
129849619|NCT04568122|467408869|FG000|Overall Study|Lost to Follow-up|48|||
129849620|NCT04568122|467408870|FG001|Overall Study|Lost to Follow-up|44|||
129849621|NCT04568122|467408871|FG002|Overall Study|Lost to Follow-up|4|||
129849622|NCT04568122|467408872|FG003|Overall Study|Lost to Follow-up|0|||
129849623|NCT04568122|467408873|FG004|Overall Study|Lost to Follow-up|0|||
129849624|NCT00700011|467408879|FG000|Overall Study|Death|0|||
129849625|NCT00700011|467408880|FG001|Overall Study|Death|1|||
129849626|NCT02797262|467408881|FG000|Overall Study|Withdrawal by Subject|5|||
129849627|NCT02797262|467408882|FG001|Overall Study|Withdrawal by Subject|1|||
129849628|NCT02797262|467408881|FG000|Overall Study|Lost to Follow-up|10|||
129849629|NCT02797262|467408882|FG001|Overall Study|Lost to Follow-up|7|||
129849630|NCT02797262|467408881|FG000|Overall Study|Death|1|||
129904122|NCT04424641|467610972|FG004|Overall Study|Sponsor decision|2|||
129849631|NCT02797262|467408882|FG001|Overall Study|Death|2|||
129849632|NCT02797262|467408881|FG000|Overall Study|Adverse Event|1|||
129849633|NCT02797262|467408882|FG001|Overall Study|Adverse Event|0|||
129849634|NCT02797262|467408881|FG000|Overall Study|COVID-19|2|||
129849635|NCT02797262|467408882|FG001|Overall Study|COVID-19|1|||
129849636|NCT02797262|467408881|FG000|Overall Study|Out-of-country|1|||
129849637|NCT02797262|467408882|FG001|Overall Study|Out-of-country|0|||
129849638|NCT01209624|467408883|FG000|Overall Study|Death|2|||
129849639|NCT01209624|467408883|FG000|Overall Study|Adverse Event|13|||
129849640|NCT01209624|467408883|FG000|Overall Study|Lack of Efficacy|17|||
129849641|NCT01209624|467408883|FG000|Overall Study|Lost to Follow-up|290|||
129849642|NCT01209624|467408883|FG000|Overall Study|Other|4|||
129849643|NCT06748040|467408888|FG000|Overall Study|Death|3|||
129849644|NCT06748040|467408889|FG001|Overall Study|Death|4|||
129849645|NCT06748040|467408888|FG000|Overall Study|Lost to Follow-up|134|||
129849646|NCT06748040|467408889|FG001|Overall Study|Lost to Follow-up|132|||
129849647|NCT06748040|467408888|FG000|Overall Study|Withdrawal by Subject|3|||
129849648|NCT06748040|467408889|FG001|Overall Study|Withdrawal by Subject|5|||
129849649|NCT01818336|467410605|FG000|Overall Study|Declined retest visit|0|||
129849650|NCT01818336|467410606|FG001|Overall Study|Declined retest visit|11|||
129849651|NCT01818336|467410605|FG000|Overall Study|Lost to Follow-up|0|||
129849652|NCT01818336|467410606|FG001|Overall Study|Lost to Follow-up|1|||
129849653|NCT00827372|467410611|FG000|Overall Study|Adverse Event|5|||
129849654|NCT00827372|467410611|FG000|Overall Study|Lack of Efficacy|3|||
129849655|NCT02293005|467410612|FG000|Overall Study|Adverse Event|2|||
129849656|NCT02293005|467410612|FG000|Overall Study|Death|4|||
129849657|NCT02293005|467410612|FG000|Overall Study|Lost to Follow-up|1|||
129849658|NCT02293005|467410612|FG000|Overall Study|Withdrawal by Subject|2|||
129849659|NCT02293005|467410612|FG000|Overall Study|Progression|17|||
129849660|NCT00608829|467410614|FG000|Overall Study|Death|6|||
129849661|NCT00608829|467410614|FG000|Overall Study|Withdrawal by Subject|4|||
129849662|NCT00608829|467410614|FG000|Overall Study|Subject refuses to follow up or return.|5|||
129849663|NCT02564471|467410617|FG000|Overall Study|Adverse Event|1|||
129849664|NCT02564471|467410618|FG001|Overall Study|Adverse Event|0|||
129849665|NCT02564471|467410619|FG002|Overall Study|Adverse Event|0|||
129849666|NCT02564471|467410620|FG003|Overall Study|Adverse Event|0|||
129849667|NCT02564471|467410617|FG000|Overall Study|Withdrawal by Subject|2|||
129849668|NCT02564471|467410618|FG001|Overall Study|Withdrawal by Subject|1|||
129849669|NCT02564471|467410619|FG002|Overall Study|Withdrawal by Subject|3|||
129849670|NCT02564471|467410620|FG003|Overall Study|Withdrawal by Subject|0|||
129849671|NCT02564471|467410617|FG000|Overall Study|Lost to Follow-up|0|||
129849672|NCT02564471|467410618|FG001|Overall Study|Lost to Follow-up|2|||
129849673|NCT02564471|467410619|FG002|Overall Study|Lost to Follow-up|0|||
129849674|NCT02564471|467410620|FG003|Overall Study|Lost to Follow-up|0|||
129849675|NCT02805257|467410621|FG000|Overall Study|Lost to Follow-up|7|||
129849676|NCT02805257|467410622|FG001|Overall Study|Lost to Follow-up|6|||
129849677|NCT02805257|467410621|FG000|Overall Study|Death|0|||
129849678|NCT02805257|467410622|FG001|Overall Study|Death|1|||
129849679|NCT02766608|467410626|FG000|Overall Study|Adverse Event|27|||
129849680|NCT02766608|467410627|FG001|Overall Study|Adverse Event|22|||
129849681|NCT02766608|467410628|FG002|Overall Study|Adverse Event|17|||
129849682|NCT02766608|467410629|FG003|Overall Study|Adverse Event|13|||
129849683|NCT02766608|467410630|FG004|Overall Study|Adverse Event|12|||
129849684|NCT02766608|467410626|FG000|Overall Study|Withdrawal by Subject|21|||
129849685|NCT02766608|467410627|FG001|Overall Study|Withdrawal by Subject|20|||
129849686|NCT02766608|467410628|FG002|Overall Study|Withdrawal by Subject|24|||
129849687|NCT02766608|467410629|FG003|Overall Study|Withdrawal by Subject|13|||
129849688|NCT02766608|467410630|FG004|Overall Study|Withdrawal by Subject|10|||
129849689|NCT02766608|467410626|FG000|Overall Study|Lack of Efficacy|16|||
129849690|NCT02766608|467410627|FG001|Overall Study|Lack of Efficacy|15|||
129849691|NCT02766608|467410628|FG002|Overall Study|Lack of Efficacy|32|||
129849692|NCT02766608|467410629|FG003|Overall Study|Lack of Efficacy|8|||
129849693|NCT02766608|467410630|FG004|Overall Study|Lack of Efficacy|2|||
129849694|NCT02766608|467410626|FG000|Overall Study|Lost to Follow-up|6|||
129849695|NCT02766608|467410627|FG001|Overall Study|Lost to Follow-up|3|||
129849696|NCT02766608|467410628|FG002|Overall Study|Lost to Follow-up|5|||
129849697|NCT02766608|467410629|FG003|Overall Study|Lost to Follow-up|2|||
129849698|NCT02766608|467410630|FG004|Overall Study|Lost to Follow-up|2|||
129849699|NCT02766608|467410626|FG000|Overall Study|Physician Decision|3|||
129849700|NCT02766608|467410627|FG001|Overall Study|Physician Decision|2|||
129849701|NCT02766608|467410628|FG002|Overall Study|Physician Decision|3|||
129849702|NCT02766608|467410629|FG003|Overall Study|Physician Decision|1|||
129849703|NCT02766608|467410630|FG004|Overall Study|Physician Decision|2|||
129849704|NCT02766608|467410626|FG000|Overall Study|Protocol disc criteria|3|||
129849705|NCT02766608|467410627|FG001|Overall Study|Protocol disc criteria|3|||
129849706|NCT02766608|467410628|FG002|Overall Study|Protocol disc criteria|4|||
129849707|NCT02766608|467410629|FG003|Overall Study|Protocol disc criteria|0|||
129849708|NCT02766608|467410630|FG004|Overall Study|Protocol disc criteria|0|||
129849709|NCT02766608|467410626|FG000|Overall Study|Protocol Violation|0|||
129849710|NCT02766608|467410627|FG001|Overall Study|Protocol Violation|4|||
129849711|NCT02766608|467410628|FG002|Overall Study|Protocol Violation|4|||
129849712|NCT02766608|467410629|FG003|Overall Study|Protocol Violation|0|||
129849713|NCT02766608|467410630|FG004|Overall Study|Protocol Violation|1|||
129849714|NCT02766608|467410626|FG000|Overall Study|Administrative Reasons|3|||
129849715|NCT02766608|467410627|FG001|Overall Study|Administrative Reasons|1|||
129849716|NCT02766608|467410628|FG002|Overall Study|Administrative Reasons|1|||
129849717|NCT02766608|467410629|FG003|Overall Study|Administrative Reasons|0|||
129849718|NCT02766608|467410630|FG004|Overall Study|Administrative Reasons|0|||
129849719|NCT02343458|467410634|FG000|Overall Study|Adverse Event|15|||
129849720|NCT02343458|467410635|FG001|Overall Study|Adverse Event|14|||
129849721|NCT02343458|467410636|FG002|Overall Study|Adverse Event|15|||
129849722|NCT02343458|467410637|FG003|Overall Study|Adverse Event|3|||
129849723|NCT02343458|467410634|FG000|Overall Study|Lack of Efficacy|3|||
129849724|NCT02343458|467410635|FG001|Overall Study|Lack of Efficacy|8|||
129849725|NCT02343458|467410636|FG002|Overall Study|Lack of Efficacy|4|||
129849726|NCT02343458|467410637|FG003|Overall Study|Lack of Efficacy|8|||
129849727|NCT02343458|467410634|FG000|Overall Study|Withdrawal by Subject|18|||
129849728|NCT02343458|467410635|FG001|Overall Study|Withdrawal by Subject|17|||
129849729|NCT02343458|467410636|FG002|Overall Study|Withdrawal by Subject|23|||
129849730|NCT02343458|467410637|FG003|Overall Study|Withdrawal by Subject|14|||
129849731|NCT02343458|467410634|FG000|Overall Study|Physician Decision|1|||
129849732|NCT02343458|467410635|FG001|Overall Study|Physician Decision|4|||
129849733|NCT02343458|467410636|FG002|Overall Study|Physician Decision|2|||
129849734|NCT02343458|467410637|FG003|Overall Study|Physician Decision|2|||
129849735|NCT02343458|467410634|FG000|Overall Study|Lost to Follow-up|5|||
129849736|NCT02343458|467410635|FG001|Overall Study|Lost to Follow-up|5|||
129849737|NCT02343458|467410636|FG002|Overall Study|Lost to Follow-up|3|||
129849738|NCT02343458|467410637|FG003|Overall Study|Lost to Follow-up|1|||
129849739|NCT02343458|467410634|FG000|Overall Study|Protocol Violation|2|||
129849740|NCT02343458|467410635|FG001|Overall Study|Protocol Violation|5|||
129849741|NCT02343458|467410636|FG002|Overall Study|Protocol Violation|2|||
129849742|NCT02343458|467410637|FG003|Overall Study|Protocol Violation|2|||
129849743|NCT02343458|467410634|FG000|Overall Study|Protocol Specified Criteria|17|||
129849744|NCT02343458|467410635|FG001|Overall Study|Protocol Specified Criteria|13|||
129849745|NCT02343458|467410636|FG002|Overall Study|Protocol Specified Criteria|14|||
129849746|NCT02343458|467410637|FG003|Overall Study|Protocol Specified Criteria|8|||
129849747|NCT02080091|467410638|FG000|Overall Study|Study Terminated|22|||
129849748|NCT02080091|467410638|FG000|Overall Study|Death|1|||
129849749|NCT02080091|467410638|FG000|Overall Study|Withdrawal by Subject|1|||
129849750|NCT02080091|467410638|FG000|Overall Study|Other|1|||
129849751|NCT02886572|467410640|FG000|Overall Study|Death|8|||
129849752|NCT00408993|467410641|FG000|Overall Study|Adverse Event|15|||
129849753|NCT00408993|467410642|FG001|Overall Study|Adverse Event|4|||
129849754|NCT00408993|467410641|FG000|Overall Study|Protocol Violation|1|||
129849755|NCT00408993|467410642|FG001|Overall Study|Protocol Violation|6|||
129849756|NCT00408993|467410641|FG000|Overall Study|Lack of Efficacy|1|||
129849757|NCT00408993|467410642|FG001|Overall Study|Lack of Efficacy|4|||
129849758|NCT00408993|467410641|FG000|Overall Study|Withdrawal by Subject|2|||
129849759|NCT00408993|467410642|FG001|Overall Study|Withdrawal by Subject|3|||
129849760|NCT03738865|467410643|FG000|Overall Study|Withdrawal by Subject|3|||
129849761|NCT03738865|467410644|FG001|Overall Study|Withdrawal by Subject|3|||
129849762|NCT03738865|467410643|FG000|Overall Study|Adverse Event|2|||
129849763|NCT03738865|467410644|FG001|Overall Study|Adverse Event|0|||
129849764|NCT03738865|467410643|FG000|Overall Study|Physician Decision|0|||
129849765|NCT03738865|467410644|FG001|Overall Study|Physician Decision|1|||
129849766|NCT00961259|467410645|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
129849767|NCT00961259|467410646|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
129849768|NCT00961259|467410647|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
129849769|NCT01324024|467410648|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
129849770|NCT01324024|467410649|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129849771|NCT02691455|467410650|FG000|Overall Study|Withdrawal by Subject|1|||
129849772|NCT02691455|467410651|FG001|Overall Study|Withdrawal by Subject|2|||
129849773|NCT02691455|467410650|FG000|Overall Study|Lost to Follow-up|15|||
129849774|NCT02691455|467410651|FG001|Overall Study|Lost to Follow-up|15|||
129849775|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129849776|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
129849777|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
129849778|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
129849779|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
129849780|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
129849781|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129849782|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
129849783|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129849784|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129849785|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
129849786|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129849787|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
129849788|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
129849789|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
129849790|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
129849791|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
129849792|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
129849793|NCT01257204|467410652|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
129849794|NCT01257204|467410653|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
129849795|NCT01257204|467410654|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
129849796|NCT01257204|467410652|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
129849797|NCT01257204|467410653|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
129849798|NCT01257204|467410654|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
129849799|NCT01257204|467410652|FG000|Follow-up Period (up to Week 48)|Other|0|||
129849800|NCT01257204|467410653|FG001|Follow-up Period (up to Week 48)|Other|0|||
129849801|NCT01257204|467410654|FG002|Follow-up Period (up to Week 48)|Other|5|||
129849802|NCT01276327|467410658|FG000|Overall Study|Adverse Event|1|||
129849803|NCT01276327|467410659|FG001|Overall Study|Adverse Event|3|||
129849804|NCT01276327|467410658|FG000|Overall Study|Withdrawal by Subject|1|||
129849805|NCT01276327|467410659|FG001|Overall Study|Withdrawal by Subject|0|||
129849806|NCT01794949|467410660|FG000|Overall Study|Lost to Follow-up|1|||
129849807|NCT01794949|467410661|FG001|Overall Study|Lost to Follow-up|0|||
129849808|NCT03766646|467410663|FG000|Overall Study|Withdrawal by Subject|1|||
129849809|NCT03766646|467410664|FG001|Overall Study|Withdrawal by Subject|0|||
129849810|NCT03766646|467410663|FG000|Overall Study|Protocol Violation|0|||
129849811|NCT03766646|467410664|FG001|Overall Study|Protocol Violation|3|||
129849812|NCT04713748|467410674|FG000|Overall Study|Not enough kits allocated|35|||
129849813|NCT02802345|467410681|FG000|Overall Study|Not Treated|0|||
129849814|NCT02802345|467410682|FG001|Overall Study|Not Treated|1|||
129849815|NCT02802345|467410681|FG000|Overall Study|Adverse Event|28|||
129849816|NCT02802345|467410682|FG001|Overall Study|Adverse Event|20|||
129849817|NCT02802345|467410681|FG000|Overall Study|Withdrawal by Subject|3|||
129849818|NCT02802345|467410682|FG001|Overall Study|Withdrawal by Subject|3|||
129849819|NCT02802345|467410681|FG000|Overall Study|Protocol Violation|0|||
129849820|NCT02802345|467410682|FG001|Overall Study|Protocol Violation|1|||
129849821|NCT02802345|467410681|FG000|Overall Study|Other than listed|1|||
129849822|NCT02802345|467410682|FG001|Overall Study|Other than listed|5|||
129849823|NCT05857527|467410685|FG000|Overall Study|Withdrawal by Subject|0|||
129849824|NCT05857527|467410686|FG001|Overall Study|Withdrawal by Subject|1|||
129849825|NCT02799082|467410689|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
129849826|NCT02799082|467410690|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
129849827|NCT02799082|467410689|FG000|Overall Study|Protocol Violation|0|||
129849828|NCT02799082|467410690|FG001|Overall Study|Protocol Violation|1|||
129849829|NCT01748994|467410695|FG000|Overall Study|Lost to Follow-up|8|||
129849830|NCT01748994|467410696|FG001|Overall Study|Lost to Follow-up|6|||
129849831|NCT02520531|467410699|FG000|Overall Study|Revision of study device components|2|||
129849832|NCT02520531|467410700|FG001|Overall Study|Revision of study device components|2|||
129849833|NCT02520531|467410699|FG000|Overall Study|Death|1|||
129849834|NCT02520531|467410700|FG001|Overall Study|Death|2|||
129849835|NCT02520531|467410699|FG000|Overall Study|Lost to Follow-up|1|||
129849836|NCT02520531|467410700|FG001|Overall Study|Lost to Follow-up|1|||
129849837|NCT02520531|467410699|FG000|Overall Study|Meet exclusion criterion|0|||
129849838|NCT02520531|467410700|FG001|Overall Study|Meet exclusion criterion|1|||
129849839|NCT02520531|467410699|FG000|Overall Study|Withdrawal by Subject|1|||
129849840|NCT02520531|467410700|FG001|Overall Study|Withdrawal by Subject|0|||
129849841|NCT02520531|467410699|FG000|Overall Study|Not study device|1|||
129849842|NCT02520531|467410700|FG001|Overall Study|Not study device|0|||
129849843|NCT01723904|467410702|FG000|Overall Study|Noncompliant|3|||
129849844|NCT01723904|467410702|FG000|Overall Study|Adverse Event|5|||
129849845|NCT01723904|467410702|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
129849846|NCT03251924|467410703|FG000|Overall Study|Disease Progression|6|||
129849847|NCT03251924|467410704|FG001|Overall Study|Disease Progression|6|||
129849848|NCT03251924|467410705|FG002|Overall Study|Disease Progression|7|||
129849849|NCT03251924|467410706|FG003|Overall Study|Disease Progression|8|||
129849850|NCT03251924|467410707|FG004|Overall Study|Disease Progression|8|||
129849851|NCT03251924|467410708|FG005|Overall Study|Disease Progression|7|||
129849852|NCT03251924|467410709|FG006|Overall Study|Disease Progression|6|||
129849853|NCT03251924|467410710|FG007|Overall Study|Disease Progression|10|||
129849854|NCT03251924|467410711|FG008|Overall Study|Disease Progression|6|||
129849855|NCT03251924|467410703|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
129849856|NCT03251924|467410704|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
129849857|NCT03251924|467410705|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
129849858|NCT03251924|467410706|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
129849859|NCT03251924|467410707|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
129849860|NCT03251924|467410708|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
129904123|NCT04424641|467610973|FG005|Overall Study|Sponsor decision|2|||
129904124|NCT04424641|467610974|FG006|Overall Study|Sponsor decision|3|||
129904125|NCT04424641|467610975|FG007|Overall Study|Sponsor decision|4|||
129904126|NCT04424641|467610968|FG000|Overall Study|Withdrawal by Subject|0|||
129849861|NCT03251924|467410709|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
129849862|NCT03251924|467410710|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
129849863|NCT03251924|467410711|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
129849864|NCT03251924|467410703|FG000|Overall Study|Death|0|||
129849865|NCT03251924|467410704|FG001|Overall Study|Death|1|||
129849866|NCT03251924|467410705|FG002|Overall Study|Death|0|||
129849867|NCT03251924|467410706|FG003|Overall Study|Death|1|||
129849868|NCT03251924|467410707|FG004|Overall Study|Death|1|||
129849869|NCT03251924|467410708|FG005|Overall Study|Death|1|||
129849870|NCT03251924|467410709|FG006|Overall Study|Death|0|||
129849871|NCT03251924|467410710|FG007|Overall Study|Death|0|||
129849872|NCT03251924|467410711|FG008|Overall Study|Death|0|||
129849873|NCT03251924|467410703|FG000|Overall Study|Study Drug Toxicity|0|||
129849874|NCT03251924|467410704|FG001|Overall Study|Study Drug Toxicity|0|||
129849875|NCT03251924|467410705|FG002|Overall Study|Study Drug Toxicity|0|||
129849876|NCT03251924|467410706|FG003|Overall Study|Study Drug Toxicity|1|||
129849877|NCT03251924|467410707|FG004|Overall Study|Study Drug Toxicity|0|||
129849878|NCT03251924|467410708|FG005|Overall Study|Study Drug Toxicity|0|||
129849879|NCT03251924|467410709|FG006|Overall Study|Study Drug Toxicity|0|||
129849880|NCT03251924|467410710|FG007|Overall Study|Study Drug Toxicity|0|||
129849881|NCT03251924|467410711|FG008|Overall Study|Study Drug Toxicity|1|||
129849882|NCT03251924|467410703|FG000|Overall Study|Other Reasons|0|||
129849883|NCT03251924|467410704|FG001|Overall Study|Other Reasons|0|||
129849884|NCT03251924|467410705|FG002|Overall Study|Other Reasons|0|||
129849885|NCT03251924|467410706|FG003|Overall Study|Other Reasons|0|||
129849886|NCT03251924|467410707|FG004|Overall Study|Other Reasons|0|||
129849887|NCT03251924|467410708|FG005|Overall Study|Other Reasons|0|||
129849888|NCT03251924|467410709|FG006|Overall Study|Other Reasons|0|||
129849889|NCT03251924|467410710|FG007|Overall Study|Other Reasons|0|||
129849890|NCT03251924|467410711|FG008|Overall Study|Other Reasons|1|||
129849891|NCT03251924|467410703|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129849892|NCT03251924|467410704|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129849893|NCT03251924|467410705|FG002|Overall Study|Participant request to discontinue study treatment|0|||
129849894|NCT03251924|467410706|FG003|Overall Study|Participant request to discontinue study treatment|0|||
129849895|NCT03251924|467410707|FG004|Overall Study|Participant request to discontinue study treatment|0|||
129849896|NCT03251924|467410708|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129849897|NCT03251924|467410709|FG006|Overall Study|Participant request to discontinue study treatment|0|||
129849898|NCT03251924|467410710|FG007|Overall Study|Participant request to discontinue study treatment|1|||
129849899|NCT03251924|467410711|FG008|Overall Study|Participant request to discontinue study treatment|0|||
129849900|NCT02617589|467410720|FG000|Randomization|Request to Discontinue Study Treatment|1|||
129849901|NCT02617589|467410721|FG001|Randomization|Request to Discontinue Study Treatment|3|||
129849902|NCT02617589|467410720|FG000|Randomization|Participant Withdrew Consent|1|||
129849903|NCT02617589|467410721|FG001|Randomization|Participant Withdrew Consent|2|||
129849904|NCT02617589|467410720|FG000|Treatment|Other Reasons|3|||
129849905|NCT02617589|467410721|FG001|Treatment|Other Reasons|3|||
129849906|NCT02617589|467410720|FG000|Treatment|Poor/Non Compliance|1|||
129849907|NCT02617589|467410721|FG001|Treatment|Poor/Non Compliance|1|||
129849908|NCT02617589|467410720|FG000|Treatment|Maximum Clinical Benefit|0|||
129849909|NCT02617589|467410721|FG001|Treatment|Maximum Clinical Benefit|2|||
129904127|NCT04424641|467610969|FG001|Overall Study|Withdrawal by Subject|0|||
129904128|NCT04424641|467610970|FG002|Overall Study|Withdrawal by Subject|0|||
129849910|NCT02617589|467410720|FG000|Treatment|Participant Withdrew Consent|2|||
129849911|NCT02617589|467410721|FG001|Treatment|Participant Withdrew Consent|6|||
129849912|NCT02617589|467410720|FG000|Treatment|Participant Request to Discontinue|12|||
129849913|NCT02617589|467410721|FG001|Treatment|Participant Request to Discontinue|21|||
129849914|NCT02617589|467410720|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
129849915|NCT02617589|467410721|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
129849916|NCT02617589|467410720|FG000|Treatment|Death|1|||
129849917|NCT02617589|467410721|FG001|Treatment|Death|1|||
129904129|NCT04424641|467610971|FG003|Overall Study|Withdrawal by Subject|0|||
129849918|NCT02617589|467410720|FG000|Treatment|Study Drug Toxicity|27|||
129849919|NCT02617589|467410721|FG001|Treatment|Study Drug Toxicity|20|||
129849920|NCT02617589|467410720|FG000|Treatment|Disease Progression|216|||
129849921|NCT02617589|467410721|FG001|Treatment|Disease Progression|136|||
129849922|NCT01649856|467410722|FG000|Overall Study|Withdrawal by Subject|14|||
129849923|NCT01649856|467410723|FG001|Overall Study|Withdrawal by Subject|14|||
129849924|NCT01649856|467410722|FG000|Overall Study|Protocol Violation|4|||
129849925|NCT01649856|467410723|FG001|Overall Study|Protocol Violation|4|||
129849926|NCT01649856|467410722|FG000|Overall Study|Treatment Failure|1|||
129849927|NCT01649856|467410723|FG001|Overall Study|Treatment Failure|1|||
129849928|NCT01649856|467410722|FG000|Overall Study|Death|69|||
129849929|NCT01649856|467410723|FG001|Overall Study|Death|34|||
129904130|NCT04424641|467610972|FG004|Overall Study|Withdrawal by Subject|1|||
129904131|NCT04424641|467610973|FG005|Overall Study|Withdrawal by Subject|0|||
129904132|NCT04424641|467610974|FG006|Overall Study|Withdrawal by Subject|0|||
129904133|NCT04424641|467610975|FG007|Overall Study|Withdrawal by Subject|0|||
129904134|NCT04424641|467610968|FG000|Overall Study|Other|0|||
129904135|NCT04424641|467610969|FG001|Overall Study|Other|0|||
129904136|NCT04424641|467610970|FG002|Overall Study|Other|1|||
129904137|NCT04424641|467610971|FG003|Overall Study|Other|0|||
129904138|NCT04424641|467610972|FG004|Overall Study|Other|0|||
129904139|NCT04424641|467610973|FG005|Overall Study|Other|0|||
129904140|NCT04424641|467610974|FG006|Overall Study|Other|0|||
129904141|NCT04424641|467610975|FG007|Overall Study|Other|0|||
129904142|NCT01613716|467610982|FG000|Overall Study|screen failures|3|||
129904143|NCT01613716|467610982|FG000|Overall Study|Lost to Follow-up|4|||
129904144|NCT01171625|467610983|FG000|Overall Study|On-Protocol|67|||
129904145|NCT01171625|467610983|FG000|Overall Study|Death|38|||
129904146|NCT01171625|467610983|FG000|Overall Study|Withdrawal by Subject|31|||
129904147|NCT01171625|467610983|FG000|Overall Study|Explanted|10|||
129904148|NCT01171625|467610983|FG000|Overall Study|Lost to Follow-up|5|||
129904149|NCT01171625|467610983|FG000|Overall Study|Patient received valve-in-valve|3|||
129904150|NCT01171625|467610983|FG000|Overall Study|Other|1|||
129904151|NCT01171625|467610983|FG000|Overall Study|Consented but did not receive device|25|||
129904152|NCT05174013|467610984|FG000|Overall Study|Lost to Follow-up|0|||
129904153|NCT05174013|467610985|FG001|Overall Study|Lost to Follow-up|0|||
129904154|NCT05174013|467610986|FG002|Overall Study|Lost to Follow-up|0|||
129904155|NCT05174013|467610987|FG003|Overall Study|Lost to Follow-up|1|||
129904156|NCT05174013|467610988|FG004|Overall Study|Lost to Follow-up|0|||
129904157|NCT05174013|467610989|FG005|Overall Study|Lost to Follow-up|0|||
129904158|NCT05174013|467610984|FG000|Overall Study|Withdrawal by Subject|0|||
129904159|NCT05174013|467610985|FG001|Overall Study|Withdrawal by Subject|0|||
129904160|NCT05174013|467610986|FG002|Overall Study|Withdrawal by Subject|1|||
129904161|NCT05174013|467610987|FG003|Overall Study|Withdrawal by Subject|0|||
129904162|NCT05174013|467610988|FG004|Overall Study|Withdrawal by Subject|0|||
129904163|NCT05174013|467610989|FG005|Overall Study|Withdrawal by Subject|0|||
129904164|NCT01930045|467610990|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904165|NCT01930045|467610991|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904166|NCT01930045|467610992|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904167|NCT01930045|467610993|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904168|NCT01930045|467610994|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904169|NCT01930045|467610995|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
129904170|NCT01930045|467610990|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
129904171|NCT01930045|467610991|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
129904172|NCT01930045|467610992|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
129904173|NCT01930045|467610993|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
129904174|NCT01930045|467610994|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
129904175|NCT01930045|467610995|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
129904176|NCT01924767|467610996|FG000|Overall Study|Adverse Event|1|||
129904177|NCT01924767|467610997|FG001|Overall Study|Adverse Event|0|||
129904178|NCT01924767|467610998|FG002|Overall Study|Adverse Event|1|||
129904179|NCT01924767|467610999|FG003|Overall Study|Adverse Event|0|||
129904180|NCT01924767|467611000|FG004|Overall Study|Adverse Event|0|||
129904181|NCT01194154|467611003|FG000|Overall Study|Adverse Event|12|||
129904182|NCT01194154|467611004|FG001|Overall Study|Adverse Event|7|||
129904183|NCT01194154|467611003|FG000|Overall Study|Lost to Follow-up|2|||
129904184|NCT01194154|467611004|FG001|Overall Study|Lost to Follow-up|3|||
129904185|NCT01194154|467611003|FG000|Overall Study|Protocol Violation|0|||
129904186|NCT01194154|467611004|FG001|Overall Study|Protocol Violation|1|||
129904187|NCT01194154|467611003|FG000|Overall Study|Withdrawal by Subject|5|||
129904188|NCT01194154|467611004|FG001|Overall Study|Withdrawal by Subject|6|||
129904189|NCT01194154|467611003|FG000|Overall Study|Blood pressure increase|5|||
129904190|NCT01194154|467611004|FG001|Overall Study|Blood pressure increase|3|||
129904191|NCT01194154|467611003|FG000|Overall Study|Hemoglobin decrease|0|||
129904192|NCT01194154|467611004|FG001|Overall Study|Hemoglobin decrease|1|||
129904193|NCT01194154|467611003|FG000|Overall Study|Hemoglobin increase|12|||
129904194|NCT01194154|467611004|FG001|Overall Study|Hemoglobin increase|3|||
129904195|NCT01194154|467611003|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
129904196|NCT01194154|467611004|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
129904197|NCT01194154|467611003|FG000|Overall Study|Treatment with prohibited medication|4|||
129904198|NCT01194154|467611004|FG001|Overall Study|Treatment with prohibited medication|5|||
129904199|NCT01194154|467611003|FG000|Overall Study|Other|4|||
129904200|NCT01194154|467611004|FG001|Overall Study|Other|0|||
129904201|NCT01194154|467611003|FG000|Overall Study|Did not receive study medication|2|||
129904202|NCT01194154|467611004|FG001|Overall Study|Did not receive study medication|4|||
129904203|NCT02314117|467611005|FG000|Overall Study|Lost to Follow-up|9|||
129904204|NCT02314117|467611006|FG001|Overall Study|Lost to Follow-up|14|||
129904205|NCT02314117|467611005|FG000|Overall Study|Withdrawal by Subject|3|||
129904206|NCT02314117|467611006|FG001|Overall Study|Withdrawal by Subject|2|||
129904207|NCT00880048|467611010|FG000|Overall Study|Adverse Event|2|||
129904208|NCT00880048|467611011|FG001|Overall Study|Adverse Event|3|||
129849930|NCT01649856|467410722|FG000|Overall Study|Stable or Progressed Disease|5|||
129849931|NCT01649856|467410723|FG001|Overall Study|Stable or Progressed Disease|3|||
129849932|NCT01649856|467410722|FG000|Overall Study|Lost to Follow-up|20|||
129849933|NCT01649856|467410723|FG001|Overall Study|Lost to Follow-up|16|||
129849934|NCT01649856|467410722|FG000|Overall Study|Lack of Compliance|6|||
129849935|NCT01649856|467410723|FG001|Overall Study|Lack of Compliance|1|||
129849936|NCT01649856|467410722|FG000|Overall Study|Other|20|||
129849937|NCT01649856|467410723|FG001|Overall Study|Other|5|||
129849938|NCT00622635|467410724|FG000|Treatment Period 1|Adverse Event|0|||
129849939|NCT00622635|467410725|FG001|Treatment Period 1|Adverse Event|0|||
129849940|NCT00622635|467410726|FG002|Treatment Period 1|Adverse Event|1|||
129849941|NCT00622635|467410727|FG003|Treatment Period 1|Adverse Event|0|||
129849942|NCT00622635|467410728|FG004|Treatment Period 1|Adverse Event|0|||
129849943|NCT00622635|467410729|FG005|Treatment Period 1|Adverse Event|0|||
129849944|NCT00622635|467410724|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129849945|NCT00622635|467410725|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129849946|NCT00622635|467410726|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129849947|NCT00622635|467410727|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129849948|NCT00622635|467410728|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129849949|NCT00622635|467410729|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129849950|NCT00622635|467410724|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849951|NCT00622635|467410725|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849952|NCT00622635|467410726|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849953|NCT00622635|467410727|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849954|NCT00622635|467410728|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
129849955|NCT00622635|467410729|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849956|NCT00622635|467410724|FG000|Treatment Period 2|Adverse Event|1|||
129849957|NCT00622635|467410725|FG001|Treatment Period 2|Adverse Event|0|||
129849958|NCT00622635|467410726|FG002|Treatment Period 2|Adverse Event|0|||
129849959|NCT00622635|467410727|FG003|Treatment Period 2|Adverse Event|0|||
129849960|NCT00622635|467410728|FG004|Treatment Period 2|Adverse Event|0|||
129849961|NCT00622635|467410729|FG005|Treatment Period 2|Adverse Event|0|||
129849962|NCT00622635|467410724|FG000|Treatment Period 3|Adverse Event|0|||
129849963|NCT00622635|467410725|FG001|Treatment Period 3|Adverse Event|0|||
129849964|NCT00622635|467410726|FG002|Treatment Period 3|Adverse Event|0|||
129849965|NCT00622635|467410727|FG003|Treatment Period 3|Adverse Event|2|||
129849966|NCT00622635|467410728|FG004|Treatment Period 3|Adverse Event|0|||
129849967|NCT00622635|467410729|FG005|Treatment Period 3|Adverse Event|0|||
129849968|NCT00622635|467410724|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129849969|NCT00622635|467410725|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129849970|NCT00622635|467410726|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129849971|NCT00622635|467410727|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129849972|NCT00622635|467410728|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129849973|NCT00622635|467410729|FG005|Treatment Period 3|Withdrawal by Subject|0|||
129849974|NCT03027466|467410734|FG000|Overall Study|Opting out of the app|1869|||
129849975|NCT03027466|467410735|FG001|Overall Study|Opting out of the app|1819|||
129849976|NCT03027466|467410736|FG002|Overall Study|Opting out of the app|1743|||
129849977|NCT03027466|467410737|FG003|Overall Study|Opting out of the app|1821|||
129849978|NCT03062891|467410747|FG000|Overall Study|Withdrawal by Subject|2|||
129849979|NCT03062891|467410748|FG001|Overall Study|Withdrawal by Subject|0|||
129849980|NCT03062891|467410747|FG000|Overall Study|Lost to Follow-up|50|||
129849981|NCT03062891|467410748|FG001|Overall Study|Lost to Follow-up|38|||
129849982|NCT01687166|467410749|FG000|Overall Study|Attempt subject|2|||
129849983|NCT01687166|467410750|FG001|Overall Study|Attempt subject|3|||
129849984|NCT01687166|467410751|FG002|Overall Study|Attempt subject|2|||
129849985|NCT01687166|467410752|FG003|Overall Study|Attempt subject|0|||
129849986|NCT01687166|467410749|FG000|Overall Study|Did not meet eligibility criteria|4|||
129849987|NCT01687166|467410750|FG001|Overall Study|Did not meet eligibility criteria|6|||
129849988|NCT01687166|467410751|FG002|Overall Study|Did not meet eligibility criteria|1|||
129849989|NCT01687166|467410752|FG003|Overall Study|Did not meet eligibility criteria|1|||
129849990|NCT01687166|467410749|FG000|Overall Study|Adverse Event|2|||
129849991|NCT01687166|467410750|FG001|Overall Study|Adverse Event|1|||
129849992|NCT01687166|467410751|FG002|Overall Study|Adverse Event|0|||
129849993|NCT01687166|467410752|FG003|Overall Study|Adverse Event|0|||
129849994|NCT01687166|467410749|FG000|Overall Study|Physician Decision|3|||
129849995|NCT01687166|467410750|FG001|Overall Study|Physician Decision|2|||
129849996|NCT01687166|467410751|FG002|Overall Study|Physician Decision|1|||
129849997|NCT01687166|467410752|FG003|Overall Study|Physician Decision|0|||
129849998|NCT01687166|467410749|FG000|Overall Study|Withdrawal by Subject|11|||
129904209|NCT00880048|467611012|FG002|Overall Study|Adverse Event|5|||
129849999|NCT01687166|467410750|FG001|Overall Study|Withdrawal by Subject|4|||
129850000|NCT01687166|467410751|FG002|Overall Study|Withdrawal by Subject|3|||
129850001|NCT01687166|467410752|FG003|Overall Study|Withdrawal by Subject|0|||
129850002|NCT01687166|467410749|FG000|Overall Study|Lost to Follow-up|2|||
129850003|NCT01687166|467410750|FG001|Overall Study|Lost to Follow-up|5|||
129850004|NCT01687166|467410751|FG002|Overall Study|Lost to Follow-up|1|||
129850005|NCT01687166|467410752|FG003|Overall Study|Lost to Follow-up|0|||
129904210|NCT00880048|467611010|FG000|Overall Study|Lack of Efficacy|1|||
129904211|NCT00880048|467611011|FG001|Overall Study|Lack of Efficacy|2|||
129904212|NCT00880048|467611012|FG002|Overall Study|Lack of Efficacy|2|||
129904213|NCT00880048|467611010|FG000|Overall Study|Protocol Violation|4|||
129904214|NCT00880048|467611011|FG001|Overall Study|Protocol Violation|6|||
129904215|NCT00880048|467611012|FG002|Overall Study|Protocol Violation|5|||
129904216|NCT00880048|467611010|FG000|Overall Study|Lost to Follow-up|6|||
129904217|NCT00880048|467611011|FG001|Overall Study|Lost to Follow-up|6|||
129904218|NCT00880048|467611012|FG002|Overall Study|Lost to Follow-up|5|||
129904219|NCT00880048|467611010|FG000|Overall Study|Physician Decision|1|||
129904220|NCT00880048|467611011|FG001|Overall Study|Physician Decision|1|||
129904221|NCT00880048|467611012|FG002|Overall Study|Physician Decision|7|||
129904222|NCT00880048|467611010|FG000|Overall Study|Withdrawal by Subject|5|||
129904223|NCT00880048|467611011|FG001|Overall Study|Withdrawal by Subject|8|||
129904224|NCT00880048|467611012|FG002|Overall Study|Withdrawal by Subject|5|||
129904225|NCT00880048|467611010|FG000|Overall Study|Study closed/terminated|9|||
129904226|NCT00880048|467611011|FG001|Overall Study|Study closed/terminated|7|||
129904227|NCT00880048|467611012|FG002|Overall Study|Study closed/terminated|6|||
129904228|NCT02954848|467611017|FG000|Overall Study|Randomized but Not Treated|0|||
129904229|NCT02954848|467611018|FG001|Overall Study|Randomized but Not Treated|1|||
129904230|NCT02954848|467611017|FG000|Overall Study|Adverse Event|2|||
129904231|NCT02954848|467611018|FG001|Overall Study|Adverse Event|3|||
129904232|NCT02954848|467611017|FG000|Overall Study|Withdrawal by Participant|0|||
129904233|NCT02954848|467611018|FG001|Overall Study|Withdrawal by Participant|1|||
129904234|NCT01184508|467611019|FG000|Overall Study|Adverse Event|4|||
129904235|NCT01184508|467611020|FG001|Overall Study|Adverse Event|6|||
129904236|NCT01184508|467611019|FG000|Overall Study|Lack of Efficacy|1|||
129904237|NCT01184508|467611020|FG001|Overall Study|Lack of Efficacy|1|||
129904238|NCT01184508|467611019|FG000|Overall Study|Lost to Follow-up|1|||
129904239|NCT01184508|467611020|FG001|Overall Study|Lost to Follow-up|1|||
129904240|NCT01184508|467611019|FG000|Overall Study|Physician Decision|1|||
129904241|NCT01184508|467611020|FG001|Overall Study|Physician Decision|0|||
129904242|NCT01184508|467611019|FG000|Overall Study|Protocol Violation|3|||
129904243|NCT01184508|467611020|FG001|Overall Study|Protocol Violation|1|||
129904244|NCT01184508|467611019|FG000|Overall Study|Sponsor Decision|5|||
129904245|NCT01184508|467611020|FG001|Overall Study|Sponsor Decision|2|||
129904246|NCT01184508|467611019|FG000|Overall Study|Withdrawal by Subject|1|||
129904247|NCT01184508|467611020|FG001|Overall Study|Withdrawal by Subject|3|||
129904248|NCT01184508|467611019|FG000|Overall Study|Randomized, Not Treated|0|||
129904249|NCT01184508|467611020|FG001|Overall Study|Randomized, Not Treated|1|||
129904250|NCT02798835|467611026|FG000|Overall Study|Protocol Violation|0|||
129904251|NCT02798835|467611027|FG001|Overall Study|Protocol Violation|0|||
129904252|NCT02798835|467611028|FG002|Overall Study|Protocol Violation|3|||
129904253|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
129904254|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
129904255|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
129904256|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
129904257|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
129904258|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
129904259|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
129904260|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
129904261|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
129904262|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904263|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904264|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904265|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904266|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
129904267|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
129904268|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904269|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904270|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
129904271|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904272|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904273|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904274|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904275|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904276|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904277|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904278|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904279|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
129904280|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
129904281|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
129904282|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
129904283|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
129904284|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
129904285|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
129904286|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
129904287|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
129904288|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904289|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904290|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904291|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904292|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904293|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
129904294|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
129904295|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129850006|NCT01687166|467410749|FG000|Overall Study|Equipment/Device Availability|0|||
129850007|NCT01687166|467410750|FG001|Overall Study|Equipment/Device Availability|1|||
129850008|NCT01687166|467410751|FG002|Overall Study|Equipment/Device Availability|0|||
129850009|NCT01687166|467410752|FG003|Overall Study|Equipment/Device Availability|0|||
129850010|NCT01687166|467410749|FG000|Overall Study|Death|1|||
129850011|NCT01687166|467410750|FG001|Overall Study|Death|1|||
129904296|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
129904297|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904298|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904299|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904300|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904301|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904302|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904303|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904304|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904305|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904306|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
129904307|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904308|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904309|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
129904310|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904311|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904312|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904313|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904314|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904315|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129850012|NCT01687166|467410751|FG002|Overall Study|Death|0|||
129850013|NCT01687166|467410752|FG003|Overall Study|Death|0|||
129850014|NCT01687166|467410749|FG000|Overall Study|Protocol Violation|1|||
129850015|NCT01687166|467410750|FG001|Overall Study|Protocol Violation|1|||
129850016|NCT01687166|467410751|FG002|Overall Study|Protocol Violation|1|||
129850017|NCT01687166|467410752|FG003|Overall Study|Protocol Violation|0|||
129850018|NCT01687166|467410749|FG000|Overall Study|Subject moved out of state|0|||
129850019|NCT01687166|467410750|FG001|Overall Study|Subject moved out of state|1|||
129850020|NCT01687166|467410751|FG002|Overall Study|Subject moved out of state|0|||
129850021|NCT01687166|467410752|FG003|Overall Study|Subject moved out of state|0|||
129850022|NCT01687166|467410749|FG000|Overall Study|Patient unable to be compliant|1|||
129850023|NCT01687166|467410750|FG001|Overall Study|Patient unable to be compliant|0|||
129850024|NCT01687166|467410751|FG002|Overall Study|Patient unable to be compliant|0|||
129850025|NCT01687166|467410752|FG003|Overall Study|Patient unable to be compliant|0|||
129850026|NCT01687166|467410749|FG000|Overall Study|Physician choice to use different device|1|||
129850027|NCT01687166|467410750|FG001|Overall Study|Physician choice to use different device|2|||
129850028|NCT01687166|467410751|FG002|Overall Study|Physician choice to use different device|4|||
129850029|NCT01687166|467410752|FG003|Overall Study|Physician choice to use different device|0|||
129850030|NCT01687166|467410749|FG000|Overall Study|Insurance|0|||
129850031|NCT01687166|467410750|FG001|Overall Study|Insurance|0|||
129850032|NCT01687166|467410751|FG002|Overall Study|Insurance|1|||
129850033|NCT01687166|467410752|FG003|Overall Study|Insurance|1|||
129904316|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904317|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904318|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
129850034|NCT01516879|467410753|FG000|Overall Study|Withdrawal by Subject|9|||
129904319|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129850035|NCT01516879|467410754|FG001|Overall Study|Withdrawal by Subject|11|||
129850036|NCT01516879|467410753|FG000|Overall Study|Death|0|||
129850037|NCT01516879|467410754|FG001|Overall Study|Death|2|||
129850038|NCT01516879|467410753|FG000|Overall Study|Lost to Follow-up|2|||
129850039|NCT01516879|467410754|FG001|Overall Study|Lost to Follow-up|11|||
129850040|NCT01516879|467410753|FG000|Overall Study|Other|5|||
129850041|NCT01516879|467410754|FG001|Overall Study|Other|10|||
129850042|NCT01600586|467410755|FG000|Overall Study|Physician Decision|3|||
129850043|NCT01600586|467410756|FG001|Overall Study|Physician Decision|3|||
129850044|NCT01898793|467410757|FG000|Overall Study|Death|2|||
129850045|NCT01898793|467410758|FG001|Overall Study|Death|1|||
129850046|NCT01898793|467410759|FG002|Overall Study|Death|4|||
129850047|NCT01898793|467410760|FG003|Overall Study|Death|0|||
129850048|NCT01898793|467410761|FG004|Overall Study|Death|0|||
129850049|NCT01898793|467410762|FG005|Overall Study|Death|0|||
129850050|NCT01898793|467410763|FG006|Overall Study|Death|0|||
129850051|NCT00931307|467410764|FG000|Overall Study|Lack of Efficacy|12|||
129850052|NCT00931307|467410764|FG000|Overall Study|Biomicroscopy|1|||
129850053|NCT02447991|467410767|FG000|Overall Study|Withdrawn by subject - no data|0|||
129850054|NCT02447991|467410768|FG001|Overall Study|Withdrawn by subject - no data|2|||
129850055|NCT02447991|467410767|FG000|Overall Study|Withdrawn by Subject - with data|4|||
129850056|NCT02447991|467410768|FG001|Overall Study|Withdrawn by Subject - with data|4|||
129850057|NCT02447991|467410767|FG000|Overall Study|Lost to Follow-up - no data|3|||
129850058|NCT02447991|467410768|FG001|Overall Study|Lost to Follow-up - no data|6|||
129850059|NCT02447991|467410767|FG000|Overall Study|Lost to follow-up - with data|0|||
129850060|NCT02447991|467410768|FG001|Overall Study|Lost to follow-up - with data|3|||
129850061|NCT02447991|467410767|FG000|Overall Study|End of study - no treatment results|3|||
129850062|NCT02447991|467410768|FG001|Overall Study|End of study - no treatment results|6|||
129850063|NCT02447991|467410767|FG000|Overall Study|End of study - partial treatment results|0|||
129850064|NCT02447991|467410768|FG001|Overall Study|End of study - partial treatment results|9|||
129850065|NCT00459134|467410769|FG000|Overall Study|Physician Decision|1|||
129850066|NCT00459134|467410770|FG001|Overall Study|Physician Decision|1|||
129850067|NCT00459134|467410769|FG000|Overall Study|Withdrawal by Subject|8|||
129850068|NCT00459134|467410770|FG001|Overall Study|Withdrawal by Subject|7|||
129850069|NCT00459134|467410769|FG000|Overall Study|Lost to Follow-up|6|||
129850070|NCT00459134|467410770|FG001|Overall Study|Lost to Follow-up|7|||
129850071|NCT00459134|467410769|FG000|Overall Study|Surgery|1|||
129850072|NCT00459134|467410770|FG001|Overall Study|Surgery|2|||
129850073|NCT00459134|467410769|FG000|Overall Study|Toxicity|4|||
129850074|NCT00459134|467410770|FG001|Overall Study|Toxicity|5|||
129850075|NCT00459134|467410769|FG000|Overall Study|Progression|1|||
129850076|NCT00459134|467410770|FG001|Overall Study|Progression|0|||
129850077|NCT00459134|467410769|FG000|Overall Study|Multiple Reasons|2|||
129850078|NCT00459134|467410770|FG001|Overall Study|Multiple Reasons|3|||
129850079|NCT00829621|467410771|FG000|Overall Study|Death|1|||
129850080|NCT00829621|467410772|FG001|Overall Study|Death|0|||
129850081|NCT00829621|467410771|FG000|Overall Study|Lost to Follow-up|3|||
129850082|NCT00829621|467410772|FG001|Overall Study|Lost to Follow-up|4|||
129850083|NCT00774995|467410773|FG000|Overall Study|Protocol Violation|0|||
129850084|NCT00774995|467410774|FG001|Overall Study|Protocol Violation|0|||
129850085|NCT00774995|467410775|FG002|Overall Study|Protocol Violation|1|||
129850086|NCT00774995|467410776|FG003|Overall Study|Protocol Violation|0|||
129850087|NCT00441337|467410780|FG000|Overall Study|Disease Progression|6|||
129850088|NCT00441337|467410781|FG001|Overall Study|Disease Progression|6|||
129850089|NCT00441337|467410782|FG002|Overall Study|Disease Progression|4|||
129850090|NCT00441337|467410783|FG003|Overall Study|Disease Progression|18|||
129850091|NCT00441337|467410780|FG000|Overall Study|Lost to Follow-up|0|||
129850092|NCT00441337|467410781|FG001|Overall Study|Lost to Follow-up|0|||
129850093|NCT00441337|467410782|FG002|Overall Study|Lost to Follow-up|0|||
129850094|NCT00441337|467410783|FG003|Overall Study|Lost to Follow-up|1|||
129850095|NCT00441337|467410780|FG000|Overall Study|Sponsor Decision|0|||
129850096|NCT00441337|467410781|FG001|Overall Study|Sponsor Decision|0|||
129850097|NCT00441337|467410782|FG002|Overall Study|Sponsor Decision|1|||
129850098|NCT00441337|467410783|FG003|Overall Study|Sponsor Decision|2|||
129850099|NCT00441337|467410780|FG000|Overall Study|Did not meet inclusion criteria|0|||
129850100|NCT00441337|467410781|FG001|Overall Study|Did not meet inclusion criteria|0|||
129850101|NCT00441337|467410782|FG002|Overall Study|Did not meet inclusion criteria|1|||
129850102|NCT00441337|467410783|FG003|Overall Study|Did not meet inclusion criteria|0|||
129850103|NCT02066298|467412338|FG000|Overall Study|Lost to Follow-up|3|||
129850104|NCT02066298|467412339|FG001|Overall Study|Lost to Follow-up|2|||
129850105|NCT02066298|467412340|FG002|Overall Study|Lost to Follow-up|3|||
129850106|NCT02066298|467412341|FG003|Overall Study|Lost to Follow-up|2|||
129850107|NCT02066298|467412342|FG004|Overall Study|Lost to Follow-up|3|||
129850108|NCT02066298|467412343|FG005|Overall Study|Lost to Follow-up|4|||
129904320|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129850109|NCT02066298|467412338|FG000|Overall Study|Withdrawal by Subject|6|||
129850110|NCT02066298|467412339|FG001|Overall Study|Withdrawal by Subject|6|||
129850111|NCT02066298|467412340|FG002|Overall Study|Withdrawal by Subject|6|||
129850112|NCT02066298|467412341|FG003|Overall Study|Withdrawal by Subject|4|||
129850113|NCT02066298|467412342|FG004|Overall Study|Withdrawal by Subject|5|||
129850114|NCT02066298|467412343|FG005|Overall Study|Withdrawal by Subject|8|||
129850115|NCT02066298|467412338|FG000|Overall Study|Physician Decision|0|||
129850116|NCT02066298|467412339|FG001|Overall Study|Physician Decision|0|||
129904321|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129850117|NCT02066298|467412340|FG002|Overall Study|Physician Decision|1|||
129904322|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904323|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
129904324|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
129904325|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
129904326|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904327|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904328|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904329|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904330|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904331|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
129904332|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
129904333|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
129904334|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
129904335|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
129904336|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
129904337|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
129904338|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
129904339|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
129904340|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904341|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904342|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904343|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904344|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904345|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904346|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
129904347|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904348|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904349|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904350|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904351|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
129904352|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904353|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904354|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904355|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904356|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904357|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904358|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904359|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904360|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904361|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904362|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904363|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904364|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904365|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904366|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904367|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
129904368|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
129904369|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
129904370|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904371|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904372|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904373|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904374|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904375|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904376|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904377|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904378|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904379|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
129904380|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
129904381|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
129904382|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904383|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904384|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904385|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904386|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904387|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904388|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904389|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129850118|NCT02066298|467412341|FG003|Overall Study|Physician Decision|0|||
129850119|NCT02066298|467412342|FG004|Overall Study|Physician Decision|1|||
129850120|NCT02066298|467412343|FG005|Overall Study|Physician Decision|0|||
129850121|NCT03143829|467412344|FG000|Overall Study|Withdrawal by Subject|2|||
129850122|NCT03143829|467412345|FG001|Overall Study|Withdrawal by Subject|5|||
129850123|NCT03143829|467412344|FG000|Overall Study|Lost to Follow-up|0|||
129850124|NCT03143829|467412345|FG001|Overall Study|Lost to Follow-up|2|||
129850125|NCT03143829|467412344|FG000|Overall Study|Death|1|||
129850126|NCT03143829|467412345|FG001|Overall Study|Death|1|||
129850127|NCT03143829|467412344|FG000|Overall Study|changed treatment, no longer eligible|2|||
129850128|NCT03143829|467412345|FG001|Overall Study|changed treatment, no longer eligible|2|||
129850129|NCT00672477|467412346|FG000|Overall Study|Adverse Event|10|||
129850130|NCT00672477|467412347|FG001|Overall Study|Adverse Event|7|||
129850131|NCT00672477|467412346|FG000|Overall Study|Death|7|||
129850132|NCT00672477|467412347|FG001|Overall Study|Death|11|||
129850133|NCT00672477|467412346|FG000|Overall Study|Physician Decision|2|||
129850134|NCT00672477|467412347|FG001|Overall Study|Physician Decision|0|||
129850135|NCT00672477|467412346|FG000|Overall Study|Protocol Violation|1|||
129850136|NCT00672477|467412347|FG001|Overall Study|Protocol Violation|1|||
129850137|NCT00672477|467412346|FG000|Overall Study|Withdrawal by Subject|5|||
129850138|NCT00672477|467412347|FG001|Overall Study|Withdrawal by Subject|3|||
129850139|NCT00672477|467412346|FG000|Overall Study|Lack of Efficacy|1|||
129850140|NCT00672477|467412347|FG001|Overall Study|Lack of Efficacy|1|||
129850141|NCT00672477|467412346|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
129850142|NCT00672477|467412347|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
129850143|NCT02348489|467412350|FG000|Overall Study|Death|336|||
129850144|NCT02348489|467412351|FG001|Overall Study|Death|335|||
129850145|NCT02348489|467412350|FG000|Overall Study|Withdrawal by Subject|14|||
129850146|NCT02348489|467412351|FG001|Overall Study|Withdrawal by Subject|27|||
129850147|NCT02348489|467412350|FG000|Overall Study|Lost to Follow-up|3|||
129850148|NCT02348489|467412351|FG001|Overall Study|Lost to Follow-up|5|||
129850149|NCT02866682|467412352|FG000|Overall Study|Death|0|||
129850150|NCT02866682|467412353|FG001|Overall Study|Death|1|||
129850151|NCT02866682|467412352|FG000|Overall Study|Lost to Follow-up|0|||
129850152|NCT02866682|467412353|FG001|Overall Study|Lost to Follow-up|4|||
129850153|NCT02866682|467412352|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
129850154|NCT02866682|467412353|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
129850155|NCT02866682|467412352|FG000|Overall Study|Other|0|||
129850156|NCT02866682|467412353|FG001|Overall Study|Other|1|||
129850157|NCT01750268|467412355|FG000|Overall Study|Lost to Follow-up|0|||
129850158|NCT01750268|467412356|FG001|Overall Study|Lost to Follow-up|2|||
129850159|NCT01750268|467412355|FG000|Overall Study|Physician Decision|0|||
129850160|NCT01750268|467412356|FG001|Overall Study|Physician Decision|3|||
129850161|NCT01750268|467412355|FG000|Overall Study|Withdrawal by Subject|2|||
129850162|NCT01750268|467412356|FG001|Overall Study|Withdrawal by Subject|0|||
129850163|NCT03087591|467412359|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
129850164|NCT03087591|467412359|FG000|Overall Study|Withdrawal by Subject|1|||
129850165|NCT02621606|467412362|FG000|Overall Study|Withdrawal by Subject|0|||
129850166|NCT02621606|467412363|FG001|Overall Study|Withdrawal by Subject|1|||
129850167|NCT02621606|467412364|FG002|Overall Study|Withdrawal by Subject|0|||
129850168|NCT00274716|467412365|FG000|Phase A|Other non-reported reason|4|||
129850169|NCT00274716|467412366|FG001|Phase A|Other non-reported reason|2|||
129850170|NCT00274716|467412367|FG002|Phase A|Other non-reported reason|1|||
129850171|NCT00274716|467412368|FG003|Phase A|Other non-reported reason|2|||
129850172|NCT00274716|467412369|FG004|Phase A|Other non-reported reason|0|||
129850173|NCT00274716|467412370|FG005|Phase A|Other non-reported reason|1|||
129850174|NCT00274716|467412365|FG000|Phase A|Participant moved|0|||
129850175|NCT00274716|467412366|FG001|Phase A|Participant moved|0|||
129850176|NCT00274716|467412367|FG002|Phase A|Participant moved|1|||
129850177|NCT00274716|467412368|FG003|Phase A|Participant moved|0|||
129850178|NCT00274716|467412369|FG004|Phase A|Participant moved|0|||
129850179|NCT00274716|467412370|FG005|Phase A|Participant moved|1|||
129850180|NCT00274716|467412365|FG000|Phase A|Site Terminated|0|||
129850181|NCT00274716|467412366|FG001|Phase A|Site Terminated|0|||
129850182|NCT00274716|467412367|FG002|Phase A|Site Terminated|0|||
129850183|NCT00274716|467412368|FG003|Phase A|Site Terminated|1|||
129850184|NCT00274716|467412369|FG004|Phase A|Site Terminated|0|||
129850185|NCT00274716|467412370|FG005|Phase A|Site Terminated|0|||
129850186|NCT00274716|467412365|FG000|Phase A|Protocol Violation|1|||
129850187|NCT00274716|467412366|FG001|Phase A|Protocol Violation|0|||
129850188|NCT00274716|467412367|FG002|Phase A|Protocol Violation|0|||
129850189|NCT00274716|467412368|FG003|Phase A|Protocol Violation|1|||
129850190|NCT00274716|467412369|FG004|Phase A|Protocol Violation|0|||
129850191|NCT00274716|467412370|FG005|Phase A|Protocol Violation|0|||
129850192|NCT00274716|467412365|FG000|Phase A|Met criteria for discontinuation|1|||
129850193|NCT00274716|467412366|FG001|Phase A|Met criteria for discontinuation|1|||
129850194|NCT00274716|467412367|FG002|Phase A|Met criteria for discontinuation|0|||
129850195|NCT00274716|467412368|FG003|Phase A|Met criteria for discontinuation|0|||
129850196|NCT00274716|467412369|FG004|Phase A|Met criteria for discontinuation|0|||
129850197|NCT00274716|467412370|FG005|Phase A|Met criteria for discontinuation|0|||
129904390|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904391|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904392|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
129904393|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
129904394|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
129904395|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
129904396|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904397|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904398|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904399|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904400|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904401|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904402|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904403|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904404|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904405|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904406|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
129904407|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904408|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
129904409|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904410|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904411|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904412|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904413|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904414|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904415|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904416|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904417|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904418|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
129904419|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
129904420|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904421|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904422|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904423|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904424|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904425|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904426|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904427|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904428|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904429|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904430|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904431|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
129904432|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
129904433|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
129904434|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
129904435|NCT00324038|467611055|FG000|Overall Study|Adverse Event|38|||
129904436|NCT00324038|467611056|FG001|Overall Study|Adverse Event|23|||
129904437|NCT00324038|467611055|FG000|Overall Study|Lack of Efficacy|5|||
129904438|NCT00324038|467611056|FG001|Overall Study|Lack of Efficacy|13|||
129904439|NCT00324038|467611055|FG000|Overall Study|Lost to Follow-up|0|||
129904440|NCT00324038|467611056|FG001|Overall Study|Lost to Follow-up|2|||
129904441|NCT00324038|467611055|FG000|Overall Study|Other|6|||
129904442|NCT00324038|467611056|FG001|Overall Study|Other|13|||
129904443|NCT03070483|467611057|FG000|Overall Study|Lost to Follow-up|2|||
129904444|NCT01585558|467611059|FG000|Overall Study|Withdrawal by Subject|4|||
129904445|NCT01585558|467611060|FG001|Overall Study|Withdrawal by Subject|5|||
129904446|NCT01585558|467611061|FG002|Overall Study|Withdrawal by Subject|8|||
129904447|NCT01585558|467611059|FG000|Overall Study|Lost to Follow-up|2|||
129904448|NCT01585558|467611060|FG001|Overall Study|Lost to Follow-up|0|||
129904449|NCT01585558|467611061|FG002|Overall Study|Lost to Follow-up|3|||
129904450|NCT01585558|467611059|FG000|Overall Study|Adverse Event|3|||
129904451|NCT01585558|467611060|FG001|Overall Study|Adverse Event|4|||
129904452|NCT01585558|467611061|FG002|Overall Study|Adverse Event|1|||
129904453|NCT01585558|467611059|FG000|Overall Study|Protocol Violation|4|||
129904454|NCT01585558|467611060|FG001|Overall Study|Protocol Violation|3|||
129904455|NCT01585558|467611061|FG002|Overall Study|Protocol Violation|2|||
129904456|NCT01585558|467611059|FG000|Overall Study|Lack of Efficacy|0|||
129904457|NCT01585558|467611060|FG001|Overall Study|Lack of Efficacy|0|||
129904458|NCT01585558|467611061|FG002|Overall Study|Lack of Efficacy|1|||
129904459|NCT00841035|467611062|FG000|Phase 1 Overall Study|Physician Decision|13|||
129904460|NCT01390402|467611077|FG000|Overall Study|Death|1|||
129904461|NCT01390402|467611077|FG000|Overall Study|Disease Progression|4|||
129904462|NCT02694978|467612832|FG000|Overall Study|Adverse Event|10|||
129904463|NCT02694978|467612833|FG001|Overall Study|Adverse Event|9|||
129904464|NCT02694978|467612832|FG000|Overall Study|Withdrawal by Subject|22|||
129904465|NCT02694978|467612833|FG001|Overall Study|Withdrawal by Subject|19|||
129904466|NCT02694978|467612832|FG000|Overall Study|Lost to Follow-up|14|||
129904467|NCT02694978|467612833|FG001|Overall Study|Lost to Follow-up|17|||
129904468|NCT02694978|467612832|FG000|Overall Study|Death|4|||
129904469|NCT02694978|467612833|FG001|Overall Study|Death|1|||
129904470|NCT02694978|467612832|FG000|Overall Study|Other-Decision of Participant|6|||
129904471|NCT02694978|467612833|FG001|Overall Study|Other-Decision of Participant|1|||
129904472|NCT02694978|467612832|FG000|Overall Study|Other-Investigator's decision|1|||
129904473|NCT02694978|467612833|FG001|Overall Study|Other-Investigator's decision|0|||
129904474|NCT02694978|467612832|FG000|Overall Study|Other-Unable to be reached|0|||
129904475|NCT02694978|467612833|FG001|Overall Study|Other-Unable to be reached|1|||
129904476|NCT02694978|467612832|FG000|Overall Study|Other-Protocol noncompliant|2|||
129904477|NCT02694978|467612833|FG001|Overall Study|Other-Protocol noncompliant|1|||
129904478|NCT02694978|467612832|FG000|Overall Study|Other-Personal reasons|3|||
129904479|NCT02694978|467612833|FG001|Overall Study|Other-Personal reasons|3|||
129904480|NCT02694978|467612832|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
129904481|NCT02694978|467612833|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
129904482|NCT00818454|467612834|FG000|Treatment Period 1|Adverse Event|0|||
129904483|NCT00818454|467612835|FG001|Treatment Period 1|Adverse Event|1|||
129904484|NCT00818454|467612836|FG002|Treatment Period 1|Adverse Event|0|||
129904485|NCT00818454|467612837|FG003|Treatment Period 1|Adverse Event|0|||
129904486|NCT00818454|467612834|FG000|Treatment Period 1|Other|3|||
129904487|NCT00818454|467612835|FG001|Treatment Period 1|Other|0|||
129904488|NCT00818454|467612836|FG002|Treatment Period 1|Other|0|||
129904489|NCT00818454|467612837|FG003|Treatment Period 1|Other|0|||
129904490|NCT00818454|467612834|FG000|Washout Period of 1 Week|Adverse Event|1|||
129904491|NCT00818454|467612835|FG001|Washout Period of 1 Week|Adverse Event|1|||
129904492|NCT00818454|467612836|FG002|Washout Period of 1 Week|Adverse Event|0|||
129904493|NCT00818454|467612837|FG003|Washout Period of 1 Week|Adverse Event|0|||
129904494|NCT00818454|467612834|FG000|Washout Period of 1 Week|Protocol Violation|2|||
129904495|NCT00818454|467612835|FG001|Washout Period of 1 Week|Protocol Violation|0|||
129904496|NCT00818454|467612836|FG002|Washout Period of 1 Week|Protocol Violation|0|||
129904497|NCT00818454|467612837|FG003|Washout Period of 1 Week|Protocol Violation|0|||
129904498|NCT00818454|467612834|FG000|Washout Period of 1 Week|Other|1|||
129904499|NCT00818454|467612835|FG001|Washout Period of 1 Week|Other|2|||
129904500|NCT00818454|467612836|FG002|Washout Period of 1 Week|Other|0|||
129904501|NCT00818454|467612837|FG003|Washout Period of 1 Week|Other|0|||
129904502|NCT00818454|467612834|FG000|Treatment Period 2|Other|2|||
129904503|NCT00818454|467612835|FG001|Treatment Period 2|Other|1|||
129904504|NCT00818454|467612836|FG002|Treatment Period 2|Other|0|||
129904505|NCT00818454|467612837|FG003|Treatment Period 2|Other|0|||
129904506|NCT00818454|467612834|FG000|Treatment Period 3|Adverse Event|0|||
129904507|NCT00818454|467612835|FG001|Treatment Period 3|Adverse Event|0|||
129904508|NCT00818454|467612836|FG002|Treatment Period 3|Adverse Event|0|||
129904509|NCT00818454|467612837|FG003|Treatment Period 3|Adverse Event|1|||
129904510|NCT02296424|467612839|FG000|Part 1|New therapy for study indication|0|||
129904511|NCT02296424|467612840|FG001|Part 1|New therapy for study indication|1|||
129904512|NCT02296424|467612841|FG002|Part 1|New therapy for study indication|0|||
129904513|NCT02296424|467612842|FG003|Part 1|New therapy for study indication|0|||
129904514|NCT02296424|467612839|FG000|Part 1|Protocol Violation|0|||
129904515|NCT02296424|467612840|FG001|Part 1|Protocol Violation|1|||
129904516|NCT02296424|467612841|FG002|Part 1|Protocol Violation|0|||
129904517|NCT02296424|467612842|FG003|Part 1|Protocol Violation|0|||
129904518|NCT02296424|467612839|FG000|Part 1|Withdrawal by Subject|0|||
129904519|NCT02296424|467612840|FG001|Part 1|Withdrawal by Subject|2|||
129904520|NCT02296424|467612841|FG002|Part 1|Withdrawal by Subject|0|||
129904521|NCT02296424|467612842|FG003|Part 1|Withdrawal by Subject|0|||
129904522|NCT02296424|467612839|FG000|Part 1|Study terminated by sponsor|0|||
129904523|NCT02296424|467612840|FG001|Part 1|Study terminated by sponsor|1|||
129904524|NCT02296424|467612841|FG002|Part 1|Study terminated by sponsor|0|||
129904525|NCT02296424|467612842|FG003|Part 1|Study terminated by sponsor|0|||
129904526|NCT02296424|467612839|FG000|Part 1|Adverse Event|2|||
129904527|NCT02296424|467612840|FG001|Part 1|Adverse Event|11|||
129904528|NCT02296424|467612841|FG002|Part 1|Adverse Event|0|||
129904529|NCT02296424|467612842|FG003|Part 1|Adverse Event|0|||
129904530|NCT02296424|467612839|FG000|Part 1|Lack of Efficacy|5|||
129904531|NCT02296424|467612840|FG001|Part 1|Lack of Efficacy|17|||
129904532|NCT02296424|467612841|FG002|Part 1|Lack of Efficacy|0|||
129904533|NCT02296424|467612842|FG003|Part 1|Lack of Efficacy|0|||
129904534|NCT02296424|467612839|FG000|Part 1|16 directly started part II|16|||
129904535|NCT02296424|467612840|FG001|Part 1|16 directly started part II|0|||
129904536|NCT02296424|467612841|FG002|Part 1|16 directly started part II|0|||
129904537|NCT02296424|467612842|FG003|Part 1|16 directly started part II|0|||
129904538|NCT02296424|467612839|FG000|Part 2|Lack of Efficacy|0|||
129904539|NCT02296424|467612840|FG001|Part 2|Lack of Efficacy|0|||
129904540|NCT02296424|467612841|FG002|Part 2|Lack of Efficacy|1|||
129904541|NCT02296424|467612842|FG003|Part 2|Lack of Efficacy|0|||
129904542|NCT02296424|467612839|FG000|Part 2|Adverse Event|0|||
129904543|NCT02296424|467612840|FG001|Part 2|Adverse Event|0|||
129904544|NCT02296424|467612841|FG002|Part 2|Adverse Event|1|||
129904545|NCT02296424|467612842|FG003|Part 2|Adverse Event|0|||
129904546|NCT02296424|467612839|FG000|Part 2|Lost to Follow-up|0|||
129904547|NCT02296424|467612840|FG001|Part 2|Lost to Follow-up|0|||
129904548|NCT02296424|467612841|FG002|Part 2|Lost to Follow-up|1|||
129904549|NCT02296424|467612842|FG003|Part 2|Lost to Follow-up|0|||
129904550|NCT00743444|467612843|FG000|First Intervention|Catheter placement problems|0|||
129904551|NCT00743444|467612844|FG001|First Intervention|Catheter placement problems|1|||
129904552|NCT00743444|467612843|FG000|Washout Period|Adverse Event|0|||
129904553|NCT00743444|467612844|FG001|Washout Period|Adverse Event|1|||
129904554|NCT00807144|467612847|FG000|Overall Study|Lost to Follow-up|0|||
129904555|NCT00807144|467612848|FG001|Overall Study|Lost to Follow-up|1|||
129904556|NCT00854906|467612851|FG000|Overall Study|One person had no ocular history|1|||
129904557|NCT00814346|467612852|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
129904558|NCT00814346|467612853|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
129904559|NCT00814346|467612852|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
129904560|NCT00814346|467612853|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
129904561|NCT00814346|467612852|FG000|Open Phase (17 Months)|Adverse Event|5|||
129904562|NCT00814346|467612853|FG001|Open Phase (17 Months)|Adverse Event|0|||
129904563|NCT00814346|467612852|FG000|Open Phase (17 Months)|Consent|2|||
129904564|NCT00814346|467612853|FG001|Open Phase (17 Months)|Consent|0|||
129904565|NCT00814346|467612852|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
129904566|NCT00814346|467612853|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
129904567|NCT00814346|467612852|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
129904568|NCT00814346|467612853|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
129904569|NCT03622580|467612854|FG000|Overall Study|Death|16|||
129904570|NCT03622580|467612855|FG001|Overall Study|Death|21|||
129904571|NCT03622580|467612856|FG002|Overall Study|Death|13|||
129904572|NCT03622580|467612854|FG000|Overall Study|Adverse Event|6|||
129904573|NCT03622580|467612855|FG001|Overall Study|Adverse Event|6|||
129904574|NCT03622580|467612856|FG002|Overall Study|Adverse Event|5|||
129904575|NCT03622580|467612854|FG000|Overall Study|Withdrawal by Subject|12|||
129904576|NCT03622580|467612855|FG001|Overall Study|Withdrawal by Subject|7|||
129904577|NCT03622580|467612856|FG002|Overall Study|Withdrawal by Subject|19|||
129904578|NCT03622580|467612854|FG000|Overall Study|Lost to Follow-up|12|||
129904579|NCT03622580|467612855|FG001|Overall Study|Lost to Follow-up|9|||
129904580|NCT03622580|467612856|FG002|Overall Study|Lost to Follow-up|9|||
129904581|NCT03622580|467612854|FG000|Overall Study|Protocol Violation|1|||
129904582|NCT03622580|467612855|FG001|Overall Study|Protocol Violation|0|||
129904583|NCT03622580|467612856|FG002|Overall Study|Protocol Violation|1|||
129904584|NCT03622580|467612854|FG000|Overall Study|Physician Decision|3|||
129904585|NCT03622580|467612855|FG001|Overall Study|Physician Decision|0|||
129904586|NCT03622580|467612856|FG002|Overall Study|Physician Decision|1|||
129904587|NCT03622580|467612854|FG000|Overall Study|Pregnancy|0|||
129904588|NCT03622580|467612855|FG001|Overall Study|Pregnancy|1|||
129904589|NCT03622580|467612856|FG002|Overall Study|Pregnancy|0|||
129904590|NCT03622580|467612854|FG000|Overall Study|Lack of Efficacy|0|||
129904591|NCT03622580|467612855|FG001|Overall Study|Lack of Efficacy|0|||
129904592|NCT03622580|467612856|FG002|Overall Study|Lack of Efficacy|1|||
129904593|NCT03622580|467612854|FG000|Overall Study|Other|2|||
129904594|NCT03622580|467612855|FG001|Overall Study|Other|0|||
129904595|NCT03622580|467612856|FG002|Overall Study|Other|3|||
129850198|NCT00274716|467412365|FG000|Phase A|Withdrawal by Subject|2|||
129850199|NCT00274716|467412366|FG001|Phase A|Withdrawal by Subject|2|||
129850200|NCT00274716|467412367|FG002|Phase A|Withdrawal by Subject|1|||
129850201|NCT00274716|467412368|FG003|Phase A|Withdrawal by Subject|3|||
129850202|NCT00274716|467412369|FG004|Phase A|Withdrawal by Subject|0|||
129850203|NCT00274716|467412370|FG005|Phase A|Withdrawal by Subject|1|||
129850204|NCT00274716|467412365|FG000|Phase A|Adverse Event|2|||
129850205|NCT00274716|467412366|FG001|Phase A|Adverse Event|3|||
129850206|NCT00274716|467412367|FG002|Phase A|Adverse Event|3|||
129850207|NCT00274716|467412368|FG003|Phase A|Adverse Event|0|||
129850208|NCT00274716|467412369|FG004|Phase A|Adverse Event|2|||
129850209|NCT00274716|467412370|FG005|Phase A|Adverse Event|0|||
129850210|NCT00274716|467412365|FG000|Phase A|Completed but did not enter Phase B|1|||
129850211|NCT00274716|467412366|FG001|Phase A|Completed but did not enter Phase B|2|||
129850212|NCT00274716|467412367|FG002|Phase A|Completed but did not enter Phase B|2|||
129904596|NCT02613871|467612859|FG000|Overall Study|Death|2|||
129904597|NCT02613871|467612859|FG000|Overall Study|Withdrew Consent|1|||
129850213|NCT00274716|467412368|FG003|Phase A|Completed but did not enter Phase B|2|||
129850214|NCT00274716|467412369|FG004|Phase A|Completed but did not enter Phase B|1|||
129850215|NCT00274716|467412370|FG005|Phase A|Completed but did not enter Phase B|1|||
129850216|NCT00274716|467412365|FG000|Phase B|Adverse Event|0|||
129904598|NCT00507689|467612860|FG000|Pre-Randomization Period|Adverse Event|1|||
129904599|NCT00507689|467612861|FG001|Pre-Randomization Period|Adverse Event|0|||
129904600|NCT00507689|467612860|FG000|Pre-Randomization Period|Physician Decision|1|||
129904601|NCT00507689|467612861|FG001|Pre-Randomization Period|Physician Decision|0|||
129904602|NCT00507689|467612860|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
129904603|NCT00507689|467612861|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
129904604|NCT00507689|467612860|FG000|Randomized Period|Adverse Event|1|||
129904605|NCT00507689|467612861|FG001|Randomized Period|Adverse Event|1|||
129904606|NCT00507689|467612860|FG000|Randomized Period|Withdrawal by Subject|0|||
129904607|NCT00507689|467612861|FG001|Randomized Period|Withdrawal by Subject|1|||
129904608|NCT00494442|467612862|FG000|Overall Study|Death|1|||
129850217|NCT00274716|467412366|FG001|Phase B|Adverse Event|0|||
129850218|NCT00274716|467412367|FG002|Phase B|Adverse Event|2|||
129850219|NCT00274716|467412368|FG003|Phase B|Adverse Event|0|||
129850220|NCT00274716|467412369|FG004|Phase B|Adverse Event|0|||
129850221|NCT00274716|467412370|FG005|Phase B|Adverse Event|1|||
129850222|NCT00274716|467412365|FG000|Phase B|Protocol Violation|0|||
129850223|NCT00274716|467412366|FG001|Phase B|Protocol Violation|2|||
129850224|NCT00274716|467412367|FG002|Phase B|Protocol Violation|0|||
129850225|NCT00274716|467412368|FG003|Phase B|Protocol Violation|0|||
129850226|NCT00274716|467412369|FG004|Phase B|Protocol Violation|0|||
129850227|NCT00274716|467412370|FG005|Phase B|Protocol Violation|0|||
129850228|NCT00274716|467412365|FG000|Phase B|Withdrawal by Subject|0|||
129850229|NCT00274716|467412366|FG001|Phase B|Withdrawal by Subject|1|||
129850230|NCT00274716|467412367|FG002|Phase B|Withdrawal by Subject|0|||
129850231|NCT00274716|467412368|FG003|Phase B|Withdrawal by Subject|0|||
129850232|NCT00274716|467412369|FG004|Phase B|Withdrawal by Subject|0|||
129850233|NCT00274716|467412370|FG005|Phase B|Withdrawal by Subject|0|||
129850234|NCT00274716|467412365|FG000|Phase B|Participant moved|1|||
129850235|NCT00274716|467412366|FG001|Phase B|Participant moved|0|||
129850236|NCT00274716|467412367|FG002|Phase B|Participant moved|0|||
129850237|NCT00274716|467412368|FG003|Phase B|Participant moved|0|||
129850238|NCT00274716|467412369|FG004|Phase B|Participant moved|0|||
129850239|NCT00274716|467412370|FG005|Phase B|Participant moved|0|||
129850240|NCT00274716|467412365|FG000|Phase B|Other non-reported reason|0|||
129850241|NCT00274716|467412366|FG001|Phase B|Other non-reported reason|0|||
129850242|NCT00274716|467412367|FG002|Phase B|Other non-reported reason|1|||
129850243|NCT00274716|467412368|FG003|Phase B|Other non-reported reason|1|||
129850244|NCT00274716|467412369|FG004|Phase B|Other non-reported reason|0|||
129850245|NCT00274716|467412370|FG005|Phase B|Other non-reported reason|0|||
129850246|NCT00274716|467412365|FG000|Phase B|Lost to Follow-up|0|||
129850247|NCT00274716|467412366|FG001|Phase B|Lost to Follow-up|1|||
129850248|NCT00274716|467412367|FG002|Phase B|Lost to Follow-up|0|||
129850249|NCT00274716|467412368|FG003|Phase B|Lost to Follow-up|0|||
129850250|NCT00274716|467412369|FG004|Phase B|Lost to Follow-up|0|||
129850251|NCT00274716|467412370|FG005|Phase B|Lost to Follow-up|0|||
129850252|NCT00982319|467412373|FG000|Overall Study|Surgery date change|1|||
129850253|NCT00982319|467412374|FG001|Overall Study|Surgery date change|0|||
129850254|NCT00982319|467412373|FG000|Overall Study|Preop values out of acceptable range|1|||
129850255|NCT00982319|467412374|FG001|Overall Study|Preop values out of acceptable range|1|||
129850256|NCT00982319|467412373|FG000|Overall Study|Pregnancy|0|||
129850257|NCT00982319|467412374|FG001|Overall Study|Pregnancy|1|||
129850258|NCT01252251|467412375|FG000|Overall Study|Withdrawal by Subject|1|||
129850259|NCT01923181|467412376|FG000|Overall Study|Protocol Violation|2|||
129850260|NCT01923181|467412377|FG001|Overall Study|Protocol Violation|2|||
129850261|NCT01923181|467412378|FG002|Overall Study|Protocol Violation|0|||
129850262|NCT01923181|467412379|FG003|Overall Study|Protocol Violation|2|||
129850263|NCT01923181|467412380|FG004|Overall Study|Protocol Violation|2|||
129850264|NCT01923181|467412381|FG005|Overall Study|Protocol Violation|1|||
129850265|NCT01923181|467412382|FG006|Overall Study|Protocol Violation|1|||
129850266|NCT01923181|467412383|FG007|Overall Study|Protocol Violation|2|||
129850267|NCT01923181|467412384|FG008|Overall Study|Protocol Violation|1|||
129850268|NCT01923181|467412376|FG000|Overall Study|Withdrawal by Subject|0|||
129850269|NCT01923181|467412377|FG001|Overall Study|Withdrawal by Subject|1|||
129850270|NCT01923181|467412378|FG002|Overall Study|Withdrawal by Subject|0|||
129850271|NCT01923181|467412379|FG003|Overall Study|Withdrawal by Subject|1|||
129904609|NCT00494442|467612863|FG001|Overall Study|Death|1|||
129904610|NCT00494442|467612862|FG000|Overall Study|Lack of Efficacy|16|||
129904611|NCT00494442|467612863|FG001|Overall Study|Lack of Efficacy|10|||
129850272|NCT01923181|467412380|FG004|Overall Study|Withdrawal by Subject|4|||
130064566|NCT03691610|468190198|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
130064567|NCT03691610|468190195|FG000|Overall Study|Lost to Follow-up|20|||
129850273|NCT01923181|467412381|FG005|Overall Study|Withdrawal by Subject|2|||
129850274|NCT01923181|467412382|FG006|Overall Study|Withdrawal by Subject|4|||
129850275|NCT01923181|467412383|FG007|Overall Study|Withdrawal by Subject|3|||
129850276|NCT01923181|467412384|FG008|Overall Study|Withdrawal by Subject|1|||
129850277|NCT01923181|467412376|FG000|Overall Study|Other|1|||
129850278|NCT01923181|467412377|FG001|Overall Study|Other|0|||
129850279|NCT01923181|467412378|FG002|Overall Study|Other|0|||
129850280|NCT01923181|467412379|FG003|Overall Study|Other|1|||
129850281|NCT01923181|467412380|FG004|Overall Study|Other|0|||
129850282|NCT01923181|467412381|FG005|Overall Study|Other|0|||
129850283|NCT01923181|467412382|FG006|Overall Study|Other|0|||
129850284|NCT01923181|467412383|FG007|Overall Study|Other|0|||
129850285|NCT01923181|467412384|FG008|Overall Study|Other|0|||
129850286|NCT01923181|467412376|FG000|Overall Study|Lost to Follow-up|0|||
129904612|NCT00494442|467612862|FG000|Overall Study|Adverse Event|0|||
129904613|NCT00494442|467612863|FG001|Overall Study|Adverse Event|2|||
129904614|NCT00494442|467612862|FG000|Overall Study|Physician Decision|0|||
129904615|NCT00494442|467612863|FG001|Overall Study|Physician Decision|1|||
129904616|NCT00494442|467612862|FG000|Overall Study|Non-compliance|0|||
129904617|NCT00494442|467612863|FG001|Overall Study|Non-compliance|1|||
129904618|NCT00494442|467612862|FG000|Overall Study|Intercurrent illness|0|||
129904619|NCT00494442|467612863|FG001|Overall Study|Intercurrent illness|1|||
129850287|NCT01923181|467412377|FG001|Overall Study|Lost to Follow-up|3|||
129850288|NCT01923181|467412378|FG002|Overall Study|Lost to Follow-up|2|||
129850289|NCT01923181|467412379|FG003|Overall Study|Lost to Follow-up|1|||
129850290|NCT01923181|467412380|FG004|Overall Study|Lost to Follow-up|2|||
129850291|NCT01923181|467412381|FG005|Overall Study|Lost to Follow-up|1|||
129850292|NCT01923181|467412382|FG006|Overall Study|Lost to Follow-up|3|||
129850293|NCT01923181|467412383|FG007|Overall Study|Lost to Follow-up|3|||
129850294|NCT01923181|467412384|FG008|Overall Study|Lost to Follow-up|1|||
129850295|NCT01863446|467412385|FG000|Overall Study|Withdrawal by Subject|1|||
129850296|NCT01863446|467412386|FG001|Overall Study|Withdrawal by Subject|0|||
129850297|NCT01863446|467412387|FG002|Overall Study|Withdrawal by Subject|1|||
129850298|NCT01863446|467412388|FG003|Overall Study|Withdrawal by Subject|2|||
129850299|NCT01863446|467412385|FG000|Overall Study|Physician Decision|0|||
129850300|NCT01863446|467412386|FG001|Overall Study|Physician Decision|0|||
129850301|NCT01863446|467412387|FG002|Overall Study|Physician Decision|1|||
129850302|NCT01863446|467412388|FG003|Overall Study|Physician Decision|0|||
129850303|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
129850304|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
129850305|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
129850306|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Death|1|||
129850307|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
129850308|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
129850309|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
129850310|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Treatment failure|1|||
129850311|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
129850312|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
129850313|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Death|1|||
129850314|NCT02840877|467412389|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
129850315|NCT02840877|467412389|FG000|6 Months to 18 Months|Treatment failure|7|||
129850316|NCT02840877|467412389|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
129850317|NCT02840877|467412389|FG000|6 Months to 18 Months|Moved/transferred out|6|||
129850318|NCT02840877|467412389|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
129850319|NCT02840877|467412389|FG000|6 Months to 18 Months|Death|4|||
129850320|NCT02840877|467412389|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
129850321|NCT02840877|467412389|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
129850322|NCT02840877|467412389|FG000|6 Months to 18 Months|Still in study.|14|||
129850323|NCT02252081|467412392|FG000|Overall Study|Withdrawal by Subject|2|||
129850324|NCT02252081|467412393|FG001|Overall Study|Withdrawal by Subject|1|||
129850325|NCT02252081|467412392|FG000|Overall Study|Adverse Event|4|||
129850326|NCT02252081|467412393|FG001|Overall Study|Adverse Event|1|||
129850327|NCT02252081|467412392|FG000|Overall Study|non compliance & others|0|||
129850328|NCT02252081|467412393|FG001|Overall Study|non compliance & others|2|||
129850329|NCT03003676|467412398|FG000|Overall Study|Lack of Efficacy|5|||
129850330|NCT03003676|467412399|FG001|Overall Study|Lack of Efficacy|7|||
129850331|NCT03003676|467412398|FG000|Overall Study|Withdrawal by Subject|0|||
129850332|NCT03003676|467412399|FG001|Overall Study|Withdrawal by Subject|1|||
129850333|NCT03003676|467412398|FG000|Overall Study|Hepatitis B infection|1|||
129850334|NCT03003676|467412399|FG001|Overall Study|Hepatitis B infection|0|||
129850335|NCT00530023|467412410|FG000|Overall Study|Withdrawal by Subject|0|||
129850336|NCT00530023|467412411|FG001|Overall Study|Withdrawal by Subject|1|||
129850337|NCT03224468|467412421|FG000|Overall Study|Did not obtain MM card|53|||
129850338|NCT03224468|467412422|FG001|Overall Study|Did not obtain MM card|0|||
129850339|NCT03224468|467412421|FG000|Overall Study|Lost to Follow-up|4|||
129850340|NCT03224468|467412422|FG001|Overall Study|Lost to Follow-up|11|||
129904620|NCT00486330|467612864|FG000|Overall Study|Adverse Event|2|||
129904621|NCT00831415|467612865|FG000|Overall Study|Adverse Event|14|||
129850341|NCT03224468|467412421|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
129850342|NCT03224468|467412422|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
129850343|NCT02461589|467412423|FG000|Overall Study|Withdrawal by Subject|5|||
129850344|NCT02461589|467412424|FG001|Overall Study|Withdrawal by Subject|1|||
129850345|NCT02461589|467412425|FG002|Overall Study|Withdrawal by Subject|3|||
129850346|NCT02461589|467412426|FG003|Overall Study|Withdrawal by Subject|2|||
129850347|NCT02461589|467412427|FG004|Overall Study|Withdrawal by Subject|1|||
129850348|NCT02461589|467412428|FG005|Overall Study|Withdrawal by Subject|2|||
129850349|NCT02461589|467412429|FG006|Overall Study|Withdrawal by Subject|1|||
129850350|NCT02461589|467412430|FG007|Overall Study|Withdrawal by Subject|3|||
129850351|NCT02461589|467412431|FG008|Overall Study|Withdrawal by Subject|3|||
129904622|NCT00831415|467612865|FG000|Overall Study|Failed to return|3|||
129904623|NCT00831415|467612865|FG000|Overall Study|Physician Decision|6|||
129904624|NCT00831415|467612865|FG000|Overall Study|Lost to Follow-up|9|||
129904625|NCT00831415|467612865|FG000|Overall Study|Protocol Violation|3|||
129904626|NCT00831415|467612865|FG000|Overall Study|Withdrawal by Subject|35|||
129904627|NCT00831415|467612865|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
129904628|NCT00831415|467612865|FG000|Overall Study|Death|1|||
129904629|NCT01290224|467612866|FG000|Overall Study|Adverse Event|1|||
129904630|NCT01290224|467612866|FG000|Overall Study|Refused Further Treatment|4|||
129904631|NCT01241292|467612867|FG000|Overall Study|Administrative Reason by Sponsor|1|||
129904632|NCT01241292|467612868|FG001|Overall Study|Administrative Reason by Sponsor|0|||
129904633|NCT01241292|467612867|FG000|Overall Study|Disease Progression|2|||
129904634|NCT01241292|467612868|FG001|Overall Study|Disease Progression|0|||
129904635|NCT01241292|467612867|FG000|Overall Study|Study Drug Toxicity|0|||
129904636|NCT01241292|467612868|FG001|Overall Study|Study Drug Toxicity|1|||
129904637|NCT01241292|467612867|FG000|Overall Study|Participant Discontinued Treatment|0|||
129904638|NCT01241292|467612868|FG001|Overall Study|Participant Discontinued Treatment|2|||
129904639|NCT03861767|467612873|FG000|Overall Study|Withdrawal by Subject|2|||
129904640|NCT03861767|467612874|FG001|Overall Study|Withdrawal by Subject|1|||
129904641|NCT03861767|467612875|FG002|Overall Study|Withdrawal by Subject|0|||
129904642|NCT03861767|467612876|FG003|Overall Study|Withdrawal by Subject|5|||
129904643|NCT03861767|467612877|FG004|Overall Study|Withdrawal by Subject|2|||
129904644|NCT03861767|467612878|FG005|Overall Study|Withdrawal by Subject|1|||
129904645|NCT03861767|467612879|FG006|Overall Study|Withdrawal by Subject|3|||
129904646|NCT03861767|467612880|FG007|Overall Study|Withdrawal by Subject|1|||
129904647|NCT03861767|467612881|FG008|Overall Study|Withdrawal by Subject|0|||
129904648|NCT03861767|467612882|FG009|Overall Study|Withdrawal by Subject|5|||
129904649|NCT00346333|467612883|FG000|Overall Study|Death|1|||
129904650|NCT00346333|467612884|FG001|Overall Study|Death|0|||
129904651|NCT00346333|467612883|FG000|Overall Study|unwilling or unable to continue|4|||
129904652|NCT00346333|467612884|FG001|Overall Study|unwilling or unable to continue|8|||
129904653|NCT00813904|467612885|FG000|Overall Study|Death|1|||
129904654|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
129904655|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
129904656|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
129904657|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
129904658|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
129904659|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
129904660|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
129904661|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
129904662|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
129904663|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
129904664|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
129904665|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
129904666|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
129904667|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
129904668|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
129904669|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
129850352|NCT02461589|467412432|FG009|Overall Study|Withdrawal by Subject|1|||
129850353|NCT02461589|467412423|FG000|Overall Study|Lost to Follow-up|0|||
129850354|NCT02461589|467412424|FG001|Overall Study|Lost to Follow-up|0|||
129850355|NCT02461589|467412425|FG002|Overall Study|Lost to Follow-up|2|||
129850356|NCT02461589|467412426|FG003|Overall Study|Lost to Follow-up|3|||
129850357|NCT02461589|467412427|FG004|Overall Study|Lost to Follow-up|1|||
129850358|NCT02461589|467412428|FG005|Overall Study|Lost to Follow-up|1|||
129850359|NCT02461589|467412429|FG006|Overall Study|Lost to Follow-up|3|||
129850360|NCT02461589|467412430|FG007|Overall Study|Lost to Follow-up|1|||
129850361|NCT02461589|467412431|FG008|Overall Study|Lost to Follow-up|3|||
129850362|NCT02461589|467412432|FG009|Overall Study|Lost to Follow-up|1|||
129850363|NCT02461589|467412423|FG000|Overall Study|Death|0|||
129850364|NCT02461589|467412424|FG001|Overall Study|Death|0|||
129850365|NCT02461589|467412425|FG002|Overall Study|Death|0|||
129850366|NCT02461589|467412426|FG003|Overall Study|Death|0|||
129850367|NCT02461589|467412427|FG004|Overall Study|Death|0|||
129850368|NCT02461589|467412428|FG005|Overall Study|Death|0|||
129850369|NCT02461589|467412429|FG006|Overall Study|Death|0|||
129904670|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
129904671|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
129904672|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
129904673|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
129850370|NCT02461589|467412430|FG007|Overall Study|Death|1|||
130064568|NCT03691610|468190196|FG001|Overall Study|Lost to Follow-up|11|||
129850371|NCT02461589|467412431|FG008|Overall Study|Death|0|||
129850372|NCT02461589|467412432|FG009|Overall Study|Death|0|||
129850373|NCT02461589|467412423|FG000|Overall Study|Unclassified|0|||
129850374|NCT02461589|467412424|FG001|Overall Study|Unclassified|0|||
129850375|NCT02461589|467412425|FG002|Overall Study|Unclassified|0|||
129850376|NCT02461589|467412426|FG003|Overall Study|Unclassified|0|||
130064569|NCT03691610|468190197|FG002|Overall Study|Lost to Follow-up|5|||
129850377|NCT02461589|467412427|FG004|Overall Study|Unclassified|0|||
129850378|NCT02461589|467412428|FG005|Overall Study|Unclassified|0|||
129850379|NCT02461589|467412429|FG006|Overall Study|Unclassified|1|||
129850380|NCT02461589|467412430|FG007|Overall Study|Unclassified|0|||
129850381|NCT02461589|467412431|FG008|Overall Study|Unclassified|0|||
129850382|NCT02461589|467412432|FG009|Overall Study|Unclassified|2|||
129850383|NCT02461589|467412423|FG000|Overall Study|Missing follow-up information|1|||
129850384|NCT02461589|467412424|FG001|Overall Study|Missing follow-up information|1|||
129850385|NCT02461589|467412425|FG002|Overall Study|Missing follow-up information|0|||
129850386|NCT02461589|467412426|FG003|Overall Study|Missing follow-up information|0|||
129850387|NCT02461589|467412427|FG004|Overall Study|Missing follow-up information|0|||
129850388|NCT02461589|467412428|FG005|Overall Study|Missing follow-up information|0|||
129850389|NCT02461589|467412429|FG006|Overall Study|Missing follow-up information|1|||
129850390|NCT02461589|467412430|FG007|Overall Study|Missing follow-up information|0|||
129850391|NCT02461589|467412431|FG008|Overall Study|Missing follow-up information|0|||
129850392|NCT02461589|467412432|FG009|Overall Study|Missing follow-up information|0|||
129850393|NCT02461589|467412423|FG000|Overall Study|Withdrawal from trial before exposure|0|||
129850394|NCT02461589|467412424|FG001|Overall Study|Withdrawal from trial before exposure|0|||
129850395|NCT02461589|467412425|FG002|Overall Study|Withdrawal from trial before exposure|0|||
129850396|NCT02461589|467412426|FG003|Overall Study|Withdrawal from trial before exposure|0|||
129850397|NCT02461589|467412427|FG004|Overall Study|Withdrawal from trial before exposure|0|||
129850398|NCT02461589|467412428|FG005|Overall Study|Withdrawal from trial before exposure|0|||
129850399|NCT02461589|467412429|FG006|Overall Study|Withdrawal from trial before exposure|0|||
129850400|NCT02461589|467412430|FG007|Overall Study|Withdrawal from trial before exposure|0|||
129850401|NCT02461589|467412431|FG008|Overall Study|Withdrawal from trial before exposure|0|||
129850402|NCT02461589|467412432|FG009|Overall Study|Withdrawal from trial before exposure|1|||
129850403|NCT04067141|467412433|FG000|First Intervention|Withdrawal by Subject|0|||
129850404|NCT04067141|467412434|FG001|First Intervention|Withdrawal by Subject|1|||
129850405|NCT04067141|467412433|FG000|Second Intervention|Adverse Event|0|||
129850406|NCT04067141|467412434|FG001|Second Intervention|Adverse Event|2|||
129850407|NCT01038921|467412435|FG000|Overall Study|Withdrawal by Subject|1|||
129850408|NCT01038921|467412436|FG001|Overall Study|Withdrawal by Subject|0|||
129850409|NCT01038921|467412435|FG000|Overall Study|Physician Decision|1|||
129850410|NCT01038921|467412436|FG001|Overall Study|Physician Decision|0|||
129850411|NCT01978119|467412437|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
129850412|NCT01978119|467412438|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
129850413|NCT01978119|467412437|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129850414|NCT01978119|467412438|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129850415|NCT01978119|467412437|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129850416|NCT01978119|467412438|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
129850417|NCT03295201|467412439|FG000|Overall Study|Lost to Follow-up|1|||
129850418|NCT03295201|467412440|FG001|Overall Study|Lost to Follow-up|1|||
129850419|NCT03295201|467412439|FG000|Overall Study|Hospital admission|0|||
129850420|NCT03295201|467412440|FG001|Overall Study|Hospital admission|1|||
129850421|NCT00733824|467412441|FG000|Phase I|Withdrawal by Subject|1|||
129850422|NCT00733824|467412442|FG001|Phase I|Withdrawal by Subject|0|||
129850423|NCT00733824|467412443|FG002|Phase I|Withdrawal by Subject|0|||
129850424|NCT00733824|467412444|FG003|Phase I|Withdrawal by Subject|0|||
129850425|NCT00733824|467412445|FG004|Phase I|Withdrawal by Subject|0|||
129850426|NCT01243944|467412446|FG000|Overall Study|Adverse Event|15|||
129850427|NCT01243944|467412447|FG001|Overall Study|Adverse Event|13|||
129850428|NCT01243944|467412446|FG000|Overall Study|Lost to Follow-up|2|||
129850429|NCT01243944|467412447|FG001|Overall Study|Lost to Follow-up|1|||
129850430|NCT01243944|467412446|FG000|Overall Study|Physician Decision|2|||
129850431|NCT01243944|467412447|FG001|Overall Study|Physician Decision|7|||
129850432|NCT01243944|467412446|FG000|Overall Study|Disease progression|12|||
129850433|NCT01243944|467412447|FG001|Overall Study|Disease progression|11|||
129850434|NCT01243944|467412446|FG000|Overall Study|Protocol deviation|1|||
129850435|NCT01243944|467412447|FG001|Overall Study|Protocol deviation|1|||
129850436|NCT01243944|467412446|FG000|Overall Study|Participant decision|10|||
129850437|NCT01243944|467412447|FG001|Overall Study|Participant decision|15|||
129850438|NCT01243944|467412446|FG000|Overall Study|Death|2|||
129850439|NCT01243944|467412447|FG001|Overall Study|Death|3|||
129850440|NCT01243944|467412446|FG000|Overall Study|Non-compliance with study treatment|1|||
129850441|NCT01243944|467412447|FG001|Overall Study|Non-compliance with study treatment|0|||
130064570|NCT03691610|468190198|FG003|Overall Study|Lost to Follow-up|2|||
130064571|NCT00622869|468190202|FG000|Overall Study|Subject Withdrew Consent|13|||
129850442|NCT01410110|467412448|FG000|Overall Study|Withdrawal by Subject|4|||
129850443|NCT01410110|467412449|FG001|Overall Study|Withdrawal by Subject|2|||
129850444|NCT01416805|467412450|FG000|Overall Study|Lost to Follow-up|4|||
129850445|NCT01416805|467412451|FG001|Overall Study|Lost to Follow-up|4|||
129850446|NCT04632940|467412455|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
129850447|NCT04632940|467412456|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
129850448|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
129850449|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
129850450|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
129850451|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
129850452|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
129850453|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
129850454|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
129850455|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
129850456|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
129850457|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
129850458|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Other than specified|0|||
129850459|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Other than specified|1|||
129850460|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
129850461|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
129850462|NCT00153101|467412461|FG000|Overall Study|Lost to Follow-up|14|||
129850463|NCT00153101|467412462|FG001|Overall Study|Lost to Follow-up|14|||
129850464|NCT00153101|467412463|FG002|Overall Study|Lost to Follow-up|12|||
129850465|NCT00153101|467412464|FG003|Overall Study|Lost to Follow-up|5|||
129850466|NCT00153101|467412465|FG004|Overall Study|Lost to Follow-up|5|||
129850467|NCT00153101|467412461|FG000|Overall Study|Withdrawal by Subject|3|||
129850468|NCT00153101|467412462|FG001|Overall Study|Withdrawal by Subject|4|||
129850469|NCT00153101|467412463|FG002|Overall Study|Withdrawal by Subject|3|||
129850470|NCT00153101|467412464|FG003|Overall Study|Withdrawal by Subject|3|||
129850471|NCT00153101|467412465|FG004|Overall Study|Withdrawal by Subject|5|||
129850472|NCT02610140|467412466|FG000|Randomization and Treatment Period|Radiological progression|23|||
129850473|NCT02610140|467412467|FG001|Randomization and Treatment Period|Radiological progression|15|||
129850474|NCT02610140|467412466|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
129850475|NCT02610140|467412467|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
129850476|NCT02610140|467412466|FG000|Randomization and Treatment Period|Protocol Violation|1|||
129850477|NCT02610140|467412467|FG001|Randomization and Treatment Period|Protocol Violation|0|||
129850478|NCT02610140|467412466|FG000|Randomization and Treatment Period|Physician Decision|0|||
129850479|NCT02610140|467412467|FG001|Randomization and Treatment Period|Physician Decision|1|||
129850480|NCT02610140|467412466|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
129850481|NCT02610140|467412467|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
129850482|NCT02610140|467412466|FG000|Randomization and Treatment Period|Death|7|||
129850483|NCT02610140|467412467|FG001|Randomization and Treatment Period|Death|1|||
129850484|NCT02610140|467412466|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
129850485|NCT02610140|467412467|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
129850486|NCT02610140|467412466|FG000|Randomization and Treatment Period|Adverse Event|44|||
129850487|NCT02610140|467412467|FG001|Randomization and Treatment Period|Adverse Event|13|||
129850488|NCT02610140|467412466|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
129850489|NCT02610140|467412467|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
129850490|NCT02610140|467412466|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
129850491|NCT02610140|467412467|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
129850492|NCT02610140|467412466|FG000|Randomization and Treatment Period|Not treated|3|||
129850493|NCT02610140|467412467|FG001|Randomization and Treatment Period|Not treated|10|||
129850494|NCT02610140|467412466|FG000|Safety Follow-up|Other|0|||
129850495|NCT02610140|467412467|FG001|Safety Follow-up|Other|2|||
129850496|NCT02610140|467412466|FG000|Safety Follow-up|Lost to Follow-up|1|||
129850497|NCT02610140|467412467|FG001|Safety Follow-up|Lost to Follow-up|0|||
129850498|NCT02610140|467412466|FG000|Safety Follow-up|No follow-up|5|||
129850499|NCT02610140|467412467|FG001|Safety Follow-up|No follow-up|3|||
129850500|NCT02610140|467412466|FG000|Safety Follow-up|Death|12|||
129850501|NCT02610140|467412467|FG001|Safety Follow-up|Death|2|||
129850502|NCT02610140|467412466|FG000|Safety Follow-up|Deterioration of general conditions|15|||
129850503|NCT02610140|467412467|FG001|Safety Follow-up|Deterioration of general conditions|5|||
129850504|NCT02610140|467412466|FG000|Safety Follow-up|Withdrawal by Subject|12|||
129904674|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
129850505|NCT02610140|467412467|FG001|Safety Follow-up|Withdrawal by Subject|12|||
129850506|NCT02610140|467412466|FG000|Active Follow-up|Progressive disease - radiological|30|||
129850507|NCT02610140|467412467|FG001|Active Follow-up|Progressive disease - radiological|22|||
129850508|NCT02610140|467412466|FG000|Active Follow-up|Death|8|||
129850509|NCT02610140|467412467|FG001|Active Follow-up|Death|1|||
129850510|NCT02610140|467412466|FG000|Active Follow-up|Withdrawal by Subject|4|||
129850511|NCT02610140|467412467|FG001|Active Follow-up|Withdrawal by Subject|0|||
129850512|NCT02610140|467412466|FG000|Active Follow-up|Progressive disease - clinical|1|||
129850513|NCT02610140|467412467|FG001|Active Follow-up|Progressive disease - clinical|2|||
129850514|NCT02610140|467412466|FG000|Active Follow-up|Deterioration of general conditions|1|||
129850515|NCT02610140|467412467|FG001|Active Follow-up|Deterioration of general conditions|0|||
129850516|NCT02610140|467412466|FG000|Active Follow-up|Ongoing but not completed|4|||
129850517|NCT02610140|467412467|FG001|Active Follow-up|Ongoing but not completed|1|||
129850518|NCT02610140|467412466|FG000|Long-term Follow-up|Death|86|||
129850519|NCT02610140|467412467|FG001|Long-term Follow-up|Death|44|||
129850520|NCT02610140|467412466|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
129850521|NCT02610140|467412467|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
129850522|NCT02610140|467412466|FG000|Long-term Follow-up|Lost to Follow-up|1|||
129850523|NCT02610140|467412467|FG001|Long-term Follow-up|Lost to Follow-up|2|||
129850524|NCT02610140|467412466|FG000|Long-term Follow-up|Ongoing but not completed|30|||
129850525|NCT02610140|467412467|FG001|Long-term Follow-up|Ongoing but not completed|17|||
129850526|NCT03169153|467412468|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129850527|NCT03169153|467412469|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129850528|NCT03169153|467412468|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
129850529|NCT03169153|467412469|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
129850530|NCT03169153|467412468|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
129850531|NCT03169153|467412469|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
129850532|NCT03169153|467412468|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
129850533|NCT03169153|467412469|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
129850534|NCT00887341|467412470|FG000|Overall Study|Refused treatment|1|||
129850535|NCT00887341|467412471|FG001|Overall Study|Refused treatment|0|||
129850536|NCT00887341|467412470|FG000|Overall Study|Withdrawal by Subject|1|||
129850537|NCT00887341|467412471|FG001|Overall Study|Withdrawal by Subject|1|||
129850538|NCT00887341|467412470|FG000|Overall Study|Adverse Event|0|||
129850539|NCT00887341|467412471|FG001|Overall Study|Adverse Event|1|||
129850540|NCT00887341|467412470|FG000|Overall Study|Lost to Follow-up|0|||
129850541|NCT00887341|467412471|FG001|Overall Study|Lost to Follow-up|1|||
129850542|NCT01591681|467412474|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
129850543|NCT01591681|467412474|FG000|Overall Study|Failed to use system during run-in|1|||
129850544|NCT00281840|467412477|FG000|Overall Study|Adverse Event|12|||
129850545|NCT00281840|467412477|FG000|Overall Study|Physician Decision|6|||
129850546|NCT00281840|467412477|FG000|Overall Study|Withdrawal by Subject|3|||
129850547|NCT00281840|467412477|FG000|Overall Study|Disease Progression|2|||
129850548|NCT00281840|467412477|FG000|Overall Study|exceed maximum delay in treatment|1|||
129850549|NCT00281840|467412477|FG000|Overall Study|Complicating Disease|1|||
129850550|NCT01079234|467412480|FG000|Main: Week 0 to 26|Adverse Event|5|||
129850551|NCT01079234|467412481|FG001|Main: Week 0 to 26|Adverse Event|4|||
129850552|NCT01079234|467412482|FG002|Main: Week 0 to 26|Adverse Event|1|||
129850553|NCT01079234|467412483|FG003|Main: Week 0 to 26|Adverse Event|0|||
129850554|NCT01079234|467412480|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
129850555|NCT01079234|467412481|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
129850556|NCT01079234|467412482|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
129850557|NCT01079234|467412483|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
129850558|NCT01079234|467412480|FG000|Main: Week 0 to 26|Protocol Violation|6|||
129850559|NCT01079234|467412481|FG001|Main: Week 0 to 26|Protocol Violation|2|||
129850560|NCT01079234|467412482|FG002|Main: Week 0 to 26|Protocol Violation|4|||
129850561|NCT01079234|467412483|FG003|Main: Week 0 to 26|Protocol Violation|0|||
129850562|NCT01079234|467412480|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
129850563|NCT01079234|467412481|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
129850564|NCT01079234|467412482|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
129850565|NCT01079234|467412483|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
129850566|NCT01079234|467412480|FG000|Main: Week 0 to 26|Unclassified|7|||
129850567|NCT01079234|467412481|FG001|Main: Week 0 to 26|Unclassified|13|||
129850568|NCT01079234|467412482|FG002|Main: Week 0 to 26|Unclassified|4|||
129850569|NCT01079234|467412483|FG003|Main: Week 0 to 26|Unclassified|0|||
129850570|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Adverse Event|0|||
129850571|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Adverse Event|0|||
129850572|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Adverse Event|1|||
129850573|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Adverse Event|0|||
129850574|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
129904675|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
129850575|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
129850576|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
129850577|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
129850578|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
129850579|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
129850580|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
129850581|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
129850582|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
129850583|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
129850584|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
129850585|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
129850586|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Unclassified|0|||
129850587|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Unclassified|0|||
129850588|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Unclassified|4|||
129850589|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Unclassified|7|||
129850590|NCT01312961|467412490|FG000|Overall Study|Adverse Event|3|||
129850591|NCT01312961|467412491|FG001|Overall Study|Adverse Event|3|||
129850592|NCT01312961|467412490|FG000|Overall Study|Lack of Efficacy|11|||
129850593|NCT01312961|467412491|FG001|Overall Study|Lack of Efficacy|1|||
129850594|NCT01312961|467412490|FG000|Overall Study|Poor compliance to protocol|1|||
129850595|NCT01312961|467412491|FG001|Overall Study|Poor compliance to protocol|0|||
129850596|NCT01312961|467412490|FG000|Overall Study|Other than specified above|2|||
129850597|NCT01312961|467412491|FG001|Overall Study|Other than specified above|3|||
129850598|NCT04278417|467412492|FG000|Overall Study|Withdrawal by Subject|20|||
129850599|NCT04278417|467412493|FG001|Overall Study|Withdrawal by Subject|20|||
129850600|NCT04278417|467412492|FG000|Overall Study|Progressive disease|0|||
129850601|NCT04278417|467412493|FG001|Overall Study|Progressive disease|2|||
129850602|NCT04278417|467412492|FG000|Overall Study|Physician Decision|4|||
129850603|NCT04278417|467412493|FG001|Overall Study|Physician Decision|6|||
129850604|NCT04278417|467412492|FG000|Overall Study|Lost to Follow-up|11|||
129850605|NCT04278417|467412493|FG001|Overall Study|Lost to Follow-up|13|||
129850606|NCT04278417|467412492|FG000|Overall Study|Death|8|||
129850607|NCT04278417|467412493|FG001|Overall Study|Death|9|||
129850608|NCT04278417|467412492|FG000|Overall Study|Adverse Event|3|||
129850609|NCT04278417|467412493|FG001|Overall Study|Adverse Event|5|||
129850610|NCT00205712|467412495|FG000|Overall Study|Lost to Follow-up|0|||
129850611|NCT00205712|467412496|FG001|Overall Study|Lost to Follow-up|1|||
129850612|NCT01652716|467412506|FG000|Overall Study|Loss of glucose control|1|||
129850613|NCT01652716|467412507|FG001|Overall Study|Loss of glucose control|0|||
129850614|NCT01652716|467412506|FG000|Overall Study|Administrative|0|||
129850615|NCT01652716|467412507|FG001|Overall Study|Administrative|2|||
129850616|NCT01652716|467412506|FG000|Overall Study|Investigator decision|1|||
129850617|NCT01652716|467412507|FG001|Overall Study|Investigator decision|4|||
129850618|NCT01652716|467412506|FG000|Overall Study|Lost to Follow-up|12|||
129850619|NCT01652716|467412507|FG001|Overall Study|Lost to Follow-up|11|||
129850620|NCT01652716|467412506|FG000|Overall Study|Protocol Violation|2|||
129850621|NCT01652716|467412507|FG001|Overall Study|Protocol Violation|1|||
129850622|NCT01652716|467412506|FG000|Overall Study|Adverse Event|7|||
129850623|NCT01652716|467412507|FG001|Overall Study|Adverse Event|10|||
129850624|NCT01652716|467412506|FG000|Overall Study|Withdrawal by Subject|33|||
129850625|NCT01652716|467412507|FG001|Overall Study|Withdrawal by Subject|18|||
129850626|NCT01337297|467412508|FG000|Overall Study|They entered to single anodal tDCS|4|||
129850627|NCT01337297|467412509|FG001|Overall Study|They entered to single anodal tDCS|3|||
129850628|NCT01337297|467412508|FG000|Overall Study|Lost to Follow-up|1|||
129850629|NCT01337297|467412509|FG001|Overall Study|Lost to Follow-up|3|||
129850630|NCT02778204|467412510|FG000|Overall Study|Adverse Event|1|||
129850631|NCT02778204|467412511|FG001|Overall Study|Adverse Event|0|||
129850632|NCT02778204|467412512|FG002|Overall Study|Adverse Event|0|||
129850633|NCT02778204|467412513|FG003|Overall Study|Adverse Event|0|||
129850634|NCT02778204|467412510|FG000|Overall Study|Withdrawal by Subject|0|||
129850635|NCT02778204|467412511|FG001|Overall Study|Withdrawal by Subject|0|||
129850636|NCT02778204|467412512|FG002|Overall Study|Withdrawal by Subject|1|||
129850637|NCT02778204|467412513|FG003|Overall Study|Withdrawal by Subject|2|||
129850638|NCT02778204|467412510|FG000|Overall Study|Lost to Follow-up|1|||
129850639|NCT02778204|467412511|FG001|Overall Study|Lost to Follow-up|0|||
129850640|NCT02778204|467412512|FG002|Overall Study|Lost to Follow-up|2|||
129850641|NCT02778204|467412513|FG003|Overall Study|Lost to Follow-up|1|||
129850642|NCT02778204|467412510|FG000|Overall Study|Protocol Violation|0|||
129850643|NCT02778204|467412511|FG001|Overall Study|Protocol Violation|0|||
129850644|NCT02778204|467412512|FG002|Overall Study|Protocol Violation|1|||
129850645|NCT02778204|467412513|FG003|Overall Study|Protocol Violation|0|||
129850646|NCT02778204|467412510|FG000|Overall Study|Eligibility Violation|0|||
129850647|NCT02778204|467412511|FG001|Overall Study|Eligibility Violation|0|||
129850648|NCT02778204|467412512|FG002|Overall Study|Eligibility Violation|0|||
129850649|NCT02778204|467412513|FG003|Overall Study|Eligibility Violation|1|||
129850650|NCT03964454|467412519|FG000|Overall Study|Lost to Follow-up|13|||
129850651|NCT03964454|467412520|FG001|Overall Study|Lost to Follow-up|7|||
129850652|NCT03964454|467412519|FG000|Overall Study|Withdrawal by Subject|4|||
129850653|NCT03964454|467412520|FG001|Overall Study|Withdrawal by Subject|11|||
129850654|NCT00201006|467414586|FG000|Overall Study|Withdrawal by Subject|7|||
129850655|NCT00201006|467414587|FG001|Overall Study|Withdrawal by Subject|2|||
129850656|NCT00201006|467414588|FG002|Overall Study|Withdrawal by Subject|3|||
129850657|NCT00201006|467414586|FG000|Overall Study|Adverse Event|1|||
129850658|NCT00201006|467414587|FG001|Overall Study|Adverse Event|0|||
129850659|NCT00201006|467414588|FG002|Overall Study|Adverse Event|1|||
129850660|NCT01694706|467414590|FG000|Overall Study|Adverse Event|0|||
129850661|NCT01694706|467414591|FG001|Overall Study|Adverse Event|1|||
129850662|NCT01694706|467414592|FG002|Overall Study|Adverse Event|0|||
129850663|NCT01694706|467414590|FG000|Overall Study|other reason not defined above|1|||
129850664|NCT01694706|467414591|FG001|Overall Study|other reason not defined above|0|||
129850665|NCT01694706|467414592|FG002|Overall Study|other reason not defined above|0|||
129850666|NCT00975975|467414593|FG000|Overall Study|Death|6|||
129850667|NCT02057757|467414600|FG000|Overall Study|Withdrawal by Subject|3|||
129850668|NCT02057757|467414601|FG001|Overall Study|Withdrawal by Subject|5|||
129850669|NCT02057757|467414600|FG000|Overall Study|Death|2|||
129850670|NCT02057757|467414601|FG001|Overall Study|Death|0|||
129850671|NCT02057757|467414600|FG000|Overall Study|Lost to Follow-up|8|||
129850672|NCT02057757|467414601|FG001|Overall Study|Lost to Follow-up|3|||
129850673|NCT02057757|467414600|FG000|Overall Study|Non-compliance|1|||
129850674|NCT02057757|467414601|FG001|Overall Study|Non-compliance|0|||
129850675|NCT03614793|467414602|FG000|Overall Study|Lost to Follow-up|1|||
129850676|NCT03614793|467414603|FG001|Overall Study|Lost to Follow-up|2|||
129850677|NCT03614793|467414602|FG000|Overall Study|Lack of Efficacy|0|||
129850678|NCT03614793|467414603|FG001|Overall Study|Lack of Efficacy|5|||
129850679|NCT03614793|467414602|FG000|Overall Study|Withdrawal by Subject|0|||
129850680|NCT03614793|467414603|FG001|Overall Study|Withdrawal by Subject|1|||
129850681|NCT03614793|467414602|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
129850682|NCT03614793|467414603|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
129850683|NCT02082522|467414604|FG000|Overall Study|Sponsor termination|5|||
129850684|NCT02082522|467414605|FG001|Overall Study|Sponsor termination|3|||
129850685|NCT02082522|467414604|FG000|Overall Study|Withdrawal by Subject|2|||
129850686|NCT02082522|467414605|FG001|Overall Study|Withdrawal by Subject|4|||
129850687|NCT02082522|467414604|FG000|Overall Study|Death|1|||
129850688|NCT02082522|467414605|FG001|Overall Study|Death|0|||
129850689|NCT02082522|467414604|FG000|Overall Study|Lost to Follow-up|1|||
129850690|NCT02082522|467414605|FG001|Overall Study|Lost to Follow-up|0|||
129850691|NCT02082522|467414604|FG000|Overall Study|Physician Decision|3|||
129850692|NCT02082522|467414605|FG001|Overall Study|Physician Decision|1|||
129850693|NCT02082522|467414604|FG000|Overall Study|Disease progression|2|||
129850694|NCT02082522|467414605|FG001|Overall Study|Disease progression|2|||
129850695|NCT02082522|467414604|FG000|Overall Study|Chemotherapy change|1|||
129850696|NCT02082522|467414605|FG001|Overall Study|Chemotherapy change|3|||
129850697|NCT00456092|467414606|FG000|Extension Phase|Grade 2 or Greater AE|2|||
129850698|NCT00456092|467414607|FG001|Extension Phase|Grade 2 or Greater AE|2|||
129850699|NCT00456092|467414608|FG002|Extension Phase|Grade 2 or Greater AE|0|||
129850700|NCT00456092|467414609|FG003|Extension Phase|Grade 2 or Greater AE|0|||
129850701|NCT00456092|467414610|FG004|Extension Phase|Grade 2 or Greater AE|2|||
129850702|NCT00456092|467414606|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
129850703|NCT00456092|467414607|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
129850704|NCT00456092|467414608|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
129850705|NCT00456092|467414609|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
129850706|NCT00456092|467414610|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
129850707|NCT00456092|467414606|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
129850708|NCT00456092|467414607|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
129850709|NCT00456092|467414608|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
129850710|NCT00456092|467414609|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
129850711|NCT00456092|467414610|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
129850712|NCT00456092|467414606|FG000|Extension Phase|Withdrew Consent|2|||
129850713|NCT00456092|467414607|FG001|Extension Phase|Withdrew Consent|0|||
129850714|NCT00456092|467414608|FG002|Extension Phase|Withdrew Consent|0|||
129850715|NCT00456092|467414609|FG003|Extension Phase|Withdrew Consent|0|||
129850716|NCT00456092|467414610|FG004|Extension Phase|Withdrew Consent|0|||
129850717|NCT00456092|467414606|FG000|Extension Phase|Lost to Follow-up|1|||
129850718|NCT00456092|467414607|FG001|Extension Phase|Lost to Follow-up|1|||
129850719|NCT00456092|467414608|FG002|Extension Phase|Lost to Follow-up|0|||
129850720|NCT00456092|467414609|FG003|Extension Phase|Lost to Follow-up|0|||
129850721|NCT00456092|467414610|FG004|Extension Phase|Lost to Follow-up|1|||
129850722|NCT00456092|467414606|FG000|Extension Phase|Other|2|||
129850723|NCT00456092|467414607|FG001|Extension Phase|Other|0|||
129850724|NCT00456092|467414608|FG002|Extension Phase|Other|0|||
129850725|NCT00456092|467414609|FG003|Extension Phase|Other|1|||
129850726|NCT00456092|467414610|FG004|Extension Phase|Other|1|||
129850727|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
129850728|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
129850729|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
129850730|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
129850731|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
129850732|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
129850733|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
129850734|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
129850735|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
129850736|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
129850737|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
129850738|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850739|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850740|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850741|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850742|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
129850743|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
129850744|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
129850745|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
129850746|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
129850747|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
129850748|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
129850749|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
129850750|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
129850751|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
129850752|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
129850753|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
129850754|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
129850755|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
129850756|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
129850757|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
129850758|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
129850759|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
129850760|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
129850761|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
129850762|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129850763|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129850764|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129850765|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129850766|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129850767|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Other|1|||
129850768|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Other|0|||
129850769|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Other|1|||
129850770|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Other|0|||
129850771|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Other|0|||
129850772|NCT01168999|467414611|FG000|Overall Study|Lost to Follow-up|2|||
129850773|NCT01168999|467414612|FG001|Overall Study|Lost to Follow-up|1|||
129850774|NCT01168999|467414613|FG002|Overall Study|Lost to Follow-up|0|||
129850775|NCT01168999|467414614|FG003|Overall Study|Lost to Follow-up|0|||
129850776|NCT03603964|467414615|FG000|Overall Study|Death|9|||
129850777|NCT03603964|467414615|FG000|Overall Study|Withdrawal by participant|7|||
129850778|NCT03603964|467414615|FG000|Overall Study|Study terminated by Sponsor|19|||
129850779|NCT04317586|467414616|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
129850780|NCT04317586|467414616|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
129850781|NCT00563797|467414617|FG000|Overall Study|Lost to Follow-up|7|||
129850782|NCT00563797|467414618|FG001|Overall Study|Lost to Follow-up|2|||
129850783|NCT04327934|467414619|FG000|Overall Study|Did not qualify|7|||
129850784|NCT04327934|467414620|FG001|Overall Study|Did not qualify|4|||
129850785|NCT04327934|467414619|FG000|Overall Study|Physician Decision|0|||
129850786|NCT04327934|467414620|FG001|Overall Study|Physician Decision|1|||
129850787|NCT03095417|467414625|FG000|Overall Study|missed|1|||
129850788|NCT03095417|467414626|FG001|Overall Study|missed|2|||
129850789|NCT03095417|467414627|FG002|Overall Study|missed|0|||
129850790|NCT03095417|467414628|FG003|Overall Study|missed|1|||
129850791|NCT03095417|467414625|FG000|Overall Study|Lost to Follow-up|2|||
129850792|NCT03095417|467414626|FG001|Overall Study|Lost to Follow-up|2|||
129850793|NCT03095417|467414627|FG002|Overall Study|Lost to Follow-up|1|||
129850794|NCT03095417|467414628|FG003|Overall Study|Lost to Follow-up|0|||
129850795|NCT03095417|467414625|FG000|Overall Study|refusal|0|||
129850796|NCT03095417|467414626|FG001|Overall Study|refusal|1|||
129850797|NCT03095417|467414627|FG002|Overall Study|refusal|0|||
129850798|NCT03095417|467414628|FG003|Overall Study|refusal|1|||
129850799|NCT03095417|467414625|FG000|Overall Study|Withdrawal by Subject|8|||
129850800|NCT03095417|467414626|FG001|Overall Study|Withdrawal by Subject|2|||
129850801|NCT03095417|467414627|FG002|Overall Study|Withdrawal by Subject|5|||
129850802|NCT03095417|467414628|FG003|Overall Study|Withdrawal by Subject|4|||
129850803|NCT03095417|467414625|FG000|Overall Study|Physician Decision|1|||
130064572|NCT00622869|468190203|FG001|Overall Study|Subject Withdrew Consent|17|||
129850804|NCT03095417|467414626|FG001|Overall Study|Physician Decision|2|||
129850805|NCT03095417|467414627|FG002|Overall Study|Physician Decision|2|||
129850806|NCT03095417|467414628|FG003|Overall Study|Physician Decision|2|||
129850807|NCT03095417|467414625|FG000|Overall Study|Death|1|||
129850808|NCT03095417|467414626|FG001|Overall Study|Death|2|||
129850809|NCT03095417|467414627|FG002|Overall Study|Death|1|||
129850810|NCT03095417|467414628|FG003|Overall Study|Death|3|||
129850811|NCT01490060|467414629|FG000|Cycle 1|Change of Treatment|0|||
129850812|NCT01490060|467414630|FG001|Cycle 1|Change of Treatment|1|||
129850813|NCT01490060|467414631|FG002|Cycle 1|Change of Treatment|1|||
129850814|NCT01490060|467414632|FG003|Cycle 1|Change of Treatment|1|||
129850815|NCT01490060|467414629|FG000|Cycle 1|Insurance Denied|0|||
129850816|NCT01490060|467414630|FG001|Cycle 1|Insurance Denied|0|||
129850817|NCT01490060|467414631|FG002|Cycle 1|Insurance Denied|2|||
129850818|NCT01490060|467414632|FG003|Cycle 1|Insurance Denied|0|||
129850819|NCT01490060|467414629|FG000|Cycle 1|Withdrawal by Subject|0|||
129850820|NCT01490060|467414630|FG001|Cycle 1|Withdrawal by Subject|0|||
129850821|NCT01490060|467414631|FG002|Cycle 1|Withdrawal by Subject|0|||
129850822|NCT01490060|467414632|FG003|Cycle 1|Withdrawal by Subject|1|||
129850823|NCT01490060|467414629|FG000|Cycle 1|Treatment at Another Facility|0|||
129850824|NCT01490060|467414630|FG001|Cycle 1|Treatment at Another Facility|0|||
129850825|NCT01490060|467414631|FG002|Cycle 1|Treatment at Another Facility|0|||
129850826|NCT01490060|467414632|FG003|Cycle 1|Treatment at Another Facility|1|||
129850827|NCT01490060|467414629|FG000|Cycle 2|Change of Treatment|1|||
129850828|NCT01490060|467414630|FG001|Cycle 2|Change of Treatment|1|||
129850829|NCT01490060|467414631|FG002|Cycle 2|Change of Treatment|0|||
129850830|NCT01490060|467414632|FG003|Cycle 2|Change of Treatment|0|||
129850831|NCT01490060|467414629|FG000|Cycle 2|Non-Compliance|0|||
129850832|NCT01490060|467414630|FG001|Cycle 2|Non-Compliance|0|||
129850833|NCT01490060|467414631|FG002|Cycle 2|Non-Compliance|1|||
129850834|NCT01490060|467414632|FG003|Cycle 2|Non-Compliance|0|||
129850835|NCT01490060|467414629|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
129850836|NCT01490060|467414630|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
129850837|NCT01490060|467414631|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
129850838|NCT01490060|467414632|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
129850839|NCT01877421|467414633|FG000|Phase 2|Lost to Follow-up|0|||
129850840|NCT01877421|467414634|FG001|Phase 2|Lost to Follow-up|0|||
129850841|NCT01877421|467414635|FG002|Phase 2|Lost to Follow-up|0|||
129850842|NCT01877421|467414636|FG003|Phase 2|Lost to Follow-up|0|||
129850843|NCT01877421|467414637|FG004|Phase 2|Lost to Follow-up|0|||
129850844|NCT01877421|467414638|FG005|Phase 2|Lost to Follow-up|0|||
129850845|NCT01877421|467414639|FG006|Phase 2|Lost to Follow-up|1|||
129850846|NCT01877421|467414640|FG007|Phase 2|Lost to Follow-up|0|||
129850847|NCT01877421|467414641|FG008|Phase 2|Lost to Follow-up|0|||
129850848|NCT01877421|467414642|FG009|Phase 2|Lost to Follow-up|0|||
129850849|NCT01877421|467414643|FG010|Phase 2|Lost to Follow-up|0|||
129850850|NCT01877421|467414644|FG011|Phase 2|Lost to Follow-up|0|||
129850851|NCT01877421|467414645|FG012|Phase 2|Lost to Follow-up|0|||
129850852|NCT01877421|467414646|FG013|Phase 2|Lost to Follow-up|0|||
129850853|NCT01877421|467414647|FG014|Phase 2|Lost to Follow-up|0|||
129850854|NCT01877421|467414648|FG015|Phase 2|Lost to Follow-up|0|||
129850855|NCT01877421|467414649|FG016|Phase 2|Lost to Follow-up|0|||
129850856|NCT01877421|467414650|FG017|Phase 2|Lost to Follow-up|0|||
129850857|NCT01877421|467414633|FG000|Phase 2|Withdrawal by Subject|0|||
129850858|NCT01877421|467414634|FG001|Phase 2|Withdrawal by Subject|0|||
129850859|NCT01877421|467414635|FG002|Phase 2|Withdrawal by Subject|0|||
129850860|NCT01877421|467414636|FG003|Phase 2|Withdrawal by Subject|0|||
129850861|NCT01877421|467414637|FG004|Phase 2|Withdrawal by Subject|0|||
129850862|NCT01877421|467414638|FG005|Phase 2|Withdrawal by Subject|0|||
129850863|NCT01877421|467414639|FG006|Phase 2|Withdrawal by Subject|0|||
129850864|NCT01877421|467414640|FG007|Phase 2|Withdrawal by Subject|0|||
129850865|NCT01877421|467414641|FG008|Phase 2|Withdrawal by Subject|1|||
129850866|NCT01877421|467414642|FG009|Phase 2|Withdrawal by Subject|0|||
129850867|NCT01877421|467414643|FG010|Phase 2|Withdrawal by Subject|1|||
129850868|NCT01877421|467414644|FG011|Phase 2|Withdrawal by Subject|0|||
129850869|NCT01877421|467414645|FG012|Phase 2|Withdrawal by Subject|1|||
129850870|NCT01877421|467414646|FG013|Phase 2|Withdrawal by Subject|0|||
129850871|NCT01877421|467414647|FG014|Phase 2|Withdrawal by Subject|0|||
129850872|NCT01877421|467414648|FG015|Phase 2|Withdrawal by Subject|1|||
129850873|NCT01877421|467414649|FG016|Phase 2|Withdrawal by Subject|0|||
129850874|NCT01877421|467414650|FG017|Phase 2|Withdrawal by Subject|0|||
129850875|NCT01877421|467414633|FG000|Phase 2|Protocol Violation|0|||
129850876|NCT01877421|467414634|FG001|Phase 2|Protocol Violation|0|||
129850877|NCT01877421|467414635|FG002|Phase 2|Protocol Violation|0|||
129850878|NCT01877421|467414636|FG003|Phase 2|Protocol Violation|0|||
129850879|NCT01877421|467414637|FG004|Phase 2|Protocol Violation|0|||
129850880|NCT01877421|467414638|FG005|Phase 2|Protocol Violation|0|||
129850881|NCT01877421|467414639|FG006|Phase 2|Protocol Violation|0|||
130064573|NCT00622869|468190204|FG002|Overall Study|Subject Withdrew Consent|11|||
129850882|NCT01877421|467414640|FG007|Phase 2|Protocol Violation|0|||
129850883|NCT01877421|467414641|FG008|Phase 2|Protocol Violation|0|||
129850884|NCT01877421|467414642|FG009|Phase 2|Protocol Violation|0|||
129850885|NCT01877421|467414643|FG010|Phase 2|Protocol Violation|1|||
129850886|NCT01877421|467414644|FG011|Phase 2|Protocol Violation|0|||
129850887|NCT01877421|467414645|FG012|Phase 2|Protocol Violation|0|||
129850888|NCT01877421|467414646|FG013|Phase 2|Protocol Violation|0|||
129850889|NCT01877421|467414647|FG014|Phase 2|Protocol Violation|0|||
129850890|NCT01877421|467414648|FG015|Phase 2|Protocol Violation|0|||
129850891|NCT01877421|467414649|FG016|Phase 2|Protocol Violation|0|||
129850892|NCT01877421|467414650|FG017|Phase 2|Protocol Violation|0|||
129850893|NCT01047683|467414651|FG000|Overall Study|Adverse Event|3|||
129850894|NCT01047683|467414652|FG001|Overall Study|Adverse Event|1|||
129850895|NCT01047683|467414653|FG002|Overall Study|Adverse Event|0|||
129850896|NCT01047683|467414651|FG000|Overall Study|Withdrew Consent|1|||
129850897|NCT01047683|467414652|FG001|Overall Study|Withdrew Consent|4|||
129850898|NCT01047683|467414653|FG002|Overall Study|Withdrew Consent|2|||
129850899|NCT01047683|467414651|FG000|Overall Study|Lost to Follow-up|0|||
129904676|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
129904677|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
129904678|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
129904679|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
129904680|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
129904681|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
129904682|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
129904683|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
129904684|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
129904685|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
129904686|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
129904687|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
129904688|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
129904689|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
129904690|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
129904691|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
129904692|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
129904693|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
129904694|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
129904695|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
129904696|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
129904697|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
129904698|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
129904699|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
129904700|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
129904701|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
129904702|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
129904703|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
129904704|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
129904705|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
129904706|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
129904707|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
129904708|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
129904709|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
129904710|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
129904711|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
129904712|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
129904713|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
129904714|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
129904715|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
129904716|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
129904717|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
129904718|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
129904719|NCT01405924|467612893|FG000|Overall Study|Protocol Violation|8|||
129904720|NCT01405924|467612893|FG000|Overall Study|Missing/Incomplete Data|2|||
129904721|NCT03184558|467612894|FG000|Overall Study|Withdrawal by Subject|2|||
129904722|NCT03184558|467612894|FG000|Overall Study|Death|16|||
129904723|NCT03184558|467612894|FG000|Overall Study|Lost to Follow-up|2|||
129904724|NCT03184558|467612894|FG000|Overall Study|Other|9|||
129904725|NCT00723450|467612902|FG000|Open-Label Phase|Adverse Event|26|||
129904726|NCT00723450|467612903|FG001|Open-Label Phase|Adverse Event|0|||
129904727|NCT00723450|467612904|FG002|Open-Label Phase|Adverse Event|0|||
129904728|NCT00723450|467612902|FG000|Open-Label Phase|Lack of Efficacy|18|||
129904729|NCT00723450|467612903|FG001|Open-Label Phase|Lack of Efficacy|0|||
129904730|NCT00723450|467612904|FG002|Open-Label Phase|Lack of Efficacy|0|||
129904731|NCT00723450|467612902|FG000|Open-Label Phase|Protocol Violation|35|||
129904732|NCT00723450|467612903|FG001|Open-Label Phase|Protocol Violation|0|||
129904733|NCT00723450|467612904|FG002|Open-Label Phase|Protocol Violation|0|||
129904734|NCT00723450|467612902|FG000|Open-Label Phase|Lost to Follow-up|7|||
129904735|NCT00723450|467612903|FG001|Open-Label Phase|Lost to Follow-up|0|||
129904736|NCT00723450|467612904|FG002|Open-Label Phase|Lost to Follow-up|0|||
129904737|NCT00723450|467612902|FG000|Open-Label Phase|Physician Decision|2|||
129904738|NCT00723450|467612903|FG001|Open-Label Phase|Physician Decision|0|||
129904739|NCT00723450|467612904|FG002|Open-Label Phase|Physician Decision|0|||
129904740|NCT00723450|467612902|FG000|Open-Label Phase|Withdrawal by Subject|37|||
129904741|NCT00723450|467612903|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129904742|NCT00723450|467612904|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129904743|NCT00723450|467612902|FG000|Randomized Phase|Adverse Event|0|||
129904744|NCT00723450|467612903|FG001|Randomized Phase|Adverse Event|26|||
129904745|NCT00723450|467612904|FG002|Randomized Phase|Adverse Event|17|||
129904746|NCT00723450|467612902|FG000|Randomized Phase|Lack of Efficacy|0|||
129850900|NCT01047683|467414652|FG001|Overall Study|Lost to Follow-up|1|||
129850901|NCT01047683|467414653|FG002|Overall Study|Lost to Follow-up|0|||
129850902|NCT01047683|467414651|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
129850903|NCT01047683|467414652|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
129850904|NCT01047683|467414653|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
129850905|NCT03698773|467414655|FG000|Overall Study|Lost to Follow-up|2|||
129850906|NCT03698773|467414656|FG001|Overall Study|Lost to Follow-up|1|||
129850907|NCT00908960|467414657|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
129850908|NCT00908960|467414658|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
129850909|NCT00908960|467414659|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
129850910|NCT05074433|467414660|FG000|Overall Study|Adverse Event|0|||
129850911|NCT05074433|467414661|FG001|Overall Study|Adverse Event|2|||
129850912|NCT05074433|467414662|FG002|Overall Study|Adverse Event|0|||
129850913|NCT05074433|467414663|FG003|Overall Study|Adverse Event|1|||
129850914|NCT05074433|467414660|FG000|Overall Study|Sponsor Request|0|||
129850915|NCT05074433|467414661|FG001|Overall Study|Sponsor Request|1|||
129850916|NCT05074433|467414662|FG002|Overall Study|Sponsor Request|1|||
129850917|NCT05074433|467414663|FG003|Overall Study|Sponsor Request|0|||
129850918|NCT05074433|467414660|FG000|Overall Study|Death|1|||
129850919|NCT05074433|467414661|FG001|Overall Study|Death|0|||
129850920|NCT05074433|467414662|FG002|Overall Study|Death|0|||
129850921|NCT05074433|467414663|FG003|Overall Study|Death|0|||
129850922|NCT05074433|467414660|FG000|Overall Study|Lost to Follow-up|0|||
129850923|NCT05074433|467414661|FG001|Overall Study|Lost to Follow-up|0|||
129850924|NCT05074433|467414662|FG002|Overall Study|Lost to Follow-up|2|||
129850925|NCT05074433|467414663|FG003|Overall Study|Lost to Follow-up|0|||
129850926|NCT05074433|467414660|FG000|Overall Study|Subject Decision|8|||
129850927|NCT05074433|467414661|FG001|Overall Study|Subject Decision|6|||
129850928|NCT05074433|467414662|FG002|Overall Study|Subject Decision|4|||
129850929|NCT05074433|467414663|FG003|Overall Study|Subject Decision|5|||
129850930|NCT01158924|467414665|FG000|Overall Study|Withdrawal by Subject|1|||
129850931|NCT01158924|467414666|FG001|Overall Study|Withdrawal by Subject|2|||
129850932|NCT01158924|467414665|FG000|Overall Study|Lost to Follow-up|0|||
129850933|NCT01158924|467414666|FG001|Overall Study|Lost to Follow-up|1|||
129850934|NCT03795922|467414667|FG000|Overall Study|Adverse Event|2|||
129850935|NCT03795922|467414668|FG001|Overall Study|Adverse Event|1|||
129850936|NCT03795922|467414667|FG000|Overall Study|Withdrawal by Subject|5|||
129850937|NCT03795922|467414668|FG001|Overall Study|Withdrawal by Subject|13|||
129850938|NCT03795922|467414667|FG000|Overall Study|Lost to Follow-up|2|||
129850939|NCT03795922|467414668|FG001|Overall Study|Lost to Follow-up|3|||
129850940|NCT03795922|467414667|FG000|Overall Study|Pregnancy|0|||
129850941|NCT03795922|467414668|FG001|Overall Study|Pregnancy|1|||
129850942|NCT03795922|467414667|FG000|Overall Study|Physician Decision|1|||
129850943|NCT03795922|467414668|FG001|Overall Study|Physician Decision|2|||
129850944|NCT03795922|467414667|FG000|Overall Study|Protocol Violation|0|||
129850945|NCT03795922|467414668|FG001|Overall Study|Protocol Violation|1|||
129850946|NCT03795922|467414667|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
129850947|NCT03795922|467414668|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
129850948|NCT00724451|467414672|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
129850949|NCT00724451|467414672|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
129850950|NCT00724451|467414672|FG000|Overall Study|Not Eligible for Treatment|431|||
129850951|NCT00724451|467414672|FG000|Overall Study|Participant Refused Treatment|89|||
129850952|NCT00724451|467414672|FG000|Overall Study|Never Started Treatment|89|||
129850953|NCT00724451|467414672|FG000|Overall Study|Unknown; No Data Sources Available|9|||
129850954|NCT00724451|467414672|FG000|Overall Study|Physician Decision|116|||
129850955|NCT00724451|467414672|FG000|Overall Study|Withdrawal by Subject|45|||
129850956|NCT00724451|467414672|FG000|Overall Study|Investigator + Participant Decision|13|||
129850957|NCT01260922|467414674|FG000|First Intervention|Withdrawal by Subject|0|||
129850958|NCT01260922|467414675|FG001|First Intervention|Withdrawal by Subject|1|||
129850959|NCT01260922|467414674|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
129850960|NCT01260922|467414675|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
129850961|NCT01260922|467414674|FG000|Second Intervention|Emesis|0|||
129850962|NCT01260922|467414675|FG001|Second Intervention|Emesis|2|||
129850963|NCT02822794|467414680|FG000|Overall Study|Withdrew Consent|1|||
129850964|NCT02822794|467414681|FG001|Overall Study|Withdrew Consent|0|||
129850965|NCT03732248|467414682|FG000|Overall Study|Withdrawal by Subject|1|||
129850966|NCT03732248|467414683|FG001|Overall Study|Withdrawal by Subject|0|||
129850967|NCT01525082|467414688|FG000|Overall Study|Death|1|||
129850968|NCT02480621|467414689|FG000|Randomization|Withdrawal by Subject|1|||
129850969|NCT02480621|467414690|FG001|Randomization|Withdrawal by Subject|0|||
129850970|NCT02480621|467414689|FG000|Randomization|Surgeon did not give intervention|0|||
129850971|NCT02480621|467414690|FG001|Randomization|Surgeon did not give intervention|1|||
129850972|NCT02480621|467414689|FG000|Follow Up|Lost to Follow-up|4|||
130116583|NCT01335477|468387107|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
129850973|NCT02480621|467414690|FG001|Follow Up|Lost to Follow-up|2|||
129850974|NCT03056690|467414691|FG000|Overall Study|Adverse Event|3|||
129850975|NCT03056690|467414692|FG001|Overall Study|Adverse Event|2|||
129850976|NCT03056690|467414691|FG000|Overall Study|Lack of Efficacy|1|||
129850977|NCT03056690|467414692|FG001|Overall Study|Lack of Efficacy|2|||
129850978|NCT03056690|467414691|FG000|Overall Study|Lost to Follow-up|3|||
129850979|NCT03056690|467414692|FG001|Overall Study|Lost to Follow-up|2|||
129850980|NCT03056690|467414691|FG000|Overall Study|Protocol Violation|2|||
129850981|NCT03056690|467414692|FG001|Overall Study|Protocol Violation|2|||
129850982|NCT03056690|467414691|FG000|Overall Study|Withdrawal by Subject|3|||
129850983|NCT03056690|467414692|FG001|Overall Study|Withdrawal by Subject|6|||
129850984|NCT03056690|467414691|FG000|Overall Study|Non-compliance with Study Drug|1|||
129850985|NCT03056690|467414692|FG001|Overall Study|Non-compliance with Study Drug|0|||
129850986|NCT03056690|467414691|FG000|Overall Study|Miscellaneous|1|||
129850987|NCT03056690|467414692|FG001|Overall Study|Miscellaneous|2|||
129850988|NCT02141516|467414699|FG000|Overall Study|Adverse Event|0|||
129850989|NCT02141516|467414700|FG001|Overall Study|Adverse Event|1|||
129850990|NCT02141516|467414701|FG002|Overall Study|Adverse Event|0|||
129850991|NCT02141516|467414699|FG000|Overall Study|Lost to Follow-up|0|||
129850992|NCT02141516|467414700|FG001|Overall Study|Lost to Follow-up|1|||
129850993|NCT02141516|467414701|FG002|Overall Study|Lost to Follow-up|0|||
129850994|NCT02141516|467414699|FG000|Overall Study|Other|0|||
129850995|NCT02141516|467414700|FG001|Overall Study|Other|3|||
129850996|NCT02141516|467414701|FG002|Overall Study|Other|0|||
129850997|NCT01440946|467414702|FG000|Overall Study|Lost to Follow-up|1|||
129850998|NCT01440946|467414703|FG001|Overall Study|Lost to Follow-up|1|||
129850999|NCT01440946|467414702|FG000|Overall Study|Physician Decision|1|||
129851000|NCT01440946|467414703|FG001|Overall Study|Physician Decision|0|||
129851001|NCT00235989|467414710|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851002|NCT00235989|467414711|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851003|NCT00235989|467414712|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851004|NCT00235989|467414713|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851005|NCT00235989|467414714|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851006|NCT00235989|467414715|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
129851007|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
129851008|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
129851009|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
129851010|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
129851011|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
129851012|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
129851013|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
129851014|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851015|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
129851016|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851017|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851018|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851019|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
129851020|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
129851021|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
129851022|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
129851023|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
129851024|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
129851025|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
129851026|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
129851027|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
129851028|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
129851029|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
129851030|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
129851031|NCT00983580|467414716|FG000|Overall Study|Cancel Prior to treatment|1|||
129851032|NCT00983580|467414717|FG001|Overall Study|Cancel Prior to treatment|3|||
129851033|NCT00983580|467414716|FG000|Overall Study|Protocol Violation|1|||
129851034|NCT00983580|467414717|FG001|Overall Study|Protocol Violation|1|||
129851035|NCT00983580|467414716|FG000|Overall Study|Ineligible|3|||
129851036|NCT00983580|467414717|FG001|Overall Study|Ineligible|0|||
129851037|NCT02316717|467414720|FG000|Overall Study|Adverse Event|2|||
129851038|NCT02316717|467414721|FG001|Overall Study|Adverse Event|2|||
129851039|NCT02316717|467414722|FG002|Overall Study|Adverse Event|0|||
129851040|NCT02316717|467414720|FG000|Overall Study|Lost to Follow-up|1|||
129851041|NCT02316717|467414721|FG001|Overall Study|Lost to Follow-up|2|||
129851042|NCT02316717|467414722|FG002|Overall Study|Lost to Follow-up|1|||
129851043|NCT02316717|467414720|FG000|Overall Study|Non compliance|3|||
129851044|NCT02316717|467414721|FG001|Overall Study|Non compliance|1|||
129851045|NCT02316717|467414722|FG002|Overall Study|Non compliance|0|||
129851046|NCT02316717|467414720|FG000|Overall Study|Protocol Violation|2|||
129851047|NCT02316717|467414721|FG001|Overall Study|Protocol Violation|0|||
129851048|NCT02316717|467414722|FG002|Overall Study|Protocol Violation|0|||
129851049|NCT02316717|467414720|FG000|Overall Study|Withdrawal by Subject|2|||
129851050|NCT02316717|467414721|FG001|Overall Study|Withdrawal by Subject|1|||
129904747|NCT00723450|467612903|FG001|Randomized Phase|Lack of Efficacy|11|||
129851051|NCT02316717|467414722|FG002|Overall Study|Withdrawal by Subject|1|||
129851052|NCT02316717|467414720|FG000|Overall Study|Death|0|||
129851053|NCT02316717|467414721|FG001|Overall Study|Death|0|||
129851054|NCT02316717|467414722|FG002|Overall Study|Death|1|||
129851055|NCT02316717|467414720|FG000|Overall Study|Physician Decision|0|||
129851056|NCT02316717|467414721|FG001|Overall Study|Physician Decision|1|||
129851057|NCT02316717|467414722|FG002|Overall Study|Physician Decision|0|||
129851058|NCT02316717|467414720|FG000|Overall Study|TBC|1|||
129851059|NCT02316717|467414721|FG001|Overall Study|TBC|0|||
129851060|NCT02316717|467414722|FG002|Overall Study|TBC|0|||
129851061|NCT01072201|467414723|FG000|Overall Study|Lost to Follow-up|0|||
129851062|NCT01072201|467414724|FG001|Overall Study|Lost to Follow-up|1|||
129851063|NCT02052466|467414725|FG000|Overall Study|Withdrawal by Subject|1|||
129851064|NCT02052466|467414725|FG000|Overall Study|Acromial fracture|1|||
129851065|NCT00360334|467414726|FG000|Overall Study|Adverse Event|7|||
129851066|NCT00360334|467414727|FG001|Overall Study|Adverse Event|4|||
129851067|NCT00360334|467414726|FG000|Overall Study|Protocol Violation|1|||
129851068|NCT00360334|467414727|FG001|Overall Study|Protocol Violation|1|||
129851069|NCT00360334|467414726|FG000|Overall Study|Physician Decision|2|||
129851070|NCT00360334|467414727|FG001|Overall Study|Physician Decision|3|||
129851071|NCT00360334|467414726|FG000|Overall Study|Lack of Efficacy|0|||
129851072|NCT00360334|467414727|FG001|Overall Study|Lack of Efficacy|1|||
129851073|NCT00360334|467414726|FG000|Overall Study|Entry criterion not met|1|||
129851074|NCT00360334|467414727|FG001|Overall Study|Entry criterion not met|2|||
129851075|NCT00360334|467414726|FG000|Overall Study|Subject decision|8|||
129851076|NCT00360334|467414727|FG001|Overall Study|Subject decision|2|||
129851077|NCT00595582|467414728|FG000|Overall Study|Pilot study that PI terminated|2|||
129851078|NCT00595582|467414728|FG000|Overall Study|Lost to Follow-up|1|||
129851079|NCT00595582|467414728|FG000|Overall Study|Adverse Event|2|||
129851080|NCT00595582|467414728|FG000|Overall Study|Physician Decision|5|||
129851081|NCT01978184|467414730|FG000|Overall Study|Progressive disease|5|||
129851082|NCT01978184|467414731|FG001|Overall Study|Progressive disease|5|||
129851083|NCT01978184|467414730|FG000|Overall Study|Other than PDA|2|||
129851084|NCT01978184|467414731|FG001|Overall Study|Other than PDA|2|||
129851085|NCT01978184|467414730|FG000|Overall Study|Physician Decision|0|||
129851086|NCT01978184|467414731|FG001|Overall Study|Physician Decision|3|||
129851087|NCT01978184|467414730|FG000|Overall Study|Noncompliance|1|||
129851088|NCT01978184|467414731|FG001|Overall Study|Noncompliance|2|||
129851089|NCT01978184|467414730|FG000|Overall Study|Death|1|||
129851090|NCT01978184|467414731|FG001|Overall Study|Death|0|||
129851091|NCT01978184|467414730|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
129851092|NCT01978184|467414731|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
129851093|NCT00965848|467414740|FG000|Overall Study|Protocol Violation|3|||
129851094|NCT00965848|467414741|FG001|Overall Study|Protocol Violation|0|||
129851095|NCT00965848|467414742|FG002|Overall Study|Protocol Violation|1|||
129851096|NCT00965848|467414740|FG000|Overall Study|Death|11|||
129851097|NCT00965848|467414741|FG001|Overall Study|Death|1|||
129851098|NCT00965848|467414742|FG002|Overall Study|Death|5|||
129851099|NCT00965848|467414740|FG000|Overall Study|Lost to Follow-up|0|||
129851100|NCT00965848|467414741|FG001|Overall Study|Lost to Follow-up|0|||
129851101|NCT00965848|467414742|FG002|Overall Study|Lost to Follow-up|1|||
129851102|NCT00965848|467414740|FG000|Overall Study|Withdrawal by Subject|1|||
129851103|NCT00965848|467414741|FG001|Overall Study|Withdrawal by Subject|0|||
129851104|NCT00965848|467414742|FG002|Overall Study|Withdrawal by Subject|0|||
129851105|NCT00965848|467414740|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
129851106|NCT00965848|467414741|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
129851107|NCT00965848|467414742|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
129851108|NCT00965848|467414740|FG000|Overall Study|Not Clinically Evaluable|7|||
129851109|NCT00965848|467414741|FG001|Overall Study|Not Clinically Evaluable|1|||
129851110|NCT00965848|467414742|FG002|Overall Study|Not Clinically Evaluable|1|||
129851111|NCT00965848|467414740|FG000|Overall Study|Other|5|||
129851112|NCT00965848|467414741|FG001|Overall Study|Other|0|||
129851113|NCT00965848|467414742|FG002|Overall Study|Other|1|||
129851114|NCT01328002|467414744|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
129851115|NCT01328002|467414745|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
129851116|NCT01328002|467414744|FG000|Open-Label Period|Adverse Event|8|||
129851117|NCT01328002|467414745|FG001|Open-Label Period|Adverse Event|0|||
129851118|NCT01328002|467414744|FG000|Open-Label Period|Lack of Efficacy|3|||
129851119|NCT01328002|467414745|FG001|Open-Label Period|Lack of Efficacy|0|||
129851120|NCT01328002|467414744|FG000|Open-Label Period|Protocol Violation|2|||
129851121|NCT01328002|467414745|FG001|Open-Label Period|Protocol Violation|0|||
129851122|NCT01328002|467414744|FG000|Open-Label Period|Withdrawal by Subject|9|||
129851123|NCT01328002|467414745|FG001|Open-Label Period|Withdrawal by Subject|0|||
129851124|NCT01328002|467414744|FG000|Open-Label Period|Lost to Follow-up|6|||
129851125|NCT01328002|467414745|FG001|Open-Label Period|Lost to Follow-up|0|||
129851126|NCT01328002|467414744|FG000|Open-Label Period|Other Reason|2|||
129851127|NCT01328002|467414745|FG001|Open-Label Period|Other Reason|0|||
129851128|NCT01328002|467414744|FG000|Double-Blind Period|Adverse Event|1|||
129851129|NCT01328002|467414745|FG001|Double-Blind Period|Adverse Event|0|||
129904748|NCT00723450|467612904|FG002|Randomized Phase|Lack of Efficacy|11|||
129851130|NCT01328002|467414744|FG000|Double-Blind Period|Lack of Efficacy|1|||
129851131|NCT01328002|467414745|FG001|Double-Blind Period|Lack of Efficacy|0|||
129851132|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
129851133|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
129851134|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
129851135|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
129851136|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
129851137|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
129851138|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
129851139|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
129851140|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
129851141|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
129851142|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
129851143|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
129851144|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
129851145|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
129851146|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
129851147|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
129851148|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
129851149|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
129851150|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
129851151|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
129851152|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
129851153|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
129851154|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
129851155|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
129851156|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
129851157|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
129851158|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
129851159|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
129851160|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
129851161|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
129851162|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
129851163|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
129851164|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
129851165|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
129851166|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
129851167|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
129851168|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
129851169|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
129851170|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
129851171|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
129851172|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
129851173|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
129851174|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
129851175|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
129851176|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
129851177|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
129851178|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
129851179|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
129851180|NCT01208233|467414751|FG000|Overall Study|Adverse Event|0|||
129851181|NCT01208233|467414752|FG001|Overall Study|Adverse Event|1|||
129851182|NCT01208233|467414753|FG002|Overall Study|Adverse Event|2|||
129851183|NCT01208233|467414754|FG003|Overall Study|Adverse Event|0|||
129851184|NCT01208233|467414755|FG004|Overall Study|Adverse Event|3|||
129851185|NCT01208233|467414756|FG005|Overall Study|Adverse Event|5|||
129851186|NCT01208233|467414751|FG000|Overall Study|Death|0|||
129851187|NCT01208233|467414752|FG001|Overall Study|Death|0|||
129851188|NCT01208233|467414753|FG002|Overall Study|Death|0|||
129851189|NCT01208233|467414754|FG003|Overall Study|Death|0|||
129851190|NCT01208233|467414755|FG004|Overall Study|Death|3|||
129851191|NCT01208233|467414756|FG005|Overall Study|Death|5|||
129851192|NCT01208233|467414751|FG000|Overall Study|Did not meet entrance criteria|2|||
129851193|NCT01208233|467414752|FG001|Overall Study|Did not meet entrance criteria|1|||
129851194|NCT01208233|467414753|FG002|Overall Study|Did not meet entrance criteria|1|||
129851195|NCT01208233|467414754|FG003|Overall Study|Did not meet entrance criteria|0|||
129851196|NCT01208233|467414755|FG004|Overall Study|Did not meet entrance criteria|1|||
129851197|NCT01208233|467414756|FG005|Overall Study|Did not meet entrance criteria|0|||
129851198|NCT01208233|467414751|FG000|Overall Study|Medication error without adverse event|0|||
129851199|NCT01208233|467414752|FG001|Overall Study|Medication error without adverse event|0|||
129851200|NCT01208233|467414753|FG002|Overall Study|Medication error without adverse event|0|||
129851201|NCT01208233|467414754|FG003|Overall Study|Medication error without adverse event|0|||
129904749|NCT00723450|467612902|FG000|Randomized Phase|Protocol Violation|0|||
129904750|NCT00723450|467612903|FG001|Randomized Phase|Protocol Violation|9|||
129904751|NCT00723450|467612904|FG002|Randomized Phase|Protocol Violation|13|||
129904752|NCT00723450|467612902|FG000|Randomized Phase|Lost to Follow-up|0|||
129904753|NCT00723450|467612903|FG001|Randomized Phase|Lost to Follow-up|2|||
129904754|NCT00723450|467612904|FG002|Randomized Phase|Lost to Follow-up|3|||
129904755|NCT00723450|467612902|FG000|Randomized Phase|Physician Decision|0|||
129904756|NCT00723450|467612903|FG001|Randomized Phase|Physician Decision|3|||
129904757|NCT00723450|467612904|FG002|Randomized Phase|Physician Decision|1|||
129904758|NCT00723450|467612902|FG000|Randomized Phase|Withdrawal by Subject|0|||
129904759|NCT00723450|467612903|FG001|Randomized Phase|Withdrawal by Subject|14|||
129904760|NCT00723450|467612904|FG002|Randomized Phase|Withdrawal by Subject|22|||
129904761|NCT00770965|467612905|FG000|Safety Set|Withdrawal by Subject|0|||
129904762|NCT00770965|467612906|FG001|Safety Set|Withdrawal by Subject|0|||
129904763|NCT00770965|467612907|FG002|Safety Set|Withdrawal by Subject|0|||
129904764|NCT00770965|467612908|FG003|Safety Set|Withdrawal by Subject|1|||
129904765|NCT00770965|467612905|FG000|Safety Set|Protocol deviation|0|||
129904766|NCT00770965|467612906|FG001|Safety Set|Protocol deviation|0|||
129904767|NCT00770965|467612907|FG002|Safety Set|Protocol deviation|1|||
129904768|NCT00770965|467612908|FG003|Safety Set|Protocol deviation|0|||
129904769|NCT00770965|467612905|FG000|Excluded Set|Administrative problems|14|||
129904770|NCT00770965|467612906|FG001|Excluded Set|Administrative problems|12|||
129904771|NCT00770965|467612907|FG002|Excluded Set|Administrative problems|12|||
129904772|NCT00770965|467612908|FG003|Excluded Set|Administrative problems|10|||
129904773|NCT00770965|467612905|FG000|Excluded Set|Withdrawal by Subject|1|||
129904774|NCT00770965|467612906|FG001|Excluded Set|Withdrawal by Subject|1|||
129904775|NCT00770965|467612907|FG002|Excluded Set|Withdrawal by Subject|2|||
129904776|NCT00770965|467612908|FG003|Excluded Set|Withdrawal by Subject|3|||
129904777|NCT03192046|467612910|FG000|Overall Study|Withdrawal by Subject|1|||
129904778|NCT03192046|467612911|FG001|Overall Study|Withdrawal by Subject|1|||
129904779|NCT00762606|467612912|FG000|Overall Study|Lost to Follow-up|18|||
129904780|NCT00762606|467612913|FG001|Overall Study|Lost to Follow-up|13|||
129904781|NCT01505881|467612914|FG000|Overall Study|Adverse Event|0|||
129904782|NCT01505881|467612915|FG001|Overall Study|Adverse Event|1|||
129904783|NCT01505881|467612914|FG000|Overall Study|Lost to Follow-up|2|||
129904784|NCT01505881|467612915|FG001|Overall Study|Lost to Follow-up|0|||
129904785|NCT01505881|467612914|FG000|Overall Study|Withdrawal by Subject|2|||
129904786|NCT01505881|467612915|FG001|Overall Study|Withdrawal by Subject|0|||
129904787|NCT00842257|467612916|FG000|Overall Study|Adverse Event|1|||
129904788|NCT00395018|467612917|FG000|On-Treatment|Death|4|||
129904789|NCT00395018|467612917|FG000|On-Treatment|Other Reason|2|||
129904790|NCT00395018|467612917|FG000|On-Treatment|Poor/non-compliance|2|||
129904791|NCT00395018|467612917|FG000|On-Treatment|Subject no longer meets study criteria|2|||
129904792|NCT00395018|467612917|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
129904793|NCT00395018|467612917|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
130064574|NCT00622869|468190202|FG000|Overall Study|Administrative Problems|11|||
130064575|NCT00622869|468190203|FG001|Overall Study|Administrative Problems|17|||
130064576|NCT00622869|468190204|FG002|Overall Study|Administrative Problems|13|||
129851202|NCT01208233|467414755|FG004|Overall Study|Medication error without adverse event|0|||
129851203|NCT01208233|467414756|FG005|Overall Study|Medication error without adverse event|1|||
129851204|NCT01208233|467414751|FG000|Overall Study|Study terminated by sponsor|0|||
129851205|NCT01208233|467414752|FG001|Overall Study|Study terminated by sponsor|0|||
129851206|NCT01208233|467414753|FG002|Overall Study|Study terminated by sponsor|0|||
129851207|NCT01208233|467414754|FG003|Overall Study|Study terminated by sponsor|0|||
129851208|NCT01208233|467414755|FG004|Overall Study|Study terminated by sponsor|10|||
130064577|NCT00622869|468190202|FG000|Overall Study|Death|12|||
130064578|NCT00622869|468190203|FG001|Overall Study|Death|15|||
130064579|NCT00622869|468190204|FG002|Overall Study|Death|10|||
129851209|NCT01208233|467414756|FG005|Overall Study|Study terminated by sponsor|7|||
129851210|NCT01208233|467414751|FG000|Overall Study|Protocol Violation|0|||
129851211|NCT01208233|467414752|FG001|Overall Study|Protocol Violation|0|||
129851212|NCT01208233|467414753|FG002|Overall Study|Protocol Violation|0|||
129851213|NCT01208233|467414754|FG003|Overall Study|Protocol Violation|0|||
129904794|NCT00395018|467612917|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
129904795|NCT04439799|467612918|FG000|Overall Study|Lost to Follow-up|6|||
129904796|NCT04439799|467612919|FG001|Overall Study|Lost to Follow-up|6|||
129904797|NCT04439799|467612918|FG000|Overall Study|Withdrawal by Subject|2|||
129904798|NCT04439799|467612919|FG001|Overall Study|Withdrawal by Subject|6|||
129904799|NCT04439799|467612918|FG000|Overall Study|Adverse Event|2|||
129904800|NCT04439799|467612919|FG001|Overall Study|Adverse Event|5|||
129904801|NCT01391130|467612927|FG000|Overall Study|Withdrawal by Subject|3|||
129904802|NCT01391130|467612928|FG001|Overall Study|Withdrawal by Subject|2|||
129904803|NCT01391130|467612927|FG000|Overall Study|Physician Decision|2|||
129904804|NCT01391130|467612928|FG001|Overall Study|Physician Decision|3|||
129904805|NCT01391130|467612927|FG000|Overall Study|Did not Receive Drug|1|||
129851214|NCT01208233|467414755|FG004|Overall Study|Protocol Violation|3|||
129851215|NCT01208233|467414756|FG005|Overall Study|Protocol Violation|0|||
129904806|NCT01391130|467612928|FG001|Overall Study|Did not Receive Drug|1|||
129904807|NCT03478696|467612929|FG000|Overall Study|Adverse Event|1|||
129904808|NCT03478696|467612930|FG001|Overall Study|Adverse Event|5|||
129904809|NCT03478696|467612929|FG000|Overall Study|Lost to Follow-up|1|||
129904810|NCT03478696|467612930|FG001|Overall Study|Lost to Follow-up|0|||
129904811|NCT03478696|467612929|FG000|Overall Study|Physician Decision|6|||
129904812|NCT03478696|467612930|FG001|Overall Study|Physician Decision|3|||
129904813|NCT03478696|467612929|FG000|Overall Study|Withdrawal by Subject|9|||
129904814|NCT03478696|467612930|FG001|Overall Study|Withdrawal by Subject|4|||
129904815|NCT03615924|467612931|FG000|Overall Study|Withdrawal by Subject|2|||
129904816|NCT03615924|467612932|FG001|Overall Study|Withdrawal by Subject|5|||
129904817|NCT03615924|467612931|FG000|Overall Study|Death|3|||
129904818|NCT03615924|467612932|FG001|Overall Study|Death|1|||
129904819|NCT03615924|467612931|FG000|Overall Study|Lost to Follow-up|1|||
129904820|NCT03615924|467612932|FG001|Overall Study|Lost to Follow-up|0|||
129904821|NCT03615924|467612931|FG000|Overall Study|Randomized in error|1|||
129904822|NCT03615924|467612932|FG001|Overall Study|Randomized in error|0|||
129904823|NCT03615924|467612931|FG000|Overall Study|Study termination by Sponsor|94|||
129904824|NCT03615924|467612932|FG001|Overall Study|Study termination by Sponsor|86|||
129904825|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
129904826|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
129904827|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
129904828|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
129904829|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
129904830|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
129904831|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
129904832|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
129904833|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
129904834|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
129904835|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
129904836|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
129904837|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
129904838|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
129904839|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
129904840|NCT02808338|467612947|FG000|Screening|Screen Failure|10|||
129904841|NCT02808338|467612947|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
129904842|NCT02808338|467612947|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
129904843|NCT00057837|467612948|FG000|Overall Study|Progression/relapse|12|||
129904844|NCT00057837|467612949|FG001|Overall Study|Progression/relapse|14|||
129904845|NCT00057837|467612948|FG000|Overall Study|Adverse Event|2|||
129904846|NCT00057837|467612949|FG001|Overall Study|Adverse Event|12|||
129904847|NCT00057837|467612948|FG000|Overall Study|Death|5|||
129904848|NCT00057837|467612949|FG001|Overall Study|Death|4|||
129904849|NCT00057837|467612948|FG000|Overall Study|Withdrawal by Subject|5|||
129904850|NCT00057837|467612949|FG001|Overall Study|Withdrawal by Subject|3|||
129904851|NCT00057837|467612948|FG000|Overall Study|Alternative therapy|0|||
129904852|NCT00057837|467612949|FG001|Overall Study|Alternative therapy|1|||
129904853|NCT00057837|467612948|FG000|Overall Study|Other complicating disease|2|||
129904854|NCT00057837|467612949|FG001|Overall Study|Other complicating disease|1|||
129904855|NCT00057837|467612948|FG000|Overall Study|Physician Decision|1|||
129904856|NCT00057837|467612949|FG001|Overall Study|Physician Decision|0|||
129904857|NCT00057837|467612948|FG000|Overall Study|Ineligible|3|||
129904858|NCT00057837|467612949|FG001|Overall Study|Ineligible|3|||
129904859|NCT00057837|467612948|FG000|Overall Study|Never started treatment|1|||
129904860|NCT00057837|467612949|FG001|Overall Study|Never started treatment|1|||
129904861|NCT02537522|467612950|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
129904862|NCT02537522|467612951|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
129904863|NCT02537522|467612952|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
129904864|NCT02537522|467612953|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
129904865|NCT02537522|467612950|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
130064580|NCT00622869|468190202|FG000|Overall Study|Lost to Follow-up|2|||
130064581|NCT00622869|468190203|FG001|Overall Study|Lost to Follow-up|4|||
129904866|NCT02537522|467612951|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
129904867|NCT02537522|467612952|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
129904868|NCT02537522|467612953|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
129904869|NCT02537522|467612950|FG000|Phase I - Contralateral|incorrect randomization|0|||
129904870|NCT02537522|467612951|FG001|Phase I - Contralateral|incorrect randomization|1|||
129904871|NCT02537522|467612952|FG002|Phase I - Contralateral|incorrect randomization|0|||
129904872|NCT02537522|467612953|FG003|Phase I - Contralateral|incorrect randomization|0|||
129904873|NCT02537522|467612950|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
129904874|NCT02537522|467612951|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
129904875|NCT02537522|467612952|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
129904876|NCT02537522|467612953|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
129904877|NCT02537522|467612950|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
129904878|NCT02537522|467612951|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
129904879|NCT02537522|467612952|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
129904880|NCT02537522|467612953|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
129904881|NCT02570711|467612955|FG000|Overall Study|Death|1|||
129904882|NCT02570711|467612956|FG001|Overall Study|Death|0|||
129904883|NCT02570711|467612955|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
129904884|NCT02570711|467612956|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
129904885|NCT02547922|467612957|FG000|Overall Study|Withdrawal by Subject|9|||
129904886|NCT02547922|467612958|FG001|Overall Study|Withdrawal by Subject|6|||
129904887|NCT02547922|467612959|FG002|Overall Study|Withdrawal by Subject|10|||
129904888|NCT02547922|467612957|FG000|Overall Study|Adverse Event|3|||
129904889|NCT02547922|467612958|FG001|Overall Study|Adverse Event|1|||
129904890|NCT02547922|467612959|FG002|Overall Study|Adverse Event|2|||
129904891|NCT02547922|467612957|FG000|Overall Study|Lost to Follow-up|1|||
129904892|NCT02547922|467612958|FG001|Overall Study|Lost to Follow-up|0|||
129904893|NCT02547922|467612959|FG002|Overall Study|Lost to Follow-up|0|||
129904894|NCT02547922|467612957|FG000|Overall Study|Lack of Efficacy|5|||
129904895|NCT02547922|467612958|FG001|Overall Study|Lack of Efficacy|7|||
129904896|NCT02547922|467612959|FG002|Overall Study|Lack of Efficacy|4|||
129904897|NCT02547922|467612957|FG000|Overall Study|Death|1|||
129904898|NCT02547922|467612958|FG001|Overall Study|Death|0|||
129904899|NCT02547922|467612959|FG002|Overall Study|Death|0|||
129904900|NCT02547922|467612957|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
129904901|NCT02547922|467612958|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
129904902|NCT02547922|467612959|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
129904903|NCT02547922|467612957|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
129904904|NCT02547922|467612958|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
129904905|NCT02547922|467612959|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
129904906|NCT02547922|467612957|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
129904907|NCT02547922|467612958|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
129904908|NCT02547922|467612959|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
129904909|NCT02547922|467612957|FG000|Overall Study|Physician Decision|2|||
129904910|NCT02547922|467612958|FG001|Overall Study|Physician Decision|1|||
129904911|NCT02547922|467612959|FG002|Overall Study|Physician Decision|2|||
129904912|NCT02547922|467612957|FG000|Overall Study|Patients did not receive IP|1|||
129904913|NCT02547922|467612958|FG001|Overall Study|Patients did not receive IP|1|||
129904914|NCT02547922|467612959|FG002|Overall Study|Patients did not receive IP|0|||
129904915|NCT01317420|467612965|FG000|Overall Study|Progressive disease according to RECIST|2|||
129904916|NCT01317420|467612966|FG001|Overall Study|Progressive disease according to RECIST|3|||
129904917|NCT01317420|467612967|FG002|Overall Study|Progressive disease according to RECIST|3|||
129904918|NCT01317420|467612968|FG003|Overall Study|Progressive disease according to RECIST|3|||
129904919|NCT01317420|467612969|FG004|Overall Study|Progressive disease according to RECIST|3|||
129904920|NCT01317420|467612970|FG005|Overall Study|Progressive disease according to RECIST|3|||
129904921|NCT01317420|467612971|FG006|Overall Study|Progressive disease according to RECIST|3|||
129904922|NCT01317420|467612972|FG007|Overall Study|Progressive disease according to RECIST|3|||
129904923|NCT01317420|467612973|FG008|Overall Study|Progressive disease according to RECIST|3|||
129904924|NCT01317420|467612974|FG009|Overall Study|Progressive disease according to RECIST|2|||
129904925|NCT01317420|467612975|FG010|Overall Study|Progressive disease according to RECIST|3|||
129904926|NCT01317420|467612976|FG011|Overall Study|Progressive disease according to RECIST|11|||
129904927|NCT01317420|467612977|FG012|Overall Study|Progressive disease according to RECIST|16|||
129904928|NCT01317420|467612965|FG000|Overall Study|Other adverse event|1|||
129904929|NCT01317420|467612966|FG001|Overall Study|Other adverse event|0|||
129904930|NCT01317420|467612967|FG002|Overall Study|Other adverse event|0|||
129904931|NCT01317420|467612968|FG003|Overall Study|Other adverse event|0|||
129904932|NCT01317420|467612969|FG004|Overall Study|Other adverse event|0|||
129904933|NCT01317420|467612970|FG005|Overall Study|Other adverse event|0|||
129904934|NCT01317420|467612971|FG006|Overall Study|Other adverse event|0|||
129904935|NCT01317420|467612972|FG007|Overall Study|Other adverse event|0|||
129904936|NCT01317420|467612973|FG008|Overall Study|Other adverse event|0|||
129904937|NCT01317420|467612974|FG009|Overall Study|Other adverse event|0|||
129904938|NCT01317420|467612975|FG010|Overall Study|Other adverse event|0|||
129904939|NCT01317420|467612976|FG011|Overall Study|Other adverse event|0|||
129904940|NCT01317420|467612977|FG012|Overall Study|Other adverse event|2|||
129904941|NCT01317420|467612965|FG000|Overall Study|Non-compliant with protocol|0|||
129904942|NCT01317420|467612966|FG001|Overall Study|Non-compliant with protocol|0|||
129904943|NCT01317420|467612967|FG002|Overall Study|Non-compliant with protocol|0|||
129904944|NCT01317420|467612968|FG003|Overall Study|Non-compliant with protocol|0|||
129904945|NCT01317420|467612969|FG004|Overall Study|Non-compliant with protocol|0|||
129904946|NCT01317420|467612970|FG005|Overall Study|Non-compliant with protocol|0|||
129904947|NCT01317420|467612971|FG006|Overall Study|Non-compliant with protocol|0|||
129904948|NCT01317420|467612972|FG007|Overall Study|Non-compliant with protocol|0|||
129904949|NCT01317420|467612973|FG008|Overall Study|Non-compliant with protocol|0|||
129904950|NCT01317420|467612974|FG009|Overall Study|Non-compliant with protocol|0|||
130064582|NCT00622869|468190204|FG002|Overall Study|Lost to Follow-up|2|||
129904951|NCT01317420|467612975|FG010|Overall Study|Non-compliant with protocol|0|||
129904952|NCT01317420|467612976|FG011|Overall Study|Non-compliant with protocol|0|||
129904953|NCT01317420|467612977|FG012|Overall Study|Non-compliant with protocol|1|||
129904954|NCT01317420|467612965|FG000|Overall Study|Refused to cont. taking trial medication|0|||
129904955|NCT01317420|467612966|FG001|Overall Study|Refused to cont. taking trial medication|0|||
129904956|NCT01317420|467612967|FG002|Overall Study|Refused to cont. taking trial medication|0|||
129904957|NCT01317420|467612968|FG003|Overall Study|Refused to cont. taking trial medication|0|||
129904958|NCT01317420|467612969|FG004|Overall Study|Refused to cont. taking trial medication|0|||
129904959|NCT01317420|467612970|FG005|Overall Study|Refused to cont. taking trial medication|0|||
129904960|NCT01317420|467612971|FG006|Overall Study|Refused to cont. taking trial medication|0|||
129904961|NCT01317420|467612972|FG007|Overall Study|Refused to cont. taking trial medication|0|||
129904962|NCT01317420|467612973|FG008|Overall Study|Refused to cont. taking trial medication|0|||
129904963|NCT01317420|467612974|FG009|Overall Study|Refused to cont. taking trial medication|0|||
129904964|NCT01317420|467612975|FG010|Overall Study|Refused to cont. taking trial medication|0|||
129904965|NCT01317420|467612976|FG011|Overall Study|Refused to cont. taking trial medication|0|||
129904966|NCT01317420|467612977|FG012|Overall Study|Refused to cont. taking trial medication|1|||
129904967|NCT01317420|467612965|FG000|Overall Study|Reason other than those specified|0|||
129904968|NCT01317420|467612966|FG001|Overall Study|Reason other than those specified|0|||
129904969|NCT01317420|467612967|FG002|Overall Study|Reason other than those specified|0|||
129904970|NCT01317420|467612968|FG003|Overall Study|Reason other than those specified|0|||
129904971|NCT01317420|467612969|FG004|Overall Study|Reason other than those specified|0|||
129904972|NCT01317420|467612970|FG005|Overall Study|Reason other than those specified|0|||
129904973|NCT01317420|467612971|FG006|Overall Study|Reason other than those specified|0|||
129904974|NCT01317420|467612972|FG007|Overall Study|Reason other than those specified|0|||
129904975|NCT01317420|467612973|FG008|Overall Study|Reason other than those specified|0|||
129904976|NCT01317420|467612974|FG009|Overall Study|Reason other than those specified|1|||
129904977|NCT01317420|467612975|FG010|Overall Study|Reason other than those specified|0|||
129904978|NCT01317420|467612976|FG011|Overall Study|Reason other than those specified|0|||
129904979|NCT01317420|467612977|FG012|Overall Study|Reason other than those specified|0|||
129904980|NCT00102063|467612979|FG000|Overall Study|Lack of Efficacy|5|||
129851216|NCT01208233|467414751|FG000|Overall Study|Other|2|||
129851217|NCT01208233|467414752|FG001|Overall Study|Other|1|||
129851218|NCT01208233|467414753|FG002|Overall Study|Other|0|||
129851219|NCT01208233|467414754|FG003|Overall Study|Other|0|||
129851220|NCT01208233|467414755|FG004|Overall Study|Other|0|||
129851221|NCT01208233|467414756|FG005|Overall Study|Other|1|||
129851222|NCT01208233|467414751|FG000|Overall Study|Withdrawal by Subject|1|||
129851223|NCT01208233|467414752|FG001|Overall Study|Withdrawal by Subject|0|||
129851224|NCT01208233|467414753|FG002|Overall Study|Withdrawal by Subject|1|||
129851225|NCT01208233|467414754|FG003|Overall Study|Withdrawal by Subject|1|||
129851226|NCT01208233|467414755|FG004|Overall Study|Withdrawal by Subject|4|||
129851227|NCT01208233|467414756|FG005|Overall Study|Withdrawal by Subject|2|||
129851228|NCT01181895|467414757|FG000|Overall Study|Adverse Event|3|||
129851229|NCT01181895|467414758|FG001|Overall Study|Adverse Event|1|||
129851230|NCT01181895|467414759|FG002|Overall Study|Adverse Event|1|||
129851231|NCT01181895|467414757|FG000|Overall Study|Lack of Efficacy|8|||
129851232|NCT01181895|467414758|FG001|Overall Study|Lack of Efficacy|9|||
129851233|NCT01181895|467414759|FG002|Overall Study|Lack of Efficacy|9|||
129851234|NCT01181895|467414757|FG000|Overall Study|Protocol Violation|2|||
129851235|NCT01181895|467414758|FG001|Overall Study|Protocol Violation|1|||
129851236|NCT01181895|467414759|FG002|Overall Study|Protocol Violation|0|||
129851237|NCT01181895|467414757|FG000|Overall Study|Lost to Follow-up|0|||
129851238|NCT01181895|467414758|FG001|Overall Study|Lost to Follow-up|1|||
129851239|NCT01181895|467414759|FG002|Overall Study|Lost to Follow-up|2|||
129851240|NCT01181895|467414757|FG000|Overall Study|Investigator Discretion|1|||
129851241|NCT01181895|467414758|FG001|Overall Study|Investigator Discretion|2|||
129851242|NCT01181895|467414759|FG002|Overall Study|Investigator Discretion|1|||
129851243|NCT01181895|467414757|FG000|Overall Study|Withdrawal by Subject|3|||
129851244|NCT01181895|467414758|FG001|Overall Study|Withdrawal by Subject|0|||
129851245|NCT01181895|467414759|FG002|Overall Study|Withdrawal by Subject|5|||
129851246|NCT00555438|467414764|FG000|10 Days Post-operative|Death|4|||
129851247|NCT00555438|467414764|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
129851248|NCT01114516|467414768|FG000|Overall Study|Lost to Follow-up|2|||
129851249|NCT01114516|467414769|FG001|Overall Study|Lost to Follow-up|1|||
129851250|NCT00061048|467414770|FG000|Overall Study|Adverse Event|2|||
129851251|NCT00061048|467414770|FG000|Overall Study|disease progression|20|||
129851252|NCT01431508|467414771|FG000|Overall Study|Lack of Efficacy|1|||
129851253|NCT01431508|467414771|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
129851254|NCT00129259|467414772|FG000|Overall Study|Lost to Follow-up|1|||
129851255|NCT00129259|467414773|FG001|Overall Study|Lost to Follow-up|1|||
129851256|NCT00129259|467414772|FG000|Overall Study|Withdrawal by Subject|2|||
129851257|NCT00129259|467414773|FG001|Overall Study|Withdrawal by Subject|1|||
129851258|NCT00129259|467414772|FG000|Overall Study|Only available minimal phone assessments|0|||
129851259|NCT00129259|467414773|FG001|Overall Study|Only available minimal phone assessments|1|||
129851260|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851261|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851262|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851263|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129904981|NCT00102063|467612980|FG001|Overall Study|Lack of Efficacy|1|||
129904982|NCT00102063|467612981|FG002|Overall Study|Lack of Efficacy|1|||
129904983|NCT00102063|467612979|FG000|Overall Study|Adverse Event|7|||
129851264|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851265|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851266|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851267|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851268|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851269|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851270|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851271|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851272|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851273|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851274|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851275|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851276|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851277|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
129851278|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
129851279|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
129851280|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
129851281|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
129851282|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
129851283|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
129851284|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
129851285|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
129851286|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
129851287|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
129851288|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851289|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851290|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851291|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851292|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851293|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851294|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851295|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851296|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851297|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
129851298|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
129851299|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851300|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851301|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
129851302|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
129851303|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
129851304|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851305|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129904984|NCT00102063|467612980|FG001|Overall Study|Adverse Event|4|||
129904985|NCT00102063|467612981|FG002|Overall Study|Adverse Event|2|||
129904986|NCT00102063|467612979|FG000|Overall Study|Withdrawal by Subject|4|||
129851306|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851307|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851308|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851309|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851310|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851311|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851312|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851313|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
129851314|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851315|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851316|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851317|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851318|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129904987|NCT00102063|467612980|FG001|Overall Study|Withdrawal by Subject|12|||
129851319|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
129851320|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851321|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851322|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851323|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851324|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851325|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851326|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851327|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851328|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851329|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
129851330|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851331|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851332|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851333|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851334|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851335|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851336|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851337|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851338|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851339|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851340|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851341|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851342|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851343|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851344|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851345|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851346|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851347|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851348|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
129851349|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851350|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851351|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851352|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851353|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851354|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851355|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851356|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
129851357|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851358|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851359|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851360|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851361|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
129851362|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851363|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851364|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851365|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851366|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
129851367|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851368|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851369|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851370|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851371|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851372|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851373|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851374|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851375|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851376|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851377|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851378|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851379|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851380|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851381|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851382|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129904988|NCT00102063|467612981|FG002|Overall Study|Withdrawal by Subject|5|||
129904989|NCT00102063|467612979|FG000|Overall Study|Lost to Follow-up|0|||
129904990|NCT00102063|467612980|FG001|Overall Study|Lost to Follow-up|0|||
129904991|NCT00102063|467612981|FG002|Overall Study|Lost to Follow-up|1|||
129904992|NCT00102063|467612979|FG000|Overall Study|Protocol Violation|0|||
129904993|NCT00102063|467612980|FG001|Overall Study|Protocol Violation|1|||
130064583|NCT00622869|468190202|FG000|Overall Study|Graft Loss|5|||
129851383|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851384|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
129851385|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
129851386|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
129851387|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
129851388|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851389|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851390|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851391|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851392|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851393|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851394|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851395|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851396|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851397|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851398|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851399|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851400|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
129851401|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
129851402|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
129851403|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
129851404|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851405|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851406|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851407|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851408|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851409|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851410|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851411|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851412|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851413|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851414|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851415|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851416|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
129851417|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
129851418|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
129851419|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
129851420|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851421|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851422|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851423|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851424|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851425|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851426|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851427|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851428|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851429|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851430|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851431|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851432|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
129851433|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851434|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851435|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851436|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851437|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851438|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851439|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851440|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851441|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129904994|NCT00102063|467612981|FG002|Overall Study|Protocol Violation|1|||
129904995|NCT01493778|467612982|FG000|Overall Study|Withdrawal by Subject|8|||
129904996|NCT05082025|467612983|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
129904997|NCT00857649|467612984|FG000|Overall Study|Adverse Event|15|||
129904998|NCT00857649|467612985|FG001|Overall Study|Adverse Event|10|||
129904999|NCT00857649|467612984|FG000|Overall Study|Non-compliance|1|||
129905000|NCT00857649|467612985|FG001|Overall Study|Non-compliance|1|||
129905001|NCT00857649|467612984|FG000|Overall Study|Protocol Violation|2|||
129905002|NCT00857649|467612985|FG001|Overall Study|Protocol Violation|2|||
129905003|NCT00857649|467612984|FG000|Overall Study|Withdrawal of Consent|10|||
129905004|NCT00857649|467612985|FG001|Overall Study|Withdrawal of Consent|7|||
129905005|NCT00857649|467612984|FG000|Overall Study|Nursing Home Placement|2|||
129905006|NCT00857649|467612985|FG001|Overall Study|Nursing Home Placement|9|||
129905007|NCT00857649|467612984|FG000|Overall Study|Other Reasons|1|||
129905008|NCT00857649|467612985|FG001|Overall Study|Other Reasons|3|||
129905009|NCT05190419|467612986|FG000|Overall Study|Lack of Efficacy|8|||
129905010|NCT05190419|467612987|FG001|Overall Study|Lack of Efficacy|0|||
129905011|NCT05190419|467612988|FG002|Overall Study|Lack of Efficacy|1|||
129905012|NCT05190419|467612989|FG003|Overall Study|Lack of Efficacy|0|||
129905013|NCT05190419|467612986|FG000|Overall Study|Withdrawal by Subject|7|||
129905014|NCT05190419|467612987|FG001|Overall Study|Withdrawal by Subject|1|||
129905015|NCT05190419|467612988|FG002|Overall Study|Withdrawal by Subject|2|||
129905016|NCT05190419|467612989|FG003|Overall Study|Withdrawal by Subject|2|||
129905017|NCT05190419|467612986|FG000|Overall Study|Adverse Event|2|||
129905018|NCT05190419|467612987|FG001|Overall Study|Adverse Event|10|||
129905019|NCT05190419|467612988|FG002|Overall Study|Adverse Event|11|||
129905020|NCT05190419|467612989|FG003|Overall Study|Adverse Event|21|||
129905021|NCT05190419|467612986|FG000|Overall Study|Lost to Follow-up|1|||
129905022|NCT05190419|467612987|FG001|Overall Study|Lost to Follow-up|2|||
129905023|NCT05190419|467612988|FG002|Overall Study|Lost to Follow-up|3|||
129905024|NCT05190419|467612989|FG003|Overall Study|Lost to Follow-up|1|||
129905025|NCT05190419|467612986|FG000|Overall Study|Other|1|||
129905026|NCT05190419|467612987|FG001|Overall Study|Other|1|||
129905027|NCT05190419|467612988|FG002|Overall Study|Other|0|||
129905028|NCT05190419|467612989|FG003|Overall Study|Other|3|||
129905029|NCT00094575|467612990|FG000|Overall Study|Death|146|||
129905030|NCT00094575|467612991|FG001|Overall Study|Death|146|||
129905031|NCT00961636|467612993|FG000|Overall Study|Adverse Event|35|||
129905032|NCT00961636|467612994|FG001|Overall Study|Adverse Event|54|||
129905033|NCT00961636|467612995|FG002|Overall Study|Adverse Event|13|||
129905034|NCT00961636|467612993|FG000|Overall Study|Flushing Symptoms|29|||
129905035|NCT00961636|467612994|FG001|Overall Study|Flushing Symptoms|46|||
129905036|NCT00961636|467612995|FG002|Overall Study|Flushing Symptoms|3|||
129905037|NCT00961636|467612993|FG000|Overall Study|Lost to Follow-up|2|||
129905038|NCT00961636|467612994|FG001|Overall Study|Lost to Follow-up|3|||
129905039|NCT00961636|467612995|FG002|Overall Study|Lost to Follow-up|1|||
129905040|NCT00961636|467612993|FG000|Overall Study|Physician Decision|3|||
129905041|NCT00961636|467612994|FG001|Overall Study|Physician Decision|1|||
129905042|NCT00961636|467612995|FG002|Overall Study|Physician Decision|1|||
129905043|NCT00961636|467612993|FG000|Overall Study|Protocol Violation|9|||
129905044|NCT00961636|467612994|FG001|Overall Study|Protocol Violation|5|||
129905045|NCT00961636|467612995|FG002|Overall Study|Protocol Violation|1|||
129905046|NCT00961636|467612993|FG000|Overall Study|Withdrawal by Subject|29|||
129905047|NCT00961636|467612994|FG001|Overall Study|Withdrawal by Subject|22|||
129905048|NCT00961636|467612995|FG002|Overall Study|Withdrawal by Subject|13|||
129905049|NCT03762668|467614878|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
129905050|NCT03762668|467614879|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
129905051|NCT01393119|467614880|FG000|Overall Study|Adverse Event|1|||
129905052|NCT01393119|467614881|FG001|Overall Study|Adverse Event|1|||
129905053|NCT01393119|467614882|FG002|Overall Study|Adverse Event|0|||
129905054|NCT01393119|467614883|FG003|Overall Study|Adverse Event|1|||
129905055|NCT01393119|467614880|FG000|Overall Study|Withdrawal by Subject|0|||
129905056|NCT01393119|467614881|FG001|Overall Study|Withdrawal by Subject|1|||
129905057|NCT01393119|467614882|FG002|Overall Study|Withdrawal by Subject|1|||
129905058|NCT01393119|467614883|FG003|Overall Study|Withdrawal by Subject|0|||
129905059|NCT01393119|467614880|FG000|Overall Study|Lack of Efficacy|1|||
129905060|NCT01393119|467614881|FG001|Overall Study|Lack of Efficacy|0|||
129905061|NCT01393119|467614882|FG002|Overall Study|Lack of Efficacy|2|||
129905062|NCT01393119|467614883|FG003|Overall Study|Lack of Efficacy|1|||
129905063|NCT01393119|467614880|FG000|Overall Study|Protocol Violation|0|||
129905064|NCT01393119|467614881|FG001|Overall Study|Protocol Violation|0|||
129905065|NCT01393119|467614882|FG002|Overall Study|Protocol Violation|1|||
129905066|NCT01393119|467614883|FG003|Overall Study|Protocol Violation|0|||
129905067|NCT01393119|467614880|FG000|Overall Study|Death|0|||
129905068|NCT01393119|467614881|FG001|Overall Study|Death|0|||
129905069|NCT01393119|467614882|FG002|Overall Study|Death|0|||
129905070|NCT01393119|467614883|FG003|Overall Study|Death|1|||
129905071|NCT01393119|467614880|FG000|Overall Study|Randomized but Not treated|1|||
129905072|NCT01393119|467614881|FG001|Overall Study|Randomized but Not treated|0|||
129905073|NCT01393119|467614882|FG002|Overall Study|Randomized but Not treated|1|||
129905074|NCT01393119|467614883|FG003|Overall Study|Randomized but Not treated|1|||
129905075|NCT01393119|467614880|FG000|Overall Study|Sponsor Termination of Study|11|||
129905076|NCT01393119|467614881|FG001|Overall Study|Sponsor Termination of Study|12|||
129905077|NCT01393119|467614882|FG002|Overall Study|Sponsor Termination of Study|9|||
129905078|NCT01393119|467614883|FG003|Overall Study|Sponsor Termination of Study|12|||
129905079|NCT00465816|467614885|FG000|Overall Study|Lost to Follow-up|0|||
129905080|NCT00465816|467614886|FG001|Overall Study|Lost to Follow-up|0|||
129905081|NCT00465816|467614887|FG002|Overall Study|Lost to Follow-up|2|||
129905082|NCT00004124|467614888|FG000|Overall Study|Received no protocol therapy|12|||
129905083|NCT00004124|467614889|FG001|Overall Study|Received no protocol therapy|20|||
129905084|NCT01759264|467614890|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
129905085|NCT01759264|467614890|FG000|Overall Study|Adverse Event|1|||
129905086|NCT01759264|467614890|FG000|Overall Study|Other|2|||
129905087|NCT01759264|467614890|FG000|Overall Study|Lost to Follow-up|2|||
129905088|NCT01759264|467614890|FG000|Overall Study|Withdrawal by Subject|3|||
129905089|NCT01759264|467614890|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
129905090|NCT02383472|467614891|FG000|Overall Study|Withdrawal by Subject|1|||
129905091|NCT02383472|467614892|FG001|Overall Study|Withdrawal by Subject|1|||
129905092|NCT02013830|467614893|FG000|Overall Study|Adverse Event|3|||
129905093|NCT02013830|467614893|FG000|Overall Study|Death|1|||
129905094|NCT02013830|467614893|FG000|Overall Study|Insufficient therapeutic response|25|||
129905095|NCT02013830|467614893|FG000|Overall Study|Refused treatment|1|||
129905096|NCT00186186|467614899|FG000|Overall Study|Lack of Efficacy|3|||
129905097|NCT00186186|467614899|FG000|Overall Study|Withdrawal by Subject|3|||
129905098|NCT00186186|467614899|FG000|Overall Study|Not reported as to reason|2|||
129905099|NCT01337635|467614900|FG000|Overall Study|Lost to Follow-up|0|||
129905100|NCT01337635|467614901|FG001|Overall Study|Lost to Follow-up|1|||
129905101|NCT02567656|467614904|FG000|Overall Study|Premature discontinuation due to PD|1|||
129905102|NCT02567656|467614905|FG001|Overall Study|Premature discontinuation due to PD|1|||
129905103|NCT02567656|467614906|FG002|Overall Study|Premature discontinuation due to PD|2|||
129905104|NCT02567656|467614907|FG003|Overall Study|Premature discontinuation due to PD|0|||
129905105|NCT02567656|467614908|FG004|Overall Study|Premature discontinuation due to PD|0|||
129905106|NCT02567656|467614909|FG005|Overall Study|Premature discontinuation due to PD|0|||
129905107|NCT01307267|467614910|FG000|Overall Study|Death|4|||
129905108|NCT01307267|467614911|FG001|Overall Study|Death|3|||
129905109|NCT01307267|467614912|FG002|Overall Study|Death|5|||
129905110|NCT01307267|467614913|FG003|Overall Study|Death|3|||
129905111|NCT01307267|467614914|FG004|Overall Study|Death|1|||
129905112|NCT01307267|467614915|FG005|Overall Study|Death|26|||
129905113|NCT01307267|467614916|FG006|Overall Study|Death|2|||
129905114|NCT01307267|467614917|FG007|Overall Study|Death|2|||
129905115|NCT01307267|467614918|FG008|Overall Study|Death|21|||
129905116|NCT01307267|467614919|FG009|Overall Study|Death|2|||
129905117|NCT01307267|467614920|FG010|Overall Study|Death|3|||
129905118|NCT01307267|467614921|FG011|Overall Study|Death|9|||
129905119|NCT01307267|467614922|FG012|Overall Study|Death|0|||
129905120|NCT01307267|467614923|FG013|Overall Study|Death|0|||
129905121|NCT01307267|467614924|FG014|Overall Study|Death|0|||
129905122|NCT01307267|467614925|FG015|Overall Study|Death|0|||
129905123|NCT01307267|467614926|FG016|Overall Study|Death|1|||
129905124|NCT01307267|467614927|FG017|Overall Study|Death|1|||
129905125|NCT01307267|467614928|FG018|Overall Study|Death|2|||
129905126|NCT01307267|467614929|FG019|Overall Study|Death|8|||
129905127|NCT01307267|467614930|FG020|Overall Study|Death|1|||
129905128|NCT01307267|467614931|FG021|Overall Study|Death|2|||
129905129|NCT01307267|467614932|FG022|Overall Study|Death|2|||
129905130|NCT01307267|467614910|FG000|Overall Study|Lost to Follow-up|0|||
129905131|NCT01307267|467614911|FG001|Overall Study|Lost to Follow-up|0|||
129905132|NCT01307267|467614912|FG002|Overall Study|Lost to Follow-up|0|||
129905133|NCT01307267|467614913|FG003|Overall Study|Lost to Follow-up|0|||
129905134|NCT01307267|467614914|FG004|Overall Study|Lost to Follow-up|0|||
129905135|NCT01307267|467614915|FG005|Overall Study|Lost to Follow-up|7|||
129905136|NCT01307267|467614916|FG006|Overall Study|Lost to Follow-up|0|||
129905137|NCT01307267|467614917|FG007|Overall Study|Lost to Follow-up|0|||
129905138|NCT01307267|467614918|FG008|Overall Study|Lost to Follow-up|1|||
129905139|NCT01307267|467614919|FG009|Overall Study|Lost to Follow-up|2|||
129905140|NCT01307267|467614920|FG010|Overall Study|Lost to Follow-up|1|||
130064584|NCT00622869|468190203|FG001|Overall Study|Graft Loss|3|||
129905141|NCT01307267|467614921|FG011|Overall Study|Lost to Follow-up|0|||
129905142|NCT01307267|467614922|FG012|Overall Study|Lost to Follow-up|0|||
129905143|NCT01307267|467614923|FG013|Overall Study|Lost to Follow-up|0|||
129905144|NCT01307267|467614924|FG014|Overall Study|Lost to Follow-up|0|||
129905145|NCT01307267|467614925|FG015|Overall Study|Lost to Follow-up|0|||
129905146|NCT01307267|467614926|FG016|Overall Study|Lost to Follow-up|0|||
129905147|NCT01307267|467614927|FG017|Overall Study|Lost to Follow-up|0|||
129905148|NCT01307267|467614928|FG018|Overall Study|Lost to Follow-up|0|||
129905149|NCT01307267|467614929|FG019|Overall Study|Lost to Follow-up|2|||
129905150|NCT01307267|467614930|FG020|Overall Study|Lost to Follow-up|0|||
129905151|NCT01307267|467614931|FG021|Overall Study|Lost to Follow-up|0|||
129905152|NCT01307267|467614932|FG022|Overall Study|Lost to Follow-up|0|||
129851442|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851443|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851444|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851445|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851446|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851447|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851448|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
129851449|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
129851450|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
129851451|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
129851452|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851453|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851454|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851455|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851456|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851457|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851458|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851459|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851460|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851461|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851462|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851463|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851464|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851465|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851466|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851467|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
129851468|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851469|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851470|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851471|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851472|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851473|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851474|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851475|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851476|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851477|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851478|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851479|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851480|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
129851481|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
129851482|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851483|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
129851484|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851485|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851486|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851487|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851488|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851489|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851490|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851491|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851492|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851493|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851494|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851495|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129905153|NCT01307267|467614910|FG000|Overall Study|Withdrawal by Subject|0|||
129905154|NCT01307267|467614911|FG001|Overall Study|Withdrawal by Subject|0|||
129851496|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
129851497|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851498|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851499|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851500|NCT00023452|467414794|FG000|Overall Study|Ineligible for Study|163|||
129851501|NCT00023452|467414795|FG001|Overall Study|Ineligible for Study|159|||
129851502|NCT00023452|467414794|FG000|Overall Study|Out of Window|129|||
129851503|NCT00023452|467414795|FG001|Overall Study|Out of Window|69|||
129851504|NCT00023452|467414794|FG000|Overall Study|Death|2|||
129851505|NCT00023452|467414795|FG001|Overall Study|Death|0|||
129851506|NCT00023452|467414794|FG000|Overall Study|Withdrawal by Subject|66|||
129851507|NCT00023452|467414795|FG001|Overall Study|Withdrawal by Subject|54|||
129851508|NCT00023452|467414794|FG000|Overall Study|Adverse Event|139|||
130064585|NCT00622869|468190204|FG002|Overall Study|Graft Loss|2|||
129905155|NCT01307267|467614912|FG002|Overall Study|Withdrawal by Subject|0|||
129905156|NCT01307267|467614913|FG003|Overall Study|Withdrawal by Subject|0|||
129905157|NCT01307267|467614914|FG004|Overall Study|Withdrawal by Subject|0|||
129905158|NCT01307267|467614915|FG005|Overall Study|Withdrawal by Subject|1|||
129905159|NCT01307267|467614916|FG006|Overall Study|Withdrawal by Subject|0|||
129905160|NCT01307267|467614917|FG007|Overall Study|Withdrawal by Subject|1|||
129905161|NCT01307267|467614918|FG008|Overall Study|Withdrawal by Subject|5|||
129905162|NCT01307267|467614919|FG009|Overall Study|Withdrawal by Subject|1|||
129905163|NCT01307267|467614920|FG010|Overall Study|Withdrawal by Subject|1|||
129905164|NCT01307267|467614921|FG011|Overall Study|Withdrawal by Subject|1|||
129905165|NCT01307267|467614922|FG012|Overall Study|Withdrawal by Subject|0|||
129905166|NCT01307267|467614923|FG013|Overall Study|Withdrawal by Subject|0|||
129905167|NCT01307267|467614924|FG014|Overall Study|Withdrawal by Subject|0|||
129905168|NCT01307267|467614925|FG015|Overall Study|Withdrawal by Subject|0|||
129905169|NCT01307267|467614926|FG016|Overall Study|Withdrawal by Subject|0|||
129905170|NCT01307267|467614927|FG017|Overall Study|Withdrawal by Subject|0|||
129905171|NCT01307267|467614928|FG018|Overall Study|Withdrawal by Subject|0|||
129905172|NCT01307267|467614929|FG019|Overall Study|Withdrawal by Subject|3|||
129905173|NCT01307267|467614930|FG020|Overall Study|Withdrawal by Subject|0|||
129905174|NCT01307267|467614931|FG021|Overall Study|Withdrawal by Subject|0|||
129905175|NCT01307267|467614932|FG022|Overall Study|Withdrawal by Subject|0|||
129905176|NCT01307267|467614910|FG000|Overall Study|Other|0|||
129905177|NCT01307267|467614911|FG001|Overall Study|Other|0|||
129905178|NCT01307267|467614912|FG002|Overall Study|Other|0|||
129905179|NCT01307267|467614913|FG003|Overall Study|Other|0|||
129905180|NCT01307267|467614914|FG004|Overall Study|Other|0|||
129905181|NCT01307267|467614915|FG005|Overall Study|Other|7|||
129905182|NCT01307267|467614916|FG006|Overall Study|Other|0|||
129905183|NCT01307267|467614917|FG007|Overall Study|Other|1|||
129905184|NCT01307267|467614918|FG008|Overall Study|Other|3|||
129905185|NCT01307267|467614919|FG009|Overall Study|Other|0|||
129905186|NCT01307267|467614920|FG010|Overall Study|Other|1|||
129905187|NCT01307267|467614921|FG011|Overall Study|Other|1|||
129905188|NCT01307267|467614922|FG012|Overall Study|Other|1|||
129905189|NCT01307267|467614923|FG013|Overall Study|Other|0|||
129905190|NCT01307267|467614924|FG014|Overall Study|Other|2|||
129905191|NCT01307267|467614925|FG015|Overall Study|Other|1|||
129905192|NCT01307267|467614926|FG016|Overall Study|Other|0|||
129905193|NCT01307267|467614927|FG017|Overall Study|Other|0|||
129905194|NCT01307267|467614928|FG018|Overall Study|Other|0|||
129905195|NCT01307267|467614929|FG019|Overall Study|Other|19|||
129905196|NCT01307267|467614930|FG020|Overall Study|Other|2|||
129905197|NCT01307267|467614931|FG021|Overall Study|Other|3|||
129905198|NCT01307267|467614932|FG022|Overall Study|Other|2|||
129905199|NCT04956575|467614933|FG000|Overall Study|Death|1|||
129905200|NCT04956575|467614934|FG001|Overall Study|Death|0|||
129905201|NCT04956575|467614935|FG002|Overall Study|Death|0|||
129905202|NCT04956575|467614936|FG003|Overall Study|Death|0|||
129905203|NCT04956575|467614937|FG004|Overall Study|Death|0|||
129905204|NCT04956575|467614938|FG005|Overall Study|Death|0|||
129905205|NCT04956575|467614939|FG006|Overall Study|Death|0|||
129905206|NCT04956575|467614940|FG007|Overall Study|Death|1|||
129905207|NCT04956575|467614941|FG008|Overall Study|Death|0|||
129905208|NCT04956575|467614942|FG009|Overall Study|Death|1|||
129905209|NCT04956575|467614943|FG010|Overall Study|Death|0|||
129905210|NCT04956575|467614944|FG011|Overall Study|Death|0|||
129905211|NCT04956575|467614933|FG000|Overall Study|Lost to Follow-up|3|||
129905212|NCT04956575|467614934|FG001|Overall Study|Lost to Follow-up|4|||
129905213|NCT04956575|467614935|FG002|Overall Study|Lost to Follow-up|2|||
129905214|NCT04956575|467614936|FG003|Overall Study|Lost to Follow-up|3|||
129905215|NCT04956575|467614937|FG004|Overall Study|Lost to Follow-up|1|||
129905216|NCT04956575|467614938|FG005|Overall Study|Lost to Follow-up|10|||
129905217|NCT04956575|467614939|FG006|Overall Study|Lost to Follow-up|11|||
129905218|NCT04956575|467614940|FG007|Overall Study|Lost to Follow-up|7|||
129905219|NCT04956575|467614941|FG008|Overall Study|Lost to Follow-up|4|||
129905220|NCT04956575|467614942|FG009|Overall Study|Lost to Follow-up|2|||
129905221|NCT04956575|467614943|FG010|Overall Study|Lost to Follow-up|3|||
129905222|NCT04956575|467614944|FG011|Overall Study|Lost to Follow-up|8|||
129905223|NCT04956575|467614933|FG000|Overall Study|Withdrawal by Subject|1|||
129905224|NCT04956575|467614934|FG001|Overall Study|Withdrawal by Subject|2|||
129905225|NCT04956575|467614935|FG002|Overall Study|Withdrawal by Subject|1|||
129905226|NCT04956575|467614936|FG003|Overall Study|Withdrawal by Subject|4|||
129905227|NCT04956575|467614937|FG004|Overall Study|Withdrawal by Subject|2|||
129905228|NCT04956575|467614938|FG005|Overall Study|Withdrawal by Subject|8|||
129905229|NCT04956575|467614939|FG006|Overall Study|Withdrawal by Subject|5|||
129905230|NCT04956575|467614940|FG007|Overall Study|Withdrawal by Subject|1|||
129905231|NCT04956575|467614941|FG008|Overall Study|Withdrawal by Subject|1|||
129905232|NCT04956575|467614942|FG009|Overall Study|Withdrawal by Subject|0|||
129905233|NCT04956575|467614943|FG010|Overall Study|Withdrawal by Subject|3|||
129905234|NCT04956575|467614944|FG011|Overall Study|Withdrawal by Subject|1|||
129905235|NCT03593876|467614945|FG000|Overall Study|Withdrawal by Subject|1|||
129905236|NCT03593876|467614945|FG000|Overall Study|Discharged home before intervention completion|2|||
129905237|NCT05136443|467614956|FG000|Overall Study|Lost to Follow-up|2|||
129905238|NCT05136443|467614956|FG000|Overall Study|Adverse Event|2|||
129905239|NCT03034915|467614967|FG000|Overall Study|Adverse Event|29|||
129905240|NCT03034915|467614968|FG001|Overall Study|Adverse Event|32|||
129905241|NCT03034915|467614969|FG002|Overall Study|Adverse Event|22|||
129905242|NCT03034915|467614967|FG000|Overall Study|Lost to Follow-up|5|||
129905243|NCT03034915|467614968|FG001|Overall Study|Lost to Follow-up|13|||
129905244|NCT03034915|467614969|FG002|Overall Study|Lost to Follow-up|3|||
129905245|NCT03034915|467614967|FG000|Overall Study|Withdrawal by Subject|29|||
129905246|NCT03034915|467614968|FG001|Overall Study|Withdrawal by Subject|46|||
129905247|NCT03034915|467614969|FG002|Overall Study|Withdrawal by Subject|41|||
129905248|NCT03034915|467614967|FG000|Overall Study|Protocol Deviation|2|||
129905249|NCT03034915|467614968|FG001|Overall Study|Protocol Deviation|14|||
129905250|NCT03034915|467614969|FG002|Overall Study|Protocol Deviation|7|||
129905251|NCT03034915|467614967|FG000|Overall Study|Lack of Efficacy|8|||
129905252|NCT03034915|467614968|FG001|Overall Study|Lack of Efficacy|16|||
129905253|NCT03034915|467614969|FG002|Overall Study|Lack of Efficacy|18|||
129905254|NCT03034915|467614967|FG000|Overall Study|Site closed|2|||
129905255|NCT03034915|467614968|FG001|Overall Study|Site closed|2|||
129905256|NCT03034915|467614969|FG002|Overall Study|Site closed|4|||
129905257|NCT03034915|467614967|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
129905258|NCT03034915|467614968|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
129905259|NCT03034915|467614969|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
129905260|NCT03034915|467614967|FG000|Overall Study|Physician Decision|1|||
129905261|NCT03034915|467614968|FG001|Overall Study|Physician Decision|5|||
129905262|NCT03034915|467614969|FG002|Overall Study|Physician Decision|2|||
129905263|NCT00424762|467614975|FG000|Overall Study|Withdrawal by Subject|18|||
129905264|NCT00424762|467614976|FG001|Overall Study|Withdrawal by Subject|19|||
129905265|NCT00424762|467614975|FG000|Overall Study|Lost to Follow-up|2|||
129905266|NCT00424762|467614976|FG001|Overall Study|Lost to Follow-up|3|||
129905267|NCT01147341|467614979|FG000|Double Blind Period|Lack of Efficacy|1|||
129905268|NCT01147341|467614980|FG001|Double Blind Period|Lack of Efficacy|1|||
129905269|NCT01147341|467614979|FG000|Double Blind Period|Withdrawal by Subject|0|||
129905270|NCT01147341|467614980|FG001|Double Blind Period|Withdrawal by Subject|1|||
129905271|NCT01147341|467614979|FG000|Open Label Period|Lack of Efficacy|3|||
129905272|NCT01147341|467614980|FG001|Open Label Period|Lack of Efficacy|0|||
129905273|NCT01147341|467614979|FG000|Open Label Period|Subject moved|1|||
129905274|NCT01147341|467614980|FG001|Open Label Period|Subject moved|0|||
129905275|NCT00367991|467614981|FG000|Overall Study|Withdrawal by Subject|1|||
129905276|NCT00367991|467614982|FG001|Overall Study|Withdrawal by Subject|1|||
129905277|NCT00367991|467614981|FG000|Overall Study|Adverse Event|1|||
129905278|NCT00367991|467614982|FG001|Overall Study|Adverse Event|1|||
129905279|NCT03024606|467614985|FG000|Overall Study|Withdrawal by Subject|9|||
129905280|NCT03024606|467614986|FG001|Overall Study|Withdrawal by Subject|10|||
129905281|NCT01968226|467614987|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
129905282|NCT04975308|467614994|FG000|Overall Study|Withdrawal by Subject|6|||
129905283|NCT04975308|467614995|FG001|Overall Study|Withdrawal by Subject|16|||
129905284|NCT04975308|467614996|FG002|Overall Study|Withdrawal by Subject|6|||
129905285|NCT04975308|467614994|FG000|Overall Study|Physician Decision|0|||
129905286|NCT04975308|467614995|FG001|Overall Study|Physician Decision|3|||
129905287|NCT04975308|467614996|FG002|Overall Study|Physician Decision|1|||
129905288|NCT04975308|467614994|FG000|Overall Study|Adverse Event|10|||
129905289|NCT04975308|467614995|FG001|Overall Study|Adverse Event|1|||
129905290|NCT04975308|467614996|FG002|Overall Study|Adverse Event|12|||
129905291|NCT04975308|467614994|FG000|Overall Study|On study treatment (Ongoing)|65|||
129905292|NCT04975308|467614995|FG001|Overall Study|On study treatment (Ongoing)|43|||
129905293|NCT04975308|467614996|FG002|Overall Study|On study treatment (Ongoing)|75|||
129905294|NCT04975308|467614994|FG000|Overall Study|Protocol Deviation|4|||
129905295|NCT04975308|467614995|FG001|Overall Study|Protocol Deviation|3|||
129905296|NCT04975308|467614996|FG002|Overall Study|Protocol Deviation|2|||
129905297|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
129905298|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905299|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905300|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905301|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905302|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
129905303|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
130064586|NCT00622869|468190202|FG000|Overall Study|Missing|0|||
130064587|NCT00622869|468190203|FG001|Overall Study|Missing|1|||
129905304|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905305|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905306|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905307|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
130064588|NCT00622869|468190204|FG002|Overall Study|Missing|1|||
129905308|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905309|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905310|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905311|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905312|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
129905313|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905314|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905315|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905316|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905317|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
129905318|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905319|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905320|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905321|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905322|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
129905323|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905324|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905325|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905326|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905327|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
129905328|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905329|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905330|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905331|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905332|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
129905333|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905334|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905335|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905336|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905337|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
129905338|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905339|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905340|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905341|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905342|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
129905343|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
129905344|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
129905345|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
129905346|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
129905347|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
129905348|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
129905349|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
129905350|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
129905351|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
129905352|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
129905353|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
129905354|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
129905355|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
129905356|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
129905357|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905358|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
129905359|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905360|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905361|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905362|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
129905363|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
129905364|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
129905365|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
129905366|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
129905367|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
129905368|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
129905369|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
129905370|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
129905371|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
129905372|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
129905373|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
129905374|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
129905375|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
129905376|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
129905377|NCT04210180|467615002|FG000|Overall Study|Withdrawal by Subject|2|||
129905378|NCT01179334|467615003|FG000|Treatment Period|Adverse Event|1|||
129905379|NCT01179334|467615004|FG001|Treatment Period|Adverse Event|0|||
129905380|NCT01179334|467615003|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
129905381|NCT01179334|467615004|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
129905382|NCT01179334|467615003|FG000|Long-term Extension (LTE) Period|Death|3|||
129905383|NCT01179334|467615004|FG001|Long-term Extension (LTE) Period|Death|0|||
129905384|NCT01179334|467615003|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
129905385|NCT01179334|467615004|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
129905386|NCT00919763|467615005|FG000|Overall Study|Adverse Event|7|||
129905387|NCT00919763|467615006|FG001|Overall Study|Adverse Event|1|||
129905388|NCT00919763|467615005|FG000|Overall Study|Lost to Follow-up|1|||
129905389|NCT00919763|467615006|FG001|Overall Study|Lost to Follow-up|0|||
129905390|NCT00919763|467615005|FG000|Overall Study|Protocol Violation|1|||
129905391|NCT00919763|467615006|FG001|Overall Study|Protocol Violation|1|||
129905392|NCT00919763|467615005|FG000|Overall Study|Withdrawal by Subject|3|||
129905393|NCT00919763|467615006|FG001|Overall Study|Withdrawal by Subject|1|||
129905394|NCT00919763|467615005|FG000|Overall Study|Non-compliance|0|||
129905395|NCT00919763|467615006|FG001|Overall Study|Non-compliance|1|||
129905396|NCT05323734|467615012|FG000|Overall Study|Adverse Event|5|||
129905397|NCT05323734|467615013|FG001|Overall Study|Adverse Event|2|||
129905398|NCT05323734|467615012|FG000|Overall Study|Physician Decision|1|||
129905399|NCT05323734|467615013|FG001|Overall Study|Physician Decision|0|||
129905400|NCT05323734|467615012|FG000|Overall Study|Lack of Efficacy|1|||
129905401|NCT05323734|467615013|FG001|Overall Study|Lack of Efficacy|2|||
129905402|NCT05323734|467615012|FG000|Overall Study|Withdrawal by Subject|2|||
129905403|NCT05323734|467615013|FG001|Overall Study|Withdrawal by Subject|0|||
129905404|NCT05323734|467615012|FG000|Overall Study|Participant Withdrawn Due|0|||
129905405|NCT05323734|467615013|FG001|Overall Study|Participant Withdrawn Due|1|||
129905406|NCT03603717|467615016|FG000|Overall Study|Lost to Follow-up|20|||
129905407|NCT03603717|467615017|FG001|Overall Study|Lost to Follow-up|20|||
129905408|NCT03603717|467615016|FG000|Overall Study|Withdrawal by Subject|16|||
129905409|NCT03603717|467615017|FG001|Overall Study|Withdrawal by Subject|10|||
129905410|NCT00732381|467615018|FG000|Overall Study|Adverse Event|1|||
129905411|NCT00732381|467615019|FG001|Overall Study|Adverse Event|0|||
129905412|NCT00732381|467615018|FG000|Overall Study|Treatment Failure|1|||
129905413|NCT00732381|467615019|FG001|Overall Study|Treatment Failure|1|||
129905414|NCT01350804|467615022|FG000|Core Study|Withdrawal by Subject|11|||
129905415|NCT01350804|467615023|FG001|Core Study|Withdrawal by Subject|17|||
129905416|NCT01350804|467615024|FG002|Core Study|Withdrawal by Subject|16|||
129905417|NCT01350804|467615025|FG003|Core Study|Withdrawal by Subject|7|||
129905418|NCT01350804|467615022|FG000|Core Study|Study terminated by Sponsor|0|||
129905419|NCT01350804|467615023|FG001|Core Study|Study terminated by Sponsor|0|||
129905420|NCT01350804|467615024|FG002|Core Study|Study terminated by Sponsor|0|||
129905421|NCT01350804|467615025|FG003|Core Study|Study terminated by Sponsor|2|||
129905422|NCT01350804|467615022|FG000|Core Study|Protocol deviation|1|||
129905423|NCT01350804|467615023|FG001|Core Study|Protocol deviation|0|||
129905424|NCT01350804|467615024|FG002|Core Study|Protocol deviation|1|||
129905425|NCT01350804|467615025|FG003|Core Study|Protocol deviation|0|||
129905426|NCT01350804|467615022|FG000|Core Study|Physician Decision|1|||
129905427|NCT01350804|467615023|FG001|Core Study|Physician Decision|0|||
129905428|NCT01350804|467615024|FG002|Core Study|Physician Decision|1|||
129905429|NCT01350804|467615025|FG003|Core Study|Physician Decision|3|||
129905430|NCT01350804|467615022|FG000|Core Study|Lost to Follow-up|3|||
129905431|NCT01350804|467615023|FG001|Core Study|Lost to Follow-up|0|||
129905432|NCT01350804|467615024|FG002|Core Study|Lost to Follow-up|2|||
129905433|NCT01350804|467615025|FG003|Core Study|Lost to Follow-up|1|||
129905434|NCT01350804|467615022|FG000|Core Study|Lack of Efficacy|16|||
129905435|NCT01350804|467615023|FG001|Core Study|Lack of Efficacy|19|||
129905436|NCT01350804|467615024|FG002|Core Study|Lack of Efficacy|18|||
129905437|NCT01350804|467615025|FG003|Core Study|Lack of Efficacy|5|||
129905438|NCT01350804|467615022|FG000|Core Study|Death|1|||
129905439|NCT01350804|467615023|FG001|Core Study|Death|1|||
129905440|NCT01350804|467615024|FG002|Core Study|Death|1|||
129905441|NCT01350804|467615025|FG003|Core Study|Death|0|||
129905442|NCT01350804|467615022|FG000|Core Study|Adverse Event|8|||
129905443|NCT01350804|467615023|FG001|Core Study|Adverse Event|10|||
129905444|NCT01350804|467615024|FG002|Core Study|Adverse Event|8|||
129905445|NCT01350804|467615025|FG003|Core Study|Adverse Event|8|||
129905446|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
130116584|NCT01335477|468387108|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
129905447|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
129905448|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
129905449|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
129905450|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
129905451|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
129905452|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
129851509|NCT00023452|467414795|FG001|Overall Study|Adverse Event|196|||
129851510|NCT00023452|467414794|FG000|Overall Study|Lost to Follow-up|293|||
129851511|NCT00023452|467414795|FG001|Overall Study|Lost to Follow-up|60|||
129851512|NCT00023452|467414794|FG000|Overall Study|Physician Decision|49|||
129851513|NCT00023452|467414795|FG001|Overall Study|Physician Decision|21|||
129851514|NCT00023452|467414794|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
129851515|NCT00023452|467414795|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
129851516|NCT00023452|467414794|FG000|Overall Study|Pregnant|53|||
129851517|NCT00023452|467414795|FG001|Overall Study|Pregnant|20|||
129851518|NCT00023452|467414794|FG000|Overall Study|Other|204|||
129851519|NCT00023452|467414795|FG001|Overall Study|Other|69|||
129851520|NCT05789875|467414796|FG000|Overall Study|Lost to Follow-up|6|||
129851521|NCT01076400|467416526|FG000|Overall Study|Adverse Event|2|||
129851522|NCT01076400|467416527|FG001|Overall Study|Adverse Event|0|||
129851523|NCT01076400|467416528|FG002|Overall Study|Adverse Event|0|||
129851524|NCT01076400|467416526|FG000|Overall Study|Progressive Disease|5|||
129851525|NCT01076400|467416527|FG001|Overall Study|Progressive Disease|0|||
129851526|NCT01076400|467416528|FG002|Overall Study|Progressive Disease|0|||
129851527|NCT03019536|467416530|FG000|Overall Study|Withdrawal by Subject|1|||
129851528|NCT03019536|467416531|FG001|Overall Study|Withdrawal by Subject|1|||
129851529|NCT03019536|467416532|FG002|Overall Study|Withdrawal by Subject|0|||
129851530|NCT03019536|467416530|FG000|Overall Study|Adverse Event|0|||
129851531|NCT03019536|467416531|FG001|Overall Study|Adverse Event|0|||
129851532|NCT03019536|467416532|FG002|Overall Study|Adverse Event|2|||
129851533|NCT01043874|467416533|FG000|Overall Study|Adverse Event|3|||
129851534|NCT01043874|467416533|FG000|Overall Study|Withdrawal by Subject|1|||
129851535|NCT01043874|467416533|FG000|Overall Study|Lack of Efficacy|1|||
129851536|NCT01043874|467416533|FG000|Overall Study|Administrative Problems|1|||
129851537|NCT00182689|467416541|FG000|Overall Study|Adverse Event|8|||
129851538|NCT00182689|467416542|FG001|Overall Study|Adverse Event|11|||
129851539|NCT00182689|467416541|FG000|Overall Study|Withdrawal by Subject|2|||
129851540|NCT00182689|467416542|FG001|Overall Study|Withdrawal by Subject|2|||
129851541|NCT00182689|467416541|FG000|Overall Study|Progression|27|||
129851542|NCT00182689|467416542|FG001|Overall Study|Progression|29|||
129851543|NCT00182689|467416541|FG000|Overall Study|Death|1|||
129851544|NCT00182689|467416542|FG001|Overall Study|Death|0|||
129851545|NCT00182689|467416541|FG000|Overall Study|not protocol specified|0|||
129851546|NCT00182689|467416542|FG001|Overall Study|not protocol specified|3|||
129851547|NCT00182689|467416541|FG000|Overall Study|Ineligible|1|||
129851548|NCT00182689|467416542|FG001|Overall Study|Ineligible|4|||
129851549|NCT00182689|467416541|FG000|Overall Study|Never received treatment|1|||
129851550|NCT00182689|467416542|FG001|Overall Study|Never received treatment|0|||
129851551|NCT03422003|467416543|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
129851552|NCT03422003|467416544|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
129851553|NCT03422003|467416543|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
129851554|NCT03422003|467416544|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
129851555|NCT01040871|467416549|FG000|Overall Study|Adverse Event|6|||
129851556|NCT01040871|467416550|FG001|Overall Study|Adverse Event|2|||
129851557|NCT01040871|467416549|FG000|Overall Study|Withdrawal by Subject|2|||
129851558|NCT01040871|467416550|FG001|Overall Study|Withdrawal by Subject|0|||
129851559|NCT01040871|467416549|FG000|Overall Study|Death|1|||
129851560|NCT01040871|467416550|FG001|Overall Study|Death|3|||
129851561|NCT01040871|467416549|FG000|Overall Study|Lack of Efficacy|1|||
129851562|NCT01040871|467416550|FG001|Overall Study|Lack of Efficacy|1|||
129905453|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
130064589|NCT00645567|468190205|FG000|Overall Study|Adverse Event|1|||
129851563|NCT01040871|467416549|FG000|Overall Study|drug supply issue|1|||
129851564|NCT01040871|467416550|FG001|Overall Study|drug supply issue|0|||
129851565|NCT01040871|467416549|FG000|Overall Study|Randomized and Not Treated|2|||
129851566|NCT01040871|467416550|FG001|Overall Study|Randomized and Not Treated|1|||
129851567|NCT02696850|467416555|FG000|Overall Study|Withdrawal by Subject|3|||
129851568|NCT02696850|467416556|FG001|Overall Study|Withdrawal by Subject|3|||
129851569|NCT02696850|467416555|FG000|Overall Study|Lost to Follow-up|8|||
129851570|NCT02696850|467416556|FG001|Overall Study|Lost to Follow-up|5|||
129851571|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
129851572|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
129851573|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
129851574|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
129851575|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Death|235|||
129851576|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Death|167|||
129851577|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Death|1|||
129851578|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Death|0|||
129851579|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
129851580|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
129851581|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
129851582|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
129905454|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
129905455|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
129851583|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
129851584|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
129851585|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
129851586|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
129851587|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Other|1|||
129851588|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Other|2|||
129851589|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Other|0|||
129851590|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Other|0|||
129851591|NCT00673049|467416557|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
129851592|NCT00673049|467416558|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
129851593|NCT00673049|467416559|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
129851594|NCT00673049|467416560|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
129851595|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
129851596|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
129851597|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
129851598|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
129851599|NCT00673049|467416557|FG000|After Progression on Erlotinib|Death|0|||
129851600|NCT00673049|467416558|FG001|After Progression on Erlotinib|Death|0|||
129851601|NCT00673049|467416559|FG002|After Progression on Erlotinib|Death|0|||
129851602|NCT00673049|467416560|FG003|After Progression on Erlotinib|Death|71|||
129851603|NCT00673049|467416557|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
129851604|NCT00673049|467416558|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
129851605|NCT00673049|467416559|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
129851606|NCT00673049|467416560|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
129851607|NCT00673049|467416557|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
129851608|NCT00673049|467416558|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
129851609|NCT00673049|467416559|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
129851610|NCT00673049|467416560|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
129851611|NCT00673049|467416557|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
129851612|NCT00673049|467416558|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
129851613|NCT00673049|467416559|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
129851614|NCT00673049|467416560|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
129851615|NCT01175824|467416561|FG000|Overall Study|Adverse Event|2|||
129851616|NCT01175824|467416562|FG001|Overall Study|Adverse Event|1|||
129851617|NCT01175824|467416561|FG000|Overall Study|Lack of Efficacy|2|||
129851618|NCT01175824|467416562|FG001|Overall Study|Lack of Efficacy|0|||
129851619|NCT01175824|467416561|FG000|Overall Study|Lost to Follow-up|0|||
129851620|NCT01175824|467416562|FG001|Overall Study|Lost to Follow-up|1|||
129851621|NCT01175824|467416561|FG000|Overall Study|Physician Decision|0|||
129851622|NCT01175824|467416562|FG001|Overall Study|Physician Decision|4|||
129851623|NCT01175824|467416561|FG000|Overall Study|Protocol Violation|2|||
129851624|NCT01175824|467416562|FG001|Overall Study|Protocol Violation|5|||
129851625|NCT01175824|467416561|FG000|Overall Study|Withdrawal by Subject|3|||
129851626|NCT01175824|467416562|FG001|Overall Study|Withdrawal by Subject|7|||
129851627|NCT01175824|467416561|FG000|Overall Study|Sponsor Decision|1|||
129851628|NCT01175824|467416562|FG001|Overall Study|Sponsor Decision|0|||
129851629|NCT01175824|467416561|FG000|Overall Study|Entry Criteria Not Met|6|||
129851630|NCT01175824|467416562|FG001|Overall Study|Entry Criteria Not Met|4|||
129905456|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
129905457|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
129905458|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
129905459|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
129905460|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
129905461|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
129905462|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
129905463|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
129905464|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
129905465|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
129905466|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
129905467|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
129905468|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
130064590|NCT02475395|468190209|FG000|Overall Study|Protocol Violation|30|||
130064591|NCT02475395|468190210|FG001|Overall Study|Protocol Violation|3|||
130116585|NCT01335477|468387107|FG000|Overall Study|Not treated|1|||
129851631|NCT00924950|467416563|FG000|Overall Study|Lost to Follow-up|2|||
129851632|NCT04193202|467416564|FG000|Overall Study|Adverse Event|2|||
129851633|NCT04193202|467416565|FG001|Overall Study|Adverse Event|1|||
129851634|NCT04193202|467416564|FG000|Overall Study|Death|0|||
129851635|NCT04193202|467416565|FG001|Overall Study|Death|1|||
129851636|NCT04193202|467416564|FG000|Overall Study|Physician Decision|1|||
129851637|NCT04193202|467416565|FG001|Overall Study|Physician Decision|1|||
129851638|NCT04193202|467416564|FG000|Overall Study|Protocol Violation|2|||
129851639|NCT04193202|467416565|FG001|Overall Study|Protocol Violation|2|||
129851640|NCT04193202|467416564|FG000|Overall Study|Withdrawal by Subject|11|||
129851641|NCT04193202|467416565|FG001|Overall Study|Withdrawal by Subject|5|||
129851642|NCT02979535|467416566|FG000|Overall Study|Non compliance with the protocol|78|||
129851643|NCT02979535|467416567|FG001|Overall Study|Non compliance with the protocol|82|||
129851644|NCT02979535|467416566|FG000|Overall Study|Consent withdrawn by participant|11|||
129851645|NCT02979535|467416567|FG001|Overall Study|Consent withdrawn by participant|18|||
129851646|NCT02979535|467416566|FG000|Overall Study|Lost to Follow-up|6|||
129851647|NCT02979535|467416567|FG001|Overall Study|Lost to Follow-up|1|||
129851648|NCT02530619|467416571|FG000|Registered for Study|Withdrawal by Subject|2|||
129851649|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
129851650|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
129851651|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
129851652|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
129851653|NCT02530619|467416571|FG000|Follow-up Period (6 Months)|Death|4|||
129851654|NCT02530619|467416571|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
129851655|NCT02530619|467416571|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
129851656|NCT01163682|467416572|FG000|Overall Study|Lost to Follow-up|6|||
129851657|NCT01163682|467416573|FG001|Overall Study|Lost to Follow-up|9|||
129851658|NCT00359762|467416574|FG000|Period II|Adverse Event|17|||
129851659|NCT00359762|467416575|FG001|Period II|Adverse Event|0|||
129851660|NCT00359762|467416576|FG002|Period II|Adverse Event|0|||
129851661|NCT00359762|467416577|FG003|Period II|Adverse Event|0|||
129851662|NCT00359762|467416578|FG004|Period II|Adverse Event|49|||
129851663|NCT00359762|467416574|FG000|Period II|Protocol Violation|18|||
129851664|NCT00359762|467416575|FG001|Period II|Protocol Violation|0|||
129851665|NCT00359762|467416576|FG002|Period II|Protocol Violation|0|||
129851666|NCT00359762|467416577|FG003|Period II|Protocol Violation|0|||
129851667|NCT00359762|467416578|FG004|Period II|Protocol Violation|11|||
129905469|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
129905470|NCT02299336|467615026|FG000|Overall Study|Withdrawal by Subject|11|||
129905471|NCT02299336|467615026|FG000|Overall Study|Adverse Event|1|||
129905472|NCT02299336|467615026|FG000|Overall Study|Death|1|||
129905473|NCT02299336|467615026|FG000|Overall Study|Lost to Follow-up|1|||
129905474|NCT02106442|467615028|FG000|Overall Study|Case Report Forms Uncollected|7|||
129905475|NCT02106442|467615028|FG000|Overall Study|Protocol Deviation|30|||
129905476|NCT00573833|467615029|FG000|Overall Study|Not Treated|2|||
129905477|NCT05328297|467616339|FG000|Overall Study|Adverse Event|5|||
129905478|NCT05328297|467616340|FG001|Overall Study|Adverse Event|7|||
129905479|NCT05328297|467616339|FG000|Overall Study|Withdrawal by Subject|4|||
129905480|NCT05328297|467616340|FG001|Overall Study|Withdrawal by Subject|3|||
129905481|NCT05328297|467616339|FG000|Overall Study|Lack of Efficacy|1|||
129905482|NCT05328297|467616340|FG001|Overall Study|Lack of Efficacy|0|||
129905483|NCT05328297|467616339|FG000|Overall Study|Lost to Follow-up|1|||
129905484|NCT05328297|467616340|FG001|Overall Study|Lost to Follow-up|0|||
129905485|NCT05328297|467616339|FG000|Overall Study|Protocol Violation|1|||
129905486|NCT05328297|467616340|FG001|Overall Study|Protocol Violation|0|||
129905487|NCT05328297|467616339|FG000|Overall Study|Randomized but not treated|1|||
129905488|NCT05328297|467616340|FG001|Overall Study|Randomized but not treated|1|||
129905489|NCT03544515|467616350|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
129905490|NCT03544515|467616351|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
129905491|NCT03544515|467616350|FG000|Overall Study|Lost to Follow-up|2|||
129905492|NCT03544515|467616351|FG001|Overall Study|Lost to Follow-up|0|||
129905493|NCT03175172|467616352|FG000|Overall Study|Death|3|||
129851668|NCT00359762|467416574|FG000|Period II|Physician Decision|17|||
129851669|NCT00359762|467416575|FG001|Period II|Physician Decision|0|||
129905494|NCT03175172|467616352|FG000|Overall Study|Withdrawal by Subject|3|||
129905495|NCT03175172|467616352|FG000|Overall Study|Lost to Follow-up|1|||
129905496|NCT03175172|467616352|FG000|Overall Study|Study Terminated by Sponsor|3|||
129905497|NCT01662336|467616353|FG000|Overall Study|Adverse Event|1|||
129905498|NCT01662336|467616353|FG000|Overall Study|No longer on LPV/r|30|||
129905499|NCT01662336|467616353|FG000|Overall Study|Other|29|||
129905500|NCT01662336|467616353|FG000|Overall Study|Withdrawal by Subject|6|||
129905501|NCT04668339|467616354|FG000|Overall Study|Physician Decision|1|||
129905502|NCT04668339|467616355|FG001|Overall Study|Physician Decision|0|||
129905503|NCT04668339|467616356|FG002|Overall Study|Physician Decision|1|||
129905504|NCT04668339|467616357|FG003|Overall Study|Physician Decision|1|||
129905505|NCT04668339|467616354|FG000|Overall Study|Lost to Follow-up|14|||
129851670|NCT00359762|467416576|FG002|Period II|Physician Decision|0|||
129851671|NCT00359762|467416577|FG003|Period II|Physician Decision|0|||
129851672|NCT00359762|467416578|FG004|Period II|Physician Decision|23|||
129851673|NCT00359762|467416574|FG000|Period II|Death|2|||
129851674|NCT00359762|467416575|FG001|Period II|Death|0|||
129851675|NCT00359762|467416576|FG002|Period II|Death|0|||
129851676|NCT00359762|467416577|FG003|Period II|Death|0|||
129851677|NCT00359762|467416578|FG004|Period II|Death|4|||
129905506|NCT04668339|467616355|FG001|Overall Study|Lost to Follow-up|12|||
129905507|NCT04668339|467616356|FG002|Overall Study|Lost to Follow-up|8|||
129905508|NCT04668339|467616357|FG003|Overall Study|Lost to Follow-up|5|||
129905509|NCT04668339|467616354|FG000|Overall Study|Adverse Event|0|||
129905510|NCT04668339|467616355|FG001|Overall Study|Adverse Event|0|||
129905511|NCT04668339|467616356|FG002|Overall Study|Adverse Event|1|||
129905512|NCT04668339|467616357|FG003|Overall Study|Adverse Event|0|||
129905513|NCT04668339|467616354|FG000|Overall Study|Other than specified|3|||
129905514|NCT04668339|467616355|FG001|Overall Study|Other than specified|0|||
129905515|NCT04668339|467616356|FG002|Overall Study|Other than specified|1|||
129905516|NCT04668339|467616357|FG003|Overall Study|Other than specified|0|||
129905517|NCT04668339|467616354|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
129905518|NCT04668339|467616355|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
129905519|NCT04668339|467616356|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
129905520|NCT04668339|467616357|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
129905521|NCT04668339|467616354|FG000|Overall Study|Vaccine not Administered|0|||
129905522|NCT04668339|467616355|FG001|Overall Study|Vaccine not Administered|0|||
129905523|NCT04668339|467616356|FG002|Overall Study|Vaccine not Administered|1|||
129905524|NCT04668339|467616357|FG003|Overall Study|Vaccine not Administered|0|||
129905525|NCT04668339|467616354|FG000|Overall Study|Protocol Violation|18|||
129905526|NCT04668339|467616355|FG001|Overall Study|Protocol Violation|23|||
129905527|NCT04668339|467616356|FG002|Overall Study|Protocol Violation|12|||
129905528|NCT04668339|467616357|FG003|Overall Study|Protocol Violation|20|||
129905529|NCT04668339|467616354|FG000|Overall Study|Withdrawal by Subject|45|||
129905530|NCT04668339|467616355|FG001|Overall Study|Withdrawal by Subject|46|||
129905531|NCT04668339|467616356|FG002|Overall Study|Withdrawal by Subject|46|||
129905532|NCT04668339|467616357|FG003|Overall Study|Withdrawal by Subject|27|||
129905533|NCT04668339|467616354|FG000|Overall Study|Study Terminated by Sponsor|59|||
129905534|NCT04668339|467616355|FG001|Overall Study|Study Terminated by Sponsor|59|||
129905535|NCT04668339|467616356|FG002|Overall Study|Study Terminated by Sponsor|71|||
129905536|NCT04668339|467616357|FG003|Overall Study|Study Terminated by Sponsor|1|||
129905537|NCT03622593|467616361|FG000|Overall Study|Withdrawal by Subject|11|||
129905538|NCT03622593|467616362|FG001|Overall Study|Withdrawal by Subject|9|||
129905539|NCT03622593|467616363|FG002|Overall Study|Withdrawal by Subject|13|||
129905540|NCT03622593|467616361|FG000|Overall Study|Death|12|||
129905541|NCT03622593|467616362|FG001|Overall Study|Death|9|||
129905542|NCT03622593|467616363|FG002|Overall Study|Death|10|||
129905543|NCT03622593|467616361|FG000|Overall Study|Lost to Follow-up|11|||
129905544|NCT03622593|467616362|FG001|Overall Study|Lost to Follow-up|5|||
129905545|NCT03622593|467616363|FG002|Overall Study|Lost to Follow-up|8|||
129905546|NCT03622593|467616361|FG000|Overall Study|Adverse Event|4|||
129905547|NCT03622593|467616362|FG001|Overall Study|Adverse Event|5|||
129905548|NCT03622593|467616363|FG002|Overall Study|Adverse Event|6|||
129905549|NCT03622593|467616361|FG000|Overall Study|Physician Decision|2|||
129905550|NCT03622593|467616362|FG001|Overall Study|Physician Decision|1|||
129905551|NCT03622593|467616363|FG002|Overall Study|Physician Decision|6|||
129905552|NCT03622593|467616361|FG000|Overall Study|Other|2|||
129905553|NCT03622593|467616362|FG001|Overall Study|Other|2|||
129905554|NCT03622593|467616363|FG002|Overall Study|Other|3|||
129905555|NCT03622593|467616361|FG000|Overall Study|Protocol Violation|0|||
129905556|NCT03622593|467616362|FG001|Overall Study|Protocol Violation|0|||
129905557|NCT03622593|467616363|FG002|Overall Study|Protocol Violation|1|||
129905558|NCT03622593|467616361|FG000|Overall Study|Pregnancy|0|||
129905559|NCT03622593|467616362|FG001|Overall Study|Pregnancy|0|||
129905560|NCT03622593|467616363|FG002|Overall Study|Pregnancy|1|||
129905561|NCT00178399|467616364|FG000|Overall Study|Physician Decision|4|||
129905562|NCT00178399|467616364|FG000|Overall Study|Withdrawal by Subject|8|||
129905563|NCT00178399|467616364|FG000|Overall Study|Lost to Follow-up|1|||
129905564|NCT02544152|467616365|FG000|Overall Study|Adverse Event|0|||
129905565|NCT02544152|467616366|FG001|Overall Study|Adverse Event|4|||
129905566|NCT02544152|467616365|FG000|Overall Study|Withdrawal by Subject|0|||
129905567|NCT02544152|467616366|FG001|Overall Study|Withdrawal by Subject|3|||
129905568|NCT02544152|467616365|FG000|Overall Study|Other|1|||
129905569|NCT02544152|467616366|FG001|Overall Study|Other|0|||
129905570|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
129905571|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
129905572|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
129905573|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
129905574|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
129905575|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
129905576|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
129905577|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
129905578|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
129905579|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
129905580|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
130064592|NCT03730194|468190211|FG000|First Stage Treatment|Withdrawal by Subject|1|||
129905581|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
129905582|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
129905583|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
129905584|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
129905585|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
129905586|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
129905587|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
129905588|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
129905589|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
129905590|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
129905591|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
129905592|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
129905593|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
129905594|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
129905595|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
129905596|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
129905597|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
129905598|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
129905599|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
129905600|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
129905601|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
129905602|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
129905603|NCT02015546|467616373|FG000|Overall Study|Withdrawal by Subject|1|||
129905604|NCT02015546|467616374|FG001|Overall Study|Withdrawal by Subject|1|||
129905605|NCT02015546|467616375|FG002|Overall Study|Withdrawal by Subject|1|||
129905606|NCT02015546|467616373|FG000|Overall Study|Screem Failure|2|||
129905607|NCT02015546|467616374|FG001|Overall Study|Screem Failure|1|||
129905608|NCT02015546|467616375|FG002|Overall Study|Screem Failure|3|||
129905609|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Adverse Event|5|||
129905610|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Adverse Event|0|||
129905611|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Adverse Event|0|||
129905612|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
129905613|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
129905614|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
129905615|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
129905616|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
129905617|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
129905618|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
129905619|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
129905620|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
129905621|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Pregnancy|1|||
129905622|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Pregnancy|0|||
129905623|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Pregnancy|0|||
129905624|NCT01426269|467616378|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
129905625|NCT01426269|467616379|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
129905626|NCT01426269|467616380|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
129905627|NCT01426269|467616378|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
129905628|NCT01426269|467616379|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
129905629|NCT01426269|467616380|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
129905630|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Adverse Event|0|||
129905631|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Adverse Event|1|||
129905632|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Adverse Event|2|||
129905633|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
129905634|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
129905635|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
129905636|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
129905637|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
129905638|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
129905639|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
129905640|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
129905641|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
129905642|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Site closed|0|||
129905643|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Site closed|6|||
129905644|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Site closed|5|||
129905645|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Relapsed|0|||
129905646|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Relapsed|9|||
129905647|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Relapsed|18|||
129905648|NCT00463788|467616381|FG000|Overall Study|Progressive Disease|86|||
129905649|NCT00463788|467616382|FG001|Overall Study|Progressive Disease|42|||
129905650|NCT00463788|467616381|FG000|Overall Study|Adverse Event|6|||
129905651|NCT00463788|467616382|FG001|Overall Study|Adverse Event|2|||
129905652|NCT00463788|467616381|FG000|Overall Study|Withdrawal by Subject|6|||
129851678|NCT00359762|467416574|FG000|Period II|Lack of Efficacy|11|||
129851679|NCT00359762|467416575|FG001|Period II|Lack of Efficacy|0|||
129851680|NCT00359762|467416576|FG002|Period II|Lack of Efficacy|0|||
129851681|NCT00359762|467416577|FG003|Period II|Lack of Efficacy|0|||
129851682|NCT00359762|467416578|FG004|Period II|Lack of Efficacy|8|||
129851683|NCT00359762|467416574|FG000|Period II|Lost to follow up|5|||
129851684|NCT00359762|467416575|FG001|Period II|Lost to follow up|0|||
129851685|NCT00359762|467416576|FG002|Period II|Lost to follow up|0|||
129851686|NCT00359762|467416577|FG003|Period II|Lost to follow up|0|||
129851687|NCT00359762|467416578|FG004|Period II|Lost to follow up|5|||
129851688|NCT00359762|467416574|FG000|Period II|Entry Criteria Not Met|8|||
129851689|NCT00359762|467416575|FG001|Period II|Entry Criteria Not Met|0|||
129851690|NCT00359762|467416576|FG002|Period II|Entry Criteria Not Met|0|||
129851691|NCT00359762|467416577|FG003|Period II|Entry Criteria Not Met|0|||
129851692|NCT00359762|467416578|FG004|Period II|Entry Criteria Not Met|4|||
129851693|NCT00359762|467416574|FG000|Period II|Subject Decision|50|||
129851694|NCT00359762|467416575|FG001|Period II|Subject Decision|0|||
129851695|NCT00359762|467416576|FG002|Period II|Subject Decision|0|||
129851696|NCT00359762|467416577|FG003|Period II|Subject Decision|0|||
129851697|NCT00359762|467416578|FG004|Period II|Subject Decision|70|||
129851698|NCT00359762|467416574|FG000|Period III|Protocol Violation|0|||
129851699|NCT00359762|467416575|FG001|Period III|Protocol Violation|5|||
129851700|NCT00359762|467416576|FG002|Period III|Protocol Violation|3|||
129851701|NCT00359762|467416577|FG003|Period III|Protocol Violation|8|||
129851702|NCT00359762|467416578|FG004|Period III|Protocol Violation|0|||
129851703|NCT00359762|467416574|FG000|Period III|Adverse Event|0|||
129851704|NCT00359762|467416575|FG001|Period III|Adverse Event|3|||
129851705|NCT00359762|467416576|FG002|Period III|Adverse Event|4|||
129851706|NCT00359762|467416577|FG003|Period III|Adverse Event|10|||
129851707|NCT00359762|467416578|FG004|Period III|Adverse Event|0|||
129851708|NCT00359762|467416574|FG000|Period III|Physician Decision|0|||
129851709|NCT00359762|467416575|FG001|Period III|Physician Decision|5|||
129851710|NCT00359762|467416576|FG002|Period III|Physician Decision|9|||
129851711|NCT00359762|467416577|FG003|Period III|Physician Decision|15|||
129851712|NCT00359762|467416578|FG004|Period III|Physician Decision|0|||
129851713|NCT00359762|467416574|FG000|Period III|Lack of Efficacy|0|||
129851714|NCT00359762|467416575|FG001|Period III|Lack of Efficacy|7|||
129851715|NCT00359762|467416576|FG002|Period III|Lack of Efficacy|5|||
129851716|NCT00359762|467416577|FG003|Period III|Lack of Efficacy|9|||
129851717|NCT00359762|467416578|FG004|Period III|Lack of Efficacy|0|||
129851718|NCT00359762|467416574|FG000|Period III|Lost to follow up|0|||
129851719|NCT00359762|467416575|FG001|Period III|Lost to follow up|1|||
129851720|NCT00359762|467416576|FG002|Period III|Lost to follow up|1|||
129851721|NCT00359762|467416577|FG003|Period III|Lost to follow up|2|||
129851722|NCT00359762|467416578|FG004|Period III|Lost to follow up|0|||
129851723|NCT00359762|467416574|FG000|Period III|Entry Criteria Not Met|0|||
129851724|NCT00359762|467416575|FG001|Period III|Entry Criteria Not Met|1|||
129851725|NCT00359762|467416576|FG002|Period III|Entry Criteria Not Met|0|||
129851726|NCT00359762|467416577|FG003|Period III|Entry Criteria Not Met|1|||
129851727|NCT00359762|467416578|FG004|Period III|Entry Criteria Not Met|0|||
129851728|NCT00359762|467416574|FG000|Period III|Subject Decision|0|||
129851729|NCT00359762|467416575|FG001|Period III|Subject Decision|7|||
129851730|NCT00359762|467416576|FG002|Period III|Subject Decision|8|||
129851731|NCT00359762|467416577|FG003|Period III|Subject Decision|20|||
129851732|NCT00359762|467416578|FG004|Period III|Subject Decision|0|||
129851733|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
129851734|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
129851735|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
129851736|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851737|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851738|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851739|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851740|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851741|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851742|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
129851743|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
129851744|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
129851745|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851746|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851747|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851748|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851749|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851750|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851751|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851752|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
129851753|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
130064593|NCT03730194|468190212|FG001|First Stage Treatment|Withdrawal by Subject|1|||
130064594|NCT03730194|468190213|FG002|First Stage Treatment|Withdrawal by Subject|0|||
129851754|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851755|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851756|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851757|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851758|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851759|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851760|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
129851761|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
129851762|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
129851763|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851764|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851765|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851766|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851767|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851768|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851769|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851770|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
129851771|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851772|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851773|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851774|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851775|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851776|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851777|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851778|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
129851779|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851780|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851781|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851782|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851783|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851784|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851785|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851786|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851787|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851788|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
129851789|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
129851790|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851791|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851792|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851793|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851794|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851795|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851796|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851797|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
129851798|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
129851799|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
129851800|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
129851801|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
129851802|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851803|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851804|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851805|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851806|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
129851807|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
129851808|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
129851809|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
129851810|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
129851811|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851812|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851813|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851814|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129905653|NCT00463788|467616382|FG001|Overall Study|Withdrawal by Subject|2|||
129905654|NCT00463788|467616381|FG000|Overall Study|Death|4|||
129905655|NCT00463788|467616382|FG001|Overall Study|Death|3|||
130064595|NCT03730194|468190214|FG003|First Stage Treatment|Withdrawal by Subject|0|||
129851815|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851816|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
129851817|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851818|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851819|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851820|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851821|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851822|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851823|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
129851824|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
129851825|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
129851826|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
129851827|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
129851828|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
129851829|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
129851830|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
129851831|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
129851832|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851833|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
129851834|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
129851835|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
129851836|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851837|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851838|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851839|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851840|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851841|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851842|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851843|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851844|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851845|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851846|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
129851847|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
129851848|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851849|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851850|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851851|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
129851852|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
129851853|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851854|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851855|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851856|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851857|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
129851858|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
129851859|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851860|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
129851861|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
129851862|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851863|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851864|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851865|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851866|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
129851867|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851868|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851869|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851870|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
129851871|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851872|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851873|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851874|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
130064596|NCT03730194|468190215|FG004|First Stage Treatment|Withdrawal by Subject|0|||
130064597|NCT03730194|468190216|FG005|First Stage Treatment|Withdrawal by Subject|0|||
130064598|NCT03730194|468190211|FG000|First Stage Treatment|Protocol Violation|3|||
129905656|NCT00463788|467616381|FG000|Overall Study|Symptomatic Deterioration|2|||
129905657|NCT00463788|467616382|FG001|Overall Study|Symptomatic Deterioration|3|||
129905658|NCT00463788|467616381|FG000|Overall Study|Lost to Follow-up|1|||
129905659|NCT00463788|467616382|FG001|Overall Study|Lost to Follow-up|0|||
129905660|NCT00463788|467616381|FG000|Overall Study|Protocol Violation|0|||
129905661|NCT00463788|467616382|FG001|Overall Study|Protocol Violation|1|||
129905662|NCT00463788|467616381|FG000|Overall Study|Other|3|||
129905663|NCT00463788|467616382|FG001|Overall Study|Other|0|||
129905664|NCT00463788|467616381|FG000|Overall Study|Randomized but not treated|1|||
129905665|NCT00463788|467616382|FG001|Overall Study|Randomized but not treated|1|||
129905666|NCT00360698|467616383|FG000|Run-In|Physician Decision|0|||
129905667|NCT00360698|467616384|FG001|Run-In|Physician Decision|1|||
129905668|NCT00360698|467616383|FG000|Run-In|Withdrawal by Subject|0|||
129905669|NCT00360698|467616384|FG001|Run-In|Withdrawal by Subject|2|||
129905670|NCT00360698|467616383|FG000|Run-In|Non compliance with treatment procedure|0|||
129905671|NCT00360698|467616384|FG001|Run-In|Non compliance with treatment procedure|1|||
129905672|NCT00360698|467616383|FG000|Run-In|Sponsor request|0|||
129905673|NCT00360698|467616384|FG001|Run-In|Sponsor request|2|||
129905674|NCT00360698|467616383|FG000|Run-In|Patient did not meet inclusion criteria|0|||
129905675|NCT00360698|467616384|FG001|Run-In|Patient did not meet inclusion criteria|1|||
129905676|NCT00360698|467616383|FG000|Run-In|Patient personal reasons|0|||
129905677|NCT00360698|467616384|FG001|Run-In|Patient personal reasons|2|||
129905678|NCT00360698|467616383|FG000|Run-In|Need of insulin with meals|0|||
129905679|NCT00360698|467616384|FG001|Run-In|Need of insulin with meals|1|||
129905680|NCT00360698|467616383|FG000|Treatment Period|Non compliance with treatment procedure|1|||
129905681|NCT00360698|467616384|FG001|Treatment Period|Non compliance with treatment procedure|0|||
129905682|NCT00360698|467616383|FG000|Treatment Period|Early termination by error|0|||
129905683|NCT00360698|467616384|FG001|Treatment Period|Early termination by error|1|||
129905684|NCT00712335|467616389|FG000|Overall Study|Withdrawal by Subject|0|||
129905685|NCT00712335|467616390|FG001|Overall Study|Withdrawal by Subject|7|||
129905686|NCT00712335|467616391|FG002|Overall Study|Withdrawal by Subject|2|||
129905687|NCT00712335|467616392|FG003|Overall Study|Withdrawal by Subject|3|||
129905688|NCT00712335|467616393|FG004|Overall Study|Withdrawal by Subject|0|||
129905689|NCT00712335|467616389|FG000|Overall Study|Lost to Follow-up|2|||
129905690|NCT00712335|467616390|FG001|Overall Study|Lost to Follow-up|5|||
129905691|NCT00712335|467616391|FG002|Overall Study|Lost to Follow-up|0|||
129905692|NCT00712335|467616392|FG003|Overall Study|Lost to Follow-up|1|||
129905693|NCT00712335|467616393|FG004|Overall Study|Lost to Follow-up|0|||
129905694|NCT00712335|467616389|FG000|Overall Study|Protocol Violation|1|||
129905695|NCT00712335|467616390|FG001|Overall Study|Protocol Violation|2|||
129905696|NCT00712335|467616391|FG002|Overall Study|Protocol Violation|1|||
129905697|NCT00712335|467616392|FG003|Overall Study|Protocol Violation|0|||
129905698|NCT00712335|467616393|FG004|Overall Study|Protocol Violation|0|||
129905699|NCT00712335|467616389|FG000|Overall Study|Lack of Efficacy|0|||
129905700|NCT00712335|467616390|FG001|Overall Study|Lack of Efficacy|0|||
129905701|NCT00712335|467616391|FG002|Overall Study|Lack of Efficacy|1|||
130116586|NCT01335477|468387108|FG001|Overall Study|Not treated|2|||
130116587|NCT01335477|468387107|FG000|Overall Study|Reason other than those stated above|2|||
129905702|NCT00712335|467616392|FG003|Overall Study|Lack of Efficacy|1|||
129905703|NCT00712335|467616393|FG004|Overall Study|Lack of Efficacy|0|||
129905704|NCT00712335|467616389|FG000|Overall Study|Other Reason|0|||
129905705|NCT00712335|467616390|FG001|Overall Study|Other Reason|3|||
129905706|NCT00712335|467616391|FG002|Overall Study|Other Reason|1|||
129905707|NCT00712335|467616392|FG003|Overall Study|Other Reason|0|||
129905708|NCT00712335|467616393|FG004|Overall Study|Other Reason|0|||
129905709|NCT03401112|467616394|FG000|Overall Study|Adverse Event|1|||
129905710|NCT03401112|467616395|FG001|Overall Study|Adverse Event|2|||
129905711|NCT03401112|467616396|FG002|Overall Study|Adverse Event|3|||
129905712|NCT03401112|467616397|FG003|Overall Study|Adverse Event|2|||
129905713|NCT03401112|467616398|FG004|Overall Study|Adverse Event|0|||
129905714|NCT03401112|467616394|FG000|Overall Study|Lost to Follow-up|1|||
129905715|NCT03401112|467616395|FG001|Overall Study|Lost to Follow-up|0|||
129905716|NCT03401112|467616396|FG002|Overall Study|Lost to Follow-up|0|||
129905717|NCT03401112|467616397|FG003|Overall Study|Lost to Follow-up|0|||
129905718|NCT03401112|467616398|FG004|Overall Study|Lost to Follow-up|0|||
129905719|NCT03401112|467616394|FG000|Overall Study|Noncompliance|1|||
129905720|NCT03401112|467616395|FG001|Overall Study|Noncompliance|2|||
129905721|NCT03401112|467616396|FG002|Overall Study|Noncompliance|3|||
129905722|NCT03401112|467616397|FG003|Overall Study|Noncompliance|0|||
129905723|NCT03401112|467616398|FG004|Overall Study|Noncompliance|0|||
129905724|NCT03401112|467616394|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
129905725|NCT03401112|467616395|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
129905726|NCT03401112|467616396|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
129905727|NCT03401112|467616397|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
129905728|NCT03401112|467616398|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
129905729|NCT03401112|467616394|FG000|Overall Study|Withdrawal by Subject|0|||
130116588|NCT01335477|468387108|FG001|Overall Study|Reason other than those stated above|2|||
130116589|NCT03031899|468387114|FG000|Overall Study|Protocol Violation|1|||
129905730|NCT03401112|467616395|FG001|Overall Study|Withdrawal by Subject|3|||
129905731|NCT03401112|467616396|FG002|Overall Study|Withdrawal by Subject|2|||
129905732|NCT03401112|467616397|FG003|Overall Study|Withdrawal by Subject|1|||
129905733|NCT03401112|467616398|FG004|Overall Study|Withdrawal by Subject|0|||
129905734|NCT03401112|467616394|FG000|Overall Study|Physician Decision|0|||
129905735|NCT03401112|467616395|FG001|Overall Study|Physician Decision|0|||
129905736|NCT03401112|467616396|FG002|Overall Study|Physician Decision|0|||
129905737|NCT03401112|467616397|FG003|Overall Study|Physician Decision|2|||
129905738|NCT03401112|467616398|FG004|Overall Study|Physician Decision|0|||
129905739|NCT03401112|467616394|FG000|Overall Study|Study was Terminated by Sponsor|0|||
129905740|NCT03401112|467616395|FG001|Overall Study|Study was Terminated by Sponsor|0|||
129905741|NCT03401112|467616396|FG002|Overall Study|Study was Terminated by Sponsor|0|||
129905742|NCT03401112|467616397|FG003|Overall Study|Study was Terminated by Sponsor|1|||
129905743|NCT03401112|467616398|FG004|Overall Study|Study was Terminated by Sponsor|0|||
129905744|NCT03401112|467616394|FG000|Overall Study|Day 1 Assessment not Done|1|||
129905745|NCT03401112|467616395|FG001|Overall Study|Day 1 Assessment not Done|0|||
129905746|NCT03401112|467616396|FG002|Overall Study|Day 1 Assessment not Done|0|||
129905747|NCT03401112|467616397|FG003|Overall Study|Day 1 Assessment not Done|0|||
129905748|NCT03401112|467616398|FG004|Overall Study|Day 1 Assessment not Done|0|||
129905749|NCT03401112|467616394|FG000|Overall Study|Not Dosed|0|||
129905750|NCT03401112|467616395|FG001|Overall Study|Not Dosed|0|||
129905751|NCT03401112|467616396|FG002|Overall Study|Not Dosed|1|||
129905752|NCT03401112|467616397|FG003|Overall Study|Not Dosed|0|||
129905753|NCT03401112|467616398|FG004|Overall Study|Not Dosed|0|||
129905754|NCT03401112|467616394|FG000|Overall Study|Missed Clinical Visit|0|||
129905755|NCT03401112|467616395|FG001|Overall Study|Missed Clinical Visit|0|||
129905756|NCT03401112|467616396|FG002|Overall Study|Missed Clinical Visit|1|||
129905757|NCT03401112|467616397|FG003|Overall Study|Missed Clinical Visit|0|||
129905758|NCT03401112|467616398|FG004|Overall Study|Missed Clinical Visit|0|||
129905759|NCT03401112|467616394|FG000|Overall Study|Missed Doses|0|||
129905760|NCT03401112|467616395|FG001|Overall Study|Missed Doses|0|||
129905761|NCT03401112|467616396|FG002|Overall Study|Missed Doses|1|||
129905762|NCT03401112|467616397|FG003|Overall Study|Missed Doses|0|||
129905763|NCT03401112|467616398|FG004|Overall Study|Missed Doses|0|||
129905764|NCT03194958|467616399|FG000|Overall Study|Death|0|||
129851875|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851876|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851877|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851878|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
129851879|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
129851880|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851881|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851882|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851883|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851884|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
129851885|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
129851886|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851887|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851888|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
129851889|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851890|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851891|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851892|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851893|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851894|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851895|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851896|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
129851897|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
129851898|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851899|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851900|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851901|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851902|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
129851903|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851904|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851905|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
129905765|NCT03194958|467616400|FG001|Overall Study|Death|1|||
129905766|NCT03194958|467616401|FG002|Overall Study|Death|1|||
129905767|NCT03194958|467616402|FG003|Overall Study|Death|1|||
129905768|NCT03194958|467616399|FG000|Overall Study|Withdrawal by Subject|24|||
129905769|NCT03194958|467616400|FG001|Overall Study|Withdrawal by Subject|27|||
129905770|NCT03194958|467616401|FG002|Overall Study|Withdrawal by Subject|7|||
129905771|NCT03194958|467616402|FG003|Overall Study|Withdrawal by Subject|22|||
129905772|NCT03194958|467616399|FG000|Overall Study|Lost to Follow-up|168|||
129905773|NCT03194958|467616400|FG001|Overall Study|Lost to Follow-up|196|||
129905774|NCT03194958|467616401|FG002|Overall Study|Lost to Follow-up|174|||
129905775|NCT03194958|467616402|FG003|Overall Study|Lost to Follow-up|186|||
129905776|NCT01202955|467616404|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
129905777|NCT01202955|467616405|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
129905778|NCT00256243|467616409|FG000|Overall Study|Lost to Follow-up|2|||
129905779|NCT00256243|467616409|FG000|Overall Study|Death|7|||
129905780|NCT00256243|467616409|FG000|Overall Study|Not treated|1|||
129905781|NCT00258895|467616410|FG000|Overall Study|Lost to Follow-up|3|||
129905782|NCT00258895|467616411|FG001|Overall Study|Lost to Follow-up|1|||
129905783|NCT00258895|467616410|FG000|Overall Study|Protocol Violation|6|||
129905784|NCT00258895|467616411|FG001|Overall Study|Protocol Violation|2|||
129905785|NCT00258895|467616410|FG000|Overall Study|Withdrawal by Subject|1|||
129905786|NCT00258895|467616411|FG001|Overall Study|Withdrawal by Subject|0|||
129905787|NCT00547118|467616412|FG000|Overall Study|Did not qualify prior to starting drug|1|||
129905788|NCT00547118|467616413|FG001|Overall Study|Did not qualify prior to starting drug|1|||
129905789|NCT00547118|467616412|FG000|Overall Study|Study suspended|7|||
129905790|NCT00547118|467616413|FG001|Overall Study|Study suspended|8|||
129905791|NCT02248480|467616414|FG000|Overall Study|Lack of Efficacy|4|||
129905792|NCT02248480|467616415|FG001|Overall Study|Lack of Efficacy|6|||
129905793|NCT02248480|467616414|FG000|Overall Study|Adverse Event|11|||
129905794|NCT02248480|467616415|FG001|Overall Study|Adverse Event|2|||
129905795|NCT02248480|467616414|FG000|Overall Study|Withdrawal by Subject|2|||
129905796|NCT02248480|467616415|FG001|Overall Study|Withdrawal by Subject|4|||
129905797|NCT02248480|467616414|FG000|Overall Study|Entry Criteria Not Met|0|||
129905798|NCT02248480|467616415|FG001|Overall Study|Entry Criteria Not Met|1|||
129905799|NCT02248480|467616414|FG000|Overall Study|Other:Physician Decision|0|||
129905800|NCT02248480|467616415|FG001|Overall Study|Other:Physician Decision|1|||
129905801|NCT01595321|467616416|FG000|Overall Study|Adverse Event|1|||
129905802|NCT01595321|467616417|FG001|Overall Study|Adverse Event|1|||
129905803|NCT01595321|467616418|FG002|Overall Study|Adverse Event|1|||
129905804|NCT01595321|467616416|FG000|Overall Study|Lack of Efficacy|0|||
129905805|NCT01595321|467616417|FG001|Overall Study|Lack of Efficacy|0|||
129905806|NCT01595321|467616418|FG002|Overall Study|Lack of Efficacy|4|||
129905807|NCT04504916|467616419|FG000|Overall Study|Study terminated|7|||
129905808|NCT04504916|467616420|FG001|Overall Study|Study terminated|8|||
129905809|NCT04504916|467616419|FG000|Overall Study|Death|54|||
129905810|NCT04504916|467616420|FG001|Overall Study|Death|18|||
129905811|NCT04504916|467616419|FG000|Overall Study|Lost to Follow-up|1|||
129905812|NCT04504916|467616420|FG001|Overall Study|Lost to Follow-up|1|||
129905813|NCT04504916|467616419|FG000|Overall Study|Withdrawal by Subject|8|||
129905814|NCT04504916|467616420|FG001|Overall Study|Withdrawal by Subject|4|||
129905815|NCT04504916|467616419|FG000|Overall Study|Did not agree to follow-up|0|||
129905816|NCT04504916|467616420|FG001|Overall Study|Did not agree to follow-up|1|||
129905817|NCT00834834|467616422|FG000|Overall Study|Withdrawal by Subject|4|||
129905818|NCT00834834|467616423|FG001|Overall Study|Withdrawal by Subject|3|||
129905819|NCT00539292|467616424|FG000|Overall Study|Physician Decision|1|||
129905820|NCT00539292|467616425|FG001|Overall Study|Physician Decision|0|||
129905821|NCT00630786|467616426|FG000|Overall Study|Physician Decision|0|||
129905822|NCT00630786|467616427|FG001|Overall Study|Physician Decision|0|||
129905823|NCT00630786|467616428|FG002|Overall Study|Physician Decision|1|||
129905824|NCT00630786|467616426|FG000|Overall Study|Withdrawal by Subject|0|||
129851906|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851907|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851908|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851909|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851910|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851911|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851912|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
129851913|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851914|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
129851915|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851916|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129905825|NCT00630786|467616427|FG001|Overall Study|Withdrawal by Subject|1|||
129905826|NCT00630786|467616428|FG002|Overall Study|Withdrawal by Subject|1|||
129905827|NCT00630786|467616426|FG000|Overall Study|Lost to Follow-up|0|||
129905828|NCT00630786|467616427|FG001|Overall Study|Lost to Follow-up|1|||
129905829|NCT00630786|467616428|FG002|Overall Study|Lost to Follow-up|0|||
129905830|NCT00630786|467616426|FG000|Overall Study|Other|1|||
130064599|NCT03730194|468190212|FG001|First Stage Treatment|Protocol Violation|3|||
129905831|NCT00630786|467616427|FG001|Overall Study|Other|0|||
129905832|NCT00630786|467616428|FG002|Overall Study|Other|0|||
129905833|NCT02020616|467616430|FG000|Overall Study|Adverse Event|0|||
129905834|NCT02020616|467616431|FG001|Overall Study|Adverse Event|0|||
129905835|NCT02020616|467616432|FG002|Overall Study|Adverse Event|0|||
129851917|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851918|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851919|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851920|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851921|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851922|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851923|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851924|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851925|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851926|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851927|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851928|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851929|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851930|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
129851931|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851932|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
129851933|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
129851934|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851935|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851936|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851937|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851938|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
129851939|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
129851940|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851941|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
129851942|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
129851943|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851944|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851945|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851946|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851947|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
129851948|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
129851949|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851950|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851951|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851952|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851953|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851954|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851955|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851956|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
129851957|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851958|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851959|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
129851960|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851961|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851962|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851963|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851964|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851965|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851966|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851967|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851968|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851969|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
129851970|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851971|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851972|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851973|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851974|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851975|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851976|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851977|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
129851978|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
129851979|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851980|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851981|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851982|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851983|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
129851984|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851985|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851986|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
129851987|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
129851988|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851989|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851990|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851991|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851992|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
129851993|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
129851994|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129851995|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
129851996|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
129851997|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129851998|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129851999|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129852000|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129852001|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
129852002|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
129852003|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852004|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852005|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
129852006|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852007|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852008|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852009|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852010|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852011|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
129852012|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852013|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852014|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852015|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852016|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852017|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852018|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852019|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
129852020|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852021|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852022|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852023|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
129852024|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852025|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852026|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852027|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852028|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
129852029|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
129852030|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852031|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852032|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
129852033|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852034|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852035|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852036|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852037|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852038|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852039|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852040|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
129852041|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852042|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852043|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852044|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852045|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129905836|NCT02020616|467616433|FG003|Overall Study|Adverse Event|0|||
129852046|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
129852047|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852048|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852049|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
129852050|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
129852051|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852052|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852053|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852054|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852055|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
129852056|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852057|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852058|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852059|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
129852060|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852061|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852062|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852063|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852064|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852065|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852066|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852067|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852068|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
129852069|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852070|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852071|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852072|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852073|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852074|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852075|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852076|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852077|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852078|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852079|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852080|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852081|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852082|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852083|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
129852084|NCT00003498|467416591|FG000|Overall Study|Not evaluable.|4|||
129852085|NCT05282004|467416595|FG000|Overall Study|Adverse Event|2|||
129852086|NCT00889421|467416596|FG000|Overall Study|Lack of Efficacy|3|||
129852087|NCT01958918|467416597|FG000|Overall Study|Death|1|||
129852088|NCT01958918|467416598|FG001|Overall Study|Death|3|||
129852089|NCT01958918|467416597|FG000|Overall Study|Lost to Follow-up|4|||
129852090|NCT01958918|467416598|FG001|Overall Study|Lost to Follow-up|7|||
129852091|NCT01958918|467416597|FG000|Overall Study|Withdrawal by Subject|13|||
129852092|NCT01958918|467416598|FG001|Overall Study|Withdrawal by Subject|8|||
129852093|NCT01958918|467416597|FG000|Overall Study|Lack of Efficacy|13|||
129852094|NCT01958918|467416598|FG001|Overall Study|Lack of Efficacy|10|||
129852095|NCT01958918|467416597|FG000|Overall Study|Adverse Event|12|||
129852096|NCT01958918|467416598|FG001|Overall Study|Adverse Event|12|||
129852097|NCT01958918|467416597|FG000|Overall Study|administrative problems|0|||
129852098|NCT01958918|467416598|FG001|Overall Study|administrative problems|2|||
129852099|NCT02013765|467416602|FG000|Overall Study|Trial was terminated by sponsor|1|||
129852100|NCT00659269|467416603|FG000|Overall Study|Physician Decision|1|||
129852101|NCT00659269|467416604|FG001|Overall Study|Physician Decision|1|||
129852102|NCT01158222|467416605|FG000|Overall Study|Not eligible for intermediate phase|17|||
129852103|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852104|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852105|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852106|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852107|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
129852108|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852109|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
129852110|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129852111|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129852112|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129852113|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
129852114|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129905837|NCT02020616|467616434|FG004|Overall Study|Adverse Event|0|||
129905838|NCT02020616|467616435|FG005|Overall Study|Adverse Event|1|||
129905839|NCT02020616|467616436|FG006|Overall Study|Adverse Event|1|||
129905840|NCT02020616|467616430|FG000|Overall Study|Physician Decision|0|||
129905841|NCT02020616|467616431|FG001|Overall Study|Physician Decision|0|||
129905842|NCT02020616|467616432|FG002|Overall Study|Physician Decision|0|||
129905843|NCT02020616|467616433|FG003|Overall Study|Physician Decision|0|||
129905844|NCT02020616|467616434|FG004|Overall Study|Physician Decision|0|||
129905845|NCT02020616|467616435|FG005|Overall Study|Physician Decision|1|||
129905846|NCT02020616|467616436|FG006|Overall Study|Physician Decision|2|||
129905847|NCT02020616|467616430|FG000|Overall Study|Withdrawal by Subject|0|||
129905848|NCT02020616|467616431|FG001|Overall Study|Withdrawal by Subject|0|||
129905849|NCT02020616|467616432|FG002|Overall Study|Withdrawal by Subject|1|||
129905850|NCT02020616|467616433|FG003|Overall Study|Withdrawal by Subject|0|||
129905851|NCT02020616|467616434|FG004|Overall Study|Withdrawal by Subject|0|||
129905852|NCT02020616|467616435|FG005|Overall Study|Withdrawal by Subject|1|||
129905853|NCT02020616|467616436|FG006|Overall Study|Withdrawal by Subject|1|||
129905854|NCT02020616|467616430|FG000|Overall Study|Lost to Follow-up|0|||
129905855|NCT02020616|467616431|FG001|Overall Study|Lost to Follow-up|1|||
129852115|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852116|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
129852117|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
129852118|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852119|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852120|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852121|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852122|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
129852123|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852124|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852125|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852126|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852127|NCT00718042|467416606|FG000|Donor Follow-up|Lost to Follow-up|13|||
129852128|NCT00718042|467416607|FG001|Donor Follow-up|Lost to Follow-up|0|||
129852129|NCT00718042|467416608|FG002|Donor Follow-up|Lost to Follow-up|0|||
129852130|NCT00718042|467416609|FG003|Donor Follow-up|Lost to Follow-up|0|||
129852131|NCT00718042|467416610|FG004|Donor Follow-up|Lost to Follow-up|19|||
129852132|NCT00718042|467416611|FG005|Donor Follow-up|Lost to Follow-up|0|||
129852133|NCT02443298|467416612|FG000|Overall Study|Adverse Event|3|||
129852134|NCT02443298|467416613|FG001|Overall Study|Adverse Event|3|||
129852135|NCT02443298|467416612|FG000|Overall Study|Withdrawal by Subject|1|||
129852136|NCT02443298|467416613|FG001|Overall Study|Withdrawal by Subject|2|||
129852137|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
129852138|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
129852139|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
129852140|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
129852141|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
129852142|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
129852143|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
129852144|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
129852145|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
129852146|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
129852147|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
129852148|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
129852149|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
129852150|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
129905856|NCT02020616|467616432|FG002|Overall Study|Lost to Follow-up|0|||
129905857|NCT02020616|467616433|FG003|Overall Study|Lost to Follow-up|1|||
129905858|NCT02020616|467616434|FG004|Overall Study|Lost to Follow-up|1|||
129905859|NCT02020616|467616435|FG005|Overall Study|Lost to Follow-up|1|||
129905860|NCT02020616|467616436|FG006|Overall Study|Lost to Follow-up|0|||
129905861|NCT02020616|467616430|FG000|Overall Study|Early Termination Criteria Met|0|||
129905862|NCT02020616|467616431|FG001|Overall Study|Early Termination Criteria Met|0|||
129905863|NCT02020616|467616432|FG002|Overall Study|Early Termination Criteria Met|1|||
129852151|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
129905864|NCT02020616|467616433|FG003|Overall Study|Early Termination Criteria Met|0|||
129905865|NCT02020616|467616434|FG004|Overall Study|Early Termination Criteria Met|0|||
129905866|NCT02020616|467616435|FG005|Overall Study|Early Termination Criteria Met|1|||
129905867|NCT02020616|467616436|FG006|Overall Study|Early Termination Criteria Met|0|||
129852152|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
129852153|NCT02464969|467416614|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
129905868|NCT02020616|467616430|FG000|Overall Study|Randomized in Error|0|||
129905869|NCT02020616|467616431|FG001|Overall Study|Randomized in Error|0|||
129905870|NCT02020616|467616432|FG002|Overall Study|Randomized in Error|0|||
129905871|NCT02020616|467616433|FG003|Overall Study|Randomized in Error|1|||
129852154|NCT02464969|467416615|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
129852155|NCT02464969|467416614|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
129852156|NCT02464969|467416615|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
129852157|NCT02464969|467416614|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
129852158|NCT02464969|467416615|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
129852159|NCT02399085|467416620|FG000|Overall Study|Adverse Event|16|||
129852160|NCT02399085|467416620|FG000|Overall Study|Death|2|||
129852161|NCT02399085|467416620|FG000|Overall Study|Withdrawal by Subject|8|||
129852162|NCT02399085|467416620|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
129852163|NCT02399085|467416620|FG000|Overall Study|Physician Decision|5|||
129852164|NCT00833924|467416621|FG000|Overall Study|Death|21|||
129852165|NCT00833924|467416621|FG000|Overall Study|Conversion|2|||
129852166|NCT00833924|467416621|FG000|Overall Study|Lost to Follow-up|2|||
129852167|NCT00833924|467416621|FG000|Overall Study|Withdrawal by Subject|13|||
129852168|NCT00833924|467416621|FG000|Overall Study|In study follow-up|71|||
129852169|NCT01975389|467416624|FG000|Overall Study|Adverse Event|10|||
129852170|NCT01975389|467416625|FG001|Overall Study|Adverse Event|6|||
129852171|NCT01975389|467416624|FG000|Overall Study|Death|61|||
129852172|NCT01975389|467416625|FG001|Overall Study|Death|54|||
129852173|NCT01975389|467416624|FG000|Overall Study|Lost to Follow-up|81|||
129852174|NCT01975389|467416625|FG001|Overall Study|Lost to Follow-up|86|||
129852175|NCT01975389|467416624|FG000|Overall Study|Withdrawal by Subject|90|||
129852176|NCT01975389|467416625|FG001|Overall Study|Withdrawal by Subject|76|||
129852177|NCT01975389|467416624|FG000|Overall Study|Other|6|||
129852178|NCT01975389|467416625|FG001|Overall Study|Other|9|||
129852179|NCT01975389|467416624|FG000|Overall Study|Randomized, not treated|4|||
129852180|NCT01975389|467416625|FG001|Overall Study|Randomized, not treated|5|||
129852181|NCT00298831|467416630|FG000|Overall Study|Adverse Event|1|||
129852182|NCT00298831|467416630|FG000|Overall Study|Lost to Follow-up|3|||
129852183|NCT00298831|467416630|FG000|Overall Study|Withdrawal by Subject|1|||
129852184|NCT00298831|467416630|FG000|Overall Study|Participants did not receive treatment|27|||
129852185|NCT00691210|467416631|FG000|Overall Study|Progression of Disease|0|||
129852186|NCT00691210|467416632|FG001|Overall Study|Progression of Disease|0|||
129852187|NCT00691210|467416633|FG002|Overall Study|Progression of Disease|0|||
129852188|NCT00691210|467416634|FG003|Overall Study|Progression of Disease|2|||
129852189|NCT00691210|467416635|FG004|Overall Study|Progression of Disease|0|||
129852190|NCT00691210|467416636|FG005|Overall Study|Progression of Disease|0|||
129852191|NCT00691210|467416637|FG006|Overall Study|Progression of Disease|0|||
129852192|NCT00691210|467416638|FG007|Overall Study|Progression of Disease|0|||
129852193|NCT00691210|467416631|FG000|Overall Study|Lack of Efficacy|0|||
129852194|NCT00691210|467416632|FG001|Overall Study|Lack of Efficacy|0|||
129852195|NCT00691210|467416633|FG002|Overall Study|Lack of Efficacy|0|||
129852196|NCT00691210|467416634|FG003|Overall Study|Lack of Efficacy|1|||
129852197|NCT00691210|467416635|FG004|Overall Study|Lack of Efficacy|0|||
129852198|NCT00691210|467416636|FG005|Overall Study|Lack of Efficacy|1|||
129852199|NCT00691210|467416637|FG006|Overall Study|Lack of Efficacy|0|||
129852200|NCT00691210|467416638|FG007|Overall Study|Lack of Efficacy|0|||
129852201|NCT01306617|467416640|FG000|Overall Study|Adverse Event|1|||
129852202|NCT01306617|467416641|FG001|Overall Study|Adverse Event|0|||
129852203|NCT01306617|467416642|FG002|Overall Study|Adverse Event|0|||
129852204|NCT01306617|467416640|FG000|Overall Study|Virologic Failure|0|||
129852205|NCT01306617|467416641|FG001|Overall Study|Virologic Failure|0|||
129852206|NCT01306617|467416642|FG002|Overall Study|Virologic Failure|5|||
129852207|NCT01306617|467416640|FG000|Overall Study|Non-compliance|0|||
129852208|NCT01306617|467416641|FG001|Overall Study|Non-compliance|1|||
129852209|NCT01306617|467416642|FG002|Overall Study|Non-compliance|0|||
129852210|NCT04028388|467416652|FG000|Overall Study|Evaluations missing|3|||
129852211|NCT04028388|467416653|FG001|Overall Study|Evaluations missing|6|||
129852212|NCT04028388|467416652|FG000|Overall Study|Not started|2|||
129852213|NCT04028388|467416653|FG001|Overall Study|Not started|0|||
129852214|NCT01994395|467416654|FG000|Overall Study|Withdrawal by Subject|1|||
129852215|NCT01994395|467416655|FG001|Overall Study|Withdrawal by Subject|2|||
129852216|NCT01940705|467416657|FG000|Overall Study|Lost to Follow-up|1|||
129852217|NCT01940705|467416658|FG001|Overall Study|Lost to Follow-up|3|||
129852218|NCT01940705|467416659|FG002|Overall Study|Lost to Follow-up|2|||
129852219|NCT01940705|467416660|FG003|Overall Study|Lost to Follow-up|2|||
129852220|NCT01940705|467416657|FG000|Overall Study|Withdrawal by Subject|2|||
129852221|NCT01940705|467416658|FG001|Overall Study|Withdrawal by Subject|2|||
129852222|NCT01940705|467416659|FG002|Overall Study|Withdrawal by Subject|3|||
129852223|NCT01940705|467416660|FG003|Overall Study|Withdrawal by Subject|2|||
129852224|NCT01940705|467416657|FG000|Overall Study|Intervention not given|0|||
129852225|NCT01940705|467416658|FG001|Overall Study|Intervention not given|3|||
129852226|NCT01940705|467416659|FG002|Overall Study|Intervention not given|3|||
129852227|NCT01940705|467416660|FG003|Overall Study|Intervention not given|0|||
129852228|NCT01940705|467416657|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
129852229|NCT01940705|467416658|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
129852230|NCT01940705|467416659|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
129905872|NCT02020616|467616434|FG004|Overall Study|Randomized in Error|0|||
129852231|NCT01940705|467416660|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
129852232|NCT03779841|467416663|FG000|Randomized Population|Did Not Receive Treatment|3|||
129852233|NCT03779841|467416664|FG001|Randomized Population|Did Not Receive Treatment|1|||
129852234|NCT03779841|467416665|FG002|Randomized Population|Did Not Receive Treatment|0|||
129852235|NCT03779841|467416663|FG000|Treated (Safety) Population|Adverse Event|1|||
129852236|NCT03779841|467416664|FG001|Treated (Safety) Population|Adverse Event|1|||
129852237|NCT03779841|467416665|FG002|Treated (Safety) Population|Adverse Event|0|||
129852238|NCT03779841|467416663|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
129852239|NCT03779841|467416664|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
129852240|NCT03779841|467416665|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
129852241|NCT03779841|467416663|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
129852242|NCT03779841|467416664|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
129852243|NCT03779841|467416665|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
129852244|NCT03779841|467416663|FG000|Treated (Safety) Population|Death|1|||
129852245|NCT03779841|467416664|FG001|Treated (Safety) Population|Death|0|||
129852246|NCT03779841|467416665|FG002|Treated (Safety) Population|Death|2|||
129852247|NCT01632579|467416666|FG000|Washout Period|Adverse Event|1|||
129852248|NCT01632579|467416667|FG001|Washout Period|Adverse Event|0|||
129852249|NCT01632579|467416668|FG002|Washout Period|Adverse Event|0|||
129852250|NCT01632579|467416669|FG003|Washout Period|Adverse Event|0|||
129852251|NCT01632579|467416670|FG004|Washout Period|Adverse Event|0|||
129852252|NCT01632579|467416671|FG005|Washout Period|Adverse Event|0|||
129852253|NCT01632579|467416672|FG006|Washout Period|Adverse Event|0|||
129852254|NCT01632579|467416673|FG007|Washout Period|Adverse Event|0|||
129852255|NCT01632579|467416674|FG008|Washout Period|Adverse Event|0|||
129852256|NCT01632579|467416666|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
129852257|NCT01632579|467416667|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
129852258|NCT01632579|467416668|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
129852259|NCT01632579|467416669|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
129852260|NCT01632579|467416670|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
129852261|NCT01632579|467416671|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
129852262|NCT01632579|467416672|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
129852263|NCT01632579|467416673|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
129852264|NCT01632579|467416674|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
129852265|NCT02788175|467416675|FG000|Overall Study|Protocol Violation|3|||
129852266|NCT02788175|467416675|FG000|Overall Study|Withdrawal by Subject|4|||
129852267|NCT02788175|467416675|FG000|Overall Study|Ineligible prior to study agent|6|||
129852268|NCT00162136|467416676|FG000|Overall Study|Adverse Event|1|||
129852269|NCT00162136|467416676|FG000|Overall Study|Death|1|||
129852270|NCT00162136|467416676|FG000|Overall Study|Disease Progression/Relapse|23|||
129852271|NCT00162136|467416676|FG000|Overall Study|Investigator Request|5|||
129852272|NCT00162136|467416676|FG000|Overall Study|Study Drug Toxicity|4|||
129852273|NCT00162136|467416676|FG000|Overall Study|Withdrawal by Subject|1|||
129852274|NCT03930745|467416677|FG000|Overall Study|Lost to Follow-up|10|||
129852275|NCT03930745|467416678|FG001|Overall Study|Lost to Follow-up|5|||
129852276|NCT03930745|467416677|FG000|Overall Study|Withdrawal by Subject|1|||
129852277|NCT03930745|467416678|FG001|Overall Study|Withdrawal by Subject|2|||
129852278|NCT03930745|467416677|FG000|Overall Study|Protocol Violation|2|||
129852279|NCT03930745|467416678|FG001|Overall Study|Protocol Violation|2|||
129852280|NCT03930745|467416677|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
129852281|NCT03930745|467416678|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
129852282|NCT03930745|467416677|FG000|Overall Study|Adverse Event|0|||
129852283|NCT03930745|467416678|FG001|Overall Study|Adverse Event|1|||
129852284|NCT03930745|467416677|FG000|Overall Study|Pregnancy|0|||
129852285|NCT03930745|467416678|FG001|Overall Study|Pregnancy|1|||
129852286|NCT03483623|467416683|FG000|Overall Study|43 complete sets achieved|1|||
129852287|NCT02770391|467416684|FG000|Overall Study|Lost to Follow-up|2|||
130064600|NCT03730194|468190213|FG002|First Stage Treatment|Protocol Violation|0|||
129852288|NCT02770391|467416684|FG000|Overall Study|Withdrawal by Subject|1|||
129852289|NCT02770391|467416684|FG000|Overall Study|Surgery delayed unevaluable|2|||
129852290|NCT02770391|467416684|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
129852291|NCT00612313|467416690|FG000|Overall Study|Withdrawal by Subject|6|||
129852292|NCT00612313|467416691|FG001|Overall Study|Withdrawal by Subject|9|||
129852293|NCT00612313|467416690|FG000|Overall Study|Lost to Follow-up|11|||
129852294|NCT00612313|467416691|FG001|Overall Study|Lost to Follow-up|4|||
129852295|NCT03403634|467416704|FG000|Overall Study|Disease progression|3|||
129852296|NCT03403634|467416704|FG000|Overall Study|Did not meet eligibility criteria|4|||
129852297|NCT01337089|467418492|FG000|Overall Study|Adverse Event|237|||
129852298|NCT01337089|467418492|FG000|Overall Study|Withdrawal by Subject|129|||
129852299|NCT01337089|467418492|FG000|Overall Study|Withdrawal by Investigator|33|||
129852300|NCT01337089|467418492|FG000|Overall Study|Met Withdrawal Criteria|3|||
129852301|NCT01337089|467418492|FG000|Overall Study|Lost to Follow-up|2|||
129852302|NCT01627249|467418495|FG000|Overall Study|Death|3|||
129852303|NCT01627249|467418496|FG001|Overall Study|Death|5|||
129852304|NCT01627249|467418497|FG002|Overall Study|Death|3|||
129852305|NCT01627249|467418495|FG000|Overall Study|Withdrawal by Subject|12|||
129905873|NCT02020616|467616435|FG005|Overall Study|Randomized in Error|0|||
129852306|NCT01627249|467418496|FG001|Overall Study|Withdrawal by Subject|6|||
129852307|NCT01627249|467418497|FG002|Overall Study|Withdrawal by Subject|9|||
129852308|NCT01627249|467418495|FG000|Overall Study|Missed Visit|1|||
129852309|NCT01627249|467418496|FG001|Overall Study|Missed Visit|1|||
129852310|NCT01627249|467418497|FG002|Overall Study|Missed Visit|0|||
129852311|NCT00966940|467418499|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
129852312|NCT00966940|467418500|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
129852313|NCT00966940|467418499|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
129852314|NCT00966940|467418500|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
129852315|NCT03455855|467418501|FG000|Overall Study|Lost to Follow-up|4|||
129852316|NCT03455855|467418502|FG001|Overall Study|Lost to Follow-up|2|||
129852317|NCT04820673|467418503|FG000|Overall Study|Adverse Event|6|||
129852318|NCT04820673|467418503|FG000|Overall Study|Due to Lack of Effectiveness|1|||
129852319|NCT04820673|467418503|FG000|Overall Study|Pregnancy|1|||
129852320|NCT04820673|467418503|FG000|Overall Study|Voluntary Withdrawal|20|||
129852321|NCT04820673|467418503|FG000|Overall Study|Lost to Follow-up|10|||
129852322|NCT00767000|467418507|FG000|54-week Study|Adverse Event|4|||
129852323|NCT00767000|467418508|FG001|54-week Study|Adverse Event|6|||
129852324|NCT00767000|467418509|FG002|54-week Study|Adverse Event|6|||
129852325|NCT00767000|467418510|FG003|54-week Study|Adverse Event|8|||
129852326|NCT00767000|467418511|FG004|54-week Study|Adverse Event|4|||
129852327|NCT00767000|467418507|FG000|54-week Study|Creaninine/creatinine clearance|2|||
129852328|NCT00767000|467418508|FG001|54-week Study|Creaninine/creatinine clearance|1|||
129852329|NCT00767000|467418509|FG002|54-week Study|Creaninine/creatinine clearance|2|||
129852330|NCT00767000|467418510|FG003|54-week Study|Creaninine/creatinine clearance|2|||
129852331|NCT00767000|467418511|FG004|54-week Study|Creaninine/creatinine clearance|4|||
129852332|NCT00767000|467418507|FG000|54-week Study|Hyperglycemia|0|||
129852333|NCT00767000|467418508|FG001|54-week Study|Hyperglycemia|0|||
129852334|NCT00767000|467418509|FG002|54-week Study|Hyperglycemia|1|||
129852335|NCT00767000|467418510|FG003|54-week Study|Hyperglycemia|0|||
129852336|NCT00767000|467418511|FG004|54-week Study|Hyperglycemia|1|||
129852337|NCT00767000|467418507|FG000|54-week Study|Hypoglycemia|0|||
129852338|NCT00767000|467418508|FG001|54-week Study|Hypoglycemia|1|||
129852339|NCT00767000|467418509|FG002|54-week Study|Hypoglycemia|0|||
129852340|NCT00767000|467418510|FG003|54-week Study|Hypoglycemia|0|||
129852341|NCT00767000|467418511|FG004|54-week Study|Hypoglycemia|0|||
129852342|NCT00767000|467418507|FG000|54-week Study|Interruption of study medication|0|||
129852343|NCT00767000|467418508|FG001|54-week Study|Interruption of study medication|0|||
129852344|NCT00767000|467418509|FG002|54-week Study|Interruption of study medication|1|||
129852345|NCT00767000|467418510|FG003|54-week Study|Interruption of study medication|0|||
129852346|NCT00767000|467418511|FG004|54-week Study|Interruption of study medication|0|||
129852347|NCT00767000|467418507|FG000|54-week Study|Lack of Efficacy|2|||
129852348|NCT00767000|467418508|FG001|54-week Study|Lack of Efficacy|0|||
129852349|NCT00767000|467418509|FG002|54-week Study|Lack of Efficacy|1|||
129852350|NCT00767000|467418510|FG003|54-week Study|Lack of Efficacy|0|||
129852351|NCT00767000|467418511|FG004|54-week Study|Lack of Efficacy|5|||
129852352|NCT00767000|467418507|FG000|54-week Study|Lost to Follow-up|4|||
129852353|NCT00767000|467418508|FG001|54-week Study|Lost to Follow-up|0|||
129852354|NCT00767000|467418509|FG002|54-week Study|Lost to Follow-up|1|||
129852355|NCT00767000|467418510|FG003|54-week Study|Lost to Follow-up|4|||
129852356|NCT00767000|467418511|FG004|54-week Study|Lost to Follow-up|2|||
129852357|NCT00767000|467418507|FG000|54-week Study|Physician Decision|4|||
129852358|NCT00767000|467418508|FG001|54-week Study|Physician Decision|0|||
129852359|NCT00767000|467418509|FG002|54-week Study|Physician Decision|1|||
129852360|NCT00767000|467418510|FG003|54-week Study|Physician Decision|1|||
129852361|NCT00767000|467418511|FG004|54-week Study|Physician Decision|1|||
129852362|NCT00767000|467418507|FG000|54-week Study|Progressive disease|0|||
129852363|NCT00767000|467418508|FG001|54-week Study|Progressive disease|0|||
129852364|NCT00767000|467418509|FG002|54-week Study|Progressive disease|1|||
129852365|NCT00767000|467418510|FG003|54-week Study|Progressive disease|0|||
129852366|NCT00767000|467418511|FG004|54-week Study|Progressive disease|0|||
129852367|NCT00767000|467418507|FG000|54-week Study|Protocol Violation|0|||
129852368|NCT00767000|467418508|FG001|54-week Study|Protocol Violation|0|||
129852369|NCT00767000|467418509|FG002|54-week Study|Protocol Violation|1|||
129852370|NCT00767000|467418510|FG003|54-week Study|Protocol Violation|2|||
129852371|NCT00767000|467418511|FG004|54-week Study|Protocol Violation|0|||
129852372|NCT00767000|467418507|FG000|54-week Study|Withdrawal by Subject|2|||
129852373|NCT00767000|467418508|FG001|54-week Study|Withdrawal by Subject|3|||
129852374|NCT00767000|467418509|FG002|54-week Study|Withdrawal by Subject|5|||
129852375|NCT00767000|467418510|FG003|54-week Study|Withdrawal by Subject|11|||
129852376|NCT00767000|467418511|FG004|54-week Study|Withdrawal by Subject|13|||
129852377|NCT00767000|467418507|FG000|54-week Study|Study terminated by sponsor|90|||
129852378|NCT00767000|467418508|FG001|54-week Study|Study terminated by sponsor|102|||
129852379|NCT00767000|467418509|FG002|54-week Study|Study terminated by sponsor|89|||
129852380|NCT00767000|467418510|FG003|54-week Study|Study terminated by sponsor|196|||
129905874|NCT02020616|467616436|FG006|Overall Study|Randomized in Error|0|||
129905875|NCT02020616|467616430|FG000|Overall Study|Lack of Efficacy|0|||
130116590|NCT03031899|468387114|FG000|Overall Study|lesion disappeared after stopping habit|1|||
130116591|NCT03740698|468387115|FG000|Overall Study|Physician Decision|0|||
130116592|NCT03740698|468387116|FG001|Overall Study|Physician Decision|1|||
130116593|NCT03740698|468387117|FG002|Overall Study|Physician Decision|1|||
129852381|NCT00767000|467418511|FG004|54-week Study|Study terminated by sponsor|194|||
129852382|NCT00767000|467418507|FG000|54-week Study|Reason not reported|0|||
129852383|NCT00767000|467418508|FG001|54-week Study|Reason not reported|0|||
129852384|NCT00767000|467418509|FG002|54-week Study|Reason not reported|0|||
129852385|NCT00767000|467418510|FG003|54-week Study|Reason not reported|1|||
129852386|NCT00767000|467418511|FG004|54-week Study|Reason not reported|0|||
129852387|NCT00767000|467418507|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
129852388|NCT00767000|467418508|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
129852389|NCT00767000|467418509|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
129852390|NCT00767000|467418510|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
129852391|NCT00767000|467418511|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
129852392|NCT02039505|467418513|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
129852393|NCT02039505|467418514|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
129852394|NCT02039505|467418515|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
129852395|NCT02039505|467418516|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852396|NCT02039505|467418517|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852397|NCT02039505|467418518|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852398|NCT02039505|467418519|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852399|NCT02039505|467418513|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
129852400|NCT02039505|467418514|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
129852401|NCT02039505|467418515|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
129852402|NCT02039505|467418516|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852403|NCT02039505|467418517|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852404|NCT02039505|467418518|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852405|NCT02039505|467418519|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852406|NCT02039505|467418513|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
129852407|NCT02039505|467418514|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852408|NCT02039505|467418515|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852409|NCT02039505|467418516|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852410|NCT02039505|467418517|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852411|NCT02039505|467418518|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852412|NCT02039505|467418519|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852413|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852414|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852415|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852416|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
129852417|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
129852418|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
129852419|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852420|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852421|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852422|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852423|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
129852424|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
129852425|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
129852426|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852427|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852428|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852429|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852430|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
129852431|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
129852432|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
129852433|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852434|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852435|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852436|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852437|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
129852438|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852439|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852440|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
130116594|NCT00094302|468387118|FG000|Overall Study|Lost to Follow-up|43|||
129905876|NCT02020616|467616431|FG001|Overall Study|Lack of Efficacy|0|||
129905877|NCT02020616|467616432|FG002|Overall Study|Lack of Efficacy|0|||
129905878|NCT02020616|467616433|FG003|Overall Study|Lack of Efficacy|0|||
129905879|NCT02020616|467616434|FG004|Overall Study|Lack of Efficacy|1|||
129905880|NCT02020616|467616435|FG005|Overall Study|Lack of Efficacy|0|||
129905881|NCT02020616|467616436|FG006|Overall Study|Lack of Efficacy|0|||
129905882|NCT02031471|467616439|FG000|24 Week Treatment Period|Adverse Event|6|||
129905883|NCT02031471|467616439|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
129905884|NCT02031471|467616439|FG000|24 Week Treatment Period|Protocol Violation|1|||
129905885|NCT02031471|467616439|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
129905886|NCT02031471|467616439|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
129905887|NCT02031471|467616439|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
129905888|NCT02031471|467616439|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
129905889|NCT00658996|467616441|FG000|First Intervention|Positive slit lamp finding|1|||
129905890|NCT00658996|467616442|FG001|First Intervention|Positive slit lamp finding|0|||
129905891|NCT00658996|467616441|FG000|First Intervention|Lack of lenses|0|||
129905892|NCT00658996|467616442|FG001|First Intervention|Lack of lenses|1|||
129905893|NCT00658996|467616441|FG000|Crossover Period|Physician Decision|1|||
129905894|NCT00658996|467616442|FG001|Crossover Period|Physician Decision|0|||
129905895|NCT00658996|467616441|FG000|Crossover Period|Ineligible|1|||
129905896|NCT00658996|467616442|FG001|Crossover Period|Ineligible|1|||
129905897|NCT00658996|467616441|FG000|Second Intervention|Developed a stye on upper lid|1|||
129905898|NCT00658996|467616442|FG001|Second Intervention|Developed a stye on upper lid|0|||
129905899|NCT00658996|467616441|FG000|Second Intervention|Positive slit lamp finding|0|||
129905900|NCT00658996|467616442|FG001|Second Intervention|Positive slit lamp finding|1|||
129905901|NCT00997386|467616443|FG000|Overall Study|Death|7|||
129905902|NCT01579916|467616445|FG000|Overall Study|Lost to Follow-up|6|||
129905903|NCT01579916|467616446|FG001|Overall Study|Lost to Follow-up|1|||
129905904|NCT01579916|467616445|FG000|Overall Study|Withdrawal by Subject|1|||
129905905|NCT01579916|467616446|FG001|Overall Study|Withdrawal by Subject|1|||
129905906|NCT01579916|467616445|FG000|Overall Study|Death|1|||
129905907|NCT01579916|467616446|FG001|Overall Study|Death|0|||
129905908|NCT02994654|467616448|FG000|Overall Study|Lost to Follow-up|1|||
129905909|NCT03351075|467617530|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
129905910|NCT03351075|467617531|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
129905911|NCT03351075|467617530|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
129905912|NCT03351075|467617531|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
130064601|NCT03730194|468190214|FG003|First Stage Treatment|Protocol Violation|0|||
130064602|NCT03730194|468190215|FG004|First Stage Treatment|Protocol Violation|0|||
130064603|NCT03730194|468190216|FG005|First Stage Treatment|Protocol Violation|0|||
130064604|NCT00115765|468190217|FG000|Overall Study|Withdrawal by Subject|22|||
130064605|NCT00115765|468190218|FG001|Overall Study|Withdrawal by Subject|53|||
130064606|NCT00115765|468190219|FG002|Overall Study|Withdrawal by Subject|76|||
130064607|NCT00115765|468190220|FG003|Overall Study|Withdrawal by Subject|15|||
129852441|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852442|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852443|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852444|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852445|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852446|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852447|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
129852448|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852449|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852450|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852451|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852452|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852453|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852454|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
129852455|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129905913|NCT03351075|467617530|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
129905914|NCT03351075|467617531|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
129905915|NCT03351075|467617530|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
129905916|NCT03351075|467617531|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
129905917|NCT03169244|467617534|FG000|Overall Study|Lost to Follow-up|1|||
129905918|NCT03169244|467617535|FG001|Overall Study|Lost to Follow-up|2|||
129905919|NCT03169244|467617534|FG000|Overall Study|Adverse Event|1|||
129905920|NCT03169244|467617535|FG001|Overall Study|Adverse Event|0|||
129905921|NCT03169244|467617534|FG000|Overall Study|Withdrawal by Subject|2|||
129905922|NCT03169244|467617535|FG001|Overall Study|Withdrawal by Subject|2|||
129905923|NCT03169244|467617534|FG000|Overall Study|Physician Decision|1|||
129905924|NCT03169244|467617535|FG001|Overall Study|Physician Decision|0|||
129852456|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852457|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852458|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852459|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852460|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852461|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
129852462|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852463|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852464|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852465|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852466|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852467|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852468|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
129852469|NCT00097591|467418520|FG000|Overall Study|Withdrawal of consent|342|||
129852470|NCT00097591|467418521|FG001|Overall Study|Withdrawal of consent|323|||
129852471|NCT00097591|467418520|FG000|Overall Study|Less than 6 months on study drug|9|||
129852472|NCT00097591|467418521|FG001|Overall Study|Less than 6 months on study drug|7|||
129852473|NCT00097591|467418520|FG000|Overall Study|Unable to attend termination visit|53|||
129852474|NCT00097591|467418521|FG001|Overall Study|Unable to attend termination visit|51|||
129852475|NCT00097591|467418520|FG000|Overall Study|Lost to follow up|6|||
129852476|NCT00097591|467418521|FG001|Overall Study|Lost to follow up|10|||
129852477|NCT00097591|467418520|FG000|Overall Study|Other|0|||
129852478|NCT00097591|467418521|FG001|Overall Study|Other|3|||
129852479|NCT00009737|467418523|FG000|Overall Study|Adverse Event|112|||
129852480|NCT00009737|467418524|FG001|Overall Study|Adverse Event|75|||
129852481|NCT00009737|467418523|FG000|Overall Study|Death|4|||
129852482|NCT00009737|467418524|FG001|Overall Study|Death|6|||
129852483|NCT00009737|467418523|FG000|Overall Study|Lack of Efficacy|17|||
129852484|NCT00009737|467418524|FG001|Overall Study|Lack of Efficacy|15|||
129852485|NCT00009737|467418523|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
129852486|NCT00009737|467418524|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
129852487|NCT00009737|467418523|FG000|Overall Study|Other Protocol Violation|1|||
129852488|NCT00009737|467418524|FG001|Overall Study|Other Protocol Violation|0|||
129852489|NCT00009737|467418523|FG000|Overall Study|Refused Treatment|15|||
129852490|NCT00009737|467418524|FG001|Overall Study|Refused Treatment|16|||
129852491|NCT00009737|467418523|FG000|Overall Study|Lost to Follow-up|1|||
129852492|NCT00009737|467418524|FG001|Overall Study|Lost to Follow-up|1|||
129852493|NCT00009737|467418523|FG000|Overall Study|Administrative/Other Reasons|7|||
129852494|NCT00009737|467418524|FG001|Overall Study|Administrative/Other Reasons|1|||
129852495|NCT04808609|467418533|FG000|Overall Study|Lost to Follow-up|0|||
129852496|NCT04808609|467418534|FG001|Overall Study|Lost to Follow-up|2|||
129852497|NCT04808609|467418533|FG000|Overall Study|Administrative Withdrawal|0|||
129852498|NCT04808609|467418534|FG001|Overall Study|Administrative Withdrawal|1|||
129852499|NCT01993719|467418536|FG000|First Drug Administration|Not treated|1|||
129852500|NCT01993719|467418537|FG001|First Drug Administration|Not treated|0|||
129852501|NCT01993719|467418538|FG002|First Drug Administration|Not treated|0|||
129852502|NCT01993719|467418539|FG003|First Drug Administration|Not treated|0|||
129852503|NCT01993719|467418540|FG004|First Drug Administration|Not treated|0|||
129852504|NCT04382326|467418546|FG000|Overall Study|Adverse Event, not serious|1|||
129852505|NCT04382326|467418547|FG001|Overall Study|Adverse Event, not serious|2|||
129852506|NCT04382326|467418546|FG000|Overall Study|Other|1|||
129852507|NCT04382326|467418547|FG001|Overall Study|Other|0|||
129852508|NCT04382326|467418546|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
129852509|NCT04382326|467418547|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
129852510|NCT04382326|467418546|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
129852511|NCT04382326|467418547|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
129852512|NCT04382326|467418546|FG000|Overall Study|Protocol Violation|29|||
129852513|NCT04382326|467418547|FG001|Overall Study|Protocol Violation|23|||
129852514|NCT04382326|467418546|FG000|Overall Study|Physician Decision|0|||
129852515|NCT04382326|467418547|FG001|Overall Study|Physician Decision|1|||
129852516|NCT04382326|467418546|FG000|Overall Study|Lost to Follow-up|48|||
129852517|NCT04382326|467418547|FG001|Overall Study|Lost to Follow-up|63|||
129852518|NCT04382326|467418546|FG000|Overall Study|Adverse Event, non-fatal|1|||
129852519|NCT04382326|467418547|FG001|Overall Study|Adverse Event, non-fatal|1|||
129852520|NCT01557946|467418550|FG000|Overall Study|Adverse Event|3|||
129852521|NCT01557946|467418551|FG001|Overall Study|Adverse Event|0|||
129852522|NCT02352493|467418553|FG000|Overall Study|Pregnancy|0|||
129852523|NCT02352493|467418554|FG001|Overall Study|Pregnancy|0|||
129852524|NCT02352493|467418555|FG002|Overall Study|Pregnancy|0|||
129852525|NCT02352493|467418556|FG003|Overall Study|Pregnancy|0|||
129852526|NCT02352493|467418557|FG004|Overall Study|Pregnancy|0|||
129852527|NCT02352493|467418558|FG005|Overall Study|Pregnancy|0|||
129852528|NCT02352493|467418559|FG006|Overall Study|Pregnancy|1|||
129852529|NCT02352493|467418560|FG007|Overall Study|Pregnancy|0|||
129852530|NCT02352493|467418561|FG008|Overall Study|Pregnancy|1|||
129852531|NCT02352493|467418562|FG009|Overall Study|Pregnancy|0|||
129852532|NCT02352493|467418563|FG010|Overall Study|Pregnancy|0|||
129852533|NCT02352493|467418564|FG011|Overall Study|Pregnancy|0|||
129852534|NCT02352493|467418565|FG012|Overall Study|Pregnancy|0|||
129852535|NCT02352493|467418566|FG013|Overall Study|Pregnancy|0|||
129852536|NCT02352493|467418567|FG014|Overall Study|Pregnancy|0|||
129852537|NCT02352493|467418568|FG015|Overall Study|Pregnancy|0|||
129852538|NCT02352493|467418569|FG016|Overall Study|Pregnancy|0|||
129852539|NCT02352493|467418570|FG017|Overall Study|Pregnancy|0|||
129852540|NCT02352493|467418553|FG000|Overall Study|Withdrawal by Subject|0|||
129852541|NCT02352493|467418554|FG001|Overall Study|Withdrawal by Subject|0|||
129852542|NCT02352493|467418555|FG002|Overall Study|Withdrawal by Subject|0|||
129852543|NCT02352493|467418556|FG003|Overall Study|Withdrawal by Subject|0|||
129852544|NCT02352493|467418557|FG004|Overall Study|Withdrawal by Subject|0|||
129852545|NCT02352493|467418558|FG005|Overall Study|Withdrawal by Subject|0|||
129852546|NCT02352493|467418559|FG006|Overall Study|Withdrawal by Subject|0|||
129852547|NCT02352493|467418560|FG007|Overall Study|Withdrawal by Subject|0|||
129852548|NCT02352493|467418561|FG008|Overall Study|Withdrawal by Subject|1|||
129852549|NCT02352493|467418562|FG009|Overall Study|Withdrawal by Subject|0|||
129852550|NCT02352493|467418563|FG010|Overall Study|Withdrawal by Subject|0|||
129852551|NCT02352493|467418564|FG011|Overall Study|Withdrawal by Subject|0|||
129852552|NCT02352493|467418565|FG012|Overall Study|Withdrawal by Subject|0|||
129852553|NCT02352493|467418566|FG013|Overall Study|Withdrawal by Subject|0|||
129852554|NCT02352493|467418567|FG014|Overall Study|Withdrawal by Subject|1|||
129852555|NCT02352493|467418568|FG015|Overall Study|Withdrawal by Subject|0|||
129852556|NCT02352493|467418569|FG016|Overall Study|Withdrawal by Subject|0|||
129852557|NCT02352493|467418570|FG017|Overall Study|Withdrawal by Subject|0|||
129852558|NCT02352493|467418553|FG000|Overall Study|Lost to Follow-up|0|||
129852559|NCT02352493|467418554|FG001|Overall Study|Lost to Follow-up|0|||
129852560|NCT02352493|467418555|FG002|Overall Study|Lost to Follow-up|0|||
129852561|NCT02352493|467418556|FG003|Overall Study|Lost to Follow-up|0|||
129852562|NCT02352493|467418557|FG004|Overall Study|Lost to Follow-up|0|||
129852563|NCT02352493|467418558|FG005|Overall Study|Lost to Follow-up|0|||
129852564|NCT02352493|467418559|FG006|Overall Study|Lost to Follow-up|0|||
129852565|NCT02352493|467418560|FG007|Overall Study|Lost to Follow-up|0|||
129852566|NCT02352493|467418561|FG008|Overall Study|Lost to Follow-up|0|||
129852567|NCT02352493|467418562|FG009|Overall Study|Lost to Follow-up|1|||
129852568|NCT02352493|467418563|FG010|Overall Study|Lost to Follow-up|0|||
129852569|NCT02352493|467418564|FG011|Overall Study|Lost to Follow-up|0|||
129852570|NCT02352493|467418565|FG012|Overall Study|Lost to Follow-up|1|||
129852571|NCT02352493|467418566|FG013|Overall Study|Lost to Follow-up|2|||
129852572|NCT02352493|467418567|FG014|Overall Study|Lost to Follow-up|0|||
129852573|NCT02352493|467418568|FG015|Overall Study|Lost to Follow-up|0|||
129852574|NCT02352493|467418569|FG016|Overall Study|Lost to Follow-up|0|||
129852575|NCT02352493|467418570|FG017|Overall Study|Lost to Follow-up|0|||
129852576|NCT01465334|467418571|FG000|Overall Study|Disease Progression|1|||
129852577|NCT01465334|467418572|FG001|Overall Study|Disease Progression|0|||
129852578|NCT01465334|467418571|FG000|Overall Study|Adverse Event|1|||
129852579|NCT01465334|467418572|FG001|Overall Study|Adverse Event|0|||
129852580|NCT01465334|467418571|FG000|Overall Study|Richter's transformation|0|||
129852581|NCT01465334|467418572|FG001|Overall Study|Richter's transformation|3|||
129852582|NCT01465334|467418571|FG000|Overall Study|Refractory Disease|0|||
129852583|NCT01465334|467418572|FG001|Overall Study|Refractory Disease|3|||
129852584|NCT00572572|467418573|FG000|Overall Study|Withdrawal by Subject|3|||
129852585|NCT00572572|467418574|FG001|Overall Study|Withdrawal by Subject|6|||
129852586|NCT01831089|467418575|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
129852587|NCT01831089|467418576|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
129852588|NCT01831089|467418577|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
129852589|NCT01831089|467418578|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
129852590|NCT01831089|467418579|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
129852591|NCT01831089|467418580|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
129852592|NCT01831089|467418575|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
129852593|NCT01831089|467418576|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
129852594|NCT01831089|467418577|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
129852595|NCT01831089|467418578|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
129852596|NCT01831089|467418579|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
129852597|NCT01831089|467418580|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
129852598|NCT01831089|467418575|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
130064608|NCT00115765|468190217|FG000|Overall Study|Physician Decision|4|||
129852599|NCT01831089|467418576|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
129852600|NCT01831089|467418577|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852601|NCT01831089|467418578|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852602|NCT01831089|467418579|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852603|NCT01831089|467418580|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852604|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
129852605|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
129905925|NCT04603924|467617536|FG000|Overall Study|Not Dosed|2|||
129905926|NCT04603924|467617537|FG001|Overall Study|Not Dosed|1|||
129905927|NCT04603924|467617536|FG000|Overall Study|Withdrawal by Subject|6|||
129905928|NCT04603924|467617537|FG001|Overall Study|Withdrawal by Subject|6|||
129905929|NCT04603924|467617536|FG000|Overall Study|Adverse Event|2|||
129905930|NCT04603924|467617537|FG001|Overall Study|Adverse Event|2|||
129905931|NCT02139046|467617540|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129905932|NCT02139046|467617541|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
129905933|NCT02139046|467617542|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
129905934|NCT02139046|467617543|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
129905935|NCT02139046|467617544|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
129905936|NCT02139046|467617540|FG000|Overall Study|Major Protocol Deviation|9|||
129905937|NCT02139046|467617541|FG001|Overall Study|Major Protocol Deviation|10|||
129905938|NCT02139046|467617542|FG002|Overall Study|Major Protocol Deviation|16|||
129905939|NCT02139046|467617543|FG003|Overall Study|Major Protocol Deviation|12|||
129905940|NCT02139046|467617544|FG004|Overall Study|Major Protocol Deviation|6|||
129905941|NCT02139046|467617540|FG000|Overall Study|Lost to Follow-up|13|||
129905942|NCT02139046|467617541|FG001|Overall Study|Lost to Follow-up|16|||
129905943|NCT02139046|467617542|FG002|Overall Study|Lost to Follow-up|16|||
129905944|NCT02139046|467617543|FG003|Overall Study|Lost to Follow-up|18|||
129905945|NCT02139046|467617544|FG004|Overall Study|Lost to Follow-up|13|||
129905946|NCT02139046|467617540|FG000|Overall Study|Voluntary Withdrawal|20|||
129905947|NCT02139046|467617541|FG001|Overall Study|Voluntary Withdrawal|8|||
129905948|NCT02139046|467617542|FG002|Overall Study|Voluntary Withdrawal|10|||
129905949|NCT02139046|467617543|FG003|Overall Study|Voluntary Withdrawal|15|||
129905950|NCT02139046|467617544|FG004|Overall Study|Voluntary Withdrawal|16|||
129905951|NCT02139046|467617540|FG000|Overall Study|Lack of Efficacy|0|||
129905952|NCT02139046|467617541|FG001|Overall Study|Lack of Efficacy|1|||
129905953|NCT02139046|467617542|FG002|Overall Study|Lack of Efficacy|2|||
129852606|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
129852607|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
129852608|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
129852609|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
129852610|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852611|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852612|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
129852613|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852614|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852615|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852616|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
129852617|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
129852618|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
129852619|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
129852620|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
129852621|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
129852622|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Global end of study|0|||
129852623|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Global end of study|0|||
129852624|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Global end of study|1|||
129852625|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Global end of study|0|||
129852626|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Global end of study|0|||
129852627|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Global end of study|0|||
129852628|NCT01831089|467418575|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
129852629|NCT01831089|467418576|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
129852630|NCT01831089|467418577|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
129852631|NCT01831089|467418578|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
129852632|NCT01831089|467418579|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
129852633|NCT01831089|467418580|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
129852634|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
129852635|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
129852636|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
129905954|NCT02139046|467617543|FG003|Overall Study|Lack of Efficacy|1|||
129905955|NCT02139046|467617544|FG004|Overall Study|Lack of Efficacy|2|||
129905956|NCT02139046|467617540|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
129905957|NCT02139046|467617541|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
129905958|NCT02139046|467617542|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
129905959|NCT02139046|467617543|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
129905960|NCT02139046|467617544|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
129905961|NCT02139046|467617540|FG000|Overall Study|Other Miscellaneous Reasons|10|||
129905962|NCT02139046|467617541|FG001|Overall Study|Other Miscellaneous Reasons|9|||
129905963|NCT02139046|467617542|FG002|Overall Study|Other Miscellaneous Reasons|4|||
129905964|NCT02139046|467617543|FG003|Overall Study|Other Miscellaneous Reasons|9|||
129905965|NCT02139046|467617544|FG004|Overall Study|Other Miscellaneous Reasons|12|||
129905966|NCT03557008|467617545|FG000|Overall Study|Withdrawal by Subject|2|||
129905967|NCT03557008|467617546|FG001|Overall Study|Withdrawal by Subject|2|||
129852637|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
129852638|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
129852639|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
129852640|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852641|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852642|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852643|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852644|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
129852645|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852646|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Death|0|||
129852647|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Death|0|||
129852648|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Death|0|||
129852649|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Death|0|||
129852650|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Death|1|||
129852651|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Death|0|||
129852652|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Global end of study|0|||
129852653|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Global end of study|0|||
129852654|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Global end of study|0|||
129852655|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Global end of study|0|||
129852656|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Global end of study|2|||
129852657|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Global end of study|0|||
129852658|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852659|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852660|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852661|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852662|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
129852663|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852664|NCT01831089|467418575|FG000|Cohort B: Arm B|Progressive disease|0|||
129852665|NCT01831089|467418576|FG001|Cohort B: Arm B|Progressive disease|0|||
129852666|NCT01831089|467418577|FG002|Cohort B: Arm B|Progressive disease|0|||
129852667|NCT01831089|467418578|FG003|Cohort B: Arm B|Progressive disease|0|||
129852668|NCT01831089|467418579|FG004|Cohort B: Arm B|Progressive disease|0|||
129852669|NCT01831089|467418580|FG005|Cohort B: Arm B|Progressive disease|8|||
129852670|NCT01831089|467418575|FG000|Cohort B: Arm B|Physician Decision|0|||
129852671|NCT01831089|467418576|FG001|Cohort B: Arm B|Physician Decision|0|||
129852672|NCT01831089|467418577|FG002|Cohort B: Arm B|Physician Decision|0|||
129852673|NCT01831089|467418578|FG003|Cohort B: Arm B|Physician Decision|0|||
129852674|NCT01831089|467418579|FG004|Cohort B: Arm B|Physician Decision|0|||
129852675|NCT01831089|467418580|FG005|Cohort B: Arm B|Physician Decision|2|||
129852676|NCT01831089|467418575|FG000|Cohort B: Arm B|Never treated|0|||
129852677|NCT01831089|467418576|FG001|Cohort B: Arm B|Never treated|0|||
129852678|NCT01831089|467418577|FG002|Cohort B: Arm B|Never treated|0|||
129852679|NCT01831089|467418578|FG003|Cohort B: Arm B|Never treated|0|||
129852680|NCT01831089|467418579|FG004|Cohort B: Arm B|Never treated|0|||
129852681|NCT01831089|467418580|FG005|Cohort B: Arm B|Never treated|2|||
129852682|NCT01831089|467418575|FG000|Cohort B: Arm B|Adverse Event|0|||
129852683|NCT01831089|467418576|FG001|Cohort B: Arm B|Adverse Event|0|||
129852684|NCT01831089|467418577|FG002|Cohort B: Arm B|Adverse Event|0|||
129852685|NCT01831089|467418578|FG003|Cohort B: Arm B|Adverse Event|0|||
129852686|NCT01831089|467418579|FG004|Cohort B: Arm B|Adverse Event|0|||
129852687|NCT01831089|467418580|FG005|Cohort B: Arm B|Adverse Event|1|||
129852688|NCT01831089|467418575|FG000|Cohort B: Arm B|Global end of study|0|||
129852689|NCT01831089|467418576|FG001|Cohort B: Arm B|Global end of study|0|||
129852690|NCT01831089|467418577|FG002|Cohort B: Arm B|Global end of study|0|||
129852691|NCT01831089|467418578|FG003|Cohort B: Arm B|Global end of study|0|||
129852692|NCT01831089|467418579|FG004|Cohort B: Arm B|Global end of study|0|||
129852693|NCT01831089|467418580|FG005|Cohort B: Arm B|Global end of study|1|||
129852694|NCT02114892|467418586|FG000|Overall Study|Lost to Follow-up|1|||
129852695|NCT02114892|467418587|FG001|Overall Study|Lost to Follow-up|2|||
129852696|NCT03525834|467418590|FG000|Overall Study|Progressive disease|1|||
129852697|NCT01751568|467418595|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
129852698|NCT01751568|467418596|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
129852699|NCT01751568|467418597|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
129852700|NCT02660944|467418606|FG000|Overall Study|Adverse Event|3|||
129852701|NCT02660944|467418607|FG001|Overall Study|Adverse Event|4|||
129852702|NCT02660944|467418606|FG000|Overall Study|Physician Decision|3|||
129852703|NCT02660944|467418607|FG001|Overall Study|Physician Decision|1|||
129852704|NCT02660944|467418606|FG000|Overall Study|Withdrawal by Subject|5|||
129852705|NCT02660944|467418607|FG001|Overall Study|Withdrawal by Subject|3|||
129852706|NCT02660944|467418606|FG000|Overall Study|Lost to Follow-up|4|||
129852707|NCT02660944|467418607|FG001|Overall Study|Lost to Follow-up|1|||
129852708|NCT02660944|467418606|FG000|Overall Study|Subject schedule|0|||
129852709|NCT02660944|467418607|FG001|Overall Study|Subject schedule|1|||
130064609|NCT00115765|468190218|FG001|Overall Study|Physician Decision|15|||
129852710|NCT02660944|467418606|FG000|Overall Study|Exclusion criteria met|2|||
129852711|NCT02660944|467418607|FG001|Overall Study|Exclusion criteria met|0|||
129852712|NCT03586999|467418608|FG000|Overall Study|Lack of Efficacy|2|||
129852713|NCT04096560|467418609|FG000|Overall Study|Reason not Specified|1|||
129852714|NCT04096560|467418610|FG001|Overall Study|Reason not Specified|0|||
129852715|NCT04096560|467418611|FG002|Overall Study|Reason not Specified|0|||
129852716|NCT04096560|467418612|FG003|Overall Study|Reason not Specified|0|||
129852717|NCT04096560|467418613|FG004|Overall Study|Reason not Specified|1|||
129852718|NCT04096560|467418614|FG005|Overall Study|Reason not Specified|1|||
129852719|NCT04096560|467418615|FG006|Overall Study|Reason not Specified|1|||
129852720|NCT04096560|467418616|FG007|Overall Study|Reason not Specified|0|||
129852721|NCT04096560|467418609|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852722|NCT04096560|467418610|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852723|NCT04096560|467418611|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852724|NCT04096560|467418612|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852725|NCT04096560|467418613|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852726|NCT04096560|467418614|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
129852727|NCT04096560|467418615|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
129852728|NCT04096560|467418616|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852729|NCT04096560|467418609|FG000|Overall Study|Study Terminated by Sponsor|0|||
129852730|NCT04096560|467418610|FG001|Overall Study|Study Terminated by Sponsor|0|||
129852731|NCT04096560|467418611|FG002|Overall Study|Study Terminated by Sponsor|0|||
129852732|NCT04096560|467418612|FG003|Overall Study|Study Terminated by Sponsor|5|||
129852733|NCT04096560|467418613|FG004|Overall Study|Study Terminated by Sponsor|6|||
129852734|NCT04096560|467418614|FG005|Overall Study|Study Terminated by Sponsor|4|||
129852735|NCT04096560|467418615|FG006|Overall Study|Study Terminated by Sponsor|6|||
129852736|NCT04096560|467418616|FG007|Overall Study|Study Terminated by Sponsor|1|||
129852737|NCT04096560|467418609|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852738|NCT04096560|467418610|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852739|NCT04096560|467418611|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852740|NCT04096560|467418612|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852741|NCT04096560|467418613|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852742|NCT04096560|467418614|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852743|NCT04096560|467418615|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852744|NCT04096560|467418616|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
129852745|NCT01485861|467418617|FG000|Phase Ib|Death|1|||
129852746|NCT01485861|467418618|FG001|Phase Ib|Death|0|||
129852747|NCT01485861|467418619|FG002|Phase Ib|Death|0|||
129852748|NCT01485861|467418620|FG003|Phase Ib|Death|0|||
129852749|NCT01485861|467418621|FG004|Phase Ib|Death|0|||
129852750|NCT01485861|467418622|FG005|Phase Ib|Death|0|||
129852751|NCT01485861|467418617|FG000|Phase Ib|Physician Decision|1|||
129852752|NCT01485861|467418618|FG001|Phase Ib|Physician Decision|1|||
129852753|NCT01485861|467418619|FG002|Phase Ib|Physician Decision|0|||
129852754|NCT01485861|467418620|FG003|Phase Ib|Physician Decision|0|||
129852755|NCT01485861|467418621|FG004|Phase Ib|Physician Decision|0|||
129852756|NCT01485861|467418622|FG005|Phase Ib|Physician Decision|0|||
129852757|NCT01485861|467418617|FG000|Phase Ib|Adverse Event|0|||
129852758|NCT01485861|467418618|FG001|Phase Ib|Adverse Event|4|||
129852759|NCT01485861|467418619|FG002|Phase Ib|Adverse Event|0|||
129852760|NCT01485861|467418620|FG003|Phase Ib|Adverse Event|0|||
129852761|NCT01485861|467418621|FG004|Phase Ib|Adverse Event|0|||
129852762|NCT01485861|467418622|FG005|Phase Ib|Adverse Event|0|||
129852763|NCT01485861|467418617|FG000|Phase Ib|Progression of disease|5|||
129852764|NCT01485861|467418618|FG001|Phase Ib|Progression of disease|0|||
129852765|NCT01485861|467418619|FG002|Phase Ib|Progression of disease|0|||
129852766|NCT01485861|467418620|FG003|Phase Ib|Progression of disease|0|||
129852767|NCT01485861|467418621|FG004|Phase Ib|Progression of disease|0|||
129852768|NCT01485861|467418622|FG005|Phase Ib|Progression of disease|0|||
129852769|NCT01485861|467418617|FG000|Phase Ib|Other|3|||
129852770|NCT01485861|467418618|FG001|Phase Ib|Other|0|||
129852771|NCT01485861|467418619|FG002|Phase Ib|Other|0|||
129852772|NCT01485861|467418620|FG003|Phase Ib|Other|0|||
129852773|NCT01485861|467418621|FG004|Phase Ib|Other|0|||
129852774|NCT01485861|467418622|FG005|Phase Ib|Other|0|||
130064610|NCT00115765|468190219|FG002|Overall Study|Physician Decision|18|||
129852775|NCT01485861|467418617|FG000|Phase Ib|Withdrawal by Subject|4|||
129852776|NCT01485861|467418618|FG001|Phase Ib|Withdrawal by Subject|1|||
129852777|NCT01485861|467418619|FG002|Phase Ib|Withdrawal by Subject|0|||
129852778|NCT01485861|467418620|FG003|Phase Ib|Withdrawal by Subject|0|||
129852779|NCT01485861|467418621|FG004|Phase Ib|Withdrawal by Subject|0|||
129852780|NCT01485861|467418622|FG005|Phase Ib|Withdrawal by Subject|0|||
129852781|NCT01485861|467418617|FG000|Phase II|Death|0|||
129852782|NCT01485861|467418618|FG001|Phase II|Death|0|||
129852783|NCT01485861|467418619|FG002|Phase II|Death|67|||
129852784|NCT01485861|467418620|FG003|Phase II|Death|71|||
129852785|NCT01485861|467418621|FG004|Phase II|Death|68|||
129852786|NCT01485861|467418622|FG005|Phase II|Death|0|||
129905968|NCT03557008|467617545|FG000|Overall Study|Early termination from study|3|||
129905969|NCT03557008|467617546|FG001|Overall Study|Early termination from study|1|||
129905970|NCT01113931|467617548|FG000|Overall Study|Adverse Event|2|||
129905971|NCT01113931|467617549|FG001|Overall Study|Adverse Event|2|||
129905972|NCT01113931|467617548|FG000|Overall Study|Physician Decision|0|||
129905973|NCT01113931|467617549|FG001|Overall Study|Physician Decision|2|||
129905974|NCT01113931|467617548|FG000|Overall Study|Lost to Follow-up|12|||
129905975|NCT01113931|467617549|FG001|Overall Study|Lost to Follow-up|9|||
129905976|NCT01113931|467617548|FG000|Overall Study|Various|2|||
129905977|NCT01113931|467617549|FG001|Overall Study|Various|4|||
129905978|NCT01113931|467617548|FG000|Overall Study|Withdrawal by Subject|3|||
129905979|NCT01113931|467617549|FG001|Overall Study|Withdrawal by Subject|0|||
129905980|NCT03959241|467617551|FG000|Overall Study|Withdrawal by Subject|7|||
129905981|NCT03959241|467617552|FG001|Overall Study|Withdrawal by Subject|8|||
129905982|NCT03959241|467617551|FG000|Overall Study|Lost to Follow-up|1|||
129905983|NCT03959241|467617552|FG001|Overall Study|Lost to Follow-up|0|||
129905984|NCT03959241|467617551|FG000|Overall Study|Move to Hospice Care|1|||
129905985|NCT03959241|467617552|FG001|Overall Study|Move to Hospice Care|0|||
129905986|NCT03959241|467617551|FG000|Overall Study|Screen Failure|1|||
129905987|NCT03959241|467617552|FG001|Overall Study|Screen Failure|0|||
129905988|NCT03959241|467617551|FG000|Overall Study|Disease Relapse|0|||
129905989|NCT03959241|467617552|FG001|Overall Study|Disease Relapse|1|||
129905990|NCT03959241|467617551|FG000|Overall Study|Off Study|1|||
129905991|NCT03959241|467617552|FG001|Overall Study|Off Study|0|||
129905992|NCT00346151|467617553|FG000|Overall Study|Withdrawal by Subject|3|||
129905993|NCT00545077|467617561|FG000|Overall Study|Treatment not received|5|||
129905994|NCT00545077|467617562|FG001|Overall Study|Treatment not received|1|||
129905995|NCT00545077|467617561|FG000|Overall Study|Disease Progression|131|||
129905996|NCT00545077|467617562|FG001|Overall Study|Disease Progression|98|||
129905997|NCT00545077|467617561|FG000|Overall Study|Withdrawal by Subject|3|||
129905998|NCT00545077|467617562|FG001|Overall Study|Withdrawal by Subject|14|||
129905999|NCT00545077|467617561|FG000|Overall Study|Physician Decision|6|||
129906000|NCT00545077|467617562|FG001|Overall Study|Physician Decision|3|||
129906001|NCT00545077|467617561|FG000|Overall Study|Lost to Follow-up|2|||
129906002|NCT00545077|467617562|FG001|Overall Study|Lost to Follow-up|0|||
129906003|NCT00545077|467617561|FG000|Overall Study|Protocol Violation|1|||
129906004|NCT00545077|467617562|FG001|Overall Study|Protocol Violation|0|||
129906005|NCT00545077|467617561|FG000|Overall Study|Adverse Event|0|||
129906006|NCT00545077|467617562|FG001|Overall Study|Adverse Event|31|||
129906007|NCT00545077|467617561|FG000|Overall Study|Death|0|||
129906008|NCT00545077|467617562|FG001|Overall Study|Death|8|||
129906009|NCT02202499|467617563|FG000|Overall Study|Cancer diagnosis|0|||
129906010|NCT02202499|467617564|FG001|Overall Study|Cancer diagnosis|0|||
129906011|NCT02202499|467617565|FG002|Overall Study|Cancer diagnosis|1|||
129906012|NCT02202499|467617563|FG000|Overall Study|Moved from area|0|||
129906013|NCT02202499|467617564|FG001|Overall Study|Moved from area|0|||
129906014|NCT02202499|467617565|FG002|Overall Study|Moved from area|1|||
129906015|NCT02202499|467617563|FG000|Overall Study|Declined before randomization|1|||
129906016|NCT02202499|467617564|FG001|Overall Study|Declined before randomization|0|||
129906017|NCT02202499|467617565|FG002|Overall Study|Declined before randomization|0|||
129906018|NCT02202499|467617563|FG000|Overall Study|Auto accident|1|||
129906019|NCT02202499|467617564|FG001|Overall Study|Auto accident|0|||
129906020|NCT02202499|467617565|FG002|Overall Study|Auto accident|0|||
129906021|NCT00535145|467617567|FG000|Phase I|Adverse Event|3|||
129906022|NCT00535145|467617567|FG000|Phase I|Lost to Follow-up|7|||
129906023|NCT00535145|467617567|FG000|Phase I|Withdrawal by Subject|6|||
129906024|NCT00535145|467617567|FG000|Phase I|(eligibility)|8|||
129906025|NCT00535145|467617567|FG000|Phase I|(protocol violation)|1|||
129906026|NCT00535145|467617567|FG000|Phase I|(PI decision)|1|||
129906027|NCT00535145|467617567|FG000|Phase I|(diagnosis)|3|||
129906028|NCT00535145|467617567|FG000|Phase II|Adverse Event|2|||
129906029|NCT00535145|467617567|FG000|Phase II|Lack of Efficacy|1|||
129906030|NCT00535145|467617567|FG000|Phase II|Lost to Follow-up|5|||
129906031|NCT00535145|467617567|FG000|Phase II|Withdrawal by Subject|5|||
129906032|NCT00535145|467617567|FG000|Phase II|Subject non-compliance|2|||
129906033|NCT03260140|467617568|FG000|Overall Study|Death|4|||
129906034|NCT03260140|467617569|FG001|Overall Study|Death|1|||
129906035|NCT03260140|467617568|FG000|Overall Study|Withdrawal by Subject|1|||
129906036|NCT03260140|467617569|FG001|Overall Study|Withdrawal by Subject|4|||
129906037|NCT01692938|467617573|FG000|Overall Study|Protocol Deviation|1|||
129906038|NCT01692938|467617574|FG001|Overall Study|Protocol Deviation|1|||
129906039|NCT01692938|467617573|FG000|Overall Study|Study completed prior to site completion|3|||
129906040|NCT01692938|467617574|FG001|Overall Study|Study completed prior to site completion|3|||
129906041|NCT02423291|467617576|FG000|Overall Study|Lack of Efficacy|14|||
129906042|NCT02423291|467617576|FG000|Overall Study|Adverse Event|1|||
129906043|NCT05283395|467617578|FG000|Overall Study|Adverse Event|4|||
129906044|NCT05283395|467617579|FG001|Overall Study|Adverse Event|4|||
129906045|NCT05283395|467617580|FG002|Overall Study|Adverse Event|0|||
129906046|NCT05283395|467617578|FG000|Overall Study|Patient Lost to Follow-Up|0|||
129906047|NCT05283395|467617579|FG001|Overall Study|Patient Lost to Follow-Up|0|||
129906048|NCT05283395|467617580|FG002|Overall Study|Patient Lost to Follow-Up|1|||
129906049|NCT05283395|467617578|FG000|Overall Study|Patient Withdrawal|2|||
129906050|NCT05283395|467617579|FG001|Overall Study|Patient Withdrawal|4|||
129906051|NCT05283395|467617580|FG002|Overall Study|Patient Withdrawal|2|||
129906052|NCT05283395|467617578|FG000|Overall Study|Investigator Decision|1|||
129906053|NCT05283395|467617579|FG001|Overall Study|Investigator Decision|0|||
129906054|NCT05283395|467617580|FG002|Overall Study|Investigator Decision|1|||
129906055|NCT05283395|467617578|FG000|Overall Study|Enrolled in error|0|||
129906056|NCT05283395|467617579|FG001|Overall Study|Enrolled in error|0|||
129906057|NCT05283395|467617580|FG002|Overall Study|Enrolled in error|1|||
129906058|NCT00424645|467617584|FG000|Overall Study|Death|1|||
129906059|NCT00424645|467617585|FG001|Overall Study|Death|0|||
129906060|NCT00959946|467617588|FG000|Overall Study|Adverse Event|0|||
129906061|NCT00959946|467617589|FG001|Overall Study|Adverse Event|0|||
129906062|NCT00959946|467617590|FG002|Overall Study|Adverse Event|2|||
129906063|NCT00959946|467617591|FG003|Overall Study|Adverse Event|1|||
129906064|NCT00959946|467617592|FG004|Overall Study|Adverse Event|0|||
129906065|NCT00959946|467617593|FG005|Overall Study|Adverse Event|1|||
129906066|NCT00959946|467617594|FG006|Overall Study|Adverse Event|0|||
129906067|NCT00959946|467617595|FG007|Overall Study|Adverse Event|0|||
129906068|NCT00959946|467617588|FG000|Overall Study|Death|0|||
129906069|NCT00959946|467617589|FG001|Overall Study|Death|0|||
129906070|NCT00959946|467617590|FG002|Overall Study|Death|0|||
129906071|NCT00959946|467617591|FG003|Overall Study|Death|0|||
129906072|NCT00959946|467617592|FG004|Overall Study|Death|0|||
129906073|NCT00959946|467617593|FG005|Overall Study|Death|1|||
129906074|NCT00959946|467617594|FG006|Overall Study|Death|0|||
129906075|NCT00959946|467617595|FG007|Overall Study|Death|0|||
129906076|NCT00959946|467617588|FG000|Overall Study|Disease Progression|2|||
129906077|NCT00959946|467617589|FG001|Overall Study|Disease Progression|4|||
129906078|NCT00959946|467617590|FG002|Overall Study|Disease Progression|2|||
129906079|NCT00959946|467617591|FG003|Overall Study|Disease Progression|4|||
129906080|NCT00959946|467617592|FG004|Overall Study|Disease Progression|4|||
129906081|NCT00959946|467617593|FG005|Overall Study|Disease Progression|6|||
129906082|NCT00959946|467617594|FG006|Overall Study|Disease Progression|2|||
129906083|NCT00959946|467617595|FG007|Overall Study|Disease Progression|2|||
129906084|NCT00959946|467617588|FG000|Overall Study|Withdrawal by Subject|0|||
129906085|NCT00959946|467617589|FG001|Overall Study|Withdrawal by Subject|0|||
129906086|NCT00959946|467617590|FG002|Overall Study|Withdrawal by Subject|0|||
129906087|NCT00959946|467617591|FG003|Overall Study|Withdrawal by Subject|0|||
129906088|NCT00959946|467617592|FG004|Overall Study|Withdrawal by Subject|0|||
129906089|NCT00959946|467617593|FG005|Overall Study|Withdrawal by Subject|1|||
129906090|NCT00959946|467617594|FG006|Overall Study|Withdrawal by Subject|0|||
129906091|NCT00959946|467617595|FG007|Overall Study|Withdrawal by Subject|0|||
129906092|NCT02115139|467617598|FG000|Overall Study|Protocol Violation|1|||
129906093|NCT02115139|467617598|FG000|Overall Study|treatment discontinuation|6|||
129906094|NCT01909778|467617599|FG000|Overall Study|failed screening|1|||
129906095|NCT02471755|467617601|FG000|Overall Study|Withdrawal by Subject|1|||
129906096|NCT02471755|467617602|FG001|Overall Study|Withdrawal by Subject|0|||
129906097|NCT02471755|467617601|FG000|Overall Study|Lost to Follow-up|0|||
129906098|NCT02471755|467617602|FG001|Overall Study|Lost to Follow-up|1|||
129906099|NCT04740164|467617603|FG000|Overall Study|Lack of Efficacy|4|||
129906100|NCT04740164|467617604|FG001|Overall Study|Lack of Efficacy|0|||
129906101|NCT04740164|467617603|FG000|Overall Study|Physician Decision|3|||
129906102|NCT04740164|467617604|FG001|Overall Study|Physician Decision|3|||
129906103|NCT04177394|467617605|FG000|Overall Study|Death|16|||
129906104|NCT04177394|467617605|FG000|Overall Study|Withdrawal by Subject|19|||
129906105|NCT04177394|467617605|FG000|Overall Study|Missed visits|61|||
129906106|NCT04177394|467617605|FG000|Overall Study|Expected Visits|15|||
129906107|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
129906108|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
129906109|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
129906110|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906111|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906112|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906113|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906114|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906115|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906116|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906117|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906118|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906119|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
129906120|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
129906121|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
129906122|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
129906123|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
129906124|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
129906125|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
129906126|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
129906127|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
129906128|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
129906129|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
129906130|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
129906131|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
129906132|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906133|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906134|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906135|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906136|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906137|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906138|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906139|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906140|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906141|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906142|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906143|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906144|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906145|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
129906146|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906147|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906148|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906149|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906150|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906151|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906152|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906153|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906154|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906155|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
129906156|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
129906157|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
129906158|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
129852787|NCT01485861|467418617|FG000|Phase II|Progression of Disease|0|||
129852788|NCT01485861|467418618|FG001|Phase II|Progression of Disease|0|||
129852789|NCT01485861|467418619|FG002|Phase II|Progression of Disease|1|||
129852790|NCT01485861|467418620|FG003|Phase II|Progression of Disease|0|||
129852791|NCT01485861|467418621|FG004|Phase II|Progression of Disease|0|||
129852792|NCT01485861|467418622|FG005|Phase II|Progression of Disease|0|||
129852793|NCT01485861|467418617|FG000|Phase II|Other|0|||
129852794|NCT01485861|467418618|FG001|Phase II|Other|0|||
129852795|NCT01485861|467418619|FG002|Phase II|Other|0|||
129852796|NCT01485861|467418620|FG003|Phase II|Other|1|||
129852797|NCT01485861|467418621|FG004|Phase II|Other|0|||
129852798|NCT01485861|467418622|FG005|Phase II|Other|0|||
129852799|NCT01485861|467418617|FG000|Phase II|Withdrawal by Subject|0|||
129852800|NCT01485861|467418618|FG001|Phase II|Withdrawal by Subject|0|||
129852801|NCT01485861|467418619|FG002|Phase II|Withdrawal by Subject|6|||
129852802|NCT01485861|467418620|FG003|Phase II|Withdrawal by Subject|3|||
129852803|NCT01485861|467418621|FG004|Phase II|Withdrawal by Subject|4|||
129852804|NCT01485861|467418622|FG005|Phase II|Withdrawal by Subject|0|||
129852805|NCT01485861|467418617|FG000|Phase II|Lost to Follow-up|0|||
129852806|NCT01485861|467418618|FG001|Phase II|Lost to Follow-up|0|||
129852807|NCT01485861|467418619|FG002|Phase II|Lost to Follow-up|2|||
129852808|NCT01485861|467418620|FG003|Phase II|Lost to Follow-up|3|||
129852809|NCT01485861|467418621|FG004|Phase II|Lost to Follow-up|5|||
129852810|NCT01485861|467418622|FG005|Phase II|Lost to Follow-up|0|||
129852811|NCT01485861|467418617|FG000|Phase II|Study Ended|0|||
129852812|NCT01485861|467418618|FG001|Phase II|Study Ended|0|||
129852813|NCT01485861|467418619|FG002|Phase II|Study Ended|7|||
129906159|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906160|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906161|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
130064611|NCT00115765|468190220|FG003|Overall Study|Physician Decision|13|||
129852814|NCT01485861|467418620|FG003|Phase II|Study Ended|8|||
129852815|NCT01485861|467418621|FG004|Phase II|Study Ended|6|||
129852816|NCT01485861|467418622|FG005|Phase II|Study Ended|0|||
129852817|NCT01485861|467418617|FG000|Safety Phase|Death|0|||
129852818|NCT01485861|467418618|FG001|Safety Phase|Death|0|||
129852819|NCT01485861|467418619|FG002|Safety Phase|Death|0|||
129852820|NCT01485861|467418620|FG003|Safety Phase|Death|0|||
129852821|NCT01485861|467418621|FG004|Safety Phase|Death|0|||
129852822|NCT01485861|467418622|FG005|Safety Phase|Death|2|||
129906162|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906163|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906164|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906165|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906166|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906167|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
129906168|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
129906169|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
129906170|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
129906171|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906172|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906173|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906174|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906175|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906176|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906177|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906178|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906179|NCT05061693|467617606|FG000|24-week Extension Period|Adverse Event|0|||
129906180|NCT05061693|467617607|FG001|24-week Extension Period|Adverse Event|0|||
129906181|NCT05061693|467617608|FG002|24-week Extension Period|Adverse Event|0|||
129906182|NCT05061693|467617609|FG003|24-week Extension Period|Adverse Event|0|||
129906183|NCT05061693|467617610|FG004|24-week Extension Period|Adverse Event|0|||
129906184|NCT05061693|467617611|FG005|24-week Extension Period|Adverse Event|0|||
129906185|NCT05061693|467617612|FG006|24-week Extension Period|Adverse Event|0|||
129906186|NCT05061693|467617613|FG007|24-week Extension Period|Adverse Event|2|||
129906187|NCT05061693|467617614|FG008|24-week Extension Period|Adverse Event|2|||
129906188|NCT05061693|467617615|FG009|24-week Extension Period|Adverse Event|0|||
129906189|NCT05061693|467617616|FG010|24-week Extension Period|Adverse Event|1|||
129906190|NCT05061693|467617617|FG011|24-week Extension Period|Adverse Event|3|||
129906191|NCT05061693|467617606|FG000|24-week Extension Period|Lack of Efficacy|0|||
129906192|NCT05061693|467617607|FG001|24-week Extension Period|Lack of Efficacy|0|||
129906193|NCT05061693|467617608|FG002|24-week Extension Period|Lack of Efficacy|0|||
129906194|NCT05061693|467617609|FG003|24-week Extension Period|Lack of Efficacy|0|||
129906195|NCT05061693|467617610|FG004|24-week Extension Period|Lack of Efficacy|0|||
129906196|NCT05061693|467617611|FG005|24-week Extension Period|Lack of Efficacy|0|||
129906197|NCT05061693|467617612|FG006|24-week Extension Period|Lack of Efficacy|0|||
129906198|NCT05061693|467617613|FG007|24-week Extension Period|Lack of Efficacy|0|||
129906199|NCT05061693|467617614|FG008|24-week Extension Period|Lack of Efficacy|0|||
129906200|NCT05061693|467617615|FG009|24-week Extension Period|Lack of Efficacy|0|||
129906201|NCT05061693|467617616|FG010|24-week Extension Period|Lack of Efficacy|2|||
129906202|NCT05061693|467617617|FG011|24-week Extension Period|Lack of Efficacy|0|||
129906203|NCT05061693|467617606|FG000|24-week Extension Period|Lost to Follow-up|0|||
129906204|NCT05061693|467617607|FG001|24-week Extension Period|Lost to Follow-up|0|||
129906205|NCT05061693|467617608|FG002|24-week Extension Period|Lost to Follow-up|0|||
129906206|NCT05061693|467617609|FG003|24-week Extension Period|Lost to Follow-up|0|||
129906207|NCT05061693|467617610|FG004|24-week Extension Period|Lost to Follow-up|0|||
129906208|NCT05061693|467617611|FG005|24-week Extension Period|Lost to Follow-up|0|||
129906209|NCT05061693|467617612|FG006|24-week Extension Period|Lost to Follow-up|1|||
129906210|NCT05061693|467617613|FG007|24-week Extension Period|Lost to Follow-up|0|||
129906211|NCT05061693|467617614|FG008|24-week Extension Period|Lost to Follow-up|1|||
129906212|NCT05061693|467617615|FG009|24-week Extension Period|Lost to Follow-up|1|||
129906213|NCT05061693|467617616|FG010|24-week Extension Period|Lost to Follow-up|0|||
129906214|NCT05061693|467617617|FG011|24-week Extension Period|Lost to Follow-up|0|||
129906215|NCT05061693|467617606|FG000|24-week Extension Period|Withdrawal by Subject|0|||
129906216|NCT05061693|467617607|FG001|24-week Extension Period|Withdrawal by Subject|0|||
129906217|NCT05061693|467617608|FG002|24-week Extension Period|Withdrawal by Subject|0|||
129906218|NCT05061693|467617609|FG003|24-week Extension Period|Withdrawal by Subject|0|||
129906219|NCT05061693|467617610|FG004|24-week Extension Period|Withdrawal by Subject|0|||
129906220|NCT05061693|467617611|FG005|24-week Extension Period|Withdrawal by Subject|0|||
129906221|NCT05061693|467617612|FG006|24-week Extension Period|Withdrawal by Subject|0|||
129906222|NCT05061693|467617613|FG007|24-week Extension Period|Withdrawal by Subject|0|||
129906223|NCT05061693|467617614|FG008|24-week Extension Period|Withdrawal by Subject|1|||
129906224|NCT05061693|467617615|FG009|24-week Extension Period|Withdrawal by Subject|2|||
129906225|NCT05061693|467617616|FG010|24-week Extension Period|Withdrawal by Subject|2|||
129906226|NCT05061693|467617617|FG011|24-week Extension Period|Withdrawal by Subject|1|||
129906227|NCT05061693|467617606|FG000|24-week Extension Period|Sponsor Decision|0|||
129906228|NCT05061693|467617607|FG001|24-week Extension Period|Sponsor Decision|0|||
129906229|NCT05061693|467617608|FG002|24-week Extension Period|Sponsor Decision|0|||
129906230|NCT05061693|467617609|FG003|24-week Extension Period|Sponsor Decision|0|||
130064612|NCT00115765|468190217|FG000|Overall Study|Lost to Follow-up|3|||
129906231|NCT05061693|467617610|FG004|24-week Extension Period|Sponsor Decision|0|||
129906232|NCT05061693|467617611|FG005|24-week Extension Period|Sponsor Decision|0|||
129906233|NCT05061693|467617612|FG006|24-week Extension Period|Sponsor Decision|0|||
129906234|NCT05061693|467617613|FG007|24-week Extension Period|Sponsor Decision|1|||
129906235|NCT05061693|467617614|FG008|24-week Extension Period|Sponsor Decision|0|||
129906236|NCT05061693|467617615|FG009|24-week Extension Period|Sponsor Decision|0|||
129906237|NCT05061693|467617616|FG010|24-week Extension Period|Sponsor Decision|0|||
129906238|NCT05061693|467617617|FG011|24-week Extension Period|Sponsor Decision|0|||
129906239|NCT05061693|467617606|FG000|24-week Extension Period|Site Closure|0|||
129906240|NCT05061693|467617607|FG001|24-week Extension Period|Site Closure|0|||
129906241|NCT05061693|467617608|FG002|24-week Extension Period|Site Closure|0|||
129906242|NCT05061693|467617609|FG003|24-week Extension Period|Site Closure|0|||
129906243|NCT05061693|467617610|FG004|24-week Extension Period|Site Closure|0|||
129906244|NCT05061693|467617611|FG005|24-week Extension Period|Site Closure|0|||
129906245|NCT05061693|467617612|FG006|24-week Extension Period|Site Closure|0|||
129906246|NCT05061693|467617613|FG007|24-week Extension Period|Site Closure|0|||
129906247|NCT05061693|467617614|FG008|24-week Extension Period|Site Closure|1|||
129906248|NCT05061693|467617615|FG009|24-week Extension Period|Site Closure|0|||
129906249|NCT05061693|467617616|FG010|24-week Extension Period|Site Closure|0|||
129906250|NCT05061693|467617617|FG011|24-week Extension Period|Site Closure|1|||
129906251|NCT01152190|467617618|FG000|Overall Study|Adverse Event|2|||
129906252|NCT01152190|467617619|FG001|Overall Study|Adverse Event|4|||
129906253|NCT01152190|467617618|FG000|Overall Study|Death|1|||
129906254|NCT01152190|467617619|FG001|Overall Study|Death|0|||
129906255|NCT01152190|467617618|FG000|Overall Study|Protocol Violation|1|||
129906256|NCT01152190|467617619|FG001|Overall Study|Protocol Violation|1|||
129906257|NCT01152190|467617618|FG000|Overall Study|Withdrawal by Subject|1|||
129906258|NCT01152190|467617619|FG001|Overall Study|Withdrawal by Subject|3|||
129906259|NCT03823911|467617620|FG000|Overall Study|Lost to Follow-up|1|||
129906260|NCT03823911|467617621|FG001|Overall Study|Lost to Follow-up|5|||
129906261|NCT03823911|467617622|FG002|Overall Study|Lost to Follow-up|2|||
129906262|NCT03823911|467617620|FG000|Overall Study|Did not meet eligibility criteria|13|||
129906263|NCT03823911|467617621|FG001|Overall Study|Did not meet eligibility criteria|7|||
129906264|NCT03823911|467617622|FG002|Overall Study|Did not meet eligibility criteria|4|||
129906265|NCT03823911|467617620|FG000|Overall Study|Death|0|||
129906266|NCT03823911|467617621|FG001|Overall Study|Death|1|||
129906267|NCT03823911|467617622|FG002|Overall Study|Death|0|||
129906268|NCT00373529|467617625|FG000|Overall Study|Physician Decision|19|||
129906269|NCT00373529|467617625|FG000|Overall Study|Withdrawal by Subject|7|||
129906270|NCT00373529|467617625|FG000|Overall Study|Adverse Event|7|||
129906271|NCT00373529|467617625|FG000|Overall Study|Treatment failure|36|||
129906272|NCT00373529|467617625|FG000|Overall Study|Disease recurrence|10|||
129906273|NCT00373529|467617625|FG000|Overall Study|Death|16|||
129906274|NCT00373529|467617625|FG000|Overall Study|Need for treatment prohibited by study|1|||
129906275|NCT00373529|467617625|FG000|Overall Study|Other|8|||
129906276|NCT00373529|467617625|FG000|Overall Study|Failed independent confirmation of AML|3|||
129906277|NCT00373529|467617625|FG000|Overall Study|Consent violation|1|||
129906278|NCT00442117|467617626|FG000|Overall Study|Adverse Event|3|||
129852823|NCT01485861|467418617|FG000|Safety Phase|Adverse Event|0|||
129852824|NCT01485861|467418618|FG001|Safety Phase|Adverse Event|0|||
129852825|NCT01485861|467418619|FG002|Safety Phase|Adverse Event|0|||
129852826|NCT01485861|467418620|FG003|Safety Phase|Adverse Event|0|||
129852827|NCT01485861|467418621|FG004|Safety Phase|Adverse Event|0|||
129852828|NCT01485861|467418622|FG005|Safety Phase|Adverse Event|1|||
129852829|NCT01485861|467418617|FG000|Safety Phase|Other|0|||
129852830|NCT01485861|467418618|FG001|Safety Phase|Other|0|||
129852831|NCT01485861|467418619|FG002|Safety Phase|Other|0|||
129852832|NCT01485861|467418620|FG003|Safety Phase|Other|0|||
129852833|NCT01485861|467418621|FG004|Safety Phase|Other|0|||
129852834|NCT01485861|467418622|FG005|Safety Phase|Other|5|||
129852835|NCT01485861|467418617|FG000|Safety Phase|Progression of Disease|0|||
129852836|NCT01485861|467418618|FG001|Safety Phase|Progression of Disease|0|||
129852837|NCT01485861|467418619|FG002|Safety Phase|Progression of Disease|0|||
129852838|NCT01485861|467418620|FG003|Safety Phase|Progression of Disease|0|||
129852839|NCT01485861|467418621|FG004|Safety Phase|Progression of Disease|0|||
129852840|NCT01485861|467418622|FG005|Safety Phase|Progression of Disease|9|||
129852841|NCT01485861|467418617|FG000|Safety Phase|Withdrawal by Subject|0|||
129906279|NCT00442117|467617627|FG001|Overall Study|Adverse Event|2|||
129906280|NCT00442117|467617626|FG000|Overall Study|Lack of Efficacy|2|||
129906281|NCT00442117|467617627|FG001|Overall Study|Lack of Efficacy|6|||
129906282|NCT00442117|467617626|FG000|Overall Study|Lost to Follow-up|1|||
129906283|NCT00442117|467617627|FG001|Overall Study|Lost to Follow-up|2|||
129906284|NCT00442117|467617626|FG000|Overall Study|Withdrawal by Subject|2|||
129906285|NCT00442117|467617627|FG001|Overall Study|Withdrawal by Subject|2|||
129852842|NCT01485861|467418618|FG001|Safety Phase|Withdrawal by Subject|0|||
129852843|NCT01485861|467418619|FG002|Safety Phase|Withdrawal by Subject|0|||
129852844|NCT01485861|467418620|FG003|Safety Phase|Withdrawal by Subject|0|||
129852845|NCT01485861|467418621|FG004|Safety Phase|Withdrawal by Subject|0|||
129852846|NCT01485861|467418622|FG005|Safety Phase|Withdrawal by Subject|6|||
129852847|NCT01485861|467418617|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852848|NCT01485861|467418618|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852849|NCT01485861|467418619|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852850|NCT01485861|467418620|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852851|NCT01485861|467418621|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852852|NCT01485861|467418622|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
129852853|NCT03653429|467418623|FG000|Overall Study|Physician Decision|4|||
129852854|NCT03653429|467418624|FG001|Overall Study|Physician Decision|10|||
129852855|NCT03321981|467418630|FG000|Overall Study|Progressive Disease (PD)|15|||
129852856|NCT03321981|467418631|FG001|Overall Study|Progressive Disease (PD)|30|||
129852857|NCT03321981|467418632|FG002|Overall Study|Progressive Disease (PD)|47|||
129852858|NCT03321981|467418630|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
129852859|NCT03321981|467418631|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
129852860|NCT03321981|467418632|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
129852861|NCT03321981|467418630|FG000|Overall Study|Adverse Event|0|||
129852862|NCT03321981|467418631|FG001|Overall Study|Adverse Event|0|||
129852863|NCT03321981|467418632|FG002|Overall Study|Adverse Event|2|||
129852864|NCT03321981|467418630|FG000|Overall Study|symptomatic deterioration|0|||
129852865|NCT03321981|467418631|FG001|Overall Study|symptomatic deterioration|1|||
129852866|NCT03321981|467418632|FG002|Overall Study|symptomatic deterioration|1|||
129852867|NCT03321981|467418630|FG000|Overall Study|Lack of compliance|0|||
129852868|NCT03321981|467418631|FG001|Overall Study|Lack of compliance|1|||
129852869|NCT03321981|467418632|FG002|Overall Study|Lack of compliance|0|||
129852870|NCT03321981|467418630|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
129852871|NCT03321981|467418631|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
129852872|NCT03321981|467418632|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
129852873|NCT03321981|467418630|FG000|Overall Study|Death|0|||
129852874|NCT03321981|467418631|FG001|Overall Study|Death|1|||
129852875|NCT03321981|467418632|FG002|Overall Study|Death|0|||
129852876|NCT03321981|467418630|FG000|Overall Study|Subject withdrawal of investigational product|0|||
129852877|NCT03321981|467418631|FG001|Overall Study|Subject withdrawal of investigational product|1|||
129852878|NCT03321981|467418632|FG002|Overall Study|Subject withdrawal of investigational product|0|||
129852879|NCT03321981|467418630|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
129852880|NCT03321981|467418631|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
129852881|NCT03321981|467418632|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
129852882|NCT03321981|467418630|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
129852883|NCT03321981|467418631|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
129852884|NCT03321981|467418632|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
129852885|NCT05061446|467418634|FG000|Overall Study|Adverse Event|2|||
129852886|NCT05061446|467418635|FG001|Overall Study|Adverse Event|0|||
129852887|NCT05061446|467418636|FG002|Overall Study|Adverse Event|0|||
129852888|NCT05061446|467418634|FG000|Overall Study|Participant no longer available due to personal reason|0|||
129852889|NCT05061446|467418635|FG001|Overall Study|Participant no longer available due to personal reason|1|||
129852890|NCT05061446|467418636|FG002|Overall Study|Participant no longer available due to personal reason|0|||
129852891|NCT03880578|467418637|FG000|Overall Study|Withdrawal by Subject|0|||
129852892|NCT03880578|467418638|FG001|Overall Study|Withdrawal by Subject|3|||
129852893|NCT03880578|467418639|FG002|Overall Study|Withdrawal by Subject|1|||
129852894|NCT03880578|467418637|FG000|Overall Study|Death|0|||
129852895|NCT03880578|467418638|FG001|Overall Study|Death|1|||
129852896|NCT03880578|467418639|FG002|Overall Study|Death|0|||
129852897|NCT02543346|467418640|FG000|Second Priming Visit|Withdrawal by Subject|0|||
129852898|NCT02543346|467418641|FG001|Second Priming Visit|Withdrawal by Subject|2|||
129852899|NCT02543346|467418642|FG002|Second Priming Visit|Withdrawal by Subject|2|||
129852900|NCT02543346|467418643|FG003|Second Priming Visit|Withdrawal by Subject|2|||
129852901|NCT02543346|467418640|FG000|Second Priming Visit|Adverse Event|1|||
129852902|NCT02543346|467418641|FG001|Second Priming Visit|Adverse Event|0|||
129852903|NCT02543346|467418642|FG002|Second Priming Visit|Adverse Event|0|||
129852904|NCT02543346|467418643|FG003|Second Priming Visit|Adverse Event|0|||
129852905|NCT01767116|467418644|FG000|Overall Study|Lost to Follow-up|2|||
129852906|NCT01767116|467418645|FG001|Overall Study|Lost to Follow-up|2|||
129852907|NCT00861341|467418646|FG000|Overall Study|Withdrawal by Subject|2|||
129852908|NCT03299192|467418647|FG000|Overall Study|Fell before classes started|1|||
129852909|NCT03299192|467418648|FG001|Overall Study|Fell before classes started|0|||
129852910|NCT03299192|467418649|FG002|Overall Study|Fell before classes started|0|||
129852911|NCT03299192|467418647|FG000|Overall Study|Other|0|||
129852912|NCT03299192|467418648|FG001|Overall Study|Other|2|||
129852913|NCT03299192|467418649|FG002|Overall Study|Other|1|||
129852914|NCT04122443|467418654|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
129852915|NCT04122443|467418655|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
129852916|NCT04122443|467418656|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
129852917|NCT04122443|467418654|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
129852918|NCT04122443|467418655|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
129852919|NCT04122443|467418656|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
129852920|NCT01916304|467418657|FG000|Overall Study|Screening failure|17|||
129852921|NCT03149328|467418659|FG000|Overall Study|Withdrawal by Subject|30|||
129852922|NCT03149328|467418660|FG001|Overall Study|Withdrawal by Subject|26|||
129852923|NCT03149328|467418659|FG000|Overall Study|Changed Dialysis Modality|18|||
129852924|NCT03149328|467418660|FG001|Overall Study|Changed Dialysis Modality|1|||
129852925|NCT03149328|467418659|FG000|Overall Study|Transplant|9|||
129852926|NCT03149328|467418660|FG001|Overall Study|Transplant|1|||
129852927|NCT03149328|467418659|FG000|Overall Study|Lost to Follow-up|25|||
129852928|NCT03149328|467418660|FG001|Overall Study|Lost to Follow-up|16|||
129852929|NCT03149328|467418659|FG000|Overall Study|Left Study Site|1|||
129852930|NCT03149328|467418660|FG001|Overall Study|Left Study Site|2|||
129852931|NCT03149328|467418659|FG000|Overall Study|Language Barrier|1|||
129852932|NCT03149328|467418660|FG001|Overall Study|Language Barrier|0|||
129852933|NCT02758236|467418661|FG000|Overall Study|Investigator discretion|43|||
129852934|NCT00818441|467418662|FG000|Overall Study|Death|69|||
129852935|NCT00818441|467418663|FG001|Overall Study|Death|26|||
129852936|NCT00818441|467418662|FG000|Overall Study|Other|5|||
129852937|NCT00818441|467418663|FG001|Overall Study|Other|0|||
129852938|NCT00818441|467418662|FG000|Overall Study|Lost to Follow-up|2|||
129852939|NCT00818441|467418663|FG001|Overall Study|Lost to Follow-up|1|||
129852940|NCT00818441|467418662|FG000|Overall Study|Withdrawal by Subject|2|||
129852941|NCT00818441|467418663|FG001|Overall Study|Withdrawal by Subject|0|||
129852942|NCT00818441|467418662|FG000|Overall Study|Adverse Event|0|||
129852943|NCT00818441|467418663|FG001|Overall Study|Adverse Event|1|||
129852944|NCT00818441|467418662|FG000|Overall Study|Study terminated by sponsor|11|||
129852945|NCT00818441|467418663|FG001|Overall Study|Study terminated by sponsor|2|||
129852946|NCT03136068|467420351|FG000|Overall Study|Lost to Follow-up|1|||
129852947|NCT03136068|467420352|FG001|Overall Study|Lost to Follow-up|1|||
129852948|NCT03136068|467420351|FG000|Overall Study|Protocol Violation|1|||
129852949|NCT03136068|467420352|FG001|Overall Study|Protocol Violation|0|||
129852950|NCT00432380|467420358|FG000|Overall Study|Migrated/moved from study area|3|||
129852951|NCT00432380|467420359|FG001|Overall Study|Migrated/moved from study area|4|||
129852952|NCT00432380|467420360|FG002|Overall Study|Migrated/moved from study area|1|||
129852953|NCT00432380|467420358|FG000|Overall Study|Adverse Event|1|||
129852954|NCT00432380|467420359|FG001|Overall Study|Adverse Event|0|||
129852955|NCT00432380|467420360|FG002|Overall Study|Adverse Event|0|||
129852956|NCT02044510|467420361|FG000|Overall Study|Adverse Event|1|||
129852957|NCT02044510|467420362|FG001|Overall Study|Adverse Event|2|||
129852958|NCT00581945|467420365|FG000|Overall Study|Adverse Event|4|||
129852959|NCT00581945|467420366|FG001|Overall Study|Adverse Event|4|||
129852960|NCT00581945|467420365|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129852961|NCT00581945|467420366|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129852962|NCT00581945|467420365|FG000|Overall Study|Withdrawal by Subject|2|||
129852963|NCT00581945|467420366|FG001|Overall Study|Withdrawal by Subject|6|||
129852964|NCT00581945|467420365|FG000|Overall Study|Death|1|||
129852965|NCT00581945|467420366|FG001|Overall Study|Death|0|||
129852966|NCT01933334|467420370|FG000|Overall Study|Adverse Event|5|||
129852967|NCT01933334|467420371|FG001|Overall Study|Adverse Event|1|||
129852968|NCT01933334|467420370|FG000|Overall Study|Withdrawal by Subject|0|||
129852969|NCT01933334|467420371|FG001|Overall Study|Withdrawal by Subject|1|||
129852970|NCT02032901|467420372|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
129852971|NCT02032901|467420373|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
129852972|NCT02032901|467420372|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
129852973|NCT02032901|467420373|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
129852974|NCT00633984|467420374|FG000|Overall Study|Lost to Follow-up|0|||
129852975|NCT00633984|467420375|FG001|Overall Study|Lost to Follow-up|6|||
129852976|NCT00633984|467420374|FG000|Overall Study|Withdrawal by Subject|8|||
129852977|NCT00633984|467420375|FG001|Overall Study|Withdrawal by Subject|7|||
129852978|NCT00633984|467420374|FG000|Overall Study|Hospitalized|1|||
129852979|NCT00633984|467420375|FG001|Overall Study|Hospitalized|0|||
129852980|NCT02496884|467420376|FG000|Overall Study|Counted twice as enrolled|2|||
129852981|NCT02496884|467420377|FG001|Overall Study|Counted twice as enrolled|0|||
129852982|NCT02496884|467420378|FG002|Overall Study|Counted twice as enrolled|0|||
129852983|NCT02496884|467420379|FG003|Overall Study|Counted twice as enrolled|0|||
129852984|NCT02496884|467420376|FG000|Overall Study|Withdrawal by Subject|0|||
129852985|NCT02496884|467420377|FG001|Overall Study|Withdrawal by Subject|3|||
129852986|NCT02496884|467420378|FG002|Overall Study|Withdrawal by Subject|0|||
129852987|NCT02496884|467420379|FG003|Overall Study|Withdrawal by Subject|0|||
129852988|NCT01033747|467420380|FG000|Overall Study|Adverse Event|9|||
129852989|NCT01033747|467420381|FG001|Overall Study|Adverse Event|4|||
129906286|NCT00442117|467617626|FG000|Overall Study|Major Deviation|25|||
129906287|NCT00442117|467617627|FG001|Overall Study|Major Deviation|20|||
129906288|NCT00442117|467617626|FG000|Overall Study|Non compliance with protocol|3|||
129906289|NCT00442117|467617627|FG001|Overall Study|Non compliance with protocol|5|||
129906290|NCT00442117|467617626|FG000|Overall Study|Met Withdrawal Criteria|2|||
129906291|NCT00442117|467617627|FG001|Overall Study|Met Withdrawal Criteria|1|||
129906292|NCT04009577|467617633|FG000|Core Study|Adverse Event|1|||
129906293|NCT04009577|467617634|FG001|Core Study|Adverse Event|0|||
129906294|NCT04009577|467617635|FG002|Core Study|Adverse Event|2|||
129906295|NCT04009577|467617636|FG003|Core Study|Adverse Event|4|||
129906296|NCT04009577|467617633|FG000|Core Study|Withdrawal by Subject|0|||
129906297|NCT04009577|467617634|FG001|Core Study|Withdrawal by Subject|0|||
129906298|NCT04009577|467617635|FG002|Core Study|Withdrawal by Subject|2|||
129906299|NCT04009577|467617636|FG003|Core Study|Withdrawal by Subject|0|||
129906300|NCT04009577|467617633|FG000|Core Study|Other|0|||
129906301|NCT04009577|467617634|FG001|Core Study|Other|0|||
129906302|NCT04009577|467617635|FG002|Core Study|Other|0|||
129906303|NCT04009577|467617636|FG003|Core Study|Other|1|||
129906304|NCT04009577|467617633|FG000|Extension Phase|Adverse Event|0|||
129906305|NCT04009577|467617634|FG001|Extension Phase|Adverse Event|0|||
129906306|NCT04009577|467617635|FG002|Extension Phase|Adverse Event|0|||
129906307|NCT04009577|467617636|FG003|Extension Phase|Adverse Event|1|||
129906308|NCT04009577|467617633|FG000|Extension Phase|Inadequate therapeutic effect|0|||
129906309|NCT04009577|467617634|FG001|Extension Phase|Inadequate therapeutic effect|0|||
129906310|NCT04009577|467617635|FG002|Extension Phase|Inadequate therapeutic effect|1|||
129906311|NCT04009577|467617636|FG003|Extension Phase|Inadequate therapeutic effect|0|||
129906312|NCT04009577|467617633|FG000|Extension Phase|Withdrawal by Subject|0|||
129906313|NCT04009577|467617634|FG001|Extension Phase|Withdrawal by Subject|0|||
129906314|NCT04009577|467617635|FG002|Extension Phase|Withdrawal by Subject|1|||
129906315|NCT04009577|467617636|FG003|Extension Phase|Withdrawal by Subject|0|||
129906316|NCT04009577|467617633|FG000|Extension Phase|Not Treated|0|||
129906317|NCT04009577|467617634|FG001|Extension Phase|Not Treated|0|||
129906318|NCT04009577|467617635|FG002|Extension Phase|Not Treated|2|||
129906319|NCT04009577|467617636|FG003|Extension Phase|Not Treated|0|||
129906320|NCT01810263|467617654|FG000|Overall Study|Lost to Follow-up|8|||
129906321|NCT01810263|467617655|FG001|Overall Study|Lost to Follow-up|7|||
129906322|NCT00688519|467617656|FG000|Overall Study|Adverse Event|2|||
129906323|NCT00688519|467617657|FG001|Overall Study|Adverse Event|3|||
129906324|NCT00688519|467617656|FG000|Overall Study|Lost to Follow-up|3|||
129906325|NCT00688519|467617657|FG001|Overall Study|Lost to Follow-up|3|||
129906326|NCT00688519|467617656|FG000|Overall Study|Lack of Efficacy|3|||
129906327|NCT00688519|467617657|FG001|Overall Study|Lack of Efficacy|1|||
129906328|NCT00688519|467617656|FG000|Overall Study|Withdrawal by Subject|7|||
129906329|NCT00688519|467617657|FG001|Overall Study|Withdrawal by Subject|6|||
129906330|NCT00688519|467617656|FG000|Overall Study|Prohibited medication|1|||
129906331|NCT00688519|467617657|FG001|Overall Study|Prohibited medication|0|||
129906332|NCT00688519|467617656|FG000|Overall Study|Non-compliance|0|||
129906333|NCT00688519|467617657|FG001|Overall Study|Non-compliance|1|||
129906334|NCT00688519|467617656|FG000|Overall Study|Subject moved out of state|1|||
129906335|NCT00688519|467617657|FG001|Overall Study|Subject moved out of state|0|||
129906336|NCT00688519|467617656|FG000|Overall Study|Investigator decision|1|||
129906337|NCT00688519|467617657|FG001|Overall Study|Investigator decision|0|||
129906338|NCT00688519|467617656|FG000|Overall Study|Subject moved out of area|1|||
129906339|NCT00688519|467617657|FG001|Overall Study|Subject moved out of area|0|||
129906340|NCT00688519|467617656|FG000|Overall Study|Pregnancy|0|||
129906341|NCT00688519|467617657|FG001|Overall Study|Pregnancy|1|||
129906342|NCT01353963|467617658|FG000|Overall Study|Adverse Event|2|||
129906343|NCT00493649|467619106|FG000|Overall Study|Adverse Event|44|||
129906344|NCT00493649|467619106|FG000|Overall Study|Patient Request|21|||
129906345|NCT00493649|467619106|FG000|Overall Study|Investigator Request|2|||
129906346|NCT00493649|467619106|FG000|Overall Study|Disease Progression|1|||
129906347|NCT00493649|467619106|FG000|Overall Study|Lost to Follow-up|1|||
129906348|NCT00493649|467619106|FG000|Overall Study|Other|13|||
129906349|NCT05219253|467619107|FG000|Overall Study|Withdrawal by Subject|1|||
129906350|NCT05219253|467619108|FG001|Overall Study|Withdrawal by Subject|2|||
129906351|NCT03086369|467619109|FG000|Overall Study|Lost to Follow-up|1|||
129906352|NCT03086369|467619110|FG001|Overall Study|Lost to Follow-up|0|||
129906353|NCT03086369|467619111|FG002|Overall Study|Lost to Follow-up|0|||
129906354|NCT03086369|467619112|FG003|Overall Study|Lost to Follow-up|2|||
129906355|NCT03086369|467619113|FG004|Overall Study|Lost to Follow-up|1|||
129906356|NCT03086369|467619109|FG000|Overall Study|Physician Decision|0|||
129906357|NCT03086369|467619110|FG001|Overall Study|Physician Decision|0|||
129906358|NCT03086369|467619111|FG002|Overall Study|Physician Decision|0|||
129906359|NCT03086369|467619112|FG003|Overall Study|Physician Decision|1|||
129906360|NCT03086369|467619113|FG004|Overall Study|Physician Decision|2|||
129906361|NCT03086369|467619109|FG000|Overall Study|Withdrawal by Subject|0|||
129906362|NCT03086369|467619110|FG001|Overall Study|Withdrawal by Subject|0|||
129906363|NCT03086369|467619111|FG002|Overall Study|Withdrawal by Subject|0|||
129906364|NCT03086369|467619112|FG003|Overall Study|Withdrawal by Subject|5|||
129906365|NCT03086369|467619113|FG004|Overall Study|Withdrawal by Subject|3|||
129906366|NCT03086369|467619109|FG000|Overall Study|Progressive Disease|0|||
130116595|NCT00094302|468387119|FG001|Overall Study|Lost to Follow-up|41|||
130116596|NCT00094302|468387118|FG000|Overall Study|Physician Decision|5|||
130116597|NCT00094302|468387119|FG001|Overall Study|Physician Decision|8|||
130116598|NCT00094302|468387118|FG000|Overall Study|Withdrawal by Subject|103|||
130116599|NCT00094302|468387119|FG001|Overall Study|Withdrawal by Subject|111|||
130116600|NCT00094302|468387118|FG000|Overall Study|Death|266|||
130116601|NCT00094302|468387119|FG001|Overall Study|Death|246|||
130116602|NCT01162499|468387125|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
130116603|NCT01162499|468387126|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
130116604|NCT01590433|468387127|FG000|Overall Study|Lost to Follow-up|20|||
130116605|NCT01590433|468387128|FG001|Overall Study|Lost to Follow-up|8|||
130116606|NCT01590433|468387127|FG000|Overall Study|Withdrawal by Subject|21|||
129852990|NCT01033747|467420380|FG000|Overall Study|Abnormal Laboratory Value|1|||
129852991|NCT01033747|467420381|FG001|Overall Study|Abnormal Laboratory Value|0|||
129852992|NCT01033747|467420380|FG000|Overall Study|Abnormal test procedure|0|||
129852993|NCT01033747|467420381|FG001|Overall Study|Abnormal test procedure|1|||
129852994|NCT01033747|467420380|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
129852995|NCT01033747|467420381|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129852996|NCT01033747|467420380|FG000|Overall Study|Protocol Violation|1|||
129852997|NCT01033747|467420381|FG001|Overall Study|Protocol Violation|0|||
129852998|NCT01033747|467420380|FG000|Overall Study|Withdrawal by Subject|9|||
129852999|NCT01033747|467420381|FG001|Overall Study|Withdrawal by Subject|6|||
129853000|NCT01033747|467420380|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
129853001|NCT01033747|467420381|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
129853002|NCT01033747|467420380|FG000|Overall Study|Stopped at end of Extension 1|2|||
129853003|NCT01033747|467420381|FG001|Overall Study|Stopped at end of Extension 1|0|||
129853004|NCT02956629|467420382|FG000|Overall Study|Adverse Event|0|||
129853005|NCT02956629|467420383|FG001|Overall Study|Adverse Event|0|||
129853006|NCT02956629|467420384|FG002|Overall Study|Adverse Event|1|||
129853007|NCT02956629|467420385|FG003|Overall Study|Adverse Event|0|||
129853008|NCT02956629|467420386|FG004|Overall Study|Adverse Event|0|||
129853009|NCT02956629|467420387|FG005|Overall Study|Adverse Event|0|||
129853010|NCT02956629|467420382|FG000|Overall Study|Lost to Follow-up|2|||
129853011|NCT02956629|467420383|FG001|Overall Study|Lost to Follow-up|5|||
129853012|NCT02956629|467420384|FG002|Overall Study|Lost to Follow-up|3|||
129853013|NCT02956629|467420385|FG003|Overall Study|Lost to Follow-up|1|||
129853014|NCT02956629|467420386|FG004|Overall Study|Lost to Follow-up|0|||
129853015|NCT02956629|467420387|FG005|Overall Study|Lost to Follow-up|1|||
129853016|NCT02956629|467420382|FG000|Overall Study|Withdrawal by Subject|3|||
129853017|NCT02956629|467420383|FG001|Overall Study|Withdrawal by Subject|1|||
129853018|NCT02956629|467420384|FG002|Overall Study|Withdrawal by Subject|0|||
129853019|NCT02956629|467420385|FG003|Overall Study|Withdrawal by Subject|0|||
129853020|NCT02956629|467420386|FG004|Overall Study|Withdrawal by Subject|0|||
129853021|NCT02956629|467420387|FG005|Overall Study|Withdrawal by Subject|0|||
129853022|NCT01931839|467420392|FG000|Overall Study|Death|0|||
129853023|NCT01931839|467420393|FG001|Overall Study|Death|1|||
129853024|NCT01931839|467420394|FG002|Overall Study|Death|2|||
129853025|NCT01931839|467420395|FG003|Overall Study|Death|0|||
129853026|NCT01931839|467420396|FG004|Overall Study|Death|0|||
129853027|NCT01931839|467420397|FG005|Overall Study|Death|0|||
129853028|NCT01931839|467420398|FG006|Overall Study|Death|0|||
129853029|NCT01931839|467420392|FG000|Overall Study|Physician Decision|1|||
129853030|NCT01931839|467420393|FG001|Overall Study|Physician Decision|0|||
129853031|NCT01931839|467420394|FG002|Overall Study|Physician Decision|1|||
129853032|NCT01931839|467420395|FG003|Overall Study|Physician Decision|0|||
129853033|NCT01931839|467420396|FG004|Overall Study|Physician Decision|0|||
129853034|NCT01931839|467420397|FG005|Overall Study|Physician Decision|0|||
129853035|NCT01931839|467420398|FG006|Overall Study|Physician Decision|1|||
129853036|NCT01931839|467420392|FG000|Overall Study|Withdrawal of consent|0|||
129853037|NCT01931839|467420393|FG001|Overall Study|Withdrawal of consent|0|||
129853038|NCT01931839|467420394|FG002|Overall Study|Withdrawal of consent|0|||
129853039|NCT01931839|467420395|FG003|Overall Study|Withdrawal of consent|0|||
129853040|NCT01931839|467420396|FG004|Overall Study|Withdrawal of consent|1|||
129853041|NCT01931839|467420397|FG005|Overall Study|Withdrawal of consent|0|||
129853042|NCT01931839|467420398|FG006|Overall Study|Withdrawal of consent|0|||
129853043|NCT01931839|467420392|FG000|Overall Study|Adverse Event|9|||
129853044|NCT01931839|467420393|FG001|Overall Study|Adverse Event|4|||
129853045|NCT01931839|467420394|FG002|Overall Study|Adverse Event|1|||
129853046|NCT01931839|467420395|FG003|Overall Study|Adverse Event|3|||
129853047|NCT01931839|467420396|FG004|Overall Study|Adverse Event|0|||
129853048|NCT01931839|467420397|FG005|Overall Study|Adverse Event|0|||
129853049|NCT01931839|467420398|FG006|Overall Study|Adverse Event|1|||
129853050|NCT01931839|467420392|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
129853051|NCT01931839|467420393|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
129853052|NCT01931839|467420394|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
129853053|NCT01931839|467420395|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
129853054|NCT01931839|467420396|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
129906367|NCT03086369|467619110|FG001|Overall Study|Progressive Disease|0|||
129906368|NCT03086369|467619111|FG002|Overall Study|Progressive Disease|0|||
129906369|NCT03086369|467619112|FG003|Overall Study|Progressive Disease|1|||
129906370|NCT03086369|467619113|FG004|Overall Study|Progressive Disease|1|||
129906371|NCT01765543|467619117|FG000|Overall Study|Death|1|||
129906372|NCT01765543|467619117|FG000|Overall Study|Withdrawal by Subject|2|||
129906373|NCT01424397|467619118|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906374|NCT01424397|467619119|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906375|NCT01424397|467619120|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
129906376|NCT01424397|467619121|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906377|NCT01424397|467619122|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906378|NCT01424397|467619123|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906379|NCT01424397|467619124|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906380|NCT01424397|467619125|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906381|NCT01424397|467619126|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906382|NCT01424397|467619127|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906383|NCT01424397|467619128|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906384|NCT01424397|467619129|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906385|NCT05876949|467619130|FG000|Overall Study|Withdrawal by Subject|1|||
129906386|NCT05876949|467619131|FG001|Overall Study|Withdrawal by Subject|3|||
129906387|NCT05876949|467619130|FG000|Overall Study|Physician Decision|0|||
129906388|NCT05876949|467619131|FG001|Overall Study|Physician Decision|2|||
129906389|NCT05876949|467619130|FG000|Overall Study|Death|0|||
129906390|NCT05876949|467619131|FG001|Overall Study|Death|1|||
129906391|NCT03644849|467619132|FG000|Overall Study|Lost to Follow-up|1|||
129906392|NCT03644849|467619133|FG001|Overall Study|Lost to Follow-up|3|||
129906393|NCT00071799|467619134|FG000|Overall Study|Adverse Event|19|||
129906394|NCT00071799|467619135|FG001|Overall Study|Adverse Event|10|||
129906395|NCT00071799|467619134|FG000|Overall Study|Protocol Violation|1|||
129906396|NCT00071799|467619135|FG001|Overall Study|Protocol Violation|7|||
129906397|NCT00071799|467619134|FG000|Overall Study|Lost to Follow-up|1|||
129906398|NCT00071799|467619135|FG001|Overall Study|Lost to Follow-up|1|||
129906399|NCT00071799|467619134|FG000|Overall Study|Withdrawal by Subject|15|||
129906400|NCT00071799|467619135|FG001|Overall Study|Withdrawal by Subject|37|||
129906401|NCT00071799|467619134|FG000|Overall Study|Physician Decision|0|||
129906402|NCT00071799|467619135|FG001|Overall Study|Physician Decision|2|||
129906403|NCT00071799|467619134|FG000|Overall Study|Lack of Efficacy|11|||
129906404|NCT00071799|467619135|FG001|Overall Study|Lack of Efficacy|18|||
129906405|NCT00071799|467619134|FG000|Overall Study|Disease Progression|23|||
129906406|NCT00071799|467619135|FG001|Overall Study|Disease Progression|20|||
129906407|NCT00071799|467619134|FG000|Overall Study|Different Central+Local Pathology Review|0|||
129906408|NCT00071799|467619135|FG001|Overall Study|Different Central+Local Pathology Review|1|||
129906409|NCT00071799|467619134|FG000|Overall Study|Not Documented|0|||
129853055|NCT01931839|467420397|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
129853056|NCT01931839|467420398|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
129853057|NCT01931839|467420392|FG000|Overall Study|Other non-compliance|15|||
129853058|NCT01931839|467420393|FG001|Overall Study|Other non-compliance|9|||
129853059|NCT01931839|467420394|FG002|Overall Study|Other non-compliance|12|||
129853060|NCT01931839|467420395|FG003|Overall Study|Other non-compliance|3|||
129853061|NCT01931839|467420396|FG004|Overall Study|Other non-compliance|0|||
129853062|NCT01931839|467420397|FG005|Overall Study|Other non-compliance|3|||
129853063|NCT01931839|467420398|FG006|Overall Study|Other non-compliance|0|||
129853064|NCT01931839|467420392|FG000|Overall Study|Lost to Follow-up|1|||
129853065|NCT01931839|467420393|FG001|Overall Study|Lost to Follow-up|2|||
129853066|NCT01931839|467420394|FG002|Overall Study|Lost to Follow-up|4|||
129853067|NCT01931839|467420395|FG003|Overall Study|Lost to Follow-up|5|||
129853068|NCT01931839|467420396|FG004|Overall Study|Lost to Follow-up|0|||
129853069|NCT01931839|467420397|FG005|Overall Study|Lost to Follow-up|0|||
129853070|NCT01931839|467420398|FG006|Overall Study|Lost to Follow-up|0|||
129853071|NCT01931839|467420392|FG000|Overall Study|Other|4|||
129853072|NCT01931839|467420393|FG001|Overall Study|Other|2|||
129853073|NCT01931839|467420394|FG002|Overall Study|Other|6|||
129853074|NCT01931839|467420395|FG003|Overall Study|Other|0|||
129853075|NCT01931839|467420396|FG004|Overall Study|Other|0|||
129853076|NCT01931839|467420397|FG005|Overall Study|Other|0|||
129853077|NCT01931839|467420398|FG006|Overall Study|Other|0|||
129853078|NCT01762761|467420399|FG000|Overall Study|Adverse Event|15|||
129853079|NCT01762761|467420400|FG001|Overall Study|Adverse Event|17|||
129853080|NCT01762761|467420399|FG000|Overall Study|Lack of Efficacy|9|||
129853081|NCT01762761|467420400|FG001|Overall Study|Lack of Efficacy|25|||
129906410|NCT00071799|467619135|FG001|Overall Study|Not Documented|2|||
129906411|NCT01177670|467619136|FG000|Overall Study|Study Terminated|115|||
129906412|NCT01177670|467619136|FG000|Overall Study|Physician Decision|50|||
129906413|NCT01177670|467619136|FG000|Overall Study|Withdrawal by Subject|4|||
129906414|NCT01145885|467619139|FG000|Overall Study|Progressive Disease|7|||
129906415|NCT03691428|467619140|FG000|Overall Study|Withdrawal by Subject|6|||
129906416|NCT03691428|467619141|FG001|Overall Study|Withdrawal by Subject|8|||
129906417|NCT02527148|467619142|FG000|Overall Study|Did not receive study intervention|1|||
129906418|NCT02527148|467619143|FG001|Overall Study|Did not receive study intervention|0|||
129906419|NCT01140048|467619144|FG000|Overall Study|Physician Decision|1|||
129906420|NCT01140048|467619144|FG000|Overall Study|Withdrawal by Subject|13|||
129906421|NCT01140048|467619144|FG000|Overall Study|Lost to Follow-up|31|||
129906422|NCT01831791|467619145|FG000|Overall Study|Withdrawal by Subject|10|||
129906423|NCT00494780|467619146|FG000|Overall Study|Adverse Event|1|||
129906424|NCT00494780|467619147|FG001|Overall Study|Adverse Event|0|||
129906425|NCT00494780|467619146|FG000|Overall Study|Withdrew before Dosed|0|||
129906426|NCT00494780|467619147|FG001|Overall Study|Withdrew before Dosed|1|||
129906427|NCT00494780|467619146|FG000|Overall Study|Progression of Study Disease|7|||
129906428|NCT00494780|467619147|FG001|Overall Study|Progression of Study Disease|8|||
129906429|NCT00494780|467619146|FG000|Overall Study|New Treatment|2|||
129906430|NCT00494780|467619147|FG001|Overall Study|New Treatment|2|||
129906431|NCT00494780|467619146|FG000|Overall Study|Non-compliance|1|||
129906432|NCT00494780|467619147|FG001|Overall Study|Non-compliance|0|||
129906433|NCT00494780|467619146|FG000|Overall Study|Residual Tumour Mass|0|||
129906434|NCT00494780|467619147|FG001|Overall Study|Residual Tumour Mass|1|||
129906435|NCT00494780|467619146|FG000|Overall Study|Insurance Issues|0|||
129906436|NCT00494780|467619147|FG001|Overall Study|Insurance Issues|1|||
129906437|NCT01254019|467619148|FG000|Overall Study|Adverse Event|0|||
129906438|NCT01254019|467619149|FG001|Overall Study|Adverse Event|2|||
129906439|NCT01254019|467619148|FG000|Overall Study|Protocol Violation|1|||
129906440|NCT01254019|467619149|FG001|Overall Study|Protocol Violation|0|||
129906441|NCT01254019|467619148|FG000|Overall Study|Withdrawal by Subject|0|||
129906442|NCT01254019|467619149|FG001|Overall Study|Withdrawal by Subject|2|||
129906443|NCT03061474|467619150|FG000|Overall Study|Adverse Event|2|||
129906444|NCT03061474|467619151|FG001|Overall Study|Adverse Event|0|||
129906445|NCT03061474|467619150|FG000|Overall Study|Safety Risk|0|||
129906446|NCT03061474|467619151|FG001|Overall Study|Safety Risk|1|||
129906447|NCT03061474|467619150|FG000|Overall Study|Participant unwilling or unable to participate|0|||
129906448|NCT03061474|467619151|FG001|Overall Study|Participant unwilling or unable to participate|2|||
129906449|NCT03061474|467619150|FG000|Overall Study|Lost to Follow-up|0|||
129906450|NCT03061474|467619151|FG001|Overall Study|Lost to Follow-up|1|||
129906451|NCT02888080|467619152|FG000|Overall Study|Subject / Guardian decision|1|||
129906452|NCT02888080|467619153|FG001|Overall Study|Subject / Guardian decision|3|||
129906453|NCT02888080|467619152|FG000|Overall Study|New Therapy for study indication|1|||
129906454|NCT02888080|467619153|FG001|Overall Study|New Therapy for study indication|0|||
129906455|NCT02888080|467619152|FG000|Overall Study|Lack of Efficacy|0|||
129906456|NCT02888080|467619153|FG001|Overall Study|Lack of Efficacy|1|||
129906457|NCT02888080|467619152|FG000|Overall Study|Adverse Event|0|||
129906458|NCT02888080|467619153|FG001|Overall Study|Adverse Event|1|||
129906459|NCT00845832|467619154|FG000|Treatment Period|Adverse Event|0|||
129906460|NCT00845832|467619155|FG001|Treatment Period|Adverse Event|2|||
129906461|NCT00845832|467619156|FG002|Treatment Period|Adverse Event|0|||
129906462|NCT00845832|467619154|FG000|Treatment Period|Protocol Violation|1|||
129906463|NCT00845832|467619155|FG001|Treatment Period|Protocol Violation|1|||
129906464|NCT00845832|467619156|FG002|Treatment Period|Protocol Violation|0|||
129906465|NCT00845832|467619154|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
129906466|NCT00845832|467619155|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
129906467|NCT00845832|467619156|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
129906468|NCT00845832|467619154|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
129906469|NCT00845832|467619155|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
129906470|NCT00845832|467619156|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
129906471|NCT00189202|467619161|FG000|Overall Study|Physician Decision|5|||
129906472|NCT00980330|467619162|FG000|Overall Study|Adverse Event|0|||
129906473|NCT00980330|467619163|FG001|Overall Study|Adverse Event|0|||
129906474|NCT00980330|467619164|FG002|Overall Study|Adverse Event|0|||
129906475|NCT00980330|467619165|FG003|Overall Study|Adverse Event|1|||
129906476|NCT00980330|467619166|FG004|Overall Study|Adverse Event|0|||
129906477|NCT00980330|467619167|FG005|Overall Study|Adverse Event|0|||
129906478|NCT00980330|467619168|FG006|Overall Study|Adverse Event|0|||
129906479|NCT00980330|467619162|FG000|Overall Study|Lost to Follow-up|1|||
129906480|NCT00980330|467619163|FG001|Overall Study|Lost to Follow-up|1|||
129906481|NCT00980330|467619164|FG002|Overall Study|Lost to Follow-up|4|||
129906482|NCT00980330|467619165|FG003|Overall Study|Lost to Follow-up|2|||
129906483|NCT00980330|467619166|FG004|Overall Study|Lost to Follow-up|1|||
129906484|NCT00980330|467619167|FG005|Overall Study|Lost to Follow-up|1|||
129906485|NCT00980330|467619168|FG006|Overall Study|Lost to Follow-up|2|||
129906486|NCT00980330|467619162|FG000|Overall Study|Withdrawal by Subject|2|||
129906487|NCT00980330|467619163|FG001|Overall Study|Withdrawal by Subject|4|||
129906488|NCT00980330|467619164|FG002|Overall Study|Withdrawal by Subject|4|||
129906489|NCT00980330|467619165|FG003|Overall Study|Withdrawal by Subject|1|||
129906490|NCT00980330|467619166|FG004|Overall Study|Withdrawal by Subject|3|||
129906491|NCT00980330|467619167|FG005|Overall Study|Withdrawal by Subject|2|||
129906492|NCT00980330|467619168|FG006|Overall Study|Withdrawal by Subject|5|||
129906493|NCT00980330|467619162|FG000|Overall Study|(not specified)|2|||
129906494|NCT00980330|467619163|FG001|Overall Study|(not specified)|0|||
129906495|NCT00980330|467619164|FG002|Overall Study|(not specified)|0|||
129906496|NCT00980330|467619165|FG003|Overall Study|(not specified)|1|||
129853082|NCT01762761|467420399|FG000|Overall Study|Protocol Violation|1|||
129853083|NCT01762761|467420400|FG001|Overall Study|Protocol Violation|1|||
129853084|NCT01762761|467420399|FG000|Overall Study|Study closed/terminated|0|||
129853085|NCT01762761|467420400|FG001|Overall Study|Study closed/terminated|2|||
129853086|NCT01762761|467420399|FG000|Overall Study|Lost to Follow-up|3|||
129853087|NCT01762761|467420400|FG001|Overall Study|Lost to Follow-up|6|||
129853088|NCT01762761|467420399|FG000|Overall Study|Physician Decision|4|||
129853089|NCT01762761|467420400|FG001|Overall Study|Physician Decision|6|||
129853090|NCT01762761|467420399|FG000|Overall Study|Withdrawal by Subject|7|||
129853091|NCT01762761|467420400|FG001|Overall Study|Withdrawal by Subject|8|||
129853092|NCT01925183|467420401|FG000|Overall Study|Adverse Event|1|||
129853093|NCT01925183|467420402|FG001|Overall Study|Adverse Event|0|||
129853094|NCT01046110|467420403|FG000|Overall Study|Adverse Event|9|||
129853095|NCT01046110|467420404|FG001|Overall Study|Adverse Event|2|||
129853096|NCT01046110|467420403|FG000|Overall Study|Lack of Efficacy|0|||
129853097|NCT01046110|467420404|FG001|Overall Study|Lack of Efficacy|1|||
129853098|NCT01046110|467420403|FG000|Overall Study|Protocol Violation|7|||
129853099|NCT01046110|467420404|FG001|Overall Study|Protocol Violation|12|||
129853100|NCT01046110|467420403|FG000|Overall Study|Withdrawal Criteria|3|||
129853101|NCT01046110|467420404|FG001|Overall Study|Withdrawal Criteria|5|||
129853102|NCT01046110|467420403|FG000|Overall Study|Unclassified|36|||
129853103|NCT01046110|467420404|FG001|Overall Study|Unclassified|35|||
129853104|NCT00575588|467420411|FG000|Overall Study|Adverse Event|11|||
129853105|NCT00575588|467420412|FG001|Overall Study|Adverse Event|13|||
129853106|NCT00575588|467420411|FG000|Overall Study|Withdrawal by Subject|27|||
129853107|NCT00575588|467420412|FG001|Overall Study|Withdrawal by Subject|31|||
129853108|NCT00575588|467420411|FG000|Overall Study|Lost to Follow-up|1|||
129853109|NCT00575588|467420412|FG001|Overall Study|Lost to Follow-up|3|||
129853110|NCT00575588|467420411|FG000|Overall Study|Death|4|||
129853111|NCT00575588|467420412|FG001|Overall Study|Death|2|||
129853112|NCT00575588|467420411|FG000|Overall Study|Incorrect enrollment|8|||
129853113|NCT00575588|467420412|FG001|Overall Study|Incorrect enrollment|4|||
129853114|NCT00575588|467420411|FG000|Overall Study|Study specific discontinuation criteria|203|||
129853115|NCT00575588|467420412|FG001|Overall Study|Study specific discontinuation criteria|218|||
129853116|NCT00575588|467420411|FG000|Overall Study|Severe non-compliance to protocol|5|||
129853117|NCT00575588|467420412|FG001|Overall Study|Severe non-compliance to protocol|7|||
129853118|NCT00575588|467420411|FG000|Overall Study|Safety reasons|2|||
129853119|NCT00575588|467420412|FG001|Overall Study|Safety reasons|1|||
129853120|NCT00575588|467420411|FG000|Overall Study|Elevated triglyceride|1|||
129853121|NCT00575588|467420412|FG001|Overall Study|Elevated triglyceride|0|||
129853122|NCT00575588|467420411|FG000|Overall Study|Patient moved|1|||
129853123|NCT00575588|467420412|FG001|Overall Study|Patient moved|3|||
129853124|NCT00575588|467420411|FG000|Overall Study|Impossible to determine HbA1c|0|||
129853125|NCT00575588|467420412|FG001|Overall Study|Impossible to determine HbA1c|1|||
129853126|NCT00614939|467420413|FG000|Overall Study|Withdrawal by Subject|10|||
129853127|NCT00614939|467420414|FG001|Overall Study|Withdrawal by Subject|17|||
129853128|NCT00614939|467420413|FG000|Overall Study|Study specific discontinuation criteris|13|||
129853129|NCT00614939|467420414|FG001|Overall Study|Study specific discontinuation criteris|16|||
129853130|NCT00614939|467420413|FG000|Overall Study|Adverse Event|2|||
129853131|NCT00614939|467420414|FG001|Overall Study|Adverse Event|5|||
129853132|NCT00614939|467420413|FG000|Overall Study|Incorrect enrollment|1|||
129853133|NCT00614939|467420414|FG001|Overall Study|Incorrect enrollment|2|||
129853134|NCT00614939|467420413|FG000|Overall Study|Death|4|||
129853135|NCT00614939|467420414|FG001|Overall Study|Death|3|||
129853136|NCT00614939|467420413|FG000|Overall Study|Poor/non-compliance|4|||
129853137|NCT00614939|467420414|FG001|Overall Study|Poor/non-compliance|0|||
129853138|NCT00614939|467420413|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
129853139|NCT00614939|467420414|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
129853140|NCT00840970|467420415|FG000|Overall Study|Adverse Event|0|||
129853141|NCT00840970|467420416|FG001|Overall Study|Adverse Event|0|||
129853142|NCT00840970|467420417|FG002|Overall Study|Adverse Event|1|||
129853143|NCT00504829|467420418|FG000|Overall Study|Protocol Violation|6|||
129853144|NCT00504829|467420419|FG001|Overall Study|Protocol Violation|4|||
129853145|NCT00504829|467420420|FG002|Overall Study|Protocol Violation|10|||
129853146|NCT01854827|467420421|FG000|Overall Study|Death|1|||
129853147|NCT02571452|467420422|FG000|Overall Study Treatment|Protocol Violation|0|||
129853148|NCT02571452|467420423|FG001|Overall Study Treatment|Protocol Violation|1|||
129853149|NCT02571452|467420422|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
129853150|NCT02571452|467420423|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
129853151|NCT02571452|467420422|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
129853152|NCT02571452|467420423|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
129906497|NCT00980330|467619166|FG004|Overall Study|(not specified)|1|||
129853153|NCT00534352|467420424|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
129853154|NCT00534352|467420424|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
129853155|NCT00534352|467420424|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
129853156|NCT00534352|467420424|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
129906498|NCT00980330|467619167|FG005|Overall Study|(not specified)|1|||
129906499|NCT00980330|467619168|FG006|Overall Study|(not specified)|0|||
129906500|NCT00666276|467619171|FG000|Overall Study|Protocol Violation|34|||
129906501|NCT00665444|467619174|FG000|Overall Study|Physician Decision|1|||
129906502|NCT00665444|467619174|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
129906503|NCT03299816|467619175|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
129906504|NCT03299816|467619176|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
129906505|NCT03299816|467619175|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
129906506|NCT03299816|467619176|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
129906507|NCT03299816|467619175|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
129906508|NCT03299816|467619176|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
129906509|NCT03520413|467619177|FG000|Overall Study|Lost to Follow-up|1|||
129906510|NCT03520413|467619178|FG001|Overall Study|Lost to Follow-up|1|||
129906511|NCT03520413|467619177|FG000|Overall Study|Withdrawal by Subject|1|||
129906512|NCT03520413|467619178|FG001|Overall Study|Withdrawal by Subject|2|||
129906513|NCT03520413|467619177|FG000|Overall Study|Death|0|||
129906514|NCT03520413|467619178|FG001|Overall Study|Death|1|||
129906515|NCT03520413|467619177|FG000|Overall Study|Physician Decision|3|||
129906516|NCT03520413|467619178|FG001|Overall Study|Physician Decision|3|||
129906517|NCT03520413|467619177|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
129906518|NCT03520413|467619178|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
129906519|NCT00869323|467619183|FG000|Maintenance Therapy|concurrent illness|1|||
129906520|NCT01135511|467619191|FG000|Overall Study|Adverse Event|0|||
129906521|NCT01135511|467619192|FG001|Overall Study|Adverse Event|1|||
129906522|NCT01135511|467619193|FG002|Overall Study|Adverse Event|2|||
129906523|NCT01135511|467619194|FG003|Overall Study|Adverse Event|0|||
129906524|NCT01135511|467619195|FG004|Overall Study|Adverse Event|0|||
129906525|NCT01135511|467619196|FG005|Overall Study|Adverse Event|1|||
129906526|NCT01135511|467619197|FG006|Overall Study|Adverse Event|0|||
129906527|NCT01135511|467619198|FG007|Overall Study|Adverse Event|1|||
129906528|NCT01135511|467619199|FG008|Overall Study|Adverse Event|0|||
129906529|NCT01135511|467619191|FG000|Overall Study|Lack of Efficacy|0|||
129906530|NCT01135511|467619192|FG001|Overall Study|Lack of Efficacy|1|||
129906531|NCT01135511|467619193|FG002|Overall Study|Lack of Efficacy|1|||
129906532|NCT01135511|467619194|FG003|Overall Study|Lack of Efficacy|2|||
129906533|NCT01135511|467619195|FG004|Overall Study|Lack of Efficacy|0|||
129906534|NCT01135511|467619196|FG005|Overall Study|Lack of Efficacy|0|||
129906535|NCT01135511|467619197|FG006|Overall Study|Lack of Efficacy|0|||
129906536|NCT01135511|467619198|FG007|Overall Study|Lack of Efficacy|0|||
129906537|NCT01135511|467619199|FG008|Overall Study|Lack of Efficacy|0|||
129906538|NCT01135511|467619191|FG000|Overall Study|Protocol Violation|0|||
129906539|NCT01135511|467619192|FG001|Overall Study|Protocol Violation|0|||
129906540|NCT01135511|467619193|FG002|Overall Study|Protocol Violation|3|||
129906541|NCT01135511|467619194|FG003|Overall Study|Protocol Violation|0|||
129906542|NCT01135511|467619195|FG004|Overall Study|Protocol Violation|0|||
129906543|NCT01135511|467619196|FG005|Overall Study|Protocol Violation|0|||
129906544|NCT01135511|467619197|FG006|Overall Study|Protocol Violation|0|||
129906545|NCT01135511|467619198|FG007|Overall Study|Protocol Violation|0|||
129906546|NCT01135511|467619199|FG008|Overall Study|Protocol Violation|0|||
129906547|NCT01135511|467619191|FG000|Overall Study|Pregnancy|0|||
129906548|NCT01135511|467619192|FG001|Overall Study|Pregnancy|0|||
129906549|NCT01135511|467619193|FG002|Overall Study|Pregnancy|0|||
129906550|NCT01135511|467619194|FG003|Overall Study|Pregnancy|1|||
129906551|NCT01135511|467619195|FG004|Overall Study|Pregnancy|0|||
129906552|NCT01135511|467619196|FG005|Overall Study|Pregnancy|0|||
129906553|NCT01135511|467619197|FG006|Overall Study|Pregnancy|0|||
129906554|NCT01135511|467619198|FG007|Overall Study|Pregnancy|0|||
129906555|NCT01135511|467619199|FG008|Overall Study|Pregnancy|0|||
129906556|NCT01135511|467619191|FG000|Overall Study|could not visit the clinic|0|||
129906557|NCT01135511|467619192|FG001|Overall Study|could not visit the clinic|1|||
129906558|NCT01135511|467619193|FG002|Overall Study|could not visit the clinic|2|||
129906559|NCT01135511|467619194|FG003|Overall Study|could not visit the clinic|0|||
129906560|NCT01135511|467619195|FG004|Overall Study|could not visit the clinic|0|||
129906561|NCT01135511|467619196|FG005|Overall Study|could not visit the clinic|0|||
129906562|NCT01135511|467619197|FG006|Overall Study|could not visit the clinic|0|||
129906563|NCT01135511|467619198|FG007|Overall Study|could not visit the clinic|0|||
129906564|NCT01135511|467619199|FG008|Overall Study|could not visit the clinic|0|||
129906565|NCT01135511|467619191|FG000|Overall Study|noncompliance with study drug taken|0|||
129906566|NCT01135511|467619192|FG001|Overall Study|noncompliance with study drug taken|0|||
129906567|NCT01135511|467619193|FG002|Overall Study|noncompliance with study drug taken|0|||
129906568|NCT01135511|467619194|FG003|Overall Study|noncompliance with study drug taken|0|||
129906569|NCT01135511|467619195|FG004|Overall Study|noncompliance with study drug taken|1|||
129906570|NCT01135511|467619196|FG005|Overall Study|noncompliance with study drug taken|0|||
129906571|NCT01135511|467619197|FG006|Overall Study|noncompliance with study drug taken|0|||
129906572|NCT01135511|467619198|FG007|Overall Study|noncompliance with study drug taken|0|||
129906573|NCT01135511|467619199|FG008|Overall Study|noncompliance with study drug taken|0|||
129906574|NCT01135511|467619191|FG000|Overall Study|Withdrawal by Subject|0|||
129906575|NCT01135511|467619192|FG001|Overall Study|Withdrawal by Subject|0|||
129906576|NCT01135511|467619193|FG002|Overall Study|Withdrawal by Subject|0|||
129906577|NCT01135511|467619194|FG003|Overall Study|Withdrawal by Subject|0|||
129906578|NCT01135511|467619195|FG004|Overall Study|Withdrawal by Subject|0|||
129906579|NCT01135511|467619196|FG005|Overall Study|Withdrawal by Subject|0|||
129906580|NCT01135511|467619197|FG006|Overall Study|Withdrawal by Subject|1|||
129906581|NCT01135511|467619198|FG007|Overall Study|Withdrawal by Subject|0|||
129906582|NCT01135511|467619199|FG008|Overall Study|Withdrawal by Subject|1|||
129906583|NCT04054635|467619200|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
129906584|NCT04054635|467619201|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
129906585|NCT04054635|467619202|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
129906586|NCT04054635|467619200|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
129906587|NCT04054635|467619201|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
129906588|NCT04054635|467619202|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
129906589|NCT00891930|467619203|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
129906590|NCT00891930|467619203|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
129906591|NCT00891930|467619203|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
129906592|NCT00891930|467619203|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
129906593|NCT00891930|467619203|FG000|Part 2 Panitumumab + AMG479|Death|30|||
129906594|NCT00638963|467619204|FG000|Overall Study|Withdrawal by Subject|1|||
129906595|NCT00638963|467619205|FG001|Overall Study|Withdrawal by Subject|0|||
129853157|NCT00534352|467420424|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
129853158|NCT00534352|467420424|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
129853159|NCT01229436|467420425|FG000|Overall Study|Withdrawal by Subject|2|||
129853160|NCT01229436|467420425|FG000|Overall Study|Lost to Follow-up|3|||
129853161|NCT04788147|467420426|FG000|Overall Study|Screen Failure|3|||
129853162|NCT04788147|467420427|FG001|Overall Study|Screen Failure|10|||
129853163|NCT04788147|467420426|FG000|Overall Study|Incomplete RMRS image session|2|||
129853164|NCT04788147|467420427|FG001|Overall Study|Incomplete RMRS image session|0|||
129853165|NCT02266381|467420430|FG000|Overall Study|Physician Decision|3|||
129853166|NCT02266381|467420431|FG001|Overall Study|Physician Decision|5|||
129853167|NCT02266381|467420432|FG002|Overall Study|Physician Decision|4|||
129853168|NCT05101252|467420435|FG000|Overall Study|Unsatisfactory Test Article|1|||
129853169|NCT05101252|467420436|FG001|Overall Study|Unsatisfactory Test Article|0|||
129853170|NCT05101252|467420435|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129853171|NCT05101252|467420436|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
129853172|NCT05101252|467420435|FG000|Overall Study|Withdrew Consent during study|0|||
129853173|NCT05101252|467420436|FG001|Overall Study|Withdrew Consent during study|1|||
129853174|NCT05101252|467420435|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
129853175|NCT05101252|467420436|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
129853176|NCT04796610|467420437|FG000|Overall Study|Withdrawal by Subject|1|||
129853177|NCT04796610|467420438|FG001|Overall Study|Withdrawal by Subject|0|||
129853178|NCT04796610|467420439|FG002|Overall Study|Withdrawal by Subject|0|||
129853179|NCT04796610|467420440|FG003|Overall Study|Withdrawal by Subject|0|||
129853180|NCT04796610|467420437|FG000|Overall Study|Lost to Follow-up|2|||
129853181|NCT04796610|467420438|FG001|Overall Study|Lost to Follow-up|0|||
129853182|NCT04796610|467420439|FG002|Overall Study|Lost to Follow-up|1|||
129853183|NCT04796610|467420440|FG003|Overall Study|Lost to Follow-up|1|||
129853184|NCT02401672|467420441|FG000|Overall Study|Withdrawal by Subject|1|||
129853185|NCT02401672|467420442|FG001|Overall Study|Withdrawal by Subject|3|||
129853186|NCT00701051|467420443|FG000|Screening|Failed Screening|40|||
129853187|NCT00701051|467420444|FG001|Screening|Failed Screening|0|||
129853188|NCT00701051|467420445|FG002|Screening|Failed Screening|0|||
129853189|NCT00701051|467420443|FG000|Screening|Time conflicts|19|||
129853190|NCT00701051|467420444|FG001|Screening|Time conflicts|0|||
129853191|NCT00701051|467420445|FG002|Screening|Time conflicts|0|||
129853192|NCT00701051|467420443|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
129853193|NCT00701051|467420444|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
129853194|NCT00701051|467420445|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
129853195|NCT02059148|467420446|FG000|Treatment 1|Protocol Violation|0|||
129853196|NCT02059148|467420447|FG001|Treatment 1|Protocol Violation|0|||
129853197|NCT02059148|467420448|FG002|Treatment 1|Protocol Violation|0|||
129853198|NCT02059148|467420449|FG003|Treatment 1|Protocol Violation|0|||
129853199|NCT02059148|467420450|FG004|Treatment 1|Protocol Violation|0|||
129906596|NCT05001945|467619208|FG000|Overall Study|Adverse Event|0|||
129906597|NCT05001945|467619209|FG001|Overall Study|Adverse Event|0|||
129853200|NCT02059148|467420451|FG005|Treatment 1|Protocol Violation|1|||
129906598|NCT05001945|467619210|FG002|Overall Study|Adverse Event|0|||
129906599|NCT05001945|467619211|FG003|Overall Study|Adverse Event|1|||
129853201|NCT01731171|467420470|FG000|Overall Study|Withdrawal by Subject|4|||
129853202|NCT01731171|467420471|FG001|Overall Study|Withdrawal by Subject|1|||
129853203|NCT01731171|467420470|FG000|Overall Study|Lost to Follow-up|3|||
129853204|NCT01731171|467420471|FG001|Overall Study|Lost to Follow-up|2|||
129853205|NCT01731171|467420470|FG000|Overall Study|Moved out of Area|0|||
129906600|NCT05001945|467619212|FG004|Overall Study|Adverse Event|0|||
129906601|NCT05001945|467619213|FG005|Overall Study|Adverse Event|0|||
129906602|NCT05001945|467619214|FG006|Overall Study|Adverse Event|0|||
129853206|NCT01731171|467420471|FG001|Overall Study|Moved out of Area|2|||
129853207|NCT01731171|467420470|FG000|Overall Study|Terminated for Lack of Adherence|0|||
129853208|NCT01731171|467420471|FG001|Overall Study|Terminated for Lack of Adherence|1|||
129853209|NCT01731171|467420470|FG000|Overall Study|Terminated for Safety Reasons|0|||
129853210|NCT01731171|467420471|FG001|Overall Study|Terminated for Safety Reasons|1|||
129853211|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
129853212|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
129853213|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
129853214|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
129906603|NCT05001945|467619215|FG007|Overall Study|Adverse Event|0|||
129906604|NCT05001945|467619208|FG000|Overall Study|Lost to Follow-up|0|||
129906605|NCT05001945|467619209|FG001|Overall Study|Lost to Follow-up|1|||
129906606|NCT05001945|467619210|FG002|Overall Study|Lost to Follow-up|1|||
129906607|NCT05001945|467619211|FG003|Overall Study|Lost to Follow-up|2|||
129906608|NCT05001945|467619212|FG004|Overall Study|Lost to Follow-up|0|||
129906609|NCT05001945|467619213|FG005|Overall Study|Lost to Follow-up|1|||
129906610|NCT05001945|467619214|FG006|Overall Study|Lost to Follow-up|0|||
129906611|NCT05001945|467619215|FG007|Overall Study|Lost to Follow-up|0|||
129906612|NCT05001945|467619208|FG000|Overall Study|Protocol Violation|1|||
129906613|NCT05001945|467619209|FG001|Overall Study|Protocol Violation|0|||
129906614|NCT05001945|467619210|FG002|Overall Study|Protocol Violation|1|||
129906615|NCT05001945|467619211|FG003|Overall Study|Protocol Violation|1|||
129906616|NCT05001945|467619212|FG004|Overall Study|Protocol Violation|0|||
129906617|NCT05001945|467619213|FG005|Overall Study|Protocol Violation|1|||
129906618|NCT05001945|467619214|FG006|Overall Study|Protocol Violation|0|||
129906619|NCT05001945|467619215|FG007|Overall Study|Protocol Violation|0|||
129906620|NCT05001945|467619208|FG000|Overall Study|Withdrawal by Subject|0|||
129906621|NCT05001945|467619209|FG001|Overall Study|Withdrawal by Subject|0|||
129906622|NCT05001945|467619210|FG002|Overall Study|Withdrawal by Subject|0|||
129906623|NCT05001945|467619211|FG003|Overall Study|Withdrawal by Subject|1|||
129906624|NCT05001945|467619212|FG004|Overall Study|Withdrawal by Subject|1|||
129906625|NCT05001945|467619213|FG005|Overall Study|Withdrawal by Subject|1|||
129906626|NCT05001945|467619214|FG006|Overall Study|Withdrawal by Subject|0|||
129906627|NCT05001945|467619215|FG007|Overall Study|Withdrawal by Subject|1|||
129906628|NCT05001945|467619208|FG000|Overall Study|Not specified by Investigator|0|||
129906629|NCT05001945|467619209|FG001|Overall Study|Not specified by Investigator|3|||
129906630|NCT05001945|467619210|FG002|Overall Study|Not specified by Investigator|0|||
129906631|NCT05001945|467619211|FG003|Overall Study|Not specified by Investigator|0|||
129906632|NCT05001945|467619212|FG004|Overall Study|Not specified by Investigator|1|||
129906633|NCT05001945|467619213|FG005|Overall Study|Not specified by Investigator|0|||
129906634|NCT05001945|467619214|FG006|Overall Study|Not specified by Investigator|0|||
129906635|NCT05001945|467619215|FG007|Overall Study|Not specified by Investigator|0|||
129906636|NCT02425111|467619216|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
129906637|NCT02425111|467619216|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
129906638|NCT02425111|467619216|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
129906639|NCT02425111|467619216|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
129906640|NCT02425111|467619216|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
129906641|NCT02425111|467619216|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
129906642|NCT01444417|467619217|FG000|Overall Study|Ineligibility Determined|0|||
129906643|NCT01444417|467619218|FG001|Overall Study|Ineligibility Determined|1|||
129906644|NCT01444417|467619217|FG000|Overall Study|Withdrawal by Subject|2|||
129906645|NCT01444417|467619218|FG001|Overall Study|Withdrawal by Subject|0|||
129906646|NCT00305695|467619219|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
129906647|NCT00305695|467619220|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
129906648|NCT00305695|467619219|FG000|Overall Study|Did not have baseline scan|1|||
129906649|NCT00305695|467619220|FG001|Overall Study|Did not have baseline scan|1|||
129906650|NCT00206375|467619221|FG000|Overall Study|Lost to Follow-up|1|||
129906651|NCT00206375|467619222|FG001|Overall Study|Lost to Follow-up|0|||
129853215|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
129853216|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
129853217|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
129906652|NCT00206375|467619223|FG002|Overall Study|Lost to Follow-up|0|||
129853218|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
129853219|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
129906653|NCT00206375|467619221|FG000|Overall Study|Withdrawal by Subject|2|||
129906654|NCT00206375|467619222|FG001|Overall Study|Withdrawal by Subject|1|||
129906655|NCT00206375|467619223|FG002|Overall Study|Withdrawal by Subject|3|||
129906656|NCT00206375|467619221|FG000|Overall Study|Study terminated due to lack of funds|0|||
129906657|NCT00206375|467619222|FG001|Overall Study|Study terminated due to lack of funds|1|||
129906658|NCT00206375|467619223|FG002|Overall Study|Study terminated due to lack of funds|1|||
129906659|NCT01121549|467619224|FG000|Overall Study|Adverse Event|10|||
129906660|NCT01121549|467619224|FG000|Overall Study|Lack of Efficacy|11|||
129853220|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
129853221|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
129853222|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
129853223|NCT00403546|467420474|FG000|Screening Phase|Screening Failure|22|||
129853224|NCT00403546|467420475|FG001|Screening Phase|Screening Failure|0|||
129853225|NCT00403546|467420476|FG002|Screening Phase|Screening Failure|0|||
129853226|NCT00403546|467420474|FG000|Screening Phase|Adverse Event|1|||
129853227|NCT00403546|467420475|FG001|Screening Phase|Adverse Event|0|||
129853228|NCT00403546|467420476|FG002|Screening Phase|Adverse Event|0|||
129853229|NCT00403546|467420474|FG000|Screening Phase|Terminated Prior to Randomization|5|||
129853230|NCT00403546|467420475|FG001|Screening Phase|Terminated Prior to Randomization|0|||
129853231|NCT00403546|467420476|FG002|Screening Phase|Terminated Prior to Randomization|0|||
129853232|NCT00403546|467420474|FG000|Randomized Trial|Early Terminations|0|||
129853233|NCT00403546|467420475|FG001|Randomized Trial|Early Terminations|17|||
129853234|NCT00403546|467420476|FG002|Randomized Trial|Early Terminations|16|||
129853235|NCT02673697|467420477|FG000|Overall Study|Adverse Event|2|||
129853236|NCT02673697|467420478|FG001|Overall Study|Adverse Event|0|||
129853237|NCT02673697|467420477|FG000|Overall Study|Death|32|||
129853238|NCT02673697|467420478|FG001|Overall Study|Death|24|||
129853239|NCT02673697|467420477|FG000|Overall Study|Lost to Follow-up|5|||
129853240|NCT02673697|467420478|FG001|Overall Study|Lost to Follow-up|2|||
129853241|NCT02673697|467420477|FG000|Overall Study|Physician Decision|2|||
129853242|NCT02673697|467420478|FG001|Overall Study|Physician Decision|1|||
129853243|NCT02673697|467420477|FG000|Overall Study|Withdrawal by Subject|10|||
129853244|NCT02673697|467420478|FG001|Overall Study|Withdrawal by Subject|7|||
129853245|NCT02673697|467420477|FG000|Overall Study|Change subj medical status|1|||
129853246|NCT02673697|467420478|FG001|Overall Study|Change subj medical status|2|||
129853247|NCT02673697|467420477|FG000|Overall Study|Explant|10|||
129853248|NCT02673697|467420478|FG001|Overall Study|Explant|5|||
129853249|NCT02673697|467420477|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
129853250|NCT02673697|467420478|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
129853251|NCT00437489|467420479|FG000|Overall Study|Study terminated by sponsor|23|||
129853252|NCT00437489|467420480|FG001|Overall Study|Study terminated by sponsor|21|||
129853253|NCT00437489|467420479|FG000|Overall Study|Lost to Follow-up|0|||
129853254|NCT00437489|467420480|FG001|Overall Study|Lost to Follow-up|1|||
129853255|NCT03893448|467420486|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
129853256|NCT03893448|467420487|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
129853257|NCT03893448|467420486|FG000|Overall Study|Physician Decision|8|||
129853258|NCT03893448|467420487|FG001|Overall Study|Physician Decision|14|||
129853259|NCT03893448|467420486|FG000|Overall Study|Lost to Follow-up|34|||
129853260|NCT03893448|467420487|FG001|Overall Study|Lost to Follow-up|27|||
129853261|NCT03893448|467420486|FG000|Overall Study|Death|1|||
129853262|NCT03893448|467420487|FG001|Overall Study|Death|0|||
129853263|NCT02604589|467420490|FG000|Overall Study|catheter dislodgement|0|||
129853264|NCT02604589|467420491|FG001|Overall Study|catheter dislodgement|0|||
129853265|NCT02604589|467420492|FG002|Overall Study|catheter dislodgement|1|||
129853266|NCT00793910|467420493|FG000|Overall Study|discarded study pills|0|||
129853267|NCT00793910|467420494|FG001|Overall Study|discarded study pills|1|||
129853268|NCT00793910|467420493|FG000|Overall Study|did not pick up medications|1|||
129853269|NCT00793910|467420494|FG001|Overall Study|did not pick up medications|1|||
129853270|NCT00793910|467420493|FG000|Overall Study|ineligible based on entry criteria|2|||
129853271|NCT00793910|467420494|FG001|Overall Study|ineligible based on entry criteria|3|||
129853272|NCT00793910|467420493|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
129853273|NCT00793910|467420494|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
129906661|NCT01121549|467619224|FG000|Overall Study|Lost to Follow-up|12|||
129906662|NCT01121549|467619224|FG000|Overall Study|Did not meet entrance criteria|9|||
129906663|NCT01121549|467619224|FG000|Overall Study|Study terminated by sponsor|197|||
129906664|NCT01121549|467619224|FG000|Overall Study|Pregnancy|1|||
129906665|NCT01121549|467619224|FG000|Overall Study|Protocol Violation|33|||
129906666|NCT01121549|467619224|FG000|Overall Study|Withdrawal by Subject|16|||
129906667|NCT01121549|467619224|FG000|Overall Study|Other|58|||
129906668|NCT04789408|467619225|FG000|Overall Study|Death|4|||
130116607|NCT01590433|468387128|FG001|Overall Study|Withdrawal by Subject|11|||
130116608|NCT01590433|468387127|FG000|Overall Study|Adverse Event|11|||
129853274|NCT00793910|467420493|FG000|Overall Study|Withdrawal by Subject|0|||
129853275|NCT00793910|467420494|FG001|Overall Study|Withdrawal by Subject|1|||
129853276|NCT01700946|467420495|FG000|Overall Study|Lost to Follow-up|1|||
129853277|NCT01700946|467420496|FG001|Overall Study|Lost to Follow-up|0|||
129853278|NCT01700946|467420495|FG000|Overall Study|Physician Decision|7|||
129853279|NCT01700946|467420496|FG001|Overall Study|Physician Decision|12|||
129853280|NCT01700946|467420495|FG000|Overall Study|Withdrawal by Subject|0|||
129853281|NCT01700946|467420496|FG001|Overall Study|Withdrawal by Subject|2|||
129853282|NCT01700946|467420495|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
129853283|NCT01700946|467420496|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
129853284|NCT01700946|467420495|FG000|Overall Study|Relapse|2|||
129906669|NCT04789408|467619226|FG001|Overall Study|Death|3|||
129906670|NCT04789408|467619227|FG002|Overall Study|Death|6|||
129906671|NCT04789408|467619225|FG000|Overall Study|Did not meet eligibility criteria|1|||
129906672|NCT04789408|467619226|FG001|Overall Study|Did not meet eligibility criteria|0|||
129906673|NCT04789408|467619227|FG002|Overall Study|Did not meet eligibility criteria|0|||
129906674|NCT04789408|467619225|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
129906675|NCT04789408|467619226|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
129906676|NCT04789408|467619227|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
129906677|NCT01420549|467619228|FG000|Overall Study|Adverse Event|1|||
129906678|NCT01420549|467619229|FG001|Overall Study|Adverse Event|1|||
129906679|NCT01420549|467619228|FG000|Overall Study|Lost to Follow-up|2|||
129906680|NCT01420549|467619229|FG001|Overall Study|Lost to Follow-up|2|||
129906681|NCT01420549|467619228|FG000|Overall Study|Protocol Violation|0|||
129906682|NCT01420549|467619229|FG001|Overall Study|Protocol Violation|1|||
129906683|NCT01420549|467619228|FG000|Overall Study|Non-adherence to medication|4|||
129906684|NCT01420549|467619229|FG001|Overall Study|Non-adherence to medication|1|||
129906685|NCT02755805|467620624|FG000|Overall Study|Lost to Follow-up|1|||
129906686|NCT02755805|467620625|FG001|Overall Study|Lost to Follow-up|2|||
129906687|NCT02755805|467620624|FG000|Overall Study|Refused assessments|1|||
129906688|NCT02755805|467620625|FG001|Overall Study|Refused assessments|0|||
129906689|NCT02755805|467620624|FG000|Overall Study|Withdrawal by Subject|0|||
129906690|NCT02755805|467620625|FG001|Overall Study|Withdrawal by Subject|2|||
129906691|NCT02252042|467620629|FG000|Overall Study|Adverse Event|9|||
129906692|NCT02252042|467620630|FG001|Overall Study|Adverse Event|6|||
129906693|NCT02252042|467620629|FG000|Overall Study|Death|209|||
129906694|NCT02252042|467620630|FG001|Overall Study|Death|217|||
129906695|NCT02252042|467620629|FG000|Overall Study|Physician Decision|0|||
129906696|NCT02252042|467620630|FG001|Overall Study|Physician Decision|2|||
129906697|NCT02252042|467620629|FG000|Overall Study|Transferred to Extension Study|7|||
129906698|NCT02252042|467620630|FG001|Overall Study|Transferred to Extension Study|1|||
129906699|NCT02252042|467620629|FG000|Overall Study|Did Not Continue on Extension Study|7|||
129906700|NCT02252042|467620630|FG001|Overall Study|Did Not Continue on Extension Study|2|||
129906701|NCT02252042|467620629|FG000|Overall Study|Withdrawal by Subject|15|||
129906702|NCT02252042|467620630|FG001|Overall Study|Withdrawal by Subject|20|||
129906703|NCT02593149|467620631|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
129906704|NCT02593149|467620632|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
129906705|NCT02593149|467620631|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
129906706|NCT02593149|467620632|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
129906707|NCT00979992|467620634|FG000|Overall Study|Ineligible - inadequate pathology|1|||
129906708|NCT00979992|467620634|FG000|Overall Study|Ineligible - wrong cell type|2|||
129906709|NCT00979992|467620634|FG000|Overall Study|Refused - Never Treated|2|||
129906710|NCT04532528|467620638|FG000|Overall Study|Adverse Event|12|||
129906711|NCT04532528|467620639|FG001|Overall Study|Adverse Event|17|||
129906712|NCT04532528|467620638|FG000|Overall Study|Withdrawal of consent|16|||
129906713|NCT04532528|467620639|FG001|Overall Study|Withdrawal of consent|17|||
129906714|NCT04532528|467620638|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
129906715|NCT04532528|467620639|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
129906716|NCT04532528|467620638|FG000|Overall Study|Lost to Follow-up|69|||
129906717|NCT04532528|467620639|FG001|Overall Study|Lost to Follow-up|68|||
129906718|NCT04532528|467620638|FG000|Overall Study|Administrative problems|12|||
129906719|NCT04532528|467620639|FG001|Overall Study|Administrative problems|14|||
129906720|NCT04532528|467620638|FG000|Overall Study|Death|3|||
129906721|NCT04532528|467620639|FG001|Overall Study|Death|3|||
129906722|NCT04532528|467620638|FG000|Overall Study|Other|38|||
129906723|NCT04532528|467620639|FG001|Overall Study|Other|46|||
129906724|NCT01636687|467620640|FG000|Induction Period|Withdrawal by Subject|1|||
129906725|NCT01636687|467620641|FG001|Induction Period|Withdrawal by Subject|0|||
129906726|NCT01636687|467620642|FG002|Induction Period|Withdrawal by Subject|0|||
129906727|NCT01636687|467620643|FG003|Induction Period|Withdrawal by Subject|0|||
129906728|NCT01636687|467620644|FG004|Induction Period|Withdrawal by Subject|0|||
129906729|NCT01636687|467620640|FG000|Induction Period|Adverse Event|1|||
129906730|NCT01636687|467620641|FG001|Induction Period|Adverse Event|0|||
129906731|NCT01636687|467620642|FG002|Induction Period|Adverse Event|0|||
129906732|NCT01636687|467620643|FG003|Induction Period|Adverse Event|0|||
129906733|NCT01636687|467620644|FG004|Induction Period|Adverse Event|1|||
129906734|NCT01636687|467620640|FG000|Induction Period|Lack of Efficacy|0|||
129906735|NCT01636687|467620641|FG001|Induction Period|Lack of Efficacy|0|||
129906736|NCT01636687|467620642|FG002|Induction Period|Lack of Efficacy|0|||
129906737|NCT01636687|467620643|FG003|Induction Period|Lack of Efficacy|0|||
129906738|NCT01636687|467620644|FG004|Induction Period|Lack of Efficacy|1|||
129906739|NCT01636687|467620640|FG000|Induction Period|Physician Decision|1|||
129906740|NCT01636687|467620641|FG001|Induction Period|Physician Decision|0|||
129906741|NCT01636687|467620642|FG002|Induction Period|Physician Decision|0|||
129906742|NCT01636687|467620643|FG003|Induction Period|Physician Decision|0|||
129906743|NCT01636687|467620644|FG004|Induction Period|Physician Decision|0|||
129906744|NCT01636687|467620640|FG000|Maintenance Period|Withdrawal by Subject|2|||
129906745|NCT01636687|467620641|FG001|Maintenance Period|Withdrawal by Subject|0|||
129906746|NCT01636687|467620642|FG002|Maintenance Period|Withdrawal by Subject|2|||
129906747|NCT01636687|467620643|FG003|Maintenance Period|Withdrawal by Subject|0|||
129906748|NCT01636687|467620644|FG004|Maintenance Period|Withdrawal by Subject|0|||
129906749|NCT01636687|467620640|FG000|Maintenance Period|Adverse Event|1|||
129906750|NCT01636687|467620641|FG001|Maintenance Period|Adverse Event|0|||
129906751|NCT01636687|467620642|FG002|Maintenance Period|Adverse Event|0|||
129906752|NCT01636687|467620643|FG003|Maintenance Period|Adverse Event|0|||
129906753|NCT01636687|467620644|FG004|Maintenance Period|Adverse Event|0|||
129906754|NCT01636687|467620640|FG000|Maintenance Period|Lack of Efficacy|4|||
129906755|NCT01636687|467620641|FG001|Maintenance Period|Lack of Efficacy|1|||
129906756|NCT01636687|467620642|FG002|Maintenance Period|Lack of Efficacy|0|||
129906757|NCT01636687|467620643|FG003|Maintenance Period|Lack of Efficacy|0|||
129906758|NCT01636687|467620644|FG004|Maintenance Period|Lack of Efficacy|0|||
129906759|NCT01636687|467620640|FG000|Maintenance Period|Lost to Follow-up|1|||
129906760|NCT01636687|467620641|FG001|Maintenance Period|Lost to Follow-up|1|||
129906761|NCT01636687|467620642|FG002|Maintenance Period|Lost to Follow-up|0|||
129906762|NCT01636687|467620643|FG003|Maintenance Period|Lost to Follow-up|0|||
129906763|NCT01636687|467620644|FG004|Maintenance Period|Lost to Follow-up|1|||
129906764|NCT01636687|467620640|FG000|Maintenance Period|Physician Decision|0|||
129906765|NCT01636687|467620641|FG001|Maintenance Period|Physician Decision|0|||
129906766|NCT01636687|467620642|FG002|Maintenance Period|Physician Decision|0|||
129906767|NCT01636687|467620643|FG003|Maintenance Period|Physician Decision|0|||
129853285|NCT01700946|467420496|FG001|Overall Study|Relapse|1|||
129853286|NCT01700946|467420495|FG000|Overall Study|Unacceptable toxicity|1|||
129853287|NCT01700946|467420496|FG001|Overall Study|Unacceptable toxicity|0|||
129853288|NCT04934670|467420504|FG000|Overall Study|Death|4|||
129853289|NCT04934670|467420505|FG001|Overall Study|Death|0|||
129853290|NCT04934670|467420504|FG000|Overall Study|Lost to Follow-up|1|||
129853291|NCT04934670|467420505|FG001|Overall Study|Lost to Follow-up|4|||
129853292|NCT00817089|467420506|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
129853293|NCT00817089|467420507|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
129853294|NCT00817089|467420508|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
129853295|NCT00817089|467420509|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
129853296|NCT00817089|467420506|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
129853297|NCT00817089|467420507|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
129853298|NCT00817089|467420508|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
129853299|NCT00817089|467420509|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
129853300|NCT03783923|467420510|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
129853301|NCT03783923|467420511|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
129853302|NCT03783923|467420510|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
129853303|NCT03783923|467420511|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
129853304|NCT03783923|467420510|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
129853305|NCT03783923|467420511|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
129853306|NCT03783923|467420510|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
129853307|NCT03783923|467420511|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
129853308|NCT03783923|467420510|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
129853309|NCT03783923|467420511|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
129853310|NCT01592708|467420512|FG000|Overall Study|Protocol Violation|3|||
129853311|NCT01592708|467420513|FG001|Overall Study|Protocol Violation|0|||
129853312|NCT01785602|467420517|FG000|Overall Study|Withdrawal by Subject|2|||
129853313|NCT01785602|467420518|FG001|Overall Study|Withdrawal by Subject|0|||
129853314|NCT01785602|467420517|FG000|Overall Study|Lost to Follow-up|1|||
129853315|NCT01785602|467420518|FG001|Overall Study|Lost to Follow-up|1|||
129853316|NCT01785602|467420517|FG000|Overall Study|Adverse Event|3|||
129853317|NCT01785602|467420518|FG001|Overall Study|Adverse Event|5|||
129853318|NCT01785602|467420517|FG000|Overall Study|Administrative problems|7|||
129853319|NCT01785602|467420518|FG001|Overall Study|Administrative problems|3|||
129853320|NCT02041429|467420520|FG000|Overall Study|Progressive Disease|2|||
129853321|NCT02041429|467420521|FG001|Overall Study|Progressive Disease|2|||
129853322|NCT02041429|467420522|FG002|Overall Study|Progressive Disease|3|||
129853323|NCT02041429|467420523|FG003|Overall Study|Progressive Disease|2|||
129853324|NCT02041429|467420520|FG000|Overall Study|Toxicity|0|||
129853325|NCT02041429|467420521|FG001|Overall Study|Toxicity|1|||
129853326|NCT02041429|467420522|FG002|Overall Study|Toxicity|4|||
129853327|NCT02041429|467420523|FG003|Overall Study|Toxicity|2|||
129853328|NCT02041429|467420520|FG000|Overall Study|Withdrawal by Subject|0|||
129853329|NCT02041429|467420521|FG001|Overall Study|Withdrawal by Subject|1|||
129906768|NCT01636687|467620644|FG004|Maintenance Period|Physician Decision|1|||
129906769|NCT01636687|467620640|FG000|Extension Period|technical problems|0|||
129853330|NCT02041429|467420522|FG002|Overall Study|Withdrawal by Subject|0|||
129853331|NCT02041429|467420523|FG003|Overall Study|Withdrawal by Subject|0|||
129853332|NCT02041429|467420520|FG000|Overall Study|On Maintenance Therapy|1|||
129853333|NCT02041429|467420521|FG001|Overall Study|On Maintenance Therapy|0|||
129853334|NCT02041429|467420522|FG002|Overall Study|On Maintenance Therapy|0|||
129853335|NCT02041429|467420523|FG003|Overall Study|On Maintenance Therapy|2|||
129853336|NCT00101101|467420524|FG000|Overall Study|never received vaccine|20|||
129853337|NCT01418209|467420525|FG000|Overall Study|Withdrawal by Subject|1|||
129853338|NCT01418209|467420526|FG001|Overall Study|Withdrawal by Subject|0|||
129853339|NCT01418209|467420527|FG002|Overall Study|Withdrawal by Subject|1|||
129853340|NCT01418209|467420525|FG000|Overall Study|Did not provide hot flash diary data|1|||
129853341|NCT01418209|467420526|FG001|Overall Study|Did not provide hot flash diary data|3|||
129853342|NCT01418209|467420527|FG002|Overall Study|Did not provide hot flash diary data|3|||
129853343|NCT01603875|467420529|FG000|Overall Study|Preexisting rabies antibody|3|||
129853344|NCT01603875|467420530|FG001|Overall Study|Preexisting rabies antibody|4|||
129853345|NCT01603875|467420531|FG002|Overall Study|Preexisting rabies antibody|3|||
129853346|NCT01603875|467420529|FG000|Overall Study|Lost to Follow-up|4|||
129853347|NCT01603875|467420530|FG001|Overall Study|Lost to Follow-up|3|||
129853348|NCT01603875|467420531|FG002|Overall Study|Lost to Follow-up|6|||
129853349|NCT01603875|467420529|FG000|Overall Study|Protocol Violation|0|||
129853350|NCT01603875|467420530|FG001|Overall Study|Protocol Violation|1|||
129853351|NCT01603875|467420531|FG002|Overall Study|Protocol Violation|0|||
129853352|NCT01971346|467420532|FG000|Overall Study|Protocol Violation|3|||
129853353|NCT01971346|467420532|FG000|Overall Study|Lost to Follow-up|2|||
129853354|NCT01971346|467420532|FG000|Overall Study|Withdrawal by Subject|2|||
129853355|NCT01971346|467420532|FG000|Overall Study|Physician Decision|1|||
129853356|NCT02460198|467420536|FG000|Overall Study|Adverse Event|1|||
129853357|NCT02460198|467420537|FG001|Overall Study|Adverse Event|3|||
129853358|NCT02460198|467420536|FG000|Overall Study|Death|36|||
129853359|NCT02460198|467420537|FG001|Overall Study|Death|28|||
129853360|NCT02460198|467420536|FG000|Overall Study|Lost to Follow-up|1|||
129853361|NCT02460198|467420537|FG001|Overall Study|Lost to Follow-up|1|||
129853362|NCT02460198|467420536|FG000|Overall Study|Transferred to Extension Study|15|||
129853363|NCT02460198|467420537|FG001|Overall Study|Transferred to Extension Study|15|||
129853364|NCT02460198|467420536|FG000|Overall Study|Withdrawal by Subject|2|||
129853365|NCT02460198|467420537|FG001|Overall Study|Withdrawal by Subject|4|||
129853366|NCT02460198|467420536|FG000|Overall Study|Site Terminated By Sponsor|0|||
129853367|NCT02460198|467420537|FG001|Overall Study|Site Terminated By Sponsor|1|||
129853368|NCT02460198|467420536|FG000|Overall Study|Did Not Continue on Extension Study|6|||
129853369|NCT02460198|467420537|FG001|Overall Study|Did Not Continue on Extension Study|11|||
129853370|NCT04382612|467420538|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
129853371|NCT04666441|467420539|FG000|Overall Study|Lost to Follow-up|1|||
129853372|NCT04666441|467420540|FG001|Overall Study|Lost to Follow-up|4|||
129853373|NCT04666441|467420541|FG002|Overall Study|Lost to Follow-up|1|||
129853374|NCT04666441|467420542|FG003|Overall Study|Lost to Follow-up|3|||
129853375|NCT04666441|467420543|FG004|Overall Study|Lost to Follow-up|0|||
129853376|NCT04666441|467420544|FG005|Overall Study|Lost to Follow-up|2|||
129853377|NCT04666441|467420545|FG006|Overall Study|Lost to Follow-up|2|||
129853378|NCT04666441|467420546|FG007|Overall Study|Lost to Follow-up|2|||
129853379|NCT04666441|467420539|FG000|Overall Study|Subject Decision|1|||
129853380|NCT04666441|467420540|FG001|Overall Study|Subject Decision|1|||
129853381|NCT04666441|467420541|FG002|Overall Study|Subject Decision|3|||
129853382|NCT04666441|467420542|FG003|Overall Study|Subject Decision|1|||
129853383|NCT04666441|467420543|FG004|Overall Study|Subject Decision|0|||
129853384|NCT04666441|467420544|FG005|Overall Study|Subject Decision|1|||
129853385|NCT04666441|467420545|FG006|Overall Study|Subject Decision|3|||
129853386|NCT04666441|467420546|FG007|Overall Study|Subject Decision|2|||
129853387|NCT03285477|467420547|FG000|Treatment and Response Assessment Period|Death|1|||
129853388|NCT03285477|467420548|FG001|Treatment and Response Assessment Period|Death|0|||
129853389|NCT03285477|467420547|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
129853390|NCT03285477|467420548|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
129853391|NCT03285477|467420547|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
129853392|NCT03285477|467420548|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
129853393|NCT03285477|467420547|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
129853394|NCT03285477|467420548|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
129853395|NCT03285477|467420547|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
129853396|NCT03285477|467420548|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
129853397|NCT01071395|467422474|FG000|Overall Study|Withdrawal by Subject|2|||
129853398|NCT01071395|467422475|FG001|Overall Study|Withdrawal by Subject|1|||
129853399|NCT01071395|467422474|FG000|Overall Study|Adverse Event|3|||
129853400|NCT01071395|467422475|FG001|Overall Study|Adverse Event|1|||
129853401|NCT01539291|467422476|FG000|Study GS-US-312-0116|Adverse Event|9|||
129853402|NCT01539291|467422477|FG001|Study GS-US-312-0116|Adverse Event|0|||
129853403|NCT01539291|467422478|FG002|Study GS-US-312-0116|Adverse Event|0|||
129853404|NCT01539291|467422479|FG003|Study GS-US-312-0116|Adverse Event|0|||
129853405|NCT01539291|467422476|FG000|Study GS-US-312-0116|Physician Decision|1|||
129853406|NCT01539291|467422477|FG001|Study GS-US-312-0116|Physician Decision|0|||
129853407|NCT01539291|467422478|FG002|Study GS-US-312-0116|Physician Decision|0|||
129853408|NCT01539291|467422479|FG003|Study GS-US-312-0116|Physician Decision|0|||
129853409|NCT01539291|467422476|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
129853410|NCT01539291|467422477|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
129853411|NCT01539291|467422478|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
129853412|NCT01539291|467422479|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
129906770|NCT01636687|467620641|FG001|Extension Period|technical problems|1|||
129906771|NCT01636687|467620642|FG002|Extension Period|technical problems|2|||
129906772|NCT01636687|467620643|FG003|Extension Period|technical problems|1|||
129906773|NCT01636687|467620644|FG004|Extension Period|technical problems|0|||
129906774|NCT01636687|467620640|FG000|Extension Period|Adverse Event|4|||
129906775|NCT01636687|467620641|FG001|Extension Period|Adverse Event|3|||
129906776|NCT01636687|467620642|FG002|Extension Period|Adverse Event|2|||
129906777|NCT01636687|467620643|FG003|Extension Period|Adverse Event|1|||
129906778|NCT01636687|467620644|FG004|Extension Period|Adverse Event|0|||
129906779|NCT01636687|467620640|FG000|Extension Period|Lack of Efficacy|7|||
129906780|NCT01636687|467620641|FG001|Extension Period|Lack of Efficacy|0|||
129906781|NCT01636687|467620642|FG002|Extension Period|Lack of Efficacy|2|||
129906782|NCT01636687|467620643|FG003|Extension Period|Lack of Efficacy|1|||
129906783|NCT01636687|467620644|FG004|Extension Period|Lack of Efficacy|0|||
129906784|NCT01636687|467620640|FG000|Extension Period|Lost to Follow-up|1|||
129906785|NCT01636687|467620641|FG001|Extension Period|Lost to Follow-up|0|||
129906786|NCT01636687|467620642|FG002|Extension Period|Lost to Follow-up|1|||
129906787|NCT01636687|467620643|FG003|Extension Period|Lost to Follow-up|0|||
129906788|NCT01636687|467620644|FG004|Extension Period|Lost to Follow-up|0|||
129906789|NCT01636687|467620640|FG000|Extension Period|Physician Decision|1|||
129906790|NCT01636687|467620641|FG001|Extension Period|Physician Decision|0|||
129906791|NCT01636687|467620642|FG002|Extension Period|Physician Decision|0|||
129906792|NCT01636687|467620643|FG003|Extension Period|Physician Decision|1|||
129906793|NCT01636687|467620644|FG004|Extension Period|Physician Decision|0|||
129906794|NCT01636687|467620640|FG000|Extension Period|study terminated by sponsor|33|||
129906795|NCT01636687|467620641|FG001|Extension Period|study terminated by sponsor|50|||
129906796|NCT01636687|467620642|FG002|Extension Period|study terminated by sponsor|17|||
129906797|NCT01636687|467620643|FG003|Extension Period|study terminated by sponsor|23|||
129906798|NCT01636687|467620644|FG004|Extension Period|study terminated by sponsor|0|||
129906799|NCT01636687|467620640|FG000|Extension Period|Withdrawal by Subject|1|||
129906800|NCT01636687|467620641|FG001|Extension Period|Withdrawal by Subject|0|||
129906801|NCT01636687|467620642|FG002|Extension Period|Withdrawal by Subject|1|||
129906802|NCT01636687|467620643|FG003|Extension Period|Withdrawal by Subject|1|||
129906803|NCT01636687|467620644|FG004|Extension Period|Withdrawal by Subject|0|||
129906804|NCT01636687|467620640|FG000|Follow-up Period|Withdrawal by Subject|1|||
129906805|NCT01636687|467620641|FG001|Follow-up Period|Withdrawal by Subject|0|||
129906806|NCT01636687|467620642|FG002|Follow-up Period|Withdrawal by Subject|0|||
129906807|NCT01636687|467620643|FG003|Follow-up Period|Withdrawal by Subject|0|||
129906808|NCT01636687|467620644|FG004|Follow-up Period|Withdrawal by Subject|1|||
129906809|NCT01460290|467620652|FG000|Overall Study|Adverse Event|3|||
129906810|NCT01460290|467620652|FG000|Overall Study|Elevated liver function|1|||
129906811|NCT01039688|467620657|FG000|Overall Study|Adverse Event|38|||
129906812|NCT01039688|467620658|FG001|Overall Study|Adverse Event|39|||
129906813|NCT01039688|467620659|FG002|Overall Study|Adverse Event|24|||
129906814|NCT01039688|467620657|FG000|Overall Study|Lack of Efficacy|20|||
129906815|NCT01039688|467620658|FG001|Overall Study|Lack of Efficacy|11|||
129906816|NCT01039688|467620659|FG002|Overall Study|Lack of Efficacy|26|||
129906817|NCT01039688|467620657|FG000|Overall Study|Lost to Follow-up|11|||
129906818|NCT01039688|467620658|FG001|Overall Study|Lost to Follow-up|9|||
129906819|NCT01039688|467620659|FG002|Overall Study|Lost to Follow-up|5|||
129906820|NCT01039688|467620657|FG000|Overall Study|Other|13|||
129906821|NCT01039688|467620658|FG001|Overall Study|Other|25|||
129906822|NCT01039688|467620659|FG002|Overall Study|Other|12|||
129906823|NCT01039688|467620657|FG000|Overall Study|Withdrawal by Subject|23|||
129906824|NCT01039688|467620658|FG001|Overall Study|Withdrawal by Subject|27|||
129906825|NCT01039688|467620659|FG002|Overall Study|Withdrawal by Subject|13|||
129906826|NCT01039688|467620657|FG000|Overall Study|Death|2|||
129906827|NCT01039688|467620658|FG001|Overall Study|Death|0|||
129906828|NCT01039688|467620659|FG002|Overall Study|Death|0|||
129906829|NCT00668863|467620660|FG000|Overall Study|Objective Progression or Relapse|42|||
129906830|NCT00668863|467620660|FG000|Overall Study|Adverse Event|13|||
129906831|NCT00668863|467620660|FG000|Overall Study|Study Terminated by Sponsor|8|||
129906832|NCT00668863|467620660|FG000|Overall Study|Global Deterioration of Health Status|4|||
129906833|NCT00668863|467620660|FG000|Overall Study|Withdrawal by Subject|1|||
129906834|NCT00668863|467620660|FG000|Overall Study|Surgery|1|||
129906835|NCT00668863|467620660|FG000|Overall Study|Subject's work scheduling problem|1|||
129906836|NCT00668863|467620660|FG000|Overall Study|Physician Decision|1|||
129906837|NCT02448446|467620665|FG000|Overall Study|Withdrawal by Subject|1|||
129906838|NCT02448446|467620666|FG001|Overall Study|Withdrawal by Subject|0|||
129906839|NCT02755116|467620672|FG000|Overall Study|surgery converted to open, pt admitted|3|||
129906840|NCT02755116|467620673|FG001|Overall Study|surgery converted to open, pt admitted|1|||
129906841|NCT01124734|467620677|FG000|Overall Study|Disease progression|13|||
129906842|NCT01124734|467620677|FG000|Overall Study|Adverse Event|1|||
129906843|NCT01124734|467620677|FG000|Overall Study|Withdrawal by Subject|1|||
129906844|NCT01124734|467620677|FG000|Overall Study|Elected for alternative treatment|2|||
129906845|NCT02214160|467620679|FG000|Overall Study|Withdrawal by Subject|1|||
129906846|NCT02214160|467620680|FG001|Overall Study|Withdrawal by Subject|0|||
129853413|NCT01539291|467422476|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
129853414|NCT01539291|467422477|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
129853415|NCT01539291|467422478|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
129853416|NCT01539291|467422479|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
129853417|NCT01539291|467422476|FG000|Study GS-US-312-0116|Other|1|||
129853418|NCT01539291|467422477|FG001|Study GS-US-312-0116|Other|0|||
129853419|NCT01539291|467422478|FG002|Study GS-US-312-0116|Other|0|||
129853420|NCT01539291|467422479|FG003|Study GS-US-312-0116|Other|0|||
129853421|NCT01539291|467422476|FG000|Study GS-US-312-0117|Adverse Event|22|||
129853422|NCT01539291|467422477|FG001|Study GS-US-312-0117|Adverse Event|1|||
129853423|NCT01539291|467422478|FG002|Study GS-US-312-0117|Adverse Event|9|||
129853424|NCT01539291|467422479|FG003|Study GS-US-312-0117|Adverse Event|12|||
129853425|NCT01539291|467422476|FG000|Study GS-US-312-0117|Physician Decision|9|||
129853426|NCT01539291|467422477|FG001|Study GS-US-312-0117|Physician Decision|0|||
129853427|NCT01539291|467422478|FG002|Study GS-US-312-0117|Physician Decision|6|||
129853428|NCT01539291|467422479|FG003|Study GS-US-312-0117|Physician Decision|4|||
129853429|NCT01539291|467422476|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
129853430|NCT01539291|467422477|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
129853431|NCT01539291|467422478|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
129853432|NCT01539291|467422479|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
129853433|NCT01539291|467422476|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
129853434|NCT01539291|467422477|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
129853435|NCT01539291|467422478|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
129853436|NCT01539291|467422479|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
129853437|NCT01539291|467422476|FG000|Study GS-US-312-0117|Other|2|||
129853438|NCT01539291|467422477|FG001|Study GS-US-312-0117|Other|1|||
129853439|NCT01539291|467422478|FG002|Study GS-US-312-0117|Other|1|||
129853440|NCT01539291|467422479|FG003|Study GS-US-312-0117|Other|1|||
129853441|NCT02627677|467422480|FG000|Overall Study|Adverse event (not progressive disease)|1|||
129853442|NCT02627677|467422481|FG001|Overall Study|Adverse event (not progressive disease)|4|||
129853443|NCT02627677|467422482|FG002|Overall Study|Adverse event (not progressive disease)|1|||
129853444|NCT02627677|467422480|FG000|Overall Study|Progressive disease|1|||
129853445|NCT02627677|467422481|FG001|Overall Study|Progressive disease|3|||
129853446|NCT02627677|467422482|FG002|Overall Study|Progressive disease|0|||
129853447|NCT02627677|467422480|FG000|Overall Study|Lack of Efficacy|1|||
129853448|NCT02627677|467422481|FG001|Overall Study|Lack of Efficacy|2|||
129853449|NCT02627677|467422482|FG002|Overall Study|Lack of Efficacy|0|||
129853450|NCT02627677|467422480|FG000|Overall Study|Lost to Follow-up|0|||
129853451|NCT02627677|467422481|FG001|Overall Study|Lost to Follow-up|0|||
129853452|NCT02627677|467422482|FG002|Overall Study|Lost to Follow-up|1|||
129853453|NCT02627677|467422480|FG000|Overall Study|Pregnancy|0|||
129853454|NCT02627677|467422481|FG001|Overall Study|Pregnancy|1|||
129853455|NCT02627677|467422482|FG002|Overall Study|Pregnancy|0|||
129853456|NCT02627677|467422480|FG000|Overall Study|Study Terminated by Sponsor|5|||
129853457|NCT02627677|467422481|FG001|Overall Study|Study Terminated by Sponsor|10|||
129853458|NCT02627677|467422482|FG002|Overall Study|Study Terminated by Sponsor|6|||
129853459|NCT02627677|467422480|FG000|Overall Study|Physician Decision|0|||
129853460|NCT02627677|467422481|FG001|Overall Study|Physician Decision|0|||
129853461|NCT02627677|467422482|FG002|Overall Study|Physician Decision|2|||
129853462|NCT02627677|467422480|FG000|Overall Study|Withdrawal by Subject|2|||
129853463|NCT02627677|467422481|FG001|Overall Study|Withdrawal by Subject|1|||
129853464|NCT02627677|467422482|FG002|Overall Study|Withdrawal by Subject|1|||
129853465|NCT02627677|467422480|FG000|Overall Study|Reason not Specified|0|||
129853466|NCT02627677|467422481|FG001|Overall Study|Reason not Specified|0|||
129853467|NCT02627677|467422482|FG002|Overall Study|Reason not Specified|1|||
129853468|NCT02627677|467422480|FG000|Overall Study|Randomized but not Treated|1|||
129853469|NCT02627677|467422481|FG001|Overall Study|Randomized but not Treated|0|||
129853470|NCT02627677|467422482|FG002|Overall Study|Randomized but not Treated|0|||
129853471|NCT00587587|467422487|FG000|Overall Study|Lost to Follow-up|6|||
129853472|NCT00587587|467422488|FG001|Overall Study|Lost to Follow-up|1|||
129853473|NCT01075321|467422493|FG000|Overall Study|Withdrawal by Subject|0|||
129853474|NCT01075321|467422494|FG001|Overall Study|Withdrawal by Subject|0|||
129853475|NCT01075321|467422495|FG002|Overall Study|Withdrawal by Subject|1|||
129853476|NCT01075321|467422496|FG003|Overall Study|Withdrawal by Subject|1|||
129853477|NCT01075321|467422493|FG000|Overall Study|Protocol Violation|0|||
129853478|NCT01075321|467422494|FG001|Overall Study|Protocol Violation|0|||
129853479|NCT01075321|467422495|FG002|Overall Study|Protocol Violation|1|||
129853480|NCT01075321|467422496|FG003|Overall Study|Protocol Violation|0|||
129853481|NCT01075321|467422493|FG000|Overall Study|Treatment Incomplete due to progression|1|||
129853482|NCT01075321|467422494|FG001|Overall Study|Treatment Incomplete due to progression|0|||
129853483|NCT01075321|467422495|FG002|Overall Study|Treatment Incomplete due to progression|0|||
129853484|NCT01075321|467422496|FG003|Overall Study|Treatment Incomplete due to progression|0|||
129853485|NCT01075321|467422493|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
129853486|NCT01075321|467422494|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
129853487|NCT01075321|467422495|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
129853488|NCT01075321|467422496|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
129853489|NCT01722331|467422497|FG000|Part 1|Adverse Event|5|||
129853490|NCT01722331|467422498|FG001|Part 1|Adverse Event|0|||
129853491|NCT01722331|467422499|FG002|Part 1|Adverse Event|0|||
129853492|NCT01722331|467422500|FG003|Part 1|Adverse Event|0|||
129853493|NCT01722331|467422501|FG004|Part 1|Adverse Event|0|||
129853494|NCT01722331|467422502|FG005|Part 1|Adverse Event|0|||
129853495|NCT01722331|467422503|FG006|Part 1|Adverse Event|0|||
129853496|NCT01722331|467422497|FG000|Part 1|Lack of Efficacy|0|||
129853497|NCT01722331|467422498|FG001|Part 1|Lack of Efficacy|0|||
129853498|NCT01722331|467422499|FG002|Part 1|Lack of Efficacy|1|||
129853499|NCT01722331|467422500|FG003|Part 1|Lack of Efficacy|0|||
129853500|NCT01722331|467422501|FG004|Part 1|Lack of Efficacy|2|||
129853501|NCT01722331|467422502|FG005|Part 1|Lack of Efficacy|0|||
129853502|NCT01722331|467422503|FG006|Part 1|Lack of Efficacy|0|||
129853503|NCT01722331|467422497|FG000|Part 1|Lost to Follow-up|1|||
129853504|NCT01722331|467422498|FG001|Part 1|Lost to Follow-up|0|||
129853505|NCT01722331|467422499|FG002|Part 1|Lost to Follow-up|2|||
129853506|NCT01722331|467422500|FG003|Part 1|Lost to Follow-up|0|||
129853507|NCT01722331|467422501|FG004|Part 1|Lost to Follow-up|1|||
129853508|NCT01722331|467422502|FG005|Part 1|Lost to Follow-up|0|||
129853509|NCT01722331|467422503|FG006|Part 1|Lost to Follow-up|0|||
129853510|NCT01722331|467422497|FG000|Part 1|Physician Decision|0|||
129853511|NCT01722331|467422498|FG001|Part 1|Physician Decision|0|||
129853512|NCT01722331|467422499|FG002|Part 1|Physician Decision|3|||
129853513|NCT01722331|467422500|FG003|Part 1|Physician Decision|0|||
129853514|NCT01722331|467422501|FG004|Part 1|Physician Decision|1|||
129853515|NCT01722331|467422502|FG005|Part 1|Physician Decision|0|||
129853516|NCT01722331|467422503|FG006|Part 1|Physician Decision|0|||
129853517|NCT01722331|467422497|FG000|Part 1|Pregnancy|1|||
129853518|NCT01722331|467422498|FG001|Part 1|Pregnancy|0|||
129853519|NCT01722331|467422499|FG002|Part 1|Pregnancy|0|||
129853520|NCT01722331|467422500|FG003|Part 1|Pregnancy|0|||
129853521|NCT01722331|467422501|FG004|Part 1|Pregnancy|0|||
129853522|NCT01722331|467422502|FG005|Part 1|Pregnancy|0|||
129853523|NCT01722331|467422503|FG006|Part 1|Pregnancy|0|||
129853524|NCT01722331|467422497|FG000|Part 1|Progressive Disease|0|||
129853525|NCT01722331|467422498|FG001|Part 1|Progressive Disease|0|||
129853526|NCT01722331|467422499|FG002|Part 1|Progressive Disease|0|||
129853527|NCT01722331|467422500|FG003|Part 1|Progressive Disease|0|||
129853528|NCT01722331|467422501|FG004|Part 1|Progressive Disease|1|||
129853529|NCT01722331|467422502|FG005|Part 1|Progressive Disease|0|||
129853530|NCT01722331|467422503|FG006|Part 1|Progressive Disease|0|||
129853531|NCT01722331|467422497|FG000|Part 1|Protocol Violation|1|||
129853532|NCT01722331|467422498|FG001|Part 1|Protocol Violation|0|||
129853533|NCT01722331|467422499|FG002|Part 1|Protocol Violation|0|||
129853534|NCT01722331|467422500|FG003|Part 1|Protocol Violation|0|||
129853535|NCT01722331|467422501|FG004|Part 1|Protocol Violation|1|||
129853536|NCT01722331|467422502|FG005|Part 1|Protocol Violation|0|||
129853537|NCT01722331|467422503|FG006|Part 1|Protocol Violation|0|||
129853538|NCT01722331|467422497|FG000|Part 1|Withdrawal by Subject|2|||
129853539|NCT01722331|467422498|FG001|Part 1|Withdrawal by Subject|0|||
129853540|NCT01722331|467422499|FG002|Part 1|Withdrawal by Subject|3|||
129853541|NCT01722331|467422500|FG003|Part 1|Withdrawal by Subject|0|||
129853542|NCT01722331|467422501|FG004|Part 1|Withdrawal by Subject|3|||
129853543|NCT01722331|467422502|FG005|Part 1|Withdrawal by Subject|0|||
129853544|NCT01722331|467422503|FG006|Part 1|Withdrawal by Subject|0|||
129853545|NCT01722331|467422497|FG000|Part 2|Adverse Event|3|||
129853546|NCT01722331|467422498|FG001|Part 2|Adverse Event|0|||
129853547|NCT01722331|467422499|FG002|Part 2|Adverse Event|0|||
129853548|NCT01722331|467422500|FG003|Part 2|Adverse Event|0|||
129853549|NCT01722331|467422501|FG004|Part 2|Adverse Event|0|||
129853550|NCT01722331|467422502|FG005|Part 2|Adverse Event|1|||
129853551|NCT01722331|467422503|FG006|Part 2|Adverse Event|0|||
129853552|NCT01722331|467422497|FG000|Part 2|Lack of Efficacy|3|||
129853553|NCT01722331|467422498|FG001|Part 2|Lack of Efficacy|0|||
129853554|NCT01722331|467422499|FG002|Part 2|Lack of Efficacy|11|||
129853555|NCT01722331|467422500|FG003|Part 2|Lack of Efficacy|0|||
129853556|NCT01722331|467422501|FG004|Part 2|Lack of Efficacy|0|||
129853557|NCT01722331|467422502|FG005|Part 2|Lack of Efficacy|3|||
129853558|NCT01722331|467422503|FG006|Part 2|Lack of Efficacy|3|||
129853559|NCT01722331|467422497|FG000|Part 2|Lost to Follow-up|0|||
129853560|NCT01722331|467422498|FG001|Part 2|Lost to Follow-up|0|||
129853561|NCT01722331|467422499|FG002|Part 2|Lost to Follow-up|3|||
129853562|NCT01722331|467422500|FG003|Part 2|Lost to Follow-up|0|||
129853563|NCT01722331|467422501|FG004|Part 2|Lost to Follow-up|0|||
129853564|NCT01722331|467422502|FG005|Part 2|Lost to Follow-up|1|||
129853565|NCT01722331|467422503|FG006|Part 2|Lost to Follow-up|1|||
129853566|NCT01722331|467422497|FG000|Part 2|Non-Compliance with Study Drug|1|||
129853567|NCT01722331|467422498|FG001|Part 2|Non-Compliance with Study Drug|0|||
129853568|NCT01722331|467422499|FG002|Part 2|Non-Compliance with Study Drug|1|||
129853569|NCT01722331|467422500|FG003|Part 2|Non-Compliance with Study Drug|0|||
129853570|NCT01722331|467422501|FG004|Part 2|Non-Compliance with Study Drug|0|||
129853571|NCT01722331|467422502|FG005|Part 2|Non-Compliance with Study Drug|0|||
129853572|NCT01722331|467422503|FG006|Part 2|Non-Compliance with Study Drug|0|||
129853573|NCT01722331|467422497|FG000|Part 2|Physician Decision|0|||
129906847|NCT02214160|467620681|FG002|Overall Study|Withdrawal by Subject|6|||
129906848|NCT02214160|467620679|FG000|Overall Study|Death|2|||
129906849|NCT02214160|467620680|FG001|Overall Study|Death|2|||
129906850|NCT02214160|467620681|FG002|Overall Study|Death|1|||
129906851|NCT02214160|467620679|FG000|Overall Study|Subject Non-Compliance|0|||
129906852|NCT02214160|467620680|FG001|Overall Study|Subject Non-Compliance|3|||
129906853|NCT02214160|467620681|FG002|Overall Study|Subject Non-Compliance|1|||
129906854|NCT02214160|467620679|FG000|Overall Study|Adverse Event|0|||
129906855|NCT02214160|467620680|FG001|Overall Study|Adverse Event|1|||
129906856|NCT02214160|467620681|FG002|Overall Study|Adverse Event|1|||
129906857|NCT02214160|467620679|FG000|Overall Study|Sponsor Decision|0|||
129906858|NCT02214160|467620680|FG001|Overall Study|Sponsor Decision|2|||
129906859|NCT02214160|467620681|FG002|Overall Study|Sponsor Decision|0|||
129906860|NCT02214160|467620679|FG000|Overall Study|Protocol Violation|1|||
129906861|NCT02214160|467620680|FG001|Overall Study|Protocol Violation|0|||
129906862|NCT02214160|467620681|FG002|Overall Study|Protocol Violation|0|||
129906863|NCT02214160|467620679|FG000|Overall Study|Physician Decision|0|||
129906864|NCT02214160|467620680|FG001|Overall Study|Physician Decision|0|||
129906865|NCT02214160|467620681|FG002|Overall Study|Physician Decision|1|||
129906866|NCT02423798|467620682|FG000|Overall Study|Withdrawal by Subject|3|||
129906867|NCT01063972|467620683|FG000|Overall Study|Death|12|||
129906868|NCT01063972|467620684|FG001|Overall Study|Death|11|||
129906869|NCT01063972|467620683|FG000|Overall Study|Incarcerated|2|||
129906870|NCT01063972|467620684|FG001|Overall Study|Incarcerated|1|||
129906871|NCT03475316|467620686|FG000|6 Month Intervention|Adverse Event|2|||
129906872|NCT03475316|467620687|FG001|6 Month Intervention|Adverse Event|1|||
129906873|NCT03475316|467620686|FG000|6 Month Intervention|Withdrawal by Subject|2|||
129906874|NCT03475316|467620687|FG001|6 Month Intervention|Withdrawal by Subject|0|||
129906875|NCT03475316|467620686|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
129906876|NCT03475316|467620687|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
129906877|NCT03475316|467620686|FG000|9 Months|Study stopped due to COVID pandemic|3|||
129906878|NCT03475316|467620687|FG001|9 Months|Study stopped due to COVID pandemic|4|||
129906879|NCT02555215|467620690|FG000|Overall Study|Other|1|||
129906880|NCT02555215|467620690|FG000|Overall Study|Investigator Decision|2|||
129906881|NCT00468052|467620691|FG000|Overall Study|Protocol Violation|7|||
129906882|NCT00468052|467620692|FG001|Overall Study|Protocol Violation|8|||
129906883|NCT00457743|467620695|FG000|Overall Study|Adverse Event|0|||
129906884|NCT00457743|467620696|FG001|Overall Study|Adverse Event|4|||
129906885|NCT00457743|467620697|FG002|Overall Study|Adverse Event|0|||
129906886|NCT00457743|467620695|FG000|Overall Study|Lack of Efficacy|3|||
129906887|NCT00457743|467620696|FG001|Overall Study|Lack of Efficacy|23|||
129906888|NCT00457743|467620697|FG002|Overall Study|Lack of Efficacy|3|||
129906889|NCT00566527|467620698|FG000|Overall Study|Reason not provided|3|||
129906890|NCT00566527|467620699|FG001|Overall Study|Reason not provided|11|||
129906891|NCT00566527|467620700|FG002|Overall Study|Reason not provided|10|||
129906892|NCT00566527|467620698|FG000|Overall Study|Adverse Event|2|||
129906893|NCT00566527|467620699|FG001|Overall Study|Adverse Event|0|||
129906894|NCT00566527|467620700|FG002|Overall Study|Adverse Event|1|||
129906895|NCT00566527|467620698|FG000|Overall Study|Physician Decision|3|||
129906896|NCT00566527|467620699|FG001|Overall Study|Physician Decision|8|||
129906897|NCT00566527|467620700|FG002|Overall Study|Physician Decision|20|||
129906898|NCT00566527|467620698|FG000|Overall Study|Lost to Follow-up|3|||
129906899|NCT00566527|467620699|FG001|Overall Study|Lost to Follow-up|4|||
129906900|NCT00566527|467620700|FG002|Overall Study|Lost to Follow-up|4|||
129906901|NCT00566527|467620698|FG000|Overall Study|Withdrawal by Subject|6|||
129906902|NCT00566527|467620699|FG001|Overall Study|Withdrawal by Subject|43|||
129906903|NCT00566527|467620700|FG002|Overall Study|Withdrawal by Subject|43|||
129906904|NCT00356265|467620701|FG000|Overall Study|Withdrawal by Subject|0|||
129906905|NCT00356265|467620702|FG001|Overall Study|Withdrawal by Subject|0|||
129906906|NCT00356265|467620703|FG002|Overall Study|Withdrawal by Subject|1|||
129906907|NCT01837966|467620704|FG000|Overall Study|Withdrawal by Subject|2|||
129906908|NCT01837966|467620705|FG001|Overall Study|Withdrawal by Subject|1|||
129906909|NCT00159783|467620709|FG000|Overall Study|Adverse Event|5|||
129906910|NCT00159783|467620710|FG001|Overall Study|Adverse Event|7|||
129906911|NCT00159783|467620711|FG002|Overall Study|Adverse Event|9|||
129906912|NCT00159783|467620709|FG000|Overall Study|Lack of Efficacy|1|||
129906913|NCT00159783|467620710|FG001|Overall Study|Lack of Efficacy|2|||
129906914|NCT00159783|467620711|FG002|Overall Study|Lack of Efficacy|3|||
129906915|NCT00159783|467620709|FG000|Overall Study|Withdrawal by Subject|7|||
129906916|NCT00159783|467620710|FG001|Overall Study|Withdrawal by Subject|11|||
129906917|NCT00159783|467620711|FG002|Overall Study|Withdrawal by Subject|12|||
129906918|NCT00159783|467620709|FG000|Overall Study|Lost to Follow-up|6|||
129906919|NCT00159783|467620710|FG001|Overall Study|Lost to Follow-up|5|||
129906920|NCT00159783|467620711|FG002|Overall Study|Lost to Follow-up|11|||
129906921|NCT00159783|467620709|FG000|Overall Study|Other|0|||
129906922|NCT00159783|467620710|FG001|Overall Study|Other|2|||
129906923|NCT00159783|467620711|FG002|Overall Study|Other|4|||
129906924|NCT02928224|467620712|FG000|Overall Study|Lost to Follow-up|1|||
129906925|NCT02928224|467620713|FG001|Overall Study|Lost to Follow-up|1|||
129906926|NCT02928224|467620714|FG002|Overall Study|Lost to Follow-up|3|||
129906927|NCT02928224|467620715|FG003|Overall Study|Lost to Follow-up|0|||
129906928|NCT02928224|467620712|FG000|Overall Study|Death|30|||
129906929|NCT02928224|467620713|FG001|Overall Study|Death|209|||
129906930|NCT02928224|467620714|FG002|Overall Study|Death|193|||
129906931|NCT02928224|467620715|FG003|Overall Study|Death|198|||
129906932|NCT02928224|467620712|FG000|Overall Study|Withdrawal by Subject|0|||
129906933|NCT02928224|467620713|FG001|Overall Study|Withdrawal by Subject|3|||
129906934|NCT02928224|467620714|FG002|Overall Study|Withdrawal by Subject|7|||
129906935|NCT02928224|467620715|FG003|Overall Study|Withdrawal by Subject|20|||
129906936|NCT02928224|467620712|FG000|Overall Study|Study participation terminated by sponsor|3|||
129906937|NCT02928224|467620713|FG001|Overall Study|Study participation terminated by sponsor|8|||
129906938|NCT02928224|467620714|FG002|Overall Study|Study participation terminated by sponsor|12|||
129906939|NCT02928224|467620715|FG003|Overall Study|Study participation terminated by sponsor|3|||
129906940|NCT02928224|467620712|FG000|Overall Study|Other|3|||
129906941|NCT02928224|467620713|FG001|Overall Study|Other|3|||
129906942|NCT02928224|467620714|FG002|Overall Study|Other|5|||
129906943|NCT02928224|467620715|FG003|Overall Study|Other|0|||
129906944|NCT01278394|467620718|FG000|Overall Study|Lost to Follow-up|1|||
129906945|NCT01236560|467620719|FG000|Overall Study|Adverse Event|0|||
129906946|NCT01236560|467620720|FG001|Overall Study|Adverse Event|2|||
129906947|NCT01236560|467620721|FG002|Overall Study|Adverse Event|1|||
129906948|NCT01236560|467620722|FG003|Overall Study|Adverse Event|3|||
129906949|NCT01236560|467620723|FG004|Overall Study|Adverse Event|0|||
129906950|NCT01236560|467620724|FG005|Overall Study|Adverse Event|0|||
129906951|NCT01236560|467620719|FG000|Overall Study|Death|0|||
129906952|NCT01236560|467620720|FG001|Overall Study|Death|1|||
129906953|NCT01236560|467620721|FG002|Overall Study|Death|0|||
129906954|NCT01236560|467620722|FG003|Overall Study|Death|1|||
129906955|NCT01236560|467620723|FG004|Overall Study|Death|0|||
129906956|NCT01236560|467620724|FG005|Overall Study|Death|0|||
129906957|NCT01236560|467620719|FG000|Overall Study|Lost to Follow-up|0|||
129853574|NCT01722331|467422498|FG001|Part 2|Physician Decision|0|||
129853575|NCT01722331|467422499|FG002|Part 2|Physician Decision|2|||
129853576|NCT01722331|467422500|FG003|Part 2|Physician Decision|0|||
129853577|NCT01722331|467422501|FG004|Part 2|Physician Decision|0|||
129853578|NCT01722331|467422502|FG005|Part 2|Physician Decision|0|||
129853579|NCT01722331|467422503|FG006|Part 2|Physician Decision|0|||
129853580|NCT01722331|467422497|FG000|Part 2|Pregnancy|0|||
129853581|NCT01722331|467422498|FG001|Part 2|Pregnancy|0|||
129853582|NCT01722331|467422499|FG002|Part 2|Pregnancy|0|||
129853583|NCT01722331|467422500|FG003|Part 2|Pregnancy|0|||
129853584|NCT01722331|467422501|FG004|Part 2|Pregnancy|0|||
129853585|NCT01722331|467422502|FG005|Part 2|Pregnancy|1|||
129853586|NCT01722331|467422503|FG006|Part 2|Pregnancy|0|||
129853587|NCT01722331|467422497|FG000|Part 2|Progressive Disease|0|||
129853588|NCT01722331|467422498|FG001|Part 2|Progressive Disease|0|||
129853589|NCT01722331|467422499|FG002|Part 2|Progressive Disease|1|||
129853590|NCT01722331|467422500|FG003|Part 2|Progressive Disease|0|||
129853591|NCT01722331|467422501|FG004|Part 2|Progressive Disease|0|||
129853592|NCT01722331|467422502|FG005|Part 2|Progressive Disease|0|||
129853593|NCT01722331|467422503|FG006|Part 2|Progressive Disease|0|||
129853594|NCT01722331|467422497|FG000|Part 2|Protocol Violation|1|||
129853595|NCT01722331|467422498|FG001|Part 2|Protocol Violation|0|||
129853596|NCT01722331|467422499|FG002|Part 2|Protocol Violation|0|||
129853597|NCT01722331|467422500|FG003|Part 2|Protocol Violation|0|||
129853598|NCT01722331|467422501|FG004|Part 2|Protocol Violation|0|||
129906958|NCT01236560|467620720|FG001|Overall Study|Lost to Follow-up|1|||
129906959|NCT01236560|467620721|FG002|Overall Study|Lost to Follow-up|1|||
129906960|NCT01236560|467620722|FG003|Overall Study|Lost to Follow-up|0|||
129906961|NCT01236560|467620723|FG004|Overall Study|Lost to Follow-up|0|||
129906962|NCT01236560|467620724|FG005|Overall Study|Lost to Follow-up|0|||
129906963|NCT01236560|467620719|FG000|Overall Study|Physician Decision|0|||
129906964|NCT01236560|467620720|FG001|Overall Study|Physician Decision|1|||
129906965|NCT01236560|467620721|FG002|Overall Study|Physician Decision|8|||
129906966|NCT01236560|467620722|FG003|Overall Study|Physician Decision|0|||
129906967|NCT01236560|467620723|FG004|Overall Study|Physician Decision|0|||
129853599|NCT01722331|467422502|FG005|Part 2|Protocol Violation|0|||
129906968|NCT01236560|467620724|FG005|Overall Study|Physician Decision|0|||
129906969|NCT01236560|467620719|FG000|Overall Study|Withdrawal by Subject|0|||
129906970|NCT01236560|467620720|FG001|Overall Study|Withdrawal by Subject|0|||
129906971|NCT01236560|467620721|FG002|Overall Study|Withdrawal by Subject|1|||
129906972|NCT01236560|467620722|FG003|Overall Study|Withdrawal by Subject|2|||
129853600|NCT01722331|467422503|FG006|Part 2|Protocol Violation|0|||
129853601|NCT01722331|467422497|FG000|Part 2|Withdrawal by Subject|5|||
129853602|NCT01722331|467422498|FG001|Part 2|Withdrawal by Subject|0|||
129853603|NCT01722331|467422499|FG002|Part 2|Withdrawal by Subject|3|||
129853604|NCT01722331|467422500|FG003|Part 2|Withdrawal by Subject|0|||
129853605|NCT01722331|467422501|FG004|Part 2|Withdrawal by Subject|0|||
129853606|NCT01722331|467422502|FG005|Part 2|Withdrawal by Subject|2|||
129853607|NCT01722331|467422503|FG006|Part 2|Withdrawal by Subject|2|||
129906973|NCT01236560|467620723|FG004|Overall Study|Withdrawal by Subject|0|||
129906974|NCT01236560|467620724|FG005|Overall Study|Withdrawal by Subject|0|||
129906975|NCT01236560|467620719|FG000|Overall Study|Progressive disease|5|||
129906976|NCT01236560|467620720|FG001|Overall Study|Progressive disease|19|||
129906977|NCT01236560|467620721|FG002|Overall Study|Progressive disease|9|||
129906978|NCT01236560|467620722|FG003|Overall Study|Progressive disease|16|||
129906979|NCT01236560|467620723|FG004|Overall Study|Progressive disease|0|||
129906980|NCT01236560|467620724|FG005|Overall Study|Progressive disease|0|||
129906981|NCT00468910|467620725|FG000|Overall Study|Lost to Follow-up|2|||
129906982|NCT00468910|467620726|FG001|Overall Study|Lost to Follow-up|1|||
129906983|NCT00468910|467620725|FG000|Overall Study|Withdrawal by Subject|2|||
129906984|NCT00468910|467620726|FG001|Overall Study|Withdrawal by Subject|1|||
129906985|NCT00468910|467620725|FG000|Overall Study|Medical Contraindication|0|||
129906986|NCT00468910|467620726|FG001|Overall Study|Medical Contraindication|1|||
129906987|NCT00457691|467620728|FG000|Overall Study|Adverse Event|4|||
129906988|NCT00457691|467620729|FG001|Overall Study|Adverse Event|1|||
129906989|NCT00457691|467620728|FG000|Overall Study|Death|163|||
129906990|NCT00457691|467620729|FG001|Overall Study|Death|148|||
129906991|NCT00457691|467620728|FG000|Overall Study|Protocol Violation|1|||
129906992|NCT00457691|467620729|FG001|Overall Study|Protocol Violation|3|||
129906993|NCT00457691|467620728|FG000|Overall Study|Lost to Follow-up|23|||
129906994|NCT00457691|467620729|FG001|Overall Study|Lost to Follow-up|14|||
129906995|NCT00457691|467620728|FG000|Overall Study|Study terminated by Sponsor|1|||
129906996|NCT00457691|467620729|FG001|Overall Study|Study terminated by Sponsor|1|||
129906997|NCT00457691|467620728|FG000|Overall Study|Subject refused (reason other than AE)|14|||
129906998|NCT00457691|467620729|FG001|Overall Study|Subject refused (reason other than AE)|19|||
129906999|NCT00457691|467620728|FG000|Overall Study|Disease progression, study terminated|180|||
129907000|NCT00457691|467620729|FG001|Overall Study|Disease progression, study terminated|196|||
129907001|NCT02079844|467620730|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
129907002|NCT02079844|467620731|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
129907003|NCT02079844|467620732|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
129907004|NCT02079844|467620730|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
129907005|NCT02079844|467620731|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
129907006|NCT02079844|467620732|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
129907007|NCT01823536|467622443|FG000|Overall Study|Lost to Follow-up|1|||
129907008|NCT01823536|467622444|FG001|Overall Study|Lost to Follow-up|0|||
129907009|NCT01823536|467622445|FG002|Overall Study|Lost to Follow-up|0|||
129907010|NCT01823536|467622446|FG003|Overall Study|Lost to Follow-up|1|||
129907011|NCT01823536|467622447|FG004|Overall Study|Lost to Follow-up|1|||
129907012|NCT01823536|467622448|FG005|Overall Study|Lost to Follow-up|0|||
129907013|NCT01823536|467622443|FG000|Overall Study|Protocol Violation|0|||
129907014|NCT01823536|467622444|FG001|Overall Study|Protocol Violation|1|||
129907015|NCT01823536|467622445|FG002|Overall Study|Protocol Violation|0|||
129907016|NCT01823536|467622446|FG003|Overall Study|Protocol Violation|0|||
129907017|NCT01823536|467622447|FG004|Overall Study|Protocol Violation|0|||
129907018|NCT01823536|467622448|FG005|Overall Study|Protocol Violation|0|||
129907019|NCT01823536|467622443|FG000|Overall Study|Withdrawal by Subject|1|||
129907020|NCT01823536|467622444|FG001|Overall Study|Withdrawal by Subject|1|||
129907021|NCT01823536|467622445|FG002|Overall Study|Withdrawal by Subject|0|||
129907022|NCT01823536|467622446|FG003|Overall Study|Withdrawal by Subject|0|||
129907023|NCT01823536|467622447|FG004|Overall Study|Withdrawal by Subject|0|||
129907024|NCT01823536|467622448|FG005|Overall Study|Withdrawal by Subject|0|||
129907025|NCT01823536|467622443|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907026|NCT01823536|467622444|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907027|NCT01823536|467622445|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
129907028|NCT01823536|467622446|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907029|NCT01823536|467622447|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907030|NCT01823536|467622448|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907031|NCT01823536|467622443|FG000|Overall Study|Met exclusion criterion No 6|0|||
129907032|NCT01823536|467622444|FG001|Overall Study|Met exclusion criterion No 6|0|||
129907033|NCT01823536|467622445|FG002|Overall Study|Met exclusion criterion No 6|0|||
129907034|NCT01823536|467622446|FG003|Overall Study|Met exclusion criterion No 6|1|||
129907035|NCT01823536|467622447|FG004|Overall Study|Met exclusion criterion No 6|0|||
129907036|NCT01823536|467622448|FG005|Overall Study|Met exclusion criterion No 6|0|||
129907037|NCT01823536|467622443|FG000|Overall Study|Subject moved out of the state|0|||
129907038|NCT01823536|467622444|FG001|Overall Study|Subject moved out of the state|0|||
129907039|NCT01823536|467622445|FG002|Overall Study|Subject moved out of the state|0|||
129907040|NCT01823536|467622446|FG003|Overall Study|Subject moved out of the state|0|||
129907041|NCT01823536|467622447|FG004|Overall Study|Subject moved out of the state|1|||
129907042|NCT01823536|467622448|FG005|Overall Study|Subject moved out of the state|0|||
129907043|NCT03648762|467622449|FG000|Overall Study|Lost to Follow-up|1|||
129907044|NCT03648762|467622450|FG001|Overall Study|Lost to Follow-up|2|||
129907045|NCT03648762|467622451|FG002|Overall Study|Lost to Follow-up|0|||
129907046|NCT03648762|467622449|FG000|Overall Study|Withdrawal by Subject|5|||
129907047|NCT03648762|467622450|FG001|Overall Study|Withdrawal by Subject|2|||
129907048|NCT03648762|467622451|FG002|Overall Study|Withdrawal by Subject|1|||
130116609|NCT01590433|468387128|FG001|Overall Study|Adverse Event|3|||
129907049|NCT00002842|467622461|FG000|Overall Study|ineligible for surgical resection|27|||
129907050|NCT02564744|467622462|FG000|Overall Study|Investigator decision|0|||
129907051|NCT02564744|467622463|FG001|Overall Study|Investigator decision|0|||
129907052|NCT02564744|467622464|FG002|Overall Study|Investigator decision|0|||
129907053|NCT02564744|467622465|FG003|Overall Study|Investigator decision|0|||
129907054|NCT02564744|467622466|FG004|Overall Study|Investigator decision|1|||
129907055|NCT02564744|467622462|FG000|Overall Study|Death|10|||
129907056|NCT02564744|467622463|FG001|Overall Study|Death|5|||
129907057|NCT02564744|467622464|FG002|Overall Study|Death|4|||
129907058|NCT02564744|467622465|FG003|Overall Study|Death|16|||
129907059|NCT02564744|467622466|FG004|Overall Study|Death|16|||
129907060|NCT02564744|467622462|FG000|Overall Study|End of study Page Missing|0|||
129907061|NCT02564744|467622463|FG001|Overall Study|End of study Page Missing|0|||
129907062|NCT02564744|467622464|FG002|Overall Study|End of study Page Missing|3|||
129907063|NCT02564744|467622465|FG003|Overall Study|End of study Page Missing|3|||
129907064|NCT02564744|467622466|FG004|Overall Study|End of study Page Missing|0|||
129907065|NCT02564744|467622462|FG000|Overall Study|Subject Withdrew Consent|1|||
129907066|NCT02564744|467622463|FG001|Overall Study|Subject Withdrew Consent|1|||
129907067|NCT02564744|467622464|FG002|Overall Study|Subject Withdrew Consent|1|||
129907068|NCT02564744|467622465|FG003|Overall Study|Subject Withdrew Consent|0|||
129907069|NCT02564744|467622466|FG004|Overall Study|Subject Withdrew Consent|2|||
129907070|NCT02564744|467622462|FG000|Overall Study|Lost to Follow-up|0|||
129907071|NCT02564744|467622463|FG001|Overall Study|Lost to Follow-up|1|||
129907072|NCT02564744|467622464|FG002|Overall Study|Lost to Follow-up|0|||
129907073|NCT02564744|467622465|FG003|Overall Study|Lost to Follow-up|0|||
129907074|NCT02564744|467622466|FG004|Overall Study|Lost to Follow-up|1|||
129907075|NCT02564744|467622462|FG000|Overall Study|Reason not specified|1|||
129907076|NCT02564744|467622463|FG001|Overall Study|Reason not specified|0|||
129907077|NCT02564744|467622464|FG002|Overall Study|Reason not specified|0|||
129907078|NCT02564744|467622465|FG003|Overall Study|Reason not specified|0|||
129907079|NCT02564744|467622466|FG004|Overall Study|Reason not specified|0|||
129907080|NCT00508924|467622467|FG000|Overall Study|Protocol Violation|0|||
129907081|NCT00508924|467622468|FG001|Overall Study|Protocol Violation|0|||
129907082|NCT00508924|467622469|FG002|Overall Study|Protocol Violation|1|||
129907083|NCT00508924|467622470|FG003|Overall Study|Protocol Violation|1|||
129907084|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
129907085|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
129907086|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
129907087|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
129907088|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
129907089|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
129907090|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
129907091|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
129907092|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
129907093|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
129907094|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
129907095|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
129907096|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
129907097|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
129907098|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
129907099|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
129907100|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
129907101|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
129907102|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
129907103|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
129907104|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
129907105|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
129907106|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
129907107|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
129907108|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
129907109|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
129907110|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
129907111|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
129907112|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
129907113|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
129907114|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
129907115|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
129907116|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
129907117|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
129907118|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
129907119|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
129907120|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
129907121|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
129907122|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
129907123|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
129907124|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
129907125|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
129907126|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
129907127|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
129907128|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
129907129|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
130064613|NCT00115765|468190218|FG001|Overall Study|Lost to Follow-up|20|||
130064614|NCT00115765|468190219|FG002|Overall Study|Lost to Follow-up|18|||
129853608|NCT01722331|467422497|FG000|Part 2|Other Protocol Specified Criteria|6|||
129853609|NCT01722331|467422498|FG001|Part 2|Other Protocol Specified Criteria|0|||
129853610|NCT01722331|467422499|FG002|Part 2|Other Protocol Specified Criteria|10|||
129853611|NCT01722331|467422500|FG003|Part 2|Other Protocol Specified Criteria|0|||
129853612|NCT01722331|467422501|FG004|Part 2|Other Protocol Specified Criteria|0|||
129853613|NCT01722331|467422502|FG005|Part 2|Other Protocol Specified Criteria|2|||
129853614|NCT01722331|467422503|FG006|Part 2|Other Protocol Specified Criteria|1|||
129853615|NCT01722331|467422497|FG000|Part 3|Adverse Event|2|||
129853616|NCT01722331|467422498|FG001|Part 3|Adverse Event|2|||
129853617|NCT01722331|467422499|FG002|Part 3|Adverse Event|0|||
129853618|NCT01722331|467422500|FG003|Part 3|Adverse Event|1|||
129853619|NCT01722331|467422501|FG004|Part 3|Adverse Event|0|||
129853620|NCT01722331|467422502|FG005|Part 3|Adverse Event|0|||
129853621|NCT01722331|467422503|FG006|Part 3|Adverse Event|0|||
129853622|NCT01722331|467422497|FG000|Part 3|Death|1|||
129853623|NCT01722331|467422498|FG001|Part 3|Death|0|||
129853624|NCT01722331|467422499|FG002|Part 3|Death|0|||
129853625|NCT01722331|467422500|FG003|Part 3|Death|0|||
129853626|NCT01722331|467422501|FG004|Part 3|Death|0|||
129853627|NCT01722331|467422502|FG005|Part 3|Death|0|||
129853628|NCT01722331|467422503|FG006|Part 3|Death|0|||
129853629|NCT01722331|467422497|FG000|Part 3|Lack of Efficacy|1|||
129853630|NCT01722331|467422498|FG001|Part 3|Lack of Efficacy|0|||
129853631|NCT01722331|467422499|FG002|Part 3|Lack of Efficacy|0|||
129853632|NCT01722331|467422500|FG003|Part 3|Lack of Efficacy|0|||
129853633|NCT01722331|467422501|FG004|Part 3|Lack of Efficacy|0|||
129853634|NCT01722331|467422502|FG005|Part 3|Lack of Efficacy|0|||
129853635|NCT01722331|467422503|FG006|Part 3|Lack of Efficacy|0|||
129853636|NCT01722331|467422497|FG000|Part 3|Lost to Follow-up|3|||
129853637|NCT01722331|467422498|FG001|Part 3|Lost to Follow-up|4|||
129853638|NCT01722331|467422499|FG002|Part 3|Lost to Follow-up|0|||
129853639|NCT01722331|467422500|FG003|Part 3|Lost to Follow-up|0|||
129853640|NCT01722331|467422501|FG004|Part 3|Lost to Follow-up|0|||
129853641|NCT01722331|467422502|FG005|Part 3|Lost to Follow-up|1|||
129853642|NCT01722331|467422503|FG006|Part 3|Lost to Follow-up|0|||
129853643|NCT01722331|467422497|FG000|Part 3|Non-Compliance with Study Drug|0|||
129853644|NCT01722331|467422498|FG001|Part 3|Non-Compliance with Study Drug|1|||
129853645|NCT01722331|467422499|FG002|Part 3|Non-Compliance with Study Drug|0|||
129853646|NCT01722331|467422500|FG003|Part 3|Non-Compliance with Study Drug|0|||
129853647|NCT01722331|467422501|FG004|Part 3|Non-Compliance with Study Drug|0|||
129853648|NCT01722331|467422502|FG005|Part 3|Non-Compliance with Study Drug|0|||
129853649|NCT01722331|467422503|FG006|Part 3|Non-Compliance with Study Drug|0|||
129853650|NCT01722331|467422497|FG000|Part 3|Physician Decision|1|||
129853651|NCT01722331|467422498|FG001|Part 3|Physician Decision|1|||
129853652|NCT01722331|467422499|FG002|Part 3|Physician Decision|0|||
129853653|NCT01722331|467422500|FG003|Part 3|Physician Decision|0|||
129853654|NCT01722331|467422501|FG004|Part 3|Physician Decision|0|||
129853655|NCT01722331|467422502|FG005|Part 3|Physician Decision|0|||
129853656|NCT01722331|467422503|FG006|Part 3|Physician Decision|1|||
129853657|NCT01722331|467422497|FG000|Part 3|Protocol Violation|2|||
129853658|NCT01722331|467422498|FG001|Part 3|Protocol Violation|1|||
129853659|NCT01722331|467422499|FG002|Part 3|Protocol Violation|0|||
129853660|NCT01722331|467422500|FG003|Part 3|Protocol Violation|0|||
129853661|NCT01722331|467422501|FG004|Part 3|Protocol Violation|0|||
129853662|NCT01722331|467422502|FG005|Part 3|Protocol Violation|0|||
129853663|NCT01722331|467422503|FG006|Part 3|Protocol Violation|0|||
129853664|NCT01722331|467422497|FG000|Part 3|Withdrawal by Subject|4|||
129853665|NCT01722331|467422498|FG001|Part 3|Withdrawal by Subject|7|||
129853666|NCT01722331|467422499|FG002|Part 3|Withdrawal by Subject|0|||
129853667|NCT01722331|467422500|FG003|Part 3|Withdrawal by Subject|0|||
129853668|NCT01722331|467422501|FG004|Part 3|Withdrawal by Subject|0|||
129853669|NCT01722331|467422502|FG005|Part 3|Withdrawal by Subject|2|||
129853670|NCT01722331|467422503|FG006|Part 3|Withdrawal by Subject|1|||
129853671|NCT01722331|467422497|FG000|Part 3|Other Protocol Specified Criteria|1|||
129853672|NCT01722331|467422498|FG001|Part 3|Other Protocol Specified Criteria|1|||
129853673|NCT01722331|467422499|FG002|Part 3|Other Protocol Specified Criteria|0|||
129853674|NCT01722331|467422500|FG003|Part 3|Other Protocol Specified Criteria|0|||
129853675|NCT01722331|467422501|FG004|Part 3|Other Protocol Specified Criteria|0|||
129853676|NCT01722331|467422502|FG005|Part 3|Other Protocol Specified Criteria|0|||
129853677|NCT01722331|467422503|FG006|Part 3|Other Protocol Specified Criteria|0|||
129853678|NCT00262834|467422504|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
129853679|NCT00262834|467422505|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
129853680|NCT00003457|467422508|FG000|Overall Study|Not evaluable|9|||
129853681|NCT02525133|467422514|FG000|Overall Study|Adverse Event|0|||
129853682|NCT02525133|467422515|FG001|Overall Study|Adverse Event|1|||
129853683|NCT02525133|467422514|FG000|Overall Study|Death|0|||
129853684|NCT02525133|467422515|FG001|Overall Study|Death|1|||
129853685|NCT02525133|467422514|FG000|Overall Study|did not meet randomization criteria|1|||
129853686|NCT02525133|467422515|FG001|Overall Study|did not meet randomization criteria|0|||
129853687|NCT02525133|467422514|FG000|Overall Study|Lost to Follow-up|5|||
129853688|NCT02525133|467422515|FG001|Overall Study|Lost to Follow-up|1|||
129853689|NCT02525133|467422514|FG000|Overall Study|randomized not enrolled|3|||
129853690|NCT02525133|467422515|FG001|Overall Study|randomized not enrolled|0|||
129853691|NCT02525133|467422514|FG000|Overall Study|Withdrawal by Subject|1|||
129853692|NCT02525133|467422515|FG001|Overall Study|Withdrawal by Subject|0|||
129853693|NCT01075074|467422516|FG000|Overall Study|Surgeon changed to open incisional case|1|||
129853694|NCT01075074|467422517|FG001|Overall Study|Surgeon changed to open incisional case|2|||
129853695|NCT01075074|467422518|FG002|Overall Study|Surgeon changed to open incisional case|2|||
129853696|NCT01054729|467422519|FG000|Overall Study|Randomized but Not Treated|0|||
129853697|NCT01054729|467422520|FG001|Overall Study|Randomized but Not Treated|1|||
129853698|NCT01054729|467422521|FG002|Overall Study|Randomized but Not Treated|0|||
129853699|NCT01054729|467422522|FG003|Overall Study|Randomized but Not Treated|0|||
129853700|NCT01054729|467422519|FG000|Overall Study|Adverse Event|1|||
129853701|NCT01054729|467422520|FG001|Overall Study|Adverse Event|1|||
129853702|NCT01054729|467422521|FG002|Overall Study|Adverse Event|2|||
129853703|NCT01054729|467422522|FG003|Overall Study|Adverse Event|1|||
129853704|NCT01054729|467422519|FG000|Overall Study|Withdrawal by Subject|1|||
129853705|NCT01054729|467422520|FG001|Overall Study|Withdrawal by Subject|0|||
129853706|NCT01054729|467422521|FG002|Overall Study|Withdrawal by Subject|1|||
129853707|NCT01054729|467422522|FG003|Overall Study|Withdrawal by Subject|0|||
129853708|NCT01054729|467422519|FG000|Overall Study|Lost to Follow-up|0|||
129853709|NCT01054729|467422520|FG001|Overall Study|Lost to Follow-up|1|||
129853710|NCT01054729|467422521|FG002|Overall Study|Lost to Follow-up|0|||
129853711|NCT01054729|467422522|FG003|Overall Study|Lost to Follow-up|0|||
129853712|NCT01054729|467422519|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
129853713|NCT01054729|467422520|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
129853714|NCT01054729|467422521|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
129853715|NCT01054729|467422522|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
129853716|NCT01054729|467422519|FG000|Overall Study|Non-responder|1|||
129853717|NCT01054729|467422520|FG001|Overall Study|Non-responder|0|||
129853718|NCT01054729|467422521|FG002|Overall Study|Non-responder|1|||
129853719|NCT01054729|467422522|FG003|Overall Study|Non-responder|1|||
129853720|NCT01054729|467422519|FG000|Overall Study|PEG/RBV Non-responder|1|||
129853721|NCT01054729|467422520|FG001|Overall Study|PEG/RBV Non-responder|0|||
129853722|NCT01054729|467422521|FG002|Overall Study|PEG/RBV Non-responder|1|||
129853723|NCT01054729|467422522|FG003|Overall Study|PEG/RBV Non-responder|0|||
129853724|NCT01054729|467422519|FG000|Overall Study|Personal/Obligations|0|||
129853725|NCT01054729|467422520|FG001|Overall Study|Personal/Obligations|1|||
129853726|NCT01054729|467422521|FG002|Overall Study|Personal/Obligations|0|||
129853727|NCT01054729|467422522|FG003|Overall Study|Personal/Obligations|0|||
129853728|NCT01054729|467422519|FG000|Overall Study|Subject moved|0|||
129853729|NCT01054729|467422520|FG001|Overall Study|Subject moved|0|||
129853730|NCT01054729|467422521|FG002|Overall Study|Subject moved|1|||
129853731|NCT01054729|467422522|FG003|Overall Study|Subject moved|0|||
129853732|NCT01054729|467422519|FG000|Overall Study|Lack of Efficacy|0|||
129853733|NCT01054729|467422520|FG001|Overall Study|Lack of Efficacy|0|||
129853734|NCT01054729|467422521|FG002|Overall Study|Lack of Efficacy|0|||
129853735|NCT01054729|467422522|FG003|Overall Study|Lack of Efficacy|1|||
129853736|NCT04265755|467422523|FG000|Overall Study|Withdrawal by Subject|39|||
129853737|NCT04265755|467422523|FG000|Overall Study|Decision by sponsor|2|||
129853738|NCT04265755|467422523|FG000|Overall Study|Lost to Follow-up|11|||
129853739|NCT04265755|467422523|FG000|Overall Study|Death|1|||
129853740|NCT01575561|467422524|FG000|Overall Study|Adverse Event|9|||
129853741|NCT01575561|467422524|FG000|Overall Study|Lack of Efficacy|8|||
129853742|NCT01575561|467422524|FG000|Overall Study|Lost to Follow-up|6|||
129853743|NCT01575561|467422524|FG000|Overall Study|Protocol Violation|4|||
129853744|NCT01575561|467422524|FG000|Overall Study|Withdrawal by Subject|11|||
129853745|NCT01575561|467422524|FG000|Overall Study|administration|1|||
129853746|NCT01992536|467422525|FG000|Overall Study|Administrative Reason|0|||
129853747|NCT01992536|467422526|FG001|Overall Study|Administrative Reason|0|||
129853748|NCT01992536|467422527|FG002|Overall Study|Administrative Reason|0|||
129853749|NCT01992536|467422528|FG003|Overall Study|Administrative Reason|0|||
129907130|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
129907131|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
129907132|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
129907133|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
129907134|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
129907135|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
129907136|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
129907137|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
129907138|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
129907139|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
129907140|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
129907141|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
129907142|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
129907143|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
129907144|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
129907145|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
129907146|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
129907147|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
129907148|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
129907149|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
129907150|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
129907151|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
129907152|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
129907153|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
129907154|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
129907155|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
129907156|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
129907157|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
129907158|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
129907159|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
129907160|NCT02594735|467622482|FG000|Overall Study|Adverse Event|1|||
129907161|NCT03844269|467622486|FG000|Overall Study|Withdrawal pre-intervention|1|||
129907162|NCT03844269|467622486|FG000|Overall Study|Did not complete the intervention|2|||
129907163|NCT00101010|467622490|FG000|Overall Study|Physician Decision|1|||
129907164|NCT02969863|467622491|FG000|Overall Study|Physician Decision|1|||
129907165|NCT02969863|467622492|FG001|Overall Study|Physician Decision|0|||
129907166|NCT02969863|467622493|FG002|Overall Study|Physician Decision|0|||
129907167|NCT02969863|467622494|FG003|Overall Study|Physician Decision|0|||
129907168|NCT02969863|467622495|FG004|Overall Study|Physician Decision|0|||
129907169|NCT02969863|467622496|FG005|Overall Study|Physician Decision|0|||
129907170|NCT03737240|467622497|FG000|Overall Study|Lost to Follow-up|16|||
129907171|NCT03737240|467622498|FG001|Overall Study|Lost to Follow-up|15|||
129907172|NCT01254188|467622499|FG000|Overall Study|Disease Progression|6|||
129907173|NCT01254188|467622499|FG000|Overall Study|Protocol Violation|6|||
129907174|NCT01254188|467622499|FG000|Overall Study|Pregnancy|2|||
129907175|NCT01254188|467622499|FG000|Overall Study|Death|4|||
129907176|NCT01254188|467622499|FG000|Overall Study|Lost to Follow-up|5|||
129907177|NCT01254188|467622499|FG000|Overall Study|Withdrawal by Subject|7|||
129907178|NCT01254188|467622499|FG000|Overall Study|Adverse Event|43|||
129907179|NCT01254188|467622499|FG000|Overall Study|per investigator discretion|20|||
129907180|NCT02957136|467622509|FG000|Overall Study|Withdrawal by Subject|2|||
129907181|NCT02957136|467622510|FG001|Overall Study|Withdrawal by Subject|1|||
129907182|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
129907183|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
129907184|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
129907185|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
129907186|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
129907187|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
129907188|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Other|1|||
129907189|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Other|2|||
129907190|NCT02200770|467622511|FG000|Open-label Period (OLP)|Adverse Event|1|||
129907191|NCT02200770|467622512|FG001|Open-label Period (OLP)|Adverse Event|2|||
129907192|NCT02200770|467622511|FG000|Open-label Period (OLP)|Death|1|||
129907193|NCT02200770|467622512|FG001|Open-label Period (OLP)|Death|2|||
129907194|NCT02200770|467622511|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
129907195|NCT02200770|467622512|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
129907196|NCT02200770|467622511|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
129907197|NCT02200770|467622512|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
129853750|NCT01992536|467422529|FG004|Overall Study|Administrative Reason|0|||
129853751|NCT01992536|467422530|FG005|Overall Study|Administrative Reason|0|||
129853752|NCT01992536|467422531|FG006|Overall Study|Administrative Reason|7|||
129853753|NCT01992536|467422532|FG007|Overall Study|Administrative Reason|0|||
129853754|NCT01992536|467422533|FG008|Overall Study|Administrative Reason|0|||
129853755|NCT01992536|467422534|FG009|Overall Study|Administrative Reason|0|||
129853756|NCT01992536|467422525|FG000|Overall Study|Lost to Follow-up|4|||
129853757|NCT01992536|467422526|FG001|Overall Study|Lost to Follow-up|2|||
129853758|NCT01992536|467422527|FG002|Overall Study|Lost to Follow-up|1|||
129853759|NCT01992536|467422528|FG003|Overall Study|Lost to Follow-up|0|||
129853760|NCT01992536|467422529|FG004|Overall Study|Lost to Follow-up|0|||
129853761|NCT01992536|467422530|FG005|Overall Study|Lost to Follow-up|1|||
129853762|NCT01992536|467422531|FG006|Overall Study|Lost to Follow-up|0|||
129853763|NCT01992536|467422532|FG007|Overall Study|Lost to Follow-up|0|||
129853764|NCT01992536|467422533|FG008|Overall Study|Lost to Follow-up|1|||
129853765|NCT01992536|467422534|FG009|Overall Study|Lost to Follow-up|1|||
129853766|NCT01992536|467422525|FG000|Overall Study|Withdrawal by Subject|0|||
129853767|NCT01992536|467422526|FG001|Overall Study|Withdrawal by Subject|1|||
129853768|NCT01992536|467422527|FG002|Overall Study|Withdrawal by Subject|0|||
129853769|NCT01992536|467422528|FG003|Overall Study|Withdrawal by Subject|2|||
129853770|NCT01992536|467422529|FG004|Overall Study|Withdrawal by Subject|0|||
129853771|NCT01992536|467422530|FG005|Overall Study|Withdrawal by Subject|0|||
129853772|NCT01992536|467422531|FG006|Overall Study|Withdrawal by Subject|0|||
129853773|NCT01992536|467422532|FG007|Overall Study|Withdrawal by Subject|0|||
129853774|NCT01992536|467422533|FG008|Overall Study|Withdrawal by Subject|0|||
129853775|NCT01992536|467422534|FG009|Overall Study|Withdrawal by Subject|0|||
129853776|NCT00406029|467422544|FG000|Overall Study|Adverse Event|12|||
129853777|NCT00406029|467422545|FG001|Overall Study|Adverse Event|2|||
129853778|NCT00406029|467422546|FG002|Overall Study|Adverse Event|5|||
129853779|NCT00406029|467422547|FG003|Overall Study|Adverse Event|10|||
129853780|NCT00406029|467422548|FG004|Overall Study|Adverse Event|7|||
129853781|NCT00406029|467422544|FG000|Overall Study|Withdrawal by Subject|3|||
129853782|NCT00406029|467422545|FG001|Overall Study|Withdrawal by Subject|4|||
129853783|NCT00406029|467422546|FG002|Overall Study|Withdrawal by Subject|2|||
129853784|NCT00406029|467422547|FG003|Overall Study|Withdrawal by Subject|2|||
129853785|NCT00406029|467422548|FG004|Overall Study|Withdrawal by Subject|0|||
129853786|NCT00406029|467422544|FG000|Overall Study|Protocol Violation|1|||
129853787|NCT00406029|467422545|FG001|Overall Study|Protocol Violation|2|||
129853788|NCT00406029|467422546|FG002|Overall Study|Protocol Violation|0|||
129853789|NCT00406029|467422547|FG003|Overall Study|Protocol Violation|2|||
129853790|NCT00406029|467422548|FG004|Overall Study|Protocol Violation|0|||
129853791|NCT00406029|467422544|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853792|NCT00406029|467422545|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853793|NCT00406029|467422546|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
129853794|NCT00406029|467422547|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853795|NCT00406029|467422548|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853796|NCT00406029|467422544|FG000|Overall Study|Randomized in Error|0|||
129853797|NCT00406029|467422545|FG001|Overall Study|Randomized in Error|0|||
129853798|NCT00406029|467422546|FG002|Overall Study|Randomized in Error|2|||
129853799|NCT00406029|467422547|FG003|Overall Study|Randomized in Error|3|||
129853800|NCT00406029|467422548|FG004|Overall Study|Randomized in Error|1|||
129853801|NCT01709227|467422550|FG000|Overall Study|Physician Decision|1|||
129853802|NCT01709227|467422551|FG001|Overall Study|Physician Decision|0|||
129853803|NCT01709227|467422550|FG000|Overall Study|Pleural Peritoneal communication|0|||
129853804|NCT01709227|467422551|FG001|Overall Study|Pleural Peritoneal communication|9|||
129853805|NCT03669081|467422554|FG000|Overall Study|Data could not be validated|1|||
129853806|NCT03669081|467422555|FG001|Overall Study|Data could not be validated|1|||
129853807|NCT00389324|467422556|FG000|Run-In Phase|Adverse Event|1|||
129853808|NCT00389324|467422556|FG000|Run-In Phase|Lost to Follow-up|1|||
129853809|NCT00389324|467422556|FG000|Run-In Phase|Withdrawal by Subject|1|||
129853810|NCT00389324|467422556|FG000|Subcutaneous Phase|Adverse Event|2|||
129853811|NCT00389324|467422556|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
129853812|NCT00389324|467422556|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
129853813|NCT00389324|467422556|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
129853814|NCT02317575|467422557|FG000|Period 1|Difficulty with venous cannulation|0|||
129853815|NCT02317575|467422558|FG001|Period 1|Difficulty with venous cannulation|1|||
129853816|NCT02317575|467422559|FG002|Period 1|Difficulty with venous cannulation|0|||
129853817|NCT02317575|467422560|FG003|Period 1|Difficulty with venous cannulation|0|||
129853818|NCT02317575|467422561|FG004|Period 1|Difficulty with venous cannulation|0|||
129853819|NCT02317575|467422557|FG000|Period 1|Withdrawal by Subject|1|||
129853820|NCT02317575|467422558|FG001|Period 1|Withdrawal by Subject|0|||
129853821|NCT02317575|467422559|FG002|Period 1|Withdrawal by Subject|0|||
129853822|NCT02317575|467422560|FG003|Period 1|Withdrawal by Subject|0|||
129853823|NCT02317575|467422561|FG004|Period 1|Withdrawal by Subject|0|||
129853824|NCT02843568|467422562|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
129907198|NCT02200770|467622511|FG000|Open-label Period (OLP)|Other|6|||
129907199|NCT02200770|467622512|FG001|Open-label Period (OLP)|Other|15|||
129907200|NCT01264679|467622513|FG000|Overall Study|Participation in Another Clinical Trial|1|||
129907201|NCT01264679|467622513|FG000|Overall Study|Physician Decision|1|||
129907202|NCT01264679|467622513|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
129907203|NCT01264679|467622513|FG000|Overall Study|Withdrawal by Subject|1|||
129907204|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
129907205|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
129907206|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
129907207|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
129907208|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129907209|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
129907210|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
129907211|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
129907212|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
129907213|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
129907214|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907215|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907216|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907217|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907218|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907219|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907220|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907221|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
129907222|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907223|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907224|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907225|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907226|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907227|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907228|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
129907229|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
129907230|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
129907231|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
129907232|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
129907233|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
129907234|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
129907235|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
129907236|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
129907237|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
129907238|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907239|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907240|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907241|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907242|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907243|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907244|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907245|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907246|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907247|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907248|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907249|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
129907250|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
129907251|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
129907252|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129907253|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129907254|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
129907255|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
129907256|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
129907257|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
129907258|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129907259|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
129907260|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907261|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907262|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907263|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907264|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
129907265|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
130116610|NCT00555009|468387129|FG000|Overall Study|Withdrawal by Subject|0|||
130116611|NCT00555009|468387130|FG001|Overall Study|Withdrawal by Subject|1|||
130116612|NCT00555009|468387129|FG000|Overall Study|Terminated by Sponsor|2|||
130116613|NCT00555009|468387130|FG001|Overall Study|Terminated by Sponsor|5|||
130116614|NCT02058628|468387131|FG000|Overall Study|Adverse Event|1|||
129853825|NCT02843568|467422563|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
129853826|NCT02843568|467422562|FG000|Overall Study|Death|3|||
129853827|NCT02843568|467422563|FG001|Overall Study|Death|3|||
129853828|NCT02843568|467422562|FG000|Overall Study|Withdrawal by Subject|1|||
129853829|NCT02843568|467422563|FG001|Overall Study|Withdrawal by Subject|1|||
129853830|NCT02843568|467422562|FG000|Overall Study|Lost to Follow-up|2|||
129853831|NCT02843568|467422563|FG001|Overall Study|Lost to Follow-up|0|||
129853832|NCT04079933|467422566|FG000|Overall Study|Withdrawal by Subject|3|||
129853833|NCT04079933|467422567|FG001|Overall Study|Withdrawal by Subject|4|||
129853834|NCT04079933|467422566|FG000|Overall Study|Lost to Follow-up|0|||
129853835|NCT04079933|467422567|FG001|Overall Study|Lost to Follow-up|1|||
129853836|NCT01459796|467422568|FG000|Overall Study|Non compliance with protocol|2|||
129853837|NCT01459796|467422569|FG001|Overall Study|Non compliance with protocol|4|||
129853838|NCT01459796|467422568|FG000|Overall Study|Adverse Event|5|||
129853839|NCT01459796|467422569|FG001|Overall Study|Adverse Event|5|||
129853840|NCT01459796|467422568|FG000|Overall Study|Withdrawal by Subject|6|||
129853841|NCT01459796|467422569|FG001|Overall Study|Withdrawal by Subject|3|||
129853842|NCT01459796|467422568|FG000|Overall Study|Lost to Follow-up|5|||
129853843|NCT01459796|467422569|FG001|Overall Study|Lost to Follow-up|4|||
129853844|NCT01459796|467422568|FG000|Overall Study|Reason unspecified|1|||
129853845|NCT01459796|467422569|FG001|Overall Study|Reason unspecified|2|||
129853846|NCT01459796|467422568|FG000|Overall Study|Decision by the sponsor|75|||
129853847|NCT01459796|467422569|FG001|Overall Study|Decision by the sponsor|108|||
129853848|NCT00345579|467422570|FG000|Overall Study|Adverse Event|9|||
129853849|NCT00345579|467422571|FG001|Overall Study|Adverse Event|6|||
129853850|NCT00345579|467422570|FG000|Overall Study|Protocol Violation|14|||
129853851|NCT00345579|467422571|FG001|Overall Study|Protocol Violation|5|||
129853852|NCT00345579|467422570|FG000|Overall Study|Withdrawal by Subject|50|||
129853853|NCT00345579|467422571|FG001|Overall Study|Withdrawal by Subject|17|||
129853854|NCT00345579|467422570|FG000|Overall Study|Lost to Follow-up|82|||
129853855|NCT00345579|467422571|FG001|Overall Study|Lost to Follow-up|36|||
129853856|NCT00345579|467422570|FG000|Overall Study|Other|9|||
129853857|NCT00345579|467422571|FG001|Overall Study|Other|1|||
129853858|NCT00413413|467422572|FG000|Single-Blind|Adverse Event|0|||
129853859|NCT00413413|467422573|FG001|Single-Blind|Adverse Event|9|||
129853860|NCT00413413|467422574|FG002|Single-Blind|Adverse Event|0|||
129853861|NCT00413413|467422572|FG000|Single-Blind|Lack of Efficacy|0|||
129853862|NCT00413413|467422573|FG001|Single-Blind|Lack of Efficacy|5|||
129853863|NCT00413413|467422574|FG002|Single-Blind|Lack of Efficacy|0|||
129853864|NCT00413413|467422572|FG000|Single-Blind|Subject no longer requires study drug|0|||
129853865|NCT00413413|467422573|FG001|Single-Blind|Subject no longer requires study drug|151|||
129853866|NCT00413413|467422574|FG002|Single-Blind|Subject no longer requires study drug|0|||
129853867|NCT00413413|467422572|FG000|Single-Blind|Protocol Violation|0|||
129853868|NCT00413413|467422573|FG001|Single-Blind|Protocol Violation|16|||
129853869|NCT00413413|467422574|FG002|Single-Blind|Protocol Violation|0|||
129853870|NCT00413413|467422572|FG000|Single-Blind|Withdrawal by Subject|0|||
129853871|NCT00413413|467422573|FG001|Single-Blind|Withdrawal by Subject|27|||
129853872|NCT00413413|467422574|FG002|Single-Blind|Withdrawal by Subject|0|||
129853873|NCT00413413|467422572|FG000|Single-Blind|Lost to Follow-up|0|||
129853874|NCT00413413|467422573|FG001|Single-Blind|Lost to Follow-up|8|||
129853875|NCT00413413|467422574|FG002|Single-Blind|Lost to Follow-up|0|||
129853876|NCT00413413|467422572|FG000|Double-Blind|Adverse Event|6|||
129853877|NCT00413413|467422573|FG001|Double-Blind|Adverse Event|0|||
129853878|NCT00413413|467422574|FG002|Double-Blind|Adverse Event|5|||
129853879|NCT00413413|467422572|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
129853880|NCT00413413|467422573|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
129853881|NCT00413413|467422574|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
129853882|NCT00413413|467422572|FG000|Double-Blind|Protocol deviation|1|||
129853883|NCT00413413|467422573|FG001|Double-Blind|Protocol deviation|2|||
129853884|NCT00413413|467422574|FG002|Double-Blind|Protocol deviation|1|||
129853885|NCT00413413|467422572|FG000|Double-Blind|Subject withdrew consent|4|||
129853886|NCT00413413|467422573|FG001|Double-Blind|Subject withdrew consent|6|||
129853887|NCT00413413|467422574|FG002|Double-Blind|Subject withdrew consent|9|||
129853888|NCT00413413|467422572|FG000|Double-Blind|Lost to Follow-up|3|||
129853889|NCT00413413|467422573|FG001|Double-Blind|Lost to Follow-up|4|||
129853890|NCT00413413|467422574|FG002|Double-Blind|Lost to Follow-up|2|||
129853891|NCT03207750|467422575|FG000|Overall Study|Adverse Event|3|||
129907266|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129853892|NCT03207750|467422576|FG001|Overall Study|Adverse Event|2|||
129853893|NCT03207750|467422575|FG000|Overall Study|Lost to Follow-up|21|||
129853894|NCT03207750|467422576|FG001|Overall Study|Lost to Follow-up|29|||
129853895|NCT03207750|467422575|FG000|Overall Study|Protocol Violation|0|||
129853896|NCT03207750|467422576|FG001|Overall Study|Protocol Violation|1|||
129853897|NCT03207750|467422575|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
129853898|NCT03207750|467422576|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
129853899|NCT03207750|467422575|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
129853900|NCT03207750|467422576|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
129907267|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
129907268|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907269|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907270|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907271|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907272|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907273|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907274|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907275|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907276|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129907277|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129907278|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129907279|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
129907280|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129907281|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
129907282|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129907283|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129907284|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907285|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907286|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907287|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
129907288|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907289|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
129907290|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
129907291|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
129907292|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907293|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907294|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907295|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
129853901|NCT03207750|467422575|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
129853902|NCT03207750|467422576|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
129853903|NCT03207750|467422575|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
129853904|NCT03207750|467422576|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
129853905|NCT03207750|467422575|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
129853906|NCT03207750|467422576|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
129853907|NCT03634579|467422581|FG000|Overall Study|study termination|9|||
129853908|NCT04111497|467422589|FG000|Overall Study|relapse of primary disease|1|||
129853909|NCT04111497|467422589|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
129853910|NCT03321019|467422590|FG000|Overall Study|Withdrawal by Subject|0|||
129853911|NCT03321019|467422591|FG001|Overall Study|Withdrawal by Subject|6|||
129853912|NCT03321019|467422590|FG000|Overall Study|Lost to Follow-up|0|||
129853913|NCT03321019|467422591|FG001|Overall Study|Lost to Follow-up|22|||
129853914|NCT01578551|467422594|FG000|Overall Study|Adverse Event|1|||
129853915|NCT01578551|467422595|FG001|Overall Study|Adverse Event|0|||
129853916|NCT00766415|467422596|FG000|Overall Study|Withdrawal by Subject|0|||
129853917|NCT00766415|467422597|FG001|Overall Study|Withdrawal by Subject|1|||
129853918|NCT01312467|467422598|FG000|Overall Study|Adverse Event|4|||
129853919|NCT01312467|467422598|FG000|Overall Study|Lost to Follow-up|1|||
129853920|NCT01312467|467422598|FG000|Overall Study|Withdrawal by Subject|2|||
129853921|NCT01312467|467422598|FG000|Overall Study|Deported to country of origin|1|||
129853922|NCT01312467|467422598|FG000|Overall Study|Another medical condition|1|||
129853923|NCT01312467|467422598|FG000|Overall Study|Ineligible|4|||
129853924|NCT02752048|467422601|FG000|Overall Study|Withdrawal by Subject|0|||
129853925|NCT02752048|467422602|FG001|Overall Study|Withdrawal by Subject|0|||
129853926|NCT02752048|467422603|FG002|Overall Study|Withdrawal by Subject|3|||
129853927|NCT00132769|467422604|FG000|Overall Study|Withdrawal by Subject|1|||
129853928|NCT00132769|467422605|FG001|Overall Study|Withdrawal by Subject|3|||
129853929|NCT00132769|467422604|FG000|Overall Study|Lack of Efficacy|7|||
129853930|NCT00132769|467422605|FG001|Overall Study|Lack of Efficacy|6|||
129853931|NCT00132769|467422604|FG000|Overall Study|Adverse Event|2|||
129853932|NCT00132769|467422605|FG001|Overall Study|Adverse Event|1|||
129853933|NCT00132769|467422604|FG000|Overall Study|Protocol Violation|1|||
129853934|NCT00132769|467422605|FG001|Overall Study|Protocol Violation|1|||
129853935|NCT04452344|467422606|FG000|Overall Study|Withdrawal by Subject|3|||
129907296|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907297|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907298|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
129853936|NCT04452344|467422607|FG001|Overall Study|Withdrawal by Subject|6|||
129853937|NCT04452344|467422606|FG000|Overall Study|Adverse Event|1|||
129853938|NCT04452344|467422607|FG001|Overall Study|Adverse Event|2|||
129853939|NCT04452344|467422606|FG000|Overall Study|Lost to Follow-up|2|||
129853940|NCT04452344|467422607|FG001|Overall Study|Lost to Follow-up|2|||
129853941|NCT04452344|467422606|FG000|Overall Study|No Post-Op Visit|6|||
129853942|NCT04452344|467422607|FG001|Overall Study|No Post-Op Visit|7|||
129853943|NCT04095858|467422613|FG000|Overall Study|Death|1|||
129853944|NCT04095858|467422614|FG001|Overall Study|Death|0|||
129853945|NCT04095858|467422613|FG000|Overall Study|Study terminated by Sponsor|2|||
129853946|NCT04095858|467422614|FG001|Overall Study|Study terminated by Sponsor|4|||
129853947|NCT01344460|467422615|FG000|Overall Study|Withdrawal by Subject|1|||
129853948|NCT01344460|467422615|FG000|Overall Study|Lost to Follow-up|2|||
129853949|NCT00560833|467422616|FG000|Overall Study|Adverse Event|16|||
129853950|NCT00560833|467422617|FG001|Overall Study|Adverse Event|10|||
129853951|NCT00560833|467422618|FG002|Overall Study|Adverse Event|25|||
129853952|NCT00560833|467422619|FG003|Overall Study|Adverse Event|23|||
129853953|NCT00560833|467422620|FG004|Overall Study|Adverse Event|35|||
129853954|NCT00560833|467422616|FG000|Overall Study|Lost to Follow-up|0|||
129853955|NCT00560833|467422617|FG001|Overall Study|Lost to Follow-up|0|||
129853956|NCT00560833|467422618|FG002|Overall Study|Lost to Follow-up|1|||
129853957|NCT00560833|467422619|FG003|Overall Study|Lost to Follow-up|0|||
129853958|NCT00560833|467422620|FG004|Overall Study|Lost to Follow-up|0|||
129853959|NCT00560833|467422616|FG000|Overall Study|Lack of Efficacy|22|||
129853960|NCT00560833|467422617|FG001|Overall Study|Lack of Efficacy|9|||
129853961|NCT00560833|467422618|FG002|Overall Study|Lack of Efficacy|6|||
129853962|NCT00560833|467422619|FG003|Overall Study|Lack of Efficacy|4|||
129853963|NCT00560833|467422620|FG004|Overall Study|Lack of Efficacy|4|||
129853964|NCT00560833|467422616|FG000|Overall Study|Participant uncooperative|5|||
129853965|NCT00560833|467422617|FG001|Overall Study|Participant uncooperative|5|||
129853966|NCT00560833|467422618|FG002|Overall Study|Participant uncooperative|4|||
129853967|NCT00560833|467422619|FG003|Overall Study|Participant uncooperative|4|||
129853968|NCT00560833|467422620|FG004|Overall Study|Participant uncooperative|2|||
129853969|NCT00560833|467422616|FG000|Overall Study|Other|1|||
129853970|NCT00560833|467422617|FG001|Overall Study|Other|1|||
129853971|NCT00560833|467422618|FG002|Overall Study|Other|3|||
129853972|NCT00560833|467422619|FG003|Overall Study|Other|0|||
129853973|NCT00560833|467422620|FG004|Overall Study|Other|0|||
129853974|NCT00560833|467422616|FG000|Overall Study|Never received drug|0|||
129853975|NCT00560833|467422617|FG001|Overall Study|Never received drug|1|||
129853976|NCT00560833|467422618|FG002|Overall Study|Never received drug|0|||
129853977|NCT00560833|467422619|FG003|Overall Study|Never received drug|0|||
129853978|NCT00560833|467422620|FG004|Overall Study|Never received drug|1|||
129853979|NCT00898677|467422623|FG000|Overall Study|Adverse Event|0|||
129853980|NCT00898677|467422624|FG001|Overall Study|Adverse Event|0|||
129853981|NCT00898677|467422625|FG002|Overall Study|Adverse Event|1|||
129853982|NCT00898677|467422626|FG003|Overall Study|Adverse Event|0|||
129853983|NCT00898677|467422623|FG000|Overall Study|Lost to Follow-up|0|||
129853984|NCT00898677|467422624|FG001|Overall Study|Lost to Follow-up|0|||
129853985|NCT00898677|467422625|FG002|Overall Study|Lost to Follow-up|2|||
129853986|NCT00898677|467422626|FG003|Overall Study|Lost to Follow-up|0|||
129853987|NCT00898677|467422623|FG000|Overall Study|Protocol Violation|1|||
129853988|NCT00898677|467422624|FG001|Overall Study|Protocol Violation|1|||
129853989|NCT00898677|467422625|FG002|Overall Study|Protocol Violation|2|||
129853990|NCT00898677|467422626|FG003|Overall Study|Protocol Violation|0|||
129853991|NCT00898677|467422623|FG000|Overall Study|Withdrawal by Subject|0|||
129853992|NCT00898677|467422624|FG001|Overall Study|Withdrawal by Subject|0|||
129853993|NCT00898677|467422625|FG002|Overall Study|Withdrawal by Subject|0|||
129853994|NCT00898677|467422626|FG003|Overall Study|Withdrawal by Subject|1|||
129853995|NCT00898677|467422623|FG000|Overall Study|Not Treated: Adverse Event|0|||
129853996|NCT00898677|467422624|FG001|Overall Study|Not Treated: Adverse Event|2|||
129853997|NCT00898677|467422625|FG002|Overall Study|Not Treated: Adverse Event|1|||
129853998|NCT00898677|467422626|FG003|Overall Study|Not Treated: Adverse Event|0|||
129853999|NCT00898677|467422623|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
129854000|NCT00898677|467422624|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
129854001|NCT00898677|467422625|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
129854002|NCT00898677|467422626|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
129854003|NCT00898677|467422623|FG000|Overall Study|Not Treated: Pregnancy|0|||
129854004|NCT00898677|467422624|FG001|Overall Study|Not Treated: Pregnancy|0|||
129854005|NCT00898677|467422625|FG002|Overall Study|Not Treated: Pregnancy|1|||
129854006|NCT00898677|467422626|FG003|Overall Study|Not Treated: Pregnancy|0|||
129854007|NCT00898677|467422623|FG000|Overall Study|Not Treated: Protocol Violation|2|||
130116615|NCT02058628|468387132|FG001|Overall Study|Adverse Event|0|||
129854008|NCT00898677|467422624|FG001|Overall Study|Not Treated: Protocol Violation|0|||
129854009|NCT00898677|467422625|FG002|Overall Study|Not Treated: Protocol Violation|2|||
129854010|NCT00898677|467422626|FG003|Overall Study|Not Treated: Protocol Violation|0|||
129854011|NCT00898677|467422623|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
129854012|NCT00898677|467422624|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
129854013|NCT00898677|467422625|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
129854014|NCT00898677|467422626|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
129854015|NCT00898677|467422623|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
130116616|NCT02058628|468387131|FG000|Overall Study|Withdrawal by Subject|2|||
129854016|NCT00898677|467422624|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
129854017|NCT00898677|467422625|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
129854018|NCT00898677|467422626|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
129854019|NCT00898677|467422623|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
129854020|NCT00898677|467422624|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
129854021|NCT00898677|467422625|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
129854022|NCT00898677|467422626|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
129854023|NCT00898677|467422623|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
129854024|NCT00898677|467422624|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
129854025|NCT00898677|467422625|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
129854026|NCT00898677|467422626|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
129854027|NCT00898677|467422623|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
129854028|NCT00898677|467422624|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
129854029|NCT00898677|467422625|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
129854030|NCT00898677|467422626|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
129854031|NCT00898677|467422623|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
129854032|NCT00898677|467422624|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
129854033|NCT00898677|467422625|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
129854034|NCT00898677|467422626|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
129854035|NCT00898677|467422623|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
129854036|NCT00898677|467422624|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
129854037|NCT00898677|467422625|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
129854038|NCT00898677|467422626|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
129854039|NCT02199691|467422627|FG000|Overall Study|Protocol Violation|3|||
129854040|NCT02199691|467422628|FG001|Overall Study|Protocol Violation|3|||
129854041|NCT02199691|467422629|FG002|Overall Study|Protocol Violation|6|||
129854042|NCT02199691|467422630|FG003|Overall Study|Protocol Violation|7|||
129854043|NCT02199691|467422627|FG000|Overall Study|Withdrawal by Subject|5|||
129854044|NCT02199691|467422628|FG001|Overall Study|Withdrawal by Subject|3|||
129854045|NCT02199691|467422629|FG002|Overall Study|Withdrawal by Subject|12|||
129854046|NCT02199691|467422630|FG003|Overall Study|Withdrawal by Subject|13|||
129854047|NCT02199691|467422627|FG000|Overall Study|Lost to Follow-up|2|||
129854048|NCT02199691|467422628|FG001|Overall Study|Lost to Follow-up|1|||
129854049|NCT02199691|467422629|FG002|Overall Study|Lost to Follow-up|9|||
129854050|NCT02199691|467422630|FG003|Overall Study|Lost to Follow-up|10|||
129854051|NCT00836875|467422633|FG000|Overall Study|Death|3|||
129854052|NCT00836875|467422634|FG001|Overall Study|Death|2|||
129854053|NCT00836875|467422633|FG000|Overall Study|Withdrawal by Subject|0|||
129854054|NCT00836875|467422634|FG001|Overall Study|Withdrawal by Subject|1|||
129854055|NCT03823651|467422636|FG000|Overall Study|Death|5|||
129854056|NCT03823651|467422637|FG001|Overall Study|Death|0|||
129854057|NCT03823651|467422636|FG000|Overall Study|Physician Decision|1|||
129854058|NCT03823651|467422637|FG001|Overall Study|Physician Decision|0|||
129854059|NCT03823651|467422636|FG000|Overall Study|Caregiver to patient who died|0|||
129854060|NCT03823651|467422637|FG001|Overall Study|Caregiver to patient who died|5|||
129854061|NCT03823651|467422636|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
129854062|NCT03823651|467422637|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
129854063|NCT00428610|467422638|FG000|Overall Study|Death Due to Adverse Event|3|||
129854064|NCT00428610|467422639|FG001|Overall Study|Death Due to Adverse Event|0|||
129854065|NCT00428610|467422640|FG002|Overall Study|Death Due to Adverse Event|5|||
129854066|NCT00428610|467422638|FG000|Overall Study|Death Due to Progressive Disease|0|||
129854067|NCT00428610|467422639|FG001|Overall Study|Death Due to Progressive Disease|0|||
129854068|NCT00428610|467422640|FG002|Overall Study|Death Due to Progressive Disease|2|||
129854069|NCT00428610|467422638|FG000|Overall Study|Adverse Event|2|||
129854070|NCT00428610|467422639|FG001|Overall Study|Adverse Event|3|||
129854071|NCT00428610|467422640|FG002|Overall Study|Adverse Event|2|||
129854072|NCT00428610|467422638|FG000|Overall Study|Investigator Decision|2|||
129854073|NCT00428610|467422639|FG001|Overall Study|Investigator Decision|1|||
129854074|NCT00428610|467422640|FG002|Overall Study|Investigator Decision|1|||
129854075|NCT00428610|467422638|FG000|Overall Study|Progressive Disease|42|||
129854076|NCT00428610|467422639|FG001|Overall Study|Progressive Disease|14|||
129854077|NCT00428610|467422640|FG002|Overall Study|Progressive Disease|22|||
130116617|NCT02058628|468387132|FG001|Overall Study|Withdrawal by Subject|2|||
129854078|NCT00428610|467422638|FG000|Overall Study|Withdrawal by Subject|4|||
129854079|NCT00428610|467422639|FG001|Overall Study|Withdrawal by Subject|0|||
129854080|NCT00428610|467422640|FG002|Overall Study|Withdrawal by Subject|0|||
129854081|NCT05350449|467422641|FG000|Overall Study|Withdrawal by Subject|4|||
129854082|NCT05350449|467422642|FG001|Overall Study|Withdrawal by Subject|8|||
129854083|NCT02239510|467424797|FG000|Overall Study|Lost to Follow-up|2|||
129854084|NCT02239510|467424798|FG001|Overall Study|Lost to Follow-up|1|||
129854085|NCT03859323|467424801|FG000|Overall Study|Lost to Follow-up|0|||
129854086|NCT03859323|467424802|FG001|Overall Study|Lost to Follow-up|0|||
129854087|NCT03859323|467424803|FG002|Overall Study|Lost to Follow-up|0|||
129854088|NCT03859323|467424804|FG003|Overall Study|Lost to Follow-up|0|||
129854089|NCT03859323|467424805|FG004|Overall Study|Lost to Follow-up|0|||
129854090|NCT03859323|467424806|FG005|Overall Study|Lost to Follow-up|0|||
129907299|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
129907300|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907301|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907302|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
129907303|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
129907304|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907305|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907306|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907307|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
129907308|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907309|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907310|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907311|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907312|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907313|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907314|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907315|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
129907316|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907317|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907318|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907319|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907320|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907321|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907322|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907323|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
129907324|NCT01595061|467622525|FG000|Overall Study|Never Treated|3|||
129907325|NCT01595061|467622525|FG000|Overall Study|Inadequate Pathology|1|||
129907326|NCT00529789|467622526|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
129907327|NCT00529789|467622526|FG000|Study Period II/III|Adverse Event|3|||
129907328|NCT00529789|467622526|FG000|Study Period II/III|Lack of Efficacy|2|||
129907329|NCT00529789|467622526|FG000|Study Period II/III|Withdrawal by Subject|1|||
129907330|NCT00529789|467622526|FG000|Study Period II/III|Protocol Violation|3|||
129907331|NCT00529789|467622526|FG000|Study Period II/III|Physician Decision|3|||
129907332|NCT00529789|467622526|FG000|Study Period II/III|Lost to Follow-up|3|||
129907333|NCT00529789|467622526|FG000|Study Period IV|Parent/Caregiver Decision|1|||
129907334|NCT00529789|467622526|FG000|Study Period IV|Adverse Event|1|||
129907335|NCT00529789|467622526|FG000|Study Period IV|Lack of Efficacy|1|||
129907336|NCT00529789|467622526|FG000|Study Period IV|Lost to Follow-up|3|||
129907337|NCT01430611|467622527|FG000|Overall Study|Adverse Event|0|||
129907338|NCT01430611|467622528|FG001|Overall Study|Adverse Event|1|||
129907339|NCT01430611|467622527|FG000|Overall Study|Protocol Violation|1|||
129907340|NCT01430611|467622528|FG001|Overall Study|Protocol Violation|0|||
129907341|NCT01430611|467622527|FG000|Overall Study|Lost to Follow-up|1|||
129907342|NCT01430611|467622528|FG001|Overall Study|Lost to Follow-up|0|||
129907343|NCT01430611|467622527|FG000|Overall Study|Withdrawal by Subject|15|||
129907344|NCT01430611|467622528|FG001|Overall Study|Withdrawal by Subject|14|||
129907345|NCT00960141|467622529|FG000|Overall Study|Adverse Event|4|||
129907346|NCT00960141|467622530|FG001|Overall Study|Adverse Event|8|||
129907347|NCT00960141|467622531|FG002|Overall Study|Adverse Event|2|||
129907348|NCT00960141|467622529|FG000|Overall Study|Lack of Efficacy|3|||
129907349|NCT00960141|467622530|FG001|Overall Study|Lack of Efficacy|4|||
129907350|NCT00960141|467622531|FG002|Overall Study|Lack of Efficacy|2|||
129907351|NCT00960141|467622529|FG000|Overall Study|Lost to Follow-up|1|||
129907352|NCT00960141|467622530|FG001|Overall Study|Lost to Follow-up|0|||
129907353|NCT00960141|467622531|FG002|Overall Study|Lost to Follow-up|0|||
129907354|NCT00960141|467622529|FG000|Overall Study|Protocol Violation|1|||
129907355|NCT00960141|467622530|FG001|Overall Study|Protocol Violation|3|||
129907356|NCT00960141|467622531|FG002|Overall Study|Protocol Violation|2|||
129907357|NCT00960141|467622529|FG000|Overall Study|Withdrawal by Subject|1|||
129907358|NCT00960141|467622530|FG001|Overall Study|Withdrawal by Subject|2|||
129907359|NCT00960141|467622531|FG002|Overall Study|Withdrawal by Subject|1|||
129907360|NCT02538107|467622532|FG000|Overall Study|Did not receive any Mircera dose|11|||
129907361|NCT02538107|467622532|FG000|Overall Study|Missing|5|||
129907362|NCT02538107|467622532|FG000|Overall Study|Necessity of dialysis|20|||
129907363|NCT02538107|467622532|FG000|Overall Study|Administration of other ESA|11|||
129907364|NCT02538107|467622532|FG000|Overall Study|No further treatment necessary|18|||
129907365|NCT02538107|467622532|FG000|Overall Study|Withdrawal by Subject|17|||
129907366|NCT02538107|467622532|FG000|Overall Study|Death|4|||
129907367|NCT02538107|467622532|FG000|Overall Study|Administrative reason|5|||
129907368|NCT02538107|467622532|FG000|Overall Study|Adverse Event|4|||
129907369|NCT02538107|467622532|FG000|Overall Study|Surgery|1|||
129907370|NCT02538107|467622532|FG000|Overall Study|Other|7|||
129907371|NCT02538107|467622532|FG000|Overall Study|Not recorded|7|||
129907372|NCT01576484|467622533|FG000|Overall Study|Adverse Event|1|||
129907373|NCT01576484|467622534|FG001|Overall Study|Adverse Event|1|||
129907374|NCT01576484|467622533|FG000|Overall Study|Protocol Violation|0|||
129854091|NCT03859323|467424807|FG006|Overall Study|Lost to Follow-up|1|||
129854092|NCT03859323|467424808|FG007|Overall Study|Lost to Follow-up|0|||
129854093|NCT03859323|467424809|FG008|Overall Study|Lost to Follow-up|0|||
129854094|NCT03859323|467424810|FG009|Overall Study|Lost to Follow-up|0|||
129854095|NCT03859323|467424811|FG010|Overall Study|Lost to Follow-up|0|||
129854096|NCT03859323|467424812|FG011|Overall Study|Lost to Follow-up|0|||
129854097|NCT03859323|467424813|FG012|Overall Study|Lost to Follow-up|0|||
129854098|NCT03859323|467424801|FG000|Overall Study|Withdrawal by Subject|0|||
129854099|NCT03859323|467424802|FG001|Overall Study|Withdrawal by Subject|0|||
129854100|NCT03859323|467424803|FG002|Overall Study|Withdrawal by Subject|1|||
129854101|NCT03859323|467424804|FG003|Overall Study|Withdrawal by Subject|0|||
129854102|NCT03859323|467424805|FG004|Overall Study|Withdrawal by Subject|0|||
129854103|NCT03859323|467424806|FG005|Overall Study|Withdrawal by Subject|1|||
129854104|NCT03859323|467424807|FG006|Overall Study|Withdrawal by Subject|0|||
129854105|NCT03859323|467424808|FG007|Overall Study|Withdrawal by Subject|0|||
129854106|NCT03859323|467424809|FG008|Overall Study|Withdrawal by Subject|0|||
129854107|NCT03859323|467424810|FG009|Overall Study|Withdrawal by Subject|1|||
129854108|NCT03859323|467424811|FG010|Overall Study|Withdrawal by Subject|1|||
129854109|NCT03859323|467424812|FG011|Overall Study|Withdrawal by Subject|2|||
129854110|NCT03859323|467424813|FG012|Overall Study|Withdrawal by Subject|1|||
129854111|NCT03859323|467424801|FG000|Overall Study|Pregnancy|0|||
129854112|NCT03859323|467424802|FG001|Overall Study|Pregnancy|0|||
129854113|NCT03859323|467424803|FG002|Overall Study|Pregnancy|0|||
129854114|NCT03859323|467424804|FG003|Overall Study|Pregnancy|0|||
129854115|NCT03859323|467424805|FG004|Overall Study|Pregnancy|0|||
129854116|NCT03859323|467424806|FG005|Overall Study|Pregnancy|0|||
129854117|NCT03859323|467424807|FG006|Overall Study|Pregnancy|0|||
129854118|NCT03859323|467424808|FG007|Overall Study|Pregnancy|0|||
129854119|NCT03859323|467424809|FG008|Overall Study|Pregnancy|0|||
129854120|NCT03859323|467424810|FG009|Overall Study|Pregnancy|1|||
129854121|NCT03859323|467424811|FG010|Overall Study|Pregnancy|0|||
129854122|NCT03859323|467424812|FG011|Overall Study|Pregnancy|0|||
129854123|NCT03859323|467424813|FG012|Overall Study|Pregnancy|0|||
129854124|NCT03794089|467424816|FG000|Overall Study|Lost to Follow-up|4|||
129854125|NCT03794089|467424817|FG001|Overall Study|Lost to Follow-up|1|||
129854126|NCT03794089|467424816|FG000|Overall Study|Withdrawal by Subject|2|||
129854127|NCT03794089|467424817|FG001|Overall Study|Withdrawal by Subject|0|||
129854128|NCT03985423|467424818|FG000|Overall Study|Adverse Event|1|||
129854129|NCT03985423|467424818|FG000|Overall Study|Death|2|||
129854130|NCT03985423|467424818|FG000|Overall Study|Physician Decision|1|||
129854131|NCT03985423|467424818|FG000|Overall Study|Withdrawal by Subject|2|||
129854132|NCT03985423|467424818|FG000|Overall Study|Lack of insurance and citizenship|1|||
129854133|NCT01045447|467424827|FG000|Overall Study|Adverse Event|0|||
129854134|NCT01045447|467424828|FG001|Overall Study|Adverse Event|1|||
129854135|NCT01045447|467424827|FG000|Overall Study|Lack of Efficacy|3|||
129854136|NCT01045447|467424828|FG001|Overall Study|Lack of Efficacy|1|||
129854137|NCT01045447|467424827|FG000|Overall Study|Protocol Violation|6|||
129854138|NCT01045447|467424828|FG001|Overall Study|Protocol Violation|3|||
129854139|NCT01045447|467424827|FG000|Overall Study|Withdrawal Criteria|10|||
129854140|NCT01045447|467424828|FG001|Overall Study|Withdrawal Criteria|10|||
129854141|NCT01045447|467424827|FG000|Overall Study|Unclassified|17|||
129854142|NCT01045447|467424828|FG001|Overall Study|Unclassified|13|||
129854143|NCT00129987|467424830|FG000|1st Educational Session|Withdrawal by Subject|141|||
129854144|NCT00129987|467424831|FG001|1st Educational Session|Withdrawal by Subject|109|||
129854145|NCT00129987|467424830|FG000|1 Year|Withdrawal by Subject|32|||
129854146|NCT00129987|467424831|FG001|1 Year|Withdrawal by Subject|21|||
129854147|NCT00116805|467424835|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
129854148|NCT00116805|467424836|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
129854149|NCT00116805|467424835|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
129854150|NCT00116805|467424836|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
129854151|NCT00116805|467424835|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
129854152|NCT00116805|467424836|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
129854153|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
129854154|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
129854155|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
129854156|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
129854157|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
129854158|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
129854159|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
129854160|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
129854161|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
129854162|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
129854163|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
129854164|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
129854165|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
129907375|NCT01576484|467622534|FG001|Overall Study|Protocol Violation|2|||
129854166|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
129854167|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
129854168|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
129854169|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
129854170|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
129854171|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
129854172|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
129854173|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
129854174|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
129854175|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
129854176|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
129854177|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
129854178|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
129854179|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
129854180|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
129854181|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
129854182|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
129854183|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
129854184|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
129854185|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
129854186|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
129854187|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
129854188|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
129854189|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
129854190|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
129854191|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
129854192|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
129854193|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
129854194|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
129854195|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
129854196|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
129854197|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
129854198|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
129854199|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
129854200|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
129854201|NCT00116805|467424835|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
129854202|NCT00116805|467424836|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
129854203|NCT00116805|467424835|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
129854204|NCT00116805|467424836|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
129854205|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
129854206|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
129854207|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
129854208|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
129854209|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
129854210|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
129854211|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
129854212|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
129854213|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
129854214|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
129854215|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
129854216|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
129854217|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
129854218|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
129854219|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
129854220|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
129854221|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
129854222|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
129854223|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
129854224|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
129854225|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
129854226|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
129854227|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
129854228|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
129907376|NCT01576484|467622533|FG000|Overall Study|Sponsor Decision|2|||
129907377|NCT01576484|467622534|FG001|Overall Study|Sponsor Decision|8|||
129907378|NCT01576484|467622533|FG000|Overall Study|Withdrawal by Subject|0|||
129907379|NCT01576484|467622534|FG001|Overall Study|Withdrawal by Subject|3|||
129907380|NCT01576484|467622533|FG000|Overall Study|Other|2|||
129907381|NCT01576484|467622534|FG001|Overall Study|Other|5|||
129907382|NCT01792830|467622538|FG000|Overall Study|Withdrawal by Subject|22|||
129907383|NCT01792830|467622539|FG001|Overall Study|Withdrawal by Subject|0|||
129907384|NCT01792830|467622540|FG002|Overall Study|Withdrawal by Subject|0|||
129907385|NCT01792830|467622541|FG003|Overall Study|Withdrawal by Subject|2|||
129907386|NCT01792830|467622542|FG004|Overall Study|Withdrawal by Subject|1|||
129907387|NCT01792830|467622543|FG005|Overall Study|Withdrawal by Subject|1|||
129907388|NCT01792830|467622544|FG006|Overall Study|Withdrawal by Subject|1|||
129907389|NCT01792830|467622545|FG007|Overall Study|Withdrawal by Subject|1|||
129907390|NCT01792830|467622546|FG008|Overall Study|Withdrawal by Subject|7|||
129907391|NCT01792830|467622547|FG009|Overall Study|Withdrawal by Subject|0|||
129907392|NCT01792830|467622548|FG010|Overall Study|Withdrawal by Subject|2|||
129907393|NCT01792830|467622538|FG000|Overall Study|Death|3|||
129907394|NCT01792830|467622539|FG001|Overall Study|Death|0|||
129907395|NCT01792830|467622540|FG002|Overall Study|Death|0|||
129907396|NCT01792830|467622541|FG003|Overall Study|Death|1|||
129907397|NCT01792830|467622542|FG004|Overall Study|Death|0|||
129907398|NCT01792830|467622543|FG005|Overall Study|Death|0|||
129907399|NCT01792830|467622544|FG006|Overall Study|Death|1|||
129907400|NCT01792830|467622545|FG007|Overall Study|Death|0|||
129907401|NCT01792830|467622546|FG008|Overall Study|Death|1|||
129907402|NCT01792830|467622547|FG009|Overall Study|Death|0|||
129907403|NCT01792830|467622548|FG010|Overall Study|Death|1|||
129907404|NCT01792830|467622538|FG000|Overall Study|Adverse Event|0|||
129907405|NCT01792830|467622539|FG001|Overall Study|Adverse Event|0|||
129907406|NCT01792830|467622540|FG002|Overall Study|Adverse Event|0|||
129907407|NCT01792830|467622541|FG003|Overall Study|Adverse Event|0|||
129907408|NCT01792830|467622542|FG004|Overall Study|Adverse Event|0|||
129907409|NCT01792830|467622543|FG005|Overall Study|Adverse Event|0|||
129907410|NCT01792830|467622544|FG006|Overall Study|Adverse Event|0|||
129907411|NCT01792830|467622545|FG007|Overall Study|Adverse Event|0|||
129907412|NCT01792830|467622546|FG008|Overall Study|Adverse Event|1|||
129907413|NCT01792830|467622547|FG009|Overall Study|Adverse Event|0|||
129907414|NCT01792830|467622548|FG010|Overall Study|Adverse Event|0|||
129907415|NCT01943799|467622564|FG000|Overall Study|Lost to Follow-up|0|||
129907416|NCT01943799|467622565|FG001|Overall Study|Lost to Follow-up|1|||
129907417|NCT01943799|467622566|FG002|Overall Study|Lost to Follow-up|1|||
129907418|NCT01943799|467622567|FG003|Overall Study|Lost to Follow-up|0|||
129907419|NCT01943799|467622564|FG000|Overall Study|Protocol Violation|1|||
129907420|NCT01943799|467622565|FG001|Overall Study|Protocol Violation|0|||
129907421|NCT01943799|467622566|FG002|Overall Study|Protocol Violation|0|||
129907422|NCT01943799|467622567|FG003|Overall Study|Protocol Violation|0|||
129907423|NCT01943799|467622564|FG000|Overall Study|Withdrawal by Subject|4|||
129907424|NCT01943799|467622565|FG001|Overall Study|Withdrawal by Subject|2|||
129907425|NCT01943799|467622566|FG002|Overall Study|Withdrawal by Subject|1|||
129907426|NCT01943799|467622567|FG003|Overall Study|Withdrawal by Subject|0|||
129907427|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
129907428|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
129907429|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
129907430|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
129907431|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
129907432|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
129907433|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
129907434|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
129907435|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
129907436|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
129907437|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
129907438|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
129907439|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
129907440|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
129907441|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
129907442|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
129907443|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
129907444|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
129907445|NCT00958633|467622572|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
129907446|NCT00958633|467622573|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
130116618|NCT02058628|468387131|FG000|Overall Study|Lost to Follow-up|2|||
129907447|NCT00958633|467622574|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
129907448|NCT03144674|467622583|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
129907449|NCT03144674|467622584|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
129907450|NCT03144674|467622585|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
129907451|NCT03144674|467622586|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
129907452|NCT03144674|467622583|FG000|Overall Study|Death|3|||
129907453|NCT03144674|467622584|FG001|Overall Study|Death|2|||
129907454|NCT03144674|467622585|FG002|Overall Study|Death|6|||
129907455|NCT03144674|467622586|FG003|Overall Study|Death|24|||
129907456|NCT03144674|467622583|FG000|Overall Study|Lost to Follow-up|0|||
129907457|NCT03144674|467622584|FG001|Overall Study|Lost to Follow-up|1|||
129907458|NCT03144674|467622585|FG002|Overall Study|Lost to Follow-up|0|||
129907459|NCT03144674|467622586|FG003|Overall Study|Lost to Follow-up|4|||
129907460|NCT03144674|467622583|FG000|Overall Study|Withdrawal by Participant|0|||
129907461|NCT03144674|467622584|FG001|Overall Study|Withdrawal by Participant|0|||
129907462|NCT03144674|467622585|FG002|Overall Study|Withdrawal by Participant|2|||
129907463|NCT03144674|467622586|FG003|Overall Study|Withdrawal by Participant|6|||
129907464|NCT03144674|467622583|FG000|Overall Study|Discharged from the Trust|0|||
129907465|NCT03144674|467622584|FG001|Overall Study|Discharged from the Trust|0|||
129907466|NCT03144674|467622585|FG002|Overall Study|Discharged from the Trust|1|||
129907467|NCT03144674|467622586|FG003|Overall Study|Discharged from the Trust|0|||
129907468|NCT03144674|467622583|FG000|Overall Study|Exclusion Criteria Met|0|||
129907469|NCT03144674|467622584|FG001|Overall Study|Exclusion Criteria Met|0|||
129907470|NCT03144674|467622585|FG002|Overall Study|Exclusion Criteria Met|1|||
129907471|NCT03144674|467622586|FG003|Overall Study|Exclusion Criteria Met|0|||
129907472|NCT03144674|467622583|FG000|Overall Study|Changed Physicians|0|||
129907473|NCT03144674|467622584|FG001|Overall Study|Changed Physicians|0|||
129907474|NCT03144674|467622585|FG002|Overall Study|Changed Physicians|0|||
129907475|NCT03144674|467622586|FG003|Overall Study|Changed Physicians|1|||
129907476|NCT03144674|467622583|FG000|Overall Study|Removed for Safety|0|||
129907477|NCT03144674|467622584|FG001|Overall Study|Removed for Safety|0|||
129907478|NCT03144674|467622585|FG002|Overall Study|Removed for Safety|0|||
129907479|NCT03144674|467622586|FG003|Overall Study|Removed for Safety|1|||
129907480|NCT03144674|467622583|FG000|Overall Study|Site Closed|0|||
129907481|NCT03144674|467622584|FG001|Overall Study|Site Closed|0|||
129907482|NCT03144674|467622585|FG002|Overall Study|Site Closed|0|||
129907483|NCT03144674|467622586|FG003|Overall Study|Site Closed|1|||
129907484|NCT03144674|467622583|FG000|Overall Study|Histological Criteria Not Met|0|||
129907485|NCT03144674|467622584|FG001|Overall Study|Histological Criteria Not Met|0|||
129907486|NCT03144674|467622585|FG002|Overall Study|Histological Criteria Not Met|0|||
129907487|NCT03144674|467622586|FG003|Overall Study|Histological Criteria Not Met|1|||
129907488|NCT03144674|467622583|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
129907489|NCT03144674|467622584|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
129907490|NCT03144674|467622585|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
129907491|NCT03144674|467622586|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
129907492|NCT03144674|467622583|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
129907493|NCT03144674|467622584|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
129907494|NCT03144674|467622585|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
129907495|NCT03144674|467622586|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
129907496|NCT01373346|467622590|FG000|Overall Study|Death|1|||
129907497|NCT01198028|467622592|FG000|Overall Study|Adverse Event|5|||
129907498|NCT01198028|467622592|FG000|Overall Study|Death|3|||
129907499|NCT01198028|467622592|FG000|Overall Study|Physician Decision|2|||
129907500|NCT01395758|467622593|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
129907501|NCT01395758|467622594|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129907502|NCT01395758|467622595|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129907503|NCT00433199|467622596|FG000|Double-Blind Period|Adverse Event|0|||
129907504|NCT00433199|467622597|FG001|Double-Blind Period|Adverse Event|25|||
129907505|NCT00433199|467622596|FG000|Double-Blind Period|Lack of Efficacy|0|||
129907506|NCT00433199|467622597|FG001|Double-Blind Period|Lack of Efficacy|2|||
129907507|NCT00433199|467622596|FG000|Double-Blind Period|Lost to Follow-up|2|||
129907508|NCT00433199|467622597|FG001|Double-Blind Period|Lost to Follow-up|5|||
129907509|NCT00433199|467622596|FG000|Double-Blind Period|Withdrawal by Subject|8|||
129907510|NCT00433199|467622597|FG001|Double-Blind Period|Withdrawal by Subject|19|||
129907511|NCT00433199|467622596|FG000|Double-Blind Period|Protocol Violation|1|||
129907512|NCT00433199|467622597|FG001|Double-Blind Period|Protocol Violation|10|||
129907513|NCT00433199|467622596|FG000|Double-Blind Period|Administrative|1|||
129907514|NCT00433199|467622597|FG001|Double-Blind Period|Administrative|5|||
129907515|NCT00433199|467622596|FG000|Open-Label Period|Adverse Event|0|||
129907516|NCT00433199|467622597|FG001|Open-Label Period|Adverse Event|19|||
129907517|NCT00433199|467622596|FG000|Open-Label Period|Lack of Efficacy|0|||
129907518|NCT00433199|467622597|FG001|Open-Label Period|Lack of Efficacy|2|||
129907519|NCT00433199|467622596|FG000|Open-Label Period|Lost to Follow-up|0|||
129907520|NCT00433199|467622597|FG001|Open-Label Period|Lost to Follow-up|3|||
129907521|NCT00433199|467622596|FG000|Open-Label Period|Withdrawal by Subject|0|||
129907522|NCT00433199|467622597|FG001|Open-Label Period|Withdrawal by Subject|7|||
129907523|NCT00433199|467622596|FG000|Open-Label Period|Protocol Violation|0|||
129907524|NCT00433199|467622597|FG001|Open-Label Period|Protocol Violation|2|||
129907525|NCT00433199|467622596|FG000|Open-Label Period|Administrative|0|||
129907526|NCT00433199|467622597|FG001|Open-Label Period|Administrative|1|||
129907527|NCT00357097|467622600|FG000|Overall Study|Did not meet inclusion criteria|5|||
129907528|NCT00357097|467622601|FG001|Overall Study|Did not meet inclusion criteria|3|||
129907529|NCT00357097|467622600|FG000|Overall Study|Adverse Event|34|||
129907530|NCT00357097|467622601|FG001|Overall Study|Adverse Event|6|||
129907531|NCT00357097|467622600|FG000|Overall Study|Withdrawal by Subject|8|||
129907532|NCT00357097|467622601|FG001|Overall Study|Withdrawal by Subject|7|||
129907533|NCT00357097|467622600|FG000|Overall Study|Non-compliance|1|||
129907534|NCT00357097|467622601|FG001|Overall Study|Non-compliance|2|||
129907535|NCT00357097|467622600|FG000|Overall Study|Lack of Efficacy|2|||
129907536|NCT00357097|467622601|FG001|Overall Study|Lack of Efficacy|8|||
129907537|NCT00357097|467622600|FG000|Overall Study|Met Exclusion Criteria|3|||
129907538|NCT00357097|467622601|FG001|Overall Study|Met Exclusion Criteria|1|||
129907539|NCT00357097|467622600|FG000|Overall Study|Other|1|||
129907540|NCT00357097|467622601|FG001|Overall Study|Other|1|||
129907541|NCT00357097|467622600|FG000|Overall Study|Increase of RLS Symptoms|0|||
129907542|NCT00357097|467622601|FG001|Overall Study|Increase of RLS Symptoms|1|||
129907543|NCT00794118|467622602|FG000|Overall Study|Lost to Follow-up|16|||
129907544|NCT00794118|467622602|FG000|Overall Study|Withdrawal by Subject|9|||
129907545|NCT00794118|467622602|FG000|Overall Study|Changed hospital center|2|||
129907546|NCT04305405|467622603|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129907547|NCT04305405|467622604|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129907548|NCT03887650|467622606|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
129907549|NCT03887650|467622607|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
129907550|NCT03887650|467622606|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
129907551|NCT03887650|467622607|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
129907552|NCT03887650|467622606|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
129907553|NCT03887650|467622607|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
129907554|NCT01170962|467622608|FG000|Treatment Period|Lack of Efficacy|96|||
129907555|NCT01170962|467622609|FG001|Treatment Period|Lack of Efficacy|91|||
129907556|NCT01170962|467622610|FG002|Treatment Period|Lack of Efficacy|7|||
129907557|NCT01170962|467622608|FG000|Treatment Period|Adverse Event|11|||
129907558|NCT01170962|467622609|FG001|Treatment Period|Adverse Event|12|||
129907559|NCT01170962|467622610|FG002|Treatment Period|Adverse Event|3|||
129907560|NCT01170962|467622608|FG000|Treatment Period|Withdrawal by Subject|2|||
129907561|NCT01170962|467622609|FG001|Treatment Period|Withdrawal by Subject|1|||
129907562|NCT01170962|467622610|FG002|Treatment Period|Withdrawal by Subject|0|||
129907563|NCT01170962|467622608|FG000|Treatment Period|Lost to Follow-up|1|||
129907564|NCT01170962|467622609|FG001|Treatment Period|Lost to Follow-up|1|||
129907565|NCT01170962|467622610|FG002|Treatment Period|Lost to Follow-up|1|||
129907566|NCT01170962|467622608|FG000|Treatment Period|Participant no longer meets criteria|0|||
129907567|NCT01170962|467622609|FG001|Treatment Period|Participant no longer meets criteria|1|||
129907568|NCT01170962|467622610|FG002|Treatment Period|Participant no longer meets criteria|0|||
129907569|NCT01170962|467622608|FG000|Treatment Period|Request to discontinue treatment|7|||
129907570|NCT01170962|467622609|FG001|Treatment Period|Request to discontinue treatment|3|||
129907571|NCT01170962|467622610|FG002|Treatment Period|Request to discontinue treatment|1|||
129907572|NCT01170962|467622608|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
129907573|NCT01170962|467622609|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
129907574|NCT01170962|467622610|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
129907575|NCT01170962|467622608|FG000|Follow up Period|Withdrawal by Subject|14|||
129907576|NCT01170962|467622609|FG001|Follow up Period|Withdrawal by Subject|10|||
129854229|NCT00116805|467424835|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
129854230|NCT00116805|467424836|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
129854231|NCT00116805|467424835|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
129854232|NCT00116805|467424836|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
129854233|NCT00116805|467424835|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
129854234|NCT00116805|467424836|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
129854235|NCT00116805|467424835|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
129854236|NCT00116805|467424836|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
129854237|NCT01782131|467424837|FG000|Overall Study|Death|93|||
129854238|NCT01782131|467424838|FG001|Overall Study|Death|96|||
129854239|NCT01782131|467424837|FG000|Overall Study|Lost to Follow-up|1|||
129854240|NCT01782131|467424838|FG001|Overall Study|Lost to Follow-up|3|||
129854241|NCT01782131|467424837|FG000|Overall Study|Withdrawal by Subject|10|||
129854242|NCT01782131|467424838|FG001|Overall Study|Withdrawal by Subject|10|||
130064615|NCT00115765|468190220|FG003|Overall Study|Lost to Follow-up|1|||
130064616|NCT00115765|468190217|FG000|Overall Study|Other|6|||
130064617|NCT00115765|468190218|FG001|Overall Study|Other|12|||
129854243|NCT01782131|467424837|FG000|Overall Study|Randomized but not treated|5|||
129907577|NCT01170962|467622610|FG002|Follow up Period|Withdrawal by Subject|2|||
129907578|NCT01170962|467622608|FG000|Follow up Period|Lost to Follow-up|13|||
129907579|NCT01170962|467622609|FG001|Follow up Period|Lost to Follow-up|8|||
129907580|NCT01170962|467622610|FG002|Follow up Period|Lost to Follow-up|1|||
129907581|NCT01170962|467622608|FG000|Follow up Period|Death|2|||
129907582|NCT01170962|467622609|FG001|Follow up Period|Death|2|||
129907583|NCT01170962|467622610|FG002|Follow up Period|Death|0|||
130064618|NCT00115765|468190219|FG002|Overall Study|Other|9|||
130064619|NCT00115765|468190220|FG003|Overall Study|Other|2|||
129854244|NCT01782131|467424838|FG001|Overall Study|Randomized but not treated|5|||
129854245|NCT01782131|467424837|FG000|Overall Study|Reason not provided|0|||
129854246|NCT01782131|467424838|FG001|Overall Study|Reason not provided|1|||
129854247|NCT00796718|467424839|FG000|Overall Study|Adverse Event|2|||
129854248|NCT00796718|467424839|FG000|Overall Study|Exclusion Criteria|1|||
129854249|NCT00796718|467424839|FG000|Overall Study|Lost to Follow-up|5|||
129854250|NCT00796718|467424839|FG000|Overall Study|Withdrawal by Informed Consent|1|||
129854251|NCT03266588|467424840|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
129854252|NCT03266588|467424841|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
129854253|NCT03266588|467424842|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
129854254|NCT03266588|467424840|FG000|Observational Period|Withdrawal by Subject|44|||
129854255|NCT03266588|467424841|FG001|Observational Period|Withdrawal by Subject|22|||
129907584|NCT01170962|467622608|FG000|Follow up Period|Others|10|||
129907585|NCT01170962|467622609|FG001|Follow up Period|Others|7|||
129907586|NCT01170962|467622610|FG002|Follow up Period|Others|3|||
129907587|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
129907588|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
129907589|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
129907590|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
129907591|NCT00837616|467622617|FG000|Overall Study|Withdrawal by Subject|0|||
129907592|NCT00837616|467622618|FG001|Overall Study|Withdrawal by Subject|1|||
129907593|NCT01597258|467622624|FG000|Overall Study|No Drug Administration|1|||
129907594|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
129907595|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
129907596|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
129907597|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
129907598|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
129907599|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
129907600|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
129907601|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
129907602|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
129907603|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
129907604|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
129907605|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
129907606|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
129907607|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
129907608|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
129907609|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
129907610|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
129907611|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
129907612|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
129907613|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
129907614|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
129907615|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
129907616|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
129907617|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
129907618|NCT00304031|467624237|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
129907619|NCT00304031|467624238|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
129907620|NCT00304031|467624239|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
129907621|NCT00925899|467624240|FG000|Part 1|Death|1|||
129907622|NCT00925899|467624241|FG001|Part 1|Death|2|||
129907623|NCT00925899|467624240|FG000|Part 1|Withdrawal by Subject|10|||
129907624|NCT00925899|467624241|FG001|Part 1|Withdrawal by Subject|9|||
129907625|NCT00683696|467624242|FG000|Overall Study|Withdrawn due to study closure|337|||
129907626|NCT00683696|467624243|FG001|Overall Study|Withdrawn due to study closure|338|||
129907627|NCT00683696|467624242|FG000|Overall Study|Withdrawn prior to study closure|13|||
129907628|NCT00683696|467624243|FG001|Overall Study|Withdrawn prior to study closure|28|||
129907629|NCT00683696|467624242|FG000|Overall Study|Lost to Follow-up|5|||
129907630|NCT00683696|467624243|FG001|Overall Study|Lost to Follow-up|6|||
129907631|NCT00683696|467624242|FG000|Overall Study|Vital status follow-up only|3|||
130116619|NCT02058628|468387132|FG001|Overall Study|Lost to Follow-up|4|||
129854256|NCT03266588|467424842|FG002|Observational Period|Withdrawal by Subject|13|||
129854257|NCT03266588|467424840|FG000|Observational Period|Non-compliance|18|||
129854258|NCT03266588|467424841|FG001|Observational Period|Non-compliance|12|||
129854259|NCT03266588|467424842|FG002|Observational Period|Non-compliance|10|||
130116620|NCT02058628|468387131|FG000|Overall Study|Not in time schedule|0|||
129854260|NCT03266588|467424840|FG000|Observational Period|Lost to Follow-up|8|||
129854261|NCT03266588|467424841|FG001|Observational Period|Lost to Follow-up|12|||
129854262|NCT03266588|467424842|FG002|Observational Period|Lost to Follow-up|4|||
129907632|NCT00683696|467624243|FG001|Overall Study|Vital status follow-up only|3|||
129907633|NCT00683696|467624242|FG000|Overall Study|Death|46|||
129907634|NCT00683696|467624243|FG001|Overall Study|Death|30|||
129907635|NCT02396316|467624244|FG000|Overall Study|Physician Decision|1|||
129907636|NCT02396316|467624245|FG001|Overall Study|Physician Decision|0|||
129907637|NCT02396316|467624244|FG000|Overall Study|Progressive disease|6|||
129907638|NCT02396316|467624245|FG001|Overall Study|Progressive disease|3|||
129907639|NCT02396316|467624244|FG000|Overall Study|Protocol Violation|0|||
129907640|NCT02396316|467624245|FG001|Overall Study|Protocol Violation|1|||
129907641|NCT02396316|467624244|FG000|Overall Study|Treatment unblinded|0|||
129907642|NCT02396316|467624245|FG001|Overall Study|Treatment unblinded|1|||
129907643|NCT01875848|467624249|FG000|Overall Study|Withdrawal by Subject|2|||
129907644|NCT01875848|467624250|FG001|Overall Study|Withdrawal by Subject|0|||
129907645|NCT02189252|467624251|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
129907646|NCT02189252|467624252|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
129907647|NCT02189252|467624253|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
129907648|NCT02189252|467624254|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
129907649|NCT02189252|467624251|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
129907650|NCT02189252|467624252|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
129907651|NCT02189252|467624253|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
129907652|NCT02189252|467624254|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
129907653|NCT00840177|467624255|FG000|Overall Study|Adverse Event|5|||
129907654|NCT00840177|467624256|FG001|Overall Study|Adverse Event|1|||
129907655|NCT00840177|467624257|FG002|Overall Study|Adverse Event|1|||
129907656|NCT00840177|467624255|FG000|Overall Study|Refusal unrelated to adverse events|1|||
129907657|NCT00840177|467624256|FG001|Overall Study|Refusal unrelated to adverse events|0|||
129907658|NCT00840177|467624257|FG002|Overall Study|Refusal unrelated to adverse events|1|||
129907659|NCT00840177|467624255|FG000|Overall Study|Progression/relapse|2|||
129907660|NCT00840177|467624256|FG001|Overall Study|Progression/relapse|0|||
129907661|NCT00840177|467624257|FG002|Overall Study|Progression/relapse|0|||
129907662|NCT00840177|467624255|FG000|Overall Study|Death|4|||
129907663|NCT00840177|467624256|FG001|Overall Study|Death|5|||
129907664|NCT00840177|467624257|FG002|Overall Study|Death|5|||
129907665|NCT00840177|467624255|FG000|Overall Study|not protocol specified|6|||
129907666|NCT00840177|467624256|FG001|Overall Study|not protocol specified|3|||
129907667|NCT00840177|467624257|FG002|Overall Study|not protocol specified|0|||
129907668|NCT00840177|467624255|FG000|Overall Study|Ineligible|0|||
129907669|NCT00840177|467624256|FG001|Overall Study|Ineligible|0|||
129907670|NCT00840177|467624257|FG002|Overall Study|Ineligible|3|||
129907671|NCT00840177|467624255|FG000|Overall Study|Did not start treatment|0|||
129907672|NCT00840177|467624256|FG001|Overall Study|Did not start treatment|0|||
129907673|NCT00840177|467624257|FG002|Overall Study|Did not start treatment|1|||
129907674|NCT01391832|467624258|FG000|Overall Study|Withdrawal by Subject|21|||
129907675|NCT01391832|467624259|FG001|Overall Study|Withdrawal by Subject|22|||
129907676|NCT01391832|467624258|FG000|Overall Study|Lost to Follow-up|0|||
129907677|NCT01391832|467624259|FG001|Overall Study|Lost to Follow-up|1|||
129907678|NCT03345901|467624265|FG000|Overall Study|The study was terminated|18|||
129907679|NCT00566735|467624266|FG000|Overall Study|Withdrawal by Subject|0|||
129907680|NCT00566735|467624267|FG001|Overall Study|Withdrawal by Subject|1|||
129907681|NCT00566735|467624266|FG000|Overall Study|Refused neuropsychological testing|2|||
129907682|NCT00566735|467624267|FG001|Overall Study|Refused neuropsychological testing|5|||
129907683|NCT00566735|467624266|FG000|Overall Study|Switched into a manic episode|0|||
129907684|NCT00566735|467624267|FG001|Overall Study|Switched into a manic episode|1|||
129907685|NCT00722046|467624268|FG000|Overall Study|Adverse Event|0|||
129907686|NCT00722046|467624269|FG001|Overall Study|Adverse Event|1|||
129907687|NCT00722046|467624270|FG002|Overall Study|Adverse Event|2|||
129907688|NCT00722046|467624271|FG003|Overall Study|Adverse Event|1|||
129907689|NCT00722046|467624272|FG004|Overall Study|Adverse Event|2|||
129907690|NCT00722046|467624273|FG005|Overall Study|Adverse Event|1|||
129907691|NCT00722046|467624274|FG006|Overall Study|Adverse Event|0|||
129907692|NCT00722046|467624268|FG000|Overall Study|Death|0|||
129907693|NCT00722046|467624269|FG001|Overall Study|Death|1|||
129907694|NCT00722046|467624270|FG002|Overall Study|Death|0|||
129907695|NCT00722046|467624271|FG003|Overall Study|Death|0|||
129907696|NCT00722046|467624272|FG004|Overall Study|Death|0|||
129907697|NCT00722046|467624273|FG005|Overall Study|Death|0|||
129907698|NCT00722046|467624274|FG006|Overall Study|Death|2|||
129907699|NCT00722046|467624268|FG000|Overall Study|Protocol Violation|1|||
129907700|NCT00722046|467624269|FG001|Overall Study|Protocol Violation|0|||
129907701|NCT00722046|467624270|FG002|Overall Study|Protocol Violation|0|||
129907702|NCT00722046|467624271|FG003|Overall Study|Protocol Violation|0|||
129907703|NCT00722046|467624272|FG004|Overall Study|Protocol Violation|0|||
129907704|NCT00722046|467624273|FG005|Overall Study|Protocol Violation|1|||
129907705|NCT00722046|467624274|FG006|Overall Study|Protocol Violation|0|||
129907706|NCT00722046|467624268|FG000|Overall Study|Withdrawal by Subject|3|||
129907707|NCT00722046|467624269|FG001|Overall Study|Withdrawal by Subject|3|||
129907708|NCT00722046|467624270|FG002|Overall Study|Withdrawal by Subject|4|||
129907709|NCT00722046|467624271|FG003|Overall Study|Withdrawal by Subject|4|||
129907710|NCT00722046|467624272|FG004|Overall Study|Withdrawal by Subject|4|||
129907711|NCT00722046|467624273|FG005|Overall Study|Withdrawal by Subject|7|||
129907712|NCT00722046|467624274|FG006|Overall Study|Withdrawal by Subject|3|||
129907713|NCT00722046|467624268|FG000|Overall Study|Randomized, but not treated|1|||
129907714|NCT00722046|467624269|FG001|Overall Study|Randomized, but not treated|1|||
129907715|NCT00722046|467624270|FG002|Overall Study|Randomized, but not treated|0|||
129907716|NCT00722046|467624271|FG003|Overall Study|Randomized, but not treated|2|||
129907717|NCT00722046|467624272|FG004|Overall Study|Randomized, but not treated|0|||
129907718|NCT00722046|467624273|FG005|Overall Study|Randomized, but not treated|0|||
129907719|NCT00722046|467624274|FG006|Overall Study|Randomized, but not treated|0|||
129907720|NCT00722046|467624268|FG000|Overall Study|Other|0|||
129907721|NCT00722046|467624269|FG001|Overall Study|Other|0|||
129854263|NCT03266588|467424840|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
129854264|NCT03266588|467424841|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
129854265|NCT03266588|467424842|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
129854266|NCT03266588|467424840|FG000|Observational Period|Protocol Deviation|1|||
129854267|NCT03266588|467424841|FG001|Observational Period|Protocol Deviation|0|||
129854268|NCT03266588|467424842|FG002|Observational Period|Protocol Deviation|0|||
129854269|NCT03266588|467424840|FG000|Observational Period|Other Reasons|3|||
129854270|NCT03266588|467424841|FG001|Observational Period|Other Reasons|0|||
129854271|NCT03266588|467424842|FG002|Observational Period|Other Reasons|1|||
129854272|NCT03266588|467424840|FG000|Long-term Treatment Period|Adverse Event|33|||
129854273|NCT03266588|467424841|FG001|Long-term Treatment Period|Adverse Event|17|||
129854274|NCT03266588|467424842|FG002|Long-term Treatment Period|Adverse Event|8|||
129854275|NCT03266588|467424840|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
129854276|NCT03266588|467424841|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
129854277|NCT03266588|467424842|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
129854278|NCT03266588|467424840|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
129854279|NCT03266588|467424841|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
129854280|NCT03266588|467424842|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
129854281|NCT03266588|467424840|FG000|Long-term Treatment Period|Non-Compliance|126|||
129854282|NCT03266588|467424841|FG001|Long-term Treatment Period|Non-Compliance|57|||
129854283|NCT03266588|467424842|FG002|Long-term Treatment Period|Non-Compliance|7|||
129854284|NCT03266588|467424840|FG000|Long-term Treatment Period|Pregnancy|11|||
129854285|NCT03266588|467424841|FG001|Long-term Treatment Period|Pregnancy|5|||
129854286|NCT03266588|467424842|FG002|Long-term Treatment Period|Pregnancy|0|||
129854287|NCT03266588|467424840|FG000|Long-term Treatment Period|Protocol Deviation|17|||
129854288|NCT03266588|467424841|FG001|Long-term Treatment Period|Protocol Deviation|10|||
129854289|NCT03266588|467424842|FG002|Long-term Treatment Period|Protocol Deviation|4|||
129854290|NCT03266588|467424840|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
129854291|NCT03266588|467424841|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
129854292|NCT03266588|467424842|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
129854293|NCT03266588|467424840|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
129854294|NCT03266588|467424841|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
129854295|NCT03266588|467424842|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
129854296|NCT03266588|467424840|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
129854297|NCT03266588|467424841|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
129854298|NCT03266588|467424842|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
129854299|NCT03266588|467424840|FG000|Long-term Treatment Period|Other Reasons|5|||
129854300|NCT03266588|467424841|FG001|Long-term Treatment Period|Other Reasons|0|||
129854301|NCT03266588|467424842|FG002|Long-term Treatment Period|Other Reasons|0|||
129854302|NCT03266588|467424840|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
129854303|NCT03266588|467424841|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
129854304|NCT03266588|467424842|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
129854305|NCT00317772|467424843|FG000|Overall Study|Adverse Event|0|||
129854306|NCT00317772|467424844|FG001|Overall Study|Adverse Event|0|||
129854307|NCT00317772|467424845|FG002|Overall Study|Adverse Event|0|||
129854308|NCT00317772|467424846|FG003|Overall Study|Adverse Event|2|||
129854309|NCT00317772|467424843|FG000|Overall Study|Disease Progression|2|||
129854310|NCT00317772|467424844|FG001|Overall Study|Disease Progression|2|||
129854311|NCT00317772|467424845|FG002|Overall Study|Disease Progression|1|||
129907722|NCT00722046|467624270|FG002|Overall Study|Other|1|||
129907723|NCT00722046|467624271|FG003|Overall Study|Other|1|||
129907724|NCT00722046|467624272|FG004|Overall Study|Other|3|||
129907725|NCT00722046|467624273|FG005|Overall Study|Other|2|||
129907726|NCT00722046|467624274|FG006|Overall Study|Other|1|||
129854312|NCT00317772|467424846|FG003|Overall Study|Disease Progression|7|||
129854313|NCT01073618|467424847|FG000|Overall Study|Death|208|||
129854314|NCT01073618|467424847|FG000|Overall Study|Adverse Event|19|||
129854315|NCT01073618|467424847|FG000|Overall Study|Other|80|||
129854316|NCT00982020|467424848|FG000|Overall Study|Adverse Event|19|||
129854317|NCT00982020|467424849|FG001|Overall Study|Adverse Event|15|||
129854318|NCT00982020|467424848|FG000|Overall Study|Withdrawal by Subject|11|||
129854319|NCT00982020|467424849|FG001|Overall Study|Withdrawal by Subject|14|||
129907727|NCT00925587|467624276|FG000|Overall Study|Protocol Specified Criteria|6|||
129854320|NCT00982020|467424848|FG000|Overall Study|Lost to Follow-up|5|||
129854321|NCT00982020|467424849|FG001|Overall Study|Lost to Follow-up|11|||
129854322|NCT00982020|467424848|FG000|Overall Study|Lack of Efficacy|10|||
129854323|NCT00982020|467424849|FG001|Overall Study|Lack of Efficacy|4|||
129854324|NCT00982020|467424848|FG000|Overall Study|Parent/Caregiver Decision|5|||
129854325|NCT00982020|467424849|FG001|Overall Study|Parent/Caregiver Decision|5|||
129854326|NCT00982020|467424848|FG000|Overall Study|Treatment Non-compliance|3|||
129854327|NCT00982020|467424849|FG001|Overall Study|Treatment Non-compliance|6|||
129854328|NCT00982020|467424848|FG000|Overall Study|Physician Decision|2|||
129854329|NCT00982020|467424849|FG001|Overall Study|Physician Decision|5|||
129854330|NCT00982020|467424848|FG000|Overall Study|Entry Criteria Not Met|2|||
129854331|NCT00982020|467424849|FG001|Overall Study|Entry Criteria Not Met|1|||
129854332|NCT00982020|467424848|FG000|Overall Study|Protocol Violation|0|||
129854333|NCT00982020|467424849|FG001|Overall Study|Protocol Violation|2|||
129854334|NCT00982020|467424848|FG000|Overall Study|Clinical Relapse|0|||
129854335|NCT00982020|467424849|FG001|Overall Study|Clinical Relapse|1|||
129854336|NCT00466193|467424850|FG000|Overall Study|Adverse Event|0|||
129854337|NCT00466193|467424851|FG001|Overall Study|Adverse Event|1|||
129854338|NCT00466193|467424850|FG000|Overall Study|Lost to Follow-up|2|||
129854339|NCT00466193|467424851|FG001|Overall Study|Lost to Follow-up|4|||
129854340|NCT00466193|467424850|FG000|Overall Study|Physician Decision|1|||
129854341|NCT00466193|467424851|FG001|Overall Study|Physician Decision|0|||
129854342|NCT00466193|467424850|FG000|Overall Study|Protocol Violation|1|||
129854343|NCT00466193|467424851|FG001|Overall Study|Protocol Violation|1|||
129854344|NCT00466193|467424850|FG000|Overall Study|Withdrawal by Subject|7|||
129854345|NCT00466193|467424851|FG001|Overall Study|Withdrawal by Subject|2|||
129854346|NCT00466193|467424850|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
129854347|NCT00466193|467424851|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
129854348|NCT02246998|467424852|FG000|Overall Study|Adverse Event|0|||
129854349|NCT02246998|467424853|FG001|Overall Study|Adverse Event|1|||
129854350|NCT02246998|467424854|FG002|Overall Study|Adverse Event|1|||
129854351|NCT02246998|467424855|FG003|Overall Study|Adverse Event|0|||
129854352|NCT02246998|467424852|FG000|Overall Study|Lost to Follow-up|1|||
129854353|NCT02246998|467424853|FG001|Overall Study|Lost to Follow-up|0|||
129854354|NCT02246998|467424854|FG002|Overall Study|Lost to Follow-up|0|||
129854355|NCT02246998|467424855|FG003|Overall Study|Lost to Follow-up|1|||
129854356|NCT02246998|467424852|FG000|Overall Study|Randomized but Never Dosed|1|||
129854357|NCT02246998|467424853|FG001|Overall Study|Randomized but Never Dosed|2|||
129854358|NCT02246998|467424854|FG002|Overall Study|Randomized but Never Dosed|2|||
129854359|NCT02246998|467424855|FG003|Overall Study|Randomized but Never Dosed|1|||
129854360|NCT01343082|467424856|FG000|The run-in Period|Not meeting criteria|3|||
129854361|NCT01343082|467424857|FG001|The run-in Period|Not meeting criteria|4|||
129854362|NCT01343082|467424858|FG002|The run-in Period|Not meeting criteria|5|||
129854363|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
129854364|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
129854365|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
129854366|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
129854367|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
129854368|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
129854369|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
129854370|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
129854371|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
129854372|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
129854373|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
129854374|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
129854375|NCT01854554|467424859|FG000|Overall Study|Denial of Insurance Coverage|12|||
129854376|NCT01854554|467424860|FG001|Overall Study|Denial of Insurance Coverage|0|||
129854377|NCT01854554|467424859|FG000|Overall Study|Decided to get treatment locally|1|||
129854378|NCT01854554|467424860|FG001|Overall Study|Decided to get treatment locally|5|||
129854379|NCT01854554|467424859|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
129854380|NCT01854554|467424860|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
129854381|NCT01854554|467424859|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129854382|NCT01854554|467424860|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
129854383|NCT01854554|467424859|FG000|Overall Study|Progression|0|||
129854384|NCT01854554|467424860|FG001|Overall Study|Progression|1|||
129854385|NCT01854554|467424859|FG000|Overall Study|Lost to Follow-up|0|||
129854386|NCT01854554|467424860|FG001|Overall Study|Lost to Follow-up|1|||
129854387|NCT02819726|467424861|FG000|Part A (All Participants)|Lost to Follow-up|0|||
129854388|NCT02819726|467424862|FG001|Part A (All Participants)|Lost to Follow-up|1|||
129854389|NCT02819726|467424863|FG002|Part A (All Participants)|Lost to Follow-up|0|||
129854390|NCT02819726|467424864|FG003|Part A (All Participants)|Lost to Follow-up|0|||
129854391|NCT02819726|467424861|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
129854392|NCT02819726|467424862|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
129854393|NCT02819726|467424863|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
129907728|NCT00925587|467624277|FG001|Overall Study|Protocol Specified Criteria|6|||
129907729|NCT00925587|467624276|FG000|Overall Study|Physician Decision|4|||
129907730|NCT00925587|467624277|FG001|Overall Study|Physician Decision|1|||
129907731|NCT00925587|467624276|FG000|Overall Study|Protocol Violation|6|||
129907732|NCT00925587|467624277|FG001|Overall Study|Protocol Violation|4|||
129907733|NCT00925587|467624276|FG000|Overall Study|Withdrawal by Subject|9|||
129907734|NCT00925587|467624277|FG001|Overall Study|Withdrawal by Subject|6|||
129907735|NCT00925587|467624276|FG000|Overall Study|Death|5|||
129907736|NCT00925587|467624277|FG001|Overall Study|Death|5|||
129907737|NCT00925587|467624276|FG000|Overall Study|Adverse Event|6|||
129907738|NCT00925587|467624277|FG001|Overall Study|Adverse Event|2|||
129907739|NCT00925587|467624276|FG000|Overall Study|Lost to Follow-up|0|||
129907740|NCT00925587|467624277|FG001|Overall Study|Lost to Follow-up|1|||
129907741|NCT00686855|467624285|FG000|Overall Study|Lost to Follow-up|1|||
129907742|NCT00686855|467624286|FG001|Overall Study|Lost to Follow-up|0|||
129907743|NCT00686855|467624285|FG000|Overall Study|Progressive GVHD|0|||
129907744|NCT00686855|467624286|FG001|Overall Study|Progressive GVHD|1|||
129854394|NCT02819726|467424864|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
129854395|NCT02819726|467424861|FG000|Part A (All Participants)|Protocol non-compliance|3|||
129854396|NCT02819726|467424862|FG001|Part A (All Participants)|Protocol non-compliance|4|||
129854397|NCT02819726|467424863|FG002|Part A (All Participants)|Protocol non-compliance|5|||
129854398|NCT02819726|467424864|FG003|Part A (All Participants)|Protocol non-compliance|0|||
129854399|NCT02819726|467424861|FG000|Part B (All Participants)|Lost to Follow-up|1|||
129854400|NCT02819726|467424862|FG001|Part B (All Participants)|Lost to Follow-up|1|||
129854401|NCT02819726|467424863|FG002|Part B (All Participants)|Lost to Follow-up|2|||
129854402|NCT02819726|467424864|FG003|Part B (All Participants)|Lost to Follow-up|2|||
129854403|NCT02819726|467424861|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
129854404|NCT02819726|467424862|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
129854405|NCT02819726|467424863|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
129854406|NCT02819726|467424864|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
129854407|NCT02819726|467424861|FG000|Part B (All Participants)|Protocol non-compliance|0|||
129854408|NCT02819726|467424862|FG001|Part B (All Participants)|Protocol non-compliance|0|||
129854409|NCT02819726|467424863|FG002|Part B (All Participants)|Protocol non-compliance|1|||
129854410|NCT02819726|467424864|FG003|Part B (All Participants)|Protocol non-compliance|0|||
129854411|NCT02613481|467424865|FG000|Overall Study|Lost to Follow-up|7|||
129854412|NCT02613481|467424865|FG000|Overall Study|Withdrawal by Subject|2|||
129854413|NCT00844194|467424866|FG000|Overall Study|Adverse Event|17|||
129854414|NCT00844194|467424867|FG001|Overall Study|Adverse Event|5|||
129854415|NCT00844194|467424866|FG000|Overall Study|Protocol Violation|1|||
129854416|NCT00844194|467424867|FG001|Overall Study|Protocol Violation|1|||
129854417|NCT00844194|467424866|FG000|Overall Study|Lost to Follow-up|1|||
129854418|NCT00844194|467424867|FG001|Overall Study|Lost to Follow-up|1|||
129854419|NCT00844194|467424866|FG000|Overall Study|Withdrawal by Subject|2|||
129854420|NCT00844194|467424867|FG001|Overall Study|Withdrawal by Subject|1|||
129854421|NCT00844194|467424866|FG000|Overall Study|Lack of Efficacy|3|||
129854422|NCT00844194|467424867|FG001|Overall Study|Lack of Efficacy|0|||
129854423|NCT00844194|467424866|FG000|Overall Study|Other reason (not specified)|1|||
129854424|NCT00844194|467424867|FG001|Overall Study|Other reason (not specified)|0|||
129854425|NCT02647658|467424868|FG000|Overall Study|Consent refusal|15|||
129854426|NCT02647658|467424869|FG001|Overall Study|Consent refusal|24|||
129854427|NCT00803023|467424870|FG000|Overall Study|Adverse Event|5|||
129854428|NCT00803023|467424871|FG001|Overall Study|Adverse Event|4|||
129854429|NCT00803023|467424872|FG002|Overall Study|Adverse Event|8|||
129854430|NCT00803023|467424873|FG003|Overall Study|Adverse Event|6|||
129854431|NCT00803023|467424870|FG000|Overall Study|Withdrawal by Subject|0|||
129854432|NCT00803023|467424871|FG001|Overall Study|Withdrawal by Subject|2|||
129854433|NCT00803023|467424872|FG002|Overall Study|Withdrawal by Subject|0|||
129854434|NCT00803023|467424873|FG003|Overall Study|Withdrawal by Subject|0|||
129854435|NCT00803023|467424870|FG000|Overall Study|Lost to Follow-up|0|||
129854436|NCT00803023|467424871|FG001|Overall Study|Lost to Follow-up|1|||
129854437|NCT00803023|467424872|FG002|Overall Study|Lost to Follow-up|2|||
129854438|NCT00803023|467424873|FG003|Overall Study|Lost to Follow-up|1|||
129854439|NCT00803023|467424870|FG000|Overall Study|Lack of Efficacy|0|||
129854440|NCT00803023|467424871|FG001|Overall Study|Lack of Efficacy|1|||
129854441|NCT00803023|467424872|FG002|Overall Study|Lack of Efficacy|1|||
129854442|NCT00803023|467424873|FG003|Overall Study|Lack of Efficacy|1|||
129854443|NCT01542528|467424874|FG000|Overall Study|Lost to Follow-up|2|||
129854444|NCT01542528|467424875|FG001|Overall Study|Lost to Follow-up|1|||
129854445|NCT01542528|467424874|FG000|Overall Study|Physician Decision|1|||
129854446|NCT01542528|467424875|FG001|Overall Study|Physician Decision|0|||
129854447|NCT01542528|467424874|FG000|Overall Study|Withdrawal by Subject|9|||
129854448|NCT01542528|467424875|FG001|Overall Study|Withdrawal by Subject|6|||
129854449|NCT01921348|467424881|FG000|Overall Study|Withdrawal by Subject|1|||
129854450|NCT01921348|467424882|FG001|Overall Study|Withdrawal by Subject|0|||
129907745|NCT02731755|467624292|FG000|First Intervention|Withdrawal by Subject|0|||
129907746|NCT02731755|467624293|FG001|First Intervention|Withdrawal by Subject|2|||
129907747|NCT01460446|467624294|FG000|Overall Study|Non-compliance|2|||
129907748|NCT01460446|467624295|FG001|Overall Study|Non-compliance|9|||
129907749|NCT01460446|467624294|FG000|Overall Study|Consent Withdrawn|0|||
129907750|NCT01460446|467624295|FG001|Overall Study|Consent Withdrawn|4|||
129907751|NCT01460446|467624294|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
129907752|NCT01460446|467624295|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
129907753|NCT01460446|467624294|FG000|Overall Study|Surgery/Illness|1|||
129907754|NCT01460446|467624295|FG001|Overall Study|Surgery/Illness|1|||
129907755|NCT01460446|467624294|FG000|Overall Study|Pregnancy|1|||
129907756|NCT01460446|467624295|FG001|Overall Study|Pregnancy|0|||
129907757|NCT01460446|467624294|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
129907758|NCT01460446|467624295|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
129907759|NCT04218110|467624296|FG000|Overall Study|Withdrawal by Subject|0|||
129907760|NCT04218110|467624297|FG001|Overall Study|Withdrawal by Subject|0|||
129907761|NCT04218110|467624298|FG002|Overall Study|Withdrawal by Subject|0|||
129907762|NCT04218110|467624299|FG003|Overall Study|Withdrawal by Subject|1|||
129907763|NCT00799396|467624300|FG000|Clopidogrel Treatment|Adverse Event|6|||
129907764|NCT00799396|467624300|FG000|Clopidogrel Treatment|Physician Decision|5|||
129907765|NCT00799396|467624300|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
129907766|NCT00799396|467624300|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
129907767|NCT00799396|467624300|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
129907768|NCT01318382|467624302|FG000|Overall Study|Physician Decision|2|||
129907769|NCT01318382|467624302|FG000|Overall Study|Device Malfunction|10|||
129907770|NCT01318382|467624302|FG000|Overall Study|Protocol Violation|1|||
129907771|NCT01867216|467624303|FG000|Overall Study|Withdrawal by Subject|2|||
129907772|NCT01867216|467624304|FG001|Overall Study|Withdrawal by Subject|0|||
129907773|NCT01867216|467624305|FG002|Overall Study|Withdrawal by Subject|0|||
129907774|NCT01867216|467624306|FG003|Overall Study|Withdrawal by Subject|0|||
129907775|NCT01867216|467624307|FG004|Overall Study|Withdrawal by Subject|1|||
129907776|NCT01867216|467624308|FG005|Overall Study|Withdrawal by Subject|0|||
129907777|NCT01867216|467624309|FG006|Overall Study|Withdrawal by Subject|1|||
129907778|NCT01867216|467624303|FG000|Overall Study|Physician Decision|1|||
129907779|NCT01867216|467624304|FG001|Overall Study|Physician Decision|0|||
129907780|NCT01867216|467624305|FG002|Overall Study|Physician Decision|0|||
129907781|NCT01867216|467624306|FG003|Overall Study|Physician Decision|0|||
129907782|NCT01867216|467624307|FG004|Overall Study|Physician Decision|0|||
129907783|NCT01867216|467624308|FG005|Overall Study|Physician Decision|0|||
129907784|NCT01867216|467624309|FG006|Overall Study|Physician Decision|0|||
129907785|NCT01867216|467624303|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
129907786|NCT01867216|467624304|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907787|NCT01867216|467624305|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907788|NCT01867216|467624306|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907789|NCT01867216|467624307|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907790|NCT01867216|467624308|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907791|NCT01867216|467624309|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907792|NCT01599104|467624312|FG000|Overall Study|Withdrawal by Subject|1|||
129907793|NCT01599104|467624313|FG001|Overall Study|Withdrawal by Subject|1|||
129907794|NCT01599104|467624314|FG002|Overall Study|Withdrawal by Subject|2|||
129907795|NCT01599104|467624312|FG000|Overall Study|Technical Problems|1|||
129907796|NCT01599104|467624313|FG001|Overall Study|Technical Problems|0|||
129907797|NCT01599104|467624314|FG002|Overall Study|Technical Problems|0|||
129907798|NCT01599104|467624312|FG000|Overall Study|Physician Decision|3|||
129907799|NCT01599104|467624313|FG001|Overall Study|Physician Decision|2|||
129907800|NCT01599104|467624314|FG002|Overall Study|Physician Decision|2|||
129907801|NCT01599104|467624312|FG000|Overall Study|Non-compliance with study treatment|0|||
129907802|NCT01599104|467624313|FG001|Overall Study|Non-compliance with study treatment|1|||
129907803|NCT01599104|467624314|FG002|Overall Study|Non-compliance with study treatment|0|||
129907804|NCT01599104|467624312|FG000|Overall Study|Lack of Efficacy|4|||
129907805|NCT01599104|467624313|FG001|Overall Study|Lack of Efficacy|4|||
129907806|NCT01599104|467624314|FG002|Overall Study|Lack of Efficacy|10|||
129907807|NCT01599104|467624312|FG000|Overall Study|Adverse Event|7|||
129907808|NCT01599104|467624313|FG001|Overall Study|Adverse Event|6|||
129907809|NCT01599104|467624314|FG002|Overall Study|Adverse Event|12|||
129907810|NCT00714714|467624315|FG000|Overall Study|Adverse Event|1|||
129907811|NCT02271854|467624322|FG000|Overall Study|Withdrawal by Subject|2|||
129907812|NCT02271854|467624322|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
129907813|NCT02271854|467624322|FG000|Overall Study|Lost to Follow-up|1|||
129907814|NCT01308567|467624327|FG000|Overall Study|Lost to Follow-up|2|||
129907815|NCT01308567|467624328|FG001|Overall Study|Lost to Follow-up|4|||
129907816|NCT01308567|467624329|FG002|Overall Study|Lost to Follow-up|4|||
129907817|NCT00542789|467624330|FG000|Overall Study|Adverse Event|18|||
129907818|NCT00542789|467624331|FG001|Overall Study|Adverse Event|17|||
129907819|NCT00542789|467624330|FG000|Overall Study|Withdrawal by Subject|7|||
129907820|NCT00542789|467624331|FG001|Overall Study|Withdrawal by Subject|3|||
129907821|NCT00542789|467624330|FG000|Overall Study|Protocol Violation|8|||
129907822|NCT00542789|467624331|FG001|Overall Study|Protocol Violation|1|||
129907823|NCT00542789|467624330|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
129854451|NCT01921348|467424881|FG000|Overall Study|Lost to Follow-up|0|||
129854452|NCT01921348|467424882|FG001|Overall Study|Lost to Follow-up|2|||
129854453|NCT00795600|467424888|FG000|Overall Study|Adverse Event|1|||
129854454|NCT00795600|467424889|FG001|Overall Study|Adverse Event|1|||
129854455|NCT00795600|467424888|FG000|Overall Study|Protocol Violation|1|||
129854456|NCT00795600|467424889|FG001|Overall Study|Protocol Violation|2|||
129854457|NCT00795600|467424888|FG000|Overall Study|Withdrawal by Subject|1|||
129854458|NCT00795600|467424889|FG001|Overall Study|Withdrawal by Subject|0|||
129854459|NCT00795600|467424888|FG000|Overall Study|Unclassified|1|||
129854460|NCT00795600|467424889|FG001|Overall Study|Unclassified|1|||
129854461|NCT03936244|467424890|FG000|Overall Study|Lost to Follow-up|5|||
129854462|NCT03936244|467424891|FG001|Overall Study|Lost to Follow-up|1|||
129854463|NCT03936244|467424890|FG000|Overall Study|Physician Decision|7|||
129854464|NCT03936244|467424891|FG001|Overall Study|Physician Decision|3|||
129854465|NCT01114646|467424892|FG000|Overall Study|Withdrawal by Subject|3|||
129854466|NCT01114646|467424893|FG001|Overall Study|Withdrawal by Subject|2|||
129854467|NCT01248884|467424898|FG000|Overall Study|Withdrawal by Subject|1|||
129854468|NCT01248884|467424899|FG001|Overall Study|Withdrawal by Subject|3|||
129854469|NCT01248884|467424900|FG002|Overall Study|Withdrawal by Subject|1|||
129854470|NCT01248884|467424898|FG000|Overall Study|Adverse Event|1|||
129854471|NCT01248884|467424899|FG001|Overall Study|Adverse Event|0|||
129854472|NCT01248884|467424900|FG002|Overall Study|Adverse Event|0|||
129854473|NCT02511431|467424901|FG000|Treatment|Lost to Follow-up|0|||
129854474|NCT02511431|467424902|FG001|Treatment|Lost to Follow-up|0|||
129854475|NCT02511431|467424903|FG002|Treatment|Lost to Follow-up|1|||
129854476|NCT02511431|467424904|FG003|Treatment|Lost to Follow-up|0|||
129854477|NCT02511431|467424905|FG004|Treatment|Lost to Follow-up|0|||
129854478|NCT02511431|467424906|FG005|Treatment|Lost to Follow-up|1|||
129854479|NCT01430130|467424911|FG000|Overall Study|Lost to Follow-up|1|||
129854480|NCT01430130|467424911|FG000|Overall Study|Infection on Control Side of Incision|1|||
129854481|NCT02828111|467424915|FG000|Overall Study|Withdrawal by Subject|0|||
129854482|NCT02828111|467424916|FG001|Overall Study|Withdrawal by Subject|0|||
129854483|NCT02828111|467424917|FG002|Overall Study|Withdrawal by Subject|2|||
129854484|NCT02828111|467424918|FG003|Overall Study|Withdrawal by Subject|0|||
129854485|NCT02828111|467424919|FG004|Overall Study|Withdrawal by Subject|0|||
129854486|NCT02828111|467424915|FG000|Overall Study|Lost to Follow-up|0|||
129854487|NCT02828111|467424916|FG001|Overall Study|Lost to Follow-up|0|||
129854488|NCT02828111|467424917|FG002|Overall Study|Lost to Follow-up|0|||
129854489|NCT02828111|467424918|FG003|Overall Study|Lost to Follow-up|1|||
129854490|NCT02828111|467424919|FG004|Overall Study|Lost to Follow-up|1|||
129854491|NCT02667912|467424922|FG000|Overall Study|Death|3|||
129854492|NCT02667912|467424923|FG001|Overall Study|Death|1|||
129854493|NCT02667912|467424922|FG000|Overall Study|Withdrawal by Subject|1|||
129854494|NCT02667912|467424923|FG001|Overall Study|Withdrawal by Subject|2|||
129854495|NCT02667912|467424922|FG000|Overall Study|Withdrawal by Subject|1|||
129854496|NCT02667912|467424923|FG001|Overall Study|Withdrawal by Subject|0|||
129854497|NCT04443218|467424924|FG000|Overall Study|Exited study for other reasons|9|||
129854498|NCT04443218|467424924|FG000|Overall Study|Withdrawal by Subject|1|||
129854499|NCT04443218|467424924|FG000|Overall Study|Lost to Follow-up|4|||
129854500|NCT04443218|467424924|FG000|Overall Study|Death|19|||
129854501|NCT00022516|467424941|FG000|Overall Study|Adverse Event|0|||
129854502|NCT00022516|467424942|FG001|Overall Study|Adverse Event|59|||
129854503|NCT00022516|467424941|FG000|Overall Study|Lack of Efficacy|0|||
129854504|NCT00022516|467424942|FG001|Overall Study|Lack of Efficacy|27|||
129854505|NCT00022516|467424941|FG000|Overall Study|Physician Decision|0|||
129854506|NCT00022516|467424942|FG001|Overall Study|Physician Decision|1|||
129854507|NCT00022516|467424941|FG000|Overall Study|Protocol Violation|1|||
129854508|NCT00022516|467424942|FG001|Overall Study|Protocol Violation|3|||
129854509|NCT00022516|467424941|FG000|Overall Study|Withdrawal by Subject|2|||
129854510|NCT00022516|467424942|FG001|Overall Study|Withdrawal by Subject|113|||
129854511|NCT00022516|467424941|FG000|Overall Study|Incomplete documentation|0|||
129854512|NCT00022516|467424942|FG001|Overall Study|Incomplete documentation|27|||
129854513|NCT02207829|467424948|FG000|Overall Study|Adverse Event|10|||
129854514|NCT02207829|467424949|FG001|Overall Study|Adverse Event|9|||
129854515|NCT02207829|467424948|FG000|Overall Study|Lack of Efficacy|7|||
129854516|NCT02207829|467424949|FG001|Overall Study|Lack of Efficacy|5|||
129854517|NCT02207829|467424948|FG000|Overall Study|Lost to Follow-up|2|||
129854518|NCT02207829|467424949|FG001|Overall Study|Lost to Follow-up|2|||
129854519|NCT02207829|467424948|FG000|Overall Study|Protocol deviation|5|||
129854520|NCT02207829|467424949|FG001|Overall Study|Protocol deviation|4|||
129854521|NCT02207829|467424948|FG000|Overall Study|Withdrew consent|18|||
129854522|NCT02207829|467424949|FG001|Overall Study|Withdrew consent|14|||
129854523|NCT00766376|467424950|FG000|Overall Study|Withdrawal by Subject|27|||
129854524|NCT01800903|467424951|FG000|Second Test Period|unable to catheterise|1|||
129854525|NCT01800903|467424952|FG001|Second Test Period|unable to catheterise|0|||
129854526|NCT01800903|467424953|FG002|Second Test Period|unable to catheterise|0|||
129854527|NCT01800903|467424954|FG003|Second Test Period|unable to catheterise|0|||
129854528|NCT01800903|467424955|FG004|Second Test Period|unable to catheterise|0|||
129854529|NCT01800903|467424956|FG005|Second Test Period|unable to catheterise|0|||
129907824|NCT00542789|467624331|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
129907825|NCT03454529|467624341|FG000|Overall Study|Did not receive treatment|6|||
129907826|NCT03454529|467624341|FG000|Overall Study|Received < 80% doses|1|||
129907827|NCT01582100|467624345|FG000|Overall Study|Adverse Event|1|||
129907828|NCT01582100|467624345|FG000|Overall Study|Withdrawal by Subject|1|||
129907829|NCT01040689|467624348|FG000|Overall Study|Adverse Event|0|||
129907830|NCT01040689|467624349|FG001|Overall Study|Adverse Event|0|||
129907831|NCT01040689|467624350|FG002|Overall Study|Adverse Event|2|||
129907832|NCT01040689|467624351|FG003|Overall Study|Adverse Event|4|||
129907833|NCT01040689|467624348|FG000|Overall Study|Lack of Efficacy|0|||
129907834|NCT01040689|467624349|FG001|Overall Study|Lack of Efficacy|0|||
129907835|NCT01040689|467624350|FG002|Overall Study|Lack of Efficacy|1|||
129907836|NCT01040689|467624351|FG003|Overall Study|Lack of Efficacy|0|||
129907837|NCT01040689|467624348|FG000|Overall Study|Lost to Follow-up|1|||
129907838|NCT01040689|467624349|FG001|Overall Study|Lost to Follow-up|0|||
129907839|NCT01040689|467624350|FG002|Overall Study|Lost to Follow-up|0|||
129907840|NCT01040689|467624351|FG003|Overall Study|Lost to Follow-up|0|||
129907841|NCT01040689|467624348|FG000|Overall Study|Withdrawal by Subject|2|||
129907842|NCT01040689|467624349|FG001|Overall Study|Withdrawal by Subject|1|||
129907843|NCT01040689|467624350|FG002|Overall Study|Withdrawal by Subject|1|||
129907844|NCT01040689|467624351|FG003|Overall Study|Withdrawal by Subject|0|||
129907845|NCT01040689|467624348|FG000|Overall Study|Other reasons not listed above|0|||
129907846|NCT01040689|467624349|FG001|Overall Study|Other reasons not listed above|1|||
129907847|NCT01040689|467624350|FG002|Overall Study|Other reasons not listed above|0|||
129907848|NCT01040689|467624351|FG003|Overall Study|Other reasons not listed above|0|||
129907849|NCT01185561|467624352|FG000|Overall Study|Lost to Follow-up|0|||
129907850|NCT01185561|467624353|FG001|Overall Study|Lost to Follow-up|4|||
129907851|NCT01185561|467624352|FG000|Overall Study|Withdrawal by Subject|2|||
129907852|NCT01185561|467624353|FG001|Overall Study|Withdrawal by Subject|8|||
129907853|NCT02616900|467624354|FG000|Overall Study|Lack of Efficacy|7|||
129907854|NCT02616900|467624354|FG000|Overall Study|Lost to Follow-up|2|||
129907855|NCT02616900|467624354|FG000|Overall Study|Protocol Violation|5|||
129907856|NCT02616900|467624354|FG000|Overall Study|Withdrawal by Subject|3|||
129907857|NCT02616900|467624354|FG000|Overall Study|Incomplete data|6|||
129907858|NCT02499159|467624355|FG000|Randomization|Protocol Violation|1|||
129907859|NCT02499159|467624356|FG001|Randomization|Protocol Violation|1|||
129907860|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
129907861|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
129907862|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
129907863|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
129907864|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
129907865|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
129907866|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Other|1|||
129907867|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Other|0|||
129907868|NCT01190007|467624357|FG000|Overall Study|Withdrawal by Subject|4|||
129907869|NCT01190007|467624357|FG000|Overall Study|Adverse Event|8|||
129907870|NCT01190007|467624357|FG000|Overall Study|Difficulty of visit for complications|1|||
129907871|NCT01190007|467624357|FG000|Overall Study|Participant was arrested|1|||
129907872|NCT00585533|467624358|FG000|Overall Study|objective or symptomatic progression|9|||
129907873|NCT01369498|467624359|FG000|Overall Study|Lack of Efficacy|9|||
129907874|NCT01369498|467624360|FG001|Overall Study|Lack of Efficacy|9|||
129907875|NCT01369498|467624361|FG002|Overall Study|Lack of Efficacy|1|||
129907876|NCT01369498|467624362|FG003|Overall Study|Lack of Efficacy|3|||
129907877|NCT01369498|467624359|FG000|Overall Study|Adverse Event|1|||
129907878|NCT01369498|467624360|FG001|Overall Study|Adverse Event|2|||
129907879|NCT01369498|467624361|FG002|Overall Study|Adverse Event|0|||
129907880|NCT01369498|467624362|FG003|Overall Study|Adverse Event|1|||
129907881|NCT01369498|467624359|FG000|Overall Study|Withdrawal of Consent|0|||
129907882|NCT01369498|467624360|FG001|Overall Study|Withdrawal of Consent|1|||
129907883|NCT01369498|467624361|FG002|Overall Study|Withdrawal of Consent|1|||
129907884|NCT01369498|467624362|FG003|Overall Study|Withdrawal of Consent|1|||
129907885|NCT01369498|467624359|FG000|Overall Study|Death|0|||
129907886|NCT01369498|467624360|FG001|Overall Study|Death|0|||
129907887|NCT01369498|467624361|FG002|Overall Study|Death|1|||
129907888|NCT01369498|467624362|FG003|Overall Study|Death|0|||
129907889|NCT01369498|467624359|FG000|Overall Study|Investigator's Discretion|1|||
129907890|NCT01369498|467624360|FG001|Overall Study|Investigator's Discretion|0|||
129907891|NCT01369498|467624361|FG002|Overall Study|Investigator's Discretion|1|||
129907892|NCT01369498|467624362|FG003|Overall Study|Investigator's Discretion|3|||
129907893|NCT01369498|467624359|FG000|Overall Study|Unknown Reason|1|||
129907894|NCT01369498|467624360|FG001|Overall Study|Unknown Reason|0|||
129907895|NCT01369498|467624361|FG002|Overall Study|Unknown Reason|11|||
129907896|NCT01369498|467624362|FG003|Overall Study|Unknown Reason|6|||
129907897|NCT01369498|467624359|FG000|Overall Study|Disease Progression|0|||
129907898|NCT01369498|467624360|FG001|Overall Study|Disease Progression|0|||
129907899|NCT01369498|467624361|FG002|Overall Study|Disease Progression|0|||
129907900|NCT01369498|467624362|FG003|Overall Study|Disease Progression|1|||
129854530|NCT03283670|467424963|FG000|Placebo Gas|Withdrawal by Subject|2|||
130064620|NCT03814590|468190223|FG000|Overall Study|Adverse Event|0|||
130064621|NCT03814590|468190224|FG001|Overall Study|Adverse Event|0|||
130064622|NCT03814590|468190225|FG002|Overall Study|Adverse Event|0|||
129854531|NCT03283670|467424963|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
129854532|NCT03283670|467424963|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
129854533|NCT00852397|467424964|FG000|Overall Study|Adverse Event|4|||
129854534|NCT00852397|467424965|FG001|Overall Study|Adverse Event|6|||
129854535|NCT00852397|467424966|FG002|Overall Study|Adverse Event|4|||
129854536|NCT00852397|467424964|FG000|Overall Study|Death|0|||
129854537|NCT00852397|467424965|FG001|Overall Study|Death|0|||
129854538|NCT00852397|467424966|FG002|Overall Study|Death|1|||
129854539|NCT00852397|467424964|FG000|Overall Study|Withdrawal by Subject|4|||
129854540|NCT00852397|467424965|FG001|Overall Study|Withdrawal by Subject|1|||
129854541|NCT00852397|467424966|FG002|Overall Study|Withdrawal by Subject|2|||
129854542|NCT00852397|467424964|FG000|Overall Study|Study terminated by sponsor|2|||
129854543|NCT00852397|467424965|FG001|Overall Study|Study terminated by sponsor|1|||
129854544|NCT00852397|467424966|FG002|Overall Study|Study terminated by sponsor|6|||
129854545|NCT00852397|467424964|FG000|Overall Study|Difficulty in study site visit|1|||
129854546|NCT00852397|467424965|FG001|Overall Study|Difficulty in study site visit|0|||
129854547|NCT00852397|467424966|FG002|Overall Study|Difficulty in study site visit|0|||
129854548|NCT00852397|467424964|FG000|Overall Study|Protocol Violation|0|||
129854549|NCT00852397|467424965|FG001|Overall Study|Protocol Violation|0|||
129854550|NCT00852397|467424966|FG002|Overall Study|Protocol Violation|1|||
129854551|NCT01850004|467424970|FG000|Overall Study|Poor/Non-compliance|1|||
129854552|NCT01850004|467424970|FG000|Overall Study|Participant Withdrew Consent|9|||
129854553|NCT01850004|467424970|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
129854554|NCT01850004|467424970|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
129854555|NCT01850004|467424970|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
129854556|NCT01850004|467424970|FG000|Overall Study|Other Reasons|2|||
129854557|NCT01850004|467424970|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
129854558|NCT01850004|467424970|FG000|Overall Study|Maximum Clinical Benefit|4|||
129854559|NCT01404312|467426779|FG000|Overall Study|Death|21|||
129854560|NCT01404312|467426780|FG001|Overall Study|Death|27|||
129854561|NCT01404312|467426779|FG000|Overall Study|Withdrawal by Subject|15|||
129854562|NCT01404312|467426780|FG001|Overall Study|Withdrawal by Subject|18|||
129854563|NCT01404312|467426779|FG000|Overall Study|Participant Unable to get to clinic|93|||
129854564|NCT01404312|467426780|FG001|Overall Study|Participant Unable to get to clinic|103|||
129854565|NCT01404312|467426779|FG000|Overall Study|Lost to Follow-up|115|||
129854566|NCT01404312|467426780|FG001|Overall Study|Lost to Follow-up|111|||
129854567|NCT01404312|467426779|FG000|Overall Study|Site closed|22|||
129854568|NCT01404312|467426780|FG001|Overall Study|Site closed|21|||
129854569|NCT01404312|467426779|FG000|Overall Study|Participant not willing to adhere to req|31|||
129854570|NCT01404312|467426780|FG001|Overall Study|Participant not willing to adhere to req|29|||
129854571|NCT01404312|467426779|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129854572|NCT01404312|467426780|FG001|Overall Study|Severe debilitation, unable to continue|2|||
129854573|NCT04419493|467426781|FG000|Wash-out After Period 1|Adverse Event|1|||
129854574|NCT04419493|467426782|FG001|Wash-out After Period 1|Adverse Event|2|||
129854575|NCT04419493|467426783|FG002|Wash-out After Period 1|Adverse Event|1|||
129854576|NCT04419493|467426784|FG003|Wash-out After Period 1|Adverse Event|0|||
129854577|NCT00524134|467426785|FG000|Overall Study|Withdrawal by Subject|1|||
129854578|NCT00524134|467426785|FG000|Overall Study|Physician Decision|1|||
129854579|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
129854580|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
129854581|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
129854582|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
129854583|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
129854584|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
129854585|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Death|1|||
129854586|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Death|0|||
129854587|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Other|4|||
129854588|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Other|0|||
129854589|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
129854590|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
129854591|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
129854592|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
129854593|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
129854594|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
130064623|NCT03814590|468190226|FG003|Overall Study|Adverse Event|0|||
129854595|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
129854596|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
129854597|NCT04831736|467426792|FG000|Overall Study|Withdrawal by Subject|0|||
129854598|NCT04831736|467426793|FG001|Overall Study|Withdrawal by Subject|1|||
130064624|NCT03814590|468190227|FG004|Overall Study|Adverse Event|0|||
129907901|NCT05082935|467624366|FG000|Overall Study|Lost to Follow-up|549|||
129907902|NCT05082935|467624367|FG001|Overall Study|Lost to Follow-up|631|||
129907903|NCT05082935|467624366|FG000|Overall Study|Withdrawal by Subject|27|||
129907904|NCT05082935|467624367|FG001|Overall Study|Withdrawal by Subject|58|||
129907905|NCT00439569|467624368|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
129907906|NCT00439569|467624368|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
129907907|NCT00439569|467624368|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
129907908|NCT01510717|467624369|FG000|Overall Study|Adverse Event|1|||
129907909|NCT01510717|467624370|FG001|Overall Study|Adverse Event|2|||
129907910|NCT01510717|467624369|FG000|Overall Study|Death|1|||
129907911|NCT01510717|467624370|FG001|Overall Study|Death|0|||
129907912|NCT01510717|467624369|FG000|Overall Study|Lost to Follow-up|0|||
129907913|NCT01510717|467624370|FG001|Overall Study|Lost to Follow-up|1|||
129907914|NCT01510717|467624369|FG000|Overall Study|Withdrawal by Subject|0|||
129907915|NCT01510717|467624370|FG001|Overall Study|Withdrawal by Subject|2|||
129907916|NCT02204982|467624371|FG000|Overall Study|Patient ineligible-medical monitor|1|||
129907917|NCT02204982|467624372|FG001|Overall Study|Patient ineligible-medical monitor|0|||
129907918|NCT02204982|467624371|FG000|Overall Study|Withdrawal by Subject|1|||
129907919|NCT02204982|467624372|FG001|Overall Study|Withdrawal by Subject|0|||
129907920|NCT02204982|467624371|FG000|Overall Study|Adverse Event|1|||
129907921|NCT02204982|467624372|FG001|Overall Study|Adverse Event|0|||
129907922|NCT02204982|467624371|FG000|Overall Study|Adverse Event and Investigator decision|1|||
129907923|NCT02204982|467624372|FG001|Overall Study|Adverse Event and Investigator decision|0|||
129907924|NCT02204982|467624371|FG000|Overall Study|Physician Decision|0|||
129907925|NCT02204982|467624372|FG001|Overall Study|Physician Decision|2|||
129907926|NCT02204982|467624371|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
129907927|NCT02204982|467624372|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
129907928|NCT02204982|467624371|FG000|Overall Study|Termination of Study bySponsor|0|||
129907929|NCT02204982|467624372|FG001|Overall Study|Termination of Study bySponsor|1|||
129907930|NCT04594759|467624373|FG000|Overall Study|Lost to Follow-up|3|||
129907931|NCT00529659|467624374|FG000|Overall Study|Adverse Event|8|||
129907932|NCT00529659|467624375|FG001|Overall Study|Adverse Event|7|||
129907933|NCT00529659|467624374|FG000|Overall Study|Lost to Follow-up|0|||
129907934|NCT00529659|467624375|FG001|Overall Study|Lost to Follow-up|2|||
129907935|NCT00529659|467624374|FG000|Overall Study|Physician Decision|0|||
129907936|NCT00529659|467624375|FG001|Overall Study|Physician Decision|2|||
129907937|NCT00529659|467624374|FG000|Overall Study|Protocol Violation|2|||
129907938|NCT00529659|467624375|FG001|Overall Study|Protocol Violation|6|||
129907939|NCT00529659|467624374|FG000|Overall Study|Withdrawal by Subject|1|||
129907940|NCT00529659|467624375|FG001|Overall Study|Withdrawal by Subject|6|||
129907941|NCT01199705|467624378|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
129907942|NCT01415349|467624379|FG000|Treatment Period 1|Adverse Event|0|||
129907943|NCT01415349|467624380|FG001|Treatment Period 1|Adverse Event|1|||
129907944|NCT01415349|467624379|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129907945|NCT01415349|467624380|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129907946|NCT03473340|467624381|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
129907947|NCT03473340|467624382|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
129907948|NCT03473340|467624381|FG000|Overall Study|Withdrawal by Subject|1|||
129907949|NCT03473340|467624382|FG001|Overall Study|Withdrawal by Subject|0|||
129907950|NCT03473340|467624381|FG000|Overall Study|Lost to Follow-up|1|||
129907951|NCT03473340|467624382|FG001|Overall Study|Lost to Follow-up|2|||
129907952|NCT01616459|467624383|FG000|Overall Study|Adverse Event|1|||
129907953|NCT01616459|467624384|FG001|Overall Study|Adverse Event|1|||
129907954|NCT01616459|467624385|FG002|Overall Study|Adverse Event|2|||
129907955|NCT01616459|467624386|FG003|Overall Study|Adverse Event|0|||
129907956|NCT01616459|467624383|FG000|Overall Study|Lost to Follow-up|1|||
129907957|NCT01616459|467624384|FG001|Overall Study|Lost to Follow-up|11|||
129907958|NCT01616459|467624385|FG002|Overall Study|Lost to Follow-up|3|||
129907959|NCT01616459|467624386|FG003|Overall Study|Lost to Follow-up|2|||
129907960|NCT01616459|467624383|FG000|Overall Study|Protocol Violation|0|||
129907961|NCT01616459|467624384|FG001|Overall Study|Protocol Violation|0|||
129907962|NCT01616459|467624385|FG002|Overall Study|Protocol Violation|0|||
129907963|NCT01616459|467624386|FG003|Overall Study|Protocol Violation|2|||
129907964|NCT01616459|467624383|FG000|Overall Study|Withdrawal by Subject|2|||
129907965|NCT01616459|467624384|FG001|Overall Study|Withdrawal by Subject|4|||
129907966|NCT01616459|467624385|FG002|Overall Study|Withdrawal by Subject|4|||
129907967|NCT01616459|467624386|FG003|Overall Study|Withdrawal by Subject|4|||
129907968|NCT01616459|467624383|FG000|Overall Study|Other reason|0|||
129907969|NCT01616459|467624384|FG001|Overall Study|Other reason|1|||
129907970|NCT01616459|467624385|FG002|Overall Study|Other reason|1|||
129907971|NCT01616459|467624386|FG003|Overall Study|Other reason|0|||
129907972|NCT03394885|467624388|FG000|Overall Study|Adverse Event|4|||
129907973|NCT03394885|467624388|FG000|Overall Study|Lack of Efficacy|1|||
129907974|NCT03394885|467624388|FG000|Overall Study|Physician Decision|1|||
129907975|NCT03394885|467624388|FG000|Overall Study|Withdrawal by Subject|8|||
129907976|NCT03394885|467624388|FG000|Overall Study|Alternative Therapy|1|||
129907977|NCT04980755|467624392|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
129907978|NCT04980755|467624392|FG000|Body Reprogramming Courses|Work commitment|2|||
129907979|NCT04980755|467624392|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
129907980|NCT04980755|467624392|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
129907981|NCT04250883|467625868|FG000|Overall Study|Lost to Follow-up|1|||
129907982|NCT04250883|467625869|FG001|Overall Study|Lost to Follow-up|0|||
129907983|NCT01188655|467625871|FG000|Overall Study|Lack of Efficacy|1|||
129907984|NCT01188655|467625871|FG000|Overall Study|Lost to Follow-up|1|||
129907985|NCT01188655|467625871|FG000|Overall Study|Other|11|||
129907986|NCT00089544|467625872|FG000|Overall Study|Ineligible|1|||
129907987|NCT00089544|467625873|FG001|Overall Study|Ineligible|0|||
129907988|NCT02407249|467625878|FG000|Overall Study|Did not complete 12-month follow-up|13|||
129907989|NCT02407249|467625878|FG000|Overall Study|Not treated|13|||
129907990|NCT04425629|467625879|FG000|Overall Study|Adverse Event|0|||
129907991|NCT04425629|467625880|FG001|Overall Study|Adverse Event|0|||
129907992|NCT04425629|467625881|FG002|Overall Study|Adverse Event|0|||
129907993|NCT04425629|467625882|FG003|Overall Study|Adverse Event|0|||
129907994|NCT04425629|467625883|FG004|Overall Study|Adverse Event|1|||
129907995|NCT04425629|467625884|FG005|Overall Study|Adverse Event|0|||
129907996|NCT04425629|467625885|FG006|Overall Study|Adverse Event|0|||
129907997|NCT04425629|467625886|FG007|Overall Study|Adverse Event|0|||
129907998|NCT04425629|467625887|FG008|Overall Study|Adverse Event|0|||
129907999|NCT04425629|467625888|FG009|Overall Study|Adverse Event|3|||
129908000|NCT04425629|467625889|FG010|Overall Study|Adverse Event|2|||
129908001|NCT04425629|467625890|FG011|Overall Study|Adverse Event|1|||
129908002|NCT04425629|467625891|FG012|Overall Study|Adverse Event|1|||
129908003|NCT04425629|467625892|FG013|Overall Study|Adverse Event|0|||
129908004|NCT04425629|467625893|FG014|Overall Study|Adverse Event|0|||
129908005|NCT04425629|467625894|FG015|Overall Study|Adverse Event|0|||
129908006|NCT04425629|467625895|FG016|Overall Study|Adverse Event|0|||
129908007|NCT04425629|467625896|FG017|Overall Study|Adverse Event|0|||
129908008|NCT04425629|467625897|FG018|Overall Study|Adverse Event|0|||
129908009|NCT04425629|467625879|FG000|Overall Study|Lost to Follow-up|1|||
129908010|NCT04425629|467625880|FG001|Overall Study|Lost to Follow-up|3|||
129908011|NCT04425629|467625881|FG002|Overall Study|Lost to Follow-up|1|||
129908012|NCT04425629|467625882|FG003|Overall Study|Lost to Follow-up|7|||
129908013|NCT04425629|467625883|FG004|Overall Study|Lost to Follow-up|1|||
129908014|NCT04425629|467625884|FG005|Overall Study|Lost to Follow-up|2|||
129908015|NCT04425629|467625885|FG006|Overall Study|Lost to Follow-up|1|||
129908016|NCT04425629|467625886|FG007|Overall Study|Lost to Follow-up|0|||
129908017|NCT04425629|467625887|FG008|Overall Study|Lost to Follow-up|1|||
129908018|NCT04425629|467625888|FG009|Overall Study|Lost to Follow-up|64|||
129908019|NCT04425629|467625889|FG010|Overall Study|Lost to Follow-up|70|||
129908020|NCT04425629|467625890|FG011|Overall Study|Lost to Follow-up|98|||
129908021|NCT04425629|467625891|FG012|Overall Study|Lost to Follow-up|30|||
129908022|NCT04425629|467625892|FG013|Overall Study|Lost to Follow-up|0|||
129908023|NCT04425629|467625893|FG014|Overall Study|Lost to Follow-up|5|||
129908024|NCT04425629|467625894|FG015|Overall Study|Lost to Follow-up|4|||
129908025|NCT04425629|467625895|FG016|Overall Study|Lost to Follow-up|0|||
129908026|NCT04425629|467625896|FG017|Overall Study|Lost to Follow-up|3|||
129908027|NCT04425629|467625897|FG018|Overall Study|Lost to Follow-up|1|||
129908028|NCT04425629|467625879|FG000|Overall Study|Subject Decision|0|||
129908029|NCT04425629|467625880|FG001|Overall Study|Subject Decision|2|||
129908030|NCT04425629|467625881|FG002|Overall Study|Subject Decision|1|||
129908031|NCT04425629|467625882|FG003|Overall Study|Subject Decision|3|||
129908032|NCT04425629|467625883|FG004|Overall Study|Subject Decision|6|||
129908033|NCT04425629|467625884|FG005|Overall Study|Subject Decision|6|||
129908034|NCT04425629|467625885|FG006|Overall Study|Subject Decision|3|||
129908035|NCT04425629|467625886|FG007|Overall Study|Subject Decision|3|||
129908036|NCT04425629|467625887|FG008|Overall Study|Subject Decision|1|||
129908037|NCT04425629|467625888|FG009|Overall Study|Subject Decision|70|||
129908038|NCT04425629|467625889|FG010|Overall Study|Subject Decision|95|||
129908039|NCT04425629|467625890|FG011|Overall Study|Subject Decision|124|||
129908040|NCT04425629|467625891|FG012|Overall Study|Subject Decision|25|||
129908041|NCT04425629|467625892|FG013|Overall Study|Subject Decision|0|||
129908042|NCT04425629|467625893|FG014|Overall Study|Subject Decision|1|||
129908043|NCT04425629|467625894|FG015|Overall Study|Subject Decision|4|||
129908044|NCT04425629|467625895|FG016|Overall Study|Subject Decision|1|||
129908045|NCT04425629|467625896|FG017|Overall Study|Subject Decision|0|||
129908046|NCT04425629|467625897|FG018|Overall Study|Subject Decision|2|||
129908047|NCT04425629|467625879|FG000|Overall Study|Death|0|||
129908048|NCT04425629|467625880|FG001|Overall Study|Death|0|||
129908049|NCT04425629|467625881|FG002|Overall Study|Death|0|||
129908050|NCT04425629|467625882|FG003|Overall Study|Death|0|||
129908051|NCT04425629|467625883|FG004|Overall Study|Death|0|||
129908052|NCT04425629|467625884|FG005|Overall Study|Death|0|||
129908053|NCT04425629|467625885|FG006|Overall Study|Death|0|||
129908054|NCT04425629|467625886|FG007|Overall Study|Death|0|||
129908055|NCT04425629|467625887|FG008|Overall Study|Death|0|||
129908056|NCT04425629|467625888|FG009|Overall Study|Death|11|||
129908057|NCT04425629|467625889|FG010|Overall Study|Death|2|||
129908058|NCT04425629|467625890|FG011|Overall Study|Death|4|||
129908059|NCT04425629|467625891|FG012|Overall Study|Death|0|||
129908060|NCT04425629|467625892|FG013|Overall Study|Death|0|||
129908061|NCT04425629|467625893|FG014|Overall Study|Death|0|||
129908062|NCT04425629|467625894|FG015|Overall Study|Death|0|||
129854599|NCT01666002|467426796|FG000|Overall Study|Lost to Follow-up|5|||
129854600|NCT01666002|467426797|FG001|Overall Study|Lost to Follow-up|0|||
129908063|NCT04425629|467625895|FG016|Overall Study|Death|0|||
129908064|NCT04425629|467625896|FG017|Overall Study|Death|0|||
129908065|NCT04425629|467625897|FG018|Overall Study|Death|0|||
129908066|NCT04425629|467625879|FG000|Overall Study|Sponsor Request|0|||
129908067|NCT04425629|467625880|FG001|Overall Study|Sponsor Request|0|||
129908068|NCT04425629|467625881|FG002|Overall Study|Sponsor Request|0|||
129908069|NCT04425629|467625882|FG003|Overall Study|Sponsor Request|2|||
129908070|NCT04425629|467625883|FG004|Overall Study|Sponsor Request|2|||
129908071|NCT04425629|467625884|FG005|Overall Study|Sponsor Request|2|||
129908072|NCT04425629|467625885|FG006|Overall Study|Sponsor Request|1|||
129908073|NCT04425629|467625886|FG007|Overall Study|Sponsor Request|0|||
129908074|NCT04425629|467625887|FG008|Overall Study|Sponsor Request|0|||
129908075|NCT04425629|467625888|FG009|Overall Study|Sponsor Request|9|||
129908076|NCT04425629|467625889|FG010|Overall Study|Sponsor Request|9|||
129908077|NCT04425629|467625890|FG011|Overall Study|Sponsor Request|10|||
129908078|NCT04425629|467625891|FG012|Overall Study|Sponsor Request|8|||
129908079|NCT04425629|467625892|FG013|Overall Study|Sponsor Request|0|||
129908080|NCT04425629|467625893|FG014|Overall Study|Sponsor Request|0|||
129908081|NCT04425629|467625894|FG015|Overall Study|Sponsor Request|1|||
129908082|NCT04425629|467625895|FG016|Overall Study|Sponsor Request|0|||
129908083|NCT04425629|467625896|FG017|Overall Study|Sponsor Request|0|||
129908084|NCT04425629|467625897|FG018|Overall Study|Sponsor Request|0|||
129908085|NCT04425629|467625879|FG000|Overall Study|Physician Decision|0|||
129908086|NCT04425629|467625880|FG001|Overall Study|Physician Decision|0|||
129908087|NCT04425629|467625881|FG002|Overall Study|Physician Decision|0|||
129908088|NCT04425629|467625882|FG003|Overall Study|Physician Decision|0|||
129908089|NCT04425629|467625883|FG004|Overall Study|Physician Decision|0|||
129908090|NCT04425629|467625884|FG005|Overall Study|Physician Decision|0|||
129908091|NCT04425629|467625885|FG006|Overall Study|Physician Decision|0|||
129908092|NCT04425629|467625886|FG007|Overall Study|Physician Decision|0|||
129908093|NCT04425629|467625887|FG008|Overall Study|Physician Decision|0|||
129908094|NCT04425629|467625888|FG009|Overall Study|Physician Decision|4|||
129908095|NCT04425629|467625889|FG010|Overall Study|Physician Decision|3|||
129908096|NCT04425629|467625890|FG011|Overall Study|Physician Decision|5|||
129908097|NCT04425629|467625891|FG012|Overall Study|Physician Decision|1|||
129908098|NCT04425629|467625892|FG013|Overall Study|Physician Decision|0|||
129908099|NCT04425629|467625893|FG014|Overall Study|Physician Decision|0|||
129908100|NCT04425629|467625894|FG015|Overall Study|Physician Decision|1|||
129908101|NCT04425629|467625895|FG016|Overall Study|Physician Decision|0|||
129908102|NCT04425629|467625896|FG017|Overall Study|Physician Decision|0|||
129908103|NCT04425629|467625897|FG018|Overall Study|Physician Decision|0|||
129854601|NCT01233817|467426798|FG000|Overall Study|Lost to Follow-up|1|||
129854602|NCT01233817|467426798|FG000|Overall Study|Withdrawal by Subject|2|||
129854603|NCT02159482|467426799|FG000|Overall Study|Withdrawal by Subject|2|||
129854604|NCT02159482|467426799|FG000|Overall Study|Physician Decision|3|||
129854605|NCT04479618|467426800|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
129854606|NCT04479618|467426801|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
129854607|NCT04479618|467426802|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
129854608|NCT04479618|467426800|FG000|Overall Study|Lack of Efficacy|1|||
129854609|NCT04479618|467426801|FG001|Overall Study|Lack of Efficacy|0|||
129854610|NCT04479618|467426802|FG002|Overall Study|Lack of Efficacy|0|||
129854611|NCT04479618|467426800|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
129854612|NCT04479618|467426801|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
129854613|NCT04479618|467426802|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
129854614|NCT04479618|467426800|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
129854615|NCT04479618|467426801|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
129908104|NCT04425629|467625879|FG000|Overall Study|Lack of Efficacy|0|||
129908105|NCT04425629|467625880|FG001|Overall Study|Lack of Efficacy|0|||
129908106|NCT04425629|467625881|FG002|Overall Study|Lack of Efficacy|0|||
129854616|NCT04479618|467426802|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
129854617|NCT04479618|467426800|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
129908107|NCT04425629|467625882|FG003|Overall Study|Lack of Efficacy|0|||
129908108|NCT04425629|467625883|FG004|Overall Study|Lack of Efficacy|0|||
129908109|NCT04425629|467625884|FG005|Overall Study|Lack of Efficacy|0|||
129908110|NCT04425629|467625885|FG006|Overall Study|Lack of Efficacy|0|||
129908111|NCT04425629|467625886|FG007|Overall Study|Lack of Efficacy|0|||
129908112|NCT04425629|467625887|FG008|Overall Study|Lack of Efficacy|0|||
129908113|NCT04425629|467625888|FG009|Overall Study|Lack of Efficacy|0|||
129908114|NCT04425629|467625889|FG010|Overall Study|Lack of Efficacy|1|||
129908115|NCT04425629|467625890|FG011|Overall Study|Lack of Efficacy|0|||
129908116|NCT04425629|467625891|FG012|Overall Study|Lack of Efficacy|0|||
129908117|NCT04425629|467625892|FG013|Overall Study|Lack of Efficacy|0|||
129908118|NCT04425629|467625893|FG014|Overall Study|Lack of Efficacy|0|||
129908119|NCT04425629|467625894|FG015|Overall Study|Lack of Efficacy|0|||
129908120|NCT04425629|467625895|FG016|Overall Study|Lack of Efficacy|0|||
129908121|NCT04425629|467625896|FG017|Overall Study|Lack of Efficacy|0|||
129908122|NCT04425629|467625897|FG018|Overall Study|Lack of Efficacy|0|||
129908123|NCT00610649|467625898|FG000|Overall Study|Adverse Event|1|||
129908124|NCT00610649|467625899|FG001|Overall Study|Adverse Event|0|||
129908125|NCT00610649|467625900|FG002|Overall Study|Adverse Event|0|||
129908126|NCT00610649|467625901|FG003|Overall Study|Adverse Event|0|||
129908127|NCT00610649|467625902|FG004|Overall Study|Adverse Event|0|||
129908128|NCT00610649|467625903|FG005|Overall Study|Adverse Event|0|||
129908129|NCT00610649|467625904|FG006|Overall Study|Adverse Event|0|||
129908130|NCT00610649|467625905|FG007|Overall Study|Adverse Event|0|||
129908131|NCT00610649|467625906|FG008|Overall Study|Adverse Event|0|||
129908132|NCT00610649|467625907|FG009|Overall Study|Adverse Event|0|||
129908133|NCT00610649|467625908|FG010|Overall Study|Adverse Event|1|||
129908134|NCT00610649|467625898|FG000|Overall Study|Family Emergency|0|||
129908135|NCT00610649|467625899|FG001|Overall Study|Family Emergency|1|||
129908136|NCT00610649|467625900|FG002|Overall Study|Family Emergency|0|||
129908137|NCT00610649|467625901|FG003|Overall Study|Family Emergency|0|||
129908138|NCT00610649|467625902|FG004|Overall Study|Family Emergency|0|||
129908139|NCT00610649|467625903|FG005|Overall Study|Family Emergency|0|||
129908140|NCT00610649|467625904|FG006|Overall Study|Family Emergency|0|||
129908141|NCT00610649|467625905|FG007|Overall Study|Family Emergency|0|||
129908142|NCT00610649|467625906|FG008|Overall Study|Family Emergency|0|||
129908143|NCT00610649|467625907|FG009|Overall Study|Family Emergency|0|||
129908144|NCT00610649|467625908|FG010|Overall Study|Family Emergency|0|||
129908145|NCT00610649|467625898|FG000|Overall Study|Withdrawal by Subject|0|||
129908146|NCT00610649|467625899|FG001|Overall Study|Withdrawal by Subject|0|||
129908147|NCT00610649|467625900|FG002|Overall Study|Withdrawal by Subject|0|||
129908148|NCT00610649|467625901|FG003|Overall Study|Withdrawal by Subject|0|||
129908149|NCT00610649|467625902|FG004|Overall Study|Withdrawal by Subject|0|||
129908150|NCT00610649|467625903|FG005|Overall Study|Withdrawal by Subject|0|||
129908151|NCT00610649|467625904|FG006|Overall Study|Withdrawal by Subject|0|||
129908152|NCT00610649|467625905|FG007|Overall Study|Withdrawal by Subject|0|||
129908153|NCT00610649|467625906|FG008|Overall Study|Withdrawal by Subject|0|||
129908154|NCT00610649|467625907|FG009|Overall Study|Withdrawal by Subject|1|||
129908155|NCT00610649|467625908|FG010|Overall Study|Withdrawal by Subject|0|||
129908156|NCT00414544|467625911|FG000|Overall Study|Lost to Follow-up|14|||
129908157|NCT01149369|467625912|FG000|Overall Study|Adverse Event|6|||
129908158|NCT01149369|467625913|FG001|Overall Study|Adverse Event|3|||
129908159|NCT01078116|467625918|FG000|Overall Study|Lost to Follow-up|17|||
129908160|NCT01078116|467625918|FG000|Overall Study|Adverse Event|5|||
129908161|NCT01078116|467625918|FG000|Overall Study|Withdrawal by Subject|8|||
129908162|NCT01078116|467625918|FG000|Overall Study|Lack of effectiveness|15|||
129908163|NCT01078116|467625918|FG000|Overall Study|Case report form not completed|3|||
129908164|NCT02601820|467625919|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
129908165|NCT02601820|467625919|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
129908166|NCT02601820|467625919|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
129908167|NCT02601820|467625919|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
129908168|NCT02242487|467625920|FG000|Overall Study|Adverse Event|13|||
129908169|NCT02242487|467625921|FG001|Overall Study|Adverse Event|15|||
129908170|NCT02242487|467625920|FG000|Overall Study|Lack of Efficacy|4|||
129908171|NCT02242487|467625921|FG001|Overall Study|Lack of Efficacy|6|||
129908172|NCT02242487|467625920|FG000|Overall Study|Protocol Violation|2|||
129908173|NCT02242487|467625921|FG001|Overall Study|Protocol Violation|0|||
130064625|NCT03814590|468190228|FG005|Overall Study|Adverse Event|1|||
130064626|NCT03814590|468190229|FG006|Overall Study|Adverse Event|1|||
130064627|NCT03814590|468190230|FG007|Overall Study|Adverse Event|1|||
130064628|NCT03814590|468190231|FG008|Overall Study|Adverse Event|0|||
130064629|NCT03814590|468190232|FG009|Overall Study|Adverse Event|0|||
129908174|NCT02242487|467625920|FG000|Overall Study|Lost to Follow-up|2|||
129908175|NCT02242487|467625921|FG001|Overall Study|Lost to Follow-up|1|||
129908176|NCT02242487|467625920|FG000|Overall Study|Other - Miscellaneous|4|||
129908177|NCT02242487|467625921|FG001|Overall Study|Other - Miscellaneous|6|||
129908178|NCT02242487|467625920|FG000|Overall Study|Withdrawal by Subject|37|||
129908179|NCT02242487|467625921|FG001|Overall Study|Withdrawal by Subject|19|||
129908180|NCT01599793|467625922|FG000|Overall Study|Adverse Event|2|||
129908181|NCT00869258|467625929|FG000|Overall Study|Physician Decision|1|||
129908182|NCT00636207|467625930|FG000|Overall Study|Adverse Event|1|||
130064630|NCT03814590|468190233|FG010|Overall Study|Adverse Event|1|||
129908183|NCT00636207|467625931|FG001|Overall Study|Adverse Event|0|||
129908184|NCT00636207|467625932|FG002|Overall Study|Adverse Event|0|||
129908185|NCT00636207|467625933|FG003|Overall Study|Adverse Event|0|||
130064631|NCT03814590|468190234|FG011|Overall Study|Adverse Event|0|||
130064632|NCT03814590|468190235|FG012|Overall Study|Adverse Event|3|||
129908186|NCT00636207|467625934|FG004|Overall Study|Adverse Event|0|||
129908187|NCT00636207|467625935|FG005|Overall Study|Adverse Event|0|||
129854618|NCT04479618|467426801|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
129854619|NCT04479618|467426802|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
129854620|NCT04479618|467426800|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
129854621|NCT04479618|467426801|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
129854622|NCT04479618|467426802|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
129854623|NCT01202773|467426803|FG000|Overall Study|Adverse Event|4|||
129854624|NCT01202773|467426804|FG001|Overall Study|Adverse Event|5|||
129854625|NCT01202773|467426805|FG002|Overall Study|Adverse Event|5|||
129854626|NCT01202773|467426803|FG000|Overall Study|Lack of Efficacy|5|||
129854627|NCT01202773|467426804|FG001|Overall Study|Lack of Efficacy|4|||
129854628|NCT01202773|467426805|FG002|Overall Study|Lack of Efficacy|9|||
129854629|NCT01202773|467426803|FG000|Overall Study|Entry Criteria Not Met|2|||
129854630|NCT01202773|467426804|FG001|Overall Study|Entry Criteria Not Met|0|||
129854631|NCT01202773|467426805|FG002|Overall Study|Entry Criteria Not Met|1|||
129854632|NCT01202773|467426803|FG000|Overall Study|Lost to Follow-up|1|||
129854633|NCT01202773|467426804|FG001|Overall Study|Lost to Follow-up|2|||
129854634|NCT01202773|467426805|FG002|Overall Study|Lost to Follow-up|2|||
129854635|NCT01202773|467426803|FG000|Overall Study|Withdrawal by Subject|13|||
129854636|NCT01202773|467426804|FG001|Overall Study|Withdrawal by Subject|6|||
129854637|NCT01202773|467426805|FG002|Overall Study|Withdrawal by Subject|5|||
129854638|NCT01202773|467426803|FG000|Overall Study|Physician Decision|2|||
129854639|NCT01202773|467426804|FG001|Overall Study|Physician Decision|0|||
129854640|NCT01202773|467426805|FG002|Overall Study|Physician Decision|0|||
129854641|NCT01202773|467426803|FG000|Overall Study|Protocol Violation|11|||
129854642|NCT01202773|467426804|FG001|Overall Study|Protocol Violation|6|||
129854643|NCT01202773|467426805|FG002|Overall Study|Protocol Violation|10|||
129854644|NCT01202773|467426803|FG000|Overall Study|Sponsor Decision|19|||
129854645|NCT01202773|467426804|FG001|Overall Study|Sponsor Decision|20|||
129854646|NCT01202773|467426805|FG002|Overall Study|Sponsor Decision|23|||
129854647|NCT00462384|467426813|FG000|Overall Study|Adverse Event|2|||
129854648|NCT00462384|467426813|FG000|Overall Study|Death|2|||
129854649|NCT00462384|467426813|FG000|Overall Study|Withdrawal by Subject|1|||
129854650|NCT00462384|467426813|FG000|Overall Study|Other|4|||
129854651|NCT00346034|467426814|FG000|Overall Study|Adverse Event|34|||
129854652|NCT00346034|467426814|FG000|Overall Study|Lack of Efficacy|8|||
129854653|NCT00346034|467426814|FG000|Overall Study|Withdrawal by Subject|13|||
129854654|NCT00346034|467426814|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
129854655|NCT00346034|467426814|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
129854656|NCT01255358|467426815|FG000|Overall Study|Adverse Event|2|||
129854657|NCT01255358|467426815|FG000|Overall Study|Protocol Violation|2|||
129854658|NCT00797667|467426816|FG000|Overall Study|Lack of Efficacy|0|||
129854659|NCT00797667|467426817|FG001|Overall Study|Lack of Efficacy|1|||
129854660|NCT00797667|467426818|FG002|Overall Study|Lack of Efficacy|0|||
129854661|NCT00797667|467426816|FG000|Overall Study|Lost to Follow-up|8|||
129854662|NCT00797667|467426817|FG001|Overall Study|Lost to Follow-up|12|||
129854663|NCT00797667|467426818|FG002|Overall Study|Lost to Follow-up|2|||
129854664|NCT00797667|467426816|FG000|Overall Study|Physician Decision|3|||
129854665|NCT00797667|467426817|FG001|Overall Study|Physician Decision|1|||
129854666|NCT00797667|467426818|FG002|Overall Study|Physician Decision|0|||
129854667|NCT00797667|467426816|FG000|Overall Study|Pregnancy|2|||
129854668|NCT00797667|467426817|FG001|Overall Study|Pregnancy|0|||
129854669|NCT00797667|467426818|FG002|Overall Study|Pregnancy|0|||
129854670|NCT00797667|467426816|FG000|Overall Study|Protocol Violation|2|||
129854671|NCT00797667|467426817|FG001|Overall Study|Protocol Violation|7|||
129854672|NCT00797667|467426818|FG002|Overall Study|Protocol Violation|0|||
129854673|NCT00797667|467426816|FG000|Overall Study|Study Terminated by Sponsor|217|||
129854674|NCT00797667|467426817|FG001|Overall Study|Study Terminated by Sponsor|216|||
129854675|NCT00797667|467426818|FG002|Overall Study|Study Terminated by Sponsor|115|||
129854676|NCT00797667|467426816|FG000|Overall Study|Withdrawal by Subject|9|||
129854677|NCT00797667|467426817|FG001|Overall Study|Withdrawal by Subject|14|||
129854678|NCT00797667|467426818|FG002|Overall Study|Withdrawal by Subject|2|||
129854679|NCT00797667|467426816|FG000|Overall Study|Adverse Event|19|||
129854680|NCT00797667|467426817|FG001|Overall Study|Adverse Event|8|||
129854681|NCT00797667|467426818|FG002|Overall Study|Adverse Event|8|||
129854682|NCT01986829|467426819|FG000|Overall Study|Death|1|||
129854683|NCT02504866|467426820|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
129854684|NCT02504866|467426821|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
129854685|NCT02504866|467426822|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
129854686|NCT03231371|467426823|FG000|Overall Study|Withdrawal by Subject|1|||
129854687|NCT03231371|467426823|FG000|Overall Study|chose or were ineligible to have MRI|12|||
129854688|NCT01732835|467426826|FG000|6-month Primary Endpoint|Did not receive device|19|||
129854689|NCT01732835|467426826|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
129854690|NCT01732835|467426826|FG000|6-month Primary Endpoint|Adverse Event|3|||
129854691|NCT01732835|467426826|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
130064633|NCT03814590|468190236|FG013|Overall Study|Adverse Event|0|||
129908188|NCT00636207|467625936|FG006|Overall Study|Adverse Event|0|||
129908189|NCT00636207|467625930|FG000|Overall Study|Withdrawal by Subject|0|||
129908190|NCT00636207|467625931|FG001|Overall Study|Withdrawal by Subject|1|||
129908191|NCT00636207|467625932|FG002|Overall Study|Withdrawal by Subject|0|||
129908192|NCT00636207|467625933|FG003|Overall Study|Withdrawal by Subject|0|||
129908193|NCT00636207|467625934|FG004|Overall Study|Withdrawal by Subject|1|||
129908194|NCT00636207|467625935|FG005|Overall Study|Withdrawal by Subject|0|||
129908195|NCT00636207|467625936|FG006|Overall Study|Withdrawal by Subject|0|||
129908196|NCT01641198|467625937|FG000|After 12 Months of Function|Lost to Follow-up|3|||
129908197|NCT01641198|467625938|FG001|After 12 Months of Function|Lost to Follow-up|2|||
129908198|NCT01641198|467625939|FG002|After 12 Months of Function|Lost to Follow-up|2|||
129908199|NCT01641198|467625937|FG000|After 12 Months of Function|Protocol Violation|1|||
129908200|NCT01641198|467625938|FG001|After 12 Months of Function|Protocol Violation|0|||
129908201|NCT01641198|467625939|FG002|After 12 Months of Function|Protocol Violation|0|||
129908202|NCT01641198|467625937|FG000|After 12 Months of Function|Adverse Event|0|||
129908203|NCT01641198|467625938|FG001|After 12 Months of Function|Adverse Event|1|||
129908204|NCT01641198|467625939|FG002|After 12 Months of Function|Adverse Event|0|||
129908205|NCT01641198|467625937|FG000|After 24 Months of Function|Lost to Follow-up|4|||
129908206|NCT01641198|467625938|FG001|After 24 Months of Function|Lost to Follow-up|9|||
129908207|NCT01641198|467625939|FG002|After 24 Months of Function|Lost to Follow-up|6|||
129908208|NCT01641198|467625937|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
129908209|NCT01641198|467625938|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
129908210|NCT01641198|467625939|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
129908211|NCT01641198|467625937|FG000|At 15-20 Years of Function|Death|1|||
129908212|NCT01641198|467625938|FG001|At 15-20 Years of Function|Death|0|||
129908213|NCT01641198|467625939|FG002|At 15-20 Years of Function|Death|1|||
129908214|NCT02529995|467625941|FG000|Part A|Ongoing Study at Data Cut-off|14|||
129908215|NCT02529995|467625942|FG001|Part A|Ongoing Study at Data Cut-off|16|||
129908216|NCT02529995|467625941|FG000|Part A|Discontinued Study|1|||
129908217|NCT02529995|467625942|FG001|Part A|Discontinued Study|0|||
129908218|NCT02529995|467625941|FG000|Part B|Ongoing Study at Data Cut-off|0|||
129908219|NCT02529995|467625942|FG001|Part B|Ongoing Study at Data Cut-off|7|||
129908220|NCT02529995|467625941|FG000|Part B|Discontinued Study|6|||
129908221|NCT02529995|467625942|FG001|Part B|Discontinued Study|5|||
129908222|NCT01075217|467625945|FG000|Overall Study|Adverse Event|1|||
129908223|NCT01075217|467625946|FG001|Overall Study|Adverse Event|1|||
129908224|NCT01075217|467625945|FG000|Overall Study|Physician Decision|1|||
129908225|NCT01075217|467625946|FG001|Overall Study|Physician Decision|0|||
129908226|NCT00364013|467625947|FG000|Overall Study|Ineligibility determined|4|||
129908227|NCT00364013|467625948|FG001|Overall Study|Ineligibility determined|2|||
129908228|NCT00364013|467625947|FG000|Overall Study|Adverse Event|4|||
129908229|NCT00364013|467625948|FG001|Overall Study|Adverse Event|3|||
129908230|NCT00364013|467625947|FG000|Overall Study|Withdrawal by Subject|13|||
129908231|NCT00364013|467625948|FG001|Overall Study|Withdrawal by Subject|18|||
129908232|NCT00364013|467625947|FG000|Overall Study|Physician Decision|3|||
129908233|NCT00364013|467625948|FG001|Overall Study|Physician Decision|3|||
129908234|NCT00364013|467625947|FG000|Overall Study|Lost to Follow-up|10|||
129908235|NCT00364013|467625948|FG001|Overall Study|Lost to Follow-up|3|||
129908236|NCT00364013|467625947|FG000|Overall Study|Protocol-specified criteria|6|||
129908237|NCT00364013|467625948|FG001|Overall Study|Protocol-specified criteria|6|||
129908238|NCT00364013|467625947|FG000|Overall Study|Other|41|||
129908239|NCT00364013|467625948|FG001|Overall Study|Other|47|||
129908240|NCT00364013|467625947|FG000|Overall Study|Ongoing|20|||
129908241|NCT00364013|467625948|FG001|Overall Study|Ongoing|13|||
129908242|NCT01943916|467625949|FG000|Overall Study|Technically invalid images|10|||
129908243|NCT01943916|467625949|FG000|Overall Study|Enrollment Failure|23|||
129908244|NCT01943916|467625949|FG000|Overall Study|Pilot Phase exclusion|100|||
129908245|NCT01943916|467625949|FG000|Overall Study|Quality Assurance Reader Fail|130|||
129908246|NCT01943916|467625949|FG000|Overall Study|Technical Failure|39|||
129908247|NCT01943916|467625949|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
129908248|NCT01943916|467625949|FG000|Overall Study|No Truth Panel Review|38|||
129908249|NCT01943916|467625949|FG000|Overall Study|Protocol Deviation|1|||
129908250|NCT05274217|467625950|FG000|Overall Study|Study terminated.|11|||
129908251|NCT05274217|467625951|FG001|Overall Study|Study terminated.|0|||
129908252|NCT03811574|467625954|FG000|Overall Study|Withdrawal by Subject|2|||
129908253|NCT03811574|467625955|FG001|Overall Study|Withdrawal by Subject|4|||
129908254|NCT03811574|467625956|FG002|Overall Study|Withdrawal by Subject|0|||
129908255|NCT01832480|467625957|FG000|Overall Study|Lost to Follow-up|33|||
129908256|NCT01832480|467625958|FG001|Overall Study|Lost to Follow-up|30|||
129908257|NCT01832480|467625957|FG000|Overall Study|Withdrawal by Subject|0|||
129908258|NCT01832480|467625958|FG001|Overall Study|Withdrawal by Subject|2|||
129908259|NCT01832480|467625957|FG000|Overall Study|post randomization ineligible|8|||
129908260|NCT01832480|467625958|FG001|Overall Study|post randomization ineligible|10|||
129908261|NCT05609032|467625959|FG000|Overall Study|Lost to Follow-up|3|||
129908262|NCT05609032|467625960|FG001|Overall Study|Lost to Follow-up|1|||
129908263|NCT05609032|467625959|FG000|Overall Study|Withdrawal by Subject|1|||
130064634|NCT03814590|468190223|FG000|Overall Study|Lost to Follow-up|0|||
129908264|NCT05609032|467625960|FG001|Overall Study|Withdrawal by Subject|0|||
129908265|NCT02261467|467625961|FG000|Overall Study|Enrolled in Error|1|||
129908266|NCT02261467|467625962|FG001|Overall Study|Enrolled in Error|0|||
129908267|NCT02261467|467625961|FG000|Overall Study|Protocol Violation|0|||
129908268|NCT02261467|467625962|FG001|Overall Study|Protocol Violation|1|||
129908269|NCT02261467|467625961|FG000|Overall Study|Personal Reasons|17|||
129908270|NCT02261467|467625962|FG001|Overall Study|Personal Reasons|22|||
129908271|NCT02261467|467625961|FG000|Overall Study|Lost to Follow-up|2|||
129908272|NCT02261467|467625962|FG001|Overall Study|Lost to Follow-up|13|||
129908273|NCT02261467|467625961|FG000|Overall Study|Adverse Event|1|||
129908274|NCT02261467|467625962|FG001|Overall Study|Adverse Event|1|||
129908275|NCT02674750|467625968|FG000|Overall Study|Death|4|||
129908276|NCT02674750|467625969|FG001|Overall Study|Death|5|||
129908277|NCT02674750|467625970|FG002|Overall Study|Death|8|||
129908278|NCT02674750|467625968|FG000|Overall Study|Lost to Follow-up|0|||
129908279|NCT02674750|467625969|FG001|Overall Study|Lost to Follow-up|8|||
129908280|NCT02674750|467625970|FG002|Overall Study|Lost to Follow-up|0|||
129908281|NCT02674750|467625968|FG000|Overall Study|Lack of Efficacy|1|||
129908282|NCT02674750|467625969|FG001|Overall Study|Lack of Efficacy|17|||
129908283|NCT02674750|467625970|FG002|Overall Study|Lack of Efficacy|3|||
129908284|NCT02674750|467625968|FG000|Overall Study|Withdrawal by Subject|0|||
129908285|NCT02674750|467625969|FG001|Overall Study|Withdrawal by Subject|7|||
129908286|NCT02674750|467625970|FG002|Overall Study|Withdrawal by Subject|1|||
129908287|NCT02674750|467625968|FG000|Overall Study|Other|0|||
129908288|NCT02674750|467625969|FG001|Overall Study|Other|8|||
129908289|NCT02674750|467625970|FG002|Overall Study|Other|0|||
129908290|NCT01685606|467625973|FG000|Overall Study|Withdrawal by Subject|1|||
129908291|NCT01787760|467625974|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
129908292|NCT01787760|467625975|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
129908293|NCT01787760|467625976|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
129908294|NCT01787760|467625974|FG000|Overall Study|Decompensated on left exotropia|0|||
129908295|NCT01787760|467625975|FG001|Overall Study|Decompensated on left exotropia|0|||
129908296|NCT01787760|467625976|FG002|Overall Study|Decompensated on left exotropia|1|||
129908297|NCT01787760|467625974|FG000|Overall Study|Dryness|0|||
129908298|NCT01787760|467625975|FG001|Overall Study|Dryness|1|||
129908299|NCT01787760|467625976|FG002|Overall Study|Dryness|0|||
129908300|NCT01787760|467625974|FG000|Overall Study|Relocation|1|||
129908301|NCT01787760|467625975|FG001|Overall Study|Relocation|1|||
129908302|NCT01787760|467625976|FG002|Overall Study|Relocation|0|||
129908303|NCT01787760|467625974|FG000|Overall Study|Lens discomfort|3|||
130064635|NCT03814590|468190224|FG001|Overall Study|Lost to Follow-up|2|||
130064636|NCT03814590|468190225|FG002|Overall Study|Lost to Follow-up|1|||
129854692|NCT01732835|467426826|FG000|2-year Extended Follow-up|Adverse Event|3|||
129854693|NCT01732835|467426826|FG000|2-year Extended Follow-up|Death|1|||
129854694|NCT02493361|467426827|FG000|Overall Study|Withdrawal by Subject|3|||
129854695|NCT02334748|467426828|FG000|Overall Study|Adverse Event|1|||
129854696|NCT02334748|467426828|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
129854697|NCT02334748|467426828|FG000|Overall Study|Patient no longer required study drug|2|||
129854698|NCT02334748|467426828|FG000|Overall Study|Lack of Efficacy|4|||
129854699|NCT03067441|467426829|FG000|Overall Study|Withdrawal by Subject|16|||
129854700|NCT03067441|467426830|FG001|Overall Study|Withdrawal by Subject|34|||
129854701|NCT03067441|467426829|FG000|Overall Study|Lost to Follow-up|7|||
129854702|NCT03067441|467426830|FG001|Overall Study|Lost to Follow-up|5|||
129854703|NCT03067441|467426829|FG000|Overall Study|Adverse Event|7|||
129854704|NCT03067441|467426830|FG001|Overall Study|Adverse Event|14|||
129854705|NCT03067441|467426829|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
129854706|NCT03067441|467426830|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
129854707|NCT03067441|467426829|FG000|Overall Study|Physician Decision|1|||
129854708|NCT03067441|467426830|FG001|Overall Study|Physician Decision|3|||
129854709|NCT03067441|467426829|FG000|Overall Study|Other|1|||
129854710|NCT03067441|467426830|FG001|Overall Study|Other|1|||
129854711|NCT02056301|467426834|FG000|Overall Study|Protocol Violation|1|||
129854712|NCT02056301|467426835|FG001|Overall Study|Protocol Violation|2|||
129854713|NCT02056301|467426834|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
129854714|NCT02056301|467426835|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
129908304|NCT01787760|467625975|FG001|Overall Study|Lens discomfort|0|||
129908305|NCT01787760|467625976|FG002|Overall Study|Lens discomfort|0|||
129908306|NCT01787760|467625974|FG000|Overall Study|Lens handling difficulty|1|||
130064637|NCT03814590|468190226|FG003|Overall Study|Lost to Follow-up|0|||
129854715|NCT02056301|467426834|FG000|Overall Study|Withdrawal by Subject|0|||
129854716|NCT02056301|467426835|FG001|Overall Study|Withdrawal by Subject|1|||
129854717|NCT02056301|467426834|FG000|Overall Study|Issues with epidural|0|||
129908307|NCT01787760|467625975|FG001|Overall Study|Lens handling difficulty|2|||
129908308|NCT01787760|467625976|FG002|Overall Study|Lens handling difficulty|0|||
129908309|NCT01787760|467625974|FG000|Overall Study|Protocol Violation|6|||
129908310|NCT01787760|467625975|FG001|Overall Study|Protocol Violation|0|||
129908311|NCT01787760|467625976|FG002|Overall Study|Protocol Violation|1|||
129908312|NCT01787760|467625974|FG000|Overall Study|Withdrawal by Subject|5|||
129854718|NCT02056301|467426835|FG001|Overall Study|Issues with epidural|3|||
129854719|NCT02209324|467426839|FG000|Overall Study|Adverse Event|2|||
129854720|NCT02209324|467426839|FG000|Overall Study|Lack of Efficacy|1|||
129854721|NCT02209324|467426839|FG000|Overall Study|Lost to Follow-up|1|||
129854722|NCT02209324|467426839|FG000|Overall Study|Physician Decision|3|||
129854723|NCT02209324|467426839|FG000|Overall Study|Protocol Violation|14|||
129854724|NCT02209324|467426839|FG000|Overall Study|Withdrawal by Subject|8|||
129854725|NCT02209324|467426839|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
129854726|NCT02209324|467426839|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
129854727|NCT02209324|467426839|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
129854728|NCT03433456|467426840|FG000|Overall Study|Death|1|||
129854729|NCT03433456|467426841|FG001|Overall Study|Death|1|||
129854730|NCT03433456|467426840|FG000|Overall Study|Lost to Follow-up|14|||
129854731|NCT03433456|467426841|FG001|Overall Study|Lost to Follow-up|11|||
129854732|NCT03433456|467426840|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
129854733|NCT03433456|467426841|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
129854734|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
129854735|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
129854736|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
129854737|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
129854738|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
129854739|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
129854740|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
129854741|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
129854742|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Other|0|||
129854743|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Other|1|||
129854744|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Other|0|||
129854745|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Other|0|||
129854746|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
129854747|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
129854748|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
129854749|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
129854750|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
129854751|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
129854752|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
129854753|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
129854754|NCT05799495|467426842|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129854755|NCT05799495|467426843|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129854756|NCT05799495|467426844|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
129854757|NCT05799495|467426845|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129854758|NCT03105362|467426846|FG000|Overall Study|Withdrawal by Subject|1|||
129854759|NCT03105362|467426846|FG000|Overall Study|Lost to Follow-up|1|||
129854760|NCT01198600|467426847|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
129854761|NCT01198600|467426848|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
129854762|NCT01198600|467426849|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
129854763|NCT01198600|467426850|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
129854764|NCT01198600|467426847|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
129854765|NCT01198600|467426848|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
129854766|NCT01198600|467426849|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
129854767|NCT01198600|467426850|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
129854768|NCT01198600|467426847|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
129854769|NCT01198600|467426848|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
129854770|NCT01198600|467426849|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
129854771|NCT01198600|467426850|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
129854772|NCT01198600|467426847|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
129854773|NCT01198600|467426848|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
129854774|NCT01198600|467426849|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
129854775|NCT01198600|467426850|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
129854776|NCT01198600|467426847|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
129854777|NCT01198600|467426848|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
129854778|NCT01198600|467426849|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
129854779|NCT01198600|467426850|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
129854780|NCT01198600|467426847|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
129854781|NCT01198600|467426848|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
129854782|NCT01198600|467426849|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
129854783|NCT01198600|467426850|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
129854784|NCT01198600|467426847|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
129854785|NCT01198600|467426848|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
129854786|NCT01198600|467426849|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
129854787|NCT01198600|467426850|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
129908313|NCT01787760|467625975|FG001|Overall Study|Withdrawal by Subject|1|||
129908314|NCT01787760|467625976|FG002|Overall Study|Withdrawal by Subject|2|||
129908315|NCT01787760|467625974|FG000|Overall Study|Lost to Follow-up|1|||
129908316|NCT01787760|467625975|FG001|Overall Study|Lost to Follow-up|0|||
129908317|NCT01787760|467625976|FG002|Overall Study|Lost to Follow-up|1|||
129908318|NCT01787760|467625974|FG000|Overall Study|Stroke|1|||
129908319|NCT01787760|467625975|FG001|Overall Study|Stroke|0|||
129908320|NCT01787760|467625976|FG002|Overall Study|Stroke|0|||
129908321|NCT01787760|467625974|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
129908322|NCT01787760|467625975|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
129908323|NCT01787760|467625976|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
129908324|NCT01787760|467625974|FG000|Overall Study|Unsatisfactory physiological response|2|||
129908325|NCT01787760|467625975|FG001|Overall Study|Unsatisfactory physiological response|4|||
129908326|NCT01787760|467625976|FG002|Overall Study|Unsatisfactory physiological response|0|||
129908327|NCT01787760|467625974|FG000|Overall Study|Unsatisfactory visual response|1|||
129908328|NCT01787760|467625975|FG001|Overall Study|Unsatisfactory visual response|1|||
129908329|NCT01787760|467625976|FG002|Overall Study|Unsatisfactory visual response|0|||
129908330|NCT01787760|467625974|FG000|Overall Study|Near vision blur|1|||
129908331|NCT01787760|467625975|FG001|Overall Study|Near vision blur|0|||
129908332|NCT01787760|467625976|FG002|Overall Study|Near vision blur|0|||
129908333|NCT03512756|467625977|FG000|Part 1|Death|23|||
129908334|NCT03512756|467625978|FG001|Part 1|Death|18|||
129908335|NCT03512756|467625979|FG002|Part 1|Death|0|||
129908336|NCT03512756|467625980|FG003|Part 1|Death|0|||
129908337|NCT03512756|467625977|FG000|Part 1|Lost to Follow-up|0|||
129908338|NCT03512756|467625978|FG001|Part 1|Lost to Follow-up|3|||
129908339|NCT03512756|467625979|FG002|Part 1|Lost to Follow-up|0|||
129908340|NCT03512756|467625980|FG003|Part 1|Lost to Follow-up|0|||
129908341|NCT03512756|467625977|FG000|Part 1|Physician Decision|0|||
129908342|NCT03512756|467625978|FG001|Part 1|Physician Decision|1|||
129908343|NCT03512756|467625979|FG002|Part 1|Physician Decision|0|||
129908344|NCT03512756|467625980|FG003|Part 1|Physician Decision|0|||
129908345|NCT03512756|467625977|FG000|Part 1|Withdrawal by Subject|2|||
129908346|NCT03512756|467625978|FG001|Part 1|Withdrawal by Subject|2|||
129908347|NCT03512756|467625979|FG002|Part 1|Withdrawal by Subject|0|||
129908348|NCT03512756|467625980|FG003|Part 1|Withdrawal by Subject|0|||
129908349|NCT03512756|467625977|FG000|Part 2|Death|0|||
129908350|NCT03512756|467625978|FG001|Part 2|Death|0|||
129908351|NCT03512756|467625979|FG002|Part 2|Death|32|||
129908352|NCT03512756|467625980|FG003|Part 2|Death|21|||
130064638|NCT03814590|468190227|FG004|Overall Study|Lost to Follow-up|1|||
130064639|NCT03814590|468190228|FG005|Overall Study|Lost to Follow-up|1|||
130064640|NCT03814590|468190229|FG006|Overall Study|Lost to Follow-up|1|||
130064641|NCT03814590|468190230|FG007|Overall Study|Lost to Follow-up|1|||
129854788|NCT03694548|467426851|FG000|Part A Survey|Protocol Violation|3|||
129854789|NCT03694548|467426852|FG001|Part A Survey|Protocol Violation|3|||
129854790|NCT03694548|467426853|FG002|Part A Survey|Protocol Violation|0|||
129854791|NCT03694548|467426851|FG000|Part B Yoga Program|Protocol Violation|0|||
129854792|NCT03694548|467426852|FG001|Part B Yoga Program|Protocol Violation|0|||
129854793|NCT03694548|467426853|FG002|Part B Yoga Program|Protocol Violation|3|||
129854794|NCT03694548|467426851|FG000|Part B Yoga Program|Did not attend intervention|0|||
129854795|NCT03694548|467426852|FG001|Part B Yoga Program|Did not attend intervention|0|||
129854796|NCT03694548|467426853|FG002|Part B Yoga Program|Did not attend intervention|8|||
129854797|NCT04177108|467426854|FG000|Overall Study|Withdrawal by Subject|4|||
129854798|NCT04177108|467426855|FG001|Overall Study|Withdrawal by Subject|8|||
129854799|NCT04177108|467426856|FG002|Overall Study|Withdrawal by Subject|9|||
129854800|NCT04177108|467426857|FG003|Overall Study|Withdrawal by Subject|11|||
129854801|NCT04177108|467426858|FG004|Overall Study|Withdrawal by Subject|13|||
129854802|NCT04177108|467426854|FG000|Overall Study|Physician Decision|23|||
129854803|NCT04177108|467426855|FG001|Overall Study|Physician Decision|15|||
129854804|NCT04177108|467426856|FG002|Overall Study|Physician Decision|18|||
129854805|NCT04177108|467426857|FG003|Overall Study|Physician Decision|29|||
129854806|NCT04177108|467426858|FG004|Overall Study|Physician Decision|23|||
129854807|NCT04177108|467426854|FG000|Overall Study|Reason Not Specified|0|||
129854808|NCT04177108|467426855|FG001|Overall Study|Reason Not Specified|1|||
129854809|NCT04177108|467426856|FG002|Overall Study|Reason Not Specified|0|||
129854810|NCT04177108|467426857|FG003|Overall Study|Reason Not Specified|0|||
129854811|NCT04177108|467426858|FG004|Overall Study|Reason Not Specified|2|||
129854812|NCT04177108|467426854|FG000|Overall Study|Lost to Follow-up|0|||
129854813|NCT04177108|467426855|FG001|Overall Study|Lost to Follow-up|0|||
129908353|NCT03512756|467625977|FG000|Part 2|Lost to Follow-up|0|||
129908354|NCT03512756|467625978|FG001|Part 2|Lost to Follow-up|0|||
129908355|NCT03512756|467625979|FG002|Part 2|Lost to Follow-up|1|||
129908356|NCT03512756|467625980|FG003|Part 2|Lost to Follow-up|0|||
129908357|NCT03512756|467625977|FG000|Part 2|Physician Decision|0|||
129908358|NCT03512756|467625978|FG001|Part 2|Physician Decision|0|||
129908359|NCT03512756|467625979|FG002|Part 2|Physician Decision|2|||
129908360|NCT03512756|467625980|FG003|Part 2|Physician Decision|4|||
129854814|NCT04177108|467426856|FG002|Overall Study|Lost to Follow-up|1|||
129908361|NCT03512756|467625977|FG000|Part 2|Study Terminated by Sponsor|0|||
129908362|NCT03512756|467625978|FG001|Part 2|Study Terminated by Sponsor|0|||
129854815|NCT04177108|467426857|FG003|Overall Study|Lost to Follow-up|1|||
129854816|NCT04177108|467426858|FG004|Overall Study|Lost to Follow-up|1|||
129854817|NCT04177108|467426854|FG000|Overall Study|Death|16|||
129854818|NCT04177108|467426855|FG001|Overall Study|Death|19|||
129854819|NCT04177108|467426856|FG002|Overall Study|Death|13|||
129854820|NCT04177108|467426857|FG003|Overall Study|Death|17|||
129854821|NCT04177108|467426858|FG004|Overall Study|Death|18|||
129854822|NCT04496258|467426862|FG000|Overall Study|Withdrawal by Subject|2|||
129854823|NCT04496258|467426863|FG001|Overall Study|Withdrawal by Subject|1|||
129854824|NCT01669343|467426865|FG000|Part A: All Patients|Withdrawal by Subject|7|||
129854825|NCT01669343|467426865|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
129854826|NCT01669343|467426865|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
129854827|NCT01669343|467426865|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
129854828|NCT01669343|467426865|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
129854829|NCT04433767|467426867|FG000|Overall Study|Adverse Event|1|||
129854830|NCT02371369|467426868|FG000|Part 1|Physician Decision|0|||
129854831|NCT02371369|467426869|FG001|Part 1|Physician Decision|3|||
129854832|NCT02371369|467426868|FG000|Part 1|Adverse Event|8|||
129854833|NCT02371369|467426869|FG001|Part 1|Adverse Event|0|||
129854834|NCT02371369|467426868|FG000|Part 1|Withdrawal by Subject|1|||
129854835|NCT02371369|467426869|FG001|Part 1|Withdrawal by Subject|6|||
129854836|NCT02371369|467426868|FG000|Part 1|Disease progression|0|||
129854837|NCT02371369|467426869|FG001|Part 1|Disease progression|1|||
129854838|NCT02371369|467426868|FG000|Part 1|Protocol Violation|0|||
129854839|NCT02371369|467426869|FG001|Part 1|Protocol Violation|1|||
129854840|NCT02371369|467426868|FG000|Part 2|Adverse Event|6|||
129854841|NCT02371369|467426869|FG001|Part 2|Adverse Event|5|||
129854842|NCT02371369|467426868|FG000|Part 2|Withdrawal by Subject|16|||
129854843|NCT02371369|467426869|FG001|Part 2|Withdrawal by Subject|6|||
129854844|NCT02371369|467426868|FG000|Part 2|Investigator decision|1|||
129854845|NCT02371369|467426869|FG001|Part 2|Investigator decision|2|||
129854846|NCT02371369|467426868|FG000|Part 2|Death|0|||
129854847|NCT02371369|467426869|FG001|Part 2|Death|1|||
129854848|NCT02371369|467426868|FG000|Part 2|Disease progression|1|||
129854849|NCT02371369|467426869|FG001|Part 2|Disease progression|0|||
129854850|NCT02371369|467426868|FG000|Part 2|Subject Noncompliance|1|||
129854851|NCT02371369|467426869|FG001|Part 2|Subject Noncompliance|0|||
129854852|NCT02371369|467426868|FG000|Part 2|Lost to Follow-up|1|||
129854853|NCT02371369|467426869|FG001|Part 2|Lost to Follow-up|1|||
129854854|NCT02371369|467426868|FG000|Part 2|Subject transitioned to commercial supply|6|||
129854855|NCT02371369|467426869|FG001|Part 2|Subject transitioned to commercial supply|4|||
129854856|NCT02371369|467426868|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
129854857|NCT02371369|467426869|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
129854858|NCT02371369|467426868|FG000|Part 2|Surgical resection of tumor|1|||
129854859|NCT02371369|467426869|FG001|Part 2|Surgical resection of tumor|1|||
129854860|NCT02371369|467426868|FG000|Part 2|Other|0|||
129854861|NCT02371369|467426869|FG001|Part 2|Other|1|||
129854862|NCT00439777|467426870|FG000|Treatment Period|Death|29|||
129854863|NCT00439777|467426871|FG001|Treatment Period|Death|21|||
129854864|NCT00439777|467426870|FG000|Treatment Period|Study terminated by sponsor|125|||
129854865|NCT00439777|467426871|FG001|Treatment Period|Study terminated by sponsor|132|||
129854866|NCT00439777|467426870|FG000|Treatment Period|Site closed by investigator|0|||
129854867|NCT00439777|467426871|FG001|Treatment Period|Site closed by investigator|1|||
129854868|NCT00439777|467426870|FG000|Treatment Period|Did not take study treatment|7|||
129854869|NCT00439777|467426871|FG001|Treatment Period|Did not take study treatment|8|||
129854870|NCT00439777|467426870|FG000|Treatment Period|Adverse Event|111|||
129854871|NCT00439777|467426871|FG001|Treatment Period|Adverse Event|92|||
129854872|NCT00439777|467426870|FG000|Treatment Period|Protocol Violation|23|||
129854873|NCT00439777|467426871|FG001|Treatment Period|Protocol Violation|30|||
129854874|NCT00439777|467426870|FG000|Treatment Period|Withdrawal by Subject|66|||
129854875|NCT00439777|467426871|FG001|Treatment Period|Withdrawal by Subject|118|||
129854876|NCT00439777|467426870|FG000|Treatment Period|Lack of Efficacy|1|||
129854877|NCT00439777|467426871|FG001|Treatment Period|Lack of Efficacy|4|||
129854878|NCT00439777|467426870|FG000|Treatment Period|Lost to Follow-up|8|||
129854879|NCT00439777|467426871|FG001|Treatment Period|Lost to Follow-up|10|||
129854880|NCT00439777|467426870|FG000|Treatment Period|Protocol driven decision point|1|||
129908363|NCT03512756|467625979|FG002|Part 2|Study Terminated by Sponsor|2|||
129854881|NCT00439777|467426871|FG001|Treatment Period|Protocol driven decision point|3|||
129854882|NCT00439777|467426870|FG000|Treatment Period|Physician Decision|7|||
129908364|NCT03512756|467625980|FG003|Part 2|Study Terminated by Sponsor|6|||
129908365|NCT03512756|467625977|FG000|Part 2|Protocol Violation|0|||
129854883|NCT00439777|467426871|FG001|Treatment Period|Physician Decision|18|||
129854884|NCT00439777|467426870|FG000|Treatment Period|Clinical endpoint reached|26|||
129854885|NCT00439777|467426871|FG001|Treatment Period|Clinical endpoint reached|13|||
129854886|NCT00439777|467426870|FG000|Treatment Period|Technical problems|3|||
129854887|NCT00439777|467426871|FG001|Treatment Period|Technical problems|1|||
129908366|NCT03512756|467625978|FG001|Part 2|Protocol Violation|0|||
129908367|NCT03512756|467625979|FG002|Part 2|Protocol Violation|1|||
129908368|NCT03512756|467625980|FG003|Part 2|Protocol Violation|0|||
129908369|NCT03512756|467625977|FG000|Part 2|Withdrawal by Subject|0|||
129908370|NCT03512756|467625978|FG001|Part 2|Withdrawal by Subject|0|||
129908371|NCT03512756|467625979|FG002|Part 2|Withdrawal by Subject|3|||
129908372|NCT03512756|467625980|FG003|Part 2|Withdrawal by Subject|9|||
129908373|NCT00736853|467625981|FG000|Open-Label Period|Physician Decision|2|||
129908374|NCT00736853|467625982|FG001|Open-Label Period|Physician Decision|0|||
129908375|NCT00736853|467625983|FG002|Open-Label Period|Physician Decision|0|||
129908376|NCT00736853|467625981|FG000|Open-Label Period|Adverse Event|31|||
129908377|NCT00736853|467625982|FG001|Open-Label Period|Adverse Event|0|||
129908378|NCT00736853|467625983|FG002|Open-Label Period|Adverse Event|0|||
129908379|NCT00736853|467625981|FG000|Open-Label Period|Withdrawal by Subject|16|||
129908380|NCT00736853|467625982|FG001|Open-Label Period|Withdrawal by Subject|0|||
129908381|NCT00736853|467625983|FG002|Open-Label Period|Withdrawal by Subject|0|||
129908382|NCT00736853|467625981|FG000|Open-Label Period|Started but not treated|42|||
129908383|NCT00736853|467625982|FG001|Open-Label Period|Started but not treated|0|||
129908384|NCT00736853|467625983|FG002|Open-Label Period|Started but not treated|0|||
129908385|NCT00736853|467625981|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
129908386|NCT00736853|467625982|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
129908387|NCT00736853|467625983|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
129908388|NCT00736853|467625981|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
129908389|NCT00736853|467625982|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
129908390|NCT00736853|467625983|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
129908391|NCT00736853|467625981|FG000|Double-Blind Period|Lack of Efficacy|0|||
129908392|NCT00736853|467625982|FG001|Double-Blind Period|Lack of Efficacy|19|||
129908393|NCT00736853|467625983|FG002|Double-Blind Period|Lack of Efficacy|42|||
129908394|NCT00736853|467625981|FG000|Double-Blind Period|Adverse Event|0|||
129908395|NCT00736853|467625982|FG001|Double-Blind Period|Adverse Event|3|||
129908396|NCT00736853|467625983|FG002|Double-Blind Period|Adverse Event|2|||
129908397|NCT00736853|467625981|FG000|Double-Blind Period|Withdrawal by Subject|0|||
129908398|NCT00736853|467625982|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129908399|NCT00736853|467625983|FG002|Double-Blind Period|Withdrawal by Subject|4|||
129908400|NCT00736853|467625981|FG000|Double-Blind Period|Ineligible to participate the study|0|||
129908401|NCT00736853|467625982|FG001|Double-Blind Period|Ineligible to participate the study|1|||
129908402|NCT00736853|467625983|FG002|Double-Blind Period|Ineligible to participate the study|0|||
129908403|NCT00801983|467625990|FG000|Period 1|Lost to Follow-up|2|||
129908404|NCT00801983|467625991|FG001|Period 1|Lost to Follow-up|0|||
129908405|NCT00801983|467625990|FG000|Period 1|Withdrawal by Subject|2|||
129908406|NCT00801983|467625991|FG001|Period 1|Withdrawal by Subject|8|||
129908407|NCT00801983|467625990|FG000|Period 2|Withdrawal by Subject|2|||
129908408|NCT00801983|467625991|FG001|Period 2|Withdrawal by Subject|1|||
129908409|NCT05135000|467625996|FG000|Overall Study|Adverse Event|2|||
129908410|NCT05135000|467625997|FG001|Overall Study|Adverse Event|0|||
129908411|NCT05135000|467625996|FG000|Overall Study|Lost to Follow-up|1|||
129908412|NCT05135000|467625997|FG001|Overall Study|Lost to Follow-up|0|||
129908413|NCT05135000|467625996|FG000|Overall Study|Study Terminated by Sponsor|6|||
129908414|NCT05135000|467625997|FG001|Overall Study|Study Terminated by Sponsor|3|||
129908415|NCT03215927|467627584|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
129908416|NCT03215927|467627585|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
129908417|NCT03215927|467627584|FG000|Open Label Extension|Adverse Event|1|||
129908418|NCT03215927|467627585|FG001|Open Label Extension|Adverse Event|0|||
129908419|NCT03215927|467627584|FG000|Open Label Extension|Lack of Efficacy|1|||
129908420|NCT03215927|467627585|FG001|Open Label Extension|Lack of Efficacy|0|||
129908421|NCT03215927|467627584|FG000|Open Label Extension|Death|0|||
129908422|NCT03215927|467627585|FG001|Open Label Extension|Death|1|||
129908423|NCT03889925|467627586|FG000|Overall Study|Lost to Follow-up|11|||
129908424|NCT03889925|467627587|FG001|Overall Study|Lost to Follow-up|10|||
129908425|NCT03073941|467627588|FG000|Overall Study|Received non-study device intraoperatively|0|||
129908426|NCT03073941|467627589|FG001|Overall Study|Received non-study device intraoperatively|2|||
129908427|NCT03073941|467627588|FG000|Overall Study|Death|1|||
129908428|NCT03073941|467627589|FG001|Overall Study|Death|0|||
129908429|NCT03073941|467627588|FG000|Overall Study|Withdrawal by Subject|1|||
129908430|NCT03073941|467627589|FG001|Overall Study|Withdrawal by Subject|3|||
129908431|NCT03073941|467627588|FG000|Overall Study|Lost to Follow-up|5|||
129908432|NCT03073941|467627589|FG001|Overall Study|Lost to Follow-up|4|||
129908433|NCT03073941|467627588|FG000|Overall Study|Adverse Event|4|||
129908434|NCT03073941|467627589|FG001|Overall Study|Adverse Event|2|||
129908435|NCT03073941|467627588|FG000|Overall Study|Met an exclusion criterion|0|||
129908436|NCT03073941|467627589|FG001|Overall Study|Met an exclusion criterion|1|||
129908437|NCT04252586|467627591|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129908438|NCT04252586|467627591|FG000|Overall Study|Adverse Event|1|||
129908439|NCT04252586|467627591|FG000|Overall Study|Death|2|||
129908440|NCT04252586|467627591|FG000|Overall Study|Study terminated by sponsor|4|||
129908441|NCT04252586|467627591|FG000|Overall Study|Sponsor request|10|||
129908442|NCT04252586|467627591|FG000|Overall Study|Did not complete treatment period|1|||
129854888|NCT00439777|467426870|FG000|Treatment Period|Participant convenience|12|||
129854889|NCT00439777|467426871|FG001|Treatment Period|Participant convenience|8|||
129854890|NCT00439777|467426870|FG000|Observational Period|Protocol Violation|0|||
129854891|NCT00439777|467426871|FG001|Observational Period|Protocol Violation|2|||
129854892|NCT00439777|467426870|FG000|Observational Period|Withdrawal by Subject|9|||
129854893|NCT00439777|467426871|FG001|Observational Period|Withdrawal by Subject|5|||
129854894|NCT00439777|467426870|FG000|Observational Period|Lost to Follow-up|1|||
129854895|NCT00439777|467426871|FG001|Observational Period|Lost to Follow-up|11|||
129854896|NCT00439777|467426870|FG000|Observational Period|Death|27|||
129854897|NCT00439777|467426871|FG001|Observational Period|Death|20|||
129854898|NCT00439777|467426870|FG000|Observational Period|Study terminated by sponsor|3|||
129854899|NCT00439777|467426871|FG001|Observational Period|Study terminated by sponsor|1|||
129854900|NCT00439777|467426870|FG000|Observational Period|Protocol driven decision point|0|||
129854901|NCT00439777|467426871|FG001|Observational Period|Protocol driven decision point|1|||
129854902|NCT00439777|467426870|FG000|Observational Period|Lack of Efficacy|1|||
129854903|NCT00439777|467426871|FG001|Observational Period|Lack of Efficacy|0|||
129854904|NCT00439777|467426870|FG000|Observational Period|Technical problems|0|||
129854905|NCT00439777|467426871|FG001|Observational Period|Technical problems|1|||
129854906|NCT03855189|467426872|FG000|Overall Study|Adverse Event|5|||
129854907|NCT03855189|467426873|FG001|Overall Study|Adverse Event|2|||
129854908|NCT03855189|467426874|FG002|Overall Study|Adverse Event|4|||
129854909|NCT03855189|467426872|FG000|Overall Study|Treatment Failure|1|||
129854910|NCT03855189|467426873|FG001|Overall Study|Treatment Failure|1|||
129854911|NCT03855189|467426874|FG002|Overall Study|Treatment Failure|2|||
129854912|NCT03855189|467426872|FG000|Overall Study|Noncompliance with Protocol|0|||
129854913|NCT03855189|467426873|FG001|Overall Study|Noncompliance with Protocol|1|||
129854914|NCT03855189|467426874|FG002|Overall Study|Noncompliance with Protocol|0|||
129854915|NCT03855189|467426872|FG000|Overall Study|Did Not Return|4|||
129854916|NCT03855189|467426873|FG001|Overall Study|Did Not Return|3|||
129854917|NCT03855189|467426874|FG002|Overall Study|Did Not Return|0|||
129854918|NCT01143259|467426875|FG000|Overall Study|Withdrawal by Subject|3|||
129854919|NCT01143259|467426876|FG001|Overall Study|Withdrawal by Subject|2|||
129854920|NCT01143259|467426875|FG000|Overall Study|Protocol Violation|13|||
129854921|NCT01143259|467426876|FG001|Overall Study|Protocol Violation|9|||
129854922|NCT01143259|467426875|FG000|Overall Study|Screen Failure|7|||
129854923|NCT01143259|467426876|FG001|Overall Study|Screen Failure|9|||
129854924|NCT00099983|467426877|FG000|Overall Study|Lost to Follow-up|2|||
129854925|NCT00099983|467426878|FG001|Overall Study|Lost to Follow-up|3|||
129854926|NCT00099983|467426877|FG000|Overall Study|Missing Source Documents|14|||
129854927|NCT00099983|467426878|FG001|Overall Study|Missing Source Documents|15|||
129854928|NCT00099983|467426877|FG000|Overall Study|Withdrawal by Subject|3|||
129854929|NCT00099983|467426878|FG001|Overall Study|Withdrawal by Subject|2|||
129854930|NCT00099983|467426877|FG000|Overall Study|Adverse Event|1|||
129854931|NCT00099983|467426878|FG001|Overall Study|Adverse Event|1|||
129854932|NCT00099983|467426877|FG000|Overall Study|Lack of Efficacy|0|||
129854933|NCT00099983|467426878|FG001|Overall Study|Lack of Efficacy|1|||
129854934|NCT00099983|467426877|FG000|Overall Study|Unable to return for appointments|1|||
129854935|NCT00099983|467426878|FG001|Overall Study|Unable to return for appointments|1|||
129854936|NCT00099983|467426877|FG000|Overall Study|Moved|1|||
129854937|NCT00099983|467426878|FG001|Overall Study|Moved|0|||
129854938|NCT00099983|467426877|FG000|Overall Study|Other psychiatric problem|1|||
129854939|NCT00099983|467426878|FG001|Overall Study|Other psychiatric problem|0|||
129854940|NCT00099983|467426877|FG000|Overall Study|Incarcerated|0|||
129854941|NCT00099983|467426878|FG001|Overall Study|Incarcerated|1|||
129854942|NCT00099983|467426877|FG000|Overall Study|Intolerant of burden of visits|0|||
129854943|NCT00099983|467426878|FG001|Overall Study|Intolerant of burden of visits|1|||
129854944|NCT00099983|467426877|FG000|Overall Study|Other issue|1|||
129854945|NCT00099983|467426878|FG001|Overall Study|Other issue|0|||
129854946|NCT02641080|467426879|FG000|Overall Study|Physician Decision|2|||
129854947|NCT02641080|467426880|FG001|Overall Study|Physician Decision|0|||
129854948|NCT02641080|467426879|FG000|Overall Study|Withdrawal by Subject|0|||
129854949|NCT02641080|467426880|FG001|Overall Study|Withdrawal by Subject|1|||
129854950|NCT02641080|467426879|FG000|Overall Study|Rehab Center denied use of pumps|0|||
129854951|NCT02641080|467426880|FG001|Overall Study|Rehab Center denied use of pumps|3|||
129854952|NCT02641080|467426879|FG000|Overall Study|Lost to Follow-up|0|||
129854953|NCT02641080|467426880|FG001|Overall Study|Lost to Follow-up|3|||
129854954|NCT00803634|467426881|FG000|Overall Study|Withdrew Consent|1|||
129854955|NCT00803634|467426882|FG001|Overall Study|Withdrew Consent|0|||
129854956|NCT00803634|467426881|FG000|Overall Study|Lost to Follow-up|2|||
129854957|NCT00803634|467426882|FG001|Overall Study|Lost to Follow-up|3|||
129854958|NCT00803634|467426881|FG000|Overall Study|Death|3|||
129854959|NCT00803634|467426882|FG001|Overall Study|Death|2|||
129854960|NCT03864900|467426887|FG000|Overall Study|Withdrawal by Subject|1|||
129854961|NCT03864900|467426888|FG001|Overall Study|Withdrawal by Subject|1|||
129854962|NCT03864900|467426887|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
129908443|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Death|186|||
129854963|NCT03864900|467426888|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
129854964|NCT00759109|467426890|FG000|Overall Study|Adverse Event|17|||
129854965|NCT00759109|467426891|FG001|Overall Study|Adverse Event|12|||
129854966|NCT00759109|467426890|FG000|Overall Study|Inability to comply|1|||
129854967|NCT00759109|467426891|FG001|Overall Study|Inability to comply|1|||
129854968|NCT00759109|467426890|FG000|Overall Study|Withdrawal by Subject|9|||
129854969|NCT00759109|467426891|FG001|Overall Study|Withdrawal by Subject|5|||
129854970|NCT00759109|467426890|FG000|Overall Study|Death|4|||
129854971|NCT00759109|467426891|FG001|Overall Study|Death|3|||
129854972|NCT00759109|467426890|FG000|Overall Study|Lost to Follow-up|4|||
129854973|NCT00759109|467426891|FG001|Overall Study|Lost to Follow-up|6|||
129854974|NCT00759109|467426890|FG000|Overall Study|Started new therapy|2|||
129854975|NCT00759109|467426891|FG001|Overall Study|Started new therapy|6|||
129854976|NCT00759109|467426890|FG000|Overall Study|HCV RNA negative|1|||
129854977|NCT00759109|467426891|FG001|Overall Study|HCV RNA negative|0|||
129854978|NCT00759109|467426890|FG000|Overall Study|Participant moved to a different city|0|||
129854979|NCT00759109|467426891|FG001|Overall Study|Participant moved to a different city|1|||
129854980|NCT00759109|467426890|FG000|Overall Study|Participant had a liver transplant|0|||
129854981|NCT00759109|467426891|FG001|Overall Study|Participant had a liver transplant|1|||
129854982|NCT00759109|467426890|FG000|Overall Study|Lost during study|1|||
129854983|NCT00759109|467426891|FG001|Overall Study|Lost during study|0|||
129854984|NCT03165045|467426892|FG000|Visit 1|No registration after visit 1|9|||
129854985|NCT03165045|467426892|FG000|Visit 1|No treatment documented|10|||
129854986|NCT03165045|467426892|FG000|Visit 1|No visit 1|10|||
129854987|NCT03165045|467426892|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
129854988|NCT03165045|467426892|FG000|Visit 2|No available total CCQ score at all|29|||
129854989|NCT03165045|467426892|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
129854990|NCT03238001|467426893|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
129854991|NCT03238001|467426893|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
129854992|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
129854993|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
129854994|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
129854995|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
129854996|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
129854997|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
129854998|NCT01827904|467426894|FG000|Main Study|Withdrawal by Subject|1|||
129854999|NCT01827904|467426895|FG001|Main Study|Withdrawal by Subject|0|||
129855000|NCT01827904|467426896|FG002|Main Study|Withdrawal by Subject|0|||
129855001|NCT01827904|467426894|FG000|Main Study|Adverse Event|1|||
129855002|NCT01827904|467426895|FG001|Main Study|Adverse Event|0|||
129855003|NCT01827904|467426896|FG002|Main Study|Adverse Event|0|||
129855004|NCT01827904|467426894|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
129855005|NCT01827904|467426895|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
129855006|NCT01827904|467426896|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
129855007|NCT01827904|467426894|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
129855008|NCT01827904|467426895|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
129855009|NCT01827904|467426896|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
129855010|NCT01827904|467426894|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
129855011|NCT01827904|467426895|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
129855012|NCT01827904|467426896|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
129855013|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
129855014|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
129855015|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
129855016|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
129855017|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
129855018|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
129855019|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
129855020|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
129855021|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
129855022|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
129855023|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
129855024|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
129855025|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Physician Decision|1|||
129855026|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Physician Decision|0|||
129855027|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Physician Decision|0|||
129855028|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
129855029|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
129855030|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
129855031|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
129855032|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
129855033|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
129855034|NCT01866709|467426903|FG000|Overall Study|Adverse Event|1|||
129855035|NCT01866709|467426904|FG001|Overall Study|Adverse Event|0|||
129908444|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Death|222|||
129908445|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Death|0|||
129908446|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
129908447|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
129908448|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
129908449|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
129908450|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
129908451|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
129908452|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
129908453|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
129908454|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
129908455|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Adverse Event|83|||
129908456|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Adverse Event|100|||
129908457|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Adverse Event|0|||
129908458|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Other|70|||
129908459|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Other|75|||
129908460|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Other|0|||
129908461|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
129908462|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
129908463|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
129908464|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
129908465|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
129908466|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
129908467|NCT00232180|467627592|FG000|Open Label Phase|Death|0|||
129908468|NCT00232180|467627593|FG001|Open Label Phase|Death|0|||
129908469|NCT00232180|467627594|FG002|Open Label Phase|Death|48|||
129908470|NCT00232180|467627592|FG000|Open Label Phase|Lost to Follow-up|0|||
129908471|NCT00232180|467627593|FG001|Open Label Phase|Lost to Follow-up|0|||
129908472|NCT00232180|467627594|FG002|Open Label Phase|Lost to Follow-up|5|||
129908473|NCT00232180|467627592|FG000|Open Label Phase|Protocol Violation|0|||
129908474|NCT00232180|467627593|FG001|Open Label Phase|Protocol Violation|0|||
129908475|NCT00232180|467627594|FG002|Open Label Phase|Protocol Violation|3|||
129908476|NCT00232180|467627592|FG000|Open Label Phase|Study terminated by sponsor|0|||
129908477|NCT00232180|467627593|FG001|Open Label Phase|Study terminated by sponsor|0|||
129908478|NCT00232180|467627594|FG002|Open Label Phase|Study terminated by sponsor|3|||
129908479|NCT00232180|467627592|FG000|Open Label Phase|Withdrawal by Subject|0|||
129908480|NCT00232180|467627593|FG001|Open Label Phase|Withdrawal by Subject|0|||
129908481|NCT00232180|467627594|FG002|Open Label Phase|Withdrawal by Subject|37|||
129908482|NCT00232180|467627592|FG000|Open Label Phase|Other|0|||
129908483|NCT00232180|467627593|FG001|Open Label Phase|Other|0|||
129908484|NCT00232180|467627594|FG002|Open Label Phase|Other|16|||
129908485|NCT00232180|467627592|FG000|Open Label Phase|Adverse Event|0|||
129908486|NCT00232180|467627593|FG001|Open Label Phase|Adverse Event|0|||
129908487|NCT00232180|467627594|FG002|Open Label Phase|Adverse Event|25|||
129908488|NCT00232180|467627592|FG000|Open Label Phase|Laboratory abnormality|0|||
129908489|NCT00232180|467627593|FG001|Open Label Phase|Laboratory abnormality|0|||
129908490|NCT00232180|467627594|FG002|Open Label Phase|Laboratory abnormality|10|||
129908491|NCT00232180|467627592|FG000|Open Label Phase|Randomized but not treated|0|||
129908492|NCT00232180|467627593|FG001|Open Label Phase|Randomized but not treated|0|||
129908493|NCT00232180|467627594|FG002|Open Label Phase|Randomized but not treated|1|||
129908494|NCT03452189|467627595|FG000|First Intervention (3 Months)|Adverse Event|1|||
129908495|NCT03452189|467627596|FG001|First Intervention (3 Months)|Adverse Event|0|||
129908496|NCT03452189|467627595|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
129908497|NCT03452189|467627596|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
129908498|NCT01571596|467627599|FG000|Overall Study|Adverse Event|2|||
129908499|NCT01571596|467627600|FG001|Overall Study|Adverse Event|0|||
129908500|NCT01571596|467627601|FG002|Overall Study|Adverse Event|0|||
129908501|NCT01571596|467627599|FG000|Overall Study|Study Terminated by the Sponsor|0|||
129908502|NCT01571596|467627600|FG001|Overall Study|Study Terminated by the Sponsor|1|||
129908503|NCT01571596|467627601|FG002|Overall Study|Study Terminated by the Sponsor|1|||
129908504|NCT04512482|467627605|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
129908505|NCT04512482|467627606|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
129908506|NCT00446459|467627607|FG000|8 Months|Protocol Violation|12|||
129908507|NCT00446459|467627607|FG000|12 Months|Protocol Violation|4|||
129908508|NCT00446459|467627607|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
129908509|NCT00391898|467627622|FG000|Overall Study|Adverse Event|3|||
129908510|NCT00391898|467627623|FG001|Overall Study|Adverse Event|0|||
129908511|NCT00391898|467627622|FG000|Overall Study|Other|8|||
129908512|NCT00391898|467627623|FG001|Overall Study|Other|10|||
129908513|NCT02918279|467627626|FG000|Overall Study|Lost to Follow-up|3|||
129908514|NCT02918279|467627627|FG001|Overall Study|Lost to Follow-up|6|||
129908515|NCT02918279|467627626|FG000|Overall Study|Withdrawal by Subject|5|||
129908516|NCT02918279|467627627|FG001|Overall Study|Withdrawal by Subject|15|||
129908517|NCT02918279|467627626|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129908518|NCT02918279|467627627|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129855036|NCT03791398|467426905|FG000|Overall Study|Progression of Disease Under Study|2|||
129855037|NCT03791398|467426906|FG001|Overall Study|Progression of Disease Under Study|0|||
129855038|NCT03791398|467426907|FG002|Overall Study|Progression of Disease Under Study|0|||
129855039|NCT03191903|467426908|FG000|Overall Study|Withdrawal by Subject|6|||
129855040|NCT03191903|467426909|FG001|Overall Study|Withdrawal by Subject|5|||
129855041|NCT03191903|467426910|FG002|Overall Study|Withdrawal by Subject|4|||
129855042|NCT03191903|467426908|FG000|Overall Study|Adverse Event|1|||
129855043|NCT03191903|467426909|FG001|Overall Study|Adverse Event|0|||
129855044|NCT03191903|467426910|FG002|Overall Study|Adverse Event|0|||
129855045|NCT00503685|467426911|FG000|Overall Study|Adverse Event|0|||
129855046|NCT00503685|467426912|FG001|Overall Study|Adverse Event|0|||
129855047|NCT00503685|467426913|FG002|Overall Study|Adverse Event|2|||
129855048|NCT00503685|467426911|FG000|Overall Study|Withdrawal by Subject|0|||
129855049|NCT00503685|467426912|FG001|Overall Study|Withdrawal by Subject|1|||
129855050|NCT00503685|467426913|FG002|Overall Study|Withdrawal by Subject|0|||
129855051|NCT00503685|467426911|FG000|Overall Study|Protocol Violation|0|||
129855052|NCT00503685|467426912|FG001|Overall Study|Protocol Violation|1|||
129855053|NCT00503685|467426913|FG002|Overall Study|Protocol Violation|0|||
129855054|NCT00503685|467426911|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129855055|NCT00503685|467426912|FG001|Overall Study|Eligibility Criteria Not Met|1|||
129855056|NCT00503685|467426913|FG002|Overall Study|Eligibility Criteria Not Met|0|||
129855057|NCT01110239|467426916|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
129855058|NCT01110239|467426917|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
129855059|NCT01110239|467426918|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
129855060|NCT01110239|467426919|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
129855061|NCT01110239|467426916|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
129855062|NCT01110239|467426917|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
129855063|NCT01110239|467426918|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
129855064|NCT01110239|467426919|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
129855065|NCT00080223|467426922|FG000|Overall Study|Adverse Event|23|||
129855066|NCT00080223|467426922|FG000|Overall Study|Death|21|||
129855067|NCT00080223|467426922|FG000|Overall Study|Withdrawal by Subject|13|||
129855068|NCT00080223|467426922|FG000|Overall Study|Lung Transplantation|9|||
129855069|NCT00080223|467426922|FG000|Overall Study|Non-compliance With Study Treatment|7|||
129855070|NCT00080223|467426922|FG000|Overall Study|Participant unwilling to continue|2|||
129855071|NCT00080223|467426922|FG000|Overall Study|Physician Decision|1|||
129855072|NCT04369469|467426923|FG000|Overall Study|Lost to Follow-up|2|||
129855073|NCT04369469|467426924|FG001|Overall Study|Lost to Follow-up|4|||
129855074|NCT04369469|467426923|FG000|Overall Study|Physician Decision|2|||
129855075|NCT04369469|467426924|FG001|Overall Study|Physician Decision|1|||
129855076|NCT04369469|467426923|FG000|Overall Study|Withdrawal by Subject|2|||
129855077|NCT04369469|467426924|FG001|Overall Study|Withdrawal by Subject|3|||
129855078|NCT04369469|467426923|FG000|Overall Study|Adverse Event|1|||
129855079|NCT04369469|467426924|FG001|Overall Study|Adverse Event|0|||
129855080|NCT04369469|467426923|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
129855081|NCT04369469|467426924|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
129855082|NCT04369469|467426923|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
129855083|NCT04369469|467426924|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
129855084|NCT04369469|467426923|FG000|Overall Study|Unable to Provide Consent|0|||
129855085|NCT04369469|467426924|FG001|Overall Study|Unable to Provide Consent|1|||
129855086|NCT05204134|467426925|FG000|Overall Study|Withdrawal by Subject|3|||
129855087|NCT05204134|467426925|FG000|Overall Study|Physician Decision|1|||
129855088|NCT03099382|467426928|FG000|Overall Study|Protocol Violation|2|||
129855089|NCT03099382|467426929|FG001|Overall Study|Protocol Violation|3|||
129855090|NCT00499369|467426930|FG000|Overall Study|Adverse Event|2|||
129855091|NCT00499369|467426931|FG001|Overall Study|Adverse Event|2|||
129855092|NCT00499369|467426932|FG002|Overall Study|Adverse Event|3|||
129855093|NCT00499369|467426933|FG003|Overall Study|Adverse Event|1|||
129855094|NCT00499369|467426934|FG004|Overall Study|Adverse Event|2|||
129908519|NCT02918279|467627626|FG000|Overall Study|Other|3|||
129908520|NCT02918279|467627627|FG001|Overall Study|Other|1|||
129855095|NCT00499369|467426930|FG000|Overall Study|Withdrawal by Subject|0|||
129908521|NCT00309907|467627628|FG000|Overall Study|Death|4|||
129855096|NCT00499369|467426931|FG001|Overall Study|Withdrawal by Subject|1|||
129855097|NCT00499369|467426932|FG002|Overall Study|Withdrawal by Subject|1|||
129855098|NCT00499369|467426933|FG003|Overall Study|Withdrawal by Subject|0|||
129855099|NCT00499369|467426934|FG004|Overall Study|Withdrawal by Subject|0|||
129855100|NCT00499369|467426930|FG000|Overall Study|Progression|10|||
129855101|NCT00499369|467426931|FG001|Overall Study|Progression|12|||
129855102|NCT00499369|467426932|FG002|Overall Study|Progression|9|||
129855103|NCT00499369|467426933|FG003|Overall Study|Progression|6|||
129855104|NCT00499369|467426934|FG004|Overall Study|Progression|10|||
129855105|NCT00499369|467426930|FG000|Overall Study|Death|0|||
129855106|NCT00499369|467426931|FG001|Overall Study|Death|1|||
129855107|NCT00499369|467426932|FG002|Overall Study|Death|0|||
129908522|NCT00309907|467627628|FG000|Overall Study|Physician Decision|1|||
129908523|NCT00309907|467627628|FG000|Overall Study|Ineligible|11|||
129908524|NCT00309907|467627628|FG000|Overall Study|Major infectious event|4|||
129855108|NCT00499369|467426933|FG003|Overall Study|Death|0|||
129855109|NCT00499369|467426934|FG004|Overall Study|Death|0|||
129855110|NCT00499369|467426930|FG000|Overall Study|Not protocol specified|2|||
129855111|NCT00499369|467426931|FG001|Overall Study|Not protocol specified|0|||
129855112|NCT00499369|467426932|FG002|Overall Study|Not protocol specified|3|||
129855113|NCT00499369|467426933|FG003|Overall Study|Not protocol specified|1|||
129855114|NCT00499369|467426934|FG004|Overall Study|Not protocol specified|0|||
129855115|NCT00499369|467426930|FG000|Overall Study|Ineligible|2|||
129855116|NCT00499369|467426931|FG001|Overall Study|Ineligible|2|||
129855117|NCT00499369|467426932|FG002|Overall Study|Ineligible|1|||
129855118|NCT00499369|467426933|FG003|Overall Study|Ineligible|1|||
129855119|NCT00499369|467426934|FG004|Overall Study|Ineligible|0|||
129855120|NCT01802411|467426935|FG000|Overall Study|Death|2|||
129855121|NCT01802411|467426936|FG001|Overall Study|Death|1|||
129855122|NCT01802411|467426935|FG000|Overall Study|Adverse Event|2|||
129855123|NCT01802411|467426936|FG001|Overall Study|Adverse Event|7|||
129855124|NCT01802411|467426935|FG000|Overall Study|Lack of Efficacy|8|||
129855125|NCT01802411|467426936|FG001|Overall Study|Lack of Efficacy|10|||
129855126|NCT01802411|467426935|FG000|Overall Study|Withdrawal by Subject|0|||
129855127|NCT01802411|467426936|FG001|Overall Study|Withdrawal by Subject|2|||
129855128|NCT01802411|467426935|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
129855129|NCT01802411|467426936|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
129855130|NCT01802411|467426935|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
129855131|NCT01802411|467426936|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
129855132|NCT01802411|467426935|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
129855133|NCT01802411|467426936|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
129855134|NCT01059617|467426939|FG000|Overall Study|Other|7|||
130064642|NCT03814590|468190231|FG008|Overall Study|Lost to Follow-up|0|||
130064643|NCT03814590|468190232|FG009|Overall Study|Lost to Follow-up|0|||
130064644|NCT03814590|468190233|FG010|Overall Study|Lost to Follow-up|1|||
130064645|NCT03814590|468190234|FG011|Overall Study|Lost to Follow-up|0|||
130064646|NCT03814590|468190235|FG012|Overall Study|Lost to Follow-up|0|||
129855135|NCT01059617|467426940|FG001|Overall Study|Other|1|||
129855136|NCT01059617|467426941|FG002|Overall Study|Other|8|||
129855137|NCT01059617|467426942|FG003|Overall Study|Other|6|||
129855138|NCT03864614|467426947|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
129855139|NCT03864614|467426948|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
129855140|NCT03864614|467426949|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
129855141|NCT03864614|467426950|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
129855142|NCT03864614|467426947|FG000|Overall Study|Withdrawal by Subject|72|||
129855143|NCT03864614|467426948|FG001|Overall Study|Withdrawal by Subject|100|||
129855144|NCT03864614|467426949|FG002|Overall Study|Withdrawal by Subject|1|||
129855145|NCT03864614|467426950|FG003|Overall Study|Withdrawal by Subject|21|||
129855146|NCT03864614|467426947|FG000|Overall Study|Lost to Follow-up|45|||
129855147|NCT03864614|467426948|FG001|Overall Study|Lost to Follow-up|54|||
129855148|NCT03864614|467426949|FG002|Overall Study|Lost to Follow-up|0|||
129855149|NCT03864614|467426950|FG003|Overall Study|Lost to Follow-up|9|||
129855150|NCT03864614|467426947|FG000|Overall Study|Adverse Event|42|||
130064647|NCT03814590|468190236|FG013|Overall Study|Lost to Follow-up|1|||
130064648|NCT03814590|468190223|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064649|NCT03814590|468190224|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064650|NCT03814590|468190225|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064651|NCT03814590|468190226|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064652|NCT03814590|468190227|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064653|NCT03814590|468190228|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130116621|NCT02058628|468387132|FG001|Overall Study|Not in time schedule|1|||
129855151|NCT03864614|467426948|FG001|Overall Study|Adverse Event|30|||
129855152|NCT03864614|467426949|FG002|Overall Study|Adverse Event|1|||
129855153|NCT03864614|467426950|FG003|Overall Study|Adverse Event|9|||
130064654|NCT03814590|468190229|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064655|NCT03814590|468190230|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064656|NCT03814590|468190231|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064657|NCT03814590|468190232|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
129855154|NCT03864614|467426947|FG000|Overall Study|Protocol Deviation|6|||
129855155|NCT03864614|467426948|FG001|Overall Study|Protocol Deviation|26|||
129855156|NCT03864614|467426949|FG002|Overall Study|Protocol Deviation|0|||
129855157|NCT03864614|467426950|FG003|Overall Study|Protocol Deviation|1|||
129855158|NCT03864614|467426947|FG000|Overall Study|Physician Decision|7|||
129855159|NCT03864614|467426948|FG001|Overall Study|Physician Decision|10|||
129855160|NCT03864614|467426949|FG002|Overall Study|Physician Decision|1|||
129855161|NCT03864614|467426950|FG003|Overall Study|Physician Decision|5|||
129855162|NCT03864614|467426947|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
129855163|NCT03864614|467426948|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
129908525|NCT01068743|467627629|FG000|Period 3|Adverse Event|0|||
129908526|NCT01068743|467627630|FG001|Period 3|Adverse Event|1|||
129908527|NCT01068743|467627631|FG002|Period 3|Adverse Event|0|||
129908528|NCT01068743|467627632|FG003|Period 3|Adverse Event|0|||
129908529|NCT02507752|467627633|FG000|Overall Study|Adverse Event|1|||
129908530|NCT02507752|467627633|FG000|Overall Study|Protocol Violation|6|||
129908531|NCT02507752|467627633|FG000|Overall Study|Lost to Follow-up|7|||
129908532|NCT02507752|467627633|FG000|Overall Study|Infusion reaction at first infusion|1|||
129908533|NCT02507752|467627633|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
129908534|NCT02507752|467627633|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
129908535|NCT01236001|467627635|FG000|Overall Study|Adverse Event|5|||
129908536|NCT01236001|467627636|FG001|Overall Study|Adverse Event|14|||
129908537|NCT01236001|467627635|FG000|Overall Study|Lack of Efficacy|6|||
129908538|NCT01236001|467627636|FG001|Overall Study|Lack of Efficacy|6|||
129908539|NCT01236001|467627635|FG000|Overall Study|Lost to Follow-up|6|||
129908540|NCT01236001|467627636|FG001|Overall Study|Lost to Follow-up|1|||
129908541|NCT01236001|467627635|FG000|Overall Study|Incompliance|1|||
129908542|NCT01236001|467627636|FG001|Overall Study|Incompliance|0|||
129908543|NCT01236001|467627635|FG000|Overall Study|Planned Visit After End of Study|0|||
129908544|NCT01236001|467627636|FG001|Overall Study|Planned Visit After End of Study|1|||
129908545|NCT02528188|467627646|FG000|Overall Study|Adverse Event|23|||
129908546|NCT02528188|467627647|FG001|Overall Study|Adverse Event|22|||
129908547|NCT02528188|467627648|FG002|Overall Study|Adverse Event|8|||
129908548|NCT02528188|467627646|FG000|Overall Study|Protocol Violation|4|||
129908549|NCT02528188|467627647|FG001|Overall Study|Protocol Violation|6|||
129908550|NCT02528188|467627648|FG002|Overall Study|Protocol Violation|4|||
129908551|NCT02528188|467627646|FG000|Overall Study|Lack of Efficacy|19|||
129908552|NCT02528188|467627647|FG001|Overall Study|Lack of Efficacy|21|||
129908553|NCT02528188|467627648|FG002|Overall Study|Lack of Efficacy|22|||
129908554|NCT02528188|467627646|FG000|Overall Study|Withdrawal by Subject|97|||
129908555|NCT02528188|467627647|FG001|Overall Study|Withdrawal by Subject|104|||
129908556|NCT02528188|467627648|FG002|Overall Study|Withdrawal by Subject|100|||
129908557|NCT02528188|467627646|FG000|Overall Study|Lost to Follow-up|25|||
129908558|NCT02528188|467627647|FG001|Overall Study|Lost to Follow-up|21|||
129908559|NCT02528188|467627648|FG002|Overall Study|Lost to Follow-up|31|||
129908560|NCT02528188|467627646|FG000|Overall Study|Death|4|||
129908561|NCT02528188|467627647|FG001|Overall Study|Death|4|||
129908562|NCT02528188|467627648|FG002|Overall Study|Death|0|||
129908563|NCT02528188|467627646|FG000|Overall Study|Other|89|||
129908564|NCT02528188|467627647|FG001|Overall Study|Other|91|||
129908565|NCT02528188|467627648|FG002|Overall Study|Other|74|||
129908566|NCT02528188|467627646|FG000|Overall Study|Randomized but not treated|6|||
129908567|NCT02528188|467627647|FG001|Overall Study|Randomized but not treated|7|||
129908568|NCT02528188|467627648|FG002|Overall Study|Randomized but not treated|12|||
129908569|NCT00933400|467627649|FG000|Overall Study|Withdrawal by Subject|21|||
129908570|NCT00933400|467627650|FG001|Overall Study|Withdrawal by Subject|1|||
129908571|NCT01041417|467627653|FG000|Overall Study|Adverse Event|5|||
129908572|NCT01041417|467627654|FG001|Overall Study|Adverse Event|2|||
129908573|NCT01041417|467627653|FG000|Overall Study|Lost to Follow-up|1|||
129908574|NCT01041417|467627654|FG001|Overall Study|Lost to Follow-up|1|||
129908575|NCT01041417|467627653|FG000|Overall Study|Death|1|||
129908576|NCT01041417|467627654|FG001|Overall Study|Death|0|||
129908577|NCT02299375|467627657|FG000|Overall Study|Adverse Event, serious fatal|1|||
129908578|NCT02299375|467627658|FG001|Overall Study|Adverse Event, serious fatal|3|||
129908579|NCT02299375|467627657|FG000|Overall Study|Adverse Event, non-fatal|8|||
129908580|NCT02299375|467627658|FG001|Overall Study|Adverse Event, non-fatal|9|||
129908581|NCT02299375|467627657|FG000|Overall Study|Lack of Efficacy|1|||
129908582|NCT02299375|467627658|FG001|Overall Study|Lack of Efficacy|3|||
129908583|NCT02299375|467627657|FG000|Overall Study|Protocol Violation|1|||
129908584|NCT02299375|467627658|FG001|Overall Study|Protocol Violation|3|||
129908585|NCT02299375|467627657|FG000|Overall Study|Other: Met stopping criteria|1|||
129908586|NCT02299375|467627658|FG001|Overall Study|Other: Met stopping criteria|0|||
129908587|NCT02299375|467627657|FG000|Overall Study|Other: Study closed/terminated|66|||
129908588|NCT02299375|467627658|FG001|Overall Study|Other: Study closed/terminated|55|||
130064658|NCT03814590|468190233|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064659|NCT03814590|468190234|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
130064660|NCT03814590|468190235|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129908589|NCT02299375|467627657|FG000|Overall Study|Lost to Follow-up|0|||
129908590|NCT02299375|467627658|FG001|Overall Study|Lost to Follow-up|2|||
129908591|NCT02299375|467627657|FG000|Overall Study|Physician Decision|1|||
129908592|NCT02299375|467627658|FG001|Overall Study|Physician Decision|1|||
130064661|NCT03814590|468190236|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129908593|NCT02299375|467627657|FG000|Overall Study|Withdrawal by Subject|1|||
129908594|NCT02299375|467627658|FG001|Overall Study|Withdrawal by Subject|4|||
129908595|NCT00704184|467627659|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
129908596|NCT00704184|467627660|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
129908597|NCT00704184|467627661|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
130116622|NCT02058628|468387131|FG000|Overall Study|The visit date was not in timeline|0|||
130116623|NCT02058628|468387132|FG001|Overall Study|The visit date was not in timeline|1|||
129855164|NCT03864614|467426949|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
129855165|NCT03864614|467426950|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
129855166|NCT03864614|467426947|FG000|Overall Study|Sponsor Decision|1|||
129855167|NCT03864614|467426948|FG001|Overall Study|Sponsor Decision|2|||
129855168|NCT03864614|467426949|FG002|Overall Study|Sponsor Decision|0|||
129855169|NCT03864614|467426950|FG003|Overall Study|Sponsor Decision|0|||
129855170|NCT03864614|467426947|FG000|Overall Study|Pregnancy|0|||
129855171|NCT03864614|467426948|FG001|Overall Study|Pregnancy|1|||
129855172|NCT03864614|467426949|FG002|Overall Study|Pregnancy|0|||
129855173|NCT03864614|467426950|FG003|Overall Study|Pregnancy|0|||
129855174|NCT03864614|467426947|FG000|Overall Study|Other|7|||
129855175|NCT03864614|467426948|FG001|Overall Study|Other|9|||
129855176|NCT03864614|467426949|FG002|Overall Study|Other|1|||
129855177|NCT03864614|467426950|FG003|Overall Study|Other|4|||
129855178|NCT03864614|467426947|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
129855179|NCT03864614|467426948|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
129855180|NCT03864614|467426949|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
129855181|NCT03864614|467426950|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
129855182|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
129855183|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
129855184|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
129855185|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
129855186|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Adverse Event|5|||
129855187|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Adverse Event|3|||
129855188|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Adverse Event|4|||
129855189|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Adverse Event|10|||
129855190|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
129855191|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
129855192|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
129855193|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
129855194|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
129855195|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
129855196|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
129855197|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
129855198|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Pregnancy|5|||
129855199|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Pregnancy|0|||
129855200|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Pregnancy|3|||
129855201|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Pregnancy|2|||
129855202|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Non-compliance|1|||
129855203|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Non-compliance|4|||
129855204|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Non-compliance|0|||
129855205|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Non-compliance|3|||
129855206|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Other|0|||
129855207|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Other|3|||
129855208|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Other|3|||
129855209|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Other|1|||
129855210|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
129855211|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
129855212|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
129855213|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
129855214|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
129855215|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
129855216|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
129855217|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
129855218|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
129855219|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
129855220|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
129855221|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
129855222|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
129855223|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
130116624|NCT02058628|468387131|FG000|Overall Study|A lot of time for study for participant|1|||
129855224|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
129855225|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
129855226|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
129855227|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
129855228|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
129855229|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
129908598|NCT00704184|467627662|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
129908599|NCT00704184|467627663|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
129908600|NCT00704184|467627659|FG000|Open-Label Treatment|Adverse Event|0|||
129908601|NCT00704184|467627660|FG001|Open-Label Treatment|Adverse Event|0|||
129908602|NCT00704184|467627661|FG002|Open-Label Treatment|Adverse Event|2|||
129908603|NCT00704184|467627662|FG003|Open-Label Treatment|Adverse Event|0|||
129908604|NCT00704184|467627663|FG004|Open-Label Treatment|Adverse Event|1|||
129908605|NCT00704184|467627659|FG000|Open-Label Treatment|Lack of Efficacy|0|||
129908606|NCT00704184|467627660|FG001|Open-Label Treatment|Lack of Efficacy|2|||
129908607|NCT00704184|467627661|FG002|Open-Label Treatment|Lack of Efficacy|2|||
129908608|NCT00704184|467627662|FG003|Open-Label Treatment|Lack of Efficacy|2|||
129908609|NCT00704184|467627663|FG004|Open-Label Treatment|Lack of Efficacy|1|||
129908610|NCT00704184|467627659|FG000|Open-Label Treatment|Physician Decision|0|||
129908611|NCT00704184|467627660|FG001|Open-Label Treatment|Physician Decision|0|||
129908612|NCT00704184|467627661|FG002|Open-Label Treatment|Physician Decision|0|||
129908613|NCT00704184|467627662|FG003|Open-Label Treatment|Physician Decision|0|||
129908614|NCT00704184|467627663|FG004|Open-Label Treatment|Physician Decision|1|||
129908615|NCT00704184|467627659|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
129908616|NCT00704184|467627660|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129908617|NCT00704184|467627661|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
129908618|NCT00704184|467627662|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
129908619|NCT00704184|467627663|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
129908620|NCT00716859|467627664|FG000|Overall Study|Adverse Event|4|||
129908621|NCT00716859|467627665|FG001|Overall Study|Adverse Event|1|||
129908622|NCT00716859|467627664|FG000|Overall Study|Lack of Efficacy|3|||
129908623|NCT00716859|467627665|FG001|Overall Study|Lack of Efficacy|0|||
129908624|NCT00716859|467627664|FG000|Overall Study|Withdrawal by Subject|1|||
129908625|NCT00716859|467627665|FG001|Overall Study|Withdrawal by Subject|3|||
129908626|NCT00716859|467627664|FG000|Overall Study|Not treated|1|||
129908627|NCT00716859|467627665|FG001|Overall Study|Not treated|1|||
129908628|NCT01764464|467627666|FG000|First Intervention|Withdrawal by Subject|1|||
129908629|NCT01764464|467627667|FG001|First Intervention|Withdrawal by Subject|0|||
129908630|NCT01764464|467627666|FG000|First Intervention|Lost to Follow-up|1|||
129908631|NCT01764464|467627667|FG001|First Intervention|Lost to Follow-up|0|||
129908632|NCT01764464|467627666|FG000|First Intervention|Adverse Event|0|||
129908633|NCT01764464|467627667|FG001|First Intervention|Adverse Event|2|||
129908634|NCT01764464|467627666|FG000|First Intervention|did not receive study drug|0|||
129908635|NCT01764464|467627667|FG001|First Intervention|did not receive study drug|1|||
129908636|NCT01764464|467627666|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
129908637|NCT01764464|467627667|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
129908638|NCT02918071|467627679|FG000|Overall Study|Withdrawal by Subject|2|||
129908639|NCT02918071|467627679|FG000|Overall Study|Lost to Follow-up|1|||
129908640|NCT00203411|467627681|FG000|Follow-up|Progressive Disease|4|||
129908641|NCT01212991|467627682|FG000|Double-blind|Lost to Follow-up|8|||
129908642|NCT01212991|467627683|FG001|Double-blind|Lost to Follow-up|4|||
129908643|NCT01212991|467627684|FG002|Double-blind|Lost to Follow-up|0|||
129908644|NCT01212991|467627682|FG000|Double-blind|Death|699|||
129908645|NCT01212991|467627683|FG001|Double-blind|Death|550|||
129908646|NCT01212991|467627684|FG002|Double-blind|Death|0|||
129908647|NCT01212991|467627682|FG000|Double-blind|Withdrawal by Subject|16|||
129908648|NCT01212991|467627683|FG001|Double-blind|Withdrawal by Subject|19|||
129908649|NCT01212991|467627684|FG002|Double-blind|Withdrawal by Subject|0|||
129908650|NCT01212991|467627682|FG000|Double-blind|Other|7|||
129908651|NCT01212991|467627683|FG001|Double-blind|Other|0|||
129908652|NCT01212991|467627684|FG002|Double-blind|Other|0|||
129908653|NCT01212991|467627682|FG000|Double-blind|Sponsor decision|142|||
129908654|NCT01212991|467627683|FG001|Double-blind|Sponsor decision|38|||
129908655|NCT01212991|467627684|FG002|Double-blind|Sponsor decision|0|||
129908656|NCT01212991|467627682|FG000|Open-label|Death|0|||
129908657|NCT01212991|467627683|FG001|Open-label|Death|0|||
129908658|NCT01212991|467627684|FG002|Open-label|Death|166|||
129908659|NCT01212991|467627682|FG000|Open-label|Lost to Follow-up|0|||
129908660|NCT01212991|467627683|FG001|Open-label|Lost to Follow-up|0|||
129908661|NCT01212991|467627684|FG002|Open-label|Lost to Follow-up|5|||
129908662|NCT01212991|467627682|FG000|Open-label|Withdrawal by Subject|0|||
129908663|NCT01212991|467627683|FG001|Open-label|Withdrawal by Subject|0|||
129908664|NCT01212991|467627684|FG002|Open-label|Withdrawal by Subject|7|||
129908665|NCT01212991|467627682|FG000|Open-label|Sponsor decision|0|||
129908666|NCT01212991|467627683|FG001|Open-label|Sponsor decision|0|||
129908667|NCT01212991|467627684|FG002|Open-label|Sponsor decision|53|||
129908668|NCT01212991|467627682|FG000|Open-label|Other|0|||
129908669|NCT01212991|467627683|FG001|Open-label|Other|0|||
129908670|NCT01212991|467627684|FG002|Open-label|Other|3|||
129908671|NCT01170026|467628752|FG000|Overall Study|Lost to Follow-up|4|||
129908672|NCT01170026|467628753|FG001|Overall Study|Lost to Follow-up|2|||
129908673|NCT04623008|467628754|FG000|Baseline to T2|Withdrawal by Subject|4|||
129908674|NCT04623008|467628755|FG001|Baseline to T2|Withdrawal by Subject|2|||
129908675|NCT04623008|467628754|FG000|Baseline to T3|Withdrawal by Subject|4|||
129908676|NCT04623008|467628755|FG001|Baseline to T3|Withdrawal by Subject|2|||
129855230|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
129855231|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
129855232|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
129855233|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
129855234|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
129855235|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
129855236|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
129855237|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
129855238|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
129855239|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
129855240|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
129855241|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
129855242|NCT03320070|467428738|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
129855243|NCT03320070|467428739|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
129855244|NCT03320070|467428738|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
129855245|NCT03320070|467428739|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
129855246|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
129855247|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
129855248|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
129855249|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
129855250|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
129855251|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
129855252|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
129855253|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
129855254|NCT00353704|467428756|FG000|Overall Study|Protocol Violation|3|||
129855255|NCT00353704|467428757|FG001|Overall Study|Protocol Violation|1|||
129855256|NCT02473614|467428758|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
129855257|NCT02473614|467428759|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
129855258|NCT01154166|467428760|FG000|Overall Study|Adverse Event|14|||
129855259|NCT01154166|467428761|FG001|Overall Study|Adverse Event|9|||
129855260|NCT01154166|467428760|FG000|Overall Study|Lost to Follow-up|1|||
129855261|NCT01154166|467428761|FG001|Overall Study|Lost to Follow-up|1|||
129855262|NCT01154166|467428760|FG000|Overall Study|Protocol Violation|4|||
129855263|NCT01154166|467428761|FG001|Overall Study|Protocol Violation|1|||
129855264|NCT01154166|467428760|FG000|Overall Study|Withdrawal by Subject|10|||
129855265|NCT01154166|467428761|FG001|Overall Study|Withdrawal by Subject|1|||
129855266|NCT01154166|467428760|FG000|Overall Study|Lack of Efficacy|3|||
129855267|NCT01154166|467428761|FG001|Overall Study|Lack of Efficacy|0|||
129855268|NCT01154166|467428760|FG000|Overall Study|Disease Progression|1|||
129855269|NCT01154166|467428761|FG001|Overall Study|Disease Progression|0|||
129855270|NCT01154166|467428760|FG000|Overall Study|Poor Compliance|1|||
129855271|NCT01154166|467428761|FG001|Overall Study|Poor Compliance|0|||
129855272|NCT01375049|467428762|FG000|Overall Study|Adverse Event|2|||
129855273|NCT01375049|467428762|FG000|Overall Study|Lost to Follow-up|1|||
129855274|NCT01375049|467428762|FG000|Overall Study|Withdrawal by Subject|2|||
129855275|NCT01375049|467428762|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
129855276|NCT04121962|467428765|FG000|Overall Study|Lost to Follow-up|42|||
129855277|NCT04121962|467428766|FG001|Overall Study|Lost to Follow-up|39|||
129855278|NCT01175382|467428767|FG000|Overall Study|Lost to Follow-up|4|||
129855279|NCT01175382|467428768|FG001|Overall Study|Lost to Follow-up|3|||
129855280|NCT01175382|467428769|FG002|Overall Study|Lost to Follow-up|1|||
129855281|NCT01175382|467428767|FG000|Overall Study|Physician Decision|0|||
129855282|NCT01175382|467428768|FG001|Overall Study|Physician Decision|1|||
129855283|NCT01175382|467428769|FG002|Overall Study|Physician Decision|0|||
129855284|NCT01175382|467428767|FG000|Overall Study|Withdrawal by Subject|0|||
129855285|NCT01175382|467428768|FG001|Overall Study|Withdrawal by Subject|0|||
129855286|NCT01175382|467428769|FG002|Overall Study|Withdrawal by Subject|1|||
129855287|NCT01175382|467428767|FG000|Overall Study|No longer having problem|1|||
129855288|NCT01175382|467428768|FG001|Overall Study|No longer having problem|0|||
129855289|NCT01175382|467428769|FG002|Overall Study|No longer having problem|1|||
129855290|NCT01175382|467428767|FG000|Overall Study|Unable/unwilling to attend visits|3|||
129855291|NCT01175382|467428768|FG001|Overall Study|Unable/unwilling to attend visits|1|||
129855292|NCT01175382|467428769|FG002|Overall Study|Unable/unwilling to attend visits|2|||
129855293|NCT01175382|467428767|FG000|Overall Study|Unwilling to follow protocol|0|||
129855294|NCT01175382|467428768|FG001|Overall Study|Unwilling to follow protocol|1|||
129855295|NCT01175382|467428769|FG002|Overall Study|Unwilling to follow protocol|0|||
129855296|NCT01175382|467428767|FG000|Overall Study|Unable to tolerate study meds|0|||
129855297|NCT01175382|467428768|FG001|Overall Study|Unable to tolerate study meds|1|||
129855298|NCT01175382|467428769|FG002|Overall Study|Unable to tolerate study meds|1|||
129855299|NCT00774787|467428770|FG000|Overall Study|Lost to Follow-up|1|||
129855300|NCT02019719|467428771|FG000|Overall Study|Adverse Event|1|||
129855301|NCT02019719|467428772|FG001|Overall Study|Adverse Event|0|||
129855302|NCT02019719|467428773|FG002|Overall Study|Adverse Event|0|||
129855303|NCT02019719|467428774|FG003|Overall Study|Adverse Event|1|||
129855304|NCT02019719|467428775|FG004|Overall Study|Adverse Event|1|||
129855305|NCT02019719|467428771|FG000|Overall Study|Protocol Violation|1|||
129855306|NCT02019719|467428772|FG001|Overall Study|Protocol Violation|1|||
129855307|NCT02019719|467428773|FG002|Overall Study|Protocol Violation|0|||
129855308|NCT02019719|467428774|FG003|Overall Study|Protocol Violation|0|||
129855309|NCT02019719|467428775|FG004|Overall Study|Protocol Violation|0|||
129855310|NCT02019719|467428771|FG000|Overall Study|Protocol defined stopping criteria|2|||
129855311|NCT02019719|467428772|FG001|Overall Study|Protocol defined stopping criteria|0|||
129855312|NCT02019719|467428773|FG002|Overall Study|Protocol defined stopping criteria|0|||
129855313|NCT02019719|467428774|FG003|Overall Study|Protocol defined stopping criteria|1|||
129855314|NCT02019719|467428775|FG004|Overall Study|Protocol defined stopping criteria|1|||
129855315|NCT02019719|467428771|FG000|Overall Study|Physician Decision|2|||
129855316|NCT02019719|467428772|FG001|Overall Study|Physician Decision|0|||
129855317|NCT02019719|467428773|FG002|Overall Study|Physician Decision|0|||
129855318|NCT02019719|467428774|FG003|Overall Study|Physician Decision|0|||
129855319|NCT02019719|467428775|FG004|Overall Study|Physician Decision|0|||
129855320|NCT02731131|467428779|FG000|Overall Study|Psychiatric Disorder|0|||
129855321|NCT02731131|467428780|FG001|Overall Study|Psychiatric Disorder|1|||
129855322|NCT02731131|467428779|FG000|Overall Study|Refused Therapy|0|||
129855323|NCT02731131|467428780|FG001|Overall Study|Refused Therapy|1|||
129855324|NCT02348216|467428785|FG000|Overall Study|Death|5|||
129855325|NCT02348216|467428786|FG001|Overall Study|Death|53|||
129855326|NCT02348216|467428787|FG002|Overall Study|Death|11|||
129855327|NCT02348216|467428788|FG003|Overall Study|Death|20|||
129855328|NCT02348216|467428789|FG004|Overall Study|Death|16|||
129855329|NCT02348216|467428790|FG005|Overall Study|Death|32|||
129855330|NCT02348216|467428791|FG006|Overall Study|Death|17|||
129855331|NCT02348216|467428785|FG000|Overall Study|Full consent withdrawal|0|||
129855332|NCT02348216|467428786|FG001|Overall Study|Full consent withdrawal|0|||
129855333|NCT02348216|467428787|FG002|Overall Study|Full consent withdrawal|0|||
129855334|NCT02348216|467428788|FG003|Overall Study|Full consent withdrawal|1|||
129855335|NCT02348216|467428789|FG004|Overall Study|Full consent withdrawal|3|||
129855336|NCT02348216|467428790|FG005|Overall Study|Full consent withdrawal|0|||
129855337|NCT02348216|467428791|FG006|Overall Study|Full consent withdrawal|3|||
129855338|NCT02348216|467428785|FG000|Overall Study|Lost to Follow-up|0|||
129855339|NCT02348216|467428786|FG001|Overall Study|Lost to Follow-up|5|||
129855340|NCT02348216|467428787|FG002|Overall Study|Lost to Follow-up|2|||
129855341|NCT02348216|467428788|FG003|Overall Study|Lost to Follow-up|0|||
129855342|NCT02348216|467428789|FG004|Overall Study|Lost to Follow-up|1|||
129855343|NCT02348216|467428790|FG005|Overall Study|Lost to Follow-up|1|||
129855344|NCT02348216|467428791|FG006|Overall Study|Lost to Follow-up|1|||
129855345|NCT02348216|467428785|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
129855346|NCT02348216|467428786|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
129855347|NCT02348216|467428787|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
129855348|NCT02348216|467428788|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
129855349|NCT02348216|467428789|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
129855350|NCT02348216|467428790|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
129855351|NCT02348216|467428791|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
129855352|NCT02348216|467428785|FG000|Overall Study|Reason not specified|2|||
129855353|NCT02348216|467428786|FG001|Overall Study|Reason not specified|19|||
129855354|NCT02348216|467428787|FG002|Overall Study|Reason not specified|11|||
129855355|NCT02348216|467428788|FG003|Overall Study|Reason not specified|17|||
129855356|NCT02348216|467428789|FG004|Overall Study|Reason not specified|21|||
129855357|NCT02348216|467428790|FG005|Overall Study|Reason not specified|17|||
129855358|NCT02348216|467428791|FG006|Overall Study|Reason not specified|19|||
129855359|NCT01055639|467428792|FG000|Overall Study|Adverse Event|0|||
129855360|NCT01055639|467428793|FG001|Overall Study|Adverse Event|1|||
129855361|NCT01055639|467428792|FG000|Overall Study|Lack of Efficacy|0|||
129855362|NCT01055639|467428793|FG001|Overall Study|Lack of Efficacy|1|||
129855363|NCT01055639|467428792|FG000|Overall Study|Lost to Follow-up|8|||
129855364|NCT01055639|467428793|FG001|Overall Study|Lost to Follow-up|11|||
129855365|NCT01055639|467428792|FG000|Overall Study|Protocol Violation|5|||
129855366|NCT01055639|467428793|FG001|Overall Study|Protocol Violation|5|||
129855367|NCT01055639|467428792|FG000|Overall Study|Withdrawal by Subject|8|||
129855368|NCT01055639|467428793|FG001|Overall Study|Withdrawal by Subject|11|||
130064662|NCT03814590|468190223|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129855369|NCT00562159|467428794|FG000|Overall Study|Adverse Event|11|||
129855370|NCT00562159|467428795|FG001|Overall Study|Adverse Event|8|||
129855371|NCT00562159|467428794|FG000|Overall Study|Lost to Follow-up|5|||
129855372|NCT00562159|467428795|FG001|Overall Study|Lost to Follow-up|4|||
129855373|NCT00562159|467428794|FG000|Overall Study|Withdrawal by Subject|9|||
129855374|NCT00562159|467428795|FG001|Overall Study|Withdrawal by Subject|8|||
129855375|NCT00562159|467428794|FG000|Overall Study|Protocol Violation|12|||
129855376|NCT00562159|467428795|FG001|Overall Study|Protocol Violation|12|||
130064663|NCT03814590|468190224|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130064664|NCT03814590|468190225|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130064665|NCT03814590|468190226|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130064666|NCT03814590|468190227|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130064667|NCT03814590|468190228|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
130064668|NCT03814590|468190229|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
129855377|NCT00562159|467428794|FG000|Overall Study|Did not meet protocol eligibility|1|||
129855378|NCT00562159|467428795|FG001|Overall Study|Did not meet protocol eligibility|1|||
129855379|NCT00765245|467428796|FG000|Overall Study|disease progression|3|||
129855380|NCT00765245|467428797|FG001|Overall Study|disease progression|2|||
129855381|NCT00765245|467428796|FG000|Overall Study|Withdrawal by Subject|3|||
129855382|NCT00765245|467428797|FG001|Overall Study|Withdrawal by Subject|0|||
129855383|NCT00765245|467428796|FG000|Overall Study|Adverse Event|5|||
129855384|NCT00765245|467428797|FG001|Overall Study|Adverse Event|0|||
129855385|NCT00765245|467428796|FG000|Overall Study|Physician Decision|1|||
129855386|NCT00765245|467428797|FG001|Overall Study|Physician Decision|0|||
129855387|NCT00765245|467428796|FG000|Overall Study|Death|1|||
129855388|NCT00765245|467428797|FG001|Overall Study|Death|0|||
129855389|NCT02546544|467428798|FG000|Overall Study|Disease Progression|14|||
129855390|NCT02546544|467428798|FG000|Overall Study|Adverse Event|1|||
129855391|NCT02546544|467428798|FG000|Overall Study|Withdrawal by Subject|1|||
129855392|NCT02223390|467428799|FG000|Overall Study|Lost to Follow-up|9|||
129855393|NCT02223390|467428800|FG001|Overall Study|Lost to Follow-up|4|||
129855394|NCT02548962|467428802|FG000|Overall Study|Withdrawal by Subject|1|||
129855395|NCT02548962|467428803|FG001|Overall Study|Withdrawal by Subject|0|||
129855396|NCT01197950|467428804|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
129855397|NCT01197950|467428805|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
129855398|NCT01197950|467428806|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
129855399|NCT04137380|467428812|FG000|Overall Study|Physician Decision|0|||
129855400|NCT04137380|467428813|FG001|Overall Study|Physician Decision|0|||
129855401|NCT04137380|467428814|FG002|Overall Study|Physician Decision|0|||
129855402|NCT04137380|467428815|FG003|Overall Study|Physician Decision|1|||
129855403|NCT04137380|467428816|FG004|Overall Study|Physician Decision|0|||
129855404|NCT04137380|467428817|FG005|Overall Study|Physician Decision|0|||
129855405|NCT04137380|467428818|FG006|Overall Study|Physician Decision|0|||
129855406|NCT03465540|467428824|FG000|Overall Study|Withdrawal by Subject|0|||
129855407|NCT03465540|467428825|FG001|Overall Study|Withdrawal by Subject|0|||
129855408|NCT03465540|467428826|FG002|Overall Study|Withdrawal by Subject|1|||
129855409|NCT03465540|467428827|FG003|Overall Study|Withdrawal by Subject|1|||
129855410|NCT03465540|467428828|FG004|Overall Study|Withdrawal by Subject|1|||
129855411|NCT03465540|467428829|FG005|Overall Study|Withdrawal by Subject|0|||
129855412|NCT03465540|467428824|FG000|Overall Study|Lost to Follow-up|0|||
129855413|NCT03465540|467428825|FG001|Overall Study|Lost to Follow-up|1|||
129855414|NCT03465540|467428826|FG002|Overall Study|Lost to Follow-up|0|||
129855415|NCT03465540|467428827|FG003|Overall Study|Lost to Follow-up|0|||
129855416|NCT03465540|467428828|FG004|Overall Study|Lost to Follow-up|1|||
129855417|NCT03465540|467428829|FG005|Overall Study|Lost to Follow-up|0|||
129855418|NCT03465540|467428824|FG000|Overall Study|Death|1|||
129855419|NCT03465540|467428825|FG001|Overall Study|Death|1|||
129855420|NCT03465540|467428826|FG002|Overall Study|Death|0|||
129855421|NCT03465540|467428827|FG003|Overall Study|Death|2|||
129855422|NCT03465540|467428828|FG004|Overall Study|Death|0|||
129855423|NCT03465540|467428829|FG005|Overall Study|Death|2|||
129855424|NCT03465540|467428824|FG000|Overall Study|Protocol specified criteria|0|||
129855425|NCT03465540|467428825|FG001|Overall Study|Protocol specified criteria|2|||
129855426|NCT03465540|467428826|FG002|Overall Study|Protocol specified criteria|2|||
129855427|NCT03465540|467428827|FG003|Overall Study|Protocol specified criteria|0|||
129855428|NCT03465540|467428828|FG004|Overall Study|Protocol specified criteria|2|||
129855429|NCT03465540|467428829|FG005|Overall Study|Protocol specified criteria|0|||
129855430|NCT00736996|467428830|FG000|Overall Study|Lost to Follow-up|1|||
129855431|NCT00736996|467428831|FG001|Overall Study|Lost to Follow-up|9|||
129855432|NCT00736996|467428832|FG002|Overall Study|Lost to Follow-up|2|||
129855433|NCT02844946|467428833|FG000|Overall Study|Lost to Follow-up|7|||
129855434|NCT02844946|467428834|FG001|Overall Study|Lost to Follow-up|0|||
129855435|NCT02806986|467428835|FG000|Treatment Stage 1|Adverse Event|1|||
129855436|NCT02806986|467428835|FG000|Treatment Stage 2|Adverse Event|3|||
129855437|NCT02806986|467428835|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
129855438|NCT04000165|467428836|FG000|Overall Study|Physician Decision|1|||
129855439|NCT04000165|467428836|FG000|Overall Study|Withdrawal by Subject|1|||
129855440|NCT01753193|467428837|FG000|Overall Study|Withdrawal by Subject|23|||
129855441|NCT01753193|467428837|FG000|Overall Study|Lost to Follow-up|6|||
129855442|NCT01753193|467428837|FG000|Overall Study|Death|1|||
129855443|NCT01753193|467428837|FG000|Overall Study|Other|16|||
129855444|NCT01131312|467428838|FG000|Overall Study|Lost to Follow-up|425|||
129908677|NCT03785782|467628756|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
129908678|NCT03785782|467628757|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
129908679|NCT03785782|467628756|FG000|Overall Study|Withdrawal by Subject|1|||
129908680|NCT03785782|467628757|FG001|Overall Study|Withdrawal by Subject|1|||
129908681|NCT03785782|467628756|FG000|Overall Study|insufficient image quality.|3|||
129908682|NCT03785782|467628757|FG001|Overall Study|insufficient image quality.|0|||
129908683|NCT03779048|467628758|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
129908684|NCT03779048|467628759|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
129908685|NCT03779048|467628760|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
129908686|NCT03779048|467628758|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
129908687|NCT03779048|467628759|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
129908688|NCT03779048|467628760|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
129908689|NCT03779048|467628758|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
129908690|NCT03779048|467628759|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
129908691|NCT03779048|467628760|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
129908692|NCT05777785|467628761|FG000|Overall Study|Withdrawal by Subject|5|||
129908693|NCT05777785|467628761|FG000|Overall Study|Lost to Follow-up|1|||
129908694|NCT04588259|467628763|FG000|Run-in Period|Run-in failure|0|||
129908695|NCT04588259|467628764|FG001|Run-in Period|Run-in failure|23|||
129908696|NCT04588259|467628763|FG000|Run-in Period|Withdrawn before randomisation|0|||
129908697|NCT04588259|467628764|FG001|Run-in Period|Withdrawn before randomisation|8|||
129908698|NCT04588259|467628763|FG000|Treatment Period|Withdrawal by Subject|6|||
129908699|NCT04588259|467628764|FG001|Treatment Period|Withdrawal by Subject|6|||
129908700|NCT02763319|467628768|FG000|Overall Study|Adverse Event|12|||
129908701|NCT02763319|467628769|FG001|Overall Study|Adverse Event|3|||
129908702|NCT02763319|467628768|FG000|Overall Study|Death|123|||
129908703|NCT02763319|467628769|FG001|Overall Study|Death|123|||
129908704|NCT02763319|467628768|FG000|Overall Study|Lost to Follow-up|6|||
129908705|NCT02763319|467628769|FG001|Overall Study|Lost to Follow-up|7|||
129908706|NCT02763319|467628768|FG000|Overall Study|Noncompliance with Study Drug|2|||
129908707|NCT02763319|467628769|FG001|Overall Study|Noncompliance with Study Drug|0|||
129908708|NCT02763319|467628768|FG000|Overall Study|"Captured as Other in Database"|29|||
129908709|NCT02763319|467628769|FG001|Overall Study|"Captured as Other in Database"|34|||
129908710|NCT02763319|467628768|FG000|Overall Study|Physician Decision|1|||
129908711|NCT02763319|467628769|FG001|Overall Study|Physician Decision|7|||
129908712|NCT02763319|467628768|FG000|Overall Study|Progressive Disease|24|||
129908713|NCT02763319|467628769|FG001|Overall Study|Progressive Disease|27|||
129908714|NCT02763319|467628768|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
129908715|NCT02763319|467628769|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
129908716|NCT02763319|467628768|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
129908717|NCT02763319|467628769|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
129908718|NCT02763319|467628768|FG000|Overall Study|Withdrawal by Subject|26|||
129908719|NCT02763319|467628769|FG001|Overall Study|Withdrawal by Subject|25|||
129908720|NCT01622868|467628773|FG000|Overall Study|Protocol Violation|7|||
129908721|NCT01622868|467628774|FG001|Overall Study|Protocol Violation|0|||
129908722|NCT00244855|467628779|FG000|Overall Study|Withdrawal by Subject|0|||
129908723|NCT00244855|467628780|FG001|Overall Study|Withdrawal by Subject|1|||
129908724|NCT04530747|467628783|FG000|Overall Study|Withdrawal by Subject|1|||
129908725|NCT04530747|467628784|FG001|Overall Study|Withdrawal by Subject|0|||
129908726|NCT03292913|467628785|FG000|Overall Study|Death|9|||
129908727|NCT03292913|467628786|FG001|Overall Study|Death|3|||
129908728|NCT03292913|467628785|FG000|Overall Study|Lost to Follow-up|49|||
129908729|NCT03292913|467628786|FG001|Overall Study|Lost to Follow-up|49|||
130064669|NCT03814590|468190230|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
130064670|NCT03814590|468190231|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130064671|NCT03814590|468190232|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
130064672|NCT03814590|468190233|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
130064673|NCT03814590|468190234|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
130064674|NCT03814590|468190235|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
130064675|NCT03814590|468190236|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
130064676|NCT03814590|468190223|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129908730|NCT03292913|467628785|FG000|Overall Study|Withdrawal by Subject|2|||
129908731|NCT03292913|467628786|FG001|Overall Study|Withdrawal by Subject|0|||
129908732|NCT03292913|467628785|FG000|Overall Study|Clinic closed due to COVID|22|||
129908733|NCT03292913|467628786|FG001|Overall Study|Clinic closed due to COVID|36|||
129908734|NCT03950622|467628787|FG000|Overall Study|Withdrawal by Subject|1|||
129908735|NCT03950622|467628788|FG001|Overall Study|Withdrawal by Subject|0|||
129908736|NCT03950622|467628787|FG000|Overall Study|Protocol Deviation|0|||
129908737|NCT03950622|467628788|FG001|Overall Study|Protocol Deviation|1|||
129855445|NCT01131312|467428839|FG001|Overall Study|Lost to Follow-up|229|||
129855446|NCT01131312|467428840|FG002|Overall Study|Lost to Follow-up|351|||
129855447|NCT00781326|467428844|FG000|Phase I|Adverse Event|1|||
129855448|NCT00781326|467428844|FG000|Phase I|Withdrawal by Subject|1|||
129855449|NCT00781326|467428844|FG000|Phase I|Physician Decision|2|||
129855450|NCT00096941|467428845|FG000|Overall Study|disease progression|3|||
129855451|NCT01343056|467428846|FG000|Overall Study|Lost to Follow-up|7|||
129855452|NCT01343056|467428847|FG001|Overall Study|Lost to Follow-up|5|||
129855453|NCT01343056|467428848|FG002|Overall Study|Lost to Follow-up|3|||
129855454|NCT01343056|467428849|FG003|Overall Study|Lost to Follow-up|9|||
129855455|NCT03029208|467428850|FG000|Overall Study|Withdrawal by Subject|2|||
129855456|NCT03029208|467428851|FG001|Overall Study|Withdrawal by Subject|3|||
129855457|NCT03029208|467428850|FG000|Overall Study|Lost to Follow-up|0|||
129855458|NCT03029208|467428851|FG001|Overall Study|Lost to Follow-up|1|||
129855459|NCT01046643|467428852|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
129855460|NCT01046643|467428853|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
129855461|NCT01046643|467428854|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
129855462|NCT01046643|467428855|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
129855463|NCT00305058|467428861|FG000|Overall Study|Participant too young|1|||
129855464|NCT00305058|467428862|FG001|Overall Study|Participant too young|0|||
129855465|NCT00305058|467428861|FG000|Overall Study|Missing data collection instrument|3|||
129855466|NCT00305058|467428862|FG001|Overall Study|Missing data collection instrument|2|||
129855467|NCT00305058|467428861|FG000|Overall Study|Missing outcome data|3|||
129855468|NCT00305058|467428862|FG001|Overall Study|Missing outcome data|2|||
129855469|NCT04102501|467428863|FG000|Overall Study|Withdrawal by Subject|7|||
129855470|NCT04102501|467428864|FG001|Overall Study|Withdrawal by Subject|9|||
129855471|NCT04102501|467428863|FG000|Overall Study|Adverse Event|1|||
129855472|NCT04102501|467428864|FG001|Overall Study|Adverse Event|3|||
129855473|NCT01427712|467428865|FG000|Overall Study|Transfer to a different hospital|2|||
129855474|NCT01427712|467428865|FG000|Overall Study|Lost to Follow-up|1|||
129855475|NCT01427712|467428865|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
129855476|NCT01427712|467428865|FG000|Overall Study|Failure to visit|1|||
129855477|NCT04798586|467428866|FG000|Overall Study|Death|2|||
129855478|NCT00968617|467428867|FG000|Overall Study|Study terminated by sponsor|6|||
129855479|NCT00661492|467428877|FG000|Overall Study|Adverse Event|16|||
129855480|NCT00661492|467428878|FG001|Overall Study|Adverse Event|13|||
129855481|NCT00661492|467428877|FG000|Overall Study|Disease Progression|44|||
129855482|NCT00661492|467428878|FG001|Overall Study|Disease Progression|14|||
129855483|NCT00661492|467428877|FG000|Overall Study|Patient Request|6|||
129855484|NCT00661492|467428878|FG001|Overall Study|Patient Request|1|||
129855485|NCT00661492|467428877|FG000|Overall Study|Investigator Request|1|||
129855486|NCT00661492|467428878|FG001|Overall Study|Investigator Request|0|||
129855487|NCT00661492|467428877|FG000|Overall Study|Lost to Follow-up|0|||
129855488|NCT00661492|467428878|FG001|Overall Study|Lost to Follow-up|1|||
129855489|NCT00661492|467428877|FG000|Overall Study|Other|1|||
129855490|NCT00661492|467428878|FG001|Overall Study|Other|0|||
129855491|NCT01024387|467428879|FG000|Overall Study|Radiographic Progression|29|||
129855492|NCT01024387|467428879|FG000|Overall Study|Symptomatic Progression|10|||
129855493|NCT01024387|467428879|FG000|Overall Study|Physician Decision|5|||
129855494|NCT01024387|467428879|FG000|Overall Study|Withdrawal by Subject|5|||
129855495|NCT01024387|467428879|FG000|Overall Study|Death|2|||
129855496|NCT01024387|467428879|FG000|Overall Study|Prolonged Treatment Delay|1|||
129855497|NCT01024387|467428879|FG000|Overall Study|Adverse Event|3|||
129855498|NCT01024387|467428879|FG000|Overall Study|Other|5|||
129855499|NCT04307186|467428880|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
129855500|NCT04307186|467428880|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
129855501|NCT04307186|467428880|FG000|Washout 3-14 Days|Progressive disease|1|||
129855502|NCT04307186|467428880|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
129855503|NCT04307186|467428880|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
129855504|NCT00927927|467428889|FG000|Overall Study|Withdrawal by Subject|0|||
129855505|NCT00927927|467428890|FG001|Overall Study|Withdrawal by Subject|0|||
129855506|NCT00927927|467428891|FG002|Overall Study|Withdrawal by Subject|0|||
129855507|NCT00927927|467428892|FG003|Overall Study|Withdrawal by Subject|0|||
129855508|NCT00927927|467428893|FG004|Overall Study|Withdrawal by Subject|0|||
129855509|NCT00927927|467428894|FG005|Overall Study|Withdrawal by Subject|0|||
129855510|NCT00927927|467428895|FG006|Overall Study|Withdrawal by Subject|0|||
129855511|NCT00927927|467428896|FG007|Overall Study|Withdrawal by Subject|2|||
129855512|NCT00927927|467428897|FG008|Overall Study|Withdrawal by Subject|0|||
129855513|NCT00927927|467428898|FG009|Overall Study|Withdrawal by Subject|0|||
129855514|NCT00927927|467428899|FG010|Overall Study|Withdrawal by Subject|0|||
129855515|NCT00927927|467428900|FG011|Overall Study|Withdrawal by Subject|2|||
129855516|NCT00927927|467428901|FG012|Overall Study|Withdrawal by Subject|0|||
129855517|NCT00927927|467428902|FG013|Overall Study|Withdrawal by Subject|0|||
129855518|NCT00927927|467428903|FG014|Overall Study|Withdrawal by Subject|0|||
129855519|NCT03135522|467428910|FG000|Overall Study|Adverse Event|1|||
129855520|NCT03135522|467428911|FG001|Overall Study|Adverse Event|0|||
129855521|NCT02838017|467428913|FG000|Overall Study|Lost to Follow-up|14|||
129908738|NCT03950622|467628787|FG000|Overall Study|Physician Decision|1|||
129908739|NCT03950622|467628788|FG001|Overall Study|Physician Decision|0|||
129908740|NCT03950622|467628787|FG000|Overall Study|Lost to Follow-up|5|||
129908741|NCT03950622|467628788|FG001|Overall Study|Lost to Follow-up|5|||
129908742|NCT03950622|467628787|FG000|Overall Study|Death|1|||
129908743|NCT03950622|467628788|FG001|Overall Study|Death|1|||
129908744|NCT01546753|467628791|FG000|Overall Study|anxiety|1|||
129908745|NCT01546753|467628792|FG001|Overall Study|anxiety|1|||
129908746|NCT01546753|467628791|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
129908747|NCT01546753|467628792|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
129908748|NCT00939510|467628793|FG000|Overall Study|Withdrawal by Subject|1|||
129908749|NCT05782231|467628809|FG000|Overall Study|Withdrawal by Subject|1|||
129908750|NCT03830866|467628812|FG000|Overall Study|Death|90|||
129908751|NCT03830866|467628813|FG001|Overall Study|Death|111|||
129908752|NCT03830866|467628812|FG000|Overall Study|Lost to Follow-up|7|||
129908753|NCT03830866|467628813|FG001|Overall Study|Lost to Follow-up|7|||
129908754|NCT03830866|467628812|FG000|Overall Study|Withdrawal by Subject|19|||
129908755|NCT03830866|467628813|FG001|Overall Study|Withdrawal by Subject|16|||
129908756|NCT03830866|467628812|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
129908757|NCT03830866|467628813|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
129908758|NCT03830866|467628812|FG000|Overall Study|Other|1|||
129908759|NCT03830866|467628813|FG001|Overall Study|Other|1|||
129908760|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
129908761|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
129908762|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
129908763|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
129908764|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
129908765|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
129908766|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
129908767|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
129908768|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
130064677|NCT03814590|468190224|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064678|NCT03814590|468190225|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064679|NCT03814590|468190226|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064680|NCT03814590|468190227|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064681|NCT03814590|468190228|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064682|NCT03814590|468190229|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064683|NCT03814590|468190230|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130064684|NCT03814590|468190231|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129855522|NCT02838017|467428914|FG001|Overall Study|Lost to Follow-up|11|||
129855523|NCT02120924|467428915|FG000|Overall Study|Lack of Efficacy|1|||
129855524|NCT02120924|467428916|FG001|Overall Study|Lack of Efficacy|2|||
129855525|NCT02120924|467428917|FG002|Overall Study|Lack of Efficacy|3|||
129855526|NCT02120924|467428915|FG000|Overall Study|Adverse Event|0|||
129855527|NCT02120924|467428916|FG001|Overall Study|Adverse Event|1|||
129855528|NCT02120924|467428917|FG002|Overall Study|Adverse Event|3|||
129855529|NCT02120924|467428915|FG000|Overall Study|Withdrawal by Subject|16|||
129855530|NCT02120924|467428916|FG001|Overall Study|Withdrawal by Subject|20|||
129855531|NCT02120924|467428917|FG002|Overall Study|Withdrawal by Subject|8|||
129855532|NCT02120924|467428915|FG000|Overall Study|Lost to Follow-up|14|||
129855533|NCT02120924|467428916|FG001|Overall Study|Lost to Follow-up|14|||
129855534|NCT02120924|467428917|FG002|Overall Study|Lost to Follow-up|11|||
129855535|NCT02120924|467428915|FG000|Overall Study|Pregnancy|2|||
129855536|NCT02120924|467428916|FG001|Overall Study|Pregnancy|0|||
129855537|NCT02120924|467428917|FG002|Overall Study|Pregnancy|0|||
129855538|NCT02120924|467428915|FG000|Overall Study|Protocol Violation|3|||
129855539|NCT02120924|467428916|FG001|Overall Study|Protocol Violation|7|||
129855540|NCT02120924|467428917|FG002|Overall Study|Protocol Violation|2|||
129855541|NCT02120924|467428915|FG000|Overall Study|Physician Decision|0|||
129908769|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
129908770|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
129908771|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
129855542|NCT02120924|467428916|FG001|Overall Study|Physician Decision|1|||
129855543|NCT02120924|467428917|FG002|Overall Study|Physician Decision|1|||
129908772|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
129908773|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
130064685|NCT03814590|468190232|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130064686|NCT03814590|468190233|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129855544|NCT02120924|467428915|FG000|Overall Study|Death|1|||
129855545|NCT02120924|467428916|FG001|Overall Study|Death|0|||
129855546|NCT02120924|467428917|FG002|Overall Study|Death|0|||
129855547|NCT02120924|467428915|FG000|Overall Study|Compliance with IP|5|||
129908774|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
129908775|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
129908776|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
129908777|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
129908778|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
129908779|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
129908780|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
129908781|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
129908782|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
129908783|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
129908784|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Death|1|||
129908785|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Death|0|||
129908786|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Death|0|||
129908787|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
129908788|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
129908789|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
129908790|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
129855548|NCT02120924|467428916|FG001|Overall Study|Compliance with IP|1|||
129855549|NCT02120924|467428917|FG002|Overall Study|Compliance with IP|1|||
129855550|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
129855551|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
129855552|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
129855553|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
129855554|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
129855555|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
129855556|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
129855557|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
129855558|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
129855559|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
129855560|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
129855561|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
129855562|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
129855563|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
129855564|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
129855565|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
129855566|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
129855567|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
129855568|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
129855569|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
129855570|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
129855571|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
129855572|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
129855573|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
129855574|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
129855575|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
129855576|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
129855577|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
129855578|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
129855579|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
129855580|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
129855581|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
129855582|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
129855583|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
129855584|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
129855585|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
129855586|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
129855587|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
129855588|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
129855589|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
129855590|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
129855591|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
129855592|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
129855593|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
129908791|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
129908792|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129855594|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
129855595|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
129855596|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
129855597|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
129855598|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
129855599|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
129855600|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
129855601|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
129855602|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
129855603|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
129855604|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
129855605|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
129855606|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
129855607|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
129855608|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
129855609|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
129855610|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
129855611|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
129855612|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
129855613|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
129855614|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
129855615|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
129855616|NCT02345512|467428921|FG000|Overall Study|Adverse Event|1|||
129855617|NCT02345512|467428921|FG000|Overall Study|Withdrawal by Subject|1|||
129855618|NCT01968434|467428924|FG000|Overall Study|Lost to Follow-up|3|||
129855619|NCT01968434|467428925|FG001|Overall Study|Lost to Follow-up|6|||
129855620|NCT00074282|467430665|FG000|Step 1|Adverse Event|32|||
129855621|NCT00074282|467430666|FG001|Step 1|Adverse Event|0|||
129855622|NCT00074282|467430667|FG002|Step 1|Adverse Event|0|||
129855623|NCT00074282|467430665|FG000|Step 1|Death|6|||
129855624|NCT00074282|467430666|FG001|Step 1|Death|0|||
129855625|NCT00074282|467430667|FG002|Step 1|Death|0|||
129855626|NCT00074282|467430665|FG000|Step 1|Withdrawal by Subject|7|||
129855627|NCT00074282|467430666|FG001|Step 1|Withdrawal by Subject|0|||
129855628|NCT00074282|467430667|FG002|Step 1|Withdrawal by Subject|0|||
129855629|NCT00074282|467430665|FG000|Step 1|Disease progression|2|||
129855630|NCT00074282|467430666|FG001|Step 1|Disease progression|0|||
129855631|NCT00074282|467430667|FG002|Step 1|Disease progression|0|||
129855632|NCT00074282|467430665|FG000|Step 1|Alternative therapy|2|||
129855633|NCT00074282|467430666|FG001|Step 1|Alternative therapy|0|||
129855634|NCT00074282|467430667|FG002|Step 1|Alternative therapy|0|||
129855635|NCT00074282|467430665|FG000|Step 1|Other complicating disease|2|||
129855636|NCT00074282|467430666|FG001|Step 1|Other complicating disease|0|||
129855637|NCT00074282|467430667|FG002|Step 1|Other complicating disease|0|||
129855638|NCT00074282|467430665|FG000|Step 1|Physician Decision|1|||
129855639|NCT00074282|467430666|FG001|Step 1|Physician Decision|0|||
129855640|NCT00074282|467430667|FG002|Step 1|Physician Decision|0|||
129855641|NCT00074282|467430665|FG000|Step 1|Ineligible|4|||
129855642|NCT00074282|467430666|FG001|Step 1|Ineligible|0|||
129855643|NCT00074282|467430667|FG002|Step 1|Ineligible|0|||
129855644|NCT00074282|467430665|FG000|Step 1|Never started treatment|2|||
129855645|NCT00074282|467430666|FG001|Step 1|Never started treatment|0|||
129855646|NCT00074282|467430667|FG002|Step 1|Never started treatment|0|||
129855647|NCT00074282|467430665|FG000|Step 2|Adverse Event|0|||
129855648|NCT00074282|467430666|FG001|Step 2|Adverse Event|2|||
129855649|NCT00074282|467430667|FG002|Step 2|Adverse Event|12|||
129855650|NCT00074282|467430665|FG000|Step 2|Disease progression|0|||
129855651|NCT00074282|467430666|FG001|Step 2|Disease progression|0|||
129855652|NCT00074282|467430667|FG002|Step 2|Disease progression|5|||
129855653|NCT00074282|467430665|FG000|Step 2|Death|0|||
129855654|NCT00074282|467430666|FG001|Step 2|Death|0|||
129855655|NCT00074282|467430667|FG002|Step 2|Death|3|||
129855656|NCT00074282|467430665|FG000|Step 2|Withdrawal by Subject|0|||
129855657|NCT00074282|467430666|FG001|Step 2|Withdrawal by Subject|0|||
129855658|NCT00074282|467430667|FG002|Step 2|Withdrawal by Subject|2|||
129855659|NCT00074282|467430665|FG000|Step 2|Physician Decision|0|||
129855660|NCT00074282|467430666|FG001|Step 2|Physician Decision|0|||
129855661|NCT00074282|467430667|FG002|Step 2|Physician Decision|1|||
129855662|NCT00074282|467430665|FG000|Step 2|Ineligible|0|||
129855663|NCT00074282|467430666|FG001|Step 2|Ineligible|0|||
129855664|NCT00074282|467430667|FG002|Step 2|Ineligible|1|||
129855665|NCT00464542|467430668|FG000|Pre-treatment|Withdrawal by Subject|2|||
129855666|NCT01773226|467430670|FG000|Overall Study|Withdrawal by Subject|1|||
129855667|NCT02055352|467430675|FG000|Overall Study|Adverse Event|0|||
129855668|NCT02055352|467430676|FG001|Overall Study|Adverse Event|1|||
129855669|NCT02055352|467430675|FG000|Overall Study|Non-eligible|0|||
129855670|NCT02055352|467430676|FG001|Overall Study|Non-eligible|1|||
129855671|NCT02055352|467430675|FG000|Overall Study|Poor compliance|1|||
129855672|NCT02055352|467430676|FG001|Overall Study|Poor compliance|1|||
129855673|NCT02055352|467430675|FG000|Overall Study|Death|1|||
129855674|NCT02055352|467430676|FG001|Overall Study|Death|2|||
129855675|NCT02055352|467430675|FG000|Overall Study|Patient decision|1|||
129855676|NCT02055352|467430676|FG001|Overall Study|Patient decision|1|||
129855677|NCT02055352|467430675|FG000|Overall Study|Use of prohibited treatment|0|||
129855678|NCT02055352|467430676|FG001|Overall Study|Use of prohibited treatment|3|||
129855679|NCT02055352|467430675|FG000|Overall Study|AE, study drug would be detrimental|1|||
129855680|NCT02055352|467430676|FG001|Overall Study|AE, study drug would be detrimental|3|||
129855681|NCT02055352|467430675|FG000|Overall Study|Withdrawal of informed consent|1|||
129855682|NCT02055352|467430676|FG001|Overall Study|Withdrawal of informed consent|0|||
129855683|NCT02055352|467430675|FG000|Overall Study|Reason unknown|1|||
129855684|NCT02055352|467430676|FG001|Overall Study|Reason unknown|5|||
129855685|NCT00489970|467430683|FG000|Persistence Year 9|Lost to Follow-up|2|||
129855686|NCT00489970|467430684|FG001|Persistence Year 9|Lost to Follow-up|2|||
129855687|NCT00489970|467430685|FG002|Persistence Year 9|Lost to Follow-up|3|||
129855688|NCT00489970|467430683|FG000|Persistence Year 9|Other|1|||
129855689|NCT00489970|467430684|FG001|Persistence Year 9|Other|0|||
129855690|NCT00489970|467430685|FG002|Persistence Year 9|Other|2|||
129855691|NCT02707055|467430692|FG000|Phase 1|Withdrawal by Subject|1|||
129855692|NCT02707055|467430693|FG001|Phase 1|Withdrawal by Subject|2|||
129855693|NCT02707055|467430692|FG000|Phase 1|Physician Decision|0|||
129855694|NCT02707055|467430693|FG001|Phase 1|Physician Decision|1|||
129855695|NCT02707055|467430692|FG000|Phase 2|Adverse Event|1|||
129855696|NCT02707055|467430693|FG001|Phase 2|Adverse Event|2|||
129855697|NCT03564496|467430694|FG000|Overall Study|Withdrawal by Subject|1|||
129855698|NCT03564496|467430695|FG001|Overall Study|Withdrawal by Subject|1|||
129855699|NCT03564496|467430696|FG002|Overall Study|Withdrawal by Subject|0|||
129855700|NCT03564496|467430694|FG000|Overall Study|Screen failure|0|||
129855701|NCT03564496|467430695|FG001|Overall Study|Screen failure|3|||
129855702|NCT03564496|467430696|FG002|Overall Study|Screen failure|0|||
129855703|NCT01159938|467430697|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855704|NCT01159938|467430698|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855705|NCT01159938|467430699|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
129855706|NCT01159938|467430700|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855707|NCT01159938|467430701|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855708|NCT02318329|467430702|FG000|Overall Study|Progressive Disease|2|||
129855709|NCT02318329|467430703|FG001|Overall Study|Progressive Disease|3|||
129855710|NCT02318329|467430704|FG002|Overall Study|Progressive Disease|2|||
129855711|NCT02318329|467430705|FG003|Overall Study|Progressive Disease|3|||
129855712|NCT02318329|467430706|FG004|Overall Study|Progressive Disease|3|||
129855713|NCT02318329|467430707|FG005|Overall Study|Progressive Disease|3|||
129855714|NCT02318329|467430708|FG006|Overall Study|Progressive Disease|1|||
129855715|NCT02318329|467430709|FG007|Overall Study|Progressive Disease|1|||
129855716|NCT02318329|467430710|FG008|Overall Study|Progressive Disease|5|||
129855717|NCT02318329|467430711|FG009|Overall Study|Progressive Disease|39|||
129855718|NCT02318329|467430702|FG000|Overall Study|Death|0|||
129855719|NCT02318329|467430703|FG001|Overall Study|Death|0|||
129855720|NCT02318329|467430704|FG002|Overall Study|Death|0|||
129855721|NCT02318329|467430705|FG003|Overall Study|Death|0|||
129855722|NCT02318329|467430706|FG004|Overall Study|Death|0|||
129855723|NCT02318329|467430707|FG005|Overall Study|Death|0|||
129855724|NCT02318329|467430708|FG006|Overall Study|Death|0|||
129855725|NCT02318329|467430709|FG007|Overall Study|Death|0|||
129855726|NCT02318329|467430710|FG008|Overall Study|Death|0|||
129855727|NCT02318329|467430711|FG009|Overall Study|Death|5|||
129855728|NCT02318329|467430702|FG000|Overall Study|Lost to Follow-up|0|||
129855729|NCT02318329|467430703|FG001|Overall Study|Lost to Follow-up|0|||
129855730|NCT02318329|467430704|FG002|Overall Study|Lost to Follow-up|0|||
129855731|NCT02318329|467430705|FG003|Overall Study|Lost to Follow-up|0|||
129855732|NCT02318329|467430706|FG004|Overall Study|Lost to Follow-up|0|||
129855733|NCT02318329|467430707|FG005|Overall Study|Lost to Follow-up|0|||
129855734|NCT02318329|467430708|FG006|Overall Study|Lost to Follow-up|0|||
129855735|NCT02318329|467430709|FG007|Overall Study|Lost to Follow-up|0|||
129855736|NCT02318329|467430710|FG008|Overall Study|Lost to Follow-up|0|||
129855737|NCT02318329|467430711|FG009|Overall Study|Lost to Follow-up|1|||
129855738|NCT02318329|467430702|FG000|Overall Study|Withdrawal by Subject|0|||
129855739|NCT02318329|467430703|FG001|Overall Study|Withdrawal by Subject|0|||
129855740|NCT02318329|467430704|FG002|Overall Study|Withdrawal by Subject|0|||
129855741|NCT02318329|467430705|FG003|Overall Study|Withdrawal by Subject|0|||
129855742|NCT02318329|467430706|FG004|Overall Study|Withdrawal by Subject|0|||
129855743|NCT02318329|467430707|FG005|Overall Study|Withdrawal by Subject|0|||
129855744|NCT02318329|467430708|FG006|Overall Study|Withdrawal by Subject|0|||
129855745|NCT02318329|467430709|FG007|Overall Study|Withdrawal by Subject|0|||
129855746|NCT02318329|467430710|FG008|Overall Study|Withdrawal by Subject|0|||
129855747|NCT02318329|467430711|FG009|Overall Study|Withdrawal by Subject|6|||
129855748|NCT02318329|467430702|FG000|Overall Study|Other|1|||
129908793|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
129908794|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
129908795|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
129908796|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
129908797|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
129855749|NCT02318329|467430703|FG001|Overall Study|Other|1|||
129855750|NCT02318329|467430704|FG002|Overall Study|Other|1|||
129855751|NCT02318329|467430705|FG003|Overall Study|Other|0|||
129908798|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
129908799|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
129908800|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
129908801|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
129908802|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
129908803|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
129908804|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
129908805|NCT00510887|467628818|FG000|Overall Study|Lost to Follow-up|1|||
129908806|NCT03485950|467628823|FG000|Overall Study|Adverse Event|1|||
129908807|NCT03485950|467628824|FG001|Overall Study|Adverse Event|0|||
129908808|NCT03485950|467628823|FG000|Overall Study|Death|3|||
129908809|NCT03485950|467628824|FG001|Overall Study|Death|2|||
129908810|NCT03485950|467628823|FG000|Overall Study|Withdrawal by Subject|3|||
129908811|NCT03485950|467628824|FG001|Overall Study|Withdrawal by Subject|0|||
129908812|NCT00988858|467628826|FG000|Overall Study|Adverse Event|7|||
129908813|NCT00988858|467628826|FG000|Overall Study|Death|1|||
129908814|NCT00988858|467628826|FG000|Overall Study|Physician Decision|1|||
129908815|NCT00988858|467628826|FG000|Overall Study|Sponsor Decision|1|||
129908816|NCT05510245|467628833|FG000|Overall Study|Withdrawal by Subject|1|||
129908817|NCT05510245|467628834|FG001|Overall Study|Withdrawal by Subject|0|||
129908818|NCT05510245|467628835|FG002|Overall Study|Withdrawal by Subject|0|||
129908819|NCT01759771|467628843|FG000|Overall Study|Withdrawal by Subject|1|||
129908820|NCT01759771|467628844|FG001|Overall Study|Withdrawal by Subject|1|||
129908821|NCT03942042|467628845|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
129908822|NCT03942042|467628846|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
129908823|NCT03942042|467628845|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
129908824|NCT03942042|467628846|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
129908825|NCT00411216|467628848|FG000|Overall Study|Ten participants were entered into the c|0|||
129908826|NCT00411216|467628849|FG001|Overall Study|Ten participants were entered into the c|2|||
129908827|NCT01251354|467628851|FG000|Overall Study|Adverse Event|1|||
129908828|NCT01251354|467628851|FG000|Overall Study|Investigator's Decision|1|||
129908829|NCT01251354|467628851|FG000|Overall Study|Disease Progression|4|||
129908830|NCT05094141|467628852|FG000|Overall Study|Death|0|||
129908831|NCT05094141|467628853|FG001|Overall Study|Death|0|||
129908832|NCT05094141|467628854|FG002|Overall Study|Death|1|||
129908833|NCT05094141|467628852|FG000|Overall Study|Withdrawal by Subject|0|||
129908834|NCT05094141|467628853|FG001|Overall Study|Withdrawal by Subject|0|||
129908835|NCT05094141|467628854|FG002|Overall Study|Withdrawal by Subject|1|||
129908836|NCT05094141|467628852|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
129908837|NCT05094141|467628853|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
129908838|NCT05094141|467628854|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
129908839|NCT05094141|467628852|FG000|Overall Study|Did not participate in randomization|0|||
129908840|NCT05094141|467628853|FG001|Overall Study|Did not participate in randomization|0|||
129908841|NCT05094141|467628854|FG002|Overall Study|Did not participate in randomization|33|||
129908842|NCT04411056|467630834|FG000|Overall Study|surgery cancelled|1|||
129908843|NCT04411056|467630835|FG001|Overall Study|surgery cancelled|0|||
129855752|NCT02318329|467430706|FG004|Overall Study|Other|0|||
129855753|NCT02318329|467430707|FG005|Overall Study|Other|0|||
129855754|NCT02318329|467430708|FG006|Overall Study|Other|0|||
129855755|NCT02318329|467430709|FG007|Overall Study|Other|0|||
129855756|NCT02318329|467430710|FG008|Overall Study|Other|1|||
129855757|NCT02318329|467430711|FG009|Overall Study|Other|1|||
129855758|NCT00086346|467430712|FG000|Randomization|Did not receive test article|4|||
129855759|NCT00086346|467430713|FG001|Randomization|Did not receive test article|4|||
129855760|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Adverse Event|94|||
129855761|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Adverse Event|11|||
129855762|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
129908844|NCT04411056|467630834|FG000|Overall Study|Equipment problem during intubation|0|||
129908845|NCT04411056|467630835|FG001|Overall Study|Equipment problem during intubation|1|||
129908846|NCT03122886|467630838|FG000|Overall Study|Withdrawal by Subject|1|||
129908847|NCT03122886|467630839|FG001|Overall Study|Withdrawal by Subject|2|||
129908848|NCT05985044|467630840|FG000|Overall Study|Death|6|||
129908849|NCT05985044|467630840|FG000|Overall Study|Lost to Follow-up|4|||
129908850|NCT05985044|467630840|FG000|Overall Study|Incapacitation|3|||
129908851|NCT05985044|467630840|FG000|Overall Study|Withdrawal by Subject|2|||
130064687|NCT03814590|468190234|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129855763|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
129855764|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
129855765|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
129855766|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
129855767|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
129855768|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
129855769|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
129855770|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
129855771|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
129855772|NCT04495374|467430714|FG000|Overall Study|Protocol Violation|2|||
129855773|NCT04495374|467430715|FG001|Overall Study|Protocol Violation|1|||
129855774|NCT01303627|467430716|FG000|Overall Study|the failure while performing URS|0|||
129855775|NCT01303627|467430717|FG001|Overall Study|the failure while performing URS|1|||
129855776|NCT02416791|467430719|FG000|6 Months|Lost to Follow-up|0|||
129855777|NCT02416791|467430720|FG001|6 Months|Lost to Follow-up|0|||
129855778|NCT02416791|467430721|FG002|6 Months|Lost to Follow-up|1|||
129855779|NCT01054820|467430722|FG000|Overall Study|Withdrawal by Subject|2|||
129855780|NCT00996996|467430724|FG000|Overall Study|Progressive Disease|10|||
129855781|NCT00996996|467430724|FG000|Overall Study|Non-compliance|8|||
129855782|NCT00996996|467430724|FG000|Overall Study|Lost to Follow-up|9|||
129855783|NCT00996996|467430724|FG000|Overall Study|Death|5|||
129855784|NCT00996996|467430724|FG000|Overall Study|Did Not Receive Study Medications|1|||
129855785|NCT04535037|467430727|FG000|Overall Study|Protocol Violation|1|||
129855786|NCT04535037|467430728|FG001|Overall Study|Protocol Violation|0|||
129855787|NCT04535037|467430727|FG000|Overall Study|Withdrawal by Subject|8|||
129855788|NCT04535037|467430728|FG001|Overall Study|Withdrawal by Subject|9|||
129855789|NCT04535037|467430727|FG000|Overall Study|Migrated / moved from the study area|1|||
129855790|NCT04535037|467430728|FG001|Overall Study|Migrated / moved from the study area|4|||
129855791|NCT04535037|467430727|FG000|Overall Study|Other|2|||
129855792|NCT04535037|467430728|FG001|Overall Study|Other|5|||
129855793|NCT02031276|467430729|FG000|Period 1 Double-blind IV|Adverse Event|6|||
129855794|NCT02031276|467430730|FG001|Period 1 Double-blind IV|Adverse Event|5|||
129855795|NCT02031276|467430731|FG002|Period 1 Double-blind IV|Adverse Event|1|||
129855796|NCT02031276|467430729|FG000|Period 1 Double-blind IV|Other|0|||
129855797|NCT02031276|467430730|FG001|Period 1 Double-blind IV|Other|1|||
129855798|NCT02031276|467430731|FG002|Period 1 Double-blind IV|Other|0|||
129855799|NCT02031276|467430729|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
129855800|NCT02031276|467430730|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
129855801|NCT02031276|467430731|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
129855802|NCT02031276|467430729|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
129855803|NCT02031276|467430730|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
129855804|NCT02031276|467430731|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
129855805|NCT02031276|467430729|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
129855806|NCT02031276|467430730|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
129855807|NCT02031276|467430731|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
129855808|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
129855809|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
129855810|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
129855811|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
129855812|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
129855813|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
129855814|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
129855815|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
129855816|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
129855817|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
129855818|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
129855819|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
129855820|NCT01148810|467430732|FG000|Overall Study|Adverse Event|0|||
129855821|NCT01148810|467430733|FG001|Overall Study|Adverse Event|2|||
129855822|NCT01148810|467430732|FG000|Overall Study|Lack of Efficacy|0|||
129855823|NCT01148810|467430733|FG001|Overall Study|Lack of Efficacy|1|||
129855824|NCT01148810|467430732|FG000|Overall Study|Withdrawal by Subject|0|||
129855825|NCT01148810|467430733|FG001|Overall Study|Withdrawal by Subject|2|||
129855826|NCT01148810|467430732|FG000|Overall Study|Protocol Violation|1|||
129855827|NCT01148810|467430733|FG001|Overall Study|Protocol Violation|0|||
129855828|NCT02417246|467430740|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
129855829|NCT02417246|467430741|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
129908852|NCT02279095|467630843|FG000|Overall Study|Non-Compliance|1|||
129908853|NCT02279095|467630843|FG000|Overall Study|Withdrawal by Subject|8|||
129855830|NCT02417246|467430740|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
129855831|NCT02417246|467430741|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
129855832|NCT02417246|467430740|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
129855833|NCT02417246|467430741|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
129855834|NCT02417246|467430740|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
129855835|NCT02417246|467430741|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
129855836|NCT01181921|467430745|FG000|Overall Study|Lost to Follow-up|1|||
129855837|NCT04408469|467430746|FG000|Overall Study|Lost to Follow-up|6|||
129855838|NCT04408469|467430747|FG001|Overall Study|Lost to Follow-up|9|||
129855839|NCT04408469|467430746|FG000|Overall Study|Withdrawal by Subject|6|||
129855840|NCT04408469|467430747|FG001|Overall Study|Withdrawal by Subject|1|||
129855841|NCT04408469|467430746|FG000|Overall Study|Dismissal due to ineligibility|0|||
129855842|NCT04408469|467430747|FG001|Overall Study|Dismissal due to ineligibility|1|||
129855843|NCT04321460|467430748|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
129855844|NCT04321460|467430749|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
129855845|NCT02162810|467430752|FG000|Overall Study|Protocol Violation|1|||
129855846|NCT02162810|467430753|FG001|Overall Study|Protocol Violation|0|||
129855847|NCT02162810|467430752|FG000|Overall Study|patients did not report compliance|4|||
129855848|NCT02162810|467430753|FG001|Overall Study|patients did not report compliance|1|||
129855849|NCT01308749|467430758|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
129855850|NCT01308749|467430759|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
129855851|NCT01308749|467430758|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
129855852|NCT01308749|467430759|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
129855853|NCT01308749|467430758|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
129855854|NCT01308749|467430759|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
129855855|NCT02519504|467430760|FG000|Overall Study|Protocol Violation|6|||
129855856|NCT02519504|467430761|FG001|Overall Study|Protocol Violation|5|||
129855857|NCT02519504|467430760|FG000|Overall Study|Ineligible for direct testing|12|||
129855858|NCT02519504|467430761|FG001|Overall Study|Ineligible for direct testing|12|||
129855859|NCT02519504|467430760|FG000|Overall Study|Did not participate in direct testing|95|||
129855860|NCT02519504|467430761|FG001|Overall Study|Did not participate in direct testing|86|||
129855861|NCT04726709|467430762|FG000|Overall Study|Withdrawal by Subject|2|||
129855862|NCT04726709|467430763|FG001|Overall Study|Withdrawal by Subject|2|||
129855863|NCT02553330|467430764|FG000|Overall Study|Study Terminated by Sponsor|2|||
129855864|NCT02553330|467430765|FG001|Overall Study|Study Terminated by Sponsor|13|||
129855865|NCT02553330|467430766|FG002|Overall Study|Study Terminated by Sponsor|12|||
129855866|NCT02553330|467430764|FG000|Overall Study|Withdrawal by Subject|3|||
129855867|NCT02553330|467430765|FG001|Overall Study|Withdrawal by Subject|19|||
129855868|NCT02553330|467430766|FG002|Overall Study|Withdrawal by Subject|21|||
129855869|NCT02553330|467430764|FG000|Overall Study|Other|0|||
129855870|NCT02553330|467430765|FG001|Overall Study|Other|1|||
129855871|NCT02553330|467430766|FG002|Overall Study|Other|0|||
129855872|NCT02553330|467430764|FG000|Overall Study|Non compliance to study treatment|0|||
129855873|NCT02553330|467430765|FG001|Overall Study|Non compliance to study treatment|1|||
129855874|NCT02553330|467430766|FG002|Overall Study|Non compliance to study treatment|0|||
129855875|NCT02553330|467430764|FG000|Overall Study|Adverse Event|0|||
129855876|NCT02553330|467430765|FG001|Overall Study|Adverse Event|1|||
129855877|NCT02553330|467430766|FG002|Overall Study|Adverse Event|0|||
129855878|NCT02553330|467430764|FG000|Overall Study|Lost to Follow-up|0|||
129855879|NCT02553330|467430765|FG001|Overall Study|Lost to Follow-up|4|||
129855880|NCT02553330|467430766|FG002|Overall Study|Lost to Follow-up|4|||
129855881|NCT03551938|467430770|FG000|3-Month Follow Up|Lost to Follow-up|39|||
129855882|NCT03551938|467430771|FG001|3-Month Follow Up|Lost to Follow-up|38|||
129855883|NCT03551938|467430770|FG000|6-Month Follow Up|Lost to Follow-up|46|||
129855884|NCT03551938|467430771|FG001|6-Month Follow Up|Lost to Follow-up|42|||
129855885|NCT03551938|467430770|FG000|9-Month Follow Up|Lost to Follow-up|44|||
129855886|NCT03551938|467430771|FG001|9-Month Follow Up|Lost to Follow-up|43|||
129855887|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Adverse Event|3|||
129855888|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Adverse Event|2|||
129855889|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Adverse Event|0|||
129855890|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Adverse Event|0|||
129855891|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Adverse Event|0|||
129855892|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Adverse Event|0|||
129855893|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Adverse Event|0|||
129855894|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
129855895|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
129855896|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855897|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855898|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855899|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855900|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855901|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Physician Decision|1|||
129855902|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Physician Decision|0|||
129855903|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Physician Decision|0|||
129855904|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Physician Decision|0|||
129855905|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Physician Decision|0|||
129908854|NCT02279095|467630843|FG000|Overall Study|Adverse Event|2|||
129908855|NCT02279095|467630843|FG000|Overall Study|Other|7|||
129908856|NCT02279095|467630843|FG000|Overall Study|Lost to Follow-up|1|||
129908857|NCT02767765|467630844|FG000|Overall Study|Adverse Event|4|||
129908858|NCT02767765|467630844|FG000|Overall Study|Death|1|||
129908859|NCT02767765|467630844|FG000|Overall Study|Insufficient response|1|||
129908860|NCT02767765|467630844|FG000|Overall Study|Lost to Follow-up|2|||
129908861|NCT02767765|467630844|FG000|Overall Study|Investigator decision|1|||
129855906|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Physician Decision|0|||
129855907|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Physician Decision|0|||
129855908|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
129855909|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
129855910|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855911|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855912|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855913|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855914|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855915|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855916|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
129855917|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855918|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855919|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855920|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855921|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855922|NCT02265705|467430772|FG000|Rescue Period|Withdrawal by Subject|0|||
129855923|NCT02265705|467430773|FG001|Rescue Period|Withdrawal by Subject|0|||
129855924|NCT02265705|467430774|FG002|Rescue Period|Withdrawal by Subject|1|||
129855925|NCT02265705|467430775|FG003|Rescue Period|Withdrawal by Subject|0|||
129855926|NCT02265705|467430776|FG004|Rescue Period|Withdrawal by Subject|0|||
129855927|NCT02265705|467430777|FG005|Rescue Period|Withdrawal by Subject|0|||
129855928|NCT02265705|467430778|FG006|Rescue Period|Withdrawal by Subject|0|||
129855929|NCT02265705|467430772|FG000|Rescue Period|Death|0|||
129855930|NCT02265705|467430773|FG001|Rescue Period|Death|0|||
129855931|NCT02265705|467430774|FG002|Rescue Period|Death|1|||
129855932|NCT02265705|467430775|FG003|Rescue Period|Death|0|||
129855933|NCT02265705|467430776|FG004|Rescue Period|Death|0|||
129855934|NCT02265705|467430777|FG005|Rescue Period|Death|0|||
129855935|NCT02265705|467430778|FG006|Rescue Period|Death|0|||
129855936|NCT02265705|467430772|FG000|Rescue Period|Lack of Efficacy|0|||
129855937|NCT02265705|467430773|FG001|Rescue Period|Lack of Efficacy|0|||
129855938|NCT02265705|467430774|FG002|Rescue Period|Lack of Efficacy|1|||
129855939|NCT02265705|467430775|FG003|Rescue Period|Lack of Efficacy|0|||
129855940|NCT02265705|467430776|FG004|Rescue Period|Lack of Efficacy|0|||
129855941|NCT02265705|467430777|FG005|Rescue Period|Lack of Efficacy|0|||
129855942|NCT02265705|467430778|FG006|Rescue Period|Lack of Efficacy|0|||
129855943|NCT02265705|467430772|FG000|Open Label Period|Adverse Event|0|||
129855944|NCT02265705|467430773|FG001|Open Label Period|Adverse Event|0|||
129855945|NCT02265705|467430774|FG002|Open Label Period|Adverse Event|0|||
129855946|NCT02265705|467430775|FG003|Open Label Period|Adverse Event|2|||
129855947|NCT02265705|467430776|FG004|Open Label Period|Adverse Event|2|||
129855948|NCT02265705|467430777|FG005|Open Label Period|Adverse Event|0|||
129855949|NCT02265705|467430778|FG006|Open Label Period|Adverse Event|0|||
129855950|NCT02265705|467430772|FG000|Open Label Period|Physician Decision|0|||
129855951|NCT02265705|467430773|FG001|Open Label Period|Physician Decision|0|||
129855952|NCT02265705|467430774|FG002|Open Label Period|Physician Decision|0|||
129855953|NCT02265705|467430775|FG003|Open Label Period|Physician Decision|0|||
129855954|NCT02265705|467430776|FG004|Open Label Period|Physician Decision|1|||
129855955|NCT02265705|467430777|FG005|Open Label Period|Physician Decision|0|||
129855956|NCT02265705|467430778|FG006|Open Label Period|Physician Decision|0|||
129855957|NCT02265705|467430772|FG000|Open Label Period|Withdrawal by Subject|0|||
129855958|NCT02265705|467430773|FG001|Open Label Period|Withdrawal by Subject|0|||
129855959|NCT02265705|467430774|FG002|Open Label Period|Withdrawal by Subject|0|||
129855960|NCT02265705|467430775|FG003|Open Label Period|Withdrawal by Subject|0|||
129855961|NCT02265705|467430776|FG004|Open Label Period|Withdrawal by Subject|2|||
129855962|NCT02265705|467430777|FG005|Open Label Period|Withdrawal by Subject|0|||
129855963|NCT02265705|467430778|FG006|Open Label Period|Withdrawal by Subject|0|||
129855964|NCT02265705|467430772|FG000|Follow-up Period|Sponsor Decision|0|||
129855965|NCT02265705|467430773|FG001|Follow-up Period|Sponsor Decision|0|||
129855966|NCT02265705|467430774|FG002|Follow-up Period|Sponsor Decision|0|||
129855967|NCT02265705|467430775|FG003|Follow-up Period|Sponsor Decision|0|||
129855968|NCT02265705|467430776|FG004|Follow-up Period|Sponsor Decision|0|||
129855969|NCT02265705|467430777|FG005|Follow-up Period|Sponsor Decision|1|||
129855970|NCT02265705|467430778|FG006|Follow-up Period|Sponsor Decision|6|||
129908862|NCT02767765|467630844|FG000|Overall Study|Non-Compliance|1|||
129855971|NCT02265705|467430772|FG000|Follow-up Period|Adverse Event|0|||
129855972|NCT02265705|467430773|FG001|Follow-up Period|Adverse Event|0|||
129855973|NCT02265705|467430774|FG002|Follow-up Period|Adverse Event|0|||
129855974|NCT02265705|467430775|FG003|Follow-up Period|Adverse Event|0|||
129855975|NCT02265705|467430776|FG004|Follow-up Period|Adverse Event|0|||
129855976|NCT02265705|467430777|FG005|Follow-up Period|Adverse Event|0|||
129855977|NCT02265705|467430778|FG006|Follow-up Period|Adverse Event|3|||
129855978|NCT02265705|467430772|FG000|Follow-up Period|Physician Decision|0|||
129855979|NCT02265705|467430773|FG001|Follow-up Period|Physician Decision|0|||
129855980|NCT02265705|467430774|FG002|Follow-up Period|Physician Decision|0|||
129855981|NCT02265705|467430775|FG003|Follow-up Period|Physician Decision|0|||
129855982|NCT02265705|467430776|FG004|Follow-up Period|Physician Decision|0|||
129855983|NCT02265705|467430777|FG005|Follow-up Period|Physician Decision|0|||
129855984|NCT02265705|467430778|FG006|Follow-up Period|Physician Decision|1|||
129855985|NCT02265705|467430772|FG000|Follow-up Period|Withdrawal by Subject|0|||
129855986|NCT02265705|467430773|FG001|Follow-up Period|Withdrawal by Subject|0|||
129855987|NCT02265705|467430774|FG002|Follow-up Period|Withdrawal by Subject|0|||
129855988|NCT02265705|467430775|FG003|Follow-up Period|Withdrawal by Subject|0|||
129855989|NCT02265705|467430776|FG004|Follow-up Period|Withdrawal by Subject|0|||
129855990|NCT02265705|467430777|FG005|Follow-up Period|Withdrawal by Subject|0|||
129855991|NCT02265705|467430778|FG006|Follow-up Period|Withdrawal by Subject|1|||
129855992|NCT00779246|467430779|FG000|Overall Study|Missing sufficient data for analysis|33|||
129855993|NCT00779246|467430780|FG001|Overall Study|Missing sufficient data for analysis|53|||
129855994|NCT02079805|467430781|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129855995|NCT02079805|467430782|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130116625|NCT02058628|468387132|FG001|Overall Study|A lot of time for study for participant|0|||
130116626|NCT02058628|468387131|FG000|Overall Study|Non compliance|1|||
130116627|NCT02058628|468387132|FG001|Overall Study|Non compliance|0|||
130116628|NCT03355742|468387133|FG000|Overall Study|Lost to Follow-up|4|||
130116629|NCT03355742|468387133|FG000|Overall Study|Withdrawal by Subject|29|||
130116630|NCT03355742|468387133|FG000|Overall Study|Physician Decision|6|||
130116631|NCT03355742|468387133|FG000|Overall Study|Death|55|||
130116632|NCT03355742|468387133|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
130116633|NCT01787825|468387135|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
130116634|NCT01787825|468387136|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
130116635|NCT01787825|468387135|FG000|Overall Study|Data Not Analyzable|5|||
130116636|NCT01787825|468387136|FG001|Overall Study|Data Not Analyzable|1|||
130116637|NCT00989261|468387141|FG000|Overall Study|Still in follow up|12|||
129855996|NCT02079805|467430781|FG000|Overall Study|Voluntary Withdrawal|0|||
129855997|NCT02079805|467430782|FG001|Overall Study|Voluntary Withdrawal|1|||
129855998|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
129855999|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
129856000|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
129856001|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
129856002|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
129856003|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
129856004|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
129856005|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
129856006|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
129856007|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
129856008|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
129856009|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
129856010|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
129856011|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129856012|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129856013|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
129856014|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
129856015|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
129856016|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
129856017|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
129856018|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
129856019|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
129856020|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
129856021|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
130116638|NCT00989261|468387142|FG001|Overall Study|Still in follow up|21|||
130116639|NCT00989261|468387141|FG000|Overall Study|Withdrawal by Subject|0|||
130116640|NCT00989261|468387142|FG001|Overall Study|Withdrawal by Subject|1|||
130116641|NCT00989261|468387141|FG000|Overall Study|Lost to Follow-up|3|||
129856022|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
129856023|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
129856024|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
129856025|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
130116642|NCT00989261|468387142|FG001|Overall Study|Lost to Follow-up|0|||
130116643|NCT01507896|468387145|FG000|Overall Study|Withdrawal by Subject|1|||
129856026|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
129856027|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
129856028|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
129856029|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
129856030|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
129856031|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129856032|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
129856033|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
129856034|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
129856035|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
129856036|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
129856037|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
129856038|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
129856039|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
129856040|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
129856041|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
129856042|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
129856043|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856044|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856045|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856046|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856047|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
129856048|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
129856049|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
129856050|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
129856051|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
129856052|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
129856053|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
129856054|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
129856055|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
129856056|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
129856057|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
129856058|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129856059|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
129856060|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
129856061|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
129856062|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129856063|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
129856064|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129856065|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129856066|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129856067|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
129856068|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129856069|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129856070|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129856071|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129856072|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129856073|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Administrative|1|||
129856074|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Administrative|1|||
129856075|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Administrative|0|||
129856076|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Administrative|1|||
129856077|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Administrative|0|||
129856078|NCT02682264|467430788|FG000|Overall Study|Withdrawal by Subject|56|||
129856079|NCT02682264|467430789|FG001|Overall Study|Withdrawal by Subject|45|||
129856080|NCT02682264|467430788|FG000|Overall Study|Lost to Follow-up|49|||
129856081|NCT02682264|467430789|FG001|Overall Study|Lost to Follow-up|41|||
130064688|NCT03814590|468190235|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130064689|NCT03814590|468190236|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129856082|NCT02682264|467430788|FG000|Overall Study|Lack of Efficacy|14|||
129856083|NCT02682264|467430789|FG001|Overall Study|Lack of Efficacy|16|||
129856084|NCT02682264|467430788|FG000|Overall Study|Withdrawal by Parent|6|||
129856085|NCT02682264|467430789|FG001|Overall Study|Withdrawal by Parent|7|||
129856086|NCT02682264|467430788|FG000|Overall Study|Adverse Event|9|||
129856087|NCT02682264|467430789|FG001|Overall Study|Adverse Event|0|||
129856088|NCT02682264|467430788|FG000|Overall Study|Noncompliance with study drug|1|||
129856089|NCT02682264|467430789|FG001|Overall Study|Noncompliance with study drug|4|||
129908863|NCT02767765|467630844|FG000|Overall Study|Withdrawal by Subject|1|||
129908864|NCT01951170|467630846|FG000|Overall Study|Investigator decision|1|||
129908865|NCT00077675|467630855|FG000|Overall Study|Adverse Event|1|||
129908866|NCT00077675|467630856|FG001|Overall Study|Adverse Event|2|||
129908867|NCT00077675|467630855|FG000|Overall Study|Lost to Follow-up|6|||
129908868|NCT00077675|467630856|FG001|Overall Study|Lost to Follow-up|3|||
129908869|NCT00077675|467630855|FG000|Overall Study|Withdrawal by Subject|1|||
129908870|NCT00077675|467630856|FG001|Overall Study|Withdrawal by Subject|0|||
129856090|NCT02682264|467430788|FG000|Overall Study|Pregnancy|1|||
129856091|NCT02682264|467430789|FG001|Overall Study|Pregnancy|2|||
129856092|NCT02682264|467430788|FG000|Overall Study|Recovery|1|||
129856093|NCT02682264|467430789|FG001|Overall Study|Recovery|2|||
129856094|NCT02682264|467430788|FG000|Overall Study|Progressive Disease|1|||
129856095|NCT02682264|467430789|FG001|Overall Study|Progressive Disease|0|||
129856096|NCT02682264|467430788|FG000|Overall Study|Technical Problems|0|||
129856097|NCT02682264|467430789|FG001|Overall Study|Technical Problems|1|||
129856098|NCT02682264|467430788|FG000|Overall Study|Moved abroad and unable to continue|0|||
129856099|NCT02682264|467430789|FG001|Overall Study|Moved abroad and unable to continue|3|||
129856100|NCT02682264|467430788|FG000|Overall Study|Stopped test article application|0|||
129856101|NCT02682264|467430789|FG001|Overall Study|Stopped test article application|1|||
129856102|NCT03447769|467430790|FG000|Overall Study|Progressive disease|138|||
129856103|NCT03447769|467430791|FG001|Overall Study|Progressive disease|148|||
129856104|NCT03447769|467430790|FG000|Overall Study|Study terminated by Sponsor|60|||
129856105|NCT03447769|467430791|FG001|Overall Study|Study terminated by Sponsor|44|||
129856106|NCT03447769|467430790|FG000|Overall Study|Adverse Event|34|||
129856107|NCT03447769|467430791|FG001|Overall Study|Adverse Event|31|||
129856108|NCT03447769|467430790|FG000|Overall Study|Patient decision|27|||
129856109|NCT03447769|467430791|FG001|Overall Study|Patient decision|27|||
129856110|NCT03447769|467430790|FG000|Overall Study|Protocol deviation|4|||
129856111|NCT03447769|467430791|FG001|Overall Study|Protocol deviation|6|||
129856112|NCT03447769|467430790|FG000|Overall Study|Death|2|||
129856113|NCT03447769|467430791|FG001|Overall Study|Death|7|||
129856114|NCT03447769|467430790|FG000|Overall Study|Technical problems|1|||
129856115|NCT03447769|467430791|FG001|Overall Study|Technical problems|0|||
129856116|NCT03447769|467430790|FG000|Overall Study|Lost to Follow-up|0|||
129856117|NCT03447769|467430791|FG001|Overall Study|Lost to Follow-up|1|||
129856118|NCT03447769|467430790|FG000|Overall Study|Physician Decision|13|||
129856119|NCT03447769|467430791|FG001|Overall Study|Physician Decision|5|||
129856120|NCT01343407|467430793|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
129856121|NCT01343407|467430794|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
129856122|NCT01343407|467430795|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
129856123|NCT01343407|467430796|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
129856124|NCT01343407|467430797|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
129856125|NCT01343407|467430798|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
129856126|NCT01343407|467430793|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856127|NCT01343407|467430794|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856128|NCT01343407|467430795|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
129856129|NCT01343407|467430796|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856130|NCT01343407|467430797|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856131|NCT01343407|467430798|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856132|NCT03950739|467430799|FG000|Treatment Phase|Adverse Event|2|||
129856133|NCT03950739|467430799|FG000|Optional Extension Phase|Death|1|||
129856134|NCT03950739|467430799|FG000|Optional Extension Phase|Progressive Disease|5|||
129856135|NCT03950739|467430799|FG000|Optional Extension Phase|Adverse Event|7|||
129856136|NCT03950739|467430799|FG000|Optional Extension Phase|Lost to Follow-up|2|||
129856137|NCT03950739|467430799|FG000|Optional Extension Phase|Site Closure|2|||
129856138|NCT03950739|467430799|FG000|Optional Extension Phase|Pregnancy|1|||
129856139|NCT03264989|467430803|FG000|Overall Study|Lost to Follow-up|1|||
129856140|NCT03264989|467430804|FG001|Overall Study|Lost to Follow-up|0|||
129856141|NCT03264989|467430803|FG000|Overall Study|New Therapy for study Indication|1|||
129856142|NCT03264989|467430804|FG001|Overall Study|New Therapy for study Indication|0|||
129856143|NCT03264989|467430803|FG000|Overall Study|Protocol Violation|0|||
129856144|NCT03264989|467430804|FG001|Overall Study|Protocol Violation|1|||
129856145|NCT03264989|467430803|FG000|Overall Study|Patient decision|13|||
129856146|NCT03264989|467430804|FG001|Overall Study|Patient decision|0|||
129856147|NCT03264989|467430803|FG000|Overall Study|Physician Decision|6|||
129856148|NCT03264989|467430804|FG001|Overall Study|Physician Decision|4|||
129908871|NCT00077675|467630855|FG000|Overall Study|Other|0|||
129908872|NCT00077675|467630856|FG001|Overall Study|Other|1|||
130064690|NCT03814590|468190223|FG000|Overall Study|UNKNOWN REASON|0|||
129856149|NCT03264989|467430803|FG000|Overall Study|Adverse Event|2|||
129856150|NCT03264989|467430804|FG001|Overall Study|Adverse Event|1|||
129856151|NCT03264989|467430803|FG000|Overall Study|Death|1|||
129856152|NCT03264989|467430804|FG001|Overall Study|Death|1|||
129856153|NCT03264989|467430803|FG000|Overall Study|Pregnancy|2|||
129856154|NCT03264989|467430804|FG001|Overall Study|Pregnancy|0|||
129856155|NCT03264989|467430803|FG000|Overall Study|End of Study|19|||
129856156|NCT03264989|467430804|FG001|Overall Study|End of Study|5|||
129856157|NCT01775137|467430810|FG000|Overall Study|Death|1|||
129856158|NCT01775137|467430810|FG000|Overall Study|Protocol deviation|2|||
129856159|NCT01775137|467430810|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129856160|NCT01775137|467430810|FG000|Overall Study|Adverse Event|1|||
129856161|NCT01775137|467430810|FG000|Overall Study|Withdrawal by participants|5|||
129856162|NCT00096135|467430817|FG000|Overall Study|Physician Decision|20|||
129856163|NCT00096135|467430818|FG001|Overall Study|Physician Decision|4|||
129856164|NCT00096135|467430817|FG000|Overall Study|Refusal of further protocol therapy|4|||
129856165|NCT00096135|467430818|FG001|Overall Study|Refusal of further protocol therapy|1|||
129856166|NCT00096135|467430817|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
129856167|NCT00096135|467430818|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
129856168|NCT00096135|467430817|FG000|Overall Study|Other, specify|15|||
129856169|NCT00096135|467430818|FG001|Overall Study|Other, specify|3|||
129856170|NCT00096135|467430817|FG000|Overall Study|Ineligible|2|||
129856171|NCT00096135|467430818|FG001|Overall Study|Ineligible|0|||
129856172|NCT00874029|467430820|FG000|Overall Study|Withdrawal by Subject|10|||
129856173|NCT00874029|467430820|FG000|Overall Study|Pregnancy|4|||
129856174|NCT00874029|467430820|FG000|Overall Study|Physician Decision|1|||
129856175|NCT00874029|467430820|FG000|Overall Study|Adverse Event|1|||
129856176|NCT00874029|467430820|FG000|Overall Study|Lost to Follow-up|5|||
129856177|NCT00856583|467430821|FG000|Overall Study|Lack of Efficacy|389|||
129856178|NCT00856583|467430822|FG001|Overall Study|Lack of Efficacy|377|||
129856179|NCT00856583|467430821|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
129856180|NCT00856583|467430822|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
129856181|NCT00856583|467430821|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
129856182|NCT00856583|467430822|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
129856183|NCT00856583|467430821|FG000|Overall Study|Non-compliance|305|||
129856184|NCT00856583|467430822|FG001|Overall Study|Non-compliance|262|||
129856185|NCT00856583|467430821|FG000|Overall Study|Withdrawal by Subject|1092|||
129856186|NCT00856583|467430822|FG001|Overall Study|Withdrawal by Subject|919|||
129856187|NCT00856583|467430821|FG000|Overall Study|Physician Decision|59|||
129856188|NCT00856583|467430822|FG001|Overall Study|Physician Decision|82|||
129856189|NCT00856583|467430821|FG000|Overall Study|Pregnancy|14|||
129856190|NCT00856583|467430822|FG001|Overall Study|Pregnancy|5|||
129856191|NCT00856583|467430821|FG000|Overall Study|Other|92|||
129856192|NCT00856583|467430822|FG001|Overall Study|Other|104|||
129856193|NCT00856583|467430821|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
129856194|NCT00856583|467430822|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
129856195|NCT00499889|467430829|FG000|Overall Study|Infection prior to treatment|1|||
129856196|NCT01898195|467430833|FG000|Smoking Abstinence|Did not have good measurements|35|||
129856197|NCT01898195|467430834|FG001|Smoking Abstinence|Did not have good measurements|38|||
129856198|NCT01898195|467430835|FG002|Smoking Abstinence|Did not have good measurements|36|||
129856199|NCT04401579|467433036|FG000|Overall Study|Death|23|||
129856200|NCT04401579|467433037|FG001|Overall Study|Death|36|||
129856201|NCT04401579|467433036|FG000|Overall Study|Lost to Follow-up|40|||
129856202|NCT04401579|467433037|FG001|Overall Study|Lost to Follow-up|41|||
129856203|NCT04401579|467433036|FG000|Overall Study|Withdrawal by Subject|8|||
129856204|NCT04401579|467433037|FG001|Overall Study|Withdrawal by Subject|16|||
129856205|NCT04401579|467433036|FG000|Overall Study|Physician Decision|1|||
129856206|NCT04401579|467433037|FG001|Overall Study|Physician Decision|2|||
129856207|NCT04401579|467433036|FG000|Overall Study|Became ineligible after enrollment|1|||
129856208|NCT04401579|467433037|FG001|Overall Study|Became ineligible after enrollment|1|||
129856209|NCT04401579|467433036|FG000|Overall Study|Enrolled but treatment not administered|7|||
129856210|NCT04401579|467433037|FG001|Overall Study|Enrolled but treatment not administered|9|||
129856211|NCT04401579|467433036|FG000|Overall Study|Adverse Event|2|||
129856212|NCT04401579|467433037|FG001|Overall Study|Adverse Event|1|||
129856213|NCT04401579|467433036|FG000|Overall Study|Scheduling error|1|||
129856214|NCT04401579|467433037|FG001|Overall Study|Scheduling error|2|||
129856215|NCT04401579|467433036|FG000|Overall Study|Transferred to another hospital|1|||
129856216|NCT04401579|467433037|FG001|Overall Study|Transferred to another hospital|2|||
129856217|NCT03521635|467433038|FG000|Overall Study|Adverse Event|1|||
129856218|NCT03521635|467433039|FG001|Overall Study|Adverse Event|1|||
129856219|NCT03521635|467433038|FG000|Overall Study|Refused to complete study visit|1|||
129856220|NCT03521635|467433039|FG001|Overall Study|Refused to complete study visit|0|||
129856221|NCT03521635|467433038|FG000|Overall Study|Refused to continue trial medication|2|||
129856222|NCT03521635|467433039|FG001|Overall Study|Refused to continue trial medication|2|||
129856223|NCT03521635|467433038|FG000|Overall Study|Lost to Follow-up|0|||
129856224|NCT03521635|467433039|FG001|Overall Study|Lost to Follow-up|1|||
129856225|NCT03521635|467433038|FG000|Overall Study|Meet exclusion criteria|0|||
129856226|NCT03521635|467433039|FG001|Overall Study|Meet exclusion criteria|1|||
129856227|NCT03521635|467433038|FG000|Overall Study|Patient not taken study medicine|0|||
129856228|NCT03521635|467433039|FG001|Overall Study|Patient not taken study medicine|1|||
129856229|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Adverse Event|5|||
129856230|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Adverse Event|8|||
129856231|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Adverse Event|4|||
129856232|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Adverse Event|8|||
129856233|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
129856234|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
129856235|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
129856236|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
129856237|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
129856238|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
129856239|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
129856240|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
130064691|NCT03814590|468190224|FG001|Overall Study|UNKNOWN REASON|0|||
130064692|NCT03814590|468190225|FG002|Overall Study|UNKNOWN REASON|0|||
129856241|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Physician Decision|1|||
129856242|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Physician Decision|0|||
129856243|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Physician Decision|0|||
129856244|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Physician Decision|0|||
129856245|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
129856246|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
129856247|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
129856248|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
129856249|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Pregnancy|0|||
129856250|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Pregnancy|1|||
129856251|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Pregnancy|0|||
129856252|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Pregnancy|0|||
129856253|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
129856254|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
129856255|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
129856256|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
129856257|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Death|0|||
129856258|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Death|1|||
129856259|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Death|0|||
129856260|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Death|0|||
129856261|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
129856262|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
129856263|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
129856264|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
129856265|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
129856266|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
129856267|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
129856268|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
129856269|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129856270|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129856271|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129856272|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
129856273|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129856274|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129856275|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129856276|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
129856277|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
129856278|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
129856279|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
129856280|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
129856281|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129856282|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129856283|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129856284|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
129856285|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129856286|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129856287|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129856288|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
129856289|NCT01227889|467433047|FG000|Randomized Phase (RP)|Adverse Event|13|||
129856290|NCT01227889|467433048|FG001|Randomized Phase (RP)|Adverse Event|0|||
129856291|NCT01227889|467433047|FG000|Randomized Phase (RP)|Physician Decision|13|||
129856292|NCT01227889|467433048|FG001|Randomized Phase (RP)|Physician Decision|5|||
129856293|NCT01227889|467433047|FG000|Randomized Phase (RP)|Progressive Disease|135|||
129856294|NCT01227889|467433048|FG001|Randomized Phase (RP)|Progressive Disease|52|||
129856295|NCT01227889|467433047|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
129856296|NCT01227889|467433048|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
129856297|NCT01227889|467433047|FG000|Randomized Phase (RP)|Missing|1|||
129856298|NCT01227889|467433048|FG001|Randomized Phase (RP)|Missing|3|||
129856299|NCT01227889|467433047|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
130064693|NCT03814590|468190226|FG003|Overall Study|UNKNOWN REASON|0|||
129908873|NCT00077675|467630855|FG000|Overall Study|Never received study treatment|3|||
129908874|NCT00077675|467630856|FG001|Overall Study|Never received study treatment|3|||
129908875|NCT02675244|467630857|FG000|Overall Study|Death|9|||
129908876|NCT02675244|467630858|FG001|Overall Study|Death|6|||
129908877|NCT02675244|467630857|FG000|Overall Study|Withdrawal by Subject|3|||
129908878|NCT02675244|467630858|FG001|Overall Study|Withdrawal by Subject|6|||
129908879|NCT02675244|467630857|FG000|Overall Study|Lost to Follow-up|1|||
129908880|NCT02675244|467630858|FG001|Overall Study|Lost to Follow-up|1|||
130064694|NCT03814590|468190227|FG004|Overall Study|UNKNOWN REASON|0|||
129856300|NCT01227889|467433048|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
129856301|NCT01227889|467433047|FG000|Crossover Phase|Adverse Event|0|||
129856302|NCT01227889|467433048|FG001|Crossover Phase|Adverse Event|1|||
129856303|NCT01227889|467433047|FG000|Crossover Phase|Physician Decision|0|||
129856304|NCT01227889|467433048|FG001|Crossover Phase|Physician Decision|3|||
129856305|NCT01227889|467433047|FG000|Crossover Phase|Progressive Disease|0|||
129856306|NCT01227889|467433048|FG001|Crossover Phase|Progressive Disease|31|||
129856307|NCT01227889|467433047|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
129856308|NCT01227889|467433048|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
129856309|NCT01227889|467433047|FG000|Crossover Phase|Withdrawal by Subject|0|||
129856310|NCT01227889|467433048|FG001|Crossover Phase|Withdrawal by Subject|1|||
129856311|NCT03268811|467433049|FG000|Overall Study|Adverse Event|0|||
129856312|NCT03268811|467433050|FG001|Overall Study|Adverse Event|1|||
129856313|NCT04827212|467433055|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
129856314|NCT04827212|467433056|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
129856315|NCT04827212|467433055|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
129856316|NCT04827212|467433056|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
129856317|NCT03434119|467433063|FG000|Overall Study|Randomized but not treated|1|||
129856318|NCT03434119|467433064|FG001|Overall Study|Randomized but not treated|0|||
129856319|NCT03434119|467433063|FG000|Overall Study|Adverse Event|1|||
129856320|NCT03434119|467433064|FG001|Overall Study|Adverse Event|0|||
129856321|NCT03434119|467433063|FG000|Overall Study|Poor Compliance to Protocol|0|||
129856322|NCT03434119|467433064|FG001|Overall Study|Poor Compliance to Protocol|1|||
129856323|NCT03434119|467433063|FG000|Overall Study|Study Terminated by Sponsor|91|||
129856324|NCT03434119|467433064|FG001|Overall Study|Study Terminated by Sponsor|102|||
129856325|NCT03434119|467433063|FG000|Overall Study|Withdrawal by Subject|7|||
129856326|NCT03434119|467433064|FG001|Overall Study|Withdrawal by Subject|5|||
129856327|NCT03434119|467433063|FG000|Overall Study|Other than specified|7|||
129856328|NCT03434119|467433064|FG001|Overall Study|Other than specified|5|||
129856329|NCT03579459|467433066|FG000|Overall Study|Adverse Event|7|||
129856330|NCT03579459|467433067|FG001|Overall Study|Adverse Event|6|||
129856331|NCT03579459|467433068|FG002|Overall Study|Adverse Event|2|||
129856332|NCT03579459|467433069|FG003|Overall Study|Adverse Event|6|||
129856333|NCT03579459|467433066|FG000|Overall Study|Death|1|||
129856334|NCT03579459|467433067|FG001|Overall Study|Death|0|||
129856335|NCT03579459|467433068|FG002|Overall Study|Death|1|||
129856336|NCT03579459|467433069|FG003|Overall Study|Death|2|||
129856337|NCT03579459|467433066|FG000|Overall Study|Lost to Follow-up|6|||
129856338|NCT03579459|467433067|FG001|Overall Study|Lost to Follow-up|2|||
129856339|NCT03579459|467433068|FG002|Overall Study|Lost to Follow-up|4|||
129856340|NCT03579459|467433069|FG003|Overall Study|Lost to Follow-up|1|||
129856341|NCT03579459|467433066|FG000|Overall Study|Physician Decision|0|||
129856342|NCT03579459|467433067|FG001|Overall Study|Physician Decision|1|||
129856343|NCT03579459|467433068|FG002|Overall Study|Physician Decision|0|||
129856344|NCT03579459|467433069|FG003|Overall Study|Physician Decision|1|||
129856345|NCT03579459|467433066|FG000|Overall Study|Protocol Violation|1|||
129856346|NCT03579459|467433067|FG001|Overall Study|Protocol Violation|2|||
129856347|NCT03579459|467433068|FG002|Overall Study|Protocol Violation|3|||
129856348|NCT03579459|467433069|FG003|Overall Study|Protocol Violation|5|||
129856349|NCT03579459|467433066|FG000|Overall Study|Withdrawal by Subject|12|||
129856350|NCT03579459|467433067|FG001|Overall Study|Withdrawal by Subject|8|||
129856351|NCT03579459|467433068|FG002|Overall Study|Withdrawal by Subject|11|||
129856352|NCT03579459|467433069|FG003|Overall Study|Withdrawal by Subject|8|||
129856353|NCT03579459|467433066|FG000|Overall Study|Medication error without associated adverse event|2|||
129856354|NCT03579459|467433067|FG001|Overall Study|Medication error without associated adverse event|1|||
129856355|NCT03579459|467433068|FG002|Overall Study|Medication error without associated adverse event|1|||
129856356|NCT03579459|467433069|FG003|Overall Study|Medication error without associated adverse event|0|||
129908881|NCT02675244|467630857|FG000|Overall Study|Ongoing at 2 Years|190|||
129856357|NCT03579459|467433066|FG000|Overall Study|Other|0|||
129856358|NCT03579459|467433067|FG001|Overall Study|Other|1|||
129856359|NCT03579459|467433068|FG002|Overall Study|Other|1|||
129856360|NCT03579459|467433069|FG003|Overall Study|Other|0|||
129856361|NCT03579459|467433066|FG000|Overall Study|Randomized not vaccinated|0|||
129856362|NCT03579459|467433067|FG001|Overall Study|Randomized not vaccinated|2|||
129856363|NCT03579459|467433068|FG002|Overall Study|Randomized not vaccinated|0|||
129856364|NCT03579459|467433069|FG003|Overall Study|Randomized not vaccinated|1|||
129856365|NCT00148343|467433072|FG000|Overall Study|Withdrawal by Subject|12|||
129856366|NCT00148343|467433073|FG001|Overall Study|Withdrawal by Subject|7|||
129908882|NCT02675244|467630858|FG001|Overall Study|Ongoing at 2 Years|185|||
129908883|NCT02706717|467630859|FG000|Overall Study|Withdrawal by Subject|1|||
129908884|NCT02706717|467630860|FG001|Overall Study|Withdrawal by Subject|8|||
129908885|NCT02706717|467630859|FG000|Overall Study|Lost to Follow-up|0|||
129908886|NCT02706717|467630860|FG001|Overall Study|Lost to Follow-up|1|||
129908887|NCT02706717|467630859|FG000|Overall Study|Physician Decision|0|||
129908888|NCT02706717|467630860|FG001|Overall Study|Physician Decision|1|||
129908889|NCT02706717|467630859|FG000|Overall Study|Death|0|||
129908890|NCT02706717|467630860|FG001|Overall Study|Death|1|||
129908891|NCT00293293|467630863|FG000|Overall Study|Withdrawal by Subject|1|||
129908892|NCT00293293|467630864|FG001|Overall Study|Withdrawal by Subject|1|||
129908893|NCT00293293|467630863|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
129908894|NCT00293293|467630864|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
129908895|NCT00293293|467630863|FG000|Overall Study|Patient discontinued chemotherapy|0|||
129908896|NCT00293293|467630864|FG001|Overall Study|Patient discontinued chemotherapy|1|||
129908897|NCT02512965|467630867|FG000|Overall Study|Withdrawal by Subject|0|||
129908898|NCT02512965|467630868|FG001|Overall Study|Withdrawal by Subject|4|||
129908899|NCT00835770|467630869|FG000|Overall Study|MS Relapse|17|||
129908900|NCT00835770|467630870|FG001|Overall Study|MS Relapse|23|||
129908901|NCT00835770|467630869|FG000|Overall Study|MS Progression|14|||
129908902|NCT00835770|467630870|FG001|Overall Study|MS Progression|9|||
129908903|NCT00835770|467630869|FG000|Overall Study|Adverse Event|113|||
129908904|NCT00835770|467630870|FG001|Overall Study|Adverse Event|124|||
129908905|NCT00835770|467630869|FG000|Overall Study|Lost to Follow-up|22|||
129908906|NCT00835770|467630870|FG001|Overall Study|Lost to Follow-up|19|||
129908907|NCT00835770|467630869|FG000|Overall Study|Consent Withdrawn|144|||
129908908|NCT00835770|467630870|FG001|Overall Study|Consent Withdrawn|156|||
129908909|NCT00835770|467630869|FG000|Overall Study|Investigator Decision|42|||
129908910|NCT00835770|467630870|FG001|Overall Study|Investigator Decision|42|||
129908911|NCT00835770|467630869|FG000|Overall Study|Participant Non-Compliance|11|||
129908912|NCT00835770|467630870|FG001|Overall Study|Participant Non-Compliance|9|||
129908913|NCT00835770|467630869|FG000|Overall Study|Death|4|||
129908914|NCT00835770|467630870|FG001|Overall Study|Death|6|||
129908915|NCT00835770|467630869|FG000|Overall Study|Other|115|||
129908916|NCT00835770|467630870|FG001|Overall Study|Other|104|||
129908917|NCT00835770|467630869|FG000|Overall Study|Other|2|||
129908918|NCT00835770|467630870|FG001|Overall Study|Other|1|||
129908919|NCT01185782|467630871|FG000|Overall Study|Adverse Event|0|||
129908920|NCT01185782|467630872|FG001|Overall Study|Adverse Event|1|||
129908921|NCT01185782|467630871|FG000|Overall Study|Protocol Violation|1|||
129908922|NCT01185782|467630872|FG001|Overall Study|Protocol Violation|0|||
129908923|NCT01185782|467630871|FG000|Overall Study|Poor Response to Treatment|3|||
129908924|NCT01185782|467630872|FG001|Overall Study|Poor Response to Treatment|1|||
129908925|NCT01185782|467630871|FG000|Overall Study|Other|2|||
129908926|NCT01185782|467630872|FG001|Overall Study|Other|5|||
129908927|NCT01185782|467630871|FG000|Overall Study|Randomized but not treated|0|||
129908928|NCT01185782|467630872|FG001|Overall Study|Randomized but not treated|4|||
129908929|NCT02988817|467630877|FG000|Overall Study|Withdrawal by Subject|1|||
129908930|NCT02988817|467630878|FG001|Overall Study|Withdrawal by Subject|0|||
129908931|NCT02988817|467630879|FG002|Overall Study|Withdrawal by Subject|0|||
129908932|NCT02988817|467630880|FG003|Overall Study|Withdrawal by Subject|1|||
129908933|NCT02988817|467630881|FG004|Overall Study|Withdrawal by Subject|3|||
129908934|NCT02988817|467630882|FG005|Overall Study|Withdrawal by Subject|1|||
129908935|NCT02988817|467630883|FG006|Overall Study|Withdrawal by Subject|2|||
129908936|NCT02988817|467630884|FG007|Overall Study|Withdrawal by Subject|1|||
129908937|NCT02988817|467630885|FG008|Overall Study|Withdrawal by Subject|1|||
129908938|NCT02988817|467630886|FG009|Overall Study|Withdrawal by Subject|1|||
129908939|NCT02988817|467630887|FG010|Overall Study|Withdrawal by Subject|1|||
129908940|NCT02988817|467630888|FG011|Overall Study|Withdrawal by Subject|12|||
129908941|NCT02988817|467630889|FG012|Overall Study|Withdrawal by Subject|6|||
129908942|NCT02988817|467630890|FG013|Overall Study|Withdrawal by Subject|6|||
129908943|NCT02988817|467630891|FG014|Overall Study|Withdrawal by Subject|4|||
129908944|NCT02988817|467630892|FG015|Overall Study|Withdrawal by Subject|5|||
129908945|NCT02988817|467630893|FG016|Overall Study|Withdrawal by Subject|4|||
129908946|NCT02988817|467630894|FG017|Overall Study|Withdrawal by Subject|11|||
129908947|NCT02988817|467630895|FG018|Overall Study|Withdrawal by Subject|4|||
129908948|NCT02988817|467630896|FG019|Overall Study|Withdrawal by Subject|2|||
129908949|NCT02988817|467630877|FG000|Overall Study|Death|0|||
129908950|NCT02988817|467630878|FG001|Overall Study|Death|1|||
129908951|NCT02988817|467630879|FG002|Overall Study|Death|3|||
129908952|NCT02988817|467630880|FG003|Overall Study|Death|1|||
129908953|NCT02988817|467630881|FG004|Overall Study|Death|6|||
129908954|NCT02988817|467630882|FG005|Overall Study|Death|10|||
129908955|NCT02988817|467630883|FG006|Overall Study|Death|1|||
129908956|NCT02988817|467630884|FG007|Overall Study|Death|2|||
129908957|NCT02988817|467630885|FG008|Overall Study|Death|1|||
129908958|NCT02988817|467630886|FG009|Overall Study|Death|5|||
129908959|NCT02988817|467630887|FG010|Overall Study|Death|1|||
129908960|NCT02988817|467630888|FG011|Overall Study|Death|8|||
129908961|NCT02988817|467630889|FG012|Overall Study|Death|9|||
129908962|NCT02988817|467630890|FG013|Overall Study|Death|17|||
129908963|NCT02988817|467630891|FG014|Overall Study|Death|18|||
129908964|NCT02988817|467630892|FG015|Overall Study|Death|30|||
129908965|NCT02988817|467630893|FG016|Overall Study|Death|17|||
129908966|NCT02988817|467630894|FG017|Overall Study|Death|38|||
129908967|NCT02988817|467630895|FG018|Overall Study|Death|14|||
129908968|NCT02988817|467630896|FG019|Overall Study|Death|16|||
129908969|NCT02988817|467630877|FG000|Overall Study|Other|0|||
129908970|NCT02988817|467630878|FG001|Overall Study|Other|0|||
129908971|NCT02988817|467630879|FG002|Overall Study|Other|0|||
129908972|NCT02988817|467630880|FG003|Overall Study|Other|1|||
129908973|NCT02988817|467630881|FG004|Overall Study|Other|1|||
129908974|NCT02988817|467630882|FG005|Overall Study|Other|0|||
129908975|NCT02988817|467630883|FG006|Overall Study|Other|0|||
129908976|NCT02988817|467630884|FG007|Overall Study|Other|0|||
129908977|NCT02988817|467630885|FG008|Overall Study|Other|0|||
129908978|NCT02988817|467630886|FG009|Overall Study|Other|0|||
129908979|NCT02988817|467630887|FG010|Overall Study|Other|0|||
129908980|NCT02988817|467630888|FG011|Overall Study|Other|0|||
129908981|NCT02988817|467630889|FG012|Overall Study|Other|0|||
129908982|NCT02988817|467630890|FG013|Overall Study|Other|0|||
129908983|NCT02988817|467630891|FG014|Overall Study|Other|0|||
129908984|NCT02988817|467630892|FG015|Overall Study|Other|1|||
129908985|NCT02988817|467630893|FG016|Overall Study|Other|0|||
129908986|NCT02988817|467630894|FG017|Overall Study|Other|0|||
129908987|NCT02988817|467630895|FG018|Overall Study|Other|0|||
129908988|NCT02988817|467630896|FG019|Overall Study|Other|0|||
129908989|NCT02988817|467630877|FG000|Overall Study|Lost to Follow-up|0|||
129908990|NCT02988817|467630878|FG001|Overall Study|Lost to Follow-up|0|||
129908991|NCT02988817|467630879|FG002|Overall Study|Lost to Follow-up|0|||
129908992|NCT02988817|467630880|FG003|Overall Study|Lost to Follow-up|0|||
129908993|NCT02988817|467630881|FG004|Overall Study|Lost to Follow-up|0|||
129908994|NCT02988817|467630882|FG005|Overall Study|Lost to Follow-up|0|||
129908995|NCT02988817|467630883|FG006|Overall Study|Lost to Follow-up|0|||
129908996|NCT02988817|467630884|FG007|Overall Study|Lost to Follow-up|0|||
129908997|NCT02988817|467630885|FG008|Overall Study|Lost to Follow-up|1|||
129908998|NCT02988817|467630886|FG009|Overall Study|Lost to Follow-up|0|||
129908999|NCT02988817|467630887|FG010|Overall Study|Lost to Follow-up|1|||
129909000|NCT02988817|467630888|FG011|Overall Study|Lost to Follow-up|1|||
129909001|NCT02988817|467630889|FG012|Overall Study|Lost to Follow-up|0|||
129909002|NCT02988817|467630890|FG013|Overall Study|Lost to Follow-up|0|||
129909003|NCT02988817|467630891|FG014|Overall Study|Lost to Follow-up|1|||
129909004|NCT02988817|467630892|FG015|Overall Study|Lost to Follow-up|1|||
129909005|NCT02988817|467630893|FG016|Overall Study|Lost to Follow-up|2|||
129909006|NCT02988817|467630894|FG017|Overall Study|Lost to Follow-up|3|||
129909007|NCT02988817|467630895|FG018|Overall Study|Lost to Follow-up|0|||
129909008|NCT02988817|467630896|FG019|Overall Study|Lost to Follow-up|0|||
129909009|NCT02988817|467630877|FG000|Overall Study|Sponsor decision|0|||
129909010|NCT02988817|467630878|FG001|Overall Study|Sponsor decision|0|||
129909011|NCT02988817|467630879|FG002|Overall Study|Sponsor decision|0|||
129909012|NCT02988817|467630880|FG003|Overall Study|Sponsor decision|0|||
129909013|NCT02988817|467630881|FG004|Overall Study|Sponsor decision|0|||
129909014|NCT02988817|467630882|FG005|Overall Study|Sponsor decision|0|||
129909015|NCT02988817|467630883|FG006|Overall Study|Sponsor decision|0|||
129909016|NCT02988817|467630884|FG007|Overall Study|Sponsor decision|0|||
129909017|NCT02988817|467630885|FG008|Overall Study|Sponsor decision|0|||
129909018|NCT02988817|467630886|FG009|Overall Study|Sponsor decision|0|||
129909019|NCT02988817|467630887|FG010|Overall Study|Sponsor decision|0|||
129909020|NCT02988817|467630888|FG011|Overall Study|Sponsor decision|1|||
129909021|NCT02988817|467630889|FG012|Overall Study|Sponsor decision|1|||
129909022|NCT02988817|467630890|FG013|Overall Study|Sponsor decision|2|||
129909023|NCT02988817|467630891|FG014|Overall Study|Sponsor decision|2|||
129909024|NCT02988817|467630892|FG015|Overall Study|Sponsor decision|6|||
129909025|NCT02988817|467630893|FG016|Overall Study|Sponsor decision|2|||
129909026|NCT02988817|467630894|FG017|Overall Study|Sponsor decision|3|||
129909027|NCT02988817|467630895|FG018|Overall Study|Sponsor decision|2|||
129909028|NCT02988817|467630896|FG019|Overall Study|Sponsor decision|7|||
129909029|NCT02988817|467630877|FG000|Overall Study|Physician Decision|0|||
129909030|NCT02988817|467630878|FG001|Overall Study|Physician Decision|0|||
129909031|NCT02988817|467630879|FG002|Overall Study|Physician Decision|0|||
129909032|NCT02988817|467630880|FG003|Overall Study|Physician Decision|0|||
129909033|NCT02988817|467630881|FG004|Overall Study|Physician Decision|0|||
129909034|NCT02988817|467630882|FG005|Overall Study|Physician Decision|0|||
129909035|NCT02988817|467630883|FG006|Overall Study|Physician Decision|0|||
129909036|NCT02988817|467630884|FG007|Overall Study|Physician Decision|0|||
129909037|NCT02988817|467630885|FG008|Overall Study|Physician Decision|0|||
129909038|NCT02988817|467630886|FG009|Overall Study|Physician Decision|0|||
129909039|NCT02988817|467630887|FG010|Overall Study|Physician Decision|0|||
129909040|NCT02988817|467630888|FG011|Overall Study|Physician Decision|0|||
129909041|NCT02988817|467630889|FG012|Overall Study|Physician Decision|0|||
129909042|NCT02988817|467630890|FG013|Overall Study|Physician Decision|0|||
129909043|NCT02988817|467630891|FG014|Overall Study|Physician Decision|0|||
129909044|NCT02988817|467630892|FG015|Overall Study|Physician Decision|1|||
129856367|NCT00148343|467433072|FG000|Overall Study|Physician Decision|3|||
129856368|NCT00148343|467433073|FG001|Overall Study|Physician Decision|4|||
129856369|NCT02528214|467433082|FG000|Overall Study|Protocol Violation|0|||
129856370|NCT02528214|467433083|FG001|Overall Study|Protocol Violation|1|||
129856371|NCT02528214|467433082|FG000|Overall Study|Adverse Event|0|||
129856372|NCT02528214|467433083|FG001|Overall Study|Adverse Event|1|||
129856373|NCT02528214|467433082|FG000|Overall Study|Other than specified above|0|||
129856374|NCT02528214|467433083|FG001|Overall Study|Other than specified above|1|||
129856375|NCT00941603|467433087|FG000|Overall Study|Adverse Event|10|||
129856376|NCT00941603|467433088|FG001|Overall Study|Adverse Event|15|||
129856377|NCT00941603|467433089|FG002|Overall Study|Adverse Event|5|||
129856378|NCT00941603|467433090|FG003|Overall Study|Adverse Event|1|||
129856379|NCT00941603|467433091|FG004|Overall Study|Adverse Event|4|||
129856380|NCT00941603|467433092|FG005|Overall Study|Adverse Event|0|||
129856381|NCT00941603|467433087|FG000|Overall Study|Lost to Follow-up|0|||
129856382|NCT00941603|467433088|FG001|Overall Study|Lost to Follow-up|0|||
129856383|NCT00941603|467433089|FG002|Overall Study|Lost to Follow-up|0|||
129856384|NCT00941603|467433090|FG003|Overall Study|Lost to Follow-up|1|||
129856385|NCT00941603|467433091|FG004|Overall Study|Lost to Follow-up|0|||
129856386|NCT00941603|467433092|FG005|Overall Study|Lost to Follow-up|2|||
129856387|NCT00941603|467433087|FG000|Overall Study|Withdrawal by Subject|0|||
129856388|NCT00941603|467433088|FG001|Overall Study|Withdrawal by Subject|0|||
129856389|NCT00941603|467433089|FG002|Overall Study|Withdrawal by Subject|0|||
129856390|NCT00941603|467433090|FG003|Overall Study|Withdrawal by Subject|2|||
129856391|NCT00941603|467433091|FG004|Overall Study|Withdrawal by Subject|0|||
129856392|NCT00941603|467433092|FG005|Overall Study|Withdrawal by Subject|1|||
129856393|NCT00941603|467433087|FG000|Overall Study|Protocol Violation|0|||
129856394|NCT00941603|467433088|FG001|Overall Study|Protocol Violation|1|||
129856395|NCT00941603|467433089|FG002|Overall Study|Protocol Violation|0|||
129856396|NCT00941603|467433090|FG003|Overall Study|Protocol Violation|0|||
129856397|NCT00941603|467433091|FG004|Overall Study|Protocol Violation|0|||
129856398|NCT00941603|467433092|FG005|Overall Study|Protocol Violation|0|||
129856399|NCT00941603|467433087|FG000|Overall Study|Did not meet protocol eligibility|1|||
129856400|NCT00941603|467433088|FG001|Overall Study|Did not meet protocol eligibility|0|||
129856401|NCT00941603|467433089|FG002|Overall Study|Did not meet protocol eligibility|0|||
129856402|NCT00941603|467433090|FG003|Overall Study|Did not meet protocol eligibility|0|||
129856403|NCT00941603|467433091|FG004|Overall Study|Did not meet protocol eligibility|0|||
129856404|NCT00941603|467433092|FG005|Overall Study|Did not meet protocol eligibility|0|||
129856405|NCT00407537|467433093|FG000|Overall Study|Death|5|||
129856406|NCT00407537|467433094|FG001|Overall Study|Death|2|||
129856407|NCT00407537|467433093|FG000|Overall Study|Adverse Event|36|||
129856408|NCT00407537|467433094|FG001|Overall Study|Adverse Event|0|||
129856409|NCT00407537|467433093|FG000|Overall Study|Lost to Follow-up|12|||
129856410|NCT00407537|467433094|FG001|Overall Study|Lost to Follow-up|19|||
129856411|NCT00407537|467433093|FG000|Overall Study|Other|6|||
129856412|NCT00407537|467433094|FG001|Overall Study|Other|7|||
129856413|NCT00407537|467433093|FG000|Overall Study|Withdrawal by Subject|34|||
129856414|NCT00407537|467433094|FG001|Overall Study|Withdrawal by Subject|16|||
129856415|NCT02014116|467433096|FG000|Overall Study|Progressive Disease|3|||
129856416|NCT02014116|467433097|FG001|Overall Study|Progressive Disease|4|||
129856417|NCT02014116|467433098|FG002|Overall Study|Progressive Disease|2|||
129856418|NCT02014116|467433099|FG003|Overall Study|Progressive Disease|6|||
129856419|NCT02014116|467433100|FG004|Overall Study|Progressive Disease|1|||
129856420|NCT02014116|467433101|FG005|Overall Study|Progressive Disease|13|||
129856421|NCT02014116|467433102|FG006|Overall Study|Progressive Disease|1|||
129856422|NCT02014116|467433103|FG007|Overall Study|Progressive Disease|3|||
129856423|NCT02014116|467433104|FG008|Overall Study|Progressive Disease|7|||
129856424|NCT02014116|467433096|FG000|Overall Study|Adverse Event|0|||
129856425|NCT02014116|467433097|FG001|Overall Study|Adverse Event|0|||
129856426|NCT02014116|467433098|FG002|Overall Study|Adverse Event|0|||
129856427|NCT02014116|467433099|FG003|Overall Study|Adverse Event|0|||
129856428|NCT02014116|467433100|FG004|Overall Study|Adverse Event|1|||
129856429|NCT02014116|467433101|FG005|Overall Study|Adverse Event|0|||
129856430|NCT02014116|467433102|FG006|Overall Study|Adverse Event|0|||
129856431|NCT02014116|467433103|FG007|Overall Study|Adverse Event|1|||
129856432|NCT02014116|467433104|FG008|Overall Study|Adverse Event|0|||
129856433|NCT02014116|467433096|FG000|Overall Study|Lost to Follow-up|0|||
129856434|NCT02014116|467433097|FG001|Overall Study|Lost to Follow-up|0|||
129856435|NCT02014116|467433098|FG002|Overall Study|Lost to Follow-up|0|||
129856436|NCT02014116|467433099|FG003|Overall Study|Lost to Follow-up|0|||
129856437|NCT02014116|467433100|FG004|Overall Study|Lost to Follow-up|0|||
129856438|NCT02014116|467433101|FG005|Overall Study|Lost to Follow-up|1|||
129856439|NCT02014116|467433102|FG006|Overall Study|Lost to Follow-up|0|||
129856440|NCT02014116|467433103|FG007|Overall Study|Lost to Follow-up|0|||
129856441|NCT02014116|467433104|FG008|Overall Study|Lost to Follow-up|1|||
129856442|NCT02014116|467433096|FG000|Overall Study|Death|0|||
129856443|NCT02014116|467433097|FG001|Overall Study|Death|0|||
129856444|NCT02014116|467433098|FG002|Overall Study|Death|0|||
129856445|NCT02014116|467433099|FG003|Overall Study|Death|0|||
129856446|NCT02014116|467433100|FG004|Overall Study|Death|0|||
129856447|NCT02014116|467433101|FG005|Overall Study|Death|0|||
129856448|NCT02014116|467433102|FG006|Overall Study|Death|0|||
129856449|NCT02014116|467433103|FG007|Overall Study|Death|1|||
129856450|NCT02014116|467433104|FG008|Overall Study|Death|1|||
129856451|NCT02014116|467433096|FG000|Overall Study|Withdrawal by Subject|0|||
129856452|NCT02014116|467433097|FG001|Overall Study|Withdrawal by Subject|0|||
129856453|NCT02014116|467433098|FG002|Overall Study|Withdrawal by Subject|1|||
129856454|NCT02014116|467433099|FG003|Overall Study|Withdrawal by Subject|1|||
129856455|NCT02014116|467433100|FG004|Overall Study|Withdrawal by Subject|0|||
129856456|NCT02014116|467433101|FG005|Overall Study|Withdrawal by Subject|1|||
129856457|NCT02014116|467433102|FG006|Overall Study|Withdrawal by Subject|0|||
129856458|NCT02014116|467433103|FG007|Overall Study|Withdrawal by Subject|0|||
129856459|NCT02014116|467433104|FG008|Overall Study|Withdrawal by Subject|0|||
129856460|NCT02014116|467433096|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
129856461|NCT02014116|467433097|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
129856462|NCT02014116|467433098|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
129856463|NCT02014116|467433099|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
129856464|NCT02014116|467433100|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
129856465|NCT02014116|467433101|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
129856466|NCT02014116|467433102|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
129856467|NCT02014116|467433103|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
129856468|NCT02014116|467433104|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
129856469|NCT02014116|467433096|FG000|Overall Study|Physician Decision|0|||
129856470|NCT02014116|467433097|FG001|Overall Study|Physician Decision|0|||
129856471|NCT02014116|467433098|FG002|Overall Study|Physician Decision|0|||
129856472|NCT02014116|467433099|FG003|Overall Study|Physician Decision|0|||
129856473|NCT02014116|467433100|FG004|Overall Study|Physician Decision|0|||
129856474|NCT02014116|467433101|FG005|Overall Study|Physician Decision|0|||
129856475|NCT02014116|467433102|FG006|Overall Study|Physician Decision|0|||
129856476|NCT02014116|467433103|FG007|Overall Study|Physician Decision|0|||
129856477|NCT02014116|467433104|FG008|Overall Study|Physician Decision|1|||
129856478|NCT00583557|467433105|FG000|Overall Study|Withdrawal by Subject|18|||
129856479|NCT00583557|467433105|FG000|Overall Study|Adverse Event|9|||
129856480|NCT00583557|467433105|FG000|Overall Study|Lack of Efficacy|31|||
129856481|NCT00583557|467433105|FG000|Overall Study|Lack of Compliance|5|||
129856482|NCT00583557|467433105|FG000|Overall Study|Other|5|||
129856483|NCT00583557|467433105|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
129856484|NCT02347761|467433106|FG000|All Collected|Death|1|||
129856485|NCT02347761|467433107|FG001|All Collected|Death|0|||
129856486|NCT02347761|467433108|FG002|All Collected|Death|0|||
129856487|NCT02347761|467433106|FG000|All Collected|Lost to Follow-up|3|||
129856488|NCT02347761|467433107|FG001|All Collected|Lost to Follow-up|2|||
129856489|NCT02347761|467433108|FG002|All Collected|Lost to Follow-up|3|||
129856490|NCT02347761|467433106|FG000|All Collected|Withdrawal by Subject|11|||
129856491|NCT02347761|467433107|FG001|All Collected|Withdrawal by Subject|11|||
129856492|NCT02347761|467433108|FG002|All Collected|Withdrawal by Subject|22|||
129856493|NCT02347761|467433106|FG000|All Collected|invetigator disretion|2|||
129856494|NCT02347761|467433107|FG001|All Collected|invetigator disretion|0|||
129856495|NCT02347761|467433108|FG002|All Collected|invetigator disretion|0|||
129856496|NCT02347761|467433106|FG000|All Collected|instillation site pain|0|||
129856497|NCT02347761|467433107|FG001|All Collected|instillation site pain|0|||
129856498|NCT02347761|467433108|FG002|All Collected|instillation site pain|1|||
129856499|NCT02347761|467433106|FG000|All Collected|exacerbation of COPD|0|||
129856500|NCT02347761|467433107|FG001|All Collected|exacerbation of COPD|0|||
129856501|NCT02347761|467433108|FG002|All Collected|exacerbation of COPD|1|||
129856502|NCT02347761|467433106|FG000|All Collected|moved/travel|0|||
129856503|NCT02347761|467433107|FG001|All Collected|moved/travel|1|||
129856504|NCT02347761|467433108|FG002|All Collected|moved/travel|0|||
129856505|NCT02347761|467433106|FG000|On Study Treatment|Lack of Efficacy|2|||
129856506|NCT02347761|467433107|FG001|On Study Treatment|Lack of Efficacy|3|||
129856507|NCT02347761|467433108|FG002|On Study Treatment|Lack of Efficacy|4|||
129856508|NCT02347761|467433106|FG000|On Study Treatment|non-compliance with study medication|0|||
129856509|NCT02347761|467433107|FG001|On Study Treatment|non-compliance with study medication|0|||
129856510|NCT02347761|467433108|FG002|On Study Treatment|non-compliance with study medication|2|||
129856511|NCT02347761|467433106|FG000|On Study Treatment|Withdrawal by Subject|7|||
129856512|NCT02347761|467433107|FG001|On Study Treatment|Withdrawal by Subject|3|||
129856513|NCT02347761|467433108|FG002|On Study Treatment|Withdrawal by Subject|5|||
129856514|NCT02347761|467433106|FG000|On Study Treatment|move/travel|2|||
129856515|NCT02347761|467433107|FG001|On Study Treatment|move/travel|6|||
129856516|NCT02347761|467433108|FG002|On Study Treatment|move/travel|5|||
129856517|NCT02347761|467433106|FG000|On Study Treatment|dissastisfaction with device|2|||
129856518|NCT02347761|467433107|FG001|On Study Treatment|dissastisfaction with device|1|||
129856519|NCT02347761|467433108|FG002|On Study Treatment|dissastisfaction with device|4|||
129856520|NCT02347761|467433106|FG000|On Study Treatment|Lost to Follow-up|2|||
129909045|NCT02988817|467630893|FG016|Overall Study|Physician Decision|0|||
129909046|NCT02988817|467630894|FG017|Overall Study|Physician Decision|0|||
129909047|NCT02988817|467630895|FG018|Overall Study|Physician Decision|1|||
129909048|NCT02988817|467630896|FG019|Overall Study|Physician Decision|1|||
129909049|NCT00529516|467630897|FG000|Overall Study|Adverse Event|2|||
129909050|NCT00529516|467630898|FG001|Overall Study|Adverse Event|1|||
129909051|NCT00529516|467630899|FG002|Overall Study|Adverse Event|0|||
129909052|NCT00529516|467630897|FG000|Overall Study|Withdrawal by Subject|1|||
129909053|NCT00529516|467630898|FG001|Overall Study|Withdrawal by Subject|1|||
129909054|NCT00529516|467630899|FG002|Overall Study|Withdrawal by Subject|0|||
129909055|NCT00529516|467630897|FG000|Overall Study|Lost to Follow-up|0|||
129909056|NCT00529516|467630898|FG001|Overall Study|Lost to Follow-up|0|||
129909057|NCT00529516|467630899|FG002|Overall Study|Lost to Follow-up|1|||
129909058|NCT03752151|467630900|FG000|Overall Study|Withdrawal by Subject|1|||
129909059|NCT03752151|467630900|FG000|Overall Study|Protocol Violation|1|||
129909060|NCT01839331|467630901|FG000|Overall Study|Early Termination|3|||
129909061|NCT01839331|467630902|FG001|Overall Study|Early Termination|0|||
129909062|NCT01839331|467630903|FG002|Overall Study|Early Termination|1|||
129909063|NCT01839331|467630904|FG003|Overall Study|Early Termination|2|||
129909064|NCT01839331|467630901|FG000|Overall Study|Protocol Violation|1|||
129909065|NCT01839331|467630902|FG001|Overall Study|Protocol Violation|6|||
129909066|NCT01839331|467630903|FG002|Overall Study|Protocol Violation|4|||
129909067|NCT01839331|467630904|FG003|Overall Study|Protocol Violation|3|||
129909068|NCT04056624|467630905|FG000|Overall Study|Withdrawal by Subject|0|||
129909069|NCT04056624|467630906|FG001|Overall Study|Withdrawal by Subject|0|||
129909070|NCT04056624|467630907|FG002|Overall Study|Withdrawal by Subject|1|||
129909071|NCT04056624|467630905|FG000|Overall Study|Protocol Violation|1|||
129909072|NCT04056624|467630906|FG001|Overall Study|Protocol Violation|2|||
129909073|NCT04056624|467630907|FG002|Overall Study|Protocol Violation|0|||
129909074|NCT03051165|467630912|FG000|Overall Study|Withdrawal by Subject|1|||
129909075|NCT03051165|467630912|FG000|Overall Study|Early termination of study|12|||
129909076|NCT02092116|467630914|FG000|Overall Study|Withdrawal by Subject|0|||
129909077|NCT02092116|467630915|FG001|Overall Study|Withdrawal by Subject|3|||
129909078|NCT02092116|467630914|FG000|Overall Study|Adverse Event|0|||
129909079|NCT02092116|467630915|FG001|Overall Study|Adverse Event|1|||
129909080|NCT03074331|467630916|FG000|Overall Study|Enrolled but Not Treated|1|||
129909081|NCT03074331|467630916|FG000|Overall Study|Lost to Follow-up|5|||
129909082|NCT03074331|467630916|FG000|Overall Study|Withdrew Consent|1|||
129909083|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
129909084|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
129909085|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909086|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909087|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909088|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
129909089|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909090|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
129909091|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909092|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909093|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909094|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909095|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
129909096|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
129909097|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909098|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909099|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909100|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909101|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909102|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909103|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909104|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909105|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
129909106|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
129909107|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909108|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
129909109|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909110|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909111|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909112|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909113|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909114|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909115|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909116|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909117|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909118|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
129909119|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
130064695|NCT03814590|468190228|FG005|Overall Study|UNKNOWN REASON|0|||
130064696|NCT03814590|468190229|FG006|Overall Study|UNKNOWN REASON|0|||
129856521|NCT02347761|467433107|FG001|On Study Treatment|Lost to Follow-up|1|||
129856522|NCT02347761|467433108|FG002|On Study Treatment|Lost to Follow-up|1|||
129856523|NCT02347761|467433106|FG000|On Study Treatment|investigator discretion|2|||
129856524|NCT02347761|467433107|FG001|On Study Treatment|investigator discretion|0|||
129856525|NCT02347761|467433108|FG002|On Study Treatment|investigator discretion|0|||
129856526|NCT02347761|467433106|FG000|On Study Treatment|durg not working|0|||
129856527|NCT02347761|467433107|FG001|On Study Treatment|durg not working|1|||
129856528|NCT02347761|467433108|FG002|On Study Treatment|durg not working|1|||
129856529|NCT02347761|467433106|FG000|On Study Treatment|Adverse Event|10|||
129856530|NCT02347761|467433107|FG001|On Study Treatment|Adverse Event|8|||
129856531|NCT02347761|467433108|FG002|On Study Treatment|Adverse Event|20|||
129856532|NCT03879798|467433109|FG000|Overall Study|Adverse Event|0|||
129856533|NCT03879798|467433110|FG001|Overall Study|Adverse Event|0|||
129856534|NCT03879798|467433111|FG002|Overall Study|Adverse Event|0|||
129856535|NCT03879798|467433112|FG003|Overall Study|Adverse Event|0|||
129856536|NCT03879798|467433113|FG004|Overall Study|Adverse Event|0|||
129856537|NCT03879798|467433114|FG005|Overall Study|Adverse Event|1|||
129856538|NCT03879798|467433109|FG000|Overall Study|Lack of Efficacy|0|||
129856539|NCT03879798|467433110|FG001|Overall Study|Lack of Efficacy|0|||
129856540|NCT03879798|467433111|FG002|Overall Study|Lack of Efficacy|0|||
129856541|NCT03879798|467433112|FG003|Overall Study|Lack of Efficacy|0|||
129856542|NCT03879798|467433113|FG004|Overall Study|Lack of Efficacy|0|||
129856543|NCT03879798|467433114|FG005|Overall Study|Lack of Efficacy|1|||
129856544|NCT03879798|467433109|FG000|Overall Study|Withdrawal by Subject|0|||
129856545|NCT03879798|467433110|FG001|Overall Study|Withdrawal by Subject|0|||
129856546|NCT03879798|467433111|FG002|Overall Study|Withdrawal by Subject|0|||
129856547|NCT03879798|467433112|FG003|Overall Study|Withdrawal by Subject|0|||
129856548|NCT03879798|467433113|FG004|Overall Study|Withdrawal by Subject|0|||
129856549|NCT03879798|467433114|FG005|Overall Study|Withdrawal by Subject|1|||
129856550|NCT03625570|467433115|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
129856551|NCT03625570|467433116|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
129856552|NCT03625570|467433115|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
129856553|NCT03625570|467433116|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
129856554|NCT03625570|467433115|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
129856555|NCT03625570|467433116|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
129856556|NCT01040130|467433122|FG000|Overall Study|Adverse Event|1|||
129856557|NCT01040130|467433123|FG001|Overall Study|Adverse Event|1|||
129856558|NCT01040130|467433124|FG002|Overall Study|Adverse Event|0|||
129856559|NCT01040130|467433125|FG003|Overall Study|Adverse Event|5|||
129856560|NCT01040130|467433126|FG004|Overall Study|Adverse Event|0|||
129856561|NCT01040130|467433127|FG005|Overall Study|Adverse Event|3|||
129856562|NCT01040130|467433122|FG000|Overall Study|Protocol Violation|0|||
129856563|NCT01040130|467433123|FG001|Overall Study|Protocol Violation|0|||
129856564|NCT01040130|467433124|FG002|Overall Study|Protocol Violation|2|||
129856565|NCT01040130|467433125|FG003|Overall Study|Protocol Violation|0|||
129856566|NCT01040130|467433126|FG004|Overall Study|Protocol Violation|0|||
129856567|NCT01040130|467433127|FG005|Overall Study|Protocol Violation|0|||
129856568|NCT01040130|467433122|FG000|Overall Study|Withdrawal by Subject|0|||
129856569|NCT01040130|467433123|FG001|Overall Study|Withdrawal by Subject|2|||
129856570|NCT01040130|467433124|FG002|Overall Study|Withdrawal by Subject|0|||
129856571|NCT01040130|467433125|FG003|Overall Study|Withdrawal by Subject|0|||
129856572|NCT01040130|467433126|FG004|Overall Study|Withdrawal by Subject|0|||
129856573|NCT01040130|467433127|FG005|Overall Study|Withdrawal by Subject|1|||
129856574|NCT01040130|467433122|FG000|Overall Study|Other reasons not listed above|2|||
129856575|NCT01040130|467433123|FG001|Overall Study|Other reasons not listed above|0|||
129856576|NCT01040130|467433124|FG002|Overall Study|Other reasons not listed above|0|||
129856577|NCT01040130|467433125|FG003|Overall Study|Other reasons not listed above|0|||
129856578|NCT01040130|467433126|FG004|Overall Study|Other reasons not listed above|0|||
129856579|NCT01040130|467433127|FG005|Overall Study|Other reasons not listed above|0|||
129856580|NCT01310036|467433130|FG000|Overall Study|Administrative/other|10|||
129856581|NCT01310036|467433130|FG000|Overall Study|Withdrew Consent|11|||
129856582|NCT01310036|467433130|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
129856583|NCT01310036|467433130|FG000|Overall Study|Progression of Disease|164|||
129856584|NCT01310036|467433130|FG000|Overall Study|Death|1|||
129856585|NCT01310036|467433130|FG000|Overall Study|Adverse event or intercurrent illness|12|||
129856586|NCT00553267|467433131|FG000|Overall Study|Adverse Event|8|||
130064697|NCT03814590|468190230|FG007|Overall Study|UNKNOWN REASON|1|||
129856587|NCT00553267|467433132|FG001|Overall Study|Adverse Event|10|||
129856588|NCT00553267|467433133|FG002|Overall Study|Adverse Event|5|||
129856589|NCT00553267|467433131|FG000|Overall Study|Non compliant with protocol|3|||
129856590|NCT00553267|467433132|FG001|Overall Study|Non compliant with protocol|3|||
129856591|NCT00553267|467433133|FG002|Overall Study|Non compliant with protocol|2|||
129856592|NCT00553267|467433131|FG000|Overall Study|Lost to Follow-up|0|||
130064698|NCT03814590|468190231|FG008|Overall Study|UNKNOWN REASON|0|||
129909120|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909121|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909122|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909123|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909124|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909125|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909126|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
129909127|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909128|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909129|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909130|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909131|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909132|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
129909133|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909134|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909135|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
129909136|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909137|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
129909138|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
129909139|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
129909140|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909141|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909142|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909143|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909144|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
129909145|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909146|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909147|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Other|2|||
129909148|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Other|1|||
129909149|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Other|0|||
129909150|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Other|0|||
129909151|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Other|1|||
129909152|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Other|1|||
129909153|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Other|0|||
129909154|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Other|0|||
129909155|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
129909156|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
129909157|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
129909158|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
129909159|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
129909160|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
129909161|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
129856593|NCT00553267|467433132|FG001|Overall Study|Lost to Follow-up|0|||
129856594|NCT00553267|467433133|FG002|Overall Study|Lost to Follow-up|1|||
129856595|NCT00553267|467433131|FG000|Overall Study|Consent withdrawn|2|||
129856596|NCT00553267|467433132|FG001|Overall Study|Consent withdrawn|3|||
129856597|NCT00553267|467433133|FG002|Overall Study|Consent withdrawn|1|||
129856598|NCT00553267|467433131|FG000|Overall Study|Specified category|1|||
129856599|NCT00553267|467433132|FG001|Overall Study|Specified category|2|||
129856600|NCT00553267|467433133|FG002|Overall Study|Specified category|1|||
129856601|NCT01175668|467433134|FG000|Overall Study|Withdrawal by Subject|2|||
129856602|NCT01175668|467433135|FG001|Overall Study|Withdrawal by Subject|0|||
129856603|NCT02328326|467433139|FG000|Overall Study|Withdrawal by Subject|10|||
129856604|NCT02328326|467433140|FG001|Overall Study|Withdrawal by Subject|3|||
129856605|NCT02328326|467433139|FG000|Overall Study|Death|2|||
129856606|NCT02328326|467433140|FG001|Overall Study|Death|1|||
129856607|NCT02328326|467433139|FG000|Overall Study|Lost to Follow-up|10|||
129856608|NCT02328326|467433140|FG001|Overall Study|Lost to Follow-up|4|||
129856609|NCT02937545|467433149|FG000|Overall Study|Withdrawal by Subject|1|||
129856610|NCT02937545|467433150|FG001|Overall Study|Withdrawal by Subject|2|||
129856611|NCT02937545|467433151|FG002|Overall Study|Withdrawal by Subject|6|||
129856612|NCT02937545|467433152|FG003|Overall Study|Withdrawal by Subject|7|||
129856613|NCT02937545|467433149|FG000|Overall Study|Lost to Follow-up|1|||
129856614|NCT02937545|467433150|FG001|Overall Study|Lost to Follow-up|0|||
129856615|NCT02937545|467433151|FG002|Overall Study|Lost to Follow-up|0|||
129856616|NCT02937545|467433152|FG003|Overall Study|Lost to Follow-up|0|||
129856617|NCT01985126|467433157|FG000|Overall Study|Death|15|||
129856618|NCT01985126|467433158|FG001|Overall Study|Death|69|||
129856619|NCT01985126|467433157|FG000|Overall Study|Lost to Follow-up|0|||
129856620|NCT01985126|467433158|FG001|Overall Study|Lost to Follow-up|8|||
129856621|NCT01985126|467433157|FG000|Overall Study|Study Terminated By Sponsor|1|||
129909162|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
129909163|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909164|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909165|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129856622|NCT01985126|467433158|FG001|Overall Study|Study Terminated By Sponsor|22|||
129856623|NCT01985126|467433157|FG000|Overall Study|Withdrawal by Subject|2|||
129856624|NCT01985126|467433158|FG001|Overall Study|Withdrawal by Subject|7|||
129856625|NCT00784043|467433166|FG000|Overall Study|Withdrawal by Subject|8|||
129856626|NCT00784043|467433167|FG001|Overall Study|Withdrawal by Subject|5|||
129856627|NCT00784043|467433166|FG000|Overall Study|Protocol Terminated|23|||
129856628|NCT00784043|467433167|FG001|Overall Study|Protocol Terminated|1|||
129856629|NCT01618838|467433168|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
129856630|NCT03965052|467433171|FG000|Overall Study|Protocol Violation|1|||
129856631|NCT03965052|467433172|FG001|Overall Study|Protocol Violation|0|||
129856632|NCT00142909|467433176|FG000|Randomization|Various Reasons|7|||
129856633|NCT00142909|467433177|FG001|Randomization|Various Reasons|10|||
129856634|NCT00142909|467433176|FG000|Medications Begin|Protocol Violation|2|||
129856635|NCT00142909|467433177|FG001|Medications Begin|Protocol Violation|0|||
129856636|NCT00142909|467433176|FG000|Medications Begin|Withdrawal by Subject|5|||
129856637|NCT00142909|467433177|FG001|Medications Begin|Withdrawal by Subject|3|||
129856638|NCT00142909|467433176|FG000|Medications Begin|Withdrawal by Subject|2|||
129856639|NCT00142909|467433177|FG001|Medications Begin|Withdrawal by Subject|0|||
129856640|NCT00345397|467433178|FG000|Overall Study|Death|1|||
129856641|NCT01870843|467433179|FG000|Overall Study|Adverse Event|10|||
129856642|NCT01870843|467433179|FG000|Overall Study|Lost to Follow-up|24|||
129856643|NCT01870843|467433179|FG000|Overall Study|Death|1|||
129856644|NCT01870843|467433179|FG000|Overall Study|Withdrawal by Subject|18|||
129856645|NCT01910519|467433180|FG000|Overall Study|Withdrawal by Subject|2|||
129856646|NCT01910519|467433181|FG001|Overall Study|Withdrawal by Subject|0|||
129856647|NCT01910519|467433180|FG000|Overall Study|Adverse Event|2|||
129856648|NCT01910519|467433181|FG001|Overall Study|Adverse Event|0|||
129856649|NCT04266028|467433184|FG000|Overall Study|Adverse Event|0|||
129856650|NCT04266028|467433185|FG001|Overall Study|Adverse Event|0|||
129856651|NCT04266028|467433186|FG002|Overall Study|Adverse Event|1|||
129856652|NCT04266028|467433187|FG003|Overall Study|Adverse Event|0|||
129856653|NCT04266028|467433188|FG004|Overall Study|Adverse Event|1|||
129856654|NCT04266028|467433189|FG005|Overall Study|Adverse Event|0|||
129856655|NCT04266028|467433190|FG006|Overall Study|Adverse Event|2|||
129856656|NCT04266028|467433191|FG007|Overall Study|Adverse Event|0|||
129856657|NCT04266028|467433184|FG000|Overall Study|temporary halt of the study|0|||
129856658|NCT04266028|467433185|FG001|Overall Study|temporary halt of the study|0|||
129856659|NCT04266028|467433186|FG002|Overall Study|temporary halt of the study|0|||
129856660|NCT04266028|467433187|FG003|Overall Study|temporary halt of the study|0|||
129856661|NCT04266028|467433188|FG004|Overall Study|temporary halt of the study|0|||
129856662|NCT04266028|467433189|FG005|Overall Study|temporary halt of the study|0|||
129856663|NCT04266028|467433190|FG006|Overall Study|temporary halt of the study|2|||
129856664|NCT04266028|467433191|FG007|Overall Study|temporary halt of the study|1|||
129856665|NCT04266028|467433184|FG000|Overall Study|Onset of birch pollen season|0|||
129856666|NCT04266028|467433185|FG001|Overall Study|Onset of birch pollen season|0|||
129856667|NCT04266028|467433186|FG002|Overall Study|Onset of birch pollen season|0|||
129856668|NCT04266028|467433187|FG003|Overall Study|Onset of birch pollen season|0|||
129856669|NCT04266028|467433188|FG004|Overall Study|Onset of birch pollen season|1|||
129856670|NCT04266028|467433189|FG005|Overall Study|Onset of birch pollen season|0|||
129856671|NCT04266028|467433190|FG006|Overall Study|Onset of birch pollen season|0|||
129856672|NCT04266028|467433191|FG007|Overall Study|Onset of birch pollen season|0|||
129856673|NCT03021187|467433194|FG000|Overall Study|Death|0|||
129856674|NCT03021187|467433195|FG001|Overall Study|Death|0|||
129856675|NCT03021187|467433196|FG002|Overall Study|Death|3|||
129856676|NCT03021187|467433197|FG003|Overall Study|Death|0|||
129856677|NCT03021187|467433194|FG000|Overall Study|Withdrawal by Subject|0|||
129856678|NCT03021187|467433195|FG001|Overall Study|Withdrawal by Subject|6|||
129856679|NCT03021187|467433196|FG002|Overall Study|Withdrawal by Subject|2|||
129856680|NCT03021187|467433197|FG003|Overall Study|Withdrawal by Subject|5|||
129856681|NCT03021187|467433194|FG000|Overall Study|Lost to Follow-up|10|||
129856682|NCT03021187|467433195|FG001|Overall Study|Lost to Follow-up|3|||
129856683|NCT03021187|467433196|FG002|Overall Study|Lost to Follow-up|1|||
129856684|NCT03021187|467433197|FG003|Overall Study|Lost to Follow-up|4|||
129856685|NCT01664078|467433198|FG000|Overall Study|Death|9|||
129856686|NCT01664078|467433198|FG000|Overall Study|Withdrawal by Subject|4|||
129856687|NCT01664078|467433198|FG000|Overall Study|Lost to Follow-up|2|||
129856688|NCT01664078|467433198|FG000|Overall Study|missed 5 year visit|1|||
129856689|NCT01664078|467433198|FG000|Overall Study|Other|53|||
129856690|NCT03351049|467433201|FG000|Overall Study|Withdrawal|26|||
129856691|NCT03351049|467433202|FG001|Overall Study|Withdrawal|22|||
129856692|NCT02720484|467433211|FG000|Treatment on Study|Adverse Event|1|||
129856693|NCT02720484|467433211|FG000|Treatment on Study|Withdrawal by Subject|1|||
129856694|NCT02720484|467433211|FG000|Treatment on Study|Progressive Disease|4|||
129856695|NCT02720484|467433211|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
129856696|NCT02720484|467433211|FG000|Follow Up for 2 Years|Death|3|||
129856697|NCT02720484|467433211|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
129856698|NCT05070897|467433214|FG000|Overall Study|Protocol Violation|123|||
129856699|NCT05070897|467433215|FG001|Overall Study|Protocol Violation|68|||
129909166|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909167|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
129856700|NCT01617629|467433216|FG000|Overall Study|Death|2|||
129856701|NCT01617629|467433216|FG000|Overall Study|Investigator's Clinical Judgement|1|||
129856702|NCT01617629|467433216|FG000|Overall Study|Reason Not Specified|1|||
129856703|NCT01617629|467433216|FG000|Overall Study|Participant Withdrew Consent|2|||
129856704|NCT01663636|467433217|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
129856705|NCT01663636|467433218|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
129856706|NCT03832946|467433219|FG000|Overall Study|Adverse Event|3|||
129856707|NCT03832946|467433220|FG001|Overall Study|Adverse Event|1|||
129856708|NCT03832946|467433219|FG000|Overall Study|Lost to Follow-up|1|||
129856709|NCT03832946|467433220|FG001|Overall Study|Lost to Follow-up|0|||
129856710|NCT03832946|467433219|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
129856711|NCT03832946|467433220|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
129856712|NCT03832946|467433219|FG000|Overall Study|Lack of Efficacy|1|||
129856713|NCT03832946|467433220|FG001|Overall Study|Lack of Efficacy|0|||
129856714|NCT03832946|467433219|FG000|Overall Study|Withdrawal by Subject|12|||
129856715|NCT03832946|467433220|FG001|Overall Study|Withdrawal by Subject|9|||
129856716|NCT02863991|467433221|FG000|Overall Study|Death|0|||
129856717|NCT02863991|467433222|FG001|Overall Study|Death|3|||
129856718|NCT02863991|467433221|FG000|Overall Study|Lack of Efficacy|0|||
129856719|NCT02863991|467433222|FG001|Overall Study|Lack of Efficacy|1|||
129856720|NCT02863991|467433221|FG000|Overall Study|Study Terminated|2|||
129856721|NCT02863991|467433222|FG001|Overall Study|Study Terminated|8|||
129856722|NCT02663817|467433223|FG000|Overall Study|Screen failure|2|||
129856723|NCT01438541|467433226|FG000|Overall Study|Physician Decision|1|||
129856724|NCT01438541|467433226|FG000|Overall Study|Withdrawal by Subject|1|||
129856725|NCT01438541|467433226|FG000|Overall Study|discharge from the hospital|5|||
129856726|NCT00136955|467435224|FG000|Overall Study|Adverse Event|8|||
129856727|NCT00136955|467435224|FG000|Overall Study|Lost to Follow-up|1|||
129856728|NCT00136955|467435224|FG000|Overall Study|Withdrawal by Subject|2|||
129856729|NCT00136955|467435224|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
129856730|NCT04450264|467435225|FG000|Overall Study|Incomplete survey|13|||
129856731|NCT04450264|467435226|FG001|Overall Study|Incomplete survey|19|||
129856732|NCT05349617|467435227|FG000|Overall Study|Death|1|||
129856733|NCT05349617|467435228|FG001|Overall Study|Death|1|||
129856734|NCT05349617|467435227|FG000|Overall Study|Lost to Follow-up|3|||
129856735|NCT05349617|467435228|FG001|Overall Study|Lost to Follow-up|8|||
129856736|NCT05349617|467435227|FG000|Overall Study|Withdrawal by Subject|2|||
129856737|NCT05349617|467435228|FG001|Overall Study|Withdrawal by Subject|10|||
129856738|NCT00987467|467435229|FG000|Overall Study|Lost to Follow-up|2|||
129856739|NCT00512135|467435230|FG000|Overall Study|Not Treated|5|||
129856740|NCT00512135|467435230|FG000|Overall Study|Lack of Efficacy|2|||
129856741|NCT00512135|467435230|FG000|Overall Study|Adverse Event|6|||
129856742|NCT00512135|467435230|FG000|Overall Study|Withdrawal by Subject|22|||
129856743|NCT00512135|467435230|FG000|Overall Study|Lost to Follow-up|27|||
129856744|NCT00512135|467435230|FG000|Overall Study|Other|22|||
129856745|NCT02646423|467435231|FG000|Overall Study|Adverse Event|5|||
129856746|NCT02646423|467435232|FG001|Overall Study|Adverse Event|7|||
129856747|NCT02646423|467435231|FG000|Overall Study|Ineligible|2|||
129856748|NCT02646423|467435232|FG001|Overall Study|Ineligible|1|||
129856749|NCT00377819|467435233|FG000|Overall Study|Adverse Event|2|||
129856750|NCT00377819|467435234|FG001|Overall Study|Adverse Event|3|||
129856751|NCT00377819|467435233|FG000|Overall Study|Withdrawal by Subject|10|||
129909168|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
130064699|NCT03814590|468190232|FG009|Overall Study|UNKNOWN REASON|0|||
129856752|NCT00377819|467435234|FG001|Overall Study|Withdrawal by Subject|4|||
129856753|NCT00377819|467435233|FG000|Overall Study|Death|0|||
129856754|NCT00377819|467435234|FG001|Overall Study|Death|1|||
129856755|NCT00377819|467435233|FG000|Overall Study|Lost to Follow-up|0|||
129856756|NCT00377819|467435234|FG001|Overall Study|Lost to Follow-up|1|||
129856757|NCT00377819|467435233|FG000|Overall Study|Protocol Violation|1|||
129856758|NCT00377819|467435234|FG001|Overall Study|Protocol Violation|1|||
129856759|NCT02807948|467435235|FG000|Overall Study|Physician Decision|1|||
129856760|NCT02807948|467435236|FG001|Overall Study|Physician Decision|0|||
129856761|NCT03727750|467435237|FG000|Overall Study|Death|45|||
129856762|NCT03727750|467435237|FG000|Overall Study|Withdrawal by Subject|2|||
129856763|NCT03727750|467435237|FG000|Overall Study|Lost to Follow-up|1|||
129856764|NCT03727750|467435237|FG000|Overall Study|Other|1|||
129856765|NCT00760929|467435241|FG000|Overall Study|Adverse Event|2|||
129856766|NCT00760929|467435242|FG001|Overall Study|Adverse Event|0|||
129856767|NCT00760929|467435243|FG002|Overall Study|Adverse Event|6|||
129856768|NCT00760929|467435244|FG003|Overall Study|Adverse Event|10|||
129856769|NCT00760929|467435241|FG000|Overall Study|Lack of Efficacy|0|||
129856770|NCT00760929|467435242|FG001|Overall Study|Lack of Efficacy|2|||
129856771|NCT00760929|467435243|FG002|Overall Study|Lack of Efficacy|1|||
129856772|NCT00760929|467435244|FG003|Overall Study|Lack of Efficacy|0|||
129856773|NCT00760929|467435241|FG000|Overall Study|Withdrawal by Subject|1|||
129856774|NCT00760929|467435242|FG001|Overall Study|Withdrawal by Subject|0|||
130116644|NCT01507896|468387145|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
129856775|NCT00760929|467435243|FG002|Overall Study|Withdrawal by Subject|9|||
129856776|NCT00760929|467435244|FG003|Overall Study|Withdrawal by Subject|1|||
129856777|NCT00760929|467435241|FG000|Overall Study|Lost to Follow-up|0|||
129856778|NCT00760929|467435242|FG001|Overall Study|Lost to Follow-up|0|||
129856779|NCT00760929|467435243|FG002|Overall Study|Lost to Follow-up|1|||
129856780|NCT00760929|467435244|FG003|Overall Study|Lost to Follow-up|0|||
129856781|NCT00760929|467435241|FG000|Overall Study|Progression of Disease|21|||
129856782|NCT00760929|467435242|FG001|Overall Study|Progression of Disease|26|||
129856783|NCT00760929|467435243|FG002|Overall Study|Progression of Disease|38|||
129856784|NCT00760929|467435244|FG003|Overall Study|Progression of Disease|42|||
129856785|NCT00760929|467435241|FG000|Overall Study|Other|2|||
129856786|NCT00760929|467435242|FG001|Overall Study|Other|0|||
129856787|NCT00760929|467435243|FG002|Overall Study|Other|2|||
129856788|NCT00760929|467435244|FG003|Overall Study|Other|1|||
129856789|NCT00760929|467435241|FG000|Overall Study|Death|0|||
129856790|NCT00760929|467435242|FG001|Overall Study|Death|0|||
129856791|NCT00760929|467435243|FG002|Overall Study|Death|1|||
129856792|NCT00760929|467435244|FG003|Overall Study|Death|0|||
129856793|NCT00760929|467435241|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129856794|NCT00760929|467435242|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
129856795|NCT00760929|467435243|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
129856796|NCT00760929|467435244|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
129856797|NCT04360824|467435246|FG000|Overall Study|Withdrawal by Subject|2|||
129856798|NCT04360824|467435247|FG001|Overall Study|Withdrawal by Subject|1|||
129856799|NCT04360824|467435246|FG000|Overall Study|Did not receive assigned treatment|1|||
129856800|NCT04360824|467435247|FG001|Overall Study|Did not receive assigned treatment|3|||
129856801|NCT00304070|467435248|FG000|Overall Study|Death|0|||
129856802|NCT00304070|467435249|FG001|Overall Study|Death|0|||
129856803|NCT00304070|467435250|FG002|Overall Study|Death|3|||
129856804|NCT00304070|467435248|FG000|Overall Study|Lost to Follow-up|0|||
129856805|NCT00304070|467435249|FG001|Overall Study|Lost to Follow-up|0|||
129856806|NCT00304070|467435250|FG002|Overall Study|Lost to Follow-up|1|||
129856807|NCT00304070|467435248|FG000|Overall Study|Physician Decision|0|||
129856808|NCT00304070|467435249|FG001|Overall Study|Physician Decision|0|||
129856809|NCT00304070|467435250|FG002|Overall Study|Physician Decision|3|||
129856810|NCT00304070|467435248|FG000|Overall Study|Withdrawal by Subject|0|||
129856811|NCT00304070|467435249|FG001|Overall Study|Withdrawal by Subject|0|||
129856812|NCT00304070|467435250|FG002|Overall Study|Withdrawal by Subject|1|||
129856813|NCT00304070|467435248|FG000|Overall Study|Progressive Disease|3|||
129856814|NCT00304070|467435249|FG001|Overall Study|Progressive Disease|7|||
129856815|NCT00304070|467435250|FG002|Overall Study|Progressive Disease|4|||
129856816|NCT00320216|467435251|FG000|Overall Study|Adverse Event|0|||
129856817|NCT00320216|467435252|FG001|Overall Study|Adverse Event|6|||
129856818|NCT00320216|467435253|FG002|Overall Study|Adverse Event|0|||
129856819|NCT00320216|467435254|FG003|Overall Study|Adverse Event|2|||
129856820|NCT00320216|467435255|FG004|Overall Study|Adverse Event|2|||
129856821|NCT00320216|467435251|FG000|Overall Study|Lack of Efficacy|6|||
129856822|NCT00320216|467435252|FG001|Overall Study|Lack of Efficacy|2|||
129856823|NCT00320216|467435253|FG002|Overall Study|Lack of Efficacy|1|||
129856824|NCT00320216|467435254|FG003|Overall Study|Lack of Efficacy|0|||
129856825|NCT00320216|467435255|FG004|Overall Study|Lack of Efficacy|1|||
129856826|NCT00320216|467435251|FG000|Overall Study|Lost to Follow-up|3|||
129856827|NCT00320216|467435252|FG001|Overall Study|Lost to Follow-up|0|||
129856828|NCT00320216|467435253|FG002|Overall Study|Lost to Follow-up|0|||
129856829|NCT00320216|467435254|FG003|Overall Study|Lost to Follow-up|0|||
129856830|NCT00320216|467435255|FG004|Overall Study|Lost to Follow-up|0|||
129856831|NCT00320216|467435251|FG000|Overall Study|Other|7|||
129856832|NCT00320216|467435252|FG001|Overall Study|Other|2|||
129856833|NCT00320216|467435253|FG002|Overall Study|Other|5|||
129856834|NCT00320216|467435254|FG003|Overall Study|Other|1|||
129856835|NCT00320216|467435255|FG004|Overall Study|Other|3|||
129856836|NCT00377676|467435256|FG000|Overall Study|Adverse Event|498|||
129856837|NCT00377676|467435257|FG001|Overall Study|Adverse Event|107|||
129856838|NCT00377676|467435256|FG000|Overall Study|Protocol Violation|33|||
129856839|NCT00377676|467435257|FG001|Overall Study|Protocol Violation|27|||
129856840|NCT00377676|467435256|FG000|Overall Study|Death|5|||
129856841|NCT00377676|467435257|FG001|Overall Study|Death|2|||
129856842|NCT00377676|467435256|FG000|Overall Study|Withdrawal by Subject|187|||
130116645|NCT00585351|468387147|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
129856843|NCT00377676|467435257|FG001|Overall Study|Withdrawal by Subject|72|||
129856844|NCT00377676|467435256|FG000|Overall Study|Lost to Follow-up|120|||
129856845|NCT00377676|467435257|FG001|Overall Study|Lost to Follow-up|56|||
129856846|NCT00377676|467435256|FG000|Overall Study|Other|118|||
129856847|NCT00377676|467435257|FG001|Overall Study|Other|58|||
129856848|NCT05348681|467435262|FG000|Overall Study|Study terminated by Sponsor|8|||
129856849|NCT05348681|467435263|FG001|Overall Study|Study terminated by Sponsor|3|||
129856850|NCT05348681|467435262|FG000|Overall Study|Withdrawal by Subject|1|||
129856851|NCT05348681|467435263|FG001|Overall Study|Withdrawal by Subject|1|||
129856852|NCT05348681|467435262|FG000|Overall Study|Lost to Follow-up|1|||
129909169|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909170|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909171|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
129909172|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909173|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909174|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909175|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909176|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909177|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
129909178|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
129909179|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909180|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909181|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909182|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
129909183|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
129909184|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909185|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909186|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909187|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909188|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
129909189|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
129909190|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909191|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909192|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909193|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
129909194|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
129909195|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909196|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909197|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909198|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909199|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909200|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
129909201|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909202|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909203|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Other|1|||
129909204|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Other|1|||
129909205|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Other|0|||
129909206|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Other|0|||
129909207|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Other|0|||
129909208|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Other|0|||
129909209|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Other|0|||
129909210|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Other|0|||
129909211|NCT00546754|467630930|FG000|Overall Study|Serious Adverse Event|1|||
129909212|NCT00546754|467630931|FG001|Overall Study|Serious Adverse Event|1|||
129909213|NCT00546754|467630930|FG000|Overall Study|Adverse Event|11|||
129909214|NCT00546754|467630931|FG001|Overall Study|Adverse Event|16|||
129909215|NCT00546754|467630930|FG000|Overall Study|Lack of Efficacy|1|||
129909216|NCT00546754|467630931|FG001|Overall Study|Lack of Efficacy|1|||
129856853|NCT05348681|467435263|FG001|Overall Study|Lost to Follow-up|1|||
129856854|NCT05348681|467435262|FG000|Overall Study|Adverse Event|1|||
129856855|NCT05348681|467435263|FG001|Overall Study|Adverse Event|0|||
129856856|NCT05348681|467435262|FG000|Overall Study|Other|2|||
129856857|NCT05348681|467435263|FG001|Overall Study|Other|1|||
129856858|NCT00782340|467435264|FG000|Open Label Titration|Adverse Event|12|||
129856859|NCT00782340|467435265|FG001|Open Label Titration|Adverse Event|0|||
129856860|NCT00782340|467435266|FG002|Open Label Titration|Adverse Event|0|||
129909217|NCT00546754|467630930|FG000|Overall Study|Lost to Follow-up|9|||
129909218|NCT00546754|467630931|FG001|Overall Study|Lost to Follow-up|15|||
129909219|NCT00546754|467630930|FG000|Overall Study|Protocol Violation|3|||
129909220|NCT00546754|467630931|FG001|Overall Study|Protocol Violation|0|||
129909221|NCT00546754|467630930|FG000|Overall Study|Withdrawal by Subject|6|||
129909222|NCT00546754|467630931|FG001|Overall Study|Withdrawal by Subject|7|||
129909223|NCT00546754|467630930|FG000|Overall Study|Dyspnea|1|||
129909224|NCT00546754|467630931|FG001|Overall Study|Dyspnea|0|||
130064700|NCT03814590|468190233|FG010|Overall Study|UNKNOWN REASON|0|||
129856861|NCT00782340|467435264|FG000|Open Label Titration|Treatment failure|50|||
129856862|NCT00782340|467435265|FG001|Open Label Titration|Treatment failure|0|||
129856863|NCT00782340|467435266|FG002|Open Label Titration|Treatment failure|0|||
129856864|NCT00782340|467435264|FG000|Open Label Titration|Protocol Violation|5|||
129909225|NCT00546754|467630930|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
129909226|NCT00546754|467630931|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
129909227|NCT00546754|467630930|FG000|Overall Study|Hip Replacement|1|||
129856865|NCT00782340|467435265|FG001|Open Label Titration|Protocol Violation|0|||
129856866|NCT00782340|467435266|FG002|Open Label Titration|Protocol Violation|0|||
129909228|NCT00546754|467630931|FG001|Overall Study|Hip Replacement|0|||
129909229|NCT00546754|467630930|FG000|Overall Study|Suicide|1|||
129909230|NCT00546754|467630931|FG001|Overall Study|Suicide|0|||
129909231|NCT00546754|467630930|FG000|Overall Study|Missing Cooperation|1|||
129909232|NCT00546754|467630931|FG001|Overall Study|Missing Cooperation|0|||
129909233|NCT00546754|467630930|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
129909234|NCT00546754|467630931|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
129909235|NCT00546754|467630930|FG000|Overall Study|Patient's Decision|0|||
129909236|NCT00546754|467630931|FG001|Overall Study|Patient's Decision|1|||
129909237|NCT00546754|467630930|FG000|Overall Study|Missing|14|||
129909238|NCT00546754|467630931|FG001|Overall Study|Missing|7|||
129909239|NCT03733119|467630932|FG000|Overall Study|Physician Decision|2|||
129909240|NCT03733119|467630933|FG001|Overall Study|Physician Decision|1|||
129909241|NCT03733119|467630932|FG000|Overall Study|ineligible to treat per protocol|0|||
129909242|NCT03733119|467630933|FG001|Overall Study|ineligible to treat per protocol|1|||
129909243|NCT03764475|467630939|FG000|Overall Study|Adverse Event|11|||
129909244|NCT03764475|467630940|FG001|Overall Study|Adverse Event|2|||
129909245|NCT03764475|467630939|FG000|Overall Study|Lost to Follow-up|24|||
129909246|NCT03764475|467630940|FG001|Overall Study|Lost to Follow-up|10|||
129909247|NCT03764475|467630939|FG000|Overall Study|Withdrawal by Subject|26|||
129909248|NCT03764475|467630940|FG001|Overall Study|Withdrawal by Subject|10|||
129909249|NCT03764475|467630939|FG000|Overall Study|Lack of Efficacy|3|||
129909250|NCT03764475|467630940|FG001|Overall Study|Lack of Efficacy|0|||
129909251|NCT03764475|467630939|FG000|Overall Study|COVID-19 Disruption|2|||
129909252|NCT03764475|467630940|FG001|Overall Study|COVID-19 Disruption|0|||
129909253|NCT00390299|467630941|FG000|Overall Study|Cancellation|1|||
129909254|NCT00390299|467630942|FG001|Overall Study|Cancellation|0|||
129909255|NCT00390299|467630943|FG002|Overall Study|Cancellation|0|||
129909256|NCT00390299|467630944|FG003|Overall Study|Cancellation|0|||
129909257|NCT00390299|467630945|FG004|Overall Study|Cancellation|0|||
129909258|NCT00970359|467630946|FG000|Overall Study|Not Treated|4|||
129909259|NCT01565148|467630947|FG000|Overall Study|Withdrawal by Subject|1|||
129909260|NCT01565148|467630948|FG001|Overall Study|Withdrawal by Subject|1|||
129909261|NCT01565148|467630949|FG002|Overall Study|Withdrawal by Subject|1|||
129909262|NCT01565148|467630950|FG003|Overall Study|Withdrawal by Subject|2|||
129909263|NCT01565148|467630947|FG000|Overall Study|Lost to Follow-up|4|||
129909264|NCT01565148|467630948|FG001|Overall Study|Lost to Follow-up|4|||
129909265|NCT01565148|467630949|FG002|Overall Study|Lost to Follow-up|0|||
129909266|NCT01565148|467630950|FG003|Overall Study|Lost to Follow-up|3|||
129909267|NCT01565148|467630947|FG000|Overall Study|Rescue Therapy|8|||
129909268|NCT01565148|467630948|FG001|Overall Study|Rescue Therapy|5|||
129909269|NCT01565148|467630949|FG002|Overall Study|Rescue Therapy|5|||
129909270|NCT01565148|467630950|FG003|Overall Study|Rescue Therapy|8|||
129909271|NCT01565148|467630947|FG000|Overall Study|Death|0|||
129909272|NCT01565148|467630948|FG001|Overall Study|Death|0|||
129909273|NCT01565148|467630949|FG002|Overall Study|Death|1|||
129909274|NCT01565148|467630950|FG003|Overall Study|Death|0|||
129909275|NCT01565148|467630947|FG000|Overall Study|Physician Decision|2|||
129909276|NCT01565148|467630948|FG001|Overall Study|Physician Decision|5|||
129909277|NCT01565148|467630949|FG002|Overall Study|Physician Decision|0|||
129909278|NCT01565148|467630950|FG003|Overall Study|Physician Decision|0|||
129909279|NCT01061671|467630951|FG000|Overall Study|Withdrawal by Subject|16|||
129909280|NCT01061671|467630952|FG001|Overall Study|Withdrawal by Subject|20|||
129909281|NCT01061671|467630951|FG000|Overall Study|Lost to Follow-up|3|||
129909282|NCT01061671|467630952|FG001|Overall Study|Lost to Follow-up|5|||
129909283|NCT01061671|467630951|FG000|Overall Study|Death|28|||
129909284|NCT01061671|467630952|FG001|Overall Study|Death|30|||
129909285|NCT05368831|467630953|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
129909286|NCT01692730|467630961|FG000|Overall Study|Lost to Follow-up|225|||
129909287|NCT01692730|467630962|FG001|Overall Study|Lost to Follow-up|227|||
129909288|NCT01199575|467630963|FG000|Overall Study|Withdrawal by Subject|5|||
129909289|NCT01849055|467630964|FG000|Overall Study|Withdrawal by Subject|0|||
129909290|NCT01849055|467630965|FG001|Overall Study|Withdrawal by Subject|0|||
129909291|NCT01849055|467630966|FG002|Overall Study|Withdrawal by Subject|1|||
129909292|NCT01849055|467630967|FG003|Overall Study|Withdrawal by Subject|0|||
129909293|NCT01849055|467630968|FG004|Overall Study|Withdrawal by Subject|0|||
129909294|NCT01849055|467630969|FG005|Overall Study|Withdrawal by Subject|0|||
129909295|NCT01239316|467630974|FG000|Overall Study|Progression/Relapse|11|||
130064701|NCT03814590|468190234|FG011|Overall Study|UNKNOWN REASON|0|||
129909296|NCT01239316|467630974|FG000|Overall Study|Adverse Event|1|||
130064702|NCT03814590|468190235|FG012|Overall Study|UNKNOWN REASON|0|||
129909297|NCT00223795|467630975|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
129909298|NCT00223795|467630976|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
129909299|NCT00223795|467630975|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
129909300|NCT00223795|467630976|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
129909301|NCT02139943|467630977|FG000|Overall Study|Adverse Event|0|||
129909302|NCT02139943|467630978|FG001|Overall Study|Adverse Event|1|||
129909303|NCT02139943|467630979|FG002|Overall Study|Adverse Event|2|||
129909304|NCT02139943|467630977|FG000|Overall Study|Lost to Follow-up|3|||
129856867|NCT00782340|467435264|FG000|Open Label Titration|Withdrawal by Subject|5|||
129856868|NCT00782340|467435265|FG001|Open Label Titration|Withdrawal by Subject|0|||
129856869|NCT00782340|467435266|FG002|Open Label Titration|Withdrawal by Subject|0|||
129856870|NCT00782340|467435264|FG000|Open Label Titration|Enrollment capped|16|||
129856871|NCT00782340|467435265|FG001|Open Label Titration|Enrollment capped|0|||
129856872|NCT00782340|467435266|FG002|Open Label Titration|Enrollment capped|0|||
129856873|NCT00782340|467435264|FG000|Open Label Titration|Did not meet responder criteria|2|||
129856874|NCT00782340|467435265|FG001|Open Label Titration|Did not meet responder criteria|0|||
129856875|NCT00782340|467435266|FG002|Open Label Titration|Did not meet responder criteria|0|||
129856876|NCT00782340|467435264|FG000|Open Label Titration|Lost to Follow-up|5|||
129856877|NCT00782340|467435265|FG001|Open Label Titration|Lost to Follow-up|0|||
129856878|NCT00782340|467435266|FG002|Open Label Titration|Lost to Follow-up|0|||
129856879|NCT00782340|467435264|FG000|Open Label Titration|Randomized in error|6|||
129856880|NCT00782340|467435265|FG001|Open Label Titration|Randomized in error|0|||
129856881|NCT00782340|467435266|FG002|Open Label Titration|Randomized in error|0|||
129856882|NCT01568047|467435272|FG000|Overall Study|Ineligibility|1|||
129856883|NCT01568047|467435273|FG001|Overall Study|Ineligibility|0|||
129856884|NCT01568047|467435274|FG002|Overall Study|Ineligibility|0|||
129856885|NCT01568047|467435275|FG003|Overall Study|Ineligibility|0|||
129856886|NCT01568047|467435272|FG000|Overall Study|Withdrawal by Subject|0|||
129856887|NCT01568047|467435273|FG001|Overall Study|Withdrawal by Subject|1|||
129856888|NCT01568047|467435274|FG002|Overall Study|Withdrawal by Subject|0|||
129856889|NCT01568047|467435275|FG003|Overall Study|Withdrawal by Subject|0|||
129856890|NCT01568047|467435272|FG000|Overall Study|Adverse Event|0|||
129856891|NCT01568047|467435273|FG001|Overall Study|Adverse Event|0|||
129856892|NCT01568047|467435274|FG002|Overall Study|Adverse Event|1|||
129856893|NCT01568047|467435275|FG003|Overall Study|Adverse Event|1|||
129856894|NCT03359096|467435276|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
129856895|NCT03359096|467435277|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
129856896|NCT03359096|467435276|FG000|First Intervention (4 Weeks)|Death|1|||
129856897|NCT03359096|467435277|FG001|First Intervention (4 Weeks)|Death|0|||
129856898|NCT03359096|467435276|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
129856899|NCT03359096|467435277|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
129856900|NCT01944046|467435278|FG000|Randomized to DB|Adverse Event|5|||
129856901|NCT01944046|467435279|FG001|Randomized to DB|Adverse Event|2|||
129856902|NCT01944046|467435278|FG000|Randomized to DB|Clinical Worsening|3|||
129856903|NCT01944046|467435279|FG001|Randomized to DB|Clinical Worsening|2|||
129856904|NCT01944046|467435278|FG000|Randomized to DB|Lost to Follow-up|3|||
129856905|NCT01944046|467435279|FG001|Randomized to DB|Lost to Follow-up|3|||
129856906|NCT01944046|467435278|FG000|Randomized to DB|Withdrawal by Subject|2|||
129856907|NCT01944046|467435279|FG001|Randomized to DB|Withdrawal by Subject|4|||
129856908|NCT01944046|467435278|FG000|Randomized to DB|Physician Decision|1|||
129856909|NCT01944046|467435279|FG001|Randomized to DB|Physician Decision|2|||
129856910|NCT01944046|467435278|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
129856911|NCT01944046|467435279|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
129856912|NCT01944046|467435278|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
129856913|NCT01944046|467435279|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
129856914|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
129856915|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
129856916|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Adverse Event|6|||
129856917|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Adverse Event|1|||
129856918|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
129856919|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
129856920|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
129856921|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
129856922|NCT02007577|467435281|FG000|Overall Study|Adverse Event|1|||
129856923|NCT02007577|467435282|FG001|Overall Study|Adverse Event|0|||
129856924|NCT02007577|467435281|FG000|Overall Study|Withdrawal by Subject|0|||
129856925|NCT02007577|467435282|FG001|Overall Study|Withdrawal by Subject|1|||
129856926|NCT02504294|467435283|FG000|Overall Study|Adverse Event|15|||
129856927|NCT02504294|467435284|FG001|Overall Study|Adverse Event|12|||
129856928|NCT02504294|467435283|FG000|Overall Study|Withdrawal by Subject|7|||
129856929|NCT02504294|467435284|FG001|Overall Study|Withdrawal by Subject|1|||
129856930|NCT02504294|467435283|FG000|Overall Study|Protocol Violation|27|||
129856931|NCT02504294|467435284|FG001|Overall Study|Protocol Violation|26|||
129856932|NCT02504294|467435283|FG000|Overall Study|Physician Decision|1|||
129856933|NCT02504294|467435284|FG001|Overall Study|Physician Decision|2|||
129856934|NCT02504294|467435283|FG000|Overall Study|Lost to Follow-up|6|||
129856935|NCT02504294|467435284|FG001|Overall Study|Lost to Follow-up|7|||
129856936|NCT01953926|467435285|FG000|Overall Study|Withdrawal by Subject|23|||
129856937|NCT01953926|467435286|FG001|Overall Study|Withdrawal by Subject|3|||
129856938|NCT01953926|467435287|FG002|Overall Study|Withdrawal by Subject|3|||
129856939|NCT01953926|467435288|FG003|Overall Study|Withdrawal by Subject|5|||
129856940|NCT01953926|467435289|FG004|Overall Study|Withdrawal by Subject|6|||
129909305|NCT02139943|467630978|FG001|Overall Study|Lost to Follow-up|2|||
129909306|NCT02139943|467630979|FG002|Overall Study|Lost to Follow-up|2|||
129909307|NCT02139943|467630977|FG000|Overall Study|Withdrawal by Subject|4|||
129909308|NCT02139943|467630978|FG001|Overall Study|Withdrawal by Subject|3|||
129909309|NCT02139943|467630979|FG002|Overall Study|Withdrawal by Subject|0|||
129909310|NCT02139943|467630977|FG000|Overall Study|Other|0|||
129909311|NCT02139943|467630978|FG001|Overall Study|Other|0|||
129909312|NCT02139943|467630979|FG002|Overall Study|Other|1|||
129909313|NCT02139943|467630977|FG000|Overall Study|Participant wishes to discontinue|2|||
129909314|NCT02139943|467630978|FG001|Overall Study|Participant wishes to discontinue|0|||
129909315|NCT02139943|467630979|FG002|Overall Study|Participant wishes to discontinue|0|||
129909316|NCT02139943|467630977|FG000|Overall Study|Participant in Poor Compliance|1|||
129909317|NCT02139943|467630978|FG001|Overall Study|Participant in Poor Compliance|0|||
129909318|NCT02139943|467630979|FG002|Overall Study|Participant in Poor Compliance|1|||
129909319|NCT02139943|467630977|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
129909320|NCT02139943|467630978|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
129909321|NCT02139943|467630979|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
129909322|NCT03750968|467630982|FG000|Overall Study|Adverse Event|2|||
129909323|NCT03750968|467630983|FG001|Overall Study|Adverse Event|0|||
129909324|NCT03750968|467630982|FG000|Overall Study|Lost to Follow-up|1|||
129909325|NCT03750968|467630983|FG001|Overall Study|Lost to Follow-up|3|||
129909326|NCT00088413|467630985|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
129909327|NCT00088413|467630986|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
129909328|NCT00088413|467630987|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
129909329|NCT00088413|467630988|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
129909330|NCT00088413|467630985|FG000|Overall Study|Adverse Events/Side Effects|0|||
129909331|NCT00088413|467630986|FG001|Overall Study|Adverse Events/Side Effects|1|||
129909332|NCT00088413|467630987|FG002|Overall Study|Adverse Events/Side Effects|1|||
129909333|NCT00088413|467630988|FG003|Overall Study|Adverse Events/Side Effects|0|||
129909334|NCT00088413|467630985|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
129909335|NCT00088413|467630986|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
129909336|NCT00088413|467630987|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
129909337|NCT00088413|467630988|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
129909338|NCT00088413|467630985|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
129909339|NCT00088413|467630986|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
129909340|NCT00088413|467630987|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
129909341|NCT00088413|467630988|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
129909342|NCT00088413|467630985|FG000|Overall Study|Death|0|||
129909343|NCT00088413|467630986|FG001|Overall Study|Death|1|||
129909344|NCT00088413|467630987|FG002|Overall Study|Death|0|||
129909345|NCT00088413|467630988|FG003|Overall Study|Death|0|||
129909346|NCT00088413|467630985|FG000|Overall Study|Progressive disease|9|||
129909347|NCT00088413|467630986|FG001|Overall Study|Progressive disease|11|||
129909348|NCT00088413|467630987|FG002|Overall Study|Progressive disease|8|||
129909349|NCT00088413|467630988|FG003|Overall Study|Progressive disease|14|||
129909350|NCT00088413|467630985|FG000|Overall Study|Other|0|||
129909351|NCT00088413|467630986|FG001|Overall Study|Other|1|||
129909352|NCT00088413|467630987|FG002|Overall Study|Other|0|||
129909353|NCT00088413|467630988|FG003|Overall Study|Other|0|||
129909354|NCT00088413|467630985|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
129909355|NCT00088413|467630986|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
130064703|NCT03814590|468190236|FG013|Overall Study|UNKNOWN REASON|0|||
130064704|NCT00567541|468190241|FG000|Overall Study|Adverse Event|0|||
130064705|NCT00567541|468190242|FG001|Overall Study|Adverse Event|1|||
130064706|NCT01890512|468190243|FG000|Overall Study|Physician Decision|1|||
130064707|NCT01890512|468190243|FG000|Overall Study|Withdrawal by Subject|1|||
130064708|NCT01890512|468190243|FG000|Overall Study|Protocol Violation|1|||
130064709|NCT00964158|468190246|FG000|Overall Study|Lost to Follow-up|0|||
130064710|NCT00964158|468190247|FG001|Overall Study|Lost to Follow-up|1|||
129856941|NCT01953926|467435290|FG005|Overall Study|Withdrawal by Subject|0|||
129856942|NCT01953926|467435291|FG006|Overall Study|Withdrawal by Subject|1|||
129856943|NCT01953926|467435285|FG000|Overall Study|Physician Decision|1|||
129856944|NCT01953926|467435286|FG001|Overall Study|Physician Decision|0|||
129856945|NCT01953926|467435287|FG002|Overall Study|Physician Decision|0|||
129856946|NCT01953926|467435288|FG003|Overall Study|Physician Decision|0|||
129856947|NCT01953926|467435289|FG004|Overall Study|Physician Decision|2|||
129909356|NCT00088413|467630987|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
129909357|NCT00088413|467630988|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
129909358|NCT00632424|467630991|FG000|Overall Study|Disease Progression|17|||
129909359|NCT00632424|467630991|FG000|Overall Study|Study Drug Toxicity|1|||
130064711|NCT00964158|468190248|FG002|Overall Study|Lost to Follow-up|2|||
129856948|NCT01953926|467435290|FG005|Overall Study|Physician Decision|0|||
129909360|NCT02531113|467630992|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
129856949|NCT01953926|467435291|FG006|Overall Study|Physician Decision|0|||
129909361|NCT02531113|467630992|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
129856950|NCT01953926|467435285|FG000|Overall Study|Lost to Follow-up|18|||
129909362|NCT02531113|467630992|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
129909363|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
129909364|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
129909365|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
129909366|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
129909367|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
129909368|NCT03807778|467630993|FG000|Overall Study|Adverse Event|0|||
129909369|NCT03807778|467630994|FG001|Overall Study|Adverse Event|0|||
129909370|NCT03807778|467630995|FG002|Overall Study|Adverse Event|3|||
129909371|NCT03807778|467630996|FG003|Overall Study|Adverse Event|5|||
129909372|NCT03807778|467630993|FG000|Overall Study|Progressive Disease|4|||
129909373|NCT03807778|467630994|FG001|Overall Study|Progressive Disease|2|||
129909374|NCT03807778|467630995|FG002|Overall Study|Progressive Disease|8|||
129909375|NCT03807778|467630996|FG003|Overall Study|Progressive Disease|15|||
129909376|NCT03807778|467630993|FG000|Overall Study|Symptomatic Deterioration|0|||
129909377|NCT03807778|467630994|FG001|Overall Study|Symptomatic Deterioration|1|||
129909378|NCT03807778|467630995|FG002|Overall Study|Symptomatic Deterioration|0|||
129909379|NCT03807778|467630996|FG003|Overall Study|Symptomatic Deterioration|1|||
129909380|NCT03807778|467630993|FG000|Overall Study|Withdrawal by Subject|0|||
129909381|NCT03807778|467630994|FG001|Overall Study|Withdrawal by Subject|1|||
129909382|NCT03807778|467630995|FG002|Overall Study|Withdrawal by Subject|0|||
129909383|NCT03807778|467630996|FG003|Overall Study|Withdrawal by Subject|1|||
129909384|NCT03807778|467630993|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
129909385|NCT03807778|467630994|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
129909386|NCT03807778|467630995|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
129909387|NCT03807778|467630996|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
129909388|NCT03422276|467632291|FG000|Overall Study|Withdrawal by Subject|21|||
129909389|NCT03422276|467632292|FG001|Overall Study|Withdrawal by Subject|25|||
129909390|NCT03422276|467632293|FG002|Overall Study|Withdrawal by Subject|14|||
129909391|NCT03422276|467632294|FG003|Overall Study|Withdrawal by Subject|16|||
129909392|NCT03422276|467632291|FG000|Overall Study|Death|14|||
129909393|NCT03422276|467632292|FG001|Overall Study|Death|21|||
129909394|NCT03422276|467632293|FG002|Overall Study|Death|3|||
129909395|NCT03422276|467632294|FG003|Overall Study|Death|1|||
129909396|NCT03422276|467632291|FG000|Overall Study|Discontinued, ineligible|4|||
129909397|NCT03422276|467632292|FG001|Overall Study|Discontinued, ineligible|3|||
129909398|NCT03422276|467632293|FG002|Overall Study|Discontinued, ineligible|0|||
129909399|NCT03422276|467632294|FG003|Overall Study|Discontinued, ineligible|0|||
129909400|NCT03422276|467632291|FG000|Overall Study|Lost to Follow-up|15|||
129909401|NCT03422276|467632292|FG001|Overall Study|Lost to Follow-up|8|||
129909402|NCT03422276|467632293|FG002|Overall Study|Lost to Follow-up|13|||
129909403|NCT03422276|467632294|FG003|Overall Study|Lost to Follow-up|4|||
129909404|NCT03422276|467632291|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
129909405|NCT03422276|467632292|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
129909406|NCT03422276|467632293|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
129909407|NCT03422276|467632294|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
129909408|NCT03422276|467632291|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
129909409|NCT03422276|467632292|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
129909410|NCT03422276|467632293|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
129909411|NCT03422276|467632294|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
129909412|NCT03422276|467632291|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
129909413|NCT03422276|467632292|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
129909414|NCT03422276|467632293|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
129909415|NCT03422276|467632294|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
129909416|NCT03422276|467632291|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
129909417|NCT03422276|467632292|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
129909418|NCT03422276|467632293|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
129909419|NCT03422276|467632294|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
129909420|NCT03422276|467632291|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
129909421|NCT03422276|467632292|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
129909422|NCT03422276|467632293|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
129909423|NCT03422276|467632294|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
129909424|NCT05938413|467632295|FG000|Overall Study|Lost to Follow-up|1|||
129909425|NCT05938413|467632296|FG001|Overall Study|Lost to Follow-up|7|||
129909426|NCT05938413|467632295|FG000|Overall Study|Withdrawal by Subject|1|||
129909427|NCT05938413|467632296|FG001|Overall Study|Withdrawal by Subject|1|||
129909428|NCT05644444|467632301|FG000|Tolerance Phase|Adverse Event|0|||
129909429|NCT05644444|467632302|FG001|Tolerance Phase|Adverse Event|2|||
129909430|NCT05644444|467632301|FG000|Treatment Phase|Adverse Event|0|||
129909431|NCT05644444|467632302|FG001|Treatment Phase|Adverse Event|2|||
129909432|NCT04817670|467632303|FG000|Overall Study|Withdrawal by Subject|1|||
129909433|NCT04817670|467632304|FG001|Overall Study|Withdrawal by Subject|0|||
129909434|NCT04817670|467632305|FG002|Overall Study|Withdrawal by Subject|0|||
129909435|NCT04817670|467632306|FG003|Overall Study|Withdrawal by Subject|0|||
129909436|NCT04817670|467632307|FG004|Overall Study|Withdrawal by Subject|0|||
129909437|NCT04817670|467632303|FG000|Overall Study|Lost to Follow-up|0|||
129909438|NCT04817670|467632304|FG001|Overall Study|Lost to Follow-up|0|||
129909439|NCT04817670|467632305|FG002|Overall Study|Lost to Follow-up|1|||
129909440|NCT04817670|467632306|FG003|Overall Study|Lost to Follow-up|0|||
129909441|NCT04817670|467632307|FG004|Overall Study|Lost to Follow-up|0|||
129909442|NCT03312907|467632308|FG000|Overall Study|Adverse Event|1|||
129909443|NCT03312907|467632309|FG001|Overall Study|Adverse Event|6|||
129909444|NCT03312907|467632310|FG002|Overall Study|Adverse Event|1|||
129909445|NCT03312907|467632308|FG000|Overall Study|Protocol Violation|2|||
129909446|NCT03312907|467632309|FG001|Overall Study|Protocol Violation|3|||
129909447|NCT03312907|467632310|FG002|Overall Study|Protocol Violation|4|||
129909448|NCT03312907|467632308|FG000|Overall Study|Lost to Follow-up|2|||
129909449|NCT03312907|467632309|FG001|Overall Study|Lost to Follow-up|3|||
129909450|NCT03312907|467632310|FG002|Overall Study|Lost to Follow-up|2|||
129856951|NCT01953926|467435286|FG001|Overall Study|Lost to Follow-up|3|||
129909451|NCT03312907|467632308|FG000|Overall Study|Physician Decision|3|||
129909452|NCT03312907|467632309|FG001|Overall Study|Physician Decision|4|||
129909453|NCT03312907|467632310|FG002|Overall Study|Physician Decision|2|||
129909454|NCT03312907|467632308|FG000|Overall Study|Withdrawal by Subject|9|||
129909455|NCT03312907|467632309|FG001|Overall Study|Withdrawal by Subject|14|||
129909456|NCT03312907|467632310|FG002|Overall Study|Withdrawal by Subject|10|||
129909457|NCT04723394|467632328|FG000|Overall Study|Adverse Event|0|||
129909458|NCT04723394|467632329|FG001|Overall Study|Adverse Event|3|||
129909459|NCT04723394|467632328|FG000|Overall Study|Death|8|||
129909460|NCT04723394|467632329|FG001|Overall Study|Death|8|||
129909461|NCT04723394|467632328|FG000|Overall Study|Lost to Follow-up|20|||
129856952|NCT01953926|467435287|FG002|Overall Study|Lost to Follow-up|0|||
129856953|NCT01953926|467435288|FG003|Overall Study|Lost to Follow-up|5|||
129856954|NCT01953926|467435289|FG004|Overall Study|Lost to Follow-up|3|||
129856955|NCT01953926|467435290|FG005|Overall Study|Lost to Follow-up|0|||
129856956|NCT01953926|467435291|FG006|Overall Study|Lost to Follow-up|0|||
129856957|NCT01953926|467435285|FG000|Overall Study|Protocol Violation|1|||
129856958|NCT01953926|467435286|FG001|Overall Study|Protocol Violation|0|||
129856959|NCT01953926|467435287|FG002|Overall Study|Protocol Violation|0|||
129856960|NCT01953926|467435288|FG003|Overall Study|Protocol Violation|0|||
129856961|NCT01953926|467435289|FG004|Overall Study|Protocol Violation|0|||
129856962|NCT01953926|467435290|FG005|Overall Study|Protocol Violation|0|||
129856963|NCT01953926|467435291|FG006|Overall Study|Protocol Violation|0|||
129856964|NCT01953926|467435285|FG000|Overall Study|Other, Disease progression|2|||
129856965|NCT01953926|467435286|FG001|Overall Study|Other, Disease progression|1|||
129856966|NCT01953926|467435287|FG002|Overall Study|Other, Disease progression|0|||
129856967|NCT01953926|467435288|FG003|Overall Study|Other, Disease progression|0|||
129856968|NCT01953926|467435289|FG004|Overall Study|Other, Disease progression|1|||
129856969|NCT01953926|467435290|FG005|Overall Study|Other, Disease progression|0|||
129856970|NCT01953926|467435291|FG006|Overall Study|Other, Disease progression|0|||
129856971|NCT01953926|467435285|FG000|Overall Study|Discontinuation of study by sponsor|41|||
129856972|NCT01953926|467435286|FG001|Overall Study|Discontinuation of study by sponsor|7|||
129856973|NCT01953926|467435287|FG002|Overall Study|Discontinuation of study by sponsor|5|||
129856974|NCT01953926|467435288|FG003|Overall Study|Discontinuation of study by sponsor|12|||
129856975|NCT01953926|467435289|FG004|Overall Study|Discontinuation of study by sponsor|46|||
129856976|NCT01953926|467435290|FG005|Overall Study|Discontinuation of study by sponsor|5|||
129856977|NCT01953926|467435291|FG006|Overall Study|Discontinuation of study by sponsor|6|||
129856978|NCT01953926|467435285|FG000|Overall Study|Not Treated|1|||
129856979|NCT01953926|467435286|FG001|Overall Study|Not Treated|0|||
129856980|NCT01953926|467435287|FG002|Overall Study|Not Treated|1|||
129909462|NCT04723394|467632329|FG001|Overall Study|Lost to Follow-up|17|||
129909463|NCT04723394|467632328|FG000|Overall Study|Physician Decision|1|||
129909464|NCT04723394|467632329|FG001|Overall Study|Physician Decision|0|||
129856981|NCT01953926|467435288|FG003|Overall Study|Not Treated|0|||
129856982|NCT01953926|467435289|FG004|Overall Study|Not Treated|0|||
129856983|NCT01953926|467435290|FG005|Overall Study|Not Treated|0|||
129856984|NCT01953926|467435291|FG006|Overall Study|Not Treated|0|||
129856985|NCT02338362|467435292|FG000|Overall Study|Withdrawal by Subject|1|||
129856986|NCT02338362|467435293|FG001|Overall Study|Withdrawal by Subject|1|||
129856987|NCT03585244|467435298|FG000|Overall Study|Withdrawal by Subject|15|||
129909465|NCT04723394|467632328|FG000|Overall Study|Withdrawal by Subject|20|||
129909466|NCT04723394|467632329|FG001|Overall Study|Withdrawal by Subject|34|||
129909467|NCT04723394|467632328|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
129909468|NCT04723394|467632329|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
129909469|NCT00774397|467632330|FG000|Overall Study|Adverse Event|1|||
129909470|NCT00774397|467632331|FG001|Overall Study|Adverse Event|3|||
129856988|NCT06281548|467435300|FG000|Overall Study|Lost to Follow-up|3|||
129856989|NCT03538626|467435302|FG000|Overall Study|Withdrawal by Subject|0|||
129856990|NCT03538626|467435303|FG001|Overall Study|Withdrawal by Subject|1|||
129856991|NCT03538626|467435304|FG002|Overall Study|Withdrawal by Subject|0|||
129856992|NCT03538626|467435305|FG003|Overall Study|Withdrawal by Subject|0|||
129856993|NCT03538626|467435306|FG004|Overall Study|Withdrawal by Subject|0|||
129856994|NCT03538626|467435307|FG005|Overall Study|Withdrawal by Subject|0|||
129856995|NCT03538626|467435308|FG006|Overall Study|Withdrawal by Subject|0|||
129856996|NCT03538626|467435309|FG007|Overall Study|Withdrawal by Subject|0|||
129856997|NCT03538626|467435302|FG000|Overall Study|Lost to Follow-up|0|||
129856998|NCT03538626|467435303|FG001|Overall Study|Lost to Follow-up|0|||
129856999|NCT03538626|467435304|FG002|Overall Study|Lost to Follow-up|0|||
129857000|NCT03538626|467435305|FG003|Overall Study|Lost to Follow-up|0|||
129857001|NCT03538626|467435306|FG004|Overall Study|Lost to Follow-up|0|||
129857002|NCT03538626|467435307|FG005|Overall Study|Lost to Follow-up|0|||
129857003|NCT03538626|467435308|FG006|Overall Study|Lost to Follow-up|1|||
129857004|NCT03538626|467435309|FG007|Overall Study|Lost to Follow-up|0|||
129857005|NCT00288587|467435310|FG000|Overall Study|Death|4|||
129857006|NCT00288587|467435311|FG001|Overall Study|Death|4|||
129857007|NCT00288587|467435310|FG000|Overall Study|Transplant|0|||
129857008|NCT00288587|467435311|FG001|Overall Study|Transplant|3|||
129857009|NCT00288587|467435310|FG000|Overall Study|Adverse Event|0|||
129857010|NCT00288587|467435311|FG001|Overall Study|Adverse Event|1|||
129857011|NCT00288587|467435310|FG000|Overall Study|Physician Decision|0|||
129857012|NCT00288587|467435311|FG001|Overall Study|Physician Decision|2|||
129857013|NCT00288587|467435310|FG000|Overall Study|Severe Aortic Stenosis|1|||
129857014|NCT00288587|467435311|FG001|Overall Study|Severe Aortic Stenosis|0|||
129857015|NCT01434602|467435316|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857016|NCT01434602|467435317|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
129857017|NCT01434602|467435318|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857018|NCT01434602|467435319|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857019|NCT01434602|467435320|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857020|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857021|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857022|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857023|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
129857024|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857025|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857026|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857027|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857028|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
129857029|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857030|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857031|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857032|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857033|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
129857034|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857035|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857036|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857037|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857038|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
129857039|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857040|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857041|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857042|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857043|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
129857044|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857045|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857046|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857047|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857048|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857049|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
129857050|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
129857051|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
129857052|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
129857053|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
129857054|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
129857055|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857056|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857057|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857058|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
129857059|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857060|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857061|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857062|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857063|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
129857064|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857065|NCT01764945|467435326|FG000|Overall Study|Adverse Event|0|||
129857066|NCT01764945|467435327|FG001|Overall Study|Adverse Event|1|||
129857067|NCT01764945|467435328|FG002|Overall Study|Adverse Event|0|||
129857068|NCT01764945|467435329|FG003|Overall Study|Adverse Event|0|||
129857069|NCT01764945|467435330|FG004|Overall Study|Adverse Event|0|||
129857070|NCT01764945|467435331|FG005|Overall Study|Adverse Event|0|||
129857071|NCT01764945|467435332|FG006|Overall Study|Adverse Event|1|||
129857072|NCT01764945|467435333|FG007|Overall Study|Adverse Event|0|||
129857073|NCT05077267|467435335|FG000|Treatment Period|Lost to Follow-up|0|||
129857074|NCT05077267|467435336|FG001|Treatment Period|Lost to Follow-up|1|||
129857075|NCT05077267|467435337|FG002|Treatment Period|Lost to Follow-up|0|||
129857076|NCT05077267|467435335|FG000|Treatment Period|Withdrawal by Subject|0|||
129857077|NCT05077267|467435336|FG001|Treatment Period|Withdrawal by Subject|1|||
129857078|NCT05077267|467435337|FG002|Treatment Period|Withdrawal by Subject|0|||
129857079|NCT05077267|467435335|FG000|Follow-up Period|Lost to Follow-up|0|||
129857080|NCT05077267|467435336|FG001|Follow-up Period|Lost to Follow-up|5|||
129857081|NCT05077267|467435337|FG002|Follow-up Period|Lost to Follow-up|7|||
129857082|NCT05077267|467435335|FG000|Follow-up Period|Withdrawal by Subject|0|||
129857083|NCT05077267|467435336|FG001|Follow-up Period|Withdrawal by Subject|2|||
129857084|NCT05077267|467435337|FG002|Follow-up Period|Withdrawal by Subject|5|||
129857085|NCT05077267|467435335|FG000|Follow-up Period|Study terminated by sponsor|0|||
129857086|NCT05077267|467435336|FG001|Follow-up Period|Study terminated by sponsor|27|||
129857087|NCT05077267|467435337|FG002|Follow-up Period|Study terminated by sponsor|23|||
129857088|NCT05077267|467435335|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
129857089|NCT05077267|467435336|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
129857090|NCT05077267|467435337|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
129857091|NCT05077267|467435335|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
129857092|NCT05077267|467435336|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
129857093|NCT05077267|467435337|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
129857094|NCT02911948|467435338|FG000|Overall Study|Protocol Violation|0|||
129857095|NCT02911948|467435339|FG001|Overall Study|Protocol Violation|1|||
129857096|NCT02911948|467435338|FG000|Overall Study|Withdrawal by Subject|0|||
129857097|NCT02911948|467435339|FG001|Overall Study|Withdrawal by Subject|2|||
129857098|NCT02911948|467435338|FG000|Overall Study|Lack of Efficacy|0|||
129857099|NCT02911948|467435339|FG001|Overall Study|Lack of Efficacy|1|||
129857100|NCT02911948|467435338|FG000|Overall Study|Unclassified|0|||
129857101|NCT02911948|467435339|FG001|Overall Study|Unclassified|3|||
129857102|NCT00586105|467435340|FG000|Overall Study|Adverse Event|4|||
129857103|NCT00586105|467435340|FG000|Overall Study|Death|2|||
129857104|NCT00586105|467435340|FG000|Overall Study|Protocol Violation|1|||
129857105|NCT00586105|467435340|FG000|Overall Study|Withdrawal by Subject|3|||
129857106|NCT00586105|467435340|FG000|Overall Study|Disease progression|19|||
129857107|NCT00586105|467435340|FG000|Overall Study|Switched to commercial drug|9|||
129857108|NCT00586105|467435340|FG000|Overall Study|Reason not reported|1|||
129857109|NCT03835533|467435343|FG000|Overall Study|Death|5|||
129857110|NCT03835533|467435344|FG001|Overall Study|Death|10|||
129857111|NCT03835533|467435345|FG002|Overall Study|Death|9|||
129857112|NCT03835533|467435343|FG000|Overall Study|Withdrawal by Subject|2|||
129857113|NCT03835533|467435344|FG001|Overall Study|Withdrawal by Subject|2|||
129857114|NCT03835533|467435345|FG002|Overall Study|Withdrawal by Subject|2|||
129857115|NCT03835533|467435343|FG000|Overall Study|Lost to Follow-up|1|||
129857116|NCT03835533|467435344|FG001|Overall Study|Lost to Follow-up|0|||
129857117|NCT03835533|467435345|FG002|Overall Study|Lost to Follow-up|0|||
129857118|NCT01136291|467435346|FG000|Overall Study|Lost to Follow-up|1|||
129857119|NCT01136291|467435347|FG001|Overall Study|Lost to Follow-up|1|||
129857120|NCT02308033|467435355|FG000|Overall Study|Normal Gram stain at Baseline|13|||
129857121|NCT02308033|467435356|FG001|Overall Study|Normal Gram stain at Baseline|10|||
129857122|NCT02308033|467435355|FG000|Overall Study|Positive for STD at Baseline|7|||
129857123|NCT02308033|467435356|FG001|Overall Study|Positive for STD at Baseline|4|||
129857124|NCT02308033|467435355|FG000|Overall Study|Lost to Follow-up|6|||
129909471|NCT00774397|467632332|FG002|Overall Study|Adverse Event|16|||
129909472|NCT00774397|467632333|FG003|Overall Study|Adverse Event|8|||
129909473|NCT00774397|467632334|FG004|Overall Study|Adverse Event|8|||
129909474|NCT00774397|467632335|FG005|Overall Study|Adverse Event|3|||
129909475|NCT00774397|467632336|FG006|Overall Study|Adverse Event|16|||
129909476|NCT00774397|467632330|FG000|Overall Study|Lack of Efficacy|11|||
129909477|NCT00774397|467632331|FG001|Overall Study|Lack of Efficacy|4|||
129909478|NCT00774397|467632332|FG002|Overall Study|Lack of Efficacy|5|||
129909479|NCT00774397|467632333|FG003|Overall Study|Lack of Efficacy|3|||
129909480|NCT00774397|467632334|FG004|Overall Study|Lack of Efficacy|27|||
129909481|NCT00774397|467632335|FG005|Overall Study|Lack of Efficacy|15|||
129909482|NCT00774397|467632336|FG006|Overall Study|Lack of Efficacy|9|||
129909483|NCT00774397|467632330|FG000|Overall Study|Protocol Violation|0|||
129909484|NCT00774397|467632331|FG001|Overall Study|Protocol Violation|1|||
129909485|NCT00774397|467632332|FG002|Overall Study|Protocol Violation|3|||
129909486|NCT00774397|467632333|FG003|Overall Study|Protocol Violation|1|||
129909487|NCT00774397|467632334|FG004|Overall Study|Protocol Violation|2|||
129909488|NCT00774397|467632335|FG005|Overall Study|Protocol Violation|1|||
129909489|NCT00774397|467632336|FG006|Overall Study|Protocol Violation|0|||
129909490|NCT00774397|467632330|FG000|Overall Study|Lost to Follow-up|0|||
129909491|NCT00774397|467632331|FG001|Overall Study|Lost to Follow-up|1|||
129909492|NCT00774397|467632332|FG002|Overall Study|Lost to Follow-up|1|||
129909493|NCT00774397|467632333|FG003|Overall Study|Lost to Follow-up|1|||
129909494|NCT00774397|467632334|FG004|Overall Study|Lost to Follow-up|0|||
129909495|NCT00774397|467632335|FG005|Overall Study|Lost to Follow-up|1|||
129909496|NCT00774397|467632336|FG006|Overall Study|Lost to Follow-up|0|||
129857125|NCT02308033|467435356|FG001|Overall Study|Lost to Follow-up|5|||
129857126|NCT01337245|467435357|FG000|Overall Study|Lost to Follow-up|1|||
129857127|NCT00364858|467435362|FG000|Overall Study|Adverse Event|1|||
129857128|NCT00364858|467435363|FG001|Overall Study|Adverse Event|5|||
129857129|NCT00364858|467435362|FG000|Overall Study|Withdrawal by Subject|1|||
129857130|NCT00364858|467435363|FG001|Overall Study|Withdrawal by Subject|1|||
129857131|NCT00364858|467435362|FG000|Overall Study|Pregnancy|1|||
129857132|NCT00364858|467435363|FG001|Overall Study|Pregnancy|1|||
129857133|NCT00364858|467435362|FG000|Overall Study|Clinical failure|2|||
129857134|NCT00364858|467435363|FG001|Overall Study|Clinical failure|13|||
129857135|NCT00364858|467435362|FG000|Overall Study|Discontinuation at baseline|1|||
129857136|NCT00364858|467435363|FG001|Overall Study|Discontinuation at baseline|0|||
129857137|NCT00364858|467435362|FG000|Overall Study|Non-compliant|1|||
129857138|NCT00364858|467435363|FG001|Overall Study|Non-compliant|0|||
129857139|NCT00364858|467435362|FG000|Overall Study|Return to Q2 regimen|0|||
129857140|NCT00364858|467435363|FG001|Overall Study|Return to Q2 regimen|1|||
129857141|NCT00364858|467435362|FG000|Overall Study|Clinical baseline issue|0|||
129857142|NCT00364858|467435363|FG001|Overall Study|Clinical baseline issue|1|||
129857143|NCT01307501|467435364|FG000|Overall Study|Treatment Failure|1|||
129857144|NCT01307501|467435364|FG000|Overall Study|Death|20|||
129857145|NCT01307501|467435364|FG000|Overall Study|Lost to Follow-up|1|||
129857146|NCT01307501|467435364|FG000|Overall Study|Starting Hospice|1|||
129857147|NCT00558285|467435365|FG000|Overall Study|Adverse Event|1|||
129857148|NCT00558285|467435366|FG001|Overall Study|Adverse Event|1|||
129857149|NCT00558285|467435367|FG002|Overall Study|Adverse Event|4|||
129857150|NCT00558285|467435368|FG003|Overall Study|Adverse Event|1|||
129857151|NCT00558285|467435369|FG004|Overall Study|Adverse Event|2|||
129857152|NCT00558285|467435365|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129857153|NCT00558285|467435366|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129857154|NCT00558285|467435367|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129909497|NCT00774397|467632330|FG000|Overall Study|Refused to continue trial medication|1|||
129909498|NCT00774397|467632331|FG001|Overall Study|Refused to continue trial medication|3|||
129909499|NCT00774397|467632332|FG002|Overall Study|Refused to continue trial medication|2|||
129909500|NCT00774397|467632333|FG003|Overall Study|Refused to continue trial medication|2|||
129909501|NCT00774397|467632334|FG004|Overall Study|Refused to continue trial medication|6|||
129857155|NCT00558285|467435368|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129857156|NCT00558285|467435369|FG004|Overall Study|Abnormal test procedure result(s)|0|||
129857157|NCT00558285|467435365|FG000|Overall Study|Subject withdrew consent|2|||
129857158|NCT00558285|467435366|FG001|Overall Study|Subject withdrew consent|0|||
129857159|NCT00558285|467435367|FG002|Overall Study|Subject withdrew consent|1|||
129857160|NCT00558285|467435368|FG003|Overall Study|Subject withdrew consent|1|||
129857161|NCT00558285|467435369|FG004|Overall Study|Subject withdrew consent|1|||
129857162|NCT00558285|467435365|FG000|Overall Study|Lost to Follow-up|1|||
129909502|NCT00774397|467632335|FG005|Overall Study|Refused to continue trial medication|2|||
129857163|NCT00558285|467435366|FG001|Overall Study|Lost to Follow-up|1|||
129909503|NCT00774397|467632336|FG006|Overall Study|Refused to continue trial medication|3|||
129909504|NCT00774397|467632330|FG000|Overall Study|Not treated|0|||
129909505|NCT00774397|467632331|FG001|Overall Study|Not treated|0|||
129909506|NCT00774397|467632332|FG002|Overall Study|Not treated|0|||
129909507|NCT00774397|467632333|FG003|Overall Study|Not treated|0|||
129909508|NCT00774397|467632334|FG004|Overall Study|Not treated|1|||
129909509|NCT00774397|467632335|FG005|Overall Study|Not treated|0|||
129857164|NCT00558285|467435367|FG002|Overall Study|Lost to Follow-up|0|||
129857165|NCT00558285|467435368|FG003|Overall Study|Lost to Follow-up|0|||
129857166|NCT00558285|467435369|FG004|Overall Study|Lost to Follow-up|0|||
129857167|NCT00558285|467435365|FG000|Overall Study|Administrative problems|0|||
129857168|NCT00558285|467435366|FG001|Overall Study|Administrative problems|0|||
129857169|NCT00558285|467435367|FG002|Overall Study|Administrative problems|0|||
129857170|NCT00558285|467435368|FG003|Overall Study|Administrative problems|1|||
129857171|NCT00558285|467435369|FG004|Overall Study|Administrative problems|1|||
129857172|NCT00558285|467435365|FG000|Overall Study|Protocol deviation|1|||
129857173|NCT00558285|467435366|FG001|Overall Study|Protocol deviation|1|||
129857174|NCT00558285|467435367|FG002|Overall Study|Protocol deviation|0|||
129857175|NCT00558285|467435368|FG003|Overall Study|Protocol deviation|1|||
129857176|NCT00558285|467435369|FG004|Overall Study|Protocol deviation|0|||
129857177|NCT02730819|467435370|FG000|Overall Study|Lost to Follow-up|9|||
129857178|NCT02121847|467435371|FG000|Overall Study|Administrative Reasons|1|||
129857179|NCT02121847|467435371|FG000|Overall Study|Adverse Event|2|||
129857180|NCT01660906|467435373|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
129857181|NCT03478891|467435374|FG000|Overall Study|Enrolled, but product never administered|0|||
129857182|NCT03478891|467435375|FG001|Overall Study|Enrolled, but product never administered|0|||
129857183|NCT03478891|467435376|FG002|Overall Study|Enrolled, but product never administered|1|||
129857184|NCT03478891|467435374|FG000|Overall Study|Moved from area|0|||
129857185|NCT03478891|467435375|FG001|Overall Study|Moved from area|0|||
129857186|NCT03478891|467435376|FG002|Overall Study|Moved from area|1|||
129857187|NCT03478891|467435374|FG000|Overall Study|Lost to Follow-up|1|||
129857188|NCT03478891|467435375|FG001|Overall Study|Lost to Follow-up|0|||
129857189|NCT03478891|467435376|FG002|Overall Study|Lost to Follow-up|1|||
129857190|NCT00809757|467435378|FG000|Overall Study|Adverse Event|2|||
129857191|NCT00809757|467435379|FG001|Overall Study|Adverse Event|3|||
129857192|NCT00809757|467435380|FG002|Overall Study|Adverse Event|3|||
129857193|NCT00809757|467435378|FG000|Overall Study|Lost to Follow-up|0|||
129857194|NCT00809757|467435379|FG001|Overall Study|Lost to Follow-up|0|||
129857195|NCT00809757|467435380|FG002|Overall Study|Lost to Follow-up|1|||
129857196|NCT00809757|467435378|FG000|Overall Study|Protocol Violation|1|||
129857197|NCT00809757|467435379|FG001|Overall Study|Protocol Violation|1|||
129857198|NCT00809757|467435380|FG002|Overall Study|Protocol Violation|1|||
129857199|NCT00809757|467435378|FG000|Overall Study|Withdrawal by Subject|2|||
129857200|NCT00809757|467435379|FG001|Overall Study|Withdrawal by Subject|1|||
129857201|NCT00809757|467435380|FG002|Overall Study|Withdrawal by Subject|3|||
129857202|NCT00809757|467435378|FG000|Overall Study|Subject Uncooperative|1|||
129857203|NCT00809757|467435379|FG001|Overall Study|Subject Uncooperative|0|||
129857204|NCT00809757|467435380|FG002|Overall Study|Subject Uncooperative|2|||
129857205|NCT00809757|467435378|FG000|Overall Study|Noncompliance with Medication|0|||
129857206|NCT00809757|467435379|FG001|Overall Study|Noncompliance with Medication|0|||
129857207|NCT00809757|467435380|FG002|Overall Study|Noncompliance with Medication|1|||
129857208|NCT00253864|467435381|FG000|Overall Study|Lost to Follow-up|5|||
129857209|NCT00253864|467435382|FG001|Overall Study|Lost to Follow-up|8|||
129857210|NCT01410448|467435386|FG000|Overall Study|No conversion to everolimus|0|||
129857211|NCT01410448|467435387|FG001|Overall Study|No conversion to everolimus|24|||
129857212|NCT01410448|467435386|FG000|Overall Study|Graft loss|4|||
129857213|NCT01410448|467435387|FG001|Overall Study|Graft loss|1|||
129857214|NCT01410448|467435386|FG000|Overall Study|Administrative issues|2|||
129857215|NCT01410448|467435387|FG001|Overall Study|Administrative issues|1|||
129857216|NCT01410448|467435386|FG000|Overall Study|Lost to Follow-up|1|||
129857217|NCT01410448|467435387|FG001|Overall Study|Lost to Follow-up|0|||
129857218|NCT01410448|467435386|FG000|Overall Study|Withdrawal by Subject|3|||
129857219|NCT01410448|467435387|FG001|Overall Study|Withdrawal by Subject|2|||
129857220|NCT01410448|467435386|FG000|Overall Study|Protocol Violation|0|||
129857221|NCT01410448|467435387|FG001|Overall Study|Protocol Violation|4|||
129857222|NCT01410448|467435386|FG000|Overall Study|Death|2|||
129857223|NCT01410448|467435387|FG001|Overall Study|Death|3|||
129857224|NCT00360529|467435388|FG000|Overall Study|Adverse Event|10|||
129857225|NCT00360529|467435389|FG001|Overall Study|Adverse Event|23|||
129857226|NCT00360529|467435390|FG002|Overall Study|Adverse Event|33|||
129857227|NCT00360529|467435388|FG000|Overall Study|Protocol Violation|3|||
129857228|NCT00360529|467435389|FG001|Overall Study|Protocol Violation|3|||
129857229|NCT00360529|467435390|FG002|Overall Study|Protocol Violation|11|||
129857230|NCT00360529|467435388|FG000|Overall Study|Lost to Follow-up|14|||
129857231|NCT00360529|467435389|FG001|Overall Study|Lost to Follow-up|10|||
129857232|NCT00360529|467435390|FG002|Overall Study|Lost to Follow-up|13|||
129857233|NCT00360529|467435388|FG000|Overall Study|Withdrawal by Subject|22|||
129857234|NCT00360529|467435389|FG001|Overall Study|Withdrawal by Subject|14|||
129857235|NCT00360529|467435390|FG002|Overall Study|Withdrawal by Subject|18|||
129909510|NCT00774397|467632336|FG006|Overall Study|Not treated|1|||
129857236|NCT00360529|467435388|FG000|Overall Study|Lack of Efficacy|8|||
129857237|NCT00360529|467435389|FG001|Overall Study|Lack of Efficacy|6|||
129857238|NCT00360529|467435390|FG002|Overall Study|Lack of Efficacy|5|||
129857239|NCT00360529|467435388|FG000|Overall Study|Reason discontinued not explained above|4|||
129857240|NCT00360529|467435389|FG001|Overall Study|Reason discontinued not explained above|9|||
129857241|NCT00360529|467435390|FG002|Overall Study|Reason discontinued not explained above|11|||
129857242|NCT03712917|467435391|FG000|Overall Study|Pregnancy|0|||
129857243|NCT03712917|467435392|FG001|Overall Study|Pregnancy|0|||
129857244|NCT03712917|467435393|FG002|Overall Study|Pregnancy|1|||
129857245|NCT03712917|467435391|FG000|Overall Study|Adverse Event|0|||
129857246|NCT03712917|467435392|FG001|Overall Study|Adverse Event|4|||
129857247|NCT03712917|467435393|FG002|Overall Study|Adverse Event|3|||
129857248|NCT03712917|467435391|FG000|Overall Study|Lost to Follow-up|9|||
129857249|NCT03712917|467435392|FG001|Overall Study|Lost to Follow-up|4|||
129857250|NCT03712917|467435393|FG002|Overall Study|Lost to Follow-up|5|||
129857251|NCT01218438|467435394|FG000|Epoch 1|Physician Decision|2|||
129857252|NCT01218438|467435394|FG000|Epoch 1|Adverse Event|1|||
129857253|NCT01218438|467435394|FG000|Epoch 3|Withdrawal by Subject|3|||
129857254|NCT01218438|467435394|FG000|Epoch 3|Adverse Event|1|||
129857255|NCT01218438|467435394|FG000|Epoch 4|Physician Decision|1|||
129857256|NCT01218438|467435394|FG000|Epoch 4|Withdrawal by Subject|2|||
129857257|NCT02091167|467435396|FG000|Overall Study|Lost to Follow-up|0|||
129857258|NCT02091167|467435397|FG001|Overall Study|Lost to Follow-up|2|||
129857259|NCT03096782|467435398|FG000|Overall Study|Death|1|||
129857260|NCT03096782|467435398|FG000|Overall Study|Participant Relapsed|1|||
129857261|NCT03662750|467435399|FG000|Overall Study|Withdrawal by Subject|1|||
129857262|NCT00932893|467435406|FG000|Overall Study|Death|115|||
129857263|NCT00932893|467435407|FG001|Overall Study|Death|24|||
129857264|NCT00932893|467435406|FG000|Overall Study|Lost to Follow-up|8|||
129857265|NCT00932893|467435407|FG001|Overall Study|Lost to Follow-up|0|||
129857266|NCT00932893|467435406|FG000|Overall Study|Withdrawal by Subject|5|||
129857267|NCT00932893|467435407|FG001|Overall Study|Withdrawal by Subject|2|||
129857268|NCT00932893|467435406|FG000|Overall Study|Other|5|||
129857269|NCT00932893|467435407|FG001|Overall Study|Other|144|||
129857270|NCT00993447|467437012|FG000|Overall Study|Withdrawal by Subject|23|||
129857271|NCT00993447|467437013|FG001|Overall Study|Withdrawal by Subject|8|||
129857272|NCT00993447|467437012|FG000|Overall Study|Protocol Violation|12|||
129857273|NCT00993447|467437013|FG001|Overall Study|Protocol Violation|8|||
129857274|NCT00993447|467437012|FG000|Overall Study|Lost to Follow-up|1|||
129857275|NCT00993447|467437013|FG001|Overall Study|Lost to Follow-up|3|||
129857276|NCT00993447|467437012|FG000|Overall Study|Adverse Event|1|||
129857277|NCT00993447|467437013|FG001|Overall Study|Adverse Event|0|||
129857278|NCT00970502|467437015|FG000|Overall Study|Withdrawal by Subject|1|||
129857279|NCT03811912|467437016|FG000|Overall Study|Withdrew Consent|4|||
129857280|NCT03811912|467437017|FG001|Overall Study|Withdrew Consent|2|||
129857281|NCT01438411|467437018|FG000|Overall Study|Adverse Event|8|||
129857282|NCT01438411|467437018|FG000|Overall Study|Lost to Follow-up|1|||
129857283|NCT01438411|467437018|FG000|Overall Study|Lack of Efficacy|1|||
129857284|NCT01438411|467437018|FG000|Overall Study|Withdrawal by Subject|3|||
129857285|NCT01863680|467437019|FG000|Overall Study|Adverse Event|17|||
129857286|NCT01863680|467437019|FG000|Overall Study|Risk of OHSS|17|||
129857287|NCT01863680|467437019|FG000|Overall Study|Spontaneous pregnancy|2|||
129857288|NCT01863680|467437019|FG000|Overall Study|Withdrawal by Subject|1|||
129857289|NCT01863680|467437019|FG000|Overall Study|Did not undergo IVF/ET|14|||
129857290|NCT01863680|467437019|FG000|Overall Study|Other|6|||
129857291|NCT00618514|467437020|FG000|Overall Study|Lost to Follow-up|11|||
129857292|NCT00618514|467437021|FG001|Overall Study|Lost to Follow-up|12|||
129857293|NCT00618514|467437022|FG002|Overall Study|Lost to Follow-up|4|||
129857294|NCT00566228|467437023|FG000|Overall Study|Withdrawal by Subject|1|||
129857295|NCT00566228|467437024|FG001|Overall Study|Withdrawal by Subject|0|||
129857296|NCT00566228|467437023|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
129857297|NCT00566228|467437024|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
129857298|NCT00566228|467437023|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
129857299|NCT00566228|467437024|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
129857300|NCT00566228|467437023|FG000|Overall Study|progressed before infusion could occur|0|||
129857301|NCT00566228|467437024|FG001|Overall Study|progressed before infusion could occur|1|||
129857302|NCT02053350|467437025|FG000|Overall Study|Withdrawal by Subject|1|||
129857303|NCT02053350|467437025|FG000|Overall Study|Adverse Event|4|||
129857304|NCT02244944|467437026|FG000|Overall Study|Withdrawal by Subject|1|||
129857305|NCT02244944|467437026|FG000|Overall Study|Study Terminated|1|||
129857306|NCT02367911|467437031|FG000|Overall Study|Withdrawal by Subject|3|||
129857307|NCT02367911|467437032|FG001|Overall Study|Withdrawal by Subject|2|||
129857308|NCT02367911|467437031|FG000|Overall Study|Lost to Follow-up|2|||
129857309|NCT02367911|467437032|FG001|Overall Study|Lost to Follow-up|2|||
129857310|NCT00902304|467437033|FG000|Overall Study|Adverse Event|4|||
129857311|NCT00902304|467437034|FG001|Overall Study|Adverse Event|10|||
129857312|NCT00902304|467437035|FG002|Overall Study|Adverse Event|25|||
129857313|NCT00902304|467437033|FG000|Overall Study|Investigator discretion|3|||
129857314|NCT00902304|467437034|FG001|Overall Study|Investigator discretion|5|||
129857315|NCT00902304|467437035|FG002|Overall Study|Investigator discretion|13|||
129857316|NCT00902304|467437033|FG000|Overall Study|Lost to Follow-up|7|||
129857317|NCT00902304|467437034|FG001|Overall Study|Lost to Follow-up|7|||
129857318|NCT00902304|467437035|FG002|Overall Study|Lost to Follow-up|7|||
129857319|NCT00902304|467437033|FG000|Overall Study|Protocol Violation|9|||
129909511|NCT00774397|467632330|FG000|Overall Study|Other than those stated above|1|||
129909512|NCT00774397|467632331|FG001|Overall Study|Other than those stated above|1|||
129909513|NCT00774397|467632332|FG002|Overall Study|Other than those stated above|3|||
129909514|NCT00774397|467632333|FG003|Overall Study|Other than those stated above|2|||
129909515|NCT00774397|467632334|FG004|Overall Study|Other than those stated above|2|||
129909516|NCT00774397|467632335|FG005|Overall Study|Other than those stated above|0|||
129909517|NCT00774397|467632336|FG006|Overall Study|Other than those stated above|1|||
129909518|NCT02765100|467632340|FG000|Overall Study|subject found ineligible after baseline|1|||
129857320|NCT00902304|467437034|FG001|Overall Study|Protocol Violation|18|||
129857321|NCT00902304|467437035|FG002|Overall Study|Protocol Violation|20|||
129857322|NCT00902304|467437033|FG000|Overall Study|Withdrawal by Subject|32|||
129857323|NCT00902304|467437034|FG001|Overall Study|Withdrawal by Subject|22|||
129857324|NCT00902304|467437035|FG002|Overall Study|Withdrawal by Subject|43|||
129857325|NCT00902304|467437033|FG000|Overall Study|includes pregnancy|3|||
129857326|NCT00902304|467437034|FG001|Overall Study|includes pregnancy|9|||
129857327|NCT00902304|467437035|FG002|Overall Study|includes pregnancy|2|||
129857328|NCT04579757|467437036|FG000|Overall Study|Adverse Event|0|||
129857329|NCT04579757|467437037|FG001|Overall Study|Adverse Event|0|||
129857330|NCT04579757|467437038|FG002|Overall Study|Adverse Event|0|||
129857331|NCT04579757|467437039|FG003|Overall Study|Adverse Event|2|||
129857332|NCT04579757|467437040|FG004|Overall Study|Adverse Event|1|||
129857333|NCT04579757|467437041|FG005|Overall Study|Adverse Event|1|||
129857334|NCT04579757|467437042|FG006|Overall Study|Adverse Event|0|||
129857335|NCT04579757|467437043|FG007|Overall Study|Adverse Event|0|||
129857336|NCT04579757|467437044|FG008|Overall Study|Adverse Event|0|||
129857337|NCT04579757|467437036|FG000|Overall Study|Death|4|||
129857338|NCT04579757|467437037|FG001|Overall Study|Death|1|||
129857339|NCT04579757|467437038|FG002|Overall Study|Death|14|||
129857340|NCT04579757|467437039|FG003|Overall Study|Death|3|||
129857341|NCT04579757|467437040|FG004|Overall Study|Death|2|||
129857342|NCT04579757|467437041|FG005|Overall Study|Death|7|||
129857343|NCT04579757|467437042|FG006|Overall Study|Death|0|||
129857344|NCT04579757|467437043|FG007|Overall Study|Death|1|||
129857345|NCT04579757|467437044|FG008|Overall Study|Death|3|||
129857346|NCT04579757|467437036|FG000|Overall Study|Physician Decision|0|||
129857347|NCT04579757|467437037|FG001|Overall Study|Physician Decision|0|||
129857348|NCT04579757|467437038|FG002|Overall Study|Physician Decision|0|||
129857349|NCT04579757|467437039|FG003|Overall Study|Physician Decision|2|||
129857350|NCT04579757|467437040|FG004|Overall Study|Physician Decision|1|||
129857351|NCT04579757|467437041|FG005|Overall Study|Physician Decision|1|||
129857352|NCT04579757|467437042|FG006|Overall Study|Physician Decision|1|||
129857353|NCT04579757|467437043|FG007|Overall Study|Physician Decision|0|||
129857354|NCT04579757|467437044|FG008|Overall Study|Physician Decision|0|||
129857355|NCT04579757|467437036|FG000|Overall Study|Study Terminated By Sponsor|0|||
129857356|NCT04579757|467437037|FG001|Overall Study|Study Terminated By Sponsor|0|||
129857357|NCT04579757|467437038|FG002|Overall Study|Study Terminated By Sponsor|0|||
129857358|NCT04579757|467437039|FG003|Overall Study|Study Terminated By Sponsor|0|||
129857359|NCT04579757|467437040|FG004|Overall Study|Study Terminated By Sponsor|2|||
129857360|NCT04579757|467437041|FG005|Overall Study|Study Terminated By Sponsor|0|||
129857361|NCT04579757|467437042|FG006|Overall Study|Study Terminated By Sponsor|0|||
129857362|NCT04579757|467437043|FG007|Overall Study|Study Terminated By Sponsor|2|||
129857363|NCT04579757|467437044|FG008|Overall Study|Study Terminated By Sponsor|0|||
129857364|NCT04579757|467437036|FG000|Overall Study|Withdrawal by Subject|1|||
129857365|NCT04579757|467437037|FG001|Overall Study|Withdrawal by Subject|1|||
129857366|NCT04579757|467437038|FG002|Overall Study|Withdrawal by Subject|0|||
129857367|NCT04579757|467437039|FG003|Overall Study|Withdrawal by Subject|0|||
129857368|NCT04579757|467437040|FG004|Overall Study|Withdrawal by Subject|2|||
129857369|NCT04579757|467437041|FG005|Overall Study|Withdrawal by Subject|1|||
129909519|NCT02765100|467632341|FG001|Overall Study|subject found ineligible after baseline|1|||
129857370|NCT04579757|467437042|FG006|Overall Study|Withdrawal by Subject|0|||
129857371|NCT04579757|467437043|FG007|Overall Study|Withdrawal by Subject|3|||
129857372|NCT04579757|467437044|FG008|Overall Study|Withdrawal by Subject|0|||
129857373|NCT04579757|467437036|FG000|Overall Study|Radiological or Clinical PD|1|||
129909520|NCT02765100|467632340|FG000|Overall Study|Lost to Follow-up|0|||
129909521|NCT02765100|467632341|FG001|Overall Study|Lost to Follow-up|1|||
129857374|NCT04579757|467437037|FG001|Overall Study|Radiological or Clinical PD|4|||
129857375|NCT04579757|467437038|FG002|Overall Study|Radiological or Clinical PD|1|||
129857376|NCT04579757|467437039|FG003|Overall Study|Radiological or Clinical PD|3|||
129857377|NCT04579757|467437040|FG004|Overall Study|Radiological or Clinical PD|9|||
129857378|NCT04579757|467437041|FG005|Overall Study|Radiological or Clinical PD|4|||
129857379|NCT04579757|467437042|FG006|Overall Study|Radiological or Clinical PD|2|||
129857380|NCT04579757|467437043|FG007|Overall Study|Radiological or Clinical PD|2|||
129857381|NCT04579757|467437044|FG008|Overall Study|Radiological or Clinical PD|0|||
129857382|NCT04579757|467437036|FG000|Overall Study|Start of New Therapy|0|||
129857383|NCT04579757|467437037|FG001|Overall Study|Start of New Therapy|0|||
129857384|NCT04579757|467437038|FG002|Overall Study|Start of New Therapy|0|||
129857385|NCT04579757|467437039|FG003|Overall Study|Start of New Therapy|0|||
129857386|NCT04579757|467437040|FG004|Overall Study|Start of New Therapy|2|||
129857387|NCT04579757|467437041|FG005|Overall Study|Start of New Therapy|1|||
129857388|NCT04579757|467437042|FG006|Overall Study|Start of New Therapy|0|||
129857389|NCT04579757|467437043|FG007|Overall Study|Start of New Therapy|0|||
129857390|NCT04579757|467437044|FG008|Overall Study|Start of New Therapy|0|||
129857391|NCT05706506|467437045|FG000|Overall Study|Adverse Event|1|||
129857392|NCT05706506|467437045|FG000|Overall Study|Withdrawal by Subject|4|||
129857393|NCT05706506|467437045|FG000|Overall Study|Lost to Follow-up|2|||
129857394|NCT05706506|467437045|FG000|Overall Study|Inadvertent Enrolment|12|||
129857395|NCT05706506|467437045|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
129857396|NCT05706506|467437045|FG000|Overall Study|Participant Moved Out of State|1|||
129857397|NCT05732454|467437046|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
129857398|NCT05732454|467437047|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
129857399|NCT05732454|467437046|FG000|Part 1: DB Period|Adverse Event|1|||
129857400|NCT05732454|467437047|FG001|Part 1: DB Period|Adverse Event|0|||
129857401|NCT05732454|467437046|FG000|Part 1: DB Period|Lost to Follow-up|1|||
129857402|NCT05732454|467437047|FG001|Part 1: DB Period|Lost to Follow-up|0|||
129857403|NCT05732454|467437046|FG000|Part 1: DB Period|Protocol Violation|0|||
129857404|NCT05732454|467437047|FG001|Part 1: DB Period|Protocol Violation|1|||
129857405|NCT05732454|467437046|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
129857406|NCT05732454|467437047|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
129857407|NCT05732454|467437046|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
129857408|NCT05732454|467437047|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
129857409|NCT05732454|467437046|FG000|Part 1: OLE Period|Adverse Event|0|||
129857410|NCT05732454|467437047|FG001|Part 1: OLE Period|Adverse Event|1|||
129857411|NCT05732454|467437046|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
129857412|NCT05732454|467437047|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
129857413|NCT01153633|467437048|FG000|Overall Study|Protocol Violation|1|||
129857414|NCT01153633|467437049|FG001|Overall Study|Protocol Violation|1|||
129857415|NCT01153633|467437048|FG000|Overall Study|Therapeutic failure|3|||
129857416|NCT01153633|467437049|FG001|Overall Study|Therapeutic failure|3|||
129857417|NCT00384085|467437050|FG000|Overall Study|Adverse Event|5|||
129857418|NCT00384085|467437051|FG001|Overall Study|Adverse Event|5|||
129857419|NCT00384085|467437052|FG002|Overall Study|Adverse Event|4|||
129857420|NCT00384085|467437050|FG000|Overall Study|Lack of Efficacy|0|||
129857421|NCT00384085|467437051|FG001|Overall Study|Lack of Efficacy|3|||
129857422|NCT00384085|467437052|FG002|Overall Study|Lack of Efficacy|2|||
129857423|NCT00384085|467437050|FG000|Overall Study|No longer Requires Study Treatment|1|||
129857424|NCT00384085|467437051|FG001|Overall Study|No longer Requires Study Treatment|0|||
129857425|NCT00384085|467437052|FG002|Overall Study|No longer Requires Study Treatment|1|||
129857426|NCT00384085|467437050|FG000|Overall Study|Protocol Violation|2|||
129857427|NCT00384085|467437051|FG001|Overall Study|Protocol Violation|2|||
129857428|NCT00384085|467437052|FG002|Overall Study|Protocol Violation|2|||
129857429|NCT00384085|467437050|FG000|Overall Study|Lost to Follow-up|9|||
129857430|NCT00384085|467437051|FG001|Overall Study|Lost to Follow-up|9|||
129857431|NCT00384085|467437052|FG002|Overall Study|Lost to Follow-up|10|||
129857432|NCT00384085|467437050|FG000|Overall Study|Progressive Disease|0|||
129857433|NCT00384085|467437051|FG001|Overall Study|Progressive Disease|1|||
129857434|NCT00384085|467437052|FG002|Overall Study|Progressive Disease|0|||
129857435|NCT00384085|467437050|FG000|Overall Study|Withdrawal by Subject|14|||
129857436|NCT00384085|467437051|FG001|Overall Study|Withdrawal by Subject|19|||
129857437|NCT00384085|467437052|FG002|Overall Study|Withdrawal by Subject|29|||
129857438|NCT00384085|467437050|FG000|Overall Study|Patient non-compliant|4|||
129857439|NCT00384085|467437051|FG001|Overall Study|Patient non-compliant|4|||
129857440|NCT00384085|467437052|FG002|Overall Study|Patient non-compliant|5|||
129857441|NCT00384085|467437050|FG000|Overall Study|Physician Decision|1|||
129857442|NCT00384085|467437051|FG001|Overall Study|Physician Decision|0|||
129857443|NCT00384085|467437052|FG002|Overall Study|Physician Decision|0|||
129857444|NCT00384085|467437050|FG000|Overall Study|Loss of site personnel|1|||
129857445|NCT00384085|467437051|FG001|Overall Study|Loss of site personnel|0|||
129857446|NCT00384085|467437052|FG002|Overall Study|Loss of site personnel|1|||
129857447|NCT00384085|467437050|FG000|Overall Study|Sponsor decision|1|||
129857448|NCT00384085|467437051|FG001|Overall Study|Sponsor decision|2|||
129857449|NCT00384085|467437052|FG002|Overall Study|Sponsor decision|1|||
129857450|NCT00384085|467437050|FG000|Overall Study|Patient moved|1|||
129857451|NCT00384085|467437051|FG001|Overall Study|Patient moved|0|||
129857452|NCT00384085|467437052|FG002|Overall Study|Patient moved|1|||
129857453|NCT00384085|467437050|FG000|Overall Study|Patient required surgery|0|||
129857454|NCT00384085|467437051|FG001|Overall Study|Patient required surgery|1|||
129857455|NCT00384085|467437052|FG002|Overall Study|Patient required surgery|0|||
129857456|NCT03725982|467437055|FG000|First Intervention|Withdrawal by Subject|0|||
129857457|NCT03725982|467437056|FG001|First Intervention|Withdrawal by Subject|1|||
129857458|NCT03725982|467437055|FG000|First Intervention|Physician Decision|1|||
129857459|NCT03725982|467437056|FG001|First Intervention|Physician Decision|1|||
129857460|NCT00352365|467437059|FG000|Induction Therapy|Adverse Event|7|||
129857461|NCT00352365|467437059|FG000|Induction Therapy|Progression/Relapse|8|||
129857462|NCT00352365|467437059|FG000|Induction Therapy|Death|7|||
129909522|NCT02652442|467632342|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
129909523|NCT00106080|467632348|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
129909524|NCT00106080|467632349|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
129909525|NCT03740009|467632350|FG000|Overall Study|Physician Decision|9|||
129909526|NCT03740009|467632350|FG000|Overall Study|Lost to Follow-up|1|||
129909527|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
129909528|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
129909529|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
129909530|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
129909531|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
129909532|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
129909533|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
129909534|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
129909535|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
129909536|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
129909537|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
129909538|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
129909539|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
129909540|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
129909541|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
129909542|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
129909543|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
129909544|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
129909545|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
129909546|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
129909547|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
129909548|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
129909549|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
129909550|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
129909551|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
129909552|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
129909553|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
130116646|NCT00585351|468387148|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
129857463|NCT00352365|467437059|FG000|Induction Therapy|Not protocol specified|1|||
129857464|NCT00352365|467437059|FG000|Induction Therapy|Not eligible|3|||
129857465|NCT00352365|467437059|FG000|Induction Therapy|Death before starting protocol therapy|1|||
129857466|NCT00352365|467437059|FG000|Maintenance Therapy|Progression/Relapse|3|||
129857467|NCT00352365|467437059|FG000|Maintenance Therapy|Death|2|||
129857468|NCT00352365|467437059|FG000|Maintenance Therapy|Not protocol specified|3|||
129857469|NCT00352365|467437059|FG000|Maintenance Therapy|Not eligible|4|||
129857470|NCT04743908|467437060|FG000|Overall Study|Death|1|||
129857471|NCT04743908|467437061|FG001|Overall Study|Death|0|||
129857472|NCT04743908|467437060|FG000|Overall Study|Lost to Follow-up|181|||
129857473|NCT04743908|467437061|FG001|Overall Study|Lost to Follow-up|180|||
129857474|NCT04743908|467437060|FG000|Overall Study|Withdrawal by Subject|1|||
129857475|NCT04743908|467437061|FG001|Overall Study|Withdrawal by Subject|2|||
129857476|NCT04837482|467437062|FG000|Period 2|Withdrawal by Subject|0|||
129857477|NCT04837482|467437063|FG001|Period 2|Withdrawal by Subject|1|||
129857478|NCT00328510|467437064|FG000|Overall Study|Gag disorder, could not use frame|4|||
129857479|NCT00328510|467437065|FG001|Overall Study|Gag disorder, could not use frame|0|||
129857480|NCT00328510|467437064|FG000|Overall Study|Dentition problems, could not use frame|1|||
129857481|NCT00328510|467437065|FG001|Overall Study|Dentition problems, could not use frame|0|||
129857482|NCT00328510|467437064|FG000|Overall Study|Withdrawal by Subject|4|||
129857483|NCT00328510|467437065|FG001|Overall Study|Withdrawal by Subject|2|||
129857484|NCT00328510|467437064|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
129857485|NCT00328510|467437065|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
129857486|NCT00328510|467437064|FG000|Overall Study|Treatment changed to a single fraction|1|||
129857487|NCT00328510|467437065|FG001|Overall Study|Treatment changed to a single fraction|1|||
129857488|NCT02624804|467437071|FG000|Overall Study|Screen Failure|5|||
129857489|NCT03073603|467437077|FG000|Overall Study|Noncompliance|3|||
129857490|NCT03073603|467437078|FG001|Overall Study|Noncompliance|1|||
129857491|NCT03073603|467437077|FG000|Overall Study|Adverse Event|5|||
129857492|NCT03073603|467437078|FG001|Overall Study|Adverse Event|3|||
129857493|NCT03073603|467437077|FG000|Overall Study|Physician Decision|1|||
129857494|NCT03073603|467437078|FG001|Overall Study|Physician Decision|2|||
129857495|NCT03073603|467437077|FG000|Overall Study|Required treatment not allowed by protocol|1|||
129857496|NCT03073603|467437078|FG001|Overall Study|Required treatment not allowed by protocol|0|||
129857497|NCT03073603|467437077|FG000|Overall Study|Financial or insurance-related|8|||
129857498|NCT03073603|467437078|FG001|Overall Study|Financial or insurance-related|0|||
129857499|NCT03073603|467437077|FG000|Overall Study|Withdrawal by Subject|0|||
129909554|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
129909555|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
129857500|NCT03073603|467437078|FG001|Overall Study|Withdrawal by Subject|1|||
129857501|NCT03073603|467437077|FG000|Overall Study|Discontinued DMT|4|||
129909556|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
129909557|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
129909558|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
129909559|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
129909560|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
129909561|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
129909562|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
129909563|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
129909564|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
129909565|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
129909566|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
129909567|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
129909568|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
129909569|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
129909570|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
129909571|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
129909572|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
129909573|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
129909574|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
129909575|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
129909576|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
129857502|NCT03073603|467437078|FG001|Overall Study|Discontinued DMT|0|||
129857503|NCT03073603|467437077|FG000|Overall Study|Restarted DMT|0|||
129857504|NCT03073603|467437078|FG001|Overall Study|Restarted DMT|1|||
129857505|NCT04757649|467437082|FG000|Overall Study|Withdrawal by Subject|1|||
129857506|NCT04757649|467437082|FG000|Overall Study|Adverse Event|1|||
129857507|NCT01286779|467437083|FG000|Overall Study|Withdrawal by Subject|9|||
129857508|NCT01286779|467437083|FG000|Overall Study|Protocol Violation|5|||
129857509|NCT01286779|467437083|FG000|Overall Study|Physician Decision|2|||
129857510|NCT01286779|467437083|FG000|Overall Study|Participant had scheduled surgery|1|||
129857511|NCT01286779|467437083|FG000|Overall Study|Participant moved to another country|1|||
129857512|NCT01286779|467437083|FG000|Overall Study|Discontinued by sponsor|1|||
129857513|NCT01659021|467437086|FG000|Main Study|Adverse Event|2|||
129857514|NCT01659021|467437087|FG001|Main Study|Adverse Event|3|||
129857515|NCT01659021|467437086|FG000|Main Study|Lost to Follow-up|1|||
129857516|NCT01659021|467437087|FG001|Main Study|Lost to Follow-up|0|||
129857517|NCT01659021|467437086|FG000|Main Study|Unknown Reasons|2|||
129857518|NCT01659021|467437087|FG001|Main Study|Unknown Reasons|1|||
129857519|NCT01659021|467437086|FG000|Main Study|Physician Decision|34|||
129857520|NCT01659021|467437087|FG001|Main Study|Physician Decision|16|||
129857521|NCT01659021|467437086|FG000|Main Study|Withdrawal by Subject|19|||
129857522|NCT01659021|467437087|FG001|Main Study|Withdrawal by Subject|16|||
129857523|NCT01659021|467437086|FG000|Main Study|Study Terminated by Sponsor|16|||
129857524|NCT01659021|467437087|FG001|Main Study|Study Terminated by Sponsor|1|||
129857525|NCT01659021|467437086|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
129857526|NCT01659021|467437087|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
129857527|NCT01659021|467437086|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
129857528|NCT01659021|467437087|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
129857529|NCT02896855|467437090|FG000|Overall Study|Death|50|||
129909577|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
129909578|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
129909579|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
130064712|NCT00964158|468190246|FG000|Overall Study|Withdrawal by Subject|0|||
130064713|NCT00964158|468190247|FG001|Overall Study|Withdrawal by Subject|0|||
129857530|NCT02896855|467437091|FG001|Overall Study|Death|40|||
129857531|NCT02896855|467437090|FG000|Overall Study|Lost to Follow-up|15|||
129857532|NCT02896855|467437091|FG001|Overall Study|Lost to Follow-up|9|||
129857533|NCT02896855|467437090|FG000|Overall Study|Withdrawal by Subject|7|||
129857534|NCT02896855|467437091|FG001|Overall Study|Withdrawal by Subject|4|||
129857535|NCT02508311|467437092|FG000|Overall Study|Withdrawal by Subject|1|||
129857536|NCT02508311|467437093|FG001|Overall Study|Withdrawal by Subject|0|||
129857537|NCT01205685|467437094|FG000|Overall Study|Disease Progression|10|||
129857538|NCT01205685|467437094|FG000|Overall Study|Withdrawal by Subject|1|||
129857539|NCT02169674|467437095|FG000|Overall Study|Withdrawal by Subject|2|||
129857540|NCT02169674|467437096|FG001|Overall Study|Withdrawal by Subject|1|||
129857541|NCT02169674|467437095|FG000|Overall Study|Seroprotected|30|||
129857542|NCT02169674|467437096|FG001|Overall Study|Seroprotected|76|||
129857543|NCT02169674|467437095|FG000|Overall Study|Lost to Follow-up|0|||
129857544|NCT02169674|467437096|FG001|Overall Study|Lost to Follow-up|1|||
129909580|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
129909581|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
129909582|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
129909583|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
129909584|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
129909585|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
129909586|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
129909587|NCT03531840|467632359|FG000|Overall Study|Death on study|3|||
129909588|NCT03531840|467632360|FG001|Overall Study|Death on study|2|||
129909589|NCT03531840|467632361|FG002|Overall Study|Death on study|1|||
129909590|NCT03531840|467632362|FG003|Overall Study|Death on study|2|||
129909591|NCT03531840|467632359|FG000|Overall Study|Death during follow up|2|||
129909592|NCT03531840|467632360|FG001|Overall Study|Death during follow up|3|||
129857545|NCT03058679|467437102|FG000|Baseline to Week 6|Lost to Follow-up|3|||
129857546|NCT03058679|467437103|FG001|Baseline to Week 6|Lost to Follow-up|2|||
129857547|NCT03058679|467437102|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
129857548|NCT03058679|467437103|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
129857549|NCT03058679|467437102|FG000|Baseline to Week 6|Adverse Event|6|||
129857550|NCT03058679|467437103|FG001|Baseline to Week 6|Adverse Event|6|||
129857551|NCT03058679|467437102|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
129857552|NCT03058679|467437103|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
129857553|NCT03058679|467437102|FG000|Baseline to Week 6|Difficulty following the diet|0|||
129857554|NCT03058679|467437103|FG001|Baseline to Week 6|Difficulty following the diet|2|||
129857555|NCT03058679|467437102|FG000|Baseline to Week 6|Physician Decision|1|||
129857556|NCT03058679|467437103|FG001|Baseline to Week 6|Physician Decision|0|||
129857557|NCT03058679|467437102|FG000|Week 6 to Week 12|Change in medication|5|||
129857558|NCT03058679|467437103|FG001|Week 6 to Week 12|Change in medication|7|||
129857559|NCT03058679|467437102|FG000|Week 6 to Week 12|Adverse Event|4|||
129857560|NCT03058679|467437103|FG001|Week 6 to Week 12|Adverse Event|3|||
129857561|NCT03058679|467437102|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
129857562|NCT03058679|467437103|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
129857563|NCT03058679|467437102|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
129857564|NCT03058679|467437103|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
129857565|NCT00574080|467437104|FG000|Overall Study|Death|10|||
129857566|NCT00574080|467437105|FG001|Overall Study|Death|10|||
129857567|NCT00599326|467437106|FG000|Overall Study|Lost to Follow-up|1|||
129857568|NCT00599326|467437106|FG000|Overall Study|Noncompliant|1|||
129857569|NCT00784810|467437109|FG000|Overall Study|Adverse Event|32|||
129857570|NCT00784810|467437110|FG001|Overall Study|Adverse Event|20|||
129857571|NCT00784810|467437109|FG000|Overall Study|Lack of Efficacy|14|||
129857572|NCT00784810|467437110|FG001|Overall Study|Lack of Efficacy|11|||
129857573|NCT00784810|467437109|FG000|Overall Study|Withdrawal by Subject|11|||
129857574|NCT00784810|467437110|FG001|Overall Study|Withdrawal by Subject|9|||
129857575|NCT00784810|467437109|FG000|Overall Study|Administrative|5|||
129857576|NCT00784810|467437110|FG001|Overall Study|Administrative|8|||
129857577|NCT00784810|467437109|FG000|Overall Study|Lost to Follow-up|1|||
129857578|NCT00784810|467437110|FG001|Overall Study|Lost to Follow-up|1|||
129857579|NCT02862106|467437111|FG000|Overall Study|Adverse Event|4|||
129857580|NCT02862106|467437112|FG001|Overall Study|Adverse Event|0|||
129857581|NCT02862106|467437111|FG000|Overall Study|Protocol Violation|16|||
129857582|NCT02862106|467437112|FG001|Overall Study|Protocol Violation|1|||
129857583|NCT02862106|467437111|FG000|Overall Study|Lost to Follow-up|15|||
129857584|NCT02862106|467437112|FG001|Overall Study|Lost to Follow-up|5|||
129857585|NCT02862106|467437111|FG000|Overall Study|Withdrawal by Subject|2|||
129857586|NCT02862106|467437112|FG001|Overall Study|Withdrawal by Subject|0|||
129909593|NCT03531840|467632361|FG002|Overall Study|Death during follow up|4|||
129857587|NCT02862106|467437111|FG000|Overall Study|Subjects moved to other city|1|||
129857588|NCT02862106|467437112|FG001|Overall Study|Subjects moved to other city|0|||
129857589|NCT00563784|467437115|FG000|Overall Study|Withdrawal by Subject|2|||
129857590|NCT00563784|467437115|FG000|Overall Study|Screen Failures|20|||
129857591|NCT01380327|467437116|FG000|Overall Study|Lost to Follow-up|0|||
129857592|NCT01380327|467437117|FG001|Overall Study|Lost to Follow-up|1|||
129857593|NCT01380327|467437118|FG002|Overall Study|Lost to Follow-up|1|||
129857594|NCT01380327|467437116|FG000|Overall Study|Protocol Violation|3|||
129857595|NCT01380327|467437117|FG001|Overall Study|Protocol Violation|2|||
129857596|NCT01380327|467437118|FG002|Overall Study|Protocol Violation|3|||
129857597|NCT01380327|467437116|FG000|Overall Study|Withdrawal by Subject|0|||
129857598|NCT01380327|467437117|FG001|Overall Study|Withdrawal by Subject|0|||
129857599|NCT01380327|467437118|FG002|Overall Study|Withdrawal by Subject|1|||
129857600|NCT01380327|467437116|FG000|Overall Study|Housing situation precluded ability to k|0|||
129857601|NCT01380327|467437117|FG001|Overall Study|Housing situation precluded ability to k|0|||
129857602|NCT01380327|467437118|FG002|Overall Study|Housing situation precluded ability to k|1|||
129909594|NCT03531840|467632362|FG003|Overall Study|Death during follow up|1|||
129909595|NCT00761605|467632364|FG000|Overall Study|Adverse Event|26|||
129857603|NCT01380327|467437116|FG000|Overall Study|Questionable onset of epilepsy|0|||
129909596|NCT00761605|467632364|FG000|Overall Study|Death|2|||
129909597|NCT00761605|467632364|FG000|Overall Study|Lack of Efficacy|26|||
129909598|NCT00761605|467632364|FG000|Overall Study|Lost to Follow-up|29|||
129909599|NCT00761605|467632364|FG000|Overall Study|Withdrawal by Subject|37|||
129909600|NCT00761605|467632364|FG000|Overall Study|Other|21|||
129909601|NCT02267824|467632365|FG000|Overall Study|Pregnancy|1|||
129909602|NCT02267824|467632366|FG001|Overall Study|Pregnancy|1|||
129909603|NCT02267824|467632365|FG000|Overall Study|Lost to Follow-up|4|||
129909604|NCT02267824|467632366|FG001|Overall Study|Lost to Follow-up|0|||
129909605|NCT02267824|467632365|FG000|Overall Study|Protocol Violation|3|||
129909606|NCT02267824|467632366|FG001|Overall Study|Protocol Violation|0|||
129909607|NCT02267824|467632365|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
129909608|NCT02267824|467632366|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
129909609|NCT03451721|467632367|FG000|Overall Study|Death|1|||
129909610|NCT01985334|467632368|FG000|Overall Study|Administrative problems|1|||
129909611|NCT01985334|467632369|FG001|Overall Study|Administrative problems|1|||
129909612|NCT01985334|467632370|FG002|Overall Study|Administrative problems|0|||
129909613|NCT01985334|467632371|FG003|Overall Study|Administrative problems|2|||
129909614|NCT01985334|467632372|FG004|Overall Study|Administrative problems|0|||
129909615|NCT01985334|467632373|FG005|Overall Study|Administrative problems|1|||
129909616|NCT01985334|467632374|FG006|Overall Study|Administrative problems|1|||
129909617|NCT01985334|467632375|FG007|Overall Study|Administrative problems|3|||
129909618|NCT01985334|467632368|FG000|Overall Study|Death|1|||
129909619|NCT01985334|467632369|FG001|Overall Study|Death|0|||
129909620|NCT01985334|467632370|FG002|Overall Study|Death|0|||
129909621|NCT01985334|467632371|FG003|Overall Study|Death|3|||
129909622|NCT01985334|467632372|FG004|Overall Study|Death|0|||
129909623|NCT01985334|467632373|FG005|Overall Study|Death|0|||
129909624|NCT01985334|467632374|FG006|Overall Study|Death|1|||
129909625|NCT01985334|467632375|FG007|Overall Study|Death|2|||
129909626|NCT01985334|467632368|FG000|Overall Study|Worsening of disease|0|||
129909627|NCT01985334|467632369|FG001|Overall Study|Worsening of disease|0|||
129909628|NCT01985334|467632370|FG002|Overall Study|Worsening of disease|0|||
129909629|NCT01985334|467632371|FG003|Overall Study|Worsening of disease|1|||
129909630|NCT01985334|467632372|FG004|Overall Study|Worsening of disease|0|||
129909631|NCT01985334|467632373|FG005|Overall Study|Worsening of disease|3|||
129909632|NCT01985334|467632374|FG006|Overall Study|Worsening of disease|0|||
129909633|NCT01985334|467632375|FG007|Overall Study|Worsening of disease|1|||
129909634|NCT01985334|467632368|FG000|Overall Study|Other|2|||
129909635|NCT01985334|467632369|FG001|Overall Study|Other|9|||
129909636|NCT01985334|467632370|FG002|Overall Study|Other|7|||
129909637|NCT01985334|467632371|FG003|Overall Study|Other|17|||
129909638|NCT01985334|467632372|FG004|Overall Study|Other|4|||
129909639|NCT01985334|467632373|FG005|Overall Study|Other|8|||
129909640|NCT01985334|467632374|FG006|Overall Study|Other|4|||
129909641|NCT01985334|467632375|FG007|Overall Study|Other|7|||
129909642|NCT01985334|467632368|FG000|Overall Study|Protocol deviation|6|||
129909643|NCT01985334|467632369|FG001|Overall Study|Protocol deviation|31|||
129909644|NCT01985334|467632370|FG002|Overall Study|Protocol deviation|25|||
129909645|NCT01985334|467632371|FG003|Overall Study|Protocol deviation|84|||
129909646|NCT01985334|467632372|FG004|Overall Study|Protocol deviation|17|||
129909647|NCT01985334|467632373|FG005|Overall Study|Protocol deviation|47|||
129909648|NCT01985334|467632374|FG006|Overall Study|Protocol deviation|15|||
129909649|NCT01985334|467632375|FG007|Overall Study|Protocol deviation|42|||
129909650|NCT01985334|467632368|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
129909651|NCT01985334|467632369|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
129909652|NCT01985334|467632370|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
129909653|NCT01985334|467632371|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
129909654|NCT01985334|467632372|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
129909655|NCT01985334|467632373|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
129909656|NCT01985334|467632374|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
129909657|NCT01985334|467632375|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
130064714|NCT00964158|468190248|FG002|Overall Study|Withdrawal by Subject|6|||
129909658|NCT01985334|467632368|FG000|Overall Study|Subject withdrawal of consent|3|||
129909659|NCT01985334|467632369|FG001|Overall Study|Subject withdrawal of consent|6|||
129909660|NCT01985334|467632370|FG002|Overall Study|Subject withdrawal of consent|2|||
129909661|NCT01985334|467632371|FG003|Overall Study|Subject withdrawal of consent|28|||
129909662|NCT01985334|467632372|FG004|Overall Study|Subject withdrawal of consent|4|||
129909663|NCT01985334|467632373|FG005|Overall Study|Subject withdrawal of consent|19|||
129909664|NCT01985334|467632374|FG006|Overall Study|Subject withdrawal of consent|0|||
129909665|NCT01985334|467632375|FG007|Overall Study|Subject withdrawal of consent|20|||
129909666|NCT01985334|467632368|FG000|Overall Study|Adverse Event|0|||
129909667|NCT01985334|467632369|FG001|Overall Study|Adverse Event|8|||
129909668|NCT01985334|467632370|FG002|Overall Study|Adverse Event|2|||
130064715|NCT01054976|468190254|FG000|Overall Study|Adverse Event|16|||
129909669|NCT01985334|467632371|FG003|Overall Study|Adverse Event|26|||
129909670|NCT01985334|467632372|FG004|Overall Study|Adverse Event|3|||
129909671|NCT01985334|467632373|FG005|Overall Study|Adverse Event|18|||
129909672|NCT01985334|467632374|FG006|Overall Study|Adverse Event|3|||
129909673|NCT01985334|467632375|FG007|Overall Study|Adverse Event|15|||
129909674|NCT01985334|467632368|FG000|Overall Study|Other|4|||
129909675|NCT01985334|467632369|FG001|Overall Study|Other|2|||
129909676|NCT01985334|467632370|FG002|Overall Study|Other|3|||
129909677|NCT01985334|467632371|FG003|Overall Study|Other|10|||
129909678|NCT01985334|467632372|FG004|Overall Study|Other|1|||
129909679|NCT01985334|467632373|FG005|Overall Study|Other|6|||
129909680|NCT01985334|467632374|FG006|Overall Study|Other|2|||
129909681|NCT01985334|467632375|FG007|Overall Study|Other|2|||
129909682|NCT01985334|467632368|FG000|Overall Study|Medication non-compliance|0|||
129909683|NCT01985334|467632369|FG001|Overall Study|Medication non-compliance|4|||
129909684|NCT01985334|467632370|FG002|Overall Study|Medication non-compliance|1|||
129909685|NCT01985334|467632371|FG003|Overall Study|Medication non-compliance|6|||
129909686|NCT01985334|467632372|FG004|Overall Study|Medication non-compliance|2|||
129909687|NCT01985334|467632373|FG005|Overall Study|Medication non-compliance|3|||
129909688|NCT01985334|467632374|FG006|Overall Study|Medication non-compliance|1|||
129909689|NCT01985334|467632375|FG007|Overall Study|Medication non-compliance|3|||
129909690|NCT01985334|467632368|FG000|Overall Study|Use of prohibited treatment|1|||
129909691|NCT01985334|467632369|FG001|Overall Study|Use of prohibited treatment|4|||
129909692|NCT01985334|467632370|FG002|Overall Study|Use of prohibited treatment|1|||
129909693|NCT01985334|467632371|FG003|Overall Study|Use of prohibited treatment|2|||
129909694|NCT01985334|467632372|FG004|Overall Study|Use of prohibited treatment|1|||
129909695|NCT01985334|467632373|FG005|Overall Study|Use of prohibited treatment|6|||
129909696|NCT01985334|467632374|FG006|Overall Study|Use of prohibited treatment|2|||
129909697|NCT01985334|467632375|FG007|Overall Study|Use of prohibited treatment|0|||
129909698|NCT01985334|467632368|FG000|Overall Study|Investigator decision|0|||
129909699|NCT01985334|467632369|FG001|Overall Study|Investigator decision|3|||
129909700|NCT01985334|467632370|FG002|Overall Study|Investigator decision|0|||
129909701|NCT01985334|467632371|FG003|Overall Study|Investigator decision|7|||
129857604|NCT01380327|467437117|FG001|Overall Study|Questionable onset of epilepsy|0|||
129857605|NCT01380327|467437118|FG002|Overall Study|Questionable onset of epilepsy|1|||
129857606|NCT03646513|467437122|FG000|Overall Study|Premature study termination|4|||
129857607|NCT01660763|467437126|FG000|Overall Study|Lack of Efficacy|45|||
129857608|NCT01660763|467437127|FG001|Overall Study|Lack of Efficacy|50|||
129857609|NCT01660763|467437126|FG000|Overall Study|Adverse Event|22|||
129857610|NCT01660763|467437127|FG001|Overall Study|Adverse Event|7|||
129857611|NCT01660763|467437126|FG000|Overall Study|Protocol Violation|1|||
129857612|NCT01660763|467437127|FG001|Overall Study|Protocol Violation|0|||
129857613|NCT01660763|467437126|FG000|Overall Study|Withdrawal by Subject|4|||
129857614|NCT01660763|467437127|FG001|Overall Study|Withdrawal by Subject|0|||
129857615|NCT01660763|467437126|FG000|Overall Study|Patient ready for early discharge|28|||
129857616|NCT01660763|467437127|FG001|Overall Study|Patient ready for early discharge|4|||
129857617|NCT03325712|467437128|FG000|Overall Study|Protocol Violation|0|||
129857618|NCT03325712|467437129|FG001|Overall Study|Protocol Violation|0|||
129857619|NCT03325712|467437130|FG002|Overall Study|Protocol Violation|0|||
129857620|NCT03325712|467437131|FG003|Overall Study|Protocol Violation|0|||
129857621|NCT03325712|467437132|FG004|Overall Study|Protocol Violation|1|||
129857622|NCT03325712|467437133|FG005|Overall Study|Protocol Violation|0|||
129857623|NCT03325712|467437134|FG006|Overall Study|Protocol Violation|0|||
129857624|NCT03325712|467437135|FG007|Overall Study|Protocol Violation|0|||
129857625|NCT03325712|467437128|FG000|Overall Study|Adverse Event|0|||
129857626|NCT03325712|467437129|FG001|Overall Study|Adverse Event|0|||
129857627|NCT03325712|467437130|FG002|Overall Study|Adverse Event|0|||
129857628|NCT03325712|467437131|FG003|Overall Study|Adverse Event|0|||
129857629|NCT03325712|467437132|FG004|Overall Study|Adverse Event|1|||
129857630|NCT03325712|467437133|FG005|Overall Study|Adverse Event|0|||
129857631|NCT03325712|467437134|FG006|Overall Study|Adverse Event|0|||
129857632|NCT03325712|467437135|FG007|Overall Study|Adverse Event|0|||
129857633|NCT02265237|467437137|FG000|As Treated (Overall Study)|Adverse Event|1|||
129857634|NCT02265237|467437138|FG001|As Treated (Overall Study)|Adverse Event|1|||
129857635|NCT02265237|467437139|FG002|As Treated (Overall Study)|Adverse Event|0|||
129857636|NCT02265237|467437140|FG003|As Treated (Overall Study)|Adverse Event|0|||
129857637|NCT02265237|467437137|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
129857638|NCT02265237|467437138|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
129857639|NCT02265237|467437139|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
129857640|NCT02265237|467437140|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
129909702|NCT01985334|467632372|FG004|Overall Study|Investigator decision|1|||
129909703|NCT01985334|467632373|FG005|Overall Study|Investigator decision|1|||
129909704|NCT01985334|467632374|FG006|Overall Study|Investigator decision|0|||
129909705|NCT01985334|467632375|FG007|Overall Study|Investigator decision|4|||
129857641|NCT02265237|467437137|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
129857642|NCT02265237|467437138|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
129857643|NCT02265237|467437139|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
129857644|NCT02265237|467437140|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
129909706|NCT01985334|467632368|FG000|Overall Study|Lost to Follow-up|0|||
129909707|NCT01985334|467632369|FG001|Overall Study|Lost to Follow-up|2|||
129909708|NCT01985334|467632370|FG002|Overall Study|Lost to Follow-up|0|||
129857645|NCT02265237|467437137|FG000|As Treated (Overall Study)|Other|2|||
129857646|NCT02265237|467437138|FG001|As Treated (Overall Study)|Other|0|||
129857647|NCT02265237|467437139|FG002|As Treated (Overall Study)|Other|3|||
129857648|NCT02265237|467437140|FG003|As Treated (Overall Study)|Other|1|||
129857649|NCT01178853|467437141|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
129857650|NCT01178853|467437142|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
129857651|NCT01178853|467437141|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
129857652|NCT01178853|467437142|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
129857653|NCT01178853|467437141|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
129857654|NCT01178853|467437142|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
129857655|NCT01178853|467437141|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
129857656|NCT01178853|467437142|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
129857657|NCT01178853|467437141|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
129857658|NCT01178853|467437142|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
129857659|NCT03550313|467437143|FG000|Overall Study|Adverse Event|0|||
129857660|NCT03550313|467437144|FG001|Overall Study|Adverse Event|1|||
129857661|NCT03550313|467437145|FG002|Overall Study|Adverse Event|0|||
129857662|NCT03550313|467437143|FG000|Overall Study|Lost to Follow-up|5|||
129857663|NCT03550313|467437144|FG001|Overall Study|Lost to Follow-up|7|||
129857664|NCT03550313|467437145|FG002|Overall Study|Lost to Follow-up|12|||
129857665|NCT03550313|467437143|FG000|Overall Study|Study terminated by sponsor|44|||
129857666|NCT03550313|467437144|FG001|Overall Study|Study terminated by sponsor|37|||
129857667|NCT03550313|467437145|FG002|Overall Study|Study terminated by sponsor|48|||
129857668|NCT03550313|467437143|FG000|Overall Study|No longer met eligibility criteria|3|||
129857669|NCT03550313|467437144|FG001|Overall Study|No longer met eligibility criteria|5|||
129857670|NCT03550313|467437145|FG002|Overall Study|No longer met eligibility criteria|6|||
129857671|NCT03550313|467437143|FG000|Overall Study|Withdrawal by parent/guardian|20|||
129857672|NCT03550313|467437144|FG001|Overall Study|Withdrawal by parent/guardian|18|||
129857673|NCT03550313|467437145|FG002|Overall Study|Withdrawal by parent/guardian|26|||
129857674|NCT03550313|467437143|FG000|Overall Study|Other|4|||
129857675|NCT03550313|467437144|FG001|Overall Study|Other|2|||
129857676|NCT03550313|467437145|FG002|Overall Study|Other|2|||
129857677|NCT03550313|467437143|FG000|Overall Study|Randomized but not vaccinated|3|||
129857678|NCT03550313|467437144|FG001|Overall Study|Randomized but not vaccinated|23|||
129857679|NCT03550313|467437145|FG002|Overall Study|Randomized but not vaccinated|2|||
129857680|NCT03550313|467437143|FG000|Overall Study|Sites terminated due to quality issues|18|||
129857681|NCT03550313|467437144|FG001|Overall Study|Sites terminated due to quality issues|17|||
129857682|NCT03550313|467437145|FG002|Overall Study|Sites terminated due to quality issues|18|||
129857683|NCT00380068|467437147|FG000|Overall Study|Adverse Event|40|||
129857684|NCT00380068|467437147|FG000|Overall Study|Withdrawal by Subject|10|||
129857685|NCT00380068|467437147|FG000|Overall Study|Not compliant|6|||
129857686|NCT00380068|467437147|FG000|Overall Study|Lost to Follow-up|1|||
129857687|NCT00380068|467437147|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
129857688|NCT00380068|467437147|FG000|Overall Study|Lung transplant|3|||
129857689|NCT00380068|467437147|FG000|Overall Study|Physician Decision|2|||
129857690|NCT00380068|467437147|FG000|Overall Study|Partipant moved away|1|||
129857691|NCT00380068|467437147|FG000|Overall Study|Lack of Efficacy|5|||
129857692|NCT01297062|467437148|FG000|Overall Study|Adverse Event|2|||
129857693|NCT01297062|467437149|FG001|Overall Study|Adverse Event|0|||
129857694|NCT01297062|467437150|FG002|Overall Study|Adverse Event|1|||
129857695|NCT01297062|467437151|FG003|Overall Study|Adverse Event|0|||
129857696|NCT01297062|467437152|FG004|Overall Study|Adverse Event|0|||
129857697|NCT01297062|467437153|FG005|Overall Study|Adverse Event|0|||
129857698|NCT01297062|467437154|FG006|Overall Study|Adverse Event|0|||
129857699|NCT01297062|467437148|FG000|Overall Study|Physician Decision|1|||
129857700|NCT01297062|467437149|FG001|Overall Study|Physician Decision|0|||
129857701|NCT01297062|467437150|FG002|Overall Study|Physician Decision|1|||
129857702|NCT01297062|467437151|FG003|Overall Study|Physician Decision|0|||
129857703|NCT01297062|467437152|FG004|Overall Study|Physician Decision|0|||
129857704|NCT01297062|467437153|FG005|Overall Study|Physician Decision|0|||
129857705|NCT01297062|467437154|FG006|Overall Study|Physician Decision|6|||
129857706|NCT01297062|467437148|FG000|Overall Study|Protocol Violation|0|||
129857707|NCT01297062|467437149|FG001|Overall Study|Protocol Violation|0|||
129857708|NCT01297062|467437150|FG002|Overall Study|Protocol Violation|0|||
129857709|NCT01297062|467437151|FG003|Overall Study|Protocol Violation|0|||
129857710|NCT01297062|467437152|FG004|Overall Study|Protocol Violation|1|||
129857711|NCT01297062|467437153|FG005|Overall Study|Protocol Violation|0|||
129857712|NCT01297062|467437154|FG006|Overall Study|Protocol Violation|0|||
129857713|NCT01297062|467437148|FG000|Overall Study|Subject Decision|1|||
129857714|NCT01297062|467437149|FG001|Overall Study|Subject Decision|1|||
129857715|NCT01297062|467437150|FG002|Overall Study|Subject Decision|0|||
129857716|NCT01297062|467437151|FG003|Overall Study|Subject Decision|1|||
129857717|NCT01297062|467437152|FG004|Overall Study|Subject Decision|1|||
129857718|NCT01297062|467437153|FG005|Overall Study|Subject Decision|1|||
129857719|NCT01297062|467437154|FG006|Overall Study|Subject Decision|2|||
129857720|NCT04964089|467437155|FG000|Overall Study|Adverse Event|8|||
129909709|NCT01985334|467632371|FG003|Overall Study|Lost to Follow-up|3|||
129909710|NCT01985334|467632372|FG004|Overall Study|Lost to Follow-up|1|||
129909711|NCT01985334|467632373|FG005|Overall Study|Lost to Follow-up|4|||
129909712|NCT01985334|467632374|FG006|Overall Study|Lost to Follow-up|0|||
129909713|NCT01985334|467632375|FG007|Overall Study|Lost to Follow-up|3|||
129909714|NCT01290341|467632376|FG000|Overall Study|Protocol Violation|7|||
129909715|NCT01290341|467632377|FG001|Overall Study|Protocol Violation|3|||
129909716|NCT01290341|467632376|FG000|Overall Study|Adverse Event|1|||
129909717|NCT01290341|467632377|FG001|Overall Study|Adverse Event|0|||
129909718|NCT01290341|467632376|FG000|Overall Study|Lost to Follow-up|21|||
129909719|NCT01290341|467632377|FG001|Overall Study|Lost to Follow-up|10|||
129909720|NCT01290341|467632376|FG000|Overall Study|Withdrawal by Subject|19|||
129909721|NCT01290341|467632377|FG001|Overall Study|Withdrawal by Subject|5|||
129909722|NCT01290341|467632376|FG000|Overall Study|Negative baseline culture and others|44|||
129909723|NCT01290341|467632377|FG001|Overall Study|Negative baseline culture and others|11|||
129909724|NCT01102231|467632382|FG000|Overall Study|Protocol Violation|3|||
129909725|NCT01102231|467632382|FG000|Overall Study|Lack of Efficacy|2|||
129909726|NCT01102231|467632382|FG000|Overall Study|Death|2|||
129909727|NCT01102231|467632382|FG000|Overall Study|Adverse Event|3|||
129909728|NCT01102231|467632382|FG000|Overall Study|Withdrawal by Subject|1|||
129909729|NCT01102231|467632382|FG000|Overall Study|Did not received the treatment|4|||
129909730|NCT02568683|467632385|FG000|Overall Study|Death|0|||
129909731|NCT02568683|467632386|FG001|Overall Study|Death|2|||
129909732|NCT02568683|467632385|FG000|Overall Study|Withdrew Consent|1|||
129909733|NCT02568683|467632386|FG001|Overall Study|Withdrew Consent|0|||
129909734|NCT02568683|467632385|FG000|Overall Study|Study Terminated By Sponsor|5|||
129909735|NCT02568683|467632386|FG001|Overall Study|Study Terminated By Sponsor|2|||
129909736|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
129909737|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909738|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909739|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909740|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909741|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
129909742|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909743|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909744|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909745|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909746|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
129909747|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909748|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909749|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909750|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909751|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
129909752|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909753|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909754|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909755|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909756|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
129909757|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909758|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909759|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909760|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909761|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
129909762|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909763|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909764|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909765|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909766|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
129909767|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909768|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909769|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
130064716|NCT01054976|468190254|FG000|Overall Study|Uncooperative participations to study|7|||
130064717|NCT01054976|468190254|FG000|Overall Study|Withdrawal by Subject|4|||
129909770|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909771|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
129909772|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129909773|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129909774|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129857721|NCT04964089|467437156|FG001|Overall Study|Adverse Event|6|||
129857722|NCT04964089|467437155|FG000|Overall Study|Non-compliance with study schedule|1|||
129857723|NCT04964089|467437156|FG001|Overall Study|Non-compliance with study schedule|0|||
129857724|NCT04964089|467437155|FG000|Overall Study|Withdrawal by Subject|6|||
129857725|NCT04964089|467437156|FG001|Overall Study|Withdrawal by Subject|5|||
129857726|NCT04964089|467437155|FG000|Overall Study|Lost to Follow-up|1|||
129857727|NCT04964089|467437156|FG001|Overall Study|Lost to Follow-up|1|||
129857728|NCT04964089|467437155|FG000|Overall Study|Progressive disease|4|||
129857729|NCT04964089|467437156|FG001|Overall Study|Progressive disease|0|||
129857730|NCT04964089|467437155|FG000|Overall Study|Physician Decision|1|||
129857731|NCT04964089|467437156|FG001|Overall Study|Physician Decision|0|||
129857732|NCT04964089|467437155|FG000|Overall Study|Participant did not want to continue study treatment|1|||
129857733|NCT04964089|467437156|FG001|Overall Study|Participant did not want to continue study treatment|0|||
129857734|NCT04964089|467437155|FG000|Overall Study|Participant moved to different state|1|||
129857735|NCT04964089|467437156|FG001|Overall Study|Participant moved to different state|0|||
129857736|NCT04964089|467437155|FG000|Overall Study|Participant decided to discontinue|0|||
129857737|NCT04964089|467437156|FG001|Overall Study|Participant decided to discontinue|1|||
129857738|NCT01165281|467437162|FG000|Overall Study|Adverse Event|12|||
129857739|NCT01165281|467437163|FG001|Overall Study|Adverse Event|14|||
129857740|NCT01165281|467437162|FG000|Overall Study|Death|3|||
129857741|NCT01165281|467437163|FG001|Overall Study|Death|4|||
129857742|NCT01165281|467437162|FG000|Overall Study|Lack of Efficacy|4|||
129857743|NCT01165281|467437163|FG001|Overall Study|Lack of Efficacy|1|||
129857744|NCT01165281|467437162|FG000|Overall Study|Lost to Follow-up|0|||
129857745|NCT01165281|467437163|FG001|Overall Study|Lost to Follow-up|1|||
129857746|NCT01165281|467437162|FG000|Overall Study|Physician Decision|8|||
129857747|NCT01165281|467437163|FG001|Overall Study|Physician Decision|1|||
129857748|NCT01165281|467437162|FG000|Overall Study|Protocol Violation|6|||
129857749|NCT01165281|467437163|FG001|Overall Study|Protocol Violation|5|||
129857750|NCT01165281|467437162|FG000|Overall Study|Withdrawal by Subject|8|||
129857751|NCT01165281|467437163|FG001|Overall Study|Withdrawal by Subject|7|||
129857752|NCT01165281|467437162|FG000|Overall Study|Noncompliance with Study Drug|1|||
129857753|NCT01165281|467437163|FG001|Overall Study|Noncompliance with Study Drug|4|||
129857754|NCT01165281|467437162|FG000|Overall Study|Progressive Disease|10|||
129857755|NCT01165281|467437163|FG001|Overall Study|Progressive Disease|14|||
129857756|NCT01165281|467437162|FG000|Overall Study|Other|6|||
129857757|NCT01165281|467437163|FG001|Overall Study|Other|0|||
129857758|NCT00363766|467437168|FG000|Overall Study|Progressive Disease|15|||
129857759|NCT00363766|467437169|FG001|Overall Study|Progressive Disease|9|||
129857760|NCT00363766|467437168|FG000|Overall Study|Adverse Event|10|||
129857761|NCT00363766|467437169|FG001|Overall Study|Adverse Event|2|||
129857762|NCT00363766|467437168|FG000|Overall Study|Disease Related Death|1|||
129857763|NCT00363766|467437169|FG001|Overall Study|Disease Related Death|3|||
129857764|NCT00363766|467437168|FG000|Overall Study|Not Disease Related Death|3|||
129857765|NCT00363766|467437169|FG001|Overall Study|Not Disease Related Death|4|||
129857766|NCT00363766|467437168|FG000|Overall Study|Withdrawal by Subject|2|||
129857767|NCT00363766|467437169|FG001|Overall Study|Withdrawal by Subject|0|||
129857768|NCT00363766|467437168|FG000|Overall Study|Physician Decision|1|||
129857769|NCT00363766|467437169|FG001|Overall Study|Physician Decision|2|||
129857770|NCT02005471|467437170|FG000|Main Study|Adverse Event|0|||
129857771|NCT02005471|467437171|FG001|Main Study|Adverse Event|1|||
129857772|NCT02005471|467437172|FG002|Main Study|Adverse Event|0|||
129857773|NCT02005471|467437173|FG003|Main Study|Adverse Event|0|||
129857774|NCT02005471|467437170|FG000|Main Study|Death|83|||
129857775|NCT02005471|467437171|FG001|Main Study|Death|52|||
129857776|NCT02005471|467437172|FG002|Main Study|Death|0|||
129857777|NCT02005471|467437173|FG003|Main Study|Death|0|||
129857778|NCT02005471|467437170|FG000|Main Study|Lost to Follow-up|4|||
129857779|NCT02005471|467437171|FG001|Main Study|Lost to Follow-up|5|||
129857780|NCT02005471|467437172|FG002|Main Study|Lost to Follow-up|0|||
129857781|NCT02005471|467437173|FG003|Main Study|Lost to Follow-up|0|||
129857782|NCT02005471|467437170|FG000|Main Study|Physician Decision|3|||
129857783|NCT02005471|467437171|FG001|Main Study|Physician Decision|1|||
129857784|NCT02005471|467437172|FG002|Main Study|Physician Decision|0|||
129857785|NCT02005471|467437173|FG003|Main Study|Physician Decision|0|||
129857786|NCT02005471|467437170|FG000|Main Study|Withdrawal by Subject|26|||
129857787|NCT02005471|467437171|FG001|Main Study|Withdrawal by Subject|11|||
129857788|NCT02005471|467437172|FG002|Main Study|Withdrawal by Subject|0|||
129857789|NCT02005471|467437173|FG003|Main Study|Withdrawal by Subject|0|||
129857790|NCT02005471|467437170|FG000|Main Study|Reason not Specified|0|||
129857791|NCT02005471|467437171|FG001|Main Study|Reason not Specified|6|||
129857792|NCT02005471|467437172|FG002|Main Study|Reason not Specified|0|||
129857793|NCT02005471|467437173|FG003|Main Study|Reason not Specified|0|||
129857794|NCT02005471|467437170|FG000|Main Study|Randomized but not Dosed|8|||
129857795|NCT02005471|467437171|FG001|Main Study|Randomized but not Dosed|0|||
129857796|NCT02005471|467437172|FG002|Main Study|Randomized but not Dosed|0|||
129857797|NCT02005471|467437173|FG003|Main Study|Randomized but not Dosed|0|||
129857798|NCT02005471|467437170|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
129857799|NCT02005471|467437171|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
129857800|NCT02005471|467437172|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
129857801|NCT02005471|467437173|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
129857802|NCT02005471|467437170|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
129857803|NCT02005471|467437171|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
129857804|NCT02005471|467437172|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
129857805|NCT02005471|467437173|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
129857806|NCT02005471|467437170|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
129857807|NCT02005471|467437171|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
129857808|NCT02005471|467437172|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
129857809|NCT02005471|467437173|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
129857810|NCT00627705|467437174|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
129857811|NCT00627705|467437175|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
129857812|NCT00627705|467437174|FG000|Overall Study|Adverse Event|1|||
129857813|NCT00627705|467437175|FG001|Overall Study|Adverse Event|0|||
129857814|NCT00627705|467437174|FG000|Overall Study|Withdrawal by Subject|0|||
129857815|NCT00627705|467437175|FG001|Overall Study|Withdrawal by Subject|2|||
129857816|NCT00627705|467437174|FG000|Overall Study|Lost to Follow-up|0|||
129857817|NCT00627705|467437175|FG001|Overall Study|Lost to Follow-up|1|||
129857818|NCT04295564|467439387|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
129857819|NCT04295564|467439388|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
129857820|NCT01682460|467439389|FG000|Overall Study|Withdrawal by Subject|2|||
129857821|NCT01682460|467439389|FG000|Overall Study|Did not meet inclusion criteria|2|||
129857822|NCT00724282|467439390|FG000|Overall Study|Withdrawal by Subject|3|||
129857823|NCT00724282|467439390|FG000|Overall Study|Physician Decision|1|||
129857824|NCT01159691|467439393|FG000|Overall Study|Lost to Follow-up|2|||
129857825|NCT01159691|467439393|FG000|Overall Study|Unknown reasons|1|||
129857826|NCT01159691|467439393|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
129857827|NCT01159691|467439393|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
129857828|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
129857829|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
129857830|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
129857831|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
129857832|NCT01928719|467439394|FG000|Overall Study|Lost to Follow-up|26|||
129857833|NCT01928719|467439395|FG001|Overall Study|Lost to Follow-up|11|||
129857834|NCT01928719|467439394|FG000|Overall Study|Withdrawal by Subject|22|||
129857835|NCT01928719|467439395|FG001|Overall Study|Withdrawal by Subject|7|||
129857836|NCT01928719|467439394|FG000|Overall Study|Protocol Violation|3|||
129857837|NCT01928719|467439395|FG001|Overall Study|Protocol Violation|1|||
129857838|NCT01928719|467439394|FG000|Overall Study|Adverse Event|1|||
129857839|NCT01928719|467439395|FG001|Overall Study|Adverse Event|0|||
129857840|NCT02105116|467439396|FG000|Overall Study|not eligible for step 2 of trial|5|||
129857841|NCT02105116|467439396|FG000|Overall Study|Death|1|||
129857842|NCT00773968|467439397|FG000|Overall Study|Adverse Event|2|||
129857843|NCT00773968|467439397|FG000|Overall Study|Death|1|||
129857844|NCT00773968|467439397|FG000|Overall Study|Failure to Return|2|||
129857845|NCT00773968|467439397|FG000|Overall Study|Lack of Efficacy|3|||
129857846|NCT00773968|467439397|FG000|Overall Study|Protocol Violation|1|||
129857847|NCT00773968|467439397|FG000|Overall Study|Withdrawal by Subject|11|||
129857848|NCT00773968|467439397|FG000|Overall Study|Screen Failure|17|||
129857849|NCT00773968|467439397|FG000|Overall Study|Other|8|||
129857850|NCT00263666|467439398|FG000|Overall Study|Adverse Event|6|||
129857851|NCT00263666|467439399|FG001|Overall Study|Adverse Event|8|||
129857852|NCT00263666|467439398|FG000|Overall Study|Lost to Follow-up|1|||
129857853|NCT00263666|467439399|FG001|Overall Study|Lost to Follow-up|2|||
129857854|NCT00263666|467439398|FG000|Overall Study|Withdrawal by Subject|0|||
129857855|NCT00263666|467439399|FG001|Overall Study|Withdrawal by Subject|1|||
129857856|NCT02492100|467439400|FG000|Overall Study|Death|1|||
129857857|NCT02332720|467439401|FG000|Part A and Part B|Lost to Follow-up|1|||
129857858|NCT02332720|467439402|FG001|Part A and Part B|Lost to Follow-up|0|||
129857859|NCT02332720|467439403|FG002|Part A and Part B|Lost to Follow-up|0|||
129857860|NCT02332720|467439404|FG003|Part A and Part B|Lost to Follow-up|0|||
129857861|NCT02332720|467439405|FG004|Part A and Part B|Lost to Follow-up|0|||
129857862|NCT02332720|467439406|FG005|Part A and Part B|Lost to Follow-up|2|||
129857863|NCT02332720|467439407|FG006|Part A and Part B|Lost to Follow-up|1|||
129857864|NCT02332720|467439408|FG007|Part A and Part B|Lost to Follow-up|1|||
129857865|NCT02332720|467439409|FG008|Part A and Part B|Lost to Follow-up|0|||
129857866|NCT02332720|467439410|FG009|Part A and Part B|Lost to Follow-up|0|||
129857867|NCT02332720|467439411|FG010|Part A and Part B|Lost to Follow-up|0|||
129857868|NCT02332720|467439412|FG011|Part A and Part B|Lost to Follow-up|0|||
129857869|NCT02332720|467439413|FG012|Part A and Part B|Lost to Follow-up|0|||
129857870|NCT02332720|467439414|FG013|Part A and Part B|Lost to Follow-up|0|||
129857871|NCT02332720|467439415|FG014|Part A and Part B|Lost to Follow-up|0|||
130064718|NCT01054976|468190254|FG000|Overall Study|Other|8|||
130064719|NCT01669811|468190260|FG000|Overall Study|Investigator decision|0|||
130064720|NCT01669811|468190261|FG001|Overall Study|Investigator decision|1|||
130064721|NCT01669811|468190260|FG000|Overall Study|Withdrawal by Subject|1|||
130064722|NCT01669811|468190261|FG001|Overall Study|Withdrawal by Subject|2|||
129857872|NCT02332720|467439416|FG015|Part A and Part B|Lost to Follow-up|1|||
129857873|NCT02332720|467439417|FG016|Part A and Part B|Lost to Follow-up|0|||
129857874|NCT02332720|467439418|FG017|Part A and Part B|Lost to Follow-up|0|||
129857875|NCT02332720|467439419|FG018|Part A and Part B|Lost to Follow-up|0|||
129857876|NCT02332720|467439420|FG019|Part A and Part B|Lost to Follow-up|0|||
129857877|NCT02332720|467439421|FG020|Part A and Part B|Lost to Follow-up|0|||
129857878|NCT02332720|467439422|FG021|Part A and Part B|Lost to Follow-up|0|||
129857879|NCT02332720|467439423|FG022|Part A and Part B|Lost to Follow-up|0|||
129857880|NCT02332720|467439401|FG000|Part A and Part B|Adverse Event|0|||
129857881|NCT02332720|467439402|FG001|Part A and Part B|Adverse Event|0|||
129857882|NCT02332720|467439403|FG002|Part A and Part B|Adverse Event|0|||
129857883|NCT02332720|467439404|FG003|Part A and Part B|Adverse Event|0|||
129857884|NCT02332720|467439405|FG004|Part A and Part B|Adverse Event|0|||
129857885|NCT02332720|467439406|FG005|Part A and Part B|Adverse Event|0|||
129857886|NCT02332720|467439407|FG006|Part A and Part B|Adverse Event|0|||
129857887|NCT02332720|467439408|FG007|Part A and Part B|Adverse Event|0|||
129857888|NCT02332720|467439409|FG008|Part A and Part B|Adverse Event|0|||
129857889|NCT02332720|467439410|FG009|Part A and Part B|Adverse Event|0|||
129857890|NCT02332720|467439411|FG010|Part A and Part B|Adverse Event|0|||
129857891|NCT02332720|467439412|FG011|Part A and Part B|Adverse Event|0|||
129857892|NCT02332720|467439413|FG012|Part A and Part B|Adverse Event|0|||
129857893|NCT02332720|467439414|FG013|Part A and Part B|Adverse Event|0|||
129857894|NCT02332720|467439415|FG014|Part A and Part B|Adverse Event|0|||
129857895|NCT02332720|467439416|FG015|Part A and Part B|Adverse Event|0|||
129857896|NCT02332720|467439417|FG016|Part A and Part B|Adverse Event|0|||
129857897|NCT02332720|467439418|FG017|Part A and Part B|Adverse Event|1|||
129857898|NCT02332720|467439419|FG018|Part A and Part B|Adverse Event|0|||
129857899|NCT02332720|467439420|FG019|Part A and Part B|Adverse Event|0|||
129857900|NCT02332720|467439421|FG020|Part A and Part B|Adverse Event|0|||
129857901|NCT02332720|467439422|FG021|Part A and Part B|Adverse Event|0|||
129857902|NCT02332720|467439423|FG022|Part A and Part B|Adverse Event|0|||
129857903|NCT02332720|467439401|FG000|Part A and Part B|Physician Decision|0|||
129857904|NCT02332720|467439402|FG001|Part A and Part B|Physician Decision|0|||
129857905|NCT02332720|467439403|FG002|Part A and Part B|Physician Decision|0|||
129857906|NCT02332720|467439404|FG003|Part A and Part B|Physician Decision|0|||
129857907|NCT02332720|467439405|FG004|Part A and Part B|Physician Decision|0|||
129857908|NCT02332720|467439406|FG005|Part A and Part B|Physician Decision|0|||
129857909|NCT02332720|467439407|FG006|Part A and Part B|Physician Decision|0|||
129857910|NCT02332720|467439408|FG007|Part A and Part B|Physician Decision|0|||
129857911|NCT02332720|467439409|FG008|Part A and Part B|Physician Decision|0|||
129857912|NCT02332720|467439410|FG009|Part A and Part B|Physician Decision|0|||
129857913|NCT02332720|467439411|FG010|Part A and Part B|Physician Decision|0|||
129857914|NCT02332720|467439412|FG011|Part A and Part B|Physician Decision|0|||
129857915|NCT02332720|467439413|FG012|Part A and Part B|Physician Decision|0|||
129857916|NCT02332720|467439414|FG013|Part A and Part B|Physician Decision|0|||
129857917|NCT02332720|467439415|FG014|Part A and Part B|Physician Decision|0|||
129857918|NCT02332720|467439416|FG015|Part A and Part B|Physician Decision|0|||
129857919|NCT02332720|467439417|FG016|Part A and Part B|Physician Decision|0|||
129857920|NCT02332720|467439418|FG017|Part A and Part B|Physician Decision|0|||
129857921|NCT02332720|467439419|FG018|Part A and Part B|Physician Decision|1|||
129857922|NCT02332720|467439420|FG019|Part A and Part B|Physician Decision|0|||
129857923|NCT02332720|467439421|FG020|Part A and Part B|Physician Decision|0|||
129857924|NCT02332720|467439422|FG021|Part A and Part B|Physician Decision|0|||
129857925|NCT02332720|467439423|FG022|Part A and Part B|Physician Decision|0|||
129857926|NCT02332720|467439401|FG000|Part A and Part B|Withdrawal by Subject|0|||
129857927|NCT02332720|467439402|FG001|Part A and Part B|Withdrawal by Subject|0|||
129857928|NCT02332720|467439403|FG002|Part A and Part B|Withdrawal by Subject|0|||
129857929|NCT02332720|467439404|FG003|Part A and Part B|Withdrawal by Subject|0|||
129857930|NCT02332720|467439405|FG004|Part A and Part B|Withdrawal by Subject|0|||
129857931|NCT02332720|467439406|FG005|Part A and Part B|Withdrawal by Subject|1|||
129857932|NCT02332720|467439407|FG006|Part A and Part B|Withdrawal by Subject|0|||
129857933|NCT02332720|467439408|FG007|Part A and Part B|Withdrawal by Subject|0|||
129857934|NCT02332720|467439409|FG008|Part A and Part B|Withdrawal by Subject|0|||
129857935|NCT02332720|467439410|FG009|Part A and Part B|Withdrawal by Subject|0|||
129857936|NCT02332720|467439411|FG010|Part A and Part B|Withdrawal by Subject|0|||
129857937|NCT02332720|467439412|FG011|Part A and Part B|Withdrawal by Subject|0|||
129857938|NCT02332720|467439413|FG012|Part A and Part B|Withdrawal by Subject|0|||
129857939|NCT02332720|467439414|FG013|Part A and Part B|Withdrawal by Subject|0|||
129857940|NCT02332720|467439415|FG014|Part A and Part B|Withdrawal by Subject|0|||
129857941|NCT02332720|467439416|FG015|Part A and Part B|Withdrawal by Subject|0|||
129857942|NCT02332720|467439417|FG016|Part A and Part B|Withdrawal by Subject|0|||
129857943|NCT02332720|467439418|FG017|Part A and Part B|Withdrawal by Subject|0|||
129857944|NCT02332720|467439419|FG018|Part A and Part B|Withdrawal by Subject|0|||
129857945|NCT02332720|467439420|FG019|Part A and Part B|Withdrawal by Subject|1|||
129857946|NCT02332720|467439421|FG020|Part A and Part B|Withdrawal by Subject|0|||
129857947|NCT02332720|467439422|FG021|Part A and Part B|Withdrawal by Subject|0|||
129857948|NCT02332720|467439423|FG022|Part A and Part B|Withdrawal by Subject|0|||
129857949|NCT03832010|467439424|FG000|Overall Study|Withdrawal by Subject|2|||
129857950|NCT03832010|467439425|FG001|Overall Study|Withdrawal by Subject|1|||
129857951|NCT03832010|467439426|FG002|Overall Study|Withdrawal by Subject|0|||
129857952|NCT03832010|467439424|FG000|Overall Study|Lost to Follow-up|2|||
129857953|NCT03832010|467439425|FG001|Overall Study|Lost to Follow-up|1|||
129857954|NCT03832010|467439426|FG002|Overall Study|Lost to Follow-up|1|||
129857955|NCT03240588|467439428|FG000|Overall Study|Death|3|||
129857956|NCT03240588|467439429|FG001|Overall Study|Death|0|||
129857957|NCT03240588|467439430|FG002|Overall Study|Death|0|||
129857958|NCT03240588|467439428|FG000|Overall Study|Adverse Event|5|||
129857959|NCT03240588|467439429|FG001|Overall Study|Adverse Event|4|||
129857960|NCT03240588|467439430|FG002|Overall Study|Adverse Event|0|||
129857961|NCT03240588|467439428|FG000|Overall Study|Lost to Follow-up|9|||
129857962|NCT03240588|467439429|FG001|Overall Study|Lost to Follow-up|4|||
129857963|NCT03240588|467439430|FG002|Overall Study|Lost to Follow-up|0|||
129857964|NCT03240588|467439428|FG000|Overall Study|Physician Decision|3|||
129857965|NCT03240588|467439429|FG001|Overall Study|Physician Decision|2|||
129857966|NCT03240588|467439430|FG002|Overall Study|Physician Decision|0|||
129857967|NCT03240588|467439428|FG000|Overall Study|Did not meet eligibility criteria|0|||
129857968|NCT03240588|467439429|FG001|Overall Study|Did not meet eligibility criteria|6|||
129857969|NCT03240588|467439430|FG002|Overall Study|Did not meet eligibility criteria|0|||
129857970|NCT03240588|467439428|FG000|Overall Study|No longer meets protocol criteria|12|||
129857971|NCT03240588|467439429|FG001|Overall Study|No longer meets protocol criteria|7|||
129857972|NCT03240588|467439430|FG002|Overall Study|No longer meets protocol criteria|0|||
129857973|NCT03240588|467439428|FG000|Overall Study|Withdrawal by Subject|60|||
129857974|NCT03240588|467439429|FG001|Overall Study|Withdrawal by Subject|52|||
129857975|NCT03240588|467439430|FG002|Overall Study|Withdrawal by Subject|7|||
129857976|NCT03240588|467439428|FG000|Overall Study|Other, additional details not available.|0|||
129857977|NCT03240588|467439429|FG001|Overall Study|Other, additional details not available.|12|||
129857978|NCT03240588|467439430|FG002|Overall Study|Other, additional details not available.|1|||
129857979|NCT03240588|467439428|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
129857980|NCT03240588|467439429|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
129857981|NCT03240588|467439430|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
129857982|NCT03240588|467439428|FG000|Overall Study|Closure of study|55|||
129857983|NCT03240588|467439429|FG001|Overall Study|Closure of study|3|||
129857984|NCT03240588|467439430|FG002|Overall Study|Closure of study|0|||
129857985|NCT03240588|467439428|FG000|Overall Study|Subject non-compliance|23|||
129857986|NCT03240588|467439429|FG001|Overall Study|Subject non-compliance|2|||
129857987|NCT03240588|467439430|FG002|Overall Study|Subject non-compliance|1|||
129857988|NCT03240588|467439428|FG000|Overall Study|Device Deficiency|1|||
129857989|NCT03240588|467439429|FG001|Overall Study|Device Deficiency|0|||
129857990|NCT03240588|467439430|FG002|Overall Study|Device Deficiency|0|||
129857991|NCT03240588|467439428|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
129857992|NCT03240588|467439429|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
129857993|NCT03240588|467439430|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
129857994|NCT03422250|467439431|FG000|Intervention|Adverse Event|0|||
129857995|NCT03422250|467439432|FG001|Intervention|Adverse Event|1|||
129857996|NCT03422250|467439433|FG002|Intervention|Adverse Event|0|||
129857997|NCT03422250|467439434|FG003|Intervention|Adverse Event|1|||
129857998|NCT03422250|467439431|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
129857999|NCT03422250|467439432|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
129909775|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129909776|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
129909777|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129909778|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129909779|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129858000|NCT03422250|467439433|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
129909780|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129909781|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
129909782|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
129858001|NCT03422250|467439434|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
129858002|NCT03422250|467439431|FG000|Follow-up|Withdrawal by Subject|0|||
129858003|NCT03422250|467439432|FG001|Follow-up|Withdrawal by Subject|0|||
129858004|NCT03422250|467439433|FG002|Follow-up|Withdrawal by Subject|0|||
129858005|NCT03422250|467439434|FG003|Follow-up|Withdrawal by Subject|1|||
129858006|NCT03422250|467439431|FG000|Follow-up|Adverse Event|0|||
129858007|NCT03422250|467439432|FG001|Follow-up|Adverse Event|0|||
129858008|NCT03422250|467439433|FG002|Follow-up|Adverse Event|0|||
129858009|NCT03422250|467439434|FG003|Follow-up|Adverse Event|1|||
129858010|NCT02091726|467439437|FG000|Overall Study|Lost to Follow-up|6|||
129858011|NCT00467870|467439438|FG000|Overall Study|Adverse Event|13|||
129858012|NCT00467870|467439439|FG001|Overall Study|Adverse Event|9|||
129858013|NCT00467870|467439440|FG002|Overall Study|Adverse Event|1|||
129858014|NCT00467870|467439441|FG003|Overall Study|Adverse Event|15|||
129858015|NCT00467870|467439442|FG004|Overall Study|Adverse Event|15|||
129858016|NCT00467870|467439443|FG005|Overall Study|Adverse Event|1|||
129858017|NCT00467870|467439438|FG000|Overall Study|Protocol Violation|2|||
129858018|NCT00467870|467439439|FG001|Overall Study|Protocol Violation|1|||
129858019|NCT00467870|467439440|FG002|Overall Study|Protocol Violation|1|||
129858020|NCT00467870|467439441|FG003|Overall Study|Protocol Violation|2|||
129858021|NCT00467870|467439442|FG004|Overall Study|Protocol Violation|0|||
129858022|NCT00467870|467439443|FG005|Overall Study|Protocol Violation|0|||
129858023|NCT00467870|467439438|FG000|Overall Study|Withdrawal by Subject|14|||
129858024|NCT00467870|467439439|FG001|Overall Study|Withdrawal by Subject|21|||
129858025|NCT00467870|467439440|FG002|Overall Study|Withdrawal by Subject|0|||
129858026|NCT00467870|467439441|FG003|Overall Study|Withdrawal by Subject|9|||
129858027|NCT00467870|467439442|FG004|Overall Study|Withdrawal by Subject|10|||
129858028|NCT00467870|467439443|FG005|Overall Study|Withdrawal by Subject|1|||
129858029|NCT00467870|467439438|FG000|Overall Study|Lost to Follow-up|5|||
129858030|NCT00467870|467439439|FG001|Overall Study|Lost to Follow-up|3|||
129858031|NCT00467870|467439440|FG002|Overall Study|Lost to Follow-up|1|||
129858032|NCT00467870|467439441|FG003|Overall Study|Lost to Follow-up|1|||
129858033|NCT00467870|467439442|FG004|Overall Study|Lost to Follow-up|3|||
129858034|NCT00467870|467439443|FG005|Overall Study|Lost to Follow-up|0|||
129858035|NCT00467870|467439438|FG000|Overall Study|Subject Non-compliance|3|||
129858036|NCT00467870|467439439|FG001|Overall Study|Subject Non-compliance|4|||
129858037|NCT00467870|467439440|FG002|Overall Study|Subject Non-compliance|0|||
129858038|NCT00467870|467439441|FG003|Overall Study|Subject Non-compliance|1|||
129858039|NCT00467870|467439442|FG004|Overall Study|Subject Non-compliance|5|||
129858040|NCT00467870|467439443|FG005|Overall Study|Subject Non-compliance|0|||
129858041|NCT00467870|467439438|FG000|Overall Study|Other/Unknown|8|||
129858042|NCT00467870|467439439|FG001|Overall Study|Other/Unknown|5|||
129858043|NCT00467870|467439440|FG002|Overall Study|Other/Unknown|1|||
129858044|NCT00467870|467439441|FG003|Overall Study|Other/Unknown|5|||
129858045|NCT00467870|467439442|FG004|Overall Study|Other/Unknown|4|||
129858046|NCT00467870|467439443|FG005|Overall Study|Other/Unknown|0|||
129858047|NCT00321919|467439444|FG000|Overall Study|Adverse Event|17|||
129858048|NCT00321919|467439445|FG001|Overall Study|Adverse Event|10|||
129858049|NCT00321919|467439444|FG000|Overall Study|Death|21|||
129858050|NCT00321919|467439445|FG001|Overall Study|Death|17|||
129858051|NCT00321919|467439444|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129858052|NCT00321919|467439445|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129858053|NCT00321919|467439444|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129858054|NCT00321919|467439445|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129858055|NCT00321919|467439444|FG000|Overall Study|Refused Treatment|23|||
129858056|NCT00321919|467439445|FG001|Overall Study|Refused Treatment|14|||
129858057|NCT00321919|467439444|FG000|Overall Study|Other Protocol Violation|2|||
129858058|NCT00321919|467439445|FG001|Overall Study|Other Protocol Violation|3|||
129858059|NCT00321919|467439444|FG000|Overall Study|Failure to Return|3|||
129858060|NCT00321919|467439445|FG001|Overall Study|Failure to Return|1|||
129858061|NCT00321919|467439444|FG000|Overall Study|Other withdrawal reason|7|||
129858062|NCT00321919|467439445|FG001|Overall Study|Other withdrawal reason|6|||
129858063|NCT02261363|467439446|FG000|Overall Study|Lost to Follow-up|21|||
129858064|NCT01517802|467439447|FG000|Overall Study|Death|1|||
129858065|NCT02590354|467439448|FG000|Phase 1|Active hepatitis B or C infection|1|||
129858066|NCT02590354|467439448|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
129858067|NCT02590354|467439448|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
129858068|NCT02590354|467439448|FG000|Phase 1|Subject does not want to participate|20|||
129858069|NCT02590354|467439448|FG000|Phase 1|Lost to Follow-up|1|||
129858070|NCT02590354|467439448|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
129858071|NCT02099838|467439449|FG000|Overall Study|Death|1|||
129858072|NCT02099838|467439450|FG001|Overall Study|Death|0|||
129858073|NCT02099838|467439449|FG000|Overall Study|Lost to Follow-up|3|||
129858074|NCT02099838|467439450|FG001|Overall Study|Lost to Follow-up|1|||
129858075|NCT02099838|467439449|FG000|Overall Study|Withdrawal by Subject|0|||
129858076|NCT02099838|467439450|FG001|Overall Study|Withdrawal by Subject|1|||
129858077|NCT02301143|467439451|FG000|Induction Period|Enrolled But Not Treated|1|||
129858078|NCT02301143|467439452|FG001|Induction Period|Enrolled But Not Treated|0|||
129858079|NCT02301143|467439451|FG000|Induction Period|Death|1|||
129858080|NCT02301143|467439452|FG001|Induction Period|Death|0|||
129858081|NCT02301143|467439451|FG000|Induction Period|Adverse Event|22|||
129858082|NCT02301143|467439452|FG001|Induction Period|Adverse Event|0|||
129858083|NCT02301143|467439451|FG000|Induction Period|Progressive Disease|8|||
129858084|NCT02301143|467439452|FG001|Induction Period|Progressive Disease|0|||
129858085|NCT02301143|467439451|FG000|Induction Period|Withdrawal by Subject|3|||
129858086|NCT02301143|467439452|FG001|Induction Period|Withdrawal by Subject|0|||
129909783|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
129909784|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
129909785|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
129909786|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909787|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909788|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909789|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
129909790|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909791|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
129909792|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
129909793|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
129909794|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
129909795|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
129909796|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
129909797|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
129909798|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
129909799|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
129909800|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
129909801|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
129909802|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
129909803|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
129909804|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
129909805|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
129909806|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
129909807|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
129909808|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
129909809|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
129909810|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
129909811|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909812|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909813|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
129909814|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909815|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909816|NCT03482635|467632410|FG000|Overall Study|Lack of Efficacy|0|||
129909817|NCT03482635|467632411|FG001|Overall Study|Lack of Efficacy|0|||
129909818|NCT03482635|467632412|FG002|Overall Study|Lack of Efficacy|1|||
129909819|NCT03482635|467632413|FG003|Overall Study|Lack of Efficacy|3|||
129909820|NCT03482635|467632410|FG000|Overall Study|Adverse Event|2|||
129909821|NCT03482635|467632411|FG001|Overall Study|Adverse Event|2|||
129909822|NCT03482635|467632412|FG002|Overall Study|Adverse Event|0|||
129909823|NCT03482635|467632413|FG003|Overall Study|Adverse Event|3|||
129909824|NCT03482635|467632410|FG000|Overall Study|Withdrawal by Subject|2|||
129909825|NCT03482635|467632411|FG001|Overall Study|Withdrawal by Subject|1|||
129909826|NCT03482635|467632412|FG002|Overall Study|Withdrawal by Subject|0|||
129909827|NCT03482635|467632413|FG003|Overall Study|Withdrawal by Subject|1|||
129909828|NCT03482635|467632410|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
129909829|NCT03482635|467632411|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
129909830|NCT03482635|467632412|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
129909831|NCT03482635|467632413|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
129909832|NCT03482635|467632410|FG000|Overall Study|Not treated|0|||
129909833|NCT03482635|467632411|FG001|Overall Study|Not treated|0|||
129909834|NCT03482635|467632412|FG002|Overall Study|Not treated|0|||
129909835|NCT03482635|467632413|FG003|Overall Study|Not treated|1|||
130116647|NCT00585351|468387149|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
130116648|NCT00585351|468387150|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
129909836|NCT03237481|467633701|FG000|Overall Study|Lost to Follow-up|1|||
129909837|NCT03237481|467633702|FG001|Overall Study|Lost to Follow-up|0|||
129909838|NCT03237481|467633703|FG002|Overall Study|Lost to Follow-up|0|||
129909839|NCT03237481|467633701|FG000|Overall Study|Protocol Violation|1|||
129909840|NCT03237481|467633702|FG001|Overall Study|Protocol Violation|0|||
129909841|NCT03237481|467633703|FG002|Overall Study|Protocol Violation|0|||
129909842|NCT03237481|467633701|FG000|Overall Study|Withdrawal by Subject|3|||
129909843|NCT03237481|467633702|FG001|Overall Study|Withdrawal by Subject|2|||
129909844|NCT03237481|467633703|FG002|Overall Study|Withdrawal by Subject|1|||
129909845|NCT03936660|467633704|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
129909846|NCT03936660|467633705|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
129909847|NCT03112174|467633706|FG000|Overall Study|Withdrawal by Subject|3|||
129909848|NCT03112174|467633707|FG001|Overall Study|Withdrawal by Subject|0|||
130116649|NCT00585351|468387151|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
129909849|NCT03112174|467633708|FG002|Overall Study|Withdrawal by Subject|11|||
129858087|NCT02301143|467439451|FG000|Induction Period|Noncompliance with Study Drug|1|||
129858088|NCT02301143|467439452|FG001|Induction Period|Noncompliance with Study Drug|0|||
129858089|NCT02301143|467439451|FG000|Induction Period|Physician Decision|4|||
129858090|NCT02301143|467439452|FG001|Induction Period|Physician Decision|0|||
129858091|NCT02301143|467439451|FG000|Induction Period|Symptomatic Deterioration|2|||
129858092|NCT02301143|467439452|FG001|Induction Period|Symptomatic Deterioration|0|||
129858093|NCT02301143|467439451|FG000|Induction Period|Protocol Violation|2|||
129858094|NCT02301143|467439452|FG001|Induction Period|Protocol Violation|0|||
129858095|NCT02301143|467439451|FG000|Induction Period|Other|1|||
129858096|NCT02301143|467439452|FG001|Induction Period|Other|0|||
129858097|NCT02301143|467439451|FG000|Investigator's Choice|Adverse Event|0|||
129858098|NCT02301143|467439452|FG001|Investigator's Choice|Adverse Event|3|||
129858099|NCT02301143|467439451|FG000|Investigator's Choice|Progressive Disease|0|||
129858100|NCT02301143|467439452|FG001|Investigator's Choice|Progressive Disease|3|||
129858101|NCT02301143|467439451|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
129858102|NCT02301143|467439452|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
129858103|NCT02301143|467439451|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
129858104|NCT02301143|467439452|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
129858105|NCT02301143|467439451|FG000|Investigator's Choice|Other|0|||
129858106|NCT02301143|467439452|FG001|Investigator's Choice|Other|1|||
129858107|NCT02301143|467439451|FG000|Investigator's Choice|Unresectable Surgery|0|||
129858108|NCT02301143|467439452|FG001|Investigator's Choice|Unresectable Surgery|1|||
129858109|NCT02536508|467439455|FG000|Overall Study|Withdrawal by Subject|18|||
129858110|NCT02536508|467439456|FG001|Overall Study|Withdrawal by Subject|13|||
129858111|NCT02536508|467439457|FG002|Overall Study|Withdrawal by Subject|7|||
129858112|NCT02536508|467439455|FG000|Overall Study|Adverse Event|14|||
129858113|NCT02536508|467439456|FG001|Overall Study|Adverse Event|13|||
129858114|NCT02536508|467439457|FG002|Overall Study|Adverse Event|6|||
129858115|NCT02536508|467439455|FG000|Overall Study|Lost to Follow-up|12|||
129858116|NCT02536508|467439456|FG001|Overall Study|Lost to Follow-up|4|||
129858117|NCT02536508|467439457|FG002|Overall Study|Lost to Follow-up|0|||
129858118|NCT02536508|467439455|FG000|Overall Study|Lack of Efficacy|3|||
129858119|NCT02536508|467439456|FG001|Overall Study|Lack of Efficacy|5|||
129858120|NCT02536508|467439457|FG002|Overall Study|Lack of Efficacy|4|||
129858121|NCT02536508|467439455|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
129858122|NCT02536508|467439456|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
129858123|NCT02536508|467439457|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
129858124|NCT02536508|467439455|FG000|Overall Study|Physician Decision|0|||
129858125|NCT02536508|467439456|FG001|Overall Study|Physician Decision|4|||
129858126|NCT02536508|467439457|FG002|Overall Study|Physician Decision|2|||
129858127|NCT02536508|467439455|FG000|Overall Study|Major Protocol Deviation|2|||
129858128|NCT02536508|467439456|FG001|Overall Study|Major Protocol Deviation|2|||
129858129|NCT02536508|467439457|FG002|Overall Study|Major Protocol Deviation|2|||
129858130|NCT02536508|467439455|FG000|Overall Study|Administrative Reasons|0|||
129858131|NCT02536508|467439456|FG001|Overall Study|Administrative Reasons|1|||
129858132|NCT02536508|467439457|FG002|Overall Study|Administrative Reasons|0|||
129858133|NCT00823719|467439460|FG000|Overall Study|Adverse Event|1|||
129858134|NCT00823719|467439461|FG001|Overall Study|Adverse Event|2|||
129858135|NCT00823719|467439460|FG000|Overall Study|Physician Decision|1|||
129858136|NCT00823719|467439461|FG001|Overall Study|Physician Decision|4|||
129858137|NCT00823719|467439460|FG000|Overall Study|Withdrawal by Subject|0|||
129858138|NCT00823719|467439461|FG001|Overall Study|Withdrawal by Subject|1|||
129858139|NCT00823719|467439460|FG000|Overall Study|Disease Progression|4|||
129858140|NCT00823719|467439461|FG001|Overall Study|Disease Progression|4|||
129858141|NCT02219932|467439469|FG000|Overall Study|Other|5|||
129858142|NCT02219932|467439470|FG001|Overall Study|Other|11|||
129858143|NCT02219932|467439469|FG000|Overall Study|Death|1|||
129858144|NCT02219932|467439470|FG001|Overall Study|Death|1|||
129858145|NCT02219932|467439469|FG000|Overall Study|Investigator Decision|0|||
129858146|NCT02219932|467439470|FG001|Overall Study|Investigator Decision|1|||
129858147|NCT02219932|467439469|FG000|Overall Study|Consent Withdrawn|11|||
129858148|NCT02219932|467439470|FG001|Overall Study|Consent Withdrawn|7|||
129858149|NCT02219932|467439469|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
129858150|NCT02219932|467439470|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
129858151|NCT02219932|467439469|FG000|Overall Study|Protocol Violation|10|||
129858152|NCT02219932|467439470|FG001|Overall Study|Protocol Violation|6|||
129858153|NCT02219932|467439469|FG000|Overall Study|Pregnancy|1|||
129858154|NCT02219932|467439470|FG001|Overall Study|Pregnancy|0|||
129858155|NCT02219932|467439469|FG000|Overall Study|Lost to Follow-up|4|||
129858156|NCT02219932|467439470|FG001|Overall Study|Lost to Follow-up|2|||
129858157|NCT02219932|467439469|FG000|Overall Study|Adverse Event|23|||
129858158|NCT02219932|467439470|FG001|Overall Study|Adverse Event|21|||
129858159|NCT00093145|467439471|FG000|Overall Study|Unacceptable Toxicity Only|2|||
129858160|NCT00093145|467439471|FG000|Overall Study|Physician Decision|5|||
129858161|NCT00093145|467439471|FG000|Overall Study|Withdrawal by Subject|9|||
129858162|NCT00093145|467439471|FG000|Overall Study|Other|1|||
129858163|NCT04389840|467439472|FG000|Overall Study|Adverse Event|0|||
129909850|NCT03112174|467633709|FG003|Overall Study|Withdrawal by Subject|9|||
129909851|NCT03112174|467633710|FG004|Overall Study|Withdrawal by Subject|7|||
129909852|NCT03112174|467633706|FG000|Overall Study|Lost to Follow-up|1|||
129909853|NCT03112174|467633707|FG001|Overall Study|Lost to Follow-up|1|||
129909854|NCT03112174|467633708|FG002|Overall Study|Lost to Follow-up|2|||
129909855|NCT03112174|467633709|FG003|Overall Study|Lost to Follow-up|3|||
129909856|NCT03112174|467633710|FG004|Overall Study|Lost to Follow-up|2|||
129909857|NCT03112174|467633706|FG000|Overall Study|Death|8|||
129909858|NCT03112174|467633707|FG001|Overall Study|Death|3|||
129909859|NCT03112174|467633708|FG002|Overall Study|Death|67|||
129909860|NCT03112174|467633709|FG003|Overall Study|Death|73|||
129909861|NCT03112174|467633710|FG004|Overall Study|Death|18|||
129909862|NCT03112174|467633706|FG000|Overall Study|Other, Not Specified|1|||
129909863|NCT03112174|467633707|FG001|Overall Study|Other, Not Specified|0|||
129909864|NCT03112174|467633708|FG002|Overall Study|Other, Not Specified|1|||
129909865|NCT03112174|467633709|FG003|Overall Study|Other, Not Specified|2|||
129909866|NCT03112174|467633710|FG004|Overall Study|Other, Not Specified|0|||
129909867|NCT04259450|467633713|FG000|Overall Study|Adverse event/ Toxicity|0|||
129909868|NCT04259450|467633714|FG001|Overall Study|Adverse event/ Toxicity|3|||
129909869|NCT04259450|467633715|FG002|Overall Study|Adverse event/ Toxicity|0|||
129909870|NCT04259450|467633716|FG003|Overall Study|Adverse event/ Toxicity|1|||
129909871|NCT04259450|467633717|FG004|Overall Study|Adverse event/ Toxicity|0|||
129909872|NCT04259450|467633718|FG005|Overall Study|Adverse event/ Toxicity|0|||
129909873|NCT04259450|467633719|FG006|Overall Study|Adverse event/ Toxicity|0|||
129909874|NCT04259450|467633720|FG007|Overall Study|Adverse event/ Toxicity|1|||
129909875|NCT04259450|467633721|FG008|Overall Study|Adverse event/ Toxicity|0|||
129909876|NCT04259450|467633722|FG009|Overall Study|Adverse event/ Toxicity|3|||
129909877|NCT04259450|467633713|FG000|Overall Study|Disease progression|2|||
129909878|NCT04259450|467633714|FG001|Overall Study|Disease progression|3|||
129909879|NCT04259450|467633715|FG002|Overall Study|Disease progression|4|||
129909880|NCT04259450|467633716|FG003|Overall Study|Disease progression|4|||
129909881|NCT04259450|467633717|FG004|Overall Study|Disease progression|6|||
129909882|NCT04259450|467633718|FG005|Overall Study|Disease progression|6|||
129909883|NCT04259450|467633719|FG006|Overall Study|Disease progression|6|||
129909884|NCT04259450|467633720|FG007|Overall Study|Disease progression|15|||
129909885|NCT04259450|467633721|FG008|Overall Study|Disease progression|6|||
129909886|NCT04259450|467633722|FG009|Overall Study|Disease progression|18|||
129909887|NCT04259450|467633713|FG000|Overall Study|Death|0|||
129909888|NCT04259450|467633714|FG001|Overall Study|Death|0|||
129909889|NCT04259450|467633715|FG002|Overall Study|Death|0|||
129909890|NCT04259450|467633716|FG003|Overall Study|Death|0|||
129909891|NCT04259450|467633717|FG004|Overall Study|Death|0|||
129909892|NCT04259450|467633718|FG005|Overall Study|Death|0|||
129909893|NCT04259450|467633719|FG006|Overall Study|Death|0|||
129909894|NCT04259450|467633720|FG007|Overall Study|Death|1|||
129909895|NCT04259450|467633721|FG008|Overall Study|Death|1|||
129909896|NCT04259450|467633722|FG009|Overall Study|Death|0|||
129909897|NCT04259450|467633713|FG000|Overall Study|Withdrawal by Subject|0|||
129909898|NCT04259450|467633714|FG001|Overall Study|Withdrawal by Subject|0|||
129909899|NCT04259450|467633715|FG002|Overall Study|Withdrawal by Subject|0|||
129909900|NCT04259450|467633716|FG003|Overall Study|Withdrawal by Subject|0|||
129909901|NCT04259450|467633717|FG004|Overall Study|Withdrawal by Subject|0|||
129858164|NCT04389840|467439473|FG001|Overall Study|Adverse Event|0|||
129858165|NCT04389840|467439474|FG002|Overall Study|Adverse Event|0|||
129858166|NCT04389840|467439475|FG003|Overall Study|Adverse Event|1|||
129858167|NCT04389840|467439476|FG004|Overall Study|Adverse Event|0|||
129858168|NCT04389840|467439477|FG005|Overall Study|Adverse Event|0|||
129858169|NCT04389840|467439472|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
129858170|NCT04389840|467439473|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
129858171|NCT04389840|467439474|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
129858172|NCT04389840|467439475|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
129858173|NCT04389840|467439476|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
129858174|NCT04389840|467439477|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
129909902|NCT04259450|467633718|FG005|Overall Study|Withdrawal by Subject|0|||
129909903|NCT04259450|467633719|FG006|Overall Study|Withdrawal by Subject|0|||
129909904|NCT04259450|467633720|FG007|Overall Study|Withdrawal by Subject|1|||
129909905|NCT04259450|467633721|FG008|Overall Study|Withdrawal by Subject|0|||
129909906|NCT04259450|467633722|FG009|Overall Study|Withdrawal by Subject|0|||
129909907|NCT04259450|467633713|FG000|Overall Study|Other than listed|0|||
129909908|NCT04259450|467633714|FG001|Overall Study|Other than listed|0|||
129909909|NCT04259450|467633715|FG002|Overall Study|Other than listed|0|||
129909910|NCT04259450|467633716|FG003|Overall Study|Other than listed|0|||
129909911|NCT04259450|467633717|FG004|Overall Study|Other than listed|0|||
129909912|NCT04259450|467633718|FG005|Overall Study|Other than listed|0|||
129909913|NCT04259450|467633719|FG006|Overall Study|Other than listed|0|||
129909914|NCT04259450|467633720|FG007|Overall Study|Other than listed|1|||
129909915|NCT04259450|467633721|FG008|Overall Study|Other than listed|1|||
129909916|NCT04259450|467633722|FG009|Overall Study|Other than listed|2|||
129858175|NCT04389840|467439472|FG000|Overall Study|Death|0|||
129858176|NCT04389840|467439473|FG001|Overall Study|Death|1|||
129858177|NCT04389840|467439474|FG002|Overall Study|Death|0|||
129858178|NCT04389840|467439475|FG003|Overall Study|Death|0|||
129858179|NCT04389840|467439476|FG004|Overall Study|Death|0|||
129858180|NCT04389840|467439477|FG005|Overall Study|Death|0|||
129858181|NCT02252211|467439478|FG000|Overall Study|Adverse Event|0|||
129858182|NCT02252211|467439479|FG001|Overall Study|Adverse Event|1|||
129858183|NCT02252211|467439480|FG002|Overall Study|Adverse Event|0|||
129858184|NCT02252211|467439478|FG000|Overall Study|Progressive disease|3|||
129858185|NCT02252211|467439479|FG001|Overall Study|Progressive disease|2|||
129858186|NCT02252211|467439480|FG002|Overall Study|Progressive disease|0|||
129858187|NCT02252211|467439478|FG000|Overall Study|Withdrawal by Subject|1|||
129858188|NCT02252211|467439479|FG001|Overall Study|Withdrawal by Subject|0|||
129858189|NCT02252211|467439480|FG002|Overall Study|Withdrawal by Subject|0|||
129858190|NCT02252211|467439478|FG000|Overall Study|Serious Adverse Event During Screening|1|||
129858191|NCT02252211|467439479|FG001|Overall Study|Serious Adverse Event During Screening|0|||
129858192|NCT02252211|467439480|FG002|Overall Study|Serious Adverse Event During Screening|1|||
129858193|NCT00968669|467439481|FG000|Overall Study|Lost to Follow-up|5|||
129858194|NCT00968669|467439482|FG001|Overall Study|Lost to Follow-up|2|||
129858195|NCT00968669|467439483|FG002|Overall Study|Lost to Follow-up|1|||
129858196|NCT00968669|467439484|FG003|Overall Study|Lost to Follow-up|4|||
129858197|NCT00968669|467439481|FG000|Overall Study|Withdrawal by Subject|9|||
129858198|NCT00968669|467439482|FG001|Overall Study|Withdrawal by Subject|7|||
129858199|NCT00968669|467439483|FG002|Overall Study|Withdrawal by Subject|5|||
129858200|NCT00968669|467439484|FG003|Overall Study|Withdrawal by Subject|3|||
129858201|NCT00968669|467439481|FG000|Overall Study|Pregnancy|0|||
129858202|NCT00968669|467439482|FG001|Overall Study|Pregnancy|0|||
129858203|NCT00968669|467439483|FG002|Overall Study|Pregnancy|2|||
129858204|NCT00968669|467439484|FG003|Overall Study|Pregnancy|0|||
129858205|NCT00968669|467439481|FG000|Overall Study|AE|1|||
129858206|NCT00968669|467439482|FG001|Overall Study|AE|0|||
129858207|NCT00968669|467439483|FG002|Overall Study|AE|0|||
129858208|NCT00968669|467439484|FG003|Overall Study|AE|0|||
129858209|NCT00968669|467439481|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
129858210|NCT00968669|467439482|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
129858211|NCT00968669|467439483|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
129858212|NCT00968669|467439484|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
129858213|NCT00968669|467439481|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
129858214|NCT00968669|467439482|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
129858215|NCT00968669|467439483|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
129858216|NCT00968669|467439484|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
129858217|NCT00968669|467439481|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
129858218|NCT00968669|467439482|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
129858219|NCT00968669|467439483|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
129858220|NCT00968669|467439484|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
129858221|NCT00968669|467439481|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
129858222|NCT00968669|467439482|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
129858223|NCT00968669|467439483|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
129858224|NCT00968669|467439484|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
129858225|NCT00968669|467439481|FG000|Overall Study|EARLY WITHDRAWAL|0|||
129858226|NCT00968669|467439482|FG001|Overall Study|EARLY WITHDRAWAL|1|||
129858227|NCT00968669|467439483|FG002|Overall Study|EARLY WITHDRAWAL|0|||
129858228|NCT00968669|467439484|FG003|Overall Study|EARLY WITHDRAWAL|0|||
129858229|NCT00968669|467439481|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
129858230|NCT00968669|467439482|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
129858231|NCT00968669|467439483|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
129858232|NCT00968669|467439484|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
129858233|NCT00968669|467439481|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
129858234|NCT00968669|467439482|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
129858235|NCT00968669|467439483|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
129858236|NCT00968669|467439484|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
129858237|NCT00968669|467439481|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
129858238|NCT00968669|467439482|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
129858239|NCT00968669|467439483|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
129858240|NCT00968669|467439484|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
129858241|NCT00968669|467439481|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
129858242|NCT00968669|467439482|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
130064723|NCT01669811|468190260|FG000|Overall Study|Adverse Event|2|||
130064724|NCT01669811|468190261|FG001|Overall Study|Adverse Event|6|||
129858243|NCT00968669|467439483|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
129858244|NCT00968669|467439484|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
129858245|NCT00968669|467439481|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
129858246|NCT00968669|467439482|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
130064725|NCT01669811|468190260|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129909917|NCT01534494|467633723|FG000|Overall Study|Withdrawal by Subject|1|||
129909918|NCT02724592|467633724|FG000|Overall Study|Lost to Follow-up|4|||
129909919|NCT02724592|467633725|FG001|Overall Study|Lost to Follow-up|1|||
129909920|NCT02584829|467633726|FG000|Overall Study|Physician Decision|1|||
129909921|NCT02584829|467633727|FG001|Overall Study|Physician Decision|0|||
129909922|NCT02584829|467633726|FG000|Overall Study|Withdrawal by Subject|0|||
129909923|NCT02584829|467633727|FG001|Overall Study|Withdrawal by Subject|1|||
129909924|NCT02584829|467633726|FG000|Overall Study|Progressive Disease|0|||
129909925|NCT02584829|467633727|FG001|Overall Study|Progressive Disease|3|||
129909926|NCT00434304|467633733|FG000|Overall Study|Adverse Event|14|||
129909927|NCT00434304|467633733|FG000|Overall Study|Lack of Efficacy|2|||
129909928|NCT00434304|467633733|FG000|Overall Study|Withdrawal by Subject|4|||
129909929|NCT05262738|467633734|FG000|Overall Study|Withdrawal by Subject|1|||
129909930|NCT05262738|467633735|FG001|Overall Study|Withdrawal by Subject|0|||
129909931|NCT02374463|467633736|FG000|Overall Study|Withdrawal by Subject|3|||
129909932|NCT02374463|467633737|FG001|Overall Study|Withdrawal by Subject|3|||
129909933|NCT01939899|467633744|FG000|Lead-in Dose Finding Phase|Death|0|||
129909934|NCT01939899|467633745|FG001|Lead-in Dose Finding Phase|Death|3|||
129909935|NCT01939899|467633746|FG002|Lead-in Dose Finding Phase|Death|1|||
129909936|NCT01939899|467633747|FG003|Lead-in Dose Finding Phase|Death|0|||
129909937|NCT01939899|467633748|FG004|Lead-in Dose Finding Phase|Death|0|||
129909938|NCT01939899|467633744|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
129909939|NCT01939899|467633745|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
129858247|NCT00968669|467439483|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
129858248|NCT00968669|467439484|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
129858249|NCT00968669|467439481|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
129858250|NCT00968669|467439482|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
129858251|NCT00968669|467439483|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
129858252|NCT00968669|467439484|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
129858253|NCT00968669|467439481|FG000|Overall Study|SPONSOR DECISION|0|||
129858254|NCT00968669|467439482|FG001|Overall Study|SPONSOR DECISION|1|||
129858255|NCT00968669|467439483|FG002|Overall Study|SPONSOR DECISION|0|||
129858256|NCT00968669|467439484|FG003|Overall Study|SPONSOR DECISION|0|||
129858257|NCT00968669|467439481|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
129858258|NCT00968669|467439482|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
129858259|NCT00968669|467439483|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
129858260|NCT00968669|467439484|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
129858261|NCT00968669|467439481|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
129858262|NCT00968669|467439482|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
129858263|NCT00968669|467439483|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
129858264|NCT00968669|467439484|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
129858265|NCT00968669|467439481|FG000|Overall Study|SUBJECT INCARCERATED|0|||
129858266|NCT00968669|467439482|FG001|Overall Study|SUBJECT INCARCERATED|1|||
129858267|NCT00968669|467439483|FG002|Overall Study|SUBJECT INCARCERATED|0|||
129858268|NCT00968669|467439484|FG003|Overall Study|SUBJECT INCARCERATED|0|||
129858269|NCT00968669|467439481|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
129858270|NCT00968669|467439482|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
129858271|NCT00968669|467439483|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
129858272|NCT00968669|467439484|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
129858273|NCT00968669|467439481|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
129858274|NCT00968669|467439482|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
129858275|NCT00968669|467439483|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
129858276|NCT00968669|467439484|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
129858277|NCT00144339|467439485|FG000|Overall Study|Adverse Event|746|||
129858278|NCT00144339|467439486|FG001|Overall Study|Adverse Event|627|||
129858279|NCT00144339|467439485|FG000|Overall Study|Protocol Violation|75|||
129858280|NCT00144339|467439486|FG001|Overall Study|Protocol Violation|48|||
129858281|NCT00144339|467439485|FG000|Overall Study|Withdrawal by Subject|403|||
129858282|NCT00144339|467439486|FG001|Overall Study|Withdrawal by Subject|300|||
129858283|NCT00144339|467439485|FG000|Overall Study|Lost to Follow-up|76|||
129858284|NCT00144339|467439486|FG001|Overall Study|Lost to Follow-up|64|||
129909940|NCT01939899|467633746|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
130064726|NCT01669811|468190261|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129858285|NCT00144339|467439485|FG000|Overall Study|Other|58|||
129858286|NCT00144339|467439486|FG001|Overall Study|Other|60|||
129858287|NCT01109992|467439487|FG000|Overall Study|Withdrawal by Subject|0|||
129858288|NCT01109992|467439488|FG001|Overall Study|Withdrawal by Subject|1|||
129858289|NCT01109992|467439487|FG000|Overall Study|Movement during rest scan.|0|||
129858290|NCT01109992|467439488|FG001|Overall Study|Movement during rest scan.|1|||
129858291|NCT00690755|467439489|FG000|Overall Study|Physician Decision|2|||
129909941|NCT01939899|467633747|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
129909942|NCT01939899|467633748|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
129909943|NCT01939899|467633744|FG000|Lead-in Dose Finding Phase|Other|0|||
129909944|NCT01939899|467633745|FG001|Lead-in Dose Finding Phase|Other|0|||
129909945|NCT01939899|467633746|FG002|Lead-in Dose Finding Phase|Other|1|||
130064727|NCT03245723|468190267|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
130064728|NCT03245723|468190268|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
129858292|NCT00690755|467439490|FG001|Overall Study|Physician Decision|0|||
129858293|NCT00690755|467439491|FG002|Overall Study|Physician Decision|46|||
129858294|NCT00690755|467439492|FG003|Overall Study|Physician Decision|5|||
129858295|NCT00690755|467439493|FG004|Overall Study|Physician Decision|0|||
129858296|NCT00690755|467439494|FG005|Overall Study|Physician Decision|4|||
129858297|NCT00690755|467439495|FG006|Overall Study|Physician Decision|0|||
129858298|NCT02952924|467439496|FG000|Overall Study|Protocol Violation|0|||
129858299|NCT02952924|467439497|FG001|Overall Study|Protocol Violation|0|||
129858300|NCT02952924|467439498|FG002|Overall Study|Protocol Violation|0|||
129858301|NCT02952924|467439499|FG003|Overall Study|Protocol Violation|0|||
129858302|NCT02952924|467439500|FG004|Overall Study|Protocol Violation|0|||
129858303|NCT02952924|467439501|FG005|Overall Study|Protocol Violation|0|||
129858304|NCT02952924|467439502|FG006|Overall Study|Protocol Violation|0|||
129858305|NCT02952924|467439503|FG007|Overall Study|Protocol Violation|0|||
129858306|NCT02952924|467439504|FG008|Overall Study|Protocol Violation|0|||
129858307|NCT02952924|467439505|FG009|Overall Study|Protocol Violation|0|||
129858308|NCT02952924|467439506|FG010|Overall Study|Protocol Violation|0|||
129858309|NCT02952924|467439507|FG011|Overall Study|Protocol Violation|0|||
129858310|NCT02952924|467439508|FG012|Overall Study|Protocol Violation|0|||
129858311|NCT02952924|467439509|FG013|Overall Study|Protocol Violation|0|||
129858312|NCT02952924|467439510|FG014|Overall Study|Protocol Violation|0|||
129858313|NCT02952924|467439511|FG015|Overall Study|Protocol Violation|0|||
129858314|NCT02952924|467439512|FG016|Overall Study|Protocol Violation|0|||
129858315|NCT02952924|467439513|FG017|Overall Study|Protocol Violation|0|||
129858316|NCT02952924|467439514|FG018|Overall Study|Protocol Violation|0|||
129858317|NCT02952924|467439515|FG019|Overall Study|Protocol Violation|1|||
129858318|NCT02952924|467439516|FG020|Overall Study|Protocol Violation|0|||
129858319|NCT02952924|467439517|FG021|Overall Study|Protocol Violation|0|||
129858320|NCT02952924|467439496|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
129858321|NCT02952924|467439497|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
129858322|NCT02952924|467439498|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
129858323|NCT02952924|467439499|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
129858324|NCT02952924|467439500|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
129858325|NCT02952924|467439501|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
129858326|NCT02952924|467439502|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
129858327|NCT02952924|467439503|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
129858328|NCT02952924|467439504|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
129858329|NCT02952924|467439505|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
129858330|NCT02952924|467439506|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
129858331|NCT02952924|467439507|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
129858332|NCT02952924|467439508|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
129858333|NCT02952924|467439509|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
129858334|NCT02952924|467439510|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
129858335|NCT02952924|467439511|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
129858336|NCT02952924|467439512|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
129858337|NCT02952924|467439513|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
129858338|NCT02952924|467439514|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
129858339|NCT02952924|467439515|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
129858340|NCT02952924|467439516|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
129858341|NCT02952924|467439517|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
129858342|NCT02952924|467439496|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858343|NCT02952924|467439497|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858344|NCT02952924|467439498|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858345|NCT02952924|467439499|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858346|NCT02952924|467439500|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858347|NCT02952924|467439501|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858348|NCT02952924|467439502|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858349|NCT02952924|467439503|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858350|NCT02952924|467439504|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858351|NCT02952924|467439505|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858352|NCT02952924|467439506|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858353|NCT02952924|467439507|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858354|NCT02952924|467439508|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858355|NCT02952924|467439509|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858356|NCT02952924|467439510|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
129909946|NCT01939899|467633747|FG003|Lead-in Dose Finding Phase|Other|0|||
129858357|NCT02952924|467439511|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858358|NCT02952924|467439512|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858359|NCT02952924|467439513|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858360|NCT02952924|467439514|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858361|NCT02952924|467439515|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858362|NCT02952924|467439516|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858363|NCT02952924|467439517|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
129858364|NCT02952924|467439496|FG000|Overall Study|Noncompliance with study drug|0|||
129858365|NCT02952924|467439497|FG001|Overall Study|Noncompliance with study drug|0|||
129858366|NCT02952924|467439498|FG002|Overall Study|Noncompliance with study drug|0|||
129858367|NCT02952924|467439499|FG003|Overall Study|Noncompliance with study drug|0|||
129858368|NCT02952924|467439500|FG004|Overall Study|Noncompliance with study drug|0|||
129858369|NCT02952924|467439501|FG005|Overall Study|Noncompliance with study drug|0|||
129858370|NCT02952924|467439502|FG006|Overall Study|Noncompliance with study drug|0|||
129858371|NCT02952924|467439503|FG007|Overall Study|Noncompliance with study drug|0|||
129858372|NCT02952924|467439504|FG008|Overall Study|Noncompliance with study drug|0|||
129858373|NCT02952924|467439505|FG009|Overall Study|Noncompliance with study drug|0|||
129858374|NCT02952924|467439506|FG010|Overall Study|Noncompliance with study drug|0|||
129858375|NCT02952924|467439507|FG011|Overall Study|Noncompliance with study drug|0|||
129858376|NCT02952924|467439508|FG012|Overall Study|Noncompliance with study drug|0|||
129858377|NCT02952924|467439509|FG013|Overall Study|Noncompliance with study drug|0|||
129858378|NCT02952924|467439510|FG014|Overall Study|Noncompliance with study drug|0|||
129858379|NCT02952924|467439511|FG015|Overall Study|Noncompliance with study drug|0|||
129858380|NCT02952924|467439512|FG016|Overall Study|Noncompliance with study drug|0|||
129858381|NCT02952924|467439513|FG017|Overall Study|Noncompliance with study drug|0|||
129858382|NCT02952924|467439514|FG018|Overall Study|Noncompliance with study drug|0|||
129858383|NCT02952924|467439515|FG019|Overall Study|Noncompliance with study drug|0|||
129858384|NCT02952924|467439516|FG020|Overall Study|Noncompliance with study drug|0|||
129858385|NCT02952924|467439517|FG021|Overall Study|Noncompliance with study drug|1|||
129858386|NCT02105948|467439522|FG000|Overall Study|Adverse Event|10|||
129858387|NCT02105948|467439523|FG001|Overall Study|Adverse Event|7|||
129858388|NCT02105948|467439524|FG002|Overall Study|Adverse Event|11|||
129858389|NCT02105948|467439525|FG003|Overall Study|Adverse Event|11|||
129858390|NCT02105948|467439522|FG000|Overall Study|Lack of Efficacy|0|||
129858391|NCT02105948|467439523|FG001|Overall Study|Lack of Efficacy|1|||
129858392|NCT02105948|467439524|FG002|Overall Study|Lack of Efficacy|3|||
129858393|NCT02105948|467439525|FG003|Overall Study|Lack of Efficacy|2|||
129858394|NCT02105948|467439522|FG000|Overall Study|Lost to Follow-up|0|||
129858395|NCT02105948|467439523|FG001|Overall Study|Lost to Follow-up|0|||
129858396|NCT02105948|467439524|FG002|Overall Study|Lost to Follow-up|2|||
129858397|NCT02105948|467439525|FG003|Overall Study|Lost to Follow-up|1|||
129858398|NCT02105948|467439522|FG000|Overall Study|Physician Decision|2|||
129858399|NCT02105948|467439523|FG001|Overall Study|Physician Decision|2|||
129858400|NCT02105948|467439524|FG002|Overall Study|Physician Decision|2|||
129858401|NCT02105948|467439525|FG003|Overall Study|Physician Decision|2|||
129858402|NCT02105948|467439522|FG000|Overall Study|Withdrawal by Subject|15|||
129858403|NCT02105948|467439523|FG001|Overall Study|Withdrawal by Subject|10|||
129858404|NCT02105948|467439524|FG002|Overall Study|Withdrawal by Subject|10|||
129858405|NCT02105948|467439525|FG003|Overall Study|Withdrawal by Subject|11|||
129858406|NCT01934218|467439527|FG000|Double-blind Phase|Adverse Event|8|||
129858407|NCT01934218|467439528|FG001|Double-blind Phase|Adverse Event|8|||
129858408|NCT01934218|467439527|FG000|Double-blind Phase|Lack of Efficacy|6|||
129858409|NCT01934218|467439528|FG001|Double-blind Phase|Lack of Efficacy|7|||
129858410|NCT01934218|467439527|FG000|Double-blind Phase|Lost to Follow-up|7|||
129858411|NCT01934218|467439528|FG001|Double-blind Phase|Lost to Follow-up|14|||
129858412|NCT01934218|467439527|FG000|Double-blind Phase|Physician Decision|1|||
129858413|NCT01934218|467439528|FG001|Double-blind Phase|Physician Decision|2|||
129858414|NCT01934218|467439527|FG000|Double-blind Phase|Protocol Violation|4|||
129858415|NCT01934218|467439528|FG001|Double-blind Phase|Protocol Violation|0|||
129909947|NCT01939899|467633748|FG004|Lead-in Dose Finding Phase|Other|0|||
129858416|NCT01934218|467439527|FG000|Double-blind Phase|Withdrawal by Subject|16|||
129858417|NCT01934218|467439528|FG001|Double-blind Phase|Withdrawal by Subject|13|||
129858418|NCT01934218|467439527|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
129858419|NCT01934218|467439528|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
129858420|NCT01934218|467439527|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
129858421|NCT01934218|467439528|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
129858422|NCT01934218|467439527|FG000|Open-Label Phase|Adverse Event|2|||
129858423|NCT01934218|467439528|FG001|Open-Label Phase|Adverse Event|4|||
129858424|NCT01934218|467439527|FG000|Open-Label Phase|Lack of Efficacy|1|||
129858425|NCT01934218|467439528|FG001|Open-Label Phase|Lack of Efficacy|4|||
129909948|NCT01939899|467633744|FG000|Phase 2|Withdrawal by Subject|0|||
129858426|NCT01934218|467439527|FG000|Open-Label Phase|Lost to Follow-up|4|||
129909949|NCT01939899|467633745|FG001|Phase 2|Withdrawal by Subject|0|||
129909950|NCT01939899|467633746|FG002|Phase 2|Withdrawal by Subject|0|||
129909951|NCT01939899|467633747|FG003|Phase 2|Withdrawal by Subject|2|||
129909952|NCT01939899|467633748|FG004|Phase 2|Withdrawal by Subject|0|||
129909953|NCT01939899|467633744|FG000|Phase 2|Disease Progression|0|||
129909954|NCT01939899|467633745|FG001|Phase 2|Disease Progression|0|||
129909955|NCT01939899|467633746|FG002|Phase 2|Disease Progression|0|||
129909956|NCT01939899|467633747|FG003|Phase 2|Disease Progression|9|||
129909957|NCT01939899|467633748|FG004|Phase 2|Disease Progression|1|||
129909958|NCT00585052|467633749|FG000|Overall Study|Withdrawal by Subject|1|||
129909959|NCT00858117|467633750|FG000|Treatment on Study|Adverse Event|2|||
129909960|NCT00858117|467633750|FG000|Follow up for 5 Years|Death|4|||
129909961|NCT00858117|467633750|FG000|Follow up for 5 Years|No further data collected for study|9|||
129909962|NCT04425863|467633752|FG000|Overall Study|Death|0|||
129909963|NCT04425863|467633753|FG001|Overall Study|Death|0|||
129909964|NCT04425863|467633754|FG002|Overall Study|Death|1|||
129909965|NCT00277355|467633757|FG000|Overall Study|Withdrawal by Subject|3|||
129909966|NCT00277355|467633758|FG001|Overall Study|Withdrawal by Subject|3|||
129909967|NCT00277355|467633757|FG000|Overall Study|Lost to Follow-up|2|||
129909968|NCT00277355|467633758|FG001|Overall Study|Lost to Follow-up|2|||
129909969|NCT00277355|467633757|FG000|Overall Study|Adverse Event|5|||
129909970|NCT00277355|467633758|FG001|Overall Study|Adverse Event|0|||
129909971|NCT00277355|467633757|FG000|Overall Study|Death|3|||
129909972|NCT00277355|467633758|FG001|Overall Study|Death|0|||
129909973|NCT00277355|467633757|FG000|Overall Study|Physician Decision|1|||
129909974|NCT00277355|467633758|FG001|Overall Study|Physician Decision|0|||
129909975|NCT05489484|467633764|FG000|Overall Study|withdrawn|1|||
129909976|NCT00444600|467633767|FG000|Overall Study|Death|7|||
129909977|NCT00444600|467633768|FG001|Overall Study|Death|5|||
129909978|NCT00444600|467633769|FG002|Overall Study|Death|3|||
129909979|NCT00444600|467633770|FG003|Overall Study|Death|2|||
129909980|NCT00444600|467633767|FG000|Overall Study|Dropped|11|||
129909981|NCT00444600|467633768|FG001|Overall Study|Dropped|11|||
129909982|NCT00444600|467633769|FG002|Overall Study|Dropped|7|||
129909983|NCT00444600|467633770|FG003|Overall Study|Dropped|7|||
129909984|NCT00444600|467633767|FG000|Overall Study|Missed visit|1|||
129909985|NCT00444600|467633768|FG001|Overall Study|Missed visit|0|||
129909986|NCT00444600|467633769|FG002|Overall Study|Missed visit|0|||
129909987|NCT00444600|467633770|FG003|Overall Study|Missed visit|1|||
129909988|NCT05132478|467633771|FG000|Overall Study|did not complete survey after consent|1|||
129909989|NCT05132478|467633772|FG001|Overall Study|did not complete survey after consent|1|||
129909990|NCT05132478|467633771|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
129909991|NCT05132478|467633772|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
129909992|NCT02549170|467633773|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
129909993|NCT02549170|467633774|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
129909994|NCT02549170|467633775|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
129909995|NCT02549170|467633776|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
129909996|NCT02549170|467633777|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
129909997|NCT02549170|467633773|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
129909998|NCT02549170|467633774|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
129909999|NCT02549170|467633775|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
129910000|NCT02549170|467633776|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
129910001|NCT02549170|467633777|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
129910002|NCT02549170|467633773|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
129910003|NCT02549170|467633774|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
129910004|NCT02549170|467633775|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
129910005|NCT02549170|467633776|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
129910006|NCT02549170|467633777|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
129910007|NCT01414738|467633778|FG000|Overall Study|Death|26|||
129910008|NCT01414738|467633778|FG000|Overall Study|Refused testing|5|||
129910009|NCT01414738|467633778|FG000|Overall Study|Lost to Follow-up|2|||
129910010|NCT01414738|467633778|FG000|Overall Study|Refused, disease progression|8|||
129910011|NCT01414738|467633778|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
129910012|NCT00703820|467633782|FG000|Overall Study|Adverse Event|12|||
129910013|NCT00703820|467633783|FG001|Overall Study|Adverse Event|17|||
129910014|NCT00703820|467633782|FG000|Overall Study|Death|5|||
129910015|NCT00703820|467633783|FG001|Overall Study|Death|0|||
129910016|NCT00703820|467633782|FG000|Overall Study|Lack of Efficacy|11|||
129910017|NCT00703820|467633783|FG001|Overall Study|Lack of Efficacy|11|||
129910018|NCT00703820|467633782|FG000|Overall Study|Received non-protocol therapy|1|||
129910019|NCT00703820|467633783|FG001|Overall Study|Received non-protocol therapy|0|||
129910020|NCT00703820|467633782|FG000|Overall Study|Physician Decision|4|||
129910021|NCT00703820|467633783|FG001|Overall Study|Physician Decision|5|||
129910022|NCT00703820|467633782|FG000|Overall Study|Withdrawal by Subject|2|||
129910023|NCT00703820|467633783|FG001|Overall Study|Withdrawal by Subject|1|||
129910024|NCT00914589|467633786|FG000|Overall Study|Adverse Event|1|||
129910025|NCT00914589|467633787|FG001|Overall Study|Adverse Event|0|||
129910026|NCT00914589|467633788|FG002|Overall Study|Adverse Event|1|||
129910027|NCT00914589|467633786|FG000|Overall Study|Protocol Violation|8|||
129910028|NCT00914589|467633787|FG001|Overall Study|Protocol Violation|6|||
129910029|NCT00914589|467633788|FG002|Overall Study|Protocol Violation|3|||
129910030|NCT00914589|467633786|FG000|Overall Study|unclassified|16|||
129910031|NCT00914589|467633787|FG001|Overall Study|unclassified|9|||
129910032|NCT00914589|467633788|FG002|Overall Study|unclassified|7|||
129910033|NCT00914589|467633786|FG000|Overall Study|Death|0|||
129910034|NCT00914589|467633787|FG001|Overall Study|Death|1|||
129910035|NCT00914589|467633788|FG002|Overall Study|Death|1|||
129910036|NCT03036813|467633789|FG000|Overall Study|Adverse Event|6|||
129910037|NCT03036813|467633790|FG001|Overall Study|Adverse Event|11|||
129910038|NCT03036813|467633791|FG002|Overall Study|Adverse Event|6|||
129910039|NCT03036813|467633789|FG000|Overall Study|Withdrawal by Subject|12|||
129910040|NCT03036813|467633790|FG001|Overall Study|Withdrawal by Subject|6|||
129910041|NCT03036813|467633791|FG002|Overall Study|Withdrawal by Subject|10|||
129910042|NCT03036813|467633789|FG000|Overall Study|Lost to Follow-up|1|||
129910043|NCT03036813|467633790|FG001|Overall Study|Lost to Follow-up|1|||
129910044|NCT03036813|467633791|FG002|Overall Study|Lost to Follow-up|0|||
129910045|NCT03036813|467633789|FG000|Overall Study|Physician Decision|2|||
129910046|NCT03036813|467633790|FG001|Overall Study|Physician Decision|1|||
129910047|NCT03036813|467633791|FG002|Overall Study|Physician Decision|1|||
129910048|NCT03036813|467633789|FG000|Overall Study|Non-Compliance|1|||
129910049|NCT03036813|467633790|FG001|Overall Study|Non-Compliance|5|||
129910050|NCT03036813|467633791|FG002|Overall Study|Non-Compliance|3|||
129910051|NCT03036813|467633789|FG000|Overall Study|Pregnancy|0|||
129910052|NCT03036813|467633790|FG001|Overall Study|Pregnancy|0|||
129910053|NCT03036813|467633791|FG002|Overall Study|Pregnancy|1|||
129910054|NCT03036813|467633789|FG000|Overall Study|Other|0|||
129910055|NCT03036813|467633790|FG001|Overall Study|Other|3|||
129910056|NCT03036813|467633791|FG002|Overall Study|Other|5|||
129910057|NCT00529100|467633794|FG000|Overall Study|Adverse Event|0|||
129910058|NCT00529100|467633795|FG001|Overall Study|Adverse Event|5|||
129910059|NCT00529100|467633794|FG000|Overall Study|Protocol Violation|0|||
129910060|NCT00529100|467633795|FG001|Overall Study|Protocol Violation|1|||
129910061|NCT00529100|467633794|FG000|Overall Study|Progressive Disease|0|||
129910062|NCT00529100|467633795|FG001|Overall Study|Progressive Disease|1|||
129910063|NCT00529100|467633794|FG000|Overall Study|Withdrawal by Subject|0|||
129910064|NCT00529100|467633795|FG001|Overall Study|Withdrawal by Subject|1|||
129910065|NCT00529100|467633794|FG000|Overall Study|Participant Ineligibility|0|||
129910066|NCT00529100|467633795|FG001|Overall Study|Participant Ineligibility|1|||
129910067|NCT00807937|467633797|FG000|Overall Study|Adverse Event|12|||
129910068|NCT00807937|467633798|FG001|Overall Study|Adverse Event|12|||
129910069|NCT00807937|467633799|FG002|Overall Study|Adverse Event|5|||
129910070|NCT00807937|467633800|FG003|Overall Study|Adverse Event|4|||
129910071|NCT00807937|467633797|FG000|Overall Study|Protocol Violation|4|||
129910072|NCT00807937|467633798|FG001|Overall Study|Protocol Violation|5|||
129910073|NCT00807937|467633799|FG002|Overall Study|Protocol Violation|3|||
129910074|NCT00807937|467633800|FG003|Overall Study|Protocol Violation|3|||
129910075|NCT00807937|467633797|FG000|Overall Study|Withdrawal by Subject|5|||
129910076|NCT00807937|467633798|FG001|Overall Study|Withdrawal by Subject|4|||
129910077|NCT00807937|467633799|FG002|Overall Study|Withdrawal by Subject|1|||
129910078|NCT00807937|467633800|FG003|Overall Study|Withdrawal by Subject|4|||
129910079|NCT00807937|467633797|FG000|Overall Study|Lost to Follow-up|4|||
129910080|NCT00807937|467633798|FG001|Overall Study|Lost to Follow-up|0|||
129910081|NCT00807937|467633799|FG002|Overall Study|Lost to Follow-up|2|||
129910082|NCT00807937|467633800|FG003|Overall Study|Lost to Follow-up|1|||
129910083|NCT00807937|467633797|FG000|Overall Study|Lack of Efficacy|0|||
129910084|NCT00807937|467633798|FG001|Overall Study|Lack of Efficacy|0|||
129910085|NCT00807937|467633799|FG002|Overall Study|Lack of Efficacy|1|||
129910086|NCT00807937|467633800|FG003|Overall Study|Lack of Efficacy|2|||
129910087|NCT00807937|467633797|FG000|Overall Study|Intake of prohibited medicine|0|||
129910088|NCT00807937|467633798|FG001|Overall Study|Intake of prohibited medicine|0|||
129910089|NCT00807937|467633799|FG002|Overall Study|Intake of prohibited medicine|2|||
129910090|NCT00807937|467633800|FG003|Overall Study|Intake of prohibited medicine|0|||
129910091|NCT00807937|467633797|FG000|Overall Study|All other reasons (not provided)|2|||
129910092|NCT00807937|467633798|FG001|Overall Study|All other reasons (not provided)|4|||
129910093|NCT00807937|467633799|FG002|Overall Study|All other reasons (not provided)|0|||
129910094|NCT00807937|467633800|FG003|Overall Study|All other reasons (not provided)|1|||
129910095|NCT04629950|467633801|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
129910096|NCT04629950|467633802|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
129910097|NCT04629950|467633803|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
129910098|NCT04629950|467633804|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
129910099|NCT04629950|467633801|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
129858427|NCT01934218|467439528|FG001|Open-Label Phase|Lost to Follow-up|2|||
129858428|NCT01934218|467439527|FG000|Open-Label Phase|Physician Decision|1|||
129858429|NCT01934218|467439528|FG001|Open-Label Phase|Physician Decision|0|||
129858430|NCT01934218|467439527|FG000|Open-Label Phase|Protocol Violation|1|||
129858431|NCT01934218|467439528|FG001|Open-Label Phase|Protocol Violation|0|||
129858432|NCT01934218|467439527|FG000|Open-Label Phase|Withdrawal by Subject|13|||
129858433|NCT01934218|467439528|FG001|Open-Label Phase|Withdrawal by Subject|11|||
129858434|NCT01934218|467439527|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
129858435|NCT01934218|467439528|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
129858436|NCT01934218|467439527|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
129858437|NCT01934218|467439528|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
129858438|NCT02232893|467439529|FG000|Overall Study|Withdrawal by Subject|4|||
129858439|NCT02232893|467439530|FG001|Overall Study|Withdrawal by Subject|1|||
129858440|NCT02232893|467439529|FG000|Overall Study|Adverse Event|0|||
129858441|NCT02232893|467439530|FG001|Overall Study|Adverse Event|1|||
129858442|NCT02232893|467439529|FG000|Overall Study|Sponsor request early termination|0|||
129858443|NCT02232893|467439530|FG001|Overall Study|Sponsor request early termination|1|||
129858444|NCT02232893|467439529|FG000|Overall Study|Developed exclusion criteria|0|||
129858445|NCT02232893|467439530|FG001|Overall Study|Developed exclusion criteria|1|||
129858446|NCT02232893|467439529|FG000|Overall Study|Other|0|||
129858447|NCT02232893|467439530|FG001|Overall Study|Other|3|||
129858448|NCT01587651|467439534|FG000|Overall Study|Adverse Event|0|||
129858449|NCT01587651|467439535|FG001|Overall Study|Adverse Event|1|||
129858450|NCT01587651|467439536|FG002|Overall Study|Adverse Event|0|||
129858451|NCT01587651|467439534|FG000|Overall Study|Protocol Violation|0|||
129858452|NCT01587651|467439535|FG001|Overall Study|Protocol Violation|1|||
129858453|NCT01587651|467439536|FG002|Overall Study|Protocol Violation|1|||
129858454|NCT01587651|467439534|FG000|Overall Study|Withdrawal by Subject|0|||
129858455|NCT01587651|467439535|FG001|Overall Study|Withdrawal by Subject|1|||
129858456|NCT01587651|467439536|FG002|Overall Study|Withdrawal by Subject|0|||
129858457|NCT03867734|467439537|FG000|Overall Study|Lost to Follow-up|2|||
129858458|NCT04323436|467439543|FG000|Overall Study|Adverse Event|7|||
129858459|NCT04323436|467439544|FG001|Overall Study|Adverse Event|0|||
129858460|NCT04323436|467439545|FG002|Overall Study|Adverse Event|0|||
129858461|NCT04323436|467439543|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
129858462|NCT04323436|467439544|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
129858463|NCT04323436|467439545|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
129858464|NCT04323436|467439543|FG000|Overall Study|Death|1|||
129858465|NCT04323436|467439544|FG001|Overall Study|Death|0|||
129858466|NCT04323436|467439545|FG002|Overall Study|Death|0|||
129858467|NCT04323436|467439543|FG000|Overall Study|Physician Decision|2|||
129858468|NCT04323436|467439544|FG001|Overall Study|Physician Decision|0|||
129858469|NCT04323436|467439545|FG002|Overall Study|Physician Decision|0|||
129858470|NCT04323436|467439543|FG000|Overall Study|Progressive disease|10|||
129858471|NCT04323436|467439544|FG001|Overall Study|Progressive disease|0|||
129858472|NCT04323436|467439545|FG002|Overall Study|Progressive disease|0|||
129858473|NCT04323436|467439543|FG000|Overall Study|Subject decision|3|||
129858474|NCT04323436|467439544|FG001|Overall Study|Subject decision|0|||
129858475|NCT04323436|467439545|FG002|Overall Study|Subject decision|0|||
129858476|NCT00839072|467439547|FG000|First Intervention Period|Withdrawal by Subject|1|||
129858477|NCT00839072|467439548|FG001|First Intervention Period|Withdrawal by Subject|0|||
129858478|NCT00839072|467439547|FG000|First Intervention Period|Adverse Event|1|||
129858479|NCT00839072|467439548|FG001|First Intervention Period|Adverse Event|1|||
129858480|NCT00839072|467439547|FG000|Second Intervention Period|Withdrawal by Subject|1|||
129858481|NCT00839072|467439548|FG001|Second Intervention Period|Withdrawal by Subject|0|||
129858482|NCT01458574|467439549|FG000|Overall Study|Adverse Event|5|||
129858483|NCT01458574|467439550|FG001|Overall Study|Adverse Event|9|||
129858484|NCT01458574|467439551|FG002|Overall Study|Adverse Event|7|||
129858485|NCT01458574|467439549|FG000|Overall Study|Lack of Efficacy|70|||
129858486|NCT01458574|467439550|FG001|Overall Study|Lack of Efficacy|53|||
129858487|NCT01458574|467439551|FG002|Overall Study|Lack of Efficacy|132|||
129858488|NCT01458574|467439549|FG000|Overall Study|Lost to Follow-up|3|||
129858489|NCT01458574|467439550|FG001|Overall Study|Lost to Follow-up|2|||
129858490|NCT01458574|467439551|FG002|Overall Study|Lost to Follow-up|1|||
130064729|NCT03245723|468190267|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
129858491|NCT01458574|467439549|FG000|Overall Study|Pregnancy|1|||
129858492|NCT01458574|467439550|FG001|Overall Study|Pregnancy|1|||
129858493|NCT01458574|467439551|FG002|Overall Study|Pregnancy|0|||
129858494|NCT01458574|467439549|FG000|Overall Study|Protocol Violation|0|||
129858495|NCT01458574|467439550|FG001|Overall Study|Protocol Violation|1|||
129858496|NCT01458574|467439551|FG002|Overall Study|Protocol Violation|0|||
129858497|NCT01458574|467439549|FG000|Overall Study|Withdrawal by Subject|6|||
129858498|NCT01458574|467439550|FG001|Overall Study|Withdrawal by Subject|3|||
129858499|NCT01458574|467439551|FG002|Overall Study|Withdrawal by Subject|5|||
129858500|NCT01458574|467439549|FG000|Overall Study|Other|2|||
130064730|NCT03245723|468190268|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
130064731|NCT03245723|468190267|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
129858501|NCT01458574|467439550|FG001|Overall Study|Other|1|||
129858502|NCT01458574|467439551|FG002|Overall Study|Other|0|||
129858503|NCT01458574|467439549|FG000|Overall Study|Randomized but not treated|0|||
129858504|NCT01458574|467439550|FG001|Overall Study|Randomized but not treated|1|||
129858505|NCT01458574|467439551|FG002|Overall Study|Randomized but not treated|0|||
129858506|NCT02125786|467439552|FG000|Overall Study|Still in Follow-up|3|||
129858507|NCT02125786|467439552|FG000|Overall Study|Screen Failure|2|||
129858508|NCT02125786|467439552|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
129858509|NCT02125786|467439552|FG000|Overall Study|Progressive Disease|44|||
129858510|NCT02125786|467439552|FG000|Overall Study|Death|8|||
129858511|NCT01682837|467439553|FG000|Baseline|Withdrawal by Subject|5|||
129858512|NCT04782323|467439556|FG000|Overall Study|Death|1|||
129858513|NCT04782323|467439557|FG001|Overall Study|Death|0|||
129858514|NCT04782323|467439558|FG002|Overall Study|Death|0|||
129858515|NCT04782323|467439559|FG003|Overall Study|Death|0|||
129858516|NCT04782323|467439560|FG004|Overall Study|Death|1|||
129858517|NCT04782323|467439561|FG005|Overall Study|Death|1|||
129858518|NCT04782323|467439562|FG006|Overall Study|Death|1|||
129858519|NCT04782323|467439563|FG007|Overall Study|Death|0|||
129858520|NCT04782323|467439556|FG000|Overall Study|Withdrawal by Subject|0|||
129858521|NCT04782323|467439557|FG001|Overall Study|Withdrawal by Subject|0|||
129858522|NCT04782323|467439558|FG002|Overall Study|Withdrawal by Subject|1|||
129858523|NCT04782323|467439559|FG003|Overall Study|Withdrawal by Subject|0|||
129858524|NCT04782323|467439560|FG004|Overall Study|Withdrawal by Subject|0|||
129858525|NCT04782323|467439561|FG005|Overall Study|Withdrawal by Subject|1|||
129858526|NCT04782323|467439562|FG006|Overall Study|Withdrawal by Subject|0|||
129858527|NCT04782323|467439563|FG007|Overall Study|Withdrawal by Subject|1|||
129858528|NCT04782323|467439556|FG000|Overall Study|Lost to Follow-up|0|||
129858529|NCT04782323|467439557|FG001|Overall Study|Lost to Follow-up|1|||
129858530|NCT04782323|467439558|FG002|Overall Study|Lost to Follow-up|1|||
129858531|NCT04782323|467439559|FG003|Overall Study|Lost to Follow-up|0|||
129858532|NCT04782323|467439560|FG004|Overall Study|Lost to Follow-up|0|||
129858533|NCT04782323|467439561|FG005|Overall Study|Lost to Follow-up|1|||
129858534|NCT04782323|467439562|FG006|Overall Study|Lost to Follow-up|1|||
129858535|NCT04782323|467439563|FG007|Overall Study|Lost to Follow-up|2|||
129858536|NCT04782323|467439556|FG000|Overall Study|randomization in error|1|||
129858537|NCT04782323|467439557|FG001|Overall Study|randomization in error|0|||
129858538|NCT04782323|467439558|FG002|Overall Study|randomization in error|0|||
129858539|NCT04782323|467439559|FG003|Overall Study|randomization in error|0|||
129858540|NCT04782323|467439560|FG004|Overall Study|randomization in error|0|||
129858541|NCT04782323|467439561|FG005|Overall Study|randomization in error|0|||
129858542|NCT04782323|467439562|FG006|Overall Study|randomization in error|0|||
129858543|NCT04782323|467439563|FG007|Overall Study|randomization in error|0|||
129858544|NCT03832192|467439568|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
129858545|NCT03832192|467439569|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
129858546|NCT03738150|467439570|FG000|Base Study|Withdrawal by Subject|1|||
129858547|NCT03738150|467439570|FG000|Extension Study|Withdrawal by Subject|1|||
129858548|NCT00724971|467439573|FG000|Overall Study|Adverse Event|5|||
129858549|NCT00724971|467439573|FG000|Overall Study|Withdrawal by Subject|1|||
129858550|NCT01692197|467439574|FG000|Overall Study|Failed Screening|3|||
129858551|NCT03086447|467439576|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129858552|NCT03086447|467439577|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
129858553|NCT03086447|467439576|FG000|Overall Study|Lost Lens|2|||
129858554|NCT03086447|467439577|FG001|Overall Study|Lost Lens|5|||
129858555|NCT03086447|467439576|FG000|Overall Study|Product quality complaint|0|||
129858556|NCT03086447|467439577|FG001|Overall Study|Product quality complaint|1|||
129858557|NCT03086447|467439576|FG000|Overall Study|Lens Damage|1|||
129858558|NCT03086447|467439577|FG001|Overall Study|Lens Damage|6|||
129858559|NCT03086447|467439576|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129858560|NCT03086447|467439577|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129858561|NCT03086447|467439576|FG000|Overall Study|Test Article No Longer Available|1|||
129858562|NCT03086447|467439577|FG001|Overall Study|Test Article No Longer Available|0|||
129858563|NCT03086447|467439576|FG000|Overall Study|Protocol Violation|2|||
129858564|NCT03086447|467439577|FG001|Overall Study|Protocol Violation|4|||
129858565|NCT03086447|467439576|FG000|Overall Study|Lost to Follow-up|0|||
129858566|NCT03086447|467439577|FG001|Overall Study|Lost to Follow-up|1|||
129858567|NCT03086447|467439576|FG000|Overall Study|Adverse Event|3|||
129858568|NCT03086447|467439577|FG001|Overall Study|Adverse Event|0|||
129858569|NCT03086447|467439576|FG000|Overall Study|Lens Discomfort|2|||
129858570|NCT03086447|467439577|FG001|Overall Study|Lens Discomfort|1|||
129858571|NCT02276482|467439578|FG000|Overall Study|Adverse Event|1|||
129858572|NCT02276482|467439579|FG001|Overall Study|Adverse Event|0|||
129858573|NCT02276482|467439578|FG000|Overall Study|Withdrawal by Subject|1|||
129858574|NCT02276482|467439579|FG001|Overall Study|Withdrawal by Subject|0|||
129858575|NCT02276482|467439578|FG000|Overall Study|Gram-negative infection|1|||
129858576|NCT02276482|467439579|FG001|Overall Study|Gram-negative infection|0|||
129910100|NCT04629950|467633802|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
129910101|NCT04629950|467633803|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
129910102|NCT04629950|467633804|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
129910103|NCT04629950|467633801|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
129910104|NCT04629950|467633802|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
129910105|NCT04629950|467633803|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
129910106|NCT04629950|467633804|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
129910107|NCT04629950|467633801|FG000|Extension Study|Withdrawal by Subject|0|||
129910108|NCT04629950|467633802|FG001|Extension Study|Withdrawal by Subject|0|||
129910109|NCT04629950|467633803|FG002|Extension Study|Withdrawal by Subject|1|||
129910110|NCT04629950|467633804|FG003|Extension Study|Withdrawal by Subject|0|||
129910111|NCT04629950|467633801|FG000|Extension Study|Adverse Event|0|||
129910112|NCT04629950|467633802|FG001|Extension Study|Adverse Event|0|||
129910113|NCT04629950|467633803|FG002|Extension Study|Adverse Event|0|||
129910114|NCT04629950|467633804|FG003|Extension Study|Adverse Event|1|||
129910115|NCT02088853|467633805|FG000|Overall Study|Pregnancy|1|||
129910116|NCT02088853|467633806|FG001|Overall Study|Pregnancy|0|||
129910117|NCT00396084|467633807|FG000|Overall Study|Adverse Event|0|||
129910118|NCT00396084|467633808|FG001|Overall Study|Adverse Event|0|||
129910119|NCT00396084|467633809|FG002|Overall Study|Adverse Event|0|||
129910120|NCT00396084|467633810|FG003|Overall Study|Adverse Event|0|||
129910121|NCT00396084|467633811|FG004|Overall Study|Adverse Event|1|||
129910122|NCT00396084|467633812|FG005|Overall Study|Adverse Event|2|||
129910123|NCT00396084|467633807|FG000|Overall Study|Withdrawal by Subject|0|||
129910124|NCT00396084|467633808|FG001|Overall Study|Withdrawal by Subject|0|||
129910125|NCT00396084|467633809|FG002|Overall Study|Withdrawal by Subject|0|||
129910126|NCT00396084|467633810|FG003|Overall Study|Withdrawal by Subject|1|||
129910127|NCT00396084|467633811|FG004|Overall Study|Withdrawal by Subject|0|||
129858577|NCT02276482|467439578|FG000|Overall Study|Reason not specified|0|||
129858578|NCT02276482|467439579|FG001|Overall Study|Reason not specified|1|||
129858579|NCT00838110|467441390|FG000|Overall Study|Death|0|||
129858580|NCT00838110|467441391|FG001|Overall Study|Death|0|||
129858581|NCT00838110|467441392|FG002|Overall Study|Death|1|||
129858582|NCT00838110|467441393|FG003|Overall Study|Death|2|||
129858583|NCT00838110|467441390|FG000|Overall Study|Adverse Event|11|||
129858584|NCT00838110|467441391|FG001|Overall Study|Adverse Event|10|||
129858585|NCT00838110|467441392|FG002|Overall Study|Adverse Event|8|||
129858586|NCT00838110|467441393|FG003|Overall Study|Adverse Event|7|||
129858587|NCT00838110|467441390|FG000|Overall Study|Withdrawal by Subject|5|||
129858588|NCT00838110|467441391|FG001|Overall Study|Withdrawal by Subject|6|||
129858589|NCT00838110|467441392|FG002|Overall Study|Withdrawal by Subject|3|||
129858590|NCT00838110|467441393|FG003|Overall Study|Withdrawal by Subject|4|||
129858591|NCT00838110|467441390|FG000|Overall Study|Other|3|||
129858592|NCT00838110|467441391|FG001|Overall Study|Other|3|||
129858593|NCT00838110|467441392|FG002|Overall Study|Other|3|||
129858594|NCT00838110|467441393|FG003|Overall Study|Other|2|||
129858595|NCT00838110|467441390|FG000|Overall Study|Protocol Violation|0|||
129858596|NCT00838110|467441391|FG001|Overall Study|Protocol Violation|2|||
129858597|NCT00838110|467441392|FG002|Overall Study|Protocol Violation|1|||
129858598|NCT00838110|467441393|FG003|Overall Study|Protocol Violation|1|||
129858599|NCT00838110|467441390|FG000|Overall Study|Lost to Follow-up|3|||
129858600|NCT00838110|467441391|FG001|Overall Study|Lost to Follow-up|0|||
129858601|NCT00838110|467441392|FG002|Overall Study|Lost to Follow-up|0|||
129858602|NCT00838110|467441393|FG003|Overall Study|Lost to Follow-up|0|||
129858603|NCT00838110|467441390|FG000|Overall Study|Did not meet eligibility criteria|0|||
129858604|NCT00838110|467441391|FG001|Overall Study|Did not meet eligibility criteria|0|||
129858605|NCT00838110|467441392|FG002|Overall Study|Did not meet eligibility criteria|1|||
129858606|NCT00838110|467441393|FG003|Overall Study|Did not meet eligibility criteria|2|||
129858607|NCT00838110|467441390|FG000|Overall Study|Randomized but not treated|0|||
129910128|NCT00396084|467633812|FG005|Overall Study|Withdrawal by Subject|0|||
129910129|NCT02708108|467633813|FG000|Overall Study|Death|1|||
129858608|NCT00838110|467441391|FG001|Overall Study|Randomized but not treated|1|||
129858609|NCT00838110|467441392|FG002|Overall Study|Randomized but not treated|0|||
129910130|NCT02708108|467633814|FG001|Overall Study|Death|2|||
129910131|NCT02708108|467633813|FG000|Overall Study|Regimen change|1|||
129910132|NCT02708108|467633814|FG001|Overall Study|Regimen change|0|||
129910133|NCT02708108|467633813|FG000|Overall Study|No MRD and no imaging available|0|||
129858610|NCT00838110|467441393|FG003|Overall Study|Randomized but not treated|0|||
129858611|NCT01262651|467441394|FG000|Overall Study|Adverse Event|40|||
129858612|NCT01262651|467441395|FG001|Overall Study|Adverse Event|35|||
129858613|NCT01262651|467441394|FG000|Overall Study|Withdrawal by Subject|15|||
129858614|NCT01262651|467441395|FG001|Overall Study|Withdrawal by Subject|11|||
129858615|NCT01262651|467441394|FG000|Overall Study|Withdrawal by Investigator|2|||
129858616|NCT01262651|467441395|FG001|Overall Study|Withdrawal by Investigator|2|||
129910134|NCT02708108|467633814|FG001|Overall Study|No MRD and no imaging available|1|||
129910135|NCT01697969|467633817|FG000|Overall Study|Did not meet inc/exc criteria|3|||
129910136|NCT01561989|467633818|FG000|Overall Study|accural target not met.|5|||
129910137|NCT01561989|467633819|FG001|Overall Study|accural target not met.|6|||
129910138|NCT00440011|467633820|FG000|Overall Study|Adverse Event|2|||
129910139|NCT00440011|467633821|FG001|Overall Study|Adverse Event|0|||
129910140|NCT00440011|467633820|FG000|Overall Study|Lost to Follow-up|0|||
129910141|NCT00440011|467633821|FG001|Overall Study|Lost to Follow-up|2|||
129910142|NCT00440011|467633820|FG000|Overall Study|Protocol Violation|1|||
129910143|NCT00440011|467633821|FG001|Overall Study|Protocol Violation|1|||
129910144|NCT00440011|467633820|FG000|Overall Study|Withdrawal by Subject|1|||
129910145|NCT00440011|467633821|FG001|Overall Study|Withdrawal by Subject|0|||
129910146|NCT01803555|467633823|FG000|Overall Study|Adverse Event|3|||
129910147|NCT01803555|467633824|FG001|Overall Study|Adverse Event|2|||
129910148|NCT01803555|467633823|FG000|Overall Study|Withdrawal by Subject|3|||
129910149|NCT01803555|467633824|FG001|Overall Study|Withdrawal by Subject|3|||
129858617|NCT01262651|467441394|FG000|Overall Study|Met Withdrawal Criteria|1|||
129858618|NCT01262651|467441395|FG001|Overall Study|Met Withdrawal Criteria|0|||
129858619|NCT04969783|467441401|FG000|Overall Study|Lost to Follow-up|2|||
129858620|NCT04969783|467441402|FG001|Overall Study|Lost to Follow-up|0|||
129858621|NCT04969783|467441401|FG000|Overall Study|Withdrawal by Subject|4|||
129858622|NCT04969783|467441402|FG001|Overall Study|Withdrawal by Subject|0|||
129858623|NCT04969783|467441401|FG000|Overall Study|Physician Decision|6|||
129858624|NCT04969783|467441402|FG001|Overall Study|Physician Decision|0|||
129858625|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
129858626|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
129858627|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
129858628|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858629|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858630|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858631|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858632|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858633|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858634|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858635|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858636|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858637|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858638|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858639|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
129858640|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
129858641|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
129858642|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858643|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858644|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858645|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858646|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858647|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858648|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858649|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858650|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858651|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858652|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858653|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
129858654|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
129858655|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
129858656|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858657|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858658|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129910150|NCT01803555|467633823|FG000|Overall Study|Non-compliance|1|||
129910151|NCT01803555|467633824|FG001|Overall Study|Non-compliance|1|||
129858659|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858660|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858661|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858662|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858663|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129910152|NCT01803555|467633823|FG000|Overall Study|Protocol Violation|3|||
129858664|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858665|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858666|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858667|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
129858668|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
129910153|NCT01803555|467633824|FG001|Overall Study|Protocol Violation|5|||
129910154|NCT01803555|467633823|FG000|Overall Study|Lost to Follow-up|0|||
129910155|NCT01803555|467633824|FG001|Overall Study|Lost to Follow-up|2|||
129910156|NCT01803555|467633823|FG000|Overall Study|Other than specified|3|||
129910157|NCT01803555|467633824|FG001|Overall Study|Other than specified|5|||
129910158|NCT01551355|467633825|FG000|Overall Study|Lost to Follow-up|51|||
129910159|NCT01551355|467633826|FG001|Overall Study|Lost to Follow-up|49|||
129910160|NCT01551355|467633827|FG002|Overall Study|Lost to Follow-up|34|||
129910161|NCT01551355|467633828|FG003|Overall Study|Lost to Follow-up|24|||
129910162|NCT01551355|467633829|FG004|Overall Study|Lost to Follow-up|9|||
129910163|NCT01551355|467633830|FG005|Overall Study|Lost to Follow-up|6|||
129910164|NCT01925339|467633831|FG000|Overall Study|Adverse Event|2|||
129910165|NCT01925339|467633832|FG001|Overall Study|Adverse Event|0|||
129910166|NCT01538719|467633833|FG000|Overall Study|Lost to Follow-up|2|||
129910167|NCT01538719|467633834|FG001|Overall Study|Lost to Follow-up|0|||
129910168|NCT03664960|467633835|FG000|Overall Study|Adverse Event|0|||
129910169|NCT03664960|467633836|FG001|Overall Study|Adverse Event|3|||
129910170|NCT03664960|467633835|FG000|Overall Study|Lost to Follow-up|3|||
129910171|NCT03664960|467633836|FG001|Overall Study|Lost to Follow-up|2|||
129910172|NCT03664960|467633835|FG000|Overall Study|Physician Decision|1|||
129910173|NCT03664960|467633836|FG001|Overall Study|Physician Decision|0|||
129910174|NCT03664960|467633835|FG000|Overall Study|Withdrawal by Subject|3|||
129910175|NCT03664960|467633836|FG001|Overall Study|Withdrawal by Subject|14|||
129910176|NCT03664960|467633835|FG000|Overall Study|Sponsor Decision|1|||
129910177|NCT03664960|467633836|FG001|Overall Study|Sponsor Decision|1|||
129910178|NCT03664960|467633835|FG000|Overall Study|Other|1|||
129910179|NCT03664960|467633836|FG001|Overall Study|Other|2|||
129910180|NCT00774852|467633838|FG000|Overall Study|Adverse Event|9|||
129910181|NCT00774852|467633839|FG001|Overall Study|Adverse Event|6|||
129910182|NCT00774852|467633838|FG000|Overall Study|Death|2|||
129910183|NCT00774852|467633839|FG001|Overall Study|Death|1|||
129910184|NCT00774852|467633838|FG000|Overall Study|Lack of Efficacy|3|||
129910185|NCT00774852|467633839|FG001|Overall Study|Lack of Efficacy|7|||
129910186|NCT00774852|467633838|FG000|Overall Study|Lost to Follow-up|9|||
129910187|NCT00774852|467633839|FG001|Overall Study|Lost to Follow-up|5|||
129910188|NCT00774852|467633838|FG000|Overall Study|Physician Decision|2|||
129910189|NCT00774852|467633839|FG001|Overall Study|Physician Decision|6|||
129910190|NCT00774852|467633838|FG000|Overall Study|Pregnancy|1|||
129910191|NCT00774852|467633839|FG001|Overall Study|Pregnancy|2|||
129910192|NCT00774852|467633838|FG000|Overall Study|Withdrawal by Subject|2|||
129910193|NCT00774852|467633839|FG001|Overall Study|Withdrawal by Subject|2|||
129910194|NCT00774852|467633838|FG000|Overall Study|Non-responder|15|||
129910195|NCT00774852|467633839|FG001|Overall Study|Non-responder|11|||
129910196|NCT00774852|467633838|FG000|Overall Study|Subject non-compliance|0|||
129910197|NCT00774852|467633839|FG001|Overall Study|Subject non-compliance|1|||
129910198|NCT00774852|467633838|FG000|Overall Study|Protocol Violation|1|||
129858669|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
129858670|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858671|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858672|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858673|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858674|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858675|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858676|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858677|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858678|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858679|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858680|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858681|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129910199|NCT00774852|467633839|FG001|Overall Study|Protocol Violation|0|||
129910200|NCT00774852|467633838|FG000|Overall Study|Subject received prohibited medication|1|||
129910201|NCT00774852|467633839|FG001|Overall Study|Subject received prohibited medication|0|||
129910202|NCT03997916|467633840|FG000|Overall Study|Protocol Violation|35|||
129910203|NCT01780298|467635246|FG000|Overall Study|Physician Decision|1|||
129910204|NCT01780298|467635247|FG001|Overall Study|Physician Decision|5|||
129910205|NCT01780298|467635248|FG002|Overall Study|Physician Decision|1|||
129910206|NCT01780298|467635249|FG003|Overall Study|Physician Decision|1|||
129910207|NCT01780298|467635246|FG000|Overall Study|Subject not matched|1|||
129910208|NCT01780298|467635247|FG001|Overall Study|Subject not matched|0|||
129910209|NCT01780298|467635248|FG002|Overall Study|Subject not matched|1|||
129910210|NCT01780298|467635249|FG003|Overall Study|Subject not matched|0|||
129910211|NCT01780298|467635246|FG000|Overall Study|Adverse Event|0|||
129910212|NCT01780298|467635247|FG001|Overall Study|Adverse Event|0|||
129910213|NCT01780298|467635248|FG002|Overall Study|Adverse Event|2|||
129858682|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
129858683|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
129910214|NCT01780298|467635249|FG003|Overall Study|Adverse Event|0|||
129910215|NCT04907474|467635250|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
129979687|NCT03752970|467889437|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
129858684|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858685|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858686|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858687|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858688|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858689|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858690|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858691|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858692|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858693|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858694|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858695|NCT02349295|467441403|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
129858696|NCT02349295|467441404|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
129858697|NCT02349295|467441405|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
129858698|NCT02349295|467441406|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
129858699|NCT02349295|467441407|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
129858700|NCT02349295|467441408|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
129858701|NCT02349295|467441409|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
129858702|NCT02349295|467441410|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
129858703|NCT02349295|467441411|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
129858704|NCT02349295|467441412|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
129858705|NCT02349295|467441413|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
129858706|NCT02349295|467441414|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
129858707|NCT02349295|467441415|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
129858708|NCT02349295|467441416|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
129858709|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858710|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858711|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858712|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858713|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858714|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858715|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858716|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
129858717|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
129858718|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
129858719|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
129858720|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858721|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858722|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858723|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858724|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858725|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858726|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858727|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858728|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858729|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858730|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
129858731|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
129858732|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
129858733|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
129858734|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858735|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858736|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858737|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858738|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858739|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858740|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858741|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858742|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858743|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858744|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
129858745|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858746|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
129858747|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858748|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858749|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129910216|NCT04907474|467635251|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
129858750|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858751|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
129858752|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
129858753|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
129858754|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
129858755|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
129858756|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
129858757|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
129858758|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
129858759|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
129858760|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
129858761|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
129858762|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
129858763|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
129858764|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
129858765|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858766|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858767|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858768|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858769|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858770|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858771|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858772|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
129858773|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
129858774|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
129858775|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
129858776|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858777|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858778|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858779|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858780|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858781|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858782|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858783|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858784|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858785|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858786|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
129858787|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
129910217|NCT03873779|467635252|FG000|Overall Study|Withdrawal by Subject|1|||
129910218|NCT02581215|467635253|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
129910219|NCT02581215|467635254|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
129910220|NCT02581215|467635253|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129910221|NCT02581215|467635254|FG001|Overall Study|Eligibility Criteria Not Met|1|||
129910222|NCT04279574|467635257|FG000|Overall Study|Death|1|||
129910223|NCT04279574|467635258|FG001|Overall Study|Death|0|||
129910224|NCT04279574|467635257|FG000|Overall Study|lost restoration, tooth fracture|1|||
129910225|NCT04279574|467635258|FG001|Overall Study|lost restoration, tooth fracture|0|||
129910226|NCT04279574|467635257|FG000|Overall Study|Lost to Follow-up|0|||
129910227|NCT04279574|467635258|FG001|Overall Study|Lost to Follow-up|1|||
129910228|NCT04188379|467635259|FG000|Overall Study|Withdrawal by Subject|10|||
129910229|NCT04188379|467635260|FG001|Overall Study|Withdrawal by Subject|3|||
129910230|NCT04188379|467635259|FG000|Overall Study|Physician Decision|0|||
129910231|NCT04188379|467635260|FG001|Overall Study|Physician Decision|1|||
129910232|NCT04188379|467635259|FG000|Overall Study|Adverse Event|3|||
129910233|NCT04188379|467635260|FG001|Overall Study|Adverse Event|1|||
129910234|NCT04188379|467635259|FG000|Overall Study|Pregnancy|1|||
129910235|NCT04188379|467635260|FG001|Overall Study|Pregnancy|0|||
129910236|NCT04188379|467635259|FG000|Overall Study|Lack of Efficacy|8|||
129910237|NCT04188379|467635260|FG001|Overall Study|Lack of Efficacy|5|||
129910238|NCT04188379|467635259|FG000|Overall Study|Other|0|||
129910239|NCT04188379|467635260|FG001|Overall Study|Other|3|||
129910240|NCT02566902|467635266|FG000|Overall Study|Protocol Violation|2|||
129858788|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858789|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858790|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858791|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129910241|NCT02566902|467635267|FG001|Overall Study|Protocol Violation|1|||
129910242|NCT02411084|467635268|FG000|Overall Study|Lack of Efficacy|6|||
129910243|NCT02411084|467635269|FG001|Overall Study|Lack of Efficacy|3|||
129910244|NCT02411084|467635268|FG000|Overall Study|Death|5|||
129910245|NCT02411084|467635269|FG001|Overall Study|Death|4|||
129910246|NCT02411084|467635268|FG000|Overall Study|Adverse Event|2|||
129910247|NCT02411084|467635269|FG001|Overall Study|Adverse Event|1|||
129910248|NCT02411084|467635268|FG000|Overall Study|Other reasons|0|||
129910249|NCT02411084|467635269|FG001|Overall Study|Other reasons|5|||
129910250|NCT05773313|467635274|FG000|Overall Study|Lost to Follow-up|3|||
129910251|NCT02748317|467635275|FG000|Overall Study|Withdrawal by Subject|14|||
129910252|NCT02748317|467635275|FG000|Overall Study|Lost to Follow-up|8|||
129910253|NCT02748317|467635275|FG000|Overall Study|Death|1|||
129910254|NCT00332241|467635277|FG000|Overall Study|Lack of Efficacy|6|||
129910255|NCT00332241|467635278|FG001|Overall Study|Lack of Efficacy|1|||
129910256|NCT00332241|467635277|FG000|Overall Study|Adverse Event|3|||
129910257|NCT00332241|467635278|FG001|Overall Study|Adverse Event|5|||
129910258|NCT00332241|467635277|FG000|Overall Study|Withdrawal by Subject|2|||
129910259|NCT00332241|467635278|FG001|Overall Study|Withdrawal by Subject|1|||
129910260|NCT00332241|467635277|FG000|Overall Study|Lost to Follow-up|4|||
129910261|NCT00332241|467635278|FG001|Overall Study|Lost to Follow-up|1|||
129910262|NCT00802464|467635280|FG000|Month 0 - Month 8|Adverse Event|0|||
129910263|NCT00802464|467635281|FG001|Month 0 - Month 8|Adverse Event|1|||
129910264|NCT00802464|467635282|FG002|Month 0 - Month 8|Adverse Event|1|||
129910265|NCT00802464|467635283|FG003|Month 0 - Month 8|Adverse Event|2|||
129910266|NCT00802464|467635280|FG000|Month 0 - Month 8|Protocol Violation|0|||
129910267|NCT00802464|467635281|FG001|Month 0 - Month 8|Protocol Violation|0|||
129910268|NCT00802464|467635282|FG002|Month 0 - Month 8|Protocol Violation|1|||
129910269|NCT00802464|467635283|FG003|Month 0 - Month 8|Protocol Violation|0|||
129910270|NCT00802464|467635280|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
129910271|NCT00802464|467635281|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
129910272|NCT00802464|467635282|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
129910273|NCT00802464|467635283|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
129910274|NCT00802464|467635280|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
129910275|NCT00802464|467635281|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
129910276|NCT00802464|467635282|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
129910277|NCT00802464|467635283|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
129910278|NCT00802464|467635280|FG000|Month 0 - Month 8|Other|0|||
129910279|NCT00802464|467635281|FG001|Month 0 - Month 8|Other|0|||
129910280|NCT00802464|467635282|FG002|Month 0 - Month 8|Other|1|||
129910281|NCT00802464|467635283|FG003|Month 0 - Month 8|Other|0|||
129910282|NCT00802464|467635280|FG000|Month 8 - Month 14|Adverse Event|0|||
129910283|NCT00802464|467635281|FG001|Month 8 - Month 14|Adverse Event|1|||
129910284|NCT00802464|467635282|FG002|Month 8 - Month 14|Adverse Event|0|||
129910285|NCT00802464|467635283|FG003|Month 8 - Month 14|Adverse Event|0|||
129910286|NCT00802464|467635280|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
129910287|NCT00802464|467635281|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
129910288|NCT00802464|467635282|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
129910289|NCT00802464|467635283|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
129910290|NCT00802464|467635280|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
129910291|NCT00802464|467635281|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
129910292|NCT00802464|467635282|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
129910293|NCT00802464|467635283|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
129910294|NCT01471691|467635286|FG000|Overall Study|Lack of Efficacy|0|||
129910295|NCT01471691|467635287|FG001|Overall Study|Lack of Efficacy|1|||
129910296|NCT01808339|467635288|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910297|NCT01808339|467635289|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910298|NCT01808339|467635290|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910299|NCT01808339|467635291|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
129910300|NCT01808339|467635292|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
129910301|NCT01808339|467635293|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
129910302|NCT01808339|467635288|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910303|NCT01808339|467635289|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129910304|NCT01808339|467635290|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910305|NCT01808339|467635291|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129910306|NCT01808339|467635292|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910307|NCT01808339|467635293|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910308|NCT01808339|467635288|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910309|NCT01808339|467635289|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910310|NCT01808339|467635290|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
129910311|NCT01808339|467635291|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910312|NCT01808339|467635292|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910313|NCT01808339|467635293|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910314|NCT02622568|467635294|FG000|Overall Study|Lost to Follow-up|5|||
129910315|NCT02622568|467635295|FG001|Overall Study|Lost to Follow-up|5|||
129910316|NCT00371787|467635296|FG000|Overall Study|Withdrawal by Subject|3|||
129910317|NCT00371787|467635297|FG001|Overall Study|Withdrawal by Subject|1|||
129910318|NCT01854385|467635298|FG000|Pre-Treatment|Withdrawal by Subject|4|||
129910319|NCT01854385|467635298|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
129910320|NCT01854385|467635298|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
129910321|NCT01854385|467635298|FG000|Pre-Treatment|Unable to come for study visits|1|||
129910322|NCT01854385|467635298|FG000|Treatment|Lost to Follow-up|1|||
129910323|NCT02597920|467635303|FG000|Overall Study|Worsening of other pre-existing disease|0|||
129910324|NCT02597920|467635304|FG001|Overall Study|Worsening of other pre-existing disease|1|||
129910325|NCT02597920|467635305|FG002|Overall Study|Worsening of other pre-existing disease|0|||
129910326|NCT02597920|467635303|FG000|Overall Study|Other adverse event|20|||
129910327|NCT02597920|467635304|FG001|Overall Study|Other adverse event|30|||
129910328|NCT02597920|467635305|FG002|Overall Study|Other adverse event|0|||
129910329|NCT02597920|467635303|FG000|Overall Study|Lost to Follow-up|7|||
129910330|NCT02597920|467635304|FG001|Overall Study|Lost to Follow-up|9|||
129910331|NCT02597920|467635305|FG002|Overall Study|Lost to Follow-up|0|||
129910332|NCT02597920|467635303|FG000|Overall Study|Refuse to continue in the study|3|||
129910333|NCT02597920|467635304|FG001|Overall Study|Refuse to continue in the study|13|||
129910334|NCT02597920|467635305|FG002|Overall Study|Refuse to continue in the study|1|||
129910335|NCT02597920|467635303|FG000|Overall Study|Other than specified|10|||
129910336|NCT02597920|467635304|FG001|Overall Study|Other than specified|31|||
129910337|NCT02597920|467635305|FG002|Overall Study|Other than specified|5|||
129910338|NCT02597920|467635303|FG000|Overall Study|Other|1|||
129910339|NCT02597920|467635304|FG001|Overall Study|Other|0|||
129910340|NCT02597920|467635305|FG002|Overall Study|Other|0|||
129910341|NCT00642850|467635306|FG000|Overall Study|Death|7|||
129910342|NCT00642850|467635306|FG000|Overall Study|Adverse Event|2|||
129910343|NCT00642850|467635306|FG000|Overall Study|Lack of Efficacy|1|||
129910344|NCT00642850|467635306|FG000|Overall Study|Protocol Violation|2|||
129910345|NCT00642850|467635306|FG000|Overall Study|Kidney transplantation|8|||
129910346|NCT00642850|467635306|FG000|Overall Study|Blood transfusion|6|||
129858792|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858793|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858794|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858795|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858796|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858797|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858798|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858799|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858800|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
129858801|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
129858802|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129910347|NCT00642850|467635306|FG000|Overall Study|Other reasons|7|||
129910348|NCT02379819|467635307|FG000|Overall Study|Withdrawal by Subject|10|||
129910349|NCT02379819|467635307|FG000|Overall Study|Death|2|||
129910350|NCT02379819|467635307|FG000|Overall Study|Lack of Efficacy|1|||
129910351|NCT02379819|467635307|FG000|Overall Study|Lost to Follow-up|1|||
129910352|NCT00350792|467635308|FG000|Overall Study|Adverse Event|11|||
129910353|NCT00350792|467635308|FG000|Overall Study|Death from Study Disease|1|||
129910354|NCT00350792|467635308|FG000|Overall Study|Death from Study Drug Toxicity|1|||
129910355|NCT00350792|467635308|FG000|Overall Study|Death Not Study Drug Related|2|||
129910356|NCT00350792|467635308|FG000|Overall Study|Protocol Violation|1|||
129910357|NCT00350792|467635308|FG000|Overall Study|Withdrawal by Subject|4|||
129910358|NCT00350792|467635308|FG000|Overall Study|Physician Decision|2|||
129910359|NCT00350792|467635308|FG000|Overall Study|Lack of Efficacy|11|||
129910360|NCT03988023|467635309|FG000|Overall Study|Non-compliance|3|||
129910361|NCT03988023|467635310|FG001|Overall Study|Non-compliance|0|||
129910362|NCT03988023|467635309|FG000|Overall Study|Withdrawal by Subject|39|||
129910363|NCT03988023|467635310|FG001|Overall Study|Withdrawal by Subject|37|||
129910364|NCT03988023|467635309|FG000|Overall Study|Adverse Event|0|||
129910365|NCT03988023|467635310|FG001|Overall Study|Adverse Event|2|||
129858803|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858804|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858805|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858806|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129910366|NCT03988023|467635309|FG000|Overall Study|Physician Decision|0|||
129910367|NCT03988023|467635310|FG001|Overall Study|Physician Decision|1|||
129910368|NCT03988023|467635309|FG000|Overall Study|Lost to Follow-up|5|||
129910369|NCT03988023|467635310|FG001|Overall Study|Lost to Follow-up|8|||
129910370|NCT03988023|467635309|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
129910371|NCT03988023|467635310|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
129910372|NCT03988023|467635309|FG000|Overall Study|Lack of Efficacy|3|||
129910373|NCT03988023|467635310|FG001|Overall Study|Lack of Efficacy|1|||
129910374|NCT03988023|467635309|FG000|Overall Study|COVID-19 pandemic|225|||
129910375|NCT03988023|467635310|FG001|Overall Study|COVID-19 pandemic|227|||
129910376|NCT00785512|467635311|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
129910377|NCT00785512|467635312|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
129910378|NCT00785512|467635311|FG000|Overall Study|Adverse Event|0|||
129910379|NCT00785512|467635312|FG001|Overall Study|Adverse Event|0|||
129910380|NCT00785512|467635311|FG000|Overall Study|Lack of Efficacy|0|||
129910381|NCT00785512|467635312|FG001|Overall Study|Lack of Efficacy|2|||
129910382|NCT00785512|467635311|FG000|Overall Study|Withdrawal by Subject|0|||
129910383|NCT00785512|467635312|FG001|Overall Study|Withdrawal by Subject|1|||
129910384|NCT00785512|467635311|FG000|Overall Study|Lost to Follow-up|3|||
129910385|NCT00785512|467635312|FG001|Overall Study|Lost to Follow-up|0|||
129910386|NCT00785512|467635311|FG000|Overall Study|Precedure Refused|0|||
129910387|NCT00785512|467635312|FG001|Overall Study|Precedure Refused|0|||
129910388|NCT00785512|467635311|FG000|Overall Study|IVRS Programing Error|0|||
129858807|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858808|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858809|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858810|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858811|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858812|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858813|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858814|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858815|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858816|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858817|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858818|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
129858819|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
129858820|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
129858821|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858822|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858823|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858824|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858825|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858826|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858827|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858828|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858829|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858830|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858831|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858832|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
129858833|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
129858834|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858835|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858836|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858837|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858838|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858839|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858840|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858841|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858842|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858843|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858844|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858845|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858846|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
129858847|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
129858848|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858849|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858850|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858851|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858852|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858853|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858854|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858855|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858856|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129910389|NCT00785512|467635312|FG001|Overall Study|IVRS Programing Error|0|||
129910390|NCT00785512|467635311|FG000|Overall Study|Physician Decision|0|||
129910391|NCT00785512|467635312|FG001|Overall Study|Physician Decision|0|||
129910392|NCT00785512|467635311|FG000|Overall Study|Lack of compliance|0|||
129910393|NCT00785512|467635312|FG001|Overall Study|Lack of compliance|1|||
129910394|NCT04452318|467635316|FG000|Overall Study|Physician Decision|1|||
129910395|NCT04452318|467635317|FG001|Overall Study|Physician Decision|2|||
129910396|NCT04452318|467635318|FG002|Overall Study|Physician Decision|0|||
129910397|NCT04452318|467635319|FG003|Overall Study|Physician Decision|2|||
129910398|NCT04452318|467635320|FG004|Overall Study|Physician Decision|0|||
129910399|NCT04452318|467635321|FG005|Overall Study|Physician Decision|2|||
129910400|NCT04452318|467635322|FG006|Overall Study|Physician Decision|5|||
129910401|NCT04452318|467635316|FG000|Overall Study|Death|2|||
129910402|NCT04452318|467635317|FG001|Overall Study|Death|3|||
129910403|NCT04452318|467635318|FG002|Overall Study|Death|0|||
129910404|NCT04452318|467635319|FG003|Overall Study|Death|0|||
129910405|NCT04452318|467635320|FG004|Overall Study|Death|0|||
129910406|NCT04452318|467635321|FG005|Overall Study|Death|0|||
129910407|NCT04452318|467635322|FG006|Overall Study|Death|0|||
129910408|NCT04452318|467635316|FG000|Overall Study|Lost to Follow-up|38|||
129910409|NCT04452318|467635317|FG001|Overall Study|Lost to Follow-up|28|||
129910410|NCT04452318|467635318|FG002|Overall Study|Lost to Follow-up|0|||
129910411|NCT04452318|467635319|FG003|Overall Study|Lost to Follow-up|3|||
129910412|NCT04452318|467635320|FG004|Overall Study|Lost to Follow-up|3|||
129910413|NCT04452318|467635321|FG005|Overall Study|Lost to Follow-up|2|||
129910414|NCT04452318|467635322|FG006|Overall Study|Lost to Follow-up|1|||
129910415|NCT04452318|467635316|FG000|Overall Study|Withdrawal by Subject|46|||
129910416|NCT04452318|467635317|FG001|Overall Study|Withdrawal by Subject|40|||
129910417|NCT04452318|467635318|FG002|Overall Study|Withdrawal by Subject|0|||
129910418|NCT04452318|467635319|FG003|Overall Study|Withdrawal by Subject|18|||
129910419|NCT04452318|467635320|FG004|Overall Study|Withdrawal by Subject|6|||
129910420|NCT04452318|467635321|FG005|Overall Study|Withdrawal by Subject|8|||
129910421|NCT04452318|467635322|FG006|Overall Study|Withdrawal by Subject|6|||
129910422|NCT00595413|467635323|FG000|Overall Study|Adverse Event|0|||
129910423|NCT00595413|467635324|FG001|Overall Study|Adverse Event|2|||
129910424|NCT00595413|467635325|FG002|Overall Study|Adverse Event|1|||
129910425|NCT00595413|467635326|FG003|Overall Study|Adverse Event|1|||
129910426|NCT00595413|467635323|FG000|Overall Study|Lost to Follow-up|2|||
129910427|NCT00595413|467635324|FG001|Overall Study|Lost to Follow-up|2|||
129910428|NCT00595413|467635325|FG002|Overall Study|Lost to Follow-up|1|||
129910429|NCT00595413|467635326|FG003|Overall Study|Lost to Follow-up|3|||
129910430|NCT00595413|467635323|FG000|Overall Study|Death|0|||
129910431|NCT00595413|467635324|FG001|Overall Study|Death|0|||
129910432|NCT00595413|467635325|FG002|Overall Study|Death|1|||
129910433|NCT00595413|467635326|FG003|Overall Study|Death|0|||
129910434|NCT00595413|467635323|FG000|Overall Study|Other|5|||
129910435|NCT00595413|467635324|FG001|Overall Study|Other|1|||
129910436|NCT00595413|467635325|FG002|Overall Study|Other|5|||
129910437|NCT00595413|467635326|FG003|Overall Study|Other|0|||
129910438|NCT04149002|467635327|FG000|Overall Study|Lost to Follow-up|1|||
129910439|NCT04149002|467635328|FG001|Overall Study|Lost to Follow-up|0|||
129910440|NCT04149002|467635327|FG000|Overall Study|Withdrawal by Subject|1|||
129910441|NCT04149002|467635328|FG001|Overall Study|Withdrawal by Subject|0|||
129910442|NCT03233633|467635329|FG000|Overall Study|Adverse Event|2|||
129910443|NCT03233633|467635329|FG000|Overall Study|Less Than 3 Days of Data|6|||
129910444|NCT04583423|467635331|FG000|Overall Study|Lost to Follow-up|0|||
129910445|NCT04583423|467635332|FG001|Overall Study|Lost to Follow-up|1|||
129910446|NCT04583423|467635333|FG002|Overall Study|Lost to Follow-up|0|||
129910447|NCT04583423|467635334|FG003|Overall Study|Lost to Follow-up|2|||
129910448|NCT04583423|467635331|FG000|Overall Study|Study Terminated by Sponsor|32|||
129910449|NCT04583423|467635332|FG001|Overall Study|Study Terminated by Sponsor|35|||
129910450|NCT04583423|467635333|FG002|Overall Study|Study Terminated by Sponsor|36|||
129910451|NCT04583423|467635334|FG003|Overall Study|Study Terminated by Sponsor|33|||
129910452|NCT04583423|467635331|FG000|Overall Study|Withdrawal by Subject|3|||
129910453|NCT04583423|467635332|FG001|Overall Study|Withdrawal by Subject|1|||
129910454|NCT04583423|467635333|FG002|Overall Study|Withdrawal by Subject|2|||
129910455|NCT04583423|467635334|FG003|Overall Study|Withdrawal by Subject|1|||
129910456|NCT01198145|467635335|FG000|Overall Study|Withdrawal by Subject|1|||
129910457|NCT01198145|467635336|FG001|Overall Study|Withdrawal by Subject|1|||
129910458|NCT00603954|467635339|FG000|Overall Study|Protocol Violation|1|||
129910459|NCT00603954|467635340|FG001|Overall Study|Protocol Violation|2|||
129910460|NCT01736215|467635341|FG000|Overall Study|Early termination of erythropoietin use|1|||
129910461|NCT01736215|467635341|FG000|Overall Study|Adverse Event|4|||
129910462|NCT01736215|467635341|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
129910463|NCT01736215|467635341|FG000|Overall Study|Insufficient data to perform analysis|8|||
129910464|NCT03447249|467635345|FG000|Overall Study|Adverse Event|1|||
129910465|NCT03447249|467635346|FG001|Overall Study|Adverse Event|0|||
129910466|NCT03447249|467635345|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129910467|NCT03447249|467635346|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129910468|NCT03447249|467635345|FG000|Overall Study|Other|3|||
129910469|NCT03447249|467635346|FG001|Overall Study|Other|0|||
129910470|NCT01248936|467635347|FG000|Overall Study|Sponsor Decision|259|||
129910471|NCT01248936|467635347|FG000|Overall Study|Progression of Disease|50|||
129910472|NCT01248936|467635347|FG000|Overall Study|Death|26|||
129858857|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858858|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858859|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858860|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
129858861|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858862|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858863|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858864|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858865|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858866|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858867|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858868|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858869|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858870|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858871|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858872|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858873|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858874|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
129858875|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858876|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858877|NCT02863926|467441417|FG000|Overall Study|Physician Decision|1|||
129858878|NCT02863926|467441418|FG001|Overall Study|Physician Decision|0|||
129858879|NCT02863926|467441417|FG000|Overall Study|Lost to Follow-up|1|||
129858880|NCT02863926|467441418|FG001|Overall Study|Lost to Follow-up|1|||
129858881|NCT01914926|467441434|FG000|Overall Study|Adverse Event|1|||
129858882|NCT01914926|467441435|FG001|Overall Study|Adverse Event|0|||
129858883|NCT01914926|467441434|FG000|Overall Study|uncooperative, agitated and removed|0|||
129858884|NCT01914926|467441435|FG001|Overall Study|uncooperative, agitated and removed|1|||
129858885|NCT01917526|467441436|FG000|Overall Study|Protocol Violation|1|||
129858886|NCT01917526|467441437|FG001|Overall Study|Protocol Violation|1|||
129858887|NCT00434057|467441438|FG000|Overall Study|Withdrawal by Subject|1|||
129858888|NCT02117570|467441439|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
129858889|NCT02117570|467441440|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
129858890|NCT02117570|467441441|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
129858891|NCT02117570|467441439|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
129858892|NCT02117570|467441440|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
129858893|NCT02117570|467441441|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
129858894|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
129858895|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
129858896|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
129858897|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
129858898|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
129858899|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
129858900|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
129858901|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
129858902|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
129858903|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
129858904|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
129858905|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
129858906|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
129858907|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
129858908|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
129858909|NCT03701555|467441442|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
129858910|NCT03701555|467441443|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
129858911|NCT03701555|467441444|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
129858912|NCT03701555|467441445|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
129858913|NCT03701555|467441446|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
129858914|NCT03701555|467441447|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
129858915|NCT03701555|467441448|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
129858916|NCT03701555|467441449|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
129858917|NCT03701555|467441450|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
129858918|NCT03701555|467441451|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
129858919|NCT03701555|467441452|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
129858920|NCT03701555|467441453|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
129858921|NCT03701555|467441454|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
129858922|NCT03701555|467441455|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
129858923|NCT03701555|467441456|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
129858924|NCT03701555|467441457|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
129858925|NCT03701555|467441458|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
129858926|NCT03701555|467441459|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
129858927|NCT03701555|467441460|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
129858928|NCT03701555|467441461|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
129858929|NCT03701555|467441462|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
129858930|NCT03701555|467441463|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
129858931|NCT03701555|467441464|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
129858932|NCT03701555|467441465|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
129858933|NCT03701555|467441466|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
129858934|NCT03701555|467441467|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
129858935|NCT03701555|467441468|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
129858936|NCT03701555|467441469|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
129858937|NCT03701555|467441470|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
129858938|NCT03701555|467441471|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
129858939|NCT03701555|467441472|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
129858940|NCT03701555|467441473|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
129858941|NCT03701555|467441474|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
129858942|NCT03701555|467441475|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
129858943|NCT03701555|467441476|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
129858944|NCT03701555|467441477|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
129858945|NCT03701555|467441442|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
129858946|NCT03701555|467441443|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
129858947|NCT03701555|467441444|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
129858948|NCT03701555|467441445|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
129858949|NCT03701555|467441446|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
129858950|NCT03701555|467441447|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
129858951|NCT03701555|467441448|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
129858952|NCT03701555|467441449|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
129858953|NCT03701555|467441450|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
129858954|NCT03701555|467441451|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
129858955|NCT03701555|467441452|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
129858956|NCT03701555|467441453|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
129858957|NCT03701555|467441454|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
129858958|NCT03701555|467441455|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
129858959|NCT03701555|467441456|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
129858960|NCT03701555|467441457|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
129858961|NCT03701555|467441458|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
129858962|NCT03701555|467441459|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
129858963|NCT03701555|467441460|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
129858964|NCT03701555|467441461|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
129858965|NCT03701555|467441462|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
129858966|NCT03701555|467441463|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
129858967|NCT03701555|467441464|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
129858968|NCT03701555|467441465|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
129858969|NCT03701555|467441466|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
129858970|NCT03701555|467441467|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
129858971|NCT03701555|467441468|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
129858972|NCT03701555|467441469|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
129858973|NCT03701555|467441470|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
129858974|NCT03701555|467441471|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
129858975|NCT03701555|467441472|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
129858976|NCT03701555|467441473|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
129858977|NCT03701555|467441474|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
129858978|NCT03701555|467441475|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
129858979|NCT03701555|467441476|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
129858980|NCT03701555|467441477|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
129858981|NCT03701555|467441442|FG000|Part 2 (Day 1)|Other|0|||
129858982|NCT03701555|467441443|FG001|Part 2 (Day 1)|Other|0|||
129858983|NCT03701555|467441444|FG002|Part 2 (Day 1)|Other|0|||
129858984|NCT03701555|467441445|FG003|Part 2 (Day 1)|Other|0|||
129858985|NCT03701555|467441446|FG004|Part 2 (Day 1)|Other|0|||
129858986|NCT03701555|467441447|FG005|Part 2 (Day 1)|Other|0|||
129858987|NCT03701555|467441448|FG006|Part 2 (Day 1)|Other|0|||
129858988|NCT03701555|467441449|FG007|Part 2 (Day 1)|Other|0|||
129858989|NCT03701555|467441450|FG008|Part 2 (Day 1)|Other|0|||
129858990|NCT03701555|467441451|FG009|Part 2 (Day 1)|Other|0|||
129858991|NCT03701555|467441452|FG010|Part 2 (Day 1)|Other|3|||
129858992|NCT03701555|467441453|FG011|Part 2 (Day 1)|Other|1|||
129858993|NCT03701555|467441454|FG012|Part 2 (Day 1)|Other|0|||
129858994|NCT03701555|467441455|FG013|Part 2 (Day 1)|Other|1|||
129858995|NCT03701555|467441456|FG014|Part 2 (Day 1)|Other|0|||
129858996|NCT03701555|467441457|FG015|Part 2 (Day 1)|Other|2|||
129858997|NCT03701555|467441458|FG016|Part 2 (Day 1)|Other|2|||
129858998|NCT03701555|467441459|FG017|Part 2 (Day 1)|Other|0|||
129858999|NCT03701555|467441460|FG018|Part 2 (Day 1)|Other|0|||
129859000|NCT03701555|467441461|FG019|Part 2 (Day 1)|Other|0|||
129859001|NCT03701555|467441462|FG020|Part 2 (Day 1)|Other|0|||
129859002|NCT03701555|467441463|FG021|Part 2 (Day 1)|Other|0|||
129859003|NCT03701555|467441464|FG022|Part 2 (Day 1)|Other|0|||
129859004|NCT03701555|467441465|FG023|Part 2 (Day 1)|Other|0|||
129859005|NCT03701555|467441466|FG024|Part 2 (Day 1)|Other|0|||
129859006|NCT03701555|467441467|FG025|Part 2 (Day 1)|Other|0|||
129859007|NCT03701555|467441468|FG026|Part 2 (Day 1)|Other|0|||
129859008|NCT03701555|467441469|FG027|Part 2 (Day 1)|Other|0|||
129859009|NCT03701555|467441470|FG028|Part 2 (Day 1)|Other|0|||
129859010|NCT03701555|467441471|FG029|Part 2 (Day 1)|Other|0|||
129859011|NCT03701555|467441472|FG030|Part 2 (Day 1)|Other|0|||
129859012|NCT03701555|467441473|FG031|Part 2 (Day 1)|Other|0|||
129859013|NCT03701555|467441474|FG032|Part 2 (Day 1)|Other|0|||
129859014|NCT03701555|467441475|FG033|Part 2 (Day 1)|Other|0|||
129859015|NCT03701555|467441476|FG034|Part 2 (Day 1)|Other|0|||
129859016|NCT03701555|467441477|FG035|Part 2 (Day 1)|Other|0|||
129859017|NCT03701555|467441442|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
129859018|NCT03701555|467441443|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
129859019|NCT03701555|467441444|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
129859020|NCT03701555|467441445|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
129859021|NCT03701555|467441446|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
129859022|NCT03701555|467441447|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
129859023|NCT03701555|467441448|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
129859024|NCT03701555|467441449|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
129859025|NCT03701555|467441450|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
129859026|NCT03701555|467441451|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
129859027|NCT03701555|467441452|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
129859028|NCT03701555|467441453|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
129859029|NCT03701555|467441454|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
129859030|NCT03701555|467441455|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
129859031|NCT03701555|467441456|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
129859032|NCT03701555|467441457|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
129859033|NCT03701555|467441458|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
129859034|NCT03701555|467441459|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
129859035|NCT03701555|467441460|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
129859036|NCT03701555|467441461|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
129859037|NCT03701555|467441462|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
129859038|NCT03701555|467441463|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
129859039|NCT03701555|467441464|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
129859040|NCT03701555|467441465|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
129859041|NCT03701555|467441466|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
129859042|NCT03701555|467441467|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
129859043|NCT03701555|467441468|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
129859044|NCT03701555|467441469|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
129859045|NCT03701555|467441470|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
129859046|NCT03701555|467441471|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
129859047|NCT03701555|467441472|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
129859048|NCT03701555|467441473|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
129859049|NCT03701555|467441474|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
129859050|NCT03701555|467441475|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
129859051|NCT03701555|467441476|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
129859052|NCT03701555|467441477|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
129859053|NCT03701555|467441442|FG000|Part 3 (Day 1)|Subject Decision|0|||
129859054|NCT03701555|467441443|FG001|Part 3 (Day 1)|Subject Decision|0|||
129859055|NCT03701555|467441444|FG002|Part 3 (Day 1)|Subject Decision|0|||
129859056|NCT03701555|467441445|FG003|Part 3 (Day 1)|Subject Decision|0|||
129859057|NCT03701555|467441446|FG004|Part 3 (Day 1)|Subject Decision|0|||
129859058|NCT03701555|467441447|FG005|Part 3 (Day 1)|Subject Decision|0|||
129859059|NCT03701555|467441448|FG006|Part 3 (Day 1)|Subject Decision|0|||
129859060|NCT03701555|467441449|FG007|Part 3 (Day 1)|Subject Decision|0|||
129859061|NCT03701555|467441450|FG008|Part 3 (Day 1)|Subject Decision|0|||
129859062|NCT03701555|467441451|FG009|Part 3 (Day 1)|Subject Decision|0|||
129859063|NCT03701555|467441452|FG010|Part 3 (Day 1)|Subject Decision|0|||
129859064|NCT03701555|467441453|FG011|Part 3 (Day 1)|Subject Decision|0|||
129859065|NCT03701555|467441454|FG012|Part 3 (Day 1)|Subject Decision|0|||
129859066|NCT03701555|467441455|FG013|Part 3 (Day 1)|Subject Decision|0|||
129859067|NCT03701555|467441456|FG014|Part 3 (Day 1)|Subject Decision|0|||
129859068|NCT03701555|467441457|FG015|Part 3 (Day 1)|Subject Decision|0|||
129859069|NCT03701555|467441458|FG016|Part 3 (Day 1)|Subject Decision|0|||
129859070|NCT03701555|467441459|FG017|Part 3 (Day 1)|Subject Decision|0|||
129859071|NCT03701555|467441460|FG018|Part 3 (Day 1)|Subject Decision|0|||
129859072|NCT03701555|467441461|FG019|Part 3 (Day 1)|Subject Decision|0|||
129859073|NCT03701555|467441462|FG020|Part 3 (Day 1)|Subject Decision|0|||
129859074|NCT03701555|467441463|FG021|Part 3 (Day 1)|Subject Decision|0|||
129859075|NCT03701555|467441464|FG022|Part 3 (Day 1)|Subject Decision|0|||
129859076|NCT03701555|467441465|FG023|Part 3 (Day 1)|Subject Decision|0|||
129859077|NCT03701555|467441466|FG024|Part 3 (Day 1)|Subject Decision|0|||
129859078|NCT03701555|467441467|FG025|Part 3 (Day 1)|Subject Decision|0|||
129859079|NCT03701555|467441468|FG026|Part 3 (Day 1)|Subject Decision|1|||
129859080|NCT03701555|467441469|FG027|Part 3 (Day 1)|Subject Decision|0|||
129859081|NCT03701555|467441470|FG028|Part 3 (Day 1)|Subject Decision|0|||
129859082|NCT03701555|467441471|FG029|Part 3 (Day 1)|Subject Decision|0|||
129859083|NCT03701555|467441472|FG030|Part 3 (Day 1)|Subject Decision|0|||
129859084|NCT03701555|467441473|FG031|Part 3 (Day 1)|Subject Decision|2|||
130064732|NCT03245723|468190268|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
130064733|NCT03245723|468190267|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
130064734|NCT03245723|468190268|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
129859085|NCT03701555|467441474|FG032|Part 3 (Day 1)|Subject Decision|1|||
129859086|NCT03701555|467441475|FG033|Part 3 (Day 1)|Subject Decision|1|||
129859087|NCT03701555|467441476|FG034|Part 3 (Day 1)|Subject Decision|0|||
129859088|NCT03701555|467441477|FG035|Part 3 (Day 1)|Subject Decision|0|||
129859089|NCT03701555|467441442|FG000|Part 3 (Day 1)|Other|0|||
129859090|NCT03701555|467441443|FG001|Part 3 (Day 1)|Other|0|||
129859091|NCT03701555|467441444|FG002|Part 3 (Day 1)|Other|0|||
129859092|NCT03701555|467441445|FG003|Part 3 (Day 1)|Other|0|||
129859093|NCT03701555|467441446|FG004|Part 3 (Day 1)|Other|0|||
129859094|NCT03701555|467441447|FG005|Part 3 (Day 1)|Other|0|||
129859095|NCT03701555|467441448|FG006|Part 3 (Day 1)|Other|0|||
129859096|NCT03701555|467441449|FG007|Part 3 (Day 1)|Other|0|||
129859097|NCT03701555|467441450|FG008|Part 3 (Day 1)|Other|0|||
129859098|NCT03701555|467441451|FG009|Part 3 (Day 1)|Other|0|||
129859099|NCT03701555|467441452|FG010|Part 3 (Day 1)|Other|0|||
129859100|NCT03701555|467441453|FG011|Part 3 (Day 1)|Other|0|||
129859101|NCT03701555|467441454|FG012|Part 3 (Day 1)|Other|0|||
129859102|NCT03701555|467441455|FG013|Part 3 (Day 1)|Other|0|||
129859103|NCT03701555|467441456|FG014|Part 3 (Day 1)|Other|0|||
129859104|NCT03701555|467441457|FG015|Part 3 (Day 1)|Other|0|||
129859105|NCT03701555|467441458|FG016|Part 3 (Day 1)|Other|0|||
129859106|NCT03701555|467441459|FG017|Part 3 (Day 1)|Other|0|||
129859107|NCT03701555|467441460|FG018|Part 3 (Day 1)|Other|0|||
129859108|NCT03701555|467441461|FG019|Part 3 (Day 1)|Other|0|||
129859109|NCT03701555|467441462|FG020|Part 3 (Day 1)|Other|0|||
129859110|NCT03701555|467441463|FG021|Part 3 (Day 1)|Other|0|||
129859111|NCT03701555|467441464|FG022|Part 3 (Day 1)|Other|0|||
129859112|NCT03701555|467441465|FG023|Part 3 (Day 1)|Other|0|||
129859113|NCT03701555|467441466|FG024|Part 3 (Day 1)|Other|1|||
129859114|NCT03701555|467441467|FG025|Part 3 (Day 1)|Other|1|||
129859115|NCT03701555|467441468|FG026|Part 3 (Day 1)|Other|0|||
129859116|NCT03701555|467441469|FG027|Part 3 (Day 1)|Other|0|||
129859117|NCT03701555|467441470|FG028|Part 3 (Day 1)|Other|0|||
129859118|NCT03701555|467441471|FG029|Part 3 (Day 1)|Other|1|||
129859119|NCT03701555|467441472|FG030|Part 3 (Day 1)|Other|1|||
129859120|NCT03701555|467441473|FG031|Part 3 (Day 1)|Other|0|||
129859121|NCT03701555|467441474|FG032|Part 3 (Day 1)|Other|1|||
129859122|NCT03701555|467441475|FG033|Part 3 (Day 1)|Other|1|||
129859123|NCT03701555|467441476|FG034|Part 3 (Day 1)|Other|0|||
129859124|NCT03701555|467441477|FG035|Part 3 (Day 1)|Other|0|||
129859125|NCT03349710|467441478|FG000|Treatment Period|Death|0|||
129859126|NCT03349710|467441479|FG001|Treatment Period|Death|0|||
129859127|NCT03349710|467441480|FG002|Treatment Period|Death|1|||
129859128|NCT03349710|467441481|FG003|Treatment Period|Death|0|||
129859129|NCT03349710|467441478|FG000|Treatment Period|Disease Progression|0|||
129859130|NCT03349710|467441479|FG001|Treatment Period|Disease Progression|2|||
129859131|NCT03349710|467441480|FG002|Treatment Period|Disease Progression|0|||
129859132|NCT03349710|467441481|FG003|Treatment Period|Disease Progression|1|||
129859133|NCT03349710|467441478|FG000|Treatment Period|Study Drug Toxicity|1|||
129859134|NCT03349710|467441479|FG001|Treatment Period|Study Drug Toxicity|0|||
129859135|NCT03349710|467441480|FG002|Treatment Period|Study Drug Toxicity|1|||
129859136|NCT03349710|467441481|FG003|Treatment Period|Study Drug Toxicity|1|||
129859137|NCT03349710|467441478|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
129859138|NCT03349710|467441479|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
129859139|NCT03349710|467441480|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
129859140|NCT03349710|467441481|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
129859141|NCT03349710|467441478|FG000|Treatment Period|admin reason by sponsor|0|||
129859142|NCT03349710|467441479|FG001|Treatment Period|admin reason by sponsor|7|||
129859143|NCT03349710|467441480|FG002|Treatment Period|admin reason by sponsor|0|||
129859144|NCT03349710|467441481|FG003|Treatment Period|admin reason by sponsor|19|||
129859145|NCT03349710|467441478|FG000|Treatment Period|Other Reason|2|||
129859146|NCT03349710|467441479|FG001|Treatment Period|Other Reason|0|||
129859147|NCT03349710|467441480|FG002|Treatment Period|Other Reason|2|||
129859148|NCT03349710|467441481|FG003|Treatment Period|Other Reason|1|||
129859149|NCT03349710|467441478|FG000|Treatment Period|completed|6|||
129859150|NCT03349710|467441479|FG001|Treatment Period|completed|0|||
129859151|NCT03349710|467441480|FG002|Treatment Period|completed|18|||
129859152|NCT03349710|467441481|FG003|Treatment Period|completed|1|||
129859153|NCT03349710|467441478|FG000|Treatment Period|participant request to discontinue|0|||
129859154|NCT03349710|467441479|FG001|Treatment Period|participant request to discontinue|0|||
129859155|NCT03349710|467441480|FG002|Treatment Period|participant request to discontinue|4|||
129859156|NCT03349710|467441481|FG003|Treatment Period|participant request to discontinue|0|||
129859157|NCT03349710|467441478|FG000|Treatment Period|participant withdrew consent|1|||
129859158|NCT03349710|467441479|FG001|Treatment Period|participant withdrew consent|0|||
129859159|NCT03349710|467441480|FG002|Treatment Period|participant withdrew consent|0|||
129859160|NCT03349710|467441481|FG003|Treatment Period|participant withdrew consent|0|||
129859161|NCT01296568|467441482|FG000|Continued Access Phase|Lost to Follow-up|1|||
129859162|NCT01296568|467441482|FG000|Continued Access Phase|Withdrawal by Subject|1|||
129859163|NCT01296568|467441482|FG000|Continued Access Phase|Disease Progression|1|||
129859164|NCT04258020|467441483|FG000|Overall Study|Withdrawal by Subject|1|||
129859165|NCT04258020|467441484|FG001|Overall Study|Withdrawal by Subject|0|||
129859166|NCT03305016|467441485|FG000|Overall Study|Withdrawal by Subject|2|||
129859167|NCT01519206|467441486|FG000|Overall Study|Lost to Follow-up|3|||
129859168|NCT01519206|467441486|FG000|Overall Study|Missed Visit|2|||
129859169|NCT04139317|467441487|FG000|Overall Study|Adverse Event|10|||
129859170|NCT04139317|467441488|FG001|Overall Study|Adverse Event|2|||
129859171|NCT04139317|467441487|FG000|Overall Study|Death|6|||
129859172|NCT04139317|467441488|FG001|Overall Study|Death|4|||
129859173|NCT04139317|467441487|FG000|Overall Study|Lost to Follow-up|1|||
129859174|NCT04139317|467441488|FG001|Overall Study|Lost to Follow-up|0|||
129859175|NCT04139317|467441487|FG000|Overall Study|Physician Decision|3|||
129859176|NCT04139317|467441488|FG001|Overall Study|Physician Decision|1|||
129859177|NCT04139317|467441487|FG000|Overall Study|Progressive Disease|19|||
129859178|NCT04139317|467441488|FG001|Overall Study|Progressive Disease|9|||
129859179|NCT04139317|467441487|FG000|Overall Study|Subject Decision|2|||
129859180|NCT04139317|467441488|FG001|Overall Study|Subject Decision|2|||
129859181|NCT06027216|467441489|FG000|Overall Study|Did not qualify|8|||
129859182|NCT02365467|467441490|FG000|Overall Study|Death|3|||
129859183|NCT02043782|467441491|FG000|Period 1|Adverse Event|0|||
129859184|NCT02043782|467441492|FG001|Period 1|Adverse Event|0|||
129859185|NCT02043782|467441493|FG002|Period 1|Adverse Event|1|||
129859186|NCT02043782|467441494|FG003|Period 1|Adverse Event|0|||
129859187|NCT02043782|467441495|FG004|Period 1|Adverse Event|0|||
129859188|NCT02043782|467441496|FG005|Period 1|Adverse Event|0|||
129859189|NCT01306162|467441499|FG000|Period 1|Adverse Event|0|||
129859190|NCT01306162|467441500|FG001|Period 1|Adverse Event|0|||
129859191|NCT01306162|467441501|FG002|Period 1|Adverse Event|0|||
129859192|NCT01306162|467441502|FG003|Period 1|Adverse Event|1|||
129859193|NCT01306162|467441499|FG000|Washout 1|Non-compliance to protocol|0|||
129859194|NCT01306162|467441500|FG001|Washout 1|Non-compliance to protocol|1|||
129859195|NCT01306162|467441501|FG002|Washout 1|Non-compliance to protocol|0|||
129859196|NCT01306162|467441502|FG003|Washout 1|Non-compliance to protocol|0|||
129859197|NCT02959437|467441503|FG000|Overall Study|Death|33|||
129859198|NCT02959437|467441504|FG001|Overall Study|Death|3|||
129859199|NCT02959437|467441505|FG002|Overall Study|Death|0|||
129859200|NCT02959437|467441506|FG003|Overall Study|Death|0|||
129859201|NCT02959437|467441503|FG000|Overall Study|Lost to Follow-up|3|||
129859202|NCT02959437|467441504|FG001|Overall Study|Lost to Follow-up|1|||
129859203|NCT02959437|467441505|FG002|Overall Study|Lost to Follow-up|0|||
129859204|NCT02959437|467441506|FG003|Overall Study|Lost to Follow-up|0|||
129859205|NCT02959437|467441503|FG000|Overall Study|Withdrawal by Subject|11|||
129859206|NCT02959437|467441504|FG001|Overall Study|Withdrawal by Subject|3|||
129859207|NCT02959437|467441505|FG002|Overall Study|Withdrawal by Subject|0|||
129859208|NCT02959437|467441506|FG003|Overall Study|Withdrawal by Subject|0|||
129859209|NCT02959437|467441503|FG000|Overall Study|Progressive Disease|9|||
129859210|NCT02959437|467441504|FG001|Overall Study|Progressive Disease|1|||
129859211|NCT02959437|467441505|FG002|Overall Study|Progressive Disease|0|||
129859212|NCT02959437|467441506|FG003|Overall Study|Progressive Disease|0|||
129859213|NCT02959437|467441503|FG000|Overall Study|Study Terminated by Sponsor|4|||
129859214|NCT02959437|467441504|FG001|Overall Study|Study Terminated by Sponsor|0|||
129859215|NCT02959437|467441505|FG002|Overall Study|Study Terminated by Sponsor|0|||
129859216|NCT02959437|467441506|FG003|Overall Study|Study Terminated by Sponsor|0|||
129859217|NCT02959437|467441503|FG000|Overall Study|Other Unspecified|2|||
129859218|NCT02959437|467441504|FG001|Overall Study|Other Unspecified|0|||
129859219|NCT02959437|467441505|FG002|Overall Study|Other Unspecified|0|||
129859220|NCT02959437|467441506|FG003|Overall Study|Other Unspecified|0|||
129859221|NCT00833989|467441511|FG000|Overall Study|Physician Decision|0|||
129859222|NCT00833989|467441512|FG001|Overall Study|Physician Decision|0|||
129859223|NCT00833989|467441513|FG002|Overall Study|Physician Decision|0|||
129859224|NCT00833989|467441514|FG003|Overall Study|Physician Decision|1|||
129859225|NCT00833989|467441511|FG000|Overall Study|Withdrawal by Subject|3|||
129859226|NCT00833989|467441512|FG001|Overall Study|Withdrawal by Subject|0|||
129859227|NCT00833989|467441513|FG002|Overall Study|Withdrawal by Subject|1|||
129859228|NCT00833989|467441514|FG003|Overall Study|Withdrawal by Subject|1|||
129859229|NCT01949480|467441515|FG000|Overall Study|Physician Decision|5|||
129859230|NCT01949480|467441516|FG001|Overall Study|Physician Decision|8|||
129859231|NCT00214136|467441517|FG000|Overall Study|Death|5|||
129859232|NCT04287920|467441518|FG000|Overall Study|Lost to Follow-up|1|||
129859233|NCT04287920|467441519|FG001|Overall Study|Lost to Follow-up|1|||
129859234|NCT04287920|467441518|FG000|Overall Study|Withdrawal by Subject|0|||
129859235|NCT04287920|467441519|FG001|Overall Study|Withdrawal by Subject|3|||
129859236|NCT04313634|467441520|FG000|Overall Study|Adverse Event|2|||
129859237|NCT04313634|467441521|FG001|Overall Study|Adverse Event|2|||
129859238|NCT04313634|467441522|FG002|Overall Study|Adverse Event|0|||
129859239|NCT04313634|467441520|FG000|Overall Study|Withdrawal by Subject|1|||
129859240|NCT04313634|467441521|FG001|Overall Study|Withdrawal by Subject|0|||
129859241|NCT04313634|467441522|FG002|Overall Study|Withdrawal by Subject|1|||
129859242|NCT04313634|467441520|FG000|Overall Study|Protocol Violation|0|||
129859243|NCT04313634|467441521|FG001|Overall Study|Protocol Violation|0|||
130064735|NCT03337139|468190271|FG000|Phase I|Withdrawal by Subject|10|||
130064736|NCT03337139|468190272|FG001|Phase I|Withdrawal by Subject|0|||
130064737|NCT00077376|468190273|FG000|Overall Study|Adverse Event|8|||
130064738|NCT00077376|468190273|FG000|Overall Study|Withdrawal by Subject|2|||
129859244|NCT04313634|467441522|FG002|Overall Study|Protocol Violation|1|||
129859245|NCT01220557|467441528|FG000|Overall Study|Lost to Follow-up|5|||
129859246|NCT01220557|467441529|FG001|Overall Study|Lost to Follow-up|3|||
129859247|NCT01220557|467441528|FG000|Overall Study|attended less than 6 lessons|1|||
129859248|NCT01220557|467441529|FG001|Overall Study|attended less than 6 lessons|2|||
129859249|NCT01196975|467441533|FG000|Overall Study|Adverse Event|2|||
129859250|NCT01196975|467441534|FG001|Overall Study|Adverse Event|2|||
129859251|NCT01196975|467441535|FG002|Overall Study|Adverse Event|0|||
129859252|NCT01196975|467441536|FG003|Overall Study|Adverse Event|0|||
129859253|NCT01196975|467441537|FG004|Overall Study|Adverse Event|2|||
129859254|NCT01196975|467441533|FG000|Overall Study|Withdrawal by Subject|2|||
129859255|NCT01196975|467441534|FG001|Overall Study|Withdrawal by Subject|1|||
129859256|NCT01196975|467441535|FG002|Overall Study|Withdrawal by Subject|0|||
129859257|NCT01196975|467441536|FG003|Overall Study|Withdrawal by Subject|1|||
129859258|NCT01196975|467441537|FG004|Overall Study|Withdrawal by Subject|0|||
129859259|NCT01196975|467441533|FG000|Overall Study|Lost to Follow-up|11|||
129859260|NCT01196975|467441534|FG001|Overall Study|Lost to Follow-up|6|||
129859261|NCT01196975|467441535|FG002|Overall Study|Lost to Follow-up|5|||
129859262|NCT01196975|467441536|FG003|Overall Study|Lost to Follow-up|5|||
129859263|NCT01196975|467441537|FG004|Overall Study|Lost to Follow-up|11|||
129859264|NCT01365494|467441538|FG000|Overall Study|Adverse Event|1|||
129859265|NCT01365494|467441539|FG001|Overall Study|Adverse Event|0|||
129859266|NCT01365494|467441538|FG000|Overall Study|Withdrawal by Subject|0|||
129859267|NCT01365494|467441539|FG001|Overall Study|Withdrawal by Subject|1|||
129859268|NCT01365494|467441538|FG000|Overall Study|Lost to Follow-up|1|||
129859269|NCT01365494|467441539|FG001|Overall Study|Lost to Follow-up|2|||
129859270|NCT04558346|467441540|FG000|Overall Study|Withdrawal by Subject|2|||
129859271|NCT04558346|467441541|FG001|Overall Study|Withdrawal by Subject|0|||
129859272|NCT04558346|467441540|FG000|Overall Study|Lost to Follow-up|0|||
129859273|NCT04558346|467441541|FG001|Overall Study|Lost to Follow-up|1|||
129859274|NCT04558346|467441540|FG000|Overall Study|Adverse Event|0|||
129859275|NCT04558346|467441541|FG001|Overall Study|Adverse Event|1|||
129859276|NCT01003249|467441544|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129859277|NCT01003249|467441545|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129859278|NCT01003249|467441544|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
129859279|NCT01003249|467441545|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
129859280|NCT01003249|467441544|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129859281|NCT01003249|467441545|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129859282|NCT01003249|467441544|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
129859283|NCT01003249|467441545|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
129859284|NCT01962974|467441546|FG000|Overall Study|Study termination|7|||
129859285|NCT03394924|467441550|FG000|Overall Study|Adverse Event|0|||
129859286|NCT03394924|467441551|FG001|Overall Study|Adverse Event|5|||
129859287|NCT03394924|467441552|FG002|Overall Study|Adverse Event|0|||
129859288|NCT03394924|467441550|FG000|Overall Study|Withdrawal by Subject|2|||
129859289|NCT03394924|467441551|FG001|Overall Study|Withdrawal by Subject|0|||
129859290|NCT03394924|467441552|FG002|Overall Study|Withdrawal by Subject|0|||
129859291|NCT03394924|467441550|FG000|Overall Study|Lost to Follow-up|0|||
129859292|NCT03394924|467441551|FG001|Overall Study|Lost to Follow-up|1|||
129859293|NCT03394924|467441552|FG002|Overall Study|Lost to Follow-up|0|||
129859294|NCT03394924|467441550|FG000|Overall Study|Did not meet all inclusion criteria|1|||
129859295|NCT03394924|467441551|FG001|Overall Study|Did not meet all inclusion criteria|0|||
129859296|NCT03394924|467441552|FG002|Overall Study|Did not meet all inclusion criteria|0|||
129859297|NCT03588572|467441555|FG000|Visitation 1|Lack of Efficacy|1|||
129859298|NCT03588572|467441556|FG001|Visitation 1|Lack of Efficacy|1|||
129859299|NCT03588572|467441555|FG000|Visitation 2|Lost to Follow-up|1|||
129859300|NCT03588572|467441556|FG001|Visitation 2|Lost to Follow-up|1|||
129859301|NCT03588572|467441555|FG000|Visitation 2|Lack of Efficacy|0|||
129859302|NCT03588572|467441556|FG001|Visitation 2|Lack of Efficacy|1|||
129859303|NCT03588572|467441555|FG000|Visitation 2|Withdrawal by Subject|1|||
129859304|NCT03588572|467441556|FG001|Visitation 2|Withdrawal by Subject|0|||
129859305|NCT03588572|467441555|FG000|Visitation 3|Lost to Follow-up|1|||
130064739|NCT00077376|468190273|FG000|Overall Study|Death|1|||
129859306|NCT03588572|467441556|FG001|Visitation 3|Lost to Follow-up|1|||
129859307|NCT03588572|467441555|FG000|Visitation 3|Physician Decision|1|||
129859308|NCT03588572|467441556|FG001|Visitation 3|Physician Decision|1|||
129859309|NCT03588572|467441555|FG000|Visitation 3|Withdrawal by Subject|1|||
129859310|NCT03588572|467441556|FG001|Visitation 3|Withdrawal by Subject|0|||
129859311|NCT00659334|467441563|FG000|Overall Study|Screen Failure|8|||
129859312|NCT00659334|467441564|FG001|Overall Study|Screen Failure|5|||
130064740|NCT00077376|468190273|FG000|Overall Study|Physician Decision|1|||
130064741|NCT00077376|468190273|FG000|Overall Study|Alternative therapy|5|||
129859313|NCT00659334|467441565|FG002|Overall Study|Screen Failure|0|||
129859314|NCT00659334|467441566|FG003|Overall Study|Screen Failure|0|||
129859315|NCT00659334|467441567|FG004|Overall Study|Screen Failure|0|||
129859316|NCT00659334|467441568|FG005|Overall Study|Screen Failure|0|||
129859317|NCT00659334|467441569|FG006|Overall Study|Screen Failure|1|||
129859318|NCT01174342|467441570|FG000|Overall Study|Conversion to cesarean section|4|||
129859319|NCT01308580|467441571|FG000|Overall Study|Lost to Follow-up|12|||
129859320|NCT01308580|467441572|FG001|Overall Study|Lost to Follow-up|7|||
129859321|NCT02535065|467441573|FG000|Overall Study|Death|13|||
129859322|NCT02535065|467441573|FG000|Overall Study|Lost to Follow-up|1|||
129859323|NCT02535065|467441573|FG000|Overall Study|Withdrawal by Subject|6|||
129859324|NCT00110617|467441575|FG000|Overall Study|Adverse Event|2|||
129859325|NCT00110617|467441576|FG001|Overall Study|Adverse Event|4|||
129859326|NCT00110617|467441575|FG000|Overall Study|Abnormal Laboratory Value|4|||
129859327|NCT00110617|467441576|FG001|Overall Study|Abnormal Laboratory Value|2|||
129859328|NCT00110617|467441575|FG000|Overall Study|Lack of Efficacy|1|||
129859329|NCT00110617|467441576|FG001|Overall Study|Lack of Efficacy|0|||
129859330|NCT00110617|467441575|FG000|Overall Study|Patient no longer requires study drug|1|||
129859331|NCT00110617|467441576|FG001|Overall Study|Patient no longer requires study drug|0|||
129859332|NCT00110617|467441575|FG000|Overall Study|Protocol Violation|5|||
129859333|NCT00110617|467441576|FG001|Overall Study|Protocol Violation|0|||
129859334|NCT00110617|467441575|FG000|Overall Study|Withdrawal by Subject|10|||
129859335|NCT00110617|467441576|FG001|Overall Study|Withdrawal by Subject|4|||
129859336|NCT00110617|467441575|FG000|Overall Study|Lost to Follow-up|9|||
129859337|NCT00110617|467441576|FG001|Overall Study|Lost to Follow-up|1|||
129859338|NCT00110617|467441575|FG000|Overall Study|Administrative problems|6|||
129859339|NCT00110617|467441576|FG001|Overall Study|Administrative problems|5|||
129859340|NCT00110617|467441575|FG000|Overall Study|Death|1|||
129859341|NCT00110617|467441576|FG001|Overall Study|Death|1|||
129859342|NCT00110617|467441575|FG000|Overall Study|Did not receive study drug|0|||
129859343|NCT00110617|467441576|FG001|Overall Study|Did not receive study drug|12|||
129859344|NCT00045110|467441578|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
129859345|NCT00045110|467441579|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
129859346|NCT00045110|467441580|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
129859347|NCT00045110|467441578|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
129859348|NCT00045110|467441579|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
129859349|NCT00045110|467441580|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
129859350|NCT00045110|467441578|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
129859351|NCT00045110|467441579|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
129859352|NCT00045110|467441580|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
129859353|NCT01218646|467441581|FG000|Overall Study|Adverse Event|0|||
129859354|NCT01218646|467441582|FG001|Overall Study|Adverse Event|0|||
129859355|NCT01218646|467441583|FG002|Overall Study|Adverse Event|1|||
129859356|NCT01218646|467441584|FG003|Overall Study|Adverse Event|0|||
129859357|NCT01218646|467441581|FG000|Overall Study|Lost to Follow-up|1|||
129859358|NCT01218646|467441582|FG001|Overall Study|Lost to Follow-up|0|||
129859359|NCT01218646|467441583|FG002|Overall Study|Lost to Follow-up|0|||
129859360|NCT01218646|467441584|FG003|Overall Study|Lost to Follow-up|0|||
129859361|NCT01218646|467441581|FG000|Overall Study|Protocol Violation|0|||
129859362|NCT01218646|467441582|FG001|Overall Study|Protocol Violation|0|||
129859363|NCT01218646|467441583|FG002|Overall Study|Protocol Violation|1|||
129859364|NCT01218646|467441584|FG003|Overall Study|Protocol Violation|1|||
129859365|NCT04537923|467444134|FG000|Overall Study|Adverse Event|2|||
129859366|NCT04537923|467444135|FG001|Overall Study|Adverse Event|1|||
129859367|NCT04537923|467444136|FG002|Overall Study|Adverse Event|2|||
129859368|NCT04537923|467444137|FG003|Overall Study|Adverse Event|4|||
129859369|NCT04537923|467444134|FG000|Overall Study|Death|3|||
129859370|NCT04537923|467444135|FG001|Overall Study|Death|3|||
129859371|NCT04537923|467444136|FG002|Overall Study|Death|1|||
129859372|NCT04537923|467444137|FG003|Overall Study|Death|11|||
129859373|NCT04537923|467444134|FG000|Overall Study|Lost to Follow-up|1|||
129859374|NCT04537923|467444135|FG001|Overall Study|Lost to Follow-up|2|||
129859375|NCT04537923|467444136|FG002|Overall Study|Lost to Follow-up|1|||
129859376|NCT04537923|467444137|FG003|Overall Study|Lost to Follow-up|6|||
129859377|NCT04537923|467444134|FG000|Overall Study|Physician Decision|1|||
129910473|NCT01248936|467635347|FG000|Overall Study|Withdrawal of Consent|20|||
129910474|NCT01248936|467635347|FG000|Overall Study|Adverse Event|8|||
129859378|NCT04537923|467444135|FG001|Overall Study|Physician Decision|0|||
129859379|NCT04537923|467444136|FG002|Overall Study|Physician Decision|2|||
129859380|NCT04537923|467444137|FG003|Overall Study|Physician Decision|5|||
129859381|NCT04537923|467444134|FG000|Overall Study|Pregnancy|1|||
129859382|NCT04537923|467444135|FG001|Overall Study|Pregnancy|0|||
129859383|NCT04537923|467444136|FG002|Overall Study|Pregnancy|0|||
129859384|NCT04537923|467444137|FG003|Overall Study|Pregnancy|0|||
129859385|NCT04537923|467444134|FG000|Overall Study|Withdrawal by Subject|4|||
129859386|NCT04537923|467444135|FG001|Overall Study|Withdrawal by Subject|4|||
129859387|NCT04537923|467444136|FG002|Overall Study|Withdrawal by Subject|4|||
129859388|NCT04537923|467444137|FG003|Overall Study|Withdrawal by Subject|58|||
129859389|NCT04537923|467444134|FG000|Overall Study|Missed study visits|2|||
129859390|NCT04537923|467444135|FG001|Overall Study|Missed study visits|0|||
129859391|NCT04537923|467444136|FG002|Overall Study|Missed study visits|0|||
129859392|NCT04537923|467444137|FG003|Overall Study|Missed study visits|3|||
129859393|NCT04537923|467444134|FG000|Overall Study|Sponsor's decision|0|||
129859394|NCT04537923|467444135|FG001|Overall Study|Sponsor's decision|0|||
129859395|NCT04537923|467444136|FG002|Overall Study|Sponsor's decision|1|||
129859396|NCT04537923|467444137|FG003|Overall Study|Sponsor's decision|1|||
129859397|NCT04537923|467444134|FG000|Overall Study|Safety reasons|1|||
129859398|NCT04537923|467444135|FG001|Overall Study|Safety reasons|0|||
129859399|NCT04537923|467444136|FG002|Overall Study|Safety reasons|0|||
129859400|NCT04537923|467444137|FG003|Overall Study|Safety reasons|0|||
129859401|NCT04745169|467444139|FG000|Overall Study|Kidney transplantation|1|||
129859402|NCT04745169|467444139|FG000|Overall Study|Participant health problems|3|||
129859403|NCT04745169|467444139|FG000|Overall Study|Physician Decision|2|||
129859404|NCT02041195|467444140|FG000|Overall Study|Adverse Event|1|||
129859405|NCT02041195|467444141|FG001|Overall Study|Adverse Event|2|||
129859406|NCT02041195|467444142|FG002|Overall Study|Adverse Event|0|||
129859407|NCT02041195|467444143|FG003|Overall Study|Adverse Event|0|||
129859408|NCT02041195|467444144|FG004|Overall Study|Adverse Event|0|||
129859409|NCT02041195|467444145|FG005|Overall Study|Adverse Event|0|||
129859410|NCT02041195|467444146|FG006|Overall Study|Adverse Event|3|||
129859411|NCT02041195|467444147|FG007|Overall Study|Adverse Event|0|||
129859412|NCT02041195|467444140|FG000|Overall Study|Withdrawal by Subject|1|||
129859413|NCT02041195|467444141|FG001|Overall Study|Withdrawal by Subject|0|||
129859414|NCT02041195|467444142|FG002|Overall Study|Withdrawal by Subject|0|||
129859415|NCT02041195|467444143|FG003|Overall Study|Withdrawal by Subject|0|||
129859416|NCT02041195|467444144|FG004|Overall Study|Withdrawal by Subject|0|||
129859417|NCT02041195|467444145|FG005|Overall Study|Withdrawal by Subject|0|||
129859418|NCT02041195|467444146|FG006|Overall Study|Withdrawal by Subject|4|||
129859419|NCT02041195|467444147|FG007|Overall Study|Withdrawal by Subject|3|||
129859420|NCT02041195|467444140|FG000|Overall Study|Unable to comply with study visits|0|||
129859421|NCT02041195|467444141|FG001|Overall Study|Unable to comply with study visits|1|||
129859422|NCT02041195|467444142|FG002|Overall Study|Unable to comply with study visits|0|||
129859423|NCT02041195|467444143|FG003|Overall Study|Unable to comply with study visits|0|||
129859424|NCT02041195|467444144|FG004|Overall Study|Unable to comply with study visits|1|||
129859425|NCT02041195|467444145|FG005|Overall Study|Unable to comply with study visits|0|||
129859426|NCT02041195|467444146|FG006|Overall Study|Unable to comply with study visits|0|||
129859427|NCT02041195|467444147|FG007|Overall Study|Unable to comply with study visits|0|||
129859428|NCT01747772|467444148|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
129859429|NCT00626522|467444149|FG000|Overall Study|Protocol Violation|0|||
129859430|NCT00626522|467444150|FG001|Overall Study|Protocol Violation|0|||
129859431|NCT00626522|467444151|FG002|Overall Study|Protocol Violation|0|||
129859432|NCT00626522|467444152|FG003|Overall Study|Protocol Violation|0|||
129859433|NCT00626522|467444153|FG004|Overall Study|Protocol Violation|1|||
129859434|NCT00626522|467444154|FG005|Overall Study|Protocol Violation|0|||
129859435|NCT00626522|467444149|FG000|Overall Study|Adverse Event|2|||
129859436|NCT00626522|467444150|FG001|Overall Study|Adverse Event|1|||
129859437|NCT00626522|467444151|FG002|Overall Study|Adverse Event|2|||
129859438|NCT00626522|467444152|FG003|Overall Study|Adverse Event|0|||
129859439|NCT00626522|467444153|FG004|Overall Study|Adverse Event|1|||
129859440|NCT00626522|467444154|FG005|Overall Study|Adverse Event|1|||
129859441|NCT00626522|467444149|FG000|Overall Study|Withdrawal by Subject|2|||
129859442|NCT00626522|467444150|FG001|Overall Study|Withdrawal by Subject|5|||
129859443|NCT00626522|467444151|FG002|Overall Study|Withdrawal by Subject|5|||
129859444|NCT00626522|467444152|FG003|Overall Study|Withdrawal by Subject|0|||
129859445|NCT00626522|467444153|FG004|Overall Study|Withdrawal by Subject|4|||
129859446|NCT00626522|467444154|FG005|Overall Study|Withdrawal by Subject|1|||
129859447|NCT00626522|467444149|FG000|Overall Study|COPD exacerbation|0|||
129859448|NCT00626522|467444150|FG001|Overall Study|COPD exacerbation|0|||
129859449|NCT00626522|467444151|FG002|Overall Study|COPD exacerbation|0|||
129859450|NCT00626522|467444152|FG003|Overall Study|COPD exacerbation|1|||
129859451|NCT00626522|467444153|FG004|Overall Study|COPD exacerbation|1|||
129859452|NCT00626522|467444154|FG005|Overall Study|COPD exacerbation|0|||
129859453|NCT00626522|467444149|FG000|Overall Study|Lost to Follow-up|0|||
129859454|NCT00626522|467444150|FG001|Overall Study|Lost to Follow-up|1|||
129859455|NCT00626522|467444151|FG002|Overall Study|Lost to Follow-up|0|||
129859456|NCT00626522|467444152|FG003|Overall Study|Lost to Follow-up|0|||
129859457|NCT00626522|467444153|FG004|Overall Study|Lost to Follow-up|0|||
129859458|NCT00626522|467444154|FG005|Overall Study|Lost to Follow-up|0|||
129859459|NCT00626522|467444149|FG000|Overall Study|Inconsistent reason reported|1|||
129859460|NCT00626522|467444150|FG001|Overall Study|Inconsistent reason reported|0|||
129859461|NCT00626522|467444151|FG002|Overall Study|Inconsistent reason reported|0|||
129859462|NCT00626522|467444152|FG003|Overall Study|Inconsistent reason reported|0|||
129859463|NCT00626522|467444153|FG004|Overall Study|Inconsistent reason reported|0|||
129859464|NCT00626522|467444154|FG005|Overall Study|Inconsistent reason reported|0|||
129859465|NCT00626522|467444149|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
129859466|NCT00626522|467444150|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
129859467|NCT00626522|467444151|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
129859468|NCT00626522|467444152|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
129859469|NCT00626522|467444153|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
129859470|NCT00626522|467444154|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
129859471|NCT00896168|467444155|FG000|Overall Study|Adverse Event|4|||
129859472|NCT00896168|467444156|FG001|Overall Study|Adverse Event|7|||
129859473|NCT00896168|467444155|FG000|Overall Study|Treatment failure|8|||
129859474|NCT00896168|467444156|FG001|Overall Study|Treatment failure|10|||
129859475|NCT00896168|467444155|FG000|Overall Study|Lost to Follow-up|1|||
129859476|NCT00896168|467444156|FG001|Overall Study|Lost to Follow-up|1|||
129859477|NCT00896168|467444155|FG000|Overall Study|Other|1|||
129859478|NCT00896168|467444156|FG001|Overall Study|Other|1|||
129859479|NCT04717596|467444164|FG000|Overall Study|Withdrawal by Subject|4|||
129859480|NCT02460991|467444166|FG000|Overall Study|Withdrawal by Subject|0|||
129859481|NCT02460991|467444167|FG001|Overall Study|Withdrawal by Subject|2|||
129859482|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
129859483|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
129859484|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Death|1|||
129859485|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Death|0|||
129859486|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
129859487|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
129859488|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
129859489|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
129859490|NCT02148250|467444171|FG000|Screening|Withdrawal by Subject|5|||
129859491|NCT02148250|467444172|FG001|Screening|Withdrawal by Subject|0|||
129859492|NCT02370602|467444175|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129859493|NCT02370602|467444176|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129859494|NCT02370602|467444177|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129859495|NCT02370602|467444178|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
129859496|NCT02370602|467444179|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
129859497|NCT02370602|467444180|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
129859498|NCT00237744|467444181|FG000|Overall Study|Withdrawal by Subject|3|||
129859499|NCT00237744|467444182|FG001|Overall Study|Withdrawal by Subject|1|||
129859500|NCT00237744|467444183|FG002|Overall Study|Withdrawal by Subject|0|||
129859501|NCT02097472|467444184|FG000|Received Vaccination 2|Adverse Event|0|||
129859502|NCT02097472|467444185|FG001|Received Vaccination 2|Adverse Event|0|||
129859503|NCT02097472|467444186|FG002|Received Vaccination 2|Adverse Event|0|||
129859504|NCT02097472|467444187|FG003|Received Vaccination 2|Adverse Event|0|||
129859505|NCT02097472|467444188|FG004|Received Vaccination 2|Adverse Event|0|||
129859506|NCT02097472|467444189|FG005|Received Vaccination 2|Adverse Event|0|||
129859507|NCT02097472|467444190|FG006|Received Vaccination 2|Adverse Event|1|||
129859508|NCT02097472|467444191|FG007|Received Vaccination 2|Adverse Event|0|||
129859509|NCT02119416|467444192|FG000|Overall Study|Protocol Violation|1|||
129859510|NCT02119416|467444193|FG001|Overall Study|Protocol Violation|1|||
129859511|NCT02119416|467444194|FG002|Overall Study|Protocol Violation|1|||
129859512|NCT02119416|467444192|FG000|Overall Study|wrong pubertal stage|1|||
129859513|NCT02119416|467444193|FG001|Overall Study|wrong pubertal stage|0|||
129859514|NCT02119416|467444194|FG002|Overall Study|wrong pubertal stage|1|||
129859515|NCT03043664|467444197|FG000|Overall Study|Lost to Follow-up|1|||
129859516|NCT03593655|467444198|FG000|First Product Use Period|Withdrawal by Subject|1|||
129859517|NCT03593655|467444199|FG001|First Product Use Period|Withdrawal by Subject|1|||
129859518|NCT03593655|467444198|FG000|First Product Use Period|Lost to Follow-up|1|||
129859519|NCT03593655|467444199|FG001|First Product Use Period|Lost to Follow-up|3|||
129859520|NCT03593655|467444198|FG000|Second Product Use Period|Withdrawal by Subject|1|||
129859521|NCT03593655|467444199|FG001|Second Product Use Period|Withdrawal by Subject|1|||
129859522|NCT03593655|467444198|FG000|Second Product Use Period|Lost to Follow-up|1|||
129859523|NCT03593655|467444199|FG001|Second Product Use Period|Lost to Follow-up|0|||
129859524|NCT03593655|467444198|FG000|Third Product Use Period|Lost to Follow-up|1|||
129859525|NCT03593655|467444199|FG001|Third Product Use Period|Lost to Follow-up|2|||
129859526|NCT03593655|467444198|FG000|Third Product Use Period|Physician Decision|0|||
129859527|NCT03593655|467444199|FG001|Third Product Use Period|Physician Decision|1|||
129859528|NCT03593655|467444198|FG000|Third Product Use Period|Withdrawal by Subject|0|||
129859529|NCT03593655|467444199|FG001|Third Product Use Period|Withdrawal by Subject|1|||
129859530|NCT03732209|467444202|FG000|Overall Study|Lost to Follow-up|4|||
129859531|NCT03732209|467444203|FG001|Overall Study|Lost to Follow-up|4|||
129859532|NCT03732209|467444202|FG000|Overall Study|Withdrawal by Subject|8|||
129859533|NCT03732209|467444203|FG001|Overall Study|Withdrawal by Subject|9|||
129859534|NCT05046795|467444204|FG000|Overall Study|Adverse Event|13|||
129859535|NCT05046795|467444205|FG001|Overall Study|Adverse Event|15|||
129859536|NCT05046795|467444204|FG000|Overall Study|Withdrawal by Subject|4|||
129859537|NCT05046795|467444205|FG001|Overall Study|Withdrawal by Subject|7|||
129859538|NCT05046795|467444204|FG000|Overall Study|Physician Decision|1|||
129859539|NCT05046795|467444205|FG001|Overall Study|Physician Decision|2|||
129859540|NCT05046795|467444204|FG000|Overall Study|Protocol Violation|1|||
129859541|NCT05046795|467444205|FG001|Overall Study|Protocol Violation|2|||
129859542|NCT05046795|467444204|FG000|Overall Study|Death|1|||
129859543|NCT05046795|467444205|FG001|Overall Study|Death|0|||
129859544|NCT05046795|467444204|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
129859545|NCT05046795|467444205|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
129859546|NCT02864082|467444206|FG000|Overall Study|Adverse Event|1|||
129859547|NCT02864082|467444207|FG001|Overall Study|Adverse Event|1|||
129859548|NCT02864082|467444206|FG000|Overall Study|Lost to Follow-up|0|||
129859549|NCT02864082|467444207|FG001|Overall Study|Lost to Follow-up|1|||
129859550|NCT02864082|467444206|FG000|Overall Study|Withdrawal by Subject|2|||
129859551|NCT02864082|467444207|FG001|Overall Study|Withdrawal by Subject|2|||
129859552|NCT01127178|467444208|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
129859553|NCT01127178|467444209|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
129859554|NCT01127178|467444208|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
129859555|NCT01127178|467444209|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
129859556|NCT01127178|467444208|FG000|Dose Escalation: Treatment Phase|Other|2|||
129859557|NCT01127178|467444209|FG001|Dose Escalation: Treatment Phase|Other|0|||
129859558|NCT01127178|467444208|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
129859559|NCT01127178|467444209|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
129859560|NCT01127178|467444208|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
129859561|NCT01127178|467444209|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
129859562|NCT01127178|467444208|FG000|Dose Escalation: Extension Phase|Other|1|||
129859563|NCT01127178|467444209|FG001|Dose Escalation: Extension Phase|Other|0|||
129859564|NCT03621696|467444210|FG000|Overall Study|Not eligible|0|||
129859565|NCT03621696|467444211|FG001|Overall Study|Not eligible|0|||
129859566|NCT03621696|467444212|FG002|Overall Study|Not eligible|0|||
129859567|NCT03621696|467444213|FG003|Overall Study|Not eligible|5|||
129859568|NCT03621696|467444210|FG000|Overall Study|Withdrawal by Subject|1|||
129859569|NCT03621696|467444211|FG001|Overall Study|Withdrawal by Subject|1|||
129859570|NCT03621696|467444212|FG002|Overall Study|Withdrawal by Subject|1|||
129859571|NCT03621696|467444213|FG003|Overall Study|Withdrawal by Subject|0|||
129859572|NCT03621696|467444210|FG000|Overall Study|Physician Decision|0|||
129859573|NCT03621696|467444211|FG001|Overall Study|Physician Decision|0|||
129859574|NCT03621696|467444212|FG002|Overall Study|Physician Decision|1|||
129859575|NCT03621696|467444213|FG003|Overall Study|Physician Decision|0|||
129859576|NCT04349553|467444214|FG000|Overall Study|Withdrawal by Subject|1|||
129859577|NCT04349553|467444215|FG001|Overall Study|Withdrawal by Subject|0|||
129859578|NCT04349553|467444216|FG002|Overall Study|Withdrawal by Subject|1|||
129859579|NCT04349553|467444217|FG003|Overall Study|Withdrawal by Subject|0|||
129859580|NCT02063724|467444218|FG000|Overall Study|Disease progression|1|||
129859581|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
129859582|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
129859583|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
129859584|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
129859585|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
129859586|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
129859587|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
129859588|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
129859589|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
129859590|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
129859591|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
129859592|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
129859593|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
129859594|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
129859595|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
129859596|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
129859597|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
129859598|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
129859599|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
129859600|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
129859601|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
129859602|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
129859603|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
129859604|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
129859605|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
129859606|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
129859607|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
129859608|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
129859609|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
129910475|NCT01248936|467635347|FG000|Overall Study|Lost to Follow-up|7|||
129910476|NCT01248936|467635347|FG000|Overall Study|Refused Treatment|1|||
129859610|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
129859611|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
129859612|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
129859613|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
129859614|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
129859615|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
129859616|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
129859617|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
129859618|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
129859619|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
129859620|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
129859621|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
129859622|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
129859623|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
129859624|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
129859625|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
129859626|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
129859627|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
129859628|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
129859629|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
129859630|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
129859631|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
129859632|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
129859633|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
129859634|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
129859635|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
129859636|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
129859637|NCT01618864|467444225|FG000|Overall Study|Withdrawal by Subject|2|||
129859638|NCT01618864|467444225|FG000|Overall Study|Lost to Follow-up|2|||
129859639|NCT05177770|467444226|FG000|Overall Study|Death|4|||
129859640|NCT05177770|467444226|FG000|Overall Study|Withdrawal by Subject|1|||
129859641|NCT05177770|467444226|FG000|Overall Study|Adverse Event prior to dosing|1|||
129859642|NCT00709722|467444231|FG000|Overall Study|Adverse Event|1|||
129859643|NCT04667117|467444232|FG000|Investigational Period|Lost to Follow-up|0|||
129859644|NCT04667117|467444233|FG001|Investigational Period|Lost to Follow-up|0|||
129859645|NCT04667117|467444234|FG002|Investigational Period|Lost to Follow-up|1|||
129859646|NCT04667117|467444232|FG000|Investigational Period|Protocol Deviation|0|||
129859647|NCT04667117|467444233|FG001|Investigational Period|Protocol Deviation|1|||
129859648|NCT04667117|467444234|FG002|Investigational Period|Protocol Deviation|0|||
129859649|NCT04667117|467444232|FG000|Extension Period|Lost to Follow-up|1|||
129859650|NCT04667117|467444233|FG001|Extension Period|Lost to Follow-up|0|||
129859651|NCT04667117|467444234|FG002|Extension Period|Lost to Follow-up|0|||
129859652|NCT02372396|467444248|FG000|Overall Study|Lost to Follow-up|7|||
129859653|NCT02372396|467444249|FG001|Overall Study|Lost to Follow-up|9|||
129859654|NCT01272934|467444252|FG000|Overall Study|Adverse Event|0|||
129859655|NCT01272934|467444253|FG001|Overall Study|Adverse Event|1|||
129859656|NCT01272934|467444252|FG000|Overall Study|Abnormal Laboratory Value|0|||
129859657|NCT01272934|467444253|FG001|Overall Study|Abnormal Laboratory Value|1|||
129859658|NCT02310750|467444256|FG000|HP Period 1|Lost to Follow-up|0|||
129859659|NCT02310750|467444257|FG001|HP Period 1|Lost to Follow-up|0|||
129859660|NCT02310750|467444258|FG002|HP Period 1|Lost to Follow-up|0|||
129859661|NCT02310750|467444259|FG003|HP Period 1|Lost to Follow-up|0|||
129859662|NCT02310750|467444260|FG004|HP Period 1|Lost to Follow-up|0|||
129859663|NCT02310750|467444261|FG005|HP Period 1|Lost to Follow-up|0|||
129859664|NCT02310750|467444262|FG006|HP Period 1|Lost to Follow-up|1|||
129859665|NCT02310750|467444263|FG007|HP Period 1|Lost to Follow-up|0|||
129859666|NCT02310750|467444264|FG008|HP Period 1|Lost to Follow-up|0|||
129859667|NCT02310750|467444265|FG009|HP Period 1|Lost to Follow-up|0|||
129859668|NCT02310750|467444266|FG010|HP Period 1|Lost to Follow-up|0|||
129859669|NCT02310750|467444267|FG011|HP Period 1|Lost to Follow-up|0|||
129859670|NCT02310750|467444268|FG012|HP Period 1|Lost to Follow-up|0|||
129859671|NCT02310750|467444269|FG013|HP Period 1|Lost to Follow-up|0|||
129859672|NCT02310750|467444270|FG014|HP Period 1|Lost to Follow-up|0|||
129859673|NCT02310750|467444271|FG015|HP Period 1|Lost to Follow-up|0|||
129859674|NCT02310750|467444256|FG000|HP Period 1|Withdrawal by Subject|1|||
129859675|NCT02310750|467444257|FG001|HP Period 1|Withdrawal by Subject|0|||
129859676|NCT02310750|467444258|FG002|HP Period 1|Withdrawal by Subject|0|||
129859677|NCT02310750|467444259|FG003|HP Period 1|Withdrawal by Subject|1|||
129859678|NCT02310750|467444260|FG004|HP Period 1|Withdrawal by Subject|0|||
129859679|NCT02310750|467444261|FG005|HP Period 1|Withdrawal by Subject|0|||
129859680|NCT02310750|467444262|FG006|HP Period 1|Withdrawal by Subject|0|||
129910477|NCT01248936|467635347|FG000|Overall Study|Other reason|3|||
129910478|NCT04556981|467635348|FG000|Overall Study|Death|0|||
129859681|NCT02310750|467444263|FG007|HP Period 1|Withdrawal by Subject|0|||
129859682|NCT02310750|467444264|FG008|HP Period 1|Withdrawal by Subject|0|||
129859683|NCT02310750|467444265|FG009|HP Period 1|Withdrawal by Subject|0|||
129859684|NCT02310750|467444266|FG010|HP Period 1|Withdrawal by Subject|0|||
129859685|NCT02310750|467444267|FG011|HP Period 1|Withdrawal by Subject|0|||
129859686|NCT02310750|467444268|FG012|HP Period 1|Withdrawal by Subject|0|||
129859687|NCT02310750|467444269|FG013|HP Period 1|Withdrawal by Subject|0|||
129859688|NCT02310750|467444270|FG014|HP Period 1|Withdrawal by Subject|0|||
129859689|NCT02310750|467444271|FG015|HP Period 1|Withdrawal by Subject|0|||
129859690|NCT02310750|467444256|FG000|HP Washout 1|Lost to Follow-up|0|||
129859691|NCT02310750|467444257|FG001|HP Washout 1|Lost to Follow-up|0|||
129859692|NCT02310750|467444258|FG002|HP Washout 1|Lost to Follow-up|1|||
129859693|NCT02310750|467444259|FG003|HP Washout 1|Lost to Follow-up|1|||
129859694|NCT02310750|467444260|FG004|HP Washout 1|Lost to Follow-up|2|||
129859695|NCT02310750|467444261|FG005|HP Washout 1|Lost to Follow-up|2|||
129859696|NCT02310750|467444262|FG006|HP Washout 1|Lost to Follow-up|3|||
129859697|NCT02310750|467444263|FG007|HP Washout 1|Lost to Follow-up|0|||
129859698|NCT02310750|467444264|FG008|HP Washout 1|Lost to Follow-up|0|||
129859699|NCT02310750|467444265|FG009|HP Washout 1|Lost to Follow-up|0|||
129859700|NCT02310750|467444266|FG010|HP Washout 1|Lost to Follow-up|0|||
129859701|NCT02310750|467444267|FG011|HP Washout 1|Lost to Follow-up|0|||
129859702|NCT02310750|467444268|FG012|HP Washout 1|Lost to Follow-up|0|||
129859703|NCT02310750|467444269|FG013|HP Washout 1|Lost to Follow-up|0|||
129859704|NCT02310750|467444270|FG014|HP Washout 1|Lost to Follow-up|0|||
129859705|NCT02310750|467444271|FG015|HP Washout 1|Lost to Follow-up|0|||
129859706|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859707|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859708|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859709|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
129859710|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859711|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
129859712|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859713|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859714|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
129859715|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
129859716|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859717|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859718|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859719|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859720|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859721|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859722|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859723|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859724|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859725|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859726|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859727|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859728|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859729|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859730|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859731|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
129859732|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859733|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859734|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859735|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859736|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859737|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859738|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859739|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859740|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859741|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859742|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859743|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859744|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859745|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
129859746|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
129859747|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
129859748|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859749|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859750|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859751|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859752|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859753|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859754|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859755|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859756|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859757|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859758|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859759|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859760|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859761|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
129859762|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
129859763|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859764|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859765|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859766|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859767|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859768|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859769|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859770|NCT02310750|467444256|FG000|HP Washout 2|Lost to Follow-up|0|||
129859771|NCT02310750|467444257|FG001|HP Washout 2|Lost to Follow-up|0|||
129859772|NCT02310750|467444258|FG002|HP Washout 2|Lost to Follow-up|0|||
129859773|NCT02310750|467444259|FG003|HP Washout 2|Lost to Follow-up|0|||
129859774|NCT02310750|467444260|FG004|HP Washout 2|Lost to Follow-up|1|||
129859775|NCT02310750|467444261|FG005|HP Washout 2|Lost to Follow-up|0|||
129859776|NCT02310750|467444262|FG006|HP Washout 2|Lost to Follow-up|7|||
129859777|NCT02310750|467444263|FG007|HP Washout 2|Lost to Follow-up|0|||
129859778|NCT02310750|467444264|FG008|HP Washout 2|Lost to Follow-up|0|||
129859779|NCT02310750|467444265|FG009|HP Washout 2|Lost to Follow-up|0|||
129859780|NCT02310750|467444266|FG010|HP Washout 2|Lost to Follow-up|0|||
129859781|NCT02310750|467444267|FG011|HP Washout 2|Lost to Follow-up|0|||
129859782|NCT02310750|467444268|FG012|HP Washout 2|Lost to Follow-up|0|||
129859783|NCT02310750|467444269|FG013|HP Washout 2|Lost to Follow-up|0|||
129859784|NCT02310750|467444270|FG014|HP Washout 2|Lost to Follow-up|0|||
129859785|NCT02310750|467444271|FG015|HP Washout 2|Lost to Follow-up|0|||
129859786|NCT01226745|467444272|FG000|Overall Study|Did not complete schedule of assessments|8|||
129859787|NCT01226745|467444273|FG001|Overall Study|Did not complete schedule of assessments|3|||
129859788|NCT01226745|467444274|FG002|Overall Study|Did not complete schedule of assessments|6|||
129859789|NCT01226745|467444275|FG003|Overall Study|Did not complete schedule of assessments|0|||
129859790|NCT01226745|467444276|FG004|Overall Study|Did not complete schedule of assessments|0|||
129859791|NCT01226745|467444277|FG005|Overall Study|Did not complete schedule of assessments|1|||
129859792|NCT01226745|467444272|FG000|Overall Study|Lost to Follow-up|2|||
129859793|NCT01226745|467444273|FG001|Overall Study|Lost to Follow-up|6|||
129859794|NCT01226745|467444274|FG002|Overall Study|Lost to Follow-up|6|||
129859795|NCT01226745|467444275|FG003|Overall Study|Lost to Follow-up|1|||
129859796|NCT01226745|467444276|FG004|Overall Study|Lost to Follow-up|1|||
129859797|NCT01226745|467444277|FG005|Overall Study|Lost to Follow-up|2|||
129859798|NCT01226745|467444272|FG000|Overall Study|Death|1|||
129859799|NCT01226745|467444273|FG001|Overall Study|Death|0|||
129859800|NCT01226745|467444274|FG002|Overall Study|Death|0|||
129859801|NCT01226745|467444275|FG003|Overall Study|Death|0|||
129859802|NCT01226745|467444276|FG004|Overall Study|Death|0|||
129859803|NCT01226745|467444277|FG005|Overall Study|Death|1|||
129859804|NCT01226745|467444272|FG000|Overall Study|Other|6|||
129859805|NCT01226745|467444273|FG001|Overall Study|Other|7|||
129859806|NCT01226745|467444274|FG002|Overall Study|Other|8|||
129859807|NCT01226745|467444275|FG003|Overall Study|Other|4|||
129859808|NCT01226745|467444276|FG004|Overall Study|Other|3|||
129859809|NCT01226745|467444277|FG005|Overall Study|Other|1|||
129859810|NCT01435577|467444280|FG000|Overall Study|Adverse Event|10|||
129859811|NCT01435577|467444281|FG001|Overall Study|Adverse Event|0|||
129859812|NCT01435577|467444280|FG000|Overall Study|Lack of Efficacy|7|||
129859813|NCT01435577|467444281|FG001|Overall Study|Lack of Efficacy|51|||
129859814|NCT01435577|467444280|FG000|Overall Study|Alternative treatment started|0|||
129859815|NCT01435577|467444281|FG001|Overall Study|Alternative treatment started|1|||
129859816|NCT00718718|467444282|FG000|Prior to Week 12|Adverse Event|0|||
129859817|NCT00718718|467444283|FG001|Prior to Week 12|Adverse Event|0|||
129859818|NCT00718718|467444284|FG002|Prior to Week 12|Adverse Event|0|||
129859819|NCT00718718|467444285|FG003|Prior to Week 12|Adverse Event|0|||
129859820|NCT00718718|467444286|FG004|Prior to Week 12|Adverse Event|0|||
129859821|NCT00718718|467444287|FG005|Prior to Week 12|Adverse Event|0|||
129859822|NCT00718718|467444288|FG006|Prior to Week 12|Adverse Event|0|||
129859823|NCT00718718|467444289|FG007|Prior to Week 12|Adverse Event|1|||
129859824|NCT00718718|467444290|FG008|Prior to Week 12|Adverse Event|1|||
129859825|NCT00718718|467444291|FG009|Prior to Week 12|Adverse Event|0|||
129859826|NCT00718718|467444282|FG000|Prior to Week 12|Withdrawal by Subject|0|||
129859827|NCT00718718|467444283|FG001|Prior to Week 12|Withdrawal by Subject|0|||
129859828|NCT00718718|467444284|FG002|Prior to Week 12|Withdrawal by Subject|0|||
129859829|NCT00718718|467444285|FG003|Prior to Week 12|Withdrawal by Subject|0|||
129859830|NCT00718718|467444286|FG004|Prior to Week 12|Withdrawal by Subject|3|||
129859831|NCT00718718|467444287|FG005|Prior to Week 12|Withdrawal by Subject|0|||
129859832|NCT00718718|467444288|FG006|Prior to Week 12|Withdrawal by Subject|1|||
129859833|NCT00718718|467444289|FG007|Prior to Week 12|Withdrawal by Subject|1|||
129859834|NCT00718718|467444290|FG008|Prior to Week 12|Withdrawal by Subject|1|||
129859835|NCT00718718|467444291|FG009|Prior to Week 12|Withdrawal by Subject|0|||
129859836|NCT00718718|467444282|FG000|Prior to Week 12|Other|1|||
129859837|NCT00718718|467444283|FG001|Prior to Week 12|Other|0|||
129859838|NCT00718718|467444284|FG002|Prior to Week 12|Other|1|||
129859839|NCT00718718|467444285|FG003|Prior to Week 12|Other|0|||
129859840|NCT00718718|467444286|FG004|Prior to Week 12|Other|0|||
129859841|NCT00718718|467444287|FG005|Prior to Week 12|Other|0|||
129859842|NCT00718718|467444288|FG006|Prior to Week 12|Other|0|||
129859843|NCT00718718|467444289|FG007|Prior to Week 12|Other|0|||
129859844|NCT00718718|467444290|FG008|Prior to Week 12|Other|0|||
129859845|NCT00718718|467444291|FG009|Prior to Week 12|Other|0|||
129859846|NCT00718718|467444282|FG000|Week 12 to End of Study|Adverse Event|0|||
129859847|NCT00718718|467444283|FG001|Week 12 to End of Study|Adverse Event|0|||
129859848|NCT00718718|467444284|FG002|Week 12 to End of Study|Adverse Event|0|||
129859849|NCT00718718|467444285|FG003|Week 12 to End of Study|Adverse Event|0|||
129859850|NCT00718718|467444286|FG004|Week 12 to End of Study|Adverse Event|0|||
129859851|NCT00718718|467444287|FG005|Week 12 to End of Study|Adverse Event|0|||
129859852|NCT00718718|467444288|FG006|Week 12 to End of Study|Adverse Event|0|||
129859853|NCT00718718|467444289|FG007|Week 12 to End of Study|Adverse Event|1|||
129859854|NCT00718718|467444290|FG008|Week 12 to End of Study|Adverse Event|0|||
129859855|NCT00718718|467444291|FG009|Week 12 to End of Study|Adverse Event|0|||
129859856|NCT00718718|467444282|FG000|Week 12 to End of Study|Death|0|||
129859857|NCT00718718|467444283|FG001|Week 12 to End of Study|Death|0|||
129859858|NCT00718718|467444284|FG002|Week 12 to End of Study|Death|0|||
129859859|NCT00718718|467444285|FG003|Week 12 to End of Study|Death|0|||
129859860|NCT00718718|467444286|FG004|Week 12 to End of Study|Death|0|||
129859861|NCT00718718|467444287|FG005|Week 12 to End of Study|Death|1|||
129859862|NCT00718718|467444288|FG006|Week 12 to End of Study|Death|0|||
129859863|NCT00718718|467444289|FG007|Week 12 to End of Study|Death|0|||
129859864|NCT00718718|467444290|FG008|Week 12 to End of Study|Death|0|||
129859865|NCT00718718|467444291|FG009|Week 12 to End of Study|Death|0|||
129859866|NCT00718718|467444282|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
129859867|NCT00718718|467444283|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
129859868|NCT00718718|467444284|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
129859869|NCT00718718|467444285|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
129859870|NCT00718718|467444286|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
129859871|NCT00718718|467444287|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
129859872|NCT00718718|467444288|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
129859873|NCT00718718|467444289|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
129859874|NCT00718718|467444290|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
129859875|NCT00718718|467444291|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
129859876|NCT00718718|467444282|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
129859877|NCT00718718|467444283|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
129859878|NCT00718718|467444284|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
129859879|NCT00718718|467444285|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
129859880|NCT00718718|467444286|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
129859881|NCT00718718|467444287|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
129859882|NCT00718718|467444288|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
129859883|NCT00718718|467444289|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
129859884|NCT00718718|467444290|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
129859885|NCT00718718|467444291|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
129859886|NCT00718718|467444282|FG000|Week 12 to End of Study|Other|0|||
129859887|NCT00718718|467444283|FG001|Week 12 to End of Study|Other|1|||
129859888|NCT00718718|467444284|FG002|Week 12 to End of Study|Other|0|||
129859889|NCT00718718|467444285|FG003|Week 12 to End of Study|Other|1|||
129859890|NCT00718718|467444286|FG004|Week 12 to End of Study|Other|0|||
129859891|NCT00718718|467444287|FG005|Week 12 to End of Study|Other|0|||
129859892|NCT00718718|467444288|FG006|Week 12 to End of Study|Other|1|||
129859893|NCT00718718|467444289|FG007|Week 12 to End of Study|Other|0|||
129859894|NCT00718718|467444290|FG008|Week 12 to End of Study|Other|0|||
129859895|NCT00718718|467444291|FG009|Week 12 to End of Study|Other|0|||
129859896|NCT02715765|467444302|FG000|Overall Study|Study Termination|3|||
129859897|NCT02715765|467444303|FG001|Overall Study|Study Termination|0|||
129859898|NCT02715765|467444304|FG002|Overall Study|Study Termination|0|||
129859899|NCT01462344|467444305|FG000|Overall Study|Withdrawal by Subject|245|||
129859900|NCT01462344|467444306|FG001|Overall Study|Withdrawal by Subject|226|||
129859901|NCT01462344|467444305|FG000|Overall Study|Adverse Event|24|||
129859902|NCT01462344|467444306|FG001|Overall Study|Adverse Event|23|||
129859903|NCT01462344|467444305|FG000|Overall Study|Asthma Exacerbation|34|||
129859904|NCT01462344|467444306|FG001|Overall Study|Asthma Exacerbation|35|||
129859905|NCT01462344|467444305|FG000|Overall Study|Lack of Efficacy|5|||
129859906|NCT01462344|467444306|FG001|Overall Study|Lack of Efficacy|6|||
129859907|NCT01462344|467444305|FG000|Overall Study|Protocol Violation|68|||
129859908|NCT01462344|467444306|FG001|Overall Study|Protocol Violation|53|||
129859909|NCT01462344|467444305|FG000|Overall Study|Lost to Follow-up|7|||
129859910|NCT01462344|467444306|FG001|Overall Study|Lost to Follow-up|7|||
129859911|NCT03387852|467444307|FG000|Overall Study|Adverse event (AE)|3|||
129859912|NCT03387852|467444308|FG001|Overall Study|Adverse event (AE)|0|||
129859913|NCT03387852|467444309|FG002|Overall Study|Adverse event (AE)|2|||
129859914|NCT03387852|467444310|FG003|Overall Study|Adverse event (AE)|0|||
129859915|NCT03387852|467444307|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
129859916|NCT03387852|467444308|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
129859917|NCT03387852|467444309|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
129859918|NCT03387852|467444310|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
129859919|NCT03387852|467444307|FG000|Overall Study|Withdrawal by participant|1|||
129859920|NCT03387852|467444308|FG001|Overall Study|Withdrawal by participant|1|||
129859921|NCT03387852|467444309|FG002|Overall Study|Withdrawal by participant|3|||
129859922|NCT03387852|467444310|FG003|Overall Study|Withdrawal by participant|2|||
129859923|NCT03387852|467444307|FG000|Overall Study|Other- Unspecified|1|||
129859924|NCT03387852|467444308|FG001|Overall Study|Other- Unspecified|1|||
129859925|NCT03387852|467444309|FG002|Overall Study|Other- Unspecified|2|||
129859926|NCT03387852|467444310|FG003|Overall Study|Other- Unspecified|1|||
129859927|NCT03387852|467444307|FG000|Overall Study|Poor compliance to protocol|0|||
129859928|NCT03387852|467444308|FG001|Overall Study|Poor compliance to protocol|0|||
129859929|NCT03387852|467444309|FG002|Overall Study|Poor compliance to protocol|0|||
129859930|NCT03387852|467444310|FG003|Overall Study|Poor compliance to protocol|1|||
129859931|NCT03387852|467444307|FG000|Overall Study|Randomized and not treated|0|||
129859932|NCT03387852|467444308|FG001|Overall Study|Randomized and not treated|0|||
129859933|NCT03387852|467444309|FG002|Overall Study|Randomized and not treated|0|||
129859934|NCT03387852|467444310|FG003|Overall Study|Randomized and not treated|1|||
129859935|NCT04177758|467444311|FG000|Overall Study|Lost to Follow-up|19|||
129859936|NCT04177758|467444312|FG001|Overall Study|Lost to Follow-up|11|||
129859937|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
129859938|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
129859939|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
129859940|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
129859941|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
129859942|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
129859943|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
129859944|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
129859945|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
129859946|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
129859947|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
129859948|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
129859949|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
129859950|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
129859951|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
129859952|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
129859953|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
129859954|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
129859955|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
129859956|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
129859957|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
129859958|NCT01781572|467444313|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
129859959|NCT01781572|467444314|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
129859960|NCT01781572|467444315|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
129859961|NCT01781572|467444313|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
129859962|NCT01781572|467444314|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
129859963|NCT01781572|467444315|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
129859964|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
129859965|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
129859966|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
129859967|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
129859968|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
129910479|NCT04556981|467635349|FG001|Overall Study|Death|1|||
129859969|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
129859970|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
129859971|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
129859972|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
129859973|NCT01781572|467444313|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
129859974|NCT01781572|467444314|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
129859975|NCT01781572|467444315|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
129859976|NCT01781572|467444313|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
129859977|NCT01781572|467444314|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
129859978|NCT01781572|467444315|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
130064742|NCT00077376|468190273|FG000|Overall Study|Complicating disease|1|||
130064743|NCT00077376|468190273|FG000|Overall Study|Still on treatment|1|||
130064744|NCT00077376|468190273|FG000|Overall Study|Symptomatic deterioration|1|||
130064745|NCT00077376|468190273|FG000|Overall Study|Surgery|1|||
130064746|NCT00077376|468190273|FG000|Overall Study|Insurance ran out|1|||
130064747|NCT03288493|468190274|FG000|Overall Study|Withdrawal by Subject|4|||
129859979|NCT01781572|467444313|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
129859980|NCT01781572|467444314|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
129859981|NCT01781572|467444315|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
129859982|NCT01781572|467444313|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
129859983|NCT01781572|467444314|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
129859984|NCT01781572|467444315|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
129859985|NCT01781572|467444313|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
129859986|NCT01781572|467444314|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
129859987|NCT01781572|467444315|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
129859988|NCT01781572|467444313|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
129859989|NCT01781572|467444314|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
129859990|NCT01781572|467444315|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
129859991|NCT03156023|467444316|FG000|Overall Study|Withdrawal by Subject|1|||
129859992|NCT03156023|467444317|FG001|Overall Study|Withdrawal by Subject|0|||
129859993|NCT03156023|467444318|FG002|Overall Study|Withdrawal by Subject|2|||
129859994|NCT03156023|467444319|FG003|Overall Study|Withdrawal by Subject|1|||
129859995|NCT03156023|467444320|FG004|Overall Study|Withdrawal by Subject|1|||
129859996|NCT03156023|467444316|FG000|Overall Study|Lost to Follow-up|0|||
129859997|NCT03156023|467444317|FG001|Overall Study|Lost to Follow-up|0|||
129859998|NCT03156023|467444318|FG002|Overall Study|Lost to Follow-up|0|||
129859999|NCT03156023|467444319|FG003|Overall Study|Lost to Follow-up|0|||
129860000|NCT03156023|467444320|FG004|Overall Study|Lost to Follow-up|1|||
129860001|NCT00726752|467444321|FG000|Overall Study|Lack of Efficacy|6|||
129860002|NCT04827576|467445554|FG000|Overall Study|Death|5|||
129860003|NCT04827576|467445555|FG001|Overall Study|Death|17|||
129860004|NCT04827576|467445556|FG002|Overall Study|Death|17|||
129860005|NCT04827576|467445557|FG003|Overall Study|Death|32|||
129860006|NCT04827576|467445554|FG000|Overall Study|Study Terminated by Sponsor|2|||
129860007|NCT04827576|467445555|FG001|Overall Study|Study Terminated by Sponsor|9|||
129860008|NCT04827576|467445556|FG002|Overall Study|Study Terminated by Sponsor|7|||
129860009|NCT04827576|467445557|FG003|Overall Study|Study Terminated by Sponsor|5|||
129860010|NCT04827576|467445554|FG000|Overall Study|Investigator's Discretion|1|||
129860011|NCT04827576|467445555|FG001|Overall Study|Investigator's Discretion|0|||
129860012|NCT04827576|467445556|FG002|Overall Study|Investigator's Discretion|2|||
129860013|NCT04827576|467445557|FG003|Overall Study|Investigator's Discretion|5|||
129860014|NCT04827576|467445554|FG000|Overall Study|Withdrew Consent|0|||
129860015|NCT04827576|467445555|FG001|Overall Study|Withdrew Consent|3|||
129860016|NCT04827576|467445556|FG002|Overall Study|Withdrew Consent|0|||
129860017|NCT04827576|467445557|FG003|Overall Study|Withdrew Consent|0|||
129860018|NCT04827576|467445554|FG000|Overall Study|Lost to Follow-up|1|||
129860019|NCT04827576|467445555|FG001|Overall Study|Lost to Follow-up|0|||
129860020|NCT04827576|467445556|FG002|Overall Study|Lost to Follow-up|0|||
129860021|NCT04827576|467445557|FG003|Overall Study|Lost to Follow-up|0|||
129860022|NCT01261611|467445558|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
129860023|NCT01261611|467445559|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
129860024|NCT01261611|467445560|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
129860025|NCT01261611|467445558|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
130064748|NCT03288493|468190275|FG001|Overall Study|Withdrawal by Subject|0|||
129860026|NCT01261611|467445559|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
129860027|NCT01261611|467445560|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
129860028|NCT01261611|467445558|FG000|Treatment Cycle 1|Adverse Event|0|||
130064749|NCT03288493|468190276|FG002|Overall Study|Withdrawal by Subject|0|||
129860029|NCT01261611|467445559|FG001|Treatment Cycle 1|Adverse Event|1|||
129860030|NCT01261611|467445560|FG002|Treatment Cycle 1|Adverse Event|0|||
129860031|NCT01261611|467445558|FG000|Treatment Cycle 1|Protocol Violation|0|||
129860032|NCT01261611|467445559|FG001|Treatment Cycle 1|Protocol Violation|0|||
129860033|NCT01261611|467445560|FG002|Treatment Cycle 1|Protocol Violation|2|||
129860034|NCT01261611|467445558|FG000|Treatment Cycle 2|Completed study|4|||
129860035|NCT01261611|467445559|FG001|Treatment Cycle 2|Completed study|0|||
129860036|NCT01261611|467445560|FG002|Treatment Cycle 2|Completed study|0|||
129860037|NCT01261611|467445558|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
129860038|NCT01261611|467445559|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
129860039|NCT01261611|467445560|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
129860040|NCT01261611|467445558|FG000|Treatment Cycle 2|Adverse Event|1|||
129860041|NCT01261611|467445559|FG001|Treatment Cycle 2|Adverse Event|0|||
129860042|NCT01261611|467445560|FG002|Treatment Cycle 2|Adverse Event|0|||
129860043|NCT01261611|467445558|FG000|Treatment Cycle 2|Protocol Violation|2|||
129860044|NCT01261611|467445559|FG001|Treatment Cycle 2|Protocol Violation|0|||
130064750|NCT03288493|468190277|FG003|Overall Study|Withdrawal by Subject|0|||
130064751|NCT03288493|468190278|FG004|Overall Study|Withdrawal by Subject|0|||
129860045|NCT01261611|467445560|FG002|Treatment Cycle 2|Protocol Violation|0|||
129860046|NCT01261611|467445558|FG000|Treatment Cycle 2|Not otherwise specified|2|||
129860047|NCT01261611|467445559|FG001|Treatment Cycle 2|Not otherwise specified|0|||
129860048|NCT01261611|467445560|FG002|Treatment Cycle 2|Not otherwise specified|0|||
129860049|NCT01261611|467445558|FG000|Treatment Cycle 3|Completed study|24|||
129860050|NCT01261611|467445559|FG001|Treatment Cycle 3|Completed study|0|||
129860051|NCT01261611|467445560|FG002|Treatment Cycle 3|Completed study|0|||
129860052|NCT01261611|467445558|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
129860053|NCT01261611|467445559|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
129860054|NCT01261611|467445560|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
129860055|NCT01261611|467445558|FG000|Treatment Cycle 3|Adverse Event|1|||
129860056|NCT01261611|467445559|FG001|Treatment Cycle 3|Adverse Event|0|||
129860057|NCT01261611|467445560|FG002|Treatment Cycle 3|Adverse Event|0|||
129860058|NCT01261611|467445558|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
129860059|NCT01261611|467445559|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
129860060|NCT01261611|467445560|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
129860061|NCT01261611|467445558|FG000|Treatment Cycle 4|Completed study|87|||
129860062|NCT01261611|467445559|FG001|Treatment Cycle 4|Completed study|0|||
129860063|NCT01261611|467445560|FG002|Treatment Cycle 4|Completed study|0|||
129860064|NCT01261611|467445558|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
129860065|NCT01261611|467445559|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
129860066|NCT01261611|467445560|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
129860067|NCT01261611|467445558|FG000|Treatment Cycle 4|Adverse Event|1|||
129860068|NCT01261611|467445559|FG001|Treatment Cycle 4|Adverse Event|0|||
129860069|NCT01261611|467445560|FG002|Treatment Cycle 4|Adverse Event|0|||
129860070|NCT01261611|467445558|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
129860071|NCT01261611|467445559|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
129860072|NCT01261611|467445560|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
129860073|NCT01261611|467445558|FG000|Treatment Cycle 4|Not otherwise specified|3|||
129860074|NCT01261611|467445559|FG001|Treatment Cycle 4|Not otherwise specified|0|||
129860075|NCT01261611|467445560|FG002|Treatment Cycle 4|Not otherwise specified|0|||
129860076|NCT01261611|467445558|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
129860077|NCT01261611|467445559|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
129860078|NCT01261611|467445560|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
129860079|NCT01261611|467445558|FG000|Treatment Cycle 5|Adverse Event|1|||
129860080|NCT01261611|467445559|FG001|Treatment Cycle 5|Adverse Event|0|||
129860081|NCT01261611|467445560|FG002|Treatment Cycle 5|Adverse Event|0|||
129860082|NCT01261611|467445558|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
129860083|NCT01261611|467445559|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
129860084|NCT01261611|467445560|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
129860085|NCT02527798|467445561|FG000|Overall Study|Physician Decision|1|||
129860086|NCT02527798|467445562|FG001|Overall Study|Physician Decision|0|||
129860087|NCT02527798|467445563|FG002|Overall Study|Physician Decision|1|||
129860088|NCT02527798|467445564|FG003|Overall Study|Physician Decision|1|||
129860089|NCT02527798|467445565|FG004|Overall Study|Physician Decision|0|||
129860090|NCT02527798|467445566|FG005|Overall Study|Physician Decision|0|||
129860091|NCT02527798|467445561|FG000|Overall Study|Death|0|||
129860092|NCT02527798|467445562|FG001|Overall Study|Death|0|||
129860093|NCT02527798|467445563|FG002|Overall Study|Death|1|||
129860094|NCT02527798|467445564|FG003|Overall Study|Death|0|||
129860095|NCT02527798|467445565|FG004|Overall Study|Death|0|||
129860096|NCT02527798|467445566|FG005|Overall Study|Death|0|||
129860097|NCT02527798|467445561|FG000|Overall Study|Withdrawal by Subject|0|||
129860098|NCT02527798|467445562|FG001|Overall Study|Withdrawal by Subject|1|||
129860099|NCT02527798|467445563|FG002|Overall Study|Withdrawal by Subject|2|||
129860100|NCT02527798|467445564|FG003|Overall Study|Withdrawal by Subject|0|||
129860101|NCT02527798|467445565|FG004|Overall Study|Withdrawal by Subject|0|||
129860102|NCT02527798|467445566|FG005|Overall Study|Withdrawal by Subject|0|||
129860103|NCT02527798|467445561|FG000|Overall Study|Reason undisclosed|1|||
129860104|NCT02527798|467445562|FG001|Overall Study|Reason undisclosed|0|||
129860105|NCT02527798|467445563|FG002|Overall Study|Reason undisclosed|1|||
129860106|NCT02527798|467445564|FG003|Overall Study|Reason undisclosed|0|||
129860107|NCT02527798|467445565|FG004|Overall Study|Reason undisclosed|0|||
129860108|NCT02527798|467445566|FG005|Overall Study|Reason undisclosed|0|||
129910480|NCT04556981|467635348|FG000|Overall Study|Lost to Follow-up|2|||
129860109|NCT02527798|467445561|FG000|Overall Study|Did not receive intervention|1|||
129860110|NCT02527798|467445562|FG001|Overall Study|Did not receive intervention|1|||
129860111|NCT02527798|467445563|FG002|Overall Study|Did not receive intervention|0|||
129860112|NCT02527798|467445564|FG003|Overall Study|Did not receive intervention|0|||
129860113|NCT02527798|467445565|FG004|Overall Study|Did not receive intervention|0|||
129860114|NCT02527798|467445566|FG005|Overall Study|Did not receive intervention|0|||
129860115|NCT02891187|467445568|FG000|Overall Study|Lost to Follow-up|1|||
129860116|NCT02891187|467445569|FG001|Overall Study|Lost to Follow-up|2|||
129860117|NCT02395120|467445572|FG000|Overall Study|Missed follow-up dental exam|57|||
129860118|NCT02395120|467445573|FG001|Overall Study|Missed follow-up dental exam|62|||
129860119|NCT02395120|467445574|FG002|Overall Study|Missed follow-up dental exam|6|||
129860120|NCT02395120|467445575|FG003|Overall Study|Missed follow-up dental exam|6|||
129910481|NCT04556981|467635349|FG001|Overall Study|Lost to Follow-up|11|||
130064752|NCT03288493|468190279|FG005|Overall Study|Withdrawal by Subject|2|||
130064753|NCT03288493|468190280|FG006|Overall Study|Withdrawal by Subject|0|||
129860121|NCT02395120|467445576|FG004|Overall Study|Missed follow-up dental exam|51|||
129860122|NCT00674986|467445577|FG000|Overall Study|Adverse Event|2|||
129860123|NCT00674986|467445578|FG001|Overall Study|Adverse Event|1|||
129860124|NCT00674986|467445577|FG000|Overall Study|Subject withdrew consent|12|||
129860125|NCT00674986|467445578|FG001|Overall Study|Subject withdrew consent|19|||
129860126|NCT00674986|467445577|FG000|Overall Study|Lost to Follow-up|25|||
129860127|NCT00674986|467445578|FG001|Overall Study|Lost to Follow-up|53|||
129860128|NCT00674986|467445577|FG000|Overall Study|Other reasons|4|||
129860129|NCT00674986|467445578|FG001|Overall Study|Other reasons|8|||
129860130|NCT04546581|467445584|FG000|Overall Study|Adverse Event|9|||
129860131|NCT04546581|467445585|FG001|Overall Study|Adverse Event|3|||
129860132|NCT04546581|467445584|FG000|Overall Study|Physician Decision|0|||
129860133|NCT04546581|467445585|FG001|Overall Study|Physician Decision|1|||
129860134|NCT04546581|467445584|FG000|Overall Study|Protocol Violation|1|||
129860135|NCT04546581|467445585|FG001|Overall Study|Protocol Violation|2|||
129860136|NCT04546581|467445584|FG000|Overall Study|Withdrawal by Subject|3|||
129860137|NCT04546581|467445585|FG001|Overall Study|Withdrawal by Subject|7|||
129860138|NCT02526693|467445586|FG000|Overall Study|Physician Decision|3|||
129860139|NCT02526693|467445587|FG001|Overall Study|Physician Decision|1|||
129860140|NCT01983293|467445588|FG000|Overall Study|Withdrawal by Subject|29|||
129860141|NCT01983293|467445589|FG001|Overall Study|Withdrawal by Subject|15|||
129860142|NCT01983293|467445588|FG000|Overall Study|Missing 12-month visit|3|||
129860143|NCT01983293|467445589|FG001|Overall Study|Missing 12-month visit|3|||
129860144|NCT01983293|467445588|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
129860145|NCT01983293|467445589|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
129860146|NCT01275625|467445590|FG000|Overall Study|Death|1|||
129860147|NCT01275625|467445590|FG000|Overall Study|Lack of Efficacy|2|||
129860148|NCT01275625|467445590|FG000|Overall Study|Lost to Follow-up|1|||
129860149|NCT01275625|467445590|FG000|Overall Study|Withdrawal by Subject|3|||
129860150|NCT01275625|467445590|FG000|Overall Study|Protocol Violation|1|||
129860151|NCT01275625|467445590|FG000|Overall Study|Adverse Event|4|||
129860152|NCT01275625|467445590|FG000|Overall Study|Other|1|||
129860153|NCT01585103|467445592|FG000|Overall Study|Unable to swallow Cytosponge|6|||
129860154|NCT01349569|467445594|FG000|Overall Study|Lack of Efficacy|4|||
129860155|NCT03581305|467445595|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
129860156|NCT03581305|467445596|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
129860157|NCT03581305|467445595|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
129860158|NCT03581305|467445596|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
129860159|NCT03581305|467445595|FG000|Serotonergic Study|Withdrawal by Subject|5|||
129860160|NCT03581305|467445596|FG001|Serotonergic Study|Withdrawal by Subject|1|||
129860161|NCT01798927|467445599|FG000|Overall Study|Withdrawal by Subject|1|||
129860162|NCT03750552|467445600|FG000|Overall Study|Adverse Event|5|||
129860163|NCT03750552|467445601|FG001|Overall Study|Adverse Event|1|||
129860164|NCT03750552|467445600|FG000|Overall Study|Withdrawal by Subject|1|||
129860165|NCT03750552|467445601|FG001|Overall Study|Withdrawal by Subject|1|||
129860166|NCT03750552|467445600|FG000|Overall Study|Other|2|||
129860167|NCT03750552|467445601|FG001|Overall Study|Other|0|||
129860168|NCT02280044|467445602|FG000|Overall Study|Planned alternate|0|||
129860169|NCT02280044|467445603|FG001|Overall Study|Planned alternate|2|||
129860170|NCT01944631|467445606|FG000|Overall Study|Adverse Event|1|||
129860171|NCT01944631|467445607|FG001|Overall Study|Adverse Event|0|||
129860172|NCT01944631|467445606|FG000|Overall Study|Lost to Follow-up|3|||
129860173|NCT01944631|467445607|FG001|Overall Study|Lost to Follow-up|1|||
129860174|NCT01944631|467445606|FG000|Overall Study|Withdrawal by Subject|0|||
129860175|NCT01944631|467445607|FG001|Overall Study|Withdrawal by Subject|1|||
129860176|NCT01003899|467445608|FG000|Overall Study|Other Adverse Event|8|||
129860177|NCT01003899|467445608|FG000|Overall Study|Not entered|4|||
129860178|NCT01003899|467445608|FG000|Overall Study|Not treated|1|||
129860179|NCT01003899|467445608|FG000|Overall Study|Progressive disease|34|||
129860180|NCT03822533|467445610|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
129860181|NCT03822533|467445611|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
129860182|NCT03822533|467445610|FG000|3 Month Follow-up|Lost to Follow-up|2|||
129860183|NCT03822533|467445611|FG001|3 Month Follow-up|Lost to Follow-up|2|||
129860184|NCT03822533|467445610|FG000|6 Month Follow-up|Lost to Follow-up|3|||
129860185|NCT03822533|467445611|FG001|6 Month Follow-up|Lost to Follow-up|0|||
129860186|NCT03822533|467445610|FG000|12 Month Follow-up|Lost to Follow-up|2|||
129860187|NCT03822533|467445611|FG001|12 Month Follow-up|Lost to Follow-up|3|||
129860188|NCT03822533|467445610|FG000|12 Month Follow-up|Pregnancy|0|||
129860189|NCT03822533|467445611|FG001|12 Month Follow-up|Pregnancy|1|||
129860190|NCT03822533|467445610|FG000|12 Month Follow-up|Surgery|2|||
129860191|NCT03822533|467445611|FG001|12 Month Follow-up|Surgery|0|||
129860192|NCT03822533|467445610|FG000|12 Month Follow-up|Wrong address|1|||
129860193|NCT03822533|467445611|FG001|12 Month Follow-up|Wrong address|0|||
129860194|NCT03822533|467445610|FG000|12 Month Follow-up|No symptoms|1|||
129860195|NCT03822533|467445611|FG001|12 Month Follow-up|No symptoms|0|||
129860196|NCT03822533|467445610|FG000|12 Month Follow-up|Changed primary care center|0|||
129860197|NCT03822533|467445611|FG001|12 Month Follow-up|Changed primary care center|1|||
129860198|NCT02489500|467445612|FG000|Overall Study|Death|1|||
129860199|NCT02489500|467445613|FG001|Overall Study|Death|1|||
129860200|NCT01412944|467445615|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860201|NCT01412944|467445616|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860202|NCT01412944|467445617|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
129860203|NCT01412944|467445618|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860204|NCT01412944|467445619|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860205|NCT01412944|467445620|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860206|NCT01412944|467445615|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860207|NCT01412944|467445616|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860208|NCT01412944|467445617|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860209|NCT01412944|467445618|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860210|NCT01412944|467445619|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860211|NCT01412944|467445620|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
129860212|NCT01412944|467445615|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860213|NCT01412944|467445616|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860214|NCT01412944|467445617|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860215|NCT01412944|467445618|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860216|NCT01412944|467445619|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860217|NCT01412944|467445620|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
129860218|NCT01412944|467445615|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
129860219|NCT01412944|467445616|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860220|NCT01412944|467445617|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860221|NCT01412944|467445618|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860222|NCT01412944|467445619|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860223|NCT01412944|467445620|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860224|NCT01412944|467445615|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
129860225|NCT01412944|467445616|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
129860226|NCT01412944|467445617|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
129860227|NCT01412944|467445618|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
129860228|NCT01412944|467445619|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
129860229|NCT01412944|467445620|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
129860230|NCT01412944|467445615|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860231|NCT01412944|467445616|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
129860232|NCT01412944|467445617|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860233|NCT01412944|467445618|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860234|NCT01412944|467445619|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860235|NCT01412944|467445620|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860236|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860237|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860238|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860239|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860240|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860241|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860242|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Adverse Event|0|||
129860243|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Adverse Event|0|||
129860244|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Adverse Event|0|||
129860245|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Adverse Event|0|||
129860246|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Adverse Event|1|||
129860247|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Adverse Event|0|||
129860248|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
129860249|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
129860250|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
129860251|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
129860252|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
129860253|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
129860254|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860255|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860256|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860257|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860258|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860259|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
129860260|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860261|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860262|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860263|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860264|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
129860265|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860266|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
129860267|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860268|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860269|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860270|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860271|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860272|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
129860273|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
129860274|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
129860275|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
129860276|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
129860277|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
129860278|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860279|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
129860280|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860281|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860282|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860283|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860284|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860285|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
129860286|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860287|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860288|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860289|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860290|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Adverse Event|0|||
129860291|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Adverse Event|1|||
129860292|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Adverse Event|0|||
129860293|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Adverse Event|0|||
129860294|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Adverse Event|0|||
129860295|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Adverse Event|0|||
129860296|NCT01990950|467445621|FG000|Overall Study|Death|3|||
129860297|NCT01990950|467445621|FG000|Overall Study|Lost to Follow-up|2|||
129860298|NCT01990950|467445621|FG000|Overall Study|Withdrawal by Subject|6|||
129860299|NCT01259713|467445623|FG000|Overall Study|Adverse Event|54|||
129860300|NCT01259713|467445624|FG001|Overall Study|Adverse Event|23|||
129860301|NCT01259713|467445623|FG000|Overall Study|Death Not Related to IFI|8|||
129860302|NCT01259713|467445624|FG001|Overall Study|Death Not Related to IFI|1|||
129860303|NCT01259713|467445623|FG000|Overall Study|Investigators Discretion|14|||
129860304|NCT01259713|467445624|FG001|Overall Study|Investigators Discretion|6|||
129860305|NCT01259713|467445623|FG000|Overall Study|Lack of Efficacy|2|||
129860306|NCT01259713|467445624|FG001|Overall Study|Lack of Efficacy|0|||
129860307|NCT01259713|467445623|FG000|Overall Study|Protocol Violation|5|||
129860308|NCT01259713|467445624|FG001|Overall Study|Protocol Violation|4|||
129860309|NCT01259713|467445623|FG000|Overall Study|Subject Withdrew Consent|12|||
129860310|NCT01259713|467445624|FG001|Overall Study|Subject Withdrew Consent|7|||
129860311|NCT06111742|467445625|FG000|Overall Study|Did not receive intervention|1|||
129860312|NCT06111742|467445626|FG001|Overall Study|Did not receive intervention|0|||
129860313|NCT06111742|467445627|FG002|Overall Study|Did not receive intervention|0|||
129860314|NCT06111742|467445625|FG000|Overall Study|Withdrawal by Subject|2|||
129860315|NCT06111742|467445626|FG001|Overall Study|Withdrawal by Subject|0|||
129860316|NCT06111742|467445627|FG002|Overall Study|Withdrawal by Subject|0|||
129860317|NCT02473952|467445628|FG000|Overall Study|Adverse Event|2|||
129860318|NCT02473952|467445629|FG001|Overall Study|Adverse Event|2|||
129860319|NCT02473952|467445628|FG000|Overall Study|Withdrawal by Subject|0|||
129860320|NCT02473952|467445629|FG001|Overall Study|Withdrawal by Subject|6|||
129860321|NCT00922428|467445634|FG000|Overall Study|retrospective/extremely implausible data|2|||
129860322|NCT00922428|467445634|FG000|Overall Study|no medication use or questionable use|13|||
129860323|NCT00448539|467445635|FG000|Overall Study|Medication non-compliance|4|||
129860324|NCT00448539|467445636|FG001|Overall Study|Medication non-compliance|1|||
129860325|NCT00448539|467445635|FG000|Overall Study|Protocol Violation|1|||
129860326|NCT00448539|467445636|FG001|Overall Study|Protocol Violation|0|||
129860327|NCT00448539|467445635|FG000|Overall Study|Request of the investigator or sponsor|67|||
129860328|NCT00448539|467445636|FG001|Overall Study|Request of the investigator or sponsor|54|||
129860329|NCT00448539|467445635|FG000|Overall Study|Withdrawal by Subject|20|||
129860330|NCT00448539|467445636|FG001|Overall Study|Withdrawal by Subject|24|||
129860331|NCT00448539|467445635|FG000|Overall Study|Diary non-compliance|1|||
129860332|NCT00448539|467445636|FG001|Overall Study|Diary non-compliance|0|||
130116650|NCT00585351|468387152|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
129860333|NCT00448539|467445635|FG000|Overall Study|Adverse Event|9|||
129860334|NCT00448539|467445636|FG001|Overall Study|Adverse Event|26|||
129860335|NCT00448539|467445635|FG000|Overall Study|Lack of Efficacy|27|||
129860336|NCT00448539|467445636|FG001|Overall Study|Lack of Efficacy|40|||
129860337|NCT00448539|467445635|FG000|Overall Study|Miscellaneous|2|||
129860338|NCT00448539|467445636|FG001|Overall Study|Miscellaneous|1|||
130116651|NCT00585351|468387153|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
129860339|NCT00448539|467445635|FG000|Overall Study|Change of meds|2|||
129860340|NCT00448539|467445636|FG001|Overall Study|Change of meds|3|||
129860341|NCT00448539|467445635|FG000|Overall Study|Lost to Follow-up|1|||
129860342|NCT00448539|467445636|FG001|Overall Study|Lost to Follow-up|3|||
129860343|NCT02103439|467445637|FG000|Overall Study|Adverse Event|0|||
129860344|NCT02103439|467445638|FG001|Overall Study|Adverse Event|2|||
129860345|NCT02103439|467445637|FG000|Overall Study|Withdrawal by Subject|3|||
129860346|NCT02103439|467445638|FG001|Overall Study|Withdrawal by Subject|1|||
129860347|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
129860348|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
129860349|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
129860350|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
129860351|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
129860352|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
129860353|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
129860354|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
129860355|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
129860356|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
129860357|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
129860358|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
129860359|NCT00695903|467445639|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
129860360|NCT00695903|467445640|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
129860361|NCT00695903|467445639|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
129860362|NCT00695903|467445640|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
129860363|NCT00695903|467445639|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
129860364|NCT00695903|467445640|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
129860365|NCT03966157|467445641|FG000|Overall Study|Physician Decision|1|||
129860366|NCT03966157|467445642|FG001|Overall Study|Physician Decision|0|||
129860367|NCT01650259|467445647|FG000|Overall Study|Improvement|105|||
129860368|NCT01650259|467445648|FG001|Overall Study|Improvement|0|||
129860369|NCT01650259|467445647|FG000|Overall Study|Adverse Event|127|||
129860370|NCT01650259|467445648|FG001|Overall Study|Adverse Event|0|||
129860371|NCT01650259|467445647|FG000|Overall Study|Lack of Efficacy|143|||
129860372|NCT01650259|467445648|FG001|Overall Study|Lack of Efficacy|0|||
129860373|NCT01650259|467445647|FG000|Overall Study|Lost to Follow-up|435|||
129860374|NCT01650259|467445648|FG001|Overall Study|Lost to Follow-up|0|||
129860375|NCT01650259|467445647|FG000|Overall Study|Patients had no visit after entry|70|||
129860376|NCT01650259|467445648|FG001|Overall Study|Patients had no visit after entry|0|||
129860377|NCT01650259|467445647|FG000|Overall Study|CRF not collected|98|||
129860378|NCT01650259|467445648|FG001|Overall Study|CRF not collected|82|||
129860379|NCT01650259|467445647|FG000|Overall Study|Not treated|1|||
129860380|NCT01650259|467445648|FG001|Overall Study|Not treated|7|||
129860381|NCT01650259|467445647|FG000|Overall Study|Other than listed|64|||
129860382|NCT01650259|467445648|FG001|Overall Study|Other than listed|146|||
129860383|NCT02663128|467445655|FG000|Period 2|Physician Decision|0|||
129860384|NCT02663128|467445656|FG001|Period 2|Physician Decision|0|||
129860385|NCT02663128|467445657|FG002|Period 2|Physician Decision|0|||
129860386|NCT02663128|467445658|FG003|Period 2|Physician Decision|0|||
129860387|NCT02663128|467445659|FG004|Period 2|Physician Decision|1|||
129860388|NCT02663128|467445660|FG005|Period 2|Physician Decision|0|||
129860389|NCT01358526|467445667|FG000|Open-label Titration Period|Adverse Event|95|||
129860390|NCT01358526|467445668|FG001|Open-label Titration Period|Adverse Event|0|||
129860391|NCT01358526|467445669|FG002|Open-label Titration Period|Adverse Event|0|||
129860392|NCT01358526|467445667|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
129860393|NCT01358526|467445668|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
129860394|NCT01358526|467445669|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
129860395|NCT01358526|467445667|FG000|Open-label Titration Period|Lost to Follow-up|25|||
129860396|NCT01358526|467445668|FG001|Open-label Titration Period|Lost to Follow-up|0|||
129860397|NCT01358526|467445669|FG002|Open-label Titration Period|Lost to Follow-up|0|||
129860398|NCT01358526|467445667|FG000|Open-label Titration Period|Lack of Efficacy|107|||
129860399|NCT01358526|467445668|FG001|Open-label Titration Period|Lack of Efficacy|0|||
129860400|NCT01358526|467445669|FG002|Open-label Titration Period|Lack of Efficacy|0|||
129860401|NCT01358526|467445667|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
129860402|NCT01358526|467445668|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
129860403|NCT01358526|467445669|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
129860404|NCT01358526|467445667|FG000|Open-label Titration Period|Administrative|8|||
129860405|NCT01358526|467445668|FG001|Open-label Titration Period|Administrative|0|||
129860406|NCT01358526|467445669|FG002|Open-label Titration Period|Administrative|0|||
129860407|NCT01358526|467445667|FG000|Open-label Titration Period|Did not qualify|178|||
129860408|NCT01358526|467445668|FG001|Open-label Titration Period|Did not qualify|0|||
129860409|NCT01358526|467445669|FG002|Open-label Titration Period|Did not qualify|0|||
129860410|NCT01358526|467445667|FG000|Double-blind Phase|Adverse Event|0|||
129860411|NCT01358526|467445668|FG001|Double-blind Phase|Adverse Event|24|||
129860412|NCT01358526|467445669|FG002|Double-blind Phase|Adverse Event|23|||
129860413|NCT01358526|467445667|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129860414|NCT01358526|467445668|FG001|Double-blind Phase|Withdrawal by Subject|10|||
129860415|NCT01358526|467445669|FG002|Double-blind Phase|Withdrawal by Subject|8|||
129860416|NCT01358526|467445667|FG000|Double-blind Phase|Lost to Follow-up|0|||
129860417|NCT01358526|467445668|FG001|Double-blind Phase|Lost to Follow-up|4|||
129860418|NCT01358526|467445669|FG002|Double-blind Phase|Lost to Follow-up|1|||
129860419|NCT01358526|467445667|FG000|Double-blind Phase|Lack of Efficacy|0|||
129860420|NCT01358526|467445668|FG001|Double-blind Phase|Lack of Efficacy|31|||
129860421|NCT01358526|467445669|FG002|Double-blind Phase|Lack of Efficacy|73|||
129860422|NCT01358526|467445667|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
129860423|NCT01358526|467445668|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
129860424|NCT01358526|467445669|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
129860425|NCT01358526|467445667|FG000|Double-blind Phase|Administrative|0|||
129860426|NCT01358526|467445668|FG001|Double-blind Phase|Administrative|6|||
129860427|NCT01358526|467445669|FG002|Double-blind Phase|Administrative|10|||
129860428|NCT03277313|467445681|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
129860429|NCT03277313|467445682|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
129860430|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
129860431|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
129860432|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
129860433|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
129860434|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
129860435|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
129860436|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
129860437|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
129860438|NCT02763384|467445685|FG000|Overall Study|Physician Decision|1|||
129860439|NCT02763384|467445685|FG000|Overall Study|Rapid decline - went on hospice|1|||
129860440|NCT02096900|467445686|FG000|Overall Study|Did not receive medication|3|||
129860441|NCT02096900|467445687|FG001|Overall Study|Did not receive medication|1|||
129860442|NCT02096900|467445686|FG000|Overall Study|Surgery cancelled- medication received|1|||
129860443|NCT02096900|467445687|FG001|Overall Study|Surgery cancelled- medication received|1|||
129860444|NCT03034577|467445690|FG000|Overall Study|Withdrawal by Subject|6|||
129860445|NCT03034577|467445691|FG001|Overall Study|Withdrawal by Subject|9|||
129860446|NCT03034577|467445690|FG000|Overall Study|Lost to Follow-up|25|||
129860447|NCT03034577|467445691|FG001|Overall Study|Lost to Follow-up|26|||
129860448|NCT01128413|467445694|FG000|Overall Study|Withdrawal by Subject|1|||
129860449|NCT01128413|467445695|FG001|Overall Study|Withdrawal by Subject|0|||
129860450|NCT01128413|467445694|FG000|Overall Study|NICOM Monitor Problems|2|||
129860451|NCT01128413|467445695|FG001|Overall Study|NICOM Monitor Problems|1|||
129860452|NCT01128413|467445694|FG000|Overall Study|Pt made DNR|1|||
129860453|NCT01128413|467445695|FG001|Overall Study|Pt made DNR|0|||
129860454|NCT02075593|467445699|FG000|Overall Study|Withdrawal by Subject|1|||
129860455|NCT02010060|467445700|FG000|Overall Study|Lost to Follow-up|1|||
129860456|NCT02010060|467445701|FG001|Overall Study|Lost to Follow-up|2|||
129860457|NCT02010060|467445702|FG002|Overall Study|Lost to Follow-up|2|||
129860458|NCT02010060|467445700|FG000|Overall Study|Injury|0|||
129860459|NCT02010060|467445701|FG001|Overall Study|Injury|1|||
129860460|NCT02010060|467445702|FG002|Overall Study|Injury|0|||
129860461|NCT00660010|467445703|FG000|Overall Study|Withdrawal by Subject|2|||
129860462|NCT00660010|467445703|FG000|Overall Study|Lost to Follow-up|3|||
129860463|NCT00660010|467445703|FG000|Overall Study|Adverse Event|1|||
129860464|NCT00660010|467445703|FG000|Overall Study|Noncompliance with visit schedule|3|||
129860465|NCT06167031|467445704|FG000|Overall Study|Lost to Follow-up|5|||
129860466|NCT06167031|467445705|FG001|Overall Study|Lost to Follow-up|1|||
129860467|NCT00920426|467447767|FG000|ITZ111451|Adverse Event|1|||
129860468|NCT00920426|467447768|FG001|ITZ111451|Adverse Event|0|||
129860469|NCT00920426|467447769|FG002|ITZ111451|Adverse Event|0|||
129860470|NCT00920426|467447770|FG003|ITZ111451|Adverse Event|0|||
129860471|NCT01432366|467447771|FG000|Overall Study|Non-Responder|7|||
129860472|NCT01432366|467447771|FG000|Overall Study|Adverse Event|8|||
129860473|NCT01432366|467447771|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
129860474|NCT01432366|467447771|FG000|Overall Study|Pregnancy|1|||
129860475|NCT01432366|467447771|FG000|Overall Study|Lost to Follow-up|13|||
129860476|NCT01432366|467447771|FG000|Overall Study|Lack of Efficacy|1|||
129860477|NCT01432366|467447771|FG000|Overall Study|Site Closed|20|||
129860478|NCT01432366|467447771|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
129860479|NCT01432366|467447771|FG000|Overall Study|Other|14|||
129860480|NCT01808690|467447772|FG000|Overall Study|Withdrawal by Subject|1|||
129860481|NCT01808690|467447773|FG001|Overall Study|Withdrawal by Subject|2|||
129860482|NCT00377234|467447780|FG000|Overall Study|Adverse Event|14|||
129860483|NCT00377234|467447781|FG001|Overall Study|Adverse Event|17|||
129860484|NCT00377234|467447780|FG000|Overall Study|Withdrawal by Subject|11|||
129860485|NCT00377234|467447781|FG001|Overall Study|Withdrawal by Subject|9|||
129860486|NCT00377234|467447780|FG000|Overall Study|Lost to Follow-up|4|||
129860487|NCT00377234|467447781|FG001|Overall Study|Lost to Follow-up|2|||
129860488|NCT00377234|467447780|FG000|Overall Study|Administrative|2|||
129860489|NCT00377234|467447781|FG001|Overall Study|Administrative|1|||
129860490|NCT00377234|467447780|FG000|Overall Study|Not assigned|3|||
129860491|NCT00377234|467447781|FG001|Overall Study|Not assigned|2|||
129860492|NCT01880424|467447782|FG000|Overall Study|Adverse Event|7|||
129860493|NCT01880424|467447783|FG001|Overall Study|Adverse Event|6|||
129860494|NCT01880424|467447782|FG000|Overall Study|Lack of Efficacy|1|||
129860495|NCT01880424|467447783|FG001|Overall Study|Lack of Efficacy|4|||
129860496|NCT01880424|467447782|FG000|Overall Study|Lost to Follow-up|3|||
129860497|NCT01880424|467447783|FG001|Overall Study|Lost to Follow-up|2|||
129860498|NCT01880424|467447782|FG000|Overall Study|Protocol Violation|11|||
129860499|NCT01880424|467447783|FG001|Overall Study|Protocol Violation|13|||
129860500|NCT01880424|467447782|FG000|Overall Study|Withdrawal by Subject|10|||
129860501|NCT01880424|467447783|FG001|Overall Study|Withdrawal by Subject|30|||
129860502|NCT01880424|467447782|FG000|Overall Study|Other|1|||
129860503|NCT01880424|467447783|FG001|Overall Study|Other|0|||
129860504|NCT02062632|467447784|FG000|Overall Study|No treatment data|1|||
129860505|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
129860506|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
129860507|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
129860508|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
129860509|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
129860510|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
129860511|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
129860512|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
129860513|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
129860514|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
129860515|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
129860516|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
129860517|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
129860518|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
129860519|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
129860520|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
129860521|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
129860522|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
129860523|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
129860524|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
129860525|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
129860526|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
129860527|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
129860528|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
129860529|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860530|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860531|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860532|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860533|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860534|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860535|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860536|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860537|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860538|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860539|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860540|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860541|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860542|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860543|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860544|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860545|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860546|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860547|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
129860548|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
129860549|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
129860550|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860551|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860552|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860553|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860554|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860555|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860556|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860557|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860558|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860559|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860560|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860561|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860562|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860563|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860564|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860565|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
129860566|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
129860567|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
129860568|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
129860569|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
129860570|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
129860571|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
129860572|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
129860573|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
129860574|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
129860575|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
129860576|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
129860577|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
129860578|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
129860579|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
129860580|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
129860581|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
129860582|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
129860583|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
129860584|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
129860585|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
129860586|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860587|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860588|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860589|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860590|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860591|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860592|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860593|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860594|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860595|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860596|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860597|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860598|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860599|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860600|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860601|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860602|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860603|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860604|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860605|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
129860606|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
129860607|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860608|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
129860609|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
129860610|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860611|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860612|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860613|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860614|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860615|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860616|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860617|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860618|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860619|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860620|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860621|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860622|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860623|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860624|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860625|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860626|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860627|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860628|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860629|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
129860630|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860631|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860632|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860633|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860634|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860635|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860636|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860637|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860638|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860639|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860640|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860641|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860642|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860643|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860644|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860645|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860646|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860647|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860648|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860649|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860650|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
129860651|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
129860652|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860653|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860654|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
129860655|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
129860656|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
129860657|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860658|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860659|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860660|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860661|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860662|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860663|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860664|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860665|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860666|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860667|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860668|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860669|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860670|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860671|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
129860672|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860673|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
129860674|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
129860675|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
129860676|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860677|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860678|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860679|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860680|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860681|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860682|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860683|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860684|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860685|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860686|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129910482|NCT04556981|467635348|FG000|Overall Study|Moved from the study area|1|||
129910483|NCT04556981|467635349|FG001|Overall Study|Moved from the study area|4|||
129910484|NCT04556981|467635348|FG000|Overall Study|Withdrawal by Subject|2|||
129910485|NCT04556981|467635349|FG001|Overall Study|Withdrawal by Subject|2|||
129860687|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860688|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860689|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860690|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860691|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
129860692|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860693|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860694|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
129860695|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860696|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860697|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860698|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860699|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860700|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860701|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860702|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860703|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860704|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860705|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860706|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860707|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860708|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860709|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860710|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860711|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
129860712|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860713|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860714|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860715|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860716|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860717|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860718|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860719|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860720|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860721|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860722|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860723|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860724|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860725|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860726|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860727|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860728|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860729|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860730|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
129860731|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860732|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860733|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860734|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860735|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860736|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860737|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860738|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860739|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860740|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860741|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860742|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860743|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860744|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860745|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860746|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860747|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860748|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860749|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860750|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860751|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
129910486|NCT04556981|467635348|FG000|Overall Study|Other|2|||
129860752|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860753|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
129860754|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860755|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
129860756|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
129860757|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860758|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860759|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860760|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860761|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860762|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860763|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860764|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860765|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860766|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860767|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860768|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860769|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860770|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
129860771|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
129860772|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
129860773|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
129860774|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
129860775|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
129860776|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
129860777|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860778|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860779|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860780|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860781|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860782|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860783|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860784|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860785|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860786|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860787|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860788|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860789|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860790|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860791|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860792|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860793|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860794|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860795|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860796|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860797|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860798|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860799|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
129860800|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
129860801|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860802|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860803|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
130064754|NCT03288493|468190274|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
130064755|NCT03288493|468190275|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
130064756|NCT03288493|468190276|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
130064757|NCT03288493|468190277|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
129860804|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860805|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
130064758|NCT03288493|468190278|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
129860806|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860807|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860808|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860809|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860810|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860811|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860812|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860813|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860814|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860815|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860816|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860817|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860818|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
129860819|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860820|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860821|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860822|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860823|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860824|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860825|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860826|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860827|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860828|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860829|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860830|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860831|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860832|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860833|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860834|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860835|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860836|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860837|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860838|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860839|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
129860840|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
129860841|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860842|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860843|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860844|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860845|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860846|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860847|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860848|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860849|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860850|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860851|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860852|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860853|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860854|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860855|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860856|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860857|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
129860858|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
129860859|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
129860860|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
129860861|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860862|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860863|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860864|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860865|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
129860866|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
129860867|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
130094773|NCT01018680|468303839|FG000|Overall Study|Withdrawal by Subject|10|||
129860868|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
129860869|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
129860870|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
129860871|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
129860872|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
129860873|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
129860874|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
129860875|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
129860876|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
129860877|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
129860878|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
129860879|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
129860880|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
129860881|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
129860882|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
129860883|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
129860884|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
129860885|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Death|0|||
129860886|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Death|0|||
129860887|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Death|0|||
129860888|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Death|0|||
129860889|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Death|0|||
129860890|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Death|0|||
129860891|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Death|0|||
129860892|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Death|0|||
129860893|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Death|0|||
129860894|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Death|0|||
129860895|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Death|0|||
129860896|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Death|0|||
129860897|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Death|0|||
129860898|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Death|0|||
129860899|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Death|0|||
129860900|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Death|0|||
129860901|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Death|0|||
129860902|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Death|0|||
129860903|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Death|1|||
129860904|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Death|0|||
129860905|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860906|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860907|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860908|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860909|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860910|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860911|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860912|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860913|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860914|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860915|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860916|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860917|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860918|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860919|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860920|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860921|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860922|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
129860923|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
129860924|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
129860925|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860926|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860927|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860928|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860929|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860930|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860931|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860932|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860933|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860934|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860935|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
130094774|NCT01018680|468303840|FG001|Overall Study|Withdrawal by Subject|10|||
129860936|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860937|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860938|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860939|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860940|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860941|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860942|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860943|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
129860944|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860945|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
129860946|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
129860947|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
129860948|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
129860949|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
129860950|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
129860951|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
129860952|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
129860953|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
129860954|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
129860955|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
129860956|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
129860957|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
129860958|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
129860959|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
129860960|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
129860961|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
129860962|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
129860963|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
129860964|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
129860965|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
129860966|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
129860967|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
129860968|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
129860969|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
129860970|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
129860971|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
129860972|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
129860973|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
129860974|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
129860975|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
129860976|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
129860977|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
129860978|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
129860979|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
129860980|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
129860981|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
129860982|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
129860983|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
129860984|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
129860985|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860986|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860987|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860988|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860989|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860990|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860991|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
130064759|NCT03288493|468190279|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
130064760|NCT03288493|468190280|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
130064761|NCT03288493|468190274|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
129910487|NCT04556981|467635349|FG001|Overall Study|Other|1|||
130064762|NCT03288493|468190275|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
129860992|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860993|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860994|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860995|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860996|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860997|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860998|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860999|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129861000|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129861001|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129861002|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
129861003|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
129861004|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
129861005|NCT00856856|467447814|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
129861006|NCT00856856|467447814|FG000|4-year Clinical Follow-up|Missed visit|1|||
129861007|NCT02696317|467447818|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
129861008|NCT02696317|467447819|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
129861009|NCT02696317|467447818|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
129861010|NCT02696317|467447819|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
129861011|NCT01343368|467447820|FG000|Overall Study|Death|1|||
129861012|NCT01343368|467447821|FG001|Overall Study|Death|0|||
129861013|NCT01343368|467447820|FG000|Overall Study|Lost to Follow-up|1|||
129861014|NCT01343368|467447821|FG001|Overall Study|Lost to Follow-up|0|||
129861015|NCT04955639|467447822|FG000|Overall Study|Withdrawal by Subject|2|||
129861016|NCT04955639|467447823|FG001|Overall Study|Withdrawal by Subject|2|||
129861017|NCT04955639|467447822|FG000|Overall Study|Week 26 survey not completed|2|||
129861018|NCT04955639|467447823|FG001|Overall Study|Week 26 survey not completed|2|||
129861019|NCT04447404|467447824|FG000|Overall Study|Death|2|||
129861020|NCT04447404|467447825|FG001|Overall Study|Death|0|||
129861021|NCT01369342|467447826|FG000|Overall Study|Withdrawal by Subject|7|||
129861022|NCT01369342|467447827|FG001|Overall Study|Withdrawal by Subject|7|||
129861023|NCT01369342|467447828|FG002|Overall Study|Withdrawal by Subject|2|||
129861024|NCT01369342|467447826|FG000|Overall Study|Lost to Follow-up|5|||
129861025|NCT01369342|467447827|FG001|Overall Study|Lost to Follow-up|2|||
129861026|NCT01369342|467447828|FG002|Overall Study|Lost to Follow-up|1|||
129861027|NCT01369342|467447826|FG000|Overall Study|Not Treated|1|||
129861028|NCT01369342|467447827|FG001|Overall Study|Not Treated|0|||
129861029|NCT01369342|467447828|FG002|Overall Study|Not Treated|0|||
129861030|NCT00321854|467447829|FG000|Overall Study|Adverse Event|41|||
129861031|NCT00321854|467447830|FG001|Overall Study|Adverse Event|43|||
129861032|NCT00321854|467447829|FG000|Overall Study|Lack of Efficacy|9|||
129861033|NCT00321854|467447830|FG001|Overall Study|Lack of Efficacy|14|||
129861034|NCT00321854|467447829|FG000|Overall Study|Protocol Violation|6|||
129861035|NCT00321854|467447830|FG001|Overall Study|Protocol Violation|5|||
129861036|NCT00321854|467447829|FG000|Overall Study|Lost to Follow-up|0|||
129861037|NCT00321854|467447830|FG001|Overall Study|Lost to Follow-up|2|||
129861038|NCT00321854|467447829|FG000|Overall Study|Withdrawal by Subject|6|||
129861039|NCT00321854|467447830|FG001|Overall Study|Withdrawal by Subject|17|||
129861040|NCT00321854|467447829|FG000|Overall Study|Other|1|||
129861041|NCT00321854|467447830|FG001|Overall Study|Other|1|||
129861042|NCT04723576|467447831|FG000|Overall Study|Withdrawal by Subject|2133|||
129861043|NCT04723576|467447832|FG001|Overall Study|Withdrawal by Subject|3234|||
129861044|NCT02384759|467447834|FG000|Overall Study|Patients not treated|3|||
129861045|NCT02384759|467447835|FG001|Overall Study|Patients not treated|2|||
129861046|NCT03759873|467447841|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
129861047|NCT03759873|467447842|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
129861048|NCT03759873|467447843|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
129861049|NCT03759873|467447844|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
129861050|NCT03759873|467447841|FG000|Overall Study|Moved outside eligible area|0|||
129861051|NCT03759873|467447842|FG001|Overall Study|Moved outside eligible area|2|||
129861052|NCT03759873|467447843|FG002|Overall Study|Moved outside eligible area|0|||
129861053|NCT03759873|467447844|FG003|Overall Study|Moved outside eligible area|0|||
129861054|NCT03759873|467447841|FG000|Overall Study|Withdrawal by Subject|0|||
129861055|NCT03759873|467447842|FG001|Overall Study|Withdrawal by Subject|0|||
129861056|NCT03759873|467447843|FG002|Overall Study|Withdrawal by Subject|1|||
130064763|NCT03288493|468190276|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130094775|NCT01018680|468303839|FG000|Overall Study|Protocol Violation|5|||
129861057|NCT03759873|467447844|FG003|Overall Study|Withdrawal by Subject|0|||
129861058|NCT03579563|467447845|FG000|Overall Study|Lost to Follow-up|0|||
129861059|NCT03579563|467447846|FG001|Overall Study|Lost to Follow-up|0|||
129861060|NCT03579563|467447847|FG002|Overall Study|Lost to Follow-up|0|||
129861061|NCT03579563|467447848|FG003|Overall Study|Lost to Follow-up|0|||
129861062|NCT03579563|467447849|FG004|Overall Study|Lost to Follow-up|1|||
129861063|NCT03579563|467447850|FG005|Overall Study|Lost to Follow-up|0|||
129861064|NCT03579563|467447845|FG000|Overall Study|Lack of Efficacy|1|||
129861065|NCT03579563|467447846|FG001|Overall Study|Lack of Efficacy|1|||
129861066|NCT03579563|467447847|FG002|Overall Study|Lack of Efficacy|4|||
129861067|NCT03579563|467447848|FG003|Overall Study|Lack of Efficacy|1|||
129861068|NCT03579563|467447849|FG004|Overall Study|Lack of Efficacy|2|||
129861069|NCT03579563|467447850|FG005|Overall Study|Lack of Efficacy|3|||
129861070|NCT03579563|467447845|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
129861071|NCT03579563|467447846|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129861072|NCT03579563|467447847|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129861073|NCT03579563|467447848|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
129861074|NCT03579563|467447849|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
129910488|NCT01388361|467635350|FG000|Overall Study|Adverse Event|0|||
129861075|NCT03579563|467447850|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
129861076|NCT03579563|467447845|FG000|Overall Study|Time/distance concern|0|||
129861077|NCT03579563|467447846|FG001|Overall Study|Time/distance concern|0|||
129861078|NCT03579563|467447847|FG002|Overall Study|Time/distance concern|1|||
129861079|NCT03579563|467447848|FG003|Overall Study|Time/distance concern|0|||
129861080|NCT03579563|467447849|FG004|Overall Study|Time/distance concern|0|||
129861081|NCT03579563|467447850|FG005|Overall Study|Time/distance concern|1|||
129861082|NCT03579563|467447845|FG000|Overall Study|COVID shutdown|2|||
129861083|NCT03579563|467447846|FG001|Overall Study|COVID shutdown|3|||
129861084|NCT03579563|467447847|FG002|Overall Study|COVID shutdown|4|||
129861085|NCT03579563|467447848|FG003|Overall Study|COVID shutdown|3|||
129861086|NCT03579563|467447849|FG004|Overall Study|COVID shutdown|1|||
129861087|NCT03579563|467447850|FG005|Overall Study|COVID shutdown|2|||
129861088|NCT03579563|467447845|FG000|Overall Study|Protocol administration error|1|||
129861089|NCT03579563|467447846|FG001|Overall Study|Protocol administration error|0|||
129861090|NCT03579563|467447847|FG002|Overall Study|Protocol administration error|1|||
129861091|NCT03579563|467447848|FG003|Overall Study|Protocol administration error|0|||
129861092|NCT03579563|467447849|FG004|Overall Study|Protocol administration error|1|||
129861093|NCT03579563|467447850|FG005|Overall Study|Protocol administration error|5|||
129861094|NCT03526250|467447851|FG000|Overall Study|Adverse Event|4|||
129861095|NCT03526250|467447851|FG000|Overall Study|Progressive Disease|16|||
129861096|NCT03526250|467447851|FG000|Overall Study|No Treatment|3|||
129861097|NCT02647359|467447852|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
129861098|NCT02647359|467447853|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
129861099|NCT02647359|467447852|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
129861100|NCT02647359|467447853|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
129861101|NCT02647359|467447852|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
129861102|NCT02647359|467447853|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
129861103|NCT02647359|467447852|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
129861104|NCT02647359|467447853|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
129861105|NCT02647359|467447852|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
129861106|NCT02647359|467447853|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
129861107|NCT02647359|467447852|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
129861108|NCT02647359|467447853|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
129861109|NCT00511004|467447854|FG000|Overall Study|Lost to Follow-up|0|||
129861110|NCT00511004|467447855|FG001|Overall Study|Lost to Follow-up|0|||
129861111|NCT00511004|467447856|FG002|Overall Study|Lost to Follow-up|4|||
129861112|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
129861113|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
129861114|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
129861115|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
129861116|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
129861117|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
129861118|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
129861119|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
129861120|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
129861121|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
129861122|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
129861123|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
129861124|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
129861125|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
129861126|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
129861127|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
129861128|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
129861129|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
129861130|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
129861131|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
129861132|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
129861133|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
130064764|NCT03288493|468190277|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
130064765|NCT03288493|468190278|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130064766|NCT03288493|468190279|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
130094776|NCT01018680|468303840|FG001|Overall Study|Protocol Violation|8|||
129861134|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
129861135|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
129861136|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
129861137|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
129861138|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
129861139|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
129861140|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
129861141|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
129861142|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
129861143|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
129861144|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
129861145|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
129861146|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
129861147|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
129861148|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
129861149|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
129861150|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
129861151|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
129861152|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
129861153|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
129861154|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
129861155|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
129861156|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
129861157|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
129861158|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
129861159|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
129861160|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
129861161|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
129861162|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
129861163|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
129861164|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
129861165|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
129861166|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
129861167|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
129861168|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
129861169|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
129861170|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
129861171|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
129861172|NCT01672801|467447865|FG000|Overall Study|Screen Failure|0|||
129861173|NCT01672801|467447866|FG001|Overall Study|Screen Failure|1|||
129861174|NCT01362140|467447867|FG000|Overall Study|Noncompliance|1|||
129861175|NCT01362140|467447868|FG001|Overall Study|Noncompliance|0|||
129861176|NCT01362140|467447867|FG000|Overall Study|Adverse Event|2|||
129861177|NCT01362140|467447868|FG001|Overall Study|Adverse Event|2|||
129861178|NCT01362140|467447867|FG000|Overall Study|Withdrawal by Subject|3|||
129861179|NCT01362140|467447868|FG001|Overall Study|Withdrawal by Subject|3|||
129861180|NCT01362140|467447867|FG000|Overall Study|Administrative Decision|0|||
129861181|NCT01362140|467447868|FG001|Overall Study|Administrative Decision|1|||
129861182|NCT01362140|467447867|FG000|Overall Study|Death|2|||
129861183|NCT01362140|467447868|FG001|Overall Study|Death|1|||
129861184|NCT01362140|467447867|FG000|Overall Study|Other|1|||
129861185|NCT01362140|467447868|FG001|Overall Study|Other|1|||
129861186|NCT01362140|467447867|FG000|Overall Study|Protocol-specified Criteria|1|||
129861187|NCT01362140|467447868|FG001|Overall Study|Protocol-specified Criteria|2|||
129861188|NCT01362140|467447867|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
129861189|NCT01362140|467447868|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
129861190|NCT00492284|467447870|FG000|Overall Study|Adverse Event|0|||
129861191|NCT00492284|467447871|FG001|Overall Study|Adverse Event|1|||
129861192|NCT00492284|467447872|FG002|Overall Study|Adverse Event|1|||
129861193|NCT00492284|467447873|FG003|Overall Study|Adverse Event|2|||
129861194|NCT00492284|467447870|FG000|Overall Study|Lost to Follow-up|0|||
129861195|NCT00492284|467447871|FG001|Overall Study|Lost to Follow-up|0|||
129861196|NCT00492284|467447872|FG002|Overall Study|Lost to Follow-up|3|||
129861197|NCT00492284|467447873|FG003|Overall Study|Lost to Follow-up|1|||
129861198|NCT00492284|467447870|FG000|Overall Study|Death|0|||
129861199|NCT00492284|467447871|FG001|Overall Study|Death|3|||
129861200|NCT00492284|467447872|FG002|Overall Study|Death|2|||
129861201|NCT00492284|467447873|FG003|Overall Study|Death|5|||
129861202|NCT00492284|467447870|FG000|Overall Study|Withdrawal by Subject|1|||
129910489|NCT01388361|467635351|FG001|Overall Study|Adverse Event|5|||
129910490|NCT01388361|467635352|FG002|Overall Study|Adverse Event|1|||
129861203|NCT00492284|467447871|FG001|Overall Study|Withdrawal by Subject|0|||
129861204|NCT00492284|467447872|FG002|Overall Study|Withdrawal by Subject|0|||
129861205|NCT00492284|467447873|FG003|Overall Study|Withdrawal by Subject|2|||
129861206|NCT06476366|467447874|FG000|Overall Study|Lost to Follow-up|1|||
129861207|NCT06476366|467447875|FG001|Overall Study|Lost to Follow-up|3|||
129861208|NCT06476366|467447874|FG000|Overall Study|Adverse Event|1|||
129861209|NCT06476366|467447875|FG001|Overall Study|Adverse Event|0|||
129861210|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
129861211|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
129861212|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
129861213|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
129861214|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
129861215|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
129861216|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
129861217|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
129861218|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
129861219|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
129861220|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
129861221|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
129861222|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
129861223|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
129861224|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
129861225|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
129861226|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
129861227|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
129861228|NCT00355082|467447883|FG000|Continuation Phase|Adverse Event|2|||
129861229|NCT00355082|467447884|FG001|Continuation Phase|Adverse Event|0|||
129861230|NCT00355082|467447885|FG002|Continuation Phase|Adverse Event|1|||
129861231|NCT00355082|467447883|FG000|Continuation Phase|Lost to Follow-up|2|||
129861232|NCT00355082|467447884|FG001|Continuation Phase|Lost to Follow-up|0|||
129861233|NCT00355082|467447885|FG002|Continuation Phase|Lost to Follow-up|1|||
129861234|NCT00355082|467447883|FG000|Continuation Phase|Protocol Violation|1|||
129861235|NCT00355082|467447884|FG001|Continuation Phase|Protocol Violation|0|||
129861236|NCT00355082|467447885|FG002|Continuation Phase|Protocol Violation|1|||
129861237|NCT00355082|467447883|FG000|Continuation Phase|Withdrawal by Subject|4|||
129861238|NCT00355082|467447884|FG001|Continuation Phase|Withdrawal by Subject|0|||
129861239|NCT00355082|467447885|FG002|Continuation Phase|Withdrawal by Subject|0|||
129861240|NCT00355082|467447883|FG000|Continuation Phase|Lack of Efficacy|5|||
129861241|NCT00355082|467447884|FG001|Continuation Phase|Lack of Efficacy|0|||
129861242|NCT00355082|467447885|FG002|Continuation Phase|Lack of Efficacy|0|||
129861243|NCT00355082|467447883|FG000|Continuation Phase|Site Closed by Sponsor|8|||
129861244|NCT00355082|467447884|FG001|Continuation Phase|Site Closed by Sponsor|0|||
129861245|NCT00355082|467447885|FG002|Continuation Phase|Site Closed by Sponsor|0|||
129861246|NCT00355082|467447883|FG000|Continuation Phase|Scheduling Error|1|||
129861247|NCT00355082|467447884|FG001|Continuation Phase|Scheduling Error|0|||
129861248|NCT00355082|467447885|FG002|Continuation Phase|Scheduling Error|0|||
129861249|NCT00355082|467447883|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
129861250|NCT00355082|467447884|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
129861251|NCT00355082|467447885|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
129861252|NCT04598152|467447889|FG000|Overall Study|Lost to Follow-up|0|||
129910491|NCT01388361|467635350|FG000|Overall Study|Protocol Violation|0|||
129861253|NCT04598152|467447890|FG001|Overall Study|Lost to Follow-up|1|||
129861254|NCT03346759|467447891|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
129861255|NCT03346759|467447892|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
129861256|NCT03346759|467447891|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
129861257|NCT03346759|467447892|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
129861258|NCT03346759|467447891|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
129910492|NCT01388361|467635351|FG001|Overall Study|Protocol Violation|0|||
129910493|NCT01388361|467635352|FG002|Overall Study|Protocol Violation|2|||
129910494|NCT01388361|467635350|FG000|Overall Study|Withdrawal criteria|12|||
129910495|NCT01388361|467635351|FG001|Overall Study|Withdrawal criteria|7|||
129910496|NCT01388361|467635352|FG002|Overall Study|Withdrawal criteria|10|||
129861259|NCT03346759|467447892|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
129861260|NCT02132611|467447893|FG000|Overall Study|Death|2|||
129861261|NCT02194621|467447895|FG000|Overall Study|6 withdrew prior to randomization|2|||
129861262|NCT02194621|467447896|FG001|Overall Study|6 withdrew prior to randomization|2|||
129861263|NCT02194621|467447897|FG002|Overall Study|6 withdrew prior to randomization|2|||
129861264|NCT02194621|467447895|FG000|Overall Study|Withdrawal by Subject|4|||
129861265|NCT02194621|467447896|FG001|Overall Study|Withdrawal by Subject|4|||
129861266|NCT02194621|467447897|FG002|Overall Study|Withdrawal by Subject|7|||
129861267|NCT02493127|467447905|FG000|Overall Study|Lost to Follow-up|1|||
129861268|NCT02493127|467447906|FG001|Overall Study|Lost to Follow-up|1|||
129910497|NCT01388361|467635350|FG000|Overall Study|Unclassified|0|||
129910498|NCT01388361|467635351|FG001|Overall Study|Unclassified|0|||
129910499|NCT01388361|467635352|FG002|Overall Study|Unclassified|1|||
130094777|NCT01018680|468303839|FG000|Overall Study|Sponsor Decision|6|||
129910500|NCT00068601|467635354|FG000|Overall Study|Ineligible|11|||
129910501|NCT00068601|467635355|FG001|Overall Study|Ineligible|13|||
129910502|NCT00068601|467635354|FG000|Overall Study|Not evaluable: withdrew consent|5|||
129910503|NCT00068601|467635355|FG001|Overall Study|Not evaluable: withdrew consent|4|||
129910504|NCT00068601|467635354|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
129910505|NCT00068601|467635355|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
129910506|NCT00068601|467635354|FG000|Overall Study|Death|11|||
129910507|NCT00068601|467635355|FG001|Overall Study|Death|3|||
129910508|NCT00068601|467635354|FG000|Overall Study|Lost to Follow-up|3|||
129910509|NCT00068601|467635355|FG001|Overall Study|Lost to Follow-up|2|||
129910510|NCT00068601|467635354|FG000|Overall Study|Missing primary outcome data|30|||
129910511|NCT00068601|467635355|FG001|Overall Study|Missing primary outcome data|34|||
129910512|NCT01070069|467635356|FG000|Overall Study|Death|1|||
129910513|NCT01070069|467635357|FG001|Overall Study|Death|0|||
129910514|NCT01070069|467635358|FG002|Overall Study|Death|2|||
129910515|NCT01070069|467635359|FG003|Overall Study|Death|0|||
129910516|NCT01070069|467635360|FG004|Overall Study|Death|1|||
129910517|NCT01070069|467635356|FG000|Overall Study|Withdrawal by Subject|1|||
129910518|NCT01070069|467635357|FG001|Overall Study|Withdrawal by Subject|1|||
129910519|NCT01070069|467635358|FG002|Overall Study|Withdrawal by Subject|4|||
129910520|NCT01070069|467635359|FG003|Overall Study|Withdrawal by Subject|0|||
129910521|NCT01070069|467635360|FG004|Overall Study|Withdrawal by Subject|0|||
129910522|NCT01070069|467635356|FG000|Overall Study|Lost to Follow-up|4|||
129910523|NCT01070069|467635357|FG001|Overall Study|Lost to Follow-up|1|||
129910524|NCT01070069|467635358|FG002|Overall Study|Lost to Follow-up|0|||
129910525|NCT01070069|467635359|FG003|Overall Study|Lost to Follow-up|0|||
129910526|NCT01070069|467635360|FG004|Overall Study|Lost to Follow-up|3|||
129910527|NCT00419341|467635372|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
129910528|NCT00419341|467635372|FG000|Wash in/Wash Out Period|Adverse Event|2|||
129910529|NCT00419341|467635372|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
129910530|NCT00419341|467635372|FG000|Efficacy Period|Withdrawal by Subject|6|||
129910531|NCT00419341|467635372|FG000|Efficacy Period|Protocol Violation|1|||
129910532|NCT00419341|467635372|FG000|Efficacy Period|Lost to Follow-up|1|||
129910533|NCT00419341|467635372|FG000|Efficacy Period|Non-compliance|1|||
129910534|NCT00419341|467635372|FG000|Efficacy Period|Termination of study site|1|||
129910535|NCT01499199|467635374|FG000|Overall Study|Adverse Event|1|||
129910536|NCT01499199|467635374|FG000|Overall Study|Lack of Efficacy|1|||
129910537|NCT04732338|467635380|FG000|Overall Study|Lost to Follow-up|3|||
129910538|NCT04732338|467635381|FG001|Overall Study|Lost to Follow-up|3|||
129910539|NCT02539225|467635387|FG000|Part A|Adverse Event|13|||
129910540|NCT02539225|467635388|FG001|Part A|Adverse Event|4|||
129910541|NCT02539225|467635387|FG000|Part A|Withdrawal by Subject|2|||
129910542|NCT02539225|467635388|FG001|Part A|Withdrawal by Subject|4|||
129910543|NCT02539225|467635387|FG000|Part A|Physician Decision|4|||
129910544|NCT02539225|467635388|FG001|Part A|Physician Decision|7|||
129910545|NCT02539225|467635387|FG000|Part A|Did Not Receive study Drug|1|||
129910546|NCT02539225|467635388|FG001|Part A|Did Not Receive study Drug|1|||
129910547|NCT02539225|467635387|FG000|Pre Treatment for Part B|Progressive disease|1|||
129910548|NCT02539225|467635388|FG001|Pre Treatment for Part B|Progressive disease|1|||
129910549|NCT02539225|467635387|FG000|Pre Treatment for Part B|Adverse Event|1|||
129910550|NCT02539225|467635388|FG001|Pre Treatment for Part B|Adverse Event|1|||
129910551|NCT02539225|467635387|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
129910552|NCT02539225|467635388|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
129910553|NCT02539225|467635387|FG000|Pre Treatment for Part B|Physician Decision|2|||
129910554|NCT02539225|467635388|FG001|Pre Treatment for Part B|Physician Decision|0|||
129910555|NCT02539225|467635387|FG000|Part B|Adverse Event|4|||
129910556|NCT02539225|467635388|FG001|Part B|Adverse Event|4|||
129910557|NCT02539225|467635387|FG000|Part B|Withdrawal by Subject|0|||
129910558|NCT02539225|467635388|FG001|Part B|Withdrawal by Subject|3|||
129910559|NCT02539225|467635387|FG000|Part B|Physician Decision|0|||
129910560|NCT02539225|467635388|FG001|Part B|Physician Decision|9|||
129910561|NCT04766034|467635391|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910562|NCT04766034|467635392|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910563|NCT04766034|467635393|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910564|NCT04766034|467635394|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910565|NCT04766034|467635395|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
129910566|NCT04766034|467635391|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910567|NCT04766034|467635392|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910568|NCT04766034|467635393|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910569|NCT04766034|467635394|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910570|NCT04766034|467635395|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
129910571|NCT04766034|467635391|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
129979688|NCT03752970|467889435|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
129910572|NCT04766034|467635392|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
129910573|NCT04766034|467635393|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
129910574|NCT04766034|467635394|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
129910575|NCT04766034|467635395|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
129910576|NCT04766034|467635391|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
129910577|NCT04766034|467635392|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
129910578|NCT04766034|467635393|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
129910579|NCT04766034|467635394|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
129910580|NCT04766034|467635395|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
129910581|NCT03960463|467637558|FG000|Overall Study|Withdrawal by Subject|2|||
129910582|NCT03960463|467637559|FG001|Overall Study|Withdrawal by Subject|0|||
129910583|NCT05568615|467637560|FG000|Overall Study|Death|1|||
129910584|NCT05568615|467637560|FG000|Overall Study|Physician Decision|1|||
129910585|NCT03529110|467637561|FG000|Overall Study|Progressive Disease|66|||
129910586|NCT03529110|467637562|FG001|Overall Study|Progressive Disease|158|||
129910587|NCT03529110|467637561|FG000|Overall Study|Clinical Progression|4|||
129910588|NCT03529110|467637562|FG001|Overall Study|Clinical Progression|12|||
129910589|NCT03529110|467637561|FG000|Overall Study|Adverse Event|35|||
129910590|NCT03529110|467637562|FG001|Overall Study|Adverse Event|17|||
129910591|NCT03529110|467637561|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
129910592|NCT03529110|467637562|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
129910593|NCT03529110|467637561|FG000|Overall Study|Lack of Efficacy|3|||
129910594|NCT03529110|467637562|FG001|Overall Study|Lack of Efficacy|3|||
129910595|NCT03529110|467637561|FG000|Overall Study|Physician Decision|2|||
129910596|NCT03529110|467637562|FG001|Overall Study|Physician Decision|8|||
129910597|NCT03529110|467637561|FG000|Overall Study|Miscellaneous|2|||
129910598|NCT03529110|467637562|FG001|Overall Study|Miscellaneous|5|||
129910599|NCT04922021|467637565|FG000|Overall Study|Withdrawal by Subject|4|||
129910600|NCT04922021|467637566|FG001|Overall Study|Withdrawal by Subject|10|||
129910601|NCT04922021|467637565|FG000|Overall Study|Adverse Event|2|||
129910602|NCT04922021|467637566|FG001|Overall Study|Adverse Event|2|||
129910603|NCT04922021|467637565|FG000|Overall Study|Lack of Efficacy|0|||
129910604|NCT04922021|467637566|FG001|Overall Study|Lack of Efficacy|1|||
129910605|NCT04922021|467637565|FG000|Overall Study|Multiple reasons|1|||
129910606|NCT04922021|467637566|FG001|Overall Study|Multiple reasons|0|||
129910607|NCT02544074|467637576|FG000|Overall Study|Withdrawal by Subject|0|||
129910608|NCT02544074|467637577|FG001|Overall Study|Withdrawal by Subject|1|||
129910609|NCT02544074|467637578|FG002|Overall Study|Withdrawal by Subject|0|||
129910610|NCT02544074|467637579|FG003|Overall Study|Withdrawal by Subject|0|||
129910611|NCT02544074|467637580|FG004|Overall Study|Withdrawal by Subject|0|||
129910612|NCT02544074|467637581|FG005|Overall Study|Withdrawal by Subject|0|||
129910613|NCT02544074|467637582|FG006|Overall Study|Withdrawal by Subject|0|||
129910614|NCT02544074|467637583|FG007|Overall Study|Withdrawal by Subject|0|||
129910615|NCT02544074|467637584|FG008|Overall Study|Withdrawal by Subject|0|||
129910616|NCT02544074|467637585|FG009|Overall Study|Withdrawal by Subject|0|||
129910617|NCT02544074|467637586|FG010|Overall Study|Withdrawal by Subject|0|||
129910618|NCT02544074|467637587|FG011|Overall Study|Withdrawal by Subject|0|||
129910619|NCT02544074|467637588|FG012|Overall Study|Withdrawal by Subject|0|||
129910620|NCT02544074|467637589|FG013|Overall Study|Withdrawal by Subject|0|||
129910621|NCT02544074|467637590|FG014|Overall Study|Withdrawal by Subject|0|||
129910622|NCT02544074|467637591|FG015|Overall Study|Withdrawal by Subject|0|||
129910623|NCT02544074|467637592|FG016|Overall Study|Withdrawal by Subject|0|||
129910624|NCT02544074|467637593|FG017|Overall Study|Withdrawal by Subject|0|||
129910625|NCT02544074|467637594|FG018|Overall Study|Withdrawal by Subject|0|||
129910626|NCT02544074|467637595|FG019|Overall Study|Withdrawal by Subject|0|||
129910627|NCT02544074|467637596|FG020|Overall Study|Withdrawal by Subject|0|||
129910628|NCT02544074|467637576|FG000|Overall Study|Tablet error|0|||
129910629|NCT02544074|467637577|FG001|Overall Study|Tablet error|0|||
129910630|NCT02544074|467637578|FG002|Overall Study|Tablet error|0|||
129910631|NCT02544074|467637579|FG003|Overall Study|Tablet error|0|||
129910632|NCT02544074|467637580|FG004|Overall Study|Tablet error|0|||
129910633|NCT02544074|467637581|FG005|Overall Study|Tablet error|1|||
129910634|NCT02544074|467637582|FG006|Overall Study|Tablet error|0|||
129910635|NCT02544074|467637583|FG007|Overall Study|Tablet error|0|||
129910636|NCT02544074|467637584|FG008|Overall Study|Tablet error|0|||
129910637|NCT02544074|467637585|FG009|Overall Study|Tablet error|1|||
129910638|NCT02544074|467637586|FG010|Overall Study|Tablet error|0|||
129910639|NCT02544074|467637587|FG011|Overall Study|Tablet error|0|||
129910640|NCT02544074|467637588|FG012|Overall Study|Tablet error|0|||
129910641|NCT02544074|467637589|FG013|Overall Study|Tablet error|0|||
130094778|NCT01018680|468303840|FG001|Overall Study|Sponsor Decision|7|||
130094779|NCT01018680|468303839|FG000|Overall Study|Lack of Efficacy|8|||
129910642|NCT02544074|467637590|FG014|Overall Study|Tablet error|0|||
129910643|NCT02544074|467637591|FG015|Overall Study|Tablet error|0|||
129910644|NCT02544074|467637592|FG016|Overall Study|Tablet error|0|||
129910645|NCT02544074|467637593|FG017|Overall Study|Tablet error|0|||
129910646|NCT02544074|467637594|FG018|Overall Study|Tablet error|0|||
129910647|NCT02544074|467637595|FG019|Overall Study|Tablet error|0|||
129910648|NCT02544074|467637596|FG020|Overall Study|Tablet error|0|||
129910649|NCT04139668|467637597|FG000|Overall Study|Withdrawal by Subject|1|||
129910650|NCT03025789|467637602|FG000|Overall Study|Lack of Efficacy|6|||
129910651|NCT03025789|467637603|FG001|Overall Study|Lack of Efficacy|1|||
129910652|NCT03025789|467637602|FG000|Overall Study|Death|1|||
129910653|NCT03025789|467637603|FG001|Overall Study|Death|0|||
129910654|NCT03025789|467637602|FG000|Overall Study|Withdrawal by Subject|0|||
129910655|NCT03025789|467637603|FG001|Overall Study|Withdrawal by Subject|2|||
129910656|NCT02723955|467637605|FG000|Escalation Phase|Death|1|||
129910657|NCT02723955|467637606|FG001|Escalation Phase|Death|1|||
129910658|NCT02723955|467637607|FG002|Escalation Phase|Death|2|||
129910659|NCT02723955|467637608|FG003|Escalation Phase|Death|7|||
129910660|NCT02723955|467637609|FG004|Escalation Phase|Death|18|||
129910661|NCT02723955|467637610|FG005|Escalation Phase|Death|17|||
129910662|NCT02723955|467637611|FG006|Escalation Phase|Death|11|||
129910663|NCT02723955|467637612|FG007|Escalation Phase|Death|21|||
129910664|NCT02723955|467637613|FG008|Escalation Phase|Death|3|||
129910665|NCT02723955|467637614|FG009|Escalation Phase|Death|0|||
129910666|NCT02723955|467637615|FG010|Escalation Phase|Death|0|||
129910667|NCT02723955|467637616|FG011|Escalation Phase|Death|0|||
129910668|NCT02723955|467637617|FG012|Escalation Phase|Death|2|||
129910669|NCT02723955|467637618|FG013|Escalation Phase|Death|4|||
129910670|NCT02723955|467637619|FG014|Escalation Phase|Death|5|||
129910671|NCT02723955|467637620|FG015|Escalation Phase|Death|6|||
129910672|NCT02723955|467637621|FG016|Escalation Phase|Death|6|||
129910673|NCT02723955|467637622|FG017|Escalation Phase|Death|7|||
129910674|NCT02723955|467637623|FG018|Escalation Phase|Death|1|||
129910675|NCT02723955|467637624|FG019|Escalation Phase|Death|3|||
129910676|NCT02723955|467637625|FG020|Escalation Phase|Death|13|||
129910677|NCT02723955|467637626|FG021|Escalation Phase|Death|3|||
129910678|NCT02723955|467637627|FG022|Escalation Phase|Death|2|||
129910679|NCT02723955|467637628|FG023|Escalation Phase|Death|4|||
129910680|NCT02723955|467637629|FG024|Escalation Phase|Death|31|||
129910681|NCT02723955|467637630|FG025|Escalation Phase|Death|7|||
129910682|NCT02723955|467637631|FG026|Escalation Phase|Death|13|||
129910683|NCT02723955|467637632|FG027|Escalation Phase|Death|0|||
129910684|NCT02723955|467637633|FG028|Escalation Phase|Death|1|||
129910685|NCT02723955|467637634|FG029|Escalation Phase|Death|0|||
129910686|NCT02723955|467637635|FG030|Escalation Phase|Death|0|||
129910687|NCT02723955|467637636|FG031|Escalation Phase|Death|0|||
129910688|NCT02723955|467637637|FG032|Escalation Phase|Death|0|||
129910689|NCT02723955|467637638|FG033|Escalation Phase|Death|0|||
129910690|NCT02723955|467637639|FG034|Escalation Phase|Death|0|||
129910691|NCT02723955|467637640|FG035|Escalation Phase|Death|0|||
129910692|NCT02723955|467637641|FG036|Escalation Phase|Death|0|||
129910693|NCT02723955|467637642|FG037|Escalation Phase|Death|0|||
129910694|NCT02723955|467637643|FG038|Escalation Phase|Death|0|||
129910695|NCT02723955|467637644|FG039|Escalation Phase|Death|0|||
129910696|NCT02723955|467637645|FG040|Escalation Phase|Death|0|||
129910697|NCT02723955|467637646|FG041|Escalation Phase|Death|0|||
130064767|NCT03288493|468190280|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
130064768|NCT03288493|468190274|FG000|Overall Study|Death|2|||
130064769|NCT03288493|468190275|FG001|Overall Study|Death|0|||
130064770|NCT03288493|468190276|FG002|Overall Study|Death|0|||
130064771|NCT03288493|468190277|FG003|Overall Study|Death|0|||
130064772|NCT03288493|468190278|FG004|Overall Study|Death|0|||
129910698|NCT02723955|467637647|FG042|Escalation Phase|Death|0|||
129910699|NCT02723955|467637605|FG000|Escalation Phase|Lost to Follow-up|0|||
129910700|NCT02723955|467637606|FG001|Escalation Phase|Lost to Follow-up|0|||
129910701|NCT02723955|467637607|FG002|Escalation Phase|Lost to Follow-up|0|||
129910702|NCT02723955|467637608|FG003|Escalation Phase|Lost to Follow-up|0|||
129910703|NCT02723955|467637609|FG004|Escalation Phase|Lost to Follow-up|0|||
129910704|NCT02723955|467637610|FG005|Escalation Phase|Lost to Follow-up|2|||
129910705|NCT02723955|467637611|FG006|Escalation Phase|Lost to Follow-up|1|||
129910706|NCT02723955|467637612|FG007|Escalation Phase|Lost to Follow-up|1|||
129910707|NCT02723955|467637613|FG008|Escalation Phase|Lost to Follow-up|1|||
129910708|NCT02723955|467637614|FG009|Escalation Phase|Lost to Follow-up|0|||
129910709|NCT02723955|467637615|FG010|Escalation Phase|Lost to Follow-up|0|||
130064773|NCT03288493|468190279|FG005|Overall Study|Death|0|||
129910710|NCT02723955|467637616|FG011|Escalation Phase|Lost to Follow-up|0|||
129910711|NCT02723955|467637617|FG012|Escalation Phase|Lost to Follow-up|1|||
129910712|NCT02723955|467637618|FG013|Escalation Phase|Lost to Follow-up|0|||
129910713|NCT02723955|467637619|FG014|Escalation Phase|Lost to Follow-up|0|||
129910714|NCT02723955|467637620|FG015|Escalation Phase|Lost to Follow-up|0|||
129910715|NCT02723955|467637621|FG016|Escalation Phase|Lost to Follow-up|1|||
129910716|NCT02723955|467637622|FG017|Escalation Phase|Lost to Follow-up|2|||
130064774|NCT03288493|468190280|FG006|Overall Study|Death|0|||
129910717|NCT02723955|467637623|FG018|Escalation Phase|Lost to Follow-up|0|||
129910718|NCT02723955|467637624|FG019|Escalation Phase|Lost to Follow-up|1|||
129910719|NCT02723955|467637625|FG020|Escalation Phase|Lost to Follow-up|2|||
129910720|NCT02723955|467637626|FG021|Escalation Phase|Lost to Follow-up|1|||
129910721|NCT02723955|467637627|FG022|Escalation Phase|Lost to Follow-up|0|||
129910722|NCT02723955|467637628|FG023|Escalation Phase|Lost to Follow-up|0|||
129910723|NCT02723955|467637629|FG024|Escalation Phase|Lost to Follow-up|1|||
129861269|NCT03230916|467447915|FG000|Overall Study|Withdrawal by Subject|0|||
129861270|NCT03230916|467447916|FG001|Overall Study|Withdrawal by Subject|0|||
129861271|NCT03230916|467447917|FG002|Overall Study|Withdrawal by Subject|0|||
129861272|NCT03230916|467447918|FG003|Overall Study|Withdrawal by Subject|0|||
129861273|NCT03230916|467447919|FG004|Overall Study|Withdrawal by Subject|0|||
129861274|NCT03230916|467447920|FG005|Overall Study|Withdrawal by Subject|1|||
129861275|NCT03230916|467447921|FG006|Overall Study|Withdrawal by Subject|0|||
129861276|NCT03230916|467447922|FG007|Overall Study|Withdrawal by Subject|0|||
129861277|NCT03230916|467447923|FG008|Overall Study|Withdrawal by Subject|0|||
129861278|NCT03230916|467447924|FG009|Overall Study|Withdrawal by Subject|0|||
129861279|NCT03230916|467447925|FG010|Overall Study|Withdrawal by Subject|0|||
129861280|NCT00680407|467447928|FG000|Overall Study|Lost to Follow-up|3|||
129861281|NCT00680407|467447929|FG001|Overall Study|Lost to Follow-up|3|||
129861282|NCT00680407|467447930|FG002|Overall Study|Lost to Follow-up|1|||
129861283|NCT00680407|467447928|FG000|Overall Study|Withdrawal by Subject|5|||
129861284|NCT00680407|467447929|FG001|Overall Study|Withdrawal by Subject|2|||
129861285|NCT00680407|467447930|FG002|Overall Study|Withdrawal by Subject|2|||
129861286|NCT03069482|467449553|FG000|Overall Study|Lost to Follow-up|0|||
129861287|NCT03069482|467449554|FG001|Overall Study|Lost to Follow-up|1|||
129861288|NCT03069482|467449553|FG000|Overall Study|Physician Decision|1|||
129861289|NCT03069482|467449554|FG001|Overall Study|Physician Decision|0|||
129861290|NCT00791765|467449555|FG000|Weeks 1 to 12|Adverse Event|0|||
129861291|NCT00791765|467449556|FG001|Weeks 1 to 12|Adverse Event|1|||
129861292|NCT00791765|467449555|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
129861293|NCT00791765|467449556|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
129861294|NCT00791765|467449555|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
129861295|NCT00791765|467449556|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
129861296|NCT00791765|467449555|FG000|Weeks 1 to 12|Physician Decision|1|||
129861297|NCT00791765|467449556|FG001|Weeks 1 to 12|Physician Decision|0|||
129861298|NCT00791765|467449555|FG000|Weeks 1 to 12|Disease progression|3|||
129861299|NCT00791765|467449556|FG001|Weeks 1 to 12|Disease progression|0|||
129861300|NCT00791765|467449555|FG000|Weeks 1 to 12|Ineligibility determined|0|||
129861301|NCT00791765|467449556|FG001|Weeks 1 to 12|Ineligibility determined|3|||
129861302|NCT00791765|467449555|FG000|Weeks 13 to 24|Protocol deviation|2|||
129861303|NCT00791765|467449556|FG001|Weeks 13 to 24|Protocol deviation|0|||
129861304|NCT00791765|467449555|FG000|Weeks 13 to 24|Adverse Event|0|||
129861305|NCT00791765|467449556|FG001|Weeks 13 to 24|Adverse Event|3|||
129861306|NCT00791765|467449555|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
129861307|NCT00791765|467449556|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
129861308|NCT00791765|467449555|FG000|Weeks 13 to 24|Disease progression|0|||
129861309|NCT00791765|467449556|FG001|Weeks 13 to 24|Disease progression|1|||
129861310|NCT00791765|467449555|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
129861311|NCT00791765|467449556|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
129861312|NCT00791765|467449555|FG000|Weeks 13 to 24|Other|0|||
129861313|NCT00791765|467449556|FG001|Weeks 13 to 24|Other|1|||
129861314|NCT01877408|467449567|FG000|Overall Study|Lost to Follow-up|0|||
129861315|NCT01877408|467449568|FG001|Overall Study|Lost to Follow-up|2|||
129861316|NCT00156065|467449569|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
129861317|NCT00156065|467449570|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
129861318|NCT00156065|467449571|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
129861319|NCT00156065|467449569|FG000|Overall Study|Adverse Event|8|||
129861320|NCT00156065|467449570|FG001|Overall Study|Adverse Event|11|||
129861321|NCT00156065|467449571|FG002|Overall Study|Adverse Event|4|||
129861322|NCT00156065|467449569|FG000|Overall Study|Lack of Efficacy|2|||
129861323|NCT00156065|467449570|FG001|Overall Study|Lack of Efficacy|9|||
129861324|NCT00156065|467449571|FG002|Overall Study|Lack of Efficacy|3|||
129861325|NCT00156065|467449569|FG000|Overall Study|Withdrawal by Subject|13|||
129861326|NCT00156065|467449570|FG001|Overall Study|Withdrawal by Subject|26|||
129861327|NCT00156065|467449571|FG002|Overall Study|Withdrawal by Subject|16|||
129861328|NCT00156065|467449569|FG000|Overall Study|Lost to Follow-up|5|||
129861329|NCT00156065|467449570|FG001|Overall Study|Lost to Follow-up|7|||
129861330|NCT00156065|467449571|FG002|Overall Study|Lost to Follow-up|1|||
129861331|NCT00156065|467449569|FG000|Overall Study|Other|2|||
129861332|NCT00156065|467449570|FG001|Overall Study|Other|9|||
129861333|NCT00156065|467449571|FG002|Overall Study|Other|3|||
129910724|NCT02723955|467637630|FG025|Escalation Phase|Lost to Follow-up|1|||
129910725|NCT02723955|467637631|FG026|Escalation Phase|Lost to Follow-up|3|||
129861334|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861335|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129910726|NCT02723955|467637632|FG027|Escalation Phase|Lost to Follow-up|0|||
129910727|NCT02723955|467637633|FG028|Escalation Phase|Lost to Follow-up|1|||
129861336|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861337|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
129861338|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861339|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861340|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
129861341|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
129861342|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
129861343|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
129861344|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
129861345|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
129861346|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861347|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861348|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861349|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
129861350|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861351|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861352|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861353|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861354|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861355|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
129861356|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861357|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861358|NCT01292603|467449572|FG000|Part 1: Regular Follow-Up Period|Death|3|||
129861359|NCT01292603|467449573|FG001|Part 1: Regular Follow-Up Period|Death|1|||
129861360|NCT01292603|467449574|FG002|Part 1: Regular Follow-Up Period|Death|3|||
129861361|NCT01292603|467449575|FG003|Part 1: Regular Follow-Up Period|Death|1|||
129861362|NCT01292603|467449576|FG004|Part 1: Regular Follow-Up Period|Death|0|||
129861363|NCT01292603|467449577|FG005|Part 1: Regular Follow-Up Period|Death|0|||
129861364|NCT01292603|467449572|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
129861365|NCT01292603|467449573|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
129861366|NCT01292603|467449574|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
129861367|NCT01292603|467449575|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
129861368|NCT01292603|467449576|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
129861369|NCT01292603|467449577|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
129861370|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Death|0|||
129861371|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Death|0|||
129861372|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Death|0|||
129861373|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Death|0|||
129861374|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Death|1|||
129861375|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Death|0|||
129861376|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861377|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861378|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861379|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861380|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
129861381|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861382|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861383|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861384|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861385|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861386|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
129861387|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
129861388|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861389|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861390|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861391|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861392|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
129861393|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
129861394|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861395|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861396|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861397|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861398|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
129861399|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
129861400|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861401|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861402|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861403|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129910728|NCT02723955|467637634|FG029|Escalation Phase|Lost to Follow-up|0|||
129910729|NCT02723955|467637635|FG030|Escalation Phase|Lost to Follow-up|0|||
129910730|NCT02723955|467637636|FG031|Escalation Phase|Lost to Follow-up|0|||
129910731|NCT02723955|467637637|FG032|Escalation Phase|Lost to Follow-up|0|||
129910732|NCT02723955|467637638|FG033|Escalation Phase|Lost to Follow-up|0|||
129910733|NCT02723955|467637639|FG034|Escalation Phase|Lost to Follow-up|0|||
129861404|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861405|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
129861406|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Death|0|||
129861407|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Death|0|||
129861408|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Death|0|||
129861409|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Death|0|||
129861410|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Death|6|||
129861411|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Death|3|||
129861412|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
129861413|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
129861414|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
129861415|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
129861416|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
129861417|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
129861418|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
129861419|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
129861420|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
129861421|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
129861422|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
129861423|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
129861424|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861425|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861426|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861427|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861428|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861429|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
129861430|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861431|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861432|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861433|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861434|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
129861435|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861436|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
129861437|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
129861438|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
129861439|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
129861440|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
129861441|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
129861442|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861443|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861444|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861445|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861446|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
129861447|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
129861448|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
129861449|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
129861450|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
129861451|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
129861452|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
129861453|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
129861454|NCT01292603|467449572|FG000|Overall Survival Status|Death|3|||
129861455|NCT01292603|467449573|FG001|Overall Survival Status|Death|1|||
129861456|NCT01292603|467449574|FG002|Overall Survival Status|Death|3|||
129861457|NCT01292603|467449575|FG003|Overall Survival Status|Death|1|||
129861458|NCT01292603|467449576|FG004|Overall Survival Status|Death|16|||
129861459|NCT01292603|467449577|FG005|Overall Survival Status|Death|10|||
129861460|NCT03870763|467449580|FG000|Overall Study|Study terminated by sponsor|0|||
129861461|NCT03870763|467449581|FG001|Overall Study|Study terminated by sponsor|2|||
129861462|NCT03870763|467449582|FG002|Overall Study|Study terminated by sponsor|0|||
129861463|NCT03870763|467449580|FG000|Overall Study|Withdrawal by Subject|0|||
129861464|NCT03870763|467449581|FG001|Overall Study|Withdrawal by Subject|1|||
129861465|NCT03870763|467449582|FG002|Overall Study|Withdrawal by Subject|0|||
129861466|NCT03870763|467449580|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
129910734|NCT02723955|467637640|FG035|Escalation Phase|Lost to Follow-up|0|||
129910735|NCT02723955|467637641|FG036|Escalation Phase|Lost to Follow-up|0|||
129910736|NCT02723955|467637642|FG037|Escalation Phase|Lost to Follow-up|0|||
129861467|NCT03870763|467449581|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
129861468|NCT03870763|467449582|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
129861469|NCT03586648|467449585|FG000|Period 1|Withdrawal by Subject|0|||
129861470|NCT03586648|467449586|FG001|Period 1|Withdrawal by Subject|1|||
129861471|NCT03586648|467449585|FG000|Period 1|Lost to Follow-up|1|||
130064775|NCT03288493|468190274|FG000|Overall Study|other reason not listed above|2|||
130064776|NCT03288493|468190275|FG001|Overall Study|other reason not listed above|0|||
130064777|NCT03288493|468190276|FG002|Overall Study|other reason not listed above|0|||
130064778|NCT03288493|468190277|FG003|Overall Study|other reason not listed above|0|||
129861472|NCT03586648|467449586|FG001|Period 1|Lost to Follow-up|1|||
129861473|NCT03586648|467449585|FG000|Period 1|Adverse Event|1|||
129861474|NCT03586648|467449586|FG001|Period 1|Adverse Event|0|||
129861475|NCT03586648|467449585|FG000|Period 1|Study related symptoms or complaints|2|||
129861476|NCT03586648|467449586|FG001|Period 1|Study related symptoms or complaints|1|||
129861477|NCT03586648|467449585|FG000|Period 1|Physician Decision|0|||
129861478|NCT03586648|467449586|FG001|Period 1|Physician Decision|1|||
129861479|NCT03586648|467449585|FG000|Period 2|Adverse Event|1|||
129861480|NCT03586648|467449586|FG001|Period 2|Adverse Event|0|||
129861481|NCT00907153|467449587|FG000|Overall Study|Lost to Follow-up|1|||
129861482|NCT00907153|467449588|FG001|Overall Study|Lost to Follow-up|1|||
129861483|NCT00907153|467449587|FG000|Overall Study|Withdrawal by Subject|1|||
129861484|NCT00907153|467449588|FG001|Overall Study|Withdrawal by Subject|3|||
129861485|NCT03147248|467449589|FG000|Overall Study|Adverse Event|0|||
129861486|NCT03147248|467449590|FG001|Overall Study|Adverse Event|2|||
129861487|NCT03147248|467449591|FG002|Overall Study|Adverse Event|2|||
129861488|NCT03147248|467449592|FG003|Overall Study|Adverse Event|2|||
129861489|NCT03147248|467449593|FG004|Overall Study|Adverse Event|6|||
129861490|NCT03147248|467449594|FG005|Overall Study|Adverse Event|11|||
129861491|NCT03147248|467449589|FG000|Overall Study|Disease progression|1|||
129861492|NCT03147248|467449590|FG001|Overall Study|Disease progression|0|||
129861493|NCT03147248|467449591|FG002|Overall Study|Disease progression|0|||
129861494|NCT03147248|467449592|FG003|Overall Study|Disease progression|0|||
129861495|NCT03147248|467449593|FG004|Overall Study|Disease progression|0|||
129861496|NCT03147248|467449594|FG005|Overall Study|Disease progression|2|||
129861497|NCT03147248|467449589|FG000|Overall Study|Withdrawal by Subject|0|||
129861498|NCT03147248|467449590|FG001|Overall Study|Withdrawal by Subject|0|||
129861499|NCT03147248|467449591|FG002|Overall Study|Withdrawal by Subject|0|||
129861500|NCT03147248|467449592|FG003|Overall Study|Withdrawal by Subject|0|||
129861501|NCT03147248|467449593|FG004|Overall Study|Withdrawal by Subject|12|||
129861502|NCT03147248|467449594|FG005|Overall Study|Withdrawal by Subject|9|||
129861503|NCT03147248|467449589|FG000|Overall Study|Protocol Violation|0|||
129861504|NCT03147248|467449590|FG001|Overall Study|Protocol Violation|0|||
129910737|NCT02723955|467637643|FG038|Escalation Phase|Lost to Follow-up|0|||
129910738|NCT02723955|467637644|FG039|Escalation Phase|Lost to Follow-up|0|||
129910739|NCT02723955|467637645|FG040|Escalation Phase|Lost to Follow-up|0|||
129910740|NCT02723955|467637646|FG041|Escalation Phase|Lost to Follow-up|0|||
129910741|NCT02723955|467637647|FG042|Escalation Phase|Lost to Follow-up|0|||
129910742|NCT02723955|467637605|FG000|Escalation Phase|Physician Decision|0|||
129910743|NCT02723955|467637606|FG001|Escalation Phase|Physician Decision|0|||
129910744|NCT02723955|467637607|FG002|Escalation Phase|Physician Decision|0|||
129910745|NCT02723955|467637608|FG003|Escalation Phase|Physician Decision|0|||
129910746|NCT02723955|467637609|FG004|Escalation Phase|Physician Decision|0|||
129910747|NCT02723955|467637610|FG005|Escalation Phase|Physician Decision|2|||
129910748|NCT02723955|467637611|FG006|Escalation Phase|Physician Decision|0|||
129910749|NCT02723955|467637612|FG007|Escalation Phase|Physician Decision|0|||
129910750|NCT02723955|467637613|FG008|Escalation Phase|Physician Decision|0|||
129910751|NCT02723955|467637614|FG009|Escalation Phase|Physician Decision|0|||
129910752|NCT02723955|467637615|FG010|Escalation Phase|Physician Decision|0|||
129910753|NCT02723955|467637616|FG011|Escalation Phase|Physician Decision|0|||
129910754|NCT02723955|467637617|FG012|Escalation Phase|Physician Decision|0|||
129910755|NCT02723955|467637618|FG013|Escalation Phase|Physician Decision|0|||
129910756|NCT02723955|467637619|FG014|Escalation Phase|Physician Decision|0|||
129910757|NCT02723955|467637620|FG015|Escalation Phase|Physician Decision|0|||
130064779|NCT03288493|468190278|FG004|Overall Study|other reason not listed above|0|||
129861505|NCT03147248|467449591|FG002|Overall Study|Protocol Violation|0|||
129861506|NCT03147248|467449592|FG003|Overall Study|Protocol Violation|0|||
129861507|NCT03147248|467449593|FG004|Overall Study|Protocol Violation|2|||
129861508|NCT03147248|467449594|FG005|Overall Study|Protocol Violation|0|||
129861509|NCT03147248|467449589|FG000|Overall Study|Lost to Follow-up|0|||
129910758|NCT02723955|467637621|FG016|Escalation Phase|Physician Decision|0|||
129910759|NCT02723955|467637622|FG017|Escalation Phase|Physician Decision|0|||
129910760|NCT02723955|467637623|FG018|Escalation Phase|Physician Decision|0|||
130064780|NCT03288493|468190279|FG005|Overall Study|other reason not listed above|0|||
129861510|NCT03147248|467449590|FG001|Overall Study|Lost to Follow-up|0|||
129910761|NCT02723955|467637624|FG019|Escalation Phase|Physician Decision|0|||
129861511|NCT03147248|467449591|FG002|Overall Study|Lost to Follow-up|0|||
129861512|NCT03147248|467449592|FG003|Overall Study|Lost to Follow-up|0|||
129910762|NCT02723955|467637625|FG020|Escalation Phase|Physician Decision|0|||
130064781|NCT03288493|468190280|FG006|Overall Study|other reason not listed above|0|||
130064782|NCT03784027|468190281|FG000|Period 1|Withdrawal by Subject|0|||
130064783|NCT03784027|468190282|FG001|Period 1|Withdrawal by Subject|1|||
130064784|NCT00646113|468192235|FG000|Overall Study|Lost to Follow-up|5|||
130064785|NCT00646113|468192235|FG000|Overall Study|Adverse Event|3|||
130064786|NCT04095442|468192236|FG000|Overall Study|Lost to Follow-up|0|||
129861513|NCT03147248|467449593|FG004|Overall Study|Lost to Follow-up|2|||
129861514|NCT03147248|467449594|FG005|Overall Study|Lost to Follow-up|0|||
129861515|NCT03147248|467449589|FG000|Overall Study|Pregnancy|0|||
129861516|NCT03147248|467449590|FG001|Overall Study|Pregnancy|0|||
129861517|NCT03147248|467449591|FG002|Overall Study|Pregnancy|0|||
129861518|NCT03147248|467449592|FG003|Overall Study|Pregnancy|0|||
129861519|NCT03147248|467449593|FG004|Overall Study|Pregnancy|1|||
129861520|NCT03147248|467449594|FG005|Overall Study|Pregnancy|0|||
129861521|NCT03147248|467449589|FG000|Overall Study|Death|0|||
129861522|NCT03147248|467449590|FG001|Overall Study|Death|0|||
129861523|NCT03147248|467449591|FG002|Overall Study|Death|0|||
129861524|NCT03147248|467449592|FG003|Overall Study|Death|0|||
129861525|NCT03147248|467449593|FG004|Overall Study|Death|0|||
129861526|NCT03147248|467449594|FG005|Overall Study|Death|4|||
129861527|NCT03147248|467449589|FG000|Overall Study|Physician Decision|0|||
129861528|NCT03147248|467449590|FG001|Overall Study|Physician Decision|0|||
129861529|NCT03147248|467449591|FG002|Overall Study|Physician Decision|0|||
129861530|NCT03147248|467449592|FG003|Overall Study|Physician Decision|0|||
129861531|NCT03147248|467449593|FG004|Overall Study|Physician Decision|2|||
129861532|NCT03147248|467449594|FG005|Overall Study|Physician Decision|4|||
129861533|NCT03147248|467449589|FG000|Overall Study|Prolonged Dosing Interval|0|||
129861534|NCT03147248|467449590|FG001|Overall Study|Prolonged Dosing Interval|0|||
129861535|NCT03147248|467449591|FG002|Overall Study|Prolonged Dosing Interval|0|||
129861536|NCT03147248|467449592|FG003|Overall Study|Prolonged Dosing Interval|0|||
129861537|NCT03147248|467449593|FG004|Overall Study|Prolonged Dosing Interval|1|||
129861538|NCT03147248|467449594|FG005|Overall Study|Prolonged Dosing Interval|1|||
129861539|NCT02388724|467449597|FG000|Overall Study|Reason not Specified|0|||
129861540|NCT02388724|467449598|FG001|Overall Study|Reason not Specified|1|||
129861541|NCT02388724|467449597|FG000|Overall Study|Major Protocol Deviation|3|||
129861542|NCT02388724|467449598|FG001|Overall Study|Major Protocol Deviation|3|||
129861543|NCT02388724|467449597|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129861544|NCT02388724|467449598|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129861545|NCT02388724|467449597|FG000|Overall Study|Voluntary Withdrawal|6|||
129861546|NCT02388724|467449598|FG001|Overall Study|Voluntary Withdrawal|5|||
129861547|NCT02388724|467449597|FG000|Overall Study|Randomized but not Treated|0|||
129861548|NCT02388724|467449598|FG001|Overall Study|Randomized but not Treated|2|||
129861549|NCT02605954|467449599|FG000|Overall Study|Adverse Event|5|||
129861550|NCT02605954|467449600|FG001|Overall Study|Adverse Event|1|||
129861551|NCT02605954|467449599|FG000|Overall Study|Investigator's Discretion|1|||
129861552|NCT02605954|467449600|FG001|Overall Study|Investigator's Discretion|0|||
129861553|NCT02605954|467449599|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129861554|NCT02605954|467449600|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129861555|NCT02605954|467449599|FG000|Overall Study|Withdrew Consent|2|||
129861556|NCT02605954|467449600|FG001|Overall Study|Withdrew Consent|2|||
129861557|NCT02605954|467449599|FG000|Overall Study|Lost to Follow-up|3|||
129861558|NCT02605954|467449600|FG001|Overall Study|Lost to Follow-up|0|||
129861559|NCT02605954|467449599|FG000|Overall Study|Randomized but not treated|0|||
129861560|NCT02605954|467449600|FG001|Overall Study|Randomized but not treated|1|||
129861561|NCT03214367|467449601|FG000|Lead-in Period|Withdrawal by Subject|50|||
129861562|NCT03214367|467449602|FG001|Lead-in Period|Withdrawal by Subject|0|||
129861563|NCT03214367|467449603|FG002|Lead-in Period|Withdrawal by Subject|0|||
129861564|NCT03214367|467449604|FG003|Lead-in Period|Withdrawal by Subject|0|||
129861565|NCT03214367|467449605|FG004|Lead-in Period|Withdrawal by Subject|2|||
129861566|NCT03214367|467449606|FG005|Lead-in Period|Withdrawal by Subject|0|||
129861567|NCT03214367|467449607|FG006|Lead-in Period|Withdrawal by Subject|0|||
129861568|NCT03214367|467449608|FG007|Lead-in Period|Withdrawal by Subject|0|||
129861569|NCT03214367|467449601|FG000|Lead-in Period|Adverse Event|3|||
129861570|NCT03214367|467449602|FG001|Lead-in Period|Adverse Event|0|||
129861571|NCT03214367|467449603|FG002|Lead-in Period|Adverse Event|0|||
129861572|NCT03214367|467449604|FG003|Lead-in Period|Adverse Event|0|||
129861573|NCT03214367|467449605|FG004|Lead-in Period|Adverse Event|0|||
129861574|NCT03214367|467449606|FG005|Lead-in Period|Adverse Event|0|||
129861575|NCT03214367|467449607|FG006|Lead-in Period|Adverse Event|0|||
129861576|NCT03214367|467449608|FG007|Lead-in Period|Adverse Event|0|||
129861577|NCT03214367|467449601|FG000|Lead-in Period|Lost to Follow-up|12|||
129861578|NCT03214367|467449602|FG001|Lead-in Period|Lost to Follow-up|0|||
129861579|NCT03214367|467449603|FG002|Lead-in Period|Lost to Follow-up|0|||
129861580|NCT03214367|467449604|FG003|Lead-in Period|Lost to Follow-up|0|||
129861581|NCT03214367|467449605|FG004|Lead-in Period|Lost to Follow-up|0|||
129861582|NCT03214367|467449606|FG005|Lead-in Period|Lost to Follow-up|0|||
129861583|NCT03214367|467449607|FG006|Lead-in Period|Lost to Follow-up|0|||
129910763|NCT02723955|467637626|FG021|Escalation Phase|Physician Decision|0|||
129910764|NCT02723955|467637627|FG022|Escalation Phase|Physician Decision|0|||
129910765|NCT02723955|467637628|FG023|Escalation Phase|Physician Decision|0|||
130116652|NCT00585351|468387154|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
129861584|NCT03214367|467449608|FG007|Lead-in Period|Lost to Follow-up|0|||
129861585|NCT03214367|467449601|FG000|Lead-in Period|Sponsor Decision|11|||
129861586|NCT03214367|467449602|FG001|Lead-in Period|Sponsor Decision|0|||
129861587|NCT03214367|467449603|FG002|Lead-in Period|Sponsor Decision|0|||
129861588|NCT03214367|467449604|FG003|Lead-in Period|Sponsor Decision|0|||
129861589|NCT03214367|467449605|FG004|Lead-in Period|Sponsor Decision|0|||
129861590|NCT03214367|467449606|FG005|Lead-in Period|Sponsor Decision|0|||
129861591|NCT03214367|467449607|FG006|Lead-in Period|Sponsor Decision|0|||
129861592|NCT03214367|467449608|FG007|Lead-in Period|Sponsor Decision|0|||
129861593|NCT03214367|467449601|FG000|Lead-in Period|Physician Decision|12|||
129861594|NCT03214367|467449602|FG001|Lead-in Period|Physician Decision|0|||
129861595|NCT03214367|467449603|FG002|Lead-in Period|Physician Decision|0|||
129861596|NCT03214367|467449604|FG003|Lead-in Period|Physician Decision|0|||
129861597|NCT03214367|467449605|FG004|Lead-in Period|Physician Decision|0|||
129861598|NCT03214367|467449606|FG005|Lead-in Period|Physician Decision|0|||
129861599|NCT03214367|467449607|FG006|Lead-in Period|Physician Decision|0|||
129861600|NCT03214367|467449608|FG007|Lead-in Period|Physician Decision|0|||
129861601|NCT03214367|467449601|FG000|Lead-in Period|Protocol Violation|5|||
129861602|NCT03214367|467449602|FG001|Lead-in Period|Protocol Violation|0|||
129861603|NCT03214367|467449603|FG002|Lead-in Period|Protocol Violation|0|||
129861604|NCT03214367|467449604|FG003|Lead-in Period|Protocol Violation|0|||
129861605|NCT03214367|467449605|FG004|Lead-in Period|Protocol Violation|0|||
129861606|NCT03214367|467449606|FG005|Lead-in Period|Protocol Violation|0|||
129861607|NCT03214367|467449607|FG006|Lead-in Period|Protocol Violation|0|||
129861608|NCT03214367|467449608|FG007|Lead-in Period|Protocol Violation|0|||
129861609|NCT03214367|467449601|FG000|Lead-in Period|Treatment Interruption|1|||
129861610|NCT03214367|467449602|FG001|Lead-in Period|Treatment Interruption|0|||
129861611|NCT03214367|467449603|FG002|Lead-in Period|Treatment Interruption|0|||
129861612|NCT03214367|467449604|FG003|Lead-in Period|Treatment Interruption|0|||
129861613|NCT03214367|467449605|FG004|Lead-in Period|Treatment Interruption|0|||
129861614|NCT03214367|467449606|FG005|Lead-in Period|Treatment Interruption|0|||
129861615|NCT03214367|467449607|FG006|Lead-in Period|Treatment Interruption|0|||
129861616|NCT03214367|467449608|FG007|Lead-in Period|Treatment Interruption|0|||
129861617|NCT03214367|467449601|FG000|Treatment Period|Adverse Event|0|||
129861618|NCT03214367|467449602|FG001|Treatment Period|Adverse Event|1|||
129861619|NCT03214367|467449603|FG002|Treatment Period|Adverse Event|4|||
129861620|NCT03214367|467449604|FG003|Treatment Period|Adverse Event|2|||
129861621|NCT03214367|467449605|FG004|Treatment Period|Adverse Event|0|||
129861622|NCT03214367|467449606|FG005|Treatment Period|Adverse Event|0|||
129861623|NCT03214367|467449607|FG006|Treatment Period|Adverse Event|0|||
129861624|NCT03214367|467449608|FG007|Treatment Period|Adverse Event|0|||
129861625|NCT03214367|467449601|FG000|Treatment Period|Death|0|||
129861626|NCT03214367|467449602|FG001|Treatment Period|Death|1|||
129861627|NCT03214367|467449603|FG002|Treatment Period|Death|1|||
129861628|NCT03214367|467449604|FG003|Treatment Period|Death|1|||
129861629|NCT03214367|467449605|FG004|Treatment Period|Death|0|||
129861630|NCT03214367|467449606|FG005|Treatment Period|Death|0|||
129861631|NCT03214367|467449607|FG006|Treatment Period|Death|0|||
129861632|NCT03214367|467449608|FG007|Treatment Period|Death|0|||
129861633|NCT03214367|467449601|FG000|Treatment Period|Lost to Follow-up|0|||
129861634|NCT03214367|467449602|FG001|Treatment Period|Lost to Follow-up|5|||
129861635|NCT03214367|467449603|FG002|Treatment Period|Lost to Follow-up|3|||
129861636|NCT03214367|467449604|FG003|Treatment Period|Lost to Follow-up|2|||
129861637|NCT03214367|467449605|FG004|Treatment Period|Lost to Follow-up|0|||
129861638|NCT03214367|467449606|FG005|Treatment Period|Lost to Follow-up|2|||
129861639|NCT03214367|467449607|FG006|Treatment Period|Lost to Follow-up|1|||
129861640|NCT03214367|467449608|FG007|Treatment Period|Lost to Follow-up|0|||
129861641|NCT03214367|467449601|FG000|Treatment Period|Sponsor Decision|0|||
129910766|NCT02723955|467637629|FG024|Escalation Phase|Physician Decision|0|||
129910767|NCT02723955|467637630|FG025|Escalation Phase|Physician Decision|0|||
130116653|NCT00585351|468387147|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
129861642|NCT03214367|467449602|FG001|Treatment Period|Sponsor Decision|3|||
129861643|NCT03214367|467449603|FG002|Treatment Period|Sponsor Decision|0|||
129861644|NCT03214367|467449604|FG003|Treatment Period|Sponsor Decision|0|||
129861645|NCT03214367|467449605|FG004|Treatment Period|Sponsor Decision|0|||
129861646|NCT03214367|467449606|FG005|Treatment Period|Sponsor Decision|0|||
129861647|NCT03214367|467449607|FG006|Treatment Period|Sponsor Decision|0|||
129861648|NCT03214367|467449608|FG007|Treatment Period|Sponsor Decision|0|||
129861649|NCT03214367|467449601|FG000|Treatment Period|Physician Decision|0|||
129861650|NCT03214367|467449602|FG001|Treatment Period|Physician Decision|1|||
129861651|NCT03214367|467449603|FG002|Treatment Period|Physician Decision|2|||
129861652|NCT03214367|467449604|FG003|Treatment Period|Physician Decision|0|||
129861653|NCT03214367|467449605|FG004|Treatment Period|Physician Decision|0|||
129861654|NCT03214367|467449606|FG005|Treatment Period|Physician Decision|0|||
129910768|NCT02723955|467637631|FG026|Escalation Phase|Physician Decision|2|||
129910769|NCT02723955|467637632|FG027|Escalation Phase|Physician Decision|0|||
129910770|NCT02723955|467637633|FG028|Escalation Phase|Physician Decision|0|||
129910771|NCT02723955|467637634|FG029|Escalation Phase|Physician Decision|0|||
129910772|NCT02723955|467637635|FG030|Escalation Phase|Physician Decision|0|||
129910773|NCT02723955|467637636|FG031|Escalation Phase|Physician Decision|0|||
129910774|NCT02723955|467637637|FG032|Escalation Phase|Physician Decision|0|||
129910775|NCT02723955|467637638|FG033|Escalation Phase|Physician Decision|0|||
129910776|NCT02723955|467637639|FG034|Escalation Phase|Physician Decision|0|||
129910777|NCT02723955|467637640|FG035|Escalation Phase|Physician Decision|0|||
129910778|NCT02723955|467637641|FG036|Escalation Phase|Physician Decision|0|||
129910779|NCT02723955|467637642|FG037|Escalation Phase|Physician Decision|0|||
129910780|NCT02723955|467637643|FG038|Escalation Phase|Physician Decision|0|||
129910781|NCT02723955|467637644|FG039|Escalation Phase|Physician Decision|0|||
129910782|NCT02723955|467637645|FG040|Escalation Phase|Physician Decision|0|||
129910783|NCT02723955|467637646|FG041|Escalation Phase|Physician Decision|0|||
129910784|NCT02723955|467637647|FG042|Escalation Phase|Physician Decision|0|||
129910785|NCT02723955|467637605|FG000|Escalation Phase|Withdrawal by Subject|0|||
129910786|NCT02723955|467637606|FG001|Escalation Phase|Withdrawal by Subject|0|||
129910787|NCT02723955|467637607|FG002|Escalation Phase|Withdrawal by Subject|0|||
129910788|NCT02723955|467637608|FG003|Escalation Phase|Withdrawal by Subject|0|||
129910789|NCT02723955|467637609|FG004|Escalation Phase|Withdrawal by Subject|1|||
129910790|NCT02723955|467637610|FG005|Escalation Phase|Withdrawal by Subject|1|||
129910791|NCT02723955|467637611|FG006|Escalation Phase|Withdrawal by Subject|1|||
129910792|NCT02723955|467637612|FG007|Escalation Phase|Withdrawal by Subject|1|||
129910793|NCT02723955|467637613|FG008|Escalation Phase|Withdrawal by Subject|0|||
129910794|NCT02723955|467637614|FG009|Escalation Phase|Withdrawal by Subject|0|||
129910795|NCT02723955|467637615|FG010|Escalation Phase|Withdrawal by Subject|0|||
129910796|NCT02723955|467637616|FG011|Escalation Phase|Withdrawal by Subject|0|||
129910797|NCT02723955|467637617|FG012|Escalation Phase|Withdrawal by Subject|1|||
129910798|NCT02723955|467637618|FG013|Escalation Phase|Withdrawal by Subject|0|||
129910799|NCT02723955|467637619|FG014|Escalation Phase|Withdrawal by Subject|0|||
129910800|NCT02723955|467637620|FG015|Escalation Phase|Withdrawal by Subject|0|||
129910801|NCT02723955|467637621|FG016|Escalation Phase|Withdrawal by Subject|1|||
129910802|NCT02723955|467637622|FG017|Escalation Phase|Withdrawal by Subject|0|||
129910803|NCT02723955|467637623|FG018|Escalation Phase|Withdrawal by Subject|0|||
129910804|NCT02723955|467637624|FG019|Escalation Phase|Withdrawal by Subject|0|||
129910805|NCT02723955|467637625|FG020|Escalation Phase|Withdrawal by Subject|0|||
129910806|NCT02723955|467637626|FG021|Escalation Phase|Withdrawal by Subject|0|||
129910807|NCT02723955|467637627|FG022|Escalation Phase|Withdrawal by Subject|0|||
129910808|NCT02723955|467637628|FG023|Escalation Phase|Withdrawal by Subject|2|||
129910809|NCT02723955|467637629|FG024|Escalation Phase|Withdrawal by Subject|0|||
129910810|NCT02723955|467637630|FG025|Escalation Phase|Withdrawal by Subject|1|||
129910811|NCT02723955|467637631|FG026|Escalation Phase|Withdrawal by Subject|0|||
129910812|NCT02723955|467637632|FG027|Escalation Phase|Withdrawal by Subject|0|||
129910813|NCT02723955|467637633|FG028|Escalation Phase|Withdrawal by Subject|1|||
129910814|NCT02723955|467637634|FG029|Escalation Phase|Withdrawal by Subject|0|||
129910815|NCT02723955|467637635|FG030|Escalation Phase|Withdrawal by Subject|0|||
129910816|NCT02723955|467637636|FG031|Escalation Phase|Withdrawal by Subject|0|||
129910817|NCT02723955|467637637|FG032|Escalation Phase|Withdrawal by Subject|0|||
129910818|NCT02723955|467637638|FG033|Escalation Phase|Withdrawal by Subject|0|||
129910819|NCT02723955|467637639|FG034|Escalation Phase|Withdrawal by Subject|0|||
129910820|NCT02723955|467637640|FG035|Escalation Phase|Withdrawal by Subject|0|||
129910821|NCT02723955|467637641|FG036|Escalation Phase|Withdrawal by Subject|0|||
129910822|NCT02723955|467637642|FG037|Escalation Phase|Withdrawal by Subject|0|||
129910823|NCT02723955|467637643|FG038|Escalation Phase|Withdrawal by Subject|0|||
129910824|NCT02723955|467637644|FG039|Escalation Phase|Withdrawal by Subject|0|||
129910825|NCT02723955|467637645|FG040|Escalation Phase|Withdrawal by Subject|0|||
129910826|NCT02723955|467637646|FG041|Escalation Phase|Withdrawal by Subject|0|||
129910827|NCT02723955|467637647|FG042|Escalation Phase|Withdrawal by Subject|0|||
129910828|NCT02723955|467637605|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910829|NCT02723955|467637606|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910830|NCT02723955|467637607|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910831|NCT02723955|467637608|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910832|NCT02723955|467637609|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
129910833|NCT02723955|467637610|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
130116654|NCT00585351|468387148|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
129910834|NCT02723955|467637611|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
129910835|NCT02723955|467637612|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
129910836|NCT02723955|467637613|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
129910837|NCT02723955|467637614|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910838|NCT02723955|467637615|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910839|NCT02723955|467637616|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910840|NCT02723955|467637617|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910841|NCT02723955|467637618|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910842|NCT02723955|467637619|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910843|NCT02723955|467637620|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910844|NCT02723955|467637621|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910845|NCT02723955|467637622|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910846|NCT02723955|467637623|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910847|NCT02723955|467637624|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910848|NCT02723955|467637625|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910849|NCT02723955|467637626|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910850|NCT02723955|467637627|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910851|NCT02723955|467637628|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910852|NCT02723955|467637629|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910853|NCT02723955|467637630|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910854|NCT02723955|467637631|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910855|NCT02723955|467637632|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910856|NCT02723955|467637633|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910857|NCT02723955|467637634|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910858|NCT02723955|467637635|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910859|NCT02723955|467637636|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910860|NCT02723955|467637637|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910861|NCT02723955|467637638|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910862|NCT02723955|467637639|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910863|NCT02723955|467637640|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910864|NCT02723955|467637641|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910865|NCT02723955|467637642|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910866|NCT02723955|467637643|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910867|NCT02723955|467637644|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910868|NCT02723955|467637645|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910869|NCT02723955|467637646|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910870|NCT02723955|467637647|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910871|NCT02723955|467637605|FG000|Escalation Phase|Site Closed|0|||
129910872|NCT02723955|467637606|FG001|Escalation Phase|Site Closed|0|||
129910873|NCT02723955|467637607|FG002|Escalation Phase|Site Closed|0|||
129910874|NCT02723955|467637608|FG003|Escalation Phase|Site Closed|0|||
129910875|NCT02723955|467637609|FG004|Escalation Phase|Site Closed|0|||
129910876|NCT02723955|467637610|FG005|Escalation Phase|Site Closed|0|||
129910877|NCT02723955|467637611|FG006|Escalation Phase|Site Closed|0|||
129910878|NCT02723955|467637612|FG007|Escalation Phase|Site Closed|0|||
129910879|NCT02723955|467637613|FG008|Escalation Phase|Site Closed|0|||
129910880|NCT02723955|467637614|FG009|Escalation Phase|Site Closed|0|||
129910881|NCT02723955|467637615|FG010|Escalation Phase|Site Closed|0|||
129910882|NCT02723955|467637616|FG011|Escalation Phase|Site Closed|0|||
129910883|NCT02723955|467637617|FG012|Escalation Phase|Site Closed|0|||
129910884|NCT02723955|467637618|FG013|Escalation Phase|Site Closed|0|||
129910885|NCT02723955|467637619|FG014|Escalation Phase|Site Closed|0|||
129910886|NCT02723955|467637620|FG015|Escalation Phase|Site Closed|1|||
129910887|NCT02723955|467637621|FG016|Escalation Phase|Site Closed|0|||
129910888|NCT02723955|467637622|FG017|Escalation Phase|Site Closed|2|||
129910889|NCT02723955|467637623|FG018|Escalation Phase|Site Closed|0|||
129910890|NCT02723955|467637624|FG019|Escalation Phase|Site Closed|0|||
129910891|NCT02723955|467637625|FG020|Escalation Phase|Site Closed|1|||
129910892|NCT02723955|467637626|FG021|Escalation Phase|Site Closed|0|||
129910893|NCT02723955|467637627|FG022|Escalation Phase|Site Closed|0|||
129910894|NCT02723955|467637628|FG023|Escalation Phase|Site Closed|0|||
129910895|NCT02723955|467637629|FG024|Escalation Phase|Site Closed|3|||
129910896|NCT02723955|467637630|FG025|Escalation Phase|Site Closed|1|||
129910897|NCT02723955|467637631|FG026|Escalation Phase|Site Closed|3|||
129910898|NCT02723955|467637632|FG027|Escalation Phase|Site Closed|1|||
129910899|NCT02723955|467637633|FG028|Escalation Phase|Site Closed|1|||
129910900|NCT02723955|467637634|FG029|Escalation Phase|Site Closed|0|||
129861655|NCT03214367|467449607|FG006|Treatment Period|Physician Decision|0|||
129861656|NCT03214367|467449608|FG007|Treatment Period|Physician Decision|0|||
129861657|NCT03214367|467449601|FG000|Treatment Period|Protocol Violation|0|||
129861658|NCT03214367|467449602|FG001|Treatment Period|Protocol Violation|3|||
129861659|NCT03214367|467449603|FG002|Treatment Period|Protocol Violation|0|||
129861660|NCT03214367|467449604|FG003|Treatment Period|Protocol Violation|0|||
129861661|NCT03214367|467449605|FG004|Treatment Period|Protocol Violation|0|||
129861662|NCT03214367|467449606|FG005|Treatment Period|Protocol Violation|0|||
129861663|NCT03214367|467449607|FG006|Treatment Period|Protocol Violation|0|||
129861664|NCT03214367|467449608|FG007|Treatment Period|Protocol Violation|0|||
129861665|NCT03214367|467449601|FG000|Treatment Period|Withdrawal by Subject|0|||
129861666|NCT03214367|467449602|FG001|Treatment Period|Withdrawal by Subject|20|||
129861667|NCT03214367|467449603|FG002|Treatment Period|Withdrawal by Subject|23|||
129861668|NCT03214367|467449604|FG003|Treatment Period|Withdrawal by Subject|14|||
129861669|NCT03214367|467449605|FG004|Treatment Period|Withdrawal by Subject|0|||
129861670|NCT03214367|467449606|FG005|Treatment Period|Withdrawal by Subject|1|||
129861671|NCT03214367|467449607|FG006|Treatment Period|Withdrawal by Subject|1|||
129861672|NCT03214367|467449608|FG007|Treatment Period|Withdrawal by Subject|1|||
129861673|NCT03508843|467449609|FG000|Overall Study|Withdrawal by Subject|1|||
129861674|NCT03508843|467449609|FG000|Overall Study|technical difficulties|2|||
129861675|NCT03555396|467449610|FG000|Overall Study|Death|3|||
129861676|NCT03555396|467449611|FG001|Overall Study|Death|1|||
129861677|NCT03555396|467449610|FG000|Overall Study|Lost to Follow-up|0|||
129861678|NCT03555396|467449611|FG001|Overall Study|Lost to Follow-up|2|||
129861679|NCT01816594|467449621|FG000|Overall Study|Local Progress|0|||
129861680|NCT01816594|467449622|FG001|Overall Study|Local Progress|2|||
129861681|NCT01816594|467449621|FG000|Overall Study|Adverse Event|9|||
129861682|NCT01816594|467449622|FG001|Overall Study|Adverse Event|0|||
129861683|NCT01816594|467449621|FG000|Overall Study|Withdrawal by Subject|1|||
129861684|NCT01816594|467449622|FG001|Overall Study|Withdrawal by Subject|0|||
129861685|NCT01816594|467449621|FG000|Overall Study|Physician Decision|1|||
129861686|NCT01816594|467449622|FG001|Overall Study|Physician Decision|0|||
129861687|NCT03905655|467449623|FG000|Overall Study|Adverse Event|1|||
129861688|NCT03905655|467449624|FG001|Overall Study|Adverse Event|0|||
129861689|NCT03905655|467449625|FG002|Overall Study|Adverse Event|1|||
129861690|NCT03905655|467449626|FG003|Overall Study|Adverse Event|1|||
129861691|NCT02566031|467449627|FG000|Overall Study|Patient/guardian decision|14|||
129861692|NCT02566031|467449628|FG001|Overall Study|Patient/guardian decision|7|||
129861693|NCT02566031|467449627|FG000|Overall Study|Protocol deviation|2|||
129861694|NCT02566031|467449628|FG001|Overall Study|Protocol deviation|3|||
129861695|NCT02566031|467449627|FG000|Overall Study|Adverse Event|3|||
129861696|NCT02566031|467449628|FG001|Overall Study|Adverse Event|1|||
129861697|NCT02566031|467449627|FG000|Overall Study|Lost to Follow-up|1|||
129861698|NCT02566031|467449628|FG001|Overall Study|Lost to Follow-up|1|||
129861699|NCT00413153|467449629|FG000|Overall Study|Withdrawal by Subject|1|||
129861700|NCT00413153|467449630|FG001|Overall Study|Withdrawal by Subject|1|||
129861701|NCT00413153|467449629|FG000|Overall Study|Adverse Event|1|||
129861702|NCT00413153|467449630|FG001|Overall Study|Adverse Event|0|||
129861703|NCT03204279|467449631|FG000|Overall Study|Withdrawal by Subject|0|||
129861704|NCT03204279|467449632|FG001|Overall Study|Withdrawal by Subject|1|||
129861705|NCT04969250|467449633|FG000|Overall Study|Protocol Violation|0|||
129861706|NCT04969250|467449634|FG001|Overall Study|Protocol Violation|2|||
129861707|NCT04969250|467449635|FG002|Overall Study|Protocol Violation|3|||
129861708|NCT04969250|467449636|FG003|Overall Study|Protocol Violation|8|||
129861709|NCT04969250|467449633|FG000|Overall Study|Withdrawal by Subject|0|||
129861710|NCT04969250|467449634|FG001|Overall Study|Withdrawal by Subject|1|||
129861711|NCT04969250|467449635|FG002|Overall Study|Withdrawal by Subject|0|||
129861712|NCT04969250|467449636|FG003|Overall Study|Withdrawal by Subject|0|||
129861713|NCT02278328|467449637|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
129861714|NCT02278328|467449638|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
129861715|NCT02278328|467449639|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
129861716|NCT02278328|467449637|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
129861717|NCT02278328|467449638|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
129861718|NCT02278328|467449639|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
129861719|NCT02278328|467449637|FG000|Neuropsych Screening|incomplete consent|0|||
129861720|NCT02278328|467449638|FG001|Neuropsych Screening|incomplete consent|0|||
129861721|NCT02278328|467449639|FG002|Neuropsych Screening|incomplete consent|2|||
129910901|NCT02723955|467637635|FG030|Escalation Phase|Site Closed|0|||
129910902|NCT02723955|467637636|FG031|Escalation Phase|Site Closed|0|||
129861722|NCT03834779|467449645|FG000|Overall Study|Death|1|||
129861723|NCT03834779|467449646|FG001|Overall Study|Death|2|||
129861724|NCT03834779|467449645|FG000|Overall Study|Lost to Follow-up|6|||
129861725|NCT03834779|467449646|FG001|Overall Study|Lost to Follow-up|4|||
129861726|NCT01292928|467449648|FG000|Overall Study|Death|8|||
129861727|NCT01292928|467449648|FG000|Overall Study|Withdrawal by Subject|8|||
129861728|NCT01292928|467449648|FG000|Overall Study|Lost to Follow-up|6|||
129861729|NCT01292928|467449648|FG000|Overall Study|Physician Decision|2|||
129910903|NCT02723955|467637637|FG032|Escalation Phase|Site Closed|0|||
129910904|NCT02723955|467637638|FG033|Escalation Phase|Site Closed|0|||
129910905|NCT02723955|467637639|FG034|Escalation Phase|Site Closed|0|||
129910906|NCT02723955|467637640|FG035|Escalation Phase|Site Closed|0|||
129910907|NCT02723955|467637641|FG036|Escalation Phase|Site Closed|0|||
129910908|NCT02723955|467637642|FG037|Escalation Phase|Site Closed|0|||
129910909|NCT02723955|467637643|FG038|Escalation Phase|Site Closed|0|||
129910910|NCT02723955|467637644|FG039|Escalation Phase|Site Closed|0|||
129910911|NCT02723955|467637645|FG040|Escalation Phase|Site Closed|0|||
129910912|NCT02723955|467637646|FG041|Escalation Phase|Site Closed|0|||
129910913|NCT02723955|467637647|FG042|Escalation Phase|Site Closed|0|||
129910914|NCT02723955|467637605|FG000|Expansion Phase|Death|0|||
129910915|NCT02723955|467637606|FG001|Expansion Phase|Death|0|||
129910916|NCT02723955|467637607|FG002|Expansion Phase|Death|0|||
129910917|NCT02723955|467637608|FG003|Expansion Phase|Death|0|||
129910918|NCT02723955|467637609|FG004|Expansion Phase|Death|0|||
129910919|NCT02723955|467637610|FG005|Expansion Phase|Death|0|||
129910920|NCT02723955|467637611|FG006|Expansion Phase|Death|0|||
129910921|NCT02723955|467637612|FG007|Expansion Phase|Death|0|||
129910922|NCT02723955|467637613|FG008|Expansion Phase|Death|0|||
129910923|NCT02723955|467637614|FG009|Expansion Phase|Death|25|||
129910924|NCT02723955|467637615|FG010|Expansion Phase|Death|69|||
129910925|NCT02723955|467637616|FG011|Expansion Phase|Death|48|||
129910926|NCT02723955|467637617|FG012|Expansion Phase|Death|0|||
129910927|NCT02723955|467637618|FG013|Expansion Phase|Death|0|||
129910928|NCT02723955|467637619|FG014|Expansion Phase|Death|0|||
129910929|NCT02723955|467637620|FG015|Expansion Phase|Death|0|||
129910930|NCT02723955|467637621|FG016|Expansion Phase|Death|0|||
129910931|NCT02723955|467637622|FG017|Expansion Phase|Death|0|||
129910932|NCT02723955|467637623|FG018|Expansion Phase|Death|0|||
129910933|NCT02723955|467637624|FG019|Expansion Phase|Death|0|||
129910934|NCT02723955|467637625|FG020|Expansion Phase|Death|0|||
129910935|NCT02723955|467637626|FG021|Expansion Phase|Death|0|||
129910936|NCT02723955|467637627|FG022|Expansion Phase|Death|0|||
129910937|NCT02723955|467637628|FG023|Expansion Phase|Death|0|||
129910938|NCT02723955|467637629|FG024|Expansion Phase|Death|0|||
129910939|NCT02723955|467637630|FG025|Expansion Phase|Death|0|||
129910940|NCT02723955|467637631|FG026|Expansion Phase|Death|0|||
129910941|NCT02723955|467637632|FG027|Expansion Phase|Death|0|||
129910942|NCT02723955|467637633|FG028|Expansion Phase|Death|0|||
129910943|NCT02723955|467637634|FG029|Expansion Phase|Death|12|||
129910944|NCT02723955|467637635|FG030|Expansion Phase|Death|202|||
129910945|NCT02723955|467637636|FG031|Expansion Phase|Death|31|||
129910946|NCT02723955|467637637|FG032|Expansion Phase|Death|17|||
129910947|NCT02723955|467637638|FG033|Expansion Phase|Death|2|||
129910948|NCT02723955|467637639|FG034|Expansion Phase|Death|3|||
129910949|NCT02723955|467637640|FG035|Expansion Phase|Death|3|||
129910950|NCT02723955|467637641|FG036|Expansion Phase|Death|1|||
129910951|NCT02723955|467637642|FG037|Expansion Phase|Death|0|||
129910952|NCT02723955|467637643|FG038|Expansion Phase|Death|0|||
129910953|NCT02723955|467637644|FG039|Expansion Phase|Death|0|||
129910954|NCT02723955|467637645|FG040|Expansion Phase|Death|0|||
129910955|NCT02723955|467637646|FG041|Expansion Phase|Death|0|||
129910956|NCT02723955|467637647|FG042|Expansion Phase|Death|0|||
129910957|NCT02723955|467637605|FG000|Expansion Phase|Lost to Follow-up|0|||
129910958|NCT02723955|467637606|FG001|Expansion Phase|Lost to Follow-up|0|||
129910959|NCT02723955|467637607|FG002|Expansion Phase|Lost to Follow-up|0|||
129910960|NCT02723955|467637608|FG003|Expansion Phase|Lost to Follow-up|0|||
129910961|NCT02723955|467637609|FG004|Expansion Phase|Lost to Follow-up|0|||
129910962|NCT02723955|467637610|FG005|Expansion Phase|Lost to Follow-up|0|||
129910963|NCT02723955|467637611|FG006|Expansion Phase|Lost to Follow-up|0|||
129910964|NCT02723955|467637612|FG007|Expansion Phase|Lost to Follow-up|0|||
130064787|NCT04095442|468192237|FG001|Overall Study|Lost to Follow-up|1|||
130064788|NCT04095442|468192236|FG000|Overall Study|Screen failure|1|||
129910965|NCT02723955|467637613|FG008|Expansion Phase|Lost to Follow-up|0|||
129910966|NCT02723955|467637614|FG009|Expansion Phase|Lost to Follow-up|0|||
129910967|NCT02723955|467637615|FG010|Expansion Phase|Lost to Follow-up|4|||
129910968|NCT02723955|467637616|FG011|Expansion Phase|Lost to Follow-up|1|||
129910969|NCT02723955|467637617|FG012|Expansion Phase|Lost to Follow-up|0|||
129910970|NCT02723955|467637618|FG013|Expansion Phase|Lost to Follow-up|0|||
129910971|NCT02723955|467637619|FG014|Expansion Phase|Lost to Follow-up|0|||
129910972|NCT02723955|467637620|FG015|Expansion Phase|Lost to Follow-up|0|||
129910973|NCT02723955|467637621|FG016|Expansion Phase|Lost to Follow-up|0|||
129910974|NCT02723955|467637622|FG017|Expansion Phase|Lost to Follow-up|0|||
129910975|NCT02723955|467637623|FG018|Expansion Phase|Lost to Follow-up|0|||
129910976|NCT02723955|467637624|FG019|Expansion Phase|Lost to Follow-up|0|||
129910977|NCT02723955|467637625|FG020|Expansion Phase|Lost to Follow-up|0|||
130064789|NCT04095442|468192237|FG001|Overall Study|Screen failure|0|||
129910978|NCT02723955|467637626|FG021|Expansion Phase|Lost to Follow-up|0|||
129910979|NCT02723955|467637627|FG022|Expansion Phase|Lost to Follow-up|0|||
129910980|NCT02723955|467637628|FG023|Expansion Phase|Lost to Follow-up|0|||
129910981|NCT02723955|467637629|FG024|Expansion Phase|Lost to Follow-up|0|||
129910982|NCT02723955|467637630|FG025|Expansion Phase|Lost to Follow-up|0|||
129910983|NCT02723955|467637631|FG026|Expansion Phase|Lost to Follow-up|0|||
130064790|NCT00562640|468192238|FG000|Overall Study|Death|0|||
129910984|NCT02723955|467637632|FG027|Expansion Phase|Lost to Follow-up|0|||
129910985|NCT02723955|467637633|FG028|Expansion Phase|Lost to Follow-up|0|||
129910986|NCT02723955|467637634|FG029|Expansion Phase|Lost to Follow-up|1|||
129910987|NCT02723955|467637635|FG030|Expansion Phase|Lost to Follow-up|19|||
129910988|NCT02723955|467637636|FG031|Expansion Phase|Lost to Follow-up|2|||
129910989|NCT02723955|467637637|FG032|Expansion Phase|Lost to Follow-up|1|||
129910990|NCT02723955|467637638|FG033|Expansion Phase|Lost to Follow-up|0|||
129910991|NCT02723955|467637639|FG034|Expansion Phase|Lost to Follow-up|0|||
129910992|NCT02723955|467637640|FG035|Expansion Phase|Lost to Follow-up|0|||
129910993|NCT02723955|467637641|FG036|Expansion Phase|Lost to Follow-up|0|||
129910994|NCT02723955|467637642|FG037|Expansion Phase|Lost to Follow-up|0|||
129910995|NCT02723955|467637643|FG038|Expansion Phase|Lost to Follow-up|0|||
129910996|NCT02723955|467637644|FG039|Expansion Phase|Lost to Follow-up|0|||
129910997|NCT02723955|467637645|FG040|Expansion Phase|Lost to Follow-up|0|||
129910998|NCT02723955|467637646|FG041|Expansion Phase|Lost to Follow-up|0|||
129910999|NCT02723955|467637647|FG042|Expansion Phase|Lost to Follow-up|0|||
129911000|NCT02723955|467637605|FG000|Expansion Phase|Physician Decision|0|||
129911001|NCT02723955|467637606|FG001|Expansion Phase|Physician Decision|0|||
129911002|NCT02723955|467637607|FG002|Expansion Phase|Physician Decision|0|||
129911003|NCT02723955|467637608|FG003|Expansion Phase|Physician Decision|0|||
129911004|NCT02723955|467637609|FG004|Expansion Phase|Physician Decision|0|||
129911005|NCT02723955|467637610|FG005|Expansion Phase|Physician Decision|0|||
129911006|NCT02723955|467637611|FG006|Expansion Phase|Physician Decision|0|||
129911007|NCT02723955|467637612|FG007|Expansion Phase|Physician Decision|0|||
129911008|NCT02723955|467637613|FG008|Expansion Phase|Physician Decision|0|||
129911009|NCT02723955|467637614|FG009|Expansion Phase|Physician Decision|0|||
129911010|NCT02723955|467637615|FG010|Expansion Phase|Physician Decision|0|||
129911011|NCT02723955|467637616|FG011|Expansion Phase|Physician Decision|0|||
129911012|NCT02723955|467637617|FG012|Expansion Phase|Physician Decision|0|||
129911013|NCT02723955|467637618|FG013|Expansion Phase|Physician Decision|0|||
129911014|NCT02723955|467637619|FG014|Expansion Phase|Physician Decision|0|||
129911015|NCT02723955|467637620|FG015|Expansion Phase|Physician Decision|0|||
129911016|NCT02723955|467637621|FG016|Expansion Phase|Physician Decision|0|||
129911017|NCT02723955|467637622|FG017|Expansion Phase|Physician Decision|0|||
129911018|NCT02723955|467637623|FG018|Expansion Phase|Physician Decision|0|||
129911019|NCT02723955|467637624|FG019|Expansion Phase|Physician Decision|0|||
129911020|NCT02723955|467637625|FG020|Expansion Phase|Physician Decision|0|||
129911021|NCT02723955|467637626|FG021|Expansion Phase|Physician Decision|0|||
129911022|NCT02723955|467637627|FG022|Expansion Phase|Physician Decision|0|||
129911023|NCT02723955|467637628|FG023|Expansion Phase|Physician Decision|0|||
129911024|NCT02723955|467637629|FG024|Expansion Phase|Physician Decision|0|||
129911025|NCT02723955|467637630|FG025|Expansion Phase|Physician Decision|0|||
129911026|NCT02723955|467637631|FG026|Expansion Phase|Physician Decision|0|||
129911027|NCT02723955|467637632|FG027|Expansion Phase|Physician Decision|0|||
129911028|NCT02723955|467637633|FG028|Expansion Phase|Physician Decision|0|||
129911029|NCT02723955|467637634|FG029|Expansion Phase|Physician Decision|0|||
129911030|NCT02723955|467637635|FG030|Expansion Phase|Physician Decision|1|||
129911031|NCT02723955|467637636|FG031|Expansion Phase|Physician Decision|1|||
129911032|NCT02723955|467637637|FG032|Expansion Phase|Physician Decision|0|||
129911033|NCT02723955|467637638|FG033|Expansion Phase|Physician Decision|0|||
129911034|NCT02723955|467637639|FG034|Expansion Phase|Physician Decision|0|||
129911035|NCT02723955|467637640|FG035|Expansion Phase|Physician Decision|0|||
129911036|NCT02723955|467637641|FG036|Expansion Phase|Physician Decision|0|||
129911037|NCT02723955|467637642|FG037|Expansion Phase|Physician Decision|0|||
129911038|NCT02723955|467637643|FG038|Expansion Phase|Physician Decision|0|||
129911039|NCT02723955|467637644|FG039|Expansion Phase|Physician Decision|0|||
129911040|NCT02723955|467637645|FG040|Expansion Phase|Physician Decision|0|||
129911041|NCT02723955|467637646|FG041|Expansion Phase|Physician Decision|0|||
129911042|NCT02723955|467637647|FG042|Expansion Phase|Physician Decision|0|||
129911043|NCT02723955|467637605|FG000|Expansion Phase|Withdrawal by Subject|0|||
129911044|NCT02723955|467637606|FG001|Expansion Phase|Withdrawal by Subject|0|||
129911045|NCT02723955|467637607|FG002|Expansion Phase|Withdrawal by Subject|0|||
129911046|NCT02723955|467637608|FG003|Expansion Phase|Withdrawal by Subject|0|||
129911047|NCT02723955|467637609|FG004|Expansion Phase|Withdrawal by Subject|0|||
129911048|NCT02723955|467637610|FG005|Expansion Phase|Withdrawal by Subject|0|||
129911049|NCT02723955|467637611|FG006|Expansion Phase|Withdrawal by Subject|0|||
129911050|NCT02723955|467637612|FG007|Expansion Phase|Withdrawal by Subject|0|||
129911051|NCT02723955|467637613|FG008|Expansion Phase|Withdrawal by Subject|0|||
129911052|NCT02723955|467637614|FG009|Expansion Phase|Withdrawal by Subject|2|||
129911053|NCT02723955|467637615|FG010|Expansion Phase|Withdrawal by Subject|1|||
129911054|NCT02723955|467637616|FG011|Expansion Phase|Withdrawal by Subject|0|||
129911055|NCT02723955|467637617|FG012|Expansion Phase|Withdrawal by Subject|0|||
129911056|NCT02723955|467637618|FG013|Expansion Phase|Withdrawal by Subject|0|||
129911057|NCT02723955|467637619|FG014|Expansion Phase|Withdrawal by Subject|0|||
130064791|NCT00562640|468192239|FG001|Overall Study|Death|1|||
130064792|NCT00562640|468192240|FG002|Overall Study|Death|1|||
130064793|NCT00562640|468192241|FG003|Overall Study|Death|0|||
129911058|NCT02723955|467637620|FG015|Expansion Phase|Withdrawal by Subject|0|||
129911059|NCT02723955|467637621|FG016|Expansion Phase|Withdrawal by Subject|0|||
129861730|NCT00130533|467449653|FG000|Overall Study|Withdrawal by Subject|33|||
129861731|NCT00130533|467449654|FG001|Overall Study|Withdrawal by Subject|6|||
129861732|NCT00130533|467449653|FG000|Overall Study|Adverse Event|34|||
129861733|NCT00130533|467449654|FG001|Overall Study|Adverse Event|1|||
129861734|NCT00130533|467449653|FG000|Overall Study|Disease relapse|9|||
129911060|NCT02723955|467637622|FG017|Expansion Phase|Withdrawal by Subject|0|||
129911061|NCT02723955|467637623|FG018|Expansion Phase|Withdrawal by Subject|0|||
129861735|NCT00130533|467449654|FG001|Overall Study|Disease relapse|13|||
129861736|NCT00130533|467449653|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
129861737|NCT00130533|467449654|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
129861738|NCT00130533|467449653|FG000|Overall Study|Death|4|||
129861739|NCT00130533|467449654|FG001|Overall Study|Death|2|||
129861740|NCT00130533|467449653|FG000|Overall Study|Protocol Violation|5|||
129861741|NCT00130533|467449654|FG001|Overall Study|Protocol Violation|1|||
129861742|NCT00130533|467449653|FG000|Overall Study|Lost to Follow-up|1|||
129861743|NCT00130533|467449654|FG001|Overall Study|Lost to Follow-up|1|||
129861744|NCT00130533|467449653|FG000|Overall Study|Sponsor´s decision|2|||
129861745|NCT00130533|467449654|FG001|Overall Study|Sponsor´s decision|0|||
129861746|NCT00130533|467449653|FG000|Overall Study|Second Primary Malignancy|0|||
129861747|NCT00130533|467449654|FG001|Overall Study|Second Primary Malignancy|1|||
129911062|NCT02723955|467637624|FG019|Expansion Phase|Withdrawal by Subject|0|||
129911063|NCT02723955|467637625|FG020|Expansion Phase|Withdrawal by Subject|0|||
129911064|NCT02723955|467637626|FG021|Expansion Phase|Withdrawal by Subject|0|||
129911065|NCT02723955|467637627|FG022|Expansion Phase|Withdrawal by Subject|0|||
129911066|NCT02723955|467637628|FG023|Expansion Phase|Withdrawal by Subject|0|||
129911067|NCT02723955|467637629|FG024|Expansion Phase|Withdrawal by Subject|0|||
129911068|NCT02723955|467637630|FG025|Expansion Phase|Withdrawal by Subject|0|||
129911069|NCT02723955|467637631|FG026|Expansion Phase|Withdrawal by Subject|0|||
129911070|NCT02723955|467637632|FG027|Expansion Phase|Withdrawal by Subject|0|||
129911071|NCT02723955|467637633|FG028|Expansion Phase|Withdrawal by Subject|0|||
129911072|NCT02723955|467637634|FG029|Expansion Phase|Withdrawal by Subject|0|||
129911073|NCT02723955|467637635|FG030|Expansion Phase|Withdrawal by Subject|8|||
129911074|NCT02723955|467637636|FG031|Expansion Phase|Withdrawal by Subject|4|||
129911075|NCT02723955|467637637|FG032|Expansion Phase|Withdrawal by Subject|0|||
129911076|NCT02723955|467637638|FG033|Expansion Phase|Withdrawal by Subject|0|||
129911077|NCT02723955|467637639|FG034|Expansion Phase|Withdrawal by Subject|0|||
129911078|NCT02723955|467637640|FG035|Expansion Phase|Withdrawal by Subject|1|||
129911079|NCT02723955|467637641|FG036|Expansion Phase|Withdrawal by Subject|0|||
129911080|NCT02723955|467637642|FG037|Expansion Phase|Withdrawal by Subject|0|||
129911081|NCT02723955|467637643|FG038|Expansion Phase|Withdrawal by Subject|0|||
130064794|NCT05263921|468192242|FG000|Overall Study|Other: family emergency.|0|||
129861748|NCT00130533|467449653|FG000|Overall Study|Other|12|||
129861749|NCT00130533|467449654|FG001|Overall Study|Other|5|||
129861750|NCT01059565|467449655|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
129861751|NCT01059565|467449656|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
129861752|NCT01059565|467449655|FG000|24-Week Randomized Phase|Adverse Event|5|||
129861753|NCT01059565|467449656|FG001|24-Week Randomized Phase|Adverse Event|0|||
129861754|NCT01059565|467449655|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
129861755|NCT01059565|467449656|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
129861756|NCT01059565|467449655|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
129861757|NCT01059565|467449656|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
129861758|NCT01059565|467449655|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
129861759|NCT01059565|467449656|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
129861760|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Adverse Event|2|||
129861761|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Adverse Event|0|||
130064795|NCT05263921|468192243|FG001|Overall Study|Other: family emergency.|0|||
130064796|NCT05263921|468192244|FG002|Overall Study|Other: family emergency.|1|||
130064797|NCT05263921|468192245|FG003|Overall Study|Other: family emergency.|0|||
130064798|NCT04656418|468192249|FG000|Overall Study|Withdrawal by Subject|1|||
130064799|NCT04656418|468192250|FG001|Overall Study|Withdrawal by Subject|3|||
130064800|NCT03097614|468192253|FG000|Overall Study|Adverse Event|3|||
129861762|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
129861763|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
129861764|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
129861765|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
129861766|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
129861767|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
129911082|NCT02723955|467637644|FG039|Expansion Phase|Withdrawal by Subject|0|||
129911083|NCT02723955|467637645|FG040|Expansion Phase|Withdrawal by Subject|0|||
130064801|NCT00603733|468192255|FG000|Active Phase ITT|Adverse Event|8|||
130064802|NCT00603733|468192256|FG001|Active Phase ITT|Adverse Event|7|||
129861768|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
130064803|NCT00603733|468192255|FG000|Active Phase ITT|Withdrawal by Subject|0|||
129861769|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
129861770|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
129861771|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
129861772|NCT03263429|467449661|FG000|Overall Study|Withdrawal by Subject|0|||
129861773|NCT03263429|467449662|FG001|Overall Study|Withdrawal by Subject|1|||
129861774|NCT03263429|467449663|FG002|Overall Study|Withdrawal by Subject|0|||
129861775|NCT03263429|467449661|FG000|Overall Study|Follow-Up Period Completed|0|||
129861776|NCT03263429|467449662|FG001|Overall Study|Follow-Up Period Completed|2|||
129861777|NCT03263429|467449663|FG002|Overall Study|Follow-Up Period Completed|0|||
129861778|NCT03263429|467449661|FG000|Overall Study|Death|3|||
129861779|NCT03263429|467449662|FG001|Overall Study|Death|5|||
129861780|NCT03263429|467449663|FG002|Overall Study|Death|16|||
129861781|NCT03263429|467449661|FG000|Overall Study|Participant unable to return|0|||
129861782|NCT03263429|467449662|FG001|Overall Study|Participant unable to return|0|||
129861783|NCT03263429|467449663|FG002|Overall Study|Participant unable to return|1|||
129861784|NCT03263429|467449661|FG000|Overall Study|Study Closed|0|||
129861785|NCT03263429|467449662|FG001|Overall Study|Study Closed|0|||
129861786|NCT03263429|467449663|FG002|Overall Study|Study Closed|1|||
129861787|NCT01605617|467449664|FG000|First Intervention|Adverse Event|0|||
129861788|NCT01605617|467449665|FG001|First Intervention|Adverse Event|1|||
129861789|NCT01605617|467449664|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
129861790|NCT01605617|467449665|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
129861791|NCT03638141|467449666|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
129861792|NCT02513563|467449670|FG000|Overall Study|Death|4|||
129861793|NCT02513563|467449670|FG000|Overall Study|Withdrawal by Subject|4|||
129861794|NCT02513563|467449670|FG000|Overall Study|Physician Decision|1|||
129861795|NCT01556438|467449673|FG000|Overall Study|Adverse Event|4|||
129861796|NCT01556438|467449674|FG001|Overall Study|Adverse Event|2|||
129861797|NCT01556438|467449673|FG000|Overall Study|Sponsor Decision|0|||
129861798|NCT01556438|467449674|FG001|Overall Study|Sponsor Decision|2|||
129861799|NCT01556438|467449673|FG000|Overall Study|Progressive Disease|0|||
129861800|NCT01556438|467449674|FG001|Overall Study|Progressive Disease|6|||
129861801|NCT01556438|467449673|FG000|Overall Study|Death|0|||
129861802|NCT01556438|467449674|FG001|Overall Study|Death|1|||
129861803|NCT03695172|467449675|FG000|Overall Study|Withdrawal by Subject|1|||
129861804|NCT03695172|467449676|FG001|Overall Study|Withdrawal by Subject|1|||
129861805|NCT03695172|467449677|FG002|Overall Study|Withdrawal by Subject|0|||
129861806|NCT02734212|467449681|FG000|Overall Study|Lost to Follow-up|5|||
129861807|NCT02734212|467449682|FG001|Overall Study|Lost to Follow-up|10|||
129861808|NCT00688636|467449685|FG000|Overall Study|Adverse Event|2|||
129861809|NCT00688636|467449686|FG001|Overall Study|Adverse Event|1|||
129861810|NCT04053764|467449687|FG000|Overall Study|Withdrawal by Subject|6|||
129861811|NCT04053764|467449688|FG001|Overall Study|Withdrawal by Subject|2|||
129861812|NCT04053764|467449687|FG000|Overall Study|Physician Decision|2|||
129861813|NCT04053764|467449688|FG001|Overall Study|Physician Decision|1|||
129861814|NCT04053764|467449687|FG000|Overall Study|Adverse Event|1|||
129861815|NCT04053764|467449688|FG001|Overall Study|Adverse Event|0|||
129861816|NCT04053764|467449687|FG000|Overall Study|Pregnancy|1|||
129861817|NCT04053764|467449688|FG001|Overall Study|Pregnancy|0|||
129861818|NCT02384954|467449692|FG000|Phase 1|Progressive Disease|2|||
129861819|NCT02384954|467449693|FG001|Phase 1|Progressive Disease|0|||
129861820|NCT02384954|467449694|FG002|Phase 1|Progressive Disease|1|||
129861821|NCT02384954|467449695|FG003|Phase 1|Progressive Disease|1|||
129861822|NCT02384954|467449696|FG004|Phase 1|Progressive Disease|0|||
129861823|NCT02384954|467449697|FG005|Phase 1|Progressive Disease|0|||
129861824|NCT02384954|467449698|FG006|Phase 1|Progressive Disease|0|||
129861825|NCT02384954|467449699|FG007|Phase 1|Progressive Disease|0|||
129861826|NCT02384954|467449700|FG008|Phase 1|Progressive Disease|0|||
129861827|NCT02384954|467449692|FG000|Phase 1|Adverse Event|0|||
129861828|NCT02384954|467449693|FG001|Phase 1|Adverse Event|0|||
129861829|NCT02384954|467449694|FG002|Phase 1|Adverse Event|1|||
129861830|NCT02384954|467449695|FG003|Phase 1|Adverse Event|0|||
129911084|NCT02723955|467637646|FG041|Expansion Phase|Withdrawal by Subject|0|||
129911085|NCT02723955|467637647|FG042|Expansion Phase|Withdrawal by Subject|0|||
129861831|NCT02384954|467449696|FG004|Phase 1|Adverse Event|0|||
129861832|NCT02384954|467449697|FG005|Phase 1|Adverse Event|0|||
129861833|NCT02384954|467449698|FG006|Phase 1|Adverse Event|0|||
129861834|NCT02384954|467449699|FG007|Phase 1|Adverse Event|0|||
129861835|NCT02384954|467449700|FG008|Phase 1|Adverse Event|0|||
129861836|NCT02384954|467449692|FG000|Phase 2|Progressive Disease|0|||
129861837|NCT02384954|467449693|FG001|Phase 2|Progressive Disease|0|||
129861838|NCT02384954|467449694|FG002|Phase 2|Progressive Disease|0|||
129861839|NCT02384954|467449695|FG003|Phase 2|Progressive Disease|0|||
129861840|NCT02384954|467449696|FG004|Phase 2|Progressive Disease|0|||
129979689|NCT03752970|467889436|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
129861841|NCT02384954|467449697|FG005|Phase 2|Progressive Disease|0|||
129861842|NCT02384954|467449698|FG006|Phase 2|Progressive Disease|0|||
129861843|NCT02384954|467449699|FG007|Phase 2|Progressive Disease|1|||
129861844|NCT02384954|467449700|FG008|Phase 2|Progressive Disease|2|||
129911086|NCT02723955|467637605|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911087|NCT02723955|467637606|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911088|NCT02723955|467637607|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911089|NCT02723955|467637608|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911090|NCT02723955|467637609|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911091|NCT02723955|467637610|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911092|NCT02723955|467637611|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911093|NCT02723955|467637612|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911094|NCT02723955|467637613|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911095|NCT02723955|467637614|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
129911096|NCT02723955|467637615|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
129911097|NCT02723955|467637616|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
129911098|NCT02723955|467637617|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911099|NCT02723955|467637618|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911100|NCT02723955|467637619|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911101|NCT02723955|467637620|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911102|NCT02723955|467637621|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911103|NCT02723955|467637622|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911104|NCT02723955|467637623|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911105|NCT02723955|467637624|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911106|NCT02723955|467637625|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911107|NCT02723955|467637626|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911108|NCT02723955|467637627|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911109|NCT02723955|467637628|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911110|NCT02723955|467637629|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911111|NCT02723955|467637630|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911112|NCT02723955|467637631|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911113|NCT02723955|467637632|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911114|NCT02723955|467637633|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911115|NCT02723955|467637634|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911116|NCT02723955|467637635|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
129911117|NCT02723955|467637636|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911118|NCT02723955|467637637|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911119|NCT02723955|467637638|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911120|NCT02723955|467637639|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911121|NCT02723955|467637640|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911122|NCT02723955|467637641|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911123|NCT02723955|467637642|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911124|NCT02723955|467637643|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911125|NCT02723955|467637644|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911126|NCT02723955|467637645|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911127|NCT02723955|467637646|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911128|NCT02723955|467637647|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911129|NCT02723955|467637605|FG000|Expansion Phase|Site Closed|0|||
129911130|NCT02723955|467637606|FG001|Expansion Phase|Site Closed|0|||
129911131|NCT02723955|467637607|FG002|Expansion Phase|Site Closed|0|||
129911132|NCT02723955|467637608|FG003|Expansion Phase|Site Closed|0|||
129911133|NCT02723955|467637609|FG004|Expansion Phase|Site Closed|0|||
129911134|NCT02723955|467637610|FG005|Expansion Phase|Site Closed|0|||
129911135|NCT02723955|467637611|FG006|Expansion Phase|Site Closed|0|||
129911136|NCT02723955|467637612|FG007|Expansion Phase|Site Closed|0|||
129911137|NCT02723955|467637613|FG008|Expansion Phase|Site Closed|0|||
129911138|NCT02723955|467637614|FG009|Expansion Phase|Site Closed|1|||
129911139|NCT02723955|467637615|FG010|Expansion Phase|Site Closed|2|||
129911140|NCT02723955|467637616|FG011|Expansion Phase|Site Closed|6|||
129911141|NCT02723955|467637617|FG012|Expansion Phase|Site Closed|0|||
129911142|NCT02723955|467637618|FG013|Expansion Phase|Site Closed|0|||
129861845|NCT02384954|467449692|FG000|Phase 2|Adverse Event|0|||
129861846|NCT02384954|467449693|FG001|Phase 2|Adverse Event|0|||
129861847|NCT02384954|467449694|FG002|Phase 2|Adverse Event|0|||
129861848|NCT02384954|467449695|FG003|Phase 2|Adverse Event|0|||
129861849|NCT02384954|467449696|FG004|Phase 2|Adverse Event|0|||
129861850|NCT02384954|467449697|FG005|Phase 2|Adverse Event|0|||
129861851|NCT02384954|467449698|FG006|Phase 2|Adverse Event|0|||
129861852|NCT02384954|467449699|FG007|Phase 2|Adverse Event|1|||
129861853|NCT02384954|467449700|FG008|Phase 2|Adverse Event|1|||
129861854|NCT02384954|467449692|FG000|Phase 2|Failure to meet continuation criteria|0|||
129861855|NCT02384954|467449693|FG001|Phase 2|Failure to meet continuation criteria|0|||
129861856|NCT02384954|467449694|FG002|Phase 2|Failure to meet continuation criteria|0|||
129861857|NCT02384954|467449695|FG003|Phase 2|Failure to meet continuation criteria|0|||
129861858|NCT02384954|467449696|FG004|Phase 2|Failure to meet continuation criteria|0|||
129861859|NCT02384954|467449697|FG005|Phase 2|Failure to meet continuation criteria|0|||
129861860|NCT02384954|467449698|FG006|Phase 2|Failure to meet continuation criteria|0|||
129861861|NCT02384954|467449699|FG007|Phase 2|Failure to meet continuation criteria|1|||
129861862|NCT02384954|467449700|FG008|Phase 2|Failure to meet continuation criteria|0|||
129861863|NCT01910129|467449705|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
129861864|NCT01910129|467449706|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
129861865|NCT01910129|467449707|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
129861866|NCT01910129|467449705|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
129861867|NCT01910129|467449706|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
129861868|NCT01910129|467449707|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
129861869|NCT03150056|467449708|FG000|Overall Study|Withdrawal by Subject|0|||
129861870|NCT03150056|467449709|FG001|Overall Study|Withdrawal by Subject|0|||
129861871|NCT03150056|467449710|FG002|Overall Study|Withdrawal by Subject|0|||
129861872|NCT03150056|467449711|FG003|Overall Study|Withdrawal by Subject|0|||
129861873|NCT03150056|467449712|FG004|Overall Study|Withdrawal by Subject|0|||
129861874|NCT03150056|467449713|FG005|Overall Study|Withdrawal by Subject|2|||
129861875|NCT03150056|467449708|FG000|Overall Study|Study terminated by Sponsor|1|||
129861876|NCT03150056|467449709|FG001|Overall Study|Study terminated by Sponsor|3|||
129861877|NCT03150056|467449710|FG002|Overall Study|Study terminated by Sponsor|1|||
129861878|NCT03150056|467449711|FG003|Overall Study|Study terminated by Sponsor|1|||
129861879|NCT03150056|467449712|FG004|Overall Study|Study terminated by Sponsor|5|||
129861880|NCT03150056|467449713|FG005|Overall Study|Study terminated by Sponsor|6|||
129861881|NCT03150056|467449708|FG000|Overall Study|Death|9|||
129861882|NCT03150056|467449709|FG001|Overall Study|Death|2|||
129861883|NCT03150056|467449710|FG002|Overall Study|Death|2|||
129861884|NCT03150056|467449711|FG003|Overall Study|Death|7|||
129861885|NCT03150056|467449712|FG004|Overall Study|Death|8|||
129861886|NCT03150056|467449713|FG005|Overall Study|Death|10|||
129861887|NCT01581281|467449714|FG000|Overall Study|Early Study Closure|15|||
129861888|NCT01581281|467449715|FG001|Overall Study|Early Study Closure|6|||
129861889|NCT01581281|467449716|FG002|Overall Study|Early Study Closure|12|||
129861890|NCT04370054|467449719|FG000|Treatment Phase|Lost to Follow-up|1|||
129861891|NCT04370054|467449719|FG000|Treatment Phase|Withdrawal by Subject|1|||
129861892|NCT04370054|467449719|FG000|Follow-Up Phase|Ongoing|75|||
129861893|NCT00722761|467449720|FG000|Overall Study|Lost to Follow-up|1|||
129861894|NCT00722761|467449721|FG001|Overall Study|Lost to Follow-up|4|||
129861895|NCT00722761|467449720|FG000|Overall Study|Withdrawal by Subject|5|||
129861896|NCT00722761|467449721|FG001|Overall Study|Withdrawal by Subject|2|||
129861897|NCT06273774|467449723|FG000|Overall Study|Participant was out of state.|0|||
129861898|NCT06273774|467449724|FG001|Overall Study|Participant was out of state.|0|||
129861899|NCT06273774|467449725|FG002|Overall Study|Participant was out of state.|0|||
129861900|NCT06273774|467449726|FG003|Overall Study|Participant was out of state.|0|||
129861901|NCT06273774|467449727|FG004|Overall Study|Participant was out of state.|0|||
129861902|NCT06273774|467449728|FG005|Overall Study|Participant was out of state.|1|||
129861903|NCT06273774|467449723|FG000|Overall Study|Lost to Follow-up|0|||
129861904|NCT06273774|467449724|FG001|Overall Study|Lost to Follow-up|0|||
129861905|NCT06273774|467449725|FG002|Overall Study|Lost to Follow-up|0|||
129861906|NCT06273774|467449726|FG003|Overall Study|Lost to Follow-up|0|||
129861907|NCT06273774|467449727|FG004|Overall Study|Lost to Follow-up|1|||
129861908|NCT06273774|467449728|FG005|Overall Study|Lost to Follow-up|0|||
129861909|NCT05819749|467449733|FG000|Overall Study|Lost to Follow-up|1|||
129861910|NCT00924287|467452156|FG000|Overall Study|Death|1|||
129861911|NCT01625897|467452157|FG000|Overall Study|Adverse Event|27|||
129861912|NCT01625897|467452158|FG001|Overall Study|Adverse Event|10|||
129861913|NCT01625897|467452157|FG000|Overall Study|Physician Decision|0|||
129861914|NCT01625897|467452158|FG001|Overall Study|Physician Decision|1|||
129861915|NCT01625897|467452157|FG000|Overall Study|Withdrawal by Subject|25|||
129861916|NCT01625897|467452158|FG001|Overall Study|Withdrawal by Subject|3|||
129861917|NCT01912612|467452161|FG000|Overall Study|Adverse Event|4|||
129861918|NCT01912612|467452162|FG001|Overall Study|Adverse Event|0|||
129861919|NCT01912612|467452163|FG002|Overall Study|Adverse Event|0|||
129861920|NCT01912612|467452161|FG000|Overall Study|Withdrew consent|1|||
129861921|NCT01912612|467452162|FG001|Overall Study|Withdrew consent|0|||
129861922|NCT01912612|467452163|FG002|Overall Study|Withdrew consent|0|||
129911143|NCT02723955|467637619|FG014|Expansion Phase|Site Closed|0|||
129911144|NCT02723955|467637620|FG015|Expansion Phase|Site Closed|0|||
129911145|NCT02723955|467637621|FG016|Expansion Phase|Site Closed|0|||
129861923|NCT01912612|467452161|FG000|Overall Study|Study design change|0|||
129861924|NCT01912612|467452162|FG001|Overall Study|Study design change|0|||
129861925|NCT01912612|467452163|FG002|Overall Study|Study design change|3|||
129861926|NCT02008890|467452165|FG000|Period 1|Withdrawal by Subject|7|||
129861927|NCT02008890|467452166|FG001|Period 1|Withdrawal by Subject|7|||
129861928|NCT02008890|467452167|FG002|Period 1|Withdrawal by Subject|5|||
129861929|NCT02008890|467452168|FG003|Period 1|Withdrawal by Subject|0|||
129861930|NCT02008890|467452169|FG004|Period 1|Withdrawal by Subject|0|||
129861931|NCT02008890|467452165|FG000|Period 1|Pregnancy|1|||
129861932|NCT02008890|467452166|FG001|Period 1|Pregnancy|0|||
129861933|NCT02008890|467452167|FG002|Period 1|Pregnancy|0|||
129861934|NCT02008890|467452168|FG003|Period 1|Pregnancy|0|||
129861935|NCT02008890|467452169|FG004|Period 1|Pregnancy|0|||
129861936|NCT02008890|467452165|FG000|Period 1|Physician Decision|1|||
129861937|NCT02008890|467452166|FG001|Period 1|Physician Decision|0|||
129861938|NCT02008890|467452167|FG002|Period 1|Physician Decision|1|||
129861939|NCT02008890|467452168|FG003|Period 1|Physician Decision|0|||
129861940|NCT02008890|467452169|FG004|Period 1|Physician Decision|0|||
129861941|NCT02008890|467452165|FG000|Period 1|Adverse Event|6|||
129861942|NCT02008890|467452166|FG001|Period 1|Adverse Event|8|||
129861943|NCT02008890|467452167|FG002|Period 1|Adverse Event|6|||
129861944|NCT02008890|467452168|FG003|Period 1|Adverse Event|0|||
129861945|NCT02008890|467452169|FG004|Period 1|Adverse Event|0|||
129861946|NCT02008890|467452165|FG000|Period 2|Adverse Event|12|||
129861947|NCT02008890|467452166|FG001|Period 2|Adverse Event|7|||
129861948|NCT02008890|467452167|FG002|Period 2|Adverse Event|0|||
129861949|NCT02008890|467452168|FG003|Period 2|Adverse Event|5|||
129861950|NCT02008890|467452169|FG004|Period 2|Adverse Event|5|||
129861951|NCT02008890|467452165|FG000|Period 2|Withdrawal by Subject|11|||
129861952|NCT02008890|467452166|FG001|Period 2|Withdrawal by Subject|8|||
129861953|NCT02008890|467452167|FG002|Period 2|Withdrawal by Subject|0|||
129861954|NCT02008890|467452168|FG003|Period 2|Withdrawal by Subject|7|||
129861955|NCT02008890|467452169|FG004|Period 2|Withdrawal by Subject|2|||
129861956|NCT02008890|467452165|FG000|Period 2|Physician Decision|4|||
129861957|NCT02008890|467452166|FG001|Period 2|Physician Decision|0|||
129861958|NCT02008890|467452167|FG002|Period 2|Physician Decision|0|||
129861959|NCT02008890|467452168|FG003|Period 2|Physician Decision|2|||
129861960|NCT02008890|467452169|FG004|Period 2|Physician Decision|1|||
129861961|NCT02008890|467452165|FG000|Period 2|Lost to Follow-up|0|||
129861962|NCT02008890|467452166|FG001|Period 2|Lost to Follow-up|0|||
129861963|NCT02008890|467452167|FG002|Period 2|Lost to Follow-up|1|||
129861964|NCT02008890|467452168|FG003|Period 2|Lost to Follow-up|0|||
129861965|NCT02008890|467452169|FG004|Period 2|Lost to Follow-up|0|||
129861966|NCT02008890|467452165|FG000|Extension Period|Withdrawal by Subject|3|||
129861967|NCT02008890|467452166|FG001|Extension Period|Withdrawal by Subject|2|||
129861968|NCT02008890|467452167|FG002|Extension Period|Withdrawal by Subject|0|||
129861969|NCT02008890|467452168|FG003|Extension Period|Withdrawal by Subject|4|||
129861970|NCT02008890|467452169|FG004|Extension Period|Withdrawal by Subject|2|||
129861971|NCT02008890|467452165|FG000|Extension Period|Lost to Follow-up|1|||
129861972|NCT02008890|467452166|FG001|Extension Period|Lost to Follow-up|0|||
129861973|NCT02008890|467452167|FG002|Extension Period|Lost to Follow-up|0|||
129861974|NCT02008890|467452168|FG003|Extension Period|Lost to Follow-up|0|||
129861975|NCT02008890|467452169|FG004|Extension Period|Lost to Follow-up|0|||
129861976|NCT02008890|467452165|FG000|Extension Period|Adverse Event|1|||
129861977|NCT02008890|467452166|FG001|Extension Period|Adverse Event|3|||
129861978|NCT02008890|467452167|FG002|Extension Period|Adverse Event|0|||
129911146|NCT02723955|467637622|FG017|Expansion Phase|Site Closed|0|||
129911147|NCT02723955|467637623|FG018|Expansion Phase|Site Closed|0|||
129911148|NCT02723955|467637624|FG019|Expansion Phase|Site Closed|0|||
130116655|NCT00585351|468387149|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
130116656|NCT00585351|468387150|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
129861979|NCT02008890|467452168|FG003|Extension Period|Adverse Event|0|||
129861980|NCT02008890|467452169|FG004|Extension Period|Adverse Event|2|||
129861981|NCT02207816|467452170|FG000|Overall Study|Serious Adverse Event|0|||
129861982|NCT02207816|467452171|FG001|Overall Study|Serious Adverse Event|5|||
129861983|NCT02207816|467452172|FG002|Overall Study|Serious Adverse Event|2|||
129861984|NCT02207816|467452170|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129861985|NCT02207816|467452171|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
129861986|NCT02207816|467452172|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129861987|NCT02207816|467452170|FG000|Overall Study|Withdrawal by Subject|4|||
129861988|NCT02207816|467452171|FG001|Overall Study|Withdrawal by Subject|9|||
129861989|NCT02207816|467452172|FG002|Overall Study|Withdrawal by Subject|7|||
129861990|NCT02207816|467452170|FG000|Overall Study|Migrated/Moved From Study Area|41|||
129861991|NCT02207816|467452171|FG001|Overall Study|Migrated/Moved From Study Area|60|||
129861992|NCT02207816|467452172|FG002|Overall Study|Migrated/Moved From Study Area|51|||
129911149|NCT02723955|467637625|FG020|Expansion Phase|Site Closed|0|||
129861993|NCT02207816|467452170|FG000|Overall Study|Lost to Follow-up|3|||
129861994|NCT02207816|467452171|FG001|Overall Study|Lost to Follow-up|9|||
129861995|NCT02207816|467452172|FG002|Overall Study|Lost to Follow-up|1|||
129861996|NCT02207816|467452170|FG000|Overall Study|Other|1|||
129861997|NCT02207816|467452171|FG001|Overall Study|Other|2|||
129861998|NCT02207816|467452172|FG002|Overall Study|Other|4|||
129861999|NCT00765843|467452175|FG000|Overall Study|Lost to Follow-up|1|||
129862000|NCT00765843|467452176|FG001|Overall Study|Lost to Follow-up|3|||
129862001|NCT00765843|467452177|FG002|Overall Study|Lost to Follow-up|2|||
129862002|NCT00765843|467452175|FG000|Overall Study|did not return to receive intervention|0|||
129862003|NCT00765843|467452176|FG001|Overall Study|did not return to receive intervention|1|||
129862004|NCT00765843|467452177|FG002|Overall Study|did not return to receive intervention|0|||
129862005|NCT00765843|467452175|FG000|Overall Study|Adverse Event|0|||
129862006|NCT00765843|467452176|FG001|Overall Study|Adverse Event|0|||
129862007|NCT00765843|467452177|FG002|Overall Study|Adverse Event|1|||
129862008|NCT02277106|467452178|FG000|Stage 2|Adverse Event|0|||
129862009|NCT02277106|467452179|FG001|Stage 2|Adverse Event|0|||
129862010|NCT02277106|467452180|FG002|Stage 2|Adverse Event|1|||
129862011|NCT01064739|467452181|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
129862012|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
129862013|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
129862014|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
129862015|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
129862016|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
129862017|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
129862018|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
129862019|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
129862020|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
129862021|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
129862022|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
129862023|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
129862024|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
129862025|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
129862026|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
129862027|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
129862028|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
129862029|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
129862030|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129862031|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
129862032|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
129862033|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129862034|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
129862035|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
129862036|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129862037|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Adverse Event|9|||
129862038|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Adverse Event|14|||
129862039|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129862040|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
129862041|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
129862042|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
129862043|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
129862044|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
129862045|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
129862046|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
129862047|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
129862048|NCT01669629|467452188|FG000|Period 1|protocol deviation|1|||
129862049|NCT01669629|467452189|FG001|Period 1|protocol deviation|2|||
129862050|NCT01221597|467452190|FG000|Overall Study|Adverse Event|4|||
129862051|NCT01221597|467452191|FG001|Overall Study|Adverse Event|1|||
129862052|NCT01221597|467452190|FG000|Overall Study|Withdrawal by Subject|20|||
129862053|NCT01221597|467452191|FG001|Overall Study|Withdrawal by Subject|6|||
129862054|NCT01221597|467452190|FG000|Overall Study|Lost to Follow-up|6|||
129862055|NCT01221597|467452191|FG001|Overall Study|Lost to Follow-up|5|||
129862056|NCT01221597|467452190|FG000|Overall Study|Protocol Violation|1|||
129862057|NCT01221597|467452191|FG001|Overall Study|Protocol Violation|0|||
129862058|NCT01221597|467452190|FG000|Overall Study|Other|3|||
129862059|NCT01221597|467452191|FG001|Overall Study|Other|4|||
129862060|NCT01221597|467452190|FG000|Overall Study|Death|2|||
129862061|NCT01221597|467452191|FG001|Overall Study|Death|0|||
129911150|NCT02723955|467637626|FG021|Expansion Phase|Site Closed|0|||
129911151|NCT02723955|467637627|FG022|Expansion Phase|Site Closed|0|||
129911152|NCT02723955|467637628|FG023|Expansion Phase|Site Closed|0|||
129911153|NCT02723955|467637629|FG024|Expansion Phase|Site Closed|0|||
129911154|NCT02723955|467637630|FG025|Expansion Phase|Site Closed|0|||
129911155|NCT02723955|467637631|FG026|Expansion Phase|Site Closed|0|||
129911156|NCT02723955|467637632|FG027|Expansion Phase|Site Closed|0|||
129911157|NCT02723955|467637633|FG028|Expansion Phase|Site Closed|0|||
129911158|NCT02723955|467637634|FG029|Expansion Phase|Site Closed|0|||
129911159|NCT02723955|467637635|FG030|Expansion Phase|Site Closed|8|||
129911160|NCT02723955|467637636|FG031|Expansion Phase|Site Closed|4|||
129911161|NCT02723955|467637637|FG032|Expansion Phase|Site Closed|2|||
129911162|NCT02723955|467637638|FG033|Expansion Phase|Site Closed|2|||
129911163|NCT02723955|467637639|FG034|Expansion Phase|Site Closed|0|||
129911164|NCT02723955|467637640|FG035|Expansion Phase|Site Closed|0|||
129911165|NCT02723955|467637641|FG036|Expansion Phase|Site Closed|0|||
129911166|NCT02723955|467637642|FG037|Expansion Phase|Site Closed|0|||
129911167|NCT02723955|467637643|FG038|Expansion Phase|Site Closed|0|||
129911168|NCT02723955|467637644|FG039|Expansion Phase|Site Closed|0|||
129911169|NCT02723955|467637645|FG040|Expansion Phase|Site Closed|0|||
129911170|NCT02723955|467637646|FG041|Expansion Phase|Site Closed|0|||
129911171|NCT02723955|467637647|FG042|Expansion Phase|Site Closed|0|||
129911172|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Death|0|||
129911173|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Death|0|||
129911174|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Death|0|||
129911175|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Death|0|||
129911176|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Death|0|||
129911177|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Death|0|||
129911178|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Death|0|||
129911179|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Death|0|||
129911180|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Death|0|||
129911181|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Death|0|||
129911182|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Death|0|||
129911183|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Death|0|||
129911184|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Death|0|||
129911185|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Death|0|||
129911186|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Death|0|||
129911187|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Death|0|||
129911188|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Death|0|||
129911189|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Death|0|||
129911190|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Death|0|||
129911191|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Death|0|||
129911192|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Death|0|||
129911193|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Death|0|||
129911194|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Death|0|||
129911195|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Death|0|||
129911196|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Death|0|||
129911197|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Death|0|||
129911198|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Death|0|||
129911199|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Death|0|||
129911200|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Death|0|||
129911201|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Death|0|||
129911202|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Death|0|||
129911203|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Death|0|||
129911204|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Death|0|||
129911205|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Death|0|||
129911206|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Death|0|||
129911207|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Death|0|||
129911208|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Death|0|||
129911209|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Death|1|||
129911210|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Death|14|||
129911211|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Death|32|||
129911212|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Death|2|||
129911213|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Death|1|||
129911214|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Death|0|||
129911215|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911216|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911217|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911218|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911219|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911220|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911221|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911222|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911223|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911224|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911225|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911226|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911227|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129862062|NCT00121238|467452193|FG000|Overall Study|disease progression before intervention|1|||
129862063|NCT00121238|467452193|FG000|Overall Study|Protocol Violation|2|||
129862064|NCT01026974|467452202|FG000|Overall Study|Withdrawal by Subject|0|||
129862065|NCT01026974|467452203|FG001|Overall Study|Withdrawal by Subject|1|||
129862066|NCT01026974|467452204|FG002|Overall Study|Withdrawal by Subject|7|||
129862067|NCT01026974|467452205|FG003|Overall Study|Withdrawal by Subject|2|||
129862068|NCT01026974|467452202|FG000|Overall Study|Lost to Follow-up|1|||
129862069|NCT01026974|467452203|FG001|Overall Study|Lost to Follow-up|1|||
129862070|NCT01026974|467452204|FG002|Overall Study|Lost to Follow-up|4|||
129862071|NCT01026974|467452205|FG003|Overall Study|Lost to Follow-up|0|||
129862072|NCT01026974|467452202|FG000|Overall Study|Adverse Event|0|||
129862073|NCT01026974|467452203|FG001|Overall Study|Adverse Event|0|||
129862074|NCT01026974|467452204|FG002|Overall Study|Adverse Event|0|||
129862075|NCT01026974|467452205|FG003|Overall Study|Adverse Event|1|||
129862076|NCT01026974|467452202|FG000|Overall Study|Inappropriate enrollment|0|||
129862077|NCT01026974|467452203|FG001|Overall Study|Inappropriate enrollment|0|||
129862078|NCT01026974|467452204|FG002|Overall Study|Inappropriate enrollment|1|||
129862079|NCT01026974|467452205|FG003|Overall Study|Inappropriate enrollment|0|||
129862080|NCT00325468|467452207|FG000|Overall Study|Adverse Event|1|||
129862081|NCT00325468|467452208|FG001|Overall Study|Adverse Event|1|||
129862082|NCT00325468|467452209|FG002|Overall Study|Adverse Event|0|||
129862083|NCT00325468|467452210|FG003|Overall Study|Adverse Event|5|||
129862084|NCT00325468|467452211|FG004|Overall Study|Adverse Event|1|||
129862085|NCT00325468|467452207|FG000|Overall Study|Death|2|||
129862086|NCT00325468|467452208|FG001|Overall Study|Death|0|||
129862087|NCT00325468|467452209|FG002|Overall Study|Death|2|||
129862088|NCT00325468|467452210|FG003|Overall Study|Death|4|||
129862089|NCT00325468|467452211|FG004|Overall Study|Death|0|||
129862090|NCT00325468|467452207|FG000|Overall Study|Lost to Follow-up|0|||
129862091|NCT00325468|467452208|FG001|Overall Study|Lost to Follow-up|0|||
129862092|NCT00325468|467452209|FG002|Overall Study|Lost to Follow-up|1|||
129862093|NCT00325468|467452210|FG003|Overall Study|Lost to Follow-up|2|||
129862094|NCT00325468|467452211|FG004|Overall Study|Lost to Follow-up|2|||
129862095|NCT00325468|467452207|FG000|Overall Study|Physician Decision|1|||
129862096|NCT00325468|467452208|FG001|Overall Study|Physician Decision|1|||
129862097|NCT00325468|467452209|FG002|Overall Study|Physician Decision|0|||
129862098|NCT00325468|467452210|FG003|Overall Study|Physician Decision|1|||
129862099|NCT00325468|467452211|FG004|Overall Study|Physician Decision|0|||
129862100|NCT00325468|467452207|FG000|Overall Study|Withdrawal by Subject|3|||
129862101|NCT00325468|467452208|FG001|Overall Study|Withdrawal by Subject|1|||
129862102|NCT00325468|467452209|FG002|Overall Study|Withdrawal by Subject|0|||
129862103|NCT00325468|467452210|FG003|Overall Study|Withdrawal by Subject|14|||
129862104|NCT00325468|467452211|FG004|Overall Study|Withdrawal by Subject|4|||
129862105|NCT00325468|467452207|FG000|Overall Study|site closure etc|4|||
129862106|NCT00325468|467452208|FG001|Overall Study|site closure etc|2|||
129862107|NCT00325468|467452209|FG002|Overall Study|site closure etc|1|||
129862108|NCT00325468|467452210|FG003|Overall Study|site closure etc|8|||
129862109|NCT00325468|467452211|FG004|Overall Study|site closure etc|1|||
129862110|NCT03280121|467452212|FG000|Overall Study|Physician Decision|1|||
129862111|NCT03280121|467452212|FG000|Overall Study|Lost to Follow-up|1|||
129862112|NCT03280121|467452212|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
129862113|NCT01314118|467452213|FG000|Overall Study|Adverse Event|9|||
129862114|NCT01314118|467452213|FG000|Overall Study|Progressive disease|27|||
129862115|NCT01314118|467452213|FG000|Overall Study|Physician Decision|11|||
129862116|NCT01314118|467452213|FG000|Overall Study|Death|4|||
129862117|NCT01314118|467452213|FG000|Overall Study|Protocol Violation|5|||
129862118|NCT01314118|467452213|FG000|Overall Study|Withdrawal by Subject|11|||
129862119|NCT01314118|467452213|FG000|Overall Study|Other|2|||
129862120|NCT01314118|467452213|FG000|Overall Study|Ongoing|62|||
129862121|NCT05585307|467452221|FG000|Overall Study|Lost to Follow-up|0|||
129862122|NCT05585307|467452222|FG001|Overall Study|Lost to Follow-up|0|||
129862123|NCT05585307|467452223|FG002|Overall Study|Lost to Follow-up|0|||
129862124|NCT05585307|467452224|FG003|Overall Study|Lost to Follow-up|0|||
129862125|NCT05585307|467452225|FG004|Overall Study|Lost to Follow-up|0|||
129862126|NCT05585307|467452226|FG005|Overall Study|Lost to Follow-up|0|||
129862127|NCT05585307|467452227|FG006|Overall Study|Lost to Follow-up|1|||
129862128|NCT05585307|467452228|FG007|Overall Study|Lost to Follow-up|0|||
129862129|NCT04420221|467452229|FG000|Overall Study|Withdrawal by Subject|0|||
129862130|NCT04420221|467452230|FG001|Overall Study|Withdrawal by Subject|0|||
129862131|NCT04420221|467452231|FG002|Overall Study|Withdrawal by Subject|0|||
129862132|NCT04420221|467452232|FG003|Overall Study|Withdrawal by Subject|0|||
129862133|NCT04420221|467452233|FG004|Overall Study|Withdrawal by Subject|0|||
129862134|NCT04420221|467452234|FG005|Overall Study|Withdrawal by Subject|20|||
129862135|NCT04420221|467452235|FG006|Overall Study|Withdrawal by Subject|5|||
129862136|NCT04420221|467452229|FG000|Overall Study|Other|0|||
129862137|NCT04420221|467452230|FG001|Overall Study|Other|0|||
129862138|NCT04420221|467452231|FG002|Overall Study|Other|0|||
129862139|NCT04420221|467452232|FG003|Overall Study|Other|0|||
129862140|NCT04420221|467452233|FG004|Overall Study|Other|0|||
129862141|NCT04420221|467452234|FG005|Overall Study|Other|1|||
129911228|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911229|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911230|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911231|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911232|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911233|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911234|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911235|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911236|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911237|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911238|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911239|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911240|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911241|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911242|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911243|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911244|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911245|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911246|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911247|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911248|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911249|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911250|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911251|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911252|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911253|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911254|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
129911255|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911256|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911257|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911258|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911259|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911260|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911261|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911262|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911263|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911264|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911265|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911266|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911267|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911268|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911269|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911270|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911271|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911272|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911273|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911274|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911275|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911276|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911277|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911278|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911279|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911280|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911281|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911282|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911283|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911284|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911285|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911286|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911287|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911288|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911289|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911290|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911291|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911292|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911293|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911294|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911295|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
130116657|NCT00585351|468387151|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
129911296|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
129911297|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
129911298|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911299|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911300|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
129911301|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
129911302|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
129911303|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
129911304|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
129911305|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
129911306|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
129911307|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
129911308|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
129911309|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
129911310|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
129911311|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
129911312|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
129911313|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
129911314|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
129911315|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
129911316|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
129911317|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
129911318|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
129911319|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
129911320|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
129911321|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
129911322|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
129911323|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
129911324|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
129911325|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
129911326|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
129911327|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
129911328|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
129911329|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
129911330|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
129911331|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
129911332|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
129911333|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
129911334|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
129911335|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
129911336|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
129911337|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
129911338|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
129911339|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
129911340|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
129911341|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
129911342|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
129911343|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
129911344|NCT04999085|467637648|FG000|Overall Study|Death|1|||
129911345|NCT00402246|467637649|FG000|Overall Study|Death|62|||
129911346|NCT00402246|467637650|FG001|Overall Study|Death|58|||
129911347|NCT00402246|467637649|FG000|Overall Study|Lost to Follow-up|20|||
129911348|NCT00402246|467637650|FG001|Overall Study|Lost to Follow-up|28|||
129911349|NCT00402246|467637649|FG000|Overall Study|Withdrawal by Subject|72|||
129911350|NCT00402246|467637650|FG001|Overall Study|Withdrawal by Subject|87|||
129911351|NCT00402246|467637649|FG000|Overall Study|Physician Decision|24|||
129911352|NCT00402246|467637650|FG001|Overall Study|Physician Decision|26|||
129911353|NCT00402246|467637649|FG000|Overall Study|Protocol Violation|25|||
129911354|NCT00402246|467637650|FG001|Overall Study|Protocol Violation|24|||
129911355|NCT00402246|467637649|FG000|Overall Study|Missed Final Visit|1|||
129911356|NCT00402246|467637650|FG001|Overall Study|Missed Final Visit|2|||
129911357|NCT00402246|467637649|FG000|Overall Study|Insurance Issues|2|||
129911358|NCT00402246|467637650|FG001|Overall Study|Insurance Issues|1|||
129911359|NCT00402246|467637649|FG000|Overall Study|Heart Transplant|0|||
129911360|NCT00402246|467637650|FG001|Overall Study|Heart Transplant|1|||
129911361|NCT00402246|467637649|FG000|Overall Study|Patient's device explanted|6|||
129911362|NCT00402246|467637650|FG001|Overall Study|Patient's device explanted|2|||
129911363|NCT00402246|467637649|FG000|Overall Study|Center Closure|5|||
129911364|NCT00402246|467637650|FG001|Overall Study|Center Closure|3|||
129911365|NCT00402246|467637649|FG000|Overall Study|Deterioriating Condition|3|||
129911366|NCT00402246|467637650|FG001|Overall Study|Deterioriating Condition|2|||
129911367|NCT01266122|467637654|FG000|Overall Study|Lost to Follow-up|6|||
129911368|NCT01266122|467637655|FG001|Overall Study|Lost to Follow-up|6|||
129911369|NCT00421889|467637656|FG000|Overall Study|Adverse Event|1|||
129911370|NCT00421889|467637657|FG001|Overall Study|Adverse Event|0|||
129911371|NCT00421889|467637658|FG002|Overall Study|Adverse Event|1|||
129911372|NCT00421889|467637659|FG003|Overall Study|Adverse Event|1|||
129911373|NCT00421889|467637660|FG004|Overall Study|Adverse Event|1|||
129862142|NCT04420221|467452235|FG006|Overall Study|Other|1|||
129862143|NCT04420221|467452229|FG000|Overall Study|Lost to Follow-up|0|||
129862144|NCT04420221|467452230|FG001|Overall Study|Lost to Follow-up|0|||
129862145|NCT04420221|467452231|FG002|Overall Study|Lost to Follow-up|0|||
129862146|NCT04420221|467452232|FG003|Overall Study|Lost to Follow-up|0|||
129862147|NCT04420221|467452233|FG004|Overall Study|Lost to Follow-up|0|||
129862148|NCT04420221|467452234|FG005|Overall Study|Lost to Follow-up|3|||
129862149|NCT04420221|467452235|FG006|Overall Study|Lost to Follow-up|2|||
129862150|NCT04420221|467452229|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
129862151|NCT04420221|467452230|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
129862152|NCT04420221|467452231|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
129862153|NCT04420221|467452232|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
129862154|NCT04420221|467452233|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
129862155|NCT04420221|467452234|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
129862156|NCT04420221|467452235|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
129862157|NCT04642638|467452236|FG000|Overall Study|Withdrawal by Subject|23|||
129862158|NCT04642638|467452237|FG001|Overall Study|Withdrawal by Subject|29|||
129862159|NCT04642638|467452238|FG002|Overall Study|Withdrawal by Subject|9|||
129862160|NCT04642638|467452239|FG003|Overall Study|Withdrawal by Subject|7|||
129862161|NCT04642638|467452240|FG004|Overall Study|Withdrawal by Subject|61|||
129862162|NCT04642638|467452241|FG005|Overall Study|Withdrawal by Subject|27|||
129862163|NCT04642638|467452236|FG000|Overall Study|Lost to Follow-up|17|||
129862164|NCT04642638|467452237|FG001|Overall Study|Lost to Follow-up|18|||
129862165|NCT04642638|467452238|FG002|Overall Study|Lost to Follow-up|5|||
129862166|NCT04642638|467452239|FG003|Overall Study|Lost to Follow-up|5|||
129862167|NCT04642638|467452240|FG004|Overall Study|Lost to Follow-up|6|||
129862168|NCT04642638|467452241|FG005|Overall Study|Lost to Follow-up|3|||
129862169|NCT04642638|467452236|FG000|Overall Study|Adverse Event|0|||
129862170|NCT04642638|467452237|FG001|Overall Study|Adverse Event|0|||
129862171|NCT04642638|467452238|FG002|Overall Study|Adverse Event|1|||
129862172|NCT04642638|467452239|FG003|Overall Study|Adverse Event|0|||
129862173|NCT04642638|467452240|FG004|Overall Study|Adverse Event|10|||
129862174|NCT04642638|467452241|FG005|Overall Study|Adverse Event|3|||
129862175|NCT04642638|467452236|FG000|Overall Study|Reason Not Specified|1|||
129862176|NCT04642638|467452237|FG001|Overall Study|Reason Not Specified|4|||
129862177|NCT04642638|467452238|FG002|Overall Study|Reason Not Specified|0|||
129862178|NCT04642638|467452239|FG003|Overall Study|Reason Not Specified|0|||
129862179|NCT04642638|467452240|FG004|Overall Study|Reason Not Specified|38|||
129862180|NCT04642638|467452241|FG005|Overall Study|Reason Not Specified|16|||
129862181|NCT04642638|467452236|FG000|Overall Study|Physician Decision|0|||
129862182|NCT04642638|467452237|FG001|Overall Study|Physician Decision|0|||
129862183|NCT04642638|467452238|FG002|Overall Study|Physician Decision|0|||
129862184|NCT04642638|467452239|FG003|Overall Study|Physician Decision|0|||
129862185|NCT04642638|467452240|FG004|Overall Study|Physician Decision|2|||
129862186|NCT04642638|467452241|FG005|Overall Study|Physician Decision|1|||
129862187|NCT04642638|467452236|FG000|Overall Study|Protocol Deviation|0|||
129862188|NCT04642638|467452237|FG001|Overall Study|Protocol Deviation|0|||
129862189|NCT04642638|467452238|FG002|Overall Study|Protocol Deviation|0|||
129862190|NCT04642638|467452239|FG003|Overall Study|Protocol Deviation|0|||
129862191|NCT04642638|467452240|FG004|Overall Study|Protocol Deviation|1|||
129862192|NCT04642638|467452241|FG005|Overall Study|Protocol Deviation|3|||
129862193|NCT04642638|467452236|FG000|Overall Study|Study Terminated|0|||
129862194|NCT04642638|467452237|FG001|Overall Study|Study Terminated|0|||
129862195|NCT04642638|467452238|FG002|Overall Study|Study Terminated|0|||
129862196|NCT04642638|467452239|FG003|Overall Study|Study Terminated|0|||
129862197|NCT04642638|467452240|FG004|Overall Study|Study Terminated|484|||
129862198|NCT04642638|467452241|FG005|Overall Study|Study Terminated|250|||
129862199|NCT04642638|467452236|FG000|Overall Study|Pregnancy|0|||
129862200|NCT04642638|467452237|FG001|Overall Study|Pregnancy|0|||
129862201|NCT04642638|467452238|FG002|Overall Study|Pregnancy|0|||
129862202|NCT04642638|467452239|FG003|Overall Study|Pregnancy|0|||
129862203|NCT04642638|467452240|FG004|Overall Study|Pregnancy|1|||
129862204|NCT04642638|467452241|FG005|Overall Study|Pregnancy|0|||
129862205|NCT00990652|467452242|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
129862206|NCT00990652|467452242|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
129862207|NCT02085408|467452244|FG000|Step 1: Induction|Disease Progression|19|||
129862208|NCT02085408|467452245|FG001|Step 1: Induction|Disease Progression|19|||
129862209|NCT02085408|467452244|FG000|Step 1: Induction|Adverse Event|18|||
129862210|NCT02085408|467452245|FG001|Step 1: Induction|Adverse Event|17|||
129862211|NCT02085408|467452244|FG000|Step 1: Induction|Death|33|||
129862212|NCT02085408|467452245|FG001|Step 1: Induction|Death|30|||
129862213|NCT02085408|467452244|FG000|Step 1: Induction|Withdrawal by Subject|16|||
129862214|NCT02085408|467452245|FG001|Step 1: Induction|Withdrawal by Subject|8|||
129862215|NCT02085408|467452244|FG000|Step 1: Induction|Alternative Therapy|15|||
129862216|NCT02085408|467452245|FG001|Step 1: Induction|Alternative Therapy|19|||
129862217|NCT02085408|467452244|FG000|Step 1: Induction|Complicating Disease|2|||
129862218|NCT02085408|467452245|FG001|Step 1: Induction|Complicating Disease|3|||
129862219|NCT02085408|467452244|FG000|Step 1: Induction|Other|27|||
129862220|NCT02085408|467452245|FG001|Step 1: Induction|Other|39|||
129862221|NCT02085408|467452244|FG000|Step 1: Induction|Never started treatment|6|||
129862222|NCT02085408|467452245|FG001|Step 1: Induction|Never started treatment|4|||
129862223|NCT02085408|467452244|FG000|Step 2: Consolidation|Disease Progression|5|||
129862224|NCT02085408|467452245|FG001|Step 2: Consolidation|Disease Progression|20|||
129862225|NCT02085408|467452244|FG000|Step 2: Consolidation|Adverse Event|9|||
129862226|NCT02085408|467452245|FG001|Step 2: Consolidation|Adverse Event|8|||
129862227|NCT02085408|467452244|FG000|Step 2: Consolidation|Death|4|||
129862228|NCT02085408|467452245|FG001|Step 2: Consolidation|Death|3|||
129862229|NCT02085408|467452244|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
129862230|NCT02085408|467452245|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
129862231|NCT02085408|467452244|FG000|Step 2: Consolidation|Alternative Therapy|9|||
129862232|NCT02085408|467452245|FG001|Step 2: Consolidation|Alternative Therapy|3|||
129862233|NCT02085408|467452244|FG000|Step 2: Consolidation|Complicating Disease|0|||
129862234|NCT02085408|467452245|FG001|Step 2: Consolidation|Complicating Disease|2|||
129862235|NCT02085408|467452244|FG000|Step 2: Consolidation|Other|6|||
129862236|NCT02085408|467452245|FG001|Step 2: Consolidation|Other|6|||
129862237|NCT02085408|467452244|FG000|Step 2: Consolidation|Never started treatment|4|||
129862238|NCT02085408|467452245|FG001|Step 2: Consolidation|Never started treatment|3|||
129862239|NCT02085408|467452244|FG000|Step 3: Maintenance|Disease Progression|13|||
129862240|NCT02085408|467452245|FG001|Step 3: Maintenance|Disease Progression|11|||
129862241|NCT02085408|467452244|FG000|Step 3: Maintenance|Adverse Event|2|||
129862242|NCT02085408|467452245|FG001|Step 3: Maintenance|Adverse Event|4|||
129862243|NCT02085408|467452244|FG000|Step 3: Maintenance|Death|1|||
129862244|NCT02085408|467452245|FG001|Step 3: Maintenance|Death|2|||
129862245|NCT02085408|467452244|FG000|Step 3: Maintenance|Alternative Therapy|1|||
129862246|NCT02085408|467452245|FG001|Step 3: Maintenance|Alternative Therapy|1|||
129862247|NCT02085408|467452244|FG000|Step 3: Maintenance|Complicating Disease|0|||
129862248|NCT02085408|467452245|FG001|Step 3: Maintenance|Complicating Disease|1|||
129862249|NCT02085408|467452244|FG000|Step 3: Maintenance|Other|3|||
129862250|NCT02085408|467452245|FG001|Step 3: Maintenance|Other|2|||
129862251|NCT02085408|467452244|FG000|Step 3: Maintenance|Never started treatment|5|||
129862252|NCT02085408|467452245|FG001|Step 3: Maintenance|Never started treatment|1|||
129862253|NCT00319098|467452246|FG000|Overall Study|Serious adverse event|3|||
129862254|NCT00319098|467452247|FG001|Overall Study|Serious adverse event|0|||
129862255|NCT00319098|467452246|FG000|Overall Study|Adverse Event|20|||
129862256|NCT00319098|467452247|FG001|Overall Study|Adverse Event|1|||
129862257|NCT00319098|467452246|FG000|Overall Study|Withdrawal by Subject|37|||
129862258|NCT00319098|467452247|FG001|Overall Study|Withdrawal by Subject|8|||
129862259|NCT00319098|467452246|FG000|Overall Study|Migrated/moved from study area|2|||
129862260|NCT00319098|467452247|FG001|Overall Study|Migrated/moved from study area|1|||
129862261|NCT00319098|467452246|FG000|Overall Study|Lost to Follow-up|37|||
129862262|NCT00319098|467452247|FG001|Overall Study|Lost to Follow-up|13|||
129862263|NCT00319098|467452246|FG000|Overall Study|Others|33|||
129862264|NCT00319098|467452247|FG001|Overall Study|Others|8|||
129862265|NCT00319098|467452246|FG000|Overall Study|Protocol Violation|3|||
129862266|NCT00319098|467452247|FG001|Overall Study|Protocol Violation|1|||
129862267|NCT00965523|467452248|FG000|Study 221|Progressive Disease|4|||
129862268|NCT00965523|467452248|FG000|Study 221|Physician Decision|3|||
129862269|NCT00965523|467452248|FG000|Study 224|Progressive Disease|5|||
129862270|NCT00965523|467452248|FG000|Study 224|Physician Decision|1|||
129862271|NCT03595904|467452250|FG000|Overall Study|Protocol Violation|3|||
129862272|NCT03595904|467452251|FG001|Overall Study|Protocol Violation|1|||
129862273|NCT03595904|467452250|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
129862274|NCT03595904|467452251|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
129862275|NCT03595904|467452250|FG000|Overall Study|Insurance complications|1|||
129862276|NCT03595904|467452251|FG001|Overall Study|Insurance complications|0|||
129862277|NCT03595904|467452250|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
129862278|NCT03595904|467452251|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
129862279|NCT02187991|467452252|FG000|Overall Study|Adverse Event|13|||
129862280|NCT02187991|467452253|FG001|Overall Study|Adverse Event|14|||
129862281|NCT02187991|467452254|FG002|Overall Study|Adverse Event|3|||
129862282|NCT02187991|467452255|FG003|Overall Study|Adverse Event|2|||
129862283|NCT02187991|467452252|FG000|Overall Study|Withdrawal by Subject|9|||
129862284|NCT02187991|467452253|FG001|Overall Study|Withdrawal by Subject|6|||
129862285|NCT02187991|467452254|FG002|Overall Study|Withdrawal by Subject|3|||
129862286|NCT02187991|467452255|FG003|Overall Study|Withdrawal by Subject|2|||
129862287|NCT02187991|467452252|FG000|Overall Study|Physician Decision|4|||
129862288|NCT02187991|467452253|FG001|Overall Study|Physician Decision|4|||
129862289|NCT02187991|467452254|FG002|Overall Study|Physician Decision|0|||
129862290|NCT02187991|467452255|FG003|Overall Study|Physician Decision|2|||
129862291|NCT02187991|467452252|FG000|Overall Study|Other, unrelated complication|7|||
129862292|NCT02187991|467452253|FG001|Overall Study|Other, unrelated complication|1|||
129862293|NCT02187991|467452254|FG002|Overall Study|Other, unrelated complication|1|||
129862294|NCT02187991|467452255|FG003|Overall Study|Other, unrelated complication|2|||
129862295|NCT02187991|467452252|FG000|Overall Study|Death|1|||
129862296|NCT02187991|467452253|FG001|Overall Study|Death|3|||
129862297|NCT02187991|467452254|FG002|Overall Study|Death|0|||
129862298|NCT02187991|467452255|FG003|Overall Study|Death|0|||
129862299|NCT01392560|467452256|FG000|Overall Study|Adverse Event|2|||
129862300|NCT01392560|467452256|FG000|Overall Study|not entered|8|||
129862301|NCT01392560|467452256|FG000|Overall Study|discontinued during placebo run-in|2|||
129862302|NCT01939028|467452257|FG000|Overall Study|Withdrawal by Subject|5|||
129862303|NCT01939028|467452257|FG000|Overall Study|Physician Decision|7|||
129862304|NCT00700401|467452265|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
129862305|NCT00700401|467452265|FG000|Overall Study|Adverse Event|5|||
129862306|NCT00700401|467452265|FG000|Overall Study|Refused Treatment|2|||
129862307|NCT00700401|467452265|FG000|Overall Study|Lost to Follow-up|1|||
129862308|NCT00700401|467452265|FG000|Overall Study|Treatment never started|1|||
129862309|NCT00700401|467452265|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
129862310|NCT00700401|467452265|FG000|Overall Study|Withdrawal by Subject|2|||
129862311|NCT03273946|467452266|FG000|Overall Study|Withdrawal by Subject|5|||
129862312|NCT03273946|467452266|FG000|Overall Study|Unwillingness of the guardian|1|||
129862313|NCT03273946|467452266|FG000|Overall Study|Participant refused to use the drug|2|||
129862314|NCT03273946|467452266|FG000|Overall Study|Participant relative refused to use drug|1|||
129862315|NCT00295750|467452269|FG000|Overall Study|Adverse Event|19|||
129862316|NCT00295750|467452270|FG001|Overall Study|Adverse Event|15|||
129862317|NCT00295750|467452271|FG002|Overall Study|Adverse Event|12|||
129862318|NCT00295750|467452269|FG000|Overall Study|Lack of Efficacy|1|||
129862319|NCT00295750|467452270|FG001|Overall Study|Lack of Efficacy|1|||
129862320|NCT00295750|467452271|FG002|Overall Study|Lack of Efficacy|0|||
129862321|NCT00295750|467452269|FG000|Overall Study|Lost to Follow-up|1|||
129862322|NCT00295750|467452270|FG001|Overall Study|Lost to Follow-up|4|||
129862323|NCT00295750|467452271|FG002|Overall Study|Lost to Follow-up|1|||
129862324|NCT00295750|467452269|FG000|Overall Study|Taking prohibited therapy|2|||
129862325|NCT00295750|467452270|FG001|Overall Study|Taking prohibited therapy|3|||
129862326|NCT00295750|467452271|FG002|Overall Study|Taking prohibited therapy|2|||
129862327|NCT00295750|467452269|FG000|Overall Study|Administrative errors|2|||
129862328|NCT00295750|467452270|FG001|Overall Study|Administrative errors|4|||
129862329|NCT00295750|467452271|FG002|Overall Study|Administrative errors|5|||
129862330|NCT00295750|467452269|FG000|Overall Study|Trial drug errors|1|||
129862331|NCT00295750|467452270|FG001|Overall Study|Trial drug errors|1|||
129862332|NCT00295750|467452271|FG002|Overall Study|Trial drug errors|0|||
129862333|NCT00295750|467452269|FG000|Overall Study|Disease progression|2|||
129862334|NCT00295750|467452270|FG001|Overall Study|Disease progression|1|||
129862335|NCT00295750|467452271|FG002|Overall Study|Disease progression|0|||
129862336|NCT00295750|467452269|FG000|Overall Study|Personal reasons|0|||
129862337|NCT00295750|467452270|FG001|Overall Study|Personal reasons|1|||
129862338|NCT00295750|467452271|FG002|Overall Study|Personal reasons|0|||
129862339|NCT00295750|467452269|FG000|Overall Study|Randomized but never received trial drug|4|||
129862340|NCT00295750|467452270|FG001|Overall Study|Randomized but never received trial drug|3|||
129862341|NCT00295750|467452271|FG002|Overall Study|Randomized but never received trial drug|3|||
129862342|NCT00295750|467452269|FG000|Overall Study|Withdrawal by Subject|9|||
129862343|NCT00295750|467452270|FG001|Overall Study|Withdrawal by Subject|4|||
129862344|NCT00295750|467452271|FG002|Overall Study|Withdrawal by Subject|7|||
129862345|NCT00295750|467452269|FG000|Overall Study|Protocol Violation|2|||
129862346|NCT00295750|467452270|FG001|Overall Study|Protocol Violation|4|||
129862347|NCT00295750|467452271|FG002|Overall Study|Protocol Violation|2|||
129862348|NCT02199028|467452277|FG000|Week 1|Adverse Event|1|||
129862349|NCT02199028|467452278|FG001|Week 1|Adverse Event|0|||
129862350|NCT02199028|467452277|FG000|Week 3|Adverse Event|1|||
129862351|NCT02199028|467452278|FG001|Week 3|Adverse Event|0|||
129862352|NCT00522275|467452279|FG000|Overall Study|Adverse Event|35|||
129862353|NCT00522275|467452279|FG000|Overall Study|Lack of Efficacy|80|||
129862354|NCT00522275|467452279|FG000|Overall Study|Subject withdrew consent|16|||
129862355|NCT00522275|467452279|FG000|Overall Study|Protocol deviation|1|||
129862356|NCT00522275|467452279|FG000|Overall Study|Unsatisfactory compliance|11|||
129862357|NCT00522275|467452279|FG000|Overall Study|Lost to Follow-up|8|||
129862358|NCT00522275|467452279|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
129862359|NCT00522275|467452279|FG000|Overall Study|Other: Subject is pregnant|2|||
129862360|NCT00522275|467452279|FG000|Overall Study|Other: Subject relocated|2|||
129862361|NCT00522275|467452279|FG000|Overall Study|Other: Subject arrested|1|||
129862362|NCT00522275|467452279|FG000|Overall Study|Other: Site / clinic closed|4|||
130116658|NCT00585351|468387152|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
129862363|NCT00522275|467452279|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
129862364|NCT00522275|467452279|FG000|Overall Study|Other: Sponsor request|2|||
129862365|NCT00522275|467452279|FG000|Overall Study|Other: Subject ran out of medication|1|||
129862366|NCT00522275|467452279|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
129862367|NCT00092131|467452280|FG000|Treatment Period I|Adverse Event|1|||
129862368|NCT00092131|467452281|FG001|Treatment Period I|Adverse Event|0|||
129862369|NCT00092131|467452280|FG000|Treatment Period II|Adverse Event|0|||
129862370|NCT00092131|467452281|FG001|Treatment Period II|Adverse Event|1|||
129862371|NCT02341417|467452282|FG000|Overall Study|Withdrawal by Subject|0|||
129911374|NCT00421889|467637661|FG005|Overall Study|Adverse Event|4|||
129911375|NCT00421889|467637662|FG006|Overall Study|Adverse Event|1|||
129911376|NCT00421889|467637663|FG007|Overall Study|Adverse Event|0|||
129911377|NCT00421889|467637664|FG008|Overall Study|Adverse Event|2|||
129911378|NCT00421889|467637656|FG000|Overall Study|Withdrawal by Subject|1|||
129911379|NCT00421889|467637657|FG001|Overall Study|Withdrawal by Subject|3|||
129911380|NCT00421889|467637658|FG002|Overall Study|Withdrawal by Subject|0|||
129911381|NCT00421889|467637659|FG003|Overall Study|Withdrawal by Subject|0|||
129911382|NCT00421889|467637660|FG004|Overall Study|Withdrawal by Subject|2|||
129911383|NCT00421889|467637661|FG005|Overall Study|Withdrawal by Subject|0|||
129911384|NCT00421889|467637662|FG006|Overall Study|Withdrawal by Subject|0|||
129911385|NCT00421889|467637663|FG007|Overall Study|Withdrawal by Subject|0|||
129911386|NCT00421889|467637664|FG008|Overall Study|Withdrawal by Subject|0|||
129911387|NCT00421889|467637656|FG000|Overall Study|Death|0|||
129911388|NCT00421889|467637657|FG001|Overall Study|Death|0|||
129911389|NCT00421889|467637658|FG002|Overall Study|Death|0|||
129911390|NCT00421889|467637659|FG003|Overall Study|Death|0|||
129911391|NCT00421889|467637660|FG004|Overall Study|Death|1|||
129911392|NCT00421889|467637661|FG005|Overall Study|Death|1|||
129911393|NCT00421889|467637662|FG006|Overall Study|Death|0|||
129911394|NCT00421889|467637663|FG007|Overall Study|Death|0|||
129911395|NCT00421889|467637664|FG008|Overall Study|Death|0|||
129911396|NCT00421889|467637656|FG000|Overall Study|Progressive disease|3|||
129911397|NCT00421889|467637657|FG001|Overall Study|Progressive disease|2|||
129911398|NCT00421889|467637658|FG002|Overall Study|Progressive disease|2|||
129911399|NCT00421889|467637659|FG003|Overall Study|Progressive disease|3|||
129911400|NCT00421889|467637660|FG004|Overall Study|Progressive disease|2|||
129911401|NCT00421889|467637661|FG005|Overall Study|Progressive disease|21|||
129911402|NCT00421889|467637662|FG006|Overall Study|Progressive disease|3|||
129911403|NCT00421889|467637663|FG007|Overall Study|Progressive disease|1|||
129911404|NCT00421889|467637664|FG008|Overall Study|Progressive disease|5|||
129911405|NCT00421889|467637656|FG000|Overall Study|Patient/Investigator request|0|||
129911406|NCT00421889|467637657|FG001|Overall Study|Patient/Investigator request|0|||
129911407|NCT00421889|467637658|FG002|Overall Study|Patient/Investigator request|0|||
129911408|NCT00421889|467637659|FG003|Overall Study|Patient/Investigator request|0|||
129911409|NCT00421889|467637660|FG004|Overall Study|Patient/Investigator request|0|||
129911410|NCT00421889|467637661|FG005|Overall Study|Patient/Investigator request|9|||
129911411|NCT00421889|467637662|FG006|Overall Study|Patient/Investigator request|0|||
129911412|NCT00421889|467637663|FG007|Overall Study|Patient/Investigator request|1|||
129911413|NCT00421889|467637664|FG008|Overall Study|Patient/Investigator request|3|||
129911414|NCT00421889|467637656|FG000|Overall Study|Lost to Follow-up|0|||
129911415|NCT00421889|467637657|FG001|Overall Study|Lost to Follow-up|0|||
129911416|NCT00421889|467637658|FG002|Overall Study|Lost to Follow-up|0|||
129911417|NCT00421889|467637659|FG003|Overall Study|Lost to Follow-up|0|||
129911418|NCT00421889|467637660|FG004|Overall Study|Lost to Follow-up|0|||
129911419|NCT00421889|467637661|FG005|Overall Study|Lost to Follow-up|0|||
129911420|NCT00421889|467637662|FG006|Overall Study|Lost to Follow-up|0|||
129911421|NCT00421889|467637663|FG007|Overall Study|Lost to Follow-up|0|||
129911422|NCT00421889|467637664|FG008|Overall Study|Lost to Follow-up|1|||
129911423|NCT03756571|467637665|FG000|Overall Study|Lost to Follow-up|1|||
129911424|NCT03756571|467637666|FG001|Overall Study|Lost to Follow-up|1|||
129911425|NCT00978042|467637667|FG000|Initial Treatment Period|Treated in Error|0|||
129911426|NCT00978042|467637668|FG001|Initial Treatment Period|Treated in Error|3|||
129911427|NCT00978042|467637667|FG000|Initial Treatment Period|Ineligibility|1|||
129911428|NCT00978042|467637668|FG001|Initial Treatment Period|Ineligibility|0|||
129911429|NCT00978042|467637667|FG000|Initial Treatment Period|Lost to Follow-up|21|||
129911430|NCT00978042|467637668|FG001|Initial Treatment Period|Lost to Follow-up|3|||
129911431|NCT00978042|467637667|FG000|Initial Treatment Period|Adverse Event|2|||
129911432|NCT00978042|467637668|FG001|Initial Treatment Period|Adverse Event|0|||
129911433|NCT00978042|467637667|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
129911434|NCT00978042|467637668|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
129911435|NCT00978042|467637667|FG000|Initial Treatment Period|Consent withdrawn|22|||
129911436|NCT00978042|467637668|FG001|Initial Treatment Period|Consent withdrawn|9|||
129911437|NCT00978042|467637667|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
129911438|NCT00978042|467637668|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
129911439|NCT00520546|467637669|FG000|Overall Study|Withdrawal by Subject|1|||
129911440|NCT00520546|467637669|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
129911441|NCT02101281|467637673|FG000|Overall Study|Adverse Event|0|||
129911442|NCT02101281|467637674|FG001|Overall Study|Adverse Event|1|||
129911443|NCT00174382|467637675|FG000|Overall Study|Death|2|||
129911444|NCT00174382|467637675|FG000|Overall Study|Adverse Event|19|||
129911445|NCT00174382|467637675|FG000|Overall Study|Withdrawal by Subject|6|||
129911446|NCT00174382|467637675|FG000|Overall Study|Protocol Violation|3|||
129911447|NCT00174382|467637675|FG000|Overall Study|Arrived early for last visit in error|1|||
129911448|NCT00174382|467637675|FG000|Overall Study|Subject felt pill not effective enough|1|||
129911449|NCT00174382|467637675|FG000|Overall Study|Lost to Follow-up|1|||
129911450|NCT00296036|467637676|FG000|Overall Study|Withdrawal by Subject|1|||
129911451|NCT00296036|467637677|FG001|Overall Study|Withdrawal by Subject|0|||
129911452|NCT00296036|467637678|FG002|Overall Study|Withdrawal by Subject|2|||
129911453|NCT00296036|467637679|FG003|Overall Study|Withdrawal by Subject|1|||
129911454|NCT00296036|467637680|FG004|Overall Study|Withdrawal by Subject|2|||
129911455|NCT00296036|467637681|FG005|Overall Study|Withdrawal by Subject|1|||
129911456|NCT00296036|467637676|FG000|Overall Study|Protocol Violation|0|||
129911457|NCT00296036|467637677|FG001|Overall Study|Protocol Violation|0|||
129911458|NCT00296036|467637678|FG002|Overall Study|Protocol Violation|0|||
129911459|NCT00296036|467637679|FG003|Overall Study|Protocol Violation|0|||
129911460|NCT00296036|467637680|FG004|Overall Study|Protocol Violation|0|||
129911461|NCT00296036|467637681|FG005|Overall Study|Protocol Violation|3|||
129911462|NCT03403413|467637682|FG000|Overall Study|Lack of Efficacy|2|||
129911463|NCT03655262|467637683|FG000|Overall Study|Withdrawal by Subject|0|||
129911464|NCT03655262|467637684|FG001|Overall Study|Withdrawal by Subject|0|||
129911465|NCT03655262|467637685|FG002|Overall Study|Withdrawal by Subject|1|||
129911466|NCT03951805|467637687|FG000|Overall Study|Adverse Event|1|||
129911467|NCT03951805|467637688|FG001|Overall Study|Adverse Event|0|||
129911468|NCT03951805|467637689|FG002|Overall Study|Adverse Event|0|||
129911469|NCT03951805|467637690|FG003|Overall Study|Adverse Event|0|||
129911470|NCT00604669|467637691|FG000|Overall Study|lack of information in chart|7|||
129911471|NCT01695954|467637692|FG000|Overall Study|Withdrawal by Subject|4|||
129911472|NCT01695954|467637693|FG001|Overall Study|Withdrawal by Subject|0|||
129911473|NCT01695954|467637692|FG000|Overall Study|Adverse Event|0|||
129911474|NCT01695954|467637693|FG001|Overall Study|Adverse Event|2|||
129911475|NCT04328727|467637695|FG000|Overall Study|Guardian Decision|1|||
129911476|NCT04328727|467637695|FG000|Overall Study|Participant decision|4|||
129911477|NCT04328727|467637695|FG000|Overall Study|Death|3|||
129911478|NCT03684044|467637696|FG000|Overall Study|Adverse Event|3|||
129911479|NCT03684044|467637697|FG001|Overall Study|Adverse Event|0|||
129911480|NCT03684044|467637696|FG000|Overall Study|Death|4|||
129911481|NCT03684044|467637697|FG001|Overall Study|Death|7|||
129911482|NCT03684044|467637696|FG000|Overall Study|Lost to Follow-up|3|||
129862372|NCT02341417|467452283|FG001|Overall Study|Withdrawal by Subject|2|||
129862373|NCT02341417|467452284|FG002|Overall Study|Withdrawal by Subject|0|||
129862374|NCT02341417|467452282|FG000|Overall Study|Decision by sponsor|2|||
129862375|NCT02341417|467452283|FG001|Overall Study|Decision by sponsor|0|||
129862376|NCT02341417|467452284|FG002|Overall Study|Decision by sponsor|0|||
129862377|NCT02341417|467452282|FG000|Overall Study|Death|0|||
129862378|NCT02341417|467452283|FG001|Overall Study|Death|0|||
129862379|NCT02341417|467452284|FG002|Overall Study|Death|1|||
129862380|NCT02576067|467452285|FG000|Overall Study|Death|0|||
129862381|NCT02576067|467452286|FG001|Overall Study|Death|1|||
129862382|NCT02576067|467452285|FG000|Overall Study|Lack of Efficacy|1|||
129862383|NCT02576067|467452286|FG001|Overall Study|Lack of Efficacy|0|||
129862384|NCT02576067|467452285|FG000|Overall Study|Lost to Follow-up|11|||
129862385|NCT02576067|467452286|FG001|Overall Study|Lost to Follow-up|0|||
129862386|NCT02576067|467452285|FG000|Overall Study|Withdrawal by Subject|11|||
129862387|NCT02576067|467452286|FG001|Overall Study|Withdrawal by Subject|2|||
129862388|NCT02576067|467452285|FG000|Overall Study|study closure of main CIRT trial)|0|||
129862389|NCT02576067|467452286|FG001|Overall Study|study closure of main CIRT trial)|8|||
129862390|NCT02576067|467452285|FG000|Overall Study|not randomized, failed run-in|7|||
129862391|NCT02576067|467452286|FG001|Overall Study|not randomized, failed run-in|0|||
129862392|NCT02576067|467452285|FG000|Overall Study|screen failure/ re-enrolled|0|||
129862393|NCT02576067|467452286|FG001|Overall Study|screen failure/ re-enrolled|25|||
129862394|NCT02576067|467452285|FG000|Overall Study|Physician Decision|4|||
129862395|NCT02576067|467452286|FG001|Overall Study|Physician Decision|0|||
129862396|NCT04773587|467452289|FG000|Overall Study|Lost to Follow-up|11|||
129862397|NCT04773587|467452290|FG001|Overall Study|Lost to Follow-up|3|||
129862398|NCT04773587|467452289|FG000|Overall Study|Adverse Event|6|||
129862399|NCT04773587|467452290|FG001|Overall Study|Adverse Event|3|||
129911483|NCT03684044|467637697|FG001|Overall Study|Lost to Follow-up|2|||
129911484|NCT03684044|467637696|FG000|Overall Study|Patient Not Available|0|||
129911485|NCT03684044|467637697|FG001|Overall Study|Patient Not Available|2|||
129862400|NCT04773587|467452289|FG000|Overall Study|Lack of Efficacy|5|||
129862401|NCT04773587|467452290|FG001|Overall Study|Lack of Efficacy|2|||
129862402|NCT04773587|467452289|FG000|Overall Study|Withdrawal by Subject|4|||
129862403|NCT04773587|467452290|FG001|Overall Study|Withdrawal by Subject|5|||
129862404|NCT04773587|467452289|FG000|Overall Study|Noncompliance|1|||
129862405|NCT04773587|467452290|FG001|Overall Study|Noncompliance|0|||
129911486|NCT03684044|467637696|FG000|Overall Study|Physician Decision|1|||
129911487|NCT03684044|467637697|FG001|Overall Study|Physician Decision|0|||
129911488|NCT03684044|467637696|FG000|Overall Study|Withdrawal by Subject|11|||
129911489|NCT03684044|467637697|FG001|Overall Study|Withdrawal by Subject|9|||
129911490|NCT03703336|467637698|FG000|Overall Study|Parent withdrew consent|29|||
129911491|NCT03703336|467637699|FG001|Overall Study|Parent withdrew consent|8|||
129911492|NCT03703336|467637698|FG000|Overall Study|Migration|3|||
129911493|NCT03703336|467637699|FG001|Overall Study|Migration|3|||
129911494|NCT03703336|467637698|FG000|Overall Study|Protocol Violation|3|||
129911495|NCT03703336|467637699|FG001|Overall Study|Protocol Violation|1|||
129911496|NCT03703336|467637698|FG000|Overall Study|Physician Decision|2|||
129911497|NCT03703336|467637699|FG001|Overall Study|Physician Decision|0|||
129911498|NCT03703336|467637698|FG000|Overall Study|Adverse Event|0|||
129911499|NCT03703336|467637699|FG001|Overall Study|Adverse Event|2|||
129911500|NCT03703336|467637698|FG000|Overall Study|Lost to Follow-up|1|||
129911501|NCT03703336|467637699|FG001|Overall Study|Lost to Follow-up|0|||
129911502|NCT03930420|467637701|FG000|Overall Study|Withdrawal by Subject|7|||
129911503|NCT03930420|467637702|FG001|Overall Study|Withdrawal by Subject|9|||
129911504|NCT00580866|467637703|FG000|Overall Study|Lost to Follow-up|2|||
129911505|NCT00580866|467637704|FG001|Overall Study|Lost to Follow-up|2|||
129911506|NCT00609336|467637705|FG000|Overall Study|Protocol Violation|3|||
129911507|NCT00609336|467637705|FG000|Overall Study|Death|1|||
129911508|NCT00609336|467637705|FG000|Overall Study|LA or Met at Surgery|9|||
129911509|NCT02238483|467637706|FG000|Overall Study|Withdrawal by Subject|2|||
129911510|NCT02238483|467637707|FG001|Overall Study|Withdrawal by Subject|7|||
129911511|NCT02238483|467637706|FG000|Overall Study|Lost to Follow-up|1|||
129911512|NCT02238483|467637707|FG001|Overall Study|Lost to Follow-up|1|||
129911513|NCT02238483|467637706|FG000|Overall Study|Protocol Violation|1|||
129911514|NCT02238483|467637707|FG001|Overall Study|Protocol Violation|2|||
129911515|NCT02238483|467637706|FG000|Overall Study|Death|1|||
129911516|NCT02238483|467637707|FG001|Overall Study|Death|0|||
129911517|NCT02238483|467637706|FG000|Overall Study|Adverse Event|7|||
129911518|NCT02238483|467637707|FG001|Overall Study|Adverse Event|3|||
129911519|NCT02238483|467637706|FG000|Overall Study|Withdrawn due to physician decision|1|||
129911520|NCT02238483|467637707|FG001|Overall Study|Withdrawn due to physician decision|0|||
129911521|NCT02238483|467637706|FG000|Overall Study|Completion status not recorded|1|||
129911522|NCT02238483|467637707|FG001|Overall Study|Completion status not recorded|1|||
129911523|NCT02238483|467637706|FG000|Overall Study|Illness in family member|1|||
129911524|NCT02238483|467637707|FG001|Overall Study|Illness in family member|0|||
129911525|NCT02477605|467637708|FG000|Overall Study|Discontinued prior to treatment|1|||
129911526|NCT02477605|467637709|FG001|Overall Study|Discontinued prior to treatment|0|||
129911527|NCT02477605|467637708|FG000|Overall Study|Lost to Follow-up|0|||
129911528|NCT02477605|467637709|FG001|Overall Study|Lost to Follow-up|2|||
129911529|NCT02477605|467637708|FG000|Overall Study|Withdrawal by Subject|0|||
129911530|NCT02477605|467637709|FG001|Overall Study|Withdrawal by Subject|1|||
129911531|NCT02477605|467637708|FG000|Overall Study|Administered gas during surgery|0|||
129911532|NCT02477605|467637709|FG001|Overall Study|Administered gas during surgery|1|||
129911533|NCT02574455|467637710|FG000|Overall Study|Death|197|||
129911534|NCT02574455|467637711|FG001|Overall Study|Death|210|||
129911535|NCT02574455|467637710|FG000|Overall Study|Withdrawal of Consent|11|||
129911536|NCT02574455|467637711|FG001|Overall Study|Withdrawal of Consent|28|||
129911537|NCT02574455|467637710|FG000|Overall Study|Lost to Follow-up|4|||
129911538|NCT02574455|467637711|FG001|Overall Study|Lost to Follow-up|4|||
129911539|NCT02574455|467637710|FG000|Overall Study|Sponsor's Decision|55|||
129911540|NCT02574455|467637711|FG001|Overall Study|Sponsor's Decision|20|||
129911541|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Death|117|||
129911542|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Death|197|||
129911543|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
129911544|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
129911545|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
129911546|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
129911547|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
129911548|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
129911549|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
129911550|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
129911551|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
129911552|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
129911553|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
129911554|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
129911555|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
129911556|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
129911557|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
129911558|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
129911559|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
129911560|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
129911561|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
129911562|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
129911563|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
129911564|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
129911565|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
129911566|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
130094780|NCT01018680|468303840|FG001|Overall Study|Lack of Efficacy|2|||
129911567|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
129911568|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
129911569|NCT00567489|467637714|FG000|Overall Study|Adverse Event|6|||
129911570|NCT00567489|467637715|FG001|Overall Study|Adverse Event|14|||
129911571|NCT00567489|467637714|FG000|Overall Study|Physician Decision|0|||
129911572|NCT00567489|467637715|FG001|Overall Study|Physician Decision|4|||
129911573|NCT00567489|467637714|FG000|Overall Study|Withdrawal by Subject|0|||
129911574|NCT00567489|467637715|FG001|Overall Study|Withdrawal by Subject|2|||
129911575|NCT00567489|467637714|FG000|Overall Study|Renal Transplantation|0|||
129911576|NCT00567489|467637715|FG001|Overall Study|Renal Transplantation|3|||
129911577|NCT00567489|467637714|FG000|Overall Study|Other|1|||
129911578|NCT00567489|467637715|FG001|Overall Study|Other|0|||
129911579|NCT03565315|467637719|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
129911580|NCT03565315|467637720|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
129911581|NCT03565315|467637721|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
129911582|NCT03565315|467637722|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
129911583|NCT01083316|467637723|FG000|Overall Study|Adverse Event|2|||
129911584|NCT01083316|467637723|FG000|Overall Study|Withdrawal by Subject|1|||
129911585|NCT04200365|467637724|FG000|Overall Study|Adverse Event|2|||
129911586|NCT04200365|467637724|FG000|Overall Study|Progressive Disease|4|||
129911587|NCT04200365|467637724|FG000|Overall Study|Lack of Efficacy|1|||
129911588|NCT04200365|467637724|FG000|Overall Study|Study Closure|4|||
129911589|NCT02318134|467637731|FG000|Overall Study|Withdrawal by Subject|2|||
129911590|NCT02318134|467637732|FG001|Overall Study|Withdrawal by Subject|1|||
129911591|NCT01976312|467637733|FG000|Overall Study|Pregnancy|0|||
129911592|NCT01976312|467637734|FG001|Overall Study|Pregnancy|1|||
129911593|NCT01976312|467637733|FG000|Overall Study|Lost to Follow-up|2|||
129911594|NCT01976312|467637734|FG001|Overall Study|Lost to Follow-up|0|||
129911595|NCT01976312|467637733|FG000|Overall Study|Withdrawal by Subject|7|||
129911596|NCT01976312|467637734|FG001|Overall Study|Withdrawal by Subject|2|||
129911597|NCT01976312|467637733|FG000|Overall Study|Adverse Event|6|||
129911598|NCT01976312|467637734|FG001|Overall Study|Adverse Event|6|||
129911599|NCT01976312|467637733|FG000|Overall Study|Protocol Violation|2|||
129911600|NCT01976312|467637734|FG001|Overall Study|Protocol Violation|0|||
129911601|NCT01609218|467637741|FG000|Period 1|Adverse Event|3|||
129911602|NCT01609218|467637742|FG001|Period 1|Adverse Event|5|||
129911603|NCT01609218|467637741|FG000|Period 1|Sponsor Decision|0|||
129911604|NCT01609218|467637742|FG001|Period 1|Sponsor Decision|1|||
129911605|NCT01609218|467637741|FG000|Period 2|Adverse Event|1|||
129911606|NCT01609218|467637742|FG001|Period 2|Adverse Event|0|||
129911607|NCT04428112|467637748|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
129911608|NCT04428112|467637749|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
129911609|NCT04428112|467637748|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
129911610|NCT04428112|467637749|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
129911611|NCT04428112|467637748|FG000|Overall Study|Withdrawal by Subject|9|||
129911612|NCT04428112|467637749|FG001|Overall Study|Withdrawal by Subject|4|||
129911613|NCT04428112|467637748|FG000|Overall Study|Lost to Follow-up|27|||
129911614|NCT04428112|467637749|FG001|Overall Study|Lost to Follow-up|7|||
129911615|NCT01207492|467637750|FG000|Overall Study|Still on study|1|||
129911616|NCT01207492|467637750|FG000|Overall Study|Withdrawal by Subject|9|||
129911617|NCT01207492|467637750|FG000|Overall Study|Physician Decision|1|||
129911618|NCT01207492|467637750|FG000|Overall Study|Progressive disease|3|||
129911619|NCT01207492|467637750|FG000|Overall Study|Toxicity|1|||
129911620|NCT02769858|467637751|FG000|Overall Study|Withdrawal by Subject|2|||
129911621|NCT04814186|467639402|FG000|Treatment Phase|Adverse Event|1|||
129911622|NCT04814186|467639402|FG000|Treatment Phase|Death|6|||
129911623|NCT04814186|467639402|FG000|Treatment Phase|Withdrawal by Subject|2|||
129911624|NCT04814186|467639402|FG000|Treatment Phase|Other|1|||
129911625|NCT04814186|467639402|FG000|Follow-Up Phase|Adverse Event|1|||
129911626|NCT04814186|467639402|FG000|Follow-Up Phase|Death|6|||
129911627|NCT04814186|467639402|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
129911628|NCT04814186|467639402|FG000|Follow-Up Phase|Other|1|||
129911629|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
129911630|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
129911631|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
129911632|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
129911633|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
129911634|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
129911635|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
129911636|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
129911637|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
129911638|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
130094781|NCT01018680|468303839|FG000|Overall Study|Lost to Follow-up|5|||
129911639|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
129911640|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
129911641|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911642|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
129911643|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
129911644|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911645|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911646|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911647|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
129911648|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
129911649|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
129911650|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
129911651|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
129911652|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
129911653|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911654|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
129911655|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911656|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911657|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911658|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911659|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
129911660|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911661|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911662|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911663|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911664|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911665|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911666|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
129911667|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911668|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911669|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911670|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911671|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911672|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911673|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911674|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911675|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911676|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
129911677|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911678|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911679|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911680|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911681|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
129911682|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
129911683|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911684|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911685|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129862406|NCT04773587|467452289|FG000|Overall Study|Protocol Violation|1|||
129862407|NCT04773587|467452290|FG001|Overall Study|Protocol Violation|0|||
129862408|NCT04773587|467452289|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
129862409|NCT04773587|467452290|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
129862410|NCT02372409|467452291|FG000|Overall Study|Lost to Follow-up|1|||
129862411|NCT02372409|467452292|FG001|Overall Study|Lost to Follow-up|0|||
129862412|NCT02372409|467452291|FG000|Overall Study|Disease progression|1|||
129862413|NCT02372409|467452292|FG001|Overall Study|Disease progression|1|||
129862414|NCT01808313|467452293|FG000|Overall Study|Adverse Event|5|||
129862415|NCT01808313|467452293|FG000|Overall Study|Protocol Violation|2|||
129862416|NCT01808313|467452293|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129862417|NCT01808313|467452293|FG000|Overall Study|Lost to Follow-up|1|||
129862418|NCT01808313|467452293|FG000|Overall Study|Physician Decision|1|||
129862419|NCT04656847|467452296|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
129862420|NCT03301051|467452297|FG000|Overall Study|Adverse Event|0|||
129862421|NCT03301051|467452298|FG001|Overall Study|Adverse Event|4|||
129862422|NCT03301051|467452297|FG000|Overall Study|Withdrawal by Subject|59|||
129911686|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911687|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
129911688|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911689|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911690|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911691|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911692|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911693|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
129911694|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
129911695|NCT05194917|467639411|FG000|Overall Study|Lost to Follow-up|7|||
129911696|NCT05194917|467639412|FG001|Overall Study|Lost to Follow-up|5|||
129911697|NCT05194917|467639413|FG002|Overall Study|Lost to Follow-up|6|||
129911698|NCT05194917|467639414|FG003|Overall Study|Lost to Follow-up|5|||
129911699|NCT04688450|467639417|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
129911700|NCT04688450|467639417|FG000|Overall Study|Withdrawal by Subject|1|||
129911701|NCT03189524|467639418|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
129911702|NCT03189524|467639419|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
129911703|NCT03189524|467639420|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
129911704|NCT03189524|467639418|FG000|Overall Study|Death|2|||
129911705|NCT03189524|467639419|FG001|Overall Study|Death|2|||
129911706|NCT03189524|467639420|FG002|Overall Study|Death|1|||
129911707|NCT03189524|467639418|FG000|Overall Study|Lost to Follow-up|1|||
129911708|NCT03189524|467639419|FG001|Overall Study|Lost to Follow-up|0|||
129911709|NCT03189524|467639420|FG002|Overall Study|Lost to Follow-up|8|||
129911710|NCT03189524|467639418|FG000|Overall Study|Withdrawal by Subject|1|||
129911711|NCT03189524|467639419|FG001|Overall Study|Withdrawal by Subject|1|||
129911712|NCT03189524|467639420|FG002|Overall Study|Withdrawal by Subject|3|||
129911713|NCT03189524|467639418|FG000|Overall Study|Progressive Disease|0|||
129911714|NCT03189524|467639419|FG001|Overall Study|Progressive Disease|2|||
129911715|NCT03189524|467639420|FG002|Overall Study|Progressive Disease|0|||
129911716|NCT02980276|467639421|FG000|Overall Study|Withdrawal by Subject|4|||
129911717|NCT02980276|467639422|FG001|Overall Study|Withdrawal by Subject|4|||
129911718|NCT02980276|467639421|FG000|Overall Study|Physician Decision|0|||
129911719|NCT02980276|467639422|FG001|Overall Study|Physician Decision|1|||
130064804|NCT00603733|468192256|FG001|Active Phase ITT|Withdrawal by Subject|3|||
130064805|NCT00603733|468192255|FG000|Active Phase ITT|Lost to Follow-up|0|||
130064806|NCT00603733|468192256|FG001|Active Phase ITT|Lost to Follow-up|1|||
130064807|NCT00603733|468192255|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
130064808|NCT00603733|468192256|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
130064809|NCT00603733|468192255|FG000|Active Phase ITT|Lack of Efficacy|1|||
129862423|NCT03301051|467452298|FG001|Overall Study|Withdrawal by Subject|65|||
129862424|NCT03301051|467452297|FG000|Overall Study|Lost to Follow-up|263|||
129862425|NCT03301051|467452298|FG001|Overall Study|Lost to Follow-up|282|||
129862426|NCT03301051|467452297|FG000|Overall Study|Protocol Violation|1|||
129862427|NCT03301051|467452298|FG001|Overall Study|Protocol Violation|3|||
129862428|NCT03301051|467452297|FG000|Overall Study|Physician Decision|1|||
129862429|NCT03301051|467452298|FG001|Overall Study|Physician Decision|3|||
129862430|NCT03301051|467452297|FG000|Overall Study|Death|1|||
129862431|NCT03301051|467452298|FG001|Overall Study|Death|1|||
129862432|NCT03301051|467452297|FG000|Overall Study|Miscellaneous|8|||
129862433|NCT03301051|467452298|FG001|Overall Study|Miscellaneous|4|||
129862434|NCT03301051|467452297|FG000|Overall Study|Randomized, not vaccinated|13|||
129862435|NCT03301051|467452298|FG001|Overall Study|Randomized, not vaccinated|10|||
129862436|NCT00047879|467452299|FG000|Overall Study|Progressive disease|4|||
129862437|NCT00047879|467452300|FG001|Overall Study|Progressive disease|3|||
129862438|NCT00622167|467452301|FG000|Overall Study|Did not meet angiographic criteria|20|||
129862439|NCT01954017|467452304|FG000|Overall Study|Adverse Event|0|||
129862440|NCT01954017|467452305|FG001|Overall Study|Adverse Event|0|||
129862441|NCT01954017|467452306|FG002|Overall Study|Adverse Event|1|||
129862442|NCT01954017|467452304|FG000|Overall Study|Death|2|||
129862443|NCT01954017|467452305|FG001|Overall Study|Death|1|||
129862444|NCT01954017|467452306|FG002|Overall Study|Death|1|||
129862445|NCT01954017|467452304|FG000|Overall Study|Withdrawal by Subject|0|||
129862446|NCT01954017|467452305|FG001|Overall Study|Withdrawal by Subject|1|||
130064810|NCT00603733|468192256|FG001|Active Phase ITT|Lack of Efficacy|2|||
129862447|NCT01954017|467452306|FG002|Overall Study|Withdrawal by Subject|0|||
129862448|NCT01954017|467452304|FG000|Overall Study|Protocol Violation|0|||
129862449|NCT01954017|467452305|FG001|Overall Study|Protocol Violation|3|||
129862450|NCT01954017|467452306|FG002|Overall Study|Protocol Violation|2|||
129862451|NCT01954017|467452304|FG000|Overall Study|Necrotizing enterocolitis|1|||
129862452|NCT01954017|467452305|FG001|Overall Study|Necrotizing enterocolitis|0|||
129862453|NCT01954017|467452306|FG002|Overall Study|Necrotizing enterocolitis|1|||
129862454|NCT01954017|467452304|FG000|Overall Study|Enteral intake stopped >7 days|0|||
129911720|NCT02980276|467639421|FG000|Overall Study|Lost to Follow-up|18|||
129862455|NCT01954017|467452305|FG001|Overall Study|Enteral intake stopped >7 days|1|||
129862456|NCT01954017|467452306|FG002|Overall Study|Enteral intake stopped >7 days|1|||
129862457|NCT01954017|467452304|FG000|Overall Study|All other reasons|2|||
129862458|NCT01954017|467452305|FG001|Overall Study|All other reasons|2|||
129862459|NCT01954017|467452306|FG002|Overall Study|All other reasons|7|||
129862460|NCT00435370|467452311|FG000|Overall Study|Adverse Event|8|||
129862461|NCT00435370|467452312|FG001|Overall Study|Adverse Event|8|||
129862462|NCT00435370|467452311|FG000|Overall Study|Withdrawal by Subject|10|||
129862463|NCT00435370|467452312|FG001|Overall Study|Withdrawal by Subject|10|||
129862464|NCT00435370|467452311|FG000|Overall Study|Antipsychotic medication changed|4|||
129862465|NCT00435370|467452312|FG001|Overall Study|Antipsychotic medication changed|2|||
129862466|NCT03674177|467452316|FG000|Overall Study|Lost to Follow-up|2|||
129862467|NCT03674177|467452317|FG001|Overall Study|Lost to Follow-up|1|||
129862468|NCT03674177|467452318|FG002|Overall Study|Lost to Follow-up|0|||
129862469|NCT03674177|467452319|FG003|Overall Study|Lost to Follow-up|2|||
129862470|NCT00714168|467452320|FG000|Overall Study|Pregnancy|5|||
129862471|NCT00714168|467452321|FG001|Overall Study|Pregnancy|4|||
129862472|NCT00714168|467452320|FG000|Overall Study|Lost to Follow-up|32|||
129862473|NCT00714168|467452321|FG001|Overall Study|Lost to Follow-up|50|||
129862474|NCT00714168|467452320|FG000|Overall Study|Relocation|4|||
129862475|NCT00714168|467452321|FG001|Overall Study|Relocation|3|||
129862476|NCT00714168|467452320|FG000|Overall Study|Non-study medical condition|3|||
129862477|NCT00714168|467452321|FG001|Overall Study|Non-study medical condition|2|||
129862478|NCT02298192|467452325|FG000|Overall Study|Unclassified|3|||
129862479|NCT02298192|467452326|FG001|Overall Study|Unclassified|2|||
129862480|NCT02298192|467452325|FG000|Overall Study|Withdrawal criteria|2|||
129862481|NCT02298192|467452326|FG001|Overall Study|Withdrawal criteria|0|||
129862482|NCT02298192|467452325|FG000|Overall Study|Withdrawal by Subject|6|||
129862483|NCT02298192|467452326|FG001|Overall Study|Withdrawal by Subject|1|||
129862484|NCT02298192|467452325|FG000|Overall Study|Lost to Follow-up|2|||
129862485|NCT02298192|467452326|FG001|Overall Study|Lost to Follow-up|1|||
129862486|NCT02298192|467452325|FG000|Overall Study|Adverse Event|6|||
129862487|NCT02298192|467452326|FG001|Overall Study|Adverse Event|2|||
129862488|NCT04764396|467452330|FG000|Overall Study|Physician Decision|1|||
129862489|NCT04764396|467452331|FG001|Overall Study|Physician Decision|0|||
129862490|NCT02653482|467452333|FG000|Overall Study|Death|1|||
129862491|NCT02653482|467452334|FG001|Overall Study|Death|1|||
129862492|NCT01864564|467452337|FG000|Overall Study|Lost to Follow-up|17|||
129862493|NCT01864564|467452338|FG001|Overall Study|Lost to Follow-up|23|||
129862494|NCT01864564|467452337|FG000|Overall Study|Withdrawal by Subject|20|||
129862495|NCT01864564|467452338|FG001|Overall Study|Withdrawal by Subject|11|||
129862496|NCT01864564|467452337|FG000|Overall Study|Protocol Violation|0|||
129862497|NCT01864564|467452338|FG001|Overall Study|Protocol Violation|27|||
129862498|NCT01864564|467452337|FG000|Overall Study|not reported|0|||
129862499|NCT01864564|467452338|FG001|Overall Study|not reported|34|||
129862500|NCT03077724|467452339|FG000|Overall Study|Lost to Follow-up|5|||
129862501|NCT03077724|467452340|FG001|Overall Study|Lost to Follow-up|1|||
129862502|NCT03077724|467452339|FG000|Overall Study|Withdrawal by Subject|3|||
129862503|NCT03077724|467452340|FG001|Overall Study|Withdrawal by Subject|1|||
129862504|NCT04414696|467452343|FG000|3-month Follow up|Withdrawal by Subject|1|||
129862505|NCT04414696|467452344|FG001|3-month Follow up|Withdrawal by Subject|0|||
129862506|NCT04414696|467452343|FG000|3-month Follow up|Lost to Follow-up|22|||
129862507|NCT04414696|467452344|FG001|3-month Follow up|Lost to Follow-up|23|||
129862508|NCT04414696|467452343|FG000|6-month Follow up|Withdrawal by Subject|1|||
129862509|NCT04414696|467452344|FG001|6-month Follow up|Withdrawal by Subject|2|||
129862510|NCT04414696|467452343|FG000|6-month Follow up|Lost to Follow-up|5|||
129862511|NCT04414696|467452344|FG001|6-month Follow up|Lost to Follow-up|2|||
129862512|NCT05912400|467454577|FG000|Overall Study|Lost to Follow-up|1|||
129862513|NCT05912400|467454578|FG001|Overall Study|Lost to Follow-up|0|||
129862514|NCT05912400|467454577|FG000|Overall Study|Physician Decision|6|||
129862515|NCT05912400|467454578|FG001|Overall Study|Physician Decision|0|||
129862516|NCT05912400|467454577|FG000|Overall Study|Withdrawal by Subject|1|||
129862517|NCT05912400|467454578|FG001|Overall Study|Withdrawal by Subject|0|||
129862518|NCT02522494|467454579|FG000|Overall Study|Lost to Follow-up|6|||
129862519|NCT02522494|467454580|FG001|Overall Study|Lost to Follow-up|2|||
129862520|NCT02522494|467454579|FG000|Overall Study|Withdrawal by Subject|1|||
129862521|NCT02522494|467454580|FG001|Overall Study|Withdrawal by Subject|0|||
129862522|NCT02522494|467454579|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
129862523|NCT02522494|467454580|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
129862524|NCT02522494|467454579|FG000|Overall Study|Participant did not watch the video|1|||
129862525|NCT02522494|467454580|FG001|Overall Study|Participant did not watch the video|0|||
129862526|NCT02522494|467454579|FG000|Overall Study|Death|0|||
129862527|NCT02522494|467454580|FG001|Overall Study|Death|1|||
129862528|NCT03461003|467454581|FG000|Overall Study|Lost to Follow-up|2|||
129862529|NCT03461003|467454582|FG001|Overall Study|Lost to Follow-up|2|||
129862530|NCT03461003|467454581|FG000|Overall Study|Withdrawal by Subject|3|||
129862531|NCT03461003|467454582|FG001|Overall Study|Withdrawal by Subject|1|||
129862532|NCT03489304|467454583|FG000|Overall Study|Lost to Follow-up|4|||
129911721|NCT02980276|467639422|FG001|Overall Study|Lost to Follow-up|18|||
129911722|NCT02980276|467639421|FG000|Overall Study|Death|1|||
129911723|NCT02980276|467639422|FG001|Overall Study|Death|0|||
129911724|NCT02980276|467639421|FG000|Overall Study|Miscellaneous other|10|||
129911725|NCT02980276|467639422|FG001|Overall Study|Miscellaneous other|4|||
129911726|NCT04300647|467639423|FG000|Pre-Crossover|Death|19|||
129911727|NCT04300647|467639424|FG001|Pre-Crossover|Death|58|||
129911728|NCT04300647|467639425|FG002|Pre-Crossover|Death|0|||
129911729|NCT04300647|467639423|FG000|Pre-Crossover|Lost to Follow-up|0|||
129911730|NCT04300647|467639424|FG001|Pre-Crossover|Lost to Follow-up|3|||
129911731|NCT04300647|467639425|FG002|Pre-Crossover|Lost to Follow-up|0|||
129911732|NCT04300647|467639423|FG000|Pre-Crossover|Withdrawal by Subject|2|||
129911733|NCT04300647|467639424|FG001|Pre-Crossover|Withdrawal by Subject|4|||
129911734|NCT04300647|467639425|FG002|Pre-Crossover|Withdrawal by Subject|0|||
129911735|NCT04300647|467639423|FG000|Pre-Crossover|On-going in Study|24|||
129911736|NCT04300647|467639424|FG001|Pre-Crossover|On-going in Study|61|||
129911737|NCT04300647|467639425|FG002|Pre-Crossover|On-going in Study|0|||
129911738|NCT04300647|467639423|FG000|Post-Crossover|Death|0|||
129911739|NCT04300647|467639424|FG001|Post-Crossover|Death|0|||
129911740|NCT04300647|467639425|FG002|Post-Crossover|Death|3|||
129911741|NCT04300647|467639423|FG000|Post-Crossover|Lost to Follow-up|0|||
129911742|NCT04300647|467639424|FG001|Post-Crossover|Lost to Follow-up|0|||
129911743|NCT04300647|467639425|FG002|Post-Crossover|Lost to Follow-up|1|||
129911744|NCT04300647|467639423|FG000|Post-Crossover|Withdrawal by Subject|0|||
129911745|NCT04300647|467639424|FG001|Post-Crossover|Withdrawal by Subject|0|||
129911746|NCT04300647|467639425|FG002|Post-Crossover|Withdrawal by Subject|1|||
129911747|NCT04300647|467639423|FG000|Post-Crossover|On-going in Study|0|||
129911748|NCT04300647|467639424|FG001|Post-Crossover|On-going in Study|0|||
129911749|NCT04300647|467639425|FG002|Post-Crossover|On-going in Study|8|||
129911750|NCT03346538|467639429|FG000|Overall Study|Physician Decision|0|||
129911751|NCT03346538|467639430|FG001|Overall Study|Physician Decision|1|||
129911752|NCT03346538|467639431|FG002|Overall Study|Physician Decision|0|||
129911753|NCT03346538|467639429|FG000|Overall Study|Withdrawal by Subject|3|||
129911754|NCT03346538|467639430|FG001|Overall Study|Withdrawal by Subject|2|||
129911755|NCT03346538|467639431|FG002|Overall Study|Withdrawal by Subject|0|||
129911756|NCT03346538|467639429|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
129911757|NCT03346538|467639430|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
129911758|NCT03346538|467639431|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
129911759|NCT01353313|467639432|FG000|Overall Study|Lost to Follow-up|22|||
129911760|NCT01353313|467639433|FG001|Overall Study|Lost to Follow-up|23|||
129911761|NCT01353313|467639432|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
129911762|NCT01353313|467639433|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
129911763|NCT02824029|467639435|FG000|Overall Study|Didn't receive treatment|2|||
129911764|NCT02824029|467639435|FG000|Overall Study|Patient decision to discontinue treatment|3|||
129911765|NCT02824029|467639435|FG000|Overall Study|Non-compliant|5|||
129911766|NCT02824029|467639435|FG000|Overall Study|Progression of disease|15|||
129911767|NCT02824029|467639435|FG000|Overall Study|Inadequate response to therapy|2|||
129911768|NCT02824029|467639435|FG000|Overall Study|Possible progression per treating physician|1|||
129911769|NCT04524390|467639437|FG000|Double Blind|Consent Withdrawal by subject|2|||
129911770|NCT04524390|467639438|FG001|Double Blind|Consent Withdrawal by subject|1|||
129911771|NCT04524390|467639439|FG002|Double Blind|Consent Withdrawal by subject|0|||
129911772|NCT04524390|467639437|FG000|Double Blind|Adverse Event|5|||
129911773|NCT04524390|467639438|FG001|Double Blind|Adverse Event|3|||
129911774|NCT04524390|467639439|FG002|Double Blind|Adverse Event|0|||
129911775|NCT04524390|467639437|FG000|Double Blind|Liver Transplant|5|||
129911776|NCT04524390|467639438|FG001|Double Blind|Liver Transplant|6|||
129911777|NCT04524390|467639439|FG002|Double Blind|Liver Transplant|0|||
129911778|NCT04524390|467639437|FG000|Double Blind|Disease Progression|0|||
129911779|NCT04524390|467639438|FG001|Double Blind|Disease Progression|1|||
129911780|NCT04524390|467639439|FG002|Double Blind|Disease Progression|0|||
129911781|NCT04524390|467639437|FG000|Open-Label|Drug interruption criteria|0|||
129911782|NCT04524390|467639438|FG001|Open-Label|Drug interruption criteria|0|||
129911783|NCT04524390|467639439|FG002|Open-Label|Drug interruption criteria|1|||
129911784|NCT04524390|467639437|FG000|Open-Label|Liver Transplant|0|||
129911785|NCT04524390|467639438|FG001|Open-Label|Liver Transplant|0|||
129911786|NCT04524390|467639439|FG002|Open-Label|Liver Transplant|1|||
129911787|NCT04524390|467639437|FG000|Open-Label|Disease Progression|0|||
129911788|NCT04524390|467639438|FG001|Open-Label|Disease Progression|0|||
129911789|NCT04524390|467639439|FG002|Open-Label|Disease Progression|1|||
129911790|NCT04524390|467639437|FG000|Open-Label|Adverse Event|0|||
129911791|NCT04524390|467639438|FG001|Open-Label|Adverse Event|0|||
129911792|NCT04524390|467639439|FG002|Open-Label|Adverse Event|3|||
129911793|NCT04524390|467639437|FG000|Open-Label|Study Termination by sponsor|0|||
129911794|NCT04524390|467639438|FG001|Open-Label|Study Termination by sponsor|0|||
129911795|NCT04524390|467639439|FG002|Open-Label|Study Termination by sponsor|45|||
129911796|NCT04540913|467639447|FG000|Overall Study|Withdrawal by Subject|14|||
129911797|NCT04540913|467639448|FG001|Overall Study|Withdrawal by Subject|3|||
129911798|NCT03613740|467639449|FG000|Overall Study|Lost to Follow-up|1|||
129911799|NCT03613740|467639450|FG001|Overall Study|Lost to Follow-up|1|||
129911800|NCT01693120|467639452|FG000|Enrollment|Lost to Follow-up|1|||
129911801|NCT01693120|467639452|FG000|Enrollment|Withdrawal by Subject|10|||
129911802|NCT01693120|467639452|FG000|Enrollment|Protocol Violation|46|||
129911803|NCT01693120|467639452|FG000|Enrollment|Physician Decision|3|||
129911804|NCT01693120|467639452|FG000|Enrollment|Adverse Event|1|||
129911805|NCT01693120|467639452|FG000|Enrollment|Study closed|8|||
129911806|NCT01693120|467639452|FG000|Enrollment|Other|1|||
129911807|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
129911808|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
129911809|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
129911810|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
129911811|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
129911812|NCT04153565|467639453|FG000|Overall Study|Death|13|||
129911813|NCT01443845|467639460|FG000|Overall Study|Protocol Violation|43|||
129911814|NCT01443845|467639461|FG001|Overall Study|Protocol Violation|45|||
129911815|NCT01443845|467639460|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
129911816|NCT01443845|467639461|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
129911817|NCT01443845|467639460|FG000|Overall Study|Deterioration in pulmonary function|1|||
129911818|NCT01443845|467639461|FG001|Overall Study|Deterioration in pulmonary function|4|||
129911819|NCT01443845|467639460|FG000|Overall Study|Lack of Efficacy|10|||
129911820|NCT01443845|467639461|FG001|Overall Study|Lack of Efficacy|5|||
129911821|NCT01443845|467639460|FG000|Overall Study|Adverse Event|64|||
129911822|NCT01443845|467639461|FG001|Overall Study|Adverse Event|138|||
129911823|NCT01443845|467639460|FG000|Overall Study|Withdrawal by Subject|63|||
129911824|NCT01443845|467639461|FG001|Overall Study|Withdrawal by Subject|67|||
129911825|NCT01443845|467639460|FG000|Overall Study|Military Conflict - Site Terminated|20|||
129911826|NCT01443845|467639461|FG001|Overall Study|Military Conflict - Site Terminated|21|||
129911827|NCT01443845|467639460|FG000|Overall Study|Lost to Follow-up|9|||
129911828|NCT01443845|467639461|FG001|Overall Study|Lost to Follow-up|13|||
129911829|NCT01610297|467639463|FG000|Overall Study|Lost to Follow-up|1|||
129911830|NCT01007396|467639464|FG000|Overall Study|Lost to Follow-up|47|||
129911831|NCT03283371|467639465|FG000|Placebo-controlled|Adverse Event|1|||
129911832|NCT03283371|467639466|FG001|Placebo-controlled|Adverse Event|1|||
129911833|NCT03283371|467639467|FG002|Placebo-controlled|Adverse Event|0|||
129911834|NCT03283371|467639468|FG003|Placebo-controlled|Adverse Event|0|||
129911835|NCT03283371|467639465|FG000|Placebo-controlled|Lack of Efficacy|1|||
129911836|NCT03283371|467639466|FG001|Placebo-controlled|Lack of Efficacy|0|||
129911837|NCT03283371|467639467|FG002|Placebo-controlled|Lack of Efficacy|0|||
129911838|NCT03283371|467639468|FG003|Placebo-controlled|Lack of Efficacy|0|||
129911839|NCT03283371|467639465|FG000|Placebo-controlled|Withdrawal by Subject|1|||
129911840|NCT03283371|467639466|FG001|Placebo-controlled|Withdrawal by Subject|1|||
129911841|NCT03283371|467639467|FG002|Placebo-controlled|Withdrawal by Subject|0|||
129911842|NCT03283371|467639468|FG003|Placebo-controlled|Withdrawal by Subject|0|||
129911843|NCT03283371|467639465|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
129911844|NCT03283371|467639466|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
129911845|NCT03283371|467639467|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
129911846|NCT03283371|467639468|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
129911847|NCT03283371|467639465|FG000|Open-label Phase|Adverse Event|0|||
129911848|NCT03283371|467639466|FG001|Open-label Phase|Adverse Event|0|||
129911849|NCT03283371|467639467|FG002|Open-label Phase|Adverse Event|2|||
129911850|NCT03283371|467639468|FG003|Open-label Phase|Adverse Event|0|||
129911851|NCT03283371|467639465|FG000|Open-label Phase|Withdrawal by Subject|0|||
129911852|NCT03283371|467639466|FG001|Open-label Phase|Withdrawal by Subject|0|||
129911853|NCT03283371|467639467|FG002|Open-label Phase|Withdrawal by Subject|1|||
129911854|NCT03283371|467639468|FG003|Open-label Phase|Withdrawal by Subject|0|||
129911855|NCT03283371|467639465|FG000|Open-label Phase|Other|0|||
129911856|NCT03283371|467639466|FG001|Open-label Phase|Other|0|||
129911857|NCT03283371|467639467|FG002|Open-label Phase|Other|1|||
129911858|NCT03283371|467639468|FG003|Open-label Phase|Other|1|||
129911859|NCT03076515|467639470|FG000|Overall Study|DMC decision based on interim analysis|25|||
129911860|NCT03076515|467639471|FG001|Overall Study|DMC decision based on interim analysis|29|||
129911861|NCT02554786|467639474|FG000|Overall Study|Subject/guardian decision|29|||
129911862|NCT02554786|467639475|FG001|Overall Study|Subject/guardian decision|17|||
129911863|NCT02554786|467639476|FG002|Overall Study|Subject/guardian decision|18|||
129911864|NCT02554786|467639477|FG003|Overall Study|Subject/guardian decision|30|||
129911865|NCT02554786|467639478|FG004|Overall Study|Subject/guardian decision|20|||
129911866|NCT02554786|467639474|FG000|Overall Study|Lost to Follow-up|4|||
129911867|NCT02554786|467639475|FG001|Overall Study|Lost to Follow-up|3|||
129911868|NCT02554786|467639476|FG002|Overall Study|Lost to Follow-up|4|||
129911869|NCT02554786|467639477|FG003|Overall Study|Lost to Follow-up|2|||
129911870|NCT02554786|467639478|FG004|Overall Study|Lost to Follow-up|2|||
129911871|NCT02554786|467639474|FG000|Overall Study|Protocol deviation|1|||
129911872|NCT02554786|467639475|FG001|Overall Study|Protocol deviation|3|||
129911873|NCT02554786|467639476|FG002|Overall Study|Protocol deviation|3|||
129862533|NCT02239679|467454587|FG000|Overall Study|Lost to Follow-up|1|||
129862534|NCT02239679|467454588|FG001|Overall Study|Lost to Follow-up|0|||
129862535|NCT02239679|467454589|FG002|Overall Study|Lost to Follow-up|0|||
129862536|NCT02239679|467454587|FG000|Overall Study|Withdrawal by Subject|2|||
129862537|NCT02239679|467454588|FG001|Overall Study|Withdrawal by Subject|3|||
129862538|NCT02239679|467454589|FG002|Overall Study|Withdrawal by Subject|1|||
129862539|NCT02047045|467454590|FG000|Baseline|Withdrawal by Subject|3|||
129862540|NCT02047045|467454591|FG001|Baseline|Withdrawal by Subject|2|||
129862541|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
129862542|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
129862543|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
129862544|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
129862545|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
129862546|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
129862547|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
129862548|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
129862549|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
129862550|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
129862551|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
129862552|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
129862553|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
129862554|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
129862555|NCT02047045|467454590|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
129862556|NCT02047045|467454591|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
129862557|NCT04066114|467454592|FG000|Overall Study|Adverse Event|1|||
129862558|NCT04066114|467454593|FG001|Overall Study|Adverse Event|0|||
129862559|NCT04066114|467454594|FG002|Overall Study|Adverse Event|0|||
129862560|NCT04066114|467454592|FG000|Overall Study|Withdrawal by Subject|1|||
129862561|NCT04066114|467454593|FG001|Overall Study|Withdrawal by Subject|0|||
129862562|NCT04066114|467454594|FG002|Overall Study|Withdrawal by Subject|0|||
129862563|NCT04066114|467454592|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129862564|NCT04066114|467454593|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
129862565|NCT04066114|467454594|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
129862566|NCT02564523|467454597|FG000|Overall Study|Withdrawal by Subject|3|||
129862567|NCT02564523|467454598|FG001|Overall Study|Withdrawal by Subject|0|||
129862568|NCT02564523|467454599|FG002|Overall Study|Withdrawal by Subject|1|||
129862569|NCT02564523|467454600|FG003|Overall Study|Withdrawal by Subject|0|||
129862570|NCT02564523|467454601|FG004|Overall Study|Withdrawal by Subject|1|||
129862571|NCT02564523|467454602|FG005|Overall Study|Withdrawal by Subject|0|||
129862572|NCT02564523|467454603|FG006|Overall Study|Withdrawal by Subject|1|||
129862573|NCT02564523|467454604|FG007|Overall Study|Withdrawal by Subject|0|||
129862574|NCT02564523|467454605|FG008|Overall Study|Withdrawal by Subject|0|||
129862575|NCT02564523|467454606|FG009|Overall Study|Withdrawal by Subject|0|||
129862576|NCT02564523|467454607|FG010|Overall Study|Withdrawal by Subject|1|||
129862577|NCT02564523|467454608|FG011|Overall Study|Withdrawal by Subject|0|||
129862578|NCT02564523|467454609|FG012|Overall Study|Withdrawal by Subject|1|||
129862579|NCT02564523|467454610|FG013|Overall Study|Withdrawal by Subject|0|||
129862580|NCT02564523|467454611|FG014|Overall Study|Withdrawal by Subject|0|||
129862581|NCT02564523|467454612|FG015|Overall Study|Withdrawal by Subject|0|||
129862582|NCT02564523|467454613|FG016|Overall Study|Withdrawal by Subject|0|||
129862583|NCT02564523|467454614|FG017|Overall Study|Withdrawal by Subject|0|||
129862584|NCT02564523|467454597|FG000|Overall Study|Adverse Event|0|||
129862585|NCT02564523|467454598|FG001|Overall Study|Adverse Event|0|||
129862586|NCT02564523|467454599|FG002|Overall Study|Adverse Event|0|||
129862587|NCT02564523|467454600|FG003|Overall Study|Adverse Event|0|||
129862588|NCT02564523|467454601|FG004|Overall Study|Adverse Event|0|||
129862589|NCT02564523|467454602|FG005|Overall Study|Adverse Event|0|||
129862590|NCT02564523|467454603|FG006|Overall Study|Adverse Event|0|||
129862591|NCT02564523|467454604|FG007|Overall Study|Adverse Event|0|||
129862592|NCT02564523|467454605|FG008|Overall Study|Adverse Event|0|||
129862593|NCT02564523|467454606|FG009|Overall Study|Adverse Event|0|||
129862594|NCT02564523|467454607|FG010|Overall Study|Adverse Event|0|||
129862595|NCT02564523|467454608|FG011|Overall Study|Adverse Event|0|||
129862596|NCT02564523|467454609|FG012|Overall Study|Adverse Event|0|||
129862597|NCT02564523|467454610|FG013|Overall Study|Adverse Event|0|||
129911874|NCT02554786|467639477|FG003|Overall Study|Protocol deviation|4|||
129862598|NCT02564523|467454611|FG014|Overall Study|Adverse Event|0|||
129862599|NCT02564523|467454612|FG015|Overall Study|Adverse Event|0|||
129862600|NCT02564523|467454613|FG016|Overall Study|Adverse Event|0|||
129862601|NCT02564523|467454614|FG017|Overall Study|Adverse Event|1|||
129862602|NCT02564523|467454597|FG000|Overall Study|Death|0|||
129862603|NCT02564523|467454598|FG001|Overall Study|Death|0|||
129862604|NCT02564523|467454599|FG002|Overall Study|Death|0|||
129862605|NCT02564523|467454600|FG003|Overall Study|Death|0|||
129862606|NCT02564523|467454601|FG004|Overall Study|Death|0|||
129862607|NCT02564523|467454602|FG005|Overall Study|Death|0|||
129862608|NCT02564523|467454603|FG006|Overall Study|Death|1|||
129862609|NCT02564523|467454604|FG007|Overall Study|Death|0|||
129862610|NCT02564523|467454605|FG008|Overall Study|Death|0|||
130064811|NCT00603733|468192255|FG000|Active Phase ITT|Subject moved, site closed|1|||
130064812|NCT00603733|468192256|FG001|Active Phase ITT|Subject moved, site closed|1|||
130064813|NCT00603733|468192255|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
130064814|NCT00603733|468192256|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
130064815|NCT00603733|468192255|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
130064816|NCT00603733|468192256|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
130064817|NCT00603733|468192255|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
129862611|NCT02564523|467454606|FG009|Overall Study|Death|0|||
129862612|NCT02564523|467454607|FG010|Overall Study|Death|1|||
129862613|NCT02564523|467454608|FG011|Overall Study|Death|0|||
129862614|NCT02564523|467454609|FG012|Overall Study|Death|0|||
129862615|NCT02564523|467454610|FG013|Overall Study|Death|0|||
129862616|NCT02564523|467454611|FG014|Overall Study|Death|0|||
129862617|NCT02564523|467454612|FG015|Overall Study|Death|0|||
129862618|NCT02564523|467454613|FG016|Overall Study|Death|0|||
129862619|NCT02564523|467454614|FG017|Overall Study|Death|0|||
129862620|NCT02564523|467454597|FG000|Overall Study|Lost to Follow-up|2|||
129862621|NCT02564523|467454598|FG001|Overall Study|Lost to Follow-up|1|||
129862622|NCT02564523|467454599|FG002|Overall Study|Lost to Follow-up|4|||
129862623|NCT02564523|467454600|FG003|Overall Study|Lost to Follow-up|0|||
129862624|NCT02564523|467454601|FG004|Overall Study|Lost to Follow-up|1|||
129862625|NCT02564523|467454602|FG005|Overall Study|Lost to Follow-up|0|||
129862626|NCT02564523|467454603|FG006|Overall Study|Lost to Follow-up|1|||
129862627|NCT02564523|467454604|FG007|Overall Study|Lost to Follow-up|0|||
129862628|NCT02564523|467454605|FG008|Overall Study|Lost to Follow-up|0|||
129862629|NCT02564523|467454606|FG009|Overall Study|Lost to Follow-up|0|||
129862630|NCT02564523|467454607|FG010|Overall Study|Lost to Follow-up|0|||
129862631|NCT02564523|467454608|FG011|Overall Study|Lost to Follow-up|1|||
129862632|NCT02564523|467454609|FG012|Overall Study|Lost to Follow-up|1|||
129862633|NCT02564523|467454610|FG013|Overall Study|Lost to Follow-up|0|||
129862634|NCT02564523|467454611|FG014|Overall Study|Lost to Follow-up|0|||
129862635|NCT02564523|467454612|FG015|Overall Study|Lost to Follow-up|0|||
129862636|NCT02564523|467454613|FG016|Overall Study|Lost to Follow-up|0|||
129862637|NCT02564523|467454614|FG017|Overall Study|Lost to Follow-up|0|||
129862638|NCT02564523|467454597|FG000|Overall Study|Physician Decision|0|||
129862639|NCT02564523|467454598|FG001|Overall Study|Physician Decision|0|||
129862640|NCT02564523|467454599|FG002|Overall Study|Physician Decision|0|||
129862641|NCT02564523|467454600|FG003|Overall Study|Physician Decision|0|||
129862642|NCT02564523|467454601|FG004|Overall Study|Physician Decision|1|||
129862643|NCT02564523|467454602|FG005|Overall Study|Physician Decision|0|||
129862644|NCT02564523|467454603|FG006|Overall Study|Physician Decision|0|||
129862645|NCT02564523|467454604|FG007|Overall Study|Physician Decision|0|||
129862646|NCT02564523|467454605|FG008|Overall Study|Physician Decision|0|||
129862647|NCT02564523|467454606|FG009|Overall Study|Physician Decision|0|||
129862648|NCT02564523|467454607|FG010|Overall Study|Physician Decision|1|||
129862649|NCT02564523|467454608|FG011|Overall Study|Physician Decision|0|||
129862650|NCT02564523|467454609|FG012|Overall Study|Physician Decision|0|||
129862651|NCT02564523|467454610|FG013|Overall Study|Physician Decision|0|||
129862652|NCT02564523|467454611|FG014|Overall Study|Physician Decision|0|||
129862653|NCT02564523|467454612|FG015|Overall Study|Physician Decision|0|||
129862654|NCT02564523|467454613|FG016|Overall Study|Physician Decision|0|||
129862655|NCT02564523|467454614|FG017|Overall Study|Physician Decision|0|||
129862656|NCT02564523|467454597|FG000|Overall Study|Protocol Violation|2|||
129862657|NCT02564523|467454598|FG001|Overall Study|Protocol Violation|2|||
129862658|NCT02564523|467454599|FG002|Overall Study|Protocol Violation|5|||
129862659|NCT02564523|467454600|FG003|Overall Study|Protocol Violation|0|||
129862660|NCT02564523|467454601|FG004|Overall Study|Protocol Violation|1|||
129862661|NCT02564523|467454602|FG005|Overall Study|Protocol Violation|0|||
129862662|NCT02564523|467454603|FG006|Overall Study|Protocol Violation|0|||
129862663|NCT02564523|467454604|FG007|Overall Study|Protocol Violation|0|||
129862664|NCT02564523|467454605|FG008|Overall Study|Protocol Violation|0|||
129862665|NCT02564523|467454606|FG009|Overall Study|Protocol Violation|0|||
129862666|NCT02564523|467454607|FG010|Overall Study|Protocol Violation|0|||
129862667|NCT02564523|467454608|FG011|Overall Study|Protocol Violation|0|||
129862668|NCT02564523|467454609|FG012|Overall Study|Protocol Violation|0|||
129862669|NCT02564523|467454610|FG013|Overall Study|Protocol Violation|0|||
129862670|NCT02564523|467454611|FG014|Overall Study|Protocol Violation|0|||
129862671|NCT02564523|467454612|FG015|Overall Study|Protocol Violation|0|||
130064818|NCT00603733|468192256|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
129862672|NCT02564523|467454613|FG016|Overall Study|Protocol Violation|0|||
129862673|NCT02564523|467454614|FG017|Overall Study|Protocol Violation|0|||
129862674|NCT02564523|467454597|FG000|Overall Study|Other|3|||
129862675|NCT02564523|467454598|FG001|Overall Study|Other|0|||
129862676|NCT02564523|467454599|FG002|Overall Study|Other|0|||
129862677|NCT02564523|467454600|FG003|Overall Study|Other|1|||
129862678|NCT02564523|467454601|FG004|Overall Study|Other|0|||
129862679|NCT02564523|467454602|FG005|Overall Study|Other|0|||
129862680|NCT02564523|467454603|FG006|Overall Study|Other|0|||
129862681|NCT02564523|467454604|FG007|Overall Study|Other|0|||
129862682|NCT02564523|467454605|FG008|Overall Study|Other|0|||
129911875|NCT02554786|467639478|FG004|Overall Study|Protocol deviation|2|||
129911876|NCT02554786|467639474|FG000|Overall Study|Technical problems|1|||
129911877|NCT02554786|467639475|FG001|Overall Study|Technical problems|1|||
129911878|NCT02554786|467639476|FG002|Overall Study|Technical problems|0|||
129911879|NCT02554786|467639477|FG003|Overall Study|Technical problems|2|||
129911880|NCT02554786|467639478|FG004|Overall Study|Technical problems|1|||
129911881|NCT02554786|467639474|FG000|Overall Study|Adverse Event|0|||
129911882|NCT02554786|467639475|FG001|Overall Study|Adverse Event|0|||
129911883|NCT02554786|467639476|FG002|Overall Study|Adverse Event|0|||
129911884|NCT02554786|467639477|FG003|Overall Study|Adverse Event|0|||
129911885|NCT02554786|467639478|FG004|Overall Study|Adverse Event|2|||
129911886|NCT02554786|467639474|FG000|Overall Study|Death|0|||
129911887|NCT02554786|467639475|FG001|Overall Study|Death|0|||
129911888|NCT02554786|467639476|FG002|Overall Study|Death|0|||
129911889|NCT02554786|467639477|FG003|Overall Study|Death|1|||
129911890|NCT02554786|467639478|FG004|Overall Study|Death|0|||
129911891|NCT02554786|467639474|FG000|Overall Study|Non-compliance with study treatment|0|||
129911892|NCT02554786|467639475|FG001|Overall Study|Non-compliance with study treatment|1|||
129911893|NCT02554786|467639476|FG002|Overall Study|Non-compliance with study treatment|1|||
129911894|NCT02554786|467639477|FG003|Overall Study|Non-compliance with study treatment|0|||
129911895|NCT02554786|467639478|FG004|Overall Study|Non-compliance with study treatment|1|||
129911896|NCT02554786|467639474|FG000|Overall Study|Physician Decision|0|||
129911897|NCT02554786|467639475|FG001|Overall Study|Physician Decision|1|||
129911898|NCT02554786|467639476|FG002|Overall Study|Physician Decision|4|||
129911899|NCT02554786|467639477|FG003|Overall Study|Physician Decision|1|||
129911900|NCT02554786|467639478|FG004|Overall Study|Physician Decision|1|||
129911901|NCT02554786|467639474|FG000|Overall Study|Pregnancy|0|||
129911902|NCT02554786|467639475|FG001|Overall Study|Pregnancy|0|||
129911903|NCT02554786|467639476|FG002|Overall Study|Pregnancy|0|||
129911904|NCT02554786|467639477|FG003|Overall Study|Pregnancy|1|||
129911905|NCT02554786|467639478|FG004|Overall Study|Pregnancy|1|||
129911906|NCT04704284|467639479|FG000|Overall Study|Withdrawal by Subject|1|||
129911907|NCT00539734|467639481|FG000|Overall Study|Protocol Violation|1|||
129911908|NCT02692417|467639484|FG000|Overall Study|Withdrawal by Subject|5|||
129911909|NCT02692417|467639485|FG001|Overall Study|Withdrawal by Subject|1|||
129911910|NCT02692417|467639484|FG000|Overall Study|Adverse Event|1|||
129911911|NCT02692417|467639485|FG001|Overall Study|Adverse Event|0|||
129911912|NCT02372253|467639486|FG000|Overall Study|Non Compliance|2|||
129911913|NCT02372253|467639487|FG001|Overall Study|Non Compliance|0|||
129911914|NCT02178098|467639493|FG000|Overall Study|Withdrawal by Subject|0|||
129911915|NCT02178098|467639494|FG001|Overall Study|Withdrawal by Subject|6|||
129911916|NCT02178098|467639493|FG000|Overall Study|Adverse Event|1|||
129911917|NCT02178098|467639494|FG001|Overall Study|Adverse Event|2|||
129911918|NCT02178098|467639493|FG000|Overall Study|Protocol Violation|1|||
129911919|NCT02178098|467639494|FG001|Overall Study|Protocol Violation|1|||
129911920|NCT02178098|467639493|FG000|Overall Study|Lost to Follow-up|0|||
129911921|NCT02178098|467639494|FG001|Overall Study|Lost to Follow-up|1|||
129911922|NCT02178098|467639493|FG000|Overall Study|Sponsor Request|1|||
129911923|NCT02178098|467639494|FG001|Overall Study|Sponsor Request|0|||
129911924|NCT02178098|467639493|FG000|Overall Study|Other|2|||
129911925|NCT02178098|467639494|FG001|Overall Study|Other|2|||
129911926|NCT01044303|467639497|FG000|Overall Study|Lost to Follow-up|2|||
129911927|NCT01109524|467639498|FG000|Overall Study|Disease Progression|29|||
129911928|NCT01109524|467639498|FG000|Overall Study|Study Drug toxicity|6|||
129911929|NCT01109524|467639498|FG000|Overall Study|Adverse Event|4|||
129911930|NCT01109524|467639498|FG000|Overall Study|Withdrawal by Subject|2|||
129911931|NCT01109524|467639498|FG000|Overall Study|Maximum clinical benefit|3|||
129911932|NCT01109524|467639498|FG000|Overall Study|Death|2|||
129911933|NCT01109524|467639498|FG000|Overall Study|No longer meets criteria|2|||
129911934|NCT01109524|467639498|FG000|Overall Study|Participant requested to end treatment|4|||
129911935|NCT01109524|467639498|FG000|Overall Study|Other|5|||
129911936|NCT04048382|467639510|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
129911937|NCT04048382|467639511|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
129911938|NCT04048382|467639510|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
129911939|NCT04048382|467639511|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
129911940|NCT04048382|467639510|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
129911941|NCT04048382|467639511|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
129911942|NCT01205048|467639513|FG000|Overall Study|Withdrawal by Subject|14|||
129911943|NCT01205048|467639513|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
129911944|NCT01205048|467639513|FG000|Overall Study|Lost to Follow-up|4|||
129911945|NCT01205048|467639513|FG000|Overall Study|Other|2|||
129911946|NCT01255670|467639514|FG000|Overall Study|Adverse Event|10|||
129911947|NCT01255670|467639515|FG001|Overall Study|Adverse Event|10|||
129911948|NCT01255670|467639514|FG000|Overall Study|Lost to Follow-up|16|||
129911949|NCT01255670|467639515|FG001|Overall Study|Lost to Follow-up|10|||
129911950|NCT01037985|467639516|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
129911951|NCT01037985|467639517|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
129911952|NCT01037985|467639516|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
130094782|NCT01018680|468303840|FG001|Overall Study|Lost to Follow-up|3|||
129911953|NCT01037985|467639517|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
129911954|NCT01037985|467639516|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
129911955|NCT01037985|467639517|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
129911956|NCT01037985|467639516|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
129911957|NCT01037985|467639517|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
129911958|NCT02269475|467639518|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
129911959|NCT02269475|467639519|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
129911960|NCT02269475|467639518|FG000|Overall Study|Withdrawal by Subject|0|||
129911961|NCT02269475|467639519|FG001|Overall Study|Withdrawal by Subject|1|||
129911962|NCT02730871|467639520|FG000|Overall Study|Adverse Event|6|||
129911963|NCT02730871|467639521|FG001|Overall Study|Adverse Event|0|||
129911964|NCT00823472|467639522|FG000|Overall Study|Physician Decision|24|||
129911965|NCT00823472|467639523|FG001|Overall Study|Physician Decision|28|||
129911966|NCT04992390|467639524|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
129911967|NCT04992390|467639525|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
129911968|NCT04992390|467639526|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
129911969|NCT04992390|467639524|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
129911970|NCT04992390|467639525|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
129911971|NCT04992390|467639526|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
129911972|NCT04992390|467639524|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
129911973|NCT04992390|467639525|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
129911974|NCT04992390|467639526|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
129862683|NCT02564523|467454606|FG009|Overall Study|Other|0|||
129911975|NCT04992390|467639524|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
129911976|NCT04992390|467639525|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
129911977|NCT04992390|467639526|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
129911978|NCT04992390|467639524|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
129862684|NCT02564523|467454607|FG010|Overall Study|Other|0|||
129862685|NCT02564523|467454608|FG011|Overall Study|Other|0|||
129862686|NCT02564523|467454609|FG012|Overall Study|Other|0|||
129862687|NCT02564523|467454610|FG013|Overall Study|Other|0|||
129862688|NCT02564523|467454611|FG014|Overall Study|Other|0|||
129862689|NCT02564523|467454612|FG015|Overall Study|Other|0|||
129862690|NCT02564523|467454613|FG016|Overall Study|Other|0|||
129862691|NCT02564523|467454614|FG017|Overall Study|Other|0|||
129862692|NCT04862143|467454629|FG000|Overall Study|Adverse Event|1|||
129862693|NCT04862143|467454629|FG000|Overall Study|Study terminated by sponsor|1|||
129862694|NCT03031938|467454630|FG000|Overall Study|Death|1|||
129862695|NCT03031938|467454631|FG001|Overall Study|Death|0|||
129862696|NCT02479412|467454634|FG000|Overall Study|Adverse Event|0|||
129862697|NCT02479412|467454635|FG001|Overall Study|Adverse Event|0|||
129862698|NCT02479412|467454636|FG002|Overall Study|Adverse Event|1|||
129862699|NCT02479412|467454637|FG003|Overall Study|Adverse Event|0|||
129862700|NCT02479412|467454638|FG004|Overall Study|Adverse Event|0|||
129862701|NCT02479412|467454639|FG005|Overall Study|Adverse Event|0|||
129862702|NCT02479412|467454640|FG006|Overall Study|Adverse Event|0|||
129862703|NCT02479412|467454641|FG007|Overall Study|Adverse Event|0|||
129862704|NCT02479412|467454642|FG008|Overall Study|Adverse Event|0|||
129862705|NCT02479412|467454634|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129862706|NCT02479412|467454635|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129862707|NCT02479412|467454636|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129862708|NCT02479412|467454637|FG003|Overall Study|Study-specific withdrawal criteria|1|||
129862709|NCT02479412|467454638|FG004|Overall Study|Study-specific withdrawal criteria|0|||
129862710|NCT02479412|467454639|FG005|Overall Study|Study-specific withdrawal criteria|0|||
129862711|NCT02479412|467454640|FG006|Overall Study|Study-specific withdrawal criteria|0|||
129862712|NCT02479412|467454641|FG007|Overall Study|Study-specific withdrawal criteria|1|||
129862713|NCT02479412|467454642|FG008|Overall Study|Study-specific withdrawal criteria|1|||
129862714|NCT02479412|467454634|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
129862715|NCT02479412|467454635|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
129862716|NCT02479412|467454636|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
129862717|NCT02479412|467454637|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
129862718|NCT02479412|467454638|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
129862719|NCT02479412|467454639|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
129862720|NCT02479412|467454640|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
129862721|NCT02479412|467454641|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
129862722|NCT02479412|467454642|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
129862723|NCT00454051|467454643|FG000|Overall Study|Adverse Event|1|||
129862724|NCT00454051|467454644|FG001|Overall Study|Adverse Event|2|||
129862725|NCT00454051|467454643|FG000|Overall Study|Withdrawal by Subject|1|||
129862726|NCT00454051|467454644|FG001|Overall Study|Withdrawal by Subject|0|||
129862727|NCT00454051|467454643|FG000|Overall Study|Protocol Violation|1|||
129862728|NCT00454051|467454644|FG001|Overall Study|Protocol Violation|1|||
129862729|NCT03117738|467454645|FG000|Overall Study|Withdrawal by Subject|3|||
129862730|NCT03117738|467454646|FG001|Overall Study|Withdrawal by Subject|1|||
129862731|NCT03117738|467454645|FG000|Overall Study|Lost to Follow-up|1|||
129862732|NCT03117738|467454646|FG001|Overall Study|Lost to Follow-up|4|||
129862733|NCT03667053|467454648|FG000|Overall Study|Withdrawal by Subject|1|||
129862734|NCT03667053|467454649|FG001|Overall Study|Withdrawal by Subject|0|||
129862735|NCT03667053|467454650|FG002|Overall Study|Withdrawal by Subject|0|||
129862736|NCT00487162|467454657|FG000|Overall Study|Adverse Event|0|||
129862737|NCT00487162|467454658|FG001|Overall Study|Adverse Event|1|||
129862738|NCT00487162|467454657|FG000|Overall Study|Physician Decision|0|||
129862739|NCT00487162|467454658|FG001|Overall Study|Physician Decision|1|||
129862740|NCT00487162|467454657|FG000|Overall Study|Withdrawal by Subject|2|||
129862741|NCT00487162|467454658|FG001|Overall Study|Withdrawal by Subject|3|||
129862742|NCT01491854|467454659|FG000|Overall Study|mainly due to premature termination|93|||
129862743|NCT01491854|467454659|FG000|Overall Study|Death|1|||
129862744|NCT01491854|467454659|FG000|Overall Study|Withdrawal by Subject|3|||
129862745|NCT01491854|467454659|FG000|Overall Study|Lost to Follow-up|33|||
129862746|NCT05545072|467454665|FG000|Overall Study|Lost to Follow-up|1|||
129862747|NCT05545072|467454666|FG001|Overall Study|Lost to Follow-up|0|||
129862748|NCT05545072|467454665|FG000|Overall Study|Study ended prematurely due to funding|2|||
129862749|NCT05545072|467454666|FG001|Overall Study|Study ended prematurely due to funding|2|||
129862750|NCT04732286|467454672|FG000|Overall Study|Progressive Disease|2|||
129862751|NCT04732286|467454672|FG000|Overall Study|Physician Decision|1|||
129862752|NCT04732286|467454672|FG000|Overall Study|Study Terminated by Sponsor|31|||
129862753|NCT04732286|467454672|FG000|Overall Study|Withdrawal by Subject|10|||
129862754|NCT04732286|467454672|FG000|Overall Study|Non-compliance With Study Drug|1|||
129862755|NCT04732286|467454672|FG000|Overall Study|Lost to Follow-up|4|||
129862756|NCT04732286|467454672|FG000|Overall Study|Death|51|||
129862757|NCT01474681|467454673|FG000|Overall Study|Death|0|||
129862758|NCT01474681|467454674|FG001|Overall Study|Death|3|||
129862759|NCT01474681|467454675|FG002|Overall Study|Death|2|||
129862760|NCT01474681|467454676|FG003|Overall Study|Death|6|||
129862761|NCT03998618|467454677|FG000|Overall Study|Death|7|||
129862762|NCT03998618|467454678|FG001|Overall Study|Death|11|||
129862763|NCT03998618|467454677|FG000|Overall Study|hospice enrollment|3|||
129862764|NCT03998618|467454678|FG001|Overall Study|hospice enrollment|3|||
129862765|NCT03998618|467454677|FG000|Overall Study|Not feeling well/health problems|3|||
129862766|NCT03998618|467454678|FG001|Overall Study|Not feeling well/health problems|5|||
129862767|NCT03998618|467454677|FG000|Overall Study|Lost to Follow-up|6|||
129862768|NCT03998618|467454678|FG001|Overall Study|Lost to Follow-up|6|||
129862769|NCT03998618|467454677|FG000|Overall Study|Withdrawal by Subject|0|||
129862770|NCT03998618|467454678|FG001|Overall Study|Withdrawal by Subject|4|||
129862771|NCT02834780|467454679|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
129862772|NCT02834780|467454680|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
129862773|NCT02834780|467454681|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
129862774|NCT02834780|467454682|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
129862775|NCT02834780|467454683|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
129862776|NCT02834780|467454684|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
129862777|NCT02834780|467454685|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
129862778|NCT02834780|467454686|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
129862779|NCT02834780|467454687|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
129862780|NCT02834780|467454688|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
129862781|NCT02834780|467454689|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
129862782|NCT02834780|467454690|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
129862783|NCT02834780|467454691|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
129862784|NCT02834780|467454679|FG000|Overall Study|Withdrawal by Subject|0|||
129862785|NCT02834780|467454680|FG001|Overall Study|Withdrawal by Subject|0|||
129862786|NCT02834780|467454681|FG002|Overall Study|Withdrawal by Subject|1|||
129862787|NCT02834780|467454682|FG003|Overall Study|Withdrawal by Subject|0|||
129862788|NCT02834780|467454683|FG004|Overall Study|Withdrawal by Subject|0|||
129862789|NCT02834780|467454684|FG005|Overall Study|Withdrawal by Subject|0|||
129862790|NCT02834780|467454685|FG006|Overall Study|Withdrawal by Subject|0|||
129862791|NCT02834780|467454686|FG007|Overall Study|Withdrawal by Subject|0|||
129862792|NCT02834780|467454687|FG008|Overall Study|Withdrawal by Subject|0|||
129862793|NCT02834780|467454688|FG009|Overall Study|Withdrawal by Subject|0|||
129911979|NCT04992390|467639525|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
129911980|NCT04992390|467639526|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
129862794|NCT02834780|467454689|FG010|Overall Study|Withdrawal by Subject|1|||
129862795|NCT02834780|467454690|FG011|Overall Study|Withdrawal by Subject|0|||
129862796|NCT02834780|467454691|FG012|Overall Study|Withdrawal by Subject|0|||
129862797|NCT02834780|467454679|FG000|Overall Study|Adverse Event|0|||
129862798|NCT02834780|467454680|FG001|Overall Study|Adverse Event|0|||
129911981|NCT04992390|467639524|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
129862799|NCT02834780|467454681|FG002|Overall Study|Adverse Event|0|||
129862800|NCT02834780|467454682|FG003|Overall Study|Adverse Event|0|||
129862801|NCT02834780|467454683|FG004|Overall Study|Adverse Event|1|||
129862802|NCT02834780|467454684|FG005|Overall Study|Adverse Event|0|||
129862803|NCT02834780|467454685|FG006|Overall Study|Adverse Event|1|||
129862804|NCT02834780|467454686|FG007|Overall Study|Adverse Event|1|||
129862805|NCT02834780|467454687|FG008|Overall Study|Adverse Event|0|||
129862806|NCT02834780|467454688|FG009|Overall Study|Adverse Event|2|||
129862807|NCT02834780|467454689|FG010|Overall Study|Adverse Event|0|||
129862808|NCT02834780|467454690|FG011|Overall Study|Adverse Event|3|||
129862809|NCT02834780|467454691|FG012|Overall Study|Adverse Event|2|||
129862810|NCT02834780|467454679|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862811|NCT02834780|467454680|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
129862812|NCT02834780|467454681|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
129862813|NCT02834780|467454682|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862814|NCT02834780|467454683|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862815|NCT02834780|467454684|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862816|NCT02834780|467454685|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862817|NCT02834780|467454686|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
129862818|NCT02834780|467454687|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
129862819|NCT02834780|467454688|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
129862820|NCT02834780|467454689|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862821|NCT02834780|467454690|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
129862822|NCT02834780|467454691|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
129862823|NCT02834780|467454679|FG000|Overall Study|Other|1|||
129862824|NCT02834780|467454680|FG001|Overall Study|Other|0|||
129862825|NCT02834780|467454681|FG002|Overall Study|Other|1|||
129862826|NCT02834780|467454682|FG003|Overall Study|Other|2|||
129862827|NCT02834780|467454683|FG004|Overall Study|Other|0|||
129862828|NCT02834780|467454684|FG005|Overall Study|Other|0|||
129862829|NCT02834780|467454685|FG006|Overall Study|Other|0|||
129862830|NCT02834780|467454686|FG007|Overall Study|Other|0|||
129862831|NCT02834780|467454687|FG008|Overall Study|Other|0|||
129862832|NCT02834780|467454688|FG009|Overall Study|Other|0|||
129862833|NCT02834780|467454689|FG010|Overall Study|Other|0|||
129862834|NCT02834780|467454690|FG011|Overall Study|Other|0|||
129862835|NCT02834780|467454691|FG012|Overall Study|Other|1|||
129862836|NCT02081846|467454692|FG000|Overall Study|Withdrawal by Subject|1|||
129862837|NCT02081846|467454693|FG001|Overall Study|Withdrawal by Subject|0|||
129862838|NCT02081846|467454692|FG000|Overall Study|invalid consent|1|||
129862839|NCT02081846|467454693|FG001|Overall Study|invalid consent|0|||
129862840|NCT03282227|467454694|FG000|Overall Study|Exposure Goals Achieved|60|||
129862841|NCT03282227|467454694|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
129862842|NCT03282227|467454694|FG000|Overall Study|Adverse Event|15|||
129862843|NCT03282227|467454694|FG000|Overall Study|Lost to Follow-up|21|||
129862844|NCT03282227|467454694|FG000|Overall Study|Withdrawal by Subject|20|||
129862845|NCT03282227|467454694|FG000|Overall Study|Lack of Efficacy|12|||
129862846|NCT03282227|467454694|FG000|Overall Study|Sponsor decision|3|||
129862847|NCT03282227|467454694|FG000|Overall Study|Physician Decision|2|||
129862848|NCT03282227|467454694|FG000|Overall Study|Pregnancy|2|||
129862849|NCT03282227|467454694|FG000|Overall Study|Other|1|||
129862850|NCT01881126|467454716|FG000|Overall Study|Non-compliance|1|||
129862851|NCT01881126|467454717|FG001|Overall Study|Non-compliance|1|||
129862852|NCT01881126|467454716|FG000|Overall Study|Adverse Event|0|||
129862853|NCT01881126|467454717|FG001|Overall Study|Adverse Event|1|||
129862854|NCT01090453|467454720|FG000|Overall Study|Withdrawal by Subject|1|||
129862855|NCT01090453|467454721|FG001|Overall Study|Withdrawal by Subject|2|||
129862856|NCT01090453|467454720|FG000|Overall Study|Lost to Follow-up|7|||
129862857|NCT01090453|467454721|FG001|Overall Study|Lost to Follow-up|7|||
129862858|NCT01090453|467454720|FG000|Overall Study|Non serious AEs|1|||
129862859|NCT01090453|467454721|FG001|Overall Study|Non serious AEs|0|||
129862860|NCT01090453|467454720|FG000|Overall Study|Protocol Violation|2|||
129862861|NCT01090453|467454721|FG001|Overall Study|Protocol Violation|0|||
129862862|NCT01090453|467454720|FG000|Overall Study|Other|2|||
129862863|NCT01090453|467454721|FG001|Overall Study|Other|4|||
129862864|NCT01090453|467454720|FG000|Overall Study|Eligibility Criteria|0|||
129862865|NCT01090453|467454721|FG001|Overall Study|Eligibility Criteria|1|||
129862866|NCT04072159|467454722|FG000|Overall Study|Lost to Follow-up|6|||
129862867|NCT04072159|467454723|FG001|Overall Study|Lost to Follow-up|6|||
129862868|NCT04072159|467454722|FG000|Overall Study|Withdrawal by Subject|2|||
129862869|NCT04072159|467454723|FG001|Overall Study|Withdrawal by Subject|0|||
129862870|NCT00695669|467454729|FG000|Overall Study|Adverse Event|0|||
129862871|NCT00695669|467454730|FG001|Overall Study|Adverse Event|0|||
129862872|NCT00695669|467454731|FG002|Overall Study|Adverse Event|2|||
129862873|NCT00695669|467454732|FG003|Overall Study|Adverse Event|0|||
129862874|NCT00695669|467454729|FG000|Overall Study|Lost to Follow-up|4|||
129862875|NCT00695669|467454730|FG001|Overall Study|Lost to Follow-up|4|||
129862876|NCT00695669|467454731|FG002|Overall Study|Lost to Follow-up|1|||
129862877|NCT00695669|467454732|FG003|Overall Study|Lost to Follow-up|4|||
129862878|NCT05045625|467454733|FG000|Overall Study|Lost to Follow-up|3|||
129911982|NCT04992390|467639525|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
129911983|NCT04992390|467639526|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
129911984|NCT04992390|467639524|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
129911985|NCT04992390|467639525|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
129911986|NCT04992390|467639526|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
129911987|NCT04992390|467639524|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
129911988|NCT04992390|467639525|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
129911989|NCT04992390|467639526|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
129911990|NCT04992390|467639524|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
129911991|NCT04992390|467639525|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
129911992|NCT04992390|467639526|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
129911993|NCT04992390|467639524|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
129911994|NCT04992390|467639525|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
129911995|NCT04992390|467639526|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
129911996|NCT04992390|467639524|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
129911997|NCT04992390|467639525|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
129911998|NCT04992390|467639526|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
129911999|NCT04992390|467639524|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
129912000|NCT04992390|467639525|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
129912001|NCT04992390|467639526|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
129912002|NCT04992390|467639524|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
129912003|NCT04992390|467639525|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
129912004|NCT04992390|467639526|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
129912005|NCT04992390|467639524|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
129912006|NCT04992390|467639525|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
129912007|NCT04992390|467639526|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
129912008|NCT04992390|467639524|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
129912009|NCT04992390|467639525|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
129912010|NCT04992390|467639526|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
129912011|NCT04992390|467639524|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
129912012|NCT04992390|467639525|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
129912013|NCT04992390|467639526|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
129912014|NCT02807779|467639527|FG000|Overall Study|Lost to Follow-up|1|||
129912015|NCT02807779|467639528|FG001|Overall Study|Lost to Follow-up|0|||
129912016|NCT02807779|467639529|FG002|Overall Study|Lost to Follow-up|0|||
129912017|NCT02807779|467639527|FG000|Overall Study|Physician Decision|2|||
129912018|NCT02807779|467639528|FG001|Overall Study|Physician Decision|0|||
129912019|NCT02807779|467639529|FG002|Overall Study|Physician Decision|1|||
129912020|NCT02807779|467639527|FG000|Overall Study|Death|1|||
129912021|NCT02807779|467639528|FG001|Overall Study|Death|1|||
129912022|NCT02807779|467639529|FG002|Overall Study|Death|0|||
129912023|NCT03783026|467640630|FG000|Treatment Phase|Adverse Event|15|||
129912024|NCT03783026|467640630|FG000|Treatment Phase|Lack of Efficacy|11|||
129912025|NCT03783026|467640630|FG000|Treatment Phase|Withdrawal by Subject|6|||
129912026|NCT03783026|467640630|FG000|Treatment Phase|Lost to Follow-up|2|||
129912027|NCT03783026|467640630|FG000|Treatment Phase|Protocol Deviation|8|||
129912028|NCT03783026|467640630|FG000|Treatment Phase|Did Not Receive Treatment|1|||
129912029|NCT03783026|467640630|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
129912030|NCT01853748|467640631|FG000|Allocation|Withdrawal by Subject|1|||
129912031|NCT01853748|467640632|FG001|Allocation|Withdrawal by Subject|13|||
129912032|NCT01853748|467640631|FG000|Allocation|not sufficient to receive intervention|0|||
129912033|NCT01853748|467640632|FG001|Allocation|not sufficient to receive intervention|1|||
129912034|NCT01853748|467640631|FG000|Follow-Up|Withdrawal by Subject|7|||
129912035|NCT01853748|467640632|FG001|Follow-Up|Withdrawal by Subject|6|||
129912036|NCT01853748|467640631|FG000|Follow-Up|Adverse Event|67|||
129912037|NCT01853748|467640632|FG001|Follow-Up|Adverse Event|7|||
129912038|NCT01853748|467640631|FG000|Follow-Up|not available for data collection|16|||
129912039|NCT01853748|467640632|FG001|Follow-Up|not available for data collection|4|||
129912040|NCT03397108|467640643|FG000|Overall Study|Lost to Follow-up|15|||
129912041|NCT03397108|467640644|FG001|Overall Study|Lost to Follow-up|0|||
129912042|NCT03397108|467640643|FG000|Overall Study|Insufficient milk production|3|||
130064819|NCT00603733|468192255|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
129912043|NCT03397108|467640644|FG001|Overall Study|Insufficient milk production|2|||
130064820|NCT00603733|468192256|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
129912044|NCT03397108|467640643|FG000|Overall Study|Withdrawal by Subject|2|||
129912045|NCT03397108|467640644|FG001|Overall Study|Withdrawal by Subject|0|||
129912046|NCT03554265|467640645|FG000|Overall Study|Withdrawal by Subject|2|||
129912047|NCT03554265|467640646|FG001|Overall Study|Withdrawal by Subject|2|||
129912048|NCT03554265|467640647|FG002|Overall Study|Withdrawal by Subject|3|||
129912049|NCT03554265|467640645|FG000|Overall Study|Physician Decision|0|||
129912050|NCT03554265|467640646|FG001|Overall Study|Physician Decision|0|||
129912051|NCT03554265|467640647|FG002|Overall Study|Physician Decision|1|||
129912052|NCT05386238|467640648|FG000|Overall Study|Lost to Follow-up|3|||
129912053|NCT05386238|467640649|FG001|Overall Study|Lost to Follow-up|2|||
129912054|NCT05386238|467640648|FG000|Overall Study|Withdrawal by Subject|0|||
129912055|NCT05386238|467640649|FG001|Overall Study|Withdrawal by Subject|1|||
129912056|NCT04755660|467640650|FG000|Overall Study|Lost to Follow-up|1|||
129912057|NCT04755660|467640651|FG001|Overall Study|Lost to Follow-up|1|||
129912058|NCT04755660|467640652|FG002|Overall Study|Lost to Follow-up|0|||
129912059|NCT04755660|467640650|FG000|Overall Study|Withdrawal by Subject|0|||
129912060|NCT04755660|467640651|FG001|Overall Study|Withdrawal by Subject|1|||
129912061|NCT04755660|467640652|FG002|Overall Study|Withdrawal by Subject|1|||
129912062|NCT04755660|467640650|FG000|Overall Study|Physician Decision|0|||
129912063|NCT04755660|467640651|FG001|Overall Study|Physician Decision|0|||
129912064|NCT04755660|467640652|FG002|Overall Study|Physician Decision|1|||
129912065|NCT05672667|467640653|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
129912066|NCT03088813|467640654|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
129912067|NCT03088813|467640655|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
129912068|NCT03088813|467640656|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
129912069|NCT03088813|467640657|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
129912070|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
129912071|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
129912072|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
129912073|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
129912074|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
129912075|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
129912076|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
129912077|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
129912078|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
129912079|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
129912080|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
129912081|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
129912082|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
129912083|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
129912084|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
129912085|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
129912086|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
129912087|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
129912088|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
129912089|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
129912090|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
129912091|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
129912092|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
129912093|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
129912094|NCT01903811|467640665|FG000|Overall Study|No measurable disease|1|||
129912095|NCT01903811|467640666|FG001|Overall Study|No measurable disease|1|||
129912096|NCT01903811|467640665|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
129912097|NCT01903811|467640666|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
129912098|NCT01903811|467640665|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
129912099|NCT01903811|467640666|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
129912100|NCT01903811|467640665|FG000|Overall Study|Withdrawal by Subject|0|||
129912101|NCT01903811|467640666|FG001|Overall Study|Withdrawal by Subject|1|||
129912102|NCT00670046|467640667|FG000|Overall Study|Lost to Follow-up|1|||
129912103|NCT00670046|467640668|FG001|Overall Study|Lost to Follow-up|1|||
129912104|NCT00670046|467640667|FG000|Overall Study|Withdrawal by Subject|0|||
129912105|NCT00670046|467640668|FG001|Overall Study|Withdrawal by Subject|1|||
129912106|NCT03624972|467640671|FG000|Overall Study|Lost to Follow-up|2|||
129912107|NCT03624972|467640672|FG001|Overall Study|Lost to Follow-up|0|||
129912108|NCT03624972|467640673|FG002|Overall Study|Lost to Follow-up|0|||
129912109|NCT03624972|467640671|FG000|Overall Study|Withdrawal by Subject|0|||
129912110|NCT03624972|467640672|FG001|Overall Study|Withdrawal by Subject|2|||
129912111|NCT03624972|467640673|FG002|Overall Study|Withdrawal by Subject|0|||
130064821|NCT00603733|468192255|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
130064822|NCT00603733|468192256|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
130064823|NCT00603733|468192255|FG000|Maintenance Phase ITT|Adverse Event|3|||
129912112|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
129912113|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
129912114|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
129912115|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
130064824|NCT00603733|468192256|FG001|Maintenance Phase ITT|Adverse Event|6|||
129912116|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
129912117|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
129912118|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
129912119|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
129912120|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
129912121|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
129912122|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
129912123|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
129912124|NCT03990649|467640681|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
129912125|NCT03990649|467640682|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
129912126|NCT03990649|467640683|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
129912127|NCT03990649|467640681|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
129912128|NCT03990649|467640682|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
129912129|NCT03990649|467640683|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
129912130|NCT03990649|467640681|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
129912131|NCT03990649|467640682|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
129912132|NCT03990649|467640683|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
129912133|NCT02647905|467640692|FG000|Overall Study|Lost to Follow-up|1|||
129912134|NCT02647905|467640692|FG000|Overall Study|Withdrawal by Subject|2|||
129912135|NCT02015520|467640693|FG000|Overall Study|Lack of Efficacy|1|||
129912136|NCT02015520|467640694|FG001|Overall Study|Lack of Efficacy|0|||
129912137|NCT02015520|467640695|FG002|Overall Study|Lack of Efficacy|3|||
129912138|NCT02015520|467640696|FG003|Overall Study|Lack of Efficacy|2|||
129912139|NCT02015520|467640693|FG000|Overall Study|Adverse Event|0|||
129912140|NCT02015520|467640694|FG001|Overall Study|Adverse Event|0|||
129912141|NCT02015520|467640695|FG002|Overall Study|Adverse Event|0|||
129912142|NCT02015520|467640696|FG003|Overall Study|Adverse Event|1|||
129912143|NCT02015520|467640693|FG000|Overall Study|Withdrawal by Subject|2|||
129912144|NCT02015520|467640694|FG001|Overall Study|Withdrawal by Subject|2|||
129912145|NCT02015520|467640695|FG002|Overall Study|Withdrawal by Subject|1|||
129912146|NCT02015520|467640696|FG003|Overall Study|Withdrawal by Subject|0|||
129912147|NCT02015520|467640693|FG000|Overall Study|Death|1|||
129912148|NCT02015520|467640694|FG001|Overall Study|Death|0|||
129912149|NCT02015520|467640695|FG002|Overall Study|Death|0|||
129912150|NCT02015520|467640696|FG003|Overall Study|Death|0|||
129912151|NCT02015520|467640693|FG000|Overall Study|Lost to Follow-up|0|||
129912152|NCT02015520|467640694|FG001|Overall Study|Lost to Follow-up|0|||
129912153|NCT02015520|467640695|FG002|Overall Study|Lost to Follow-up|1|||
129912154|NCT02015520|467640696|FG003|Overall Study|Lost to Follow-up|0|||
129912155|NCT02015520|467640693|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
129912156|NCT02015520|467640694|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
129912157|NCT02015520|467640695|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
129912158|NCT02015520|467640696|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
129912159|NCT02015520|467640693|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
129912160|NCT02015520|467640694|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
129912161|NCT02015520|467640695|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
129912162|NCT02015520|467640696|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
129912163|NCT05119855|467640697|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
129912164|NCT05119855|467640698|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
129912165|NCT05119855|467640697|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
129912166|NCT05119855|467640698|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
129912167|NCT05119855|467640697|FG000|Overall Study|Lost to Follow-up|6|||
129912168|NCT05119855|467640698|FG001|Overall Study|Lost to Follow-up|8|||
129912169|NCT02932579|467640699|FG000|Overall Study|Withdrawal by Subject|4|||
129912170|NCT02932579|467640700|FG001|Overall Study|Withdrawal by Subject|1|||
129912171|NCT01972724|467640701|FG000|Double-Blind|Rescue Criteria Met|1|||
129912172|NCT01972724|467640702|FG001|Double-Blind|Rescue Criteria Met|0|||
129912173|NCT01972724|467640703|FG002|Double-Blind|Rescue Criteria Met|0|||
129912174|NCT01972724|467640701|FG000|Double-Blind|Adverse Event|1|||
130064825|NCT00603733|468192255|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
130064826|NCT00603733|468192256|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
130064827|NCT00603733|468192255|FG000|Maintenance Phase ITT|Protocol Violation|1|||
130064828|NCT00603733|468192256|FG001|Maintenance Phase ITT|Protocol Violation|1|||
130064829|NCT00603733|468192255|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
130064830|NCT00603733|468192256|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
130064831|NCT00603733|468192255|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
129912175|NCT01972724|467640702|FG001|Double-Blind|Adverse Event|0|||
129912176|NCT01972724|467640703|FG002|Double-Blind|Adverse Event|0|||
129912177|NCT01972724|467640701|FG000|Double-Blind|Withdrawal of Consent|2|||
129912178|NCT01972724|467640702|FG001|Double-Blind|Withdrawal of Consent|1|||
129912179|NCT01972724|467640703|FG002|Double-Blind|Withdrawal of Consent|0|||
129912180|NCT01972724|467640701|FG000|Double-Blind|Significant Protocol Deviation|5|||
129912181|NCT01972724|467640702|FG001|Double-Blind|Significant Protocol Deviation|8|||
129912182|NCT01972724|467640703|FG002|Double-Blind|Significant Protocol Deviation|0|||
129912183|NCT01972724|467640701|FG000|Open-Label|Withdrew Consent|0|||
129912184|NCT01972724|467640702|FG001|Open-Label|Withdrew Consent|0|||
129912185|NCT01972724|467640703|FG002|Open-Label|Withdrew Consent|3|||
129912186|NCT01972724|467640701|FG000|Open-Label|Significant Protocol Deviation|0|||
129912187|NCT01972724|467640702|FG001|Open-Label|Significant Protocol Deviation|0|||
129912188|NCT01972724|467640703|FG002|Open-Label|Significant Protocol Deviation|2|||
129912189|NCT00111813|467640710|FG000|Overall Study|Adverse Event|1|||
129912190|NCT00111813|467640711|FG001|Overall Study|Adverse Event|2|||
129912191|NCT00111813|467640712|FG002|Overall Study|Adverse Event|4|||
129912192|NCT00111813|467640713|FG003|Overall Study|Adverse Event|2|||
129912193|NCT00111813|467640714|FG004|Overall Study|Adverse Event|2|||
129912194|NCT00111813|467640715|FG005|Overall Study|Adverse Event|2|||
129912195|NCT00111813|467640710|FG000|Overall Study|Progressive disease|2|||
129912196|NCT00111813|467640711|FG001|Overall Study|Progressive disease|1|||
129912197|NCT00111813|467640712|FG002|Overall Study|Progressive disease|5|||
129912198|NCT00111813|467640713|FG003|Overall Study|Progressive disease|3|||
129912199|NCT00111813|467640714|FG004|Overall Study|Progressive disease|4|||
129912200|NCT00111813|467640715|FG005|Overall Study|Progressive disease|3|||
129912201|NCT00111813|467640710|FG000|Overall Study|Lack of Efficacy|0|||
129912202|NCT00111813|467640711|FG001|Overall Study|Lack of Efficacy|0|||
129912203|NCT00111813|467640712|FG002|Overall Study|Lack of Efficacy|0|||
129912204|NCT00111813|467640713|FG003|Overall Study|Lack of Efficacy|0|||
129912205|NCT00111813|467640714|FG004|Overall Study|Lack of Efficacy|0|||
129912206|NCT00111813|467640715|FG005|Overall Study|Lack of Efficacy|1|||
129912207|NCT00111813|467640710|FG000|Overall Study|Other|0|||
129912208|NCT00111813|467640711|FG001|Overall Study|Other|0|||
129912209|NCT00111813|467640712|FG002|Overall Study|Other|1|||
129912210|NCT00111813|467640713|FG003|Overall Study|Other|0|||
129912211|NCT00111813|467640714|FG004|Overall Study|Other|0|||
129912212|NCT00111813|467640715|FG005|Overall Study|Other|0|||
129912213|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
129912214|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
129912215|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
129912216|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
129912217|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
129912218|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
129912219|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
129912220|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
129912221|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
129912222|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
129912223|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
129912224|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
129912225|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
129912226|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
130064832|NCT00603733|468192256|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
130064833|NCT00603733|468192255|FG000|Maintenance Phase ITT|Physician Decision|0|||
130064834|NCT00603733|468192256|FG001|Maintenance Phase ITT|Physician Decision|1|||
130064835|NCT00603733|468192255|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
129912227|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
129912228|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
129912229|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
129912230|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
129912231|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
129912232|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
129912233|NCT03201562|467640726|FG000|Overall Study|Physician Decision|0|||
129912234|NCT03201562|467640727|FG001|Overall Study|Physician Decision|0|||
129912235|NCT03201562|467640728|FG002|Overall Study|Physician Decision|1|||
129912236|NCT03201562|467640726|FG000|Overall Study|Adverse Event|0|||
130064836|NCT00603733|468192256|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
130064837|NCT01297309|468192262|FG000|Overall Study|Eligibility failure|2|||
130064838|NCT01297309|468192262|FG000|Overall Study|Screen failure|2|||
129912237|NCT03201562|467640727|FG001|Overall Study|Adverse Event|0|||
129912238|NCT03201562|467640728|FG002|Overall Study|Adverse Event|1|||
129912239|NCT03201562|467640726|FG000|Overall Study|Lost to Follow-up|0|||
129912240|NCT03201562|467640727|FG001|Overall Study|Lost to Follow-up|1|||
130064839|NCT01297309|468192262|FG000|Overall Study|Withdrawal by Subject|5|||
129912241|NCT03201562|467640728|FG002|Overall Study|Lost to Follow-up|2|||
129912242|NCT00031694|467640735|FG000|Overall Study|Adverse Event|12|||
129912243|NCT00031694|467640735|FG000|Overall Study|Death|2|||
129912244|NCT00031694|467640735|FG000|Overall Study|Withdrawal by Subject|5|||
129912245|NCT02556138|467640739|FG000|Overall Study|Withdrawal by Subject|1|||
129912246|NCT04939246|467640740|FG000|After Treatment|Death|4|||
129912247|NCT04939246|467640740|FG000|After Treatment|Lost to Follow-up|1|||
129912248|NCT04939246|467640740|FG000|After Treatment|Discharged to hospice|2|||
129912249|NCT04994509|467640741|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
129912250|NCT04994509|467640742|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
129912251|NCT04994509|467640743|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
129912252|NCT04994509|467640741|FG000|Overall Study|Withdrew Consent|73|||
129912253|NCT04994509|467640742|FG001|Overall Study|Withdrew Consent|72|||
129912254|NCT04994509|467640743|FG002|Overall Study|Withdrew Consent|46|||
129912255|NCT04994509|467640741|FG000|Overall Study|Lost to Follow-up|39|||
129912256|NCT04994509|467640742|FG001|Overall Study|Lost to Follow-up|36|||
129912257|NCT04994509|467640743|FG002|Overall Study|Lost to Follow-up|26|||
129912258|NCT04994509|467640741|FG000|Overall Study|HIV-1 Infection|4|||
129912259|NCT04994509|467640742|FG001|Overall Study|HIV-1 Infection|20|||
129912260|NCT04994509|467640743|FG002|Overall Study|HIV-1 Infection|12|||
129912261|NCT04994509|467640741|FG000|Overall Study|Investigator's Discretion|9|||
129912262|NCT04994509|467640742|FG001|Overall Study|Investigator's Discretion|8|||
129912263|NCT04994509|467640743|FG002|Overall Study|Investigator's Discretion|11|||
129912264|NCT04994509|467640741|FG000|Overall Study|Randomized but Never Treated|10|||
129912265|NCT04994509|467640742|FG001|Overall Study|Randomized but Never Treated|10|||
129912266|NCT04994509|467640743|FG002|Overall Study|Randomized but Never Treated|3|||
129912267|NCT04994509|467640741|FG000|Overall Study|Pregnancy|5|||
129912268|NCT04994509|467640742|FG001|Overall Study|Pregnancy|5|||
129912269|NCT04994509|467640743|FG002|Overall Study|Pregnancy|0|||
129912270|NCT04994509|467640741|FG000|Overall Study|Death|0|||
129912271|NCT04994509|467640742|FG001|Overall Study|Death|5|||
129912272|NCT04994509|467640743|FG002|Overall Study|Death|0|||
129912273|NCT04994509|467640741|FG000|Overall Study|Adverse Event|2|||
129912274|NCT04994509|467640742|FG001|Overall Study|Adverse Event|1|||
129912275|NCT04994509|467640743|FG002|Overall Study|Adverse Event|0|||
129912276|NCT04994509|467640741|FG000|Overall Study|Non-compliance With Study Drug|1|||
129912277|NCT04994509|467640742|FG001|Overall Study|Non-compliance With Study Drug|1|||
129912278|NCT04994509|467640743|FG002|Overall Study|Non-compliance With Study Drug|1|||
129912279|NCT04994509|467640741|FG000|Overall Study|Withdrew Assent|3|||
129912280|NCT04994509|467640742|FG001|Overall Study|Withdrew Assent|0|||
129912281|NCT04994509|467640743|FG002|Overall Study|Withdrew Assent|0|||
129912282|NCT04994509|467640741|FG000|Overall Study|Protocol Violation|1|||
129912283|NCT04994509|467640742|FG001|Overall Study|Protocol Violation|0|||
129912284|NCT04994509|467640743|FG002|Overall Study|Protocol Violation|0|||
129912285|NCT02576509|467642447|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
129912286|NCT02576509|467642448|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
129912287|NCT02576509|467642447|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
129912288|NCT02576509|467642448|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
129912289|NCT02576509|467642447|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
129912290|NCT02576509|467642448|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
129912291|NCT02576509|467642447|FG000|Treatment Period|Disease progression|263|||
129912292|NCT02576509|467642448|FG001|Treatment Period|Disease progression|244|||
129912293|NCT02576509|467642447|FG000|Treatment Period|Study drug toxicity|37|||
129912294|NCT02576509|467642448|FG001|Treatment Period|Study drug toxicity|41|||
129912295|NCT02576509|467642447|FG000|Treatment Period|Death|1|||
129912296|NCT02576509|467642448|FG001|Treatment Period|Death|1|||
129912297|NCT02576509|467642447|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
129912298|NCT02576509|467642448|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
129912299|NCT02576509|467642447|FG000|Treatment Period|Participant request to stop treatment|8|||
130064840|NCT01297309|468192262|FG000|Overall Study|Adverse Event|1|||
129912300|NCT02576509|467642448|FG001|Treatment Period|Participant request to stop treatment|18|||
129912301|NCT02576509|467642447|FG000|Treatment Period|Participant withdrew consent|3|||
129912302|NCT02576509|467642448|FG001|Treatment Period|Participant withdrew consent|7|||
129912303|NCT02576509|467642447|FG000|Treatment Period|Lost to Follow-up|0|||
129912304|NCT02576509|467642448|FG001|Treatment Period|Lost to Follow-up|1|||
129912305|NCT02576509|467642447|FG000|Treatment Period|Maximum clinical benefit|1|||
129912306|NCT02576509|467642448|FG001|Treatment Period|Maximum clinical benefit|0|||
129912307|NCT02576509|467642447|FG000|Treatment Period|Poor/non-compliance|1|||
129912308|NCT02576509|467642448|FG001|Treatment Period|Poor/non-compliance|1|||
129912309|NCT02576509|467642447|FG000|Treatment Period|Participant no longer meets criteria|1|||
129912310|NCT02576509|467642448|FG001|Treatment Period|Participant no longer meets criteria|0|||
130064841|NCT01297309|468192262|FG000|Overall Study|Investigator Decision|2|||
130064842|NCT01297309|468192262|FG000|Overall Study|Death|1|||
130064843|NCT01297309|468192262|FG000|Overall Study|Participant not entering extensionperiod|1|||
129912311|NCT02576509|467642447|FG000|Treatment Period|Other reason|12|||
129912312|NCT02576509|467642448|FG001|Treatment Period|Other reason|8|||
129912313|NCT02576509|467642447|FG000|Treatment Period|NOT REPORTED|1|||
129912314|NCT02576509|467642448|FG001|Treatment Period|NOT REPORTED|0|||
129912315|NCT02576509|467642447|FG000|Treatment Period|Administrative reason by sponsor|0|||
129912316|NCT02576509|467642448|FG001|Treatment Period|Administrative reason by sponsor|1|||
129912317|NCT03725722|467642453|FG000|Overall Study|Lack of Efficacy|2|||
130064844|NCT02254551|468192269|FG000|Dose Escalation|Physician Decision|1|||
130064845|NCT02254551|468192269|FG000|Dose Escalation|Dose-limiting toxicity|2|||
129862879|NCT01857531|467454747|FG000|Overall Study|Withdrawal by Subject|4|||
129862880|NCT03943095|467454748|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
129862881|NCT03943095|467454749|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
129862882|NCT03943095|467454748|FG000|Overall Study|Withdrawal by Subject|1|||
129862883|NCT03943095|467454749|FG001|Overall Study|Withdrawal by Subject|0|||
129862884|NCT02269670|467454750|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
129862885|NCT04657211|467454753|FG000|Overall Study|Withdrawal by Subject|21|||
129862886|NCT04657211|467454753|FG000|Overall Study|Lost to Follow-up|113|||
129862887|NCT04657211|467454753|FG000|Overall Study|Death|47|||
129862888|NCT04657211|467454753|FG000|Overall Study|Transfer to another institution|21|||
129862889|NCT04657211|467454753|FG000|Overall Study|Other|29|||
129862890|NCT02693665|467454754|FG000|Overall Study|Death|3|||
129862891|NCT02693665|467454755|FG001|Overall Study|Death|2|||
129862892|NCT02693665|467454754|FG000|Overall Study|Lost to Follow-up|7|||
129862893|NCT02693665|467454755|FG001|Overall Study|Lost to Follow-up|3|||
129862894|NCT02693665|467454754|FG000|Overall Study|Protocol Violation|1|||
129862895|NCT02693665|467454755|FG001|Overall Study|Protocol Violation|0|||
129862896|NCT02693665|467454754|FG000|Overall Study|Withdrawal by Subject|2|||
129862897|NCT02693665|467454755|FG001|Overall Study|Withdrawal by Subject|0|||
129862898|NCT02693665|467454754|FG000|Overall Study|patient wanted to leave it behind|1|||
129862899|NCT02693665|467454755|FG001|Overall Study|patient wanted to leave it behind|0|||
129862900|NCT02693665|467454754|FG000|Overall Study|anxiety|1|||
129862901|NCT02693665|467454755|FG001|Overall Study|anxiety|0|||
129862902|NCT02693665|467454754|FG000|Overall Study|family issues|1|||
129862903|NCT02693665|467454755|FG001|Overall Study|family issues|0|||
129862904|NCT02693665|467454754|FG000|Overall Study|no reason given|1|||
129862905|NCT02693665|467454755|FG001|Overall Study|no reason given|0|||
129862906|NCT00710424|467454758|FG000|Overall Study|Adverse Event|30|||
129862907|NCT00710424|467454759|FG001|Overall Study|Adverse Event|12|||
129862908|NCT00710424|467454758|FG000|Overall Study|Lack of Efficacy|4|||
129862909|NCT00710424|467454759|FG001|Overall Study|Lack of Efficacy|5|||
129862910|NCT00710424|467454758|FG000|Overall Study|Withdrawal by Subject|5|||
129862911|NCT00710424|467454759|FG001|Overall Study|Withdrawal by Subject|3|||
129862912|NCT00710424|467454758|FG000|Overall Study|Lost to Follow-up|0|||
129862913|NCT00710424|467454759|FG001|Overall Study|Lost to Follow-up|1|||
129862914|NCT00710424|467454758|FG000|Overall Study|Refused medication, no side effects|1|||
129862915|NCT00710424|467454759|FG001|Overall Study|Refused medication, no side effects|0|||
129862916|NCT00710424|467454758|FG000|Overall Study|Non-compliance with stable analgesia|1|||
129862917|NCT00710424|467454759|FG001|Overall Study|Non-compliance with stable analgesia|0|||
129862918|NCT00710424|467454758|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
129862919|NCT00710424|467454759|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
129862920|NCT00710424|467454758|FG000|Overall Study|Subject thought medication changed|1|||
129862921|NCT00710424|467454759|FG001|Overall Study|Subject thought medication changed|0|||
129862922|NCT00710424|467454758|FG000|Overall Study|Ceased treatment due to travel|1|||
129862923|NCT00710424|467454759|FG001|Overall Study|Ceased treatment due to travel|0|||
129862924|NCT00710424|467454758|FG000|Overall Study|Subject preferred paracetamol|0|||
129862925|NCT00710424|467454759|FG001|Overall Study|Subject preferred paracetamol|1|||
129862926|NCT00710424|467454758|FG000|Overall Study|Felt good so stopped treatment|0|||
129862927|NCT00710424|467454759|FG001|Overall Study|Felt good so stopped treatment|1|||
129862928|NCT01962493|467454760|FG000|Overall Study|Adverse Event|1|||
129862929|NCT01962493|467454761|FG001|Overall Study|Adverse Event|2|||
129862930|NCT01962493|467454760|FG000|Overall Study|Protocol Violation|0|||
129862931|NCT01962493|467454761|FG001|Overall Study|Protocol Violation|1|||
129862932|NCT01962493|467454760|FG000|Overall Study|Withdrawal by Subject|4|||
129862933|NCT01962493|467454761|FG001|Overall Study|Withdrawal by Subject|2|||
129862934|NCT03776136|467454762|FG000|Overall Study|Death|85|||
129862935|NCT03776136|467454762|FG000|Overall Study|Withdrawal by Subject|3|||
129862936|NCT03776136|467454762|FG000|Overall Study|Sponsor Decision|15|||
129862937|NCT02621931|467456580|FG000|Overall Study|Death|0|||
129862938|NCT02621931|467456581|FG001|Overall Study|Death|1|||
129862939|NCT02621931|467456582|FG002|Overall Study|Death|0|||
129862940|NCT02621931|467456580|FG000|Overall Study|Adverse Event|8|||
129862941|NCT02621931|467456581|FG001|Overall Study|Adverse Event|5|||
130064846|NCT03587584|468192273|FG000|Overall Study|SOC deviations|4|||
129862942|NCT02621931|467456582|FG002|Overall Study|Adverse Event|7|||
129862943|NCT02621931|467456580|FG000|Overall Study|Withdrawal by Subject|12|||
129862944|NCT02621931|467456581|FG001|Overall Study|Withdrawal by Subject|10|||
129862945|NCT02621931|467456582|FG002|Overall Study|Withdrawal by Subject|11|||
129862946|NCT02621931|467456580|FG000|Overall Study|Protocol Violation|2|||
129862947|NCT02621931|467456581|FG001|Overall Study|Protocol Violation|2|||
129862948|NCT02621931|467456582|FG002|Overall Study|Protocol Violation|2|||
129862949|NCT02621931|467456580|FG000|Overall Study|Pregnancy|2|||
129862950|NCT02621931|467456581|FG001|Overall Study|Pregnancy|0|||
129862951|NCT02621931|467456582|FG002|Overall Study|Pregnancy|0|||
129862952|NCT02621931|467456580|FG000|Overall Study|Noncompliance to study procedures|0|||
130064847|NCT03587584|468192274|FG001|Overall Study|SOC deviations|6|||
130064848|NCT03587584|468192273|FG000|Overall Study|Incomplete data|0|||
130064849|NCT03587584|468192274|FG001|Overall Study|Incomplete data|3|||
130064850|NCT00387348|468192275|FG000|Overall Study|Death|1|||
130064851|NCT00387348|468192276|FG001|Overall Study|Death|1|||
130064852|NCT00387348|468192277|FG002|Overall Study|Death|0|||
130064853|NCT00387348|468192275|FG000|Overall Study|Physician Decision|1|||
129862953|NCT02621931|467456581|FG001|Overall Study|Noncompliance to study procedures|1|||
129862954|NCT02621931|467456582|FG002|Overall Study|Noncompliance to study procedures|2|||
129862955|NCT02621931|467456580|FG000|Overall Study|Lost to Follow-up|8|||
129862956|NCT02621931|467456581|FG001|Overall Study|Lost to Follow-up|7|||
129862957|NCT02621931|467456582|FG002|Overall Study|Lost to Follow-up|10|||
129862958|NCT02621931|467456580|FG000|Overall Study|Lack of Efficacy|0|||
129862959|NCT02621931|467456581|FG001|Overall Study|Lack of Efficacy|0|||
129862960|NCT02621931|467456582|FG002|Overall Study|Lack of Efficacy|1|||
129862961|NCT02621931|467456580|FG000|Overall Study|Other|1|||
129862962|NCT02621931|467456581|FG001|Overall Study|Other|1|||
129862963|NCT02621931|467456582|FG002|Overall Study|Other|3|||
129862964|NCT01588184|467456583|FG000|Overall Study|Death|1|||
129862965|NCT01588184|467456584|FG001|Overall Study|Death|0|||
129862966|NCT01588184|467456585|FG002|Overall Study|Death|0|||
129862967|NCT01588184|467456586|FG003|Overall Study|Death|1|||
129862968|NCT01588184|467456587|FG004|Overall Study|Death|1|||
129862969|NCT01588184|467456588|FG005|Overall Study|Death|1|||
129862970|NCT01588184|467456583|FG000|Overall Study|Withdrawal by Subject|2|||
129862971|NCT01588184|467456584|FG001|Overall Study|Withdrawal by Subject|4|||
129862972|NCT01588184|467456585|FG002|Overall Study|Withdrawal by Subject|0|||
129862973|NCT01588184|467456586|FG003|Overall Study|Withdrawal by Subject|1|||
129862974|NCT01588184|467456587|FG004|Overall Study|Withdrawal by Subject|0|||
129862975|NCT01588184|467456588|FG005|Overall Study|Withdrawal by Subject|0|||
129862976|NCT01588184|467456583|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
129862977|NCT01588184|467456584|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
129862978|NCT01588184|467456585|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
129862979|NCT01588184|467456586|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
129862980|NCT01588184|467456587|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
129862981|NCT01588184|467456588|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
129862982|NCT01588184|467456583|FG000|Overall Study|multiple reasons|0|||
129862983|NCT01588184|467456584|FG001|Overall Study|multiple reasons|3|||
129862984|NCT01588184|467456585|FG002|Overall Study|multiple reasons|0|||
129862985|NCT01588184|467456586|FG003|Overall Study|multiple reasons|1|||
129862986|NCT01588184|467456587|FG004|Overall Study|multiple reasons|0|||
129862987|NCT01588184|467456588|FG005|Overall Study|multiple reasons|0|||
129862988|NCT02811861|467456589|FG000|Overall Study|Radiological Disease Progression|123|||
129862989|NCT02811861|467456590|FG001|Overall Study|Radiological Disease Progression|97|||
129862990|NCT02811861|467456591|FG002|Overall Study|Radiological Disease Progression|174|||
129862991|NCT02811861|467456589|FG000|Overall Study|Clinical Disease Progression|20|||
129862992|NCT02811861|467456590|FG001|Overall Study|Clinical Disease Progression|19|||
129862993|NCT02811861|467456591|FG002|Overall Study|Clinical Disease Progression|22|||
129862994|NCT02811861|467456589|FG000|Overall Study|Adverse Event|63|||
129862995|NCT02811861|467456590|FG001|Overall Study|Adverse Event|60|||
129862996|NCT02811861|467456591|FG002|Overall Study|Adverse Event|41|||
129862997|NCT02811861|467456589|FG000|Overall Study|Lost to Follow-up|0|||
129862998|NCT02811861|467456590|FG001|Overall Study|Lost to Follow-up|0|||
129862999|NCT02811861|467456591|FG002|Overall Study|Lost to Follow-up|1|||
129863000|NCT02811861|467456589|FG000|Overall Study|Subject Choice|29|||
129863001|NCT02811861|467456590|FG001|Overall Study|Subject Choice|17|||
129863002|NCT02811861|467456591|FG002|Overall Study|Subject Choice|23|||
129863003|NCT02811861|467456589|FG000|Overall Study|Withdrawal by Subject|4|||
129863004|NCT02811861|467456590|FG001|Overall Study|Withdrawal by Subject|4|||
129863005|NCT02811861|467456591|FG002|Overall Study|Withdrawal by Subject|9|||
129863006|NCT02811861|467456589|FG000|Overall Study|Other|4|||
129863007|NCT02811861|467456590|FG001|Overall Study|Other|13|||
129863008|NCT02811861|467456591|FG002|Overall Study|Other|3|||
129863009|NCT02811861|467456589|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
129863010|NCT02811861|467456590|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
129863011|NCT02811861|467456591|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
129863012|NCT02811861|467456589|FG000|Overall Study|Randomized but not treated|2|||
129863013|NCT02811861|467456590|FG001|Overall Study|Randomized but not treated|3|||
129863014|NCT02811861|467456591|FG002|Overall Study|Randomized but not treated|17|||
129863015|NCT02925455|467456592|FG000|Overall Study|Withdrawal by Subject|2|||
129863016|NCT02925455|467456593|FG001|Overall Study|Withdrawal by Subject|0|||
129863017|NCT00360308|467456596|FG000|Overall Study|Adverse Event|15|||
129863018|NCT00360308|467456597|FG001|Overall Study|Adverse Event|14|||
129863019|NCT00360308|467456598|FG002|Overall Study|Adverse Event|25|||
129863020|NCT00360308|467456596|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
129863021|NCT00360308|467456597|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
129863022|NCT00360308|467456598|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
130064854|NCT00387348|468192276|FG001|Overall Study|Physician Decision|0|||
129863023|NCT00360308|467456596|FG000|Overall Study|Protocol Violation|2|||
129863024|NCT00360308|467456597|FG001|Overall Study|Protocol Violation|1|||
129863025|NCT00360308|467456598|FG002|Overall Study|Protocol Violation|2|||
129863026|NCT00360308|467456596|FG000|Overall Study|Withdrawal by Subject|11|||
129863027|NCT00360308|467456597|FG001|Overall Study|Withdrawal by Subject|7|||
129863028|NCT00360308|467456598|FG002|Overall Study|Withdrawal by Subject|14|||
129863029|NCT00360308|467456596|FG000|Overall Study|Lack of Efficacy|3|||
129863030|NCT00360308|467456597|FG001|Overall Study|Lack of Efficacy|0|||
129863031|NCT00360308|467456598|FG002|Overall Study|Lack of Efficacy|2|||
129863032|NCT00360308|467456596|FG000|Overall Study|Other|2|||
129863033|NCT00360308|467456597|FG001|Overall Study|Other|1|||
129863034|NCT00360308|467456598|FG002|Overall Study|Other|1|||
129863035|NCT00360308|467456596|FG000|Overall Study|Study termination by sponsor|43|||
129863036|NCT00360308|467456597|FG001|Overall Study|Study termination by sponsor|55|||
129863037|NCT00360308|467456598|FG002|Overall Study|Study termination by sponsor|44|||
129863038|NCT01217073|467456599|FG000|Base Period|Adverse Event|1|||
129863039|NCT01217073|467456600|FG001|Base Period|Adverse Event|0|||
129863040|NCT01217073|467456601|FG002|Base Period|Adverse Event|1|||
129863041|NCT01217073|467456602|FG003|Base Period|Adverse Event|0|||
129863042|NCT01217073|467456603|FG004|Base Period|Adverse Event|4|||
129863043|NCT01217073|467456604|FG005|Base Period|Adverse Event|1|||
129863044|NCT01217073|467456605|FG006|Base Period|Adverse Event|0|||
129863045|NCT01217073|467456606|FG007|Base Period|Adverse Event|0|||
129863046|NCT01217073|467456599|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
129863047|NCT01217073|467456600|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863048|NCT01217073|467456601|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863049|NCT01217073|467456602|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863050|NCT01217073|467456603|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863051|NCT01217073|467456604|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863052|NCT01217073|467456605|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863053|NCT01217073|467456606|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863054|NCT01217073|467456599|FG000|Base Period|Excluded medication|0|||
129863055|NCT01217073|467456600|FG001|Base Period|Excluded medication|0|||
129863056|NCT01217073|467456601|FG002|Base Period|Excluded medication|0|||
129863057|NCT01217073|467456602|FG003|Base Period|Excluded medication|0|||
129863058|NCT01217073|467456603|FG004|Base Period|Excluded medication|1|||
129863059|NCT01217073|467456604|FG005|Base Period|Excluded medication|0|||
129863060|NCT01217073|467456605|FG006|Base Period|Excluded medication|0|||
129863061|NCT01217073|467456606|FG007|Base Period|Excluded medication|0|||
129863062|NCT01217073|467456599|FG000|Base Period|Lack of Efficacy|0|||
129863063|NCT01217073|467456600|FG001|Base Period|Lack of Efficacy|0|||
129863064|NCT01217073|467456601|FG002|Base Period|Lack of Efficacy|0|||
129863065|NCT01217073|467456602|FG003|Base Period|Lack of Efficacy|0|||
129863066|NCT01217073|467456603|FG004|Base Period|Lack of Efficacy|0|||
129863067|NCT01217073|467456604|FG005|Base Period|Lack of Efficacy|1|||
129863068|NCT01217073|467456605|FG006|Base Period|Lack of Efficacy|0|||
129863069|NCT01217073|467456606|FG007|Base Period|Lack of Efficacy|0|||
129863070|NCT01217073|467456599|FG000|Base Period|Lost to Follow-up|0|||
129863071|NCT01217073|467456600|FG001|Base Period|Lost to Follow-up|0|||
129863072|NCT01217073|467456601|FG002|Base Period|Lost to Follow-up|1|||
129863073|NCT01217073|467456602|FG003|Base Period|Lost to Follow-up|1|||
129863074|NCT01217073|467456603|FG004|Base Period|Lost to Follow-up|3|||
129863075|NCT01217073|467456604|FG005|Base Period|Lost to Follow-up|0|||
129863076|NCT01217073|467456605|FG006|Base Period|Lost to Follow-up|0|||
129863077|NCT01217073|467456606|FG007|Base Period|Lost to Follow-up|0|||
129863078|NCT01217073|467456599|FG000|Base Period|Physician Decision|0|||
129863079|NCT01217073|467456600|FG001|Base Period|Physician Decision|0|||
129863080|NCT01217073|467456601|FG002|Base Period|Physician Decision|0|||
129863081|NCT01217073|467456602|FG003|Base Period|Physician Decision|0|||
129863082|NCT01217073|467456603|FG004|Base Period|Physician Decision|1|||
129863083|NCT01217073|467456604|FG005|Base Period|Physician Decision|0|||
129863084|NCT01217073|467456605|FG006|Base Period|Physician Decision|0|||
129863085|NCT01217073|467456606|FG007|Base Period|Physician Decision|0|||
129863086|NCT01217073|467456599|FG000|Base Period|Protocol Violation|1|||
129863087|NCT01217073|467456600|FG001|Base Period|Protocol Violation|0|||
129863088|NCT01217073|467456601|FG002|Base Period|Protocol Violation|0|||
129863089|NCT01217073|467456602|FG003|Base Period|Protocol Violation|0|||
129863090|NCT01217073|467456603|FG004|Base Period|Protocol Violation|1|||
129863091|NCT01217073|467456604|FG005|Base Period|Protocol Violation|2|||
129863092|NCT01217073|467456605|FG006|Base Period|Protocol Violation|0|||
129863093|NCT01217073|467456606|FG007|Base Period|Protocol Violation|0|||
129863094|NCT01217073|467456599|FG000|Base Period|Withdrawal by Subject|4|||
129863095|NCT01217073|467456600|FG001|Base Period|Withdrawal by Subject|5|||
129863096|NCT01217073|467456601|FG002|Base Period|Withdrawal by Subject|5|||
129863097|NCT01217073|467456602|FG003|Base Period|Withdrawal by Subject|1|||
129863098|NCT01217073|467456603|FG004|Base Period|Withdrawal by Subject|5|||
129863099|NCT01217073|467456604|FG005|Base Period|Withdrawal by Subject|5|||
129863100|NCT01217073|467456605|FG006|Base Period|Withdrawal by Subject|0|||
129863101|NCT01217073|467456606|FG007|Base Period|Withdrawal by Subject|0|||
129863102|NCT01217073|467456599|FG000|Extension Period|Adverse Event|0|||
130064855|NCT00387348|468192277|FG002|Overall Study|Physician Decision|1|||
130064856|NCT00387348|468192275|FG000|Overall Study|Withdrawal by Subject|0|||
130064857|NCT00387348|468192276|FG001|Overall Study|Withdrawal by Subject|2|||
130064858|NCT00387348|468192277|FG002|Overall Study|Withdrawal by Subject|2|||
130064859|NCT00387348|468192275|FG000|Overall Study|Adverse Event|1|||
130064860|NCT00387348|468192276|FG001|Overall Study|Adverse Event|0|||
130064861|NCT00387348|468192277|FG002|Overall Study|Adverse Event|1|||
130064862|NCT00505752|468192278|FG000|Overall Study|Adverse Event|1|||
129863103|NCT01217073|467456600|FG001|Extension Period|Adverse Event|0|||
129912318|NCT03725722|467642454|FG001|Overall Study|Lack of Efficacy|1|||
129912319|NCT03725722|467642455|FG002|Overall Study|Lack of Efficacy|2|||
129912320|NCT03725722|467642456|FG003|Overall Study|Lack of Efficacy|0|||
129912321|NCT03725722|467642457|FG004|Overall Study|Lack of Efficacy|2|||
129912322|NCT03725722|467642453|FG000|Overall Study|Adverse Event|2|||
129912323|NCT03725722|467642454|FG001|Overall Study|Adverse Event|2|||
129912324|NCT03725722|467642455|FG002|Overall Study|Adverse Event|1|||
129912325|NCT03725722|467642456|FG003|Overall Study|Adverse Event|0|||
129912326|NCT03725722|467642457|FG004|Overall Study|Adverse Event|6|||
129912327|NCT03725722|467642453|FG000|Overall Study|Withdrawal by Subject|4|||
129912328|NCT03725722|467642454|FG001|Overall Study|Withdrawal by Subject|1|||
129912329|NCT03725722|467642455|FG002|Overall Study|Withdrawal by Subject|0|||
129912330|NCT03725722|467642456|FG003|Overall Study|Withdrawal by Subject|4|||
129912331|NCT03725722|467642457|FG004|Overall Study|Withdrawal by Subject|4|||
129912332|NCT03725722|467642453|FG000|Overall Study|Lost to Follow-up|3|||
129912333|NCT03725722|467642454|FG001|Overall Study|Lost to Follow-up|1|||
129912334|NCT03725722|467642455|FG002|Overall Study|Lost to Follow-up|2|||
129912335|NCT03725722|467642456|FG003|Overall Study|Lost to Follow-up|2|||
129863104|NCT01217073|467456601|FG002|Extension Period|Adverse Event|0|||
129863105|NCT01217073|467456602|FG003|Extension Period|Adverse Event|0|||
129863106|NCT01217073|467456603|FG004|Extension Period|Adverse Event|0|||
129863107|NCT01217073|467456604|FG005|Extension Period|Adverse Event|0|||
129863108|NCT01217073|467456605|FG006|Extension Period|Adverse Event|19|||
129863109|NCT01217073|467456606|FG007|Extension Period|Adverse Event|5|||
129863110|NCT01217073|467456599|FG000|Extension Period|ALT/AST|0|||
129863111|NCT01217073|467456600|FG001|Extension Period|ALT/AST|0|||
129863112|NCT01217073|467456601|FG002|Extension Period|ALT/AST|0|||
129863113|NCT01217073|467456602|FG003|Extension Period|ALT/AST|0|||
129863114|NCT01217073|467456603|FG004|Extension Period|ALT/AST|0|||
129863115|NCT01217073|467456604|FG005|Extension Period|ALT/AST|0|||
129863116|NCT01217073|467456605|FG006|Extension Period|ALT/AST|2|||
129863117|NCT01217073|467456606|FG007|Extension Period|ALT/AST|0|||
129863118|NCT01217073|467456599|FG000|Extension Period|Contraindication to study medication|0|||
129863119|NCT01217073|467456600|FG001|Extension Period|Contraindication to study medication|0|||
129863120|NCT01217073|467456601|FG002|Extension Period|Contraindication to study medication|0|||
129863121|NCT01217073|467456602|FG003|Extension Period|Contraindication to study medication|0|||
129863122|NCT01217073|467456603|FG004|Extension Period|Contraindication to study medication|0|||
129863123|NCT01217073|467456604|FG005|Extension Period|Contraindication to study medication|0|||
129863124|NCT01217073|467456605|FG006|Extension Period|Contraindication to study medication|1|||
129863125|NCT01217073|467456606|FG007|Extension Period|Contraindication to study medication|0|||
129863126|NCT01217073|467456599|FG000|Extension Period|Creatinine/eGFR|0|||
129863127|NCT01217073|467456600|FG001|Extension Period|Creatinine/eGFR|0|||
129863128|NCT01217073|467456601|FG002|Extension Period|Creatinine/eGFR|0|||
129863129|NCT01217073|467456602|FG003|Extension Period|Creatinine/eGFR|0|||
129863130|NCT01217073|467456603|FG004|Extension Period|Creatinine/eGFR|0|||
129863131|NCT01217073|467456604|FG005|Extension Period|Creatinine/eGFR|0|||
129863132|NCT01217073|467456605|FG006|Extension Period|Creatinine/eGFR|11|||
129863133|NCT01217073|467456606|FG007|Extension Period|Creatinine/eGFR|1|||
129863134|NCT01217073|467456599|FG000|Extension Period|Death|0|||
129863135|NCT01217073|467456600|FG001|Extension Period|Death|0|||
129863136|NCT01217073|467456601|FG002|Extension Period|Death|0|||
129912336|NCT03725722|467642457|FG004|Overall Study|Lost to Follow-up|1|||
130064863|NCT00505752|468192279|FG001|Overall Study|Adverse Event|0|||
129863137|NCT01217073|467456602|FG003|Extension Period|Death|0|||
129863138|NCT01217073|467456603|FG004|Extension Period|Death|0|||
129863139|NCT01217073|467456604|FG005|Extension Period|Death|0|||
129863140|NCT01217073|467456605|FG006|Extension Period|Death|1|||
129863141|NCT01217073|467456606|FG007|Extension Period|Death|0|||
129863142|NCT01217073|467456599|FG000|Extension Period|Excluded medication|0|||
129863143|NCT01217073|467456600|FG001|Extension Period|Excluded medication|0|||
129863144|NCT01217073|467456601|FG002|Extension Period|Excluded medication|0|||
129863145|NCT01217073|467456602|FG003|Extension Period|Excluded medication|0|||
129863146|NCT01217073|467456603|FG004|Extension Period|Excluded medication|0|||
129863147|NCT01217073|467456604|FG005|Extension Period|Excluded medication|0|||
129863148|NCT01217073|467456605|FG006|Extension Period|Excluded medication|2|||
129863149|NCT01217073|467456606|FG007|Extension Period|Excluded medication|0|||
129912337|NCT03725722|467642453|FG000|Overall Study|Personal reasons|0|||
129912338|NCT03725722|467642454|FG001|Overall Study|Personal reasons|0|||
129912339|NCT03725722|467642455|FG002|Overall Study|Personal reasons|1|||
130064864|NCT00505752|468192280|FG002|Overall Study|Adverse Event|1|||
129912340|NCT03725722|467642456|FG003|Overall Study|Personal reasons|0|||
129912341|NCT03725722|467642457|FG004|Overall Study|Personal reasons|1|||
129912342|NCT03725722|467642453|FG000|Overall Study|COVID-19 situation|0|||
129912343|NCT03725722|467642454|FG001|Overall Study|COVID-19 situation|1|||
129912344|NCT03725722|467642455|FG002|Overall Study|COVID-19 situation|0|||
129912345|NCT03725722|467642456|FG003|Overall Study|COVID-19 situation|0|||
129912346|NCT03725722|467642457|FG004|Overall Study|COVID-19 situation|0|||
129912347|NCT05505045|467642458|FG000|Overall Study|Withdrawal by Subject|2|||
129912348|NCT05505045|467642459|FG001|Overall Study|Withdrawal by Subject|1|||
129912349|NCT01643070|467642460|FG000|Overall Study|Withdrawal by Subject|3|||
129912350|NCT01643070|467642461|FG001|Overall Study|Withdrawal by Subject|1|||
129912351|NCT01643070|467642460|FG000|Overall Study|Death|1|||
129912352|NCT01643070|467642461|FG001|Overall Study|Death|0|||
129912353|NCT01643070|467642460|FG000|Overall Study|Pregressive disease|0|||
129912354|NCT01643070|467642461|FG001|Overall Study|Pregressive disease|2|||
129912355|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
129912356|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
129912357|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
129912358|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
129912359|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
129912360|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
129912361|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
129912362|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
129912363|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
129912364|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
129912365|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
129912366|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
129912367|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
129912368|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
129912369|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
129912370|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
129912371|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
129912372|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
129912373|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
129912374|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
129912375|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
129912376|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
129912377|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
129912378|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
129912379|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
129912380|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
129912381|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
129912382|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
129912383|NCT01600014|467642462|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
129912384|NCT01600014|467642463|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
129912385|NCT01600014|467642462|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
129912386|NCT01600014|467642463|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
129912387|NCT01600014|467642462|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
129863150|NCT01217073|467456599|FG000|Extension Period|Lack of Efficacy|0|||
129863151|NCT01217073|467456600|FG001|Extension Period|Lack of Efficacy|0|||
129863152|NCT01217073|467456601|FG002|Extension Period|Lack of Efficacy|0|||
129863153|NCT01217073|467456602|FG003|Extension Period|Lack of Efficacy|0|||
129863154|NCT01217073|467456603|FG004|Extension Period|Lack of Efficacy|0|||
129863155|NCT01217073|467456604|FG005|Extension Period|Lack of Efficacy|0|||
129863156|NCT01217073|467456605|FG006|Extension Period|Lack of Efficacy|3|||
129863157|NCT01217073|467456606|FG007|Extension Period|Lack of Efficacy|0|||
129863158|NCT01217073|467456599|FG000|Extension Period|Lost to Follow-up|0|||
129863159|NCT01217073|467456600|FG001|Extension Period|Lost to Follow-up|0|||
129863160|NCT01217073|467456601|FG002|Extension Period|Lost to Follow-up|0|||
129912388|NCT01600014|467642463|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
129912389|NCT04278586|467642464|FG000|Overall Study|Withdrawal by Subject|13|||
129912390|NCT04278586|467642465|FG001|Overall Study|Withdrawal by Subject|6|||
129912391|NCT04278586|467642464|FG000|Overall Study|Lost to Follow-up|37|||
129912392|NCT04278586|467642465|FG001|Overall Study|Lost to Follow-up|24|||
129863161|NCT01217073|467456602|FG003|Extension Period|Lost to Follow-up|0|||
129912393|NCT04310735|467642471|FG000|Overall Study|Withdrawal by Subject|1|||
129863162|NCT01217073|467456603|FG004|Extension Period|Lost to Follow-up|0|||
129863163|NCT01217073|467456604|FG005|Extension Period|Lost to Follow-up|0|||
129863164|NCT01217073|467456605|FG006|Extension Period|Lost to Follow-up|9|||
129912394|NCT04310735|467642472|FG001|Overall Study|Withdrawal by Subject|3|||
129912395|NCT04310735|467642473|FG002|Overall Study|Withdrawal by Subject|8|||
129912396|NCT04310735|467642471|FG000|Overall Study|Equipment malfunction|0|||
129912397|NCT04310735|467642472|FG001|Overall Study|Equipment malfunction|1|||
129912398|NCT04310735|467642473|FG002|Overall Study|Equipment malfunction|0|||
129912399|NCT04038957|467642479|FG000|Overall Study|Withdrawal by Subject|1|||
129912400|NCT04038957|467642479|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
129912401|NCT01998984|467642484|FG000|Overall Study|Adverse Event|0|||
129912402|NCT01998984|467642485|FG001|Overall Study|Adverse Event|0|||
129912403|NCT01998984|467642486|FG002|Overall Study|Adverse Event|0|||
129912404|NCT01998984|467642487|FG003|Overall Study|Adverse Event|1|||
129912405|NCT01998984|467642484|FG000|Overall Study|Lost to Follow-up|0|||
130064865|NCT00505752|468192281|FG003|Overall Study|Adverse Event|0|||
130064866|NCT00505752|468192278|FG000|Overall Study|Lost to Follow-up|1|||
130064867|NCT00505752|468192279|FG001|Overall Study|Lost to Follow-up|0|||
130064868|NCT00505752|468192280|FG002|Overall Study|Lost to Follow-up|0|||
130064869|NCT00505752|468192281|FG003|Overall Study|Lost to Follow-up|0|||
130064870|NCT00505752|468192278|FG000|Overall Study|Lack of ovarian response|1|||
130064871|NCT00505752|468192279|FG001|Overall Study|Lack of ovarian response|3|||
130064872|NCT00505752|468192280|FG002|Overall Study|Lack of ovarian response|0|||
130064873|NCT00505752|468192281|FG003|Overall Study|Lack of ovarian response|0|||
130064874|NCT00505752|468192278|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130064875|NCT00505752|468192279|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130064876|NCT00505752|468192280|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
130064877|NCT00505752|468192281|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129912406|NCT01998984|467642485|FG001|Overall Study|Lost to Follow-up|1|||
129912407|NCT01998984|467642486|FG002|Overall Study|Lost to Follow-up|0|||
129912408|NCT01998984|467642487|FG003|Overall Study|Lost to Follow-up|1|||
129912409|NCT01998984|467642484|FG000|Overall Study|Withdrawal by Subject|0|||
129912410|NCT01998984|467642485|FG001|Overall Study|Withdrawal by Subject|0|||
129912411|NCT01998984|467642486|FG002|Overall Study|Withdrawal by Subject|1|||
129912412|NCT01998984|467642487|FG003|Overall Study|Withdrawal by Subject|0|||
129912413|NCT01998984|467642484|FG000|Overall Study|Other|0|||
129912414|NCT01998984|467642485|FG001|Overall Study|Other|0|||
129912415|NCT01998984|467642486|FG002|Overall Study|Other|0|||
129912416|NCT01998984|467642487|FG003|Overall Study|Other|1|||
129912417|NCT01843374|467642488|FG000|Overall Study|Death|155|||
129912418|NCT01843374|467642489|FG001|Overall Study|Death|313|||
129912419|NCT01843374|467642488|FG000|Overall Study|Withdrawal by Subject|14|||
129912420|NCT01843374|467642489|FG001|Overall Study|Withdrawal by Subject|20|||
129912421|NCT01843374|467642488|FG000|Overall Study|Withdrawing due to Other reason|20|||
129912422|NCT01843374|467642489|FG001|Overall Study|Withdrawing due to Other reason|46|||
129912423|NCT02605837|467642490|FG000|Overall Study|Adverse Event|3|||
129912424|NCT02605837|467642491|FG001|Overall Study|Adverse Event|1|||
129912425|NCT02605837|467642490|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129912426|NCT02605837|467642491|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129912427|NCT02605837|467642490|FG000|Overall Study|Withdrawal by Subject|8|||
129912428|NCT02605837|467642491|FG001|Overall Study|Withdrawal by Subject|8|||
129912429|NCT02605837|467642490|FG000|Overall Study|Physician Decision|0|||
129912430|NCT02605837|467642491|FG001|Overall Study|Physician Decision|1|||
129912431|NCT02652260|467642492|FG000|Base Study|Pregnancy|0|||
129912432|NCT02652260|467642493|FG001|Base Study|Pregnancy|1|||
129912433|NCT02652260|467642492|FG000|Base Study|Withdrawal by Subject|0|||
129912434|NCT02652260|467642493|FG001|Base Study|Withdrawal by Subject|1|||
129912435|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
129912436|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
129912437|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
129912438|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
129912439|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
129912440|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
129912441|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
129912442|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
130064878|NCT00505752|468192278|FG000|Overall Study|No oocytes retrieved|0|||
129912443|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
129912444|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
129912445|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
130064879|NCT00505752|468192279|FG001|Overall Study|No oocytes retrieved|2|||
129912446|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
129912447|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
129912448|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
129912449|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
129912450|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
129912451|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
130064880|NCT00505752|468192280|FG002|Overall Study|No oocytes retrieved|0|||
130064881|NCT00505752|468192281|FG003|Overall Study|No oocytes retrieved|1|||
130064882|NCT00505752|468192278|FG000|Overall Study|No Fertilization|1|||
129912452|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
129912453|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
129912454|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
129912455|NCT02652260|467642492|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
129912456|NCT02652260|467642493|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
129912457|NCT02652260|467642492|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
129912458|NCT02652260|467642493|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
129912459|NCT05056246|467642494|FG000|Overall Study|Adverse Event|0|||
129912460|NCT05056246|467642495|FG001|Overall Study|Adverse Event|0|||
129912461|NCT05056246|467642496|FG002|Overall Study|Adverse Event|0|||
129912462|NCT05056246|467642497|FG003|Overall Study|Adverse Event|0|||
129912463|NCT05056246|467642498|FG004|Overall Study|Adverse Event|1|||
129912464|NCT05056246|467642494|FG000|Overall Study|Lost to Follow-up|0|||
129912465|NCT05056246|467642495|FG001|Overall Study|Lost to Follow-up|0|||
129912466|NCT05056246|467642496|FG002|Overall Study|Lost to Follow-up|0|||
129912467|NCT05056246|467642497|FG003|Overall Study|Lost to Follow-up|2|||
129912468|NCT05056246|467642498|FG004|Overall Study|Lost to Follow-up|0|||
129912469|NCT05056246|467642494|FG000|Overall Study|Withdrawal by Subject|0|||
129912470|NCT05056246|467642495|FG001|Overall Study|Withdrawal by Subject|1|||
129912471|NCT05056246|467642496|FG002|Overall Study|Withdrawal by Subject|0|||
129912472|NCT05056246|467642497|FG003|Overall Study|Withdrawal by Subject|0|||
129912473|NCT05056246|467642498|FG004|Overall Study|Withdrawal by Subject|0|||
129912474|NCT04714320|467642500|FG000|Overall Study|Voluntary Withdrawal|4|||
129912475|NCT04714320|467642501|FG001|Overall Study|Voluntary Withdrawal|1|||
129912476|NCT04714320|467642502|FG002|Overall Study|Voluntary Withdrawal|2|||
129912477|NCT04714320|467642500|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
129912478|NCT04714320|467642501|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
129912479|NCT04714320|467642502|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
129912480|NCT04714320|467642500|FG000|Overall Study|Reason Not Specified|1|||
129912481|NCT04714320|467642501|FG001|Overall Study|Reason Not Specified|3|||
129912482|NCT04714320|467642502|FG002|Overall Study|Reason Not Specified|3|||
129912483|NCT05057897|467642503|FG000|Overall Study|Site closure|2|||
129912484|NCT05057897|467642504|FG001|Overall Study|Site closure|2|||
129912485|NCT05057897|467642503|FG000|Overall Study|Death|1|||
129912486|NCT05057897|467642504|FG001|Overall Study|Death|0|||
129912487|NCT03575052|467642513|FG000|Overall Study|Adverse Event|6|||
129912488|NCT03575052|467642514|FG001|Overall Study|Adverse Event|10|||
129912489|NCT03575052|467642513|FG000|Overall Study|Not further specified|5|||
129912490|NCT03575052|467642514|FG001|Overall Study|Not further specified|7|||
129912491|NCT03575052|467642513|FG000|Overall Study|Withdrawal by Subject|5|||
129912492|NCT03575052|467642514|FG001|Overall Study|Withdrawal by Subject|6|||
129912493|NCT03575052|467642513|FG000|Overall Study|Lost to Follow-up|3|||
129912494|NCT03575052|467642514|FG001|Overall Study|Lost to Follow-up|0|||
129912495|NCT03575052|467642513|FG000|Overall Study|Death|2|||
129912496|NCT03575052|467642514|FG001|Overall Study|Death|1|||
129912497|NCT03575052|467642513|FG000|Overall Study|Lack of Efficacy|2|||
129912498|NCT03575052|467642514|FG001|Overall Study|Lack of Efficacy|1|||
129912499|NCT03575052|467642513|FG000|Overall Study|Study drug noncompliance|1|||
129912500|NCT03575052|467642514|FG001|Overall Study|Study drug noncompliance|2|||
129912501|NCT03575052|467642513|FG000|Overall Study|Protocol Violation|0|||
129912502|NCT03575052|467642514|FG001|Overall Study|Protocol Violation|2|||
129912503|NCT03575052|467642513|FG000|Overall Study|Physician Decision|1|||
129912504|NCT03575052|467642514|FG001|Overall Study|Physician Decision|0|||
129912505|NCT03438188|467642515|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
129912506|NCT03438188|467642516|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
129912507|NCT03438188|467642517|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
129912508|NCT03438188|467642515|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
129912509|NCT03438188|467642516|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
129912510|NCT03438188|467642517|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
129912511|NCT03438188|467642515|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
129912512|NCT03438188|467642516|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
129912513|NCT03438188|467642517|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
129912514|NCT03438188|467642515|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
129912515|NCT03438188|467642516|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
129912516|NCT03438188|467642517|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
129912517|NCT03438188|467642515|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
129912518|NCT03438188|467642516|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
129912519|NCT03438188|467642517|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
129912520|NCT04300231|467642518|FG000|Overall Study|Protocol Violation|4|||
129912521|NCT04300231|467642519|FG001|Overall Study|Protocol Violation|3|||
129912522|NCT04300231|467642520|FG002|Overall Study|Protocol Violation|0|||
129912523|NCT04300231|467642521|FG003|Overall Study|Protocol Violation|2|||
129912524|NCT02300298|467642528|FG000|Disposition for Nintedanib|Progressive disease|10|||
130064883|NCT00505752|468192279|FG001|Overall Study|No Fertilization|1|||
129912525|NCT02300298|467642529|FG001|Disposition for Nintedanib|Progressive disease|0|||
129912526|NCT02300298|467642528|FG000|Disposition for Docetaxel|Progressive disease|0|||
129912527|NCT02300298|467642529|FG001|Disposition for Docetaxel|Progressive disease|6|||
129912528|NCT02300298|467642528|FG000|Disposition for Docetaxel|other adverse event|0|||
129912529|NCT02300298|467642529|FG001|Disposition for Docetaxel|other adverse event|4|||
129912530|NCT03285763|467642530|FG000|Overall Study|Death|470|||
129912531|NCT03285763|467642530|FG000|Overall Study|Lost to Follow-up|18|||
129912532|NCT03285763|467642530|FG000|Overall Study|Physician Decision|2|||
129912533|NCT03285763|467642530|FG000|Overall Study|Study Terminated By Sponsor|79|||
129912534|NCT03285763|467642530|FG000|Overall Study|Withdrawal by Subject|33|||
129912535|NCT03456076|467642531|FG000|Overall Study|Withdrawal by Subject|5|||
129912536|NCT03456076|467642532|FG001|Overall Study|Withdrawal by Subject|9|||
129912537|NCT03456076|467642531|FG000|Overall Study|Protocol deviation|0|||
129912538|NCT03456076|467642532|FG001|Overall Study|Protocol deviation|1|||
129912539|NCT03456076|467642531|FG000|Overall Study|Lost to Follow-up|0|||
129912540|NCT03456076|467642532|FG001|Overall Study|Lost to Follow-up|1|||
129912541|NCT03456076|467642531|FG000|Overall Study|Death|2|||
129912542|NCT03456076|467642532|FG001|Overall Study|Death|5|||
129912543|NCT03456076|467642531|FG000|Overall Study|Study ongoing|123|||
129912544|NCT03456076|467642532|FG001|Overall Study|Study ongoing|111|||
129912545|NCT00505934|467642533|FG000|Overall Study|Adverse Event|1|||
129912546|NCT00505934|467642533|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
129912547|NCT00505934|467642533|FG000|Overall Study|Other: IV dose needed to be changed|1|||
129912548|NCT03050814|467642534|FG000|Overall Study|Screen failures|0|||
129912549|NCT03050814|467642535|FG001|Overall Study|Screen failures|0|||
129912550|NCT03050814|467642536|FG002|Overall Study|Screen failures|4|||
129912551|NCT05137236|467642540|FG000|Part A|Other than Specified|1|||
129912552|NCT05137236|467642541|FG001|Part A|Other than Specified|0|||
129912553|NCT05137236|467642542|FG002|Part A|Other than Specified|0|||
129912554|NCT05137236|467642543|FG003|Part A|Other than Specified|0|||
129912555|NCT05137236|467642544|FG004|Part A|Other than Specified|0|||
129912556|NCT05137236|467642545|FG005|Part A|Other than Specified|0|||
129912557|NCT05137236|467642546|FG006|Part A|Other than Specified|0|||
129912558|NCT05137236|467642547|FG007|Part A|Other than Specified|0|||
129912559|NCT05137236|467642540|FG000|Part A|Withdrawal by Subject|0|||
129912560|NCT05137236|467642541|FG001|Part A|Withdrawal by Subject|4|||
129912561|NCT05137236|467642542|FG002|Part A|Withdrawal by Subject|1|||
129912562|NCT05137236|467642543|FG003|Part A|Withdrawal by Subject|1|||
129912563|NCT05137236|467642544|FG004|Part A|Withdrawal by Subject|3|||
129912564|NCT05137236|467642545|FG005|Part A|Withdrawal by Subject|2|||
129912565|NCT05137236|467642546|FG006|Part A|Withdrawal by Subject|0|||
129912566|NCT05137236|467642547|FG007|Part A|Withdrawal by Subject|0|||
129912567|NCT05137236|467642540|FG000|Part A|Lost to Follow-up|5|||
130064884|NCT00505752|468192280|FG002|Overall Study|No Fertilization|2|||
130064885|NCT00505752|468192281|FG003|Overall Study|No Fertilization|1|||
130064886|NCT00505752|468192278|FG000|Overall Study|All embryos/blastocysts discarded|0|||
130064887|NCT00505752|468192279|FG001|Overall Study|All embryos/blastocysts discarded|0|||
129912568|NCT05137236|467642541|FG001|Part A|Lost to Follow-up|7|||
129912569|NCT05137236|467642542|FG002|Part A|Lost to Follow-up|1|||
129912570|NCT05137236|467642543|FG003|Part A|Lost to Follow-up|3|||
129912571|NCT05137236|467642544|FG004|Part A|Lost to Follow-up|3|||
129912572|NCT05137236|467642545|FG005|Part A|Lost to Follow-up|8|||
129912573|NCT05137236|467642546|FG006|Part A|Lost to Follow-up|0|||
129912574|NCT05137236|467642547|FG007|Part A|Lost to Follow-up|0|||
129912575|NCT05137236|467642540|FG000|Part B|Withdrawal by Subject|0|||
129912576|NCT05137236|467642541|FG001|Part B|Withdrawal by Subject|0|||
129912577|NCT05137236|467642542|FG002|Part B|Withdrawal by Subject|0|||
129912578|NCT05137236|467642543|FG003|Part B|Withdrawal by Subject|0|||
129912579|NCT05137236|467642544|FG004|Part B|Withdrawal by Subject|0|||
129912580|NCT05137236|467642545|FG005|Part B|Withdrawal by Subject|0|||
130064888|NCT00505752|468192280|FG002|Overall Study|All embryos/blastocysts discarded|1|||
130064889|NCT00505752|468192281|FG003|Overall Study|All embryos/blastocysts discarded|1|||
130064890|NCT00505752|468192278|FG000|Overall Study|Other|1|||
129912581|NCT05137236|467642546|FG006|Part B|Withdrawal by Subject|0|||
129912582|NCT05137236|467642547|FG007|Part B|Withdrawal by Subject|2|||
129912583|NCT05137236|467642540|FG000|Part B|Lost to Follow-up|0|||
129912584|NCT05137236|467642541|FG001|Part B|Lost to Follow-up|0|||
129912585|NCT05137236|467642542|FG002|Part B|Lost to Follow-up|0|||
129912586|NCT05137236|467642543|FG003|Part B|Lost to Follow-up|0|||
130064891|NCT00505752|468192279|FG001|Overall Study|Other|2|||
129912587|NCT05137236|467642544|FG004|Part B|Lost to Follow-up|0|||
129912588|NCT05137236|467642545|FG005|Part B|Lost to Follow-up|0|||
129912589|NCT05137236|467642546|FG006|Part B|Lost to Follow-up|5|||
129912590|NCT05137236|467642547|FG007|Part B|Lost to Follow-up|5|||
129912591|NCT05137236|467642540|FG000|Part B|Death|0|||
129912592|NCT05137236|467642541|FG001|Part B|Death|0|||
129912593|NCT05137236|467642542|FG002|Part B|Death|0|||
129912594|NCT05137236|467642543|FG003|Part B|Death|0|||
129912595|NCT05137236|467642544|FG004|Part B|Death|0|||
129912596|NCT05137236|467642545|FG005|Part B|Death|0|||
129912597|NCT05137236|467642546|FG006|Part B|Death|0|||
130064892|NCT00505752|468192280|FG002|Overall Study|Other|1|||
129912598|NCT05137236|467642547|FG007|Part B|Death|2|||
129912599|NCT02724956|467642548|FG000|Overall Study|Physician Decision|1|||
129912600|NCT02724956|467642549|FG001|Overall Study|Physician Decision|0|||
129912601|NCT02724956|467642548|FG000|Overall Study|Lack of Efficacy|0|||
129912602|NCT02724956|467642549|FG001|Overall Study|Lack of Efficacy|1|||
129912603|NCT02724956|467642548|FG000|Overall Study|Withdrawal by Subject|0|||
129912604|NCT02724956|467642549|FG001|Overall Study|Withdrawal by Subject|1|||
129912605|NCT00431834|467642550|FG000|Overall Study|Withdrawal by Subject|7|||
129912606|NCT00431834|467642550|FG000|Overall Study|Death|3|||
129912607|NCT00431834|467642550|FG000|Overall Study|Missed Endpoint Visit|2|||
129912608|NCT00431834|467642550|FG000|Overall Study|Lost to Follow-up|1|||
129912609|NCT02461628|467642554|FG000|Overall Study|Refused to complete survey|4|||
129912610|NCT02461628|467642555|FG001|Overall Study|Refused to complete survey|7|||
129912611|NCT02121002|467642567|FG000|Overall Study|Physician Decision|2|||
129912612|NCT02121002|467642568|FG001|Overall Study|Physician Decision|0|||
129912613|NCT02121002|467642569|FG002|Overall Study|Physician Decision|0|||
129912614|NCT02121002|467642567|FG000|Overall Study|Withdrawal by Subject|3|||
129912615|NCT02121002|467642568|FG001|Overall Study|Withdrawal by Subject|1|||
129912616|NCT02121002|467642569|FG002|Overall Study|Withdrawal by Subject|4|||
129912617|NCT02121002|467642567|FG000|Overall Study|Protocol Violation|1|||
129912618|NCT02121002|467642568|FG001|Overall Study|Protocol Violation|2|||
129912619|NCT02121002|467642569|FG002|Overall Study|Protocol Violation|4|||
129912620|NCT02121002|467642567|FG000|Overall Study|Concomitant therapy|0|||
129912621|NCT02121002|467642568|FG001|Overall Study|Concomitant therapy|1|||
129912622|NCT02121002|467642569|FG002|Overall Study|Concomitant therapy|1|||
129912623|NCT02121002|467642567|FG000|Overall Study|Others|1|||
129912624|NCT02121002|467642568|FG001|Overall Study|Others|0|||
129912625|NCT02121002|467642569|FG002|Overall Study|Others|1|||
129912626|NCT02590432|467642570|FG000|Open-label Treatment Period|Adverse Event|97|||
129912627|NCT02590432|467642571|FG001|Open-label Treatment Period|Adverse Event|79|||
129912628|NCT02590432|467642572|FG002|Open-label Treatment Period|Adverse Event|0|||
129912629|NCT02590432|467642573|FG003|Open-label Treatment Period|Adverse Event|0|||
129912630|NCT02590432|467642574|FG004|Open-label Treatment Period|Adverse Event|0|||
129912631|NCT02590432|467642575|FG005|Open-label Treatment Period|Adverse Event|0|||
129912632|NCT02590432|467642576|FG006|Open-label Treatment Period|Adverse Event|0|||
129912633|NCT02590432|467642577|FG007|Open-label Treatment Period|Adverse Event|0|||
129912634|NCT02590432|467642578|FG008|Open-label Treatment Period|Adverse Event|0|||
129912635|NCT02590432|467642570|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
129912636|NCT02590432|467642571|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
129912637|NCT02590432|467642572|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
129912638|NCT02590432|467642573|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
129912639|NCT02590432|467642574|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
129912640|NCT02590432|467642575|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
129912641|NCT02590432|467642576|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
129912642|NCT02590432|467642577|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
129912643|NCT02590432|467642578|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
129912644|NCT02590432|467642570|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
129912645|NCT02590432|467642571|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
129912646|NCT02590432|467642572|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
129912647|NCT02590432|467642573|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
129912648|NCT02590432|467642574|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
129912649|NCT02590432|467642575|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
129912650|NCT02590432|467642576|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
129912651|NCT02590432|467642577|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
130064893|NCT00505752|468192281|FG003|Overall Study|Other|2|||
130064894|NCT01149343|468192282|FG000|Overall Study|Withdrawal by Subject|1|||
130064895|NCT01149343|468192283|FG001|Overall Study|Withdrawal by Subject|1|||
130064896|NCT01149343|468192284|FG002|Overall Study|Withdrawal by Subject|1|||
130064897|NCT01149343|468192285|FG003|Overall Study|Withdrawal by Subject|5|||
130064898|NCT01149343|468192282|FG000|Overall Study|Death|10|||
130064899|NCT01149343|468192283|FG001|Overall Study|Death|13|||
130064900|NCT01149343|468192284|FG002|Overall Study|Death|18|||
129912652|NCT02590432|467642578|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
129912653|NCT02590432|467642570|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
129912654|NCT02590432|467642571|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
129912655|NCT02590432|467642572|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129912656|NCT02590432|467642573|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
129912657|NCT02590432|467642574|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
129912658|NCT02590432|467642575|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
129912659|NCT02590432|467642576|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
129912660|NCT02590432|467642577|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
129912661|NCT02590432|467642578|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
129912662|NCT02590432|467642570|FG000|Open-label Treatment Period|Protocol Violation|10|||
129912663|NCT02590432|467642571|FG001|Open-label Treatment Period|Protocol Violation|4|||
130064901|NCT01149343|468192285|FG003|Overall Study|Death|18|||
130064902|NCT01149343|468192282|FG000|Overall Study|Lost to Follow-up|1|||
129912664|NCT02590432|467642572|FG002|Open-label Treatment Period|Protocol Violation|0|||
129912665|NCT02590432|467642573|FG003|Open-label Treatment Period|Protocol Violation|0|||
129912666|NCT02590432|467642574|FG004|Open-label Treatment Period|Protocol Violation|0|||
129912667|NCT02590432|467642575|FG005|Open-label Treatment Period|Protocol Violation|0|||
129912668|NCT02590432|467642576|FG006|Open-label Treatment Period|Protocol Violation|0|||
129912669|NCT02590432|467642577|FG007|Open-label Treatment Period|Protocol Violation|0|||
129912670|NCT02590432|467642578|FG008|Open-label Treatment Period|Protocol Violation|0|||
129912671|NCT02590432|467642570|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
129912672|NCT02590432|467642571|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
129912673|NCT02590432|467642572|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912674|NCT02590432|467642573|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912675|NCT02590432|467642574|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912676|NCT02590432|467642575|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912677|NCT02590432|467642576|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912678|NCT02590432|467642577|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912679|NCT02590432|467642578|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912680|NCT02590432|467642570|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
129912681|NCT02590432|467642571|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
129912682|NCT02590432|467642572|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912683|NCT02590432|467642573|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912684|NCT02590432|467642574|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912685|NCT02590432|467642575|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912686|NCT02590432|467642576|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912687|NCT02590432|467642577|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912688|NCT02590432|467642578|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912689|NCT02590432|467642570|FG000|Double-blind Treatment Period|Adverse Event|0|||
129912690|NCT02590432|467642571|FG001|Double-blind Treatment Period|Adverse Event|0|||
129912691|NCT02590432|467642572|FG002|Double-blind Treatment Period|Adverse Event|14|||
129912692|NCT02590432|467642573|FG003|Double-blind Treatment Period|Adverse Event|12|||
129912693|NCT02590432|467642574|FG004|Double-blind Treatment Period|Adverse Event|6|||
129912694|NCT02590432|467642575|FG005|Double-blind Treatment Period|Adverse Event|22|||
129912695|NCT02590432|467642576|FG006|Double-blind Treatment Period|Adverse Event|20|||
129912696|NCT02590432|467642577|FG007|Double-blind Treatment Period|Adverse Event|0|||
129912697|NCT02590432|467642578|FG008|Double-blind Treatment Period|Adverse Event|0|||
129912698|NCT02590432|467642570|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129912699|NCT02590432|467642571|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129912700|NCT02590432|467642572|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
129912701|NCT02590432|467642573|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
129912702|NCT02590432|467642574|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
129912703|NCT02590432|467642575|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
129912704|NCT02590432|467642576|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
129912705|NCT02590432|467642577|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
129912706|NCT02590432|467642578|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
129912707|NCT02590432|467642570|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
129912708|NCT02590432|467642571|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
129912709|NCT02590432|467642572|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
129912710|NCT02590432|467642573|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
129912711|NCT02590432|467642574|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
129912712|NCT02590432|467642575|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
129912713|NCT02590432|467642576|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
129912714|NCT02590432|467642577|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
130116659|NCT00585351|468387153|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
130116660|NCT00585351|468387154|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
129912715|NCT02590432|467642578|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
129912716|NCT02590432|467642570|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129912717|NCT02590432|467642571|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129912718|NCT02590432|467642572|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129912719|NCT02590432|467642573|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129912720|NCT02590432|467642574|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
129912721|NCT02590432|467642575|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
129912722|NCT02590432|467642576|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
129912723|NCT02590432|467642577|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
129912724|NCT02590432|467642578|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
129912725|NCT02590432|467642570|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912726|NCT02590432|467642571|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912727|NCT02590432|467642572|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912728|NCT02590432|467642573|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912729|NCT02590432|467642574|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912730|NCT02590432|467642575|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
129912731|NCT02590432|467642576|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912732|NCT02590432|467642577|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912733|NCT02590432|467642578|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912734|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912735|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912736|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912737|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912738|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912739|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912740|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912741|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
129912742|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
129912743|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912744|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912745|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912746|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912747|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912748|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912749|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912750|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
129912751|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912752|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912753|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912754|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912755|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912756|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912757|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912758|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912759|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
129912760|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
129912761|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912762|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912763|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912764|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912765|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912766|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912767|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912768|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912769|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
129912770|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912771|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912772|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912773|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912774|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912775|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912776|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912777|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912778|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
129912779|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912780|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912781|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912782|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912783|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912784|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912785|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912786|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
129912787|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912788|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912789|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912790|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129863165|NCT01217073|467456606|FG007|Extension Period|Lost to Follow-up|1|||
129863166|NCT01217073|467456599|FG000|Extension Period|Non-compliance with study drug|0|||
129863167|NCT01217073|467456600|FG001|Extension Period|Non-compliance with study drug|0|||
129863168|NCT01217073|467456601|FG002|Extension Period|Non-compliance with study drug|0|||
129863169|NCT01217073|467456602|FG003|Extension Period|Non-compliance with study drug|0|||
129863170|NCT01217073|467456603|FG004|Extension Period|Non-compliance with study drug|0|||
129863171|NCT01217073|467456604|FG005|Extension Period|Non-compliance with study drug|0|||
129863172|NCT01217073|467456605|FG006|Extension Period|Non-compliance with study drug|0|||
129863173|NCT01217073|467456606|FG007|Extension Period|Non-compliance with study drug|1|||
129863174|NCT01217073|467456599|FG000|Extension Period|Physician Decision|0|||
129863175|NCT01217073|467456600|FG001|Extension Period|Physician Decision|0|||
129863176|NCT01217073|467456601|FG002|Extension Period|Physician Decision|0|||
129863177|NCT01217073|467456602|FG003|Extension Period|Physician Decision|0|||
129863178|NCT01217073|467456603|FG004|Extension Period|Physician Decision|0|||
129863179|NCT01217073|467456604|FG005|Extension Period|Physician Decision|0|||
129863180|NCT01217073|467456605|FG006|Extension Period|Physician Decision|4|||
129863181|NCT01217073|467456606|FG007|Extension Period|Physician Decision|1|||
129863182|NCT01217073|467456599|FG000|Extension Period|Protocol Violation|0|||
129863183|NCT01217073|467456600|FG001|Extension Period|Protocol Violation|0|||
129863184|NCT01217073|467456601|FG002|Extension Period|Protocol Violation|0|||
129863185|NCT01217073|467456602|FG003|Extension Period|Protocol Violation|0|||
129863186|NCT01217073|467456603|FG004|Extension Period|Protocol Violation|0|||
129863187|NCT01217073|467456604|FG005|Extension Period|Protocol Violation|0|||
129863188|NCT01217073|467456605|FG006|Extension Period|Protocol Violation|2|||
129863189|NCT01217073|467456606|FG007|Extension Period|Protocol Violation|1|||
129863190|NCT01217073|467456599|FG000|Extension Period|Site discontinued study participation|0|||
129863191|NCT01217073|467456600|FG001|Extension Period|Site discontinued study participation|0|||
129863192|NCT01217073|467456601|FG002|Extension Period|Site discontinued study participation|0|||
129863193|NCT01217073|467456602|FG003|Extension Period|Site discontinued study participation|0|||
129863194|NCT01217073|467456603|FG004|Extension Period|Site discontinued study participation|0|||
129863195|NCT01217073|467456604|FG005|Extension Period|Site discontinued study participation|0|||
129863196|NCT01217073|467456605|FG006|Extension Period|Site discontinued study participation|7|||
129863197|NCT01217073|467456606|FG007|Extension Period|Site discontinued study participation|2|||
129863198|NCT01217073|467456599|FG000|Extension Period|Withdrawal by Subject|0|||
129863199|NCT01217073|467456600|FG001|Extension Period|Withdrawal by Subject|0|||
129863200|NCT01217073|467456601|FG002|Extension Period|Withdrawal by Subject|0|||
129863201|NCT01217073|467456602|FG003|Extension Period|Withdrawal by Subject|0|||
129863202|NCT01217073|467456603|FG004|Extension Period|Withdrawal by Subject|0|||
129863203|NCT01217073|467456604|FG005|Extension Period|Withdrawal by Subject|0|||
129863204|NCT01217073|467456605|FG006|Extension Period|Withdrawal by Subject|30|||
129863205|NCT01217073|467456606|FG007|Extension Period|Withdrawal by Subject|8|||
129863206|NCT04004611|467456607|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863207|NCT04004611|467456608|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863208|NCT04004611|467456609|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863209|NCT04004611|467456610|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863210|NCT04004611|467456611|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863211|NCT04004611|467456612|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863212|NCT04004611|467456613|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863213|NCT04004611|467456614|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863214|NCT04004611|467456615|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
129863215|NCT04004611|467456607|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863216|NCT04004611|467456608|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863217|NCT04004611|467456609|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863218|NCT04004611|467456610|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863219|NCT04004611|467456611|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863220|NCT04004611|467456612|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
129863221|NCT04004611|467456613|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
129863222|NCT04004611|467456614|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863223|NCT04004611|467456615|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
129863224|NCT04004611|467456607|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863225|NCT04004611|467456608|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863226|NCT04004611|467456609|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863227|NCT04004611|467456610|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
130154855|NCT00958126|468526626|FG005|Overall Study|Moved away from study area|0|||
129863228|NCT04004611|467456611|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
129863229|NCT04004611|467456612|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863230|NCT04004611|467456613|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863231|NCT04004611|467456614|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863232|NCT04004611|467456615|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863233|NCT04004611|467456607|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
129912791|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912792|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912793|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912794|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912795|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
129912796|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912797|NCT02006758|467642579|FG000|Overall Study|Protocol Violation|1|||
129912798|NCT02006758|467642579|FG000|Overall Study|Death|1|||
129912799|NCT02006758|467642579|FG000|Overall Study|Lost to Follow-up|4|||
130064903|NCT01149343|468192283|FG001|Overall Study|Lost to Follow-up|0|||
130064904|NCT01149343|468192284|FG002|Overall Study|Lost to Follow-up|0|||
130064905|NCT01149343|468192285|FG003|Overall Study|Lost to Follow-up|1|||
130064906|NCT01149343|468192282|FG000|Overall Study|Other|8|||
130064907|NCT01149343|468192283|FG001|Overall Study|Other|10|||
130064908|NCT01149343|468192284|FG002|Overall Study|Other|2|||
130064909|NCT01149343|468192285|FG003|Overall Study|Other|14|||
130064910|NCT01149343|468192282|FG000|Overall Study|Sponsor study termination|0|||
129912800|NCT02006758|467642579|FG000|Overall Study|Withdrawal by Subject|4|||
129912801|NCT02006758|467642579|FG000|Overall Study|Procedurally excluded|1|||
129912802|NCT02006758|467642579|FG000|Overall Study|Other|2|||
129912803|NCT04788641|467642580|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
129912804|NCT04788641|467642581|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
129912805|NCT04788641|467642582|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
129912806|NCT04788641|467642583|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
129912807|NCT04788641|467642580|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
129912808|NCT04788641|467642581|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
129912809|NCT04788641|467642582|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
129912810|NCT04788641|467642583|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
129912811|NCT04788641|467642580|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
129912812|NCT04788641|467642581|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
129912813|NCT04788641|467642582|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
129912814|NCT04788641|467642583|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
129912815|NCT02740231|467642588|FG000|Overall Study|Withdrawal by Subject|1|||
129912816|NCT02740231|467642589|FG001|Overall Study|Withdrawal by Subject|1|||
129912817|NCT02740231|467642590|FG002|Overall Study|Withdrawal by Subject|1|||
129912818|NCT02740231|467642591|FG003|Overall Study|Withdrawal by Subject|0|||
129912819|NCT02740231|467642588|FG000|Overall Study|Lack of Efficacy|0|||
129912820|NCT02740231|467642589|FG001|Overall Study|Lack of Efficacy|1|||
129912821|NCT02740231|467642590|FG002|Overall Study|Lack of Efficacy|0|||
129912822|NCT02740231|467642591|FG003|Overall Study|Lack of Efficacy|4|||
129912823|NCT02740231|467642588|FG000|Overall Study|Lost to Follow-up|1|||
129912824|NCT02740231|467642589|FG001|Overall Study|Lost to Follow-up|3|||
129912825|NCT02740231|467642590|FG002|Overall Study|Lost to Follow-up|0|||
129912826|NCT02740231|467642591|FG003|Overall Study|Lost to Follow-up|3|||
129912827|NCT02740231|467642588|FG000|Overall Study|Adverse Event|0|||
129912828|NCT02740231|467642589|FG001|Overall Study|Adverse Event|1|||
129912829|NCT02740231|467642590|FG002|Overall Study|Adverse Event|0|||
129912830|NCT02740231|467642591|FG003|Overall Study|Adverse Event|1|||
129912831|NCT02462759|467642592|FG000|Part 1: Double Blind|Death|1|||
129912832|NCT02462759|467642593|FG001|Part 1: Double Blind|Death|0|||
129912833|NCT02462759|467642594|FG002|Part 1: Double Blind|Death|0|||
129912834|NCT00243503|467642597|FG000|Overall Study|Adverse Event|11|||
129912835|NCT00243503|467642597|FG000|Overall Study|Withdrawal by Subject|1|||
129912836|NCT00243503|467642597|FG000|Overall Study|Lack of Efficacy|44|||
129912837|NCT00243503|467642597|FG000|Overall Study|Death|1|||
129912838|NCT00243503|467642597|FG000|Overall Study|Other|1|||
129912839|NCT01000480|467642598|FG000|Induction Phase|Adverse Event|2|||
129912840|NCT01000480|467642598|FG000|Induction Phase|Lost to Follow-up|1|||
129912841|NCT01000480|467642598|FG000|Induction Phase|Physician Decision|1|||
129912842|NCT01000480|467642598|FG000|Induction Phase|Entry Criteria Not Met|3|||
129912843|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Adverse Event|4|||
129912844|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
129912845|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
129912846|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Physician Decision|1|||
129912847|NCT04600752|467642603|FG000|Overall Study|Physician Decision|0|||
129912848|NCT04600752|467642604|FG001|Overall Study|Physician Decision|0|||
129912849|NCT04600752|467642605|FG002|Overall Study|Physician Decision|1|||
129912850|NCT04600752|467642603|FG000|Overall Study|Adverse Event|0|||
129912851|NCT04600752|467642604|FG001|Overall Study|Adverse Event|1|||
130064911|NCT01149343|468192283|FG001|Overall Study|Sponsor study termination|0|||
130116661|NCT00585351|468387147|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
130116662|NCT00585351|468387148|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
130064912|NCT01149343|468192284|FG002|Overall Study|Sponsor study termination|0|||
130064913|NCT01149343|468192285|FG003|Overall Study|Sponsor study termination|2|||
129912852|NCT04600752|467642605|FG002|Overall Study|Adverse Event|0|||
129912853|NCT04600752|467642603|FG000|Overall Study|Withdrawal by Subject|2|||
129912854|NCT04600752|467642604|FG001|Overall Study|Withdrawal by Subject|1|||
129912855|NCT04600752|467642605|FG002|Overall Study|Withdrawal by Subject|0|||
130064914|NCT01149343|468192282|FG000|Overall Study|Recurrence / Progressive disease|0|||
130064915|NCT01149343|468192283|FG001|Overall Study|Recurrence / Progressive disease|0|||
129863234|NCT04004611|467456608|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
129863235|NCT04004611|467456609|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
129863236|NCT04004611|467456610|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
129863237|NCT04004611|467456611|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
129863238|NCT04004611|467456612|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
129863239|NCT04004611|467456613|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
129863240|NCT04004611|467456614|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
129863241|NCT04004611|467456615|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
129863242|NCT04004611|467456607|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
129863243|NCT04004611|467456608|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863244|NCT04004611|467456609|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
129863245|NCT04004611|467456610|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863246|NCT04004611|467456611|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863247|NCT04004611|467456612|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863248|NCT04004611|467456613|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863249|NCT04004611|467456614|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863250|NCT04004611|467456615|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863251|NCT04004611|467456607|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863252|NCT04004611|467456608|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
129863253|NCT04004611|467456609|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863254|NCT04004611|467456610|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863255|NCT04004611|467456611|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863256|NCT04004611|467456612|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863257|NCT04004611|467456613|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863258|NCT04004611|467456614|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863259|NCT04004611|467456615|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863260|NCT04420689|467456616|FG000|Overall Study|COVID-19 related hospitalization|0|||
129863261|NCT04420689|467456617|FG001|Overall Study|COVID-19 related hospitalization|0|||
129863262|NCT04420689|467456618|FG002|Overall Study|COVID-19 related hospitalization|0|||
129863263|NCT04420689|467456619|FG003|Overall Study|COVID-19 related hospitalization|0|||
129863264|NCT04420689|467456620|FG004|Overall Study|COVID-19 related hospitalization|1|||
129863265|NCT04420689|467456621|FG005|Overall Study|COVID-19 related hospitalization|0|||
129863266|NCT04420689|467456622|FG006|Overall Study|COVID-19 related hospitalization|0|||
129863267|NCT04420689|467456616|FG000|Overall Study|Physician Decision|0|||
129863268|NCT04420689|467456617|FG001|Overall Study|Physician Decision|0|||
129863269|NCT04420689|467456618|FG002|Overall Study|Physician Decision|0|||
129863270|NCT04420689|467456619|FG003|Overall Study|Physician Decision|0|||
129863271|NCT04420689|467456620|FG004|Overall Study|Physician Decision|0|||
129863272|NCT04420689|467456621|FG005|Overall Study|Physician Decision|1|||
129863273|NCT04420689|467456622|FG006|Overall Study|Physician Decision|0|||
129863274|NCT00515502|467456623|FG000|Treatment Period 1|Adverse Event|0|||
129863275|NCT00515502|467456624|FG001|Treatment Period 1|Adverse Event|0|||
129863276|NCT00515502|467456625|FG002|Treatment Period 1|Adverse Event|0|||
129863277|NCT00515502|467456626|FG003|Treatment Period 1|Adverse Event|0|||
129863278|NCT00515502|467456627|FG004|Treatment Period 1|Adverse Event|0|||
129863279|NCT00515502|467456628|FG005|Treatment Period 1|Adverse Event|0|||
129863280|NCT00515502|467456629|FG006|Treatment Period 1|Adverse Event|1|||
129863281|NCT00515502|467456630|FG007|Treatment Period 1|Adverse Event|0|||
129863282|NCT00515502|467456631|FG008|Treatment Period 1|Adverse Event|1|||
129863283|NCT00515502|467456632|FG009|Treatment Period 1|Adverse Event|0|||
129863284|NCT00515502|467456633|FG010|Treatment Period 1|Adverse Event|0|||
129863285|NCT00515502|467456634|FG011|Treatment Period 1|Adverse Event|1|||
129863286|NCT00515502|467456623|FG000|Treatment Period 2|Adverse Event|0|||
129863287|NCT00515502|467456624|FG001|Treatment Period 2|Adverse Event|1|||
129863288|NCT00515502|467456625|FG002|Treatment Period 2|Adverse Event|0|||
129863289|NCT00515502|467456626|FG003|Treatment Period 2|Adverse Event|0|||
129863290|NCT00515502|467456627|FG004|Treatment Period 2|Adverse Event|0|||
129863291|NCT00515502|467456628|FG005|Treatment Period 2|Adverse Event|0|||
129863292|NCT00515502|467456629|FG006|Treatment Period 2|Adverse Event|0|||
129863293|NCT00515502|467456630|FG007|Treatment Period 2|Adverse Event|0|||
129863294|NCT00515502|467456631|FG008|Treatment Period 2|Adverse Event|0|||
129863295|NCT00515502|467456632|FG009|Treatment Period 2|Adverse Event|0|||
129863296|NCT00515502|467456633|FG010|Treatment Period 2|Adverse Event|0|||
129863297|NCT00515502|467456634|FG011|Treatment Period 2|Adverse Event|0|||
129863298|NCT02732938|467456638|FG000|Overall Study|Death|0|||
129863299|NCT02732938|467456639|FG001|Overall Study|Death|11|||
129863300|NCT02732938|467456640|FG002|Overall Study|Death|0|||
130064916|NCT01149343|468192284|FG002|Overall Study|Recurrence / Progressive disease|1|||
130064917|NCT01149343|468192285|FG003|Overall Study|Recurrence / Progressive disease|0|||
130064918|NCT01925612|468192286|FG000|Overall Study|Progressive Disease|1|||
130064919|NCT01925612|468192287|FG001|Overall Study|Progressive Disease|1|||
130064920|NCT01925612|468192288|FG002|Overall Study|Progressive Disease|1|||
130064921|NCT01925612|468192289|FG003|Overall Study|Progressive Disease|0|||
130064922|NCT01925612|468192290|FG004|Overall Study|Progressive Disease|0|||
130064923|NCT01925612|468192286|FG000|Overall Study|Adverse Event|3|||
130064924|NCT01925612|468192287|FG001|Overall Study|Adverse Event|3|||
130064925|NCT01925612|468192288|FG002|Overall Study|Adverse Event|0|||
130064926|NCT01925612|468192289|FG003|Overall Study|Adverse Event|1|||
130064927|NCT01925612|468192290|FG004|Overall Study|Adverse Event|2|||
129863301|NCT02732938|467456638|FG000|Overall Study|Randomized but did not receive treatment|0|||
129863302|NCT02732938|467456639|FG001|Overall Study|Randomized but did not receive treatment|1|||
129863303|NCT02732938|467456640|FG002|Overall Study|Randomized but did not receive treatment|0|||
129863304|NCT02732938|467456638|FG000|Overall Study|Refused further follow-up|1|||
129863305|NCT02732938|467456639|FG001|Overall Study|Refused further follow-up|0|||
129863306|NCT02732938|467456640|FG002|Overall Study|Refused further follow-up|0|||
129863307|NCT02732938|467456638|FG000|Overall Study|Study terminated by sponsor|3|||
129863308|NCT02732938|467456639|FG001|Overall Study|Study terminated by sponsor|6|||
129863309|NCT02732938|467456640|FG002|Overall Study|Study terminated by sponsor|0|||
129863310|NCT03927950|467456641|FG000|Overall Study|Adverse Event|9|||
129863311|NCT03647501|467456642|FG000|Overall Study|Lost to Follow-up|1|||
129863312|NCT03647501|467456643|FG001|Overall Study|Lost to Follow-up|1|||
129863313|NCT03647501|467456642|FG000|Overall Study|Withdrawal by Subject|0|||
129863314|NCT03647501|467456643|FG001|Overall Study|Withdrawal by Subject|1|||
129863315|NCT04530448|467456644|FG000|Overall Study|Physician Decision|3|||
129863316|NCT04530448|467456645|FG001|Overall Study|Physician Decision|0|||
129863317|NCT01433354|467456648|FG000|Overall Study|Adverse Event|6|||
129863318|NCT01433354|467456648|FG000|Overall Study|Lost to Follow-up|1|||
129863319|NCT01433354|467456648|FG000|Overall Study|Administrative problems|90|||
129863320|NCT01433354|467456648|FG000|Overall Study|Protocol Violation|2|||
129863321|NCT01433354|467456648|FG000|Overall Study|Lack of Efficacy|17|||
129863322|NCT01433354|467456648|FG000|Overall Study|Subject Withdrew Consent|3|||
129863323|NCT01540851|467456652|FG000|Overall Study|Lost to Follow-up|14|||
129863324|NCT01540851|467456653|FG001|Overall Study|Lost to Follow-up|15|||
129863325|NCT01540851|467456652|FG000|Overall Study|Withdrawal by Subject|7|||
129863326|NCT01540851|467456653|FG001|Overall Study|Withdrawal by Subject|3|||
129863327|NCT02013622|467456654|FG000|Overall Study|Lost to Follow-up|10|||
129863328|NCT02013622|467456654|FG000|Overall Study|Adverse Event|3|||
129863329|NCT02013622|467456654|FG000|Overall Study|Met Withdrawal Criteria|3|||
129863330|NCT02013622|467456654|FG000|Overall Study|Withdrawal by Subject|6|||
129863331|NCT02013622|467456654|FG000|Overall Study|Protocol Deviation|1|||
129863332|NCT02013622|467456654|FG000|Overall Study|Lack of Efficacy|1|||
129863333|NCT04307004|467456662|FG000|Randomization 1|Withdrawal by Subject|25|||
129863334|NCT04307004|467456663|FG001|Randomization 1|Withdrawal by Subject|26|||
129863335|NCT04307004|467456664|FG002|Randomization 1|Withdrawal by Subject|0|||
129863336|NCT04307004|467456665|FG003|Randomization 1|Withdrawal by Subject|0|||
129863337|NCT04307004|467456662|FG000|Randomization 2|Withdrawal by Subject|0|||
129863338|NCT04307004|467456663|FG001|Randomization 2|Withdrawal by Subject|0|||
129863339|NCT04307004|467456664|FG002|Randomization 2|Withdrawal by Subject|28|||
129863340|NCT04307004|467456665|FG003|Randomization 2|Withdrawal by Subject|23|||
129863341|NCT01324271|467456666|FG000|Overall Study|Lost to Follow-up|3|||
129863342|NCT01324271|467456667|FG001|Overall Study|Lost to Follow-up|0|||
129863343|NCT01324271|467456666|FG000|Overall Study|Physician Decision|1|||
129863344|NCT01324271|467456667|FG001|Overall Study|Physician Decision|0|||
129863345|NCT05130970|467456668|FG000|Overall Study|Adverse Event|1|||
129863346|NCT05130970|467456669|FG001|Overall Study|Adverse Event|1|||
129912856|NCT04600752|467642603|FG000|Overall Study|Lack of Efficacy|1|||
130064928|NCT01093755|468192294|FG000|Overall Study|Withdrawal by Subject|3|||
130064929|NCT01093755|468192295|FG001|Overall Study|Withdrawal by Subject|4|||
130064930|NCT00868166|468192296|FG000|Overall Study|Death|58|||
129863347|NCT05130970|467456668|FG000|Overall Study|Death|0|||
129863348|NCT05130970|467456669|FG001|Overall Study|Death|1|||
129863349|NCT05130970|467456668|FG000|Overall Study|Lost to Follow-up|0|||
129863350|NCT05130970|467456669|FG001|Overall Study|Lost to Follow-up|1|||
129863351|NCT05130970|467456668|FG000|Overall Study|Physician Decision|0|||
129863352|NCT05130970|467456669|FG001|Overall Study|Physician Decision|1|||
129863353|NCT05130970|467456668|FG000|Overall Study|Withdrawal by Subject|1|||
129863354|NCT05130970|467456669|FG001|Overall Study|Withdrawal by Subject|1|||
129863355|NCT03996473|467456670|FG000|Treatment Assignment|Withdrawal by Subject|1|||
129863356|NCT03996473|467456670|FG000|Treatment Assignment|Progressive disease|6|||
129863357|NCT03996473|467456670|FG000|Treatment Assignment|Study drug never administered|1|||
129863358|NCT03996473|467456670|FG000|Active Follow-up|Death|1|||
129863359|NCT03996473|467456670|FG000|Long-term Follow-up|Death|5|||
129863360|NCT06116591|467456671|FG000|Overall Study|No longer met eligibility criteria|0|||
130064931|NCT00868166|468192297|FG001|Overall Study|Death|65|||
130064932|NCT00868166|468192296|FG000|Overall Study|Withdrawal by Subject|33|||
129912857|NCT04600752|467642604|FG001|Overall Study|Lack of Efficacy|0|||
129912858|NCT04600752|467642605|FG002|Overall Study|Lack of Efficacy|0|||
129912859|NCT02374307|467642606|FG000|3-months Follow-up|Lost to Follow-up|1|||
129912860|NCT02374307|467642607|FG001|3-months Follow-up|Lost to Follow-up|2|||
129912861|NCT02374307|467642606|FG000|3-months Follow-up|Withdrawal by Subject|1|||
129912862|NCT02374307|467642607|FG001|3-months Follow-up|Withdrawal by Subject|4|||
129912863|NCT02374307|467642606|FG000|3-months Follow-up|Death|1|||
129912864|NCT02374307|467642607|FG001|3-months Follow-up|Death|2|||
129912865|NCT02374307|467642606|FG000|3-months Follow-up|Missed first follow-up|5|||
129912866|NCT02374307|467642607|FG001|3-months Follow-up|Missed first follow-up|1|||
129912867|NCT02374307|467642606|FG000|6-months Follow-up|Lost to Follow-up|1|||
129912868|NCT02374307|467642607|FG001|6-months Follow-up|Lost to Follow-up|2|||
129912869|NCT02374307|467642606|FG000|6-months Follow-up|Death|2|||
129912870|NCT02374307|467642607|FG001|6-months Follow-up|Death|1|||
129912871|NCT02374307|467642606|FG000|6-months Follow-up|Withdrawal by Subject|0|||
129912872|NCT02374307|467642607|FG001|6-months Follow-up|Withdrawal by Subject|3|||
129912873|NCT00087139|467642613|FG000|Overall Study|Adverse Event|18|||
129912874|NCT00087139|467642614|FG001|Overall Study|Adverse Event|17|||
129912875|NCT00087139|467642615|FG002|Overall Study|Adverse Event|13|||
129912876|NCT00087139|467642613|FG000|Overall Study|Death|2|||
129912877|NCT00087139|467642614|FG001|Overall Study|Death|1|||
129912878|NCT00087139|467642615|FG002|Overall Study|Death|0|||
129912879|NCT00087139|467642613|FG000|Overall Study|Withdrawal by Subject|3|||
129912880|NCT00087139|467642614|FG001|Overall Study|Withdrawal by Subject|2|||
129912881|NCT00087139|467642615|FG002|Overall Study|Withdrawal by Subject|2|||
129912882|NCT00087139|467642613|FG000|Overall Study|Physician Decision|1|||
129912883|NCT00087139|467642614|FG001|Overall Study|Physician Decision|1|||
129912884|NCT00087139|467642615|FG002|Overall Study|Physician Decision|1|||
129912885|NCT00087139|467642613|FG000|Overall Study|Disease progression|9|||
129912886|NCT00087139|467642614|FG001|Overall Study|Disease progression|19|||
129912887|NCT00087139|467642615|FG002|Overall Study|Disease progression|12|||
130064933|NCT00868166|468192297|FG001|Overall Study|Withdrawal by Subject|25|||
130064934|NCT00868166|468192296|FG000|Overall Study|Protocol Violation|1|||
129912888|NCT00087139|467642613|FG000|Overall Study|Ineligible|4|||
129912889|NCT00087139|467642614|FG001|Overall Study|Ineligible|7|||
129912890|NCT00087139|467642615|FG002|Overall Study|Ineligible|4|||
129912891|NCT00087139|467642613|FG000|Overall Study|Symptomatic deterioration|1|||
129912892|NCT00087139|467642614|FG001|Overall Study|Symptomatic deterioration|1|||
129912893|NCT00087139|467642615|FG002|Overall Study|Symptomatic deterioration|3|||
129912894|NCT00087139|467642613|FG000|Overall Study|Use of coumadin|1|||
129912895|NCT00087139|467642614|FG001|Overall Study|Use of coumadin|0|||
129912896|NCT00087139|467642615|FG002|Overall Study|Use of coumadin|0|||
129912897|NCT00087139|467642613|FG000|Overall Study|Response achieved|0|||
129912898|NCT00087139|467642614|FG001|Overall Study|Response achieved|1|||
129912899|NCT00087139|467642615|FG002|Overall Study|Response achieved|0|||
129912900|NCT00087139|467642613|FG000|Overall Study|Extradural disease|0|||
129912901|NCT00087139|467642614|FG001|Overall Study|Extradural disease|0|||
129912902|NCT00087139|467642615|FG002|Overall Study|Extradural disease|1|||
129912903|NCT00065260|467642618|FG000|Overall Study|Death|0|||
129912904|NCT00065260|467642619|FG001|Overall Study|Death|1|||
129912905|NCT00001277|467642620|FG000|Overall Study|Adverse Event|0|||
129912906|NCT00001277|467642621|FG001|Overall Study|Adverse Event|0|||
129912907|NCT00001277|467642622|FG002|Overall Study|Adverse Event|1|||
129912908|NCT00001277|467642620|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
129912909|NCT00001277|467642621|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
129912910|NCT00001277|467642622|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
129912911|NCT03101371|467642625|FG000|Overall Study|Physician Decision|0|||
129912912|NCT03101371|467642626|FG001|Overall Study|Physician Decision|1|||
129912913|NCT03101371|467642625|FG000|Overall Study|Lost to Follow-up|1|||
129912914|NCT03101371|467642626|FG001|Overall Study|Lost to Follow-up|4|||
129912915|NCT03101371|467642625|FG000|Overall Study|Did not meet eligibility criteria|2|||
129912916|NCT03101371|467642626|FG001|Overall Study|Did not meet eligibility criteria|1|||
129912917|NCT04019444|467642628|FG000|Overall Study|Withdrawal by Subject|0|||
129912918|NCT04019444|467642629|FG001|Overall Study|Withdrawal by Subject|1|||
129912919|NCT04019444|467642630|FG002|Overall Study|Withdrawal by Subject|0|||
129912920|NCT04019444|467642631|FG003|Overall Study|Withdrawal by Subject|1|||
129912921|NCT04019444|467642628|FG000|Overall Study|Solicited Event|0|||
130064935|NCT00868166|468192297|FG001|Overall Study|Protocol Violation|0|||
129912922|NCT04019444|467642629|FG001|Overall Study|Solicited Event|0|||
129912923|NCT04019444|467642630|FG002|Overall Study|Solicited Event|2|||
129912924|NCT04019444|467642631|FG003|Overall Study|Solicited Event|0|||
129912925|NCT01303445|467642643|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
129912926|NCT01303445|467642644|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
129912927|NCT01303445|467642643|FG000|Second Intervention (7 Days)|Adverse Event|0|||
129912928|NCT01303445|467642644|FG001|Second Intervention (7 Days)|Adverse Event|2|||
129912929|NCT01303445|467642643|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
129912930|NCT01303445|467642644|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
130064936|NCT00868166|468192296|FG000|Overall Study|Lost to Follow-up|1|||
129912931|NCT01303445|467642643|FG000|Washout (14 Days)|Protocol Violation|1|||
129912932|NCT01303445|467642644|FG001|Washout (14 Days)|Protocol Violation|0|||
129912933|NCT01303445|467642643|FG000|Washout (14 Days)|Lost to Follow-up|0|||
129912934|NCT01303445|467642644|FG001|Washout (14 Days)|Lost to Follow-up|2|||
129912935|NCT01303445|467642643|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
129912936|NCT01303445|467642644|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
129912937|NCT01303445|467642643|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
129912938|NCT01303445|467642644|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
129912939|NCT03481660|467644345|FG000|Overall Study|Adverse Event|5|||
129912940|NCT03481660|467644346|FG001|Overall Study|Adverse Event|4|||
129912941|NCT03481660|467644345|FG000|Overall Study|Death|13|||
129912942|NCT03481660|467644346|FG001|Overall Study|Death|9|||
129912943|NCT03481660|467644345|FG000|Overall Study|Lost to Follow-up|2|||
129912944|NCT03481660|467644346|FG001|Overall Study|Lost to Follow-up|2|||
129912945|NCT03481660|467644345|FG000|Overall Study|Physician Decision|2|||
129912946|NCT03481660|467644346|FG001|Overall Study|Physician Decision|3|||
129912947|NCT03481660|467644345|FG000|Overall Study|Withdrawal by Subject|14|||
129912948|NCT03481660|467644346|FG001|Overall Study|Withdrawal by Subject|7|||
129912949|NCT03398148|467644347|FG000|Substudy 1 Period 1|Adverse Event|5|||
129912950|NCT03398148|467644348|FG001|Substudy 1 Period 1|Adverse Event|2|||
129912951|NCT03398148|467644349|FG002|Substudy 1 Period 1|Adverse Event|2|||
129912952|NCT03398148|467644350|FG003|Substudy 1 Period 1|Adverse Event|0|||
129912953|NCT03398148|467644351|FG004|Substudy 1 Period 1|Adverse Event|8|||
129912954|NCT03398148|467644352|FG005|Substudy 1 Period 1|Adverse Event|0|||
129912955|NCT03398148|467644353|FG006|Substudy 1 Period 1|Adverse Event|0|||
129912956|NCT03398148|467644354|FG007|Substudy 1 Period 1|Adverse Event|0|||
129912957|NCT03398148|467644355|FG008|Substudy 1 Period 1|Adverse Event|0|||
129912958|NCT03398148|467644356|FG009|Substudy 1 Period 1|Adverse Event|0|||
129912959|NCT03398148|467644357|FG010|Substudy 1 Period 1|Adverse Event|0|||
129912960|NCT03398148|467644358|FG011|Substudy 1 Period 1|Adverse Event|0|||
129912961|NCT03398148|467644359|FG012|Substudy 1 Period 1|Adverse Event|0|||
129912962|NCT03398148|467644360|FG013|Substudy 1 Period 1|Adverse Event|0|||
129912963|NCT03398148|467644361|FG014|Substudy 1 Period 1|Adverse Event|0|||
129912964|NCT03398148|467644347|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
129912965|NCT03398148|467644348|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
129912966|NCT03398148|467644349|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912967|NCT03398148|467644350|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
129912968|NCT03398148|467644351|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
129912969|NCT03398148|467644352|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912970|NCT03398148|467644353|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912971|NCT03398148|467644354|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912972|NCT03398148|467644355|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912973|NCT03398148|467644356|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912974|NCT03398148|467644357|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912975|NCT03398148|467644358|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912976|NCT03398148|467644359|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912977|NCT03398148|467644360|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912978|NCT03398148|467644361|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912979|NCT03398148|467644347|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
129912980|NCT03398148|467644348|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
129912981|NCT03398148|467644349|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
129912982|NCT03398148|467644350|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
129912983|NCT03398148|467644351|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
129912984|NCT03398148|467644352|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
129912985|NCT03398148|467644353|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
129912986|NCT03398148|467644354|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
129912987|NCT03398148|467644355|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
129912988|NCT03398148|467644356|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
129912989|NCT03398148|467644357|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
129912990|NCT03398148|467644358|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
129912991|NCT03398148|467644359|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
129912992|NCT03398148|467644360|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
129912993|NCT03398148|467644361|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
129912994|NCT03398148|467644347|FG000|Substudy 1 Period 1|Other|0|||
129912995|NCT03398148|467644348|FG001|Substudy 1 Period 1|Other|1|||
129912996|NCT03398148|467644349|FG002|Substudy 1 Period 1|Other|0|||
129912997|NCT03398148|467644350|FG003|Substudy 1 Period 1|Other|0|||
129912998|NCT03398148|467644351|FG004|Substudy 1 Period 1|Other|3|||
129912999|NCT03398148|467644352|FG005|Substudy 1 Period 1|Other|0|||
130116663|NCT00585351|468387149|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
129913000|NCT03398148|467644353|FG006|Substudy 1 Period 1|Other|0|||
129913001|NCT03398148|467644354|FG007|Substudy 1 Period 1|Other|0|||
129913002|NCT03398148|467644355|FG008|Substudy 1 Period 1|Other|0|||
129913003|NCT03398148|467644356|FG009|Substudy 1 Period 1|Other|0|||
129913004|NCT03398148|467644357|FG010|Substudy 1 Period 1|Other|0|||
129913005|NCT03398148|467644358|FG011|Substudy 1 Period 1|Other|0|||
129913006|NCT03398148|467644359|FG012|Substudy 1 Period 1|Other|0|||
129913007|NCT03398148|467644360|FG013|Substudy 1 Period 1|Other|0|||
129913008|NCT03398148|467644361|FG014|Substudy 1 Period 1|Other|0|||
129913009|NCT03398148|467644347|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913010|NCT03398148|467644348|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913011|NCT03398148|467644349|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913012|NCT03398148|467644350|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913013|NCT03398148|467644351|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
129913014|NCT03398148|467644352|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913015|NCT03398148|467644353|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913016|NCT03398148|467644354|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913017|NCT03398148|467644355|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913018|NCT03398148|467644356|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913019|NCT03398148|467644357|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913020|NCT03398148|467644358|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913021|NCT03398148|467644359|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913022|NCT03398148|467644360|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913023|NCT03398148|467644361|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913024|NCT03398148|467644347|FG000|Substudy 1 Period 2|Adverse Event|0|||
129913025|NCT03398148|467644348|FG001|Substudy 1 Period 2|Adverse Event|0|||
129913026|NCT03398148|467644349|FG002|Substudy 1 Period 2|Adverse Event|0|||
129913027|NCT03398148|467644350|FG003|Substudy 1 Period 2|Adverse Event|0|||
129913028|NCT03398148|467644351|FG004|Substudy 1 Period 2|Adverse Event|0|||
129913029|NCT03398148|467644352|FG005|Substudy 1 Period 2|Adverse Event|2|||
129913030|NCT03398148|467644353|FG006|Substudy 1 Period 2|Adverse Event|4|||
129913031|NCT03398148|467644354|FG007|Substudy 1 Period 2|Adverse Event|0|||
129913032|NCT03398148|467644355|FG008|Substudy 1 Period 2|Adverse Event|0|||
129913033|NCT03398148|467644356|FG009|Substudy 1 Period 2|Adverse Event|0|||
129913034|NCT03398148|467644357|FG010|Substudy 1 Period 2|Adverse Event|0|||
129913035|NCT03398148|467644358|FG011|Substudy 1 Period 2|Adverse Event|0|||
129913036|NCT03398148|467644359|FG012|Substudy 1 Period 2|Adverse Event|0|||
129913037|NCT03398148|467644360|FG013|Substudy 1 Period 2|Adverse Event|0|||
129913038|NCT03398148|467644361|FG014|Substudy 1 Period 2|Adverse Event|0|||
129913039|NCT03398148|467644347|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913040|NCT03398148|467644348|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913041|NCT03398148|467644349|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913042|NCT03398148|467644350|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913043|NCT03398148|467644351|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913044|NCT03398148|467644352|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913045|NCT03398148|467644353|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
129913046|NCT03398148|467644354|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
129913047|NCT03398148|467644355|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913048|NCT03398148|467644356|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913049|NCT03398148|467644357|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913050|NCT03398148|467644358|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913051|NCT03398148|467644359|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913052|NCT03398148|467644360|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913053|NCT03398148|467644361|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913054|NCT03398148|467644347|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
129913055|NCT03398148|467644348|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
129913056|NCT03398148|467644349|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
129913057|NCT03398148|467644350|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
129913058|NCT03398148|467644351|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
129913059|NCT03398148|467644352|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
129913060|NCT03398148|467644353|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
129913061|NCT03398148|467644354|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
129913062|NCT03398148|467644355|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
129913063|NCT03398148|467644356|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
129913064|NCT03398148|467644357|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
129913065|NCT03398148|467644358|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
129913066|NCT03398148|467644359|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
129913067|NCT03398148|467644360|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
129913068|NCT03398148|467644361|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
129913069|NCT03398148|467644347|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913070|NCT03398148|467644348|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913071|NCT03398148|467644349|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913072|NCT03398148|467644350|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913073|NCT03398148|467644351|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913074|NCT03398148|467644352|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913075|NCT03398148|467644353|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
129913076|NCT03398148|467644354|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913077|NCT03398148|467644355|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913078|NCT03398148|467644356|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913079|NCT03398148|467644357|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913080|NCT03398148|467644358|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
130064937|NCT00868166|468192297|FG001|Overall Study|Lost to Follow-up|3|||
129913081|NCT03398148|467644359|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913082|NCT03398148|467644360|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913083|NCT03398148|467644361|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913084|NCT03398148|467644347|FG000|Substudy 1 Period 2|Other|0|||
129913085|NCT03398148|467644348|FG001|Substudy 1 Period 2|Other|0|||
129913086|NCT03398148|467644349|FG002|Substudy 1 Period 2|Other|0|||
129913087|NCT03398148|467644350|FG003|Substudy 1 Period 2|Other|0|||
129913088|NCT03398148|467644351|FG004|Substudy 1 Period 2|Other|0|||
129913089|NCT03398148|467644352|FG005|Substudy 1 Period 2|Other|0|||
129913090|NCT03398148|467644353|FG006|Substudy 1 Period 2|Other|1|||
129913091|NCT03398148|467644354|FG007|Substudy 1 Period 2|Other|0|||
129913092|NCT03398148|467644355|FG008|Substudy 1 Period 2|Other|0|||
129913093|NCT03398148|467644356|FG009|Substudy 1 Period 2|Other|0|||
129913094|NCT03398148|467644357|FG010|Substudy 1 Period 2|Other|0|||
129913095|NCT03398148|467644358|FG011|Substudy 1 Period 2|Other|0|||
129913096|NCT03398148|467644359|FG012|Substudy 1 Period 2|Other|0|||
129913097|NCT03398148|467644360|FG013|Substudy 1 Period 2|Other|0|||
129913098|NCT03398148|467644361|FG014|Substudy 1 Period 2|Other|0|||
129913099|NCT03398148|467644347|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913100|NCT03398148|467644348|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913101|NCT03398148|467644349|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913102|NCT03398148|467644350|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913103|NCT03398148|467644351|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913104|NCT03398148|467644352|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913105|NCT03398148|467644353|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
129913106|NCT03398148|467644354|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913107|NCT03398148|467644355|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913108|NCT03398148|467644356|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913109|NCT03398148|467644357|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913110|NCT03398148|467644358|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913111|NCT03398148|467644359|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913112|NCT03398148|467644360|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913113|NCT03398148|467644361|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913114|NCT03398148|467644347|FG000|Substudy 2 Period 1|Adverse Event|0|||
129913115|NCT03398148|467644348|FG001|Substudy 2 Period 1|Adverse Event|0|||
129913116|NCT03398148|467644349|FG002|Substudy 2 Period 1|Adverse Event|0|||
129913117|NCT03398148|467644350|FG003|Substudy 2 Period 1|Adverse Event|0|||
129913118|NCT03398148|467644351|FG004|Substudy 2 Period 1|Adverse Event|0|||
129913119|NCT03398148|467644352|FG005|Substudy 2 Period 1|Adverse Event|0|||
129913120|NCT03398148|467644353|FG006|Substudy 2 Period 1|Adverse Event|0|||
129913121|NCT03398148|467644354|FG007|Substudy 2 Period 1|Adverse Event|0|||
129913122|NCT03398148|467644355|FG008|Substudy 2 Period 1|Adverse Event|0|||
129913123|NCT03398148|467644356|FG009|Substudy 2 Period 1|Adverse Event|12|||
129913124|NCT03398148|467644357|FG010|Substudy 2 Period 1|Adverse Event|2|||
129913125|NCT03398148|467644358|FG011|Substudy 2 Period 1|Adverse Event|0|||
129913126|NCT03398148|467644359|FG012|Substudy 2 Period 1|Adverse Event|0|||
129913127|NCT03398148|467644360|FG013|Substudy 2 Period 1|Adverse Event|0|||
129913128|NCT03398148|467644361|FG014|Substudy 2 Period 1|Adverse Event|0|||
129913129|NCT03398148|467644347|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913130|NCT03398148|467644348|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913131|NCT03398148|467644349|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913132|NCT03398148|467644350|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913133|NCT03398148|467644351|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913134|NCT03398148|467644352|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913135|NCT03398148|467644353|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913136|NCT03398148|467644354|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913137|NCT03398148|467644355|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913138|NCT03398148|467644356|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
129913139|NCT03398148|467644357|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
129913140|NCT03398148|467644358|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913141|NCT03398148|467644359|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913142|NCT03398148|467644360|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913143|NCT03398148|467644361|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913144|NCT03398148|467644347|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
129913145|NCT03398148|467644348|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
129913146|NCT03398148|467644349|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
129913147|NCT03398148|467644350|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
129913148|NCT03398148|467644351|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
129913149|NCT03398148|467644352|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
129913150|NCT03398148|467644353|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
129913151|NCT03398148|467644354|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
129913152|NCT03398148|467644355|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
129913153|NCT03398148|467644356|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
129913154|NCT03398148|467644357|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
129913155|NCT03398148|467644358|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
129913156|NCT03398148|467644359|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
129913157|NCT03398148|467644360|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
130064938|NCT00868166|468192296|FG000|Overall Study|Adverse Event|9|||
130064939|NCT00868166|468192297|FG001|Overall Study|Adverse Event|10|||
130064940|NCT00868166|468192296|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
130064941|NCT00868166|468192297|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
130064942|NCT00868166|468192296|FG000|Overall Study|Non-compliance with IMP|1|||
130064943|NCT00868166|468192297|FG001|Overall Study|Non-compliance with IMP|1|||
130064944|NCT01231607|468192307|FG000|Overall Study|Adverse Event|0|||
130064945|NCT01231607|468192308|FG001|Overall Study|Adverse Event|8|||
130064946|NCT01231607|468192309|FG002|Overall Study|Adverse Event|4|||
130064947|NCT01231607|468192310|FG003|Overall Study|Adverse Event|4|||
130116664|NCT00585351|468387150|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
129863361|NCT06116591|467456672|FG001|Overall Study|No longer met eligibility criteria|1|||
129863362|NCT06116591|467456671|FG000|Overall Study|Other: Change in life situation|0|||
129863363|NCT06116591|467456672|FG001|Overall Study|Other: Change in life situation|1|||
129863364|NCT01381692|467456673|FG000|Overall Study|Adverse Event|1|||
129863365|NCT01381692|467456674|FG001|Overall Study|Adverse Event|0|||
129863366|NCT01381692|467456675|FG002|Overall Study|Adverse Event|0|||
129863367|NCT01381692|467456676|FG003|Overall Study|Adverse Event|0|||
129863368|NCT01381692|467456677|FG004|Overall Study|Adverse Event|0|||
129863369|NCT01381692|467456678|FG005|Overall Study|Adverse Event|0|||
129863370|NCT01270347|467456679|FG000|Core Phase|Adverse Event|1|||
129863371|NCT01270347|467456680|FG001|Core Phase|Adverse Event|6|||
129863372|NCT01270347|467456679|FG000|Core Phase|Withdrawal by Subject|1|||
129863373|NCT01270347|467456680|FG001|Core Phase|Withdrawal by Subject|2|||
129863374|NCT01270347|467456679|FG000|Core Phase|Lost to Follow-up|0|||
129863375|NCT01270347|467456680|FG001|Core Phase|Lost to Follow-up|1|||
129863376|NCT01270347|467456679|FG000|Core Phase|Miscellaneous|8|||
129863377|NCT01270347|467456680|FG001|Core Phase|Miscellaneous|14|||
129863378|NCT01270347|467456679|FG000|Extension Phase|Adverse Event|1|||
129863379|NCT01270347|467456680|FG001|Extension Phase|Adverse Event|3|||
129863380|NCT01270347|467456679|FG000|Extension Phase|Withdrawal by Subject|3|||
129863381|NCT01270347|467456680|FG001|Extension Phase|Withdrawal by Subject|4|||
129863382|NCT01270347|467456679|FG000|Extension Phase|Miscellaneous|2|||
129863383|NCT01270347|467456680|FG001|Extension Phase|Miscellaneous|2|||
129863384|NCT02189798|467456681|FG000|Extended Use Phase|Withdrawal by Subject|0|||
129863385|NCT02189798|467456682|FG001|Extended Use Phase|Withdrawal by Subject|4|||
129863386|NCT02189798|467456681|FG000|Extended Use Phase|Physician Decision|1|||
129863387|NCT02189798|467456682|FG001|Extended Use Phase|Physician Decision|0|||
129863388|NCT02189798|467456681|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
129863389|NCT02189798|467456682|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
129863390|NCT02189798|467456681|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
129863391|NCT02189798|467456682|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
129863392|NCT02189798|467456681|FG000|Extended Use Phase|Travel Issues|2|||
129863393|NCT02189798|467456682|FG001|Extended Use Phase|Travel Issues|1|||
129863394|NCT02189798|467456681|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
129863395|NCT02189798|467456682|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
129863396|NCT02273141|467456683|FG000|Overall Study|Adverse Event|0|||
129863397|NCT02273141|467456684|FG001|Overall Study|Adverse Event|1|||
129863398|NCT02273141|467456683|FG000|Overall Study|Lost to Follow-up|1|||
129863399|NCT02273141|467456684|FG001|Overall Study|Lost to Follow-up|3|||
129863400|NCT02273141|467456683|FG000|Overall Study|Withdrawal by Subject|10|||
129863401|NCT02273141|467456684|FG001|Overall Study|Withdrawal by Subject|15|||
129863402|NCT02273141|467456683|FG000|Overall Study|Various|6|||
129863403|NCT02273141|467456684|FG001|Overall Study|Various|6|||
129863404|NCT00529399|467456685|FG000|Overall Study|Lost to Follow-up|1|||
129863405|NCT00529399|467456686|FG001|Overall Study|Lost to Follow-up|0|||
129863406|NCT00529399|467456687|FG002|Overall Study|Lost to Follow-up|1|||
129863407|NCT00529399|467456685|FG000|Overall Study|Withdrawal by Subject|1|||
129863408|NCT00529399|467456686|FG001|Overall Study|Withdrawal by Subject|0|||
129863409|NCT00529399|467456687|FG002|Overall Study|Withdrawal by Subject|1|||
129863410|NCT00529399|467456685|FG000|Overall Study|Non-compliant|0|||
129863411|NCT00529399|467456686|FG001|Overall Study|Non-compliant|1|||
129863412|NCT00529399|467456687|FG002|Overall Study|Non-compliant|0|||
129863413|NCT04313881|467456692|FG000|Overall Study|Death|138|||
129863414|NCT04313881|467456693|FG001|Overall Study|Death|126|||
129863415|NCT04313881|467456692|FG000|Overall Study|Study terminated by sponsor|108|||
129863416|NCT04313881|467456693|FG001|Overall Study|Study terminated by sponsor|129|||
129863417|NCT04313881|467456692|FG000|Overall Study|Consent withdrawn|19|||
129863418|NCT04313881|467456693|FG001|Overall Study|Consent withdrawn|15|||
129863419|NCT04313881|467456692|FG000|Overall Study|Reason not Specified|3|||
129863420|NCT04313881|467456693|FG001|Overall Study|Reason not Specified|1|||
129863421|NCT01572727|467456694|FG000|Overall Study|Adverse Event|43|||
129863422|NCT01572727|467456695|FG001|Overall Study|Adverse Event|15|||
129863423|NCT01572727|467456694|FG000|Overall Study|Lost to Follow-up|1|||
129863424|NCT01572727|467456695|FG001|Overall Study|Lost to Follow-up|1|||
130064948|NCT01231607|468192311|FG004|Overall Study|Adverse Event|5|||
130064949|NCT01231607|468192307|FG000|Overall Study|Lost to Follow-up|13|||
130064950|NCT01231607|468192308|FG001|Overall Study|Lost to Follow-up|11|||
130064951|NCT01231607|468192309|FG002|Overall Study|Lost to Follow-up|10|||
130064952|NCT01231607|468192310|FG003|Overall Study|Lost to Follow-up|10|||
130064953|NCT01231607|468192311|FG004|Overall Study|Lost to Follow-up|4|||
130064954|NCT01231607|468192307|FG000|Overall Study|Physician Decision|4|||
130064955|NCT01231607|468192308|FG001|Overall Study|Physician Decision|4|||
129913158|NCT03398148|467644361|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
129913159|NCT03398148|467644347|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913160|NCT03398148|467644348|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913161|NCT03398148|467644349|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913162|NCT03398148|467644350|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913163|NCT03398148|467644351|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913164|NCT03398148|467644352|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913165|NCT03398148|467644353|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913166|NCT03398148|467644354|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913167|NCT03398148|467644355|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913168|NCT03398148|467644356|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913169|NCT03398148|467644357|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
129913170|NCT03398148|467644358|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913171|NCT03398148|467644359|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913172|NCT03398148|467644360|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913173|NCT03398148|467644361|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913174|NCT03398148|467644347|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913175|NCT03398148|467644348|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913176|NCT03398148|467644349|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913177|NCT03398148|467644350|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913178|NCT03398148|467644351|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913179|NCT03398148|467644352|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913180|NCT03398148|467644353|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913181|NCT03398148|467644354|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913182|NCT03398148|467644355|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913183|NCT03398148|467644356|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913184|NCT03398148|467644357|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
129913185|NCT03398148|467644358|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913186|NCT03398148|467644359|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913187|NCT03398148|467644360|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913188|NCT03398148|467644361|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913189|NCT03398148|467644347|FG000|Substudy 2 Period 1|Other|0|||
129913190|NCT03398148|467644348|FG001|Substudy 2 Period 1|Other|0|||
129913191|NCT03398148|467644349|FG002|Substudy 2 Period 1|Other|0|||
129913192|NCT03398148|467644350|FG003|Substudy 2 Period 1|Other|0|||
129913193|NCT03398148|467644351|FG004|Substudy 2 Period 1|Other|0|||
129913194|NCT03398148|467644352|FG005|Substudy 2 Period 1|Other|0|||
129913195|NCT03398148|467644353|FG006|Substudy 2 Period 1|Other|0|||
129913196|NCT03398148|467644354|FG007|Substudy 2 Period 1|Other|0|||
129913197|NCT03398148|467644355|FG008|Substudy 2 Period 1|Other|0|||
129913198|NCT03398148|467644356|FG009|Substudy 2 Period 1|Other|4|||
129913199|NCT03398148|467644357|FG010|Substudy 2 Period 1|Other|4|||
129913200|NCT03398148|467644358|FG011|Substudy 2 Period 1|Other|0|||
129913201|NCT03398148|467644359|FG012|Substudy 2 Period 1|Other|0|||
129913202|NCT03398148|467644360|FG013|Substudy 2 Period 1|Other|0|||
129913203|NCT03398148|467644361|FG014|Substudy 2 Period 1|Other|0|||
129913204|NCT03398148|467644347|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913205|NCT03398148|467644348|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913206|NCT03398148|467644349|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
130064956|NCT01231607|468192309|FG002|Overall Study|Physician Decision|3|||
129913207|NCT03398148|467644350|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913208|NCT03398148|467644351|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913209|NCT03398148|467644352|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913210|NCT03398148|467644353|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913211|NCT03398148|467644354|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
130064957|NCT01231607|468192310|FG003|Overall Study|Physician Decision|5|||
130064958|NCT01231607|468192311|FG004|Overall Study|Physician Decision|4|||
130064959|NCT01231607|468192307|FG000|Overall Study|Protocol Violation|3|||
129913212|NCT03398148|467644355|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913213|NCT03398148|467644356|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913214|NCT03398148|467644357|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
129913215|NCT03398148|467644358|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913216|NCT03398148|467644359|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913217|NCT03398148|467644360|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913218|NCT03398148|467644361|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913219|NCT03398148|467644347|FG000|Substudy 2 Period 2|Adverse Event|0|||
130064960|NCT01231607|468192308|FG001|Overall Study|Protocol Violation|2|||
130064961|NCT01231607|468192309|FG002|Overall Study|Protocol Violation|0|||
130064962|NCT01231607|468192310|FG003|Overall Study|Protocol Violation|2|||
130064963|NCT01231607|468192311|FG004|Overall Study|Protocol Violation|2|||
130064964|NCT01231607|468192307|FG000|Overall Study|Withdrawal by Subject|9|||
130064965|NCT01231607|468192308|FG001|Overall Study|Withdrawal by Subject|9|||
130064966|NCT01231607|468192309|FG002|Overall Study|Withdrawal by Subject|14|||
130064967|NCT01231607|468192310|FG003|Overall Study|Withdrawal by Subject|17|||
130064968|NCT01231607|468192311|FG004|Overall Study|Withdrawal by Subject|9|||
130064969|NCT02267278|468192312|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
130064970|NCT02267278|468192312|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
130064971|NCT02267278|468192312|FG000|Overall Study|Developed new cancer diagnoses|2|||
130064972|NCT02267278|468192312|FG000|Overall Study|prescribed prohibited medication|1|||
130064973|NCT00085917|468192320|FG000|Overall Study|Adverse Event|4|||
130064974|NCT00085917|468192321|FG001|Overall Study|Adverse Event|3|||
130064975|NCT01429077|468192322|FG000|Overall Study|Lost to Follow-up|0|||
130064976|NCT01429077|468192323|FG001|Overall Study|Lost to Follow-up|3|||
130064977|NCT03067129|468192325|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
130064978|NCT03067129|468192326|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
130064979|NCT03067129|468192327|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
130064980|NCT03067129|468192328|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
130064981|NCT03067129|468192325|FG000|Overall Study|Withdrawal by Subject|0|||
130064982|NCT03067129|468192326|FG001|Overall Study|Withdrawal by Subject|0|||
130064983|NCT03067129|468192327|FG002|Overall Study|Withdrawal by Subject|1|||
130064984|NCT03067129|468192328|FG003|Overall Study|Withdrawal by Subject|2|||
130064985|NCT03067129|468192325|FG000|Overall Study|Lost to Follow-up|5|||
130064986|NCT03067129|468192326|FG001|Overall Study|Lost to Follow-up|5|||
130064987|NCT03067129|468192327|FG002|Overall Study|Lost to Follow-up|4|||
130064988|NCT03067129|468192328|FG003|Overall Study|Lost to Follow-up|3|||
130064989|NCT03372603|468192329|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
130064990|NCT03372603|468192330|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
130064991|NCT03372603|468192329|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
130064992|NCT03372603|468192330|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
130064993|NCT02806947|468192331|FG000|Overall Study|Withdrawal by Subject|5|||
130064994|NCT02806947|468192332|FG001|Overall Study|Withdrawal by Subject|1|||
130064995|NCT02029638|468192334|FG000|Overall Study|Death|0|||
130064996|NCT02029638|468192335|FG001|Overall Study|Death|0|||
130064997|NCT02029638|468192336|FG002|Overall Study|Death|1|||
130064998|NCT02029638|468192334|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
130064999|NCT02029638|468192335|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
130065000|NCT02029638|468192336|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
130065001|NCT01153841|468192337|FG000|Overall Study|Adverse Event|1|||
130065002|NCT01153841|468192338|FG001|Overall Study|Adverse Event|0|||
129913220|NCT03398148|467644348|FG001|Substudy 2 Period 2|Adverse Event|0|||
129913221|NCT03398148|467644349|FG002|Substudy 2 Period 2|Adverse Event|0|||
129913222|NCT03398148|467644350|FG003|Substudy 2 Period 2|Adverse Event|0|||
129913223|NCT03398148|467644351|FG004|Substudy 2 Period 2|Adverse Event|0|||
129913224|NCT03398148|467644352|FG005|Substudy 2 Period 2|Adverse Event|0|||
129913225|NCT03398148|467644353|FG006|Substudy 2 Period 2|Adverse Event|0|||
129913226|NCT03398148|467644354|FG007|Substudy 2 Period 2|Adverse Event|0|||
129913227|NCT03398148|467644355|FG008|Substudy 2 Period 2|Adverse Event|0|||
129913228|NCT03398148|467644356|FG009|Substudy 2 Period 2|Adverse Event|0|||
129913229|NCT03398148|467644357|FG010|Substudy 2 Period 2|Adverse Event|0|||
129913230|NCT03398148|467644358|FG011|Substudy 2 Period 2|Adverse Event|0|||
130065003|NCT01153841|468192337|FG000|Overall Study|Withdrawal by Subject|1|||
130065004|NCT01153841|468192338|FG001|Overall Study|Withdrawal by Subject|0|||
130065005|NCT01153841|468192337|FG000|Overall Study|Protocol Violation|2|||
130065006|NCT01153841|468192338|FG001|Overall Study|Protocol Violation|0|||
130065007|NCT01153841|468192337|FG000|Overall Study|Lost to Follow-up|2|||
130065008|NCT01153841|468192338|FG001|Overall Study|Lost to Follow-up|0|||
130065009|NCT02563925|468192339|FG000|Overall Study|Withdrawal by Subject|2|||
130065010|NCT00400712|468192340|FG000|Overall Study|Death|1|||
130065011|NCT00400712|468192341|FG001|Overall Study|Death|0|||
130065012|NCT00400712|468192340|FG000|Overall Study|Withdrawal by Subject|11|||
130065013|NCT00400712|468192341|FG001|Overall Study|Withdrawal by Subject|12|||
130065014|NCT00400712|468192340|FG000|Overall Study|Physician Decision|5|||
130065015|NCT00400712|468192341|FG001|Overall Study|Physician Decision|4|||
130065016|NCT03956225|468192343|FG000|Overall Study|Lack of Efficacy|1|||
130065017|NCT03956225|468192344|FG001|Overall Study|Lack of Efficacy|1|||
130065018|NCT03956225|468192343|FG000|Overall Study|Lost to Follow-up|0|||
130065019|NCT03956225|468192344|FG001|Overall Study|Lost to Follow-up|1|||
130065020|NCT03956225|468192343|FG000|Overall Study|Withdrawal by Subject|2|||
130065021|NCT03956225|468192344|FG001|Overall Study|Withdrawal by Subject|1|||
130065022|NCT03956225|468192343|FG000|Overall Study|Other Reasons|2|||
130065023|NCT03956225|468192344|FG001|Overall Study|Other Reasons|1|||
130065024|NCT02260648|468192345|FG000|Overall Study|Adverse Event|3|||
129913231|NCT03398148|467644359|FG012|Substudy 2 Period 2|Adverse Event|0|||
129913232|NCT03398148|467644360|FG013|Substudy 2 Period 2|Adverse Event|1|||
130065025|NCT02260648|468192346|FG001|Overall Study|Adverse Event|0|||
129913233|NCT03398148|467644361|FG014|Substudy 2 Period 2|Adverse Event|3|||
129913234|NCT03398148|467644347|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
129913235|NCT03398148|467644348|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
129913236|NCT03398148|467644349|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
129913237|NCT03398148|467644350|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
129913238|NCT03398148|467644351|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
129913239|NCT03398148|467644352|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
129913240|NCT03398148|467644353|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
129913241|NCT03398148|467644354|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
129913242|NCT03398148|467644355|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
129913243|NCT03398148|467644356|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
129913244|NCT03398148|467644357|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
129913245|NCT03398148|467644358|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
129913246|NCT03398148|467644359|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
129913247|NCT03398148|467644360|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
129913248|NCT03398148|467644361|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
129913249|NCT03398148|467644347|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913250|NCT03398148|467644348|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913251|NCT03398148|467644349|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913252|NCT03398148|467644350|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913253|NCT03398148|467644351|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913254|NCT03398148|467644352|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913255|NCT03398148|467644353|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913256|NCT03398148|467644354|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913257|NCT03398148|467644355|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913258|NCT03398148|467644356|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913259|NCT03398148|467644357|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913260|NCT03398148|467644358|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
129913261|NCT03398148|467644359|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913262|NCT03398148|467644360|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
129913263|NCT03398148|467644361|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
129913264|NCT03398148|467644347|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
129913265|NCT03398148|467644348|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
129913266|NCT03398148|467644349|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
129913267|NCT03398148|467644350|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
129913268|NCT03398148|467644351|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
129913269|NCT03398148|467644352|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
129913270|NCT03398148|467644353|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
129913271|NCT03398148|467644354|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
129913272|NCT03398148|467644355|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
129913273|NCT03398148|467644356|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
129913274|NCT03398148|467644357|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
129913275|NCT03398148|467644358|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
129913276|NCT03398148|467644359|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
129913277|NCT03398148|467644360|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
129913278|NCT03398148|467644361|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
129913279|NCT03398148|467644347|FG000|Substudy 2 Period 2|Other|0|||
129913280|NCT03398148|467644348|FG001|Substudy 2 Period 2|Other|0|||
129913281|NCT03398148|467644349|FG002|Substudy 2 Period 2|Other|0|||
129913282|NCT03398148|467644350|FG003|Substudy 2 Period 2|Other|0|||
129913283|NCT03398148|467644351|FG004|Substudy 2 Period 2|Other|0|||
129913284|NCT03398148|467644352|FG005|Substudy 2 Period 2|Other|0|||
129913285|NCT03398148|467644353|FG006|Substudy 2 Period 2|Other|0|||
129913286|NCT03398148|467644354|FG007|Substudy 2 Period 2|Other|0|||
130065026|NCT02260648|468192347|FG002|Overall Study|Adverse Event|1|||
130065027|NCT02260648|468192345|FG000|Overall Study|Withdrawal by Subject|1|||
130065028|NCT02260648|468192346|FG001|Overall Study|Withdrawal by Subject|1|||
130065029|NCT02260648|468192347|FG002|Overall Study|Withdrawal by Subject|0|||
130065030|NCT02260648|468192345|FG000|Overall Study|Protocol Violation|1|||
129913287|NCT03398148|467644355|FG008|Substudy 2 Period 2|Other|0|||
129913288|NCT03398148|467644356|FG009|Substudy 2 Period 2|Other|0|||
129913289|NCT03398148|467644357|FG010|Substudy 2 Period 2|Other|0|||
129913290|NCT03398148|467644358|FG011|Substudy 2 Period 2|Other|0|||
129913291|NCT03398148|467644359|FG012|Substudy 2 Period 2|Other|0|||
129913292|NCT03398148|467644360|FG013|Substudy 2 Period 2|Other|1|||
129913293|NCT03398148|467644361|FG014|Substudy 2 Period 2|Other|1|||
129913294|NCT03398148|467644347|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913295|NCT03398148|467644348|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913296|NCT03398148|467644349|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913297|NCT03398148|467644350|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913298|NCT03398148|467644351|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913299|NCT03398148|467644352|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913300|NCT03398148|467644353|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
130065031|NCT02260648|468192346|FG001|Overall Study|Protocol Violation|0|||
130065032|NCT02260648|468192347|FG002|Overall Study|Protocol Violation|0|||
129913301|NCT03398148|467644354|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913302|NCT03398148|467644355|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
129863425|NCT01572727|467456694|FG000|Overall Study|Physician Decision|23|||
129863426|NCT01572727|467456695|FG001|Overall Study|Physician Decision|9|||
129863427|NCT01572727|467456694|FG000|Overall Study|Progressive disease|59|||
129863428|NCT01572727|467456695|FG001|Overall Study|Progressive disease|82|||
129863429|NCT01572727|467456694|FG000|Overall Study|Protocol Violation|0|||
129863430|NCT01572727|467456695|FG001|Overall Study|Protocol Violation|1|||
129863431|NCT01572727|467456694|FG000|Overall Study|Study terminated by sponsor|61|||
129863432|NCT01572727|467456695|FG001|Overall Study|Study terminated by sponsor|83|||
129863433|NCT01572727|467456694|FG000|Overall Study|Parent/guardian decision|14|||
129863434|NCT01572727|467456695|FG001|Overall Study|Parent/guardian decision|9|||
129863435|NCT01572727|467456694|FG000|Overall Study|Death|2|||
129863436|NCT01572727|467456695|FG001|Overall Study|Death|2|||
129863437|NCT01572727|467456694|FG000|Overall Study|Untreated|4|||
129863438|NCT01572727|467456695|FG001|Overall Study|Untreated|7|||
129863439|NCT02195986|467456698|FG000|Overall Study|Adverse Event|3|||
129863440|NCT02195986|467456699|FG001|Overall Study|Adverse Event|0|||
129863441|NCT02195986|467456700|FG002|Overall Study|Adverse Event|0|||
129863442|NCT02195986|467456698|FG000|Overall Study|Withdrawal by Subject|0|||
129863443|NCT02195986|467456699|FG001|Overall Study|Withdrawal by Subject|3|||
129863444|NCT02195986|467456700|FG002|Overall Study|Withdrawal by Subject|0|||
129863445|NCT02195986|467456698|FG000|Overall Study|Family Emergency|0|||
129863446|NCT02195986|467456699|FG001|Overall Study|Family Emergency|0|||
129863447|NCT02195986|467456700|FG002|Overall Study|Family Emergency|1|||
129863448|NCT02195986|467456698|FG000|Overall Study|Protocol Violation|0|||
129863449|NCT02195986|467456699|FG001|Overall Study|Protocol Violation|1|||
129863450|NCT02195986|467456700|FG002|Overall Study|Protocol Violation|1|||
129863451|NCT02195986|467456698|FG000|Overall Study|Non-compliance|0|||
129863452|NCT02195986|467456699|FG001|Overall Study|Non-compliance|1|||
129863453|NCT02195986|467456700|FG002|Overall Study|Non-compliance|0|||
129863454|NCT03449030|467456703|FG000|Overall Study|Withdrawal by Subject|0|||
129863455|NCT03449030|467456704|FG001|Overall Study|Withdrawal by Subject|0|||
129863456|NCT03449030|467456705|FG002|Overall Study|Withdrawal by Subject|0|||
129863457|NCT03449030|467456706|FG003|Overall Study|Withdrawal by Subject|1|||
129863458|NCT03449030|467456707|FG004|Overall Study|Withdrawal by Subject|1|||
129863459|NCT03449030|467456708|FG005|Overall Study|Withdrawal by Subject|1|||
129863460|NCT03449030|467456709|FG006|Overall Study|Withdrawal by Subject|1|||
129863461|NCT03449030|467456710|FG007|Overall Study|Withdrawal by Subject|2|||
129863462|NCT03449030|467456711|FG008|Overall Study|Withdrawal by Subject|0|||
129863463|NCT03449030|467456712|FG009|Overall Study|Withdrawal by Subject|0|||
129863464|NCT03449030|467456703|FG000|Overall Study|Symptomatic Deterioration|0|||
129863465|NCT03449030|467456704|FG001|Overall Study|Symptomatic Deterioration|1|||
129863466|NCT03449030|467456705|FG002|Overall Study|Symptomatic Deterioration|0|||
129863467|NCT03449030|467456706|FG003|Overall Study|Symptomatic Deterioration|0|||
129863468|NCT03449030|467456707|FG004|Overall Study|Symptomatic Deterioration|0|||
129863469|NCT03449030|467456708|FG005|Overall Study|Symptomatic Deterioration|1|||
129863470|NCT03449030|467456709|FG006|Overall Study|Symptomatic Deterioration|1|||
129863471|NCT03449030|467456710|FG007|Overall Study|Symptomatic Deterioration|0|||
129863472|NCT03449030|467456711|FG008|Overall Study|Symptomatic Deterioration|2|||
129863473|NCT03449030|467456712|FG009|Overall Study|Symptomatic Deterioration|0|||
129863474|NCT03449030|467456703|FG000|Overall Study|Progressive Disease|1|||
129863475|NCT03449030|467456704|FG001|Overall Study|Progressive Disease|0|||
129863476|NCT03449030|467456705|FG002|Overall Study|Progressive Disease|1|||
129863477|NCT03449030|467456706|FG003|Overall Study|Progressive Disease|4|||
129863478|NCT03449030|467456707|FG004|Overall Study|Progressive Disease|5|||
129863479|NCT03449030|467456708|FG005|Overall Study|Progressive Disease|3|||
129863480|NCT03449030|467456709|FG006|Overall Study|Progressive Disease|0|||
129863481|NCT03449030|467456710|FG007|Overall Study|Progressive Disease|1|||
129863482|NCT03449030|467456711|FG008|Overall Study|Progressive Disease|1|||
129863483|NCT03449030|467456712|FG009|Overall Study|Progressive Disease|1|||
129863484|NCT03449030|467456703|FG000|Overall Study|Adverse Event|0|||
129863485|NCT03449030|467456704|FG001|Overall Study|Adverse Event|0|||
129863486|NCT03449030|467456705|FG002|Overall Study|Adverse Event|0|||
129863487|NCT03449030|467456706|FG003|Overall Study|Adverse Event|0|||
129863488|NCT03449030|467456707|FG004|Overall Study|Adverse Event|0|||
129863489|NCT03449030|467456708|FG005|Overall Study|Adverse Event|2|||
129863490|NCT03449030|467456709|FG006|Overall Study|Adverse Event|0|||
129863491|NCT03449030|467456710|FG007|Overall Study|Adverse Event|0|||
129863492|NCT03449030|467456711|FG008|Overall Study|Adverse Event|0|||
129863493|NCT03449030|467456712|FG009|Overall Study|Adverse Event|0|||
129863494|NCT03449030|467456703|FG000|Overall Study|Death|0|||
129863495|NCT03449030|467456704|FG001|Overall Study|Death|0|||
129863496|NCT03449030|467456705|FG002|Overall Study|Death|0|||
129913303|NCT03398148|467644356|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
129863497|NCT03449030|467456706|FG003|Overall Study|Death|0|||
129863498|NCT03449030|467456707|FG004|Overall Study|Death|1|||
129863499|NCT03449030|467456708|FG005|Overall Study|Death|0|||
129863500|NCT03449030|467456709|FG006|Overall Study|Death|0|||
129863501|NCT03449030|467456710|FG007|Overall Study|Death|0|||
129863502|NCT03449030|467456711|FG008|Overall Study|Death|0|||
129863503|NCT03449030|467456712|FG009|Overall Study|Death|0|||
129913304|NCT03398148|467644357|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913305|NCT03398148|467644358|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913306|NCT03398148|467644359|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
129913307|NCT03398148|467644360|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913308|NCT03398148|467644361|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
129913309|NCT02791230|467644362|FG000|Overall Study|Adverse Event|10|||
129913310|NCT02791230|467644363|FG001|Overall Study|Adverse Event|9|||
129913311|NCT02791230|467644364|FG002|Overall Study|Adverse Event|66|||
129913312|NCT02791230|467644362|FG000|Overall Study|Death|38|||
129913313|NCT02791230|467644363|FG001|Overall Study|Death|25|||
129913314|NCT02791230|467644364|FG002|Overall Study|Death|184|||
129913315|NCT02791230|467644362|FG000|Overall Study|Lack of Efficacy|1|||
129913316|NCT02791230|467644363|FG001|Overall Study|Lack of Efficacy|0|||
129913317|NCT02791230|467644364|FG002|Overall Study|Lack of Efficacy|3|||
129913318|NCT02791230|467644362|FG000|Overall Study|Lost to Follow-up|0|||
129913319|NCT02791230|467644363|FG001|Overall Study|Lost to Follow-up|0|||
129913320|NCT02791230|467644364|FG002|Overall Study|Lost to Follow-up|10|||
129913321|NCT02791230|467644362|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
129913322|NCT02791230|467644363|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
129913323|NCT02791230|467644364|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
129913324|NCT02791230|467644362|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
129913325|NCT02791230|467644363|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
129913326|NCT02791230|467644364|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
129913327|NCT02791230|467644362|FG000|Overall Study|Study sites terminated by sponsor|1|||
129913328|NCT02791230|467644363|FG001|Overall Study|Study sites terminated by sponsor|0|||
130065033|NCT02260648|468192345|FG000|Overall Study|Discontinue Due to Study Termination|13|||
130065034|NCT02260648|468192346|FG001|Overall Study|Discontinue Due to Study Termination|12|||
130065035|NCT02260648|468192347|FG002|Overall Study|Discontinue Due to Study Termination|7|||
130065036|NCT04093258|468192348|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
130065037|NCT04093258|468192349|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
130065038|NCT00594204|468192350|FG000|Overall Study|Adverse Event|15|||
129863504|NCT02415400|467456713|FG000|Overall Study|Adverse Event|0|||
129863505|NCT02415400|467456714|FG001|Overall Study|Adverse Event|1|||
129863506|NCT02415400|467456715|FG002|Overall Study|Adverse Event|1|||
129863507|NCT02415400|467456716|FG003|Overall Study|Adverse Event|2|||
129863508|NCT02415400|467456713|FG000|Overall Study|Participant request to stop therapy|4|||
129863509|NCT02415400|467456714|FG001|Overall Study|Participant request to stop therapy|3|||
129863510|NCT02415400|467456715|FG002|Overall Study|Participant request to stop therapy|8|||
129863511|NCT02415400|467456716|FG003|Overall Study|Participant request to stop therapy|6|||
129863512|NCT02415400|467456713|FG000|Overall Study|Participant withdrew consent|14|||
129863513|NCT02415400|467456714|FG001|Overall Study|Participant withdrew consent|12|||
129863514|NCT02415400|467456715|FG002|Overall Study|Participant withdrew consent|30|||
129863515|NCT02415400|467456716|FG003|Overall Study|Participant withdrew consent|21|||
129863516|NCT02415400|467456713|FG000|Overall Study|Death|39|||
129863517|NCT02415400|467456714|FG001|Overall Study|Death|41|||
129863518|NCT02415400|467456715|FG002|Overall Study|Death|35|||
129863519|NCT02415400|467456716|FG003|Overall Study|Death|42|||
129863520|NCT02415400|467456713|FG000|Overall Study|Lost to Follow-up|3|||
129863521|NCT02415400|467456714|FG001|Overall Study|Lost to Follow-up|3|||
129863522|NCT02415400|467456715|FG002|Overall Study|Lost to Follow-up|2|||
129863523|NCT02415400|467456716|FG003|Overall Study|Lost to Follow-up|5|||
129863524|NCT02415400|467456713|FG000|Overall Study|Poor/Non-Compliance|0|||
129863525|NCT02415400|467456714|FG001|Overall Study|Poor/Non-Compliance|1|||
129863526|NCT02415400|467456715|FG002|Overall Study|Poor/Non-Compliance|3|||
129863527|NCT02415400|467456716|FG003|Overall Study|Poor/Non-Compliance|4|||
129863528|NCT02415400|467456713|FG000|Overall Study|Participant no longer meets criteria|2|||
129863529|NCT02415400|467456714|FG001|Overall Study|Participant no longer meets criteria|0|||
129863530|NCT02415400|467456715|FG002|Overall Study|Participant no longer meets criteria|0|||
129863531|NCT02415400|467456716|FG003|Overall Study|Participant no longer meets criteria|1|||
129863532|NCT02415400|467456713|FG000|Overall Study|Participant doesn't answer phone|1|||
129863533|NCT02415400|467456714|FG001|Overall Study|Participant doesn't answer phone|0|||
129863534|NCT02415400|467456715|FG002|Overall Study|Participant doesn't answer phone|0|||
129863535|NCT02415400|467456716|FG003|Overall Study|Participant doesn't answer phone|0|||
129863536|NCT02415400|467456713|FG000|Overall Study|Participant wanted home visits|1|||
129863537|NCT02415400|467456714|FG001|Overall Study|Participant wanted home visits|0|||
129863538|NCT02415400|467456715|FG002|Overall Study|Participant wanted home visits|0|||
129863539|NCT02415400|467456716|FG003|Overall Study|Participant wanted home visits|0|||
129863540|NCT02415400|467456713|FG000|Overall Study|Randomized in error|2|||
129863541|NCT02415400|467456714|FG001|Overall Study|Randomized in error|0|||
129863542|NCT02415400|467456715|FG002|Overall Study|Randomized in error|0|||
129913329|NCT02791230|467644364|FG002|Overall Study|Study sites terminated by sponsor|5|||
129913330|NCT02791230|467644362|FG000|Overall Study|Other|9|||
129913331|NCT02791230|467644363|FG001|Overall Study|Other|1|||
129913332|NCT02791230|467644364|FG002|Overall Study|Other|28|||
129913333|NCT02791230|467644362|FG000|Overall Study|Protocol Violation|0|||
129913334|NCT02791230|467644363|FG001|Overall Study|Protocol Violation|0|||
129913335|NCT02791230|467644364|FG002|Overall Study|Protocol Violation|4|||
129913336|NCT02791230|467644362|FG000|Overall Study|Withdrawal by Subject|24|||
129913337|NCT02791230|467644363|FG001|Overall Study|Withdrawal by Subject|13|||
129913338|NCT02791230|467644364|FG002|Overall Study|Withdrawal by Subject|172|||
129913339|NCT02791230|467644362|FG000|Overall Study|Enrolled but not treated|0|||
129913340|NCT02791230|467644363|FG001|Overall Study|Enrolled but not treated|0|||
129913341|NCT02791230|467644364|FG002|Overall Study|Enrolled but not treated|5|||
129913342|NCT01259401|467644365|FG000|4-month Follow-up|Death|0|||
129913343|NCT01259401|467644366|FG001|4-month Follow-up|Death|1|||
129913344|NCT01259401|467644365|FG000|4-month Follow-up|Lost to Follow-up|0|||
129913345|NCT01259401|467644366|FG001|4-month Follow-up|Lost to Follow-up|1|||
129913346|NCT04201834|467644374|FG000|Overall Study|Screen fail|1|||
129913347|NCT04104321|467644377|FG000|Overall Study|didn't take the study drug|3|||
129913348|NCT03481777|467644378|FG000|Overall Study|Withdrawal by Subject|36|||
129913349|NCT03481777|467644379|FG001|Overall Study|Withdrawal by Subject|31|||
129913350|NCT03481777|467644378|FG000|Overall Study|Non stroke = non target population|277|||
129913351|NCT03481777|467644379|FG001|Overall Study|Non stroke = non target population|254|||
129913352|NCT05696080|467644380|FG000|Overall Study|Lost to Follow-up|2|||
129913353|NCT05696080|467644381|FG001|Overall Study|Lost to Follow-up|1|||
129913354|NCT05696080|467644380|FG000|Overall Study|Physician Decision|1|||
129913355|NCT05696080|467644381|FG001|Overall Study|Physician Decision|0|||
129913356|NCT05696080|467644380|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129913357|NCT05696080|467644381|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129913358|NCT05696080|467644380|FG000|Overall Study|Withdrawal by Subject|12|||
129913359|NCT05696080|467644381|FG001|Overall Study|Withdrawal by Subject|0|||
129913360|NCT03954184|467644384|FG000|Overall Study|Lost to Follow-up|500|||
129913361|NCT03954184|467644385|FG001|Overall Study|Lost to Follow-up|0|||
129913362|NCT03398200|467644386|FG000|Overall Study|Withdrawal by Subject|0|||
129913363|NCT03398200|467644387|FG001|Overall Study|Withdrawal by Subject|1|||
129863543|NCT02415400|467456716|FG003|Overall Study|Randomized in error|0|||
129863544|NCT02415400|467456713|FG000|Overall Study|No study drug on site|0|||
129863545|NCT02415400|467456714|FG001|Overall Study|No study drug on site|1|||
129863546|NCT02415400|467456715|FG002|Overall Study|No study drug on site|0|||
129863547|NCT02415400|467456716|FG003|Overall Study|No study drug on site|0|||
129863548|NCT02415400|467456713|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
129863549|NCT02415400|467456714|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
129863550|NCT02415400|467456715|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
129863551|NCT02415400|467456716|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
129863552|NCT02415400|467456713|FG000|Overall Study|Coagulation values cannot be set|0|||
129863553|NCT02415400|467456714|FG001|Overall Study|Coagulation values cannot be set|0|||
129863554|NCT02415400|467456715|FG002|Overall Study|Coagulation values cannot be set|1|||
129863555|NCT02415400|467456716|FG003|Overall Study|Coagulation values cannot be set|0|||
129863556|NCT02415400|467456713|FG000|Overall Study|State regulations prevent participation|0|||
129863557|NCT02415400|467456714|FG001|Overall Study|State regulations prevent participation|0|||
129863558|NCT02415400|467456715|FG002|Overall Study|State regulations prevent participation|1|||
129863559|NCT02415400|467456716|FG003|Overall Study|State regulations prevent participation|0|||
129863560|NCT02415400|467456713|FG000|Overall Study|Poor treatment monitoring|0|||
129863561|NCT02415400|467456714|FG001|Overall Study|Poor treatment monitoring|0|||
129863562|NCT02415400|467456715|FG002|Overall Study|Poor treatment monitoring|1|||
129863563|NCT02415400|467456716|FG003|Overall Study|Poor treatment monitoring|0|||
129863564|NCT02415400|467456713|FG000|Overall Study|Participant in jail|0|||
129863565|NCT02415400|467456714|FG001|Overall Study|Participant in jail|0|||
129913364|NCT05478525|467644388|FG000|Overall Study|Withdrawal by Subject|0|||
129913365|NCT05478525|467644389|FG001|Overall Study|Withdrawal by Subject|1|||
129913366|NCT05478525|467644390|FG002|Overall Study|Withdrawal by Subject|2|||
129913367|NCT05478525|467644391|FG003|Overall Study|Withdrawal by Subject|0|||
129913368|NCT05478525|467644388|FG000|Overall Study|COVID-19 Infection|2|||
129913369|NCT05478525|467644389|FG001|Overall Study|COVID-19 Infection|0|||
129913370|NCT05478525|467644390|FG002|Overall Study|COVID-19 Infection|1|||
129913371|NCT05478525|467644391|FG003|Overall Study|COVID-19 Infection|1|||
129913372|NCT01649271|467644392|FG000|Overall Study|Progressive disease|4|||
129913373|NCT01649271|467644393|FG001|Overall Study|Progressive disease|5|||
129913374|NCT01649271|467644392|FG000|Overall Study|Other Adverse Event|0|||
129913375|NCT01649271|467644393|FG001|Overall Study|Other Adverse Event|2|||
129863566|NCT02415400|467456715|FG002|Overall Study|Participant in jail|1|||
129863567|NCT02415400|467456716|FG003|Overall Study|Participant in jail|0|||
129913376|NCT01649271|467644392|FG000|Overall Study|Withdrawal by Subject|1|||
129913377|NCT01649271|467644393|FG001|Overall Study|Withdrawal by Subject|0|||
129913378|NCT01649271|467644392|FG000|Overall Study|Other than stated above|1|||
129913379|NCT01649271|467644393|FG001|Overall Study|Other than stated above|0|||
129863568|NCT02415400|467456713|FG000|Overall Study|Investigator decision|0|||
129863569|NCT02415400|467456714|FG001|Overall Study|Investigator decision|0|||
130065039|NCT00594204|468192351|FG001|Overall Study|Adverse Event|3|||
129913380|NCT05644002|467644394|FG000|Overall Study|Lost to Follow-up|1|||
129913381|NCT05644002|467644395|FG001|Overall Study|Lost to Follow-up|2|||
129913382|NCT05644002|467644394|FG000|Overall Study|Withdrawal by Subject|0|||
129913383|NCT05644002|467644395|FG001|Overall Study|Withdrawal by Subject|1|||
129913384|NCT04842500|467644396|FG000|Overall Study|Withdrawal by Subject|4|||
129913385|NCT04842500|467644397|FG001|Overall Study|Withdrawal by Subject|1|||
129913386|NCT04842500|467644398|FG002|Overall Study|Withdrawal by Subject|2|||
129913387|NCT04842500|467644399|FG003|Overall Study|Withdrawal by Subject|3|||
129913388|NCT04842500|467644396|FG000|Overall Study|Protocol Violation|1|||
129913389|NCT04842500|467644397|FG001|Overall Study|Protocol Violation|0|||
129913390|NCT04842500|467644398|FG002|Overall Study|Protocol Violation|0|||
129913391|NCT04842500|467644399|FG003|Overall Study|Protocol Violation|1|||
129913392|NCT05756075|467644402|FG000|Overall Study|Withdrawal by Subject|16|||
129913393|NCT05756075|467644403|FG001|Overall Study|Withdrawal by Subject|9|||
129913394|NCT03821844|467644404|FG000|Overall Study|Death|37|||
129913395|NCT03821844|467644405|FG001|Overall Study|Death|31|||
129913396|NCT03821844|467644404|FG000|Overall Study|Discharged|10|||
129913397|NCT03821844|467644405|FG001|Overall Study|Discharged|14|||
129913398|NCT03821844|467644404|FG000|Overall Study|Not present in facility at followup|2|||
129913399|NCT03821844|467644405|FG001|Overall Study|Not present in facility at followup|3|||
129913400|NCT03899961|467644407|FG000|Overall Study|-delivery prior to|2|||
129913401|NCT03899961|467644408|FG001|Overall Study|-delivery prior to|7|||
129913402|NCT03899961|467644407|FG000|Overall Study|req general anesth|1|||
129913403|NCT03899961|467644408|FG001|Overall Study|req general anesth|2|||
129913404|NCT03899961|467644407|FG000|Overall Study|capacity|5|||
129913405|NCT03899961|467644408|FG001|Overall Study|capacity|6|||
129913406|NCT03899961|467644407|FG000|Overall Study|Withdrawal by Subject|1|||
129913407|NCT03899961|467644408|FG001|Overall Study|Withdrawal by Subject|1|||
129913408|NCT02058108|467644409|FG000|Overall Study|Abnormal Laboratory Values|0|||
129913409|NCT02058108|467644410|FG001|Overall Study|Abnormal Laboratory Values|1|||
129913410|NCT02058108|467644409|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
129913411|NCT02058108|467644410|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129913412|NCT02058108|467644409|FG000|Overall Study|No longer requires study drug|0|||
129913413|NCT02058108|467644410|FG001|Overall Study|No longer requires study drug|1|||
129913414|NCT02058108|467644409|FG000|Overall Study|Withdrawal by Subject|1|||
129913415|NCT02058108|467644410|FG001|Overall Study|Withdrawal by Subject|0|||
129913416|NCT02058108|467644409|FG000|Overall Study|Administrative problems|3|||
129913417|NCT02058108|467644410|FG001|Overall Study|Administrative problems|3|||
129913418|NCT02058108|467644409|FG000|Overall Study|Protocol Violation|0|||
129913419|NCT02058108|467644410|FG001|Overall Study|Protocol Violation|1|||
129913420|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
129913421|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
129913422|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
129913423|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
129913424|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
129913425|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913426|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913427|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
129913428|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913429|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913430|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
129913431|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
129913432|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
129913433|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
129913434|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
129913435|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
129913436|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
129913437|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
129913438|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
129913439|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
129913440|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
129913441|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
129913442|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
129913443|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
129913444|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
129913445|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913446|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913447|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
129913448|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913449|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913450|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913451|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
129913452|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913453|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913454|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913455|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
129913456|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
129913457|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
129913458|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
129913459|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
129913460|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913461|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913462|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913463|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913464|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
129913465|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
129913466|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
129913467|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
129913468|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
129913469|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
129913470|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
129913471|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
129913472|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
129913473|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
129913474|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
129913475|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
129913476|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
129913477|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
129913478|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
129913479|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
129913480|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
129913481|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
129913482|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
129913483|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
129913484|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
129913485|NCT04711135|467644419|FG000|Overall Study|Physician Decision|0|||
129913486|NCT04711135|467644420|FG001|Overall Study|Physician Decision|1|||
129913487|NCT04711135|467644419|FG000|Overall Study|Ongoing treatment|0|||
129913488|NCT04711135|467644420|FG001|Overall Study|Ongoing treatment|1|||
129913489|NCT00998881|467644423|FG000|Overall Study|Adverse Event|2|||
129913490|NCT00998881|467644424|FG001|Overall Study|Adverse Event|2|||
129913491|NCT00998881|467644423|FG000|Overall Study|Lack of Efficacy|1|||
129913492|NCT00998881|467644424|FG001|Overall Study|Lack of Efficacy|0|||
129913493|NCT00998881|467644423|FG000|Overall Study|Physician Decision|3|||
129913494|NCT00998881|467644424|FG001|Overall Study|Physician Decision|0|||
129913495|NCT00998881|467644423|FG000|Overall Study|Withdrawal by Subject|1|||
129913496|NCT00998881|467644424|FG001|Overall Study|Withdrawal by Subject|0|||
129913497|NCT00998881|467644423|FG000|Overall Study|Personal matter|1|||
129913498|NCT00998881|467644424|FG001|Overall Study|Personal matter|0|||
129913499|NCT00818246|467644425|FG000|Overall Study|Impossible to match pictures|5|||
129913500|NCT01121991|467644426|FG000|Overall Study|Lack of Ovarian Response|2|||
129913501|NCT01121991|467644426|FG000|Overall Study|No Oocytes Retrieved|3|||
129913502|NCT01121991|467644426|FG000|Overall Study|No Fertilization|1|||
129913503|NCT00409838|467644427|FG000|Short-term Period|Adverse Event|0|||
129913504|NCT00409838|467644428|FG001|Short-term Period|Adverse Event|1|||
129913505|NCT00409838|467644427|FG000|Short-term Period|Lost to Follow-up|0|||
129913506|NCT00409838|467644428|FG001|Short-term Period|Lost to Follow-up|1|||
129913507|NCT00409838|467644427|FG000|Short-term Period|Withdrawal by Subject|2|||
129913508|NCT00409838|467644428|FG001|Short-term Period|Withdrawal by Subject|3|||
129913509|NCT00409838|467644427|FG000|Short-term Period|Never Treated|1|||
129913510|NCT00409838|467644428|FG001|Short-term Period|Never Treated|0|||
129913511|NCT00409838|467644427|FG000|Long-term Extension Period|Adverse Event|10|||
129913512|NCT00409838|467644428|FG001|Long-term Extension Period|Adverse Event|0|||
130116665|NCT00585351|468387151|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
129913513|NCT00409838|467644427|FG000|Long-term Extension Period|Death|1|||
129913514|NCT00409838|467644428|FG001|Long-term Extension Period|Death|0|||
130116666|NCT00585351|468387152|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
130154856|NCT00958126|468526627|FG006|Overall Study|Moved away from study area|0|||
130065040|NCT00594204|468192350|FG000|Overall Study|Lost to Follow-up|9|||
130065041|NCT00594204|468192351|FG001|Overall Study|Lost to Follow-up|5|||
130065042|NCT00594204|468192350|FG000|Overall Study|Withdrawal by Subject|23|||
130065043|NCT00594204|468192351|FG001|Overall Study|Withdrawal by Subject|29|||
130065044|NCT00594204|468192350|FG000|Overall Study|Other|4|||
130065045|NCT00594204|468192351|FG001|Overall Study|Other|3|||
130065046|NCT00594204|468192350|FG000|Overall Study|Lack of Efficacy|3|||
130065047|NCT00594204|468192351|FG001|Overall Study|Lack of Efficacy|4|||
130065048|NCT00594204|468192350|FG000|Overall Study|Randomized but not treated|4|||
130065049|NCT00594204|468192351|FG001|Overall Study|Randomized but not treated|1|||
130065050|NCT01529385|468192352|FG000|Overall Study|Lost to Follow-up|2|||
130065051|NCT01529385|468192353|FG001|Overall Study|Lost to Follow-up|1|||
130065052|NCT01401465|468192354|FG000|Treatment Period 1|Adverse Event|4|||
130065053|NCT01401465|468192355|FG001|Treatment Period 1|Adverse Event|1|||
130065054|NCT01401465|468192354|FG000|Treatment Period 1|Pregnancy|0|||
130065055|NCT01401465|468192355|FG001|Treatment Period 1|Pregnancy|1|||
130065056|NCT01401465|468192354|FG000|Treatment Period 1|Protocol Violation|5|||
130065057|NCT01401465|468192355|FG001|Treatment Period 1|Protocol Violation|0|||
130065058|NCT01401465|468192354|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130065059|NCT01401465|468192355|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130065060|NCT01401465|468192354|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
130065061|NCT01401465|468192355|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
130065062|NCT01401465|468192354|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
130065063|NCT01401465|468192355|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
130065064|NCT01401465|468192354|FG000|Treatment Period 1|Scheduling Difficulties|1|||
130065065|NCT01401465|468192355|FG001|Treatment Period 1|Scheduling Difficulties|1|||
130065066|NCT01401465|468192354|FG000|Treatment Period 2|Lost to Follow-up|0|||
130065067|NCT01401465|468192355|FG001|Treatment Period 2|Lost to Follow-up|1|||
130065068|NCT01401465|468192354|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130065069|NCT01401465|468192355|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130065070|NCT00986427|468192356|FG000|Overall Study|Lost to Follow-up|2|||
130065071|NCT00986427|468192357|FG001|Overall Study|Lost to Follow-up|0|||
130065072|NCT00986427|468192356|FG000|Overall Study|Lack of Efficacy|1|||
130065073|NCT00986427|468192357|FG001|Overall Study|Lack of Efficacy|0|||
130065074|NCT00986427|468192356|FG000|Overall Study|Withdrawal by Subject|1|||
130065075|NCT00986427|468192357|FG001|Overall Study|Withdrawal by Subject|0|||
130065076|NCT01115738|468192358|FG000|Overall Study|Death|1|||
130065077|NCT01115738|468192359|FG001|Overall Study|Death|0|||
130065078|NCT01115738|468192360|FG002|Overall Study|Death|0|||
130065079|NCT01115738|468192358|FG000|Overall Study|Lost to Follow-up|0|||
130065080|NCT01115738|468192359|FG001|Overall Study|Lost to Follow-up|0|||
130065081|NCT01115738|468192360|FG002|Overall Study|Lost to Follow-up|1|||
130065082|NCT01115738|468192358|FG000|Overall Study|Physician Decision|18|||
130065083|NCT01115738|468192359|FG001|Overall Study|Physician Decision|15|||
130065084|NCT01115738|468192360|FG002|Overall Study|Physician Decision|17|||
130065085|NCT01115738|468192358|FG000|Overall Study|Withdrawal by Subject|6|||
130065086|NCT01115738|468192359|FG001|Overall Study|Withdrawal by Subject|6|||
130065087|NCT01115738|468192360|FG002|Overall Study|Withdrawal by Subject|9|||
129863570|NCT02415400|467456715|FG002|Overall Study|Investigator decision|1|||
129863571|NCT02415400|467456716|FG003|Overall Study|Investigator decision|1|||
129863572|NCT02415400|467456713|FG000|Overall Study|Site closure; participant won't transfer|0|||
129863573|NCT02415400|467456714|FG001|Overall Study|Site closure; participant won't transfer|0|||
129863574|NCT02415400|467456715|FG002|Overall Study|Site closure; participant won't transfer|0|||
129863575|NCT02415400|467456716|FG003|Overall Study|Site closure; participant won't transfer|1|||
129863576|NCT02270450|467456717|FG000|Overall Study|Refusal unrelated to adverse event|3|||
129863577|NCT02270450|467456718|FG001|Overall Study|Refusal unrelated to adverse event|1|||
129863578|NCT02270450|467456719|FG002|Overall Study|Refusal unrelated to adverse event|5|||
129863579|NCT02270450|467456720|FG003|Overall Study|Refusal unrelated to adverse event|14|||
129863580|NCT02270450|467456717|FG000|Overall Study|Progression/relapse|1|||
129863581|NCT02270450|467456718|FG001|Overall Study|Progression/relapse|2|||
129863582|NCT02270450|467456719|FG002|Overall Study|Progression/relapse|4|||
129863583|NCT02270450|467456720|FG003|Overall Study|Progression/relapse|9|||
129863584|NCT02270450|467456717|FG000|Overall Study|Death|19|||
129863585|NCT02270450|467456718|FG001|Overall Study|Death|19|||
129863586|NCT02270450|467456719|FG002|Overall Study|Death|31|||
129863587|NCT02270450|467456720|FG003|Overall Study|Death|59|||
129863588|NCT02363738|467456721|FG000|Overall Study|Adverse Event|5|||
129863589|NCT02363738|467456722|FG001|Overall Study|Adverse Event|2|||
129863590|NCT02363738|467456721|FG000|Overall Study|Lack of Efficacy|1|||
129863591|NCT02363738|467456722|FG001|Overall Study|Lack of Efficacy|2|||
129863592|NCT02363738|467456721|FG000|Overall Study|Lost to Follow-up|2|||
129863593|NCT02363738|467456722|FG001|Overall Study|Lost to Follow-up|1|||
129863594|NCT02576678|467456728|FG000|Overall Study|Adverse Event|0|||
129863595|NCT02576678|467456729|FG001|Overall Study|Adverse Event|0|||
129863596|NCT02576678|467456730|FG002|Overall Study|Adverse Event|2|||
129863597|NCT02576678|467456728|FG000|Overall Study|Withdrawal by Subject|3|||
129863598|NCT02576678|467456729|FG001|Overall Study|Withdrawal by Subject|1|||
130065088|NCT01763866|468192367|FG000|Overall Study|Withdrawal by Subject|2|||
130065089|NCT01763866|468192368|FG001|Overall Study|Withdrawal by Subject|1|||
130065090|NCT01763866|468192369|FG002|Overall Study|Withdrawal by Subject|4|||
130065091|NCT01763866|468192370|FG003|Overall Study|Withdrawal by Subject|0|||
130065092|NCT01763866|468192371|FG004|Overall Study|Withdrawal by Subject|0|||
130065093|NCT01763866|468192372|FG005|Overall Study|Withdrawal by Subject|3|||
130065094|NCT01763866|468192373|FG006|Overall Study|Withdrawal by Subject|4|||
130065095|NCT01763866|468192374|FG007|Overall Study|Withdrawal by Subject|0|||
130065096|NCT01763866|468192375|FG008|Overall Study|Withdrawal by Subject|1|||
130065097|NCT01763866|468192376|FG009|Overall Study|Withdrawal by Subject|1|||
130065098|NCT01763866|468192377|FG010|Overall Study|Withdrawal by Subject|2|||
130065099|NCT01763866|468192378|FG011|Overall Study|Withdrawal by Subject|2|||
130065100|NCT01763866|468192379|FG012|Overall Study|Withdrawal by Subject|2|||
130065101|NCT01763866|468192380|FG013|Overall Study|Withdrawal by Subject|0|||
130065102|NCT01763866|468192381|FG014|Overall Study|Withdrawal by Subject|6|||
130065103|NCT01763866|468192382|FG015|Overall Study|Withdrawal by Subject|3|||
130065104|NCT01763866|468192383|FG016|Overall Study|Withdrawal by Subject|0|||
130065105|NCT01763866|468192384|FG017|Overall Study|Withdrawal by Subject|1|||
130065106|NCT01763866|468192385|FG018|Overall Study|Withdrawal by Subject|1|||
130065107|NCT01763866|468192386|FG019|Overall Study|Withdrawal by Subject|1|||
130065108|NCT01763866|468192387|FG020|Overall Study|Withdrawal by Subject|2|||
130065109|NCT01763866|468192388|FG021|Overall Study|Withdrawal by Subject|1|||
130065110|NCT01763866|468192389|FG022|Overall Study|Withdrawal by Subject|2|||
130065111|NCT01763866|468192390|FG023|Overall Study|Withdrawal by Subject|1|||
130065112|NCT01763866|468192367|FG000|Overall Study|Decision by sponsor|0|||
130065113|NCT01763866|468192368|FG001|Overall Study|Decision by sponsor|0|||
130065114|NCT01763866|468192369|FG002|Overall Study|Decision by sponsor|1|||
130065115|NCT01763866|468192370|FG003|Overall Study|Decision by sponsor|0|||
130065116|NCT01763866|468192371|FG004|Overall Study|Decision by sponsor|2|||
130065117|NCT01763866|468192372|FG005|Overall Study|Decision by sponsor|0|||
130065118|NCT01763866|468192373|FG006|Overall Study|Decision by sponsor|2|||
130065119|NCT01763866|468192374|FG007|Overall Study|Decision by sponsor|0|||
130065120|NCT01763866|468192375|FG008|Overall Study|Decision by sponsor|2|||
130065121|NCT01763866|468192376|FG009|Overall Study|Decision by sponsor|0|||
130065122|NCT01763866|468192377|FG010|Overall Study|Decision by sponsor|6|||
130065123|NCT01763866|468192378|FG011|Overall Study|Decision by sponsor|0|||
130065124|NCT01763866|468192379|FG012|Overall Study|Decision by sponsor|1|||
130065125|NCT01763866|468192380|FG013|Overall Study|Decision by sponsor|0|||
130065126|NCT01763866|468192381|FG014|Overall Study|Decision by sponsor|5|||
130065127|NCT01763866|468192382|FG015|Overall Study|Decision by sponsor|0|||
130065128|NCT01763866|468192383|FG016|Overall Study|Decision by sponsor|0|||
130065129|NCT01763866|468192384|FG017|Overall Study|Decision by sponsor|0|||
130065130|NCT01763866|468192385|FG018|Overall Study|Decision by sponsor|4|||
129863599|NCT02576678|467456730|FG002|Overall Study|Withdrawal by Subject|2|||
129863600|NCT02576678|467456728|FG000|Overall Study|Lost to Follow-up|0|||
129863601|NCT02576678|467456729|FG001|Overall Study|Lost to Follow-up|0|||
129863602|NCT02576678|467456730|FG002|Overall Study|Lost to Follow-up|1|||
129863603|NCT02576678|467456728|FG000|Overall Study|Miscellaneous|2|||
129863604|NCT02576678|467456729|FG001|Overall Study|Miscellaneous|0|||
129863605|NCT02576678|467456730|FG002|Overall Study|Miscellaneous|0|||
129863606|NCT02491671|467456731|FG000|Overall Study|Adverse Event|6|||
130065131|NCT01763866|468192386|FG019|Overall Study|Decision by sponsor|0|||
130065132|NCT01763866|468192387|FG020|Overall Study|Decision by sponsor|2|||
130065133|NCT01763866|468192388|FG021|Overall Study|Decision by sponsor|0|||
130065134|NCT01763866|468192389|FG022|Overall Study|Decision by sponsor|1|||
130065135|NCT01763866|468192390|FG023|Overall Study|Decision by sponsor|0|||
130065136|NCT01763866|468192367|FG000|Overall Study|Lost to Follow-up|0|||
130116667|NCT00585351|468387153|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
129863607|NCT02491671|467456732|FG001|Overall Study|Adverse Event|8|||
129863608|NCT02491671|467456731|FG000|Overall Study|Death|0|||
129863609|NCT02491671|467456732|FG001|Overall Study|Death|2|||
130065137|NCT01763866|468192368|FG001|Overall Study|Lost to Follow-up|0|||
130065138|NCT01763866|468192369|FG002|Overall Study|Lost to Follow-up|0|||
130065139|NCT01763866|468192370|FG003|Overall Study|Lost to Follow-up|0|||
130065140|NCT01763866|468192371|FG004|Overall Study|Lost to Follow-up|0|||
130065141|NCT01763866|468192372|FG005|Overall Study|Lost to Follow-up|0|||
130065142|NCT01763866|468192373|FG006|Overall Study|Lost to Follow-up|1|||
130065143|NCT01763866|468192374|FG007|Overall Study|Lost to Follow-up|0|||
130065144|NCT01763866|468192375|FG008|Overall Study|Lost to Follow-up|0|||
130065145|NCT01763866|468192376|FG009|Overall Study|Lost to Follow-up|0|||
130065146|NCT01763866|468192377|FG010|Overall Study|Lost to Follow-up|0|||
129863610|NCT02491671|467456731|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
129863611|NCT02491671|467456732|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
130065147|NCT01763866|468192378|FG011|Overall Study|Lost to Follow-up|0|||
130065148|NCT01763866|468192379|FG012|Overall Study|Lost to Follow-up|1|||
130065149|NCT01763866|468192380|FG013|Overall Study|Lost to Follow-up|0|||
130065150|NCT01763866|468192381|FG014|Overall Study|Lost to Follow-up|1|||
130065151|NCT01763866|468192382|FG015|Overall Study|Lost to Follow-up|0|||
129863612|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
129863613|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
129863614|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
129863615|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
129863616|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
129863617|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
129863618|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
129863619|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
129863620|NCT02251990|467456736|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
129863621|NCT02251990|467456737|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
129863622|NCT02251990|467456736|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
129863623|NCT02251990|467456737|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
129863624|NCT03265600|467456738|FG000|Overall Study|Lost to Follow-up|17|||
129863625|NCT03265600|467456739|FG001|Overall Study|Lost to Follow-up|5|||
129863626|NCT03265600|467456738|FG000|Overall Study|Withdrawal by Subject|4|||
129863627|NCT03265600|467456739|FG001|Overall Study|Withdrawal by Subject|2|||
129863628|NCT03265600|467456738|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
129863629|NCT03265600|467456739|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
129863630|NCT04330638|467456740|FG000|Overall Study|Adverse Event|9|||
129863631|NCT04330638|467456741|FG001|Overall Study|Adverse Event|10|||
129863632|NCT04330638|467456742|FG002|Overall Study|Adverse Event|15|||
129863633|NCT04330638|467456743|FG003|Overall Study|Adverse Event|6|||
129863634|NCT04330638|467456744|FG004|Overall Study|Adverse Event|10|||
129863635|NCT04330638|467456745|FG005|Overall Study|Adverse Event|5|||
129863636|NCT04330638|467456740|FG000|Overall Study|Other|2|||
129863637|NCT04330638|467456741|FG001|Overall Study|Other|2|||
129863638|NCT04330638|467456742|FG002|Overall Study|Other|5|||
129863639|NCT04330638|467456743|FG003|Overall Study|Other|1|||
129863640|NCT04330638|467456744|FG004|Overall Study|Other|3|||
129863641|NCT04330638|467456745|FG005|Overall Study|Other|2|||
129863642|NCT04330638|467456740|FG000|Overall Study|Withdrawal by Subject|4|||
129863643|NCT04330638|467456741|FG001|Overall Study|Withdrawal by Subject|0|||
129863644|NCT04330638|467456742|FG002|Overall Study|Withdrawal by Subject|0|||
129863645|NCT04330638|467456743|FG003|Overall Study|Withdrawal by Subject|0|||
129863646|NCT04330638|467456744|FG004|Overall Study|Withdrawal by Subject|0|||
129863647|NCT04330638|467456745|FG005|Overall Study|Withdrawal by Subject|0|||
129863648|NCT04330638|467456740|FG000|Overall Study|Lost to Follow-up|3|||
129863649|NCT04330638|467456741|FG001|Overall Study|Lost to Follow-up|2|||
129863650|NCT04330638|467456742|FG002|Overall Study|Lost to Follow-up|3|||
129863651|NCT04330638|467456743|FG003|Overall Study|Lost to Follow-up|2|||
129863652|NCT04330638|467456744|FG004|Overall Study|Lost to Follow-up|3|||
129863653|NCT04330638|467456745|FG005|Overall Study|Lost to Follow-up|0|||
129863654|NCT00322348|467456746|FG000|Overall Study|Adverse Event|0|||
129863655|NCT00322348|467456747|FG001|Overall Study|Adverse Event|1|||
129863656|NCT00322348|467456746|FG000|Overall Study|Withdrawal by Subject|1|||
129863657|NCT00322348|467456747|FG001|Overall Study|Withdrawal by Subject|4|||
129863658|NCT00322348|467456746|FG000|Overall Study|Lost to Follow-up|1|||
129863659|NCT00322348|467456747|FG001|Overall Study|Lost to Follow-up|0|||
129863660|NCT00322348|467456746|FG000|Overall Study|Death|0|||
129863661|NCT00322348|467456747|FG001|Overall Study|Death|2|||
129863662|NCT00322348|467456746|FG000|Overall Study|Disease Progression|30|||
129863663|NCT00322348|467456747|FG001|Overall Study|Disease Progression|25|||
129863664|NCT00322348|467456746|FG000|Overall Study|Reasons not specified|5|||
129863665|NCT00322348|467456747|FG001|Overall Study|Reasons not specified|1|||
129863666|NCT03336619|467456748|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
129863667|NCT03336619|467456749|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
129863668|NCT03336619|467456748|FG000|Overall Study|Withdrawal by Subject|17|||
129863669|NCT03336619|467456749|FG001|Overall Study|Withdrawal by Subject|16|||
129863670|NCT03336619|467456748|FG000|Overall Study|Adverse Event|2|||
129863671|NCT03336619|467456749|FG001|Overall Study|Adverse Event|5|||
129863672|NCT03336619|467456748|FG000|Overall Study|Physician Decision|3|||
129863673|NCT03336619|467456749|FG001|Overall Study|Physician Decision|0|||
129863674|NCT02820623|467456750|FG000|Overall Study|Withdrawal by Subject|1|||
129863675|NCT02820623|467456751|FG001|Overall Study|Withdrawal by Subject|3|||
129863676|NCT02820623|467456752|FG002|Overall Study|Withdrawal by Subject|3|||
129863677|NCT02820623|467456750|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
129863678|NCT02820623|467456751|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
129863679|NCT02820623|467456752|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
129863680|NCT02820623|467456750|FG000|Overall Study|Therapist unable to enroll clients|1|||
129863681|NCT02820623|467456751|FG001|Overall Study|Therapist unable to enroll clients|1|||
129863682|NCT02820623|467456752|FG002|Overall Study|Therapist unable to enroll clients|3|||
129863683|NCT02820623|467456750|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
129863684|NCT02820623|467456751|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
129863685|NCT02820623|467456752|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
129863686|NCT01965834|467456753|FG000|Overall Study|Lack of Efficacy|4|||
129863687|NCT00744653|467456755|FG000|Overall Study|antineoplastic treatment|11|||
129863688|NCT00744653|467456755|FG000|Overall Study|Death|1|||
129863689|NCT00744653|467456755|FG000|Overall Study|Lost to Follow-up|1|||
129863690|NCT00744653|467456755|FG000|Overall Study|Physician Decision|3|||
129863691|NCT03826667|467456756|FG000|Overall Study|Protocol deviation|21|||
129863692|NCT00617344|467456757|FG000|Overall Study|Serious adverse event|1|||
129863693|NCT00617344|467456758|FG001|Overall Study|Serious adverse event|0|||
129863694|NCT00617344|467456759|FG002|Overall Study|Serious adverse event|0|||
129863695|NCT00617344|467456757|FG000|Overall Study|Other Adverse Event|1|||
129863696|NCT00617344|467456758|FG001|Overall Study|Other Adverse Event|1|||
129863697|NCT00617344|467456759|FG002|Overall Study|Other Adverse Event|0|||
129863698|NCT00617344|467456757|FG000|Overall Study|Protocol Violation|10|||
129863699|NCT00617344|467456758|FG001|Overall Study|Protocol Violation|8|||
129863700|NCT00617344|467456759|FG002|Overall Study|Protocol Violation|5|||
129863701|NCT00617344|467456757|FG000|Overall Study|Lost to Follow-up|5|||
129863702|NCT00617344|467456758|FG001|Overall Study|Lost to Follow-up|4|||
129863703|NCT00617344|467456759|FG002|Overall Study|Lost to Follow-up|1|||
129863704|NCT00617344|467456757|FG000|Overall Study|Withdrawal by Subject|8|||
129863705|NCT00617344|467456758|FG001|Overall Study|Withdrawal by Subject|9|||
129863706|NCT00617344|467456759|FG002|Overall Study|Withdrawal by Subject|2|||
129863707|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
129863708|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
129863709|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
129863710|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
129863711|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
129863712|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
129863713|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
129863714|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
129863715|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
129863716|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
129863717|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
129863718|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
129863719|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
129863720|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
129863721|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
129863722|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
129863723|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
129863724|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
129863725|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
129863726|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
129863727|NCT00941330|467456768|FG000|Overall Study|Other|1|||
129863728|NCT00941330|467456769|FG001|Overall Study|Other|0|||
129863729|NCT00941330|467456768|FG000|Overall Study|Physician Decision|0|||
129863730|NCT00941330|467456769|FG001|Overall Study|Physician Decision|2|||
129863731|NCT02985866|467458344|FG000|Overall Study|Poor CGM data|1|||
129863732|NCT02985866|467458345|FG001|Overall Study|Poor CGM data|1|||
129863733|NCT00686166|467458350|FG000|Overall Study|Adverse Event|7|||
129863734|NCT00686166|467458350|FG000|Overall Study|Withdrawal by Subject|1|||
129863735|NCT00686166|467458350|FG000|Overall Study|Progression/Relapse|1|||
129863736|NCT00686166|467458350|FG000|Overall Study|Death|1|||
129863737|NCT00686166|467458350|FG000|Overall Study|Not Protocol Specified|1|||
129863738|NCT00686166|467458350|FG000|Overall Study|Ineligible|5|||
129863739|NCT00686166|467458350|FG000|Overall Study|Did not begin protocol therapy|4|||
129863740|NCT01549613|467458353|FG000|Overall Study|Lost to Follow-up|11|||
129913515|NCT00409838|467644427|FG000|Long-term Extension Period|Lack of Efficacy|2|||
129863741|NCT01549613|467458354|FG001|Overall Study|Lost to Follow-up|11|||
129863742|NCT02216123|467458355|FG000|Overall Study|Lost to Follow-up|4|||
129863743|NCT02216123|467458356|FG001|Overall Study|Lost to Follow-up|2|||
129863744|NCT02216123|467458355|FG000|Overall Study|Withdrawal by Subject|2|||
129863745|NCT02216123|467458356|FG001|Overall Study|Withdrawal by Subject|0|||
129863746|NCT04477187|467458359|FG000|Overall Study|Lost to Follow-up|2|||
129863747|NCT00464815|467458361|FG000|Overall Study|Withdrawal by Subject|6|||
129863748|NCT00464815|467458362|FG001|Overall Study|Withdrawal by Subject|3|||
129863749|NCT00254982|467458363|FG000|Overall Study|Other|2|||
129863750|NCT00254982|467458364|FG001|Overall Study|Other|1|||
129863751|NCT00254982|467458363|FG000|Overall Study|Lack of Efficacy|5|||
129863752|NCT00254982|467458364|FG001|Overall Study|Lack of Efficacy|3|||
129863753|NCT00254982|467458363|FG000|Overall Study|Lost to Follow-up|5|||
129863754|NCT00254982|467458364|FG001|Overall Study|Lost to Follow-up|3|||
129863755|NCT00254982|467458363|FG000|Overall Study|Adverse Event|18|||
129863756|NCT00254982|467458364|FG001|Overall Study|Adverse Event|16|||
129863757|NCT00254982|467458363|FG000|Overall Study|Withdrawal by Subject|1|||
129863758|NCT00254982|467458364|FG001|Overall Study|Withdrawal by Subject|1|||
129863759|NCT00254982|467458363|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
129863760|NCT00254982|467458364|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
129863761|NCT00254982|467458363|FG000|Overall Study|Protocol deviation|1|||
129863762|NCT00254982|467458364|FG001|Overall Study|Protocol deviation|1|||
129863763|NCT00254982|467458363|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
129863764|NCT00254982|467458364|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
129863765|NCT00254982|467458363|FG000|Overall Study|Malignancy|0|||
129863766|NCT00254982|467458364|FG001|Overall Study|Malignancy|2|||
129863767|NCT00254982|467458363|FG000|Overall Study|Opportunistic infection|1|||
129863768|NCT00254982|467458364|FG001|Overall Study|Opportunistic infection|0|||
129863769|NCT00254982|467458363|FG000|Overall Study|Abnormal liver function tests|2|||
129863770|NCT00254982|467458364|FG001|Overall Study|Abnormal liver function tests|1|||
129863771|NCT01613248|467458369|FG000|Overall Study|Adverse Event|0|||
129863772|NCT01613248|467458370|FG001|Overall Study|Adverse Event|0|||
129863773|NCT01613248|467458371|FG002|Overall Study|Adverse Event|0|||
129863774|NCT01613248|467458372|FG003|Overall Study|Adverse Event|1|||
129863775|NCT01613248|467458373|FG004|Overall Study|Adverse Event|0|||
129863776|NCT01613248|467458374|FG005|Overall Study|Adverse Event|0|||
129863777|NCT01613248|467458369|FG000|Overall Study|Withdrawal by Subject|3|||
129863778|NCT01613248|467458370|FG001|Overall Study|Withdrawal by Subject|2|||
129863779|NCT01613248|467458371|FG002|Overall Study|Withdrawal by Subject|2|||
129863780|NCT01613248|467458372|FG003|Overall Study|Withdrawal by Subject|5|||
129863781|NCT01613248|467458373|FG004|Overall Study|Withdrawal by Subject|0|||
129863782|NCT01613248|467458374|FG005|Overall Study|Withdrawal by Subject|1|||
129863783|NCT01613248|467458369|FG000|Overall Study|Lost to Follow-up|5|||
129863784|NCT01613248|467458370|FG001|Overall Study|Lost to Follow-up|7|||
129863785|NCT01613248|467458371|FG002|Overall Study|Lost to Follow-up|4|||
129863786|NCT01613248|467458372|FG003|Overall Study|Lost to Follow-up|8|||
129863787|NCT01613248|467458373|FG004|Overall Study|Lost to Follow-up|4|||
129863788|NCT01613248|467458374|FG005|Overall Study|Lost to Follow-up|2|||
129863789|NCT01613248|467458369|FG000|Overall Study|Study Terminated by Sponsor|4|||
129863790|NCT01613248|467458370|FG001|Overall Study|Study Terminated by Sponsor|6|||
129863791|NCT01613248|467458371|FG002|Overall Study|Study Terminated by Sponsor|8|||
129863792|NCT01613248|467458372|FG003|Overall Study|Study Terminated by Sponsor|8|||
129863793|NCT01613248|467458373|FG004|Overall Study|Study Terminated by Sponsor|9|||
129863794|NCT01613248|467458374|FG005|Overall Study|Study Terminated by Sponsor|11|||
129863795|NCT01613248|467458369|FG000|Overall Study|Physician Decision|8|||
129863796|NCT01613248|467458370|FG001|Overall Study|Physician Decision|8|||
129863797|NCT01613248|467458371|FG002|Overall Study|Physician Decision|9|||
129863798|NCT01613248|467458372|FG003|Overall Study|Physician Decision|4|||
129863799|NCT01613248|467458373|FG004|Overall Study|Physician Decision|7|||
129863800|NCT01613248|467458374|FG005|Overall Study|Physician Decision|6|||
129863801|NCT01613248|467458369|FG000|Overall Study|Lack of Qualifying Event|9|||
129863802|NCT01613248|467458370|FG001|Overall Study|Lack of Qualifying Event|11|||
129863803|NCT01613248|467458371|FG002|Overall Study|Lack of Qualifying Event|10|||
129863804|NCT01613248|467458372|FG003|Overall Study|Lack of Qualifying Event|11|||
129863805|NCT01613248|467458373|FG004|Overall Study|Lack of Qualifying Event|15|||
129863806|NCT01613248|467458374|FG005|Overall Study|Lack of Qualifying Event|18|||
129863807|NCT01613248|467458369|FG000|Overall Study|Pregnancy|0|||
129863808|NCT01613248|467458370|FG001|Overall Study|Pregnancy|0|||
129863809|NCT01613248|467458371|FG002|Overall Study|Pregnancy|0|||
129863810|NCT01613248|467458372|FG003|Overall Study|Pregnancy|1|||
129863811|NCT01613248|467458373|FG004|Overall Study|Pregnancy|0|||
129863812|NCT01613248|467458374|FG005|Overall Study|Pregnancy|0|||
129863813|NCT02015676|467458386|FG000|Overall Study|Adverse Event|2|||
129863814|NCT02015676|467458387|FG001|Overall Study|Adverse Event|18|||
129863815|NCT02015676|467458388|FG002|Overall Study|Adverse Event|0|||
129863816|NCT02015676|467458386|FG000|Overall Study|Lack of Efficacy|2|||
129863817|NCT02015676|467458387|FG001|Overall Study|Lack of Efficacy|4|||
129863818|NCT02015676|467458388|FG002|Overall Study|Lack of Efficacy|0|||
129863819|NCT02015676|467458386|FG000|Overall Study|Protocol Violation|1|||
129863820|NCT02015676|467458387|FG001|Overall Study|Protocol Violation|0|||
129863821|NCT02015676|467458388|FG002|Overall Study|Protocol Violation|0|||
129863822|NCT02015676|467458386|FG000|Overall Study|Withdrawal by Subject|1|||
129863823|NCT02015676|467458387|FG001|Overall Study|Withdrawal by Subject|7|||
129863824|NCT02015676|467458388|FG002|Overall Study|Withdrawal by Subject|1|||
129863825|NCT02015676|467458386|FG000|Overall Study|Administrative reasons|0|||
129863826|NCT02015676|467458387|FG001|Overall Study|Administrative reasons|3|||
129863827|NCT02015676|467458388|FG002|Overall Study|Administrative reasons|1|||
129863828|NCT02015676|467458386|FG000|Overall Study|Death|0|||
129863829|NCT02015676|467458387|FG001|Overall Study|Death|1|||
129863830|NCT02015676|467458388|FG002|Overall Study|Death|0|||
129863831|NCT02015676|467458386|FG000|Overall Study|Disease progression|3|||
129863832|NCT02015676|467458387|FG001|Overall Study|Disease progression|1|||
129863833|NCT02015676|467458388|FG002|Overall Study|Disease progression|1|||
129863834|NCT00476476|467458389|FG000|Overall Study|Adverse Event|2|||
129863835|NCT00476476|467458390|FG001|Overall Study|Adverse Event|7|||
129863836|NCT00476476|467458389|FG000|Overall Study|Progressive Disease|0|||
129863837|NCT00476476|467458390|FG001|Overall Study|Progressive Disease|17|||
129863838|NCT03321396|467458394|FG000|Overall Study|Physician Decision|1|||
129863839|NCT03644186|467458401|FG000|Overall Study|Withdrawal by Subject|1|||
129863840|NCT03644186|467458402|FG001|Overall Study|Withdrawal by Subject|1|||
129863841|NCT04391023|467458403|FG000|Overall Study|Withdrawal by Subject|2|||
129863842|NCT04391023|467458404|FG001|Overall Study|Withdrawal by Subject|2|||
129863843|NCT01869491|467458405|FG000|Overall Study|Adverse Event|3|||
129863844|NCT01869491|467458406|FG001|Overall Study|Adverse Event|5|||
129863845|NCT01869491|467458405|FG000|Overall Study|Lack of Efficacy|0|||
129863846|NCT01869491|467458406|FG001|Overall Study|Lack of Efficacy|3|||
129863847|NCT01869491|467458405|FG000|Overall Study|Withdrawal by Subject|6|||
129863848|NCT01869491|467458406|FG001|Overall Study|Withdrawal by Subject|7|||
129863849|NCT01869491|467458405|FG000|Overall Study|Lost to Follow-up|11|||
129863850|NCT01869491|467458406|FG001|Overall Study|Lost to Follow-up|9|||
129863851|NCT01869491|467458405|FG000|Overall Study|No further need of investigational product|1|||
129863852|NCT01869491|467458406|FG001|Overall Study|No further need of investigational product|0|||
129863853|NCT04009291|467458407|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863854|NCT04009291|467458408|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863855|NCT04009291|467458409|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863856|NCT04009291|467458410|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863857|NCT04009291|467458411|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
129863858|NCT04009291|467458407|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863859|NCT04009291|467458408|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863860|NCT04009291|467458409|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863861|NCT04009291|467458410|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863862|NCT04009291|467458411|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
129863863|NCT05553808|467458414|FG000|Overall Study|Death|25|||
129863864|NCT05553808|467458415|FG001|Overall Study|Death|62|||
129863865|NCT05553808|467458414|FG000|Overall Study|Site Closed|6|||
129863866|NCT05553808|467458415|FG001|Overall Study|Site Closed|6|||
129863867|NCT05553808|467458414|FG000|Overall Study|Lost to Follow-up|1|||
129863868|NCT05553808|467458415|FG001|Overall Study|Lost to Follow-up|0|||
129863869|NCT05553808|467458414|FG000|Overall Study|Withdrawal by Subject|3|||
129863870|NCT05553808|467458415|FG001|Overall Study|Withdrawal by Subject|2|||
129863871|NCT00727272|467458422|FG000|Washout Period A|Adverse Event|0|||
129863872|NCT00727272|467458423|FG001|Washout Period A|Adverse Event|0|||
129863873|NCT00727272|467458424|FG002|Washout Period A|Adverse Event|1|||
129863874|NCT00727272|467458422|FG000|Washout Period B|Withdrawal by Subject|0|||
129863875|NCT00727272|467458423|FG001|Washout Period B|Withdrawal by Subject|0|||
129863876|NCT00727272|467458424|FG002|Washout Period B|Withdrawal by Subject|1|||
129863877|NCT00651664|467458425|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
129863878|NCT00651664|467458426|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
129863879|NCT00651664|467458427|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
129863880|NCT00651664|467458428|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
129863881|NCT00651664|467458429|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
129863882|NCT00651664|467458430|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
129863883|NCT00651664|467458431|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
129863884|NCT00651664|467458432|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
129863885|NCT00651664|467458433|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
129863886|NCT00651664|467458434|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
129863887|NCT00651664|467458425|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863888|NCT00651664|467458426|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863889|NCT00651664|467458427|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863890|NCT00651664|467458428|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863891|NCT00651664|467458429|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863892|NCT00651664|467458430|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863893|NCT00651664|467458431|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863894|NCT00651664|467458432|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863895|NCT00651664|467458433|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863896|NCT00651664|467458434|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863897|NCT00651664|467458425|FG000|Overall Study|Progressive Disease|3|||
129863898|NCT00651664|467458426|FG001|Overall Study|Progressive Disease|3|||
129863899|NCT00651664|467458427|FG002|Overall Study|Progressive Disease|3|||
129863900|NCT00651664|467458428|FG003|Overall Study|Progressive Disease|12|||
129863901|NCT00651664|467458429|FG004|Overall Study|Progressive Disease|4|||
129863902|NCT00651664|467458430|FG005|Overall Study|Progressive Disease|1|||
129863903|NCT00651664|467458431|FG006|Overall Study|Progressive Disease|3|||
129863904|NCT00651664|467458432|FG007|Overall Study|Progressive Disease|6|||
129863905|NCT00651664|467458433|FG008|Overall Study|Progressive Disease|5|||
129863906|NCT00651664|467458434|FG009|Overall Study|Progressive Disease|5|||
129863907|NCT00651664|467458425|FG000|Overall Study|Patient Declined Further Treatment|0|||
129863908|NCT00651664|467458426|FG001|Overall Study|Patient Declined Further Treatment|0|||
129863909|NCT00651664|467458427|FG002|Overall Study|Patient Declined Further Treatment|0|||
129913516|NCT00409838|467644428|FG001|Long-term Extension Period|Lack of Efficacy|0|||
129863910|NCT00651664|467458428|FG003|Overall Study|Patient Declined Further Treatment|1|||
129863911|NCT00651664|467458429|FG004|Overall Study|Patient Declined Further Treatment|1|||
129913517|NCT00409838|467644427|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
129913518|NCT00409838|467644428|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
129913519|NCT00409838|467644427|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
130065152|NCT01763866|468192383|FG016|Overall Study|Lost to Follow-up|0|||
130065153|NCT01763866|468192384|FG017|Overall Study|Lost to Follow-up|0|||
130065154|NCT01763866|468192385|FG018|Overall Study|Lost to Follow-up|1|||
130065155|NCT01763866|468192386|FG019|Overall Study|Lost to Follow-up|1|||
130065156|NCT01763866|468192387|FG020|Overall Study|Lost to Follow-up|0|||
130065157|NCT01763866|468192388|FG021|Overall Study|Lost to Follow-up|0|||
130065158|NCT01763866|468192389|FG022|Overall Study|Lost to Follow-up|0|||
130065159|NCT01763866|468192390|FG023|Overall Study|Lost to Follow-up|1|||
130065160|NCT01763866|468192367|FG000|Overall Study|Death|0|||
130065161|NCT01763866|468192368|FG001|Overall Study|Death|0|||
130065162|NCT01763866|468192369|FG002|Overall Study|Death|0|||
130065163|NCT01763866|468192370|FG003|Overall Study|Death|0|||
129863912|NCT00651664|467458430|FG005|Overall Study|Patient Declined Further Treatment|1|||
129863913|NCT00651664|467458431|FG006|Overall Study|Patient Declined Further Treatment|0|||
129863914|NCT00651664|467458432|FG007|Overall Study|Patient Declined Further Treatment|0|||
129863915|NCT00651664|467458433|FG008|Overall Study|Patient Declined Further Treatment|0|||
129863916|NCT00651664|467458434|FG009|Overall Study|Patient Declined Further Treatment|1|||
129863917|NCT00651664|467458425|FG000|Overall Study|Symptomatic Deterioration|0|||
129863918|NCT00651664|467458426|FG001|Overall Study|Symptomatic Deterioration|0|||
129863919|NCT00651664|467458427|FG002|Overall Study|Symptomatic Deterioration|0|||
129863920|NCT00651664|467458428|FG003|Overall Study|Symptomatic Deterioration|1|||
129863921|NCT00651664|467458429|FG004|Overall Study|Symptomatic Deterioration|0|||
129863922|NCT00651664|467458430|FG005|Overall Study|Symptomatic Deterioration|0|||
129863923|NCT00651664|467458431|FG006|Overall Study|Symptomatic Deterioration|1|||
129863924|NCT00651664|467458432|FG007|Overall Study|Symptomatic Deterioration|0|||
129863925|NCT00651664|467458433|FG008|Overall Study|Symptomatic Deterioration|1|||
129863926|NCT00651664|467458434|FG009|Overall Study|Symptomatic Deterioration|0|||
129863927|NCT00651664|467458425|FG000|Overall Study|Reason not Specified|0|||
129863928|NCT00651664|467458426|FG001|Overall Study|Reason not Specified|0|||
129863929|NCT00651664|467458427|FG002|Overall Study|Reason not Specified|0|||
129863930|NCT00651664|467458428|FG003|Overall Study|Reason not Specified|0|||
129863931|NCT00651664|467458429|FG004|Overall Study|Reason not Specified|0|||
129863932|NCT00651664|467458430|FG005|Overall Study|Reason not Specified|0|||
129863933|NCT00651664|467458431|FG006|Overall Study|Reason not Specified|1|||
129863934|NCT00651664|467458432|FG007|Overall Study|Reason not Specified|0|||
129863935|NCT00651664|467458433|FG008|Overall Study|Reason not Specified|0|||
129863936|NCT00651664|467458434|FG009|Overall Study|Reason not Specified|0|||
129863937|NCT00535730|467458435|FG000|Overall Study|Adverse Event|1|||
129863938|NCT00535730|467458436|FG001|Overall Study|Adverse Event|1|||
129863939|NCT00535730|467458435|FG000|Overall Study|Lost to Follow-up|0|||
129863940|NCT00535730|467458436|FG001|Overall Study|Lost to Follow-up|1|||
129863941|NCT00535730|467458435|FG000|Overall Study|Physician Decision|0|||
129863942|NCT00535730|467458436|FG001|Overall Study|Physician Decision|1|||
129863943|NCT00535730|467458435|FG000|Overall Study|Protocol Violation|1|||
129863944|NCT00535730|467458436|FG001|Overall Study|Protocol Violation|0|||
129863945|NCT00535730|467458435|FG000|Overall Study|Withdrawal by Subject|0|||
129863946|NCT00535730|467458436|FG001|Overall Study|Withdrawal by Subject|4|||
129863947|NCT02293538|467458437|FG000|Overall Study|Adverse Event|0|||
129863948|NCT02293538|467458438|FG001|Overall Study|Adverse Event|1|||
129863949|NCT02293538|467458437|FG000|Overall Study|Lost to Follow-up|1|||
129863950|NCT02293538|467458438|FG001|Overall Study|Lost to Follow-up|0|||
129863951|NCT02293538|467458437|FG000|Overall Study|Withdrawal by Subject|0|||
129863952|NCT02293538|467458438|FG001|Overall Study|Withdrawal by Subject|1|||
129863953|NCT00936858|467458439|FG000|Overall Study|Death|3|||
129863954|NCT00936858|467458439|FG000|Overall Study|Progression|29|||
129863955|NCT00936858|467458439|FG000|Overall Study|Withdrawal by Subject|5|||
129863956|NCT00936858|467458439|FG000|Overall Study|Adverse Event|1|||
129863957|NCT00936858|467458439|FG000|Overall Study|Physician Decision|7|||
129863958|NCT00936858|467458439|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
129863959|NCT00936858|467458439|FG000|Overall Study|Lost to Follow-up|1|||
129863960|NCT00989287|467458442|FG000|Overall Study|Adverse Event|1|||
129863961|NCT00989287|467458443|FG001|Overall Study|Adverse Event|0|||
129863962|NCT00989287|467458442|FG000|Overall Study|Lost to Follow-up|0|||
129863963|NCT00989287|467458443|FG001|Overall Study|Lost to Follow-up|1|||
129863964|NCT00729833|467458444|FG000|Overall Study|Death|5|||
129863965|NCT00729833|467458445|FG001|Overall Study|Death|1|||
129863966|NCT00729833|467458446|FG002|Overall Study|Death|3|||
129863967|NCT00729833|467458447|FG003|Overall Study|Death|5|||
129863968|NCT00729833|467458444|FG000|Overall Study|Study Terminated by Sponsor|0|||
129863969|NCT00729833|467458445|FG001|Overall Study|Study Terminated by Sponsor|0|||
129863970|NCT00729833|467458446|FG002|Overall Study|Study Terminated by Sponsor|1|||
129863971|NCT00729833|467458447|FG003|Overall Study|Study Terminated by Sponsor|0|||
129863972|NCT00729833|467458444|FG000|Overall Study|Lost to Follow-up|1|||
129863973|NCT00729833|467458445|FG001|Overall Study|Lost to Follow-up|0|||
130065164|NCT01763866|468192371|FG004|Overall Study|Death|0|||
130065165|NCT01763866|468192372|FG005|Overall Study|Death|0|||
129863974|NCT00729833|467458446|FG002|Overall Study|Lost to Follow-up|0|||
129863975|NCT00729833|467458447|FG003|Overall Study|Lost to Follow-up|0|||
129863976|NCT00729833|467458444|FG000|Overall Study|Withdrawal by Subject|3|||
129863977|NCT00729833|467458445|FG001|Overall Study|Withdrawal by Subject|1|||
129863978|NCT00729833|467458446|FG002|Overall Study|Withdrawal by Subject|3|||
129863979|NCT00729833|467458447|FG003|Overall Study|Withdrawal by Subject|0|||
129863980|NCT00729833|467458444|FG000|Overall Study|Unspecified Reasons|11|||
129863981|NCT00729833|467458445|FG001|Overall Study|Unspecified Reasons|5|||
129863982|NCT00729833|467458446|FG002|Overall Study|Unspecified Reasons|5|||
129863983|NCT00729833|467458447|FG003|Overall Study|Unspecified Reasons|1|||
129863984|NCT01041638|467458448|FG000|Overall Study|Adverse Event|4|||
129863985|NCT01041638|467458448|FG000|Overall Study|Death|1|||
129863986|NCT01041638|467458448|FG000|Overall Study|Lack of Efficacy|7|||
129863987|NCT01041638|467458448|FG000|Overall Study|Physician Decision|4|||
129863988|NCT01041638|467458448|FG000|Overall Study|Withdrawal by Subject|11|||
129863989|NCT00417079|467458449|FG000|Overall Study|Disease progression|267|||
129863990|NCT00417079|467458450|FG001|Overall Study|Disease progression|180|||
129863991|NCT00417079|467458449|FG000|Overall Study|Adverse Event|32|||
129863992|NCT00417079|467458450|FG001|Overall Study|Adverse Event|67|||
129863993|NCT00417079|467458449|FG000|Overall Study|Non-compliance to protocol|0|||
129863994|NCT00417079|467458450|FG001|Overall Study|Non-compliance to protocol|1|||
129863995|NCT00417079|467458449|FG000|Overall Study|Lost to Follow-up|2|||
129863996|NCT00417079|467458450|FG001|Overall Study|Lost to Follow-up|0|||
129863997|NCT00417079|467458449|FG000|Overall Study|Withdrawal by Subject|17|||
129863998|NCT00417079|467458450|FG001|Overall Study|Withdrawal by Subject|8|||
129863999|NCT00417079|467458449|FG000|Overall Study|Not treated|6|||
129864000|NCT00417079|467458450|FG001|Overall Study|Not treated|7|||
129864001|NCT00417079|467458449|FG000|Overall Study|Screened failure|2|||
129864002|NCT00417079|467458450|FG001|Overall Study|Screened failure|1|||
129864003|NCT00417079|467458449|FG000|Overall Study|Investigator's decision|1|||
129864004|NCT00417079|467458450|FG001|Overall Study|Investigator's decision|4|||
129864005|NCT00417079|467458449|FG000|Overall Study|Non-confirmed Disease progression|1|||
129864006|NCT00417079|467458450|FG001|Overall Study|Non-confirmed Disease progression|1|||
129864007|NCT00417079|467458449|FG000|Overall Study|Clinical deterioration|1|||
129864008|NCT00417079|467458450|FG001|Overall Study|Clinical deterioration|0|||
129864009|NCT00417079|467458449|FG000|Overall Study|Screening error|2|||
129864010|NCT00417079|467458450|FG001|Overall Study|Screening error|1|||
129864011|NCT00417079|467458449|FG000|Overall Study|Withdrawal by subject's family|0|||
129864012|NCT00417079|467458450|FG001|Overall Study|Withdrawal by subject's family|1|||
129864013|NCT00417079|467458449|FG000|Overall Study|Patient unable to come to the clinic|0|||
129864014|NCT00417079|467458450|FG001|Overall Study|Patient unable to come to the clinic|1|||
129864015|NCT00417079|467458449|FG000|Overall Study|abnormal liver function tests|0|||
129864016|NCT00417079|467458450|FG001|Overall Study|abnormal liver function tests|1|||
129864017|NCT01687257|467458452|FG000|Overall Study|Efficacy Failure|6|||
129864018|NCT01687257|467458453|FG001|Overall Study|Efficacy Failure|0|||
129864019|NCT01687257|467458454|FG002|Overall Study|Efficacy Failure|5|||
129864020|NCT01687257|467458452|FG000|Overall Study|Subject Withdrew Consent|1|||
129864021|NCT01687257|467458453|FG001|Overall Study|Subject Withdrew Consent|1|||
129864022|NCT01687257|467458454|FG002|Overall Study|Subject Withdrew Consent|1|||
129864023|NCT01687257|467458452|FG000|Overall Study|Adverse Event|1|||
129864024|NCT01687257|467458453|FG001|Overall Study|Adverse Event|0|||
129864025|NCT01687257|467458454|FG002|Overall Study|Adverse Event|0|||
129864026|NCT01687257|467458452|FG000|Overall Study|Investigator's Discretion|0|||
129864027|NCT01687257|467458453|FG001|Overall Study|Investigator's Discretion|3|||
129864028|NCT01687257|467458454|FG002|Overall Study|Investigator's Discretion|0|||
129864029|NCT04403698|467458456|FG000|Overall Study|Adverse Event|1|||
129864030|NCT04403698|467458457|FG001|Overall Study|Adverse Event|1|||
129864031|NCT04403698|467458456|FG000|Overall Study|Lost to Follow-up|1|||
129864032|NCT04403698|467458457|FG001|Overall Study|Lost to Follow-up|0|||
129864033|NCT04403698|467458456|FG000|Overall Study|Protocol Violation|0|||
129864034|NCT04403698|467458457|FG001|Overall Study|Protocol Violation|1|||
129864035|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
129864036|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
129864037|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
129864038|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
129864039|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
129864040|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864041|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
129864042|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864043|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864044|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864045|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
129864046|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
129864047|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
129864048|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
129864049|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
129864050|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864051|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864052|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129864053|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864054|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864055|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864056|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864057|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
129864058|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864059|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864060|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864061|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864062|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864063|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
129864064|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864065|NCT03152552|467458458|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
129864066|NCT03152552|467458459|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
129864067|NCT03152552|467458460|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
129864068|NCT03152552|467458461|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
129864069|NCT03152552|467458462|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
129864070|NCT04899349|467458465|FG000|Overall Study|Study terminated by Sponsor|2|||
129864071|NCT04899349|467458466|FG001|Overall Study|Study terminated by Sponsor|0|||
129864072|NCT01022762|467458468|FG000|Overall Study|Adverse Event|3|||
129864073|NCT01022762|467458469|FG001|Overall Study|Adverse Event|1|||
129864074|NCT01022762|467458468|FG000|Overall Study|Lack of Efficacy|0|||
129864075|NCT01022762|467458469|FG001|Overall Study|Lack of Efficacy|1|||
129864076|NCT01022762|467458468|FG000|Overall Study|Protocol Violation|7|||
129864077|NCT01022762|467458469|FG001|Overall Study|Protocol Violation|6|||
129864078|NCT01022762|467458468|FG000|Overall Study|Unclassified|12|||
129864079|NCT01022762|467458469|FG001|Overall Study|Unclassified|20|||
129864080|NCT01302119|467458470|FG000|Overall Study|Withdrawal by Subject|30|||
129864081|NCT01302119|467458471|FG001|Overall Study|Withdrawal by Subject|20|||
129864082|NCT01302119|467458470|FG000|Overall Study|Lost to Follow-up|10|||
129864083|NCT01302119|467458471|FG001|Overall Study|Lost to Follow-up|4|||
129864084|NCT01302119|467458470|FG000|Overall Study|Adverse Event|2|||
129864085|NCT01302119|467458471|FG001|Overall Study|Adverse Event|1|||
129864086|NCT01302119|467458470|FG000|Overall Study|Non-compliance|4|||
129864087|NCT01302119|467458471|FG001|Overall Study|Non-compliance|2|||
129864088|NCT01302119|467458470|FG000|Overall Study|Non-specific|4|||
129864089|NCT01302119|467458471|FG001|Overall Study|Non-specific|1|||
129864090|NCT04084314|467458472|FG000|Overall Study|Subject/guardian decision|91|||
129864091|NCT04084314|467458472|FG000|Overall Study|Adverse Event|24|||
129864092|NCT04084314|467458472|FG000|Overall Study|Lost to Follow-up|19|||
129864093|NCT04084314|467458472|FG000|Overall Study|New therapy for study indication|9|||
129864094|NCT04084314|467458472|FG000|Overall Study|Pregnancy|9|||
129864095|NCT04084314|467458472|FG000|Overall Study|Withdrawal of informed consent|8|||
129864096|NCT04084314|467458472|FG000|Overall Study|Physician Decision|4|||
129864097|NCT04084314|467458472|FG000|Overall Study|Protocol Deviation|3|||
129864098|NCT00802074|467458476|FG000|Overall Study|Adverse Event|1|||
129864099|NCT00802074|467458477|FG001|Overall Study|Adverse Event|1|||
129864100|NCT00802074|467458478|FG002|Overall Study|Adverse Event|1|||
129864101|NCT00802074|467458479|FG003|Overall Study|Adverse Event|0|||
129864102|NCT00802074|467458480|FG004|Overall Study|Adverse Event|0|||
129864103|NCT00802074|467458481|FG005|Overall Study|Adverse Event|0|||
129864104|NCT00802074|467458476|FG000|Overall Study|Withdrawal by Subject|1|||
129864105|NCT00802074|467458477|FG001|Overall Study|Withdrawal by Subject|0|||
129864106|NCT00802074|467458478|FG002|Overall Study|Withdrawal by Subject|0|||
129864107|NCT00802074|467458479|FG003|Overall Study|Withdrawal by Subject|0|||
129864108|NCT00802074|467458480|FG004|Overall Study|Withdrawal by Subject|0|||
129864109|NCT00802074|467458481|FG005|Overall Study|Withdrawal by Subject|0|||
129864110|NCT03743038|467458482|FG000|Overall Study|Physician Decision|1|||
129864111|NCT01300546|467458483|FG000|Overall Study|Withdrawal by Subject|1|||
129864112|NCT01300546|467458484|FG001|Overall Study|Withdrawal by Subject|0|||
129864113|NCT01300546|467458483|FG000|Overall Study|Lost to Follow-up|0|||
129864114|NCT01300546|467458484|FG001|Overall Study|Lost to Follow-up|2|||
129864115|NCT01300546|467458483|FG000|Overall Study|Lack of Efficacy|0|||
129864116|NCT01300546|467458484|FG001|Overall Study|Lack of Efficacy|3|||
129864117|NCT01300546|467458483|FG000|Overall Study|Adverse Event|0|||
129913520|NCT00409838|467644428|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
129913521|NCT00409838|467644427|FG000|Long-term Extension Period|Pregnancy|1|||
130065166|NCT01763866|468192373|FG006|Overall Study|Death|0|||
129864118|NCT01300546|467458484|FG001|Overall Study|Adverse Event|1|||
129864119|NCT00613951|467458493|FG000|Overall Study|Adverse Event|1|||
129864120|NCT00613951|467458494|FG001|Overall Study|Adverse Event|0|||
129864121|NCT00613951|467458495|FG002|Overall Study|Adverse Event|1|||
129864122|NCT00613951|467458493|FG000|Overall Study|Lack of Efficacy|0|||
129913522|NCT00409838|467644428|FG001|Long-term Extension Period|Pregnancy|0|||
129913523|NCT01619410|467644429|FG000|Overall Study|Lost to Follow-up|7|||
129913524|NCT01619410|467644430|FG001|Overall Study|Lost to Follow-up|4|||
129913525|NCT01250769|467644432|FG000|Overall Study|Withdrawal by Subject|0|||
129913526|NCT01250769|467644433|FG001|Overall Study|Withdrawal by Subject|1|||
129913527|NCT01250769|467644434|FG002|Overall Study|Withdrawal by Subject|1|||
129913528|NCT01250769|467644435|FG003|Overall Study|Withdrawal by Subject|0|||
129913529|NCT01250769|467644432|FG000|Overall Study|Adverse Event|0|||
129913530|NCT01250769|467644433|FG001|Overall Study|Adverse Event|0|||
129913531|NCT01250769|467644434|FG002|Overall Study|Adverse Event|1|||
129913532|NCT01250769|467644435|FG003|Overall Study|Adverse Event|0|||
129913533|NCT00999167|467644437|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
129913534|NCT00999167|467644438|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
129913535|NCT00999167|467644439|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
129913536|NCT00999167|467644437|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
129913537|NCT00999167|467644438|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
129913538|NCT00999167|467644439|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
129913539|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
129913540|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
129913541|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
129913542|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
129913543|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
129913544|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
129913545|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
129913546|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
129913547|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
129913548|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
129913549|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
129913550|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
129913551|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
129913552|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
129913553|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
129913554|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
129913555|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
129913556|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
129913557|NCT05052996|467644444|FG000|Overall Study|Still on study|0|||
129913558|NCT05052996|467644445|FG001|Overall Study|Still on study|0|||
129913559|NCT05052996|467644446|FG002|Overall Study|Still on study|47|||
129913560|NCT05052996|467644447|FG003|Overall Study|Still on study|44|||
129913561|NCT05052996|467644444|FG000|Overall Study|Cohort terminated by sponsor|21|||
129913562|NCT05052996|467644445|FG001|Overall Study|Cohort terminated by sponsor|12|||
129913563|NCT05052996|467644446|FG002|Overall Study|Cohort terminated by sponsor|0|||
129913564|NCT05052996|467644447|FG003|Overall Study|Cohort terminated by sponsor|0|||
129913565|NCT05052996|467644444|FG000|Overall Study|Withdrew consent|1|||
129913566|NCT05052996|467644445|FG001|Overall Study|Withdrew consent|0|||
129913567|NCT05052996|467644446|FG002|Overall Study|Withdrew consent|1|||
129913568|NCT05052996|467644447|FG003|Overall Study|Withdrew consent|2|||
129913569|NCT05052996|467644444|FG000|Overall Study|Lost to Follow-up|1|||
129913570|NCT05052996|467644445|FG001|Overall Study|Lost to Follow-up|0|||
129913571|NCT05052996|467644446|FG002|Overall Study|Lost to Follow-up|0|||
129913572|NCT05052996|467644447|FG003|Overall Study|Lost to Follow-up|2|||
129913573|NCT05052996|467644444|FG000|Overall Study|Adverse Event|0|||
129913574|NCT05052996|467644445|FG001|Overall Study|Adverse Event|0|||
129913575|NCT05052996|467644446|FG002|Overall Study|Adverse Event|2|||
129913576|NCT05052996|467644447|FG003|Overall Study|Adverse Event|0|||
129913577|NCT05052996|467644444|FG000|Overall Study|Randomized but never treated|0|||
129913578|NCT05052996|467644445|FG001|Overall Study|Randomized but never treated|0|||
129913579|NCT05052996|467644446|FG002|Overall Study|Randomized but never treated|1|||
129913580|NCT05052996|467644447|FG003|Overall Study|Randomized but never treated|1|||
129913581|NCT05052996|467644444|FG000|Overall Study|Protocol Violation|1|||
129913582|NCT05052996|467644445|FG001|Overall Study|Protocol Violation|0|||
129913583|NCT05052996|467644446|FG002|Overall Study|Protocol Violation|0|||
129913584|NCT05052996|467644447|FG003|Overall Study|Protocol Violation|0|||
129913585|NCT00522951|467644451|FG000|Period 1|body motion|0|||
129913586|NCT00522951|467644452|FG001|Period 1|body motion|1|||
129913587|NCT00522951|467644451|FG000|Washout Period|Adverse Event|0|||
129913588|NCT00522951|467644452|FG001|Washout Period|Adverse Event|1|||
129913589|NCT00522951|467644451|FG000|Washout Period|Death|0|||
129913590|NCT00522951|467644452|FG001|Washout Period|Death|1|||
129913591|NCT00522951|467644451|FG000|Period 2|Withdrawal by Subject|1|||
129913592|NCT00522951|467644452|FG001|Period 2|Withdrawal by Subject|0|||
129913593|NCT00522951|467644451|FG000|Period 2|residual contrast medium|1|||
129913594|NCT00522951|467644452|FG001|Period 2|residual contrast medium|1|||
129864123|NCT00613951|467458494|FG001|Overall Study|Lack of Efficacy|1|||
129864124|NCT00613951|467458495|FG002|Overall Study|Lack of Efficacy|1|||
129864125|NCT00613951|467458493|FG000|Overall Study|Protocol Violation|1|||
130065167|NCT01763866|468192374|FG007|Overall Study|Death|0|||
130065168|NCT01763866|468192375|FG008|Overall Study|Death|0|||
130065169|NCT01763866|468192376|FG009|Overall Study|Death|0|||
130065170|NCT01763866|468192377|FG010|Overall Study|Death|0|||
130065171|NCT01763866|468192378|FG011|Overall Study|Death|0|||
130065172|NCT01763866|468192379|FG012|Overall Study|Death|0|||
130065173|NCT01763866|468192380|FG013|Overall Study|Death|0|||
130065174|NCT01763866|468192381|FG014|Overall Study|Death|0|||
130065175|NCT01763866|468192382|FG015|Overall Study|Death|0|||
130065176|NCT01763866|468192383|FG016|Overall Study|Death|1|||
130065177|NCT01763866|468192384|FG017|Overall Study|Death|0|||
130065178|NCT01763866|468192385|FG018|Overall Study|Death|0|||
130065179|NCT01763866|468192386|FG019|Overall Study|Death|0|||
130065180|NCT01763866|468192387|FG020|Overall Study|Death|0|||
130065181|NCT01763866|468192388|FG021|Overall Study|Death|0|||
130065182|NCT01763866|468192389|FG022|Overall Study|Death|0|||
130065183|NCT01763866|468192390|FG023|Overall Study|Death|0|||
130065184|NCT06025396|468194612|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
130065185|NCT06025396|468194613|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
130065186|NCT06025396|468194614|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
130065187|NCT06025396|468194615|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
130065188|NCT06025396|468194616|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
130065189|NCT06025396|468194612|FG000|Overall Study|Withdrawal by Subject|0|||
130065190|NCT06025396|468194613|FG001|Overall Study|Withdrawal by Subject|1|||
130065191|NCT06025396|468194614|FG002|Overall Study|Withdrawal by Subject|1|||
130065192|NCT06025396|468194615|FG003|Overall Study|Withdrawal by Subject|0|||
130065193|NCT06025396|468194616|FG004|Overall Study|Withdrawal by Subject|0|||
130065194|NCT02109744|468194619|FG000|Overall Study|Death|1|||
130065195|NCT02109744|468194620|FG001|Overall Study|Death|1|||
130065196|NCT02109744|468194619|FG000|Overall Study|no marrow exam|1|||
130065197|NCT02109744|468194620|FG001|Overall Study|no marrow exam|0|||
130065198|NCT03287245|468194621|FG000|Overall Study|Study terminated by sponsor|3|||
130065199|NCT03287245|468194622|FG001|Overall Study|Study terminated by sponsor|0|||
130065200|NCT03287245|468194623|FG002|Overall Study|Study terminated by sponsor|3|||
130065201|NCT03287245|468194624|FG003|Overall Study|Study terminated by sponsor|1|||
130065202|NCT03287245|468194621|FG000|Overall Study|Adverse Event|1|||
130065203|NCT03287245|468194622|FG001|Overall Study|Adverse Event|0|||
130065204|NCT03287245|468194623|FG002|Overall Study|Adverse Event|0|||
130065205|NCT03287245|468194624|FG003|Overall Study|Adverse Event|0|||
130065206|NCT03287245|468194621|FG000|Overall Study|Withdrawal by Subject|8|||
130065207|NCT03287245|468194622|FG001|Overall Study|Withdrawal by Subject|3|||
130065208|NCT03287245|468194623|FG002|Overall Study|Withdrawal by Subject|3|||
130065209|NCT03287245|468194624|FG003|Overall Study|Withdrawal by Subject|0|||
130065210|NCT03287245|468194621|FG000|Overall Study|Physician Decision|3|||
130065211|NCT03287245|468194622|FG001|Overall Study|Physician Decision|2|||
130065212|NCT03287245|468194623|FG002|Overall Study|Physician Decision|0|||
130065213|NCT03287245|468194624|FG003|Overall Study|Physician Decision|0|||
130065214|NCT02150213|468194625|FG000|Overall Study|Lost to Follow-up|1|||
130065215|NCT02150213|468194625|FG000|Overall Study|Withdrawal by Subject|1|||
130065216|NCT02678312|468194626|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
130065217|NCT02678312|468194627|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130065218|NCT02678312|468194628|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130065219|NCT02678312|468194629|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130065220|NCT02678312|468194630|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
130065221|NCT02678312|468194626|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
130065222|NCT02678312|468194627|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130065223|NCT02678312|468194628|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130065224|NCT02678312|468194629|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130065225|NCT02678312|468194630|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
130065226|NCT02678312|468194626|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
130065227|NCT02678312|468194627|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130065228|NCT02678312|468194628|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130065229|NCT02678312|468194629|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
129864126|NCT00613951|467458494|FG001|Overall Study|Protocol Violation|1|||
130065230|NCT02678312|468194630|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
130065231|NCT02678312|468194626|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
130065232|NCT02678312|468194627|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
130065233|NCT02678312|468194628|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
130065234|NCT02678312|468194629|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
130065235|NCT02678312|468194630|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
130065236|NCT02678312|468194626|FG000|Part 2 Double Blind Epoch|Death|0|||
130065237|NCT02678312|468194627|FG001|Part 2 Double Blind Epoch|Death|0|||
130065238|NCT02678312|468194628|FG002|Part 2 Double Blind Epoch|Death|0|||
129864127|NCT00613951|467458495|FG002|Overall Study|Protocol Violation|1|||
129913595|NCT03101930|467644457|FG000|Overall Study|Withdrawal by Subject|2|||
129913596|NCT03101930|467644458|FG001|Overall Study|Withdrawal by Subject|1|||
129913597|NCT03101930|467644459|FG002|Overall Study|Withdrawal by Subject|2|||
129913598|NCT01747486|467644460|FG000|Stage 1|Physician Decision|3|||
129913599|NCT01747486|467644461|FG001|Stage 1|Physician Decision|0|||
129913600|NCT01747486|467644460|FG000|Stage 1|Withdrawal by Subject|4|||
129913601|NCT01747486|467644461|FG001|Stage 1|Withdrawal by Subject|3|||
129913602|NCT01747486|467644460|FG000|Stage 1|Disease progression|4|||
129913603|NCT01747486|467644461|FG001|Stage 1|Disease progression|9|||
129913604|NCT01747486|467644460|FG000|Stage 1|Death|1|||
129913605|NCT01747486|467644461|FG001|Stage 1|Death|1|||
129913606|NCT01747486|467644460|FG000|Stage 2|Physician Decision|2|||
129913607|NCT01747486|467644461|FG001|Stage 2|Physician Decision|0|||
129913608|NCT01747486|467644460|FG000|Stage 2|Withdrawal by Subject|1|||
129913609|NCT01747486|467644461|FG001|Stage 2|Withdrawal by Subject|0|||
129913610|NCT01747486|467644460|FG000|Stage 2|New Cancer Therapy|3|||
129913611|NCT01747486|467644461|FG001|Stage 2|New Cancer Therapy|0|||
129913612|NCT01747486|467644460|FG000|Stage 2|Disease Progression|3|||
129913613|NCT01747486|467644461|FG001|Stage 2|Disease Progression|0|||
129913614|NCT01771731|467644462|FG000|Overall Study|Physician Decision|1|||
129913615|NCT01771731|467644463|FG001|Overall Study|Physician Decision|0|||
129913616|NCT01771731|467644462|FG000|Overall Study|Protocol Violation|0|||
129913617|NCT01771731|467644463|FG001|Overall Study|Protocol Violation|1|||
129913618|NCT01771731|467644462|FG000|Overall Study|Adverse event: Pain Crisis|1|||
129913619|NCT01771731|467644463|FG001|Overall Study|Adverse event: Pain Crisis|1|||
129913620|NCT00976495|467644464|FG000|Overall Study|Withdrawal by Subject|0|||
129913621|NCT00976495|467644465|FG001|Overall Study|Withdrawal by Subject|1|||
129913622|NCT00976495|467644466|FG002|Overall Study|Withdrawal by Subject|0|||
129913623|NCT02538341|467644467|FG000|Overall Study|Lost to Follow-up|51|||
129913624|NCT02538341|467644468|FG001|Overall Study|Lost to Follow-up|46|||
129913625|NCT02538341|467644467|FG000|Overall Study|Withdrawal by Subject|3|||
129913626|NCT02538341|467644468|FG001|Overall Study|Withdrawal by Subject|1|||
129913627|NCT02538341|467644467|FG000|Overall Study|Death|2|||
129913628|NCT02538341|467644468|FG001|Overall Study|Death|0|||
129913629|NCT00331136|467644469|FG000|Overall Study|Adverse Event|3|||
129913630|NCT00331136|467644470|FG001|Overall Study|Adverse Event|5|||
129913631|NCT00331136|467644471|FG002|Overall Study|Adverse Event|0|||
129913632|NCT00331136|467644472|FG003|Overall Study|Adverse Event|1|||
129913633|NCT00331136|467644469|FG000|Overall Study|Withdrawal by Subject|0|||
129913634|NCT00331136|467644470|FG001|Overall Study|Withdrawal by Subject|1|||
129913635|NCT00331136|467644471|FG002|Overall Study|Withdrawal by Subject|0|||
129913636|NCT00331136|467644472|FG003|Overall Study|Withdrawal by Subject|0|||
129913637|NCT00331136|467644469|FG000|Overall Study|Lost to Follow-up|0|||
129913638|NCT00331136|467644470|FG001|Overall Study|Lost to Follow-up|1|||
129913639|NCT00331136|467644471|FG002|Overall Study|Lost to Follow-up|0|||
129913640|NCT00331136|467644472|FG003|Overall Study|Lost to Follow-up|0|||
129913641|NCT00331136|467644469|FG000|Overall Study|Protocol Violation|1|||
129913642|NCT00331136|467644470|FG001|Overall Study|Protocol Violation|0|||
129913643|NCT00331136|467644471|FG002|Overall Study|Protocol Violation|0|||
129913644|NCT00331136|467644472|FG003|Overall Study|Protocol Violation|0|||
129913645|NCT00331136|467644469|FG000|Overall Study|Not treated|1|||
129913646|NCT00331136|467644470|FG001|Overall Study|Not treated|0|||
129913647|NCT00331136|467644471|FG002|Overall Study|Not treated|0|||
129913648|NCT00331136|467644472|FG003|Overall Study|Not treated|0|||
129913649|NCT02321514|467644473|FG000|Overall Study|Death|15|||
129913650|NCT02321514|467644473|FG000|Overall Study|Missed Visit|7|||
129913651|NCT02321514|467644473|FG000|Overall Study|Study Exit|3|||
129913652|NCT04484935|467644476|FG000|Overall Study|Other|0|||
129913653|NCT04484935|467644477|FG001|Overall Study|Other|1|||
129913654|NCT04484935|467644476|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129913655|NCT04484935|467644477|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129913656|NCT04484935|467644476|FG000|Overall Study|Lost to Follow-up|1|||
129913657|NCT04484935|467644477|FG001|Overall Study|Lost to Follow-up|0|||
129913658|NCT04484935|467644476|FG000|Overall Study|Death|2|||
129913659|NCT04484935|467644477|FG001|Overall Study|Death|1|||
129913660|NCT01094184|467644481|FG000|Overall Study|Death|35|||
129913661|NCT01094184|467644482|FG001|Overall Study|Death|11|||
129913662|NCT03892564|467644483|FG000|Overall Study|Withdrawal by Subject|2|||
129913663|NCT01216176|467646537|FG000|Overall Study|Adverse Event|0|||
129913664|NCT01216176|467646538|FG001|Overall Study|Adverse Event|8|||
129913665|NCT01216176|467646539|FG002|Overall Study|Adverse Event|0|||
129913666|NCT01216176|467646537|FG000|Overall Study|Physician Decision|0|||
129913667|NCT01216176|467646538|FG001|Overall Study|Physician Decision|0|||
129913668|NCT01216176|467646539|FG002|Overall Study|Physician Decision|1|||
129913669|NCT00212355|467646542|FG000|Overall Study|Adverse Event|1|||
129913670|NCT00212355|467646542|FG000|Overall Study|Withdrawal by Subject|1|||
129913671|NCT00212355|467646542|FG000|Overall Study|A change of address|1|||
129913672|NCT00186992|467646546|FG000|Overall Study|Withdrawal by Subject|5|||
129913673|NCT00186992|467646546|FG000|Overall Study|Physician's discretion|13|||
129913674|NCT00186992|467646546|FG000|Overall Study|PI Discretion|4|||
129913675|NCT00186992|467646546|FG000|Overall Study|Ineligible|2|||
130065239|NCT02678312|468194629|FG003|Part 2 Double Blind Epoch|Death|8|||
130065240|NCT02678312|468194630|FG004|Part 2 Double Blind Epoch|Death|12|||
130065241|NCT02678312|468194626|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
130065242|NCT02678312|468194627|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
130065243|NCT02678312|468194628|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
130065244|NCT02678312|468194629|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
130065245|NCT02678312|468194630|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
130065246|NCT02678312|468194626|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130065247|NCT02678312|468194627|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130065248|NCT02678312|468194628|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
130065249|NCT02678312|468194629|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
129864128|NCT00613951|467458493|FG000|Overall Study|Unclassified|5|||
129864129|NCT00613951|467458494|FG001|Overall Study|Unclassified|3|||
129864130|NCT00613951|467458495|FG002|Overall Study|Unclassified|2|||
129864131|NCT04439110|467458496|FG000|Overall Study|Ineligible|2|||
129864132|NCT04439110|467458496|FG000|Overall Study|Adverse Event|4|||
129864133|NCT04439110|467458496|FG000|Overall Study|Death|2|||
129864134|NCT04439110|467458496|FG000|Overall Study|Disease proression|25|||
129864135|NCT04439110|467458496|FG000|Overall Study|Withdrawal by Subject|1|||
129864136|NCT04439110|467458496|FG000|Overall Study|Alternative therapy|1|||
129864137|NCT04439110|467458496|FG000|Overall Study|Other complicating disease|1|||
129864138|NCT04439110|467458496|FG000|Overall Study|Personal reasons|1|||
129864139|NCT04439110|467458496|FG000|Overall Study|Still on treatment|1|||
129864140|NCT00127608|467458497|FG000|Overall Study|VZV DNA negative|1|||
129864141|NCT00506493|467458503|FG000|Overall Study|Death|6|||
129864142|NCT00506493|467458503|FG000|Overall Study|Withdrawal by Subject|5|||
129864143|NCT01266642|467458504|FG000|Overall Study|Protocol Violation|0|||
129864144|NCT01266642|467458505|FG001|Overall Study|Protocol Violation|1|||
129864145|NCT00955357|467459924|FG000|Titration Phase|Adverse Event|9|||
129864146|NCT00955357|467459925|FG001|Titration Phase|Adverse Event|46|||
129864147|NCT00955357|467459924|FG000|Titration Phase|Lack of Efficacy|0|||
129864148|NCT00955357|467459925|FG001|Titration Phase|Lack of Efficacy|2|||
129864149|NCT00955357|467459924|FG000|Titration Phase|Protocol Violation|3|||
129864150|NCT00955357|467459925|FG001|Titration Phase|Protocol Violation|7|||
129864151|NCT00955357|467459924|FG000|Titration Phase|Lost to Follow-up|1|||
129864152|NCT00955357|467459925|FG001|Titration Phase|Lost to Follow-up|3|||
129864153|NCT00955357|467459924|FG000|Titration Phase|Withdrawal by Subject|3|||
129864154|NCT00955357|467459925|FG001|Titration Phase|Withdrawal by Subject|5|||
129864155|NCT00955357|467459924|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
129864156|NCT00955357|467459925|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
129864157|NCT00955357|467459924|FG000|Titration Phase|Study medication not tolerated|0|||
129864158|NCT00955357|467459925|FG001|Titration Phase|Study medication not tolerated|1|||
129864159|NCT00955357|467459924|FG000|Titration Phase|Non compliance to study procedures|0|||
129864160|NCT00955357|467459925|FG001|Titration Phase|Non compliance to study procedures|1|||
129864161|NCT00955357|467459924|FG000|Maintenance Phase|Adverse Event|3|||
129864162|NCT00955357|467459925|FG001|Maintenance Phase|Adverse Event|23|||
129864163|NCT00955357|467459924|FG000|Maintenance Phase|Lack of Efficacy|0|||
129864164|NCT00955357|467459925|FG001|Maintenance Phase|Lack of Efficacy|4|||
129864165|NCT00955357|467459924|FG000|Maintenance Phase|Protocol Violation|2|||
129864166|NCT00955357|467459925|FG001|Maintenance Phase|Protocol Violation|6|||
129864167|NCT00955357|467459924|FG000|Maintenance Phase|Lost to Follow-up|2|||
129864168|NCT00955357|467459925|FG001|Maintenance Phase|Lost to Follow-up|7|||
129864169|NCT00955357|467459924|FG000|Maintenance Phase|Withdrawal by Subject|4|||
129864170|NCT00955357|467459925|FG001|Maintenance Phase|Withdrawal by Subject|4|||
129864171|NCT00955357|467459924|FG000|Maintenance Phase|Patient moving out of area|0|||
129864172|NCT00955357|467459925|FG001|Maintenance Phase|Patient moving out of area|1|||
129864173|NCT00955357|467459924|FG000|Maintenance Phase|Non compliance to study procedures|1|||
129864174|NCT00955357|467459925|FG001|Maintenance Phase|Non compliance to study procedures|0|||
129864175|NCT01925950|467459927|FG000|Part 2|Withdrawal by Subject|1|||
129864176|NCT01925950|467459928|FG001|Part 2|Withdrawal by Subject|0|||
129864177|NCT00381940|467459929|FG000|Overall Study|Lack of Efficacy|3|||
129864178|NCT00381940|467459929|FG000|Overall Study|Protocol Violation|1|||
129864179|NCT00381940|467459929|FG000|Overall Study|Ineligible|1|||
129864180|NCT03162224|467459930|FG000|Overall Study|Death|4|||
129864181|NCT03162224|467459931|FG001|Overall Study|Death|5|||
129864182|NCT03162224|467459932|FG002|Overall Study|Death|8|||
129864183|NCT03162224|467459930|FG000|Overall Study|Withdrawal by Subject|1|||
129864184|NCT03162224|467459931|FG001|Overall Study|Withdrawal by Subject|0|||
129864185|NCT03162224|467459932|FG002|Overall Study|Withdrawal by Subject|1|||
129864186|NCT03162224|467459930|FG000|Overall Study|Lost to Follow-up|0|||
129913676|NCT00186992|467646546|FG000|Overall Study|Lost to Follow-up|2|||
129864187|NCT03162224|467459931|FG001|Overall Study|Lost to Follow-up|1|||
129864188|NCT03162224|467459932|FG002|Overall Study|Lost to Follow-up|0|||
129864189|NCT03162224|467459930|FG000|Overall Study|Other|6|||
130065250|NCT02678312|468194630|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
129864190|NCT03162224|467459931|FG001|Overall Study|Other|2|||
129913677|NCT00186992|467646546|FG000|Overall Study|Still on Study|9|||
129913678|NCT03683069|467646547|FG000|Overall Study|see limitations|12|||
129913679|NCT03683069|467646548|FG001|Overall Study|see limitations|13|||
129913680|NCT03769168|467646549|FG000|Overall Study|Adverse Event|0|||
129913681|NCT03769168|467646550|FG001|Overall Study|Adverse Event|1|||
129913682|NCT03769168|467646549|FG000|Overall Study|Lack of Efficacy|2|||
129913683|NCT03769168|467646550|FG001|Overall Study|Lack of Efficacy|4|||
129913684|NCT03769168|467646549|FG000|Overall Study|Post study access to treatment|3|||
129913685|NCT03769168|467646550|FG001|Overall Study|Post study access to treatment|11|||
129913686|NCT03769168|467646549|FG000|Overall Study|Physician Decision|1|||
129913687|NCT03769168|467646550|FG001|Overall Study|Physician Decision|4|||
129913688|NCT03769168|467646549|FG000|Overall Study|Subject Decision|2|||
129913689|NCT03769168|467646550|FG001|Overall Study|Subject Decision|4|||
129913690|NCT03769168|467646549|FG000|Overall Study|Guardian decision|1|||
129913691|NCT03769168|467646550|FG001|Overall Study|Guardian decision|0|||
129913692|NCT04941287|467646551|FG000|Overall Study|Rapid decline before starting treatment|3|||
129913693|NCT04941287|467646552|FG001|Overall Study|Rapid decline before starting treatment|1|||
129913694|NCT04065048|467646553|FG000|Overall Study|Withdrawal by Subject|1|||
129913695|NCT04065048|467646554|FG001|Overall Study|Withdrawal by Subject|2|||
129913696|NCT04065048|467646555|FG002|Overall Study|Withdrawal by Subject|1|||
129913697|NCT04065048|467646556|FG003|Overall Study|Withdrawal by Subject|1|||
129913698|NCT04065048|467646553|FG000|Overall Study|Adverse Event|1|||
129913699|NCT04065048|467646554|FG001|Overall Study|Adverse Event|0|||
129913700|NCT04065048|467646555|FG002|Overall Study|Adverse Event|1|||
129913701|NCT04065048|467646556|FG003|Overall Study|Adverse Event|0|||
129913702|NCT05104697|467646557|FG000|Overall Study|Withdrawal by Subject|0|||
129913703|NCT05104697|467646558|FG001|Overall Study|Withdrawal by Subject|1|||
129913704|NCT03845465|467646559|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
129913705|NCT03845465|467646560|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
129913706|NCT03845465|467646559|FG000|6-month Data Collection|Withdrawal by Subject|0|||
129913707|NCT03845465|467646560|FG001|6-month Data Collection|Withdrawal by Subject|2|||
129913708|NCT03845465|467646559|FG000|12-month Data Collection|Withdrawal by Subject|0|||
129913709|NCT03845465|467646560|FG001|12-month Data Collection|Withdrawal by Subject|2|||
129913710|NCT05307978|467646576|FG000|Overall Study|Lost to Follow-up|0|||
129913711|NCT05307978|467646577|FG001|Overall Study|Lost to Follow-up|1|||
129913712|NCT05307978|467646578|FG002|Overall Study|Lost to Follow-up|0|||
129913713|NCT05307978|467646579|FG003|Overall Study|Lost to Follow-up|4|||
129913714|NCT05307978|467646580|FG004|Overall Study|Lost to Follow-up|0|||
129913715|NCT05307978|467646581|FG005|Overall Study|Lost to Follow-up|0|||
129913716|NCT05307978|467646582|FG006|Overall Study|Lost to Follow-up|1|||
129913717|NCT03324984|467646583|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
129913718|NCT03324984|467646584|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
129913719|NCT05656911|467646585|FG000|Treatment Phase|Physician Decision|2|||
129913720|NCT05656911|467646586|FG001|Treatment Phase|Physician Decision|0|||
129913721|NCT05656911|467646585|FG000|Treatment Phase|Lack of Efficacy|6|||
129913722|NCT05656911|467646586|FG001|Treatment Phase|Lack of Efficacy|3|||
129913723|NCT05656911|467646585|FG000|Treatment Phase|Subject Decision|4|||
129913724|NCT05656911|467646586|FG001|Treatment Phase|Subject Decision|2|||
129913725|NCT05656911|467646585|FG000|Treatment Phase|Other Reasons|1|||
129913726|NCT05656911|467646586|FG001|Treatment Phase|Other Reasons|0|||
129913727|NCT05656911|467646585|FG000|Treatment Phase|Adverse Event|3|||
129913728|NCT05656911|467646586|FG001|Treatment Phase|Adverse Event|1|||
129913729|NCT05656911|467646585|FG000|Follow-up Phase|Subject Decision|0|||
129913730|NCT05656911|467646586|FG001|Follow-up Phase|Subject Decision|1|||
129913731|NCT05656911|467646585|FG000|Follow-up Phase|Missing|1|||
129913732|NCT05656911|467646586|FG001|Follow-up Phase|Missing|0|||
129913733|NCT05075408|467646587|FG000|Overall Study|Withdrawal by Subject|5|||
129913734|NCT05075408|467646588|FG001|Overall Study|Withdrawal by Subject|3|||
129913735|NCT05075408|467646589|FG002|Overall Study|Withdrawal by Subject|4|||
129913736|NCT05075408|467646587|FG000|Overall Study|Adverse Event|5|||
129913737|NCT05075408|467646588|FG001|Overall Study|Adverse Event|7|||
129913738|NCT05075408|467646589|FG002|Overall Study|Adverse Event|8|||
129913739|NCT05075408|467646587|FG000|Overall Study|Protocol Violation|0|||
130065251|NCT02678312|468194626|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
130065252|NCT02678312|468194627|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
130065253|NCT02678312|468194628|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
129913740|NCT05075408|467646588|FG001|Overall Study|Protocol Violation|1|||
129913741|NCT05075408|467646589|FG002|Overall Study|Protocol Violation|0|||
130065254|NCT02678312|468194629|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
129913742|NCT05075408|467646587|FG000|Overall Study|Lost to Follow-up|2|||
129913743|NCT05075408|467646588|FG001|Overall Study|Lost to Follow-up|1|||
129913744|NCT05075408|467646589|FG002|Overall Study|Lost to Follow-up|1|||
129913745|NCT05075408|467646587|FG000|Overall Study|Physician Decision|1|||
129913746|NCT05075408|467646588|FG001|Overall Study|Physician Decision|0|||
129913747|NCT05075408|467646589|FG002|Overall Study|Physician Decision|0|||
129913748|NCT05075408|467646587|FG000|Overall Study|Other-unspecified|3|||
129913749|NCT05075408|467646588|FG001|Overall Study|Other-unspecified|2|||
130065255|NCT02678312|468194630|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
130065256|NCT00971425|468194631|FG000|Overall Study|Adverse Event|1|||
130065257|NCT00971425|468194632|FG001|Overall Study|Adverse Event|1|||
130065258|NCT00971425|468194631|FG000|Overall Study|Withdrawal by Subject|0|||
130065259|NCT00971425|468194632|FG001|Overall Study|Withdrawal by Subject|1|||
130065260|NCT02759562|468194633|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
130065261|NCT02759562|468194634|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
130065262|NCT02759562|468194633|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
130065263|NCT02759562|468194634|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
130065264|NCT04624672|468194639|FG000|Overall Study|Early Study Closure|2|||
130065265|NCT04624672|468194640|FG001|Overall Study|Early Study Closure|1|||
130065266|NCT03472040|468194641|FG000|Overall Study|Physician Decision|0|||
130065267|NCT03472040|468194642|FG001|Overall Study|Physician Decision|3|||
130065268|NCT03472040|468194641|FG000|Overall Study|Withdrawal by Subject|10|||
130065269|NCT03472040|468194642|FG001|Overall Study|Withdrawal by Subject|23|||
130065270|NCT03472040|468194641|FG000|Overall Study|Perceived Lack of Efficacy|29|||
130065271|NCT03472040|468194642|FG001|Overall Study|Perceived Lack of Efficacy|30|||
130065272|NCT03472040|468194641|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
130065273|NCT03472040|468194642|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
130065274|NCT03472040|468194641|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
130065275|NCT03472040|468194642|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
130065276|NCT03472040|468194641|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
130065277|NCT03472040|468194642|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
130065278|NCT03472040|468194641|FG000|Overall Study|Subject Non-compliance|2|||
130065279|NCT03472040|468194642|FG001|Overall Study|Subject Non-compliance|5|||
130065280|NCT03472040|468194641|FG000|Overall Study|Discontinuation due to Rash|0|||
130065281|NCT03472040|468194642|FG001|Overall Study|Discontinuation due to Rash|1|||
130065282|NCT03472040|468194641|FG000|Overall Study|Subsequent Ineligibility|0|||
130065283|NCT03472040|468194642|FG001|Overall Study|Subsequent Ineligibility|2|||
130065284|NCT03472040|468194641|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
130065285|NCT03472040|468194642|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
130065286|NCT02769832|468194643|FG000|Overall Study|Death|30|||
130065287|NCT00225147|468194652|FG000|Open-label Phase|Lost to Follow-up|0|||
130065288|NCT00225147|468194653|FG001|Open-label Phase|Lost to Follow-up|0|||
130065289|NCT00225147|468194654|FG002|Open-label Phase|Lost to Follow-up|0|||
130065290|NCT00225147|468194655|FG003|Open-label Phase|Lost to Follow-up|4|||
130065291|NCT00225147|468194652|FG000|Open-label Phase|Withdrawal by Subject|0|||
130065292|NCT00225147|468194653|FG001|Open-label Phase|Withdrawal by Subject|0|||
130065293|NCT00225147|468194654|FG002|Open-label Phase|Withdrawal by Subject|0|||
130065294|NCT00225147|468194655|FG003|Open-label Phase|Withdrawal by Subject|6|||
130065295|NCT02685995|468194661|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
130065296|NCT02685995|468194662|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
130065297|NCT03625141|468194663|FG000|Overall Study|Adverse Event|0|||
130065298|NCT03625141|468194664|FG001|Overall Study|Adverse Event|2|||
130065299|NCT03625141|468194663|FG000|Overall Study|Study Terminated By Sponsor|1|||
130065300|NCT03625141|468194664|FG001|Overall Study|Study Terminated By Sponsor|13|||
130065301|NCT03625141|468194663|FG000|Overall Study|Withdrawal by Subject|3|||
130065302|NCT03625141|468194664|FG001|Overall Study|Withdrawal by Subject|0|||
130065303|NCT03625141|468194663|FG000|Overall Study|Withdrawal Of Consent|0|||
130065304|NCT03625141|468194664|FG001|Overall Study|Withdrawal Of Consent|1|||
130065305|NCT03625141|468194663|FG000|Overall Study|Death|11|||
130065306|NCT03625141|468194664|FG001|Overall Study|Death|47|||
129864191|NCT03162224|467459932|FG002|Overall Study|Other|1|||
129864192|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
129864193|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
129864194|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
130065307|NCT03625141|468194663|FG000|Overall Study|Progressive Disease|0|||
130065308|NCT03625141|468194664|FG001|Overall Study|Progressive Disease|2|||
130065309|NCT00433446|468194666|FG000|Overall Study|Adverse Event|4|||
130065310|NCT00433446|468194666|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130065311|NCT00433446|468194666|FG000|Overall Study|Progression|44|||
130065312|NCT00433446|468194666|FG000|Overall Study|Other - Not Protocol specified|3|||
130065313|NCT00433446|468194666|FG000|Overall Study|Ineligible|9|||
130065314|NCT03819218|468194667|FG000|Overall Study|Protocol Violation|1|||
130065315|NCT01188538|468194668|FG000|Overall Study|Lost to Follow-up|0|||
130065316|NCT01188538|468194669|FG001|Overall Study|Lost to Follow-up|1|||
130065317|NCT02501902|468194670|FG000|Overall Study|Subject Refused Further Follow-up|0|||
130065318|NCT02501902|468194671|FG001|Overall Study|Subject Refused Further Follow-up|0|||
130065319|NCT02501902|468194672|FG002|Overall Study|Subject Refused Further Follow-up|0|||
130065320|NCT02501902|468194673|FG003|Overall Study|Subject Refused Further Follow-up|0|||
130065321|NCT02501902|468194674|FG004|Overall Study|Subject Refused Further Follow-up|0|||
130065322|NCT02501902|468194675|FG005|Overall Study|Subject Refused Further Follow-up|0|||
130065323|NCT02501902|468194676|FG006|Overall Study|Subject Refused Further Follow-up|0|||
129913750|NCT05075408|467646589|FG002|Overall Study|Other-unspecified|0|||
129913751|NCT02837510|467646590|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
129913752|NCT02837510|467646591|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
129913753|NCT02837510|467646590|FG000|Washout (2 Weeks)|Adverse Event|0|||
129913754|NCT02837510|467646591|FG001|Washout (2 Weeks)|Adverse Event|1|||
129913755|NCT02837510|467646590|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
129913756|NCT02837510|467646591|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
129913757|NCT02837510|467646590|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
129913758|NCT02837510|467646591|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
129913759|NCT02837510|467646590|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
129913760|NCT02837510|467646591|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
129913761|NCT02837510|467646590|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
129913762|NCT02837510|467646591|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
129913763|NCT05419505|467646592|FG000|Overall Study|Adverse Event|0|||
129913764|NCT05419505|467646593|FG001|Overall Study|Adverse Event|0|||
129913765|NCT05419505|467646594|FG002|Overall Study|Adverse Event|0|||
129913766|NCT05419505|467646595|FG003|Overall Study|Adverse Event|1|||
129913767|NCT05419505|467646596|FG004|Overall Study|Adverse Event|0|||
129913768|NCT05419505|467646597|FG005|Overall Study|Adverse Event|0|||
129913769|NCT05419505|467646598|FG006|Overall Study|Adverse Event|0|||
129913770|NCT05419505|467646599|FG007|Overall Study|Adverse Event|0|||
129913771|NCT05419505|467646592|FG000|Overall Study|Withdrawal by Subject|1|||
129913772|NCT05419505|467646593|FG001|Overall Study|Withdrawal by Subject|2|||
129913773|NCT05419505|467646594|FG002|Overall Study|Withdrawal by Subject|0|||
129913774|NCT05419505|467646595|FG003|Overall Study|Withdrawal by Subject|0|||
129913775|NCT05419505|467646596|FG004|Overall Study|Withdrawal by Subject|0|||
129913776|NCT05419505|467646597|FG005|Overall Study|Withdrawal by Subject|0|||
129913777|NCT05419505|467646598|FG006|Overall Study|Withdrawal by Subject|1|||
129913778|NCT05419505|467646599|FG007|Overall Study|Withdrawal by Subject|0|||
129913779|NCT05419505|467646592|FG000|Overall Study|Lost to Follow-up|2|||
129913780|NCT05419505|467646593|FG001|Overall Study|Lost to Follow-up|1|||
129913781|NCT05419505|467646594|FG002|Overall Study|Lost to Follow-up|0|||
129913782|NCT05419505|467646595|FG003|Overall Study|Lost to Follow-up|0|||
129913783|NCT05419505|467646596|FG004|Overall Study|Lost to Follow-up|1|||
129913784|NCT05419505|467646597|FG005|Overall Study|Lost to Follow-up|2|||
129913785|NCT05419505|467646598|FG006|Overall Study|Lost to Follow-up|0|||
129913786|NCT05419505|467646599|FG007|Overall Study|Lost to Follow-up|1|||
129913787|NCT02780388|467646602|FG000|Overall Study|Lost to Follow-up|0|||
129913788|NCT02780388|467646603|FG001|Overall Study|Lost to Follow-up|1|||
129913789|NCT02780388|467646604|FG002|Overall Study|Lost to Follow-up|0|||
129913790|NCT02780388|467646605|FG003|Overall Study|Lost to Follow-up|0|||
129913791|NCT02780388|467646606|FG004|Overall Study|Lost to Follow-up|0|||
129913792|NCT02780388|467646602|FG000|Overall Study|Withdrawal by Subject|1|||
129913793|NCT02780388|467646603|FG001|Overall Study|Withdrawal by Subject|1|||
129913794|NCT02780388|467646604|FG002|Overall Study|Withdrawal by Subject|0|||
129913795|NCT02780388|467646605|FG003|Overall Study|Withdrawal by Subject|0|||
129913796|NCT02780388|467646606|FG004|Overall Study|Withdrawal by Subject|0|||
129913797|NCT04527146|467646607|FG000|Overall Study|Withdrawal by Subject|12|||
129913798|NCT04527146|467646608|FG001|Overall Study|Withdrawal by Subject|15|||
129913799|NCT04527146|467646609|FG002|Overall Study|Withdrawal by Subject|7|||
129913800|NCT04527146|467646610|FG003|Overall Study|Withdrawal by Subject|16|||
129913801|NCT04527146|467646607|FG000|Overall Study|Lost to Follow-up|13|||
129913802|NCT04527146|467646608|FG001|Overall Study|Lost to Follow-up|9|||
129913803|NCT04527146|467646609|FG002|Overall Study|Lost to Follow-up|16|||
129913804|NCT04527146|467646610|FG003|Overall Study|Lost to Follow-up|13|||
129913805|NCT04527146|467646607|FG000|Overall Study|Death|0|||
129913806|NCT04527146|467646608|FG001|Overall Study|Death|1|||
129913807|NCT04527146|467646609|FG002|Overall Study|Death|1|||
129913808|NCT04527146|467646610|FG003|Overall Study|Death|0|||
129913809|NCT04527146|467646607|FG000|Overall Study|Adverse Event|0|||
129913810|NCT04527146|467646608|FG001|Overall Study|Adverse Event|0|||
129913811|NCT04527146|467646609|FG002|Overall Study|Adverse Event|1|||
129913812|NCT04527146|467646610|FG003|Overall Study|Adverse Event|0|||
129913813|NCT04527146|467646607|FG000|Overall Study|Ineligible after randomization|2|||
129913814|NCT04527146|467646608|FG001|Overall Study|Ineligible after randomization|0|||
129913815|NCT04527146|467646609|FG002|Overall Study|Ineligible after randomization|2|||
129913816|NCT04527146|467646610|FG003|Overall Study|Ineligible after randomization|2|||
129913817|NCT04527146|467646607|FG000|Overall Study|Moved to a different group|6|||
129913818|NCT04527146|467646608|FG001|Overall Study|Moved to a different group|3|||
129913819|NCT04527146|467646609|FG002|Overall Study|Moved to a different group|0|||
129913820|NCT04527146|467646610|FG003|Overall Study|Moved to a different group|2|||
129913821|NCT05107401|467646611|FG000|Overall Study|Lost to Follow-up|13|||
129913822|NCT05107401|467646612|FG001|Overall Study|Lost to Follow-up|12|||
129913823|NCT04468776|467646619|FG000|Overall Study|Lost to Follow-up|4|||
129913824|NCT04468776|467646620|FG001|Overall Study|Lost to Follow-up|3|||
129913825|NCT04468776|467646621|FG002|Overall Study|Lost to Follow-up|4|||
129913826|NCT04468776|467646619|FG000|Overall Study|Withdrawal by Subject|1|||
129913827|NCT04468776|467646620|FG001|Overall Study|Withdrawal by Subject|10|||
129913828|NCT04468776|467646621|FG002|Overall Study|Withdrawal by Subject|4|||
129913829|NCT04468776|467646619|FG000|Overall Study|Physician Decision|0|||
129913830|NCT04468776|467646620|FG001|Overall Study|Physician Decision|1|||
129913831|NCT04468776|467646621|FG002|Overall Study|Physician Decision|1|||
129913832|NCT04440176|467646624|FG000|Overall Study|Withdrawal by Subject|5|||
129913833|NCT04440176|467646625|FG001|Overall Study|Withdrawal by Subject|3|||
129913834|NCT04440176|467646624|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129913835|NCT04440176|467646625|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129913836|NCT04440176|467646624|FG000|Overall Study|Adverse Event|2|||
129913837|NCT04440176|467646625|FG001|Overall Study|Adverse Event|6|||
129913838|NCT04440176|467646624|FG000|Overall Study|Lost to Follow-up|22|||
129913839|NCT04440176|467646625|FG001|Overall Study|Lost to Follow-up|23|||
129913840|NCT04440176|467646624|FG000|Overall Study|Medication error without associated adverse event|0|||
129913841|NCT04440176|467646625|FG001|Overall Study|Medication error without associated adverse event|1|||
129913842|NCT04440176|467646624|FG000|Overall Study|No longer met eligibility criteria|7|||
129913843|NCT04440176|467646625|FG001|Overall Study|No longer met eligibility criteria|1|||
129913844|NCT04440176|467646624|FG000|Overall Study|Other|1|||
129913845|NCT04440176|467646625|FG001|Overall Study|Other|2|||
129913846|NCT04440176|467646624|FG000|Overall Study|Protocol deviation|6|||
129913847|NCT04440176|467646625|FG001|Overall Study|Protocol deviation|8|||
129913848|NCT04440176|467646624|FG000|Overall Study|Randomized but not vaccinated|6|||
129913849|NCT04440176|467646625|FG001|Overall Study|Randomized but not vaccinated|3|||
129913850|NCT04608045|467646632|FG000|Overall Study|Physician Decision|1|||
129913851|NCT03103321|467646634|FG000|Overall Study|Protocol Violation|1|||
129913852|NCT03103321|467646635|FG001|Overall Study|Protocol Violation|1|||
129913853|NCT03103321|467646636|FG002|Overall Study|Protocol Violation|1|||
129913854|NCT03103321|467646637|FG003|Overall Study|Protocol Violation|0|||
129913855|NCT04247542|467646638|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
129913856|NCT04247542|467646639|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
129913857|NCT04247542|467646640|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
129913858|NCT04247542|467646638|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
129913859|NCT04247542|467646639|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
129913860|NCT04247542|467646640|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
129913861|NCT04118452|467646641|FG000|Overall Study|Lost to Follow-up|5|||
129913862|NCT04118452|467646642|FG001|Overall Study|Lost to Follow-up|5|||
129913863|NCT04118452|467646641|FG000|Overall Study|Withdrawal by Subject|17|||
129913864|NCT04118452|467646642|FG001|Overall Study|Withdrawal by Subject|17|||
129913865|NCT04847999|467646643|FG000|Overall Study|Lost to Follow-up|0|||
129913866|NCT04847999|467646644|FG001|Overall Study|Lost to Follow-up|1|||
129913867|NCT02879448|467646645|FG000|Overall Study|Death|251|||
129913868|NCT02879448|467646646|FG001|Overall Study|Death|263|||
129913869|NCT02879448|467646645|FG000|Overall Study|Lost to Follow-up|23|||
129913870|NCT02879448|467646646|FG001|Overall Study|Lost to Follow-up|28|||
129913871|NCT02879448|467646645|FG000|Overall Study|Withdrawal by Subject|42|||
129913872|NCT02879448|467646646|FG001|Overall Study|Withdrawal by Subject|79|||
129913873|NCT02879448|467646645|FG000|Overall Study|Other Reasons|8|||
129913874|NCT02879448|467646646|FG001|Overall Study|Other Reasons|12|||
129913875|NCT05952076|467646647|FG000|Overall Study|Death|1|||
129913876|NCT05952076|467646648|FG001|Overall Study|Death|1|||
129913877|NCT05952076|467646647|FG000|Overall Study|Lost to Follow-up|0|||
129913878|NCT05952076|467646648|FG001|Overall Study|Lost to Follow-up|1|||
129913879|NCT05288283|467646649|FG000|Overall Study|Study Terminated Early|1|||
129913880|NCT05288283|467646650|FG001|Overall Study|Study Terminated Early|1|||
129913881|NCT05086744|467646651|FG000|Part A|Adverse Event|0|||
129913882|NCT05086744|467646652|FG001|Part A|Adverse Event|1|||
129913883|NCT05086744|467646651|FG000|Part A|Lack of Efficacy|3|||
129913884|NCT05086744|467646652|FG001|Part A|Lack of Efficacy|0|||
129913885|NCT05086744|467646651|FG000|Part A|Protocol deviation|1|||
129913886|NCT05086744|467646652|FG001|Part A|Protocol deviation|0|||
129913887|NCT05086744|467646651|FG000|Part A|Subject decision|1|||
129913888|NCT05086744|467646652|FG001|Part A|Subject decision|0|||
129913889|NCT05086744|467646651|FG000|Part B|Adverse Event|0|||
129913890|NCT05086744|467646652|FG001|Part B|Adverse Event|1|||
129913891|NCT05086744|467646651|FG000|Part B|Lack of Efficacy|0|||
129913892|NCT05086744|467646652|FG001|Part B|Lack of Efficacy|1|||
129913893|NCT05086744|467646651|FG000|Part B|Study terminated by sponsor|1|||
129913894|NCT05086744|467646652|FG001|Part B|Study terminated by sponsor|6|||
129913895|NCT01704079|467646653|FG000|Overall Study|Withdrawal by Subject|5|||
129913896|NCT01704079|467646654|FG001|Overall Study|Withdrawal by Subject|7|||
129913897|NCT01704079|467646653|FG000|Overall Study|Lost to Follow-up|2|||
129913898|NCT01704079|467646654|FG001|Overall Study|Lost to Follow-up|5|||
129913899|NCT01704079|467646653|FG000|Overall Study|Adverse Event|4|||
129913900|NCT01704079|467646654|FG001|Overall Study|Adverse Event|7|||
129913901|NCT01704079|467646653|FG000|Overall Study|Protocol Violation|1|||
129913902|NCT01704079|467646654|FG001|Overall Study|Protocol Violation|0|||
129913903|NCT01704079|467646653|FG000|Overall Study|Subject noncompliance|2|||
129913904|NCT01704079|467646654|FG001|Overall Study|Subject noncompliance|3|||
129913905|NCT01704079|467646653|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
129913906|NCT01704079|467646654|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
129913907|NCT05986565|467646655|FG000|Overall Study|Lost to Follow-up|8|||
129913908|NCT05986565|467646656|FG001|Overall Study|Lost to Follow-up|3|||
129913909|NCT05986565|467646655|FG000|Overall Study|Withdrawal by Subject|0|||
129913910|NCT05986565|467646656|FG001|Overall Study|Withdrawal by Subject|1|||
129913911|NCT02991807|467646658|FG000|Overall Study|Withdrawal by Subject|2|||
129913912|NCT02991807|467646659|FG001|Overall Study|Withdrawal by Subject|1|||
129913913|NCT02991807|467646658|FG000|Overall Study|Physician Decision|0|||
129913914|NCT02991807|467646659|FG001|Overall Study|Physician Decision|1|||
129913915|NCT02991807|467646658|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
129913916|NCT02991807|467646659|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
129913917|NCT00792636|467646661|FG000|Overall Study|Protocol Violation|17|||
129913918|NCT00792636|467646662|FG001|Overall Study|Protocol Violation|23|||
129913919|NCT00792636|467646663|FG002|Overall Study|Protocol Violation|20|||
129913920|NCT00792636|467646661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
129913921|NCT00792636|467646662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
129913922|NCT00792636|467646663|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
129913923|NCT00792636|467646661|FG000|Overall Study|Lost to Follow-up|13|||
129913924|NCT00792636|467646662|FG001|Overall Study|Lost to Follow-up|19|||
129913925|NCT00792636|467646663|FG002|Overall Study|Lost to Follow-up|14|||
129913926|NCT00792636|467646661|FG000|Overall Study|Withdrew Consent|10|||
129913927|NCT00792636|467646662|FG001|Overall Study|Withdrew Consent|13|||
129913928|NCT00792636|467646663|FG002|Overall Study|Withdrew Consent|9|||
129913929|NCT00792636|467646661|FG000|Overall Study|Lack of Efficacy|3|||
129913930|NCT00792636|467646662|FG001|Overall Study|Lack of Efficacy|4|||
129913931|NCT00792636|467646663|FG002|Overall Study|Lack of Efficacy|13|||
129913932|NCT00792636|467646661|FG000|Overall Study|Adverse Event|4|||
129913933|NCT00792636|467646662|FG001|Overall Study|Adverse Event|2|||
129913934|NCT00792636|467646663|FG002|Overall Study|Adverse Event|3|||
129913935|NCT00792636|467646661|FG000|Overall Study|Investigator Discretion|2|||
129913936|NCT00792636|467646662|FG001|Overall Study|Investigator Discretion|0|||
129913937|NCT00792636|467646663|FG002|Overall Study|Investigator Discretion|2|||
129913938|NCT01046136|467646664|FG000|Overall Study|Withdrawal by Subject|0|||
129913939|NCT01046136|467646665|FG001|Overall Study|Withdrawal by Subject|4|||
129913940|NCT01046136|467646664|FG000|Overall Study|Physician Decision|1|||
129913941|NCT01046136|467646665|FG001|Overall Study|Physician Decision|1|||
129913942|NCT01046136|467646664|FG000|Overall Study|Lost to Follow-up|3|||
129913943|NCT01046136|467646665|FG001|Overall Study|Lost to Follow-up|3|||
129913944|NCT04579250|467646666|FG000|Overall Study|Withdrawal by Subject|1|||
129913945|NCT04579250|467646667|FG001|Overall Study|Withdrawal by Subject|1|||
129913946|NCT04579250|467646668|FG002|Overall Study|Withdrawal by Subject|0|||
129913947|NCT04579250|467646666|FG000|Overall Study|Lost to Follow-up|1|||
129913948|NCT04579250|467646667|FG001|Overall Study|Lost to Follow-up|1|||
129864195|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
129864196|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
129864197|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
129864198|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
129864199|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
129864200|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
129864201|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
129864202|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
129864203|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
129864204|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
129864205|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
129864206|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
129864207|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
129864208|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
129864209|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
129864210|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
129864211|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
129864212|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Other|0|||
129913949|NCT04579250|467646668|FG002|Overall Study|Lost to Follow-up|0|||
129864213|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Other|1|||
129864214|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Other|1|||
129864215|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Other|0|||
129864216|NCT04162769|467459933|FG000|OLE Period (52-Week)|Adverse Event|0|||
129864217|NCT04162769|467459934|FG001|OLE Period (52-Week)|Adverse Event|0|||
129913950|NCT04579250|467646666|FG000|Overall Study|Moved from area|0|||
129913951|NCT04579250|467646667|FG001|Overall Study|Moved from area|1|||
129913952|NCT04579250|467646668|FG002|Overall Study|Moved from area|2|||
129913953|NCT00727909|467646669|FG000|Overall Study|Withdrawal by Subject|5|||
129913954|NCT00727909|467646670|FG001|Overall Study|Withdrawal by Subject|11|||
129864218|NCT04162769|467459935|FG002|OLE Period (52-Week)|Adverse Event|0|||
129864219|NCT04162769|467459936|FG003|OLE Period (52-Week)|Adverse Event|5|||
129864220|NCT04162769|467459933|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
129864221|NCT04162769|467459934|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
129864222|NCT04162769|467459935|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
129864223|NCT04162769|467459936|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
129864224|NCT04162769|467459933|FG000|OLE Period (52-Week)|Physician Decision|0|||
129864225|NCT04162769|467459934|FG001|OLE Period (52-Week)|Physician Decision|0|||
129864226|NCT04162769|467459935|FG002|OLE Period (52-Week)|Physician Decision|0|||
129864227|NCT04162769|467459936|FG003|OLE Period (52-Week)|Physician Decision|1|||
129864228|NCT04162769|467459933|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
129864229|NCT04162769|467459934|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
129864230|NCT04162769|467459935|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
129864231|NCT04162769|467459936|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
129864232|NCT04162769|467459933|FG000|OLE Period (52-Week)|Protocol deviation|0|||
129864233|NCT04162769|467459934|FG001|OLE Period (52-Week)|Protocol deviation|0|||
129864234|NCT04162769|467459935|FG002|OLE Period (52-Week)|Protocol deviation|0|||
129864235|NCT04162769|467459936|FG003|OLE Period (52-Week)|Protocol deviation|2|||
129864236|NCT00725452|467459939|FG000|Overall Study|Adverse Event|3|||
129864237|NCT00725452|467459939|FG000|Overall Study|Lack of Efficacy|2|||
129864238|NCT00725452|467459939|FG000|Overall Study|Reason not specified|1|||
129864239|NCT00725452|467459939|FG000|Overall Study|Physician Decision|1|||
129864240|NCT00725452|467459939|FG000|Overall Study|Withdrawal by Subject|3|||
129864241|NCT00725452|467459939|FG000|Overall Study|Lost to Follow-up|1|||
129864242|NCT00620750|467459941|FG000|Overall Study|Lost to Follow-up|25|||
129864243|NCT00746590|467459942|FG000|Overall Study|Death|1|||
129864244|NCT04402866|467459943|FG000|Overall Study|Discontinued Prior to Treatment|0|||
129864245|NCT04402866|467459944|FG001|Overall Study|Discontinued Prior to Treatment|0|||
129864246|NCT04402866|467459945|FG002|Overall Study|Discontinued Prior to Treatment|0|||
129864247|NCT04402866|467459946|FG003|Overall Study|Discontinued Prior to Treatment|0|||
129864248|NCT04402866|467459947|FG004|Overall Study|Discontinued Prior to Treatment|2|||
129864249|NCT04402866|467459948|FG005|Overall Study|Discontinued Prior to Treatment|3|||
129864250|NCT04402866|467459943|FG000|Overall Study|Adverse Event|2|||
129864251|NCT04402866|467459944|FG001|Overall Study|Adverse Event|1|||
129864252|NCT04402866|467459945|FG002|Overall Study|Adverse Event|0|||
129864253|NCT04402866|467459946|FG003|Overall Study|Adverse Event|0|||
129864254|NCT04402866|467459947|FG004|Overall Study|Adverse Event|13|||
129864255|NCT04402866|467459948|FG005|Overall Study|Adverse Event|8|||
129864256|NCT04402866|467459943|FG000|Overall Study|Miscellaneous|0|||
129864257|NCT04402866|467459944|FG001|Overall Study|Miscellaneous|0|||
129864258|NCT04402866|467459945|FG002|Overall Study|Miscellaneous|1|||
129864259|NCT04402866|467459946|FG003|Overall Study|Miscellaneous|0|||
129864260|NCT04402866|467459947|FG004|Overall Study|Miscellaneous|0|||
129864261|NCT04402866|467459948|FG005|Overall Study|Miscellaneous|0|||
129864262|NCT04402866|467459943|FG000|Overall Study|Lost to Follow-up|0|||
129864263|NCT04402866|467459944|FG001|Overall Study|Lost to Follow-up|0|||
129864264|NCT04402866|467459945|FG002|Overall Study|Lost to Follow-up|0|||
129864265|NCT04402866|467459946|FG003|Overall Study|Lost to Follow-up|0|||
129864266|NCT04402866|467459947|FG004|Overall Study|Lost to Follow-up|0|||
129864267|NCT04402866|467459948|FG005|Overall Study|Lost to Follow-up|1|||
129864268|NCT04402866|467459943|FG000|Overall Study|Withdrawal by Subject|0|||
129864269|NCT04402866|467459944|FG001|Overall Study|Withdrawal by Subject|0|||
129864270|NCT04402866|467459945|FG002|Overall Study|Withdrawal by Subject|0|||
129864271|NCT04402866|467459946|FG003|Overall Study|Withdrawal by Subject|0|||
129864272|NCT04402866|467459947|FG004|Overall Study|Withdrawal by Subject|0|||
129864273|NCT04402866|467459948|FG005|Overall Study|Withdrawal by Subject|2|||
129864274|NCT00971048|467459951|FG000|Overall Study|Protocol Violation|1|||
129864275|NCT00971048|467459952|FG001|Overall Study|Protocol Violation|2|||
129864276|NCT00971048|467459953|FG002|Overall Study|Protocol Violation|0|||
129864277|NCT00971048|467459954|FG003|Overall Study|Protocol Violation|1|||
129864278|NCT00971048|467459951|FG000|Overall Study|Adverse Event|0|||
129864279|NCT00971048|467459952|FG001|Overall Study|Adverse Event|0|||
129864280|NCT00971048|467459953|FG002|Overall Study|Adverse Event|1|||
129864281|NCT00971048|467459954|FG003|Overall Study|Adverse Event|0|||
129864282|NCT00971048|467459951|FG000|Overall Study|Physician Decision|0|||
129864283|NCT00971048|467459952|FG001|Overall Study|Physician Decision|0|||
129864284|NCT00971048|467459953|FG002|Overall Study|Physician Decision|0|||
129864285|NCT00971048|467459954|FG003|Overall Study|Physician Decision|1|||
129864286|NCT01654549|467459955|FG000|Overall Study|H.pylori eradication not successful|0|||
129864287|NCT01654549|467459956|FG001|Overall Study|H.pylori eradication not successful|1|||
129864288|NCT02308748|467459965|FG000|Period 1|Withdrawal by Subject|0|||
129864289|NCT02308748|467459966|FG001|Period 1|Withdrawal by Subject|0|||
129864290|NCT02308748|467459967|FG002|Period 1|Withdrawal by Subject|1|||
129864291|NCT02308748|467459968|FG003|Period 1|Withdrawal by Subject|0|||
129864292|NCT02308748|467459969|FG004|Period 1|Withdrawal by Subject|0|||
129864293|NCT02308748|467459970|FG005|Period 1|Withdrawal by Subject|0|||
129864294|NCT02308748|467459971|FG006|Period 1|Withdrawal by Subject|0|||
129864295|NCT02308748|467459972|FG007|Period 1|Withdrawal by Subject|0|||
129913955|NCT00727909|467646671|FG002|Overall Study|Withdrawal by Subject|8|||
129913956|NCT00727909|467646672|FG003|Overall Study|Withdrawal by Subject|5|||
129913957|NCT00727909|467646669|FG000|Overall Study|Death|0|||
129913958|NCT00727909|467646670|FG001|Overall Study|Death|0|||
129913959|NCT00727909|467646671|FG002|Overall Study|Death|1|||
129913960|NCT00727909|467646672|FG003|Overall Study|Death|0|||
129913961|NCT03446157|467646673|FG000|Overall Study|Death|11|||
129913962|NCT03446157|467646674|FG001|Overall Study|Death|9|||
129913963|NCT03446157|467646673|FG000|Overall Study|Lost to Follow-up|0|||
129913964|NCT03446157|467646674|FG001|Overall Study|Lost to Follow-up|1|||
129913965|NCT03446157|467646673|FG000|Overall Study|Withdrawal by Subject|2|||
129913966|NCT03446157|467646674|FG001|Overall Study|Withdrawal by Subject|1|||
129913967|NCT00411151|467646675|FG000|Overall Study|Death|38|||
129913968|NCT00411151|467646675|FG000|Overall Study|Withdrawal by Subject|2|||
129913969|NCT00411151|467646675|FG000|Overall Study|Lost to Follow-up|2|||
129913970|NCT00411151|467646675|FG000|Overall Study|Protocol Violation|1|||
129913971|NCT00411151|467646675|FG000|Overall Study|Trial prematurely closed|4|||
129913972|NCT04110054|467646676|FG000|Overall Study|COVID-19 reason other than AE|0|||
129913973|NCT04110054|467646677|FG001|Overall Study|COVID-19 reason other than AE|0|||
129913974|NCT04110054|467646678|FG002|Overall Study|COVID-19 reason other than AE|2|||
129913975|NCT04110054|467646679|FG003|Overall Study|COVID-19 reason other than AE|0|||
129913976|NCT04110054|467646676|FG000|Overall Study|Withdrawal by Subject|0|||
129913977|NCT04110054|467646677|FG001|Overall Study|Withdrawal by Subject|3|||
129913978|NCT04110054|467646678|FG002|Overall Study|Withdrawal by Subject|2|||
129913979|NCT04110054|467646679|FG003|Overall Study|Withdrawal by Subject|0|||
129913980|NCT04110054|467646676|FG000|Overall Study|Adverse Event|1|||
129913981|NCT04110054|467646677|FG001|Overall Study|Adverse Event|1|||
129913982|NCT04110054|467646678|FG002|Overall Study|Adverse Event|4|||
129913983|NCT04110054|467646679|FG003|Overall Study|Adverse Event|3|||
129913984|NCT00093015|467646680|FG000|Overall Study|Withdrawal by Subject|194|||
129913985|NCT00093015|467646681|FG001|Overall Study|Withdrawal by Subject|171|||
129913986|NCT00093015|467646680|FG000|Overall Study|Lost to Follow-up|96|||
129913987|NCT00093015|467646681|FG001|Overall Study|Lost to Follow-up|108|||
129913988|NCT00093015|467646680|FG000|Overall Study|Death|375|||
129913989|NCT00093015|467646681|FG001|Overall Study|Death|385|||
129913990|NCT00632203|467646683|FG000|Overall Study|Did not start study treatment|1|||
129913991|NCT00632203|467646684|FG001|Overall Study|Did not start study treatment|0|||
129913992|NCT03432858|467646694|FG000|Overall Study|Protocol Violation|2|||
129913993|NCT03432858|467646695|FG001|Overall Study|Protocol Violation|1|||
129913994|NCT03432858|467646696|FG002|Overall Study|Protocol Violation|9|||
129913995|NCT03432858|467646694|FG000|Overall Study|Withdrawal by Subject|0|||
129913996|NCT03432858|467646695|FG001|Overall Study|Withdrawal by Subject|1|||
129913997|NCT03432858|467646696|FG002|Overall Study|Withdrawal by Subject|1|||
129913998|NCT03432858|467646694|FG000|Overall Study|Procedure canceled/rescheduled|0|||
129913999|NCT03432858|467646695|FG001|Overall Study|Procedure canceled/rescheduled|9|||
129914000|NCT03432858|467646696|FG002|Overall Study|Procedure canceled/rescheduled|6|||
129914001|NCT03432858|467646694|FG000|Overall Study|Required postop mobilization with splinting|0|||
129914002|NCT03432858|467646695|FG001|Overall Study|Required postop mobilization with splinting|0|||
129914003|NCT03432858|467646696|FG002|Overall Study|Required postop mobilization with splinting|1|||
129914004|NCT04402294|467646697|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
129914005|NCT04402294|467646698|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
129914006|NCT04402294|467646697|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
129914007|NCT04402294|467646698|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
129914008|NCT05096819|467648840|FG000|Overall Study|Withdrawal by Subject|3|||
130065324|NCT02501902|468194677|FG007|Overall Study|Subject Refused Further Follow-up|1|||
130065325|NCT02501902|468194670|FG000|Overall Study|Study Terminated by Sponsor|0|||
130065326|NCT02501902|468194671|FG001|Overall Study|Study Terminated by Sponsor|3|||
130065327|NCT02501902|468194672|FG002|Overall Study|Study Terminated by Sponsor|0|||
130065328|NCT02501902|468194673|FG003|Overall Study|Study Terminated by Sponsor|1|||
130065329|NCT02501902|468194674|FG004|Overall Study|Study Terminated by Sponsor|1|||
130065330|NCT02501902|468194675|FG005|Overall Study|Study Terminated by Sponsor|0|||
130065331|NCT02501902|468194676|FG006|Overall Study|Study Terminated by Sponsor|2|||
130065332|NCT02501902|468194677|FG007|Overall Study|Study Terminated by Sponsor|4|||
130065333|NCT02501902|468194670|FG000|Overall Study|Death|3|||
130065334|NCT02501902|468194671|FG001|Overall Study|Death|4|||
130065335|NCT02501902|468194672|FG002|Overall Study|Death|4|||
130065336|NCT02501902|468194673|FG003|Overall Study|Death|10|||
130065337|NCT02501902|468194674|FG004|Overall Study|Death|10|||
130065338|NCT02501902|468194675|FG005|Overall Study|Death|11|||
130065339|NCT02501902|468194676|FG006|Overall Study|Death|7|||
130065340|NCT02501902|468194677|FG007|Overall Study|Death|15|||
129914009|NCT05096819|467648841|FG001|Overall Study|Withdrawal by Subject|0|||
129914010|NCT03547908|467648842|FG000|Blinded Phase|Lost to Follow-up|3|||
129914011|NCT03547908|467648843|FG001|Blinded Phase|Lost to Follow-up|3|||
129914012|NCT03547908|467648844|FG002|Blinded Phase|Lost to Follow-up|0|||
129914013|NCT03547908|467648845|FG003|Blinded Phase|Lost to Follow-up|0|||
130065341|NCT02513771|468194678|FG000|Overall Study|Lost to Follow-up|1|||
129864296|NCT02308748|467459973|FG008|Period 1|Withdrawal by Subject|0|||
129864297|NCT02308748|467459974|FG009|Period 1|Withdrawal by Subject|0|||
129864298|NCT02308748|467459965|FG000|Period 2|Adverse Event|0|||
129864299|NCT02308748|467459966|FG001|Period 2|Adverse Event|0|||
129864300|NCT02308748|467459967|FG002|Period 2|Adverse Event|0|||
129864301|NCT02308748|467459968|FG003|Period 2|Adverse Event|0|||
129864302|NCT02308748|467459969|FG004|Period 2|Adverse Event|0|||
130065342|NCT02513771|468194679|FG001|Overall Study|Lost to Follow-up|1|||
130065343|NCT02513771|468194678|FG000|Overall Study|Not being able to get to clinic|1|||
129864303|NCT02308748|467459970|FG005|Period 2|Adverse Event|0|||
129864304|NCT02308748|467459971|FG006|Period 2|Adverse Event|0|||
129864305|NCT02308748|467459972|FG007|Period 2|Adverse Event|1|||
129864306|NCT02308748|467459973|FG008|Period 2|Adverse Event|0|||
129864307|NCT02308748|467459974|FG009|Period 2|Adverse Event|0|||
129864308|NCT02308748|467459965|FG000|Period 3|Protocol Violation|0|||
129864309|NCT02308748|467459966|FG001|Period 3|Protocol Violation|0|||
129864310|NCT02308748|467459967|FG002|Period 3|Protocol Violation|0|||
129864311|NCT02308748|467459968|FG003|Period 3|Protocol Violation|0|||
129864312|NCT02308748|467459969|FG004|Period 3|Protocol Violation|0|||
129864313|NCT02308748|467459970|FG005|Period 3|Protocol Violation|0|||
129864314|NCT02308748|467459971|FG006|Period 3|Protocol Violation|0|||
129864315|NCT02308748|467459972|FG007|Period 3|Protocol Violation|0|||
129864316|NCT02308748|467459973|FG008|Period 3|Protocol Violation|0|||
129864317|NCT02308748|467459974|FG009|Period 3|Protocol Violation|1|||
129864318|NCT02308748|467459965|FG000|Period 5|Adverse Event|1|||
129864319|NCT02308748|467459966|FG001|Period 5|Adverse Event|0|||
129864320|NCT02308748|467459967|FG002|Period 5|Adverse Event|0|||
129864321|NCT02308748|467459968|FG003|Period 5|Adverse Event|0|||
129864322|NCT02308748|467459969|FG004|Period 5|Adverse Event|0|||
129864323|NCT02308748|467459970|FG005|Period 5|Adverse Event|0|||
129864324|NCT02308748|467459971|FG006|Period 5|Adverse Event|0|||
129864325|NCT02308748|467459972|FG007|Period 5|Adverse Event|0|||
129864326|NCT02308748|467459973|FG008|Period 5|Adverse Event|1|||
129864327|NCT02308748|467459974|FG009|Period 5|Adverse Event|0|||
129864328|NCT03570619|467459982|FG000|Overall Study|Adverse Event|2|||
129864329|NCT03570619|467459983|FG001|Overall Study|Adverse Event|0|||
129864330|NCT03570619|467459984|FG002|Overall Study|Adverse Event|1|||
129864331|NCT03570619|467459982|FG000|Overall Study|new diagnosis of new malignancy|1|||
129864332|NCT03570619|467459983|FG001|Overall Study|new diagnosis of new malignancy|0|||
129864333|NCT03570619|467459984|FG002|Overall Study|new diagnosis of new malignancy|0|||
129864334|NCT03570619|467459982|FG000|Overall Study|Physician Decision|1|||
129864335|NCT03570619|467459983|FG001|Overall Study|Physician Decision|1|||
129864336|NCT03570619|467459984|FG002|Overall Study|Physician Decision|0|||
129864337|NCT03570619|467459982|FG000|Overall Study|Withdrawal by Subject|0|||
129864338|NCT03570619|467459983|FG001|Overall Study|Withdrawal by Subject|2|||
129864339|NCT03570619|467459984|FG002|Overall Study|Withdrawal by Subject|0|||
129864340|NCT01565707|467459987|FG000|Overall Study|Adverse Event|1|||
129864341|NCT01565707|467459988|FG001|Overall Study|Adverse Event|6|||
129864342|NCT01565707|467459989|FG002|Overall Study|Adverse Event|2|||
129864343|NCT01565707|467459990|FG003|Overall Study|Adverse Event|1|||
129864344|NCT01565707|467459987|FG000|Overall Study|Lost to Follow-up|1|||
129864345|NCT01565707|467459988|FG001|Overall Study|Lost to Follow-up|0|||
129864346|NCT01565707|467459989|FG002|Overall Study|Lost to Follow-up|0|||
129864347|NCT01565707|467459990|FG003|Overall Study|Lost to Follow-up|0|||
129864348|NCT01565707|467459987|FG000|Overall Study|Protocol Violation|1|||
129864349|NCT01565707|467459988|FG001|Overall Study|Protocol Violation|0|||
129864350|NCT01565707|467459989|FG002|Overall Study|Protocol Violation|0|||
129864351|NCT01565707|467459990|FG003|Overall Study|Protocol Violation|1|||
129864352|NCT01565707|467459987|FG000|Overall Study|Withdrawal by Subject|3|||
129864353|NCT01565707|467459988|FG001|Overall Study|Withdrawal by Subject|1|||
129864354|NCT01565707|467459989|FG002|Overall Study|Withdrawal by Subject|1|||
129864355|NCT01565707|467459990|FG003|Overall Study|Withdrawal by Subject|1|||
129864356|NCT01565707|467459987|FG000|Overall Study|Randomized but not evaluable|2|||
129864357|NCT01565707|467459988|FG001|Overall Study|Randomized but not evaluable|0|||
129864358|NCT01565707|467459989|FG002|Overall Study|Randomized but not evaluable|0|||
129864359|NCT01565707|467459990|FG003|Overall Study|Randomized but not evaluable|0|||
129864360|NCT01565707|467459987|FG000|Overall Study|Miscellaneous|1|||
129864361|NCT01565707|467459988|FG001|Overall Study|Miscellaneous|1|||
129864362|NCT01565707|467459989|FG002|Overall Study|Miscellaneous|0|||
129864363|NCT01565707|467459990|FG003|Overall Study|Miscellaneous|2|||
129864364|NCT05207813|467459991|FG000|Overall Study|Lost to Follow-up|2|||
129864365|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
129864366|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
129864367|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
129864368|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129864369|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129864370|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129864371|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864372|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
130065344|NCT02513771|468194679|FG001|Overall Study|Not being able to get to clinic|0|||
130065345|NCT01797445|468194680|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
130065346|NCT01797445|468194681|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
130065347|NCT01797445|468194680|FG000|Double-Blind Phase|Adverse Event|3|||
130065348|NCT01797445|468194681|FG001|Double-Blind Phase|Adverse Event|0|||
130065349|NCT01797445|468194680|FG000|Double-Blind Phase|Death|5|||
130065350|NCT01797445|468194681|FG001|Double-Blind Phase|Death|4|||
130065351|NCT01797445|468194680|FG000|Double-Blind Phase|Pregnancy|0|||
130065352|NCT01797445|468194681|FG001|Double-Blind Phase|Pregnancy|1|||
130065353|NCT01797445|468194680|FG000|Double-Blind Phase|Lack of Efficacy|1|||
130065354|NCT01797445|468194681|FG001|Double-Blind Phase|Lack of Efficacy|2|||
130065355|NCT01797445|468194680|FG000|Double-Blind Phase|Investigator's Discretion|15|||
130065356|NCT01797445|468194681|FG001|Double-Blind Phase|Investigator's Discretion|17|||
130065357|NCT01797445|468194680|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
130065358|NCT01797445|468194681|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
130065359|NCT01797445|468194680|FG000|Double-Blind Phase|Protocol Violation|0|||
130065360|NCT01797445|468194681|FG001|Double-Blind Phase|Protocol Violation|1|||
130065361|NCT01797445|468194680|FG000|Double-Blind Phase|Withdrew Consent|20|||
130065362|NCT01797445|468194681|FG001|Double-Blind Phase|Withdrew Consent|35|||
130065363|NCT01797445|468194680|FG000|Double-Blind Phase|Lost to Follow-up|34|||
130065364|NCT01797445|468194681|FG001|Double-Blind Phase|Lost to Follow-up|26|||
130065365|NCT01797445|468194680|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
130065366|NCT01797445|468194681|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
130065367|NCT01595438|468194682|FG000|Overall Study|Lost to Follow-up|20|||
130065368|NCT01595438|468194683|FG001|Overall Study|Lost to Follow-up|20|||
130065369|NCT01595438|468194682|FG000|Overall Study|Withdrawal by Subject|12|||
129914014|NCT03547908|467648842|FG000|Blinded Phase|Withdrew Consent|2|||
129914015|NCT03547908|467648843|FG001|Blinded Phase|Withdrew Consent|3|||
129914016|NCT03547908|467648844|FG002|Blinded Phase|Withdrew Consent|0|||
129914017|NCT03547908|467648845|FG003|Blinded Phase|Withdrew Consent|0|||
129914018|NCT03547908|467648842|FG000|Blinded Phase|Investigator's Discretion|2|||
129914019|NCT03547908|467648843|FG001|Blinded Phase|Investigator's Discretion|1|||
129914020|NCT03547908|467648844|FG002|Blinded Phase|Investigator's Discretion|0|||
129914021|NCT03547908|467648845|FG003|Blinded Phase|Investigator's Discretion|0|||
129914022|NCT03547908|467648842|FG000|Blinded Phase|Death|2|||
129914023|NCT03547908|467648843|FG001|Blinded Phase|Death|0|||
129914024|NCT03547908|467648844|FG002|Blinded Phase|Death|0|||
129914025|NCT03547908|467648845|FG003|Blinded Phase|Death|0|||
129914026|NCT03547908|467648842|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
129914027|NCT03547908|467648843|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
129914028|NCT03547908|467648844|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
129914029|NCT03547908|467648845|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
129914030|NCT03547908|467648842|FG000|Blinded Phase|Adverse Event|1|||
129914031|NCT03547908|467648843|FG001|Blinded Phase|Adverse Event|0|||
129914032|NCT03547908|467648844|FG002|Blinded Phase|Adverse Event|0|||
129914033|NCT03547908|467648845|FG003|Blinded Phase|Adverse Event|0|||
129914034|NCT03547908|467648842|FG000|Blinded Phase|Randomized But Never Treated|1|||
129914035|NCT03547908|467648843|FG001|Blinded Phase|Randomized But Never Treated|0|||
129914036|NCT03547908|467648844|FG002|Blinded Phase|Randomized But Never Treated|0|||
129914037|NCT03547908|467648845|FG003|Blinded Phase|Randomized But Never Treated|0|||
129914038|NCT03547908|467648842|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
129914039|NCT03547908|467648843|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
129914040|NCT03547908|467648844|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
129914041|NCT03547908|467648845|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
130065370|NCT01595438|468194683|FG001|Overall Study|Withdrawal by Subject|12|||
130065371|NCT01595438|468194682|FG000|Overall Study|Other Eligibility criteria|11|||
129914042|NCT03547908|467648842|FG000|Open-label Extension Phase|Death|0|||
129914043|NCT03547908|467648843|FG001|Open-label Extension Phase|Death|0|||
129914044|NCT03547908|467648844|FG002|Open-label Extension Phase|Death|1|||
129914045|NCT03547908|467648845|FG003|Open-label Extension Phase|Death|0|||
129914046|NCT02152137|467648847|FG000|Overall Study|Withdrawal by Subject|1|||
130065372|NCT01595438|468194683|FG001|Overall Study|Other Eligibility criteria|9|||
130065373|NCT00650091|468194684|FG000|Amended Study Design|Withdrawal by Subject|12|||
130065374|NCT00650091|468194685|FG001|Amended Study Design|Withdrawal by Subject|11|||
130065375|NCT00650091|468194686|FG002|Amended Study Design|Withdrawal by Subject|0|||
130065376|NCT00650091|468194684|FG000|Amended Study Design|Physician Decision|5|||
130065377|NCT00650091|468194685|FG001|Amended Study Design|Physician Decision|0|||
130065378|NCT00650091|468194686|FG002|Amended Study Design|Physician Decision|0|||
130065379|NCT00650091|468194684|FG000|Amended Study Design|Adverse Event|1|||
130065380|NCT00650091|468194685|FG001|Amended Study Design|Adverse Event|4|||
129914047|NCT02152137|467648847|FG000|Overall Study|Originally assigned to Arm B|3|||
129914048|NCT03358875|467648848|FG000|Overall Study|Death|409|||
129914049|NCT03358875|467648849|FG001|Overall Study|Death|223|||
129914050|NCT03358875|467648848|FG000|Overall Study|Study Closed by Sponsor|66|||
129914051|NCT03358875|467648849|FG001|Overall Study|Study Closed by Sponsor|29|||
129914052|NCT03358875|467648848|FG000|Overall Study|Withdrawal by Subject|13|||
130065381|NCT00650091|468194686|FG002|Amended Study Design|Adverse Event|0|||
130065382|NCT00650091|468194684|FG000|Amended Study Design|Lung transplantation|4|||
130065383|NCT00650091|468194685|FG001|Amended Study Design|Lung transplantation|2|||
130065384|NCT00650091|468194686|FG002|Amended Study Design|Lung transplantation|0|||
130065385|NCT00650091|468194684|FG000|Amended Study Design|Other|1|||
130065386|NCT00650091|468194685|FG001|Amended Study Design|Other|3|||
130065387|NCT00650091|468194686|FG002|Amended Study Design|Other|0|||
130065388|NCT04116073|468194695|FG000|Overall Study|Withdrawal by Subject|2|||
130065389|NCT04116073|468194695|FG000|Overall Study|failed to maintained eligibility|1|||
130065390|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
130065391|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
130065392|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
130065393|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
130065394|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
130065395|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
130065396|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Death|1|||
130065397|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Death|3|||
130065398|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
130065399|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
130065400|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
130065401|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
130065402|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
130065403|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
130065404|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
130065405|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
130065406|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
130065407|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
130065408|NCT02553317|468194702|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
130065409|NCT02553317|468194703|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
130065410|NCT03483116|468194704|FG000|Overall Study|Adverse Event|0|||
130065411|NCT03483116|468194705|FG001|Overall Study|Adverse Event|1|||
130065412|NCT03483116|468194706|FG002|Overall Study|Adverse Event|0|||
130065413|NCT03483116|468194707|FG003|Overall Study|Adverse Event|1|||
130065414|NCT03483116|468194704|FG000|Overall Study|Protocol Violation|1|||
130065415|NCT03483116|468194705|FG001|Overall Study|Protocol Violation|0|||
130065416|NCT03483116|468194706|FG002|Overall Study|Protocol Violation|0|||
130065417|NCT03483116|468194707|FG003|Overall Study|Protocol Violation|7|||
130065418|NCT03483116|468194704|FG000|Overall Study|Lost to Follow-up|9|||
130065419|NCT03483116|468194705|FG001|Overall Study|Lost to Follow-up|4|||
130065420|NCT03483116|468194706|FG002|Overall Study|Lost to Follow-up|9|||
130065421|NCT03483116|468194707|FG003|Overall Study|Lost to Follow-up|5|||
130065422|NCT03483116|468194704|FG000|Overall Study|Death|1|||
130065423|NCT03483116|468194705|FG001|Overall Study|Death|0|||
130065424|NCT03483116|468194706|FG002|Overall Study|Death|2|||
130065425|NCT03483116|468194707|FG003|Overall Study|Death|1|||
130065426|NCT03483116|468194704|FG000|Overall Study|Withdrawal by Subject|14|||
130065427|NCT03483116|468194705|FG001|Overall Study|Withdrawal by Subject|16|||
130065428|NCT03483116|468194706|FG002|Overall Study|Withdrawal by Subject|14|||
129914053|NCT03358875|467648849|FG001|Overall Study|Withdrawal by Subject|16|||
129914054|NCT03358875|467648848|FG000|Overall Study|Lost to Follow-up|13|||
129914055|NCT03358875|467648849|FG001|Overall Study|Lost to Follow-up|2|||
129914056|NCT03358875|467648848|FG000|Overall Study|Miscellaneous|33|||
129914057|NCT03358875|467648849|FG001|Overall Study|Miscellaneous|0|||
129914058|NCT03358875|467648848|FG000|Overall Study|Remained on Study|1|||
129914059|NCT03358875|467648849|FG001|Overall Study|Remained on Study|0|||
129914060|NCT06194214|467648853|FG000|Overall Study|Adverse Event|1|||
129914061|NCT05687903|467648854|FG000|Overall Study|Protocol Deviation|1|||
129914062|NCT05687903|467648855|FG001|Overall Study|Protocol Deviation|1|||
129914063|NCT05687903|467648856|FG002|Overall Study|Protocol Deviation|0|||
129914064|NCT05687903|467648857|FG003|Overall Study|Protocol Deviation|1|||
130065429|NCT03483116|468194707|FG003|Overall Study|Withdrawal by Subject|16|||
130065430|NCT03483116|468194704|FG000|Overall Study|Unknown other reason|3|||
130065431|NCT03483116|468194705|FG001|Overall Study|Unknown other reason|2|||
130065432|NCT03483116|468194706|FG002|Overall Study|Unknown other reason|1|||
130065433|NCT03483116|468194707|FG003|Overall Study|Unknown other reason|1|||
130065434|NCT01181102|468194708|FG000|Overall Study|Adverse Event|28|||
130065435|NCT01181102|468194709|FG001|Overall Study|Adverse Event|26|||
130065436|NCT01181102|468194708|FG000|Overall Study|Lack of Efficacy|3|||
130065437|NCT01181102|468194709|FG001|Overall Study|Lack of Efficacy|1|||
130065438|NCT01181102|468194708|FG000|Overall Study|Lost to Follow-up|2|||
129914065|NCT05687903|467648858|FG004|Overall Study|Protocol Deviation|0|||
129914066|NCT05613205|467648859|FG000|Overall Study|Lost to Follow-up|0|||
129914067|NCT05613205|467648860|FG001|Overall Study|Lost to Follow-up|0|||
129914068|NCT05613205|467648861|FG002|Overall Study|Lost to Follow-up|1|||
130065439|NCT01181102|468194709|FG001|Overall Study|Lost to Follow-up|0|||
130065440|NCT01181102|468194708|FG000|Overall Study|Physician Decision|3|||
130065441|NCT01181102|468194709|FG001|Overall Study|Physician Decision|1|||
130065442|NCT01181102|468194708|FG000|Overall Study|Protocol Violation|5|||
130065443|NCT01181102|468194709|FG001|Overall Study|Protocol Violation|6|||
130065444|NCT01181102|468194708|FG000|Overall Study|Withdrawal by Subject|10|||
130065445|NCT01181102|468194709|FG001|Overall Study|Withdrawal by Subject|12|||
130065446|NCT04685499|468194715|FG000|Overall Study|Study Terminated Early|1|||
129864373|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
129864374|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864375|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864376|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864377|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
129864378|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
129864379|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864380|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864381|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864382|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864383|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
129864384|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
129864385|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
129864386|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129864387|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129864388|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129864389|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
129864390|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
129864391|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
129864392|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
129864393|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
129864394|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
129864395|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129864396|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129864397|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129864398|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
129864399|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
129864400|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
129864401|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129864402|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129864403|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129864404|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
129864405|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
129864406|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
129864407|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129864408|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129864409|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129864410|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
129864411|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
129864412|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
129864413|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
129864414|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
129864415|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
129864416|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
129864417|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
129864418|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
129864419|NCT02625623|467460002|FG000|Overall Study|Participants randomized but not treated|9|||
129864420|NCT02625623|467460003|FG001|Overall Study|Participants randomized but not treated|1|||
129864421|NCT00808808|467460004|FG000|Overall Study|Vaccinated; survey not completed|131|||
129864422|NCT00808808|467460005|FG001|Overall Study|Vaccinated; survey not completed|169|||
129864423|NCT00808808|467460006|FG002|Overall Study|Vaccinated; survey not completed|302|||
129864424|NCT00808808|467460004|FG000|Overall Study|Employee was not vaccinated.|2686|||
129864425|NCT00808808|467460005|FG001|Overall Study|Employee was not vaccinated.|2268|||
129864426|NCT00808808|467460006|FG002|Overall Study|Employee was not vaccinated.|2255|||
129864427|NCT01371851|467460008|FG000|Overall Study|Lost to Follow-up|5|||
129864428|NCT01371851|467460009|FG001|Overall Study|Lost to Follow-up|8|||
130065447|NCT03176277|468194716|FG000|Part A Dose Escalation Study|Adverse Event|1|||
130065448|NCT03176277|468194717|FG001|Part A Dose Escalation Study|Adverse Event|0|||
129914069|NCT05613205|467648862|FG003|Overall Study|Lost to Follow-up|1|||
129914070|NCT05613205|467648863|FG004|Overall Study|Lost to Follow-up|0|||
129914071|NCT05613205|467648859|FG000|Overall Study|Withdrawal by Subject|0|||
129914072|NCT05613205|467648860|FG001|Overall Study|Withdrawal by Subject|0|||
129914073|NCT05613205|467648861|FG002|Overall Study|Withdrawal by Subject|1|||
129914074|NCT05613205|467648862|FG003|Overall Study|Withdrawal by Subject|1|||
129914075|NCT05613205|467648863|FG004|Overall Study|Withdrawal by Subject|0|||
129914076|NCT00448669|467648864|FG000|Overall Study|Lost to Follow-up|52|||
129914077|NCT00448669|467648865|FG001|Overall Study|Lost to Follow-up|63|||
129914078|NCT00448669|467648864|FG000|Overall Study|Withdrawal by Subject|90|||
129914079|NCT00448669|467648865|FG001|Overall Study|Withdrawal by Subject|74|||
129914080|NCT00448669|467648864|FG000|Overall Study|Relocated|49|||
129914081|NCT00448669|467648865|FG001|Overall Study|Relocated|36|||
129914082|NCT00448669|467648864|FG000|Overall Study|Were withdrawn by investigator|10|||
129914083|NCT00448669|467648865|FG001|Overall Study|Were withdrawn by investigator|6|||
129914084|NCT00448669|467648864|FG000|Overall Study|Death|2|||
129914085|NCT00448669|467648865|FG001|Overall Study|Death|4|||
129914086|NCT00448669|467648864|FG000|Overall Study|Had other reasons|5|||
129914087|NCT00448669|467648865|FG001|Overall Study|Had other reasons|6|||
129914088|NCT00448669|467648864|FG000|Overall Study|HIV-infected at enrollment|1|||
129914089|NCT00448669|467648865|FG001|Overall Study|HIV-infected at enrollment|2|||
129914090|NCT00448669|467648864|FG000|Overall Study|Never started drug|9|||
129914091|NCT00448669|467648865|FG001|Overall Study|Never started drug|7|||
129914092|NCT04287985|467648866|FG000|Overall Study|Adverse Event|1|||
129914093|NCT04287985|467648867|FG001|Overall Study|Adverse Event|0|||
129914094|NCT04287985|467648868|FG002|Overall Study|Adverse Event|0|||
129914095|NCT04287985|467648869|FG003|Overall Study|Adverse Event|0|||
129914096|NCT04287985|467648866|FG000|Overall Study|Protocol Violation|0|||
129914097|NCT04287985|467648867|FG001|Overall Study|Protocol Violation|1|||
129914098|NCT04287985|467648868|FG002|Overall Study|Protocol Violation|0|||
129914099|NCT04287985|467648869|FG003|Overall Study|Protocol Violation|0|||
129914100|NCT04287985|467648866|FG000|Overall Study|Physician Decision|0|||
129914101|NCT04287985|467648867|FG001|Overall Study|Physician Decision|0|||
129914102|NCT04287985|467648868|FG002|Overall Study|Physician Decision|0|||
129914103|NCT04287985|467648869|FG003|Overall Study|Physician Decision|1|||
129914104|NCT04287985|467648866|FG000|Overall Study|Withdrawal by Subject|2|||
129914105|NCT04287985|467648867|FG001|Overall Study|Withdrawal by Subject|1|||
129914106|NCT04287985|467648868|FG002|Overall Study|Withdrawal by Subject|1|||
129914107|NCT04287985|467648869|FG003|Overall Study|Withdrawal by Subject|2|||
129914108|NCT01340066|467648874|FG000|Placebo Run in Period|Screen Failures|27|||
129914109|NCT01340066|467648875|FG001|Placebo Run in Period|Screen Failures|0|||
129914110|NCT01340066|467648876|FG002|Placebo Run in Period|Screen Failures|0|||
129914111|NCT01340066|467648874|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
129914112|NCT01340066|467648875|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
129914113|NCT01340066|467648876|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
129914114|NCT01340066|467648874|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
129914115|NCT01340066|467648875|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
129914116|NCT01340066|467648876|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
129914117|NCT01340066|467648874|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
129914118|NCT01340066|467648875|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
129914119|NCT01340066|467648876|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
129914120|NCT02789020|467648877|FG000|Overall Study|Withdrawal by Subject|6|||
129914121|NCT02789020|467648878|FG001|Overall Study|Withdrawal by Subject|5|||
129914122|NCT03771352|467648894|FG000|Overall Study|Screen failure|2|||
129914123|NCT03771352|467648894|FG000|Overall Study|Withdrawal by Subject|2|||
129914124|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
129914125|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
129914126|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
129914127|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
129914128|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
129914129|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
129914130|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
129914131|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
129914132|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
129914133|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
129914134|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
129914135|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
129914136|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
129914137|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
129914138|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
129914139|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
129914140|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
129914141|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
129914142|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
129914143|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
129914144|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
129914145|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
129914146|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
129914147|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
129914148|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
129914149|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
129914150|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
129914151|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
129914152|NCT04238247|467648908|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
129914153|NCT04238247|467648909|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
129914154|NCT04238247|467648910|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
129914155|NCT04238247|467648911|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
129914156|NCT04238247|467648908|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
129914157|NCT04238247|467648909|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
129914158|NCT04238247|467648910|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
129914159|NCT04238247|467648911|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
129914160|NCT04238247|467648908|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
129914161|NCT04238247|467648909|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
129914162|NCT04238247|467648910|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
129914163|NCT04238247|467648911|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
129914164|NCT04238247|467648908|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
129914165|NCT04238247|467648909|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
129914166|NCT04238247|467648910|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
129914167|NCT04238247|467648911|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
129914168|NCT03092726|467648912|FG000|Overall Study|Adverse Event|3|||
129914169|NCT03092726|467648913|FG001|Overall Study|Adverse Event|10|||
129914170|NCT03092726|467648912|FG000|Overall Study|Lack of Efficacy|0|||
129914171|NCT03092726|467648913|FG001|Overall Study|Lack of Efficacy|1|||
129914172|NCT03092726|467648912|FG000|Overall Study|Lost to Follow-up|1|||
129914173|NCT03092726|467648913|FG001|Overall Study|Lost to Follow-up|0|||
129914174|NCT03092726|467648912|FG000|Overall Study|Withdrawal by Subject|5|||
129914175|NCT03092726|467648913|FG001|Overall Study|Withdrawal by Subject|3|||
129914176|NCT04950127|467648914|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
129914177|NCT04950127|467648915|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
129914178|NCT04950127|467648916|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914179|NCT04950127|467648917|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914180|NCT04950127|467648918|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914181|NCT04950127|467648919|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914182|NCT04950127|467648914|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
129914183|NCT04950127|467648915|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
129914184|NCT04950127|467648916|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914185|NCT04950127|467648917|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914186|NCT04950127|467648918|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914187|NCT04950127|467648919|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914188|NCT04950127|467648914|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
129914189|NCT04950127|467648915|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
129914190|NCT04950127|467648916|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914191|NCT04950127|467648917|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914192|NCT04950127|467648918|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914193|NCT04950127|467648919|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914194|NCT04950127|467648914|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914195|NCT04950127|467648915|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914196|NCT04950127|467648916|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914197|NCT04950127|467648917|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914198|NCT04950127|467648918|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914199|NCT04950127|467648919|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
129914200|NCT04950127|467648914|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914201|NCT04950127|467648915|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914202|NCT04950127|467648916|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914203|NCT04950127|467648917|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914204|NCT04950127|467648918|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914205|NCT04950127|467648919|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
129914206|NCT03833167|467648924|FG000|Overall Study|Withdrawal by Subject|4|||
129914207|NCT03833167|467648925|FG001|Overall Study|Withdrawal by Subject|6|||
129914208|NCT03833167|467648924|FG000|Overall Study|Ongoing|186|||
129914209|NCT03833167|467648925|FG001|Overall Study|Ongoing|194|||
130065449|NCT03176277|468194718|FG002|Part A Dose Escalation Study|Adverse Event|1|||
130065450|NCT03176277|468194719|FG003|Part A Dose Escalation Study|Adverse Event|0|||
130065451|NCT03176277|468194716|FG000|Part A Dose Escalation Study|Physician Decision|1|||
130065452|NCT03176277|468194717|FG001|Part A Dose Escalation Study|Physician Decision|1|||
130065453|NCT03176277|468194718|FG002|Part A Dose Escalation Study|Physician Decision|2|||
129914210|NCT03833167|467648924|FG000|Overall Study|Lost to Follow-up|1|||
129914211|NCT03833167|467648925|FG001|Overall Study|Lost to Follow-up|1|||
129914212|NCT03833167|467648924|FG000|Overall Study|Physician Decision|0|||
129914213|NCT03833167|467648925|FG001|Overall Study|Physician Decision|2|||
129914214|NCT03833167|467648924|FG000|Overall Study|Death|34|||
129914215|NCT03833167|467648925|FG001|Overall Study|Death|22|||
129914216|NCT01948661|467648927|FG000|Overall Study|Withdrawal by Subject|2|||
129914217|NCT01948661|467648928|FG001|Overall Study|Withdrawal by Subject|4|||
129914218|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Adverse Event|4|||
129914219|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Adverse Event|1|||
129914220|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
129914221|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
129914222|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
129914223|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
129914224|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
129914225|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
129914226|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
129914227|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
129914228|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Other|6|||
129914229|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Other|1|||
129914230|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Missing|1|||
129914231|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Missing|0|||
129914232|NCT03271489|467648929|FG000|Open-Label (OL) Period|Adverse Event|2|||
129914233|NCT03271489|467648930|FG001|Open-Label (OL) Period|Adverse Event|0|||
129914234|NCT03271489|467648929|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
129914235|NCT03271489|467648930|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
129914236|NCT03271489|467648929|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
129914237|NCT03271489|467648930|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
129914238|NCT03271489|467648929|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
129914239|NCT03271489|467648930|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
129914240|NCT03271489|467648929|FG000|Open-Label (OL) Period|No Specified|2|||
129914241|NCT03271489|467648930|FG001|Open-Label (OL) Period|No Specified|2|||
129914242|NCT03271489|467648929|FG000|Open-Label (OL) Period|Missing|2|||
129914243|NCT03271489|467648930|FG001|Open-Label (OL) Period|Missing|0|||
129914244|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
129914245|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
129914246|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
129914247|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
129914248|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
129914249|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
129914250|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
129914251|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
129914252|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
129914253|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
129914254|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
129914255|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
129914256|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
129914257|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
129914258|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
129914259|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
129914260|NCT03330795|467648931|FG000|Overall Study|Death|3|||
129914261|NCT03330795|467648931|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
129914262|NCT05064735|467648932|FG000|Overall Study|Withdrawal by Subject|7|||
129914263|NCT05064735|467648933|FG001|Overall Study|Withdrawal by Subject|8|||
130065454|NCT03176277|468194719|FG003|Part A Dose Escalation Study|Physician Decision|0|||
130065455|NCT03176277|468194716|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
130065456|NCT03176277|468194717|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
129914264|NCT05064735|467648932|FG000|Overall Study|Lost to Follow-up|7|||
129914265|NCT05064735|467648933|FG001|Overall Study|Lost to Follow-up|2|||
130065457|NCT03176277|468194718|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
130065458|NCT03176277|468194719|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
129914266|NCT05064735|467648932|FG000|Overall Study|Physician Decision|2|||
129914267|NCT05064735|467648933|FG001|Overall Study|Physician Decision|1|||
129914268|NCT05064735|467648932|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
129914269|NCT05064735|467648933|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
129914270|NCT05064735|467648932|FG000|Overall Study|Site Closure|7|||
129914271|NCT05064735|467648933|FG001|Overall Study|Site Closure|2|||
129914272|NCT02886286|467648934|FG000|Overall Study|pump motor stall|0|||
129914273|NCT02886286|467648935|FG001|Overall Study|pump motor stall|1|||
129914274|NCT02376790|467648936|FG000|Overall Study|Withdrawal by Subject|43|||
129914275|NCT02376790|467648937|FG001|Overall Study|Withdrawal by Subject|36|||
129914276|NCT02376790|467648938|FG002|Overall Study|Withdrawal by Subject|37|||
129914277|NCT02376790|467648936|FG000|Overall Study|Decision by Sponsor|2|||
129914278|NCT02376790|467648937|FG001|Overall Study|Decision by Sponsor|1|||
129914279|NCT02376790|467648938|FG002|Overall Study|Decision by Sponsor|4|||
129914280|NCT02376790|467648936|FG000|Overall Study|Lost to Follow-up|15|||
129914281|NCT02376790|467648937|FG001|Overall Study|Lost to Follow-up|10|||
129914282|NCT02376790|467648938|FG002|Overall Study|Lost to Follow-up|12|||
129914283|NCT03014453|467648939|FG000|Overall Study|Lost to Follow-up|12|||
129914284|NCT03014453|467648939|FG000|Overall Study|Discontinued GER|3|||
129914285|NCT03014453|467648939|FG000|Overall Study|Excluded|19|||
129914286|NCT03014453|467648939|FG000|Overall Study|Refused to take part in|37|||
129914287|NCT05450458|467648940|FG000|Overall Study|Lost to Follow-up|4|||
129914288|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
129914289|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
129914290|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
129914291|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
129914292|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
129914293|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
129914294|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
129914295|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
129914296|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129914297|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129914298|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129914299|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
129914300|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129914301|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
129914302|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129914303|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129914304|NCT02794480|467648941|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
129914305|NCT02794480|467648942|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129914306|NCT02794480|467648943|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129914307|NCT02794480|467648944|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
129914308|NCT00262301|467648945|FG000|Double-blind Phase|Lost to Follow-up|1|||
129914309|NCT00262301|467648946|FG001|Double-blind Phase|Lost to Follow-up|0|||
129914310|NCT00262301|467648947|FG002|Double-blind Phase|Lost to Follow-up|0|||
129914311|NCT00262301|467648945|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
129914312|NCT00262301|467648946|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
129914313|NCT00262301|467648947|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
129914314|NCT01017146|467648948|FG000|Overall Study|Adverse Event|11|||
129914315|NCT01017146|467648949|FG001|Overall Study|Adverse Event|1|||
129914316|NCT01017146|467648948|FG000|Overall Study|Lost to Follow-up|14|||
129914317|NCT01017146|467648949|FG001|Overall Study|Lost to Follow-up|14|||
129914318|NCT01017146|467648948|FG000|Overall Study|Noncompliance with Study Product|1|||
129914319|NCT01017146|467648949|FG001|Overall Study|Noncompliance with Study Product|1|||
129914320|NCT01017146|467648948|FG000|Overall Study|Withdrawal by Subject|32|||
129914321|NCT01017146|467648949|FG001|Overall Study|Withdrawal by Subject|16|||
129914322|NCT01017146|467648948|FG000|Overall Study|Relocation|0|||
129914323|NCT01017146|467648949|FG001|Overall Study|Relocation|4|||
129914324|NCT01017146|467648948|FG000|Overall Study|Pregnancy|2|||
129914325|NCT01017146|467648949|FG001|Overall Study|Pregnancy|1|||
129914326|NCT01017146|467648948|FG000|Overall Study|Protocol Violation|2|||
129914327|NCT01017146|467648949|FG001|Overall Study|Protocol Violation|0|||
129914328|NCT01017146|467648948|FG000|Overall Study|Took Excluded Medication|2|||
130065459|NCT03176277|468194716|FG000|Part A Dose Escalation Study|Progressive disease|3|||
130065460|NCT03176277|468194717|FG001|Part A Dose Escalation Study|Progressive disease|1|||
130065461|NCT03176277|468194718|FG002|Part A Dose Escalation Study|Progressive disease|3|||
129914329|NCT01017146|467648949|FG001|Overall Study|Took Excluded Medication|0|||
129914330|NCT01017146|467648948|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129914331|NCT01017146|467648949|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
129914332|NCT01017146|467648948|FG000|Overall Study|Change in Work Situation|1|||
129914333|NCT01017146|467648949|FG001|Overall Study|Change in Work Situation|0|||
129914334|NCT00901901|467648953|FG000|Treatment Period|Adverse Event|120|||
129914335|NCT00901901|467648954|FG001|Treatment Period|Adverse Event|128|||
129914336|NCT00901901|467648953|FG000|Treatment Period|Withdrawal by Subject|26|||
130065462|NCT03176277|468194719|FG003|Part A Dose Escalation Study|Progressive disease|0|||
129864429|NCT01371851|467460008|FG000|Overall Study|was arrested and put in jail|0|||
129864430|NCT01371851|467460009|FG001|Overall Study|was arrested and put in jail|1|||
129864431|NCT01371851|467460008|FG000|Overall Study|non study related adverse event|1|||
129864432|NCT01371851|467460009|FG001|Overall Study|non study related adverse event|0|||
129864433|NCT01371851|467460008|FG000|Overall Study|Blood Pressure outside study parameters|2|||
129864434|NCT01371851|467460009|FG001|Overall Study|Blood Pressure outside study parameters|0|||
129864435|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
129864436|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
129864437|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
129864438|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
129864439|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
129864440|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
129864441|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
129864442|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
129864443|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
129864444|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
129864445|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
129864446|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
129864447|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
129864448|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
129864449|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
129864450|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
129864451|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
129864452|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
129864453|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
129864454|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
129864455|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
129864456|NCT00833638|467460010|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
129864457|NCT00833638|467460011|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
129864458|NCT00833638|467460012|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
129864459|NCT00833638|467460010|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
129864460|NCT00833638|467460011|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
129864461|NCT00833638|467460012|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
129864462|NCT02352948|467460013|FG000|Overall Study|Death|47|||
129864463|NCT02352948|467460014|FG001|Overall Study|Death|48|||
129864464|NCT02352948|467460015|FG002|Overall Study|Death|114|||
129864465|NCT02352948|467460016|FG003|Overall Study|Death|74|||
129864466|NCT02352948|467460017|FG004|Overall Study|Death|77|||
129864467|NCT02352948|467460018|FG005|Overall Study|Death|44|||
129864468|NCT02352948|467460013|FG000|Overall Study|Lost to Follow-up|1|||
129864469|NCT02352948|467460014|FG001|Overall Study|Lost to Follow-up|0|||
129864470|NCT02352948|467460015|FG002|Overall Study|Lost to Follow-up|2|||
129864471|NCT02352948|467460016|FG003|Overall Study|Lost to Follow-up|1|||
129864472|NCT02352948|467460017|FG004|Overall Study|Lost to Follow-up|2|||
129864473|NCT02352948|467460018|FG005|Overall Study|Lost to Follow-up|1|||
129864474|NCT02352948|467460013|FG000|Overall Study|Withdrawal by Subject|1|||
129864475|NCT02352948|467460014|FG001|Overall Study|Withdrawal by Subject|10|||
129864476|NCT02352948|467460015|FG002|Overall Study|Withdrawal by Subject|11|||
129864477|NCT02352948|467460016|FG003|Overall Study|Withdrawal by Subject|23|||
129864478|NCT02352948|467460017|FG004|Overall Study|Withdrawal by Subject|9|||
129864479|NCT02352948|467460018|FG005|Overall Study|Withdrawal by Subject|4|||
129864480|NCT02352948|467460013|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129864481|NCT02352948|467460014|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129864482|NCT02352948|467460015|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129864483|NCT02352948|467460016|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129864484|NCT02352948|467460017|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129864485|NCT02352948|467460018|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
129864486|NCT02352948|467460013|FG000|Overall Study|Other|0|||
129864487|NCT02352948|467460014|FG001|Overall Study|Other|0|||
129864488|NCT02352948|467460015|FG002|Overall Study|Other|2|||
129864489|NCT02352948|467460016|FG003|Overall Study|Other|0|||
129864490|NCT02352948|467460017|FG004|Overall Study|Other|0|||
129864491|NCT02352948|467460018|FG005|Overall Study|Other|0|||
130065463|NCT00634114|468194720|FG000|Overall Study|Adverse Event|6|||
130065464|NCT00634114|468194721|FG001|Overall Study|Adverse Event|8|||
129864492|NCT00490646|467460019|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
129864493|NCT00490646|467460020|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
129864494|NCT00490646|467460019|FG000|Overall Study|Never Treated (had an adverse event)|1|||
129864495|NCT00490646|467460020|FG001|Overall Study|Never Treated (had an adverse event)|0|||
129864496|NCT00490646|467460019|FG000|Overall Study|Never Treated (withdrew consent)|0|||
130065465|NCT00634114|468194722|FG002|Overall Study|Adverse Event|3|||
130065466|NCT00634114|468194720|FG000|Overall Study|Withdrawal by Subject|9|||
129914337|NCT00901901|467648954|FG001|Treatment Period|Withdrawal by Subject|24|||
129914338|NCT00901901|467648953|FG000|Treatment Period|Physician Decision|2|||
129914339|NCT00901901|467648954|FG001|Treatment Period|Physician Decision|2|||
129914340|NCT00901901|467648953|FG000|Treatment Period|Lost to Follow-up|3|||
129914341|NCT00901901|467648954|FG001|Treatment Period|Lost to Follow-up|5|||
129914342|NCT00901901|467648953|FG000|Treatment Period|Noncompliance with study medication|4|||
129914343|NCT00901901|467648954|FG001|Treatment Period|Noncompliance with study medication|1|||
129914344|NCT00901901|467648953|FG000|Treatment Period|Missing|1|||
129914345|NCT00901901|467648954|FG001|Treatment Period|Missing|0|||
129914346|NCT00901901|467648953|FG000|Treatment Period|Never treated|0|||
129914347|NCT00901901|467648954|FG001|Treatment Period|Never treated|3|||
129914348|NCT00901901|467648953|FG000|Treatment Period|Protocol driven decision point|0|||
129914349|NCT00901901|467648954|FG001|Treatment Period|Protocol driven decision point|2|||
129914350|NCT00901901|467648953|FG000|Treatment Period|Study terminated by sponsor|2|||
129914351|NCT00901901|467648954|FG001|Treatment Period|Study terminated by sponsor|0|||
129914352|NCT00901901|467648953|FG000|Treatment Period|Protocol Violation|5|||
129914353|NCT00901901|467648954|FG001|Treatment Period|Protocol Violation|9|||
129914354|NCT00901901|467648953|FG000|Treatment Period|Switch to commercial drug|1|||
129914355|NCT00901901|467648954|FG001|Treatment Period|Switch to commercial drug|1|||
129914356|NCT00901901|467648953|FG000|Treatment Period|Transfer to treatment continuation study|5|||
129914357|NCT00901901|467648954|FG001|Treatment Period|Transfer to treatment continuation study|2|||
129914358|NCT00901901|467648953|FG000|Follow-up Period|Death|181|||
129914359|NCT00901901|467648954|FG001|Follow-up Period|Death|208|||
129914360|NCT00901901|467648953|FG000|Follow-up Period|Protocol driven decision point|47|||
129914361|NCT00901901|467648954|FG001|Follow-up Period|Protocol driven decision point|36|||
129914362|NCT00901901|467648953|FG000|Follow-up Period|Withdrawal by Subject|6|||
129914363|NCT00901901|467648954|FG001|Follow-up Period|Withdrawal by Subject|9|||
129914364|NCT00901901|467648953|FG000|Follow-up Period|Lost to Follow-up|12|||
129914365|NCT00901901|467648954|FG001|Follow-up Period|Lost to Follow-up|8|||
129914366|NCT00901901|467648953|FG000|Follow-up Period|Missing|94|||
129914367|NCT00901901|467648954|FG001|Follow-up Period|Missing|80|||
129914368|NCT05171777|467648957|FG000|Treatment Crossover Period|Adverse Event|9|||
129914369|NCT05171777|467648958|FG001|Treatment Crossover Period|Adverse Event|6|||
129914370|NCT05171777|467648959|FG002|Treatment Crossover Period|Adverse Event|0|||
129914371|NCT05171777|467648960|FG003|Treatment Crossover Period|Adverse Event|0|||
129914372|NCT05171777|467648957|FG000|Treatment Crossover Period|Death|5|||
129914373|NCT05171777|467648958|FG001|Treatment Crossover Period|Death|5|||
129914374|NCT05171777|467648959|FG002|Treatment Crossover Period|Death|0|||
129914375|NCT05171777|467648960|FG003|Treatment Crossover Period|Death|0|||
129914376|NCT05171777|467648957|FG000|Treatment Crossover Period|Disease Relapse|0|||
129914377|NCT05171777|467648958|FG001|Treatment Crossover Period|Disease Relapse|1|||
129914378|NCT05171777|467648959|FG002|Treatment Crossover Period|Disease Relapse|0|||
129914379|NCT05171777|467648960|FG003|Treatment Crossover Period|Disease Relapse|0|||
129914380|NCT05171777|467648957|FG000|Treatment Crossover Period|Reason not Specified|2|||
129914381|NCT05171777|467648958|FG001|Treatment Crossover Period|Reason not Specified|1|||
129914382|NCT05171777|467648959|FG002|Treatment Crossover Period|Reason not Specified|0|||
129914383|NCT05171777|467648960|FG003|Treatment Crossover Period|Reason not Specified|0|||
129914384|NCT05171777|467648957|FG000|Treatment Crossover Period|Physician Decision|0|||
129914385|NCT05171777|467648958|FG001|Treatment Crossover Period|Physician Decision|1|||
129914386|NCT05171777|467648959|FG002|Treatment Crossover Period|Physician Decision|0|||
129914387|NCT05171777|467648960|FG003|Treatment Crossover Period|Physician Decision|0|||
129914388|NCT05171777|467648957|FG000|Treatment Crossover Period|Progressive Disease|13|||
129914389|NCT05171777|467648958|FG001|Treatment Crossover Period|Progressive Disease|9|||
129914390|NCT05171777|467648959|FG002|Treatment Crossover Period|Progressive Disease|0|||
129914391|NCT05171777|467648960|FG003|Treatment Crossover Period|Progressive Disease|0|||
129914392|NCT05171777|467648957|FG000|Treatment Crossover Period|Protocol Violation|0|||
129914393|NCT05171777|467648958|FG001|Treatment Crossover Period|Protocol Violation|2|||
129914394|NCT05171777|467648959|FG002|Treatment Crossover Period|Protocol Violation|0|||
129914395|NCT05171777|467648960|FG003|Treatment Crossover Period|Protocol Violation|0|||
129914396|NCT05171777|467648957|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
129914397|NCT05171777|467648958|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
129914398|NCT05171777|467648959|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
129914399|NCT05171777|467648960|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
129914400|NCT05171777|467648957|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
129914401|NCT05171777|467648958|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
129914402|NCT05171777|467648959|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
129914403|NCT05171777|467648960|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
129914404|NCT05171777|467648957|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
129914405|NCT05171777|467648958|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
129914406|NCT05171777|467648959|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
129914407|NCT05171777|467648960|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
129914408|NCT05171777|467648957|FG000|Treatment Continuation Period|Death|0|||
130065467|NCT00634114|468194721|FG001|Overall Study|Withdrawal by Subject|6|||
130065468|NCT00634114|468194722|FG002|Overall Study|Withdrawal by Subject|11|||
130065469|NCT00634114|468194720|FG000|Overall Study|Lost to Follow-up|0|||
130065470|NCT00634114|468194721|FG001|Overall Study|Lost to Follow-up|0|||
130065471|NCT00634114|468194722|FG002|Overall Study|Lost to Follow-up|1|||
130065472|NCT00634114|468194720|FG000|Overall Study|Protocol Violation|3|||
130065473|NCT00634114|468194721|FG001|Overall Study|Protocol Violation|3|||
130065474|NCT00634114|468194722|FG002|Overall Study|Protocol Violation|1|||
129864497|NCT00490646|467460020|FG001|Overall Study|Never Treated (withdrew consent)|1|||
129864498|NCT05608629|467460022|FG000|Overall Study|Lost to Follow-up|2|||
129864499|NCT01453595|467460023|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129864500|NCT01453595|467460024|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129864501|NCT01453595|467460025|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129864502|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
129864503|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
129864504|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
129864505|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
129864506|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Other reason|4|||
129864507|NCT00983073|467460026|FG000|Maintenance Period|Adverse Event|5|||
129864508|NCT00983073|467460026|FG000|Maintenance Period|Withdrawal by Subject|2|||
129864509|NCT00983073|467460026|FG000|Maintenance Period|Lack of Efficacy|2|||
129864510|NCT00983073|467460026|FG000|Maintenance Period|Other Reason|7|||
129864511|NCT02962908|467460029|FG000|Overall Study|Lost to Follow-up|0|||
129864512|NCT02962908|467460030|FG001|Overall Study|Lost to Follow-up|3|||
129864513|NCT02962908|467460031|FG002|Overall Study|Lost to Follow-up|0|||
129864514|NCT02962908|467460032|FG003|Overall Study|Lost to Follow-up|1|||
129864515|NCT02962908|467460029|FG000|Overall Study|Withdrawal by Subject|0|||
129864516|NCT02962908|467460030|FG001|Overall Study|Withdrawal by Subject|3|||
129864517|NCT02962908|467460031|FG002|Overall Study|Withdrawal by Subject|0|||
129864518|NCT02962908|467460032|FG003|Overall Study|Withdrawal by Subject|2|||
129864519|NCT02962908|467460029|FG000|Overall Study|Protocol Violation|0|||
129864520|NCT02962908|467460030|FG001|Overall Study|Protocol Violation|1|||
129864521|NCT02962908|467460031|FG002|Overall Study|Protocol Violation|0|||
129864522|NCT02962908|467460032|FG003|Overall Study|Protocol Violation|0|||
129864523|NCT02962908|467460029|FG000|Overall Study|Physician Decision|0|||
129864524|NCT02962908|467460030|FG001|Overall Study|Physician Decision|1|||
129864525|NCT02962908|467460031|FG002|Overall Study|Physician Decision|0|||
129864526|NCT02962908|467460032|FG003|Overall Study|Physician Decision|0|||
129864527|NCT01261338|467460033|FG000|Overall Study|Withdrawal by Subject|3|||
129864528|NCT01261338|467460034|FG001|Overall Study|Withdrawal by Subject|2|||
129864529|NCT02313428|467460035|FG000|Overall Study|Lost to Follow-up|1|||
129864530|NCT02313428|467460036|FG001|Overall Study|Lost to Follow-up|1|||
129864531|NCT05374421|467460037|FG000|Overall Study|Withdrawal by Subject|3|||
129864532|NCT05374421|467460038|FG001|Overall Study|Withdrawal by Subject|4|||
129864533|NCT02899728|467460039|FG000|Overall Study|Withdrawal by Subject|1|||
129864534|NCT02899728|467460040|FG001|Overall Study|Withdrawal by Subject|1|||
129864535|NCT05557942|467460041|FG000|Overall Study|Death|0|||
129864536|NCT05557942|467460042|FG001|Overall Study|Death|0|||
129864537|NCT05557942|467460043|FG002|Overall Study|Death|0|||
129864538|NCT05557942|467460044|FG003|Overall Study|Death|2|||
129864539|NCT05557942|467460045|FG004|Overall Study|Death|1|||
129864540|NCT05557942|467460046|FG005|Overall Study|Death|1|||
129864541|NCT05557942|467460041|FG000|Overall Study|Physician Decision|1|||
129864542|NCT05557942|467460042|FG001|Overall Study|Physician Decision|1|||
129864543|NCT05557942|467460043|FG002|Overall Study|Physician Decision|2|||
129864544|NCT05557942|467460044|FG003|Overall Study|Physician Decision|3|||
129864545|NCT05557942|467460045|FG004|Overall Study|Physician Decision|0|||
129864546|NCT05557942|467460046|FG005|Overall Study|Physician Decision|2|||
129864547|NCT05557942|467460041|FG000|Overall Study|Study terminated by sponsor|17|||
130065475|NCT00634114|468194720|FG000|Overall Study|Pregnancy|1|||
129864548|NCT05557942|467460042|FG001|Overall Study|Study terminated by sponsor|17|||
129864549|NCT05557942|467460043|FG002|Overall Study|Study terminated by sponsor|14|||
129864550|NCT05557942|467460044|FG003|Overall Study|Study terminated by sponsor|40|||
129864551|NCT05557942|467460045|FG004|Overall Study|Study terminated by sponsor|45|||
129864552|NCT05557942|467460046|FG005|Overall Study|Study terminated by sponsor|37|||
130065476|NCT00634114|468194721|FG001|Overall Study|Pregnancy|0|||
130065477|NCT00634114|468194722|FG002|Overall Study|Pregnancy|0|||
130065478|NCT00634114|468194720|FG000|Overall Study|Incorrect enrolment|0|||
130065479|NCT00634114|468194721|FG001|Overall Study|Incorrect enrolment|1|||
130065480|NCT00634114|468194722|FG002|Overall Study|Incorrect enrolment|0|||
129864553|NCT05557942|467460041|FG000|Overall Study|Protocol Violation|0|||
129864554|NCT05557942|467460042|FG001|Overall Study|Protocol Violation|0|||
129864555|NCT05557942|467460043|FG002|Overall Study|Protocol Violation|0|||
129864556|NCT05557942|467460044|FG003|Overall Study|Protocol Violation|0|||
129864557|NCT05557942|467460045|FG004|Overall Study|Protocol Violation|0|||
129864558|NCT05557942|467460046|FG005|Overall Study|Protocol Violation|1|||
129864559|NCT05557942|467460041|FG000|Overall Study|Withdrawal by Subject|0|||
130065481|NCT00634114|468194720|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
130065482|NCT00634114|468194721|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
129864560|NCT05557942|467460042|FG001|Overall Study|Withdrawal by Subject|0|||
129864561|NCT05557942|467460043|FG002|Overall Study|Withdrawal by Subject|0|||
129864562|NCT05557942|467460044|FG003|Overall Study|Withdrawal by Subject|0|||
129864563|NCT05557942|467460045|FG004|Overall Study|Withdrawal by Subject|2|||
129864564|NCT05557942|467460046|FG005|Overall Study|Withdrawal by Subject|0|||
129864575|NCT00655980|467460052|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
129864576|NCT00655980|467460053|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
129864577|NCT00655980|467460054|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
129864578|NCT05540522|467460055|FG000|Overall Study|Adverse Event|1|||
129864579|NCT05540522|467460056|FG001|Overall Study|Adverse Event|0|||
129864580|NCT05540522|467460057|FG002|Overall Study|Adverse Event|2|||
129864581|NCT05540522|467460058|FG003|Overall Study|Adverse Event|5|||
129864582|NCT05540522|467460055|FG000|Overall Study|Lost to Follow-up|487|||
129864583|NCT05540522|467460056|FG001|Overall Study|Lost to Follow-up|427|||
129864584|NCT05540522|467460057|FG002|Overall Study|Lost to Follow-up|146|||
129864585|NCT05540522|467460058|FG003|Overall Study|Lost to Follow-up|166|||
129864586|NCT05540522|467460055|FG000|Overall Study|Physician Decision|11|||
129864587|NCT05540522|467460056|FG001|Overall Study|Physician Decision|19|||
129864588|NCT05540522|467460057|FG002|Overall Study|Physician Decision|8|||
129864589|NCT05540522|467460058|FG003|Overall Study|Physician Decision|13|||
129864590|NCT05540522|467460055|FG000|Overall Study|Pregnancy|1|||
129864591|NCT05540522|467460056|FG001|Overall Study|Pregnancy|0|||
129864592|NCT05540522|467460057|FG002|Overall Study|Pregnancy|0|||
129864593|NCT05540522|467460058|FG003|Overall Study|Pregnancy|0|||
129864594|NCT05540522|467460055|FG000|Overall Study|Protocol Violation|3|||
129864595|NCT05540522|467460056|FG001|Overall Study|Protocol Violation|1|||
129864596|NCT05540522|467460057|FG002|Overall Study|Protocol Violation|9|||
129864597|NCT05540522|467460058|FG003|Overall Study|Protocol Violation|7|||
129864598|NCT05540522|467460055|FG000|Overall Study|Withdrawal by Subject|168|||
129864599|NCT05540522|467460056|FG001|Overall Study|Withdrawal by Subject|134|||
129864600|NCT05540522|467460057|FG002|Overall Study|Withdrawal by Subject|331|||
129864601|NCT05540522|467460058|FG003|Overall Study|Withdrawal by Subject|322|||
129864602|NCT05540522|467460055|FG000|Overall Study|Death|7|||
129864603|NCT05540522|467460056|FG001|Overall Study|Death|9|||
129864604|NCT05540522|467460057|FG002|Overall Study|Death|49|||
129864605|NCT05540522|467460058|FG003|Overall Study|Death|46|||
129864606|NCT05540522|467460055|FG000|Overall Study|Not vaccinated|34|||
129864607|NCT05540522|467460056|FG001|Overall Study|Not vaccinated|53|||
129864608|NCT05540522|467460057|FG002|Overall Study|Not vaccinated|57|||
129864609|NCT05540522|467460058|FG003|Overall Study|Not vaccinated|50|||
129864610|NCT05540522|467460055|FG000|Overall Study|No longer meets eligibility criteria|0|||
129864611|NCT05540522|467460056|FG001|Overall Study|No longer meets eligibility criteria|0|||
129864612|NCT05540522|467460057|FG002|Overall Study|No longer meets eligibility criteria|3|||
129864613|NCT05540522|467460058|FG003|Overall Study|No longer meets eligibility criteria|2|||
129864614|NCT05540522|467460055|FG000|Overall Study|Other (Unspecified)|8|||
129864615|NCT05540522|467460056|FG001|Overall Study|Other (Unspecified)|10|||
129864616|NCT05540522|467460057|FG002|Overall Study|Other (Unspecified)|4|||
129864617|NCT05540522|467460058|FG003|Overall Study|Other (Unspecified)|2|||
129864618|NCT03754803|467460059|FG000|Overall Study|Withdrawal by Subject|2|||
129864619|NCT05239039|467460060|FG000|Overall Study|Withdrawal by Subject|0|||
129864620|NCT05239039|467460061|FG001|Overall Study|Withdrawal by Subject|1|||
129864621|NCT00936390|467460064|FG000|Overall Study|Protocol Violation|21|||
129864622|NCT00936390|467460065|FG001|Overall Study|Protocol Violation|25|||
129864623|NCT04348604|467460066|FG000|Week 8|Withdrawal by Subject|1|||
129864624|NCT04348604|467460067|FG001|Week 8|Withdrawal by Subject|1|||
129864625|NCT04348604|467460066|FG000|Week 8|Lost to Follow-up|1|||
129864626|NCT04348604|467460067|FG001|Week 8|Lost to Follow-up|2|||
129864627|NCT04348604|467460066|FG000|Week 8|Suspended|0|||
130065483|NCT00634114|468194722|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
129864628|NCT04348604|467460067|FG001|Week 8|Suspended|1|||
129864629|NCT04348604|467460066|FG000|Week 12|Lost to Follow-up|1|||
129864630|NCT04348604|467460067|FG001|Week 12|Lost to Follow-up|2|||
129864631|NCT04348604|467460066|FG000|Week 12|Withdrawal by Subject|1|||
130065484|NCT00634114|468194720|FG000|Overall Study|Difficult to continue|3|||
129864632|NCT04348604|467460067|FG001|Week 12|Withdrawal by Subject|0|||
129864633|NCT04348604|467460066|FG000|Week 24|Lost to Follow-up|2|||
129864634|NCT04348604|467460067|FG001|Week 24|Lost to Follow-up|1|||
129914409|NCT05171777|467648958|FG001|Treatment Continuation Period|Death|0|||
129914410|NCT05171777|467648959|FG002|Treatment Continuation Period|Death|1|||
129914411|NCT05171777|467648960|FG003|Treatment Continuation Period|Death|6|||
129914412|NCT05171777|467648957|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
129914413|NCT05171777|467648958|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
129914414|NCT05171777|467648959|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
129914415|NCT05171777|467648960|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
129914416|NCT00632749|467648961|FG000|Overall Study|Progressive disease|3|||
129914417|NCT00632749|467648962|FG001|Overall Study|Progressive disease|2|||
129914418|NCT00632749|467648963|FG002|Overall Study|Progressive disease|2|||
129914419|NCT00632749|467648964|FG003|Overall Study|Progressive disease|2|||
129914420|NCT00632749|467648965|FG004|Overall Study|Progressive disease|4|||
129914421|NCT00632749|467648966|FG005|Overall Study|Progressive disease|4|||
129914422|NCT00632749|467648967|FG006|Overall Study|Progressive disease|3|||
129914423|NCT00632749|467648968|FG007|Overall Study|Progressive disease|2|||
129914424|NCT00632749|467648969|FG008|Overall Study|Progressive disease|3|||
129914425|NCT00632749|467648970|FG009|Overall Study|Progressive disease|2|||
129914426|NCT00632749|467648971|FG010|Overall Study|Progressive disease|4|||
129914427|NCT00632749|467648972|FG011|Overall Study|Progressive disease|3|||
129914428|NCT00632749|467648973|FG012|Overall Study|Progressive disease|2|||
129914429|NCT00632749|467648974|FG013|Overall Study|Progressive disease|4|||
129914430|NCT00632749|467648961|FG000|Overall Study|Other Adverse event|1|||
129914431|NCT00632749|467648962|FG001|Overall Study|Other Adverse event|1|||
129914432|NCT00632749|467648963|FG002|Overall Study|Other Adverse event|1|||
129914433|NCT00632749|467648964|FG003|Overall Study|Other Adverse event|1|||
129914434|NCT00632749|467648965|FG004|Overall Study|Other Adverse event|2|||
129914435|NCT00632749|467648966|FG005|Overall Study|Other Adverse event|4|||
129914436|NCT00632749|467648967|FG006|Overall Study|Other Adverse event|1|||
129914437|NCT00632749|467648968|FG007|Overall Study|Other Adverse event|2|||
129914438|NCT00632749|467648969|FG008|Overall Study|Other Adverse event|2|||
129914439|NCT00632749|467648970|FG009|Overall Study|Other Adverse event|0|||
129914440|NCT00632749|467648971|FG010|Overall Study|Other Adverse event|1|||
129914441|NCT00632749|467648972|FG011|Overall Study|Other Adverse event|0|||
129914442|NCT00632749|467648973|FG012|Overall Study|Other Adverse event|1|||
129914443|NCT00632749|467648974|FG013|Overall Study|Other Adverse event|0|||
129914444|NCT00632749|467648961|FG000|Overall Study|Refuse to continue medication|0|||
129914445|NCT00632749|467648962|FG001|Overall Study|Refuse to continue medication|0|||
129914446|NCT00632749|467648963|FG002|Overall Study|Refuse to continue medication|0|||
129914447|NCT00632749|467648964|FG003|Overall Study|Refuse to continue medication|1|||
129914448|NCT00632749|467648965|FG004|Overall Study|Refuse to continue medication|0|||
129914449|NCT00632749|467648966|FG005|Overall Study|Refuse to continue medication|0|||
129914450|NCT00632749|467648967|FG006|Overall Study|Refuse to continue medication|0|||
129914451|NCT00632749|467648968|FG007|Overall Study|Refuse to continue medication|0|||
129914452|NCT00632749|467648969|FG008|Overall Study|Refuse to continue medication|0|||
129914453|NCT00632749|467648970|FG009|Overall Study|Refuse to continue medication|1|||
129914454|NCT00632749|467648971|FG010|Overall Study|Refuse to continue medication|0|||
129914455|NCT00632749|467648972|FG011|Overall Study|Refuse to continue medication|0|||
129914456|NCT00632749|467648973|FG012|Overall Study|Refuse to continue medication|0|||
129914457|NCT00632749|467648974|FG013|Overall Study|Refuse to continue medication|0|||
129914458|NCT00632749|467648961|FG000|Overall Study|Reason other than those specified above|0|||
129914459|NCT00632749|467648962|FG001|Overall Study|Reason other than those specified above|2|||
129914460|NCT00632749|467648963|FG002|Overall Study|Reason other than those specified above|0|||
129914461|NCT00632749|467648964|FG003|Overall Study|Reason other than those specified above|0|||
129914462|NCT00632749|467648965|FG004|Overall Study|Reason other than those specified above|1|||
129914463|NCT00632749|467648966|FG005|Overall Study|Reason other than those specified above|0|||
129914464|NCT00632749|467648967|FG006|Overall Study|Reason other than those specified above|1|||
129914465|NCT00632749|467648968|FG007|Overall Study|Reason other than those specified above|0|||
129914466|NCT00632749|467648969|FG008|Overall Study|Reason other than those specified above|0|||
129914467|NCT00632749|467648970|FG009|Overall Study|Reason other than those specified above|0|||
129914468|NCT00632749|467648971|FG010|Overall Study|Reason other than those specified above|2|||
129914469|NCT00632749|467648972|FG011|Overall Study|Reason other than those specified above|1|||
129914470|NCT00632749|467648973|FG012|Overall Study|Reason other than those specified above|0|||
129914471|NCT00632749|467648974|FG013|Overall Study|Reason other than those specified above|2|||
129914472|NCT01136876|467648975|FG000|Overall Study|Lost to Follow-up|0|||
129914473|NCT01136876|467648976|FG001|Overall Study|Lost to Follow-up|1|||
129914474|NCT01136876|467648975|FG000|Overall Study|Physician Decision|3|||
129914475|NCT01136876|467648976|FG001|Overall Study|Physician Decision|5|||
129914476|NCT01136876|467648975|FG000|Overall Study|Missing NGAL measurement|2|||
129914477|NCT01136876|467648976|FG001|Overall Study|Missing NGAL measurement|5|||
129914478|NCT04128319|467648979|FG000|Overall Study|Death|3|||
129914479|NCT00976937|467648982|FG000|Overall Study|Adverse Event|4|||
129914480|NCT00976937|467648983|FG001|Overall Study|Adverse Event|5|||
129914481|NCT00976937|467648982|FG000|Overall Study|Lost to Follow-up|2|||
129914482|NCT00976937|467648983|FG001|Overall Study|Lost to Follow-up|1|||
129864635|NCT02097108|467460068|FG000|Overall Study|Adverse Event|1|||
129864636|NCT02097108|467460068|FG000|Overall Study|patient was abroad for 6 months|1|||
129864637|NCT05245864|467460069|FG000|Overall Study|Withdrawal by Subject|1|||
129864638|NCT05245864|467460070|FG001|Overall Study|Withdrawal by Subject|1|||
129864639|NCT01329029|467460071|FG000|Overall Study|Withdrawal by Subject|117|||
129864640|NCT01329029|467460072|FG001|Overall Study|Withdrawal by Subject|87|||
129864641|NCT01329029|467460071|FG000|Overall Study|Adverse Event|82|||
129864642|NCT01329029|467460072|FG001|Overall Study|Adverse Event|29|||
129864643|NCT01329029|467460071|FG000|Overall Study|Death|16|||
129864644|NCT01329029|467460072|FG001|Overall Study|Death|19|||
129864645|NCT01329029|467460071|FG000|Overall Study|Other|14|||
129864646|NCT01329029|467460072|FG001|Overall Study|Other|20|||
129864647|NCT01329029|467460071|FG000|Overall Study|COPD Exacerbation|11|||
129864648|NCT01329029|467460072|FG001|Overall Study|COPD Exacerbation|18|||
129864649|NCT01329029|467460071|FG000|Overall Study|Physician Decision|16|||
129864650|NCT01329029|467460072|FG001|Overall Study|Physician Decision|13|||
129864651|NCT01329029|467460071|FG000|Overall Study|Lost to Follow-up|8|||
129864652|NCT01329029|467460072|FG001|Overall Study|Lost to Follow-up|5|||
129864653|NCT01329029|467460071|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
129864654|NCT01329029|467460072|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
129864655|NCT02119260|467462403|FG000|Overall Study|Adverse Event|1|||
129864656|NCT02119260|467462404|FG001|Overall Study|Adverse Event|0|||
129864657|NCT02119260|467462405|FG002|Overall Study|Adverse Event|0|||
129864658|NCT02119260|467462406|FG003|Overall Study|Adverse Event|0|||
129864659|NCT02119260|467462407|FG004|Overall Study|Adverse Event|0|||
129864660|NCT02119260|467462408|FG005|Overall Study|Adverse Event|0|||
129864661|NCT02119260|467462409|FG006|Overall Study|Adverse Event|0|||
129864662|NCT02119260|467462403|FG000|Overall Study|Withdrew consent|0|||
129864663|NCT02119260|467462404|FG001|Overall Study|Withdrew consent|1|||
129864664|NCT02119260|467462405|FG002|Overall Study|Withdrew consent|1|||
129864665|NCT02119260|467462406|FG003|Overall Study|Withdrew consent|0|||
129864666|NCT02119260|467462407|FG004|Overall Study|Withdrew consent|0|||
129864667|NCT02119260|467462408|FG005|Overall Study|Withdrew consent|0|||
129864668|NCT02119260|467462409|FG006|Overall Study|Withdrew consent|0|||
129864669|NCT00844857|467462410|FG000|Overall Study|Adverse Event|24|||
129864670|NCT00844857|467462411|FG001|Overall Study|Adverse Event|5|||
129864671|NCT00844857|467462410|FG000|Overall Study|Sponsor Decision|1|||
129864672|NCT00844857|467462411|FG001|Overall Study|Sponsor Decision|1|||
129864673|NCT00844857|467462410|FG000|Overall Study|Physician Decision|2|||
129864674|NCT00844857|467462411|FG001|Overall Study|Physician Decision|0|||
129864675|NCT00844857|467462410|FG000|Overall Study|Parent/Caregiver Decision|6|||
129864676|NCT00844857|467462411|FG001|Overall Study|Parent/Caregiver Decision|2|||
129864677|NCT00844857|467462410|FG000|Overall Study|Withdrawal by Subject|8|||
129864678|NCT00844857|467462411|FG001|Overall Study|Withdrawal by Subject|7|||
129864679|NCT00844857|467462410|FG000|Overall Study|Protocol Violation|6|||
129864680|NCT00844857|467462411|FG001|Overall Study|Protocol Violation|0|||
129864681|NCT00844857|467462410|FG000|Overall Study|Lack of Efficacy|5|||
129864682|NCT00844857|467462411|FG001|Overall Study|Lack of Efficacy|5|||
129864683|NCT00844857|467462410|FG000|Overall Study|Clinical Relapse|0|||
129864684|NCT00844857|467462411|FG001|Overall Study|Clinical Relapse|1|||
129864685|NCT00844857|467462410|FG000|Overall Study|Entry Criteria Not Met|0|||
129864686|NCT00844857|467462411|FG001|Overall Study|Entry Criteria Not Met|1|||
129864687|NCT00844857|467462410|FG000|Overall Study|Lost to Follow-up|2|||
129864688|NCT00844857|467462411|FG001|Overall Study|Lost to Follow-up|3|||
129864689|NCT00844857|467462410|FG000|Overall Study|Did Not Take Study Drug|3|||
129864690|NCT00844857|467462411|FG001|Overall Study|Did Not Take Study Drug|1|||
129864691|NCT00844857|467462410|FG000|Overall Study|Good Clinical Practice Violations|21|||
129864692|NCT00844857|467462411|FG001|Overall Study|Good Clinical Practice Violations|11|||
129864693|NCT02057874|467462412|FG000|Overall Study|participant did not return for scan|1|||
129864694|NCT01738984|467462413|FG000|Overall Study|Pregnancy|4|||
129864695|NCT01738984|467462414|FG001|Overall Study|Pregnancy|0|||
129864696|NCT01738984|467462413|FG000|Overall Study|Withdrawal by Subject|1|||
129864697|NCT01738984|467462414|FG001|Overall Study|Withdrawal by Subject|0|||
129864698|NCT01738984|467462413|FG000|Overall Study|Lost to Follow-up|59|||
129864699|NCT01738984|467462414|FG001|Overall Study|Lost to Follow-up|39|||
129864700|NCT00857207|467462418|FG000|Overall Study|Withdrawal by Subject|13|||
129864701|NCT00857207|467462419|FG001|Overall Study|Withdrawal by Subject|0|||
129864702|NCT00857207|467462418|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
129864703|NCT00857207|467462419|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
129864704|NCT00857207|467462418|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
129864705|NCT00857207|467462419|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
129864706|NCT01258608|467462420|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
129864707|NCT01258608|467462421|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
129864708|NCT01258608|467462420|FG000|Overall Study|Clinical progression|1|||
129864709|NCT01258608|467462421|FG001|Overall Study|Clinical progression|0|||
129864710|NCT01258608|467462420|FG000|Overall Study|Sponsor decision|0|||
129864711|NCT01258608|467462421|FG001|Overall Study|Sponsor decision|1|||
129914483|NCT00976937|467648982|FG000|Overall Study|Withdrawal by Subject|5|||
129914484|NCT00976937|467648983|FG001|Overall Study|Withdrawal by Subject|3|||
129914485|NCT00976937|467648982|FG000|Overall Study|Poor compliance to protocol|3|||
129914486|NCT00976937|467648983|FG001|Overall Study|Poor compliance to protocol|0|||
129914487|NCT00976937|467648982|FG000|Overall Study|Personal and Familial Reason|2|||
129914488|NCT00976937|467648983|FG001|Overall Study|Personal and Familial Reason|2|||
129914489|NCT01011946|467648984|FG000|Overall Study|Transferred to another hospital|2|||
129914490|NCT01011946|467648984|FG000|Overall Study|No pathological lab value|1|||
129914491|NCT03988842|467648985|FG000|Overall Study|Death|1|||
129914492|NCT00709098|467648988|FG000|Double-blind Period|Withdrawal of consent|3|||
129914493|NCT00709098|467648989|FG001|Double-blind Period|Withdrawal of consent|3|||
129914494|NCT00709098|467648990|FG002|Double-blind Period|Withdrawal of consent|0|||
129914495|NCT00709098|467648988|FG000|Double-blind Period|Administrative reason|1|||
129914496|NCT00709098|467648989|FG001|Double-blind Period|Administrative reason|3|||
129914497|NCT00709098|467648990|FG002|Double-blind Period|Administrative reason|0|||
129914498|NCT00709098|467648988|FG000|Double-blind Period|Death|1|||
129914499|NCT00709098|467648989|FG001|Double-blind Period|Death|1|||
129914500|NCT00709098|467648990|FG002|Double-blind Period|Death|0|||
129914501|NCT00709098|467648988|FG000|Double-blind Period|Lost to Follow-up|1|||
129914502|NCT00709098|467648989|FG001|Double-blind Period|Lost to Follow-up|1|||
129914503|NCT00709098|467648990|FG002|Double-blind Period|Lost to Follow-up|0|||
129914504|NCT00709098|467648988|FG000|Open-label Period|Withdrawal of consent|0|||
129914505|NCT00709098|467648989|FG001|Open-label Period|Withdrawal of consent|0|||
129914506|NCT00709098|467648990|FG002|Open-label Period|Withdrawal of consent|7|||
129914507|NCT00709098|467648988|FG000|Open-label Period|Administrative reason|0|||
129914508|NCT00709098|467648989|FG001|Open-label Period|Administrative reason|0|||
129914509|NCT00709098|467648990|FG002|Open-label Period|Administrative reason|5|||
129914510|NCT00709098|467648988|FG000|Open-label Period|Death|0|||
129914511|NCT00709098|467648989|FG001|Open-label Period|Death|0|||
129914512|NCT00709098|467648990|FG002|Open-label Period|Death|1|||
129914513|NCT00709098|467648988|FG000|Open-label Period|Lost to Follow-up|0|||
129914514|NCT00709098|467648989|FG001|Open-label Period|Lost to Follow-up|0|||
129914515|NCT00709098|467648990|FG002|Open-label Period|Lost to Follow-up|1|||
129914516|NCT01227265|467648992|FG000|Overall Study|Did Not Receive Treatment|1|||
129914517|NCT01227265|467648993|FG001|Overall Study|Did Not Receive Treatment|2|||
129914518|NCT01227265|467648994|FG002|Overall Study|Did Not Receive Treatment|0|||
129914519|NCT01227265|467648992|FG000|Overall Study|Administrative|1|||
129914520|NCT01227265|467648993|FG001|Overall Study|Administrative|0|||
129914521|NCT01227265|467648994|FG002|Overall Study|Administrative|2|||
129914522|NCT01227265|467648992|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
129914523|NCT01227265|467648993|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
129914524|NCT01227265|467648994|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
129914525|NCT01227265|467648992|FG000|Overall Study|Protocol Violation|2|||
129914526|NCT01227265|467648993|FG001|Overall Study|Protocol Violation|1|||
129914527|NCT01227265|467648994|FG002|Overall Study|Protocol Violation|0|||
129914528|NCT01227265|467648992|FG000|Overall Study|Withdrawal by Subject|7|||
129914529|NCT01227265|467648993|FG001|Overall Study|Withdrawal by Subject|7|||
129914530|NCT01227265|467648994|FG002|Overall Study|Withdrawal by Subject|3|||
129914531|NCT01227265|467648992|FG000|Overall Study|Lost to Follow-up|2|||
129914532|NCT01227265|467648993|FG001|Overall Study|Lost to Follow-up|0|||
129914533|NCT01227265|467648994|FG002|Overall Study|Lost to Follow-up|3|||
129914534|NCT01227265|467648992|FG000|Overall Study|Adverse Event|6|||
129914535|NCT01227265|467648993|FG001|Overall Study|Adverse Event|10|||
129914536|NCT01227265|467648994|FG002|Overall Study|Adverse Event|5|||
129914537|NCT03582722|467649000|FG000|Overall Study|Lost to Follow-up|1|||
129914538|NCT03582722|467649001|FG001|Overall Study|Lost to Follow-up|4|||
129914539|NCT03582722|467649000|FG000|Overall Study|Withdrawal by Subject|3|||
129914540|NCT03582722|467649001|FG001|Overall Study|Withdrawal by Subject|3|||
129914541|NCT03690206|467649002|FG000|Overall Study|Withdrawal by Subject|2|||
129914542|NCT03690206|467649003|FG001|Overall Study|Withdrawal by Subject|0|||
129914543|NCT03690206|467649004|FG002|Overall Study|Withdrawal by Subject|0|||
129914544|NCT03690206|467649002|FG000|Overall Study|ICF withdrawal|2|||
129914545|NCT03690206|467649003|FG001|Overall Study|ICF withdrawal|0|||
129914546|NCT03690206|467649004|FG002|Overall Study|ICF withdrawal|0|||
129914547|NCT06024174|467649005|FG000|Overall Study|Other Reasons|1|||
129914548|NCT06024174|467649005|FG000|Overall Study|Study terminated by Sponsor|4|||
129914549|NCT05028582|467649006|FG000|Overall Study|Lost to Follow-up|11|||
129914550|NCT05028582|467649007|FG001|Overall Study|Lost to Follow-up|9|||
129914551|NCT05028582|467649006|FG000|Overall Study|Withdrawal by Subject|9|||
129914552|NCT05028582|467649007|FG001|Overall Study|Withdrawal by Subject|10|||
129914553|NCT05028582|467649006|FG000|Overall Study|Adverse Event|5|||
129914554|NCT05028582|467649007|FG001|Overall Study|Adverse Event|2|||
129914555|NCT05028582|467649006|FG000|Overall Study|Miscellaneous|3|||
129914556|NCT05028582|467649007|FG001|Overall Study|Miscellaneous|2|||
129914557|NCT05028582|467649006|FG000|Overall Study|Lack of Efficacy|3|||
129914558|NCT05028582|467649007|FG001|Overall Study|Lack of Efficacy|1|||
129914559|NCT05028582|467649006|FG000|Overall Study|Physician Decision|0|||
129914560|NCT05028582|467649007|FG001|Overall Study|Physician Decision|1|||
129914561|NCT01959698|467649008|FG000|Overall Study|Adverse Event|0|||
129914562|NCT01959698|467649009|FG001|Overall Study|Adverse Event|0|||
129914563|NCT01959698|467649010|FG002|Overall Study|Adverse Event|0|||
129914564|NCT01959698|467649011|FG003|Overall Study|Adverse Event|0|||
129914565|NCT01959698|467649012|FG004|Overall Study|Adverse Event|0|||
129914566|NCT01959698|467649013|FG005|Overall Study|Adverse Event|0|||
129914567|NCT01959698|467649014|FG006|Overall Study|Adverse Event|1|||
129914568|NCT01959698|467649008|FG000|Overall Study|Physician Decision|1|||
129914569|NCT01959698|467649009|FG001|Overall Study|Physician Decision|0|||
129914570|NCT01959698|467649010|FG002|Overall Study|Physician Decision|1|||
130116668|NCT00585351|468387154|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
130116669|NCT00585351|468387147|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
130116670|NCT00585351|468387148|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
130116671|NCT00585351|468387149|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130116672|NCT00585351|468387150|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129864712|NCT01258608|467462420|FG000|Overall Study|Physician Decision|6|||
129864713|NCT01258608|467462421|FG001|Overall Study|Physician Decision|1|||
129914571|NCT01959698|467649011|FG003|Overall Study|Physician Decision|2|||
129914572|NCT01959698|467649012|FG004|Overall Study|Physician Decision|0|||
129914573|NCT01959698|467649013|FG005|Overall Study|Physician Decision|3|||
129914574|NCT01959698|467649014|FG006|Overall Study|Physician Decision|3|||
129914575|NCT03744312|467651320|FG000|Overall Study|Withdrawal by Subject|0|||
129914576|NCT03744312|467651321|FG001|Overall Study|Withdrawal by Subject|1|||
129914577|NCT03744312|467651320|FG000|Overall Study|Screen fail|0|||
129914578|NCT03744312|467651321|FG001|Overall Study|Screen fail|1|||
129914579|NCT03012841|467651322|FG000|Overall Study|Protocol Violation|0|||
129914580|NCT03012841|467651323|FG001|Overall Study|Protocol Violation|10|||
129864714|NCT01258608|467462420|FG000|Overall Study|Lost to Follow-up|0|||
129864715|NCT01258608|467462421|FG001|Overall Study|Lost to Follow-up|1|||
129864716|NCT01258608|467462420|FG000|Overall Study|Lack of compliance|1|||
129864717|NCT01258608|467462421|FG001|Overall Study|Lack of compliance|0|||
129864718|NCT01258608|467462420|FG000|Overall Study|Lack of Efficacy|0|||
129864719|NCT01258608|467462421|FG001|Overall Study|Lack of Efficacy|1|||
129864720|NCT01258608|467462420|FG000|Overall Study|Adverse Event|6|||
129864721|NCT01258608|467462421|FG001|Overall Study|Adverse Event|10|||
129864722|NCT01258608|467462420|FG000|Overall Study|Withdrawal by Subject|6|||
129864723|NCT01258608|467462421|FG001|Overall Study|Withdrawal by Subject|5|||
129864724|NCT02943408|467462423|FG000|Overall Study|Lost to Follow-up|7|||
129864725|NCT02943408|467462424|FG001|Overall Study|Lost to Follow-up|1|||
129864726|NCT02943408|467462423|FG000|Overall Study|Withdrawal by Subject|0|||
129864727|NCT02943408|467462424|FG001|Overall Study|Withdrawal by Subject|1|||
129864728|NCT01621126|467462427|FG000|Overall Study|Physician Decision|6|||
129864729|NCT00886340|467462429|FG000|Overall Study|Withdrawal by Subject|0|||
129864730|NCT00886340|467462430|FG001|Overall Study|Withdrawal by Subject|7|||
129864731|NCT01949311|467462431|FG000|Overall Study|Lost to Follow-up|73|||
129864732|NCT01949311|467462431|FG000|Overall Study|Terminated by Sponsor|708|||
129864733|NCT01949311|467462431|FG000|Overall Study|Withdrawal by Subject|375|||
129864734|NCT01949311|467462431|FG000|Overall Study|Lack of Efficacy|50|||
129864735|NCT01949311|467462431|FG000|Overall Study|Protocol Deviation|34|||
129864736|NCT01949311|467462431|FG000|Overall Study|Pregnancy|20|||
129864737|NCT01949311|467462431|FG000|Overall Study|Physician Decision|9|||
129864738|NCT01949311|467462431|FG000|Overall Study|Other|4|||
129864739|NCT01949311|467462431|FG000|Overall Study|Adverse Event|107|||
129864740|NCT02338154|467462432|FG000|Overall Study|Death|46|||
129864741|NCT02338154|467462432|FG000|Overall Study|Valve Implant Failure|17|||
129864742|NCT02338154|467462432|FG000|Overall Study|Valve Explant|11|||
129864743|NCT02338154|467462432|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
129864744|NCT02338154|467462432|FG000|Overall Study|Lost to Follow-up|8|||
129864745|NCT02338154|467462432|FG000|Overall Study|Other Reason|3|||
129914581|NCT03012841|467651322|FG000|Overall Study|Lost to Follow-up|6|||
129914582|NCT03012841|467651323|FG001|Overall Study|Lost to Follow-up|1|||
129914583|NCT03012841|467651322|FG000|Overall Study|Withdrawal by Subject|6|||
129914584|NCT03012841|467651323|FG001|Overall Study|Withdrawal by Subject|0|||
129914585|NCT03012841|467651322|FG000|Overall Study|Unable to complete 12 month visit|6|||
129914586|NCT03012841|467651323|FG001|Overall Study|Unable to complete 12 month visit|0|||
129864746|NCT02338154|467462432|FG000|Overall Study|Patients Without Exit Form|47|||
129864747|NCT02338154|467462432|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
129864748|NCT02120027|467462435|FG000|Overall Study|Adverse Event|4|||
129864749|NCT02120027|467462436|FG001|Overall Study|Adverse Event|5|||
129914587|NCT03012841|467651322|FG000|Overall Study|Subject relocation|1|||
129914588|NCT03012841|467651323|FG001|Overall Study|Subject relocation|0|||
129864750|NCT02120027|467462435|FG000|Overall Study|Lack of Efficacy|3|||
129864751|NCT02120027|467462436|FG001|Overall Study|Lack of Efficacy|5|||
129864752|NCT02120027|467462435|FG000|Overall Study|Lost to Follow-up|5|||
129864753|NCT02120027|467462436|FG001|Overall Study|Lost to Follow-up|13|||
129864754|NCT02120027|467462435|FG000|Overall Study|Other|4|||
129914589|NCT03012841|467651322|FG000|Overall Study|Seasonal winter travel|1|||
129914590|NCT03012841|467651323|FG001|Overall Study|Seasonal winter travel|0|||
129914591|NCT03012841|467651322|FG000|Overall Study|Physician Decision|0|||
129914592|NCT03012841|467651323|FG001|Overall Study|Physician Decision|2|||
129914593|NCT03012841|467651322|FG000|Overall Study|No ablation performed|0|||
129864755|NCT02120027|467462436|FG001|Overall Study|Other|0|||
129914594|NCT03012841|467651323|FG001|Overall Study|No ablation performed|2|||
129914595|NCT03012841|467651322|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
129914596|NCT03012841|467651323|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
129914597|NCT03012841|467651322|FG000|Overall Study|Insurance change|0|||
129914598|NCT03012841|467651323|FG001|Overall Study|Insurance change|1|||
129914599|NCT03416023|467651334|FG000|Overall Study|Exclusion criteria failure|1|||
129914600|NCT03416023|467651334|FG000|Overall Study|Withdrawal by Subject|6|||
129914601|NCT03416023|467651334|FG000|Overall Study|Explanted|7|||
129914602|NCT03416023|467651334|FG000|Overall Study|Physician Decision|1|||
129914603|NCT03416023|467651334|FG000|Overall Study|Lost to Follow-up|1|||
129914604|NCT03416023|467651334|FG000|Overall Study|Death|1|||
129914605|NCT04878354|467651335|FG000|Overall Study|Adverse Event|4|||
129914606|NCT04878354|467651336|FG001|Overall Study|Adverse Event|13|||
129914607|NCT04878354|467651335|FG000|Overall Study|Withdrawal by Subject|14|||
129914608|NCT04878354|467651336|FG001|Overall Study|Withdrawal by Subject|12|||
129914609|NCT04878354|467651335|FG000|Overall Study|Lost to Follow-up|4|||
129914610|NCT04878354|467651336|FG001|Overall Study|Lost to Follow-up|1|||
129914611|NCT04878354|467651335|FG000|Overall Study|Lack of Efficacy|1|||
129914612|NCT04878354|467651336|FG001|Overall Study|Lack of Efficacy|0|||
129914613|NCT04878354|467651335|FG000|Overall Study|Protocol Violation|0|||
129914614|NCT04878354|467651336|FG001|Overall Study|Protocol Violation|1|||
129914615|NCT04878354|467651335|FG000|Overall Study|"Reason stated as other in CRF"|2|||
129914616|NCT04878354|467651336|FG001|Overall Study|"Reason stated as other in CRF"|3|||
129914617|NCT05510232|467651337|FG000|Overall Study|Withdrawal by Subject|2|||
129914618|NCT05510232|467651338|FG001|Overall Study|Withdrawal by Subject|7|||
129914619|NCT05510232|467651339|FG002|Overall Study|Withdrawal by Subject|6|||
129914620|NCT04855760|467651341|FG000|Overall Study|Adverse Event|21|||
129914621|NCT04855760|467651341|FG000|Overall Study|Withdrawal by Subject|116|||
129914622|NCT04855760|467651341|FG000|Overall Study|Lack of Efficacy|21|||
129914623|NCT04855760|467651341|FG000|Overall Study|Lost to Follow-up|49|||
129864756|NCT02120027|467462435|FG000|Overall Study|Physician Decision|4|||
129864757|NCT02120027|467462436|FG001|Overall Study|Physician Decision|3|||
129864758|NCT02120027|467462435|FG000|Overall Study|Protocol Violation|18|||
129864759|NCT02120027|467462436|FG001|Overall Study|Protocol Violation|21|||
129864760|NCT02120027|467462435|FG000|Overall Study|Study terminated by Sponsor|45|||
129864761|NCT02120027|467462436|FG001|Overall Study|Study terminated by Sponsor|47|||
129864762|NCT02120027|467462435|FG000|Overall Study|Withdrawal by Subject|33|||
129864763|NCT02120027|467462436|FG001|Overall Study|Withdrawal by Subject|25|||
129864764|NCT00447057|467462442|FG000|Overall Study|Adverse Event|4|||
129864765|NCT00447057|467462443|FG001|Overall Study|Adverse Event|10|||
129864766|NCT00447057|467462444|FG002|Overall Study|Adverse Event|0|||
129864767|NCT00447057|467462445|FG003|Overall Study|Adverse Event|3|||
129864768|NCT00447057|467462442|FG000|Overall Study|Death due to study disease|6|||
129864769|NCT00447057|467462443|FG001|Overall Study|Death due to study disease|4|||
129864770|NCT00447057|467462444|FG002|Overall Study|Death due to study disease|1|||
129864771|NCT00447057|467462445|FG003|Overall Study|Death due to study disease|1|||
129864772|NCT00447057|467462442|FG000|Overall Study|Lost to Follow-up|0|||
129864773|NCT00447057|467462443|FG001|Overall Study|Lost to Follow-up|1|||
129864774|NCT00447057|467462444|FG002|Overall Study|Lost to Follow-up|0|||
129864775|NCT00447057|467462445|FG003|Overall Study|Lost to Follow-up|0|||
129864776|NCT00447057|467462442|FG000|Overall Study|Entry criteria not met|1|||
129864777|NCT00447057|467462443|FG001|Overall Study|Entry criteria not met|1|||
129864778|NCT00447057|467462444|FG002|Overall Study|Entry criteria not met|0|||
129864779|NCT00447057|467462445|FG003|Overall Study|Entry criteria not met|0|||
129864780|NCT00447057|467462442|FG000|Overall Study|Protocol Violation|0|||
129864781|NCT00447057|467462443|FG001|Overall Study|Protocol Violation|1|||
129864782|NCT00447057|467462444|FG002|Overall Study|Protocol Violation|0|||
129864783|NCT00447057|467462445|FG003|Overall Study|Protocol Violation|0|||
129864784|NCT00447057|467462442|FG000|Overall Study|Withdrawal by Subject|4|||
129864785|NCT00447057|467462443|FG001|Overall Study|Withdrawal by Subject|5|||
129864786|NCT00447057|467462444|FG002|Overall Study|Withdrawal by Subject|1|||
129864787|NCT00447057|467462445|FG003|Overall Study|Withdrawal by Subject|1|||
129864788|NCT00447057|467462442|FG000|Overall Study|Physician Decision|9|||
129864789|NCT00447057|467462443|FG001|Overall Study|Physician Decision|6|||
129864790|NCT00447057|467462444|FG002|Overall Study|Physician Decision|3|||
129864791|NCT00447057|467462445|FG003|Overall Study|Physician Decision|1|||
129864792|NCT00447057|467462442|FG000|Overall Study|Sponsor decision|1|||
129864793|NCT00447057|467462443|FG001|Overall Study|Sponsor decision|1|||
129864794|NCT00447057|467462444|FG002|Overall Study|Sponsor decision|0|||
129864795|NCT00447057|467462445|FG003|Overall Study|Sponsor decision|0|||
129864796|NCT00447057|467462442|FG000|Overall Study|Progressive disease|58|||
129864797|NCT00447057|467462443|FG001|Overall Study|Progressive disease|43|||
129864798|NCT00447057|467462444|FG002|Overall Study|Progressive disease|13|||
129864799|NCT00447057|467462445|FG003|Overall Study|Progressive disease|18|||
129864800|NCT00447057|467462442|FG000|Overall Study|Death due to adverse event|0|||
129864801|NCT00447057|467462443|FG001|Overall Study|Death due to adverse event|0|||
129864802|NCT00447057|467462444|FG002|Overall Study|Death due to adverse event|1|||
129864803|NCT00447057|467462445|FG003|Overall Study|Death due to adverse event|2|||
129864804|NCT00447057|467462442|FG000|Overall Study|Death, study drug related|0|||
129864805|NCT00447057|467462443|FG001|Overall Study|Death, study drug related|1|||
129864806|NCT00447057|467462444|FG002|Overall Study|Death, study drug related|0|||
129864807|NCT00447057|467462445|FG003|Overall Study|Death, study drug related|0|||
130065485|NCT00634114|468194721|FG001|Overall Study|Difficult to continue|1|||
130065486|NCT00634114|468194722|FG002|Overall Study|Difficult to continue|1|||
130065487|NCT00634114|468194720|FG000|Overall Study|Other reason|1|||
129864808|NCT00440531|467462446|FG000|Overall Study|Adverse Event|1|||
129864809|NCT00440531|467462447|FG001|Overall Study|Adverse Event|0|||
129864810|NCT00440531|467462448|FG002|Overall Study|Adverse Event|2|||
129864811|NCT00440531|467462446|FG000|Overall Study|Withdrawal by Subject|2|||
129864812|NCT00440531|467462447|FG001|Overall Study|Withdrawal by Subject|0|||
129864813|NCT00440531|467462448|FG002|Overall Study|Withdrawal by Subject|0|||
129864814|NCT00440531|467462446|FG000|Overall Study|Protocol Violation|1|||
129864815|NCT00440531|467462447|FG001|Overall Study|Protocol Violation|2|||
129864816|NCT00440531|467462448|FG002|Overall Study|Protocol Violation|0|||
129864817|NCT00440531|467462446|FG000|Overall Study|Lost to Follow-up|4|||
129864818|NCT00440531|467462447|FG001|Overall Study|Lost to Follow-up|3|||
129864819|NCT00440531|467462448|FG002|Overall Study|Lost to Follow-up|5|||
129864820|NCT00440531|467462446|FG000|Overall Study|see pre-assignment details|2|||
129864821|NCT00440531|467462447|FG001|Overall Study|see pre-assignment details|0|||
129864822|NCT00440531|467462448|FG002|Overall Study|see pre-assignment details|0|||
129864823|NCT01471054|467462452|FG000|Overall Study|Study terminated prematurely|4|||
129864824|NCT01471054|467462453|FG001|Overall Study|Study terminated prematurely|0|||
129864825|NCT01843192|467462454|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
129864826|NCT01843192|467462455|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
129864827|NCT01843192|467462456|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
129864828|NCT04493216|467462457|FG000|Overall Study|Study terminated by sponsor|30|||
129864829|NCT04493216|467462458|FG001|Overall Study|Study terminated by sponsor|33|||
129864830|NCT04493216|467462459|FG002|Overall Study|Study terminated by sponsor|28|||
129864831|NCT04493216|467462460|FG003|Overall Study|Study terminated by sponsor|27|||
129864832|NCT04493216|467462457|FG000|Overall Study|Withdrawal by Subject|2|||
129864833|NCT04493216|467462458|FG001|Overall Study|Withdrawal by Subject|1|||
129864834|NCT04493216|467462459|FG002|Overall Study|Withdrawal by Subject|1|||
129864835|NCT04493216|467462460|FG003|Overall Study|Withdrawal by Subject|2|||
129864836|NCT04493216|467462457|FG000|Overall Study|Protocol Violation|1|||
129864837|NCT04493216|467462458|FG001|Overall Study|Protocol Violation|2|||
129864838|NCT04493216|467462459|FG002|Overall Study|Protocol Violation|0|||
129864839|NCT04493216|467462460|FG003|Overall Study|Protocol Violation|2|||
129864840|NCT04493216|467462457|FG000|Overall Study|Physician Decision|0|||
129864841|NCT04493216|467462458|FG001|Overall Study|Physician Decision|0|||
129864842|NCT04493216|467462459|FG002|Overall Study|Physician Decision|1|||
129864843|NCT04493216|467462460|FG003|Overall Study|Physician Decision|0|||
129864844|NCT04493216|467462457|FG000|Overall Study|Lost to Follow-up|2|||
129864845|NCT04493216|467462458|FG001|Overall Study|Lost to Follow-up|1|||
129864846|NCT04493216|467462459|FG002|Overall Study|Lost to Follow-up|0|||
129864847|NCT04493216|467462460|FG003|Overall Study|Lost to Follow-up|1|||
129864848|NCT04493216|467462457|FG000|Overall Study|Adverse Event|1|||
129864849|NCT04493216|467462458|FG001|Overall Study|Adverse Event|4|||
129864850|NCT04493216|467462459|FG002|Overall Study|Adverse Event|5|||
129864851|NCT04493216|467462460|FG003|Overall Study|Adverse Event|2|||
129864852|NCT04493216|467462457|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
129864853|NCT04493216|467462458|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
129864854|NCT04493216|467462459|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
129864855|NCT04493216|467462460|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
129864856|NCT02181803|467462463|FG000|Overall Study|Withdrawal by Subject|0|||
130065488|NCT00634114|468194721|FG001|Overall Study|Other reason|1|||
129864857|NCT02181803|467462464|FG001|Overall Study|Withdrawal by Subject|2|||
129864858|NCT02181803|467462465|FG002|Overall Study|Withdrawal by Subject|0|||
129864859|NCT02181803|467462466|FG003|Overall Study|Withdrawal by Subject|0|||
129864860|NCT02181803|467462467|FG004|Overall Study|Withdrawal by Subject|0|||
129864861|NCT02181803|467462468|FG005|Overall Study|Withdrawal by Subject|0|||
129864862|NCT02181803|467462469|FG006|Overall Study|Withdrawal by Subject|0|||
129864863|NCT02181803|467462470|FG007|Overall Study|Withdrawal by Subject|0|||
130065489|NCT00634114|468194722|FG002|Overall Study|Other reason|1|||
130065490|NCT02940626|468194723|FG000|Overall Study|Death|40|||
129864864|NCT02181803|467462471|FG008|Overall Study|Withdrawal by Subject|0|||
129864865|NCT02181803|467462463|FG000|Overall Study|Physician Decision|0|||
129864866|NCT02181803|467462464|FG001|Overall Study|Physician Decision|0|||
129864867|NCT02181803|467462465|FG002|Overall Study|Physician Decision|0|||
129864868|NCT02181803|467462466|FG003|Overall Study|Physician Decision|1|||
130065491|NCT02940626|468194724|FG001|Overall Study|Death|32|||
130065492|NCT02940626|468194723|FG000|Overall Study|Lost to Follow-up|5|||
130065493|NCT02940626|468194724|FG001|Overall Study|Lost to Follow-up|2|||
130065494|NCT02940626|468194723|FG000|Overall Study|Withdrawal by Subject|1|||
130065495|NCT02940626|468194724|FG001|Overall Study|Withdrawal by Subject|0|||
129864869|NCT02181803|467462467|FG004|Overall Study|Physician Decision|0|||
129864870|NCT02181803|467462468|FG005|Overall Study|Physician Decision|0|||
130065496|NCT02940626|468194723|FG000|Overall Study|Transfer to Hospice Care|1|||
130065497|NCT02940626|468194724|FG001|Overall Study|Transfer to Hospice Care|0|||
130065498|NCT02940626|468194723|FG000|Overall Study|Prohibited Concomitant Medication|0|||
130116673|NCT00585351|468387151|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129864871|NCT02181803|467462469|FG006|Overall Study|Physician Decision|0|||
129864872|NCT02181803|467462470|FG007|Overall Study|Physician Decision|1|||
129864873|NCT02181803|467462471|FG008|Overall Study|Physician Decision|0|||
129864874|NCT02181803|467462463|FG000|Overall Study|Adverse Event|0|||
129864875|NCT02181803|467462464|FG001|Overall Study|Adverse Event|2|||
129864876|NCT02181803|467462465|FG002|Overall Study|Adverse Event|0|||
129864877|NCT02181803|467462466|FG003|Overall Study|Adverse Event|1|||
129864878|NCT02181803|467462467|FG004|Overall Study|Adverse Event|0|||
129864879|NCT02181803|467462468|FG005|Overall Study|Adverse Event|0|||
129864880|NCT02181803|467462469|FG006|Overall Study|Adverse Event|1|||
129864881|NCT02181803|467462470|FG007|Overall Study|Adverse Event|0|||
129864882|NCT02181803|467462471|FG008|Overall Study|Adverse Event|0|||
129864883|NCT00951041|467462472|FG000|Overall Study|Withdrawal by Subject|1|||
129864884|NCT00951041|467462473|FG001|Overall Study|Withdrawal by Subject|1|||
129864885|NCT00951041|467462472|FG000|Overall Study|Lost to Follow-up|1|||
129864886|NCT00951041|467462473|FG001|Overall Study|Lost to Follow-up|0|||
129864887|NCT00951041|467462472|FG000|Overall Study|Other|3|||
129864888|NCT00951041|467462473|FG001|Overall Study|Other|0|||
129864889|NCT01514448|467462474|FG000|Overall Study|Death|7|||
129864890|NCT01514448|467462475|FG001|Overall Study|Death|8|||
129864891|NCT01514448|467462474|FG000|Overall Study|Withdrawal by Subject|2|||
129864892|NCT01514448|467462475|FG001|Overall Study|Withdrawal by Subject|0|||
129864893|NCT01514448|467462474|FG000|Overall Study|Lost to Follow-up|2|||
129864894|NCT01514448|467462475|FG001|Overall Study|Lost to Follow-up|0|||
129864895|NCT01514448|467462474|FG000|Overall Study|New Cancer Therapy|1|||
129864896|NCT01514448|467462475|FG001|Overall Study|New Cancer Therapy|0|||
129864897|NCT02314624|467462476|FG000|Overall Study|No participating patient|16|||
129864898|NCT02314624|467462477|FG001|Overall Study|No participating patient|13|||
129864899|NCT02314624|467462476|FG000|Overall Study|Participant withdrew|7|||
129864900|NCT02314624|467462477|FG001|Overall Study|Participant withdrew|2|||
129864901|NCT02314624|467462476|FG000|Overall Study|Lost to Follow-up|2|||
129864902|NCT02314624|467462477|FG001|Overall Study|Lost to Follow-up|5|||
129864903|NCT02314624|467462476|FG000|Overall Study|Dropped/Excluded by PI|6|||
129864904|NCT02314624|467462477|FG001|Overall Study|Dropped/Excluded by PI|6|||
129864905|NCT03151005|467462478|FG000|Overall Study|Lost to Follow-up|5|||
129864906|NCT03151005|467462479|FG001|Overall Study|Lost to Follow-up|5|||
129864907|NCT03912259|467462482|FG000|Overall Study|Adverse Event (AE)|2|||
129864908|NCT03912259|467462483|FG001|Overall Study|Adverse Event (AE)|4|||
129864909|NCT03912259|467462482|FG000|Overall Study|Lack of Efficacy|4|||
129864910|NCT03912259|467462483|FG001|Overall Study|Lack of Efficacy|1|||
129864911|NCT03912259|467462482|FG000|Overall Study|Withdrawal by Subject|11|||
129864912|NCT03912259|467462483|FG001|Overall Study|Withdrawal by Subject|1|||
129864913|NCT04786444|467462484|FG000|Overall Study|Withdrawal by Subject|4|||
129864914|NCT04786444|467462485|FG001|Overall Study|Withdrawal by Subject|7|||
129864915|NCT04786444|467462486|FG002|Overall Study|Withdrawal by Subject|2|||
129864916|NCT04786444|467462484|FG000|Overall Study|Lost to Follow-up|11|||
129864917|NCT04786444|467462485|FG001|Overall Study|Lost to Follow-up|9|||
129864918|NCT04786444|467462486|FG002|Overall Study|Lost to Follow-up|10|||
129864919|NCT04786444|467462484|FG000|Overall Study|Subject would like to become pregnant|0|||
129864920|NCT04786444|467462485|FG001|Overall Study|Subject would like to become pregnant|1|||
129864921|NCT04786444|467462486|FG002|Overall Study|Subject would like to become pregnant|0|||
129864922|NCT02131272|467462487|FG000|Overall Study|Withdrawal by parent|0|||
129864923|NCT02131272|467462488|FG001|Overall Study|Withdrawal by parent|1|||
129864924|NCT02131272|467462487|FG000|Overall Study|Withdrawal by Subject|0|||
129864925|NCT02131272|467462488|FG001|Overall Study|Withdrawal by Subject|1|||
129864926|NCT02131272|467462487|FG000|Overall Study|Withdrawal Criteria|1|||
129864927|NCT02131272|467462488|FG001|Overall Study|Withdrawal Criteria|0|||
129864928|NCT02462876|467462489|FG000|Overall Study|Death|3|||
129864929|NCT02462876|467462489|FG000|Overall Study|Lost to Follow-up|7|||
129864930|NCT02462876|467462489|FG000|Overall Study|Surgical Bypass|9|||
129864931|NCT02462876|467462489|FG000|Overall Study|Amputation Above the Metatarsals|1|||
129864932|NCT02462876|467462489|FG000|Overall Study|36 months follow-up visit missed|1|||
129864933|NCT02462876|467462489|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
129864934|NCT02462876|467462489|FG000|Overall Study|Patient did not come back to the vascular department|1|||
129864935|NCT02462876|467462489|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
129864936|NCT02462876|467462489|FG000|Overall Study|Patient refused to come back|1|||
129914624|NCT04855760|467651341|FG000|Overall Study|Protocol Violation|2|||
129914625|NCT04855760|467651341|FG000|Overall Study|Physician Decision|5|||
129914626|NCT04855760|467651341|FG000|Overall Study|Pregnancy|1|||
129914627|NCT04855760|467651341|FG000|Overall Study|Non-Compliance with Study Drug|11|||
129914628|NCT04855760|467651341|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
129914629|NCT04855760|467651341|FG000|Overall Study|Study Completed by Sponsor|202|||
129914630|NCT04855760|467651341|FG000|Overall Study|Other|13|||
129914631|NCT01631214|467651350|FG000|Overall Study|Withdrawal by Subject|276|||
129914632|NCT01631214|467651351|FG001|Overall Study|Withdrawal by Subject|290|||
129914633|NCT01631214|467651350|FG000|Overall Study|Death|113|||
129914634|NCT01631214|467651351|FG001|Overall Study|Death|106|||
129914635|NCT01631214|467651350|FG000|Overall Study|Lost to Follow-up|54|||
129914636|NCT01631214|467651351|FG001|Overall Study|Lost to Follow-up|40|||
129914637|NCT01631214|467651350|FG000|Overall Study|Adverse Event|45|||
129914638|NCT01631214|467651351|FG001|Overall Study|Adverse Event|45|||
129914639|NCT01631214|467651350|FG000|Overall Study|Other|22|||
129914640|NCT01631214|467651351|FG001|Overall Study|Other|19|||
129914641|NCT01631214|467651350|FG000|Overall Study|Noncompliance|16|||
129914642|NCT01631214|467651351|FG001|Overall Study|Noncompliance|15|||
129914643|NCT01631214|467651350|FG000|Overall Study|Requirement for Alternative Therapy|8|||
129914644|NCT01631214|467651351|FG001|Overall Study|Requirement for Alternative Therapy|3|||
129914645|NCT01631214|467651350|FG000|Overall Study|Protocol Deviation|4|||
129914646|NCT01631214|467651351|FG001|Overall Study|Protocol Deviation|3|||
129914647|NCT01631214|467651350|FG000|Overall Study|Ineligibility determined|5|||
129914648|NCT01631214|467651351|FG001|Overall Study|Ineligibility determined|2|||
129914649|NCT01631214|467651350|FG000|Overall Study|Administrative Decision|1|||
129914650|NCT01631214|467651351|FG001|Overall Study|Administrative Decision|0|||
129914651|NCT04112316|467651357|FG000|First Period (8 Weeks)|Protocol Violation|1|||
129914652|NCT04112316|467651358|FG001|First Period (8 Weeks)|Protocol Violation|0|||
129914653|NCT04112316|467651357|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
129914654|NCT04112316|467651358|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
129914655|NCT03857620|467651359|FG000|Overall Study|Death|4|||
129914656|NCT03857620|467651360|FG001|Overall Study|Death|5|||
129914657|NCT03857620|467651361|FG002|Overall Study|Death|7|||
129914658|NCT03857620|467651359|FG000|Overall Study|Lost to Follow-up|2|||
129914659|NCT03857620|467651360|FG001|Overall Study|Lost to Follow-up|5|||
129914660|NCT03857620|467651361|FG002|Overall Study|Lost to Follow-up|3|||
129914661|NCT03857620|467651359|FG000|Overall Study|Disease progression or relapse after study registration|1|||
129914662|NCT03857620|467651360|FG001|Overall Study|Disease progression or relapse after study registration|5|||
129914663|NCT03857620|467651361|FG002|Overall Study|Disease progression or relapse after study registration|1|||
129914664|NCT03857620|467651359|FG000|Overall Study|Ineligible|5|||
129914665|NCT03857620|467651360|FG001|Overall Study|Ineligible|0|||
129914666|NCT03857620|467651361|FG002|Overall Study|Ineligible|2|||
129914667|NCT03857620|467651359|FG000|Overall Study|No malignancy|1|||
129914668|NCT03857620|467651360|FG001|Overall Study|No malignancy|0|||
129914669|NCT03857620|467651361|FG002|Overall Study|No malignancy|1|||
129914670|NCT03857620|467651359|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
129914671|NCT03857620|467651360|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
129914672|NCT03857620|467651361|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
129914673|NCT03857620|467651359|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
129914674|NCT03857620|467651360|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
129914675|NCT03857620|467651361|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
129914676|NCT03857620|467651359|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
129914677|NCT03857620|467651360|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
129914678|NCT03857620|467651361|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
129914679|NCT03857620|467651359|FG000|Overall Study|Surgery not performed, patient decision|0|||
129914680|NCT03857620|467651360|FG001|Overall Study|Surgery not performed, patient decision|3|||
129914681|NCT03857620|467651361|FG002|Overall Study|Surgery not performed, patient decision|1|||
129914682|NCT03857620|467651359|FG000|Overall Study|Surgery not performed, other reason|3|||
129914683|NCT03857620|467651360|FG001|Overall Study|Surgery not performed, other reason|1|||
129914684|NCT03857620|467651361|FG002|Overall Study|Surgery not performed, other reason|4|||
129914685|NCT03857620|467651359|FG000|Overall Study|Worsening performance status after surgery performed|0|||
129914686|NCT03857620|467651360|FG001|Overall Study|Worsening performance status after surgery performed|1|||
129914687|NCT03857620|467651361|FG002|Overall Study|Worsening performance status after surgery performed|1|||
129914688|NCT02473250|467651362|FG000|Overall Study|Lost to Follow-up|10|||
129914689|NCT02473250|467651362|FG000|Overall Study|Physician Decision|5|||
129914690|NCT02473250|467651362|FG000|Overall Study|Did not tolerate medication washout|3|||
129914691|NCT02473250|467651362|FG000|Overall Study|Antidepressant effect of divalproex|2|||
129914692|NCT03517553|467651363|FG000|Overall Study|Withdrawal by Subject|2|||
129914693|NCT03271151|467651364|FG000|Overall Study|Lost to Follow-up|1|||
129914694|NCT03271151|467651365|FG001|Overall Study|Lost to Follow-up|3|||
129914695|NCT03271151|467651364|FG000|Overall Study|Withdrawal by Subject|1|||
129914696|NCT03271151|467651365|FG001|Overall Study|Withdrawal by Subject|0|||
130065499|NCT02940626|468194724|FG001|Overall Study|Prohibited Concomitant Medication|1|||
130065500|NCT01996904|468194725|FG000|Overall Study|Lost to Follow-up|38|||
130065501|NCT01996904|468194726|FG001|Overall Study|Lost to Follow-up|27|||
130065502|NCT04664855|468194728|FG000|Overall Study|Withdrawal by Subject|0|||
130065503|NCT04664855|468194729|FG001|Overall Study|Withdrawal by Subject|2|||
130065504|NCT05127421|468194730|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
130065505|NCT05127421|468194731|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
130065506|NCT05127421|468194732|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
130065507|NCT05127421|468194733|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
130065508|NCT05127421|468194730|FG000|4-Week Double-Blind Period|Physician Decision|1|||
130065509|NCT05127421|468194731|FG001|4-Week Double-Blind Period|Physician Decision|0|||
130065510|NCT05127421|468194732|FG002|4-Week Double-Blind Period|Physician Decision|0|||
130065511|NCT05127421|468194733|FG003|4-Week Double-Blind Period|Physician Decision|0|||
130065512|NCT05127421|468194730|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
130065513|NCT05127421|468194731|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
130065514|NCT05127421|468194732|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
130065515|NCT05127421|468194733|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
130065516|NCT05127421|468194730|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
130065517|NCT05127421|468194731|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
130065518|NCT05127421|468194732|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
130065519|NCT05127421|468194733|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
130065520|NCT05127421|468194730|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
130065521|NCT05127421|468194731|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
130065522|NCT05127421|468194732|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
130065523|NCT05127421|468194733|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
130065524|NCT05127421|468194730|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
130065525|NCT05127421|468194731|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
130065526|NCT05127421|468194732|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
130065527|NCT05127421|468194733|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
130065528|NCT05127421|468194730|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
130065529|NCT05127421|468194731|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
130065530|NCT05127421|468194732|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
130065531|NCT05127421|468194733|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
130065532|NCT05127421|468194730|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130065533|NCT05127421|468194731|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130065534|NCT05127421|468194732|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
130065535|NCT05127421|468194733|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
130065536|NCT02219087|468194734|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
130065537|NCT02219087|468194735|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
130065538|NCT00574496|468194738|FG000|Overall Study|Withdrawal by Subject|1|||
130065539|NCT03454412|468194739|FG000|Baseline Assesment|Physician Decision|12|||
130065540|NCT01518244|468194740|FG000|Overall Study|Adverse Event|3|||
130116674|NCT00585351|468387152|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129864937|NCT02462876|467462489|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
129864938|NCT02462876|467462489|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
129864939|NCT03166618|467462494|FG000|Overall Study|Study was Terminated|0|||
129864940|NCT03166618|467462495|FG001|Overall Study|Study was Terminated|1|||
129864941|NCT02163733|467462499|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
129864942|NCT02163733|467462500|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
129864943|NCT02163733|467462501|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
129864944|NCT02163733|467462499|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
129864945|NCT02163733|467462500|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
129864946|NCT02163733|467462501|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
129864947|NCT01260350|467462508|FG000|Overall Study|Lack of Efficacy|0|||
129864948|NCT01260350|467462509|FG001|Overall Study|Lack of Efficacy|0|||
129864949|NCT01260350|467462510|FG002|Overall Study|Lack of Efficacy|0|||
129864950|NCT01260350|467462511|FG003|Overall Study|Lack of Efficacy|0|||
129864951|NCT01260350|467462512|FG004|Overall Study|Lack of Efficacy|0|||
130065541|NCT03543358|468194741|FG000|Overall Study|Death|1|||
130065542|NCT03543358|468194742|FG001|Overall Study|Death|0|||
130065543|NCT03543358|468194741|FG000|Overall Study|Disease Progression|1|||
130065544|NCT03543358|468194742|FG001|Overall Study|Disease Progression|0|||
130065545|NCT03543358|468194741|FG000|Overall Study|Parent Study Closure|1|||
130065546|NCT03543358|468194742|FG001|Overall Study|Parent Study Closure|0|||
130065547|NCT01766817|468194743|FG000|Overall Study|Drug-related adverse event|1|||
130065548|NCT01766817|468194744|FG001|Overall Study|Drug-related adverse event|2|||
130065549|NCT01766817|468194745|FG002|Overall Study|Drug-related adverse event|1|||
130065550|NCT01766817|468194743|FG000|Overall Study|Drug-unrelated adverse event|3|||
130065551|NCT01766817|468194744|FG001|Overall Study|Drug-unrelated adverse event|3|||
130065552|NCT01766817|468194745|FG002|Overall Study|Drug-unrelated adverse event|3|||
130065553|NCT01766817|468194743|FG000|Overall Study|Death|1|||
129914697|NCT04093362|467651366|FG000|Overall Study|Study Termination|1|||
129914698|NCT04093362|467651367|FG001|Overall Study|Study Termination|1|||
129914699|NCT04093362|467651366|FG000|Overall Study|Withdrawal of Consent|1|||
129914700|NCT04093362|467651367|FG001|Overall Study|Withdrawal of Consent|0|||
129914701|NCT04093362|467651366|FG000|Overall Study|Death|1|||
129914702|NCT04093362|467651367|FG001|Overall Study|Death|3|||
129914703|NCT04093362|467651366|FG000|Overall Study|Reason not Specified|1|||
129914704|NCT04093362|467651367|FG001|Overall Study|Reason not Specified|2|||
129914705|NCT03433339|467651370|FG000|Overall Study|Lost to Follow-up|2|||
129914706|NCT03433339|467651371|FG001|Overall Study|Lost to Follow-up|0|||
129914707|NCT03433339|467651370|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
129914708|NCT03433339|467651371|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
129914709|NCT03433339|467651370|FG000|Overall Study|Withdrawal by Subject|0|||
129914710|NCT03433339|467651371|FG001|Overall Study|Withdrawal by Subject|2|||
129914711|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914712|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914713|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914714|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914715|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
129914716|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914717|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914718|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914719|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914720|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
129914721|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914722|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914723|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914724|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914725|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
129914726|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914727|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914728|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914729|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914730|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
129914731|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914732|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914733|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
130065554|NCT01766817|468194744|FG001|Overall Study|Death|1|||
130065555|NCT01766817|468194745|FG002|Overall Study|Death|0|||
130065556|NCT01766817|468194743|FG000|Overall Study|Unable to take study drug|0|||
130065557|NCT01766817|468194744|FG001|Overall Study|Unable to take study drug|1|||
130065558|NCT01766817|468194745|FG002|Overall Study|Unable to take study drug|0|||
130065559|NCT01766817|468194743|FG000|Overall Study|Withdrawal by Subject|2|||
130065560|NCT01766817|468194744|FG001|Overall Study|Withdrawal by Subject|0|||
130065561|NCT01766817|468194745|FG002|Overall Study|Withdrawal by Subject|3|||
130065562|NCT01766817|468194743|FG000|Overall Study|Subject non-compliance|0|||
130065563|NCT01766817|468194744|FG001|Overall Study|Subject non-compliance|1|||
130065564|NCT01766817|468194745|FG002|Overall Study|Subject non-compliance|2|||
130065565|NCT01766817|468194743|FG000|Overall Study|Physician Decision|3|||
130065566|NCT01766817|468194744|FG001|Overall Study|Physician Decision|3|||
130065567|NCT01766817|468194745|FG002|Overall Study|Physician Decision|4|||
130065568|NCT01766817|468194743|FG000|Overall Study|Other|1|||
130065569|NCT01766817|468194744|FG001|Overall Study|Other|0|||
130065570|NCT01766817|468194745|FG002|Overall Study|Other|0|||
129914734|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914735|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
129914736|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130065571|NCT00178464|468194746|FG000|Overall Study|Withdrawal by Subject|1|||
129914737|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
129914738|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
129914739|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
130065572|NCT00178464|468194746|FG000|Overall Study|Physician Decision|1|||
130065573|NCT00870818|468194748|FG000|Overall Study|Lost to Follow-up|3|||
130065574|NCT00870818|468194749|FG001|Overall Study|Lost to Follow-up|2|||
130065575|NCT00870818|468194750|FG002|Overall Study|Lost to Follow-up|1|||
130065576|NCT00870818|468194751|FG003|Overall Study|Lost to Follow-up|0|||
130065577|NCT00870818|468194752|FG004|Overall Study|Lost to Follow-up|0|||
130065578|NCT00870818|468194748|FG000|Overall Study|Withdrawal by Subject|0|||
130065579|NCT00870818|468194749|FG001|Overall Study|Withdrawal by Subject|0|||
130065580|NCT00870818|468194750|FG002|Overall Study|Withdrawal by Subject|1|||
129914740|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
129914741|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914742|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914743|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914744|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914745|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
129914746|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914747|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914748|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914749|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914750|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
129914751|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
129914752|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
129914753|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
129914754|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
129914755|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
129914756|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
129914757|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
129914758|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
129914759|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
129914760|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
129914761|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
129914762|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
129914763|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
129914764|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
129914765|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
129914766|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914767|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
129914768|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914769|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914770|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914771|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914772|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914773|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
129914774|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914775|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914776|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
129914777|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
129914778|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
129914779|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
129914780|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
129914781|NCT03289039|467651394|FG000|Overall Study|Withdrawal by Subject|0|||
130065581|NCT00870818|468194751|FG003|Overall Study|Withdrawal by Subject|2|||
130065582|NCT00870818|468194752|FG004|Overall Study|Withdrawal by Subject|0|||
130065583|NCT00870818|468194748|FG000|Overall Study|Terminated by sponsor|29|||
130065584|NCT00870818|468194749|FG001|Overall Study|Terminated by sponsor|70|||
130065585|NCT00870818|468194750|FG002|Overall Study|Terminated by sponsor|36|||
130065586|NCT00870818|468194751|FG003|Overall Study|Terminated by sponsor|36|||
130065587|NCT00870818|468194752|FG004|Overall Study|Terminated by sponsor|38|||
130065588|NCT00870818|468194748|FG000|Overall Study|Other|0|||
130065589|NCT00870818|468194749|FG001|Overall Study|Other|1|||
130065590|NCT00870818|468194750|FG002|Overall Study|Other|0|||
130065591|NCT00870818|468194751|FG003|Overall Study|Other|0|||
130065592|NCT00870818|468194752|FG004|Overall Study|Other|0|||
130065593|NCT02227108|468194755|FG000|Overall Study|Did not receive treatment|2|||
130065594|NCT02227108|468194755|FG000|Overall Study|Other|3|||
130065595|NCT02227108|468194755|FG000|Overall Study|Progressive disease|17|||
130065596|NCT02227108|468194755|FG000|Overall Study|Initiation of alternative therapy|2|||
130065597|NCT02227108|468194755|FG000|Overall Study|Investigator discretion|1|||
130065598|NCT02227108|468194755|FG000|Overall Study|Adverse Event|6|||
130065599|NCT04900038|468194756|FG000|Overall Study|Adverse Event|1|||
130065600|NCT04900038|468194757|FG001|Overall Study|Adverse Event|0|||
130065601|NCT04900038|468194758|FG002|Overall Study|Adverse Event|1|||
129914782|NCT03289039|467651395|FG001|Overall Study|Withdrawal by Subject|1|||
129914783|NCT03289039|467651394|FG000|Overall Study|Became ineligible prior to treatment start|0|||
130065602|NCT04900038|468194759|FG003|Overall Study|Adverse Event|1|||
130065603|NCT04900038|468194756|FG000|Overall Study|Withdrawal by Subject|0|||
130065604|NCT04900038|468194757|FG001|Overall Study|Withdrawal by Subject|1|||
130065605|NCT04900038|468194758|FG002|Overall Study|Withdrawal by Subject|0|||
130065606|NCT04900038|468194759|FG003|Overall Study|Withdrawal by Subject|0|||
130065607|NCT04900038|468194756|FG000|Overall Study|Study terminated by sponsor|18|||
130065608|NCT04900038|468194757|FG001|Overall Study|Study terminated by sponsor|15|||
130065609|NCT04900038|468194758|FG002|Overall Study|Study terminated by sponsor|17|||
130065610|NCT04900038|468194759|FG003|Overall Study|Study terminated by sponsor|14|||
130065611|NCT04900038|468194756|FG000|Overall Study|Protocol Deviation|1|||
130065612|NCT04900038|468194757|FG001|Overall Study|Protocol Deviation|1|||
129914784|NCT03289039|467651395|FG001|Overall Study|Became ineligible prior to treatment start|1|||
129914785|NCT03289039|467651394|FG000|Overall Study|progressed before treatment start|1|||
129914786|NCT03289039|467651395|FG001|Overall Study|progressed before treatment start|0|||
129914787|NCT04732494|467651396|FG000|Overall Study|Death|39|||
129914788|NCT04732494|467651397|FG001|Overall Study|Death|36|||
129914789|NCT04732494|467651396|FG000|Overall Study|Study Closed by Sponsor|20|||
129914790|NCT04732494|467651397|FG001|Overall Study|Study Closed by Sponsor|15|||
129914791|NCT04732494|467651396|FG000|Overall Study|Withdrawal by Subject|2|||
129914792|NCT04732494|467651397|FG001|Overall Study|Withdrawal by Subject|7|||
129914793|NCT04732494|467651396|FG000|Overall Study|Lost to Follow-up|1|||
129914794|NCT04732494|467651397|FG001|Overall Study|Lost to Follow-up|5|||
129914795|NCT01718743|467651398|FG000|Overall Study|Physician Decision|7|||
129914796|NCT01718743|467651398|FG000|Overall Study|Withdrawal by Subject|14|||
129914797|NCT01718743|467651398|FG000|Overall Study|Progressive Disease|22|||
129914798|NCT01718743|467651398|FG000|Overall Study|Toxicity|1|||
129914799|NCT01718743|467651398|FG000|Overall Study|Malignancy|1|||
129914800|NCT05136404|467651402|FG000|Period 1|Adverse Event|0|||
129914801|NCT05136404|467651403|FG001|Period 1|Adverse Event|1|||
129914802|NCT05136404|467651404|FG002|Period 1|Adverse Event|1|||
129914803|NCT05136404|467651402|FG000|Period 2|Inappropriate Behavior|0|||
129914804|NCT05136404|467651403|FG001|Period 2|Inappropriate Behavior|0|||
129914805|NCT05136404|467651404|FG002|Period 2|Inappropriate Behavior|1|||
129914806|NCT05136404|467651402|FG000|Period 3|Adverse Event|0|||
129914807|NCT05136404|467651403|FG001|Period 3|Adverse Event|0|||
129914808|NCT05136404|467651404|FG002|Period 3|Adverse Event|1|||
129914809|NCT03263026|467651406|FG000|Overall Study|Withdrawal by Subject|1|||
129914810|NCT03263026|467651407|FG001|Overall Study|Withdrawal by Subject|0|||
129914811|NCT03263026|467651406|FG000|Overall Study|Death|1|||
129914812|NCT03263026|467651407|FG001|Overall Study|Death|0|||
129914813|NCT03263026|467651406|FG000|Overall Study|Other/ Various|41|||
129914814|NCT03263026|467651407|FG001|Overall Study|Other/ Various|29|||
129914815|NCT03739996|467651410|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
129914816|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
129914817|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
129914818|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
129914819|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
129914820|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
129914821|NCT03739996|467651410|FG000|Step 3 (SOC ART)|Death|1|||
129914822|NCT03739996|467651410|FG000|Step 3 (SOC ART)|Participant moved|1|||
129914823|NCT02553642|467651411|FG000|Overall Study|Withdrawal by Subject|0|||
129914824|NCT02553642|467651412|FG001|Overall Study|Withdrawal by Subject|3|||
129914825|NCT02553642|467651411|FG000|Overall Study|Physician Decision|0|||
129914826|NCT02553642|467651412|FG001|Overall Study|Physician Decision|1|||
129914827|NCT02553642|467651411|FG000|Overall Study|Additional cancer dx|0|||
129914828|NCT02553642|467651412|FG001|Overall Study|Additional cancer dx|1|||
129914829|NCT02553642|467651411|FG000|Overall Study|Never started treatment|0|||
129914830|NCT02553642|467651412|FG001|Overall Study|Never started treatment|1|||
129914831|NCT05444192|467651413|FG000|Overall Study|Lost to Follow-up|1|||
129914832|NCT05444192|467651414|FG001|Overall Study|Lost to Follow-up|0|||
129914833|NCT00894543|467651418|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
129914834|NCT00894543|467651419|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
129914835|NCT00894543|467651418|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
129914836|NCT00894543|467651419|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
129914837|NCT01532388|467651420|FG000|3-month Follow-up|Lost to Follow-up|68|||
129914838|NCT01532388|467651421|FG001|3-month Follow-up|Lost to Follow-up|68|||
129914839|NCT01532388|467651420|FG000|6-month Follow-up|Lost to Follow-up|74|||
129914840|NCT01532388|467651421|FG001|6-month Follow-up|Lost to Follow-up|66|||
129914841|NCT01532388|467651420|FG000|12-month Follow-up|Lost to Follow-up|69|||
129914842|NCT01532388|467651421|FG001|12-month Follow-up|Lost to Follow-up|67|||
129914843|NCT02538900|467651424|FG000|Overall Study|Death|2|||
129914844|NCT02538900|467651425|FG001|Overall Study|Death|2|||
129914845|NCT02538900|467651426|FG002|Overall Study|Death|2|||
129914846|NCT02538900|467651424|FG000|Overall Study|Withdrawal by Subject|18|||
129914847|NCT02538900|467651425|FG001|Overall Study|Withdrawal by Subject|16|||
129914848|NCT02538900|467651426|FG002|Overall Study|Withdrawal by Subject|15|||
129914849|NCT02874534|467651427|FG000|Overall Study|Withdrawal by Subject|5|||
129914850|NCT02874534|467651428|FG001|Overall Study|Withdrawal by Subject|8|||
129914851|NCT02874534|467651427|FG000|Overall Study|Lost to Follow-up|2|||
129914852|NCT02874534|467651428|FG001|Overall Study|Lost to Follow-up|2|||
129914853|NCT02874534|467651427|FG000|Overall Study|Ongoing in study|1|||
129914854|NCT02874534|467651428|FG001|Overall Study|Ongoing in study|1|||
129914855|NCT02923180|467651429|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
129914856|NCT02923180|467651429|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
129914857|NCT05198310|467651430|FG000|Overall Study|Lost to Follow-up|0|||
129914858|NCT05198310|467651431|FG001|Overall Study|Lost to Follow-up|1|||
129914859|NCT05198310|467651432|FG002|Overall Study|Lost to Follow-up|0|||
129914860|NCT05198310|467651433|FG003|Overall Study|Lost to Follow-up|0|||
129864952|NCT01260350|467462513|FG005|Overall Study|Lack of Efficacy|0|||
129864953|NCT01260350|467462514|FG006|Overall Study|Lack of Efficacy|0|||
129864954|NCT01260350|467462515|FG007|Overall Study|Lack of Efficacy|0|||
129864955|NCT01260350|467462516|FG008|Overall Study|Lack of Efficacy|0|||
129864956|NCT01260350|467462517|FG009|Overall Study|Lack of Efficacy|0|||
129864957|NCT01260350|467462518|FG010|Overall Study|Lack of Efficacy|0|||
129864958|NCT01260350|467462519|FG011|Overall Study|Lack of Efficacy|0|||
129864959|NCT01260350|467462520|FG012|Overall Study|Lack of Efficacy|0|||
129864960|NCT01260350|467462521|FG013|Overall Study|Lack of Efficacy|0|||
129864961|NCT01260350|467462522|FG014|Overall Study|Lack of Efficacy|0|||
129864962|NCT01260350|467462523|FG015|Overall Study|Lack of Efficacy|0|||
129864963|NCT01260350|467462524|FG016|Overall Study|Lack of Efficacy|0|||
129864964|NCT01260350|467462525|FG017|Overall Study|Lack of Efficacy|1|||
129864965|NCT01260350|467462526|FG018|Overall Study|Lack of Efficacy|0|||
129864966|NCT01260350|467462527|FG019|Overall Study|Lack of Efficacy|0|||
129864967|NCT01260350|467462528|FG020|Overall Study|Lack of Efficacy|3|||
129864968|NCT01260350|467462529|FG021|Overall Study|Lack of Efficacy|0|||
129864969|NCT01260350|467462508|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864970|NCT01260350|467462509|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864971|NCT01260350|467462510|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864972|NCT01260350|467462511|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864973|NCT01260350|467462512|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864974|NCT01260350|467462513|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864975|NCT01260350|467462514|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864976|NCT01260350|467462515|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864977|NCT01260350|467462516|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
129864978|NCT01260350|467462517|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864979|NCT01260350|467462518|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864980|NCT01260350|467462519|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864981|NCT01260350|467462520|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864982|NCT01260350|467462521|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864983|NCT01260350|467462522|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864984|NCT01260350|467462523|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864985|NCT01260350|467462524|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864986|NCT01260350|467462525|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864987|NCT01260350|467462526|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864988|NCT01260350|467462527|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864989|NCT01260350|467462528|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864990|NCT01260350|467462529|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864991|NCT02794285|467462532|FG000|Overall Study|Adverse Event|11|||
129864992|NCT02794285|467462533|FG001|Overall Study|Adverse Event|4|||
129864993|NCT02794285|467462534|FG002|Overall Study|Adverse Event|5|||
129864994|NCT02794285|467462535|FG003|Overall Study|Adverse Event|8|||
129864995|NCT02794285|467462532|FG000|Overall Study|Condition Under Investigation Improved|1|||
129864996|NCT02794285|467462533|FG001|Overall Study|Condition Under Investigation Improved|0|||
129864997|NCT02794285|467462534|FG002|Overall Study|Condition Under Investigation Improved|0|||
129864998|NCT02794285|467462535|FG003|Overall Study|Condition Under Investigation Improved|0|||
129864999|NCT02794285|467462532|FG000|Overall Study|Condition Under Investigation Worsened|0|||
129865000|NCT02794285|467462533|FG001|Overall Study|Condition Under Investigation Worsened|2|||
129865001|NCT02794285|467462534|FG002|Overall Study|Condition Under Investigation Worsened|1|||
129865002|NCT02794285|467462535|FG003|Overall Study|Condition Under Investigation Worsened|0|||
129865003|NCT02794285|467462532|FG000|Overall Study|Death|2|||
129865004|NCT02794285|467462533|FG001|Overall Study|Death|1|||
129865005|NCT02794285|467462534|FG002|Overall Study|Death|2|||
129865006|NCT02794285|467462535|FG003|Overall Study|Death|0|||
129865007|NCT02794285|467462532|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
129865008|NCT02794285|467462533|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
129865009|NCT02794285|467462534|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
129865010|NCT02794285|467462535|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
129865011|NCT02794285|467462532|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
129865012|NCT02794285|467462533|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
129865013|NCT02794285|467462534|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
129865014|NCT02794285|467462535|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
129865015|NCT02794285|467462532|FG000|Overall Study|Lack of Efficacy|10|||
129865016|NCT02794285|467462533|FG001|Overall Study|Lack of Efficacy|6|||
129865017|NCT02794285|467462534|FG002|Overall Study|Lack of Efficacy|3|||
129865018|NCT02794285|467462535|FG003|Overall Study|Lack of Efficacy|3|||
129865019|NCT02794285|467462532|FG000|Overall Study|Lost to Follow-up|5|||
129865020|NCT02794285|467462533|FG001|Overall Study|Lost to Follow-up|6|||
129865021|NCT02794285|467462534|FG002|Overall Study|Lost to Follow-up|3|||
129865022|NCT02794285|467462535|FG003|Overall Study|Lost to Follow-up|1|||
129865023|NCT02794285|467462532|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
129865024|NCT02794285|467462533|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
129914861|NCT05198310|467651434|FG004|Overall Study|Lost to Follow-up|0|||
129914862|NCT05198310|467651435|FG005|Overall Study|Lost to Follow-up|0|||
129914863|NCT05198310|467651436|FG006|Overall Study|Lost to Follow-up|0|||
129914864|NCT05198310|467651437|FG007|Overall Study|Lost to Follow-up|0|||
129914865|NCT05198310|467651430|FG000|Overall Study|Withdrawal by Subject|0|||
129914866|NCT05198310|467651431|FG001|Overall Study|Withdrawal by Subject|0|||
129914867|NCT05198310|467651432|FG002|Overall Study|Withdrawal by Subject|0|||
129914868|NCT05198310|467651433|FG003|Overall Study|Withdrawal by Subject|2|||
129914869|NCT05198310|467651434|FG004|Overall Study|Withdrawal by Subject|0|||
129914870|NCT05198310|467651435|FG005|Overall Study|Withdrawal by Subject|2|||
129914871|NCT05198310|467651436|FG006|Overall Study|Withdrawal by Subject|1|||
129914872|NCT05198310|467651437|FG007|Overall Study|Withdrawal by Subject|3|||
129914873|NCT04436107|467651438|FG000|Overall Study|Sponsor Ended Study|2|||
129914874|NCT04436107|467651439|FG001|Overall Study|Sponsor Ended Study|4|||
129914875|NCT04436107|467651440|FG002|Overall Study|Sponsor Ended Study|8|||
129914876|NCT04436107|467651441|FG003|Overall Study|Sponsor Ended Study|20|||
129914877|NCT04436107|467651438|FG000|Overall Study|Death|3|||
129914878|NCT04436107|467651439|FG001|Overall Study|Death|5|||
129914879|NCT04436107|467651440|FG002|Overall Study|Death|3|||
129914880|NCT04436107|467651441|FG003|Overall Study|Death|18|||
129914881|NCT04436107|467651438|FG000|Overall Study|Withdrawal by Subject|1|||
129914882|NCT04436107|467651439|FG001|Overall Study|Withdrawal by Subject|1|||
129914883|NCT04436107|467651440|FG002|Overall Study|Withdrawal by Subject|0|||
129914884|NCT04436107|467651441|FG003|Overall Study|Withdrawal by Subject|1|||
129914885|NCT01095796|467651442|FG000|Overall Study|Randomized but Not Treated|5|||
129914886|NCT01095796|467651443|FG001|Overall Study|Randomized but Not Treated|2|||
129914887|NCT01095796|467651442|FG000|Overall Study|Adverse Event|9|||
129914888|NCT01095796|467651443|FG001|Overall Study|Adverse Event|19|||
129914889|NCT01095796|467651442|FG000|Overall Study|Death|3|||
129914890|NCT01095796|467651443|FG001|Overall Study|Death|2|||
129914891|NCT01095796|467651442|FG000|Overall Study|Pregnancy|2|||
129914892|NCT01095796|467651443|FG001|Overall Study|Pregnancy|0|||
129914893|NCT01095796|467651442|FG000|Overall Study|Lack of Efficacy|5|||
129914894|NCT01095796|467651443|FG001|Overall Study|Lack of Efficacy|3|||
129914895|NCT01095796|467651442|FG000|Overall Study|Investigator's Discretion|7|||
129914896|NCT01095796|467651443|FG001|Overall Study|Investigator's Discretion|2|||
129914897|NCT01095796|467651442|FG000|Overall Study|Withdrew Consent|16|||
129914898|NCT01095796|467651443|FG001|Overall Study|Withdrew Consent|22|||
129914899|NCT01095796|467651442|FG000|Overall Study|Lost to Follow-up|27|||
129914900|NCT01095796|467651443|FG001|Overall Study|Lost to Follow-up|29|||
129914901|NCT01095796|467651442|FG000|Overall Study|Participant Noncompliance|5|||
129914902|NCT01095796|467651443|FG001|Overall Study|Participant Noncompliance|10|||
129914903|NCT01095796|467651442|FG000|Overall Study|Protocol Violation|1|||
129914904|NCT01095796|467651443|FG001|Overall Study|Protocol Violation|0|||
129914905|NCT01095796|467651442|FG000|Overall Study|Participant Transferred to Another Study|215|||
129914906|NCT01095796|467651443|FG001|Overall Study|Participant Transferred to Another Study|200|||
129914907|NCT01989455|467651448|FG000|Overall Study|Adverse Event|0|||
130065613|NCT04900038|468194758|FG002|Overall Study|Protocol Deviation|0|||
130065614|NCT04900038|468194759|FG003|Overall Study|Protocol Deviation|0|||
130065615|NCT04900038|468194756|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
130065616|NCT04900038|468194757|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
130065617|NCT04900038|468194758|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
130065618|NCT04900038|468194759|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
130065619|NCT04900038|468194756|FG000|Overall Study|Lost to Follow-up|0|||
130065620|NCT04900038|468194757|FG001|Overall Study|Lost to Follow-up|0|||
130065621|NCT04900038|468194758|FG002|Overall Study|Lost to Follow-up|0|||
130065622|NCT04900038|468194759|FG003|Overall Study|Lost to Follow-up|1|||
130065623|NCT02486952|468194760|FG000|Overall Study|Not Started Induction Therapy|3|||
130065624|NCT02486952|468194760|FG000|Overall Study|Adverse Event|1|||
130065625|NCT02486952|468194760|FG000|Overall Study|Death|15|||
130065626|NCT02486952|468194760|FG000|Overall Study|Lack of Efficacy|3|||
130065627|NCT02486952|468194760|FG000|Overall Study|Lost to Follow-up|26|||
129914908|NCT01989455|467651449|FG001|Overall Study|Adverse Event|1|||
129914909|NCT01989455|467651450|FG002|Overall Study|Adverse Event|0|||
129914910|NCT01989455|467651451|FG003|Overall Study|Adverse Event|0|||
130065628|NCT02486952|468194760|FG000|Overall Study|Other|2|||
129914911|NCT01989455|467651452|FG004|Overall Study|Adverse Event|0|||
129914912|NCT01989455|467651448|FG000|Overall Study|Withdrawal by Subject|0|||
129914913|NCT01989455|467651449|FG001|Overall Study|Withdrawal by Subject|1|||
129914914|NCT01989455|467651450|FG002|Overall Study|Withdrawal by Subject|0|||
129914915|NCT01989455|467651451|FG003|Overall Study|Withdrawal by Subject|0|||
129914916|NCT01989455|467651452|FG004|Overall Study|Withdrawal by Subject|0|||
129914917|NCT01989455|467651448|FG000|Overall Study|Technical problems with infusion|0|||
129914918|NCT01989455|467651449|FG001|Overall Study|Technical problems with infusion|0|||
130065629|NCT01928485|468194762|FG000|Overall Study|Physician Decision|0|||
130065630|NCT01928485|468194763|FG001|Overall Study|Physician Decision|1|||
129914919|NCT01989455|467651450|FG002|Overall Study|Technical problems with infusion|1|||
129914920|NCT01989455|467651451|FG003|Overall Study|Technical problems with infusion|0|||
129914921|NCT01989455|467651452|FG004|Overall Study|Technical problems with infusion|1|||
129914922|NCT02638337|467651453|FG000|Overall Study|Adverse Event|6|||
129914923|NCT02638337|467651454|FG001|Overall Study|Adverse Event|10|||
129914924|NCT02638337|467651453|FG000|Overall Study|Protocol Violation|3|||
129914925|NCT02638337|467651454|FG001|Overall Study|Protocol Violation|0|||
129914926|NCT02638337|467651453|FG000|Overall Study|Withdrawal by Subject|13|||
129914927|NCT02638337|467651454|FG001|Overall Study|Withdrawal by Subject|16|||
129914928|NCT02638337|467651453|FG000|Overall Study|Lost to Follow-up|7|||
129914929|NCT02638337|467651454|FG001|Overall Study|Lost to Follow-up|7|||
130116675|NCT00585351|468387153|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130116676|NCT00585351|468387154|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
130116677|NCT00585351|468387147|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130116678|NCT00585351|468387148|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130116679|NCT00585351|468387149|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130116680|NCT00585351|468387150|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130116681|NCT00585351|468387151|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130116682|NCT00585351|468387152|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
130116683|NCT00585351|468387153|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
130116684|NCT00585351|468387154|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
130116685|NCT00585351|468387147|FG000|Enrollment Period (Intervention)|Death|0|||
130116686|NCT00585351|468387148|FG001|Enrollment Period (Intervention)|Death|0|||
130116687|NCT00585351|468387149|FG002|Enrollment Period (Intervention)|Death|0|||
130116688|NCT00585351|468387150|FG003|Enrollment Period (Intervention)|Death|0|||
130116689|NCT00585351|468387151|FG004|Enrollment Period (Intervention)|Death|1|||
130116690|NCT00585351|468387152|FG005|Enrollment Period (Intervention)|Death|0|||
130116691|NCT00585351|468387153|FG006|Enrollment Period (Intervention)|Death|1|||
130116692|NCT00585351|468387154|FG007|Enrollment Period (Intervention)|Death|0|||
130116693|NCT00585351|468387147|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130116694|NCT00585351|468387148|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130116695|NCT00585351|468387149|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130116696|NCT00585351|468387150|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130116697|NCT00585351|468387151|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
130116698|NCT00585351|468387152|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
130116699|NCT00585351|468387153|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130116700|NCT00585351|468387154|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
130116701|NCT01842958|468387156|FG000|Overall Study|Lost to Follow-up|1|||
130116702|NCT01842958|468387157|FG001|Overall Study|Lost to Follow-up|1|||
130116703|NCT01829477|468387158|FG000|Overall Study|Study Terminated by Sponsor|15|||
130116704|NCT01829477|468387159|FG001|Overall Study|Study Terminated by Sponsor|15|||
129865025|NCT02794285|467462534|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
129865026|NCT02794285|467462535|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
129865027|NCT02794285|467462532|FG000|Overall Study|Withdrawal by Subject|38|||
129865028|NCT02794285|467462533|FG001|Overall Study|Withdrawal by Subject|29|||
129865029|NCT02794285|467462534|FG002|Overall Study|Withdrawal by Subject|20|||
129865030|NCT02794285|467462535|FG003|Overall Study|Withdrawal by Subject|12|||
129865031|NCT02794285|467462532|FG000|Overall Study|Missing|1|||
129865032|NCT02794285|467462533|FG001|Overall Study|Missing|0|||
129865033|NCT02794285|467462534|FG002|Overall Study|Missing|0|||
129865034|NCT02794285|467462535|FG003|Overall Study|Missing|0|||
129865035|NCT02794285|467462532|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
129865036|NCT02794285|467462533|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
129865037|NCT02794285|467462534|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
129865038|NCT02794285|467462535|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
129865039|NCT02794285|467462532|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
129865040|NCT02794285|467462533|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
129865041|NCT02794285|467462534|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
129865042|NCT02794285|467462535|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
129865043|NCT00868439|467462536|FG000|Overall Study|Adverse Event|4|||
129865044|NCT00868439|467462537|FG001|Overall Study|Adverse Event|3|||
129865045|NCT00868439|467462536|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
129865046|NCT00868439|467462537|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
129865047|NCT00868439|467462536|FG000|Overall Study|Death|0|||
129865048|NCT00868439|467462537|FG001|Overall Study|Death|1|||
129865049|NCT00868439|467462536|FG000|Overall Study|Protocol Violation|1|||
130116705|NCT01829477|468387158|FG000|Overall Study|Withdrawal by Subject|1|||
129865050|NCT00868439|467462537|FG001|Overall Study|Protocol Violation|1|||
129914930|NCT02638337|467651453|FG000|Overall Study|Other - Miscellaneous|4|||
129865051|NCT00868439|467462536|FG000|Overall Study|Physician Decision|1|||
129865052|NCT00868439|467462537|FG001|Overall Study|Physician Decision|0|||
129865053|NCT00868439|467462536|FG000|Overall Study|Withdrawal by Subject|0|||
129914931|NCT02638337|467651454|FG001|Overall Study|Other - Miscellaneous|3|||
129865054|NCT00868439|467462537|FG001|Overall Study|Withdrawal by Subject|1|||
130065631|NCT04111107|468194764|FG000|Overall Study|Withdrawal by Subject|6|||
130065632|NCT04111107|468194764|FG000|Overall Study|Declining Health|5|||
130065633|NCT02721251|468194765|FG000|Overall Study|Withdrawal by Subject|8|||
130065634|NCT02721251|468194766|FG001|Overall Study|Withdrawal by Subject|7|||
130065635|NCT02721251|468194767|FG002|Overall Study|Withdrawal by Subject|9|||
130065636|NCT02721251|468194765|FG000|Overall Study|poor adherence|2|||
130065637|NCT02721251|468194766|FG001|Overall Study|poor adherence|2|||
130065638|NCT02721251|468194767|FG002|Overall Study|poor adherence|2|||
130065639|NCT01714817|468194768|FG000|Year 1 Period|Lack of Efficacy|11|||
130065640|NCT01714817|468194769|FG001|Year 1 Period|Lack of Efficacy|9|||
130065641|NCT01714817|468194768|FG000|Year 1 Period|Adverse Event|20|||
130065642|NCT01714817|468194769|FG001|Year 1 Period|Adverse Event|17|||
130065643|NCT01714817|468194768|FG000|Year 1 Period|Withdrawal by Subject|6|||
130065644|NCT01714817|468194769|FG001|Year 1 Period|Withdrawal by Subject|7|||
130065645|NCT01714817|468194768|FG000|Year 1 Period|Death|1|||
130065646|NCT01714817|468194769|FG001|Year 1 Period|Death|1|||
130065647|NCT01714817|468194768|FG000|Year 1 Period|Lost to Follow-up|0|||
130065648|NCT01714817|468194769|FG001|Year 1 Period|Lost to Follow-up|2|||
130065649|NCT01714817|468194768|FG000|Year 1 Period|Poor / non-compliance|0|||
130065650|NCT01714817|468194769|FG001|Year 1 Period|Poor / non-compliance|1|||
130065651|NCT01714817|468194768|FG000|Year 1 Period|Pregnancy|2|||
129865055|NCT00937924|467462548|FG000|Overall Study|Lost to Follow-up|44|||
129865056|NCT00937924|467462549|FG001|Overall Study|Lost to Follow-up|44|||
129865057|NCT00937924|467462550|FG002|Overall Study|Lost to Follow-up|41|||
129865058|NCT00224874|467462551|FG000|Overall Study|Withdrawal by Subject|0|||
129865059|NCT00224874|467462552|FG001|Overall Study|Withdrawal by Subject|0|||
129865060|NCT00224874|467462553|FG002|Overall Study|Withdrawal by Subject|1|||
129865061|NCT00224874|467462554|FG003|Overall Study|Withdrawal by Subject|0|||
129865062|NCT05072080|467462557|FG000|Overall Study|Death|0|||
129865063|NCT05072080|467462558|FG001|Overall Study|Death|0|||
129865064|NCT05072080|467462559|FG002|Overall Study|Death|1|||
129865065|NCT05072080|467462560|FG003|Overall Study|Death|0|||
129865066|NCT05072080|467462557|FG000|Overall Study|Lost to Follow-up|65|||
129865067|NCT05072080|467462558|FG001|Overall Study|Lost to Follow-up|70|||
129865068|NCT05072080|467462559|FG002|Overall Study|Lost to Follow-up|58|||
129865069|NCT05072080|467462560|FG003|Overall Study|Lost to Follow-up|23|||
129865070|NCT05072080|467462557|FG000|Overall Study|Physician Decision|2|||
129865071|NCT05072080|467462558|FG001|Overall Study|Physician Decision|1|||
129865072|NCT05072080|467462559|FG002|Overall Study|Physician Decision|1|||
129865073|NCT05072080|467462560|FG003|Overall Study|Physician Decision|0|||
129865074|NCT05072080|467462557|FG000|Overall Study|Withdrawal by Subject|45|||
129865075|NCT05072080|467462558|FG001|Overall Study|Withdrawal by Subject|30|||
129865076|NCT05072080|467462559|FG002|Overall Study|Withdrawal by Subject|27|||
129865077|NCT05072080|467462560|FG003|Overall Study|Withdrawal by Subject|7|||
129865078|NCT05072080|467462557|FG000|Overall Study|Sponsor Decision|0|||
129865079|NCT05072080|467462558|FG001|Overall Study|Sponsor Decision|1|||
129865080|NCT05072080|467462559|FG002|Overall Study|Sponsor Decision|0|||
129865081|NCT05072080|467462560|FG003|Overall Study|Sponsor Decision|0|||
129865082|NCT05072080|467462557|FG000|Overall Study|Subject moved|1|||
129865083|NCT05072080|467462558|FG001|Overall Study|Subject moved|3|||
129865084|NCT05072080|467462559|FG002|Overall Study|Subject moved|5|||
129865085|NCT05072080|467462560|FG003|Overall Study|Subject moved|2|||
129865086|NCT05072080|467462557|FG000|Overall Study|Withdrawal by parent|0|||
129865087|NCT05072080|467462558|FG001|Overall Study|Withdrawal by parent|0|||
129865088|NCT05072080|467462559|FG002|Overall Study|Withdrawal by parent|1|||
129865089|NCT05072080|467462560|FG003|Overall Study|Withdrawal by parent|0|||
129865090|NCT05072080|467462557|FG000|Overall Study|Subject was deployed|0|||
129865091|NCT05072080|467462558|FG001|Overall Study|Subject was deployed|1|||
129865092|NCT05072080|467462559|FG002|Overall Study|Subject was deployed|0|||
129865093|NCT05072080|467462560|FG003|Overall Study|Subject was deployed|0|||
129865094|NCT05072080|467462557|FG000|Overall Study|Subject left site without receiving dose|0|||
129865095|NCT05072080|467462558|FG001|Overall Study|Subject left site without receiving dose|1|||
129865096|NCT05072080|467462559|FG002|Overall Study|Subject left site without receiving dose|0|||
129865097|NCT05072080|467462560|FG003|Overall Study|Subject left site without receiving dose|0|||
129865098|NCT05072080|467462557|FG000|Overall Study|Subject incarcerated|0|||
129865099|NCT05072080|467462558|FG001|Overall Study|Subject incarcerated|1|||
129865100|NCT05072080|467462559|FG002|Overall Study|Subject incarcerated|0|||
129865101|NCT05072080|467462560|FG003|Overall Study|Subject incarcerated|1|||
129865102|NCT05072080|467462557|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
129865103|NCT05072080|467462558|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
129865104|NCT05072080|467462559|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
129865105|NCT05072080|467462560|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
129865106|NCT05072080|467462557|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
130065652|NCT01714817|468194769|FG001|Year 1 Period|Pregnancy|0|||
130065653|NCT01714817|468194768|FG000|Year 1 Period|Participant no longer meets criteria|6|||
130065654|NCT01714817|468194769|FG001|Year 1 Period|Participant no longer meets criteria|2|||
129865107|NCT05072080|467462558|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
129865108|NCT05072080|467462559|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
129865109|NCT05072080|467462560|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
129865110|NCT02633137|467462561|FG000|Overall Study|Adverse Event|1|||
129865111|NCT02633137|467462561|FG000|Overall Study|Lack of Efficacy|2|||
129865112|NCT02633137|467462561|FG000|Overall Study|Withdrawal by Subject|1|||
129865113|NCT01972841|467462562|FG000|Overall Study|Randomized but Never Received Treatment|2|||
129865114|NCT01972841|467462563|FG001|Overall Study|Randomized but Never Received Treatment|5|||
129865115|NCT01972841|467462564|FG002|Overall Study|Randomized but Never Received Treatment|4|||
129865116|NCT01972841|467462565|FG003|Overall Study|Randomized but Never Received Treatment|2|||
129865117|NCT01972841|467462566|FG004|Overall Study|Randomized but Never Received Treatment|6|||
129865118|NCT01972841|467462567|FG005|Overall Study|Randomized but Never Received Treatment|13|||
129865119|NCT01972841|467462562|FG000|Overall Study|Adverse Event|13|||
129865120|NCT01972841|467462563|FG001|Overall Study|Adverse Event|8|||
129865121|NCT01972841|467462564|FG002|Overall Study|Adverse Event|12|||
129865122|NCT01972841|467462565|FG003|Overall Study|Adverse Event|9|||
129865123|NCT01972841|467462566|FG004|Overall Study|Adverse Event|21|||
129865124|NCT01972841|467462567|FG005|Overall Study|Adverse Event|26|||
129865125|NCT01972841|467462562|FG000|Overall Study|Lack of Efficacy|1|||
129865126|NCT01972841|467462563|FG001|Overall Study|Lack of Efficacy|0|||
129865127|NCT01972841|467462564|FG002|Overall Study|Lack of Efficacy|0|||
129865128|NCT01972841|467462565|FG003|Overall Study|Lack of Efficacy|2|||
129865129|NCT01972841|467462566|FG004|Overall Study|Lack of Efficacy|4|||
129865130|NCT01972841|467462567|FG005|Overall Study|Lack of Efficacy|1|||
129865131|NCT01972841|467462562|FG000|Overall Study|Lost to Follow-up|4|||
129865132|NCT01972841|467462563|FG001|Overall Study|Lost to Follow-up|2|||
129865133|NCT01972841|467462564|FG002|Overall Study|Lost to Follow-up|4|||
129865134|NCT01972841|467462565|FG003|Overall Study|Lost to Follow-up|2|||
129865135|NCT01972841|467462566|FG004|Overall Study|Lost to Follow-up|9|||
129865136|NCT01972841|467462567|FG005|Overall Study|Lost to Follow-up|3|||
129865137|NCT01972841|467462562|FG000|Overall Study|Protocol Violation|2|||
129865138|NCT01972841|467462563|FG001|Overall Study|Protocol Violation|2|||
129865139|NCT01972841|467462564|FG002|Overall Study|Protocol Violation|3|||
129865140|NCT01972841|467462565|FG003|Overall Study|Protocol Violation|5|||
129865141|NCT01972841|467462566|FG004|Overall Study|Protocol Violation|9|||
129865142|NCT01972841|467462567|FG005|Overall Study|Protocol Violation|4|||
129865143|NCT01972841|467462562|FG000|Overall Study|Withdrawal by participants|21|||
129865144|NCT01972841|467462563|FG001|Overall Study|Withdrawal by participants|27|||
129865145|NCT01972841|467462564|FG002|Overall Study|Withdrawal by participants|23|||
129865146|NCT01972841|467462565|FG003|Overall Study|Withdrawal by participants|16|||
129865147|NCT01972841|467462566|FG004|Overall Study|Withdrawal by participants|33|||
129865148|NCT01972841|467462567|FG005|Overall Study|Withdrawal by participants|34|||
129865149|NCT01972841|467462562|FG000|Overall Study|Miscellaneous|0|||
129865150|NCT01972841|467462563|FG001|Overall Study|Miscellaneous|0|||
129865151|NCT01972841|467462564|FG002|Overall Study|Miscellaneous|4|||
129865152|NCT01972841|467462565|FG003|Overall Study|Miscellaneous|1|||
129865153|NCT01972841|467462566|FG004|Overall Study|Miscellaneous|0|||
129865154|NCT01972841|467462567|FG005|Overall Study|Miscellaneous|4|||
129865155|NCT01972841|467462562|FG000|Overall Study|Did not have end of treatment page|0|||
129865156|NCT01972841|467462563|FG001|Overall Study|Did not have end of treatment page|0|||
129865157|NCT01972841|467462564|FG002|Overall Study|Did not have end of treatment page|0|||
129865158|NCT01972841|467462565|FG003|Overall Study|Did not have end of treatment page|0|||
129865159|NCT01972841|467462566|FG004|Overall Study|Did not have end of treatment page|1|||
129865160|NCT01972841|467462567|FG005|Overall Study|Did not have end of treatment page|0|||
129865161|NCT04969198|467462568|FG000|Overall Study|Withdrawal by Subject|20|||
129865162|NCT04969198|467462568|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
129865163|NCT04969198|467462568|FG000|Overall Study|Lost to Follow-up|20|||
129865164|NCT02701985|467462569|FG000|Overall Study|Withdrawal by Subject|1|||
129865165|NCT02701985|467462570|FG001|Overall Study|Withdrawal by Subject|1|||
129865166|NCT02701985|467462569|FG000|Overall Study|Lost to Follow-up|1|||
129865167|NCT02701985|467462570|FG001|Overall Study|Lost to Follow-up|0|||
129865168|NCT02701985|467462569|FG000|Overall Study|Death|1|||
129865169|NCT02701985|467462570|FG001|Overall Study|Death|0|||
129865170|NCT02701985|467462569|FG000|Overall Study|Adverse Event|0|||
129865171|NCT02701985|467462570|FG001|Overall Study|Adverse Event|5|||
129865172|NCT01640808|467462571|FG000|Overall Study|Unable to continue dynamic CT|14|||
129865173|NCT01640808|467462572|FG001|Overall Study|Unable to continue dynamic CT|4|||
129865174|NCT01640808|467462571|FG000|Overall Study|Withdrawal by Subject|12|||
129865175|NCT01640808|467462572|FG001|Overall Study|Withdrawal by Subject|4|||
129865176|NCT01640808|467462571|FG000|Overall Study|Lost to Follow-up|4|||
129865177|NCT01640808|467462572|FG001|Overall Study|Lost to Follow-up|0|||
129865178|NCT01640808|467462571|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
129865179|NCT01640808|467462572|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
129865180|NCT01640808|467462571|FG000|Overall Study|Administration of anticancer drugs|2|||
129865181|NCT01640808|467462572|FG001|Overall Study|Administration of anticancer drugs|1|||
129865182|NCT01640808|467462571|FG000|Overall Study|Physician Decision|19|||
129865183|NCT01640808|467462572|FG001|Overall Study|Physician Decision|5|||
129865184|NCT01640808|467462571|FG000|Overall Study|Randomized but not treated|4|||
129865185|NCT01640808|467462572|FG001|Overall Study|Randomized but not treated|2|||
129865186|NCT01178086|467462573|FG000|Overall Study|Participant refusal|7|||
129865187|NCT01178086|467462573|FG000|Overall Study|Physician Decision|44|||
129865188|NCT01178086|467462573|FG000|Overall Study|Switch to other CLL therapy|113|||
129865189|NCT01178086|467462573|FG000|Overall Study|Death|59|||
129865190|NCT01178086|467462573|FG000|Overall Study|Other unspecified|89|||
129865191|NCT01178086|467462573|FG000|Overall Study|Excluded from EAS|20|||
129865192|NCT03543254|467462574|FG000|Overall Study|Lost to Follow-up|1|||
129865193|NCT00234065|467462575|FG000|Overall Study|Adverse Event|268|||
129865194|NCT00234065|467462576|FG001|Overall Study|Adverse Event|166|||
129865195|NCT00234065|467462575|FG000|Overall Study|Withdrawal by Subject|73|||
129865196|NCT00234065|467462576|FG001|Overall Study|Withdrawal by Subject|56|||
129865197|NCT00234065|467462575|FG000|Overall Study|Physician Decision|23|||
129865198|NCT00234065|467462576|FG001|Overall Study|Physician Decision|22|||
129865199|NCT00234065|467462575|FG000|Overall Study|Not Classified|111|||
129865200|NCT00234065|467462576|FG001|Overall Study|Not Classified|112|||
129865201|NCT00126438|467462577|FG000|Overall Study|Withdrawal due to adverse event|1|||
129865202|NCT00126438|467462578|FG001|Overall Study|Withdrawal due to adverse event|0|||
129865203|NCT00126438|467462577|FG000|Overall Study|Lost to Follow-up|22|||
129865204|NCT00126438|467462578|FG001|Overall Study|Lost to Follow-up|0|||
129865205|NCT00126438|467462577|FG000|Overall Study|Protocol Violation|8|||
129865206|NCT00126438|467462578|FG001|Overall Study|Protocol Violation|8|||
129865207|NCT00126438|467462577|FG000|Overall Study|Withdrawal by Subject|3|||
129865208|NCT00126438|467462578|FG001|Overall Study|Withdrawal by Subject|2|||
129865209|NCT00593567|467464623|FG000|Overall Study|Adverse Event|2|||
129865210|NCT00593567|467464624|FG001|Overall Study|Adverse Event|0|||
129865211|NCT00593567|467464623|FG000|Overall Study|Physician Decision|2|||
129865212|NCT00593567|467464624|FG001|Overall Study|Physician Decision|0|||
129865213|NCT00593567|467464623|FG000|Overall Study|Protocol Violation|13|||
129865214|NCT00593567|467464624|FG001|Overall Study|Protocol Violation|7|||
129865215|NCT00593567|467464623|FG000|Overall Study|Lack of Efficacy|2|||
129865216|NCT00593567|467464624|FG001|Overall Study|Lack of Efficacy|1|||
129865217|NCT00593567|467464623|FG000|Overall Study|Withdrawal by Subject|1|||
129865218|NCT00593567|467464624|FG001|Overall Study|Withdrawal by Subject|2|||
129865219|NCT01559844|467464625|FG000|Overall Study|Consent Withdrawn|7|||
129865220|NCT01559844|467464625|FG000|Overall Study|Death|5|||
129865221|NCT01559844|467464625|FG000|Overall Study|Efficacy Failure|10|||
129865222|NCT01559844|467464625|FG000|Overall Study|No Longer A Transplant Candidate|3|||
129865223|NCT01786512|467464626|FG000|Overall Study|Lost to Follow-up|0|||
129865224|NCT01786512|467464627|FG001|Overall Study|Lost to Follow-up|0|||
129865225|NCT01786512|467464628|FG002|Overall Study|Lost to Follow-up|0|||
129865226|NCT01786512|467464629|FG003|Overall Study|Lost to Follow-up|0|||
129865227|NCT01786512|467464630|FG004|Overall Study|Lost to Follow-up|0|||
129865228|NCT01786512|467464631|FG005|Overall Study|Lost to Follow-up|0|||
129865229|NCT01786512|467464632|FG006|Overall Study|Lost to Follow-up|0|||
129865230|NCT01786512|467464633|FG007|Overall Study|Lost to Follow-up|0|||
129865231|NCT01786512|467464634|FG008|Overall Study|Lost to Follow-up|0|||
129865232|NCT01786512|467464635|FG009|Overall Study|Lost to Follow-up|1|||
129865233|NCT01786512|467464636|FG010|Overall Study|Lost to Follow-up|0|||
129865234|NCT01786512|467464626|FG000|Overall Study|Decision by sponsor|0|||
129865235|NCT01786512|467464627|FG001|Overall Study|Decision by sponsor|0|||
129865236|NCT01786512|467464628|FG002|Overall Study|Decision by sponsor|0|||
129865237|NCT01786512|467464629|FG003|Overall Study|Decision by sponsor|0|||
129865238|NCT01786512|467464630|FG004|Overall Study|Decision by sponsor|0|||
129865239|NCT01786512|467464631|FG005|Overall Study|Decision by sponsor|0|||
129865240|NCT01786512|467464632|FG006|Overall Study|Decision by sponsor|0|||
129865241|NCT01786512|467464633|FG007|Overall Study|Decision by sponsor|0|||
129865242|NCT01786512|467464634|FG008|Overall Study|Decision by sponsor|0|||
129865243|NCT01786512|467464635|FG009|Overall Study|Decision by sponsor|0|||
129865244|NCT01786512|467464636|FG010|Overall Study|Decision by sponsor|2|||
129865245|NCT01786512|467464626|FG000|Overall Study|Withdrawal by Subject|0|||
129865246|NCT01786512|467464627|FG001|Overall Study|Withdrawal by Subject|1|||
129865247|NCT01786512|467464628|FG002|Overall Study|Withdrawal by Subject|0|||
129865248|NCT01786512|467464629|FG003|Overall Study|Withdrawal by Subject|0|||
129865249|NCT01786512|467464630|FG004|Overall Study|Withdrawal by Subject|0|||
129865250|NCT01786512|467464631|FG005|Overall Study|Withdrawal by Subject|0|||
129865251|NCT01786512|467464632|FG006|Overall Study|Withdrawal by Subject|1|||
129865252|NCT01786512|467464633|FG007|Overall Study|Withdrawal by Subject|0|||
129865253|NCT01786512|467464634|FG008|Overall Study|Withdrawal by Subject|0|||
129865254|NCT01786512|467464635|FG009|Overall Study|Withdrawal by Subject|3|||
129865255|NCT01786512|467464636|FG010|Overall Study|Withdrawal by Subject|7|||
129865256|NCT01786512|467464626|FG000|Overall Study|Death|0|||
129865257|NCT01786512|467464627|FG001|Overall Study|Death|0|||
129865258|NCT01786512|467464628|FG002|Overall Study|Death|0|||
129865259|NCT01786512|467464629|FG003|Overall Study|Death|0|||
129865260|NCT01786512|467464630|FG004|Overall Study|Death|0|||
129865261|NCT01786512|467464631|FG005|Overall Study|Death|0|||
129865262|NCT01786512|467464632|FG006|Overall Study|Death|0|||
129865263|NCT01786512|467464633|FG007|Overall Study|Death|0|||
129865264|NCT01786512|467464634|FG008|Overall Study|Death|4|||
129865265|NCT01786512|467464635|FG009|Overall Study|Death|1|||
129865266|NCT01786512|467464636|FG010|Overall Study|Death|3|||
129865267|NCT00605293|467464637|FG000|Overall Study|Death|2|||
129865268|NCT00605293|467464638|FG001|Overall Study|Death|1|||
129865269|NCT00605293|467464637|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129865270|NCT00605293|467464638|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129865271|NCT00605293|467464637|FG000|Overall Study|Adverse Event|1|||
129865272|NCT00605293|467464638|FG001|Overall Study|Adverse Event|0|||
129865273|NCT00605293|467464637|FG000|Overall Study|Holidays Dialysis Out|1|||
129865274|NCT00605293|467464638|FG001|Overall Study|Holidays Dialysis Out|0|||
129865275|NCT00605293|467464637|FG000|Overall Study|Blood Transfusion|7|||
129865276|NCT00605293|467464638|FG001|Overall Study|Blood Transfusion|1|||
129865277|NCT00605293|467464637|FG000|Overall Study|Renal Transplantation|3|||
129865278|NCT00605293|467464638|FG001|Overall Study|Renal Transplantation|1|||
129865279|NCT00605293|467464637|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
129865280|NCT00605293|467464638|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
129865281|NCT00605293|467464637|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
129865282|NCT00605293|467464638|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
129865283|NCT00605293|467464637|FG000|Overall Study|Principal Investigator Decision|0|||
129865284|NCT00605293|467464638|FG001|Overall Study|Principal Investigator Decision|1|||
129865285|NCT03137303|467464639|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
129865286|NCT03137303|467464640|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
129865287|NCT03137303|467464639|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
129914932|NCT05512962|467651455|FG000|Overall Study|Withdrawal by Subject|1|||
129914933|NCT05512962|467651456|FG001|Overall Study|Withdrawal by Subject|0|||
129914934|NCT02860130|467651457|FG000|Overall Study|Adverse Event|2|||
130065655|NCT01714817|468194768|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
130065656|NCT01714817|468194769|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
130065657|NCT01714817|468194768|FG000|Year 1 Period|Change in Concomitant Medication|0|||
130065658|NCT01714817|468194769|FG001|Year 1 Period|Change in Concomitant Medication|1|||
130065659|NCT01714817|468194768|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
130065660|NCT01714817|468194769|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
130065661|NCT01714817|468194768|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
130065662|NCT01714817|468194769|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
130065663|NCT01714817|468194768|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
130065664|NCT01714817|468194769|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
130065665|NCT01714817|468194768|FG000|Year 2 Period|Lack of Efficacy|4|||
130065666|NCT01714817|468194769|FG001|Year 2 Period|Lack of Efficacy|12|||
130065667|NCT01714817|468194768|FG000|Year 2 Period|Adverse Event|7|||
130065668|NCT01714817|468194769|FG001|Year 2 Period|Adverse Event|6|||
130065669|NCT01714817|468194768|FG000|Year 2 Period|Participant request to stop treatment|4|||
130065670|NCT01714817|468194769|FG001|Year 2 Period|Participant request to stop treatment|4|||
130065671|NCT01714817|468194768|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
130065672|NCT01714817|468194769|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
130065673|NCT01714817|468194768|FG000|Year 2 Period|Participant withdrew consent|1|||
130065674|NCT01714817|468194769|FG001|Year 2 Period|Participant withdrew consent|5|||
130065675|NCT01714817|468194768|FG000|Year 2 Period|Participant no longer meets criteria|1|||
130065676|NCT01714817|468194769|FG001|Year 2 Period|Participant no longer meets criteria|4|||
130065677|NCT01714817|468194768|FG000|Year 2 Period|Lost to Follow-up|2|||
130065678|NCT01714817|468194769|FG001|Year 2 Period|Lost to Follow-up|0|||
130065679|NCT01714817|468194768|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
130065680|NCT01714817|468194769|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
130065681|NCT01714817|468194768|FG000|Year 2 Period|Pregnancy|1|||
130065682|NCT01714817|468194769|FG001|Year 2 Period|Pregnancy|1|||
130065683|NCT01714817|468194768|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
130065684|NCT01714817|468194769|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
130065685|NCT01714817|468194768|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
130065686|NCT01714817|468194769|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
130065687|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
130065688|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
130065689|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
130065690|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
129865288|NCT03137303|467464640|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
129865289|NCT03137303|467464639|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
129865290|NCT03137303|467464640|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
129865291|NCT03137303|467464639|FG000|T3: 9-month Follow-up|Death|1|||
129865292|NCT03137303|467464640|FG001|T3: 9-month Follow-up|Death|0|||
129865293|NCT03137303|467464639|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
129865294|NCT03137303|467464640|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
129914935|NCT02860130|467651458|FG001|Overall Study|Adverse Event|3|||
130065691|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
130065692|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
130065693|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
130065694|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
130065695|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
130065696|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
130065697|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
130065698|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
130116706|NCT01829477|468387159|FG001|Overall Study|Withdrawal by Subject|0|||
129865295|NCT03137303|467464639|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
129865296|NCT03137303|467464640|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
129865297|NCT03137303|467464639|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
129865298|NCT03137303|467464640|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
129865299|NCT03561090|467464641|FG000|Overall Study|Adverse Event|11|||
129865300|NCT03561090|467464642|FG001|Overall Study|Adverse Event|7|||
129865301|NCT03561090|467464641|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129865302|NCT03561090|467464642|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129865303|NCT03561090|467464641|FG000|Overall Study|Protocol Violation|2|||
129865304|NCT03561090|467464642|FG001|Overall Study|Protocol Violation|2|||
129865305|NCT03561090|467464641|FG000|Overall Study|Withdrawal by Subject|7|||
129865306|NCT03561090|467464642|FG001|Overall Study|Withdrawal by Subject|7|||
129865307|NCT03561090|467464641|FG000|Overall Study|Lost to Follow-up|7|||
129865308|NCT03561090|467464642|FG001|Overall Study|Lost to Follow-up|2|||
129865309|NCT03561090|467464641|FG000|Overall Study|Study Terminated by Sponsor|10|||
129865310|NCT03561090|467464642|FG001|Overall Study|Study Terminated by Sponsor|15|||
129865311|NCT03561090|467464641|FG000|Overall Study|Randomized by Mistake|1|||
129865312|NCT03561090|467464642|FG001|Overall Study|Randomized by Mistake|1|||
129865313|NCT03561090|467464641|FG000|Overall Study|Other Not Specified|0|||
129865314|NCT03561090|467464642|FG001|Overall Study|Other Not Specified|2|||
129865315|NCT00713648|467464649|FG000|Overall Study|Adverse Event|1|||
129865316|NCT00713648|467464649|FG000|Overall Study|Unclassified|2|||
129865317|NCT00713648|467464649|FG000|Overall Study|According to Protocol|2|||
129865318|NCT00713648|467464649|FG000|Overall Study|Development of antibodies|3|||
129865319|NCT02633800|467464650|FG000|Overall Study|Death|3|||
129865320|NCT02633800|467464651|FG001|Overall Study|Death|3|||
129865321|NCT02633800|467464650|FG000|Overall Study|Reason not provided|1|||
129865322|NCT02633800|467464651|FG001|Overall Study|Reason not provided|0|||
129865323|NCT02633800|467464650|FG000|Overall Study|Radiologic(al) progression|23|||
129865324|NCT02633800|467464651|FG001|Overall Study|Radiologic(al) progression|23|||
129865325|NCT02633800|467464650|FG000|Overall Study|Clinical progression|3|||
129865326|NCT02633800|467464651|FG001|Overall Study|Clinical progression|6|||
129865327|NCT02633800|467464650|FG000|Overall Study|Study terminated by sponsor|6|||
129865328|NCT02633800|467464651|FG001|Overall Study|Study terminated by sponsor|5|||
129865329|NCT02633800|467464650|FG000|Overall Study|Adverse event, non-fatal|7|||
129865330|NCT02633800|467464651|FG001|Overall Study|Adverse event, non-fatal|2|||
129865331|NCT02633800|467464650|FG000|Overall Study|Withdrawal by Subject|0|||
129865332|NCT02633800|467464651|FG001|Overall Study|Withdrawal by Subject|3|||
129865333|NCT02633800|467464650|FG000|Overall Study|Patient Request|1|||
129865334|NCT02633800|467464651|FG001|Overall Study|Patient Request|1|||
129865335|NCT00082173|467464652|FG000|Overall Study|Withdrawal by Subject|3|||
129865336|NCT00082173|467464653|FG001|Overall Study|Withdrawal by Subject|5|||
129865337|NCT00082173|467464652|FG000|Overall Study|Lost to Follow-up|1|||
129865338|NCT00082173|467464653|FG001|Overall Study|Lost to Follow-up|0|||
129865339|NCT00082173|467464652|FG000|Overall Study|Adverse Event|1|||
129865340|NCT00082173|467464653|FG001|Overall Study|Adverse Event|0|||
129865341|NCT00082173|467464652|FG000|Overall Study|Culture negative or resistant at baselin|5|||
129865342|NCT00082173|467464653|FG001|Overall Study|Culture negative or resistant at baselin|6|||
129865343|NCT01733732|467464654|FG000|Overall Study|Adverse Event|1|||
129865344|NCT01733732|467464655|FG001|Overall Study|Adverse Event|0|||
129865345|NCT01733732|467464654|FG000|Overall Study|Did not attend all study visits|1|||
129865346|NCT01733732|467464655|FG001|Overall Study|Did not attend all study visits|0|||
129865347|NCT01358968|467464661|FG000|Period 2|Adverse Event|0|||
129865348|NCT01358968|467464662|FG001|Period 2|Adverse Event|1|||
129865349|NCT01358968|467464663|FG002|Period 2|Adverse Event|0|||
129865350|NCT01358968|467464664|FG003|Period 2|Adverse Event|0|||
129865351|NCT01358968|467464661|FG000|Continued Access Phase|Progression of Disease|0|||
129865352|NCT01358968|467464662|FG001|Continued Access Phase|Progression of Disease|0|||
129865353|NCT01358968|467464663|FG002|Continued Access Phase|Progression of Disease|8|||
130116707|NCT00818623|468387164|FG000|Overall Study|Adverse Event|1|||
129865354|NCT01358968|467464664|FG003|Continued Access Phase|Progression of Disease|4|||
129865355|NCT01358968|467464661|FG000|Continued Access Phase|Protocol Violation|0|||
129865356|NCT01358968|467464662|FG001|Continued Access Phase|Protocol Violation|0|||
129865357|NCT01358968|467464663|FG002|Continued Access Phase|Protocol Violation|0|||
129865358|NCT01358968|467464664|FG003|Continued Access Phase|Protocol Violation|2|||
129865359|NCT01358968|467464661|FG000|Continued Access Phase|Withdrawal by Subject|0|||
129914936|NCT02860130|467651457|FG000|Overall Study|Protocol Violation|1|||
129914937|NCT02860130|467651458|FG001|Overall Study|Protocol Violation|1|||
129914938|NCT02860130|467651457|FG000|Overall Study|Withdrawal by Subject|0|||
129914939|NCT02860130|467651458|FG001|Overall Study|Withdrawal by Subject|2|||
129914940|NCT02860130|467651457|FG000|Overall Study|Physician Decision|2|||
129914941|NCT02860130|467651458|FG001|Overall Study|Physician Decision|2|||
129914942|NCT02860130|467651457|FG000|Overall Study|Other|2|||
129914943|NCT02860130|467651458|FG001|Overall Study|Other|1|||
129914944|NCT05575076|467651460|FG000|Overall Study|Adverse Event|24|||
129914945|NCT05575076|467651460|FG000|Overall Study|Death|7|||
129914946|NCT05575076|467651460|FG000|Overall Study|Lost to Follow-up|16|||
129914947|NCT05575076|467651460|FG000|Overall Study|Non-Compliance|3|||
129914948|NCT05575076|467651460|FG000|Overall Study|Physician Decision|6|||
129914949|NCT05575076|467651460|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
129914950|NCT05575076|467651460|FG000|Overall Study|Withdrawal by Subject|71|||
129914951|NCT05575076|467651460|FG000|Overall Study|Study Terminated by Sponsor|630|||
129914952|NCT05575076|467651460|FG000|Overall Study|Other|17|||
129914953|NCT03380390|467651461|FG000|Overall Study|Adverse Event|3|||
129914954|NCT01127373|467651462|FG000|Overall Study|Not Treated|3|||
129914955|NCT01127373|467651462|FG000|Overall Study|Lost to Follow-up|7|||
129914956|NCT01127373|467651462|FG000|Overall Study|Withdrawal by Subject|1|||
129914957|NCT01127373|467651462|FG000|Overall Study|Disease progression|1|||
129914958|NCT01426412|467651469|FG000|Overall Study|Withdrawal by Subject|1|||
129914959|NCT01426412|467651470|FG001|Overall Study|Withdrawal by Subject|0|||
129914960|NCT01426412|467651471|FG002|Overall Study|Withdrawal by Subject|0|||
129914961|NCT01426412|467651472|FG003|Overall Study|Withdrawal by Subject|0|||
129914962|NCT01426412|467651473|FG004|Overall Study|Withdrawal by Subject|1|||
129914963|NCT01426412|467651474|FG005|Overall Study|Withdrawal by Subject|0|||
129914964|NCT01426412|467651475|FG006|Overall Study|Withdrawal by Subject|0|||
129914965|NCT01426412|467651476|FG007|Overall Study|Withdrawal by Subject|3|||
129914966|NCT01426412|467651477|FG008|Overall Study|Withdrawal by Subject|1|||
129914967|NCT01084707|467651479|FG000|Overall Study|Withdrawal by Subject|6|||
129914968|NCT02272816|467651480|FG000|Overall Study|Adverse Event|1|||
129914969|NCT02671435|467651485|FG000|Overall Study|Death|1|||
129914970|NCT02671435|467651486|FG001|Overall Study|Death|3|||
129914971|NCT02671435|467651487|FG002|Overall Study|Death|0|||
129914972|NCT02671435|467651488|FG003|Overall Study|Death|16|||
129914973|NCT02671435|467651489|FG004|Overall Study|Death|14|||
129914974|NCT02671435|467651490|FG005|Overall Study|Death|29|||
129914975|NCT02671435|467651491|FG006|Overall Study|Death|34|||
129914976|NCT02671435|467651492|FG007|Overall Study|Death|28|||
129914977|NCT02671435|467651493|FG008|Overall Study|Death|19|||
129914978|NCT02671435|467651494|FG009|Overall Study|Death|10|||
129914979|NCT02671435|467651495|FG010|Overall Study|Death|8|||
129914980|NCT02671435|467651496|FG011|Overall Study|Death|29|||
129914981|NCT02671435|467651497|FG012|Overall Study|Death|29|||
129914982|NCT02671435|467651498|FG013|Overall Study|Death|29|||
129914983|NCT02671435|467651499|FG014|Overall Study|Death|27|||
129914984|NCT02671435|467651485|FG000|Overall Study|Lost to Follow-up|0|||
129914985|NCT02671435|467651486|FG001|Overall Study|Lost to Follow-up|0|||
129914986|NCT02671435|467651487|FG002|Overall Study|Lost to Follow-up|1|||
129914987|NCT02671435|467651488|FG003|Overall Study|Lost to Follow-up|0|||
129914988|NCT02671435|467651489|FG004|Overall Study|Lost to Follow-up|1|||
129914989|NCT02671435|467651490|FG005|Overall Study|Lost to Follow-up|1|||
129914990|NCT02671435|467651491|FG006|Overall Study|Lost to Follow-up|2|||
129914991|NCT02671435|467651492|FG007|Overall Study|Lost to Follow-up|2|||
129914992|NCT02671435|467651493|FG008|Overall Study|Lost to Follow-up|0|||
129914993|NCT02671435|467651494|FG009|Overall Study|Lost to Follow-up|2|||
129914994|NCT02671435|467651495|FG010|Overall Study|Lost to Follow-up|0|||
129914995|NCT02671435|467651496|FG011|Overall Study|Lost to Follow-up|3|||
129914996|NCT02671435|467651497|FG012|Overall Study|Lost to Follow-up|3|||
129914997|NCT02671435|467651498|FG013|Overall Study|Lost to Follow-up|2|||
129914998|NCT02671435|467651499|FG014|Overall Study|Lost to Follow-up|0|||
129914999|NCT02671435|467651485|FG000|Overall Study|Withdrawal by Subject|2|||
129915000|NCT02671435|467651486|FG001|Overall Study|Withdrawal by Subject|0|||
129915001|NCT02671435|467651487|FG002|Overall Study|Withdrawal by Subject|2|||
129915002|NCT02671435|467651488|FG003|Overall Study|Withdrawal by Subject|2|||
129915003|NCT02671435|467651489|FG004|Overall Study|Withdrawal by Subject|2|||
129915004|NCT02671435|467651490|FG005|Overall Study|Withdrawal by Subject|7|||
129915005|NCT02671435|467651491|FG006|Overall Study|Withdrawal by Subject|2|||
129915006|NCT02671435|467651492|FG007|Overall Study|Withdrawal by Subject|7|||
129915007|NCT02671435|467651493|FG008|Overall Study|Withdrawal by Subject|1|||
129915008|NCT02671435|467651494|FG009|Overall Study|Withdrawal by Subject|1|||
129915009|NCT02671435|467651495|FG010|Overall Study|Withdrawal by Subject|2|||
129915010|NCT02671435|467651496|FG011|Overall Study|Withdrawal by Subject|4|||
129915011|NCT02671435|467651497|FG012|Overall Study|Withdrawal by Subject|4|||
129915012|NCT02671435|467651498|FG013|Overall Study|Withdrawal by Subject|4|||
129915013|NCT02671435|467651499|FG014|Overall Study|Withdrawal by Subject|2|||
129915014|NCT02671435|467651485|FG000|Overall Study|Un-specified|0|||
129915015|NCT02671435|467651486|FG001|Overall Study|Un-specified|0|||
129865360|NCT01358968|467464662|FG001|Continued Access Phase|Withdrawal by Subject|0|||
129865361|NCT01358968|467464663|FG002|Continued Access Phase|Withdrawal by Subject|3|||
129865362|NCT01358968|467464664|FG003|Continued Access Phase|Withdrawal by Subject|0|||
129865363|NCT01358968|467464661|FG000|Continued Access Phase|Death|0|||
129865364|NCT01358968|467464662|FG001|Continued Access Phase|Death|0|||
129865365|NCT01358968|467464663|FG002|Continued Access Phase|Death|1|||
129865366|NCT01358968|467464664|FG003|Continued Access Phase|Death|1|||
129865367|NCT01814371|467464665|FG000|Overall Study|Lost to Follow-up|30|||
129865368|NCT01814371|467464666|FG001|Overall Study|Lost to Follow-up|27|||
129865369|NCT01692782|467464667|FG000|Overall Study|Adverse Event|12|||
129865370|NCT01692782|467464668|FG001|Overall Study|Adverse Event|32|||
129865371|NCT01692782|467464669|FG002|Overall Study|Adverse Event|2|||
129865372|NCT01692782|467464667|FG000|Overall Study|Lack of Efficacy|1|||
129865373|NCT01692782|467464668|FG001|Overall Study|Lack of Efficacy|2|||
129865374|NCT01692782|467464669|FG002|Overall Study|Lack of Efficacy|0|||
129865375|NCT01692782|467464667|FG000|Overall Study|Lost to Follow-up|2|||
129865376|NCT01692782|467464668|FG001|Overall Study|Lost to Follow-up|7|||
129865377|NCT01692782|467464669|FG002|Overall Study|Lost to Follow-up|1|||
129865378|NCT01692782|467464667|FG000|Overall Study|Pregnancy|1|||
129865379|NCT01692782|467464668|FG001|Overall Study|Pregnancy|0|||
129865380|NCT01692782|467464669|FG002|Overall Study|Pregnancy|0|||
129865381|NCT01692782|467464667|FG000|Overall Study|Protocol Violation|1|||
129865382|NCT01692782|467464668|FG001|Overall Study|Protocol Violation|0|||
129865383|NCT01692782|467464669|FG002|Overall Study|Protocol Violation|2|||
129865384|NCT01692782|467464667|FG000|Overall Study|Non-complance with study drug|0|||
129865385|NCT01692782|467464668|FG001|Overall Study|Non-complance with study drug|4|||
129865386|NCT01692782|467464669|FG002|Overall Study|Non-complance with study drug|1|||
129865387|NCT01692782|467464667|FG000|Overall Study|Non-compliant with study visits|0|||
129865388|NCT01692782|467464668|FG001|Overall Study|Non-compliant with study visits|0|||
129865389|NCT01692782|467464669|FG002|Overall Study|Non-compliant with study visits|1|||
129865390|NCT01692782|467464667|FG000|Overall Study|SAE not related to study drug|0|||
129865391|NCT01692782|467464668|FG001|Overall Study|SAE not related to study drug|1|||
129865392|NCT01692782|467464669|FG002|Overall Study|SAE not related to study drug|0|||
129865393|NCT01692782|467464667|FG000|Overall Study|Withdrawal by Subject|3|||
129865394|NCT01692782|467464668|FG001|Overall Study|Withdrawal by Subject|10|||
129865395|NCT01692782|467464669|FG002|Overall Study|Withdrawal by Subject|3|||
129865396|NCT03252587|467464670|FG000|Overall Study|Adverse Event|3|||
129865397|NCT03252587|467464671|FG001|Overall Study|Adverse Event|8|||
129865398|NCT03252587|467464672|FG002|Overall Study|Adverse Event|6|||
129865399|NCT03252587|467464673|FG003|Overall Study|Adverse Event|12|||
129865400|NCT03252587|467464670|FG000|Overall Study|Lack of Efficacy|7|||
129865401|NCT03252587|467464671|FG001|Overall Study|Lack of Efficacy|2|||
129865402|NCT03252587|467464672|FG002|Overall Study|Lack of Efficacy|2|||
129865403|NCT03252587|467464673|FG003|Overall Study|Lack of Efficacy|4|||
129865404|NCT03252587|467464670|FG000|Overall Study|Lost to Follow-up|2|||
129865405|NCT03252587|467464671|FG001|Overall Study|Lost to Follow-up|0|||
129865406|NCT03252587|467464672|FG002|Overall Study|Lost to Follow-up|0|||
129865407|NCT03252587|467464673|FG003|Overall Study|Lost to Follow-up|2|||
129865408|NCT03252587|467464670|FG000|Overall Study|Pregnancy|2|||
129865409|NCT03252587|467464671|FG001|Overall Study|Pregnancy|1|||
129865410|NCT03252587|467464672|FG002|Overall Study|Pregnancy|0|||
129865411|NCT03252587|467464673|FG003|Overall Study|Pregnancy|1|||
129865412|NCT03252587|467464670|FG000|Overall Study|Withdrawal by Subject|8|||
129865413|NCT03252587|467464671|FG001|Overall Study|Withdrawal by Subject|4|||
129865414|NCT03252587|467464672|FG002|Overall Study|Withdrawal by Subject|4|||
129865415|NCT03252587|467464673|FG003|Overall Study|Withdrawal by Subject|4|||
129865416|NCT03252587|467464670|FG000|Overall Study|Other Reasons|2|||
129865417|NCT03252587|467464671|FG001|Overall Study|Other Reasons|5|||
129865418|NCT03252587|467464672|FG002|Overall Study|Other Reasons|5|||
129865419|NCT03252587|467464673|FG003|Overall Study|Other Reasons|4|||
129865420|NCT04052204|467464674|FG000|Overall Study|Death|1|||
129865421|NCT04052204|467464675|FG001|Overall Study|Death|0|||
129865422|NCT04052204|467464676|FG002|Overall Study|Death|0|||
129865423|NCT04052204|467464674|FG000|Overall Study|Progressive disease|1|||
129865424|NCT04052204|467464675|FG001|Overall Study|Progressive disease|0|||
129865425|NCT04052204|467464676|FG002|Overall Study|Progressive disease|0|||
129865426|NCT04052204|467464674|FG000|Overall Study|Other|1|||
129865427|NCT04052204|467464675|FG001|Overall Study|Other|0|||
129865428|NCT04052204|467464676|FG002|Overall Study|Other|0|||
129865429|NCT03945188|467464677|FG000|Overall Study|Protocol Violation|1|||
129865430|NCT03945188|467464678|FG001|Overall Study|Protocol Violation|0|||
129865431|NCT03945188|467464677|FG000|Overall Study|Disease worsening|79|||
129865432|NCT03945188|467464678|FG001|Overall Study|Disease worsening|73|||
129865433|NCT03945188|467464677|FG000|Overall Study|Physician Decision|2|||
129865434|NCT03945188|467464678|FG001|Overall Study|Physician Decision|2|||
129865435|NCT03945188|467464677|FG000|Overall Study|Lack of Efficacy|7|||
129865436|NCT03945188|467464678|FG001|Overall Study|Lack of Efficacy|4|||
129865437|NCT03945188|467464677|FG000|Overall Study|Pregnancy|2|||
129865438|NCT03945188|467464678|FG001|Overall Study|Pregnancy|0|||
129865439|NCT03945188|467464677|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
129915016|NCT02671435|467651487|FG002|Overall Study|Un-specified|0|||
129915017|NCT02671435|467651488|FG003|Overall Study|Un-specified|0|||
129915018|NCT02671435|467651489|FG004|Overall Study|Un-specified|1|||
129915019|NCT02671435|467651490|FG005|Overall Study|Un-specified|3|||
129915020|NCT02671435|467651491|FG006|Overall Study|Un-specified|2|||
129915021|NCT02671435|467651492|FG007|Overall Study|Un-specified|3|||
129915022|NCT02671435|467651493|FG008|Overall Study|Un-specified|0|||
129915023|NCT02671435|467651494|FG009|Overall Study|Un-specified|5|||
129915024|NCT02671435|467651495|FG010|Overall Study|Un-specified|8|||
129915025|NCT02671435|467651496|FG011|Overall Study|Un-specified|4|||
129915026|NCT02671435|467651497|FG012|Overall Study|Un-specified|5|||
129915027|NCT02671435|467651498|FG013|Overall Study|Un-specified|9|||
129915028|NCT02671435|467651499|FG014|Overall Study|Un-specified|8|||
129915029|NCT02412748|467651502|FG000|Overall Study|Lost to Follow-up|38|||
129915030|NCT02412748|467651503|FG001|Overall Study|Lost to Follow-up|39|||
129915031|NCT03069313|467651504|FG000|Overall Study|Adverse Event|5|||
129915032|NCT04820686|467651508|FG000|Overall Study|Withdrawal by Subject|5|||
129915033|NCT04820686|467651509|FG001|Overall Study|Withdrawal by Subject|2|||
129915034|NCT04820686|467651510|FG002|Overall Study|Withdrawal by Subject|3|||
129915035|NCT04820686|467651508|FG000|Overall Study|Study Termination|25|||
129915036|NCT04820686|467651509|FG001|Overall Study|Study Termination|13|||
129915037|NCT04820686|467651510|FG002|Overall Study|Study Termination|14|||
129915038|NCT04820686|467651508|FG000|Overall Study|Adverse Event|0|||
129915039|NCT04820686|467651509|FG001|Overall Study|Adverse Event|1|||
129915040|NCT04820686|467651510|FG002|Overall Study|Adverse Event|0|||
129915041|NCT01872078|467651511|FG000|Overall Study|Adverse Event|0|||
129915042|NCT01872078|467651512|FG001|Overall Study|Adverse Event|0|||
129915043|NCT01872078|467651513|FG002|Overall Study|Adverse Event|1|||
129915044|NCT01872078|467651514|FG003|Overall Study|Adverse Event|0|||
129915045|NCT01872078|467651511|FG000|Overall Study|Dose administration non-compliance|0|||
129915046|NCT01872078|467651512|FG001|Overall Study|Dose administration non-compliance|0|||
129915047|NCT01872078|467651513|FG002|Overall Study|Dose administration non-compliance|0|||
129915048|NCT01872078|467651514|FG003|Overall Study|Dose administration non-compliance|1|||
129915049|NCT01872078|467651511|FG000|Overall Study|Protocol Violation|0|||
129915050|NCT01872078|467651512|FG001|Overall Study|Protocol Violation|0|||
129915051|NCT01872078|467651513|FG002|Overall Study|Protocol Violation|1|||
129915052|NCT01872078|467651514|FG003|Overall Study|Protocol Violation|0|||
129915053|NCT01872078|467651511|FG000|Overall Study|Withdrawal by Subject|0|||
129915054|NCT01872078|467651512|FG001|Overall Study|Withdrawal by Subject|0|||
129915055|NCT01872078|467651513|FG002|Overall Study|Withdrawal by Subject|1|||
129915056|NCT01872078|467651514|FG003|Overall Study|Withdrawal by Subject|0|||
129915057|NCT01872078|467651511|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
129915058|NCT01872078|467651512|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
129915059|NCT01872078|467651513|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
129915060|NCT01872078|467651514|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
129915061|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
129915062|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
129915063|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
129915064|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
129915065|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
129915066|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
129915067|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
129915068|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
129915069|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
129915070|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
129915071|NCT01424670|467651515|FG000|Continuation Period|Adverse Event|13|||
129915072|NCT01424670|467651516|FG001|Continuation Period|Adverse Event|5|||
129915073|NCT01424670|467651515|FG000|Continuation Period|Lost to Follow-up|2|||
129915074|NCT01424670|467651516|FG001|Continuation Period|Lost to Follow-up|0|||
129915075|NCT01424670|467651515|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
129915076|NCT01424670|467651516|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
130065699|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
130065700|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
130065701|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
129915077|NCT01424670|467651515|FG000|Continuation Period|Physician Decision|5|||
129915078|NCT01424670|467651516|FG001|Continuation Period|Physician Decision|4|||
129915079|NCT01424670|467651515|FG000|Continuation Period|Withdrawal by Subject|13|||
129915080|NCT01424670|467651516|FG001|Continuation Period|Withdrawal by Subject|4|||
129915081|NCT00761189|467651517|FG000|Overall Study|Adverse Event|42|||
129915082|NCT00761189|467651517|FG000|Overall Study|Lack of Efficacy|45|||
129915083|NCT00761189|467651517|FG000|Overall Study|Lost to Follow-up|36|||
130065702|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
130065703|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
129915084|NCT00761189|467651517|FG000|Overall Study|Withdrawal by Subject|49|||
129915085|NCT00761189|467651517|FG000|Overall Study|Other|13|||
130065704|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
130065705|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
130065706|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
130065707|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
130065708|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
130065709|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
130065710|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
130065711|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
130065712|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
130065713|NCT01714817|468194768|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
129865440|NCT03945188|467464678|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
129865441|NCT03945188|467464677|FG000|Overall Study|Adverse Event|10|||
129865442|NCT03945188|467464678|FG001|Overall Study|Adverse Event|5|||
129865443|NCT03945188|467464677|FG000|Overall Study|Other|2|||
129865444|NCT03945188|467464678|FG001|Overall Study|Other|2|||
129865445|NCT03945188|467464677|FG000|Overall Study|Lost to Follow-up|1|||
129865446|NCT03945188|467464678|FG001|Overall Study|Lost to Follow-up|2|||
129865447|NCT01618162|467464699|FG000|Overall Study|Protocol Violation|13|||
129865448|NCT01618162|467464700|FG001|Overall Study|Protocol Violation|10|||
129865449|NCT01618162|467464699|FG000|Overall Study|Adverse Event|9|||
129865450|NCT01618162|467464700|FG001|Overall Study|Adverse Event|2|||
129865451|NCT01618162|467464699|FG000|Overall Study|Withdrawal Criteria|2|||
129865452|NCT01618162|467464700|FG001|Overall Study|Withdrawal Criteria|10|||
129865453|NCT01618162|467464699|FG000|Overall Study|Unclassified|14|||
129865454|NCT01618162|467464700|FG001|Overall Study|Unclassified|13|||
129865455|NCT03152526|467464706|FG000|Overall Study|Withdrawal by Subject|0|||
129865456|NCT03152526|467464707|FG001|Overall Study|Withdrawal by Subject|1|||
129865457|NCT02395042|467464708|FG000|Treatment 1 Period|Adverse Event|1|||
129865458|NCT02395042|467464709|FG001|Treatment 1 Period|Adverse Event|3|||
129865459|NCT02395042|467464710|FG002|Treatment 1 Period|Adverse Event|1|||
129865460|NCT02395042|467464708|FG000|Treatment 1 Period|Lack of Efficacy|1|||
129865461|NCT02395042|467464709|FG001|Treatment 1 Period|Lack of Efficacy|1|||
129865462|NCT02395042|467464710|FG002|Treatment 1 Period|Lack of Efficacy|0|||
129865463|NCT02395042|467464708|FG000|Treatment 1 Period|Lost to Follow-up|1|||
129865464|NCT02395042|467464709|FG001|Treatment 1 Period|Lost to Follow-up|0|||
129865465|NCT02395042|467464710|FG002|Treatment 1 Period|Lost to Follow-up|0|||
129865466|NCT02395042|467464708|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
129865467|NCT02395042|467464709|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
129865468|NCT02395042|467464710|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
129865469|NCT02395042|467464708|FG000|Treatment 2 Period|Lack of Efficacy|1|||
129865470|NCT02395042|467464709|FG001|Treatment 2 Period|Lack of Efficacy|1|||
129865471|NCT02395042|467464710|FG002|Treatment 2 Period|Lack of Efficacy|0|||
129865472|NCT02807558|467464711|FG000|Overall Study|Consent withdrawn by participant|4|||
129865473|NCT02807558|467464712|FG001|Overall Study|Consent withdrawn by participant|0|||
129865474|NCT02807558|467464713|FG002|Overall Study|Consent withdrawn by participant|4|||
129865475|NCT02807558|467464714|FG003|Overall Study|Consent withdrawn by participant|2|||
129865476|NCT02807558|467464715|FG004|Overall Study|Consent withdrawn by participant|1|||
129865477|NCT02807558|467464716|FG005|Overall Study|Consent withdrawn by participant|0|||
129865478|NCT02807558|467464711|FG000|Overall Study|Non-compliance with Study Drug|0|||
129865479|NCT02807558|467464712|FG001|Overall Study|Non-compliance with Study Drug|0|||
129865480|NCT02807558|467464713|FG002|Overall Study|Non-compliance with Study Drug|1|||
129865481|NCT02807558|467464714|FG003|Overall Study|Non-compliance with Study Drug|0|||
129865482|NCT02807558|467464715|FG004|Overall Study|Non-compliance with Study Drug|0|||
129865483|NCT02807558|467464716|FG005|Overall Study|Non-compliance with Study Drug|0|||
129865484|NCT02807558|467464711|FG000|Overall Study|Adverse Event|0|||
129865485|NCT02807558|467464712|FG001|Overall Study|Adverse Event|0|||
129865486|NCT02807558|467464713|FG002|Overall Study|Adverse Event|9|||
129865487|NCT02807558|467464714|FG003|Overall Study|Adverse Event|0|||
129865488|NCT02807558|467464715|FG004|Overall Study|Adverse Event|0|||
129865489|NCT02807558|467464716|FG005|Overall Study|Adverse Event|0|||
129865490|NCT02807558|467464711|FG000|Overall Study|Death|23|||
129915086|NCT03481816|467651521|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
129915087|NCT03481816|467651522|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
130065714|NCT01714817|468194769|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
130065715|NCT02921763|468194770|FG000|Overall Study|Adverse Event|4|||
129865491|NCT02807558|467464712|FG001|Overall Study|Death|2|||
129865492|NCT02807558|467464713|FG002|Overall Study|Death|3|||
129865493|NCT02807558|467464714|FG003|Overall Study|Death|43|||
129865494|NCT02807558|467464715|FG004|Overall Study|Death|24|||
129865495|NCT02807558|467464716|FG005|Overall Study|Death|15|||
129865496|NCT02807558|467464711|FG000|Overall Study|Progressive Disease|0|||
129865497|NCT02807558|467464712|FG001|Overall Study|Progressive Disease|0|||
129865498|NCT02807558|467464713|FG002|Overall Study|Progressive Disease|1|||
129865499|NCT02807558|467464714|FG003|Overall Study|Progressive Disease|0|||
129915088|NCT03481816|467651521|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
129915089|NCT03481816|467651522|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
129915090|NCT03481816|467651521|FG000|Dose Expansion|Withdrawal by Subject|0|||
129915091|NCT03481816|467651522|FG001|Dose Expansion|Withdrawal by Subject|2|||
129915092|NCT03481816|467651521|FG000|Dose Expansion|Physician Decision|0|||
129915093|NCT03481816|467651522|FG001|Dose Expansion|Physician Decision|5|||
129915094|NCT04924062|467652854|FG000|Overall Study|Death|49|||
129915095|NCT04924062|467652855|FG001|Overall Study|Death|63|||
129915096|NCT04924062|467652854|FG000|Overall Study|Participant On-going|26|||
129915097|NCT04924062|467652855|FG001|Overall Study|Participant On-going|20|||
129915098|NCT04607044|467652858|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
129915099|NCT04607044|467652858|FG000|Overall Study|Adverse Event|1|||
129915100|NCT04607044|467652858|FG000|Overall Study|Did not receive study device|3|||
129915101|NCT04607044|467652858|FG000|Overall Study|Death|1|||
129915102|NCT03651895|467652859|FG000|First Drug Assignment|Adverse Event|4|||
129915103|NCT03651895|467652860|FG001|First Drug Assignment|Adverse Event|5|||
129915104|NCT03651895|467652859|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
129915105|NCT03651895|467652860|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
129915106|NCT02525692|467652861|FG000|Overall Study|Withdrawal by Subject|1|||
129915107|NCT02525692|467652862|FG001|Overall Study|Withdrawal by Subject|1|||
129915108|NCT02525692|467652863|FG002|Overall Study|Withdrawal by Subject|0|||
129915109|NCT02525692|467652864|FG003|Overall Study|Withdrawal by Subject|5|||
129915110|NCT02525692|467652865|FG004|Overall Study|Withdrawal by Subject|0|||
129915111|NCT02525692|467652866|FG005|Overall Study|Withdrawal by Subject|1|||
129915112|NCT02525692|467652861|FG000|Overall Study|Death|16|||
129915113|NCT02525692|467652862|FG001|Overall Study|Death|18|||
129915114|NCT02525692|467652863|FG002|Overall Study|Death|7|||
129915115|NCT02525692|467652864|FG003|Overall Study|Death|20|||
129915116|NCT02525692|467652865|FG004|Overall Study|Death|3|||
129915117|NCT02525692|467652866|FG005|Overall Study|Death|6|||
129915118|NCT02525692|467652861|FG000|Overall Study|Lost to Follow-up|0|||
129915119|NCT02525692|467652862|FG001|Overall Study|Lost to Follow-up|0|||
129915120|NCT02525692|467652863|FG002|Overall Study|Lost to Follow-up|1|||
129915121|NCT02525692|467652864|FG003|Overall Study|Lost to Follow-up|5|||
129915122|NCT02525692|467652865|FG004|Overall Study|Lost to Follow-up|0|||
129915123|NCT02525692|467652866|FG005|Overall Study|Lost to Follow-up|0|||
129915124|NCT02396199|467652867|FG000|Overall Study|Lost to Follow-up|1|||
129915125|NCT02396199|467652867|FG000|Overall Study|Death|4|||
129915126|NCT04337372|467652876|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
129915127|NCT04337372|467652877|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
129915128|NCT04337372|467652878|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
129915129|NCT04337372|467652879|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
129915130|NCT04337372|467652876|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
129915131|NCT04337372|467652877|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
129915132|NCT04337372|467652878|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
129915133|NCT04337372|467652879|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
129915134|NCT04337372|467652876|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
129915135|NCT04337372|467652877|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
129915136|NCT04337372|467652878|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
129915137|NCT04337372|467652879|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
129915138|NCT04337372|467652876|FG000|Day 2: EEG Measures|Protocol Violation|6|||
129915139|NCT04337372|467652877|FG001|Day 2: EEG Measures|Protocol Violation|6|||
129915140|NCT04337372|467652878|FG002|Day 2: EEG Measures|Protocol Violation|5|||
129915141|NCT04337372|467652879|FG003|Day 2: EEG Measures|Protocol Violation|17|||
129915142|NCT05307783|467652880|FG000|Overall Study|Death|7|||
129915143|NCT05307783|467652880|FG000|Overall Study|Lost to Follow-up|4|||
129915144|NCT04883645|467652881|FG000|Overall Study|Death|1|||
129915145|NCT04869982|467652882|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
129915146|NCT04869982|467652883|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
129915147|NCT04869982|467652882|FG000|Overall Study|Migrated / moved from the study area|1|||
129915148|NCT04869982|467652883|FG001|Overall Study|Migrated / moved from the study area|1|||
129915149|NCT04869982|467652882|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
129915150|NCT04869982|467652883|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
129915151|NCT04869982|467652882|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
129915152|NCT04869982|467652883|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
129915153|NCT04869982|467652882|FG000|Overall Study|Solicited adverse event|2|||
129915154|NCT04869982|467652883|FG001|Overall Study|Solicited adverse event|1|||
129915155|NCT00567398|467652884|FG000|Overall Study|Adverse Event|6|||
130116708|NCT00818623|468387165|FG001|Overall Study|Adverse Event|0|||
130116709|NCT00818623|468387166|FG002|Overall Study|Adverse Event|1|||
129915156|NCT00567398|467652885|FG001|Overall Study|Adverse Event|14|||
129915157|NCT00567398|467652884|FG000|Overall Study|Physician Decision|0|||
129915158|NCT00567398|467652885|FG001|Overall Study|Physician Decision|4|||
129915159|NCT00567398|467652884|FG000|Overall Study|Withdrawal by Subject|0|||
129915160|NCT00567398|467652885|FG001|Overall Study|Withdrawal by Subject|2|||
129915161|NCT00567398|467652884|FG000|Overall Study|Renal Transplantation|0|||
129865500|NCT02807558|467464715|FG004|Overall Study|Progressive Disease|0|||
129865501|NCT02807558|467464716|FG005|Overall Study|Progressive Disease|0|||
129865502|NCT02807558|467464711|FG000|Overall Study|Other than specified|1|||
129865503|NCT02807558|467464712|FG001|Overall Study|Other than specified|0|||
129865504|NCT02807558|467464713|FG002|Overall Study|Other than specified|2|||
129865505|NCT02807558|467464714|FG003|Overall Study|Other than specified|0|||
129865506|NCT02807558|467464715|FG004|Overall Study|Other than specified|1|||
129865507|NCT02807558|467464716|FG005|Overall Study|Other than specified|1|||
129865508|NCT02807558|467464711|FG000|Overall Study|Lack of Efficacy|0|||
129865509|NCT02807558|467464712|FG001|Overall Study|Lack of Efficacy|0|||
129865510|NCT02807558|467464713|FG002|Overall Study|Lack of Efficacy|9|||
129865511|NCT02807558|467464714|FG003|Overall Study|Lack of Efficacy|0|||
129865512|NCT02807558|467464715|FG004|Overall Study|Lack of Efficacy|0|||
129865513|NCT02807558|467464716|FG005|Overall Study|Lack of Efficacy|0|||
129865514|NCT02477111|467464717|FG000|Overall Study|Death|28|||
129865515|NCT02477111|467464717|FG000|Overall Study|Withdrawal by Subject|19|||
129865516|NCT02477111|467464717|FG000|Overall Study|Lost to Follow-up|4|||
129865517|NCT02192502|467464719|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
129865518|NCT02192502|467464720|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
129865519|NCT02192502|467464719|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
129865520|NCT02192502|467464720|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
129865521|NCT02192502|467464719|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
129865522|NCT02192502|467464720|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
129865523|NCT01328574|467464729|FG000|Overall Study|Refused further treatment|1|||
129865524|NCT00003298|467464730|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
129865525|NCT00003298|467464730|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
129865526|NCT00003298|467464730|FG000|Surgery|Unresectable at surgery|3|||
129865527|NCT00003298|467464730|FG000|Surgery|Progression before surgery|2|||
129865528|NCT00003298|467464730|FG000|Surgery|Unevaluable and off study|2|||
129865529|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
129865530|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
129865531|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
129865532|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
129865533|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
129865534|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
129865535|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
129865536|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
129865537|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
129865538|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
129865539|NCT01994954|467464735|FG000|Overall Study|Death|1|||
129865540|NCT01994954|467464736|FG001|Overall Study|Death|0|||
129865541|NCT01994954|467464735|FG000|Overall Study|Withdrawal by Subject|9|||
129865542|NCT01994954|467464736|FG001|Overall Study|Withdrawal by Subject|14|||
129865543|NCT01994954|467464735|FG000|Overall Study|Physician Decision|2|||
129865544|NCT01994954|467464736|FG001|Overall Study|Physician Decision|2|||
129865545|NCT01994954|467464735|FG000|Overall Study|Lost to Follow-up|8|||
129865546|NCT01994954|467464736|FG001|Overall Study|Lost to Follow-up|10|||
129865547|NCT01994954|467464735|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
129865548|NCT01994954|467464736|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
129865549|NCT00675766|467464737|FG000|Overall Study|Lost to Follow-up|6|||
129865550|NCT00675766|467464738|FG001|Overall Study|Lost to Follow-up|5|||
129865551|NCT00675766|467464739|FG002|Overall Study|Lost to Follow-up|21|||
129865552|NCT00675766|467464740|FG003|Overall Study|Lost to Follow-up|26|||
129865553|NCT01454583|467464747|FG000|1st Year|Lost to Follow-up|1057|||
129865554|NCT01454583|467464748|FG001|1st Year|Lost to Follow-up|318|||
129865555|NCT01454583|467464749|FG002|1st Year|Lost to Follow-up|180|||
129865556|NCT01454583|467464747|FG000|2nd Year|Lost to Follow-up|3965|||
129865557|NCT01454583|467464748|FG001|2nd Year|Lost to Follow-up|1049|||
129865558|NCT01454583|467464749|FG002|2nd Year|Lost to Follow-up|737|||
129865559|NCT01454583|467464747|FG000|3rd Year|Lost to Follow-up|1959|||
129865560|NCT01454583|467464748|FG001|3rd Year|Lost to Follow-up|512|||
129865561|NCT01454583|467464749|FG002|3rd Year|Lost to Follow-up|297|||
129865562|NCT02677116|467464752|FG000|Overall Study|Adverse Event|0|||
129865563|NCT02677116|467464753|FG001|Overall Study|Adverse Event|1|||
129865564|NCT02677116|467464754|FG002|Overall Study|Adverse Event|0|||
129865565|NCT02677116|467464755|FG003|Overall Study|Adverse Event|0|||
129865566|NCT02677116|467464756|FG004|Overall Study|Adverse Event|0|||
129865567|NCT02677116|467464757|FG005|Overall Study|Adverse Event|1|||
129865568|NCT02677116|467464758|FG006|Overall Study|Adverse Event|1|||
129865569|NCT02677116|467464759|FG007|Overall Study|Adverse Event|0|||
129865570|NCT02677116|467464760|FG008|Overall Study|Adverse Event|0|||
129865571|NCT02677116|467464752|FG000|Overall Study|Physician Decision|0|||
129865572|NCT02677116|467464753|FG001|Overall Study|Physician Decision|2|||
129865573|NCT02677116|467464754|FG002|Overall Study|Physician Decision|3|||
129865574|NCT02677116|467464755|FG003|Overall Study|Physician Decision|2|||
129915162|NCT00567398|467652885|FG001|Overall Study|Renal Transplantation|3|||
129915163|NCT00567398|467652884|FG000|Overall Study|Other|1|||
129915164|NCT00567398|467652885|FG001|Overall Study|Other|0|||
129915165|NCT02201108|467652888|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
129915166|NCT02201108|467652889|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
129915167|NCT02201108|467652890|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
129915168|NCT02201108|467652888|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
129915169|NCT02201108|467652889|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
129915170|NCT02201108|467652890|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
129915171|NCT02201108|467652888|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
129915172|NCT02201108|467652889|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
129915173|NCT02201108|467652890|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
129915174|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
129915175|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
129915176|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
129915177|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
129915178|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
129915179|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
129915180|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Other reason|4|||
129915181|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Other reason|7|||
129915182|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Other reason|0|||
129915183|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
129915184|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
129915185|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
129915186|NCT02201108|467652888|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
129915187|NCT02201108|467652889|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
129915188|NCT02201108|467652890|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
129915189|NCT02201108|467652888|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
129915190|NCT02201108|467652889|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
129915191|NCT02201108|467652890|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
129915192|NCT03055377|467652900|FG000|Treatment Phase|Lost to Follow-up|28|||
129915193|NCT03055377|467652901|FG001|Treatment Phase|Lost to Follow-up|24|||
129915194|NCT03055377|467652900|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
129915195|NCT03055377|467652901|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
129915196|NCT04143061|467652903|FG000|Overall Study|Protocol Deviation|0|||
129915197|NCT04143061|467652904|FG001|Overall Study|Protocol Deviation|0|||
129915198|NCT04143061|467652905|FG002|Overall Study|Protocol Deviation|0|||
129915199|NCT04143061|467652906|FG003|Overall Study|Protocol Deviation|0|||
129915200|NCT04143061|467652907|FG004|Overall Study|Protocol Deviation|0|||
129915201|NCT04143061|467652908|FG005|Overall Study|Protocol Deviation|0|||
129915202|NCT04143061|467652909|FG006|Overall Study|Protocol Deviation|5|||
129915203|NCT04143061|467652910|FG007|Overall Study|Protocol Deviation|5|||
129915204|NCT04143061|467652903|FG000|Overall Study|Withdrawal by Subject|2|||
129915205|NCT04143061|467652904|FG001|Overall Study|Withdrawal by Subject|0|||
129915206|NCT04143061|467652905|FG002|Overall Study|Withdrawal by Subject|0|||
129915207|NCT04143061|467652906|FG003|Overall Study|Withdrawal by Subject|0|||
129915208|NCT04143061|467652907|FG004|Overall Study|Withdrawal by Subject|0|||
129915209|NCT04143061|467652908|FG005|Overall Study|Withdrawal by Subject|1|||
129915210|NCT04143061|467652909|FG006|Overall Study|Withdrawal by Subject|0|||
129915211|NCT04143061|467652910|FG007|Overall Study|Withdrawal by Subject|0|||
129915212|NCT04143061|467652903|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129915213|NCT04143061|467652904|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129915214|NCT04143061|467652905|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129915215|NCT04143061|467652906|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129915216|NCT04143061|467652907|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
129915217|NCT04143061|467652908|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
129915218|NCT04143061|467652909|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
129915219|NCT04143061|467652910|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
130065716|NCT02921763|468194770|FG000|Overall Study|Lost to Follow-up|4|||
130065717|NCT02921763|468194770|FG000|Overall Study|Lack of Efficacy|3|||
130065718|NCT02921763|468194770|FG000|Overall Study|Protocol Violation|2|||
130065719|NCT02921763|468194770|FG000|Overall Study|Withdrawal by Subject|2|||
129915220|NCT03602014|467652911|FG000|Overall Study|Lost to Follow-up|2|||
129915221|NCT03602014|467652912|FG001|Overall Study|Lost to Follow-up|0|||
129915222|NCT03602014|467652913|FG002|Overall Study|Lost to Follow-up|0|||
129915223|NCT04905407|467652914|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
129915224|NCT04905407|467652915|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
129915225|NCT04905407|467652916|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
129915226|NCT04905407|467652917|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
129915227|NCT04905407|467652914|FG000|Part 1 and Part 2|Death|7|||
130065720|NCT02921763|468194770|FG000|Overall Study|Physician Decision|1|||
129915228|NCT04905407|467652915|FG001|Part 1 and Part 2|Death|7|||
129915229|NCT04905407|467652916|FG002|Part 1 and Part 2|Death|7|||
129865575|NCT02677116|467464756|FG004|Overall Study|Physician Decision|1|||
129865576|NCT02677116|467464757|FG005|Overall Study|Physician Decision|3|||
129865577|NCT02677116|467464758|FG006|Overall Study|Physician Decision|1|||
129915230|NCT04905407|467652917|FG003|Part 1 and Part 2|Death|0|||
129915231|NCT04905407|467652914|FG000|Part 1 and Part 2|Other than specified|0|||
129915232|NCT04905407|467652915|FG001|Part 1 and Part 2|Other than specified|0|||
129915233|NCT04905407|467652916|FG002|Part 1 and Part 2|Other than specified|1|||
129915234|NCT04905407|467652917|FG003|Part 1 and Part 2|Other than specified|0|||
129915235|NCT04905407|467652914|FG000|Part 3|Death|0|||
129915236|NCT04905407|467652915|FG001|Part 3|Death|0|||
129915237|NCT04905407|467652916|FG002|Part 3|Death|0|||
129915238|NCT04905407|467652917|FG003|Part 3|Death|2|||
129915239|NCT04823611|467652918|FG000|Overall Study|Adverse Event|2|||
129915240|NCT04823611|467652919|FG001|Overall Study|Adverse Event|0|||
129915241|NCT04823611|467652920|FG002|Overall Study|Adverse Event|1|||
129915242|NCT04823611|467652921|FG003|Overall Study|Adverse Event|0|||
129915243|NCT04823611|467652922|FG004|Overall Study|Adverse Event|0|||
129915244|NCT04823611|467652923|FG005|Overall Study|Adverse Event|0|||
129915245|NCT04823611|467652924|FG006|Overall Study|Adverse Event|0|||
129915246|NCT01894061|467652926|FG000|Overall Study|Screen failure|1|||
129915247|NCT01894061|467652926|FG000|Overall Study|Withdrawal by Subject|1|||
129915248|NCT01673984|467652927|FG000|Overall Study|Adverse Event|1|||
129915249|NCT01673984|467652928|FG001|Overall Study|Adverse Event|0|||
129915250|NCT01673984|467652927|FG000|Overall Study|Study termination|9|||
129915251|NCT01673984|467652928|FG001|Overall Study|Study termination|6|||
129915252|NCT04437433|467652929|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
129915253|NCT04437433|467652930|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
129915254|NCT04437433|467652929|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
129915255|NCT04437433|467652930|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
129915256|NCT04437433|467652929|FG000|Overall Study|Adverse Event|9|||
129915257|NCT04437433|467652930|FG001|Overall Study|Adverse Event|0|||
129915258|NCT04437433|467652929|FG000|Overall Study|Lack of Efficacy|4|||
129915259|NCT04437433|467652930|FG001|Overall Study|Lack of Efficacy|0|||
129915260|NCT04437433|467652929|FG000|Overall Study|Withdrawal by Subject|4|||
129915261|NCT04437433|467652930|FG001|Overall Study|Withdrawal by Subject|1|||
129915262|NCT04437433|467652929|FG000|Overall Study|Protocol Deviation|0|||
129915263|NCT04437433|467652930|FG001|Overall Study|Protocol Deviation|1|||
129915264|NCT04437433|467652929|FG000|Overall Study|Other, not specified|0|||
129915265|NCT04437433|467652930|FG001|Overall Study|Other, not specified|1|||
129915266|NCT04048681|467652931|FG000|Overall Study|family emergency|0|||
129915267|NCT04048681|467652932|FG001|Overall Study|family emergency|0|||
129915268|NCT04048681|467652933|FG002|Overall Study|family emergency|0|||
129915269|NCT04048681|467652934|FG003|Overall Study|family emergency|1|||
129915270|NCT04048681|467652935|FG004|Overall Study|family emergency|0|||
129915271|NCT02919449|467652936|FG000|Overall Study|Withdrawal by Subject|1|||
129915272|NCT02919449|467652936|FG000|Overall Study|Investigator decision|1|||
129915273|NCT05623345|467652939|FG000|Overall Study|Withdrawal by Subject|14|||
129915274|NCT05623345|467652940|FG001|Overall Study|Withdrawal by Subject|0|||
129915275|NCT05623345|467652941|FG002|Overall Study|Withdrawal by Subject|9|||
129915276|NCT05623345|467652942|FG003|Overall Study|Withdrawal by Subject|20|||
129915277|NCT05623345|467652939|FG000|Overall Study|Lost to Follow-up|3|||
129915278|NCT05623345|467652940|FG001|Overall Study|Lost to Follow-up|0|||
129915279|NCT05623345|467652941|FG002|Overall Study|Lost to Follow-up|7|||
129915280|NCT05623345|467652942|FG003|Overall Study|Lost to Follow-up|2|||
129915281|NCT05623345|467652939|FG000|Overall Study|Termination of Study By Sponsor|37|||
129915282|NCT05623345|467652940|FG001|Overall Study|Termination of Study By Sponsor|4|||
129915283|NCT05623345|467652941|FG002|Overall Study|Termination of Study By Sponsor|40|||
129915284|NCT05623345|467652942|FG003|Overall Study|Termination of Study By Sponsor|38|||
129915285|NCT05384730|467652943|FG000|Overall Study|Adverse Event|1|||
129865578|NCT02677116|467464759|FG007|Overall Study|Physician Decision|1|||
129865579|NCT02677116|467464760|FG008|Overall Study|Physician Decision|2|||
129865580|NCT02677116|467464752|FG000|Overall Study|Withdrawal by parent or guardian|2|||
129865581|NCT02677116|467464753|FG001|Overall Study|Withdrawal by parent or guardian|1|||
129865582|NCT02677116|467464754|FG002|Overall Study|Withdrawal by parent or guardian|0|||
129915286|NCT05384730|467652944|FG001|Overall Study|Adverse Event|0|||
129915287|NCT05384730|467652943|FG000|Overall Study|Lack of social support|2|||
129915288|NCT05384730|467652944|FG001|Overall Study|Lack of social support|0|||
129915289|NCT05384730|467652943|FG000|Overall Study|Hospital readmission|2|||
129915290|NCT05384730|467652944|FG001|Overall Study|Hospital readmission|0|||
129915291|NCT05384730|467652943|FG000|Overall Study|Disease progression|5|||
129915292|NCT05384730|467652944|FG001|Overall Study|Disease progression|0|||
129915293|NCT05384730|467652943|FG000|Overall Study|Overwhelmed with College commitments|0|||
129915294|NCT05384730|467652944|FG001|Overall Study|Overwhelmed with College commitments|2|||
129865583|NCT02677116|467464755|FG003|Overall Study|Withdrawal by parent or guardian|1|||
129915295|NCT01772472|467652946|FG000|Overall Study|Death|126|||
129915296|NCT01772472|467652947|FG001|Overall Study|Death|94|||
129915297|NCT01772472|467652946|FG000|Overall Study|Lost to Follow-up|51|||
129915298|NCT01772472|467652947|FG001|Overall Study|Lost to Follow-up|50|||
129865584|NCT02677116|467464756|FG004|Overall Study|Withdrawal by parent or guardian|0|||
129865585|NCT02677116|467464757|FG005|Overall Study|Withdrawal by parent or guardian|0|||
129865586|NCT02677116|467464758|FG006|Overall Study|Withdrawal by parent or guardian|2|||
129865587|NCT02677116|467464759|FG007|Overall Study|Withdrawal by parent or guardian|1|||
129865588|NCT02677116|467464760|FG008|Overall Study|Withdrawal by parent or guardian|0|||
129865589|NCT02677116|467464752|FG000|Overall Study|Withdrawal by Subject|1|||
129865590|NCT02677116|467464753|FG001|Overall Study|Withdrawal by Subject|0|||
129865591|NCT02677116|467464754|FG002|Overall Study|Withdrawal by Subject|0|||
129865592|NCT02677116|467464755|FG003|Overall Study|Withdrawal by Subject|0|||
129865593|NCT02677116|467464756|FG004|Overall Study|Withdrawal by Subject|0|||
129865594|NCT02677116|467464757|FG005|Overall Study|Withdrawal by Subject|0|||
129865595|NCT02677116|467464758|FG006|Overall Study|Withdrawal by Subject|0|||
129865596|NCT02677116|467464759|FG007|Overall Study|Withdrawal by Subject|0|||
129865597|NCT02677116|467464760|FG008|Overall Study|Withdrawal by Subject|0|||
129865598|NCT03182868|467464761|FG000|Overall Study|Protocol Violation|3|||
129865599|NCT03182868|467464762|FG001|Overall Study|Protocol Violation|0|||
129865600|NCT03182868|467464763|FG002|Overall Study|Protocol Violation|4|||
129865601|NCT03182868|467464764|FG003|Overall Study|Protocol Violation|1|||
129865602|NCT03182868|467464765|FG004|Overall Study|Protocol Violation|8|||
129865603|NCT02363946|467464767|FG000|Overall Study|Lost to Follow-up|0|||
129865604|NCT02363946|467464768|FG001|Overall Study|Lost to Follow-up|0|||
129865605|NCT02363946|467464769|FG002|Overall Study|Lost to Follow-up|0|||
129865606|NCT02363946|467464770|FG003|Overall Study|Lost to Follow-up|0|||
129865607|NCT02363946|467464771|FG004|Overall Study|Lost to Follow-up|0|||
129865608|NCT02363946|467464772|FG005|Overall Study|Lost to Follow-up|0|||
129865609|NCT02363946|467464773|FG006|Overall Study|Lost to Follow-up|0|||
129865610|NCT02363946|467464774|FG007|Overall Study|Lost to Follow-up|1|||
129865611|NCT02363946|467464775|FG008|Overall Study|Lost to Follow-up|0|||
129865612|NCT02363946|467464776|FG009|Overall Study|Lost to Follow-up|0|||
129865613|NCT02363946|467464777|FG010|Overall Study|Lost to Follow-up|0|||
129865614|NCT02363946|467464778|FG011|Overall Study|Lost to Follow-up|0|||
129865615|NCT02363946|467464779|FG012|Overall Study|Lost to Follow-up|0|||
129865616|NCT01967732|467464780|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
129865617|NCT01967732|467464781|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
129865618|NCT01967732|467464782|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
129865619|NCT01967732|467464783|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
129865620|NCT01967732|467464780|FG000|First Intervention (Day 1)|Poor venous access|0|||
129865621|NCT01967732|467464781|FG001|First Intervention (Day 1)|Poor venous access|1|||
129865622|NCT01967732|467464782|FG002|First Intervention (Day 1)|Poor venous access|0|||
129865623|NCT01967732|467464783|FG003|First Intervention (Day 1)|Poor venous access|0|||
129865624|NCT03342638|467464784|FG000|Overall Study|Withdrawal by Subject|1|||
129865625|NCT03342638|467464785|FG001|Overall Study|Withdrawal by Subject|0|||
129865626|NCT03342638|467464784|FG000|Overall Study|Physician Decision|0|||
129865627|NCT03342638|467464785|FG001|Overall Study|Physician Decision|1|||
129865628|NCT01292239|467464801|FG000|Overall Study|Other|1|||
129865629|NCT01292239|467464802|FG001|Overall Study|Other|1|||
129865630|NCT01292239|467464801|FG000|Overall Study|Withdrawal by Subject|3|||
129865631|NCT01292239|467464802|FG001|Overall Study|Withdrawal by Subject|6|||
129865632|NCT00113568|467464803|FG000|Overall Study|Adverse Event|97|||
129865633|NCT00113568|467464803|FG000|Overall Study|Death|1|||
129865634|NCT00113568|467464803|FG000|Overall Study|Lack of Efficacy|30|||
129865635|NCT00113568|467464803|FG000|Overall Study|Lost to Follow-up|156|||
129865636|NCT00113568|467464803|FG000|Overall Study|Protocol Violation|32|||
129865637|NCT00113568|467464803|FG000|Overall Study|Withdrawal by Subject|117|||
129865638|NCT00113568|467464803|FG000|Overall Study|Other|112|||
129865639|NCT00262821|467464804|FG000|Overall Study|Ineligible - wrong stage|0|||
129865640|NCT00262821|467464805|FG001|Overall Study|Ineligible - wrong stage|3|||
129865641|NCT00262821|467464804|FG000|Overall Study|Ineligible - wrong cell type|2|||
129865642|NCT00262821|467464805|FG001|Overall Study|Ineligible - wrong cell type|2|||
129865643|NCT00262821|467464804|FG000|Overall Study|Ineligible - wrong primary|0|||
129865644|NCT00262821|467464805|FG001|Overall Study|Ineligible - wrong primary|1|||
129865645|NCT00262821|467464804|FG000|Overall Study|Ineligible - inadequate pathology|1|||
129865646|NCT00262821|467464805|FG001|Overall Study|Ineligible - inadequate pathology|3|||
129865647|NCT00262821|467464804|FG000|Overall Study|Ineligible - elevated creatinine|0|||
129865648|NCT00262821|467464805|FG001|Overall Study|Ineligible - elevated creatinine|2|||
129865649|NCT00262821|467464804|FG000|Overall Study|Ineligible - required test not done|1|||
129865650|NCT00262821|467464805|FG001|Overall Study|Ineligible - required test not done|4|||
129865651|NCT00262821|467464804|FG000|Overall Study|Inevaluable - inadequate data|0|||
129865652|NCT00262821|467464805|FG001|Overall Study|Inevaluable - inadequate data|4|||
129865653|NCT01988779|467464807|FG000|Overall Study|Withdrawal by Subject|2|||
129865654|NCT01988779|467464808|FG001|Overall Study|Withdrawal by Subject|2|||
129865655|NCT01988779|467464807|FG000|Overall Study|Protocol Violation|1|||
129865656|NCT01988779|467464808|FG001|Overall Study|Protocol Violation|0|||
129865657|NCT00584727|467464809|FG000|First Intervention|Discontinuation|0|||
129865658|NCT00584727|467464810|FG001|First Intervention|Discontinuation|0|||
129865659|NCT00584727|467464811|FG002|First Intervention|Discontinuation|1|||
129865660|NCT00584727|467464812|FG003|First Intervention|Discontinuation|0|||
129865661|NCT00584727|467464813|FG004|First Intervention|Discontinuation|0|||
129865662|NCT00584727|467464814|FG005|First Intervention|Discontinuation|0|||
129865663|NCT00584727|467464809|FG000|Third Intervention|Protocol Violation|0|||
129865664|NCT00584727|467464810|FG001|Third Intervention|Protocol Violation|0|||
129865665|NCT00584727|467464811|FG002|Third Intervention|Protocol Violation|1|||
129865666|NCT00584727|467464812|FG003|Third Intervention|Protocol Violation|0|||
129865667|NCT00584727|467464813|FG004|Third Intervention|Protocol Violation|4|||
129865668|NCT00584727|467464814|FG005|Third Intervention|Protocol Violation|2|||
129865669|NCT00377403|467464816|FG000|Overall Study|Unable to contact for telephone intervie|4|||
129865670|NCT00377403|467464817|FG001|Overall Study|Unable to contact for telephone intervie|7|||
129865671|NCT01922076|467464818|FG000|Overall Study|Adverse Event|0|||
129865672|NCT01922076|467464819|FG001|Overall Study|Adverse Event|0|||
129865673|NCT01922076|467464820|FG002|Overall Study|Adverse Event|0|||
129915299|NCT01772472|467652946|FG000|Overall Study|Other|9|||
129915300|NCT01772472|467652947|FG001|Overall Study|Other|7|||
129915301|NCT01772472|467652946|FG000|Overall Study|Physician Decision|1|||
129915302|NCT01772472|467652947|FG001|Overall Study|Physician Decision|7|||
129915303|NCT01772472|467652946|FG000|Overall Study|Withdrawal by Subject|115|||
129915304|NCT01772472|467652947|FG001|Overall Study|Withdrawal by Subject|90|||
129915305|NCT01772472|467652946|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
129915306|NCT01772472|467652947|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
129915307|NCT02697136|467652948|FG000|Overall Study|Adverse Event|3|||
129915308|NCT02697136|467652949|FG001|Overall Study|Adverse Event|0|||
129865674|NCT01922076|467464821|FG003|Overall Study|Adverse Event|0|||
129865675|NCT01922076|467464822|FG004|Overall Study|Adverse Event|1|||
129865676|NCT01922076|467464823|FG005|Overall Study|Adverse Event|0|||
129865677|NCT01922076|467464824|FG006|Overall Study|Adverse Event|0|||
129865678|NCT01922076|467464818|FG000|Overall Study|Physician Decision|0|||
129865679|NCT01922076|467464819|FG001|Overall Study|Physician Decision|0|||
129865680|NCT01922076|467464820|FG002|Overall Study|Physician Decision|1|||
129865681|NCT01922076|467464821|FG003|Overall Study|Physician Decision|0|||
129865682|NCT01922076|467464822|FG004|Overall Study|Physician Decision|0|||
129865683|NCT01922076|467464823|FG005|Overall Study|Physician Decision|0|||
129865684|NCT01922076|467464824|FG006|Overall Study|Physician Decision|0|||
129865685|NCT01922076|467464818|FG000|Overall Study|Withdrawal by Subject|0|||
129865686|NCT01922076|467464819|FG001|Overall Study|Withdrawal by Subject|0|||
129865687|NCT01922076|467464820|FG002|Overall Study|Withdrawal by Subject|0|||
129865688|NCT01922076|467464821|FG003|Overall Study|Withdrawal by Subject|1|||
129865689|NCT01922076|467464822|FG004|Overall Study|Withdrawal by Subject|0|||
129865690|NCT01922076|467464823|FG005|Overall Study|Withdrawal by Subject|1|||
129865691|NCT01922076|467464824|FG006|Overall Study|Withdrawal by Subject|1|||
129865692|NCT01018394|467464827|FG000|Overall Study|Withdrawal by Subject|5|||
129865693|NCT01018394|467464828|FG001|Overall Study|Withdrawal by Subject|5|||
129865694|NCT01018394|467464827|FG000|Overall Study|Lost to Follow-up|4|||
129865695|NCT01018394|467464828|FG001|Overall Study|Lost to Follow-up|3|||
129865696|NCT00683644|467464829|FG000|Overall Study|Withdrawal by Subject|4|||
129865697|NCT00683644|467464830|FG001|Overall Study|Withdrawal by Subject|2|||
129865698|NCT00683644|467464829|FG000|Overall Study|Lost to Follow-up|1|||
129865699|NCT00683644|467464830|FG001|Overall Study|Lost to Follow-up|4|||
129865700|NCT00683644|467464829|FG000|Overall Study|Adverse Event|1|||
129865701|NCT00683644|467464830|FG001|Overall Study|Adverse Event|2|||
129865702|NCT00683644|467464829|FG000|Overall Study|Low copper, other health problems,|7|||
129865703|NCT00683644|467464830|FG001|Overall Study|Low copper, other health problems,|6|||
129865704|NCT01669122|467464833|FG000|Period I|Lost to Follow-up|1|||
129865705|NCT01669122|467464833|FG000|Washout Period II|Protocol Violation|2|||
129865706|NCT03762473|467464834|FG000|Overall Study|Death|1|||
129865707|NCT03762473|467464835|FG001|Overall Study|Death|0|||
129865708|NCT05132699|467464836|FG000|Overall Study|Withdrawal by Subject|3|||
129865709|NCT05132699|467464837|FG001|Overall Study|Withdrawal by Subject|0|||
129865710|NCT02858895|467464840|FG000|Overall Study|Disease progression|31|||
129865711|NCT02858895|467464840|FG000|Overall Study|Death|2|||
129915309|NCT03578536|467652953|FG000|Overall Study|Lost to Follow-up|1|||
129915310|NCT04431726|467652954|FG000|Overall Study|Ongoing in the Study|55|||
129915311|NCT04116736|467652955|FG000|Overall Study|Withdrew consent during study|3|||
129865712|NCT02858895|467464840|FG000|Overall Study|Adverse Event|1|||
129865713|NCT02858895|467464840|FG000|Overall Study|Withdrawal by Subject|3|||
129865714|NCT02858895|467464840|FG000|Overall Study|hospice,|1|||
129865715|NCT02858895|467464840|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
129865716|NCT02277444|467464849|FG000|Overall Study|Adverse Event|10|||
129865717|NCT02277444|467464849|FG000|Overall Study|Withdrawal by Subject|3|||
129865718|NCT02277444|467464849|FG000|Overall Study|Other|1|||
129915312|NCT04116736|467652956|FG001|Overall Study|Withdrew consent during study|1|||
129915313|NCT04116736|467652955|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
129915314|NCT04116736|467652956|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
129915315|NCT04116736|467652955|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
129865719|NCT02277444|467464849|FG000|Overall Study|Enrolled and not Treated|3|||
129865720|NCT02277444|467464849|FG000|Overall Study|Ongoing|113|||
129865721|NCT00785291|467467113|FG000|Overall Study|Never began treatment|8|||
129865722|NCT00785291|467467114|FG001|Overall Study|Never began treatment|4|||
129865723|NCT00785291|467467115|FG002|Overall Study|Never began treatment|4|||
129865724|NCT00785291|467467113|FG000|Overall Study|Adverse Event|39|||
129865725|NCT00785291|467467114|FG001|Overall Study|Adverse Event|70|||
129865726|NCT00785291|467467115|FG002|Overall Study|Adverse Event|56|||
129865727|NCT00785291|467467113|FG000|Overall Study|Death|7|||
129865728|NCT00785291|467467114|FG001|Overall Study|Death|4|||
129865729|NCT00785291|467467115|FG002|Overall Study|Death|3|||
129865730|NCT00785291|467467113|FG000|Overall Study|Withdrawal by Subject|35|||
129865731|NCT00785291|467467114|FG001|Overall Study|Withdrawal by Subject|36|||
129865732|NCT00785291|467467115|FG002|Overall Study|Withdrawal by Subject|17|||
129865733|NCT00785291|467467113|FG000|Overall Study|Alternative Therapy|12|||
129865734|NCT00785291|467467114|FG001|Overall Study|Alternative Therapy|6|||
129865735|NCT00785291|467467115|FG002|Overall Study|Alternative Therapy|7|||
129865736|NCT00785291|467467113|FG000|Overall Study|Complicating illness|6|||
129865737|NCT00785291|467467114|FG001|Overall Study|Complicating illness|4|||
129865738|NCT00785291|467467115|FG002|Overall Study|Complicating illness|4|||
129865739|NCT00785291|467467113|FG000|Overall Study|Other Medical Reasons|29|||
129865740|NCT00785291|467467114|FG001|Overall Study|Other Medical Reasons|25|||
129865741|NCT00785291|467467115|FG002|Overall Study|Other Medical Reasons|15|||
129865742|NCT00570674|467467116|FG000|Overall Study|Withdrawal by Subject|0|||
129865743|NCT00570674|467467117|FG001|Overall Study|Withdrawal by Subject|0|||
129865744|NCT00570674|467467118|FG002|Overall Study|Withdrawal by Subject|1|||
129865745|NCT00570674|467467119|FG003|Overall Study|Withdrawal by Subject|0|||
129865746|NCT00570674|467467120|FG004|Overall Study|Withdrawal by Subject|0|||
129865747|NCT00570674|467467121|FG005|Overall Study|Withdrawal by Subject|0|||
129865748|NCT00570674|467467122|FG006|Overall Study|Withdrawal by Subject|0|||
129865749|NCT02979639|467467123|FG000|Overall Study|Withdrawal based on medical judgement|1|||
129865750|NCT02979639|467467123|FG000|Overall Study|Lost to Follow-up|8|||
129865751|NCT02979639|467467123|FG000|Overall Study|Withdrawal by Subject|3|||
129865752|NCT02979639|467467123|FG000|Overall Study|Adverse Event|2|||
129865753|NCT04050865|467467126|FG000|Overall Study|Adverse Event|1|||
129865754|NCT04050865|467467127|FG001|Overall Study|Adverse Event|0|||
129865755|NCT04050865|467467126|FG000|Overall Study|no insert|1|||
129865756|NCT04050865|467467127|FG001|Overall Study|no insert|0|||
129865757|NCT04050865|467467126|FG000|Overall Study|Only 1 insert|2|||
129865758|NCT04050865|467467127|FG001|Overall Study|Only 1 insert|3|||
129865759|NCT04050865|467467126|FG000|Overall Study|Physician Decision|0|||
129865760|NCT04050865|467467127|FG001|Overall Study|Physician Decision|1|||
129865761|NCT04050865|467467126|FG000|Overall Study|Withdrawal by Subject|0|||
129865762|NCT04050865|467467127|FG001|Overall Study|Withdrawal by Subject|1|||
129865763|NCT04205630|467467136|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
129865764|NCT04205630|467467136|FG000|Overall Study|Disease clinical progression|7|||
129865765|NCT04205630|467467136|FG000|Overall Study|Withdrawal by Subject|2|||
129865766|NCT04205630|467467136|FG000|Overall Study|Adverse Event|17|||
129865767|NCT04205630|467467136|FG000|Overall Study|Other|1|||
129865768|NCT00160680|467467147|FG000|Overall Study|Adverse Event|0|||
129865769|NCT00160680|467467148|FG001|Overall Study|Adverse Event|1|||
129865770|NCT00160680|467467147|FG000|Overall Study|Lack of Efficacy|2|||
129865771|NCT00160680|467467148|FG001|Overall Study|Lack of Efficacy|1|||
129865772|NCT00160680|467467147|FG000|Overall Study|Lost to Follow-up|3|||
129865773|NCT00160680|467467148|FG001|Overall Study|Lost to Follow-up|2|||
129865774|NCT00160680|467467147|FG000|Overall Study|Withdrawal by Subject|4|||
129865775|NCT00160680|467467148|FG001|Overall Study|Withdrawal by Subject|9|||
129865776|NCT03393000|467467149|FG000|Overall Study|Death|11|||
129865777|NCT03393000|467467149|FG000|Overall Study|Withdrawal by Subject|2|||
129865778|NCT03393000|467467149|FG000|Overall Study|Physician Decision|1|||
129865779|NCT01773070|467467150|FG000|Overall Study|Withdrawal by Subject|24|||
129865780|NCT01773070|467467150|FG000|Overall Study|Lost to Follow-up|39|||
129865781|NCT01773070|467467150|FG000|Overall Study|Other|15|||
129865782|NCT01773070|467467150|FG000|Overall Study|Death (unrelated to study procedures)|3|||
129865783|NCT02450331|467467151|FG000|Overall Study|Death|162|||
129865784|NCT02450331|467467152|FG001|Overall Study|Death|171|||
129865785|NCT02450331|467467151|FG000|Overall Study|Lost to Follow-up|14|||
129865786|NCT02450331|467467152|FG001|Overall Study|Lost to Follow-up|12|||
129865787|NCT02450331|467467151|FG000|Overall Study|Withdrawal by Subject|55|||
129865788|NCT02450331|467467152|FG001|Overall Study|Withdrawal by Subject|44|||
129865789|NCT02450331|467467151|FG000|Overall Study|Non-specified other|1|||
129865790|NCT02450331|467467152|FG001|Overall Study|Non-specified other|1|||
129865791|NCT02723864|467467153|FG000|Overall Study|Refused further treatment|1|||
129865792|NCT02723864|467467154|FG001|Overall Study|Refused further treatment|0|||
129865793|NCT02723864|467467155|FG002|Overall Study|Refused further treatment|0|||
129865794|NCT02723864|467467156|FG003|Overall Study|Refused further treatment|0|||
129865795|NCT02723864|467467157|FG004|Overall Study|Refused further treatment|1|||
129865796|NCT02723864|467467158|FG005|Overall Study|Refused further treatment|2|||
129915316|NCT04116736|467652956|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
129915317|NCT04116736|467652955|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
129915318|NCT04116736|467652956|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
129915319|NCT04116736|467652955|FG000|Overall Study|Subject was enrolled in error|2|||
129915320|NCT04116736|467652956|FG001|Overall Study|Subject was enrolled in error|0|||
129915321|NCT04116736|467652955|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
129915322|NCT04116736|467652956|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
129915323|NCT04116736|467652955|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
129915324|NCT04116736|467652956|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
129915325|NCT04116736|467652955|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
129915326|NCT04116736|467652956|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
129915327|NCT04157348|467652960|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
129915328|NCT04157348|467652961|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
129915329|NCT04157348|467652960|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129915330|NCT04157348|467652961|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129915331|NCT04157348|467652960|FG000|Double-blind Treatment Period|Adverse Event|0|||
129915332|NCT04157348|467652961|FG001|Double-blind Treatment Period|Adverse Event|1|||
129915333|NCT04157348|467652960|FG000|Open-label Extension Period|Adverse Event|1|||
129915334|NCT04157348|467652961|FG001|Open-label Extension Period|Adverse Event|1|||
129915335|NCT04157348|467652960|FG000|Open-label Extension Period|Death|0|||
129915336|NCT04157348|467652961|FG001|Open-label Extension Period|Death|1|||
129915337|NCT04157348|467652960|FG000|Open-label Extension Period|Lack of Efficacy|2|||
129915338|NCT04157348|467652961|FG001|Open-label Extension Period|Lack of Efficacy|2|||
129915339|NCT04157348|467652960|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
129915340|NCT04157348|467652961|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129915341|NCT04157348|467652960|FG000|Open-label Extension Period|Ongoing|60|||
129915342|NCT04157348|467652961|FG001|Open-label Extension Period|Ongoing|57|||
129915343|NCT04157348|467652960|FG000|Open-label Extension Period|other reasons|1|||
129915344|NCT04157348|467652961|FG001|Open-label Extension Period|other reasons|1|||
129915345|NCT04854096|467652962|FG000|Overall Study|Adverse Event|1|||
129915346|NCT04854096|467652963|FG001|Overall Study|Adverse Event|0|||
129915347|NCT04854096|467652962|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
129915348|NCT04854096|467652963|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
129915349|NCT04854096|467652962|FG000|Overall Study|Withdrawal by Subject|1|||
129915350|NCT04854096|467652963|FG001|Overall Study|Withdrawal by Subject|0|||
129915351|NCT04854096|467652962|FG000|Overall Study|Other reasons|1|||
129915352|NCT04854096|467652963|FG001|Overall Study|Other reasons|0|||
129915353|NCT04757610|467652964|FG000|Overall Study|Adverse Event|13|||
129915354|NCT04757610|467652965|FG001|Overall Study|Adverse Event|10|||
129915355|NCT04757610|467652966|FG002|Overall Study|Adverse Event|5|||
129915356|NCT04757610|467652964|FG000|Overall Study|Death|5|||
129915357|NCT04757610|467652965|FG001|Overall Study|Death|13|||
129915358|NCT04757610|467652966|FG002|Overall Study|Death|8|||
129915359|NCT04757610|467652964|FG000|Overall Study|Lack of Efficacy|1|||
129915360|NCT04757610|467652965|FG001|Overall Study|Lack of Efficacy|2|||
129915361|NCT04757610|467652966|FG002|Overall Study|Lack of Efficacy|3|||
129915362|NCT04757610|467652964|FG000|Overall Study|Lost to Follow-up|7|||
129915363|NCT04757610|467652965|FG001|Overall Study|Lost to Follow-up|2|||
129915364|NCT04757610|467652966|FG002|Overall Study|Lost to Follow-up|7|||
129915365|NCT04757610|467652964|FG000|Overall Study|Physician Decision|4|||
129915366|NCT04757610|467652965|FG001|Overall Study|Physician Decision|1|||
129915367|NCT04757610|467652966|FG002|Overall Study|Physician Decision|2|||
129915368|NCT04757610|467652964|FG000|Overall Study|Withdrawal by Subject|26|||
129915369|NCT04757610|467652965|FG001|Overall Study|Withdrawal by Subject|25|||
129915370|NCT04757610|467652966|FG002|Overall Study|Withdrawal by Subject|25|||
129915371|NCT04757610|467652964|FG000|Overall Study|Study Terminated by Sponsor|105|||
129915372|NCT04757610|467652965|FG001|Overall Study|Study Terminated by Sponsor|105|||
129915373|NCT04757610|467652966|FG002|Overall Study|Study Terminated by Sponsor|110|||
129865797|NCT02723864|467467159|FG006|Overall Study|Refused further treatment|0|||
129865798|NCT02723864|467467153|FG000|Overall Study|Exceed treatment hold time|0|||
129865799|NCT02723864|467467154|FG001|Overall Study|Exceed treatment hold time|1|||
129865800|NCT02723864|467467155|FG002|Overall Study|Exceed treatment hold time|0|||
129865801|NCT02723864|467467156|FG003|Overall Study|Exceed treatment hold time|0|||
129865802|NCT02723864|467467157|FG004|Overall Study|Exceed treatment hold time|0|||
129865803|NCT02723864|467467158|FG005|Overall Study|Exceed treatment hold time|0|||
129865804|NCT02723864|467467159|FG006|Overall Study|Exceed treatment hold time|0|||
129865805|NCT02723864|467467153|FG000|Overall Study|Clinical progression|0|||
129865806|NCT02723864|467467154|FG001|Overall Study|Clinical progression|0|||
129865807|NCT02723864|467467155|FG002|Overall Study|Clinical progression|1|||
129915374|NCT04757610|467652964|FG000|Overall Study|Randomized in Error|1|||
129915375|NCT04757610|467652965|FG001|Overall Study|Randomized in Error|0|||
129915376|NCT04757610|467652966|FG002|Overall Study|Randomized in Error|0|||
129915377|NCT02965846|467652967|FG000|Overall Study|Lost to Follow-up|1|||
129915378|NCT02965846|467652968|FG001|Overall Study|Lost to Follow-up|0|||
129915379|NCT02965846|467652969|FG002|Overall Study|Lost to Follow-up|0|||
129915380|NCT02965846|467652967|FG000|Overall Study|Withdrawal by Subject|0|||
129915381|NCT02965846|467652968|FG001|Overall Study|Withdrawal by Subject|1|||
129915382|NCT02965846|467652969|FG002|Overall Study|Withdrawal by Subject|0|||
129915383|NCT02965846|467652967|FG000|Overall Study|Study Terminated By Sponsor|4|||
129915384|NCT02965846|467652968|FG001|Overall Study|Study Terminated By Sponsor|4|||
129915385|NCT02965846|467652969|FG002|Overall Study|Study Terminated By Sponsor|0|||
129915386|NCT02965846|467652967|FG000|Overall Study|Participants not randomized|0|||
129915387|NCT02965846|467652968|FG001|Overall Study|Participants not randomized|0|||
129915388|NCT02965846|467652969|FG002|Overall Study|Participants not randomized|33|||
129915389|NCT00879333|467652970|FG000|Overall Study|Adverse Event|94|||
129915390|NCT00879333|467652971|FG001|Overall Study|Adverse Event|34|||
129915391|NCT00879333|467652970|FG000|Overall Study|Abnormal Laboratory Value|1|||
129915392|NCT00879333|467652971|FG001|Overall Study|Abnormal Laboratory Value|0|||
129915393|NCT00879333|467652970|FG000|Overall Study|Withdrawal by Subject|20|||
130065721|NCT02921763|468194770|FG000|Overall Study|No data obtained|2|||
130065722|NCT01582971|468194771|FG000|Overall Study|Death|2|||
130065723|NCT01582971|468194772|FG001|Overall Study|Death|1|||
130065724|NCT01582971|468194771|FG000|Overall Study|Lost to Follow-up|18|||
130065725|NCT01582971|468194772|FG001|Overall Study|Lost to Follow-up|21|||
130065726|NCT01582971|468194771|FG000|Overall Study|Withdrawal by Subject|4|||
129865808|NCT02723864|467467156|FG003|Overall Study|Clinical progression|0|||
129865809|NCT02723864|467467157|FG004|Overall Study|Clinical progression|0|||
129865810|NCT02723864|467467158|FG005|Overall Study|Clinical progression|3|||
129865811|NCT02723864|467467159|FG006|Overall Study|Clinical progression|1|||
129865812|NCT02723864|467467153|FG000|Overall Study|Physician Decision|0|||
129865813|NCT02723864|467467154|FG001|Overall Study|Physician Decision|0|||
129865814|NCT02723864|467467155|FG002|Overall Study|Physician Decision|0|||
129865815|NCT02723864|467467156|FG003|Overall Study|Physician Decision|0|||
129865816|NCT02723864|467467157|FG004|Overall Study|Physician Decision|0|||
129865817|NCT02723864|467467158|FG005|Overall Study|Physician Decision|0|||
129865818|NCT02723864|467467159|FG006|Overall Study|Physician Decision|1|||
129865819|NCT02723864|467467153|FG000|Overall Study|Changes in patient condition|0|||
129865820|NCT02723864|467467154|FG001|Overall Study|Changes in patient condition|0|||
129865821|NCT02723864|467467155|FG002|Overall Study|Changes in patient condition|0|||
129865822|NCT02723864|467467156|FG003|Overall Study|Changes in patient condition|0|||
129865823|NCT02723864|467467157|FG004|Overall Study|Changes in patient condition|0|||
129865824|NCT02723864|467467158|FG005|Overall Study|Changes in patient condition|1|||
129865825|NCT02723864|467467159|FG006|Overall Study|Changes in patient condition|0|||
129865826|NCT02723864|467467153|FG000|Overall Study|Patient choice|0|||
129865827|NCT02723864|467467154|FG001|Overall Study|Patient choice|0|||
129865828|NCT02723864|467467155|FG002|Overall Study|Patient choice|0|||
129865829|NCT02723864|467467156|FG003|Overall Study|Patient choice|0|||
129865830|NCT02723864|467467157|FG004|Overall Study|Patient choice|0|||
129865831|NCT02723864|467467158|FG005|Overall Study|Patient choice|1|||
129865832|NCT02723864|467467159|FG006|Overall Study|Patient choice|0|||
129865833|NCT02723864|467467153|FG000|Overall Study|Adverse Event|0|||
129865834|NCT02723864|467467154|FG001|Overall Study|Adverse Event|0|||
129865835|NCT02723864|467467155|FG002|Overall Study|Adverse Event|0|||
129865836|NCT02723864|467467156|FG003|Overall Study|Adverse Event|0|||
129865837|NCT02723864|467467157|FG004|Overall Study|Adverse Event|0|||
129865838|NCT02723864|467467158|FG005|Overall Study|Adverse Event|1|||
129865839|NCT02723864|467467159|FG006|Overall Study|Adverse Event|0|||
129865840|NCT02723864|467467153|FG000|Overall Study|Started new treatment|0|||
129865841|NCT02723864|467467154|FG001|Overall Study|Started new treatment|0|||
129865842|NCT02723864|467467155|FG002|Overall Study|Started new treatment|0|||
129865843|NCT02723864|467467156|FG003|Overall Study|Started new treatment|0|||
129865844|NCT02723864|467467157|FG004|Overall Study|Started new treatment|0|||
129865845|NCT02723864|467467158|FG005|Overall Study|Started new treatment|1|||
129865846|NCT02723864|467467159|FG006|Overall Study|Started new treatment|0|||
129865847|NCT02723864|467467153|FG000|Overall Study|Switched to alternative treatment|0|||
129865848|NCT02723864|467467154|FG001|Overall Study|Switched to alternative treatment|0|||
129865849|NCT02723864|467467155|FG002|Overall Study|Switched to alternative treatment|0|||
129865850|NCT02723864|467467156|FG003|Overall Study|Switched to alternative treatment|0|||
129865851|NCT02723864|467467157|FG004|Overall Study|Switched to alternative treatment|0|||
129865852|NCT02723864|467467158|FG005|Overall Study|Switched to alternative treatment|1|||
129865853|NCT02723864|467467159|FG006|Overall Study|Switched to alternative treatment|0|||
129865854|NCT02723864|467467153|FG000|Overall Study|Late determination of ineligibility|0|||
129865855|NCT02723864|467467154|FG001|Overall Study|Late determination of ineligibility|0|||
129865856|NCT02723864|467467155|FG002|Overall Study|Late determination of ineligibility|0|||
129865857|NCT02723864|467467156|FG003|Overall Study|Late determination of ineligibility|0|||
129865858|NCT02723864|467467157|FG004|Overall Study|Late determination of ineligibility|0|||
129865859|NCT02723864|467467158|FG005|Overall Study|Late determination of ineligibility|1|||
129865860|NCT02723864|467467159|FG006|Overall Study|Late determination of ineligibility|0|||
130065727|NCT01582971|468194772|FG001|Overall Study|Withdrawal by Subject|2|||
129865861|NCT03232983|467467164|FG000|Period 1|Physician Decision|0|||
129865862|NCT03232983|467467165|FG001|Period 1|Physician Decision|0|||
129865863|NCT03232983|467467166|FG002|Period 1|Physician Decision|1|||
129865864|NCT03232983|467467167|FG003|Period 1|Physician Decision|0|||
129865865|NCT03232983|467467164|FG000|Washout Period 2|Physician Decision|0|||
129865866|NCT03232983|467467165|FG001|Washout Period 2|Physician Decision|0|||
129865867|NCT03232983|467467166|FG002|Washout Period 2|Physician Decision|1|||
129865868|NCT03232983|467467167|FG003|Washout Period 2|Physician Decision|0|||
129865869|NCT03232983|467467164|FG000|Washout Period 2|Withdrawal by Subject|0|||
129865870|NCT03232983|467467165|FG001|Washout Period 2|Withdrawal by Subject|0|||
129865871|NCT03232983|467467166|FG002|Washout Period 2|Withdrawal by Subject|0|||
129865872|NCT03232983|467467167|FG003|Washout Period 2|Withdrawal by Subject|1|||
129865873|NCT03232983|467467164|FG000|Period 4|Withdrawal by Subject|1|||
129865874|NCT03232983|467467165|FG001|Period 4|Withdrawal by Subject|0|||
129865875|NCT03232983|467467166|FG002|Period 4|Withdrawal by Subject|0|||
129865876|NCT03232983|467467167|FG003|Period 4|Withdrawal by Subject|0|||
129865877|NCT03643952|467467168|FG000|Overall Study|Lack of Efficacy|1|||
129865878|NCT00530855|467467172|FG000|Overall Study|Lack of Efficacy|20|||
129865879|NCT00530855|467467172|FG000|Overall Study|Withdrawal by Subject|30|||
129865880|NCT00530855|467467172|FG000|Overall Study|Fatal Serious AE|3|||
129865881|NCT00530855|467467172|FG000|Overall Study|Non Fatal Serious AE|7|||
129865882|NCT00530855|467467172|FG000|Overall Study|Non Fatal Non Serious AE|12|||
129865883|NCT00530855|467467172|FG000|Overall Study|Protocol Violation|3|||
129865884|NCT00530855|467467172|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
129865885|NCT00530855|467467172|FG000|Overall Study|Lost to Follow-up|9|||
129865886|NCT00530855|467467172|FG000|Overall Study|Other reason for premature termination|17|||
129865887|NCT00815295|467467173|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
129865888|NCT00815295|467467174|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
129865889|NCT00815295|467467175|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
129865890|NCT01292876|467467176|FG000|Overall Study|Physician Decision|4|||
129865891|NCT01627327|467467177|FG000|Overall Study|Adverse Event|6|||
129865892|NCT01627327|467467178|FG001|Overall Study|Adverse Event|12|||
129865893|NCT01627327|467467177|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
129865894|NCT01627327|467467178|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
129865895|NCT01627327|467467177|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
129865896|NCT01627327|467467178|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
129865897|NCT01627327|467467177|FG000|Overall Study|Protocol Violation|4|||
129865898|NCT01627327|467467178|FG001|Overall Study|Protocol Violation|10|||
129865899|NCT01627327|467467177|FG000|Overall Study|Lost to Follow-up|1|||
129865900|NCT01627327|467467178|FG001|Overall Study|Lost to Follow-up|3|||
129865901|NCT01627327|467467177|FG000|Overall Study|Physician Decision|1|||
129865902|NCT01627327|467467178|FG001|Overall Study|Physician Decision|0|||
129865903|NCT01627327|467467177|FG000|Overall Study|Withdrawal by Subject|3|||
129865904|NCT01627327|467467178|FG001|Overall Study|Withdrawal by Subject|3|||
129865905|NCT04528069|467467184|FG000|Overall Study|Adverse Event|1|||
129865906|NCT04528069|467467184|FG000|Overall Study|Lost to Follow-up|1|||
129865907|NCT04528069|467467184|FG000|Overall Study|Patient Unable to Come|1|||
129865908|NCT04528069|467467184|FG000|Overall Study|Patient Unable to Attend|1|||
129865909|NCT02525874|467467187|FG000|Overall Study|Other|1|||
129865910|NCT02525874|467467187|FG000|Overall Study|Investigator Decision|1|||
129865911|NCT02525874|467467187|FG000|Overall Study|Consent withdrawn|22|||
129865912|NCT02525874|467467187|FG000|Overall Study|Non-compliance with study drug|3|||
129865913|NCT02525874|467467187|FG000|Overall Study|Adverse Event|17|||
129865914|NCT02525874|467467187|FG000|Overall Study|Lost to Follow-up|7|||
129865915|NCT02525874|467467187|FG000|Overall Study|Disease progression, defined by protocol|2|||
129865916|NCT02525874|467467187|FG000|Overall Study|Disease relapse|4|||
129865917|NCT02525874|467467187|FG000|Overall Study|Alternative Treatment for MS|2|||
129865918|NCT02525874|467467187|FG000|Overall Study|New lesions in Brain|1|||
129865919|NCT04124926|467467202|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
129865920|NCT04124926|467467203|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
129865921|NCT04124926|467467204|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
129865922|NCT04124926|467467205|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
129865923|NCT04124926|467467206|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
129865924|NCT04124926|467467202|FG000|Healing Phase|Protocol Violation|0|||
129865925|NCT04124926|467467203|FG001|Healing Phase|Protocol Violation|1|||
129865926|NCT04124926|467467204|FG002|Healing Phase|Protocol Violation|0|||
129865927|NCT04124926|467467205|FG003|Healing Phase|Protocol Violation|0|||
129865928|NCT04124926|467467206|FG004|Healing Phase|Protocol Violation|0|||
129865929|NCT04124926|467467202|FG000|Healing Phase|Lost to Follow-up|5|||
129865930|NCT04124926|467467203|FG001|Healing Phase|Lost to Follow-up|4|||
129865931|NCT04124926|467467204|FG002|Healing Phase|Lost to Follow-up|0|||
129865932|NCT04124926|467467205|FG003|Healing Phase|Lost to Follow-up|0|||
129865933|NCT04124926|467467206|FG004|Healing Phase|Lost to Follow-up|0|||
129865934|NCT04124926|467467202|FG000|Healing Phase|Voluntary Withdrawal|10|||
130065728|NCT01582971|468194771|FG000|Overall Study|Other|15|||
130065729|NCT01582971|468194772|FG001|Overall Study|Other|13|||
130065730|NCT02554253|468194780|FG000|Overall Study|ineligible after enrollment|1|||
130065731|NCT02554253|468194781|FG001|Overall Study|ineligible after enrollment|0|||
129865935|NCT04124926|467467203|FG001|Healing Phase|Voluntary Withdrawal|7|||
129865936|NCT04124926|467467204|FG002|Healing Phase|Voluntary Withdrawal|0|||
129865937|NCT04124926|467467205|FG003|Healing Phase|Voluntary Withdrawal|0|||
129865938|NCT04124926|467467206|FG004|Healing Phase|Voluntary Withdrawal|0|||
129865939|NCT04124926|467467202|FG000|Healing Phase|Withdrawal of Consent|5|||
129865940|NCT04124926|467467203|FG001|Healing Phase|Withdrawal of Consent|3|||
129865941|NCT04124926|467467204|FG002|Healing Phase|Withdrawal of Consent|0|||
129865942|NCT04124926|467467205|FG003|Healing Phase|Withdrawal of Consent|0|||
129865943|NCT04124926|467467206|FG004|Healing Phase|Withdrawal of Consent|0|||
129865944|NCT04124926|467467202|FG000|Healing Phase|Miscellaneous|8|||
129865945|NCT04124926|467467203|FG001|Healing Phase|Miscellaneous|7|||
129865946|NCT04124926|467467204|FG002|Healing Phase|Miscellaneous|0|||
129865947|NCT04124926|467467205|FG003|Healing Phase|Miscellaneous|0|||
129865948|NCT04124926|467467206|FG004|Healing Phase|Miscellaneous|0|||
129865949|NCT04124926|467467202|FG000|Healing Phase|Randomized but not Treated|0|||
129865950|NCT04124926|467467203|FG001|Healing Phase|Randomized but not Treated|3|||
129865951|NCT04124926|467467204|FG002|Healing Phase|Randomized but not Treated|0|||
129865952|NCT04124926|467467205|FG003|Healing Phase|Randomized but not Treated|0|||
129865953|NCT04124926|467467206|FG004|Healing Phase|Randomized but not Treated|0|||
129865954|NCT04124926|467467202|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
129865955|NCT04124926|467467203|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
129865956|NCT04124926|467467204|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
129865957|NCT04124926|467467205|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
129865958|NCT04124926|467467206|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
129865959|NCT04124926|467467202|FG000|Maintenance Phase|Protocol Violation|0|||
129865960|NCT04124926|467467203|FG001|Maintenance Phase|Protocol Violation|0|||
129865961|NCT04124926|467467204|FG002|Maintenance Phase|Protocol Violation|3|||
129865962|NCT04124926|467467205|FG003|Maintenance Phase|Protocol Violation|0|||
129865963|NCT04124926|467467206|FG004|Maintenance Phase|Protocol Violation|0|||
129865964|NCT04124926|467467202|FG000|Maintenance Phase|Lost to Follow-up|0|||
129865965|NCT04124926|467467203|FG001|Maintenance Phase|Lost to Follow-up|0|||
129865966|NCT04124926|467467204|FG002|Maintenance Phase|Lost to Follow-up|7|||
129865967|NCT04124926|467467205|FG003|Maintenance Phase|Lost to Follow-up|8|||
129865968|NCT04124926|467467206|FG004|Maintenance Phase|Lost to Follow-up|9|||
129865969|NCT04124926|467467202|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
129865970|NCT04124926|467467203|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
129865971|NCT04124926|467467204|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
129865972|NCT04124926|467467205|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
129865973|NCT04124926|467467206|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
129865974|NCT04124926|467467202|FG000|Maintenance Phase|Pregnancy|0|||
129865975|NCT04124926|467467203|FG001|Maintenance Phase|Pregnancy|0|||
129865976|NCT04124926|467467204|FG002|Maintenance Phase|Pregnancy|0|||
129865977|NCT04124926|467467205|FG003|Maintenance Phase|Pregnancy|1|||
129865978|NCT04124926|467467206|FG004|Maintenance Phase|Pregnancy|0|||
129865979|NCT04124926|467467202|FG000|Maintenance Phase|Lack of Efficacy|0|||
129865980|NCT04124926|467467203|FG001|Maintenance Phase|Lack of Efficacy|0|||
129865981|NCT04124926|467467204|FG002|Maintenance Phase|Lack of Efficacy|0|||
129865982|NCT04124926|467467205|FG003|Maintenance Phase|Lack of Efficacy|0|||
129865983|NCT04124926|467467206|FG004|Maintenance Phase|Lack of Efficacy|1|||
129865984|NCT04124926|467467202|FG000|Maintenance Phase|Withdrawal of Consent|0|||
129865985|NCT04124926|467467203|FG001|Maintenance Phase|Withdrawal of Consent|0|||
129865986|NCT04124926|467467204|FG002|Maintenance Phase|Withdrawal of Consent|5|||
129865987|NCT04124926|467467205|FG003|Maintenance Phase|Withdrawal of Consent|5|||
129865988|NCT04124926|467467206|FG004|Maintenance Phase|Withdrawal of Consent|5|||
129865989|NCT04124926|467467202|FG000|Maintenance Phase|Miscellaneous|0|||
129865990|NCT04124926|467467203|FG001|Maintenance Phase|Miscellaneous|0|||
129865991|NCT04124926|467467204|FG002|Maintenance Phase|Miscellaneous|1|||
129865992|NCT04124926|467467205|FG003|Maintenance Phase|Miscellaneous|2|||
129865993|NCT04124926|467467206|FG004|Maintenance Phase|Miscellaneous|4|||
129865994|NCT04124926|467467202|FG000|Maintenance Phase|Randomized but not Treated|0|||
129865995|NCT04124926|467467203|FG001|Maintenance Phase|Randomized but not Treated|0|||
129865996|NCT04124926|467467204|FG002|Maintenance Phase|Randomized but not Treated|2|||
129865997|NCT04124926|467467205|FG003|Maintenance Phase|Randomized but not Treated|2|||
129865998|NCT04124926|467467206|FG004|Maintenance Phase|Randomized but not Treated|0|||
129865999|NCT00423176|467467207|FG000|Overall Study|Adverse Event|4|||
129866000|NCT00423176|467467208|FG001|Overall Study|Adverse Event|6|||
129866001|NCT00423176|467467207|FG000|Overall Study|Treatment Failure|1|||
129866002|NCT00423176|467467208|FG001|Overall Study|Treatment Failure|6|||
129866003|NCT00423176|467467207|FG000|Overall Study|Lost to Follow-up|4|||
129866004|NCT00423176|467467208|FG001|Overall Study|Lost to Follow-up|7|||
129866005|NCT00423176|467467207|FG000|Overall Study|Withdrawal by Subject|4|||
129866006|NCT00423176|467467208|FG001|Overall Study|Withdrawal by Subject|3|||
129866007|NCT00423176|467467207|FG000|Overall Study|Protocol Violation|1|||
129866008|NCT00423176|467467208|FG001|Overall Study|Protocol Violation|3|||
129866009|NCT00423176|467467207|FG000|Overall Study|Did not meet protocol eligibility|2|||
129866010|NCT00423176|467467208|FG001|Overall Study|Did not meet protocol eligibility|4|||
129866011|NCT04867369|467467211|FG000|Overall Study|Withdrawal by Subject|1|||
129866012|NCT04867369|467467212|FG001|Overall Study|Withdrawal by Subject|0|||
129866013|NCT05554237|467467213|FG000|Part 2 (7 Days)|Adverse Event|0|||
129866014|NCT05554237|467467214|FG001|Part 2 (7 Days)|Adverse Event|0|||
129866015|NCT05554237|467467215|FG002|Part 2 (7 Days)|Adverse Event|0|||
129866016|NCT05554237|467467216|FG003|Part 2 (7 Days)|Adverse Event|0|||
129866017|NCT05554237|467467217|FG004|Part 2 (7 Days)|Adverse Event|2|||
129866018|NCT05554237|467467218|FG005|Part 2 (7 Days)|Adverse Event|0|||
129866019|NCT05554237|467467219|FG006|Part 2 (7 Days)|Adverse Event|0|||
129866020|NCT05554237|467467220|FG007|Part 2 (7 Days)|Adverse Event|0|||
129866021|NCT05554237|467467221|FG008|Part 2 (7 Days)|Adverse Event|0|||
129866022|NCT05554237|467467222|FG009|Part 2 (7 Days)|Adverse Event|1|||
129866023|NCT05554237|467467223|FG010|Part 2 (7 Days)|Adverse Event|0|||
129866024|NCT05554237|467467224|FG011|Part 2 (7 Days)|Adverse Event|0|||
129866025|NCT05554237|467467225|FG012|Part 2 (7 Days)|Adverse Event|1|||
129866026|NCT05554237|467467226|FG013|Part 2 (7 Days)|Adverse Event|0|||
129866027|NCT04435366|467467227|FG000|Year 1 (12 Months)|Adverse Event|3|||
129866028|NCT04435366|467467228|FG001|Year 1 (12 Months)|Adverse Event|0|||
129866029|NCT04435366|467467229|FG002|Year 1 (12 Months)|Adverse Event|2|||
129866030|NCT04435366|467467227|FG000|Year 1 (12 Months)|Death|2|||
129866031|NCT04435366|467467228|FG001|Year 1 (12 Months)|Death|0|||
129866032|NCT04435366|467467229|FG002|Year 1 (12 Months)|Death|1|||
129866033|NCT04435366|467467227|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
129866034|NCT04435366|467467228|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
129866035|NCT04435366|467467229|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
129866036|NCT04435366|467467227|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
129866037|NCT04435366|467467228|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
129866038|NCT04435366|467467229|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
129866039|NCT04435366|467467227|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
129866040|NCT04435366|467467228|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
129866041|NCT04435366|467467229|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
129866042|NCT04435366|467467227|FG000|Year 1 (12 Months)|Not treated|0|||
129866043|NCT04435366|467467228|FG001|Year 1 (12 Months)|Not treated|0|||
129866044|NCT04435366|467467229|FG002|Year 1 (12 Months)|Not treated|1|||
129866045|NCT04435366|467467227|FG000|Year 2 (12 Months)|Death|1|||
129866046|NCT04435366|467467228|FG001|Year 2 (12 Months)|Death|4|||
129866047|NCT04435366|467467229|FG002|Year 2 (12 Months)|Death|6|||
129866048|NCT04435366|467467227|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
129866049|NCT04435366|467467228|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
129866050|NCT04435366|467467229|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
129866051|NCT04435366|467467227|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
129866052|NCT04435366|467467228|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
129866053|NCT04435366|467467229|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
129866054|NCT04435366|467467227|FG000|Year 2 (12 Months)|Adverse Event|2|||
129866055|NCT04435366|467467228|FG001|Year 2 (12 Months)|Adverse Event|1|||
129866056|NCT04435366|467467229|FG002|Year 2 (12 Months)|Adverse Event|6|||
129866057|NCT03492281|467467233|FG000|Overall Study|Withdrawal by Subject|21|||
129866058|NCT03492281|467467234|FG001|Overall Study|Withdrawal by Subject|14|||
129866059|NCT03492281|467467235|FG002|Overall Study|Withdrawal by Subject|13|||
129866060|NCT03492281|467467233|FG000|Overall Study|Lost to Follow-up|14|||
129866061|NCT03492281|467467234|FG001|Overall Study|Lost to Follow-up|15|||
129866062|NCT03492281|467467235|FG002|Overall Study|Lost to Follow-up|10|||
129866063|NCT03492281|467467233|FG000|Overall Study|Adverse Event|6|||
129866064|NCT03492281|467467234|FG001|Overall Study|Adverse Event|8|||
129866065|NCT03492281|467467235|FG002|Overall Study|Adverse Event|13|||
129866066|NCT03492281|467467233|FG000|Overall Study|Lack of Efficacy|3|||
129866067|NCT03492281|467467234|FG001|Overall Study|Lack of Efficacy|0|||
129866068|NCT03492281|467467235|FG002|Overall Study|Lack of Efficacy|1|||
129866069|NCT03492281|467467233|FG000|Overall Study|Physician Decision|1|||
129866070|NCT03492281|467467234|FG001|Overall Study|Physician Decision|0|||
129866071|NCT03492281|467467235|FG002|Overall Study|Physician Decision|3|||
129866072|NCT03492281|467467233|FG000|Overall Study|Protocol Violation|0|||
129866073|NCT03492281|467467234|FG001|Overall Study|Protocol Violation|2|||
129866074|NCT03492281|467467235|FG002|Overall Study|Protocol Violation|1|||
129866075|NCT03492281|467467233|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
129866076|NCT03492281|467467234|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
129866077|NCT03492281|467467235|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
129866078|NCT03492281|467467233|FG000|Overall Study|Death|0|||
129866079|NCT03492281|467467234|FG001|Overall Study|Death|0|||
129866080|NCT03492281|467467235|FG002|Overall Study|Death|1|||
129866081|NCT03492281|467467233|FG000|Overall Study|Captured as Other in Database|8|||
129866082|NCT03492281|467467234|FG001|Overall Study|Captured as Other in Database|6|||
129866083|NCT03492281|467467235|FG002|Overall Study|Captured as Other in Database|3|||
129866084|NCT04575467|467467236|FG000|Overall Study|Adverse Event|0|||
129866085|NCT04575467|467467237|FG001|Overall Study|Adverse Event|1|||
129866086|NCT04575467|467467238|FG002|Overall Study|Adverse Event|0|||
130065732|NCT02554253|468194780|FG000|Overall Study|converted to transcatheter procedure|0|||
129866087|NCT04575467|467467239|FG003|Overall Study|Adverse Event|0|||
129866088|NCT01483924|467467240|FG000|Overall Study|Withdrawal by Subject|2|||
129866089|NCT01483924|467467241|FG001|Overall Study|Withdrawal by Subject|0|||
129866090|NCT01483924|467467242|FG002|Overall Study|Withdrawal by Subject|0|||
129866091|NCT01483924|467467243|FG003|Overall Study|Withdrawal by Subject|1|||
129866092|NCT01483924|467467244|FG004|Overall Study|Withdrawal by Subject|1|||
129866093|NCT01483924|467467240|FG000|Overall Study|Adverse Event|0|||
129866094|NCT01483924|467467241|FG001|Overall Study|Adverse Event|0|||
129866095|NCT01483924|467467242|FG002|Overall Study|Adverse Event|1|||
129866096|NCT01483924|467467243|FG003|Overall Study|Adverse Event|1|||
129866097|NCT01483924|467467244|FG004|Overall Study|Adverse Event|0|||
129866098|NCT01483924|467467240|FG000|Overall Study|Non-compliance|0|||
129866099|NCT01483924|467467241|FG001|Overall Study|Non-compliance|0|||
129866100|NCT01483924|467467242|FG002|Overall Study|Non-compliance|0|||
129866101|NCT01483924|467467243|FG003|Overall Study|Non-compliance|1|||
129866102|NCT01483924|467467244|FG004|Overall Study|Non-compliance|1|||
129866103|NCT01483924|467467240|FG000|Overall Study|Sponsor concern over ECG result|0|||
129866104|NCT01483924|467467241|FG001|Overall Study|Sponsor concern over ECG result|0|||
129866105|NCT01483924|467467242|FG002|Overall Study|Sponsor concern over ECG result|0|||
129866106|NCT01483924|467467243|FG003|Overall Study|Sponsor concern over ECG result|1|||
129866107|NCT01483924|467467244|FG004|Overall Study|Sponsor concern over ECG result|0|||
129866108|NCT03565887|467467250|FG000|Overall Study|Adverse Event|1|||
129866109|NCT03565887|467467251|FG001|Overall Study|Adverse Event|0|||
129866110|NCT03565887|467467250|FG000|Overall Study|Withdrawal by Subject|0|||
129866111|NCT03565887|467467251|FG001|Overall Study|Withdrawal by Subject|2|||
129866112|NCT00449176|467467253|FG000|Overall Study|Withdrawal by Subject|39|||
129866113|NCT00449176|467467254|FG001|Overall Study|Withdrawal by Subject|43|||
129866114|NCT00449176|467467255|FG002|Overall Study|Withdrawal by Subject|59|||
129866115|NCT00449176|467467253|FG000|Overall Study|Lost to Follow-up|13|||
129866116|NCT00449176|467467254|FG001|Overall Study|Lost to Follow-up|8|||
129866117|NCT00449176|467467255|FG002|Overall Study|Lost to Follow-up|12|||
129866118|NCT00449176|467467253|FG000|Overall Study|Adverse Event|51|||
129866119|NCT00449176|467467254|FG001|Overall Study|Adverse Event|107|||
129866120|NCT00449176|467467255|FG002|Overall Study|Adverse Event|15|||
129866121|NCT00449176|467467253|FG000|Overall Study|Lack of Efficacy|13|||
129866122|NCT00449176|467467254|FG001|Overall Study|Lack of Efficacy|7|||
129866123|NCT00449176|467467255|FG002|Overall Study|Lack of Efficacy|50|||
129866124|NCT00449176|467467253|FG000|Overall Study|Study drug non-compliant|14|||
129866125|NCT00449176|467467254|FG001|Overall Study|Study drug non-compliant|11|||
129866126|NCT00449176|467467255|FG002|Overall Study|Study drug non-compliant|11|||
129866127|NCT00449176|467467253|FG000|Overall Study|all other|22|||
129866128|NCT00449176|467467254|FG001|Overall Study|all other|19|||
129866129|NCT00449176|467467255|FG002|Overall Study|all other|20|||
129866130|NCT00295022|467467259|FG000|Overall Study|Adverse Event|1|||
129866131|NCT00295022|467467260|FG001|Overall Study|Adverse Event|1|||
129866132|NCT00295022|467467261|FG002|Overall Study|Adverse Event|2|||
129866133|NCT00295022|467467259|FG000|Overall Study|Lost to Follow-up|0|||
129866134|NCT00295022|467467260|FG001|Overall Study|Lost to Follow-up|0|||
129866135|NCT00295022|467467261|FG002|Overall Study|Lost to Follow-up|1|||
129866136|NCT00295022|467467259|FG000|Overall Study|Withdrawal by Subject|0|||
129866137|NCT00295022|467467260|FG001|Overall Study|Withdrawal by Subject|0|||
129866138|NCT00295022|467467261|FG002|Overall Study|Withdrawal by Subject|2|||
129866139|NCT00734630|467467262|FG000|Overall Study|Lack of Efficacy|4|||
129866140|NCT00734630|467467263|FG001|Overall Study|Lack of Efficacy|4|||
129866141|NCT00734630|467467262|FG000|Overall Study|Withdrawal by Subject|7|||
129866142|NCT00734630|467467263|FG001|Overall Study|Withdrawal by Subject|9|||
129866143|NCT00734630|467467262|FG000|Overall Study|Lost to Follow-up|13|||
129866144|NCT00734630|467467263|FG001|Overall Study|Lost to Follow-up|7|||
129866145|NCT00734630|467467262|FG000|Overall Study|Protocol Violation|0|||
129866146|NCT00734630|467467263|FG001|Overall Study|Protocol Violation|3|||
129866147|NCT00734630|467467262|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129866148|NCT00734630|467467263|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
129866149|NCT00734630|467467262|FG000|Overall Study|Adverse Event|3|||
130065733|NCT02554253|468194781|FG001|Overall Study|converted to transcatheter procedure|1|||
130065734|NCT02554253|468194780|FG000|Overall Study|received both drugs|0|||
129866150|NCT00734630|467467263|FG001|Overall Study|Adverse Event|6|||
129866151|NCT00734630|467467262|FG000|Overall Study|Randomized in Error|0|||
129866152|NCT00734630|467467263|FG001|Overall Study|Randomized in Error|1|||
129866153|NCT00734630|467467262|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
129866154|NCT00734630|467467263|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
129866155|NCT00734630|467467262|FG000|Overall Study|Poor Compliance|1|||
129866156|NCT00734630|467467263|FG001|Overall Study|Poor Compliance|1|||
129866157|NCT02300220|467467270|FG000|Overall Study|Lost to Follow-up|1|||
129866158|NCT02300220|467467271|FG001|Overall Study|Lost to Follow-up|2|||
129866159|NCT02300220|467467270|FG000|Overall Study|Death|1|||
129866160|NCT02300220|467467271|FG001|Overall Study|Death|1|||
129866161|NCT02300220|467467270|FG000|Overall Study|Adverse Event|1|||
129915394|NCT00879333|467652971|FG001|Overall Study|Withdrawal by Subject|7|||
129915395|NCT00879333|467652970|FG000|Overall Study|Lost to Follow-up|2|||
129915396|NCT00879333|467652971|FG001|Overall Study|Lost to Follow-up|1|||
129915397|NCT00879333|467652970|FG000|Overall Study|Administrative Problems|2|||
129915398|NCT00879333|467652971|FG001|Overall Study|Administrative Problems|0|||
129915399|NCT00879333|467652970|FG000|Overall Study|Death|16|||
129915400|NCT00879333|467652971|FG001|Overall Study|Death|5|||
129915401|NCT00879333|467652970|FG000|Overall Study|Disease Progression|292|||
129915402|NCT00879333|467652971|FG001|Overall Study|Disease Progression|169|||
129915403|NCT00879333|467652970|FG000|Overall Study|Protocol Violation|1|||
129915404|NCT00879333|467652971|FG001|Overall Study|Protocol Violation|1|||
129915405|NCT04154384|467652972|FG000|Overall Study|Lost to Follow-up|24|||
129915406|NCT04154384|467652973|FG001|Overall Study|Lost to Follow-up|33|||
129915407|NCT04154384|467652974|FG002|Overall Study|Lost to Follow-up|0|||
129915408|NCT04154384|467652972|FG000|Overall Study|Withdrawal by Subject|7|||
129915409|NCT04154384|467652973|FG001|Overall Study|Withdrawal by Subject|18|||
129915410|NCT04154384|467652974|FG002|Overall Study|Withdrawal by Subject|0|||
129915411|NCT04154384|467652972|FG000|Overall Study|Missing outcome data|1|||
129915412|NCT04154384|467652973|FG001|Overall Study|Missing outcome data|0|||
129915413|NCT04154384|467652974|FG002|Overall Study|Missing outcome data|0|||
129915414|NCT05048186|467652975|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
129915415|NCT05048186|467652976|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
129915416|NCT05048186|467652975|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
129915417|NCT05048186|467652976|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
129915418|NCT00951379|467652977|FG000|Overall Study|Adverse Event|4|||
129915419|NCT00951379|467652978|FG001|Overall Study|Adverse Event|1|||
129915420|NCT00951379|467652977|FG000|Overall Study|Withdrawal by Subject|1|||
129915421|NCT00951379|467652978|FG001|Overall Study|Withdrawal by Subject|0|||
129915422|NCT00951379|467652977|FG000|Overall Study|Noncompliance|1|||
129915423|NCT00951379|467652978|FG001|Overall Study|Noncompliance|0|||
129915424|NCT00951379|467652977|FG000|Overall Study|Disease Progression|0|||
129915425|NCT00951379|467652978|FG001|Overall Study|Disease Progression|1|||
129915426|NCT04218266|467652979|FG000|Overall Study|Death|1|||
129915427|NCT04218266|467652980|FG001|Overall Study|Death|2|||
129915428|NCT04218266|467652981|FG002|Overall Study|Death|3|||
129915429|NCT04218266|467652979|FG000|Overall Study|Adverse Event|13|||
129915430|NCT04218266|467652980|FG001|Overall Study|Adverse Event|14|||
129915431|NCT04218266|467652981|FG002|Overall Study|Adverse Event|11|||
129915432|NCT04218266|467652979|FG000|Overall Study|Other|7|||
129915433|NCT04218266|467652980|FG001|Overall Study|Other|5|||
129915434|NCT04218266|467652981|FG002|Overall Study|Other|14|||
129915435|NCT04218266|467652979|FG000|Overall Study|Physician Decision|1|||
129915436|NCT04218266|467652980|FG001|Overall Study|Physician Decision|3|||
129915437|NCT04218266|467652981|FG002|Overall Study|Physician Decision|2|||
129915438|NCT04218266|467652979|FG000|Overall Study|Non-compliance with study drug|0|||
129915439|NCT04218266|467652980|FG001|Overall Study|Non-compliance with study drug|0|||
129915440|NCT04218266|467652981|FG002|Overall Study|Non-compliance with study drug|1|||
129915441|NCT04218266|467652979|FG000|Overall Study|Withdrawal by Subject|1|||
129915442|NCT04218266|467652980|FG001|Overall Study|Withdrawal by Subject|3|||
129915443|NCT04218266|467652981|FG002|Overall Study|Withdrawal by Subject|1|||
129915444|NCT04218266|467652979|FG000|Overall Study|Study drug never administered|2|||
129915445|NCT04218266|467652980|FG001|Overall Study|Study drug never administered|0|||
129915446|NCT04218266|467652981|FG002|Overall Study|Study drug never administered|0|||
129915447|NCT01494922|467652983|FG000|Overall Study|Adverse Event|1|||
129915448|NCT02891915|467652984|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
129915449|NCT02891915|467652985|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
129915450|NCT02891915|467652984|FG000|Overall Study|Withdrawal by Subject|3|||
129915451|NCT02891915|467652985|FG001|Overall Study|Withdrawal by Subject|3|||
129915452|NCT02891915|467652984|FG000|Overall Study|Became Ineligible After Enrollment|2|||
129915453|NCT02891915|467652985|FG001|Overall Study|Became Ineligible After Enrollment|1|||
129915454|NCT02891915|467652984|FG000|Overall Study|Lost to Follow-up|1|||
129915455|NCT02891915|467652985|FG001|Overall Study|Lost to Follow-up|4|||
129915456|NCT02891915|467652984|FG000|Overall Study|Physician Decision|1|||
129915457|NCT02891915|467652985|FG001|Overall Study|Physician Decision|0|||
129915458|NCT01091168|467652986|FG000|Overall Study|Progressive disease|250|||
129915459|NCT01091168|467652987|FG001|Overall Study|Progressive disease|234|||
129915460|NCT01091168|467652986|FG000|Overall Study|Adverse Event|21|||
129915461|NCT01091168|467652987|FG001|Overall Study|Adverse Event|24|||
129915462|NCT01091168|467652986|FG000|Overall Study|Lost to Follow-up|0|||
129915463|NCT01091168|467652987|FG001|Overall Study|Lost to Follow-up|1|||
129915464|NCT01091168|467652986|FG000|Overall Study|Physician, patient's decision, other|27|||
129915465|NCT01091168|467652987|FG001|Overall Study|Physician, patient's decision, other|37|||
129915466|NCT04567615|467652990|FG000|Randomization|Participant withdrew consent|1|||
130065735|NCT02554253|468194781|FG001|Overall Study|received both drugs|1|||
130065736|NCT01736254|468194784|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
130065737|NCT01736254|468194784|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
129915467|NCT04567615|467652991|FG001|Randomization|Participant withdrew consent|0|||
129915468|NCT04567615|467652992|FG002|Randomization|Participant withdrew consent|0|||
129915469|NCT04567615|467652990|FG000|Randomization|Adverse event unrelated to study drug|0|||
129915470|NCT04567615|467652991|FG001|Randomization|Adverse event unrelated to study drug|1|||
129915471|NCT04567615|467652992|FG002|Randomization|Adverse event unrelated to study drug|0|||
129915472|NCT04567615|467652990|FG000|Treatment Period|Participant Withdrew Consent|2|||
129915473|NCT04567615|467652991|FG001|Treatment Period|Participant Withdrew Consent|5|||
129915474|NCT04567615|467652992|FG002|Treatment Period|Participant Withdrew Consent|1|||
129915475|NCT04567615|467652990|FG000|Treatment Period|Death|1|||
129915476|NCT04567615|467652991|FG001|Treatment Period|Death|2|||
129915477|NCT04567615|467652992|FG002|Treatment Period|Death|0|||
129915478|NCT04567615|467652990|FG000|Treatment Period|Lost to Follow-up|0|||
129915479|NCT04567615|467652991|FG001|Treatment Period|Lost to Follow-up|1|||
129915480|NCT04567615|467652992|FG002|Treatment Period|Lost to Follow-up|0|||
129915481|NCT04567615|467652990|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
129915482|NCT04567615|467652991|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
130065738|NCT02559206|468194785|FG000|Overall Study|Adverse Event|0|||
130065739|NCT02559206|468194786|FG001|Overall Study|Adverse Event|4|||
130065740|NCT02559206|468194787|FG002|Overall Study|Adverse Event|1|||
130065741|NCT02559206|468194788|FG003|Overall Study|Adverse Event|5|||
130065742|NCT02559206|468194789|FG004|Overall Study|Adverse Event|3|||
130065743|NCT02559206|468194790|FG005|Overall Study|Adverse Event|0|||
130065744|NCT02559206|468194791|FG006|Overall Study|Adverse Event|1|||
130065745|NCT02559206|468194792|FG007|Overall Study|Adverse Event|0|||
130065746|NCT02559206|468194785|FG000|Overall Study|Protocol Violation|1|||
130065747|NCT02559206|468194786|FG001|Overall Study|Protocol Violation|0|||
130065748|NCT02559206|468194787|FG002|Overall Study|Protocol Violation|1|||
130065749|NCT02559206|468194788|FG003|Overall Study|Protocol Violation|0|||
130065750|NCT02559206|468194789|FG004|Overall Study|Protocol Violation|0|||
130065751|NCT02559206|468194790|FG005|Overall Study|Protocol Violation|2|||
130065752|NCT02559206|468194791|FG006|Overall Study|Protocol Violation|0|||
130065753|NCT02559206|468194792|FG007|Overall Study|Protocol Violation|0|||
130065754|NCT02559206|468194785|FG000|Overall Study|Withdrawal by Subject|3|||
130065755|NCT02559206|468194786|FG001|Overall Study|Withdrawal by Subject|3|||
130065756|NCT02559206|468194787|FG002|Overall Study|Withdrawal by Subject|1|||
130065757|NCT02559206|468194788|FG003|Overall Study|Withdrawal by Subject|3|||
129866162|NCT02300220|467467271|FG001|Overall Study|Adverse Event|1|||
129866163|NCT02300220|467467270|FG000|Overall Study|Protocol Violation|1|||
129866164|NCT02300220|467467271|FG001|Overall Study|Protocol Violation|0|||
129866165|NCT02300220|467467270|FG000|Overall Study|Withdrawal by Subject|0|||
129866166|NCT02300220|467467271|FG001|Overall Study|Withdrawal by Subject|2|||
129866167|NCT02300220|467467270|FG000|Overall Study|Did not tolerate IMP|0|||
129866168|NCT02300220|467467271|FG001|Overall Study|Did not tolerate IMP|1|||
129866169|NCT01441102|467467273|FG000|Overall Study|Adverse Event|1|||
129866170|NCT01441102|467467273|FG000|Overall Study|Withdrawal by Subject|2|||
129866171|NCT03085485|467467274|FG000|Overall Study|Death|1|||
129866172|NCT03085485|467467275|FG001|Overall Study|Death|0|||
129866173|NCT03085485|467467274|FG000|Overall Study|Lost to Follow-up|1|||
129866174|NCT03085485|467467275|FG001|Overall Study|Lost to Follow-up|0|||
129866175|NCT02291614|467467278|FG000|Overall Study|Lost to Follow-up|0|||
129866176|NCT02291614|467467279|FG001|Overall Study|Lost to Follow-up|0|||
129866177|NCT02291614|467467280|FG002|Overall Study|Lost to Follow-up|0|||
129866178|NCT02291614|467467281|FG003|Overall Study|Lost to Follow-up|0|||
129866179|NCT02291614|467467282|FG004|Overall Study|Lost to Follow-up|0|||
129866180|NCT02291614|467467283|FG005|Overall Study|Lost to Follow-up|0|||
129866181|NCT02291614|467467284|FG006|Overall Study|Lost to Follow-up|0|||
129866182|NCT02291614|467467285|FG007|Overall Study|Lost to Follow-up|1|||
129866183|NCT02291614|467467286|FG008|Overall Study|Lost to Follow-up|0|||
129915483|NCT04567615|467652992|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
129915484|NCT04567615|467652990|FG000|Treatment Period|Disease Progression|85|||
129915485|NCT04567615|467652991|FG001|Treatment Period|Disease Progression|63|||
129915486|NCT04567615|467652992|FG002|Treatment Period|Disease Progression|16|||
129915487|NCT04567615|467652990|FG000|Treatment Period|Study Drug Toxicity|3|||
129915488|NCT04567615|467652991|FG001|Treatment Period|Study Drug Toxicity|10|||
129915489|NCT04567615|467652992|FG002|Treatment Period|Study Drug Toxicity|4|||
129915490|NCT04567615|467652990|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
130065758|NCT02559206|468194789|FG004|Overall Study|Withdrawal by Subject|5|||
130065759|NCT02559206|468194790|FG005|Overall Study|Withdrawal by Subject|4|||
130065760|NCT02559206|468194791|FG006|Overall Study|Withdrawal by Subject|1|||
130065761|NCT02559206|468194792|FG007|Overall Study|Withdrawal by Subject|2|||
130065762|NCT02559206|468194785|FG000|Overall Study|Lost to Follow-up|3|||
130065763|NCT02559206|468194786|FG001|Overall Study|Lost to Follow-up|5|||
129866184|NCT02291614|467467287|FG009|Overall Study|Lost to Follow-up|0|||
129866185|NCT02291614|467467288|FG010|Overall Study|Lost to Follow-up|0|||
129866186|NCT02291614|467467278|FG000|Overall Study|Withdrawal by Subject|0|||
129866187|NCT02291614|467467279|FG001|Overall Study|Withdrawal by Subject|1|||
130065764|NCT02559206|468194787|FG002|Overall Study|Lost to Follow-up|3|||
129915491|NCT04567615|467652991|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
129915492|NCT04567615|467652992|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
129915493|NCT04567615|467652990|FG000|Treatment Period|Other Reasons|1|||
129915494|NCT04567615|467652991|FG001|Treatment Period|Other Reasons|2|||
129915495|NCT04567615|467652992|FG002|Treatment Period|Other Reasons|0|||
129915496|NCT04567615|467652990|FG000|Treatment Period|Still On-going Treatment|21|||
129915497|NCT04567615|467652991|FG001|Treatment Period|Still On-going Treatment|22|||
129915498|NCT04567615|467652992|FG002|Treatment Period|Still On-going Treatment|2|||
129915499|NCT04059354|467654368|FG000|Overall Study|COVID-19 pandemic|3|||
129915500|NCT05403801|467654369|FG000|Overall Study|Withdrawal by Subject|2|||
130065765|NCT02559206|468194788|FG003|Overall Study|Lost to Follow-up|3|||
129866188|NCT02291614|467467280|FG002|Overall Study|Withdrawal by Subject|0|||
129866189|NCT02291614|467467281|FG003|Overall Study|Withdrawal by Subject|0|||
129866190|NCT02291614|467467282|FG004|Overall Study|Withdrawal by Subject|0|||
129866191|NCT02291614|467467283|FG005|Overall Study|Withdrawal by Subject|0|||
129866192|NCT02291614|467467284|FG006|Overall Study|Withdrawal by Subject|0|||
129866193|NCT02291614|467467285|FG007|Overall Study|Withdrawal by Subject|0|||
129866194|NCT02291614|467467286|FG008|Overall Study|Withdrawal by Subject|0|||
129866195|NCT02291614|467467287|FG009|Overall Study|Withdrawal by Subject|2|||
129866196|NCT02291614|467467288|FG010|Overall Study|Withdrawal by Subject|2|||
129866197|NCT02291614|467467278|FG000|Overall Study|Decision by sponsor|0|||
129866198|NCT02291614|467467279|FG001|Overall Study|Decision by sponsor|0|||
129866199|NCT02291614|467467280|FG002|Overall Study|Decision by sponsor|0|||
129866200|NCT02291614|467467281|FG003|Overall Study|Decision by sponsor|1|||
129866201|NCT02291614|467467282|FG004|Overall Study|Decision by sponsor|0|||
129866202|NCT02291614|467467283|FG005|Overall Study|Decision by sponsor|0|||
129866203|NCT02291614|467467284|FG006|Overall Study|Decision by sponsor|0|||
129866204|NCT02291614|467467285|FG007|Overall Study|Decision by sponsor|0|||
129866205|NCT02291614|467467286|FG008|Overall Study|Decision by sponsor|0|||
129866206|NCT02291614|467467287|FG009|Overall Study|Decision by sponsor|0|||
129866207|NCT02291614|467467288|FG010|Overall Study|Decision by sponsor|0|||
129866208|NCT02291614|467467278|FG000|Overall Study|Death|0|||
129866209|NCT02291614|467467279|FG001|Overall Study|Death|0|||
129866210|NCT02291614|467467280|FG002|Overall Study|Death|1|||
129866211|NCT02291614|467467281|FG003|Overall Study|Death|0|||
129866212|NCT02291614|467467282|FG004|Overall Study|Death|1|||
129866213|NCT02291614|467467283|FG005|Overall Study|Death|1|||
129866214|NCT02291614|467467284|FG006|Overall Study|Death|1|||
129866215|NCT02291614|467467285|FG007|Overall Study|Death|0|||
129866216|NCT02291614|467467286|FG008|Overall Study|Death|0|||
129866217|NCT02291614|467467287|FG009|Overall Study|Death|0|||
129866218|NCT02291614|467467288|FG010|Overall Study|Death|0|||
129866219|NCT00843167|467467289|FG000|Treatment Period|Adverse Event|1|||
129866220|NCT00843167|467467290|FG001|Treatment Period|Adverse Event|5|||
129866221|NCT00843167|467467289|FG000|Treatment Period|Withdrawal by Subject|2|||
129866222|NCT00843167|467467290|FG001|Treatment Period|Withdrawal by Subject|3|||
129866223|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
129866224|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
129866225|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
129866226|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
129866227|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
129866228|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
129866229|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866230|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866231|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866232|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866233|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
129866234|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866235|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866236|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866237|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866238|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
129866239|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
129866240|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
129866241|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
130065766|NCT02559206|468194789|FG004|Overall Study|Lost to Follow-up|2|||
129866242|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
129866243|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
129866244|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866245|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866246|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866247|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866248|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Other|1|||
129866249|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Other|0|||
129866250|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Other|0|||
130065767|NCT02559206|468194790|FG005|Overall Study|Lost to Follow-up|5|||
129915501|NCT02349412|467654372|FG000|Overall Study|Withdrawal by Subject|7|||
129915502|NCT02349412|467654373|FG001|Overall Study|Withdrawal by Subject|7|||
129915503|NCT03460236|467654374|FG000|Overall Study|failed radiographic screening|16|||
129915504|NCT03460236|467654374|FG000|Overall Study|Withdrawal by Subject|11|||
129915505|NCT00979576|467654377|FG000|Combination Treatment Phase|Progressive disease|3|||
129915506|NCT00979576|467654378|FG001|Combination Treatment Phase|Progressive disease|1|||
129915507|NCT00979576|467654379|FG002|Combination Treatment Phase|Progressive disease|5|||
129915508|NCT00979576|467654377|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
129915509|NCT00979576|467654378|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
129915510|NCT00979576|467654379|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
129915511|NCT00979576|467654377|FG000|Combination Treatment Phase|Adverse Event|0|||
129915512|NCT00979576|467654378|FG001|Combination Treatment Phase|Adverse Event|2|||
129915513|NCT00979576|467654379|FG002|Combination Treatment Phase|Adverse Event|2|||
129915514|NCT00979576|467654377|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
129915515|NCT00979576|467654378|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
129915516|NCT00979576|467654379|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
129915517|NCT04840199|467654380|FG000|Overall Study|Study Terminated by Sponsor|8|||
129915518|NCT04840199|467654381|FG001|Overall Study|Study Terminated by Sponsor|9|||
129915519|NCT04840199|467654380|FG000|Overall Study|Lost to Follow-up|0|||
129915520|NCT04840199|467654381|FG001|Overall Study|Lost to Follow-up|2|||
129915521|NCT04840199|467654380|FG000|Overall Study|Withdrawal by Subject|2|||
129915522|NCT04840199|467654381|FG001|Overall Study|Withdrawal by Subject|0|||
129915523|NCT04840199|467654380|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
129915524|NCT04840199|467654381|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
129915525|NCT05215847|467654382|FG000|Overall Study|Lost to Follow-up|1|||
129915526|NCT02819843|467654389|FG000|Overall Study|Disease progression before RT|0|||
129915527|NCT02819843|467654390|FG001|Overall Study|Disease progression before RT|1|||
129915528|NCT03055858|467654392|FG000|Overall Study|Death|9|||
129915529|NCT03055858|467654392|FG000|Overall Study|Withdrawal by Subject|11|||
129915530|NCT03055858|467654392|FG000|Overall Study|Lost to Follow-up|6|||
129915531|NCT03055858|467654392|FG000|Overall Study|Missed Follow-Up Visits|18|||
129915532|NCT04586920|467654393|FG000|Overall Study|Lost to Follow-up|0|||
129915533|NCT04586920|467654394|FG001|Overall Study|Lost to Follow-up|0|||
129915534|NCT04586920|467654395|FG002|Overall Study|Lost to Follow-up|0|||
129915535|NCT04586920|467654396|FG003|Overall Study|Lost to Follow-up|0|||
129915536|NCT04586920|467654397|FG004|Overall Study|Lost to Follow-up|0|||
129915537|NCT04586920|467654398|FG005|Overall Study|Lost to Follow-up|0|||
129915538|NCT04586920|467654399|FG006|Overall Study|Lost to Follow-up|1|||
129915539|NCT04586920|467654400|FG007|Overall Study|Lost to Follow-up|1|||
129915540|NCT04586920|467654401|FG008|Overall Study|Lost to Follow-up|0|||
129915541|NCT04586920|467654402|FG009|Overall Study|Lost to Follow-up|1|||
129915542|NCT04586920|467654403|FG010|Overall Study|Lost to Follow-up|0|||
129915543|NCT04586920|467654404|FG011|Overall Study|Lost to Follow-up|0|||
129915544|NCT04586920|467654405|FG012|Overall Study|Lost to Follow-up|0|||
129915545|NCT04586920|467654406|FG013|Overall Study|Lost to Follow-up|1|||
129915546|NCT04586920|467654407|FG014|Overall Study|Lost to Follow-up|0|||
129915547|NCT04586920|467654408|FG015|Overall Study|Lost to Follow-up|0|||
130116710|NCT00818623|468387167|FG003|Overall Study|Adverse Event|0|||
130116711|NCT00818623|468387168|FG004|Overall Study|Adverse Event|0|||
130116712|NCT00818623|468387169|FG005|Overall Study|Adverse Event|1|||
130116713|NCT00818623|468387170|FG006|Overall Study|Adverse Event|0|||
130116714|NCT00818623|468387171|FG007|Overall Study|Adverse Event|0|||
130116715|NCT00818623|468387164|FG000|Overall Study|Bad prostate specific antigen response|0|||
130116716|NCT00818623|468387165|FG001|Overall Study|Bad prostate specific antigen response|3|||
130116717|NCT00818623|468387166|FG002|Overall Study|Bad prostate specific antigen response|2|||
130116718|NCT00818623|468387167|FG003|Overall Study|Bad prostate specific antigen response|5|||
130116719|NCT00818623|468387168|FG004|Overall Study|Bad prostate specific antigen response|0|||
130116720|NCT00818623|468387169|FG005|Overall Study|Bad prostate specific antigen response|1|||
130116721|NCT00818623|468387170|FG006|Overall Study|Bad prostate specific antigen response|0|||
130116722|NCT00818623|468387171|FG007|Overall Study|Bad prostate specific antigen response|0|||
130116723|NCT00818623|468387164|FG000|Overall Study|Withdrawal by Subject|0|||
130116724|NCT00818623|468387165|FG001|Overall Study|Withdrawal by Subject|1|||
130116725|NCT00818623|468387166|FG002|Overall Study|Withdrawal by Subject|1|||
130116726|NCT00818623|468387167|FG003|Overall Study|Withdrawal by Subject|0|||
130116727|NCT00818623|468387168|FG004|Overall Study|Withdrawal by Subject|0|||
130116728|NCT00818623|468387169|FG005|Overall Study|Withdrawal by Subject|1|||
129915548|NCT04586920|467654409|FG016|Overall Study|Lost to Follow-up|0|||
129915549|NCT04586920|467654410|FG017|Overall Study|Lost to Follow-up|0|||
129915550|NCT04586920|467654393|FG000|Overall Study|Withdrawal by Subject|0|||
130116729|NCT00818623|468387170|FG006|Overall Study|Withdrawal by Subject|1|||
130116730|NCT00818623|468387171|FG007|Overall Study|Withdrawal by Subject|1|||
130116731|NCT00818623|468387164|FG000|Overall Study|Protocol Violation|1|||
130116732|NCT00818623|468387165|FG001|Overall Study|Protocol Violation|0|||
129915551|NCT04586920|467654394|FG001|Overall Study|Withdrawal by Subject|0|||
129915552|NCT04586920|467654395|FG002|Overall Study|Withdrawal by Subject|0|||
129915553|NCT04586920|467654396|FG003|Overall Study|Withdrawal by Subject|0|||
129915554|NCT04586920|467654397|FG004|Overall Study|Withdrawal by Subject|0|||
129915555|NCT04586920|467654398|FG005|Overall Study|Withdrawal by Subject|0|||
129915556|NCT04586920|467654399|FG006|Overall Study|Withdrawal by Subject|0|||
129915557|NCT04586920|467654400|FG007|Overall Study|Withdrawal by Subject|1|||
129915558|NCT04586920|467654401|FG008|Overall Study|Withdrawal by Subject|0|||
129915559|NCT04586920|467654402|FG009|Overall Study|Withdrawal by Subject|1|||
129915560|NCT04586920|467654403|FG010|Overall Study|Withdrawal by Subject|0|||
129915561|NCT04586920|467654404|FG011|Overall Study|Withdrawal by Subject|1|||
129915562|NCT04586920|467654405|FG012|Overall Study|Withdrawal by Subject|0|||
129915563|NCT04586920|467654406|FG013|Overall Study|Withdrawal by Subject|0|||
129915564|NCT04586920|467654407|FG014|Overall Study|Withdrawal by Subject|0|||
129915565|NCT04586920|467654408|FG015|Overall Study|Withdrawal by Subject|0|||
129915566|NCT04586920|467654409|FG016|Overall Study|Withdrawal by Subject|0|||
129915567|NCT04586920|467654410|FG017|Overall Study|Withdrawal by Subject|0|||
129915568|NCT02728557|467654415|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
129915569|NCT02728557|467654416|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
129915570|NCT02728557|467654415|FG000|Overall Study|Dissatisfaction with research tasks|0|||
129915571|NCT02728557|467654416|FG001|Overall Study|Dissatisfaction with research tasks|1|||
129915572|NCT02728557|467654415|FG000|Overall Study|Scheduling or change in availability|1|||
129915573|NCT02728557|467654416|FG001|Overall Study|Scheduling or change in availability|1|||
129915574|NCT03897686|467654417|FG000|Overall Study|Protocol Violation|1|||
129915575|NCT03897686|467654418|FG001|Overall Study|Protocol Violation|1|||
129915576|NCT03897686|467654417|FG000|Overall Study|Withdrawal by Subject|1|||
129915577|NCT03897686|467654418|FG001|Overall Study|Withdrawal by Subject|1|||
129915578|NCT03416010|467654419|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
129915579|NCT03416010|467654420|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
129915580|NCT03416010|467654419|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
129915581|NCT03416010|467654420|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
129915582|NCT03416010|467654419|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
129915583|NCT03416010|467654420|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
129915584|NCT03416010|467654419|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
129915585|NCT03416010|467654420|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
129915586|NCT03416010|467654419|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
129915587|NCT03416010|467654420|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
129915588|NCT03416010|467654419|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
129915589|NCT03416010|467654420|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
129915590|NCT03416010|467654419|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
129915591|NCT03416010|467654420|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
129915592|NCT05415436|467654424|FG000|Overall Study|Surgeon cancelled procedure|1|||
129915593|NCT05415436|467654425|FG001|Overall Study|Surgeon cancelled procedure|0|||
129866251|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Other|0|||
129866252|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Other|0|||
129866253|NCT01662310|467467293|FG000|Double-Blind Phase|Adverse Event|0|||
129866254|NCT01662310|467467294|FG001|Double-Blind Phase|Adverse Event|0|||
129866255|NCT01662310|467467295|FG002|Double-Blind Phase|Adverse Event|1|||
129866256|NCT01662310|467467296|FG003|Double-Blind Phase|Adverse Event|0|||
129866257|NCT01662310|467467297|FG004|Double-Blind Phase|Adverse Event|0|||
129866258|NCT01662310|467467293|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129866259|NCT01662310|467467294|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129866260|NCT01662310|467467295|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129866261|NCT01662310|467467296|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129866262|NCT01662310|467467297|FG004|Double-Blind Phase|Lost to Follow-up|0|||
129866263|NCT01662310|467467293|FG000|Double-Blind Phase|Pregnancy|0|||
129866264|NCT01662310|467467294|FG001|Double-Blind Phase|Pregnancy|2|||
129866265|NCT01662310|467467295|FG002|Double-Blind Phase|Pregnancy|0|||
129866266|NCT01662310|467467296|FG003|Double-Blind Phase|Pregnancy|0|||
129866267|NCT01662310|467467297|FG004|Double-Blind Phase|Pregnancy|0|||
129866268|NCT01662310|467467293|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129866269|NCT01662310|467467294|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
129866270|NCT01662310|467467295|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
129866271|NCT01662310|467467296|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129866272|NCT01662310|467467297|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129866273|NCT01662310|467467293|FG000|Double-Blind Phase|Other|0|||
129866274|NCT01662310|467467294|FG001|Double-Blind Phase|Other|0|||
129866275|NCT01662310|467467295|FG002|Double-Blind Phase|Other|1|||
129866276|NCT01662310|467467296|FG003|Double-Blind Phase|Other|0|||
129866277|NCT01662310|467467297|FG004|Double-Blind Phase|Other|0|||
129866278|NCT01662310|467467293|FG000|Double-Blind Phase|Randomized but not treated|0|||
129866279|NCT01662310|467467294|FG001|Double-Blind Phase|Randomized but not treated|1|||
129866280|NCT01662310|467467295|FG002|Double-Blind Phase|Randomized but not treated|0|||
129866281|NCT01662310|467467296|FG003|Double-Blind Phase|Randomized but not treated|0|||
129915594|NCT05415436|467654424|FG000|Overall Study|Death|1|||
129915595|NCT05415436|467654425|FG001|Overall Study|Death|0|||
129915596|NCT03819686|467654432|FG000|Overall Study|Lost to Follow-up|2|||
129915597|NCT03819686|467654433|FG001|Overall Study|Lost to Follow-up|3|||
129915598|NCT03157167|467654447|FG000|Overall Study|Withdrawal by Subject|1|||
129915599|NCT03157167|467654448|FG001|Overall Study|Withdrawal by Subject|0|||
129915600|NCT03157167|467654449|FG002|Overall Study|Withdrawal by Subject|0|||
129915601|NCT06023082|467654453|FG000|Overall Study|Withdrawal by Subject|2|||
129915602|NCT06023082|467654453|FG000|Overall Study|Lost to Follow-up|15|||
129915603|NCT06023082|467654453|FG000|Overall Study|Side effects|5|||
129915604|NCT03584516|467654454|FG000|Part 1|Death|2|||
129915605|NCT03584516|467654455|FG001|Part 1|Death|3|||
129915606|NCT03584516|467654456|FG002|Part 1|Death|0|||
129915607|NCT03584516|467654457|FG003|Part 1|Death|0|||
129915608|NCT03584516|467654458|FG004|Part 1|Death|0|||
129915609|NCT03584516|467654459|FG005|Part 1|Death|0|||
129915610|NCT03584516|467654454|FG000|Part 1|Withdrawal by Subject|2|||
129915611|NCT03584516|467654455|FG001|Part 1|Withdrawal by Subject|0|||
129915612|NCT03584516|467654456|FG002|Part 1|Withdrawal by Subject|0|||
129915613|NCT03584516|467654457|FG003|Part 1|Withdrawal by Subject|0|||
129915614|NCT03584516|467654458|FG004|Part 1|Withdrawal by Subject|0|||
129915615|NCT03584516|467654459|FG005|Part 1|Withdrawal by Subject|0|||
129915616|NCT03584516|467654454|FG000|Part 1|Lost to Follow-up|1|||
129915617|NCT03584516|467654455|FG001|Part 1|Lost to Follow-up|0|||
129915618|NCT03584516|467654456|FG002|Part 1|Lost to Follow-up|0|||
129915619|NCT03584516|467654457|FG003|Part 1|Lost to Follow-up|0|||
129915620|NCT03584516|467654458|FG004|Part 1|Lost to Follow-up|0|||
129915621|NCT03584516|467654459|FG005|Part 1|Lost to Follow-up|0|||
129915622|NCT03584516|467654454|FG000|Part 1|Study Terminated by Sponsor|0|||
129915623|NCT03584516|467654455|FG001|Part 1|Study Terminated by Sponsor|2|||
129915624|NCT03584516|467654456|FG002|Part 1|Study Terminated by Sponsor|0|||
129915625|NCT03584516|467654457|FG003|Part 1|Study Terminated by Sponsor|0|||
129915626|NCT03584516|467654458|FG004|Part 1|Study Terminated by Sponsor|0|||
129915627|NCT03584516|467654459|FG005|Part 1|Study Terminated by Sponsor|0|||
129915628|NCT03584516|467654454|FG000|Part 1 Expansion|Death|0|||
129915629|NCT03584516|467654455|FG001|Part 1 Expansion|Death|0|||
129915630|NCT03584516|467654456|FG002|Part 1 Expansion|Death|9|||
129915631|NCT03584516|467654457|FG003|Part 1 Expansion|Death|8|||
129915632|NCT03584516|467654458|FG004|Part 1 Expansion|Death|4|||
129915633|NCT03584516|467654459|FG005|Part 1 Expansion|Death|5|||
129915634|NCT03584516|467654454|FG000|Part 1 Expansion|Lost to Follow-up|0|||
129915635|NCT03584516|467654455|FG001|Part 1 Expansion|Lost to Follow-up|0|||
129915636|NCT03584516|467654456|FG002|Part 1 Expansion|Lost to Follow-up|0|||
129915637|NCT03584516|467654457|FG003|Part 1 Expansion|Lost to Follow-up|1|||
129915638|NCT03584516|467654458|FG004|Part 1 Expansion|Lost to Follow-up|0|||
129915639|NCT03584516|467654459|FG005|Part 1 Expansion|Lost to Follow-up|0|||
129915640|NCT03584516|467654454|FG000|Part 1 Expansion|Physician Decision|0|||
129915641|NCT03584516|467654455|FG001|Part 1 Expansion|Physician Decision|0|||
129915642|NCT03584516|467654456|FG002|Part 1 Expansion|Physician Decision|4|||
129915643|NCT03584516|467654457|FG003|Part 1 Expansion|Physician Decision|3|||
129915644|NCT03584516|467654458|FG004|Part 1 Expansion|Physician Decision|2|||
129915645|NCT03584516|467654459|FG005|Part 1 Expansion|Physician Decision|3|||
129915646|NCT03584516|467654454|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
129915647|NCT03584516|467654455|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
129915648|NCT03584516|467654456|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
129915649|NCT03584516|467654457|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
129915650|NCT03584516|467654458|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
129915651|NCT03584516|467654459|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
129915652|NCT03584516|467654454|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
129915653|NCT03584516|467654455|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
129915654|NCT03584516|467654456|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
129915655|NCT03584516|467654457|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
129915656|NCT03584516|467654458|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
129915657|NCT03584516|467654459|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
129915658|NCT03584516|467654454|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
130065768|NCT02559206|468194791|FG006|Overall Study|Lost to Follow-up|1|||
130065769|NCT02559206|468194792|FG007|Overall Study|Lost to Follow-up|4|||
129915659|NCT03584516|467654455|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915660|NCT03584516|467654456|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915661|NCT03584516|467654457|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
129915662|NCT03584516|467654458|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915663|NCT03584516|467654459|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915664|NCT03584516|467654454|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915665|NCT03584516|467654455|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915666|NCT03584516|467654456|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915667|NCT03584516|467654457|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130065770|NCT02559206|468194785|FG000|Overall Study|Lack of Efficacy|1|||
129915668|NCT03584516|467654458|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
130065771|NCT02559206|468194786|FG001|Overall Study|Lack of Efficacy|0|||
130065772|NCT02559206|468194787|FG002|Overall Study|Lack of Efficacy|3|||
129866282|NCT01662310|467467297|FG004|Double-Blind Phase|Randomized but not treated|0|||
129866283|NCT01662310|467467293|FG000|Open-Label Extension Phase|Adverse Event|0|||
129866284|NCT01662310|467467294|FG001|Open-Label Extension Phase|Adverse Event|0|||
129866285|NCT01662310|467467295|FG002|Open-Label Extension Phase|Adverse Event|0|||
129866286|NCT01662310|467467296|FG003|Open-Label Extension Phase|Adverse Event|3|||
129866287|NCT01662310|467467297|FG004|Open-Label Extension Phase|Adverse Event|0|||
129866288|NCT01662310|467467293|FG000|Open-Label Extension Phase|Death|0|||
129866289|NCT01662310|467467294|FG001|Open-Label Extension Phase|Death|0|||
129866290|NCT01662310|467467295|FG002|Open-Label Extension Phase|Death|0|||
129866291|NCT01662310|467467296|FG003|Open-Label Extension Phase|Death|1|||
129866292|NCT01662310|467467297|FG004|Open-Label Extension Phase|Death|0|||
129866293|NCT01662310|467467293|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
129866294|NCT01662310|467467294|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
129866295|NCT01662310|467467295|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
129866296|NCT01662310|467467296|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
129866297|NCT01662310|467467297|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
129866298|NCT01662310|467467293|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129866299|NCT01662310|467467294|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129866300|NCT01662310|467467295|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129866301|NCT01662310|467467296|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
129866302|NCT01662310|467467297|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
129866303|NCT01662310|467467293|FG000|Open-Label Extension Phase|Pregnancy|0|||
129866304|NCT01662310|467467294|FG001|Open-Label Extension Phase|Pregnancy|0|||
129866305|NCT01662310|467467295|FG002|Open-Label Extension Phase|Pregnancy|0|||
129866306|NCT01662310|467467296|FG003|Open-Label Extension Phase|Pregnancy|1|||
129866307|NCT01662310|467467297|FG004|Open-Label Extension Phase|Pregnancy|0|||
129866308|NCT01662310|467467293|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
129866309|NCT01662310|467467294|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
129866310|NCT01662310|467467295|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
129866311|NCT01662310|467467296|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
129866312|NCT01662310|467467297|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
129866313|NCT04302350|467467301|FG000|Overall Study|Physician Decision|1|||
129866314|NCT04302350|467467302|FG001|Overall Study|Physician Decision|1|||
129866315|NCT04302350|467467303|FG002|Overall Study|Physician Decision|2|||
129866316|NCT04302350|467467301|FG000|Overall Study|Lack of Efficacy|1|||
129866317|NCT04302350|467467302|FG001|Overall Study|Lack of Efficacy|1|||
129866318|NCT04302350|467467303|FG002|Overall Study|Lack of Efficacy|4|||
129866319|NCT04302350|467467301|FG000|Overall Study|Adverse Event|0|||
129866320|NCT04302350|467467302|FG001|Overall Study|Adverse Event|1|||
129866321|NCT04302350|467467303|FG002|Overall Study|Adverse Event|2|||
129866322|NCT02012491|467467306|FG000|Overall Study|Lost to Follow-up|1|||
129866323|NCT02012491|467467307|FG001|Overall Study|Lost to Follow-up|0|||
129866324|NCT02012491|467467306|FG000|Overall Study|Protocol Violation|0|||
129866325|NCT02012491|467467307|FG001|Overall Study|Protocol Violation|1|||
129866326|NCT02012491|467467306|FG000|Overall Study|Withdrawal by Subject|1|||
129866327|NCT02012491|467467307|FG001|Overall Study|Withdrawal by Subject|0|||
129866328|NCT00450411|467467308|FG000|Overall Study|Protocol Violation|6|||
129866329|NCT00450411|467467308|FG000|Overall Study|No protocol treatment|2|||
129866330|NCT02137369|467467319|FG000|Overall Study|Withdrawal by Subject|3|||
129866331|NCT02137369|467467320|FG001|Overall Study|Withdrawal by Subject|2|||
129866332|NCT02137369|467467319|FG000|Overall Study|Adverse Event|2|||
129866333|NCT02137369|467467320|FG001|Overall Study|Adverse Event|0|||
129866334|NCT02137369|467467319|FG000|Overall Study|Lost to Follow-up|1|||
129866335|NCT02137369|467467320|FG001|Overall Study|Lost to Follow-up|0|||
129866336|NCT02137369|467467319|FG000|Overall Study|Moved away|2|||
129866337|NCT02137369|467467320|FG001|Overall Study|Moved away|0|||
129866338|NCT03969719|467467321|FG000|Overall Study|Other reasons not specified|1|||
129866339|NCT03969719|467467322|FG001|Overall Study|Other reasons not specified|1|||
129866340|NCT03969719|467467323|FG002|Overall Study|Other reasons not specified|3|||
129866341|NCT03969719|467467321|FG000|Overall Study|Withdrawal by Subject|2|||
129866342|NCT03969719|467467322|FG001|Overall Study|Withdrawal by Subject|3|||
129866343|NCT03969719|467467323|FG002|Overall Study|Withdrawal by Subject|2|||
129866344|NCT03969719|467467321|FG000|Overall Study|Protocol Violation|1|||
129866345|NCT03969719|467467322|FG001|Overall Study|Protocol Violation|2|||
129866346|NCT03969719|467467323|FG002|Overall Study|Protocol Violation|0|||
129866347|NCT03969719|467467321|FG000|Overall Study|Adverse Event|0|||
129866348|NCT03969719|467467322|FG001|Overall Study|Adverse Event|2|||
129866349|NCT03969719|467467323|FG002|Overall Study|Adverse Event|0|||
129866350|NCT03969719|467467321|FG000|Overall Study|Lost to Follow-up|0|||
129866351|NCT03969719|467467322|FG001|Overall Study|Lost to Follow-up|1|||
129866352|NCT03969719|467467323|FG002|Overall Study|Lost to Follow-up|0|||
129866353|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
129866354|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
130065773|NCT02559206|468194788|FG003|Overall Study|Lack of Efficacy|2|||
129915669|NCT03584516|467654459|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
129915670|NCT04868110|467654462|FG000|Overall Study|Withdrawal by Subject|3|||
129915671|NCT04868110|467654463|FG001|Overall Study|Withdrawal by Subject|4|||
129915672|NCT00593489|467654473|FG000|Allocation|did not attend workshop; allocation not|2|||
129915673|NCT00593489|467654474|FG001|Allocation|did not attend workshop; allocation not|1|||
129915674|NCT02742519|467654475|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
129915675|NCT02742519|467654476|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
129915676|NCT02742519|467654477|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
129915677|NCT02742519|467654475|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
129915678|NCT02742519|467654476|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
129915679|NCT02742519|467654477|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
129915680|NCT02742519|467654475|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
129915681|NCT02742519|467654476|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
129915682|NCT02742519|467654477|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
129915683|NCT04377308|467654479|FG000|Overall Study|Withdrawal by Subject|0|||
129915684|NCT04377308|467654480|FG001|Overall Study|Withdrawal by Subject|1|||
129915685|NCT02759016|467654481|FG000|Overall Study|Not treated with BI 836826|1|||
129915686|NCT02759016|467654482|FG001|Overall Study|Not treated with BI 836826|0|||
129915687|NCT02759016|467654481|FG000|Overall Study|Progressive disease|1|||
129915688|NCT02759016|467654482|FG001|Overall Study|Progressive disease|0|||
129915689|NCT02759016|467654481|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
129915690|NCT02759016|467654482|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
129915691|NCT02759016|467654481|FG000|Overall Study|Other not defined above|2|||
129915692|NCT02759016|467654482|FG001|Overall Study|Other not defined above|1|||
129915693|NCT03580369|467654483|FG000|Overall Study|No treatment due to mis-randomization|1|||
129915694|NCT03580369|467654484|FG001|Overall Study|No treatment due to mis-randomization|0|||
129915695|NCT03580369|467654485|FG002|Overall Study|No treatment due to mis-randomization|0|||
129915696|NCT03580369|467654486|FG003|Overall Study|No treatment due to mis-randomization|0|||
129915697|NCT03580369|467654487|FG004|Overall Study|No treatment due to mis-randomization|3|||
129915698|NCT03580369|467654488|FG005|Overall Study|No treatment due to mis-randomization|0|||
129915699|NCT03580369|467654489|FG006|Overall Study|No treatment due to mis-randomization|0|||
129915700|NCT03580369|467654490|FG007|Overall Study|No treatment due to mis-randomization|0|||
129915701|NCT03580369|467654483|FG000|Overall Study|Reason unknown|0|||
129915702|NCT03580369|467654484|FG001|Overall Study|Reason unknown|0|||
129915703|NCT03580369|467654485|FG002|Overall Study|Reason unknown|1|||
129915704|NCT03580369|467654486|FG003|Overall Study|Reason unknown|0|||
129915705|NCT03580369|467654487|FG004|Overall Study|Reason unknown|0|||
129915706|NCT03580369|467654488|FG005|Overall Study|Reason unknown|0|||
129915707|NCT03580369|467654489|FG006|Overall Study|Reason unknown|0|||
129915708|NCT03580369|467654490|FG007|Overall Study|Reason unknown|0|||
129915709|NCT03580369|467654483|FG000|Overall Study|Technical problems|0|||
129915710|NCT03580369|467654484|FG001|Overall Study|Technical problems|0|||
129915711|NCT03580369|467654485|FG002|Overall Study|Technical problems|0|||
129915712|NCT03580369|467654486|FG003|Overall Study|Technical problems|0|||
129915713|NCT03580369|467654487|FG004|Overall Study|Technical problems|1|||
129915714|NCT03580369|467654488|FG005|Overall Study|Technical problems|0|||
129915715|NCT03580369|467654489|FG006|Overall Study|Technical problems|2|||
129915716|NCT03580369|467654490|FG007|Overall Study|Technical problems|0|||
129915717|NCT03580369|467654483|FG000|Overall Study|Pregnancy|2|||
129915718|NCT03580369|467654484|FG001|Overall Study|Pregnancy|0|||
129915719|NCT03580369|467654485|FG002|Overall Study|Pregnancy|3|||
129915720|NCT03580369|467654486|FG003|Overall Study|Pregnancy|0|||
129915721|NCT03580369|467654487|FG004|Overall Study|Pregnancy|2|||
129915722|NCT03580369|467654488|FG005|Overall Study|Pregnancy|0|||
129915723|NCT03580369|467654489|FG006|Overall Study|Pregnancy|0|||
129915724|NCT03580369|467654490|FG007|Overall Study|Pregnancy|0|||
129915725|NCT03580369|467654483|FG000|Overall Study|Lost to Follow-up|2|||
129915726|NCT03580369|467654484|FG001|Overall Study|Lost to Follow-up|0|||
129915727|NCT03580369|467654485|FG002|Overall Study|Lost to Follow-up|2|||
129915728|NCT03580369|467654486|FG003|Overall Study|Lost to Follow-up|0|||
129915729|NCT03580369|467654487|FG004|Overall Study|Lost to Follow-up|3|||
129915730|NCT03580369|467654488|FG005|Overall Study|Lost to Follow-up|0|||
129915731|NCT03580369|467654489|FG006|Overall Study|Lost to Follow-up|1|||
129915732|NCT03580369|467654490|FG007|Overall Study|Lost to Follow-up|0|||
129915733|NCT03580369|467654483|FG000|Overall Study|Physician Decision|4|||
129915734|NCT03580369|467654484|FG001|Overall Study|Physician Decision|0|||
129915735|NCT03580369|467654485|FG002|Overall Study|Physician Decision|4|||
129915736|NCT03580369|467654486|FG003|Overall Study|Physician Decision|1|||
129915737|NCT03580369|467654487|FG004|Overall Study|Physician Decision|1|||
129915738|NCT03580369|467654488|FG005|Overall Study|Physician Decision|0|||
129915739|NCT03580369|467654489|FG006|Overall Study|Physician Decision|0|||
129915740|NCT03580369|467654490|FG007|Overall Study|Physician Decision|0|||
129915741|NCT03580369|467654483|FG000|Overall Study|Lack of Efficacy|3|||
129915742|NCT03580369|467654484|FG001|Overall Study|Lack of Efficacy|0|||
129915743|NCT03580369|467654485|FG002|Overall Study|Lack of Efficacy|7|||
129915744|NCT03580369|467654486|FG003|Overall Study|Lack of Efficacy|0|||
129866355|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
129866356|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
129866357|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
129866358|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
129866359|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
129866360|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
129866361|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
129866362|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
129866363|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
129866364|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
129866365|NCT01297959|467467328|FG000|Overall Study|Adverse Event|0|||
129866366|NCT01297959|467467329|FG001|Overall Study|Adverse Event|1|||
129866367|NCT01297959|467467328|FG000|Overall Study|Protocol Violation|2|||
129866368|NCT01297959|467467329|FG001|Overall Study|Protocol Violation|1|||
129866369|NCT01297959|467467328|FG000|Overall Study|Withdrawal by Subject|5|||
129866370|NCT01297959|467467329|FG001|Overall Study|Withdrawal by Subject|4|||
129866371|NCT01297959|467467328|FG000|Overall Study|Physician Decision|0|||
129866372|NCT01297959|467467329|FG001|Overall Study|Physician Decision|1|||
129866373|NCT01297959|467467328|FG000|Overall Study|Unrelated medical illness / complication|0|||
129866374|NCT01297959|467467329|FG001|Overall Study|Unrelated medical illness / complication|2|||
129866375|NCT01297959|467467328|FG000|Overall Study|Other|13|||
129866376|NCT01297959|467467329|FG001|Overall Study|Other|7|||
129866377|NCT01667432|467467330|FG000|Overall Study|Premature Study Termination|26|||
129866378|NCT01667432|467467330|FG000|Overall Study|Failure to Return|10|||
129866379|NCT01667432|467467330|FG000|Overall Study|Moved to Another Center|3|||
129866380|NCT01667432|467467330|FG000|Overall Study|Lost to Follow-up|3|||
129866381|NCT01667432|467467330|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
129866382|NCT01667432|467467330|FG000|Overall Study|Insufficient Therapeutic Response|4|||
129866383|NCT01667432|467467330|FG000|Overall Study|Adverse Event|1|||
129866384|NCT01667432|467467330|FG000|Overall Study|Protocol Deviation|2|||
129866385|NCT01667432|467467330|FG000|Overall Study|Principal Investigator Decision|1|||
129866386|NCT01667432|467467330|FG000|Overall Study|Reason Not Specified|2|||
129866387|NCT01667432|467467330|FG000|Overall Study|Missing Information|4|||
129866388|NCT02077166|467467331|FG000|Overall Study|Death|6|||
129866389|NCT02077166|467467332|FG001|Overall Study|Death|7|||
129866390|NCT02077166|467467333|FG002|Overall Study|Death|5|||
129866391|NCT02077166|467467334|FG003|Overall Study|Death|6|||
129866392|NCT02077166|467467335|FG004|Overall Study|Death|4|||
129866393|NCT02077166|467467336|FG005|Overall Study|Death|32|||
129866394|NCT02077166|467467337|FG006|Overall Study|Death|22|||
129866395|NCT02077166|467467331|FG000|Overall Study|Study Closure by Sponsor|3|||
129866396|NCT02077166|467467332|FG001|Overall Study|Study Closure by Sponsor|0|||
129866397|NCT02077166|467467333|FG002|Overall Study|Study Closure by Sponsor|2|||
129866398|NCT02077166|467467334|FG003|Overall Study|Study Closure by Sponsor|2|||
129866399|NCT02077166|467467335|FG004|Overall Study|Study Closure by Sponsor|2|||
129866400|NCT02077166|467467336|FG005|Overall Study|Study Closure by Sponsor|12|||
129866401|NCT02077166|467467337|FG006|Overall Study|Study Closure by Sponsor|4|||
129866402|NCT02077166|467467331|FG000|Overall Study|Lost to Follow-up|0|||
129866403|NCT02077166|467467332|FG001|Overall Study|Lost to Follow-up|0|||
129866404|NCT02077166|467467333|FG002|Overall Study|Lost to Follow-up|0|||
129866405|NCT02077166|467467334|FG003|Overall Study|Lost to Follow-up|0|||
129866406|NCT02077166|467467335|FG004|Overall Study|Lost to Follow-up|0|||
129866407|NCT02077166|467467336|FG005|Overall Study|Lost to Follow-up|1|||
129866408|NCT02077166|467467337|FG006|Overall Study|Lost to Follow-up|0|||
129866409|NCT02077166|467467331|FG000|Overall Study|Withdrawal by Subject|3|||
129866410|NCT02077166|467467332|FG001|Overall Study|Withdrawal by Subject|0|||
129866411|NCT02077166|467467333|FG002|Overall Study|Withdrawal by Subject|1|||
129866412|NCT02077166|467467334|FG003|Overall Study|Withdrawal by Subject|1|||
129866413|NCT02077166|467467335|FG004|Overall Study|Withdrawal by Subject|1|||
129866414|NCT02077166|467467336|FG005|Overall Study|Withdrawal by Subject|3|||
129866415|NCT02077166|467467337|FG006|Overall Study|Withdrawal by Subject|0|||
129866416|NCT02077166|467467331|FG000|Overall Study|Other, Not Specified|0|||
129866417|NCT02077166|467467332|FG001|Overall Study|Other, Not Specified|0|||
129866418|NCT02077166|467467333|FG002|Overall Study|Other, Not Specified|1|||
129866419|NCT02077166|467467334|FG003|Overall Study|Other, Not Specified|0|||
129866420|NCT02077166|467467335|FG004|Overall Study|Other, Not Specified|1|||
129866421|NCT02077166|467467336|FG005|Overall Study|Other, Not Specified|7|||
129866422|NCT02077166|467467337|FG006|Overall Study|Other, Not Specified|8|||
129866423|NCT01712009|467469496|FG000|Overall Study|Withdrawal by Subject|24|||
129866424|NCT01712009|467469497|FG001|Overall Study|Withdrawal by Subject|15|||
129866425|NCT01712009|467469498|FG002|Overall Study|Withdrawal by Subject|8|||
129866426|NCT01712009|467469496|FG000|Overall Study|Lost to Follow-up|2|||
129866427|NCT01712009|467469497|FG001|Overall Study|Lost to Follow-up|0|||
129866428|NCT01712009|467469498|FG002|Overall Study|Lost to Follow-up|1|||
129866429|NCT01712009|467469496|FG000|Overall Study|Decision by Sponsor|12|||
129866430|NCT01712009|467469497|FG001|Overall Study|Decision by Sponsor|14|||
129915745|NCT03580369|467654487|FG004|Overall Study|Lack of Efficacy|2|||
129866431|NCT01712009|467469498|FG002|Overall Study|Decision by Sponsor|12|||
129866432|NCT02160314|467469499|FG000|Overall Study|Adverse Event|0|||
129866433|NCT02160314|467469500|FG001|Overall Study|Adverse Event|6|||
129866434|NCT02160314|467469499|FG000|Overall Study|Protocol Violation|0|||
129866435|NCT02160314|467469500|FG001|Overall Study|Protocol Violation|4|||
129866436|NCT02160314|467469499|FG000|Overall Study|Withdrawal by Subject|1|||
129866437|NCT02160314|467469500|FG001|Overall Study|Withdrawal by Subject|2|||
129915746|NCT03580369|467654488|FG005|Overall Study|Lack of Efficacy|0|||
129915747|NCT03580369|467654489|FG006|Overall Study|Lack of Efficacy|3|||
129915748|NCT03580369|467654490|FG007|Overall Study|Lack of Efficacy|0|||
129915749|NCT03580369|467654483|FG000|Overall Study|Protocol Violation|6|||
129866438|NCT02160314|467469499|FG000|Overall Study|Lost to Follow-up|0|||
129866439|NCT02160314|467469500|FG001|Overall Study|Lost to Follow-up|1|||
129866440|NCT01377480|467469504|FG000|Overall Study|Protocol Violation|0|||
129866441|NCT01377480|467469505|FG001|Overall Study|Protocol Violation|0|||
129866442|NCT01377480|467469506|FG002|Overall Study|Protocol Violation|0|||
129866443|NCT01377480|467469507|FG003|Overall Study|Protocol Violation|4|||
129866444|NCT01377480|467469504|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
129866445|NCT01377480|467469505|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
129866446|NCT01377480|467469506|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
129866447|NCT01377480|467469507|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
129866448|NCT01377480|467469504|FG000|Overall Study|Withdrawal by Subject|0|||
129866449|NCT01377480|467469505|FG001|Overall Study|Withdrawal by Subject|0|||
129866450|NCT01377480|467469506|FG002|Overall Study|Withdrawal by Subject|1|||
129866451|NCT01377480|467469507|FG003|Overall Study|Withdrawal by Subject|0|||
129866452|NCT01377480|467469504|FG000|Overall Study|Serious adverse event|0|||
129866453|NCT01377480|467469505|FG001|Overall Study|Serious adverse event|0|||
129866454|NCT01377480|467469506|FG002|Overall Study|Serious adverse event|1|||
129866455|NCT01377480|467469507|FG003|Overall Study|Serious adverse event|1|||
129866456|NCT01377480|467469504|FG000|Overall Study|Other|0|||
129866457|NCT01377480|467469505|FG001|Overall Study|Other|0|||
129866458|NCT01377480|467469506|FG002|Overall Study|Other|7|||
129866459|NCT01377480|467469507|FG003|Overall Study|Other|6|||
129866460|NCT03576768|467469511|FG000|Overall Study|Lost to Follow-up|3|||
129866461|NCT03576768|467469512|FG001|Overall Study|Lost to Follow-up|3|||
129866462|NCT03576768|467469513|FG002|Overall Study|Lost to Follow-up|0|||
129866463|NCT03576768|467469514|FG003|Overall Study|Lost to Follow-up|0|||
129866464|NCT00590902|467469515|FG000|Overall Study|Death|1|||
129866465|NCT01986881|467469516|FG000|Overall Study|Death|228|||
129866466|NCT01986881|467469517|FG001|Overall Study|Death|233|||
129866467|NCT01986881|467469518|FG002|Overall Study|Death|247|||
129866468|NCT01986881|467469516|FG000|Overall Study|Lost to Follow-up|51|||
129866469|NCT01986881|467469517|FG001|Overall Study|Lost to Follow-up|44|||
129866470|NCT01986881|467469518|FG002|Overall Study|Lost to Follow-up|55|||
129866471|NCT01986881|467469516|FG000|Overall Study|Physician Decision|7|||
129866472|NCT01986881|467469517|FG001|Overall Study|Physician Decision|4|||
129866473|NCT01986881|467469518|FG002|Overall Study|Physician Decision|6|||
129866474|NCT01986881|467469516|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
129866475|NCT01986881|467469517|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
129866476|NCT01986881|467469518|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
129866477|NCT01986881|467469516|FG000|Overall Study|Withdrawal by Subject|41|||
129866478|NCT01986881|467469517|FG001|Overall Study|Withdrawal by Subject|60|||
129866479|NCT01986881|467469518|FG002|Overall Study|Withdrawal by Subject|45|||
129915750|NCT03580369|467654484|FG001|Overall Study|Protocol Violation|0|||
129915751|NCT03580369|467654485|FG002|Overall Study|Protocol Violation|6|||
129915752|NCT03580369|467654486|FG003|Overall Study|Protocol Violation|1|||
129915753|NCT03580369|467654487|FG004|Overall Study|Protocol Violation|8|||
129915754|NCT03580369|467654488|FG005|Overall Study|Protocol Violation|2|||
129915755|NCT03580369|467654489|FG006|Overall Study|Protocol Violation|1|||
129915756|NCT03580369|467654490|FG007|Overall Study|Protocol Violation|0|||
129915757|NCT03580369|467654483|FG000|Overall Study|Adverse Event|7|||
129915758|NCT03580369|467654484|FG001|Overall Study|Adverse Event|0|||
129915759|NCT03580369|467654485|FG002|Overall Study|Adverse Event|14|||
129866480|NCT01986881|467469516|FG000|Overall Study|Subject Moved|0|||
129866481|NCT01986881|467469517|FG001|Overall Study|Subject Moved|1|||
129866482|NCT01986881|467469518|FG002|Overall Study|Subject Moved|0|||
129866483|NCT01986881|467469516|FG000|Overall Study|Other|1|||
129866484|NCT01986881|467469517|FG001|Overall Study|Other|2|||
129866485|NCT01986881|467469518|FG002|Overall Study|Other|2|||
129866486|NCT03563716|467469527|FG000|Overall Study|Death|20|||
129866487|NCT03563716|467469528|FG001|Overall Study|Death|14|||
129866488|NCT03563716|467469527|FG000|Overall Study|Withdrawal by Subject|3|||
129866489|NCT03563716|467469528|FG001|Overall Study|Withdrawal by Subject|3|||
129866490|NCT03563716|467469527|FG000|Overall Study|Still on Study|45|||
129866491|NCT03563716|467469528|FG001|Overall Study|Still on Study|50|||
129866492|NCT02583425|467469529|FG000|Screening|Did not meet entry criteria|12|||
129866493|NCT02583425|467469529|FG000|Baseline|Did not meet continued criteria|5|||
129915760|NCT03580369|467654486|FG003|Overall Study|Adverse Event|1|||
130065774|NCT02559206|468194789|FG004|Overall Study|Lack of Efficacy|2|||
130065775|NCT02559206|468194790|FG005|Overall Study|Lack of Efficacy|3|||
130065776|NCT02559206|468194791|FG006|Overall Study|Lack of Efficacy|3|||
129866494|NCT02583425|467469529|FG000|Treatment Period|Adverse Event|1|||
130065777|NCT02559206|468194792|FG007|Overall Study|Lack of Efficacy|3|||
130065778|NCT02559206|468194785|FG000|Overall Study|Other Not Specified|0|||
130065779|NCT02559206|468194786|FG001|Overall Study|Other Not Specified|0|||
130065780|NCT02559206|468194787|FG002|Overall Study|Other Not Specified|0|||
130065781|NCT02559206|468194788|FG003|Overall Study|Other Not Specified|1|||
130065782|NCT02559206|468194789|FG004|Overall Study|Other Not Specified|0|||
130065783|NCT02559206|468194790|FG005|Overall Study|Other Not Specified|0|||
130065784|NCT02559206|468194791|FG006|Overall Study|Other Not Specified|0|||
130065785|NCT02559206|468194792|FG007|Overall Study|Other Not Specified|0|||
130065786|NCT01561560|468194793|FG000|First Two Weeks of Wear|Time/job conflict|0|||
130065787|NCT01561560|468194794|FG001|First Two Weeks of Wear|Time/job conflict|1|||
130065788|NCT01561560|468194793|FG000|First Two Weeks of Wear|Adverse Event|0|||
130065789|NCT01561560|468194794|FG001|First Two Weeks of Wear|Adverse Event|1|||
130065790|NCT01561560|468194793|FG000|Second Two Weeks of Wear|Adverse Event|0|||
130065791|NCT01561560|468194794|FG001|Second Two Weeks of Wear|Adverse Event|1|||
130065792|NCT01871896|468194797|FG000|Overall Study|Lost to Follow-up|1|||
130065793|NCT01512108|468195989|FG000|Overall Study|Adverse Event|9|||
130065794|NCT01512108|468195990|FG001|Overall Study|Adverse Event|4|||
130065795|NCT01512108|468195989|FG000|Overall Study|Protocol Violation|1|||
130065796|NCT01512108|468195990|FG001|Overall Study|Protocol Violation|2|||
130065797|NCT01512108|468195989|FG000|Overall Study|Withdrawal Criteria|1|||
130065798|NCT01512108|468195990|FG001|Overall Study|Withdrawal Criteria|0|||
130065799|NCT01512108|468195989|FG000|Overall Study|Unclassified|11|||
130065800|NCT01512108|468195990|FG001|Overall Study|Unclassified|3|||
130065801|NCT06422377|468195996|FG000|Overall Study|Study Terminated by Sponsor|1|||
130065802|NCT02843178|468195998|FG000|Overall Study|Lost to Follow-up|8|||
130065803|NCT02843178|468195999|FG001|Overall Study|Lost to Follow-up|8|||
130065804|NCT02843178|468196000|FG002|Overall Study|Lost to Follow-up|6|||
130065805|NCT02843178|468196001|FG003|Overall Study|Lost to Follow-up|3|||
130065806|NCT02843178|468195998|FG000|Overall Study|Withdrawal by Subject|0|||
130065807|NCT02843178|468195999|FG001|Overall Study|Withdrawal by Subject|0|||
130065808|NCT02843178|468196000|FG002|Overall Study|Withdrawal by Subject|1|||
130065809|NCT02843178|468196001|FG003|Overall Study|Withdrawal by Subject|1|||
130065810|NCT02701192|468196004|FG000|Overall Study|Protocol Violation|2|||
130065811|NCT02701192|468196004|FG000|Overall Study|Lost to Follow-up|4|||
130065812|NCT00949910|468196005|FG000|Overall Study|Progressive Disease|3750|||
130065813|NCT00949910|468196005|FG000|Overall Study|Symptomatic Deterioration|1088|||
130065814|NCT00949910|468196005|FG000|Overall Study|Lost to Follow-up|100|||
130065815|NCT00949910|468196005|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
130116733|NCT00818623|468387166|FG002|Overall Study|Protocol Violation|0|||
130116734|NCT00818623|468387167|FG003|Overall Study|Protocol Violation|0|||
129866495|NCT01597050|467469532|FG000|Overall Study|Withdrawal by Subject|1|||
129866496|NCT01597050|467469533|FG001|Overall Study|Withdrawal by Subject|0|||
129866497|NCT00483184|467469534|FG000|Overall Study|Withdrawal by Subject|2|||
129866498|NCT00483184|467469535|FG001|Overall Study|Withdrawal by Subject|2|||
129866499|NCT00483184|467469536|FG002|Overall Study|Withdrawal by Subject|0|||
129866500|NCT00483184|467469534|FG000|Overall Study|Lost to Follow-up|1|||
129866501|NCT00483184|467469535|FG001|Overall Study|Lost to Follow-up|0|||
129866502|NCT00483184|467469536|FG002|Overall Study|Lost to Follow-up|0|||
129866503|NCT00483184|467469534|FG000|Overall Study|Adverse Event|1|||
129866504|NCT00483184|467469535|FG001|Overall Study|Adverse Event|2|||
129866505|NCT00483184|467469536|FG002|Overall Study|Adverse Event|2|||
129866506|NCT00483184|467469534|FG000|Overall Study|Protocol Violation|1|||
129866507|NCT00483184|467469535|FG001|Overall Study|Protocol Violation|0|||
129866508|NCT00483184|467469536|FG002|Overall Study|Protocol Violation|1|||
129866509|NCT00558428|467469537|FG000|Overall Study|Adverse Event|6|||
129866510|NCT00558428|467469538|FG001|Overall Study|Adverse Event|22|||
129866511|NCT00558428|467469539|FG002|Overall Study|Adverse Event|3|||
129866512|NCT00558428|467469540|FG003|Overall Study|Adverse Event|4|||
129866513|NCT00558428|467469537|FG000|Overall Study|Lost to Follow-up|0|||
129866514|NCT00558428|467469538|FG001|Overall Study|Lost to Follow-up|1|||
130065816|NCT00949910|468196005|FG000|Overall Study|Participant Refusal|390|||
130116735|NCT00818623|468387168|FG004|Overall Study|Protocol Violation|1|||
130116736|NCT00818623|468387169|FG005|Overall Study|Protocol Violation|0|||
130065817|NCT00949910|468196005|FG000|Overall Study|Death Due to Malignant Disease|456|||
130065818|NCT00949910|468196005|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
130065819|NCT00949910|468196005|FG000|Overall Study|Death Due to Adverse Event|115|||
130116737|NCT00818623|468387170|FG006|Overall Study|Protocol Violation|1|||
129866515|NCT00558428|467469539|FG002|Overall Study|Lost to Follow-up|0|||
129866516|NCT00558428|467469540|FG003|Overall Study|Lost to Follow-up|0|||
130065820|NCT00949910|468196005|FG000|Overall Study|Death Due to Toxicity|3|||
130065821|NCT00949910|468196005|FG000|Overall Study|Death from Unknown Cause|5|||
130065822|NCT00949910|468196005|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
130065823|NCT00949910|468196005|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
130116738|NCT00818623|468387171|FG007|Overall Study|Protocol Violation|0|||
129915761|NCT03580369|467654487|FG004|Overall Study|Adverse Event|6|||
129915762|NCT03580369|467654488|FG005|Overall Study|Adverse Event|0|||
129915763|NCT03580369|467654489|FG006|Overall Study|Adverse Event|1|||
129915764|NCT03580369|467654490|FG007|Overall Study|Adverse Event|0|||
129866517|NCT00558428|467469537|FG000|Overall Study|Lack of Efficacy|0|||
129866518|NCT00558428|467469538|FG001|Overall Study|Lack of Efficacy|0|||
129915765|NCT03580369|467654483|FG000|Overall Study|Withdrawal by Subject|19|||
129915766|NCT03580369|467654484|FG001|Overall Study|Withdrawal by Subject|0|||
129915767|NCT03580369|467654485|FG002|Overall Study|Withdrawal by Subject|17|||
129915768|NCT03580369|467654486|FG003|Overall Study|Withdrawal by Subject|0|||
129915769|NCT03580369|467654487|FG004|Overall Study|Withdrawal by Subject|16|||
129915770|NCT03580369|467654488|FG005|Overall Study|Withdrawal by Subject|1|||
129915771|NCT03580369|467654489|FG006|Overall Study|Withdrawal by Subject|7|||
129915772|NCT03580369|467654490|FG007|Overall Study|Withdrawal by Subject|0|||
129915773|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
129915774|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
129915775|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
129915776|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
129915777|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
129915778|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
129915779|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
129915780|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
129915781|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
129915782|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
129915783|NCT03939312|467654493|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
129915784|NCT03939312|467654493|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
129915785|NCT02119650|467654495|FG000|Overall Study|Adverse Event|3|||
129915786|NCT02119650|467654496|FG001|Overall Study|Adverse Event|4|||
129866519|NCT00558428|467469539|FG002|Overall Study|Lack of Efficacy|1|||
129866520|NCT00558428|467469540|FG003|Overall Study|Lack of Efficacy|2|||
129866521|NCT00558428|467469537|FG000|Overall Study|Non compliant with protocol|1|||
129866522|NCT00558428|467469538|FG001|Overall Study|Non compliant with protocol|0|||
129866523|NCT00558428|467469539|FG002|Overall Study|Non compliant with protocol|0|||
129866524|NCT00558428|467469540|FG003|Overall Study|Non compliant with protocol|3|||
129866525|NCT00558428|467469537|FG000|Overall Study|Consent withdrawn|2|||
129866526|NCT00558428|467469538|FG001|Overall Study|Consent withdrawn|1|||
129866527|NCT00558428|467469539|FG002|Overall Study|Consent withdrawn|0|||
129866528|NCT00558428|467469540|FG003|Overall Study|Consent withdrawn|1|||
129866529|NCT00558428|467469537|FG000|Overall Study|Other|3|||
129866530|NCT00558428|467469538|FG001|Overall Study|Other|0|||
129866531|NCT00558428|467469539|FG002|Overall Study|Other|0|||
129866532|NCT00558428|467469540|FG003|Overall Study|Other|1|||
129866533|NCT05224050|467469541|FG000|Overall Study|Withdrawal by Subject|9|||
129866534|NCT05224050|467469541|FG000|Overall Study|Lost to Follow-up|3|||
129866535|NCT01137474|467469542|FG000|Overall Study|Adverse Event|3|||
129866536|NCT01137474|467469543|FG001|Overall Study|Adverse Event|5|||
129866537|NCT01137474|467469544|FG002|Overall Study|Adverse Event|1|||
129866538|NCT01137474|467469545|FG003|Overall Study|Adverse Event|3|||
129866539|NCT01137474|467469542|FG000|Overall Study|Withdrawal by Subject|7|||
129866540|NCT01137474|467469543|FG001|Overall Study|Withdrawal by Subject|2|||
129866541|NCT01137474|467469544|FG002|Overall Study|Withdrawal by Subject|6|||
129866542|NCT01137474|467469545|FG003|Overall Study|Withdrawal by Subject|9|||
129866543|NCT01137474|467469542|FG000|Overall Study|No longer met study criteria|6|||
129866544|NCT01137474|467469543|FG001|Overall Study|No longer met study criteria|1|||
129866545|NCT01137474|467469544|FG002|Overall Study|No longer met study criteria|0|||
129866546|NCT01137474|467469545|FG003|Overall Study|No longer met study criteria|5|||
129866547|NCT01137474|467469542|FG000|Overall Study|Lost to Follow-up|5|||
129866548|NCT01137474|467469543|FG001|Overall Study|Lost to Follow-up|1|||
129866549|NCT01137474|467469544|FG002|Overall Study|Lost to Follow-up|0|||
129866550|NCT01137474|467469545|FG003|Overall Study|Lost to Follow-up|2|||
129866551|NCT01137474|467469542|FG000|Overall Study|Lack of Efficacy|0|||
129866552|NCT01137474|467469543|FG001|Overall Study|Lack of Efficacy|0|||
129866553|NCT01137474|467469544|FG002|Overall Study|Lack of Efficacy|0|||
129915787|NCT02119650|467654495|FG000|Overall Study|Subject decision|2|||
129866554|NCT01137474|467469545|FG003|Overall Study|Lack of Efficacy|2|||
129866555|NCT01137474|467469542|FG000|Overall Study|Other|3|||
129915788|NCT02119650|467654496|FG001|Overall Study|Subject decision|3|||
129915789|NCT02119650|467654495|FG000|Overall Study|Disease progression|11|||
129915790|NCT02119650|467654496|FG001|Overall Study|Disease progression|14|||
129866556|NCT01137474|467469543|FG001|Overall Study|Other|1|||
129866557|NCT01137474|467469544|FG002|Overall Study|Other|0|||
129866558|NCT01137474|467469545|FG003|Overall Study|Other|0|||
129866559|NCT01137474|467469542|FG000|Overall Study|Pregnancy|0|||
129866560|NCT01137474|467469543|FG001|Overall Study|Pregnancy|1|||
129866561|NCT01137474|467469544|FG002|Overall Study|Pregnancy|0|||
129866562|NCT01137474|467469545|FG003|Overall Study|Pregnancy|0|||
129866563|NCT01137474|467469542|FG000|Overall Study|Administrative reason by sponsor|0|||
129866564|NCT01137474|467469543|FG001|Overall Study|Administrative reason by sponsor|1|||
129866565|NCT01137474|467469544|FG002|Overall Study|Administrative reason by sponsor|0|||
129866566|NCT01137474|467469545|FG003|Overall Study|Administrative reason by sponsor|0|||
129866567|NCT02219048|467469546|FG000|Overall Study|Adverse Event|2|||
129866568|NCT02219048|467469547|FG001|Overall Study|Adverse Event|5|||
129866569|NCT02219048|467469546|FG000|Overall Study|No longer meets eligibility criteria|1|||
129866570|NCT02219048|467469547|FG001|Overall Study|No longer meets eligibility criteria|0|||
129866571|NCT02219048|467469546|FG000|Overall Study|Study terminated by sponsor|16|||
129866572|NCT02219048|467469547|FG001|Overall Study|Study terminated by sponsor|15|||
129866573|NCT02219048|467469546|FG000|Overall Study|Withdrawal by Subject|2|||
129866574|NCT02219048|467469547|FG001|Overall Study|Withdrawal by Subject|0|||
129866575|NCT02219048|467469546|FG000|Overall Study|Other|0|||
129866576|NCT02219048|467469547|FG001|Overall Study|Other|1|||
129866577|NCT04794803|467469548|FG000|Overall Study|Death|1|||
129866578|NCT04794803|467469549|FG001|Overall Study|Death|3|||
129866579|NCT04794803|467469548|FG000|Overall Study|Lost to Follow-up|2|||
129866580|NCT04794803|467469549|FG001|Overall Study|Lost to Follow-up|2|||
129866581|NCT04794803|467469548|FG000|Overall Study|Withdrawal by Subject|1|||
129866582|NCT04794803|467469549|FG001|Overall Study|Withdrawal by Subject|0|||
129866583|NCT04794803|467469548|FG000|Overall Study|Physician Decision|1|||
129866584|NCT04794803|467469549|FG001|Overall Study|Physician Decision|1|||
129866585|NCT04794803|467469548|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
129866586|NCT04794803|467469549|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
129866587|NCT04794803|467469548|FG000|Overall Study|Refused to continue the treatment|1|||
129866588|NCT04794803|467469549|FG001|Overall Study|Refused to continue the treatment|0|||
129866589|NCT04794803|467469548|FG000|Overall Study|Patient admitted to ICU|0|||
129866590|NCT04794803|467469549|FG001|Overall Study|Patient admitted to ICU|1|||
129866591|NCT00911534|467469550|FG000|Overall Study|Adverse Event|4|||
129866592|NCT00911534|467469551|FG001|Overall Study|Adverse Event|4|||
129866593|NCT00911534|467469550|FG000|Overall Study|Lost to Follow-up|2|||
129866594|NCT00911534|467469551|FG001|Overall Study|Lost to Follow-up|4|||
129866595|NCT00911534|467469550|FG000|Overall Study|Withdrawal by Subject|2|||
129866596|NCT00911534|467469551|FG001|Overall Study|Withdrawal by Subject|1|||
129866597|NCT00911534|467469550|FG000|Overall Study|Lack of Efficacy|4|||
129866598|NCT00911534|467469551|FG001|Overall Study|Lack of Efficacy|1|||
129866599|NCT00911534|467469550|FG000|Overall Study|Withdrawal of consent|1|||
129866600|NCT00911534|467469551|FG001|Overall Study|Withdrawal of consent|4|||
129866601|NCT00911534|467469550|FG000|Overall Study|Other|2|||
129866602|NCT00911534|467469551|FG001|Overall Study|Other|2|||
129866603|NCT03896035|467469552|FG000|Overall Study|Lost to Follow-up|2|||
129866604|NCT03896035|467469553|FG001|Overall Study|Lost to Follow-up|6|||
129866605|NCT03896035|467469552|FG000|Overall Study|Withdrawal by Subject|0|||
129866606|NCT03896035|467469553|FG001|Overall Study|Withdrawal by Subject|1|||
129866607|NCT03896035|467469552|FG000|Overall Study|Health/family health issues during COVID|0|||
129866608|NCT03896035|467469553|FG001|Overall Study|Health/family health issues during COVID|4|||
129866609|NCT01506193|467469554|FG000|Overall Study|Protocol Violation|1|||
129866610|NCT01506193|467469555|FG001|Overall Study|Protocol Violation|0|||
129866611|NCT01506193|467469556|FG002|Overall Study|Protocol Violation|1|||
129866612|NCT01506193|467469554|FG000|Overall Study|Migrated/moved from study area|0|||
129866613|NCT01506193|467469555|FG001|Overall Study|Migrated/moved from study area|0|||
129866614|NCT01506193|467469556|FG002|Overall Study|Migrated/moved from study area|1|||
129866615|NCT01506193|467469554|FG000|Overall Study|Adverse event, non-fatal|0|||
129866616|NCT01506193|467469555|FG001|Overall Study|Adverse event, non-fatal|0|||
129866617|NCT01506193|467469556|FG002|Overall Study|Adverse event, non-fatal|1|||
129866618|NCT01506193|467469554|FG000|Overall Study|Withdrawal by Subject|5|||
129866619|NCT01506193|467469555|FG001|Overall Study|Withdrawal by Subject|1|||
129866620|NCT01506193|467469556|FG002|Overall Study|Withdrawal by Subject|8|||
129866621|NCT01506193|467469554|FG000|Overall Study|Lost to Follow-up|8|||
129866622|NCT01506193|467469555|FG001|Overall Study|Lost to Follow-up|3|||
129866623|NCT01506193|467469556|FG002|Overall Study|Lost to Follow-up|3|||
129866624|NCT01388816|467469557|FG000|Overall Study|Adverse Event|0|||
129866625|NCT01388816|467469558|FG001|Overall Study|Adverse Event|2|||
129866626|NCT01388816|467469559|FG002|Overall Study|Adverse Event|0|||
129866627|NCT01388816|467469560|FG003|Overall Study|Adverse Event|0|||
129866628|NCT01388816|467469557|FG000|Overall Study|Lost to Follow-up|0|||
129866629|NCT01388816|467469558|FG001|Overall Study|Lost to Follow-up|1|||
129866630|NCT01388816|467469559|FG002|Overall Study|Lost to Follow-up|0|||
129866631|NCT01388816|467469560|FG003|Overall Study|Lost to Follow-up|0|||
129866632|NCT01388816|467469557|FG000|Overall Study|Withdrawal by Subject|2|||
129866633|NCT01388816|467469558|FG001|Overall Study|Withdrawal by Subject|1|||
129866634|NCT01388816|467469559|FG002|Overall Study|Withdrawal by Subject|1|||
129866635|NCT01388816|467469560|FG003|Overall Study|Withdrawal by Subject|0|||
129866636|NCT01388816|467469557|FG000|Overall Study|Protocol Violation|0|||
129866637|NCT01388816|467469558|FG001|Overall Study|Protocol Violation|0|||
129866638|NCT01388816|467469559|FG002|Overall Study|Protocol Violation|2|||
129866639|NCT01388816|467469560|FG003|Overall Study|Protocol Violation|0|||
129915791|NCT02119650|467654495|FG000|Overall Study|Death|5|||
129866640|NCT00743366|467469561|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
129866641|NCT00743366|467469562|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
129866642|NCT03206203|467469563|FG000|Treatment|Death|38|||
129866643|NCT03206203|467469564|FG001|Treatment|Death|26|||
129866644|NCT03206203|467469565|FG002|Treatment|Death|0|||
129866645|NCT03206203|467469563|FG000|Treatment|Withdrawal by Subject|1|||
129866646|NCT03206203|467469564|FG001|Treatment|Withdrawal by Subject|0|||
129866647|NCT03206203|467469565|FG002|Treatment|Withdrawal by Subject|0|||
129866648|NCT03206203|467469563|FG000|Treatment|Lost to Follow-up|4|||
129866649|NCT03206203|467469564|FG001|Treatment|Lost to Follow-up|0|||
129866650|NCT03206203|467469565|FG002|Treatment|Lost to Follow-up|0|||
129866651|NCT03206203|467469563|FG000|Treatment|N/A in Follow-Up|8|||
129866652|NCT03206203|467469564|FG001|Treatment|N/A in Follow-Up|1|||
129866653|NCT03206203|467469565|FG002|Treatment|N/A in Follow-Up|0|||
129866654|NCT03206203|467469563|FG000|Treatment|Disease progression|0|||
129866655|NCT03206203|467469564|FG001|Treatment|Disease progression|1|||
129866656|NCT03206203|467469565|FG002|Treatment|Disease progression|0|||
129866657|NCT03206203|467469563|FG000|Treatment|Refused follow-up|0|||
129866658|NCT03206203|467469564|FG001|Treatment|Refused follow-up|1|||
129866659|NCT03206203|467469565|FG002|Treatment|Refused follow-up|0|||
129866660|NCT03206203|467469563|FG000|Treatment|Cross over to Arm 1|0|||
129866661|NCT03206203|467469564|FG001|Treatment|Cross over to Arm 1|19|||
129866662|NCT03206203|467469565|FG002|Treatment|Cross over to Arm 1|0|||
129866663|NCT03206203|467469563|FG000|Optional Cross-Over|Death|0|||
129866664|NCT03206203|467469564|FG001|Optional Cross-Over|Death|0|||
129866665|NCT03206203|467469565|FG002|Optional Cross-Over|Death|14|||
129866666|NCT03206203|467469563|FG000|Optional Cross-Over|Refused follow-up|0|||
129866667|NCT03206203|467469564|FG001|Optional Cross-Over|Refused follow-up|0|||
129866668|NCT03206203|467469565|FG002|Optional Cross-Over|Refused follow-up|2|||
129866669|NCT00335322|467469566|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
129866670|NCT00335322|467469567|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
129866671|NCT00335322|467469568|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
129866672|NCT01152580|467469569|FG000|Overall Study|Withdrawal by Subject|0|||
129866673|NCT01152580|467469570|FG001|Overall Study|Withdrawal by Subject|1|||
129866674|NCT02275065|467469571|FG000|Overall Study|Randomized but not treated|1|||
129866675|NCT02275065|467469572|FG001|Overall Study|Randomized but not treated|0|||
129866676|NCT02275065|467469573|FG002|Overall Study|Randomized but not treated|1|||
129866677|NCT02275065|467469574|FG003|Overall Study|Randomized but not treated|1|||
129866678|NCT02275065|467469575|FG004|Overall Study|Randomized but not treated|0|||
129866679|NCT03015402|467469576|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129866680|NCT03015402|467469577|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
129866681|NCT03015402|467469576|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129866682|NCT03015402|467469577|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
129866683|NCT03213158|467469578|FG000|Overall Study|Withdrawal by Subject|1|||
129866684|NCT03213158|467469578|FG000|Overall Study|Physician Decision|2|||
129866685|NCT01995461|467469579|FG000|Overall Study|Death|1|||
129866686|NCT01995461|467469579|FG000|Overall Study|Lost to Follow-up|2|||
129866687|NCT01995461|467469579|FG000|Overall Study|Withdrawal by Subject|2|||
129866688|NCT00736645|467469582|FG000|Overall Study|Adverse Event|0|||
129866689|NCT00736645|467469583|FG001|Overall Study|Adverse Event|2|||
129866690|NCT00736645|467469584|FG002|Overall Study|Adverse Event|0|||
129866691|NCT00736645|467469585|FG003|Overall Study|Adverse Event|0|||
129866692|NCT03792126|467469587|FG000|Overall Study|Adverse Event|1|||
129866693|NCT03792126|467469588|FG001|Overall Study|Adverse Event|2|||
129866694|NCT03792126|467469587|FG000|Overall Study|Death|0|||
129866695|NCT03792126|467469588|FG001|Overall Study|Death|1|||
129866696|NCT03792126|467469587|FG000|Overall Study|Lost to Follow-up|1|||
129866697|NCT03792126|467469588|FG001|Overall Study|Lost to Follow-up|0|||
129866698|NCT03792126|467469587|FG000|Overall Study|Withdrawal by Subject|0|||
129866699|NCT03792126|467469588|FG001|Overall Study|Withdrawal by Subject|1|||
129866700|NCT03792126|467469587|FG000|Overall Study|COVID-19 Restrictions|1|||
129866701|NCT03792126|467469588|FG001|Overall Study|COVID-19 Restrictions|3|||
129866702|NCT03792126|467469587|FG000|Overall Study|Symptoms resolved|0|||
129866703|NCT03792126|467469588|FG001|Overall Study|Symptoms resolved|3|||
129866704|NCT03240692|467469589|FG000|Overall Study|Physician Decision|1|||
129866705|NCT03240692|467469589|FG000|Overall Study|Withdrawal by Subject|1|||
129866706|NCT04322682|467469590|FG000|Overall Study|Withdrawal by Subject|33|||
129866707|NCT04322682|467469591|FG001|Overall Study|Withdrawal by Subject|47|||
129866708|NCT04322682|467469590|FG000|Overall Study|Death|5|||
129866709|NCT04322682|467469591|FG001|Overall Study|Death|9|||
129866710|NCT04322682|467469590|FG000|Overall Study|Lost to Follow-up|4|||
129866711|NCT04322682|467469591|FG001|Overall Study|Lost to Follow-up|8|||
129866712|NCT04322682|467469590|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
129866713|NCT04322682|467469591|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
129866714|NCT02238379|467469592|FG000|Overall Study|Lost to Follow-up|1|||
129866715|NCT02238379|467469593|FG001|Overall Study|Lost to Follow-up|0|||
129866716|NCT04123067|467469594|FG000|Overall Study|Lost to Follow-up|0|||
129866717|NCT04123067|467469595|FG001|Overall Study|Lost to Follow-up|1|||
129866718|NCT00441090|467469596|FG000|Overall Study|Adverse Event|0|||
130065824|NCT00949910|468196005|FG000|Overall Study|Switched to Commercial Treatment|4|||
130065825|NCT00949910|468196005|FG000|Overall Study|Violation of Eligibility|23|||
130065826|NCT00949910|468196005|FG000|Overall Study|Logistical Reasons|13|||
130065827|NCT00949910|468196005|FG000|Overall Study|Non-Compliance|10|||
129866719|NCT00441090|467469597|FG001|Overall Study|Adverse Event|1|||
129866720|NCT00441090|467469598|FG002|Overall Study|Adverse Event|1|||
129866721|NCT00441090|467469599|FG003|Overall Study|Adverse Event|0|||
129866722|NCT00441090|467469600|FG004|Overall Study|Adverse Event|0|||
129866723|NCT00441090|467469596|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866724|NCT00441090|467469597|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866725|NCT00441090|467469598|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866726|NCT00441090|467469599|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
129866727|NCT00441090|467469600|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866728|NCT00441090|467469596|FG000|Overall Study|Withdrawal by Subject|1|||
129866729|NCT00441090|467469597|FG001|Overall Study|Withdrawal by Subject|0|||
129866730|NCT00441090|467469598|FG002|Overall Study|Withdrawal by Subject|1|||
129866731|NCT00441090|467469599|FG003|Overall Study|Withdrawal by Subject|0|||
129866732|NCT00441090|467469600|FG004|Overall Study|Withdrawal by Subject|0|||
129866733|NCT00441090|467469596|FG000|Overall Study|Lack of Efficacy|1|||
129866734|NCT00441090|467469597|FG001|Overall Study|Lack of Efficacy|0|||
129866735|NCT00441090|467469598|FG002|Overall Study|Lack of Efficacy|0|||
129866736|NCT00441090|467469599|FG003|Overall Study|Lack of Efficacy|0|||
129866737|NCT00441090|467469600|FG004|Overall Study|Lack of Efficacy|0|||
129866738|NCT00605280|467469601|FG000|Year 1|Protocol Violation|0|||
129866739|NCT00605280|467469602|FG001|Year 1|Protocol Violation|0|||
129866740|NCT00605280|467469603|FG002|Year 1|Protocol Violation|0|||
129866741|NCT00605280|467469604|FG003|Year 1|Protocol Violation|1|||
129866742|NCT00605280|467469601|FG000|Year 1|Adverse Event|3|||
129866743|NCT00605280|467469602|FG001|Year 1|Adverse Event|1|||
129866744|NCT00605280|467469603|FG002|Year 1|Adverse Event|1|||
129866745|NCT00605280|467469604|FG003|Year 1|Adverse Event|5|||
129866746|NCT00605280|467469601|FG000|Year 1|Physician Decision|7|||
129866747|NCT00605280|467469602|FG001|Year 1|Physician Decision|4|||
129866748|NCT00605280|467469603|FG002|Year 1|Physician Decision|0|||
129866749|NCT00605280|467469604|FG003|Year 1|Physician Decision|6|||
129866750|NCT00605280|467469601|FG000|Year 1|Withdrawal by Subject|2|||
129866751|NCT00605280|467469602|FG001|Year 1|Withdrawal by Subject|4|||
129866752|NCT00605280|467469603|FG002|Year 1|Withdrawal by Subject|0|||
129866753|NCT00605280|467469604|FG003|Year 1|Withdrawal by Subject|4|||
129866754|NCT00605280|467469601|FG000|Year 1|Other|2|||
129866755|NCT00605280|467469602|FG001|Year 1|Other|1|||
129866756|NCT00605280|467469603|FG002|Year 1|Other|0|||
129866757|NCT00605280|467469604|FG003|Year 1|Other|1|||
129866758|NCT00605280|467469601|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
129866759|NCT00605280|467469602|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
129866760|NCT00605280|467469603|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
129866761|NCT00605280|467469604|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
129866762|NCT00605280|467469601|FG000|Year 2|Adverse Event|4|||
129866763|NCT00605280|467469602|FG001|Year 2|Adverse Event|0|||
129866764|NCT00605280|467469603|FG002|Year 2|Adverse Event|2|||
129866765|NCT00605280|467469604|FG003|Year 2|Adverse Event|4|||
129866766|NCT00605280|467469601|FG000|Year 2|Physician Decision|11|||
129866767|NCT00605280|467469602|FG001|Year 2|Physician Decision|6|||
129866768|NCT00605280|467469603|FG002|Year 2|Physician Decision|4|||
129866769|NCT00605280|467469604|FG003|Year 2|Physician Decision|11|||
129866770|NCT00605280|467469601|FG000|Year 2|Withdrawal by Subject|4|||
129866771|NCT00605280|467469602|FG001|Year 2|Withdrawal by Subject|0|||
129866772|NCT00605280|467469603|FG002|Year 2|Withdrawal by Subject|0|||
129866773|NCT00605280|467469604|FG003|Year 2|Withdrawal by Subject|4|||
129866774|NCT00605280|467469601|FG000|Year 2|Other|1|||
129866775|NCT00605280|467469602|FG001|Year 2|Other|0|||
129866776|NCT00605280|467469603|FG002|Year 2|Other|0|||
129866777|NCT00605280|467469604|FG003|Year 2|Other|1|||
129866778|NCT00605280|467469601|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
129866779|NCT00605280|467469602|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
129866780|NCT00605280|467469603|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
129866781|NCT00605280|467469604|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
129866782|NCT00605280|467469601|FG000|Year 3 Extension|Adverse Event|2|||
130065828|NCT00949910|468196005|FG000|Overall Study|Prolonged Dosing Interruption|4|||
130065829|NCT00949910|468196005|FG000|Overall Study|Adverse Event|83|||
129866783|NCT00605280|467469602|FG001|Year 3 Extension|Adverse Event|0|||
129866784|NCT00605280|467469603|FG002|Year 3 Extension|Adverse Event|0|||
129866785|NCT00605280|467469604|FG003|Year 3 Extension|Adverse Event|2|||
129866786|NCT00605280|467469601|FG000|Year 3 Extension|Physician Decision|0|||
129866787|NCT00605280|467469602|FG001|Year 3 Extension|Physician Decision|0|||
129866788|NCT00605280|467469603|FG002|Year 3 Extension|Physician Decision|0|||
129866789|NCT00605280|467469604|FG003|Year 3 Extension|Physician Decision|2|||
129866790|NCT00605280|467469601|FG000|Year 3 Extension|Withdrawal by Subject|2|||
129866791|NCT00605280|467469602|FG001|Year 3 Extension|Withdrawal by Subject|0|||
129866792|NCT00605280|467469603|FG002|Year 3 Extension|Withdrawal by Subject|0|||
129915792|NCT02119650|467654496|FG001|Overall Study|Death|1|||
129915793|NCT02119650|467654495|FG000|Overall Study|Noncompliance with study treatment|1|||
129915794|NCT02119650|467654496|FG001|Overall Study|Noncompliance with study treatment|1|||
129915795|NCT02119650|467654495|FG000|Overall Study|Study terminated by the sponsor|1|||
129915796|NCT02119650|467654496|FG001|Overall Study|Study terminated by the sponsor|0|||
129915797|NCT02119650|467654495|FG000|Overall Study|Physician Decision|0|||
129915798|NCT02119650|467654496|FG001|Overall Study|Physician Decision|2|||
129915799|NCT02119650|467654495|FG000|Overall Study|Multiple reasons for termination|2|||
130065830|NCT00949910|468196005|FG000|Overall Study|Serious Adverse Event|6|||
130065831|NCT00949910|468196005|FG000|Overall Study|Physician/Participant Decision|7|||
130065832|NCT00949910|468196005|FG000|Overall Study|Other|4|||
130065833|NCT00949910|468196005|FG000|Overall Study|No Data|9|||
130065834|NCT02293993|468196008|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
130065835|NCT02293993|468196009|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
130065836|NCT02293993|468196010|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
130065837|NCT02293993|468196011|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
129866793|NCT00605280|467469604|FG003|Year 3 Extension|Withdrawal by Subject|5|||
129866794|NCT00605280|467469601|FG000|Year 3 Extension|Other|2|||
129866795|NCT00605280|467469602|FG001|Year 3 Extension|Other|0|||
129866796|NCT00605280|467469603|FG002|Year 3 Extension|Other|0|||
129866797|NCT00605280|467469604|FG003|Year 3 Extension|Other|0|||
129866798|NCT00605280|467469601|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
129866799|NCT00605280|467469602|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
129866800|NCT00605280|467469603|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
129866801|NCT00605280|467469604|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
129866802|NCT01775904|467469608|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
129866803|NCT01775904|467469608|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
129866804|NCT00518115|467469609|FG000|Overall Study|Adverse Event|6|||
129866805|NCT00518115|467469610|FG001|Overall Study|Adverse Event|1|||
129866806|NCT00518115|467469611|FG002|Overall Study|Adverse Event|5|||
129866807|NCT00518115|467469612|FG003|Overall Study|Adverse Event|6|||
129866808|NCT00518115|467469613|FG004|Overall Study|Adverse Event|5|||
129866809|NCT00518115|467469614|FG005|Overall Study|Adverse Event|5|||
129866810|NCT00518115|467469615|FG006|Overall Study|Adverse Event|5|||
129866811|NCT00518115|467469616|FG007|Overall Study|Adverse Event|10|||
129866812|NCT00518115|467469617|FG008|Overall Study|Adverse Event|2|||
129866813|NCT00518115|467469618|FG009|Overall Study|Adverse Event|9|||
129866814|NCT00518115|467469609|FG000|Overall Study|Lost to Follow-up|0|||
129866815|NCT00518115|467469610|FG001|Overall Study|Lost to Follow-up|0|||
129866816|NCT00518115|467469611|FG002|Overall Study|Lost to Follow-up|2|||
129866817|NCT00518115|467469612|FG003|Overall Study|Lost to Follow-up|3|||
129866818|NCT00518115|467469613|FG004|Overall Study|Lost to Follow-up|1|||
129866819|NCT00518115|467469614|FG005|Overall Study|Lost to Follow-up|3|||
129866820|NCT00518115|467469615|FG006|Overall Study|Lost to Follow-up|0|||
129866821|NCT00518115|467469616|FG007|Overall Study|Lost to Follow-up|1|||
129866822|NCT00518115|467469617|FG008|Overall Study|Lost to Follow-up|1|||
129866823|NCT00518115|467469618|FG009|Overall Study|Lost to Follow-up|1|||
129866824|NCT00518115|467469609|FG000|Overall Study|Protocol Violation|1|||
129866825|NCT00518115|467469610|FG001|Overall Study|Protocol Violation|3|||
129866826|NCT00518115|467469611|FG002|Overall Study|Protocol Violation|1|||
129866827|NCT00518115|467469612|FG003|Overall Study|Protocol Violation|0|||
129866828|NCT00518115|467469613|FG004|Overall Study|Protocol Violation|0|||
129866829|NCT00518115|467469614|FG005|Overall Study|Protocol Violation|0|||
129866830|NCT00518115|467469615|FG006|Overall Study|Protocol Violation|0|||
129866831|NCT00518115|467469616|FG007|Overall Study|Protocol Violation|0|||
129866832|NCT00518115|467469617|FG008|Overall Study|Protocol Violation|0|||
129866833|NCT00518115|467469618|FG009|Overall Study|Protocol Violation|0|||
129915800|NCT02119650|467654496|FG001|Overall Study|Multiple reasons for termination|1|||
129866834|NCT00518115|467469609|FG000|Overall Study|Withdrawal by Subject|1|||
129866835|NCT00518115|467469610|FG001|Overall Study|Withdrawal by Subject|1|||
129915801|NCT01721291|467654498|FG000|Overall Study|Withdrawal by Subject|1|||
129915802|NCT01721291|467654499|FG001|Overall Study|Withdrawal by Subject|0|||
129915803|NCT01721291|467654498|FG000|Overall Study|did not like the treatment|1|||
129866836|NCT00518115|467469611|FG002|Overall Study|Withdrawal by Subject|5|||
129866837|NCT00518115|467469612|FG003|Overall Study|Withdrawal by Subject|0|||
129866838|NCT00518115|467469613|FG004|Overall Study|Withdrawal by Subject|2|||
129915804|NCT01721291|467654499|FG001|Overall Study|did not like the treatment|0|||
129915805|NCT04442126|467654510|FG000|Overall Study|Withdrawal by Subject|0|||
129866839|NCT00518115|467469614|FG005|Overall Study|Withdrawal by Subject|1|||
129866840|NCT00518115|467469615|FG006|Overall Study|Withdrawal by Subject|0|||
129866841|NCT00518115|467469616|FG007|Overall Study|Withdrawal by Subject|2|||
129866842|NCT00518115|467469617|FG008|Overall Study|Withdrawal by Subject|1|||
129866843|NCT00518115|467469618|FG009|Overall Study|Withdrawal by Subject|3|||
129866844|NCT00518115|467469609|FG000|Overall Study|Lack of Efficacy|1|||
129866845|NCT00518115|467469610|FG001|Overall Study|Lack of Efficacy|0|||
129915806|NCT04442126|467654511|FG001|Overall Study|Withdrawal by Subject|0|||
129866846|NCT00518115|467469611|FG002|Overall Study|Lack of Efficacy|1|||
129866847|NCT00518115|467469612|FG003|Overall Study|Lack of Efficacy|1|||
129866848|NCT00518115|467469613|FG004|Overall Study|Lack of Efficacy|0|||
129866849|NCT00518115|467469614|FG005|Overall Study|Lack of Efficacy|0|||
129866850|NCT00518115|467469615|FG006|Overall Study|Lack of Efficacy|0|||
129866851|NCT00518115|467469616|FG007|Overall Study|Lack of Efficacy|1|||
129866852|NCT00518115|467469617|FG008|Overall Study|Lack of Efficacy|0|||
129866853|NCT00518115|467469618|FG009|Overall Study|Lack of Efficacy|0|||
129866854|NCT00518115|467469609|FG000|Overall Study|Non-Compliance|1|||
129866855|NCT00518115|467469610|FG001|Overall Study|Non-Compliance|0|||
129866856|NCT00518115|467469611|FG002|Overall Study|Non-Compliance|1|||
129866857|NCT00518115|467469612|FG003|Overall Study|Non-Compliance|0|||
129866858|NCT00518115|467469613|FG004|Overall Study|Non-Compliance|1|||
129866859|NCT00518115|467469614|FG005|Overall Study|Non-Compliance|1|||
129866860|NCT00518115|467469615|FG006|Overall Study|Non-Compliance|1|||
129866861|NCT00518115|467469616|FG007|Overall Study|Non-Compliance|1|||
129866862|NCT00518115|467469617|FG008|Overall Study|Non-Compliance|0|||
129866863|NCT00518115|467469618|FG009|Overall Study|Non-Compliance|1|||
129866864|NCT00518115|467469609|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
129866865|NCT00518115|467469610|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
129866866|NCT00518115|467469611|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866867|NCT00518115|467469612|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866868|NCT00518115|467469613|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866869|NCT00518115|467469614|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
129866870|NCT00518115|467469615|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866871|NCT00518115|467469616|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866872|NCT00518115|467469617|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866873|NCT00518115|467469618|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866874|NCT00518115|467469609|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
129866875|NCT00518115|467469610|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866876|NCT00518115|467469611|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866877|NCT00518115|467469612|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866878|NCT00518115|467469613|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866879|NCT00518115|467469614|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866880|NCT00518115|467469615|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866881|NCT00518115|467469616|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866882|NCT00518115|467469617|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866883|NCT00518115|467469618|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866884|NCT00518115|467469609|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866885|NCT00518115|467469610|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866886|NCT00518115|467469611|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
129866887|NCT00518115|467469612|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866888|NCT00518115|467469613|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866889|NCT00518115|467469614|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866890|NCT00518115|467469615|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866891|NCT00518115|467469616|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866892|NCT00518115|467469617|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
129866893|NCT00518115|467469618|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866894|NCT00518115|467469609|FG000|Overall Study|Wrong Monotherapy Administered|0|||
129866895|NCT00518115|467469610|FG001|Overall Study|Wrong Monotherapy Administered|0|||
129866896|NCT00518115|467469611|FG002|Overall Study|Wrong Monotherapy Administered|1|||
129866897|NCT00518115|467469612|FG003|Overall Study|Wrong Monotherapy Administered|0|||
129866898|NCT00518115|467469613|FG004|Overall Study|Wrong Monotherapy Administered|0|||
129866899|NCT00518115|467469614|FG005|Overall Study|Wrong Monotherapy Administered|0|||
129866900|NCT00518115|467469615|FG006|Overall Study|Wrong Monotherapy Administered|1|||
129866901|NCT00518115|467469616|FG007|Overall Study|Wrong Monotherapy Administered|0|||
129866902|NCT00518115|467469617|FG008|Overall Study|Wrong Monotherapy Administered|0|||
129866903|NCT00518115|467469618|FG009|Overall Study|Wrong Monotherapy Administered|0|||
129866904|NCT00518115|467469609|FG000|Overall Study|Violation of Exclusion Criteria|0|||
129915807|NCT04442126|467654512|FG002|Overall Study|Withdrawal by Subject|0|||
129915808|NCT04442126|467654513|FG003|Overall Study|Withdrawal by Subject|2|||
130065838|NCT02293993|468196008|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
130065839|NCT02293993|468196009|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
130065840|NCT02293993|468196010|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
129866905|NCT00518115|467469610|FG001|Overall Study|Violation of Exclusion Criteria|0|||
129866906|NCT00518115|467469611|FG002|Overall Study|Violation of Exclusion Criteria|0|||
129866907|NCT00518115|467469612|FG003|Overall Study|Violation of Exclusion Criteria|1|||
129866908|NCT00518115|467469613|FG004|Overall Study|Violation of Exclusion Criteria|0|||
129866909|NCT00518115|467469614|FG005|Overall Study|Violation of Exclusion Criteria|0|||
129866910|NCT00518115|467469615|FG006|Overall Study|Violation of Exclusion Criteria|1|||
129866911|NCT00518115|467469616|FG007|Overall Study|Violation of Exclusion Criteria|0|||
129866912|NCT00518115|467469617|FG008|Overall Study|Violation of Exclusion Criteria|0|||
129866913|NCT00518115|467469618|FG009|Overall Study|Violation of Exclusion Criteria|0|||
129866914|NCT00518115|467469609|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
129866915|NCT00518115|467469610|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
129866916|NCT00518115|467469611|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
129866917|NCT00518115|467469612|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
129866918|NCT00518115|467469613|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
129866919|NCT00518115|467469614|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
129866920|NCT00518115|467469615|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
129866921|NCT00518115|467469616|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
129866922|NCT00518115|467469617|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
129866923|NCT00518115|467469618|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
129866924|NCT00518115|467469609|FG000|Overall Study|Withdrew Consent|0|||
129866925|NCT00518115|467469610|FG001|Overall Study|Withdrew Consent|0|||
129866926|NCT00518115|467469611|FG002|Overall Study|Withdrew Consent|0|||
129866927|NCT00518115|467469612|FG003|Overall Study|Withdrew Consent|0|||
129866928|NCT00518115|467469613|FG004|Overall Study|Withdrew Consent|0|||
129866929|NCT00518115|467469614|FG005|Overall Study|Withdrew Consent|1|||
129866930|NCT00518115|467469615|FG006|Overall Study|Withdrew Consent|0|||
129866931|NCT00518115|467469616|FG007|Overall Study|Withdrew Consent|0|||
129866932|NCT00518115|467469617|FG008|Overall Study|Withdrew Consent|0|||
129866933|NCT00518115|467469618|FG009|Overall Study|Withdrew Consent|0|||
129866934|NCT00518115|467469609|FG000|Overall Study|Moved Out of State|0|||
129866935|NCT00518115|467469610|FG001|Overall Study|Moved Out of State|0|||
129866936|NCT00518115|467469611|FG002|Overall Study|Moved Out of State|0|||
129866937|NCT00518115|467469612|FG003|Overall Study|Moved Out of State|0|||
129866938|NCT00518115|467469613|FG004|Overall Study|Moved Out of State|0|||
129866939|NCT00518115|467469614|FG005|Overall Study|Moved Out of State|0|||
129866940|NCT00518115|467469615|FG006|Overall Study|Moved Out of State|0|||
129866941|NCT00518115|467469616|FG007|Overall Study|Moved Out of State|0|||
129866942|NCT00518115|467469617|FG008|Overall Study|Moved Out of State|0|||
129866943|NCT00518115|467469618|FG009|Overall Study|Moved Out of State|1|||
129866944|NCT04891419|467469619|FG000|Overall Study|Withdrawal by Subject|4|||
129866945|NCT04891419|467469620|FG001|Overall Study|Withdrawal by Subject|0|||
129866946|NCT04891419|467469619|FG000|Overall Study|Lost to Follow-up|1|||
129866947|NCT04891419|467469620|FG001|Overall Study|Lost to Follow-up|3|||
129866948|NCT00827918|467469621|FG000|Overall Study|Adverse Event|4|||
129866949|NCT00827918|467469622|FG001|Overall Study|Adverse Event|0|||
129866950|NCT00827918|467469623|FG002|Overall Study|Adverse Event|0|||
129866951|NCT00827918|467469621|FG000|Overall Study|Lack of Efficacy|16|||
129866952|NCT00827918|467469622|FG001|Overall Study|Lack of Efficacy|4|||
129915809|NCT04442126|467654514|FG004|Overall Study|Withdrawal by Subject|1|||
129915810|NCT04442126|467654515|FG005|Overall Study|Withdrawal by Subject|0|||
129915811|NCT04442126|467654516|FG006|Overall Study|Withdrawal by Subject|1|||
129915812|NCT04442126|467654517|FG007|Overall Study|Withdrawal by Subject|1|||
129915813|NCT04442126|467654518|FG008|Overall Study|Withdrawal by Subject|3|||
129915814|NCT04442126|467654510|FG000|Overall Study|Death|1|||
129915815|NCT04442126|467654511|FG001|Overall Study|Death|0|||
129915816|NCT04442126|467654512|FG002|Overall Study|Death|0|||
129915817|NCT04442126|467654513|FG003|Overall Study|Death|1|||
129915818|NCT04442126|467654514|FG004|Overall Study|Death|2|||
129915819|NCT04442126|467654515|FG005|Overall Study|Death|2|||
129915820|NCT04442126|467654516|FG006|Overall Study|Death|4|||
129915821|NCT04442126|467654517|FG007|Overall Study|Death|1|||
129915822|NCT04442126|467654518|FG008|Overall Study|Death|5|||
129915823|NCT04442126|467654510|FG000|Overall Study|Study Terminated by Sponsor|0|||
130065841|NCT02293993|468196011|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
129866953|NCT00827918|467469623|FG002|Overall Study|Lack of Efficacy|15|||
129866954|NCT00827918|467469621|FG000|Overall Study|Physician Decision|1|||
129866955|NCT00827918|467469622|FG001|Overall Study|Physician Decision|0|||
129866956|NCT00827918|467469623|FG002|Overall Study|Physician Decision|0|||
129866957|NCT00827918|467469621|FG000|Overall Study|Pregnancy|0|||
129866958|NCT00827918|467469622|FG001|Overall Study|Pregnancy|1|||
129866959|NCT00827918|467469623|FG002|Overall Study|Pregnancy|0|||
129866960|NCT00827918|467469621|FG000|Overall Study|Progressive Disease|1|||
129915824|NCT04442126|467654511|FG001|Overall Study|Study Terminated by Sponsor|0|||
129915825|NCT04442126|467654512|FG002|Overall Study|Study Terminated by Sponsor|0|||
129915826|NCT04442126|467654513|FG003|Overall Study|Study Terminated by Sponsor|0|||
129866961|NCT00827918|467469622|FG001|Overall Study|Progressive Disease|1|||
129866962|NCT00827918|467469623|FG002|Overall Study|Progressive Disease|0|||
129866963|NCT00827918|467469621|FG000|Overall Study|Protocol Violation|0|||
129866964|NCT00827918|467469622|FG001|Overall Study|Protocol Violation|1|||
129866965|NCT00827918|467469623|FG002|Overall Study|Protocol Violation|0|||
129915827|NCT04442126|467654514|FG004|Overall Study|Study Terminated by Sponsor|0|||
129866966|NCT00827918|467469621|FG000|Overall Study|Withdrawal by Subject|6|||
129866967|NCT00827918|467469622|FG001|Overall Study|Withdrawal by Subject|2|||
129866968|NCT00827918|467469623|FG002|Overall Study|Withdrawal by Subject|6|||
129915828|NCT04442126|467654515|FG005|Overall Study|Study Terminated by Sponsor|1|||
129915829|NCT04442126|467654516|FG006|Overall Study|Study Terminated by Sponsor|4|||
129915830|NCT04442126|467654517|FG007|Overall Study|Study Terminated by Sponsor|2|||
129915831|NCT04442126|467654518|FG008|Overall Study|Study Terminated by Sponsor|10|||
129915832|NCT04442126|467654510|FG000|Overall Study|Lost to Follow-up|0|||
129915833|NCT04442126|467654511|FG001|Overall Study|Lost to Follow-up|0|||
129915834|NCT04442126|467654512|FG002|Overall Study|Lost to Follow-up|0|||
129915835|NCT04442126|467654513|FG003|Overall Study|Lost to Follow-up|0|||
129915836|NCT04442126|467654514|FG004|Overall Study|Lost to Follow-up|0|||
129915837|NCT04442126|467654515|FG005|Overall Study|Lost to Follow-up|0|||
129915838|NCT04442126|467654516|FG006|Overall Study|Lost to Follow-up|0|||
129915839|NCT04442126|467654517|FG007|Overall Study|Lost to Follow-up|1|||
129915840|NCT04442126|467654518|FG008|Overall Study|Lost to Follow-up|2|||
129915841|NCT04442126|467654510|FG000|Overall Study|Progressive Disease|0|||
129915842|NCT04442126|467654511|FG001|Overall Study|Progressive Disease|1|||
129915843|NCT04442126|467654512|FG002|Overall Study|Progressive Disease|3|||
129915844|NCT04442126|467654513|FG003|Overall Study|Progressive Disease|0|||
129915845|NCT04442126|467654514|FG004|Overall Study|Progressive Disease|3|||
129915846|NCT04442126|467654515|FG005|Overall Study|Progressive Disease|0|||
129915847|NCT04442126|467654516|FG006|Overall Study|Progressive Disease|0|||
129915848|NCT04442126|467654517|FG007|Overall Study|Progressive Disease|0|||
129915849|NCT04442126|467654518|FG008|Overall Study|Progressive Disease|0|||
129915850|NCT04442126|467654510|FG000|Overall Study|Other|0|||
129915851|NCT04442126|467654511|FG001|Overall Study|Other|0|||
129915852|NCT04442126|467654512|FG002|Overall Study|Other|0|||
129915853|NCT04442126|467654513|FG003|Overall Study|Other|0|||
129915854|NCT04442126|467654514|FG004|Overall Study|Other|0|||
129915855|NCT04442126|467654515|FG005|Overall Study|Other|0|||
129915856|NCT04442126|467654516|FG006|Overall Study|Other|0|||
129915857|NCT04442126|467654517|FG007|Overall Study|Other|0|||
129915858|NCT04442126|467654518|FG008|Overall Study|Other|1|||
129915859|NCT06450405|467654519|FG000|Overall Study|Study funding terminated.|0|||
129915860|NCT06450405|467654520|FG001|Overall Study|Study funding terminated.|2|||
129915861|NCT05134337|467655847|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
129915862|NCT05134337|467655848|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
129915863|NCT04923347|467655849|FG000|Overall Study|Withdrawal by Subject|14|||
129915864|NCT03424811|467655850|FG000|Overall Study|Lost to Follow-up|9|||
129915865|NCT03424811|467655851|FG001|Overall Study|Lost to Follow-up|0|||
129915866|NCT03948763|467655852|FG000|Overall Study|Sponsor's decision|0|||
129915867|NCT03948763|467655853|FG001|Overall Study|Sponsor's decision|2|||
129915868|NCT03948763|467655854|FG002|Overall Study|Sponsor's decision|6|||
129915869|NCT03948763|467655855|FG003|Overall Study|Sponsor's decision|4|||
129915870|NCT03948763|467655856|FG004|Overall Study|Sponsor's decision|0|||
129915871|NCT03948763|467655852|FG000|Overall Study|Physician Decision|0|||
129915872|NCT03948763|467655853|FG001|Overall Study|Physician Decision|0|||
129915873|NCT03948763|467655854|FG002|Overall Study|Physician Decision|1|||
129915874|NCT03948763|467655855|FG003|Overall Study|Physician Decision|0|||
129915875|NCT03948763|467655856|FG004|Overall Study|Physician Decision|0|||
129915876|NCT03948763|467655852|FG000|Overall Study|Lost to Follow-up|0|||
129915877|NCT03948763|467655853|FG001|Overall Study|Lost to Follow-up|0|||
129915878|NCT03948763|467655854|FG002|Overall Study|Lost to Follow-up|0|||
129915879|NCT03948763|467655855|FG003|Overall Study|Lost to Follow-up|0|||
129915880|NCT03948763|467655856|FG004|Overall Study|Lost to Follow-up|1|||
129915881|NCT03948763|467655852|FG000|Overall Study|Death|2|||
129915882|NCT03948763|467655853|FG001|Overall Study|Death|12|||
129915883|NCT03948763|467655854|FG002|Overall Study|Death|13|||
129915884|NCT03948763|467655855|FG003|Overall Study|Death|10|||
129915885|NCT03948763|467655856|FG004|Overall Study|Death|11|||
130065842|NCT02293993|468196008|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
130065843|NCT02293993|468196009|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
130065844|NCT02293993|468196010|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
129915886|NCT03948763|467655852|FG000|Overall Study|Withdrawal by Subject|1|||
129915887|NCT03948763|467655853|FG001|Overall Study|Withdrawal by Subject|1|||
129915888|NCT03948763|467655854|FG002|Overall Study|Withdrawal by Subject|0|||
129915889|NCT03948763|467655855|FG003|Overall Study|Withdrawal by Subject|2|||
130065845|NCT02293993|468196011|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
130065846|NCT02293993|468196008|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
130065847|NCT02293993|468196009|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
129915890|NCT03948763|467655856|FG004|Overall Study|Withdrawal by Subject|4|||
129915891|NCT04511702|467655857|FG000|Overall Study|Lost to Follow-up|3|||
129915892|NCT04511702|467655858|FG001|Overall Study|Lost to Follow-up|0|||
129915893|NCT04511702|467655859|FG002|Overall Study|Lost to Follow-up|4|||
130065848|NCT02293993|468196010|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
129915894|NCT04511702|467655857|FG000|Overall Study|Withdrawal by Subject|17|||
129915895|NCT04511702|467655858|FG001|Overall Study|Withdrawal by Subject|1|||
129915896|NCT04511702|467655859|FG002|Overall Study|Withdrawal by Subject|8|||
129915897|NCT02840474|467655862|FG000|Overall Study|Lost to Follow-up|1|||
129915898|NCT02840474|467655863|FG001|Overall Study|Lost to Follow-up|0|||
129915899|NCT03192891|467655864|FG000|Overall Study|Lost to Follow-up|55|||
129915900|NCT05141903|467655866|FG000|Overall Study|Withdrawal by Subject|0|||
129915901|NCT05141903|467655867|FG001|Overall Study|Withdrawal by Subject|1|||
129915902|NCT05141903|467655868|FG002|Overall Study|Withdrawal by Subject|1|||
129915903|NCT05141903|467655869|FG003|Overall Study|Withdrawal by Subject|0|||
129915904|NCT05141903|467655870|FG004|Overall Study|Withdrawal by Subject|0|||
129915905|NCT05141903|467655866|FG000|Overall Study|Other|1|||
129915906|NCT05141903|467655867|FG001|Overall Study|Other|1|||
129915907|NCT05141903|467655868|FG002|Overall Study|Other|0|||
129915908|NCT05141903|467655869|FG003|Overall Study|Other|0|||
129915909|NCT05141903|467655870|FG004|Overall Study|Other|0|||
129915910|NCT04716634|467655871|FG000|Overall Study|Death|24|||
129915911|NCT04716634|467655872|FG001|Overall Study|Death|24|||
129915912|NCT04716634|467655873|FG002|Overall Study|Death|8|||
129915913|NCT04716634|467655871|FG000|Overall Study|Closed by Sponsor|4|||
129915914|NCT04716634|467655872|FG001|Overall Study|Closed by Sponsor|4|||
129915915|NCT04716634|467655873|FG002|Overall Study|Closed by Sponsor|5|||
129915916|NCT04716634|467655871|FG000|Overall Study|Lost to Follow-up|1|||
129915917|NCT04716634|467655872|FG001|Overall Study|Lost to Follow-up|0|||
129915918|NCT04716634|467655873|FG002|Overall Study|Lost to Follow-up|1|||
129915919|NCT04716634|467655871|FG000|Overall Study|Withdrawal by Subject|0|||
129915920|NCT04716634|467655872|FG001|Overall Study|Withdrawal by Subject|0|||
129915921|NCT04716634|467655873|FG002|Overall Study|Withdrawal by Subject|1|||
129915922|NCT02630823|467655882|FG000|Overall Study|Withdrawal by Subject|1|||
129915923|NCT02630823|467655882|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
129915924|NCT05387447|467655883|FG000|Overall Study|Participants changed their minds about study participation.|3|||
129915925|NCT05387447|467655884|FG001|Overall Study|Participants changed their minds about study participation.|5|||
129915926|NCT03391466|467655887|FG000|Overall Study|Death|82|||
129915927|NCT03391466|467655888|FG001|Overall Study|Death|85|||
129915928|NCT03391466|467655887|FG000|Overall Study|Still on study|93|||
129915929|NCT03391466|467655888|FG001|Overall Study|Still on study|74|||
129915930|NCT03391466|467655887|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
129915931|NCT03391466|467655888|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
129915932|NCT03391466|467655887|FG000|Overall Study|Lost to Follow-up|5|||
129915933|NCT03391466|467655888|FG001|Overall Study|Lost to Follow-up|5|||
129915934|NCT03391466|467655887|FG000|Overall Study|Investigator decision|0|||
129915935|NCT03391466|467655888|FG001|Overall Study|Investigator decision|1|||
129915936|NCT03391466|467655887|FG000|Overall Study|Other|0|||
129915937|NCT03391466|467655888|FG001|Overall Study|Other|1|||
129915938|NCT03655132|467655891|FG000|Overall Study|Lost to Follow-up|2|||
129915939|NCT03655132|467655892|FG001|Overall Study|Lost to Follow-up|1|||
129915940|NCT03655132|467655891|FG000|Overall Study|Withdrawal by Subject|0|||
129915941|NCT03655132|467655892|FG001|Overall Study|Withdrawal by Subject|1|||
129915942|NCT03655132|467655891|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
129915943|NCT03655132|467655892|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
129915944|NCT01707030|467655901|FG000|Overall Study|Death|1|||
129915945|NCT01707030|467655902|FG001|Overall Study|Death|1|||
129915946|NCT01707030|467655901|FG000|Overall Study|Withdrawal by Subject|2|||
129915947|NCT01707030|467655902|FG001|Overall Study|Withdrawal by Subject|3|||
129915948|NCT01707030|467655901|FG000|Overall Study|Lost to Follow-up|8|||
129915949|NCT01707030|467655902|FG001|Overall Study|Lost to Follow-up|13|||
129915950|NCT04820855|467655903|FG000|Overall Study|Lost to Follow-up|6|||
129915951|NCT04820855|467655904|FG001|Overall Study|Lost to Follow-up|9|||
129915952|NCT00650104|467655906|FG000|Overall Study|Adverse Event|17|||
129915953|NCT00650104|467655906|FG000|Overall Study|Death|2|||
129915954|NCT00650104|467655906|FG000|Overall Study|Withdrawal by Subject|11|||
129915955|NCT00650104|467655906|FG000|Overall Study|Physician Decision|7|||
129915956|NCT00650104|467655906|FG000|Overall Study|Lost to Follow-up|1|||
129915957|NCT00650104|467655906|FG000|Overall Study|Non-compliance|2|||
129915958|NCT00650104|467655906|FG000|Overall Study|Sponsor Terminated Dosing|1|||
129915959|NCT01376700|467655907|FG000|Overall Study|Sponsor terminated study early|8|||
130065849|NCT02293993|468196011|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
130065850|NCT02293993|468196008|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
129915960|NCT01376700|467655907|FG000|Overall Study|Low or high titer inhibitor|8|||
129915961|NCT00601900|467655919|FG000|Overall Study|Withdrawal by Subject|0|||
129915962|NCT00601900|467655920|FG001|Overall Study|Withdrawal by Subject|3|||
129915963|NCT02500758|467655924|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
129915964|NCT02500758|467655925|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
129915965|NCT02500758|467655924|FG000|Washout (1 Week)|Lost to Follow-up|2|||
129915966|NCT02500758|467655925|FG001|Washout (1 Week)|Lost to Follow-up|2|||
129915967|NCT02500758|467655924|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
129915968|NCT02500758|467655925|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
129915969|NCT02500758|467655924|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
129866969|NCT00127101|467469624|FG000|Base Protocol|Adverse Event|0|||
129866970|NCT00127101|467469625|FG001|Base Protocol|Adverse Event|2|||
129866971|NCT00127101|467469626|FG002|Base Protocol|Adverse Event|1|||
129866972|NCT00127101|467469627|FG003|Base Protocol|Adverse Event|0|||
129866973|NCT00127101|467469628|FG004|Base Protocol|Adverse Event|0|||
129866974|NCT00127101|467469629|FG005|Base Protocol|Adverse Event|0|||
129866975|NCT00127101|467469624|FG000|Base Protocol|Lack of Efficacy|1|||
129866976|NCT00127101|467469625|FG001|Base Protocol|Lack of Efficacy|0|||
129866977|NCT00127101|467469626|FG002|Base Protocol|Lack of Efficacy|0|||
129866978|NCT00127101|467469627|FG003|Base Protocol|Lack of Efficacy|0|||
129866979|NCT00127101|467469628|FG004|Base Protocol|Lack of Efficacy|2|||
129866980|NCT00127101|467469629|FG005|Base Protocol|Lack of Efficacy|0|||
129866981|NCT00127101|467469624|FG000|Base Protocol|Withdrawal by Subject|1|||
129866982|NCT00127101|467469625|FG001|Base Protocol|Withdrawal by Subject|2|||
129866983|NCT00127101|467469626|FG002|Base Protocol|Withdrawal by Subject|1|||
129866984|NCT00127101|467469627|FG003|Base Protocol|Withdrawal by Subject|0|||
129866985|NCT00127101|467469628|FG004|Base Protocol|Withdrawal by Subject|0|||
129866986|NCT00127101|467469629|FG005|Base Protocol|Withdrawal by Subject|1|||
129866987|NCT00127101|467469624|FG000|Continuation Phase|Adverse Event|0|||
129866988|NCT00127101|467469625|FG001|Continuation Phase|Adverse Event|0|||
129866989|NCT00127101|467469626|FG002|Continuation Phase|Adverse Event|0|||
129866990|NCT00127101|467469627|FG003|Continuation Phase|Adverse Event|0|||
129866991|NCT00127101|467469628|FG004|Continuation Phase|Adverse Event|1|||
129866992|NCT00127101|467469629|FG005|Continuation Phase|Adverse Event|1|||
129866993|NCT00127101|467469624|FG000|Continuation Phase|Lack of Efficacy|0|||
129866994|NCT00127101|467469625|FG001|Continuation Phase|Lack of Efficacy|0|||
129866995|NCT00127101|467469626|FG002|Continuation Phase|Lack of Efficacy|0|||
129866996|NCT00127101|467469627|FG003|Continuation Phase|Lack of Efficacy|0|||
129866997|NCT00127101|467469628|FG004|Continuation Phase|Lack of Efficacy|0|||
129866998|NCT00127101|467469629|FG005|Continuation Phase|Lack of Efficacy|1|||
129866999|NCT00127101|467469624|FG000|Continuation Phase|Withdrawal by Subject|0|||
129867000|NCT00127101|467469625|FG001|Continuation Phase|Withdrawal by Subject|0|||
129867001|NCT00127101|467469626|FG002|Continuation Phase|Withdrawal by Subject|1|||
129867002|NCT00127101|467469627|FG003|Continuation Phase|Withdrawal by Subject|0|||
129867003|NCT00127101|467469628|FG004|Continuation Phase|Withdrawal by Subject|2|||
129867004|NCT00127101|467469629|FG005|Continuation Phase|Withdrawal by Subject|1|||
129867005|NCT01302847|467469630|FG000|Overall Study|Death|0|||
129867006|NCT01302847|467469631|FG001|Overall Study|Death|1|||
129867007|NCT01302847|467469632|FG002|Overall Study|Death|0|||
129867008|NCT01302847|467469633|FG003|Overall Study|Death|0|||
129867009|NCT01302847|467469634|FG004|Overall Study|Death|0|||
129867010|NCT01302847|467469635|FG005|Overall Study|Death|1|||
129867011|NCT01302847|467469636|FG006|Overall Study|Death|1|||
129867012|NCT01302847|467469637|FG007|Overall Study|Death|0|||
129867013|NCT01302847|467469630|FG000|Overall Study|Pregnancy|2|||
129867014|NCT01302847|467469631|FG001|Overall Study|Pregnancy|0|||
129867015|NCT01302847|467469632|FG002|Overall Study|Pregnancy|0|||
129867016|NCT01302847|467469633|FG003|Overall Study|Pregnancy|0|||
129867017|NCT01302847|467469634|FG004|Overall Study|Pregnancy|0|||
129867018|NCT01302847|467469635|FG005|Overall Study|Pregnancy|0|||
129867019|NCT01302847|467469636|FG006|Overall Study|Pregnancy|0|||
129867020|NCT01302847|467469637|FG007|Overall Study|Pregnancy|0|||
129867021|NCT01302847|467469630|FG000|Overall Study|Virologic failure|0|||
129867022|NCT01302847|467469631|FG001|Overall Study|Virologic failure|2|||
129867023|NCT01302847|467469632|FG002|Overall Study|Virologic failure|0|||
129867024|NCT01302847|467469633|FG003|Overall Study|Virologic failure|2|||
129867025|NCT01302847|467469634|FG004|Overall Study|Virologic failure|1|||
129867026|NCT01302847|467469635|FG005|Overall Study|Virologic failure|3|||
129867027|NCT01302847|467469636|FG006|Overall Study|Virologic failure|1|||
129867028|NCT01302847|467469637|FG007|Overall Study|Virologic failure|2|||
129867029|NCT01302847|467469630|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129867030|NCT01302847|467469631|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129867031|NCT01302847|467469632|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130116739|NCT00818623|468387164|FG000|Overall Study|Need of additional treatment|0|||
129867032|NCT01302847|467469633|FG003|Overall Study|Severe debilitation, unable to continue|0|||
129867033|NCT01302847|467469634|FG004|Overall Study|Severe debilitation, unable to continue|0|||
129867034|NCT01302847|467469635|FG005|Overall Study|Severe debilitation, unable to continue|1|||
129867035|NCT01302847|467469636|FG006|Overall Study|Severe debilitation, unable to continue|1|||
129867036|NCT01302847|467469637|FG007|Overall Study|Severe debilitation, unable to continue|0|||
129867037|NCT01302847|467469630|FG000|Overall Study|Not able to get to clinic|1|||
129867038|NCT01302847|467469631|FG001|Overall Study|Not able to get to clinic|1|||
129867039|NCT01302847|467469632|FG002|Overall Study|Not able to get to clinic|0|||
129867040|NCT01302847|467469633|FG003|Overall Study|Not able to get to clinic|0|||
129867041|NCT01302847|467469634|FG004|Overall Study|Not able to get to clinic|0|||
129867042|NCT01302847|467469635|FG005|Overall Study|Not able to get to clinic|0|||
129867043|NCT01302847|467469636|FG006|Overall Study|Not able to get to clinic|0|||
129867044|NCT01302847|467469637|FG007|Overall Study|Not able to get to clinic|0|||
129867045|NCT01302847|467469630|FG000|Overall Study|Site closing|2|||
129867046|NCT01302847|467469631|FG001|Overall Study|Site closing|2|||
129867047|NCT01302847|467469632|FG002|Overall Study|Site closing|0|||
129867048|NCT01302847|467469633|FG003|Overall Study|Site closing|0|||
129867049|NCT01302847|467469634|FG004|Overall Study|Site closing|0|||
129867050|NCT01302847|467469635|FG005|Overall Study|Site closing|0|||
129867051|NCT01302847|467469636|FG006|Overall Study|Site closing|0|||
129867052|NCT01302847|467469637|FG007|Overall Study|Site closing|0|||
129867053|NCT01302847|467469630|FG000|Overall Study|Withdrawal by Subject|1|||
129867054|NCT01302847|467469631|FG001|Overall Study|Withdrawal by Subject|0|||
129867055|NCT01302847|467469632|FG002|Overall Study|Withdrawal by Subject|0|||
129867056|NCT01302847|467469633|FG003|Overall Study|Withdrawal by Subject|0|||
129867057|NCT01302847|467469634|FG004|Overall Study|Withdrawal by Subject|1|||
129867058|NCT01302847|467469635|FG005|Overall Study|Withdrawal by Subject|0|||
129867059|NCT01302847|467469636|FG006|Overall Study|Withdrawal by Subject|0|||
129867060|NCT01302847|467469637|FG007|Overall Study|Withdrawal by Subject|1|||
129867061|NCT01302847|467469630|FG000|Overall Study|Not willing to adhere to requirements|5|||
129867062|NCT01302847|467469631|FG001|Overall Study|Not willing to adhere to requirements|0|||
129867063|NCT01302847|467469632|FG002|Overall Study|Not willing to adhere to requirements|1|||
129867064|NCT01302847|467469633|FG003|Overall Study|Not willing to adhere to requirements|0|||
129867065|NCT01302847|467469634|FG004|Overall Study|Not willing to adhere to requirements|0|||
129867066|NCT01302847|467469635|FG005|Overall Study|Not willing to adhere to requirements|0|||
129867067|NCT01302847|467469636|FG006|Overall Study|Not willing to adhere to requirements|0|||
129867068|NCT01302847|467469637|FG007|Overall Study|Not willing to adhere to requirements|2|||
129867069|NCT01302847|467469630|FG000|Overall Study|Site unable to contact participant|2|||
129867070|NCT01302847|467469631|FG001|Overall Study|Site unable to contact participant|1|||
129867071|NCT01302847|467469632|FG002|Overall Study|Site unable to contact participant|0|||
129867072|NCT01302847|467469633|FG003|Overall Study|Site unable to contact participant|0|||
129867073|NCT01302847|467469634|FG004|Overall Study|Site unable to contact participant|0|||
129867074|NCT01302847|467469635|FG005|Overall Study|Site unable to contact participant|0|||
129867075|NCT01302847|467469636|FG006|Overall Study|Site unable to contact participant|2|||
129867076|NCT01302847|467469637|FG007|Overall Study|Site unable to contact participant|0|||
129867077|NCT00374322|467469638|FG000|Overall Study|Lost to Follow-up|92|||
129867078|NCT00374322|467469639|FG001|Overall Study|Lost to Follow-up|90|||
129867079|NCT00374322|467469638|FG000|Overall Study|Protocol Violation|8|||
129867080|NCT00374322|467469639|FG001|Overall Study|Protocol Violation|3|||
129867081|NCT00374322|467469638|FG000|Overall Study|Withdrawal by Subject|235|||
129867082|NCT00374322|467469639|FG001|Overall Study|Withdrawal by Subject|167|||
129867083|NCT00374322|467469638|FG000|Overall Study|Sponsor Terminated Study|866|||
129867084|NCT00374322|467469639|FG001|Overall Study|Sponsor Terminated Study|990|||
129867085|NCT00374322|467469638|FG000|Overall Study|Physician Decision|36|||
129867086|NCT00374322|467469639|FG001|Overall Study|Physician Decision|32|||
129867087|NCT00374322|467469638|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
129867088|NCT00374322|467469639|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
129867089|NCT00374322|467469638|FG000|Overall Study|Sponsor Decision|2|||
129867090|NCT00374322|467469639|FG001|Overall Study|Sponsor Decision|3|||
129867091|NCT00374322|467469638|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
129867092|NCT00374322|467469639|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
129867093|NCT00374322|467469638|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
129867094|NCT00374322|467469639|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
129867095|NCT00374322|467469638|FG000|Overall Study|Severe Toxicity|1|||
129867096|NCT00374322|467469639|FG001|Overall Study|Severe Toxicity|0|||
129867097|NCT00374322|467469638|FG000|Overall Study|Site Closed|2|||
129867098|NCT00374322|467469639|FG001|Overall Study|Site Closed|2|||
129867099|NCT00374322|467469638|FG000|Overall Study|Participant Changed Physician|1|||
129867100|NCT00374322|467469639|FG001|Overall Study|Participant Changed Physician|0|||
129867101|NCT00374322|467469638|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
129867102|NCT00374322|467469639|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
129867103|NCT00374322|467469638|FG000|Overall Study|Noncompliance with Study Requirements|0|||
129867104|NCT00374322|467469639|FG001|Overall Study|Noncompliance with Study Requirements|1|||
129867105|NCT00374322|467469638|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
129867106|NCT00374322|467469639|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
129867107|NCT00374322|467469638|FG000|Overall Study|Did Not Receive Study Medication|8|||
129867108|NCT00374322|467469639|FG001|Overall Study|Did Not Receive Study Medication|6|||
129867109|NCT00707031|467469640|FG000|Overall Study|Adverse Event|45|||
129867110|NCT00707031|467469641|FG001|Overall Study|Adverse Event|45|||
129867111|NCT00707031|467469640|FG000|Overall Study|Lack of Efficacy|19|||
129867112|NCT00707031|467469641|FG001|Overall Study|Lack of Efficacy|6|||
129867113|NCT00707031|467469640|FG000|Overall Study|Lost to Follow-up|2|||
129867114|NCT00707031|467469641|FG001|Overall Study|Lost to Follow-up|1|||
129867115|NCT00707031|467469640|FG000|Overall Study|Protocol Violation|1|||
129867116|NCT00707031|467469641|FG001|Overall Study|Protocol Violation|0|||
129867117|NCT00707031|467469640|FG000|Overall Study|Withdrawal by Subject|7|||
129867118|NCT00707031|467469641|FG001|Overall Study|Withdrawal by Subject|8|||
129915970|NCT02500758|467655925|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
129867119|NCT00707031|467469640|FG000|Overall Study|Poor Compliance to Protocol|7|||
129867120|NCT00707031|467469641|FG001|Overall Study|Poor Compliance to Protocol|13|||
129867121|NCT00707031|467469640|FG000|Overall Study|Familial or Personal Reasons|12|||
129867122|NCT00707031|467469641|FG001|Overall Study|Familial or Personal Reasons|15|||
129867123|NCT00707031|467469640|FG000|Overall Study|Serious Noncompliance|2|||
129867124|NCT00707031|467469641|FG001|Overall Study|Serious Noncompliance|3|||
129867125|NCT00707031|467469640|FG000|Overall Study|Sponsor Decision|9|||
129867126|NCT00707031|467469641|FG001|Overall Study|Sponsor Decision|8|||
129867127|NCT01389973|467469647|FG000|Overall Study|Lost to Follow-up|1|||
129867128|NCT01389973|467469647|FG000|Overall Study|Trial Stopped by Sponsor|9|||
129867129|NCT01389973|467469647|FG000|Overall Study|Other|10|||
129867130|NCT02626780|467469648|FG000|Overall Study|Withdrawal by Subject|3|||
129867131|NCT04304833|467469649|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
129867132|NCT04304833|467469650|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
129867133|NCT03456700|467469651|FG000|Overall Study|Withdrawal by Subject|1|||
129867134|NCT01951625|467469652|FG000|Treatment Period|Protocol Violation|2|||
129867135|NCT01951625|467469653|FG001|Treatment Period|Protocol Violation|0|||
129867136|NCT01951625|467469654|FG002|Treatment Period|Protocol Violation|1|||
129867137|NCT01951625|467469655|FG003|Treatment Period|Protocol Violation|3|||
129867138|NCT01951625|467469656|FG004|Treatment Period|Protocol Violation|2|||
129867139|NCT01951625|467469652|FG000|Treatment Period|Physician Decision|0|||
129867140|NCT01951625|467469653|FG001|Treatment Period|Physician Decision|0|||
129867141|NCT01951625|467469654|FG002|Treatment Period|Physician Decision|0|||
129867142|NCT01951625|467469655|FG003|Treatment Period|Physician Decision|0|||
129867143|NCT01951625|467469656|FG004|Treatment Period|Physician Decision|1|||
129867144|NCT01951625|467469652|FG000|Treatment Period|Protocol driven decision point|0|||
129867145|NCT01951625|467469653|FG001|Treatment Period|Protocol driven decision point|5|||
129867146|NCT01951625|467469654|FG002|Treatment Period|Protocol driven decision point|0|||
129867147|NCT01951625|467469655|FG003|Treatment Period|Protocol driven decision point|2|||
129867148|NCT01951625|467469656|FG004|Treatment Period|Protocol driven decision point|1|||
129867149|NCT01951625|467469652|FG000|Treatment Period|Non compliance with study drug|1|||
129867150|NCT01951625|467469653|FG001|Treatment Period|Non compliance with study drug|2|||
129867151|NCT01951625|467469654|FG002|Treatment Period|Non compliance with study drug|2|||
129867152|NCT01951625|467469655|FG003|Treatment Period|Non compliance with study drug|0|||
129867153|NCT01951625|467469656|FG004|Treatment Period|Non compliance with study drug|0|||
129867154|NCT01951625|467469652|FG000|Treatment Period|Death|3|||
129867155|NCT01951625|467469653|FG001|Treatment Period|Death|2|||
129867156|NCT01951625|467469654|FG002|Treatment Period|Death|2|||
129867157|NCT01951625|467469655|FG003|Treatment Period|Death|1|||
129867158|NCT01951625|467469656|FG004|Treatment Period|Death|2|||
129867159|NCT01951625|467469652|FG000|Treatment Period|Adverse Event|7|||
129867160|NCT01951625|467469653|FG001|Treatment Period|Adverse Event|10|||
129867161|NCT01951625|467469654|FG002|Treatment Period|Adverse Event|9|||
129867162|NCT01951625|467469655|FG003|Treatment Period|Adverse Event|8|||
129867163|NCT01951625|467469656|FG004|Treatment Period|Adverse Event|8|||
129867164|NCT01951625|467469652|FG000|Treatment Period|Withdrawal by Subject|5|||
129867165|NCT01951625|467469653|FG001|Treatment Period|Withdrawal by Subject|2|||
129867166|NCT01951625|467469654|FG002|Treatment Period|Withdrawal by Subject|1|||
129867167|NCT01951625|467469655|FG003|Treatment Period|Withdrawal by Subject|7|||
129867168|NCT01951625|467469656|FG004|Treatment Period|Withdrawal by Subject|3|||
129867169|NCT01951625|467469652|FG000|Treatment Period|Lost to Follow-up|1|||
129867170|NCT01951625|467469653|FG001|Treatment Period|Lost to Follow-up|0|||
129867171|NCT01951625|467469654|FG002|Treatment Period|Lost to Follow-up|0|||
129867172|NCT01951625|467469655|FG003|Treatment Period|Lost to Follow-up|1|||
129867173|NCT01951625|467469656|FG004|Treatment Period|Lost to Follow-up|0|||
129867174|NCT01951625|467469652|FG000|Follow Up Period|Non-compliance with study drug|1|||
129867175|NCT01951625|467469653|FG001|Follow Up Period|Non-compliance with study drug|0|||
129867176|NCT01951625|467469654|FG002|Follow Up Period|Non-compliance with study drug|0|||
129867177|NCT01951625|467469655|FG003|Follow Up Period|Non-compliance with study drug|0|||
129867178|NCT01951625|467469656|FG004|Follow Up Period|Non-compliance with study drug|0|||
129867179|NCT01951625|467469652|FG000|Follow Up Period|Death|1|||
129867180|NCT01951625|467469653|FG001|Follow Up Period|Death|3|||
129867181|NCT01951625|467469654|FG002|Follow Up Period|Death|2|||
129915971|NCT02500758|467655924|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
129867182|NCT01951625|467469655|FG003|Follow Up Period|Death|2|||
129867183|NCT01951625|467469656|FG004|Follow Up Period|Death|1|||
129867184|NCT01951625|467469652|FG000|Follow Up Period|Logistical difficulties|1|||
129867185|NCT01951625|467469653|FG001|Follow Up Period|Logistical difficulties|2|||
129867186|NCT01951625|467469654|FG002|Follow Up Period|Logistical difficulties|0|||
129867187|NCT01951625|467469655|FG003|Follow Up Period|Logistical difficulties|0|||
129867188|NCT01951625|467469656|FG004|Follow Up Period|Logistical difficulties|0|||
129867189|NCT01951625|467469652|FG000|Follow Up Period|Adverse Event|0|||
129867190|NCT01951625|467469653|FG001|Follow Up Period|Adverse Event|3|||
129867191|NCT01951625|467469654|FG002|Follow Up Period|Adverse Event|2|||
129867192|NCT01951625|467469655|FG003|Follow Up Period|Adverse Event|3|||
129915972|NCT02500758|467655925|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
129867193|NCT01951625|467469656|FG004|Follow Up Period|Adverse Event|5|||
129867194|NCT01951625|467469652|FG000|Follow Up Period|Withdrawal by Subject|4|||
129867195|NCT01951625|467469653|FG001|Follow Up Period|Withdrawal by Subject|1|||
129867196|NCT01951625|467469654|FG002|Follow Up Period|Withdrawal by Subject|0|||
129867197|NCT01951625|467469655|FG003|Follow Up Period|Withdrawal by Subject|5|||
129867198|NCT01951625|467469656|FG004|Follow Up Period|Withdrawal by Subject|3|||
129867199|NCT01951625|467469652|FG000|Follow Up Period|Lost to Follow-up|1|||
129867200|NCT01951625|467469653|FG001|Follow Up Period|Lost to Follow-up|0|||
129867201|NCT01951625|467469654|FG002|Follow Up Period|Lost to Follow-up|0|||
129867202|NCT01951625|467469655|FG003|Follow Up Period|Lost to Follow-up|1|||
129867203|NCT01951625|467469656|FG004|Follow Up Period|Lost to Follow-up|1|||
129867204|NCT03053050|467469659|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
129867205|NCT03053050|467469660|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
129867206|NCT03053050|467469661|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
129867207|NCT03053050|467469662|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
129867208|NCT03053050|467469659|FG000|Randomized Phase|Withdrew Consent|16|||
129867209|NCT03053050|467469660|FG001|Randomized Phase|Withdrew Consent|8|||
129867210|NCT03053050|467469661|FG002|Randomized Phase|Withdrew Consent|9|||
129867211|NCT03053050|467469662|FG003|Randomized Phase|Withdrew Consent|0|||
129867212|NCT03053050|467469659|FG000|Randomized Phase|Investigator's Discretion|6|||
129867213|NCT03053050|467469660|FG001|Randomized Phase|Investigator's Discretion|6|||
129867214|NCT03053050|467469661|FG002|Randomized Phase|Investigator's Discretion|3|||
129867215|NCT03053050|467469662|FG003|Randomized Phase|Investigator's Discretion|0|||
129867216|NCT03053050|467469659|FG000|Randomized Phase|Lost to Follow-up|5|||
129867217|NCT03053050|467469660|FG001|Randomized Phase|Lost to Follow-up|1|||
129867218|NCT03053050|467469661|FG002|Randomized Phase|Lost to Follow-up|1|||
129867219|NCT03053050|467469662|FG003|Randomized Phase|Lost to Follow-up|0|||
129867220|NCT03053050|467469659|FG000|Randomized Phase|Adverse Event|0|||
129867221|NCT03053050|467469660|FG001|Randomized Phase|Adverse Event|1|||
129867222|NCT03053050|467469661|FG002|Randomized Phase|Adverse Event|0|||
129867223|NCT03053050|467469662|FG003|Randomized Phase|Adverse Event|0|||
129867224|NCT03053050|467469659|FG000|Randomized Phase|Randomized but Never Treated|2|||
129867225|NCT03053050|467469660|FG001|Randomized Phase|Randomized but Never Treated|2|||
129867226|NCT03053050|467469661|FG002|Randomized Phase|Randomized but Never Treated|2|||
129867227|NCT03053050|467469662|FG003|Randomized Phase|Randomized but Never Treated|0|||
129867228|NCT03053050|467469659|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
129867229|NCT03053050|467469660|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
129867230|NCT03053050|467469661|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
129867231|NCT03053050|467469662|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
129867232|NCT03053050|467469659|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
129867233|NCT03053050|467469660|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
129867234|NCT03053050|467469661|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
129867235|NCT03053050|467469662|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
129867236|NCT03053050|467469659|FG000|Open-label Phase|Withdrew Consent|0|||
129867237|NCT03053050|467469660|FG001|Open-label Phase|Withdrew Consent|0|||
129867238|NCT03053050|467469661|FG002|Open-label Phase|Withdrew Consent|0|||
129867239|NCT03053050|467469662|FG003|Open-label Phase|Withdrew Consent|6|||
129867240|NCT03053050|467469659|FG000|Open-label Phase|Investigator's Discretion|0|||
129867241|NCT03053050|467469660|FG001|Open-label Phase|Investigator's Discretion|0|||
129867242|NCT03053050|467469661|FG002|Open-label Phase|Investigator's Discretion|0|||
129867243|NCT03053050|467469662|FG003|Open-label Phase|Investigator's Discretion|4|||
129867244|NCT05338333|467469663|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
129867245|NCT05338333|467469664|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
129867246|NCT02459574|467469668|FG000|Overall Study|Withdrawal by Subject|6|||
129867247|NCT02459574|467469669|FG001|Overall Study|Withdrawal by Subject|6|||
129867248|NCT02459574|467469670|FG002|Overall Study|Withdrawal by Subject|2|||
129867249|NCT02459574|467469668|FG000|Overall Study|Lost to Follow-up|1|||
129867250|NCT02459574|467469669|FG001|Overall Study|Lost to Follow-up|1|||
129867251|NCT02459574|467469670|FG002|Overall Study|Lost to Follow-up|0|||
129867252|NCT02459574|467469668|FG000|Overall Study|Death|0|||
129867253|NCT02459574|467469669|FG001|Overall Study|Death|1|||
129867254|NCT02459574|467469670|FG002|Overall Study|Death|0|||
129867255|NCT00251745|467469671|FG000|Overall Study|Adverse Event|7|||
129867256|NCT00251745|467469672|FG001|Overall Study|Adverse Event|9|||
129867257|NCT00251745|467469673|FG002|Overall Study|Adverse Event|11|||
129867258|NCT00251745|467469671|FG000|Overall Study|Lost to Follow-up|4|||
129867259|NCT00251745|467469672|FG001|Overall Study|Lost to Follow-up|2|||
129867260|NCT00251745|467469673|FG002|Overall Study|Lost to Follow-up|5|||
129867261|NCT00251745|467469671|FG000|Overall Study|Withdrawal by Subject|13|||
129867262|NCT00251745|467469672|FG001|Overall Study|Withdrawal by Subject|7|||
129867263|NCT00251745|467469673|FG002|Overall Study|Withdrawal by Subject|3|||
129867264|NCT00251745|467469671|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129867265|NCT00251745|467469672|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
129867266|NCT00251745|467469673|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
129867267|NCT00251745|467469671|FG000|Overall Study|Lack of Efficacy|3|||
129867268|NCT00251745|467469672|FG001|Overall Study|Lack of Efficacy|0|||
129867269|NCT00251745|467469673|FG002|Overall Study|Lack of Efficacy|0|||
129867270|NCT00251745|467469671|FG000|Overall Study|Noncompliant|0|||
129867271|NCT00251745|467469672|FG001|Overall Study|Noncompliant|2|||
129867272|NCT00251745|467469673|FG002|Overall Study|Noncompliant|2|||
129867273|NCT00251745|467469671|FG000|Overall Study|Pregnancy|0|||
129867274|NCT00251745|467469672|FG001|Overall Study|Pregnancy|1|||
129867275|NCT00251745|467469673|FG002|Overall Study|Pregnancy|0|||
129867276|NCT00251745|467469671|FG000|Overall Study|Per Subject Request|0|||
129867277|NCT00251745|467469672|FG001|Overall Study|Per Subject Request|0|||
129867278|NCT00251745|467469673|FG002|Overall Study|Per Subject Request|1|||
129867279|NCT00251745|467469671|FG000|Overall Study|Per Investigator Request|1|||
129867280|NCT00251745|467469672|FG001|Overall Study|Per Investigator Request|0|||
129867281|NCT00251745|467469673|FG002|Overall Study|Per Investigator Request|0|||
129867282|NCT04866017|467469676|FG000|Overall Study|Study Terminated by Sponsor|13|||
129867283|NCT04866017|467469677|FG001|Overall Study|Study Terminated by Sponsor|14|||
129867284|NCT04866017|467469678|FG002|Overall Study|Study Terminated by Sponsor|13|||
129915973|NCT00274469|467655927|FG000|Overall Study|Death|63|||
129915974|NCT00274469|467655928|FG001|Overall Study|Death|74|||
129915975|NCT00274469|467655927|FG000|Overall Study|Did not consent to OS follow-up|16|||
129915976|NCT00274469|467655928|FG001|Overall Study|Did not consent to OS follow-up|19|||
129915977|NCT04093752|467655932|FG000|Overall Study|Adverse Event|7|||
129915978|NCT04093752|467655933|FG001|Overall Study|Adverse Event|19|||
129915979|NCT04093752|467655934|FG002|Overall Study|Adverse Event|18|||
129915980|NCT04093752|467655935|FG003|Overall Study|Adverse Event|4|||
129915981|NCT04093752|467655932|FG000|Overall Study|Withdrawal by Subject|6|||
129915982|NCT04093752|467655933|FG001|Overall Study|Withdrawal by Subject|6|||
129915983|NCT04093752|467655934|FG002|Overall Study|Withdrawal by Subject|8|||
129915984|NCT04093752|467655935|FG003|Overall Study|Withdrawal by Subject|20|||
129915985|NCT04093752|467655932|FG000|Overall Study|Lost to Follow-up|2|||
129915986|NCT04093752|467655933|FG001|Overall Study|Lost to Follow-up|1|||
129915987|NCT04093752|467655934|FG002|Overall Study|Lost to Follow-up|1|||
129915988|NCT04093752|467655935|FG003|Overall Study|Lost to Follow-up|1|||
129915989|NCT04093752|467655932|FG000|Overall Study|Death|0|||
129915990|NCT04093752|467655933|FG001|Overall Study|Death|0|||
129915991|NCT04093752|467655934|FG002|Overall Study|Death|1|||
129915992|NCT04093752|467655935|FG003|Overall Study|Death|2|||
129915993|NCT04093752|467655932|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
129915994|NCT04093752|467655933|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
129915995|NCT04093752|467655934|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
129915996|NCT04093752|467655935|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
129915997|NCT04093752|467655932|FG000|Overall Study|Covid 19|0|||
129915998|NCT04093752|467655933|FG001|Overall Study|Covid 19|0|||
129915999|NCT04093752|467655934|FG002|Overall Study|Covid 19|0|||
129916000|NCT04093752|467655935|FG003|Overall Study|Covid 19|1|||
129916001|NCT04093752|467655932|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
129916002|NCT04093752|467655933|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
129916003|NCT04093752|467655934|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
129916004|NCT04093752|467655935|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
129916005|NCT04093752|467655932|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
129916006|NCT04093752|467655933|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
129916007|NCT04093752|467655934|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
129916008|NCT04093752|467655935|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
129867285|NCT04866017|467469676|FG000|Overall Study|Death|8|||
129867286|NCT04866017|467469677|FG001|Overall Study|Death|4|||
130094783|NCT01018680|468303839|FG000|Overall Study|Entry Criteria Not Met|1|||
129867287|NCT04866017|467469678|FG002|Overall Study|Death|8|||
129867288|NCT04866017|467469676|FG000|Overall Study|Withdrawal by Subject|1|||
129867289|NCT04866017|467469677|FG001|Overall Study|Withdrawal by Subject|0|||
129867290|NCT04866017|467469678|FG002|Overall Study|Withdrawal by Subject|1|||
129867291|NCT04866017|467469676|FG000|Overall Study|Physician Decision|0|||
129867292|NCT04866017|467469677|FG001|Overall Study|Physician Decision|1|||
129916009|NCT04093752|467655932|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
129916010|NCT04093752|467655933|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
129916011|NCT04093752|467655934|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
129916012|NCT04093752|467655935|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
129916013|NCT02140645|467655937|FG000|Overall Study|Not linked|5489|||
129916014|NCT02140645|467655938|FG001|Overall Study|Not linked|61654|||
129916015|NCT02140645|467655939|FG002|Overall Study|Not linked|4236|||
129916016|NCT02140645|467655940|FG003|Overall Study|Not linked|13833|||
129916017|NCT02140645|467655941|FG004|Overall Study|Not linked|3286|||
129916018|NCT02140645|467655942|FG005|Overall Study|Not linked|70896|||
129916019|NCT01101451|467655943|FG000|Overall Study|Eligible and never treated|0|||
129916020|NCT01101451|467655944|FG001|Overall Study|Eligible and never treated|5|||
129916021|NCT01101451|467655943|FG000|Overall Study|Ineligible and treated|12|||
129867293|NCT04866017|467469678|FG002|Overall Study|Physician Decision|0|||
129916022|NCT01101451|467655944|FG001|Overall Study|Ineligible and treated|8|||
129916023|NCT01101451|467655943|FG000|Overall Study|Ineligible and never treated|2|||
129916024|NCT01101451|467655944|FG001|Overall Study|Ineligible and never treated|2|||
129916025|NCT00073749|467655953|FG000|Overall Study|Disease Progression|2|||
129916026|NCT00073749|467655954|FG001|Overall Study|Disease Progression|0|||
129916027|NCT00073749|467655955|FG002|Overall Study|Disease Progression|3|||
129916028|NCT00073749|467655956|FG003|Overall Study|Disease Progression|2|||
129916029|NCT00073749|467655957|FG004|Overall Study|Disease Progression|3|||
129916030|NCT00073749|467655958|FG005|Overall Study|Disease Progression|1|||
129916031|NCT00073749|467655959|FG006|Overall Study|Disease Progression|3|||
129916032|NCT00073749|467655953|FG000|Overall Study|Death|0|||
129916033|NCT00073749|467655954|FG001|Overall Study|Death|1|||
129916034|NCT00073749|467655955|FG002|Overall Study|Death|1|||
129916035|NCT00073749|467655956|FG003|Overall Study|Death|0|||
129916036|NCT00073749|467655957|FG004|Overall Study|Death|0|||
129916037|NCT00073749|467655958|FG005|Overall Study|Death|0|||
129916038|NCT00073749|467655959|FG006|Overall Study|Death|29|||
129916039|NCT00073749|467655953|FG000|Overall Study|Adverse Event|0|||
129916040|NCT00073749|467655954|FG001|Overall Study|Adverse Event|3|||
129916041|NCT00073749|467655955|FG002|Overall Study|Adverse Event|6|||
129916042|NCT00073749|467655956|FG003|Overall Study|Adverse Event|4|||
129916043|NCT00073749|467655957|FG004|Overall Study|Adverse Event|2|||
129916044|NCT00073749|467655958|FG005|Overall Study|Adverse Event|1|||
129916045|NCT00073749|467655959|FG006|Overall Study|Adverse Event|0|||
129916046|NCT00073749|467655953|FG000|Overall Study|Physician Decision|0|||
129916047|NCT00073749|467655954|FG001|Overall Study|Physician Decision|0|||
129916048|NCT00073749|467655955|FG002|Overall Study|Physician Decision|1|||
129916049|NCT00073749|467655956|FG003|Overall Study|Physician Decision|0|||
129916050|NCT00073749|467655957|FG004|Overall Study|Physician Decision|0|||
129916051|NCT00073749|467655958|FG005|Overall Study|Physician Decision|2|||
129916052|NCT00073749|467655959|FG006|Overall Study|Physician Decision|0|||
129916053|NCT00073749|467655953|FG000|Overall Study|Withdrawal by Subject|0|||
129916054|NCT00073749|467655954|FG001|Overall Study|Withdrawal by Subject|1|||
129916055|NCT00073749|467655955|FG002|Overall Study|Withdrawal by Subject|0|||
129916056|NCT00073749|467655956|FG003|Overall Study|Withdrawal by Subject|0|||
129916057|NCT00073749|467655957|FG004|Overall Study|Withdrawal by Subject|1|||
129916058|NCT00073749|467655958|FG005|Overall Study|Withdrawal by Subject|0|||
129916059|NCT00073749|467655959|FG006|Overall Study|Withdrawal by Subject|2|||
129916060|NCT00073749|467655953|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
129916061|NCT00073749|467655954|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129916062|NCT00073749|467655955|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
129916063|NCT00073749|467655956|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129916064|NCT00073749|467655957|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
129916065|NCT00073749|467655958|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
129916066|NCT00073749|467655959|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
129916067|NCT00073749|467655953|FG000|Overall Study|Lost to Follow-up|0|||
129916068|NCT00073749|467655954|FG001|Overall Study|Lost to Follow-up|0|||
129916069|NCT00073749|467655955|FG002|Overall Study|Lost to Follow-up|0|||
129916070|NCT00073749|467655956|FG003|Overall Study|Lost to Follow-up|0|||
129916071|NCT00073749|467655957|FG004|Overall Study|Lost to Follow-up|0|||
129916072|NCT00073749|467655958|FG005|Overall Study|Lost to Follow-up|0|||
129916073|NCT00073749|467655959|FG006|Overall Study|Lost to Follow-up|2|||
129916074|NCT00073749|467655953|FG000|Overall Study|Other|0|||
129916075|NCT00073749|467655954|FG001|Overall Study|Other|0|||
129916076|NCT00073749|467655955|FG002|Overall Study|Other|0|||
129916077|NCT00073749|467655956|FG003|Overall Study|Other|0|||
129916078|NCT00073749|467655957|FG004|Overall Study|Other|0|||
129916079|NCT00073749|467655958|FG005|Overall Study|Other|2|||
129916080|NCT00073749|467655959|FG006|Overall Study|Other|0|||
129916081|NCT00611559|467655960|FG000|Overall Study|Lost to Follow-up|0|||
129916082|NCT00611559|467655961|FG001|Overall Study|Lost to Follow-up|1|||
129916083|NCT00611559|467655962|FG002|Overall Study|Lost to Follow-up|0|||
129916084|NCT00611559|467655960|FG000|Overall Study|Protocol Violation|1|||
129916085|NCT00611559|467655961|FG001|Overall Study|Protocol Violation|0|||
129916086|NCT00611559|467655962|FG002|Overall Study|Protocol Violation|1|||
129916087|NCT04999592|467655963|FG000|Overall Study|Withdrawal by Subject|1|||
129916088|NCT04999592|467655964|FG001|Overall Study|Withdrawal by Subject|0|||
130065851|NCT02293993|468196009|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
130065852|NCT02293993|468196010|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
129916089|NCT04095104|467655965|FG000|Overall Study|Withdrawal by Subject|0|||
129916090|NCT04095104|467655966|FG001|Overall Study|Withdrawal by Subject|1|||
129916091|NCT03912831|467655967|FG000|Overall Study|Death|1|||
129916092|NCT03912831|467655968|FG001|Overall Study|Death|1|||
129916093|NCT03912831|467655969|FG002|Overall Study|Death|1|||
129916094|NCT03912831|467655970|FG003|Overall Study|Death|1|||
129916095|NCT03912831|467655971|FG004|Overall Study|Death|1|||
129916096|NCT03912831|467655972|FG005|Overall Study|Death|1|||
129916097|NCT03912831|467655967|FG000|Overall Study|Reason not Specified|0|||
129916098|NCT03912831|467655968|FG001|Overall Study|Reason not Specified|0|||
129867294|NCT01475136|467469679|FG000|Overall Study|Sponsor Decision|0|||
129867295|NCT01475136|467469680|FG001|Overall Study|Sponsor Decision|1|||
129867296|NCT01475136|467469681|FG002|Overall Study|Sponsor Decision|0|||
129867297|NCT01475136|467469682|FG003|Overall Study|Sponsor Decision|0|||
129867298|NCT01475136|467469679|FG000|Overall Study|Entry Criteria Not Met|0|||
129867299|NCT01475136|467469680|FG001|Overall Study|Entry Criteria Not Met|2|||
129867300|NCT01475136|467469681|FG002|Overall Study|Entry Criteria Not Met|3|||
129867301|NCT01475136|467469682|FG003|Overall Study|Entry Criteria Not Met|1|||
129867302|NCT01475136|467469679|FG000|Overall Study|Withdrawal by Subject|0|||
129867303|NCT01475136|467469680|FG001|Overall Study|Withdrawal by Subject|0|||
129867304|NCT01475136|467469681|FG002|Overall Study|Withdrawal by Subject|0|||
129867305|NCT01475136|467469682|FG003|Overall Study|Withdrawal by Subject|2|||
129867306|NCT01475136|467469679|FG000|Overall Study|Adverse Event|1|||
129867307|NCT01475136|467469680|FG001|Overall Study|Adverse Event|0|||
129867308|NCT01475136|467469681|FG002|Overall Study|Adverse Event|0|||
129867309|NCT01475136|467469682|FG003|Overall Study|Adverse Event|1|||
129867310|NCT01475136|467469679|FG000|Overall Study|Death|0|||
129867311|NCT01475136|467469680|FG001|Overall Study|Death|0|||
129867312|NCT01475136|467469681|FG002|Overall Study|Death|0|||
129867313|NCT01475136|467469682|FG003|Overall Study|Death|1|||
129867314|NCT00003508|467471443|FG000|Overall Study|Not evaluable|5|||
129867315|NCT04918784|467471444|FG000|Overall Study|Amputation - no longer eligible|1|||
129867316|NCT04918784|467471445|FG001|Overall Study|Amputation - no longer eligible|2|||
129867317|NCT04918784|467471444|FG000|Overall Study|Death|1|||
129867318|NCT04918784|467471445|FG001|Overall Study|Death|0|||
129867319|NCT04918784|467471444|FG000|Overall Study|patient non-compliance|3|||
129867320|NCT04918784|467471445|FG001|Overall Study|patient non-compliance|1|||
129867321|NCT04918784|467471444|FG000|Overall Study|Adverse Event|1|||
129867322|NCT04918784|467471445|FG001|Overall Study|Adverse Event|0|||
129867323|NCT04179175|467471449|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
129867324|NCT04179175|467471450|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
129867325|NCT04179175|467471451|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
129867326|NCT04179175|467471452|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
129867327|NCT04179175|467471453|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
129867328|NCT04179175|467471454|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
129867329|NCT04179175|467471449|FG000|Overall Study|Adverse Event|5|||
129867330|NCT04179175|467471450|FG001|Overall Study|Adverse Event|3|||
129867331|NCT04179175|467471451|FG002|Overall Study|Adverse Event|3|||
129867332|NCT04179175|467471452|FG003|Overall Study|Adverse Event|4|||
129867333|NCT04179175|467471453|FG004|Overall Study|Adverse Event|6|||
129867334|NCT04179175|467471454|FG005|Overall Study|Adverse Event|6|||
129867335|NCT04179175|467471449|FG000|Overall Study|Lack of Efficacy|5|||
129867336|NCT04179175|467471450|FG001|Overall Study|Lack of Efficacy|1|||
129867337|NCT04179175|467471451|FG002|Overall Study|Lack of Efficacy|3|||
129867338|NCT04179175|467471452|FG003|Overall Study|Lack of Efficacy|2|||
129867339|NCT04179175|467471453|FG004|Overall Study|Lack of Efficacy|18|||
129867340|NCT04179175|467471454|FG005|Overall Study|Lack of Efficacy|7|||
129867341|NCT04179175|467471449|FG000|Overall Study|Lost to Follow-up|5|||
129867342|NCT04179175|467471450|FG001|Overall Study|Lost to Follow-up|3|||
129867343|NCT04179175|467471451|FG002|Overall Study|Lost to Follow-up|2|||
129867344|NCT04179175|467471452|FG003|Overall Study|Lost to Follow-up|2|||
129867345|NCT04179175|467471453|FG004|Overall Study|Lost to Follow-up|4|||
129867346|NCT04179175|467471454|FG005|Overall Study|Lost to Follow-up|5|||
129867347|NCT04179175|467471449|FG000|Overall Study|Physician Decision|2|||
129867348|NCT04179175|467471450|FG001|Overall Study|Physician Decision|0|||
129867349|NCT04179175|467471451|FG002|Overall Study|Physician Decision|2|||
129867350|NCT04179175|467471452|FG003|Overall Study|Physician Decision|3|||
129867351|NCT04179175|467471453|FG004|Overall Study|Physician Decision|1|||
129867352|NCT04179175|467471454|FG005|Overall Study|Physician Decision|1|||
129867353|NCT04179175|467471449|FG000|Overall Study|Pregnancy|3|||
129867354|NCT04179175|467471450|FG001|Overall Study|Pregnancy|0|||
129867355|NCT04179175|467471451|FG002|Overall Study|Pregnancy|3|||
129867356|NCT04179175|467471452|FG003|Overall Study|Pregnancy|0|||
129867357|NCT04179175|467471453|FG004|Overall Study|Pregnancy|1|||
129867358|NCT04179175|467471454|FG005|Overall Study|Pregnancy|2|||
129867359|NCT04179175|467471449|FG000|Overall Study|Withdrawal by Subject|22|||
129867360|NCT04179175|467471450|FG001|Overall Study|Withdrawal by Subject|10|||
129867361|NCT04179175|467471451|FG002|Overall Study|Withdrawal by Subject|12|||
129867362|NCT04179175|467471452|FG003|Overall Study|Withdrawal by Subject|8|||
129867363|NCT04179175|467471453|FG004|Overall Study|Withdrawal by Subject|23|||
129867364|NCT04179175|467471454|FG005|Overall Study|Withdrawal by Subject|31|||
129867365|NCT04179175|467471449|FG000|Overall Study|Technical problems|0|||
129867366|NCT04179175|467471450|FG001|Overall Study|Technical problems|0|||
129867367|NCT04179175|467471451|FG002|Overall Study|Technical problems|1|||
129867368|NCT04179175|467471452|FG003|Overall Study|Technical problems|1|||
129867369|NCT04179175|467471453|FG004|Overall Study|Technical problems|0|||
129867370|NCT04179175|467471454|FG005|Overall Study|Technical problems|0|||
129916099|NCT03912831|467655969|FG002|Overall Study|Reason not Specified|0|||
129867371|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
129867372|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
129867373|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
129867374|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
129867375|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
129867376|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
129867377|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Death|1|||
129867378|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Death|0|||
129867379|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Adverse Event|1|||
129867380|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Adverse Event|0|||
129867381|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Physician Decision|2|||
129867382|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Physician Decision|1|||
129867383|NCT02586025|467471464|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
129867384|NCT02586025|467471465|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
129867385|NCT02586025|467471464|FG000|Adjuvant Treatment|Recurrent Disease|4|||
129867386|NCT02586025|467471465|FG001|Adjuvant Treatment|Recurrent Disease|5|||
129867387|NCT02586025|467471464|FG000|Adjuvant Treatment|Physician Decision|0|||
129867388|NCT02586025|467471465|FG001|Adjuvant Treatment|Physician Decision|1|||
129867389|NCT02586025|467471464|FG000|Adjuvant Treatment|Pregnancy|1|||
129867390|NCT02586025|467471465|FG001|Adjuvant Treatment|Pregnancy|0|||
129867391|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Death|11|||
129867392|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Death|11|||
129867393|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
129867394|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
129867395|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
129867396|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
129867397|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
129867398|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
129867399|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
129867400|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
129867401|NCT00175825|467471466|FG000|Overall Study|Adverse Event|3|||
129867402|NCT00175825|467471467|FG001|Overall Study|Adverse Event|2|||
129867403|NCT00175825|467471468|FG002|Overall Study|Adverse Event|1|||
129867404|NCT00175825|467471469|FG003|Overall Study|Adverse Event|1|||
129867405|NCT00175825|467471466|FG000|Overall Study|Lost to Follow-up|1|||
129867406|NCT00175825|467471467|FG001|Overall Study|Lost to Follow-up|2|||
129867407|NCT00175825|467471468|FG002|Overall Study|Lost to Follow-up|0|||
129867408|NCT00175825|467471469|FG003|Overall Study|Lost to Follow-up|0|||
129867409|NCT00175825|467471466|FG000|Overall Study|Withdrawal by Subject|1|||
129867410|NCT00175825|467471467|FG001|Overall Study|Withdrawal by Subject|0|||
129867411|NCT00175825|467471468|FG002|Overall Study|Withdrawal by Subject|0|||
129867412|NCT00175825|467471469|FG003|Overall Study|Withdrawal by Subject|0|||
129867413|NCT02030015|467471470|FG000|Overall Study|Withdrawal by Subject|3|||
129867414|NCT02030015|467471470|FG000|Overall Study|Death|13|||
129867415|NCT03014674|467471472|FG000|Overall Study|Withdrawal by Subject|1|||
129867416|NCT03014674|467471473|FG001|Overall Study|Withdrawal by Subject|0|||
129867417|NCT03014674|467471474|FG002|Overall Study|Withdrawal by Subject|0|||
129867418|NCT03224182|467471475|FG000|Overall Study|Study Drug Not Instilled|6|||
129867419|NCT03224182|467471476|FG001|Overall Study|Study Drug Not Instilled|1|||
129867420|NCT03224182|467471475|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
129867421|NCT03224182|467471476|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
129867422|NCT03224182|467471475|FG000|Overall Study|Withdrew of Consent|4|||
129867423|NCT03224182|467471476|FG001|Overall Study|Withdrew of Consent|2|||
129867424|NCT03224182|467471475|FG000|Overall Study|Investigator Decision|3|||
129867425|NCT03224182|467471476|FG001|Overall Study|Investigator Decision|1|||
129867426|NCT03224182|467471475|FG000|Overall Study|Sponsor Decision|26|||
129867427|NCT03224182|467471476|FG001|Overall Study|Sponsor Decision|12|||
129867428|NCT03224182|467471475|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
129867429|NCT03224182|467471476|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
129867430|NCT03224182|467471475|FG000|Overall Study|Lost to Follow-up|1|||
129867431|NCT03224182|467471476|FG001|Overall Study|Lost to Follow-up|0|||
129867432|NCT03224182|467471475|FG000|Overall Study|Participant Had Recurrence|11|||
129867433|NCT03224182|467471476|FG001|Overall Study|Participant Had Recurrence|5|||
129867434|NCT03224182|467471475|FG000|Overall Study|Death|0|||
129867435|NCT03224182|467471476|FG001|Overall Study|Death|1|||
129867436|NCT03224182|467471475|FG000|Overall Study|Reason not Specified|3|||
129867437|NCT03224182|467471476|FG001|Overall Study|Reason not Specified|3|||
129867438|NCT03224182|467471475|FG000|Overall Study|Other|1|||
129867439|NCT03224182|467471476|FG001|Overall Study|Other|0|||
129867440|NCT02822222|467471477|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
129867441|NCT02822222|467471478|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
129867442|NCT04279314|467471479|FG000|Overall Study|Adverse Event|55|||
129867443|NCT04279314|467471479|FG000|Overall Study|Withdrawal by Subject|5|||
129867444|NCT04279314|467471479|FG000|Overall Study|Lack of Efficacy|5|||
129867445|NCT04279314|467471479|FG000|Overall Study|Protocol Violation|3|||
129867446|NCT04279314|467471479|FG000|Overall Study|Other (not COVID-19 related)|2|||
129867447|NCT02481310|467471480|FG000|Follow up|Still in follow up|0|||
129867448|NCT02481310|467471481|FG001|Follow up|Still in follow up|3|||
129867449|NCT02481310|467471482|FG002|Follow up|Still in follow up|0|||
129867450|NCT00833560|467471483|FG000|Overall Study|Toxicity|13|||
129867451|NCT00833560|467471483|FG000|Overall Study|Adverse Event|11|||
129867452|NCT00833560|467471483|FG000|Overall Study|Protocol Violation|6|||
129867453|NCT00833560|467471483|FG000|Overall Study|Lack of Efficacy|4|||
129867454|NCT00833560|467471483|FG000|Overall Study|Death|2|||
129867455|NCT00833560|467471483|FG000|Overall Study|Pregression of other disease|1|||
129867456|NCT00833560|467471483|FG000|Overall Study|Other|5|||
129867457|NCT00643916|467471484|FG000|Overall Study|Protocol Violation|0|||
129867458|NCT00643916|467471485|FG001|Overall Study|Protocol Violation|1|||
129867459|NCT00643916|467471486|FG002|Overall Study|Protocol Violation|1|||
129867460|NCT00643916|467471487|FG003|Overall Study|Protocol Violation|1|||
129867461|NCT00643916|467471488|FG004|Overall Study|Protocol Violation|0|||
129867462|NCT00643916|467471489|FG005|Overall Study|Protocol Violation|0|||
129867463|NCT00643916|467471484|FG000|Overall Study|Lost to Follow-up|0|||
129867464|NCT00643916|467471485|FG001|Overall Study|Lost to Follow-up|1|||
129867465|NCT00643916|467471486|FG002|Overall Study|Lost to Follow-up|0|||
129867466|NCT00643916|467471487|FG003|Overall Study|Lost to Follow-up|0|||
129867467|NCT00643916|467471488|FG004|Overall Study|Lost to Follow-up|0|||
129867468|NCT00643916|467471489|FG005|Overall Study|Lost to Follow-up|0|||
129867469|NCT00643916|467471484|FG000|Overall Study|Withdrawal by Subject|2|||
129867470|NCT00643916|467471485|FG001|Overall Study|Withdrawal by Subject|2|||
129867471|NCT00643916|467471486|FG002|Overall Study|Withdrawal by Subject|2|||
129867472|NCT00643916|467471487|FG003|Overall Study|Withdrawal by Subject|1|||
129867473|NCT00643916|467471488|FG004|Overall Study|Withdrawal by Subject|0|||
129867474|NCT00643916|467471489|FG005|Overall Study|Withdrawal by Subject|1|||
129867475|NCT00643916|467471484|FG000|Overall Study|Not Vaccinated|2|||
129867476|NCT00643916|467471485|FG001|Overall Study|Not Vaccinated|2|||
129867477|NCT00643916|467471486|FG002|Overall Study|Not Vaccinated|3|||
129867478|NCT00643916|467471487|FG003|Overall Study|Not Vaccinated|0|||
129867479|NCT00643916|467471488|FG004|Overall Study|Not Vaccinated|2|||
129867480|NCT00643916|467471489|FG005|Overall Study|Not Vaccinated|0|||
129867481|NCT00499031|467471490|FG000|Overall Study|Improper pre-protocol treatment|1|||
129867482|NCT00499031|467471490|FG000|Overall Study|Required test not done|1|||
129867483|NCT00499031|467471490|FG000|Overall Study|Never treated|1|||
129867484|NCT02606279|467471500|FG000|Overall Study|Lost to Follow-up|0|||
129867485|NCT02606279|467471501|FG001|Overall Study|Lost to Follow-up|1|||
129867486|NCT02184611|467471502|FG000|Overall Study|Lack of Efficacy|11|||
129867487|NCT02184611|467471503|FG001|Overall Study|Lack of Efficacy|15|||
129867488|NCT02184611|467471502|FG000|Overall Study|Withdrawal by Subject|5|||
129867489|NCT02184611|467471503|FG001|Overall Study|Withdrawal by Subject|6|||
129867490|NCT02184611|467471502|FG000|Overall Study|Adverse Event|4|||
129867491|NCT02184611|467471503|FG001|Overall Study|Adverse Event|5|||
129867492|NCT02184611|467471502|FG000|Overall Study|Protocol Violation|1|||
129867493|NCT02184611|467471503|FG001|Overall Study|Protocol Violation|1|||
129867494|NCT02184611|467471502|FG000|Overall Study|Protocol defined stopping criteria|0|||
129867495|NCT02184611|467471503|FG001|Overall Study|Protocol defined stopping criteria|1|||
129867496|NCT00985725|467471506|FG000|Overall Study|Adverse Event|4|||
129867497|NCT00985725|467471507|FG001|Overall Study|Adverse Event|1|||
129867498|NCT00985725|467471506|FG000|Overall Study|Protocol Violation|1|||
129867499|NCT00985725|467471507|FG001|Overall Study|Protocol Violation|3|||
129867500|NCT00985725|467471506|FG000|Overall Study|Withdrawal by Subject|4|||
129867501|NCT00985725|467471507|FG001|Overall Study|Withdrawal by Subject|4|||
129867502|NCT00985725|467471506|FG000|Overall Study|Lost to Follow-up|1|||
129867503|NCT00985725|467471507|FG001|Overall Study|Lost to Follow-up|1|||
129867504|NCT00985725|467471506|FG000|Overall Study|Lack of Efficacy|0|||
129867505|NCT00985725|467471507|FG001|Overall Study|Lack of Efficacy|1|||
129867506|NCT00985725|467471506|FG000|Overall Study|Non-compliance|1|||
129867507|NCT00985725|467471507|FG001|Overall Study|Non-compliance|2|||
129867508|NCT00985725|467471506|FG000|Overall Study|Out-of-window visits|0|||
129867509|NCT00985725|467471507|FG001|Overall Study|Out-of-window visits|1|||
129867510|NCT02428296|467471512|FG000|Overall Study|Adverse Event|7|||
129867511|NCT02428296|467471512|FG000|Overall Study|Withdrawal by Subject|2|||
129867512|NCT02230956|467471515|FG000|Overall Study|Adverse Event|1|||
129867513|NCT02230956|467471516|FG001|Overall Study|Adverse Event|1|||
129867514|NCT02230956|467471517|FG002|Overall Study|Adverse Event|0|||
129867515|NCT02230956|467471515|FG000|Overall Study|Lack of Efficacy|1|||
129867516|NCT02230956|467471516|FG001|Overall Study|Lack of Efficacy|1|||
129867517|NCT02230956|467471517|FG002|Overall Study|Lack of Efficacy|1|||
129867518|NCT02230956|467471515|FG000|Overall Study|Lost to Follow-up|1|||
129867519|NCT02230956|467471516|FG001|Overall Study|Lost to Follow-up|1|||
129867520|NCT02230956|467471517|FG002|Overall Study|Lost to Follow-up|2|||
129867521|NCT02230956|467471515|FG000|Overall Study|Personal Reasons|2|||
129867522|NCT02230956|467471516|FG001|Overall Study|Personal Reasons|1|||
129867523|NCT02230956|467471517|FG002|Overall Study|Personal Reasons|1|||
129867524|NCT02230956|467471515|FG000|Overall Study|Protocol Violation|0|||
129867525|NCT02230956|467471516|FG001|Overall Study|Protocol Violation|1|||
129916100|NCT03912831|467655970|FG003|Overall Study|Reason not Specified|0|||
129916101|NCT03912831|467655971|FG004|Overall Study|Reason not Specified|1|||
129916102|NCT03912831|467655972|FG005|Overall Study|Reason not Specified|0|||
129916103|NCT03912831|467655967|FG000|Overall Study|Withdrawal by Participant|0|||
129916104|NCT03912831|467655968|FG001|Overall Study|Withdrawal by Participant|0|||
129916105|NCT03912831|467655969|FG002|Overall Study|Withdrawal by Participant|0|||
129916106|NCT03912831|467655970|FG003|Overall Study|Withdrawal by Participant|0|||
129916107|NCT03912831|467655971|FG004|Overall Study|Withdrawal by Participant|1|||
129916108|NCT03912831|467655972|FG005|Overall Study|Withdrawal by Participant|0|||
129916109|NCT04774237|467655974|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916110|NCT04774237|467655975|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916111|NCT04774237|467655976|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916112|NCT04774237|467655977|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916113|NCT04774237|467655978|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
129916114|NCT04774237|467655979|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916115|NCT03152786|467657182|FG000|Overall Study|Withdrawal by Subject|2|||
129916116|NCT03152786|467657183|FG001|Overall Study|Withdrawal by Subject|1|||
129916117|NCT00753090|467657195|FG000|Overall Study|Withdrawal by Subject|10|||
129916118|NCT00753090|467657196|FG001|Overall Study|Withdrawal by Subject|10|||
129916119|NCT00753090|467657195|FG000|Overall Study|Death|17|||
129916120|NCT00753090|467657196|FG001|Overall Study|Death|6|||
129916121|NCT00753090|467657195|FG000|Overall Study|Study Prosthesis Removed|12|||
129916122|NCT00753090|467657196|FG001|Overall Study|Study Prosthesis Removed|3|||
129916123|NCT00753090|467657195|FG000|Overall Study|Lost to Follow-up|2|||
129916124|NCT00753090|467657196|FG001|Overall Study|Lost to Follow-up|2|||
129916125|NCT00753090|467657195|FG000|Overall Study|Other|127|||
129916126|NCT00753090|467657196|FG001|Overall Study|Other|75|||
129916127|NCT06066541|467657197|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
129916128|NCT06066541|467657198|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
129916129|NCT06066541|467657199|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
129916130|NCT06066541|467657200|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
129916131|NCT06066541|467657201|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
129916132|NCT06066541|467657202|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
129916133|NCT06066541|467657203|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
129916134|NCT06066541|467657197|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
129916135|NCT06066541|467657198|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
129916136|NCT06066541|467657199|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
129916137|NCT06066541|467657200|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
129916138|NCT06066541|467657201|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
129916139|NCT06066541|467657202|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
129916140|NCT06066541|467657203|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
129916141|NCT04533022|467657204|FG000|Overall Study|Withdrawal by Subject|15|||
129916142|NCT04533022|467657204|FG000|Overall Study|Adverse Event|6|||
129916143|NCT04533022|467657204|FG000|Overall Study|Death|1|||
129916144|NCT04533022|467657204|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
129916145|NCT04533022|467657204|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
129916146|NCT02163447|467657205|FG000|Overall Study|Withdrawal by Subject|2|||
129916147|NCT02163447|467657206|FG001|Overall Study|Withdrawal by Subject|0|||
129916148|NCT02163447|467657207|FG002|Overall Study|Withdrawal by Subject|1|||
129916149|NCT02163447|467657205|FG000|Overall Study|Lost to Follow-up|1|||
129916150|NCT02163447|467657206|FG001|Overall Study|Lost to Follow-up|3|||
129916151|NCT02163447|467657207|FG002|Overall Study|Lost to Follow-up|0|||
129916152|NCT02163447|467657205|FG000|Overall Study|Moved out of study area|2|||
129916153|NCT02163447|467657206|FG001|Overall Study|Moved out of study area|3|||
129916154|NCT02163447|467657207|FG002|Overall Study|Moved out of study area|2|||
129916155|NCT02163447|467657205|FG000|Overall Study|Became HIV infected at time of delivery|1|||
129916156|NCT02163447|467657206|FG001|Overall Study|Became HIV infected at time of delivery|0|||
129916157|NCT02163447|467657207|FG002|Overall Study|Became HIV infected at time of delivery|0|||
129916158|NCT04052516|467657209|FG000|Overall Study|Withdrawal by Subject|4|||
129916159|NCT04052516|467657210|FG001|Overall Study|Withdrawal by Subject|5|||
129916160|NCT04052516|467657211|FG002|Overall Study|Withdrawal by Subject|6|||
129916161|NCT04052516|467657209|FG000|Overall Study|Adverse Event|3|||
129916162|NCT04052516|467657210|FG001|Overall Study|Adverse Event|2|||
129916163|NCT04052516|467657211|FG002|Overall Study|Adverse Event|8|||
129916164|NCT04052516|467657209|FG000|Overall Study|Lost to Follow-up|2|||
129916165|NCT04052516|467657210|FG001|Overall Study|Lost to Follow-up|5|||
129916166|NCT04052516|467657211|FG002|Overall Study|Lost to Follow-up|3|||
129916167|NCT04052516|467657209|FG000|Overall Study|Protocol Violation|1|||
129916168|NCT04052516|467657210|FG001|Overall Study|Protocol Violation|1|||
129916169|NCT04052516|467657211|FG002|Overall Study|Protocol Violation|0|||
129916170|NCT04052516|467657209|FG000|Overall Study|Death|1|||
129916171|NCT04052516|467657210|FG001|Overall Study|Death|0|||
129916172|NCT04052516|467657211|FG002|Overall Study|Death|0|||
129916173|NCT04052516|467657209|FG000|Overall Study|Physician Decision|0|||
129916174|NCT04052516|467657210|FG001|Overall Study|Physician Decision|1|||
129916175|NCT04052516|467657211|FG002|Overall Study|Physician Decision|0|||
129916176|NCT04052516|467657209|FG000|Overall Study|Pregnancy|1|||
129916177|NCT04052516|467657210|FG001|Overall Study|Pregnancy|0|||
129916178|NCT04052516|467657211|FG002|Overall Study|Pregnancy|0|||
129916179|NCT04052516|467657209|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
129916180|NCT04052516|467657210|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
129916181|NCT04052516|467657211|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
129916182|NCT04052516|467657209|FG000|Overall Study|Reason not recorded|0|||
129916183|NCT04052516|467657210|FG001|Overall Study|Reason not recorded|1|||
129916184|NCT04052516|467657211|FG002|Overall Study|Reason not recorded|0|||
129916185|NCT05113966|467657212|FG000|Overall Study|Death|21|||
129916186|NCT05113966|467657212|FG000|Overall Study|Study Terminated by Sponsor|9|||
129916187|NCT05386355|467657213|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916188|NCT05386355|467657214|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916189|NCT05386355|467657215|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916190|NCT05386355|467657216|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
130065853|NCT02293993|468196011|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
130065854|NCT01280266|468196016|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
130065855|NCT01280266|468196017|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
130065856|NCT01280266|468196016|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
130065857|NCT01280266|468196017|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
130065858|NCT04295356|468196018|FG000|Overall Study|Physician Decision|1|||
130065859|NCT04295356|468196019|FG001|Overall Study|Physician Decision|0|||
130065860|NCT04295356|468196018|FG000|Overall Study|Lost to Follow-up|0|||
130065861|NCT04295356|468196019|FG001|Overall Study|Lost to Follow-up|3|||
130065862|NCT04295356|468196018|FG000|Overall Study|Protocol Violation|0|||
130065863|NCT04295356|468196019|FG001|Overall Study|Protocol Violation|1|||
130065864|NCT01106391|468196022|FG000|Overall Study|Death|12|||
130065865|NCT01106391|468196022|FG000|Overall Study|Withdrawal by Subject|7|||
130065866|NCT04268004|468196029|FG000|Overall Study|Excluded from analyses|0|||
130065867|NCT04268004|468196030|FG001|Overall Study|Excluded from analyses|1|||
130065868|NCT03783442|468196031|FG000|Overall Study|Death|252|||
130065869|NCT03783442|468196032|FG001|Overall Study|Death|268|||
130065870|NCT03783442|468196031|FG000|Overall Study|Withdrawal by Subject|19|||
130065871|NCT03783442|468196032|FG001|Overall Study|Withdrawal by Subject|21|||
130065872|NCT03783442|468196031|FG000|Overall Study|Lost to Follow-up|7|||
130065873|NCT03783442|468196032|FG001|Overall Study|Lost to Follow-up|6|||
130065874|NCT03783442|468196031|FG000|Overall Study|Sponsor Ended Study|48|||
130065875|NCT03783442|468196032|FG001|Overall Study|Sponsor Ended Study|28|||
130065876|NCT00881361|468196033|FG000|Overall Study|Terminated prior to surgery|27|||
130065877|NCT00881361|468196034|FG001|Overall Study|Terminated prior to surgery|7|||
130065878|NCT00881361|468196035|FG002|Overall Study|Terminated prior to surgery|0|||
130065879|NCT00881361|468196033|FG000|Overall Study|Ineligible|17|||
130065880|NCT00881361|468196034|FG001|Overall Study|Ineligible|2|||
130065881|NCT00881361|468196035|FG002|Overall Study|Ineligible|2|||
130065882|NCT01381718|468196036|FG000|Overall Study|Withdrawal by Subject|2|||
130065883|NCT01381718|468196037|FG001|Overall Study|Withdrawal by Subject|5|||
130065884|NCT01381718|468196036|FG000|Overall Study|Lost to Follow-up|3|||
130065885|NCT01381718|468196037|FG001|Overall Study|Lost to Follow-up|5|||
130065886|NCT01381718|468196036|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
130065887|NCT01381718|468196037|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
130065888|NCT01413542|468196042|FG000|Overall Study|Physician Decision|1|||
130065889|NCT01413542|468196043|FG001|Overall Study|Physician Decision|0|||
130065890|NCT01413542|468196044|FG002|Overall Study|Physician Decision|3|||
130065891|NCT01413542|468196045|FG003|Overall Study|Physician Decision|0|||
130065892|NCT01413542|468196042|FG000|Overall Study|Adverse Event|0|||
130065893|NCT01413542|468196043|FG001|Overall Study|Adverse Event|0|||
130065894|NCT01413542|468196044|FG002|Overall Study|Adverse Event|0|||
130065895|NCT01413542|468196045|FG003|Overall Study|Adverse Event|1|||
130065896|NCT02505542|468196046|FG000|Part A: Open-Label Period|Adverse Event|31|||
129916191|NCT06143670|467657217|FG000|Overall Study|Lost to Follow-up|0|||
129916192|NCT06143670|467657218|FG001|Overall Study|Lost to Follow-up|1|||
129916193|NCT06143670|467657217|FG000|Overall Study|Withdrawal by Subject|3|||
129916194|NCT06143670|467657218|FG001|Overall Study|Withdrawal by Subject|0|||
130065897|NCT02505542|468196047|FG001|Part A: Open-Label Period|Adverse Event|0|||
130065898|NCT02505542|468196048|FG002|Part A: Open-Label Period|Adverse Event|0|||
130065899|NCT02505542|468196049|FG003|Part A: Open-Label Period|Adverse Event|0|||
130065900|NCT02505542|468196046|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
130065901|NCT02505542|468196047|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
130065902|NCT02505542|468196048|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
130065903|NCT02505542|468196049|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
129867526|NCT02230956|467471517|FG002|Overall Study|Protocol Violation|1|||
129867527|NCT02230956|467471515|FG000|Overall Study|Other Miscellaneous Reason|0|||
129867528|NCT02230956|467471516|FG001|Overall Study|Other Miscellaneous Reason|1|||
129867529|NCT02230956|467471517|FG002|Overall Study|Other Miscellaneous Reason|2|||
129867530|NCT00338884|467471518|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
129867531|NCT00338884|467471518|FG000|Overall Study|Adverse Event|14|||
129867532|NCT00338884|467471518|FG000|Overall Study|Death|8|||
129867533|NCT00338884|467471518|FG000|Overall Study|Other|4|||
129867534|NCT00338884|467471518|FG000|Overall Study|Global Deterioration of Health Status|3|||
129867535|NCT00338884|467471518|FG000|Overall Study|Withdrawal by Subject|3|||
129867536|NCT00338884|467471518|FG000|Overall Study|Lost to Follow-up|1|||
129867537|NCT00338884|467471518|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
129867538|NCT01970982|467471520|FG000|Overall Study|Withdrawal by Subject|0|||
129867539|NCT01970982|467471521|FG001|Overall Study|Withdrawal by Subject|0|||
129867540|NCT01970982|467471522|FG002|Overall Study|Withdrawal by Subject|2|||
129867541|NCT01984684|467471527|FG000|Overall Study|Lost to Follow-up|25|||
129867542|NCT01984684|467471528|FG001|Overall Study|Lost to Follow-up|24|||
129867543|NCT01984684|467471527|FG000|Overall Study|Adverse Event|8|||
129867544|NCT01984684|467471528|FG001|Overall Study|Adverse Event|12|||
129867545|NCT01984684|467471527|FG000|Overall Study|Withdrawal by Subject|9|||
129867546|NCT01984684|467471528|FG001|Overall Study|Withdrawal by Subject|9|||
129867547|NCT01984684|467471527|FG000|Overall Study|Lack of Efficacy|3|||
129867548|NCT01984684|467471528|FG001|Overall Study|Lack of Efficacy|6|||
129867549|NCT01984684|467471527|FG000|Overall Study|Physician Decision|4|||
129867550|NCT01984684|467471528|FG001|Overall Study|Physician Decision|2|||
129867551|NCT01984684|467471527|FG000|Overall Study|Protocol Violation|4|||
129867552|NCT01984684|467471528|FG001|Overall Study|Protocol Violation|2|||
129867553|NCT01984684|467471527|FG000|Overall Study|Death|0|||
129867554|NCT01984684|467471528|FG001|Overall Study|Death|1|||
129867555|NCT01984684|467471527|FG000|Overall Study|Noncompliance with study drug|2|||
129867556|NCT01984684|467471528|FG001|Overall Study|Noncompliance with study drug|1|||
129867557|NCT01984684|467471527|FG000|Overall Study|Subject incarcerated|1|||
129867558|NCT01984684|467471528|FG001|Overall Study|Subject incarcerated|0|||
129867559|NCT01984684|467471527|FG000|Overall Study|Study drug not available at site|1|||
129867560|NCT01984684|467471528|FG001|Overall Study|Study drug not available at site|1|||
129867561|NCT01984684|467471527|FG000|Overall Study|Subject had inadequate IV access|0|||
129867562|NCT01984684|467471528|FG001|Overall Study|Subject had inadequate IV access|1|||
129867563|NCT05711641|467471533|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
129867564|NCT05711641|467471534|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
129867565|NCT05711641|467471533|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
129867566|NCT05711641|467471534|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
129867567|NCT04575051|467471535|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
129867568|NCT04575051|467471536|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
129867569|NCT04575051|467471537|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
129867570|NCT04575051|467471538|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
129867571|NCT04575051|467471539|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
129867572|NCT04575051|467471535|FG000|Time Period 1|Missing follow up|1|||
129867573|NCT04575051|467471536|FG001|Time Period 1|Missing follow up|3|||
129867574|NCT04575051|467471537|FG002|Time Period 1|Missing follow up|1|||
129867575|NCT04575051|467471538|FG003|Time Period 1|Missing follow up|3|||
129867576|NCT04575051|467471539|FG004|Time Period 1|Missing follow up|2|||
129867577|NCT04575051|467471535|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
129867578|NCT04575051|467471536|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
129867579|NCT04575051|467471537|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
129867580|NCT04575051|467471538|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
129867581|NCT04575051|467471539|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
129867582|NCT04575051|467471535|FG000|Time Period 2|Missing follow up|1|||
129867583|NCT04575051|467471536|FG001|Time Period 2|Missing follow up|8|||
129867584|NCT04575051|467471537|FG002|Time Period 2|Missing follow up|7|||
129867585|NCT04575051|467471538|FG003|Time Period 2|Missing follow up|0|||
129867586|NCT04575051|467471539|FG004|Time Period 2|Missing follow up|1|||
129867587|NCT04575051|467471535|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
129867588|NCT04575051|467471536|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
129867589|NCT04575051|467471537|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
129867590|NCT04575051|467471538|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
129867591|NCT04575051|467471539|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
129867592|NCT04575051|467471535|FG000|Time Period 3|Missing follow up|8|||
129867593|NCT04575051|467471536|FG001|Time Period 3|Missing follow up|6|||
129867594|NCT04575051|467471537|FG002|Time Period 3|Missing follow up|4|||
129867595|NCT04575051|467471538|FG003|Time Period 3|Missing follow up|3|||
129867596|NCT04575051|467471539|FG004|Time Period 3|Missing follow up|0|||
129916195|NCT03747484|467657219|FG000|Overall Study|Lack of Efficacy|0|||
129916196|NCT03747484|467657220|FG001|Overall Study|Lack of Efficacy|1|||
129916197|NCT03747484|467657221|FG002|Overall Study|Lack of Efficacy|1|||
129916198|NCT03747484|467657222|FG003|Overall Study|Lack of Efficacy|2|||
129916199|NCT03747484|467657223|FG004|Overall Study|Lack of Efficacy|2|||
129916200|NCT02597946|467657227|FG000|Overall Study|Withdrawal by Subject|1|||
129916201|NCT02597946|467657227|FG000|Overall Study|Progressive disease|16|||
129916202|NCT02597946|467657227|FG000|Overall Study|Other than above|1|||
129916203|NCT03625882|467657231|FG000|Overall Study|Protocol Violation|3|||
129916204|NCT05058391|467657239|FG000|Overall Study|Adverse Event|1|||
129916205|NCT03833245|467657240|FG000|Overall Study|Death|0|||
129916206|NCT03833245|467657241|FG001|Overall Study|Death|1|||
129916207|NCT05038566|467657243|FG000|Overall Study|Technical Difficulties with the Device|0|||
129916208|NCT05038566|467657244|FG001|Overall Study|Technical Difficulties with the Device|1|||
129916209|NCT05919082|467657245|FG000|Overall Study|Adverse Event|3|||
129916210|NCT05919082|467657246|FG001|Overall Study|Adverse Event|0|||
129916211|NCT05919082|467657245|FG000|Overall Study|Lost to Follow-up|0|||
129916212|NCT05919082|467657246|FG001|Overall Study|Lost to Follow-up|1|||
129916213|NCT05919082|467657245|FG000|Overall Study|Withdrawal by Subject|8|||
129916214|NCT05919082|467657246|FG001|Overall Study|Withdrawal by Subject|9|||
129916215|NCT05919082|467657245|FG000|Overall Study|Lack of Efficacy|0|||
129916216|NCT05919082|467657246|FG001|Overall Study|Lack of Efficacy|1|||
129916217|NCT05919082|467657245|FG000|Overall Study|Investigator Decision|1|||
129916218|NCT05919082|467657246|FG001|Overall Study|Investigator Decision|0|||
129916219|NCT03089398|467657255|FG000|Overall Study|Death|4|||
129916220|NCT03089398|467657256|FG001|Overall Study|Death|9|||
129916221|NCT03089398|467657255|FG000|Overall Study|Lost to Follow-up|21|||
129916222|NCT03089398|467657256|FG001|Overall Study|Lost to Follow-up|30|||
129916223|NCT03089398|467657255|FG000|Overall Study|Withdrawal by Subject|2|||
129916224|NCT03089398|467657256|FG001|Overall Study|Withdrawal by Subject|2|||
129916225|NCT05062265|467657257|FG000|Overall Study|Withdrawal by Subject|1|||
129916226|NCT05062265|467657258|FG001|Overall Study|Withdrawal by Subject|0|||
129916227|NCT05439603|467657259|FG000|Overall Study|met withdrawal criteria|2|||
129916228|NCT02682316|467657264|FG000|Overall Study|Benign Final Pathology|27|||
129916229|NCT02682316|467657265|FG001|Overall Study|Benign Final Pathology|26|||
129916230|NCT02682316|467657264|FG000|Overall Study|Reoperation before 30 days|7|||
129916231|NCT02682316|467657265|FG001|Overall Study|Reoperation before 30 days|6|||
129916232|NCT02682316|467657264|FG000|Overall Study|Ineligible|1|||
129916233|NCT02682316|467657265|FG001|Overall Study|Ineligible|0|||
129916234|NCT02682316|467657264|FG000|Overall Study|Death|1|||
129916235|NCT02682316|467657265|FG001|Overall Study|Death|0|||
129916236|NCT02682316|467657264|FG000|Overall Study|Lost to Follow-up|7|||
129916237|NCT02682316|467657265|FG001|Overall Study|Lost to Follow-up|3|||
129916238|NCT00150813|467657267|FG000|Overall Study|Adverse Event|1|||
129916239|NCT00150813|467657267|FG000|Overall Study|Lack of Efficacy|1|||
129916240|NCT00150813|467657267|FG000|Overall Study|Lost to Follow-up|5|||
129916241|NCT00150813|467657267|FG000|Overall Study|Withdrawal by Subject|5|||
129916242|NCT00150813|467657267|FG000|Overall Study|Remission|3|||
129916243|NCT00150813|467657267|FG000|Overall Study|Planned pregancy|1|||
129916244|NCT00150813|467657267|FG000|Overall Study|Switch to commercially available LEV|2|||
129916245|NCT03052608|467657269|FG000|Treatment Phase|Adverse Event|10|||
129916246|NCT03052608|467657270|FG001|Treatment Phase|Adverse Event|12|||
129916247|NCT03052608|467657269|FG000|Treatment Phase|Death|6|||
129916248|NCT03052608|467657270|FG001|Treatment Phase|Death|4|||
129916249|NCT03052608|467657269|FG000|Treatment Phase|Withdrawal by Subject|4|||
129916250|NCT03052608|467657270|FG001|Treatment Phase|Withdrawal by Subject|12|||
129916251|NCT03052608|467657269|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
129916252|NCT03052608|467657270|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
129916253|NCT03052608|467657269|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
129916254|NCT03052608|467657270|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
129916255|NCT03052608|467657269|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
129916256|NCT03052608|467657270|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
129916257|NCT03052608|467657269|FG000|Treatment Phase|Ongoing|103|||
129916258|NCT03052608|467657270|FG001|Treatment Phase|Ongoing|31|||
129916259|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Death|23|||
129916260|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Death|28|||
129916261|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
129916262|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
129916263|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
129916264|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
129916265|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Ongoing|122|||
129916266|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Ongoing|99|||
129916267|NCT03113500|467657271|FG000|Overall Study|Withdrawal by Subject|1|||
129916268|NCT05249439|467657273|FG000|Overall Study|Withdrawal by Subject|2|||
129916269|NCT05249439|467657274|FG001|Overall Study|Withdrawal by Subject|5|||
129916270|NCT05249439|467657273|FG000|Overall Study|Physician Decision|3|||
129916271|NCT05249439|467657274|FG001|Overall Study|Physician Decision|1|||
129867597|NCT04575051|467471535|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
129867598|NCT04575051|467471536|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
129867599|NCT04575051|467471537|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
129867600|NCT04575051|467471538|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
129867601|NCT04575051|467471539|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
129867602|NCT04575051|467471535|FG000|Time Period 4|Missing follow up|17|||
129867603|NCT04575051|467471536|FG001|Time Period 4|Missing follow up|3|||
129867604|NCT04575051|467471537|FG002|Time Period 4|Missing follow up|4|||
129867605|NCT04575051|467471538|FG003|Time Period 4|Missing follow up|2|||
129867606|NCT04575051|467471539|FG004|Time Period 4|Missing follow up|1|||
129867607|NCT04575051|467471535|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
129867608|NCT04575051|467471536|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
129867609|NCT04575051|467471537|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
129867610|NCT04575051|467471538|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
129867611|NCT04575051|467471539|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
129867612|NCT04575051|467471535|FG000|Time Period 5|Missing follow up|11|||
129867613|NCT04575051|467471536|FG001|Time Period 5|Missing follow up|8|||
129867614|NCT04575051|467471537|FG002|Time Period 5|Missing follow up|12|||
129867615|NCT04575051|467471538|FG003|Time Period 5|Missing follow up|3|||
129867616|NCT04575051|467471539|FG004|Time Period 5|Missing follow up|11|||
129867617|NCT03624504|467471540|FG000|Overall Study|Unsuccessful Implant|1|||
129867618|NCT02862457|467471541|FG000|Overall Study|Death|1|||
129867619|NCT02862457|467471542|FG001|Overall Study|Death|3|||
129867620|NCT02862457|467471543|FG002|Overall Study|Death|2|||
129867621|NCT02862457|467471544|FG003|Overall Study|Death|3|||
129867622|NCT02862457|467471545|FG004|Overall Study|Death|0|||
129867623|NCT02862457|467471546|FG005|Overall Study|Death|2|||
129867624|NCT02862457|467471547|FG006|Overall Study|Death|1|||
129867625|NCT02862457|467471541|FG000|Overall Study|Lost to Follow-up|1|||
129867626|NCT02862457|467471542|FG001|Overall Study|Lost to Follow-up|0|||
129867627|NCT02862457|467471543|FG002|Overall Study|Lost to Follow-up|0|||
129867628|NCT02862457|467471544|FG003|Overall Study|Lost to Follow-up|1|||
129867629|NCT02862457|467471545|FG004|Overall Study|Lost to Follow-up|0|||
129867630|NCT02862457|467471546|FG005|Overall Study|Lost to Follow-up|0|||
129867631|NCT02862457|467471547|FG006|Overall Study|Lost to Follow-up|0|||
129867632|NCT02862457|467471541|FG000|Overall Study|Withdrawal by Subject|0|||
129867633|NCT02862457|467471542|FG001|Overall Study|Withdrawal by Subject|0|||
129867634|NCT02862457|467471543|FG002|Overall Study|Withdrawal by Subject|1|||
129867635|NCT02862457|467471544|FG003|Overall Study|Withdrawal by Subject|0|||
129867636|NCT02862457|467471545|FG004|Overall Study|Withdrawal by Subject|0|||
129867637|NCT02862457|467471546|FG005|Overall Study|Withdrawal by Subject|1|||
129867638|NCT02862457|467471547|FG006|Overall Study|Withdrawal by Subject|0|||
129867639|NCT00951483|467471550|FG000|Overall Study|Physician Decision|4|||
129867640|NCT00951483|467471551|FG001|Overall Study|Physician Decision|0|||
129867641|NCT00951483|467471550|FG000|Overall Study|Withdrawal by Subject|15|||
129867642|NCT00951483|467471551|FG001|Overall Study|Withdrawal by Subject|0|||
129867643|NCT03364751|467471554|FG000|Overall Study|Withdrawal by Subject|1|||
129867644|NCT03364751|467471555|FG001|Overall Study|Withdrawal by Subject|0|||
129867645|NCT03364751|467471556|FG002|Overall Study|Withdrawal by Subject|0|||
129867646|NCT03364751|467471557|FG003|Overall Study|Withdrawal by Subject|0|||
129867647|NCT03364751|467471554|FG000|Overall Study|Lost to Follow-up|0|||
129867648|NCT03364751|467471555|FG001|Overall Study|Lost to Follow-up|1|||
129867649|NCT03364751|467471556|FG002|Overall Study|Lost to Follow-up|0|||
129867650|NCT03364751|467471557|FG003|Overall Study|Lost to Follow-up|0|||
129867651|NCT03583554|467471558|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
129867652|NCT03583554|467471559|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
129867653|NCT03583554|467471560|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
129867654|NCT03178266|467471561|FG000|Overall Study|Death|0|||
129867655|NCT03178266|467471562|FG001|Overall Study|Death|1|||
129867656|NCT03178266|467471561|FG000|Overall Study|Disont. Early|0|||
129867657|NCT03178266|467471562|FG001|Overall Study|Disont. Early|1|||
129867658|NCT03178266|467471561|FG000|Overall Study|Withdrawal by Subject|0|||
129867659|NCT03178266|467471562|FG001|Overall Study|Withdrawal by Subject|2|||
129867660|NCT02342886|467471563|FG000|Overall Study|Treatment non-compliance|1|||
129867661|NCT02342886|467471564|FG001|Overall Study|Treatment non-compliance|0|||
129867662|NCT02342886|467471565|FG002|Overall Study|Treatment non-compliance|0|||
129867663|NCT02342886|467471566|FG003|Overall Study|Treatment non-compliance|1|||
129867664|NCT02342886|467471567|FG004|Overall Study|Treatment non-compliance|0|||
129867665|NCT02342886|467471563|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
129867666|NCT02342886|467471564|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
129867667|NCT02342886|467471565|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
129867668|NCT02342886|467471566|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
129867669|NCT02342886|467471567|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
129867670|NCT02342886|467471563|FG000|Overall Study|Adverse event/specific toxicity|4|||
129916272|NCT03526861|467657279|FG000|Initial Treatment Period|Not dosed|1|||
129916273|NCT03526861|467657280|FG001|Initial Treatment Period|Not dosed|1|||
129916274|NCT03526861|467657281|FG002|Initial Treatment Period|Not dosed|1|||
129916275|NCT03526861|467657282|FG003|Initial Treatment Period|Not dosed|0|||
129916276|NCT03526861|467657283|FG004|Initial Treatment Period|Not dosed|0|||
129916277|NCT03526861|467657284|FG005|Initial Treatment Period|Not dosed|0|||
129916278|NCT03526861|467657285|FG006|Initial Treatment Period|Not dosed|0|||
129916279|NCT03526861|467657286|FG007|Initial Treatment Period|Not dosed|0|||
129916280|NCT03526861|467657287|FG008|Initial Treatment Period|Not dosed|0|||
129916281|NCT03526861|467657279|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
129916282|NCT03526861|467657280|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
129916283|NCT03526861|467657281|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
129916284|NCT03526861|467657282|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916285|NCT03526861|467657283|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916286|NCT03526861|467657284|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916287|NCT03526861|467657285|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916288|NCT03526861|467657286|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916289|NCT03526861|467657287|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916290|NCT03526861|467657279|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
129916291|NCT03526861|467657280|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
130116740|NCT00818623|468387165|FG001|Overall Study|Need of additional treatment|0|||
129867671|NCT02342886|467471564|FG001|Overall Study|Adverse event/specific toxicity|3|||
129867672|NCT02342886|467471565|FG002|Overall Study|Adverse event/specific toxicity|11|||
129867673|NCT02342886|467471566|FG003|Overall Study|Adverse event/specific toxicity|2|||
129867674|NCT02342886|467471567|FG004|Overall Study|Adverse event/specific toxicity|1|||
129867675|NCT02342886|467471563|FG000|Overall Study|Lost to Follow-up|1|||
129867676|NCT02342886|467471564|FG001|Overall Study|Lost to Follow-up|0|||
129867677|NCT02342886|467471565|FG002|Overall Study|Lost to Follow-up|0|||
129867678|NCT02342886|467471566|FG003|Overall Study|Lost to Follow-up|0|||
129867679|NCT02342886|467471567|FG004|Overall Study|Lost to Follow-up|0|||
129867680|NCT02342886|467471563|FG000|Overall Study|Death|1|||
129867681|NCT02342886|467471564|FG001|Overall Study|Death|2|||
129867682|NCT02342886|467471565|FG002|Overall Study|Death|1|||
129867683|NCT02342886|467471566|FG003|Overall Study|Death|0|||
129867684|NCT02342886|467471567|FG004|Overall Study|Death|1|||
129867685|NCT02342886|467471563|FG000|Overall Study|Withdrawal by Subject|0|||
129867686|NCT02342886|467471564|FG001|Overall Study|Withdrawal by Subject|1|||
129867687|NCT02342886|467471565|FG002|Overall Study|Withdrawal by Subject|0|||
129867688|NCT02342886|467471566|FG003|Overall Study|Withdrawal by Subject|1|||
129867689|NCT02342886|467471567|FG004|Overall Study|Withdrawal by Subject|0|||
129867690|NCT02342886|467471563|FG000|Overall Study|Investigator/sponsor decision|0|||
129867691|NCT02342886|467471564|FG001|Overall Study|Investigator/sponsor decision|2|||
129867692|NCT02342886|467471565|FG002|Overall Study|Investigator/sponsor decision|0|||
129867693|NCT02342886|467471566|FG003|Overall Study|Investigator/sponsor decision|3|||
129867694|NCT02342886|467471567|FG004|Overall Study|Investigator/sponsor decision|1|||
129867695|NCT02342886|467471563|FG000|Overall Study|Pregnancy|0|||
129867696|NCT02342886|467471564|FG001|Overall Study|Pregnancy|0|||
129867697|NCT02342886|467471565|FG002|Overall Study|Pregnancy|2|||
129867698|NCT02342886|467471566|FG003|Overall Study|Pregnancy|0|||
129867699|NCT02342886|467471567|FG004|Overall Study|Pregnancy|0|||
129867700|NCT02342886|467471563|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867701|NCT02342886|467471564|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867702|NCT02342886|467471565|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
129867703|NCT02342886|467471566|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867704|NCT02342886|467471567|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867705|NCT02342886|467471563|FG000|Overall Study|Protocol Violation|0|||
129867706|NCT02342886|467471564|FG001|Overall Study|Protocol Violation|0|||
129867707|NCT02342886|467471565|FG002|Overall Study|Protocol Violation|0|||
129867708|NCT02342886|467471566|FG003|Overall Study|Protocol Violation|2|||
129867709|NCT02342886|467471567|FG004|Overall Study|Protocol Violation|0|||
129867710|NCT01328080|467471568|FG000|Overall Study|Lost to Follow-up|5|||
129867711|NCT00862134|467471569|FG000|Overall Study|Death|1|||
129867712|NCT00862134|467471570|FG001|Overall Study|Death|0|||
129867713|NCT00862134|467471569|FG000|Overall Study|Physician Decision|0|||
129867714|NCT00862134|467471570|FG001|Overall Study|Physician Decision|1|||
129916292|NCT03526861|467657281|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
129916293|NCT03526861|467657282|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916294|NCT03526861|467657283|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916295|NCT03526861|467657284|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129867715|NCT00862134|467471569|FG000|Overall Study|Withdrawal by Subject|1|||
129867716|NCT00862134|467471570|FG001|Overall Study|Withdrawal by Subject|2|||
129867717|NCT00862134|467471569|FG000|Overall Study|Sponsor terminated study|5|||
129867718|NCT00862134|467471570|FG001|Overall Study|Sponsor terminated study|7|||
129867719|NCT00862134|467471569|FG000|Overall Study|Adverse Event|2|||
129867720|NCT00862134|467471570|FG001|Overall Study|Adverse Event|2|||
129867721|NCT00862134|467471569|FG000|Overall Study|Withdrew prior to dosing|2|||
129867722|NCT00862134|467471570|FG001|Overall Study|Withdrew prior to dosing|0|||
129867723|NCT02191267|467471571|FG000|Overall Study|Withdrawal by Subject|1|||
129867724|NCT02191267|467471572|FG001|Overall Study|Withdrawal by Subject|0|||
129867725|NCT02191267|467471573|FG002|Overall Study|Withdrawal by Subject|0|||
129867726|NCT00765674|467471574|FG000|Overall Study|Adverse Event|7|||
129867727|NCT00765674|467471575|FG001|Overall Study|Adverse Event|2|||
129867728|NCT00765674|467471576|FG002|Overall Study|Adverse Event|8|||
129867729|NCT00765674|467471577|FG003|Overall Study|Adverse Event|11|||
129867730|NCT00765674|467471574|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
129867731|NCT00765674|467471575|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
129867732|NCT00765674|467471576|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
129867733|NCT00765674|467471577|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
129867734|NCT00765674|467471574|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129867735|NCT00765674|467471575|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
129867736|NCT00765674|467471576|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
129867737|NCT00765674|467471577|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
129867738|NCT00765674|467471574|FG000|Overall Study|Lack of Efficacy|2|||
129867739|NCT00765674|467471575|FG001|Overall Study|Lack of Efficacy|3|||
129867740|NCT00765674|467471576|FG002|Overall Study|Lack of Efficacy|1|||
129867741|NCT00765674|467471577|FG003|Overall Study|Lack of Efficacy|2|||
129867742|NCT00765674|467471574|FG000|Overall Study|Protocol Violation|2|||
129867743|NCT00765674|467471575|FG001|Overall Study|Protocol Violation|0|||
129867744|NCT00765674|467471576|FG002|Overall Study|Protocol Violation|1|||
129867745|NCT00765674|467471577|FG003|Overall Study|Protocol Violation|0|||
129867746|NCT00765674|467471574|FG000|Overall Study|Withdrawal by Subject|5|||
129867747|NCT00765674|467471575|FG001|Overall Study|Withdrawal by Subject|7|||
129867748|NCT00765674|467471576|FG002|Overall Study|Withdrawal by Subject|3|||
129867749|NCT00765674|467471577|FG003|Overall Study|Withdrawal by Subject|8|||
129867750|NCT00765674|467471574|FG000|Overall Study|Lost to Follow-up|4|||
129867751|NCT00765674|467471575|FG001|Overall Study|Lost to Follow-up|6|||
129867752|NCT00765674|467471576|FG002|Overall Study|Lost to Follow-up|2|||
129867753|NCT00765674|467471577|FG003|Overall Study|Lost to Follow-up|1|||
129867754|NCT00765674|467471574|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
129867755|NCT00765674|467471575|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
129867756|NCT00765674|467471576|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
129867757|NCT00765674|467471577|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
129867758|NCT01813474|467471578|FG000|Overall Study|Withdrawal by Subject|0|||
129867759|NCT01813474|467471579|FG001|Overall Study|Withdrawal by Subject|0|||
129867760|NCT01813474|467471580|FG002|Overall Study|Withdrawal by Subject|1|||
129867761|NCT01813474|467471578|FG000|Overall Study|Adverse Event|1|||
129867762|NCT01813474|467471579|FG001|Overall Study|Adverse Event|1|||
129867763|NCT01813474|467471580|FG002|Overall Study|Adverse Event|0|||
129867764|NCT01813474|467471578|FG000|Overall Study|Lack of Efficacy|2|||
129867765|NCT01813474|467471579|FG001|Overall Study|Lack of Efficacy|6|||
129867766|NCT01813474|467471580|FG002|Overall Study|Lack of Efficacy|9|||
129867767|NCT01813474|467471578|FG000|Overall Study|Death|0|||
129867768|NCT01813474|467471579|FG001|Overall Study|Death|0|||
129867769|NCT01813474|467471580|FG002|Overall Study|Death|1|||
129867770|NCT00316082|467471581|FG000|Overall Study|Lack of Efficacy|2|||
129867771|NCT00316082|467471582|FG001|Overall Study|Lack of Efficacy|3|||
129867772|NCT00316082|467471583|FG002|Overall Study|Lack of Efficacy|3|||
129867773|NCT00316082|467471584|FG003|Overall Study|Lack of Efficacy|4|||
129867774|NCT00316082|467471585|FG004|Overall Study|Lack of Efficacy|6|||
129867775|NCT00316082|467471581|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
129867776|NCT00316082|467471582|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
129867777|NCT00316082|467471583|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
129867778|NCT00316082|467471584|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
129867779|NCT00316082|467471585|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
129867780|NCT00316082|467471581|FG000|Overall Study|Lost to Follow-up|7|||
129867781|NCT00316082|467471582|FG001|Overall Study|Lost to Follow-up|6|||
129867782|NCT00316082|467471583|FG002|Overall Study|Lost to Follow-up|7|||
129867783|NCT00316082|467471584|FG003|Overall Study|Lost to Follow-up|8|||
129867784|NCT00316082|467471585|FG004|Overall Study|Lost to Follow-up|6|||
129867785|NCT00316082|467471581|FG000|Overall Study|Poor/noncompliance|6|||
129867786|NCT00316082|467471582|FG001|Overall Study|Poor/noncompliance|1|||
129867787|NCT00316082|467471583|FG002|Overall Study|Poor/noncompliance|4|||
129867788|NCT00316082|467471584|FG003|Overall Study|Poor/noncompliance|1|||
129867789|NCT00316082|467471585|FG004|Overall Study|Poor/noncompliance|4|||
129867790|NCT00316082|467471581|FG000|Overall Study|Adverse Event|4|||
129867791|NCT00316082|467471582|FG001|Overall Study|Adverse Event|2|||
129916296|NCT03526861|467657285|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916297|NCT03526861|467657286|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916298|NCT03526861|467657287|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916299|NCT03526861|467657279|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916300|NCT03526861|467657280|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916301|NCT03526861|467657281|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916302|NCT03526861|467657282|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
129916303|NCT03526861|467657283|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
129916304|NCT03526861|467657284|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916305|NCT03526861|467657285|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
129916306|NCT03526861|467657286|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916307|NCT03526861|467657287|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916308|NCT03526861|467657279|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916309|NCT03526861|467657280|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916310|NCT03526861|467657281|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916311|NCT03526861|467657282|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
129916312|NCT03526861|467657283|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
129916313|NCT03526861|467657284|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
129916314|NCT03526861|467657285|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
129916315|NCT03526861|467657286|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
129916316|NCT03526861|467657287|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916317|NCT03526861|467657279|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916318|NCT03526861|467657280|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916319|NCT03526861|467657281|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916320|NCT03526861|467657282|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
129916321|NCT03526861|467657283|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916322|NCT03526861|467657284|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916323|NCT03526861|467657285|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916324|NCT03526861|467657286|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916325|NCT03526861|467657287|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916326|NCT03526861|467657279|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916327|NCT03526861|467657280|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916328|NCT03526861|467657281|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916329|NCT03526861|467657282|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916330|NCT03526861|467657283|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916331|NCT03526861|467657284|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916332|NCT03526861|467657285|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916333|NCT03526861|467657286|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916334|NCT03526861|467657287|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
129916335|NCT03526861|467657279|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916336|NCT03526861|467657280|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916337|NCT03526861|467657281|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916338|NCT03526861|467657282|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916339|NCT03526861|467657283|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916340|NCT03526861|467657284|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916341|NCT03526861|467657285|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916342|NCT03526861|467657286|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916343|NCT03526861|467657287|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
129916344|NCT03526861|467657279|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916345|NCT03526861|467657280|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129867792|NCT00316082|467471583|FG002|Overall Study|Adverse Event|5|||
129867793|NCT00316082|467471584|FG003|Overall Study|Adverse Event|1|||
129867794|NCT00316082|467471585|FG004|Overall Study|Adverse Event|3|||
129867795|NCT00316082|467471581|FG000|Overall Study|Subject no longer meets study criteria|3|||
129867796|NCT00316082|467471582|FG001|Overall Study|Subject no longer meets study criteria|1|||
129867797|NCT00316082|467471583|FG002|Overall Study|Subject no longer meets study criteria|2|||
129867798|NCT00316082|467471584|FG003|Overall Study|Subject no longer meets study criteria|2|||
129867799|NCT00316082|467471585|FG004|Overall Study|Subject no longer meets study criteria|1|||
129867800|NCT00316082|467471581|FG000|Overall Study|Physician Decision|1|||
129867801|NCT00316082|467471582|FG001|Overall Study|Physician Decision|1|||
129867802|NCT00316082|467471583|FG002|Overall Study|Physician Decision|2|||
129867803|NCT00316082|467471584|FG003|Overall Study|Physician Decision|1|||
129867804|NCT00316082|467471585|FG004|Overall Study|Physician Decision|1|||
129867805|NCT00316082|467471581|FG000|Overall Study|Death|0|||
129867806|NCT00316082|467471582|FG001|Overall Study|Death|0|||
129867807|NCT00316082|467471583|FG002|Overall Study|Death|1|||
129916346|NCT03526861|467657281|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916347|NCT03526861|467657282|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916348|NCT03526861|467657283|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916349|NCT03526861|467657284|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916350|NCT03526861|467657285|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916351|NCT03526861|467657286|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916352|NCT03526861|467657287|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
129916353|NCT03527160|467657289|FG000|Overall Study|No urine collected|13|||
129916354|NCT03527160|467657289|FG000|Overall Study|No clinical serum creatinine collected|6|||
129916355|NCT03527160|467657289|FG000|Overall Study|Did not meet inclusion|2|||
129916356|NCT03767517|467657290|FG000|Overall Study|Lost to Follow-up|16|||
129916357|NCT03767517|467657291|FG001|Overall Study|Lost to Follow-up|10|||
129916358|NCT03767517|467657290|FG000|Overall Study|Death|2|||
129916359|NCT03767517|467657291|FG001|Overall Study|Death|3|||
129916360|NCT03775109|467658485|FG000|Overall Study|Adverse Event|1|||
129916361|NCT03775109|467658486|FG001|Overall Study|Adverse Event|0|||
129916362|NCT03775109|467658485|FG000|Overall Study|COVID-19 outbreak|2|||
129916363|NCT03775109|467658486|FG001|Overall Study|COVID-19 outbreak|0|||
129916364|NCT03775109|467658485|FG000|Overall Study|Lost to Follow-up|0|||
129916365|NCT03775109|467658486|FG001|Overall Study|Lost to Follow-up|2|||
129916366|NCT03775109|467658485|FG000|Overall Study|Withdrawal by Subject|1|||
130065904|NCT02505542|468196046|FG000|Part A: Open-Label Period|Protocol Violation|1|||
130065905|NCT02505542|468196047|FG001|Part A: Open-Label Period|Protocol Violation|0|||
130065906|NCT02505542|468196048|FG002|Part A: Open-Label Period|Protocol Violation|0|||
130065907|NCT02505542|468196049|FG003|Part A: Open-Label Period|Protocol Violation|0|||
130065908|NCT02505542|468196046|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
130065909|NCT02505542|468196047|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
130065910|NCT02505542|468196048|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
130065911|NCT02505542|468196049|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
130065912|NCT02505542|468196046|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
130065913|NCT02505542|468196047|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
130065914|NCT02505542|468196048|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
130065915|NCT02505542|468196049|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
130065916|NCT02505542|468196046|FG000|Part A: Open-Label Period|New medical history available|1|||
130065917|NCT02505542|468196047|FG001|Part A: Open-Label Period|New medical history available|0|||
130065918|NCT02505542|468196048|FG002|Part A: Open-Label Period|New medical history available|0|||
129867808|NCT00316082|467471584|FG003|Overall Study|Death|0|||
129867809|NCT00316082|467471585|FG004|Overall Study|Death|0|||
129916367|NCT03775109|467658486|FG001|Overall Study|Withdrawal by Subject|1|||
129916368|NCT03775109|467658485|FG000|Overall Study|Death|0|||
129916369|NCT03775109|467658486|FG001|Overall Study|Death|1|||
129916370|NCT03775109|467658485|FG000|Overall Study|Lack of Efficacy|1|||
129916371|NCT03775109|467658486|FG001|Overall Study|Lack of Efficacy|0|||
130065919|NCT02505542|468196049|FG003|Part A: Open-Label Period|New medical history available|0|||
130065920|NCT02505542|468196046|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
130116741|NCT00818623|468387166|FG002|Overall Study|Need of additional treatment|0|||
130116742|NCT00818623|468387167|FG003|Overall Study|Need of additional treatment|0|||
129867810|NCT00316082|467471581|FG000|Overall Study|Administrative reason by sponsor|0|||
129867811|NCT00316082|467471582|FG001|Overall Study|Administrative reason by sponsor|0|||
129867812|NCT00316082|467471583|FG002|Overall Study|Administrative reason by sponsor|1|||
129867813|NCT00316082|467471584|FG003|Overall Study|Administrative reason by sponsor|0|||
129916372|NCT03347383|467658487|FG000|Overall Study|Death|39|||
129916373|NCT03347383|467658487|FG000|Overall Study|Withdrawal by Subject|3|||
129916374|NCT03347383|467658487|FG000|Overall Study|Lost to Follow-up|9|||
129867814|NCT00316082|467471585|FG004|Overall Study|Administrative reason by sponsor|0|||
129867815|NCT00528775|467471590|FG000|Overall Study|Other not specified|1|||
129867816|NCT00829387|467471593|FG000|Overall Study|Withdrawal by Subject|2|||
129867817|NCT00829387|467471594|FG001|Overall Study|Withdrawal by Subject|3|||
129867818|NCT00829387|467471593|FG000|Overall Study|Disqualified by PI|1|||
129867819|NCT00829387|467471594|FG001|Overall Study|Disqualified by PI|0|||
129867820|NCT03519854|467471597|FG000|Overall Study|Technical Error|0|||
129867821|NCT03519854|467471598|FG001|Overall Study|Technical Error|0|||
129867822|NCT03519854|467471599|FG002|Overall Study|Technical Error|1|||
129867823|NCT03519854|467471600|FG003|Overall Study|Technical Error|0|||
129867824|NCT03519854|467471601|FG004|Overall Study|Technical Error|0|||
129867825|NCT03519854|467471602|FG005|Overall Study|Technical Error|0|||
129867826|NCT03519854|467471603|FG006|Overall Study|Technical Error|0|||
129867827|NCT03519854|467471604|FG007|Overall Study|Technical Error|0|||
129867828|NCT03519854|467471605|FG008|Overall Study|Technical Error|0|||
129867829|NCT03519854|467471606|FG009|Overall Study|Technical Error|0|||
129867830|NCT03519854|467471607|FG010|Overall Study|Technical Error|0|||
129867831|NCT03519854|467471608|FG011|Overall Study|Technical Error|0|||
129867832|NCT03519854|467471609|FG012|Overall Study|Technical Error|0|||
129867833|NCT03519854|467471610|FG013|Overall Study|Technical Error|0|||
129867834|NCT03519854|467471611|FG014|Overall Study|Technical Error|0|||
129867835|NCT03519854|467471612|FG015|Overall Study|Technical Error|0|||
129867836|NCT03519854|467471613|FG016|Overall Study|Technical Error|0|||
130065921|NCT02505542|468196047|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
130065922|NCT02505542|468196048|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
130065923|NCT02505542|468196049|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
130065924|NCT02505542|468196046|FG000|Part A: Open-Label Period|Pregnancy|2|||
130065925|NCT02505542|468196047|FG001|Part A: Open-Label Period|Pregnancy|0|||
130065926|NCT02505542|468196048|FG002|Part A: Open-Label Period|Pregnancy|0|||
130065927|NCT02505542|468196049|FG003|Part A: Open-Label Period|Pregnancy|0|||
130065928|NCT02505542|468196046|FG000|Part A: Open-Label Period|Sponsor directive|1|||
130065929|NCT02505542|468196047|FG001|Part A: Open-Label Period|Sponsor directive|0|||
130065930|NCT02505542|468196048|FG002|Part A: Open-Label Period|Sponsor directive|0|||
130065931|NCT02505542|468196049|FG003|Part A: Open-Label Period|Sponsor directive|0|||
130065932|NCT02505542|468196046|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
130065933|NCT02505542|468196047|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
130065934|NCT02505542|468196048|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
130065935|NCT02505542|468196049|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
130065936|NCT02505542|468196046|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
130065937|NCT02505542|468196047|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
130065938|NCT02505542|468196048|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
130065939|NCT02505542|468196049|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
130065940|NCT02505542|468196046|FG000|Part A: Open-Label Period|Non-compliance|1|||
130065941|NCT02505542|468196047|FG001|Part A: Open-Label Period|Non-compliance|0|||
129867837|NCT03519854|467471614|FG017|Overall Study|Technical Error|0|||
129867838|NCT02747238|467471615|FG000|Overall Study|Lack of Efficacy|0|||
129867839|NCT02747238|467471616|FG001|Overall Study|Lack of Efficacy|1|||
129867840|NCT02747238|467471615|FG000|Overall Study|Data lost|3|||
129867841|NCT02747238|467471616|FG001|Overall Study|Data lost|5|||
129867842|NCT00951275|467471617|FG000|Overall Study|Administrative Reason|1|||
129867843|NCT00951275|467471617|FG000|Overall Study|Adverse Event|7|||
129867844|NCT00951275|467471617|FG000|Overall Study|Withdrawal by Subject|4|||
129867845|NCT00951275|467471617|FG000|Overall Study|Protocol Violation|1|||
129867846|NCT01112579|467471621|FG000|Overall Study|Missed Visit|1|||
130065942|NCT02505542|468196048|FG002|Part A: Open-Label Period|Non-compliance|0|||
129867847|NCT01112579|467471622|FG001|Overall Study|Missed Visit|1|||
129867848|NCT01112579|467471621|FG000|Overall Study|Death|0|||
129867849|NCT01112579|467471622|FG001|Overall Study|Death|2|||
129867850|NCT00818753|467471623|FG000|Overall Study|Protocol Violation|1|||
129867851|NCT00818753|467471624|FG001|Overall Study|Protocol Violation|0|||
129867852|NCT00818753|467471625|FG002|Overall Study|Protocol Violation|0|||
129867853|NCT00818753|467471623|FG000|Overall Study|Other reason (not specified)|0|||
129867854|NCT00818753|467471624|FG001|Overall Study|Other reason (not specified)|0|||
130065943|NCT02505542|468196049|FG003|Part A: Open-Label Period|Non-compliance|0|||
130065944|NCT02505542|468196046|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
129867855|NCT00818753|467471625|FG002|Overall Study|Other reason (not specified)|1|||
129867856|NCT00818753|467471623|FG000|Overall Study|Randomised and not treated|2|||
129867857|NCT00818753|467471624|FG001|Overall Study|Randomised and not treated|0|||
129867858|NCT00818753|467471625|FG002|Overall Study|Randomised and not treated|0|||
129867859|NCT04154787|467471626|FG000|Overall Study|Adverse Event|0|||
130065945|NCT02505542|468196047|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
129867860|NCT04154787|467471627|FG001|Overall Study|Adverse Event|1|||
129867861|NCT04154787|467471628|FG002|Overall Study|Adverse Event|0|||
129867862|NCT04154787|467471626|FG000|Overall Study|Patient Requires Other Treatment|0|||
130065946|NCT02505542|468196048|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
130065947|NCT02505542|468196049|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
129867863|NCT04154787|467471627|FG001|Overall Study|Patient Requires Other Treatment|1|||
129867864|NCT04154787|467471628|FG002|Overall Study|Patient Requires Other Treatment|0|||
129867865|NCT04154787|467471626|FG000|Overall Study|Study Terminated By Sponsor|0|||
129867866|NCT04154787|467471627|FG001|Overall Study|Study Terminated By Sponsor|6|||
129867867|NCT04154787|467471628|FG002|Overall Study|Study Terminated By Sponsor|1|||
129867868|NCT04154787|467471626|FG000|Overall Study|Subject Decision|0|||
129867869|NCT04154787|467471627|FG001|Overall Study|Subject Decision|1|||
129867870|NCT04154787|467471628|FG002|Overall Study|Subject Decision|0|||
129867871|NCT04154787|467471626|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
129867872|NCT04154787|467471627|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
129867873|NCT04154787|467471628|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
129867874|NCT03703466|467471629|FG000|Overall Study|Death|2|||
129867875|NCT03703466|467471630|FG001|Overall Study|Death|1|||
129867876|NCT03703466|467471631|FG002|Overall Study|Death|0|||
129867877|NCT03703466|467471629|FG000|Overall Study|Withdrawal by Subject|0|||
129867878|NCT03703466|467471630|FG001|Overall Study|Withdrawal by Subject|3|||
129867879|NCT03703466|467471631|FG002|Overall Study|Withdrawal by Subject|0|||
129867880|NCT03703466|467471629|FG000|Overall Study|Completed < 3 Cycles|2|||
129867881|NCT03703466|467471630|FG001|Overall Study|Completed < 3 Cycles|2|||
129867882|NCT03703466|467471631|FG002|Overall Study|Completed < 3 Cycles|2|||
129867883|NCT04508699|467471633|FG000|Overall Study|Lack of Efficacy|2|||
129867884|NCT04508699|467471634|FG001|Overall Study|Lack of Efficacy|15|||
129867885|NCT04508699|467471633|FG000|Overall Study|Withdrawal by Subject|0|||
129867886|NCT04508699|467471634|FG001|Overall Study|Withdrawal by Subject|2|||
129867887|NCT03355326|467471635|FG000|Overall Study|Protocol Violation|3|||
129867888|NCT03355326|467471636|FG001|Overall Study|Protocol Violation|3|||
129867889|NCT00608582|467471639|FG000|Overall Study|Lost to Follow-up|2|||
129867890|NCT00608582|467471640|FG001|Overall Study|Lost to Follow-up|0|||
129867891|NCT00608582|467471639|FG000|Overall Study|No Best Response in Phase 1 located|1|||
129867892|NCT00608582|467471640|FG001|Overall Study|No Best Response in Phase 1 located|1|||
129867893|NCT00608582|467471639|FG000|Overall Study|Illicit Drug Use|1|||
129867894|NCT00608582|467471640|FG001|Overall Study|Illicit Drug Use|0|||
129867895|NCT00608582|467471639|FG000|Overall Study|Early stage Design Change|0|||
129867896|NCT00608582|467471640|FG001|Overall Study|Early stage Design Change|3|||
129867897|NCT04605978|467473309|FG000|Overall Study|Adverse Event|2|||
129867898|NCT04605978|467473310|FG001|Overall Study|Adverse Event|1|||
129867899|NCT04605978|467473309|FG000|Overall Study|Withdrawal nonmedical reason|1|||
129867900|NCT04605978|467473310|FG001|Overall Study|Withdrawal nonmedical reason|1|||
129867901|NCT05159622|467473311|FG000|Overall Study|Lost to Follow-up|4|||
129867902|NCT05159622|467473312|FG001|Overall Study|Lost to Follow-up|5|||
129867903|NCT03318523|467473313|FG000|PC Period: Up to Year 1|Adverse Event|1|||
129867904|NCT03318523|467473314|FG001|PC Period: Up to Year 1|Adverse Event|0|||
129867905|NCT03318523|467473315|FG002|PC Period: Up to Year 1|Adverse Event|2|||
129867906|NCT03318523|467473316|FG003|PC Period: Up to Year 1|Adverse Event|0|||
129867907|NCT03318523|467473317|FG004|PC Period: Up to Year 1|Adverse Event|0|||
129867908|NCT03318523|467473318|FG005|PC Period: Up to Year 1|Adverse Event|0|||
129867909|NCT03318523|467473319|FG006|PC Period: Up to Year 1|Adverse Event|0|||
129867910|NCT03318523|467473320|FG007|PC Period: Up to Year 1|Adverse Event|0|||
129867911|NCT03318523|467473321|FG008|PC Period: Up to Year 1|Adverse Event|0|||
129867912|NCT03318523|467473322|FG009|PC Period: Up to Year 1|Adverse Event|0|||
129867913|NCT03318523|467473313|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
129867914|NCT03318523|467473314|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
129867915|NCT03318523|467473315|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867916|NCT03318523|467473316|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
129867917|NCT03318523|467473317|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867918|NCT03318523|467473318|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867919|NCT03318523|467473319|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867920|NCT03318523|467473320|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867921|NCT03318523|467473321|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867922|NCT03318523|467473322|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867923|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867924|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
130065948|NCT02505542|468196046|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
129867925|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867926|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867927|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
129867928|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867929|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867930|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
129867931|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867932|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
130065949|NCT02505542|468196047|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
129867933|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129916375|NCT05691452|467658495|FG000|Overall Study|Withdrawal by Subject|1|||
129916376|NCT05691452|467658496|FG001|Overall Study|Withdrawal by Subject|1|||
129916377|NCT05691452|467658497|FG002|Overall Study|Withdrawal by Subject|0|||
129916378|NCT05691452|467658495|FG000|Overall Study|Physician Decision|1|||
129916379|NCT05691452|467658496|FG001|Overall Study|Physician Decision|0|||
129916380|NCT05691452|467658497|FG002|Overall Study|Physician Decision|0|||
129916381|NCT05691452|467658495|FG000|Overall Study|Lost to Follow-up|0|||
129916382|NCT05691452|467658496|FG001|Overall Study|Lost to Follow-up|0|||
129916383|NCT05691452|467658497|FG002|Overall Study|Lost to Follow-up|1|||
129916384|NCT05691452|467658495|FG000|Overall Study|Adverse Event|0|||
129916385|NCT05691452|467658496|FG001|Overall Study|Adverse Event|0|||
129916386|NCT05691452|467658497|FG002|Overall Study|Adverse Event|1|||
129916387|NCT01938547|467658500|FG000|Overall Study|Physician Decision|1|||
129916388|NCT05320432|467658503|FG000|Overall Study|Withdrawal by Subject|0|||
129916389|NCT05320432|467658504|FG001|Overall Study|Withdrawal by Subject|2|||
129916390|NCT04842643|467658505|FG000|Overall Study|Physician Decision|1|||
129916391|NCT04842643|467658505|FG000|Overall Study|Other|1|||
130065950|NCT02505542|468196048|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
129867934|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867935|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867936|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867937|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
129867938|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867939|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867940|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
129867941|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
129867942|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
129867943|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867944|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867945|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867946|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867947|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867948|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
129867949|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867950|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867951|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867952|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867953|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867954|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867955|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867956|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867957|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867958|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867959|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867960|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867961|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867962|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
129867963|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867964|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867965|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867966|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867967|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
129867968|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
129867969|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
129867970|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
129867971|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
129867972|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
129867973|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129916392|NCT03484702|467658506|FG000|Treatment Period|Death|3|||
129916393|NCT03484702|467658507|FG001|Treatment Period|Death|1|||
129916394|NCT03484702|467658508|FG002|Treatment Period|Death|0|||
129916395|NCT03484702|467658509|FG003|Treatment Period|Death|0|||
130065951|NCT02505542|468196049|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
129916396|NCT03484702|467658510|FG004|Treatment Period|Death|0|||
129916397|NCT03484702|467658511|FG005|Treatment Period|Death|0|||
129916398|NCT03484702|467658506|FG000|Treatment Period|Adverse Event|1|||
129916399|NCT03484702|467658507|FG001|Treatment Period|Adverse Event|0|||
129916400|NCT03484702|467658508|FG002|Treatment Period|Adverse Event|0|||
129916401|NCT03484702|467658509|FG003|Treatment Period|Adverse Event|0|||
129916402|NCT03484702|467658510|FG004|Treatment Period|Adverse Event|0|||
129916403|NCT03484702|467658511|FG005|Treatment Period|Adverse Event|0|||
129916404|NCT03484702|467658506|FG000|Treatment Period|Participant Withdrew from Study|0|||
129916405|NCT03484702|467658507|FG001|Treatment Period|Participant Withdrew from Study|1|||
129916406|NCT03484702|467658508|FG002|Treatment Period|Participant Withdrew from Study|0|||
129916407|NCT03484702|467658509|FG003|Treatment Period|Participant Withdrew from Study|0|||
129916408|NCT03484702|467658510|FG004|Treatment Period|Participant Withdrew from Study|0|||
129916409|NCT03484702|467658511|FG005|Treatment Period|Participant Withdrew from Study|0|||
129916410|NCT03484702|467658506|FG000|Treatment Period|Physician Decision|0|||
129916411|NCT03484702|467658507|FG001|Treatment Period|Physician Decision|1|||
129916412|NCT03484702|467658508|FG002|Treatment Period|Physician Decision|0|||
129916413|NCT03484702|467658509|FG003|Treatment Period|Physician Decision|0|||
129916414|NCT03484702|467658510|FG004|Treatment Period|Physician Decision|0|||
129916415|NCT03484702|467658511|FG005|Treatment Period|Physician Decision|1|||
129916416|NCT00739648|467658520|FG000|Overall Study|Adverse Event|3|||
129916417|NCT00739648|467658521|FG001|Overall Study|Adverse Event|15|||
129916418|NCT00739648|467658520|FG000|Overall Study|Withdrawal by Subject|13|||
129916419|NCT00739648|467658521|FG001|Overall Study|Withdrawal by Subject|25|||
129916420|NCT00739648|467658520|FG000|Overall Study|Lost to Follow-up|4|||
129916421|NCT00739648|467658521|FG001|Overall Study|Lost to Follow-up|7|||
129916422|NCT00739648|467658520|FG000|Overall Study|Death|2|||
129916423|NCT00739648|467658521|FG001|Overall Study|Death|0|||
129916424|NCT00739648|467658520|FG000|Overall Study|Do not know|4|||
129916425|NCT00739648|467658521|FG001|Overall Study|Do not know|6|||
129916426|NCT05110495|467658522|FG000|Overall Study|Lost to Follow-up|1|||
129916427|NCT05110495|467658522|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
129916428|NCT04173663|467658523|FG000|Overall Study|Withdrawal by Subject|1|||
129916429|NCT04173663|467658524|FG001|Overall Study|Withdrawal by Subject|6|||
129916430|NCT04173663|467658523|FG000|Overall Study|Lost to Follow-up|17|||
129916431|NCT04173663|467658524|FG001|Overall Study|Lost to Follow-up|24|||
129916432|NCT01757665|467658526|FG000|Overall Study|Still on Study - Visit Completed|240|||
129916433|NCT01757665|467658527|FG001|Overall Study|Still on Study - Visit Completed|30|||
129916434|NCT01757665|467658526|FG000|Overall Study|Still on Study - Visit Pending|398|||
129916435|NCT01757665|467658527|FG001|Overall Study|Still on Study - Visit Pending|40|||
129916436|NCT01757665|467658526|FG000|Overall Study|Still on Study - Missed Visit|14|||
129916437|NCT01757665|467658527|FG001|Overall Study|Still on Study - Missed Visit|1|||
129916438|NCT01757665|467658526|FG000|Overall Study|Death|25|||
129916439|NCT01757665|467658527|FG001|Overall Study|Death|8|||
129916440|NCT01757665|467658526|FG000|Overall Study|Explant|1|||
129916441|NCT01757665|467658527|FG001|Overall Study|Explant|2|||
129916442|NCT01757665|467658526|FG000|Overall Study|Withdrawal by Subject|10|||
129916443|NCT01757665|467658527|FG001|Overall Study|Withdrawal by Subject|0|||
129916444|NCT01757665|467658526|FG000|Overall Study|Lost to Follow-up|1|||
129916445|NCT01757665|467658527|FG001|Overall Study|Lost to Follow-up|1|||
129916446|NCT01757665|467658526|FG000|Overall Study|Not Implanted with Device|5|||
129916447|NCT01757665|467658527|FG001|Overall Study|Not Implanted with Device|1|||
129916448|NCT05816551|467658530|FG000|Overall Study|Withdrawal by Subject|0|||
129916449|NCT05816551|467658531|FG001|Overall Study|Withdrawal by Subject|1|||
129916450|NCT05816551|467658530|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
129916451|NCT05816551|467658531|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
129916452|NCT02651324|467658540|FG000|Overall Study|drug not administered, due dispensing issue|1|||
129916453|NCT02651324|467658541|FG001|Overall Study|drug not administered, due dispensing issue|0|||
129916454|NCT05461131|467658542|FG000|Overall Study|Lost to Follow-up|0|||
129916455|NCT05461131|467658543|FG001|Overall Study|Lost to Follow-up|2|||
129916456|NCT03101904|467658545|FG000|Wash Out (10 Days)|Adverse Event|1|||
129916457|NCT03101904|467658546|FG001|Wash Out (10 Days)|Adverse Event|0|||
129916458|NCT03101904|467658545|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
130065952|NCT02505542|468196046|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
130065953|NCT02505542|468196047|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
129916459|NCT03101904|467658546|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
129916460|NCT04538417|467658547|FG000|Overall Study|Withdrawal by Subject|2|||
129916461|NCT03385629|467658549|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
129916462|NCT03385629|467658550|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
129916463|NCT03385629|467658549|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
129916464|NCT03385629|467658550|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
129916465|NCT03385629|467658549|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
129916466|NCT03385629|467658550|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
129916467|NCT05633407|467658554|FG000|Overall Study|Physician Decision|2|||
129916468|NCT05633407|467658555|FG001|Overall Study|Physician Decision|0|||
129916469|NCT05633407|467658554|FG000|Overall Study|Adverse Event|1|||
129916470|NCT05633407|467658555|FG001|Overall Study|Adverse Event|0|||
129916471|NCT05633407|467658554|FG000|Overall Study|Withdrawal by Subject|1|||
129916472|NCT05633407|467658555|FG001|Overall Study|Withdrawal by Subject|0|||
129867974|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867975|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867976|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867977|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
129867978|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867979|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867980|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
129867981|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
129867982|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867983|NCT03581981|467473326|FG000|Overall Study|Withdrawal by Subject|12|||
129867984|NCT03581981|467473327|FG001|Overall Study|Withdrawal by Subject|13|||
129867985|NCT03581981|467473326|FG000|Overall Study|Physician Decision|1|||
129867986|NCT03581981|467473327|FG001|Overall Study|Physician Decision|2|||
129867987|NCT03581981|467473326|FG000|Overall Study|Lost to Follow-up|0|||
129867988|NCT03581981|467473327|FG001|Overall Study|Lost to Follow-up|4|||
129867989|NCT02080871|467473328|FG000|Overall Study|Death|1|||
129867990|NCT02080871|467473328|FG000|Overall Study|Lost to Follow-up|1|||
129867991|NCT00234052|467473329|FG000|Treatment|Withdrawal by Subject|3|||
129867992|NCT00234052|467473329|FG000|Treatment|Adverse Event|5|||
129867993|NCT00234052|467473329|FG000|Treatment|Death|2|||
129867994|NCT00234052|467473329|FG000|Treatment|Progressive Disease|11|||
129867995|NCT00234052|467473329|FG000|Follow-up for 5 Years|Death|41|||
129867996|NCT00234052|467473329|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
129867997|NCT00234052|467473329|FG000|Follow-up for 5 Years|Other|7|||
129867998|NCT01410474|467473330|FG000|Overall Study|Withdrawal by Subject|0|||
129867999|NCT01410474|467473331|FG001|Overall Study|Withdrawal by Subject|1|||
129868000|NCT00828984|467473333|FG000|Overall Study|Adverse Event|2|||
129868001|NCT00828984|467473334|FG001|Overall Study|Adverse Event|3|||
129868002|NCT00828984|467473335|FG002|Overall Study|Adverse Event|0|||
129868003|NCT00828984|467473333|FG000|Overall Study|Lost to Follow-up|5|||
129868004|NCT00828984|467473334|FG001|Overall Study|Lost to Follow-up|3|||
129868005|NCT00828984|467473335|FG002|Overall Study|Lost to Follow-up|1|||
129868006|NCT00828984|467473333|FG000|Overall Study|Withdrawal by Subject|4|||
129868007|NCT00828984|467473334|FG001|Overall Study|Withdrawal by Subject|4|||
129868008|NCT00828984|467473335|FG002|Overall Study|Withdrawal by Subject|4|||
129868009|NCT00828984|467473333|FG000|Overall Study|Ineligable|1|||
129868010|NCT00828984|467473334|FG001|Overall Study|Ineligable|2|||
129868011|NCT00828984|467473335|FG002|Overall Study|Ineligable|0|||
129868012|NCT00828984|467473333|FG000|Overall Study|Medical Contraindication|0|||
129868013|NCT00828984|467473334|FG001|Overall Study|Medical Contraindication|1|||
129868014|NCT00828984|467473335|FG002|Overall Study|Medical Contraindication|0|||
129868015|NCT00828984|467473333|FG000|Overall Study|Noncompliant|1|||
129868016|NCT00828984|467473334|FG001|Overall Study|Noncompliant|2|||
129868017|NCT00828984|467473335|FG002|Overall Study|Noncompliant|3|||
129868018|NCT00828984|467473333|FG000|Overall Study|ConMed|1|||
129868019|NCT00828984|467473334|FG001|Overall Study|ConMed|1|||
129868020|NCT00828984|467473335|FG002|Overall Study|ConMed|1|||
129868021|NCT01615328|467473339|FG000|Overall Study|Lost to Follow-up|3|||
129868022|NCT01615328|467473340|FG001|Overall Study|Lost to Follow-up|5|||
129868023|NCT00863655|467473341|FG000|Overall Study|Protocol Violation|4|||
129868024|NCT00863655|467473342|FG001|Overall Study|Protocol Violation|0|||
129868025|NCT00863655|467473341|FG000|Overall Study|Adverse Event|52|||
129868026|NCT00863655|467473342|FG001|Overall Study|Adverse Event|8|||
129868027|NCT00863655|467473341|FG000|Overall Study|Withdrawal by Subject|47|||
129868028|NCT00863655|467473342|FG001|Overall Study|Withdrawal by Subject|7|||
129868029|NCT00863655|467473341|FG000|Overall Study|Administrative problems|1|||
129868030|NCT00863655|467473342|FG001|Overall Study|Administrative problems|0|||
129868031|NCT00863655|467473341|FG000|Overall Study|Death|7|||
129868032|NCT00863655|467473342|FG001|Overall Study|Death|1|||
129868033|NCT00863655|467473341|FG000|Overall Study|New cancer therapy|5|||
129868034|NCT00863655|467473342|FG001|Overall Study|New cancer therapy|1|||
129868035|NCT00863655|467473341|FG000|Overall Study|Disease progression|364|||
129868036|NCT00863655|467473342|FG001|Overall Study|Disease progression|221|||
129868037|NCT00863655|467473341|FG000|Overall Study|Treatment completed as per protocol|5|||
129868038|NCT00863655|467473342|FG001|Overall Study|Treatment completed as per protocol|1|||
129868039|NCT02157779|467473345|FG000|Overall Study|Logistical|9|||
129868040|NCT02157779|467473346|FG001|Overall Study|Logistical|3|||
129868041|NCT02157779|467473345|FG000|Overall Study|Stopped attending, reason unknown|11|||
129868042|NCT02157779|467473346|FG001|Overall Study|Stopped attending, reason unknown|7|||
129868043|NCT02157779|467473345|FG000|Overall Study|No response to outreach after Baseline|1|||
129868044|NCT02157779|467473346|FG001|Overall Study|No response to outreach after Baseline|1|||
129868045|NCT02157779|467473345|FG000|Overall Study|Moved|1|||
129868046|NCT02157779|467473346|FG001|Overall Study|Moved|0|||
129916473|NCT05633407|467658554|FG000|Overall Study|Other|1|||
129916474|NCT05633407|467658555|FG001|Overall Study|Other|1|||
129868047|NCT02157779|467473345|FG000|Overall Study|Medical|1|||
129868048|NCT02157779|467473346|FG001|Overall Study|Medical|0|||
129868049|NCT02157779|467473345|FG000|Overall Study|Legal issue|1|||
129868050|NCT02157779|467473346|FG001|Overall Study|Legal issue|0|||
129868051|NCT02548455|467473347|FG000|Overall Study|Withdrawal by Subject|27|||
129868052|NCT02548455|467473347|FG000|Overall Study|Death|26|||
129868053|NCT02548455|467473347|FG000|Overall Study|Lost to Follow-up|14|||
129868054|NCT02548455|467473347|FG000|Overall Study|Visit not completed|173|||
129868055|NCT00002558|467473352|FG000|Overall Study|Withdrawal by Subject|0|||
129868056|NCT00002558|467473353|FG001|Overall Study|Withdrawal by Subject|1|||
129868057|NCT02261493|467473356|FG000|Overall Study|Noncompliance|0|||
129868058|NCT02261493|467473357|FG001|Overall Study|Noncompliance|0|||
129868059|NCT02261493|467473358|FG002|Overall Study|Noncompliance|2|||
129868060|NCT02261493|467473356|FG000|Overall Study|Physician Decision|0|||
129868061|NCT02261493|467473357|FG001|Overall Study|Physician Decision|1|||
129868062|NCT02261493|467473358|FG002|Overall Study|Physician Decision|0|||
129868063|NCT02261493|467473356|FG000|Overall Study|Undisclosed alcohol abuse|0|||
129868064|NCT02261493|467473357|FG001|Overall Study|Undisclosed alcohol abuse|1|||
129868065|NCT02261493|467473358|FG002|Overall Study|Undisclosed alcohol abuse|0|||
129868066|NCT02261493|467473356|FG000|Overall Study|Protocol Violation|1|||
129868067|NCT02261493|467473357|FG001|Overall Study|Protocol Violation|0|||
129868068|NCT02261493|467473358|FG002|Overall Study|Protocol Violation|0|||
129868069|NCT02261493|467473356|FG000|Overall Study|Personal Reasons|14|||
129868070|NCT02261493|467473357|FG001|Overall Study|Personal Reasons|14|||
129868071|NCT02261493|467473358|FG002|Overall Study|Personal Reasons|16|||
129868072|NCT02261493|467473356|FG000|Overall Study|Lost to Follow-up|14|||
129868073|NCT02261493|467473357|FG001|Overall Study|Lost to Follow-up|27|||
129868074|NCT02261493|467473358|FG002|Overall Study|Lost to Follow-up|8|||
129868075|NCT02261493|467473356|FG000|Overall Study|Pregnancy|1|||
129868076|NCT02261493|467473357|FG001|Overall Study|Pregnancy|2|||
129868077|NCT02261493|467473358|FG002|Overall Study|Pregnancy|0|||
129868078|NCT02261493|467473356|FG000|Overall Study|Lack of Efficacy|0|||
129868079|NCT02261493|467473357|FG001|Overall Study|Lack of Efficacy|1|||
129868080|NCT02261493|467473358|FG002|Overall Study|Lack of Efficacy|0|||
129868081|NCT02261493|467473356|FG000|Overall Study|Adverse Event|0|||
129868082|NCT02261493|467473357|FG001|Overall Study|Adverse Event|1|||
129868083|NCT02261493|467473358|FG002|Overall Study|Adverse Event|0|||
129868084|NCT02065336|467473359|FG000|Extension Phase|Study Terminated by Sponsor|0|||
129868085|NCT02065336|467473360|FG001|Extension Phase|Study Terminated by Sponsor|0|||
129868086|NCT02065336|467473361|FG002|Extension Phase|Study Terminated by Sponsor|0|||
129868087|NCT02065336|467473362|FG003|Extension Phase|Study Terminated by Sponsor|0|||
129868088|NCT02065336|467473363|FG004|Extension Phase|Study Terminated by Sponsor|0|||
129868089|NCT02065336|467473364|FG005|Extension Phase|Study Terminated by Sponsor|0|||
129868090|NCT02065336|467473365|FG006|Extension Phase|Study Terminated by Sponsor|0|||
129868091|NCT02065336|467473366|FG007|Extension Phase|Study Terminated by Sponsor|0|||
129868092|NCT02065336|467473367|FG008|Extension Phase|Study Terminated by Sponsor|2|||
129868093|NCT02065336|467473368|FG009|Extension Phase|Study Terminated by Sponsor|8|||
129868094|NCT00626028|467473369|FG000|Overall Study|Adverse Event|1|||
129868095|NCT00626028|467473370|FG001|Overall Study|Adverse Event|1|||
129868096|NCT00626028|467473369|FG000|Overall Study|Device Failure|0|||
129868097|NCT00626028|467473370|FG001|Overall Study|Device Failure|1|||
129868098|NCT00626028|467473369|FG000|Overall Study|Physician Decision|2|||
129868099|NCT00626028|467473370|FG001|Overall Study|Physician Decision|1|||
129868100|NCT00626028|467473369|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
129868101|NCT00626028|467473370|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
129868102|NCT00831779|467473372|FG000|Overall Study|Lost to Follow-up|1|||
129868103|NCT00831779|467473373|FG001|Overall Study|Lost to Follow-up|0|||
129868104|NCT00831779|467473372|FG000|Overall Study|No longer met criteria|0|||
129868105|NCT00831779|467473373|FG001|Overall Study|No longer met criteria|1|||
129868106|NCT02436330|467473374|FG000|Cohort 1|Lost to Follow-up|5|||
129868107|NCT02436330|467473375|FG001|Cohort 1|Lost to Follow-up|2|||
129868108|NCT02436330|467473374|FG000|Cohort 1|Withdrawal by Subject|0|||
129868109|NCT02436330|467473375|FG001|Cohort 1|Withdrawal by Subject|1|||
129868110|NCT02436330|467473374|FG000|Cohort 2|Lost to Follow-up|2|||
129868111|NCT02436330|467473375|FG001|Cohort 2|Lost to Follow-up|0|||
129868112|NCT02436330|467473374|FG000|Cohort 2|Withdrawal by Subject|2|||
129916475|NCT02814838|467658560|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
129868113|NCT02436330|467473375|FG001|Cohort 2|Withdrawal by Subject|3|||
129868114|NCT02436330|467473374|FG000|Cohort 3|Lost to Follow-up|1|||
129868115|NCT02436330|467473375|FG001|Cohort 3|Lost to Follow-up|0|||
129868116|NCT02436330|467473374|FG000|Cohort 3|Withdrawal by Subject|4|||
129868117|NCT02436330|467473375|FG001|Cohort 3|Withdrawal by Subject|0|||
129868118|NCT02436330|467473374|FG000|Cohort 4|Lost to Follow-up|1|||
129868119|NCT02436330|467473375|FG001|Cohort 4|Lost to Follow-up|0|||
129868120|NCT02436330|467473374|FG000|Cohort 4|Withdrawal by Subject|1|||
129868121|NCT02436330|467473375|FG001|Cohort 4|Withdrawal by Subject|0|||
129868122|NCT02436330|467473374|FG000|Cohort 5|Lost to Follow-up|3|||
129868123|NCT02436330|467473375|FG001|Cohort 5|Lost to Follow-up|2|||
129868124|NCT02436330|467473374|FG000|Cohort 5|Withdrawal by Subject|3|||
129868125|NCT02436330|467473375|FG001|Cohort 5|Withdrawal by Subject|2|||
129868126|NCT02436330|467473374|FG000|Cohort 6|Lost to Follow-up|2|||
129868127|NCT02436330|467473375|FG001|Cohort 6|Lost to Follow-up|0|||
130065954|NCT02505542|468196048|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
130065955|NCT02505542|468196049|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
130065956|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Adverse Event|0|||
130065957|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Adverse Event|0|||
130065958|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Adverse Event|1|||
130065959|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Adverse Event|3|||
130065960|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
130065961|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
130065962|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
130065963|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
130065964|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
130065965|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
130065966|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
130065967|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
130065968|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
130065969|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
130065970|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
130065971|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
130065972|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
130065973|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
130065974|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
130065975|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
130065976|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
130065977|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
130065978|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
130065979|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
129868128|NCT02436330|467473374|FG000|Cohort 6|Withdrawal by Subject|1|||
129868129|NCT02436330|467473375|FG001|Cohort 6|Withdrawal by Subject|1|||
129868130|NCT00162370|467473377|FG000|Efficacy Population|Lost to Follow-up|51|||
129868131|NCT04040751|467473378|FG000|Overall Study|Withdrawal by Subject|2|||
129868132|NCT04040751|467473379|FG001|Overall Study|Withdrawal by Subject|0|||
129868133|NCT04040751|467473380|FG002|Overall Study|Withdrawal by Subject|2|||
129868134|NCT04040751|467473381|FG003|Overall Study|Withdrawal by Subject|0|||
129868135|NCT00540124|467473383|FG000|Overall Study|Adverse Event|0|||
129868136|NCT00540124|467473384|FG001|Overall Study|Adverse Event|2|||
129868137|NCT00540124|467473385|FG002|Overall Study|Adverse Event|1|||
129868138|NCT00540124|467473383|FG000|Overall Study|Entry Criteria Not Met|2|||
129868139|NCT00540124|467473384|FG001|Overall Study|Entry Criteria Not Met|0|||
129868140|NCT00540124|467473385|FG002|Overall Study|Entry Criteria Not Met|0|||
129868141|NCT00540124|467473383|FG000|Overall Study|Lack of Efficacy|1|||
129868142|NCT00540124|467473384|FG001|Overall Study|Lack of Efficacy|0|||
129868143|NCT00540124|467473385|FG002|Overall Study|Lack of Efficacy|0|||
129868144|NCT00540124|467473383|FG000|Overall Study|Withdrawal by Subject|1|||
129868145|NCT00540124|467473384|FG001|Overall Study|Withdrawal by Subject|1|||
129868146|NCT00540124|467473385|FG002|Overall Study|Withdrawal by Subject|0|||
129868147|NCT00587964|467473387|FG000|Overall Study|Withdrawal by Subject|1|||
129868148|NCT00587964|467473387|FG000|Overall Study|Lost to Follow-up|1|||
129868149|NCT00587964|467473387|FG000|Overall Study|Patient found to be ineligible|1|||
129868150|NCT00587964|467473387|FG000|Overall Study|Patient did not receive intervention|5|||
129868151|NCT00587964|467473387|FG000|Overall Study|Progression of Disease|4|||
129868152|NCT01569438|467473392|FG000|Overall Study|Lack of Efficacy|1|||
129868153|NCT01569438|467473393|FG001|Overall Study|Lack of Efficacy|2|||
129868154|NCT01569438|467473392|FG000|Overall Study|Withdrawal by Subject|0|||
129868155|NCT01569438|467473393|FG001|Overall Study|Withdrawal by Subject|3|||
129868156|NCT01569438|467473392|FG000|Overall Study|Adverse Event|2|||
129868157|NCT01569438|467473393|FG001|Overall Study|Adverse Event|15|||
129868158|NCT01569438|467473392|FG000|Overall Study|Protocol Violation|2|||
129868159|NCT01569438|467473393|FG001|Overall Study|Protocol Violation|0|||
129868160|NCT01569438|467473392|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
129868161|NCT01569438|467473393|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
129868162|NCT01569438|467473392|FG000|Overall Study|Sponsor/Physician decision|1|||
129868163|NCT01569438|467473393|FG001|Overall Study|Sponsor/Physician decision|1|||
129868164|NCT01569438|467473392|FG000|Overall Study|Unable to adhere to study schedule|0|||
129868165|NCT01569438|467473393|FG001|Overall Study|Unable to adhere to study schedule|1|||
130065980|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
130065981|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
130065982|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
130065983|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
130065984|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Miscalculation|0|||
130065985|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Miscalculation|1|||
129868166|NCT01207102|467473394|FG000|Overall Study|Withdrawal by Subject|5|||
129868167|NCT01207102|467473394|FG000|Overall Study|Adverse Event|2|||
129916476|NCT02814838|467658561|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
129916477|NCT02814838|467658560|FG000|Overall Study|Consent withdrawal|1|||
129916478|NCT02814838|467658561|FG001|Overall Study|Consent withdrawal|1|||
129916479|NCT02910713|467658563|FG000|Overall Study|Protocol Violation|2|||
129916480|NCT02910713|467658563|FG000|Overall Study|Subject Choice|4|||
129916481|NCT02910713|467658563|FG000|Overall Study|Received One Application|10|||
129916482|NCT02910713|467658563|FG000|Overall Study|Received Neither Application|18|||
129916483|NCT02910713|467658563|FG000|Overall Study|Enrollment cap|7|||
129916484|NCT02910713|467658563|FG000|Overall Study|Investigator Discretion|1|||
129916485|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
129916486|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916487|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916488|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916489|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916490|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
129916491|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
129916492|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
129916493|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
129916494|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
129916495|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
129916496|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
129916497|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
129916498|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
129916499|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
129916500|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
129916501|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916502|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916503|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916504|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916505|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
129916506|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
129916507|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
129916508|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
129916509|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
129916510|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
129916511|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
129916512|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
129916513|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
129916514|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
129916515|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Death|0|||
129916516|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Death|0|||
129916517|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Death|1|||
129916518|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Death|0|||
129916519|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Death|0|||
129916520|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
129916521|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
129916522|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
129916523|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
129916524|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
129916525|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916526|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916527|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
129916528|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916529|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916530|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
129916531|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
129916532|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
129916533|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
129916534|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
129916535|NCT03940703|467659768|FG000|Overall Study|Still under treatment|31|||
129916536|NCT03940703|467659769|FG001|Overall Study|Still under treatment|0|||
129916537|NCT04521478|467659770|FG000|Overall Study|Protocol Violation|2|||
129916538|NCT04521478|467659771|FG001|Overall Study|Protocol Violation|0|||
129916539|NCT04521478|467659772|FG002|Overall Study|Protocol Violation|1|||
129916540|NCT04521478|467659773|FG003|Overall Study|Protocol Violation|0|||
129916541|NCT04521478|467659774|FG004|Overall Study|Protocol Violation|0|||
130065986|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Miscalculation|0|||
129868168|NCT01207102|467473394|FG000|Overall Study|progression|2|||
129868169|NCT01207102|467473394|FG000|Overall Study|Withdrawal by Treating Physician|1|||
129868170|NCT01777854|467473397|FG000|Overall Study|Physician Decision|3|||
129868171|NCT01777854|467473398|FG001|Overall Study|Physician Decision|3|||
129868172|NCT03649230|467473399|FG000|Overall Study|Adverse Event|12|||
129868173|NCT03649230|467473399|FG000|Overall Study|Death|8|||
129868174|NCT03649230|467473399|FG000|Overall Study|Withdrawal by Subject|6|||
129868175|NCT03649230|467473399|FG000|Overall Study|Physician Decision|5|||
129868176|NCT03649230|467473399|FG000|Overall Study|Disease progression|5|||
129868177|NCT03649230|467473399|FG000|Overall Study|Switched to non-HEC|5|||
129868178|NCT03649230|467473399|FG000|Overall Study|Chemotherapy discontinued|4|||
129868179|NCT03649230|467473399|FG000|Overall Study|Received only 3 HEC cycles|4|||
129868180|NCT03649230|467473399|FG000|Overall Study|Screen Failure|3|||
129868181|NCT03649230|467473399|FG000|Overall Study|Patient stopped treatment|2|||
129868182|NCT03649230|467473399|FG000|Overall Study|Protocol Violation|1|||
129868183|NCT03649230|467473399|FG000|Overall Study|Non-compliance|1|||
129868184|NCT03649230|467473399|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
129868185|NCT01693068|467473401|FG000|Randomization Period|On-study|2|||
129868186|NCT01693068|467473402|FG001|Randomization Period|On-study|5|||
129868187|NCT01693068|467473403|FG002|Randomization Period|On-study|0|||
129868188|NCT01693068|467473401|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
129868189|NCT01693068|467473402|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
129868190|NCT01693068|467473403|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
129868191|NCT01239030|467473413|FG000|Double Blind|Adverse Event|0|||
129868192|NCT01239030|467473414|FG001|Double Blind|Adverse Event|1|||
129868193|NCT01239030|467473415|FG002|Double Blind|Adverse Event|0|||
129868194|NCT01239030|467473416|FG003|Double Blind|Adverse Event|2|||
129868195|NCT01239030|467473417|FG004|Double Blind|Adverse Event|0|||
129868196|NCT01239030|467473413|FG000|Double Blind|Withdrawal by Subject|0|||
129868197|NCT01239030|467473414|FG001|Double Blind|Withdrawal by Subject|1|||
129868198|NCT01239030|467473415|FG002|Double Blind|Withdrawal by Subject|1|||
129868199|NCT01239030|467473416|FG003|Double Blind|Withdrawal by Subject|0|||
129868200|NCT01239030|467473417|FG004|Double Blind|Withdrawal by Subject|1|||
129868201|NCT01239030|467473413|FG000|Double Blind|Lost to Follow-up|1|||
129868202|NCT01239030|467473414|FG001|Double Blind|Lost to Follow-up|1|||
129868203|NCT01239030|467473415|FG002|Double Blind|Lost to Follow-up|0|||
129868204|NCT01239030|467473416|FG003|Double Blind|Lost to Follow-up|0|||
129868205|NCT01239030|467473417|FG004|Double Blind|Lost to Follow-up|0|||
129868206|NCT01239030|467473413|FG000|Double Blind|Physician Decision|0|||
129868207|NCT01239030|467473414|FG001|Double Blind|Physician Decision|1|||
129868208|NCT01239030|467473415|FG002|Double Blind|Physician Decision|0|||
129868209|NCT01239030|467473416|FG003|Double Blind|Physician Decision|0|||
129868210|NCT01239030|467473417|FG004|Double Blind|Physician Decision|0|||
129868211|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
129868212|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
129868213|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
129868214|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
129868215|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
129868216|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
129868217|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
129868218|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
129868219|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
129868220|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
129868221|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
129868222|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
129868223|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
129868224|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
129868225|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
129868226|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
129868227|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
129868228|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
129868229|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
129868230|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
129868231|NCT02432105|467473422|FG000|Overall Study|Lost to Follow-up|1|||
130065987|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Miscalculation|0|||
129868232|NCT02432105|467473423|FG001|Overall Study|Lost to Follow-up|1|||
129868233|NCT02432105|467473424|FG002|Overall Study|Lost to Follow-up|0|||
129868234|NCT02432105|467473422|FG000|Overall Study|Withdrawal by Subject|1|||
129868235|NCT02432105|467473423|FG001|Overall Study|Withdrawal by Subject|0|||
129868236|NCT02432105|467473424|FG002|Overall Study|Withdrawal by Subject|1|||
129868237|NCT02432105|467473422|FG000|Overall Study|Culture positive for yeast|0|||
129868238|NCT02432105|467473423|FG001|Overall Study|Culture positive for yeast|1|||
130065988|NCT02505542|468196046|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
130065989|NCT02505542|468196047|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
129868239|NCT02432105|467473424|FG002|Overall Study|Culture positive for yeast|0|||
129868240|NCT02432105|467473422|FG000|Overall Study|Randomized in error|0|||
129868241|NCT02432105|467473423|FG001|Overall Study|Randomized in error|0|||
129868242|NCT02432105|467473424|FG002|Overall Study|Randomized in error|2|||
129868243|NCT01400503|467473425|FG000|Overall Study|Withdrawal by Subject|1|||
129868244|NCT01400503|467473425|FG000|Overall Study|Study Terminated by Sponsor|58|||
129868245|NCT01400503|467473425|FG000|Overall Study|Other|1|||
129868246|NCT00058123|467473426|FG000|Overall Study|Wrong histology|9|||
129868247|NCT00058123|467473426|FG000|Overall Study|Received >3 prior treatments|1|||
129868248|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
129868249|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
129868250|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
129868251|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868252|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868253|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868254|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868255|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868256|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868257|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
129868258|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
129868259|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
129868260|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868261|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868262|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868263|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868264|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868265|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868266|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
129868267|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
129868268|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
129868269|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868270|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868271|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868272|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868273|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868274|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868275|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129868276|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868277|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
129868278|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868279|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868280|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868281|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868282|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868283|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868284|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868285|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868286|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129868287|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129916542|NCT04521478|467659775|FG005|Overall Study|Protocol Violation|0|||
129916543|NCT04521478|467659770|FG000|Overall Study|Technical Problems|0|||
129916544|NCT04521478|467659771|FG001|Overall Study|Technical Problems|0|||
129916545|NCT04521478|467659772|FG002|Overall Study|Technical Problems|0|||
129916546|NCT04521478|467659773|FG003|Overall Study|Technical Problems|1|||
129916547|NCT04521478|467659774|FG004|Overall Study|Technical Problems|0|||
129916548|NCT04521478|467659775|FG005|Overall Study|Technical Problems|0|||
129916549|NCT04521478|467659770|FG000|Overall Study|Burden of Study Procedures|1|||
129916550|NCT04521478|467659771|FG001|Overall Study|Burden of Study Procedures|0|||
129868288|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868289|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868290|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129916551|NCT04521478|467659772|FG002|Overall Study|Burden of Study Procedures|0|||
129916552|NCT04521478|467659773|FG003|Overall Study|Burden of Study Procedures|1|||
129916553|NCT04521478|467659774|FG004|Overall Study|Burden of Study Procedures|0|||
129916554|NCT04521478|467659775|FG005|Overall Study|Burden of Study Procedures|1|||
130065990|NCT02505542|468196048|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
130065991|NCT02505542|468196049|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
130065992|NCT02759861|468196052|FG000|Overall Study|Death|1|||
130065993|NCT01522443|468196053|FG000|Overall Study|No longer receiving clinical benefit|36|||
130065994|NCT01522443|468196054|FG001|Overall Study|No longer receiving clinical benefit|28|||
130065995|NCT01522443|468196053|FG000|Overall Study|Adverse Event|10|||
130065996|NCT01522443|468196054|FG001|Overall Study|Adverse Event|15|||
130065997|NCT01522443|468196053|FG000|Overall Study|Withdrawal by Subject|5|||
130065998|NCT01522443|468196054|FG001|Overall Study|Withdrawal by Subject|8|||
130065999|NCT01522443|468196053|FG000|Overall Study|No study treatment given|1|||
130066000|NCT01522443|468196054|FG001|Overall Study|No study treatment given|1|||
130066001|NCT01522443|468196053|FG000|Overall Study|Other|1|||
130066002|NCT01522443|468196054|FG001|Overall Study|Other|3|||
130066003|NCT05590767|468196057|FG000|Overall Study|Protocol Violation|1|||
130066004|NCT05590767|468196057|FG000|Overall Study|surgery canceled|1|||
130066005|NCT05590767|468196057|FG000|Overall Study|interscalene brachial block not performed|1|||
130066006|NCT01764256|468196058|FG000|Received All Vaccinations|Adverse Event|1|||
130066007|NCT01764256|468196059|FG001|Received All Vaccinations|Adverse Event|1|||
130066008|NCT01764256|468196060|FG002|Received All Vaccinations|Adverse Event|0|||
130066009|NCT01764256|468196061|FG003|Received All Vaccinations|Adverse Event|0|||
130066010|NCT01764256|468196058|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
130066011|NCT01764256|468196059|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
130066012|NCT01764256|468196060|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
130066013|NCT01764256|468196061|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
130066014|NCT01764256|468196058|FG000|Received All Vaccinations|Lost to Follow-up|1|||
130066015|NCT01764256|468196059|FG001|Received All Vaccinations|Lost to Follow-up|0|||
130066016|NCT01764256|468196060|FG002|Received All Vaccinations|Lost to Follow-up|0|||
130066017|NCT01764256|468196061|FG003|Received All Vaccinations|Lost to Follow-up|0|||
130066018|NCT01764256|468196058|FG000|Completed Study|Lost to Follow-up|0|||
130066019|NCT01764256|468196059|FG001|Completed Study|Lost to Follow-up|0|||
130066020|NCT01764256|468196060|FG002|Completed Study|Lost to Follow-up|0|||
130066021|NCT01764256|468196061|FG003|Completed Study|Lost to Follow-up|1|||
130066022|NCT00776555|468196071|FG000|Overall Study|Study terminated|3|||
130066023|NCT00776555|468196072|FG001|Overall Study|Study terminated|0|||
130066024|NCT00585923|468196075|FG000|Overall Study|Physician decided not to continue|31|||
130066025|NCT00585923|468196076|FG001|Overall Study|Physician decided not to continue|33|||
130066026|NCT00618449|468196077|FG000|Overall Study|Lost to Follow-up|98|||
130066027|NCT00618449|468196078|FG001|Overall Study|Lost to Follow-up|110|||
130066028|NCT01441115|468196079|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
130066029|NCT04311177|468196084|FG000|Overall Study|Adverse Event|3|||
130066030|NCT04311177|468196085|FG001|Overall Study|Adverse Event|1|||
130066031|NCT04311177|468196084|FG000|Overall Study|Physician Decision|4|||
130066032|NCT04311177|468196085|FG001|Overall Study|Physician Decision|3|||
130066033|NCT04311177|468196084|FG000|Overall Study|Withdrawal by Subject|1|||
130066034|NCT04311177|468196085|FG001|Overall Study|Withdrawal by Subject|0|||
130066035|NCT01681576|468196088|FG000|Period 1|Adverse Event|1|||
130066036|NCT01681576|468196089|FG001|Period 1|Adverse Event|0|||
130066037|NCT01681576|468196088|FG000|Period 1|Protocol Deviation|1|||
130066038|NCT01681576|468196089|FG001|Period 1|Protocol Deviation|0|||
129868291|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868292|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868293|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
129868294|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
129868295|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
129868296|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868297|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868298|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868299|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868300|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868301|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868302|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868303|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
129868304|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
129868305|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
129868306|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
130066039|NCT01681576|468196088|FG000|Period 2|subject/guardian decision|3|||
130066040|NCT01681576|468196089|FG001|Period 2|subject/guardian decision|1|||
130066041|NCT01681576|468196088|FG000|Period 2|Non-compliance with study treatment|1|||
130066042|NCT01681576|468196089|FG001|Period 2|Non-compliance with study treatment|0|||
130066043|NCT03103906|468196094|FG000|Overall Study|Adverse Event|2|||
130066044|NCT03103906|468196095|FG001|Overall Study|Adverse Event|3|||
130066045|NCT03103906|468196094|FG000|Overall Study|Other|2|||
130066046|NCT03103906|468196095|FG001|Overall Study|Other|0|||
130066047|NCT03571256|468196096|FG000|Overall Study|Adverse Event|3|||
130066048|NCT03571256|468196097|FG001|Overall Study|Adverse Event|0|||
130066049|NCT03571256|468196098|FG002|Overall Study|Adverse Event|1|||
130066050|NCT03571256|468196096|FG000|Overall Study|Withdrawal by Subject|3|||
130066051|NCT03571256|468196097|FG001|Overall Study|Withdrawal by Subject|1|||
129868307|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129916555|NCT04521478|467659770|FG000|Overall Study|Lack of Efficacy|0|||
129916556|NCT04521478|467659771|FG001|Overall Study|Lack of Efficacy|0|||
129916557|NCT04521478|467659772|FG002|Overall Study|Lack of Efficacy|0|||
129916558|NCT04521478|467659773|FG003|Overall Study|Lack of Efficacy|0|||
129916559|NCT04521478|467659774|FG004|Overall Study|Lack of Efficacy|1|||
129916560|NCT04521478|467659775|FG005|Overall Study|Lack of Efficacy|1|||
129916561|NCT04521478|467659770|FG000|Overall Study|Adverse Event|7|||
129916562|NCT04521478|467659771|FG001|Overall Study|Adverse Event|0|||
129916563|NCT04521478|467659772|FG002|Overall Study|Adverse Event|2|||
129916564|NCT04521478|467659773|FG003|Overall Study|Adverse Event|1|||
129916565|NCT04521478|467659774|FG004|Overall Study|Adverse Event|2|||
129916566|NCT04521478|467659775|FG005|Overall Study|Adverse Event|7|||
129916567|NCT04521478|467659770|FG000|Overall Study|No Reason Available|0|||
129916568|NCT04521478|467659771|FG001|Overall Study|No Reason Available|2|||
129916569|NCT04521478|467659772|FG002|Overall Study|No Reason Available|0|||
129916570|NCT04521478|467659773|FG003|Overall Study|No Reason Available|0|||
129916571|NCT04521478|467659774|FG004|Overall Study|No Reason Available|1|||
129916572|NCT04521478|467659775|FG005|Overall Study|No Reason Available|0|||
129916573|NCT04521478|467659770|FG000|Overall Study|Other than listed|3|||
129916574|NCT04521478|467659771|FG001|Overall Study|Other than listed|3|||
129916575|NCT04521478|467659772|FG002|Overall Study|Other than listed|3|||
129916576|NCT04521478|467659773|FG003|Overall Study|Other than listed|2|||
129916577|NCT04521478|467659774|FG004|Overall Study|Other than listed|3|||
129916578|NCT04521478|467659775|FG005|Overall Study|Other than listed|3|||
129916579|NCT04521478|467659770|FG000|Overall Study|Not treated|0|||
129916580|NCT04521478|467659771|FG001|Overall Study|Not treated|0|||
129916581|NCT04521478|467659772|FG002|Overall Study|Not treated|0|||
129916582|NCT04521478|467659773|FG003|Overall Study|Not treated|0|||
129916583|NCT04521478|467659774|FG004|Overall Study|Not treated|0|||
129916584|NCT04521478|467659775|FG005|Overall Study|Not treated|1|||
129916585|NCT04850807|467659780|FG000|Overall Study|Death|50|||
129916586|NCT04850807|467659781|FG001|Overall Study|Death|55|||
129916587|NCT04850807|467659780|FG000|Overall Study|Discharged|17|||
129916588|NCT04850807|467659781|FG001|Overall Study|Discharged|13|||
129916589|NCT04850807|467659780|FG000|Overall Study|Incomplete baseline data|3|||
129916590|NCT04850807|467659781|FG001|Overall Study|Incomplete baseline data|2|||
129916591|NCT02187003|467659782|FG000|Overall Study|Adverse Event|2|||
129916592|NCT02187003|467659783|FG001|Overall Study|Adverse Event|0|||
129916593|NCT02187003|467659782|FG000|Overall Study|Lost to Follow-up|14|||
129916594|NCT02187003|467659783|FG001|Overall Study|Lost to Follow-up|10|||
129916595|NCT02187003|467659782|FG000|Overall Study|Withdrawal by Subject|3|||
130066052|NCT03571256|468196098|FG002|Overall Study|Withdrawal by Subject|1|||
129868308|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
129868309|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868310|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868311|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868312|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
129868313|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
129868314|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
129868315|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
129868316|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
129868317|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868318|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868319|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868320|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
129868321|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
129868322|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
129868323|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
129868324|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
129868325|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
129868326|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
129868327|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
130066053|NCT03571256|468196096|FG000|Overall Study|Other than specified|0|||
130066054|NCT03571256|468196097|FG001|Overall Study|Other than specified|1|||
129916596|NCT02187003|467659783|FG001|Overall Study|Withdrawal by Subject|7|||
129916597|NCT02187003|467659782|FG000|Overall Study|Protocol Violation|2|||
129916598|NCT02187003|467659783|FG001|Overall Study|Protocol Violation|4|||
129916599|NCT02187003|467659782|FG000|Overall Study|Other|5|||
129916600|NCT02187003|467659783|FG001|Overall Study|Other|5|||
129916601|NCT02187003|467659782|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129916602|NCT02187003|467659783|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
129916603|NCT04593472|467659784|FG000|Overall Study|Death|31|||
129916604|NCT04593472|467659785|FG001|Overall Study|Death|27|||
130066055|NCT03571256|468196098|FG002|Overall Study|Other than specified|1|||
129916605|NCT04593472|467659784|FG000|Overall Study|Withdrawal by Subject|12|||
129868328|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
129868329|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868330|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868331|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
129868332|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868333|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868334|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868335|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868336|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868337|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868338|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868339|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868340|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868341|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
129868342|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868343|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868344|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868345|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868346|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868347|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868348|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868349|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
129868350|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
129868351|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868352|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868353|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868354|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868355|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868356|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868357|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
129868358|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
129868359|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868360|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868361|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868362|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868363|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868364|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
129868365|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868366|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
129868367|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
129868368|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868369|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868370|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868371|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868372|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
129868373|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
129868374|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868375|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
129868376|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868377|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868378|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868379|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868380|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868381|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868382|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868383|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868384|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
129868385|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
129868386|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868387|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868388|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868389|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868390|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
129868391|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
129868392|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868393|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
130066056|NCT03571256|468196096|FG000|Overall Study|Protocol Violation|0|||
129868394|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
129868395|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868396|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868397|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868398|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868399|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
129868400|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
129868401|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868402|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
129868403|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129868404|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868405|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868406|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868407|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868408|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868409|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129868410|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868411|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129868412|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129868413|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868414|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868415|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868416|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868417|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129868418|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
129868419|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868420|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
129868421|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
129868422|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868423|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868424|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868425|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868426|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
129868427|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
129868428|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868429|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
129868430|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
129868431|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868432|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868433|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868434|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868435|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129868436|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129868437|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868438|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
129868439|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868440|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868441|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868442|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868443|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868444|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868445|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868446|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868447|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868448|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868449|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868450|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868451|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868452|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868453|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
129868454|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868455|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868456|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
130066057|NCT03571256|468196097|FG001|Overall Study|Protocol Violation|1|||
129868457|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129868458|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868459|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
130066058|NCT03571256|468196098|FG002|Overall Study|Protocol Violation|1|||
129916606|NCT04593472|467659785|FG001|Overall Study|Withdrawal by Subject|12|||
129916607|NCT04593472|467659784|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
129916608|NCT04593472|467659785|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
129916609|NCT04593472|467659784|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
129916610|NCT04593472|467659785|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
129916611|NCT04593472|467659784|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
129916612|NCT04593472|467659785|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
129916613|NCT04593472|467659784|FG000|Overall Study|Lost to Follow-up|0|||
129916614|NCT04593472|467659785|FG001|Overall Study|Lost to Follow-up|2|||
129916615|NCT04593472|467659784|FG000|Overall Study|Still collecting 24-month assessment|17|||
129916616|NCT04593472|467659785|FG001|Overall Study|Still collecting 24-month assessment|10|||
129916617|NCT03896516|467659786|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
129916618|NCT03896516|467659787|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
129916619|NCT03896516|467659786|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
129916620|NCT03896516|467659787|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
129916621|NCT03896516|467659786|FG000|Washout Period|Physician Decision|3|||
129916622|NCT03896516|467659787|FG001|Washout Period|Physician Decision|1|||
129916623|NCT03896516|467659786|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
129916624|NCT03896516|467659787|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
129916625|NCT04549168|467659790|FG000|Randomization Phase|Adverse Event|0|||
129916626|NCT04549168|467659791|FG001|Randomization Phase|Adverse Event|0|||
129916627|NCT04549168|467659792|FG002|Randomization Phase|Adverse Event|1|||
129916628|NCT04549168|467659790|FG000|Randomization Phase|Other|0|||
129916629|NCT04549168|467659791|FG001|Randomization Phase|Other|2|||
129916630|NCT04549168|467659792|FG002|Randomization Phase|Other|0|||
129916631|NCT04549168|467659790|FG000|Randomization Phase|Withdrawal by Subject|0|||
129916632|NCT04549168|467659791|FG001|Randomization Phase|Withdrawal by Subject|2|||
129916633|NCT04549168|467659792|FG002|Randomization Phase|Withdrawal by Subject|1|||
129916634|NCT02662062|467659796|FG000|Overall Study|Withdrawal by Subject|1|||
129916635|NCT06311084|467659797|FG000|Overall Study|Lost to Follow-up|14|||
129916636|NCT03988634|467659798|FG000|Double-Blind|Adverse Event|4|||
129916637|NCT03988634|467659799|FG001|Double-Blind|Adverse Event|0|||
129916638|NCT03988634|467659800|FG002|Double-Blind|Adverse Event|0|||
129916639|NCT03988634|467659798|FG000|Double-Blind|Death|18|||
129916640|NCT03988634|467659799|FG001|Double-Blind|Death|26|||
129916641|NCT03988634|467659800|FG002|Double-Blind|Death|0|||
129916642|NCT03988634|467659798|FG000|Double-Blind|Lost to Follow-up|6|||
129916643|NCT03988634|467659799|FG001|Double-Blind|Lost to Follow-up|7|||
129916644|NCT03988634|467659800|FG002|Double-Blind|Lost to Follow-up|0|||
129916645|NCT03988634|467659798|FG000|Double-Blind|Physician Decision|9|||
129916646|NCT03988634|467659799|FG001|Double-Blind|Physician Decision|5|||
129916647|NCT03988634|467659800|FG002|Double-Blind|Physician Decision|0|||
129916648|NCT03988634|467659798|FG000|Double-Blind|Subject decision|24|||
129916649|NCT03988634|467659799|FG001|Double-Blind|Subject decision|13|||
129916650|NCT03988634|467659800|FG002|Double-Blind|Subject decision|0|||
130066059|NCT04142216|468196100|FG000|Overall Study|Hospitalization|0|||
130066060|NCT04142216|468196101|FG001|Overall Study|Hospitalization|2|||
130066061|NCT04142216|468196100|FG000|Overall Study|Death|3|||
129868460|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868461|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868462|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129868463|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129868464|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868465|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
129868466|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
129868467|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868468|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868469|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868470|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868471|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868472|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
129868473|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868474|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
129868475|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
129916651|NCT03988634|467659798|FG000|Open-Label|Adverse Event|0|||
129916652|NCT03988634|467659799|FG001|Open-Label|Adverse Event|0|||
129916653|NCT03988634|467659800|FG002|Open-Label|Adverse Event|7|||
129916654|NCT03988634|467659798|FG000|Open-Label|Physician Decision|0|||
129868476|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129916655|NCT03988634|467659799|FG001|Open-Label|Physician Decision|0|||
129916656|NCT03988634|467659800|FG002|Open-Label|Physician Decision|1|||
129916657|NCT03988634|467659798|FG000|Open-Label|Technical problems|0|||
129916658|NCT03988634|467659799|FG001|Open-Label|Technical problems|0|||
130066062|NCT04142216|468196101|FG001|Overall Study|Death|1|||
129868477|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868478|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868479|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868480|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
129868481|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868482|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868483|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
129868484|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
129868485|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868486|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868487|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868488|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868489|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
129868490|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868491|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868492|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
129868493|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
129868494|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868495|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868496|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868497|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868498|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868499|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868500|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868501|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868502|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
129868503|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868504|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868505|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868506|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868507|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868508|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868509|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868510|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
129868511|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868512|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868513|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868514|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868515|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868516|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868517|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
129868518|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
129868519|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
129868520|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
129868521|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
129868522|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
129868523|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
129868524|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
129868525|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
129868526|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
129868527|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868528|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868529|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
129868530|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868531|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868532|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868533|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868534|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868535|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868536|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868537|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868538|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
129868539|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868540|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868541|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868542|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868543|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868544|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
129868545|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129916659|NCT03988634|467659800|FG002|Open-Label|Technical problems|1|||
129916660|NCT04725240|467659801|FG000|Overall Study|Adverse Event|2|||
129916661|NCT00676715|467659808|FG000|Treatment Period (TP)|Adverse Event|0|||
129916662|NCT00676715|467659809|FG001|Treatment Period (TP)|Adverse Event|3|||
129916663|NCT00676715|467659810|FG002|Treatment Period (TP)|Adverse Event|2|||
129916664|NCT00676715|467659811|FG003|Treatment Period (TP)|Adverse Event|2|||
129916665|NCT00676715|467659808|FG000|Treatment Period (TP)|Death|0|||
129916666|NCT00676715|467659809|FG001|Treatment Period (TP)|Death|0|||
129916667|NCT00676715|467659810|FG002|Treatment Period (TP)|Death|1|||
129916668|NCT00676715|467659811|FG003|Treatment Period (TP)|Death|0|||
129916669|NCT00676715|467659808|FG000|Treatment Period (TP)|Failure to return|1|||
129916670|NCT00676715|467659809|FG001|Treatment Period (TP)|Failure to return|0|||
129916671|NCT00676715|467659810|FG002|Treatment Period (TP)|Failure to return|0|||
129916672|NCT00676715|467659811|FG003|Treatment Period (TP)|Failure to return|0|||
129916673|NCT00676715|467659808|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
129916674|NCT00676715|467659809|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
129916675|NCT00676715|467659810|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
129916676|NCT00676715|467659811|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
129916677|NCT00676715|467659808|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
129916678|NCT00676715|467659809|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
129916679|NCT00676715|467659810|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
129916680|NCT00676715|467659811|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
129916681|NCT00676715|467659808|FG000|Treatment Period (TP)|Withdrew consent|3|||
129916682|NCT00676715|467659809|FG001|Treatment Period (TP)|Withdrew consent|3|||
129916683|NCT00676715|467659810|FG002|Treatment Period (TP)|Withdrew consent|3|||
129916684|NCT00676715|467659811|FG003|Treatment Period (TP)|Withdrew consent|3|||
129916685|NCT00676715|467659808|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
129916686|NCT00676715|467659809|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
129916687|NCT00676715|467659810|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
129916688|NCT00676715|467659811|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
129916689|NCT00676715|467659808|FG000|Treatment Period (TP)|Administrative|0|||
129916690|NCT00676715|467659809|FG001|Treatment Period (TP)|Administrative|0|||
129916691|NCT00676715|467659810|FG002|Treatment Period (TP)|Administrative|0|||
129916692|NCT00676715|467659811|FG003|Treatment Period (TP)|Administrative|1|||
129916693|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
129916694|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
129916695|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
129916696|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
129916697|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
129916698|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
129916699|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
129916700|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
129916701|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
129916702|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
129916703|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
130066063|NCT04142216|468196100|FG000|Overall Study|Referral to another hemodialysis unit|3|||
129916704|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
129916705|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
129916706|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
129916707|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
129916708|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
129916709|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Death|1|||
129916710|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Death|1|||
129916711|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Death|1|||
130066064|NCT04142216|468196101|FG001|Overall Study|Referral to another hemodialysis unit|2|||
130066065|NCT04142216|468196100|FG000|Overall Study|Use of clove|0|||
130066066|NCT04142216|468196101|FG001|Overall Study|Use of clove|1|||
130066067|NCT02007954|468196102|FG000|Overall Study|Received liver transplant|3|||
130066068|NCT02007954|468196102|FG000|Overall Study|Switch in treatment modality|2|||
130066069|NCT02007954|468196102|FG000|Overall Study|Disease progression and unrelated AE|1|||
130066070|NCT02007954|468196102|FG000|Overall Study|Death|1|||
130116743|NCT00818623|468387168|FG004|Overall Study|Need of additional treatment|1|||
129916712|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Death|0|||
129916713|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Reason not provided|3|||
129916714|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Reason not provided|4|||
129916715|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Reason not provided|1|||
129916716|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Reason not provided|4|||
129916717|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
129916718|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
129916719|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
130066071|NCT01195363|468196105|FG000|Overall Study|Lost to Follow-up|7|||
130116744|NCT00818623|468387169|FG005|Overall Study|Need of additional treatment|0|||
129868546|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868547|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
129868548|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868549|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868550|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868551|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868552|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868553|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868554|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868555|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
129868556|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129868557|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868558|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868559|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868560|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868561|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129868562|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868563|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Death|0|||
129868564|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Death|0|||
129868565|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Death|0|||
129868566|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Death|0|||
129868567|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Death|0|||
129868568|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Death|0|||
129868569|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Death|0|||
129868570|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Death|1|||
129868571|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Death|0|||
129868572|NCT02085252|467473451|FG000|Overall Study|Withdrawal of Consent|1|||
129868573|NCT02085252|467473452|FG001|Overall Study|Withdrawal of Consent|0|||
129868574|NCT02085252|467473451|FG000|Overall Study|Adverse Event|0|||
129868575|NCT02085252|467473452|FG001|Overall Study|Adverse Event|1|||
129868576|NCT02085252|467473451|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
129868577|NCT02085252|467473452|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
129868578|NCT02085252|467473451|FG000|Overall Study|Reason Not Specified|0|||
129868579|NCT02085252|467473452|FG001|Overall Study|Reason Not Specified|1|||
129868580|NCT02085252|467473451|FG000|Overall Study|Reason Unknown|0|||
129868581|NCT02085252|467473452|FG001|Overall Study|Reason Unknown|1|||
129868582|NCT03260868|467473454|FG000|Overall Study|Poor Compliance to Protocol|0|||
129868583|NCT03260868|467473455|FG001|Overall Study|Poor Compliance to Protocol|2|||
129868584|NCT03260868|467473454|FG000|Overall Study|Study Terminated By Sponsor|2|||
129868585|NCT03260868|467473455|FG001|Overall Study|Study Terminated By Sponsor|1|||
129868586|NCT03260868|467473454|FG000|Overall Study|Other than specified above|1|||
129868587|NCT03260868|467473455|FG001|Overall Study|Other than specified above|0|||
129868588|NCT02925676|467473456|FG000|Overall Study|Withdrawal by Subject|1|||
129868589|NCT00541450|467473457|FG000|Phase A|Adverse Event|3|||
129868590|NCT00541450|467473458|FG001|Phase A|Adverse Event|0|||
129868591|NCT00541450|467473457|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
129868592|NCT00541450|467473458|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
129868593|NCT00541450|467473457|FG000|Phase A|Hyperglycemia|0|||
129868594|NCT00541450|467473458|FG001|Phase A|Hyperglycemia|1|||
129868595|NCT00541450|467473457|FG000|Phase A|Lost to Follow-up|6|||
129868596|NCT00541450|467473458|FG001|Phase A|Lost to Follow-up|4|||
129868597|NCT00541450|467473457|FG000|Phase A|Physician Decision|2|||
129868598|NCT00541450|467473458|FG001|Phase A|Physician Decision|0|||
129868599|NCT00541450|467473457|FG000|Phase A|Protocol Violation|2|||
129868600|NCT00541450|467473458|FG001|Phase A|Protocol Violation|3|||
129868601|NCT00541450|467473457|FG000|Phase A|Withdrawal by Subject|7|||
129868602|NCT00541450|467473458|FG001|Phase A|Withdrawal by Subject|7|||
129868603|NCT00541450|467473457|FG000|Phase B|Adverse Event|6|||
129868604|NCT00541450|467473458|FG001|Phase B|Adverse Event|6|||
129868605|NCT00541450|467473457|FG000|Phase B|Hyperglycemia|10|||
129868606|NCT00541450|467473458|FG001|Phase B|Hyperglycemia|9|||
129868607|NCT00541450|467473457|FG000|Phase B|Lost to Follow-up|6|||
129868608|NCT00541450|467473458|FG001|Phase B|Lost to Follow-up|4|||
129868609|NCT00541450|467473457|FG000|Phase B|Physician Decision|4|||
129868610|NCT00541450|467473458|FG001|Phase B|Physician Decision|2|||
129868611|NCT00541450|467473457|FG000|Phase B|Pregnancy|0|||
129868612|NCT00541450|467473458|FG001|Phase B|Pregnancy|1|||
129868613|NCT00541450|467473457|FG000|Phase B|Protocol Violation|3|||
129868614|NCT00541450|467473458|FG001|Phase B|Protocol Violation|3|||
129868615|NCT00541450|467473457|FG000|Phase B|Withdrawal by Subject|8|||
129868616|NCT00541450|467473458|FG001|Phase B|Withdrawal by Subject|6|||
129868617|NCT01298999|467473459|FG000|Overall Study|Physician Decision|0|||
129868618|NCT01298999|467473460|FG001|Overall Study|Physician Decision|1|||
129868619|NCT01298999|467473459|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
129868620|NCT01298999|467473460|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
129868621|NCT00803452|467473461|FG000|Overall Study|Adverse Event|0|||
129916720|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
129916721|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
129916722|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
129916723|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
129916724|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
129916725|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Adverse Event|0|||
129916726|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Adverse Event|3|||
129916727|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Adverse Event|1|||
129916728|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Adverse Event|0|||
129916729|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Death|2|||
129916730|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Death|0|||
129916731|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Death|2|||
129916732|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Death|2|||
129916733|NCT01820260|467659812|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916734|NCT01820260|467659813|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916735|NCT01820260|467659814|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916736|NCT01820260|467659815|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916737|NCT01820260|467659816|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916738|NCT01820260|467659817|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916739|NCT01820260|467659818|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
130066072|NCT01195363|468196106|FG001|Overall Study|Lost to Follow-up|4|||
130066073|NCT01195363|468196105|FG000|Overall Study|Adverse Event|3|||
130066074|NCT01195363|468196106|FG001|Overall Study|Adverse Event|1|||
130066075|NCT01195363|468196105|FG000|Overall Study|Lack of Efficacy|0|||
130066076|NCT01195363|468196106|FG001|Overall Study|Lack of Efficacy|4|||
130066077|NCT01195363|468196105|FG000|Overall Study|incarceration|1|||
130066078|NCT01195363|468196106|FG001|Overall Study|incarceration|0|||
129916740|NCT01820260|467659819|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916741|NCT01820260|467659820|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916742|NCT01820260|467659821|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916743|NCT01820260|467659822|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916744|NCT01820260|467659823|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916745|NCT01820260|467659824|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916746|NCT01820260|467659825|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916747|NCT01820260|467659812|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916748|NCT01820260|467659813|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916749|NCT01820260|467659814|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916750|NCT01820260|467659815|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916751|NCT01820260|467659816|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916752|NCT01820260|467659817|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916753|NCT01820260|467659818|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916754|NCT01820260|467659819|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130066079|NCT00377429|468196108|FG000|Overall Study|Withdrawal by Subject|5|||
130066080|NCT00377429|468196108|FG000|Overall Study|Adverse Event|8|||
130066081|NCT00377429|468196108|FG000|Overall Study|Physician Decision|1|||
130066082|NCT00377429|468196108|FG000|Overall Study|Patient non-compliance|1|||
130066083|NCT05691829|468197693|FG000|Overall Study|Physician Decision|2|||
130066084|NCT05691829|468197693|FG000|Overall Study|Eligibility criteria not met|3|||
130066085|NCT00453180|468197698|FG000|Overall Study|Lost to Follow-up|2|||
130066086|NCT00453180|468197699|FG001|Overall Study|Lost to Follow-up|1|||
130066087|NCT00453180|468197698|FG000|Overall Study|Adverse Event|1|||
130066088|NCT00453180|468197699|FG001|Overall Study|Adverse Event|2|||
130066089|NCT02420795|468197706|FG000|Overall Study|Withdrawal by Subject|1|||
130066090|NCT02420795|468197707|FG001|Overall Study|Withdrawal by Subject|0|||
130066091|NCT02420795|468197708|FG002|Overall Study|Withdrawal by Subject|0|||
130066092|NCT02420795|468197706|FG000|Overall Study|Adverse Event|1|||
130066093|NCT02420795|468197707|FG001|Overall Study|Adverse Event|0|||
130066094|NCT02420795|468197708|FG002|Overall Study|Adverse Event|0|||
130066095|NCT02420795|468197706|FG000|Overall Study|Progressive disease|2|||
130066096|NCT02420795|468197707|FG001|Overall Study|Progressive disease|2|||
130066097|NCT02420795|468197708|FG002|Overall Study|Progressive disease|4|||
130066098|NCT02420795|468197706|FG000|Overall Study|Death|0|||
130066099|NCT02420795|468197707|FG001|Overall Study|Death|0|||
130066100|NCT02420795|468197708|FG002|Overall Study|Death|1|||
130066101|NCT01002742|468197711|FG000|Overall Study|Determined to be ineligible|0|||
129916755|NCT01820260|467659820|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916756|NCT01820260|467659821|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
129916757|NCT01820260|467659822|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130066102|NCT01002742|468197712|FG001|Overall Study|Determined to be ineligible|1|||
130066103|NCT02862548|468197724|FG000|Randomized Phase (Up to Week 48)|Death|0|||
130066104|NCT02862548|468197725|FG001|Randomized Phase (Up to Week 48)|Death|1|||
130066105|NCT02862548|468197724|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
130066106|NCT02862548|468197725|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
130066107|NCT02862548|468197724|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
130066108|NCT02862548|468197725|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
130066109|NCT02862548|468197724|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
130066110|NCT02862548|468197725|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
130066111|NCT00880763|468197726|FG000|Extension Period (Part 2)|Adverse Event|0|||
130066112|NCT00880763|468197727|FG001|Extension Period (Part 2)|Adverse Event|0|||
130066113|NCT00880763|468197728|FG002|Extension Period (Part 2)|Adverse Event|1|||
130066114|NCT00880763|468197729|FG003|Extension Period (Part 2)|Adverse Event|1|||
130066115|NCT00880763|468197726|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
130066116|NCT00880763|468197727|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
130066117|NCT00880763|468197728|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
130066118|NCT00880763|468197729|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
130066119|NCT00880763|468197726|FG000|Extension Period (Part 2)|Physician Decision|0|||
130066120|NCT00880763|468197727|FG001|Extension Period (Part 2)|Physician Decision|1|||
130066121|NCT00880763|468197728|FG002|Extension Period (Part 2)|Physician Decision|1|||
130066122|NCT00880763|468197729|FG003|Extension Period (Part 2)|Physician Decision|0|||
130066123|NCT00880763|468197726|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
130066124|NCT00880763|468197727|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
130066125|NCT00880763|468197728|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
130066126|NCT00880763|468197729|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
130066127|NCT00656084|468197730|FG000|Overall Study|Adverse Event|4|||
130066128|NCT00656084|468197730|FG000|Overall Study|Withdrawal by Subject|1|||
130066129|NCT00656084|468197730|FG000|Overall Study|Patient Request|1|||
130066130|NCT00656084|468197730|FG000|Overall Study|Investigator Request|1|||
130066131|NCT01293006|468197731|FG000|Period 2|Lost to Follow-up|1|||
130066132|NCT01293006|468197732|FG001|Period 2|Lost to Follow-up|0|||
130066133|NCT01293006|468197733|FG002|Period 2|Lost to Follow-up|0|||
129868622|NCT00803452|467473462|FG001|Overall Study|Adverse Event|2|||
129868623|NCT00803452|467473461|FG000|Overall Study|Lost to Follow-up|0|||
129868624|NCT00803452|467473462|FG001|Overall Study|Lost to Follow-up|3|||
129868625|NCT03360942|467473463|FG000|Overall Study|Device explanted|2|||
129868626|NCT03360942|467473463|FG000|Overall Study|Study closure|1|||
129868627|NCT03360942|467473463|FG000|Overall Study|Withdrawal by Subject|2|||
129868628|NCT05073133|467473464|FG000|Overall Study|Death|2|||
129868629|NCT00289887|467475091|FG000|Overall Study|Adverse Event|3|||
129868630|NCT00289887|467475092|FG001|Overall Study|Adverse Event|3|||
129868631|NCT00289887|467475091|FG000|Overall Study|Lack of Efficacy|3|||
129868632|NCT00289887|467475092|FG001|Overall Study|Lack of Efficacy|11|||
129868633|NCT00289887|467475091|FG000|Overall Study|Lost to Follow-up|3|||
129868634|NCT00289887|467475092|FG001|Overall Study|Lost to Follow-up|3|||
129868635|NCT00289887|467475091|FG000|Overall Study|Protocol Violation|3|||
129868636|NCT00289887|467475092|FG001|Overall Study|Protocol Violation|1|||
129868637|NCT00289887|467475091|FG000|Overall Study|Withdrawal by Subject|3|||
129868638|NCT00289887|467475092|FG001|Overall Study|Withdrawal by Subject|8|||
129868639|NCT00289887|467475091|FG000|Overall Study|Other|7|||
129868640|NCT00289887|467475092|FG001|Overall Study|Other|3|||
129868641|NCT01266850|467475093|FG000|Overall Study|Lost to Follow-up|19|||
129868642|NCT01266850|467475094|FG001|Overall Study|Lost to Follow-up|19|||
129868643|NCT01266850|467475095|FG002|Overall Study|Lost to Follow-up|13|||
129868644|NCT01266850|467475096|FG003|Overall Study|Lost to Follow-up|13|||
129868645|NCT01266850|467475097|FG004|Overall Study|Lost to Follow-up|12|||
129868646|NCT01266850|467475093|FG000|Overall Study|Withdrawal by Subject|8|||
129868647|NCT01266850|467475094|FG001|Overall Study|Withdrawal by Subject|9|||
129868648|NCT01266850|467475095|FG002|Overall Study|Withdrawal by Subject|6|||
130066134|NCT01293006|468197734|FG003|Period 2|Lost to Follow-up|0|||
130066135|NCT01494987|468197735|FG000|Overall Study|Adverse Event|6|||
130066136|NCT01494987|468197736|FG001|Overall Study|Adverse Event|5|||
130066137|NCT01494987|468197735|FG000|Overall Study|Hyperglycemia|6|||
130066138|NCT01494987|468197736|FG001|Overall Study|Hyperglycemia|4|||
129868649|NCT01266850|467475096|FG003|Overall Study|Withdrawal by Subject|9|||
129868650|NCT01266850|467475097|FG004|Overall Study|Withdrawal by Subject|12|||
129868651|NCT01266850|467475093|FG000|Overall Study|Physician Decision|3|||
129868652|NCT01266850|467475094|FG001|Overall Study|Physician Decision|6|||
129868653|NCT01266850|467475095|FG002|Overall Study|Physician Decision|4|||
129868654|NCT01266850|467475096|FG003|Overall Study|Physician Decision|4|||
129868655|NCT01266850|467475097|FG004|Overall Study|Physician Decision|3|||
129868656|NCT01266850|467475093|FG000|Overall Study|Protocol Violation|0|||
129868657|NCT01266850|467475094|FG001|Overall Study|Protocol Violation|1|||
129868658|NCT01266850|467475095|FG002|Overall Study|Protocol Violation|0|||
129868659|NCT01266850|467475096|FG003|Overall Study|Protocol Violation|1|||
129868660|NCT01266850|467475097|FG004|Overall Study|Protocol Violation|2|||
129868661|NCT01266850|467475093|FG000|Overall Study|Adverse Event|0|||
129868662|NCT01266850|467475094|FG001|Overall Study|Adverse Event|0|||
129868663|NCT01266850|467475095|FG002|Overall Study|Adverse Event|0|||
129868664|NCT01266850|467475096|FG003|Overall Study|Adverse Event|0|||
129868665|NCT01266850|467475097|FG004|Overall Study|Adverse Event|1|||
129868666|NCT01266850|467475093|FG000|Overall Study|Site Closure|0|||
130066139|NCT01494987|468197735|FG000|Overall Study|Investigator's Discretion|1|||
130066140|NCT01494987|468197736|FG001|Overall Study|Investigator's Discretion|2|||
130066141|NCT01494987|468197735|FG000|Overall Study|Lost to Follow-up|1|||
130066142|NCT01494987|468197736|FG001|Overall Study|Lost to Follow-up|1|||
130066143|NCT01494987|468197735|FG000|Overall Study|Protocol Violation|3|||
130066144|NCT01494987|468197736|FG001|Overall Study|Protocol Violation|3|||
130066145|NCT01494987|468197735|FG000|Overall Study|Subject Non-Compliance|9|||
130066146|NCT01494987|468197736|FG001|Overall Study|Subject Non-Compliance|10|||
130066147|NCT01494987|468197735|FG000|Overall Study|Subject Withdrew Consent|2|||
130066148|NCT01494987|468197736|FG001|Overall Study|Subject Withdrew Consent|3|||
130066149|NCT00436982|468197739|FG000|Overall Study|Withdrawal by Subject|3|||
130066150|NCT00436982|468197740|FG001|Overall Study|Withdrawal by Subject|1|||
130066151|NCT00436982|468197739|FG000|Overall Study|Did not receive allocated intervention|0|||
130066152|NCT00436982|468197740|FG001|Overall Study|Did not receive allocated intervention|1|||
130066153|NCT00436982|468197739|FG000|Overall Study|no RSA data|1|||
130066154|NCT00436982|468197740|FG001|Overall Study|no RSA data|2|||
130066155|NCT00953225|468197744|FG000|Overall Study|Withdrawal by Subject|2|||
129868667|NCT01266850|467475094|FG001|Overall Study|Site Closure|1|||
129868668|NCT01266850|467475095|FG002|Overall Study|Site Closure|1|||
129868669|NCT01266850|467475096|FG003|Overall Study|Site Closure|1|||
129868670|NCT01266850|467475097|FG004|Overall Study|Site Closure|0|||
129868671|NCT00437645|467475101|FG000|Overall Study|Adverse Event|15|||
129868672|NCT00437645|467475102|FG001|Overall Study|Adverse Event|84|||
129868673|NCT00437645|467475101|FG000|Overall Study|Withdrawal by Subject|10|||
129868674|NCT00437645|467475102|FG001|Overall Study|Withdrawal by Subject|22|||
129868675|NCT00437645|467475101|FG000|Overall Study|Protocol Violation|3|||
129868676|NCT00437645|467475102|FG001|Overall Study|Protocol Violation|3|||
129868677|NCT00437645|467475101|FG000|Overall Study|Lost to Follow-up|2|||
129868678|NCT00437645|467475102|FG001|Overall Study|Lost to Follow-up|3|||
129868679|NCT00437645|467475101|FG000|Overall Study|Administrative problems|2|||
129868680|NCT00437645|467475102|FG001|Overall Study|Administrative problems|1|||
129868681|NCT00437645|467475101|FG000|Overall Study|Lack of Efficacy|2|||
129868682|NCT00437645|467475102|FG001|Overall Study|Lack of Efficacy|1|||
129868683|NCT00437645|467475101|FG000|Overall Study|Condition no longer requires study drug|1|||
129868684|NCT00437645|467475102|FG001|Overall Study|Condition no longer requires study drug|1|||
129868685|NCT03751631|467475106|FG000|Overall Study|Withdrawal by Subject|0|||
129868686|NCT03751631|467475107|FG001|Overall Study|Withdrawal by Subject|0|||
129868687|NCT03751631|467475108|FG002|Overall Study|Withdrawal by Subject|1|||
129868688|NCT03751631|467475109|FG003|Overall Study|Withdrawal by Subject|1|||
129868689|NCT03751631|467475110|FG004|Overall Study|Withdrawal by Subject|0|||
129868690|NCT03751631|467475111|FG005|Overall Study|Withdrawal by Subject|0|||
129868691|NCT03382782|467475116|FG000|Cohort 1|Withdrawal by Subject|11|||
129868692|NCT03382782|467475117|FG001|Cohort 1|Withdrawal by Subject|5|||
129868693|NCT03382782|467475118|FG002|Cohort 1|Withdrawal by Subject|0|||
129868694|NCT03382782|467475116|FG000|Cohort 2|Withdrawal by Subject|1|||
129868695|NCT03382782|467475117|FG001|Cohort 2|Withdrawal by Subject|1|||
129868696|NCT03382782|467475118|FG002|Cohort 2|Withdrawal by Subject|0|||
129868697|NCT03382782|467475116|FG000|Cohort 3|Withdrawal by Subject|1|||
129868698|NCT03382782|467475117|FG001|Cohort 3|Withdrawal by Subject|2|||
129868699|NCT03382782|467475118|FG002|Cohort 3|Withdrawal by Subject|0|||
129868700|NCT00428090|467475121|FG000|Overall Study|Adverse Event|10|||
129868701|NCT00428090|467475122|FG001|Overall Study|Adverse Event|8|||
129868702|NCT00428090|467475123|FG002|Overall Study|Adverse Event|10|||
129868703|NCT00428090|467475124|FG003|Overall Study|Adverse Event|11|||
129868704|NCT00428090|467475121|FG000|Overall Study|Lost to Follow-up|3|||
129868705|NCT00428090|467475122|FG001|Overall Study|Lost to Follow-up|6|||
129868706|NCT00428090|467475123|FG002|Overall Study|Lost to Follow-up|1|||
129868707|NCT00428090|467475124|FG003|Overall Study|Lost to Follow-up|4|||
129868708|NCT00428090|467475121|FG000|Overall Study|Protocol Violation|3|||
129916758|NCT01820260|467659823|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
130066156|NCT00953225|468197745|FG001|Overall Study|Withdrawal by Subject|0|||
130066157|NCT00640146|468197747|FG000|Overall Study|Adverse Event|2|||
130066158|NCT00640146|468197748|FG001|Overall Study|Adverse Event|0|||
130066159|NCT00640146|468197747|FG000|Overall Study|Lost to Follow-up|0|||
129868709|NCT00428090|467475122|FG001|Overall Study|Protocol Violation|1|||
129868710|NCT00428090|467475123|FG002|Overall Study|Protocol Violation|3|||
129868711|NCT00428090|467475124|FG003|Overall Study|Protocol Violation|3|||
129868712|NCT00428090|467475121|FG000|Overall Study|Withdrawal by Subject|10|||
129868713|NCT00428090|467475122|FG001|Overall Study|Withdrawal by Subject|12|||
129868714|NCT00428090|467475123|FG002|Overall Study|Withdrawal by Subject|15|||
129868715|NCT00428090|467475124|FG003|Overall Study|Withdrawal by Subject|5|||
129868716|NCT00428090|467475121|FG000|Overall Study|Sponsor terminated study|0|||
129868717|NCT00428090|467475122|FG001|Overall Study|Sponsor terminated study|1|||
129868718|NCT00428090|467475123|FG002|Overall Study|Sponsor terminated study|0|||
129868719|NCT00428090|467475124|FG003|Overall Study|Sponsor terminated study|0|||
129868720|NCT00428090|467475121|FG000|Overall Study|Non-compliance|4|||
129868721|NCT00428090|467475122|FG001|Overall Study|Non-compliance|0|||
129916759|NCT01820260|467659824|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916760|NCT01820260|467659825|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916761|NCT04831281|467659827|FG000|Overall Study|Adverse Event|1|||
129916762|NCT04831281|467659828|FG001|Overall Study|Adverse Event|0|||
129916763|NCT04831281|467659829|FG002|Overall Study|Adverse Event|3|||
129916764|NCT04831281|467659827|FG000|Overall Study|Withdrawal by Subject|0|||
129916765|NCT04831281|467659828|FG001|Overall Study|Withdrawal by Subject|1|||
129916766|NCT04831281|467659829|FG002|Overall Study|Withdrawal by Subject|2|||
129916767|NCT04831281|467659827|FG000|Overall Study|Undetermined|1|||
129916768|NCT04831281|467659828|FG001|Overall Study|Undetermined|1|||
129916769|NCT04831281|467659829|FG002|Overall Study|Undetermined|0|||
129916770|NCT02249949|467659830|FG000|Overall Study|Cancelled prior to treatment|2|||
129916771|NCT02097420|467659831|FG000|Overall Study|Death|6|||
129916772|NCT02097420|467659831|FG000|Overall Study|Valve explanted|13|||
129916773|NCT02097420|467659831|FG000|Overall Study|Other Reason|1|||
129916774|NCT03161379|467659839|FG000|Overall Study|Withdrawal by Subject|4|||
129916775|NCT03161379|467659839|FG000|Overall Study|disease progression during chemotherapy|5|||
129916776|NCT03161379|467659839|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
129916777|NCT03161379|467659839|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
129916778|NCT02312960|467659844|FG000|Overall Study|Death|24|||
129916779|NCT02312960|467659845|FG001|Overall Study|Death|32|||
129916780|NCT02312960|467659846|FG002|Overall Study|Death|25|||
129916781|NCT02312960|467659847|FG003|Overall Study|Death|11|||
129916782|NCT02312960|467659848|FG004|Overall Study|Death|5|||
129916783|NCT02312960|467659849|FG005|Overall Study|Death|5|||
129916784|NCT02312960|467659850|FG006|Overall Study|Death|8|||
129916785|NCT02312960|467659851|FG007|Overall Study|Death|5|||
129916786|NCT02312960|467659852|FG008|Overall Study|Death|7|||
129916787|NCT02312960|467659853|FG009|Overall Study|Death|3|||
129916788|NCT02312960|467659854|FG010|Overall Study|Death|3|||
129916789|NCT02312960|467659855|FG011|Overall Study|Death|1|||
129916790|NCT02312960|467659856|FG012|Overall Study|Death|25|||
129916791|NCT02312960|467659857|FG013|Overall Study|Death|19|||
129916792|NCT02312960|467659844|FG000|Overall Study|Missing|0|||
129916793|NCT02312960|467659845|FG001|Overall Study|Missing|0|||
129916794|NCT02312960|467659846|FG002|Overall Study|Missing|2|||
129916795|NCT02312960|467659847|FG003|Overall Study|Missing|0|||
129916796|NCT02312960|467659848|FG004|Overall Study|Missing|0|||
129916797|NCT02312960|467659849|FG005|Overall Study|Missing|0|||
129916798|NCT02312960|467659850|FG006|Overall Study|Missing|0|||
129916799|NCT02312960|467659851|FG007|Overall Study|Missing|0|||
129916800|NCT02312960|467659852|FG008|Overall Study|Missing|0|||
129916801|NCT02312960|467659853|FG009|Overall Study|Missing|0|||
129916802|NCT02312960|467659854|FG010|Overall Study|Missing|0|||
129916803|NCT02312960|467659855|FG011|Overall Study|Missing|0|||
129916804|NCT02312960|467659856|FG012|Overall Study|Missing|0|||
129916805|NCT02312960|467659857|FG013|Overall Study|Missing|0|||
129916806|NCT02312960|467659844|FG000|Overall Study|Lost to Follow-up|0|||
129916807|NCT02312960|467659845|FG001|Overall Study|Lost to Follow-up|0|||
129916808|NCT02312960|467659846|FG002|Overall Study|Lost to Follow-up|1|||
129916809|NCT02312960|467659847|FG003|Overall Study|Lost to Follow-up|0|||
129916810|NCT02312960|467659848|FG004|Overall Study|Lost to Follow-up|0|||
129916811|NCT02312960|467659849|FG005|Overall Study|Lost to Follow-up|0|||
130066160|NCT00640146|468197748|FG001|Overall Study|Lost to Follow-up|1|||
130066161|NCT00640146|468197747|FG000|Overall Study|Lack of Efficacy|0|||
130066162|NCT00640146|468197748|FG001|Overall Study|Lack of Efficacy|1|||
130066163|NCT00640146|468197747|FG000|Overall Study|Withdrawal by Subject|1|||
130066164|NCT00640146|468197748|FG001|Overall Study|Withdrawal by Subject|1|||
130066165|NCT00640146|468197747|FG000|Overall Study|Randomized but not treated|1|||
130066166|NCT00640146|468197748|FG001|Overall Study|Randomized but not treated|3|||
130066167|NCT04058158|468197751|FG000|Period 1|Death|1|||
130066168|NCT04058158|468197752|FG001|Period 1|Death|0|||
130066169|NCT04058158|468197751|FG000|Period 1|Adverse Event|1|||
130066170|NCT04058158|468197752|FG001|Period 1|Adverse Event|1|||
130066171|NCT04058158|468197751|FG000|Period 1|Pregnancy|0|||
129916812|NCT02312960|467659850|FG006|Overall Study|Lost to Follow-up|1|||
129916813|NCT02312960|467659851|FG007|Overall Study|Lost to Follow-up|1|||
129916814|NCT02312960|467659852|FG008|Overall Study|Lost to Follow-up|0|||
130066172|NCT04058158|468197752|FG001|Period 1|Pregnancy|1|||
130066173|NCT04847141|468197753|FG000|Overall Study|Adverse Event|1|||
130116745|NCT00818623|468387170|FG006|Overall Study|Need of additional treatment|0|||
129916815|NCT02312960|467659853|FG009|Overall Study|Lost to Follow-up|1|||
129916816|NCT02312960|467659854|FG010|Overall Study|Lost to Follow-up|0|||
130066174|NCT04847141|468197754|FG001|Overall Study|Adverse Event|0|||
130066175|NCT04847141|468197755|FG002|Overall Study|Adverse Event|1|||
129916817|NCT02312960|467659855|FG011|Overall Study|Lost to Follow-up|0|||
129916818|NCT02312960|467659856|FG012|Overall Study|Lost to Follow-up|1|||
129916819|NCT02312960|467659857|FG013|Overall Study|Lost to Follow-up|0|||
129916820|NCT02312960|467659844|FG000|Overall Study|Withdrawal by Subject|1|||
129916821|NCT02312960|467659845|FG001|Overall Study|Withdrawal by Subject|2|||
129916822|NCT02312960|467659846|FG002|Overall Study|Withdrawal by Subject|0|||
130066176|NCT04847141|468197753|FG000|Overall Study|Withdrawal by Subject|2|||
129868722|NCT00428090|467475123|FG002|Overall Study|Non-compliance|1|||
129868723|NCT00428090|467475124|FG003|Overall Study|Non-compliance|3|||
129868724|NCT00428090|467475121|FG000|Overall Study|Par. did not returned to visit|1|||
129868725|NCT00428090|467475122|FG001|Overall Study|Par. did not returned to visit|0|||
129868726|NCT00428090|467475123|FG002|Overall Study|Par. did not returned to visit|0|||
129868727|NCT00428090|467475124|FG003|Overall Study|Par. did not returned to visit|1|||
129868728|NCT00428090|467475121|FG000|Overall Study|Follow-Up visit not possible|1|||
129868729|NCT00428090|467475122|FG001|Overall Study|Follow-Up visit not possible|0|||
129868730|NCT00428090|467475123|FG002|Overall Study|Follow-Up visit not possible|0|||
129868731|NCT00428090|467475124|FG003|Overall Study|Follow-Up visit not possible|0|||
129868732|NCT00428090|467475121|FG000|Overall Study|Prohibited medication used for SAE|1|||
129868733|NCT00428090|467475122|FG001|Overall Study|Prohibited medication used for SAE|0|||
129868734|NCT00428090|467475123|FG002|Overall Study|Prohibited medication used for SAE|0|||
129868735|NCT00428090|467475124|FG003|Overall Study|Prohibited medication used for SAE|0|||
130066177|NCT04847141|468197754|FG001|Overall Study|Withdrawal by Subject|4|||
130066178|NCT04847141|468197755|FG002|Overall Study|Withdrawal by Subject|3|||
130066179|NCT04847141|468197753|FG000|Overall Study|Lost to Follow-up|7|||
130066180|NCT04847141|468197754|FG001|Overall Study|Lost to Follow-up|5|||
130066181|NCT04847141|468197755|FG002|Overall Study|Lost to Follow-up|7|||
130066182|NCT04847141|468197753|FG000|Overall Study|Reason not Specified|0|||
130066183|NCT04847141|468197754|FG001|Overall Study|Reason not Specified|1|||
130066184|NCT04847141|468197755|FG002|Overall Study|Reason not Specified|0|||
130066185|NCT02215616|468197756|FG000|Overall Study|Sponsor requested to stop study drug|0|||
130066186|NCT02215616|468197757|FG001|Overall Study|Sponsor requested to stop study drug|0|||
130066187|NCT02215616|468197758|FG002|Overall Study|Sponsor requested to stop study drug|1|||
130066188|NCT02215616|468197759|FG003|Overall Study|Sponsor requested to stop study drug|4|||
130066189|NCT02215616|468197756|FG000|Overall Study|Death|1|||
130066190|NCT02215616|468197757|FG001|Overall Study|Death|0|||
130066191|NCT02215616|468197758|FG002|Overall Study|Death|0|||
130066192|NCT02215616|468197759|FG003|Overall Study|Death|0|||
130066193|NCT02215616|468197756|FG000|Overall Study|Adverse Event|7|||
130066194|NCT02215616|468197757|FG001|Overall Study|Adverse Event|4|||
130066195|NCT02215616|468197758|FG002|Overall Study|Adverse Event|9|||
130066196|NCT02215616|468197759|FG003|Overall Study|Adverse Event|2|||
130066197|NCT02215616|468197756|FG000|Overall Study|Withdrawal by Subject|1|||
130066198|NCT02215616|468197757|FG001|Overall Study|Withdrawal by Subject|8|||
130066199|NCT02215616|468197758|FG002|Overall Study|Withdrawal by Subject|2|||
130066200|NCT02215616|468197759|FG003|Overall Study|Withdrawal by Subject|5|||
130066201|NCT02215616|468197756|FG000|Overall Study|Non-compliance|0|||
130066202|NCT02215616|468197757|FG001|Overall Study|Non-compliance|2|||
130066203|NCT02215616|468197758|FG002|Overall Study|Non-compliance|1|||
130066204|NCT02215616|468197759|FG003|Overall Study|Non-compliance|0|||
130066205|NCT02215616|468197756|FG000|Overall Study|Protocol Violation|0|||
130066206|NCT02215616|468197757|FG001|Overall Study|Protocol Violation|2|||
130066207|NCT02215616|468197758|FG002|Overall Study|Protocol Violation|0|||
130066208|NCT02215616|468197759|FG003|Overall Study|Protocol Violation|0|||
130066209|NCT02215616|468197756|FG000|Overall Study|Lost to Follow-up|1|||
130066210|NCT02215616|468197757|FG001|Overall Study|Lost to Follow-up|1|||
130066211|NCT02215616|468197758|FG002|Overall Study|Lost to Follow-up|0|||
130066212|NCT02215616|468197759|FG003|Overall Study|Lost to Follow-up|1|||
130066213|NCT02215616|468197756|FG000|Overall Study|Other than specified|1|||
130066214|NCT02215616|468197757|FG001|Overall Study|Other than specified|0|||
130066215|NCT02215616|468197758|FG002|Overall Study|Other than specified|1|||
129868736|NCT00428090|467475121|FG000|Overall Study|Death of par.|1|||
129868737|NCT00428090|467475122|FG001|Overall Study|Death of par.|0|||
129868738|NCT00428090|467475123|FG002|Overall Study|Death of par.|1|||
129868739|NCT00428090|467475124|FG003|Overall Study|Death of par.|0|||
129868740|NCT00428090|467475121|FG000|Overall Study|Visit 7 exceed the visit window|0|||
129868741|NCT00428090|467475122|FG001|Overall Study|Visit 7 exceed the visit window|1|||
129868742|NCT00428090|467475123|FG002|Overall Study|Visit 7 exceed the visit window|0|||
129868743|NCT00428090|467475124|FG003|Overall Study|Visit 7 exceed the visit window|0|||
129868744|NCT00428090|467475121|FG000|Overall Study|Medical monitor terminated par.|0|||
129868745|NCT00428090|467475122|FG001|Overall Study|Medical monitor terminated par.|1|||
129868746|NCT00428090|467475123|FG002|Overall Study|Medical monitor terminated par.|0|||
129868747|NCT00428090|467475124|FG003|Overall Study|Medical monitor terminated par.|0|||
130066216|NCT02215616|468197759|FG003|Overall Study|Other than specified|1|||
130066217|NCT03583606|468197760|FG000|Overall Study|Lost to Follow-up|0|||
130066218|NCT03583606|468197761|FG001|Overall Study|Lost to Follow-up|1|||
130066219|NCT03583606|468197762|FG002|Overall Study|Lost to Follow-up|0|||
130066220|NCT03583606|468197760|FG000|Overall Study|Ineligible at baseline|1|||
129868748|NCT00428090|467475121|FG000|Overall Study|Mental status of par. was|0|||
129868749|NCT00428090|467475122|FG001|Overall Study|Mental status of par. was|1|||
129868750|NCT00428090|467475123|FG002|Overall Study|Mental status of par. was|0|||
129868751|NCT00428090|467475124|FG003|Overall Study|Mental status of par. was|0|||
130066221|NCT03583606|468197761|FG001|Overall Study|Ineligible at baseline|0|||
130066222|NCT03583606|468197762|FG002|Overall Study|Ineligible at baseline|0|||
130066223|NCT03728140|468197768|FG000|Overall Study|Abnormal embryo transfer operation|10|||
130066224|NCT03728140|468197769|FG001|Overall Study|Abnormal embryo transfer operation|7|||
129868752|NCT00428090|467475121|FG000|Overall Study|Worsening of AD|0|||
129868753|NCT00428090|467475122|FG001|Overall Study|Worsening of AD|0|||
129868754|NCT00428090|467475123|FG002|Overall Study|Worsening of AD|1|||
129868755|NCT00428090|467475124|FG003|Overall Study|Worsening of AD|0|||
129868756|NCT00428090|467475121|FG000|Overall Study|Excluded for concerning QTc value|0|||
129868757|NCT00428090|467475122|FG001|Overall Study|Excluded for concerning QTc value|0|||
129868758|NCT00428090|467475123|FG002|Overall Study|Excluded for concerning QTc value|1|||
129868759|NCT00428090|467475124|FG003|Overall Study|Excluded for concerning QTc value|0|||
129868760|NCT00428090|467475121|FG000|Overall Study|Insufficient AD documentation|0|||
129868761|NCT00428090|467475122|FG001|Overall Study|Insufficient AD documentation|0|||
129868762|NCT00428090|467475123|FG002|Overall Study|Insufficient AD documentation|1|||
129868763|NCT00428090|467475124|FG003|Overall Study|Insufficient AD documentation|0|||
129868764|NCT00428090|467475121|FG000|Overall Study|High MMSE scores|0|||
129868765|NCT00428090|467475122|FG001|Overall Study|High MMSE scores|0|||
129868766|NCT00428090|467475123|FG002|Overall Study|High MMSE scores|1|||
129868767|NCT00428090|467475124|FG003|Overall Study|High MMSE scores|0|||
129868768|NCT00428090|467475121|FG000|Overall Study|Deterioration of cognitive status|0|||
129868769|NCT00428090|467475122|FG001|Overall Study|Deterioration of cognitive status|0|||
129868770|NCT00428090|467475123|FG002|Overall Study|Deterioration of cognitive status|1|||
129868771|NCT00428090|467475124|FG003|Overall Study|Deterioration of cognitive status|0|||
129868772|NCT00428090|467475121|FG000|Overall Study|Serious adverse event|0|||
129868773|NCT00428090|467475122|FG001|Overall Study|Serious adverse event|0|||
129868774|NCT00428090|467475123|FG002|Overall Study|Serious adverse event|1|||
129868775|NCT00428090|467475124|FG003|Overall Study|Serious adverse event|0|||
129868776|NCT00428090|467475121|FG000|Overall Study|Excluded for heart insufficiency|0|||
129868777|NCT00428090|467475122|FG001|Overall Study|Excluded for heart insufficiency|0|||
129868778|NCT00428090|467475123|FG002|Overall Study|Excluded for heart insufficiency|1|||
129868779|NCT00428090|467475124|FG003|Overall Study|Excluded for heart insufficiency|0|||
129868780|NCT00428090|467475121|FG000|Overall Study|Raised Creatinine Value|0|||
129868781|NCT00428090|467475122|FG001|Overall Study|Raised Creatinine Value|0|||
129868782|NCT00428090|467475123|FG002|Overall Study|Raised Creatinine Value|0|||
129868783|NCT00428090|467475124|FG003|Overall Study|Raised Creatinine Value|1|||
129868784|NCT03409666|467475125|FG000|Overall Study|Physician Decision|0|||
129868785|NCT03409666|467475126|FG001|Overall Study|Physician Decision|1|||
129868786|NCT03409666|467475125|FG000|Overall Study|Protocol Violation|0|||
129868787|NCT03409666|467475126|FG001|Overall Study|Protocol Violation|3|||
129868788|NCT01791725|467475130|FG000|Overall Study|Withdrawal by Subject|0|||
129868789|NCT01791725|467475131|FG001|Overall Study|Withdrawal by Subject|1|||
129868790|NCT01791725|467475132|FG002|Overall Study|Withdrawal by Subject|0|||
129868791|NCT00512148|467475133|FG000|Primay Study Period|Withdrawal by Subject|1|||
129868792|NCT00677833|467475134|FG000|Overall Study|Withdrawal by Subject|4|||
129868793|NCT00677833|467475135|FG001|Overall Study|Withdrawal by Subject|0|||
129868794|NCT00677833|467475136|FG002|Overall Study|Withdrawal by Subject|1|||
129868795|NCT00677833|467475137|FG003|Overall Study|Withdrawal by Subject|3|||
129868796|NCT00677833|467475134|FG000|Overall Study|Lost to Follow-up|0|||
129868797|NCT00677833|467475135|FG001|Overall Study|Lost to Follow-up|0|||
129868798|NCT00677833|467475136|FG002|Overall Study|Lost to Follow-up|1|||
129868799|NCT00677833|467475137|FG003|Overall Study|Lost to Follow-up|0|||
129868800|NCT03255824|467475138|FG000|Overall Study|Under-sedation|2|||
129868801|NCT03255824|467475139|FG001|Overall Study|Under-sedation|1|||
129868802|NCT02001194|467475141|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
129868803|NCT02001194|467475142|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
129868804|NCT02001194|467475143|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
129868805|NCT02001194|467475144|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
129868806|NCT02001194|467475141|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
129868807|NCT02001194|467475142|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
129868808|NCT02001194|467475143|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
129868809|NCT02001194|467475144|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
129868810|NCT02690974|467475148|FG000|Overall Study|Adverse Event|16|||
129868811|NCT02690974|467475148|FG000|Overall Study|Death|9|||
129868812|NCT02690974|467475148|FG000|Overall Study|Subject/guardian decision|4|||
129868813|NCT02690974|467475148|FG000|Overall Study|Lost to Follow-up|3|||
129868814|NCT02690974|467475148|FG000|Overall Study|Withdrawal of Informed Consent|3|||
129868815|NCT02690974|467475148|FG000|Overall Study|Physician Decision|2|||
129868816|NCT02690974|467475148|FG000|Overall Study|Non-compliance with study treatment|1|||
129868817|NCT02690974|467475148|FG000|Overall Study|Protocol-defined stopping criteria|1|||
129868818|NCT02690974|467475148|FG000|Overall Study|Protocol Deviation|1|||
129868819|NCT01666951|467475153|FG000|Overall Study|Not dosed|1|||
129868820|NCT01666951|467475154|FG001|Overall Study|Not dosed|1|||
130066225|NCT01082367|468197770|FG000|Double-blind Period|Administrative problems|0|||
129868821|NCT00522301|467475155|FG000|Overall Study|Withdrawal by Subject|1|||
129868822|NCT00522301|467475155|FG000|Overall Study|Adverse Event|5|||
130066226|NCT01082367|468197771|FG001|Double-blind Period|Administrative problems|1|||
129916823|NCT02312960|467659847|FG003|Overall Study|Withdrawal by Subject|0|||
129916824|NCT02312960|467659848|FG004|Overall Study|Withdrawal by Subject|1|||
129916825|NCT02312960|467659849|FG005|Overall Study|Withdrawal by Subject|0|||
129916826|NCT02312960|467659850|FG006|Overall Study|Withdrawal by Subject|1|||
129916827|NCT02312960|467659851|FG007|Overall Study|Withdrawal by Subject|2|||
129916828|NCT02312960|467659852|FG008|Overall Study|Withdrawal by Subject|2|||
129916829|NCT02312960|467659853|FG009|Overall Study|Withdrawal by Subject|3|||
129916830|NCT02312960|467659854|FG010|Overall Study|Withdrawal by Subject|0|||
129916831|NCT02312960|467659855|FG011|Overall Study|Withdrawal by Subject|0|||
129916832|NCT02312960|467659856|FG012|Overall Study|Withdrawal by Subject|2|||
129916833|NCT02312960|467659857|FG013|Overall Study|Withdrawal by Subject|0|||
129916834|NCT02728076|467659858|FG000|Overall Study|Physician Decision|4|||
129916835|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Adverse Event|2|||
129916836|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Adverse Event|1|||
129916837|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Adverse Event|1|||
129916838|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
129916839|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
129916840|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
129916841|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
129916842|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
129916843|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
129916844|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
129916845|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
129916846|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
129916847|NCT05458011|467659859|FG000|OL Period (12 Weeks)|Adverse Event|1|||
129916848|NCT05458011|467659860|FG001|OL Period (12 Weeks)|Adverse Event|2|||
129916849|NCT05458011|467659861|FG002|OL Period (12 Weeks)|Adverse Event|1|||
129916850|NCT05458011|467659859|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
129916851|NCT05458011|467659860|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
129916852|NCT05458011|467659861|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
129916853|NCT00931710|467659863|FG000|Overall Study|Adverse Event|16|||
129916854|NCT00931710|467659864|FG001|Overall Study|Adverse Event|10|||
129916855|NCT00931710|467659863|FG000|Overall Study|Abnormal test procedure results|2|||
129916856|NCT00931710|467659864|FG001|Overall Study|Abnormal test procedure results|0|||
129916857|NCT00931710|467659863|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
129916858|NCT00931710|467659864|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
129916859|NCT00931710|467659863|FG000|Overall Study|Patient withdrew consent|4|||
129916860|NCT00931710|467659864|FG001|Overall Study|Patient withdrew consent|9|||
129916861|NCT00931710|467659863|FG000|Overall Study|Lost to Follow-up|6|||
129916862|NCT00931710|467659864|FG001|Overall Study|Lost to Follow-up|5|||
129916863|NCT00931710|467659863|FG000|Overall Study|Protocol deviation|1|||
129916864|NCT00931710|467659864|FG001|Overall Study|Protocol deviation|2|||
129916865|NCT02913872|467659865|FG000|Overall Study|Withdrawal by Subject|1|||
129916866|NCT03361748|467659873|FG000|Overall Study|Death|77|||
129916867|NCT03361748|467659873|FG000|Overall Study|Lost to Follow-up|4|||
129916868|NCT03361748|467659873|FG000|Overall Study|Withdrawal by Subject|20|||
129916869|NCT01361711|467659874|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
129916870|NCT01361711|467659874|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
129916871|NCT01361711|467659874|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
129916872|NCT01361711|467659874|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
129916873|NCT01361711|467659874|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
129916874|NCT01361711|467659874|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
129916875|NCT01361711|467659874|FG000|Completed Week 18 of Treatment|Other|9|||
129916876|NCT01361711|467659874|FG000|10 Year Follow-up|Still in follow-up|22|||
129916877|NCT01361711|467659874|FG000|10 Year Follow-up|Death|7|||
129916878|NCT01361711|467659874|FG000|10 Year Follow-up|Developed new cancer|1|||
129916879|NCT01361711|467659874|FG000|10 Year Follow-up|Lost to Follow-up|2|||
129916880|NCT01361711|467659874|FG000|10 Year Follow-up|New treatment started|6|||
129916881|NCT01361711|467659874|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
129916882|NCT01361711|467659874|FG000|10 Year Follow-up|Progressive Disease|1|||
129916883|NCT02596126|467659875|FG000|Overall Study|Lost to Follow-up|12|||
129916884|NCT02596126|467659876|FG001|Overall Study|Lost to Follow-up|21|||
129916885|NCT02596126|467659875|FG000|Overall Study|Protocol Violation|7|||
129916886|NCT02596126|467659876|FG001|Overall Study|Protocol Violation|9|||
129916887|NCT05179395|467659877|FG000|Overall Study|Lack of Efficacy|1|||
129916888|NCT05792423|467659882|FG000|Overall Study|Withdrawal by Subject|2|||
129916889|NCT02471638|467659883|FG000|Overall Study|Early Term Withdrawal|10|||
129916890|NCT04178733|467661286|FG000|Overall Study|Investigator Decision|0|||
129916891|NCT04178733|467661287|FG001|Overall Study|Investigator Decision|0|||
129916892|NCT04178733|467661288|FG002|Overall Study|Investigator Decision|0|||
129916893|NCT04178733|467661289|FG003|Overall Study|Investigator Decision|1|||
129916894|NCT04178733|467661290|FG004|Overall Study|Investigator Decision|2|||
129916895|NCT02287311|467661294|FG000|Cohort 1: Dose Level 1|Death|2|||
129916896|NCT02287311|467661295|FG001|Cohort 1: Dose Level 1|Death|0|||
129916897|NCT02287311|467661296|FG002|Cohort 1: Dose Level 1|Death|0|||
129916898|NCT02287311|467661297|FG003|Cohort 1: Dose Level 1|Death|3|||
129916899|NCT02287311|467661298|FG004|Cohort 1: Dose Level 1|Death|0|||
129916900|NCT02287311|467661299|FG005|Cohort 1: Dose Level 1|Death|0|||
129916901|NCT02287311|467661300|FG006|Cohort 1: Dose Level 1|Death|1|||
129916902|NCT02287311|467661301|FG007|Cohort 1: Dose Level 1|Death|0|||
129916903|NCT02287311|467661302|FG008|Cohort 1: Dose Level 1|Death|0|||
129916904|NCT02287311|467661294|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916905|NCT02287311|467661295|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916906|NCT02287311|467661296|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916907|NCT02287311|467661297|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
129916908|NCT02287311|467661298|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916909|NCT02287311|467661299|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916910|NCT02287311|467661300|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
129916911|NCT02287311|467661301|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916912|NCT02287311|467661302|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916913|NCT02287311|467661294|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
129916914|NCT02287311|467661295|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
129916915|NCT02287311|467661296|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
130066227|NCT01082367|468197770|FG000|Double-blind Period|Lack of Efficacy|5|||
130066228|NCT01082367|468197771|FG001|Double-blind Period|Lack of Efficacy|11|||
130066229|NCT01082367|468197770|FG000|Double-blind Period|Adverse Event|0|||
129868823|NCT00337272|467475156|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
129868824|NCT00337272|467475157|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
129868825|NCT00337272|467475156|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
129868826|NCT00337272|467475157|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
129868827|NCT00337272|467475156|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
129868828|NCT00337272|467475157|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
129868829|NCT00337272|467475156|FG000|Treatment Period|Non-compliance|1|||
129868830|NCT00337272|467475157|FG001|Treatment Period|Non-compliance|1|||
129868831|NCT00337272|467475156|FG000|Treatment Period|Withdrawal by Subject|0|||
129868832|NCT00337272|467475157|FG001|Treatment Period|Withdrawal by Subject|1|||
129868833|NCT00337272|467475156|FG000|Withdrawal Period|Non-compliance|0|||
129868834|NCT00337272|467475157|FG001|Withdrawal Period|Non-compliance|1|||
129868835|NCT02366910|467475161|FG000|Overall Study|Withdrawal by Subject|2|||
129868836|NCT02366910|467475161|FG000|Overall Study|Screen Failure|3|||
129868837|NCT02623322|467475165|FG000|Overall Study|Lost to Follow-up|2|||
129868838|NCT02623322|467475166|FG001|Overall Study|Lost to Follow-up|1|||
129868839|NCT02623322|467475167|FG002|Overall Study|Lost to Follow-up|0|||
129868840|NCT03284788|467475168|FG000|Overall Study|Withdrawal by Subject|2|||
129868841|NCT03813238|467475175|FG000|Overall Study|Adverse Event|0|||
129868842|NCT03813238|467475176|FG001|Overall Study|Adverse Event|6|||
129868843|NCT03813238|467475175|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129868844|NCT03813238|467475176|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129868845|NCT03813238|467475175|FG000|Overall Study|Lost to Follow-up|0|||
129868846|NCT03813238|467475176|FG001|Overall Study|Lost to Follow-up|1|||
129868847|NCT03813238|467475175|FG000|Overall Study|Other than specified|1|||
129868848|NCT03813238|467475176|FG001|Overall Study|Other than specified|2|||
129868849|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
129868850|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
129868851|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
129868852|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
129868853|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
129868854|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129868855|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
129868856|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
129868857|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
129868858|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
129868859|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
129868860|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
129868861|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Death|6|||
129868862|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Death|3|||
129868863|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Death|0|||
129868864|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Death|1|||
129868865|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Death|1|||
129868866|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Death|0|||
129868867|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
129916916|NCT02287311|467661297|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
129916917|NCT02287311|467661298|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
129916918|NCT02287311|467661299|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
129916919|NCT02287311|467661300|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
130066230|NCT01082367|468197771|FG001|Double-blind Period|Adverse Event|1|||
129916920|NCT02287311|467661301|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
129916921|NCT02287311|467661302|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
130066231|NCT01082367|468197770|FG000|Follow-up (F-U) Period|Administrative problems|1|||
129916922|NCT02287311|467661294|FG000|Cohort 2: Dose Level 2|Death|0|||
129916923|NCT02287311|467661295|FG001|Cohort 2: Dose Level 2|Death|2|||
129916924|NCT02287311|467661296|FG002|Cohort 2: Dose Level 2|Death|0|||
129916925|NCT02287311|467661297|FG003|Cohort 2: Dose Level 2|Death|0|||
129916926|NCT02287311|467661298|FG004|Cohort 2: Dose Level 2|Death|2|||
129916927|NCT02287311|467661299|FG005|Cohort 2: Dose Level 2|Death|0|||
129916928|NCT02287311|467661300|FG006|Cohort 2: Dose Level 2|Death|0|||
129916929|NCT02287311|467661301|FG007|Cohort 2: Dose Level 2|Death|2|||
129916930|NCT02287311|467661302|FG008|Cohort 2: Dose Level 2|Death|0|||
129916931|NCT02287311|467661294|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916932|NCT02287311|467661295|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916933|NCT02287311|467661296|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916934|NCT02287311|467661297|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916935|NCT02287311|467661298|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
129916936|NCT02287311|467661299|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916937|NCT02287311|467661300|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916938|NCT02287311|467661301|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916939|NCT02287311|467661302|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916940|NCT02287311|467661294|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916941|NCT02287311|467661295|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
129916942|NCT02287311|467661296|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916943|NCT02287311|467661297|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916944|NCT02287311|467661298|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916945|NCT02287311|467661299|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916946|NCT02287311|467661300|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916947|NCT02287311|467661301|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916948|NCT02287311|467661302|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916949|NCT02287311|467661294|FG000|Cohort 3: Dose Level 3|Death|0|||
129916950|NCT02287311|467661295|FG001|Cohort 3: Dose Level 3|Death|0|||
129916951|NCT02287311|467661296|FG002|Cohort 3: Dose Level 3|Death|4|||
129916952|NCT02287311|467661297|FG003|Cohort 3: Dose Level 3|Death|0|||
129916953|NCT02287311|467661298|FG004|Cohort 3: Dose Level 3|Death|0|||
129916954|NCT02287311|467661299|FG005|Cohort 3: Dose Level 3|Death|4|||
129916955|NCT02287311|467661300|FG006|Cohort 3: Dose Level 3|Death|0|||
129916956|NCT02287311|467661301|FG007|Cohort 3: Dose Level 3|Death|0|||
129916957|NCT02287311|467661302|FG008|Cohort 3: Dose Level 3|Death|2|||
129916958|NCT02287311|467661294|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916959|NCT02287311|467661295|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916960|NCT02287311|467661296|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
129916961|NCT02287311|467661297|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916962|NCT02287311|467661298|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916963|NCT02287311|467661299|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
129916964|NCT02287311|467661300|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916965|NCT02287311|467661301|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916966|NCT02287311|467661302|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916967|NCT02287311|467661294|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916968|NCT02287311|467661295|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916969|NCT02287311|467661296|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916970|NCT02287311|467661297|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916971|NCT02287311|467661298|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916972|NCT02287311|467661299|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
129916973|NCT02287311|467661300|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129868868|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
129868869|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
129868870|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
129868871|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
129868872|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
129868873|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868874|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
129868875|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
129916974|NCT02287311|467661301|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916975|NCT02287311|467661302|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
129916976|NCT05418296|467661307|FG000|Overall Study|Withdrawal by Subject|4|||
129916977|NCT05418296|467661308|FG001|Overall Study|Withdrawal by Subject|1|||
129916978|NCT03713086|467661315|FG000|Overall Study|Withdrawal by Subject|0|||
129916979|NCT03713086|467661316|FG001|Overall Study|Withdrawal by Subject|2|||
129916980|NCT03713086|467661317|FG002|Overall Study|Withdrawal by Subject|1|||
129916981|NCT03713086|467661318|FG003|Overall Study|Withdrawal by Subject|0|||
129916982|NCT03713086|467661315|FG000|Overall Study|Lost to Follow-up|0|||
129916983|NCT03713086|467661316|FG001|Overall Study|Lost to Follow-up|1|||
129916984|NCT03713086|467661317|FG002|Overall Study|Lost to Follow-up|0|||
129916985|NCT03713086|467661318|FG003|Overall Study|Lost to Follow-up|1|||
129916986|NCT05374837|467661323|FG000|Overall Study|Lost to Follow-up|17|||
129916987|NCT05374837|467661324|FG001|Overall Study|Lost to Follow-up|18|||
129916988|NCT05054374|467661341|FG000|Overall Study|Withdrawal by Subject|1|||
129916989|NCT05054374|467661342|FG001|Overall Study|Withdrawal by Subject|0|||
129916990|NCT05054374|467661343|FG002|Overall Study|Withdrawal by Subject|0|||
129916991|NCT05054374|467661344|FG003|Overall Study|Withdrawal by Subject|0|||
129916992|NCT05054374|467661341|FG000|Overall Study|Progressive Disease|5|||
129916993|NCT05054374|467661342|FG001|Overall Study|Progressive Disease|0|||
129916994|NCT05054374|467661343|FG002|Overall Study|Progressive Disease|0|||
129916995|NCT05054374|467661344|FG003|Overall Study|Progressive Disease|0|||
129916996|NCT03453619|467661348|FG000|Core Study (Part A)|Physician Decision|0|||
129916997|NCT03453619|467661349|FG001|Core Study (Part A)|Physician Decision|0|||
129916998|NCT03453619|467661350|FG002|Core Study (Part A)|Physician Decision|2|||
129916999|NCT03453619|467661351|FG003|Core Study (Part A)|Physician Decision|0|||
129917000|NCT03453619|467661348|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
129917001|NCT03453619|467661349|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
129917002|NCT03453619|467661350|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
129917003|NCT03453619|467661351|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
129917004|NCT03453619|467661348|FG000|Core Study (Part A)|Other|0|||
129917005|NCT03453619|467661349|FG001|Core Study (Part A)|Other|1|||
129917006|NCT03453619|467661350|FG002|Core Study (Part A)|Other|0|||
129917007|NCT03453619|467661351|FG003|Core Study (Part A)|Other|0|||
129917008|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
129917009|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
129917010|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
129917011|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
129917012|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
129917013|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
129917014|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
129917015|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
129917016|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
129917017|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
129917018|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
129917019|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
129917020|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
129917021|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
129917022|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
129917023|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
129917024|NCT04089371|467661352|FG000|Overall Study|Withdrawal by Subject|0|||
129917025|NCT04089371|467661353|FG001|Overall Study|Withdrawal by Subject|1|||
129917026|NCT04089371|467661352|FG000|Overall Study|Study terminated early|0|||
129917027|NCT04089371|467661353|FG001|Overall Study|Study terminated early|9|||
129917028|NCT05229120|467661354|FG000|Overall Study|Withdrawal by Subject|8|||
129917029|NCT05862870|467661357|FG000|Overall Study|Lost to Follow-up|3|||
129917030|NCT02900924|467661358|FG000|Overall Study|Death|52|||
129917031|NCT02900924|467661358|FG000|Overall Study|Lost to Follow-up|4|||
129917032|NCT02900924|467661358|FG000|Overall Study|Withdrawal by Subject|20|||
129917033|NCT02900924|467661358|FG000|Overall Study|Missed Visit|33|||
129917034|NCT02365766|467661378|FG000|Overall Study|Withdrawal by Subject|0|||
129917035|NCT02365766|467661379|FG001|Overall Study|Withdrawal by Subject|0|||
129917036|NCT02365766|467661380|FG002|Overall Study|Withdrawal by Subject|1|||
129917037|NCT02365766|467661378|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129917038|NCT02365766|467661379|FG001|Overall Study|Eligibility Criteria Not Met|0|||
129917039|NCT02365766|467661380|FG002|Overall Study|Eligibility Criteria Not Met|1|||
129917040|NCT03763708|467661384|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
129917041|NCT03763708|467661385|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917042|NCT03763708|467661386|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917043|NCT03763708|467661387|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917044|NCT03763708|467661388|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917045|NCT03763708|467661389|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917046|NCT03763708|467661390|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917047|NCT03763708|467661391|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
130066232|NCT01082367|468197771|FG001|Follow-up (F-U) Period|Administrative problems|0|||
130066233|NCT01082367|468197770|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
130066234|NCT01082367|468197771|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
130066235|NCT01082367|468197770|FG000|Follow-up (F-U) Period|Adverse Event|0|||
129917048|NCT03763708|467661392|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917049|NCT03763708|467661384|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917050|NCT03763708|467661385|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917051|NCT03763708|467661386|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
129917052|NCT03763708|467661387|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917053|NCT03763708|467661388|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917054|NCT03763708|467661389|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917055|NCT03763708|467661390|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917056|NCT03763708|467661391|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
130066236|NCT01082367|468197771|FG001|Follow-up (F-U) Period|Adverse Event|1|||
130066237|NCT04190186|468197772|FG000|Overall Study|ILR is no longer functioning|0|||
130066238|NCT04190186|468197773|FG001|Overall Study|ILR is no longer functioning|1|||
130066239|NCT04190186|468197772|FG000|Overall Study|Lost to Follow-up|0|||
130066240|NCT04190186|468197773|FG001|Overall Study|Lost to Follow-up|1|||
130066241|NCT04190186|468197772|FG000|Overall Study|Withdrawal by Subject|2|||
130066242|NCT04190186|468197773|FG001|Overall Study|Withdrawal by Subject|0|||
130066243|NCT04190186|468197772|FG000|Overall Study|Subject choice to explant|1|||
130066244|NCT04190186|468197773|FG001|Overall Study|Subject choice to explant|0|||
130066245|NCT04190186|468197772|FG000|Overall Study|Physician Decision|0|||
130066246|NCT04190186|468197773|FG001|Overall Study|Physician Decision|1|||
130066247|NCT04190186|468197772|FG000|Overall Study|Study was stopped|4|||
129868876|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868877|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868878|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868879|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
129868880|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
129868881|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
129868882|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
129868883|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
129868884|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
129868885|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
129868886|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
129868887|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
129868888|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
129868889|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
129868890|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
129868891|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
129868892|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
129868893|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
129868894|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
129868895|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
129868896|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
129868897|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868898|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868899|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868900|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868901|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868902|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
129868903|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Death|0|||
129868904|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Death|0|||
129868905|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Death|0|||
129868906|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Death|0|||
129868907|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Death|0|||
129868908|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Death|107|||
129868909|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868910|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868911|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868912|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868913|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868914|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
129868915|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868916|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868917|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868918|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868919|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868920|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
129868921|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868922|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868923|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868924|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868925|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868926|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
129868927|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
129868928|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
129868929|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
129868930|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
129868931|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
130066248|NCT04190186|468197773|FG001|Overall Study|Study was stopped|5|||
130066249|NCT02016898|468197774|FG000|Overall Study|Death|1|||
130066250|NCT02016898|468197775|FG001|Overall Study|Death|1|||
130066251|NCT02016898|468197774|FG000|Overall Study|Lost to Follow-up|4|||
130116746|NCT00818623|468387171|FG007|Overall Study|Need of additional treatment|0|||
129868932|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
129868933|NCT01690130|467475183|FG000|Overall Study|Subject have cancelled visit.|1|||
129868934|NCT01690130|467475184|FG001|Overall Study|Subject have cancelled visit.|0|||
129868935|NCT01644734|467475185|FG000|Overall Study|Adverse Event|4|||
129868936|NCT01644734|467475185|FG000|Overall Study|Lost to Follow-up|17|||
129868937|NCT01644734|467475185|FG000|Overall Study|Reasons other than stated above|7|||
129868938|NCT01644734|467475185|FG000|Overall Study|Missing documentation|238|||
129868939|NCT03338894|467475186|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
129868940|NCT04465357|467475187|FG000|Overall Study|Adverse Event|2|||
129868941|NCT04465357|467475187|FG000|Overall Study|Lack of Efficacy|1|||
129868942|NCT04465357|467475187|FG000|Overall Study|Lost to Follow-up|2|||
129868943|NCT04465357|467475187|FG000|Overall Study|Withdrawal by Subject|6|||
129868944|NCT04465357|467475187|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
129868945|NCT01375114|467475189|FG000|Overall Study|Lost to Follow-up|1|||
129868946|NCT01375114|467475190|FG001|Overall Study|Lost to Follow-up|0|||
129868947|NCT01375114|467475191|FG002|Overall Study|Lost to Follow-up|1|||
129868948|NCT01375114|467475189|FG000|Overall Study|Disease Progression|3|||
129868949|NCT01375114|467475190|FG001|Overall Study|Disease Progression|2|||
129868950|NCT01375114|467475191|FG002|Overall Study|Disease Progression|2|||
129868951|NCT01375114|467475189|FG000|Overall Study|Patient Changed Mind|0|||
129868952|NCT01375114|467475190|FG001|Overall Study|Patient Changed Mind|0|||
129868953|NCT01375114|467475191|FG002|Overall Study|Patient Changed Mind|2|||
129868954|NCT01375114|467475189|FG000|Overall Study|Pruritus|0|||
129868955|NCT01375114|467475190|FG001|Overall Study|Pruritus|0|||
129868956|NCT01375114|467475191|FG002|Overall Study|Pruritus|1|||
129868957|NCT01375114|467475189|FG000|Overall Study|Restlessness|0|||
129868958|NCT01375114|467475190|FG001|Overall Study|Restlessness|0|||
129868959|NCT01375114|467475191|FG002|Overall Study|Restlessness|1|||
129868960|NCT01375114|467475189|FG000|Overall Study|Diarrhea|0|||
129868961|NCT01375114|467475190|FG001|Overall Study|Diarrhea|0|||
129868962|NCT01375114|467475191|FG002|Overall Study|Diarrhea|1|||
129868963|NCT01375114|467475189|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
129868964|NCT01375114|467475190|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
129868965|NCT01375114|467475191|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
129868966|NCT01375114|467475189|FG000|Overall Study|Nausea|0|||
129868967|NCT01375114|467475190|FG001|Overall Study|Nausea|1|||
129868968|NCT01375114|467475191|FG002|Overall Study|Nausea|0|||
129868969|NCT01375114|467475189|FG000|Overall Study|Increased AST/ALT|0|||
129868970|NCT01375114|467475190|FG001|Overall Study|Increased AST/ALT|1|||
129868971|NCT01375114|467475191|FG002|Overall Study|Increased AST/ALT|0|||
129868972|NCT01375114|467475189|FG000|Overall Study|Vaginal Hemorrhage|0|||
129868973|NCT01375114|467475190|FG001|Overall Study|Vaginal Hemorrhage|1|||
129868974|NCT01375114|467475191|FG002|Overall Study|Vaginal Hemorrhage|0|||
129868975|NCT01375114|467475189|FG000|Overall Study|Family problem|0|||
129868976|NCT01375114|467475190|FG001|Overall Study|Family problem|1|||
129868977|NCT01375114|467475191|FG002|Overall Study|Family problem|0|||
129868978|NCT01375114|467475189|FG000|Overall Study|Protocol Violation|2|||
129868979|NCT01375114|467475190|FG001|Overall Study|Protocol Violation|0|||
129868980|NCT01375114|467475191|FG002|Overall Study|Protocol Violation|0|||
129868981|NCT03575325|467475192|FG000|Overall Study|Death|1|||
129868982|NCT02618967|467475193|FG000|Overall Study|Lost to Follow-up|0|||
129868983|NCT02618967|467475194|FG001|Overall Study|Lost to Follow-up|0|||
129868984|NCT02618967|467475195|FG002|Overall Study|Lost to Follow-up|1|||
129868985|NCT02618967|467475196|FG003|Overall Study|Lost to Follow-up|0|||
129868986|NCT02618967|467475197|FG004|Overall Study|Lost to Follow-up|2|||
129868987|NCT02618967|467475198|FG005|Overall Study|Lost to Follow-up|0|||
129868988|NCT02618967|467475199|FG006|Overall Study|Lost to Follow-up|0|||
129868989|NCT02618967|467475200|FG007|Overall Study|Lost to Follow-up|0|||
129868990|NCT02618967|467475193|FG000|Overall Study|Withdrawal by Subject|1|||
129868991|NCT02618967|467475194|FG001|Overall Study|Withdrawal by Subject|0|||
129868992|NCT02618967|467475195|FG002|Overall Study|Withdrawal by Subject|0|||
129868993|NCT02618967|467475196|FG003|Overall Study|Withdrawal by Subject|0|||
129868994|NCT02618967|467475197|FG004|Overall Study|Withdrawal by Subject|0|||
129868995|NCT02618967|467475198|FG005|Overall Study|Withdrawal by Subject|0|||
129868996|NCT02618967|467475199|FG006|Overall Study|Withdrawal by Subject|0|||
129868997|NCT02618967|467475200|FG007|Overall Study|Withdrawal by Subject|0|||
129868998|NCT02612311|467475201|FG000|Overall Study|Adverse Event|16|||
129868999|NCT02612311|467475202|FG001|Overall Study|Adverse Event|12|||
129869000|NCT02612311|467475203|FG002|Overall Study|Adverse Event|7|||
129869001|NCT02612311|467475204|FG003|Overall Study|Adverse Event|13|||
129869002|NCT02612311|467475201|FG000|Overall Study|Death|29|||
129869003|NCT02612311|467475202|FG001|Overall Study|Death|10|||
129869004|NCT02612311|467475203|FG002|Overall Study|Death|11|||
129917057|NCT03763708|467661392|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129869005|NCT02612311|467475204|FG003|Overall Study|Death|11|||
129869006|NCT02612311|467475201|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
129869007|NCT02612311|467475202|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
129869008|NCT02612311|467475203|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
129869009|NCT02612311|467475204|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
129869010|NCT02612311|467475201|FG000|Overall Study|Investigator's Decision|11|||
129869011|NCT02612311|467475202|FG001|Overall Study|Investigator's Decision|15|||
129869012|NCT02612311|467475203|FG002|Overall Study|Investigator's Decision|6|||
129869013|NCT02612311|467475204|FG003|Overall Study|Investigator's Decision|6|||
129869014|NCT02612311|467475201|FG000|Overall Study|Lack of Efficacy|0|||
129869015|NCT02612311|467475202|FG001|Overall Study|Lack of Efficacy|0|||
129869016|NCT02612311|467475203|FG002|Overall Study|Lack of Efficacy|1|||
129869017|NCT02612311|467475204|FG003|Overall Study|Lack of Efficacy|1|||
129869018|NCT02612311|467475201|FG000|Overall Study|Lost to Follow-up|2|||
129869019|NCT02612311|467475202|FG001|Overall Study|Lost to Follow-up|2|||
129869020|NCT02612311|467475203|FG002|Overall Study|Lost to Follow-up|1|||
129869021|NCT02612311|467475204|FG003|Overall Study|Lost to Follow-up|2|||
129869022|NCT02612311|467475201|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
129869023|NCT02612311|467475202|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
129869024|NCT02612311|467475203|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
129869025|NCT02612311|467475204|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
129869026|NCT02612311|467475201|FG000|Overall Study|Site Terminated by Sponsor|29|||
129869027|NCT02612311|467475202|FG001|Overall Study|Site Terminated by Sponsor|12|||
129869028|NCT02612311|467475203|FG002|Overall Study|Site Terminated by Sponsor|13|||
129869029|NCT02612311|467475204|FG003|Overall Study|Site Terminated by Sponsor|5|||
129869030|NCT02612311|467475201|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
129869031|NCT02612311|467475202|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
129869032|NCT02612311|467475203|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
129869033|NCT02612311|467475204|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
129869034|NCT02612311|467475201|FG000|Overall Study|Reason Not Specified|3|||
129869035|NCT02612311|467475202|FG001|Overall Study|Reason Not Specified|7|||
129869036|NCT02612311|467475203|FG002|Overall Study|Reason Not Specified|4|||
129869037|NCT02612311|467475204|FG003|Overall Study|Reason Not Specified|5|||
129869038|NCT02612311|467475201|FG000|Overall Study|Unknown/Missing|10|||
129869039|NCT02612311|467475202|FG001|Overall Study|Unknown/Missing|13|||
129869040|NCT02612311|467475203|FG002|Overall Study|Unknown/Missing|4|||
129869041|NCT02612311|467475204|FG003|Overall Study|Unknown/Missing|0|||
129869042|NCT02612311|467475201|FG000|Overall Study|Non-Compliance with Study|1|||
129869043|NCT02612311|467475202|FG001|Overall Study|Non-Compliance with Study|0|||
129869044|NCT02612311|467475203|FG002|Overall Study|Non-Compliance with Study|0|||
129869045|NCT02612311|467475204|FG003|Overall Study|Non-Compliance with Study|0|||
129869046|NCT04393441|467475205|FG000|Overall Study|Adverse Event|0|||
129869047|NCT04393441|467475206|FG001|Overall Study|Adverse Event|3|||
129869048|NCT04393441|467475205|FG000|Overall Study|Withdrawal by Subject|5|||
129869049|NCT04393441|467475206|FG001|Overall Study|Withdrawal by Subject|7|||
129869050|NCT04393441|467475205|FG000|Overall Study|Lost to Follow-up|0|||
129869051|NCT04393441|467475206|FG001|Overall Study|Lost to Follow-up|2|||
129869052|NCT04393441|467475205|FG000|Overall Study|Protocol Deviation|2|||
129869053|NCT04393441|467475206|FG001|Overall Study|Protocol Deviation|1|||
129869054|NCT04393441|467475205|FG000|Overall Study|Reason not Specified|1|||
129869055|NCT04393441|467475206|FG001|Overall Study|Reason not Specified|1|||
129869056|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
129869057|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
129869058|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|disease progression|58|||
129869059|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|disease progression|47|||
129869060|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Death|3|||
129869061|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Death|6|||
129869062|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
129869063|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
129869064|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
129869065|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
129869066|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
129869067|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
129869068|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Other|2|||
129869069|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Other|1|||
129869070|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
129869071|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
129869072|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
130066252|NCT02016898|468197775|FG001|Overall Study|Lost to Follow-up|4|||
129869073|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
129869074|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Death|0|||
129869075|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Death|1|||
129869076|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
129869077|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
129869078|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
129869079|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
130066253|NCT00618995|468197776|FG000|Period 1|Adverse Event|0|||
129869080|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
129869081|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
129869082|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
129869083|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
129869084|NCT01749982|467475216|FG000|Overall Study|Physician Decision|0|||
129869085|NCT01749982|467475217|FG001|Overall Study|Physician Decision|0|||
129869086|NCT01749982|467475218|FG002|Overall Study|Physician Decision|0|||
129869087|NCT01749982|467475219|FG003|Overall Study|Physician Decision|1|||
129869088|NCT01749982|467475216|FG000|Overall Study|Lost to Follow-up|0|||
129869089|NCT01749982|467475217|FG001|Overall Study|Lost to Follow-up|0|||
129869090|NCT01749982|467475218|FG002|Overall Study|Lost to Follow-up|0|||
129869091|NCT01749982|467475219|FG003|Overall Study|Lost to Follow-up|1|||
129869092|NCT01749982|467475216|FG000|Overall Study|Withdrawal by Subject|0|||
129869093|NCT01749982|467475217|FG001|Overall Study|Withdrawal by Subject|0|||
129869094|NCT01749982|467475218|FG002|Overall Study|Withdrawal by Subject|0|||
129869095|NCT01749982|467475219|FG003|Overall Study|Withdrawal by Subject|1|||
129869096|NCT01596582|467475220|FG000|Overall Study|Deemed ineligible after study visit|3|||
129869097|NCT01596582|467475221|FG001|Overall Study|Deemed ineligible after study visit|6|||
129869098|NCT01596582|467475220|FG000|Overall Study|Missing all outcome data|1|||
129869099|NCT01596582|467475221|FG001|Overall Study|Missing all outcome data|1|||
129869100|NCT03923933|467475226|FG000|Overall Study|Lost to Follow-up|1|||
129869101|NCT03923933|467475227|FG001|Overall Study|Lost to Follow-up|0|||
129869102|NCT03923933|467475226|FG000|Overall Study|Withdrawal by Subject|0|||
129869103|NCT03923933|467475227|FG001|Overall Study|Withdrawal by Subject|1|||
129869104|NCT00419263|467475228|FG000|Overall Study|Lost to Follow-up|2|||
129869105|NCT00419263|467475229|FG001|Overall Study|Lost to Follow-up|1|||
129869106|NCT00419263|467475230|FG002|Overall Study|Lost to Follow-up|1|||
129869107|NCT00419263|467475228|FG000|Overall Study|Randomized in Error, Not Treated|1|||
129869108|NCT00419263|467475229|FG001|Overall Study|Randomized in Error, Not Treated|1|||
129869109|NCT00419263|467475230|FG002|Overall Study|Randomized in Error, Not Treated|0|||
129869110|NCT00419263|467475228|FG000|Overall Study|Adverse Event|0|||
129869111|NCT00419263|467475229|FG001|Overall Study|Adverse Event|0|||
129869112|NCT00419263|467475230|FG002|Overall Study|Adverse Event|1|||
129869113|NCT00419263|467475228|FG000|Overall Study|Withdrawal by Subject|0|||
129869114|NCT00419263|467475229|FG001|Overall Study|Withdrawal by Subject|0|||
129869115|NCT00419263|467475230|FG002|Overall Study|Withdrawal by Subject|1|||
129869116|NCT03311373|467475233|FG000|Overall Study|Adverse Event|1|||
129869117|NCT03311373|467475233|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
129869118|NCT03311373|467475233|FG000|Overall Study|Lost to Follow-up|1|||
129869119|NCT03311373|467475233|FG000|Overall Study|Physician Decision|1|||
129869120|NCT03311373|467475233|FG000|Overall Study|Withdrawal by Subject|3|||
129869121|NCT00977665|467475234|FG000|Overall Study|Withdrawal by Subject|1|||
129869122|NCT00977665|467475235|FG001|Overall Study|Withdrawal by Subject|3|||
129869123|NCT00977665|467475234|FG000|Overall Study|Physician Decision|2|||
129869124|NCT00977665|467475235|FG001|Overall Study|Physician Decision|1|||
129869125|NCT00977665|467475234|FG000|Overall Study|Sponsor requested withdrawal|0|||
129869126|NCT00977665|467475235|FG001|Overall Study|Sponsor requested withdrawal|1|||
129869127|NCT00977665|467475234|FG000|Overall Study|Lost to Follow-up|1|||
129869128|NCT00977665|467475235|FG001|Overall Study|Lost to Follow-up|0|||
129869129|NCT00977665|467475234|FG000|Overall Study|Death|3|||
129869130|NCT00977665|467475235|FG001|Overall Study|Death|2|||
129869131|NCT00977665|467475234|FG000|Overall Study|Adverse Event|14|||
129869132|NCT00977665|467475235|FG001|Overall Study|Adverse Event|7|||
129869133|NCT00977665|467475234|FG000|Overall Study|Treatment failure|0|||
129869134|NCT00977665|467475235|FG001|Overall Study|Treatment failure|1|||
129869135|NCT02151266|467475244|FG000|Overall Study|Lost to Follow-up|1|||
129869136|NCT02151266|467475245|FG001|Overall Study|Lost to Follow-up|4|||
129869137|NCT02151266|467475246|FG002|Overall Study|Lost to Follow-up|1|||
129869138|NCT02151266|467475244|FG000|Overall Study|Did NOT receive intervention|3|||
129869139|NCT02151266|467475245|FG001|Overall Study|Did NOT receive intervention|6|||
129869140|NCT02151266|467475246|FG002|Overall Study|Did NOT receive intervention|2|||
129869141|NCT02151266|467475244|FG000|Overall Study|Not able to exercise|4|||
129869142|NCT02151266|467475245|FG001|Overall Study|Not able to exercise|5|||
129869143|NCT02151266|467475246|FG002|Overall Study|Not able to exercise|4|||
129869144|NCT02816138|467475250|FG000|Overall Study|Adverse Event|1|||
129869145|NCT00981084|467475251|FG000|Post Intervention (Data Analysis)|poor effort|1|||
129869146|NCT00981084|467475252|FG001|Post Intervention (Data Analysis)|poor effort|1|||
129869147|NCT00981084|467475251|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
129869148|NCT00981084|467475252|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
129869149|NCT02291679|467475253|FG000|Overall Study|Adverse Event|2|||
130066254|NCT00618995|468197777|FG001|Period 1|Adverse Event|0|||
129869150|NCT02291679|467475254|FG001|Overall Study|Adverse Event|12|||
129869151|NCT02291679|467475255|FG002|Overall Study|Adverse Event|19|||
129869152|NCT02291679|467475253|FG000|Overall Study|Protocol Violation|5|||
129869153|NCT02291679|467475254|FG001|Overall Study|Protocol Violation|1|||
129869154|NCT02291679|467475255|FG002|Overall Study|Protocol Violation|7|||
129869155|NCT02291679|467475253|FG000|Overall Study|Withdrew Consent|18|||
129917058|NCT03763708|467661384|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917059|NCT03763708|467661385|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917060|NCT03763708|467661386|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917061|NCT03763708|467661387|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
129917062|NCT03763708|467661388|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917063|NCT03763708|467661389|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917064|NCT03763708|467661390|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917065|NCT03763708|467661391|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917066|NCT03763708|467661392|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917067|NCT03763708|467661384|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917068|NCT03763708|467661385|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917069|NCT03763708|467661386|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917070|NCT03763708|467661387|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917071|NCT03763708|467661388|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
129917072|NCT03763708|467661389|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917073|NCT03763708|467661390|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917074|NCT03763708|467661391|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917075|NCT03763708|467661392|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917076|NCT03763708|467661384|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917077|NCT03763708|467661385|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917078|NCT03763708|467661386|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917079|NCT03763708|467661387|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917080|NCT03763708|467661388|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917081|NCT03763708|467661389|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
129917082|NCT03763708|467661390|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917083|NCT03763708|467661391|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917084|NCT03763708|467661392|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917085|NCT03763708|467661384|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917086|NCT03763708|467661385|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917087|NCT03763708|467661386|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917088|NCT03763708|467661387|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917089|NCT03763708|467661388|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917090|NCT03763708|467661389|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917091|NCT03763708|467661390|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
129917092|NCT03763708|467661391|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917093|NCT03763708|467661392|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917094|NCT03763708|467661384|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
129917095|NCT03763708|467661385|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
129917096|NCT03763708|467661386|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
129917097|NCT03763708|467661387|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
129917098|NCT03763708|467661388|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
129917099|NCT03763708|467661389|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
129917100|NCT03763708|467661390|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
129917101|NCT03763708|467661391|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
129917102|NCT03763708|467661392|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
129917103|NCT03763708|467661384|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
129917104|NCT03763708|467661385|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
129917105|NCT03763708|467661386|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
129917106|NCT03763708|467661387|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
129917107|NCT03763708|467661388|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
129917108|NCT03763708|467661389|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
129917109|NCT03763708|467661390|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
129917110|NCT03763708|467661391|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
129917111|NCT03763708|467661392|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
129917112|NCT03763708|467661384|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
129917113|NCT03763708|467661385|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
129917114|NCT03763708|467661386|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
129917115|NCT03763708|467661387|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
129917116|NCT03763708|467661388|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
129917117|NCT03763708|467661389|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
129917118|NCT03763708|467661390|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
129917119|NCT03763708|467661391|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
129917120|NCT03763708|467661392|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
129917121|NCT02307565|467661395|FG000|Overall Study|Adverse Event|3|||
129917122|NCT02307565|467661396|FG001|Overall Study|Adverse Event|2|||
130066255|NCT00618995|468197778|FG002|Period 1|Adverse Event|1|||
129917123|NCT02307565|467661395|FG000|Overall Study|Withdrawal by Subject|2|||
129917124|NCT02307565|467661396|FG001|Overall Study|Withdrawal by Subject|2|||
129917125|NCT04936035|467661403|FG000|Overall Study|Adverse Event|0|||
129917126|NCT04936035|467661404|FG001|Overall Study|Adverse Event|1|||
130066256|NCT00618995|468197779|FG003|Period 1|Adverse Event|0|||
129917127|NCT04936035|467661405|FG002|Overall Study|Adverse Event|0|||
130066257|NCT00618995|468197776|FG000|Period 1|Protocol Violation|0|||
129869156|NCT02291679|467475254|FG001|Overall Study|Withdrew Consent|10|||
129869157|NCT02291679|467475255|FG002|Overall Study|Withdrew Consent|15|||
129869158|NCT02291679|467475253|FG000|Overall Study|Lost to Follow-up|12|||
129869159|NCT02291679|467475254|FG001|Overall Study|Lost to Follow-up|10|||
129869160|NCT02291679|467475255|FG002|Overall Study|Lost to Follow-up|9|||
129869161|NCT02291679|467475253|FG000|Overall Study|Insufficient Therapeutic Response|5|||
129869162|NCT02291679|467475254|FG001|Overall Study|Insufficient Therapeutic Response|5|||
129869163|NCT02291679|467475255|FG002|Overall Study|Insufficient Therapeutic Response|7|||
129869164|NCT02291679|467475253|FG000|Overall Study|Other|2|||
129869165|NCT02291679|467475254|FG001|Overall Study|Other|4|||
129869166|NCT02291679|467475255|FG002|Overall Study|Other|2|||
129869167|NCT00725296|467475256|FG000|Overall Study|Adverse Event|11|||
129869168|NCT00725296|467475256|FG000|Overall Study|Lack of Efficacy|7|||
129869169|NCT00725296|467475256|FG000|Overall Study|Withdrawal by Subject|3|||
129869170|NCT00725296|467475256|FG000|Overall Study|Non-Compliance|2|||
129869171|NCT00725296|467475256|FG000|Overall Study|Lost to Follow-up|1|||
129869172|NCT00725296|467475256|FG000|Overall Study|Other|38|||
129869173|NCT02127372|467476799|FG000|Overall Study|Withdrawal by Subject|1|||
129869174|NCT02127372|467476800|FG001|Overall Study|Withdrawal by Subject|0|||
129869175|NCT03320018|467476803|FG000|Treatment Period|Withdrawal by Subject|1|||
129869176|NCT03320018|467476804|FG001|Treatment Period|Withdrawal by Subject|0|||
129869177|NCT03320018|467476803|FG000|Day 90 Follow up|Death|0|||
129869178|NCT03320018|467476804|FG001|Day 90 Follow up|Death|1|||
129869179|NCT00420199|467476805|FG000|Overall Study|Participant no longer met study criteria|1|||
129869180|NCT00420199|467476806|FG001|Overall Study|Participant no longer met study criteria|0|||
129869181|NCT04020341|467476809|FG000|Overall Study|Adverse Event|8|||
129869182|NCT04020341|467476810|FG001|Overall Study|Adverse Event|6|||
129869183|NCT04020341|467476809|FG000|Overall Study|Lost to Follow-up|8|||
129869184|NCT04020341|467476810|FG001|Overall Study|Lost to Follow-up|2|||
129869185|NCT04020341|467476809|FG000|Overall Study|Withdrawal by Subject|16|||
129869186|NCT04020341|467476810|FG001|Overall Study|Withdrawal by Subject|16|||
129869187|NCT04020341|467476809|FG000|Overall Study|Participant not able to swallow the tablet|1|||
129869188|NCT04020341|467476810|FG001|Overall Study|Participant not able to swallow the tablet|0|||
129869189|NCT04020341|467476809|FG000|Overall Study|Physician Decision|0|||
129869190|NCT04020341|467476810|FG001|Overall Study|Physician Decision|2|||
129869191|NCT04020341|467476809|FG000|Overall Study|Protocol Deviation|0|||
129869192|NCT04020341|467476810|FG001|Overall Study|Protocol Deviation|2|||
129869193|NCT05763628|467476811|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
129869194|NCT05763628|467476812|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
129869195|NCT05763628|467476811|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
129869196|NCT05763628|467476812|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
129869197|NCT05763628|467476811|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
129869198|NCT05763628|467476812|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
129869199|NCT04683926|467476813|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
129869200|NCT04683926|467476814|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
129869201|NCT04683926|467476815|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
129869202|NCT04683926|467476816|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
129869203|NCT02123108|467476819|FG000|Overall Study|Death|2|||
129869204|NCT02123108|467476820|FG001|Overall Study|Death|3|||
129869205|NCT00716092|467476821|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
129869206|NCT00716092|467476822|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
129869207|NCT00716092|467476823|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
129869208|NCT01132326|467476824|FG000|Overall Study|Lack of Efficacy|25|||
129869209|NCT01132326|467476824|FG000|Overall Study|Adverse Event|37|||
129869210|NCT01132326|467476824|FG000|Overall Study|Protocol Violation|1|||
129869211|NCT01132326|467476824|FG000|Overall Study|Lost to Follow-up|16|||
129869212|NCT01132326|467476824|FG000|Overall Study|Withdrawal by Subject|40|||
129869213|NCT01132326|467476824|FG000|Overall Study|Physician Decision|10|||
129869214|NCT01132326|467476824|FG000|Overall Study|Study Termination|80|||
129869215|NCT01132326|467476824|FG000|Overall Study|Declining Health|1|||
129869216|NCT01132326|467476824|FG000|Overall Study|Pregnancy|1|||
129869217|NCT01132326|467476824|FG000|Overall Study|Caregiver Withdrew Consent|1|||
129869218|NCT01132326|467476824|FG000|Overall Study|Death|5|||
129869219|NCT01132326|467476824|FG000|Overall Study|Subject Unable to Come To Visits|1|||
129869220|NCT00677235|467476825|FG000|Overall Study|Withdrawal by Subject|1|||
129869221|NCT00677235|467476826|FG001|Overall Study|Withdrawal by Subject|1|||
129869222|NCT00677235|467476825|FG000|Overall Study|Lost to Follow-up|2|||
129869223|NCT00677235|467476826|FG001|Overall Study|Lost to Follow-up|1|||
129869224|NCT00677235|467476825|FG000|Overall Study|Death|37|||
129869225|NCT00677235|467476826|FG001|Overall Study|Death|36|||
129869226|NCT00677235|467476825|FG000|Overall Study|Adverse Experience|1|||
129869227|NCT00677235|467476826|FG001|Overall Study|Adverse Experience|0|||
129869228|NCT00952367|467476827|FG000|Overall Study|Withdrawal by Subject|2|||
129869229|NCT00952367|467476827|FG000|Overall Study|Noncoordination|1|||
129869230|NCT00952367|467476827|FG000|Overall Study|Protocol Violation|3|||
129869231|NCT01040260|467476828|FG000|Overall Study|Withdrawal by Subject|12|||
129869232|NCT01040260|467476829|FG001|Overall Study|Withdrawal by Subject|6|||
129917128|NCT04936035|467661406|FG003|Overall Study|Adverse Event|0|||
129917129|NCT04936035|467661407|FG004|Overall Study|Adverse Event|0|||
129917130|NCT04936035|467661403|FG000|Overall Study|Death|0|||
129917131|NCT04936035|467661404|FG001|Overall Study|Death|0|||
129917132|NCT04936035|467661405|FG002|Overall Study|Death|0|||
129917133|NCT04936035|467661406|FG003|Overall Study|Death|1|||
129917134|NCT04936035|467661407|FG004|Overall Study|Death|0|||
129917135|NCT04936035|467661403|FG000|Overall Study|Lost to Follow-up|0|||
129917136|NCT04936035|467661404|FG001|Overall Study|Lost to Follow-up|1|||
129917137|NCT04936035|467661405|FG002|Overall Study|Lost to Follow-up|1|||
129917138|NCT04936035|467661406|FG003|Overall Study|Lost to Follow-up|2|||
129917139|NCT04936035|467661407|FG004|Overall Study|Lost to Follow-up|1|||
129917140|NCT04936035|467661403|FG000|Overall Study|Physician Decision|0|||
129917141|NCT04936035|467661404|FG001|Overall Study|Physician Decision|1|||
129917142|NCT04936035|467661405|FG002|Overall Study|Physician Decision|0|||
129917143|NCT04936035|467661406|FG003|Overall Study|Physician Decision|0|||
129917144|NCT04936035|467661407|FG004|Overall Study|Physician Decision|0|||
129869233|NCT01040260|467476828|FG000|Overall Study|Lost to Follow-up|3|||
129869234|NCT01040260|467476829|FG001|Overall Study|Lost to Follow-up|5|||
129869235|NCT04570436|467476833|FG000|Overall Study|Adverse Event|0|||
129869236|NCT04570436|467476834|FG001|Overall Study|Adverse Event|0|||
129869237|NCT04570436|467476835|FG002|Overall Study|Adverse Event|1|||
129869238|NCT04570436|467476836|FG003|Overall Study|Adverse Event|0|||
129869239|NCT04570436|467476837|FG004|Overall Study|Adverse Event|0|||
129869240|NCT04570436|467476838|FG005|Overall Study|Adverse Event|0|||
129869241|NCT04570436|467476839|FG006|Overall Study|Adverse Event|0|||
129869242|NCT04570436|467476840|FG007|Overall Study|Adverse Event|0|||
129869243|NCT04570436|467476841|FG008|Overall Study|Adverse Event|0|||
129869244|NCT04570436|467476842|FG009|Overall Study|Adverse Event|0|||
129869245|NCT04570436|467476833|FG000|Overall Study|Physician Decision|1|||
129869246|NCT04570436|467476834|FG001|Overall Study|Physician Decision|0|||
129869247|NCT04570436|467476835|FG002|Overall Study|Physician Decision|0|||
129869248|NCT04570436|467476836|FG003|Overall Study|Physician Decision|0|||
129869249|NCT04570436|467476837|FG004|Overall Study|Physician Decision|0|||
129869250|NCT04570436|467476838|FG005|Overall Study|Physician Decision|0|||
129869251|NCT04570436|467476839|FG006|Overall Study|Physician Decision|0|||
129869252|NCT04570436|467476840|FG007|Overall Study|Physician Decision|0|||
129869253|NCT04570436|467476841|FG008|Overall Study|Physician Decision|0|||
129869254|NCT04570436|467476842|FG009|Overall Study|Physician Decision|0|||
129869255|NCT00781391|467476843|FG000|Overall Study|never received study drug|24|||
129869256|NCT00781391|467476844|FG001|Overall Study|never received study drug|23|||
129869257|NCT00781391|467476845|FG002|Overall Study|never received study drug|32|||
129869258|NCT00781391|467476843|FG000|Overall Study|Protocol Violation|19|||
129869259|NCT00781391|467476844|FG001|Overall Study|Protocol Violation|17|||
129869260|NCT00781391|467476845|FG002|Overall Study|Protocol Violation|20|||
129869261|NCT00781391|467476843|FG000|Overall Study|Death|789|||
129869262|NCT00781391|467476844|FG001|Overall Study|Death|730|||
129869263|NCT00781391|467476845|FG002|Overall Study|Death|706|||
129869264|NCT00781391|467476843|FG000|Overall Study|Withdrawal by Subject|47|||
129869265|NCT00781391|467476844|FG001|Overall Study|Withdrawal by Subject|37|||
129869266|NCT00781391|467476845|FG002|Overall Study|Withdrawal by Subject|25|||
129869267|NCT00781391|467476843|FG000|Overall Study|Lost to Follow-up|0|||
129869268|NCT00781391|467476844|FG001|Overall Study|Lost to Follow-up|0|||
129869269|NCT00781391|467476845|FG002|Overall Study|Lost to Follow-up|1|||
129869270|NCT00689221|467476848|FG000|Overall Study|Ongoing at cut-off date|39|||
129869271|NCT00689221|467476849|FG001|Overall Study|Ongoing at cut-off date|36|||
129917145|NCT04936035|467661403|FG000|Overall Study|Protocol Deviation|0|||
129917146|NCT04936035|467661404|FG001|Overall Study|Protocol Deviation|0|||
130116747|NCT00818623|468387164|FG000|Overall Study|Lack of trial drug at site|0|||
129869272|NCT01812655|467476850|FG000|Overall Study|Protocol Violation|1|||
129869273|NCT01812655|467476851|FG001|Overall Study|Protocol Violation|1|||
129869274|NCT01812655|467476852|FG002|Overall Study|Protocol Violation|0|||
129869275|NCT04435665|467476854|FG000|Overall Study|Lost to Follow-up|0|||
129869276|NCT04435665|467476855|FG001|Overall Study|Lost to Follow-up|0|||
129869277|NCT04435665|467476856|FG002|Overall Study|Lost to Follow-up|0|||
129869278|NCT04435665|467476857|FG003|Overall Study|Lost to Follow-up|1|||
129869279|NCT04672941|467476858|FG000|Overall Study|Investigator decision|1|||
129869280|NCT04672941|467476858|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
129869281|NCT04672941|467476858|FG000|Overall Study|COVID-19 related but no adverse event|1|||
129869282|NCT04672941|467476858|FG000|Overall Study|Adverse Event|2|||
129869283|NCT04672941|467476858|FG000|Overall Study|Lost to Follow-up|2|||
129869284|NCT00765388|467476859|FG000|Period 1|Lack of Efficacy|1|||
129869285|NCT00765388|467476860|FG001|Period 1|Lack of Efficacy|2|||
129869286|NCT00765388|467476859|FG000|Period 1|Lost to Follow-up|0|||
129869287|NCT00765388|467476860|FG001|Period 1|Lost to Follow-up|1|||
129917147|NCT04936035|467661405|FG002|Overall Study|Protocol Deviation|1|||
129917148|NCT04936035|467661406|FG003|Overall Study|Protocol Deviation|0|||
129917149|NCT04936035|467661407|FG004|Overall Study|Protocol Deviation|0|||
129917150|NCT04936035|467661403|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
129917151|NCT04936035|467661404|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
129869288|NCT00765388|467476859|FG000|Period 1|Herpes Zoster|0|||
129869289|NCT00765388|467476860|FG001|Period 1|Herpes Zoster|1|||
129869290|NCT00765388|467476859|FG000|Period 1|Hip operation|0|||
129869291|NCT00765388|467476860|FG001|Period 1|Hip operation|1|||
129869292|NCT01563536|467476869|FG000|Overall Study|Withdrawal by Subject|0|||
129869293|NCT01563536|467476870|FG001|Overall Study|Withdrawal by Subject|2|||
129917152|NCT04936035|467661405|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
129917153|NCT04936035|467661406|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
129917154|NCT04936035|467661407|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
129917155|NCT04936035|467661403|FG000|Overall Study|Reason Unknown|0|||
129917156|NCT04936035|467661404|FG001|Overall Study|Reason Unknown|0|||
129917157|NCT04936035|467661405|FG002|Overall Study|Reason Unknown|0|||
129917158|NCT04936035|467661406|FG003|Overall Study|Reason Unknown|0|||
129917159|NCT04936035|467661407|FG004|Overall Study|Reason Unknown|1|||
129917160|NCT04936035|467661403|FG000|Overall Study|Withdrawal by Subject|1|||
129917161|NCT04936035|467661404|FG001|Overall Study|Withdrawal by Subject|0|||
129917162|NCT04936035|467661405|FG002|Overall Study|Withdrawal by Subject|0|||
129917163|NCT04936035|467661406|FG003|Overall Study|Withdrawal by Subject|0|||
129917164|NCT04936035|467661407|FG004|Overall Study|Withdrawal by Subject|0|||
129917165|NCT04936035|467661403|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917166|NCT04936035|467661404|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917167|NCT04936035|467661405|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917168|NCT04936035|467661406|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
129917169|NCT04936035|467661407|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917170|NCT04936035|467661403|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917171|NCT04936035|467661404|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917172|NCT04936035|467661405|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917173|NCT04936035|467661406|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917174|NCT04936035|467661407|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
129917175|NCT04936035|467661403|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129917176|NCT04936035|467661404|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129917177|NCT04936035|467661405|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129917178|NCT04936035|467661406|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129869294|NCT01563536|467476869|FG000|Overall Study|Lost to Follow-up|1|||
129917179|NCT04936035|467661407|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
129917180|NCT03978871|467661418|FG000|Overall Study|Lost to Follow-up|11|||
129917181|NCT03978871|467661419|FG001|Overall Study|Lost to Follow-up|12|||
129917182|NCT04072822|467661420|FG000|Treatment|Adverse Event|9|||
129917183|NCT04072822|467661421|FG001|Treatment|Adverse Event|5|||
129917184|NCT04072822|467661420|FG000|Treatment|Met Stopping Criteria|13|||
129917185|NCT04072822|467661421|FG001|Treatment|Met Stopping Criteria|24|||
129917186|NCT04072822|467661420|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
129917187|NCT04072822|467661421|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
129917188|NCT04072822|467661420|FG000|Treatment|Withdrawal by Subject|0|||
129917189|NCT04072822|467661421|FG001|Treatment|Withdrawal by Subject|2|||
129917190|NCT04072822|467661420|FG000|Treatment|Death|0|||
129917191|NCT04072822|467661421|FG001|Treatment|Death|2|||
129917192|NCT04072822|467661420|FG000|Treatment|Lost to Follow-up|11|||
129917193|NCT04072822|467661421|FG001|Treatment|Lost to Follow-up|3|||
129917194|NCT04072822|467661420|FG000|Treatment|Physician Decision|1|||
129917195|NCT04072822|467661421|FG001|Treatment|Physician Decision|0|||
129917196|NCT04072822|467661420|FG000|Treatment|Other|7|||
129917197|NCT04072822|467661421|FG001|Treatment|Other|9|||
129917198|NCT04072822|467661420|FG000|Follow-up|Withdrawal by Subject|1|||
129917199|NCT04072822|467661421|FG001|Follow-up|Withdrawal by Subject|0|||
130066258|NCT00618995|468197777|FG001|Period 1|Protocol Violation|1|||
130066259|NCT00618995|468197778|FG002|Period 1|Protocol Violation|1|||
130066260|NCT00618995|468197779|FG003|Period 1|Protocol Violation|0|||
130066261|NCT00618995|468197776|FG000|Period 2|Protocol Violation|0|||
130066262|NCT00618995|468197777|FG001|Period 2|Protocol Violation|0|||
130066263|NCT00618995|468197778|FG002|Period 2|Protocol Violation|1|||
130066264|NCT00618995|468197779|FG003|Period 2|Protocol Violation|0|||
129869295|NCT01563536|467476870|FG001|Overall Study|Lost to Follow-up|0|||
129869296|NCT00538590|467476873|FG000|Overall Study|Death|1|||
129917200|NCT04072822|467661420|FG000|Follow-up|Lost to Follow-up|5|||
129917201|NCT04072822|467661421|FG001|Follow-up|Lost to Follow-up|4|||
130066265|NCT00618995|468197776|FG000|Period 4|Adverse Event|1|||
130066266|NCT00618995|468197777|FG001|Period 4|Adverse Event|0|||
129917202|NCT04391894|467661423|FG000|Overall Study|Adverse Event|1|||
130066267|NCT00618995|468197778|FG002|Period 4|Adverse Event|0|||
130066268|NCT00618995|468197779|FG003|Period 4|Adverse Event|0|||
130066269|NCT02988219|468197782|FG000|Overall Study|Lack of Efficacy|1|||
129917203|NCT04391894|467661424|FG001|Overall Study|Adverse Event|1|||
129917204|NCT04391894|467661425|FG002|Overall Study|Adverse Event|1|||
129917205|NCT04391894|467661426|FG003|Overall Study|Adverse Event|1|||
129917206|NCT04391894|467661427|FG004|Overall Study|Adverse Event|1|||
129917207|NCT04391894|467661423|FG000|Overall Study|Lost to Follow-up|1|||
129917208|NCT04391894|467661424|FG001|Overall Study|Lost to Follow-up|0|||
129917209|NCT04391894|467661425|FG002|Overall Study|Lost to Follow-up|0|||
129917210|NCT04391894|467661426|FG003|Overall Study|Lost to Follow-up|0|||
129917211|NCT04391894|467661427|FG004|Overall Study|Lost to Follow-up|0|||
129917212|NCT04391894|467661423|FG000|Overall Study|Protocol Violation|0|||
129917213|NCT04391894|467661424|FG001|Overall Study|Protocol Violation|0|||
129917214|NCT04391894|467661425|FG002|Overall Study|Protocol Violation|0|||
129917215|NCT04391894|467661426|FG003|Overall Study|Protocol Violation|1|||
130066270|NCT02988219|468197783|FG001|Overall Study|Lack of Efficacy|1|||
130066271|NCT02988219|468197782|FG000|Overall Study|Withdrawal by Subject|0|||
130066272|NCT02988219|468197783|FG001|Overall Study|Withdrawal by Subject|2|||
130066273|NCT02677220|468197784|FG000|Overall Study|Adverse Event|1|||
130066274|NCT00965146|468197785|FG000|Overall Study|Death|7|||
129869297|NCT00538590|467476874|FG001|Overall Study|Death|0|||
129869298|NCT01256567|467476875|FG000|Overall Study|Withdrawal by Subject|1|||
129869299|NCT00671931|467476881|FG000|Overall Study|Physician Decision|1|||
129869300|NCT00671931|467476882|FG001|Overall Study|Physician Decision|0|||
129869301|NCT00671931|467476883|FG002|Overall Study|Physician Decision|0|||
129869302|NCT00671931|467476884|FG003|Overall Study|Physician Decision|2|||
129869303|NCT00671931|467476885|FG004|Overall Study|Physician Decision|1|||
129869304|NCT01169675|467476888|FG000|Overall Study|Progressive disease|13|||
129869305|NCT01169675|467476889|FG001|Overall Study|Progressive disease|2|||
129869306|NCT01169675|467476890|FG002|Overall Study|Progressive disease|5|||
129869307|NCT01169675|467476891|FG003|Overall Study|Progressive disease|15|||
129869308|NCT01169675|467476892|FG004|Overall Study|Progressive disease|1|||
129869309|NCT01169675|467476888|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129869310|NCT01169675|467476889|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129869311|NCT01169675|467476890|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129869312|NCT01169675|467476891|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129869313|NCT01169675|467476892|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129869314|NCT01169675|467476888|FG000|Overall Study|Adverse Event|5|||
129869315|NCT01169675|467476889|FG001|Overall Study|Adverse Event|1|||
129869316|NCT01169675|467476890|FG002|Overall Study|Adverse Event|2|||
129869317|NCT01169675|467476891|FG003|Overall Study|Adverse Event|0|||
129869318|NCT01169675|467476892|FG004|Overall Study|Adverse Event|0|||
129869319|NCT01169675|467476888|FG000|Overall Study|Withdrawal by Subject|1|||
129869320|NCT01169675|467476889|FG001|Overall Study|Withdrawal by Subject|0|||
129869321|NCT01169675|467476890|FG002|Overall Study|Withdrawal by Subject|0|||
129869322|NCT01169675|467476891|FG003|Overall Study|Withdrawal by Subject|1|||
129869323|NCT01169675|467476892|FG004|Overall Study|Withdrawal by Subject|2|||
129869324|NCT01169675|467476888|FG000|Overall Study|Other Reason Not Defined Above|0|||
129869325|NCT01169675|467476889|FG001|Overall Study|Other Reason Not Defined Above|0|||
129869326|NCT01169675|467476890|FG002|Overall Study|Other Reason Not Defined Above|0|||
129869327|NCT01169675|467476891|FG003|Overall Study|Other Reason Not Defined Above|1|||
129869328|NCT01169675|467476892|FG004|Overall Study|Other Reason Not Defined Above|1|||
129869329|NCT04839965|467476893|FG000|Overall Study|Death|6|||
129869330|NCT04839965|467476894|FG001|Overall Study|Death|6|||
129869331|NCT04839965|467476893|FG000|Overall Study|Lost to Follow-up|1|||
129869332|NCT04839965|467476894|FG001|Overall Study|Lost to Follow-up|0|||
129869333|NCT02365519|467476895|FG000|Randomized and Treated|Adverse Event|0|||
129869334|NCT02365519|467476896|FG001|Randomized and Treated|Adverse Event|1|||
129869335|NCT02365519|467476897|FG002|Randomized and Treated|Adverse Event|0|||
129869336|NCT02365519|467476895|FG000|Randomized and Treated|Withdrawal by Subject|0|||
129869337|NCT02365519|467476896|FG001|Randomized and Treated|Withdrawal by Subject|1|||
129869338|NCT02365519|467476897|FG002|Randomized and Treated|Withdrawal by Subject|1|||
129869339|NCT02048072|467476898|FG000|Overall Study|Adverse Event|3|||
129869340|NCT02048072|467476898|FG000|Overall Study|Lost to Follow-up|1|||
129869341|NCT02355028|467476899|FG000|Overall Study|Adverse Event|2|||
129869342|NCT02355028|467476900|FG001|Overall Study|Adverse Event|0|||
129869343|NCT02355028|467476899|FG000|Overall Study|Withdrawal by Subject|1|||
129869344|NCT02355028|467476900|FG001|Overall Study|Withdrawal by Subject|1|||
129869345|NCT02355028|467476899|FG000|Overall Study|Deemed ineligible after randomization|8|||
129869346|NCT02355028|467476900|FG001|Overall Study|Deemed ineligible after randomization|4|||
129869347|NCT02276222|467476901|FG000|Overall Study|Adverse Event|62|||
129869348|NCT02276222|467476902|FG001|Overall Study|Adverse Event|11|||
129917216|NCT04391894|467661427|FG004|Overall Study|Protocol Violation|0|||
130066275|NCT00965146|468197785|FG000|Overall Study|Lost to Follow-up|22|||
130066276|NCT00965146|468197785|FG000|Overall Study|Withdrawal by Subject|17|||
129869349|NCT02276222|467476901|FG000|Overall Study|Death|3|||
129869350|NCT02276222|467476902|FG001|Overall Study|Death|4|||
129917217|NCT04391894|467661423|FG000|Overall Study|Withdrawal by Subject|2|||
129917218|NCT04391894|467661424|FG001|Overall Study|Withdrawal by Subject|0|||
129917219|NCT04391894|467661425|FG002|Overall Study|Withdrawal by Subject|3|||
129917220|NCT04391894|467661426|FG003|Overall Study|Withdrawal by Subject|0|||
129917221|NCT04391894|467661427|FG004|Overall Study|Withdrawal by Subject|1|||
129917222|NCT04391894|467661423|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917223|NCT04391894|467661424|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917224|NCT04391894|467661425|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917225|NCT04391894|467661426|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917226|NCT04391894|467661427|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
129917227|NCT02323321|467661431|FG000|Overall Study|Re-Transplant|1|||
129917228|NCT02323321|467661431|FG000|Overall Study|Death|12|||
129917229|NCT00446225|467661432|FG000|Overall Study|Protocol Violation|1|||
129917230|NCT00446225|467661433|FG001|Overall Study|Protocol Violation|0|||
129917231|NCT04450342|467661434|FG000|Overall Study|Adverse Event|1|||
129917232|NCT04450342|467661435|FG001|Overall Study|Adverse Event|1|||
129917233|NCT04450342|467661436|FG002|Overall Study|Adverse Event|0|||
129917234|NCT04450342|467661434|FG000|Overall Study|Device not used|1|||
129917235|NCT04450342|467661435|FG001|Overall Study|Device not used|0|||
130066277|NCT00965146|468197785|FG000|Overall Study|Unable to return|1|||
130066278|NCT00965146|468197785|FG000|Overall Study|Unwilling to return|11|||
130066279|NCT00965146|468197785|FG000|Overall Study|Intercurrent illness|1|||
130066280|NCT00965146|468197785|FG000|Overall Study|Revision / Removal of Study Implant|6|||
130066281|NCT00965146|468197785|FG000|Overall Study|Overall Study Termination|145|||
130066282|NCT01504971|468197786|FG000|Overall Study|Physician Decision|13|||
130066283|NCT00936117|468197787|FG000|Overall Study|Adverse Event|7|||
130066284|NCT00936117|468197787|FG000|Overall Study|Unable to continue oral medication|3|||
129869351|NCT02276222|467476901|FG000|Overall Study|Lack of Efficacy|13|||
129869352|NCT02276222|467476902|FG001|Overall Study|Lack of Efficacy|3|||
129869353|NCT02276222|467476901|FG000|Overall Study|Protocol Violation|3|||
129869354|NCT02276222|467476902|FG001|Overall Study|Protocol Violation|2|||
129869355|NCT02276222|467476901|FG000|Overall Study|Withdrawal by Subject|79|||
129869356|NCT02276222|467476902|FG001|Overall Study|Withdrawal by Subject|33|||
129869357|NCT02276222|467476901|FG000|Overall Study|non compliance with study medication|6|||
129869358|NCT02276222|467476902|FG001|Overall Study|non compliance with study medication|2|||
129869359|NCT02276222|467476901|FG000|Overall Study|sponsor decision|0|||
129869360|NCT02276222|467476902|FG001|Overall Study|sponsor decision|3|||
129869361|NCT02276222|467476901|FG000|Overall Study|Lost to Follow-up|15|||
129869362|NCT02276222|467476902|FG001|Overall Study|Lost to Follow-up|5|||
129869363|NCT02276222|467476901|FG000|Overall Study|Physician Decision|2|||
129869364|NCT02276222|467476902|FG001|Overall Study|Physician Decision|1|||
129869365|NCT02276222|467476901|FG000|Overall Study|sheduling conflict|1|||
129869366|NCT02276222|467476902|FG001|Overall Study|sheduling conflict|0|||
129869367|NCT02276222|467476901|FG000|Overall Study|subject withdrew after randomization|1|||
129869368|NCT02276222|467476902|FG001|Overall Study|subject withdrew after randomization|0|||
129869369|NCT01971723|467476903|FG000|Overall Study|Withdrawal by Subject|1|||
129869370|NCT01971723|467476904|FG001|Overall Study|Withdrawal by Subject|1|||
129869371|NCT01971723|467476903|FG000|Overall Study|Protocol Violation|1|||
129869372|NCT01971723|467476904|FG001|Overall Study|Protocol Violation|2|||
129869373|NCT03645759|467476905|FG000|Overall Study|Lost to Follow-up|3|||
129869374|NCT03645759|467476906|FG001|Overall Study|Lost to Follow-up|2|||
129869375|NCT01648270|467476907|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
129869376|NCT00902694|467476908|FG000|Overall Study|Death|1|||
129869377|NCT00902694|467476909|FG001|Overall Study|Death|3|||
129869378|NCT00902694|467476908|FG000|Overall Study|Lost to Follow-up|1|||
129869379|NCT00902694|467476909|FG001|Overall Study|Lost to Follow-up|0|||
129869380|NCT00902694|467476908|FG000|Overall Study|Censored per protocol|3|||
129869381|NCT00902694|467476909|FG001|Overall Study|Censored per protocol|1|||
129869382|NCT00902694|467476908|FG000|Overall Study|Pregnancy|1|||
129869383|NCT00902694|467476909|FG001|Overall Study|Pregnancy|1|||
129869384|NCT00902694|467476908|FG000|Overall Study|Incarceration|1|||
129869385|NCT00902694|467476909|FG001|Overall Study|Incarceration|0|||
129869386|NCT04969263|467476910|FG000|Overall Study|Death|1|||
129869387|NCT04969263|467476910|FG000|Overall Study|Lost to Follow-up|2|||
129869388|NCT04969263|467476910|FG000|Overall Study|Withdrawal by Subject|5|||
129869389|NCT04969263|467476910|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
129869390|NCT02693743|467476912|FG000|Overall Study|Physician Decision|1|||
129869391|NCT02693743|467476913|FG001|Overall Study|Physician Decision|0|||
129869392|NCT01024608|467476915|FG000|Overall Study|Adverse Event|1|||
129869393|NCT01024608|467476916|FG001|Overall Study|Adverse Event|0|||
129869394|NCT01024608|467476915|FG000|Overall Study|Withdrawal by Subject|1|||
129869395|NCT01024608|467476916|FG001|Overall Study|Withdrawal by Subject|0|||
129869396|NCT01024608|467476915|FG000|Overall Study|Lost to Follow-up|0|||
129917236|NCT04450342|467661436|FG002|Overall Study|Device not used|0|||
129917237|NCT04450342|467661434|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
130066285|NCT00225212|468197794|FG000|Overall Study|Disease progression|2|||
129869397|NCT01024608|467476916|FG001|Overall Study|Lost to Follow-up|1|||
129869398|NCT01024608|467476915|FG000|Overall Study|Protocol Violation|0|||
129869399|NCT01024608|467476916|FG001|Overall Study|Protocol Violation|3|||
129869400|NCT01024608|467476915|FG000|Overall Study|Never received study treatment|2|||
129869401|NCT01024608|467476916|FG001|Overall Study|Never received study treatment|0|||
129869402|NCT01592370|467476932|FG000|Overall Study|Disease Progression|62|||
129869403|NCT01592370|467476933|FG001|Overall Study|Disease Progression|16|||
129869404|NCT01592370|467476934|FG002|Overall Study|Disease Progression|52|||
129869405|NCT01592370|467476935|FG003|Overall Study|Disease Progression|3|||
129869406|NCT01592370|467476936|FG004|Overall Study|Disease Progression|3|||
129869407|NCT01592370|467476937|FG005|Overall Study|Disease Progression|31|||
129869408|NCT01592370|467476938|FG006|Overall Study|Disease Progression|14|||
129869409|NCT01592370|467476932|FG000|Overall Study|Study Drug Toxicity|14|||
129869410|NCT01592370|467476933|FG001|Overall Study|Study Drug Toxicity|3|||
129869411|NCT01592370|467476934|FG002|Overall Study|Study Drug Toxicity|0|||
129869412|NCT01592370|467476935|FG003|Overall Study|Study Drug Toxicity|0|||
129869413|NCT01592370|467476936|FG004|Overall Study|Study Drug Toxicity|0|||
129869414|NCT01592370|467476937|FG005|Overall Study|Study Drug Toxicity|0|||
129869415|NCT01592370|467476938|FG006|Overall Study|Study Drug Toxicity|1|||
129869416|NCT01592370|467476932|FG000|Overall Study|AE unrelated to study drug|4|||
129869417|NCT01592370|467476933|FG001|Overall Study|AE unrelated to study drug|3|||
129869418|NCT01592370|467476934|FG002|Overall Study|AE unrelated to study drug|0|||
129869419|NCT01592370|467476935|FG003|Overall Study|AE unrelated to study drug|0|||
129869420|NCT01592370|467476936|FG004|Overall Study|AE unrelated to study drug|0|||
129869421|NCT01592370|467476937|FG005|Overall Study|AE unrelated to study drug|0|||
129869422|NCT01592370|467476938|FG006|Overall Study|AE unrelated to study drug|1|||
129869423|NCT01592370|467476932|FG000|Overall Study|Request to discontinue study treatment|5|||
129869424|NCT01592370|467476933|FG001|Overall Study|Request to discontinue study treatment|0|||
129869425|NCT01592370|467476934|FG002|Overall Study|Request to discontinue study treatment|2|||
129869426|NCT01592370|467476935|FG003|Overall Study|Request to discontinue study treatment|0|||
129869427|NCT01592370|467476936|FG004|Overall Study|Request to discontinue study treatment|1|||
129869428|NCT01592370|467476937|FG005|Overall Study|Request to discontinue study treatment|2|||
129869429|NCT01592370|467476938|FG006|Overall Study|Request to discontinue study treatment|0|||
129869430|NCT01592370|467476932|FG000|Overall Study|Withdrew consent|1|||
129869431|NCT01592370|467476933|FG001|Overall Study|Withdrew consent|2|||
129869432|NCT01592370|467476934|FG002|Overall Study|Withdrew consent|1|||
129869433|NCT01592370|467476935|FG003|Overall Study|Withdrew consent|1|||
129869434|NCT01592370|467476936|FG004|Overall Study|Withdrew consent|0|||
129869435|NCT01592370|467476937|FG005|Overall Study|Withdrew consent|0|||
129869436|NCT01592370|467476938|FG006|Overall Study|Withdrew consent|0|||
129869437|NCT01592370|467476932|FG000|Overall Study|Maximum clinical benefit|11|||
129869438|NCT01592370|467476933|FG001|Overall Study|Maximum clinical benefit|1|||
129869439|NCT01592370|467476934|FG002|Overall Study|Maximum clinical benefit|7|||
129869440|NCT01592370|467476935|FG003|Overall Study|Maximum clinical benefit|1|||
129869441|NCT01592370|467476936|FG004|Overall Study|Maximum clinical benefit|0|||
129869442|NCT01592370|467476937|FG005|Overall Study|Maximum clinical benefit|0|||
129869443|NCT01592370|467476938|FG006|Overall Study|Maximum clinical benefit|0|||
129869444|NCT01592370|467476932|FG000|Overall Study|No longer meets study criteria|1|||
129869445|NCT01592370|467476933|FG001|Overall Study|No longer meets study criteria|0|||
129869446|NCT01592370|467476934|FG002|Overall Study|No longer meets study criteria|0|||
129869447|NCT01592370|467476935|FG003|Overall Study|No longer meets study criteria|0|||
129869448|NCT01592370|467476936|FG004|Overall Study|No longer meets study criteria|0|||
129869449|NCT01592370|467476937|FG005|Overall Study|No longer meets study criteria|0|||
129869450|NCT01592370|467476938|FG006|Overall Study|No longer meets study criteria|0|||
129869451|NCT01592370|467476932|FG000|Overall Study|Other Reasons|6|||
129869452|NCT01592370|467476933|FG001|Overall Study|Other Reasons|0|||
129869453|NCT01592370|467476934|FG002|Overall Study|Other Reasons|10|||
129869454|NCT01592370|467476935|FG003|Overall Study|Other Reasons|0|||
129869455|NCT01592370|467476936|FG004|Overall Study|Other Reasons|0|||
129869456|NCT01592370|467476937|FG005|Overall Study|Other Reasons|1|||
129869457|NCT01592370|467476938|FG006|Overall Study|Other Reasons|0|||
129869458|NCT02412137|467476943|FG000|Overall Study|Withdrawal by Subject|2|||
129869459|NCT02412137|467476944|FG001|Overall Study|Withdrawal by Subject|0|||
129869460|NCT02412137|467476943|FG000|Overall Study|Lost to Follow-up|21|||
129869461|NCT02412137|467476944|FG001|Overall Study|Lost to Follow-up|14|||
129869462|NCT02412137|467476943|FG000|Overall Study|Physician Decision|28|||
129917238|NCT04450342|467661435|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
129917239|NCT04450342|467661436|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
129869463|NCT02412137|467476944|FG001|Overall Study|Physician Decision|9|||
129869464|NCT01323530|467478885|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
129869465|NCT01323530|467478886|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869466|NCT01323530|467478887|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869467|NCT01323530|467478888|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869468|NCT01323530|467478889|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869469|NCT01323530|467478890|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
129869470|NCT01323530|467478891|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869471|NCT01323530|467478885|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129917240|NCT04450342|467661434|FG000|Overall Study|Physician Decision|1|||
129869472|NCT01323530|467478886|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129917241|NCT04450342|467661435|FG001|Overall Study|Physician Decision|0|||
129917242|NCT04450342|467661436|FG002|Overall Study|Physician Decision|1|||
129917243|NCT04450342|467661434|FG000|Overall Study|Protocol Deviation|0|||
129917244|NCT04450342|467661435|FG001|Overall Study|Protocol Deviation|1|||
129917245|NCT04450342|467661436|FG002|Overall Study|Protocol Deviation|0|||
129917246|NCT04450342|467661434|FG000|Overall Study|Reoperation|1|||
129917247|NCT04450342|467661435|FG001|Overall Study|Reoperation|1|||
129917248|NCT04450342|467661436|FG002|Overall Study|Reoperation|0|||
129917249|NCT04450342|467661434|FG000|Overall Study|Screen Failures|0|||
129917250|NCT04450342|467661435|FG001|Overall Study|Screen Failures|0|||
129917251|NCT04450342|467661436|FG002|Overall Study|Screen Failures|2|||
129917252|NCT04450342|467661434|FG000|Overall Study|Site Terminated by Sponsor|1|||
129917253|NCT04450342|467661435|FG001|Overall Study|Site Terminated by Sponsor|1|||
129917254|NCT04450342|467661436|FG002|Overall Study|Site Terminated by Sponsor|1|||
129917255|NCT04450342|467661434|FG000|Overall Study|Study Terminated by Sponsor|31|||
129917256|NCT04450342|467661435|FG001|Overall Study|Study Terminated by Sponsor|29|||
129917257|NCT04450342|467661436|FG002|Overall Study|Study Terminated by Sponsor|6|||
129917258|NCT04450342|467661434|FG000|Overall Study|Withdrawal by Subject|0|||
129917259|NCT04450342|467661435|FG001|Overall Study|Withdrawal by Subject|1|||
129917260|NCT04450342|467661436|FG002|Overall Study|Withdrawal by Subject|2|||
129917261|NCT03396588|467661437|FG000|Overall Study|Physician Decision|2|||
129917262|NCT03396588|467661438|FG001|Overall Study|Physician Decision|3|||
129917263|NCT00812461|467661439|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
129917264|NCT00812461|467661440|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
129917265|NCT00812461|467661439|FG000|All Treated Patients|Adverse Event|8|||
129917266|NCT00812461|467661440|FG001|All Treated Patients|Adverse Event|15|||
129917267|NCT00812461|467661439|FG000|All Treated Patients|Lack of Efficacy|13|||
129917268|NCT00812461|467661440|FG001|All Treated Patients|Lack of Efficacy|7|||
129917269|NCT00812461|467661439|FG000|All Treated Patients|Non-compliance|6|||
129917270|NCT00812461|467661440|FG001|All Treated Patients|Non-compliance|9|||
129917271|NCT00812461|467661439|FG000|All Treated Patients|Protocol Violation|36|||
129917272|NCT00812461|467661440|FG001|All Treated Patients|Protocol Violation|27|||
129917273|NCT00812461|467661439|FG000|All Treated Patients|Withdrawal by Subject|45|||
129917274|NCT00812461|467661440|FG001|All Treated Patients|Withdrawal by Subject|54|||
129917275|NCT00812461|467661439|FG000|All Treated Patients|Lost to Follow-up|11|||
129917276|NCT00812461|467661440|FG001|All Treated Patients|Lost to Follow-up|14|||
129917277|NCT00812461|467661439|FG000|All Treated Patients|Other Reason|13|||
129917278|NCT00812461|467661440|FG001|All Treated Patients|Other Reason|21|||
129917279|NCT04402489|467663028|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917280|NCT04402489|467663029|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
129917281|NCT04402489|467663030|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917282|NCT04402489|467663031|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917283|NCT04402489|467663032|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917284|NCT04402489|467663028|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
129917285|NCT04402489|467663029|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917286|NCT04402489|467663030|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917287|NCT04402489|467663031|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917288|NCT04402489|467663032|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917289|NCT04402489|467663028|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
129917290|NCT04402489|467663029|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
129917291|NCT04402489|467663030|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
129917292|NCT04402489|467663031|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
129917293|NCT04402489|467663032|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
129917294|NCT04402489|467663028|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
130066286|NCT00225212|468197794|FG000|Overall Study|Death|1|||
130066287|NCT00225212|468197794|FG000|Overall Study|Adverse Event|2|||
129917295|NCT04402489|467663029|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917296|NCT04402489|467663030|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
129917297|NCT04402489|467663031|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917298|NCT04402489|467663032|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917299|NCT04402489|467663028|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917300|NCT04402489|467663029|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917301|NCT04402489|467663030|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917302|NCT04402489|467663031|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
129917303|NCT04402489|467663032|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917304|NCT04402489|467663028|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
129917305|NCT04402489|467663029|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
129917306|NCT04402489|467663030|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
129917307|NCT04402489|467663031|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
129917308|NCT04402489|467663032|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
129917309|NCT04833777|467663038|FG000|Overall Study|Lost to Follow-up|1|||
129917310|NCT04833777|467663039|FG001|Overall Study|Lost to Follow-up|0|||
129917311|NCT03648840|467663046|FG000|First IV Infusion Session|Adverse Event|0|||
129917312|NCT03648840|467663047|FG001|First IV Infusion Session|Adverse Event|2|||
129917313|NCT03648840|467663046|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
129917314|NCT03648840|467663047|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
129917315|NCT03648840|467663046|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
129917316|NCT03648840|467663047|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
129917317|NCT03648840|467663046|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
129917318|NCT03648840|467663047|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
129917319|NCT05382936|467663050|FG000|Overall Study|Progressive Disease|3|||
129917320|NCT05382936|467663051|FG001|Overall Study|Progressive Disease|5|||
129917321|NCT05382936|467663052|FG002|Overall Study|Progressive Disease|2|||
129917322|NCT05382936|467663053|FG003|Overall Study|Progressive Disease|5|||
129917323|NCT05382936|467663050|FG000|Overall Study|Adverse Event|0|||
129917324|NCT05382936|467663051|FG001|Overall Study|Adverse Event|1|||
129917325|NCT05382936|467663052|FG002|Overall Study|Adverse Event|1|||
129917326|NCT05382936|467663053|FG003|Overall Study|Adverse Event|0|||
129917327|NCT05382936|467663050|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
129917328|NCT05382936|467663051|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
129917329|NCT05382936|467663052|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
129917330|NCT05382936|467663053|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
129917331|NCT05382936|467663050|FG000|Overall Study|Withdrawal by Subject|0|||
129917332|NCT05382936|467663051|FG001|Overall Study|Withdrawal by Subject|0|||
129917333|NCT05382936|467663052|FG002|Overall Study|Withdrawal by Subject|1|||
129917334|NCT05382936|467663053|FG003|Overall Study|Withdrawal by Subject|1|||
129917335|NCT05063994|467663054|FG000|Cortef Run-In|Withdrawal of Consent|1|||
129917336|NCT05063994|467663055|FG001|Cortef Run-In|Withdrawal of Consent|0|||
129917337|NCT05063994|467663056|FG002|Cortef Run-In|Withdrawal of Consent|0|||
129917338|NCT05063994|467663054|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
129917339|NCT05063994|467663055|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
129917340|NCT05063994|467663056|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
129917341|NCT05063994|467663054|FG000|Treatment|Physician Decision|0|||
129917342|NCT05063994|467663055|FG001|Treatment|Physician Decision|0|||
129917343|NCT05063994|467663056|FG002|Treatment|Physician Decision|1|||
129917344|NCT05063994|467663054|FG000|Treatment|Withdrawal by Subject|0|||
129917345|NCT05063994|467663055|FG001|Treatment|Withdrawal by Subject|0|||
129917346|NCT05063994|467663056|FG002|Treatment|Withdrawal by Subject|1|||
129917347|NCT05063994|467663054|FG000|Treatment|Withdrawal of Consent|0|||
129917348|NCT05063994|467663055|FG001|Treatment|Withdrawal of Consent|0|||
129917349|NCT05063994|467663056|FG002|Treatment|Withdrawal of Consent|1|||
129917350|NCT04630262|467663060|FG000|Overall Study|Intraoperative Screen Failure|5|||
129917351|NCT04630262|467663060|FG000|Overall Study|Study terminated prematurely|71|||
129917352|NCT04630262|467663060|FG000|Overall Study|Withdrawal by Subject|2|||
129917353|NCT04630262|467663060|FG000|Overall Study|Physician Decision|2|||
129917354|NCT01195831|467663062|FG000|Overall Study|Lost to Follow-up|2|||
129917355|NCT01195831|467663063|FG001|Overall Study|Lost to Follow-up|4|||
129917356|NCT01195831|467663062|FG000|Overall Study|Withdrawal by Subject|2|||
129917357|NCT01195831|467663063|FG001|Overall Study|Withdrawal by Subject|2|||
129917358|NCT01195831|467663062|FG000|Overall Study|Adverse Event|4|||
129917359|NCT01195831|467663063|FG001|Overall Study|Adverse Event|2|||
129917360|NCT01195831|467663062|FG000|Overall Study|Protocol Violation|0|||
129917361|NCT01195831|467663063|FG001|Overall Study|Protocol Violation|2|||
129917362|NCT01857934|467663064|FG000|Overall Study|Relapse or progression|2|||
129917363|NCT01857934|467663064|FG000|Overall Study|Unacceptable toxicity|3|||
129917364|NCT01857934|467663064|FG000|Overall Study|Unwillingness or inability to comply|2|||
129917365|NCT01857934|467663064|FG000|Overall Study|Physician Decision|3|||
129917366|NCT04703322|467663066|FG000|Overall Study|Ongoing|8|||
129917367|NCT04703322|467663066|FG000|Overall Study|Withdrawal by Subject|1|||
129917368|NCT04638998|467663070|FG000|Overall Study|Withdrawal by Subject|1|||
129917369|NCT04638998|467663071|FG001|Overall Study|Withdrawal by Subject|3|||
129917370|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior use|4424|||
129917371|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior use|24726|||
129917372|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior use|0|||
129917373|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior use|0|||
129917374|NCT03692676|467663072|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
129917375|NCT03692676|467663073|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
129917376|NCT03692676|467663074|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
129917377|NCT03692676|467663075|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
129917378|NCT03692676|467663072|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
129917379|NCT03692676|467663073|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
129917380|NCT03692676|467663074|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
129917381|NCT03692676|467663075|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
129917382|NCT03692676|467663072|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
129917383|NCT03692676|467663073|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
129917384|NCT03692676|467663074|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
129917385|NCT03692676|467663075|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
129917386|NCT03692676|467663072|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
129917387|NCT03692676|467663073|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
129917388|NCT03692676|467663074|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
129917389|NCT03692676|467663075|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
129917390|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
129917391|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
129917392|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
129917393|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
129917394|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
129917395|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
129917396|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
129917397|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
129917398|NCT03692676|467663072|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
129917399|NCT03692676|467663073|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
129917400|NCT03692676|467663074|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
129917401|NCT03692676|467663075|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
129917402|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
129917403|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
129917404|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
129917405|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
129917406|NCT03692676|467663072|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
129917407|NCT03692676|467663073|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
129917408|NCT03692676|467663074|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
129917409|NCT03692676|467663075|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
129917410|NCT03692676|467663072|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
129917411|NCT03692676|467663073|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
129917412|NCT03692676|467663074|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
129917413|NCT03692676|467663075|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
129917414|NCT03692676|467663072|FG000|Overall Study|Other|0|||
129917415|NCT03692676|467663073|FG001|Overall Study|Other|805|||
129917416|NCT03692676|467663074|FG002|Overall Study|Other|758|||
129917417|NCT03692676|467663075|FG003|Overall Study|Other|277|||
129917418|NCT03692676|467663072|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
129917419|NCT03692676|467663073|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
129917420|NCT03692676|467663074|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
129917421|NCT03692676|467663075|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
129917422|NCT03692611|467663077|FG000|Overall Study|Found to be ineligible postrandomization|3|||
129917423|NCT03692611|467663078|FG001|Overall Study|Found to be ineligible postrandomization|0|||
129917424|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
129917425|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
129917426|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
129917427|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
129917428|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
129917429|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
129917430|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
129917431|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
129917432|NCT02549339|467663088|FG000|12-month Follow-up|Lack of Efficacy|0|||
129917433|NCT02549339|467663089|FG001|12-month Follow-up|Lack of Efficacy|2|||
129917434|NCT02549339|467663088|FG000|12-month Follow-up|Withdrawal by Subject|8|||
129917435|NCT02549339|467663089|FG001|12-month Follow-up|Withdrawal by Subject|3|||
129917436|NCT02549339|467663088|FG000|12-month Follow-up|Lost to Follow-up|1|||
129917437|NCT02549339|467663089|FG001|12-month Follow-up|Lost to Follow-up|3|||
129917438|NCT02549339|467663088|FG000|12-month Follow-up|Other|0|||
129917439|NCT02549339|467663089|FG001|12-month Follow-up|Other|3|||
129917440|NCT03016169|467663090|FG000|Overall Study|Lost to Follow-up|4|||
129917441|NCT03016169|467663090|FG000|Overall Study|Death|54|||
129917442|NCT03016169|467663090|FG000|Overall Study|Device Explant|11|||
129917443|NCT03016169|467663090|FG000|Overall Study|Withdrawal by Subject|19|||
129917444|NCT03016169|467663090|FG000|Overall Study|Other Reasons|1|||
129917445|NCT02724878|467663091|FG000|Overall Study|Still on Active Therapy|15|||
129917446|NCT02724878|467663091|FG000|Overall Study|Disease Progression|31|||
129917447|NCT02724878|467663091|FG000|Overall Study|Toxicity|5|||
129917448|NCT02724878|467663091|FG000|Overall Study|Death|1|||
129917449|NCT02724878|467663091|FG000|Overall Study|Withdrawal by Subject|4|||
129917450|NCT02724878|467663091|FG000|Overall Study|Lost to Follow-up|2|||
129917451|NCT02724878|467663091|FG000|Overall Study|Protocol Violation|1|||
129917452|NCT02724878|467663091|FG000|Overall Study|Ineligible for Study Drug|5|||
129917453|NCT02724878|467663091|FG000|Overall Study|not started|1|||
129917454|NCT03958955|467663093|FG000|Overall Study|Adverse Event|1|||
129917455|NCT04838262|467663094|FG000|Overall Study|Withdrawal by Subject|9|||
129917456|NCT04838262|467663095|FG001|Overall Study|Withdrawal by Subject|4|||
129917457|NCT03175029|467663098|FG000|Overall Study|Withdrawal by Subject|2|||
129917458|NCT03175029|467663099|FG001|Overall Study|Withdrawal by Subject|1|||
129917459|NCT03175029|467663098|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
129917460|NCT03175029|467663099|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
129917461|NCT00512070|467663102|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
129917462|NCT00512070|467663103|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
129917463|NCT00512070|467663104|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
129917464|NCT00512070|467663102|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
129917465|NCT00512070|467663103|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
129917466|NCT00512070|467663104|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
129917467|NCT00961571|467663105|FG000|Overall Study|Physician Decision|39|||
129917468|NCT02506959|467663109|FG000|Overall Study|Physician Decision|2|||
129917469|NCT02506959|467663110|FG001|Overall Study|Physician Decision|1|||
129917470|NCT04382898|467663112|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
129917471|NCT04382898|467663113|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917472|NCT04382898|467663114|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917473|NCT04382898|467663115|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917474|NCT04382898|467663116|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917475|NCT04382898|467663112|FG000|Part 1: Dose Titration|Death|6|||
129917476|NCT04382898|467663113|FG001|Part 1: Dose Titration|Death|0|||
129917477|NCT04382898|467663114|FG002|Part 1: Dose Titration|Death|0|||
129917478|NCT04382898|467663115|FG003|Part 1: Dose Titration|Death|0|||
129917479|NCT04382898|467663116|FG004|Part 1: Dose Titration|Death|0|||
129917480|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129869473|NCT01323530|467478887|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129869474|NCT01323530|467478888|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129869475|NCT01323530|467478889|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
129869476|NCT01323530|467478890|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129869477|NCT01323530|467478891|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129869478|NCT01323530|467478885|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869479|NCT01323530|467478886|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
129869480|NCT01323530|467478887|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869481|NCT01323530|467478888|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869482|NCT01323530|467478889|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
129869483|NCT01323530|467478890|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
129869484|NCT01323530|467478891|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869485|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869486|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869487|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869488|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869489|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129917481|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129917482|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
129917483|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129917484|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129917485|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
129869490|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129917486|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
129917487|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
129917488|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
129917489|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
129869491|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
129869492|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129917490|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Death|0|||
129917491|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Death|17|||
130066288|NCT00225212|468197794|FG000|Overall Study|Intercurrent illness|1|||
129869493|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869494|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869495|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869496|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869497|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869498|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
129869499|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869500|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869501|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869502|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869503|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869504|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869505|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
129869506|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869507|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869508|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869509|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869510|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869511|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869512|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
129869513|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869514|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869515|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869516|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869517|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869518|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869519|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
129869520|NCT02532179|467478892|FG000|Overall Study|Lost to Follow-up|1|||
129869521|NCT02532179|467478892|FG000|Overall Study|Pregnancy|1|||
129869522|NCT02532179|467478892|FG000|Overall Study|Subject received depot steroid injection|1|||
129869523|NCT01735201|467478897|FG000|Overall Study|Adverse Event|1|||
129869524|NCT01735201|467478898|FG001|Overall Study|Adverse Event|1|||
129869525|NCT01735201|467478899|FG002|Overall Study|Adverse Event|0|||
129869526|NCT01735201|467478900|FG003|Overall Study|Adverse Event|1|||
129869527|NCT01735201|467478901|FG004|Overall Study|Adverse Event|1|||
130066289|NCT01309841|468197797|FG000|Overall Study|Other|0|||
130066290|NCT01309841|468197798|FG001|Overall Study|Other|1|||
130066291|NCT01309841|468197799|FG002|Overall Study|Other|1|||
129869528|NCT01735201|467478902|FG005|Overall Study|Adverse Event|3|||
129869529|NCT01735201|467478903|FG006|Overall Study|Adverse Event|2|||
129869530|NCT01735201|467478904|FG007|Overall Study|Adverse Event|1|||
129869531|NCT01735201|467478897|FG000|Overall Study|Personal Reasons|1|||
129869532|NCT01735201|467478898|FG001|Overall Study|Personal Reasons|0|||
129869533|NCT01735201|467478899|FG002|Overall Study|Personal Reasons|0|||
129869534|NCT01735201|467478900|FG003|Overall Study|Personal Reasons|0|||
129869535|NCT01735201|467478901|FG004|Overall Study|Personal Reasons|0|||
129869536|NCT01735201|467478902|FG005|Overall Study|Personal Reasons|0|||
129869537|NCT01735201|467478903|FG006|Overall Study|Personal Reasons|0|||
129869538|NCT01735201|467478904|FG007|Overall Study|Personal Reasons|0|||
129869539|NCT01735201|467478897|FG000|Overall Study|Protocol Violation|1|||
129869540|NCT01735201|467478898|FG001|Overall Study|Protocol Violation|0|||
129869541|NCT01735201|467478899|FG002|Overall Study|Protocol Violation|0|||
129869542|NCT01735201|467478900|FG003|Overall Study|Protocol Violation|0|||
129869543|NCT01735201|467478901|FG004|Overall Study|Protocol Violation|0|||
129869544|NCT01735201|467478902|FG005|Overall Study|Protocol Violation|0|||
129869545|NCT01735201|467478903|FG006|Overall Study|Protocol Violation|0|||
129869546|NCT01735201|467478904|FG007|Overall Study|Protocol Violation|0|||
129869547|NCT01735201|467478897|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129869548|NCT01735201|467478898|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129869549|NCT01735201|467478899|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129869550|NCT01735201|467478900|FG003|Overall Study|Other Miscellaneous Reasons|1|||
129869551|NCT01735201|467478901|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129869552|NCT01735201|467478902|FG005|Overall Study|Other Miscellaneous Reasons|2|||
129869553|NCT01735201|467478903|FG006|Overall Study|Other Miscellaneous Reasons|1|||
129869554|NCT01735201|467478904|FG007|Overall Study|Other Miscellaneous Reasons|1|||
129869555|NCT01553318|467478905|FG000|Overall Study|Protocol Violation|3|||
129869556|NCT01553318|467478906|FG001|Overall Study|Protocol Violation|2|||
129869557|NCT04128293|467478907|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129869558|NCT04128293|467478908|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129869559|NCT04128293|467478909|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129917492|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Death|13|||
130066292|NCT01309841|468197797|FG000|Overall Study|Lost to Follow-up|7|||
130066293|NCT01309841|468197798|FG001|Overall Study|Lost to Follow-up|6|||
129869560|NCT04128293|467478910|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129869561|NCT01357616|467478911|FG000|Overall Study|Adverse Event|1|||
129869562|NCT01357616|467478912|FG001|Overall Study|Adverse Event|1|||
129869563|NCT01357616|467478911|FG000|Overall Study|Lost to Follow-up|4|||
129869564|NCT01357616|467478912|FG001|Overall Study|Lost to Follow-up|3|||
129869565|NCT01357616|467478911|FG000|Overall Study|Protocol Violation|0|||
129869566|NCT01357616|467478912|FG001|Overall Study|Protocol Violation|2|||
129869567|NCT01357616|467478911|FG000|Overall Study|Inadequate Control of IOP|1|||
129869568|NCT01357616|467478912|FG001|Overall Study|Inadequate Control of IOP|2|||
129869569|NCT01357616|467478911|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
129869570|NCT01357616|467478912|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
129869571|NCT01357616|467478911|FG000|Overall Study|Withdrawal by Subject|1|||
129869572|NCT01357616|467478912|FG001|Overall Study|Withdrawal by Subject|0|||
129869573|NCT03432364|467478914|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
129869574|NCT01699022|467478919|FG000|Overall Study|Early discontinuation from the study|3|||
129869575|NCT02066402|467478922|FG000|Overall Study|Adverse Event|1|||
129869576|NCT02066402|467478923|FG001|Overall Study|Adverse Event|2|||
129869577|NCT02066402|467478922|FG000|Overall Study|Lost to Follow-up|11|||
129869578|NCT02066402|467478923|FG001|Overall Study|Lost to Follow-up|8|||
129869579|NCT02066402|467478922|FG000|Overall Study|Withdrawal by Subject|14|||
129869580|NCT02066402|467478923|FG001|Overall Study|Withdrawal by Subject|11|||
129869581|NCT02066402|467478922|FG000|Overall Study|Progressive disease-clinical progression|0|||
129869582|NCT02066402|467478923|FG001|Overall Study|Progressive disease-clinical progression|1|||
129869583|NCT02066402|467478922|FG000|Overall Study|Protocol driven decision point|0|||
129869584|NCT02066402|467478923|FG001|Overall Study|Protocol driven decision point|1|||
129869585|NCT00152464|467478924|FG000|Overall Study|Adverse Event|3|||
129869586|NCT00152464|467478925|FG001|Overall Study|Adverse Event|6|||
129869587|NCT00152464|467478924|FG000|Overall Study|Lost to Follow-up|8|||
129869588|NCT00152464|467478925|FG001|Overall Study|Lost to Follow-up|4|||
129869589|NCT00152464|467478924|FG000|Overall Study|Protocol Violation|3|||
129869590|NCT00152464|467478925|FG001|Overall Study|Protocol Violation|1|||
129869591|NCT00152464|467478924|FG000|Overall Study|Withdrawal by Subject|21|||
129869592|NCT00152464|467478925|FG001|Overall Study|Withdrawal by Subject|22|||
129869593|NCT00152464|467478924|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
129869594|NCT00152464|467478925|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
129869595|NCT00152464|467478924|FG000|Overall Study|Eczema deterioration|0|||
129869596|NCT00152464|467478925|FG001|Overall Study|Eczema deterioration|1|||
129869597|NCT00152464|467478924|FG000|Overall Study|Parent decision|1|||
129869598|NCT00152464|467478925|FG001|Overall Study|Parent decision|1|||
129869599|NCT00152464|467478924|FG000|Overall Study|Investigator decision|1|||
129869600|NCT00152464|467478925|FG001|Overall Study|Investigator decision|0|||
129869601|NCT00152464|467478924|FG000|Overall Study|Lack of Efficacy|1|||
129869602|NCT00152464|467478925|FG001|Overall Study|Lack of Efficacy|0|||
129869603|NCT00152464|467478924|FG000|Overall Study|Eczema poorly controlled|1|||
129869604|NCT00152464|467478925|FG001|Overall Study|Eczema poorly controlled|0|||
129869605|NCT00152464|467478924|FG000|Overall Study|Patient relocated|1|||
129869606|NCT00152464|467478925|FG001|Overall Study|Patient relocated|0|||
129869607|NCT04493931|467478927|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
129869608|NCT04493931|467478928|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869609|NCT04493931|467478929|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869610|NCT04493931|467478930|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869611|NCT04493931|467478931|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869612|NCT04493931|467478932|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
130066294|NCT01309841|468197799|FG002|Overall Study|Lost to Follow-up|4|||
129869613|NCT04493931|467478933|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869614|NCT04493931|467478927|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869615|NCT04493931|467478928|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
129869616|NCT04493931|467478929|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869617|NCT04493931|467478930|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869618|NCT04493931|467478931|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869619|NCT04493931|467478932|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869620|NCT04493931|467478933|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869621|NCT04493931|467478927|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869622|NCT04493931|467478928|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
130066295|NCT01309841|468197797|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
129869623|NCT04493931|467478929|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869624|NCT04493931|467478930|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869625|NCT04493931|467478931|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869626|NCT04493931|467478932|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869627|NCT04493931|467478933|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869628|NCT04493931|467478927|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869629|NCT04493931|467478928|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869630|NCT04493931|467478929|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
129869631|NCT04493931|467478930|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869632|NCT04493931|467478931|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869633|NCT04493931|467478932|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869634|NCT04493931|467478933|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869635|NCT00430248|467478935|FG000|Overall Study|Adverse Event|49|||
129869636|NCT00430248|467478936|FG001|Overall Study|Adverse Event|61|||
129869637|NCT00430248|467478937|FG002|Overall Study|Adverse Event|64|||
129869638|NCT00430248|467478935|FG000|Overall Study|Protocol Violation|10|||
129869639|NCT00430248|467478936|FG001|Overall Study|Protocol Violation|2|||
129869640|NCT00430248|467478937|FG002|Overall Study|Protocol Violation|4|||
129869641|NCT00430248|467478935|FG000|Overall Study|Personal Reasons|12|||
129869642|NCT00430248|467478936|FG001|Overall Study|Personal Reasons|24|||
129869643|NCT00430248|467478937|FG002|Overall Study|Personal Reasons|9|||
129869644|NCT00430248|467478935|FG000|Overall Study|Lost to Follow-up|28|||
129869645|NCT00430248|467478936|FG001|Overall Study|Lost to Follow-up|33|||
129869646|NCT00430248|467478937|FG002|Overall Study|Lost to Follow-up|28|||
129869647|NCT00430248|467478935|FG000|Overall Study|Therapeutic Failure|1|||
129869648|NCT00430248|467478936|FG001|Overall Study|Therapeutic Failure|1|||
129869649|NCT00430248|467478937|FG002|Overall Study|Therapeutic Failure|1|||
129869650|NCT00430248|467478935|FG000|Overall Study|Withdrawal by Subject|14|||
129869651|NCT00430248|467478936|FG001|Overall Study|Withdrawal by Subject|20|||
129869652|NCT00430248|467478937|FG002|Overall Study|Withdrawal by Subject|16|||
129869653|NCT00430248|467478935|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129869654|NCT00430248|467478936|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
129869655|NCT00430248|467478937|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129869656|NCT00430248|467478935|FG000|Overall Study|Gout Flare|3|||
129869657|NCT00430248|467478936|FG001|Overall Study|Gout Flare|7|||
129869658|NCT00430248|467478937|FG002|Overall Study|Gout Flare|2|||
129869659|NCT00430248|467478935|FG000|Overall Study|Reason Not Specified|8|||
129869660|NCT00430248|467478936|FG001|Overall Study|Reason Not Specified|8|||
129869661|NCT00430248|467478937|FG002|Overall Study|Reason Not Specified|11|||
129869662|NCT01754467|467478943|FG000|Overall Study|Lost to Follow-up|1|||
129869663|NCT01970462|467478944|FG000|Overall Study|Lost to Follow-up|0|||
129869664|NCT01970462|467478945|FG001|Overall Study|Lost to Follow-up|2|||
129869665|NCT00929162|467478946|FG000|Overall Study|Adverse Event|8|||
129869666|NCT00929162|467478947|FG001|Overall Study|Adverse Event|5|||
129869667|NCT00929162|467478946|FG000|Overall Study|Withdrawal by Subject|3|||
129869668|NCT00929162|467478947|FG001|Overall Study|Withdrawal by Subject|1|||
129869669|NCT00929162|467478946|FG000|Overall Study|Protocol Violation|32|||
129869670|NCT00929162|467478947|FG001|Overall Study|Protocol Violation|30|||
129869671|NCT00929162|467478946|FG000|Overall Study|Other termination reason|5|||
129869672|NCT00929162|467478947|FG001|Overall Study|Other termination reason|6|||
129869673|NCT01274182|467478948|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129869674|NCT01274182|467478949|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129869675|NCT01274182|467478950|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
129869676|NCT01274182|467478948|FG000|Overall Study|Adverse Event|4|||
129869677|NCT01274182|467478949|FG001|Overall Study|Adverse Event|5|||
129869678|NCT01274182|467478950|FG002|Overall Study|Adverse Event|3|||
129869679|NCT01274182|467478948|FG000|Overall Study|Withdrawal by Subject|5|||
129869680|NCT01274182|467478949|FG001|Overall Study|Withdrawal by Subject|5|||
129869681|NCT01274182|467478950|FG002|Overall Study|Withdrawal by Subject|3|||
129869682|NCT01274182|467478948|FG000|Overall Study|Lost to Follow-up|2|||
129869683|NCT01274182|467478949|FG001|Overall Study|Lost to Follow-up|3|||
129869684|NCT01274182|467478950|FG002|Overall Study|Lost to Follow-up|1|||
129869685|NCT01274182|467478948|FG000|Overall Study|Protocol Violation|3|||
129869686|NCT01274182|467478949|FG001|Overall Study|Protocol Violation|2|||
129869687|NCT01274182|467478950|FG002|Overall Study|Protocol Violation|0|||
129869688|NCT01274182|467478948|FG000|Overall Study|Death|1|||
129869689|NCT01274182|467478949|FG001|Overall Study|Death|0|||
129869690|NCT01274182|467478950|FG002|Overall Study|Death|1|||
129869691|NCT01822587|467478951|FG000|Overall Study|Lost to Follow-up|7|||
129869692|NCT01822587|467478952|FG001|Overall Study|Lost to Follow-up|9|||
129869693|NCT01822587|467478953|FG002|Overall Study|Lost to Follow-up|12|||
129869694|NCT01822587|467478951|FG000|Overall Study|Physician Decision|9|||
129869695|NCT01822587|467478952|FG001|Overall Study|Physician Decision|6|||
129869696|NCT01822587|467478953|FG002|Overall Study|Physician Decision|6|||
129869697|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
129869698|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
129869699|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
129869700|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
129869701|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
129869702|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
129917493|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Death|1|||
129869703|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
129869704|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
129869705|NCT02355002|467478954|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
129869706|NCT02355002|467478955|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
129869707|NCT02355002|467478954|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
129869708|NCT02355002|467478955|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
129869709|NCT02355002|467478954|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
129869710|NCT02355002|467478955|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
129869711|NCT00708916|467478956|FG000|Overall Study|Subject Noncompliance|2|||
129869712|NCT00708916|467478956|FG000|Overall Study|Adverse Event|2|||
129869713|NCT03205371|467478966|FG000|Overall Study|Withdrawal by Subject|4|||
129869714|NCT03205371|467478967|FG001|Overall Study|Withdrawal by Subject|1|||
129869715|NCT03205371|467478968|FG002|Overall Study|Withdrawal by Subject|0|||
129869716|NCT03205371|467478969|FG003|Overall Study|Withdrawal by Subject|0|||
129869717|NCT03205371|467478970|FG004|Overall Study|Withdrawal by Subject|0|||
129869718|NCT03205371|467478971|FG005|Overall Study|Withdrawal by Subject|0|||
129869719|NCT03205371|467478972|FG006|Overall Study|Withdrawal by Subject|4|||
129869720|NCT03205371|467478973|FG007|Overall Study|Withdrawal by Subject|0|||
129869721|NCT03205371|467478974|FG008|Overall Study|Withdrawal by Subject|2|||
129869722|NCT03205371|467478975|FG009|Overall Study|Withdrawal by Subject|0|||
129869723|NCT03205371|467478976|FG010|Overall Study|Withdrawal by Subject|0|||
129869724|NCT03205371|467478977|FG011|Overall Study|Withdrawal by Subject|1|||
129869725|NCT03205371|467478966|FG000|Overall Study|Lost to Follow-up|0|||
129869726|NCT03205371|467478967|FG001|Overall Study|Lost to Follow-up|0|||
129869727|NCT03205371|467478968|FG002|Overall Study|Lost to Follow-up|0|||
129869728|NCT03205371|467478969|FG003|Overall Study|Lost to Follow-up|0|||
129869729|NCT03205371|467478970|FG004|Overall Study|Lost to Follow-up|0|||
129869730|NCT03205371|467478971|FG005|Overall Study|Lost to Follow-up|0|||
129869731|NCT03205371|467478972|FG006|Overall Study|Lost to Follow-up|5|||
129869732|NCT03205371|467478973|FG007|Overall Study|Lost to Follow-up|2|||
129869733|NCT03205371|467478974|FG008|Overall Study|Lost to Follow-up|3|||
129869734|NCT03205371|467478975|FG009|Overall Study|Lost to Follow-up|0|||
129869735|NCT03205371|467478976|FG010|Overall Study|Lost to Follow-up|0|||
129869736|NCT03205371|467478977|FG011|Overall Study|Lost to Follow-up|0|||
129869737|NCT03205371|467478966|FG000|Overall Study|Protocol Violation|0|||
129869738|NCT03205371|467478967|FG001|Overall Study|Protocol Violation|0|||
129869739|NCT03205371|467478968|FG002|Overall Study|Protocol Violation|0|||
129869740|NCT03205371|467478969|FG003|Overall Study|Protocol Violation|0|||
129869741|NCT03205371|467478970|FG004|Overall Study|Protocol Violation|0|||
129869742|NCT03205371|467478971|FG005|Overall Study|Protocol Violation|0|||
129869743|NCT03205371|467478972|FG006|Overall Study|Protocol Violation|1|||
129869744|NCT03205371|467478973|FG007|Overall Study|Protocol Violation|0|||
129869745|NCT03205371|467478974|FG008|Overall Study|Protocol Violation|0|||
129869746|NCT03205371|467478975|FG009|Overall Study|Protocol Violation|0|||
129869747|NCT03205371|467478976|FG010|Overall Study|Protocol Violation|0|||
129869748|NCT03205371|467478977|FG011|Overall Study|Protocol Violation|0|||
129869749|NCT03205371|467478966|FG000|Overall Study|Adverse Event|0|||
129869750|NCT03205371|467478967|FG001|Overall Study|Adverse Event|0|||
129869751|NCT03205371|467478968|FG002|Overall Study|Adverse Event|0|||
129869752|NCT03205371|467478969|FG003|Overall Study|Adverse Event|0|||
129869753|NCT03205371|467478970|FG004|Overall Study|Adverse Event|0|||
129869754|NCT03205371|467478971|FG005|Overall Study|Adverse Event|0|||
129869755|NCT03205371|467478972|FG006|Overall Study|Adverse Event|0|||
129869756|NCT03205371|467478973|FG007|Overall Study|Adverse Event|1|||
129869757|NCT03205371|467478974|FG008|Overall Study|Adverse Event|0|||
129869758|NCT03205371|467478975|FG009|Overall Study|Adverse Event|0|||
129869759|NCT03205371|467478976|FG010|Overall Study|Adverse Event|0|||
129869760|NCT03205371|467478977|FG011|Overall Study|Adverse Event|0|||
129869761|NCT01077544|467478981|FG000|Overall Study|New Cancer Therapy|3|||
129869762|NCT01077544|467478982|FG001|Overall Study|New Cancer Therapy|3|||
129869763|NCT01077544|467478981|FG000|Overall Study|Adverse Event|0|||
129869764|NCT01077544|467478982|FG001|Overall Study|Adverse Event|1|||
129869765|NCT01077544|467478981|FG000|Overall Study|Disease Progression|0|||
129869766|NCT01077544|467478982|FG001|Overall Study|Disease Progression|1|||
129869767|NCT03804710|467478985|FG000|Overall Study|Adverse Event|0|||
129869768|NCT03804710|467478986|FG001|Overall Study|Adverse Event|3|||
129869769|NCT03804710|467478985|FG000|Overall Study|Withdrawal by Subject|2|||
130066296|NCT01309841|468197798|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129869770|NCT03804710|467478986|FG001|Overall Study|Withdrawal by Subject|1|||
129869771|NCT03804710|467478985|FG000|Overall Study|Other|0|||
129869772|NCT03804710|467478986|FG001|Overall Study|Other|1|||
129869773|NCT04542018|467478987|FG000|Overall Study|Withdrawal by Subject|0|||
129869774|NCT04542018|467478988|FG001|Overall Study|Withdrawal by Subject|0|||
129869775|NCT04542018|467478989|FG002|Overall Study|Withdrawal by Subject|4|||
129869776|NCT04542018|467478987|FG000|Overall Study|Protocol Violation|0|||
129869777|NCT04542018|467478988|FG001|Overall Study|Protocol Violation|0|||
129869778|NCT04542018|467478989|FG002|Overall Study|Protocol Violation|2|||
130066297|NCT01309841|468197799|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
130066298|NCT01309841|468197797|FG000|Overall Study|Lack of Efficacy|0|||
130066299|NCT01309841|468197798|FG001|Overall Study|Lack of Efficacy|0|||
130066300|NCT01309841|468197799|FG002|Overall Study|Lack of Efficacy|2|||
130066301|NCT01309841|468197797|FG000|Overall Study|Adverse Event|9|||
130066302|NCT01309841|468197798|FG001|Overall Study|Adverse Event|22|||
130066303|NCT01309841|468197799|FG002|Overall Study|Adverse Event|11|||
130066304|NCT01309841|468197797|FG000|Overall Study|Death|1|||
130066305|NCT01309841|468197798|FG001|Overall Study|Death|0|||
130066306|NCT01309841|468197799|FG002|Overall Study|Death|0|||
130066307|NCT01309841|468197797|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129869779|NCT02454101|467478990|FG000|Overall Study|Adverse Event|2|||
129869780|NCT02454101|467478991|FG001|Overall Study|Adverse Event|3|||
129869781|NCT02454101|467478990|FG000|Overall Study|Lost to Follow-up|3|||
129869782|NCT02454101|467478991|FG001|Overall Study|Lost to Follow-up|4|||
129869783|NCT04510675|467478992|FG000|Overall Study|Withdrawal by Subject|5|||
129869784|NCT04198805|467478993|FG000|Overall Study|Death|0|||
129869785|NCT04198805|467478994|FG001|Overall Study|Death|0|||
129869786|NCT04198805|467478995|FG002|Overall Study|Death|0|||
129869787|NCT04198805|467478996|FG003|Overall Study|Death|1|||
129869788|NCT04198805|467478993|FG000|Overall Study|Early Termination|8|||
129869789|NCT04198805|467478994|FG001|Overall Study|Early Termination|4|||
129869790|NCT04198805|467478995|FG002|Overall Study|Early Termination|6|||
129869791|NCT04198805|467478996|FG003|Overall Study|Early Termination|9|||
129869792|NCT01330433|467478997|FG000|Overall Study|Death|1|||
129869793|NCT01330433|467478998|FG001|Overall Study|Death|3|||
129869794|NCT01330433|467478997|FG000|Overall Study|Lost to Follow-up|1|||
129869795|NCT01330433|467478998|FG001|Overall Study|Lost to Follow-up|0|||
129869796|NCT01494584|467478999|FG000|Overall Study|Study Closed/Terminated|1|||
129869797|NCT01499082|467479000|FG000|Overall Study|Randomized but not Treated|0|||
129869798|NCT01499082|467479001|FG001|Overall Study|Randomized but not Treated|1|||
129869799|NCT01499082|467479000|FG000|Overall Study|Adverse Event|12|||
129869800|NCT01499082|467479001|FG001|Overall Study|Adverse Event|16|||
129869801|NCT01499082|467479000|FG000|Overall Study|Lack of Efficacy|1|||
129869802|NCT01499082|467479001|FG001|Overall Study|Lack of Efficacy|1|||
129869803|NCT01499082|467479000|FG000|Overall Study|Protocol Violation|6|||
129869804|NCT01499082|467479001|FG001|Overall Study|Protocol Violation|8|||
129869805|NCT01499082|467479000|FG000|Overall Study|Diverse Reasons|18|||
129869806|NCT01499082|467479001|FG001|Overall Study|Diverse Reasons|14|||
129869807|NCT01499082|467479000|FG000|Overall Study|Site Closure for Noncompliance|5|||
129869808|NCT01499082|467479001|FG001|Overall Study|Site Closure for Noncompliance|2|||
129869809|NCT01499082|467479000|FG000|Overall Study|Hypoglycemia|2|||
129869810|NCT01499082|467479001|FG001|Overall Study|Hypoglycemia|3|||
129869811|NCT01499082|467479000|FG000|Overall Study|Lost to Follow-up|1|||
129869812|NCT01499082|467479001|FG001|Overall Study|Lost to Follow-up|3|||
129869813|NCT03599349|467479002|FG000|Overall Study|Lost to Follow-up|1|||
129869814|NCT01830127|467479008|FG000|Overall Study|Adverse Event|1|||
129869815|NCT01830127|467479009|FG001|Overall Study|Adverse Event|6|||
129869816|NCT01830127|467479008|FG000|Overall Study|Lack of Efficacy|3|||
129869817|NCT01830127|467479009|FG001|Overall Study|Lack of Efficacy|0|||
129869818|NCT01830127|467479008|FG000|Overall Study|Withdrawal by Subject|1|||
129869819|NCT01830127|467479009|FG001|Overall Study|Withdrawal by Subject|1|||
129869820|NCT01830127|467479008|FG000|Overall Study|Other reason not defined above|0|||
129869821|NCT01830127|467479009|FG001|Overall Study|Other reason not defined above|2|||
129869822|NCT00567190|467479015|FG000|Overall Study|Death|235|||
129869823|NCT00567190|467479016|FG001|Overall Study|Death|280|||
129869824|NCT00567190|467479015|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
129869825|NCT00567190|467479016|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
129869826|NCT00344461|467479022|FG000|Overall Study|Adverse Event|6|||
129869827|NCT00344461|467479022|FG000|Overall Study|Death|1|||
129869828|NCT00344461|467479022|FG000|Overall Study|Lack of Efficacy|2|||
129869829|NCT00344461|467479022|FG000|Overall Study|Lost to Follow-up|2|||
129869830|NCT00344461|467479022|FG000|Overall Study|Physician Decision|2|||
129869831|NCT00344461|467479022|FG000|Overall Study|Protocol Violation|6|||
129869832|NCT00344461|467479022|FG000|Overall Study|Withdrawal by Subject|2|||
129869833|NCT00636610|467479023|FG000|Overall Study|Adverse Event|4|||
129869834|NCT00636610|467479024|FG001|Overall Study|Adverse Event|4|||
130066308|NCT01309841|468197798|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
130066309|NCT01309841|468197799|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
130066310|NCT01309841|468197797|FG000|Overall Study|Withdrawal by Subject|17|||
130066311|NCT01309841|468197798|FG001|Overall Study|Withdrawal by Subject|6|||
130066312|NCT01309841|468197799|FG002|Overall Study|Withdrawal by Subject|13|||
129869835|NCT00636610|467479023|FG000|Overall Study|Death|6|||
129869836|NCT00636610|467479024|FG001|Overall Study|Death|3|||
129869837|NCT00636610|467479023|FG000|Overall Study|Physician decision to withdraw patient|15|||
129869838|NCT00636610|467479024|FG001|Overall Study|Physician decision to withdraw patient|9|||
129869839|NCT00636610|467479023|FG000|Overall Study|Subject decision to withdraw|15|||
129869840|NCT00636610|467479024|FG001|Overall Study|Subject decision to withdraw|11|||
129869841|NCT00636610|467479023|FG000|Overall Study|Disease progression - radiographic|41|||
129917494|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Death|0|||
129917495|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
129917496|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
129917497|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
129917498|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
129917499|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
129917500|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
129917501|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
129917502|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
129917503|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
129917504|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
129917505|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Other|0|||
129917506|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Other|0|||
129917507|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Other|1|||
129917508|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Other|0|||
129917509|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Other|0|||
129917510|NCT03932682|467663117|FG000|Overall Study|Death|1|||
129917511|NCT03932682|467663118|FG001|Overall Study|Death|2|||
129917512|NCT03932682|467663117|FG000|Overall Study|Withdrawal by Subject|37|||
129917513|NCT03932682|467663118|FG001|Overall Study|Withdrawal by Subject|45|||
129917514|NCT03932682|467663117|FG000|Overall Study|Lost to Follow-up|19|||
129917515|NCT03932682|467663118|FG001|Overall Study|Lost to Follow-up|25|||
129917516|NCT03932682|467663117|FG000|Overall Study|Protocol Violation|0|||
129917517|NCT03932682|467663118|FG001|Overall Study|Protocol Violation|2|||
129917518|NCT03932682|467663117|FG000|Overall Study|Other|9|||
129869842|NCT00636610|467479024|FG001|Overall Study|Disease progression - radiographic|51|||
129869843|NCT00636610|467479023|FG000|Overall Study|Disease progression - clinical|8|||
129869844|NCT00636610|467479024|FG001|Overall Study|Disease progression - clinical|3|||
129869845|NCT00636610|467479023|FG000|Overall Study|Reason for discontinuation not available|3|||
129869846|NCT00636610|467479024|FG001|Overall Study|Reason for discontinuation not available|2|||
129869847|NCT00553696|467479032|FG000|Overall Study|Adverse Event|2|||
129869848|NCT00553696|467479033|FG001|Overall Study|Adverse Event|4|||
129869849|NCT00553696|467479034|FG002|Overall Study|Adverse Event|0|||
129869850|NCT00553696|467479035|FG003|Overall Study|Adverse Event|1|||
129869851|NCT00553696|467479032|FG000|Overall Study|Global deterioration of health status|0|||
129869852|NCT00553696|467479033|FG001|Overall Study|Global deterioration of health status|2|||
129869853|NCT00553696|467479034|FG002|Overall Study|Global deterioration of health status|0|||
129869854|NCT00553696|467479035|FG003|Overall Study|Global deterioration of health status|0|||
129869855|NCT00553696|467479032|FG000|Overall Study|Objective progression or relapse|2|||
129869856|NCT00553696|467479033|FG001|Overall Study|Objective progression or relapse|9|||
129869857|NCT00553696|467479034|FG002|Overall Study|Objective progression or relapse|6|||
129869858|NCT00553696|467479035|FG003|Overall Study|Objective progression or relapse|0|||
129869859|NCT00553696|467479032|FG000|Overall Study|Withdrawal by Subject|0|||
129869860|NCT00553696|467479033|FG001|Overall Study|Withdrawal by Subject|1|||
129869861|NCT00553696|467479034|FG002|Overall Study|Withdrawal by Subject|0|||
129869862|NCT00553696|467479035|FG003|Overall Study|Withdrawal by Subject|0|||
129869863|NCT00686881|467479036|FG000|Overall Study|Withdrawal by Subject|11|||
129869864|NCT00686881|467479037|FG001|Overall Study|Withdrawal by Subject|18|||
129869865|NCT00686881|467479036|FG000|Overall Study|Lost to Follow-up|0|||
129869866|NCT00686881|467479037|FG001|Overall Study|Lost to Follow-up|1|||
129869867|NCT00686881|467479036|FG000|Overall Study|Treatment-related adverse event|10|||
129869868|NCT00686881|467479037|FG001|Overall Study|Treatment-related adverse event|9|||
129869869|NCT00686881|467479036|FG000|Overall Study|Met discontinuation criteria|5|||
129869870|NCT00686881|467479037|FG001|Overall Study|Met discontinuation criteria|0|||
129869871|NCT00686881|467479036|FG000|Overall Study|Onset of malignant tumor|11|||
129869872|NCT00686881|467479037|FG001|Overall Study|Onset of malignant tumor|11|||
129869873|NCT00686881|467479036|FG000|Overall Study|Lack of Efficacy|4|||
129869874|NCT00686881|467479037|FG001|Overall Study|Lack of Efficacy|3|||
129869875|NCT00686881|467479036|FG000|Overall Study|Physician Decision|1|||
129869876|NCT00686881|467479037|FG001|Overall Study|Physician Decision|0|||
129917519|NCT03932682|467663118|FG001|Overall Study|Other|23|||
129869877|NCT00686881|467479036|FG000|Overall Study|Circumstances of site|1|||
129869878|NCT00686881|467479037|FG001|Overall Study|Circumstances of site|1|||
129869879|NCT00686881|467479036|FG000|Overall Study|Did not meet protocol eligibility|1|||
129869880|NCT00686881|467479037|FG001|Overall Study|Did not meet protocol eligibility|0|||
129869881|NCT00686881|467479036|FG000|Overall Study|Irregular visits|1|||
129869882|NCT00686881|467479037|FG001|Overall Study|Irregular visits|0|||
129917520|NCT03126019|467663124|FG000|Overall Study|Death|5|||
129917521|NCT03126019|467663125|FG001|Overall Study|Death|27|||
129917522|NCT03126019|467663124|FG000|Overall Study|Lost to Follow-up|2|||
129917523|NCT03126019|467663125|FG001|Overall Study|Lost to Follow-up|4|||
129869883|NCT00686881|467479036|FG000|Overall Study|Study discontinuation|35|||
129917524|NCT03126019|467663124|FG000|Overall Study|Withdrawal by Subject|1|||
129917525|NCT03126019|467663125|FG001|Overall Study|Withdrawal by Subject|9|||
129917526|NCT03126019|467663124|FG000|Overall Study|Physician Decision|1|||
130066313|NCT01309841|468197797|FG000|Overall Study|Did Not Receive Treatment|2|||
130066314|NCT01309841|468197798|FG001|Overall Study|Did Not Receive Treatment|0|||
130066315|NCT01309841|468197799|FG002|Overall Study|Did Not Receive Treatment|1|||
130066316|NCT01309841|468197797|FG000|Overall Study|Severe non-compliance with protocol|0|||
130066317|NCT01309841|468197798|FG001|Overall Study|Severe non-compliance with protocol|5|||
130066318|NCT01309841|468197799|FG002|Overall Study|Severe non-compliance with protocol|2|||
130066319|NCT03699631|468197800|FG000|Overall Study|Adverse Event|3|||
130066320|NCT01324622|468197801|FG000|Overall Study|Lost to Follow-up|7|||
130066321|NCT01324622|468197802|FG001|Overall Study|Lost to Follow-up|7|||
130066322|NCT01324622|468197801|FG000|Overall Study|Death|1|||
130066323|NCT01324622|468197802|FG001|Overall Study|Death|0|||
130066324|NCT01324622|468197801|FG000|Overall Study|Lack of Efficacy|1|||
130116748|NCT00818623|468387165|FG001|Overall Study|Lack of trial drug at site|0|||
130116749|NCT00818623|468387166|FG002|Overall Study|Lack of trial drug at site|0|||
129869884|NCT00686881|467479037|FG001|Overall Study|Study discontinuation|32|||
129869885|NCT00686881|467479036|FG000|Overall Study|Never received study drug|2|||
129869886|NCT00686881|467479037|FG001|Overall Study|Never received study drug|6|||
129869887|NCT05899686|467479038|FG000|Overall Study|Protocol Violation|1|||
129869888|NCT02170025|467479039|FG000|Overall Study|Adverse Event|2|||
129869889|NCT02170025|467479040|FG001|Overall Study|Adverse Event|0|||
129869890|NCT00572195|467479041|FG000|Overall Study|Withdrawal by Subject|50|||
129869891|NCT00572195|467479041|FG000|Overall Study|Death|9|||
129869892|NCT00572195|467479041|FG000|Overall Study|Adverse Event|4|||
129869893|NCT00572195|467479041|FG000|Overall Study|Lost to Follow-up|5|||
129869894|NCT03657277|467479042|FG000|Overall Study|Physician Decision|2|||
129869895|NCT03657277|467479042|FG000|Overall Study|Lost to Follow-up|1|||
129869896|NCT03657277|467479042|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
129869897|NCT04349280|467479043|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
129869898|NCT04349280|467479044|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
129869899|NCT04349280|467479043|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
129869900|NCT04349280|467479044|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
129869901|NCT04349280|467479043|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
129869902|NCT04349280|467479044|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
129869903|NCT00657618|467479045|FG000|Overall Study|Adverse Event|32|||
129869904|NCT00657618|467479045|FG000|Overall Study|Withdrawal by Subject|8|||
129869905|NCT00657618|467479045|FG000|Overall Study|negative for leishmaniasis|2|||
129869906|NCT00657618|467479045|FG000|Overall Study|didn't start due to schedule conflicts|1|||
129869907|NCT04981678|467479046|FG000|Overall Study|Lost to Follow-up|0|||
129869908|NCT04981678|467479047|FG001|Overall Study|Lost to Follow-up|1|||
129869909|NCT04922554|467479048|FG000|Overall Study|Adverse Event|4|||
129869910|NCT04922554|467479049|FG001|Overall Study|Adverse Event|0|||
129869911|NCT04922554|467479048|FG000|Overall Study|Withdrawal by Subject|1|||
129869912|NCT04922554|467479049|FG001|Overall Study|Withdrawal by Subject|0|||
129869913|NCT03597568|467480615|FG000|Overall Study|Withdrawal by Subject|1|||
129869914|NCT03597568|467480616|FG001|Overall Study|Withdrawal by Subject|1|||
129869915|NCT03597568|467480615|FG000|Overall Study|Unable to analyze vascular data|1|||
129869916|NCT03597568|467480616|FG001|Overall Study|Unable to analyze vascular data|1|||
129869917|NCT02052310|467480617|FG000|Overall Study|Death|64|||
129869918|NCT02052310|467480618|FG001|Overall Study|Death|54|||
129869919|NCT02052310|467480617|FG000|Overall Study|Withdrawal by Subject|37|||
129869920|NCT02052310|467480618|FG001|Overall Study|Withdrawal by Subject|49|||
129869921|NCT02052310|467480617|FG000|Overall Study|Other than specified|32|||
129869922|NCT02052310|467480618|FG001|Overall Study|Other than specified|29|||
129869923|NCT02052310|467480617|FG000|Overall Study|Adverse Event|29|||
129869924|NCT02052310|467480618|FG001|Overall Study|Adverse Event|22|||
129869925|NCT02052310|467480617|FG000|Overall Study|Kidney Transplant|23|||
129869926|NCT02052310|467480618|FG001|Overall Study|Kidney Transplant|29|||
129869927|NCT02052310|467480617|FG000|Overall Study|Physician Decision|14|||
129869928|NCT02052310|467480618|FG001|Overall Study|Physician Decision|7|||
129869929|NCT02052310|467480617|FG000|Overall Study|Lack of Efficacy|6|||
129869930|NCT02052310|467480618|FG001|Overall Study|Lack of Efficacy|1|||
129869931|NCT02052310|467480617|FG000|Overall Study|Site Terminated by Sponsor|5|||
129869932|NCT02052310|467480618|FG001|Overall Study|Site Terminated by Sponsor|13|||
129869933|NCT02052310|467480617|FG000|Overall Study|Lost to Follow-up|4|||
129869934|NCT02052310|467480618|FG001|Overall Study|Lost to Follow-up|2|||
129869935|NCT02052310|467480617|FG000|Overall Study|Protocol Violation|1|||
129869936|NCT02052310|467480618|FG001|Overall Study|Protocol Violation|6|||
129869937|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
129869938|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
129869939|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
129869940|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
129869941|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
129869942|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
130066325|NCT01324622|468197802|FG001|Overall Study|Lack of Efficacy|0|||
130066326|NCT00138424|468197803|FG000|Overall Study|Physician Decision|0|||
129869943|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
129869944|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
129869945|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Other|18|||
129869946|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
129869947|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
129869948|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Other|1|||
129869949|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
129869950|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
129869951|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
129869952|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
129869953|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
129869954|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
129869955|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
129869956|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
129869957|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
130066327|NCT00138424|468197804|FG001|Overall Study|Physician Decision|1|||
130066328|NCT00138424|468197805|FG002|Overall Study|Physician Decision|0|||
130066329|NCT00138424|468197806|FG003|Overall Study|Physician Decision|0|||
130066330|NCT00413062|468197807|FG000|Overall Study|Adverse event/serious adverse event|289|||
130066331|NCT00413062|468197808|FG001|Overall Study|Adverse event/serious adverse event|56|||
130066332|NCT00413062|468197807|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
130066333|NCT00413062|468197808|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
130066334|NCT00413062|468197807|FG000|Overall Study|Withdrawal of informed consent|111|||
130066335|NCT00413062|468197808|FG001|Overall Study|Withdrawal of informed consent|36|||
130066336|NCT00413062|468197807|FG000|Overall Study|Pregnancy|15|||
130066337|NCT00413062|468197808|FG001|Overall Study|Pregnancy|5|||
130066338|NCT00413062|468197807|FG000|Overall Study|Pregnancy wish|17|||
130066339|NCT00413062|468197808|FG001|Overall Study|Pregnancy wish|6|||
130066340|NCT00413062|468197807|FG000|Overall Study|Lost to Follow-up|175|||
130066341|NCT00413062|468197808|FG001|Overall Study|Lost to Follow-up|73|||
130066342|NCT00413062|468197807|FG000|Overall Study|Other reason|70|||
130066343|NCT00413062|468197808|FG001|Overall Study|Other reason|34|||
130066344|NCT02176291|468197809|FG000|Overall Study|Death|1|||
130066345|NCT02176291|468197810|FG001|Overall Study|Death|0|||
130066346|NCT02176291|468197809|FG000|Overall Study|non compliance with protocol|2|||
130066347|NCT02176291|468197810|FG001|Overall Study|non compliance with protocol|0|||
130066348|NCT02176291|468197809|FG000|Overall Study|Withdrawal by Subject|2|||
130066349|NCT02176291|468197810|FG001|Overall Study|Withdrawal by Subject|0|||
130066350|NCT02815293|468197813|FG000|Overall Study|Study termination by sponsor|10|||
130066351|NCT02815293|468197814|FG001|Overall Study|Study termination by sponsor|7|||
130066352|NCT02815293|468197815|FG002|Overall Study|Study termination by sponsor|0|||
130066353|NCT02815293|468197813|FG000|Overall Study|Participants not randomized|0|||
130066354|NCT02815293|468197814|FG001|Overall Study|Participants not randomized|0|||
130116750|NCT00818623|468387167|FG003|Overall Study|Lack of trial drug at site|0|||
129869958|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
129869959|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
129869960|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
129869961|NCT01505387|467480620|FG000|Overall Study|Protocol Violation|1|||
129869962|NCT01505387|467480621|FG001|Overall Study|Protocol Violation|0|||
129869963|NCT01505387|467480620|FG000|Overall Study|Withdrawal by Subject|1|||
129869964|NCT01505387|467480621|FG001|Overall Study|Withdrawal by Subject|1|||
129869965|NCT01197508|467480628|FG000|Overall Study|Withdrawal by Subject|8|||
129869966|NCT01197508|467480629|FG001|Overall Study|Withdrawal by Subject|7|||
129869967|NCT01197508|467480630|FG002|Overall Study|Withdrawal by Subject|15|||
129869968|NCT01197508|467480631|FG003|Overall Study|Withdrawal by Subject|4|||
129869969|NCT01197508|467480628|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
129869970|NCT01197508|467480629|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
129869971|NCT01197508|467480630|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
129869972|NCT01197508|467480631|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
129869973|NCT01197508|467480628|FG000|Overall Study|Adverse Event|10|||
129869974|NCT01197508|467480629|FG001|Overall Study|Adverse Event|13|||
129869975|NCT01197508|467480630|FG002|Overall Study|Adverse Event|23|||
129869976|NCT01197508|467480631|FG003|Overall Study|Adverse Event|3|||
129869977|NCT01197508|467480628|FG000|Overall Study|Severe non-compliance to protocol|0|||
129869978|NCT01197508|467480629|FG001|Overall Study|Severe non-compliance to protocol|3|||
129869979|NCT01197508|467480630|FG002|Overall Study|Severe non-compliance to protocol|1|||
129869980|NCT01197508|467480631|FG003|Overall Study|Severe non-compliance to protocol|3|||
129869981|NCT01197508|467480628|FG000|Overall Study|Condition under investigation worsened|1|||
129869982|NCT01197508|467480629|FG001|Overall Study|Condition under investigation worsened|1|||
129869983|NCT01197508|467480630|FG002|Overall Study|Condition under investigation worsened|1|||
130066355|NCT02815293|468197815|FG002|Overall Study|Participants not randomized|18|||
130066356|NCT02815293|468197813|FG000|Overall Study|Adverse Event|0|||
130066357|NCT02815293|468197814|FG001|Overall Study|Adverse Event|1|||
130066358|NCT02815293|468197815|FG002|Overall Study|Adverse Event|0|||
130066359|NCT00006604|468197816|FG000|Overall Study|Met study objective - no further FU|1|||
130066360|NCT00006604|468197817|FG001|Overall Study|Met study objective - no further FU|0|||
130066361|NCT00006604|468197818|FG002|Overall Study|Met study objective - no further FU|0|||
130066362|NCT00006604|468197819|FG003|Overall Study|Met study objective - no further FU|0|||
130066363|NCT00006604|468197820|FG004|Overall Study|Met study objective - no further FU|0|||
130066364|NCT00006604|468197821|FG005|Overall Study|Met study objective - no further FU|0|||
130066365|NCT00006604|468197822|FG006|Overall Study|Met study objective - no further FU|0|||
130066366|NCT00006604|468197823|FG007|Overall Study|Met study objective - no further FU|0|||
130066367|NCT00006604|468197824|FG008|Overall Study|Met study objective - no further FU|0|||
130066368|NCT00006604|468197825|FG009|Overall Study|Met study objective - no further FU|0|||
130066369|NCT00006604|468197826|FG010|Overall Study|Met study objective - no further FU|0|||
130066370|NCT00006604|468197827|FG011|Overall Study|Met study objective - no further FU|0|||
130066371|NCT00006604|468197828|FG012|Overall Study|Met study objective - no further FU|0|||
130066372|NCT00006604|468197829|FG013|Overall Study|Met study objective - no further FU|0|||
130066373|NCT00006604|468197830|FG014|Overall Study|Met study objective - no further FU|1|||
130066374|NCT00006604|468197831|FG015|Overall Study|Met study objective - no further FU|1|||
130066375|NCT00006604|468197832|FG016|Overall Study|Met study objective - no further FU|0|||
130066376|NCT00006604|468197816|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
130066377|NCT00006604|468197817|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
130066378|NCT00006604|468197818|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
130066379|NCT00006604|468197819|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
130066380|NCT00006604|468197820|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
130066381|NCT00006604|468197821|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
130066382|NCT00006604|468197822|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
130066383|NCT00006604|468197823|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
130116751|NCT00818623|468387168|FG004|Overall Study|Lack of trial drug at site|2|||
130116752|NCT00818623|468387169|FG005|Overall Study|Lack of trial drug at site|0|||
130116753|NCT00818623|468387170|FG006|Overall Study|Lack of trial drug at site|1|||
130116754|NCT00818623|468387171|FG007|Overall Study|Lack of trial drug at site|0|||
129869984|NCT01197508|467480631|FG003|Overall Study|Condition under investigation worsened|1|||
129869985|NCT01197508|467480628|FG000|Overall Study|Lack of Efficacy|1|||
129869986|NCT01197508|467480629|FG001|Overall Study|Lack of Efficacy|2|||
129869987|NCT01197508|467480630|FG002|Overall Study|Lack of Efficacy|2|||
129869988|NCT01197508|467480631|FG003|Overall Study|Lack of Efficacy|1|||
129869989|NCT01197508|467480628|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129917527|NCT03126019|467663125|FG001|Overall Study|Physician Decision|0|||
129917528|NCT03126019|467663124|FG000|Overall Study|Transitioned to Rollover Study|0|||
129917529|NCT03126019|467663125|FG001|Overall Study|Transitioned to Rollover Study|11|||
129917530|NCT03126019|467663124|FG000|Overall Study|Did Not Return to Site for Care|0|||
129917531|NCT03126019|467663125|FG001|Overall Study|Did Not Return to Site for Care|1|||
129917532|NCT03126019|467663124|FG000|Overall Study|Site Closed|0|||
129917533|NCT03126019|467663125|FG001|Overall Study|Site Closed|1|||
129917534|NCT01566695|467663126|FG000|Overall Study|Lack of Efficacy|1|||
129917535|NCT01566695|467663127|FG001|Overall Study|Lack of Efficacy|0|||
129917536|NCT01566695|467663126|FG000|Overall Study|Adverse Event|3|||
129917537|NCT01566695|467663127|FG001|Overall Study|Adverse Event|0|||
129869990|NCT01197508|467480629|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129869991|NCT01197508|467480630|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129869992|NCT01197508|467480631|FG003|Overall Study|Study-specific withdrawal criteria|2|||
129869993|NCT01197508|467480628|FG000|Overall Study|Lost to Follow-up|1|||
129869994|NCT01197508|467480629|FG001|Overall Study|Lost to Follow-up|1|||
129869995|NCT01197508|467480630|FG002|Overall Study|Lost to Follow-up|2|||
129869996|NCT01197508|467480631|FG003|Overall Study|Lost to Follow-up|0|||
129869997|NCT01197508|467480628|FG000|Overall Study|Other|2|||
129869998|NCT01197508|467480629|FG001|Overall Study|Other|3|||
129869999|NCT01197508|467480630|FG002|Overall Study|Other|2|||
129870000|NCT01197508|467480631|FG003|Overall Study|Other|2|||
129870001|NCT00266825|467480632|FG000|Completed Follow-Up|Lost to Follow-up|14|||
129870002|NCT00266825|467480633|FG001|Completed Follow-Up|Lost to Follow-up|19|||
129870003|NCT00266825|467480632|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
129870004|NCT00266825|467480633|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
129917538|NCT01566695|467663126|FG000|Overall Study|Death|79|||
129917539|NCT01566695|467663127|FG001|Overall Study|Death|86|||
129917540|NCT01566695|467663126|FG000|Overall Study|Withdrawal by Subject|13|||
129870005|NCT01301391|467480636|FG000|Overall Study|Death|13|||
129917541|NCT01566695|467663127|FG001|Overall Study|Withdrawal by Subject|12|||
129870006|NCT01301391|467480636|FG000|Overall Study|Lost to Follow-up|3|||
129917542|NCT01566695|467663126|FG000|Overall Study|Lost to Follow-up|0|||
129917543|NCT01566695|467663127|FG001|Overall Study|Lost to Follow-up|3|||
129917544|NCT01566695|467663126|FG000|Overall Study|Other reasons|11|||
129917545|NCT01566695|467663127|FG001|Overall Study|Other reasons|8|||
130066384|NCT00006604|468197824|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
130066385|NCT00006604|468197825|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
129917546|NCT05956002|467663128|FG000|Treatment Period 3|Adverse Event|0|||
130066386|NCT00006604|468197826|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
130066387|NCT00006604|468197827|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
130066388|NCT00006604|468197828|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
130066389|NCT00006604|468197829|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
130066390|NCT00006604|468197830|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
130066391|NCT00006604|468197831|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
130066392|NCT00006604|468197832|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
130066393|NCT00006604|468197816|FG000|Overall Study|Death|0|||
130066394|NCT00006604|468197817|FG001|Overall Study|Death|0|||
130066395|NCT00006604|468197818|FG002|Overall Study|Death|0|||
130066396|NCT00006604|468197819|FG003|Overall Study|Death|0|||
130066397|NCT00006604|468197820|FG004|Overall Study|Death|0|||
130066398|NCT00006604|468197821|FG005|Overall Study|Death|0|||
130066399|NCT00006604|468197822|FG006|Overall Study|Death|0|||
130066400|NCT00006604|468197823|FG007|Overall Study|Death|0|||
130066401|NCT00006604|468197824|FG008|Overall Study|Death|0|||
130066402|NCT00006604|468197825|FG009|Overall Study|Death|1|||
130066403|NCT00006604|468197826|FG010|Overall Study|Death|1|||
130066404|NCT00006604|468197827|FG011|Overall Study|Death|1|||
130066405|NCT00006604|468197828|FG012|Overall Study|Death|0|||
130066406|NCT00006604|468197829|FG013|Overall Study|Death|0|||
130066407|NCT00006604|468197830|FG014|Overall Study|Death|0|||
130066408|NCT00006604|468197831|FG015|Overall Study|Death|0|||
130066409|NCT00006604|468197832|FG016|Overall Study|Death|0|||
130066410|NCT00006604|468197816|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130066411|NCT00006604|468197817|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130066412|NCT00006604|468197818|FG002|Overall Study|Severe debilitation, unable to continue|0|||
130066413|NCT00006604|468197819|FG003|Overall Study|Severe debilitation, unable to continue|0|||
130066414|NCT00006604|468197820|FG004|Overall Study|Severe debilitation, unable to continue|0|||
130066415|NCT00006604|468197821|FG005|Overall Study|Severe debilitation, unable to continue|0|||
130066416|NCT00006604|468197822|FG006|Overall Study|Severe debilitation, unable to continue|3|||
130066417|NCT00006604|468197823|FG007|Overall Study|Severe debilitation, unable to continue|0|||
130066418|NCT00006604|468197824|FG008|Overall Study|Severe debilitation, unable to continue|0|||
130066419|NCT00006604|468197825|FG009|Overall Study|Severe debilitation, unable to continue|5|||
130066420|NCT00006604|468197826|FG010|Overall Study|Severe debilitation, unable to continue|0|||
130066421|NCT00006604|468197827|FG011|Overall Study|Severe debilitation, unable to continue|2|||
130066422|NCT00006604|468197828|FG012|Overall Study|Severe debilitation, unable to continue|1|||
130066423|NCT00006604|468197829|FG013|Overall Study|Severe debilitation, unable to continue|0|||
130066424|NCT00006604|468197830|FG014|Overall Study|Severe debilitation, unable to continue|2|||
130066425|NCT00006604|468197831|FG015|Overall Study|Severe debilitation, unable to continue|0|||
130066426|NCT00006604|468197832|FG016|Overall Study|Severe debilitation, unable to continue|0|||
130066427|NCT00006604|468197816|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
130066428|NCT00006604|468197817|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
130066429|NCT00006604|468197818|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
130066430|NCT00006604|468197819|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
130066431|NCT00006604|468197820|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
130066432|NCT00006604|468197821|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
130066433|NCT00006604|468197822|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
129870007|NCT01301391|467480636|FG000|Overall Study|Physician Decision|2|||
129870008|NCT01301391|467480636|FG000|Overall Study|Sponsor's decision|8|||
129870009|NCT02799784|467480640|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
129870010|NCT02799784|467480641|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
129870011|NCT02799784|467480640|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
129870012|NCT02799784|467480641|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
129870013|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
129870014|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
129870015|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
129870016|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
129870017|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
129870018|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
130066434|NCT00006604|468197823|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
130066435|NCT00006604|468197824|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
130066436|NCT00006604|468197825|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
130066437|NCT00006604|468197826|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
129870019|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
129870020|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
130066438|NCT00006604|468197827|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
130066439|NCT00006604|468197828|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
130066440|NCT00006604|468197829|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
130066441|NCT00006604|468197830|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
129917547|NCT05956002|467663129|FG001|Treatment Period 3|Adverse Event|0|||
129917548|NCT05956002|467663130|FG002|Treatment Period 3|Adverse Event|1|||
129917549|NCT05956002|467663131|FG003|Treatment Period 3|Adverse Event|0|||
129917550|NCT02281955|467663134|FG000|Overall Study|Death|1|||
129870021|NCT02570126|467480646|FG000|Overall Study|Lost to Follow-up|2|||
129870022|NCT02570126|467480647|FG001|Overall Study|Lost to Follow-up|0|||
129870023|NCT02570126|467480646|FG000|Overall Study|Unable To Arrange Visit 3|1|||
129870024|NCT02570126|467480647|FG001|Overall Study|Unable To Arrange Visit 3|0|||
129870025|NCT02570126|467480646|FG000|Overall Study|Violation Of Procedures GSK|0|||
129870026|NCT02570126|467480647|FG001|Overall Study|Violation Of Procedures GSK|1|||
129870027|NCT02570126|467480646|FG000|Overall Study|Protocol Violation|0|||
129870028|NCT02570126|467480647|FG001|Overall Study|Protocol Violation|1|||
129870029|NCT02570126|467480646|FG000|Overall Study|Withdrawal by Subject|3|||
129870030|NCT02570126|467480647|FG001|Overall Study|Withdrawal by Subject|7|||
129870031|NCT00917579|467480648|FG000|Washout >= 2 Weeks|Adverse Event|1|||
129870032|NCT00917579|467480649|FG001|Washout >= 2 Weeks|Adverse Event|0|||
129870033|NCT00917579|467480648|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
129870034|NCT00917579|467480649|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
129870035|NCT00754338|467480650|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870036|NCT00754338|467480651|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
129870037|NCT00754338|467480652|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
129870038|NCT00754338|467480653|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870039|NCT00754338|467480650|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870040|NCT00754338|467480651|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
129870041|NCT00754338|467480652|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870042|NCT00754338|467480653|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
129917551|NCT00378105|467663140|FG000|Overall Study|Adverse Event|3|||
129917552|NCT00378105|467663141|FG001|Overall Study|Adverse Event|1|||
129917553|NCT00378105|467663140|FG000|Overall Study|Withdrawal by Subject|3|||
129917554|NCT00378105|467663141|FG001|Overall Study|Withdrawal by Subject|3|||
129917555|NCT00378105|467663140|FG000|Overall Study|Death|1|||
129917556|NCT00378105|467663141|FG001|Overall Study|Death|0|||
129917557|NCT00378105|467663140|FG000|Overall Study|Going to transplant|7|||
129917558|NCT00378105|467663141|FG001|Overall Study|Going to transplant|8|||
129917559|NCT00378105|467663140|FG000|Overall Study|Progressive disease|3|||
129917560|NCT00378105|467663141|FG001|Overall Study|Progressive disease|3|||
129917561|NCT00378105|467663140|FG000|Overall Study|remain on study|3|||
129917562|NCT00378105|467663141|FG001|Overall Study|remain on study|11|||
129917563|NCT00378105|467663140|FG000|Overall Study|Physician Decision|0|||
129917564|NCT00378105|467663141|FG001|Overall Study|Physician Decision|2|||
129917565|NCT00378105|467663140|FG000|Overall Study|Going non-protocol therapy|0|||
129917566|NCT00378105|467663141|FG001|Overall Study|Going non-protocol therapy|1|||
129917567|NCT00378105|467663140|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
129917568|NCT00378105|467663141|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
129917569|NCT05192200|467663142|FG000|Treatment Period|Other|1|||
129917570|NCT05192200|467663142|FG000|Treatment Period|Lack of Efficacy|1|||
129917571|NCT05192200|467663142|FG000|Treatment Period|Withdrawal by Subject|1|||
129917572|NCT05192200|467663142|FG000|Follow-up|Withdrawal by Subject|1|||
129917573|NCT04533347|467663145|FG000|Overall Study|Adverse Event|1|||
129917574|NCT04533347|467663146|FG001|Overall Study|Adverse Event|2|||
129917575|NCT04533347|467663145|FG000|Overall Study|Lost to Follow-up|2|||
129917576|NCT04533347|467663146|FG001|Overall Study|Lost to Follow-up|0|||
129917577|NCT04533347|467663145|FG000|Overall Study|Withdrawal by Subject|1|||
129917578|NCT04533347|467663146|FG001|Overall Study|Withdrawal by Subject|0|||
129917579|NCT03907397|467663147|FG000|Overall Study|Lost to Follow-up|0|||
129917580|NCT03907397|467663148|FG001|Overall Study|Lost to Follow-up|1|||
129917581|NCT03907397|467663147|FG000|Overall Study|Physician Decision|2|||
129917582|NCT03907397|467663148|FG001|Overall Study|Physician Decision|1|||
129917583|NCT03907397|467663147|FG000|Overall Study|Withdrawal by Subject|5|||
129917584|NCT03907397|467663148|FG001|Overall Study|Withdrawal by Subject|4|||
129917585|NCT03907397|467663147|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
129917586|NCT03907397|467663148|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
129870043|NCT04385368|467480662|FG000|Overall Study|Death|5|||
129870044|NCT04385368|467480663|FG001|Overall Study|Death|5|||
129870045|NCT04385368|467480662|FG000|Overall Study|Physician Decision|3|||
129870046|NCT04385368|467480663|FG001|Overall Study|Physician Decision|0|||
129917587|NCT00220740|467663154|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
129917588|NCT00220740|467663155|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
130116755|NCT00818623|468387164|FG000|Overall Study|Disease progression|0|||
130116756|NCT00818623|468387165|FG001|Overall Study|Disease progression|0|||
129917589|NCT00220740|467663154|FG000|Efficacy Period|Adverse Event|1|||
129917590|NCT00220740|467663155|FG001|Efficacy Period|Adverse Event|1|||
129917591|NCT00220740|467663154|FG000|Efficacy Period|Withdrawal by Subject|1|||
129917592|NCT00220740|467663155|FG001|Efficacy Period|Withdrawal by Subject|0|||
129917593|NCT00220740|467663154|FG000|Efficacy Period|Protocol Violation|1|||
130116757|NCT00818623|468387166|FG002|Overall Study|Disease progression|0|||
130066442|NCT00006604|468197831|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
130066443|NCT00006604|468197832|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
130066444|NCT00006604|468197816|FG000|Overall Study|Site closing|0|||
130066445|NCT00006604|468197817|FG001|Overall Study|Site closing|0|||
130066446|NCT00006604|468197818|FG002|Overall Study|Site closing|1|||
130066447|NCT00006604|468197819|FG003|Overall Study|Site closing|1|||
130066448|NCT00006604|468197820|FG004|Overall Study|Site closing|0|||
130066449|NCT00006604|468197821|FG005|Overall Study|Site closing|0|||
129870047|NCT04385368|467480662|FG000|Overall Study|Withdrawal by Subject|4|||
129870048|NCT04385368|467480663|FG001|Overall Study|Withdrawal by Subject|3|||
129870049|NCT02740049|467480665|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
129870050|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
129870051|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
129870052|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
129870053|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
129870054|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
129870055|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
129870056|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
129870057|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
129870058|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870059|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870060|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870061|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870062|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
129870063|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
129870064|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
129870065|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
129870066|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
129870067|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
129870068|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
129870069|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870070|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
129870071|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870072|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870073|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870074|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Adverse Event|4|||
129870075|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Adverse Event|2|||
129870076|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Adverse Event|1|||
129870077|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Adverse Event|0|||
129870078|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Adverse Event|0|||
129870079|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Adverse Event|0|||
129870080|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870081|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870082|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870083|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870084|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
129870085|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
129870086|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870087|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870088|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870089|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870090|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870091|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
129870092|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870093|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870094|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870095|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870096|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
129870097|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870098|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870099|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870100|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870101|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870102|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
129917594|NCT00220740|467663155|FG001|Efficacy Period|Protocol Violation|0|||
129917595|NCT00220740|467663154|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
130066450|NCT00006604|468197822|FG006|Overall Study|Site closing|0|||
130066451|NCT00006604|468197823|FG007|Overall Study|Site closing|1|||
130066452|NCT00006604|468197824|FG008|Overall Study|Site closing|0|||
130066453|NCT00006604|468197825|FG009|Overall Study|Site closing|0|||
130066454|NCT00006604|468197826|FG010|Overall Study|Site closing|0|||
130066455|NCT00006604|468197827|FG011|Overall Study|Site closing|1|||
130066456|NCT00006604|468197828|FG012|Overall Study|Site closing|1|||
130066457|NCT00006604|468197829|FG013|Overall Study|Site closing|1|||
130066458|NCT00006604|468197830|FG014|Overall Study|Site closing|0|||
130066459|NCT00006604|468197831|FG015|Overall Study|Site closing|0|||
130066460|NCT00006604|468197832|FG016|Overall Study|Site closing|1|||
130066461|NCT00006604|468197816|FG000|Overall Study|Withdrawal by Subject|1|||
130066462|NCT00006604|468197817|FG001|Overall Study|Withdrawal by Subject|0|||
130066463|NCT00006604|468197818|FG002|Overall Study|Withdrawal by Subject|2|||
130066464|NCT00006604|468197819|FG003|Overall Study|Withdrawal by Subject|0|||
130116758|NCT00818623|468387167|FG003|Overall Study|Disease progression|0|||
129870103|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
129870104|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870105|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870106|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870107|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870108|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
129870109|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
129870110|NCT02316769|467480672|FG000|Overall Study|Physician Decision|1|||
129870111|NCT02316769|467480673|FG001|Overall Study|Physician Decision|0|||
129870112|NCT02316769|467480672|FG000|Overall Study|Withdrawal by Subject|1|||
129870113|NCT02316769|467480673|FG001|Overall Study|Withdrawal by Subject|0|||
129870114|NCT02054806|467480674|FG000|Overall Study|Sponsor Decision|31|||
129870115|NCT02054806|467480674|FG000|Overall Study|Withdrawal by Subject|43|||
129870116|NCT02054806|467480674|FG000|Overall Study|Protocol Violation|2|||
129870117|NCT02054806|467480674|FG000|Overall Study|Lost to Follow-up|10|||
129870118|NCT02054806|467480674|FG000|Overall Study|Death|391|||
129870119|NCT04721925|467480675|FG000|2-Month Assessment|Lost to Follow-up|5|||
129870120|NCT04721925|467480676|FG001|2-Month Assessment|Lost to Follow-up|3|||
129870121|NCT04721925|467480675|FG000|4-Month Assessment|Lost to Follow-up|3|||
129870122|NCT04721925|467480676|FG001|4-Month Assessment|Lost to Follow-up|6|||
129870123|NCT01113502|467480680|FG000|Overall Study|Withdrawal by Subject|1|||
129870124|NCT01113502|467480681|FG001|Overall Study|Withdrawal by Subject|0|||
129870125|NCT01113502|467480682|FG002|Overall Study|Withdrawal by Subject|1|||
129870126|NCT01113502|467480683|FG003|Overall Study|Withdrawal by Subject|1|||
129870127|NCT01113502|467480684|FG004|Overall Study|Withdrawal by Subject|0|||
129870128|NCT01113502|467480680|FG000|Overall Study|Adverse Event|0|||
129870129|NCT01113502|467480681|FG001|Overall Study|Adverse Event|0|||
129870130|NCT01113502|467480682|FG002|Overall Study|Adverse Event|3|||
129870131|NCT01113502|467480683|FG003|Overall Study|Adverse Event|2|||
129870132|NCT01113502|467480684|FG004|Overall Study|Adverse Event|0|||
129870133|NCT04535947|467480695|FG000|Overall Study|Adverse Event|1|||
129870134|NCT04535947|467480696|FG001|Overall Study|Adverse Event|4|||
129870135|NCT04535947|467480695|FG000|Overall Study|Other reasons not specified|2|||
129870136|NCT04535947|467480696|FG001|Overall Study|Other reasons not specified|0|||
129870137|NCT04535947|467480695|FG000|Overall Study|Withdrawal by Subject|1|||
129870138|NCT04535947|467480696|FG001|Overall Study|Withdrawal by Subject|1|||
129870139|NCT03002610|467480697|FG000|Overall Study|Withdrawal by Subject|6|||
129870140|NCT03002610|467480698|FG001|Overall Study|Withdrawal by Subject|25|||
129870141|NCT03002610|467480699|FG002|Overall Study|Withdrawal by Subject|13|||
129870142|NCT03802123|467480700|FG000|Overall Study|Withdrawal by Subject|3|||
129870143|NCT03802123|467480700|FG000|Overall Study|Physician Decision|1|||
129870144|NCT03802123|467480700|FG000|Overall Study|Subject moved to hospice care|1|||
129870145|NCT03802123|467480700|FG000|Overall Study|technician error|1|||
129870146|NCT03802123|467480700|FG000|Overall Study|Death|3|||
129870147|NCT01362439|467480704|FG000|Overall Study|Adverse Event|1|||
129870148|NCT01362439|467480704|FG000|Overall Study|Lack of Efficacy|3|||
129870149|NCT01362439|467480704|FG000|Overall Study|Lost to Follow-up|2|||
129870150|NCT01362439|467480704|FG000|Overall Study|Study medication non-compliant|1|||
129870151|NCT01362439|467480704|FG000|Overall Study|Participant who withdrew consent|8|||
129870152|NCT00658567|467480706|FG000|Overall Study|Adverse Event|5|||
129870153|NCT00658567|467480707|FG001|Overall Study|Adverse Event|2|||
129870154|NCT00658567|467480708|FG002|Overall Study|Adverse Event|3|||
129870155|NCT00658567|467480706|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
129870156|NCT00658567|467480707|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
129870157|NCT00658567|467480708|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
129870158|NCT00658567|467480706|FG000|Overall Study|Physician Decision|0|||
129870159|NCT00658567|467480707|FG001|Overall Study|Physician Decision|1|||
129870160|NCT00658567|467480708|FG002|Overall Study|Physician Decision|0|||
129870161|NCT00658567|467480706|FG000|Overall Study|At Discretion of Sponsor|1|||
130066465|NCT00006604|468197820|FG004|Overall Study|Withdrawal by Subject|1|||
130066466|NCT00006604|468197821|FG005|Overall Study|Withdrawal by Subject|2|||
130066467|NCT00006604|468197822|FG006|Overall Study|Withdrawal by Subject|2|||
130066468|NCT00006604|468197823|FG007|Overall Study|Withdrawal by Subject|0|||
130066469|NCT00006604|468197824|FG008|Overall Study|Withdrawal by Subject|1|||
130066470|NCT00006604|468197825|FG009|Overall Study|Withdrawal by Subject|3|||
130066471|NCT00006604|468197826|FG010|Overall Study|Withdrawal by Subject|2|||
129870162|NCT00658567|467480707|FG001|Overall Study|At Discretion of Sponsor|1|||
129870163|NCT00658567|467480708|FG002|Overall Study|At Discretion of Sponsor|1|||
129870164|NCT02835339|467480709|FG000|Overall Study|Did not receive allocated intervention|13|||
129870165|NCT02835339|467480710|FG001|Overall Study|Did not receive allocated intervention|16|||
129870166|NCT03923959|467480711|FG000|Overall Study|Death|16|||
129870167|NCT03923959|467480712|FG001|Overall Study|Death|12|||
129870168|NCT03923959|467480711|FG000|Overall Study|Lost to Follow-up|56|||
129870169|NCT03923959|467480712|FG001|Overall Study|Lost to Follow-up|56|||
129870170|NCT03923959|467480711|FG000|Overall Study|Withdrawal by Subject|1|||
129870171|NCT03923959|467480712|FG001|Overall Study|Withdrawal by Subject|1|||
129870172|NCT03923959|467480711|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
129870173|NCT03923959|467480712|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
129870174|NCT04918147|467480713|FG000|Overall Study|Disease flare as defined in protocol|0|||
129870175|NCT04918147|467480714|FG001|Overall Study|Disease flare as defined in protocol|2|||
129870176|NCT02954354|467480715|FG000|Overall Study|Adverse Event|2|||
129870177|NCT02954354|467480716|FG001|Overall Study|Adverse Event|2|||
129870178|NCT02954354|467480717|FG002|Overall Study|Adverse Event|4|||
129870179|NCT02954354|467480715|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
129870180|NCT02954354|467480716|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
129870181|NCT02954354|467480717|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
129870182|NCT02954354|467480715|FG000|Overall Study|Lack of Efficacy|0|||
129870183|NCT02954354|467480716|FG001|Overall Study|Lack of Efficacy|2|||
129870184|NCT02954354|467480717|FG002|Overall Study|Lack of Efficacy|0|||
129870185|NCT02954354|467480715|FG000|Overall Study|Withdrawal by Subject|17|||
129870186|NCT02954354|467480716|FG001|Overall Study|Withdrawal by Subject|9|||
129870187|NCT02954354|467480717|FG002|Overall Study|Withdrawal by Subject|11|||
129870188|NCT02954354|467480715|FG000|Overall Study|Lost to Follow-up|12|||
129870189|NCT02954354|467480716|FG001|Overall Study|Lost to Follow-up|5|||
129870190|NCT02954354|467480717|FG002|Overall Study|Lost to Follow-up|0|||
129870191|NCT02954354|467480715|FG000|Overall Study|Miscellaneous|2|||
129870192|NCT02954354|467480716|FG001|Overall Study|Miscellaneous|2|||
129870193|NCT02954354|467480717|FG002|Overall Study|Miscellaneous|1|||
129870194|NCT03338829|467480718|FG000|Overall Study|Lost to Follow-up|4|||
129870195|NCT03338829|467480719|FG001|Overall Study|Lost to Follow-up|2|||
129870196|NCT03338829|467480720|FG002|Overall Study|Lost to Follow-up|4|||
129870197|NCT03338829|467480718|FG000|Overall Study|Pregnancy loss|1|||
129870198|NCT03338829|467480719|FG001|Overall Study|Pregnancy loss|1|||
129870199|NCT03338829|467480720|FG002|Overall Study|Pregnancy loss|0|||
129870200|NCT03338829|467480718|FG000|Overall Study|Protocol Violation|0|||
129870201|NCT03338829|467480719|FG001|Overall Study|Protocol Violation|1|||
129870202|NCT03338829|467480720|FG002|Overall Study|Protocol Violation|0|||
129870203|NCT02684006|467480721|FG000|Overall Study|Other|18|||
129870204|NCT02684006|467480722|FG001|Overall Study|Other|6|||
129870205|NCT02684006|467480721|FG000|Overall Study|Protocol Violation|2|||
129870206|NCT02684006|467480722|FG001|Overall Study|Protocol Violation|1|||
129870207|NCT02684006|467480721|FG000|Overall Study|Non-compliance with study drug|1|||
129870208|NCT02684006|467480722|FG001|Overall Study|Non-compliance with study drug|1|||
129870209|NCT02684006|467480721|FG000|Overall Study|No longer met eligibility criteria|6|||
129870210|NCT02684006|467480722|FG001|Overall Study|No longer met eligibility criteria|2|||
129870211|NCT02684006|467480721|FG000|Overall Study|Lost to Follow-up|0|||
129870212|NCT02684006|467480722|FG001|Overall Study|Lost to Follow-up|1|||
129870213|NCT02684006|467480721|FG000|Overall Study|Death|25|||
129870214|NCT02684006|467480722|FG001|Overall Study|Death|22|||
129870215|NCT02684006|467480721|FG000|Overall Study|Global deterioration of health status|18|||
129870216|NCT02684006|467480722|FG001|Overall Study|Global deterioration of health status|20|||
129870217|NCT02684006|467480721|FG000|Overall Study|Physician Decision|15|||
129870218|NCT02684006|467480722|FG001|Overall Study|Physician Decision|8|||
129870219|NCT02684006|467480721|FG000|Overall Study|Adverse Event|86|||
129870220|NCT02684006|467480722|FG001|Overall Study|Adverse Event|65|||
129870221|NCT02684006|467480721|FG000|Overall Study|Withdrawal by Subject|29|||
129870222|NCT02684006|467480722|FG001|Overall Study|Withdrawal by Subject|43|||
129870223|NCT02684006|467480721|FG000|Overall Study|Progressive disease|236|||
130066472|NCT00006604|468197827|FG011|Overall Study|Withdrawal by Subject|0|||
130066473|NCT00006604|468197828|FG012|Overall Study|Withdrawal by Subject|1|||
129870224|NCT02684006|467480722|FG001|Overall Study|Progressive disease|266|||
129870225|NCT02684006|467480721|FG000|Overall Study|Participation terminated by sponsor|6|||
129870226|NCT02684006|467480722|FG001|Overall Study|Participation terminated by sponsor|9|||
129870227|NCT04495179|467480723|FG000|Overall Study|Lost to Follow-up|0|||
129870228|NCT04495179|467480724|FG001|Overall Study|Lost to Follow-up|1|||
129870229|NCT04495179|467480723|FG000|Overall Study|Withdrawal by Subject|2|||
129870230|NCT04495179|467480724|FG001|Overall Study|Withdrawal by Subject|4|||
130066474|NCT00006604|468197829|FG013|Overall Study|Withdrawal by Subject|2|||
130066475|NCT00006604|468197830|FG014|Overall Study|Withdrawal by Subject|1|||
130066476|NCT00006604|468197831|FG015|Overall Study|Withdrawal by Subject|0|||
130066477|NCT00006604|468197832|FG016|Overall Study|Withdrawal by Subject|1|||
130066478|NCT00006604|468197816|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
130066479|NCT00006604|468197817|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
130066480|NCT00006604|468197818|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
130066481|NCT00006604|468197819|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
130066482|NCT00006604|468197820|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
130066483|NCT00006604|468197821|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
130066484|NCT00006604|468197822|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
130066485|NCT00006604|468197823|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
130066486|NCT00006604|468197824|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
130066487|NCT00006604|468197825|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
130066488|NCT00006604|468197826|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
130066489|NCT00006604|468197827|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
130066490|NCT00006604|468197828|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
130066491|NCT00006604|468197829|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
130066492|NCT00006604|468197830|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
130066493|NCT00006604|468197831|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
130066494|NCT00006604|468197832|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
130066495|NCT00006604|468197816|FG000|Overall Study|Lost to Follow-up|0|||
130066496|NCT00006604|468197817|FG001|Overall Study|Lost to Follow-up|0|||
130066497|NCT00006604|468197818|FG002|Overall Study|Lost to Follow-up|0|||
130066498|NCT00006604|468197819|FG003|Overall Study|Lost to Follow-up|0|||
130066499|NCT00006604|468197820|FG004|Overall Study|Lost to Follow-up|0|||
130066500|NCT00006604|468197821|FG005|Overall Study|Lost to Follow-up|0|||
130066501|NCT00006604|468197822|FG006|Overall Study|Lost to Follow-up|0|||
130066502|NCT00006604|468197823|FG007|Overall Study|Lost to Follow-up|1|||
130066503|NCT00006604|468197824|FG008|Overall Study|Lost to Follow-up|0|||
130066504|NCT00006604|468197825|FG009|Overall Study|Lost to Follow-up|2|||
130066505|NCT00006604|468197826|FG010|Overall Study|Lost to Follow-up|0|||
130066506|NCT00006604|468197827|FG011|Overall Study|Lost to Follow-up|0|||
130066507|NCT00006604|468197828|FG012|Overall Study|Lost to Follow-up|0|||
130066508|NCT00006604|468197829|FG013|Overall Study|Lost to Follow-up|0|||
129870231|NCT04495179|467480723|FG000|Overall Study|Study terminated by sponsor|0|||
129870232|NCT04495179|467480724|FG001|Overall Study|Study terminated by sponsor|18|||
129870233|NCT04495179|467480723|FG000|Overall Study|Death|0|||
129870234|NCT04495179|467480724|FG001|Overall Study|Death|4|||
129870235|NCT04495179|467480723|FG000|Overall Study|Adverse Event|0|||
129870236|NCT04495179|467480724|FG001|Overall Study|Adverse Event|1|||
129870237|NCT01368965|467480728|FG000|Overall Study|Lost to Follow-up|12|||
129870238|NCT02355743|467480739|FG000|Overall Study|Withdrawal by Subject|1|||
129870239|NCT02355743|467480739|FG000|Overall Study|Lost to Follow-up|1|||
129870240|NCT04212091|467480740|FG000|Overall Study|Lost to Follow-up|0|||
129870241|NCT04212091|467480741|FG001|Overall Study|Lost to Follow-up|0|||
129870242|NCT04212091|467480742|FG002|Overall Study|Lost to Follow-up|0|||
129870243|NCT04212091|467480743|FG003|Overall Study|Lost to Follow-up|0|||
129870244|NCT04212091|467480744|FG004|Overall Study|Lost to Follow-up|1|||
129870245|NCT04212091|467480745|FG005|Overall Study|Lost to Follow-up|1|||
129870246|NCT04212091|467480740|FG000|Overall Study|Participant unable to adhere to visit|0|||
129870247|NCT04212091|467480741|FG001|Overall Study|Participant unable to adhere to visit|0|||
129870248|NCT04212091|467480742|FG002|Overall Study|Participant unable to adhere to visit|0|||
129870249|NCT04212091|467480743|FG003|Overall Study|Participant unable to adhere to visit|0|||
129870250|NCT04212091|467480744|FG004|Overall Study|Participant unable to adhere to visit|1|||
129870251|NCT04212091|467480745|FG005|Overall Study|Participant unable to adhere to visit|0|||
129870252|NCT00715429|467480746|FG000|Overall Study|Did not complete the study diary|0|||
129870253|NCT00715429|467480747|FG001|Overall Study|Did not complete the study diary|1|||
129870254|NCT04085328|467480748|FG000|Overall Study|Witihdrew Consent|16|||
129870255|NCT04085328|467480749|FG001|Overall Study|Witihdrew Consent|16|||
129870256|NCT04085328|467480748|FG000|Overall Study|Adverse Event|8|||
129870257|NCT04085328|467480749|FG001|Overall Study|Adverse Event|7|||
129870258|NCT04085328|467480748|FG000|Overall Study|Lost to Follow-up|7|||
129870259|NCT04085328|467480749|FG001|Overall Study|Lost to Follow-up|2|||
129870260|NCT04085328|467480748|FG000|Overall Study|Physician Decision|0|||
129870261|NCT04085328|467480749|FG001|Overall Study|Physician Decision|1|||
129870262|NCT04085328|467480748|FG000|Overall Study|Pregnancy|0|||
129870263|NCT04085328|467480749|FG001|Overall Study|Pregnancy|1|||
129870264|NCT04085328|467480748|FG000|Overall Study|Reasons Related to COVID-19|5|||
130066509|NCT00006604|468197830|FG014|Overall Study|Lost to Follow-up|0|||
130066510|NCT00006604|468197831|FG015|Overall Study|Lost to Follow-up|1|||
130066511|NCT00006604|468197832|FG016|Overall Study|Lost to Follow-up|3|||
130066512|NCT00006604|468197816|FG000|Overall Study|Other Reason|0|||
130066513|NCT00006604|468197817|FG001|Overall Study|Other Reason|0|||
130066514|NCT00006604|468197818|FG002|Overall Study|Other Reason|0|||
130066515|NCT00006604|468197819|FG003|Overall Study|Other Reason|0|||
129870265|NCT04085328|467480749|FG001|Overall Study|Reasons Related to COVID-19|8|||
129870266|NCT04085328|467480748|FG000|Overall Study|Did not meet inclusion criteria|1|||
129870267|NCT04085328|467480749|FG001|Overall Study|Did not meet inclusion criteria|1|||
129870268|NCT04085328|467480748|FG000|Overall Study|Early termination|1|||
129870269|NCT04085328|467480749|FG001|Overall Study|Early termination|0|||
129870270|NCT00514735|467480750|FG000|Overall Study|Withdrawal by Subject|13|||
129870271|NCT00514735|467480751|FG001|Overall Study|Withdrawal by Subject|5|||
129870272|NCT00514735|467480750|FG000|Overall Study|Death|1|||
129870273|NCT00514735|467480751|FG001|Overall Study|Death|0|||
129870274|NCT00514735|467480750|FG000|Overall Study|Lost to Follow-up|0|||
129870275|NCT00514735|467480751|FG001|Overall Study|Lost to Follow-up|1|||
129870276|NCT01428076|467480762|FG000|Overall Study|Adverse Event|0|||
129870277|NCT01428076|467480763|FG001|Overall Study|Adverse Event|1|||
129870278|NCT02216773|467480764|FG000|Overall Study|Disease progression|4|||
129870279|NCT02216773|467480765|FG001|Overall Study|Disease progression|2|||
129870280|NCT02216773|467480764|FG000|Overall Study|Insufficient FLRV|4|||
129870281|NCT02216773|467480765|FG001|Overall Study|Insufficient FLRV|0|||
129870282|NCT02216773|467480764|FG000|Overall Study|Abandoned|4|||
129870283|NCT02216773|467480765|FG001|Overall Study|Abandoned|3|||
129870284|NCT04274894|467480766|FG000|Overall Study|Adverse Event|7|||
129870285|NCT04274894|467480766|FG000|Overall Study|Withdrew consent|5|||
129870286|NCT04274894|467480766|FG000|Overall Study|Lost to Follow-up|9|||
129870287|NCT04274894|467480766|FG000|Overall Study|COVID-19 infection|1|||
129870288|NCT04274894|467480766|FG000|Overall Study|Other, not specified|20|||
129870289|NCT01936857|467480767|FG000|Overall Study|Sent to prison or 06 center|11|||
129870290|NCT01936857|467480768|FG001|Overall Study|Sent to prison or 06 center|12|||
129870291|NCT01936857|467480767|FG000|Overall Study|Lost to Follow-up|10|||
129870292|NCT01936857|467480768|FG001|Overall Study|Lost to Follow-up|7|||
129870293|NCT01936857|467480767|FG000|Overall Study|Death|7|||
129870294|NCT01936857|467480768|FG001|Overall Study|Death|3|||
129870295|NCT01936857|467480767|FG000|Overall Study|Moved|2|||
129870296|NCT01936857|467480768|FG001|Overall Study|Moved|1|||
129870297|NCT01936857|467480767|FG000|Overall Study|Withdrawal by Subject|1|||
129870298|NCT01936857|467480768|FG001|Overall Study|Withdrawal by Subject|0|||
129870299|NCT01936857|467480767|FG000|Overall Study|Side effect of medication|1|||
129870300|NCT01936857|467480768|FG001|Overall Study|Side effect of medication|0|||
129870301|NCT01936857|467480767|FG000|Overall Study|Other|2|||
129870302|NCT01936857|467480768|FG001|Overall Study|Other|2|||
129870303|NCT02279043|467480769|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
129870304|NCT02279043|467480770|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
129870305|NCT02279043|467480771|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
129870306|NCT02279043|467480769|FG000|Overall Study|Lost to Follow-up|46|||
129870307|NCT02279043|467480770|FG001|Overall Study|Lost to Follow-up|88|||
129870308|NCT02279043|467480771|FG002|Overall Study|Lost to Follow-up|0|||
129870309|NCT02124265|467480772|FG000|Overall Study|Adverse Event|1|||
129870310|NCT00490282|467480773|FG000|Overall Study|Withdrawal by Subject|3|||
129870311|NCT01666808|467480774|FG000|Overall Study|Lost to Follow-up|9|||
129870312|NCT01666808|467480775|FG001|Overall Study|Lost to Follow-up|15|||
129870313|NCT01666808|467480774|FG000|Overall Study|Withdrawal by Subject|3|||
129870314|NCT01666808|467480775|FG001|Overall Study|Withdrawal by Subject|1|||
129870315|NCT01666808|467480774|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
129870316|NCT01666808|467480775|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
129870317|NCT01525602|467480776|FG000|Overall Study|Adverse Event|1|||
129870318|NCT01525602|467480777|FG001|Overall Study|Adverse Event|0|||
129870319|NCT01525602|467480778|FG002|Overall Study|Adverse Event|1|||
129870320|NCT01525602|467480779|FG003|Overall Study|Adverse Event|1|||
129870321|NCT01525602|467480780|FG004|Overall Study|Adverse Event|3|||
129870322|NCT01525602|467480781|FG005|Overall Study|Adverse Event|3|||
129870323|NCT01525602|467480782|FG006|Overall Study|Adverse Event|0|||
129870324|NCT01525602|467480783|FG007|Overall Study|Adverse Event|1|||
129870325|NCT01525602|467480776|FG000|Overall Study|Disease progression|6|||
129870326|NCT01525602|467480777|FG001|Overall Study|Disease progression|3|||
129870327|NCT01525602|467480778|FG002|Overall Study|Disease progression|2|||
129870328|NCT01525602|467480779|FG003|Overall Study|Disease progression|5|||
129870329|NCT01525602|467480780|FG004|Overall Study|Disease progression|22|||
129870330|NCT01525602|467480781|FG005|Overall Study|Disease progression|2|||
129870331|NCT01525602|467480782|FG006|Overall Study|Disease progression|3|||
129870332|NCT01525602|467480783|FG007|Overall Study|Disease progression|3|||
129870333|NCT01525602|467480776|FG000|Overall Study|Clinical progression|2|||
129870334|NCT01525602|467480777|FG001|Overall Study|Clinical progression|0|||
129870335|NCT01525602|467480778|FG002|Overall Study|Clinical progression|0|||
129870336|NCT01525602|467480779|FG003|Overall Study|Clinical progression|0|||
129870337|NCT01525602|467480780|FG004|Overall Study|Clinical progression|0|||
129870338|NCT01525602|467480781|FG005|Overall Study|Clinical progression|0|||
129870339|NCT01525602|467480782|FG006|Overall Study|Clinical progression|1|||
129870340|NCT01525602|467480783|FG007|Overall Study|Clinical progression|1|||
129870341|NCT01525602|467480776|FG000|Overall Study|Non-compliance|0|||
129870342|NCT01525602|467480777|FG001|Overall Study|Non-compliance|0|||
129870343|NCT01525602|467480778|FG002|Overall Study|Non-compliance|0|||
129870344|NCT01525602|467480779|FG003|Overall Study|Non-compliance|0|||
129870345|NCT01525602|467480780|FG004|Overall Study|Non-compliance|1|||
129870346|NCT01525602|467480781|FG005|Overall Study|Non-compliance|0|||
129870347|NCT01525602|467480782|FG006|Overall Study|Non-compliance|0|||
129870348|NCT01525602|467480783|FG007|Overall Study|Non-compliance|0|||
129870349|NCT01525602|467480776|FG000|Overall Study|Withdrawal by Subject|0|||
129870350|NCT01525602|467480777|FG001|Overall Study|Withdrawal by Subject|0|||
129870351|NCT01525602|467480778|FG002|Overall Study|Withdrawal by Subject|0|||
129870352|NCT01525602|467480779|FG003|Overall Study|Withdrawal by Subject|0|||
129870353|NCT01525602|467480780|FG004|Overall Study|Withdrawal by Subject|3|||
129870354|NCT01525602|467480781|FG005|Overall Study|Withdrawal by Subject|1|||
129870355|NCT01525602|467480782|FG006|Overall Study|Withdrawal by Subject|0|||
129870356|NCT01525602|467480783|FG007|Overall Study|Withdrawal by Subject|1|||
129870357|NCT01525602|467480776|FG000|Overall Study|Physician Decision|0|||
129870358|NCT01525602|467480777|FG001|Overall Study|Physician Decision|0|||
129870359|NCT01525602|467480778|FG002|Overall Study|Physician Decision|0|||
129870360|NCT01525602|467480779|FG003|Overall Study|Physician Decision|0|||
129870361|NCT01525602|467480780|FG004|Overall Study|Physician Decision|3|||
129870362|NCT01525602|467480781|FG005|Overall Study|Physician Decision|0|||
129870363|NCT01525602|467480782|FG006|Overall Study|Physician Decision|1|||
129870364|NCT01525602|467480783|FG007|Overall Study|Physician Decision|0|||
129870365|NCT01525602|467480776|FG000|Overall Study|Death|0|||
129870366|NCT01525602|467480777|FG001|Overall Study|Death|0|||
129870367|NCT01525602|467480778|FG002|Overall Study|Death|0|||
129870368|NCT01525602|467480779|FG003|Overall Study|Death|0|||
129870369|NCT01525602|467480780|FG004|Overall Study|Death|1|||
129870370|NCT01525602|467480781|FG005|Overall Study|Death|1|||
129870371|NCT01525602|467480782|FG006|Overall Study|Death|0|||
129870372|NCT01525602|467480783|FG007|Overall Study|Death|0|||
129870373|NCT01525602|467480776|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870374|NCT01525602|467480777|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870375|NCT01525602|467480778|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870376|NCT01525602|467480779|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870377|NCT01525602|467480780|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870378|NCT01525602|467480781|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870379|NCT01525602|467480782|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
129870380|NCT01525602|467480783|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
129870381|NCT01194570|467482394|FG000|Overall Study|Adverse Event|22|||
129870382|NCT01194570|467482395|FG001|Overall Study|Adverse Event|40|||
129870383|NCT01194570|467482394|FG000|Overall Study|Death|6|||
129870384|NCT01194570|467482395|FG001|Overall Study|Death|20|||
129870385|NCT01194570|467482394|FG000|Overall Study|Lack of Efficacy|32|||
129870386|NCT01194570|467482395|FG001|Overall Study|Lack of Efficacy|33|||
129870387|NCT01194570|467482394|FG000|Overall Study|Lost to Follow-up|4|||
129870388|NCT01194570|467482395|FG001|Overall Study|Lost to Follow-up|15|||
129870389|NCT01194570|467482394|FG000|Overall Study|Non-Compliance|2|||
129870390|NCT01194570|467482395|FG001|Overall Study|Non-Compliance|2|||
129870391|NCT01194570|467482394|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129870392|NCT01194570|467482395|FG001|Overall Study|Non-Compliance With Study Drug|2|||
129870393|NCT01194570|467482394|FG000|Overall Study|Other|18|||
129870394|NCT01194570|467482395|FG001|Overall Study|Other|47|||
129870395|NCT01194570|467482394|FG000|Overall Study|Physician Decision|10|||
129870396|NCT01194570|467482395|FG001|Overall Study|Physician Decision|25|||
129870397|NCT01194570|467482394|FG000|Overall Study|Protocol Violation|1|||
129870398|NCT01194570|467482395|FG001|Overall Study|Protocol Violation|2|||
129870399|NCT01194570|467482394|FG000|Overall Study|Study Terminated By Sponsor|0|||
129870400|NCT01194570|467482395|FG001|Overall Study|Study Terminated By Sponsor|1|||
129870401|NCT01194570|467482394|FG000|Overall Study|Withdrawal by Subject|57|||
129870402|NCT01194570|467482395|FG001|Overall Study|Withdrawal by Subject|82|||
129870403|NCT01194570|467482394|FG000|Overall Study|Pregnancy|1|||
129870404|NCT01194570|467482395|FG001|Overall Study|Pregnancy|1|||
129870405|NCT03076970|467482399|FG000|Washout Period 2|Adverse Event|0|||
129870406|NCT03076970|467482400|FG001|Washout Period 2|Adverse Event|0|||
129870407|NCT03076970|467482401|FG002|Washout Period 2|Adverse Event|0|||
129870408|NCT03076970|467482402|FG003|Washout Period 2|Adverse Event|0|||
129870409|NCT03076970|467482403|FG004|Washout Period 2|Adverse Event|1|||
129870410|NCT03076970|467482404|FG005|Washout Period 2|Adverse Event|0|||
129870411|NCT03076970|467482399|FG000|Period 3|Withdrawal by Subject|0|||
129870412|NCT03076970|467482400|FG001|Period 3|Withdrawal by Subject|0|||
129870413|NCT03076970|467482401|FG002|Period 3|Withdrawal by Subject|0|||
129870414|NCT03076970|467482402|FG003|Period 3|Withdrawal by Subject|0|||
129870415|NCT03076970|467482403|FG004|Period 3|Withdrawal by Subject|0|||
129870416|NCT03076970|467482404|FG005|Period 3|Withdrawal by Subject|1|||
129870417|NCT03076970|467482399|FG000|Period 3|Failure to meet I/E criteria|0|||
129870418|NCT03076970|467482400|FG001|Period 3|Failure to meet I/E criteria|0|||
129870419|NCT03076970|467482401|FG002|Period 3|Failure to meet I/E criteria|0|||
129870420|NCT03076970|467482402|FG003|Period 3|Failure to meet I/E criteria|0|||
129870421|NCT03076970|467482403|FG004|Period 3|Failure to meet I/E criteria|1|||
129870422|NCT03076970|467482404|FG005|Period 3|Failure to meet I/E criteria|0|||
129870423|NCT02543658|467482405|FG000|Overall Study|Lack of Efficacy|0|||
129870424|NCT02543658|467482406|FG001|Overall Study|Lack of Efficacy|4|||
129870425|NCT00789815|467482407|FG000|Overall Study|Protocol Violation|6|||
129870426|NCT00789815|467482408|FG001|Overall Study|Protocol Violation|1|||
129870427|NCT00789815|467482407|FG000|Overall Study|Intubation due to massive bleeding|1|||
129870428|NCT00789815|467482408|FG001|Overall Study|Intubation due to massive bleeding|0|||
129870429|NCT01111123|467482414|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
129870430|NCT01111123|467482415|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
129870431|NCT01111123|467482414|FG000|Maintenance Phase|Lost to Follow-up|0|||
129870432|NCT01111123|467482415|FG001|Maintenance Phase|Lost to Follow-up|2|||
129870433|NCT00119405|467482416|FG000|Overall Study|Withdrawal by Subject|1|||
129870434|NCT02563002|467482430|FG000|Overall Study|Death|72|||
129870435|NCT02563002|467482431|FG001|Overall Study|Death|87|||
129870436|NCT02563002|467482430|FG000|Overall Study|Lost to Follow-up|5|||
129870437|NCT02563002|467482431|FG001|Overall Study|Lost to Follow-up|0|||
129870438|NCT02563002|467482430|FG000|Overall Study|Physician Decision|0|||
129870439|NCT02563002|467482431|FG001|Overall Study|Physician Decision|2|||
129870440|NCT02563002|467482430|FG000|Overall Study|Withdrawal by Subject|2|||
129870441|NCT02563002|467482431|FG001|Overall Study|Withdrawal by Subject|10|||
129870442|NCT02563002|467482430|FG000|Overall Study|Sponsor decision|74|||
129870443|NCT02563002|467482431|FG001|Overall Study|Sponsor decision|55|||
129870444|NCT03466086|467482432|FG000|Period 1|Sponsor decision due to study timeline|1|||
129870445|NCT03466086|467482433|FG001|Period 1|Sponsor decision due to study timeline|0|||
129870446|NCT03466086|467482432|FG000|Period 1|Withdrawal by Subject|1|||
129870447|NCT03466086|467482433|FG001|Period 1|Withdrawal by Subject|0|||
129870448|NCT00595504|467482434|FG000|Overall Study|Withdrawal by Subject|1|||
129870449|NCT00595504|467482435|FG001|Overall Study|Withdrawal by Subject|3|||
129870450|NCT00595504|467482434|FG000|Overall Study|Physician Decision|1|||
129870451|NCT00595504|467482435|FG001|Overall Study|Physician Decision|0|||
129870452|NCT01949870|467482436|FG000|Overall Study|Lack of Efficacy|2|||
129870453|NCT01949870|467482436|FG000|Overall Study|Adverse Event|1|||
129870454|NCT01949870|467482436|FG000|Overall Study|Study termination|1|||
129870455|NCT01949870|467482436|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
129870456|NCT00677352|467482437|FG000|Treatment Phase|Adverse Event|14|||
129870457|NCT00677352|467482438|FG001|Treatment Phase|Adverse Event|22|||
129870458|NCT00677352|467482437|FG000|Treatment Phase|Lack of Efficacy|2|||
129870459|NCT00677352|467482438|FG001|Treatment Phase|Lack of Efficacy|3|||
129870460|NCT00677352|467482437|FG000|Treatment Phase|Lost to Follow-up|0|||
129870461|NCT00677352|467482438|FG001|Treatment Phase|Lost to Follow-up|1|||
129870462|NCT00677352|467482437|FG000|Treatment Phase|Withdrawal by Subject|7|||
129870463|NCT00677352|467482438|FG001|Treatment Phase|Withdrawal by Subject|7|||
129870464|NCT00677352|467482437|FG000|Treatment Phase|Physician Decision|1|||
129870465|NCT00677352|467482438|FG001|Treatment Phase|Physician Decision|0|||
129870466|NCT00677352|467482437|FG000|Treatment Phase|Pregnancy|0|||
129870467|NCT00677352|467482438|FG001|Treatment Phase|Pregnancy|1|||
129870468|NCT00677352|467482437|FG000|Treatment Phase|Protocol Violation|1|||
129870469|NCT00677352|467482438|FG001|Treatment Phase|Protocol Violation|1|||
129870470|NCT00677352|467482437|FG000|Treatment Phase|Transference or work related matter|0|||
129870471|NCT00677352|467482438|FG001|Treatment Phase|Transference or work related matter|5|||
129870472|NCT00677352|467482437|FG000|Treatment Phase|Not treated|0|||
129870473|NCT00677352|467482438|FG001|Treatment Phase|Not treated|2|||
129870474|NCT00677352|467482437|FG000|Tapering Phase|Adverse Event|1|||
129870475|NCT00677352|467482438|FG001|Tapering Phase|Adverse Event|5|||
129870476|NCT00677352|467482437|FG000|Tapering Phase|Withdrawal by Subject|5|||
129870477|NCT00677352|467482438|FG001|Tapering Phase|Withdrawal by Subject|3|||
129870478|NCT00677352|467482437|FG000|Tapering Phase|Pregnancy|0|||
129870479|NCT00677352|467482438|FG001|Tapering Phase|Pregnancy|1|||
129870480|NCT00677352|467482437|FG000|Tapering Phase|Job transfer|0|||
129870481|NCT00677352|467482438|FG001|Tapering Phase|Job transfer|1|||
129870482|NCT02182973|467482439|FG000|Overall Study|Withdrawal by Subject|3|||
129870483|NCT02182973|467482440|FG001|Overall Study|Withdrawal by Subject|0|||
129870484|NCT01235546|467482441|FG000|Overall Study|Staff error, medication not administered|1|||
129870485|NCT01235546|467482442|FG001|Overall Study|Staff error, medication not administered|0|||
129870486|NCT01235546|467482441|FG000|Overall Study|Protocol Violation|1|||
129870487|NCT01235546|467482442|FG001|Overall Study|Protocol Violation|1|||
129870488|NCT01123382|467482443|FG000|Overall Study|Withdrawal by Subject|1|||
129870489|NCT01123382|467482444|FG001|Overall Study|Withdrawal by Subject|4|||
129870490|NCT01123382|467482443|FG000|Overall Study|Lost to Follow-up|1|||
129870491|NCT01123382|467482444|FG001|Overall Study|Lost to Follow-up|2|||
129870492|NCT01281644|467482445|FG000|Overall Study|Lost to Follow-up|3|||
129870493|NCT01281644|467482445|FG000|Overall Study|Withdrawal by Subject|2|||
129870494|NCT01755702|467482446|FG000|Wash Out Period I|Other Reason|3|||
129870495|NCT01755702|467482446|FG000|Washout Period II|Other Reason|5|||
129870496|NCT00594854|467482447|FG000|Overall Study|Study terminated|7|||
129870497|NCT00594854|467482448|FG001|Overall Study|Study terminated|10|||
129870498|NCT03172702|467482449|FG000|Overall Study|Adverse Event|9|||
129870499|NCT03172702|467482449|FG000|Overall Study|Death|2|||
129870500|NCT03172702|467482449|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
129917596|NCT00220740|467663155|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
129917597|NCT01057433|467663156|FG000|Overall Study|Adverse Event|1|||
129917598|NCT05268302|467663157|FG000|Overall Study|Death|0|||
129917599|NCT05268302|467663158|FG001|Overall Study|Death|1|||
129917600|NCT02811679|467663159|FG000|Overall Study|Adverse Event|1|||
129917601|NCT02811679|467663159|FG000|Overall Study|Lack of Efficacy|6|||
129917602|NCT02811679|467663159|FG000|Overall Study|Early study closure due to slow accrual|3|||
129917603|NCT05319860|467663161|FG000|Overall Study|Death|1|||
129917604|NCT05319860|467663162|FG001|Overall Study|Death|1|||
129917605|NCT05319860|467663161|FG000|Overall Study|Lost to Follow-up|3|||
129917606|NCT05319860|467663162|FG001|Overall Study|Lost to Follow-up|1|||
129917607|NCT05319860|467663161|FG000|Overall Study|Withdrawal by Subject|1|||
129917608|NCT05319860|467663162|FG001|Overall Study|Withdrawal by Subject|7|||
129917609|NCT04314895|467663163|FG000|Overall Study|Lost to Follow-up|1|||
129917610|NCT04314895|467663163|FG000|Overall Study|Death|10|||
129917611|NCT04314895|467663163|FG000|Overall Study|Physician Decision|2|||
129917612|NCT03941860|467663164|FG000|Overall Study|Withdrawal by Subject|0|||
129917613|NCT03941860|467663165|FG001|Overall Study|Withdrawal by Subject|1|||
129917614|NCT01180634|467665290|FG000|Overall Study|Adverse Event|4|||
129917615|NCT01180634|467665291|FG001|Overall Study|Adverse Event|1|||
129917616|NCT01180634|467665290|FG000|Overall Study|Miscellaneous|2|||
129917617|NCT01180634|467665291|FG001|Overall Study|Miscellaneous|0|||
129917618|NCT01180634|467665290|FG000|Overall Study|Withdrawal by Subject|4|||
129917619|NCT01180634|467665291|FG001|Overall Study|Withdrawal by Subject|0|||
129917620|NCT04419168|467665292|FG000|Overall Study|Protocol Violation|1|||
129917621|NCT04419168|467665293|FG001|Overall Study|Protocol Violation|1|||
129917622|NCT04419168|467665292|FG000|Overall Study|Lost to Follow-up|7|||
129917623|NCT04419168|467665293|FG001|Overall Study|Lost to Follow-up|7|||
129917624|NCT04419168|467665292|FG000|Overall Study|Missed 6-month Visit|48|||
129917625|NCT04419168|467665293|FG001|Overall Study|Missed 6-month Visit|45|||
129917626|NCT04490915|467665294|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
129917627|NCT04490915|467665295|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
129917628|NCT04490915|467665294|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129917629|NCT04490915|467665295|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129917630|NCT04490915|467665294|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129917631|NCT04490915|467665295|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
129917632|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
129917633|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
129917634|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
129917635|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
129917636|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
129917637|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
129917638|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
129917639|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
129917640|NCT05009251|467665296|FG000|Overall Study|Protocol Violation|100|||
129917641|NCT05009251|467665297|FG001|Overall Study|Protocol Violation|105|||
129917642|NCT05009251|467665298|FG002|Overall Study|Protocol Violation|119|||
129917643|NCT05009251|467665299|FG003|Overall Study|Protocol Violation|120|||
129917644|NCT05009251|467665300|FG004|Overall Study|Protocol Violation|119|||
129917645|NCT05009251|467665296|FG000|Overall Study|Death|25|||
129917646|NCT05009251|467665297|FG001|Overall Study|Death|22|||
129917647|NCT05009251|467665298|FG002|Overall Study|Death|24|||
129917648|NCT05009251|467665299|FG003|Overall Study|Death|19|||
129917649|NCT05009251|467665300|FG004|Overall Study|Death|15|||
129917650|NCT05406921|467665304|FG000|Overall Study|Withdrawal by Subject|25|||
129917651|NCT05406921|467665305|FG001|Overall Study|Withdrawal by Subject|0|||
129917652|NCT05406921|467665306|FG002|Overall Study|Withdrawal by Subject|25|||
129917653|NCT05406921|467665304|FG000|Overall Study|Protocol Violation|0|||
129917654|NCT05406921|467665305|FG001|Overall Study|Protocol Violation|12|||
129917655|NCT05406921|467665306|FG002|Overall Study|Protocol Violation|0|||
129917656|NCT00616967|467665311|FG000|Overall Study|Withdrawal by Subject|0|||
129917657|NCT00616967|467665312|FG001|Overall Study|Withdrawal by Subject|0|||
129917658|NCT00616967|467665313|FG002|Overall Study|Withdrawal by Subject|1|||
129917659|NCT02910583|467665314|FG000|Overall Study|Death|7|||
129917660|NCT02910583|467665315|FG001|Overall Study|Death|3|||
129917661|NCT02910583|467665314|FG000|Overall Study|Lost to Follow-up|1|||
129917662|NCT02910583|467665315|FG001|Overall Study|Lost to Follow-up|0|||
129917663|NCT02910583|467665314|FG000|Overall Study|Withdrawal by Subject|12|||
129917664|NCT02910583|467665315|FG001|Overall Study|Withdrawal by Subject|8|||
129917665|NCT02910583|467665314|FG000|Overall Study|Other, Not Specified|6|||
129917666|NCT02910583|467665315|FG001|Overall Study|Other, Not Specified|3|||
129917667|NCT01331005|467665317|FG000|Overall Study|Lost to Follow-up|2|||
129917668|NCT01331005|467665318|FG001|Overall Study|Lost to Follow-up|1|||
129917669|NCT01331005|467665317|FG000|Overall Study|Withdrawal by Subject|2|||
129917670|NCT01331005|467665318|FG001|Overall Study|Withdrawal by Subject|3|||
129917671|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
129979690|NCT03752970|467889437|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
129870501|NCT03172702|467482449|FG000|Overall Study|Withdrawal by Subject|5|||
129870502|NCT03172702|467482449|FG000|Overall Study|Other|2|||
129870503|NCT06134180|467482460|FG000|Overall Study|Lost to Follow-up|4|||
129870504|NCT02152982|467482461|FG000|Overall Study|Ineligible|4|||
129870505|NCT02152982|467482462|FG001|Overall Study|Ineligible|4|||
129870506|NCT02152982|467482461|FG000|Overall Study|Did not start treatment|12|||
129870507|NCT02152982|467482462|FG001|Overall Study|Did not start treatment|6|||
129870508|NCT00569582|467482463|FG000|Overall Study|Withdrawal by Subject|5|||
129870509|NCT00569582|467482463|FG000|Overall Study|Death|2|||
129870510|NCT00569582|467482463|FG000|Overall Study|Adverse Event|7|||
129870511|NCT00569582|467482463|FG000|Overall Study|Subject was too ill to travel.|1|||
129870512|NCT00569582|467482463|FG000|Overall Study|Subject was non-compliant.|1|||
129917672|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
129917673|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
129917674|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
129917675|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
129917676|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
129917677|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
129917678|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
129917679|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
129917680|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
129917681|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
129917682|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
129917683|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
129870513|NCT02782169|467482472|FG000|Overall Study|Lost to Follow-up|1|||
129870514|NCT02782169|467482473|FG001|Overall Study|Lost to Follow-up|2|||
129870515|NCT02975973|467482474|FG000|Overall Study|Adverse Event|1|||
129870516|NCT02975973|467482475|FG001|Overall Study|Adverse Event|1|||
129870517|NCT02975973|467482476|FG002|Overall Study|Adverse Event|1|||
129870518|NCT02975973|467482477|FG003|Overall Study|Adverse Event|0|||
129870519|NCT00771810|467482478|FG000|Overall Study|Adverse Event|3|||
129870520|NCT00771810|467482479|FG001|Overall Study|Adverse Event|0|||
129870521|NCT00771810|467482480|FG002|Overall Study|Adverse Event|2|||
129870522|NCT00771810|467482478|FG000|Overall Study|Lost to Follow-up|0|||
129870523|NCT00771810|467482479|FG001|Overall Study|Lost to Follow-up|0|||
129870524|NCT00771810|467482480|FG002|Overall Study|Lost to Follow-up|1|||
129870525|NCT00771810|467482478|FG000|Overall Study|Physician Decision|1|||
129870526|NCT00771810|467482479|FG001|Overall Study|Physician Decision|2|||
129917684|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
129917685|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
129917686|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
129917687|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
129917688|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
129917689|NCT02029443|467665334|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
129917690|NCT02029443|467665335|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
129917691|NCT02029443|467665336|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
129917692|NCT02029443|467665337|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
129917693|NCT02029443|467665338|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
129917694|NCT02029443|467665334|FG000|Overall Study|Death|13|||
129917695|NCT02029443|467665335|FG001|Overall Study|Death|2|||
129917696|NCT02029443|467665336|FG002|Overall Study|Death|2|||
129917697|NCT02029443|467665337|FG003|Overall Study|Death|11|||
129917698|NCT02029443|467665338|FG004|Overall Study|Death|2|||
129917699|NCT02029443|467665334|FG000|Overall Study|Lost to Follow-up|1|||
129917700|NCT02029443|467665335|FG001|Overall Study|Lost to Follow-up|0|||
129917701|NCT02029443|467665336|FG002|Overall Study|Lost to Follow-up|1|||
129917702|NCT02029443|467665337|FG003|Overall Study|Lost to Follow-up|1|||
129917703|NCT02029443|467665338|FG004|Overall Study|Lost to Follow-up|0|||
129917704|NCT02029443|467665334|FG000|Overall Study|Started other anti-cancer therapy|17|||
129917705|NCT02029443|467665335|FG001|Overall Study|Started other anti-cancer therapy|4|||
129917706|NCT02029443|467665336|FG002|Overall Study|Started other anti-cancer therapy|7|||
129917707|NCT02029443|467665337|FG003|Overall Study|Started other anti-cancer therapy|9|||
129917708|NCT02029443|467665338|FG004|Overall Study|Started other anti-cancer therapy|3|||
129917709|NCT02029443|467665334|FG000|Overall Study|Withdrawal by Subject|3|||
130066516|NCT00006604|468197820|FG004|Overall Study|Other Reason|0|||
130066517|NCT00006604|468197821|FG005|Overall Study|Other Reason|1|||
130066518|NCT00006604|468197822|FG006|Overall Study|Other Reason|0|||
130066519|NCT00006604|468197823|FG007|Overall Study|Other Reason|0|||
130066520|NCT00006604|468197824|FG008|Overall Study|Other Reason|0|||
129870527|NCT00771810|467482480|FG002|Overall Study|Physician Decision|2|||
129870528|NCT00771810|467482478|FG000|Overall Study|Protocol Violation|0|||
129870529|NCT00771810|467482479|FG001|Overall Study|Protocol Violation|1|||
129870530|NCT00771810|467482480|FG002|Overall Study|Protocol Violation|1|||
129870531|NCT00771810|467482478|FG000|Overall Study|Withdrawal by Subject|1|||
129870532|NCT00771810|467482479|FG001|Overall Study|Withdrawal by Subject|2|||
129917710|NCT02029443|467665335|FG001|Overall Study|Withdrawal by Subject|1|||
129917711|NCT02029443|467665336|FG002|Overall Study|Withdrawal by Subject|1|||
129917712|NCT02029443|467665337|FG003|Overall Study|Withdrawal by Subject|1|||
129917713|NCT02029443|467665338|FG004|Overall Study|Withdrawal by Subject|0|||
129917714|NCT02029443|467665334|FG000|Overall Study|Other|6|||
129917715|NCT02029443|467665335|FG001|Overall Study|Other|6|||
129917716|NCT02029443|467665336|FG002|Overall Study|Other|4|||
129917717|NCT02029443|467665337|FG003|Overall Study|Other|2|||
129917718|NCT02029443|467665338|FG004|Overall Study|Other|0|||
129917719|NCT03393975|467665340|FG000|Urgent Treatment Period|Physician Decision|0|||
129917720|NCT03393975|467665341|FG001|Urgent Treatment Period|Physician Decision|0|||
129917721|NCT03393975|467665342|FG002|Urgent Treatment Period|Physician Decision|0|||
129917722|NCT03393975|467665343|FG003|Urgent Treatment Period|Physician Decision|1|||
129917723|NCT03393975|467665340|FG000|Prophylaxis Period 1|Reason not Specified|0|||
129917724|NCT03393975|467665341|FG001|Prophylaxis Period 1|Reason not Specified|1|||
129917725|NCT03393975|467665342|FG002|Prophylaxis Period 1|Reason not Specified|0|||
129917726|NCT03393975|467665343|FG003|Prophylaxis Period 1|Reason not Specified|0|||
129917727|NCT03393975|467665340|FG000|Prophylaxis Period 2|Reason not Specified|0|||
129917728|NCT03393975|467665341|FG001|Prophylaxis Period 2|Reason not Specified|1|||
129917729|NCT03393975|467665342|FG002|Prophylaxis Period 2|Reason not Specified|0|||
129917730|NCT03393975|467665343|FG003|Prophylaxis Period 2|Reason not Specified|0|||
129917731|NCT05021640|467665347|FG000|Overall Study|Lost to Follow-up|0|||
129917732|NCT05021640|467665348|FG001|Overall Study|Lost to Follow-up|0|||
129917733|NCT05021640|467665349|FG002|Overall Study|Lost to Follow-up|0|||
129917734|NCT05021640|467665350|FG003|Overall Study|Lost to Follow-up|0|||
129917735|NCT05021640|467665351|FG004|Overall Study|Lost to Follow-up|1|||
129917736|NCT04737772|467665352|FG000|Phase 2 Study|Lost to Follow-up|15|||
129917737|NCT04737772|467665353|FG001|Phase 2 Study|Lost to Follow-up|15|||
129917738|NCT04737772|467665352|FG000|Phase 2 Study|Withdrawal by Subject|0|||
129917739|NCT04737772|467665353|FG001|Phase 2 Study|Withdrawal by Subject|1|||
129917740|NCT04737772|467665352|FG000|Phase 2 Study|Did not take any coaching calls|4|||
129917741|NCT04737772|467665353|FG001|Phase 2 Study|Did not take any coaching calls|0|||
129917742|NCT04737772|467665352|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
129917743|NCT04737772|467665353|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
129917744|NCT04737772|467665352|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
129917745|NCT04737772|467665353|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
129917746|NCT04083235|467665354|FG000|Overall Study|Death|252|||
129917747|NCT04083235|467665355|FG001|Overall Study|Death|277|||
129917748|NCT04083235|467665354|FG000|Overall Study|Withdrawal by Subject|13|||
129917749|NCT04083235|467665355|FG001|Overall Study|Withdrawal by Subject|17|||
129917750|NCT04083235|467665354|FG000|Overall Study|Lost to Follow-up|1|||
129917751|NCT04083235|467665355|FG001|Overall Study|Lost to Follow-up|1|||
129917752|NCT04083235|467665354|FG000|Overall Study|Does not meet entry criteria|1|||
129917753|NCT04083235|467665355|FG001|Overall Study|Does not meet entry criteria|0|||
129917754|NCT04083235|467665354|FG000|Overall Study|Did not receive treatment|13|||
129917755|NCT04083235|467665355|FG001|Overall Study|Did not receive treatment|8|||
129917756|NCT04083235|467665354|FG000|Overall Study|Ongoing at the time of DCO|44|||
129917757|NCT04083235|467665355|FG001|Overall Study|Ongoing at the time of DCO|7|||
129917758|NCT04263311|467665359|FG000|Overall Study|Lost to Follow-up|1|||
129917759|NCT04263311|467665360|FG001|Overall Study|Lost to Follow-up|2|||
129917760|NCT04263311|467665361|FG002|Overall Study|Lost to Follow-up|0|||
129917761|NCT04263311|467665359|FG000|Overall Study|Health Issues|1|||
129917762|NCT04263311|467665360|FG001|Overall Study|Health Issues|0|||
129917763|NCT04263311|467665361|FG002|Overall Study|Health Issues|0|||
129917764|NCT04263311|467665359|FG000|Overall Study|Left the country|1|||
129917765|NCT04263311|467665360|FG001|Overall Study|Left the country|0|||
129917766|NCT04263311|467665361|FG002|Overall Study|Left the country|0|||
129917767|NCT04263311|467665359|FG000|Overall Study|Unable to maintain time commitment|1|||
129917768|NCT04263311|467665360|FG001|Overall Study|Unable to maintain time commitment|0|||
129917769|NCT04263311|467665361|FG002|Overall Study|Unable to maintain time commitment|0|||
129917770|NCT04263311|467665359|FG000|Overall Study|No longer interested|1|||
129917771|NCT04263311|467665360|FG001|Overall Study|No longer interested|0|||
129917772|NCT04263311|467665361|FG002|Overall Study|No longer interested|0|||
129917773|NCT04263311|467665359|FG000|Overall Study|Ineligible post consent|0|||
129917774|NCT04263311|467665360|FG001|Overall Study|Ineligible post consent|0|||
129917775|NCT04263311|467665361|FG002|Overall Study|Ineligible post consent|5|||
129917776|NCT02592330|467665362|FG000|Overall Study|Withdrawal by Subject|1|||
129917777|NCT02592330|467665363|FG001|Overall Study|Withdrawal by Subject|0|||
129917778|NCT02592330|467665362|FG000|Overall Study|Failed Biopsy|1|||
129917779|NCT02592330|467665363|FG001|Overall Study|Failed Biopsy|0|||
129917780|NCT04673929|467665364|FG000|Overall Study|Death|73|||
129917781|NCT04673929|467665364|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
129917782|NCT02927769|467665366|FG000|Induction Phase|Study drug toxicity|1|||
129917783|NCT02927769|467665367|FG001|Induction Phase|Study drug toxicity|1|||
129917784|NCT02927769|467665366|FG000|Induction Phase|Disease progression|0|||
129917785|NCT02927769|467665367|FG001|Induction Phase|Disease progression|1|||
129917786|NCT02927769|467665366|FG000|Intensification Phase|Study drug toxicity|1|||
129917787|NCT02927769|467665367|FG001|Intensification Phase|Study drug toxicity|0|||
129917788|NCT02807636|467665370|FG000|Overall Study|Lost to Follow-up|10|||
129917789|NCT02807636|467665371|FG001|Overall Study|Lost to Follow-up|13|||
129917790|NCT02807636|467665372|FG002|Overall Study|Lost to Follow-up|6|||
129917791|NCT02807636|467665370|FG000|Overall Study|Protocol Deviation|1|||
129917792|NCT02807636|467665371|FG001|Overall Study|Protocol Deviation|0|||
129917793|NCT02807636|467665372|FG002|Overall Study|Protocol Deviation|0|||
129917794|NCT02807636|467665370|FG000|Overall Study|Symptomatic Deterioration|0|||
129917795|NCT02807636|467665371|FG001|Overall Study|Symptomatic Deterioration|1|||
129917796|NCT02807636|467665372|FG002|Overall Study|Symptomatic Deterioration|0|||
129917797|NCT02807636|467665370|FG000|Overall Study|Withdrawal by Subject|39|||
129917798|NCT02807636|467665371|FG001|Overall Study|Withdrawal by Subject|28|||
129917799|NCT02807636|467665372|FG002|Overall Study|Withdrawal by Subject|24|||
129917800|NCT02807636|467665370|FG000|Overall Study|Death|303|||
129917801|NCT02807636|467665371|FG001|Overall Study|Death|332|||
129917802|NCT02807636|467665372|FG002|Overall Study|Death|272|||
129917803|NCT02807636|467665370|FG000|Overall Study|Study Terminated By Sponsor|47|||
129917804|NCT02807636|467665371|FG001|Overall Study|Study Terminated By Sponsor|76|||
129917805|NCT02807636|467665372|FG002|Overall Study|Study Terminated By Sponsor|60|||
129917806|NCT02807636|467665370|FG000|Overall Study|Physician Decision|0|||
129917807|NCT02807636|467665371|FG001|Overall Study|Physician Decision|1|||
129917808|NCT02807636|467665372|FG002|Overall Study|Physician Decision|0|||
129917809|NCT05082909|467665373|FG000|Overall Study|Protocol Violation|0|||
129917810|NCT05082909|467665374|FG001|Overall Study|Protocol Violation|0|||
129917811|NCT05082909|467665375|FG002|Overall Study|Protocol Violation|1|||
129917812|NCT05082909|467665376|FG003|Overall Study|Protocol Violation|0|||
129917813|NCT05082909|467665377|FG004|Overall Study|Protocol Violation|0|||
129917814|NCT05082909|467665378|FG005|Overall Study|Protocol Violation|0|||
129917815|NCT04088630|467665379|FG000|Overall Study|Lost to Follow-up|3|||
129917816|NCT04088630|467665380|FG001|Overall Study|Lost to Follow-up|2|||
129917817|NCT04088630|467665381|FG002|Overall Study|Lost to Follow-up|6|||
129917818|NCT04088630|467665379|FG000|Overall Study|Death|3|||
129917819|NCT04088630|467665380|FG001|Overall Study|Death|1|||
129917820|NCT04088630|467665381|FG002|Overall Study|Death|1|||
129917821|NCT04088630|467665379|FG000|Overall Study|Physician Decision|0|||
129917822|NCT04088630|467665380|FG001|Overall Study|Physician Decision|1|||
129917823|NCT04088630|467665381|FG002|Overall Study|Physician Decision|1|||
129917824|NCT03315754|467665384|FG000|Overall Study|COVID-19 complications leading to death|1|||
129917825|NCT03315754|467665384|FG000|Overall Study|insurance coverage issue|1|||
129917826|NCT02954341|467665385|FG000|Overall Study|Attempted Implant unsuccessful|5|||
129917827|NCT02954341|467665385|FG000|Overall Study|Death|90|||
129917828|NCT02954341|467665385|FG000|Overall Study|Withdrawal by Subject|4|||
129870533|NCT00771810|467482480|FG002|Overall Study|Withdrawal by Subject|0|||
129870534|NCT00771810|467482478|FG000|Overall Study|Other|0|||
129870535|NCT00771810|467482479|FG001|Overall Study|Other|0|||
129870536|NCT00771810|467482480|FG002|Overall Study|Other|1|||
129870537|NCT00045305|467482484|FG000|Overall Study|Lack of Efficacy|6|||
129870538|NCT00045305|467482484|FG000|Overall Study|Adverse Event|3|||
129870539|NCT00045305|467482484|FG000|Overall Study|Death|3|||
129870540|NCT00045305|467482484|FG000|Overall Study|site error|2|||
129870541|NCT03848403|467482490|FG000|Period 2 (Day 8)|Adverse Event|1|||
129870542|NCT03848403|467482491|FG001|Period 2 (Day 8)|Adverse Event|2|||
129870543|NCT03848403|467482492|FG002|Period 2 (Day 8)|Adverse Event|2|||
129870544|NCT03848403|467482490|FG000|Period 2 (Day 8)|Physician Decision|0|||
129870545|NCT03848403|467482491|FG001|Period 2 (Day 8)|Physician Decision|1|||
129870546|NCT03848403|467482492|FG002|Period 2 (Day 8)|Physician Decision|0|||
129870547|NCT03848403|467482490|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
129870548|NCT03848403|467482491|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
129870549|NCT03848403|467482492|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
129870550|NCT01939548|467482493|FG000|Overall Study|Non compliance|0|||
129917829|NCT02954341|467665385|FG000|Overall Study|Physician Decision|13|||
129917830|NCT02954341|467665385|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
129917831|NCT02954341|467665385|FG000|Overall Study|Not implanted due to physician's decision|1|||
129917832|NCT02954341|467665385|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
129917833|NCT05227209|467665389|FG000|Overall Study|Adverse Event|11|||
129917834|NCT05227209|467665389|FG000|Overall Study|Lost to Follow-up|1|||
129870551|NCT01939548|467482494|FG001|Overall Study|Non compliance|2|||
129870552|NCT01939548|467482495|FG002|Overall Study|Non compliance|0|||
129870553|NCT01939548|467482493|FG000|Overall Study|Study Terminated by Sponsor|17|||
129917835|NCT05227209|467665389|FG000|Overall Study|Withdrawal by Subject|7|||
129917836|NCT05227209|467665389|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
129870554|NCT01939548|467482494|FG001|Overall Study|Study Terminated by Sponsor|19|||
129917837|NCT04245501|467665392|FG000|Overall Study|Adverse Event|2|||
129917838|NCT04245501|467665393|FG001|Overall Study|Adverse Event|0|||
129917839|NCT04245501|467665392|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
129870555|NCT01939548|467482495|FG002|Overall Study|Study Terminated by Sponsor|12|||
129917840|NCT04245501|467665393|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
129917841|NCT01426425|467665394|FG000|Overall Study|Exited prior to EP study|22|||
129917842|NCT01426425|467665394|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
130116759|NCT00818623|468387168|FG004|Overall Study|Disease progression|0|||
129870556|NCT01939548|467482493|FG000|Overall Study|Insufficient Clinical Response|1|||
129870557|NCT01939548|467482494|FG001|Overall Study|Insufficient Clinical Response|0|||
129870558|NCT01939548|467482495|FG002|Overall Study|Insufficient Clinical Response|0|||
129870559|NCT01939548|467482493|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129870560|NCT01939548|467482494|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
129870561|NCT01939548|467482495|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
129870562|NCT01939548|467482493|FG000|Overall Study|Withdrawal by Subject|4|||
129870563|NCT01939548|467482494|FG001|Overall Study|Withdrawal by Subject|4|||
129870564|NCT01939548|467482495|FG002|Overall Study|Withdrawal by Subject|1|||
129870565|NCT01939548|467482493|FG000|Overall Study|Protocol Violation|7|||
129870566|NCT01939548|467482494|FG001|Overall Study|Protocol Violation|6|||
129870567|NCT01939548|467482495|FG002|Overall Study|Protocol Violation|5|||
129870568|NCT01939548|467482493|FG000|Overall Study|Lost to Follow-up|5|||
129870569|NCT01939548|467482494|FG001|Overall Study|Lost to Follow-up|5|||
129870570|NCT01939548|467482495|FG002|Overall Study|Lost to Follow-up|3|||
129870571|NCT01939548|467482493|FG000|Overall Study|Adverse Event|2|||
129870572|NCT01939548|467482494|FG001|Overall Study|Adverse Event|9|||
129870573|NCT01939548|467482495|FG002|Overall Study|Adverse Event|7|||
129870574|NCT01939548|467482493|FG000|Overall Study|Death|0|||
129870575|NCT01939548|467482494|FG001|Overall Study|Death|0|||
129870576|NCT01939548|467482495|FG002|Overall Study|Death|1|||
129870577|NCT01939548|467482493|FG000|Overall Study|Participant dropped|0|||
129870578|NCT01939548|467482494|FG001|Overall Study|Participant dropped|0|||
129870579|NCT01939548|467482495|FG002|Overall Study|Participant dropped|1|||
129870580|NCT01939548|467482493|FG000|Overall Study|Participant unwilling to continue|0|||
129870581|NCT01939548|467482494|FG001|Overall Study|Participant unwilling to continue|1|||
129870582|NCT01939548|467482495|FG002|Overall Study|Participant unwilling to continue|0|||
129870583|NCT01939548|467482493|FG000|Overall Study|Participant withdrew consent|0|||
129870584|NCT01939548|467482494|FG001|Overall Study|Participant withdrew consent|2|||
129870585|NCT01939548|467482495|FG002|Overall Study|Participant withdrew consent|0|||
129870586|NCT01939548|467482493|FG000|Overall Study|Did not complete follow-up|0|||
129870587|NCT01939548|467482494|FG001|Overall Study|Did not complete follow-up|1|||
129870588|NCT01939548|467482495|FG002|Overall Study|Did not complete follow-up|0|||
129870589|NCT02114151|467482503|FG000|Overall Study|Death|1|||
129870590|NCT02114151|467482503|FG000|Overall Study|Lost to Follow-up|1|||
129870591|NCT02114151|467482503|FG000|Overall Study|Withdrawal by Subject|5|||
129870592|NCT02638948|467482506|FG000|Overall Study|Withdrawal by Subject|4|||
129870593|NCT02638948|467482507|FG001|Overall Study|Withdrawal by Subject|5|||
129870594|NCT02638948|467482508|FG002|Overall Study|Withdrawal by Subject|3|||
129870595|NCT02638948|467482509|FG003|Overall Study|Withdrawal by Subject|1|||
129870596|NCT02638948|467482506|FG000|Overall Study|Administrative Reason by Sponsor|0|||
129870597|NCT02638948|467482507|FG001|Overall Study|Administrative Reason by Sponsor|1|||
129870598|NCT02638948|467482508|FG002|Overall Study|Administrative Reason by Sponsor|0|||
129870599|NCT02638948|467482509|FG003|Overall Study|Administrative Reason by Sponsor|4|||
129870600|NCT02638948|467482506|FG000|Overall Study|Adverse Event|0|||
129870601|NCT02638948|467482507|FG001|Overall Study|Adverse Event|0|||
129870602|NCT02638948|467482508|FG002|Overall Study|Adverse Event|1|||
129870603|NCT02638948|467482509|FG003|Overall Study|Adverse Event|1|||
129870604|NCT02638948|467482506|FG000|Overall Study|Lack of Efficacy|1|||
129870605|NCT02638948|467482507|FG001|Overall Study|Lack of Efficacy|1|||
129870606|NCT02638948|467482508|FG002|Overall Study|Lack of Efficacy|0|||
129870607|NCT02638948|467482509|FG003|Overall Study|Lack of Efficacy|0|||
129870608|NCT02638948|467482506|FG000|Overall Study|Lost to Follow-up|0|||
129870609|NCT02638948|467482507|FG001|Overall Study|Lost to Follow-up|0|||
129870610|NCT02638948|467482508|FG002|Overall Study|Lost to Follow-up|1|||
129870611|NCT02638948|467482509|FG003|Overall Study|Lost to Follow-up|1|||
129870612|NCT02638948|467482506|FG000|Overall Study|Poor/Non-Compliance|0|||
129870613|NCT02638948|467482507|FG001|Overall Study|Poor/Non-Compliance|2|||
129870614|NCT02638948|467482508|FG002|Overall Study|Poor/Non-Compliance|1|||
129870615|NCT02638948|467482509|FG003|Overall Study|Poor/Non-Compliance|0|||
129870616|NCT02638948|467482506|FG000|Overall Study|Participant no longer met study criteria|0|||
129870617|NCT02638948|467482507|FG001|Overall Study|Participant no longer met study criteria|1|||
129870618|NCT02638948|467482508|FG002|Overall Study|Participant no longer met study criteria|0|||
129870619|NCT02638948|467482509|FG003|Overall Study|Participant no longer met study criteria|0|||
129870620|NCT02638948|467482506|FG000|Overall Study|Other than specified above|4|||
129870621|NCT02638948|467482507|FG001|Overall Study|Other than specified above|1|||
129870622|NCT02638948|467482508|FG002|Overall Study|Other than specified above|1|||
129870623|NCT02638948|467482509|FG003|Overall Study|Other than specified above|1|||
129870624|NCT00810264|467482513|FG000|Overall Study|Lost to Follow-up|191|||
129870625|NCT00810264|467482513|FG000|Overall Study|Withdrawal by subject or physician|721|||
129870626|NCT00810264|467482513|FG000|Overall Study|Death|641|||
129870627|NCT06213701|467482514|FG000|Overall Study|Withdrawal by Subject|2|||
129870628|NCT06213701|467482515|FG001|Overall Study|Withdrawal by Subject|1|||
129870629|NCT06213701|467482516|FG002|Overall Study|Withdrawal by Subject|0|||
129870630|NCT02495025|467482523|FG000|Overall Study|Lost to Follow-up|21|||
129870631|NCT02495025|467482524|FG001|Overall Study|Lost to Follow-up|14|||
129870632|NCT02495025|467482523|FG000|Overall Study|Withdrawal by Subject|5|||
129870633|NCT02495025|467482524|FG001|Overall Study|Withdrawal by Subject|0|||
129870634|NCT02134587|467482528|FG000|Overall Study|Did not completed all meetings|30|||
129870635|NCT00265889|467482529|FG000|Overall Study|Physician Decision|1|||
129870636|NCT00265889|467482529|FG000|Overall Study|Protocol Violation|1|||
129870637|NCT00265889|467482529|FG000|Overall Study|Insurance denied the request|3|||
129870638|NCT01515748|467482533|FG000|Overall Study|Withdrawal by Subject|32|||
129870639|NCT01515748|467482534|FG001|Overall Study|Withdrawal by Subject|41|||
129870640|NCT01515748|467482533|FG000|Overall Study|Lost to Follow-up|2|||
129870641|NCT01515748|467482534|FG001|Overall Study|Lost to Follow-up|4|||
129870642|NCT01515748|467482533|FG000|Overall Study|Other than specified above|5|||
129870643|NCT01515748|467482534|FG001|Overall Study|Other than specified above|10|||
129870644|NCT03221387|467482537|FG000|Overall Study|Lost to Follow-up|1|||
129870645|NCT03221387|467482537|FG000|Overall Study|Lung transplant|1|||
129870646|NCT04102579|467482541|FG000|Overall Study|Withdrawal by Subject|3|||
129870647|NCT04102579|467482542|FG001|Overall Study|Withdrawal by Subject|4|||
129870648|NCT04102579|467482541|FG000|Overall Study|Lost to Follow-up|0|||
129870649|NCT04102579|467482542|FG001|Overall Study|Lost to Follow-up|1|||
129870650|NCT04102579|467482541|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
129870651|NCT04102579|467482542|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
129870652|NCT04102579|467482541|FG000|Overall Study|Other than Specified|1|||
129870653|NCT04102579|467482542|FG001|Overall Study|Other than Specified|0|||
129870654|NCT04102579|467482541|FG000|Overall Study|Not Dosed with Study Drug|0|||
129870655|NCT04102579|467482542|FG001|Overall Study|Not Dosed with Study Drug|1|||
129870656|NCT01337674|467484128|FG000|Treatment Period 1|Adverse Event|0|||
129870657|NCT01337674|467484129|FG001|Treatment Period 1|Adverse Event|1|||
129870658|NCT01337674|467484130|FG002|Treatment Period 1|Adverse Event|0|||
129870659|NCT01337674|467484131|FG003|Treatment Period 1|Adverse Event|0|||
129870660|NCT01337674|467484128|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
129870661|NCT01337674|467484129|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
129870662|NCT01337674|467484130|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
129870663|NCT01337674|467484131|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
129870664|NCT01337674|467484128|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129870665|NCT01337674|467484129|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129870666|NCT01337674|467484130|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129870667|NCT01337674|467484131|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129870668|NCT01203930|467484132|FG000|Overall Study|Disease Progression|0|||
129870669|NCT01203930|467484133|FG001|Overall Study|Disease Progression|4|||
129870670|NCT01203930|467484132|FG000|Overall Study|Death|3|||
129870671|NCT01203930|467484133|FG001|Overall Study|Death|1|||
129870672|NCT01203930|467484132|FG000|Overall Study|Withdrew Consent|1|||
129870673|NCT01203930|467484133|FG001|Overall Study|Withdrew Consent|10|||
129870674|NCT01203930|467484132|FG000|Overall Study|Investigator Request|0|||
129870675|NCT01203930|467484133|FG001|Overall Study|Investigator Request|8|||
129870676|NCT01203930|467484132|FG000|Overall Study|Study Terminated by Sponsor|0|||
129870677|NCT01203930|467484133|FG001|Overall Study|Study Terminated by Sponsor|12|||
129870678|NCT01203930|467484132|FG000|Overall Study|Poor tolerance of study drug|0|||
129870679|NCT01203930|467484133|FG001|Overall Study|Poor tolerance of study drug|1|||
129870680|NCT01203930|467484132|FG000|Overall Study|Adverse Event|17|||
129870681|NCT01203930|467484133|FG001|Overall Study|Adverse Event|5|||
129870682|NCT02178059|467484134|FG000|Washout|Physician Decision|1|||
129870683|NCT02178059|467484135|FG001|Washout|Physician Decision|0|||
129870684|NCT05178121|467484136|FG000|Overall Study|Other|4|||
129870685|NCT05178121|467484136|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
129870686|NCT02035332|467484140|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
129870687|NCT00662857|467484141|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
129870688|NCT00662857|467484142|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
129870689|NCT00662857|467484141|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
129870690|NCT00662857|467484142|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
129870691|NCT00662857|467484141|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
129870692|NCT00662857|467484142|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
129870693|NCT00838682|467484143|FG000|Overall Study|Lost to Follow-up|21|||
129870694|NCT00838682|467484144|FG001|Overall Study|Lost to Follow-up|14|||
129870695|NCT00838682|467484143|FG000|Overall Study|detection of exclusion criteria|4|||
129870696|NCT00838682|467484144|FG001|Overall Study|detection of exclusion criteria|3|||
129870697|NCT00838682|467484143|FG000|Overall Study|Protocol Violation|0|||
129870698|NCT00838682|467484144|FG001|Overall Study|Protocol Violation|1|||
129870699|NCT00838682|467484143|FG000|Overall Study|Withdrawal by Subject|0|||
129870700|NCT00838682|467484144|FG001|Overall Study|Withdrawal by Subject|1|||
129870701|NCT03966053|467484145|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
129870702|NCT00989092|467484148|FG000|Overall Study|Physician Decision|9|||
129870703|NCT00989092|467484149|FG001|Overall Study|Physician Decision|6|||
129870704|NCT00989092|467484148|FG000|Overall Study|Adverse Event|20|||
129870705|NCT00989092|467484149|FG001|Overall Study|Adverse Event|1|||
129870706|NCT00989092|467484148|FG000|Overall Study|Chemotherapy initiated|12|||
129870707|NCT00989092|467484149|FG001|Overall Study|Chemotherapy initiated|4|||
129870708|NCT00989092|467484148|FG000|Overall Study|Withdrawal by Subject|17|||
129870709|NCT00989092|467484149|FG001|Overall Study|Withdrawal by Subject|9|||
129870710|NCT00989092|467484148|FG000|Overall Study|Death|14|||
129870711|NCT00989092|467484149|FG001|Overall Study|Death|2|||
129870712|NCT00989092|467484148|FG000|Overall Study|Ineligibility determined|3|||
129870713|NCT00989092|467484149|FG001|Overall Study|Ineligibility determined|3|||
129870714|NCT00989092|467484148|FG000|Overall Study|Lost to Follow-up|6|||
129870715|NCT00989092|467484149|FG001|Overall Study|Lost to Follow-up|2|||
129870716|NCT00989092|467484148|FG000|Overall Study|Other|3|||
129870717|NCT00989092|467484149|FG001|Overall Study|Other|1|||
129870718|NCT00989092|467484148|FG000|Overall Study|Protocol deviation|2|||
129870719|NCT00989092|467484149|FG001|Overall Study|Protocol deviation|0|||
129870720|NCT00989092|467484148|FG000|Overall Study|Erythropoietin therapy initiated|2|||
129870721|NCT00989092|467484149|FG001|Overall Study|Erythropoietin therapy initiated|0|||
129870722|NCT00989092|467484148|FG000|Overall Study|Did not receive study drug|2|||
129870723|NCT00989092|467484149|FG001|Overall Study|Did not receive study drug|0|||
129870724|NCT04098406|467484153|FG000|Overall Study|Adverse Event|2|||
129870725|NCT04098406|467484154|FG001|Overall Study|Adverse Event|1|||
129870726|NCT04098406|467484153|FG000|Overall Study|Withdrawal by Subject|1|||
129870727|NCT04098406|467484154|FG001|Overall Study|Withdrawal by Subject|0|||
129870728|NCT01332227|467484155|FG000|Overall Study|Adverse Event|4|||
129870729|NCT01332227|467484156|FG001|Overall Study|Adverse Event|1|||
129870730|NCT01332227|467484155|FG000|Overall Study|Withdrawal by Subject|5|||
129870731|NCT01332227|467484156|FG001|Overall Study|Withdrawal by Subject|1|||
129870732|NCT01332227|467484155|FG000|Overall Study|Lost to Follow-up|2|||
129870733|NCT01332227|467484156|FG001|Overall Study|Lost to Follow-up|0|||
129870734|NCT01332227|467484155|FG000|Overall Study|Lack of Efficacy|3|||
129870735|NCT01332227|467484156|FG001|Overall Study|Lack of Efficacy|1|||
129870736|NCT01332227|467484155|FG000|Overall Study|Poor compliance/noncompliance|1|||
129870737|NCT01332227|467484156|FG001|Overall Study|Poor compliance/noncompliance|1|||
129870738|NCT01332227|467484155|FG000|Overall Study|Patient moved from area|1|||
129870739|NCT01332227|467484156|FG001|Overall Study|Patient moved from area|0|||
129870740|NCT01332227|467484155|FG000|Overall Study|Patient began prohibited medication|0|||
129870741|NCT01332227|467484156|FG001|Overall Study|Patient began prohibited medication|1|||
129870742|NCT00514943|467484157|FG000|Stage 1|Progressive disease|4|||
129870743|NCT00514943|467484158|FG001|Stage 1|Progressive disease|8|||
129870744|NCT00514943|467484157|FG000|Stage 1|Other Adverse Event|16|||
129870745|NCT00514943|467484158|FG001|Stage 1|Other Adverse Event|6|||
129870746|NCT00514943|467484157|FG000|Stage 1|Not treated|1|||
129870747|NCT00514943|467484158|FG001|Stage 1|Not treated|2|||
129870748|NCT00514943|467484157|FG000|Stage 1|Patient refused to continue study meds|8|||
129870749|NCT00514943|467484158|FG001|Stage 1|Patient refused to continue study meds|3|||
129870750|NCT00514943|467484157|FG000|Stage 1|Other than stated above|1|||
129870751|NCT00514943|467484158|FG001|Stage 1|Other than stated above|7|||
129870752|NCT00514943|467484157|FG000|Stage 2|Progressive disease|27|||
129870753|NCT00514943|467484158|FG001|Stage 2|Progressive disease|24|||
129870754|NCT00514943|467484157|FG000|Stage 2|Other Adverse Event|3|||
129870755|NCT00514943|467484158|FG001|Stage 2|Other Adverse Event|10|||
129870756|NCT00514943|467484157|FG000|Stage 2|Patient refused to continue study meds|2|||
129870757|NCT00514943|467484158|FG001|Stage 2|Patient refused to continue study meds|0|||
129870758|NCT00514943|467484157|FG000|Stage 2|Other than stated above|0|||
129870759|NCT00514943|467484158|FG001|Stage 2|Other than stated above|2|||
129870760|NCT02173548|467484163|FG000|Overall Study|Lost to Follow-up|0|||
129870761|NCT02173548|467484164|FG001|Overall Study|Lost to Follow-up|2|||
129870762|NCT02173548|467484163|FG000|Overall Study|Withdrawal by Subject|1|||
129870763|NCT02173548|467484164|FG001|Overall Study|Withdrawal by Subject|0|||
129870764|NCT01783418|467484168|FG000|Overall Study|Withdrawal by Subject|1|||
129870765|NCT01783418|467484169|FG001|Overall Study|Withdrawal by Subject|0|||
129870766|NCT03548207|467484170|FG000|Overall Study|Death|10|||
129870767|NCT03548207|467484171|FG001|Overall Study|Death|23|||
129870768|NCT03548207|467484172|FG002|Overall Study|Death|3|||
130066521|NCT00006604|468197825|FG009|Overall Study|Other Reason|1|||
130066522|NCT00006604|468197826|FG010|Overall Study|Other Reason|0|||
129870769|NCT03548207|467484170|FG000|Overall Study|Lost to Follow-up|0|||
129870770|NCT03548207|467484171|FG001|Overall Study|Lost to Follow-up|2|||
129870771|NCT03548207|467484172|FG002|Overall Study|Lost to Follow-up|0|||
129870772|NCT03548207|467484170|FG000|Overall Study|Withdrawal by Subject|0|||
129870773|NCT03548207|467484171|FG001|Overall Study|Withdrawal by Subject|3|||
129870774|NCT03548207|467484172|FG002|Overall Study|Withdrawal by Subject|0|||
129870775|NCT03548207|467484170|FG000|Overall Study|Sponsor decision|19|||
130066523|NCT00006604|468197827|FG011|Overall Study|Other Reason|0|||
129870776|NCT03548207|467484171|FG001|Overall Study|Sponsor decision|40|||
129870777|NCT03548207|467484172|FG002|Overall Study|Sponsor decision|6|||
129870778|NCT03548207|467484170|FG000|Overall Study|Randomized but not treated|6|||
129870779|NCT03548207|467484171|FG001|Overall Study|Randomized but not treated|10|||
130066524|NCT00006604|468197828|FG012|Overall Study|Other Reason|0|||
130066525|NCT00006604|468197829|FG013|Overall Study|Other Reason|0|||
130066526|NCT00006604|468197830|FG014|Overall Study|Other Reason|0|||
130066527|NCT00006604|468197831|FG015|Overall Study|Other Reason|0|||
130066528|NCT00006604|468197832|FG016|Overall Study|Other Reason|0|||
130066529|NCT01056341|468197835|FG000|Overall Study|Treatment Intolerance|0|||
130066530|NCT01056341|468197836|FG001|Overall Study|Treatment Intolerance|2|||
130066531|NCT01056341|468197837|FG002|Overall Study|Treatment Intolerance|0|||
130066532|NCT01056341|468197838|FG003|Overall Study|Treatment Intolerance|2|||
130066533|NCT01056341|468197839|FG004|Overall Study|Treatment Intolerance|0|||
130066534|NCT01056341|468197835|FG000|Overall Study|Lack of Efficacy|32|||
130066535|NCT01056341|468197836|FG001|Overall Study|Lack of Efficacy|30|||
130066536|NCT01056341|468197837|FG002|Overall Study|Lack of Efficacy|7|||
130066537|NCT01056341|468197838|FG003|Overall Study|Lack of Efficacy|25|||
130066538|NCT01056341|468197839|FG004|Overall Study|Lack of Efficacy|9|||
130066539|NCT01056341|468197835|FG000|Overall Study|Other reasons|4|||
130066540|NCT01056341|468197836|FG001|Overall Study|Other reasons|4|||
130066541|NCT01056341|468197837|FG002|Overall Study|Other reasons|8|||
130066542|NCT01056341|468197838|FG003|Overall Study|Other reasons|9|||
130066543|NCT01056341|468197839|FG004|Overall Study|Other reasons|5|||
130066544|NCT01167582|468197840|FG000|Overall Study|Lost to Follow-up|0|||
130066545|NCT01167582|468197841|FG001|Overall Study|Lost to Follow-up|1|||
130066546|NCT01182337|468197842|FG000|Overall Study|Withdrawal by Subject|3|||
130066547|NCT01182337|468197843|FG001|Overall Study|Withdrawal by Subject|1|||
130066548|NCT01182337|468197842|FG000|Overall Study|Lost to Follow-up|0|||
130066549|NCT01182337|468197843|FG001|Overall Study|Lost to Follow-up|1|||
130066550|NCT00575094|468197846|FG000|Overall Study|Adverse Event|2|||
130066551|NCT00575094|468197846|FG000|Overall Study|Withdrawal by Subject|1|||
130066552|NCT00772382|468197847|FG000|Overall Study|Adverse Event|19|||
130066553|NCT00772382|468197847|FG000|Overall Study|Death|6|||
130066554|NCT00772382|468197847|FG000|Overall Study|Lack of Efficacy|4|||
130066555|NCT00772382|468197847|FG000|Overall Study|Physician Decision|5|||
130066556|NCT00772382|468197847|FG000|Overall Study|Protocol Violation|1|||
130066557|NCT00772382|468197847|FG000|Overall Study|Withdrawal by Subject|10|||
130066558|NCT00772382|468197847|FG000|Overall Study|Other Reasons|10|||
130066559|NCT00643604|468197853|FG000|Overall Study|Death|1|||
130066560|NCT02702011|468197854|FG000|Overall Study|Withdrawal by Subject|0|||
130066561|NCT02702011|468197855|FG001|Overall Study|Withdrawal by Subject|1|||
130066562|NCT02702011|468197856|FG002|Overall Study|Withdrawal by Subject|0|||
130066563|NCT02702011|468197857|FG003|Overall Study|Withdrawal by Subject|0|||
130066564|NCT00475540|468197858|FG000|36 Months|Lost to Follow-up|4|||
130066565|NCT00475540|468197859|FG001|36 Months|Lost to Follow-up|4|||
130066566|NCT00475540|468197858|FG000|36 Months|Death|1|||
130066567|NCT00475540|468197859|FG001|36 Months|Death|2|||
130066568|NCT00475540|468197858|FG000|36 Months|Censored due to reoperation|3|||
130066569|NCT00475540|468197859|FG001|36 Months|Censored due to reoperation|0|||
130066570|NCT02148211|468197860|FG000|Overall Study|Lost to Follow-up|352|||
130066571|NCT02726113|468197861|FG000|Total Enrollment|Physician Decision|0|||
130066572|NCT02726113|468197862|FG001|Total Enrollment|Physician Decision|1|||
130066573|NCT02726113|468197861|FG000|Total Enrollment|Protocol Violation|1|||
130066574|NCT02726113|468197862|FG001|Total Enrollment|Protocol Violation|0|||
130066575|NCT02726113|468197861|FG000|Total Enrollment|Withdrawal by Subject|2|||
130066576|NCT02726113|468197862|FG001|Total Enrollment|Withdrawal by Subject|1|||
130066577|NCT02726113|468197861|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
130066578|NCT02726113|468197862|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
130066579|NCT02726113|468197861|FG000|Genomic Analysis|Protocol Violation|1|||
130066580|NCT02726113|468197862|FG001|Genomic Analysis|Protocol Violation|0|||
130066581|NCT02726113|468197861|FG000|Genomic Analysis|Withdrawal by Subject|2|||
130066582|NCT02726113|468197862|FG001|Genomic Analysis|Withdrawal by Subject|1|||
130066583|NCT02726113|468197861|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
130066584|NCT02726113|468197862|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
130066585|NCT03287869|468199711|FG000|Overall Study|Adverse Event|14|||
130066586|NCT03287869|468199712|FG001|Overall Study|Adverse Event|12|||
130066587|NCT03287869|468199711|FG000|Overall Study|Lack of Efficacy|1|||
130066588|NCT03287869|468199712|FG001|Overall Study|Lack of Efficacy|0|||
130066589|NCT03287869|468199711|FG000|Overall Study|Lost to Follow-up|13|||
130066590|NCT03287869|468199712|FG001|Overall Study|Lost to Follow-up|19|||
130066591|NCT03287869|468199711|FG000|Overall Study|Non-Compliance With Study Drug|5|||
130066592|NCT03287869|468199712|FG001|Overall Study|Non-Compliance With Study Drug|9|||
130066593|NCT03287869|468199711|FG000|Overall Study|Progressive Disease|1|||
130066594|NCT03287869|468199712|FG001|Overall Study|Progressive Disease|0|||
130066595|NCT03287869|468199711|FG000|Overall Study|Protocol Deviation|2|||
130066596|NCT03287869|468199712|FG001|Overall Study|Protocol Deviation|1|||
130066597|NCT03287869|468199711|FG000|Overall Study|Withdrawal by Subject|36|||
130066598|NCT03287869|468199712|FG001|Overall Study|Withdrawal by Subject|43|||
130066599|NCT03287869|468199711|FG000|Overall Study|Early Closure of the Site|0|||
130066600|NCT03287869|468199712|FG001|Overall Study|Early Closure of the Site|1|||
130066601|NCT03287869|468199711|FG000|Overall Study|Physician Decision|5|||
130066602|NCT03287869|468199712|FG001|Overall Study|Physician Decision|5|||
130066603|NCT03287869|468199711|FG000|Overall Study|Reason not Specified|6|||
130066604|NCT03287869|468199712|FG001|Overall Study|Reason not Specified|3|||
130066605|NCT03488238|468199713|FG000|Overall Study|Equipment malfunction|1|||
130066606|NCT03488238|468199713|FG000|Overall Study|Adverse Event|1|||
130066607|NCT02670928|468199714|FG000|Overall Study|Adverse Event|3|||
130066608|NCT02670928|468199715|FG001|Overall Study|Adverse Event|1|||
130066609|NCT02670928|468199714|FG000|Overall Study|Withdrawal by Subject|4|||
130066610|NCT02670928|468199715|FG001|Overall Study|Withdrawal by Subject|0|||
130066611|NCT02670928|468199714|FG000|Overall Study|Lost to Follow-up|1|||
130066612|NCT02670928|468199715|FG001|Overall Study|Lost to Follow-up|0|||
130066613|NCT02670928|468199714|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
130066614|NCT02670928|468199715|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
130066615|NCT02591238|468199716|FG000|Overall Study|Pregnancy|1|||
130066616|NCT02591238|468199717|FG001|Overall Study|Pregnancy|0|||
130066617|NCT02591238|468199718|FG002|Overall Study|Pregnancy|0|||
130066618|NCT02591238|468199719|FG003|Overall Study|Pregnancy|0|||
129870780|NCT03548207|467484172|FG002|Overall Study|Randomized but not treated|4|||
129870781|NCT00415610|467484173|FG000|Overall Study|Death|3|||
129870782|NCT00415610|467484174|FG001|Overall Study|Death|2|||
129870783|NCT00415610|467484175|FG002|Overall Study|Death|5|||
129870784|NCT00999466|467484178|FG000|Main Part|Withdrawal by Subject|0|||
129870785|NCT00999466|467484179|FG001|Main Part|Withdrawal by Subject|0|||
129870786|NCT00999466|467484180|FG002|Main Part|Withdrawal by Subject|2|||
129870787|NCT00999466|467484178|FG000|Main Part|Adverse Event|0|||
129870788|NCT00999466|467484179|FG001|Main Part|Adverse Event|4|||
130066619|NCT02591238|468199716|FG000|Overall Study|Withdrawal by Subject|0|||
130066620|NCT02591238|468199717|FG001|Overall Study|Withdrawal by Subject|0|||
130066621|NCT02591238|468199718|FG002|Overall Study|Withdrawal by Subject|0|||
130066622|NCT02591238|468199719|FG003|Overall Study|Withdrawal by Subject|1|||
130066623|NCT02591238|468199716|FG000|Overall Study|influenza|0|||
129870789|NCT00999466|467484180|FG002|Main Part|Adverse Event|2|||
129870790|NCT03040713|467484181|FG000|Overall Study|Positive amyloid scan|3|||
129870791|NCT04539821|467484182|FG000|Overall Study|Withdrawal by Subject|2|||
129870792|NCT04539821|467484182|FG000|Overall Study|continued care with their physician|20|||
129870793|NCT04539821|467484182|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
129870794|NCT02641392|467484183|FG000|Overall Study|Lost to Follow-up|0|||
129870795|NCT02641392|467484184|FG001|Overall Study|Lost to Follow-up|0|||
129870796|NCT02641392|467484185|FG002|Overall Study|Lost to Follow-up|2|||
129870797|NCT02641392|467484183|FG000|Overall Study|Withdrawal by Subject|0|||
129870798|NCT02641392|467484184|FG001|Overall Study|Withdrawal by Subject|0|||
129870799|NCT02641392|467484185|FG002|Overall Study|Withdrawal by Subject|17|||
129870800|NCT02641392|467484183|FG000|Overall Study|Adverse Event|0|||
129870801|NCT02641392|467484184|FG001|Overall Study|Adverse Event|1|||
129870802|NCT02641392|467484185|FG002|Overall Study|Adverse Event|25|||
129870803|NCT02641392|467484183|FG000|Overall Study|Study Terminated by Sponsor|4|||
129870804|NCT02641392|467484184|FG001|Overall Study|Study Terminated by Sponsor|12|||
129870805|NCT02641392|467484185|FG002|Overall Study|Study Terminated by Sponsor|144|||
129870806|NCT02641392|467484183|FG000|Overall Study|Lack of Efficacy|0|||
129870807|NCT02641392|467484184|FG001|Overall Study|Lack of Efficacy|0|||
129870808|NCT02641392|467484185|FG002|Overall Study|Lack of Efficacy|101|||
129870809|NCT02641392|467484183|FG000|Overall Study|Miscellaneous|0|||
129870810|NCT02641392|467484184|FG001|Overall Study|Miscellaneous|0|||
129870811|NCT02641392|467484185|FG002|Overall Study|Miscellaneous|3|||
129870812|NCT02641392|467484183|FG000|Overall Study|Death|0|||
129870813|NCT02641392|467484184|FG001|Overall Study|Death|0|||
129870814|NCT02641392|467484185|FG002|Overall Study|Death|1|||
129870815|NCT02691182|467484186|FG000|Overall Study|Withdrawal by Subject|4|||
129870816|NCT02691182|467484187|FG001|Overall Study|Withdrawal by Subject|7|||
129870817|NCT02691182|467484188|FG002|Overall Study|Withdrawal by Subject|6|||
129870818|NCT02691182|467484189|FG003|Overall Study|Withdrawal by Subject|8|||
129870819|NCT02691182|467484186|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
129870820|NCT02691182|467484187|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
129870821|NCT02691182|467484188|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
130066624|NCT02591238|468199717|FG001|Overall Study|influenza|0|||
130066625|NCT02591238|468199718|FG002|Overall Study|influenza|0|||
130066626|NCT02591238|468199719|FG003|Overall Study|influenza|1|||
130066627|NCT02591238|468199716|FG000|Overall Study|personal circumstances|0|||
129870822|NCT02691182|467484189|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
129870823|NCT02691182|467484186|FG000|Overall Study|Lost to Follow-up|8|||
129870824|NCT02691182|467484187|FG001|Overall Study|Lost to Follow-up|33|||
129870825|NCT02691182|467484188|FG002|Overall Study|Lost to Follow-up|19|||
129870826|NCT02691182|467484189|FG003|Overall Study|Lost to Follow-up|22|||
129870827|NCT02691182|467484186|FG000|Overall Study|Adverse Event|3|||
129870828|NCT02691182|467484187|FG001|Overall Study|Adverse Event|10|||
129870829|NCT02691182|467484188|FG002|Overall Study|Adverse Event|10|||
130066628|NCT02591238|468199717|FG001|Overall Study|personal circumstances|0|||
130066629|NCT02591238|468199718|FG002|Overall Study|personal circumstances|0|||
130066630|NCT02591238|468199719|FG003|Overall Study|personal circumstances|1|||
129917843|NCT01426425|467665394|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
129917844|NCT03281291|467665400|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
129917845|NCT03281291|467665401|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
129917846|NCT03281291|467665402|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
129917847|NCT03281291|467665403|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
129917848|NCT03281291|467665404|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
129917849|NCT03281291|467665400|FG000|Overall Study|Protocol Deviation|2|||
129917850|NCT03281291|467665401|FG001|Overall Study|Protocol Deviation|0|||
129917851|NCT03281291|467665402|FG002|Overall Study|Protocol Deviation|1|||
129917852|NCT03281291|467665403|FG003|Overall Study|Protocol Deviation|2|||
129917853|NCT03281291|467665404|FG004|Overall Study|Protocol Deviation|1|||
129917854|NCT03281291|467665400|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
129917855|NCT03281291|467665401|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
129917856|NCT03281291|467665402|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
129917857|NCT03281291|467665403|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
129917858|NCT03281291|467665404|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
129917859|NCT03281291|467665400|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
129917860|NCT03281291|467665401|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
129917861|NCT03281291|467665402|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
129917862|NCT03281291|467665403|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
129917863|NCT03281291|467665404|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
129917864|NCT03281291|467665400|FG000|Overall Study|Lost to Follow-up|10|||
129917865|NCT03281291|467665401|FG001|Overall Study|Lost to Follow-up|10|||
129917866|NCT03281291|467665402|FG002|Overall Study|Lost to Follow-up|4|||
129870830|NCT02691182|467484189|FG003|Overall Study|Adverse Event|11|||
129870831|NCT02691182|467484186|FG000|Overall Study|Physician Decision|3|||
129870832|NCT02691182|467484187|FG001|Overall Study|Physician Decision|7|||
129870833|NCT02691182|467484188|FG002|Overall Study|Physician Decision|14|||
129870834|NCT02691182|467484189|FG003|Overall Study|Physician Decision|8|||
129870835|NCT02691182|467484186|FG000|Overall Study|Lack of Efficacy|0|||
129870836|NCT02691182|467484187|FG001|Overall Study|Lack of Efficacy|0|||
129870837|NCT02691182|467484188|FG002|Overall Study|Lack of Efficacy|0|||
129870838|NCT02691182|467484189|FG003|Overall Study|Lack of Efficacy|4|||
129870839|NCT02691182|467484186|FG000|Overall Study|Protocol Violation|2|||
129870840|NCT02691182|467484187|FG001|Overall Study|Protocol Violation|6|||
129870841|NCT02691182|467484188|FG002|Overall Study|Protocol Violation|6|||
129870842|NCT02691182|467484189|FG003|Overall Study|Protocol Violation|8|||
129870843|NCT02691182|467484186|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
129870844|NCT02691182|467484187|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
129870845|NCT02691182|467484188|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
129870846|NCT02691182|467484189|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
129870847|NCT02691182|467484186|FG000|Overall Study|Missing|0|||
129870848|NCT02691182|467484187|FG001|Overall Study|Missing|5|||
129870849|NCT02691182|467484188|FG002|Overall Study|Missing|1|||
129870850|NCT02691182|467484189|FG003|Overall Study|Missing|5|||
129870851|NCT00645164|467484190|FG000|Overall Study|Lost to Follow-up|2|||
129870852|NCT00645164|467484190|FG000|Overall Study|Withdrawal by Subject|4|||
129870853|NCT00645164|467484190|FG000|Overall Study|Protocol Violation|1|||
129870854|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
129870855|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
129870856|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
129870857|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
129870858|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
129870859|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
129870860|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
129870861|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
129870862|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
129870863|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
130066631|NCT02591238|468199716|FG000|Overall Study|personal circumstances|0|||
130066632|NCT02591238|468199717|FG001|Overall Study|personal circumstances|1|||
130066633|NCT02591238|468199718|FG002|Overall Study|personal circumstances|0|||
130066634|NCT02591238|468199719|FG003|Overall Study|personal circumstances|0|||
130066635|NCT01634113|468199720|FG000|Overall Study|Not treated|0|||
130066636|NCT01634113|468199721|FG001|Overall Study|Not treated|0|||
130066637|NCT01634113|468199722|FG002|Overall Study|Not treated|1|||
130066638|NCT00324740|468199723|FG000|Overall Study|Withdrawal by Subject|1|||
130066639|NCT00324740|468199724|FG001|Overall Study|Withdrawal by Subject|0|||
129870864|NCT00117676|467484191|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
129870865|NCT00117676|467484192|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
129917867|NCT03281291|467665403|FG003|Overall Study|Lost to Follow-up|6|||
129917868|NCT03281291|467665404|FG004|Overall Study|Lost to Follow-up|10|||
129917869|NCT03281291|467665400|FG000|Overall Study|Other|0|||
129917870|NCT03281291|467665401|FG001|Overall Study|Other|2|||
129917871|NCT03281291|467665402|FG002|Overall Study|Other|0|||
129917872|NCT03281291|467665403|FG003|Overall Study|Other|2|||
129917873|NCT03281291|467665404|FG004|Overall Study|Other|1|||
129917874|NCT05524233|467665405|FG000|Overall Study|Lost to Follow-up|2|||
129917875|NCT05524233|467665405|FG000|Overall Study|Adverse Event|2|||
129917876|NCT05524233|467665405|FG000|Overall Study|Withdrawal by Subject|1|||
129917877|NCT04390048|467665406|FG000|Overall Study|Withdrawal by Subject|1|||
129917878|NCT04390048|467665407|FG001|Overall Study|Withdrawal by Subject|3|||
129917879|NCT04556656|467665409|FG000|Overall Study|Withdrawal by Subject|14|||
129917880|NCT04556656|467665410|FG001|Overall Study|Withdrawal by Subject|12|||
129917881|NCT04556656|467665409|FG000|Overall Study|Physician Decision|1|||
129917882|NCT04556656|467665410|FG001|Overall Study|Physician Decision|0|||
129917883|NCT04556656|467665409|FG000|Overall Study|Adverse Event|4|||
129917884|NCT04556656|467665410|FG001|Overall Study|Adverse Event|7|||
129917885|NCT04556656|467665409|FG000|Overall Study|Death|4|||
129917886|NCT04556656|467665410|FG001|Overall Study|Death|0|||
129917887|NCT04556656|467665409|FG000|Overall Study|Lost to Follow-up|3|||
129917888|NCT04556656|467665410|FG001|Overall Study|Lost to Follow-up|2|||
129917889|NCT04556656|467665409|FG000|Overall Study|Not further specified|2|||
129917890|NCT04556656|467665410|FG001|Overall Study|Not further specified|1|||
129917891|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917892|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917893|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917894|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917895|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917896|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917897|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
129917898|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917899|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917900|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917901|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917902|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917903|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917904|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917905|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917906|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917907|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917908|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917909|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917910|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917911|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917912|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917913|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917914|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917915|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917916|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917917|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917918|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917919|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917920|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917921|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
129917922|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917923|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917924|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917925|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917926|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917927|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917928|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917929|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917930|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917931|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917932|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917933|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917934|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917935|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
130066640|NCT00324740|468199725|FG002|Overall Study|Withdrawal by Subject|1|||
130066641|NCT00520299|468199728|FG000|Overall Study|Withdrawal by Subject|0|||
130066642|NCT00520299|468199729|FG001|Overall Study|Withdrawal by Subject|0|||
129870866|NCT00117676|467484191|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
129917936|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917937|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917938|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129870867|NCT00117676|467484192|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
129870868|NCT00117676|467484191|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
129870869|NCT00117676|467484192|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
129870870|NCT00117676|467484191|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
129870871|NCT00117676|467484192|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
129870872|NCT00117676|467484191|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
129870873|NCT00117676|467484192|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
129870874|NCT00117676|467484191|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
129870875|NCT00117676|467484192|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
129917939|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917940|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917941|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917942|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917943|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917944|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917945|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
129917946|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
129917947|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
129917948|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
129917949|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
129917950|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
129917951|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
129917952|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
129917953|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
129917954|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
129917955|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
129917956|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
129917957|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
129917958|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
129917959|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
129917960|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
129917961|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
129917962|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
129917963|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
129917964|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
129917965|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
129917966|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
129917967|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
129917968|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
129917969|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
129917970|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
129917971|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
129917972|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917973|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917974|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917975|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917976|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917977|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917978|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
129917979|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917980|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130066643|NCT00520299|468199730|FG002|Overall Study|Withdrawal by Subject|2|||
130066644|NCT00520299|468199728|FG000|Overall Study|Progressive disease|0|||
129870876|NCT00117676|467484191|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
129870877|NCT00117676|467484192|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
129870878|NCT00117676|467484191|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
129870879|NCT00117676|467484192|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
129917981|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917982|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917983|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917984|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
129917985|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917986|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
130066645|NCT00520299|468199729|FG001|Overall Study|Progressive disease|3|||
129917987|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917988|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917989|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917990|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917991|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917992|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917993|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917994|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917995|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917996|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917997|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917998|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917999|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918000|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918001|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918002|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918003|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
129918004|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918005|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
129918006|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918007|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918008|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
129918009|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918010|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918011|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
129918012|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918013|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918014|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918015|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918016|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918017|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918018|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918019|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918020|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918021|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918022|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918023|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918024|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918025|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918026|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918027|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918028|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918029|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918030|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918031|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918032|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918033|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918034|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918035|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918036|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918037|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918038|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918039|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918040|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918041|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
129918042|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918043|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
129918044|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
129918045|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
129918046|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918047|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918048|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918049|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918050|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
130066646|NCT00520299|468199730|FG002|Overall Study|Progressive disease|4|||
130066647|NCT01352845|468199732|FG000|Overall Study|Lost to Follow-up|313|||
130066648|NCT01352845|468199733|FG001|Overall Study|Lost to Follow-up|92|||
130066649|NCT01352845|468199732|FG000|Overall Study|No Longer Willing to Participate|205|||
130066650|NCT01352845|468199733|FG001|Overall Study|No Longer Willing to Participate|58|||
130066651|NCT01352845|468199732|FG000|Overall Study|Withdrawal by Subject|48|||
130066652|NCT01352845|468199733|FG001|Overall Study|Withdrawal by Subject|16|||
130066653|NCT01352845|468199732|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
130066654|NCT01352845|468199733|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
130066655|NCT01352845|468199732|FG000|Overall Study|Pregnancy|27|||
130066656|NCT01352845|468199733|FG001|Overall Study|Pregnancy|7|||
130066657|NCT01352845|468199732|FG000|Overall Study|Adverse Event|22|||
130066658|NCT01352845|468199733|FG001|Overall Study|Adverse Event|6|||
130066659|NCT01352845|468199732|FG000|Overall Study|Other|17|||
130066660|NCT01352845|468199733|FG001|Overall Study|Other|7|||
130066661|NCT01352845|468199732|FG000|Overall Study|Protocol Violation|12|||
130066662|NCT01352845|468199733|FG001|Overall Study|Protocol Violation|6|||
130066663|NCT01352845|468199732|FG000|Overall Study|Death|3|||
130066664|NCT01352845|468199733|FG001|Overall Study|Death|0|||
130066665|NCT01357980|468199738|FG000|Overall Study|Lack of Efficacy|0|||
130066666|NCT01357980|468199739|FG001|Overall Study|Lack of Efficacy|1|||
129870880|NCT00117676|467484191|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
129870881|NCT00117676|467484192|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
129870882|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
129870883|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
129870884|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
129870885|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
129870886|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
129870887|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
129870888|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
129870889|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
129870890|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
129870891|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
129870892|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
129870893|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
129870894|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
129870895|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
129870896|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
129870897|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
129870898|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
129870899|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
129870900|NCT00117676|467484191|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
129870901|NCT00117676|467484192|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
129870902|NCT00117676|467484191|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
129870903|NCT00117676|467484192|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
129870904|NCT00117676|467484191|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
129870905|NCT00117676|467484192|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
129870906|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
129870907|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
129870908|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
129870909|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
129870910|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
129870911|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
129870912|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
129870913|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
129870914|NCT00117676|467484191|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
129870915|NCT00117676|467484192|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
129870916|NCT00117676|467484191|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
129870917|NCT00117676|467484192|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
130066667|NCT01357980|468199740|FG002|Overall Study|Lack of Efficacy|0|||
130066668|NCT01357980|468199741|FG003|Overall Study|Lack of Efficacy|0|||
130066669|NCT01357980|468199738|FG000|Overall Study|Consent withdrawn|0|||
130066670|NCT01357980|468199739|FG001|Overall Study|Consent withdrawn|0|||
130066671|NCT01357980|468199740|FG002|Overall Study|Consent withdrawn|1|||
130066672|NCT01357980|468199741|FG003|Overall Study|Consent withdrawn|0|||
130066673|NCT02528253|468199742|FG000|Overall Study|Adverse Event|3|||
130066674|NCT02528253|468199743|FG001|Overall Study|Adverse Event|4|||
130066675|NCT02528253|468199744|FG002|Overall Study|Adverse Event|4|||
130066676|NCT02528253|468199745|FG003|Overall Study|Adverse Event|8|||
130066677|NCT02528253|468199746|FG004|Overall Study|Adverse Event|18|||
130066678|NCT02528253|468199742|FG000|Overall Study|Death|2|||
129870918|NCT00117676|467484191|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
129870919|NCT00117676|467484192|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
129870920|NCT00117676|467484191|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
129870921|NCT00117676|467484192|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
129870922|NCT00117676|467484191|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
129870923|NCT00117676|467484192|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
129870924|NCT00952822|467484193|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
129870925|NCT00952822|467484194|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
129870926|NCT00952822|467484195|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
129870927|NCT00952822|467484196|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
129870928|NCT00952822|467484193|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
129870929|NCT00952822|467484194|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
129870930|NCT00952822|467484195|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
129870931|NCT00952822|467484196|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
129870932|NCT00691938|467484199|FG000|Overall Study|QTc prolongation|1|||
129870933|NCT00691938|467484200|FG001|Overall Study|QTc prolongation|0|||
129870934|NCT00691938|467484201|FG002|Overall Study|QTc prolongation|0|||
129870935|NCT00691938|467484202|FG003|Overall Study|QTc prolongation|0|||
129870936|NCT00691938|467484203|FG004|Overall Study|QTc prolongation|0|||
129870937|NCT00691938|467484204|FG005|Overall Study|QTc prolongation|0|||
129870938|NCT00691938|467484205|FG006|Overall Study|QTc prolongation|0|||
129870939|NCT04860518|467484209|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
129870940|NCT04860518|467484210|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
129870941|NCT04555096|467484215|FG000|Overall Study|Death|4|||
129870942|NCT04555096|467484216|FG001|Overall Study|Death|4|||
129870943|NCT04555096|467484215|FG000|Overall Study|Withdrawal by Subject|1|||
129870944|NCT04555096|467484216|FG001|Overall Study|Withdrawal by Subject|0|||
129870945|NCT04555096|467484215|FG000|Overall Study|Other|0|||
129870946|NCT04555096|467484216|FG001|Overall Study|Other|1|||
129870947|NCT03641313|467484219|FG000|Overall Study|Death|1|||
129870948|NCT03641313|467484219|FG000|Overall Study|Withdrawal by Subject|2|||
129870949|NCT03641313|467484219|FG000|Overall Study|Declining health|1|||
129870950|NCT03641313|467484219|FG000|Overall Study|Adverse Event|1|||
129870951|NCT04642898|467484220|FG000|Overall Study|Withdrawal by Subject|2|||
129870952|NCT04642898|467484221|FG001|Overall Study|Withdrawal by Subject|4|||
129870953|NCT04642898|467484222|FG002|Overall Study|Withdrawal by Subject|4|||
129870954|NCT04642898|467484223|FG003|Overall Study|Withdrawal by Subject|6|||
129870955|NCT04642898|467484224|FG004|Overall Study|Withdrawal by Subject|2|||
129870956|NCT04642898|467484225|FG005|Overall Study|Withdrawal by Subject|6|||
129870957|NCT04642898|467484220|FG000|Overall Study|Lost to Follow-up|0|||
129870958|NCT04642898|467484221|FG001|Overall Study|Lost to Follow-up|0|||
129870959|NCT04642898|467484222|FG002|Overall Study|Lost to Follow-up|0|||
129870960|NCT04642898|467484223|FG003|Overall Study|Lost to Follow-up|2|||
129870961|NCT04642898|467484224|FG004|Overall Study|Lost to Follow-up|0|||
129870962|NCT04642898|467484225|FG005|Overall Study|Lost to Follow-up|1|||
129870963|NCT04642898|467484220|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
129870964|NCT04642898|467484221|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
129870965|NCT04642898|467484222|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
129870966|NCT04642898|467484223|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
129870967|NCT04642898|467484224|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
129870968|NCT04642898|467484225|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
129870969|NCT04642898|467484220|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870970|NCT04642898|467484221|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870971|NCT04642898|467484222|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870972|NCT04642898|467484223|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870973|NCT04642898|467484224|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
129870974|NCT04642898|467484225|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870975|NCT03574597|467484226|FG000|Overall Study|Withdrawal by Subject|67|||
129870976|NCT03574597|467484227|FG001|Overall Study|Withdrawal by Subject|96|||
129870977|NCT03574597|467484226|FG000|Overall Study|Lost to Follow-up|192|||
129870978|NCT03574597|467484227|FG001|Overall Study|Lost to Follow-up|188|||
129870979|NCT03434678|467484228|FG000|Overall Study|Withdrawal by Subject|13|||
129870980|NCT03434678|467484229|FG001|Overall Study|Withdrawal by Subject|13|||
129870981|NCT03434678|467484228|FG000|Overall Study|Found to be ineligible post randomization|2|||
129870982|NCT03434678|467484229|FG001|Overall Study|Found to be ineligible post randomization|1|||
129870983|NCT06060457|467484232|FG000|Overall Study|Adverse Event|1|||
129870984|NCT06060457|467484233|FG001|Overall Study|Adverse Event|1|||
129870985|NCT06060457|467484232|FG000|Overall Study|Death|2|||
129870986|NCT06060457|467484233|FG001|Overall Study|Death|2|||
130066679|NCT02528253|468199743|FG001|Overall Study|Death|2|||
129870987|NCT06060457|467484232|FG000|Overall Study|Lost to Follow-up|17|||
129870988|NCT06060457|467484233|FG001|Overall Study|Lost to Follow-up|19|||
129870989|NCT06060457|467484232|FG000|Overall Study|Physician Decision|0|||
129870990|NCT06060457|467484233|FG001|Overall Study|Physician Decision|1|||
129870991|NCT06060457|467484232|FG000|Overall Study|Protocol Violation|1|||
129870992|NCT06060457|467484233|FG001|Overall Study|Protocol Violation|1|||
129870993|NCT06060457|467484232|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
129918051|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918052|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918053|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918054|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918055|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918056|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918057|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918058|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918059|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918060|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918061|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918062|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918063|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918064|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918065|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918066|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918067|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918068|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918069|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
129918070|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918071|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
129918072|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
129918073|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918074|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918075|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918076|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
130116760|NCT00818623|468387169|FG005|Overall Study|Disease progression|0|||
130116761|NCT00818623|468387170|FG006|Overall Study|Disease progression|1|||
129870994|NCT06060457|467484233|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
129870995|NCT06060457|467484232|FG000|Overall Study|Withdrawal by Subject|12|||
129870996|NCT06060457|467484233|FG001|Overall Study|Withdrawal by Subject|15|||
129870997|NCT06060457|467484232|FG000|Overall Study|Other Than Specified|2|||
129870998|NCT06060457|467484233|FG001|Overall Study|Other Than Specified|1|||
129870999|NCT02061202|467484234|FG000|Overall Study|Lost to Follow-up|1|||
129871000|NCT02061202|467484235|FG001|Overall Study|Lost to Follow-up|1|||
129871001|NCT01533493|467484236|FG000|Overall Study|Adverse Event|2|||
129871002|NCT01533493|467484237|FG001|Overall Study|Adverse Event|1|||
129871003|NCT01533493|467484236|FG000|Overall Study|Withdrawal by Subject|1|||
129871004|NCT01533493|467484237|FG001|Overall Study|Withdrawal by Subject|2|||
129871005|NCT01533493|467484236|FG000|Overall Study|Lost to Follow-up|2|||
129871006|NCT01533493|467484237|FG001|Overall Study|Lost to Follow-up|0|||
129871007|NCT05163522|467484240|FG000|Overall Study|Withdrawal by Subject|0|||
129871008|NCT05163522|467484241|FG001|Overall Study|Withdrawal by Subject|0|||
129871009|NCT05163522|467484242|FG002|Overall Study|Withdrawal by Subject|1|||
129871010|NCT05163522|467484243|FG003|Overall Study|Withdrawal by Subject|0|||
129871011|NCT05163522|467484244|FG004|Overall Study|Withdrawal by Subject|0|||
129871012|NCT05163522|467484245|FG005|Overall Study|Withdrawal by Subject|0|||
129871013|NCT05163522|467484246|FG006|Overall Study|Withdrawal by Subject|0|||
129871014|NCT05163522|467484247|FG007|Overall Study|Withdrawal by Subject|0|||
129871015|NCT05163522|467484248|FG008|Overall Study|Withdrawal by Subject|0|||
129871016|NCT05163522|467484249|FG009|Overall Study|Withdrawal by Subject|0|||
129871017|NCT05163522|467484250|FG010|Overall Study|Withdrawal by Subject|0|||
129871018|NCT02660827|467484251|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
129871019|NCT02660827|467484251|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
129871020|NCT02660827|467484251|FG000|From Study to End of Continued Access|Adverse Event|3|||
129871021|NCT02660827|467484251|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
129871022|NCT02660827|467484251|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
129871023|NCT02660827|467484251|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
129871024|NCT02660827|467484251|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
129871025|NCT02660827|467484251|FG000|Period 2: Continued Access Period|Adverse Event|3|||
130066680|NCT02528253|468199744|FG002|Overall Study|Death|1|||
130066681|NCT02528253|468199745|FG003|Overall Study|Death|0|||
130066682|NCT02528253|468199746|FG004|Overall Study|Death|1|||
130066683|NCT02528253|468199742|FG000|Overall Study|Insufficient clinical response|7|||
130066684|NCT02528253|468199743|FG001|Overall Study|Insufficient clinical response|10|||
130066685|NCT02528253|468199744|FG002|Overall Study|Insufficient clinical response|13|||
130066686|NCT02528253|468199745|FG003|Overall Study|Insufficient clinical response|12|||
130066687|NCT02528253|468199746|FG004|Overall Study|Insufficient clinical response|16|||
130066688|NCT02528253|468199742|FG000|Overall Study|Lost to Follow-up|16|||
130066689|NCT02528253|468199743|FG001|Overall Study|Lost to Follow-up|9|||
130066690|NCT02528253|468199744|FG002|Overall Study|Lost to Follow-up|31|||
130066691|NCT02528253|468199745|FG003|Overall Study|Lost to Follow-up|16|||
130066692|NCT02528253|468199746|FG004|Overall Study|Lost to Follow-up|34|||
130066693|NCT02528253|468199742|FG000|Overall Study|Other|21|||
130066694|NCT02528253|468199743|FG001|Overall Study|Other|22|||
130066695|NCT02528253|468199744|FG002|Overall Study|Other|58|||
130066696|NCT02528253|468199745|FG003|Overall Study|Other|52|||
130066697|NCT02528253|468199746|FG004|Overall Study|Other|76|||
130066698|NCT02528253|468199742|FG000|Overall Study|Withdrawal by Subject|25|||
130066699|NCT02528253|468199743|FG001|Overall Study|Withdrawal by Subject|20|||
130066700|NCT02528253|468199744|FG002|Overall Study|Withdrawal by Subject|29|||
130066701|NCT02528253|468199745|FG003|Overall Study|Withdrawal by Subject|48|||
130066702|NCT02528253|468199746|FG004|Overall Study|Withdrawal by Subject|73|||
130066703|NCT02528253|468199742|FG000|Overall Study|Protocol Violation|1|||
130066704|NCT02528253|468199743|FG001|Overall Study|Protocol Violation|2|||
130066705|NCT02528253|468199744|FG002|Overall Study|Protocol Violation|4|||
130066706|NCT02528253|468199745|FG003|Overall Study|Protocol Violation|0|||
130066707|NCT02528253|468199746|FG004|Overall Study|Protocol Violation|4|||
130066708|NCT02528253|468199742|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
130066709|NCT02528253|468199743|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
130066710|NCT02528253|468199744|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
130066711|NCT02528253|468199745|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
130066712|NCT02528253|468199746|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
130066713|NCT04507776|468199747|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
130066714|NCT00094835|468199748|FG000|Overall Study|Physician Decision|1|||
130066715|NCT00094835|468199749|FG001|Overall Study|Physician Decision|0|||
130066716|NCT00094835|468199750|FG002|Overall Study|Physician Decision|0|||
130066717|NCT00094835|468199751|FG003|Overall Study|Physician Decision|0|||
130066718|NCT00094835|468199752|FG004|Overall Study|Physician Decision|0|||
130066719|NCT00094835|468199753|FG005|Overall Study|Physician Decision|1|||
130066720|NCT00094835|468199754|FG006|Overall Study|Physician Decision|0|||
130066721|NCT00094835|468199748|FG000|Overall Study|Withdrawal by Subject|0|||
130066722|NCT00094835|468199749|FG001|Overall Study|Withdrawal by Subject|0|||
130066723|NCT00094835|468199750|FG002|Overall Study|Withdrawal by Subject|0|||
130066724|NCT00094835|468199751|FG003|Overall Study|Withdrawal by Subject|0|||
130066725|NCT00094835|468199752|FG004|Overall Study|Withdrawal by Subject|0|||
130066726|NCT00094835|468199753|FG005|Overall Study|Withdrawal by Subject|0|||
130066727|NCT00094835|468199754|FG006|Overall Study|Withdrawal by Subject|1|||
130066728|NCT00094835|468199748|FG000|Overall Study|Lost to Follow-up|0|||
130066729|NCT00094835|468199749|FG001|Overall Study|Lost to Follow-up|0|||
130066730|NCT00094835|468199750|FG002|Overall Study|Lost to Follow-up|0|||
130066731|NCT00094835|468199751|FG003|Overall Study|Lost to Follow-up|0|||
130066732|NCT00094835|468199752|FG004|Overall Study|Lost to Follow-up|1|||
130066733|NCT00094835|468199753|FG005|Overall Study|Lost to Follow-up|0|||
130066734|NCT00094835|468199754|FG006|Overall Study|Lost to Follow-up|0|||
129871026|NCT02953938|467484252|FG000|Overall Study|Adverse Event|0|||
129871027|NCT02953938|467484253|FG001|Overall Study|Adverse Event|1|||
129871028|NCT02953938|467484252|FG000|Overall Study|Withdrawal by Subject|1|||
129871029|NCT02953938|467484253|FG001|Overall Study|Withdrawal by Subject|1|||
129871030|NCT00313820|467484257|FG000|Assigned to Treatment|Other|1|||
130066735|NCT00094835|468199748|FG000|Overall Study|Death|1|||
130066736|NCT00094835|468199749|FG001|Overall Study|Death|0|||
130066737|NCT00094835|468199750|FG002|Overall Study|Death|0|||
130066738|NCT00094835|468199751|FG003|Overall Study|Death|0|||
130066739|NCT00094835|468199752|FG004|Overall Study|Death|1|||
130066740|NCT00094835|468199753|FG005|Overall Study|Death|0|||
130066741|NCT00094835|468199754|FG006|Overall Study|Death|0|||
130066742|NCT00094835|468199748|FG000|Overall Study|Non-compliance|1|||
130066743|NCT00094835|468199749|FG001|Overall Study|Non-compliance|2|||
130066744|NCT00094835|468199750|FG002|Overall Study|Non-compliance|2|||
130066745|NCT00094835|468199751|FG003|Overall Study|Non-compliance|0|||
130066746|NCT00094835|468199752|FG004|Overall Study|Non-compliance|2|||
130066747|NCT00094835|468199753|FG005|Overall Study|Non-compliance|2|||
130066748|NCT00094835|468199754|FG006|Overall Study|Non-compliance|1|||
130066749|NCT00094835|468199748|FG000|Overall Study|Other|1|||
130066750|NCT00094835|468199749|FG001|Overall Study|Other|1|||
130066751|NCT00094835|468199750|FG002|Overall Study|Other|1|||
130066752|NCT00094835|468199751|FG003|Overall Study|Other|1|||
130066753|NCT00094835|468199752|FG004|Overall Study|Other|0|||
130066754|NCT00094835|468199753|FG005|Overall Study|Other|0|||
129871031|NCT00313820|467484258|FG001|Assigned to Treatment|Other|0|||
129871032|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
129871033|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
129871034|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
129871035|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
129871036|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
129871037|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
129871038|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
129871039|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
129871040|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
129871041|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
129871042|NCT00939484|467485799|FG000|Overall Study|Progression/Relapse|8|||
129871043|NCT00939484|467485800|FG001|Overall Study|Progression/Relapse|20|||
129871044|NCT00939484|467485801|FG002|Overall Study|Progression/Relapse|3|||
129871045|NCT01224925|467485802|FG000|Overall Study|Lost to Follow-up|3|||
129871046|NCT01224925|467485803|FG001|Overall Study|Lost to Follow-up|2|||
129871047|NCT00245102|467485805|FG000|Overall Study|Not Treated|1|||
129871048|NCT00245102|467485806|FG001|Overall Study|Not Treated|0|||
129871049|NCT00245102|467485807|FG002|Overall Study|Not Treated|1|||
129871050|NCT00245102|467485808|FG003|Overall Study|Not Treated|0|||
129871051|NCT00245102|467485809|FG004|Overall Study|Not Treated|0|||
129871052|NCT00245102|467485810|FG005|Overall Study|Not Treated|0|||
129871053|NCT00245102|467485805|FG000|Overall Study|Protocol Violation|1|||
129871054|NCT00245102|467485806|FG001|Overall Study|Protocol Violation|0|||
129871055|NCT00245102|467485807|FG002|Overall Study|Protocol Violation|0|||
129871056|NCT00245102|467485808|FG003|Overall Study|Protocol Violation|0|||
129871057|NCT00245102|467485809|FG004|Overall Study|Protocol Violation|0|||
129871058|NCT00245102|467485810|FG005|Overall Study|Protocol Violation|0|||
129871059|NCT00245102|467485805|FG000|Overall Study|Death|0|||
129871060|NCT00245102|467485806|FG001|Overall Study|Death|0|||
129871061|NCT00245102|467485807|FG002|Overall Study|Death|0|||
129871062|NCT00245102|467485808|FG003|Overall Study|Death|1|||
129871063|NCT00245102|467485809|FG004|Overall Study|Death|0|||
129871064|NCT00245102|467485810|FG005|Overall Study|Death|0|||
129871065|NCT00245102|467485805|FG000|Overall Study|Adverse Event|4|||
129871066|NCT00245102|467485806|FG001|Overall Study|Adverse Event|2|||
129871067|NCT00245102|467485807|FG002|Overall Study|Adverse Event|5|||
129871068|NCT00245102|467485808|FG003|Overall Study|Adverse Event|1|||
129871069|NCT00245102|467485809|FG004|Overall Study|Adverse Event|0|||
129871070|NCT00245102|467485810|FG005|Overall Study|Adverse Event|2|||
129871071|NCT00245102|467485805|FG000|Overall Study|Decline in performance|0|||
129871072|NCT00245102|467485806|FG001|Overall Study|Decline in performance|2|||
129871073|NCT00245102|467485807|FG002|Overall Study|Decline in performance|0|||
129871074|NCT00245102|467485808|FG003|Overall Study|Decline in performance|1|||
129871075|NCT00245102|467485809|FG004|Overall Study|Decline in performance|0|||
129871076|NCT00245102|467485810|FG005|Overall Study|Decline in performance|2|||
129871077|NCT00245102|467485805|FG000|Overall Study|Participant needed surgery|0|||
129871078|NCT00245102|467485806|FG001|Overall Study|Participant needed surgery|0|||
129871079|NCT00245102|467485807|FG002|Overall Study|Participant needed surgery|1|||
129871080|NCT00245102|467485808|FG003|Overall Study|Participant needed surgery|0|||
129871081|NCT00245102|467485809|FG004|Overall Study|Participant needed surgery|0|||
129871082|NCT00245102|467485810|FG005|Overall Study|Participant needed surgery|0|||
129871083|NCT00245102|467485805|FG000|Overall Study|Clinical progression|1|||
129871084|NCT00245102|467485806|FG001|Overall Study|Clinical progression|0|||
129871085|NCT00245102|467485807|FG002|Overall Study|Clinical progression|0|||
129871086|NCT00245102|467485808|FG003|Overall Study|Clinical progression|0|||
129871087|NCT00245102|467485809|FG004|Overall Study|Clinical progression|0|||
129871088|NCT00245102|467485810|FG005|Overall Study|Clinical progression|0|||
129871089|NCT01756352|467485813|FG000|Overall Study|moved away and lost to followup|1|||
129871090|NCT03315143|467485814|FG000|Overall Study|Death|240|||
129871091|NCT03315143|467485815|FG001|Overall Study|Death|246|||
129871092|NCT03315143|467485814|FG000|Overall Study|Withdrawal by Subject|57|||
129871093|NCT03315143|467485815|FG001|Overall Study|Withdrawal by Subject|68|||
129871094|NCT03315143|467485814|FG000|Overall Study|Site Terminated by Sponsor|256|||
129871095|NCT03315143|467485815|FG001|Overall Study|Site Terminated by Sponsor|282|||
129871096|NCT03315143|467485814|FG000|Overall Study|Study Terminated by Sponsor|4723|||
129871097|NCT03315143|467485815|FG001|Overall Study|Study Terminated by Sponsor|4664|||
129871098|NCT03315143|467485814|FG000|Overall Study|Reason not Specified|16|||
129871099|NCT03315143|467485815|FG001|Overall Study|Reason not Specified|32|||
129871100|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
129871101|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
129871102|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
129871103|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
129871104|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
129871105|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
130066755|NCT00094835|468199754|FG006|Overall Study|Other|0|||
130066756|NCT03024255|468199757|FG000|Overall Study|Adverse Event|1|||
130066757|NCT03024255|468199758|FG001|Overall Study|Adverse Event|4|||
130066758|NCT03024255|468199759|FG002|Overall Study|Adverse Event|8|||
130066759|NCT03024255|468199760|FG003|Overall Study|Adverse Event|0|||
130066760|NCT03024255|468199757|FG000|Overall Study|Withdrawal by Subject|3|||
130066761|NCT03024255|468199758|FG001|Overall Study|Withdrawal by Subject|1|||
130066762|NCT03024255|468199759|FG002|Overall Study|Withdrawal by Subject|0|||
129918077|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918078|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918079|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918080|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918081|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918082|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918083|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918084|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918085|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918086|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918087|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
130066763|NCT03024255|468199760|FG003|Overall Study|Withdrawal by Subject|3|||
130066764|NCT03024255|468199757|FG000|Overall Study|Protocol Violation|0|||
129871106|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
129871107|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
129871108|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
129871109|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
129871110|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
129871111|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
129871112|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
129871113|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
129871114|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
129871115|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
129871116|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
129871117|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
129871118|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
129871119|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
129871120|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
129871121|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
129871122|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Death|143|||
129871123|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Death|136|||
129871124|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
129871125|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
129871126|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
129871127|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
129871128|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
129871129|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
129871130|NCT01127646|467485818|FG000|Overall Study|Entry Criteria Not Met|1|||
129871131|NCT01127646|467485819|FG001|Overall Study|Entry Criteria Not Met|0|||
129871132|NCT01127646|467485818|FG000|Overall Study|Protocol Violation|0|||
129871133|NCT01127646|467485819|FG001|Overall Study|Protocol Violation|1|||
129871134|NCT04067401|467485820|FG000|Overall Study|Withdrawal by Subject|7|||
129871135|NCT04067401|467485821|FG001|Overall Study|Withdrawal by Subject|0|||
129871136|NCT04067401|467485820|FG000|Overall Study|no data provided|1|||
129871137|NCT04067401|467485821|FG001|Overall Study|no data provided|0|||
129871138|NCT01662063|467485824|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
129871139|NCT01662063|467485825|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
129871140|NCT01662063|467485826|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
129871141|NCT01662063|467485824|FG000|Overall Study|Lack of Efficacy|1|||
129871142|NCT01662063|467485825|FG001|Overall Study|Lack of Efficacy|6|||
129871143|NCT01662063|467485826|FG002|Overall Study|Lack of Efficacy|0|||
129871144|NCT01662063|467485824|FG000|Overall Study|Lost to Follow-up|0|||
129871145|NCT01662063|467485825|FG001|Overall Study|Lost to Follow-up|4|||
129871146|NCT01662063|467485826|FG002|Overall Study|Lost to Follow-up|0|||
129871147|NCT01662063|467485824|FG000|Overall Study|Protocol Violation|1|||
129871148|NCT01662063|467485825|FG001|Overall Study|Protocol Violation|0|||
130066765|NCT03024255|468199758|FG001|Overall Study|Protocol Violation|0|||
130066766|NCT03024255|468199759|FG002|Overall Study|Protocol Violation|2|||
129871149|NCT01662063|467485826|FG002|Overall Study|Protocol Violation|0|||
129871150|NCT01662063|467485824|FG000|Overall Study|Withdrawal by Subject|2|||
129871151|NCT01662063|467485825|FG001|Overall Study|Withdrawal by Subject|4|||
130066767|NCT03024255|468199760|FG003|Overall Study|Protocol Violation|0|||
130066768|NCT03024255|468199757|FG000|Overall Study|Lost to Follow-up|1|||
129871152|NCT01662063|467485826|FG002|Overall Study|Withdrawal by Subject|1|||
129871153|NCT01662063|467485824|FG000|Overall Study|Physician Decision|0|||
129871154|NCT01662063|467485825|FG001|Overall Study|Physician Decision|2|||
129871155|NCT01662063|467485826|FG002|Overall Study|Physician Decision|0|||
129871156|NCT01662063|467485824|FG000|Overall Study|Other|0|||
129871157|NCT01662063|467485825|FG001|Overall Study|Other|1|||
129871158|NCT01662063|467485826|FG002|Overall Study|Other|0|||
129871159|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
129871160|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
129871161|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
130116762|NCT00818623|468387171|FG007|Overall Study|Disease progression|0|||
130116763|NCT00602030|468387172|FG000|Lead-in Phase|Disease Progression|2|||
129871162|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
129871163|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
129871164|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
129871165|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
129871166|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
129871167|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
129871168|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
129871169|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
129871170|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
129871171|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
129871172|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
129871173|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
129871174|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
129871175|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
129871176|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
129871177|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
129871178|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
129871179|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
129871180|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
129871181|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Death|3|||
129871182|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Death|0|||
129871183|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
129871184|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
129871185|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
129871186|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
129871187|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
129871188|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
129871189|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
129871190|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
129871191|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
129871192|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
129871193|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
129871194|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
129871195|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
129871196|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
129871197|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
129871198|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
129871199|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
129871200|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
129871201|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
129871202|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
129871203|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
129871204|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
129871205|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
129871206|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
129871207|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
129871208|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
129871209|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
129871210|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
129871211|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
129871212|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
129871213|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
129871214|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
129918088|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129871215|NCT01477853|467485829|FG000|Phase A|Adverse Event|1|||
129871216|NCT01477853|467485830|FG001|Phase A|Adverse Event|2|||
129871217|NCT01477853|467485831|FG002|Phase A|Adverse Event|2|||
129871218|NCT01477853|467485829|FG000|Phase A|Lost to Follow-up|4|||
129871219|NCT01477853|467485830|FG001|Phase A|Lost to Follow-up|3|||
129871220|NCT01477853|467485831|FG002|Phase A|Lost to Follow-up|2|||
129871221|NCT01477853|467485829|FG000|Phase A|Physician Decision|1|||
129871222|NCT01477853|467485830|FG001|Phase A|Physician Decision|0|||
129871223|NCT01477853|467485831|FG002|Phase A|Physician Decision|1|||
129871224|NCT01477853|467485829|FG000|Phase A|Study terminated by sponsor|37|||
129871225|NCT01477853|467485830|FG001|Phase A|Study terminated by sponsor|40|||
129871226|NCT01477853|467485831|FG002|Phase A|Study terminated by sponsor|39|||
129871227|NCT01477853|467485829|FG000|Phase B|Lost to Follow-up|0|||
129871228|NCT01477853|467485830|FG001|Phase B|Lost to Follow-up|1|||
129871229|NCT01477853|467485831|FG002|Phase B|Lost to Follow-up|0|||
129871230|NCT01477853|467485829|FG000|Phase B|Study terminated by sponsor|12|||
129871231|NCT01477853|467485830|FG001|Phase B|Study terminated by sponsor|10|||
129871232|NCT01477853|467485831|FG002|Phase B|Study terminated by sponsor|11|||
129871233|NCT01050816|467485832|FG000|Overall Study|Lost to Follow-up|2|||
129871234|NCT01050816|467485832|FG000|Overall Study|patient's refusal|2|||
129871235|NCT03086330|467485833|FG000|Overall Study|Withdrawal by Subject|3|||
129871236|NCT03086330|467485834|FG001|Overall Study|Withdrawal by Subject|2|||
129871237|NCT03086330|467485833|FG000|Overall Study|Lost to Follow-up|1|||
129871238|NCT03086330|467485834|FG001|Overall Study|Lost to Follow-up|2|||
129871239|NCT01814748|467485842|FG000|Overall Study|Lost to Follow-up|1|||
129871240|NCT01814748|467485843|FG001|Overall Study|Lost to Follow-up|2|||
129871241|NCT01814748|467485842|FG000|Overall Study|Study site terminated by sponsor|1|||
129871242|NCT01814748|467485843|FG001|Overall Study|Study site terminated by sponsor|1|||
129871243|NCT01814748|467485842|FG000|Overall Study|Withdrawal by Subject|6|||
129871244|NCT01814748|467485843|FG001|Overall Study|Withdrawal by Subject|4|||
129871245|NCT04044456|467485844|FG000|Overall Study|Lost to Follow-up|4|||
129871246|NCT04044456|467485845|FG001|Overall Study|Lost to Follow-up|1|||
129871247|NCT04044456|467485844|FG000|Overall Study|Withdrawal by Subject|1|||
129871248|NCT04044456|467485845|FG001|Overall Study|Withdrawal by Subject|0|||
129871249|NCT01972529|467485846|FG000|Overall Study|Adverse Event|0|||
129871250|NCT01972529|467485847|FG001|Overall Study|Adverse Event|1|||
129871251|NCT01972529|467485848|FG002|Overall Study|Adverse Event|0|||
129871252|NCT01972529|467485849|FG003|Overall Study|Adverse Event|0|||
129871253|NCT01972529|467485846|FG000|Overall Study|Lost to Follow-up|1|||
129871254|NCT01972529|467485847|FG001|Overall Study|Lost to Follow-up|0|||
129871255|NCT01972529|467485848|FG002|Overall Study|Lost to Follow-up|0|||
129871256|NCT01972529|467485849|FG003|Overall Study|Lost to Follow-up|0|||
129871257|NCT01972529|467485846|FG000|Overall Study|Participant Choice|0|||
129871258|NCT01972529|467485847|FG001|Overall Study|Participant Choice|1|||
129871259|NCT01972529|467485848|FG002|Overall Study|Participant Choice|0|||
129871260|NCT01972529|467485849|FG003|Overall Study|Participant Choice|0|||
129871261|NCT01972529|467485846|FG000|Overall Study|Withdrawl of Consent|1|||
129871262|NCT01972529|467485847|FG001|Overall Study|Withdrawl of Consent|2|||
129871263|NCT01972529|467485848|FG002|Overall Study|Withdrawl of Consent|0|||
129871264|NCT01972529|467485849|FG003|Overall Study|Withdrawl of Consent|1|||
129871265|NCT01972529|467485846|FG000|Overall Study|Other|0|||
129871266|NCT01972529|467485847|FG001|Overall Study|Other|0|||
129871267|NCT01972529|467485848|FG002|Overall Study|Other|0|||
129871268|NCT01972529|467485849|FG003|Overall Study|Other|2|||
129871269|NCT01972529|467485846|FG000|Overall Study|Not treated|0|||
129871270|NCT01972529|467485847|FG001|Overall Study|Not treated|1|||
129871271|NCT01972529|467485848|FG002|Overall Study|Not treated|2|||
129871272|NCT01972529|467485849|FG003|Overall Study|Not treated|1|||
129871273|NCT02274857|467485850|FG000|Overall Study|Adverse Event|1|||
129871274|NCT02274857|467485851|FG001|Overall Study|Adverse Event|0|||
129871275|NCT02274857|467485850|FG000|Overall Study|Death|1|||
129871276|NCT02274857|467485851|FG001|Overall Study|Death|2|||
129871277|NCT02274857|467485850|FG000|Overall Study|Lost to Follow-up|3|||
129871278|NCT02274857|467485851|FG001|Overall Study|Lost to Follow-up|0|||
129871279|NCT02274857|467485850|FG000|Overall Study|Physician Decision|2|||
129871280|NCT02274857|467485851|FG001|Overall Study|Physician Decision|0|||
129871281|NCT02274857|467485850|FG000|Overall Study|Trial screen failure|0|||
129871282|NCT02274857|467485851|FG001|Overall Study|Trial screen failure|2|||
129871283|NCT02274857|467485850|FG000|Overall Study|Withdrawal by Subject|11|||
129871284|NCT02274857|467485851|FG001|Overall Study|Withdrawal by Subject|2|||
129871285|NCT02274857|467485850|FG000|Overall Study|Other|2|||
129871286|NCT02274857|467485851|FG001|Overall Study|Other|0|||
129871287|NCT00330174|467485854|FG000|Overall Study|Withdrawal by Subject|7|||
129871288|NCT00330174|467485855|FG001|Overall Study|Withdrawal by Subject|7|||
129871289|NCT00330174|467485854|FG000|Overall Study|Lost to Follow-up|4|||
129871290|NCT00330174|467485855|FG001|Overall Study|Lost to Follow-up|1|||
129871291|NCT00330174|467485854|FG000|Overall Study|Clinical deterioration|1|||
129871292|NCT00330174|467485855|FG001|Overall Study|Clinical deterioration|2|||
129871293|NCT00330174|467485854|FG000|Overall Study|Excessive missed visits|3|||
129871294|NCT00330174|467485855|FG001|Overall Study|Excessive missed visits|8|||
129918089|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918090|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918091|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918092|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918093|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918094|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918095|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918096|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
129918097|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918098|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
129918099|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
129918100|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
129918101|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918102|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918103|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918104|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918105|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918106|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918107|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918108|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918109|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918110|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918111|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918112|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918113|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918114|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918115|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918116|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918117|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918118|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918119|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918120|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918121|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918122|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
129918123|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918124|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918125|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918126|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918127|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918128|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918129|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
129918130|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918131|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918132|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918133|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918134|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918135|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918136|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918137|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918138|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918139|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918140|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918141|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130066769|NCT03024255|468199758|FG001|Overall Study|Lost to Follow-up|2|||
130066770|NCT03024255|468199759|FG002|Overall Study|Lost to Follow-up|1|||
130066771|NCT03024255|468199760|FG003|Overall Study|Lost to Follow-up|1|||
130066772|NCT03024255|468199757|FG000|Overall Study|Lack of Efficacy|1|||
130066773|NCT03024255|468199758|FG001|Overall Study|Lack of Efficacy|0|||
130066774|NCT03024255|468199759|FG002|Overall Study|Lack of Efficacy|0|||
129918142|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918143|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
130066775|NCT03024255|468199760|FG003|Overall Study|Lack of Efficacy|0|||
130066776|NCT03024255|468199757|FG000|Overall Study|Protocol Noncompliance|1|||
130066777|NCT03024255|468199758|FG001|Overall Study|Protocol Noncompliance|1|||
130066778|NCT03024255|468199759|FG002|Overall Study|Protocol Noncompliance|0|||
130066779|NCT03024255|468199760|FG003|Overall Study|Protocol Noncompliance|1|||
129871295|NCT00330174|467485854|FG000|Overall Study|Miscellaneous reasons|7|||
129871296|NCT00330174|467485855|FG001|Overall Study|Miscellaneous reasons|1|||
129871297|NCT00611858|467485856|FG000|Overall Study|Adverse Event|2|||
129871298|NCT00611858|467485856|FG000|Overall Study|Withdrawal by Subject|2|||
129871299|NCT01844284|467485857|FG000|Overall Study|Lost to Follow-up|12|||
129871300|NCT01844284|467485858|FG001|Overall Study|Lost to Follow-up|7|||
129871301|NCT01058304|467485859|FG000|Overall Study|Withdrawal by Subject|8|||
129871302|NCT01058304|467485860|FG001|Overall Study|Withdrawal by Subject|5|||
129871303|NCT01058304|467485859|FG000|Overall Study|Lost to Follow-up|13|||
129871304|NCT01058304|467485860|FG001|Overall Study|Lost to Follow-up|16|||
129871305|NCT01058304|467485859|FG000|Overall Study|Developed exclusion criterion|6|||
129871306|NCT01058304|467485860|FG001|Overall Study|Developed exclusion criterion|12|||
129871307|NCT01820559|467485861|FG000|Overall Study|Adverse Event|4|||
129871308|NCT01820559|467485862|FG001|Overall Study|Adverse Event|6|||
129871309|NCT01820559|467485863|FG002|Overall Study|Adverse Event|13|||
129871310|NCT01820559|467485861|FG000|Overall Study|Withdrawal by Subject|1|||
129871311|NCT01820559|467485862|FG001|Overall Study|Withdrawal by Subject|2|||
129871312|NCT01820559|467485863|FG002|Overall Study|Withdrawal by Subject|5|||
129871313|NCT01820559|467485861|FG000|Overall Study|Protocol Violation|2|||
129871314|NCT01820559|467485862|FG001|Overall Study|Protocol Violation|1|||
129871315|NCT01820559|467485863|FG002|Overall Study|Protocol Violation|3|||
129871316|NCT01820559|467485861|FG000|Overall Study|Subject's non-compliance|1|||
129871317|NCT01820559|467485862|FG001|Overall Study|Subject's non-compliance|0|||
129871318|NCT01820559|467485863|FG002|Overall Study|Subject's non-compliance|2|||
129871319|NCT01820559|467485861|FG000|Overall Study|Lost to Follow-up|3|||
129871320|NCT01820559|467485862|FG001|Overall Study|Lost to Follow-up|2|||
129871321|NCT01820559|467485863|FG002|Overall Study|Lost to Follow-up|2|||
129871322|NCT01820559|467485861|FG000|Overall Study|At sponsor request|0|||
129871323|NCT01820559|467485862|FG001|Overall Study|At sponsor request|0|||
129871324|NCT01820559|467485863|FG002|Overall Study|At sponsor request|1|||
129871325|NCT01820559|467485861|FG000|Overall Study|Lack of Efficacy|3|||
129871326|NCT01820559|467485862|FG001|Overall Study|Lack of Efficacy|2|||
129871327|NCT01820559|467485863|FG002|Overall Study|Lack of Efficacy|3|||
129871328|NCT02755597|467485864|FG000|Overall Study|Withdrew consent|27|||
129871329|NCT02755597|467485865|FG001|Overall Study|Withdrew consent|11|||
129871330|NCT02755597|467485864|FG000|Overall Study|Lost to Follow-up|1|||
129871331|NCT02755597|467485865|FG001|Overall Study|Lost to Follow-up|0|||
129871332|NCT02755597|467485864|FG000|Overall Study|Death|78|||
129871333|NCT02755597|467485865|FG001|Overall Study|Death|36|||
129871334|NCT02755597|467485864|FG000|Overall Study|Study terminated by Sponsor|67|||
129871335|NCT02755597|467485865|FG001|Overall Study|Study terminated by Sponsor|47|||
129871336|NCT02755597|467485864|FG000|Overall Study|Other, not specified|20|||
129871337|NCT02755597|467485865|FG001|Overall Study|Other, not specified|3|||
129871338|NCT02755597|467485864|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
129871339|NCT02755597|467485865|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
129871340|NCT02657031|467485871|FG000|Overall Study|Adverse Event|1|||
129871341|NCT02657031|467485872|FG001|Overall Study|Adverse Event|2|||
129871342|NCT05007392|467485873|FG000|Overall Study|Randomized but not treated|1|||
129871343|NCT05007392|467485874|FG001|Overall Study|Randomized but not treated|2|||
129871344|NCT05007392|467485873|FG000|Overall Study|Other|5|||
129871345|NCT05007392|467485874|FG001|Overall Study|Other|4|||
129871346|NCT05007392|467485873|FG000|Overall Study|Lost to Follow-up|1|||
129871347|NCT05007392|467485874|FG001|Overall Study|Lost to Follow-up|2|||
129871348|NCT05007392|467485873|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
130066780|NCT00817206|468199761|FG000|Overall Study|Adverse Event|10|||
130066781|NCT00817206|468199762|FG001|Overall Study|Adverse Event|3|||
129871349|NCT05007392|467485874|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
129871350|NCT05007392|467485873|FG000|Overall Study|Use of prohibited concomitant drug|1|||
129871351|NCT05007392|467485874|FG001|Overall Study|Use of prohibited concomitant drug|1|||
129871352|NCT05007392|467485873|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
129871353|NCT05007392|467485874|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
129871354|NCT05007392|467485873|FG000|Overall Study|Adverse Event|10|||
129871355|NCT05007392|467485874|FG001|Overall Study|Adverse Event|6|||
129871356|NCT05007392|467485873|FG000|Overall Study|Participant choice|5|||
129871357|NCT05007392|467485874|FG001|Overall Study|Participant choice|10|||
129871358|NCT05007392|467485873|FG000|Overall Study|Withdrawal of consent|5|||
130066782|NCT00817206|468199761|FG000|Overall Study|Protocol Violation|0|||
129871359|NCT05007392|467485874|FG001|Overall Study|Withdrawal of consent|4|||
129871360|NCT01218126|467485875|FG000|Overall Study|Adverse Event|8|||
129871361|NCT01218126|467485876|FG001|Overall Study|Adverse Event|10|||
129871362|NCT01218126|467485877|FG002|Overall Study|Adverse Event|12|||
129871363|NCT01218126|467485878|FG003|Overall Study|Adverse Event|16|||
129871364|NCT01218126|467485875|FG000|Overall Study|Lack of Efficacy|7|||
130066783|NCT00817206|468199762|FG001|Overall Study|Protocol Violation|2|||
130066784|NCT00817206|468199761|FG000|Overall Study|Lost to Follow-up|0|||
130066785|NCT00817206|468199762|FG001|Overall Study|Lost to Follow-up|1|||
130066786|NCT00817206|468199761|FG000|Overall Study|Death|2|||
130066787|NCT00817206|468199762|FG001|Overall Study|Death|0|||
130066788|NCT00817206|468199761|FG000|Overall Study|Withdrawal by Subject|7|||
130066789|NCT00817206|468199762|FG001|Overall Study|Withdrawal by Subject|3|||
130066790|NCT00817206|468199761|FG000|Overall Study|Physician Decision|2|||
130066791|NCT00817206|468199762|FG001|Overall Study|Physician Decision|0|||
130066792|NCT00126581|468199763|FG000|Overall Study|Adverse Event|3|||
130066793|NCT00126581|468199764|FG001|Overall Study|Adverse Event|7|||
130066794|NCT00126581|468199763|FG000|Overall Study|Death|3|||
130066795|NCT00126581|468199764|FG001|Overall Study|Death|2|||
130066796|NCT00126581|468199763|FG000|Overall Study|Withdrawal by Subject|1|||
130066797|NCT00126581|468199764|FG001|Overall Study|Withdrawal by Subject|4|||
130116764|NCT00602030|468387173|FG001|Lead-in Phase|Disease Progression|3|||
130116765|NCT00602030|468387174|FG002|Lead-in Phase|Disease Progression|0|||
130116766|NCT00602030|468387175|FG003|Lead-in Phase|Disease Progression|0|||
130116767|NCT00602030|468387176|FG004|Lead-in Phase|Disease Progression|0|||
130116768|NCT00602030|468387172|FG000|Lead-in Phase|Adverse Event|0|||
130116769|NCT00602030|468387173|FG001|Lead-in Phase|Adverse Event|2|||
130116770|NCT00602030|468387174|FG002|Lead-in Phase|Adverse Event|0|||
130116771|NCT00602030|468387175|FG003|Lead-in Phase|Adverse Event|0|||
130116772|NCT00602030|468387176|FG004|Lead-in Phase|Adverse Event|0|||
130116773|NCT00602030|468387172|FG000|Double-blind Phase|Disease progression|0|||
130116774|NCT00602030|468387173|FG001|Double-blind Phase|Disease progression|0|||
130116775|NCT00602030|468387174|FG002|Double-blind Phase|Disease progression|33|||
130116776|NCT00602030|468387175|FG003|Double-blind Phase|Disease progression|30|||
130116777|NCT00602030|468387176|FG004|Double-blind Phase|Disease progression|0|||
130116778|NCT00602030|468387172|FG000|Double-blind Phase|Adverse Event|0|||
130116779|NCT00602030|468387173|FG001|Double-blind Phase|Adverse Event|0|||
130116780|NCT00602030|468387174|FG002|Double-blind Phase|Adverse Event|9|||
130116781|NCT00602030|468387175|FG003|Double-blind Phase|Adverse Event|18|||
130116782|NCT00602030|468387176|FG004|Double-blind Phase|Adverse Event|0|||
130116783|NCT00602030|468387172|FG000|Double-blind Phase|Consent withdrawal|0|||
130116784|NCT00602030|468387173|FG001|Double-blind Phase|Consent withdrawal|0|||
130116785|NCT00602030|468387174|FG002|Double-blind Phase|Consent withdrawal|4|||
130116786|NCT00602030|468387175|FG003|Double-blind Phase|Consent withdrawal|3|||
130116787|NCT00602030|468387176|FG004|Double-blind Phase|Consent withdrawal|0|||
130116788|NCT00602030|468387172|FG000|Double-blind Phase|Death|0|||
130116789|NCT00602030|468387173|FG001|Double-blind Phase|Death|0|||
130116790|NCT00602030|468387174|FG002|Double-blind Phase|Death|3|||
130116791|NCT00602030|468387175|FG003|Double-blind Phase|Death|3|||
130116792|NCT00602030|468387176|FG004|Double-blind Phase|Death|0|||
130116793|NCT00602030|468387172|FG000|Double-blind Phase|Administrative decision|0|||
130116794|NCT00602030|468387173|FG001|Double-blind Phase|Administrative decision|0|||
130116795|NCT00602030|468387174|FG002|Double-blind Phase|Administrative decision|0|||
130116796|NCT00602030|468387175|FG003|Double-blind Phase|Administrative decision|2|||
130116797|NCT00602030|468387176|FG004|Double-blind Phase|Administrative decision|0|||
130116798|NCT00602030|468387172|FG000|Double-blind Phase|Ineligibility|0|||
130116799|NCT00602030|468387173|FG001|Double-blind Phase|Ineligibility|0|||
130116800|NCT00602030|468387174|FG002|Double-blind Phase|Ineligibility|0|||
130116801|NCT00602030|468387175|FG003|Double-blind Phase|Ineligibility|1|||
130116802|NCT00602030|468387176|FG004|Double-blind Phase|Ineligibility|0|||
130116803|NCT00602030|468387172|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
130116804|NCT00602030|468387173|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
130116805|NCT00602030|468387174|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
130116806|NCT00602030|468387175|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
130116807|NCT00602030|468387176|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
130116808|NCT00602030|468387172|FG000|Double-blind Phase|Reason not specified|0|||
130116809|NCT00602030|468387173|FG001|Double-blind Phase|Reason not specified|0|||
130116810|NCT00602030|468387174|FG002|Double-blind Phase|Reason not specified|4|||
130116811|NCT00602030|468387175|FG003|Double-blind Phase|Reason not specified|2|||
130116812|NCT00602030|468387176|FG004|Double-blind Phase|Reason not specified|0|||
130116813|NCT00602030|468387172|FG000|Crossover Phase|Disease Progression|0|||
130116814|NCT00602030|468387173|FG001|Crossover Phase|Disease Progression|0|||
130116815|NCT00602030|468387174|FG002|Crossover Phase|Disease Progression|0|||
130116816|NCT00602030|468387175|FG003|Crossover Phase|Disease Progression|0|||
130116817|NCT00602030|468387176|FG004|Crossover Phase|Disease Progression|11|||
130116818|NCT00602030|468387172|FG000|Crossover Phase|Adverse Event|0|||
130116819|NCT00602030|468387173|FG001|Crossover Phase|Adverse Event|0|||
130116820|NCT00602030|468387174|FG002|Crossover Phase|Adverse Event|0|||
130116821|NCT00602030|468387175|FG003|Crossover Phase|Adverse Event|0|||
130116822|NCT00602030|468387176|FG004|Crossover Phase|Adverse Event|3|||
130116823|NCT00602030|468387172|FG000|Crossover Phase|Consent withdrawal|0|||
130066798|NCT00126581|468199763|FG000|Overall Study|Alternative therapy|3|||
130116824|NCT00602030|468387173|FG001|Crossover Phase|Consent withdrawal|0|||
130066799|NCT00126581|468199764|FG001|Overall Study|Alternative therapy|3|||
130116825|NCT00602030|468387174|FG002|Crossover Phase|Consent withdrawal|0|||
130116826|NCT00602030|468387175|FG003|Crossover Phase|Consent withdrawal|0|||
129918144|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918145|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918146|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918147|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
129918148|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
129918149|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
129918150|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
129918151|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918152|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
129918153|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
129918154|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918155|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918156|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918157|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918158|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918159|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918160|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918161|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918162|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918163|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918164|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918165|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918166|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918167|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918168|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918169|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918170|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918171|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918172|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918173|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918174|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
129918175|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918176|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918177|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918178|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918179|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918180|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
129918181|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918182|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918183|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
129918184|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918185|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918186|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
129918187|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918188|NCT02783300|467665418|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918189|NCT02783300|467665419|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918190|NCT02783300|467665420|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129871365|NCT01218126|467485876|FG001|Overall Study|Lack of Efficacy|2|||
129871366|NCT01218126|467485877|FG002|Overall Study|Lack of Efficacy|2|||
129871367|NCT01218126|467485878|FG003|Overall Study|Lack of Efficacy|6|||
129871368|NCT01218126|467485875|FG000|Overall Study|Protocol Violation|5|||
129871369|NCT01218126|467485876|FG001|Overall Study|Protocol Violation|2|||
129871370|NCT01218126|467485877|FG002|Overall Study|Protocol Violation|2|||
129871371|NCT01218126|467485878|FG003|Overall Study|Protocol Violation|3|||
129871372|NCT01218126|467485875|FG000|Overall Study|Protocol-defined stopping criteria|1|||
129871373|NCT01218126|467485876|FG001|Overall Study|Protocol-defined stopping criteria|1|||
129871374|NCT01218126|467485877|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129871375|NCT01218126|467485878|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129871376|NCT01218126|467485875|FG000|Overall Study|Lost to Follow-up|0|||
129871377|NCT01218126|467485876|FG001|Overall Study|Lost to Follow-up|0|||
129871378|NCT01218126|467485877|FG002|Overall Study|Lost to Follow-up|0|||
129871379|NCT01218126|467485878|FG003|Overall Study|Lost to Follow-up|2|||
129871380|NCT01218126|467485875|FG000|Overall Study|Physician Decision|1|||
129871381|NCT01218126|467485876|FG001|Overall Study|Physician Decision|2|||
129871382|NCT01218126|467485877|FG002|Overall Study|Physician Decision|4|||
130066800|NCT00126581|468199763|FG000|Overall Study|Other illness/MD discretion|3|||
130066801|NCT00126581|468199764|FG001|Overall Study|Other illness/MD discretion|4|||
130066802|NCT00793182|468199765|FG000|Overall Study|Adverse Event|0|||
130066803|NCT00793182|468199766|FG001|Overall Study|Adverse Event|1|||
130066804|NCT02034552|468199767|FG000|Overall Study|Never treated|3|||
130066805|NCT02034552|468199768|FG001|Overall Study|Never treated|2|||
130066806|NCT02034552|468199769|FG002|Overall Study|Never treated|0|||
130066807|NCT02034552|468199767|FG000|Overall Study|Radiological progression|3|||
130066808|NCT02034552|468199768|FG001|Overall Study|Radiological progression|5|||
130066809|NCT02034552|468199769|FG002|Overall Study|Radiological progression|4|||
130066810|NCT02034552|468199767|FG000|Overall Study|AE not assoc. with disease progression|1|||
130066811|NCT02034552|468199768|FG001|Overall Study|AE not assoc. with disease progression|4|||
130066812|NCT02034552|468199769|FG002|Overall Study|AE not assoc. with disease progression|2|||
130066813|NCT02034552|468199767|FG000|Overall Study|AE associated with disease progression|0|||
130066814|NCT02034552|468199768|FG001|Overall Study|AE associated with disease progression|1|||
130066815|NCT02034552|468199769|FG002|Overall Study|AE associated with disease progression|0|||
130066816|NCT02034552|468199767|FG000|Overall Study|Withdrawal by Subject|2|||
130066817|NCT02034552|468199768|FG001|Overall Study|Withdrawal by Subject|1|||
130066818|NCT02034552|468199769|FG002|Overall Study|Withdrawal by Subject|1|||
130066819|NCT02034552|468199767|FG000|Overall Study|Non-compliance with study drug|0|||
130066820|NCT02034552|468199768|FG001|Overall Study|Non-compliance with study drug|0|||
130066821|NCT02034552|468199769|FG002|Overall Study|Non-compliance with study drug|1|||
130066822|NCT02034552|468199767|FG000|Overall Study|Clinical progression|5|||
130066823|NCT02034552|468199768|FG001|Overall Study|Clinical progression|7|||
130066824|NCT02034552|468199769|FG002|Overall Study|Clinical progression|9|||
130066825|NCT02197897|468199775|FG000|Overall Study|not eligible|1|||
130066826|NCT02384395|468199776|FG000|Overall Study|Physician Decision|4|||
130066827|NCT02384395|468199776|FG000|Overall Study|Withdrawal by Subject|3|||
130066828|NCT02384395|468199776|FG000|Overall Study|Lost to Follow-up|3|||
130066829|NCT00291499|468199781|FG000|Overall Study|Adverse Event|3|||
130066830|NCT00291499|468199782|FG001|Overall Study|Adverse Event|8|||
130066831|NCT00291499|468199781|FG000|Overall Study|Change to other therapy|2|||
130066832|NCT00291499|468199782|FG001|Overall Study|Change to other therapy|1|||
130066833|NCT00291499|468199781|FG000|Overall Study|Intercurrent illness|1|||
130066834|NCT00291499|468199782|FG001|Overall Study|Intercurrent illness|0|||
130066835|NCT00291499|468199781|FG000|Overall Study|Protocol Violation|2|||
130066836|NCT00291499|468199782|FG001|Overall Study|Protocol Violation|2|||
130066837|NCT00291499|468199781|FG000|Overall Study|Other reasons|1|||
130066838|NCT00291499|468199782|FG001|Overall Study|Other reasons|4|||
130066839|NCT01532570|468199783|FG000|Overall Study|Lack of Efficacy|1|||
130066840|NCT01532570|468199784|FG001|Overall Study|Lack of Efficacy|0|||
130066841|NCT01532570|468199785|FG002|Overall Study|Lack of Efficacy|0|||
130066842|NCT01532570|468199786|FG003|Overall Study|Lack of Efficacy|0|||
130066843|NCT01532570|468199783|FG000|Overall Study|Withdrawal by Subject|0|||
130066844|NCT01532570|468199784|FG001|Overall Study|Withdrawal by Subject|1|||
130066845|NCT01532570|468199785|FG002|Overall Study|Withdrawal by Subject|0|||
130066846|NCT01532570|468199786|FG003|Overall Study|Withdrawal by Subject|0|||
130066847|NCT03939637|468199790|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
130066848|NCT03939637|468199791|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
130066849|NCT03939637|468199790|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
130066850|NCT03939637|468199791|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
130066851|NCT05224076|468199792|FG000|Overall Study|Lost to Follow-up|24|||
130066852|NCT04325906|468199793|FG000|Overall Study|Withdrawal by Subject|2|||
130066853|NCT04325906|468199794|FG001|Overall Study|Withdrawal by Subject|0|||
130066854|NCT01665768|468199795|FG000|Overall Study|Adverse Event|3|||
130066855|NCT01665768|468199795|FG000|Overall Study|Lack of Efficacy|19|||
130066856|NCT01665768|468199795|FG000|Overall Study|Withdrawal by Subject|1|||
130066857|NCT01329341|468199796|FG000|Overall Study|Withdrawal by Subject|44|||
130066858|NCT03017846|468199797|FG000|Overall Study|Lost to Follow-up|3|||
130066859|NCT03017846|468199797|FG000|Overall Study|Adverse Event|2|||
130066860|NCT02151682|468199798|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130066861|NCT02151682|468199799|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
130066862|NCT02151682|468199800|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130066863|NCT02151682|468199801|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130116827|NCT00602030|468387176|FG004|Crossover Phase|Consent withdrawal|2|||
130066864|NCT02151682|468199802|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130066865|NCT02151682|468199803|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
130066866|NCT02151682|468199798|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130066867|NCT02151682|468199799|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
130066868|NCT02151682|468199800|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130066869|NCT02151682|468199801|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130066870|NCT02151682|468199802|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130066871|NCT02151682|468199803|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
130066872|NCT02151682|468199798|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130066873|NCT02151682|468199799|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
130066874|NCT02151682|468199800|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130066875|NCT02151682|468199801|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130066876|NCT02151682|468199802|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130066877|NCT02151682|468199803|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
130066878|NCT02151682|468199798|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
130066879|NCT02151682|468199799|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
130066880|NCT02151682|468199800|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130066881|NCT02151682|468199801|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130066882|NCT02151682|468199802|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130066883|NCT02151682|468199803|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
130066884|NCT02151682|468199798|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
130066885|NCT02151682|468199799|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130066886|NCT02151682|468199800|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130066887|NCT02151682|468199801|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
129918191|NCT02783300|467665421|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918192|NCT02783300|467665422|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918193|NCT02783300|467665423|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918194|NCT02783300|467665424|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918195|NCT02783300|467665425|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918196|NCT02783300|467665426|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918197|NCT02783300|467665427|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918198|NCT02783300|467665428|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918199|NCT02783300|467665429|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918200|NCT02783300|467665430|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918201|NCT02783300|467665431|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918202|NCT02783300|467665432|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918203|NCT02783300|467665433|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918204|NCT02783300|467665434|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918205|NCT02783300|467665435|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918206|NCT02783300|467665436|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918207|NCT02783300|467665437|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918208|NCT02783300|467665438|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918209|NCT02783300|467665439|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918210|NCT02783300|467665440|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918211|NCT02783300|467665441|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918212|NCT02783300|467665442|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918213|NCT02783300|467665443|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918214|NCT02783300|467665444|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
129918215|NCT02783300|467665418|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918216|NCT02783300|467665419|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918217|NCT02783300|467665420|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918218|NCT02783300|467665421|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918219|NCT02783300|467665422|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918220|NCT02783300|467665423|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918221|NCT02783300|467665424|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918222|NCT02783300|467665425|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918223|NCT02783300|467665426|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918224|NCT02783300|467665427|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918225|NCT02783300|467665428|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918226|NCT02783300|467665429|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918227|NCT02783300|467665430|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918228|NCT02783300|467665431|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918229|NCT02783300|467665432|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918230|NCT02783300|467665433|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918231|NCT02783300|467665434|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918232|NCT02783300|467665435|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918233|NCT02783300|467665436|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918234|NCT02783300|467665437|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918235|NCT02783300|467665438|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918236|NCT02783300|467665439|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918237|NCT02783300|467665440|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918238|NCT02783300|467665441|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
130066888|NCT02151682|468199802|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130066889|NCT02151682|468199803|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
130066890|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130066891|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130066892|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
130066893|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130066894|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130066895|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
130066896|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
130066897|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
130066898|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
130066899|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
130066900|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
130066901|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
130066902|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
129871383|NCT01218126|467485878|FG003|Overall Study|Physician Decision|2|||
129871384|NCT01218126|467485875|FG000|Overall Study|Withdrawal by Subject|2|||
129871385|NCT01218126|467485876|FG001|Overall Study|Withdrawal by Subject|5|||
129871386|NCT01218126|467485877|FG002|Overall Study|Withdrawal by Subject|4|||
129871387|NCT01218126|467485878|FG003|Overall Study|Withdrawal by Subject|6|||
129871388|NCT01860703|467485879|FG000|Overall Study|Adverse Event|1|||
129871389|NCT01860703|467485880|FG001|Overall Study|Adverse Event|4|||
129871390|NCT01860703|467485881|FG002|Overall Study|Adverse Event|0|||
129871391|NCT01860703|467485882|FG003|Overall Study|Adverse Event|2|||
129871392|NCT01860703|467485879|FG000|Overall Study|Withdrawal by Subject|0|||
129871393|NCT01860703|467485880|FG001|Overall Study|Withdrawal by Subject|1|||
129871394|NCT01860703|467485881|FG002|Overall Study|Withdrawal by Subject|0|||
129871395|NCT01860703|467485882|FG003|Overall Study|Withdrawal by Subject|0|||
129871396|NCT01860703|467485879|FG000|Overall Study|Personal reason|1|||
129871397|NCT01860703|467485880|FG001|Overall Study|Personal reason|0|||
129871398|NCT01860703|467485881|FG002|Overall Study|Personal reason|1|||
129871399|NCT01860703|467485882|FG003|Overall Study|Personal reason|0|||
129871400|NCT02453685|467485887|FG000|Overall Study|Adverse Event|0|||
129871401|NCT02453685|467485888|FG001|Overall Study|Adverse Event|1|||
129871402|NCT02453685|467485887|FG000|Overall Study|Protocol Violation|7|||
129871403|NCT02453685|467485888|FG001|Overall Study|Protocol Violation|4|||
129871404|NCT02453685|467485887|FG000|Overall Study|Lost to Follow-up|0|||
129871405|NCT02453685|467485888|FG001|Overall Study|Lost to Follow-up|1|||
129871406|NCT02453685|467485887|FG000|Overall Study|Withdrawal by Subject|8|||
129871407|NCT02453685|467485888|FG001|Overall Study|Withdrawal by Subject|4|||
129871408|NCT02453685|467485887|FG000|Overall Study|Unclassified|4|||
129871409|NCT02453685|467485888|FG001|Overall Study|Unclassified|2|||
129871410|NCT00453986|467485889|FG000|Overall Study|Lost to Follow-up|6|||
129871411|NCT00453986|467485890|FG001|Overall Study|Lost to Follow-up|5|||
129871412|NCT00453986|467485891|FG002|Overall Study|Lost to Follow-up|6|||
129871413|NCT00453986|467485892|FG003|Overall Study|Lost to Follow-up|2|||
129871414|NCT00453986|467485893|FG004|Overall Study|Lost to Follow-up|0|||
129871415|NCT02778100|467485896|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
129871416|NCT02778100|467485897|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
129871417|NCT00522626|467485902|FG000|Overall Study|Lost to Follow-up|7|||
129871418|NCT03419364|467485905|FG000|Overall Study|Delivery due to maternal condition|2|||
129871419|NCT03419364|467485906|FG001|Overall Study|Delivery due to maternal condition|0|||
129871420|NCT03419364|467485907|FG002|Overall Study|Delivery due to maternal condition|0|||
129871421|NCT01338025|467485911|FG000|Overall Study|Unexpected closure of study|10|||
129871422|NCT01338025|467485912|FG001|Overall Study|Unexpected closure of study|9|||
129871423|NCT01338025|467485911|FG000|Overall Study|Withdrawal by Subject|0|||
129871424|NCT01338025|467485912|FG001|Overall Study|Withdrawal by Subject|2|||
129871425|NCT01338025|467485911|FG000|Overall Study|Found ineligible after starting|1|||
129871426|NCT01338025|467485912|FG001|Overall Study|Found ineligible after starting|0|||
129871427|NCT04120233|467485915|FG000|Overall Study|Adverse Event|0|||
129871428|NCT04120233|467485916|FG001|Overall Study|Adverse Event|0|||
129871429|NCT04120233|467485917|FG002|Overall Study|Adverse Event|0|||
129871430|NCT04120233|467485918|FG003|Overall Study|Adverse Event|0|||
129871431|NCT04120233|467485919|FG004|Overall Study|Adverse Event|1|||
129871432|NCT04120233|467485920|FG005|Overall Study|Adverse Event|0|||
129871433|NCT03779906|467485921|FG000|Overall Study|Lost to Follow-up|7|||
129871434|NCT03779906|467485921|FG000|Overall Study|COVID pandemic|1|||
129871435|NCT02553460|467485924|FG000|Overall Study|Death|3|||
129871436|NCT02553460|467485924|FG000|Overall Study|Withdrawal by Subject|1|||
129871437|NCT02553460|467485924|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
129871438|NCT02553460|467485924|FG000|Overall Study|Relapse or Transplant|14|||
129871439|NCT02553460|467485924|FG000|Overall Study|No response to treatment|2|||
130066903|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
129871440|NCT02553460|467485924|FG000|Overall Study|CAR T cells|2|||
129871441|NCT04814368|467485925|FG000|Overall Study|Study Terminated by Sponsor|0|||
129871442|NCT04814368|467485926|FG001|Overall Study|Study Terminated by Sponsor|3|||
130066904|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
130066905|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
130066906|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
130066907|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
130066908|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130066909|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130066910|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
130066911|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130066912|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130066913|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
130066914|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130066915|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130066916|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
130066917|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130066918|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130066919|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
130066920|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130066921|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130066922|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
130066923|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130066924|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130066925|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
130066926|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
130066927|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
130066928|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
130066929|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
130066930|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
130066931|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
130066932|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
130066933|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
130066934|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
130066935|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
130066936|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
130066937|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
130066938|NCT02151682|468199798|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130066939|NCT02151682|468199799|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130066940|NCT02151682|468199800|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
130066941|NCT02151682|468199801|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130066942|NCT02151682|468199802|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130066943|NCT02151682|468199803|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
130066944|NCT02151682|468199798|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130066945|NCT02151682|468199799|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130066946|NCT02151682|468199800|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130066947|NCT02151682|468199801|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130066948|NCT02151682|468199802|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
130066949|NCT02151682|468199803|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
130066950|NCT02151682|468199798|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130066951|NCT02151682|468199799|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
129871443|NCT04814368|467485927|FG002|Overall Study|Study Terminated by Sponsor|0|||
129871444|NCT04814368|467485928|FG003|Overall Study|Study Terminated by Sponsor|2|||
129871445|NCT04814368|467485925|FG000|Overall Study|Subject Decision|1|||
129871446|NCT04814368|467485926|FG001|Overall Study|Subject Decision|2|||
129871447|NCT04814368|467485927|FG002|Overall Study|Subject Decision|0|||
129871448|NCT04814368|467485928|FG003|Overall Study|Subject Decision|0|||
129871449|NCT01953003|467487485|FG000|Overall Study|Not treated|0|||
129871450|NCT01953003|467487486|FG001|Overall Study|Not treated|1|||
129871451|NCT01953003|467487485|FG000|Overall Study|Progressive disease|35|||
129871452|NCT01953003|467487486|FG001|Overall Study|Progressive disease|45|||
129871453|NCT01953003|467487485|FG000|Overall Study|Related Adverse events|7|||
129871454|NCT01953003|467487486|FG001|Overall Study|Related Adverse events|2|||
129871455|NCT01953003|467487485|FG000|Overall Study|Non-related adverse events|0|||
130066952|NCT02151682|468199800|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130066953|NCT02151682|468199801|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130066954|NCT02151682|468199802|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
130066955|NCT02151682|468199803|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
130066956|NCT02151682|468199798|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130066957|NCT02151682|468199799|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130066958|NCT02151682|468199800|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130066959|NCT02151682|468199801|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130066960|NCT02151682|468199802|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
130066961|NCT02151682|468199803|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
130066962|NCT02151682|468199798|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130066963|NCT02151682|468199799|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130066964|NCT02151682|468199800|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
129871456|NCT01953003|467487486|FG001|Overall Study|Non-related adverse events|2|||
129871457|NCT01953003|467487485|FG000|Overall Study|Protocol Violation|0|||
129871458|NCT01953003|467487486|FG001|Overall Study|Protocol Violation|1|||
129871459|NCT01953003|467487485|FG000|Overall Study|Withdrawal by Subject|14|||
129871460|NCT01953003|467487486|FG001|Overall Study|Withdrawal by Subject|4|||
129871461|NCT00224770|467487495|FG000|Overall Study|Lost to Follow-up|4|||
129871462|NCT00224770|467487496|FG001|Overall Study|Lost to Follow-up|2|||
129871463|NCT00224770|467487497|FG002|Overall Study|Lost to Follow-up|0|||
129871464|NCT01106430|467487498|FG000|Overall Study|Adverse Event|8|||
129871465|NCT01106430|467487499|FG001|Overall Study|Adverse Event|10|||
129871466|NCT01106430|467487498|FG000|Overall Study|Lack of Efficacy|2|||
129871467|NCT01106430|467487499|FG001|Overall Study|Lack of Efficacy|13|||
129871468|NCT01106430|467487498|FG000|Overall Study|Lost to Follow-up|5|||
129871469|NCT01106430|467487499|FG001|Overall Study|Lost to Follow-up|1|||
129871470|NCT01106430|467487498|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
129871471|NCT01106430|467487499|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
129871472|NCT01106430|467487498|FG000|Overall Study|Moved Out Of State|0|||
129871473|NCT01106430|467487499|FG001|Overall Study|Moved Out Of State|1|||
129871474|NCT01106430|467487498|FG000|Overall Study|Refused To Take Medication|0|||
129871475|NCT01106430|467487499|FG001|Overall Study|Refused To Take Medication|1|||
129871476|NCT01106430|467487498|FG000|Overall Study|Noncompliance|0|||
129871477|NCT01106430|467487499|FG001|Overall Study|Noncompliance|1|||
129871478|NCT01106430|467487498|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
129871479|NCT01106430|467487499|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
129918239|NCT02783300|467665442|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918240|NCT02783300|467665443|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918241|NCT02783300|467665444|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
129918242|NCT03930342|467665450|FG000|Overall Study|Lost to Follow-up|70|||
129918243|NCT03930342|467665451|FG001|Overall Study|Lost to Follow-up|77|||
129918244|NCT05691309|467666932|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
129918245|NCT05691309|467666932|FG000|Overall Study|vancomycin levels not evaluable|2|||
129918246|NCT01804816|467666933|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
129918247|NCT01804816|467666933|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
129918248|NCT04421378|467666939|FG000|Overall Study|Adverse Event|2|||
129918249|NCT04421378|467666940|FG001|Overall Study|Adverse Event|7|||
129918250|NCT04421378|467666941|FG002|Overall Study|Adverse Event|0|||
129918251|NCT04421378|467666942|FG003|Overall Study|Adverse Event|1|||
129918252|NCT04421378|467666943|FG004|Overall Study|Adverse Event|0|||
129918253|NCT04421378|467666939|FG000|Overall Study|Physician Decision|1|||
129918254|NCT04421378|467666940|FG001|Overall Study|Physician Decision|2|||
129918255|NCT04421378|467666941|FG002|Overall Study|Physician Decision|0|||
129918256|NCT04421378|467666942|FG003|Overall Study|Physician Decision|0|||
129918257|NCT04421378|467666943|FG004|Overall Study|Physician Decision|0|||
129918258|NCT04421378|467666939|FG000|Overall Study|Progressive Disease|16|||
129918259|NCT04421378|467666940|FG001|Overall Study|Progressive Disease|4|||
129918260|NCT04421378|467666941|FG002|Overall Study|Progressive Disease|18|||
129918261|NCT04421378|467666942|FG003|Overall Study|Progressive Disease|11|||
129918262|NCT04421378|467666943|FG004|Overall Study|Progressive Disease|3|||
129918263|NCT04421378|467666939|FG000|Overall Study|Study Terminated by Sponsor|0|||
129918264|NCT04421378|467666940|FG001|Overall Study|Study Terminated by Sponsor|1|||
129918265|NCT04421378|467666941|FG002|Overall Study|Study Terminated by Sponsor|1|||
129918266|NCT04421378|467666942|FG003|Overall Study|Study Terminated by Sponsor|0|||
129918267|NCT04421378|467666943|FG004|Overall Study|Study Terminated by Sponsor|0|||
129871480|NCT01106430|467487498|FG000|Overall Study|Previous Use Of Marijuana|1|||
129918268|NCT04421378|467666939|FG000|Overall Study|Withdrawal by Subject|3|||
129918269|NCT04421378|467666940|FG001|Overall Study|Withdrawal by Subject|1|||
129918270|NCT04421378|467666941|FG002|Overall Study|Withdrawal by Subject|0|||
129918271|NCT04421378|467666942|FG003|Overall Study|Withdrawal by Subject|2|||
129871481|NCT01106430|467487499|FG001|Overall Study|Previous Use Of Marijuana|0|||
129871482|NCT01106430|467487498|FG000|Overall Study|Protocol Violation|7|||
129871483|NCT01106430|467487499|FG001|Overall Study|Protocol Violation|2|||
129871484|NCT01106430|467487498|FG000|Overall Study|Withdrawal by Subject|8|||
129918272|NCT04421378|467666943|FG004|Overall Study|Withdrawal by Subject|0|||
129918273|NCT04421378|467666939|FG000|Overall Study|Other|1|||
129918274|NCT04421378|467666940|FG001|Overall Study|Other|0|||
129918275|NCT04421378|467666941|FG002|Overall Study|Other|0|||
130066965|NCT02151682|468199801|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130116828|NCT00638157|468387199|FG000|Overall Study|Adverse Event|0|||
130066966|NCT02151682|468199802|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
130066967|NCT02151682|468199803|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
130066968|NCT00992186|468199804|FG000|Overall Study|Withdrawal by Subject|2|||
130066969|NCT00992186|468199804|FG000|Overall Study|Protocol Violation|1|||
130066970|NCT00992186|468199804|FG000|Overall Study|Physician Decision|1|||
130066971|NCT00992186|468199804|FG000|Overall Study|Adverse Event|9|||
130066972|NCT00992186|468199804|FG000|Overall Study|Progressive Disease|30|||
130066973|NCT00992186|468199804|FG000|Overall Study|Refusal To Receive Study Agent|3|||
130066974|NCT00168064|468199805|FG000|Overall Study|Adverse Event|26|||
130066975|NCT00168064|468199806|FG001|Overall Study|Adverse Event|22|||
130066976|NCT00168064|468199805|FG000|Overall Study|Withdrawal by Subject|3|||
130066977|NCT00168064|468199806|FG001|Overall Study|Withdrawal by Subject|4|||
130066978|NCT00168064|468199805|FG000|Overall Study|Lack of Efficacy|4|||
130066979|NCT00168064|468199806|FG001|Overall Study|Lack of Efficacy|4|||
129871485|NCT01106430|467487499|FG001|Overall Study|Withdrawal by Subject|4|||
129871486|NCT03704584|467487500|FG000|Overall Study|Withdrawal by Subject|1|||
130066980|NCT00168064|468199805|FG000|Overall Study|Lost to Follow-up|4|||
129871487|NCT03704584|467487501|FG001|Overall Study|Withdrawal by Subject|0|||
129871488|NCT03439189|467487502|FG000|Overall Study|Protocol Violation|19|||
129871489|NCT03439189|467487502|FG000|Overall Study|Lack of Efficacy|63|||
129871490|NCT04791761|467487506|FG000|Overall Study|Lost to Follow-up|8|||
129871491|NCT04791761|467487507|FG001|Overall Study|Lost to Follow-up|6|||
129871492|NCT04791761|467487508|FG002|Overall Study|Lost to Follow-up|10|||
129871493|NCT04791761|467487506|FG000|Overall Study|Withdrawal by Subject|0|||
129871494|NCT04791761|467487507|FG001|Overall Study|Withdrawal by Subject|1|||
129871495|NCT04791761|467487508|FG002|Overall Study|Withdrawal by Subject|1|||
129871496|NCT04791761|467487506|FG000|Overall Study|Protocol Violation|0|||
129871497|NCT04791761|467487507|FG001|Overall Study|Protocol Violation|1|||
129871498|NCT04791761|467487508|FG002|Overall Study|Protocol Violation|1|||
129871499|NCT00508261|467487511|FG000|Overall Study|Other|0|||
129871500|NCT00508261|467487512|FG001|Overall Study|Other|1|||
129871501|NCT00508261|467487513|FG002|Overall Study|Other|1|||
130066981|NCT00168064|468199806|FG001|Overall Study|Lost to Follow-up|3|||
130066982|NCT00168064|468199805|FG000|Overall Study|Non-compliance|2|||
129871502|NCT00508261|467487514|FG003|Overall Study|Other|0|||
129871503|NCT00508261|467487511|FG000|Overall Study|Serious Adverse Event|0|||
129871504|NCT00508261|467487512|FG001|Overall Study|Serious Adverse Event|1|||
129871505|NCT00508261|467487513|FG002|Overall Study|Serious Adverse Event|0|||
129871506|NCT00508261|467487514|FG003|Overall Study|Serious Adverse Event|0|||
129871507|NCT00508261|467487511|FG000|Overall Study|Withdrawal by Subject|3|||
129871508|NCT00508261|467487512|FG001|Overall Study|Withdrawal by Subject|4|||
129871509|NCT00508261|467487513|FG002|Overall Study|Withdrawal by Subject|4|||
129871510|NCT00508261|467487514|FG003|Overall Study|Withdrawal by Subject|0|||
129871511|NCT00508261|467487511|FG000|Overall Study|Migrated/ moved from study area|0|||
129871512|NCT00508261|467487512|FG001|Overall Study|Migrated/ moved from study area|1|||
129871513|NCT00508261|467487513|FG002|Overall Study|Migrated/ moved from study area|0|||
129871514|NCT00508261|467487514|FG003|Overall Study|Migrated/ moved from study area|0|||
129871515|NCT00508261|467487511|FG000|Overall Study|Lost to Follow-up|0|||
129871516|NCT00508261|467487512|FG001|Overall Study|Lost to Follow-up|1|||
129871517|NCT00508261|467487513|FG002|Overall Study|Lost to Follow-up|1|||
129871518|NCT00508261|467487514|FG003|Overall Study|Lost to Follow-up|1|||
129871519|NCT00180479|467487515|FG000|Overall Study|Death|4|||
129871520|NCT00180479|467487516|FG001|Overall Study|Death|2|||
129871521|NCT00180479|467487515|FG000|Overall Study|Lost to Follow-up|9|||
129871522|NCT00180479|467487516|FG001|Overall Study|Lost to Follow-up|7|||
129871523|NCT00180479|467487515|FG000|Overall Study|Withdrawal by Subject|3|||
129871524|NCT00180479|467487516|FG001|Overall Study|Withdrawal by Subject|3|||
129871525|NCT00180479|467487515|FG000|Overall Study|Informed consent not signed|0|||
129871526|NCT00180479|467487516|FG001|Overall Study|Informed consent not signed|1|||
129871527|NCT02459262|467487523|FG000|Overall Study|Withdrawal by Subject|0|||
129871528|NCT02459262|467487524|FG001|Overall Study|Withdrawal by Subject|0|||
129871529|NCT02459262|467487525|FG002|Overall Study|Withdrawal by Subject|0|||
129871530|NCT02459262|467487526|FG003|Overall Study|Withdrawal by Subject|0|||
129871531|NCT02459262|467487527|FG004|Overall Study|Withdrawal by Subject|0|||
129871532|NCT02459262|467487528|FG005|Overall Study|Withdrawal by Subject|0|||
130066983|NCT00168064|468199806|FG001|Overall Study|Non-compliance|3|||
130066984|NCT00168064|468199805|FG000|Overall Study|Concurrent Illness|4|||
129871533|NCT02459262|467487529|FG006|Overall Study|Withdrawal by Subject|0|||
129871534|NCT02459262|467487530|FG007|Overall Study|Withdrawal by Subject|0|||
129871535|NCT02459262|467487531|FG008|Overall Study|Withdrawal by Subject|0|||
129871536|NCT02459262|467487532|FG009|Overall Study|Withdrawal by Subject|1|||
129871537|NCT02459262|467487533|FG010|Overall Study|Withdrawal by Subject|0|||
129871538|NCT03518125|467487535|FG000|Overall Study|Lost to Follow-up|0|||
129871539|NCT03518125|467487536|FG001|Overall Study|Lost to Follow-up|2|||
130066985|NCT00168064|468199806|FG001|Overall Study|Concurrent Illness|3|||
130066986|NCT00168064|468199805|FG000|Overall Study|Subject's Best interest|2|||
130066987|NCT00168064|468199806|FG001|Overall Study|Subject's Best interest|2|||
129871540|NCT03518125|467487537|FG002|Overall Study|Lost to Follow-up|0|||
130066988|NCT00168064|468199805|FG000|Overall Study|Various|4|||
130066989|NCT00168064|468199806|FG001|Overall Study|Various|3|||
130066990|NCT01896856|468199807|FG000|Overall Study|Transportation issues / Non-compliance|0|||
130066991|NCT01896856|468199808|FG001|Overall Study|Transportation issues / Non-compliance|0|||
130066992|NCT01896856|468199809|FG002|Overall Study|Transportation issues / Non-compliance|1|||
130066993|NCT01896856|468199810|FG003|Overall Study|Transportation issues / Non-compliance|0|||
130066994|NCT01896856|468199811|FG004|Overall Study|Transportation issues / Non-compliance|0|||
130066995|NCT01896856|468199812|FG005|Overall Study|Transportation issues / Non-compliance|0|||
130066996|NCT00282867|468199813|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
130066997|NCT00282867|468199814|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
130066998|NCT00282867|468199815|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
130066999|NCT00830960|468199816|FG000|Overall Study|Death|5|||
130067000|NCT00830960|468199817|FG001|Overall Study|Death|4|||
130067001|NCT00830960|468199818|FG002|Overall Study|Death|3|||
130067002|NCT00830960|468199819|FG003|Overall Study|Death|2|||
130067003|NCT00830960|468199820|FG004|Overall Study|Death|6|||
130067004|NCT00830960|468199821|FG005|Overall Study|Death|1|||
130067005|NCT00830960|468199816|FG000|Overall Study|Lost to Follow-up|1|||
130067006|NCT00830960|468199817|FG001|Overall Study|Lost to Follow-up|1|||
130067007|NCT00830960|468199818|FG002|Overall Study|Lost to Follow-up|1|||
130067008|NCT00830960|468199819|FG003|Overall Study|Lost to Follow-up|0|||
130067009|NCT00830960|468199820|FG004|Overall Study|Lost to Follow-up|0|||
130067010|NCT00830960|468199821|FG005|Overall Study|Lost to Follow-up|1|||
130067011|NCT00830960|468199816|FG000|Overall Study|Withdrawal by Subject|19|||
130067012|NCT00830960|468199817|FG001|Overall Study|Withdrawal by Subject|19|||
130067013|NCT00830960|468199818|FG002|Overall Study|Withdrawal by Subject|18|||
130067014|NCT00830960|468199819|FG003|Overall Study|Withdrawal by Subject|23|||
130067015|NCT00830960|468199820|FG004|Overall Study|Withdrawal by Subject|16|||
129918276|NCT04421378|467666942|FG003|Overall Study|Other|0|||
129918277|NCT04421378|467666943|FG004|Overall Study|Other|0|||
129918278|NCT03090152|467666944|FG000|Overall Study|Withdrawal by Subject|0|||
129918279|NCT03090152|467666945|FG001|Overall Study|Withdrawal by Subject|2|||
129918280|NCT03090152|467666946|FG002|Overall Study|Withdrawal by Subject|1|||
129918281|NCT03090152|467666944|FG000|Overall Study|Surgery Canceled|1|||
129918282|NCT03090152|467666945|FG001|Overall Study|Surgery Canceled|0|||
129918283|NCT03090152|467666946|FG002|Overall Study|Surgery Canceled|0|||
129918284|NCT03090152|467666944|FG000|Overall Study|Epidural catheter could not be placed|0|||
129918285|NCT03090152|467666945|FG001|Overall Study|Epidural catheter could not be placed|2|||
129918286|NCT03090152|467666946|FG002|Overall Study|Epidural catheter could not be placed|0|||
129918287|NCT00170573|467666950|FG000|Overall Study|Violation of inclusion criteria|13|||
129918288|NCT05470400|467666953|FG000|Overall Study|Lost to Follow-up|0|||
129918289|NCT05470400|467666954|FG001|Overall Study|Lost to Follow-up|0|||
129918290|NCT05470400|467666955|FG002|Overall Study|Lost to Follow-up|0|||
129918291|NCT05470400|467666956|FG003|Overall Study|Lost to Follow-up|0|||
129918292|NCT05470400|467666957|FG004|Overall Study|Lost to Follow-up|0|||
129918293|NCT05470400|467666958|FG005|Overall Study|Lost to Follow-up|0|||
129918294|NCT05470400|467666959|FG006|Overall Study|Lost to Follow-up|0|||
129918295|NCT05470400|467666960|FG007|Overall Study|Lost to Follow-up|1|||
129918296|NCT05470400|467666953|FG000|Overall Study|Withdrawal by Subject|1|||
129918297|NCT05470400|467666954|FG001|Overall Study|Withdrawal by Subject|0|||
129918298|NCT05470400|467666955|FG002|Overall Study|Withdrawal by Subject|0|||
129918299|NCT05470400|467666956|FG003|Overall Study|Withdrawal by Subject|0|||
129918300|NCT05470400|467666957|FG004|Overall Study|Withdrawal by Subject|0|||
129918301|NCT05470400|467666958|FG005|Overall Study|Withdrawal by Subject|1|||
129918302|NCT05470400|467666959|FG006|Overall Study|Withdrawal by Subject|0|||
129918303|NCT05470400|467666960|FG007|Overall Study|Withdrawal by Subject|2|||
129918304|NCT03138512|467666961|FG000|Randomization|Participants withdrew consent|0|||
129918305|NCT03138512|467666962|FG001|Randomization|Participants withdrew consent|1|||
129918306|NCT03138512|467666963|FG002|Randomization|Participants withdrew consent|1|||
129918307|NCT03138512|467666964|FG003|Randomization|Participants withdrew consent|0|||
129918308|NCT03138512|467666965|FG004|Randomization|Participants withdrew consent|0|||
129918309|NCT03138512|467666961|FG000|Randomization|Participant no longer meets study criteria|0|||
129918310|NCT03138512|467666962|FG001|Randomization|Participant no longer meets study criteria|3|||
129918311|NCT03138512|467666963|FG002|Randomization|Participant no longer meets study criteria|1|||
129918312|NCT03138512|467666964|FG003|Randomization|Participant no longer meets study criteria|1|||
129918313|NCT03138512|467666965|FG004|Randomization|Participant no longer meets study criteria|3|||
129918314|NCT03138512|467666961|FG000|Randomization|Other reasons|1|||
129918315|NCT03138512|467666962|FG001|Randomization|Other reasons|0|||
130067016|NCT00830960|468199821|FG005|Overall Study|Withdrawal by Subject|21|||
130067017|NCT00830960|468199816|FG000|Overall Study|Sponsor Decision|1|||
130067018|NCT00830960|468199817|FG001|Overall Study|Sponsor Decision|2|||
130067019|NCT00830960|468199818|FG002|Overall Study|Sponsor Decision|3|||
130067020|NCT00830960|468199819|FG003|Overall Study|Sponsor Decision|4|||
130067021|NCT00830960|468199820|FG004|Overall Study|Sponsor Decision|5|||
130067022|NCT00830960|468199821|FG005|Overall Study|Sponsor Decision|7|||
130067023|NCT00830960|468199816|FG000|Overall Study|No study drug received|7|||
130067024|NCT00830960|468199817|FG001|Overall Study|No study drug received|2|||
130067025|NCT00830960|468199818|FG002|Overall Study|No study drug received|4|||
130067026|NCT00830960|468199819|FG003|Overall Study|No study drug received|3|||
130067027|NCT00830960|468199820|FG004|Overall Study|No study drug received|5|||
130067028|NCT00830960|468199821|FG005|Overall Study|No study drug received|7|||
130067029|NCT02855450|468199822|FG000|Overall Study|Adverse Event|1|||
129871541|NCT03518125|467487538|FG003|Overall Study|Lost to Follow-up|0|||
129871542|NCT03518125|467487539|FG004|Overall Study|Lost to Follow-up|3|||
129871543|NCT03518125|467487540|FG005|Overall Study|Lost to Follow-up|5|||
129871544|NCT03518125|467487535|FG000|Overall Study|Physician Decision|0|||
129871545|NCT03518125|467487536|FG001|Overall Study|Physician Decision|1|||
129871546|NCT03518125|467487537|FG002|Overall Study|Physician Decision|0|||
129871547|NCT03518125|467487538|FG003|Overall Study|Physician Decision|0|||
129871548|NCT03518125|467487539|FG004|Overall Study|Physician Decision|0|||
129871549|NCT03518125|467487540|FG005|Overall Study|Physician Decision|0|||
129871550|NCT03518125|467487535|FG000|Overall Study|Withdrawal by Subject|1|||
129871551|NCT03518125|467487536|FG001|Overall Study|Withdrawal by Subject|1|||
129871552|NCT03518125|467487537|FG002|Overall Study|Withdrawal by Subject|0|||
129871553|NCT03518125|467487538|FG003|Overall Study|Withdrawal by Subject|1|||
129871554|NCT03518125|467487539|FG004|Overall Study|Withdrawal by Subject|1|||
129871555|NCT03518125|467487540|FG005|Overall Study|Withdrawal by Subject|3|||
129871556|NCT03518125|467487535|FG000|Overall Study|Missed Day 394 Visit|1|||
129871557|NCT03518125|467487536|FG001|Overall Study|Missed Day 394 Visit|0|||
129871558|NCT03518125|467487537|FG002|Overall Study|Missed Day 394 Visit|0|||
129871559|NCT03518125|467487538|FG003|Overall Study|Missed Day 394 Visit|0|||
129871560|NCT03518125|467487539|FG004|Overall Study|Missed Day 394 Visit|0|||
129871561|NCT03518125|467487540|FG005|Overall Study|Missed Day 394 Visit|0|||
129871562|NCT01078155|467487545|FG000|Overall Study|Adverse Event|7|||
129871563|NCT01078155|467487545|FG000|Overall Study|Lack of Efficacy|16|||
129871564|NCT01078155|467487545|FG000|Overall Study|Participant's Decision|6|||
129871565|NCT01078155|467487545|FG000|Overall Study|Lost to Follow-up|15|||
129871566|NCT03286751|467487546|FG000|Washout Period 1|Withdrawal by Subject|0|||
129871567|NCT03286751|467487547|FG001|Washout Period 1|Withdrawal by Subject|0|||
129871568|NCT03286751|467487548|FG002|Washout Period 1|Withdrawal by Subject|0|||
129871569|NCT03286751|467487549|FG003|Washout Period 1|Withdrawal by Subject|0|||
129871570|NCT03286751|467487550|FG004|Washout Period 1|Withdrawal by Subject|1|||
129871571|NCT03286751|467487551|FG005|Washout Period 1|Withdrawal by Subject|0|||
129871572|NCT03286751|467487546|FG000|Washout Period 2|Personal Reasons|0|||
129871573|NCT03286751|467487547|FG001|Washout Period 2|Personal Reasons|1|||
129871574|NCT03286751|467487548|FG002|Washout Period 2|Personal Reasons|0|||
129871575|NCT03286751|467487549|FG003|Washout Period 2|Personal Reasons|0|||
129871576|NCT03286751|467487550|FG004|Washout Period 2|Personal Reasons|0|||
129871577|NCT03286751|467487551|FG005|Washout Period 2|Personal Reasons|0|||
129871578|NCT03286751|467487546|FG000|Washout Period 5|Adverse Event|0|||
129871579|NCT03286751|467487547|FG001|Washout Period 5|Adverse Event|0|||
129871580|NCT03286751|467487548|FG002|Washout Period 5|Adverse Event|0|||
129871581|NCT03286751|467487549|FG003|Washout Period 5|Adverse Event|0|||
129871582|NCT03286751|467487550|FG004|Washout Period 5|Adverse Event|1|||
129871583|NCT03286751|467487551|FG005|Washout Period 5|Adverse Event|0|||
129871584|NCT00238433|467487552|FG000|Overall Study|Screen failure|1|||
129871585|NCT00238433|467487552|FG000|Overall Study|Lost to Follow-up|1|||
129871586|NCT00238433|467487552|FG000|Overall Study|Death|1|||
129871587|NCT02403180|467487558|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
129871588|NCT02403180|467487559|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
129871589|NCT02403180|467487558|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
129871590|NCT02403180|467487559|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
129871591|NCT01445652|467487563|FG000|Overall Study|Not comfortable in lenses|5|||
129871592|NCT01445652|467487564|FG001|Overall Study|Not comfortable in lenses|0|||
129871593|NCT01445652|467487563|FG000|Overall Study|Failed to attend scheduled visit|2|||
129871594|NCT01445652|467487564|FG001|Overall Study|Failed to attend scheduled visit|3|||
129871595|NCT01445652|467487563|FG000|Overall Study|Failed teach session|2|||
129871596|NCT01445652|467487564|FG001|Overall Study|Failed teach session|0|||
129871597|NCT01445652|467487563|FG000|Overall Study|Adverse Event|1|||
129871598|NCT01445652|467487564|FG001|Overall Study|Adverse Event|0|||
129871599|NCT03595332|467487567|FG000|Overall Study|Lost to Follow-up|16|||
130067030|NCT02855450|468199823|FG001|Overall Study|Adverse Event|0|||
130067031|NCT02855450|468199822|FG000|Overall Study|Lost to Follow-up|4|||
130067032|NCT02855450|468199823|FG001|Overall Study|Lost to Follow-up|0|||
130067033|NCT05159362|468199824|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
130067034|NCT05159362|468199825|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
130067035|NCT05159362|468199826|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
130067036|NCT01376245|468199827|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
130067037|NCT01376245|468199828|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130067038|NCT01376245|468199829|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130067039|NCT01376245|468199830|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
130116829|NCT00638157|468387200|FG001|Overall Study|Adverse Event|1|||
129918316|NCT03138512|467666963|FG002|Randomization|Other reasons|0|||
129918317|NCT03138512|467666964|FG003|Randomization|Other reasons|0|||
129918318|NCT03138512|467666965|FG004|Randomization|Other reasons|0|||
129918319|NCT03138512|467666961|FG000|Treatment Part A|Disease recurrence|10|||
129918320|NCT03138512|467666962|FG001|Treatment Part A|Disease recurrence|20|||
129918321|NCT03138512|467666963|FG002|Treatment Part A|Disease recurrence|0|||
129918322|NCT03138512|467666964|FG003|Treatment Part A|Disease recurrence|0|||
129918323|NCT03138512|467666965|FG004|Treatment Part A|Disease recurrence|0|||
129918324|NCT03138512|467666961|FG000|Treatment Part A|Study Drug Toxicity|132|||
129918325|NCT03138512|467666962|FG001|Treatment Part A|Study Drug Toxicity|5|||
129918326|NCT03138512|467666963|FG002|Treatment Part A|Study Drug Toxicity|0|||
129918327|NCT03138512|467666964|FG003|Treatment Part A|Study Drug Toxicity|0|||
129918328|NCT03138512|467666965|FG004|Treatment Part A|Study Drug Toxicity|0|||
129918329|NCT03138512|467666961|FG000|Treatment Part A|Death|1|||
129918330|NCT03138512|467666962|FG001|Treatment Part A|Death|0|||
129918331|NCT03138512|467666963|FG002|Treatment Part A|Death|0|||
129918332|NCT03138512|467666964|FG003|Treatment Part A|Death|0|||
129918333|NCT03138512|467666965|FG004|Treatment Part A|Death|0|||
129918334|NCT03138512|467666961|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
129918335|NCT03138512|467666962|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
129918336|NCT03138512|467666963|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
129918337|NCT03138512|467666964|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
129918338|NCT03138512|467666965|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
129918339|NCT03138512|467666961|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
129918340|NCT03138512|467666962|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
129918341|NCT03138512|467666963|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
129918342|NCT03138512|467666964|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
129918343|NCT03138512|467666965|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
129918344|NCT03138512|467666961|FG000|Treatment Part A|Participant withdrew consent|2|||
129918345|NCT03138512|467666962|FG001|Treatment Part A|Participant withdrew consent|4|||
129918346|NCT03138512|467666963|FG002|Treatment Part A|Participant withdrew consent|0|||
129918347|NCT03138512|467666964|FG003|Treatment Part A|Participant withdrew consent|0|||
129918348|NCT03138512|467666965|FG004|Treatment Part A|Participant withdrew consent|0|||
129918349|NCT03138512|467666961|FG000|Treatment Part A|Lost to Follow-up|0|||
129918350|NCT03138512|467666962|FG001|Treatment Part A|Lost to Follow-up|1|||
129918351|NCT03138512|467666963|FG002|Treatment Part A|Lost to Follow-up|0|||
129918352|NCT03138512|467666964|FG003|Treatment Part A|Lost to Follow-up|0|||
129918353|NCT03138512|467666965|FG004|Treatment Part A|Lost to Follow-up|0|||
129918354|NCT03138512|467666961|FG000|Treatment Part A|Poor/non-compliance|1|||
129918355|NCT03138512|467666962|FG001|Treatment Part A|Poor/non-compliance|0|||
129918356|NCT03138512|467666963|FG002|Treatment Part A|Poor/non-compliance|0|||
129918357|NCT03138512|467666964|FG003|Treatment Part A|Poor/non-compliance|0|||
129918358|NCT03138512|467666965|FG004|Treatment Part A|Poor/non-compliance|0|||
129918359|NCT03138512|467666961|FG000|Treatment Part A|Pregnancy|0|||
129918360|NCT03138512|467666962|FG001|Treatment Part A|Pregnancy|1|||
129918361|NCT03138512|467666963|FG002|Treatment Part A|Pregnancy|0|||
129918362|NCT03138512|467666964|FG003|Treatment Part A|Pregnancy|0|||
129918363|NCT03138512|467666965|FG004|Treatment Part A|Pregnancy|0|||
129918364|NCT03138512|467666961|FG000|Treatment Part A|Other reasons|11|||
129918365|NCT03138512|467666962|FG001|Treatment Part A|Other reasons|8|||
129918366|NCT03138512|467666963|FG002|Treatment Part A|Other reasons|0|||
129918367|NCT03138512|467666964|FG003|Treatment Part A|Other reasons|0|||
129918368|NCT03138512|467666965|FG004|Treatment Part A|Other reasons|0|||
129918369|NCT03138512|467666961|FG000|Treatment Part B|Disease recurrence|0|||
129918370|NCT03138512|467666962|FG001|Treatment Part B|Disease recurrence|0|||
129918371|NCT03138512|467666963|FG002|Treatment Part B|Disease recurrence|6|||
129918372|NCT03138512|467666964|FG003|Treatment Part B|Disease recurrence|12|||
129918373|NCT03138512|467666965|FG004|Treatment Part B|Disease recurrence|10|||
129918374|NCT03138512|467666961|FG000|Treatment Part B|Study drug toxicity|0|||
129918375|NCT03138512|467666962|FG001|Treatment Part B|Study drug toxicity|0|||
129918376|NCT03138512|467666963|FG002|Treatment Part B|Study drug toxicity|63|||
129918377|NCT03138512|467666964|FG003|Treatment Part B|Study drug toxicity|3|||
130067040|NCT01376245|468199831|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
129918378|NCT03138512|467666965|FG004|Treatment Part B|Study drug toxicity|45|||
129918379|NCT03138512|467666961|FG000|Treatment Part B|Death|0|||
129918380|NCT03138512|467666962|FG001|Treatment Part B|Death|0|||
129918381|NCT03138512|467666963|FG002|Treatment Part B|Death|1|||
129918382|NCT03138512|467666964|FG003|Treatment Part B|Death|0|||
129918383|NCT03138512|467666965|FG004|Treatment Part B|Death|0|||
129918384|NCT03138512|467666961|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
129918385|NCT03138512|467666962|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
129918386|NCT03138512|467666963|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
129918387|NCT03138512|467666964|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
129918388|NCT03138512|467666965|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
129871600|NCT03595332|467487568|FG001|Overall Study|Lost to Follow-up|22|||
129871601|NCT03595332|467487567|FG000|Overall Study|Unable to retrieve ID from school|0|||
130067041|NCT01376245|468199827|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
130067042|NCT01376245|468199828|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130067043|NCT01376245|468199829|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130067044|NCT01376245|468199830|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130067045|NCT01376245|468199831|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
130067046|NCT01376245|468199827|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
130067047|NCT01376245|468199828|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130067048|NCT01376245|468199829|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130067049|NCT01376245|468199830|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130067050|NCT01376245|468199831|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
130067051|NCT01376245|468199827|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
130067052|NCT01376245|468199828|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130067053|NCT01376245|468199829|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130116830|NCT00638157|468387199|FG000|Overall Study|Clinical (symptomatic) failure|1|||
130116831|NCT00638157|468387200|FG001|Overall Study|Clinical (symptomatic) failure|1|||
130116832|NCT00638157|468387199|FG000|Overall Study|Microbiological failure|1|||
130116833|NCT00638157|468387200|FG001|Overall Study|Microbiological failure|0|||
130116834|NCT00638157|468387199|FG000|Overall Study|Lost to Follow-up|1|||
130116835|NCT00638157|468387200|FG001|Overall Study|Lost to Follow-up|0|||
130116836|NCT00638157|468387199|FG000|Overall Study|Physician Decision|1|||
130116837|NCT00638157|468387200|FG001|Overall Study|Physician Decision|0|||
130116838|NCT00638157|468387199|FG000|Overall Study|Other|1|||
130116839|NCT00638157|468387200|FG001|Overall Study|Other|2|||
130116840|NCT00638157|468387199|FG000|Overall Study|Randomized, not treated|2|||
130116841|NCT00638157|468387200|FG001|Overall Study|Randomized, not treated|0|||
130116842|NCT00876733|468387201|FG000|Overall Study|Adverse Event|34|||
130116843|NCT00876733|468387202|FG001|Overall Study|Adverse Event|20|||
130116844|NCT00876733|468387203|FG002|Overall Study|Adverse Event|10|||
130116845|NCT00876733|468387204|FG003|Overall Study|Adverse Event|3|||
130116846|NCT00876733|468387201|FG000|Overall Study|Lack of Efficacy|17|||
130116847|NCT00876733|468387202|FG001|Overall Study|Lack of Efficacy|9|||
130116848|NCT00876733|468387203|FG002|Overall Study|Lack of Efficacy|10|||
130116849|NCT00876733|468387204|FG003|Overall Study|Lack of Efficacy|1|||
130116850|NCT00876733|468387201|FG000|Overall Study|Lost to Follow-up|26|||
130116851|NCT00876733|468387202|FG001|Overall Study|Lost to Follow-up|10|||
129871602|NCT03595332|467487568|FG001|Overall Study|Unable to retrieve ID from school|2|||
129871603|NCT02227875|467487569|FG000|Overall Study|Protocol Violation|10|||
129871604|NCT02227875|467487570|FG001|Overall Study|Protocol Violation|7|||
129871605|NCT02227875|467487569|FG000|Overall Study|Other|1|||
129871606|NCT02227875|467487570|FG001|Overall Study|Other|3|||
129871607|NCT02227875|467487569|FG000|Overall Study|Physician Decision|1|||
129871608|NCT02227875|467487570|FG001|Overall Study|Physician Decision|0|||
129871609|NCT02227875|467487569|FG000|Overall Study|Adverse Event|3|||
129871610|NCT02227875|467487570|FG001|Overall Study|Adverse Event|0|||
129871611|NCT02227875|467487569|FG000|Overall Study|Withdrawal by Subject|12|||
129871612|NCT02227875|467487570|FG001|Overall Study|Withdrawal by Subject|13|||
129871613|NCT02227875|467487569|FG000|Overall Study|Lost to Follow-up|10|||
129871614|NCT02227875|467487570|FG001|Overall Study|Lost to Follow-up|10|||
129871615|NCT04209725|467487573|FG000|Overall Study|Adverse Event|1|||
129871616|NCT00166296|467487574|FG000|Overall Study|Withdrawal by Subject|1|||
129871617|NCT00166296|467487575|FG001|Overall Study|Withdrawal by Subject|3|||
129871618|NCT00166296|467487574|FG000|Overall Study|Adverse Event|2|||
129871619|NCT00166296|467487575|FG001|Overall Study|Adverse Event|4|||
129871620|NCT00166296|467487574|FG000|Overall Study|Lost to Follow-up|4|||
129871621|NCT00166296|467487575|FG001|Overall Study|Lost to Follow-up|2|||
129871622|NCT03412396|467487592|FG000|Overall Study|Withdrawal by Subject|2|||
129871623|NCT03412396|467487592|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
129871624|NCT03412396|467487592|FG000|Overall Study|Did not undergo RP|2|||
129871625|NCT04899245|467487601|FG000|Overall Study|Withdrawal by Subject|3|||
129871626|NCT04899245|467487602|FG001|Overall Study|Withdrawal by Subject|5|||
129871627|NCT04899245|467487603|FG002|Overall Study|Withdrawal by Subject|2|||
130116852|NCT00876733|468387203|FG002|Overall Study|Lost to Follow-up|3|||
130116853|NCT00876733|468387204|FG003|Overall Study|Lost to Follow-up|2|||
130116854|NCT00876733|468387201|FG000|Overall Study|Data not available|14|||
130116855|NCT00876733|468387202|FG001|Overall Study|Data not available|3|||
130116856|NCT00876733|468387203|FG002|Overall Study|Data not available|7|||
129871628|NCT04899245|467487601|FG000|Overall Study|No longer eligible - Left staff position|0|||
129871629|NCT04899245|467487602|FG001|Overall Study|No longer eligible - Left staff position|0|||
129871630|NCT04899245|467487603|FG002|Overall Study|No longer eligible - Left staff position|1|||
129871631|NCT04899245|467487601|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
130067054|NCT01376245|468199830|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
130067055|NCT01376245|468199831|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
129871632|NCT04899245|467487602|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
129871633|NCT04899245|467487603|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
129871634|NCT04899245|467487601|FG000|Overall Study|No longer eligible - Moved away from area|2|||
129871635|NCT04899245|467487602|FG001|Overall Study|No longer eligible - Moved away from area|2|||
129871636|NCT04899245|467487603|FG002|Overall Study|No longer eligible - Moved away from area|0|||
129871637|NCT02753595|467487608|FG000|Overall Study|Sponsor termination|2|||
129871638|NCT02753595|467487609|FG001|Overall Study|Sponsor termination|2|||
129871639|NCT01570868|467487610|FG000|Overall Study|Adverse Event|8|||
129871640|NCT01570868|467487611|FG001|Overall Study|Adverse Event|1|||
129871641|NCT01570868|467487610|FG000|Overall Study|FDA Recommendation|23|||
129871642|NCT01570868|467487611|FG001|Overall Study|FDA Recommendation|3|||
129871643|NCT01570868|467487610|FG000|Overall Study|Physician Decision|10|||
129871644|NCT01570868|467487611|FG001|Overall Study|Physician Decision|4|||
129871645|NCT01570868|467487610|FG000|Overall Study|Lost to Follow-up|1|||
129871646|NCT01570868|467487611|FG001|Overall Study|Lost to Follow-up|0|||
129871647|NCT01570868|467487610|FG000|Overall Study|Withdrawal by Subject|1|||
129871648|NCT01570868|467487611|FG001|Overall Study|Withdrawal by Subject|0|||
129871649|NCT02515279|467487615|FG000|Overall Study|Adverse Event|7|||
129871650|NCT02515279|467487615|FG000|Overall Study|Lack of Efficacy|31|||
129871651|NCT02515279|467487615|FG000|Overall Study|Lost to Follow-up|9|||
129918389|NCT03138512|467666961|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
129918390|NCT03138512|467666962|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
129918391|NCT03138512|467666963|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
129918392|NCT03138512|467666964|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
129918393|NCT03138512|467666965|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
129918394|NCT03138512|467666961|FG000|Treatment Part B|Participant withdrew consent|0|||
129918395|NCT03138512|467666962|FG001|Treatment Part B|Participant withdrew consent|0|||
129918396|NCT03138512|467666963|FG002|Treatment Part B|Participant withdrew consent|1|||
129918397|NCT03138512|467666964|FG003|Treatment Part B|Participant withdrew consent|1|||
129918398|NCT03138512|467666965|FG004|Treatment Part B|Participant withdrew consent|2|||
129918399|NCT03138512|467666961|FG000|Treatment Part B|Lost to Follow-up|0|||
129918400|NCT03138512|467666962|FG001|Treatment Part B|Lost to Follow-up|0|||
129918401|NCT03138512|467666963|FG002|Treatment Part B|Lost to Follow-up|0|||
129918402|NCT03138512|467666964|FG003|Treatment Part B|Lost to Follow-up|1|||
129918403|NCT03138512|467666965|FG004|Treatment Part B|Lost to Follow-up|0|||
129918404|NCT03138512|467666961|FG000|Treatment Part B|Poor/non-compliance|0|||
129918405|NCT03138512|467666962|FG001|Treatment Part B|Poor/non-compliance|0|||
129918406|NCT03138512|467666963|FG002|Treatment Part B|Poor/non-compliance|1|||
129918407|NCT03138512|467666964|FG003|Treatment Part B|Poor/non-compliance|1|||
129918408|NCT03138512|467666965|FG004|Treatment Part B|Poor/non-compliance|1|||
129918409|NCT03138512|467666961|FG000|Treatment Part B|Other reasons|0|||
129918410|NCT03138512|467666962|FG001|Treatment Part B|Other reasons|0|||
129918411|NCT03138512|467666963|FG002|Treatment Part B|Other reasons|3|||
129918412|NCT03138512|467666964|FG003|Treatment Part B|Other reasons|1|||
129918413|NCT03138512|467666965|FG004|Treatment Part B|Other reasons|5|||
129918414|NCT05323084|467666967|FG000|Period 2 - Washout|Lost to Follow-up|0|||
129918415|NCT05323084|467666968|FG001|Period 2 - Washout|Lost to Follow-up|1|||
129918416|NCT04382404|467666969|FG000|Overall Study|Adverse Event|1|||
129918417|NCT04382404|467666969|FG000|Overall Study|Lost to Follow-up|2|||
129918418|NCT05687916|467666971|FG000|Overall Study|Adverse Event|1|||
129918419|NCT05687916|467666972|FG001|Overall Study|Adverse Event|2|||
129871652|NCT02515279|467487615|FG000|Overall Study|Withdrawal by Subject|18|||
129871653|NCT02515279|467487615|FG000|Overall Study|End-of-treatment visit not attended|17|||
129871654|NCT02515279|467487615|FG000|Overall Study|Other|22|||
129871655|NCT01800968|467487617|FG000|Overall Study|Death|23|||
129918420|NCT05687916|467666973|FG002|Overall Study|Adverse Event|0|||
129918421|NCT05687916|467666971|FG000|Overall Study|Withdrawal by Subject|1|||
129918422|NCT05687916|467666972|FG001|Overall Study|Withdrawal by Subject|0|||
129918423|NCT05687916|467666973|FG002|Overall Study|Withdrawal by Subject|1|||
129918424|NCT05687916|467666971|FG000|Overall Study|Protocol Violation|0|||
129918425|NCT05687916|467666972|FG001|Overall Study|Protocol Violation|2|||
129871656|NCT01800968|467487618|FG001|Overall Study|Death|16|||
129871657|NCT01800968|467487617|FG000|Overall Study|Lost to Follow-up|5|||
129871658|NCT01800968|467487618|FG001|Overall Study|Lost to Follow-up|7|||
129871659|NCT01800968|467487617|FG000|Overall Study|Withdrawal by Subject|7|||
129918426|NCT05687916|467666973|FG002|Overall Study|Protocol Violation|1|||
129918427|NCT05687916|467666971|FG000|Overall Study|Reason not Specified|1|||
129918428|NCT05687916|467666972|FG001|Overall Study|Reason not Specified|0|||
129918429|NCT05687916|467666973|FG002|Overall Study|Reason not Specified|0|||
129918430|NCT03332017|467666974|FG000|Overall Study|Lost to Follow-up|1|||
129871660|NCT01800968|467487618|FG001|Overall Study|Withdrawal by Subject|9|||
129918431|NCT03332017|467666975|FG001|Overall Study|Lost to Follow-up|2|||
129918432|NCT03332017|467666974|FG000|Overall Study|Death|17|||
129918433|NCT03332017|467666975|FG001|Overall Study|Death|16|||
129918434|NCT03332017|467666974|FG000|Overall Study|Withdrawal by Subject|6|||
130067056|NCT01376245|468199827|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
130067057|NCT01376245|468199828|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130067058|NCT01376245|468199829|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130067059|NCT01376245|468199830|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130067060|NCT01376245|468199831|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
130067061|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
130067062|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
130067063|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
130067064|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
130067065|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
130067066|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
130067067|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
130067068|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
130067069|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
130067070|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
130067071|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130067072|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130067073|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
130067074|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
130067075|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
130067076|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130067077|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
130116857|NCT00876733|468387204|FG003|Overall Study|Data not available|1|||
129871661|NCT01800968|467487617|FG000|Overall Study|Physician Decision|1|||
129871662|NCT01800968|467487618|FG001|Overall Study|Physician Decision|0|||
129871663|NCT03185481|467487622|FG000|Overall Study|Adverse Event|1|||
129871664|NCT03185481|467487622|FG000|Overall Study|Study Terminated by Sponsor|4|||
129871665|NCT01422408|467487623|FG000|Overall Study|Adverse Event|1|||
129871666|NCT01422408|467487623|FG000|Overall Study|Withdrawal by Subject|3|||
129871667|NCT03371940|467487629|FG000|Overall Study|Withdrawal by Subject|8|||
129871668|NCT03371940|467487630|FG001|Overall Study|Withdrawal by Subject|1|||
129871669|NCT03371940|467487631|FG002|Overall Study|Withdrawal by Subject|3|||
129871670|NCT03371940|467487632|FG003|Overall Study|Withdrawal by Subject|4|||
129871671|NCT05099926|467487638|FG000|Overall Study|Lost to Follow-up|1|||
129871672|NCT00386022|467487642|FG000|Plus Estrogen|Lost to Follow-up|2|||
129871673|NCT00386022|467487643|FG001|Plus Estrogen|Lost to Follow-up|0|||
129871674|NCT00386022|467487642|FG000|Plus Estrogen|Adverse Event|0|||
129871675|NCT00386022|467487643|FG001|Plus Estrogen|Adverse Event|1|||
129871676|NCT00724152|467487645|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
129871677|NCT00724152|467487646|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
129871678|NCT00724152|467487647|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
129871679|NCT00724152|467487645|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
129871680|NCT00724152|467487646|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
129871681|NCT00724152|467487647|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
129871682|NCT03266770|467487651|FG000|Overall Study|Physician Decision|3|||
129871683|NCT03266770|467487651|FG000|Overall Study|Insufficient study supplies|1|||
129871684|NCT03266770|467487651|FG000|Overall Study|Adverse Event|1|||
129871685|NCT00031486|467487655|FG000|Overall Study|Adverse Event|1|||
129871686|NCT00031486|467487656|FG001|Overall Study|Adverse Event|0|||
129871687|NCT00031486|467487655|FG000|Overall Study|Lost to Follow-up|0|||
129871688|NCT00031486|467487656|FG001|Overall Study|Lost to Follow-up|1|||
129871689|NCT00031486|467487655|FG000|Overall Study|Withdrawal by Subject|3|||
129871690|NCT00031486|467487656|FG001|Overall Study|Withdrawal by Subject|2|||
129871691|NCT00031486|467487655|FG000|Overall Study|Death|0|||
129871692|NCT00031486|467487656|FG001|Overall Study|Death|3|||
129871693|NCT00031486|467487655|FG000|Overall Study|Non-compliant|0|||
129871694|NCT00031486|467487656|FG001|Overall Study|Non-compliant|4|||
129871695|NCT00031486|467487655|FG000|Overall Study|Did not meet eligibility requirement|2|||
129871696|NCT00031486|467487656|FG001|Overall Study|Did not meet eligibility requirement|1|||
129871697|NCT00031486|467487655|FG000|Overall Study|Other|1|||
130116858|NCT02843074|468387205|FG000|Overall Study|Withdrawal by Subject|5|||
129871698|NCT00031486|467487656|FG001|Overall Study|Other|1|||
129871699|NCT03078816|467487657|FG000|Overall Study|Withdrawal by Subject|1|||
129871700|NCT00949884|467489411|FG000|Overall Study|Adverse Event|14|||
129871701|NCT00949884|467489412|FG001|Overall Study|Adverse Event|3|||
129871702|NCT00949884|467489413|FG002|Overall Study|Adverse Event|12|||
129871703|NCT00949884|467489411|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
129871704|NCT00949884|467489412|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
129871705|NCT00949884|467489413|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
129871706|NCT00949884|467489411|FG000|Overall Study|Lost to Follow-up|7|||
129871707|NCT00949884|467489412|FG001|Overall Study|Lost to Follow-up|5|||
130067078|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
129918435|NCT03332017|467666975|FG001|Overall Study|Withdrawal by Subject|14|||
129918436|NCT03332017|467666974|FG000|Overall Study|Other|1|||
129918437|NCT03332017|467666975|FG001|Overall Study|Other|3|||
129918438|NCT03332017|467666974|FG000|Overall Study|Remained in Study (Ongoing)|47|||
129918439|NCT03332017|467666975|FG001|Overall Study|Remained in Study (Ongoing)|110|||
129918440|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
129918441|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
129918442|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
129918443|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918444|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918445|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918446|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918447|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918448|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918449|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918450|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918451|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918452|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918453|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
129871708|NCT00949884|467489413|FG002|Overall Study|Lost to Follow-up|5|||
129871709|NCT00949884|467489411|FG000|Overall Study|Physician Decision|5|||
129871710|NCT00949884|467489412|FG001|Overall Study|Physician Decision|0|||
129871711|NCT00949884|467489413|FG002|Overall Study|Physician Decision|6|||
129871712|NCT00949884|467489411|FG000|Overall Study|Treatment non-compliance|5|||
129871713|NCT00949884|467489412|FG001|Overall Study|Treatment non-compliance|0|||
129871714|NCT00949884|467489413|FG002|Overall Study|Treatment non-compliance|8|||
129871715|NCT00949884|467489411|FG000|Overall Study|Withdrawal by Subject|13|||
129871716|NCT00949884|467489412|FG001|Overall Study|Withdrawal by Subject|4|||
129871717|NCT00949884|467489413|FG002|Overall Study|Withdrawal by Subject|16|||
129918454|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
129871718|NCT00949884|467489411|FG000|Overall Study|Lack of Efficacy|4|||
129871719|NCT00949884|467489412|FG001|Overall Study|Lack of Efficacy|2|||
129871720|NCT00949884|467489413|FG002|Overall Study|Lack of Efficacy|7|||
129871721|NCT00949884|467489411|FG000|Overall Study|Study terminated by sponsor|0|||
129871722|NCT00949884|467489412|FG001|Overall Study|Study terminated by sponsor|0|||
129871723|NCT00949884|467489413|FG002|Overall Study|Study terminated by sponsor|1|||
129871724|NCT03092375|467489414|FG000|Overall Study|Lack of Efficacy|0|||
129871725|NCT03092375|467489415|FG001|Overall Study|Lack of Efficacy|1|||
129871726|NCT03092375|467489416|FG002|Overall Study|Lack of Efficacy|1|||
129871727|NCT03092375|467489417|FG003|Overall Study|Lack of Efficacy|0|||
129871728|NCT01255592|467489420|FG000|Overall Study|Adverse Event|5|||
129871729|NCT01255592|467489421|FG001|Overall Study|Adverse Event|0|||
129871730|NCT01255592|467489420|FG000|Overall Study|Withdrawal by Subject|1|||
129871731|NCT01255592|467489421|FG001|Overall Study|Withdrawal by Subject|0|||
129871732|NCT01255592|467489420|FG000|Overall Study|Other|0|||
129871733|NCT01255592|467489421|FG001|Overall Study|Other|1|||
129871734|NCT01777321|467489423|FG000|Overall Study|Withdrawal by Subject|0|||
129871735|NCT01777321|467489424|FG001|Overall Study|Withdrawal by Subject|1|||
129871736|NCT00089141|467489425|FG000|Overall Study|Termination of trial|18|||
129871737|NCT00089141|467489426|FG001|Overall Study|Termination of trial|24|||
129871738|NCT05131165|467489427|FG000|Overall Study|Death|1|||
129871739|NCT05131165|467489428|FG001|Overall Study|Death|1|||
129871740|NCT05131165|467489429|FG002|Overall Study|Death|0|||
129871741|NCT05131165|467489427|FG000|Overall Study|Lost to Follow-up|2|||
129871742|NCT05131165|467489428|FG001|Overall Study|Lost to Follow-up|2|||
129871743|NCT05131165|467489429|FG002|Overall Study|Lost to Follow-up|5|||
129871744|NCT05131165|467489427|FG000|Overall Study|Transferred out of clinic|1|||
129871745|NCT05131165|467489428|FG001|Overall Study|Transferred out of clinic|0|||
129871746|NCT05131165|467489429|FG002|Overall Study|Transferred out of clinic|3|||
129871747|NCT05131165|467489427|FG000|Overall Study|Dropped out|1|||
129871748|NCT05131165|467489428|FG001|Overall Study|Dropped out|2|||
129871749|NCT05131165|467489429|FG002|Overall Study|Dropped out|0|||
129918455|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918456|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918457|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918458|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129871750|NCT00526630|467489437|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
129871751|NCT00526630|467489438|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
129918459|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918460|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129871752|NCT00526630|467489437|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
129871753|NCT00526630|467489438|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
129871754|NCT05168579|467489439|FG000|Overall Study|Lack of Consent|1|||
129871755|NCT05168579|467489440|FG001|Overall Study|Lack of Consent|0|||
130067079|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
130067080|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
130067081|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130067082|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
130067083|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
130067084|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
130067085|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129871756|NCT05168579|467489439|FG000|Overall Study|Conflicts with time|2|||
129871757|NCT05168579|467489440|FG001|Overall Study|Conflicts with time|0|||
129871758|NCT05168579|467489439|FG000|Overall Study|Time slots were full|3|||
129918461|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918462|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918463|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918464|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918465|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918466|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
129918467|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
129918468|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918469|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918470|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918471|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918472|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918473|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918474|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918475|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918476|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918477|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918478|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918479|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
129918480|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
129871759|NCT05168579|467489440|FG001|Overall Study|Time slots were full|0|||
129871760|NCT05168579|467489439|FG000|Overall Study|Lost to Follow-up|0|||
129871761|NCT05168579|467489440|FG001|Overall Study|Lost to Follow-up|15|||
129918481|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918482|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918483|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918484|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918485|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918486|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129871762|NCT00840801|467489441|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
129871763|NCT00840801|467489442|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
129871764|NCT00840801|467489443|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
129871765|NCT00840801|467489441|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
129871766|NCT00840801|467489442|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
129871767|NCT00840801|467489443|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
129871768|NCT00840801|467489441|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
129871769|NCT00840801|467489442|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
129871770|NCT00840801|467489443|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
129871771|NCT00840801|467489441|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
129871772|NCT00840801|467489442|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
129871773|NCT00840801|467489443|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
129871774|NCT01242748|467489444|FG000|Overall Study|Adverse Event|10|||
129871775|NCT01242748|467489445|FG001|Overall Study|Adverse Event|5|||
129871776|NCT01242748|467489444|FG000|Overall Study|Lost to Follow-up|6|||
129871777|NCT01242748|467489445|FG001|Overall Study|Lost to Follow-up|2|||
129871778|NCT01242748|467489444|FG000|Overall Study|Physician Decision|3|||
129871779|NCT01242748|467489445|FG001|Overall Study|Physician Decision|2|||
129871780|NCT01242748|467489444|FG000|Overall Study|Protocol Violation|1|||
129871781|NCT01242748|467489445|FG001|Overall Study|Protocol Violation|0|||
129871782|NCT01242748|467489444|FG000|Overall Study|Withdrawal by Subject|10|||
129871783|NCT01242748|467489445|FG001|Overall Study|Withdrawal by Subject|2|||
129871784|NCT01242748|467489444|FG000|Overall Study|Miscellaneous reasons|8|||
129918487|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918488|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918489|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129871785|NCT01242748|467489445|FG001|Overall Study|Miscellaneous reasons|3|||
129871786|NCT01750879|467489451|FG000|Overall Study|Adverse Event|8|||
129871787|NCT01750879|467489452|FG001|Overall Study|Adverse Event|0|||
129871788|NCT01750879|467489451|FG000|Overall Study|Lack of Efficacy|1|||
129871789|NCT01750879|467489452|FG001|Overall Study|Lack of Efficacy|0|||
129871790|NCT01750879|467489451|FG000|Overall Study|Withdrawal by Subject|1|||
129871791|NCT01750879|467489452|FG001|Overall Study|Withdrawal by Subject|0|||
129871792|NCT01750879|467489451|FG000|Overall Study|Did not complete per protocol|0|||
129871793|NCT01750879|467489452|FG001|Overall Study|Did not complete per protocol|3|||
129871794|NCT02093663|467489459|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
129871795|NCT02093663|467489460|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871796|NCT02093663|467489461|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871797|NCT02093663|467489462|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871798|NCT02093663|467489463|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871799|NCT02093663|467489459|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
129871800|NCT02093663|467489460|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871801|NCT02093663|467489461|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130067086|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129871802|NCT02093663|467489462|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871803|NCT02093663|467489463|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871804|NCT02093663|467489459|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
129871805|NCT02093663|467489460|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
129871806|NCT02093663|467489461|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
129871807|NCT02093663|467489462|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
129871808|NCT02093663|467489463|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
129918490|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918491|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918492|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
129918493|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
129918494|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
129918495|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918496|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130067087|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
130067088|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
130067089|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
130067090|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
130067091|NCT01376245|468199827|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
130067092|NCT01376245|468199828|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
130067093|NCT01376245|468199829|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
130067094|NCT01376245|468199830|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
130067095|NCT01376245|468199831|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
130067096|NCT01335698|468199832|FG000|Treatment Stage 1|Lack of Efficacy|3|||
130067097|NCT01335698|468199833|FG001|Treatment Stage 1|Lack of Efficacy|1|||
130067098|NCT01335698|468199834|FG002|Treatment Stage 1|Lack of Efficacy|3|||
130067099|NCT01335698|468199835|FG003|Treatment Stage 1|Lack of Efficacy|3|||
130067100|NCT01335698|468199836|FG004|Treatment Stage 1|Lack of Efficacy|1|||
130067101|NCT01335698|468199832|FG000|Treatment Stage 1|Adverse Event|1|||
130067102|NCT01335698|468199833|FG001|Treatment Stage 1|Adverse Event|2|||
130067103|NCT01335698|468199834|FG002|Treatment Stage 1|Adverse Event|2|||
130067104|NCT01335698|468199835|FG003|Treatment Stage 1|Adverse Event|1|||
130067105|NCT01335698|468199836|FG004|Treatment Stage 1|Adverse Event|1|||
130067106|NCT01335698|468199832|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
130067107|NCT01335698|468199833|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
130067108|NCT01335698|468199834|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
130067109|NCT01335698|468199835|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
130067110|NCT01335698|468199836|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
130067111|NCT01335698|468199832|FG000|Treatment Stage 1|Lost to Follow-up|1|||
130067112|NCT01335698|468199833|FG001|Treatment Stage 1|Lost to Follow-up|1|||
130067113|NCT01335698|468199834|FG002|Treatment Stage 1|Lost to Follow-up|0|||
129918497|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918498|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918499|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918500|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918501|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130116859|NCT02843074|468387205|FG000|Overall Study|Progressive disease|1|||
129918502|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130067114|NCT01335698|468199835|FG003|Treatment Stage 1|Lost to Follow-up|0|||
130067115|NCT01335698|468199836|FG004|Treatment Stage 1|Lost to Follow-up|0|||
130067116|NCT01335698|468199832|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
130067117|NCT01335698|468199833|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
130116860|NCT02843074|468387205|FG000|Overall Study|Physician Decision|1|||
130116861|NCT02843074|468387205|FG000|Overall Study|Lost to Follow-up|1|||
129871809|NCT02093663|467489459|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871810|NCT02093663|467489460|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
130067118|NCT01335698|468199834|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
130067119|NCT01335698|468199835|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
130067120|NCT01335698|468199836|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
130067121|NCT01335698|468199832|FG000|Treatment Stage 1|No longer meets study criteria|1|||
130067122|NCT01335698|468199833|FG001|Treatment Stage 1|No longer meets study criteria|1|||
130067123|NCT01335698|468199834|FG002|Treatment Stage 1|No longer meets study criteria|0|||
130067124|NCT01335698|468199835|FG003|Treatment Stage 1|No longer meets study criteria|1|||
130067125|NCT01335698|468199836|FG004|Treatment Stage 1|No longer meets study criteria|0|||
130067126|NCT01335698|468199832|FG000|Treatment Stage 1|Other|1|||
130067127|NCT01335698|468199833|FG001|Treatment Stage 1|Other|0|||
130067128|NCT01335698|468199834|FG002|Treatment Stage 1|Other|0|||
130067129|NCT01335698|468199835|FG003|Treatment Stage 1|Other|1|||
130067130|NCT01335698|468199836|FG004|Treatment Stage 1|Other|0|||
130067131|NCT01335698|468199832|FG000|Treatment Stage 2|Lack of Efficacy|2|||
130067132|NCT01335698|468199833|FG001|Treatment Stage 2|Lack of Efficacy|1|||
130067133|NCT01335698|468199834|FG002|Treatment Stage 2|Lack of Efficacy|3|||
130067134|NCT01335698|468199835|FG003|Treatment Stage 2|Lack of Efficacy|1|||
130067135|NCT01335698|468199836|FG004|Treatment Stage 2|Lack of Efficacy|0|||
130067136|NCT01335698|468199832|FG000|Treatment Stage 2|Adverse Event|2|||
130067137|NCT01335698|468199833|FG001|Treatment Stage 2|Adverse Event|0|||
130067138|NCT01335698|468199834|FG002|Treatment Stage 2|Adverse Event|0|||
130067139|NCT01335698|468199835|FG003|Treatment Stage 2|Adverse Event|3|||
130067140|NCT01335698|468199836|FG004|Treatment Stage 2|Adverse Event|0|||
130067141|NCT01335698|468199832|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
130067142|NCT01335698|468199833|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
130067143|NCT01335698|468199834|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
130067144|NCT01335698|468199835|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
130067145|NCT01335698|468199836|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
130067146|NCT01335698|468199832|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
130067147|NCT01335698|468199833|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
130067148|NCT01335698|468199834|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
130067149|NCT01335698|468199835|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
130067150|NCT01335698|468199836|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
130067151|NCT01335698|468199832|FG000|Treatment Stage 2|Lost to Follow-up|1|||
130067152|NCT01335698|468199833|FG001|Treatment Stage 2|Lost to Follow-up|0|||
130067153|NCT01335698|468199834|FG002|Treatment Stage 2|Lost to Follow-up|0|||
130067154|NCT01335698|468199835|FG003|Treatment Stage 2|Lost to Follow-up|0|||
130067155|NCT01335698|468199836|FG004|Treatment Stage 2|Lost to Follow-up|0|||
130067156|NCT01335698|468199832|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
130067157|NCT01335698|468199833|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
130067158|NCT01335698|468199834|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
130067159|NCT01335698|468199835|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
130067160|NCT01335698|468199836|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
130067161|NCT01335698|468199832|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
130067162|NCT01335698|468199833|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
130067163|NCT01335698|468199834|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
130067164|NCT01335698|468199835|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
130067165|NCT01335698|468199836|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
130067166|NCT01335698|468199832|FG000|Treatment Stage 2|Switched to another formulation|1|||
130067167|NCT01335698|468199833|FG001|Treatment Stage 2|Switched to another formulation|1|||
130067168|NCT01335698|468199834|FG002|Treatment Stage 2|Switched to another formulation|0|||
130067169|NCT01335698|468199835|FG003|Treatment Stage 2|Switched to another formulation|0|||
130067170|NCT01335698|468199836|FG004|Treatment Stage 2|Switched to another formulation|0|||
130067171|NCT01357889|468199837|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
129871811|NCT02093663|467489461|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
129871812|NCT02093663|467489462|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871813|NCT02093663|467489463|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871814|NCT02093663|467489459|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871815|NCT02093663|467489460|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871816|NCT02093663|467489461|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
129918503|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
130067172|NCT01357889|468199838|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
130067173|NCT01357889|468199837|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
130067174|NCT01357889|468199838|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
130067175|NCT01357889|468199837|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
130067176|NCT01357889|468199838|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
130067177|NCT01357889|468199837|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
130067178|NCT01357889|468199838|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
130067179|NCT01357889|468199837|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
130067180|NCT01357889|468199838|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
130067181|NCT01357889|468199837|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
130067182|NCT01357889|468199838|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
130067183|NCT01357889|468199837|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
130067184|NCT01357889|468199838|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
130067185|NCT01357889|468199837|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
130067186|NCT01357889|468199838|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
130067187|NCT01357889|468199837|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
130067188|NCT01357889|468199838|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
130067189|NCT01357889|468199837|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
130067190|NCT01357889|468199838|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
130067191|NCT01357889|468199837|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
130067192|NCT01357889|468199838|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
130067193|NCT01357889|468199837|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
130067194|NCT01357889|468199838|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
130067195|NCT01357889|468199837|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
130067196|NCT01357889|468199838|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
130067197|NCT00105560|468199839|FG000|Overall Study|Lost to Follow-up|1|||
130067198|NCT01086150|468199842|FG000|Overall Study|Withdrawal by Subject|0|||
130067199|NCT01086150|468199843|FG001|Overall Study|Withdrawal by Subject|4|||
130067200|NCT01086150|468199844|FG002|Overall Study|Withdrawal by Subject|1|||
130067201|NCT01086150|468199842|FG000|Overall Study|Lost to Follow-up|0|||
130067202|NCT01086150|468199843|FG001|Overall Study|Lost to Follow-up|1|||
130067203|NCT01086150|468199844|FG002|Overall Study|Lost to Follow-up|0|||
130067204|NCT01086150|468199842|FG000|Overall Study|Screen Failure|0|||
130067205|NCT01086150|468199843|FG001|Overall Study|Screen Failure|1|||
130067206|NCT01086150|468199844|FG002|Overall Study|Screen Failure|0|||
130067207|NCT00805545|468199845|FG000|Overall Study|Protocol Violation|3|||
130067208|NCT00805545|468199846|FG001|Overall Study|Protocol Violation|2|||
130067209|NCT00805545|468199845|FG000|Overall Study|Protocol Violation|3|||
129871817|NCT02093663|467489462|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871818|NCT02093663|467489463|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
130067210|NCT00805545|468199846|FG001|Overall Study|Protocol Violation|1|||
130067211|NCT03448224|468199847|FG000|Overall Study|Provided same answer to every question|1|||
130067212|NCT03448224|468199848|FG001|Overall Study|Provided same answer to every question|0|||
130067213|NCT01021813|468199849|FG000|DB Treatment Phase|Adverse Event|60|||
130067214|NCT01021813|468199850|FG001|DB Treatment Phase|Adverse Event|22|||
130067215|NCT01021813|468199851|FG002|DB Treatment Phase|Adverse Event|0|||
130067216|NCT01021813|468199852|FG003|DB Treatment Phase|Adverse Event|0|||
130067217|NCT01021813|468199853|FG004|DB Treatment Phase|Adverse Event|0|||
130067218|NCT01021813|468199849|FG000|DB Treatment Phase|Lack of Efficacy|44|||
130067219|NCT01021813|468199850|FG001|DB Treatment Phase|Lack of Efficacy|28|||
130067220|NCT01021813|468199851|FG002|DB Treatment Phase|Lack of Efficacy|0|||
130067221|NCT01021813|468199852|FG003|DB Treatment Phase|Lack of Efficacy|0|||
130067222|NCT01021813|468199853|FG004|DB Treatment Phase|Lack of Efficacy|0|||
130067223|NCT01021813|468199849|FG000|DB Treatment Phase|Lost to Follow-up|14|||
130067224|NCT01021813|468199850|FG001|DB Treatment Phase|Lost to Follow-up|12|||
130067225|NCT01021813|468199851|FG002|DB Treatment Phase|Lost to Follow-up|0|||
130067226|NCT01021813|468199852|FG003|DB Treatment Phase|Lost to Follow-up|0|||
130067227|NCT01021813|468199853|FG004|DB Treatment Phase|Lost to Follow-up|0|||
130067228|NCT01021813|468199849|FG000|DB Treatment Phase|Physician Decision|17|||
130067229|NCT01021813|468199850|FG001|DB Treatment Phase|Physician Decision|8|||
130067230|NCT01021813|468199851|FG002|DB Treatment Phase|Physician Decision|0|||
130067231|NCT01021813|468199852|FG003|DB Treatment Phase|Physician Decision|0|||
130067232|NCT01021813|468199853|FG004|DB Treatment Phase|Physician Decision|0|||
129871819|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
129871820|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
129871821|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
129871822|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
129871823|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
129918504|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918505|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
129918506|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
130067233|NCT01021813|468199849|FG000|DB Treatment Phase|Pregnancy|1|||
130067234|NCT01021813|468199850|FG001|DB Treatment Phase|Pregnancy|0|||
130067235|NCT01021813|468199851|FG002|DB Treatment Phase|Pregnancy|0|||
130067236|NCT01021813|468199852|FG003|DB Treatment Phase|Pregnancy|0|||
130067237|NCT01021813|468199853|FG004|DB Treatment Phase|Pregnancy|0|||
130067238|NCT01021813|468199849|FG000|DB Treatment Phase|Protocol Violation|4|||
130067239|NCT01021813|468199850|FG001|DB Treatment Phase|Protocol Violation|3|||
130067240|NCT01021813|468199851|FG002|DB Treatment Phase|Protocol Violation|0|||
130067241|NCT01021813|468199852|FG003|DB Treatment Phase|Protocol Violation|0|||
130067242|NCT01021813|468199853|FG004|DB Treatment Phase|Protocol Violation|0|||
130067243|NCT01021813|468199849|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
130067244|NCT01021813|468199850|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
130067245|NCT01021813|468199851|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
130067246|NCT01021813|468199852|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
130067247|NCT01021813|468199853|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
130067248|NCT01021813|468199849|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
130067249|NCT01021813|468199850|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
130067250|NCT01021813|468199851|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
130067251|NCT01021813|468199852|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
130067252|NCT01021813|468199853|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
130067253|NCT01021813|468199849|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130067254|NCT01021813|468199850|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130067255|NCT01021813|468199851|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130067256|NCT01021813|468199852|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
130067257|NCT01021813|468199853|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
130067258|NCT01021813|468199849|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130067259|NCT01021813|468199850|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130067260|NCT01021813|468199851|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130067261|NCT01021813|468199852|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
130067262|NCT01021813|468199853|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
130067263|NCT01021813|468199849|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130067264|NCT01021813|468199850|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130067265|NCT01021813|468199851|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
130067266|NCT01021813|468199852|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130067267|NCT01021813|468199853|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
130067268|NCT01021813|468199849|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
130067269|NCT01021813|468199850|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
130067270|NCT01021813|468199851|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
130067271|NCT01021813|468199852|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
130067272|NCT01021813|468199853|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
130067273|NCT00764478|468199854|FG000|Overall Study|Adverse Event|1|||
130067274|NCT00764478|468199855|FG001|Overall Study|Adverse Event|1|||
130067275|NCT00764478|468199856|FG002|Overall Study|Adverse Event|1|||
130067276|NCT00764478|468199854|FG000|Overall Study|Withdrawal by Subject|7|||
130067277|NCT00764478|468199855|FG001|Overall Study|Withdrawal by Subject|12|||
130067278|NCT00764478|468199856|FG002|Overall Study|Withdrawal by Subject|1|||
130067279|NCT00764478|468199854|FG000|Overall Study|Lost to Follow-up|7|||
130067280|NCT00764478|468199855|FG001|Overall Study|Lost to Follow-up|8|||
130067281|NCT00764478|468199856|FG002|Overall Study|Lost to Follow-up|5|||
130067282|NCT00764478|468199854|FG000|Overall Study|Protocol Violation|0|||
130067283|NCT00764478|468199855|FG001|Overall Study|Protocol Violation|1|||
130067284|NCT00764478|468199856|FG002|Overall Study|Protocol Violation|1|||
130067285|NCT02270684|468199857|FG000|Overall Study|Lost to Follow-up|0|||
130067286|NCT02270684|468199858|FG001|Overall Study|Lost to Follow-up|3|||
130067287|NCT02270684|468199857|FG000|Overall Study|Study terminated|1|||
130067288|NCT02270684|468199858|FG001|Overall Study|Study terminated|0|||
129918507|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
129918508|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918509|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918510|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918511|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918512|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918513|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918514|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918515|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918516|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
130067289|NCT00862121|468199861|FG000|Overall Study|Adverse Event|1|||
130067290|NCT00862121|468199862|FG001|Overall Study|Adverse Event|2|||
130067291|NCT00862121|468199861|FG000|Overall Study|Lack of Efficacy|0|||
130067292|NCT00862121|468199862|FG001|Overall Study|Lack of Efficacy|3|||
130067293|NCT00862121|468199861|FG000|Overall Study|Protocol Violation|0|||
130067294|NCT00862121|468199862|FG001|Overall Study|Protocol Violation|1|||
130067295|NCT00862121|468199861|FG000|Overall Study|Exclusion criterion violation|0|||
130067296|NCT00862121|468199862|FG001|Overall Study|Exclusion criterion violation|1|||
130067297|NCT00862121|468199861|FG000|Overall Study|Incorrect randomisation|0|||
130067298|NCT00862121|468199862|FG001|Overall Study|Incorrect randomisation|1|||
130067299|NCT00171314|468199867|FG000|Overall Study|Adverse Event|44|||
130116862|NCT02843074|468387205|FG000|Overall Study|Death|9|||
130116863|NCT01199601|468387209|FG000|Overall Study|Lost to Follow-up|47|||
129871824|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
129871825|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
129871826|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
129871827|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
129871828|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
129871829|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129871830|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129871831|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129871832|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
129871833|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
129871834|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871835|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871836|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871837|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871838|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
129871839|NCT00508404|467489466|FG000|Overall Study|Ongoing at Data Cut-off|12|||
129871840|NCT00508404|467489466|FG000|Overall Study|Adverse Event|2|||
129871841|NCT00508404|467489466|FG000|Overall Study|Death|16|||
129871842|NCT00508404|467489466|FG000|Overall Study|Physician Decision|2|||
129871843|NCT00508404|467489466|FG000|Overall Study|Withdrawal by Subject|3|||
129871844|NCT00508404|467489466|FG000|Overall Study|Protocol-specified Criteria|2|||
129871845|NCT00508404|467489466|FG000|Overall Study|Lost to Follow-up|2|||
129871846|NCT00508404|467489466|FG000|Overall Study|Other - Not Specified|3|||
129871847|NCT01424930|467489468|FG000|Overall Study|Adverse Event|0|||
129871848|NCT01424930|467489469|FG001|Overall Study|Adverse Event|1|||
129871849|NCT01424930|467489468|FG000|Overall Study|Death|1|||
129871850|NCT01424930|467489469|FG001|Overall Study|Death|0|||
129871851|NCT01424930|467489468|FG000|Overall Study|Progressive Disease|3|||
129871852|NCT01424930|467489469|FG001|Overall Study|Progressive Disease|6|||
129871853|NCT01424930|467489468|FG000|Overall Study|Screen Failure|0|||
129871854|NCT01424930|467489469|FG001|Overall Study|Screen Failure|1|||
129871855|NCT01424930|467489468|FG000|Overall Study|Reason not specified|0|||
129871856|NCT01424930|467489469|FG001|Overall Study|Reason not specified|6|||
129871857|NCT01621880|467489470|FG000|Overall Study|Adverse Event|5|||
129871858|NCT01621880|467489471|FG001|Overall Study|Adverse Event|1|||
129871859|NCT01621880|467489470|FG000|Overall Study|Withdrawal by Subject|5|||
129871860|NCT01621880|467489471|FG001|Overall Study|Withdrawal by Subject|4|||
129871861|NCT00106184|467489473|FG000|Overall Study|Withdrawal by Subject|3|||
129871862|NCT00106184|467489474|FG001|Overall Study|Withdrawal by Subject|2|||
129871863|NCT02313909|467489475|FG000|Overall Study|Consent withdrawn by participant|33|||
129871864|NCT02313909|467489476|FG001|Overall Study|Consent withdrawn by participant|33|||
129871865|NCT02313909|467489475|FG000|Overall Study|Lost to Follow-up|24|||
129871866|NCT02313909|467489476|FG001|Overall Study|Lost to Follow-up|17|||
129871867|NCT00948974|467489482|FG000|Overall Study|Lost to Follow-up|23|||
129871868|NCT00948974|467489483|FG001|Overall Study|Lost to Follow-up|20|||
129871869|NCT00409682|467489491|FG000|Open-label Induction Period|Adverse Event|1|||
129871870|NCT00409682|467489492|FG001|Open-label Induction Period|Adverse Event|0|||
129871871|NCT00409682|467489493|FG002|Open-label Induction Period|Adverse Event|0|||
129871872|NCT00409682|467489491|FG000|Open-label Induction Period|Lack of Efficacy|1|||
129871873|NCT00409682|467489492|FG001|Open-label Induction Period|Lack of Efficacy|0|||
129871874|NCT00409682|467489493|FG002|Open-label Induction Period|Lack of Efficacy|0|||
129871875|NCT00409682|467489491|FG000|Open-label Induction Period|Protocol Violation|1|||
129871876|NCT00409682|467489492|FG001|Open-label Induction Period|Protocol Violation|0|||
129871877|NCT00409682|467489493|FG002|Open-label Induction Period|Protocol Violation|0|||
129871878|NCT00409682|467489491|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
129871879|NCT00409682|467489492|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
129871880|NCT00409682|467489493|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
129871881|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
129871882|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
129918517|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918518|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
129918519|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918520|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
129918521|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129871883|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
129871884|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
129871885|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
129871886|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
129871887|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
129871888|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
129871889|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
130067300|NCT00171314|468199868|FG001|Overall Study|Adverse Event|41|||
130067301|NCT00171314|468199867|FG000|Overall Study|Lack of Efficacy|19|||
130067302|NCT00171314|468199868|FG001|Overall Study|Lack of Efficacy|14|||
130067303|NCT00171314|468199867|FG000|Overall Study|Withdrawal by Subject|9|||
130067304|NCT00171314|468199868|FG001|Overall Study|Withdrawal by Subject|6|||
130067305|NCT00171314|468199867|FG000|Overall Study|Abnormal Test Procedure Results|9|||
130067306|NCT00171314|468199868|FG001|Overall Study|Abnormal Test Procedure Results|3|||
130067307|NCT00171314|468199867|FG000|Overall Study|Protocol Violation|3|||
130067308|NCT00171314|468199868|FG001|Overall Study|Protocol Violation|7|||
130067309|NCT00171314|468199867|FG000|Overall Study|Administrative Problems|4|||
130067310|NCT00171314|468199868|FG001|Overall Study|Administrative Problems|3|||
130067311|NCT00171314|468199867|FG000|Overall Study|Lost to Follow-up|1|||
130067312|NCT00171314|468199868|FG001|Overall Study|Lost to Follow-up|3|||
130067313|NCT00171314|468199867|FG000|Overall Study|Death|2|||
130067314|NCT00171314|468199868|FG001|Overall Study|Death|1|||
130067315|NCT01033487|468199872|FG000|Fourth Intervention Period|Adverse Event|0|||
130067316|NCT01033487|468199873|FG001|Fourth Intervention Period|Adverse Event|0|||
130067317|NCT01033487|468199874|FG002|Fourth Intervention Period|Adverse Event|0|||
130067318|NCT01033487|468199875|FG003|Fourth Intervention Period|Adverse Event|0|||
130067319|NCT01033487|468199876|FG004|Fourth Intervention Period|Adverse Event|0|||
130067320|NCT01033487|468199877|FG005|Fourth Intervention Period|Adverse Event|0|||
130067321|NCT01033487|468199878|FG006|Fourth Intervention Period|Adverse Event|0|||
130067322|NCT01033487|468199879|FG007|Fourth Intervention Period|Adverse Event|0|||
130067323|NCT01033487|468199880|FG008|Fourth Intervention Period|Adverse Event|1|||
130067324|NCT01033487|468199881|FG009|Fourth Intervention Period|Adverse Event|0|||
130067325|NCT02939599|468199882|FG000|Overall Study|Adverse Event|1|||
130067326|NCT02939599|468199883|FG001|Overall Study|Adverse Event|0|||
130067327|NCT02939599|468199882|FG000|Overall Study|Study Terminated By Sponsor|2|||
130067328|NCT02939599|468199883|FG001|Overall Study|Study Terminated By Sponsor|2|||
130067329|NCT03326869|468201281|FG000|Overall Study|Study data has been lost to natural disa|1|||
130067330|NCT03326869|468201282|FG001|Overall Study|Study data has been lost to natural disa|1|||
130067331|NCT00525785|468201284|FG000|Overall Study|Withdrawal by Subject|1|||
130067332|NCT00525785|468201284|FG000|Overall Study|Lack of Efficacy|1|||
130067333|NCT00525785|468201284|FG000|Overall Study|Physician Decision|1|||
130067334|NCT02455388|468201285|FG000|Overall Study|Protocol Violation|1|||
130067335|NCT02455388|468201286|FG001|Overall Study|Protocol Violation|0|||
130067336|NCT02455388|468201287|FG002|Overall Study|Protocol Violation|4|||
130067337|NCT02455388|468201285|FG000|Overall Study|Withdrawal by Subject|0|||
130067338|NCT02455388|468201286|FG001|Overall Study|Withdrawal by Subject|0|||
130067339|NCT02455388|468201287|FG002|Overall Study|Withdrawal by Subject|7|||
130067340|NCT01316939|468201288|FG000|Overall Study|Study closed/terminated|26|||
130067341|NCT01316939|468201289|FG001|Overall Study|Study closed/terminated|25|||
130067342|NCT01316939|468201290|FG002|Overall Study|Study closed/terminated|23|||
130067343|NCT01316939|468201288|FG000|Overall Study|Lack of Efficacy|24|||
130067344|NCT01316939|468201289|FG001|Overall Study|Lack of Efficacy|25|||
130067345|NCT01316939|468201290|FG002|Overall Study|Lack of Efficacy|25|||
130067346|NCT01316939|468201288|FG000|Overall Study|Adverse Event|9|||
130067347|NCT01316939|468201289|FG001|Overall Study|Adverse Event|12|||
130067348|NCT01316939|468201290|FG002|Overall Study|Adverse Event|11|||
130067349|NCT01316939|468201288|FG000|Overall Study|Withdrawal by Subject|1|||
130067350|NCT01316939|468201289|FG001|Overall Study|Withdrawal by Subject|3|||
130067351|NCT01316939|468201290|FG002|Overall Study|Withdrawal by Subject|6|||
130067352|NCT01316939|468201288|FG000|Overall Study|Physician Decision|2|||
130067353|NCT01316939|468201289|FG001|Overall Study|Physician Decision|2|||
130067354|NCT01316939|468201290|FG002|Overall Study|Physician Decision|1|||
130067355|NCT01316939|468201288|FG000|Overall Study|Lost to Follow-up|0|||
130067356|NCT01316939|468201289|FG001|Overall Study|Lost to Follow-up|0|||
130067357|NCT01316939|468201290|FG002|Overall Study|Lost to Follow-up|2|||
130067358|NCT01316939|468201288|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
130067359|NCT01316939|468201289|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
130067360|NCT01316939|468201290|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
130067361|NCT01316939|468201288|FG000|Overall Study|Protocol Violation|0|||
130067362|NCT01316939|468201289|FG001|Overall Study|Protocol Violation|1|||
130067363|NCT01316939|468201290|FG002|Overall Study|Protocol Violation|0|||
130067364|NCT03628599|468201292|FG000|Overall Study|Adverse Event|0|||
130067365|NCT03628599|468201293|FG001|Overall Study|Adverse Event|1|||
130067366|NCT01624506|468201294|FG000|Overall Study|Lost to Follow-up|29|||
130067367|NCT01624506|468201295|FG001|Overall Study|Lost to Follow-up|15|||
130067368|NCT01624506|468201294|FG000|Overall Study|Withdrawal by Subject|9|||
130067369|NCT01624506|468201295|FG001|Overall Study|Withdrawal by Subject|2|||
130067370|NCT01624506|468201294|FG000|Overall Study|Death|1|||
130067371|NCT01624506|468201295|FG001|Overall Study|Death|0|||
130067372|NCT01624506|468201294|FG000|Overall Study|LINX explants|23|||
130067373|NCT01624506|468201295|FG001|Overall Study|LINX explants|0|||
130067374|NCT01624506|468201294|FG000|Overall Study|Adverse Event|3|||
130067375|NCT01624506|468201295|FG001|Overall Study|Adverse Event|0|||
130067376|NCT00132314|468201301|FG000|Overall Study|Lost to Follow-up|70|||
130067377|NCT00132314|468201302|FG001|Overall Study|Lost to Follow-up|62|||
130067378|NCT00132314|468201301|FG000|Overall Study|Lacked SSN|1|||
130067379|NCT00132314|468201302|FG001|Overall Study|Lacked SSN|3|||
130067380|NCT00132314|468201301|FG000|Overall Study|Refused intervention at baseline|2|||
130067381|NCT00132314|468201302|FG001|Overall Study|Refused intervention at baseline|7|||
130067382|NCT02966353|468201305|FG000|Overall Study|Withdrawal by Subject|7|||
130067383|NCT02966353|468201305|FG000|Overall Study|Adverse Event|4|||
130067384|NCT02966353|468201305|FG000|Overall Study|Death|4|||
130067385|NCT02966353|468201305|FG000|Overall Study|Physician Decision|3|||
130067386|NCT02966353|468201305|FG000|Overall Study|Progressive disease|2|||
130067387|NCT02966353|468201305|FG000|Overall Study|Protocol deviation|2|||
130067388|NCT00093470|468201306|FG000|Overall Study|Disease progression|39|||
130067389|NCT00093470|468201307|FG001|Overall Study|Disease progression|0|||
130067390|NCT00093470|468201306|FG000|Overall Study|Adverse Event|15|||
130067391|NCT00093470|468201307|FG001|Overall Study|Adverse Event|0|||
130067392|NCT00093470|468201306|FG000|Overall Study|Death|2|||
130067393|NCT00093470|468201307|FG001|Overall Study|Death|0|||
130067394|NCT00093470|468201306|FG000|Overall Study|Withdrawal by Subject|8|||
130067395|NCT00093470|468201307|FG001|Overall Study|Withdrawal by Subject|0|||
130067396|NCT00093470|468201306|FG000|Overall Study|Alternative therapy|2|||
130067397|NCT00093470|468201307|FG001|Overall Study|Alternative therapy|0|||
130067398|NCT00093470|468201306|FG000|Overall Study|Other complicating disease|3|||
130067399|NCT00093470|468201307|FG001|Overall Study|Other complicating disease|0|||
130067400|NCT00093470|468201306|FG000|Overall Study|Physician Decision|2|||
130067401|NCT00093470|468201307|FG001|Overall Study|Physician Decision|0|||
130067402|NCT00093470|468201306|FG000|Overall Study|Never started treatment|1|||
130067403|NCT00093470|468201307|FG001|Overall Study|Never started treatment|0|||
130067404|NCT00093470|468201306|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
130067405|NCT00093470|468201307|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
130067406|NCT05905601|468201308|FG000|Overall Study|Lost to Follow-up|1|||
130067407|NCT05905601|468201309|FG001|Overall Study|Lost to Follow-up|3|||
130067408|NCT02514772|468201310|FG000|Overall Study|Adverse Event|1|||
130067409|NCT02514772|468201311|FG001|Overall Study|Adverse Event|0|||
130067410|NCT02514772|468201310|FG000|Overall Study|Death|0|||
130067411|NCT02514772|468201311|FG001|Overall Study|Death|1|||
130067412|NCT02514772|468201310|FG000|Overall Study|Withdrawal by Subject|2|||
130067413|NCT02514772|468201311|FG001|Overall Study|Withdrawal by Subject|1|||
130067414|NCT01415908|468201312|FG000|Overall Study|Withdrawal by Subject|1|||
130067415|NCT01415908|468201313|FG001|Overall Study|Withdrawal by Subject|0|||
130067416|NCT03250377|468201314|FG000|Overall Study|Adverse Event|2|||
130067417|NCT03250377|468201315|FG001|Overall Study|Adverse Event|4|||
130067418|NCT03250377|468201316|FG002|Overall Study|Adverse Event|0|||
130067419|NCT03250377|468201317|FG003|Overall Study|Adverse Event|4|||
130067420|NCT03250377|468201314|FG000|Overall Study|Lack of Efficacy|5|||
130067421|NCT03250377|468201315|FG001|Overall Study|Lack of Efficacy|14|||
130067422|NCT03250377|468201316|FG002|Overall Study|Lack of Efficacy|1|||
130067423|NCT03250377|468201317|FG003|Overall Study|Lack of Efficacy|3|||
130067424|NCT03250377|468201314|FG000|Overall Study|Protocol Violation|0|||
130067425|NCT03250377|468201315|FG001|Overall Study|Protocol Violation|2|||
130067426|NCT03250377|468201316|FG002|Overall Study|Protocol Violation|0|||
130067427|NCT03250377|468201317|FG003|Overall Study|Protocol Violation|1|||
130067428|NCT03250377|468201314|FG000|Overall Study|Lost to Follow-up|0|||
130067429|NCT03250377|468201315|FG001|Overall Study|Lost to Follow-up|1|||
130067430|NCT03250377|468201316|FG002|Overall Study|Lost to Follow-up|0|||
130067431|NCT03250377|468201317|FG003|Overall Study|Lost to Follow-up|0|||
130067432|NCT03250377|468201314|FG000|Overall Study|Withdrawal by Subject|7|||
130067433|NCT03250377|468201315|FG001|Overall Study|Withdrawal by Subject|7|||
130067434|NCT03250377|468201316|FG002|Overall Study|Withdrawal by Subject|0|||
130067435|NCT03250377|468201317|FG003|Overall Study|Withdrawal by Subject|4|||
130067436|NCT03250377|468201314|FG000|Overall Study|Investigator's Judgment|1|||
130067437|NCT03250377|468201315|FG001|Overall Study|Investigator's Judgment|0|||
130067438|NCT03250377|468201316|FG002|Overall Study|Investigator's Judgment|0|||
130067439|NCT03250377|468201317|FG003|Overall Study|Investigator's Judgment|0|||
130067440|NCT03250377|468201314|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
130067441|NCT03250377|468201315|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
130067442|NCT03250377|468201316|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
130067443|NCT03250377|468201317|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
130067444|NCT03250377|468201314|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
130067445|NCT03250377|468201315|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
130067446|NCT03250377|468201316|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
130067447|NCT03250377|468201317|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
130067448|NCT03250377|468201314|FG000|Overall Study|Epilepsy Surgery|0|||
130067449|NCT03250377|468201315|FG001|Overall Study|Epilepsy Surgery|1|||
130116864|NCT01199601|468387210|FG001|Overall Study|Lost to Follow-up|66|||
130067450|NCT03250377|468201316|FG002|Overall Study|Epilepsy Surgery|2|||
130067451|NCT03250377|468201317|FG003|Overall Study|Epilepsy Surgery|0|||
130067452|NCT03250377|468201314|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
130067453|NCT03250377|468201315|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
130067454|NCT03250377|468201316|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
130067455|NCT03250377|468201317|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
130067456|NCT03250377|468201314|FG000|Overall Study|Request From The Sponsor|0|||
130067457|NCT03250377|468201315|FG001|Overall Study|Request From The Sponsor|1|||
130067458|NCT03250377|468201316|FG002|Overall Study|Request From The Sponsor|0|||
130067459|NCT03250377|468201317|FG003|Overall Study|Request From The Sponsor|0|||
130067460|NCT03250377|468201314|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
130067461|NCT03250377|468201315|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
130067462|NCT03250377|468201316|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
130067463|NCT03250377|468201317|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
130067464|NCT03250377|468201314|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
130067465|NCT03250377|468201315|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
130067466|NCT03250377|468201316|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
130067467|NCT03250377|468201317|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
130067468|NCT03250377|468201314|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
130067469|NCT03250377|468201315|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
130067470|NCT03250377|468201316|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
130067471|NCT03250377|468201317|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
130067472|NCT03250377|468201314|FG000|Overall Study|Pregnancy Event|0|||
129918522|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918523|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918524|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918525|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918526|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918527|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918528|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918529|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918530|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918531|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918532|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918533|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918534|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
129918535|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
129918536|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
129918537|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918538|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918539|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918540|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918541|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918542|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918543|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918544|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918545|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918546|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918547|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918548|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
129918549|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
129918550|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918551|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918552|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918553|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918554|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918555|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918556|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918557|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918558|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918559|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918560|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918561|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
130067473|NCT03250377|468201315|FG001|Overall Study|Pregnancy Event|1|||
130067474|NCT03250377|468201316|FG002|Overall Study|Pregnancy Event|0|||
130067475|NCT03250377|468201317|FG003|Overall Study|Pregnancy Event|0|||
130067476|NCT03250377|468201314|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
130067477|NCT03250377|468201315|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
130067478|NCT03250377|468201316|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
130116865|NCT01199601|468387209|FG000|Overall Study|Withdrawal by Subject|15|||
129918562|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
129918563|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918564|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918565|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918566|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918567|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918568|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918569|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918570|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918571|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918572|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918573|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
129918574|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
129918575|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
129918576|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918577|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918578|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918579|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918580|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918581|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918582|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918583|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918584|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918585|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918586|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918587|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918588|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
129918589|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918590|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918591|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918592|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918593|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918594|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918595|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918596|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918597|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918598|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918599|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
129918600|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
129918601|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
129918602|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918603|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918604|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918605|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918606|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918607|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918608|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918609|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918610|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918611|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918612|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
129918613|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
129918614|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
129918615|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918616|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918617|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918618|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918619|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918620|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918621|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
130116866|NCT01199601|468387210|FG001|Overall Study|Withdrawal by Subject|3|||
129918622|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918623|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918624|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918625|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918626|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918627|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918628|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
129918629|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
129918630|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
129918631|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918632|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918633|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918634|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918635|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918636|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918637|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918638|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918639|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918640|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918641|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918642|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
129918643|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
129918644|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918645|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918646|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918647|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918648|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918649|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918650|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918651|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918652|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918653|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918654|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
129918655|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
129918656|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
129918657|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918658|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918659|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918660|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918661|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
129918662|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
129918663|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
129918664|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
129918665|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
129918666|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
129918667|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
129918668|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
129918669|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
129918670|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
129918671|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
129918672|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
129918673|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
129918674|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918675|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918676|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918677|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918678|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918679|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918680|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
129918681|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
129918682|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
129918683|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918684|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918685|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918686|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918687|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918688|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918689|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918690|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918691|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
130067479|NCT03250377|468201317|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
129918692|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918693|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
129918694|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
129918695|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
129918696|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918697|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918698|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918699|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918700|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918701|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918702|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918703|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918704|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918705|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918706|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
129918707|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
129918708|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
129918709|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918710|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918711|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918712|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918713|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918714|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918715|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918716|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918717|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918718|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918719|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918720|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918721|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918722|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
129918723|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
129918724|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
129918725|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
129918726|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918727|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918728|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918729|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130067480|NCT03250377|468201314|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
130067481|NCT03250377|468201315|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
130067482|NCT03250377|468201316|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
130067483|NCT03250377|468201317|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
130067484|NCT03250377|468201314|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
130067485|NCT03250377|468201315|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
130067486|NCT03250377|468201316|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
130067487|NCT03250377|468201317|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
130067488|NCT03250377|468201314|FG000|Overall Study|Patient requested to change hospital|0|||
130067489|NCT03250377|468201315|FG001|Overall Study|Patient requested to change hospital|0|||
130067490|NCT03250377|468201316|FG002|Overall Study|Patient requested to change hospital|0|||
130067491|NCT03250377|468201317|FG003|Overall Study|Patient requested to change hospital|1|||
130067492|NCT03250377|468201314|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
130067493|NCT03250377|468201315|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
130067494|NCT03250377|468201316|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
130067495|NCT03250377|468201317|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
130067496|NCT04603391|468201319|FG000|First Intervention (4 Days)|Adverse Event|1|||
130067497|NCT04603391|468201320|FG001|First Intervention (4 Days)|Adverse Event|0|||
130067498|NCT04603391|468201319|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
130067499|NCT04603391|468201320|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
129871890|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
129871891|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
129871892|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
129871893|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
129871894|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
129871895|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
129871896|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
129871897|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
129871898|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
130067500|NCT03260894|468201322|FG000|Overall Study|Death|6|||
129871899|NCT01896869|467489496|FG000|Overall Study|Withdrawal by Subject|0|||
130067501|NCT03260894|468201323|FG001|Overall Study|Death|8|||
130067502|NCT03260894|468201322|FG000|Overall Study|Withdrawal by Subject|4|||
130067503|NCT03260894|468201323|FG001|Overall Study|Withdrawal by Subject|11|||
130067504|NCT03260894|468201322|FG000|Overall Study|On-going at clinical cut off date|36|||
130067505|NCT03260894|468201323|FG001|Overall Study|On-going at clinical cut off date|31|||
130067506|NCT00318565|468201324|FG000|Overall Study|Excluded per protocol|24|||
130067507|NCT00426556|468201325|FG000|Phase I - Core Phase|Disease Progression|0|||
130067508|NCT00426556|468201326|FG001|Phase I - Core Phase|Disease Progression|6|||
130067509|NCT00426556|468201327|FG002|Phase I - Core Phase|Disease Progression|2|||
130067510|NCT00426556|468201328|FG003|Phase I - Core Phase|Disease Progression|0|||
130067511|NCT00426556|468201325|FG000|Phase I - Core Phase|Adverse Event|1|||
130067512|NCT00426556|468201326|FG001|Phase I - Core Phase|Adverse Event|3|||
130067513|NCT00426556|468201327|FG002|Phase I - Core Phase|Adverse Event|1|||
130116867|NCT01199601|468387209|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
130116868|NCT01199601|468387210|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
129871900|NCT01896869|467489497|FG001|Overall Study|Withdrawal by Subject|6|||
129871901|NCT01896869|467489496|FG000|Overall Study|Lost to Follow-up|1|||
129871902|NCT01896869|467489497|FG001|Overall Study|Lost to Follow-up|0|||
129871903|NCT00118716|467489503|FG000|Overall Study|Adverse Event|2|||
129871904|NCT00118716|467489504|FG001|Overall Study|Adverse Event|7|||
129871905|NCT00118716|467489503|FG000|Overall Study|Protocol Violation|5|||
129871906|NCT00118716|467489504|FG001|Overall Study|Protocol Violation|4|||
129871907|NCT00118716|467489503|FG000|Overall Study|Withdrawal by Subject|0|||
129871908|NCT00118716|467489504|FG001|Overall Study|Withdrawal by Subject|1|||
129871909|NCT00118716|467489503|FG000|Overall Study|Exacerbation|2|||
129871910|NCT00118716|467489504|FG001|Overall Study|Exacerbation|2|||
129871911|NCT00118716|467489503|FG000|Overall Study|Discontinued by sponsor|1|||
129871912|NCT00118716|467489504|FG001|Overall Study|Discontinued by sponsor|1|||
129871913|NCT00118716|467489503|FG000|Overall Study|Non-compliance|1|||
129871914|NCT00118716|467489504|FG001|Overall Study|Non-compliance|3|||
129871915|NCT00118716|467489503|FG000|Overall Study|misrandomized|1|||
129871916|NCT00118716|467489504|FG001|Overall Study|misrandomized|1|||
129871917|NCT00118716|467489503|FG000|Overall Study|Expired drug use|1|||
129871918|NCT00118716|467489504|FG001|Overall Study|Expired drug use|2|||
129871919|NCT00118716|467489503|FG000|Overall Study|Investigator discretion|0|||
129871920|NCT00118716|467489504|FG001|Overall Study|Investigator discretion|1|||
129871921|NCT00454571|467489506|FG000|Overall Study|Adverse Event|2|||
129871922|NCT00454571|467489507|FG001|Overall Study|Adverse Event|0|||
129871923|NCT00454571|467489506|FG000|Overall Study|Physician Decision|0|||
129871924|NCT00454571|467489507|FG001|Overall Study|Physician Decision|1|||
129871925|NCT00454571|467489506|FG000|Overall Study|Protocol Violation|1|||
129871926|NCT00454571|467489507|FG001|Overall Study|Protocol Violation|0|||
129871927|NCT00454571|467489506|FG000|Overall Study|Withdrawal by Subject|10|||
129871928|NCT00454571|467489507|FG001|Overall Study|Withdrawal by Subject|5|||
129871929|NCT02436811|467489508|FG000|Overall Study|Lost to Follow-up|2|||
129871930|NCT02436811|467489509|FG001|Overall Study|Lost to Follow-up|9|||
129871931|NCT02436811|467489510|FG002|Overall Study|Lost to Follow-up|7|||
129871932|NCT02657317|467489511|FG000|Overall Study|Withdrawal by Subject|2|||
129871933|NCT02657317|467489512|FG001|Overall Study|Withdrawal by Subject|0|||
129871934|NCT02657317|467489511|FG000|Overall Study|Lost to Follow-up|3|||
129871935|NCT02657317|467489512|FG001|Overall Study|Lost to Follow-up|3|||
129871936|NCT01201811|467489513|FG000|Overall Study|Adverse Event|6|||
129871937|NCT01201811|467489513|FG000|Overall Study|Disease progression|3|||
129871938|NCT01201811|467489513|FG000|Overall Study|Withdrawal by Subject|3|||
129871939|NCT01201811|467489513|FG000|Overall Study|Death|4|||
129871940|NCT01201811|467489513|FG000|Overall Study|Treatment Failure|2|||
129871941|NCT01201811|467489513|FG000|Overall Study|Physician Decision|1|||
129871942|NCT01089374|467489514|FG000|Overall Study|Lost to Follow-up|3|||
129871943|NCT01089374|467489515|FG001|Overall Study|Lost to Follow-up|0|||
129871944|NCT01089374|467489514|FG000|Overall Study|Withdrawal by Subject|1|||
129871945|NCT01089374|467489515|FG001|Overall Study|Withdrawal by Subject|0|||
129871946|NCT01089374|467489514|FG000|Overall Study|Study closed early - low accrual|6|||
129871947|NCT01089374|467489515|FG001|Overall Study|Study closed early - low accrual|0|||
129871948|NCT02856113|467489516|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129918730|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918731|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918732|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130067514|NCT00426556|468201328|FG003|Phase I - Core Phase|Adverse Event|0|||
129871949|NCT02856113|467489517|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129871950|NCT02856113|467489516|FG000|Overall Study|Significant Protocol Deviation|1|||
129871951|NCT02856113|467489517|FG001|Overall Study|Significant Protocol Deviation|0|||
129871952|NCT02856113|467489516|FG000|Overall Study|Lost to Follow-up|3|||
129871953|NCT02856113|467489517|FG001|Overall Study|Lost to Follow-up|5|||
129871954|NCT02856113|467489516|FG000|Overall Study|Voluntary Withdrawal|3|||
129871955|NCT02856113|467489517|FG001|Overall Study|Voluntary Withdrawal|5|||
129871956|NCT02856113|467489516|FG000|Overall Study|Pregnancy|0|||
129871957|NCT02856113|467489517|FG001|Overall Study|Pregnancy|1|||
129871958|NCT02856113|467489516|FG000|Overall Study|Principal Investigator Discretion|2|||
129871959|NCT02856113|467489517|FG001|Overall Study|Principal Investigator Discretion|1|||
129871960|NCT02856113|467489516|FG000|Overall Study|Randomized but not Treated|1|||
129871961|NCT02856113|467489517|FG001|Overall Study|Randomized but not Treated|0|||
129871962|NCT02856113|467489516|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
129871963|NCT02856113|467489517|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
129871964|NCT03494166|467489518|FG000|Overall Study|Death|0|||
129871965|NCT03494166|467489519|FG001|Overall Study|Death|0|||
129871966|NCT03494166|467489520|FG002|Overall Study|Death|0|||
129871967|NCT03494166|467489521|FG003|Overall Study|Death|1|||
129871968|NCT03494166|467489522|FG004|Overall Study|Death|3|||
129871969|NCT03494166|467489523|FG005|Overall Study|Death|0|||
129871970|NCT03494166|467489518|FG000|Overall Study|Lost to Follow-up|2|||
129871971|NCT03494166|467489519|FG001|Overall Study|Lost to Follow-up|2|||
129871972|NCT03494166|467489520|FG002|Overall Study|Lost to Follow-up|2|||
129871973|NCT03494166|467489521|FG003|Overall Study|Lost to Follow-up|2|||
129871974|NCT03494166|467489522|FG004|Overall Study|Lost to Follow-up|14|||
129871975|NCT03494166|467489523|FG005|Overall Study|Lost to Follow-up|0|||
129871976|NCT03494166|467489518|FG000|Overall Study|Withdrawal by Subject|10|||
129871977|NCT03494166|467489519|FG001|Overall Study|Withdrawal by Subject|7|||
129871978|NCT03494166|467489520|FG002|Overall Study|Withdrawal by Subject|0|||
129871979|NCT03494166|467489521|FG003|Overall Study|Withdrawal by Subject|5|||
129871980|NCT03494166|467489522|FG004|Overall Study|Withdrawal by Subject|3|||
129871981|NCT03494166|467489523|FG005|Overall Study|Withdrawal by Subject|17|||
129871982|NCT03494166|467489518|FG000|Overall Study|Screen failure|1|||
129871983|NCT03494166|467489519|FG001|Overall Study|Screen failure|0|||
129871984|NCT03494166|467489520|FG002|Overall Study|Screen failure|0|||
129871985|NCT03494166|467489521|FG003|Overall Study|Screen failure|0|||
129871986|NCT03494166|467489522|FG004|Overall Study|Screen failure|1|||
129871987|NCT03494166|467489523|FG005|Overall Study|Screen failure|0|||
129871988|NCT02857426|467489524|FG000|Overall Study|Disease progression|34|||
129871989|NCT02857426|467489525|FG001|Overall Study|Disease progression|13|||
129871990|NCT02857426|467489524|FG000|Overall Study|Study drug toxicity|4|||
129871991|NCT02857426|467489525|FG001|Overall Study|Study drug toxicity|1|||
129871992|NCT02857426|467489524|FG000|Overall Study|Death|1|||
129871993|NCT02857426|467489525|FG001|Overall Study|Death|0|||
129871994|NCT02857426|467489524|FG000|Overall Study|Adverse event unrelated to study drug|6|||
129871995|NCT02857426|467489525|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129871996|NCT02857426|467489524|FG000|Overall Study|Participant withdrew consent|1|||
129871997|NCT02857426|467489525|FG001|Overall Study|Participant withdrew consent|1|||
129871998|NCT02857426|467489524|FG000|Overall Study|Maximum clinical benefit|1|||
129871999|NCT02857426|467489525|FG001|Overall Study|Maximum clinical benefit|0|||
129872000|NCT02857426|467489524|FG000|Overall Study|Completed treatment|0|||
129872001|NCT02857426|467489525|FG001|Overall Study|Completed treatment|2|||
129872002|NCT02831257|467489529|FG000|Overall Study|Lack of Efficacy|3|||
129872003|NCT02831257|467489529|FG000|Overall Study|Adverse Event|2|||
129872004|NCT02831257|467489529|FG000|Overall Study|Physician Decision|1|||
129872005|NCT02831257|467489529|FG000|Overall Study|Withdrawal by Subject|6|||
129872006|NCT00855595|467489530|FG000|Overall Study|Withdrawal by Subject|1|||
129872007|NCT00855595|467489531|FG001|Overall Study|Withdrawal by Subject|2|||
129872008|NCT00855595|467489530|FG000|Overall Study|Lost to Follow-up|3|||
129872009|NCT00855595|467489531|FG001|Overall Study|Lost to Follow-up|3|||
129872010|NCT00855595|467489530|FG000|Overall Study|Adverse Event|1|||
129872011|NCT00855595|467489531|FG001|Overall Study|Adverse Event|1|||
129872012|NCT00855595|467489530|FG000|Overall Study|patient moved out of state|1|||
129872013|NCT00855595|467489531|FG001|Overall Study|patient moved out of state|0|||
129872014|NCT00855595|467489530|FG000|Overall Study|patient left country|0|||
129872015|NCT00855595|467489531|FG001|Overall Study|patient left country|1|||
129872016|NCT01780935|467489532|FG000|Overall Study|Admin problems due to early termination|321|||
129872017|NCT01780935|467489533|FG001|Overall Study|Admin problems due to early termination|309|||
129872018|NCT01780935|467489532|FG000|Overall Study|Adverse Event|2|||
129872019|NCT01780935|467489533|FG001|Overall Study|Adverse Event|4|||
129872020|NCT01780935|467489532|FG000|Overall Study|Death|1|||
129872021|NCT01780935|467489533|FG001|Overall Study|Death|6|||
129872022|NCT01780935|467489532|FG000|Overall Study|Lost to Follow-up|2|||
129918733|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
130067515|NCT00426556|468201325|FG000|Phase I - Core Phase|Death|0|||
129872023|NCT01780935|467489533|FG001|Overall Study|Lost to Follow-up|6|||
129872024|NCT01780935|467489532|FG000|Overall Study|Physician Decision|1|||
129872025|NCT01780935|467489533|FG001|Overall Study|Physician Decision|1|||
129872026|NCT01780935|467489532|FG000|Overall Study|Protocol deviation|0|||
129872027|NCT01780935|467489533|FG001|Overall Study|Protocol deviation|1|||
129872028|NCT01780935|467489532|FG000|Overall Study|Patient withdrew consent|8|||
129872029|NCT01780935|467489533|FG001|Overall Study|Patient withdrew consent|9|||
129872030|NCT04035200|467489534|FG000|Overall Study|Lost to Follow-up|0|||
129872031|NCT04035200|467489535|FG001|Overall Study|Lost to Follow-up|1|||
129872032|NCT04035200|467489536|FG002|Overall Study|Lost to Follow-up|0|||
129918734|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918735|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
129918736|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918737|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
129918738|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
129918739|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918740|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918741|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918742|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918743|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918744|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918745|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918746|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918747|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918748|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
129918749|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
129918750|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
129918751|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
129918752|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918753|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918754|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918755|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918756|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918757|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918758|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918759|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918760|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918761|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
129918762|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
129918763|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
129918764|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
129918765|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918766|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918767|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918768|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918769|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918770|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918771|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918772|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918773|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918774|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
129918775|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
129918776|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
129918777|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
129918778|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918779|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918780|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918781|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918782|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918783|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918784|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918785|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918786|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918787|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
129918788|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
129918789|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
129918790|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
129918791|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918792|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918793|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130116869|NCT02669264|468387211|FG000|Overall Study|Death|5|||
130116870|NCT02669264|468387212|FG001|Overall Study|Death|5|||
130116871|NCT02669264|468387213|FG002|Overall Study|Death|3|||
129918794|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
130116872|NCT02669264|468387214|FG003|Overall Study|Death|3|||
130116873|NCT02669264|468387215|FG004|Overall Study|Death|3|||
129872033|NCT04035200|467489534|FG000|Overall Study|Withdrawal by Subject|1|||
129872034|NCT04035200|467489535|FG001|Overall Study|Withdrawal by Subject|4|||
129872035|NCT04035200|467489536|FG002|Overall Study|Withdrawal by Subject|4|||
129872036|NCT04035200|467489534|FG000|Overall Study|COVID-19|1|||
129872037|NCT04035200|467489535|FG001|Overall Study|COVID-19|0|||
129872038|NCT04035200|467489536|FG002|Overall Study|COVID-19|0|||
129872039|NCT04035200|467489534|FG000|Overall Study|Early Termination|0|||
129872040|NCT04035200|467489535|FG001|Overall Study|Early Termination|1|||
129872041|NCT04035200|467489536|FG002|Overall Study|Early Termination|0|||
129872042|NCT04035200|467489534|FG000|Overall Study|Non-compliance|0|||
129872043|NCT04035200|467489535|FG001|Overall Study|Non-compliance|1|||
129872044|NCT04035200|467489536|FG002|Overall Study|Non-compliance|0|||
129872045|NCT03033225|467489537|FG000|Overall Study|Withdrawal by Subject|5|||
129872046|NCT03685591|467489545|FG000|Overall Study|Global Deterioration of Health Status|0|||
129872047|NCT03685591|467489546|FG001|Overall Study|Global Deterioration of Health Status|0|||
129872048|NCT03685591|467489547|FG002|Overall Study|Global Deterioration of Health Status|0|||
129872049|NCT03685591|467489548|FG003|Overall Study|Global Deterioration of Health Status|1|||
130067516|NCT00426556|468201326|FG001|Phase I - Core Phase|Death|1|||
130067517|NCT00426556|468201327|FG002|Phase I - Core Phase|Death|0|||
130067518|NCT00426556|468201328|FG003|Phase I - Core Phase|Death|0|||
130067519|NCT00426556|468201325|FG000|Phase I - Extension Phase|Adverse Event|0|||
130067520|NCT00426556|468201326|FG001|Phase I - Extension Phase|Adverse Event|1|||
130067521|NCT00426556|468201327|FG002|Phase I - Extension Phase|Adverse Event|1|||
130067522|NCT00426556|468201328|FG003|Phase I - Extension Phase|Adverse Event|0|||
130067523|NCT00426556|468201325|FG000|Phase I - Extension Phase|Disease Progression|5|||
130067524|NCT00426556|468201326|FG001|Phase I - Extension Phase|Disease Progression|5|||
129872050|NCT03685591|467489549|FG004|Overall Study|Global Deterioration of Health Status|2|||
129872051|NCT03685591|467489550|FG005|Overall Study|Global Deterioration of Health Status|4|||
129872052|NCT03685591|467489551|FG006|Overall Study|Global Deterioration of Health Status|1|||
129872053|NCT03685591|467489552|FG007|Overall Study|Global Deterioration of Health Status|1|||
129872054|NCT03685591|467489553|FG008|Overall Study|Global Deterioration of Health Status|0|||
129918795|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918796|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918797|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918798|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918799|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918800|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
129918801|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
129918802|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
129918803|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
129918804|NCT01809691|467666992|FG000|Overall Study|Currently on Treatment|192|||
129918805|NCT01809691|467666993|FG001|Overall Study|Currently on Treatment|100|||
129918806|NCT01809691|467666992|FG000|Overall Study|No Protocol Treatment|10|||
129918807|NCT01809691|467666993|FG001|Overall Study|No Protocol Treatment|11|||
129918808|NCT01809691|467666992|FG000|Overall Study|Adverse Event|80|||
129918809|NCT01809691|467666993|FG001|Overall Study|Adverse Event|21|||
129918810|NCT01809691|467666992|FG000|Overall Study|Disease Progression|226|||
129918811|NCT01809691|467666993|FG001|Overall Study|Disease Progression|372|||
129918812|NCT01809691|467666992|FG000|Overall Study|Death|26|||
129918813|NCT01809691|467666993|FG001|Overall Study|Death|13|||
129918814|NCT01809691|467666992|FG000|Overall Study|Participant Refusal|70|||
129918815|NCT01809691|467666993|FG001|Overall Study|Participant Refusal|72|||
129918816|NCT01809691|467666992|FG000|Overall Study|Other, Not Specified|34|||
129918817|NCT01809691|467666993|FG001|Overall Study|Other, Not Specified|52|||
129918818|NCT01580488|467666994|FG000|Overall Study|Withdrawal by Subject|1|||
130067525|NCT00426556|468201327|FG002|Phase I - Extension Phase|Disease Progression|6|||
130067526|NCT00426556|468201328|FG003|Phase I - Extension Phase|Disease Progression|0|||
129918819|NCT04401800|467666997|FG000|Overall Study|Death|17|||
129918820|NCT04401800|467666997|FG000|Overall Study|Lost to Follow-up|5|||
129918821|NCT04401800|467666997|FG000|Overall Study|Withdrawal by Subject|4|||
129918822|NCT03338790|467667004|FG000|Overall Study|Disease Progression|65|||
129918823|NCT03338790|467667005|FG001|Overall Study|Disease Progression|43|||
129918824|NCT03338790|467667006|FG002|Overall Study|Disease Progression|50|||
130067527|NCT00426556|468201325|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
130067528|NCT00426556|468201326|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
129872055|NCT03685591|467489545|FG000|Overall Study|Progressive Disease|1|||
129872056|NCT03685591|467489546|FG001|Overall Study|Progressive Disease|1|||
129872057|NCT03685591|467489547|FG002|Overall Study|Progressive Disease|0|||
129872058|NCT03685591|467489548|FG003|Overall Study|Progressive Disease|3|||
129872059|NCT03685591|467489549|FG004|Overall Study|Progressive Disease|5|||
130067529|NCT00426556|468201327|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
130067530|NCT00426556|468201328|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
129872060|NCT03685591|467489550|FG005|Overall Study|Progressive Disease|4|||
129872061|NCT03685591|467489551|FG006|Overall Study|Progressive Disease|3|||
129918825|NCT03338790|467667007|FG003|Overall Study|Disease Progression|37|||
129918826|NCT03338790|467667004|FG000|Overall Study|Study Drug Toxicity|9|||
129918827|NCT03338790|467667005|FG001|Overall Study|Study Drug Toxicity|8|||
129918828|NCT03338790|467667006|FG002|Overall Study|Study Drug Toxicity|15|||
129918829|NCT03338790|467667007|FG003|Overall Study|Study Drug Toxicity|0|||
129918830|NCT03338790|467667004|FG000|Overall Study|Death|1|||
129918831|NCT03338790|467667005|FG001|Overall Study|Death|1|||
129918832|NCT03338790|467667006|FG002|Overall Study|Death|1|||
129918833|NCT03338790|467667007|FG003|Overall Study|Death|0|||
129918834|NCT03338790|467667004|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
129918835|NCT03338790|467667005|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
129918836|NCT03338790|467667006|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
129918837|NCT03338790|467667007|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
129918838|NCT03338790|467667004|FG000|Overall Study|Participant request to discontinue study treatment|3|||
129918839|NCT03338790|467667005|FG001|Overall Study|Participant request to discontinue study treatment|3|||
129918840|NCT03338790|467667006|FG002|Overall Study|Participant request to discontinue study treatment|2|||
129918841|NCT03338790|467667007|FG003|Overall Study|Participant request to discontinue study treatment|1|||
129918842|NCT03338790|467667004|FG000|Overall Study|Poor/non-compliance|0|||
129918843|NCT03338790|467667005|FG001|Overall Study|Poor/non-compliance|1|||
129918844|NCT03338790|467667006|FG002|Overall Study|Poor/non-compliance|0|||
129918845|NCT03338790|467667007|FG003|Overall Study|Poor/non-compliance|0|||
129918846|NCT03338790|467667004|FG000|Overall Study|Participant withdrew consent|1|||
129918847|NCT03338790|467667005|FG001|Overall Study|Participant withdrew consent|0|||
129918848|NCT03338790|467667006|FG002|Overall Study|Participant withdrew consent|1|||
129918849|NCT03338790|467667007|FG003|Overall Study|Participant withdrew consent|1|||
129918850|NCT03338790|467667004|FG000|Overall Study|Other reasons|0|||
129918851|NCT03338790|467667005|FG001|Overall Study|Other reasons|5|||
129918852|NCT03338790|467667006|FG002|Overall Study|Other reasons|0|||
129918853|NCT03338790|467667007|FG003|Overall Study|Other reasons|2|||
129918854|NCT03338790|467667004|FG000|Overall Study|Not reported|0|||
129918855|NCT03338790|467667005|FG001|Overall Study|Not reported|0|||
129918856|NCT03338790|467667006|FG002|Overall Study|Not reported|1|||
129918857|NCT03338790|467667007|FG003|Overall Study|Not reported|0|||
129918858|NCT03338790|467667004|FG000|Overall Study|Completed treatment period|1|||
129918859|NCT03338790|467667005|FG001|Overall Study|Completed treatment period|2|||
129918860|NCT03338790|467667006|FG002|Overall Study|Completed treatment period|0|||
129918861|NCT03338790|467667007|FG003|Overall Study|Completed treatment period|0|||
129918862|NCT04588298|467667014|FG000|Overall Study|Adverse Event|0|||
129918863|NCT04588298|467667015|FG001|Overall Study|Adverse Event|0|||
129918864|NCT04588298|467667016|FG002|Overall Study|Adverse Event|1|||
129918865|NCT04588298|467667017|FG003|Overall Study|Adverse Event|0|||
129918866|NCT04588298|467667018|FG004|Overall Study|Adverse Event|2|||
129918867|NCT04588298|467667014|FG000|Overall Study|Withdrawal by Subject|1|||
129918868|NCT04588298|467667015|FG001|Overall Study|Withdrawal by Subject|0|||
129918869|NCT04588298|467667016|FG002|Overall Study|Withdrawal by Subject|0|||
129918870|NCT04588298|467667017|FG003|Overall Study|Withdrawal by Subject|1|||
129918871|NCT04588298|467667018|FG004|Overall Study|Withdrawal by Subject|0|||
129918872|NCT03846505|467667020|FG000|Treatment Phase|Withdrawal by Subject|9|||
129918873|NCT03846505|467667021|FG001|Treatment Phase|Withdrawal by Subject|11|||
129918874|NCT03846505|467667020|FG000|Treatment Phase|Lost to Follow-up|6|||
129918875|NCT03846505|467667021|FG001|Treatment Phase|Lost to Follow-up|2|||
129918876|NCT03846505|467667020|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
129918877|NCT03846505|467667021|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
129918878|NCT03846505|467667020|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
129918879|NCT03846505|467667021|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
129918880|NCT03535272|467667024|FG000|Overall Study|Lost to Follow-up|71|||
129918881|NCT03535272|467667025|FG001|Overall Study|Lost to Follow-up|73|||
129918882|NCT03892616|467667026|FG000|Washout Period 2|Met discontinuation criterion|0|||
129918883|NCT03892616|467667027|FG001|Washout Period 2|Met discontinuation criterion|0|||
129918884|NCT03892616|467667028|FG002|Washout Period 2|Met discontinuation criterion|0|||
129918885|NCT03892616|467667029|FG003|Washout Period 2|Met discontinuation criterion|0|||
129918886|NCT03892616|467667030|FG004|Washout Period 2|Met discontinuation criterion|0|||
129918887|NCT03892616|467667031|FG005|Washout Period 2|Met discontinuation criterion|0|||
129918888|NCT03892616|467667032|FG006|Washout Period 2|Met discontinuation criterion|0|||
129918889|NCT03892616|467667033|FG007|Washout Period 2|Met discontinuation criterion|0|||
129918890|NCT03892616|467667034|FG008|Washout Period 2|Met discontinuation criterion|1|||
130067531|NCT00426556|468201325|FG000|Phase II - Core Phase|Disease Progression|0|||
130067532|NCT00426556|468201326|FG001|Phase II - Core Phase|Disease Progression|0|||
129918891|NCT03892616|467667035|FG009|Washout Period 2|Met discontinuation criterion|0|||
129918892|NCT03892616|467667036|FG010|Washout Period 2|Met discontinuation criterion|0|||
129918893|NCT03892616|467667037|FG011|Washout Period 2|Met discontinuation criterion|0|||
129918894|NCT05592418|467667041|FG000|Overall Study|Adverse Event|1|||
129918895|NCT05592418|467667042|FG001|Overall Study|Adverse Event|0|||
129918896|NCT05592418|467667041|FG000|Overall Study|Lost to Follow-up|1|||
129872062|NCT03685591|467489552|FG007|Overall Study|Progressive Disease|2|||
129872063|NCT03685591|467489553|FG008|Overall Study|Progressive Disease|1|||
129872064|NCT03685591|467489545|FG000|Overall Study|Other|0|||
129872065|NCT03685591|467489546|FG001|Overall Study|Other|0|||
129872066|NCT03685591|467489547|FG002|Overall Study|Other|1|||
129872067|NCT03685591|467489548|FG003|Overall Study|Other|0|||
129872068|NCT03685591|467489549|FG004|Overall Study|Other|2|||
129872069|NCT03685591|467489550|FG005|Overall Study|Other|3|||
129872070|NCT03685591|467489551|FG006|Overall Study|Other|0|||
129872071|NCT03685591|467489552|FG007|Overall Study|Other|0|||
129872072|NCT03685591|467489553|FG008|Overall Study|Other|0|||
129872073|NCT03685591|467489545|FG000|Overall Study|Withdrawal by Subject|0|||
129872074|NCT03685591|467489546|FG001|Overall Study|Withdrawal by Subject|0|||
129872075|NCT03685591|467489547|FG002|Overall Study|Withdrawal by Subject|0|||
129872076|NCT03685591|467489548|FG003|Overall Study|Withdrawal by Subject|0|||
129872077|NCT03685591|467489549|FG004|Overall Study|Withdrawal by Subject|3|||
129872078|NCT03685591|467489550|FG005|Overall Study|Withdrawal by Subject|2|||
129872079|NCT03685591|467489551|FG006|Overall Study|Withdrawal by Subject|0|||
129872080|NCT03685591|467489552|FG007|Overall Study|Withdrawal by Subject|0|||
129872081|NCT03685591|467489553|FG008|Overall Study|Withdrawal by Subject|1|||
129872082|NCT03685591|467489545|FG000|Overall Study|Adverse Event|0|||
129872083|NCT03685591|467489546|FG001|Overall Study|Adverse Event|0|||
129872084|NCT03685591|467489547|FG002|Overall Study|Adverse Event|0|||
129872085|NCT03685591|467489548|FG003|Overall Study|Adverse Event|1|||
129872086|NCT03685591|467489549|FG004|Overall Study|Adverse Event|1|||
129872087|NCT03685591|467489550|FG005|Overall Study|Adverse Event|4|||
129872088|NCT03685591|467489551|FG006|Overall Study|Adverse Event|0|||
129872089|NCT03685591|467489552|FG007|Overall Study|Adverse Event|1|||
129872090|NCT03685591|467489553|FG008|Overall Study|Adverse Event|1|||
129872091|NCT00168038|467489554|FG000|Overall Study|Adverse Event|1|||
129872092|NCT00168038|467489554|FG000|Overall Study|Therapy failure|1|||
129872093|NCT01685138|467489555|FG000|Overall Study|Lost to Follow-up|1|||
129872094|NCT01685138|467489555|FG000|Overall Study|Protocol Violation|1|||
129872095|NCT01685138|467489555|FG000|Overall Study|No longer requires treatment|1|||
129872096|NCT01685138|467489555|FG000|Overall Study|Subject/guardian decision|2|||
129872097|NCT01685138|467489555|FG000|Overall Study|Physician Decision|6|||
129872098|NCT01685138|467489555|FG000|Overall Study|Death|10|||
129872099|NCT01685138|467489555|FG000|Overall Study|Adverse Event|18|||
129872100|NCT01685138|467489555|FG000|Overall Study|Progressive disease|53|||
129872101|NCT02220894|467489560|FG000|Overall Study|Adverse Event|127|||
129872102|NCT02220894|467489561|FG001|Overall Study|Adverse Event|74|||
129872103|NCT02220894|467489560|FG000|Overall Study|Death|418|||
129872104|NCT02220894|467489561|FG001|Overall Study|Death|508|||
129872105|NCT02220894|467489560|FG000|Overall Study|Lost to Follow-up|0|||
129872106|NCT02220894|467489561|FG001|Overall Study|Lost to Follow-up|4|||
129872107|NCT02220894|467489560|FG000|Overall Study|Site Terminated by Sponsor|2|||
129872108|NCT02220894|467489561|FG001|Overall Study|Site Terminated by Sponsor|0|||
129872109|NCT02220894|467489560|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
129872110|NCT02220894|467489561|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
129872111|NCT02220894|467489560|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129872112|NCT02220894|467489561|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129872113|NCT02220894|467489560|FG000|Overall Study|Withdrawal by Subject|10|||
129872114|NCT02220894|467489561|FG001|Overall Study|Withdrawal by Subject|9|||
129872115|NCT00500903|467489566|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
129872116|NCT00500903|467489567|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
129872117|NCT00500903|467489568|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
129872118|NCT00500903|467489566|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
129872119|NCT00500903|467489567|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129872120|NCT00500903|467489568|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129872121|NCT00500903|467489566|FG000|Overall Study|Progressive Disease|41|||
129872122|NCT00500903|467489567|FG001|Overall Study|Progressive Disease|2|||
129872123|NCT00500903|467489568|FG002|Overall Study|Progressive Disease|15|||
129872124|NCT00500903|467489566|FG000|Overall Study|Patient Declined Further Treatment|0|||
129872125|NCT00500903|467489567|FG001|Overall Study|Patient Declined Further Treatment|0|||
129872126|NCT00500903|467489568|FG002|Overall Study|Patient Declined Further Treatment|3|||
129872127|NCT00500903|467489566|FG000|Overall Study|Symptomatic Deterioration|2|||
129872128|NCT00500903|467489567|FG001|Overall Study|Symptomatic Deterioration|0|||
129872129|NCT00500903|467489568|FG002|Overall Study|Symptomatic Deterioration|0|||
129872130|NCT00500903|467489566|FG000|Overall Study|Reason Not Specified|10|||
129872131|NCT00500903|467489567|FG001|Overall Study|Reason Not Specified|0|||
129872132|NCT00500903|467489568|FG002|Overall Study|Reason Not Specified|2|||
129872133|NCT01648348|467489573|FG000|Overall Study|Cancel|1|||
129872134|NCT01648348|467489574|FG001|Overall Study|Cancel|0|||
129872135|NCT01648348|467489575|FG002|Overall Study|Cancel|0|||
129872136|NCT01648348|467489576|FG003|Overall Study|Cancel|0|||
129872137|NCT01648348|467489577|FG004|Overall Study|Cancel|3|||
129872138|NCT01648348|467489578|FG005|Overall Study|Cancel|6|||
129872139|NCT01648348|467489573|FG000|Overall Study|Replaced for MTD analysis|1|||
129872140|NCT01648348|467489574|FG001|Overall Study|Replaced for MTD analysis|0|||
129872141|NCT01648348|467489575|FG002|Overall Study|Replaced for MTD analysis|1|||
129872142|NCT01648348|467489576|FG003|Overall Study|Replaced for MTD analysis|0|||
129872143|NCT01648348|467489577|FG004|Overall Study|Replaced for MTD analysis|0|||
129872144|NCT01648348|467489578|FG005|Overall Study|Replaced for MTD analysis|0|||
129872145|NCT00696410|467489579|FG000|Overall Study|Lost to Follow-up|2|||
129872146|NCT00696410|467489580|FG001|Overall Study|Lost to Follow-up|0|||
129872147|NCT00696410|467489579|FG000|Overall Study|Withdrawal by Subject|8|||
129872148|NCT00696410|467489580|FG001|Overall Study|Withdrawal by Subject|0|||
129872149|NCT00696410|467489579|FG000|Overall Study|Physician Decision|3|||
129872150|NCT00696410|467489580|FG001|Overall Study|Physician Decision|0|||
129872151|NCT01951638|467489581|FG000|Treatment Period|Protocol Violation|0|||
129872152|NCT01951638|467489582|FG001|Treatment Period|Protocol Violation|0|||
129872153|NCT01951638|467489583|FG002|Treatment Period|Protocol Violation|0|||
129872154|NCT01951638|467489584|FG003|Treatment Period|Protocol Violation|2|||
129872155|NCT01951638|467489585|FG004|Treatment Period|Protocol Violation|0|||
129872156|NCT01951638|467489581|FG000|Treatment Period|Protocol-driven decision point|1|||
129872157|NCT01951638|467489582|FG001|Treatment Period|Protocol-driven decision point|3|||
129872158|NCT01951638|467489583|FG002|Treatment Period|Protocol-driven decision point|0|||
129872159|NCT01951638|467489584|FG003|Treatment Period|Protocol-driven decision point|0|||
129872160|NCT01951638|467489585|FG004|Treatment Period|Protocol-driven decision point|0|||
129872161|NCT01951638|467489581|FG000|Treatment Period|Logistical difficulties|0|||
129872162|NCT01951638|467489582|FG001|Treatment Period|Logistical difficulties|1|||
129872163|NCT01951638|467489583|FG002|Treatment Period|Logistical difficulties|1|||
129872164|NCT01951638|467489584|FG003|Treatment Period|Logistical difficulties|0|||
129872165|NCT01951638|467489585|FG004|Treatment Period|Logistical difficulties|0|||
129872166|NCT01951638|467489581|FG000|Treatment Period|Withdrawal by Subject|9|||
129872167|NCT01951638|467489582|FG001|Treatment Period|Withdrawal by Subject|6|||
129872168|NCT01951638|467489583|FG002|Treatment Period|Withdrawal by Subject|4|||
129872169|NCT01951638|467489584|FG003|Treatment Period|Withdrawal by Subject|5|||
129872170|NCT01951638|467489585|FG004|Treatment Period|Withdrawal by Subject|4|||
129872171|NCT01951638|467489581|FG000|Treatment Period|Death|0|||
129872172|NCT01951638|467489582|FG001|Treatment Period|Death|0|||
129872173|NCT01951638|467489583|FG002|Treatment Period|Death|0|||
129872174|NCT01951638|467489584|FG003|Treatment Period|Death|3|||
129872175|NCT01951638|467489585|FG004|Treatment Period|Death|1|||
129872176|NCT01951638|467489581|FG000|Treatment Period|Adverse Event|3|||
129872177|NCT01951638|467489582|FG001|Treatment Period|Adverse Event|4|||
129872178|NCT01951638|467489583|FG002|Treatment Period|Adverse Event|8|||
129872179|NCT01951638|467489584|FG003|Treatment Period|Adverse Event|6|||
129872180|NCT01951638|467489585|FG004|Treatment Period|Adverse Event|5|||
129872181|NCT01951638|467489581|FG000|Follow-up Period|Protocol Violation|0|||
129872182|NCT01951638|467489582|FG001|Follow-up Period|Protocol Violation|0|||
129872183|NCT01951638|467489583|FG002|Follow-up Period|Protocol Violation|0|||
129872184|NCT01951638|467489584|FG003|Follow-up Period|Protocol Violation|1|||
129872185|NCT01951638|467489585|FG004|Follow-up Period|Protocol Violation|0|||
129872186|NCT01951638|467489581|FG000|Follow-up Period|Logistical difficulties|0|||
129872187|NCT01951638|467489582|FG001|Follow-up Period|Logistical difficulties|2|||
129872188|NCT01951638|467489583|FG002|Follow-up Period|Logistical difficulties|0|||
129872189|NCT01951638|467489584|FG003|Follow-up Period|Logistical difficulties|0|||
129872190|NCT01951638|467489585|FG004|Follow-up Period|Logistical difficulties|1|||
129872191|NCT01951638|467489581|FG000|Follow-up Period|Withdrawal by Subject|1|||
129872192|NCT01951638|467489582|FG001|Follow-up Period|Withdrawal by Subject|5|||
129872193|NCT01951638|467489583|FG002|Follow-up Period|Withdrawal by Subject|2|||
129872194|NCT01951638|467489584|FG003|Follow-up Period|Withdrawal by Subject|1|||
129872195|NCT01951638|467489585|FG004|Follow-up Period|Withdrawal by Subject|2|||
129872196|NCT01951638|467489581|FG000|Follow-up Period|Lost to Follow-up|0|||
129872197|NCT01951638|467489582|FG001|Follow-up Period|Lost to Follow-up|1|||
129872198|NCT01951638|467489583|FG002|Follow-up Period|Lost to Follow-up|0|||
129872199|NCT01951638|467489584|FG003|Follow-up Period|Lost to Follow-up|1|||
129872200|NCT01951638|467489585|FG004|Follow-up Period|Lost to Follow-up|0|||
129872201|NCT01951638|467489581|FG000|Follow-up Period|Death|1|||
129872202|NCT01951638|467489582|FG001|Follow-up Period|Death|0|||
130067533|NCT00426556|468201327|FG002|Phase II - Core Phase|Disease Progression|0|||
130116874|NCT02669264|468387216|FG005|Overall Study|Death|6|||
129872203|NCT01951638|467489583|FG002|Follow-up Period|Death|1|||
129872204|NCT01951638|467489584|FG003|Follow-up Period|Death|4|||
129872205|NCT01951638|467489585|FG004|Follow-up Period|Death|1|||
129872206|NCT01951638|467489581|FG000|Follow-up Period|Adverse Event|0|||
129872207|NCT01951638|467489582|FG001|Follow-up Period|Adverse Event|1|||
129872208|NCT01951638|467489583|FG002|Follow-up Period|Adverse Event|2|||
129872209|NCT01951638|467489584|FG003|Follow-up Period|Adverse Event|1|||
129872210|NCT01951638|467489585|FG004|Follow-up Period|Adverse Event|1|||
129872211|NCT00552084|467489586|FG000|Overall Study|Adverse Event|2|||
129872212|NCT00552084|467489587|FG001|Overall Study|Adverse Event|3|||
129872213|NCT00552084|467489586|FG000|Overall Study|Withdrawal by Subject|4|||
129872214|NCT00552084|467489587|FG001|Overall Study|Withdrawal by Subject|5|||
129872215|NCT00552084|467489586|FG000|Overall Study|Protocol Violation|1|||
129918897|NCT05592418|467667042|FG001|Overall Study|Lost to Follow-up|3|||
129918898|NCT05592418|467667041|FG000|Overall Study|Withdrawal by Subject|2|||
129918899|NCT05592418|467667042|FG001|Overall Study|Withdrawal by Subject|7|||
129918900|NCT05569252|467667046|FG000|Overall Study|Adverse event (central vision loss)|1|||
129918901|NCT05569252|467667047|FG001|Overall Study|Adverse event (central vision loss)|0|||
129918902|NCT05569252|467667048|FG002|Overall Study|Adverse event (central vision loss)|0|||
129918903|NCT05569252|467667049|FG003|Overall Study|Adverse event (central vision loss)|0|||
129918904|NCT03665597|467667050|FG000|Period 1|Adverse Event|1|||
129918905|NCT03665597|467667051|FG001|Period 1|Adverse Event|0|||
129918906|NCT03665597|467667052|FG002|Period 1|Adverse Event|0|||
129918907|NCT03665597|467667053|FG003|Period 1|Adverse Event|1|||
129918908|NCT03665597|467667054|FG004|Period 1|Adverse Event|0|||
129918909|NCT03665597|467667055|FG005|Period 1|Adverse Event|0|||
129918910|NCT03665597|467667056|FG006|Period 1|Adverse Event|0|||
129918911|NCT03665597|467667050|FG000|Period 1|Screen Failure|0|||
129918912|NCT03665597|467667051|FG001|Period 1|Screen Failure|0|||
129918913|NCT03665597|467667052|FG002|Period 1|Screen Failure|0|||
129918914|NCT03665597|467667053|FG003|Period 1|Screen Failure|1|||
129918915|NCT03665597|467667054|FG004|Period 1|Screen Failure|0|||
129918916|NCT03665597|467667055|FG005|Period 1|Screen Failure|0|||
129918917|NCT03665597|467667056|FG006|Period 1|Screen Failure|0|||
129918918|NCT03665597|467667050|FG000|Period 1|Death|0|||
129918919|NCT03665597|467667051|FG001|Period 1|Death|0|||
129918920|NCT03665597|467667052|FG002|Period 1|Death|0|||
129918921|NCT03665597|467667053|FG003|Period 1|Death|0|||
129918922|NCT03665597|467667054|FG004|Period 1|Death|0|||
129918923|NCT03665597|467667055|FG005|Period 1|Death|0|||
129918924|NCT03665597|467667056|FG006|Period 1|Death|45|||
129918925|NCT03665597|467667050|FG000|Period 1|Withdrawal by Subject|0|||
129918926|NCT03665597|467667051|FG001|Period 1|Withdrawal by Subject|0|||
129918927|NCT03665597|467667052|FG002|Period 1|Withdrawal by Subject|0|||
129918928|NCT03665597|467667053|FG003|Period 1|Withdrawal by Subject|0|||
129918929|NCT03665597|467667054|FG004|Period 1|Withdrawal by Subject|0|||
129918930|NCT03665597|467667055|FG005|Period 1|Withdrawal by Subject|0|||
129918931|NCT03665597|467667056|FG006|Period 1|Withdrawal by Subject|5|||
129918932|NCT03665597|467667050|FG000|Period 2|Adverse Event|0|||
129918933|NCT03665597|467667051|FG001|Period 2|Adverse Event|0|||
129918934|NCT03665597|467667052|FG002|Period 2|Adverse Event|0|||
129918935|NCT03665597|467667053|FG003|Period 2|Adverse Event|0|||
129918936|NCT03665597|467667054|FG004|Period 2|Adverse Event|0|||
129918937|NCT03665597|467667055|FG005|Period 2|Adverse Event|1|||
129918938|NCT03665597|467667056|FG006|Period 2|Adverse Event|0|||
129918939|NCT03665597|467667050|FG000|Period 3|Adverse Event|0|||
130067534|NCT00426556|468201328|FG003|Phase II - Core Phase|Disease Progression|16|||
130067535|NCT00426556|468201325|FG000|Phase II - Core Phase|Adverse Event|0|||
130067536|NCT00426556|468201326|FG001|Phase II - Core Phase|Adverse Event|0|||
129918940|NCT03665597|467667051|FG001|Period 3|Adverse Event|1|||
129918941|NCT03665597|467667052|FG002|Period 3|Adverse Event|0|||
129918942|NCT03665597|467667053|FG003|Period 3|Adverse Event|0|||
129918943|NCT03665597|467667054|FG004|Period 3|Adverse Event|0|||
129918944|NCT03665597|467667055|FG005|Period 3|Adverse Event|0|||
129918945|NCT03665597|467667056|FG006|Period 3|Adverse Event|0|||
129918946|NCT03665597|467667050|FG000|Period 3|Death|0|||
129918947|NCT03665597|467667051|FG001|Period 3|Death|0|||
129918948|NCT03665597|467667052|FG002|Period 3|Death|0|||
129918949|NCT03665597|467667053|FG003|Period 3|Death|0|||
129918950|NCT03665597|467667054|FG004|Period 3|Death|1|||
129918951|NCT03665597|467667055|FG005|Period 3|Death|0|||
129918952|NCT03665597|467667056|FG006|Period 3|Death|0|||
129918953|NCT03665597|467667050|FG000|Period 4|Adverse Event|2|||
129918954|NCT03665597|467667051|FG001|Period 4|Adverse Event|2|||
129918955|NCT03665597|467667052|FG002|Period 4|Adverse Event|2|||
129918956|NCT03665597|467667053|FG003|Period 4|Adverse Event|2|||
129918957|NCT03665597|467667054|FG004|Period 4|Adverse Event|1|||
129918958|NCT03665597|467667055|FG005|Period 4|Adverse Event|0|||
129918959|NCT03665597|467667056|FG006|Period 4|Adverse Event|0|||
129918960|NCT03665597|467667050|FG000|Period 4|Death|0|||
129918961|NCT03665597|467667051|FG001|Period 4|Death|0|||
129918962|NCT03665597|467667052|FG002|Period 4|Death|2|||
129918963|NCT03665597|467667053|FG003|Period 4|Death|0|||
129918964|NCT03665597|467667054|FG004|Period 4|Death|0|||
129918965|NCT03665597|467667055|FG005|Period 4|Death|0|||
129918966|NCT03665597|467667056|FG006|Period 4|Death|0|||
130067537|NCT00426556|468201327|FG002|Phase II - Core Phase|Adverse Event|0|||
129918967|NCT03665597|467667050|FG000|Period 4|Physician Decision|1|||
129918968|NCT03665597|467667051|FG001|Period 4|Physician Decision|2|||
129918969|NCT03665597|467667052|FG002|Period 4|Physician Decision|0|||
129918970|NCT03665597|467667053|FG003|Period 4|Physician Decision|0|||
129918971|NCT03665597|467667054|FG004|Period 4|Physician Decision|0|||
129918972|NCT03665597|467667055|FG005|Period 4|Physician Decision|0|||
129918973|NCT03665597|467667056|FG006|Period 4|Physician Decision|0|||
129918974|NCT04831216|467667057|FG000|Overall Study|Lost to Follow-up|32|||
129918975|NCT03110315|467667064|FG000|Overall Study|Withdrawal by Subject|1|||
129918976|NCT03110315|467667065|FG001|Overall Study|Withdrawal by Subject|0|||
129918977|NCT04727554|467667070|FG000|Overall Study|Lost to Follow-up|0|||
129918978|NCT04727554|467667071|FG001|Overall Study|Lost to Follow-up|1|||
130116875|NCT02669264|468387217|FG006|Overall Study|Death|3|||
130116876|NCT02669264|468387211|FG000|Overall Study|Withdrawal by Subject|0|||
130116877|NCT02669264|468387212|FG001|Overall Study|Withdrawal by Subject|1|||
130116878|NCT02669264|468387213|FG002|Overall Study|Withdrawal by Subject|0|||
130116879|NCT02669264|468387214|FG003|Overall Study|Withdrawal by Subject|0|||
130116880|NCT02669264|468387215|FG004|Overall Study|Withdrawal by Subject|1|||
130116881|NCT02669264|468387216|FG005|Overall Study|Withdrawal by Subject|0|||
130116882|NCT02669264|468387217|FG006|Overall Study|Withdrawal by Subject|0|||
130116883|NCT02669264|468387211|FG000|Overall Study|Lost to Follow-up|0|||
130116884|NCT02669264|468387212|FG001|Overall Study|Lost to Follow-up|0|||
130116885|NCT02669264|468387213|FG002|Overall Study|Lost to Follow-up|0|||
130116886|NCT02669264|468387214|FG003|Overall Study|Lost to Follow-up|0|||
130116887|NCT02669264|468387215|FG004|Overall Study|Lost to Follow-up|1|||
130116888|NCT02669264|468387216|FG005|Overall Study|Lost to Follow-up|0|||
130116889|NCT02669264|468387217|FG006|Overall Study|Lost to Follow-up|0|||
130116890|NCT02669264|468387211|FG000|Overall Study|Miscellaneous|0|||
130116891|NCT02669264|468387212|FG001|Overall Study|Miscellaneous|0|||
130067538|NCT00426556|468201328|FG003|Phase II - Core Phase|Adverse Event|8|||
130067539|NCT00426556|468201325|FG000|Phase II - Extension Phase|Disease Progression|0|||
130067540|NCT00426556|468201326|FG001|Phase II - Extension Phase|Disease Progression|0|||
130067541|NCT00426556|468201327|FG002|Phase II - Extension Phase|Disease Progression|0|||
130067542|NCT00426556|468201328|FG003|Phase II - Extension Phase|Disease Progression|21|||
130067543|NCT00426556|468201325|FG000|Phase II - Extension Phase|Adverse Event|0|||
130067544|NCT00426556|468201326|FG001|Phase II - Extension Phase|Adverse Event|0|||
130067545|NCT00426556|468201327|FG002|Phase II - Extension Phase|Adverse Event|0|||
130067546|NCT00426556|468201328|FG003|Phase II - Extension Phase|Adverse Event|2|||
130067547|NCT03970824|468201329|FG000|Overall Study|Withdrawal by Subject|1|||
130067548|NCT03970824|468201330|FG001|Overall Study|Withdrawal by Subject|1|||
130067549|NCT03970824|468201331|FG002|Overall Study|Withdrawal by Subject|3|||
130067550|NCT03970824|468201329|FG000|Overall Study|Lost to Follow-up|0|||
130067551|NCT03970824|468201330|FG001|Overall Study|Lost to Follow-up|2|||
130067552|NCT03970824|468201331|FG002|Overall Study|Lost to Follow-up|1|||
130067553|NCT03970824|468201329|FG000|Overall Study|Adverse Event|1|||
130067554|NCT03970824|468201330|FG001|Overall Study|Adverse Event|0|||
130067555|NCT03970824|468201331|FG002|Overall Study|Adverse Event|0|||
130067556|NCT01361919|468201338|FG000|Overall Study|technical issues|10|||
130067557|NCT01361919|468201339|FG001|Overall Study|technical issues|12|||
129918979|NCT04727554|467667070|FG000|Overall Study|Death|2|||
129918980|NCT04727554|467667071|FG001|Overall Study|Death|6|||
129918981|NCT04727554|467667070|FG000|Overall Study|Withdrawal by Subject|1|||
129918982|NCT04727554|467667071|FG001|Overall Study|Withdrawal by Subject|0|||
129918983|NCT05371652|467667072|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
129918984|NCT05371652|467667072|FG000|Overall Study|Withdrawal by Subject|12|||
129918985|NCT05371652|467667072|FG000|Overall Study|Adverse Event|1|||
129918986|NCT05371652|467667072|FG000|Overall Study|Other|11|||
129918987|NCT04024813|467668755|FG000|Overall Study|Study terminated by Sponsor|1|||
129918988|NCT02729311|467668756|FG000|Overall Study|Withdrawal by Subject|8|||
129918989|NCT02729311|467668757|FG001|Overall Study|Withdrawal by Subject|2|||
129918990|NCT05034952|467668758|FG000|Overall Study|Adverse Event|1|||
129918991|NCT05034952|467668759|FG001|Overall Study|Adverse Event|0|||
130067558|NCT01361919|468201340|FG002|Overall Study|technical issues|10|||
130067559|NCT01767519|468201344|FG000|Overall Study|Other Reasons|4|||
130067560|NCT01767519|468201345|FG001|Overall Study|Other Reasons|4|||
130067561|NCT01767519|468201346|FG002|Overall Study|Other Reasons|2|||
130067562|NCT01767519|468201344|FG000|Overall Study|Protocol Violation|0|||
130067563|NCT01767519|468201345|FG001|Overall Study|Protocol Violation|3|||
130067564|NCT01767519|468201346|FG002|Overall Study|Protocol Violation|0|||
130067565|NCT01767519|468201344|FG000|Overall Study|Personal Reasons|1|||
130067566|NCT01767519|468201345|FG001|Overall Study|Personal Reasons|0|||
130067567|NCT01767519|468201346|FG002|Overall Study|Personal Reasons|0|||
130067568|NCT01767519|468201344|FG000|Overall Study|Lost to Follow-up|3|||
130067569|NCT01767519|468201345|FG001|Overall Study|Lost to Follow-up|1|||
130067570|NCT01767519|468201346|FG002|Overall Study|Lost to Follow-up|2|||
130116892|NCT02669264|468387213|FG002|Overall Study|Miscellaneous|0|||
130116893|NCT02669264|468387214|FG003|Overall Study|Miscellaneous|0|||
130116894|NCT02669264|468387215|FG004|Overall Study|Miscellaneous|0|||
130116895|NCT02669264|468387216|FG005|Overall Study|Miscellaneous|0|||
130116896|NCT02669264|468387217|FG006|Overall Study|Miscellaneous|2|||
129918992|NCT05034952|467668760|FG002|Overall Study|Adverse Event|0|||
129918993|NCT05034952|467668761|FG003|Overall Study|Adverse Event|0|||
129918994|NCT05034952|467668758|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129918995|NCT05034952|467668759|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129918996|NCT05034952|467668760|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
129918997|NCT05034952|467668761|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
129918998|NCT05034952|467668758|FG000|Overall Study|Lost to Follow-up|1|||
130067571|NCT01767519|468201344|FG000|Overall Study|Lack of Efficacy|1|||
130116897|NCT01688037|468387218|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
130116898|NCT01688037|468387219|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
130067572|NCT01767519|468201345|FG001|Overall Study|Lack of Efficacy|0|||
130067573|NCT01767519|468201346|FG002|Overall Study|Lack of Efficacy|0|||
130067574|NCT01767519|468201344|FG000|Overall Study|Adverse Event|5|||
130067575|NCT01767519|468201345|FG001|Overall Study|Adverse Event|5|||
130067576|NCT01767519|468201346|FG002|Overall Study|Adverse Event|1|||
130067577|NCT00039741|468201347|FG000|Overall Study|Death|0|||
129872216|NCT00552084|467489587|FG001|Overall Study|Protocol Violation|0|||
129872217|NCT00552084|467489586|FG000|Overall Study|change in anti-arrythmic drug|1|||
129872218|NCT00552084|467489587|FG001|Overall Study|change in anti-arrythmic drug|1|||
129872219|NCT02240108|467490690|FG000|Overall Study|Other than specified|8|||
129872220|NCT02240108|467490691|FG001|Overall Study|Other than specified|6|||
129872221|NCT02240108|467490690|FG000|Overall Study|Adverse Event|1|||
129872222|NCT02240108|467490691|FG001|Overall Study|Adverse Event|9|||
129872223|NCT02240108|467490690|FG000|Overall Study|Pregnancy|1|||
129872224|NCT02240108|467490691|FG001|Overall Study|Pregnancy|0|||
129872225|NCT02240108|467490690|FG000|Overall Study|Withdrawal by Subject|4|||
129872226|NCT02240108|467490691|FG001|Overall Study|Withdrawal by Subject|9|||
129872227|NCT02240108|467490690|FG000|Overall Study|StudyTerminated by Sponsor|0|||
129872228|NCT02240108|467490691|FG001|Overall Study|StudyTerminated by Sponsor|1|||
129872229|NCT01345630|467490692|FG000|Overall Study|Adverse Event|22|||
129872230|NCT01345630|467490693|FG001|Overall Study|Adverse Event|23|||
129872231|NCT01345630|467490692|FG000|Overall Study|Lost to Follow-up|17|||
129872232|NCT01345630|467490693|FG001|Overall Study|Lost to Follow-up|16|||
129872233|NCT01345630|467490692|FG000|Overall Study|Protocol Violation|4|||
129872234|NCT01345630|467490693|FG001|Overall Study|Protocol Violation|1|||
129872235|NCT01345630|467490692|FG000|Overall Study|Medication error without associated AE|0|||
129872236|NCT01345630|467490693|FG001|Overall Study|Medication error without associated AE|1|||
129872237|NCT01345630|467490692|FG000|Overall Study|Study terminated by sponsor|254|||
129872238|NCT01345630|467490693|FG001|Overall Study|Study terminated by sponsor|285|||
129872239|NCT01345630|467490692|FG000|Overall Study|Other reasons|6|||
129872240|NCT01345630|467490693|FG001|Overall Study|Other reasons|8|||
129872241|NCT01345630|467490692|FG000|Overall Study|Withdrawn due to pregnancy|1|||
129872242|NCT01345630|467490693|FG001|Overall Study|Withdrawn due to pregnancy|2|||
129872243|NCT01345630|467490692|FG000|Overall Study|No longer willing to participate|9|||
129872244|NCT01345630|467490693|FG001|Overall Study|No longer willing to participate|12|||
129872245|NCT01345630|467490692|FG000|Overall Study|Insufficient clinical response|48|||
129872246|NCT01345630|467490693|FG001|Overall Study|Insufficient clinical response|11|||
129872247|NCT04233372|467490694|FG000|Overall Study|Lost to Follow-up|104|||
129872248|NCT04233372|467490694|FG000|Overall Study|Adverse Event|8|||
129872249|NCT04233372|467490694|FG000|Overall Study|Withdrawal by Subject|2|||
129872250|NCT03938454|467490695|FG000|Overall Study|Protocol Violation|1|||
129872251|NCT03938454|467490695|FG000|Overall Study|Withdrawal by Subject|2|||
129872252|NCT03938454|467490695|FG000|Overall Study|Lost to Follow-up|3|||
129872253|NCT01090310|467490696|FG000|Core Study|Adverse Event|2|||
129872254|NCT01090310|467490697|FG001|Core Study|Adverse Event|2|||
129872255|NCT01090310|467490698|FG002|Core Study|Adverse Event|1|||
129872256|NCT01090310|467490699|FG003|Core Study|Adverse Event|1|||
129872257|NCT01090310|467490696|FG000|Core Study|Subject withdrew consent|0|||
129872258|NCT01090310|467490697|FG001|Core Study|Subject withdrew consent|3|||
129872259|NCT01090310|467490698|FG002|Core Study|Subject withdrew consent|1|||
129872260|NCT01090310|467490699|FG003|Core Study|Subject withdrew consent|1|||
129872261|NCT01090310|467490696|FG000|Core Study|Abnormal test procedure result|0|||
129872262|NCT01090310|467490697|FG001|Core Study|Abnormal test procedure result|0|||
129872263|NCT01090310|467490698|FG002|Core Study|Abnormal test procedure result|1|||
129872264|NCT01090310|467490699|FG003|Core Study|Abnormal test procedure result|0|||
129872265|NCT01090310|467490696|FG000|Core Study|Administrative reasons|5|||
129872266|NCT01090310|467490697|FG001|Core Study|Administrative reasons|6|||
129872267|NCT01090310|467490698|FG002|Core Study|Administrative reasons|4|||
129872268|NCT01090310|467490699|FG003|Core Study|Administrative reasons|4|||
129872269|NCT01090310|467490696|FG000|Core Study|Protocol deviation|1|||
129872270|NCT01090310|467490697|FG001|Core Study|Protocol deviation|0|||
129872271|NCT01090310|467490698|FG002|Core Study|Protocol deviation|0|||
129872272|NCT01090310|467490699|FG003|Core Study|Protocol deviation|1|||
129872273|NCT01090310|467490696|FG000|Extension Study|Aministrative problems|13|||
129918999|NCT05034952|467668759|FG001|Overall Study|Lost to Follow-up|4|||
130067578|NCT00039741|468201348|FG001|Overall Study|Death|1|||
130067579|NCT00039741|468201349|FG002|Overall Study|Death|0|||
129872274|NCT01090310|467490697|FG001|Extension Study|Aministrative problems|15|||
129872275|NCT01090310|467490698|FG002|Extension Study|Aministrative problems|14|||
129872276|NCT01090310|467490699|FG003|Extension Study|Aministrative problems|18|||
129872277|NCT01090310|467490696|FG000|Extension Study|Adverse Event|0|||
129872278|NCT01090310|467490697|FG001|Extension Study|Adverse Event|0|||
129872279|NCT01090310|467490698|FG002|Extension Study|Adverse Event|0|||
129872280|NCT01090310|467490699|FG003|Extension Study|Adverse Event|1|||
129872281|NCT01090310|467490696|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
129872282|NCT01090310|467490697|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
130067580|NCT00039741|468201350|FG003|Overall Study|Death|0|||
130067581|NCT00039741|468201347|FG000|Overall Study|Lost to Follow-up|3|||
130067582|NCT00039741|468201348|FG001|Overall Study|Lost to Follow-up|1|||
130067583|NCT00039741|468201349|FG002|Overall Study|Lost to Follow-up|5|||
130067584|NCT00039741|468201350|FG003|Overall Study|Lost to Follow-up|2|||
130067585|NCT00039741|468201347|FG000|Overall Study|Confounding medical condition|1|||
130067586|NCT00039741|468201348|FG001|Overall Study|Confounding medical condition|0|||
130067587|NCT00039741|468201349|FG002|Overall Study|Confounding medical condition|0|||
130067588|NCT00039741|468201350|FG003|Overall Study|Confounding medical condition|0|||
130067589|NCT00039741|468201347|FG000|Overall Study|Not able to get to clinic|5|||
130067590|NCT00039741|468201348|FG001|Overall Study|Not able to get to clinic|2|||
130067591|NCT00039741|468201349|FG002|Overall Study|Not able to get to clinic|0|||
130067592|NCT00039741|468201350|FG003|Overall Study|Not able to get to clinic|3|||
130067593|NCT00039741|468201347|FG000|Overall Study|Moved|3|||
130067594|NCT00039741|468201348|FG001|Overall Study|Moved|2|||
130067595|NCT00039741|468201349|FG002|Overall Study|Moved|3|||
130067596|NCT00039741|468201350|FG003|Overall Study|Moved|6|||
130067597|NCT00039741|468201347|FG000|Overall Study|Non-compliance with protocol|1|||
130067598|NCT00039741|468201348|FG001|Overall Study|Non-compliance with protocol|0|||
130067599|NCT00039741|468201349|FG002|Overall Study|Non-compliance with protocol|1|||
130067600|NCT00039741|468201350|FG003|Overall Study|Non-compliance with protocol|0|||
130067601|NCT00039741|468201347|FG000|Overall Study|Withdrew consent|0|||
130067602|NCT00039741|468201348|FG001|Overall Study|Withdrew consent|5|||
130067603|NCT00039741|468201349|FG002|Overall Study|Withdrew consent|0|||
130067604|NCT00039741|468201350|FG003|Overall Study|Withdrew consent|1|||
130067605|NCT00039741|468201347|FG000|Overall Study|Missed final visit|2|||
129919000|NCT05034952|467668760|FG002|Overall Study|Lost to Follow-up|3|||
129919001|NCT05034952|467668761|FG003|Overall Study|Lost to Follow-up|3|||
129919002|NCT05034952|467668758|FG000|Overall Study|Other|0|||
129919003|NCT05034952|467668759|FG001|Overall Study|Other|0|||
129919004|NCT05034952|467668760|FG002|Overall Study|Other|0|||
129919005|NCT05034952|467668761|FG003|Overall Study|Other|1|||
129919006|NCT04950660|467668766|FG000|Overall Study|Protocol Violation|4|||
129919007|NCT04950660|467668767|FG001|Overall Study|Protocol Violation|2|||
129919008|NCT04950660|467668766|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
129919009|NCT04950660|467668767|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
129919010|NCT04950660|467668766|FG000|Overall Study|Withdrawal by Subject|0|||
129919011|NCT04950660|467668767|FG001|Overall Study|Withdrawal by Subject|1|||
129919012|NCT04950660|467668766|FG000|Overall Study|Hypotension|1|||
129919013|NCT04950660|467668767|FG001|Overall Study|Hypotension|0|||
129919014|NCT02437318|467668768|FG000|Overall Study|Progressive disease|207|||
129919015|NCT02437318|467668769|FG001|Overall Study|Progressive disease|240|||
129919016|NCT02437318|467668768|FG000|Overall Study|Subject/guardian decision|24|||
129919017|NCT02437318|467668769|FG001|Overall Study|Subject/guardian decision|11|||
129919018|NCT02437318|467668768|FG000|Overall Study|Physician Decision|29|||
129919019|NCT02437318|467668769|FG001|Overall Study|Physician Decision|22|||
129919020|NCT02437318|467668768|FG000|Overall Study|Adverse Event|14|||
129919021|NCT02437318|467668769|FG001|Overall Study|Adverse Event|4|||
129919022|NCT02437318|467668768|FG000|Overall Study|Death|4|||
129919023|NCT02437318|467668769|FG001|Overall Study|Death|4|||
129919024|NCT02437318|467668768|FG000|Overall Study|Protocol deviation|5|||
129919025|NCT02437318|467668769|FG001|Overall Study|Protocol deviation|7|||
129919026|NCT02437318|467668768|FG000|Overall Study|Sponsor decision|1|||
129919027|NCT02437318|467668769|FG001|Overall Study|Sponsor decision|0|||
129919028|NCT00920621|467668771|FG000|Overall Study|Lost to Follow-up|16|||
129919029|NCT00920621|467668772|FG001|Overall Study|Lost to Follow-up|17|||
129919030|NCT00920621|467668773|FG002|Overall Study|Lost to Follow-up|19|||
129919031|NCT00920621|467668774|FG003|Overall Study|Lost to Follow-up|21|||
129919032|NCT00920621|467668771|FG000|Overall Study|Fetal/neonatal deaths|16|||
129919033|NCT00920621|467668772|FG001|Overall Study|Fetal/neonatal deaths|14|||
129919034|NCT00920621|467668773|FG002|Overall Study|Fetal/neonatal deaths|16|||
129919035|NCT00920621|467668774|FG003|Overall Study|Fetal/neonatal deaths|14|||
129919036|NCT00920621|467668771|FG000|Overall Study|Blood sample not collected|22|||
129919037|NCT00920621|467668772|FG001|Overall Study|Blood sample not collected|14|||
129919038|NCT00920621|467668773|FG002|Overall Study|Blood sample not collected|0|||
129919039|NCT00920621|467668774|FG003|Overall Study|Blood sample not collected|0|||
130067606|NCT00039741|468201348|FG001|Overall Study|Missed final visit|1|||
130067607|NCT00039741|468201349|FG002|Overall Study|Missed final visit|2|||
130067608|NCT00039741|468201350|FG003|Overall Study|Missed final visit|2|||
130067609|NCT00946881|468201351|FG000|First Treatment|Withdrawal by Subject|1|||
129919040|NCT04321031|467668777|FG000|Overall Study|Adverse Event|0|||
129919041|NCT04321031|467668778|FG001|Overall Study|Adverse Event|2|||
129919042|NCT04321031|467668779|FG002|Overall Study|Adverse Event|2|||
129919043|NCT04321031|467668780|FG003|Overall Study|Adverse Event|2|||
129919044|NCT04321031|467668781|FG004|Overall Study|Adverse Event|2|||
129919045|NCT04321031|467668782|FG005|Overall Study|Adverse Event|2|||
129919046|NCT04321031|467668783|FG006|Overall Study|Adverse Event|0|||
129919047|NCT04321031|467668777|FG000|Overall Study|Lost to Follow-up|0|||
129919048|NCT04321031|467668778|FG001|Overall Study|Lost to Follow-up|0|||
129919049|NCT04321031|467668779|FG002|Overall Study|Lost to Follow-up|0|||
130067610|NCT00946881|468201351|FG000|First Treatment|Patient relocated to another state|1|||
129872283|NCT01090310|467490698|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
129872284|NCT01090310|467490699|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
129872285|NCT01090310|467490696|FG000|Extension Study|Subject withdrew consent|0|||
129872286|NCT01090310|467490697|FG001|Extension Study|Subject withdrew consent|1|||
129872287|NCT01090310|467490698|FG002|Extension Study|Subject withdrew consent|0|||
129872288|NCT01090310|467490699|FG003|Extension Study|Subject withdrew consent|0|||
129872289|NCT01142388|467490700|FG000|Overall Study|Lack of Efficacy|21|||
129872290|NCT01142388|467490701|FG001|Overall Study|Lack of Efficacy|31|||
129872291|NCT01142388|467490700|FG000|Overall Study|Adverse Event|9|||
129872292|NCT01142388|467490701|FG001|Overall Study|Adverse Event|5|||
129872293|NCT01142388|467490700|FG000|Overall Study|Death|3|||
129872294|NCT01142388|467490701|FG001|Overall Study|Death|2|||
129872295|NCT01142388|467490700|FG000|Overall Study|Withdrawal by Subject|5|||
129872296|NCT01142388|467490701|FG001|Overall Study|Withdrawal by Subject|3|||
129872297|NCT01142388|467490700|FG000|Overall Study|Alternative therapy|1|||
129872298|NCT01142388|467490701|FG001|Overall Study|Alternative therapy|0|||
129872299|NCT01142388|467490700|FG000|Overall Study|Other complications|0|||
129872300|NCT01142388|467490701|FG001|Overall Study|Other complications|2|||
129872301|NCT01142388|467490700|FG000|Overall Study|Other|1|||
129872302|NCT01142388|467490701|FG001|Overall Study|Other|1|||
129872303|NCT01142388|467490700|FG000|Overall Study|Never started therapy|7|||
129872304|NCT01142388|467490701|FG001|Overall Study|Never started therapy|3|||
129872305|NCT00695786|467490702|FG000|Overall Study|Adverse Event|0|||
129872306|NCT00695786|467490703|FG001|Overall Study|Adverse Event|3|||
129872307|NCT00695786|467490704|FG002|Overall Study|Adverse Event|4|||
129872308|NCT00695786|467490705|FG003|Overall Study|Adverse Event|2|||
129872309|NCT00695786|467490702|FG000|Overall Study|Lost to Follow-up|0|||
129872310|NCT00695786|467490703|FG001|Overall Study|Lost to Follow-up|5|||
129872311|NCT00695786|467490704|FG002|Overall Study|Lost to Follow-up|1|||
129872312|NCT00695786|467490705|FG003|Overall Study|Lost to Follow-up|1|||
129872313|NCT00695786|467490702|FG000|Overall Study|Withdrawal by Subject|0|||
129872314|NCT00695786|467490703|FG001|Overall Study|Withdrawal by Subject|4|||
129872315|NCT00695786|467490704|FG002|Overall Study|Withdrawal by Subject|3|||
129872316|NCT00695786|467490705|FG003|Overall Study|Withdrawal by Subject|1|||
129872317|NCT00695786|467490702|FG000|Overall Study|Deemed Ineligible|1|||
129872318|NCT00695786|467490703|FG001|Overall Study|Deemed Ineligible|0|||
129872319|NCT00695786|467490704|FG002|Overall Study|Deemed Ineligible|0|||
129872320|NCT00695786|467490705|FG003|Overall Study|Deemed Ineligible|0|||
129872321|NCT00695786|467490702|FG000|Overall Study|Lack of Efficacy|0|||
129872322|NCT00695786|467490703|FG001|Overall Study|Lack of Efficacy|0|||
129872323|NCT00695786|467490704|FG002|Overall Study|Lack of Efficacy|0|||
129872324|NCT00695786|467490705|FG003|Overall Study|Lack of Efficacy|4|||
129872325|NCT01364922|467490709|FG000|Open-label (OL) Period|Adverse Event|7|||
129872326|NCT01364922|467490710|FG001|Open-label (OL) Period|Adverse Event|0|||
129872327|NCT01364922|467490711|FG002|Open-label (OL) Period|Adverse Event|0|||
129872328|NCT01364922|467490709|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
129872329|NCT01364922|467490710|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
129872330|NCT01364922|467490711|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
129872331|NCT01364922|467490709|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
129872332|NCT01364922|467490710|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
129872333|NCT01364922|467490711|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
129919050|NCT04321031|467668780|FG003|Overall Study|Lost to Follow-up|1|||
129919051|NCT04321031|467668781|FG004|Overall Study|Lost to Follow-up|0|||
129919052|NCT04321031|467668782|FG005|Overall Study|Lost to Follow-up|2|||
129919053|NCT04321031|467668783|FG006|Overall Study|Lost to Follow-up|1|||
129919054|NCT04321031|467668777|FG000|Overall Study|Withdrawal by Subject|2|||
129919055|NCT04321031|467668778|FG001|Overall Study|Withdrawal by Subject|2|||
129919056|NCT04321031|467668779|FG002|Overall Study|Withdrawal by Subject|1|||
129919057|NCT04321031|467668780|FG003|Overall Study|Withdrawal by Subject|3|||
129919058|NCT04321031|467668781|FG004|Overall Study|Withdrawal by Subject|1|||
129919059|NCT04321031|467668782|FG005|Overall Study|Withdrawal by Subject|0|||
129919060|NCT04321031|467668783|FG006|Overall Study|Withdrawal by Subject|1|||
129919061|NCT04321031|467668777|FG000|Overall Study|Non-compliance with study drug|0|||
129872334|NCT01364922|467490709|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
129872335|NCT01364922|467490710|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
129872336|NCT01364922|467490711|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
129872337|NCT01364922|467490709|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
129872338|NCT01364922|467490710|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
129872339|NCT01364922|467490711|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
129872340|NCT01364922|467490709|FG000|Open-label (OL) Period|Other, Unspecified|1|||
129872341|NCT01364922|467490710|FG001|Open-label (OL) Period|Other, Unspecified|0|||
129872342|NCT01364922|467490711|FG002|Open-label (OL) Period|Other, Unspecified|0|||
129872343|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
129872344|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
129872345|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
129919062|NCT04321031|467668778|FG001|Overall Study|Non-compliance with study drug|0|||
129919063|NCT04321031|467668779|FG002|Overall Study|Non-compliance with study drug|0|||
129919064|NCT04321031|467668780|FG003|Overall Study|Non-compliance with study drug|0|||
129919065|NCT04321031|467668781|FG004|Overall Study|Non-compliance with study drug|0|||
129919066|NCT04321031|467668782|FG005|Overall Study|Non-compliance with study drug|1|||
129919067|NCT04321031|467668783|FG006|Overall Study|Non-compliance with study drug|0|||
129919068|NCT04321031|467668777|FG000|Overall Study|Other|0|||
129919069|NCT04321031|467668778|FG001|Overall Study|Other|0|||
129919070|NCT04321031|467668779|FG002|Overall Study|Other|0|||
129919071|NCT04321031|467668780|FG003|Overall Study|Other|1|||
129919072|NCT04321031|467668781|FG004|Overall Study|Other|0|||
129919073|NCT04321031|467668782|FG005|Overall Study|Other|0|||
129919074|NCT04321031|467668783|FG006|Overall Study|Other|0|||
129919075|NCT03143153|467668786|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
129919076|NCT03143153|467668787|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
129919077|NCT03143153|467668788|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
129919078|NCT03143153|467668786|FG000|Pre-Treatment|Participant withdrew consent|0|||
129919079|NCT03143153|467668787|FG001|Pre-Treatment|Participant withdrew consent|1|||
129919080|NCT03143153|467668788|FG002|Pre-Treatment|Participant withdrew consent|12|||
129919081|NCT03143153|467668786|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
129919082|NCT03143153|467668787|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
129919083|NCT03143153|467668788|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
129919084|NCT03143153|467668786|FG000|Pre-Treatment|Other Reasons|1|||
129872346|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
129872347|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
129872348|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
129872349|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Adverse Event|0|||
129872350|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Adverse Event|0|||
129872351|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Adverse Event|1|||
129872352|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
129872353|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
129872354|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
129872355|NCT04244396|467490712|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
129872356|NCT04244396|467490712|FG000|Overall Study|Withdrawal by Subject|2|||
129872357|NCT04244396|467490712|FG000|Overall Study|Study termination|37|||
129872358|NCT01787097|467490713|FG000|Overall Study|Withdrawal by Subject|1|||
129872359|NCT01787097|467490714|FG001|Overall Study|Withdrawal by Subject|0|||
129872360|NCT01787097|467490715|FG002|Overall Study|Withdrawal by Subject|0|||
129872361|NCT01787097|467490716|FG003|Overall Study|Withdrawal by Subject|0|||
129872362|NCT00553501|467490723|FG000|Overall Study|Adverse Event|2|||
129872363|NCT00553501|467490723|FG000|Overall Study|Death|1|||
129872364|NCT00553501|467490723|FG000|Overall Study|Progression|1|||
129872365|NCT02293395|467490724|FG000|Overall Study|Lost to Follow-up|1|||
129872366|NCT02293395|467490725|FG001|Overall Study|Lost to Follow-up|0|||
129872367|NCT02293395|467490724|FG000|Overall Study|Withdrawal by Subject|8|||
129872368|NCT02293395|467490725|FG001|Overall Study|Withdrawal by Subject|7|||
129872369|NCT01464021|467490728|FG000|Overall Study|Withdrawal by Subject|13|||
129872370|NCT01464021|467490728|FG000|Overall Study|Lost to Follow-up|1|||
129872371|NCT01464021|467490728|FG000|Overall Study|Lack of Efficacy|1|||
129872372|NCT01464021|467490728|FG000|Overall Study|various|11|||
129872373|NCT00861614|467490729|FG000|Overall Study|Disease Progression|182|||
129872374|NCT00861614|467490730|FG001|Overall Study|Disease Progression|263|||
129872375|NCT00861614|467490729|FG000|Overall Study|Study Drug Toxicity|79|||
129872376|NCT00861614|467490730|FG001|Overall Study|Study Drug Toxicity|6|||
129872377|NCT00861614|467490729|FG000|Overall Study|Death|32|||
129872378|NCT00861614|467490730|FG001|Overall Study|Death|19|||
129872379|NCT00861614|467490729|FG000|Overall Study|Adverse Event|27|||
129872380|NCT00861614|467490730|FG001|Overall Study|Adverse Event|23|||
129872381|NCT00861614|467490729|FG000|Overall Study|Withdrawal by Subject|34|||
129872382|NCT00861614|467490730|FG001|Overall Study|Withdrawal by Subject|35|||
129872383|NCT00861614|467490729|FG000|Overall Study|Other|17|||
129872384|NCT00861614|467490730|FG001|Overall Study|Other|22|||
129872385|NCT03391765|467490731|FG000|Overall Study|Adverse Event|2|||
129872386|NCT03391765|467490732|FG001|Overall Study|Adverse Event|0|||
129872387|NCT03391765|467490733|FG002|Overall Study|Adverse Event|0|||
129872388|NCT03391765|467490734|FG003|Overall Study|Adverse Event|2|||
130067611|NCT00946881|468201351|FG000|Retreatment|Withdrawal by Subject|1|||
129872389|NCT03391765|467490731|FG000|Overall Study|Withdrew consent|5|||
129872390|NCT03391765|467490732|FG001|Overall Study|Withdrew consent|7|||
129872391|NCT03391765|467490733|FG002|Overall Study|Withdrew consent|2|||
129872392|NCT03391765|467490734|FG003|Overall Study|Withdrew consent|5|||
129872393|NCT03391765|467490731|FG000|Overall Study|Other, not specified|44|||
129872394|NCT03391765|467490732|FG001|Overall Study|Other, not specified|38|||
129919085|NCT03143153|467668787|FG001|Pre-Treatment|Other Reasons|2|||
129919086|NCT03143153|467668788|FG002|Pre-Treatment|Other Reasons|1|||
129872395|NCT03391765|467490733|FG002|Overall Study|Other, not specified|21|||
129872396|NCT03391765|467490734|FG003|Overall Study|Other, not specified|16|||
129872397|NCT00944658|467490735|FG000|Treatment 12 Weeks|Adverse Event|0|||
129919087|NCT03143153|467668786|FG000|Pre-Treatment|Disease Progression|1|||
129872398|NCT00944658|467490736|FG001|Treatment 12 Weeks|Adverse Event|2|||
129872399|NCT01289418|467490740|FG000|Day 8 Survey|email address invalid|283|||
129872400|NCT01289418|467490740|FG000|Day 8 Survey|participants did not complete the survey|1935|||
129872401|NCT01289418|467490740|FG000|Day 29 Survey|email address invalid|283|||
129872402|NCT01289418|467490740|FG000|Day 29 Survey|participants did not complete the survey|2185|||
129872403|NCT02832622|467490746|FG000|Overall Study|MPP not programmed|1259|||
129872404|NCT02832622|467490746|FG000|Overall Study|Withdrawal by Subject|123|||
129872405|NCT02832622|467490746|FG000|Overall Study|Death|119|||
129872406|NCT02832622|467490746|FG000|Overall Study|Unsuccessful CRT implant|93|||
129872407|NCT02832622|467490746|FG000|Overall Study|Lost to Follow-up|45|||
129872408|NCT02832622|467490746|FG000|Overall Study|Patient non-compliance|42|||
129872409|NCT02832622|467490746|FG000|Overall Study|Withdrawal by other reasons|25|||
129872410|NCT02832622|467490746|FG000|Overall Study|System explant|24|||
129872411|NCT02832622|467490746|FG000|Overall Study|Physician Decision|6|||
129872412|NCT02472652|467490747|FG000|Overall Study|Lost to Follow-up|1|||
129872413|NCT00998400|467490752|FG000|Overall Study|Lack of interest/motivation|1|||
129872414|NCT00998400|467490753|FG001|Overall Study|Lack of interest/motivation|2|||
129872415|NCT00998400|467490752|FG000|Overall Study|Logistical problems|1|||
129872416|NCT00998400|467490753|FG001|Overall Study|Logistical problems|0|||
129872417|NCT03185832|467490754|FG000|Overall Study|Death|9|||
129872418|NCT03185832|467490755|FG001|Overall Study|Death|14|||
129872419|NCT03185832|467490756|FG002|Overall Study|Death|9|||
129872420|NCT03185832|467490757|FG003|Overall Study|Death|7|||
129872421|NCT03185832|467490754|FG000|Overall Study|Withdrawn - vital status available|0|||
129872422|NCT03185832|467490755|FG001|Overall Study|Withdrawn - vital status available|1|||
129872423|NCT03185832|467490756|FG002|Overall Study|Withdrawn - vital status available|1|||
129872424|NCT03185832|467490757|FG003|Overall Study|Withdrawn - vital status available|4|||
129872425|NCT01083641|467490758|FG000|Overall Study|Withdrawal by Subject|2|||
129872426|NCT03386032|467490759|FG000|Overall Study|Lack of Efficacy|6|||
129872427|NCT03386032|467490760|FG001|Overall Study|Lack of Efficacy|2|||
129872428|NCT03386032|467490761|FG002|Overall Study|Lack of Efficacy|0|||
129872429|NCT03386032|467490759|FG000|Overall Study|Adverse Event|2|||
129872430|NCT03386032|467490760|FG001|Overall Study|Adverse Event|2|||
129872431|NCT03386032|467490761|FG002|Overall Study|Adverse Event|0|||
129872432|NCT03386032|467490759|FG000|Overall Study|Withdrawal by Subject|1|||
129872433|NCT03386032|467490760|FG001|Overall Study|Withdrawal by Subject|0|||
129872434|NCT03386032|467490761|FG002|Overall Study|Withdrawal by Subject|0|||
129872435|NCT03386032|467490759|FG000|Overall Study|Lost to Follow-up|9|||
129872436|NCT03386032|467490760|FG001|Overall Study|Lost to Follow-up|3|||
129872437|NCT03386032|467490761|FG002|Overall Study|Lost to Follow-up|0|||
129872438|NCT01807156|467490766|FG000|Overall Study|Physician Decision|1|||
129872439|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
129872440|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
129872441|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
129872442|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
129872443|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
129872444|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
129872445|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
129872446|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
129872447|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
129872448|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
129872449|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
129872450|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
129872451|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
129872452|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
129872453|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
129872454|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
129872455|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
129872456|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
129872457|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
129872458|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
129872459|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
129872460|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
129872461|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
129872462|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
129872463|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
129872464|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
129872465|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
129872466|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
129872467|NCT01493687|467490769|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
129872468|NCT01493687|467490770|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
129872469|NCT02364180|467490774|FG000|Overall Study|Screen Fail|1|||
129872470|NCT02323646|467490775|FG000|Treatment Course 1|Adverse Event|1|||
129872471|NCT02323646|467490776|FG001|Treatment Course 1|Adverse Event|0|||
129872472|NCT02323646|467490777|FG002|Treatment Course 1|Adverse Event|1|||
129872473|NCT02323646|467490775|FG000|Treatment Course 1|Heavy Bleeding|1|||
129872474|NCT02323646|467490776|FG001|Treatment Course 1|Heavy Bleeding|1|||
130067612|NCT00293423|468201352|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
130067613|NCT00293423|468201353|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
130067614|NCT00293423|468201352|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
130067615|NCT00293423|468201353|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
130067616|NCT00293423|468201352|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
130067617|NCT00293423|468201353|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
130067618|NCT00293423|468201352|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
130067619|NCT00293423|468201353|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
130067620|NCT00293423|468201352|FG000|Surgical Resection|processing error during surgical resection|1|||
130067621|NCT00293423|468201353|FG001|Surgical Resection|processing error during surgical resection|0|||
130067622|NCT00293423|468201352|FG000|Surgical Resection|Withdrawal by Subject|4|||
130067623|NCT00293423|468201353|FG001|Surgical Resection|Withdrawal by Subject|0|||
130067624|NCT00293423|468201352|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
130067625|NCT00293423|468201353|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
130067626|NCT00507416|468201354|FG000|Overall Study|Adverse Event|58|||
130067627|NCT00507416|468201355|FG001|Overall Study|Adverse Event|67|||
130067628|NCT00507416|468201356|FG002|Overall Study|Adverse Event|65|||
130067629|NCT00507416|468201354|FG000|Overall Study|Protocol Violation|1|||
130067630|NCT00507416|468201355|FG001|Overall Study|Protocol Violation|2|||
130067631|NCT00507416|468201356|FG002|Overall Study|Protocol Violation|0|||
130067632|NCT00507416|468201354|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
130067633|NCT00507416|468201355|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
130067634|NCT00507416|468201356|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
130067635|NCT00507416|468201354|FG000|Overall Study|Progressive Disease|20|||
130067636|NCT00507416|468201355|FG001|Overall Study|Progressive Disease|10|||
130067637|NCT00507416|468201356|FG002|Overall Study|Progressive Disease|13|||
130067638|NCT00507416|468201354|FG000|Overall Study|Patient declined further treatment|18|||
130067639|NCT00507416|468201355|FG001|Overall Study|Patient declined further treatment|14|||
130067640|NCT00507416|468201356|FG002|Overall Study|Patient declined further treatment|11|||
130067641|NCT00507416|468201354|FG000|Overall Study|Other|11|||
129872475|NCT02323646|467490777|FG002|Treatment Course 1|Heavy Bleeding|0|||
129872476|NCT02323646|467490775|FG000|Treatment Course 1|Lost to Follow-up|1|||
129872477|NCT02323646|467490776|FG001|Treatment Course 1|Lost to Follow-up|0|||
129872478|NCT02323646|467490777|FG002|Treatment Course 1|Lost to Follow-up|2|||
129872479|NCT02323646|467490775|FG000|Treatment Course 1|Withdrawal by Subject|0|||
129872480|NCT02323646|467490776|FG001|Treatment Course 1|Withdrawal by Subject|2|||
129872481|NCT02323646|467490777|FG002|Treatment Course 1|Withdrawal by Subject|0|||
129872482|NCT02323646|467490775|FG000|Treatment Course 2|Adverse Event|1|||
129872483|NCT02323646|467490776|FG001|Treatment Course 2|Adverse Event|0|||
129872484|NCT02323646|467490777|FG002|Treatment Course 2|Adverse Event|1|||
129872485|NCT02323646|467490775|FG000|Treatment Course 2|Lost to Follow-up|0|||
129872486|NCT02323646|467490776|FG001|Treatment Course 2|Lost to Follow-up|0|||
129872487|NCT02323646|467490777|FG002|Treatment Course 2|Lost to Follow-up|1|||
129872488|NCT02323646|467490775|FG000|Treatment Course 2|Non-compliance|0|||
129872489|NCT02323646|467490776|FG001|Treatment Course 2|Non-compliance|1|||
129872490|NCT02323646|467490777|FG002|Treatment Course 2|Non-compliance|1|||
129872491|NCT00521144|467490778|FG000|Overall Study|Not Treated|0|||
129872492|NCT00521144|467490779|FG001|Overall Study|Not Treated|0|||
129872493|NCT00521144|467490780|FG002|Overall Study|Not Treated|0|||
129872494|NCT00521144|467490781|FG003|Overall Study|Not Treated|1|||
129872495|NCT00521144|467490782|FG004|Overall Study|Not Treated|0|||
129872496|NCT00521144|467490778|FG000|Overall Study|Adverse Event|0|||
129872497|NCT00521144|467490779|FG001|Overall Study|Adverse Event|1|||
129872498|NCT00521144|467490780|FG002|Overall Study|Adverse Event|0|||
129872499|NCT00521144|467490781|FG003|Overall Study|Adverse Event|0|||
129872500|NCT00521144|467490782|FG004|Overall Study|Adverse Event|1|||
129872501|NCT00521144|467490778|FG000|Overall Study|Progressive Disease|4|||
129872502|NCT00521144|467490779|FG001|Overall Study|Progressive Disease|2|||
129872503|NCT00521144|467490780|FG002|Overall Study|Progressive Disease|2|||
129872504|NCT00521144|467490781|FG003|Overall Study|Progressive Disease|0|||
129872505|NCT00521144|467490782|FG004|Overall Study|Progressive Disease|6|||
129872506|NCT01370525|467490783|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
129872507|NCT01370525|467490784|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
129872508|NCT01370525|467490783|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129872509|NCT01370525|467490784|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129872510|NCT01370525|467490783|FG000|Overall Study|Adverse Event|0|||
129872511|NCT01370525|467490784|FG001|Overall Study|Adverse Event|1|||
129872512|NCT01370525|467490783|FG000|Overall Study|Protocol Violation|2|||
129872513|NCT01370525|467490784|FG001|Overall Study|Protocol Violation|1|||
129872514|NCT01370525|467490783|FG000|Overall Study|Lost to follow up|2|||
130067642|NCT00507416|468201355|FG001|Overall Study|Other|16|||
130067643|NCT00507416|468201356|FG002|Overall Study|Other|13|||
130067644|NCT00507416|468201354|FG000|Overall Study|Did not Receive Study Treatment|3|||
130067645|NCT00507416|468201355|FG001|Overall Study|Did not Receive Study Treatment|9|||
130067646|NCT00507416|468201356|FG002|Overall Study|Did not Receive Study Treatment|4|||
130067647|NCT02157506|468201359|FG000|Overall Study|Adverse Event|0|||
130067648|NCT02157506|468201360|FG001|Overall Study|Adverse Event|1|||
130067649|NCT02157506|468201361|FG002|Overall Study|Adverse Event|0|||
130067650|NCT02157506|468201362|FG003|Overall Study|Adverse Event|0|||
130067651|NCT02157506|468201363|FG004|Overall Study|Adverse Event|0|||
130067652|NCT02157506|468201359|FG000|Overall Study|Lost to Follow-up|0|||
130067653|NCT02157506|468201360|FG001|Overall Study|Lost to Follow-up|0|||
130067654|NCT02157506|468201361|FG002|Overall Study|Lost to Follow-up|1|||
130067655|NCT02157506|468201362|FG003|Overall Study|Lost to Follow-up|0|||
130067656|NCT02157506|468201363|FG004|Overall Study|Lost to Follow-up|0|||
130067657|NCT03101514|468201364|FG000|Overall Study|Withdrawal by Subject|4|||
130067658|NCT03101514|468201364|FG000|Overall Study|Protocol Violation|2|||
130067659|NCT03101514|468201364|FG000|Overall Study|patient's information was incomplete|1|||
130067660|NCT03498287|468201374|FG000|Overall Study|Withdrawal by Subject|3|||
130067661|NCT03498287|468201375|FG001|Overall Study|Withdrawal by Subject|0|||
130067662|NCT03498287|468201374|FG000|Overall Study|Protocol Violation|0|||
130067663|NCT03498287|468201375|FG001|Overall Study|Protocol Violation|4|||
130067664|NCT03498287|468201374|FG000|Overall Study|Adverse Event|0|||
130067665|NCT03498287|468201375|FG001|Overall Study|Adverse Event|1|||
130067666|NCT01374217|468201378|FG000|Overall Study|Lack of Efficacy|13|||
130067667|NCT01740388|468201379|FG000|Overall Study|Withdrawal by Subject|1|||
130067668|NCT01740388|468201380|FG001|Overall Study|Withdrawal by Subject|2|||
130067669|NCT01740388|468201379|FG000|Overall Study|Lost to Follow-up|2|||
130067670|NCT01740388|468201380|FG001|Overall Study|Lost to Follow-up|0|||
130067671|NCT01740388|468201379|FG000|Overall Study|Physician Decision|2|||
130067672|NCT01740388|468201380|FG001|Overall Study|Physician Decision|6|||
130067673|NCT01740388|468201379|FG000|Overall Study|Subjects missing data, completed|41|||
130067674|NCT01740388|468201380|FG001|Overall Study|Subjects missing data, completed|36|||
130067675|NCT01117012|468201381|FG000|Overall Study|Adverse Event|0|||
130067676|NCT01117012|468201382|FG001|Overall Study|Adverse Event|1|||
130067677|NCT01117012|468201381|FG000|Overall Study|Death|1|||
130067678|NCT01117012|468201382|FG001|Overall Study|Death|1|||
130067679|NCT01117012|468201381|FG000|Overall Study|Withdrawal by Subject|3|||
130067680|NCT01117012|468201382|FG001|Overall Study|Withdrawal by Subject|0|||
130067681|NCT01117012|468201381|FG000|Overall Study|Undefined|4|||
130067682|NCT01117012|468201382|FG001|Overall Study|Undefined|3|||
130067683|NCT03695393|468201385|FG000|Overall Study|Death|3|||
130067684|NCT03695393|468201386|FG001|Overall Study|Death|1|||
130067685|NCT03695393|468201385|FG000|Overall Study|Lost to Follow-up|0|||
130067686|NCT03695393|468201386|FG001|Overall Study|Lost to Follow-up|1|||
130067687|NCT00673894|468201387|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
130067688|NCT00673894|468201388|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
130067689|NCT00673894|468201387|FG000|First Intervention 4 Weeks|Adverse Event|1|||
130067690|NCT00673894|468201388|FG001|First Intervention 4 Weeks|Adverse Event|0|||
130067691|NCT01641991|468201389|FG000|Overall Study|Physician Decision|0|||
130067692|NCT01641991|468201390|FG001|Overall Study|Physician Decision|1|||
130067693|NCT01641991|468201391|FG002|Overall Study|Physician Decision|7|||
130067694|NCT01641991|468201392|FG003|Overall Study|Physician Decision|5|||
130067695|NCT01641991|468201389|FG000|Overall Study|Withdrawal by Subject|4|||
130067696|NCT01641991|468201390|FG001|Overall Study|Withdrawal by Subject|2|||
129872515|NCT01370525|467490784|FG001|Overall Study|Lost to follow up|6|||
129872516|NCT02940574|467490791|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
129872517|NCT02940574|467490792|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
129872518|NCT02940574|467490791|FG000|1-year Follow-up|Lost to Follow-up|3|||
129872519|NCT02940574|467490792|FG001|1-year Follow-up|Lost to Follow-up|4|||
129872520|NCT00387894|467490793|FG000|Overall Study|Withdrawal by Subject|1|||
129872521|NCT02421666|467490796|FG000|6-month Follow-up|Lost to Follow-up|8|||
129872522|NCT02421666|467490797|FG001|6-month Follow-up|Lost to Follow-up|7|||
129872523|NCT02421666|467490796|FG000|6-month Follow-up|Withdrawal by Subject|5|||
129872524|NCT02421666|467490797|FG001|6-month Follow-up|Withdrawal by Subject|6|||
129872525|NCT02421666|467490796|FG000|12-month Follow-up|Lost to Follow-up|5|||
129872526|NCT02421666|467490797|FG001|12-month Follow-up|Lost to Follow-up|5|||
130067697|NCT01641991|468201391|FG002|Overall Study|Withdrawal by Subject|1|||
130067698|NCT01641991|468201392|FG003|Overall Study|Withdrawal by Subject|5|||
130067699|NCT01641991|468201389|FG000|Overall Study|Adverse Event|2|||
130067700|NCT01641991|468201390|FG001|Overall Study|Adverse Event|1|||
130067701|NCT01641991|468201391|FG002|Overall Study|Adverse Event|2|||
130067702|NCT01641991|468201392|FG003|Overall Study|Adverse Event|1|||
130067703|NCT01641991|468201389|FG000|Overall Study|Lost to Follow-up|0|||
130067704|NCT01641991|468201390|FG001|Overall Study|Lost to Follow-up|2|||
130067705|NCT01641991|468201391|FG002|Overall Study|Lost to Follow-up|3|||
130067706|NCT01641991|468201392|FG003|Overall Study|Lost to Follow-up|1|||
130067707|NCT01641991|468201389|FG000|Overall Study|Protocol Violation|1|||
130116899|NCT01688037|468387220|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
129872527|NCT02421666|467490796|FG000|12-month Follow-up|Withdrawal by Subject|6|||
129872528|NCT02421666|467490797|FG001|12-month Follow-up|Withdrawal by Subject|11|||
129872529|NCT01119768|467490802|FG000|Treatment Period|Lack of Efficacy|18|||
129872530|NCT01119768|467490803|FG001|Treatment Period|Lack of Efficacy|25|||
129872531|NCT01059643|467490804|FG000|Overall Study|Adverse Event|3|||
129872532|NCT01059643|467490804|FG000|Overall Study|Withdrawal by Subject|2|||
129872533|NCT01059643|467490804|FG000|Overall Study|Physician Decision|1|||
129872534|NCT00689026|467490822|FG000|Overall Study|Withdrawal by Subject|13|||
129872535|NCT00689026|467490823|FG001|Overall Study|Withdrawal by Subject|6|||
129872536|NCT00459342|467490824|FG000|Overall Study|Not eligible|1|||
129872537|NCT02686034|467490825|FG000|Run-In Period 1|Eligibility|12|||
129872538|NCT02686034|467490826|FG001|Run-In Period 1|Eligibility|10|||
129872539|NCT02686034|467490825|FG000|Run-In Period 1|Withdrawal by Subject|4|||
129872540|NCT02686034|467490826|FG001|Run-In Period 1|Withdrawal by Subject|3|||
129872541|NCT02686034|467490825|FG000|Run-In Period 1|Lost to Follow-up|4|||
129872542|NCT02686034|467490826|FG001|Run-In Period 1|Lost to Follow-up|4|||
129872543|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
129872544|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
129872545|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
129872546|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
129872547|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Adverse Event|0|||
129872548|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Adverse Event|2|||
129872549|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
129872550|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
129872551|NCT02686034|467490825|FG000|Open Label Period 3|Lost to Follow-up|0|||
129872552|NCT02686034|467490826|FG001|Open Label Period 3|Lost to Follow-up|1|||
129872553|NCT03017079|467490827|FG000|Overall Study|Physician Decision|1|||
129872554|NCT03017079|467490828|FG001|Overall Study|Physician Decision|1|||
129872555|NCT03017079|467490827|FG000|Overall Study|Death|3|||
129872556|NCT03017079|467490828|FG001|Overall Study|Death|2|||
129872557|NCT03017079|467490827|FG000|Overall Study|Lack of Efficacy|2|||
129872558|NCT03017079|467490828|FG001|Overall Study|Lack of Efficacy|2|||
129872559|NCT03017079|467490827|FG000|Overall Study|Protocol Violation|0|||
129872560|NCT03017079|467490828|FG001|Overall Study|Protocol Violation|1|||
129872561|NCT00643123|467491873|FG000|Overall Study|Lost to Follow-up|4|||
129872562|NCT00643123|467491874|FG001|Overall Study|Lost to Follow-up|0|||
129872563|NCT00643123|467491873|FG000|Overall Study|Withdrawal by Subject|1|||
129872564|NCT00643123|467491874|FG001|Overall Study|Withdrawal by Subject|1|||
129872565|NCT02923739|467491875|FG000|Overall Study|Withdrawal by Subject|2|||
129872566|NCT02923739|467491876|FG001|Overall Study|Withdrawal by Subject|0|||
129872567|NCT02923739|467491877|FG002|Overall Study|Withdrawal by Subject|0|||
129872568|NCT02923739|467491878|FG003|Overall Study|Withdrawal by Subject|0|||
129872569|NCT02923739|467491875|FG000|Overall Study|Failed Screening|3|||
129872570|NCT02923739|467491876|FG001|Overall Study|Failed Screening|0|||
129872571|NCT02923739|467491877|FG002|Overall Study|Failed Screening|0|||
129872572|NCT02923739|467491878|FG003|Overall Study|Failed Screening|0|||
129872573|NCT01591382|467491883|FG000|Overall Study|Discharged Prior to Study Completion|2|||
129872574|NCT01591382|467491884|FG001|Overall Study|Discharged Prior to Study Completion|1|||
129872575|NCT01591382|467491883|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
129872576|NCT01591382|467491884|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
129872577|NCT00855062|467491892|FG000|Step1|Early Study Closure|5|||
129872578|NCT00855062|467491893|FG001|Step1|Early Study Closure|7|||
129872579|NCT00855062|467491892|FG000|Step1|Adverse Event|1|||
129872580|NCT00855062|467491893|FG001|Step1|Adverse Event|1|||
129872581|NCT00855062|467491892|FG000|Step1|Protocol Violation|1|||
129872582|NCT00855062|467491893|FG001|Step1|Protocol Violation|0|||
129872583|NCT00855062|467491892|FG000|Step1|Pregnancy|1|||
129872584|NCT00855062|467491893|FG001|Step1|Pregnancy|0|||
129872585|NCT00855062|467491892|FG000|Step1|Withdrawal by Subject|2|||
129872586|NCT00855062|467491893|FG001|Step1|Withdrawal by Subject|3|||
129872587|NCT00855062|467491892|FG000|Step2|Early Study Closure|6|||
129872588|NCT00855062|467491893|FG001|Step2|Early Study Closure|2|||
129872589|NCT00855062|467491892|FG000|Step2|Adverse Event|0|||
129872590|NCT00855062|467491893|FG001|Step2|Adverse Event|3|||
129872591|NCT00855062|467491892|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
129872592|NCT00855062|467491893|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
129872593|NCT01960725|467491896|FG000|Overall Study|Lost to Follow-up|4|||
129872594|NCT01960725|467491897|FG001|Overall Study|Lost to Follow-up|3|||
129872595|NCT01960725|467491896|FG000|Overall Study|Withdrawal by Subject|1|||
129872596|NCT01960725|467491897|FG001|Overall Study|Withdrawal by Subject|0|||
129872597|NCT01960725|467491896|FG000|Overall Study|unable to obtain blood sample|1|||
129872598|NCT01960725|467491897|FG001|Overall Study|unable to obtain blood sample|2|||
129872599|NCT02110901|467491898|FG000|Overall Study|Death|6|||
129872600|NCT02110901|467491899|FG001|Overall Study|Death|3|||
129872601|NCT02110901|467491898|FG000|Overall Study|Lost to Follow-up|12|||
129872602|NCT02110901|467491899|FG001|Overall Study|Lost to Follow-up|8|||
129872603|NCT02110901|467491898|FG000|Overall Study|Withdrawal by Subject|7|||
129872604|NCT02110901|467491899|FG001|Overall Study|Withdrawal by Subject|3|||
129872605|NCT02110901|467491898|FG000|Overall Study|received a kidney transplant|5|||
129872606|NCT02110901|467491899|FG001|Overall Study|received a kidney transplant|0|||
129872607|NCT02634788|467491900|FG000|Overall Study|Adverse Event|0|||
129872608|NCT02634788|467491901|FG001|Overall Study|Adverse Event|8|||
129872609|NCT02634788|467491902|FG002|Overall Study|Adverse Event|3|||
129872610|NCT02634788|467491903|FG003|Overall Study|Adverse Event|1|||
129872611|NCT02634788|467491900|FG000|Overall Study|Lack of Efficacy|4|||
129872612|NCT02634788|467491901|FG001|Overall Study|Lack of Efficacy|0|||
129872613|NCT02634788|467491902|FG002|Overall Study|Lack of Efficacy|1|||
129872614|NCT02634788|467491903|FG003|Overall Study|Lack of Efficacy|4|||
129872615|NCT02634788|467491900|FG000|Overall Study|Lost to Follow-up|0|||
129872616|NCT02634788|467491901|FG001|Overall Study|Lost to Follow-up|1|||
129872617|NCT02634788|467491902|FG002|Overall Study|Lost to Follow-up|0|||
129872618|NCT02634788|467491903|FG003|Overall Study|Lost to Follow-up|0|||
129872619|NCT02634788|467491900|FG000|Overall Study|Withdrawal by Subject|0|||
129872620|NCT02634788|467491901|FG001|Overall Study|Withdrawal by Subject|1|||
129872621|NCT02634788|467491902|FG002|Overall Study|Withdrawal by Subject|1|||
129872622|NCT02634788|467491903|FG003|Overall Study|Withdrawal by Subject|0|||
129872623|NCT00758459|467491904|FG000|Overall Study|Adverse Event|3|||
129872624|NCT00758459|467491905|FG001|Overall Study|Adverse Event|2|||
129872625|NCT00758459|467491904|FG000|Overall Study|Protocol Violation|0|||
129872626|NCT00758459|467491905|FG001|Overall Study|Protocol Violation|1|||
129872627|NCT00758459|467491904|FG000|Overall Study|Withdrawal by Subject|0|||
129872628|NCT00758459|467491905|FG001|Overall Study|Withdrawal by Subject|1|||
129872629|NCT02496767|467491920|FG000|Open-label Lead-in Phase|Adverse Event|176|||
129872630|NCT02496767|467491921|FG001|Open-label Lead-in Phase|Adverse Event|0|||
129872631|NCT02496767|467491922|FG002|Open-label Lead-in Phase|Adverse Event|0|||
129872632|NCT02496767|467491923|FG003|Open-label Lead-in Phase|Adverse Event|0|||
129872633|NCT02496767|467491924|FG004|Open-label Lead-in Phase|Adverse Event|0|||
129872634|NCT02496767|467491925|FG005|Open-label Lead-in Phase|Adverse Event|0|||
129872635|NCT02496767|467491926|FG006|Open-label Lead-in Phase|Adverse Event|0|||
129872636|NCT02496767|467491927|FG007|Open-label Lead-in Phase|Adverse Event|0|||
129872637|NCT02496767|467491920|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
129872638|NCT02496767|467491921|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
129872639|NCT02496767|467491922|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
129872640|NCT02496767|467491923|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
129872641|NCT02496767|467491924|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
129872642|NCT02496767|467491925|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
129872643|NCT02496767|467491926|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
129872644|NCT02496767|467491927|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
129872645|NCT02496767|467491920|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
129872646|NCT02496767|467491921|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872647|NCT02496767|467491922|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872648|NCT02496767|467491923|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872649|NCT02496767|467491924|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872650|NCT02496767|467491925|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872651|NCT02496767|467491926|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872652|NCT02496767|467491927|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872653|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872654|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
129872655|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
129872656|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
129872657|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
129872658|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872659|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872660|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872661|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872662|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
129872663|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
129872664|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
129872665|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
129872666|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872667|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872668|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872669|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
129872670|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
129872671|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
130067708|NCT01641991|468201390|FG001|Overall Study|Protocol Violation|1|||
130067709|NCT01641991|468201391|FG002|Overall Study|Protocol Violation|3|||
130067710|NCT01641991|468201392|FG003|Overall Study|Protocol Violation|0|||
130067711|NCT01641991|468201389|FG000|Overall Study|Pregnancy|0|||
130067712|NCT01641991|468201390|FG001|Overall Study|Pregnancy|0|||
130067713|NCT01641991|468201391|FG002|Overall Study|Pregnancy|1|||
130067714|NCT01641991|468201392|FG003|Overall Study|Pregnancy|0|||
130067715|NCT01641991|468201389|FG000|Overall Study|no longer eligible|2|||
130067716|NCT01641991|468201390|FG001|Overall Study|no longer eligible|1|||
130067717|NCT01641991|468201391|FG002|Overall Study|no longer eligible|0|||
130067718|NCT01641991|468201392|FG003|Overall Study|no longer eligible|4|||
130067719|NCT00493974|468201393|FG000|Overall Study|Death|1|||
130067720|NCT00493974|468201394|FG001|Overall Study|Death|2|||
130067721|NCT00493974|468201393|FG000|Overall Study|Withdrawal by Subject|8|||
130067722|NCT00493974|468201394|FG001|Overall Study|Withdrawal by Subject|6|||
130067723|NCT00493974|468201393|FG000|Overall Study|Lost to Follow-up|4|||
130067724|NCT00493974|468201394|FG001|Overall Study|Lost to Follow-up|6|||
130067725|NCT02555657|468201395|FG000|Overall Study|Death|274|||
129872672|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
129872673|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
129872674|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
129872675|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
129872676|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
129872677|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
129872678|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
129872679|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
129872680|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
129872681|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
129872682|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
129872683|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
129872684|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
129872685|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872686|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
129872687|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
129872688|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
129872689|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
129872690|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872691|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872692|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872693|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872694|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
129872695|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
129872696|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872697|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872698|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872699|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872700|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872701|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872702|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
129872703|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872704|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
129872705|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
129872706|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872707|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872708|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872709|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872710|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
129872711|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872712|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872713|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872714|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872715|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872716|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872717|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872718|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872719|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
130067726|NCT02555657|468201396|FG001|Overall Study|Death|262|||
130067727|NCT02555657|468201395|FG000|Overall Study|Physician Decision|0|||
130067728|NCT02555657|468201396|FG001|Overall Study|Physician Decision|1|||
130067729|NCT02555657|468201395|FG000|Overall Study|Sponsor Decision|27|||
130067730|NCT02555657|468201396|FG001|Overall Study|Sponsor Decision|15|||
129872720|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872721|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872722|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
129872723|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872724|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
129872725|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872726|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872727|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872728|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872729|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872730|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
129872731|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
130067731|NCT02555657|468201395|FG000|Overall Study|Withdrawal by Subject|11|||
130067732|NCT02555657|468201396|FG001|Overall Study|Withdrawal by Subject|32|||
130067733|NCT02807363|468201397|FG000|Dosing Period|Adverse Event|0|||
130067734|NCT02807363|468201398|FG001|Dosing Period|Adverse Event|1|||
130067735|NCT02807363|468201399|FG002|Dosing Period|Adverse Event|0|||
130067736|NCT02807363|468201400|FG003|Dosing Period|Adverse Event|0|||
130067737|NCT02188719|468201401|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
130067738|NCT02188719|468201402|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
130067739|NCT02188719|468201403|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
130067740|NCT02188719|468201404|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
130067741|NCT00966693|468201405|FG000|Overall Study|Adverse Event|0|||
130067742|NCT00966693|468201406|FG001|Overall Study|Adverse Event|0|||
130067743|NCT00966693|468201407|FG002|Overall Study|Adverse Event|1|||
130067744|NCT00966693|468201408|FG003|Overall Study|Adverse Event|2|||
130067745|NCT00966693|468201405|FG000|Overall Study|Death|0|||
130067746|NCT00966693|468201406|FG001|Overall Study|Death|0|||
130067747|NCT00966693|468201407|FG002|Overall Study|Death|1|||
130067748|NCT00966693|468201408|FG003|Overall Study|Death|0|||
130067749|NCT00966693|468201405|FG000|Overall Study|Withdrawal by Subject|1|||
130067750|NCT00966693|468201406|FG001|Overall Study|Withdrawal by Subject|0|||
130067751|NCT00966693|468201407|FG002|Overall Study|Withdrawal by Subject|0|||
130067752|NCT00966693|468201408|FG003|Overall Study|Withdrawal by Subject|5|||
130067753|NCT00966693|468201405|FG000|Overall Study|Disease Progression|0|||
130067754|NCT00966693|468201406|FG001|Overall Study|Disease Progression|0|||
129872732|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
129872733|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Death|0|||
129872734|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Death|0|||
129872735|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Death|0|||
129872736|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Death|0|||
129872737|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Death|0|||
129872738|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Death|0|||
129872739|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Death|1|||
129872740|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Death|2|||
129872741|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872742|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872743|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872744|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872745|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872746|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
129872747|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
129872748|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
129872749|NCT01281202|467491928|FG000|Overall Study|Adverse Event|2|||
129872750|NCT01281202|467491929|FG001|Overall Study|Adverse Event|0|||
129872751|NCT01281202|467491928|FG000|Overall Study|Withdrawal by Subject|2|||
129872752|NCT01281202|467491929|FG001|Overall Study|Withdrawal by Subject|2|||
129872753|NCT01281202|467491928|FG000|Overall Study|Protocol Violation|11|||
129872754|NCT01281202|467491929|FG001|Overall Study|Protocol Violation|10|||
129872755|NCT01281202|467491928|FG000|Overall Study|Administrative|2|||
129872756|NCT01281202|467491929|FG001|Overall Study|Administrative|8|||
129872757|NCT01281202|467491928|FG000|Overall Study|Lost to Follow-up|11|||
129872758|NCT01281202|467491929|FG001|Overall Study|Lost to Follow-up|13|||
129872759|NCT01281202|467491928|FG000|Overall Study|Incarceration|0|||
129872760|NCT01281202|467491929|FG001|Overall Study|Incarceration|3|||
129872761|NCT02889133|467491933|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
129872762|NCT02889133|467491934|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
129872763|NCT02889133|467491933|FG000|Completed Primary Outcome|Manufacturing error|3|||
129872764|NCT02889133|467491934|FG001|Completed Primary Outcome|Manufacturing error|8|||
129872765|NCT02889133|467491933|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
129872766|NCT02889133|467491934|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
129872767|NCT02889133|467491933|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
130067755|NCT00966693|468201407|FG002|Overall Study|Disease Progression|1|||
130067756|NCT00966693|468201408|FG003|Overall Study|Disease Progression|16|||
130067757|NCT01578785|468201409|FG000|Overall Study|Withdrawal by Subject|0|||
130067758|NCT01578785|468201410|FG001|Overall Study|Withdrawal by Subject|1|||
130067759|NCT01578785|468201409|FG000|Overall Study|Study terminated by sponsor|59|||
130067760|NCT01578785|468201410|FG001|Overall Study|Study terminated by sponsor|118|||
130067761|NCT01164865|468201411|FG000|Overall Study|Lost to Follow-up|2|||
130067762|NCT01164865|468201412|FG001|Overall Study|Lost to Follow-up|1|||
130067763|NCT03371732|468201413|FG000|Overall Study|Withdrawal by Subject|9|||
130116900|NCT01688037|468387218|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
130116901|NCT01688037|468387219|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
130116902|NCT01688037|468387220|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
130116903|NCT01688037|468387218|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
130116904|NCT01688037|468387219|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
130116905|NCT01688037|468387220|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
130116906|NCT01688037|468387218|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130116907|NCT01688037|468387219|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
130116908|NCT01688037|468387220|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
130116909|NCT01688037|468387218|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
130116910|NCT01688037|468387219|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
130116911|NCT01688037|468387220|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
130116912|NCT01688037|468387218|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
130116913|NCT01688037|468387219|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
130116914|NCT01688037|468387220|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
130116915|NCT01688037|468387218|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
130116916|NCT01688037|468387219|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
130116917|NCT01688037|468387220|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
130116918|NCT01688037|468387218|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
130116919|NCT01688037|468387219|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
130116920|NCT01688037|468387220|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
130116921|NCT01688037|468387218|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
130116922|NCT01688037|468387219|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
130116923|NCT01688037|468387220|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
130116924|NCT01688037|468387218|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
130116925|NCT01688037|468387219|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
130116926|NCT01688037|468387220|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
130116927|NCT03035227|468387221|FG000|Overall Study|study stopped due to PI leaving institut|1|||
130116928|NCT03035227|468387222|FG001|Overall Study|study stopped due to PI leaving institut|1|||
130116929|NCT02100956|468387223|FG000|At Least One Week Between Injections|Adverse Event|0|||
130116930|NCT02100956|468387224|FG001|At Least One Week Between Injections|Adverse Event|1|||
130116931|NCT00859469|468387226|FG000|Overall Study|Adverse Event|2|||
130116932|NCT00859469|468387226|FG000|Overall Study|Lack of Efficacy|9|||
130116933|NCT00859469|468387226|FG000|Overall Study|Withdrawal by Subject|1|||
130116934|NCT00859469|468387226|FG000|Overall Study|Death|16|||
130116935|NCT02220907|468387227|FG000|Overall Study|Adverse Event|7|||
130116936|NCT02220907|468387227|FG000|Overall Study|Physician Decision|1|||
130116937|NCT02220907|468387227|FG000|Overall Study|Withdrawal by Subject|2|||
130116938|NCT02220907|468387227|FG000|Overall Study|Conflict with the stopping criteria|1|||
130116939|NCT03111147|468387228|FG000|Overall Study|Lost to Follow-up|2|||
130116940|NCT03111147|468387229|FG001|Overall Study|Lost to Follow-up|5|||
130116941|NCT03111147|468387228|FG000|Overall Study|Withdrawal by Subject|4|||
130116942|NCT03111147|468387229|FG001|Overall Study|Withdrawal by Subject|3|||
130116943|NCT03111147|468387228|FG000|Overall Study|Protocol Violation|2|||
130116944|NCT03111147|468387229|FG001|Overall Study|Protocol Violation|1|||
130116945|NCT03111147|468387228|FG000|Overall Study|Death|1|||
130116946|NCT03111147|468387229|FG001|Overall Study|Death|1|||
130116947|NCT00095199|468387232|FG000|Overall Study|Adverse Event|40|||
130116948|NCT00095199|468387233|FG001|Overall Study|Adverse Event|22|||
130116949|NCT00095199|468387234|FG002|Overall Study|Adverse Event|26|||
130116950|NCT00095199|468387235|FG003|Overall Study|Adverse Event|11|||
130116951|NCT00095199|468387232|FG000|Overall Study|Progressive disease|213|||
130116952|NCT00095199|468387233|FG001|Overall Study|Progressive disease|179|||
130116953|NCT00095199|468387234|FG002|Overall Study|Progressive disease|105|||
129872768|NCT02889133|467491934|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
129872769|NCT02889133|467491933|FG000|Completed Primary Outcome|Protocol Violation|1|||
129872770|NCT02889133|467491934|FG001|Completed Primary Outcome|Protocol Violation|0|||
130116954|NCT00095199|468387235|FG003|Overall Study|Progressive disease|98|||
130116955|NCT00095199|468387232|FG000|Overall Study|Death|10|||
130067764|NCT03371732|468201414|FG001|Overall Study|Withdrawal by Subject|3|||
130067765|NCT03371732|468201413|FG000|Overall Study|Refusal to continue|3|||
130116956|NCT00095199|468387233|FG001|Overall Study|Death|6|||
130116957|NCT00095199|468387234|FG002|Overall Study|Death|11|||
130116958|NCT00095199|468387235|FG003|Overall Study|Death|9|||
130116959|NCT00095199|468387232|FG000|Overall Study|Withdrawal by Subject|21|||
130067766|NCT03371732|468201414|FG001|Overall Study|Refusal to continue|4|||
130067767|NCT02581982|468201417|FG000|Overall Study|Lack of Efficacy|12|||
130067768|NCT02581982|468201417|FG000|Overall Study|Adverse Event|3|||
130067769|NCT02581982|468201417|FG000|Overall Study|Physician Decision|1|||
130067770|NCT00599027|468201418|FG000|Overall Study|Withdrawal by Subject|1|||
130067771|NCT00599027|468201419|FG001|Overall Study|Withdrawal by Subject|1|||
130067772|NCT00599027|468201418|FG000|Overall Study|Adverse Event|0|||
130067773|NCT00599027|468201419|FG001|Overall Study|Adverse Event|1|||
130067774|NCT00599027|468201418|FG000|Overall Study|Treatment Failure|0|||
130067775|NCT00599027|468201419|FG001|Overall Study|Treatment Failure|1|||
130067776|NCT00405821|468201420|FG000|Overall Study|Death|5|||
130067777|NCT00405821|468201421|FG001|Overall Study|Death|7|||
130067778|NCT00405821|468201420|FG000|Overall Study|Lost to Follow-up|7|||
129872771|NCT02889133|467491933|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
129872772|NCT02889133|467491934|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
129872773|NCT02889133|467491933|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
129872774|NCT02889133|467491934|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
129872775|NCT02889133|467491933|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
129872776|NCT02889133|467491934|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
129872777|NCT02889133|467491933|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
129872778|NCT02889133|467491934|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
129872779|NCT02889133|467491933|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
129872780|NCT02889133|467491934|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
129872781|NCT02277990|467491935|FG000|Overall Study|Death|170|||
129872782|NCT02277990|467491936|FG001|Overall Study|Death|188|||
129872783|NCT02277990|467491935|FG000|Overall Study|Withdrawal by Subject|64|||
129872784|NCT02277990|467491936|FG001|Overall Study|Withdrawal by Subject|53|||
129872785|NCT02277990|467491935|FG000|Overall Study|Physician Decision|40|||
129872786|NCT02277990|467491936|FG001|Overall Study|Physician Decision|34|||
129872787|NCT02277990|467491935|FG000|Overall Study|Lost to Follow-up|66|||
129872788|NCT02277990|467491936|FG001|Overall Study|Lost to Follow-up|69|||
129872789|NCT02277990|467491935|FG000|Overall Study|Had other reason|26|||
129872790|NCT02277990|467491936|FG001|Overall Study|Had other reason|32|||
129872791|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
129872792|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
129872793|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
129872794|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
129872795|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
129872796|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
129872797|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
129872798|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
129872799|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
129872800|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
129872801|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
129872802|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
129872803|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
129872804|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
129872805|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
129872806|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
129872807|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
129872808|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
129872809|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
129872810|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
129872811|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
129872812|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
129872813|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
129872814|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
129872815|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
129872816|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
129872817|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
129872818|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
129872819|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
129872820|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
129872821|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
129872822|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
129872823|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
129872824|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
129872825|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
130067779|NCT00405821|468201421|FG001|Overall Study|Lost to Follow-up|7|||
130067780|NCT00405821|468201420|FG000|Overall Study|Protocol Violation|1|||
130067781|NCT00405821|468201421|FG001|Overall Study|Protocol Violation|0|||
129872826|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
129872827|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
129872828|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
129872829|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
129872830|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
129872831|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
129872832|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
129872833|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
129872834|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
129872835|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
129872836|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
129872837|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
129872838|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
129872839|NCT05479604|467491945|FG000|Overall Study|Lost to Follow-up|1|||
129872840|NCT05479604|467491946|FG001|Overall Study|Lost to Follow-up|5|||
129872841|NCT03138733|467491947|FG000|Overall Study|Death|17|||
129872842|NCT03138733|467491948|FG001|Overall Study|Death|18|||
129872843|NCT03138733|467491947|FG000|Overall Study|Withdrawal by Subject|11|||
129872844|NCT03138733|467491948|FG001|Overall Study|Withdrawal by Subject|6|||
129872845|NCT03138733|467491947|FG000|Overall Study|Lost to Follow-up|3|||
129872846|NCT03138733|467491948|FG001|Overall Study|Lost to Follow-up|2|||
129872847|NCT03138733|467491947|FG000|Overall Study|Adverse Event|1|||
129872848|NCT03138733|467491948|FG001|Overall Study|Adverse Event|0|||
129872849|NCT03138733|467491947|FG000|Overall Study|Protocol Violation|1|||
129872850|NCT03138733|467491948|FG001|Overall Study|Protocol Violation|3|||
129872851|NCT03138733|467491947|FG000|Overall Study|Administrative or logistical reason|1|||
129872852|NCT03138733|467491948|FG001|Overall Study|Administrative or logistical reason|0|||
129872853|NCT03138733|467491947|FG000|Overall Study|The patient was transferred to another hospital|1|||
129872854|NCT03138733|467491948|FG001|Overall Study|The patient was transferred to another hospital|0|||
129872855|NCT04252742|467491956|FG000|Overall Study|Decision by sponsor|0|||
129872856|NCT04252742|467491957|FG001|Overall Study|Decision by sponsor|2|||
129872857|NCT04252742|467491956|FG000|Overall Study|Withdrawal by Subject|15|||
129872858|NCT04252742|467491957|FG001|Overall Study|Withdrawal by Subject|9|||
129872859|NCT04252742|467491956|FG000|Overall Study|Lost to Follow-up|0|||
129872860|NCT04252742|467491957|FG001|Overall Study|Lost to Follow-up|1|||
129872861|NCT04270747|467491960|FG000|Through Week 16|Adverse Event|1|||
129872862|NCT04270747|467491961|FG001|Through Week 16|Adverse Event|2|||
129872863|NCT04270747|467491962|FG002|Through Week 16|Adverse Event|0|||
129872864|NCT04270747|467491960|FG000|Through Week 16|Death|0|||
129872865|NCT04270747|467491961|FG001|Through Week 16|Death|2|||
129872866|NCT04270747|467491962|FG002|Through Week 16|Death|0|||
129872867|NCT04270747|467491960|FG000|Through Week 16|Consent Withdrawn|3|||
129872868|NCT04270747|467491961|FG001|Through Week 16|Consent Withdrawn|3|||
129872869|NCT04270747|467491962|FG002|Through Week 16|Consent Withdrawn|0|||
129872870|NCT04270747|467491960|FG000|Through Week 16|Physician Decision|1|||
129872871|NCT04270747|467491961|FG001|Through Week 16|Physician Decision|1|||
129872872|NCT04270747|467491962|FG002|Through Week 16|Physician Decision|0|||
129872873|NCT04270747|467491960|FG000|Through Week 16|Lost to Follow-up|2|||
129872874|NCT04270747|467491961|FG001|Through Week 16|Lost to Follow-up|0|||
129872875|NCT04270747|467491962|FG002|Through Week 16|Lost to Follow-up|0|||
129872876|NCT04270747|467491960|FG000|Through Week 16|Protocol Violation|1|||
129872877|NCT04270747|467491961|FG001|Through Week 16|Protocol Violation|2|||
129872878|NCT04270747|467491962|FG002|Through Week 16|Protocol Violation|0|||
129872879|NCT04270747|467491960|FG000|Through Week 16|Protocol Specified Criteria|6|||
129872880|NCT04270747|467491961|FG001|Through Week 16|Protocol Specified Criteria|7|||
129872881|NCT04270747|467491962|FG002|Through Week 16|Protocol Specified Criteria|0|||
129872882|NCT04270747|467491960|FG000|Through Week 16|Miscellaneous|1|||
129872883|NCT04270747|467491961|FG001|Through Week 16|Miscellaneous|1|||
129872884|NCT04270747|467491962|FG002|Through Week 16|Miscellaneous|0|||
129872885|NCT04270747|467491960|FG000|Post Week 16|Adverse Event|7|||
129872886|NCT04270747|467491961|FG001|Post Week 16|Adverse Event|5|||
129872887|NCT04270747|467491962|FG002|Post Week 16|Adverse Event|1|||
129872888|NCT04270747|467491960|FG000|Post Week 16|Death|2|||
129872889|NCT04270747|467491961|FG001|Post Week 16|Death|0|||
129872890|NCT04270747|467491962|FG002|Post Week 16|Death|2|||
129872891|NCT04270747|467491960|FG000|Post Week 16|Consent Withdrawn|4|||
129872892|NCT04270747|467491961|FG001|Post Week 16|Consent Withdrawn|3|||
129872893|NCT04270747|467491962|FG002|Post Week 16|Consent Withdrawn|6|||
129872894|NCT04270747|467491960|FG000|Post Week 16|Physician Decision|3|||
129872895|NCT04270747|467491961|FG001|Post Week 16|Physician Decision|1|||
129872896|NCT04270747|467491962|FG002|Post Week 16|Physician Decision|1|||
129919088|NCT03143153|467668787|FG001|Pre-Treatment|Disease Progression|1|||
129919089|NCT03143153|467668788|FG002|Pre-Treatment|Disease Progression|2|||
129919090|NCT03143153|467668786|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
129919091|NCT03143153|467668787|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
129919092|NCT03143153|467668788|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
129919093|NCT03143153|467668786|FG000|Treatment|Disease progression|174|||
129919094|NCT03143153|467668787|FG001|Treatment|Disease progression|184|||
129919095|NCT03143153|467668788|FG002|Treatment|Disease progression|193|||
129919096|NCT03143153|467668786|FG000|Treatment|Study drug toxicity|59|||
129919097|NCT03143153|467668787|FG001|Treatment|Study drug toxicity|33|||
129919098|NCT03143153|467668788|FG002|Treatment|Study drug toxicity|40|||
129919099|NCT03143153|467668786|FG000|Treatment|Death|5|||
129919100|NCT03143153|467668787|FG001|Treatment|Death|3|||
129919101|NCT03143153|467668788|FG002|Treatment|Death|4|||
129919102|NCT03143153|467668786|FG000|Treatment|Adverse event unrelated to study drug|19|||
129919103|NCT03143153|467668787|FG001|Treatment|Adverse event unrelated to study drug|28|||
129919104|NCT03143153|467668788|FG002|Treatment|Adverse event unrelated to study drug|12|||
129919105|NCT03143153|467668786|FG000|Treatment|Participant request to discontinue study treatment|13|||
129919106|NCT03143153|467668787|FG001|Treatment|Participant request to discontinue study treatment|15|||
129919107|NCT03143153|467668788|FG002|Treatment|Participant request to discontinue study treatment|20|||
129919108|NCT03143153|467668786|FG000|Treatment|Participant withdrew consent|3|||
129919109|NCT03143153|467668787|FG001|Treatment|Participant withdrew consent|4|||
129919110|NCT03143153|467668788|FG002|Treatment|Participant withdrew consent|12|||
129919111|NCT03143153|467668786|FG000|Treatment|Pregnancy|1|||
129919112|NCT03143153|467668787|FG001|Treatment|Pregnancy|0|||
129919113|NCT03143153|467668788|FG002|Treatment|Pregnancy|0|||
129919114|NCT03143153|467668786|FG000|Treatment|Maximum clinical benefit|1|||
129919115|NCT03143153|467668787|FG001|Treatment|Maximum clinical benefit|3|||
129919116|NCT03143153|467668788|FG002|Treatment|Maximum clinical benefit|4|||
129919117|NCT03143153|467668786|FG000|Treatment|Completed treatment as per Protocol|13|||
129919118|NCT03143153|467668787|FG001|Treatment|Completed treatment as per Protocol|8|||
129919119|NCT03143153|467668788|FG002|Treatment|Completed treatment as per Protocol|0|||
129919120|NCT03143153|467668786|FG000|Treatment|Other reasons|12|||
129919121|NCT03143153|467668787|FG001|Treatment|Other reasons|7|||
129919122|NCT03143153|467668788|FG002|Treatment|Other reasons|15|||
129919123|NCT03143153|467668786|FG000|Treatment|Not reported|1|||
129919124|NCT03143153|467668787|FG001|Treatment|Not reported|0|||
129919125|NCT03143153|467668788|FG002|Treatment|Not reported|0|||
129919126|NCT02312557|467668789|FG000|Overall Study|Survival follow-up|4|||
129919127|NCT04237298|467668790|FG000|Overall Study|Lost to Follow-up|4|||
129919128|NCT04237298|467668791|FG001|Overall Study|Lost to Follow-up|5|||
129919129|NCT02530671|467668792|FG000|Overall Study|Lost to Follow-up|2|||
129919130|NCT02530671|467668793|FG001|Overall Study|Lost to Follow-up|0|||
129919131|NCT02530671|467668792|FG000|Overall Study|Withdrawal by Subject|1|||
129919132|NCT02530671|467668793|FG001|Overall Study|Withdrawal by Subject|0|||
129919133|NCT02736409|467668794|FG000|Overall Study|Withdrawal by Subject|4|||
129919134|NCT02736409|467668795|FG001|Overall Study|Withdrawal by Subject|2|||
129919135|NCT02736409|467668796|FG002|Overall Study|Withdrawal by Subject|17|||
129919136|NCT02736409|467668797|FG003|Overall Study|Withdrawal by Subject|3|||
129919137|NCT02736409|467668794|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129919138|NCT02736409|467668795|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129919139|NCT02736409|467668796|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129919140|NCT02736409|467668797|FG003|Overall Study|Non-Compliance with Study Drug|1|||
129919141|NCT02736409|467668794|FG000|Overall Study|Adverse Event|0|||
129919142|NCT02736409|467668795|FG001|Overall Study|Adverse Event|1|||
129919143|NCT02736409|467668796|FG002|Overall Study|Adverse Event|5|||
129919144|NCT02736409|467668797|FG003|Overall Study|Adverse Event|4|||
129919145|NCT02736409|467668794|FG000|Overall Study|Other|0|||
129919146|NCT02736409|467668795|FG001|Overall Study|Other|0|||
129919147|NCT02736409|467668796|FG002|Overall Study|Other|1|||
129919148|NCT02736409|467668797|FG003|Overall Study|Other|1|||
129919149|NCT02736409|467668794|FG000|Overall Study|Pregnancy|0|||
129919150|NCT02736409|467668795|FG001|Overall Study|Pregnancy|0|||
129919151|NCT02736409|467668796|FG002|Overall Study|Pregnancy|1|||
129919152|NCT02736409|467668797|FG003|Overall Study|Pregnancy|0|||
129919153|NCT02736409|467668794|FG000|Overall Study|Lost to Follow-up|0|||
129919154|NCT02736409|467668795|FG001|Overall Study|Lost to Follow-up|0|||
129919155|NCT02736409|467668796|FG002|Overall Study|Lost to Follow-up|2|||
129919156|NCT02736409|467668797|FG003|Overall Study|Lost to Follow-up|1|||
129919157|NCT02736409|467668794|FG000|Overall Study|Physician Decision|0|||
129919158|NCT02736409|467668795|FG001|Overall Study|Physician Decision|0|||
129919159|NCT02736409|467668796|FG002|Overall Study|Physician Decision|0|||
129919160|NCT02736409|467668797|FG003|Overall Study|Physician Decision|2|||
129919161|NCT01415154|467668798|FG000|Overall Study|Lack of Efficacy|4|||
129919162|NCT01415154|467668799|FG001|Overall Study|Lack of Efficacy|5|||
129919163|NCT01415154|467668798|FG000|Overall Study|Withdrawal by Subject|7|||
129919164|NCT01415154|467668799|FG001|Overall Study|Withdrawal by Subject|8|||
129919165|NCT01415154|467668798|FG000|Overall Study|Lost to Follow-up|1|||
129919166|NCT01415154|467668799|FG001|Overall Study|Lost to Follow-up|4|||
129872897|NCT04270747|467491960|FG000|Post Week 16|Lost to Follow-up|2|||
129872898|NCT04270747|467491961|FG001|Post Week 16|Lost to Follow-up|1|||
129872899|NCT04270747|467491962|FG002|Post Week 16|Lost to Follow-up|0|||
129872900|NCT04270747|467491960|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
129872901|NCT04270747|467491961|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
129872902|NCT04270747|467491962|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
129872903|NCT04270747|467491960|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
129872904|NCT04270747|467491961|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
129872905|NCT04270747|467491962|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
129872906|NCT04270747|467491960|FG000|Post Week 16|Miscellaneous|1|||
129872907|NCT04270747|467491961|FG001|Post Week 16|Miscellaneous|0|||
129872908|NCT04270747|467491962|FG002|Post Week 16|Miscellaneous|1|||
129872909|NCT01784068|467491966|FG000|NTCS Phase|Adverse Event|5|||
129872910|NCT01784068|467491967|FG001|NTCS Phase|Adverse Event|0|||
129872911|NCT01784068|467491966|FG000|NTCS Phase|Physician Decision|2|||
129872912|NCT01784068|467491967|FG001|NTCS Phase|Physician Decision|0|||
129872913|NCT01784068|467491966|FG000|NTCS Phase|Patient/guardian decision|3|||
129872914|NCT01784068|467491967|FG001|NTCS Phase|Patient/guardian decision|0|||
129872915|NCT01784068|467491966|FG000|NTCS Phase|Death|2|||
129872916|NCT01784068|467491967|FG001|NTCS Phase|Death|0|||
129872917|NCT01784068|467491966|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
129872918|NCT01784068|467491967|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
129872919|NCT01784068|467491966|FG000|TFR Phase|Physician Decision|0|||
129872920|NCT01784068|467491967|FG001|TFR Phase|Physician Decision|1|||
129872921|NCT01784068|467491966|FG000|TFR Phase|Patient/guardian decision|0|||
129872922|NCT01784068|467491967|FG001|TFR Phase|Patient/guardian decision|3|||
129872923|NCT01784068|467491966|FG000|TFR Phase|Death|0|||
129872924|NCT01784068|467491967|FG001|TFR Phase|Death|1|||
129872925|NCT01784068|467491966|FG000|TFR Phase|Lack of Efficacy|0|||
129872926|NCT01784068|467491967|FG001|TFR Phase|Lack of Efficacy|88|||
129872927|NCT00946296|467491968|FG000|Overall Study|Physician Decision|3|||
129872928|NCT00946296|467491969|FG001|Overall Study|Physician Decision|0|||
129872929|NCT02068495|467491975|FG000|Overall Study|Case Report Forms Uncollected|60|||
129872930|NCT02068495|467491975|FG000|Overall Study|Protocol Deviation|49|||
129872931|NCT04992546|467491977|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
129872932|NCT04992546|467491977|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
129872933|NCT04992546|467491977|FG000|Open-Label Treatment Period|Adverse Event|3|||
129872934|NCT04992546|467491977|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
129872935|NCT02703922|467491978|FG000|Overall Study|Death|5|||
129872936|NCT02703922|467491979|FG001|Overall Study|Death|8|||
129872937|NCT02703922|467491978|FG000|Overall Study|Lost to Follow-up|10|||
129872938|NCT02703922|467491979|FG001|Overall Study|Lost to Follow-up|10|||
129872939|NCT00394355|467491981|FG000|Overall Study|Adverse Event|10|||
129872940|NCT00394355|467491982|FG001|Overall Study|Adverse Event|6|||
129872941|NCT00394355|467491983|FG002|Overall Study|Adverse Event|7|||
129872942|NCT00394355|467491984|FG003|Overall Study|Adverse Event|8|||
129872943|NCT00394355|467491981|FG000|Overall Study|Did not meet protocol eligibility|1|||
129872944|NCT00394355|467491982|FG001|Overall Study|Did not meet protocol eligibility|5|||
129872945|NCT00394355|467491983|FG002|Overall Study|Did not meet protocol eligibility|4|||
129872946|NCT00394355|467491984|FG003|Overall Study|Did not meet protocol eligibility|2|||
129872947|NCT00394355|467491981|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
129872948|NCT00394355|467491982|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
129872949|NCT00394355|467491983|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
129872950|NCT00394355|467491984|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
129872951|NCT00394355|467491981|FG000|Overall Study|Subject withdrawal - related to drug|1|||
129872952|NCT00394355|467491982|FG001|Overall Study|Subject withdrawal - related to drug|0|||
129872953|NCT00394355|467491983|FG002|Overall Study|Subject withdrawal - related to drug|0|||
129872954|NCT00394355|467491984|FG003|Overall Study|Subject withdrawal - related to drug|0|||
129872955|NCT00394355|467491981|FG000|Overall Study|Lost to Follow-up|7|||
129872956|NCT00394355|467491982|FG001|Overall Study|Lost to Follow-up|5|||
129872957|NCT00394355|467491983|FG002|Overall Study|Lost to Follow-up|4|||
129872958|NCT00394355|467491984|FG003|Overall Study|Lost to Follow-up|3|||
129872959|NCT00394355|467491981|FG000|Overall Study|Noncompliance with protocol|4|||
129872960|NCT00394355|467491982|FG001|Overall Study|Noncompliance with protocol|3|||
129872961|NCT00394355|467491983|FG002|Overall Study|Noncompliance with protocol|10|||
129872962|NCT00394355|467491984|FG003|Overall Study|Noncompliance with protocol|8|||
129872963|NCT00394355|467491981|FG000|Overall Study|Administrative|0|||
129872964|NCT00394355|467491982|FG001|Overall Study|Administrative|1|||
129872965|NCT00394355|467491983|FG002|Overall Study|Administrative|1|||
129872966|NCT00394355|467491984|FG003|Overall Study|Administrative|1|||
129872967|NCT00394355|467491981|FG000|Overall Study|Lack of Efficacy|0|||
129872968|NCT00394355|467491982|FG001|Overall Study|Lack of Efficacy|0|||
129872969|NCT00394355|467491983|FG002|Overall Study|Lack of Efficacy|2|||
129872970|NCT00394355|467491984|FG003|Overall Study|Lack of Efficacy|3|||
129872971|NCT02618616|467491985|FG000|Overall Study|Lack of Efficacy|4|||
130067782|NCT00405821|468201420|FG000|Overall Study|initiated ART|9|||
130067783|NCT00405821|468201421|FG001|Overall Study|initiated ART|8|||
130067784|NCT03479216|468201435|FG000|Overall Study|Withdrawal by Subject|3|||
130067785|NCT03479216|468201436|FG001|Overall Study|Withdrawal by Subject|2|||
129872972|NCT02618616|467491986|FG001|Overall Study|Lack of Efficacy|0|||
129872973|NCT02618616|467491985|FG000|Overall Study|Pregnancy|0|||
129872974|NCT02618616|467491986|FG001|Overall Study|Pregnancy|1|||
129872975|NCT02618616|467491985|FG000|Overall Study|Adverse Event|8|||
129872976|NCT02618616|467491986|FG001|Overall Study|Adverse Event|0|||
129872977|NCT02618616|467491985|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
129872978|NCT02618616|467491986|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
129872979|NCT02618616|467491985|FG000|Overall Study|Consent withdrawn by subject|8|||
129872980|NCT02618616|467491986|FG001|Overall Study|Consent withdrawn by subject|5|||
129872981|NCT02618616|467491985|FG000|Overall Study|Lost to Follow-up|0|||
129872982|NCT02618616|467491986|FG001|Overall Study|Lost to Follow-up|1|||
129872983|NCT04225988|467491989|FG000|Overall Study|Withdrawal by Subject|2|||
129872984|NCT04225988|467491990|FG001|Overall Study|Withdrawal by Subject|0|||
129872985|NCT03538951|467491995|FG000|Overall Study|Withdrawal by Subject|1|||
129872986|NCT03538951|467491996|FG001|Overall Study|Withdrawal by Subject|2|||
129919167|NCT01415154|467668798|FG000|Overall Study|Protocol Violation|0|||
129919168|NCT01415154|467668799|FG001|Overall Study|Protocol Violation|1|||
129919169|NCT01415154|467668798|FG000|Overall Study|Satisfactory Response|0|||
129919170|NCT01415154|467668799|FG001|Overall Study|Satisfactory Response|1|||
129919171|NCT01415154|467668798|FG000|Overall Study|Adverse Event|1|||
129919172|NCT01415154|467668799|FG001|Overall Study|Adverse Event|1|||
129919173|NCT05536440|467668818|FG000|Overall Study|Adverse Event|0|||
129919174|NCT05536440|467668819|FG001|Overall Study|Adverse Event|0|||
129919175|NCT05536440|467668820|FG002|Overall Study|Adverse Event|0|||
129919176|NCT05536440|467668821|FG003|Overall Study|Adverse Event|0|||
129919177|NCT05536440|467668822|FG004|Overall Study|Adverse Event|0|||
129919178|NCT05536440|467668823|FG005|Overall Study|Adverse Event|0|||
129919179|NCT05536440|467668824|FG006|Overall Study|Adverse Event|0|||
129919180|NCT05536440|467668825|FG007|Overall Study|Adverse Event|0|||
129919181|NCT05536440|467668826|FG008|Overall Study|Adverse Event|1|||
129919182|NCT06283173|467668827|FG000|Overall Study|Did not show for first visit|10|||
129919183|NCT06283173|467668827|FG000|Overall Study|Lost to Follow-up|12|||
129919184|NCT06283173|467668827|FG000|Overall Study|Physician Decision|7|||
129919185|NCT03436745|467668836|FG000|Overall Study|Ineligible|0|||
129919186|NCT03436745|467668837|FG001|Overall Study|Ineligible|0|||
129919187|NCT03436745|467668838|FG002|Overall Study|Ineligible|1|||
129919188|NCT03673111|467668842|FG000|Overall Study|Protocol Violation|0|||
129919189|NCT03673111|467668843|FG001|Overall Study|Protocol Violation|0|||
129919190|NCT03673111|467668844|FG002|Overall Study|Protocol Violation|0|||
129919191|NCT03673111|467668845|FG003|Overall Study|Protocol Violation|0|||
129919192|NCT03673111|467668846|FG004|Overall Study|Protocol Violation|0|||
129919193|NCT03673111|467668847|FG005|Overall Study|Protocol Violation|0|||
129919194|NCT03673111|467668848|FG006|Overall Study|Protocol Violation|0|||
129919195|NCT03673111|467668849|FG007|Overall Study|Protocol Violation|0|||
129919196|NCT03673111|467668850|FG008|Overall Study|Protocol Violation|0|||
129919197|NCT03673111|467668851|FG009|Overall Study|Protocol Violation|0|||
129919198|NCT03673111|467668852|FG010|Overall Study|Protocol Violation|1|||
129919199|NCT03673111|467668853|FG011|Overall Study|Protocol Violation|0|||
129919200|NCT03673111|467668854|FG012|Overall Study|Protocol Violation|0|||
129919201|NCT03673111|467668855|FG013|Overall Study|Protocol Violation|0|||
129919202|NCT03673111|467668842|FG000|Overall Study|Adverse Event|1|||
129919203|NCT03673111|467668843|FG001|Overall Study|Adverse Event|0|||
129919204|NCT03673111|467668844|FG002|Overall Study|Adverse Event|0|||
129919205|NCT03673111|467668845|FG003|Overall Study|Adverse Event|0|||
129919206|NCT03673111|467668846|FG004|Overall Study|Adverse Event|0|||
129919207|NCT03673111|467668847|FG005|Overall Study|Adverse Event|0|||
129919208|NCT03673111|467668848|FG006|Overall Study|Adverse Event|0|||
129919209|NCT03673111|467668849|FG007|Overall Study|Adverse Event|0|||
129919210|NCT03673111|467668850|FG008|Overall Study|Adverse Event|0|||
129919211|NCT03673111|467668851|FG009|Overall Study|Adverse Event|0|||
129919212|NCT03673111|467668852|FG010|Overall Study|Adverse Event|0|||
129919213|NCT03673111|467668853|FG011|Overall Study|Adverse Event|0|||
129919214|NCT03673111|467668854|FG012|Overall Study|Adverse Event|0|||
129919215|NCT03673111|467668855|FG013|Overall Study|Adverse Event|0|||
129919216|NCT04485039|467668858|FG000|TPOXX Only|Adverse Event|2|||
129919217|NCT04485039|467668858|FG000|TPOXX Only|Physician Decision|1|||
129919218|NCT04485039|467668858|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
129919219|NCT04485039|467668858|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
129919220|NCT04005716|467668862|FG000|Overall Study|Death|175|||
129919221|NCT04005716|467668863|FG001|Overall Study|Death|196|||
129919222|NCT04005716|467668862|FG000|Overall Study|Withdrawal by Subject|1|||
129919223|NCT04005716|467668863|FG001|Overall Study|Withdrawal by Subject|6|||
129919224|NCT04005716|467668862|FG000|Overall Study|Lost to Follow-up|2|||
130067786|NCT03479216|468201435|FG000|Overall Study|Physician Decision|2|||
129919225|NCT04005716|467668863|FG001|Overall Study|Lost to Follow-up|2|||
129919226|NCT04021602|467668864|FG000|Overall Study|Lost to Follow-up|3|||
129919227|NCT04021602|467668865|FG001|Overall Study|Lost to Follow-up|3|||
129919228|NCT04021602|467668866|FG002|Overall Study|Lost to Follow-up|1|||
129919229|NCT04021602|467668864|FG000|Overall Study|Adverse Event|1|||
129919230|NCT04021602|467668865|FG001|Overall Study|Adverse Event|0|||
129919231|NCT04021602|467668866|FG002|Overall Study|Adverse Event|1|||
129919232|NCT02120456|467668867|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919233|NCT02120456|467668868|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919234|NCT02120456|467668869|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919235|NCT02120456|467668870|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919236|NCT02120456|467668871|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919237|NCT02120456|467668872|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919238|NCT02120456|467668873|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
129919239|NCT02120456|467668874|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919240|NCT02120456|467668875|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919241|NCT02120456|467668867|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919242|NCT02120456|467668868|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919243|NCT02120456|467668869|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919244|NCT02120456|467668870|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919245|NCT02120456|467668871|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919246|NCT02120456|467668872|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919247|NCT02120456|467668873|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
129919248|NCT02120456|467668874|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919249|NCT02120456|467668875|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919250|NCT02120456|467668867|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919251|NCT02120456|467668868|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919252|NCT02120456|467668869|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919253|NCT02120456|467668870|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919254|NCT02120456|467668871|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919255|NCT02120456|467668872|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919256|NCT02120456|467668873|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919257|NCT02120456|467668874|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919258|NCT02120456|467668875|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
129919259|NCT04347161|467668878|FG000|Overall Study|Death|0|||
129919260|NCT04347161|467668879|FG001|Overall Study|Death|2|||
129919261|NCT04347161|467668878|FG000|Overall Study|Withdrawal by Subject|1|||
129919262|NCT04347161|467668879|FG001|Overall Study|Withdrawal by Subject|0|||
129919263|NCT04347161|467668878|FG000|Overall Study|Lost to Follow-up|0|||
129919264|NCT04347161|467668879|FG001|Overall Study|Lost to Follow-up|1|||
129919265|NCT04347161|467668878|FG000|Overall Study|No longer on study medication|1|||
129919266|NCT04347161|467668879|FG001|Overall Study|No longer on study medication|1|||
129919267|NCT04169373|467668880|FG000|Week 1 to Week 14|Adverse Event|1|||
129919268|NCT04169373|467668881|FG001|Week 1 to Week 14|Adverse Event|0|||
129919269|NCT04169373|467668882|FG002|Week 1 to Week 14|Adverse Event|1|||
129919270|NCT04169373|467668883|FG003|Week 1 to Week 14|Adverse Event|2|||
129919271|NCT04169373|467668880|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
129919272|NCT04169373|467668881|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
129919273|NCT04169373|467668882|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
129919274|NCT04169373|467668883|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
129919275|NCT04169373|467668880|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
129919276|NCT04169373|467668881|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
129919277|NCT04169373|467668882|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
129919278|NCT04169373|467668883|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
129919279|NCT04169373|467668880|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
129919280|NCT04169373|467668881|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
129919281|NCT04169373|467668882|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
129919282|NCT04169373|467668883|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
129919283|NCT04169373|467668880|FG000|Week 1 to Week 14|Other|1|||
129919284|NCT04169373|467668881|FG001|Week 1 to Week 14|Other|3|||
129919285|NCT04169373|467668882|FG002|Week 1 to Week 14|Other|3|||
129919286|NCT04169373|467668883|FG003|Week 1 to Week 14|Other|5|||
129919287|NCT04169373|467668880|FG000|Week 14 to Week 52|Adverse Event|1|||
129919288|NCT04169373|467668881|FG001|Week 14 to Week 52|Adverse Event|0|||
129919289|NCT04169373|467668882|FG002|Week 14 to Week 52|Adverse Event|0|||
129919290|NCT04169373|467668883|FG003|Week 14 to Week 52|Adverse Event|1|||
129919291|NCT04169373|467668880|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
129919292|NCT04169373|467668881|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
129919293|NCT04169373|467668882|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
129919294|NCT04169373|467668883|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
129919295|NCT04169373|467668880|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
129919296|NCT04169373|467668881|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
129919297|NCT04169373|467668882|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
129919298|NCT04169373|467668883|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
129919299|NCT04169373|467668880|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
129919300|NCT04169373|467668881|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
129919301|NCT04169373|467668882|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
129919302|NCT04169373|467668883|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
129919303|NCT04169373|467668880|FG000|Week 14 to Week 52|Other|4|||
129919304|NCT04169373|467668881|FG001|Week 14 to Week 52|Other|5|||
129919305|NCT04169373|467668882|FG002|Week 14 to Week 52|Other|4|||
129919306|NCT04169373|467668883|FG003|Week 14 to Week 52|Other|5|||
129919307|NCT04169373|467668880|FG000|Week 14 to Week 52|Ongoing|0|||
129919308|NCT04169373|467668881|FG001|Week 14 to Week 52|Ongoing|1|||
129919309|NCT04169373|467668882|FG002|Week 14 to Week 52|Ongoing|0|||
129919310|NCT04169373|467668883|FG003|Week 14 to Week 52|Ongoing|0|||
129919311|NCT03135548|467668885|FG000|Overall Study|Lost to Follow-up|3|||
129919312|NCT03135548|467668886|FG001|Overall Study|Lost to Follow-up|0|||
129919313|NCT03135548|467668887|FG002|Overall Study|Lost to Follow-up|0|||
129919314|NCT03135548|467668885|FG000|Overall Study|Withdrawal by Subject|2|||
129919315|NCT03135548|467668886|FG001|Overall Study|Withdrawal by Subject|2|||
129919316|NCT03135548|467668887|FG002|Overall Study|Withdrawal by Subject|1|||
129919317|NCT03135548|467668885|FG000|Overall Study|Other than listed|0|||
129919318|NCT03135548|467668886|FG001|Overall Study|Other than listed|2|||
129919319|NCT03135548|467668887|FG002|Overall Study|Other than listed|2|||
129919320|NCT03445988|467668893|FG000|Overall Study|Lost to Follow-up|14|||
129919321|NCT03445988|467668894|FG001|Overall Study|Lost to Follow-up|26|||
129919322|NCT03445988|467668895|FG002|Overall Study|Lost to Follow-up|27|||
129919323|NCT03445988|467668896|FG003|Overall Study|Lost to Follow-up|66|||
129919324|NCT03445988|467668893|FG000|Overall Study|Withdrawal by Subject|7|||
129919325|NCT03445988|467668894|FG001|Overall Study|Withdrawal by Subject|4|||
129919326|NCT03445988|467668895|FG002|Overall Study|Withdrawal by Subject|3|||
129919327|NCT03445988|467668896|FG003|Overall Study|Withdrawal by Subject|5|||
129919328|NCT03445988|467668893|FG000|Overall Study|Death (unrelated to study)|5|||
129919329|NCT03445988|467668894|FG001|Overall Study|Death (unrelated to study)|1|||
129919330|NCT03445988|467668895|FG002|Overall Study|Death (unrelated to study)|2|||
129919331|NCT03445988|467668896|FG003|Overall Study|Death (unrelated to study)|4|||
129919332|NCT03988608|467668897|FG000|Overall Study|Adverse Event|1|||
129919333|NCT03988608|467668897|FG000|Overall Study|Lost to Follow-up|1|||
129919334|NCT03988608|467668897|FG000|Overall Study|Withdrawal by Subject|3|||
129919335|NCT03988608|467668897|FG000|Overall Study|Death|1|||
129919336|NCT02689284|467668904|FG000|Overall Study|Adverse Event|1|||
129919337|NCT02689284|467668905|FG001|Overall Study|Adverse Event|8|||
129919338|NCT02689284|467668904|FG000|Overall Study|Death|0|||
129919339|NCT02689284|467668905|FG001|Overall Study|Death|1|||
129919340|NCT02689284|467668904|FG000|Overall Study|Physician Decision|1|||
129919341|NCT02689284|467668905|FG001|Overall Study|Physician Decision|2|||
129919342|NCT02689284|467668904|FG000|Overall Study|Withdrawal by Subject|0|||
129919343|NCT02689284|467668905|FG001|Overall Study|Withdrawal by Subject|1|||
129919344|NCT02689284|467668904|FG000|Overall Study|progression of cancer|1|||
129919345|NCT02689284|467668905|FG001|Overall Study|progression of cancer|72|||
129919346|NCT02689284|467668904|FG000|Overall Study|decreased heart function|0|||
129919347|NCT02689284|467668905|FG001|Overall Study|decreased heart function|1|||
129919348|NCT02689284|467668904|FG000|Overall Study|concern for anemia|0|||
129919349|NCT02689284|467668905|FG001|Overall Study|concern for anemia|1|||
129919350|NCT02689284|467668904|FG000|Overall Study|no measurable cancer for evaluation|0|||
129919351|NCT02689284|467668905|FG001|Overall Study|no measurable cancer for evaluation|1|||
129919352|NCT03519581|467668908|FG000|Overall Study|Lost to Follow-up|3|||
129919353|NCT03519581|467668909|FG001|Overall Study|Lost to Follow-up|2|||
129919354|NCT03519581|467668908|FG000|Overall Study|Adverse Event|5|||
129919355|NCT03519581|467668909|FG001|Overall Study|Adverse Event|2|||
129919356|NCT03519581|467668908|FG000|Overall Study|Withdrawal by Subject|2|||
129919357|NCT03519581|467668909|FG001|Overall Study|Withdrawal by Subject|0|||
129919358|NCT03519581|467668908|FG000|Overall Study|Change to insurance|2|||
129919359|NCT03519581|467668909|FG001|Overall Study|Change to insurance|1|||
129919360|NCT03519581|467668908|FG000|Overall Study|Other|2|||
129919361|NCT03519581|467668909|FG001|Overall Study|Other|4|||
129919362|NCT01494662|467668911|FG000|Overall Study|Withdrawal by Subject|0|||
129919363|NCT01494662|467668912|FG001|Overall Study|Withdrawal by Subject|0|||
129919364|NCT01494662|467668913|FG002|Overall Study|Withdrawal by Subject|1|||
129919365|NCT01494662|467668914|FG003|Overall Study|Withdrawal by Subject|0|||
129919366|NCT01494662|467668915|FG004|Overall Study|Withdrawal by Subject|0|||
129919367|NCT01494662|467668916|FG005|Overall Study|Withdrawal by Subject|0|||
130067787|NCT03479216|468201436|FG001|Overall Study|Physician Decision|3|||
129919368|NCT01494662|467668917|FG006|Overall Study|Withdrawal by Subject|0|||
129919369|NCT01494662|467668911|FG000|Overall Study|Physician Decision|0|||
129919370|NCT01494662|467668912|FG001|Overall Study|Physician Decision|0|||
129919371|NCT01494662|467668913|FG002|Overall Study|Physician Decision|1|||
129919372|NCT01494662|467668914|FG003|Overall Study|Physician Decision|0|||
129919373|NCT01494662|467668915|FG004|Overall Study|Physician Decision|0|||
129919374|NCT01494662|467668916|FG005|Overall Study|Physician Decision|0|||
129919375|NCT01494662|467668917|FG006|Overall Study|Physician Decision|0|||
129919376|NCT05311384|467668918|FG000|Overall Study|Uncontrolled health conditions|2|||
129919377|NCT05311384|467668918|FG000|Overall Study|Withdrawal by Subject|1|||
129919378|NCT02724631|467668921|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
129919379|NCT04060355|467670278|FG000|Overall Study|Lost to Follow-up|41|||
129919380|NCT01140880|467670279|FG000|Overall Study|Death|0|||
129919381|NCT01140880|467670280|FG001|Overall Study|Death|1|||
129919382|NCT01140880|467670279|FG000|Overall Study|Withdrawal by Subject|6|||
129919383|NCT01140880|467670280|FG001|Overall Study|Withdrawal by Subject|3|||
129919384|NCT01140880|467670279|FG000|Overall Study|Lost to Follow-up|8|||
129919385|NCT01140880|467670280|FG001|Overall Study|Lost to Follow-up|10|||
129919386|NCT01140880|467670279|FG000|Overall Study|Protocol Violation|0|||
129919387|NCT01140880|467670280|FG001|Overall Study|Protocol Violation|30|||
129919388|NCT02992925|467670286|FG000|Cohort 2|Physician Decision|0|||
129919389|NCT02992925|467670287|FG001|Cohort 2|Physician Decision|0|||
129919390|NCT02992925|467670288|FG002|Cohort 2|Physician Decision|1|||
129919391|NCT02992925|467670289|FG003|Cohort 2|Physician Decision|0|||
129919392|NCT02992925|467670286|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
129919393|NCT02992925|467670287|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
129919394|NCT02992925|467670288|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
129919395|NCT02992925|467670289|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
129919396|NCT03779204|467670290|FG000|Overall Study|Lost to Follow-up|2|||
129919397|NCT03779204|467670291|FG001|Overall Study|Lost to Follow-up|0|||
129919398|NCT04150718|467670292|FG000|Overall Study|Withdrawal by Subject|2|||
129919399|NCT04150718|467670293|FG001|Overall Study|Withdrawal by Subject|7|||
129919400|NCT04150718|467670294|FG002|Overall Study|Withdrawal by Subject|1|||
129919401|NCT04150718|467670292|FG000|Overall Study|Lost to Follow-up|1|||
129919402|NCT04150718|467670293|FG001|Overall Study|Lost to Follow-up|2|||
129919403|NCT04150718|467670294|FG002|Overall Study|Lost to Follow-up|0|||
129919404|NCT04150718|467670292|FG000|Overall Study|Ineligible|1|||
129919405|NCT04150718|467670293|FG001|Overall Study|Ineligible|0|||
129919406|NCT04150718|467670294|FG002|Overall Study|Ineligible|10|||
129919407|NCT05633953|467670295|FG000|Overall Study|Adverse Event|7|||
129919408|NCT05633953|467670295|FG000|Overall Study|Death|30|||
129919409|NCT05633953|467670295|FG000|Overall Study|Lost to Follow-up|1|||
129919410|NCT05633953|467670295|FG000|Overall Study|Osilodrostat discontinued|4|||
129919411|NCT05633953|467670295|FG000|Overall Study|Physician Decision|1|||
129919412|NCT05633953|467670295|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
129919413|NCT05633953|467670295|FG000|Overall Study|Progressive disease|2|||
129919414|NCT04034251|467670296|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
129919415|NCT04034251|467670297|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
129919416|NCT04034251|467670298|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
129919417|NCT04783935|467670311|FG000|Overall Study|Withdrawal by Subject|6|||
129919418|NCT04783935|467670311|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
129919419|NCT04783935|467670311|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
129919420|NCT04783935|467670311|FG000|Overall Study|Lost to Follow-up|3|||
129919421|NCT04783935|467670311|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
129919422|NCT05273749|467670315|FG000|Overall Study|Adverse Event|14|||
129919423|NCT05273749|467670316|FG001|Overall Study|Adverse Event|8|||
129919424|NCT05273749|467670315|FG000|Overall Study|Lack of Efficacy|2|||
129919425|NCT05273749|467670316|FG001|Overall Study|Lack of Efficacy|8|||
129919426|NCT05273749|467670315|FG000|Overall Study|Physician Decision|0|||
129919427|NCT05273749|467670316|FG001|Overall Study|Physician Decision|2|||
129919428|NCT05273749|467670315|FG000|Overall Study|Withdrawal by Subject|14|||
129919429|NCT05273749|467670316|FG001|Overall Study|Withdrawal by Subject|16|||
129919430|NCT05273749|467670315|FG000|Overall Study|Lost to Follow-up|10|||
129919431|NCT05273749|467670316|FG001|Overall Study|Lost to Follow-up|10|||
129919432|NCT05273749|467670315|FG000|Overall Study|Pregnancy|1|||
129919433|NCT05273749|467670316|FG001|Overall Study|Pregnancy|0|||
129919434|NCT05273749|467670315|FG000|Overall Study|Non-Compliance|3|||
129919435|NCT05273749|467670316|FG001|Overall Study|Non-Compliance|2|||
129919436|NCT05273749|467670315|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
129919437|NCT05273749|467670316|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
129919438|NCT04956861|467670321|FG000|Overall Study|Withdrawal by Subject|4|||
129919439|NCT04956861|467670322|FG001|Overall Study|Withdrawal by Subject|4|||
129919440|NCT04956861|467670323|FG002|Overall Study|Withdrawal by Subject|2|||
129919441|NCT04956861|467670321|FG000|Overall Study|Physician Decision|4|||
129919442|NCT04956861|467670322|FG001|Overall Study|Physician Decision|5|||
129919443|NCT04956861|467670323|FG002|Overall Study|Physician Decision|1|||
129919444|NCT05337748|467670327|FG000|Overall Study|Withdrawal by Subject|1|||
129919445|NCT05337748|467670328|FG001|Overall Study|Withdrawal by Subject|0|||
129919446|NCT05337748|467670327|FG000|Overall Study|Death|1|||
129919447|NCT05337748|467670328|FG001|Overall Study|Death|0|||
129919448|NCT04806594|467670329|FG000|Overall Study|Withdrawal by Subject|2|||
129919449|NCT04806594|467670329|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
129919450|NCT02543281|467670332|FG000|Overall Study|Lost to Follow-up|0|||
129919451|NCT02543281|467670333|FG001|Overall Study|Lost to Follow-up|0|||
129919452|NCT02543281|467670334|FG002|Overall Study|Lost to Follow-up|1|||
129919453|NCT05563246|467670335|FG000|Overall Study|Withdrawal by Subject|1|||
129919454|NCT05563246|467670336|FG001|Overall Study|Withdrawal by Subject|2|||
129919455|NCT05563246|467670337|FG002|Overall Study|Withdrawal by Subject|0|||
129919456|NCT05563246|467670338|FG003|Overall Study|Withdrawal by Subject|0|||
129919457|NCT05563246|467670335|FG000|Overall Study|Protocol Deviation|0|||
129919458|NCT05563246|467670336|FG001|Overall Study|Protocol Deviation|1|||
129919459|NCT05563246|467670337|FG002|Overall Study|Protocol Deviation|0|||
129919460|NCT05563246|467670338|FG003|Overall Study|Protocol Deviation|0|||
129919461|NCT05563246|467670335|FG000|Overall Study|Physician Decision|0|||
129919462|NCT05563246|467670336|FG001|Overall Study|Physician Decision|1|||
129919463|NCT05563246|467670337|FG002|Overall Study|Physician Decision|0|||
129919464|NCT05563246|467670338|FG003|Overall Study|Physician Decision|0|||
129919465|NCT05563246|467670335|FG000|Overall Study|Adverse Event|0|||
129919466|NCT05563246|467670336|FG001|Overall Study|Adverse Event|0|||
129919467|NCT05563246|467670337|FG002|Overall Study|Adverse Event|2|||
129919468|NCT05563246|467670338|FG003|Overall Study|Adverse Event|0|||
129919469|NCT05563246|467670335|FG000|Overall Study|Lost to Follow-up|0|||
129919470|NCT05563246|467670336|FG001|Overall Study|Lost to Follow-up|0|||
129919471|NCT05563246|467670337|FG002|Overall Study|Lost to Follow-up|1|||
129919472|NCT05563246|467670338|FG003|Overall Study|Lost to Follow-up|0|||
129919473|NCT01416831|467670340|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
129919474|NCT01416831|467670341|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
129919475|NCT05215314|467670342|FG000|Overall Study|Lost to Follow-up|2|||
129919476|NCT05215314|467670343|FG001|Overall Study|Lost to Follow-up|2|||
129919477|NCT05215314|467670342|FG000|Overall Study|Withdrawal by Subject|2|||
129919478|NCT05215314|467670343|FG001|Overall Study|Withdrawal by Subject|0|||
129919479|NCT05215314|467670342|FG000|Overall Study|Physician Decision|1|||
129919480|NCT05215314|467670343|FG001|Overall Study|Physician Decision|0|||
129919481|NCT04784559|467670344|FG000|Overall Study|Withdrawal by Subject|3|||
129919482|NCT04784559|467670345|FG001|Overall Study|Withdrawal by Subject|2|||
129919483|NCT04784559|467670346|FG002|Overall Study|Withdrawal by Subject|1|||
129919484|NCT04784559|467670344|FG000|Overall Study|Death|2|||
129919485|NCT04784559|467670345|FG001|Overall Study|Death|1|||
129919486|NCT04784559|467670346|FG002|Overall Study|Death|2|||
129919487|NCT04784559|467670344|FG000|Overall Study|Lost to Follow-up|0|||
130067788|NCT01181778|468201439|FG000|Overall Study|Physician Decision|48|||
130067789|NCT01265420|468201440|FG000|Overall Study|Lost to Follow-up|1|||
130067790|NCT03862131|468201441|FG000|Overall Study|Lost to Follow-up|1|||
130067791|NCT03862131|468201442|FG001|Overall Study|Lost to Follow-up|0|||
130067792|NCT03862131|468201443|FG002|Overall Study|Lost to Follow-up|1|||
130067793|NCT03862131|468201441|FG000|Overall Study|Determined to be ineligible|0|||
130067794|NCT03862131|468201442|FG001|Overall Study|Determined to be ineligible|0|||
130067795|NCT03862131|468201443|FG002|Overall Study|Determined to be ineligible|5|||
130067796|NCT03862131|468201441|FG000|Overall Study|Death|4|||
130067797|NCT03862131|468201442|FG001|Overall Study|Death|4|||
130067798|NCT03862131|468201443|FG002|Overall Study|Death|0|||
130067799|NCT03862131|468201441|FG000|Overall Study|Withdrawal by Subject|5|||
130067800|NCT03862131|468201442|FG001|Overall Study|Withdrawal by Subject|3|||
130067801|NCT03862131|468201443|FG002|Overall Study|Withdrawal by Subject|0|||
129919488|NCT04784559|467670345|FG001|Overall Study|Lost to Follow-up|0|||
129919489|NCT04784559|467670346|FG002|Overall Study|Lost to Follow-up|2|||
129919490|NCT04784559|467670344|FG000|Overall Study|Participant worsened, PI decision|1|||
129919491|NCT04784559|467670345|FG001|Overall Study|Participant worsened, PI decision|0|||
129919492|NCT04784559|467670346|FG002|Overall Study|Participant worsened, PI decision|0|||
129919493|NCT04784559|467670344|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
129919494|NCT04784559|467670345|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
129919495|NCT04784559|467670346|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
129919496|NCT04784559|467670344|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
130067802|NCT03862131|468201441|FG000|Overall Study|Physician Decision|0|||
129919497|NCT04784559|467670345|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
129919498|NCT04784559|467670346|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
129919499|NCT04784559|467670344|FG000|Overall Study|Did not meet all inclusion criteria|0|||
129919500|NCT04784559|467670345|FG001|Overall Study|Did not meet all inclusion criteria|1|||
129919501|NCT04784559|467670346|FG002|Overall Study|Did not meet all inclusion criteria|0|||
129919502|NCT04784559|467670344|FG000|Overall Study|The participant was transferred to IRCU|0|||
130067803|NCT03862131|468201442|FG001|Overall Study|Physician Decision|1|||
130067804|NCT03862131|468201443|FG002|Overall Study|Physician Decision|0|||
129919503|NCT04784559|467670345|FG001|Overall Study|The participant was transferred to IRCU|1|||
129919504|NCT04784559|467670346|FG002|Overall Study|The participant was transferred to IRCU|0|||
129919505|NCT04784559|467670344|FG000|Overall Study|SAE|0|||
130067805|NCT02332798|468203485|FG000|Overall Study|Unwilling to Participate in Study|0|||
129919506|NCT04784559|467670345|FG001|Overall Study|SAE|1|||
129919507|NCT04784559|467670346|FG002|Overall Study|SAE|0|||
130067806|NCT02332798|468203486|FG001|Overall Study|Unwilling to Participate in Study|1|||
129919508|NCT04784559|467670344|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
129919509|NCT04784559|467670345|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
129919510|NCT04784559|467670346|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
129919511|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
129919512|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
129919513|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
129919514|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
129919515|NCT04294225|467670349|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
129919516|NCT04812535|467670351|FG000|Overall Study|Withdrawal by Subject|0|||
129919517|NCT04812535|467670352|FG001|Overall Study|Withdrawal by Subject|0|||
129919518|NCT04812535|467670353|FG002|Overall Study|Withdrawal by Subject|0|||
129919519|NCT04812535|467670354|FG003|Overall Study|Withdrawal by Subject|1|||
129919520|NCT04812535|467670351|FG000|Overall Study|Death|7|||
129919521|NCT04812535|467670352|FG001|Overall Study|Death|2|||
129919522|NCT04812535|467670353|FG002|Overall Study|Death|4|||
129919523|NCT04812535|467670354|FG003|Overall Study|Death|1|||
129919524|NCT04812535|467670351|FG000|Overall Study|Due to premature study termination by sponsor|2|||
129919525|NCT04812535|467670352|FG001|Overall Study|Due to premature study termination by sponsor|0|||
129919526|NCT04812535|467670353|FG002|Overall Study|Due to premature study termination by sponsor|1|||
129919527|NCT04812535|467670354|FG003|Overall Study|Due to premature study termination by sponsor|3|||
129919528|NCT03336333|467670355|FG000|Overall Study|Remained on study at time of data cut-off|202|||
129919529|NCT03336333|467670356|FG001|Overall Study|Remained on study at time of data cut-off|219|||
129919530|NCT03336333|467670357|FG002|Overall Study|Remained on study at time of data cut-off|102|||
129919531|NCT03336333|467670355|FG000|Overall Study|Death|14|||
129919532|NCT03336333|467670356|FG001|Overall Study|Death|16|||
129919533|NCT03336333|467670357|FG002|Overall Study|Death|8|||
129919534|NCT03336333|467670355|FG000|Overall Study|Withdrawal by Subject|16|||
129919535|NCT03336333|467670356|FG001|Overall Study|Withdrawal by Subject|5|||
129919536|NCT03336333|467670357|FG002|Overall Study|Withdrawal by Subject|1|||
129919537|NCT03336333|467670355|FG000|Overall Study|Physician Decision|5|||
129919538|NCT03336333|467670356|FG001|Overall Study|Physician Decision|1|||
129919539|NCT03336333|467670357|FG002|Overall Study|Physician Decision|0|||
129919540|NCT03336333|467670355|FG000|Overall Study|Lost to Follow-up|1|||
129919541|NCT03336333|467670356|FG001|Overall Study|Lost to Follow-up|0|||
129919542|NCT03336333|467670357|FG002|Overall Study|Lost to Follow-up|0|||
129919543|NCT03792555|467670364|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
129919544|NCT03792555|467670365|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
129919545|NCT03792555|467670366|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
129919546|NCT03792555|467670364|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
129919547|NCT03792555|467670365|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
129919548|NCT03792555|467670366|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
129919549|NCT03792555|467670364|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
129919550|NCT03792555|467670365|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
129919551|NCT03792555|467670366|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
129919552|NCT03623321|467670367|FG000|Overall Study|Adverse Event|32|||
129919553|NCT03623321|467670367|FG000|Overall Study|Death|9|||
129919554|NCT03623321|467670367|FG000|Overall Study|Lack of Efficacy|9|||
129919555|NCT03623321|467670367|FG000|Overall Study|Lost to Follow-up|6|||
129919556|NCT03623321|467670367|FG000|Overall Study|Noncompliance with study drug|6|||
129919557|NCT03623321|467670367|FG000|Overall Study|Use of prohibited medication|3|||
129919558|NCT03623321|467670367|FG000|Overall Study|Physician Decision|5|||
129919559|NCT03623321|467670367|FG000|Overall Study|Protocol Violation|1|||
129919560|NCT03623321|467670367|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
129919561|NCT03623321|467670367|FG000|Overall Study|Not further specified|43|||
129919562|NCT02243709|467670369|FG000|Phase 1|Lost to Follow-up|0|||
129919563|NCT02243709|467670370|FG001|Phase 1|Lost to Follow-up|1|||
129919564|NCT02243709|467670369|FG000|Phase 1|Withdrawal by Subject|1|||
129919565|NCT02243709|467670370|FG001|Phase 1|Withdrawal by Subject|0|||
129919566|NCT02243709|467670369|FG000|Phase 1|Protocol Violation|0|||
129919567|NCT02243709|467670370|FG001|Phase 1|Protocol Violation|1|||
129919568|NCT02243709|467670369|FG000|Phase 1|Adverse Event|0|||
129919569|NCT02243709|467670370|FG001|Phase 1|Adverse Event|1|||
129919570|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Physician Decision|1|||
129919571|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Physician Decision|0|||
129919572|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
129919573|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
129919574|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
129919575|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
129919576|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Pregnancy|0|||
130067807|NCT02332798|468203487|FG002|Overall Study|Unwilling to Participate in Study|1|||
129919577|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Pregnancy|2|||
129919578|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
129919579|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
129919580|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
129919581|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
129919582|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
129919583|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
129919584|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
129919585|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
129919586|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
129919587|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
129919588|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
129919589|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
129919590|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
129919591|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
129919592|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
129919593|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
129919594|NCT01785719|467670373|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
129919595|NCT01785719|467670374|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
129919596|NCT01785719|467670373|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
129919597|NCT01785719|467670374|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
129919598|NCT01785719|467670373|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
129919599|NCT01785719|467670374|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
129919600|NCT03443323|467670375|FG000|Overall Study|Lost to Follow-up|2|||
129919601|NCT03443323|467670376|FG001|Overall Study|Lost to Follow-up|2|||
129919602|NCT03443323|467670375|FG000|Overall Study|PI withdrawal|1|||
129919603|NCT03443323|467670376|FG001|Overall Study|PI withdrawal|0|||
129919604|NCT04610892|467670378|FG000|Overall Study|Adverse Event|1|||
129919605|NCT04610892|467670379|FG001|Overall Study|Adverse Event|0|||
129919606|NCT04610892|467670380|FG002|Overall Study|Adverse Event|0|||
129919607|NCT04610892|467670381|FG003|Overall Study|Adverse Event|1|||
129919608|NCT04610892|467670382|FG004|Overall Study|Adverse Event|3|||
129919609|NCT04610892|467670378|FG000|Overall Study|Death|0|||
129919610|NCT04610892|467670379|FG001|Overall Study|Death|1|||
129919611|NCT04610892|467670380|FG002|Overall Study|Death|0|||
129919612|NCT04610892|467670381|FG003|Overall Study|Death|1|||
129919613|NCT04610892|467670382|FG004|Overall Study|Death|0|||
129919614|NCT04610892|467670378|FG000|Overall Study|Withdrawal by Subject|3|||
129919615|NCT04610892|467670379|FG001|Overall Study|Withdrawal by Subject|2|||
129919616|NCT04610892|467670380|FG002|Overall Study|Withdrawal by Subject|0|||
129919617|NCT04610892|467670381|FG003|Overall Study|Withdrawal by Subject|6|||
129919618|NCT04610892|467670382|FG004|Overall Study|Withdrawal by Subject|6|||
129919619|NCT04610892|467670378|FG000|Overall Study|Subjects who did not receive treatment|1|||
129919620|NCT04610892|467670379|FG001|Overall Study|Subjects who did not receive treatment|0|||
129919621|NCT04610892|467670380|FG002|Overall Study|Subjects who did not receive treatment|0|||
129919622|NCT04610892|467670381|FG003|Overall Study|Subjects who did not receive treatment|0|||
129919623|NCT04610892|467670382|FG004|Overall Study|Subjects who did not receive treatment|2|||
129919624|NCT05520190|467670383|FG000|Overall Study|Lost to Follow-up|7|||
129919625|NCT05520190|467670383|FG000|Overall Study|Withdrawal by Subject|2|||
129919626|NCT01999075|467670384|FG000|Overall Study|Lost to Follow-up|0|||
129919627|NCT01999075|467670385|FG001|Overall Study|Lost to Follow-up|2|||
129919628|NCT01999075|467670384|FG000|Overall Study|Withdrawal by Subject|2|||
129919629|NCT01999075|467670385|FG001|Overall Study|Withdrawal by Subject|7|||
129919630|NCT01999075|467670384|FG000|Overall Study|Enrolled in drug trial|3|||
129919631|NCT01999075|467670385|FG001|Overall Study|Enrolled in drug trial|1|||
129919632|NCT01999075|467670384|FG000|Overall Study|Became ineligible|0|||
129919633|NCT01999075|467670385|FG001|Overall Study|Became ineligible|2|||
129919634|NCT03056040|467670391|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
129919635|NCT03056040|467670392|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
129919636|NCT03056040|467670391|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
129919637|NCT03056040|467670392|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
129919638|NCT03056040|467670391|FG000|Primary Evaluation Period|Pregnancy|0|||
129919639|NCT03056040|467670392|FG001|Primary Evaluation Period|Pregnancy|1|||
129919640|NCT03056040|467670391|FG000|Primary Evaluation Period|Randomized, not treated|1|||
129919641|NCT03056040|467670392|FG001|Primary Evaluation Period|Randomized, not treated|1|||
129919642|NCT03056040|467670391|FG000|Extension Period|Physician Decision|3|||
129919643|NCT03056040|467670392|FG001|Extension Period|Physician Decision|3|||
129919644|NCT03056040|467670391|FG000|Extension Period|Lost to Follow-up|0|||
130067808|NCT02332798|468203485|FG000|Overall Study|Positive Urine Drug Test|0|||
130067809|NCT02332798|468203486|FG001|Overall Study|Positive Urine Drug Test|1|||
129919645|NCT03056040|467670392|FG001|Extension Period|Lost to Follow-up|1|||
129919646|NCT03056040|467670391|FG000|Extension Period|Death|0|||
130067810|NCT02332798|468203487|FG002|Overall Study|Positive Urine Drug Test|0|||
129919647|NCT03056040|467670392|FG001|Extension Period|Death|3|||
129919648|NCT03056040|467670391|FG000|Extension Period|Withdrawal by Subject|1|||
129919649|NCT03056040|467670392|FG001|Extension Period|Withdrawal by Subject|0|||
129919650|NCT05268393|467670396|FG000|Overall Study|Withdrawal by Subject|2|||
129919651|NCT05268393|467670397|FG001|Overall Study|Withdrawal by Subject|1|||
129919652|NCT04410042|467670401|FG000|Overall Study|Not Eligible|1|||
129919653|NCT04410042|467670402|FG001|Overall Study|Not Eligible|1|||
129919654|NCT03720795|467670405|FG000|Phase 1|Lost to Follow-up|4|||
129919655|NCT03720795|467670405|FG000|Phase 1|Withdrawal by Subject|6|||
129919656|NCT03720795|467670405|FG000|Phase 1|Protocol Violation|1|||
129919657|NCT03720795|467670405|FG000|Phase 1|Other|1|||
129919658|NCT03720795|467670405|FG000|Phase 2|Lost to Follow-up|5|||
129919659|NCT03720795|467670405|FG000|Phase 2|Withdrawal by Subject|10|||
129919660|NCT03720795|467670405|FG000|Phase 2|Protocol Violation|2|||
129919661|NCT03720795|467670405|FG000|3 Month Follow Up|Lost to Follow-up|2|||
129919662|NCT03302494|467670406|FG000|Overall Study|Other|7|||
129919663|NCT03302494|467670407|FG001|Overall Study|Other|4|||
129919664|NCT03302494|467670408|FG002|Overall Study|Other|6|||
129919665|NCT03302494|467670406|FG000|Overall Study|Withdrawal by Subject|10|||
129919666|NCT03302494|467670407|FG001|Overall Study|Withdrawal by Subject|2|||
129919667|NCT03302494|467670408|FG002|Overall Study|Withdrawal by Subject|9|||
129919668|NCT03302494|467670406|FG000|Overall Study|Study Terminated by Sponsor|32|||
129919669|NCT03302494|467670407|FG001|Overall Study|Study Terminated by Sponsor|29|||
129919670|NCT03302494|467670408|FG002|Overall Study|Study Terminated by Sponsor|30|||
129919671|NCT03302494|467670406|FG000|Overall Study|Physician Decision|1|||
129919672|NCT03302494|467670407|FG001|Overall Study|Physician Decision|0|||
129919673|NCT03302494|467670408|FG002|Overall Study|Physician Decision|1|||
129919674|NCT03302494|467670406|FG000|Overall Study|Lost to Follow-up|1|||
129919675|NCT03302494|467670407|FG001|Overall Study|Lost to Follow-up|3|||
129919676|NCT03302494|467670408|FG002|Overall Study|Lost to Follow-up|3|||
129919677|NCT03302494|467670406|FG000|Overall Study|Death|13|||
129919678|NCT03302494|467670407|FG001|Overall Study|Death|11|||
129919679|NCT03302494|467670408|FG002|Overall Study|Death|4|||
129919680|NCT03302494|467670406|FG000|Overall Study|Adverse Event|1|||
129919681|NCT03302494|467670407|FG001|Overall Study|Adverse Event|2|||
129919682|NCT03302494|467670408|FG002|Overall Study|Adverse Event|0|||
129919683|NCT03302494|467670406|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
129919684|NCT03302494|467670407|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
129919685|NCT03302494|467670408|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
129919686|NCT05134233|467670409|FG000|Overall Study|Pregnancy|1|||
129919687|NCT05134233|467670409|FG000|Overall Study|MEP value too low|2|||
129919688|NCT05134233|467670409|FG000|Overall Study|Lost to Follow-up|1|||
129919689|NCT04763265|467670410|FG000|Overall Study|Adverse Event|1|||
129919690|NCT04763265|467670411|FG001|Overall Study|Adverse Event|0|||
129919691|NCT04763265|467670410|FG000|Overall Study|Lost to Follow-up|2|||
129919692|NCT04763265|467670411|FG001|Overall Study|Lost to Follow-up|4|||
129919693|NCT04763265|467670410|FG000|Overall Study|Withdrawal by Subject|0|||
129919694|NCT04763265|467670411|FG001|Overall Study|Withdrawal by Subject|1|||
129919695|NCT05071807|467670414|FG000|Overall Study|Withdrawal by Subject|4|||
129919696|NCT05071807|467670415|FG001|Overall Study|Withdrawal by Subject|0|||
129919697|NCT05071807|467670414|FG000|Overall Study|Unrelated medical issues|3|||
129919698|NCT05071807|467670415|FG001|Overall Study|Unrelated medical issues|0|||
129919699|NCT05071807|467670414|FG000|Overall Study|Relocated|0|||
129919700|NCT05071807|467670415|FG001|Overall Study|Relocated|1|||
129919701|NCT05609760|467670426|FG000|Overall Study|Lost to Follow-up|0|||
129919702|NCT05609760|467670427|FG001|Overall Study|Lost to Follow-up|1|||
129919703|NCT05609760|467670426|FG000|Overall Study|Withdrawal by Subject|1|||
129919704|NCT05609760|467670427|FG001|Overall Study|Withdrawal by Subject|0|||
129919705|NCT04049643|467670428|FG000|Overall Study|Lack of Efficacy|1|||
129919706|NCT04049643|467670429|FG001|Overall Study|Lack of Efficacy|1|||
130067811|NCT02332798|468203485|FG000|Overall Study|Abnormal Laboratory Findings|1|||
129919707|NCT04049643|467670430|FG002|Overall Study|Lack of Efficacy|0|||
129919708|NCT04049643|467670428|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129919709|NCT04049643|467670429|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129919710|NCT04049643|467670430|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
129919711|NCT05089734|467670431|FG000|Overall Study|Still on study|122|||
130067812|NCT02332798|468203486|FG001|Overall Study|Abnormal Laboratory Findings|0|||
129919712|NCT05089734|467670432|FG001|Overall Study|Still on study|101|||
129919713|NCT05089734|467670431|FG000|Overall Study|Death|161|||
129919714|NCT05089734|467670432|FG001|Overall Study|Death|179|||
129919715|NCT05089734|467670431|FG000|Overall Study|Withdrew consent|11|||
129919716|NCT05089734|467670432|FG001|Overall Study|Withdrew consent|24|||
129919717|NCT05089734|467670431|FG000|Overall Study|Lost to Follow-up|5|||
129919718|NCT05089734|467670432|FG001|Overall Study|Lost to Follow-up|0|||
130067813|NCT02332798|468203487|FG002|Overall Study|Abnormal Laboratory Findings|0|||
129919719|NCT05302596|467670433|FG000|Overall Study|Withdrawal by Subject|1|||
129919720|NCT05302596|467670434|FG001|Overall Study|Withdrawal by Subject|1|||
129919721|NCT03376321|467672103|FG000|Overall Study|Other|5|||
129919722|NCT03376321|467672104|FG001|Overall Study|Other|1|||
129919723|NCT03376321|467672103|FG000|Overall Study|Withdrawal by Subject|8|||
129919724|NCT03376321|467672104|FG001|Overall Study|Withdrawal by Subject|14|||
129919725|NCT03376321|467672103|FG000|Overall Study|Lost to Follow-up|1|||
129919726|NCT03376321|467672104|FG001|Overall Study|Lost to Follow-up|7|||
129919727|NCT03376321|467672103|FG000|Overall Study|Death|4|||
129919728|NCT03376321|467672104|FG001|Overall Study|Death|0|||
129919729|NCT03376321|467672103|FG000|Overall Study|Randomized, not treated|5|||
129919730|NCT03376321|467672104|FG001|Overall Study|Randomized, not treated|3|||
129919731|NCT02671903|467672105|FG000|Period 0 (Run-In)|Death|0|||
129919732|NCT02671903|467672106|FG001|Period 0 (Run-In)|Death|0|||
129919733|NCT02671903|467672107|FG002|Period 0 (Run-In)|Death|3|||
129919734|NCT02671903|467672105|FG000|Period 0 (Run-In)|Physician Decision|0|||
129919735|NCT02671903|467672106|FG001|Period 0 (Run-In)|Physician Decision|0|||
129919736|NCT02671903|467672107|FG002|Period 0 (Run-In)|Physician Decision|4|||
129919737|NCT02671903|467672105|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
129919738|NCT02671903|467672106|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
129919739|NCT02671903|467672107|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
129919740|NCT02671903|467672105|FG000|Period 0 (Run-In)|Protocol Violation|0|||
129919741|NCT02671903|467672106|FG001|Period 0 (Run-In)|Protocol Violation|0|||
129919742|NCT02671903|467672107|FG002|Period 0 (Run-In)|Protocol Violation|1|||
129919743|NCT02671903|467672105|FG000|Period 0 (Run-In)|Adverse Event|0|||
129919744|NCT02671903|467672106|FG001|Period 0 (Run-In)|Adverse Event|0|||
129919745|NCT02671903|467672107|FG002|Period 0 (Run-In)|Adverse Event|1|||
129919746|NCT02671903|467672105|FG000|Period 0 (Run-In)|Implantation Failure|0|||
129919747|NCT02671903|467672106|FG001|Period 0 (Run-In)|Implantation Failure|0|||
129919748|NCT02671903|467672107|FG002|Period 0 (Run-In)|Implantation Failure|2|||
129919749|NCT02671903|467672105|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
129919750|NCT02671903|467672106|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
129919751|NCT02671903|467672107|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
129919752|NCT04258709|467672108|FG000|Overall Study|Lost to Follow-up|10|||
129919753|NCT04258709|467672109|FG001|Overall Study|Lost to Follow-up|4|||
129919754|NCT04258709|467672108|FG000|Overall Study|Withdrawal by Subject|1|||
129919755|NCT04258709|467672109|FG001|Overall Study|Withdrawal by Subject|0|||
129919756|NCT04258709|467672108|FG000|Overall Study|Fetal demise|0|||
129919757|NCT04258709|467672109|FG001|Overall Study|Fetal demise|1|||
129919758|NCT04258709|467672108|FG000|Overall Study|Protocol Violation|1|||
129919759|NCT04258709|467672109|FG001|Overall Study|Protocol Violation|1|||
129919760|NCT02287610|467672110|FG000|Overall Study|Lost to Follow-up|3|||
129919761|NCT02287610|467672110|FG000|Overall Study|Withdrawal by Subject|8|||
129919762|NCT02287610|467672110|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
129919763|NCT06074523|467672111|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
129919764|NCT06074523|467672111|FG000|Overall Study|Withdrawal by Subject|1|||
129919765|NCT04318548|467672117|FG000|Overall Study|Adverse Event|0|||
129919766|NCT04318548|467672118|FG001|Overall Study|Adverse Event|0|||
129919767|NCT04318548|467672119|FG002|Overall Study|Adverse Event|1|||
129919768|NCT04318548|467672117|FG000|Overall Study|Lost to Follow-up|6|||
129919769|NCT04318548|467672118|FG001|Overall Study|Lost to Follow-up|13|||
129919770|NCT04318548|467672119|FG002|Overall Study|Lost to Follow-up|9|||
129919771|NCT04318548|467672117|FG000|Overall Study|Protocol Violation|1|||
129919772|NCT04318548|467672118|FG001|Overall Study|Protocol Violation|0|||
129919773|NCT04318548|467672119|FG002|Overall Study|Protocol Violation|2|||
129919774|NCT04318548|467672117|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
129919775|NCT04318548|467672118|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
129919776|NCT04318548|467672119|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
129919777|NCT04318548|467672117|FG000|Overall Study|Migrated / moved from the study area|0|||
129919778|NCT04318548|467672118|FG001|Overall Study|Migrated / moved from the study area|0|||
129919779|NCT04318548|467672119|FG002|Overall Study|Migrated / moved from the study area|1|||
129919780|NCT04318548|467672117|FG000|Overall Study|Other|1|||
129919781|NCT04318548|467672118|FG001|Overall Study|Other|2|||
129919782|NCT04318548|467672119|FG002|Overall Study|Other|3|||
129919783|NCT05247489|467672120|FG000|Overall Study|Lost to Follow-up|5|||
129919784|NCT05247489|467672121|FG001|Overall Study|Lost to Follow-up|1|||
129919785|NCT05247489|467672120|FG000|Overall Study|Withdrawal by Subject|6|||
129919786|NCT05247489|467672121|FG001|Overall Study|Withdrawal by Subject|7|||
129919787|NCT05247489|467672120|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
129919788|NCT05247489|467672121|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
129919789|NCT05247489|467672120|FG000|Overall Study|Left Country|1|||
129919790|NCT05247489|467672121|FG001|Overall Study|Left Country|0|||
129919791|NCT05247489|467672120|FG000|Overall Study|Noncompliance with Investigational Product|1|||
129919792|NCT05247489|467672121|FG001|Overall Study|Noncompliance with Investigational Product|0|||
129919793|NCT05247489|467672120|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
129919794|NCT05247489|467672121|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
129919795|NCT03771898|467672122|FG000|Overall Study|Adverse Event|1|||
129919796|NCT03771898|467672123|FG001|Overall Study|Adverse Event|0|||
129919797|NCT03771898|467672124|FG002|Overall Study|Adverse Event|0|||
130067814|NCT03788967|468203488|FG000|Overall Study|Lost to Follow-up|14|||
130067815|NCT03788967|468203489|FG001|Overall Study|Lost to Follow-up|10|||
130067816|NCT03788967|468203488|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
130067817|NCT03788967|468203489|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
130067818|NCT03788967|468203488|FG000|Overall Study|Participant Withdrawal of Consent|13|||
130067819|NCT03788967|468203489|FG001|Overall Study|Participant Withdrawal of Consent|5|||
129919798|NCT03771898|467672125|FG003|Overall Study|Adverse Event|0|||
129919799|NCT03771898|467672126|FG004|Overall Study|Adverse Event|0|||
129919800|NCT03771898|467672122|FG000|Overall Study|Lost to Follow-up|1|||
129919801|NCT03771898|467672123|FG001|Overall Study|Lost to Follow-up|1|||
129919802|NCT03771898|467672124|FG002|Overall Study|Lost to Follow-up|1|||
129919803|NCT03771898|467672125|FG003|Overall Study|Lost to Follow-up|0|||
129919804|NCT03771898|467672126|FG004|Overall Study|Lost to Follow-up|0|||
129919805|NCT03771898|467672122|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129919806|NCT03771898|467672123|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129919807|NCT03771898|467672124|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129919808|NCT03771898|467672125|FG003|Overall Study|Withdrawal by parent/guardian|0|||
129919809|NCT03771898|467672126|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129919810|NCT03771898|467672122|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919811|NCT03771898|467672123|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919812|NCT03771898|467672124|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919813|NCT03771898|467672125|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919814|NCT03771898|467672126|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
129919815|NCT04541706|467672127|FG000|Overall Study|Withdrawal by Subject|3|||
129919816|NCT04541706|467672127|FG000|Overall Study|Progressive disease|33|||
129919817|NCT04541706|467672127|FG000|Overall Study|Physician Decision|1|||
129919818|NCT04541706|467672127|FG000|Overall Study|Lost to Follow-up|2|||
129919819|NCT04541706|467672127|FG000|Overall Study|Death|5|||
129919820|NCT04541706|467672127|FG000|Overall Study|Adverse Event|1|||
129919821|NCT04927065|467672132|FG000|First Booster|Adverse Event|1|||
129919822|NCT04927065|467672133|FG001|First Booster|Adverse Event|0|||
129919823|NCT04927065|467672134|FG002|First Booster|Adverse Event|0|||
129919824|NCT04927065|467672135|FG003|First Booster|Adverse Event|0|||
129919825|NCT04927065|467672136|FG004|First Booster|Adverse Event|0|||
129919826|NCT04927065|467672137|FG005|First Booster|Adverse Event|0|||
129919827|NCT04927065|467672138|FG006|First Booster|Adverse Event|0|||
129919828|NCT04927065|467672139|FG007|First Booster|Adverse Event|1|||
129919829|NCT04927065|467672140|FG008|First Booster|Adverse Event|0|||
129919830|NCT04927065|467672141|FG009|First Booster|Adverse Event|0|||
129919831|NCT04927065|467672142|FG010|First Booster|Adverse Event|0|||
129919832|NCT04927065|467672143|FG011|First Booster|Adverse Event|0|||
129919833|NCT04927065|467672144|FG012|First Booster|Adverse Event|0|||
129919834|NCT04927065|467672145|FG013|First Booster|Adverse Event|0|||
129919835|NCT04927065|467672146|FG014|First Booster|Adverse Event|0|||
129919836|NCT04927065|467672147|FG015|First Booster|Adverse Event|0|||
129919837|NCT04927065|467672132|FG000|First Booster|Death|1|||
129919838|NCT04927065|467672133|FG001|First Booster|Death|0|||
129919839|NCT04927065|467672134|FG002|First Booster|Death|0|||
129919840|NCT04927065|467672135|FG003|First Booster|Death|1|||
129919841|NCT04927065|467672136|FG004|First Booster|Death|0|||
129919842|NCT04927065|467672137|FG005|First Booster|Death|1|||
129919843|NCT04927065|467672138|FG006|First Booster|Death|0|||
129919844|NCT04927065|467672139|FG007|First Booster|Death|0|||
129919845|NCT04927065|467672140|FG008|First Booster|Death|0|||
129919846|NCT04927065|467672141|FG009|First Booster|Death|0|||
129919847|NCT04927065|467672142|FG010|First Booster|Death|0|||
129919848|NCT04927065|467672143|FG011|First Booster|Death|0|||
129919849|NCT04927065|467672144|FG012|First Booster|Death|0|||
129919850|NCT04927065|467672145|FG013|First Booster|Death|0|||
129919851|NCT04927065|467672146|FG014|First Booster|Death|0|||
129919852|NCT04927065|467672147|FG015|First Booster|Death|0|||
129919853|NCT04927065|467672132|FG000|First Booster|Lost to Follow-up|8|||
129919854|NCT04927065|467672133|FG001|First Booster|Lost to Follow-up|20|||
129919855|NCT04927065|467672134|FG002|First Booster|Lost to Follow-up|0|||
129919856|NCT04927065|467672135|FG003|First Booster|Lost to Follow-up|11|||
129919857|NCT04927065|467672136|FG004|First Booster|Lost to Follow-up|43|||
129919858|NCT04927065|467672137|FG005|First Booster|Lost to Follow-up|30|||
129919859|NCT04927065|467672138|FG006|First Booster|Lost to Follow-up|28|||
129919860|NCT04927065|467672139|FG007|First Booster|Lost to Follow-up|23|||
129919861|NCT04927065|467672140|FG008|First Booster|Lost to Follow-up|4|||
129919862|NCT04927065|467672141|FG009|First Booster|Lost to Follow-up|15|||
129919863|NCT04927065|467672142|FG010|First Booster|Lost to Follow-up|0|||
129919864|NCT04927065|467672143|FG011|First Booster|Lost to Follow-up|0|||
129919865|NCT04927065|467672144|FG012|First Booster|Lost to Follow-up|0|||
129919866|NCT04927065|467672145|FG013|First Booster|Lost to Follow-up|0|||
129919867|NCT04927065|467672146|FG014|First Booster|Lost to Follow-up|0|||
129919868|NCT04927065|467672147|FG015|First Booster|Lost to Follow-up|0|||
129919869|NCT04927065|467672132|FG000|First Booster|Physician Decision|1|||
130067820|NCT03788967|468203488|FG000|Overall Study|Adverse Event|1|||
130067821|NCT03788967|468203489|FG001|Overall Study|Adverse Event|1|||
130067822|NCT03788967|468203488|FG000|Overall Study|COVID-19|1|||
130067823|NCT03788967|468203489|FG001|Overall Study|COVID-19|2|||
130067824|NCT03927911|468203490|FG000|Overall Study|problems with eDiary|0|||
130067825|NCT03927911|468203491|FG001|Overall Study|problems with eDiary|1|||
129919870|NCT04927065|467672133|FG001|First Booster|Physician Decision|0|||
129919871|NCT04927065|467672134|FG002|First Booster|Physician Decision|0|||
129919872|NCT04927065|467672135|FG003|First Booster|Physician Decision|3|||
129919873|NCT04927065|467672136|FG004|First Booster|Physician Decision|1|||
129919874|NCT04927065|467672137|FG005|First Booster|Physician Decision|1|||
129919875|NCT04927065|467672138|FG006|First Booster|Physician Decision|0|||
129919876|NCT04927065|467672139|FG007|First Booster|Physician Decision|3|||
129919877|NCT04927065|467672140|FG008|First Booster|Physician Decision|0|||
129919878|NCT04927065|467672141|FG009|First Booster|Physician Decision|0|||
129919879|NCT04927065|467672142|FG010|First Booster|Physician Decision|0|||
129919880|NCT04927065|467672143|FG011|First Booster|Physician Decision|0|||
129919881|NCT04927065|467672144|FG012|First Booster|Physician Decision|0|||
129919882|NCT04927065|467672145|FG013|First Booster|Physician Decision|0|||
129919883|NCT04927065|467672146|FG014|First Booster|Physician Decision|0|||
129919884|NCT04927065|467672147|FG015|First Booster|Physician Decision|0|||
129919885|NCT04927065|467672132|FG000|First Booster|Protocol Violation|4|||
129919886|NCT04927065|467672133|FG001|First Booster|Protocol Violation|4|||
129919887|NCT04927065|467672134|FG002|First Booster|Protocol Violation|0|||
129919888|NCT04927065|467672135|FG003|First Booster|Protocol Violation|3|||
129919889|NCT04927065|467672136|FG004|First Booster|Protocol Violation|0|||
129919890|NCT04927065|467672137|FG005|First Booster|Protocol Violation|0|||
129919891|NCT04927065|467672138|FG006|First Booster|Protocol Violation|0|||
129919892|NCT04927065|467672139|FG007|First Booster|Protocol Violation|2|||
129919893|NCT04927065|467672140|FG008|First Booster|Protocol Violation|0|||
129919894|NCT04927065|467672141|FG009|First Booster|Protocol Violation|0|||
129919895|NCT04927065|467672142|FG010|First Booster|Protocol Violation|0|||
129919896|NCT04927065|467672143|FG011|First Booster|Protocol Violation|0|||
129919897|NCT04927065|467672144|FG012|First Booster|Protocol Violation|0|||
129919898|NCT04927065|467672145|FG013|First Booster|Protocol Violation|0|||
129919899|NCT04927065|467672146|FG014|First Booster|Protocol Violation|0|||
129919900|NCT04927065|467672147|FG015|First Booster|Protocol Violation|0|||
129919901|NCT04927065|467672132|FG000|First Booster|Withdrawal by Subject|8|||
129919902|NCT04927065|467672133|FG001|First Booster|Withdrawal by Subject|23|||
129919903|NCT04927065|467672134|FG002|First Booster|Withdrawal by Subject|0|||
129919904|NCT04927065|467672135|FG003|First Booster|Withdrawal by Subject|19|||
129919905|NCT04927065|467672136|FG004|First Booster|Withdrawal by Subject|20|||
129919906|NCT04927065|467672137|FG005|First Booster|Withdrawal by Subject|15|||
129919907|NCT04927065|467672138|FG006|First Booster|Withdrawal by Subject|6|||
129919908|NCT04927065|467672139|FG007|First Booster|Withdrawal by Subject|24|||
129919909|NCT04927065|467672140|FG008|First Booster|Withdrawal by Subject|0|||
129919910|NCT04927065|467672141|FG009|First Booster|Withdrawal by Subject|4|||
129919911|NCT04927065|467672142|FG010|First Booster|Withdrawal by Subject|0|||
129919912|NCT04927065|467672143|FG011|First Booster|Withdrawal by Subject|0|||
129919913|NCT04927065|467672144|FG012|First Booster|Withdrawal by Subject|0|||
129919914|NCT04927065|467672145|FG013|First Booster|Withdrawal by Subject|0|||
129919915|NCT04927065|467672146|FG014|First Booster|Withdrawal by Subject|0|||
129919916|NCT04927065|467672147|FG015|First Booster|Withdrawal by Subject|0|||
129919917|NCT04927065|467672132|FG000|First Booster|Other Than Specified|1|||
129919918|NCT04927065|467672133|FG001|First Booster|Other Than Specified|1|||
129919919|NCT04927065|467672134|FG002|First Booster|Other Than Specified|0|||
129919920|NCT04927065|467672135|FG003|First Booster|Other Than Specified|1|||
129919921|NCT04927065|467672136|FG004|First Booster|Other Than Specified|2|||
129919922|NCT04927065|467672137|FG005|First Booster|Other Than Specified|3|||
129919923|NCT04927065|467672138|FG006|First Booster|Other Than Specified|2|||
129919924|NCT04927065|467672139|FG007|First Booster|Other Than Specified|6|||
130067826|NCT03927911|468203492|FG002|Overall Study|problems with eDiary|0|||
129919925|NCT04927065|467672140|FG008|First Booster|Other Than Specified|0|||
129919926|NCT04927065|467672141|FG009|First Booster|Other Than Specified|4|||
129919927|NCT04927065|467672142|FG010|First Booster|Other Than Specified|0|||
129919928|NCT04927065|467672143|FG011|First Booster|Other Than Specified|0|||
129919929|NCT04927065|467672144|FG012|First Booster|Other Than Specified|0|||
129919930|NCT04927065|467672145|FG013|First Booster|Other Than Specified|0|||
129919931|NCT04927065|467672146|FG014|First Booster|Other Than Specified|0|||
129919932|NCT04927065|467672147|FG015|First Booster|Other Than Specified|0|||
129919933|NCT04927065|467672132|FG000|Second Booster|Death|0|||
129919934|NCT04927065|467672133|FG001|Second Booster|Death|0|||
129919935|NCT04927065|467672134|FG002|Second Booster|Death|0|||
129919936|NCT04927065|467672135|FG003|Second Booster|Death|0|||
129919937|NCT04927065|467672136|FG004|Second Booster|Death|0|||
129919938|NCT04927065|467672137|FG005|Second Booster|Death|0|||
129919939|NCT04927065|467672138|FG006|Second Booster|Death|0|||
129919940|NCT04927065|467672139|FG007|Second Booster|Death|0|||
130067827|NCT03927911|468203493|FG003|Overall Study|problems with eDiary|1|||
129919941|NCT04927065|467672140|FG008|Second Booster|Death|0|||
129919942|NCT04927065|467672141|FG009|Second Booster|Death|0|||
129919943|NCT04927065|467672142|FG010|Second Booster|Death|2|||
129919944|NCT04927065|467672143|FG011|Second Booster|Death|0|||
129919945|NCT04927065|467672144|FG012|Second Booster|Death|2|||
129919946|NCT04927065|467672145|FG013|Second Booster|Death|2|||
129919947|NCT04927065|467672146|FG014|Second Booster|Death|0|||
129919948|NCT04927065|467672147|FG015|Second Booster|Death|0|||
129919949|NCT04927065|467672132|FG000|Second Booster|Lost to Follow-up|0|||
129919950|NCT04927065|467672133|FG001|Second Booster|Lost to Follow-up|0|||
129919951|NCT04927065|467672134|FG002|Second Booster|Lost to Follow-up|3|||
129919952|NCT04927065|467672135|FG003|Second Booster|Lost to Follow-up|0|||
129919953|NCT04927065|467672136|FG004|Second Booster|Lost to Follow-up|0|||
129919954|NCT04927065|467672137|FG005|Second Booster|Lost to Follow-up|0|||
129919955|NCT04927065|467672138|FG006|Second Booster|Lost to Follow-up|0|||
129919956|NCT04927065|467672139|FG007|Second Booster|Lost to Follow-up|0|||
129919957|NCT04927065|467672140|FG008|Second Booster|Lost to Follow-up|0|||
129919958|NCT04927065|467672141|FG009|Second Booster|Lost to Follow-up|0|||
129919959|NCT04927065|467672142|FG010|Second Booster|Lost to Follow-up|14|||
129919960|NCT04927065|467672143|FG011|Second Booster|Lost to Follow-up|10|||
129919961|NCT04927065|467672144|FG012|Second Booster|Lost to Follow-up|13|||
129919962|NCT04927065|467672145|FG013|Second Booster|Lost to Follow-up|16|||
129919963|NCT04927065|467672146|FG014|Second Booster|Lost to Follow-up|0|||
129919964|NCT04927065|467672147|FG015|Second Booster|Lost to Follow-up|0|||
129919965|NCT04927065|467672132|FG000|Second Booster|Physician Decision|0|||
129919966|NCT04927065|467672133|FG001|Second Booster|Physician Decision|0|||
129919967|NCT04927065|467672134|FG002|Second Booster|Physician Decision|0|||
129919968|NCT04927065|467672135|FG003|Second Booster|Physician Decision|0|||
129919969|NCT04927065|467672136|FG004|Second Booster|Physician Decision|0|||
129919970|NCT04927065|467672137|FG005|Second Booster|Physician Decision|0|||
129919971|NCT04927065|467672138|FG006|Second Booster|Physician Decision|0|||
129919972|NCT04927065|467672139|FG007|Second Booster|Physician Decision|0|||
129919973|NCT04927065|467672140|FG008|Second Booster|Physician Decision|0|||
129919974|NCT04927065|467672141|FG009|Second Booster|Physician Decision|0|||
129919975|NCT04927065|467672142|FG010|Second Booster|Physician Decision|0|||
129919976|NCT04927065|467672143|FG011|Second Booster|Physician Decision|3|||
129919977|NCT04927065|467672144|FG012|Second Booster|Physician Decision|0|||
129919978|NCT04927065|467672145|FG013|Second Booster|Physician Decision|1|||
129919979|NCT04927065|467672146|FG014|Second Booster|Physician Decision|0|||
129919980|NCT04927065|467672147|FG015|Second Booster|Physician Decision|0|||
129919981|NCT04927065|467672132|FG000|Second Booster|Withdrawal by Subject|0|||
129919982|NCT04927065|467672133|FG001|Second Booster|Withdrawal by Subject|0|||
129919983|NCT04927065|467672134|FG002|Second Booster|Withdrawal by Subject|4|||
129919984|NCT04927065|467672135|FG003|Second Booster|Withdrawal by Subject|0|||
129919985|NCT04927065|467672136|FG004|Second Booster|Withdrawal by Subject|0|||
129919986|NCT04927065|467672137|FG005|Second Booster|Withdrawal by Subject|0|||
129919987|NCT04927065|467672138|FG006|Second Booster|Withdrawal by Subject|0|||
129919988|NCT04927065|467672139|FG007|Second Booster|Withdrawal by Subject|0|||
129919989|NCT04927065|467672140|FG008|Second Booster|Withdrawal by Subject|0|||
129919990|NCT04927065|467672141|FG009|Second Booster|Withdrawal by Subject|0|||
129919991|NCT04927065|467672142|FG010|Second Booster|Withdrawal by Subject|3|||
129919992|NCT04927065|467672143|FG011|Second Booster|Withdrawal by Subject|16|||
129919993|NCT04927065|467672144|FG012|Second Booster|Withdrawal by Subject|13|||
129919994|NCT04927065|467672145|FG013|Second Booster|Withdrawal by Subject|9|||
129919995|NCT04927065|467672146|FG014|Second Booster|Withdrawal by Subject|0|||
129919996|NCT04927065|467672147|FG015|Second Booster|Withdrawal by Subject|0|||
129919997|NCT04927065|467672132|FG000|Second Booster|Other Than Specified|0|||
129919998|NCT04927065|467672133|FG001|Second Booster|Other Than Specified|0|||
129919999|NCT04927065|467672134|FG002|Second Booster|Other Than Specified|0|||
129920000|NCT04927065|467672135|FG003|Second Booster|Other Than Specified|0|||
129920001|NCT04927065|467672136|FG004|Second Booster|Other Than Specified|0|||
129920002|NCT04927065|467672137|FG005|Second Booster|Other Than Specified|0|||
129920003|NCT04927065|467672138|FG006|Second Booster|Other Than Specified|0|||
129920004|NCT04927065|467672139|FG007|Second Booster|Other Than Specified|0|||
129920005|NCT04927065|467672140|FG008|Second Booster|Other Than Specified|0|||
129920006|NCT04927065|467672141|FG009|Second Booster|Other Than Specified|0|||
129920007|NCT04927065|467672142|FG010|Second Booster|Other Than Specified|1|||
129920008|NCT04927065|467672143|FG011|Second Booster|Other Than Specified|1|||
129920009|NCT04927065|467672144|FG012|Second Booster|Other Than Specified|4|||
129920010|NCT04927065|467672145|FG013|Second Booster|Other Than Specified|0|||
129920011|NCT04927065|467672146|FG014|Second Booster|Other Than Specified|0|||
129920012|NCT04927065|467672147|FG015|Second Booster|Other Than Specified|0|||
129920013|NCT04927065|467672132|FG000|Third Booster|Lost to Follow-up|0|||
129920014|NCT04927065|467672133|FG001|Third Booster|Lost to Follow-up|0|||
130067828|NCT03927911|468203494|FG004|Overall Study|problems with eDiary|0|||
129920015|NCT04927065|467672134|FG002|Third Booster|Lost to Follow-up|0|||
129920016|NCT04927065|467672135|FG003|Third Booster|Lost to Follow-up|0|||
129920017|NCT04927065|467672136|FG004|Third Booster|Lost to Follow-up|0|||
129920018|NCT04927065|467672137|FG005|Third Booster|Lost to Follow-up|0|||
130067829|NCT03927911|468203495|FG005|Overall Study|problems with eDiary|4|||
130067830|NCT03927911|468203490|FG000|Overall Study|Adverse Event|0|||
130067831|NCT03927911|468203491|FG001|Overall Study|Adverse Event|0|||
130067832|NCT03927911|468203492|FG002|Overall Study|Adverse Event|0|||
130067833|NCT03927911|468203493|FG003|Overall Study|Adverse Event|0|||
130067834|NCT03927911|468203494|FG004|Overall Study|Adverse Event|0|||
130067835|NCT03927911|468203495|FG005|Overall Study|Adverse Event|1|||
130067836|NCT03927911|468203490|FG000|Overall Study|not treated -study terminated by sponsor|0|||
130067837|NCT03927911|468203491|FG001|Overall Study|not treated -study terminated by sponsor|1|||
130067838|NCT03927911|468203492|FG002|Overall Study|not treated -study terminated by sponsor|0|||
130067839|NCT03927911|468203493|FG003|Overall Study|not treated -study terminated by sponsor|0|||
130067840|NCT03927911|468203494|FG004|Overall Study|not treated -study terminated by sponsor|0|||
130067841|NCT03927911|468203495|FG005|Overall Study|not treated -study terminated by sponsor|0|||
130067842|NCT03927911|468203490|FG000|Overall Study|Surgery cancelled|0|||
130067843|NCT03927911|468203491|FG001|Overall Study|Surgery cancelled|0|||
130067844|NCT03927911|468203492|FG002|Overall Study|Surgery cancelled|0|||
130067845|NCT03927911|468203493|FG003|Overall Study|Surgery cancelled|1|||
130067846|NCT03927911|468203494|FG004|Overall Study|Surgery cancelled|0|||
130067847|NCT03927911|468203495|FG005|Overall Study|Surgery cancelled|1|||
130067848|NCT03927911|468203490|FG000|Overall Study|Protocol Violation|0|||
130067849|NCT03927911|468203491|FG001|Overall Study|Protocol Violation|0|||
130067850|NCT03927911|468203492|FG002|Overall Study|Protocol Violation|0|||
130067851|NCT03927911|468203493|FG003|Overall Study|Protocol Violation|0|||
130067852|NCT03927911|468203494|FG004|Overall Study|Protocol Violation|0|||
130067853|NCT03927911|468203495|FG005|Overall Study|Protocol Violation|1|||
130067854|NCT04432376|468203496|FG000|Double-blind Treatment Period|Adverse Event|2|||
130067855|NCT04432376|468203497|FG001|Double-blind Treatment Period|Adverse Event|6|||
130067856|NCT04432376|468203498|FG002|Double-blind Treatment Period|Adverse Event|0|||
130067857|NCT04432376|468203496|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
130067858|NCT04432376|468203497|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130067859|NCT04432376|468203498|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130067860|NCT04432376|468203496|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130067861|NCT04432376|468203497|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130067862|NCT04432376|468203498|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130067863|NCT04432376|468203496|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130067864|NCT04432376|468203497|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130067865|NCT04432376|468203498|FG002|Double-blind Treatment Period|Protocol Violation|0|||
130067866|NCT04432376|468203496|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
130067867|NCT04432376|468203497|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
130067868|NCT04432376|468203498|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
130067869|NCT01824693|468203499|FG000|Overall Study|Death|0|||
130067870|NCT01824693|468203500|FG001|Overall Study|Death|1|||
130067871|NCT01824693|468203501|FG002|Overall Study|Death|0|||
130067872|NCT01824693|468203499|FG000|Overall Study|Physician Decision|1|||
130067873|NCT01824693|468203500|FG001|Overall Study|Physician Decision|1|||
130067874|NCT01824693|468203501|FG002|Overall Study|Physician Decision|1|||
130067875|NCT01824693|468203499|FG000|Overall Study|Withdrawal by Subject|0|||
130067876|NCT01824693|468203500|FG001|Overall Study|Withdrawal by Subject|0|||
130067877|NCT01824693|468203501|FG002|Overall Study|Withdrawal by Subject|1|||
130067878|NCT01824693|468203499|FG000|Overall Study|Progressive Disease|0|||
129920019|NCT04927065|467672138|FG006|Third Booster|Lost to Follow-up|0|||
130067879|NCT01824693|468203500|FG001|Overall Study|Progressive Disease|5|||
130067880|NCT01824693|468203501|FG002|Overall Study|Progressive Disease|0|||
130067881|NCT01824693|468203499|FG000|Overall Study|Ineligible|0|||
130067882|NCT01824693|468203500|FG001|Overall Study|Ineligible|0|||
130067883|NCT01824693|468203501|FG002|Overall Study|Ineligible|3|||
130067884|NCT01824693|468203499|FG000|Overall Study|No Transplant Planned|0|||
130067885|NCT01824693|468203500|FG001|Overall Study|No Transplant Planned|0|||
130067886|NCT01824693|468203501|FG002|Overall Study|No Transplant Planned|10|||
130067887|NCT00801892|468203502|FG000|Main Study Period|Withdrawal by Subject|0|||
130067888|NCT00801892|468203503|FG001|Main Study Period|Withdrawal by Subject|1|||
130067889|NCT00801892|468203502|FG000|Sham Crossover Period|Lost to Follow-up|0|||
130067890|NCT00801892|468203503|FG001|Sham Crossover Period|Lost to Follow-up|2|||
130067891|NCT01188096|468203517|FG000|Overall Study|progression of disease|4|||
130067892|NCT01188096|468203517|FG000|Overall Study|Withdrawal by Subject|2|||
129920020|NCT04927065|467672139|FG007|Third Booster|Lost to Follow-up|0|||
129920021|NCT04927065|467672140|FG008|Third Booster|Lost to Follow-up|0|||
129920022|NCT04927065|467672141|FG009|Third Booster|Lost to Follow-up|0|||
130067893|NCT00851253|468203518|FG000|Overall Study|Disease Progression|1|||
129920023|NCT04927065|467672142|FG010|Third Booster|Lost to Follow-up|0|||
129920024|NCT04927065|467672143|FG011|Third Booster|Lost to Follow-up|0|||
130067894|NCT00851253|468203519|FG001|Overall Study|Disease Progression|0|||
129920025|NCT04927065|467672144|FG012|Third Booster|Lost to Follow-up|0|||
130067895|NCT02062398|468203520|FG000|Overall Study|Implant removal|1|||
130067896|NCT01779648|468203521|FG000|Overall Study|Protocol Violation|1|||
130067897|NCT01779648|468203522|FG001|Overall Study|Protocol Violation|0|||
129920026|NCT04927065|467672145|FG013|Third Booster|Lost to Follow-up|0|||
129920027|NCT04927065|467672146|FG014|Third Booster|Lost to Follow-up|0|||
129920028|NCT04927065|467672147|FG015|Third Booster|Lost to Follow-up|1|||
129920029|NCT04927065|467672132|FG000|Third Booster|Withdrawal by Subject|0|||
129920030|NCT04927065|467672133|FG001|Third Booster|Withdrawal by Subject|0|||
129920031|NCT04927065|467672134|FG002|Third Booster|Withdrawal by Subject|0|||
129920032|NCT04927065|467672135|FG003|Third Booster|Withdrawal by Subject|0|||
129920033|NCT04927065|467672136|FG004|Third Booster|Withdrawal by Subject|0|||
129920034|NCT04927065|467672137|FG005|Third Booster|Withdrawal by Subject|0|||
129920035|NCT04927065|467672138|FG006|Third Booster|Withdrawal by Subject|0|||
129920036|NCT04927065|467672139|FG007|Third Booster|Withdrawal by Subject|0|||
129920037|NCT04927065|467672140|FG008|Third Booster|Withdrawal by Subject|0|||
129920038|NCT04927065|467672141|FG009|Third Booster|Withdrawal by Subject|0|||
129920039|NCT04927065|467672142|FG010|Third Booster|Withdrawal by Subject|0|||
129920040|NCT04927065|467672143|FG011|Third Booster|Withdrawal by Subject|0|||
129920041|NCT04927065|467672144|FG012|Third Booster|Withdrawal by Subject|0|||
130067898|NCT00415519|468203523|FG000|Overall Study|Adverse Event|1|||
130067899|NCT00415519|468203524|FG001|Overall Study|Adverse Event|0|||
130067900|NCT00415519|468203523|FG000|Overall Study|Withdrawal by Subject|2|||
129920042|NCT04927065|467672145|FG013|Third Booster|Withdrawal by Subject|0|||
129920043|NCT04927065|467672146|FG014|Third Booster|Withdrawal by Subject|0|||
129920044|NCT04927065|467672147|FG015|Third Booster|Withdrawal by Subject|1|||
129920045|NCT03406871|467672148|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
129920046|NCT03406871|467672149|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
129920047|NCT03406871|467672150|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
129920048|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
129920049|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
129920050|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
129920051|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
129920052|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
129920053|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
129920054|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
129920055|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
129920056|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
129920057|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Death|0|||
129920058|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Death|1|||
129920059|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Death|0|||
129920060|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
129920061|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
129920062|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
129920063|NCT03366649|467672151|FG000|Overall Study|Failed preoperative screening|4|||
129920064|NCT03366649|467672152|FG001|Overall Study|Failed preoperative screening|0|||
129920065|NCT03366649|467672153|FG002|Overall Study|Failed preoperative screening|0|||
129920066|NCT03366649|467672151|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
129920067|NCT03366649|467672152|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
129920068|NCT03366649|467672153|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
129920069|NCT01744782|467672159|FG000|Overall Study|Death|1|||
129920070|NCT03683719|467672167|FG000|Overall Study|Lack of Efficacy|1|||
129920071|NCT03683719|467672168|FG001|Overall Study|Lack of Efficacy|3|||
129920072|NCT03683719|467672169|FG002|Overall Study|Lack of Efficacy|4|||
129920073|NCT03683719|467672170|FG003|Overall Study|Lack of Efficacy|0|||
129920074|NCT03683719|467672171|FG004|Overall Study|Lack of Efficacy|4|||
129920075|NCT03683719|467672167|FG000|Overall Study|Adverse Event|6|||
129920076|NCT03683719|467672168|FG001|Overall Study|Adverse Event|6|||
129920077|NCT03683719|467672169|FG002|Overall Study|Adverse Event|0|||
129920078|NCT03683719|467672170|FG003|Overall Study|Adverse Event|1|||
129920079|NCT03683719|467672171|FG004|Overall Study|Adverse Event|3|||
129920080|NCT03683719|467672167|FG000|Overall Study|Withdrawal by Subject|4|||
129920081|NCT03683719|467672168|FG001|Overall Study|Withdrawal by Subject|4|||
130067901|NCT00415519|468203524|FG001|Overall Study|Withdrawal by Subject|0|||
130067902|NCT00415519|468203523|FG000|Overall Study|Patient's convenience|1|||
130067903|NCT00415519|468203524|FG001|Overall Study|Patient's convenience|0|||
129920082|NCT03683719|467672169|FG002|Overall Study|Withdrawal by Subject|3|||
129920083|NCT03683719|467672170|FG003|Overall Study|Withdrawal by Subject|5|||
129920084|NCT03683719|467672171|FG004|Overall Study|Withdrawal by Subject|5|||
129920085|NCT03683719|467672167|FG000|Overall Study|Lost to Follow-up|1|||
129920086|NCT03683719|467672168|FG001|Overall Study|Lost to Follow-up|0|||
129920087|NCT03683719|467672169|FG002|Overall Study|Lost to Follow-up|0|||
129920088|NCT03683719|467672170|FG003|Overall Study|Lost to Follow-up|1|||
129920089|NCT03683719|467672171|FG004|Overall Study|Lost to Follow-up|1|||
129920090|NCT03683719|467672167|FG000|Overall Study|Other personal reasons|0|||
130067904|NCT03485222|468203531|FG000|Overall Study|Death|0|||
130067905|NCT03485222|468203532|FG001|Overall Study|Death|1|||
129920091|NCT03683719|467672168|FG001|Overall Study|Other personal reasons|0|||
129920092|NCT03683719|467672169|FG002|Overall Study|Other personal reasons|1|||
129920093|NCT03683719|467672170|FG003|Overall Study|Other personal reasons|0|||
129920094|NCT03683719|467672171|FG004|Overall Study|Other personal reasons|1|||
129920095|NCT01413100|467672172|FG000|Overall Study|Withdrawal by Subject|1|||
129920096|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
129920097|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
129920098|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
129920099|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
129920100|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
129920101|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
129920102|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
129920103|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
129920104|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
129920105|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
129920106|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
129920107|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
129920108|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
129920109|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
129920110|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
129920111|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
129920112|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
129920113|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
129920114|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
129920115|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
129920116|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
129920117|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
129920118|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
129920119|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
129920120|NCT05369403|467672173|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
130067906|NCT03485222|468203531|FG000|Overall Study|Lost to Follow-up|2|||
130067907|NCT03485222|468203532|FG001|Overall Study|Lost to Follow-up|1|||
130067908|NCT03657810|468203533|FG000|Overall Study|Adverse Event|0|||
130067909|NCT03657810|468203534|FG001|Overall Study|Adverse Event|1|||
130067910|NCT03657810|468203535|FG002|Overall Study|Adverse Event|0|||
130067911|NCT03657810|468203533|FG000|Overall Study|Lack of Efficacy|4|||
130067912|NCT03657810|468203534|FG001|Overall Study|Lack of Efficacy|1|||
130067913|NCT03657810|468203535|FG002|Overall Study|Lack of Efficacy|3|||
130067914|NCT03657810|468203533|FG000|Overall Study|Protocol Violation|1|||
130067915|NCT03657810|468203534|FG001|Overall Study|Protocol Violation|0|||
130067916|NCT03657810|468203535|FG002|Overall Study|Protocol Violation|0|||
130067917|NCT03657810|468203533|FG000|Overall Study|Lost to Follow-up|0|||
130067918|NCT03657810|468203534|FG001|Overall Study|Lost to Follow-up|1|||
130067919|NCT03657810|468203535|FG002|Overall Study|Lost to Follow-up|0|||
130067920|NCT03657810|468203533|FG000|Overall Study|Not provided|0|||
130067921|NCT03657810|468203534|FG001|Overall Study|Not provided|1|||
130067922|NCT03657810|468203535|FG002|Overall Study|Not provided|0|||
130067923|NCT00688545|468203536|FG000|Overall Study|Lost to Follow-up|1|||
130067924|NCT00688545|468203537|FG001|Overall Study|Lost to Follow-up|4|||
130067925|NCT00688545|468203536|FG000|Overall Study|Insurance/cost of drug|0|||
130067926|NCT00688545|468203537|FG001|Overall Study|Insurance/cost of drug|1|||
130067927|NCT00688545|468203536|FG000|Overall Study|Withdrawal by Subject|2|||
130067928|NCT00688545|468203537|FG001|Overall Study|Withdrawal by Subject|3|||
130067929|NCT00688545|468203536|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
130067930|NCT00688545|468203537|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
130067931|NCT01705587|468203541|FG000|Overall Study|Withdrawal by Subject|0|||
130067932|NCT01705587|468203542|FG001|Overall Study|Withdrawal by Subject|1|||
130067933|NCT01373918|468203543|FG000|Overall Study|Physician Decision|0|||
130067934|NCT01373918|468203544|FG001|Overall Study|Physician Decision|1|||
130067935|NCT03004976|468203546|FG000|Overall Study|Lost to Follow-up|7|||
130067936|NCT03004976|468203547|FG001|Overall Study|Lost to Follow-up|5|||
130067937|NCT03004976|468203546|FG000|Overall Study|Physician Decision|1|||
130067938|NCT03004976|468203547|FG001|Overall Study|Physician Decision|0|||
130067939|NCT03004976|468203546|FG000|Overall Study|Withdrawal by Subject|1|||
130116960|NCT00095199|468387233|FG001|Overall Study|Withdrawal by Subject|16|||
130067940|NCT03004976|468203547|FG001|Overall Study|Withdrawal by Subject|0|||
130067941|NCT03004976|468203546|FG000|Overall Study|Death|4|||
130067942|NCT03004976|468203547|FG001|Overall Study|Death|1|||
130067943|NCT02137837|468203551|FG000|Overall Study|Adverse Event|0|||
130067944|NCT02137837|468203552|FG001|Overall Study|Adverse Event|2|||
130067945|NCT02137837|468203553|FG002|Overall Study|Adverse Event|1|||
129920121|NCT05369403|467672174|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
129920122|NCT05369403|467672175|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
129920123|NCT05369403|467672173|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
129920124|NCT05369403|467672174|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
129920125|NCT05369403|467672175|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
129920126|NCT05369403|467672173|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
129920127|NCT05369403|467672174|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
129920128|NCT05369403|467672175|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
129920129|NCT04896476|467672187|FG000|Overall Study|Withdrawal by Subject|1|||
129920130|NCT04896476|467672187|FG000|Overall Study|Lost to Follow-up|2|||
129920131|NCT03476187|467672188|FG000|Overall Study|Protocol Violation|7|||
129920132|NCT03476187|467672188|FG000|Overall Study|Physician Decision|5|||
129920133|NCT03924986|467672189|FG000|Overall Study|Death|57|||
129920134|NCT03924986|467672190|FG001|Overall Study|Death|66|||
129920135|NCT03924986|467672189|FG000|Overall Study|Study Concluded by Sponsor|51|||
129920136|NCT03924986|467672190|FG001|Overall Study|Study Concluded by Sponsor|41|||
129920137|NCT03924986|467672189|FG000|Overall Study|Withdrawal by Subject|15|||
129920138|NCT03924986|467672190|FG001|Overall Study|Withdrawal by Subject|20|||
129920139|NCT03924986|467672189|FG000|Overall Study|Lost to Follow-up|7|||
129920140|NCT03924986|467672190|FG001|Overall Study|Lost to Follow-up|5|||
129920141|NCT03924986|467672189|FG000|Overall Study|Miscellaneous|1|||
129920142|NCT03924986|467672190|FG001|Overall Study|Miscellaneous|0|||
129920143|NCT05948670|467672192|FG000|Overall Study|Protocol Violation|6|||
129920144|NCT05948670|467672193|FG001|Overall Study|Protocol Violation|8|||
129920145|NCT05948670|467672192|FG000|Overall Study|Withdrawal by Subject|0|||
129920146|NCT05948670|467672193|FG001|Overall Study|Withdrawal by Subject|1|||
129920147|NCT03699709|467672194|FG000|Overall Study|Death|1|||
129920148|NCT03699709|467672195|FG001|Overall Study|Death|2|||
129920149|NCT03699709|467672194|FG000|Overall Study|Lost to Follow-up|10|||
129920150|NCT03699709|467672195|FG001|Overall Study|Lost to Follow-up|3|||
129920151|NCT03699709|467672194|FG000|Overall Study|Withdrawal by Subject|5|||
129920152|NCT03699709|467672195|FG001|Overall Study|Withdrawal by Subject|0|||
129920153|NCT03699709|467672194|FG000|Overall Study|incarcerated|1|||
129920154|NCT03699709|467672195|FG001|Overall Study|incarcerated|0|||
129920155|NCT03699709|467672194|FG000|Overall Study|scheduled, but no show|0|||
129920156|NCT03699709|467672195|FG001|Overall Study|scheduled, but no show|1|||
129920157|NCT04562649|467672197|FG000|Overall Study|Withdrawal by Subject|11|||
129920158|NCT04562649|467672198|FG001|Overall Study|Withdrawal by Subject|8|||
129920159|NCT04562649|467672197|FG000|Overall Study|Lost to Follow-up|26|||
129920160|NCT04562649|467672198|FG001|Overall Study|Lost to Follow-up|20|||
129920161|NCT04029688|467672202|FG000|Overall Study|Death|8|||
129920162|NCT04029688|467672203|FG001|Overall Study|Death|3|||
129920163|NCT04029688|467672204|FG002|Overall Study|Death|6|||
129920164|NCT04029688|467672205|FG003|Overall Study|Death|2|||
129920165|NCT04029688|467672206|FG004|Overall Study|Death|5|||
129920166|NCT04029688|467672207|FG005|Overall Study|Death|0|||
129920167|NCT04029688|467672208|FG006|Overall Study|Death|2|||
129920168|NCT04029688|467672209|FG007|Overall Study|Death|3|||
129920169|NCT04029688|467672202|FG000|Overall Study|Study Terminated by Sponsor|0|||
129920170|NCT04029688|467672203|FG001|Overall Study|Study Terminated by Sponsor|0|||
129920171|NCT04029688|467672204|FG002|Overall Study|Study Terminated by Sponsor|0|||
129920172|NCT04029688|467672205|FG003|Overall Study|Study Terminated by Sponsor|0|||
129920173|NCT04029688|467672206|FG004|Overall Study|Study Terminated by Sponsor|1|||
129920174|NCT04029688|467672207|FG005|Overall Study|Study Terminated by Sponsor|3|||
129920175|NCT04029688|467672208|FG006|Overall Study|Study Terminated by Sponsor|1|||
129920176|NCT04029688|467672209|FG007|Overall Study|Study Terminated by Sponsor|3|||
129920177|NCT04029688|467672202|FG000|Overall Study|Withdrawal by Subject|0|||
129920178|NCT04029688|467672203|FG001|Overall Study|Withdrawal by Subject|0|||
129920179|NCT04029688|467672204|FG002|Overall Study|Withdrawal by Subject|0|||
129920180|NCT04029688|467672205|FG003|Overall Study|Withdrawal by Subject|1|||
130067946|NCT02137837|468203551|FG000|Overall Study|Refusal unrelated to adverse event|2|||
130067947|NCT02137837|468203552|FG001|Overall Study|Refusal unrelated to adverse event|2|||
130067948|NCT02137837|468203553|FG002|Overall Study|Refusal unrelated to adverse event|1|||
129920181|NCT04029688|467672206|FG004|Overall Study|Withdrawal by Subject|0|||
129920182|NCT04029688|467672207|FG005|Overall Study|Withdrawal by Subject|0|||
129920183|NCT04029688|467672208|FG006|Overall Study|Withdrawal by Subject|0|||
129920184|NCT04029688|467672209|FG007|Overall Study|Withdrawal by Subject|0|||
129920185|NCT04739956|467672217|FG000|Overall Study|Withdrawal by Subject|1|||
129920186|NCT04739956|467672218|FG001|Overall Study|Withdrawal by Subject|1|||
129920187|NCT03920111|467672219|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
130067949|NCT02137837|468203551|FG000|Overall Study|Progression/relapse|9|||
129920188|NCT03920111|467672220|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
129920189|NCT03920111|467672221|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
129920190|NCT03396926|467672224|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
130067950|NCT02137837|468203552|FG001|Overall Study|Progression/relapse|7|||
130067951|NCT02137837|468203553|FG002|Overall Study|Progression/relapse|7|||
130067952|NCT02137837|468203551|FG000|Overall Study|Not protocol specified|2|||
130067953|NCT02137837|468203552|FG001|Overall Study|Not protocol specified|1|||
130067954|NCT02137837|468203553|FG002|Overall Study|Not protocol specified|3|||
130067955|NCT02141217|468203554|FG000|Overall Study|Adverse Event|1|||
130067956|NCT02141217|468203555|FG001|Overall Study|Adverse Event|2|||
130067957|NCT02141217|468203554|FG000|Overall Study|Protocol Violation|1|||
130067958|NCT02141217|468203555|FG001|Overall Study|Protocol Violation|4|||
130067959|NCT02141217|468203554|FG000|Overall Study|Withdrawal by Subject|6|||
130067960|NCT02141217|468203555|FG001|Overall Study|Withdrawal by Subject|0|||
130067961|NCT02141217|468203554|FG000|Overall Study|Lost to Follow-up|1|||
130067962|NCT02141217|468203555|FG001|Overall Study|Lost to Follow-up|1|||
130067963|NCT02141217|468203554|FG000|Overall Study|Physician Decision|1|||
130067964|NCT02141217|468203555|FG001|Overall Study|Physician Decision|0|||
130067965|NCT02141217|468203554|FG000|Overall Study|Surgical Intervention|1|||
130067966|NCT02141217|468203555|FG001|Overall Study|Surgical Intervention|1|||
130067967|NCT00448760|468203560|FG000|Overall Study|Death|3|||
130067968|NCT01306032|468203566|FG000|First Intervention|Adverse Event|1|||
130067969|NCT01306032|468203567|FG001|First Intervention|Adverse Event|0|||
130067970|NCT01306032|468203568|FG002|First Intervention|Adverse Event|1|||
130067971|NCT01306032|468203569|FG003|First Intervention|Adverse Event|0|||
130067972|NCT01306032|468203570|FG004|First Intervention|Adverse Event|0|||
130067973|NCT01306032|468203571|FG005|First Intervention|Adverse Event|1|||
130067974|NCT01306032|468203566|FG000|First Intervention|Withdrawal by Subject|0|||
130067975|NCT01306032|468203567|FG001|First Intervention|Withdrawal by Subject|2|||
130067976|NCT01306032|468203568|FG002|First Intervention|Withdrawal by Subject|0|||
130067977|NCT01306032|468203569|FG003|First Intervention|Withdrawal by Subject|1|||
130067978|NCT01306032|468203570|FG004|First Intervention|Withdrawal by Subject|0|||
130067979|NCT01306032|468203571|FG005|First Intervention|Withdrawal by Subject|0|||
130067980|NCT01306032|468203566|FG000|First Intervention|Death|0|||
130067981|NCT01306032|468203567|FG001|First Intervention|Death|0|||
130067982|NCT01306032|468203568|FG002|First Intervention|Death|1|||
130067983|NCT01306032|468203569|FG003|First Intervention|Death|0|||
130067984|NCT01306032|468203570|FG004|First Intervention|Death|0|||
130067985|NCT01306032|468203571|FG005|First Intervention|Death|0|||
130067986|NCT01306032|468203566|FG000|First Intervention|Ineligible|0|||
130067987|NCT01306032|468203567|FG001|First Intervention|Ineligible|0|||
130067988|NCT01306032|468203568|FG002|First Intervention|Ineligible|0|||
130067989|NCT01306032|468203569|FG003|First Intervention|Ineligible|0|||
130067990|NCT01306032|468203570|FG004|First Intervention|Ineligible|0|||
130067991|NCT01306032|468203571|FG005|First Intervention|Ineligible|1|||
130067992|NCT01306032|468203566|FG000|First Intervention|Progressive disease|0|||
130067993|NCT01306032|468203567|FG001|First Intervention|Progressive disease|0|||
130067994|NCT01306032|468203568|FG002|First Intervention|Progressive disease|0|||
130067995|NCT01306032|468203569|FG003|First Intervention|Progressive disease|0|||
130067996|NCT01306032|468203570|FG004|First Intervention|Progressive disease|2|||
130067997|NCT01306032|468203571|FG005|First Intervention|Progressive disease|0|||
130067998|NCT01306032|468203566|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
130067999|NCT01306032|468203567|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
130068000|NCT01306032|468203568|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
130068001|NCT01306032|468203569|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
130068002|NCT01306032|468203570|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
130068003|NCT01306032|468203571|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
130068004|NCT01306032|468203566|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
130068005|NCT01306032|468203567|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
130068006|NCT01306032|468203568|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
130068007|NCT01306032|468203569|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
130068008|NCT01306032|468203570|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
130068009|NCT01306032|468203571|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
130068010|NCT01213264|468203572|FG000|Overall Study|Adverse Event|1|||
130068011|NCT01213264|468203573|FG001|Overall Study|Adverse Event|0|||
130068012|NCT01213264|468203574|FG002|Overall Study|Adverse Event|0|||
130068013|NCT01213264|468203572|FG000|Overall Study|Lost to Follow-up|1|||
130068014|NCT01213264|468203573|FG001|Overall Study|Lost to Follow-up|2|||
130068015|NCT01213264|468203574|FG002|Overall Study|Lost to Follow-up|6|||
130068016|NCT05507580|468203576|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
130068017|NCT05507580|468203577|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
130068018|NCT05507580|468203578|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
130068019|NCT05507580|468203579|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
130068020|NCT05507580|468203580|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
130068021|NCT05507580|468203581|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
130068022|NCT05507580|468203576|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
130068023|NCT05507580|468203577|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130068024|NCT05507580|468203578|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130068025|NCT05507580|468203579|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129920191|NCT03396926|467672225|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
129920192|NCT00450658|467672226|FG000|Overall Study|Adverse Event|24|||
129920193|NCT00450658|467672227|FG001|Overall Study|Adverse Event|15|||
129920194|NCT00450658|467672226|FG000|Overall Study|Withdrawal by Subject|43|||
129920195|NCT00450658|467672227|FG001|Overall Study|Withdrawal by Subject|26|||
129920196|NCT00450658|467672226|FG000|Overall Study|Lost to Follow-up|22|||
129920197|NCT00450658|467672227|FG001|Overall Study|Lost to Follow-up|5|||
129920198|NCT00450658|467672226|FG000|Overall Study|UGI ulcer|33|||
129920199|NCT00450658|467672227|FG001|Overall Study|UGI ulcer|34|||
129920200|NCT00450658|467672226|FG000|Overall Study|misc|21|||
129920201|NCT00450658|467672227|FG001|Overall Study|misc|10|||
129920202|NCT05763823|467672228|FG000|Overall Study|Death|6|||
129920203|NCT05763823|467672228|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129920204|NCT05763823|467672228|FG000|Overall Study|Withdrawal by Subject|6|||
129920205|NCT01573442|467672231|FG000|Overall Study|Cancels|9|||
129920206|NCT01573442|467672232|FG001|Overall Study|Cancels|10|||
129920207|NCT05710107|467672234|FG000|Overall Study|Withdrawal by Subject|1|||
129920208|NCT05710107|467672235|FG001|Overall Study|Withdrawal by Subject|1|||
129920209|NCT05710107|467672234|FG000|Overall Study|Lost to Follow-up|8|||
129920210|NCT05710107|467672235|FG001|Overall Study|Lost to Follow-up|9|||
129920211|NCT05710107|467672234|FG000|Overall Study|Unable to place assigned block|2|||
129920212|NCT05710107|467672235|FG001|Overall Study|Unable to place assigned block|0|||
129920213|NCT05710107|467672234|FG000|Overall Study|Withdrawn by study team|0|||
129920214|NCT05710107|467672235|FG001|Overall Study|Withdrawn by study team|1|||
129920215|NCT04166773|467672236|FG000|Overall Study|Adverse Event|2|||
129920216|NCT04166773|467672237|FG001|Overall Study|Adverse Event|0|||
129920217|NCT04166773|467672238|FG002|Overall Study|Adverse Event|2|||
129920218|NCT04166773|467672239|FG003|Overall Study|Adverse Event|1|||
129920219|NCT04166773|467672236|FG000|Overall Study|Lost to Follow-up|4|||
129920220|NCT04166773|467672237|FG001|Overall Study|Lost to Follow-up|2|||
129920221|NCT04166773|467672238|FG002|Overall Study|Lost to Follow-up|1|||
129920222|NCT04166773|467672239|FG003|Overall Study|Lost to Follow-up|3|||
129920223|NCT04166773|467672236|FG000|Overall Study|Physician Decision|0|||
129920224|NCT04166773|467672237|FG001|Overall Study|Physician Decision|0|||
129920225|NCT04166773|467672238|FG002|Overall Study|Physician Decision|0|||
129920226|NCT04166773|467672239|FG003|Overall Study|Physician Decision|1|||
129920227|NCT04166773|467672236|FG000|Overall Study|Withdrawal by Subject|1|||
129920228|NCT04166773|467672237|FG001|Overall Study|Withdrawal by Subject|1|||
129920229|NCT04166773|467672238|FG002|Overall Study|Withdrawal by Subject|2|||
129920230|NCT04166773|467672239|FG003|Overall Study|Withdrawal by Subject|5|||
129920231|NCT04456517|467672241|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
129920232|NCT04456517|467672242|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
129920233|NCT02919683|467672243|FG000|Post-Surgery Follow-Up|Death|2|||
129920234|NCT02919683|467672244|FG001|Post-Surgery Follow-Up|Death|2|||
129920235|NCT02919683|467672243|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
129920236|NCT02919683|467672244|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
129920237|NCT05551637|467672245|FG000|Overall Study|Lack of Efficacy|0|||
129920238|NCT05551637|467672246|FG001|Overall Study|Lack of Efficacy|6|||
129920239|NCT05551637|467672245|FG000|Overall Study|Lost to Follow-up|1|||
129920240|NCT05551637|467672246|FG001|Overall Study|Lost to Follow-up|1|||
129920241|NCT06491433|467672247|FG000|Overall Study|Protocol Violation|51|||
129920242|NCT06491433|467672247|FG000|Overall Study|consent withdrawal|2|||
129920243|NCT06491433|467672247|FG000|Overall Study|screen failure|1|||
129920244|NCT01606215|467672252|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
129920245|NCT01606215|467672253|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
129920246|NCT04592549|467672254|FG000|Overall Study|Withdrawal by Subject|0|||
129920247|NCT04592549|467672255|FG001|Overall Study|Withdrawal by Subject|1|||
129920248|NCT04592549|467672256|FG002|Overall Study|Withdrawal by Subject|0|||
129920249|NCT04592549|467672257|FG003|Overall Study|Withdrawal by Subject|1|||
129920250|NCT04592549|467672258|FG004|Overall Study|Withdrawal by Subject|1|||
129920251|NCT04592549|467672259|FG005|Overall Study|Withdrawal by Subject|0|||
129920252|NCT04592549|467672254|FG000|Overall Study|Lost to Follow-up|2|||
129920253|NCT04592549|467672255|FG001|Overall Study|Lost to Follow-up|0|||
129920254|NCT04592549|467672256|FG002|Overall Study|Lost to Follow-up|0|||
129920255|NCT04592549|467672257|FG003|Overall Study|Lost to Follow-up|1|||
129920256|NCT04592549|467672258|FG004|Overall Study|Lost to Follow-up|1|||
129920257|NCT04592549|467672259|FG005|Overall Study|Lost to Follow-up|1|||
129920258|NCT05184192|467672260|FG000|Overall Study|Lost to Follow-up|4|||
129920259|NCT05184192|467672261|FG001|Overall Study|Lost to Follow-up|7|||
129920260|NCT05184192|467672260|FG000|Overall Study|Adverse Event|1|||
129920261|NCT05184192|467672261|FG001|Overall Study|Adverse Event|4|||
129920262|NCT05184192|467672260|FG000|Overall Study|PI withdrawal|1|||
129920263|NCT05184192|467672261|FG001|Overall Study|PI withdrawal|2|||
129920264|NCT05184192|467672260|FG000|Overall Study|Withdrew due to adverse effect|1|||
129920265|NCT05184192|467672261|FG001|Overall Study|Withdrew due to adverse effect|0|||
129920266|NCT05184192|467672260|FG000|Overall Study|Medication schedule|1|||
129920267|NCT05184192|467672261|FG001|Overall Study|Medication schedule|0|||
129920268|NCT05184192|467672260|FG000|Overall Study|Concern for adverse effects|0|||
129920269|NCT05184192|467672261|FG001|Overall Study|Concern for adverse effects|4|||
129920270|NCT02727699|467673862|FG000|Overall Study|Adverse Event|2|||
129920271|NCT02727699|467673863|FG001|Overall Study|Adverse Event|0|||
129920272|NCT02727699|467673862|FG000|Overall Study|Withdrawal by Subject|5|||
129920273|NCT02727699|467673863|FG001|Overall Study|Withdrawal by Subject|3|||
129920274|NCT02727699|467673862|FG000|Overall Study|Protocol Violation|0|||
129920275|NCT02727699|467673863|FG001|Overall Study|Protocol Violation|1|||
129920276|NCT02727699|467673862|FG000|Overall Study|Physician Decision|0|||
129920277|NCT02727699|467673863|FG001|Overall Study|Physician Decision|1|||
129920278|NCT02727699|467673862|FG000|Overall Study|Lost to Follow-up|1|||
129920279|NCT02727699|467673863|FG001|Overall Study|Lost to Follow-up|0|||
129920280|NCT02727699|467673862|FG000|Overall Study|Sponsor Decision|1|||
129920281|NCT02727699|467673863|FG001|Overall Study|Sponsor Decision|0|||
129920282|NCT03131648|467673868|FG000|Initial Treatment Period|Not dosed|2|||
129920283|NCT03131648|467673869|FG001|Initial Treatment Period|Not dosed|2|||
129920284|NCT03131648|467673870|FG002|Initial Treatment Period|Not dosed|0|||
129920285|NCT03131648|467673871|FG003|Initial Treatment Period|Not dosed|0|||
129920286|NCT03131648|467673872|FG004|Initial Treatment Period|Not dosed|0|||
129920287|NCT03131648|467673873|FG005|Initial Treatment Period|Not dosed|0|||
129920288|NCT03131648|467673874|FG006|Initial Treatment Period|Not dosed|0|||
129920289|NCT03131648|467673875|FG007|Initial Treatment Period|Not dosed|0|||
129920290|NCT03131648|467673868|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
129920291|NCT03131648|467673869|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
129920292|NCT03131648|467673870|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920293|NCT03131648|467673871|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920294|NCT03131648|467673872|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920295|NCT03131648|467673873|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920296|NCT03131648|467673874|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920297|NCT03131648|467673875|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920298|NCT03131648|467673868|FG000|Open-label Treatment|Discontinued IMP|0|||
129920299|NCT03131648|467673869|FG001|Open-label Treatment|Discontinued IMP|0|||
129920300|NCT03131648|467673870|FG002|Open-label Treatment|Discontinued IMP|0|||
129920301|NCT03131648|467673871|FG003|Open-label Treatment|Discontinued IMP|0|||
129920302|NCT03131648|467673872|FG004|Open-label Treatment|Discontinued IMP|0|||
129920303|NCT03131648|467673873|FG005|Open-label Treatment|Discontinued IMP|0|||
129920304|NCT03131648|467673874|FG006|Open-label Treatment|Discontinued IMP|112|||
129920305|NCT03131648|467673875|FG007|Open-label Treatment|Discontinued IMP|0|||
129920306|NCT03131648|467673868|FG000|Open-label Treatment|Completed Week 50|0|||
129920307|NCT03131648|467673869|FG001|Open-label Treatment|Completed Week 50|0|||
129920308|NCT03131648|467673870|FG002|Open-label Treatment|Completed Week 50|0|||
129920309|NCT03131648|467673871|FG003|Open-label Treatment|Completed Week 50|0|||
129920310|NCT03131648|467673872|FG004|Open-label Treatment|Completed Week 50|0|||
129920311|NCT03131648|467673873|FG005|Open-label Treatment|Completed Week 50|0|||
129920312|NCT03131648|467673874|FG006|Open-label Treatment|Completed Week 50|6|||
129920313|NCT03131648|467673875|FG007|Open-label Treatment|Completed Week 50|0|||
129920314|NCT03131648|467673868|FG000|Maintenance Treatment Period|Not dosed|0|||
129920315|NCT03131648|467673869|FG001|Maintenance Treatment Period|Not dosed|0|||
129920316|NCT03131648|467673870|FG002|Maintenance Treatment Period|Not dosed|3|||
129920317|NCT03131648|467673871|FG003|Maintenance Treatment Period|Not dosed|2|||
129920318|NCT03131648|467673872|FG004|Maintenance Treatment Period|Not dosed|1|||
129920319|NCT03131648|467673873|FG005|Maintenance Treatment Period|Not dosed|0|||
129920320|NCT03131648|467673874|FG006|Maintenance Treatment Period|Not dosed|0|||
129920321|NCT03131648|467673875|FG007|Maintenance Treatment Period|Not dosed|0|||
129920322|NCT03131648|467673868|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
129920323|NCT03131648|467673869|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
129920324|NCT03131648|467673870|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
129920325|NCT03131648|467673871|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
129920326|NCT03131648|467673872|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
129920327|NCT03131648|467673873|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
129920328|NCT03131648|467673874|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
129920329|NCT03131648|467673875|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
129920330|NCT03131648|467673868|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920331|NCT03131648|467673869|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920332|NCT03131648|467673870|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
129920333|NCT03131648|467673871|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
129920334|NCT03131648|467673872|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
129920335|NCT03131648|467673873|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
129920336|NCT03131648|467673874|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920337|NCT03131648|467673875|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920338|NCT03131648|467673868|FG000|Maintenance Treatment Period|Completed Week 50|0|||
129920339|NCT03131648|467673869|FG001|Maintenance Treatment Period|Completed Week 50|0|||
129920340|NCT03131648|467673870|FG002|Maintenance Treatment Period|Completed Week 50|0|||
129920341|NCT03131648|467673871|FG003|Maintenance Treatment Period|Completed Week 50|0|||
129920342|NCT03131648|467673872|FG004|Maintenance Treatment Period|Completed Week 50|1|||
129920343|NCT03131648|467673873|FG005|Maintenance Treatment Period|Completed Week 50|0|||
129920344|NCT03131648|467673874|FG006|Maintenance Treatment Period|Completed Week 50|0|||
129920345|NCT03131648|467673875|FG007|Maintenance Treatment Period|Completed Week 50|0|||
129920346|NCT03131648|467673868|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920347|NCT03131648|467673869|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920348|NCT03131648|467673870|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920349|NCT03131648|467673871|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920350|NCT03131648|467673872|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920351|NCT03131648|467673873|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920352|NCT03131648|467673874|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920353|NCT03131648|467673875|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
129920354|NCT05324124|467673876|FG000|Period 1|Withdrawal by Subject|1|||
129920355|NCT05324124|467673877|FG001|Period 1|Withdrawal by Subject|0|||
129920356|NCT05324124|467673876|FG000|Period 1|Physician Decision|0|||
129920357|NCT05324124|467673877|FG001|Period 1|Physician Decision|1|||
129920358|NCT04241068|467673878|FG000|Core Treatment Period|Adverse Event|91|||
129920359|NCT04241068|467673878|FG000|Core Treatment Period|Change of Treatment|4|||
129920360|NCT04241068|467673878|FG000|Core Treatment Period|Consent Withdrawn|143|||
129920361|NCT04241068|467673878|FG000|Core Treatment Period|Death|26|||
129920362|NCT04241068|467673878|FG000|Core Treatment Period|Disease Progression|67|||
129920363|NCT04241068|467673878|FG000|Core Treatment Period|Investigator Decision|40|||
129920364|NCT04241068|467673878|FG000|Core Treatment Period|Loss of Capacity|9|||
129920365|NCT04241068|467673878|FG000|Core Treatment Period|Lost to Follow-up|11|||
129920366|NCT04241068|467673878|FG000|Core Treatment Period|Relocation|4|||
129920367|NCT04241068|467673878|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
129920368|NCT04241068|467673878|FG000|Core Treatment Period|Study Visit Burden|40|||
129920369|NCT04241068|467673878|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
129920370|NCT04241068|467673878|FG000|Core Treatment Period|Missing|2|||
129920371|NCT04241068|467673878|FG000|Core Treatment Period|Reason Not Specified|41|||
129920372|NCT04241068|467673878|FG000|LTE Period|Adverse Event|19|||
129920373|NCT04241068|467673878|FG000|LTE Period|Change of Treatment|1|||
129920374|NCT04241068|467673878|FG000|LTE Period|Consent Withdrawn|71|||
129920375|NCT04241068|467673878|FG000|LTE Period|Death|8|||
129920376|NCT04241068|467673878|FG000|LTE Period|Disease Progression|11|||
129920377|NCT04241068|467673878|FG000|LTE Period|Investigator Decision|12|||
129920378|NCT04241068|467673878|FG000|LTE Period|Loss of Capacity|2|||
129920379|NCT04241068|467673878|FG000|LTE Period|Lost to Follow-up|7|||
129920380|NCT04241068|467673878|FG000|LTE Period|Relocation|6|||
129920381|NCT04241068|467673878|FG000|LTE Period|Site Terminated by Sponsor|26|||
129920382|NCT04241068|467673878|FG000|LTE Period|Study Terminated by Sponsor|276|||
129920383|NCT04241068|467673878|FG000|LTE Period|Study Visit Burden|10|||
129920384|NCT04241068|467673878|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
129920385|NCT04241068|467673878|FG000|LTE Period|Reason Not Specified|65|||
129920386|NCT03792256|467673879|FG000|Overall Study|Death|0|||
129920387|NCT03792256|467673880|FG001|Overall Study|Death|1|||
129920388|NCT03792256|467673879|FG000|Overall Study|Lack of Efficacy|0|||
129920389|NCT03792256|467673880|FG001|Overall Study|Lack of Efficacy|1|||
129920390|NCT03792256|467673879|FG000|Overall Study|Withdrawal by Subject|0|||
129920391|NCT03792256|467673880|FG001|Overall Study|Withdrawal by Subject|1|||
129920392|NCT04760678|467673883|FG000|Overall Study|Death|13|||
129920393|NCT04760678|467673883|FG000|Overall Study|Lost to Follow-up|48|||
129920394|NCT04760678|467673883|FG000|Overall Study|Withdrawal by Subject|1|||
129920395|NCT05368103|467673886|FG000|Overall Study|Withdrawal by Subject|4|||
129920396|NCT05368103|467673886|FG000|Overall Study|Lost to Follow-up|1|||
129920397|NCT05368103|467673886|FG000|Overall Study|Lack of Efficacy|3|||
129920398|NCT03675282|467673887|FG000|Overall Study|Lost to Follow-up|4|||
129920399|NCT03675282|467673888|FG001|Overall Study|Lost to Follow-up|8|||
129920400|NCT03675282|467673889|FG002|Overall Study|Lost to Follow-up|1|||
129920401|NCT03675282|467673890|FG003|Overall Study|Lost to Follow-up|0|||
129920402|NCT03675282|467673891|FG004|Overall Study|Lost to Follow-up|2|||
129920403|NCT03675282|467673892|FG005|Overall Study|Lost to Follow-up|7|||
129920404|NCT03675282|467673887|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
129920405|NCT03675282|467673888|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
129920406|NCT03675282|467673889|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
129920407|NCT03675282|467673890|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
129920408|NCT03675282|467673891|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
129920409|NCT03675282|467673892|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
129920410|NCT03675282|467673887|FG000|Overall Study|Physician Decision|1|||
129920411|NCT03675282|467673888|FG001|Overall Study|Physician Decision|0|||
129920412|NCT03675282|467673889|FG002|Overall Study|Physician Decision|0|||
129920413|NCT03675282|467673890|FG003|Overall Study|Physician Decision|0|||
129920414|NCT03675282|467673891|FG004|Overall Study|Physician Decision|0|||
129920415|NCT03675282|467673892|FG005|Overall Study|Physician Decision|0|||
129920416|NCT05875142|467673893|FG000|Overall Study|Lost to Follow-up|0|||
129920417|NCT05875142|467673894|FG001|Overall Study|Lost to Follow-up|1|||
129920418|NCT05875142|467673895|FG002|Overall Study|Lost to Follow-up|1|||
129920419|NCT05784662|467673896|FG000|Overall Study|Lost to Follow-up|21|||
129920420|NCT05784662|467673897|FG001|Overall Study|Lost to Follow-up|17|||
129920421|NCT03853746|467673899|FG000|Overall Study|Withdrawal by Subject|1|||
129920422|NCT00999804|467673900|FG000|Overall Study|Lack of Efficacy|9|||
129920423|NCT00999804|467673901|FG001|Overall Study|Lack of Efficacy|2|||
129920424|NCT00999804|467673900|FG000|Overall Study|Adverse Event|4|||
129920425|NCT00999804|467673901|FG001|Overall Study|Adverse Event|3|||
129920426|NCT00999804|467673900|FG000|Overall Study|Withdrawal by Subject|4|||
129920427|NCT00999804|467673901|FG001|Overall Study|Withdrawal by Subject|0|||
129920428|NCT00999804|467673900|FG000|Overall Study|Death|1|||
129920429|NCT00999804|467673901|FG001|Overall Study|Death|0|||
129920430|NCT00999804|467673900|FG000|Overall Study|Ineligible|3|||
129920431|NCT00999804|467673901|FG001|Overall Study|Ineligible|0|||
129920432|NCT05256706|467673903|FG000|Overall Study|Lost to Follow-up|9|||
129920433|NCT05256706|467673904|FG001|Overall Study|Lost to Follow-up|3|||
129920434|NCT05256706|467673903|FG000|Overall Study|Withdrawal by Subject|7|||
129920435|NCT05256706|467673904|FG001|Overall Study|Withdrawal by Subject|11|||
129920436|NCT05256706|467673903|FG000|Overall Study|Screen Failures|3|||
129920437|NCT05256706|467673904|FG001|Overall Study|Screen Failures|0|||
129920438|NCT01997840|467673905|FG000|Overall Study|Lost to Follow-up|0|||
129920439|NCT01997840|467673906|FG001|Overall Study|Lost to Follow-up|0|||
129920440|NCT01997840|467673907|FG002|Overall Study|Lost to Follow-up|1|||
129920441|NCT01997840|467673908|FG003|Overall Study|Lost to Follow-up|0|||
129920442|NCT01997840|467673905|FG000|Overall Study|Withdrawal by participant|0|||
129920443|NCT01997840|467673906|FG001|Overall Study|Withdrawal by participant|0|||
129920444|NCT01997840|467673907|FG002|Overall Study|Withdrawal by participant|8|||
129920445|NCT01997840|467673908|FG003|Overall Study|Withdrawal by participant|1|||
129920446|NCT01997840|467673905|FG000|Overall Study|Physician Decision|0|||
129920447|NCT01997840|467673906|FG001|Overall Study|Physician Decision|0|||
129920448|NCT01997840|467673907|FG002|Overall Study|Physician Decision|3|||
129920449|NCT01997840|467673908|FG003|Overall Study|Physician Decision|0|||
129920450|NCT01997840|467673905|FG000|Overall Study|Progressive disease|3|||
129920451|NCT01997840|467673906|FG001|Overall Study|Progressive disease|4|||
129920452|NCT01997840|467673907|FG002|Overall Study|Progressive disease|57|||
129920453|NCT01997840|467673908|FG003|Overall Study|Progressive disease|8|||
129920454|NCT01997840|467673905|FG000|Overall Study|Other reasons|0|||
129920455|NCT01997840|467673906|FG001|Overall Study|Other reasons|0|||
129920456|NCT01997840|467673907|FG002|Overall Study|Other reasons|1|||
129920457|NCT01997840|467673908|FG003|Overall Study|Other reasons|0|||
129920458|NCT01997840|467673905|FG000|Overall Study|Adverse Event|0|||
129920459|NCT01997840|467673906|FG001|Overall Study|Adverse Event|0|||
129920460|NCT01997840|467673907|FG002|Overall Study|Adverse Event|15|||
129920461|NCT01997840|467673908|FG003|Overall Study|Adverse Event|2|||
129920462|NCT03850678|467673909|FG000|Overall Study|Withdrawal by Subject|3|||
129920463|NCT03850678|467673910|FG001|Overall Study|Withdrawal by Subject|0|||
129920464|NCT03850678|467673909|FG000|Overall Study|Experimenter Error|1|||
129920465|NCT03850678|467673910|FG001|Overall Study|Experimenter Error|1|||
129920466|NCT03850678|467673909|FG000|Overall Study|Did Not Condition To Experiment|7|||
129920467|NCT03850678|467673910|FG001|Overall Study|Did Not Condition To Experiment|2|||
129920468|NCT04322643|467673920|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
129920469|NCT03891667|467673921|FG000|Overall Study|Physician Decision|1|||
129920470|NCT03891667|467673922|FG001|Overall Study|Physician Decision|1|||
129920471|NCT03891667|467673921|FG000|Overall Study|COVID related pause|1|||
129920472|NCT03891667|467673922|FG001|Overall Study|COVID related pause|0|||
129920473|NCT03891667|467673921|FG000|Overall Study|Withdrawal by Subject|0|||
129920474|NCT03891667|467673922|FG001|Overall Study|Withdrawal by Subject|1|||
129920475|NCT03891667|467673921|FG000|Overall Study|Adverse Event|0|||
129920476|NCT03891667|467673922|FG001|Overall Study|Adverse Event|1|||
129920477|NCT05076708|467673932|FG000|Overall Study|Withdrawal by Subject|4|||
129920478|NCT05076708|467673932|FG000|Overall Study|Lost to study during switch phase|8|||
129920479|NCT04717492|467673935|FG000|Overall Study|Withdrawal by Subject|2|||
129920480|NCT04717492|467673936|FG001|Overall Study|Withdrawal by Subject|13|||
129920481|NCT04717492|467673935|FG000|Overall Study|Lost to Follow-up|2|||
129920482|NCT04717492|467673936|FG001|Overall Study|Lost to Follow-up|9|||
129920483|NCT03150810|467673937|FG000|Overall Study|Death|4|||
129920484|NCT03150810|467673938|FG001|Overall Study|Death|8|||
129920485|NCT03150810|467673939|FG002|Overall Study|Death|7|||
129920486|NCT03150810|467673940|FG003|Overall Study|Death|2|||
129920487|NCT03150810|467673941|FG004|Overall Study|Death|2|||
129920488|NCT03150810|467673942|FG005|Overall Study|Death|10|||
129920489|NCT03150810|467673943|FG006|Overall Study|Death|8|||
129920490|NCT03150810|467673944|FG007|Overall Study|Death|6|||
129920491|NCT03150810|467673945|FG008|Overall Study|Death|18|||
129920492|NCT03150810|467673946|FG009|Overall Study|Death|3|||
129920493|NCT03150810|467673947|FG010|Overall Study|Death|19|||
129920494|NCT03150810|467673948|FG011|Overall Study|Death|1|||
129920495|NCT03150810|467673949|FG012|Overall Study|Death|19|||
129920496|NCT03150810|467673937|FG000|Overall Study|Withdrawal by Subject|0|||
129920497|NCT03150810|467673938|FG001|Overall Study|Withdrawal by Subject|1|||
129920498|NCT03150810|467673939|FG002|Overall Study|Withdrawal by Subject|1|||
129920499|NCT03150810|467673940|FG003|Overall Study|Withdrawal by Subject|1|||
129920500|NCT03150810|467673941|FG004|Overall Study|Withdrawal by Subject|0|||
129920501|NCT03150810|467673942|FG005|Overall Study|Withdrawal by Subject|0|||
129920502|NCT03150810|467673943|FG006|Overall Study|Withdrawal by Subject|2|||
129920503|NCT03150810|467673944|FG007|Overall Study|Withdrawal by Subject|0|||
129920504|NCT03150810|467673945|FG008|Overall Study|Withdrawal by Subject|2|||
129920505|NCT03150810|467673946|FG009|Overall Study|Withdrawal by Subject|0|||
129920506|NCT03150810|467673947|FG010|Overall Study|Withdrawal by Subject|1|||
129920507|NCT03150810|467673948|FG011|Overall Study|Withdrawal by Subject|0|||
129920508|NCT03150810|467673949|FG012|Overall Study|Withdrawal by Subject|1|||
129920509|NCT03150810|467673937|FG000|Overall Study|Sponsor Decision|0|||
129920510|NCT03150810|467673938|FG001|Overall Study|Sponsor Decision|2|||
129920511|NCT03150810|467673939|FG002|Overall Study|Sponsor Decision|0|||
129920512|NCT03150810|467673940|FG003|Overall Study|Sponsor Decision|0|||
129920513|NCT03150810|467673941|FG004|Overall Study|Sponsor Decision|1|||
129920514|NCT03150810|467673942|FG005|Overall Study|Sponsor Decision|1|||
129920515|NCT03150810|467673943|FG006|Overall Study|Sponsor Decision|0|||
129920516|NCT03150810|467673944|FG007|Overall Study|Sponsor Decision|0|||
129920517|NCT03150810|467673945|FG008|Overall Study|Sponsor Decision|1|||
129920518|NCT03150810|467673946|FG009|Overall Study|Sponsor Decision|0|||
129920519|NCT03150810|467673947|FG010|Overall Study|Sponsor Decision|0|||
129920520|NCT03150810|467673948|FG011|Overall Study|Sponsor Decision|0|||
129920521|NCT03150810|467673949|FG012|Overall Study|Sponsor Decision|5|||
129920522|NCT03150810|467673937|FG000|Overall Study|Lost to Follow-up|0|||
129920523|NCT03150810|467673938|FG001|Overall Study|Lost to Follow-up|1|||
129920524|NCT03150810|467673939|FG002|Overall Study|Lost to Follow-up|1|||
129920525|NCT03150810|467673940|FG003|Overall Study|Lost to Follow-up|0|||
129920526|NCT03150810|467673941|FG004|Overall Study|Lost to Follow-up|0|||
129920527|NCT03150810|467673942|FG005|Overall Study|Lost to Follow-up|0|||
129920528|NCT03150810|467673943|FG006|Overall Study|Lost to Follow-up|1|||
129920529|NCT03150810|467673944|FG007|Overall Study|Lost to Follow-up|0|||
129920530|NCT03150810|467673945|FG008|Overall Study|Lost to Follow-up|0|||
129920531|NCT03150810|467673946|FG009|Overall Study|Lost to Follow-up|0|||
129920532|NCT03150810|467673947|FG010|Overall Study|Lost to Follow-up|1|||
129920533|NCT03150810|467673948|FG011|Overall Study|Lost to Follow-up|0|||
129920534|NCT03150810|467673949|FG012|Overall Study|Lost to Follow-up|0|||
129920535|NCT03150810|467673937|FG000|Overall Study|Physician Decision|0|||
129920536|NCT03150810|467673938|FG001|Overall Study|Physician Decision|0|||
129920537|NCT03150810|467673939|FG002|Overall Study|Physician Decision|0|||
129920538|NCT03150810|467673940|FG003|Overall Study|Physician Decision|0|||
129920539|NCT03150810|467673941|FG004|Overall Study|Physician Decision|0|||
129920540|NCT03150810|467673942|FG005|Overall Study|Physician Decision|1|||
129920541|NCT03150810|467673943|FG006|Overall Study|Physician Decision|1|||
129920542|NCT03150810|467673944|FG007|Overall Study|Physician Decision|0|||
129920543|NCT03150810|467673945|FG008|Overall Study|Physician Decision|0|||
129920544|NCT03150810|467673946|FG009|Overall Study|Physician Decision|0|||
129920545|NCT03150810|467673947|FG010|Overall Study|Physician Decision|0|||
129920546|NCT03150810|467673948|FG011|Overall Study|Physician Decision|0|||
129920547|NCT03150810|467673949|FG012|Overall Study|Physician Decision|0|||
129920548|NCT03150810|467673937|FG000|Overall Study|Site withdrawal from study|0|||
129920549|NCT03150810|467673938|FG001|Overall Study|Site withdrawal from study|1|||
129920550|NCT03150810|467673939|FG002|Overall Study|Site withdrawal from study|0|||
129920551|NCT03150810|467673940|FG003|Overall Study|Site withdrawal from study|0|||
129920552|NCT03150810|467673941|FG004|Overall Study|Site withdrawal from study|0|||
130068026|NCT05507580|468203580|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130068027|NCT05507580|468203581|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130068028|NCT05507580|468203576|FG000|Double-Blind Treatment Period|Other, not specified|5|||
130068029|NCT05507580|468203577|FG001|Double-Blind Treatment Period|Other, not specified|4|||
129920553|NCT03150810|467673942|FG005|Overall Study|Site withdrawal from study|0|||
129920554|NCT03150810|467673943|FG006|Overall Study|Site withdrawal from study|0|||
129920555|NCT03150810|467673944|FG007|Overall Study|Site withdrawal from study|0|||
129920556|NCT03150810|467673945|FG008|Overall Study|Site withdrawal from study|0|||
129920557|NCT03150810|467673946|FG009|Overall Study|Site withdrawal from study|1|||
129920558|NCT03150810|467673947|FG010|Overall Study|Site withdrawal from study|1|||
129920559|NCT03150810|467673948|FG011|Overall Study|Site withdrawal from study|0|||
129920560|NCT03150810|467673949|FG012|Overall Study|Site withdrawal from study|0|||
129920561|NCT03150810|467673937|FG000|Overall Study|Hospice|0|||
129920562|NCT03150810|467673938|FG001|Overall Study|Hospice|0|||
129920563|NCT03150810|467673939|FG002|Overall Study|Hospice|0|||
129920564|NCT03150810|467673940|FG003|Overall Study|Hospice|0|||
130068030|NCT05507580|468203578|FG002|Double-Blind Treatment Period|Other, not specified|0|||
129920565|NCT03150810|467673941|FG004|Overall Study|Hospice|0|||
129920566|NCT03150810|467673942|FG005|Overall Study|Hospice|1|||
129920567|NCT03150810|467673943|FG006|Overall Study|Hospice|0|||
129920568|NCT03150810|467673944|FG007|Overall Study|Hospice|0|||
129920569|NCT03150810|467673945|FG008|Overall Study|Hospice|0|||
129920570|NCT03150810|467673946|FG009|Overall Study|Hospice|0|||
129920571|NCT03150810|467673947|FG010|Overall Study|Hospice|0|||
129920572|NCT03150810|467673948|FG011|Overall Study|Hospice|0|||
129920573|NCT03150810|467673949|FG012|Overall Study|Hospice|0|||
129920574|NCT03150810|467673937|FG000|Overall Study|Participant relocated abroad.|0|||
129920575|NCT03150810|467673938|FG001|Overall Study|Participant relocated abroad.|0|||
129920576|NCT03150810|467673939|FG002|Overall Study|Participant relocated abroad.|0|||
129920577|NCT03150810|467673940|FG003|Overall Study|Participant relocated abroad.|0|||
129920578|NCT03150810|467673941|FG004|Overall Study|Participant relocated abroad.|0|||
129920579|NCT03150810|467673942|FG005|Overall Study|Participant relocated abroad.|1|||
129920580|NCT03150810|467673943|FG006|Overall Study|Participant relocated abroad.|0|||
129920581|NCT03150810|467673944|FG007|Overall Study|Participant relocated abroad.|0|||
129920582|NCT03150810|467673945|FG008|Overall Study|Participant relocated abroad.|0|||
129920583|NCT03150810|467673946|FG009|Overall Study|Participant relocated abroad.|0|||
129920584|NCT03150810|467673947|FG010|Overall Study|Participant relocated abroad.|0|||
129920585|NCT03150810|467673948|FG011|Overall Study|Participant relocated abroad.|0|||
129920586|NCT03150810|467673949|FG012|Overall Study|Participant relocated abroad.|0|||
129920587|NCT03150810|467673937|FG000|Overall Study|Transferred care to oncologist|0|||
129920588|NCT03150810|467673938|FG001|Overall Study|Transferred care to oncologist|0|||
129920589|NCT03150810|467673939|FG002|Overall Study|Transferred care to oncologist|0|||
129920590|NCT03150810|467673940|FG003|Overall Study|Transferred care to oncologist|0|||
129920591|NCT03150810|467673941|FG004|Overall Study|Transferred care to oncologist|0|||
129920592|NCT03150810|467673942|FG005|Overall Study|Transferred care to oncologist|0|||
129920593|NCT03150810|467673943|FG006|Overall Study|Transferred care to oncologist|2|||
129920594|NCT03150810|467673944|FG007|Overall Study|Transferred care to oncologist|0|||
129920595|NCT03150810|467673945|FG008|Overall Study|Transferred care to oncologist|0|||
129920596|NCT03150810|467673946|FG009|Overall Study|Transferred care to oncologist|0|||
129920597|NCT03150810|467673947|FG010|Overall Study|Transferred care to oncologist|0|||
130068031|NCT05507580|468203579|FG003|Double-Blind Treatment Period|Other, not specified|0|||
130068032|NCT05507580|468203580|FG004|Double-Blind Treatment Period|Other, not specified|0|||
129920598|NCT03150810|467673948|FG011|Overall Study|Transferred care to oncologist|0|||
129920599|NCT03150810|467673949|FG012|Overall Study|Transferred care to oncologist|0|||
129920600|NCT03903146|467673951|FG000|Overall Study|Lost to Follow-up|6|||
129920601|NCT03903146|467673952|FG001|Overall Study|Lost to Follow-up|4|||
129920602|NCT03903146|467673951|FG000|Overall Study|Withdrawal by Subject|0|||
129920603|NCT03903146|467673952|FG001|Overall Study|Withdrawal by Subject|1|||
129920604|NCT04176965|467673953|FG000|Overall Study|Death|1|||
129920605|NCT04176965|467673954|FG001|Overall Study|Death|2|||
129920606|NCT04176965|467673953|FG000|Overall Study|Lost to Follow-up|10|||
129920607|NCT04176965|467673954|FG001|Overall Study|Lost to Follow-up|2|||
129920608|NCT04176965|467673953|FG000|Overall Study|Withdrawal by Subject|6|||
129920609|NCT04176965|467673954|FG001|Overall Study|Withdrawal by Subject|1|||
129920610|NCT04072380|467673956|FG000|Overall Study|Adverse Event|4|||
129920611|NCT04072380|467673957|FG001|Overall Study|Adverse Event|6|||
129920612|NCT04072380|467673958|FG002|Overall Study|Adverse Event|0|||
129920613|NCT04072380|467673956|FG000|Overall Study|Withdrawal by Subject|3|||
129920614|NCT04072380|467673957|FG001|Overall Study|Withdrawal by Subject|1|||
129920615|NCT04072380|467673958|FG002|Overall Study|Withdrawal by Subject|1|||
129920616|NCT04072380|467673956|FG000|Overall Study|Physician Decision|2|||
129920617|NCT04072380|467673957|FG001|Overall Study|Physician Decision|0|||
129920618|NCT04072380|467673958|FG002|Overall Study|Physician Decision|0|||
129920619|NCT04072380|467673956|FG000|Overall Study|Protocol Violation|0|||
129920620|NCT04072380|467673957|FG001|Overall Study|Protocol Violation|2|||
129920621|NCT04072380|467673958|FG002|Overall Study|Protocol Violation|3|||
129920622|NCT04072380|467673956|FG000|Overall Study|Intercurrent Illness and Others|3|||
129920623|NCT04072380|467673957|FG001|Overall Study|Intercurrent Illness and Others|5|||
129920624|NCT04072380|467673958|FG002|Overall Study|Intercurrent Illness and Others|6|||
129920625|NCT03033576|467673961|FG000|Overall Study|Ineligible|1|||
129920626|NCT03033576|467673962|FG001|Overall Study|Ineligible|1|||
129920627|NCT03033576|467673961|FG000|Overall Study|Adverse Event|4|||
129920628|NCT03033576|467673962|FG001|Overall Study|Adverse Event|20|||
129920629|NCT03033576|467673961|FG000|Overall Study|Progression/relapse|9|||
129920630|NCT03033576|467673962|FG001|Overall Study|Progression/relapse|36|||
129920631|NCT03033576|467673961|FG000|Overall Study|Death|1|||
129920632|NCT03033576|467673962|FG001|Overall Study|Death|1|||
129920633|NCT03033576|467673961|FG000|Overall Study|Patient refusal|1|||
129920634|NCT03033576|467673962|FG001|Overall Study|Patient refusal|6|||
129920635|NCT03033576|467673961|FG000|Overall Study|Other, unspecified reasons|0|||
129920636|NCT03033576|467673962|FG001|Overall Study|Other, unspecified reasons|4|||
129920637|NCT03033576|467673961|FG000|Overall Study|Currently on protocol therapy|0|||
129920638|NCT03033576|467673962|FG001|Overall Study|Currently on protocol therapy|2|||
129920639|NCT05179837|467673963|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
129920640|NCT05179837|467673963|FG000|Overall Study|Device malfunctioned|1|||
129920641|NCT05179837|467673963|FG000|Overall Study|Image quality too low|2|||
129920642|NCT05051124|467673964|FG000|Overall Study|Lost to Follow-up|2|||
129920643|NCT05051124|467673964|FG000|Overall Study|Withdrawal by Subject|1|||
129920644|NCT05051124|467673964|FG000|Overall Study|Residential relocation|2|||
129920645|NCT05051124|467673964|FG000|Overall Study|Death|1|||
129920646|NCT04782973|467673965|FG000|Overall Study|Withdrawal by Subject|5|||
129920647|NCT04782973|467673965|FG000|Overall Study|Protocol Violation|6|||
129920648|NCT04782973|467673965|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
129920649|NCT03557697|467673966|FG000|Overall Study|Withdrawal by Subject|2|||
129920650|NCT03557697|467673967|FG001|Overall Study|Withdrawal by Subject|4|||
129920651|NCT04749615|467673968|FG000|Overall Study|Lost to Follow-up|6|||
129920652|NCT04749615|467673969|FG001|Overall Study|Lost to Follow-up|10|||
129920653|NCT05478499|467673986|FG000|Overall Study|Adverse Event|4|||
129920654|NCT05478499|467673987|FG001|Overall Study|Adverse Event|2|||
129920655|NCT05478499|467673986|FG000|Overall Study|Withdrawal by Subject|3|||
129920656|NCT05478499|467673987|FG001|Overall Study|Withdrawal by Subject|2|||
129920657|NCT05478499|467673986|FG000|Overall Study|Lack of Efficacy|1|||
129920658|NCT05478499|467673987|FG001|Overall Study|Lack of Efficacy|0|||
129920659|NCT05478499|467673986|FG000|Overall Study|Lost to Follow-up|1|||
129920660|NCT05478499|467673987|FG001|Overall Study|Lost to Follow-up|0|||
129920661|NCT05478499|467673986|FG000|Overall Study|Other reasons|0|||
129920662|NCT05478499|467673987|FG001|Overall Study|Other reasons|1|||
129920663|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
129920664|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
129920665|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
129920666|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920667|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920668|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920669|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920670|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920671|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
129920672|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920673|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920674|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920675|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920676|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920677|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920678|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
129920679|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
129920680|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920681|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920682|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920683|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920684|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
129920685|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920686|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920687|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920688|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920689|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920690|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920691|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920692|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
129920693|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920694|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920695|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920696|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920697|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920698|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920699|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920700|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920701|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
129920702|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920703|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920704|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920705|NCT02962895|467673988|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920706|NCT02962895|467673989|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920707|NCT02962895|467673990|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920708|NCT02962895|467673991|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920709|NCT02962895|467673992|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920710|NCT02962895|467673993|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920711|NCT02962895|467673994|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
129920712|NCT02962895|467673988|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920713|NCT02962895|467673989|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920714|NCT02962895|467673990|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920715|NCT02962895|467673991|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920716|NCT02962895|467673992|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
129920717|NCT02962895|467673993|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920718|NCT02962895|467673994|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
129920719|NCT02962895|467673988|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920720|NCT02962895|467673989|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920721|NCT02962895|467673990|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920722|NCT02962895|467673991|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920723|NCT02962895|467673992|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920724|NCT02962895|467673993|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920725|NCT02962895|467673994|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
129920726|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920727|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
129920728|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920729|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920730|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920731|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920732|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920733|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920734|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920735|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920736|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920737|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
129920738|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920739|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920740|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920741|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920742|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920743|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920744|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
129920745|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920746|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920747|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920748|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
129920749|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
129920750|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
129920751|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920752|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920753|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920754|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
129920755|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
129920756|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
129920757|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
129920758|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
129920759|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
129920760|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
129920761|NCT05481320|467673995|FG000|Overall Study|Withdrawal by Subject|1|||
129920762|NCT05481320|467673996|FG001|Overall Study|Withdrawal by Subject|1|||
129920763|NCT05481320|467673995|FG000|Overall Study|Care recipent passed away|0|||
129920764|NCT05481320|467673996|FG001|Overall Study|Care recipent passed away|1|||
129920765|NCT05481320|467673995|FG000|Overall Study|Out-of-window assessment|0|||
129920766|NCT05481320|467673996|FG001|Overall Study|Out-of-window assessment|1|||
129920767|NCT05481320|467673995|FG000|Overall Study|No longer a primary caregiver|3|||
129920768|NCT05481320|467673996|FG001|Overall Study|No longer a primary caregiver|0|||
129920769|NCT05481320|467673995|FG000|Overall Study|Unable to contact|1|||
129920770|NCT05481320|467673996|FG001|Overall Study|Unable to contact|0|||
129920771|NCT05282173|467673998|FG000|Overall Study|Missed|3|||
129920772|NCT05282173|467673999|FG001|Overall Study|Missed|2|||
129920773|NCT05282173|467674000|FG002|Overall Study|Missed|4|||
129920774|NCT03364647|467674002|FG000|Overall Study|Withdrawal by Subject|3|||
129920775|NCT03364647|467674003|FG001|Overall Study|Withdrawal by Subject|1|||
129920776|NCT03476460|467674004|FG000|Overall Study|Withdrawal by Subject|3|||
129920777|NCT03476460|467674005|FG001|Overall Study|Withdrawal by Subject|2|||
129920778|NCT03476460|467674004|FG000|Overall Study|Non-compliance with treatment|3|||
129920779|NCT03476460|467674005|FG001|Overall Study|Non-compliance with treatment|0|||
129920780|NCT03476460|467674004|FG000|Overall Study|Missing laboratory tests|5|||
129920781|NCT03476460|467674005|FG001|Overall Study|Missing laboratory tests|5|||
129920782|NCT03476460|467674004|FG000|Overall Study|Adverse Event|0|||
129920783|NCT03476460|467674005|FG001|Overall Study|Adverse Event|1|||
129920784|NCT06037369|467674016|FG000|Overall Study|Lost to Follow-up|0|||
129920785|NCT06037369|467674017|FG001|Overall Study|Lost to Follow-up|1|||
129920786|NCT05351554|467674024|FG000|Overall Study|Study terminated by sponsor|1|||
129920787|NCT03774082|467674025|FG000|Overall Study|Death|6|||
129920788|NCT03774082|467674026|FG001|Overall Study|Death|3|||
129920789|NCT03774082|467674027|FG002|Overall Study|Death|2|||
129920790|NCT03774082|467674025|FG000|Overall Study|Subject decision|0|||
129920791|NCT03774082|467674026|FG001|Overall Study|Subject decision|3|||
129920792|NCT03774082|467674027|FG002|Overall Study|Subject decision|0|||
129920793|NCT03774082|467674025|FG000|Overall Study|Lost to Follow-up|2|||
129920794|NCT03774082|467674026|FG001|Overall Study|Lost to Follow-up|0|||
129920795|NCT03774082|467674027|FG002|Overall Study|Lost to Follow-up|0|||
129920796|NCT03774082|467674025|FG000|Overall Study|Guardian decision|0|||
129920797|NCT03774082|467674026|FG001|Overall Study|Guardian decision|0|||
129920798|NCT03774082|467674027|FG002|Overall Study|Guardian decision|1|||
129920799|NCT03774082|467674025|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
129920800|NCT03774082|467674026|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
129920801|NCT03774082|467674027|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
129920802|NCT05093829|467674028|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920803|NCT05093829|467674029|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920804|NCT05093829|467674030|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
129920805|NCT05093829|467674031|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920806|NCT05093829|467674032|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920807|NCT04353661|467676040|FG000|Overall Study|Protocol Violation|0|||
129920808|NCT04353661|467676041|FG001|Overall Study|Protocol Violation|0|||
129920809|NCT04353661|467676042|FG002|Overall Study|Protocol Violation|1|||
129920810|NCT04353661|467676040|FG000|Overall Study|Study termination by the Sponsor|1|||
129920811|NCT04353661|467676041|FG001|Overall Study|Study termination by the Sponsor|1|||
129920812|NCT04353661|467676042|FG002|Overall Study|Study termination by the Sponsor|1|||
129920813|NCT00667251|467676043|FG000|Overall Study|Disease progression|232|||
129920814|NCT00667251|467676044|FG001|Overall Study|Disease progression|203|||
129920815|NCT00667251|467676043|FG000|Overall Study|Toxicity|44|||
129920816|NCT00667251|467676044|FG001|Overall Study|Toxicity|23|||
129920817|NCT00667251|467676043|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
129920818|NCT00667251|467676044|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
129920819|NCT00667251|467676043|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
129920820|NCT00667251|467676044|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
129920821|NCT00667251|467676043|FG000|Overall Study|Symptomatic progression|8|||
129920822|NCT00667251|467676044|FG001|Overall Study|Symptomatic progression|4|||
129920823|NCT00667251|467676043|FG000|Overall Study|Death|6|||
129920824|NCT00667251|467676044|FG001|Overall Study|Death|11|||
129920825|NCT00667251|467676043|FG000|Overall Study|Intercurrent illness|5|||
129920826|NCT00667251|467676044|FG001|Overall Study|Intercurrent illness|6|||
129920827|NCT00667251|467676043|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
129920828|NCT00667251|467676044|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
129920829|NCT00667251|467676043|FG000|Overall Study|Randomized not Treated|4|||
129920830|NCT00667251|467676044|FG001|Overall Study|Randomized not Treated|1|||
129920831|NCT02995434|467676049|FG000|Overall Study|Adverse Event|1|||
129920832|NCT02995434|467676050|FG001|Overall Study|Adverse Event|0|||
129920833|NCT02995434|467676049|FG000|Overall Study|Withdrawal by Subject|6|||
129920834|NCT02995434|467676050|FG001|Overall Study|Withdrawal by Subject|3|||
129920835|NCT03047928|467676051|FG000|Overall Study|Adverse Event|0|||
129920836|NCT03047928|467676052|FG001|Overall Study|Adverse Event|2|||
129920837|NCT03047928|467676053|FG002|Overall Study|Adverse Event|0|||
129920838|NCT03047928|467676051|FG000|Overall Study|Protocol Violation|0|||
129920839|NCT03047928|467676052|FG001|Overall Study|Protocol Violation|1|||
129920840|NCT03047928|467676053|FG002|Overall Study|Protocol Violation|0|||
129920841|NCT03047928|467676051|FG000|Overall Study|included in another protocol|0|||
129920842|NCT03047928|467676052|FG001|Overall Study|included in another protocol|1|||
129920843|NCT03047928|467676053|FG002|Overall Study|included in another protocol|0|||
129920844|NCT04179500|467676054|FG000|Treatment|Withdrawal by Subject|1|||
129920845|NCT04179500|467676054|FG000|Treatment|Adverse Event|2|||
129920846|NCT04179500|467676054|FG000|Treatment|pyrazinamide resistance|1|||
129920847|NCT04492007|467676055|FG000|Overall Study|Lost to Follow-up|1|||
129920848|NCT04492007|467676056|FG001|Overall Study|Lost to Follow-up|1|||
129920849|NCT04492007|467676057|FG002|Overall Study|Lost to Follow-up|2|||
129920850|NCT04492007|467676058|FG003|Overall Study|Lost to Follow-up|2|||
129920851|NCT04492007|467676055|FG000|Overall Study|Protocol Violation|1|||
129920852|NCT04492007|467676056|FG001|Overall Study|Protocol Violation|1|||
129920853|NCT04492007|467676057|FG002|Overall Study|Protocol Violation|1|||
129920854|NCT04492007|467676058|FG003|Overall Study|Protocol Violation|1|||
130068033|NCT05507580|468203581|FG005|Double-Blind Treatment Period|Other, not specified|0|||
130068034|NCT05507580|468203576|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
130068035|NCT05507580|468203577|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
130068036|NCT05507580|468203578|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
130068037|NCT05507580|468203579|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
130068038|NCT05507580|468203580|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
130068039|NCT05507580|468203581|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
130068040|NCT05507580|468203576|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
129920855|NCT04492007|467676055|FG000|Overall Study|Withdrawal by Subject|0|||
129920856|NCT04492007|467676056|FG001|Overall Study|Withdrawal by Subject|0|||
129920857|NCT04492007|467676057|FG002|Overall Study|Withdrawal by Subject|1|||
129920858|NCT04492007|467676058|FG003|Overall Study|Withdrawal by Subject|1|||
129920859|NCT04177823|467676061|FG000|Overall Study|Physician Decision|1|||
129920860|NCT04177823|467676061|FG000|Overall Study|Withdrawal by Subject|1|||
129920861|NCT05178316|467676064|FG000|Overall Study|Adverse Event|5|||
129920862|NCT05178316|467676065|FG001|Overall Study|Adverse Event|4|||
129920863|NCT05178316|467676066|FG002|Overall Study|Adverse Event|9|||
129920864|NCT05178316|467676064|FG000|Overall Study|Enrolled in Error|1|||
129920865|NCT05178316|467676065|FG001|Overall Study|Enrolled in Error|2|||
129920866|NCT05178316|467676066|FG002|Overall Study|Enrolled in Error|1|||
129920867|NCT05178316|467676064|FG000|Overall Study|Lost to Follow-up|3|||
129920868|NCT05178316|467676065|FG001|Overall Study|Lost to Follow-up|15|||
129920869|NCT05178316|467676066|FG002|Overall Study|Lost to Follow-up|11|||
129920870|NCT05178316|467676064|FG000|Overall Study|Noncompliance|1|||
129920871|NCT05178316|467676065|FG001|Overall Study|Noncompliance|3|||
129920872|NCT05178316|467676066|FG002|Overall Study|Noncompliance|1|||
129920873|NCT05178316|467676064|FG000|Overall Study|Other|0|||
129920874|NCT05178316|467676065|FG001|Overall Study|Other|1|||
129920875|NCT05178316|467676066|FG002|Overall Study|Other|0|||
129920876|NCT05178316|467676064|FG000|Overall Study|Physician Decision|0|||
129920877|NCT05178316|467676065|FG001|Overall Study|Physician Decision|3|||
129920878|NCT05178316|467676066|FG002|Overall Study|Physician Decision|2|||
129920879|NCT05178316|467676064|FG000|Overall Study|Protocol deviation|1|||
129920880|NCT05178316|467676065|FG001|Overall Study|Protocol deviation|0|||
129920881|NCT05178316|467676066|FG002|Overall Study|Protocol deviation|1|||
129920882|NCT05178316|467676064|FG000|Overall Study|Sponsor decision|1|||
129920883|NCT05178316|467676065|FG001|Overall Study|Sponsor decision|0|||
129920884|NCT05178316|467676066|FG002|Overall Study|Sponsor decision|1|||
129920885|NCT05178316|467676064|FG000|Overall Study|Withdrawal by Subject|5|||
129920886|NCT05178316|467676065|FG001|Overall Study|Withdrawal by Subject|11|||
129920887|NCT05178316|467676066|FG002|Overall Study|Withdrawal by Subject|5|||
129920888|NCT03457142|467676067|FG000|Overall Study|Death|1|||
129920889|NCT01748448|467676070|FG000|Treatment Period|Consent withdrawn by subject|1|||
129920890|NCT01748448|467676071|FG001|Treatment Period|Consent withdrawn by subject|0|||
129920891|NCT01748448|467676070|FG000|Treatment Period|Adverse Event|1|||
129920892|NCT01748448|467676071|FG001|Treatment Period|Adverse Event|0|||
129920893|NCT01748448|467676070|FG000|Treatment Period|Personal|0|||
129920894|NCT01748448|467676071|FG001|Treatment Period|Personal|1|||
129920895|NCT02907099|467676072|FG000|Overall Study|Adverse Event|1|||
129920896|NCT02907099|467676072|FG000|Overall Study|Withdrawal by Subject|2|||
129920897|NCT02907099|467676072|FG000|Overall Study|Screen Fail|2|||
129920898|NCT04977947|467676073|FG000|Overall Study|Lost to Follow-up|1|||
129920899|NCT04977947|467676074|FG001|Overall Study|Lost to Follow-up|1|||
129920900|NCT03436290|467676075|FG000|Overall Study|Post-randomization Exclusion|1|||
129920901|NCT03436290|467676076|FG001|Overall Study|Post-randomization Exclusion|0|||
129920902|NCT03436290|467676075|FG000|Overall Study|Death|6|||
129920903|NCT03436290|467676076|FG001|Overall Study|Death|0|||
129920904|NCT03436290|467676075|FG000|Overall Study|Withdrawal by Subject|4|||
129920905|NCT03436290|467676076|FG001|Overall Study|Withdrawal by Subject|0|||
129920906|NCT03436290|467676075|FG000|Overall Study|Protocol Violation|30|||
130068041|NCT05507580|468203577|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
130068042|NCT05507580|468203578|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
129920907|NCT03436290|467676076|FG001|Overall Study|Protocol Violation|0|||
129920908|NCT04274764|467676077|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
129920909|NCT04274764|467676078|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
129920910|NCT02677298|467676081|FG000|Double Blind Phase|Adverse Event|2|||
129920911|NCT02677298|467676082|FG001|Double Blind Phase|Adverse Event|1|||
129920912|NCT02677298|467676083|FG002|Double Blind Phase|Adverse Event|0|||
129920913|NCT02677298|467676081|FG000|Double Blind Phase|Physician Decision|5|||
129920914|NCT02677298|467676082|FG001|Double Blind Phase|Physician Decision|0|||
129920915|NCT02677298|467676083|FG002|Double Blind Phase|Physician Decision|0|||
130068043|NCT05507580|468203579|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
130068044|NCT05507580|468203580|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
130068045|NCT05507580|468203581|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
130068046|NCT05507580|468203576|FG000|Single-Blind Treatment Period|Other, not specified|0|||
130068047|NCT05507580|468203577|FG001|Single-Blind Treatment Period|Other, not specified|0|||
130068048|NCT05507580|468203578|FG002|Single-Blind Treatment Period|Other, not specified|2|||
130068049|NCT05507580|468203579|FG003|Single-Blind Treatment Period|Other, not specified|7|||
130068050|NCT05507580|468203580|FG004|Single-Blind Treatment Period|Other, not specified|3|||
130068051|NCT05507580|468203581|FG005|Single-Blind Treatment Period|Other, not specified|5|||
130068052|NCT03496662|468203582|FG000|Overall Study|Adverse Event|0|||
130068053|NCT03496662|468203583|FG001|Overall Study|Adverse Event|0|||
130068054|NCT03496662|468203584|FG002|Overall Study|Adverse Event|4|||
130068055|NCT03496662|468203582|FG000|Overall Study|Withdrawal by Subject|1|||
130068056|NCT03496662|468203583|FG001|Overall Study|Withdrawal by Subject|0|||
130068057|NCT03496662|468203584|FG002|Overall Study|Withdrawal by Subject|2|||
130068058|NCT03496662|468203582|FG000|Overall Study|Death|0|||
130068059|NCT03496662|468203583|FG001|Overall Study|Death|0|||
130068060|NCT03496662|468203584|FG002|Overall Study|Death|2|||
130068061|NCT03496662|468203582|FG000|Overall Study|Noncompliance|0|||
130068062|NCT03496662|468203583|FG001|Overall Study|Noncompliance|0|||
130068063|NCT03496662|468203584|FG002|Overall Study|Noncompliance|1|||
130068064|NCT02378883|468203585|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
130068065|NCT02378883|468203585|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
130068066|NCT02378883|468203585|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
130068067|NCT02378883|468203585|FG000|30 Day Follow-Up|Physician Decision|2|||
130068068|NCT02378883|468203585|FG000|30 Day Follow-Up|Missed Visit|2|||
130068069|NCT02378883|468203585|FG000|30 Day Follow-Up|Death|1|||
130068070|NCT02378883|468203585|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
130068071|NCT02378883|468203585|FG000|12 Months Follow-Up|Death|2|||
130068072|NCT03037307|468203586|FG000|Period 1|Did Not Meet Study Criteria|0|||
130068073|NCT03037307|468203587|FG001|Period 1|Did Not Meet Study Criteria|0|||
130068074|NCT03037307|468203588|FG002|Period 1|Did Not Meet Study Criteria|0|||
130068075|NCT03037307|468203589|FG003|Period 1|Did Not Meet Study Criteria|1|||
130068076|NCT03037307|468203590|FG004|Period 1|Did Not Meet Study Criteria|0|||
130068077|NCT03037307|468203591|FG005|Period 1|Did Not Meet Study Criteria|0|||
130068078|NCT00691093|468203592|FG000|Overall Study|Adverse Event|1|||
130068079|NCT00691093|468203592|FG000|Overall Study|Lost to Follow-up|1|||
130068080|NCT00691093|468203592|FG000|Overall Study|Lack of Efficacy|1|||
130068081|NCT00691093|468203592|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
130068082|NCT00493467|468203594|FG000|Overall Study|Death|1|||
130068083|NCT05489081|468203595|FG000|Overall Study|student left classroom|0|||
130068084|NCT05489081|468203596|FG001|Overall Study|student left classroom|1|||
130068085|NCT05489081|468203595|FG000|Overall Study|teacher left school|0|||
130068086|NCT05489081|468203596|FG001|Overall Study|teacher left school|2|||
130068087|NCT00810810|468203597|FG000|Overall Study|Withdrawal by Subject|0|||
130068088|NCT00810810|468203598|FG001|Overall Study|Withdrawal by Subject|8|||
130068089|NCT00810810|468203599|FG002|Overall Study|Withdrawal by Subject|10|||
130068090|NCT00810810|468203600|FG003|Overall Study|Withdrawal by Subject|8|||
130068091|NCT00810810|468203597|FG000|Overall Study|Physician Decision|0|||
130068092|NCT00810810|468203598|FG001|Overall Study|Physician Decision|3|||
130068093|NCT00810810|468203599|FG002|Overall Study|Physician Decision|1|||
130068094|NCT00810810|468203600|FG003|Overall Study|Physician Decision|5|||
130068095|NCT01409993|468203601|FG000|Overall Study|Adverse Event|4|||
130068096|NCT01409993|468203602|FG001|Overall Study|Adverse Event|4|||
130068097|NCT01409993|468203603|FG002|Overall Study|Adverse Event|3|||
130068098|NCT01409993|468203604|FG003|Overall Study|Adverse Event|1|||
130068099|NCT01409993|468203601|FG000|Overall Study|Withdrawal by Subject|0|||
130068100|NCT01409993|468203602|FG001|Overall Study|Withdrawal by Subject|0|||
130068101|NCT01409993|468203603|FG002|Overall Study|Withdrawal by Subject|0|||
130068102|NCT01409993|468203604|FG003|Overall Study|Withdrawal by Subject|4|||
130068103|NCT01409993|468203601|FG000|Overall Study|Lost to Follow-up|0|||
130068104|NCT01409993|468203602|FG001|Overall Study|Lost to Follow-up|1|||
130068105|NCT01409993|468203603|FG002|Overall Study|Lost to Follow-up|0|||
130068106|NCT01409993|468203604|FG003|Overall Study|Lost to Follow-up|0|||
130068107|NCT01700985|468203605|FG000|Overall Study|Incarcerated|0|||
129920916|NCT02677298|467676081|FG000|Double Blind Phase|Lost to Follow-up|11|||
130068108|NCT01700985|468203606|FG001|Overall Study|Incarcerated|1|||
130068109|NCT03074149|468203607|FG000|Overall Study|Reason unknown|22|||
130068110|NCT03074149|468203608|FG001|Overall Study|Reason unknown|35|||
130068111|NCT03074149|468203607|FG000|Overall Study|Death|10|||
130068112|NCT03074149|468203608|FG001|Overall Study|Death|45|||
130068113|NCT00067470|468203611|FG000|Overall Study|Withdrawal by Subject|0|||
130068114|NCT00067470|468203612|FG001|Overall Study|Withdrawal by Subject|1|||
130068115|NCT00050622|468203613|FG000|Overall Study|Adverse Event|1|||
130068116|NCT00416312|468203617|FG000|Overall Study|tumors not visible on imaging|2|||
129920917|NCT02677298|467676082|FG001|Double Blind Phase|Lost to Follow-up|7|||
130068117|NCT02727660|468203620|FG000|Overall Study|Lack of Efficacy|40|||
129920918|NCT02677298|467676083|FG002|Double Blind Phase|Lost to Follow-up|0|||
129920919|NCT02677298|467676081|FG000|Double Blind Phase|Withdrawal by Subject|11|||
129920920|NCT02677298|467676082|FG001|Double Blind Phase|Withdrawal by Subject|8|||
129920921|NCT02677298|467676083|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129920922|NCT02677298|467676081|FG000|Double Blind Phase|No study drug available at site|0|||
129920923|NCT02677298|467676082|FG001|Double Blind Phase|No study drug available at site|1|||
129920924|NCT02677298|467676083|FG002|Double Blind Phase|No study drug available at site|0|||
129920925|NCT02677298|467676081|FG000|Open Label Phase|Adverse Event|0|||
129920926|NCT02677298|467676082|FG001|Open Label Phase|Adverse Event|0|||
129920927|NCT02677298|467676083|FG002|Open Label Phase|Adverse Event|4|||
129920928|NCT02677298|467676081|FG000|Open Label Phase|Physician Decision|0|||
129920929|NCT02677298|467676082|FG001|Open Label Phase|Physician Decision|0|||
129920930|NCT02677298|467676083|FG002|Open Label Phase|Physician Decision|1|||
129920931|NCT02677298|467676081|FG000|Open Label Phase|Lost to Follow-up|0|||
129920932|NCT02677298|467676082|FG001|Open Label Phase|Lost to Follow-up|0|||
129920933|NCT02677298|467676083|FG002|Open Label Phase|Lost to Follow-up|17|||
129920934|NCT02677298|467676081|FG000|Open Label Phase|Withdrawal by Subject|0|||
129920935|NCT02677298|467676082|FG001|Open Label Phase|Withdrawal by Subject|0|||
129920936|NCT02677298|467676083|FG002|Open Label Phase|Withdrawal by Subject|38|||
129920937|NCT03611621|467676084|FG000|Overall Study|Graft loss|3|||
129920938|NCT03611621|467676084|FG000|Overall Study|Death|3|||
129920939|NCT03611621|467676084|FG000|Overall Study|Lost to Follow-up|1|||
129920940|NCT03039023|467676098|FG000|Overall Study|Withdrawal by Subject|1|||
129920941|NCT03039023|467676099|FG001|Overall Study|Withdrawal by Subject|0|||
129920942|NCT03039023|467676100|FG002|Overall Study|Withdrawal by Subject|1|||
129920943|NCT03039023|467676101|FG003|Overall Study|Withdrawal by Subject|1|||
129920944|NCT03039023|467676102|FG004|Overall Study|Withdrawal by Subject|0|||
129920945|NCT03039023|467676098|FG000|Overall Study|Physician Decision|0|||
129920946|NCT03039023|467676099|FG001|Overall Study|Physician Decision|0|||
129920947|NCT03039023|467676100|FG002|Overall Study|Physician Decision|0|||
129920948|NCT03039023|467676101|FG003|Overall Study|Physician Decision|1|||
129920949|NCT03039023|467676102|FG004|Overall Study|Physician Decision|0|||
129920950|NCT04130438|467676103|FG000|Overall Study|Lost to Follow-up|0|||
129920951|NCT04130438|467676104|FG001|Overall Study|Lost to Follow-up|0|||
129920952|NCT04130438|467676105|FG002|Overall Study|Lost to Follow-up|1|||
129920953|NCT03232138|467676108|FG000|Overall Study|Physician Decision|1|||
129920954|NCT03232138|467676109|FG001|Overall Study|Physician Decision|0|||
129920955|NCT03232138|467676108|FG000|Overall Study|Adverse Event|2|||
129920956|NCT03232138|467676109|FG001|Overall Study|Adverse Event|0|||
129920957|NCT03232138|467676108|FG000|Overall Study|Withdrawal by Subject|1|||
129920958|NCT03232138|467676109|FG001|Overall Study|Withdrawal by Subject|2|||
129920959|NCT04142788|467676110|FG000|Overall Study|Trial terminated prematurely|2|||
129920960|NCT04142788|467676111|FG001|Overall Study|Trial terminated prematurely|2|||
129920961|NCT05516147|467676115|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
129920962|NCT04764448|467676117|FG000|Overall Study|Study terminated by sponsor|2|||
129920963|NCT04764448|467676118|FG001|Overall Study|Study terminated by sponsor|2|||
129920964|NCT04764448|467676119|FG002|Overall Study|Study terminated by sponsor|5|||
129920965|NCT04764448|467676117|FG000|Overall Study|Withdrawal by Subject|3|||
129920966|NCT04764448|467676118|FG001|Overall Study|Withdrawal by Subject|3|||
129920967|NCT04764448|467676119|FG002|Overall Study|Withdrawal by Subject|1|||
129920968|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Other|0|||
129920969|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Other|0|||
129920970|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Other|0|||
129920971|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Other|0|||
129920972|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Other|0|||
129920973|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Other|0|||
129920974|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Other|0|||
129920975|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Other|0|||
129920976|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Other|0|||
129920977|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Other|0|||
129920978|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Other|1|||
129920979|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Other|1|||
129920980|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Other|1|||
129920981|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Other|0|||
129920982|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Other|3|||
129920983|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Other|1|||
129920984|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Other|1|||
129920985|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Other|0|||
129920986|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920987|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920988|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920989|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920990|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920991|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920992|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
129920993|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920994|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
129920995|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920996|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920997|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920998|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
129920999|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921000|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921001|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921002|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921003|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921004|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921005|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921006|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921007|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921008|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921009|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921010|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921011|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
129921012|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921013|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921014|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921015|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921016|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921017|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921018|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921019|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921020|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921021|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921022|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921023|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921024|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921025|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921026|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921027|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921028|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921029|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921030|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921031|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
129921032|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921033|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921034|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921035|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921036|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921037|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921038|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921039|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921040|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Death|0|||
129921041|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Death|0|||
129921042|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Death|0|||
129921043|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Death|0|||
129921044|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Death|0|||
129921045|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Death|0|||
129921046|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Death|0|||
129921047|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Death|0|||
129921048|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Death|0|||
129921049|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Death|1|||
129921050|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Death|0|||
129921051|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Death|1|||
129921052|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Death|0|||
129921053|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Death|1|||
129921054|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Death|0|||
129921055|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Death|0|||
129921056|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Death|2|||
129921057|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Death|0|||
129921058|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
129921059|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
129921060|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
129921061|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
129921062|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
129921063|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
129921064|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
129921065|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
130068118|NCT02727660|468203621|FG001|Overall Study|Lack of Efficacy|40|||
130068119|NCT02727660|468203622|FG002|Overall Study|Lack of Efficacy|70|||
130068120|NCT02727660|468203620|FG000|Overall Study|Adverse Event|28|||
130068121|NCT02727660|468203621|FG001|Overall Study|Adverse Event|21|||
130068122|NCT02727660|468203622|FG002|Overall Study|Adverse Event|32|||
130068123|NCT02727660|468203620|FG000|Overall Study|Withdrawal by Subject|26|||
130068124|NCT02727660|468203621|FG001|Overall Study|Withdrawal by Subject|25|||
130068125|NCT02727660|468203622|FG002|Overall Study|Withdrawal by Subject|30|||
130068126|NCT02727660|468203620|FG000|Overall Study|Physician Decision|3|||
130068127|NCT02727660|468203621|FG001|Overall Study|Physician Decision|8|||
130068128|NCT02727660|468203622|FG002|Overall Study|Physician Decision|14|||
130068129|NCT02727660|468203620|FG000|Overall Study|Lost to Follow-up|5|||
130068130|NCT02727660|468203621|FG001|Overall Study|Lost to Follow-up|9|||
130068131|NCT02727660|468203622|FG002|Overall Study|Lost to Follow-up|8|||
130068132|NCT02727660|468203620|FG000|Overall Study|Protocol Violation|7|||
130068133|NCT02727660|468203621|FG001|Overall Study|Protocol Violation|5|||
130068134|NCT02727660|468203622|FG002|Overall Study|Protocol Violation|5|||
130068135|NCT02727660|468203620|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
130068136|NCT02727660|468203621|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
130068137|NCT02727660|468203622|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
130068138|NCT02727660|468203620|FG000|Overall Study|Administrative Reasons|2|||
130068139|NCT02727660|468203621|FG001|Overall Study|Administrative Reasons|3|||
130068140|NCT02727660|468203622|FG002|Overall Study|Administrative Reasons|4|||
130068141|NCT00050960|468203623|FG000|Overall Study|Progressive Disease|137|||
130068142|NCT00050960|468203624|FG001|Overall Study|Progressive Disease|93|||
130068143|NCT00050960|468203623|FG000|Overall Study|Stable Disease|19|||
130068144|NCT00050960|468203624|FG001|Overall Study|Stable Disease|48|||
129921066|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
129921067|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
130068145|NCT00050960|468203623|FG000|Overall Study|Partial Response|14|||
130068146|NCT00050960|468203624|FG001|Overall Study|Partial Response|19|||
130068147|NCT00050960|468203623|FG000|Overall Study|Complete Response|0|||
130068148|NCT00050960|468203624|FG001|Overall Study|Complete Response|2|||
130068149|NCT00050960|468203623|FG000|Overall Study|Adverse Event|62|||
130068150|NCT00050960|468203624|FG001|Overall Study|Adverse Event|61|||
130068151|NCT00050960|468203623|FG000|Overall Study|Lost to Follow-up|0|||
130068152|NCT00050960|468203624|FG001|Overall Study|Lost to Follow-up|1|||
130068153|NCT00050960|468203623|FG000|Overall Study|Withdrawal by Subject|23|||
130068154|NCT00050960|468203624|FG001|Overall Study|Withdrawal by Subject|18|||
130068155|NCT00050960|468203623|FG000|Overall Study|Administrative|31|||
130068156|NCT00050960|468203624|FG001|Overall Study|Administrative|46|||
130068157|NCT00050960|468203623|FG000|Overall Study|Non-compliance|3|||
130068158|NCT00050960|468203624|FG001|Overall Study|Non-compliance|1|||
130068159|NCT00050960|468203623|FG000|Overall Study|Death|13|||
130068160|NCT00050960|468203624|FG001|Overall Study|Death|15|||
130068161|NCT00305604|468203625|FG000|Overall Study|Adverse Event|6|||
130068162|NCT00305604|468203626|FG001|Overall Study|Adverse Event|3|||
130068163|NCT00305604|468203625|FG000|Overall Study|Lack of Efficacy|11|||
130068164|NCT00305604|468203626|FG001|Overall Study|Lack of Efficacy|18|||
130068165|NCT00305604|468203625|FG000|Overall Study|Lost to Follow-up|0|||
130068166|NCT00305604|468203626|FG001|Overall Study|Lost to Follow-up|4|||
130068167|NCT00305604|468203625|FG000|Overall Study|Protocol Violation|2|||
130068168|NCT00305604|468203626|FG001|Overall Study|Protocol Violation|1|||
130068169|NCT00305604|468203625|FG000|Overall Study|Withdrawal by Subject|12|||
130068170|NCT00305604|468203626|FG001|Overall Study|Withdrawal by Subject|21|||
130068171|NCT00305604|468203625|FG000|Overall Study|Patient moved|1|||
130068172|NCT00305604|468203626|FG001|Overall Study|Patient moved|0|||
130068173|NCT01248364|468203627|FG000|Overall Study|Adverse Event|0|||
130068174|NCT01248364|468203628|FG001|Overall Study|Adverse Event|1|||
130068175|NCT01248364|468203629|FG002|Overall Study|Adverse Event|0|||
130068176|NCT01248364|468203630|FG003|Overall Study|Adverse Event|0|||
130068177|NCT00764946|468203631|FG000|Overall Study|Lack of Efficacy|1|||
130068178|NCT00764946|468203632|FG001|Overall Study|Lack of Efficacy|0|||
130068179|NCT00764946|468203633|FG002|Overall Study|Lack of Efficacy|0|||
130068180|NCT00764946|468203631|FG000|Overall Study|Lost to Follow-up|3|||
130068181|NCT00764946|468203632|FG001|Overall Study|Lost to Follow-up|4|||
130068182|NCT00764946|468203633|FG002|Overall Study|Lost to Follow-up|0|||
130068183|NCT00764946|468203631|FG000|Overall Study|Physician Decision|2|||
130068184|NCT00764946|468203632|FG001|Overall Study|Physician Decision|4|||
130068185|NCT00764946|468203633|FG002|Overall Study|Physician Decision|0|||
129921068|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
130068186|NCT00764946|468203631|FG000|Overall Study|Adverse Event|3|||
130068187|NCT00764946|468203632|FG001|Overall Study|Adverse Event|2|||
130068188|NCT00764946|468203633|FG002|Overall Study|Adverse Event|1|||
129921069|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
130068189|NCT00764946|468203631|FG000|Overall Study|Withdrawal by Subject|3|||
129921070|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
130068190|NCT00764946|468203632|FG001|Overall Study|Withdrawal by Subject|6|||
130068191|NCT00764946|468203633|FG002|Overall Study|Withdrawal by Subject|2|||
129921071|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
129921072|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
129921073|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
129921074|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
129921075|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
129921076|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Adverse Event|0|||
129921077|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Adverse Event|0|||
129921078|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Adverse Event|0|||
129921079|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Adverse Event|0|||
129921080|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Adverse Event|0|||
129921081|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Adverse Event|0|||
129921082|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Adverse Event|2|||
129921083|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Adverse Event|0|||
129921084|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Adverse Event|0|||
129921085|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Adverse Event|0|||
129921086|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Adverse Event|1|||
129921087|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Adverse Event|2|||
129921088|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Adverse Event|0|||
129921089|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Adverse Event|1|||
129921090|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Adverse Event|0|||
129921091|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Adverse Event|0|||
129921092|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Adverse Event|1|||
129921093|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Adverse Event|0|||
129921094|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
129921095|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
129921096|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
129921097|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
129921098|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
130068192|NCT00764946|468203631|FG000|Overall Study|Never Treated|1|||
130068193|NCT00764946|468203632|FG001|Overall Study|Never Treated|1|||
130068194|NCT00764946|468203633|FG002|Overall Study|Never Treated|1|||
130068195|NCT01192204|468203634|FG000|Overall Study|could not keep recall appointments|1|||
130068196|NCT01192204|468203635|FG001|Overall Study|could not keep recall appointments|0|||
130068197|NCT02146248|468203636|FG000|Overall Study|Withdrawal by Subject|2|||
130068198|NCT02431468|468203638|FG000|Overall Study|Adverse Event|2|||
130068199|NCT02431468|468203639|FG001|Overall Study|Adverse Event|4|||
130068200|NCT02431468|468203640|FG002|Overall Study|Adverse Event|5|||
130068201|NCT02431468|468203638|FG000|Overall Study|Withdrawal by Subject|4|||
130068202|NCT02431468|468203639|FG001|Overall Study|Withdrawal by Subject|12|||
130068203|NCT02431468|468203640|FG002|Overall Study|Withdrawal by Subject|2|||
130068204|NCT02431468|468203638|FG000|Overall Study|noncompliance, investigator termination,|2|||
130068205|NCT02431468|468203639|FG001|Overall Study|noncompliance, investigator termination,|2|||
130068206|NCT02431468|468203640|FG002|Overall Study|noncompliance, investigator termination,|2|||
130068207|NCT03589885|468203641|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
129921099|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
129921100|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
129921101|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
129921102|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
129921103|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
129921104|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
129921105|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
129921106|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
129921107|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
129921108|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
129921109|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
129921110|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
129921111|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
129921112|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921113|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921114|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921115|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921116|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921117|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921118|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921119|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921120|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921121|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921122|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921123|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921124|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129921125|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
130068208|NCT03589885|468203642|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
129921126|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
129921127|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921128|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129921129|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921130|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Other|0|||
129921131|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Other|0|||
129921132|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Other|0|||
129921133|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Other|0|||
129921134|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Other|0|||
129921135|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Other|0|||
129921136|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Other|0|||
129921137|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Other|0|||
129921138|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Other|0|||
129921139|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Other|0|||
129921140|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Other|0|||
129921141|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Other|0|||
129921142|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Other|0|||
129921143|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Other|0|||
129921144|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Other|0|||
129921145|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Other|0|||
129921146|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Other|0|||
129921147|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Other|1|||
129921148|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921149|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921150|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921151|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921152|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921153|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921154|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921155|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921156|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921157|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921158|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921159|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921160|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921161|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921162|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921163|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921164|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921165|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
129921166|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
129921167|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
129921168|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
129921169|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
129921170|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
129921171|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
129921172|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
129921173|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
129921174|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
129921175|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
129921176|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
129921177|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
129921178|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
129921179|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
129921180|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
129921181|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
129921182|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
129921183|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
129921184|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
129921185|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
129921186|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
129921187|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
129921188|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
129921189|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
129921190|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
129921191|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
130068209|NCT03589885|468203643|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
130068210|NCT03589885|468203644|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
130068211|NCT03589885|468203645|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
130068212|NCT03589885|468203641|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
129921192|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
129921193|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
129921194|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
129921195|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
129921196|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
129921197|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
130068213|NCT03589885|468203642|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130068214|NCT03589885|468203643|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
130068215|NCT03589885|468203644|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130068216|NCT03589885|468203645|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
130068217|NCT03589885|468203641|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130068218|NCT03589885|468203642|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
130068219|NCT03589885|468203643|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130068220|NCT03589885|468203644|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130068221|NCT03589885|468203645|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
130068222|NCT03589885|468203641|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130068223|NCT03589885|468203642|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130068224|NCT03589885|468203643|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
130068225|NCT03589885|468203644|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130068226|NCT03589885|468203645|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
130068227|NCT03589885|468203641|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
130068228|NCT03589885|468203642|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
130068229|NCT03589885|468203643|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
130068230|NCT03589885|468203644|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
130068231|NCT03589885|468203645|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
130068232|NCT03589885|468203641|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
130068233|NCT03589885|468203642|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
130068234|NCT03589885|468203643|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
130068235|NCT03589885|468203644|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
130068236|NCT03589885|468203645|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
130068237|NCT03589885|468203641|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
130068238|NCT03589885|468203642|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
130068239|NCT03589885|468203643|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
130068240|NCT03589885|468203644|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
130068241|NCT03589885|468203645|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
130068242|NCT03589885|468203641|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130068243|NCT03589885|468203642|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
130068244|NCT03589885|468203643|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130068245|NCT03589885|468203644|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130068246|NCT03589885|468203645|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
130068247|NCT02247401|468203646|FG000|Overall Study|Adverse Event|1|||
130068248|NCT02247401|468203647|FG001|Overall Study|Adverse Event|0|||
130068249|NCT02247401|468203648|FG002|Overall Study|Adverse Event|0|||
130068250|NCT02247401|468203646|FG000|Overall Study|Withdrawal by Subject|4|||
130068251|NCT02247401|468203647|FG001|Overall Study|Withdrawal by Subject|1|||
130068252|NCT02247401|468203648|FG002|Overall Study|Withdrawal by Subject|1|||
130068253|NCT02247401|468203646|FG000|Overall Study|Lost to Follow-up|1|||
130068254|NCT02247401|468203647|FG001|Overall Study|Lost to Follow-up|1|||
130068255|NCT02247401|468203648|FG002|Overall Study|Lost to Follow-up|1|||
130068256|NCT00192036|468203651|FG000|Overall Study|Protocol Violation|3|||
130068257|NCT00192036|468203651|FG000|Overall Study|Adverse Event|6|||
130068258|NCT00192036|468203651|FG000|Overall Study|Patient/Physician Perception|1|||
130068259|NCT00192036|468203651|FG000|Overall Study|Objective Tumor Progression|4|||
130068260|NCT00192036|468203651|FG000|Overall Study|Clinical Disease Progression|1|||
130068261|NCT00192036|468203651|FG000|Overall Study|Death|1|||
130068262|NCT00192036|468203651|FG000|Overall Study|Unknown or Not Specified|5|||
130068263|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
130068264|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
130068265|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
130068266|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
130068267|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
130068268|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
130068269|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
130068270|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
130068271|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
130068272|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
130068273|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
130068274|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
130068275|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
130068276|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
130068277|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
129921198|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
129921199|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
129921200|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
129921201|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
129921202|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
129921203|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
129921204|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
129921205|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
129921206|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
129921207|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
129921208|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
129921209|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
129921210|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
129921211|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
129921212|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
129921213|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
129921214|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
129921215|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
129921216|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
129921217|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
129921218|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
129921219|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
129921220|NCT04952909|467676150|FG000|Overall Study|Death|3|||
129921221|NCT05308004|467676151|FG000|Overall Study|Not seen by Palliative Care NP|0|||
129921222|NCT05308004|467676152|FG001|Overall Study|Not seen by Palliative Care NP|1|||
129921223|NCT03575897|467676153|FG000|Overall Study|Lost to Follow-up|12|||
129921224|NCT03575897|467676154|FG001|Overall Study|Lost to Follow-up|13|||
129921225|NCT05116787|467676161|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
129921226|NCT05116787|467676162|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
129921227|NCT05116787|467676161|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
129921228|NCT05116787|467676162|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
130068278|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
130068279|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
130068280|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
130068281|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
130068282|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
130068283|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
130068284|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
130068285|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
130068286|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
130068287|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
130068288|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
130068289|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
130068290|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
130068291|NCT00476996|468203653|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
130068292|NCT00476996|468203654|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
129921229|NCT05116787|467676161|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
129921230|NCT05116787|467676162|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
129921231|NCT05116787|467676161|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
129921232|NCT05116787|467676162|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
129921233|NCT04359108|467676163|FG000|Overall Study|Withdrawal by Subject|1|||
129921234|NCT04359108|467676164|FG001|Overall Study|Withdrawal by Subject|0|||
129921235|NCT04359108|467676163|FG000|Overall Study|Unable or too feeble to walk independently|0|||
129921236|NCT04359108|467676164|FG001|Overall Study|Unable or too feeble to walk independently|2|||
129921237|NCT04359108|467676163|FG000|Overall Study|Argus II system stopped functioning|0|||
129921238|NCT04359108|467676164|FG001|Overall Study|Argus II system stopped functioning|1|||
129921239|NCT04359108|467676163|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
129921240|NCT04359108|467676164|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
129921241|NCT06393088|467676165|FG000|Overall Study|Withdrawal by Subject|0|||
129921242|NCT06393088|467676166|FG001|Overall Study|Withdrawal by Subject|2|||
129921243|NCT02515773|467676167|FG000|Overall Study|Withdrawal by Subject|12|||
129921244|NCT02515773|467676168|FG001|Overall Study|Withdrawal by Subject|2|||
129921245|NCT02515773|467676167|FG000|Overall Study|Lost to Follow-up|119|||
129921246|NCT02515773|467676168|FG001|Overall Study|Lost to Follow-up|126|||
129921247|NCT02515773|467676167|FG000|Overall Study|Discharged from Clinic Services|53|||
129921248|NCT02515773|467676168|FG001|Overall Study|Discharged from Clinic Services|84|||
129921249|NCT02515773|467676167|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
129921250|NCT02515773|467676168|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
130068293|NCT00476996|468203655|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
129921251|NCT02515773|467676167|FG000|Overall Study|Follow-up at non-study site|8|||
129921252|NCT02515773|467676168|FG001|Overall Study|Follow-up at non-study site|16|||
129921253|NCT02515773|467676167|FG000|Overall Study|Moved from area|9|||
129921254|NCT02515773|467676168|FG001|Overall Study|Moved from area|14|||
129921255|NCT03652688|467676169|FG000|Baseline|Withdrawal by Subject|0|||
129921256|NCT03652688|467676170|FG001|Baseline|Withdrawal by Subject|3|||
129921257|NCT03652688|467676169|FG000|Follow-up|Lost to Follow-up|56|||
129921258|NCT03652688|467676170|FG001|Follow-up|Lost to Follow-up|54|||
129921259|NCT04924660|467676171|FG000|United States|Death|29|||
129921260|NCT04924660|467676172|FG001|United States|Death|32|||
129921261|NCT04924660|467676173|FG002|United States|Death|34|||
129921262|NCT04924660|467676174|FG003|United States|Death|25|||
129921263|NCT04924660|467676175|FG004|United States|Death|26|||
129921264|NCT04924660|467676176|FG005|United States|Death|23|||
129921265|NCT04924660|467676171|FG000|United States|Lost to Follow-up|15|||
129921266|NCT04924660|467676172|FG001|United States|Lost to Follow-up|10|||
129921267|NCT04924660|467676173|FG002|United States|Lost to Follow-up|13|||
129921268|NCT04924660|467676174|FG003|United States|Lost to Follow-up|5|||
129921269|NCT04924660|467676175|FG004|United States|Lost to Follow-up|19|||
129921270|NCT04924660|467676176|FG005|United States|Lost to Follow-up|20|||
129921271|NCT04924660|467676171|FG000|United States|Withdrawal by Subject|8|||
129921272|NCT04924660|467676172|FG001|United States|Withdrawal by Subject|3|||
129921273|NCT04924660|467676173|FG002|United States|Withdrawal by Subject|3|||
129921274|NCT04924660|467676174|FG003|United States|Withdrawal by Subject|3|||
129921275|NCT04924660|467676175|FG004|United States|Withdrawal by Subject|8|||
129921276|NCT04924660|467676176|FG005|United States|Withdrawal by Subject|4|||
129921277|NCT04924660|467676171|FG000|Spain|Death|0|||
129921278|NCT04924660|467676172|FG001|Spain|Death|0|||
129921279|NCT04924660|467676173|FG002|Spain|Death|0|||
129921280|NCT04924660|467676174|FG003|Spain|Death|0|||
129921281|NCT04924660|467676175|FG004|Spain|Death|0|||
129921282|NCT04924660|467676176|FG005|Spain|Death|2|||
129921283|NCT04924660|467676171|FG000|Spain|Lost to Follow-up|0|||
129921284|NCT04924660|467676172|FG001|Spain|Lost to Follow-up|0|||
129921285|NCT04924660|467676173|FG002|Spain|Lost to Follow-up|0|||
129921286|NCT04924660|467676174|FG003|Spain|Lost to Follow-up|0|||
129921287|NCT04924660|467676175|FG004|Spain|Lost to Follow-up|1|||
129921288|NCT04924660|467676176|FG005|Spain|Lost to Follow-up|0|||
129921289|NCT04924660|467676171|FG000|Brazil|Death|0|||
129921290|NCT04924660|467676172|FG001|Brazil|Death|0|||
129921291|NCT04924660|467676173|FG002|Brazil|Death|0|||
129921292|NCT04924660|467676174|FG003|Brazil|Death|0|||
129921293|NCT04924660|467676175|FG004|Brazil|Death|1|||
129921294|NCT04924660|467676176|FG005|Brazil|Death|0|||
129921295|NCT04924660|467676171|FG000|Italy|Lost to Follow-up|0|||
129921296|NCT04924660|467676172|FG001|Italy|Lost to Follow-up|0|||
129921297|NCT04924660|467676173|FG002|Italy|Lost to Follow-up|0|||
129921298|NCT04924660|467676174|FG003|Italy|Lost to Follow-up|0|||
129921299|NCT04924660|467676175|FG004|Italy|Lost to Follow-up|0|||
129921300|NCT04924660|467676176|FG005|Italy|Lost to Follow-up|1|||
129921301|NCT04924660|467676171|FG000|South Africa|Death|0|||
129921302|NCT04924660|467676172|FG001|South Africa|Death|0|||
129921303|NCT04924660|467676173|FG002|South Africa|Death|0|||
129921304|NCT04924660|467676174|FG003|South Africa|Death|0|||
129921305|NCT04924660|467676175|FG004|South Africa|Death|0|||
129921306|NCT04924660|467676176|FG005|South Africa|Death|1|||
129921307|NCT04924660|467676171|FG000|South Africa|Lost to Follow-up|0|||
129921308|NCT04924660|467676172|FG001|South Africa|Lost to Follow-up|0|||
129921309|NCT04924660|467676173|FG002|South Africa|Lost to Follow-up|0|||
129921310|NCT04924660|467676174|FG003|South Africa|Lost to Follow-up|0|||
129921311|NCT04924660|467676175|FG004|South Africa|Lost to Follow-up|0|||
129921312|NCT04924660|467676176|FG005|South Africa|Lost to Follow-up|1|||
129921313|NCT03611491|467676177|FG000|Overall Study|Lost to Follow-up|1|||
129921314|NCT05894577|467676178|FG000|Overall Study|No receipt of study drug|14|||
129921315|NCT05894577|467676179|FG001|Overall Study|No receipt of study drug|13|||
129921316|NCT05894577|467676178|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
129921317|NCT05894577|467676179|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
129921318|NCT05894577|467676178|FG000|Overall Study|Screen Fail|2|||
129921319|NCT05894577|467676179|FG001|Overall Study|Screen Fail|0|||
129921320|NCT05894577|467676178|FG000|Overall Study|Study drug recall|86|||
129921321|NCT05894577|467676179|FG001|Overall Study|Study drug recall|63|||
129921322|NCT04015167|467676192|FG000|Overall Study|Lost to Follow-up|40|||
129921323|NCT04015167|467676192|FG000|Overall Study|Adverse Event|5|||
129921324|NCT04015167|467676192|FG000|Overall Study|Withdrawal by Subject|2|||
129921325|NCT04015167|467676192|FG000|Overall Study|Subject went to jail|1|||
129921326|NCT03640312|467676193|FG000|Overall Study|Lost to Follow-up|3|||
129921327|NCT03640312|467676194|FG001|Overall Study|Lost to Follow-up|6|||
129921328|NCT02761057|467676200|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
129921329|NCT02761057|467676201|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
129921330|NCT02761057|467676202|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
129921331|NCT02761057|467676203|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
129921332|NCT02761057|467676200|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
129921333|NCT02761057|467676201|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
129921334|NCT02761057|467676202|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
129921335|NCT02761057|467676203|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
129921336|NCT02761057|467676200|FG000|Overall Study|Currently On Study Treatment|0|||
129921337|NCT02761057|467676201|FG001|Overall Study|Currently On Study Treatment|3|||
129921338|NCT02761057|467676202|FG002|Overall Study|Currently On Study Treatment|0|||
129921339|NCT02761057|467676203|FG003|Overall Study|Currently On Study Treatment|0|||
129921340|NCT02761057|467676200|FG000|Overall Study|Adverse Event|11|||
129921341|NCT02761057|467676201|FG001|Overall Study|Adverse Event|9|||
129921342|NCT02761057|467676202|FG002|Overall Study|Adverse Event|5|||
129921343|NCT02761057|467676203|FG003|Overall Study|Adverse Event|3|||
129921344|NCT02761057|467676200|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
129921345|NCT02761057|467676201|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
129921346|NCT02761057|467676202|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
129921347|NCT02761057|467676203|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
129921348|NCT02761057|467676200|FG000|Overall Study|Progression/Relapse|29|||
129921349|NCT02761057|467676201|FG001|Overall Study|Progression/Relapse|27|||
129921350|NCT02761057|467676202|FG002|Overall Study|Progression/Relapse|20|||
129921351|NCT02761057|467676203|FG003|Overall Study|Progression/Relapse|23|||
129921352|NCT02761057|467676200|FG000|Overall Study|Death|2|||
129921353|NCT02761057|467676201|FG001|Overall Study|Death|2|||
129921354|NCT02761057|467676202|FG002|Overall Study|Death|1|||
129921355|NCT02761057|467676203|FG003|Overall Study|Death|1|||
129921356|NCT02761057|467676200|FG000|Overall Study|Other - Not Protocol Specified|2|||
129921357|NCT02761057|467676201|FG001|Overall Study|Other - Not Protocol Specified|1|||
129921358|NCT02761057|467676202|FG002|Overall Study|Other - Not Protocol Specified|2|||
129921359|NCT02761057|467676203|FG003|Overall Study|Other - Not Protocol Specified|0|||
129921360|NCT04876118|467676204|FG000|Overall Study|Pregnancy|1|||
129921361|NCT04876118|467676204|FG000|Overall Study|Withdrawal by Subject|14|||
129921362|NCT04229992|467677893|FG000|Overall Study|Withdrawal by Subject|0|||
129921363|NCT04229992|467677894|FG001|Overall Study|Withdrawal by Subject|2|||
129921364|NCT04229992|467677895|FG002|Overall Study|Withdrawal by Subject|1|||
129921365|NCT04229992|467677896|FG003|Overall Study|Withdrawal by Subject|1|||
129921366|NCT04229992|467677893|FG000|Overall Study|Adverse Event|1|||
129921367|NCT04229992|467677894|FG001|Overall Study|Adverse Event|1|||
129921368|NCT04229992|467677895|FG002|Overall Study|Adverse Event|3|||
129921369|NCT04229992|467677896|FG003|Overall Study|Adverse Event|1|||
129921370|NCT04229992|467677893|FG000|Overall Study|Lost to Follow-up|0|||
129921371|NCT04229992|467677894|FG001|Overall Study|Lost to Follow-up|0|||
129921372|NCT04229992|467677895|FG002|Overall Study|Lost to Follow-up|0|||
129921373|NCT04229992|467677896|FG003|Overall Study|Lost to Follow-up|1|||
129921374|NCT03770273|467677897|FG000|Overall Study|Adverse Event|2|||
129921375|NCT03770273|467677898|FG001|Overall Study|Adverse Event|0|||
129921376|NCT03770273|467677897|FG000|Overall Study|Lost to Follow-up|1|||
129921377|NCT03770273|467677898|FG001|Overall Study|Lost to Follow-up|1|||
129921378|NCT00418886|467677899|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
129921379|NCT00418886|467677900|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
129921380|NCT00418886|467677899|FG000|Randomized Period|Death|122|||
129921381|NCT00418886|467677900|FG001|Randomized Period|Death|147|||
129921382|NCT00418886|467677899|FG000|Randomized Period|Withdrawal by Subject|9|||
129921383|NCT00418886|467677900|FG001|Randomized Period|Withdrawal by Subject|10|||
129921384|NCT00418886|467677899|FG000|Randomized Period|Lost to Follow-up|4|||
129921385|NCT00418886|467677900|FG001|Randomized Period|Lost to Follow-up|6|||
129921386|NCT00418886|467677899|FG000|Randomized Period|withdrawn due to other reason|1|||
129921387|NCT00418886|467677900|FG001|Randomized Period|withdrawn due to other reason|0|||
129921388|NCT00418886|467677899|FG000|Randomized Period|randomised but no treatment received|0|||
129921389|NCT00418886|467677900|FG001|Randomized Period|randomised but no treatment received|1|||
129921390|NCT04060654|467677901|FG000|Overall Study|Withdrawal by Subject|1|||
129921391|NCT04060654|467677901|FG000|Overall Study|Lost to Follow-up|5|||
129921392|NCT03707951|467677902|FG000|Overall Study|Lost to Follow-up|8|||
129921393|NCT03707951|467677903|FG001|Overall Study|Lost to Follow-up|17|||
129921394|NCT03707951|467677902|FG000|Overall Study|Withdrawal by Subject|6|||
129921395|NCT03707951|467677903|FG001|Overall Study|Withdrawal by Subject|6|||
129921396|NCT04887129|467677904|FG000|Overall Study|Lost to Follow-up|0|||
129921397|NCT04887129|467677905|FG001|Overall Study|Lost to Follow-up|24|||
129921398|NCT04887129|467677904|FG000|Overall Study|Withdrawal by Subject|9|||
129921399|NCT04887129|467677905|FG001|Overall Study|Withdrawal by Subject|57|||
129921400|NCT04887129|467677904|FG000|Overall Study|Other|2|||
129921401|NCT04887129|467677905|FG001|Overall Study|Other|9|||
129921402|NCT05177848|467677910|FG000|Overall Study|Lost to Follow-up|1|||
129921403|NCT05177848|467677911|FG001|Overall Study|Lost to Follow-up|4|||
129921404|NCT05177848|467677910|FG000|Overall Study|Discontinued|2|||
129921405|NCT05177848|467677911|FG001|Overall Study|Discontinued|1|||
129921406|NCT02035787|467677912|FG000|Overall Study- 12 Months|Adverse Event|3|||
129921407|NCT02035787|467677913|FG001|Overall Study- 12 Months|Adverse Event|0|||
129921408|NCT02035787|467677912|FG000|Overall Study- 12 Months|Complete response|4|||
129921409|NCT02035787|467677913|FG001|Overall Study- 12 Months|Complete response|1|||
129921410|NCT02035787|467677912|FG000|Overall Study- 12 Months|Protocol Violation|1|||
129921411|NCT02035787|467677913|FG001|Overall Study- 12 Months|Protocol Violation|1|||
129921412|NCT06414213|467677914|FG000|Overall Study|Lost to Follow-up|1|||
129921413|NCT06414213|467677915|FG001|Overall Study|Lost to Follow-up|1|||
129921414|NCT06414213|467677916|FG002|Overall Study|Lost to Follow-up|3|||
129921415|NCT03338933|467677917|FG000|Screening Visit|Lost to Follow-up|1|||
129921416|NCT03338933|467677918|FG001|Screening Visit|Lost to Follow-up|3|||
129921417|NCT03338933|467677919|FG002|Screening Visit|Lost to Follow-up|1|||
129921418|NCT03338933|467677920|FG003|Screening Visit|Lost to Follow-up|4|||
129921419|NCT03338933|467677917|FG000|Screening Visit|Screen fail after consent|2|||
129921420|NCT03338933|467677918|FG001|Screening Visit|Screen fail after consent|7|||
129921421|NCT03338933|467677919|FG002|Screening Visit|Screen fail after consent|1|||
129921422|NCT03338933|467677920|FG003|Screening Visit|Screen fail after consent|4|||
129921423|NCT03338933|467677917|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
129921424|NCT03338933|467677918|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
129921425|NCT03338933|467677919|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
129921426|NCT03338933|467677920|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
129921427|NCT03338933|467677917|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
129921428|NCT03338933|467677918|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
129921429|NCT03338933|467677919|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
129921430|NCT03338933|467677920|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
129921431|NCT03338933|467677917|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
129921432|NCT03338933|467677918|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
129921433|NCT03338933|467677919|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
129921434|NCT03338933|467677920|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
129921435|NCT01084876|467677922|FG000|Main Study Treatment Period|Adverse Event|12|||
129921436|NCT01084876|467677923|FG001|Main Study Treatment Period|Adverse Event|7|||
129921437|NCT01084876|467677922|FG000|Main Study Treatment Period|Disease Progression|41|||
129921438|NCT01084876|467677923|FG001|Main Study Treatment Period|Disease Progression|24|||
129921439|NCT01084876|467677922|FG000|Main Study Treatment Period|Physician Decision|2|||
129921440|NCT01084876|467677923|FG001|Main Study Treatment Period|Physician Decision|0|||
129921441|NCT01084876|467677922|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
129921442|NCT01084876|467677923|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
129921443|NCT01084876|467677922|FG000|Main Study Treatment Period|Other Reason|0|||
129921444|NCT01084876|467677923|FG001|Main Study Treatment Period|Other Reason|1|||
129921445|NCT01084876|467677922|FG000|Main Study Treatment Period|Other|0|||
129921446|NCT01084876|467677923|FG001|Main Study Treatment Period|Other|1|||
129921447|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
129921448|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
129921449|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
129921450|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
129921451|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
129921452|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
129921453|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
129921454|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
129921455|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
129921456|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
129921457|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Other|6|||
129921458|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Other|9|||
129921459|NCT02924272|467677933|FG000|Overall Study|Site Terminated by Sponsor|4|||
129921460|NCT02924272|467677934|FG001|Overall Study|Site Terminated by Sponsor|1|||
129921461|NCT02924272|467677933|FG000|Overall Study|Withdrawal by Subject|2|||
129921462|NCT02924272|467677934|FG001|Overall Study|Withdrawal by Subject|0|||
129921463|NCT02924272|467677933|FG000|Overall Study|Adverse Event|3|||
129921464|NCT02924272|467677934|FG001|Overall Study|Adverse Event|0|||
129921465|NCT02924272|467677933|FG000|Overall Study|Progressive Disease|11|||
129921466|NCT02924272|467677934|FG001|Overall Study|Progressive Disease|8|||
129921467|NCT02924272|467677933|FG000|Overall Study|Clinical Deterioration|1|||
129921468|NCT02924272|467677934|FG001|Overall Study|Clinical Deterioration|0|||
129921469|NCT02924272|467677933|FG000|Overall Study|Death|1|||
129921470|NCT02924272|467677934|FG001|Overall Study|Death|0|||
129921471|NCT02924272|467677933|FG000|Overall Study|Reason Not Specified|1|||
129921472|NCT02924272|467677934|FG001|Overall Study|Reason Not Specified|0|||
129921473|NCT03468218|467677942|FG000|Overall Study|Adverse Event|5|||
130068294|NCT00476996|468203656|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
130068295|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
130068296|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
130068297|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
130068298|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
130068299|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
129921474|NCT03468218|467677942|FG000|Overall Study|Progressive Disease|16|||
129921475|NCT03468218|467677942|FG000|Overall Study|Death|1|||
129921476|NCT03468218|467677942|FG000|Overall Study|Alternate therapy|1|||
129921477|NCT03468218|467677942|FG000|Overall Study|Withdrawal by Subject|2|||
129921478|NCT03829410|467677944|FG000|Overall Study|Adverse Event|1|||
129921479|NCT03829410|467677945|FG001|Overall Study|Adverse Event|0|||
129921480|NCT03829410|467677946|FG002|Overall Study|Adverse Event|1|||
129921481|NCT03829410|467677947|FG003|Overall Study|Adverse Event|4|||
129921482|NCT03829410|467677944|FG000|Overall Study|Physician Decision|0|||
129921483|NCT03829410|467677945|FG001|Overall Study|Physician Decision|0|||
129921484|NCT03829410|467677946|FG002|Overall Study|Physician Decision|0|||
129921485|NCT03829410|467677947|FG003|Overall Study|Physician Decision|2|||
129921486|NCT03829410|467677944|FG000|Overall Study|Disease Progressing|3|||
129921487|NCT03829410|467677945|FG001|Overall Study|Disease Progressing|4|||
129921488|NCT03829410|467677946|FG002|Overall Study|Disease Progressing|2|||
129921489|NCT03829410|467677947|FG003|Overall Study|Disease Progressing|31|||
129921490|NCT03829410|467677944|FG000|Overall Study|Miscellaneous|2|||
129921491|NCT03829410|467677945|FG001|Overall Study|Miscellaneous|4|||
129921492|NCT03829410|467677946|FG002|Overall Study|Miscellaneous|3|||
129921493|NCT03829410|467677947|FG003|Overall Study|Miscellaneous|10|||
129921494|NCT03719443|467677948|FG000|Overall Study|Lost to Follow-up|0|||
129921495|NCT03719443|467677949|FG001|Overall Study|Lost to Follow-up|0|||
129921496|NCT03719443|467677950|FG002|Overall Study|Lost to Follow-up|1|||
129921497|NCT03719443|467677951|FG003|Overall Study|Lost to Follow-up|0|||
129921498|NCT03719443|467677952|FG004|Overall Study|Lost to Follow-up|1|||
129921499|NCT03719443|467677953|FG005|Overall Study|Lost to Follow-up|0|||
129921500|NCT03719443|467677954|FG006|Overall Study|Lost to Follow-up|1|||
129921501|NCT03719443|467677948|FG000|Overall Study|Withdrawal by Subject|0|||
129921502|NCT03719443|467677949|FG001|Overall Study|Withdrawal by Subject|0|||
129921503|NCT03719443|467677950|FG002|Overall Study|Withdrawal by Subject|1|||
129921504|NCT03719443|467677951|FG003|Overall Study|Withdrawal by Subject|0|||
129921505|NCT03719443|467677952|FG004|Overall Study|Withdrawal by Subject|0|||
129921506|NCT03719443|467677953|FG005|Overall Study|Withdrawal by Subject|0|||
129921507|NCT03719443|467677954|FG006|Overall Study|Withdrawal by Subject|0|||
129921508|NCT06205407|467677955|FG000|Period 2|Withdrawal by Subject|0|||
129921509|NCT06205407|467677956|FG001|Period 2|Withdrawal by Subject|1|||
129921510|NCT06205407|467677955|FG000|Period 2|Adverse Event|2|||
129921511|NCT06205407|467677956|FG001|Period 2|Adverse Event|1|||
129921512|NCT04676022|467677958|FG000|Overall Study|Screen Failure/|1|||
129921513|NCT04676022|467677959|FG001|Overall Study|Screen Failure/|1|||
129921514|NCT04676022|467677960|FG002|Overall Study|Screen Failure/|85|||
129921515|NCT04676022|467677958|FG000|Overall Study|Lost to Follow-up|1|||
129921516|NCT04676022|467677959|FG001|Overall Study|Lost to Follow-up|1|||
129921517|NCT04676022|467677960|FG002|Overall Study|Lost to Follow-up|0|||
129921518|NCT04676022|467677958|FG000|Overall Study|Adverse Event|2|||
129921519|NCT04676022|467677959|FG001|Overall Study|Adverse Event|0|||
129921520|NCT04676022|467677960|FG002|Overall Study|Adverse Event|1|||
129921521|NCT04676022|467677958|FG000|Overall Study|Physician Decision|2|||
129921522|NCT04676022|467677959|FG001|Overall Study|Physician Decision|0|||
129921523|NCT04676022|467677960|FG002|Overall Study|Physician Decision|1|||
129921524|NCT04676022|467677958|FG000|Overall Study|Withdrawal by Subject|3|||
129921525|NCT04676022|467677959|FG001|Overall Study|Withdrawal by Subject|1|||
129921526|NCT04676022|467677960|FG002|Overall Study|Withdrawal by Subject|6|||
129921527|NCT04676022|467677958|FG000|Overall Study|Will not move forward with permanent implant|6|||
129921528|NCT04676022|467677959|FG001|Overall Study|Will not move forward with permanent implant|0|||
129921529|NCT04676022|467677960|FG002|Overall Study|Will not move forward with permanent implant|0|||
129921530|NCT04676022|467677958|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
129921531|NCT04676022|467677959|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
129921532|NCT04676022|467677960|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
129921533|NCT05409183|467677964|FG000|Complete Study|Adverse Event|1|||
129921534|NCT05409183|467677965|FG001|Complete Study|Adverse Event|2|||
129921535|NCT05409183|467677964|FG000|Complete Study|Withdrawal by Subject|3|||
129921536|NCT05409183|467677965|FG001|Complete Study|Withdrawal by Subject|0|||
129921537|NCT02274662|467677966|FG000|Overall Study|Death|1|||
129921538|NCT02274662|467677966|FG000|Overall Study|Lost to Follow-up|3|||
129921539|NCT03194217|467677967|FG000|Overall Study|Adverse Event|0|||
129921540|NCT03194217|467677968|FG001|Overall Study|Adverse Event|2|||
129921541|NCT03194217|467677969|FG002|Overall Study|Adverse Event|3|||
129921542|NCT03194217|467677970|FG003|Overall Study|Adverse Event|3|||
129921543|NCT03194217|467677967|FG000|Overall Study|Failure to meet randomisation criteria|0|||
129921544|NCT03194217|467677968|FG001|Overall Study|Failure to meet randomisation criteria|0|||
129921545|NCT03194217|467677969|FG002|Overall Study|Failure to meet randomisation criteria|0|||
129921546|NCT03194217|467677970|FG003|Overall Study|Failure to meet randomisation criteria|1|||
129921547|NCT03194217|467677967|FG000|Overall Study|Other|0|||
129921548|NCT03194217|467677968|FG001|Overall Study|Other|1|||
129921549|NCT03194217|467677969|FG002|Overall Study|Other|1|||
129921550|NCT03194217|467677970|FG003|Overall Study|Other|0|||
130116961|NCT00095199|468387234|FG002|Overall Study|Withdrawal by Subject|13|||
130116962|NCT00095199|468387235|FG003|Overall Study|Withdrawal by Subject|22|||
130116963|NCT00095199|468387232|FG000|Overall Study|Protocol Violation|4|||
130116964|NCT00095199|468387233|FG001|Overall Study|Protocol Violation|4|||
130116965|NCT00095199|468387234|FG002|Overall Study|Protocol Violation|2|||
130116966|NCT00095199|468387235|FG003|Overall Study|Protocol Violation|0|||
130116967|NCT00095199|468387232|FG000|Overall Study|Liver function test results elevated|0|||
130116968|NCT00095199|468387233|FG001|Overall Study|Liver function test results elevated|0|||
130116969|NCT00095199|468387234|FG002|Overall Study|Liver function test results elevated|1|||
130116970|NCT00095199|468387235|FG003|Overall Study|Liver function test results elevated|1|||
130116971|NCT00095199|468387232|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
130116972|NCT00095199|468387233|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
130116973|NCT00095199|468387234|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
130116974|NCT00095199|468387235|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
130116975|NCT00095199|468387232|FG000|Overall Study|Physician Decision|5|||
130116976|NCT00095199|468387233|FG001|Overall Study|Physician Decision|6|||
130116977|NCT00095199|468387234|FG002|Overall Study|Physician Decision|1|||
130116978|NCT00095199|468387235|FG003|Overall Study|Physician Decision|1|||
130116979|NCT00095199|468387232|FG000|Overall Study|Not eligible|1|||
130116980|NCT00095199|468387233|FG001|Overall Study|Not eligible|7|||
130116981|NCT00095199|468387234|FG002|Overall Study|Not eligible|0|||
130116982|NCT00095199|468387235|FG003|Overall Study|Not eligible|1|||
130116983|NCT00095199|468387232|FG000|Overall Study|Started Palliative Radiotherapy|1|||
130116984|NCT00095199|468387233|FG001|Overall Study|Started Palliative Radiotherapy|0|||
130116985|NCT00095199|468387234|FG002|Overall Study|Started Palliative Radiotherapy|0|||
130116986|NCT00095199|468387235|FG003|Overall Study|Started Palliative Radiotherapy|0|||
130116987|NCT00095199|468387232|FG000|Overall Study|Started radiotherapy regimen|0|||
130116988|NCT00095199|468387233|FG001|Overall Study|Started radiotherapy regimen|1|||
130116989|NCT00095199|468387234|FG002|Overall Study|Started radiotherapy regimen|0|||
130116990|NCT00095199|468387235|FG003|Overall Study|Started radiotherapy regimen|0|||
130116991|NCT00095199|468387232|FG000|Overall Study|Primary tumor removed in other surgery|0|||
130116992|NCT00095199|468387233|FG001|Overall Study|Primary tumor removed in other surgery|1|||
130116993|NCT00095199|468387234|FG002|Overall Study|Primary tumor removed in other surgery|0|||
130116994|NCT00095199|468387235|FG003|Overall Study|Primary tumor removed in other surgery|0|||
130116995|NCT00095199|468387232|FG000|Overall Study|Data inadvertently lost by site|1|||
130116996|NCT00095199|468387233|FG001|Overall Study|Data inadvertently lost by site|0|||
130116997|NCT00095199|468387234|FG002|Overall Study|Data inadvertently lost by site|0|||
130116998|NCT00095199|468387235|FG003|Overall Study|Data inadvertently lost by site|0|||
129921551|NCT02936752|467677971|FG000|Overall Study|Death|2|||
129921552|NCT02936752|467677972|FG001|Overall Study|Death|1|||
129921553|NCT02936752|467677971|FG000|Overall Study|Physician Decision|4|||
129921554|NCT02936752|467677972|FG001|Overall Study|Physician Decision|0|||
129921555|NCT02936752|467677971|FG000|Overall Study|Withdrawal by Subject|0|||
129921556|NCT02936752|467677972|FG001|Overall Study|Withdrawal by Subject|2|||
129921557|NCT04489771|467677975|FG000|Overall Study|Death|27|||
129921558|NCT04489771|467677976|FG001|Overall Study|Death|25|||
129921559|NCT04489771|467677975|FG000|Overall Study|Withdrawal by Subject|1|||
129921560|NCT04489771|467677976|FG001|Overall Study|Withdrawal by Subject|0|||
129921561|NCT04489771|467677975|FG000|Overall Study|Participants Ongoing in Study|50|||
129921562|NCT04489771|467677976|FG001|Overall Study|Participants Ongoing in Study|51|||
129921563|NCT04509674|467677981|FG000|Overall Study|Not treated|33|||
129921564|NCT04509674|467677982|FG001|Overall Study|Not treated|26|||
129921565|NCT04509674|467677981|FG000|Overall Study|Protocol Violation|9|||
129921566|NCT04509674|467677982|FG001|Overall Study|Protocol Violation|10|||
129921567|NCT04509674|467677981|FG000|Overall Study|Lost to Follow-up|31|||
129921568|NCT04509674|467677982|FG001|Overall Study|Lost to Follow-up|39|||
129921569|NCT04509674|467677981|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
129921570|NCT04509674|467677982|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
129921571|NCT04509674|467677981|FG000|Overall Study|Adverse event, serious fatal event|11|||
129921572|NCT04509674|467677982|FG001|Overall Study|Adverse event, serious fatal event|4|||
129921573|NCT04509674|467677981|FG000|Overall Study|Adverse event, non-fatal event|107|||
129921574|NCT04509674|467677982|FG001|Overall Study|Adverse event, non-fatal event|118|||
129921575|NCT04509674|467677981|FG000|Overall Study|Other reason than listed|106|||
129921576|NCT04509674|467677982|FG001|Overall Study|Other reason than listed|95|||
129921577|NCT03197662|467677983|FG000|Overall Study|Withdrawn by family|0|||
129921578|NCT03197662|467677984|FG001|Overall Study|Withdrawn by family|2|||
129921579|NCT01214616|467677985|FG000|Overall Study|Progressive disease|2|||
130116999|NCT01896297|468387238|FG000|Overall Study|Died in post treatment phase|1|||
130117000|NCT04527471|468388727|FG000|Overall Study|Adverse Event|1|||
130117001|NCT04527471|468388728|FG001|Overall Study|Adverse Event|0|||
130117002|NCT04527471|468388727|FG000|Overall Study|Lost to Follow-up|1|||
130117003|NCT04527471|468388728|FG001|Overall Study|Lost to Follow-up|0|||
130117004|NCT00096265|468388736|FG000|Overall Study|Ineligible|1|||
130117005|NCT00096265|468388737|FG001|Overall Study|Ineligible|0|||
130117006|NCT00096265|468388738|FG002|Overall Study|Ineligible|0|||
130068300|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
130068301|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
130068302|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
130068303|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Death|0|||
130068304|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Death|0|||
130068305|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Death|0|||
130068306|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Death|7|||
130068307|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
130068308|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
130068309|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
130068310|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
130068311|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
130068312|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
130068313|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
130068314|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
130068315|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
130068316|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
130068317|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
130068318|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
130068319|NCT00476996|468203653|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
130068320|NCT00476996|468203654|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
130068321|NCT00476996|468203655|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
130068322|NCT00476996|468203656|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
130068323|NCT01769469|468203659|FG000|Overall Study|Consent Withdrawn|5|||
130068324|NCT01769469|468203659|FG000|Overall Study|Moved Out Of Area|3|||
130068325|NCT01769469|468203659|FG000|Overall Study|Lost to Follow-up|17|||
130068326|NCT01769469|468203659|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
130068327|NCT01769469|468203659|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
130068328|NCT02394795|468203667|FG000|Overall Study|Adverse Event|92|||
130068329|NCT02394795|468203668|FG001|Overall Study|Adverse Event|70|||
130068330|NCT02394795|468203667|FG000|Overall Study|Lost to Follow-up|0|||
130068331|NCT02394795|468203668|FG001|Overall Study|Lost to Follow-up|1|||
130068332|NCT02394795|468203667|FG000|Overall Study|Withdrawal by Subject|17|||
130068333|NCT02394795|468203668|FG001|Overall Study|Withdrawal by Subject|26|||
130068334|NCT02394795|468203667|FG000|Overall Study|Lack of Efficacy|181|||
130068335|NCT02394795|468203668|FG001|Overall Study|Lack of Efficacy|211|||
130068336|NCT02394795|468203667|FG000|Overall Study|Death|4|||
130068337|NCT02394795|468203668|FG001|Overall Study|Death|5|||
130068338|NCT02394795|468203667|FG000|Overall Study|Physician Decision|109|||
130068339|NCT02394795|468203668|FG001|Overall Study|Physician Decision|93|||
129921580|NCT01214616|467677986|FG001|Overall Study|Progressive disease|2|||
129921581|NCT01214616|467677987|FG002|Overall Study|Progressive disease|2|||
129921582|NCT01214616|467677988|FG003|Overall Study|Progressive disease|4|||
129921583|NCT01214616|467677985|FG000|Overall Study|Dose limiting toxicity|0|||
129921584|NCT01214616|467677986|FG001|Overall Study|Dose limiting toxicity|2|||
129921585|NCT01214616|467677987|FG002|Overall Study|Dose limiting toxicity|0|||
129921586|NCT01214616|467677988|FG003|Overall Study|Dose limiting toxicity|0|||
129921587|NCT01214616|467677985|FG000|Overall Study|Other adverse events|0|||
129921588|NCT01214616|467677986|FG001|Overall Study|Other adverse events|1|||
129921589|NCT01214616|467677987|FG002|Overall Study|Other adverse events|1|||
129921590|NCT01214616|467677988|FG003|Overall Study|Other adverse events|1|||
129921591|NCT01214616|467677985|FG000|Overall Study|Withdrawal by Subject|1|||
129921592|NCT01214616|467677986|FG001|Overall Study|Withdrawal by Subject|0|||
129921593|NCT01214616|467677987|FG002|Overall Study|Withdrawal by Subject|0|||
129921594|NCT01214616|467677988|FG003|Overall Study|Withdrawal by Subject|1|||
129921595|NCT03721952|467677989|FG000|Overall Study|Lost to Follow-up|0|||
129921596|NCT03721952|467677990|FG001|Overall Study|Lost to Follow-up|0|||
129921597|NCT03721952|467677991|FG002|Overall Study|Lost to Follow-up|2|||
129921598|NCT03721952|467677992|FG003|Overall Study|Lost to Follow-up|0|||
129921599|NCT03721952|467677993|FG004|Overall Study|Lost to Follow-up|0|||
129921600|NCT03721952|467677989|FG000|Overall Study|Protocol Violation|0|||
129921601|NCT03721952|467677990|FG001|Overall Study|Protocol Violation|1|||
129921602|NCT03721952|467677991|FG002|Overall Study|Protocol Violation|0|||
129921603|NCT03721952|467677992|FG003|Overall Study|Protocol Violation|0|||
129921604|NCT03721952|467677993|FG004|Overall Study|Protocol Violation|0|||
129921605|NCT03721952|467677989|FG000|Overall Study|Withdrawal by Subject|1|||
129921606|NCT03721952|467677990|FG001|Overall Study|Withdrawal by Subject|0|||
129921607|NCT03721952|467677991|FG002|Overall Study|Withdrawal by Subject|40|||
129921608|NCT03721952|467677992|FG003|Overall Study|Withdrawal by Subject|28|||
129921609|NCT03721952|467677993|FG004|Overall Study|Withdrawal by Subject|0|||
129921610|NCT05292365|467677996|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
129921611|NCT05292365|467677997|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
129921612|NCT05292365|467677998|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
129921613|NCT05292365|467677999|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
129921614|NCT04495894|467678008|FG000|Overall Study|Withdrawal by Subject|2|||
129921615|NCT04495894|467678009|FG001|Overall Study|Withdrawal by Subject|0|||
129921616|NCT04495894|467678010|FG002|Overall Study|Withdrawal by Subject|2|||
129921617|NCT04495894|467678011|FG003|Overall Study|Withdrawal by Subject|3|||
129921618|NCT04495894|467678008|FG000|Overall Study|Early termination|0|||
129921619|NCT04495894|467678009|FG001|Overall Study|Early termination|0|||
129921620|NCT04495894|467678010|FG002|Overall Study|Early termination|3|||
129921621|NCT04495894|467678011|FG003|Overall Study|Early termination|0|||
129921622|NCT05579899|467678013|FG000|Overall Study|Lost to Follow-up|3|||
129921623|NCT05579899|467678014|FG001|Overall Study|Lost to Follow-up|1|||
129921624|NCT05579899|467678013|FG000|Overall Study|Adverse Event|0|||
129921625|NCT05579899|467678014|FG001|Overall Study|Adverse Event|3|||
129921626|NCT05579899|467678013|FG000|Overall Study|Pregnancy|0|||
129921627|NCT05579899|467678014|FG001|Overall Study|Pregnancy|1|||
129921628|NCT05579899|467678013|FG000|Overall Study|Withdrawal by Subject|0|||
129921629|NCT05579899|467678014|FG001|Overall Study|Withdrawal by Subject|3|||
129921630|NCT01000961|467678018|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
129921631|NCT01000961|467678019|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129921632|NCT01000961|467678018|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
129921633|NCT01000961|467678019|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
129921634|NCT04185298|467678023|FG000|Overall Study|Lost to Follow-up|1|||
129921635|NCT04185298|467678024|FG001|Overall Study|Lost to Follow-up|3|||
129921636|NCT04185298|467678023|FG000|Overall Study|Withdrawal by Subject|0|||
129921637|NCT04185298|467678024|FG001|Overall Study|Withdrawal by Subject|3|||
129921638|NCT01798498|467678025|FG000|Overall Study|Lost to Follow-up|1|||
129921639|NCT03896789|467678026|FG000|Baseline|Lost to Follow-up|1|||
129921640|NCT03896789|467678027|FG001|Baseline|Lost to Follow-up|2|||
129921641|NCT03896789|467678026|FG000|Baseline|Death|3|||
129921642|NCT03896789|467678027|FG001|Baseline|Death|6|||
129921643|NCT03896789|467678026|FG000|Post-Randomization|Lost to Follow-up|12|||
129921644|NCT03896789|467678027|FG001|Post-Randomization|Lost to Follow-up|11|||
129921645|NCT03896789|467678026|FG000|Post-Randomization|Death|12|||
129921646|NCT03896789|467678027|FG001|Post-Randomization|Death|13|||
129921647|NCT03447470|467678028|FG000|Overall Study|Death|0|||
129921648|NCT03447470|467678029|FG001|Overall Study|Death|1|||
129921649|NCT03447470|467678030|FG002|Overall Study|Death|3|||
129921650|NCT03447470|467678031|FG003|Overall Study|Death|0|||
129921651|NCT03447470|467678032|FG004|Overall Study|Death|1|||
129921652|NCT03447470|467678033|FG005|Overall Study|Death|0|||
129921653|NCT03447470|467678034|FG006|Overall Study|Death|3|||
129921654|NCT03447470|467678035|FG007|Overall Study|Death|3|||
129921655|NCT03447470|467678036|FG008|Overall Study|Death|1|||
129921656|NCT03447470|467678028|FG000|Overall Study|Withdrawal by Subject|1|||
129921657|NCT03447470|467678029|FG001|Overall Study|Withdrawal by Subject|0|||
129921658|NCT03447470|467678030|FG002|Overall Study|Withdrawal by Subject|0|||
129921659|NCT03447470|467678031|FG003|Overall Study|Withdrawal by Subject|0|||
129921660|NCT03447470|467678032|FG004|Overall Study|Withdrawal by Subject|1|||
129921661|NCT03447470|467678033|FG005|Overall Study|Withdrawal by Subject|0|||
129921662|NCT03447470|467678034|FG006|Overall Study|Withdrawal by Subject|1|||
129921663|NCT03447470|467678035|FG007|Overall Study|Withdrawal by Subject|1|||
129921664|NCT03447470|467678036|FG008|Overall Study|Withdrawal by Subject|3|||
129921665|NCT03447470|467678028|FG000|Overall Study|Treatment discontinued|3|||
129921666|NCT03447470|467678029|FG001|Overall Study|Treatment discontinued|2|||
129921667|NCT03447470|467678030|FG002|Overall Study|Treatment discontinued|4|||
129921668|NCT03447470|467678031|FG003|Overall Study|Treatment discontinued|6|||
129921669|NCT03447470|467678032|FG004|Overall Study|Treatment discontinued|2|||
130068340|NCT02031432|468203673|FG000|Overall Study|Protocol Violation|1|||
130068341|NCT02031432|468203673|FG000|Overall Study|Lack of Efficacy|5|||
130068342|NCT02031432|468203673|FG000|Overall Study|Cancer Progression|2|||
130068343|NCT02031432|468203673|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
130068344|NCT02031432|468203673|FG000|Overall Study|Adverse Event|8|||
130068345|NCT02031432|468203673|FG000|Overall Study|Withdrawal by Subject|5|||
130068346|NCT02031432|468203673|FG000|Overall Study|Lost to Follow-up|1|||
129921670|NCT03447470|467678033|FG005|Overall Study|Treatment discontinued|1|||
129921671|NCT03447470|467678034|FG006|Overall Study|Treatment discontinued|2|||
129921672|NCT03447470|467678035|FG007|Overall Study|Treatment discontinued|4|||
129921673|NCT03447470|467678036|FG008|Overall Study|Treatment discontinued|3|||
129921674|NCT03382652|467678037|FG000|Overall Study|Lost to Follow-up|6|||
129921675|NCT03382652|467678037|FG000|Overall Study|Death|4|||
129921676|NCT03382652|467678037|FG000|Overall Study|Revision|5|||
129921677|NCT03382652|467678037|FG000|Overall Study|Patient withdrew|3|||
130068347|NCT02031432|468203673|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
129921678|NCT03382652|467678037|FG000|Overall Study|Other reasons|21|||
129921679|NCT04810650|467678038|FG000|Overall Study|Disenrolled in error|0|||
129921680|NCT04810650|467678039|FG001|Overall Study|Disenrolled in error|0|||
129921681|NCT04810650|467678040|FG002|Overall Study|Disenrolled in error|0|||
129921682|NCT04810650|467678041|FG003|Overall Study|Disenrolled in error|0|||
129921683|NCT04810650|467678042|FG004|Overall Study|Disenrolled in error|0|||
129921684|NCT04810650|467678043|FG005|Overall Study|Disenrolled in error|0|||
129921685|NCT04810650|467678044|FG006|Overall Study|Disenrolled in error|0|||
129921686|NCT04810650|467678045|FG007|Overall Study|Disenrolled in error|0|||
129921687|NCT04810650|467678046|FG008|Overall Study|Disenrolled in error|1|||
129921688|NCT04810650|467678047|FG009|Overall Study|Disenrolled in error|0|||
129921689|NCT04810650|467678048|FG010|Overall Study|Disenrolled in error|0|||
129921690|NCT04810650|467678049|FG011|Overall Study|Disenrolled in error|0|||
129921691|NCT04810650|467678050|FG012|Overall Study|Disenrolled in error|0|||
129921692|NCT04810650|467678051|FG013|Overall Study|Disenrolled in error|0|||
129921693|NCT04810650|467678038|FG000|Overall Study|Death|0|||
129921694|NCT04810650|467678039|FG001|Overall Study|Death|0|||
129921695|NCT04810650|467678040|FG002|Overall Study|Death|0|||
129921696|NCT04810650|467678041|FG003|Overall Study|Death|0|||
129921697|NCT04810650|467678042|FG004|Overall Study|Death|0|||
129921698|NCT04810650|467678043|FG005|Overall Study|Death|0|||
129921699|NCT04810650|467678044|FG006|Overall Study|Death|2|||
129921700|NCT04810650|467678045|FG007|Overall Study|Death|2|||
129921701|NCT04810650|467678046|FG008|Overall Study|Death|0|||
129921702|NCT04810650|467678047|FG009|Overall Study|Death|1|||
129921703|NCT04810650|467678048|FG010|Overall Study|Death|0|||
129921704|NCT04810650|467678049|FG011|Overall Study|Death|0|||
129921705|NCT04810650|467678050|FG012|Overall Study|Death|2|||
129921706|NCT04810650|467678051|FG013|Overall Study|Death|1|||
129921707|NCT04810650|467678038|FG000|Overall Study|Moved/transferred care|0|||
129921708|NCT04810650|467678039|FG001|Overall Study|Moved/transferred care|0|||
129921709|NCT04810650|467678040|FG002|Overall Study|Moved/transferred care|0|||
129921710|NCT04810650|467678041|FG003|Overall Study|Moved/transferred care|0|||
129921711|NCT04810650|467678042|FG004|Overall Study|Moved/transferred care|0|||
129921712|NCT04810650|467678043|FG005|Overall Study|Moved/transferred care|0|||
129921713|NCT04810650|467678044|FG006|Overall Study|Moved/transferred care|0|||
129921714|NCT04810650|467678045|FG007|Overall Study|Moved/transferred care|1|||
129921715|NCT04810650|467678046|FG008|Overall Study|Moved/transferred care|12|||
129921716|NCT04810650|467678047|FG009|Overall Study|Moved/transferred care|10|||
129921717|NCT04810650|467678048|FG010|Overall Study|Moved/transferred care|0|||
129921718|NCT04810650|467678049|FG011|Overall Study|Moved/transferred care|0|||
129921719|NCT04810650|467678050|FG012|Overall Study|Moved/transferred care|0|||
129921720|NCT04810650|467678051|FG013|Overall Study|Moved/transferred care|0|||
129921721|NCT04810650|467678038|FG000|Overall Study|Lost to Follow-up|15|||
129921722|NCT04810650|467678039|FG001|Overall Study|Lost to Follow-up|12|||
129921723|NCT04810650|467678040|FG002|Overall Study|Lost to Follow-up|7|||
129921724|NCT04810650|467678041|FG003|Overall Study|Lost to Follow-up|9|||
129921725|NCT04810650|467678042|FG004|Overall Study|Lost to Follow-up|10|||
129921726|NCT04810650|467678043|FG005|Overall Study|Lost to Follow-up|6|||
129921727|NCT04810650|467678044|FG006|Overall Study|Lost to Follow-up|0|||
129921728|NCT04810650|467678045|FG007|Overall Study|Lost to Follow-up|0|||
129921729|NCT04810650|467678046|FG008|Overall Study|Lost to Follow-up|0|||
129921730|NCT04810650|467678047|FG009|Overall Study|Lost to Follow-up|0|||
129921731|NCT04810650|467678048|FG010|Overall Study|Lost to Follow-up|1|||
129921732|NCT04810650|467678049|FG011|Overall Study|Lost to Follow-up|0|||
129921733|NCT04810650|467678050|FG012|Overall Study|Lost to Follow-up|3|||
130068348|NCT02031432|468203673|FG000|Overall Study|Death|10|||
129921734|NCT04810650|467678051|FG013|Overall Study|Lost to Follow-up|9|||
129921735|NCT04810650|467678038|FG000|Overall Study|Participant declined|0|||
129921736|NCT04810650|467678039|FG001|Overall Study|Participant declined|0|||
129921737|NCT04810650|467678040|FG002|Overall Study|Participant declined|0|||
129921738|NCT04810650|467678041|FG003|Overall Study|Participant declined|0|||
129921739|NCT04810650|467678042|FG004|Overall Study|Participant declined|0|||
129921740|NCT04810650|467678043|FG005|Overall Study|Participant declined|0|||
129921741|NCT04810650|467678044|FG006|Overall Study|Participant declined|0|||
129921742|NCT04810650|467678045|FG007|Overall Study|Participant declined|0|||
129921743|NCT04810650|467678046|FG008|Overall Study|Participant declined|0|||
129921744|NCT04810650|467678047|FG009|Overall Study|Participant declined|0|||
129921745|NCT04810650|467678048|FG010|Overall Study|Participant declined|2|||
129921746|NCT04810650|467678049|FG011|Overall Study|Participant declined|0|||
129921747|NCT04810650|467678050|FG012|Overall Study|Participant declined|0|||
129921748|NCT04810650|467678051|FG013|Overall Study|Participant declined|0|||
129921749|NCT05794243|467678052|FG000|Overall Study|Withdrawal by Subject|1|||
129921750|NCT05794243|467678053|FG001|Overall Study|Withdrawal by Subject|0|||
130068349|NCT01617187|468203674|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
129921751|NCT05794243|467678054|FG002|Overall Study|Withdrawal by Subject|1|||
129921752|NCT05794243|467678052|FG000|Overall Study|Physician Decision|0|||
129921753|NCT05794243|467678053|FG001|Overall Study|Physician Decision|3|||
129921754|NCT05794243|467678054|FG002|Overall Study|Physician Decision|1|||
129921755|NCT04788511|467678055|FG000|Overall Study|Withdrawal by Subject|2|||
130068350|NCT01617187|468203675|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
129921756|NCT04788511|467678056|FG001|Overall Study|Withdrawal by Subject|1|||
129921757|NCT04788511|467678055|FG000|Overall Study|Lost to Follow-up|2|||
130068351|NCT01617187|468203676|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
129921758|NCT04788511|467678056|FG001|Overall Study|Lost to Follow-up|7|||
129921759|NCT04788511|467678055|FG000|Overall Study|Death|3|||
129921760|NCT04788511|467678056|FG001|Overall Study|Death|4|||
129921761|NCT04187833|467678057|FG000|Overall Study|Withdrawal by Subject|1|||
129921762|NCT05008835|467678059|FG000|Overall Study|Adverse Event|5|||
129921763|NCT05008835|467678060|FG001|Overall Study|Adverse Event|2|||
129921764|NCT05008835|467678061|FG002|Overall Study|Adverse Event|1|||
129921765|NCT05008835|467678059|FG000|Overall Study|Lack of Efficacy|0|||
129921766|NCT05008835|467678060|FG001|Overall Study|Lack of Efficacy|0|||
129921767|NCT05008835|467678061|FG002|Overall Study|Lack of Efficacy|1|||
129921768|NCT05008835|467678059|FG000|Overall Study|Study terminated by sponsor|0|||
129921769|NCT05008835|467678060|FG001|Overall Study|Study terminated by sponsor|0|||
129921770|NCT05008835|467678061|FG002|Overall Study|Study terminated by sponsor|1|||
129921771|NCT05008835|467678059|FG000|Overall Study|Not further specified|3|||
129921772|NCT05008835|467678060|FG001|Overall Study|Not further specified|2|||
129921773|NCT05008835|467678061|FG002|Overall Study|Not further specified|1|||
129921774|NCT04171999|467678062|FG000|Overall Study|deemed ineligible after randomization|2|||
129921775|NCT04171999|467678063|FG001|Overall Study|deemed ineligible after randomization|1|||
129921776|NCT04948697|467678064|FG000|Overall Study|Progressive disease|27|||
129921777|NCT04948697|467678065|FG001|Overall Study|Progressive disease|18|||
129921778|NCT04948697|467678064|FG000|Overall Study|Adverse Event|14|||
129921779|NCT04948697|467678065|FG001|Overall Study|Adverse Event|4|||
129921780|NCT04948697|467678064|FG000|Overall Study|Participant moved to long term extension study|7|||
129921781|NCT04948697|467678065|FG001|Overall Study|Participant moved to long term extension study|4|||
129921782|NCT04948697|467678064|FG000|Overall Study|Withdrawal by Subject|10|||
129921783|NCT04948697|467678065|FG001|Overall Study|Withdrawal by Subject|0|||
129921784|NCT04948697|467678064|FG000|Overall Study|Closed by Sponsor|3|||
129921785|NCT04948697|467678065|FG001|Overall Study|Closed by Sponsor|2|||
129921786|NCT04948697|467678064|FG000|Overall Study|Physician Decision|0|||
129921787|NCT04948697|467678065|FG001|Overall Study|Physician Decision|2|||
129921788|NCT04948697|467678064|FG000|Overall Study|Lost to Follow-up|0|||
129921789|NCT04948697|467678065|FG001|Overall Study|Lost to Follow-up|1|||
129921790|NCT04948697|467678064|FG000|Overall Study|Other-Miscellaneous|1|||
129921791|NCT04948697|467678065|FG001|Overall Study|Other-Miscellaneous|0|||
129921792|NCT04948697|467678064|FG000|Overall Study|Randomized but not treated|0|||
129921793|NCT04948697|467678065|FG001|Overall Study|Randomized but not treated|1|||
129921794|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
129921795|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
129921796|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
129921797|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
129921798|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
129921799|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
129921800|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
129921801|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
129921802|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
129921803|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
129921804|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
129921805|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
129921806|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
129921807|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
129921808|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
130117007|NCT01506323|468388739|FG000|Overall Study|Lost to Follow-up|5|||
129921809|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
129921810|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
129921811|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
129921812|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
129921813|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
129921814|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
129921815|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
129921816|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
129921817|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
129921818|NCT03365882|467678068|FG000|Randomization|Still Receiving Protocol Treatment|2|||
129921819|NCT03365882|467678069|FG001|Randomization|Still Receiving Protocol Treatment|0|||
129921820|NCT03365882|467678068|FG000|Randomization|Adverse Event|1|||
129921821|NCT03365882|467678069|FG001|Randomization|Adverse Event|2|||
129921822|NCT03365882|467678068|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
129921823|NCT03365882|467678069|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
129921824|NCT03365882|467678068|FG000|Randomization|Progression/Relapse|21|||
129921825|NCT03365882|467678069|FG001|Randomization|Progression/Relapse|3|||
129921826|NCT03365882|467678068|FG000|Randomization|Death|1|||
129921827|NCT03365882|467678069|FG001|Randomization|Death|0|||
129921828|NCT03365882|467678068|FG000|Randomization|Other - Not Protocol Specified|1|||
129921829|NCT03365882|467678069|FG001|Randomization|Other - Not Protocol Specified|1|||
129921830|NCT03365882|467678068|FG000|Randomization|Major Protocol Deviation|0|||
129921831|NCT03365882|467678069|FG001|Randomization|Major Protocol Deviation|1|||
129921832|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
129921833|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
129921834|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
129921835|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
129921836|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
129921837|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
129921838|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
129921839|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
129921840|NCT04515576|467680603|FG000|Overall Study|Withdrawal by Subject|0|||
130068352|NCT01617187|468203677|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
129921841|NCT04515576|467680604|FG001|Overall Study|Withdrawal by Subject|0|||
129921842|NCT04515576|467680605|FG002|Overall Study|Withdrawal by Subject|0|||
129921843|NCT04515576|467680606|FG003|Overall Study|Withdrawal by Subject|0|||
129921844|NCT04515576|467680607|FG004|Overall Study|Withdrawal by Subject|0|||
129921845|NCT04515576|467680608|FG005|Overall Study|Withdrawal by Subject|1|||
129921846|NCT04971395|467680609|FG000|Overall Study|Withdrawal by Subject|0|||
129921847|NCT04971395|467680610|FG001|Overall Study|Withdrawal by Subject|1|||
129921848|NCT04971395|467680611|FG002|Overall Study|Withdrawal by Subject|0|||
129921849|NCT03953508|467680612|FG000|Baseline|Lost to Follow-up|3|||
129921850|NCT03953508|467680613|FG001|Baseline|Lost to Follow-up|2|||
129921851|NCT03953508|467680612|FG000|6-month Follow-up|Lost to Follow-up|62|||
129921852|NCT03953508|467680613|FG001|6-month Follow-up|Lost to Follow-up|70|||
129921853|NCT03771417|467680614|FG000|Overall Study|Withdrawal by Subject|1|||
129921854|NCT03771417|467680615|FG001|Overall Study|Withdrawal by Subject|0|||
129921855|NCT03771417|467680616|FG002|Overall Study|Withdrawal by Subject|0|||
129921856|NCT03771417|467680614|FG000|Overall Study|Covid-19 Shutdown|0|||
129921857|NCT03771417|467680615|FG001|Overall Study|Covid-19 Shutdown|1|||
129921858|NCT03771417|467680616|FG002|Overall Study|Covid-19 Shutdown|0|||
129921859|NCT02100813|467680617|FG000|Overall Study|Adverse Event|0|||
129921860|NCT02100813|467680618|FG001|Overall Study|Adverse Event|0|||
129921861|NCT02100813|467680619|FG002|Overall Study|Adverse Event|0|||
129921862|NCT02100813|467680620|FG003|Overall Study|Adverse Event|0|||
129921863|NCT02100813|467680621|FG004|Overall Study|Adverse Event|0|||
129921864|NCT02100813|467680622|FG005|Overall Study|Adverse Event|0|||
129921865|NCT02100813|467680623|FG006|Overall Study|Adverse Event|0|||
129921866|NCT02100813|467680624|FG007|Overall Study|Adverse Event|1|||
129921867|NCT04856163|467680625|FG000|Overall Study|Lost to Follow-up|97|||
129921868|NCT04856163|467680626|FG001|Overall Study|Lost to Follow-up|100|||
129921869|NCT00881621|467680632|FG000|Overall Study|Physician Decision|34|||
129921870|NCT03936322|467680637|FG000|Overall Study|Lost to Follow-up|1|||
129921871|NCT03936322|467680637|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
129921872|NCT05434078|467680639|FG000|Overall Study|Lost to Follow-up|2|||
129921873|NCT05434078|467680640|FG001|Overall Study|Lost to Follow-up|1|||
129921874|NCT05434078|467680639|FG000|Overall Study|Withdrawal by Subject|1|||
129921875|NCT05434078|467680640|FG001|Overall Study|Withdrawal by Subject|0|||
129921876|NCT01160211|467680641|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
129921877|NCT01160211|467680642|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
129921878|NCT01160211|467680643|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
129921879|NCT01160211|467680641|FG000|Overall Study|Lost to Follow-up|4|||
129921880|NCT01160211|467680642|FG001|Overall Study|Lost to Follow-up|8|||
129921881|NCT01160211|467680643|FG002|Overall Study|Lost to Follow-up|4|||
129921882|NCT01160211|467680641|FG000|Overall Study|Physician Decision|1|||
129921883|NCT01160211|467680642|FG001|Overall Study|Physician Decision|0|||
129921884|NCT01160211|467680643|FG002|Overall Study|Physician Decision|0|||
129921885|NCT01160211|467680641|FG000|Overall Study|Withdrawal by Subject|4|||
129921886|NCT01160211|467680642|FG001|Overall Study|Withdrawal by Subject|2|||
129921887|NCT01160211|467680643|FG002|Overall Study|Withdrawal by Subject|2|||
130068353|NCT01617187|468203674|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
130068354|NCT01617187|468203675|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
129921888|NCT01160211|467680641|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
129921889|NCT01160211|467680642|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
129921890|NCT01160211|467680643|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
129921891|NCT02734290|467680647|FG000|Overall Study|Adverse Event|1|||
129921892|NCT02734290|467680648|FG001|Overall Study|Adverse Event|0|||
129921893|NCT02734290|467680647|FG000|Overall Study|Death|1|||
129921894|NCT02734290|467680648|FG001|Overall Study|Death|0|||
129921895|NCT03158129|467680649|FG000|Overall Study|Adverse Event|0|||
130117008|NCT01506323|468388740|FG001|Overall Study|Lost to Follow-up|4|||
129921896|NCT03158129|467680650|FG001|Overall Study|Adverse Event|1|||
129921897|NCT03158129|467680651|FG002|Overall Study|Adverse Event|0|||
129921898|NCT03158129|467680652|FG003|Overall Study|Adverse Event|0|||
129921899|NCT03158129|467680649|FG000|Overall Study|Death|0|||
129921900|NCT03158129|467680650|FG001|Overall Study|Death|0|||
129921901|NCT03158129|467680651|FG002|Overall Study|Death|0|||
129921902|NCT03158129|467680652|FG003|Overall Study|Death|1|||
129921903|NCT03158129|467680649|FG000|Overall Study|High surgical risk|1|||
129921904|NCT03158129|467680650|FG001|Overall Study|High surgical risk|1|||
129921905|NCT03158129|467680651|FG002|Overall Study|High surgical risk|0|||
129921906|NCT03158129|467680652|FG003|Overall Study|High surgical risk|0|||
129921907|NCT03158129|467680649|FG000|Overall Study|Progression|1|||
129921908|NCT03158129|467680650|FG001|Overall Study|Progression|1|||
129921909|NCT03158129|467680651|FG002|Overall Study|Progression|0|||
129921910|NCT03158129|467680652|FG003|Overall Study|Progression|0|||
129921911|NCT03158129|467680649|FG000|Overall Study|Lack of resectability|0|||
129921912|NCT03158129|467680650|FG001|Overall Study|Lack of resectability|1|||
129921913|NCT03158129|467680651|FG002|Overall Study|Lack of resectability|0|||
129921914|NCT03158129|467680652|FG003|Overall Study|Lack of resectability|0|||
129921915|NCT03158129|467680649|FG000|Overall Study|Declined surgery|0|||
129921916|NCT03158129|467680650|FG001|Overall Study|Declined surgery|1|||
129921917|NCT03158129|467680651|FG002|Overall Study|Declined surgery|0|||
129921918|NCT03158129|467680652|FG003|Overall Study|Declined surgery|0|||
129921919|NCT03158129|467680649|FG000|Overall Study|No longer surgical candidate|0|||
129921920|NCT03158129|467680650|FG001|Overall Study|No longer surgical candidate|0|||
129921921|NCT03158129|467680651|FG002|Overall Study|No longer surgical candidate|0|||
129921922|NCT03158129|467680652|FG003|Overall Study|No longer surgical candidate|1|||
129921923|NCT02577835|467680653|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
129921924|NCT02979522|467680654|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
129921925|NCT02979522|467680655|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
129921926|NCT02979522|467680654|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
129921927|NCT02979522|467680655|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
129921928|NCT04064164|467680656|FG000|Overall Study|Withdrawal by Subject|8|||
129921929|NCT04064164|467680657|FG001|Overall Study|Withdrawal by Subject|8|||
129921930|NCT04059484|467680658|FG000|Overall Study|Adverse Event|2|||
129921931|NCT04059484|467680659|FG001|Overall Study|Adverse Event|5|||
129921932|NCT04059484|467680658|FG000|Overall Study|Withdrawal by Subject|5|||
129921933|NCT04059484|467680659|FG001|Overall Study|Withdrawal by Subject|3|||
129921934|NCT04059484|467680658|FG000|Overall Study|Progressive disease|112|||
129921935|NCT04059484|467680659|FG001|Overall Study|Progressive disease|112|||
129921936|NCT04059484|467680658|FG000|Overall Study|Other|8|||
129921937|NCT04059484|467680659|FG001|Overall Study|Other|3|||
129921938|NCT04059484|467680658|FG000|Overall Study|Ongoing|20|||
129921939|NCT04059484|467680659|FG001|Overall Study|Ongoing|20|||
129921940|NCT02949362|467680660|FG000|Retrospective Period|Inform consent not signed by participant|4|||
129921941|NCT02949362|467680661|FG001|Retrospective Period|Inform consent not signed by participant|1|||
129921942|NCT02949362|467680662|FG002|Retrospective Period|Inform consent not signed by participant|0|||
129921943|NCT02949362|467680663|FG003|Retrospective Period|Inform consent not signed by participant|0|||
129921944|NCT02949362|467680660|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
129921945|NCT02949362|467680661|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
129921946|NCT02949362|467680662|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
129921947|NCT02949362|467680663|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
129921948|NCT02949362|467680660|FG000|Prospective Period|Other|0|||
129921949|NCT02949362|467680661|FG001|Prospective Period|Other|0|||
129921950|NCT02949362|467680662|FG002|Prospective Period|Other|0|||
129921951|NCT02949362|467680663|FG003|Prospective Period|Other|4|||
129921952|NCT04633122|467680667|FG000|Overall Study|Remained on treatment|19|||
129921953|NCT04633122|467680668|FG001|Overall Study|Remained on treatment|14|||
129921954|NCT04633122|467680667|FG000|Overall Study|Survival follow-up stopped|22|||
129921955|NCT04633122|467680668|FG001|Overall Study|Survival follow-up stopped|25|||
129921956|NCT03307343|467680669|FG000|Overall Study|Withdrawal by Subject|1|||
129921957|NCT03307343|467680670|FG001|Overall Study|Withdrawal by Subject|2|||
129921958|NCT03307343|467680669|FG000|Overall Study|Pregnancy|0|||
129921959|NCT03307343|467680670|FG001|Overall Study|Pregnancy|2|||
129921960|NCT03307343|467680669|FG000|Overall Study|Physician Decision|1|||
129921961|NCT03307343|467680670|FG001|Overall Study|Physician Decision|0|||
129921962|NCT03307343|467680669|FG000|Overall Study|Lost to Follow-up|0|||
129921963|NCT03307343|467680670|FG001|Overall Study|Lost to Follow-up|2|||
129921964|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
129921965|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
129921966|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
129921967|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
129921968|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129921969|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
129921970|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129921971|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129921972|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
129921973|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129921974|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129921975|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129921976|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
129921977|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
129921978|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
129921979|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
129921980|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
129921981|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
129921982|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
129921983|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
129921984|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129921985|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129921986|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129921987|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
129921988|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
129921989|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
129921990|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
129921991|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
129921992|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
129921993|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
129921994|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
129921995|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
129921996|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
129921997|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
129921998|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
129921999|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
129922000|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
129922001|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
129922002|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
129922003|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
129922004|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
129922005|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
129922006|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
129922007|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
129922008|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
129922009|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
129922010|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
129922011|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
129922012|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
129922013|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
129922014|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
129922015|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
129922016|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
129922017|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
129922018|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
129922019|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
129922020|NCT04624633|467680677|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
129922021|NCT04624633|467680678|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
129922022|NCT04624633|467680677|FG000|Overall Study|Death|1|||
129922023|NCT04624633|467680678|FG001|Overall Study|Death|0|||
129922024|NCT04316871|467680679|FG000|Overall Study|Protocol Violation|2|||
129922025|NCT04316871|467680680|FG001|Overall Study|Protocol Violation|2|||
129922026|NCT04316871|467680681|FG002|Overall Study|Protocol Violation|2|||
129922027|NCT04316871|467680682|FG003|Overall Study|Protocol Violation|2|||
129922028|NCT05087992|467680683|FG000|Overall Study|Adverse Event|0|||
129922029|NCT05087992|467680684|FG001|Overall Study|Adverse Event|1|||
129922030|NCT05087992|467680685|FG002|Overall Study|Adverse Event|0|||
129922031|NCT05087992|467680683|FG000|Overall Study|Withdrawal by Subject|2|||
129922032|NCT05087992|467680684|FG001|Overall Study|Withdrawal by Subject|0|||
129922033|NCT05087992|467680685|FG002|Overall Study|Withdrawal by Subject|0|||
129922034|NCT05087992|467680683|FG000|Overall Study|clinical disease progression|3|||
129922035|NCT05087992|467680684|FG001|Overall Study|clinical disease progression|1|||
129922036|NCT05087992|467680685|FG002|Overall Study|clinical disease progression|0|||
129922037|NCT05087992|467680683|FG000|Overall Study|objective disease progression|4|||
129922038|NCT05087992|467680684|FG001|Overall Study|objective disease progression|1|||
129922039|NCT05087992|467680685|FG002|Overall Study|objective disease progression|0|||
129922040|NCT01842542|467680686|FG000|Overall Study|Withdrawal by Subject|2|||
129922041|NCT01842542|467680686|FG000|Overall Study|Lack of Efficacy|1|||
129922042|NCT01842542|467680686|FG000|Overall Study|Protocol Non-compliance|2|||
129922043|NCT01842542|467680686|FG000|Overall Study|Lost to Follow-up|1|||
129922044|NCT01824394|467680692|FG000|Overall Study|Early Termination|1|||
129922045|NCT01824394|467680693|FG001|Overall Study|Early Termination|1|||
129922046|NCT01824394|467680694|FG002|Overall Study|Early Termination|3|||
129922047|NCT01824394|467680692|FG000|Overall Study|Withdrawn due to Study Termination|91|||
129922048|NCT01824394|467680693|FG001|Overall Study|Withdrawn due to Study Termination|83|||
129922049|NCT01824394|467680694|FG002|Overall Study|Withdrawn due to Study Termination|41|||
129922050|NCT01824394|467680692|FG000|Overall Study|Lost to Follow-up|0|||
129922051|NCT01824394|467680693|FG001|Overall Study|Lost to Follow-up|9|||
129922052|NCT01824394|467680694|FG002|Overall Study|Lost to Follow-up|3|||
129922053|NCT01824394|467680692|FG000|Overall Study|Death|3|||
129922054|NCT01824394|467680693|FG001|Overall Study|Death|2|||
129922055|NCT01824394|467680694|FG002|Overall Study|Death|4|||
129922056|NCT01824394|467680692|FG000|Overall Study|Discontinued Subjects|1|||
129922057|NCT01824394|467680693|FG001|Overall Study|Discontinued Subjects|1|||
129922058|NCT01824394|467680694|FG002|Overall Study|Discontinued Subjects|2|||
129922059|NCT01824394|467680692|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
129922060|NCT01824394|467680693|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
129922061|NCT01824394|467680694|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
129922062|NCT05780437|467680695|FG000|Overall Study|Withdrawal by Subject|22|||
129922063|NCT05780437|467680696|FG001|Overall Study|Withdrawal by Subject|16|||
129922064|NCT03452579|467680697|FG000|Overall Study|Death|0|||
129922065|NCT03452579|467680698|FG001|Overall Study|Death|1|||
129922066|NCT03452579|467680697|FG000|Overall Study|Withdrawal by Subject|2|||
129922067|NCT03452579|467680698|FG001|Overall Study|Withdrawal by Subject|0|||
129922068|NCT03452579|467680697|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
129922069|NCT03452579|467680698|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
129922070|NCT03452579|467680697|FG000|Overall Study|Physician Decision|1|||
129922071|NCT03452579|467680698|FG001|Overall Study|Physician Decision|1|||
129922072|NCT03452579|467680697|FG000|Overall Study|Adverse Event|1|||
129922073|NCT03452579|467680698|FG001|Overall Study|Adverse Event|4|||
129922074|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
129922075|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
129922076|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
129922077|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
129922078|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
129922079|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
129922080|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
129922081|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
129922082|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
129922083|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
129922084|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
129922085|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
129922086|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
129922087|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
129922088|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
129922089|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
129922090|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
129922091|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
129922092|NCT04209465|467680705|FG000|Overall Study|Adverse Event|0|||
129922093|NCT04209465|467680706|FG001|Overall Study|Adverse Event|0|||
129922094|NCT04209465|467680707|FG002|Overall Study|Adverse Event|0|||
129922095|NCT04209465|467680708|FG003|Overall Study|Adverse Event|0|||
129922096|NCT04209465|467680709|FG004|Overall Study|Adverse Event|0|||
129922097|NCT04209465|467680710|FG005|Overall Study|Adverse Event|1|||
129922098|NCT04209465|467680711|FG006|Overall Study|Adverse Event|0|||
129922099|NCT04209465|467680712|FG007|Overall Study|Adverse Event|0|||
129922100|NCT04209465|467680713|FG008|Overall Study|Adverse Event|1|||
129922101|NCT04209465|467680714|FG009|Overall Study|Adverse Event|0|||
129922102|NCT04209465|467680715|FG010|Overall Study|Adverse Event|2|||
129922103|NCT04209465|467680716|FG011|Overall Study|Adverse Event|1|||
129922104|NCT04209465|467680717|FG012|Overall Study|Adverse Event|1|||
129922105|NCT04209465|467680705|FG000|Overall Study|Death|1|||
129922106|NCT04209465|467680706|FG001|Overall Study|Death|0|||
129922107|NCT04209465|467680707|FG002|Overall Study|Death|0|||
129922108|NCT04209465|467680708|FG003|Overall Study|Death|0|||
129922109|NCT04209465|467680709|FG004|Overall Study|Death|2|||
129922110|NCT04209465|467680710|FG005|Overall Study|Death|7|||
129922111|NCT04209465|467680711|FG006|Overall Study|Death|2|||
129922112|NCT04209465|467680712|FG007|Overall Study|Death|2|||
129922113|NCT04209465|467680713|FG008|Overall Study|Death|1|||
129922114|NCT04209465|467680714|FG009|Overall Study|Death|1|||
129922115|NCT04209465|467680715|FG010|Overall Study|Death|1|||
129922116|NCT04209465|467680716|FG011|Overall Study|Death|0|||
129922117|NCT04209465|467680717|FG012|Overall Study|Death|10|||
129922118|NCT04209465|467680705|FG000|Overall Study|Physician Decision|0|||
129922119|NCT04209465|467680706|FG001|Overall Study|Physician Decision|1|||
129922120|NCT04209465|467680707|FG002|Overall Study|Physician Decision|0|||
129922121|NCT04209465|467680708|FG003|Overall Study|Physician Decision|0|||
129922122|NCT04209465|467680709|FG004|Overall Study|Physician Decision|0|||
129922123|NCT04209465|467680710|FG005|Overall Study|Physician Decision|0|||
129922124|NCT04209465|467680711|FG006|Overall Study|Physician Decision|0|||
129922125|NCT04209465|467680712|FG007|Overall Study|Physician Decision|0|||
129922126|NCT04209465|467680713|FG008|Overall Study|Physician Decision|0|||
129922127|NCT04209465|467680714|FG009|Overall Study|Physician Decision|0|||
129922128|NCT04209465|467680715|FG010|Overall Study|Physician Decision|0|||
129922129|NCT04209465|467680716|FG011|Overall Study|Physician Decision|0|||
129922130|NCT04209465|467680717|FG012|Overall Study|Physician Decision|0|||
129922131|NCT04209465|467680705|FG000|Overall Study|Progressive Disease|0|||
129922132|NCT04209465|467680706|FG001|Overall Study|Progressive Disease|0|||
129922133|NCT04209465|467680707|FG002|Overall Study|Progressive Disease|1|||
129922134|NCT04209465|467680708|FG003|Overall Study|Progressive Disease|2|||
129922135|NCT04209465|467680709|FG004|Overall Study|Progressive Disease|8|||
129922136|NCT04209465|467680710|FG005|Overall Study|Progressive Disease|5|||
129922137|NCT04209465|467680711|FG006|Overall Study|Progressive Disease|3|||
129922138|NCT04209465|467680712|FG007|Overall Study|Progressive Disease|4|||
129922139|NCT04209465|467680713|FG008|Overall Study|Progressive Disease|1|||
129922140|NCT04209465|467680714|FG009|Overall Study|Progressive Disease|3|||
129922141|NCT04209465|467680715|FG010|Overall Study|Progressive Disease|2|||
129922142|NCT04209465|467680716|FG011|Overall Study|Progressive Disease|1|||
129922143|NCT04209465|467680717|FG012|Overall Study|Progressive Disease|0|||
129922144|NCT04209465|467680705|FG000|Overall Study|Withdrawal by Subject|0|||
129922145|NCT04209465|467680706|FG001|Overall Study|Withdrawal by Subject|0|||
129922146|NCT04209465|467680707|FG002|Overall Study|Withdrawal by Subject|0|||
129922147|NCT04209465|467680708|FG003|Overall Study|Withdrawal by Subject|0|||
129922148|NCT04209465|467680709|FG004|Overall Study|Withdrawal by Subject|0|||
129922149|NCT04209465|467680710|FG005|Overall Study|Withdrawal by Subject|1|||
129922150|NCT04209465|467680711|FG006|Overall Study|Withdrawal by Subject|2|||
129922151|NCT04209465|467680712|FG007|Overall Study|Withdrawal by Subject|0|||
129922152|NCT04209465|467680713|FG008|Overall Study|Withdrawal by Subject|1|||
129922153|NCT04209465|467680714|FG009|Overall Study|Withdrawal by Subject|0|||
129922154|NCT04209465|467680715|FG010|Overall Study|Withdrawal by Subject|0|||
129922155|NCT04209465|467680716|FG011|Overall Study|Withdrawal by Subject|2|||
129922156|NCT04209465|467680717|FG012|Overall Study|Withdrawal by Subject|2|||
129922157|NCT04209465|467680705|FG000|Overall Study|Lost to Follow-up|0|||
129922158|NCT04209465|467680706|FG001|Overall Study|Lost to Follow-up|0|||
129922159|NCT04209465|467680707|FG002|Overall Study|Lost to Follow-up|0|||
129922160|NCT04209465|467680708|FG003|Overall Study|Lost to Follow-up|0|||
129922161|NCT04209465|467680709|FG004|Overall Study|Lost to Follow-up|0|||
129922162|NCT04209465|467680710|FG005|Overall Study|Lost to Follow-up|1|||
129922163|NCT04209465|467680711|FG006|Overall Study|Lost to Follow-up|0|||
129922164|NCT04209465|467680712|FG007|Overall Study|Lost to Follow-up|0|||
129922165|NCT04209465|467680713|FG008|Overall Study|Lost to Follow-up|1|||
129922166|NCT04209465|467680714|FG009|Overall Study|Lost to Follow-up|0|||
129922167|NCT04209465|467680715|FG010|Overall Study|Lost to Follow-up|0|||
129922168|NCT04209465|467680716|FG011|Overall Study|Lost to Follow-up|1|||
129922169|NCT04209465|467680717|FG012|Overall Study|Lost to Follow-up|0|||
129922170|NCT04209465|467680705|FG000|Overall Study|Started new therapy|0|||
129922171|NCT04209465|467680706|FG001|Overall Study|Started new therapy|0|||
129922172|NCT04209465|467680707|FG002|Overall Study|Started new therapy|0|||
129922173|NCT04209465|467680708|FG003|Overall Study|Started new therapy|0|||
129922174|NCT04209465|467680709|FG004|Overall Study|Started new therapy|0|||
130068355|NCT01617187|468203676|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
129922175|NCT04209465|467680710|FG005|Overall Study|Started new therapy|1|||
129922176|NCT04209465|467680711|FG006|Overall Study|Started new therapy|0|||
129922177|NCT04209465|467680712|FG007|Overall Study|Started new therapy|0|||
129922178|NCT04209465|467680713|FG008|Overall Study|Started new therapy|0|||
129922179|NCT04209465|467680714|FG009|Overall Study|Started new therapy|0|||
129922180|NCT04209465|467680715|FG010|Overall Study|Started new therapy|0|||
129922181|NCT04209465|467680716|FG011|Overall Study|Started new therapy|0|||
129922182|NCT04209465|467680717|FG012|Overall Study|Started new therapy|0|||
129922183|NCT04209465|467680705|FG000|Overall Study|Study terminated early by sponsor|0|||
129922184|NCT04209465|467680706|FG001|Overall Study|Study terminated early by sponsor|0|||
129922185|NCT04209465|467680707|FG002|Overall Study|Study terminated early by sponsor|0|||
129922186|NCT04209465|467680708|FG003|Overall Study|Study terminated early by sponsor|0|||
130068356|NCT01617187|468203677|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
129922187|NCT04209465|467680709|FG004|Overall Study|Study terminated early by sponsor|0|||
129922188|NCT04209465|467680710|FG005|Overall Study|Study terminated early by sponsor|0|||
129922189|NCT04209465|467680711|FG006|Overall Study|Study terminated early by sponsor|3|||
130068357|NCT01617187|468203674|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
130068358|NCT01617187|468203675|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
130068359|NCT01617187|468203676|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
130068360|NCT01617187|468203677|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
130068361|NCT01617187|468203674|FG000|Treatment Through Study Completion|Adverse Event|1|||
130068362|NCT01617187|468203675|FG001|Treatment Through Study Completion|Adverse Event|1|||
130068363|NCT01617187|468203676|FG002|Treatment Through Study Completion|Adverse Event|0|||
130068364|NCT01617187|468203677|FG003|Treatment Through Study Completion|Adverse Event|1|||
129922190|NCT04209465|467680712|FG007|Overall Study|Study terminated early by sponsor|0|||
129922191|NCT04209465|467680713|FG008|Overall Study|Study terminated early by sponsor|0|||
129922192|NCT04209465|467680714|FG009|Overall Study|Study terminated early by sponsor|0|||
129922193|NCT04209465|467680715|FG010|Overall Study|Study terminated early by sponsor|0|||
129922194|NCT04209465|467680716|FG011|Overall Study|Study terminated early by sponsor|0|||
129922195|NCT04209465|467680717|FG012|Overall Study|Study terminated early by sponsor|3|||
129922196|NCT04209465|467680705|FG000|Overall Study|Other|0|||
129922197|NCT04209465|467680706|FG001|Overall Study|Other|0|||
129922198|NCT04209465|467680707|FG002|Overall Study|Other|0|||
129922199|NCT04209465|467680708|FG003|Overall Study|Other|0|||
129922200|NCT04209465|467680709|FG004|Overall Study|Other|0|||
129922201|NCT04209465|467680710|FG005|Overall Study|Other|0|||
129922202|NCT04209465|467680711|FG006|Overall Study|Other|0|||
129922203|NCT04209465|467680712|FG007|Overall Study|Other|0|||
129922204|NCT04209465|467680713|FG008|Overall Study|Other|1|||
129922205|NCT04209465|467680714|FG009|Overall Study|Other|0|||
129922206|NCT04209465|467680715|FG010|Overall Study|Other|0|||
129922207|NCT04209465|467680716|FG011|Overall Study|Other|0|||
129922208|NCT04209465|467680717|FG012|Overall Study|Other|0|||
129922209|NCT05603143|467680718|FG000|Overall Study|Withdrew consent|6|||
129922210|NCT05603143|467680719|FG001|Overall Study|Withdrew consent|2|||
129922211|NCT05603143|467680718|FG000|Overall Study|Randomized but never treated|0|||
129922212|NCT05603143|467680719|FG001|Overall Study|Randomized but never treated|3|||
129922213|NCT05603143|467680718|FG000|Overall Study|Adverse Event|2|||
129922214|NCT05603143|467680719|FG001|Overall Study|Adverse Event|0|||
129922215|NCT05603143|467680718|FG000|Overall Study|Death|0|||
129922216|NCT05603143|467680719|FG001|Overall Study|Death|1|||
129922217|NCT05603143|467680718|FG000|Overall Study|Investigator's discretion|1|||
129922218|NCT05603143|467680719|FG001|Overall Study|Investigator's discretion|0|||
129922219|NCT05603143|467680718|FG000|Overall Study|Lost to Follow-up|0|||
129922220|NCT05603143|467680719|FG001|Overall Study|Lost to Follow-up|1|||
129922221|NCT05603143|467680718|FG000|Overall Study|Protocol Violation|0|||
129922222|NCT05603143|467680719|FG001|Overall Study|Protocol Violation|1|||
129922223|NCT03097549|467680720|FG000|Overall Study|Withdrawal by Subject|1|||
129922224|NCT03097549|467680721|FG001|Overall Study|Withdrawal by Subject|0|||
129922225|NCT03097549|467680720|FG000|Overall Study|Lost to Follow-up|1|||
129922226|NCT03097549|467680721|FG001|Overall Study|Lost to Follow-up|0|||
129922227|NCT05783102|467680722|FG000|Overall Study|Lost to Follow-up|1|||
129922228|NCT05783102|467680722|FG000|Overall Study|Withdrawal by Subject|2|||
129922229|NCT04505904|467680723|FG000|Overall Study|Withdrawal by Subject|1|||
129922230|NCT04505904|467680724|FG001|Overall Study|Withdrawal by Subject|2|||
129922231|NCT04505904|467680725|FG002|Overall Study|Withdrawal by Subject|0|||
129922232|NCT04505904|467680726|FG003|Overall Study|Withdrawal by Subject|0|||
129922233|NCT04505904|467680723|FG000|Overall Study|Physician Decision|1|||
129922234|NCT04505904|467680724|FG001|Overall Study|Physician Decision|0|||
129922235|NCT04505904|467680725|FG002|Overall Study|Physician Decision|0|||
129922236|NCT04505904|467680726|FG003|Overall Study|Physician Decision|0|||
129922237|NCT04505904|467680723|FG000|Overall Study|Adverse Event|0|||
129922238|NCT04505904|467680724|FG001|Overall Study|Adverse Event|1|||
129922239|NCT04505904|467680725|FG002|Overall Study|Adverse Event|0|||
129922240|NCT04505904|467680726|FG003|Overall Study|Adverse Event|0|||
129922241|NCT04277442|467680729|FG000|Overall Study|Death|1|||
129922242|NCT03544281|467680730|FG000|Main Study Phase|Death|3|||
129922243|NCT03544281|467680731|FG001|Main Study Phase|Death|2|||
129922244|NCT03544281|467680732|FG002|Main Study Phase|Death|6|||
129922245|NCT03544281|467680733|FG003|Main Study Phase|Death|8|||
129922246|NCT03544281|467680734|FG004|Main Study Phase|Death|4|||
129922247|NCT03544281|467680735|FG005|Main Study Phase|Death|2|||
129922248|NCT03544281|467680736|FG006|Main Study Phase|Death|4|||
129922249|NCT03544281|467680737|FG007|Main Study Phase|Death|5|||
129922250|NCT03544281|467680738|FG008|Main Study Phase|Death|5|||
129922251|NCT03544281|467680739|FG009|Main Study Phase|Death|8|||
129922252|NCT03544281|467680740|FG010|Main Study Phase|Death|6|||
129922253|NCT03544281|467680741|FG011|Main Study Phase|Death|4|||
129922254|NCT03544281|467680742|FG012|Main Study Phase|Death|0|||
129922255|NCT03544281|467680743|FG013|Main Study Phase|Death|0|||
130068365|NCT01617187|468203674|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
130068366|NCT01617187|468203675|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
130068367|NCT01617187|468203676|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
130068368|NCT01617187|468203677|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
129922256|NCT03544281|467680744|FG014|Main Study Phase|Death|0|||
129922257|NCT03544281|467680745|FG015|Main Study Phase|Death|0|||
129922258|NCT03544281|467680746|FG016|Main Study Phase|Death|0|||
129922259|NCT03544281|467680747|FG017|Main Study Phase|Death|0|||
129922260|NCT03544281|467680748|FG018|Main Study Phase|Death|0|||
129922261|NCT03544281|467680749|FG019|Main Study Phase|Death|0|||
129922262|NCT03544281|467680750|FG020|Main Study Phase|Death|0|||
129922263|NCT03544281|467680751|FG021|Main Study Phase|Death|0|||
129922264|NCT03544281|467680730|FG000|Main Study Phase|Lost to Follow-up|0|||
129922265|NCT03544281|467680731|FG001|Main Study Phase|Lost to Follow-up|0|||
129922266|NCT03544281|467680732|FG002|Main Study Phase|Lost to Follow-up|0|||
129922267|NCT03544281|467680733|FG003|Main Study Phase|Lost to Follow-up|0|||
129922268|NCT03544281|467680734|FG004|Main Study Phase|Lost to Follow-up|0|||
129922269|NCT03544281|467680735|FG005|Main Study Phase|Lost to Follow-up|0|||
129922270|NCT03544281|467680736|FG006|Main Study Phase|Lost to Follow-up|0|||
129922271|NCT03544281|467680737|FG007|Main Study Phase|Lost to Follow-up|0|||
129922272|NCT03544281|467680738|FG008|Main Study Phase|Lost to Follow-up|0|||
129922273|NCT03544281|467680739|FG009|Main Study Phase|Lost to Follow-up|0|||
129922274|NCT03544281|467680740|FG010|Main Study Phase|Lost to Follow-up|1|||
129922275|NCT03544281|467680741|FG011|Main Study Phase|Lost to Follow-up|0|||
129922276|NCT03544281|467680742|FG012|Main Study Phase|Lost to Follow-up|0|||
129922277|NCT03544281|467680743|FG013|Main Study Phase|Lost to Follow-up|0|||
129922278|NCT03544281|467680744|FG014|Main Study Phase|Lost to Follow-up|0|||
129922279|NCT03544281|467680745|FG015|Main Study Phase|Lost to Follow-up|0|||
129922280|NCT03544281|467680746|FG016|Main Study Phase|Lost to Follow-up|0|||
129922281|NCT03544281|467680747|FG017|Main Study Phase|Lost to Follow-up|0|||
129922282|NCT03544281|467680748|FG018|Main Study Phase|Lost to Follow-up|0|||
129922283|NCT03544281|467680749|FG019|Main Study Phase|Lost to Follow-up|0|||
129922284|NCT03544281|467680750|FG020|Main Study Phase|Lost to Follow-up|0|||
129922285|NCT03544281|467680751|FG021|Main Study Phase|Lost to Follow-up|0|||
129922286|NCT03544281|467680730|FG000|Main Study Phase|Physician Decision|0|||
129922287|NCT03544281|467680731|FG001|Main Study Phase|Physician Decision|0|||
129922288|NCT03544281|467680732|FG002|Main Study Phase|Physician Decision|0|||
129922289|NCT03544281|467680733|FG003|Main Study Phase|Physician Decision|0|||
129922290|NCT03544281|467680734|FG004|Main Study Phase|Physician Decision|0|||
129922291|NCT03544281|467680735|FG005|Main Study Phase|Physician Decision|0|||
129922292|NCT03544281|467680736|FG006|Main Study Phase|Physician Decision|0|||
129922293|NCT03544281|467680737|FG007|Main Study Phase|Physician Decision|1|||
129922294|NCT03544281|467680738|FG008|Main Study Phase|Physician Decision|0|||
129922295|NCT03544281|467680739|FG009|Main Study Phase|Physician Decision|0|||
129922296|NCT03544281|467680740|FG010|Main Study Phase|Physician Decision|0|||
129922297|NCT03544281|467680741|FG011|Main Study Phase|Physician Decision|0|||
129922298|NCT03544281|467680742|FG012|Main Study Phase|Physician Decision|0|||
129922299|NCT03544281|467680743|FG013|Main Study Phase|Physician Decision|0|||
129922300|NCT03544281|467680744|FG014|Main Study Phase|Physician Decision|0|||
129922301|NCT03544281|467680745|FG015|Main Study Phase|Physician Decision|0|||
129922302|NCT03544281|467680746|FG016|Main Study Phase|Physician Decision|0|||
129922303|NCT03544281|467680747|FG017|Main Study Phase|Physician Decision|0|||
129922304|NCT03544281|467680748|FG018|Main Study Phase|Physician Decision|0|||
129922305|NCT03544281|467680749|FG019|Main Study Phase|Physician Decision|0|||
129922306|NCT03544281|467680750|FG020|Main Study Phase|Physician Decision|0|||
129922307|NCT03544281|467680751|FG021|Main Study Phase|Physician Decision|0|||
129922308|NCT03544281|467680730|FG000|Main Study Phase|Withdrawal by Subject|2|||
129922309|NCT03544281|467680731|FG001|Main Study Phase|Withdrawal by Subject|0|||
129922310|NCT03544281|467680732|FG002|Main Study Phase|Withdrawal by Subject|1|||
129922311|NCT03544281|467680733|FG003|Main Study Phase|Withdrawal by Subject|2|||
129922312|NCT03544281|467680734|FG004|Main Study Phase|Withdrawal by Subject|0|||
129922313|NCT03544281|467680735|FG005|Main Study Phase|Withdrawal by Subject|0|||
129922314|NCT03544281|467680736|FG006|Main Study Phase|Withdrawal by Subject|0|||
129922315|NCT03544281|467680737|FG007|Main Study Phase|Withdrawal by Subject|0|||
129922316|NCT03544281|467680738|FG008|Main Study Phase|Withdrawal by Subject|2|||
129922317|NCT03544281|467680739|FG009|Main Study Phase|Withdrawal by Subject|3|||
129922318|NCT03544281|467680740|FG010|Main Study Phase|Withdrawal by Subject|0|||
129922319|NCT03544281|467680741|FG011|Main Study Phase|Withdrawal by Subject|4|||
129922320|NCT03544281|467680742|FG012|Main Study Phase|Withdrawal by Subject|0|||
129922321|NCT03544281|467680743|FG013|Main Study Phase|Withdrawal by Subject|0|||
129922322|NCT03544281|467680744|FG014|Main Study Phase|Withdrawal by Subject|0|||
129922323|NCT03544281|467680745|FG015|Main Study Phase|Withdrawal by Subject|0|||
129922324|NCT03544281|467680746|FG016|Main Study Phase|Withdrawal by Subject|0|||
129922325|NCT03544281|467680747|FG017|Main Study Phase|Withdrawal by Subject|0|||
129922326|NCT03544281|467680748|FG018|Main Study Phase|Withdrawal by Subject|0|||
129922327|NCT03544281|467680749|FG019|Main Study Phase|Withdrawal by Subject|0|||
129922328|NCT03544281|467680750|FG020|Main Study Phase|Withdrawal by Subject|0|||
129922329|NCT03544281|467680751|FG021|Main Study Phase|Withdrawal by Subject|0|||
129922330|NCT03544281|467680730|FG000|Main Study Phase|Ongoing|3|||
129922331|NCT03544281|467680731|FG001|Main Study Phase|Ongoing|1|||
129922332|NCT03544281|467680732|FG002|Main Study Phase|Ongoing|2|||
129922333|NCT03544281|467680733|FG003|Main Study Phase|Ongoing|4|||
129922334|NCT03544281|467680734|FG004|Main Study Phase|Ongoing|2|||
129922335|NCT03544281|467680735|FG005|Main Study Phase|Ongoing|4|||
129922336|NCT03544281|467680736|FG006|Main Study Phase|Ongoing|4|||
129922337|NCT03544281|467680737|FG007|Main Study Phase|Ongoing|0|||
129922338|NCT03544281|467680738|FG008|Main Study Phase|Ongoing|2|||
129922339|NCT03544281|467680739|FG009|Main Study Phase|Ongoing|2|||
129922340|NCT03544281|467680740|FG010|Main Study Phase|Ongoing|1|||
129922341|NCT03544281|467680741|FG011|Main Study Phase|Ongoing|0|||
129922342|NCT03544281|467680742|FG012|Main Study Phase|Ongoing|0|||
129922343|NCT03544281|467680743|FG013|Main Study Phase|Ongoing|0|||
129922344|NCT03544281|467680744|FG014|Main Study Phase|Ongoing|0|||
129922345|NCT03544281|467680745|FG015|Main Study Phase|Ongoing|0|||
129922346|NCT03544281|467680746|FG016|Main Study Phase|Ongoing|0|||
129922347|NCT03544281|467680747|FG017|Main Study Phase|Ongoing|0|||
129922348|NCT03544281|467680748|FG018|Main Study Phase|Ongoing|0|||
129922349|NCT03544281|467680749|FG019|Main Study Phase|Ongoing|0|||
129922350|NCT03544281|467680750|FG020|Main Study Phase|Ongoing|0|||
129922351|NCT03544281|467680751|FG021|Main Study Phase|Ongoing|0|||
129922352|NCT03544281|467680730|FG000|Main Study Phase|Investigator Site Closed|0|||
129922353|NCT03544281|467680731|FG001|Main Study Phase|Investigator Site Closed|0|||
129922354|NCT03544281|467680732|FG002|Main Study Phase|Investigator Site Closed|0|||
129922355|NCT03544281|467680733|FG003|Main Study Phase|Investigator Site Closed|0|||
129922356|NCT03544281|467680734|FG004|Main Study Phase|Investigator Site Closed|0|||
129922357|NCT03544281|467680735|FG005|Main Study Phase|Investigator Site Closed|0|||
129922358|NCT03544281|467680736|FG006|Main Study Phase|Investigator Site Closed|0|||
129922359|NCT03544281|467680737|FG007|Main Study Phase|Investigator Site Closed|0|||
129922360|NCT03544281|467680738|FG008|Main Study Phase|Investigator Site Closed|0|||
129922361|NCT03544281|467680739|FG009|Main Study Phase|Investigator Site Closed|1|||
129922362|NCT03544281|467680740|FG010|Main Study Phase|Investigator Site Closed|0|||
129922363|NCT03544281|467680741|FG011|Main Study Phase|Investigator Site Closed|0|||
129922364|NCT03544281|467680742|FG012|Main Study Phase|Investigator Site Closed|0|||
129922365|NCT03544281|467680743|FG013|Main Study Phase|Investigator Site Closed|0|||
129922366|NCT03544281|467680744|FG014|Main Study Phase|Investigator Site Closed|0|||
129922367|NCT03544281|467680745|FG015|Main Study Phase|Investigator Site Closed|0|||
129922368|NCT03544281|467680746|FG016|Main Study Phase|Investigator Site Closed|0|||
129922369|NCT03544281|467680747|FG017|Main Study Phase|Investigator Site Closed|0|||
129922370|NCT03544281|467680748|FG018|Main Study Phase|Investigator Site Closed|0|||
129922371|NCT03544281|467680749|FG019|Main Study Phase|Investigator Site Closed|0|||
129922372|NCT03544281|467680750|FG020|Main Study Phase|Investigator Site Closed|0|||
129922373|NCT03544281|467680751|FG021|Main Study Phase|Investigator Site Closed|0|||
129922374|NCT03544281|467680730|FG000|Main Study Phase|Did not receive study treatment|0|||
129922375|NCT03544281|467680731|FG001|Main Study Phase|Did not receive study treatment|0|||
129922376|NCT03544281|467680732|FG002|Main Study Phase|Did not receive study treatment|0|||
129922377|NCT03544281|467680733|FG003|Main Study Phase|Did not receive study treatment|0|||
129922378|NCT03544281|467680734|FG004|Main Study Phase|Did not receive study treatment|0|||
129922379|NCT03544281|467680735|FG005|Main Study Phase|Did not receive study treatment|0|||
129922380|NCT03544281|467680736|FG006|Main Study Phase|Did not receive study treatment|1|||
129922381|NCT03544281|467680737|FG007|Main Study Phase|Did not receive study treatment|0|||
129922382|NCT03544281|467680738|FG008|Main Study Phase|Did not receive study treatment|0|||
129922383|NCT03544281|467680739|FG009|Main Study Phase|Did not receive study treatment|0|||
129922384|NCT03544281|467680740|FG010|Main Study Phase|Did not receive study treatment|0|||
129922385|NCT03544281|467680741|FG011|Main Study Phase|Did not receive study treatment|0|||
129922386|NCT03544281|467680742|FG012|Main Study Phase|Did not receive study treatment|0|||
129922387|NCT03544281|467680743|FG013|Main Study Phase|Did not receive study treatment|0|||
129922388|NCT03544281|467680744|FG014|Main Study Phase|Did not receive study treatment|0|||
129922389|NCT03544281|467680745|FG015|Main Study Phase|Did not receive study treatment|0|||
129922390|NCT03544281|467680746|FG016|Main Study Phase|Did not receive study treatment|0|||
129922391|NCT03544281|467680747|FG017|Main Study Phase|Did not receive study treatment|0|||
129922392|NCT03544281|467680748|FG018|Main Study Phase|Did not receive study treatment|0|||
129922393|NCT03544281|467680749|FG019|Main Study Phase|Did not receive study treatment|0|||
129922394|NCT03544281|467680750|FG020|Main Study Phase|Did not receive study treatment|0|||
129922395|NCT03544281|467680751|FG021|Main Study Phase|Did not receive study treatment|0|||
129922396|NCT03544281|467680730|FG000|PACT Phase|Adverse Event|0|||
129922397|NCT03544281|467680731|FG001|PACT Phase|Adverse Event|0|||
129922398|NCT03544281|467680732|FG002|PACT Phase|Adverse Event|0|||
129922399|NCT03544281|467680733|FG003|PACT Phase|Adverse Event|0|||
129922400|NCT03544281|467680734|FG004|PACT Phase|Adverse Event|0|||
129922401|NCT03544281|467680735|FG005|PACT Phase|Adverse Event|0|||
129922402|NCT03544281|467680736|FG006|PACT Phase|Adverse Event|0|||
129922403|NCT03544281|467680737|FG007|PACT Phase|Adverse Event|0|||
129922404|NCT03544281|467680738|FG008|PACT Phase|Adverse Event|0|||
129922405|NCT03544281|467680739|FG009|PACT Phase|Adverse Event|0|||
129922406|NCT03544281|467680740|FG010|PACT Phase|Adverse Event|0|||
129922407|NCT03544281|467680741|FG011|PACT Phase|Adverse Event|0|||
129922408|NCT03544281|467680742|FG012|PACT Phase|Adverse Event|1|||
129922409|NCT03544281|467680743|FG013|PACT Phase|Adverse Event|0|||
129922410|NCT03544281|467680744|FG014|PACT Phase|Adverse Event|0|||
129922411|NCT03544281|467680745|FG015|PACT Phase|Adverse Event|0|||
129922412|NCT03544281|467680746|FG016|PACT Phase|Adverse Event|0|||
129922413|NCT03544281|467680747|FG017|PACT Phase|Adverse Event|1|||
129922414|NCT03544281|467680748|FG018|PACT Phase|Adverse Event|1|||
129922415|NCT03544281|467680749|FG019|PACT Phase|Adverse Event|0|||
129922416|NCT03544281|467680750|FG020|PACT Phase|Adverse Event|0|||
129922417|NCT03544281|467680751|FG021|PACT Phase|Adverse Event|0|||
129922418|NCT03092518|467680753|FG000|Overall Study|Ineligible|2|||
129922419|NCT02547987|467680756|FG000|Overall Study|Withdrawal by Subject|1|||
129922420|NCT02547987|467680756|FG000|Overall Study|Adverse Event|2|||
129922421|NCT04282148|467680757|FG000|Overall Study|Death|7|||
129922422|NCT04282148|467680757|FG000|Overall Study|Withdrawal by Subject|1|||
129922423|NCT04282148|467680757|FG000|Overall Study|Physician Decision|1|||
129922424|NCT02146378|467680758|FG000|Overall Study|No information of administration|2|||
129922425|NCT04925986|467680759|FG000|Overall Study|Death|0|||
129922426|NCT04925986|467680760|FG001|Overall Study|Death|0|||
129922427|NCT04925986|467680761|FG002|Overall Study|Death|2|||
129922428|NCT04925986|467680762|FG003|Overall Study|Death|0|||
129922429|NCT04925986|467680759|FG000|Overall Study|Lack of Efficacy|1|||
129922430|NCT04925986|467680760|FG001|Overall Study|Lack of Efficacy|2|||
129922431|NCT04925986|467680761|FG002|Overall Study|Lack of Efficacy|0|||
129922432|NCT04925986|467680762|FG003|Overall Study|Lack of Efficacy|1|||
129922433|NCT04925986|467680759|FG000|Overall Study|Withdrawal by Subject|0|||
129922434|NCT04925986|467680760|FG001|Overall Study|Withdrawal by Subject|0|||
129922435|NCT04925986|467680761|FG002|Overall Study|Withdrawal by Subject|1|||
129922436|NCT04925986|467680762|FG003|Overall Study|Withdrawal by Subject|2|||
129922437|NCT06181760|467680763|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
129922438|NCT06181760|467680764|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
129922439|NCT06181760|467680765|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
129922440|NCT06181760|467680766|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
129922441|NCT03524612|467680767|FG000|Overall Study|Lack of Efficacy|10|||
129922442|NCT03524612|467680767|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
129922443|NCT03524612|467680767|FG000|Overall Study|Adverse Event|10|||
129922444|NCT03524612|467680767|FG000|Overall Study|Withdrawal by Subject|7|||
129922445|NCT03524612|467680767|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
129922446|NCT03524612|467680767|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
129922447|NCT03524612|467680767|FG000|Overall Study|New therapy for study indication|6|||
129922448|NCT03524612|467680767|FG000|Overall Study|Death|3|||
129922449|NCT03524612|467680767|FG000|Overall Study|Lost to Follow-up|2|||
129922450|NCT03524612|467680767|FG000|Overall Study|Protocol Violation|1|||
129922451|NCT04770532|467680768|FG000|Overall Study|Withdrawal by Subject|0|||
129922452|NCT04770532|467680769|FG001|Overall Study|Withdrawal by Subject|3|||
129922453|NCT04770532|467680768|FG000|Overall Study|Physician Decision|1|||
129922454|NCT04770532|467680769|FG001|Overall Study|Physician Decision|0|||
129922455|NCT04770532|467680768|FG000|Overall Study|Death|2|||
129922456|NCT04770532|467680769|FG001|Overall Study|Death|2|||
129922457|NCT05457647|467680771|FG000|Overall Study|Lost to Follow-up|3|||
129922458|NCT04938492|467680772|FG000|Overall Study|Lost to Follow-up|17|||
129922459|NCT04938492|467680773|FG001|Overall Study|Lost to Follow-up|18|||
129922460|NCT02683447|467680774|FG000|Overall Study|Lost to Follow-up|2|||
129922461|NCT03448107|467680775|FG000|Overall Study|Lost to Follow-up|229|||
129922462|NCT03448107|467680776|FG001|Overall Study|Lost to Follow-up|258|||
129922463|NCT04025554|467680777|FG000|Overall Study|Adverse Event|3|||
129922464|NCT03115476|467680778|FG000|LP0084-1369|Death|1|||
129922465|NCT03115476|467680779|FG001|LP0084-1369|Death|0|||
129922466|NCT03115476|467680780|FG002|LP0084-1369|Death|2|||
129922467|NCT03115476|467680778|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
129922468|NCT03115476|467680779|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
129922469|NCT03115476|467680780|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
129922470|NCT05257486|467680784|FG000|Overall Study|Protocol Violation|3|||
129922471|NCT03976362|467680785|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
129922472|NCT03976362|467680786|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129922473|NCT03976362|467680787|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
130068369|NCT01617187|468203674|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
130068370|NCT01617187|468203675|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
129922474|NCT03976362|467680785|FG000|Induction Phase|Death|62|||
129922475|NCT03976362|467680786|FG001|Induction Phase|Death|0|||
129922476|NCT03976362|467680787|FG002|Induction Phase|Death|0|||
129922477|NCT03976362|467680785|FG000|Maintenance Phase|Participants Ongoing|0|||
129922478|NCT03976362|467680786|FG001|Maintenance Phase|Participants Ongoing|106|||
129922479|NCT03976362|467680787|FG002|Maintenance Phase|Participants Ongoing|103|||
129922480|NCT03976362|467680785|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129922481|NCT03976362|467680786|FG001|Maintenance Phase|Withdrawal by Subject|4|||
129922482|NCT03976362|467680787|FG002|Maintenance Phase|Withdrawal by Subject|4|||
129922483|NCT03976362|467680785|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
129922484|NCT03976362|467680786|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
129922485|NCT03976362|467680787|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
129922486|NCT03976362|467680785|FG000|Maintenance Phase|Death|0|||
130117009|NCT01506323|468388739|FG000|Overall Study|Withdrawal by Subject|4|||
130117010|NCT01506323|468388740|FG001|Overall Study|Withdrawal by Subject|4|||
130117011|NCT01506323|468388739|FG000|Overall Study|Lack of Efficacy|1|||
130117012|NCT01506323|468388740|FG001|Overall Study|Lack of Efficacy|3|||
130117013|NCT01506323|468388739|FG000|Overall Study|Moved out of area|5|||
130117014|NCT01506323|468388740|FG001|Overall Study|Moved out of area|2|||
130117015|NCT01506323|468388739|FG000|Overall Study|Schedule or Transportation conflict|8|||
130117016|NCT01506323|468388740|FG001|Overall Study|Schedule or Transportation conflict|0|||
130117017|NCT01506323|468388739|FG000|Overall Study|Started another treatment|1|||
130117018|NCT01506323|468388740|FG001|Overall Study|Started another treatment|0|||
130117019|NCT02891200|468388741|FG000|Overall Study|Lost to Follow-up|31|||
130117020|NCT02891200|468388742|FG001|Overall Study|Lost to Follow-up|36|||
130117021|NCT02891200|468388741|FG000|Overall Study|Death|10|||
130117022|NCT02891200|468388742|FG001|Overall Study|Death|9|||
130117023|NCT02891200|468388741|FG000|Overall Study|Withdrawal by Subject|1|||
130117024|NCT02891200|468388742|FG001|Overall Study|Withdrawal by Subject|4|||
130117025|NCT00444795|468388744|FG000|Overall Study|Not Treated|1|||
130117026|NCT00444795|468388744|FG000|Overall Study|Treated Prior to the Contract Date|2|||
130117027|NCT00988169|468388745|FG000|Overall Study|Withdrawal by Subject|1|||
130117028|NCT03083483|468388756|FG000|Overall Study|Adverse Event|1|||
130117029|NCT03083483|468388757|FG001|Overall Study|Adverse Event|1|||
130117030|NCT03083483|468388758|FG002|Overall Study|Adverse Event|1|||
130117031|NCT03083483|468388756|FG000|Overall Study|Lost to Follow-up|2|||
130117032|NCT03083483|468388757|FG001|Overall Study|Lost to Follow-up|1|||
130117033|NCT03083483|468388758|FG002|Overall Study|Lost to Follow-up|1|||
130117034|NCT03083483|468388756|FG000|Overall Study|technological issues|1|||
130117035|NCT03083483|468388757|FG001|Overall Study|technological issues|0|||
130117036|NCT03083483|468388758|FG002|Overall Study|technological issues|1|||
130117037|NCT02710071|468388759|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
130117038|NCT02710071|468388760|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
130117039|NCT02710071|468388759|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
130117040|NCT02710071|468388760|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
130117041|NCT02637557|468388767|FG000|Overall Study|Adverse Event|3|||
130117042|NCT02637557|468388768|FG001|Overall Study|Adverse Event|1|||
130117043|NCT02637557|468388769|FG002|Overall Study|Adverse Event|3|||
130117044|NCT02637557|468388770|FG003|Overall Study|Adverse Event|3|||
130117045|NCT02637557|468388767|FG000|Overall Study|Lost to Follow-up|1|||
130117046|NCT02637557|468388768|FG001|Overall Study|Lost to Follow-up|1|||
130117047|NCT02637557|468388769|FG002|Overall Study|Lost to Follow-up|0|||
130117048|NCT02637557|468388770|FG003|Overall Study|Lost to Follow-up|1|||
130117049|NCT02637557|468388767|FG000|Overall Study|Physician Decision|1|||
130117050|NCT02637557|468388768|FG001|Overall Study|Physician Decision|0|||
130117051|NCT02637557|468388769|FG002|Overall Study|Physician Decision|0|||
130117052|NCT02637557|468388770|FG003|Overall Study|Physician Decision|0|||
129922487|NCT03976362|467680786|FG001|Maintenance Phase|Death|186|||
129922488|NCT03976362|467680787|FG002|Maintenance Phase|Death|187|||
129922489|NCT00613106|467680788|FG000|Overall Study|Adverse Event|3|||
129922490|NCT00613106|467680789|FG001|Overall Study|Adverse Event|1|||
129922491|NCT00613106|467680788|FG000|Overall Study|Withdrawal by Subject|6|||
129922492|NCT00613106|467680789|FG001|Overall Study|Withdrawal by Subject|3|||
129922493|NCT00613106|467680788|FG000|Overall Study|Lost to Follow-up|7|||
129922494|NCT00613106|467680789|FG001|Overall Study|Lost to Follow-up|2|||
129922495|NCT00613106|467680788|FG000|Overall Study|misc|4|||
129922496|NCT00613106|467680789|FG001|Overall Study|misc|3|||
129922497|NCT05084508|467680798|FG000|Overall Study|Lost to Follow-up|6|||
129922498|NCT05084508|467680799|FG001|Overall Study|Lost to Follow-up|3|||
129922499|NCT05084508|467680800|FG002|Overall Study|Lost to Follow-up|7|||
129922500|NCT05084508|467680801|FG003|Overall Study|Lost to Follow-up|3|||
129922501|NCT05084508|467680798|FG000|Overall Study|Withdrawal by Subject|0|||
129922502|NCT05084508|467680799|FG001|Overall Study|Withdrawal by Subject|2|||
129922503|NCT05084508|467680800|FG002|Overall Study|Withdrawal by Subject|3|||
129922504|NCT05084508|467680801|FG003|Overall Study|Withdrawal by Subject|1|||
129922505|NCT05084508|467680798|FG000|Overall Study|Other|0|||
129922506|NCT05084508|467680799|FG001|Overall Study|Other|0|||
129922507|NCT05084508|467680800|FG002|Overall Study|Other|0|||
130117053|NCT02637557|468388767|FG000|Overall Study|Protocol Violation|2|||
130117054|NCT02637557|468388768|FG001|Overall Study|Protocol Violation|0|||
130117055|NCT02637557|468388769|FG002|Overall Study|Protocol Violation|2|||
130117056|NCT02637557|468388770|FG003|Overall Study|Protocol Violation|1|||
129922508|NCT05084508|467680801|FG003|Overall Study|Other|1|||
129922509|NCT05296525|467680802|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
129922510|NCT05296525|467680803|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
129922511|NCT05296525|467680804|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
129922512|NCT05296525|467680805|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
130117057|NCT02637557|468388767|FG000|Overall Study|Withdrawal by Subject|1|||
129922513|NCT04065841|467680810|FG000|Overall Study|Adverse Event|4|||
130117058|NCT02637557|468388768|FG001|Overall Study|Withdrawal by Subject|3|||
130117059|NCT02637557|468388769|FG002|Overall Study|Withdrawal by Subject|4|||
129922514|NCT04065841|467680811|FG001|Overall Study|Adverse Event|2|||
129922515|NCT04065841|467680812|FG002|Overall Study|Adverse Event|10|||
130068371|NCT01617187|468203676|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
130068372|NCT01617187|468203677|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
130068373|NCT01617187|468203674|FG000|Treatment Through Study Completion|Protocol Violation|1|||
130068374|NCT01617187|468203675|FG001|Treatment Through Study Completion|Protocol Violation|0|||
130068375|NCT01617187|468203676|FG002|Treatment Through Study Completion|Protocol Violation|0|||
130068376|NCT01617187|468203677|FG003|Treatment Through Study Completion|Protocol Violation|1|||
130068377|NCT01770145|468205468|FG000|Baseline|Adverse Event|20|||
130068378|NCT01770145|468205468|FG000|Baseline|Withdrawal by Subject|1|||
130068379|NCT01770145|468205468|FG000|Baseline|Lost to Follow-up|1|||
130068380|NCT01770145|468205468|FG000|Baseline|Unable to define optimal dose|4|||
130068381|NCT01770145|468205468|FG000|Treatment|Adverse Event|3|||
130068382|NCT01770145|468205468|FG000|Treatment|Withdrawal by Subject|1|||
130068383|NCT00595868|468205469|FG000|Overall Study|Lost to Follow-up|45|||
130068384|NCT00595868|468205470|FG001|Overall Study|Lost to Follow-up|50|||
130068385|NCT05406440|468205471|FG000|Overall Study|Lost to Follow-up|0|||
130068386|NCT05406440|468205472|FG001|Overall Study|Lost to Follow-up|0|||
130068387|NCT05406440|468205473|FG002|Overall Study|Lost to Follow-up|0|||
130068388|NCT05406440|468205474|FG003|Overall Study|Lost to Follow-up|0|||
130068389|NCT05406440|468205475|FG004|Overall Study|Lost to Follow-up|2|||
130068390|NCT05406440|468205476|FG005|Overall Study|Lost to Follow-up|0|||
130068391|NCT05406440|468205477|FG006|Overall Study|Lost to Follow-up|0|||
130068392|NCT05406440|468205471|FG000|Overall Study|Physician Decision|0|||
130068393|NCT05406440|468205472|FG001|Overall Study|Physician Decision|0|||
130068394|NCT05406440|468205473|FG002|Overall Study|Physician Decision|0|||
130068395|NCT05406440|468205474|FG003|Overall Study|Physician Decision|0|||
130068396|NCT05406440|468205475|FG004|Overall Study|Physician Decision|1|||
130068397|NCT05406440|468205476|FG005|Overall Study|Physician Decision|0|||
130068398|NCT05406440|468205477|FG006|Overall Study|Physician Decision|0|||
130068399|NCT05406440|468205471|FG000|Overall Study|Withdrawal by Subject|0|||
130068400|NCT05406440|468205472|FG001|Overall Study|Withdrawal by Subject|0|||
130068401|NCT05406440|468205473|FG002|Overall Study|Withdrawal by Subject|0|||
130068402|NCT05406440|468205474|FG003|Overall Study|Withdrawal by Subject|0|||
130068403|NCT05406440|468205475|FG004|Overall Study|Withdrawal by Subject|0|||
130068404|NCT05406440|468205476|FG005|Overall Study|Withdrawal by Subject|2|||
130068405|NCT05406440|468205477|FG006|Overall Study|Withdrawal by Subject|0|||
130068406|NCT04268303|468205479|FG000|Overall Study|Lost to Follow-up|1|||
130068407|NCT04268303|468205480|FG001|Overall Study|Lost to Follow-up|1|||
130068408|NCT04268303|468205481|FG002|Overall Study|Lost to Follow-up|2|||
130068409|NCT04268303|468205479|FG000|Overall Study|Withdrawal by Subject|0|||
130068410|NCT04268303|468205480|FG001|Overall Study|Withdrawal by Subject|1|||
130068411|NCT04268303|468205481|FG002|Overall Study|Withdrawal by Subject|1|||
129922516|NCT04065841|467680813|FG003|Overall Study|Adverse Event|1|||
129922517|NCT04065841|467680810|FG000|Overall Study|Lost to Follow-up|1|||
129922518|NCT04065841|467680811|FG001|Overall Study|Lost to Follow-up|2|||
129922519|NCT04065841|467680812|FG002|Overall Study|Lost to Follow-up|2|||
129922520|NCT04065841|467680813|FG003|Overall Study|Lost to Follow-up|2|||
129922521|NCT04065841|467680810|FG000|Overall Study|Physician Decision|1|||
129922522|NCT04065841|467680811|FG001|Overall Study|Physician Decision|0|||
129922523|NCT04065841|467680812|FG002|Overall Study|Physician Decision|0|||
129922524|NCT04065841|467680813|FG003|Overall Study|Physician Decision|0|||
129922525|NCT04065841|467680810|FG000|Overall Study|Protocol Violation|0|||
129922526|NCT04065841|467680811|FG001|Overall Study|Protocol Violation|1|||
129922527|NCT04065841|467680812|FG002|Overall Study|Protocol Violation|0|||
129922528|NCT04065841|467680813|FG003|Overall Study|Protocol Violation|0|||
129922529|NCT04065841|467680810|FG000|Overall Study|Study terminated by Sponsor|22|||
130068412|NCT04268303|468205479|FG000|Overall Study|Adverse Event|2|||
130068413|NCT04268303|468205480|FG001|Overall Study|Adverse Event|0|||
130068414|NCT04268303|468205481|FG002|Overall Study|Adverse Event|0|||
129922530|NCT04065841|467680811|FG001|Overall Study|Study terminated by Sponsor|16|||
130068415|NCT05742841|468205485|FG000|Overall Study|Withdrawal by Subject|1|||
130068416|NCT05742841|468205485|FG000|Overall Study|Lost to Follow-up|1|||
130068417|NCT01711541|468205486|FG000|Overall Study|Cancel prior to treatment|0|||
130068418|NCT01711541|468205487|FG001|Overall Study|Cancel prior to treatment|0|||
130068419|NCT01711541|468205488|FG002|Overall Study|Cancel prior to treatment|0|||
129922531|NCT04065841|467680812|FG002|Overall Study|Study terminated by Sponsor|28|||
129922532|NCT04065841|467680813|FG003|Overall Study|Study terminated by Sponsor|17|||
130068420|NCT01711541|468205489|FG003|Overall Study|Cancel prior to treatment|1|||
130068421|NCT01711541|468205490|FG004|Overall Study|Cancel prior to treatment|0|||
130068422|NCT01711541|468205486|FG000|Overall Study|Ineligible|0|||
129922533|NCT04065841|467680810|FG000|Overall Study|Withdrawal by Subject|1|||
129922534|NCT04065841|467680811|FG001|Overall Study|Withdrawal by Subject|1|||
129922535|NCT04065841|467680812|FG002|Overall Study|Withdrawal by Subject|2|||
130068423|NCT01711541|468205487|FG001|Overall Study|Ineligible|1|||
130068424|NCT01711541|468205488|FG002|Overall Study|Ineligible|0|||
130068425|NCT01711541|468205489|FG003|Overall Study|Ineligible|0|||
130068426|NCT01711541|468205490|FG004|Overall Study|Ineligible|0|||
129922536|NCT04065841|467680813|FG003|Overall Study|Withdrawal by Subject|0|||
129922537|NCT01420237|467680814|FG000|Overall Study|Death|13|||
129922538|NCT01420237|467680814|FG000|Overall Study|Withdrawal by Subject|41|||
129922539|NCT01420237|467680814|FG000|Overall Study|Lost to Follow-up|32|||
129922540|NCT01420237|467680814|FG000|Overall Study|Adverse Event|10|||
129922541|NCT01420237|467680814|FG000|Overall Study|Investigative Site Termination|43|||
129922542|NCT01420237|467680814|FG000|Overall Study|Censored because study device not implanted|21|||
129922543|NCT01420237|467680814|FG000|Overall Study|Censored because surgery not performed|2|||
129922544|NCT01420237|467680814|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
129922545|NCT01420237|467680814|FG000|Overall Study|Sponsor terminated study early|127|||
129922546|NCT04492722|467680815|FG000|Overall Study|Adverse Event|7|||
129922547|NCT04492722|467680816|FG001|Overall Study|Adverse Event|2|||
129922548|NCT04492722|467680817|FG002|Overall Study|Adverse Event|3|||
129922549|NCT04492722|467680818|FG003|Overall Study|Adverse Event|0|||
129922550|NCT04492722|467680815|FG000|Overall Study|Death|0|||
129922551|NCT04492722|467680816|FG001|Overall Study|Death|0|||
129922552|NCT04492722|467680817|FG002|Overall Study|Death|0|||
129922553|NCT04492722|467680818|FG003|Overall Study|Death|1|||
129922554|NCT04492722|467680815|FG000|Overall Study|Lost to Follow-up|0|||
129922555|NCT04492722|467680816|FG001|Overall Study|Lost to Follow-up|1|||
129922556|NCT04492722|467680817|FG002|Overall Study|Lost to Follow-up|0|||
129922557|NCT04492722|467680818|FG003|Overall Study|Lost to Follow-up|1|||
129922558|NCT04492722|467680815|FG000|Overall Study|Physician Decision|0|||
129922559|NCT04492722|467680816|FG001|Overall Study|Physician Decision|3|||
129922560|NCT04492722|467680817|FG002|Overall Study|Physician Decision|1|||
129922561|NCT04492722|467680818|FG003|Overall Study|Physician Decision|1|||
129922562|NCT04492722|467680815|FG000|Overall Study|Withdrawal by Subject|6|||
129922563|NCT04492722|467680816|FG001|Overall Study|Withdrawal by Subject|6|||
129922564|NCT04492722|467680817|FG002|Overall Study|Withdrawal by Subject|0|||
129922565|NCT04492722|467680818|FG003|Overall Study|Withdrawal by Subject|3|||
129922566|NCT04492722|467680815|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
129922567|NCT04492722|467680816|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
129922568|NCT04492722|467680817|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
129922569|NCT04492722|467680818|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
129922570|NCT04492722|467680815|FG000|Overall Study|Due to Covid-19 pandemic|7|||
129922571|NCT04492722|467680816|FG001|Overall Study|Due to Covid-19 pandemic|3|||
129922572|NCT04492722|467680817|FG002|Overall Study|Due to Covid-19 pandemic|7|||
129922573|NCT04492722|467680818|FG003|Overall Study|Due to Covid-19 pandemic|6|||
129922574|NCT04492722|467680815|FG000|Overall Study|Failure to meet randomisation criteria|2|||
129922575|NCT04492722|467680816|FG001|Overall Study|Failure to meet randomisation criteria|3|||
129922576|NCT04492722|467680817|FG002|Overall Study|Failure to meet randomisation criteria|4|||
129922577|NCT04492722|467680818|FG003|Overall Study|Failure to meet randomisation criteria|2|||
129922578|NCT04492722|467680815|FG000|Overall Study|Early termination from the study|54|||
129922579|NCT04492722|467680816|FG001|Overall Study|Early termination from the study|51|||
129922580|NCT04492722|467680817|FG002|Overall Study|Early termination from the study|50|||
129922581|NCT04492722|467680818|FG003|Overall Study|Early termination from the study|50|||
129922582|NCT04492722|467680815|FG000|Overall Study|Missing|3|||
129922583|NCT04492722|467680816|FG001|Overall Study|Missing|0|||
129922584|NCT04492722|467680817|FG002|Overall Study|Missing|0|||
129922585|NCT04492722|467680818|FG003|Overall Study|Missing|5|||
129922586|NCT04492722|467680815|FG000|Overall Study|Participants who did not receive treatment|0|||
129922587|NCT04492722|467680816|FG001|Overall Study|Participants who did not receive treatment|1|||
129922588|NCT04492722|467680817|FG002|Overall Study|Participants who did not receive treatment|4|||
129922589|NCT04492722|467680818|FG003|Overall Study|Participants who did not receive treatment|0|||
129922590|NCT03631784|467680820|FG000|Overall Study|Participants Ongoing|1|||
129922591|NCT03631784|467680821|FG001|Overall Study|Participants Ongoing|0|||
129922592|NCT03631784|467680820|FG000|Overall Study|Withdrawal by Subject|3|||
129922593|NCT03631784|467680821|FG001|Overall Study|Withdrawal by Subject|3|||
129922594|NCT03631784|467680820|FG000|Overall Study|Sponsor's Decision|36|||
129922595|NCT03631784|467680821|FG001|Overall Study|Sponsor's Decision|52|||
129922596|NCT03631784|467680820|FG000|Overall Study|Lost to Follow-up|1|||
129922597|NCT03631784|467680821|FG001|Overall Study|Lost to Follow-up|0|||
129922598|NCT03631784|467680820|FG000|Overall Study|Death|71|||
129922599|NCT03631784|467680821|FG001|Overall Study|Death|49|||
129922600|NCT05030233|467680827|FG000|Overall Study|withdrawn for transfer|1|||
129922601|NCT05030233|467680828|FG001|Overall Study|withdrawn for transfer|0|||
129922602|NCT04437615|467680829|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
129922603|NCT02921230|467682962|FG000|Overall Study|Withdrawal by Subject|20|||
129922604|NCT02921230|467682963|FG001|Overall Study|Withdrawal by Subject|8|||
129922605|NCT02921230|467682962|FG000|Overall Study|Death|12|||
129922606|NCT02921230|467682963|FG001|Overall Study|Death|3|||
129922607|NCT02921230|467682962|FG000|Overall Study|Protocol Violation|17|||
129922608|NCT02921230|467682963|FG001|Overall Study|Protocol Violation|6|||
129922609|NCT02921230|467682962|FG000|Overall Study|Early completion|5|||
129922610|NCT02921230|467682963|FG001|Overall Study|Early completion|1|||
129922611|NCT02921230|467682962|FG000|Overall Study|Pending data entry|1|||
130117060|NCT02637557|468388770|FG003|Overall Study|Withdrawal by Subject|2|||
130117061|NCT00613574|468388771|FG000|Overall Study|Adverse Event|3|||
130117062|NCT00613574|468388771|FG000|Overall Study|Lost to Follow-up|2|||
130117063|NCT00613574|468388771|FG000|Overall Study|Other|1|||
130117064|NCT04604184|468388778|FG000|Overall Study|Adverse Event|5|||
130117065|NCT04604184|468388779|FG001|Overall Study|Adverse Event|5|||
130117066|NCT04604184|468388778|FG000|Overall Study|Death|2|||
130117067|NCT04604184|468388779|FG001|Overall Study|Death|1|||
130117068|NCT04604184|468388778|FG000|Overall Study|Withdrawal by Subject|1|||
130117069|NCT04604184|468388779|FG001|Overall Study|Withdrawal by Subject|3|||
130117070|NCT04604184|468388778|FG000|Overall Study|Not treated|2|||
130117071|NCT04604184|468388779|FG001|Overall Study|Not treated|2|||
130117072|NCT04604184|468388778|FG000|Overall Study|Due to sponsor decision|9|||
130117073|NCT04604184|468388779|FG001|Overall Study|Due to sponsor decision|7|||
130117074|NCT04604184|468388778|FG000|Overall Study|Physician Decision|0|||
130117075|NCT04604184|468388779|FG001|Overall Study|Physician Decision|1|||
130117076|NCT04604184|468388778|FG000|Overall Study|Transfer to healthcare|1|||
130117077|NCT04604184|468388779|FG001|Overall Study|Transfer to healthcare|0|||
130117078|NCT01751412|468388780|FG000|Overall Study|Disease Progression Before Treatment|1|||
130117079|NCT02711956|468388783|FG000|Overall Study|Adverse Event|0|||
130117080|NCT02711956|468388784|FG001|Overall Study|Adverse Event|0|||
130117081|NCT02711956|468388785|FG002|Overall Study|Adverse Event|0|||
130117082|NCT02711956|468388786|FG003|Overall Study|Adverse Event|1|||
130117083|NCT02711956|468388787|FG004|Overall Study|Adverse Event|2|||
130117084|NCT02711956|468388788|FG005|Overall Study|Adverse Event|0|||
130117085|NCT02711956|468388789|FG006|Overall Study|Adverse Event|0|||
130117086|NCT02711956|468388790|FG007|Overall Study|Adverse Event|1|||
130117087|NCT02711956|468388791|FG008|Overall Study|Adverse Event|1|||
130117088|NCT02711956|468388792|FG009|Overall Study|Adverse Event|1|||
130117089|NCT02711956|468388793|FG010|Overall Study|Adverse Event|1|||
130117090|NCT02711956|468388794|FG011|Overall Study|Adverse Event|0|||
130117091|NCT02711956|468388795|FG012|Overall Study|Adverse Event|0|||
130117092|NCT02711956|468388796|FG013|Overall Study|Adverse Event|0|||
130117093|NCT02711956|468388797|FG014|Overall Study|Adverse Event|2|||
130117094|NCT02711956|468388783|FG000|Overall Study|Physician Decision|0|||
130117095|NCT02711956|468388784|FG001|Overall Study|Physician Decision|0|||
130117096|NCT02711956|468388785|FG002|Overall Study|Physician Decision|0|||
130117097|NCT02711956|468388786|FG003|Overall Study|Physician Decision|2|||
130117098|NCT02711956|468388787|FG004|Overall Study|Physician Decision|0|||
130117099|NCT02711956|468388788|FG005|Overall Study|Physician Decision|0|||
130117100|NCT02711956|468388789|FG006|Overall Study|Physician Decision|0|||
130117101|NCT02711956|468388790|FG007|Overall Study|Physician Decision|0|||
130117102|NCT02711956|468388791|FG008|Overall Study|Physician Decision|0|||
130117103|NCT02711956|468388792|FG009|Overall Study|Physician Decision|0|||
130117104|NCT02711956|468388793|FG010|Overall Study|Physician Decision|0|||
130117105|NCT02711956|468388794|FG011|Overall Study|Physician Decision|0|||
130117106|NCT02711956|468388795|FG012|Overall Study|Physician Decision|0|||
130117107|NCT02711956|468388796|FG013|Overall Study|Physician Decision|0|||
130117108|NCT02711956|468388797|FG014|Overall Study|Physician Decision|0|||
130117109|NCT02711956|468388783|FG000|Overall Study|Withdrawal by Subject|0|||
130117110|NCT02711956|468388784|FG001|Overall Study|Withdrawal by Subject|0|||
130117111|NCT02711956|468388785|FG002|Overall Study|Withdrawal by Subject|0|||
130117112|NCT02711956|468388786|FG003|Overall Study|Withdrawal by Subject|0|||
130117113|NCT02711956|468388787|FG004|Overall Study|Withdrawal by Subject|0|||
130117114|NCT02711956|468388788|FG005|Overall Study|Withdrawal by Subject|0|||
130117115|NCT02711956|468388789|FG006|Overall Study|Withdrawal by Subject|1|||
130117116|NCT02711956|468388790|FG007|Overall Study|Withdrawal by Subject|0|||
130117117|NCT02711956|468388791|FG008|Overall Study|Withdrawal by Subject|0|||
130117118|NCT02711956|468388792|FG009|Overall Study|Withdrawal by Subject|0|||
130117119|NCT02711956|468388793|FG010|Overall Study|Withdrawal by Subject|0|||
130117120|NCT02711956|468388794|FG011|Overall Study|Withdrawal by Subject|1|||
130117121|NCT02711956|468388795|FG012|Overall Study|Withdrawal by Subject|6|||
129922612|NCT02921230|467682963|FG001|Overall Study|Pending data entry|0|||
129922613|NCT01396278|467682966|FG000|Overall Study|Adverse Event|0|||
129922614|NCT01396278|467682967|FG001|Overall Study|Adverse Event|0|||
129922615|NCT01396278|467682968|FG002|Overall Study|Adverse Event|0|||
129922616|NCT01396278|467682969|FG003|Overall Study|Adverse Event|2|||
130117122|NCT02711956|468388796|FG013|Overall Study|Withdrawal by Subject|0|||
130117123|NCT02711956|468388797|FG014|Overall Study|Withdrawal by Subject|1|||
130117124|NCT02711956|468388783|FG000|Overall Study|Clinical progression|1|||
129922617|NCT01396278|467682970|FG004|Overall Study|Adverse Event|0|||
130117125|NCT02711956|468388784|FG001|Overall Study|Clinical progression|0|||
130117126|NCT02711956|468388785|FG002|Overall Study|Clinical progression|0|||
130117127|NCT02711956|468388786|FG003|Overall Study|Clinical progression|0|||
130117128|NCT02711956|468388787|FG004|Overall Study|Clinical progression|0|||
130117129|NCT02711956|468388788|FG005|Overall Study|Clinical progression|0|||
130117130|NCT02711956|468388789|FG006|Overall Study|Clinical progression|1|||
130117131|NCT02711956|468388790|FG007|Overall Study|Clinical progression|0|||
129922618|NCT01396278|467682966|FG000|Overall Study|Withdraw due to trial termination|2|||
130068427|NCT00728936|468205491|FG000|Overall Study|Withdrawal by Subject|0|||
130068428|NCT00728936|468205492|FG001|Overall Study|Withdrawal by Subject|0|||
130068429|NCT00728936|468205493|FG002|Overall Study|Withdrawal by Subject|0|||
130068430|NCT00728936|468205494|FG003|Overall Study|Withdrawal by Subject|0|||
130068431|NCT00728936|468205495|FG004|Overall Study|Withdrawal by Subject|0|||
130068432|NCT00728936|468205496|FG005|Overall Study|Withdrawal by Subject|1|||
130068433|NCT00728936|468205497|FG006|Overall Study|Withdrawal by Subject|0|||
130068434|NCT01175590|468205505|FG000|Overall Study|Lost to Follow-up|1|||
130068435|NCT01175590|468205506|FG001|Overall Study|Lost to Follow-up|0|||
130068436|NCT01175590|468205505|FG000|Overall Study|Withdrawal by Subject|0|||
130068437|NCT01175590|468205506|FG001|Overall Study|Withdrawal by Subject|2|||
130068438|NCT01175590|468205505|FG000|Overall Study|Adverse Event|4|||
130068439|NCT01175590|468205506|FG001|Overall Study|Adverse Event|0|||
130068440|NCT01175590|468205505|FG000|Overall Study|Physician Decision|1|||
130068441|NCT01175590|468205506|FG001|Overall Study|Physician Decision|4|||
130068442|NCT01175590|468205505|FG000|Overall Study|Lack of Efficacy|1|||
130068443|NCT01175590|468205506|FG001|Overall Study|Lack of Efficacy|1|||
130068444|NCT01175590|468205505|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
130068445|NCT01175590|468205506|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
130068446|NCT01175590|468205505|FG000|Overall Study|Treated not as randomized|3|||
130068447|NCT01175590|468205506|FG001|Overall Study|Treated not as randomized|2|||
130068448|NCT01175590|468205505|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
130068449|NCT01175590|468205506|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
130068450|NCT01175590|468205505|FG000|Overall Study|Protocol Violation|0|||
130068451|NCT01175590|468205506|FG001|Overall Study|Protocol Violation|1|||
130068452|NCT00877006|468205514|FG000|Treatment Period|Death|2|||
130068453|NCT00877006|468205515|FG001|Treatment Period|Death|1|||
130068454|NCT00877006|468205514|FG000|Treatment Period|Adverse Event|10|||
130068455|NCT00877006|468205515|FG001|Treatment Period|Adverse Event|3|||
130068456|NCT00877006|468205514|FG000|Treatment Period|Withdrawal by Subject|2|||
130068457|NCT00877006|468205515|FG001|Treatment Period|Withdrawal by Subject|3|||
130068458|NCT00877006|468205514|FG000|Treatment Period|Protocol Violation|1|||
130068459|NCT00877006|468205515|FG001|Treatment Period|Protocol Violation|0|||
130068460|NCT00877006|468205514|FG000|Treatment Period|Lost to Follow-up|0|||
130068461|NCT00877006|468205515|FG001|Treatment Period|Lost to Follow-up|1|||
130068462|NCT00877006|468205514|FG000|Treatment Period|Disease Progression|1|||
130068463|NCT00877006|468205515|FG001|Treatment Period|Disease Progression|2|||
130068464|NCT00877006|468205514|FG000|Treatment Period|Started New Treatment Regimen|2|||
130068465|NCT00877006|468205515|FG001|Treatment Period|Started New Treatment Regimen|5|||
130068466|NCT00877006|468205514|FG000|Treatment Period|Other|4|||
130068467|NCT00877006|468205515|FG001|Treatment Period|Other|4|||
130068468|NCT00877006|468205514|FG000|Treatment Period|Randomized but Not Treated|3|||
130068469|NCT00877006|468205515|FG001|Treatment Period|Randomized but Not Treated|8|||
130068470|NCT00877006|468205514|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
130068471|NCT00877006|468205515|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
130068472|NCT00877006|468205514|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
130068473|NCT00877006|468205515|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
130068474|NCT00877006|468205514|FG000|Long-Term Follow-up Period|Death|26|||
130068475|NCT00877006|468205515|FG001|Long-Term Follow-up Period|Death|18|||
130068476|NCT00877006|468205514|FG000|Long-Term Follow-up Period|Other|7|||
130068477|NCT00877006|468205515|FG001|Long-Term Follow-up Period|Other|9|||
130068478|NCT04671342|468205516|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
130068479|NCT04671342|468205516|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
130068480|NCT04671342|468205516|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
130068481|NCT04671342|468205516|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
130068482|NCT04671342|468205516|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
130068483|NCT04671342|468205516|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
130068484|NCT03911869|468205517|FG000|Safety Lead-in Phase|Death|7|||
130068485|NCT03911869|468205518|FG001|Safety Lead-in Phase|Death|0|||
130068486|NCT03911869|468205519|FG002|Safety Lead-in Phase|Death|0|||
130068487|NCT03911869|468205517|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
130068488|NCT03911869|468205518|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
130068489|NCT03911869|468205519|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
130068490|NCT03911869|468205517|FG000|Safety Lead-in Phase|Other|1|||
130068491|NCT03911869|468205518|FG001|Safety Lead-in Phase|Other|0|||
130068492|NCT03911869|468205519|FG002|Safety Lead-in Phase|Other|0|||
130068493|NCT03911869|468205517|FG000|Phase 2|Death|0|||
130068494|NCT03911869|468205518|FG001|Phase 2|Death|3|||
130068495|NCT03911869|468205519|FG002|Phase 2|Death|0|||
130068496|NCT01878097|468205520|FG000|Baseline|Surveys not fully completed|2497|||
130068497|NCT01878097|468205521|FG001|Baseline|Surveys not fully completed|1800|||
130068498|NCT01878097|468205520|FG000|Implementation Year 1|Surveys not fully completed|3202|||
130068499|NCT01878097|468205521|FG001|Implementation Year 1|Surveys not fully completed|2549|||
130068500|NCT01878097|468205520|FG000|Implementation Year 2|Surveys not fully completed|3281|||
130068501|NCT01878097|468205521|FG001|Implementation Year 2|Surveys not fully completed|2841|||
130068502|NCT01878097|468205520|FG000|Implementation Year 3|Surveys not fully completed|3494|||
130068503|NCT01878097|468205521|FG001|Implementation Year 3|Surveys not fully completed|2980|||
130068504|NCT01878097|468205520|FG000|Implementation Year 4|Surveys not fully completed|3604|||
130068505|NCT01878097|468205521|FG001|Implementation Year 4|Surveys not fully completed|3007|||
130068506|NCT00367341|468205522|FG000|Overall Study|Physician Decision|1|||
130068507|NCT00367341|468205523|FG001|Overall Study|Physician Decision|0|||
130068508|NCT00367341|468205522|FG000|Overall Study|Protocol Violation|1|||
130068509|NCT00367341|468205523|FG001|Overall Study|Protocol Violation|0|||
130068510|NCT03325556|468205524|FG000|Open-label Period|Lack of Response in OL period|70|||
130068511|NCT03325556|468205525|FG001|Open-label Period|Lack of Response in OL period|0|||
130068512|NCT03325556|468205526|FG002|Open-label Period|Lack of Response in OL period|0|||
130068513|NCT03325556|468205524|FG000|Open-label Period|Adverse Event|27|||
130068514|NCT03325556|468205525|FG001|Open-label Period|Adverse Event|0|||
130068515|NCT03325556|468205526|FG002|Open-label Period|Adverse Event|0|||
130068516|NCT03325556|468205524|FG000|Open-label Period|Death|1|||
130068517|NCT03325556|468205525|FG001|Open-label Period|Death|0|||
130068518|NCT03325556|468205526|FG002|Open-label Period|Death|0|||
130068519|NCT03325556|468205524|FG000|Open-label Period|Lost to Follow-up|1|||
130068520|NCT03325556|468205525|FG001|Open-label Period|Lost to Follow-up|0|||
130068521|NCT03325556|468205526|FG002|Open-label Period|Lost to Follow-up|0|||
130068522|NCT03325556|468205524|FG000|Open-label Period|Non-compliance with study drug|5|||
130068523|NCT03325556|468205525|FG001|Open-label Period|Non-compliance with study drug|0|||
130068524|NCT03325556|468205526|FG002|Open-label Period|Non-compliance with study drug|0|||
130068525|NCT03325556|468205524|FG000|Open-label Period|Use of prohibited medication|1|||
130068526|NCT03325556|468205525|FG001|Open-label Period|Use of prohibited medication|0|||
130068527|NCT03325556|468205526|FG002|Open-label Period|Use of prohibited medication|0|||
130068528|NCT03325556|468205524|FG000|Open-label Period|Protocol Violation|4|||
130068529|NCT03325556|468205525|FG001|Open-label Period|Protocol Violation|0|||
130068530|NCT03325556|468205526|FG002|Open-label Period|Protocol Violation|0|||
130068531|NCT03325556|468205524|FG000|Open-label Period|Withdrawal by Subject|17|||
130068532|NCT03325556|468205525|FG001|Open-label Period|Withdrawal by Subject|0|||
130068533|NCT03325556|468205526|FG002|Open-label Period|Withdrawal by Subject|0|||
130068534|NCT03325556|468205524|FG000|Open-label Period|Not otherwise specified|8|||
130068535|NCT03325556|468205525|FG001|Open-label Period|Not otherwise specified|0|||
130068536|NCT03325556|468205526|FG002|Open-label Period|Not otherwise specified|0|||
130068537|NCT03325556|468205524|FG000|Open-label Period|Administrative discont. at study termination|41|||
130068538|NCT03325556|468205525|FG001|Open-label Period|Administrative discont. at study termination|0|||
130068539|NCT03325556|468205526|FG002|Open-label Period|Administrative discont. at study termination|0|||
130068540|NCT03325556|468205524|FG000|Double-blind Period|Relapse|0|||
130068541|NCT03325556|468205525|FG001|Double-blind Period|Relapse|15|||
130068542|NCT03325556|468205526|FG002|Double-blind Period|Relapse|34|||
130068543|NCT03325556|468205524|FG000|Double-blind Period|Adverse Event|0|||
130068544|NCT03325556|468205525|FG001|Double-blind Period|Adverse Event|3|||
130068545|NCT03325556|468205526|FG002|Double-blind Period|Adverse Event|1|||
130068546|NCT03325556|468205524|FG000|Double-blind Period|Noncompliance with study drug|0|||
130068547|NCT03325556|468205525|FG001|Double-blind Period|Noncompliance with study drug|0|||
130068548|NCT03325556|468205526|FG002|Double-blind Period|Noncompliance with study drug|1|||
130068549|NCT03325556|468205524|FG000|Double-blind Period|Use of prohibited medication|0|||
130068550|NCT03325556|468205525|FG001|Double-blind Period|Use of prohibited medication|1|||
130068551|NCT03325556|468205526|FG002|Double-blind Period|Use of prohibited medication|0|||
130068552|NCT03325556|468205524|FG000|Double-blind Period|Physician Decision|0|||
130068553|NCT03325556|468205525|FG001|Double-blind Period|Physician Decision|0|||
130068554|NCT03325556|468205526|FG002|Double-blind Period|Physician Decision|1|||
130068555|NCT03325556|468205524|FG000|Double-blind Period|Withdrawal by Subject|0|||
130068556|NCT03325556|468205525|FG001|Double-blind Period|Withdrawal by Subject|6|||
130068557|NCT03325556|468205526|FG002|Double-blind Period|Withdrawal by Subject|4|||
130068558|NCT03325556|468205524|FG000|Double-blind Period|Not otherwise specified|0|||
130068559|NCT03325556|468205525|FG001|Double-blind Period|Not otherwise specified|1|||
130068560|NCT03325556|468205526|FG002|Double-blind Period|Not otherwise specified|5|||
130068561|NCT03325556|468205524|FG000|Double-blind Period|Administrative discont. at study termination|0|||
130068562|NCT03325556|468205525|FG001|Double-blind Period|Administrative discont. at study termination|35|||
130068563|NCT03325556|468205526|FG002|Double-blind Period|Administrative discont. at study termination|31|||
130068564|NCT02119026|468205527|FG000|1st-line Treatment|Adverse Event|9|||
130068565|NCT02119026|468205528|FG001|1st-line Treatment|Adverse Event|14|||
130068566|NCT02119026|468205527|FG000|1st-line Treatment|Physician Decision|3|||
130068567|NCT02119026|468205528|FG001|1st-line Treatment|Physician Decision|8|||
130068568|NCT02119026|468205527|FG000|1st-line Treatment|Withdrawal by Subject|4|||
130068569|NCT02119026|468205528|FG001|1st-line Treatment|Withdrawal by Subject|10|||
130068570|NCT02119026|468205527|FG000|1st-line Treatment|Patient condition or compliance|6|||
130068571|NCT02119026|468205528|FG001|1st-line Treatment|Patient condition or compliance|4|||
130068572|NCT02119026|468205527|FG000|1st-line Treatment|Surgery of metastases|2|||
130068573|NCT02119026|468205528|FG001|1st-line Treatment|Surgery of metastases|1|||
130068574|NCT02119026|468205527|FG000|1st-line Treatment|Death|2|||
130068575|NCT02119026|468205528|FG001|1st-line Treatment|Death|1|||
129922619|NCT01396278|467682967|FG001|Overall Study|Withdraw due to trial termination|1|||
129922620|NCT01396278|467682968|FG002|Overall Study|Withdraw due to trial termination|1|||
129922621|NCT01396278|467682969|FG003|Overall Study|Withdraw due to trial termination|0|||
129922622|NCT01396278|467682970|FG004|Overall Study|Withdraw due to trial termination|2|||
129922623|NCT04552223|467682974|FG000|Overall Study|Withdrawal by Subject|1|||
129922624|NCT03701399|467682979|FG000|Overall Study|Adverse Event|3|||
129922625|NCT03701399|467682980|FG001|Overall Study|Adverse Event|5|||
129922626|NCT03701399|467682979|FG000|Overall Study|Withdrawal by Subject|6|||
129922627|NCT03701399|467682980|FG001|Overall Study|Withdrawal by Subject|3|||
129922628|NCT03701399|467682979|FG000|Overall Study|Investigators decision|1|||
129922629|NCT03701399|467682980|FG001|Overall Study|Investigators decision|2|||
129922630|NCT03701399|467682979|FG000|Overall Study|Lost to Follow-up|1|||
129922631|NCT03701399|467682980|FG001|Overall Study|Lost to Follow-up|2|||
129922632|NCT03701399|467682979|FG000|Overall Study|Death|1|||
129922633|NCT03701399|467682980|FG001|Overall Study|Death|1|||
129922634|NCT03701399|467682979|FG000|Overall Study|Randomized but not treated|1|||
129922635|NCT03701399|467682980|FG001|Overall Study|Randomized but not treated|0|||
129922636|NCT04342494|467682981|FG000|Overall Study|Questionnaire partially completed|1|||
129922637|NCT04342494|467682982|FG001|Overall Study|Questionnaire partially completed|0|||
129922638|NCT04342494|467682983|FG002|Overall Study|Questionnaire partially completed|2|||
129922639|NCT04342494|467682984|FG003|Overall Study|Questionnaire partially completed|0|||
129922640|NCT04342494|467682985|FG004|Overall Study|Questionnaire partially completed|1|||
129922641|NCT04342494|467682981|FG000|Overall Study|Lost to Follow-up|49|||
129922642|NCT04342494|467682982|FG001|Overall Study|Lost to Follow-up|38|||
129922643|NCT04342494|467682983|FG002|Overall Study|Lost to Follow-up|34|||
129922644|NCT04342494|467682984|FG003|Overall Study|Lost to Follow-up|34|||
129922645|NCT04342494|467682985|FG004|Overall Study|Lost to Follow-up|35|||
129922646|NCT05119023|467682986|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
129922647|NCT05119023|467682986|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
129922648|NCT05119023|467682986|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
129922649|NCT04806451|467682990|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
129922650|NCT04806451|467682991|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
129922651|NCT04806451|467682990|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
129922652|NCT04806451|467682991|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
129922653|NCT04806451|467682990|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
129922654|NCT04806451|467682991|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
129922655|NCT05835336|467682992|FG000|Overall Study|Withdrawal by Subject|5|||
129922656|NCT05835336|467682992|FG000|Overall Study|Did not complete the personalization process|3|||
129922657|NCT03134196|467682999|FG000|Overall Study|Death|2|||
129922658|NCT03134196|467683000|FG001|Overall Study|Death|1|||
129922659|NCT03134196|467682999|FG000|Overall Study|Lost to Follow-up|13|||
129922660|NCT03134196|467683000|FG001|Overall Study|Lost to Follow-up|15|||
129922661|NCT03134196|467682999|FG000|Overall Study|Physician Decision|0|||
129922662|NCT03134196|467683000|FG001|Overall Study|Physician Decision|1|||
129922663|NCT03134196|467682999|FG000|Overall Study|Withdrawal by Subject|19|||
129922664|NCT03134196|467683000|FG001|Overall Study|Withdrawal by Subject|12|||
129922665|NCT03134196|467682999|FG000|Overall Study|Site Unable to Contact Participant|2|||
129922666|NCT03134196|467683000|FG001|Overall Study|Site Unable to Contact Participant|0|||
129922667|NCT03134196|467682999|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
129922668|NCT03134196|467683000|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
129922669|NCT03134196|467682999|FG000|Overall Study|Scheduling Conflict|1|||
129922670|NCT03134196|467683000|FG001|Overall Study|Scheduling Conflict|0|||
129922671|NCT06516705|467683009|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
129922672|NCT06516705|467683010|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
129922673|NCT06516705|467683009|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
129922674|NCT06516705|467683010|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
129922675|NCT06516705|467683009|FG000|T3 ( 3 Month After Education)|covid-19|1|||
129922676|NCT06516705|467683010|FG001|T3 ( 3 Month After Education)|covid-19|2|||
129922677|NCT06516705|467683009|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
129922678|NCT06516705|467683010|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
129922679|NCT06516705|467683009|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
129922680|NCT06516705|467683010|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
129922681|NCT06516705|467683009|FG000|T4 ( 6 Month After Education)|covid-19|3|||
129922682|NCT06516705|467683010|FG001|T4 ( 6 Month After Education)|covid-19|2|||
129922683|NCT06516705|467683009|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
129922684|NCT06516705|467683010|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
129922693|NCT04292223|467683016|FG000|Overall Study|Adverse Event|1|||
129922694|NCT04292223|467683016|FG000|Overall Study|Lost to Follow-up|1|||
129922695|NCT04292223|467683016|FG000|Overall Study|Noncompliance with study drug|2|||
129922696|NCT04292223|467683016|FG000|Overall Study|Patient moved out of the state|1|||
129922697|NCT00753545|467683017|FG000|Overall Study|Death|98|||
129922698|NCT00753545|467683018|FG001|Overall Study|Death|112|||
129922699|NCT00753545|467683017|FG000|Overall Study|Lost to Follow-up|2|||
129922700|NCT00753545|467683018|FG001|Overall Study|Lost to Follow-up|3|||
129922701|NCT00753545|467683017|FG000|Overall Study|Protocol Violation|1|||
129922702|NCT00753545|467683018|FG001|Overall Study|Protocol Violation|0|||
129922703|NCT00753545|467683017|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
129922704|NCT00753545|467683018|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
129922705|NCT05453773|467683019|FG000|Overall Study|Withdrawal by Subject|3|||
129922706|NCT05453773|467683019|FG000|Overall Study|Lost to Follow-up|3|||
129922707|NCT05453773|467683019|FG000|Overall Study|Difficult Blood Draw|3|||
129922708|NCT02023866|467683023|FG000|Overall Study|Non-compliance|2|||
129922709|NCT02023866|467683023|FG000|Overall Study|Adverse Event|3|||
129922710|NCT02023866|467683023|FG000|Overall Study|Withdrawal by Subject|1|||
129922711|NCT04091750|467683037|FG000|Overall Study|Adverse Event|4|||
129922712|NCT04091750|467683037|FG000|Overall Study|Withdrawal by Subject|1|||
129922713|NCT04293055|467683038|FG000|Overall Study|Lost to Follow-up|1|||
129922714|NCT04293055|467683039|FG001|Overall Study|Lost to Follow-up|1|||
129922715|NCT04293055|467683038|FG000|Overall Study|Did not trigger randomization|6|||
129922716|NCT04293055|467683039|FG001|Overall Study|Did not trigger randomization|5|||
129922717|NCT03560609|467683040|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
129922718|NCT03560609|467683041|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
129922719|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
129922720|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
129922721|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
129922722|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
129922723|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
129922724|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
129922725|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
129922726|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
129922727|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
129922728|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
129922729|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
129922730|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
129922731|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
129922732|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
129922733|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
129922734|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
129922735|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
129922736|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
129922737|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922738|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
129922739|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
129922740|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922741|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922742|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
129922743|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922744|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922745|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922746|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
129922747|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922748|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
129922749|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
129922750|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
129922751|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
129922752|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922753|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922754|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922755|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
129922756|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
129922757|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
129922758|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
129922759|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
129922760|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
129922761|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
129922762|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
129922763|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
129922764|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
129922765|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
129922766|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
129922767|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
129922768|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
129922769|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
129922770|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
129922771|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
129922772|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
129922773|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922774|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922775|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922776|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922777|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922778|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922779|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
129922780|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
129922781|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
129922782|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Death|0|||
129922783|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Death|0|||
129922784|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Death|0|||
129922785|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Death|0|||
129922786|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Death|0|||
129922787|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Death|0|||
129922788|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Death|0|||
129922789|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Death|1|||
129922790|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Death|3|||
129922791|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922792|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922793|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922794|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922795|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922796|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922797|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
129922798|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
129922799|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
129922800|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922801|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922802|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922803|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922804|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922805|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922806|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922807|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
129922808|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
129922809|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922810|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922811|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922812|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922813|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922814|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922815|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
129922816|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
129922817|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
129922818|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922819|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922820|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922821|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922822|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922823|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922824|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
129922825|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
129922826|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
129922827|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922828|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922829|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922830|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
130117132|NCT02711956|468388791|FG008|Overall Study|Clinical progression|1|||
130117133|NCT02711956|468388792|FG009|Overall Study|Clinical progression|0|||
130117134|NCT02711956|468388793|FG010|Overall Study|Clinical progression|0|||
130117135|NCT02711956|468388794|FG011|Overall Study|Clinical progression|2|||
130117136|NCT02711956|468388795|FG012|Overall Study|Clinical progression|4|||
130117137|NCT02711956|468388796|FG013|Overall Study|Clinical progression|1|||
130117138|NCT02711956|468388797|FG014|Overall Study|Clinical progression|1|||
130117139|NCT02711956|468388783|FG000|Overall Study|Radiographic progression|1|||
130117140|NCT02711956|468388784|FG001|Overall Study|Radiographic progression|1|||
130117141|NCT02711956|468388785|FG002|Overall Study|Radiographic progression|2|||
130117142|NCT02711956|468388786|FG003|Overall Study|Radiographic progression|0|||
130117143|NCT02711956|468388787|FG004|Overall Study|Radiographic progression|1|||
129922831|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922832|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922833|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
129922834|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
130117144|NCT02711956|468388788|FG005|Overall Study|Radiographic progression|0|||
130117145|NCT02711956|468388789|FG006|Overall Study|Radiographic progression|0|||
130117146|NCT02711956|468388790|FG007|Overall Study|Radiographic progression|0|||
130117147|NCT02711956|468388791|FG008|Overall Study|Radiographic progression|2|||
130117148|NCT02711956|468388792|FG009|Overall Study|Radiographic progression|1|||
130117149|NCT02711956|468388793|FG010|Overall Study|Radiographic progression|0|||
130117150|NCT02711956|468388794|FG011|Overall Study|Radiographic progression|5|||
130117151|NCT02711956|468388795|FG012|Overall Study|Radiographic progression|3|||
130117152|NCT02711956|468388796|FG013|Overall Study|Radiographic progression|0|||
130117153|NCT02711956|468388797|FG014|Overall Study|Radiographic progression|1|||
130117154|NCT02711956|468388783|FG000|Overall Study|PSA progression with clinical progression|0|||
130117155|NCT02711956|468388784|FG001|Overall Study|PSA progression with clinical progression|0|||
130117156|NCT02711956|468388785|FG002|Overall Study|PSA progression with clinical progression|0|||
130117157|NCT02711956|468388786|FG003|Overall Study|PSA progression with clinical progression|0|||
130117158|NCT02711956|468388787|FG004|Overall Study|PSA progression with clinical progression|1|||
130117159|NCT02711956|468388788|FG005|Overall Study|PSA progression with clinical progression|0|||
130117160|NCT02711956|468388789|FG006|Overall Study|PSA progression with clinical progression|0|||
130117161|NCT02711956|468388790|FG007|Overall Study|PSA progression with clinical progression|0|||
130117162|NCT02711956|468388791|FG008|Overall Study|PSA progression with clinical progression|0|||
130117163|NCT02711956|468388792|FG009|Overall Study|PSA progression with clinical progression|0|||
130117164|NCT02711956|468388793|FG010|Overall Study|PSA progression with clinical progression|0|||
130117165|NCT02711956|468388794|FG011|Overall Study|PSA progression with clinical progression|0|||
130117166|NCT02711956|468388795|FG012|Overall Study|PSA progression with clinical progression|1|||
130117167|NCT02711956|468388796|FG013|Overall Study|PSA progression with clinical progression|1|||
130117168|NCT02711956|468388797|FG014|Overall Study|PSA progression with clinical progression|0|||
130117169|NCT02711956|468388783|FG000|Overall Study|PSA progression with radiographic progression|0|||
130117170|NCT02711956|468388784|FG001|Overall Study|PSA progression with radiographic progression|1|||
130117171|NCT02711956|468388785|FG002|Overall Study|PSA progression with radiographic progression|0|||
130117172|NCT02711956|468388786|FG003|Overall Study|PSA progression with radiographic progression|0|||
130117173|NCT02711956|468388787|FG004|Overall Study|PSA progression with radiographic progression|0|||
130117174|NCT02711956|468388788|FG005|Overall Study|PSA progression with radiographic progression|2|||
130117175|NCT02711956|468388789|FG006|Overall Study|PSA progression with radiographic progression|2|||
130117176|NCT02711956|468388790|FG007|Overall Study|PSA progression with radiographic progression|1|||
130117177|NCT02711956|468388791|FG008|Overall Study|PSA progression with radiographic progression|0|||
130117178|NCT02711956|468388792|FG009|Overall Study|PSA progression with radiographic progression|1|||
130117179|NCT02711956|468388793|FG010|Overall Study|PSA progression with radiographic progression|0|||
130117180|NCT02711956|468388794|FG011|Overall Study|PSA progression with radiographic progression|1|||
130117181|NCT02711956|468388795|FG012|Overall Study|PSA progression with radiographic progression|2|||
130117182|NCT02711956|468388796|FG013|Overall Study|PSA progression with radiographic progression|3|||
130117183|NCT02711956|468388797|FG014|Overall Study|PSA progression with radiographic progression|3|||
130117184|NCT03734237|468388798|FG000|Overall Study|Lost to Follow-up|1|||
130117185|NCT03734237|468388799|FG001|Overall Study|Lost to Follow-up|3|||
130117186|NCT03734237|468388800|FG002|Overall Study|Lost to Follow-up|0|||
130117187|NCT03734237|468388798|FG000|Overall Study|Withdrawal by Subject|7|||
130117188|NCT03734237|468388799|FG001|Overall Study|Withdrawal by Subject|9|||
130117189|NCT03734237|468388800|FG002|Overall Study|Withdrawal by Subject|10|||
130117190|NCT01844583|468388801|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
130117191|NCT01844583|468388802|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
129922835|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
130117192|NCT01625377|468388803|FG000|Overall Study|Death|1|||
130117193|NCT01625377|468388804|FG001|Overall Study|Death|1|||
130117194|NCT01625377|468388803|FG000|Overall Study|Administrative Problem|1|||
130117195|NCT01625377|468388804|FG001|Overall Study|Administrative Problem|1|||
130068576|NCT02119026|468205527|FG000|2nd-line Treatment|Lost to Follow-up|2|||
130068577|NCT02119026|468205528|FG001|2nd-line Treatment|Lost to Follow-up|0|||
130068578|NCT02119026|468205527|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
130068579|NCT02119026|468205528|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
130068580|NCT02119026|468205527|FG000|2nd-line Treatment|Adverse Event|4|||
130068581|NCT02119026|468205528|FG001|2nd-line Treatment|Adverse Event|1|||
130068582|NCT00340834|468205529|FG000|Core Phase of Study|Adverse Event|26|||
130068583|NCT00340834|468205530|FG001|Core Phase of Study|Adverse Event|9|||
129922836|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Other|0|||
129922837|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Other|0|||
129922838|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Other|0|||
129922839|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Other|0|||
129922840|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Other|0|||
130068584|NCT00340834|468205531|FG002|Core Phase of Study|Adverse Event|9|||
130068585|NCT00340834|468205532|FG003|Core Phase of Study|Adverse Event|0|||
130068586|NCT00340834|468205533|FG004|Core Phase of Study|Adverse Event|0|||
130068587|NCT00340834|468205529|FG000|Core Phase of Study|Withdrawal by Subject|11|||
130068588|NCT00340834|468205530|FG001|Core Phase of Study|Withdrawal by Subject|9|||
130068589|NCT00340834|468205531|FG002|Core Phase of Study|Withdrawal by Subject|16|||
130068590|NCT00340834|468205532|FG003|Core Phase of Study|Withdrawal by Subject|0|||
130068591|NCT00340834|468205533|FG004|Core Phase of Study|Withdrawal by Subject|0|||
130068592|NCT00340834|468205529|FG000|Core Phase of Study|Administrative Problems|6|||
130068593|NCT00340834|468205530|FG001|Core Phase of Study|Administrative Problems|2|||
130068594|NCT00340834|468205531|FG002|Core Phase of Study|Administrative Problems|7|||
130068595|NCT00340834|468205532|FG003|Core Phase of Study|Administrative Problems|0|||
130068596|NCT00340834|468205533|FG004|Core Phase of Study|Administrative Problems|0|||
130068597|NCT00340834|468205529|FG000|Core Phase of Study|Lack of Efficacy|3|||
130068598|NCT00340834|468205530|FG001|Core Phase of Study|Lack of Efficacy|3|||
130068599|NCT00340834|468205531|FG002|Core Phase of Study|Lack of Efficacy|7|||
130068600|NCT00340834|468205532|FG003|Core Phase of Study|Lack of Efficacy|0|||
130068601|NCT00340834|468205533|FG004|Core Phase of Study|Lack of Efficacy|0|||
130068602|NCT00340834|468205529|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
130068603|NCT00340834|468205530|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
130068604|NCT00340834|468205531|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
130068605|NCT00340834|468205532|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
130068606|NCT00340834|468205533|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
130068607|NCT00340834|468205529|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
130068608|NCT00340834|468205530|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
130068609|NCT00340834|468205531|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
130068610|NCT00340834|468205532|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
130068611|NCT00340834|468205533|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
130068612|NCT00340834|468205529|FG000|Core Phase of Study|Lost to Follow-up|1|||
130068613|NCT00340834|468205530|FG001|Core Phase of Study|Lost to Follow-up|1|||
130068614|NCT00340834|468205531|FG002|Core Phase of Study|Lost to Follow-up|4|||
130068615|NCT00340834|468205532|FG003|Core Phase of Study|Lost to Follow-up|0|||
130068616|NCT00340834|468205533|FG004|Core Phase of Study|Lost to Follow-up|0|||
130068617|NCT00340834|468205529|FG000|Core Phase of Study|Death|2|||
130068618|NCT00340834|468205530|FG001|Core Phase of Study|Death|0|||
130068619|NCT00340834|468205531|FG002|Core Phase of Study|Death|0|||
130068620|NCT00340834|468205532|FG003|Core Phase of Study|Death|0|||
130068621|NCT00340834|468205533|FG004|Core Phase of Study|Death|0|||
130068622|NCT00340834|468205529|FG000|Core Phase of Study|Protocol Violation|0|||
130068623|NCT00340834|468205530|FG001|Core Phase of Study|Protocol Violation|0|||
130068624|NCT00340834|468205531|FG002|Core Phase of Study|Protocol Violation|2|||
130068625|NCT00340834|468205532|FG003|Core Phase of Study|Protocol Violation|0|||
130068626|NCT00340834|468205533|FG004|Core Phase of Study|Protocol Violation|0|||
130068627|NCT00340834|468205529|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
130117196|NCT01625377|468388803|FG000|Overall Study|Protocol Violation|0|||
129922841|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Other|0|||
129922842|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Other|110|||
129922843|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Other|9|||
129922844|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Other|17|||
129922845|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
129922846|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922847|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922848|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922849|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922850|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
130068628|NCT00340834|468205530|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
130117197|NCT01625377|468388804|FG001|Overall Study|Protocol Violation|3|||
129922851|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
130068629|NCT00340834|468205531|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
130068630|NCT00340834|468205532|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
130117198|NCT01625377|468388803|FG000|Overall Study|Adverse Event|3|||
129922852|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922853|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922854|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922855|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922856|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922857|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922858|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
129922859|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922860|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922861|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922862|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922863|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922864|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
129922865|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922866|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922867|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922868|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922869|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922870|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
129922871|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922872|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922873|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922874|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922875|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922876|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922877|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
129922878|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922879|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922880|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922881|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922882|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922883|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
129922884|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922885|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922886|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922887|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922888|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922889|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922890|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
129922891|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922892|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922893|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922894|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922895|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922896|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
129922897|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922898|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922899|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922900|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922901|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922902|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922903|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
129922904|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922905|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922906|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922907|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922908|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922909|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
129922910|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922911|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922912|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922913|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922914|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922915|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922916|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
129922917|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129922918|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129922919|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130117199|NCT01625377|468388804|FG001|Overall Study|Adverse Event|16|||
130117200|NCT01625377|468388803|FG000|Overall Study|Graft loss|1|||
130068631|NCT00340834|468205533|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
130068632|NCT00340834|468205529|FG000|Extension Phase of Study|Subject withdrew consent|26|||
130068633|NCT00340834|468205530|FG001|Extension Phase of Study|Subject withdrew consent|31|||
130068634|NCT00340834|468205531|FG002|Extension Phase of Study|Subject withdrew consent|0|||
130068635|NCT00340834|468205532|FG003|Extension Phase of Study|Subject withdrew consent|12|||
130068636|NCT00340834|468205533|FG004|Extension Phase of Study|Subject withdrew consent|15|||
130068637|NCT00340834|468205529|FG000|Extension Phase of Study|Adverse Event|21|||
130068638|NCT00340834|468205530|FG001|Extension Phase of Study|Adverse Event|22|||
130068639|NCT00340834|468205531|FG002|Extension Phase of Study|Adverse Event|0|||
130068640|NCT00340834|468205532|FG003|Extension Phase of Study|Adverse Event|19|||
130068641|NCT00340834|468205533|FG004|Extension Phase of Study|Adverse Event|7|||
130068642|NCT00340834|468205529|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
130068643|NCT00340834|468205530|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
130068644|NCT00340834|468205531|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
130068645|NCT00340834|468205532|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
130068646|NCT00340834|468205533|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
130068647|NCT00340834|468205529|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
130068648|NCT00340834|468205530|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
130068649|NCT00340834|468205531|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
130068650|NCT00340834|468205532|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
130068651|NCT00340834|468205533|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
130068652|NCT00340834|468205529|FG000|Extension Phase of Study|Lost to Follow-up|1|||
130068653|NCT00340834|468205530|FG001|Extension Phase of Study|Lost to Follow-up|1|||
130068654|NCT00340834|468205531|FG002|Extension Phase of Study|Lost to Follow-up|0|||
130068655|NCT00340834|468205532|FG003|Extension Phase of Study|Lost to Follow-up|2|||
130068656|NCT00340834|468205533|FG004|Extension Phase of Study|Lost to Follow-up|3|||
130068657|NCT00340834|468205529|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
130068658|NCT00340834|468205530|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
130068659|NCT00340834|468205531|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
130068660|NCT00340834|468205532|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
130068661|NCT00340834|468205533|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
130068662|NCT00340834|468205529|FG000|Extension Phase of Study|Administrative problems|3|||
130068663|NCT00340834|468205530|FG001|Extension Phase of Study|Administrative problems|0|||
130068664|NCT00340834|468205531|FG002|Extension Phase of Study|Administrative problems|0|||
130068665|NCT00340834|468205532|FG003|Extension Phase of Study|Administrative problems|1|||
130068666|NCT00340834|468205533|FG004|Extension Phase of Study|Administrative problems|1|||
130068667|NCT00340834|468205529|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
130068668|NCT00340834|468205530|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
130068669|NCT00340834|468205531|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
130068670|NCT00340834|468205532|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
130068671|NCT00340834|468205533|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
130068672|NCT00340834|468205529|FG000|Extension Phase of Study|Protocol Violation|3|||
130068673|NCT00340834|468205530|FG001|Extension Phase of Study|Protocol Violation|0|||
130068674|NCT00340834|468205531|FG002|Extension Phase of Study|Protocol Violation|0|||
130068675|NCT00340834|468205532|FG003|Extension Phase of Study|Protocol Violation|0|||
130068676|NCT00340834|468205533|FG004|Extension Phase of Study|Protocol Violation|0|||
130068677|NCT00340834|468205529|FG000|Extension Phase of Study|Death|0|||
130068678|NCT00340834|468205530|FG001|Extension Phase of Study|Death|0|||
130068679|NCT00340834|468205531|FG002|Extension Phase of Study|Death|0|||
130068680|NCT00340834|468205532|FG003|Extension Phase of Study|Death|0|||
130068681|NCT00340834|468205533|FG004|Extension Phase of Study|Death|1|||
130068682|NCT02786836|468205536|FG000|Overall Study|Death|1|||
130068683|NCT02786836|468205536|FG000|Overall Study|Lack of Efficacy|2|||
130068684|NCT02786836|468205536|FG000|Overall Study|Protocol Violation|3|||
130068685|NCT02786836|468205536|FG000|Overall Study|Withdrawal by Subject|3|||
130068686|NCT02786836|468205536|FG000|Overall Study|Liver Transplantation|2|||
130068687|NCT02786836|468205536|FG000|Overall Study|Device or Pharmacy Issues|3|||
130117201|NCT01625377|468388804|FG001|Overall Study|Graft loss|0|||
129922920|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
130068688|NCT01143714|468205538|FG000|Overall Study|Adverse Event|4|||
130068689|NCT01143714|468205539|FG001|Overall Study|Adverse Event|2|||
130068690|NCT01143714|468205538|FG000|Overall Study|Withdrawal by Subject|1|||
130068691|NCT01143714|468205539|FG001|Overall Study|Withdrawal by Subject|0|||
130068692|NCT01143714|468205538|FG000|Overall Study|Subject non-compliance|0|||
130068693|NCT01143714|468205539|FG001|Overall Study|Subject non-compliance|1|||
130117202|NCT01625377|468388803|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130117203|NCT01625377|468388804|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129922921|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129922922|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
129922923|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922924|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922925|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922926|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922927|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922928|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
129922929|NCT02262728|467683066|FG000|Follow-up Phase (3 Years)|Death|0|||
129922930|NCT02262728|467683067|FG001|Follow-up Phase (3 Years)|Death|1|||
129922931|NCT02262728|467683066|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
129922932|NCT02262728|467683067|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
129922933|NCT02262728|467683066|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
129922934|NCT02262728|467683067|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
129922935|NCT00227344|467683070|FG000|Overall Study|study terminated early|12|||
129922936|NCT00227344|467683071|FG001|Overall Study|study terminated early|5|||
129922937|NCT01987895|467683072|FG000|Overall Study|Withdrawal by Subject|12|||
129922938|NCT01987895|467683073|FG001|Overall Study|Withdrawal by Subject|7|||
129922939|NCT01987895|467683072|FG000|Overall Study|Physician Decision|8|||
129922940|NCT01987895|467683073|FG001|Overall Study|Physician Decision|10|||
129922941|NCT01987895|467683072|FG000|Overall Study|Death|7|||
129922942|NCT01987895|467683073|FG001|Overall Study|Death|7|||
129922943|NCT01987895|467683072|FG000|Overall Study|Lost to Follow-up|3|||
129922944|NCT01987895|467683073|FG001|Overall Study|Lost to Follow-up|5|||
129922945|NCT01987895|467683072|FG000|Overall Study|randomized before giving IC|0|||
129922946|NCT01987895|467683073|FG001|Overall Study|randomized before giving IC|1|||
129922947|NCT05364671|467683074|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
129922948|NCT05364671|467683075|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
129922949|NCT05364671|467683074|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
129922950|NCT05364671|467683075|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
129922951|NCT05364671|467683074|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
129922952|NCT05364671|467683075|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
129922953|NCT05364671|467683074|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
129922954|NCT05364671|467683075|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
129922955|NCT05364671|467683074|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
129922956|NCT05364671|467683075|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
129922957|NCT05256017|467683076|FG000|Treatment Period|Withdrawal by Subject|1|||
129922958|NCT05256017|467683077|FG001|Treatment Period|Withdrawal by Subject|1|||
129922959|NCT05256017|467683076|FG000|Follow-up|Lost to Follow-up|7|||
129922960|NCT05256017|467683077|FG001|Follow-up|Lost to Follow-up|1|||
129922961|NCT05256017|467683076|FG000|Follow-up|Withdrawal by Subject|1|||
129922962|NCT05256017|467683077|FG001|Follow-up|Withdrawal by Subject|0|||
129922963|NCT05256017|467683076|FG000|Follow-up|Death|0|||
129922964|NCT05256017|467683077|FG001|Follow-up|Death|1|||
129922965|NCT03536754|467683082|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
129922966|NCT03536754|467683083|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
129922967|NCT03536754|467683084|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
129922968|NCT03536754|467683085|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
129922969|NCT03536754|467683086|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
129922970|NCT03536754|467683082|FG000|Open Label Extension|Other|0|||
129922971|NCT03536754|467683083|FG001|Open Label Extension|Other|0|||
129922972|NCT03536754|467683084|FG002|Open Label Extension|Other|0|||
129922973|NCT03536754|467683085|FG003|Open Label Extension|Other|0|||
129922974|NCT03536754|467683086|FG004|Open Label Extension|Other|1|||
129922975|NCT04858321|467683088|FG000|Overall Study|Withdrawal by Subject|3|||
129922976|NCT05057247|467683089|FG000|Overall Study|Death|4|||
129922977|NCT05057247|467683089|FG000|Overall Study|Physician Decision|3|||
129922978|NCT05057247|467683089|FG000|Overall Study|Progressive Disease|7|||
129922979|NCT05057247|467683089|FG000|Overall Study|Withdrawal by Subject|3|||
129922980|NCT05057247|467683089|FG000|Overall Study|Adverse Event|6|||
129922981|NCT05057247|467683089|FG000|Overall Study|Subject Non-Compliance|1|||
129922982|NCT05057247|467683089|FG000|Overall Study|On treatment|2|||
129922983|NCT04632992|467683100|FG000|Overall Study|Adverse Event|0|||
129922984|NCT04632992|467683101|FG001|Overall Study|Adverse Event|0|||
129922985|NCT04632992|467683102|FG002|Overall Study|Adverse Event|0|||
130068694|NCT01143714|468205538|FG000|Overall Study|wound closed = deemed healed|1|||
129922986|NCT04632992|467683103|FG003|Overall Study|Adverse Event|0|||
129922987|NCT04632992|467683104|FG004|Overall Study|Adverse Event|0|||
129922988|NCT04632992|467683105|FG005|Overall Study|Adverse Event|0|||
129922989|NCT04632992|467683106|FG006|Overall Study|Adverse Event|0|||
129922990|NCT04632992|467683107|FG007|Overall Study|Adverse Event|0|||
129922991|NCT04632992|467683108|FG008|Overall Study|Adverse Event|0|||
129922992|NCT04632992|467683109|FG009|Overall Study|Adverse Event|0|||
129922993|NCT04632992|467683110|FG010|Overall Study|Adverse Event|0|||
129922994|NCT04632992|467683111|FG011|Overall Study|Adverse Event|0|||
130068695|NCT01143714|468205539|FG001|Overall Study|wound closed = deemed healed|0|||
130068696|NCT01143714|468205538|FG000|Overall Study|wound size increased|1|||
130068697|NCT01143714|468205539|FG001|Overall Study|wound size increased|0|||
130068698|NCT01387074|468205540|FG000|Overall Study|Lost to Follow-up|7|||
130068699|NCT01387074|468205540|FG000|Overall Study|Lack of Efficacy|1|||
130068700|NCT03892707|468205547|FG000|Overall Study|Screen failure|6|||
130068701|NCT03892707|468205548|FG001|Overall Study|Screen failure|0|||
130068702|NCT03892707|468205547|FG000|Overall Study|Pain resolution|0|||
130068703|NCT03892707|468205548|FG001|Overall Study|Pain resolution|4|||
130068704|NCT03892707|468205547|FG000|Overall Study|Withdrawal by Subject|0|||
130068705|NCT03892707|468205548|FG001|Overall Study|Withdrawal by Subject|1|||
130068706|NCT03892707|468205547|FG000|Overall Study|Other (long business trip)|0|||
130068707|NCT03892707|468205548|FG001|Overall Study|Other (long business trip)|1|||
130068708|NCT01807949|468205549|FG000|Overall Study|Adverse Event|1|||
130068709|NCT01807949|468205550|FG001|Overall Study|Adverse Event|2|||
130068710|NCT01807949|468205551|FG002|Overall Study|Adverse Event|2|||
130068711|NCT01807949|468205549|FG000|Overall Study|Withdrawal by Subject|1|||
130068712|NCT01807949|468205550|FG001|Overall Study|Withdrawal by Subject|2|||
130068713|NCT01807949|468205551|FG002|Overall Study|Withdrawal by Subject|2|||
130068714|NCT01807949|468205549|FG000|Overall Study|Non-Compliance|0|||
130068715|NCT01807949|468205550|FG001|Overall Study|Non-Compliance|0|||
130068716|NCT01807949|468205551|FG002|Overall Study|Non-Compliance|1|||
130068717|NCT01807949|468205549|FG000|Overall Study|Undefined|0|||
130068718|NCT01807949|468205550|FG001|Overall Study|Undefined|1|||
130068719|NCT01807949|468205551|FG002|Overall Study|Undefined|2|||
130068720|NCT01807949|468205549|FG000|Overall Study|Randomized But Not Treated|0|||
130068721|NCT01807949|468205550|FG001|Overall Study|Randomized But Not Treated|2|||
130068722|NCT01807949|468205551|FG002|Overall Study|Randomized But Not Treated|2|||
130068723|NCT01181141|468205552|FG000|Overall Study|Adverse Event|2|||
130068724|NCT01181141|468205553|FG001|Overall Study|Adverse Event|1|||
130068725|NCT01181141|468205552|FG000|Overall Study|Lack of Efficacy|1|||
130068726|NCT01181141|468205553|FG001|Overall Study|Lack of Efficacy|0|||
130068727|NCT01181141|468205552|FG000|Overall Study|Lost to Follow-up|1|||
130068728|NCT01181141|468205553|FG001|Overall Study|Lost to Follow-up|1|||
130068729|NCT01181141|468205552|FG000|Overall Study|Physician Decision|2|||
130068730|NCT01181141|468205553|FG001|Overall Study|Physician Decision|0|||
130068731|NCT01181141|468205552|FG000|Overall Study|Protocol Violation|3|||
130068732|NCT01181141|468205553|FG001|Overall Study|Protocol Violation|1|||
130068733|NCT01181141|468205552|FG000|Overall Study|Withdrawal by Subject|3|||
130068734|NCT01181141|468205553|FG001|Overall Study|Withdrawal by Subject|1|||
130068735|NCT00290589|468205554|FG000|Overall Study|Lost to Follow-up|2|||
130068736|NCT00290589|468205555|FG001|Overall Study|Lost to Follow-up|2|||
130068737|NCT00118911|468205556|FG000|Overall Study|Withdrawal by Subject|2|||
130068738|NCT00118911|468205557|FG001|Overall Study|Withdrawal by Subject|5|||
130068739|NCT05014542|468205558|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
130068740|NCT05014542|468205559|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
130068741|NCT05014542|468205558|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
130068742|NCT05014542|468205559|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
130068743|NCT05014542|468205558|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
130068744|NCT05014542|468205559|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
130068745|NCT05014542|468205558|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
130068746|NCT05014542|468205559|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
130068747|NCT00555568|468205560|FG000|Overall Study|Lost to Follow-up|26|||
130068748|NCT00555568|468205561|FG001|Overall Study|Lost to Follow-up|16|||
130068749|NCT00555568|468205562|FG002|Overall Study|Lost to Follow-up|16|||
130068750|NCT04702984|468205563|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
130068751|NCT06000501|468205566|FG000|Overall Study|Screen failure|3|||
130068752|NCT06000501|468205566|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
130068753|NCT06000501|468205566|FG000|Overall Study|Physician Decision|4|||
130068754|NCT06000501|468205566|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
130068755|NCT06000501|468205566|FG000|Overall Study|Scheduling issues|2|||
130068756|NCT01588353|468205567|FG000|Step2|Withdrawal by Subject|0|||
130068757|NCT01588353|468205568|FG001|Step2|Withdrawal by Subject|1|||
130068758|NCT01588353|468205569|FG002|Step2|Withdrawal by Subject|0|||
130068759|NCT01588353|468205567|FG000|Step3|Adverse Event|0|||
130068760|NCT01588353|468205568|FG001|Step3|Adverse Event|0|||
130068761|NCT01588353|468205569|FG002|Step3|Adverse Event|2|||
130068762|NCT05067452|468205571|FG000|Overall Study|Lost to Follow-up|0|||
130068763|NCT05067452|468205572|FG001|Overall Study|Lost to Follow-up|4|||
130068764|NCT02156804|468205573|FG000|Overall Study|Withdrawal by Subject|1|||
130068765|NCT03228394|468205574|FG000|Overall Study|Lost to Follow-up|0|||
130068766|NCT03228394|468205575|FG001|Overall Study|Lost to Follow-up|0|||
130068767|NCT03228394|468205576|FG002|Overall Study|Lost to Follow-up|1|||
130068768|NCT03228394|468205577|FG003|Overall Study|Lost to Follow-up|1|||
130068769|NCT03228394|468205578|FG004|Overall Study|Lost to Follow-up|0|||
130068770|NCT03228394|468205579|FG005|Overall Study|Lost to Follow-up|0|||
130068771|NCT03228394|468205580|FG006|Overall Study|Lost to Follow-up|2|||
130068772|NCT03228394|468205581|FG007|Overall Study|Lost to Follow-up|0|||
129922995|NCT04632992|467683112|FG012|Overall Study|Adverse Event|1|||
129922996|NCT04632992|467683113|FG013|Overall Study|Adverse Event|0|||
129922997|NCT04632992|467683100|FG000|Overall Study|Death|17|||
129922998|NCT04632992|467683101|FG001|Overall Study|Death|1|||
129922999|NCT04632992|467683102|FG002|Overall Study|Death|14|||
129923000|NCT04632992|467683103|FG003|Overall Study|Death|14|||
129923001|NCT04632992|467683104|FG004|Overall Study|Death|13|||
129923002|NCT04632992|467683105|FG005|Overall Study|Death|6|||
129923003|NCT04632992|467683106|FG006|Overall Study|Death|7|||
129923004|NCT04632992|467683107|FG007|Overall Study|Death|12|||
129923005|NCT04632992|467683108|FG008|Overall Study|Death|15|||
129923006|NCT04632992|467683109|FG009|Overall Study|Death|20|||
129923007|NCT04632992|467683110|FG010|Overall Study|Death|8|||
129923008|NCT04632992|467683111|FG011|Overall Study|Death|2|||
129923009|NCT04632992|467683112|FG012|Overall Study|Death|10|||
129923010|NCT04632992|467683113|FG013|Overall Study|Death|1|||
129923011|NCT04632992|467683100|FG000|Overall Study|Lost to Follow-up|1|||
129923012|NCT04632992|467683101|FG001|Overall Study|Lost to Follow-up|0|||
129923013|NCT04632992|467683102|FG002|Overall Study|Lost to Follow-up|1|||
129923014|NCT04632992|467683103|FG003|Overall Study|Lost to Follow-up|0|||
129923015|NCT04632992|467683104|FG004|Overall Study|Lost to Follow-up|2|||
129923016|NCT04632992|467683105|FG005|Overall Study|Lost to Follow-up|0|||
129923017|NCT04632992|467683106|FG006|Overall Study|Lost to Follow-up|1|||
129923018|NCT04632992|467683107|FG007|Overall Study|Lost to Follow-up|1|||
129923019|NCT04632992|467683108|FG008|Overall Study|Lost to Follow-up|1|||
129923020|NCT04632992|467683109|FG009|Overall Study|Lost to Follow-up|1|||
129923021|NCT04632992|467683110|FG010|Overall Study|Lost to Follow-up|2|||
129923022|NCT04632992|467683111|FG011|Overall Study|Lost to Follow-up|0|||
129923023|NCT04632992|467683112|FG012|Overall Study|Lost to Follow-up|0|||
129923024|NCT04632992|467683113|FG013|Overall Study|Lost to Follow-up|0|||
129923025|NCT04632992|467683100|FG000|Overall Study|Reason not Specified|2|||
129923026|NCT04632992|467683101|FG001|Overall Study|Reason not Specified|0|||
129923027|NCT04632992|467683102|FG002|Overall Study|Reason not Specified|1|||
129923028|NCT04632992|467683103|FG003|Overall Study|Reason not Specified|1|||
129923029|NCT04632992|467683104|FG004|Overall Study|Reason not Specified|0|||
129923030|NCT04632992|467683105|FG005|Overall Study|Reason not Specified|0|||
129923031|NCT04632992|467683106|FG006|Overall Study|Reason not Specified|0|||
129923032|NCT04632992|467683107|FG007|Overall Study|Reason not Specified|0|||
129923033|NCT04632992|467683108|FG008|Overall Study|Reason not Specified|0|||
129923034|NCT04632992|467683109|FG009|Overall Study|Reason not Specified|0|||
129923035|NCT04632992|467683110|FG010|Overall Study|Reason not Specified|1|||
129923036|NCT04632992|467683111|FG011|Overall Study|Reason not Specified|0|||
129923037|NCT04632992|467683112|FG012|Overall Study|Reason not Specified|0|||
129923038|NCT04632992|467683113|FG013|Overall Study|Reason not Specified|0|||
129923039|NCT04632992|467683100|FG000|Overall Study|Physician Decision|0|||
129923040|NCT04632992|467683101|FG001|Overall Study|Physician Decision|0|||
129923041|NCT04632992|467683102|FG002|Overall Study|Physician Decision|0|||
129923042|NCT04632992|467683103|FG003|Overall Study|Physician Decision|2|||
129923043|NCT04632992|467683104|FG004|Overall Study|Physician Decision|1|||
129923044|NCT04632992|467683105|FG005|Overall Study|Physician Decision|0|||
129923045|NCT04632992|467683106|FG006|Overall Study|Physician Decision|0|||
129923046|NCT04632992|467683107|FG007|Overall Study|Physician Decision|0|||
129923047|NCT04632992|467683108|FG008|Overall Study|Physician Decision|0|||
129923048|NCT04632992|467683109|FG009|Overall Study|Physician Decision|0|||
129923049|NCT04632992|467683110|FG010|Overall Study|Physician Decision|0|||
129923050|NCT04632992|467683111|FG011|Overall Study|Physician Decision|0|||
129923051|NCT04632992|467683112|FG012|Overall Study|Physician Decision|3|||
129923052|NCT04632992|467683113|FG013|Overall Study|Physician Decision|0|||
129923053|NCT04632992|467683100|FG000|Overall Study|Progressive Disease|0|||
129923054|NCT04632992|467683101|FG001|Overall Study|Progressive Disease|0|||
129923055|NCT04632992|467683102|FG002|Overall Study|Progressive Disease|0|||
129923056|NCT04632992|467683103|FG003|Overall Study|Progressive Disease|0|||
129923057|NCT04632992|467683104|FG004|Overall Study|Progressive Disease|1|||
129923058|NCT04632992|467683105|FG005|Overall Study|Progressive Disease|0|||
129923059|NCT04632992|467683106|FG006|Overall Study|Progressive Disease|0|||
129923060|NCT04632992|467683107|FG007|Overall Study|Progressive Disease|0|||
129923061|NCT04632992|467683108|FG008|Overall Study|Progressive Disease|0|||
129923062|NCT04632992|467683109|FG009|Overall Study|Progressive Disease|1|||
129923063|NCT04632992|467683110|FG010|Overall Study|Progressive Disease|1|||
129923064|NCT04632992|467683111|FG011|Overall Study|Progressive Disease|0|||
129923065|NCT04632992|467683112|FG012|Overall Study|Progressive Disease|2|||
129923066|NCT04632992|467683113|FG013|Overall Study|Progressive Disease|0|||
129923067|NCT04632992|467683100|FG000|Overall Study|Withdrawal by Subject|4|||
129923068|NCT04632992|467683101|FG001|Overall Study|Withdrawal by Subject|1|||
129923069|NCT04632992|467683102|FG002|Overall Study|Withdrawal by Subject|5|||
129923070|NCT04632992|467683103|FG003|Overall Study|Withdrawal by Subject|4|||
129923071|NCT04632992|467683104|FG004|Overall Study|Withdrawal by Subject|3|||
129923072|NCT04632992|467683105|FG005|Overall Study|Withdrawal by Subject|3|||
129923073|NCT04632992|467683106|FG006|Overall Study|Withdrawal by Subject|0|||
129923074|NCT04632992|467683107|FG007|Overall Study|Withdrawal by Subject|5|||
130117204|NCT01625377|468388803|FG000|Overall Study|Abnormal laboratory values|1|||
130117205|NCT01625377|468388804|FG001|Overall Study|Abnormal laboratory values|0|||
130117206|NCT03294538|468388809|FG000|Overall Study|Adverse Event|0|||
129923075|NCT04632992|467683108|FG008|Overall Study|Withdrawal by Subject|0|||
129923076|NCT04632992|467683109|FG009|Overall Study|Withdrawal by Subject|2|||
129923077|NCT04632992|467683110|FG010|Overall Study|Withdrawal by Subject|8|||
129923078|NCT04632992|467683111|FG011|Overall Study|Withdrawal by Subject|0|||
129923079|NCT04632992|467683112|FG012|Overall Study|Withdrawal by Subject|1|||
129923080|NCT04632992|467683113|FG013|Overall Study|Withdrawal by Subject|1|||
129923081|NCT05647304|467683114|FG000|Overall Study|Withdrawal by Subject|1|||
129923082|NCT05647304|467683115|FG001|Overall Study|Withdrawal by Subject|0|||
129923083|NCT03603600|467683116|FG000|Overall Study|Withdrawal by Subject|5|||
129923084|NCT03603600|467683117|FG001|Overall Study|Withdrawal by Subject|7|||
129923085|NCT03603600|467683116|FG000|Overall Study|Lost to Follow-up|2|||
129923086|NCT03603600|467683117|FG001|Overall Study|Lost to Follow-up|3|||
129923087|NCT03603600|467683116|FG000|Overall Study|Death|3|||
129923088|NCT03603600|467683117|FG001|Overall Study|Death|1|||
129923089|NCT03603600|467683116|FG000|Overall Study|Physician Decision|2|||
129923090|NCT03603600|467683117|FG001|Overall Study|Physician Decision|1|||
129923091|NCT03603600|467683116|FG000|Overall Study|Other reason|1|||
129923092|NCT03603600|467683117|FG001|Overall Study|Other reason|0|||
129923093|NCT03812679|467685252|FG000|Overall Study|Adverse Event|2|||
129923094|NCT03812679|467685252|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
129923095|NCT03812679|467685252|FG000|Overall Study|Renal transplant|1|||
129923096|NCT03812679|467685252|FG000|Overall Study|Withdrawal by Subject|1|||
129923097|NCT03812679|467685252|FG000|Overall Study|Termination of study|2|||
129923098|NCT03812679|467685252|FG000|Overall Study|Water device replacement|1|||
129923099|NCT05028634|467685253|FG000|Overall Study|Withdrawal by Subject|0|||
129923100|NCT05028634|467685254|FG001|Overall Study|Withdrawal by Subject|1|||
129923101|NCT05653427|467685255|FG000|Overall Study|Study Terminated by Sponsor|13|||
129923102|NCT05486078|467685263|FG000|Overall Study|4 drop out and one withdrawn|5|||
129923103|NCT04256941|467685264|FG000|Overall Study|Withdrawal by Subject|0|||
129923104|NCT04256941|467685265|FG001|Overall Study|Withdrawal by Subject|1|||
129923105|NCT04256941|467685264|FG000|Overall Study|Death|1|||
129923106|NCT04256941|467685265|FG001|Overall Study|Death|0|||
129923107|NCT04256941|467685264|FG000|Overall Study|Disease Progession|0|||
129923108|NCT04256941|467685265|FG001|Overall Study|Disease Progession|2|||
129923109|NCT02908477|467685272|FG000|Overall Study|Withdrawal by Subject|8|||
129923110|NCT02908477|467685273|FG001|Overall Study|Withdrawal by Subject|28|||
129923111|NCT02140554|467685274|FG000|Overall Study|Withdrawal of consent|1|||
129923112|NCT02140554|467685275|FG001|Overall Study|Withdrawal of consent|0|||
129923113|NCT02140554|467685276|FG002|Overall Study|Withdrawal of consent|4|||
129923114|NCT02140554|467685274|FG000|Overall Study|Physician Decision|1|||
129923115|NCT02140554|467685275|FG001|Overall Study|Physician Decision|0|||
129923116|NCT02140554|467685276|FG002|Overall Study|Physician Decision|2|||
129923117|NCT02140554|467685274|FG000|Overall Study|Death|0|||
129923118|NCT02140554|467685275|FG001|Overall Study|Death|0|||
129923119|NCT02140554|467685276|FG002|Overall Study|Death|1|||
129923120|NCT02140554|467685274|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
129923121|NCT02140554|467685275|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
129923122|NCT02140554|467685276|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
129923123|NCT05590403|467685277|FG000|Overall Study|Lost to Follow-up|13|||
129923124|NCT05590403|467685278|FG001|Overall Study|Lost to Follow-up|1|||
129923125|NCT05590403|467685279|FG002|Overall Study|Lost to Follow-up|7|||
129923126|NCT05590403|467685280|FG003|Overall Study|Lost to Follow-up|3|||
129923127|NCT05590403|467685281|FG004|Overall Study|Lost to Follow-up|4|||
129923128|NCT05590403|467685277|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
129923129|NCT05590403|467685278|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
129923130|NCT05590403|467685279|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
129923131|NCT05590403|467685280|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
130117207|NCT03294538|468388810|FG001|Overall Study|Adverse Event|1|||
130117208|NCT03294538|468388811|FG002|Overall Study|Adverse Event|1|||
129923132|NCT05590403|467685281|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
129923133|NCT05590403|467685277|FG000|Overall Study|Other|2|||
129923134|NCT05590403|467685278|FG001|Overall Study|Other|0|||
129923135|NCT05590403|467685279|FG002|Overall Study|Other|2|||
129923136|NCT05590403|467685280|FG003|Overall Study|Other|2|||
129923137|NCT05590403|467685281|FG004|Overall Study|Other|0|||
129923138|NCT05590403|467685277|FG000|Overall Study|Migrated / moved from the study area|1|||
129923139|NCT05590403|467685278|FG001|Overall Study|Migrated / moved from the study area|1|||
129923140|NCT05590403|467685279|FG002|Overall Study|Migrated / moved from the study area|0|||
129923141|NCT05590403|467685280|FG003|Overall Study|Migrated / moved from the study area|3|||
129923142|NCT05590403|467685281|FG004|Overall Study|Migrated / moved from the study area|1|||
130117209|NCT03294538|468388809|FG000|Overall Study|Lost to Follow-up|1|||
129923143|NCT05590403|467685277|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
129923144|NCT05590403|467685278|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
129923145|NCT05590403|467685279|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
129923146|NCT05590403|467685280|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
129923147|NCT05590403|467685281|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
129923148|NCT05659537|467685282|FG000|Overall Study|Adverse Event|5|||
129923149|NCT05659537|467685282|FG000|Overall Study|Lost to Follow-up|4|||
129923150|NCT05659537|467685282|FG000|Overall Study|Withdrawal by Subject|13|||
129923151|NCT05659537|467685282|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
129923152|NCT05659537|467685282|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
129923153|NCT05659537|467685282|FG000|Overall Study|Participant was suffering from anaemia|1|||
129923154|NCT04728347|467685283|FG000|Overall Study|Sponsor decision|0|||
129923155|NCT04728347|467685284|FG001|Overall Study|Sponsor decision|0|||
129923156|NCT04728347|467685285|FG002|Overall Study|Sponsor decision|1|||
129923157|NCT04728347|467685286|FG003|Overall Study|Sponsor decision|0|||
129923158|NCT03766009|467685288|FG000|Usual Care|Death|0|||
129923159|NCT03766009|467685289|FG001|Usual Care|Death|0|||
129923160|NCT03766009|467685290|FG002|Usual Care|Death|0|||
129923161|NCT03766009|467685291|FG003|Usual Care|Death|1|||
129923162|NCT03766009|467685292|FG004|Usual Care|Death|0|||
129923163|NCT03766009|467685293|FG005|Usual Care|Death|0|||
129923164|NCT03766009|467685288|FG000|Usual Care|Lost to Follow-up|0|||
129923165|NCT03766009|467685289|FG001|Usual Care|Lost to Follow-up|0|||
129923166|NCT03766009|467685290|FG002|Usual Care|Lost to Follow-up|0|||
129923167|NCT03766009|467685291|FG003|Usual Care|Lost to Follow-up|1|||
129923168|NCT03766009|467685292|FG004|Usual Care|Lost to Follow-up|0|||
129923169|NCT03766009|467685293|FG005|Usual Care|Lost to Follow-up|0|||
129923170|NCT03766009|467685288|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923171|NCT03766009|467685289|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923172|NCT03766009|467685290|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
129923173|NCT03766009|467685291|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923174|NCT03766009|467685292|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
129923175|NCT03766009|467685293|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923176|NCT03766009|467685288|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923177|NCT03766009|467685289|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
129923178|NCT03766009|467685290|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923179|NCT03766009|467685291|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
129923180|NCT03766009|467685292|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923181|NCT03766009|467685293|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923182|NCT03766009|467685288|FG000|Usual Care|No treatment or declined surgery|0|||
129923183|NCT03766009|467685289|FG001|Usual Care|No treatment or declined surgery|0|||
129923184|NCT03766009|467685290|FG002|Usual Care|No treatment or declined surgery|0|||
129923185|NCT03766009|467685291|FG003|Usual Care|No treatment or declined surgery|2|||
129923186|NCT03766009|467685292|FG004|Usual Care|No treatment or declined surgery|0|||
129923187|NCT03766009|467685293|FG005|Usual Care|No treatment or declined surgery|0|||
129923188|NCT03766009|467685288|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
129923189|NCT03766009|467685289|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
129923190|NCT03766009|467685290|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
129923191|NCT03766009|467685291|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
129923192|NCT03766009|467685292|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
129923193|NCT03766009|467685293|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
129923194|NCT03766009|467685288|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923195|NCT03766009|467685289|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
129923196|NCT03766009|467685290|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923197|NCT03766009|467685291|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923198|NCT03766009|467685292|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923199|NCT03766009|467685293|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
130068773|NCT03228394|468205574|FG000|Overall Study|Withdrawal by Subject|0|||
130068774|NCT03228394|468205575|FG001|Overall Study|Withdrawal by Subject|0|||
130068775|NCT03228394|468205576|FG002|Overall Study|Withdrawal by Subject|1|||
130068776|NCT03228394|468205577|FG003|Overall Study|Withdrawal by Subject|0|||
129923200|NCT03766009|467685288|FG000|Usual Care|Ineligible|0|||
129923201|NCT03766009|467685289|FG001|Usual Care|Ineligible|1|||
129923202|NCT03766009|467685290|FG002|Usual Care|Ineligible|0|||
129923203|NCT03766009|467685291|FG003|Usual Care|Ineligible|0|||
129923204|NCT03766009|467685292|FG004|Usual Care|Ineligible|0|||
129923205|NCT03766009|467685293|FG005|Usual Care|Ineligible|0|||
129923206|NCT03766009|467685288|FG000|Usual Care|Other: Staff turnover|0|||
129923207|NCT03766009|467685289|FG001|Usual Care|Other: Staff turnover|0|||
129923208|NCT03766009|467685290|FG002|Usual Care|Other: Staff turnover|0|||
130068777|NCT03228394|468205578|FG004|Overall Study|Withdrawal by Subject|0|||
129923209|NCT03766009|467685291|FG003|Usual Care|Other: Staff turnover|0|||
129923210|NCT03766009|467685292|FG004|Usual Care|Other: Staff turnover|0|||
129923211|NCT03766009|467685293|FG005|Usual Care|Other: Staff turnover|2|||
129923212|NCT04526704|467685298|FG000|Overall Study|Adverse Event|1|||
129923213|NCT04526704|467685299|FG001|Overall Study|Adverse Event|0|||
129923214|NCT04526704|467685298|FG000|Overall Study|Physician Decision|1|||
129923215|NCT04526704|467685299|FG001|Overall Study|Physician Decision|0|||
129923216|NCT04526704|467685298|FG000|Overall Study|Withdrawal by Subject|2|||
129923217|NCT04526704|467685299|FG001|Overall Study|Withdrawal by Subject|0|||
129923218|NCT02737436|467685300|FG000|Washout Period|Lost to Follow-up|5|||
129923219|NCT02737436|467685301|FG001|Washout Period|Lost to Follow-up|11|||
129923220|NCT02737436|467685300|FG000|Data Analysis|Scanning data problems|5|||
129923221|NCT02737436|467685301|FG001|Data Analysis|Scanning data problems|8|||
129923222|NCT02105766|467685302|FG000|Overall Study|Physician Decision|1|||
129923223|NCT02105766|467685303|FG001|Overall Study|Physician Decision|1|||
129923224|NCT02105766|467685304|FG002|Overall Study|Physician Decision|0|||
129923225|NCT02105766|467685302|FG000|Overall Study|Lost to Follow-up|2|||
129923226|NCT02105766|467685303|FG001|Overall Study|Lost to Follow-up|0|||
129923227|NCT02105766|467685304|FG002|Overall Study|Lost to Follow-up|0|||
129923228|NCT02105766|467685302|FG000|Overall Study|Death|1|||
129923229|NCT02105766|467685303|FG001|Overall Study|Death|1|||
129923230|NCT02105766|467685304|FG002|Overall Study|Death|0|||
129923231|NCT00554788|467685305|FG000|Overall Study|Adverse Event|0|||
129923232|NCT00554788|467685306|FG001|Overall Study|Adverse Event|1|||
129923233|NCT00554788|467685307|FG002|Overall Study|Adverse Event|2|||
129923234|NCT00554788|467685305|FG000|Overall Study|Lost to Follow-up|4|||
129923235|NCT00554788|467685306|FG001|Overall Study|Lost to Follow-up|3|||
129923236|NCT00554788|467685307|FG002|Overall Study|Lost to Follow-up|3|||
129923237|NCT00554788|467685305|FG000|Overall Study|Physician Decision|1|||
129923238|NCT00554788|467685306|FG001|Overall Study|Physician Decision|1|||
129923239|NCT00554788|467685307|FG002|Overall Study|Physician Decision|3|||
129923240|NCT00554788|467685305|FG000|Overall Study|Withdrawal by Subject|0|||
129923241|NCT00554788|467685306|FG001|Overall Study|Withdrawal by Subject|0|||
129923242|NCT00554788|467685307|FG002|Overall Study|Withdrawal by Subject|1|||
129923243|NCT00554788|467685305|FG000|Overall Study|Refusal of further protocol therapy|0|||
129923244|NCT00554788|467685306|FG001|Overall Study|Refusal of further protocol therapy|1|||
129923245|NCT00554788|467685307|FG002|Overall Study|Refusal of further protocol therapy|1|||
129923246|NCT00554788|467685305|FG000|Overall Study|Progressive disease|0|||
129923247|NCT00554788|467685306|FG001|Overall Study|Progressive disease|0|||
129923248|NCT00554788|467685307|FG002|Overall Study|Progressive disease|3|||
129923249|NCT00554788|467685305|FG000|Overall Study|Ineligible|2|||
129923250|NCT00554788|467685306|FG001|Overall Study|Ineligible|0|||
129923251|NCT00554788|467685307|FG002|Overall Study|Ineligible|1|||
129923252|NCT03897465|467685308|FG000|Overall Study|Lost to Follow-up|2|||
129923253|NCT03897465|467685309|FG001|Overall Study|Lost to Follow-up|1|||
129923254|NCT03897465|467685308|FG000|Overall Study|Adverse Event|2|||
129923255|NCT03897465|467685309|FG001|Overall Study|Adverse Event|0|||
129923256|NCT03897465|467685308|FG000|Overall Study|complete healing by V2|1|||
129923257|NCT03897465|467685309|FG001|Overall Study|complete healing by V2|0|||
129923258|NCT03897465|467685308|FG000|Overall Study|occurence of exclusion criterion|1|||
129923259|NCT03897465|467685309|FG001|Overall Study|occurence of exclusion criterion|1|||
129923260|NCT03897465|467685308|FG000|Overall Study|Other|1|||
129923261|NCT03897465|467685309|FG001|Overall Study|Other|0|||
129923262|NCT02985957|467685311|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923263|NCT02985957|467685312|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923264|NCT02985957|467685313|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923265|NCT02985957|467685314|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923266|NCT02985957|467685315|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129923267|NCT02985957|467685316|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923268|NCT02985957|467685317|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923269|NCT02985957|467685311|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
129923270|NCT02985957|467685312|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129923271|NCT02985957|467685313|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
129923272|NCT02985957|467685314|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
129923273|NCT02985957|467685315|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
129923274|NCT02985957|467685316|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
129923275|NCT02985957|467685317|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
129923276|NCT02985957|467685311|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923277|NCT02985957|467685312|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923278|NCT02985957|467685313|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923279|NCT02985957|467685314|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923280|NCT02985957|467685315|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923281|NCT02985957|467685316|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923282|NCT02985957|467685317|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
129923283|NCT02985957|467685311|FG000|Treatment Period|Death|0|||
129923284|NCT02985957|467685312|FG001|Treatment Period|Death|0|||
129923285|NCT02985957|467685313|FG002|Treatment Period|Death|0|||
129923286|NCT02985957|467685314|FG003|Treatment Period|Death|0|||
129923287|NCT02985957|467685315|FG004|Treatment Period|Death|1|||
129923288|NCT02985957|467685316|FG005|Treatment Period|Death|0|||
129923289|NCT02985957|467685317|FG006|Treatment Period|Death|0|||
129923290|NCT02985957|467685311|FG000|Treatment Period|Participant withdrew consent|0|||
129923291|NCT02985957|467685312|FG001|Treatment Period|Participant withdrew consent|0|||
129923292|NCT02985957|467685313|FG002|Treatment Period|Participant withdrew consent|0|||
129923293|NCT02985957|467685314|FG003|Treatment Period|Participant withdrew consent|1|||
129923294|NCT02985957|467685315|FG004|Treatment Period|Participant withdrew consent|3|||
129923295|NCT02985957|467685316|FG005|Treatment Period|Participant withdrew consent|0|||
129923296|NCT02985957|467685317|FG006|Treatment Period|Participant withdrew consent|1|||
129923297|NCT02985957|467685311|FG000|Treatment Period|Lost to Follow-up|0|||
129923298|NCT02985957|467685312|FG001|Treatment Period|Lost to Follow-up|0|||
129923299|NCT02985957|467685313|FG002|Treatment Period|Lost to Follow-up|0|||
129923300|NCT02985957|467685314|FG003|Treatment Period|Lost to Follow-up|0|||
129923301|NCT02985957|467685315|FG004|Treatment Period|Lost to Follow-up|1|||
129923302|NCT02985957|467685316|FG005|Treatment Period|Lost to Follow-up|0|||
129923303|NCT02985957|467685317|FG006|Treatment Period|Lost to Follow-up|0|||
129923304|NCT02985957|467685311|FG000|Treatment Period|Other reasons|0|||
130068778|NCT03228394|468205579|FG005|Overall Study|Withdrawal by Subject|0|||
130068779|NCT03228394|468205580|FG006|Overall Study|Withdrawal by Subject|1|||
130068780|NCT03228394|468205581|FG007|Overall Study|Withdrawal by Subject|3|||
130068781|NCT03228394|468205574|FG000|Overall Study|Protocol Violation|0|||
130068782|NCT03228394|468205575|FG001|Overall Study|Protocol Violation|0|||
130068783|NCT03228394|468205576|FG002|Overall Study|Protocol Violation|0|||
130068784|NCT03228394|468205577|FG003|Overall Study|Protocol Violation|1|||
130068785|NCT03228394|468205578|FG004|Overall Study|Protocol Violation|0|||
130068786|NCT03228394|468205579|FG005|Overall Study|Protocol Violation|0|||
130068787|NCT03228394|468205580|FG006|Overall Study|Protocol Violation|0|||
130068788|NCT03228394|468205581|FG007|Overall Study|Protocol Violation|0|||
130068789|NCT03228394|468205574|FG000|Overall Study|Physician Decision|0|||
130068790|NCT03228394|468205575|FG001|Overall Study|Physician Decision|0|||
130068791|NCT03228394|468205576|FG002|Overall Study|Physician Decision|0|||
130068792|NCT03228394|468205577|FG003|Overall Study|Physician Decision|0|||
130068793|NCT03228394|468205578|FG004|Overall Study|Physician Decision|0|||
130068794|NCT03228394|468205579|FG005|Overall Study|Physician Decision|0|||
130068795|NCT03228394|468205580|FG006|Overall Study|Physician Decision|1|||
130068796|NCT03228394|468205581|FG007|Overall Study|Physician Decision|0|||
130068797|NCT03228394|468205574|FG000|Overall Study|Noncompliance|0|||
130068798|NCT03228394|468205575|FG001|Overall Study|Noncompliance|0|||
130068799|NCT03228394|468205576|FG002|Overall Study|Noncompliance|0|||
130068800|NCT03228394|468205577|FG003|Overall Study|Noncompliance|0|||
130068801|NCT03228394|468205578|FG004|Overall Study|Noncompliance|0|||
130068802|NCT03228394|468205579|FG005|Overall Study|Noncompliance|0|||
130068803|NCT03228394|468205580|FG006|Overall Study|Noncompliance|1|||
130068804|NCT03228394|468205581|FG007|Overall Study|Noncompliance|0|||
130068805|NCT04581863|468205582|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
130068806|NCT04581863|468205583|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
130068807|NCT01803711|468205586|FG000|Overall Study|Adverse Event|1|||
130068808|NCT01803711|468205587|FG001|Overall Study|Adverse Event|1|||
130068809|NCT01170221|468205591|FG000|Overall Study|Lost to Follow-up|22|||
130068810|NCT01170221|468205592|FG001|Overall Study|Lost to Follow-up|21|||
130068811|NCT01170221|468205591|FG000|Overall Study|Withdrawal by Subject|9|||
130068812|NCT01170221|468205592|FG001|Overall Study|Withdrawal by Subject|7|||
130068813|NCT01170221|468205591|FG000|Overall Study|Subject completed only screening and LFU|1|||
130068814|NCT01170221|468205592|FG001|Overall Study|Subject completed only screening and LFU|0|||
130068815|NCT01170221|468205591|FG000|Overall Study|Randomized but not treated|1|||
130068816|NCT01170221|468205592|FG001|Overall Study|Randomized but not treated|0|||
130068817|NCT00432562|468205593|FG000|Overall Study|Death|3|||
130068818|NCT00432562|468205594|FG001|Overall Study|Death|0|||
130068819|NCT02693691|468205595|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
130068820|NCT02693691|468205595|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
130068821|NCT02693691|468205595|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
130068822|NCT02693691|468205595|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
130068823|NCT02693691|468205595|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
130068824|NCT02693691|468205595|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
130068825|NCT02693691|468205595|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
130068826|NCT01315847|468205598|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
130068827|NCT01315847|468205599|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
130068828|NCT01315847|468205598|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
130068829|NCT01315847|468205599|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
130068830|NCT05425719|468205604|FG000|Overall Study|Lost to Follow-up|4|||
129923305|NCT02985957|467685312|FG001|Treatment Period|Other reasons|0|||
130117210|NCT03294538|468388810|FG001|Overall Study|Lost to Follow-up|0|||
130117211|NCT03294538|468388811|FG002|Overall Study|Lost to Follow-up|0|||
130117212|NCT03294538|468388809|FG000|Overall Study|Outside of Visit Window|4|||
129923306|NCT02985957|467685313|FG002|Treatment Period|Other reasons|1|||
129923307|NCT02985957|467685314|FG003|Treatment Period|Other reasons|3|||
129923308|NCT02985957|467685315|FG004|Treatment Period|Other reasons|6|||
129923309|NCT02985957|467685316|FG005|Treatment Period|Other reasons|0|||
129923310|NCT02985957|467685317|FG006|Treatment Period|Other reasons|1|||
129923311|NCT02985957|467685311|FG000|Treatment Period|Not reported|0|||
129923312|NCT02985957|467685312|FG001|Treatment Period|Not reported|1|||
129923313|NCT02985957|467685313|FG002|Treatment Period|Not reported|2|||
129923314|NCT02985957|467685314|FG003|Treatment Period|Not reported|5|||
129923315|NCT02985957|467685315|FG004|Treatment Period|Not reported|0|||
129923316|NCT02985957|467685316|FG005|Treatment Period|Not reported|0|||
129923317|NCT02985957|467685317|FG006|Treatment Period|Not reported|0|||
129923318|NCT02985957|467685311|FG000|Treatment Period|Maximum clinical benefit|0|||
129923319|NCT02985957|467685312|FG001|Treatment Period|Maximum clinical benefit|0|||
129923320|NCT02985957|467685313|FG002|Treatment Period|Maximum clinical benefit|1|||
129923321|NCT02985957|467685314|FG003|Treatment Period|Maximum clinical benefit|1|||
129923322|NCT02985957|467685315|FG004|Treatment Period|Maximum clinical benefit|0|||
129923323|NCT02985957|467685316|FG005|Treatment Period|Maximum clinical benefit|0|||
129923324|NCT02985957|467685317|FG006|Treatment Period|Maximum clinical benefit|2|||
129923325|NCT02985957|467685311|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
129923326|NCT02985957|467685312|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
129923327|NCT02985957|467685313|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
129923328|NCT02985957|467685314|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
129923329|NCT02985957|467685315|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
129923330|NCT02985957|467685316|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
129923331|NCT02985957|467685317|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
129923332|NCT02985957|467685311|FG000|Treatment Period|Study drug toxicity|1|||
129923333|NCT02985957|467685312|FG001|Treatment Period|Study drug toxicity|23|||
129923334|NCT02985957|467685313|FG002|Treatment Period|Study drug toxicity|20|||
129923335|NCT02985957|467685314|FG003|Treatment Period|Study drug toxicity|11|||
129923336|NCT02985957|467685315|FG004|Treatment Period|Study drug toxicity|19|||
129923337|NCT02985957|467685316|FG005|Treatment Period|Study drug toxicity|3|||
129923338|NCT02985957|467685317|FG006|Treatment Period|Study drug toxicity|5|||
129923339|NCT02985957|467685311|FG000|Treatment Period|Disease progression|0|||
129923340|NCT02985957|467685312|FG001|Treatment Period|Disease progression|16|||
129923341|NCT02985957|467685313|FG002|Treatment Period|Disease progression|20|||
129923342|NCT02985957|467685314|FG003|Treatment Period|Disease progression|39|||
129923343|NCT02985957|467685315|FG004|Treatment Period|Disease progression|29|||
129923344|NCT02985957|467685316|FG005|Treatment Period|Disease progression|11|||
129923345|NCT02985957|467685317|FG006|Treatment Period|Disease progression|28|||
129923346|NCT02985957|467685311|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
129923347|NCT02985957|467685312|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
129923348|NCT02985957|467685313|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
129923349|NCT02985957|467685314|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
129923350|NCT02985957|467685315|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
129923351|NCT02985957|467685316|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
129923352|NCT02985957|467685317|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
129923353|NCT02985957|467685311|FG000|Treatment Period|Poor/Non-Compliance|0|||
129923354|NCT02985957|467685312|FG001|Treatment Period|Poor/Non-Compliance|0|||
129923355|NCT02985957|467685313|FG002|Treatment Period|Poor/Non-Compliance|0|||
129923356|NCT02985957|467685314|FG003|Treatment Period|Poor/Non-Compliance|0|||
129923357|NCT02985957|467685315|FG004|Treatment Period|Poor/Non-Compliance|1|||
129923358|NCT02985957|467685316|FG005|Treatment Period|Poor/Non-Compliance|1|||
129923359|NCT02985957|467685317|FG006|Treatment Period|Poor/Non-Compliance|0|||
129923360|NCT02985957|467685311|FG000|Treatment Period|Continuing in Treatment Period|0|||
129923361|NCT02985957|467685312|FG001|Treatment Period|Continuing in Treatment Period|1|||
129923362|NCT02985957|467685313|FG002|Treatment Period|Continuing in Treatment Period|0|||
129923363|NCT02985957|467685314|FG003|Treatment Period|Continuing in Treatment Period|4|||
129923364|NCT02985957|467685315|FG004|Treatment Period|Continuing in Treatment Period|4|||
129923365|NCT02985957|467685316|FG005|Treatment Period|Continuing in Treatment Period|0|||
129923366|NCT02985957|467685317|FG006|Treatment Period|Continuing in Treatment Period|0|||
129923367|NCT04719390|467685330|FG000|Overall Study|Withdrawal by Subject|1|||
129923368|NCT06190691|467685331|FG000|Overall Study|Adverse Event|2|||
129923369|NCT06190691|467685332|FG001|Overall Study|Adverse Event|0|||
129923370|NCT06190691|467685333|FG002|Overall Study|Adverse Event|0|||
129923371|NCT06190691|467685334|FG003|Overall Study|Adverse Event|0|||
129923372|NCT05746455|467685335|FG000|Overall Study|Discharged from Clinical Service|1|||
129923373|NCT05746455|467685335|FG000|Overall Study|Lost to Follow-up|1|||
129923374|NCT02485938|467685336|FG000|Overall Study|Withdrawal of consent|2|||
129923375|NCT02485938|467685337|FG001|Overall Study|Withdrawal of consent|0|||
130117213|NCT03294538|468388810|FG001|Overall Study|Outside of Visit Window|4|||
130117214|NCT03294538|468388811|FG002|Overall Study|Outside of Visit Window|1|||
130117215|NCT00449072|468388818|FG000|Overall Study|Adverse Event|3|||
130117216|NCT00449072|468388819|FG001|Overall Study|Adverse Event|1|||
130117217|NCT00449072|468388818|FG000|Overall Study|Protocol Violation|14|||
130117218|NCT00449072|468388819|FG001|Overall Study|Protocol Violation|12|||
130117219|NCT00449072|468388818|FG000|Overall Study|Lost to Follow-up|5|||
130117220|NCT00449072|468388819|FG001|Overall Study|Lost to Follow-up|7|||
130117221|NCT00449072|468388818|FG000|Overall Study|Withdrawal by Subject|11|||
130117222|NCT00449072|468388819|FG001|Overall Study|Withdrawal by Subject|8|||
130117223|NCT00449072|468388818|FG000|Overall Study|Lack of Efficacy|1|||
130117224|NCT00449072|468388819|FG001|Overall Study|Lack of Efficacy|1|||
129923376|NCT03016754|467685340|FG000|Overall Study|Death|5|||
129923377|NCT03016754|467685341|FG001|Overall Study|Death|4|||
129923378|NCT03016754|467685342|FG002|Overall Study|Death|5|||
129923379|NCT03016754|467685343|FG003|Overall Study|Death|1|||
129923380|NCT03016754|467685340|FG000|Overall Study|Lost to Follow-up|23|||
129923381|NCT03016754|467685341|FG001|Overall Study|Lost to Follow-up|17|||
129923382|NCT03016754|467685342|FG002|Overall Study|Lost to Follow-up|4|||
129923383|NCT03016754|467685343|FG003|Overall Study|Lost to Follow-up|2|||
129923384|NCT03016754|467685340|FG000|Overall Study|Withdrawal by Subject|6|||
129923385|NCT03016754|467685341|FG001|Overall Study|Withdrawal by Subject|6|||
129923386|NCT03016754|467685342|FG002|Overall Study|Withdrawal by Subject|2|||
129923387|NCT03016754|467685343|FG003|Overall Study|Withdrawal by Subject|2|||
129923388|NCT03016754|467685340|FG000|Overall Study|Other/Unknown|2|||
129923389|NCT03016754|467685341|FG001|Overall Study|Other/Unknown|4|||
129923390|NCT03016754|467685342|FG002|Overall Study|Other/Unknown|2|||
129923391|NCT03016754|467685343|FG003|Overall Study|Other/Unknown|1|||
129923392|NCT03016754|467685340|FG000|Overall Study|Protocol Violation|0|||
129923393|NCT03016754|467685341|FG001|Overall Study|Protocol Violation|0|||
129923394|NCT03016754|467685342|FG002|Overall Study|Protocol Violation|0|||
129923395|NCT03016754|467685343|FG003|Overall Study|Protocol Violation|4|||
129923396|NCT03839940|467685344|FG000|Overall Study|Withdrawal by Subject|3|||
129923397|NCT03839940|467685345|FG001|Overall Study|Withdrawal by Subject|0|||
129923398|NCT03839940|467685344|FG000|Overall Study|Protocol Violation|0|||
129923399|NCT03839940|467685345|FG001|Overall Study|Protocol Violation|1|||
129923400|NCT03839940|467685344|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
129923401|NCT03839940|467685345|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
129923402|NCT03241745|467685346|FG000|Overall Study|Adverse Event|7|||
129923403|NCT03241745|467685346|FG000|Overall Study|Death|1|||
129923404|NCT03241745|467685346|FG000|Overall Study|Withdrawal by Subject|5|||
129923405|NCT03241745|467685346|FG000|Overall Study|Treatment delay >28 days|2|||
129923406|NCT03241745|467685346|FG000|Overall Study|Lack of Efficacy|14|||
129923407|NCT03023410|467685347|FG000|Overall Study|study termination|0|||
129923408|NCT03023410|467685348|FG001|Overall Study|study termination|1|||
129923409|NCT04799899|467685350|FG000|Overall Study|Lost to Follow-up|2|||
129923410|NCT04799899|467685351|FG001|Overall Study|Lost to Follow-up|4|||
129923411|NCT00470704|467685352|FG000|Overall Study|Withdrawal by Subject|4|||
129923412|NCT00470704|467685353|FG001|Overall Study|Withdrawal by Subject|3|||
129923413|NCT00470704|467685352|FG000|Overall Study|Relapse/Progression|37|||
129923414|NCT00470704|467685353|FG001|Overall Study|Relapse/Progression|42|||
129923415|NCT00470704|467685352|FG000|Overall Study|toxicity|0|||
129923416|NCT00470704|467685353|FG001|Overall Study|toxicity|1|||
129923417|NCT04019873|467685354|FG000|Overall Study|Discontinued from the treatment|1|||
129923418|NCT04019873|467685355|FG001|Overall Study|Discontinued from the treatment|39|||
129923419|NCT04019873|467685356|FG002|Overall Study|Discontinued from the treatment|2|||
129923420|NCT04683744|467685357|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
129923421|NCT04683744|467685358|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
129923422|NCT04683744|467685359|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
129923423|NCT04295798|467685367|FG000|Overall Study|Lost to Follow-up|1|||
129923424|NCT04927364|467685368|FG000|Overall Study|Withdrawal by Subject|3|||
129923425|NCT04927364|467685368|FG000|Overall Study|Unable to complete preassessment MRI|1|||
129923426|NCT04650269|467685374|FG000|Overall Study|Death|3|||
129923427|NCT04650269|467685374|FG000|Overall Study|Lost to Follow-up|6|||
129923428|NCT01437709|467685375|FG000|Overall Study|Adverse Event|0|||
129923429|NCT01437709|467685376|FG001|Overall Study|Adverse Event|1|||
129923430|NCT01437709|467685377|FG002|Overall Study|Adverse Event|0|||
130117225|NCT00449072|468388818|FG000|Overall Study|Physician Decision|1|||
130117226|NCT00449072|468388819|FG001|Overall Study|Physician Decision|0|||
130117227|NCT00449072|468388818|FG000|Overall Study|Not treated|0|||
130117228|NCT00449072|468388819|FG001|Overall Study|Not treated|1|||
129923431|NCT01437709|467685375|FG000|Overall Study|Pt trasnferred care|0|||
129923432|NCT01437709|467685376|FG001|Overall Study|Pt trasnferred care|1|||
129923433|NCT01437709|467685377|FG002|Overall Study|Pt trasnferred care|0|||
129923434|NCT00085735|467685378|FG000|Overall Study|Adverse Event|1|||
129923435|NCT00085735|467685379|FG001|Overall Study|Adverse Event|0|||
130117229|NCT00449072|468388818|FG000|Overall Study|Excluded medication|0|||
130117230|NCT00449072|468388819|FG001|Overall Study|Excluded medication|2|||
129923436|NCT00085735|467685380|FG002|Overall Study|Adverse Event|0|||
130117231|NCT00449072|468388818|FG000|Overall Study|Non-compliance|2|||
130117232|NCT00449072|468388819|FG001|Overall Study|Non-compliance|5|||
130117233|NCT00449072|468388818|FG000|Overall Study|Sponsor decision|1|||
130117234|NCT00449072|468388819|FG001|Overall Study|Sponsor decision|3|||
130117235|NCT00449072|468388818|FG000|Overall Study|Relocation|3|||
130117236|NCT00449072|468388819|FG001|Overall Study|Relocation|2|||
130117237|NCT01769378|468388820|FG000|Overall Study|Adverse Event|10|||
130117238|NCT01769378|468388821|FG001|Overall Study|Adverse Event|0|||
130117239|NCT01769378|468388820|FG000|Overall Study|Entry criteria not met|1|||
130117240|NCT01769378|468388821|FG001|Overall Study|Entry criteria not met|0|||
130117241|NCT01769378|468388820|FG000|Overall Study|Protocol Violation|1|||
130117242|NCT01769378|468388821|FG001|Overall Study|Protocol Violation|1|||
130117243|NCT01769378|468388820|FG000|Overall Study|Withdrawal by Subject|10|||
130117244|NCT01769378|468388821|FG001|Overall Study|Withdrawal by Subject|3|||
130117245|NCT01769378|468388820|FG000|Overall Study|Sponsor Decision|1|||
130117246|NCT01769378|468388821|FG001|Overall Study|Sponsor Decision|0|||
130117247|NCT01769378|468388820|FG000|Overall Study|Lost to Follow-up|2|||
130117248|NCT01769378|468388821|FG001|Overall Study|Lost to Follow-up|0|||
129923437|NCT00085735|467685381|FG003|Overall Study|Adverse Event|0|||
129923438|NCT00085735|467685382|FG004|Overall Study|Adverse Event|0|||
129923439|NCT00085735|467685383|FG005|Overall Study|Adverse Event|0|||
129923440|NCT00085735|467685378|FG000|Overall Study|Lack of Efficacy|2|||
129923441|NCT00085735|467685379|FG001|Overall Study|Lack of Efficacy|4|||
129923442|NCT00085735|467685380|FG002|Overall Study|Lack of Efficacy|6|||
129923443|NCT00085735|467685381|FG003|Overall Study|Lack of Efficacy|3|||
129923444|NCT00085735|467685382|FG004|Overall Study|Lack of Efficacy|4|||
129923445|NCT00085735|467685383|FG005|Overall Study|Lack of Efficacy|3|||
129923446|NCT00085735|467685378|FG000|Overall Study|Lost to Follow-up|0|||
129923447|NCT00085735|467685379|FG001|Overall Study|Lost to Follow-up|1|||
129923448|NCT00085735|467685380|FG002|Overall Study|Lost to Follow-up|0|||
129923449|NCT00085735|467685381|FG003|Overall Study|Lost to Follow-up|0|||
129923450|NCT00085735|467685382|FG004|Overall Study|Lost to Follow-up|1|||
129923451|NCT00085735|467685383|FG005|Overall Study|Lost to Follow-up|0|||
129923452|NCT00085735|467685378|FG000|Overall Study|Physician Decision|2|||
129923453|NCT00085735|467685379|FG001|Overall Study|Physician Decision|3|||
129923454|NCT00085735|467685380|FG002|Overall Study|Physician Decision|2|||
129923455|NCT00085735|467685381|FG003|Overall Study|Physician Decision|3|||
129923456|NCT00085735|467685382|FG004|Overall Study|Physician Decision|11|||
129923457|NCT00085735|467685383|FG005|Overall Study|Physician Decision|8|||
129923458|NCT00085735|467685378|FG000|Overall Study|Protocol Violation|1|||
129923459|NCT00085735|467685379|FG001|Overall Study|Protocol Violation|0|||
129923460|NCT00085735|467685380|FG002|Overall Study|Protocol Violation|0|||
129923461|NCT00085735|467685381|FG003|Overall Study|Protocol Violation|0|||
129923462|NCT00085735|467685382|FG004|Overall Study|Protocol Violation|0|||
129923463|NCT00085735|467685383|FG005|Overall Study|Protocol Violation|0|||
129923464|NCT00085735|467685378|FG000|Overall Study|Withdrawal by Subject|1|||
129923465|NCT00085735|467685379|FG001|Overall Study|Withdrawal by Subject|0|||
129923466|NCT00085735|467685380|FG002|Overall Study|Withdrawal by Subject|4|||
129923467|NCT00085735|467685381|FG003|Overall Study|Withdrawal by Subject|5|||
129923468|NCT00085735|467685382|FG004|Overall Study|Withdrawal by Subject|7|||
129923469|NCT00085735|467685383|FG005|Overall Study|Withdrawal by Subject|8|||
129923470|NCT00085735|467685378|FG000|Overall Study|Patient ineligible|1|||
129923471|NCT00085735|467685379|FG001|Overall Study|Patient ineligible|0|||
129923472|NCT00085735|467685380|FG002|Overall Study|Patient ineligible|3|||
129923473|NCT00085735|467685381|FG003|Overall Study|Patient ineligible|7|||
129923474|NCT00085735|467685382|FG004|Overall Study|Patient ineligible|17|||
129923475|NCT00085735|467685383|FG005|Overall Study|Patient ineligible|8|||
129923476|NCT00085735|467685378|FG000|Overall Study|Excess residual disease|2|||
129923477|NCT00085735|467685379|FG001|Overall Study|Excess residual disease|2|||
129923478|NCT00085735|467685380|FG002|Overall Study|Excess residual disease|1|||
129923479|NCT00085735|467685381|FG003|Overall Study|Excess residual disease|1|||
129923480|NCT00085735|467685382|FG004|Overall Study|Excess residual disease|1|||
129923481|NCT00085735|467685383|FG005|Overall Study|Excess residual disease|4|||
129923482|NCT00085735|467685378|FG000|Overall Study|Reason not documented|1|||
129923483|NCT00085735|467685379|FG001|Overall Study|Reason not documented|0|||
129923484|NCT00085735|467685380|FG002|Overall Study|Reason not documented|1|||
129923485|NCT00085735|467685381|FG003|Overall Study|Reason not documented|0|||
129923486|NCT00085735|467685382|FG004|Overall Study|Reason not documented|1|||
129923487|NCT00085735|467685383|FG005|Overall Study|Reason not documented|0|||
129923488|NCT00085735|467685378|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
130117249|NCT00718159|468388822|FG000|Overall Study|Progressive Disease|3|||
130117250|NCT00718159|468388823|FG001|Overall Study|Progressive Disease|3|||
129923489|NCT00085735|467685379|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
129923490|NCT00085735|467685380|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
129923491|NCT00085735|467685381|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
129923492|NCT00085735|467685382|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
129923493|NCT00085735|467685383|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
130117251|NCT00718159|468388824|FG002|Overall Study|Progressive Disease|2|||
129923494|NCT02919306|467685384|FG000|Overall Study|Withdrawal by Subject|1|||
129923495|NCT02919306|467685385|FG001|Overall Study|Withdrawal by Subject|0|||
129923496|NCT02919306|467685384|FG000|Overall Study|Protocol Violation|1|||
129923497|NCT02919306|467685385|FG001|Overall Study|Protocol Violation|0|||
129923498|NCT04473222|467685386|FG000|Overall Study|Lost to Follow-up|13|||
129923499|NCT04473222|467685387|FG001|Overall Study|Lost to Follow-up|13|||
129923500|NCT04473222|467685386|FG000|Overall Study|Withdrawal by Subject|0|||
129923501|NCT04473222|467685387|FG001|Overall Study|Withdrawal by Subject|1|||
129923502|NCT04473222|467685386|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
129923503|NCT04473222|467685387|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
129923504|NCT04195698|467685390|FG000|Overall Study|Adverse Event|4|||
129923505|NCT04195698|467685391|FG001|Overall Study|Adverse Event|11|||
129923506|NCT04195698|467685390|FG000|Overall Study|Withdrawal by Subject|9|||
129923507|NCT04195698|467685391|FG001|Overall Study|Withdrawal by Subject|10|||
129923508|NCT04195698|467685390|FG000|Overall Study|Lost to Follow-up|5|||
129923509|NCT04195698|467685391|FG001|Overall Study|Lost to Follow-up|4|||
129923510|NCT04195698|467685390|FG000|Overall Study|Lack of Efficacy|2|||
129923511|NCT04195698|467685391|FG001|Overall Study|Lack of Efficacy|10|||
129923512|NCT04195698|467685390|FG000|Overall Study|Other|5|||
129923513|NCT04195698|467685391|FG001|Overall Study|Other|4|||
129923514|NCT05459688|467685392|FG000|Overall Study|Lost to Follow-up|6|||
129923515|NCT05459688|467685392|FG000|Overall Study|Physician Decision|1|||
129923516|NCT05459688|467685392|FG000|Overall Study|Withdrawal by Subject|19|||
129923517|NCT05459688|467685392|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
129923518|NCT04908722|467685393|FG000|Overall Study|Protocol deviation|1|||
129923519|NCT04908722|467685394|FG001|Overall Study|Protocol deviation|0|||
129923520|NCT04908722|467685395|FG002|Overall Study|Protocol deviation|0|||
129923521|NCT04908722|467685396|FG003|Overall Study|Protocol deviation|0|||
129923522|NCT04908722|467685397|FG004|Overall Study|Protocol deviation|0|||
129923523|NCT04908722|467685398|FG005|Overall Study|Protocol deviation|1|||
129923524|NCT04908722|467685393|FG000|Overall Study|Lost to Follow-up|33|||
129923525|NCT04908722|467685394|FG001|Overall Study|Lost to Follow-up|33|||
129923526|NCT04908722|467685395|FG002|Overall Study|Lost to Follow-up|36|||
129923527|NCT04908722|467685396|FG003|Overall Study|Lost to Follow-up|30|||
129923528|NCT04908722|467685397|FG004|Overall Study|Lost to Follow-up|32|||
129923529|NCT04908722|467685398|FG005|Overall Study|Lost to Follow-up|34|||
129923530|NCT04908722|467685393|FG000|Overall Study|Physician Decision|1|||
129923531|NCT04908722|467685394|FG001|Overall Study|Physician Decision|1|||
129923532|NCT04908722|467685395|FG002|Overall Study|Physician Decision|1|||
129923533|NCT04908722|467685396|FG003|Overall Study|Physician Decision|2|||
129923534|NCT04908722|467685397|FG004|Overall Study|Physician Decision|0|||
129923535|NCT04908722|467685398|FG005|Overall Study|Physician Decision|0|||
129923536|NCT04908722|467685393|FG000|Overall Study|Death|1|||
129923537|NCT04908722|467685394|FG001|Overall Study|Death|0|||
129923538|NCT04908722|467685395|FG002|Overall Study|Death|0|||
129923539|NCT04908722|467685396|FG003|Overall Study|Death|0|||
129923540|NCT04908722|467685397|FG004|Overall Study|Death|0|||
129923541|NCT04908722|467685398|FG005|Overall Study|Death|1|||
129923542|NCT04908722|467685393|FG000|Overall Study|Withdrawal by Subject|12|||
129923543|NCT04908722|467685394|FG001|Overall Study|Withdrawal by Subject|8|||
129923544|NCT04908722|467685395|FG002|Overall Study|Withdrawal by Subject|7|||
129923545|NCT04908722|467685396|FG003|Overall Study|Withdrawal by Subject|6|||
129923546|NCT04908722|467685397|FG004|Overall Study|Withdrawal by Subject|12|||
129923547|NCT04908722|467685398|FG005|Overall Study|Withdrawal by Subject|14|||
129923548|NCT04908722|467685393|FG000|Overall Study|Other|3|||
129923549|NCT04908722|467685394|FG001|Overall Study|Other|1|||
129923550|NCT04908722|467685395|FG002|Overall Study|Other|3|||
129923551|NCT04908722|467685396|FG003|Overall Study|Other|2|||
129923552|NCT04908722|467685397|FG004|Overall Study|Other|4|||
129923553|NCT04908722|467685398|FG005|Overall Study|Other|1|||
129923554|NCT04908722|467685393|FG000|Overall Study|Initiated prohibited medication|0|||
129923555|NCT04908722|467685394|FG001|Overall Study|Initiated prohibited medication|0|||
129923556|NCT04908722|467685395|FG002|Overall Study|Initiated prohibited medication|0|||
129923557|NCT04908722|467685396|FG003|Overall Study|Initiated prohibited medication|1|||
129923558|NCT04908722|467685397|FG004|Overall Study|Initiated prohibited medication|0|||
129923559|NCT04908722|467685398|FG005|Overall Study|Initiated prohibited medication|1|||
129923560|NCT04908722|467685393|FG000|Overall Study|Randomized but not vaccinated|3|||
129923561|NCT04908722|467685394|FG001|Overall Study|Randomized but not vaccinated|1|||
129923562|NCT04908722|467685395|FG002|Overall Study|Randomized but not vaccinated|2|||
129923563|NCT04908722|467685396|FG003|Overall Study|Randomized but not vaccinated|2|||
129923564|NCT04908722|467685397|FG004|Overall Study|Randomized but not vaccinated|3|||
129923565|NCT04908722|467685398|FG005|Overall Study|Randomized but not vaccinated|4|||
129923566|NCT02319759|467685399|FG000|Week 0 - 16|Lack of Efficacy|1|||
129923567|NCT02319759|467685400|FG001|Week 0 - 16|Lack of Efficacy|0|||
129923568|NCT02319759|467685401|FG002|Week 0 - 16|Lack of Efficacy|0|||
129923569|NCT02319759|467685402|FG003|Week 0 - 16|Lack of Efficacy|0|||
129923570|NCT02319759|467685403|FG004|Week 0 - 16|Lack of Efficacy|0|||
130068831|NCT05425719|468205605|FG001|Overall Study|Lost to Follow-up|0|||
130117252|NCT00718159|468388825|FG003|Overall Study|Progressive Disease|0|||
130117253|NCT00718159|468388826|FG004|Overall Study|Progressive Disease|6|||
130117254|NCT00718159|468388827|FG005|Overall Study|Progressive Disease|0|||
130117255|NCT00718159|468388828|FG006|Overall Study|Progressive Disease|0|||
130117256|NCT00718159|468388822|FG000|Overall Study|Death due to Adverse Event|0|||
130117257|NCT00718159|468388823|FG001|Overall Study|Death due to Adverse Event|0|||
130117258|NCT00718159|468388824|FG002|Overall Study|Death due to Adverse Event|0|||
130117259|NCT00718159|468388825|FG003|Overall Study|Death due to Adverse Event|2|||
130117260|NCT00718159|468388826|FG004|Overall Study|Death due to Adverse Event|2|||
130117261|NCT00718159|468388827|FG005|Overall Study|Death due to Adverse Event|0|||
130117262|NCT00718159|468388828|FG006|Overall Study|Death due to Adverse Event|0|||
130117263|NCT00718159|468388822|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
130117264|NCT00718159|468388823|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
130117265|NCT00718159|468388824|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
130117266|NCT00718159|468388825|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
130117267|NCT00718159|468388826|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
130117268|NCT00718159|468388827|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
130117269|NCT00718159|468388828|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
130117270|NCT00718159|468388822|FG000|Overall Study|Investigator Decision|0|||
130117271|NCT00718159|468388823|FG001|Overall Study|Investigator Decision|0|||
130117272|NCT00718159|468388824|FG002|Overall Study|Investigator Decision|0|||
130117273|NCT00718159|468388825|FG003|Overall Study|Investigator Decision|0|||
130117274|NCT00718159|468388826|FG004|Overall Study|Investigator Decision|0|||
130117275|NCT00718159|468388827|FG005|Overall Study|Investigator Decision|1|||
130117276|NCT00718159|468388828|FG006|Overall Study|Investigator Decision|1|||
130117277|NCT01798485|468388837|FG000|Overall Study|Adverse Event|32|||
130117278|NCT01798485|468388838|FG001|Overall Study|Adverse Event|40|||
130117279|NCT01798485|468388837|FG000|Overall Study|Withdrawal by Subject|27|||
130117280|NCT01798485|468388838|FG001|Overall Study|Withdrawal by Subject|31|||
130117281|NCT01798485|468388837|FG000|Overall Study|Lost to Follow-up|0|||
130117282|NCT01798485|468388838|FG001|Overall Study|Lost to Follow-up|3|||
130117283|NCT01798485|468388837|FG000|Overall Study|Physician Decision|14|||
130117284|NCT01798485|468388838|FG001|Overall Study|Physician Decision|10|||
130117285|NCT01798485|468388837|FG000|Overall Study|Objective Disease Progression|152|||
130117286|NCT01798485|468388838|FG001|Overall Study|Objective Disease Progression|106|||
130117287|NCT01798485|468388837|FG000|Overall Study|Death|25|||
130117288|NCT01798485|468388838|FG001|Overall Study|Death|22|||
130117289|NCT01798485|468388837|FG000|Overall Study|Sponsor Decision|61|||
130117290|NCT01798485|468388838|FG001|Overall Study|Sponsor Decision|54|||
130117291|NCT01798485|468388837|FG000|Overall Study|Clinical Progression|35|||
130117292|NCT01798485|468388838|FG001|Overall Study|Clinical Progression|24|||
130117293|NCT00681863|468388839|FG000|Overall Study|Adverse Event|1|||
130117294|NCT00681863|468388839|FG000|Overall Study|Lost to Follow-up|2|||
130117295|NCT00681863|468388839|FG000|Overall Study|Lack of Efficacy|2|||
130117296|NCT00681863|468388839|FG000|Overall Study|Other|18|||
130117297|NCT01076166|468388840|FG000|Overall Study|Adverse Event|3|||
130117298|NCT01076166|468388840|FG000|Overall Study|Symptoms improved/resolved|6|||
130117299|NCT05476679|468388845|FG000|Overall Study|Withdrawal by Subject|0|||
130117300|NCT05476679|468388846|FG001|Overall Study|Withdrawal by Subject|0|||
130117301|NCT05476679|468388847|FG002|Overall Study|Withdrawal by Subject|0|||
130117302|NCT05476679|468388848|FG003|Overall Study|Withdrawal by Subject|1|||
130117303|NCT05476679|468388849|FG004|Overall Study|Withdrawal by Subject|0|||
130117304|NCT05476679|468388845|FG000|Overall Study|Lost to Follow-up|0|||
130117305|NCT05476679|468388846|FG001|Overall Study|Lost to Follow-up|0|||
130117306|NCT05476679|468388847|FG002|Overall Study|Lost to Follow-up|0|||
130117307|NCT05476679|468388848|FG003|Overall Study|Lost to Follow-up|1|||
130117308|NCT05476679|468388849|FG004|Overall Study|Lost to Follow-up|0|||
130117309|NCT01498484|468388852|FG000|Overall Study|Death|6|||
130117310|NCT01498484|468388853|FG001|Overall Study|Death|3|||
130117311|NCT01498484|468388854|FG002|Overall Study|Death|1|||
130117312|NCT01498484|468388855|FG003|Overall Study|Death|1|||
130117313|NCT01498484|468388856|FG004|Overall Study|Death|0|||
130117314|NCT01498484|468388857|FG005|Overall Study|Death|0|||
130117315|NCT01498484|468388858|FG006|Overall Study|Death|10|||
129923571|NCT02319759|467685399|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
130117316|NCT01498484|468388859|FG007|Overall Study|Death|1|||
130117317|NCT01498484|468388860|FG008|Overall Study|Death|0|||
130117318|NCT01498484|468388852|FG000|Overall Study|Physician Decision|3|||
130117319|NCT01498484|468388853|FG001|Overall Study|Physician Decision|2|||
130117320|NCT01498484|468388854|FG002|Overall Study|Physician Decision|1|||
130117321|NCT01498484|468388855|FG003|Overall Study|Physician Decision|1|||
130117322|NCT01498484|468388856|FG004|Overall Study|Physician Decision|0|||
130117323|NCT01498484|468388857|FG005|Overall Study|Physician Decision|0|||
130117324|NCT01498484|468388858|FG006|Overall Study|Physician Decision|8|||
130117325|NCT01498484|468388859|FG007|Overall Study|Physician Decision|13|||
130117326|NCT01498484|468388860|FG008|Overall Study|Physician Decision|1|||
130117327|NCT01498484|468388852|FG000|Overall Study|Adverse Event|0|||
130117328|NCT01498484|468388853|FG001|Overall Study|Adverse Event|0|||
130117329|NCT01498484|468388854|FG002|Overall Study|Adverse Event|0|||
129923572|NCT02319759|467685400|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
129923573|NCT02319759|467685401|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
129923574|NCT02319759|467685402|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
129923575|NCT02319759|467685403|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
129923576|NCT02319759|467685399|FG000|Week 16 - 24|Lack of Efficacy|1|||
129923577|NCT02319759|467685400|FG001|Week 16 - 24|Lack of Efficacy|0|||
129923578|NCT02319759|467685401|FG002|Week 16 - 24|Lack of Efficacy|1|||
129923579|NCT02319759|467685402|FG003|Week 16 - 24|Lack of Efficacy|0|||
129923580|NCT02319759|467685403|FG004|Week 16 - 24|Lack of Efficacy|0|||
129923581|NCT02319759|467685399|FG000|Week 16 - 24|Lost to Follow-up|1|||
129923582|NCT02319759|467685400|FG001|Week 16 - 24|Lost to Follow-up|0|||
129923583|NCT02319759|467685401|FG002|Week 16 - 24|Lost to Follow-up|0|||
129923584|NCT02319759|467685402|FG003|Week 16 - 24|Lost to Follow-up|0|||
129923585|NCT02319759|467685403|FG004|Week 16 - 24|Lost to Follow-up|0|||
129923586|NCT02319759|467685399|FG000|Week 16 - 24|Withdrawal by Subject|0|||
129923587|NCT02319759|467685400|FG001|Week 16 - 24|Withdrawal by Subject|0|||
129923588|NCT02319759|467685401|FG002|Week 16 - 24|Withdrawal by Subject|2|||
129923589|NCT02319759|467685402|FG003|Week 16 - 24|Withdrawal by Subject|0|||
129923590|NCT02319759|467685403|FG004|Week 16 - 24|Withdrawal by Subject|0|||
129923591|NCT02319759|467685399|FG000|Week 24 - 56|Adverse Event|0|||
129923592|NCT02319759|467685400|FG001|Week 24 - 56|Adverse Event|0|||
129923593|NCT02319759|467685401|FG002|Week 24 - 56|Adverse Event|2|||
129923594|NCT02319759|467685402|FG003|Week 24 - 56|Adverse Event|0|||
129923595|NCT02319759|467685403|FG004|Week 24 - 56|Adverse Event|0|||
129923596|NCT02319759|467685399|FG000|Week 24 - 56|Lack of Efficacy|0|||
129923597|NCT02319759|467685400|FG001|Week 24 - 56|Lack of Efficacy|0|||
129923598|NCT02319759|467685401|FG002|Week 24 - 56|Lack of Efficacy|0|||
129923599|NCT02319759|467685402|FG003|Week 24 - 56|Lack of Efficacy|2|||
129923600|NCT02319759|467685403|FG004|Week 24 - 56|Lack of Efficacy|1|||
129923601|NCT02319759|467685399|FG000|Week 24 - 56|Withdrawal by Subject|0|||
129923602|NCT02319759|467685400|FG001|Week 24 - 56|Withdrawal by Subject|1|||
129923603|NCT02319759|467685401|FG002|Week 24 - 56|Withdrawal by Subject|0|||
129923604|NCT02319759|467685402|FG003|Week 24 - 56|Withdrawal by Subject|0|||
129923605|NCT02319759|467685403|FG004|Week 24 - 56|Withdrawal by Subject|0|||
129923606|NCT02319759|467685399|FG000|Week 24 - 56|Lost to Follow-up|0|||
129923607|NCT02319759|467685400|FG001|Week 24 - 56|Lost to Follow-up|0|||
129923608|NCT02319759|467685401|FG002|Week 24 - 56|Lost to Follow-up|0|||
129923609|NCT02319759|467685402|FG003|Week 24 - 56|Lost to Follow-up|0|||
129923610|NCT02319759|467685403|FG004|Week 24 - 56|Lost to Follow-up|1|||
129923611|NCT06424236|467685406|FG000|Overall Study|Adverse Event|0|||
129923612|NCT06424236|467685407|FG001|Overall Study|Adverse Event|1|||
129923613|NCT06424236|467685408|FG002|Overall Study|Adverse Event|0|||
129923614|NCT06424236|467685406|FG000|Overall Study|Withdrawal by Subject|3|||
129923615|NCT06424236|467685407|FG001|Overall Study|Withdrawal by Subject|1|||
129923616|NCT06424236|467685408|FG002|Overall Study|Withdrawal by Subject|2|||
129923617|NCT06424236|467685406|FG000|Overall Study|Physician Decision|0|||
129923618|NCT06424236|467685407|FG001|Overall Study|Physician Decision|1|||
129923619|NCT06424236|467685408|FG002|Overall Study|Physician Decision|0|||
129923620|NCT06424236|467685406|FG000|Overall Study|Study Terminated by Sponsor|11|||
129923621|NCT06424236|467685407|FG001|Overall Study|Study Terminated by Sponsor|20|||
129923622|NCT06424236|467685408|FG002|Overall Study|Study Terminated by Sponsor|16|||
129923623|NCT06424236|467685406|FG000|Overall Study|Lost to Follow-up|0|||
129923624|NCT06424236|467685407|FG001|Overall Study|Lost to Follow-up|1|||
129923625|NCT06424236|467685408|FG002|Overall Study|Lost to Follow-up|0|||
129923626|NCT06424236|467685406|FG000|Overall Study|Disease Progression|0|||
129923627|NCT06424236|467685407|FG001|Overall Study|Disease Progression|1|||
129923628|NCT06424236|467685408|FG002|Overall Study|Disease Progression|2|||
129923629|NCT06424236|467685406|FG000|Overall Study|Other|0|||
129923630|NCT06424236|467685407|FG001|Overall Study|Other|0|||
129923631|NCT06424236|467685408|FG002|Overall Study|Other|1|||
129923632|NCT03339713|467685410|FG000|Overall Study|Lost to Follow-up|2|||
129923633|NCT03339713|467685411|FG001|Overall Study|Lost to Follow-up|1|||
129923634|NCT03339713|467685410|FG000|Overall Study|Protocol Violation|1|||
129923635|NCT03339713|467685411|FG001|Overall Study|Protocol Violation|0|||
129923636|NCT03339713|467685410|FG000|Overall Study|Withdrawal by Subject|1|||
129923637|NCT03339713|467685411|FG001|Overall Study|Withdrawal by Subject|1|||
129923638|NCT01959425|467685412|FG000|Overall Study|Withdrawal by Subject|5|||
129923639|NCT01959425|467685413|FG001|Overall Study|Withdrawal by Subject|4|||
129923640|NCT01959425|467685412|FG000|Overall Study|Lost to Follow-up|1|||
129923641|NCT01959425|467685413|FG001|Overall Study|Lost to Follow-up|0|||
129923642|NCT01959425|467685412|FG000|Overall Study|Discontinued Subjects|6|||
129923643|NCT01959425|467685413|FG001|Overall Study|Discontinued Subjects|4|||
129923644|NCT05540665|467685415|FG000|Overall Study|Study terminated by sponsor|6|||
129923645|NCT05540665|467685416|FG001|Overall Study|Study terminated by sponsor|6|||
129923646|NCT05540665|467685417|FG002|Overall Study|Study terminated by sponsor|7|||
129923647|NCT02619838|467685418|FG000|Overall Study|Lost to Follow-up|9|||
129923648|NCT02619838|467685418|FG000|Overall Study|Withdrawal by Subject|15|||
129923649|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
129923650|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
129923651|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
129923652|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
129923653|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
129923654|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
129923655|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
129923656|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
129923657|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
129923658|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
129923659|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
129923660|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
129923661|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
129923662|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
129923663|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
129923664|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
129923665|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
129923666|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
129923667|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
129923668|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
129923669|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
129923670|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
129923671|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
129923672|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
129923673|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
129923674|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
129923675|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
129923676|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
129923677|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
129923678|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
129923679|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
129923680|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
129923681|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
129923682|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
129923683|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
129923684|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
129923685|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
129923686|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
129923687|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
129923688|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
129923689|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
129923690|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
129923691|NCT02359890|467685424|FG000|Overall Study|Not meeting eligibility|4|||
129923692|NCT02359890|467685424|FG000|Overall Study|Never treated with study catheter|6|||
129923693|NCT02489903|467685428|FG000|Screening|Screen Failure|24|||
129923694|NCT02489903|467685429|FG001|Screening|Screen Failure|0|||
129923695|NCT02489903|467685430|FG002|Screening|Screen Failure|0|||
129923696|NCT02489903|467685431|FG003|Screening|Screen Failure|8|||
129923697|NCT02489903|467685428|FG000|Randomized and Received Treatment|Protocol Violation|0|||
129923698|NCT02489903|467685429|FG001|Randomized and Received Treatment|Protocol Violation|1|||
129923699|NCT02489903|467685430|FG002|Randomized and Received Treatment|Protocol Violation|0|||
129923700|NCT02489903|467685431|FG003|Randomized and Received Treatment|Protocol Violation|0|||
129923701|NCT02489903|467685428|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
129923702|NCT02489903|467685429|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
129923703|NCT02489903|467685430|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
129923704|NCT02489903|467685431|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
129923705|NCT02489903|467685428|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
129923706|NCT02489903|467685429|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
129923707|NCT02489903|467685430|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
129923708|NCT02489903|467685431|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
129923709|NCT02489903|467685428|FG000|Randomized and Received Treatment|Death|10|||
129923710|NCT02489903|467685429|FG001|Randomized and Received Treatment|Death|1|||
129923711|NCT02489903|467685430|FG002|Randomized and Received Treatment|Death|0|||
129923712|NCT02489903|467685431|FG003|Randomized and Received Treatment|Death|0|||
129923713|NCT05126433|467685432|FG000|Overall Study|Withdrawal by Subject|3|||
129923714|NCT05126433|467685433|FG001|Overall Study|Withdrawal by Subject|0|||
129923715|NCT05126433|467685434|FG002|Overall Study|Withdrawal by Subject|4|||
129923716|NCT05126433|467685432|FG000|Overall Study|Death|9|||
129923717|NCT05126433|467685433|FG001|Overall Study|Death|3|||
129923718|NCT05126433|467685434|FG002|Overall Study|Death|5|||
130117330|NCT01498484|468388855|FG003|Overall Study|Adverse Event|0|||
130117331|NCT01498484|468388856|FG004|Overall Study|Adverse Event|0|||
130117332|NCT01498484|468388857|FG005|Overall Study|Adverse Event|1|||
129923719|NCT05126433|467685432|FG000|Overall Study|Study Terminated by sponsor|0|||
129923720|NCT05126433|467685433|FG001|Overall Study|Study Terminated by sponsor|1|||
129923721|NCT05126433|467685434|FG002|Overall Study|Study Terminated by sponsor|2|||
129923722|NCT05126433|467685432|FG000|Overall Study|Progressive Disease|1|||
129923723|NCT05126433|467685433|FG001|Overall Study|Progressive Disease|4|||
129923724|NCT05126433|467685434|FG002|Overall Study|Progressive Disease|3|||
129923725|NCT05126433|467685432|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
129923726|NCT05126433|467685433|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
129923727|NCT05126433|467685434|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
129923728|NCT04137289|467685435|FG000|Overall Study|Death|0|||
129923729|NCT04137289|467685436|FG001|Overall Study|Death|0|||
129923730|NCT04137289|467685437|FG002|Overall Study|Death|0|||
129923731|NCT04137289|467685438|FG003|Overall Study|Death|0|||
129923732|NCT04137289|467685439|FG004|Overall Study|Death|0|||
129923733|NCT04137289|467685440|FG005|Overall Study|Death|0|||
129923734|NCT04137289|467685441|FG006|Overall Study|Death|1|||
129923735|NCT04137289|467685442|FG007|Overall Study|Death|0|||
129923736|NCT04137289|467685443|FG008|Overall Study|Death|0|||
129923737|NCT04137289|467685435|FG000|Overall Study|Clinical disease progression|0|||
129923738|NCT04137289|467685436|FG001|Overall Study|Clinical disease progression|0|||
129923739|NCT04137289|467685437|FG002|Overall Study|Clinical disease progression|0|||
129923740|NCT04137289|467685438|FG003|Overall Study|Clinical disease progression|4|||
129923741|NCT04137289|467685439|FG004|Overall Study|Clinical disease progression|4|||
129923742|NCT04137289|467685440|FG005|Overall Study|Clinical disease progression|2|||
129923743|NCT04137289|467685441|FG006|Overall Study|Clinical disease progression|5|||
129923744|NCT04137289|467685442|FG007|Overall Study|Clinical disease progression|1|||
129923745|NCT04137289|467685443|FG008|Overall Study|Clinical disease progression|0|||
129923746|NCT04137289|467685435|FG000|Overall Study|Lost to Follow-up|0|||
129923747|NCT04137289|467685436|FG001|Overall Study|Lost to Follow-up|0|||
129923748|NCT04137289|467685437|FG002|Overall Study|Lost to Follow-up|0|||
129923749|NCT04137289|467685438|FG003|Overall Study|Lost to Follow-up|1|||
129923750|NCT04137289|467685439|FG004|Overall Study|Lost to Follow-up|0|||
129923751|NCT04137289|467685440|FG005|Overall Study|Lost to Follow-up|0|||
129923752|NCT04137289|467685441|FG006|Overall Study|Lost to Follow-up|0|||
129923753|NCT04137289|467685442|FG007|Overall Study|Lost to Follow-up|0|||
129923754|NCT04137289|467685443|FG008|Overall Study|Lost to Follow-up|0|||
129923755|NCT04137289|467685435|FG000|Overall Study|Adverse Event|0|||
129923756|NCT04137289|467685436|FG001|Overall Study|Adverse Event|0|||
129923757|NCT04137289|467685437|FG002|Overall Study|Adverse Event|1|||
129923758|NCT04137289|467685438|FG003|Overall Study|Adverse Event|0|||
129923759|NCT04137289|467685439|FG004|Overall Study|Adverse Event|0|||
129923760|NCT04137289|467685440|FG005|Overall Study|Adverse Event|1|||
129923761|NCT04137289|467685441|FG006|Overall Study|Adverse Event|0|||
129923762|NCT04137289|467685442|FG007|Overall Study|Adverse Event|0|||
129923763|NCT04137289|467685443|FG008|Overall Study|Adverse Event|0|||
129923764|NCT04137289|467685435|FG000|Overall Study|Lack of clinical benefit|0|||
129923765|NCT04137289|467685436|FG001|Overall Study|Lack of clinical benefit|0|||
129923766|NCT04137289|467685437|FG002|Overall Study|Lack of clinical benefit|0|||
129923767|NCT04137289|467685438|FG003|Overall Study|Lack of clinical benefit|0|||
129923768|NCT04137289|467685439|FG004|Overall Study|Lack of clinical benefit|0|||
129923769|NCT04137289|467685440|FG005|Overall Study|Lack of clinical benefit|0|||
129923770|NCT04137289|467685441|FG006|Overall Study|Lack of clinical benefit|0|||
129923771|NCT04137289|467685442|FG007|Overall Study|Lack of clinical benefit|0|||
129923772|NCT04137289|467685443|FG008|Overall Study|Lack of clinical benefit|1|||
129923773|NCT04137289|467685435|FG000|Overall Study|Objective disease progression|1|||
129923774|NCT04137289|467685436|FG001|Overall Study|Objective disease progression|1|||
129923775|NCT04137289|467685437|FG002|Overall Study|Objective disease progression|6|||
129923776|NCT04137289|467685438|FG003|Overall Study|Objective disease progression|18|||
129923777|NCT04137289|467685439|FG004|Overall Study|Objective disease progression|12|||
129923778|NCT04137289|467685440|FG005|Overall Study|Objective disease progression|20|||
129923779|NCT04137289|467685441|FG006|Overall Study|Objective disease progression|18|||
129923780|NCT04137289|467685442|FG007|Overall Study|Objective disease progression|7|||
129923781|NCT04137289|467685443|FG008|Overall Study|Objective disease progression|6|||
129923782|NCT03869866|467687193|FG000|Overall Study|Protocol Violation|1|||
129923783|NCT03869866|467687193|FG000|Overall Study|Withdrawal by Subject|3|||
130117333|NCT01498484|468388858|FG006|Overall Study|Adverse Event|0|||
129923784|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
129923785|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
129923786|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
130117334|NCT01498484|468388859|FG007|Overall Study|Adverse Event|0|||
129923787|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
129923788|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
129923789|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
129923790|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Death|0|||
129923791|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Death|0|||
129923792|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Death|0|||
129923793|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Death|0|||
129923794|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Death|0|||
129923795|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Death|2|||
129923796|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923797|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923798|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923799|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923800|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923801|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
129923802|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923803|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923804|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923805|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923806|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
129923807|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923808|NCT01073566|467687200|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
129923809|NCT01073566|467687201|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
129923810|NCT05006872|467687221|FG000|Overall Study|Lost to Follow-up|37|||
129923811|NCT05006872|467687222|FG001|Overall Study|Lost to Follow-up|31|||
129923812|NCT05499377|467687228|FG000|Overall Study|Withdrawal by Subject|2|||
129923813|NCT05499377|467687229|FG001|Overall Study|Withdrawal by Subject|0|||
129923814|NCT05499377|467687228|FG000|Overall Study|Physician Decision|1|||
129923815|NCT05499377|467687229|FG001|Overall Study|Physician Decision|0|||
129923816|NCT02677805|467687231|FG000|Double Blind Phase|Lost to Follow-up|8|||
129923817|NCT02677805|467687232|FG001|Double Blind Phase|Lost to Follow-up|3|||
129923818|NCT02677805|467687233|FG002|Double Blind Phase|Lost to Follow-up|0|||
129923819|NCT02677805|467687231|FG000|Double Blind Phase|Withdrawal by Subject|5|||
129923820|NCT02677805|467687232|FG001|Double Blind Phase|Withdrawal by Subject|2|||
129923821|NCT02677805|467687233|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129923822|NCT02677805|467687231|FG000|Open Label Phase|Lost to Follow-up|0|||
129923823|NCT02677805|467687232|FG001|Open Label Phase|Lost to Follow-up|0|||
129923824|NCT02677805|467687233|FG002|Open Label Phase|Lost to Follow-up|10|||
129923825|NCT02677805|467687231|FG000|Open Label Phase|Withdrawal by Subject|0|||
129923826|NCT02677805|467687232|FG001|Open Label Phase|Withdrawal by Subject|0|||
129923827|NCT02677805|467687233|FG002|Open Label Phase|Withdrawal by Subject|6|||
129923828|NCT04350463|467687238|FG000|Overall Study|Other reason|0|||
129923829|NCT04350463|467687239|FG001|Overall Study|Other reason|0|||
129923830|NCT04350463|467687240|FG002|Overall Study|Other reason|0|||
129923831|NCT04350463|467687241|FG003|Overall Study|Other reason|1|||
129923832|NCT04350463|467687238|FG000|Overall Study|Lost to Follow-up|0|||
129923833|NCT04350463|467687239|FG001|Overall Study|Lost to Follow-up|0|||
129923834|NCT04350463|467687240|FG002|Overall Study|Lost to Follow-up|0|||
129923835|NCT04350463|467687241|FG003|Overall Study|Lost to Follow-up|2|||
129923836|NCT04350463|467687238|FG000|Overall Study|Withdrawal by Subject|4|||
129923837|NCT04350463|467687239|FG001|Overall Study|Withdrawal by Subject|0|||
129923838|NCT04350463|467687240|FG002|Overall Study|Withdrawal by Subject|1|||
129923839|NCT04350463|467687241|FG003|Overall Study|Withdrawal by Subject|4|||
129923840|NCT04350463|467687238|FG000|Overall Study|Adverse Event|0|||
129923841|NCT04350463|467687239|FG001|Overall Study|Adverse Event|0|||
129923842|NCT04350463|467687240|FG002|Overall Study|Adverse Event|0|||
129923843|NCT04350463|467687241|FG003|Overall Study|Adverse Event|2|||
129923844|NCT04350463|467687238|FG000|Overall Study|Death|27|||
129923845|NCT04350463|467687239|FG001|Overall Study|Death|2|||
129923846|NCT04350463|467687240|FG002|Overall Study|Death|13|||
129923847|NCT04350463|467687241|FG003|Overall Study|Death|26|||
129923848|NCT04111536|467687242|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129923849|NCT04111536|467687243|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129923850|NCT04111536|467687242|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
129923851|NCT04111536|467687243|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
129923852|NCT04111536|467687242|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
129923853|NCT04111536|467687243|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129923854|NCT04111536|467687242|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
129923855|NCT04111536|467687243|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
129923856|NCT05714761|467687244|FG000|Overall Study|Lost to Follow-up|3|||
129923857|NCT05714761|467687244|FG000|Overall Study|Withdrawal by Subject|3|||
129923858|NCT05714761|467687244|FG000|Overall Study|unblinding of sensor data|1|||
129923859|NCT05714761|467687244|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
129923860|NCT05714761|467687244|FG000|Overall Study|did not return second CGM sensor|4|||
129923861|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
129923862|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
129923863|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
129923864|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
129923865|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
129923866|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
129923867|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
129923868|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
129923869|NCT02547233|467687246|FG000|12-month Follow-up|Withdrawal by Subject|10|||
129923870|NCT02547233|467687247|FG001|12-month Follow-up|Withdrawal by Subject|10|||
129923871|NCT02547233|467687246|FG000|12-month Follow-up|Lost to Follow-up|3|||
129923872|NCT02547233|467687247|FG001|12-month Follow-up|Lost to Follow-up|3|||
129923873|NCT02547233|467687246|FG000|12-month Follow-up|Lack of Efficacy|1|||
129923874|NCT02547233|467687247|FG001|12-month Follow-up|Lack of Efficacy|2|||
129923875|NCT02547233|467687246|FG000|12-month Follow-up|Protocol Violation|0|||
129923876|NCT02547233|467687247|FG001|12-month Follow-up|Protocol Violation|1|||
129923877|NCT02547233|467687246|FG000|12-month Follow-up|Other|0|||
129923878|NCT02547233|467687247|FG001|12-month Follow-up|Other|1|||
129923879|NCT05362487|467687248|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
129923880|NCT04096040|467687249|FG000|Overall Study|Protocol Violation|12|||
129923881|NCT04096040|467687249|FG000|Overall Study|Non-compliant site|4|||
129923882|NCT04973254|467687250|FG000|Overall Study|Not adherent|0|||
129923883|NCT04973254|467687251|FG001|Overall Study|Not adherent|1|||
129923884|NCT04973254|467687252|FG002|Overall Study|Not adherent|0|||
129923885|NCT05170009|467687253|FG000|Overall Study|Physician Decision|0|||
129923886|NCT05170009|467687254|FG001|Overall Study|Physician Decision|1|||
129923887|NCT05415722|467687255|FG000|Overall Study|Lost to Follow-up|0|||
129923888|NCT05415722|467687256|FG001|Overall Study|Lost to Follow-up|2|||
129923889|NCT05415722|467687257|FG002|Overall Study|Lost to Follow-up|0|||
129923890|NCT05415722|467687258|FG003|Overall Study|Lost to Follow-up|1|||
129923891|NCT05415722|467687259|FG004|Overall Study|Lost to Follow-up|0|||
129923892|NCT05415722|467687260|FG005|Overall Study|Lost to Follow-up|0|||
129923893|NCT05415722|467687261|FG006|Overall Study|Lost to Follow-up|1|||
129923894|NCT05415722|467687255|FG000|Overall Study|Physician Decision|0|||
129923895|NCT05415722|467687256|FG001|Overall Study|Physician Decision|0|||
129923896|NCT05415722|467687257|FG002|Overall Study|Physician Decision|0|||
129923897|NCT05415722|467687258|FG003|Overall Study|Physician Decision|1|||
129923898|NCT05415722|467687259|FG004|Overall Study|Physician Decision|0|||
129923899|NCT05415722|467687260|FG005|Overall Study|Physician Decision|0|||
129923900|NCT05415722|467687261|FG006|Overall Study|Physician Decision|1|||
129923901|NCT05415722|467687255|FG000|Overall Study|Protocol Violation|0|||
129923902|NCT05415722|467687256|FG001|Overall Study|Protocol Violation|0|||
129923903|NCT05415722|467687257|FG002|Overall Study|Protocol Violation|0|||
129923904|NCT05415722|467687258|FG003|Overall Study|Protocol Violation|1|||
129923905|NCT05415722|467687259|FG004|Overall Study|Protocol Violation|0|||
129923906|NCT05415722|467687260|FG005|Overall Study|Protocol Violation|0|||
129923907|NCT05415722|467687261|FG006|Overall Study|Protocol Violation|0|||
129923908|NCT05415722|467687255|FG000|Overall Study|Sponsor Discretion|0|||
129923909|NCT05415722|467687256|FG001|Overall Study|Sponsor Discretion|0|||
129923910|NCT05415722|467687257|FG002|Overall Study|Sponsor Discretion|0|||
129923911|NCT05415722|467687258|FG003|Overall Study|Sponsor Discretion|0|||
129923912|NCT05415722|467687259|FG004|Overall Study|Sponsor Discretion|1|||
129923913|NCT05415722|467687260|FG005|Overall Study|Sponsor Discretion|1|||
129923914|NCT05415722|467687261|FG006|Overall Study|Sponsor Discretion|0|||
129923915|NCT05415722|467687255|FG000|Overall Study|Withdrawal by Subject|0|||
129923916|NCT05415722|467687256|FG001|Overall Study|Withdrawal by Subject|1|||
129923917|NCT05415722|467687257|FG002|Overall Study|Withdrawal by Subject|0|||
129923918|NCT05415722|467687258|FG003|Overall Study|Withdrawal by Subject|1|||
129923919|NCT05415722|467687259|FG004|Overall Study|Withdrawal by Subject|1|||
129923920|NCT05415722|467687260|FG005|Overall Study|Withdrawal by Subject|0|||
129923921|NCT05415722|467687261|FG006|Overall Study|Withdrawal by Subject|1|||
129923922|NCT04629716|467687264|FG000|Overall Study|Lost to Follow-up|7|||
129923923|NCT04629716|467687265|FG001|Overall Study|Lost to Follow-up|3|||
129923924|NCT04537715|467687267|FG000|Overall Study|Death|3|||
129923925|NCT04537715|467687268|FG001|Overall Study|Death|1|||
129923926|NCT04537715|467687267|FG000|Overall Study|Withdrawal by Subject|3|||
129923927|NCT04537715|467687268|FG001|Overall Study|Withdrawal by Subject|1|||
129923928|NCT04537715|467687267|FG000|Overall Study|Other|4|||
129923929|NCT04537715|467687268|FG001|Overall Study|Other|3|||
129923930|NCT04537715|467687267|FG000|Overall Study|Progressive disease|1|||
129923931|NCT04537715|467687268|FG001|Overall Study|Progressive disease|0|||
129923932|NCT04623671|467687270|FG000|Overall Study|Adverse Event|0|||
129923933|NCT04623671|467687271|FG001|Overall Study|Adverse Event|1|||
129923934|NCT04623671|467687270|FG000|Overall Study|Lost to Follow-up|2|||
129923935|NCT04623671|467687271|FG001|Overall Study|Lost to Follow-up|1|||
129923936|NCT04623671|467687270|FG000|Overall Study|Death|5|||
129923937|NCT04623671|467687271|FG001|Overall Study|Death|5|||
129923938|NCT04542317|467687272|FG000|Overall Study|Care recipients passed away|18|||
129923939|NCT04542317|467687273|FG001|Overall Study|Care recipients passed away|13|||
129923940|NCT04542317|467687272|FG000|Overall Study|No longer a primary caregiver|5|||
129923941|NCT04542317|467687273|FG001|Overall Study|No longer a primary caregiver|1|||
129923942|NCT04542317|467687272|FG000|Overall Study|Withdrawal by Subject|4|||
129923943|NCT04542317|467687273|FG001|Overall Study|Withdrawal by Subject|2|||
129923944|NCT04542317|467687272|FG000|Overall Study|Caregivers passed away|0|||
129923945|NCT04542317|467687273|FG001|Overall Study|Caregivers passed away|2|||
129923946|NCT03848065|467687276|FG000|Overall Study|Death|0|||
129923947|NCT03848065|467687277|FG001|Overall Study|Death|1|||
129923948|NCT03848065|467687278|FG002|Overall Study|Death|0|||
129923949|NCT03848065|467687276|FG000|Overall Study|Lost to Follow-up|0|||
129923950|NCT03848065|467687277|FG001|Overall Study|Lost to Follow-up|0|||
129923951|NCT03848065|467687278|FG002|Overall Study|Lost to Follow-up|1|||
129923952|NCT03848065|467687276|FG000|Overall Study|Physician Decision|0|||
129923953|NCT03848065|467687277|FG001|Overall Study|Physician Decision|0|||
129923954|NCT03848065|467687278|FG002|Overall Study|Physician Decision|1|||
129923955|NCT03496168|467687279|FG000|Overall Study|Other Reasons|1|||
129923956|NCT03496168|467687279|FG000|Overall Study|Adverse Event|1|||
129923957|NCT03270501|467687286|FG000|Overall Study|Screen failure|6|||
129923958|NCT03270501|467687286|FG000|Overall Study|Lost to Follow-up|2|||
129923959|NCT03270501|467687286|FG000|Overall Study|Adverse Event|1|||
129923960|NCT04599062|467687289|FG000|Overall Study|Physician Decision|1|||
129923961|NCT04599062|467687290|FG001|Overall Study|Physician Decision|0|||
129923962|NCT04074759|467687292|FG000|Overall Study|Withdrawal by Subject|0|||
129923963|NCT04074759|467687293|FG001|Overall Study|Withdrawal by Subject|0|||
129923964|NCT04074759|467687294|FG002|Overall Study|Withdrawal by Subject|0|||
129923965|NCT04074759|467687295|FG003|Overall Study|Withdrawal by Subject|0|||
129923966|NCT04074759|467687296|FG004|Overall Study|Withdrawal by Subject|0|||
129923967|NCT04074759|467687297|FG005|Overall Study|Withdrawal by Subject|2|||
129923968|NCT04074759|467687298|FG006|Overall Study|Withdrawal by Subject|0|||
129923969|NCT04074759|467687299|FG007|Overall Study|Withdrawal by Subject|2|||
129923970|NCT04074759|467687300|FG008|Overall Study|Withdrawal by Subject|1|||
129923971|NCT04074759|467687301|FG009|Overall Study|Withdrawal by Subject|2|||
129923972|NCT04074759|467687302|FG010|Overall Study|Withdrawal by Subject|9|||
129923973|NCT04074759|467687303|FG011|Overall Study|Withdrawal by Subject|2|||
129923974|NCT04074759|467687304|FG012|Overall Study|Withdrawal by Subject|1|||
129923975|NCT04074759|467687305|FG013|Overall Study|Withdrawal by Subject|3|||
129923976|NCT04074759|467687306|FG014|Overall Study|Withdrawal by Subject|2|||
129923977|NCT04074759|467687307|FG015|Overall Study|Withdrawal by Subject|0|||
129923978|NCT04074759|467687308|FG016|Overall Study|Withdrawal by Subject|0|||
129923979|NCT04074759|467687309|FG017|Overall Study|Withdrawal by Subject|3|||
129923980|NCT04074759|467687310|FG018|Overall Study|Withdrawal by Subject|1|||
129923981|NCT04074759|467687292|FG000|Overall Study|Death|1|||
129923982|NCT04074759|467687293|FG001|Overall Study|Death|0|||
129923983|NCT04074759|467687294|FG002|Overall Study|Death|1|||
129923984|NCT04074759|467687295|FG003|Overall Study|Death|1|||
129923985|NCT04074759|467687296|FG004|Overall Study|Death|2|||
129923986|NCT04074759|467687297|FG005|Overall Study|Death|0|||
129923987|NCT04074759|467687298|FG006|Overall Study|Death|1|||
129923988|NCT04074759|467687299|FG007|Overall Study|Death|0|||
129923989|NCT04074759|467687300|FG008|Overall Study|Death|3|||
129923990|NCT04074759|467687301|FG009|Overall Study|Death|2|||
129923991|NCT04074759|467687302|FG010|Overall Study|Death|4|||
129923992|NCT04074759|467687303|FG011|Overall Study|Death|1|||
129923993|NCT04074759|467687304|FG012|Overall Study|Death|0|||
129923994|NCT04074759|467687305|FG013|Overall Study|Death|2|||
129923995|NCT04074759|467687306|FG014|Overall Study|Death|1|||
129923996|NCT04074759|467687307|FG015|Overall Study|Death|0|||
129923997|NCT04074759|467687308|FG016|Overall Study|Death|1|||
129923998|NCT04074759|467687309|FG017|Overall Study|Death|0|||
129923999|NCT04074759|467687310|FG018|Overall Study|Death|1|||
129924000|NCT04074759|467687292|FG000|Overall Study|Lost to Follow-up|0|||
129924001|NCT04074759|467687293|FG001|Overall Study|Lost to Follow-up|0|||
129924002|NCT04074759|467687294|FG002|Overall Study|Lost to Follow-up|0|||
129924003|NCT04074759|467687295|FG003|Overall Study|Lost to Follow-up|0|||
129924004|NCT04074759|467687296|FG004|Overall Study|Lost to Follow-up|0|||
129924005|NCT04074759|467687297|FG005|Overall Study|Lost to Follow-up|0|||
129924006|NCT04074759|467687298|FG006|Overall Study|Lost to Follow-up|0|||
129924007|NCT04074759|467687299|FG007|Overall Study|Lost to Follow-up|0|||
129924008|NCT04074759|467687300|FG008|Overall Study|Lost to Follow-up|0|||
129924009|NCT04074759|467687301|FG009|Overall Study|Lost to Follow-up|0|||
129924010|NCT04074759|467687302|FG010|Overall Study|Lost to Follow-up|1|||
129924011|NCT04074759|467687303|FG011|Overall Study|Lost to Follow-up|0|||
129924012|NCT04074759|467687304|FG012|Overall Study|Lost to Follow-up|0|||
129924013|NCT04074759|467687305|FG013|Overall Study|Lost to Follow-up|0|||
129924014|NCT04074759|467687306|FG014|Overall Study|Lost to Follow-up|0|||
129924015|NCT04074759|467687307|FG015|Overall Study|Lost to Follow-up|0|||
129924016|NCT04074759|467687308|FG016|Overall Study|Lost to Follow-up|1|||
129924017|NCT04074759|467687309|FG017|Overall Study|Lost to Follow-up|0|||
129924018|NCT04074759|467687310|FG018|Overall Study|Lost to Follow-up|1|||
129924019|NCT04074759|467687292|FG000|Overall Study|Other|0|||
129924020|NCT04074759|467687293|FG001|Overall Study|Other|1|||
129924021|NCT04074759|467687294|FG002|Overall Study|Other|1|||
129924022|NCT04074759|467687295|FG003|Overall Study|Other|0|||
129924023|NCT04074759|467687296|FG004|Overall Study|Other|2|||
129924024|NCT04074759|467687297|FG005|Overall Study|Other|1|||
129924025|NCT04074759|467687298|FG006|Overall Study|Other|2|||
129924026|NCT04074759|467687299|FG007|Overall Study|Other|1|||
129924027|NCT04074759|467687300|FG008|Overall Study|Other|1|||
129924028|NCT04074759|467687301|FG009|Overall Study|Other|4|||
129924029|NCT04074759|467687302|FG010|Overall Study|Other|4|||
129924030|NCT04074759|467687303|FG011|Overall Study|Other|2|||
129924031|NCT04074759|467687304|FG012|Overall Study|Other|0|||
129924032|NCT04074759|467687305|FG013|Overall Study|Other|0|||
129924033|NCT04074759|467687306|FG014|Overall Study|Other|0|||
129924034|NCT04074759|467687307|FG015|Overall Study|Other|1|||
129924035|NCT04074759|467687308|FG016|Overall Study|Other|0|||
129924036|NCT04074759|467687309|FG017|Overall Study|Other|0|||
129924037|NCT04074759|467687310|FG018|Overall Study|Other|0|||
130068832|NCT05425719|468205604|FG000|Overall Study|Withdrew consent|1|||
130068833|NCT05425719|468205605|FG001|Overall Study|Withdrew consent|1|||
130068834|NCT04682353|468205606|FG000|Overall Study|Lost to Follow-up|0|||
130068835|NCT04682353|468205607|FG001|Overall Study|Lost to Follow-up|1|||
130068836|NCT04682353|468205608|FG002|Overall Study|Lost to Follow-up|0|||
130068837|NCT04682353|468205609|FG003|Overall Study|Lost to Follow-up|1|||
130068838|NCT04682353|468205606|FG000|Overall Study|Personal reasons|0|||
130068839|NCT04682353|468205607|FG001|Overall Study|Personal reasons|1|||
130068840|NCT04682353|468205608|FG002|Overall Study|Personal reasons|0|||
130068841|NCT04682353|468205609|FG003|Overall Study|Personal reasons|0|||
130068842|NCT01586806|468205610|FG000|Overall Study|Protocol Violation|0|||
130068843|NCT01586806|468205611|FG001|Overall Study|Protocol Violation|1|||
130068844|NCT01586806|468205612|FG002|Overall Study|Protocol Violation|0|||
130068845|NCT01586806|468205610|FG000|Overall Study|Withdrawal by Subject|1|||
130068846|NCT01586806|468205611|FG001|Overall Study|Withdrawal by Subject|0|||
130068847|NCT01586806|468205612|FG002|Overall Study|Withdrawal by Subject|0|||
130068848|NCT01586806|468205610|FG000|Overall Study|Lost to Follow-up|2|||
130068849|NCT01586806|468205611|FG001|Overall Study|Lost to Follow-up|3|||
130068850|NCT01586806|468205612|FG002|Overall Study|Lost to Follow-up|2|||
130068851|NCT00862654|468205613|FG000|Overall Study|Lack of Efficacy|1|||
130068852|NCT00862654|468205614|FG001|Overall Study|Lack of Efficacy|0|||
130068853|NCT00862654|468205615|FG002|Overall Study|Lack of Efficacy|1|||
130068854|NCT00862654|468205616|FG003|Overall Study|Lack of Efficacy|0|||
130068855|NCT00862654|468205613|FG000|Overall Study|Lost to Follow-up|1|||
130068856|NCT00862654|468205614|FG001|Overall Study|Lost to Follow-up|2|||
130068857|NCT00862654|468205615|FG002|Overall Study|Lost to Follow-up|1|||
130068858|NCT00862654|468205616|FG003|Overall Study|Lost to Follow-up|3|||
130068859|NCT00862654|468205613|FG000|Overall Study|Adverse Event|0|||
130068860|NCT00862654|468205614|FG001|Overall Study|Adverse Event|1|||
130068861|NCT00862654|468205615|FG002|Overall Study|Adverse Event|1|||
130068862|NCT00862654|468205616|FG003|Overall Study|Adverse Event|0|||
130068863|NCT00862654|468205613|FG000|Overall Study|Pregnancy|1|||
130068864|NCT00862654|468205614|FG001|Overall Study|Pregnancy|1|||
130068865|NCT00862654|468205615|FG002|Overall Study|Pregnancy|0|||
130068866|NCT00862654|468205616|FG003|Overall Study|Pregnancy|0|||
130068867|NCT00862654|468205613|FG000|Overall Study|Withdrawal by Subject|2|||
130068868|NCT00862654|468205614|FG001|Overall Study|Withdrawal by Subject|2|||
130068869|NCT00862654|468205615|FG002|Overall Study|Withdrawal by Subject|2|||
130068870|NCT00862654|468205616|FG003|Overall Study|Withdrawal by Subject|3|||
130068871|NCT00862654|468205613|FG000|Overall Study|Subject mistake|0|||
130068872|NCT00862654|468205614|FG001|Overall Study|Subject mistake|1|||
130068873|NCT00862654|468205615|FG002|Overall Study|Subject mistake|0|||
130068874|NCT00862654|468205616|FG003|Overall Study|Subject mistake|0|||
130068875|NCT00862654|468205613|FG000|Overall Study|Familly constraint|0|||
130068876|NCT00862654|468205614|FG001|Overall Study|Familly constraint|1|||
129924038|NCT04074759|467687292|FG000|Overall Study|Missing end of study status|0|||
129924039|NCT04074759|467687293|FG001|Overall Study|Missing end of study status|0|||
129924040|NCT04074759|467687294|FG002|Overall Study|Missing end of study status|0|||
129924041|NCT04074759|467687295|FG003|Overall Study|Missing end of study status|0|||
129924042|NCT04074759|467687296|FG004|Overall Study|Missing end of study status|0|||
129924043|NCT04074759|467687297|FG005|Overall Study|Missing end of study status|0|||
129924044|NCT04074759|467687298|FG006|Overall Study|Missing end of study status|0|||
129924045|NCT04074759|467687299|FG007|Overall Study|Missing end of study status|0|||
129924046|NCT04074759|467687300|FG008|Overall Study|Missing end of study status|0|||
129924047|NCT04074759|467687301|FG009|Overall Study|Missing end of study status|0|||
129924048|NCT04074759|467687302|FG010|Overall Study|Missing end of study status|2|||
129924049|NCT04074759|467687303|FG011|Overall Study|Missing end of study status|0|||
129924050|NCT04074759|467687304|FG012|Overall Study|Missing end of study status|0|||
129924051|NCT04074759|467687305|FG013|Overall Study|Missing end of study status|0|||
130068877|NCT00862654|468205615|FG002|Overall Study|Familly constraint|0|||
130068878|NCT00862654|468205616|FG003|Overall Study|Familly constraint|0|||
130068879|NCT00862654|468205613|FG000|Overall Study|Never used study drugs|1|||
130068880|NCT00862654|468205614|FG001|Overall Study|Never used study drugs|0|||
130068881|NCT00862654|468205615|FG002|Overall Study|Never used study drugs|0|||
130068882|NCT00862654|468205616|FG003|Overall Study|Never used study drugs|0|||
130068883|NCT00862654|468205613|FG000|Overall Study|Included after end of inclusions|0|||
130068884|NCT00862654|468205614|FG001|Overall Study|Included after end of inclusions|0|||
130068885|NCT00862654|468205615|FG002|Overall Study|Included after end of inclusions|1|||
130068886|NCT00862654|468205616|FG003|Overall Study|Included after end of inclusions|0|||
130068887|NCT04377672|468205617|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
130068888|NCT03954444|468205618|FG000|Overall Study|Withdrawal by Subject|5|||
130068889|NCT03954444|468205619|FG001|Overall Study|Withdrawal by Subject|5|||
130068890|NCT03954444|468205620|FG002|Overall Study|Withdrawal by Subject|5|||
130068891|NCT03954444|468205618|FG000|Overall Study|Adverse Event|1|||
130068892|NCT03954444|468205619|FG001|Overall Study|Adverse Event|3|||
130068893|NCT03954444|468205620|FG002|Overall Study|Adverse Event|2|||
130068894|NCT03954444|468205618|FG000|Overall Study|Protocol Violation|0|||
130068895|NCT03954444|468205619|FG001|Overall Study|Protocol Violation|3|||
130068896|NCT03954444|468205620|FG002|Overall Study|Protocol Violation|5|||
130068897|NCT03954444|468205618|FG000|Overall Study|Use of prohibited therapy|1|||
130068898|NCT03954444|468205619|FG001|Overall Study|Use of prohibited therapy|1|||
130068899|NCT03954444|468205620|FG002|Overall Study|Use of prohibited therapy|2|||
130068900|NCT03954444|468205618|FG000|Overall Study|Lost to Follow-up|1|||
130068901|NCT03954444|468205619|FG001|Overall Study|Lost to Follow-up|0|||
130068902|NCT03954444|468205620|FG002|Overall Study|Lost to Follow-up|1|||
130068903|NCT03954444|468205618|FG000|Overall Study|Non-compliant with study drug application|2|||
130068904|NCT03954444|468205619|FG001|Overall Study|Non-compliant with study drug application|2|||
130068905|NCT03954444|468205620|FG002|Overall Study|Non-compliant with study drug application|0|||
130068906|NCT03954444|468205618|FG000|Overall Study|Administrative reasons|0|||
130068907|NCT03954444|468205619|FG001|Overall Study|Administrative reasons|0|||
130068908|NCT03954444|468205620|FG002|Overall Study|Administrative reasons|1|||
130068909|NCT03954444|468205618|FG000|Overall Study|Miscellaneous|3|||
130068910|NCT03954444|468205619|FG001|Overall Study|Miscellaneous|2|||
130068911|NCT03954444|468205620|FG002|Overall Study|Miscellaneous|1|||
130068912|NCT02447458|468205621|FG000|Overall Study|Other|0|||
130068913|NCT02447458|468205622|FG001|Overall Study|Other|0|||
130068914|NCT02447458|468205623|FG002|Overall Study|Other|1|||
130068915|NCT02447458|468205624|FG003|Overall Study|Other|0|||
130068916|NCT02447458|468205625|FG004|Overall Study|Other|0|||
130068917|NCT02447458|468205626|FG005|Overall Study|Other|0|||
129924052|NCT04074759|467687306|FG014|Overall Study|Missing end of study status|0|||
129924053|NCT04074759|467687307|FG015|Overall Study|Missing end of study status|0|||
129924054|NCT04074759|467687308|FG016|Overall Study|Missing end of study status|1|||
129924055|NCT04074759|467687309|FG017|Overall Study|Missing end of study status|0|||
129924056|NCT04074759|467687310|FG018|Overall Study|Missing end of study status|0|||
129924057|NCT05329220|467687313|FG000|Active Trial Period|Adverse Event|0|||
129924058|NCT05329220|467687314|FG001|Active Trial Period|Adverse Event|0|||
129924059|NCT05329220|467687315|FG002|Active Trial Period|Adverse Event|0|||
129924060|NCT05329220|467687316|FG003|Active Trial Period|Adverse Event|0|||
129924061|NCT05329220|467687317|FG004|Active Trial Period|Adverse Event|1|||
129924062|NCT05329220|467687318|FG005|Active Trial Period|Adverse Event|0|||
129924063|NCT05329220|467687313|FG000|Active Trial Period|Lost to Follow-up|0|||
129924064|NCT05329220|467687314|FG001|Active Trial Period|Lost to Follow-up|0|||
129924065|NCT05329220|467687315|FG002|Active Trial Period|Lost to Follow-up|0|||
129924066|NCT05329220|467687316|FG003|Active Trial Period|Lost to Follow-up|0|||
129924067|NCT05329220|467687317|FG004|Active Trial Period|Lost to Follow-up|32|||
129924068|NCT05329220|467687318|FG005|Active Trial Period|Lost to Follow-up|28|||
129924069|NCT05329220|467687313|FG000|Active Trial Period|Physician Decision|0|||
129924070|NCT05329220|467687314|FG001|Active Trial Period|Physician Decision|0|||
129924071|NCT05329220|467687315|FG002|Active Trial Period|Physician Decision|0|||
129924072|NCT05329220|467687316|FG003|Active Trial Period|Physician Decision|0|||
129924073|NCT05329220|467687317|FG004|Active Trial Period|Physician Decision|2|||
129924074|NCT05329220|467687318|FG005|Active Trial Period|Physician Decision|0|||
129924075|NCT05329220|467687313|FG000|Active Trial Period|Protocol Violation|0|||
129924076|NCT05329220|467687314|FG001|Active Trial Period|Protocol Violation|0|||
129924077|NCT05329220|467687315|FG002|Active Trial Period|Protocol Violation|0|||
129924078|NCT05329220|467687316|FG003|Active Trial Period|Protocol Violation|0|||
129924079|NCT05329220|467687317|FG004|Active Trial Period|Protocol Violation|1|||
129924080|NCT05329220|467687318|FG005|Active Trial Period|Protocol Violation|3|||
129924081|NCT05329220|467687313|FG000|Active Trial Period|Withdrawal by Subject|0|||
129924082|NCT05329220|467687314|FG001|Active Trial Period|Withdrawal by Subject|0|||
129924083|NCT05329220|467687315|FG002|Active Trial Period|Withdrawal by Subject|0|||
129924084|NCT05329220|467687316|FG003|Active Trial Period|Withdrawal by Subject|1|||
129924085|NCT05329220|467687317|FG004|Active Trial Period|Withdrawal by Subject|12|||
129924086|NCT05329220|467687318|FG005|Active Trial Period|Withdrawal by Subject|13|||
129924087|NCT05329220|467687313|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924088|NCT05329220|467687314|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924089|NCT05329220|467687315|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924090|NCT05329220|467687316|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
130068918|NCT02133742|468205627|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
130068919|NCT02133742|468205627|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
130068920|NCT02133742|468205627|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
129924091|NCT05329220|467687317|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924092|NCT05329220|467687318|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
129924093|NCT05329220|467687313|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924094|NCT05329220|467687314|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924095|NCT05329220|467687315|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924096|NCT05329220|467687316|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924097|NCT05329220|467687317|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924098|NCT05329220|467687318|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
129924099|NCT05329220|467687313|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
129924100|NCT05329220|467687314|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
129924101|NCT05329220|467687315|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
129924102|NCT05329220|467687316|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
129924103|NCT05329220|467687317|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
129924104|NCT05329220|467687318|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
129924105|NCT05329220|467687313|FG000|Follow-up Period|Adverse Event|0|||
129924106|NCT05329220|467687314|FG001|Follow-up Period|Adverse Event|0|||
129924107|NCT05329220|467687315|FG002|Follow-up Period|Adverse Event|0|||
129924108|NCT05329220|467687316|FG003|Follow-up Period|Adverse Event|0|||
129924109|NCT05329220|467687317|FG004|Follow-up Period|Adverse Event|2|||
129924110|NCT05329220|467687318|FG005|Follow-up Period|Adverse Event|1|||
129924111|NCT05329220|467687313|FG000|Follow-up Period|Death|0|||
129924112|NCT05329220|467687314|FG001|Follow-up Period|Death|0|||
129924113|NCT05329220|467687315|FG002|Follow-up Period|Death|1|||
129924114|NCT05329220|467687316|FG003|Follow-up Period|Death|1|||
129924115|NCT05329220|467687317|FG004|Follow-up Period|Death|0|||
129924116|NCT05329220|467687318|FG005|Follow-up Period|Death|1|||
129924117|NCT05329220|467687313|FG000|Follow-up Period|Lost to Follow-up|0|||
129924118|NCT05329220|467687314|FG001|Follow-up Period|Lost to Follow-up|1|||
129924119|NCT05329220|467687315|FG002|Follow-up Period|Lost to Follow-up|2|||
129924120|NCT05329220|467687316|FG003|Follow-up Period|Lost to Follow-up|2|||
129924121|NCT05329220|467687317|FG004|Follow-up Period|Lost to Follow-up|113|||
129924122|NCT05329220|467687318|FG005|Follow-up Period|Lost to Follow-up|89|||
129924123|NCT05329220|467687313|FG000|Follow-up Period|Physician Decision|0|||
129924124|NCT05329220|467687314|FG001|Follow-up Period|Physician Decision|0|||
129924125|NCT05329220|467687315|FG002|Follow-up Period|Physician Decision|0|||
129924126|NCT05329220|467687316|FG003|Follow-up Period|Physician Decision|0|||
129924127|NCT05329220|467687317|FG004|Follow-up Period|Physician Decision|2|||
129924128|NCT05329220|467687318|FG005|Follow-up Period|Physician Decision|2|||
129924129|NCT05329220|467687313|FG000|Follow-up Period|Protocol Violation|0|||
129924130|NCT05329220|467687314|FG001|Follow-up Period|Protocol Violation|0|||
129924131|NCT05329220|467687315|FG002|Follow-up Period|Protocol Violation|0|||
129924132|NCT05329220|467687316|FG003|Follow-up Period|Protocol Violation|0|||
129924133|NCT05329220|467687317|FG004|Follow-up Period|Protocol Violation|0|||
129924134|NCT05329220|467687318|FG005|Follow-up Period|Protocol Violation|1|||
129924135|NCT05329220|467687313|FG000|Follow-up Period|Withdrawal by Subject|0|||
129924136|NCT05329220|467687314|FG001|Follow-up Period|Withdrawal by Subject|0|||
129924137|NCT05329220|467687315|FG002|Follow-up Period|Withdrawal by Subject|1|||
129924138|NCT05329220|467687316|FG003|Follow-up Period|Withdrawal by Subject|1|||
129924139|NCT05329220|467687317|FG004|Follow-up Period|Withdrawal by Subject|34|||
129924140|NCT05329220|467687318|FG005|Follow-up Period|Withdrawal by Subject|35|||
129924141|NCT05329220|467687313|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924142|NCT05329220|467687314|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924143|NCT05329220|467687315|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
129924144|NCT05329220|467687316|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924145|NCT05329220|467687317|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924146|NCT05329220|467687318|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924147|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924148|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924149|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924150|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924151|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
130117335|NCT01498484|468388860|FG008|Overall Study|Adverse Event|0|||
129924152|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924153|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924154|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
130117336|NCT01498484|468388852|FG000|Overall Study|Withdrawal by Subject|0|||
130117337|NCT01498484|468388853|FG001|Overall Study|Withdrawal by Subject|0|||
129924155|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924156|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924157|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
129924158|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924159|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924160|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924161|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924162|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924163|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924164|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
129924165|NCT05329220|467687313|FG000|Follow-up Period|EARLY TERMINATION|0|||
129924166|NCT05329220|467687314|FG001|Follow-up Period|EARLY TERMINATION|0|||
129924167|NCT05329220|467687315|FG002|Follow-up Period|EARLY TERMINATION|0|||
129924168|NCT05329220|467687316|FG003|Follow-up Period|EARLY TERMINATION|0|||
129924169|NCT05329220|467687317|FG004|Follow-up Period|EARLY TERMINATION|0|||
129924170|NCT05329220|467687318|FG005|Follow-up Period|EARLY TERMINATION|1|||
129924171|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924172|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924173|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924174|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924175|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924176|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
129924177|NCT05329220|467687313|FG000|Follow-up Period|DROPPED|0|||
129924178|NCT05329220|467687314|FG001|Follow-up Period|DROPPED|0|||
129924179|NCT05329220|467687315|FG002|Follow-up Period|DROPPED|0|||
129924180|NCT05329220|467687316|FG003|Follow-up Period|DROPPED|0|||
129924181|NCT05329220|467687317|FG004|Follow-up Period|DROPPED|0|||
129924182|NCT05329220|467687318|FG005|Follow-up Period|DROPPED|1|||
129924183|NCT05329220|467687313|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924184|NCT05329220|467687314|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924185|NCT05329220|467687315|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924186|NCT05329220|467687316|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924187|NCT05329220|467687317|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924188|NCT05329220|467687318|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
129924189|NCT03931174|467687321|FG000|Providers|Staff left organization|26|||
129924190|NCT03931174|467687322|FG001|Providers|Staff left organization|25|||
129924191|NCT03931174|467687321|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
129924192|NCT03931174|467687322|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
129924193|NCT03931174|467687321|FG000|Providers|Lost to Follow-up|4|||
129924194|NCT03931174|467687322|FG001|Providers|Lost to Follow-up|4|||
129924195|NCT03931174|467687321|FG000|Patients|Post-consent screening failure|1|||
129924196|NCT03931174|467687322|FG001|Patients|Post-consent screening failure|1|||
129924197|NCT03931174|467687321|FG000|Patients|Death|1|||
129924198|NCT03931174|467687322|FG001|Patients|Death|1|||
129924199|NCT03931174|467687321|FG000|Patients|Lost to Follow-up|60|||
129924200|NCT03931174|467687322|FG001|Patients|Lost to Follow-up|89|||
129924201|NCT03322267|467687323|FG000|Overall Study|Lack of Efficacy|11|||
129924202|NCT03322267|467687323|FG000|Overall Study|Adverse Event|1|||
129924203|NCT03322267|467687323|FG000|Overall Study|Withdrawal by Subject|2|||
129924204|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
129924205|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
129924206|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
129924207|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
129924208|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
129924209|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
129924210|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
129924211|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
129924212|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
129924213|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
129924214|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
129924215|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
129924216|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
129924217|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
129924218|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
129924219|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
129924220|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
129924221|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
130068921|NCT02133742|468205627|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
130068922|NCT02133742|468205627|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
129924222|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
129924223|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
129924224|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924225|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
129924226|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924227|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924228|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924229|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
129924230|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
129924231|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
129924232|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
129924233|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
129924234|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
129924235|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
129924236|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
129924237|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
129924238|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
129924239|NCT03852472|467687333|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
129924240|NCT03852472|467687334|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
129924241|NCT03852472|467687335|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
129924242|NCT03852472|467687336|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
129924243|NCT03852472|467687337|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
129924244|NCT03852472|467687333|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
129924245|NCT03852472|467687334|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
129924246|NCT03852472|467687335|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
129924247|NCT03852472|467687336|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
129924248|NCT03852472|467687337|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
129924249|NCT03852472|467687333|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
129924250|NCT03852472|467687334|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
129924251|NCT03852472|467687335|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
129924252|NCT03852472|467687336|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
129924253|NCT03852472|467687337|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
129924254|NCT03852472|467687333|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
129924255|NCT03852472|467687334|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
129924256|NCT03852472|467687335|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
129924257|NCT03852472|467687336|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
129924258|NCT03852472|467687337|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
129924259|NCT03852472|467687333|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
129924260|NCT03852472|467687334|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
129924261|NCT03852472|467687335|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
129924262|NCT03852472|467687336|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
129924263|NCT03852472|467687337|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
129924264|NCT03852472|467687333|FG000|Period 2 - Week 44|Adverse Event|0|||
129924265|NCT03852472|467687334|FG001|Period 2 - Week 44|Adverse Event|3|||
129924266|NCT03852472|467687335|FG002|Period 2 - Week 44|Adverse Event|1|||
129924267|NCT03852472|467687336|FG003|Period 2 - Week 44|Adverse Event|2|||
129924268|NCT03852472|467687337|FG004|Period 2 - Week 44|Adverse Event|2|||
129924269|NCT03852472|467687333|FG000|Period 2 - Week 44|COVID-19 Related|0|||
129924270|NCT03852472|467687334|FG001|Period 2 - Week 44|COVID-19 Related|0|||
129924271|NCT03852472|467687335|FG002|Period 2 - Week 44|COVID-19 Related|0|||
129924272|NCT03852472|467687336|FG003|Period 2 - Week 44|COVID-19 Related|1|||
129924273|NCT03852472|467687337|FG004|Period 2 - Week 44|COVID-19 Related|0|||
129924274|NCT03852472|467687333|FG000|Period 2 - Week 44|Reason not stated|0|||
129924275|NCT03852472|467687334|FG001|Period 2 - Week 44|Reason not stated|0|||
129924276|NCT03852472|467687335|FG002|Period 2 - Week 44|Reason not stated|0|||
129924277|NCT03852472|467687336|FG003|Period 2 - Week 44|Reason not stated|0|||
129924278|NCT03852472|467687337|FG004|Period 2 - Week 44|Reason not stated|1|||
129924279|NCT06457802|467687338|FG000|Overall Study|Early termination of study prior to participant completion|2|||
129924280|NCT06457802|467687339|FG001|Overall Study|Early termination of study prior to participant completion|2|||
129924281|NCT01467427|467687340|FG000|Overall Study|Withdrawal by Subject|1|||
129924282|NCT01467427|467687341|FG001|Overall Study|Withdrawal by Subject|0|||
129924283|NCT01467427|467687340|FG000|Overall Study|Not continuing in extension phase|0|||
129924284|NCT01467427|467687341|FG001|Overall Study|Not continuing in extension phase|2|||
129924285|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
129924286|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
129924287|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
129924288|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
129924289|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
129924290|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
129924291|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
129924292|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
129924293|NCT03161028|467687342|FG000|Overall Study|Withdrawal by Subject|6|||
129924294|NCT03161028|467687343|FG001|Overall Study|Withdrawal by Subject|4|||
129924295|NCT03161028|467687342|FG000|Overall Study|Adverse Event|5|||
129924296|NCT03161028|467687343|FG001|Overall Study|Adverse Event|1|||
129924297|NCT03161028|467687342|FG000|Overall Study|Study drug side effects|2|||
129924298|NCT03161028|467687343|FG001|Overall Study|Study drug side effects|2|||
129924299|NCT03161028|467687342|FG000|Overall Study|Administrative PD/UP|4|||
129924300|NCT03161028|467687343|FG001|Overall Study|Administrative PD/UP|2|||
129924301|NCT03161028|467687342|FG000|Overall Study|Lost to Follow-up|2|||
129924302|NCT03161028|467687343|FG001|Overall Study|Lost to Follow-up|0|||
129924303|NCT03161028|467687342|FG000|Overall Study|Unable to comply with procedures|1|||
129924304|NCT03161028|467687343|FG001|Overall Study|Unable to comply with procedures|1|||
129924305|NCT03492216|467687344|FG000|Overall Study|Death|1|||
129924306|NCT03492216|467687345|FG001|Overall Study|Death|0|||
129924307|NCT03492216|467687346|FG002|Overall Study|Death|4|||
129924308|NCT03492216|467687347|FG003|Overall Study|Death|0|||
129924309|NCT03492216|467687344|FG000|Overall Study|Withdrawal by Subject|5|||
129924310|NCT03492216|467687345|FG001|Overall Study|Withdrawal by Subject|3|||
129924311|NCT03492216|467687346|FG002|Overall Study|Withdrawal by Subject|1|||
129924312|NCT03492216|467687347|FG003|Overall Study|Withdrawal by Subject|1|||
129924313|NCT03492216|467687344|FG000|Overall Study|Lost to Follow-up|9|||
129924314|NCT03492216|467687345|FG001|Overall Study|Lost to Follow-up|2|||
129924315|NCT03492216|467687346|FG002|Overall Study|Lost to Follow-up|7|||
129924316|NCT03492216|467687347|FG003|Overall Study|Lost to Follow-up|8|||
129924317|NCT03492216|467687344|FG000|Overall Study|Moved|5|||
129924318|NCT03492216|467687345|FG001|Overall Study|Moved|3|||
129924319|NCT03492216|467687346|FG002|Overall Study|Moved|3|||
129924320|NCT03492216|467687347|FG003|Overall Study|Moved|5|||
129924321|NCT03492216|467687344|FG000|Overall Study|Too ill|0|||
129924322|NCT03492216|467687345|FG001|Overall Study|Too ill|1|||
129924323|NCT03492216|467687346|FG002|Overall Study|Too ill|0|||
129924324|NCT03492216|467687347|FG003|Overall Study|Too ill|0|||
129924325|NCT03492216|467687344|FG000|Overall Study|Incarcerated|0|||
129924326|NCT03492216|467687345|FG001|Overall Study|Incarcerated|0|||
129924327|NCT03492216|467687346|FG002|Overall Study|Incarcerated|2|||
129924328|NCT03492216|467687347|FG003|Overall Study|Incarcerated|0|||
129924329|NCT00736723|467687348|FG000|Overall Study|Withdrawal by Subject|4|||
129924330|NCT00736723|467687349|FG001|Overall Study|Withdrawal by Subject|3|||
129924331|NCT04797897|467687350|FG000|Overall Study|Study Termination by Sponsor|1|||
129924332|NCT04797897|467687351|FG001|Overall Study|Study Termination by Sponsor|1|||
129924333|NCT03024437|467687357|FG000|Overall Study|Adverse Event|0|||
129924334|NCT03024437|467687358|FG001|Overall Study|Adverse Event|1|||
129924335|NCT03024437|467687359|FG002|Overall Study|Adverse Event|3|||
129924336|NCT03024437|467687360|FG003|Overall Study|Adverse Event|5|||
129924337|NCT03024437|467687361|FG004|Overall Study|Adverse Event|0|||
129924338|NCT03024437|467687357|FG000|Overall Study|Physician Decision|1|||
129924339|NCT03024437|467687358|FG001|Overall Study|Physician Decision|0|||
129924340|NCT03024437|467687359|FG002|Overall Study|Physician Decision|0|||
129924341|NCT03024437|467687360|FG003|Overall Study|Physician Decision|1|||
129924342|NCT03024437|467687361|FG004|Overall Study|Physician Decision|0|||
129924343|NCT03024437|467687357|FG000|Overall Study|Disease progression, relapse|1|||
129924344|NCT03024437|467687358|FG001|Overall Study|Disease progression, relapse|0|||
129924345|NCT03024437|467687359|FG002|Overall Study|Disease progression, relapse|0|||
129924346|NCT03024437|467687360|FG003|Overall Study|Disease progression, relapse|3|||
129924347|NCT03024437|467687361|FG004|Overall Study|Disease progression, relapse|0|||
129924348|NCT03024437|467687357|FG000|Overall Study|Disease progression, refractory disease|4|||
129924349|NCT03024437|467687358|FG001|Overall Study|Disease progression, refractory disease|4|||
130068923|NCT01688635|468205629|FG000|Washout 1|Withdrawal by Subject|1|||
130068924|NCT01688635|468205630|FG001|Washout 1|Withdrawal by Subject|0|||
130068925|NCT01688635|468205629|FG000|Washout 1|Adverse Event|0|||
129924350|NCT03024437|467687359|FG002|Overall Study|Disease progression, refractory disease|2|||
129924351|NCT03024437|467687360|FG003|Overall Study|Disease progression, refractory disease|2|||
129924352|NCT03024437|467687361|FG004|Overall Study|Disease progression, refractory disease|1|||
129924353|NCT03024437|467687357|FG000|Overall Study|Newly diagnosed cancer|0|||
129924354|NCT03024437|467687358|FG001|Overall Study|Newly diagnosed cancer|0|||
129924355|NCT03024437|467687359|FG002|Overall Study|Newly diagnosed cancer|0|||
129924356|NCT03024437|467687360|FG003|Overall Study|Newly diagnosed cancer|1|||
129924357|NCT03024437|467687361|FG004|Overall Study|Newly diagnosed cancer|0|||
130068926|NCT01688635|468205630|FG001|Washout 1|Adverse Event|1|||
130068927|NCT01688635|468205629|FG000|Washout 1|Physician Decision|0|||
129924358|NCT03024437|467687357|FG000|Overall Study|Moved out of state|0|||
129924359|NCT03024437|467687358|FG001|Overall Study|Moved out of state|1|||
130068928|NCT01688635|468205630|FG001|Washout 1|Physician Decision|1|||
129924360|NCT03024437|467687359|FG002|Overall Study|Moved out of state|0|||
129924361|NCT03024437|467687360|FG003|Overall Study|Moved out of state|0|||
129924362|NCT03024437|467687361|FG004|Overall Study|Moved out of state|0|||
129924363|NCT03024437|467687357|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924364|NCT03024437|467687358|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924365|NCT03024437|467687359|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
129924366|NCT03024437|467687360|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924367|NCT03024437|467687361|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924368|NCT02601313|467687362|FG000|Overall Study|Death|2|||
129924369|NCT02601313|467687363|FG001|Overall Study|Death|41|||
129924370|NCT02601313|467687364|FG002|Overall Study|Death|6|||
129924371|NCT02601313|467687362|FG000|Overall Study|Enrolled but never treated|0|||
129924372|NCT02601313|467687363|FG001|Overall Study|Enrolled but never treated|6|||
129924373|NCT02601313|467687364|FG002|Overall Study|Enrolled but never treated|3|||
129924374|NCT02601313|467687362|FG000|Overall Study|Enrolled, did not initiate AC|4|||
129924375|NCT02601313|467687363|FG001|Overall Study|Enrolled, did not initiate AC|0|||
129924376|NCT02601313|467687364|FG002|Overall Study|Enrolled, did not initiate AC|0|||
129924377|NCT02601313|467687362|FG000|Overall Study|Full consent withdrawal|0|||
129924378|NCT02601313|467687363|FG001|Overall Study|Full consent withdrawal|3|||
129924379|NCT02601313|467687364|FG002|Overall Study|Full consent withdrawal|2|||
129924380|NCT02601313|467687362|FG000|Overall Study|Lost to Follow-up|0|||
129924381|NCT02601313|467687363|FG001|Overall Study|Lost to Follow-up|1|||
129924382|NCT02601313|467687364|FG002|Overall Study|Lost to Follow-up|1|||
129924383|NCT02364557|467687365|FG000|Overall Study|Protocol Violation|3|||
129924384|NCT02364557|467687366|FG001|Overall Study|Protocol Violation|1|||
129924385|NCT04828005|467687367|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
129924386|NCT04828005|467687368|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
129924387|NCT04828005|467687369|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
129924388|NCT04828005|467687370|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
129924389|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
129924390|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
129924391|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
129924392|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
129924393|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
129924394|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
129924395|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
129924396|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
129924397|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
129924398|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
129924399|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
129924400|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
129924401|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
129924402|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
129924403|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
129924404|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
129924405|NCT04828005|467687367|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
129924406|NCT04828005|467687368|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
129924407|NCT04828005|467687369|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
129924408|NCT04828005|467687370|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
129924409|NCT04828005|467687367|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
129924410|NCT04828005|467687368|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
129924411|NCT04828005|467687369|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
129924412|NCT04828005|467687370|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
129924413|NCT04828005|467687367|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
129924414|NCT04828005|467687368|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
129924415|NCT04828005|467687369|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
129924416|NCT04828005|467687370|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
129924417|NCT04828005|467687367|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
130117338|NCT01498484|468388854|FG002|Overall Study|Withdrawal by Subject|0|||
129924418|NCT04828005|467687368|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
129924419|NCT04828005|467687369|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
129924420|NCT04828005|467687370|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
129924421|NCT02975882|467689275|FG000|Overall Study|Adverse Event|1|||
129924422|NCT02975882|467689276|FG001|Overall Study|Adverse Event|2|||
129924423|NCT02975882|467689277|FG002|Overall Study|Adverse Event|1|||
129924424|NCT02975882|467689278|FG003|Overall Study|Adverse Event|1|||
129924425|NCT02975882|467689275|FG000|Overall Study|Death|0|||
129924426|NCT02975882|467689276|FG001|Overall Study|Death|1|||
129924427|NCT02975882|467689277|FG002|Overall Study|Death|0|||
129924428|NCT02975882|467689278|FG003|Overall Study|Death|0|||
129924429|NCT02975882|467689275|FG000|Overall Study|Lack of Efficacy|3|||
130117339|NCT01498484|468388855|FG003|Overall Study|Withdrawal by Subject|1|||
129924430|NCT02975882|467689276|FG001|Overall Study|Lack of Efficacy|7|||
129924431|NCT02975882|467689277|FG002|Overall Study|Lack of Efficacy|4|||
129924432|NCT02975882|467689278|FG003|Overall Study|Lack of Efficacy|3|||
129924433|NCT02975882|467689275|FG000|Overall Study|Physician Decision|0|||
129924434|NCT02975882|467689276|FG001|Overall Study|Physician Decision|2|||
129924435|NCT02975882|467689277|FG002|Overall Study|Physician Decision|4|||
129924436|NCT02975882|467689278|FG003|Overall Study|Physician Decision|2|||
129924437|NCT02975882|467689275|FG000|Overall Study|Ineligible|0|||
129924438|NCT02975882|467689276|FG001|Overall Study|Ineligible|1|||
129924439|NCT02975882|467689277|FG002|Overall Study|Ineligible|0|||
129924440|NCT02975882|467689278|FG003|Overall Study|Ineligible|0|||
129924441|NCT03867500|467689279|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
129924442|NCT04802967|467689286|FG000|Part B|Withdrawal by Subject|0|||
129924443|NCT04802967|467689287|FG001|Part B|Withdrawal by Subject|0|||
129924444|NCT04802967|467689288|FG002|Part B|Withdrawal by Subject|0|||
129924445|NCT04802967|467689289|FG003|Part B|Withdrawal by Subject|0|||
129924446|NCT04802967|467689290|FG004|Part B|Withdrawal by Subject|0|||
129924447|NCT04802967|467689291|FG005|Part B|Withdrawal by Subject|1|||
129924448|NCT04802967|467689292|FG006|Part B|Withdrawal by Subject|0|||
129924449|NCT04802967|467689293|FG007|Part B|Withdrawal by Subject|0|||
129924450|NCT04802967|467689294|FG008|Part B|Withdrawal by Subject|0|||
129924451|NCT04802967|467689295|FG009|Part B|Withdrawal by Subject|0|||
129924452|NCT03524118|467689300|FG000|Overall Study|Lost to Follow-up|0|||
129924453|NCT03524118|467689301|FG001|Overall Study|Lost to Follow-up|0|||
129924454|NCT03524118|467689302|FG002|Overall Study|Lost to Follow-up|0|||
129924455|NCT03524118|467689303|FG003|Overall Study|Lost to Follow-up|0|||
129924456|NCT03524118|467689304|FG004|Overall Study|Lost to Follow-up|1|||
129924457|NCT03524118|467689305|FG005|Overall Study|Lost to Follow-up|0|||
129924458|NCT03524118|467689300|FG000|Overall Study|Other|0|||
129924459|NCT03524118|467689301|FG001|Overall Study|Other|1|||
129924460|NCT03524118|467689302|FG002|Overall Study|Other|0|||
129924461|NCT03524118|467689303|FG003|Overall Study|Other|0|||
129924462|NCT03524118|467689304|FG004|Overall Study|Other|1|||
129924463|NCT03524118|467689305|FG005|Overall Study|Other|1|||
129924464|NCT03524118|467689300|FG000|Overall Study|Physician Decision|0|||
129924465|NCT03524118|467689301|FG001|Overall Study|Physician Decision|0|||
129924466|NCT03524118|467689302|FG002|Overall Study|Physician Decision|0|||
129924467|NCT03524118|467689303|FG003|Overall Study|Physician Decision|0|||
129924468|NCT03524118|467689304|FG004|Overall Study|Physician Decision|1|||
129924469|NCT03524118|467689305|FG005|Overall Study|Physician Decision|0|||
129924470|NCT03524118|467689300|FG000|Overall Study|Protocol Violation|0|||
129924471|NCT03524118|467689301|FG001|Overall Study|Protocol Violation|0|||
129924472|NCT03524118|467689302|FG002|Overall Study|Protocol Violation|1|||
129924473|NCT03524118|467689303|FG003|Overall Study|Protocol Violation|0|||
129924474|NCT03524118|467689304|FG004|Overall Study|Protocol Violation|1|||
129924475|NCT03524118|467689305|FG005|Overall Study|Protocol Violation|0|||
129924476|NCT03524118|467689300|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129924477|NCT03524118|467689301|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129924478|NCT03524118|467689302|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129924479|NCT03524118|467689303|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
129924480|NCT03524118|467689304|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
129924481|NCT03524118|467689305|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129924482|NCT01824875|467689306|FG000|Overall Study|Disease progression|22|||
129924483|NCT01824875|467689307|FG001|Overall Study|Disease progression|15|||
129924484|NCT01824875|467689306|FG000|Overall Study|Withdrawal by Subject|5|||
129924485|NCT01824875|467689307|FG001|Overall Study|Withdrawal by Subject|4|||
129924486|NCT01824875|467689306|FG000|Overall Study|Adverse Event|4|||
129924487|NCT01824875|467689307|FG001|Overall Study|Adverse Event|10|||
129924488|NCT01824875|467689306|FG000|Overall Study|Alternative therapy|3|||
129924489|NCT01824875|467689307|FG001|Overall Study|Alternative therapy|0|||
129924490|NCT01824875|467689306|FG000|Overall Study|Complicating disease|1|||
129924491|NCT01824875|467689307|FG001|Overall Study|Complicating disease|0|||
129924492|NCT01824875|467689306|FG000|Overall Study|Physician Decision|0|||
129924493|NCT01824875|467689307|FG001|Overall Study|Physician Decision|1|||
129924494|NCT01824875|467689306|FG000|Overall Study|Non-compliance|1|||
129924495|NCT01824875|467689307|FG001|Overall Study|Non-compliance|1|||
129924496|NCT01824875|467689306|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
129924497|NCT01824875|467689307|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
129924498|NCT01824875|467689306|FG000|Overall Study|Administrative issues|0|||
129924499|NCT01824875|467689307|FG001|Overall Study|Administrative issues|2|||
129924500|NCT01824875|467689306|FG000|Overall Study|Ineligible or never started treatment|9|||
129924501|NCT01824875|467689307|FG001|Overall Study|Ineligible or never started treatment|5|||
129924502|NCT01824875|467689306|FG000|Overall Study|Other|0|||
129924503|NCT01824875|467689307|FG001|Overall Study|Other|2|||
129924504|NCT01098812|467689310|FG000|Overall Study|Death|2|||
129924505|NCT01098812|467689311|FG001|Overall Study|Death|0|||
129924506|NCT01098812|467689312|FG002|Overall Study|Death|1|||
130068929|NCT01688635|468205629|FG000|Washout 2|Physician Decision|1|||
129924507|NCT01098812|467689310|FG000|Overall Study|Lost to Follow-up|0|||
129924508|NCT01098812|467689311|FG001|Overall Study|Lost to Follow-up|1|||
129924509|NCT01098812|467689312|FG002|Overall Study|Lost to Follow-up|0|||
129924510|NCT04625283|467689315|FG000|Overall Study|post randomization exclusion|28|||
129924511|NCT04625283|467689316|FG001|Overall Study|post randomization exclusion|20|||
129924512|NCT02817776|467689317|FG000|Overall Study|Excluded|33|||
129924513|NCT02817776|467689317|FG000|Overall Study|Lost to Follow-up|20|||
129924514|NCT02817776|467689317|FG000|Overall Study|Withdrawal by Subject|33|||
129924515|NCT02817776|467689317|FG000|Overall Study|Death|2|||
129924516|NCT03462030|467689320|FG000|Overall Study|Withdrawal by Subject|1|||
129924517|NCT03462030|467689321|FG001|Overall Study|Withdrawal by Subject|1|||
129924518|NCT02598388|467689322|FG000|Overall Study|Lost to Follow-up|1|||
129924519|NCT02598388|467689323|FG001|Overall Study|Lost to Follow-up|0|||
129924520|NCT02598388|467689324|FG002|Overall Study|Lost to Follow-up|1|||
129924521|NCT02598388|467689325|FG003|Overall Study|Lost to Follow-up|0|||
129924522|NCT02598388|467689326|FG004|Overall Study|Lost to Follow-up|5|||
129924523|NCT02598388|467689327|FG005|Overall Study|Lost to Follow-up|1|||
129924524|NCT02598388|467689328|FG006|Overall Study|Lost to Follow-up|2|||
129924525|NCT02598388|467689329|FG007|Overall Study|Lost to Follow-up|1|||
129924526|NCT02598388|467689330|FG008|Overall Study|Lost to Follow-up|0|||
129924527|NCT02598388|467689331|FG009|Overall Study|Lost to Follow-up|0|||
129924528|NCT02598388|467689332|FG010|Overall Study|Lost to Follow-up|1|||
129924529|NCT02598388|467689333|FG011|Overall Study|Lost to Follow-up|0|||
129924530|NCT02598388|467689322|FG000|Overall Study|Withdrawal by Subject|0|||
129924531|NCT02598388|467689323|FG001|Overall Study|Withdrawal by Subject|0|||
129924532|NCT02598388|467689324|FG002|Overall Study|Withdrawal by Subject|0|||
129924533|NCT02598388|467689325|FG003|Overall Study|Withdrawal by Subject|0|||
129924534|NCT02598388|467689326|FG004|Overall Study|Withdrawal by Subject|2|||
129924535|NCT02598388|467689327|FG005|Overall Study|Withdrawal by Subject|0|||
129924536|NCT02598388|467689328|FG006|Overall Study|Withdrawal by Subject|2|||
129924537|NCT02598388|467689329|FG007|Overall Study|Withdrawal by Subject|0|||
129924538|NCT02598388|467689330|FG008|Overall Study|Withdrawal by Subject|0|||
129924539|NCT02598388|467689331|FG009|Overall Study|Withdrawal by Subject|1|||
129924540|NCT02598388|467689332|FG010|Overall Study|Withdrawal by Subject|0|||
129924541|NCT02598388|467689333|FG011|Overall Study|Withdrawal by Subject|0|||
129924542|NCT02598388|467689322|FG000|Overall Study|Other|0|||
129924543|NCT02598388|467689323|FG001|Overall Study|Other|0|||
129924544|NCT02598388|467689324|FG002|Overall Study|Other|1|||
129924545|NCT02598388|467689325|FG003|Overall Study|Other|0|||
129924546|NCT02598388|467689326|FG004|Overall Study|Other|3|||
129924547|NCT02598388|467689327|FG005|Overall Study|Other|0|||
129924548|NCT02598388|467689328|FG006|Overall Study|Other|1|||
129924549|NCT02598388|467689329|FG007|Overall Study|Other|0|||
129924550|NCT02598388|467689330|FG008|Overall Study|Other|0|||
129924551|NCT02598388|467689331|FG009|Overall Study|Other|0|||
129924552|NCT02598388|467689332|FG010|Overall Study|Other|0|||
129924553|NCT02598388|467689333|FG011|Overall Study|Other|0|||
129924554|NCT05020249|467689334|FG000|Overall Study|Protocol Violation|1|||
129924555|NCT05020249|467689335|FG001|Overall Study|Protocol Violation|0|||
129924556|NCT04971681|467689346|FG000|Followup|Lost to Follow-up|1|||
129924557|NCT04971681|467689347|FG001|Followup|Lost to Follow-up|0|||
129924558|NCT00686335|467689348|FG000|Run-in Period|Adverse Event|1|||
129924559|NCT00686335|467689348|FG000|Run-in Period|asthma exacerbation|1|||
129924560|NCT00686335|467689348|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
129924561|NCT04149704|467689349|FG000|Three Month Follow-up|Death|2|||
129924562|NCT04149704|467689350|FG001|Three Month Follow-up|Death|0|||
129924563|NCT04149704|467689351|FG002|Three Month Follow-up|Death|0|||
129924564|NCT04149704|467689352|FG003|Three Month Follow-up|Death|0|||
129924565|NCT04149704|467689349|FG000|Three Month Follow-up|Lost to Follow-up|1|||
129924566|NCT04149704|467689350|FG001|Three Month Follow-up|Lost to Follow-up|4|||
129924567|NCT04149704|467689351|FG002|Three Month Follow-up|Lost to Follow-up|5|||
129924568|NCT04149704|467689352|FG003|Three Month Follow-up|Lost to Follow-up|5|||
129924569|NCT04149704|467689349|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
129924570|NCT04149704|467689350|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
129924571|NCT04149704|467689351|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
129924572|NCT04149704|467689352|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
129924573|NCT04149704|467689349|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
129924574|NCT04149704|467689350|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
129924575|NCT04149704|467689351|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
129924576|NCT04149704|467689352|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
129924577|NCT02268253|467689353|FG000|Stage 1|Withdrawal by Subject|1|||
129924578|NCT02268253|467689354|FG001|Stage 1|Withdrawal by Subject|0|||
129924579|NCT02268253|467689355|FG002|Stage 1|Withdrawal by Subject|0|||
129924580|NCT02268253|467689356|FG003|Stage 1|Withdrawal by Subject|0|||
129924581|NCT02268253|467689357|FG004|Stage 1|Withdrawal by Subject|0|||
129924582|NCT02268253|467689358|FG005|Stage 1|Withdrawal by Subject|0|||
129924583|NCT02268253|467689359|FG006|Stage 1|Withdrawal by Subject|0|||
129924584|NCT02268253|467689353|FG000|Stage 1|Death|0|||
129924585|NCT02268253|467689354|FG001|Stage 1|Death|2|||
129924586|NCT02268253|467689355|FG002|Stage 1|Death|2|||
129924587|NCT02268253|467689356|FG003|Stage 1|Death|2|||
129924588|NCT02268253|467689357|FG004|Stage 1|Death|1|||
129924589|NCT02268253|467689358|FG005|Stage 1|Death|1|||
129924590|NCT02268253|467689359|FG006|Stage 1|Death|0|||
129924591|NCT02268253|467689353|FG000|Stage 2|Disease Recurrence/ Progression|0|||
129924592|NCT02268253|467689354|FG001|Stage 2|Disease Recurrence/ Progression|0|||
129924593|NCT02268253|467689355|FG002|Stage 2|Disease Recurrence/ Progression|1|||
129924594|NCT02268253|467689356|FG003|Stage 2|Disease Recurrence/ Progression|0|||
129924595|NCT02268253|467689357|FG004|Stage 2|Disease Recurrence/ Progression|0|||
129924596|NCT02268253|467689358|FG005|Stage 2|Disease Recurrence/ Progression|0|||
129924597|NCT02268253|467689359|FG006|Stage 2|Disease Recurrence/ Progression|0|||
129924598|NCT02268253|467689353|FG000|Stage 2|Withdrawal by Subject|0|||
129924599|NCT02268253|467689354|FG001|Stage 2|Withdrawal by Subject|0|||
129924600|NCT02268253|467689355|FG002|Stage 2|Withdrawal by Subject|2|||
129924601|NCT02268253|467689356|FG003|Stage 2|Withdrawal by Subject|0|||
129924602|NCT02268253|467689357|FG004|Stage 2|Withdrawal by Subject|0|||
129924603|NCT02268253|467689358|FG005|Stage 2|Withdrawal by Subject|2|||
129924604|NCT02268253|467689359|FG006|Stage 2|Withdrawal by Subject|0|||
129924605|NCT02268253|467689353|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924606|NCT02268253|467689354|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924607|NCT02268253|467689355|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
129924608|NCT02268253|467689356|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924609|NCT02268253|467689357|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924610|NCT02268253|467689358|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
129924611|NCT02268253|467689359|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924612|NCT02268253|467689353|FG000|Stage 2|Death|0|||
129924613|NCT02268253|467689354|FG001|Stage 2|Death|0|||
129924614|NCT02268253|467689355|FG002|Stage 2|Death|19|||
129924615|NCT02268253|467689356|FG003|Stage 2|Death|0|||
129924616|NCT02268253|467689357|FG004|Stage 2|Death|0|||
129924617|NCT02268253|467689358|FG005|Stage 2|Death|20|||
129924618|NCT02268253|467689359|FG006|Stage 2|Death|1|||
129924619|NCT02268253|467689353|FG000|Stage 2|Lost to Follow-up|0|||
129924620|NCT02268253|467689354|FG001|Stage 2|Lost to Follow-up|0|||
129924621|NCT02268253|467689355|FG002|Stage 2|Lost to Follow-up|0|||
129924622|NCT02268253|467689356|FG003|Stage 2|Lost to Follow-up|0|||
129924623|NCT02268253|467689357|FG004|Stage 2|Lost to Follow-up|0|||
129924624|NCT02268253|467689358|FG005|Stage 2|Lost to Follow-up|4|||
129924625|NCT02268253|467689359|FG006|Stage 2|Lost to Follow-up|0|||
129924626|NCT02268253|467689353|FG000|Stage 2|Transferred to Hospice|0|||
129924627|NCT02268253|467689354|FG001|Stage 2|Transferred to Hospice|0|||
129924628|NCT02268253|467689355|FG002|Stage 2|Transferred to Hospice|0|||
129924629|NCT02268253|467689356|FG003|Stage 2|Transferred to Hospice|0|||
129924630|NCT02268253|467689357|FG004|Stage 2|Transferred to Hospice|0|||
129924631|NCT02268253|467689358|FG005|Stage 2|Transferred to Hospice|2|||
129924632|NCT02268253|467689359|FG006|Stage 2|Transferred to Hospice|0|||
129924633|NCT02268253|467689353|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
129924634|NCT02268253|467689354|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
129924635|NCT02268253|467689355|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
129924636|NCT02268253|467689356|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
129924637|NCT02268253|467689357|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
129924638|NCT02268253|467689358|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
129924639|NCT02268253|467689359|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
129924640|NCT02268253|467689353|FG000|Stage 3A|Withdrawal by Subject|0|||
129924641|NCT02268253|467689354|FG001|Stage 3A|Withdrawal by Subject|0|||
129924642|NCT02268253|467689355|FG002|Stage 3A|Withdrawal by Subject|2|||
129924643|NCT02268253|467689356|FG003|Stage 3A|Withdrawal by Subject|0|||
129924644|NCT02268253|467689357|FG004|Stage 3A|Withdrawal by Subject|0|||
129924645|NCT02268253|467689358|FG005|Stage 3A|Withdrawal by Subject|0|||
129924646|NCT02268253|467689359|FG006|Stage 3A|Withdrawal by Subject|0|||
129924647|NCT02268253|467689353|FG000|Stage 3A|Physician Decision|0|||
129924648|NCT02268253|467689354|FG001|Stage 3A|Physician Decision|0|||
129924649|NCT02268253|467689355|FG002|Stage 3A|Physician Decision|2|||
129924650|NCT02268253|467689356|FG003|Stage 3A|Physician Decision|0|||
129924651|NCT02268253|467689357|FG004|Stage 3A|Physician Decision|0|||
129924652|NCT02268253|467689358|FG005|Stage 3A|Physician Decision|0|||
129924653|NCT02268253|467689359|FG006|Stage 3A|Physician Decision|0|||
129924654|NCT02268253|467689353|FG000|Stage 3A|Study Terminated by Sponsor|0|||
129924655|NCT02268253|467689354|FG001|Stage 3A|Study Terminated by Sponsor|0|||
129924656|NCT02268253|467689355|FG002|Stage 3A|Study Terminated by Sponsor|2|||
129924657|NCT02268253|467689356|FG003|Stage 3A|Study Terminated by Sponsor|0|||
129924658|NCT02268253|467689357|FG004|Stage 3A|Study Terminated by Sponsor|0|||
129924659|NCT02268253|467689358|FG005|Stage 3A|Study Terminated by Sponsor|0|||
129924660|NCT02268253|467689359|FG006|Stage 3A|Study Terminated by Sponsor|0|||
129924661|NCT02268253|467689353|FG000|Stage 3A|Lost to Follow-up|0|||
129924662|NCT02268253|467689354|FG001|Stage 3A|Lost to Follow-up|0|||
129924663|NCT02268253|467689355|FG002|Stage 3A|Lost to Follow-up|1|||
129924664|NCT02268253|467689356|FG003|Stage 3A|Lost to Follow-up|0|||
130068930|NCT01688635|468205630|FG001|Washout 2|Physician Decision|0|||
130068931|NCT01688635|468205629|FG000|Washout 2|Withdrawal by Subject|1|||
130068932|NCT01688635|468205630|FG001|Washout 2|Withdrawal by Subject|0|||
130068933|NCT01688635|468205629|FG000|Washout 2|Sponsor Decision|1|||
130068934|NCT01688635|468205630|FG001|Washout 2|Sponsor Decision|2|||
130068935|NCT01688635|468205629|FG000|Washout 3|Withdrawal by Subject|1|||
130068936|NCT01688635|468205630|FG001|Washout 3|Withdrawal by Subject|0|||
130068937|NCT02293902|468205632|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
130068938|NCT02293902|468205633|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
130068939|NCT02293902|468205634|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
130068940|NCT02293902|468205635|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
130068941|NCT02293902|468205636|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
130068942|NCT02293902|468205632|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
130068943|NCT02293902|468205633|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
130068944|NCT02293902|468205634|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
130068945|NCT02293902|468205635|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
130068946|NCT02293902|468205636|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
130068947|NCT02293902|468205632|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
130068948|NCT02293902|468205633|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130068949|NCT02293902|468205634|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130068950|NCT02293902|468205635|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130068951|NCT02293902|468205636|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
130068952|NCT02293902|468205632|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
130068953|NCT02293902|468205633|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
130068954|NCT02293902|468205634|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
130068955|NCT02293902|468205635|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
130068956|NCT02293902|468205636|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
130068957|NCT02293902|468205632|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
130068958|NCT02293902|468205633|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
130068959|NCT02293902|468205634|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
130068960|NCT02293902|468205635|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
130068961|NCT02293902|468205636|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
130094784|NCT01018680|468303840|FG001|Overall Study|Entry Criteria Not Met|4|||
130094785|NCT01018680|468303839|FG000|Overall Study|Physician Decision|3|||
130094786|NCT01018680|468303840|FG001|Overall Study|Physician Decision|1|||
130094787|NCT02930889|468303841|FG000|Overall Study|Lost to Follow-up|2|||
130094788|NCT02930889|468303841|FG000|Overall Study|Withdrawal by Subject|6|||
130094789|NCT02930889|468303841|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
130094790|NCT02985541|468303844|FG000|Overall Study|Withdrawal by Subject|33|||
130094791|NCT02985541|468303844|FG000|Overall Study|Lost to Follow-up|26|||
130094792|NCT02985541|468303844|FG000|Overall Study|Adverse Event|27|||
130094793|NCT02985541|468303844|FG000|Overall Study|Physician Decision|2|||
130094794|NCT02985541|468303844|FG000|Overall Study|Pregnancy|2|||
130094795|NCT02985541|468303844|FG000|Overall Study|Wish for pregnancy|44|||
130094796|NCT02985541|468303844|FG000|Overall Study|Other reason|5|||
130094797|NCT02985541|468303844|FG000|Overall Study|Not valid for analysis|2|||
130094798|NCT03996694|468303848|FG000|First Washout (7 Days)|positive urine drug screen|0|||
130094799|NCT03996694|468303849|FG001|First Washout (7 Days)|positive urine drug screen|0|||
130094800|NCT03996694|468303850|FG002|First Washout (7 Days)|positive urine drug screen|1|||
130094801|NCT03996694|468303851|FG003|First Washout (7 Days)|positive urine drug screen|0|||
130094802|NCT03996694|468303852|FG004|First Washout (7 Days)|positive urine drug screen|0|||
130094803|NCT03996694|468303853|FG005|First Washout (7 Days)|positive urine drug screen|0|||
130094804|NCT03996694|468303848|FG000|First Washout (7 Days)|Adverse Event|0|||
130094805|NCT03996694|468303849|FG001|First Washout (7 Days)|Adverse Event|1|||
130094806|NCT03996694|468303850|FG002|First Washout (7 Days)|Adverse Event|0|||
129924665|NCT02268253|467689357|FG004|Stage 3A|Lost to Follow-up|0|||
129924666|NCT02268253|467689358|FG005|Stage 3A|Lost to Follow-up|0|||
129924667|NCT02268253|467689359|FG006|Stage 3A|Lost to Follow-up|0|||
129924668|NCT02268253|467689353|FG000|Stage 3A|Death|0|||
129924669|NCT02268253|467689354|FG001|Stage 3A|Death|0|||
129924670|NCT02268253|467689355|FG002|Stage 3A|Death|5|||
129924671|NCT02268253|467689356|FG003|Stage 3A|Death|0|||
129924672|NCT02268253|467689357|FG004|Stage 3A|Death|0|||
129924673|NCT02268253|467689358|FG005|Stage 3A|Death|0|||
129924674|NCT02268253|467689359|FG006|Stage 3A|Death|0|||
129924675|NCT05672069|467689360|FG000|Overall Study|Implant removal|1|||
130094807|NCT03996694|468303851|FG003|First Washout (7 Days)|Adverse Event|0|||
130094808|NCT03996694|468303852|FG004|First Washout (7 Days)|Adverse Event|0|||
130094809|NCT03996694|468303853|FG005|First Washout (7 Days)|Adverse Event|0|||
129924676|NCT05672069|467689360|FG000|Overall Study|Lost to Follow-up|2|||
129924677|NCT05949788|467689361|FG000|Overall Study|severe birth deformity|2|||
129924678|NCT05949788|467689362|FG001|Overall Study|severe birth deformity|7|||
129924679|NCT05949788|467689361|FG000|Overall Study|twin-twin transfusion syndrome|2|||
129924680|NCT05949788|467689362|FG001|Overall Study|twin-twin transfusion syndrome|7|||
129924681|NCT05949788|467689361|FG000|Overall Study|neonatal hemolytic disease|3|||
129924682|NCT05949788|467689362|FG001|Overall Study|neonatal hemolytic disease|8|||
129924683|NCT05949788|467689361|FG000|Overall Study|death within 14 days after birth|2|||
129924684|NCT05949788|467689362|FG001|Overall Study|death within 14 days after birth|6|||
129924685|NCT05949788|467689361|FG000|Overall Study|transfer to another hospital|2|||
129924686|NCT05949788|467689362|FG001|Overall Study|transfer to another hospital|6|||
129924687|NCT05213390|467689363|FG000|Overall Study|Withdrawal by Subject|2|||
129924688|NCT05213390|467689363|FG000|Overall Study|Lost to Follow-up|12|||
129924689|NCT05213390|467689363|FG000|Overall Study|Protocol Violation|9|||
129924690|NCT01824537|467689364|FG000|Overall Study|Lost to Follow-up|78|||
129924691|NCT01824537|467689365|FG001|Overall Study|Lost to Follow-up|87|||
129924692|NCT03808818|467689380|FG000|Overall Study|Death|6|||
129924693|NCT03808818|467689381|FG001|Overall Study|Death|6|||
129924694|NCT03808818|467689380|FG000|Overall Study|Withdrawal by Subject|7|||
129924695|NCT03808818|467689381|FG001|Overall Study|Withdrawal by Subject|18|||
129924696|NCT03808818|467689380|FG000|Overall Study|Lost to Follow-up|31|||
129924697|NCT03808818|467689381|FG001|Overall Study|Lost to Follow-up|33|||
129924698|NCT02191618|467689388|FG000|Overall Study|Withdrawal by Subject|3|||
129924699|NCT02191618|467689388|FG000|Overall Study|Missed Visit|4|||
129924700|NCT03031470|467689390|FG000|Overall Study|Adverse Event|3|||
129924701|NCT03031470|467689391|FG001|Overall Study|Adverse Event|0|||
130117340|NCT01498484|468388856|FG004|Overall Study|Withdrawal by Subject|0|||
130117341|NCT01498484|468388857|FG005|Overall Study|Withdrawal by Subject|0|||
130117342|NCT01498484|468388858|FG006|Overall Study|Withdrawal by Subject|1|||
130117343|NCT01498484|468388859|FG007|Overall Study|Withdrawal by Subject|0|||
130117344|NCT01498484|468388860|FG008|Overall Study|Withdrawal by Subject|0|||
130117345|NCT01498484|468388852|FG000|Overall Study|Other|5|||
130117346|NCT01498484|468388853|FG001|Overall Study|Other|2|||
130117347|NCT01498484|468388854|FG002|Overall Study|Other|0|||
130117348|NCT01498484|468388855|FG003|Overall Study|Other|0|||
129924702|NCT03031470|467689390|FG000|Overall Study|Death|3|||
129924703|NCT03031470|467689391|FG001|Overall Study|Death|1|||
129924704|NCT03031470|467689390|FG000|Overall Study|Lost to Follow-up|1|||
129924705|NCT03031470|467689391|FG001|Overall Study|Lost to Follow-up|1|||
129924706|NCT03031470|467689390|FG000|Overall Study|Withdrawal by Subject|1|||
129924707|NCT03031470|467689391|FG001|Overall Study|Withdrawal by Subject|0|||
129924708|NCT03031470|467689390|FG000|Overall Study|Protocol entry criteria not met|0|||
129924709|NCT03031470|467689391|FG001|Overall Study|Protocol entry criteria not met|1|||
129924710|NCT03031470|467689390|FG000|Overall Study|Cancel the operation|0|||
129924711|NCT03031470|467689391|FG001|Overall Study|Cancel the operation|1|||
129924712|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
129924713|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
129924714|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
129924715|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
129924716|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
129924717|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
129924718|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
129924719|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
129924720|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
129924721|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
129924722|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
129924723|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
129924724|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
129924725|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
129924726|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
129924727|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
130068962|NCT04021706|468207779|FG000|Overall Study|Adverse Event|2|||
130068963|NCT04021706|468207780|FG001|Overall Study|Adverse Event|0|||
130068964|NCT04021706|468207779|FG000|Overall Study|Withdrawal by Subject|1|||
130068965|NCT04021706|468207780|FG001|Overall Study|Withdrawal by Subject|2|||
130068966|NCT04021706|468207779|FG000|Overall Study|Physician Decision|1|||
130068967|NCT04021706|468207780|FG001|Overall Study|Physician Decision|0|||
130068968|NCT01412151|468207781|FG000|Week 0 - 306 - Treatment Period|Death|1|||
130068969|NCT01412151|468207781|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
130068970|NCT01412151|468207781|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
130068971|NCT01412151|468207781|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
130068972|NCT03127852|468207783|FG000|Overall Study|Withdrawal by Subject|4|||
130068973|NCT03127852|468207784|FG001|Overall Study|Withdrawal by Subject|1|||
130068974|NCT03127852|468207783|FG000|Overall Study|Death|1|||
130068975|NCT03127852|468207784|FG001|Overall Study|Death|1|||
130068976|NCT00859573|468207786|FG000|Overall Study|Withdrawal by Subject|4|||
130068977|NCT00859573|468207787|FG001|Overall Study|Withdrawal by Subject|1|||
130068978|NCT00859573|468207786|FG000|Overall Study|Physician Decision|1|||
130068979|NCT00859573|468207787|FG001|Overall Study|Physician Decision|1|||
130117349|NCT01498484|468388856|FG004|Overall Study|Other|1|||
129924728|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
129924729|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
129924730|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
129924731|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
129924732|NCT04663737|467689397|FG000|Overall Study|Withdrawal by Subject|2|||
129924733|NCT04663737|467689398|FG001|Overall Study|Withdrawal by Subject|0|||
129924734|NCT01943409|467689402|FG000|Overall Study|resumed oral/entral|24|||
129924735|NCT01943409|467689403|FG001|Overall Study|resumed oral/entral|20|||
129924736|NCT01943409|467689402|FG000|Overall Study|Protocol Violation|14|||
129924737|NCT01943409|467689403|FG001|Overall Study|Protocol Violation|24|||
129924738|NCT01943409|467689402|FG000|Overall Study|Death|3|||
129924739|NCT01943409|467689403|FG001|Overall Study|Death|1|||
129924740|NCT01943409|467689402|FG000|Overall Study|Withdrawal by Subject|4|||
129924741|NCT01943409|467689403|FG001|Overall Study|Withdrawal by Subject|3|||
129924742|NCT02310646|467689404|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
129924743|NCT02310646|467689405|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
129924744|NCT02310646|467689404|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
129924745|NCT02310646|467689405|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
129924746|NCT04700163|467689406|FG000|Overall Study|Lost to Follow-up|0|||
129924747|NCT04700163|467689407|FG001|Overall Study|Lost to Follow-up|0|||
129924748|NCT04700163|467689408|FG002|Overall Study|Lost to Follow-up|0|||
129924749|NCT04700163|467689409|FG003|Overall Study|Lost to Follow-up|0|||
129924750|NCT04700163|467689410|FG004|Overall Study|Lost to Follow-up|0|||
129924751|NCT04700163|467689411|FG005|Overall Study|Lost to Follow-up|1|||
129924752|NCT03865498|467689418|FG000|Overall Study|Lack of Efficacy|12|||
129924753|NCT03865498|467689419|FG001|Overall Study|Lack of Efficacy|11|||
129924754|NCT03865498|467689418|FG000|Overall Study|Lost to Follow-up|125|||
129924755|NCT03865498|467689419|FG001|Overall Study|Lost to Follow-up|133|||
129924756|NCT03865498|467689418|FG000|Overall Study|Withdrawal by Subject|2|||
129924757|NCT03865498|467689419|FG001|Overall Study|Withdrawal by Subject|4|||
129924758|NCT05869383|467689420|FG000|Overall Study|Withdrawal by Subject|2|||
129924759|NCT05869383|467689421|FG001|Overall Study|Withdrawal by Subject|0|||
129924760|NCT04137367|467689422|FG000|Overall Study|Lost to Follow-up|8|||
129924761|NCT04137367|467689423|FG001|Overall Study|Lost to Follow-up|6|||
129924762|NCT04137367|467689424|FG002|Overall Study|Lost to Follow-up|4|||
129924763|NCT03907878|467689425|FG000|Treatment Period|Withdrawal by Subject|5|||
129924764|NCT03907878|467689425|FG000|Treatment Period|Adverse Event|4|||
129924765|NCT03907878|467689425|FG000|Treatment Period|Lack of Efficacy|1|||
129924766|NCT03907878|467689425|FG000|Treatment Period|Protocol Violation|1|||
129924767|NCT03907878|467689425|FG000|Follow-up Period|Adverse Event|3|||
129924768|NCT03907878|467689425|FG000|Follow-up Period|Withdrawal by Subject|3|||
129924769|NCT05144009|467689426|FG000|Overall Study|Lost to Follow-up|0|||
129924770|NCT05144009|467689427|FG001|Overall Study|Lost to Follow-up|1|||
129924771|NCT05144009|467689426|FG000|Overall Study|Study Termination by the Sponsor|11|||
129924772|NCT05144009|467689427|FG001|Overall Study|Study Termination by the Sponsor|11|||
129924773|NCT05144009|467689426|FG000|Overall Study|Disease Progression|1|||
129924774|NCT05144009|467689427|FG001|Overall Study|Disease Progression|0|||
129924775|NCT05144009|467689426|FG000|Overall Study|Participant Decision|0|||
129924776|NCT05144009|467689427|FG001|Overall Study|Participant Decision|2|||
129924777|NCT05144009|467689426|FG000|Overall Study|Death|5|||
129924778|NCT05144009|467689427|FG001|Overall Study|Death|10|||
129924779|NCT04499924|467689428|FG000|Overall Study|Study termination by sponsor|4|||
129924780|NCT04499924|467689429|FG001|Overall Study|Study termination by sponsor|6|||
129924781|NCT04499924|467689428|FG000|Overall Study|Withdrawal by Subject|1|||
129924782|NCT04499924|467689429|FG001|Overall Study|Withdrawal by Subject|3|||
129924783|NCT01648023|467689434|FG000|Overall Study|Screen Fail Post Randomization|1|||
129924784|NCT01648023|467689435|FG001|Overall Study|Screen Fail Post Randomization|2|||
129924785|NCT02231164|467689442|FG000|Overall Study|Adverse Event|1|||
129924786|NCT02231164|467689443|FG001|Overall Study|Adverse Event|1|||
129924787|NCT02231164|467689442|FG000|Overall Study|Lack of Efficacy|4|||
129924788|NCT02231164|467689443|FG001|Overall Study|Lack of Efficacy|3|||
129924789|NCT02231164|467689442|FG000|Overall Study|Withdrawal by Subject|1|||
129924790|NCT02231164|467689443|FG001|Overall Study|Withdrawal by Subject|2|||
129924791|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
129924792|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
129924793|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
129924794|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
129924795|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
129924796|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
130117350|NCT01498484|468388857|FG005|Overall Study|Other|0|||
130117351|NCT01498484|468388858|FG006|Overall Study|Other|3|||
130117352|NCT01498484|468388859|FG007|Overall Study|Other|0|||
129924797|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
129924798|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
129924799|NCT02547363|467689444|FG000|12-month Follow-up|Withdrawal by Subject|4|||
130117353|NCT01498484|468388860|FG008|Overall Study|Other|1|||
129924800|NCT02547363|467689445|FG001|12-month Follow-up|Withdrawal by Subject|3|||
129924801|NCT02547363|467689444|FG000|12-month Follow-up|Lost to Follow-up|4|||
129924802|NCT02547363|467689445|FG001|12-month Follow-up|Lost to Follow-up|1|||
129924803|NCT02547363|467689444|FG000|12-month Follow-up|Lack of Efficacy|1|||
129924804|NCT02547363|467689445|FG001|12-month Follow-up|Lack of Efficacy|1|||
129924805|NCT02547363|467689444|FG000|12-month Follow-up|Other|1|||
129924806|NCT02547363|467689445|FG001|12-month Follow-up|Other|0|||
129924807|NCT05281562|467689448|FG000|Overall Study|Ineligible patient|1|||
129924808|NCT05281562|467689449|FG001|Overall Study|Ineligible patient|0|||
129924809|NCT04436276|467689450|FG000|Overall Study|Adverse Event|0|||
129924810|NCT04436276|467689451|FG001|Overall Study|Adverse Event|0|||
129924811|NCT04436276|467689452|FG002|Overall Study|Adverse Event|0|||
129924812|NCT04436276|467689453|FG003|Overall Study|Adverse Event|0|||
129924813|NCT04436276|467689454|FG004|Overall Study|Adverse Event|0|||
129924814|NCT04436276|467689455|FG005|Overall Study|Adverse Event|0|||
129924815|NCT04436276|467689456|FG006|Overall Study|Adverse Event|0|||
129924816|NCT04436276|467689457|FG007|Overall Study|Adverse Event|0|||
129924817|NCT04436276|467689458|FG008|Overall Study|Adverse Event|0|||
129924818|NCT04436276|467689459|FG009|Overall Study|Adverse Event|0|||
129924819|NCT04436276|467689460|FG010|Overall Study|Adverse Event|0|||
129924820|NCT04436276|467689461|FG011|Overall Study|Adverse Event|0|||
129924821|NCT04436276|467689462|FG012|Overall Study|Adverse Event|0|||
129924822|NCT04436276|467689463|FG013|Overall Study|Adverse Event|0|||
129924823|NCT04436276|467689464|FG014|Overall Study|Adverse Event|0|||
129924824|NCT04436276|467689465|FG015|Overall Study|Adverse Event|0|||
129924825|NCT04436276|467689466|FG016|Overall Study|Adverse Event|1|||
129924826|NCT04436276|467689467|FG017|Overall Study|Adverse Event|0|||
129924827|NCT04436276|467689468|FG018|Overall Study|Adverse Event|0|||
129924828|NCT04436276|467689469|FG019|Overall Study|Adverse Event|0|||
129924829|NCT04436276|467689470|FG020|Overall Study|Adverse Event|0|||
129924830|NCT04436276|467689471|FG021|Overall Study|Adverse Event|0|||
129924831|NCT04436276|467689472|FG022|Overall Study|Adverse Event|0|||
129924832|NCT04436276|467689450|FG000|Overall Study|Death|0|||
129924833|NCT04436276|467689451|FG001|Overall Study|Death|0|||
129924834|NCT04436276|467689452|FG002|Overall Study|Death|0|||
129924835|NCT04436276|467689453|FG003|Overall Study|Death|0|||
129924836|NCT04436276|467689454|FG004|Overall Study|Death|0|||
129924837|NCT04436276|467689455|FG005|Overall Study|Death|0|||
129924838|NCT04436276|467689456|FG006|Overall Study|Death|0|||
129924839|NCT04436276|467689457|FG007|Overall Study|Death|0|||
129924840|NCT04436276|467689458|FG008|Overall Study|Death|0|||
129924841|NCT04436276|467689459|FG009|Overall Study|Death|0|||
129924842|NCT04436276|467689460|FG010|Overall Study|Death|0|||
129924843|NCT04436276|467689461|FG011|Overall Study|Death|0|||
129924844|NCT04436276|467689462|FG012|Overall Study|Death|1|||
129924845|NCT04436276|467689463|FG013|Overall Study|Death|0|||
129924846|NCT04436276|467689464|FG014|Overall Study|Death|1|||
129924847|NCT04436276|467689465|FG015|Overall Study|Death|0|||
129924848|NCT04436276|467689466|FG016|Overall Study|Death|0|||
129924849|NCT04436276|467689467|FG017|Overall Study|Death|0|||
129924850|NCT04436276|467689468|FG018|Overall Study|Death|0|||
129924851|NCT04436276|467689469|FG019|Overall Study|Death|2|||
129924852|NCT04436276|467689470|FG020|Overall Study|Death|0|||
129924853|NCT04436276|467689471|FG021|Overall Study|Death|1|||
129924854|NCT04436276|467689472|FG022|Overall Study|Death|0|||
129924855|NCT04436276|467689450|FG000|Overall Study|Lost to Follow-up|0|||
129924856|NCT04436276|467689451|FG001|Overall Study|Lost to Follow-up|2|||
129924857|NCT04436276|467689452|FG002|Overall Study|Lost to Follow-up|2|||
129924858|NCT04436276|467689453|FG003|Overall Study|Lost to Follow-up|1|||
129924859|NCT04436276|467689454|FG004|Overall Study|Lost to Follow-up|4|||
129924860|NCT04436276|467689455|FG005|Overall Study|Lost to Follow-up|1|||
129924861|NCT04436276|467689456|FG006|Overall Study|Lost to Follow-up|0|||
129924862|NCT04436276|467689457|FG007|Overall Study|Lost to Follow-up|0|||
129924863|NCT04436276|467689458|FG008|Overall Study|Lost to Follow-up|1|||
129924864|NCT04436276|467689459|FG009|Overall Study|Lost to Follow-up|0|||
129924865|NCT04436276|467689460|FG010|Overall Study|Lost to Follow-up|5|||
129924866|NCT04436276|467689461|FG011|Overall Study|Lost to Follow-up|5|||
129924867|NCT04436276|467689462|FG012|Overall Study|Lost to Follow-up|4|||
129924868|NCT04436276|467689463|FG013|Overall Study|Lost to Follow-up|1|||
129924869|NCT04436276|467689464|FG014|Overall Study|Lost to Follow-up|7|||
129924870|NCT04436276|467689465|FG015|Overall Study|Lost to Follow-up|7|||
129924871|NCT04436276|467689466|FG016|Overall Study|Lost to Follow-up|1|||
129924872|NCT04436276|467689467|FG017|Overall Study|Lost to Follow-up|0|||
129924873|NCT04436276|467689468|FG018|Overall Study|Lost to Follow-up|1|||
129924874|NCT04436276|467689469|FG019|Overall Study|Lost to Follow-up|1|||
129924875|NCT04436276|467689470|FG020|Overall Study|Lost to Follow-up|2|||
129924876|NCT04436276|467689471|FG021|Overall Study|Lost to Follow-up|1|||
129924877|NCT04436276|467689472|FG022|Overall Study|Lost to Follow-up|1|||
129924878|NCT04436276|467689450|FG000|Overall Study|Physician Decision|1|||
129924879|NCT04436276|467689451|FG001|Overall Study|Physician Decision|0|||
129924880|NCT04436276|467689452|FG002|Overall Study|Physician Decision|2|||
129924881|NCT04436276|467689453|FG003|Overall Study|Physician Decision|1|||
129924882|NCT04436276|467689454|FG004|Overall Study|Physician Decision|0|||
129924883|NCT04436276|467689455|FG005|Overall Study|Physician Decision|0|||
129924884|NCT04436276|467689456|FG006|Overall Study|Physician Decision|0|||
129924885|NCT04436276|467689457|FG007|Overall Study|Physician Decision|0|||
129924886|NCT04436276|467689458|FG008|Overall Study|Physician Decision|0|||
129924887|NCT04436276|467689459|FG009|Overall Study|Physician Decision|0|||
129924888|NCT04436276|467689460|FG010|Overall Study|Physician Decision|0|||
129924889|NCT04436276|467689461|FG011|Overall Study|Physician Decision|1|||
129924890|NCT04436276|467689462|FG012|Overall Study|Physician Decision|2|||
129924891|NCT04436276|467689463|FG013|Overall Study|Physician Decision|0|||
129924892|NCT04436276|467689464|FG014|Overall Study|Physician Decision|0|||
129924893|NCT04436276|467689465|FG015|Overall Study|Physician Decision|0|||
129924894|NCT04436276|467689466|FG016|Overall Study|Physician Decision|0|||
129924895|NCT04436276|467689467|FG017|Overall Study|Physician Decision|0|||
129924896|NCT04436276|467689468|FG018|Overall Study|Physician Decision|0|||
129924897|NCT04436276|467689469|FG019|Overall Study|Physician Decision|0|||
129924898|NCT04436276|467689470|FG020|Overall Study|Physician Decision|1|||
129924899|NCT04436276|467689471|FG021|Overall Study|Physician Decision|2|||
129924900|NCT04436276|467689472|FG022|Overall Study|Physician Decision|0|||
129924901|NCT04436276|467689450|FG000|Overall Study|Protocol Violation|0|||
129924902|NCT04436276|467689451|FG001|Overall Study|Protocol Violation|0|||
129924903|NCT04436276|467689452|FG002|Overall Study|Protocol Violation|0|||
129924904|NCT04436276|467689453|FG003|Overall Study|Protocol Violation|0|||
129924905|NCT04436276|467689454|FG004|Overall Study|Protocol Violation|0|||
129924906|NCT04436276|467689455|FG005|Overall Study|Protocol Violation|0|||
129924907|NCT04436276|467689456|FG006|Overall Study|Protocol Violation|0|||
129924908|NCT04436276|467689457|FG007|Overall Study|Protocol Violation|0|||
129924909|NCT04436276|467689458|FG008|Overall Study|Protocol Violation|0|||
129924910|NCT04436276|467689459|FG009|Overall Study|Protocol Violation|0|||
129924911|NCT04436276|467689460|FG010|Overall Study|Protocol Violation|0|||
129924912|NCT04436276|467689461|FG011|Overall Study|Protocol Violation|0|||
129924913|NCT04436276|467689462|FG012|Overall Study|Protocol Violation|0|||
129924914|NCT04436276|467689463|FG013|Overall Study|Protocol Violation|1|||
129924915|NCT04436276|467689464|FG014|Overall Study|Protocol Violation|0|||
129924916|NCT04436276|467689465|FG015|Overall Study|Protocol Violation|1|||
129924917|NCT04436276|467689466|FG016|Overall Study|Protocol Violation|0|||
129924918|NCT04436276|467689467|FG017|Overall Study|Protocol Violation|0|||
129924919|NCT04436276|467689468|FG018|Overall Study|Protocol Violation|0|||
129924920|NCT04436276|467689469|FG019|Overall Study|Protocol Violation|0|||
129924921|NCT04436276|467689470|FG020|Overall Study|Protocol Violation|0|||
129924922|NCT04436276|467689471|FG021|Overall Study|Protocol Violation|0|||
129924923|NCT04436276|467689472|FG022|Overall Study|Protocol Violation|0|||
129924924|NCT04436276|467689450|FG000|Overall Study|Withdrawal by Subject|25|||
129924925|NCT04436276|467689451|FG001|Overall Study|Withdrawal by Subject|22|||
129924926|NCT04436276|467689452|FG002|Overall Study|Withdrawal by Subject|24|||
129924927|NCT04436276|467689453|FG003|Overall Study|Withdrawal by Subject|23|||
129924928|NCT04436276|467689454|FG004|Overall Study|Withdrawal by Subject|14|||
129924929|NCT04436276|467689455|FG005|Overall Study|Withdrawal by Subject|0|||
129924930|NCT04436276|467689456|FG006|Overall Study|Withdrawal by Subject|0|||
129924931|NCT04436276|467689457|FG007|Overall Study|Withdrawal by Subject|1|||
129924932|NCT04436276|467689458|FG008|Overall Study|Withdrawal by Subject|0|||
129924933|NCT04436276|467689459|FG009|Overall Study|Withdrawal by Subject|1|||
129924934|NCT04436276|467689460|FG010|Overall Study|Withdrawal by Subject|17|||
129924935|NCT04436276|467689461|FG011|Overall Study|Withdrawal by Subject|7|||
129924936|NCT04436276|467689462|FG012|Overall Study|Withdrawal by Subject|10|||
129924937|NCT04436276|467689463|FG013|Overall Study|Withdrawal by Subject|6|||
129924938|NCT04436276|467689464|FG014|Overall Study|Withdrawal by Subject|20|||
129924939|NCT04436276|467689465|FG015|Overall Study|Withdrawal by Subject|6|||
129924940|NCT04436276|467689466|FG016|Overall Study|Withdrawal by Subject|11|||
129924941|NCT04436276|467689467|FG017|Overall Study|Withdrawal by Subject|4|||
129924942|NCT04436276|467689468|FG018|Overall Study|Withdrawal by Subject|14|||
129924943|NCT04436276|467689469|FG019|Overall Study|Withdrawal by Subject|24|||
129924944|NCT04436276|467689470|FG020|Overall Study|Withdrawal by Subject|24|||
129924945|NCT04436276|467689471|FG021|Overall Study|Withdrawal by Subject|16|||
129924946|NCT04436276|467689472|FG022|Overall Study|Withdrawal by Subject|14|||
129924947|NCT04436276|467689450|FG000|Overall Study|Other|3|||
129924948|NCT04436276|467689451|FG001|Overall Study|Other|2|||
129924949|NCT04436276|467689452|FG002|Overall Study|Other|5|||
129924950|NCT04436276|467689453|FG003|Overall Study|Other|9|||
129924951|NCT04436276|467689454|FG004|Overall Study|Other|23|||
129924952|NCT04436276|467689455|FG005|Overall Study|Other|1|||
129924953|NCT04436276|467689456|FG006|Overall Study|Other|0|||
129924954|NCT04436276|467689457|FG007|Overall Study|Other|0|||
129924955|NCT04436276|467689458|FG008|Overall Study|Other|0|||
129924956|NCT04436276|467689459|FG009|Overall Study|Other|0|||
129924957|NCT04436276|467689460|FG010|Overall Study|Other|3|||
129924958|NCT04436276|467689461|FG011|Overall Study|Other|1|||
129924959|NCT04436276|467689462|FG012|Overall Study|Other|1|||
129924960|NCT04436276|467689463|FG013|Overall Study|Other|2|||
129924961|NCT04436276|467689464|FG014|Overall Study|Other|3|||
129924962|NCT04436276|467689465|FG015|Overall Study|Other|0|||
129924963|NCT04436276|467689466|FG016|Overall Study|Other|0|||
129924964|NCT04436276|467689467|FG017|Overall Study|Other|6|||
129924965|NCT04436276|467689468|FG018|Overall Study|Other|1|||
129924966|NCT04436276|467689469|FG019|Overall Study|Other|0|||
129924967|NCT04436276|467689470|FG020|Overall Study|Other|2|||
129924968|NCT04436276|467689471|FG021|Overall Study|Other|2|||
129924969|NCT04436276|467689472|FG022|Overall Study|Other|60|||
129924970|NCT05977530|467689474|FG000|Overall Study|Withdrawal by Subject|1|||
129924971|NCT05977530|467689474|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
130068980|NCT01432457|468207788|FG000|Overall Study|Adverse Event|7|||
129924972|NCT00506519|467691031|FG000|Overall Study|Death|4|||
129924973|NCT00506519|467691032|FG001|Overall Study|Death|6|||
129924974|NCT00506519|467691033|FG002|Overall Study|Death|0|||
129924975|NCT00506519|467691031|FG000|Overall Study|Adverse Event|1|||
129924976|NCT00506519|467691032|FG001|Overall Study|Adverse Event|0|||
129924977|NCT00506519|467691033|FG002|Overall Study|Adverse Event|0|||
129924978|NCT01129102|467691034|FG000|Overall Study|No study drug treatment|2|||
129924979|NCT01129102|467691035|FG001|Overall Study|No study drug treatment|3|||
129924980|NCT01129102|467691036|FG002|Overall Study|No study drug treatment|1|||
129924981|NCT01129102|467691034|FG000|Overall Study|Withdrawal by Subject|2|||
129924982|NCT01129102|467691035|FG001|Overall Study|Withdrawal by Subject|0|||
129924983|NCT01129102|467691036|FG002|Overall Study|Withdrawal by Subject|3|||
129924984|NCT01129102|467691034|FG000|Overall Study|Protocol Violation|0|||
129924985|NCT01129102|467691035|FG001|Overall Study|Protocol Violation|1|||
129924986|NCT01129102|467691036|FG002|Overall Study|Protocol Violation|1|||
129924987|NCT01129102|467691034|FG000|Overall Study|Pregnancy|0|||
129924988|NCT01129102|467691035|FG001|Overall Study|Pregnancy|0|||
129924989|NCT01129102|467691036|FG002|Overall Study|Pregnancy|1|||
129924990|NCT01129102|467691034|FG000|Overall Study|Adverse Event|2|||
129924991|NCT01129102|467691035|FG001|Overall Study|Adverse Event|2|||
129924992|NCT01129102|467691036|FG002|Overall Study|Adverse Event|1|||
129924993|NCT01129102|467691034|FG000|Overall Study|Lost to Follow-up|2|||
129924994|NCT01129102|467691035|FG001|Overall Study|Lost to Follow-up|0|||
129924995|NCT01129102|467691036|FG002|Overall Study|Lost to Follow-up|0|||
129924996|NCT03379675|467691037|FG000|Overall Study|Lost to Follow-up|0|||
129924997|NCT03379675|467691038|FG001|Overall Study|Lost to Follow-up|1|||
129924998|NCT03379675|467691039|FG002|Overall Study|Lost to Follow-up|0|||
129924999|NCT03379675|467691037|FG000|Overall Study|Adverse Event|2|||
129925000|NCT03379675|467691038|FG001|Overall Study|Adverse Event|0|||
129925001|NCT03379675|467691039|FG002|Overall Study|Adverse Event|0|||
129925002|NCT03379675|467691037|FG000|Overall Study|Withdrawal by Subject|2|||
129925003|NCT03379675|467691038|FG001|Overall Study|Withdrawal by Subject|1|||
129925004|NCT03379675|467691039|FG002|Overall Study|Withdrawal by Subject|2|||
129925005|NCT02979327|467691041|FG000|First Intervention|Protocol Violation|1|||
129925006|NCT02979327|467691042|FG001|First Intervention|Protocol Violation|0|||
129925007|NCT03474679|467691051|FG000|Overall Study|Death|7|||
129925008|NCT03474679|467691051|FG000|Overall Study|Withdrawal by Subject|1|||
129925009|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
129925010|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
129925011|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
129925012|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
129925013|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
129925014|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
129925015|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Death|6|||
129925016|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Death|0|||
129925017|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Death|0|||
129925018|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
129925019|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
130068981|NCT01432457|468207789|FG001|Overall Study|Adverse Event|10|||
130068982|NCT01432457|468207790|FG002|Overall Study|Adverse Event|16|||
130068983|NCT01432457|468207788|FG000|Overall Study|Lack of Efficacy|2|||
130068984|NCT01432457|468207789|FG001|Overall Study|Lack of Efficacy|1|||
130068985|NCT01432457|468207790|FG002|Overall Study|Lack of Efficacy|1|||
129925020|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
129925021|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
129925022|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
129925023|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
129925024|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
129925025|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
129925026|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
129925027|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Other|5|||
129925028|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Other|0|||
129925029|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Other|0|||
129925030|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
129925031|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
130068986|NCT01432457|468207788|FG000|Overall Study|Lost to Follow-up|11|||
129925032|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
129925033|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Other|0|||
129925034|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Other|1|||
129925035|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Other|1|||
129925036|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
129925037|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
129925038|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
129925039|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
129925040|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
129925041|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
129925042|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
129925043|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
129925044|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
129925045|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
129925046|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
129925047|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
129925048|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Death|0|||
129925049|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Death|6|||
129925050|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Death|11|||
129925051|NCT02573493|467691057|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
129925052|NCT02573493|467691058|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
129925053|NCT02573493|467691059|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
129925054|NCT02573493|467691060|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
129925055|NCT04332926|467691061|FG000|Overall Study|Withdrawal by Subject|6|||
129925056|NCT04332926|467691061|FG000|Overall Study|Physician Decision|6|||
129925057|NCT04016662|467691071|FG000|Run-In Phase|Death|1|||
129925058|NCT04016662|467691071|FG000|Run-In Phase|Withdrawal by Subject|11|||
129925059|NCT04016662|467691071|FG000|Run-In Phase|Not meeting screening eligibility|9|||
129925060|NCT04016662|467691071|FG000|Run-In Phase|Physician Decision|3|||
129925061|NCT04016662|467691071|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
129925062|NCT04016662|467691071|FG000|PLGS (12 Weeks)|Death|1|||
129925063|NCT04016662|467691071|FG000|SAP (12 Weeks)|Death|1|||
129925064|NCT01802788|467691072|FG000|Overall Study|Withdrawal by Subject|102|||
129925065|NCT01802788|467691073|FG001|Overall Study|Withdrawal by Subject|5|||
129925066|NCT01802788|467691072|FG000|Overall Study|Death|382|||
129925067|NCT01802788|467691073|FG001|Overall Study|Death|18|||
129925068|NCT01802788|467691072|FG000|Overall Study|Lost to Follow-up|31|||
129925069|NCT01802788|467691073|FG001|Overall Study|Lost to Follow-up|2|||
129925070|NCT01802788|467691072|FG000|Overall Study|Physician Decision|3|||
129925071|NCT01802788|467691073|FG001|Overall Study|Physician Decision|0|||
129925072|NCT01802788|467691072|FG000|Overall Study|Patient Non-Compliance|1|||
129925073|NCT01802788|467691073|FG001|Overall Study|Patient Non-Compliance|0|||
129925074|NCT01802788|467691072|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
129925075|NCT01802788|467691073|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
129925076|NCT01802788|467691072|FG000|Overall Study|Other Reasons|19|||
129925077|NCT01802788|467691073|FG001|Overall Study|Other Reasons|0|||
129925078|NCT03021096|467691074|FG000|Overall Study|Lost to Follow-up|4|||
129925079|NCT03021096|467691074|FG000|Overall Study|Protocol Violation|2|||
129925080|NCT03904147|467691079|FG000|Overall Study|Death|15|||
129925081|NCT03904147|467691080|FG001|Overall Study|Death|13|||
129925082|NCT03904147|467691081|FG002|Overall Study|Death|15|||
129925083|NCT03904147|467691079|FG000|Overall Study|Withdrawal by Subject|7|||
129925084|NCT03904147|467691080|FG001|Overall Study|Withdrawal by Subject|12|||
129925085|NCT03904147|467691081|FG002|Overall Study|Withdrawal by Subject|1|||
129925086|NCT03904147|467691079|FG000|Overall Study|1Y visit completed after 365 days|1|||
129925087|NCT03904147|467691080|FG001|Overall Study|1Y visit completed after 365 days|1|||
129925088|NCT03904147|467691081|FG002|Overall Study|1Y visit completed after 365 days|0|||
129925089|NCT00764751|467691089|FG000|Overall Study|Adverse Event|1|||
129925090|NCT00764751|467691090|FG001|Overall Study|Adverse Event|1|||
129925091|NCT00764751|467691089|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
129925092|NCT00764751|467691090|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
129925093|NCT03011333|467691096|FG000|Overall Study|Lost to Follow-up|0|||
129925094|NCT03011333|467691097|FG001|Overall Study|Lost to Follow-up|1|||
129925095|NCT03011333|467691098|FG002|Overall Study|Lost to Follow-up|0|||
129925096|NCT03011333|467691099|FG003|Overall Study|Lost to Follow-up|1|||
129925097|NCT03011333|467691100|FG004|Overall Study|Lost to Follow-up|4|||
129925098|NCT03011333|467691101|FG005|Overall Study|Lost to Follow-up|4|||
129925099|NCT03011333|467691102|FG006|Overall Study|Lost to Follow-up|5|||
129925100|NCT02998268|467691106|FG000|Overall Study|Adverse Event|0|||
129925101|NCT02998268|467691107|FG001|Overall Study|Adverse Event|2|||
130117354|NCT00319956|468388861|FG000|Overall Study|Death|20|||
129925102|NCT02998268|467691106|FG000|Overall Study|Withdrawal by Subject|0|||
129925103|NCT02998268|467691107|FG001|Overall Study|Withdrawal by Subject|1|||
129925104|NCT05269667|467691108|FG000|Overall Study|Study Terminated by Sponsor|4|||
130117355|NCT00319956|468388862|FG001|Overall Study|Death|24|||
129925105|NCT04413708|467691109|FG000|Overall Study|Lost to Follow-up|1|||
129925106|NCT04413708|467691110|FG001|Overall Study|Lost to Follow-up|2|||
129925107|NCT05399459|467691121|FG000|Overall Study|Randomized but not treated|29|||
129925108|NCT05399459|467691122|FG001|Overall Study|Randomized but not treated|30|||
129925109|NCT05399459|467691123|FG002|Overall Study|Randomized but not treated|38|||
129925110|NCT05399459|467691121|FG000|Overall Study|Lost to Follow-up|1|||
129925111|NCT05399459|467691122|FG001|Overall Study|Lost to Follow-up|0|||
129925112|NCT05399459|467691123|FG002|Overall Study|Lost to Follow-up|0|||
129925113|NCT03020199|467691126|FG000|Treatment Period|Adverse Event|0|||
129925114|NCT03020199|467691127|FG001|Treatment Period|Adverse Event|2|||
129925115|NCT03020199|467691126|FG000|Treatment Period|Lack of Efficacy|1|||
129925116|NCT03020199|467691127|FG001|Treatment Period|Lack of Efficacy|6|||
129925117|NCT03020199|467691126|FG000|Treatment Period|Lost to Follow-up|1|||
129925118|NCT03020199|467691127|FG001|Treatment Period|Lost to Follow-up|6|||
129925119|NCT03020199|467691126|FG000|Treatment Period|Physician Decision|0|||
129925120|NCT03020199|467691127|FG001|Treatment Period|Physician Decision|1|||
129925121|NCT03020199|467691126|FG000|Treatment Period|Subject/guardian decision|8|||
129925122|NCT03020199|467691127|FG001|Treatment Period|Subject/guardian decision|15|||
129925123|NCT03020199|467691126|FG000|Treatment Period|Subjects not treated|3|||
129925124|NCT03020199|467691127|FG001|Treatment Period|Subjects not treated|4|||
129925125|NCT03020199|467691126|FG000|Follow-up Period|Disease relapse|32|||
129925126|NCT03020199|467691127|FG001|Follow-up Period|Disease relapse|7|||
129925127|NCT03020199|467691126|FG000|Follow-up Period|Lack of Efficacy|1|||
129925128|NCT03020199|467691127|FG001|Follow-up Period|Lack of Efficacy|2|||
129925129|NCT03020199|467691126|FG000|Follow-up Period|Lost to Follow-up|4|||
129925130|NCT03020199|467691127|FG001|Follow-up Period|Lost to Follow-up|6|||
129925131|NCT03020199|467691126|FG000|Follow-up Period|Physician Decision|2|||
129925132|NCT03020199|467691127|FG001|Follow-up Period|Physician Decision|2|||
129925133|NCT03020199|467691126|FG000|Follow-up Period|Protocol Violation|1|||
129925134|NCT03020199|467691127|FG001|Follow-up Period|Protocol Violation|2|||
129925135|NCT03020199|467691126|FG000|Follow-up Period|Study terminated by Sponsor|6|||
129925136|NCT03020199|467691127|FG001|Follow-up Period|Study terminated by Sponsor|3|||
129925137|NCT03020199|467691126|FG000|Follow-up Period|Subject/guardian decision|14|||
129925138|NCT03020199|467691127|FG001|Follow-up Period|Subject/guardian decision|9|||
129925139|NCT05583578|467691128|FG000|Overall Study|Withdrawal by Subject|2|||
129925140|NCT05583578|467691129|FG001|Overall Study|Withdrawal by Subject|0|||
129925141|NCT05201079|467691130|FG000|Overall Study|Adverse Event|7|||
129925142|NCT05201079|467691131|FG001|Overall Study|Adverse Event|11|||
129925143|NCT05201079|467691130|FG000|Overall Study|Death|1|||
129925144|NCT05201079|467691131|FG001|Overall Study|Death|1|||
129925145|NCT05201079|467691130|FG000|Overall Study|Lack of Efficacy|0|||
129925146|NCT05201079|467691131|FG001|Overall Study|Lack of Efficacy|2|||
129925147|NCT05201079|467691130|FG000|Overall Study|Lost to Follow-up|0|||
129925148|NCT05201079|467691131|FG001|Overall Study|Lost to Follow-up|1|||
129925149|NCT05201079|467691130|FG000|Overall Study|Physician Decision|1|||
129925150|NCT05201079|467691131|FG001|Overall Study|Physician Decision|1|||
129925151|NCT05201079|467691130|FG000|Overall Study|Protocol Violation|1|||
129925152|NCT05201079|467691131|FG001|Overall Study|Protocol Violation|0|||
129925153|NCT05201079|467691130|FG000|Overall Study|Withdrawal by Subject|1|||
129925154|NCT05201079|467691131|FG001|Overall Study|Withdrawal by Subject|0|||
129925155|NCT05201079|467691130|FG000|Overall Study|Forbidden medication|9|||
129925156|NCT05201079|467691131|FG001|Overall Study|Forbidden medication|5|||
129925157|NCT05201079|467691130|FG000|Overall Study|Transfer to another hospital|0|||
129925158|NCT05201079|467691131|FG001|Overall Study|Transfer to another hospital|1|||
129925159|NCT05201079|467691130|FG000|Overall Study|Clinical condition|1|||
129925160|NCT05201079|467691131|FG001|Overall Study|Clinical condition|0|||
129925161|NCT05201079|467691130|FG000|Overall Study|SAE and sepsis|1|||
129925162|NCT05201079|467691131|FG001|Overall Study|SAE and sepsis|0|||
129925163|NCT05386030|467691135|FG000|Overall Study|Death|1|||
129925164|NCT05386030|467691136|FG001|Overall Study|Death|0|||
129925165|NCT05386030|467691135|FG000|Overall Study|Physician Decision|2|||
129925166|NCT05386030|467691136|FG001|Overall Study|Physician Decision|1|||
129925167|NCT05386030|467691135|FG000|Overall Study|Lost to Follow-up|19|||
129925168|NCT05386030|467691136|FG001|Overall Study|Lost to Follow-up|7|||
129925169|NCT05386030|467691135|FG000|Overall Study|Withdrawal by Subject|20|||
129925170|NCT05386030|467691136|FG001|Overall Study|Withdrawal by Subject|10|||
129925171|NCT05386030|467691135|FG000|Overall Study|Eligibility criteria violation|1|||
129925172|NCT05386030|467691136|FG001|Overall Study|Eligibility criteria violation|1|||
129925173|NCT05386030|467691135|FG000|Overall Study|Personal Reasons|1|||
129925174|NCT05386030|467691136|FG001|Overall Study|Personal Reasons|0|||
129925175|NCT04719832|467691137|FG000|Overall Study|Adverse Event|2|||
129925176|NCT04719832|467691138|FG001|Overall Study|Adverse Event|0|||
129925177|NCT04719832|467691137|FG000|Overall Study|Lack of Efficacy|2|||
129925178|NCT04719832|467691138|FG001|Overall Study|Lack of Efficacy|4|||
129925179|NCT04719832|467691137|FG000|Overall Study|Lost to Follow-up|0|||
129925180|NCT04719832|467691138|FG001|Overall Study|Lost to Follow-up|2|||
129925181|NCT04719832|467691137|FG000|Overall Study|Physician Decision|0|||
129925182|NCT04719832|467691138|FG001|Overall Study|Physician Decision|1|||
129925183|NCT04719832|467691137|FG000|Overall Study|Pregnancy|1|||
129925184|NCT04719832|467691138|FG001|Overall Study|Pregnancy|1|||
129925185|NCT04719832|467691137|FG000|Overall Study|Withdrawal by Subject|5|||
129925186|NCT04719832|467691138|FG001|Overall Study|Withdrawal by Subject|5|||
129925187|NCT04719832|467691137|FG000|Overall Study|Randomized, not treated|0|||
129925188|NCT04719832|467691138|FG001|Overall Study|Randomized, not treated|2|||
129925189|NCT04719832|467691137|FG000|Overall Study|GCP violations|4|||
129925190|NCT04719832|467691138|FG001|Overall Study|GCP violations|7|||
129925191|NCT05228457|467691139|FG000|Overall Study|Withdrawal by Subject|1|||
129925192|NCT05228457|467691140|FG001|Overall Study|Withdrawal by Subject|1|||
129925193|NCT04880863|467691141|FG000|Overall Study|Adverse Event|1|||
129925194|NCT04880863|467691141|FG000|Overall Study|Patient decision|2|||
129925195|NCT04880863|467691141|FG000|Overall Study|Confirmed Disease Progression|15|||
129925196|NCT04880863|467691141|FG000|Overall Study|Death|3|||
129925197|NCT04880863|467691141|FG000|Overall Study|Physician Decision|4|||
129925198|NCT04880863|467691141|FG000|Overall Study|Unconfirmed Disease Progression|4|||
129925199|NCT04880863|467691141|FG000|Overall Study|Withdrawal by Subject|2|||
129925200|NCT04880863|467691141|FG000|Overall Study|Study discontinuation by the sponsor|4|||
129925201|NCT04880863|467691141|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
129925202|NCT04880863|467691141|FG000|Overall Study|Not received study drug NAP|2|||
129925203|NCT04898673|467691142|FG000|Overall Study|Screenfail|1|||
129925204|NCT04898673|467691143|FG001|Overall Study|Screenfail|0|||
129925205|NCT01544114|467691146|FG000|Overall Study|Withdrawal by Subject|0|||
129925206|NCT01544114|467691147|FG001|Overall Study|Withdrawal by Subject|0|||
129925207|NCT01544114|467691148|FG002|Overall Study|Withdrawal by Subject|3|||
129925208|NCT01544114|467691146|FG000|Overall Study|Lost to Follow-up|0|||
129925209|NCT01544114|467691147|FG001|Overall Study|Lost to Follow-up|2|||
129925210|NCT01544114|467691148|FG002|Overall Study|Lost to Follow-up|0|||
129925211|NCT01544114|467691146|FG000|Overall Study|Adverse Event|1|||
129925212|NCT01544114|467691147|FG001|Overall Study|Adverse Event|1|||
129925213|NCT01544114|467691148|FG002|Overall Study|Adverse Event|2|||
129925214|NCT01544114|467691146|FG000|Overall Study|Protocol Violation|0|||
129925215|NCT01544114|467691147|FG001|Overall Study|Protocol Violation|1|||
129925216|NCT01544114|467691148|FG002|Overall Study|Protocol Violation|0|||
129925217|NCT01733316|467691153|FG000|RP103 Phase|Non-compliance|1|||
129925218|NCT01733316|467691153|FG000|Long Term Extension Phase|Adverse Event|1|||
129925219|NCT01733316|467691153|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
129925220|NCT01733316|467691153|FG000|Long Term Extension Phase|Sponsor Decision|2|||
129925221|NCT05239455|467691163|FG000|Overall Study|Adverse Event|1|||
129925222|NCT05239455|467691163|FG000|Overall Study|Sponsor Decision|5|||
129925223|NCT05239455|467691163|FG000|Overall Study|Incomplete Blood Collection|1|||
129925224|NCT01799265|467691164|FG000|Overall Study|Lost to Follow-up|1|||
129925225|NCT01799265|467691165|FG001|Overall Study|Lost to Follow-up|0|||
129925226|NCT01799265|467691164|FG000|Overall Study|Protocol Violation|2|||
129925227|NCT01799265|467691165|FG001|Overall Study|Protocol Violation|1|||
129925228|NCT01799265|467691164|FG000|Overall Study|inadequate sleep study|0|||
129925229|NCT01799265|467691165|FG001|Overall Study|inadequate sleep study|2|||
129925230|NCT03459729|467691166|FG000|Overall Study|Physician Decision|2|||
129925231|NCT04200456|467691171|FG000|Overall Study|Physician Decision|0|||
129925232|NCT04200456|467691172|FG001|Overall Study|Physician Decision|1|||
129925233|NCT04200456|467691171|FG000|Overall Study|Withdrawal by Subject|2|||
129925234|NCT04200456|467691172|FG001|Overall Study|Withdrawal by Subject|2|||
129925235|NCT04200456|467691171|FG000|Overall Study|Lack of Efficacy|1|||
129925236|NCT04200456|467691172|FG001|Overall Study|Lack of Efficacy|1|||
129925237|NCT04200456|467691171|FG000|Overall Study|Adverse event, non-fatal|0|||
129925238|NCT04200456|467691172|FG001|Overall Study|Adverse event, non-fatal|1|||
129925239|NCT04200456|467691171|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
129925240|NCT04200456|467691172|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
129925241|NCT01186367|467693331|FG000|Overall Study|Lost to Follow-up|7|||
129925242|NCT01186367|467693332|FG001|Overall Study|Lost to Follow-up|4|||
129925243|NCT01186367|467693333|FG002|Overall Study|Lost to Follow-up|7|||
129925244|NCT01186367|467693331|FG000|Overall Study|Did not receive study treatment|0|||
129925245|NCT01186367|467693332|FG001|Overall Study|Did not receive study treatment|1|||
129925246|NCT01186367|467693333|FG002|Overall Study|Did not receive study treatment|0|||
129925247|NCT03945292|467693334|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
129925248|NCT03945292|467693335|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925249|NCT03945292|467693336|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
129925250|NCT03945292|467693337|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925251|NCT03945292|467693338|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925252|NCT03945292|467693339|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925253|NCT03945292|467693340|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925254|NCT03945292|467693341|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925255|NCT03945292|467693334|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925256|NCT03945292|467693335|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
130068987|NCT01432457|468207789|FG001|Overall Study|Lost to Follow-up|15|||
129925257|NCT03945292|467693336|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
129925258|NCT03945292|467693337|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925259|NCT03945292|467693338|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925260|NCT03945292|467693339|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925261|NCT03945292|467693340|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925262|NCT03945292|467693341|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925263|NCT03945292|467693334|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925264|NCT03945292|467693335|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925265|NCT03945292|467693336|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925266|NCT03945292|467693337|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925267|NCT03945292|467693338|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925268|NCT03945292|467693339|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925269|NCT03945292|467693340|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925270|NCT03945292|467693341|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
129925271|NCT04987320|467693342|FG000|Overall Study|Withdrawal by Subject|0|||
129925272|NCT04987320|467693343|FG001|Overall Study|Withdrawal by Subject|1|||
129925273|NCT02675751|467693346|FG000|Overall Study|Lost to Follow-up|16|||
129925274|NCT03371381|467693347|FG000|Overall Study|Death|5|||
129925275|NCT03371381|467693347|FG000|Overall Study|Study terminated by sponsor|3|||
129925276|NCT03371381|467693347|FG000|Overall Study|Other|4|||
129925277|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
129925278|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925279|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925280|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925281|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925282|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925283|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925284|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925285|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925286|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
129925287|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925288|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925289|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925290|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925291|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
129925292|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
129925293|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
129925294|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925295|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925296|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925297|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925298|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925299|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
129925300|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925301|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925302|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925303|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925304|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925305|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
129925306|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925307|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
129925308|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925309|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925310|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925311|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925312|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
129925313|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
129925314|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
129925315|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
129925316|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
129925317|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
129925318|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
129925319|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925320|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925321|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925322|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
129925323|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925324|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
129925325|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
129925326|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925327|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925328|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925329|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
129925330|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
129925331|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925332|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
129925333|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
129925334|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
129925335|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
129925336|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
129925337|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
129925338|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
129925339|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
129925340|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925341|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925342|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925343|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925344|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
129925345|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
129925346|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
129925347|NCT06019559|467693355|FG000|Overall Study|Withdrawal by Subject|7|||
129925348|NCT06019559|467693356|FG001|Overall Study|Withdrawal by Subject|6|||
129925349|NCT06019559|467693357|FG002|Overall Study|Withdrawal by Subject|5|||
129925350|NCT06019559|467693355|FG000|Overall Study|Lost to Follow-up|2|||
129925351|NCT06019559|467693356|FG001|Overall Study|Lost to Follow-up|0|||
129925352|NCT06019559|467693357|FG002|Overall Study|Lost to Follow-up|3|||
129925353|NCT06215521|467693359|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925354|NCT06215521|467693360|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
129925355|NCT06215521|467693361|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925356|NCT06215521|467693362|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925357|NCT06215521|467693363|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925358|NCT06215521|467693364|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925359|NCT04044768|467693365|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
129925360|NCT04044768|467693366|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
129925361|NCT01574274|467693367|FG000|Overall Study|Ineligible|0|||
129925362|NCT01574274|467693368|FG001|Overall Study|Ineligible|1|||
129925363|NCT01574274|467693367|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
129925364|NCT01574274|467693368|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
129925365|NCT01574274|467693367|FG000|Overall Study|Ph+ B-ALL|3|||
129925366|NCT01574274|467693368|FG001|Overall Study|Ph+ B-ALL|4|||
129925367|NCT01574274|467693367|FG000|Overall Study|Induction Death|2|||
129925368|NCT01574274|467693368|FG001|Overall Study|Induction Death|0|||
129925369|NCT01574274|467693367|FG000|Overall Study|Induction Failure|4|||
129925370|NCT01574274|467693368|FG001|Overall Study|Induction Failure|1|||
129925371|NCT01574274|467693367|FG000|Overall Study|Adverse Event|16|||
129925372|NCT01574274|467693368|FG001|Overall Study|Adverse Event|13|||
129925373|NCT01574274|467693367|FG000|Overall Study|Remission Death|1|||
129925374|NCT01574274|467693368|FG001|Overall Study|Remission Death|0|||
129925375|NCT01574274|467693367|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
129925376|NCT01574274|467693368|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
129925377|NCT01574274|467693367|FG000|Overall Study|Other, unknown|3|||
129925378|NCT01574274|467693368|FG001|Overall Study|Other, unknown|2|||
129925379|NCT05089019|467693372|FG000|Period 1|Withdrawal by Subject|0|||
129925380|NCT05089019|467693373|FG001|Period 1|Withdrawal by Subject|1|||
129925381|NCT05089019|467693372|FG000|Washout Period|Adverse Event|3|||
129925382|NCT05089019|467693373|FG001|Washout Period|Adverse Event|4|||
129925383|NCT05089019|467693372|FG000|Washout Period|Lost to Follow-up|1|||
129925384|NCT05089019|467693373|FG001|Washout Period|Lost to Follow-up|0|||
129925385|NCT05089019|467693372|FG000|Washout Period|Physician Decision|2|||
129925386|NCT05089019|467693373|FG001|Washout Period|Physician Decision|0|||
129925387|NCT05089019|467693372|FG000|Washout Period|Withdrawal by Subject|6|||
129925388|NCT05089019|467693373|FG001|Washout Period|Withdrawal by Subject|3|||
129925389|NCT05089019|467693372|FG000|Period 2|Adverse Event|4|||
129925390|NCT05089019|467693373|FG001|Period 2|Adverse Event|2|||
129925391|NCT05089019|467693372|FG000|Period 2|Lost to Follow-up|1|||
129925392|NCT05089019|467693373|FG001|Period 2|Lost to Follow-up|0|||
129925393|NCT05089019|467693372|FG000|Period 2|Withdrawal by Subject|0|||
129925394|NCT05089019|467693373|FG001|Period 2|Withdrawal by Subject|1|||
129925395|NCT03858634|467693374|FG000|Overall Study|Withdrawal by Subject|1|||
129925396|NCT03858634|467693375|FG001|Overall Study|Withdrawal by Subject|0|||
129925397|NCT03858634|467693374|FG000|Overall Study|Adverse Event|1|||
129925398|NCT03858634|467693375|FG001|Overall Study|Adverse Event|0|||
129925399|NCT03858634|467693374|FG000|Overall Study|Lost to Follow-up|0|||
129925400|NCT03858634|467693375|FG001|Overall Study|Lost to Follow-up|1|||
129925401|NCT03858634|467693374|FG000|Overall Study|Other, Not Specified|1|||
129925402|NCT03858634|467693375|FG001|Overall Study|Other, Not Specified|1|||
129925403|NCT04676763|467693376|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
129925404|NCT04676763|467693377|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
129925405|NCT04676763|467693378|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
129925406|NCT04676763|467693376|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
129925407|NCT04676763|467693377|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
129925408|NCT04676763|467693378|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
129925409|NCT04676763|467693376|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
129925410|NCT04676763|467693377|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
129925411|NCT04676763|467693378|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
129925412|NCT03150173|467693379|FG000|Overall Study|Lost to Follow-up|13|||
129925413|NCT03150173|467693380|FG001|Overall Study|Lost to Follow-up|5|||
129925414|NCT01593917|467693381|FG000|Overall Study|Death|67|||
129925415|NCT01593917|467693381|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
129925416|NCT01593917|467693381|FG000|Overall Study|Withdrawal by Subject|23|||
129925417|NCT01593917|467693381|FG000|Overall Study|Lost to Follow-up|12|||
129925418|NCT01593917|467693381|FG000|Overall Study|Protocol Violation|5|||
129925419|NCT01593917|467693381|FG000|Overall Study|Physician Decision|3|||
129925420|NCT02043678|467693386|FG000|Overall Study|Never treated|11|||
129925421|NCT02043678|467693387|FG001|Overall Study|Never treated|9|||
129925422|NCT02043678|467693386|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
129925423|NCT02043678|467693387|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
129925424|NCT02043678|467693386|FG000|Overall Study|AE without clinical PD|54|||
129925425|NCT02043678|467693387|FG001|Overall Study|AE without clinical PD|36|||
129925426|NCT02043678|467693386|FG000|Overall Study|Lost to Follow-up|1|||
129925427|NCT02043678|467693387|FG001|Overall Study|Lost to Follow-up|1|||
129925428|NCT02043678|467693386|FG000|Overall Study|Other|10|||
129925429|NCT02043678|467693387|FG001|Overall Study|Other|14|||
129925430|NCT02043678|467693386|FG000|Overall Study|Clinical PD|114|||
129925431|NCT02043678|467693387|FG001|Overall Study|Clinical PD|148|||
129925432|NCT02043678|467693386|FG000|Overall Study|Radiological PD|100|||
129925433|NCT02043678|467693387|FG001|Overall Study|Radiological PD|90|||
129925434|NCT02043678|467693386|FG000|Overall Study|Protocol-driven decision point|59|||
129925435|NCT02043678|467693387|FG001|Overall Study|Protocol-driven decision point|58|||
129925436|NCT02043678|467693386|FG000|Overall Study|Withdrawal by Subject|16|||
129925437|NCT02043678|467693387|FG001|Overall Study|Withdrawal by Subject|20|||
129925438|NCT02043678|467693386|FG000|Overall Study|Protocol Violation|1|||
129925439|NCT02043678|467693387|FG001|Overall Study|Protocol Violation|0|||
129925440|NCT02043678|467693386|FG000|Overall Study|Deterioration of general conditions|1|||
129925441|NCT02043678|467693387|FG001|Overall Study|Deterioration of general conditions|1|||
129925442|NCT02043678|467693386|FG000|Overall Study|Logistical difficulties|2|||
129925443|NCT02043678|467693387|FG001|Overall Study|Logistical difficulties|0|||
129925444|NCT02043678|467693386|FG000|Overall Study|Non-compliance with study drug|3|||
129925445|NCT02043678|467693387|FG001|Overall Study|Non-compliance with study drug|1|||
129925446|NCT02043678|467693386|FG000|Overall Study|Physician Decision|4|||
129925447|NCT02043678|467693387|FG001|Overall Study|Physician Decision|3|||
129925448|NCT02043678|467693386|FG000|Overall Study|Subject decision|0|||
129925449|NCT02043678|467693387|FG001|Overall Study|Subject decision|1|||
129925450|NCT02043678|467693386|FG000|Overall Study|Switching to other therapy|3|||
129925451|NCT02043678|467693387|FG001|Overall Study|Switching to other therapy|2|||
129925452|NCT02043678|467693386|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
129925453|NCT02043678|467693387|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
129925454|NCT02043678|467693386|FG000|Overall Study|Missing|1|||
129925455|NCT02043678|467693387|FG001|Overall Study|Missing|0|||
129925456|NCT02043678|467693386|FG000|Overall Study|Adverse Event|0|||
129925457|NCT02043678|467693387|FG001|Overall Study|Adverse Event|1|||
129925458|NCT05543629|467693388|FG000|Overall Study|Death|1|||
129925459|NCT05543629|467693389|FG001|Overall Study|Death|0|||
129925460|NCT05543629|467693390|FG002|Overall Study|Death|1|||
129925461|NCT05543629|467693391|FG003|Overall Study|Death|0|||
129925462|NCT05543629|467693392|FG004|Overall Study|Death|0|||
129925463|NCT05543629|467693393|FG005|Overall Study|Death|1|||
129925464|NCT05543629|467693394|FG006|Overall Study|Death|2|||
129925465|NCT05543629|467693395|FG007|Overall Study|Death|2|||
129925466|NCT05543629|467693388|FG000|Overall Study|Other Reasons|0|||
129925467|NCT05543629|467693389|FG001|Overall Study|Other Reasons|0|||
129925468|NCT05543629|467693390|FG002|Overall Study|Other Reasons|0|||
129925469|NCT05543629|467693391|FG003|Overall Study|Other Reasons|0|||
129925470|NCT05543629|467693392|FG004|Overall Study|Other Reasons|1|||
129925471|NCT05543629|467693393|FG005|Overall Study|Other Reasons|0|||
129925472|NCT05543629|467693394|FG006|Overall Study|Other Reasons|0|||
129925473|NCT05543629|467693395|FG007|Overall Study|Other Reasons|0|||
129925474|NCT05543629|467693388|FG000|Overall Study|Physician Decision|0|||
129925475|NCT05543629|467693389|FG001|Overall Study|Physician Decision|0|||
129925476|NCT05543629|467693390|FG002|Overall Study|Physician Decision|3|||
129925477|NCT05543629|467693391|FG003|Overall Study|Physician Decision|0|||
129925478|NCT05543629|467693392|FG004|Overall Study|Physician Decision|0|||
129925479|NCT05543629|467693393|FG005|Overall Study|Physician Decision|0|||
129925480|NCT05543629|467693394|FG006|Overall Study|Physician Decision|1|||
129925481|NCT05543629|467693395|FG007|Overall Study|Physician Decision|0|||
129925482|NCT05543629|467693388|FG000|Overall Study|Study terminated by Sponsor|1|||
129925483|NCT05543629|467693389|FG001|Overall Study|Study terminated by Sponsor|0|||
129925484|NCT05543629|467693390|FG002|Overall Study|Study terminated by Sponsor|0|||
129925485|NCT05543629|467693391|FG003|Overall Study|Study terminated by Sponsor|1|||
129925486|NCT05543629|467693392|FG004|Overall Study|Study terminated by Sponsor|0|||
129925487|NCT05543629|467693393|FG005|Overall Study|Study terminated by Sponsor|4|||
129925488|NCT05543629|467693394|FG006|Overall Study|Study terminated by Sponsor|1|||
129925489|NCT05543629|467693395|FG007|Overall Study|Study terminated by Sponsor|0|||
129925490|NCT05543629|467693388|FG000|Overall Study|Withdrawal by Subject|1|||
129925491|NCT05543629|467693389|FG001|Overall Study|Withdrawal by Subject|1|||
129925492|NCT05543629|467693390|FG002|Overall Study|Withdrawal by Subject|0|||
129925493|NCT05543629|467693391|FG003|Overall Study|Withdrawal by Subject|2|||
129925494|NCT05543629|467693392|FG004|Overall Study|Withdrawal by Subject|1|||
129925495|NCT05543629|467693393|FG005|Overall Study|Withdrawal by Subject|1|||
129925496|NCT05543629|467693394|FG006|Overall Study|Withdrawal by Subject|1|||
129925497|NCT05543629|467693395|FG007|Overall Study|Withdrawal by Subject|1|||
129925498|NCT05543629|467693388|FG000|Overall Study|Not Reported|2|||
129925499|NCT05543629|467693389|FG001|Overall Study|Not Reported|2|||
129925500|NCT05543629|467693390|FG002|Overall Study|Not Reported|0|||
129925501|NCT05543629|467693391|FG003|Overall Study|Not Reported|0|||
129925502|NCT05543629|467693392|FG004|Overall Study|Not Reported|1|||
129925503|NCT05543629|467693393|FG005|Overall Study|Not Reported|1|||
129925504|NCT05543629|467693394|FG006|Overall Study|Not Reported|3|||
129925505|NCT05543629|467693395|FG007|Overall Study|Not Reported|0|||
129925506|NCT03216057|467693396|FG000|Overall Study|Lost to Follow-up|2|||
129925507|NCT03216057|467693397|FG001|Overall Study|Lost to Follow-up|2|||
129925508|NCT04568603|467693398|FG000|Overall Study|Physician Decision|1|||
129925509|NCT04564742|467693399|FG000|Overall Study|Lost to Follow-up|1|||
129925510|NCT04564742|467693400|FG001|Overall Study|Lost to Follow-up|0|||
129925511|NCT04564742|467693399|FG000|Overall Study|Consent Withdrawal|4|||
129925512|NCT04564742|467693400|FG001|Overall Study|Consent Withdrawal|4|||
129925513|NCT03313076|467693404|FG000|Overall Study|Withdrawal by Subject|2|||
129925514|NCT03313076|467693405|FG001|Overall Study|Withdrawal by Subject|0|||
129925515|NCT03313076|467693406|FG002|Overall Study|Withdrawal by Subject|0|||
129925516|NCT03313076|467693407|FG003|Overall Study|Withdrawal by Subject|0|||
129925517|NCT03313076|467693404|FG000|Overall Study|Lost to Follow-up|0|||
129925518|NCT03313076|467693405|FG001|Overall Study|Lost to Follow-up|2|||
129925519|NCT03313076|467693406|FG002|Overall Study|Lost to Follow-up|2|||
129925520|NCT03313076|467693407|FG003|Overall Study|Lost to Follow-up|2|||
129925521|NCT04307355|467693408|FG000|Overall Study|Non-Compliance|3|||
129925522|NCT04307355|467693409|FG001|Overall Study|Non-Compliance|3|||
129925523|NCT04307355|467693410|FG002|Overall Study|Non-Compliance|0|||
129925524|NCT04032704|467693414|FG000|Part A|Withdrawal by Subject|0|||
129925525|NCT04032704|467693415|FG001|Part A|Withdrawal by Subject|0|||
129925526|NCT04032704|467693416|FG002|Part A|Withdrawal by Subject|3|||
129925527|NCT04032704|467693417|FG003|Part A|Withdrawal by Subject|0|||
129925528|NCT04032704|467693418|FG004|Part A|Withdrawal by Subject|1|||
129925529|NCT04032704|467693419|FG005|Part A|Withdrawal by Subject|7|||
129925530|NCT04032704|467693420|FG006|Part A|Withdrawal by Subject|0|||
129925531|NCT04032704|467693421|FG007|Part A|Withdrawal by Subject|0|||
129925532|NCT04032704|467693422|FG008|Part A|Withdrawal by Subject|0|||
129925533|NCT04032704|467693423|FG009|Part A|Withdrawal by Subject|0|||
129925534|NCT04032704|467693424|FG010|Part A|Withdrawal by Subject|0|||
129925535|NCT04032704|467693425|FG011|Part A|Withdrawal by Subject|0|||
129925536|NCT04032704|467693426|FG012|Part A|Withdrawal by Subject|0|||
129925537|NCT04032704|467693427|FG013|Part A|Withdrawal by Subject|0|||
129925538|NCT04032704|467693428|FG014|Part A|Withdrawal by Subject|0|||
129925539|NCT04032704|467693429|FG015|Part A|Withdrawal by Subject|0|||
129925540|NCT04032704|467693430|FG016|Part A|Withdrawal by Subject|0|||
129925541|NCT04032704|467693431|FG017|Part A|Withdrawal by Subject|0|||
129925542|NCT04032704|467693414|FG000|Part A|Lost to Follow-up|1|||
129925543|NCT04032704|467693415|FG001|Part A|Lost to Follow-up|0|||
129925544|NCT04032704|467693416|FG002|Part A|Lost to Follow-up|0|||
129925545|NCT04032704|467693417|FG003|Part A|Lost to Follow-up|0|||
129925546|NCT04032704|467693418|FG004|Part A|Lost to Follow-up|0|||
129925547|NCT04032704|467693419|FG005|Part A|Lost to Follow-up|0|||
129925548|NCT04032704|467693420|FG006|Part A|Lost to Follow-up|0|||
129925549|NCT04032704|467693421|FG007|Part A|Lost to Follow-up|0|||
129925550|NCT04032704|467693422|FG008|Part A|Lost to Follow-up|0|||
129925551|NCT04032704|467693423|FG009|Part A|Lost to Follow-up|0|||
129925552|NCT04032704|467693424|FG010|Part A|Lost to Follow-up|0|||
129925553|NCT04032704|467693425|FG011|Part A|Lost to Follow-up|0|||
129925554|NCT04032704|467693426|FG012|Part A|Lost to Follow-up|0|||
129925555|NCT04032704|467693427|FG013|Part A|Lost to Follow-up|0|||
129925556|NCT04032704|467693428|FG014|Part A|Lost to Follow-up|0|||
129925557|NCT04032704|467693429|FG015|Part A|Lost to Follow-up|0|||
129925558|NCT04032704|467693430|FG016|Part A|Lost to Follow-up|0|||
129925559|NCT04032704|467693431|FG017|Part A|Lost to Follow-up|0|||
129925560|NCT04032704|467693414|FG000|Part A|Death|9|||
129925561|NCT04032704|467693415|FG001|Part A|Death|2|||
129925562|NCT04032704|467693416|FG002|Part A|Death|10|||
129925563|NCT04032704|467693417|FG003|Part A|Death|7|||
129925564|NCT04032704|467693418|FG004|Part A|Death|4|||
129925565|NCT04032704|467693419|FG005|Part A|Death|5|||
129925566|NCT04032704|467693420|FG006|Part A|Death|0|||
129925567|NCT04032704|467693421|FG007|Part A|Death|0|||
129925568|NCT04032704|467693422|FG008|Part A|Death|0|||
129925569|NCT04032704|467693423|FG009|Part A|Death|0|||
129925570|NCT04032704|467693424|FG010|Part A|Death|0|||
129925571|NCT04032704|467693425|FG011|Part A|Death|0|||
129925572|NCT04032704|467693426|FG012|Part A|Death|0|||
129925573|NCT04032704|467693427|FG013|Part A|Death|0|||
129925574|NCT04032704|467693428|FG014|Part A|Death|0|||
129925575|NCT04032704|467693429|FG015|Part A|Death|0|||
129925576|NCT04032704|467693430|FG016|Part A|Death|0|||
129925577|NCT04032704|467693431|FG017|Part A|Death|0|||
129925578|NCT04032704|467693414|FG000|Part B|Other|0|||
129925579|NCT04032704|467693415|FG001|Part B|Other|0|||
129925580|NCT04032704|467693416|FG002|Part B|Other|0|||
129925581|NCT04032704|467693417|FG003|Part B|Other|0|||
129925582|NCT04032704|467693418|FG004|Part B|Other|0|||
129925583|NCT04032704|467693419|FG005|Part B|Other|0|||
129925584|NCT04032704|467693420|FG006|Part B|Other|0|||
129925585|NCT04032704|467693421|FG007|Part B|Other|1|||
129925586|NCT04032704|467693422|FG008|Part B|Other|2|||
129925587|NCT04032704|467693423|FG009|Part B|Other|1|||
129925588|NCT04032704|467693424|FG010|Part B|Other|1|||
129925589|NCT04032704|467693425|FG011|Part B|Other|1|||
129925590|NCT04032704|467693426|FG012|Part B|Other|5|||
130117356|NCT02607800|468388864|FG000|Overall Study|Lost to Follow-up|7|||
129925591|NCT04032704|467693427|FG013|Part B|Other|13|||
129925592|NCT04032704|467693428|FG014|Part B|Other|0|||
129925593|NCT04032704|467693429|FG015|Part B|Other|0|||
129925594|NCT04032704|467693430|FG016|Part B|Other|0|||
129925595|NCT04032704|467693431|FG017|Part B|Other|0|||
129925596|NCT04032704|467693414|FG000|Part B|Study termination by Sponsor|0|||
129925597|NCT04032704|467693415|FG001|Part B|Study termination by Sponsor|0|||
129925598|NCT04032704|467693416|FG002|Part B|Study termination by Sponsor|0|||
129925599|NCT04032704|467693417|FG003|Part B|Study termination by Sponsor|0|||
129925600|NCT04032704|467693418|FG004|Part B|Study termination by Sponsor|0|||
129925601|NCT04032704|467693419|FG005|Part B|Study termination by Sponsor|0|||
129925602|NCT04032704|467693420|FG006|Part B|Study termination by Sponsor|0|||
129925603|NCT04032704|467693421|FG007|Part B|Study termination by Sponsor|0|||
129925604|NCT04032704|467693422|FG008|Part B|Study termination by Sponsor|1|||
129925605|NCT04032704|467693423|FG009|Part B|Study termination by Sponsor|0|||
129925606|NCT04032704|467693424|FG010|Part B|Study termination by Sponsor|0|||
129925607|NCT04032704|467693425|FG011|Part B|Study termination by Sponsor|0|||
129925608|NCT04032704|467693426|FG012|Part B|Study termination by Sponsor|0|||
129925609|NCT04032704|467693427|FG013|Part B|Study termination by Sponsor|0|||
129925610|NCT04032704|467693428|FG014|Part B|Study termination by Sponsor|0|||
129925611|NCT04032704|467693429|FG015|Part B|Study termination by Sponsor|0|||
129925612|NCT04032704|467693430|FG016|Part B|Study termination by Sponsor|0|||
129925613|NCT04032704|467693431|FG017|Part B|Study termination by Sponsor|0|||
129925614|NCT04032704|467693414|FG000|Part B|Withdrawal by Subject|0|||
129925615|NCT04032704|467693415|FG001|Part B|Withdrawal by Subject|0|||
129925616|NCT04032704|467693416|FG002|Part B|Withdrawal by Subject|0|||
129925617|NCT04032704|467693417|FG003|Part B|Withdrawal by Subject|0|||
130117357|NCT02607800|468388865|FG001|Overall Study|Lost to Follow-up|10|||
130117358|NCT02607800|468388864|FG000|Overall Study|Withdrew Consent|2|||
129925618|NCT04032704|467693418|FG004|Part B|Withdrawal by Subject|0|||
129925619|NCT04032704|467693419|FG005|Part B|Withdrawal by Subject|0|||
129925620|NCT04032704|467693420|FG006|Part B|Withdrawal by Subject|3|||
129925621|NCT04032704|467693421|FG007|Part B|Withdrawal by Subject|2|||
129925622|NCT04032704|467693422|FG008|Part B|Withdrawal by Subject|2|||
129925623|NCT04032704|467693423|FG009|Part B|Withdrawal by Subject|1|||
129925624|NCT04032704|467693424|FG010|Part B|Withdrawal by Subject|4|||
129925625|NCT04032704|467693425|FG011|Part B|Withdrawal by Subject|6|||
129925626|NCT04032704|467693426|FG012|Part B|Withdrawal by Subject|2|||
129925627|NCT04032704|467693427|FG013|Part B|Withdrawal by Subject|1|||
129925628|NCT04032704|467693428|FG014|Part B|Withdrawal by Subject|0|||
129925629|NCT04032704|467693429|FG015|Part B|Withdrawal by Subject|1|||
129925630|NCT04032704|467693430|FG016|Part B|Withdrawal by Subject|0|||
129925631|NCT04032704|467693431|FG017|Part B|Withdrawal by Subject|0|||
129925632|NCT04032704|467693414|FG000|Part B|Lost to Follow-up|0|||
129925633|NCT04032704|467693415|FG001|Part B|Lost to Follow-up|0|||
129925634|NCT04032704|467693416|FG002|Part B|Lost to Follow-up|0|||
129925635|NCT04032704|467693417|FG003|Part B|Lost to Follow-up|0|||
129925636|NCT04032704|467693418|FG004|Part B|Lost to Follow-up|0|||
129925637|NCT04032704|467693419|FG005|Part B|Lost to Follow-up|0|||
129925638|NCT04032704|467693420|FG006|Part B|Lost to Follow-up|0|||
129925639|NCT04032704|467693421|FG007|Part B|Lost to Follow-up|0|||
129925640|NCT04032704|467693422|FG008|Part B|Lost to Follow-up|0|||
129925641|NCT04032704|467693423|FG009|Part B|Lost to Follow-up|0|||
129925642|NCT04032704|467693424|FG010|Part B|Lost to Follow-up|0|||
129925643|NCT04032704|467693425|FG011|Part B|Lost to Follow-up|1|||
129925644|NCT04032704|467693426|FG012|Part B|Lost to Follow-up|0|||
129925645|NCT04032704|467693427|FG013|Part B|Lost to Follow-up|0|||
129925646|NCT04032704|467693428|FG014|Part B|Lost to Follow-up|0|||
129925647|NCT04032704|467693429|FG015|Part B|Lost to Follow-up|0|||
129925648|NCT04032704|467693430|FG016|Part B|Lost to Follow-up|0|||
129925649|NCT04032704|467693431|FG017|Part B|Lost to Follow-up|0|||
129925650|NCT04032704|467693414|FG000|Part B|Death|0|||
129925651|NCT04032704|467693415|FG001|Part B|Death|0|||
129925652|NCT04032704|467693416|FG002|Part B|Death|0|||
129925653|NCT04032704|467693417|FG003|Part B|Death|0|||
129925654|NCT04032704|467693418|FG004|Part B|Death|0|||
129925655|NCT04032704|467693419|FG005|Part B|Death|0|||
129925656|NCT04032704|467693420|FG006|Part B|Death|13|||
129925657|NCT04032704|467693421|FG007|Part B|Death|13|||
129925658|NCT04032704|467693422|FG008|Part B|Death|14|||
129925659|NCT04032704|467693423|FG009|Part B|Death|12|||
129925660|NCT04032704|467693424|FG010|Part B|Death|12|||
129925661|NCT04032704|467693425|FG011|Part B|Death|13|||
129925662|NCT04032704|467693426|FG012|Part B|Death|7|||
129925663|NCT04032704|467693427|FG013|Part B|Death|17|||
129925664|NCT04032704|467693428|FG014|Part B|Death|2|||
129925665|NCT04032704|467693429|FG015|Part B|Death|1|||
129925666|NCT04032704|467693430|FG016|Part B|Death|2|||
129925667|NCT04032704|467693431|FG017|Part B|Death|2|||
129925668|NCT02861300|467693432|FG000|Overall Study|Death|0|||
129925669|NCT02861300|467693433|FG001|Overall Study|Death|0|||
129925670|NCT02861300|467693434|FG002|Overall Study|Death|0|||
129925671|NCT02861300|467693435|FG003|Overall Study|Death|0|||
129925672|NCT02861300|467693436|FG004|Overall Study|Death|0|||
129925673|NCT02861300|467693437|FG005|Overall Study|Death|0|||
129925674|NCT02861300|467693438|FG006|Overall Study|Death|24|||
129925675|NCT02861300|467693432|FG000|Overall Study|Delay in treatment|0|||
129925676|NCT02861300|467693433|FG001|Overall Study|Delay in treatment|0|||
129925677|NCT02861300|467693434|FG002|Overall Study|Delay in treatment|0|||
129925678|NCT02861300|467693435|FG003|Overall Study|Delay in treatment|0|||
129925679|NCT02861300|467693436|FG004|Overall Study|Delay in treatment|0|||
129925680|NCT02861300|467693437|FG005|Overall Study|Delay in treatment|1|||
129925681|NCT02861300|467693438|FG006|Overall Study|Delay in treatment|0|||
129925682|NCT02861300|467693432|FG000|Overall Study|Disease Progression|0|||
129925683|NCT02861300|467693433|FG001|Overall Study|Disease Progression|1|||
129925684|NCT02861300|467693434|FG002|Overall Study|Disease Progression|0|||
129925685|NCT02861300|467693435|FG003|Overall Study|Disease Progression|0|||
129925686|NCT02861300|467693436|FG004|Overall Study|Disease Progression|0|||
129925687|NCT02861300|467693437|FG005|Overall Study|Disease Progression|0|||
129925688|NCT02861300|467693438|FG006|Overall Study|Disease Progression|2|||
129925689|NCT02861300|467693432|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
129925690|NCT02861300|467693433|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
129925691|NCT02861300|467693434|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
129925692|NCT02861300|467693435|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
129925693|NCT02861300|467693436|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
129925694|NCT02861300|467693437|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
129925695|NCT02861300|467693438|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
129925696|NCT02861300|467693432|FG000|Overall Study|Clinical Complications|0|||
129925697|NCT02861300|467693433|FG001|Overall Study|Clinical Complications|0|||
129925698|NCT02861300|467693434|FG002|Overall Study|Clinical Complications|0|||
129925699|NCT02861300|467693435|FG003|Overall Study|Clinical Complications|0|||
129925700|NCT02861300|467693436|FG004|Overall Study|Clinical Complications|0|||
129925701|NCT02861300|467693437|FG005|Overall Study|Clinical Complications|0|||
129925702|NCT02861300|467693438|FG006|Overall Study|Clinical Complications|1|||
129925703|NCT02465268|467693439|FG000|Overall Study|Withdrawal by Subject|4|||
129925704|NCT02465268|467693440|FG001|Overall Study|Withdrawal by Subject|3|||
129925705|NCT02465268|467693441|FG002|Overall Study|Withdrawal by Subject|1|||
129925706|NCT02465268|467693439|FG000|Overall Study|Not evaluable per protocol criteria|3|||
129925707|NCT02465268|467693440|FG001|Overall Study|Not evaluable per protocol criteria|2|||
129925708|NCT02465268|467693441|FG002|Overall Study|Not evaluable per protocol criteria|1|||
129925709|NCT02465268|467693439|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
129925710|NCT02465268|467693440|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
129925711|NCT02465268|467693441|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
129925712|NCT02465268|467693439|FG000|Overall Study|Study drug did not pass QA/QC|1|||
129925713|NCT02465268|467693440|FG001|Overall Study|Study drug did not pass QA/QC|0|||
129925714|NCT02465268|467693441|FG002|Overall Study|Study drug did not pass QA/QC|0|||
129925715|NCT02465268|467693439|FG000|Overall Study|Adverse Event|0|||
129925716|NCT02465268|467693440|FG001|Overall Study|Adverse Event|1|||
129925717|NCT02465268|467693441|FG002|Overall Study|Adverse Event|0|||
129925718|NCT02465268|467693439|FG000|Overall Study|Physician Decision|0|||
129925719|NCT02465268|467693440|FG001|Overall Study|Physician Decision|1|||
129925720|NCT02465268|467693441|FG002|Overall Study|Physician Decision|0|||
129925721|NCT03133546|467693442|FG000|Overall Study|Death|46|||
129925722|NCT03133546|467693443|FG001|Overall Study|Death|43|||
129925723|NCT03133546|467693442|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
129925724|NCT03133546|467693443|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
129925725|NCT04907851|467693444|FG000|Overall Study|Consent withdrawn|1|||
129925726|NCT04907851|467693445|FG001|Overall Study|Consent withdrawn|2|||
129925727|NCT04907851|467693446|FG002|Overall Study|Consent withdrawn|0|||
129925728|NCT04907851|467693444|FG000|Overall Study|Death|5|||
129925729|NCT04907851|467693445|FG001|Overall Study|Death|15|||
129925730|NCT04907851|467693446|FG002|Overall Study|Death|10|||
129925731|NCT01210807|467693451|FG000|Overall Study|Lost to Follow-up|1|||
129925732|NCT01210807|467693452|FG001|Overall Study|Lost to Follow-up|2|||
129925733|NCT01210807|467693451|FG000|Overall Study|Not implanted bilaterally|2|||
129925734|NCT01210807|467693452|FG001|Overall Study|Not implanted bilaterally|1|||
129925735|NCT05477186|467693457|FG000|Overall Study|Vaccine not administered|0|||
129925736|NCT05477186|467693458|FG001|Overall Study|Vaccine not administered|2|||
129925737|NCT05477186|467693459|FG002|Overall Study|Vaccine not administered|1|||
129925738|NCT05477186|467693460|FG003|Overall Study|Vaccine not administered|0|||
129925739|NCT05477186|467693461|FG004|Overall Study|Vaccine not administered|1|||
129925740|NCT05477186|467693462|FG005|Overall Study|Vaccine not administered|0|||
129925741|NCT05477186|467693463|FG006|Overall Study|Vaccine not administered|0|||
129925742|NCT05477186|467693457|FG000|Overall Study|Withdrawal by Subject|1|||
129925743|NCT05477186|467693458|FG001|Overall Study|Withdrawal by Subject|0|||
129925744|NCT05477186|467693459|FG002|Overall Study|Withdrawal by Subject|0|||
129925745|NCT05477186|467693460|FG003|Overall Study|Withdrawal by Subject|0|||
129925746|NCT05477186|467693461|FG004|Overall Study|Withdrawal by Subject|0|||
129925747|NCT05477186|467693462|FG005|Overall Study|Withdrawal by Subject|1|||
129925748|NCT05477186|467693463|FG006|Overall Study|Withdrawal by Subject|0|||
129925749|NCT05477186|467693457|FG000|Overall Study|Lost to Follow-up|1|||
129925750|NCT05477186|467693458|FG001|Overall Study|Lost to Follow-up|0|||
129925751|NCT05477186|467693459|FG002|Overall Study|Lost to Follow-up|2|||
129925752|NCT05477186|467693460|FG003|Overall Study|Lost to Follow-up|1|||
129925753|NCT05477186|467693461|FG004|Overall Study|Lost to Follow-up|1|||
129925754|NCT05477186|467693462|FG005|Overall Study|Lost to Follow-up|0|||
129925755|NCT05477186|467693463|FG006|Overall Study|Lost to Follow-up|2|||
129925756|NCT00324805|467693464|FG000|Overall Study|Adverse Event|62|||
129925757|NCT00324805|467693465|FG001|Overall Study|Adverse Event|203|||
129925758|NCT00324805|467693464|FG000|Overall Study|Progression|7|||
129925759|NCT00324805|467693465|FG001|Overall Study|Progression|35|||
129925760|NCT00324805|467693464|FG000|Overall Study|Withdrawal by Subject|51|||
129925761|NCT00324805|467693465|FG001|Overall Study|Withdrawal by Subject|174|||
129925762|NCT00324805|467693464|FG000|Overall Study|Death|6|||
129925763|NCT00324805|467693465|FG001|Overall Study|Death|9|||
129925764|NCT00324805|467693464|FG000|Overall Study|Alternative therapy|4|||
129925765|NCT00324805|467693465|FG001|Overall Study|Alternative therapy|8|||
129925766|NCT00324805|467693464|FG000|Overall Study|Other complicating disease|1|||
129925767|NCT00324805|467693465|FG001|Overall Study|Other complicating disease|9|||
129925768|NCT00324805|467693464|FG000|Overall Study|Other reasons|7|||
129925769|NCT00324805|467693465|FG001|Overall Study|Other reasons|26|||
129925770|NCT00324805|467693464|FG000|Overall Study|Other|0|||
129925771|NCT00324805|467693465|FG001|Overall Study|Other|2|||
129925772|NCT00324805|467693464|FG000|Overall Study|Did not start therapy|12|||
129925773|NCT00324805|467693465|FG001|Overall Study|Did not start therapy|17|||
129925774|NCT05792085|467693467|FG000|Overall Study|Death|0|||
129925775|NCT05792085|467693468|FG001|Overall Study|Death|0|||
129925776|NCT05792085|467693469|FG002|Overall Study|Death|0|||
129925777|NCT05792085|467693470|FG003|Overall Study|Death|0|||
129925778|NCT05792085|467693471|FG004|Overall Study|Death|1|||
129925779|NCT01919554|467693472|FG000|Overall Study|Withdrawal by Subject|0|||
129925780|NCT01919554|467693473|FG001|Overall Study|Withdrawal by Subject|0|||
129925781|NCT01919554|467693474|FG002|Overall Study|Withdrawal by Subject|1|||
129925782|NCT01919554|467693475|FG003|Overall Study|Withdrawal by Subject|1|||
129925783|NCT04524442|467693478|FG000|Overall Study|Subject Decision|1|||
129925784|NCT03213691|467693481|FG000|Overall Study|Adverse Event|2|||
129925785|NCT03213691|467693481|FG000|Overall Study|Death|3|||
129925786|NCT03213691|467693481|FG000|Overall Study|Physician Decision|1|||
129925787|NCT03213691|467693481|FG000|Overall Study|Progressive Disease|14|||
129925788|NCT03213691|467693481|FG000|Overall Study|Ineligible|1|||
129925789|NCT01152450|467693484|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
129925790|NCT01152450|467693485|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
129925791|NCT01152450|467693486|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
129925792|NCT01152450|467693487|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
129925793|NCT01152450|467693488|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
129925794|NCT01152450|467693489|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
129925795|NCT01152450|467693484|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
129925796|NCT01152450|467693485|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
129925797|NCT01152450|467693486|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
129925798|NCT01152450|467693487|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
129925799|NCT01152450|467693488|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
129925800|NCT01152450|467693489|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
129925801|NCT01152450|467693484|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925802|NCT01152450|467693485|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
129925803|NCT01152450|467693486|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
129925804|NCT01152450|467693487|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925805|NCT01152450|467693488|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925806|NCT01152450|467693489|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925807|NCT03058289|467693493|FG000|Overall Study|Radiographic Deterioration|0|||
129925808|NCT03058289|467693494|FG001|Overall Study|Radiographic Deterioration|3|||
129925809|NCT03058289|467693495|FG002|Overall Study|Radiographic Deterioration|1|||
129925810|NCT03058289|467693496|FG003|Overall Study|Radiographic Deterioration|2|||
129925811|NCT03058289|467693497|FG004|Overall Study|Radiographic Deterioration|6|||
129925812|NCT03058289|467693498|FG005|Overall Study|Radiographic Deterioration|3|||
129925813|NCT03058289|467693499|FG006|Overall Study|Radiographic Deterioration|0|||
129925814|NCT03058289|467693500|FG007|Overall Study|Radiographic Deterioration|4|||
129925815|NCT03058289|467693501|FG008|Overall Study|Radiographic Deterioration|2|||
129925816|NCT03058289|467693493|FG000|Overall Study|Adverse Event|2|||
129925817|NCT03058289|467693494|FG001|Overall Study|Adverse Event|0|||
129925818|NCT03058289|467693495|FG002|Overall Study|Adverse Event|1|||
129925819|NCT03058289|467693496|FG003|Overall Study|Adverse Event|3|||
129925820|NCT03058289|467693497|FG004|Overall Study|Adverse Event|1|||
129925821|NCT03058289|467693498|FG005|Overall Study|Adverse Event|0|||
129925822|NCT03058289|467693499|FG006|Overall Study|Adverse Event|1|||
129925823|NCT03058289|467693500|FG007|Overall Study|Adverse Event|3|||
129925824|NCT03058289|467693501|FG008|Overall Study|Adverse Event|0|||
129925825|NCT03058289|467693493|FG000|Overall Study|Withdrawal by Subject|0|||
129925826|NCT03058289|467693494|FG001|Overall Study|Withdrawal by Subject|0|||
129925827|NCT03058289|467693495|FG002|Overall Study|Withdrawal by Subject|0|||
129925828|NCT03058289|467693496|FG003|Overall Study|Withdrawal by Subject|2|||
129925829|NCT03058289|467693497|FG004|Overall Study|Withdrawal by Subject|0|||
129925830|NCT03058289|467693498|FG005|Overall Study|Withdrawal by Subject|2|||
129925831|NCT03058289|467693499|FG006|Overall Study|Withdrawal by Subject|0|||
129925832|NCT03058289|467693500|FG007|Overall Study|Withdrawal by Subject|4|||
129925833|NCT03058289|467693501|FG008|Overall Study|Withdrawal by Subject|1|||
129925834|NCT03058289|467693493|FG000|Overall Study|Physician Decision|1|||
129925835|NCT03058289|467693494|FG001|Overall Study|Physician Decision|0|||
129925836|NCT03058289|467693495|FG002|Overall Study|Physician Decision|0|||
129925837|NCT03058289|467693496|FG003|Overall Study|Physician Decision|2|||
129925838|NCT03058289|467693497|FG004|Overall Study|Physician Decision|1|||
129925839|NCT03058289|467693498|FG005|Overall Study|Physician Decision|0|||
129925840|NCT03058289|467693499|FG006|Overall Study|Physician Decision|2|||
129925841|NCT03058289|467693500|FG007|Overall Study|Physician Decision|3|||
129925842|NCT03058289|467693501|FG008|Overall Study|Physician Decision|0|||
129925843|NCT03058289|467693493|FG000|Overall Study|Clinical Deterioration|2|||
129925844|NCT03058289|467693494|FG001|Overall Study|Clinical Deterioration|0|||
129925845|NCT03058289|467693495|FG002|Overall Study|Clinical Deterioration|0|||
129925846|NCT03058289|467693496|FG003|Overall Study|Clinical Deterioration|2|||
129925847|NCT03058289|467693497|FG004|Overall Study|Clinical Deterioration|1|||
129925848|NCT03058289|467693498|FG005|Overall Study|Clinical Deterioration|1|||
129925849|NCT03058289|467693499|FG006|Overall Study|Clinical Deterioration|0|||
129925850|NCT03058289|467693500|FG007|Overall Study|Clinical Deterioration|3|||
129925851|NCT03058289|467693501|FG008|Overall Study|Clinical Deterioration|2|||
129925852|NCT03058289|467693493|FG000|Overall Study|Lost to Follow-up|0|||
129925853|NCT03058289|467693494|FG001|Overall Study|Lost to Follow-up|0|||
129925854|NCT03058289|467693495|FG002|Overall Study|Lost to Follow-up|0|||
129925855|NCT03058289|467693496|FG003|Overall Study|Lost to Follow-up|0|||
129925856|NCT03058289|467693497|FG004|Overall Study|Lost to Follow-up|1|||
129925857|NCT03058289|467693498|FG005|Overall Study|Lost to Follow-up|0|||
129925858|NCT03058289|467693499|FG006|Overall Study|Lost to Follow-up|0|||
129925859|NCT03058289|467693500|FG007|Overall Study|Lost to Follow-up|0|||
129925860|NCT03058289|467693501|FG008|Overall Study|Lost to Follow-up|0|||
129925861|NCT03058289|467693493|FG000|Overall Study|Refused Further Treatment|0|||
129925862|NCT03058289|467693494|FG001|Overall Study|Refused Further Treatment|0|||
129925863|NCT03058289|467693495|FG002|Overall Study|Refused Further Treatment|1|||
129925864|NCT03058289|467693496|FG003|Overall Study|Refused Further Treatment|0|||
129925865|NCT03058289|467693497|FG004|Overall Study|Refused Further Treatment|1|||
129925866|NCT03058289|467693498|FG005|Overall Study|Refused Further Treatment|0|||
129925867|NCT03058289|467693499|FG006|Overall Study|Refused Further Treatment|0|||
129925868|NCT03058289|467693500|FG007|Overall Study|Refused Further Treatment|0|||
129925869|NCT03058289|467693501|FG008|Overall Study|Refused Further Treatment|0|||
129925870|NCT03058289|467693493|FG000|Overall Study|Rapid Progression of Disease|0|||
129925871|NCT03058289|467693494|FG001|Overall Study|Rapid Progression of Disease|0|||
129925872|NCT03058289|467693495|FG002|Overall Study|Rapid Progression of Disease|0|||
129925873|NCT03058289|467693496|FG003|Overall Study|Rapid Progression of Disease|1|||
129925874|NCT03058289|467693497|FG004|Overall Study|Rapid Progression of Disease|0|||
129925875|NCT03058289|467693498|FG005|Overall Study|Rapid Progression of Disease|0|||
129925876|NCT03058289|467693499|FG006|Overall Study|Rapid Progression of Disease|0|||
129925877|NCT03058289|467693500|FG007|Overall Study|Rapid Progression of Disease|0|||
129925878|NCT03058289|467693501|FG008|Overall Study|Rapid Progression of Disease|0|||
129925879|NCT05546411|467693502|FG000|Overall Study|Progressive Disease|1|||
129925880|NCT05546411|467693503|FG001|Overall Study|Progressive Disease|0|||
129925881|NCT05546411|467693502|FG000|Overall Study|Adverse Event|0|||
129925882|NCT05546411|467693503|FG001|Overall Study|Adverse Event|1|||
129925883|NCT05546411|467693502|FG000|Overall Study|Metastatic disease|1|||
129925884|NCT05546411|467693503|FG001|Overall Study|Metastatic disease|0|||
129925885|NCT02606422|467693504|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
129925886|NCT02606422|467693505|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
129925887|NCT02606422|467693504|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
129925888|NCT02606422|467693505|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
129925889|NCT02606422|467693504|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
129925890|NCT02606422|467693505|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
129925891|NCT02606422|467693504|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
129925892|NCT02606422|467693505|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
129925893|NCT04625465|467693506|FG000|Overall Study|Lost to Follow-up|2|||
129925894|NCT04625465|467693507|FG001|Overall Study|Lost to Follow-up|2|||
129925895|NCT04625465|467693508|FG002|Overall Study|Lost to Follow-up|1|||
129925896|NCT04625465|467693509|FG003|Overall Study|Lost to Follow-up|0|||
129925897|NCT04625465|467693510|FG004|Overall Study|Lost to Follow-up|0|||
129925898|NCT04625465|467693511|FG005|Overall Study|Lost to Follow-up|2|||
129925899|NCT04625465|467693512|FG006|Overall Study|Lost to Follow-up|0|||
129925900|NCT04625465|467693513|FG007|Overall Study|Lost to Follow-up|0|||
129925901|NCT04625465|467693506|FG000|Overall Study|Death|1|||
129925902|NCT04625465|467693507|FG001|Overall Study|Death|0|||
129925903|NCT04625465|467693508|FG002|Overall Study|Death|0|||
129925904|NCT04625465|467693509|FG003|Overall Study|Death|0|||
129925905|NCT04625465|467693510|FG004|Overall Study|Death|0|||
129925906|NCT04625465|467693511|FG005|Overall Study|Death|0|||
129925907|NCT04625465|467693512|FG006|Overall Study|Death|0|||
129925908|NCT04625465|467693513|FG007|Overall Study|Death|0|||
129925909|NCT04625465|467693506|FG000|Overall Study|Withdrawal by Subject|1|||
129925910|NCT04625465|467693507|FG001|Overall Study|Withdrawal by Subject|0|||
129925911|NCT04625465|467693508|FG002|Overall Study|Withdrawal by Subject|4|||
129925912|NCT04625465|467693509|FG003|Overall Study|Withdrawal by Subject|4|||
129925913|NCT04625465|467693510|FG004|Overall Study|Withdrawal by Subject|4|||
129925914|NCT04625465|467693511|FG005|Overall Study|Withdrawal by Subject|0|||
129925915|NCT04625465|467693512|FG006|Overall Study|Withdrawal by Subject|0|||
129925916|NCT04625465|467693513|FG007|Overall Study|Withdrawal by Subject|0|||
129925917|NCT05704543|467693514|FG000|Overall Study|Withdrawal by Subject|1|||
129925918|NCT05704543|467693515|FG001|Overall Study|Withdrawal by Subject|1|||
129925919|NCT05704543|467693516|FG002|Overall Study|Withdrawal by Subject|0|||
129925920|NCT05704543|467693517|FG003|Overall Study|Withdrawal by Subject|2|||
129925921|NCT05704543|467693514|FG000|Overall Study|Lost to Follow-up|1|||
129925922|NCT05704543|467693515|FG001|Overall Study|Lost to Follow-up|2|||
129925923|NCT05704543|467693516|FG002|Overall Study|Lost to Follow-up|0|||
129925924|NCT05704543|467693517|FG003|Overall Study|Lost to Follow-up|0|||
129925925|NCT03691935|467693519|FG000|Overall Study|Physician Decision|2|||
129925926|NCT03691935|467693520|FG001|Overall Study|Physician Decision|1|||
129925927|NCT03691935|467693519|FG000|Overall Study|Adverse Event|3|||
129925928|NCT03691935|467693520|FG001|Overall Study|Adverse Event|0|||
129925929|NCT05576155|467693521|FG000|Overall Study|Withdrawal by Subject|1|||
129925930|NCT05576155|467693522|FG001|Overall Study|Withdrawal by Subject|1|||
129925931|NCT05309291|467693523|FG000|Overall Study|Adverse Event|0|||
129925932|NCT05309291|467693524|FG001|Overall Study|Adverse Event|1|||
129925933|NCT05209152|467693527|FG000|Overall Study|Sponsor decision|1|||
129925934|NCT05209152|467693528|FG001|Overall Study|Sponsor decision|2|||
129925935|NCT05209152|467693527|FG000|Overall Study|Death|3|||
129925936|NCT05209152|467693528|FG001|Overall Study|Death|1|||
129925937|NCT02696707|467695065|FG000|Per Protocol Population|Physician Decision|2|||
129925938|NCT02696707|467695066|FG001|Per Protocol Population|Physician Decision|1|||
129925939|NCT02696707|467695065|FG000|Per Protocol Population|Participant Decision|0|||
129925940|NCT02696707|467695066|FG001|Per Protocol Population|Participant Decision|2|||
129925941|NCT02696707|467695065|FG000|Completed Study as Planned|Reason = LVEF|2|||
129925942|NCT02696707|467695066|FG001|Completed Study as Planned|Reason = LVEF|2|||
129925943|NCT02696707|467695065|FG000|Completed Study as Planned|Protocol Violation|2|||
129925944|NCT02696707|467695066|FG001|Completed Study as Planned|Protocol Violation|6|||
129925945|NCT02696707|467695065|FG000|Completed Study as Planned|Metastatic disease|3|||
129925946|NCT02696707|467695066|FG001|Completed Study as Planned|Metastatic disease|0|||
129925947|NCT02696707|467695065|FG000|Completed Study as Planned|Location|1|||
129925948|NCT02696707|467695066|FG001|Completed Study as Planned|Location|1|||
129925949|NCT05251909|467695071|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
129925950|NCT05251909|467695072|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
130117359|NCT02607800|468388865|FG001|Overall Study|Withdrew Consent|0|||
130117360|NCT02607800|468388864|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
130117361|NCT02607800|468388865|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
130117362|NCT00753714|468388866|FG000|Overall Study|Lack of Efficacy|21|||
130117363|NCT00753714|468388867|FG001|Overall Study|Lack of Efficacy|34|||
130117364|NCT00753714|468388866|FG000|Overall Study|Adverse Event|26|||
130117365|NCT00753714|468388867|FG001|Overall Study|Adverse Event|18|||
130117366|NCT00753714|468388866|FG000|Overall Study|Protocol Violation|1|||
130117367|NCT00753714|468388867|FG001|Overall Study|Protocol Violation|0|||
130117368|NCT00753714|468388866|FG000|Overall Study|Lost to Follow-up|0|||
130117369|NCT00753714|468388867|FG001|Overall Study|Lost to Follow-up|1|||
130117370|NCT00753714|468388866|FG000|Overall Study|Withdrawal by Subject|2|||
130117371|NCT00753714|468388867|FG001|Overall Study|Withdrawal by Subject|1|||
130117372|NCT00753714|468388866|FG000|Overall Study|Death|3|||
130117373|NCT00753714|468388867|FG001|Overall Study|Death|3|||
130117374|NCT00753714|468388866|FG000|Overall Study|Other|7|||
130117375|NCT00753714|468388867|FG001|Overall Study|Other|5|||
130117376|NCT02486796|468388868|FG000|Overall Study|Withdrawal by Subject|1|||
130117377|NCT02486796|468388869|FG001|Overall Study|Withdrawal by Subject|1|||
130117378|NCT02486796|468388868|FG000|Overall Study|Physician Decision|1|||
130117379|NCT02486796|468388869|FG001|Overall Study|Physician Decision|0|||
130117380|NCT01185288|468388870|FG000|Overall Study|Adverse Event|7|||
130117381|NCT01185288|468388871|FG001|Overall Study|Adverse Event|6|||
130117382|NCT01185288|468388870|FG000|Overall Study|Withdrawal by Subject|6|||
129925951|NCT06181227|467695073|FG000|Overall Study|Study terminated by sponsor|7|||
129925952|NCT06181227|467695074|FG001|Overall Study|Study terminated by sponsor|9|||
129925953|NCT05543915|467695075|FG000|Overall Study|Lost to Follow-up|0|||
129925954|NCT05543915|467695076|FG001|Overall Study|Lost to Follow-up|1|||
129925955|NCT00433329|467695079|FG000|Overall Study|Adverse Event|9|||
129925956|NCT00433329|467695079|FG000|Overall Study|Death|4|||
129925957|NCT00433329|467695079|FG000|Overall Study|Withdrew consent|3|||
129925958|NCT00433329|467695079|FG000|Overall Study|Discontinued sildenafil|2|||
129925959|NCT00433329|467695079|FG000|Overall Study|Moved out of state|1|||
129925960|NCT00433329|467695079|FG000|Overall Study|Lost to Follow-up|1|||
129925961|NCT00433329|467695079|FG000|Overall Study|Physician Decision|1|||
129925962|NCT03381196|467695080|FG000|Overall Study|Withdrawal by Subject|7|||
129925963|NCT03381196|467695081|FG001|Overall Study|Withdrawal by Subject|7|||
129925964|NCT03381196|467695080|FG000|Overall Study|Other|0|||
129925965|NCT03381196|467695081|FG001|Overall Study|Other|1|||
129925966|NCT03381196|467695080|FG000|Overall Study|Lost to Follow-up|5|||
129925967|NCT03381196|467695081|FG001|Overall Study|Lost to Follow-up|4|||
129925968|NCT03381196|467695080|FG000|Overall Study|Death|0|||
129925969|NCT03381196|467695081|FG001|Overall Study|Death|1|||
129925970|NCT03381196|467695080|FG000|Overall Study|Adverse Event|1|||
129925971|NCT03381196|467695081|FG001|Overall Study|Adverse Event|0|||
129925972|NCT03381196|467695080|FG000|Overall Study|Randomized, not treated|3|||
129925973|NCT03381196|467695081|FG001|Overall Study|Randomized, not treated|6|||
129925974|NCT04225273|467695091|FG000|Overall Study|Lost to Follow-up|3|||
129925975|NCT05270408|467695093|FG000|Started Treatment|Withdrawal by Subject|0|||
129925976|NCT05270408|467695094|FG001|Started Treatment|Withdrawal by Subject|0|||
129925977|NCT05270408|467695095|FG002|Started Treatment|Withdrawal by Subject|3|||
129925978|NCT05270408|467695093|FG000|Started Treatment|Adverse Event|0|||
129925979|NCT05270408|467695094|FG001|Started Treatment|Adverse Event|0|||
129925980|NCT05270408|467695095|FG002|Started Treatment|Adverse Event|1|||
129925981|NCT05270408|467695093|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
129925982|NCT05270408|467695094|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
129925983|NCT05270408|467695095|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
129925984|NCT03768505|467695096|FG000|Overall Study|sponsor decision|76|||
129925985|NCT03768505|467695096|FG000|Overall Study|Death|35|||
129925986|NCT03768505|467695096|FG000|Overall Study|Other -Various|30|||
129925987|NCT03768505|467695096|FG000|Overall Study|Withdrawal by Subject|22|||
129925988|NCT03768505|467695096|FG000|Overall Study|Lost to Follow-up|6|||
129925989|NCT02815566|467695097|FG000|Overall Study|Adverse Event|1|||
129925990|NCT02815566|467695098|FG001|Overall Study|Adverse Event|1|||
129925991|NCT02815566|467695097|FG000|Overall Study|Withdrawal by Subject|1|||
129925992|NCT02815566|467695098|FG001|Overall Study|Withdrawal by Subject|0|||
129925993|NCT02815566|467695097|FG000|Overall Study|Lost to Follow-up|0|||
129925994|NCT02815566|467695098|FG001|Overall Study|Lost to Follow-up|1|||
129925995|NCT03252847|467695099|FG000|Overall Study|Withdrawal by Subject|0|||
129925996|NCT03252847|467695100|FG001|Overall Study|Withdrawal by Subject|0|||
129925997|NCT03252847|467695101|FG002|Overall Study|Withdrawal by Subject|1|||
130117383|NCT01185288|468388871|FG001|Overall Study|Withdrawal by Subject|4|||
129925998|NCT03252847|467695102|FG003|Overall Study|Withdrawal by Subject|0|||
129925999|NCT03252847|467695103|FG004|Overall Study|Withdrawal by Subject|0|||
129926000|NCT03252847|467695104|FG005|Overall Study|Withdrawal by Subject|0|||
130117384|NCT01185288|468388870|FG000|Overall Study|Lost to Follow-up|2|||
130117385|NCT01185288|468388871|FG001|Overall Study|Lost to Follow-up|5|||
130117386|NCT01185288|468388870|FG000|Overall Study|Lack of Efficacy|2|||
130117387|NCT01185288|468388871|FG001|Overall Study|Lack of Efficacy|0|||
129926001|NCT03252847|467695105|FG006|Overall Study|Withdrawal by Subject|0|||
129926002|NCT03252847|467695099|FG000|Overall Study|Other: Patient decision|0|||
129926003|NCT03252847|467695100|FG001|Overall Study|Other: Patient decision|0|||
129926004|NCT03252847|467695101|FG002|Overall Study|Other: Patient decision|0|||
129926005|NCT03252847|467695102|FG003|Overall Study|Other: Patient decision|0|||
129926006|NCT03252847|467695103|FG004|Overall Study|Other: Patient decision|1|||
129926007|NCT03252847|467695104|FG005|Overall Study|Other: Patient decision|0|||
129926008|NCT03252847|467695105|FG006|Overall Study|Other: Patient decision|0|||
129926009|NCT02993159|467695106|FG000|Overall Study|Withdrawal by Subject|1|||
129926010|NCT02993159|467695107|FG001|Overall Study|Withdrawal by Subject|3|||
129926011|NCT02993159|467695106|FG000|Overall Study|Protocol Violation|1|||
129926012|NCT02993159|467695107|FG001|Overall Study|Protocol Violation|0|||
129926013|NCT02993159|467695106|FG000|Overall Study|Opted out of surgery|2|||
129926014|NCT02993159|467695107|FG001|Overall Study|Opted out of surgery|0|||
129926015|NCT02993159|467695106|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
129926016|NCT02993159|467695107|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
129926017|NCT02993159|467695106|FG000|Overall Study|Physician Decision|0|||
129926018|NCT02993159|467695107|FG001|Overall Study|Physician Decision|1|||
129926019|NCT04992520|467695109|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
129926020|NCT04992520|467695110|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
130117388|NCT01185288|468388870|FG000|Overall Study|Investigator discretion|1|||
130117389|NCT01185288|468388871|FG001|Overall Study|Investigator discretion|0|||
130117390|NCT01185288|468388870|FG000|Overall Study|Did not meet inclusion criteria|1|||
130117391|NCT01185288|468388871|FG001|Overall Study|Did not meet inclusion criteria|0|||
130117392|NCT01185288|468388870|FG000|Overall Study|Noncompliance|0|||
130117393|NCT01185288|468388871|FG001|Overall Study|Noncompliance|1|||
130117394|NCT00278512|468388872|FG000|Overall Study|Death|1|||
130117395|NCT00278512|468388873|FG001|Overall Study|Death|0|||
130117396|NCT01202747|468388874|FG000|Overall Study|Withdrawal by Subject|1|||
130117397|NCT01620177|468388875|FG000|Overall Study|Failure at Screening Visit|43|||
130117398|NCT01620177|468388875|FG000|Overall Study|Withdrawal by Subject|26|||
129926021|NCT04992520|467695111|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
129926022|NCT04992520|467695112|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
129926023|NCT04992520|467695113|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
129926024|NCT04992520|467695114|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
129926025|NCT04992520|467695109|FG000|Part A: First Challenge|Non-compliance|0|||
129926026|NCT04992520|467695110|FG001|Part A: First Challenge|Non-compliance|0|||
129926027|NCT04992520|467695111|FG002|Part A: First Challenge|Non-compliance|0|||
129926028|NCT04992520|467695112|FG003|Part A: First Challenge|Non-compliance|1|||
129926029|NCT04992520|467695113|FG004|Part A: First Challenge|Non-compliance|0|||
129926030|NCT04992520|467695114|FG005|Part A: First Challenge|Non-compliance|0|||
129926031|NCT04992520|467695109|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926032|NCT04992520|467695110|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926033|NCT04992520|467695111|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
129926034|NCT04992520|467695112|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926035|NCT04992520|467695113|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926036|NCT04992520|467695114|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
129926037|NCT04992520|467695109|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926038|NCT04992520|467695110|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926039|NCT04992520|467695111|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
129926040|NCT04992520|467695112|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926041|NCT04992520|467695113|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926042|NCT04992520|467695114|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926043|NCT06103188|467695117|FG000|Overall Study|Lost to Follow-up|1|||
129926044|NCT06103188|467695118|FG001|Overall Study|Lost to Follow-up|6|||
129926045|NCT06103188|467695119|FG002|Overall Study|Lost to Follow-up|4|||
129926046|NCT01175356|467695122|FG000|Overall Study|Death|1|||
129926047|NCT01175356|467695122|FG000|Overall Study|Lack of Efficacy|12|||
129926048|NCT01175356|467695122|FG000|Overall Study|Lost to Follow-up|1|||
129926049|NCT01175356|467695122|FG000|Overall Study|Physician Decision|23|||
129926050|NCT01175356|467695122|FG000|Overall Study|Ineligible|1|||
129926051|NCT01175356|467695122|FG000|Overall Study|Treatment Slot Not Available|18|||
129926052|NCT01175356|467695122|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
130117399|NCT01620177|468388875|FG000|Overall Study|Lost to Follow-up|7|||
130117400|NCT01620177|468388875|FG000|Overall Study|Physician Decision|2|||
130117401|NCT01620177|468388875|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
130117402|NCT01626885|468388881|FG000|Overall Study|Adverse Event|8|||
130117403|NCT01626885|468388881|FG000|Overall Study|Withdrawal by Subject|4|||
130117404|NCT01533428|468388884|FG000|Overall Study|Adverse Event|0|||
130117405|NCT01533428|468388885|FG001|Overall Study|Adverse Event|1|||
129926053|NCT01175356|467695122|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
129926054|NCT01175356|467695122|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
129926055|NCT01175356|467695122|FG000|Overall Study|Inadequate stem cell for transplant|1|||
130117406|NCT01533428|468388884|FG000|Overall Study|Lost to Follow-up|2|||
130117407|NCT01533428|468388885|FG001|Overall Study|Lost to Follow-up|1|||
130117408|NCT01533428|468388884|FG000|Overall Study|Withdrawal by Subject|7|||
130117409|NCT01533428|468388885|FG001|Overall Study|Withdrawal by Subject|6|||
130117410|NCT01364870|468388886|FG000|Overall Study|Withdrawal by Subject|13|||
130117411|NCT01364870|468388887|FG001|Overall Study|Withdrawal by Subject|24|||
130117412|NCT01364870|468388888|FG002|Overall Study|Withdrawal by Subject|10|||
130117413|NCT01364870|468388886|FG000|Overall Study|Adverse Event|8|||
130117414|NCT01364870|468388887|FG001|Overall Study|Adverse Event|6|||
130117415|NCT01364870|468388888|FG002|Overall Study|Adverse Event|4|||
130117416|NCT01364870|468388886|FG000|Overall Study|Protocol Violation|1|||
130117417|NCT01364870|468388887|FG001|Overall Study|Protocol Violation|0|||
130117418|NCT01364870|468388888|FG002|Overall Study|Protocol Violation|0|||
130117419|NCT02666430|468388889|FG000|Period 1|Lost to Follow-up|1|||
130117420|NCT02666430|468388890|FG001|Period 1|Lost to Follow-up|0|||
130117421|NCT02666430|468388889|FG000|Period 1|Adverse Event|0|||
130117422|NCT02666430|468388890|FG001|Period 1|Adverse Event|1|||
130117423|NCT02666430|468388889|FG000|Period 2|Withdrawal by Subject|1|||
130117424|NCT02666430|468388890|FG001|Period 2|Withdrawal by Subject|4|||
130117425|NCT02666430|468388889|FG000|Period 3|Lost to Follow-up|1|||
130117426|NCT02666430|468388890|FG001|Period 3|Lost to Follow-up|0|||
130117427|NCT03828461|468388891|FG000|Overall Study|Lost to Follow-up|1|||
130117428|NCT03828461|468388891|FG000|Overall Study|Withdrawal by Subject|3|||
130117429|NCT00576199|468388892|FG000|Overall Study|Adverse Event|12|||
130117430|NCT00576199|468388892|FG000|Overall Study|Insufficient Therapeutic Response|14|||
130117431|NCT00576199|468388892|FG000|Overall Study|Refused Treatment|2|||
130117432|NCT00576199|468388892|FG000|Overall Study|Reason Unspecified|2|||
130117433|NCT04317053|468388894|FG000|Overall Study|Withdrawn (screen failure)|4|||
130117434|NCT04317053|468388895|FG001|Overall Study|Withdrawn (screen failure)|2|||
130117435|NCT00832078|468390498|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
130117436|NCT00832078|468390499|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
130117437|NCT00832078|468390498|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
130117438|NCT00832078|468390499|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
130117439|NCT01767597|468390500|FG000|Overall Study|Incomplete intervention|3|||
130117440|NCT01767597|468390501|FG001|Overall Study|Incomplete intervention|1|||
129926056|NCT01175356|467695122|FG000|Overall Study|Initiation other tx prior to completion|9|||
129926057|NCT04005794|467695127|FG000|Overall Study|Lost to Follow-up|0|||
129926058|NCT04005794|467695128|FG001|Overall Study|Lost to Follow-up|4|||
129926059|NCT04005794|467695129|FG002|Overall Study|Lost to Follow-up|0|||
129926060|NCT04313972|467695132|FG000|Overall Study|Withdrawal by Subject|0|||
129926061|NCT04313972|467695133|FG001|Overall Study|Withdrawal by Subject|1|||
129926062|NCT00104676|467695149|FG000|Overall Study|Death|3|||
129926063|NCT00104676|467695150|FG001|Overall Study|Death|2|||
129926064|NCT00104676|467695149|FG000|Overall Study|Withdrawal by Subject|0|||
129926065|NCT00104676|467695150|FG001|Overall Study|Withdrawal by Subject|2|||
129926066|NCT00104676|467695149|FG000|Overall Study|treatment interruption|4|||
129926067|NCT00104676|467695150|FG001|Overall Study|treatment interruption|10|||
129926068|NCT05808257|467695153|FG000|Overall Study|Lost to Follow-up|8|||
129926069|NCT05808257|467695154|FG001|Overall Study|Lost to Follow-up|8|||
129926070|NCT04568486|467695155|FG000|Overall Study|Withdrawal by Subject|26|||
129926071|NCT04568486|467695155|FG000|Overall Study|Lost to Follow-up|7|||
130117441|NCT01767597|468390500|FG000|Overall Study|Withdrawal by Subject|1|||
130117442|NCT01767597|468390501|FG001|Overall Study|Withdrawal by Subject|0|||
129926072|NCT04042233|467695156|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
129926073|NCT04042233|467695157|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
129926074|NCT04042233|467695156|FG000|Overall Study|Protocol Violation|0|||
129926075|NCT04042233|467695157|FG001|Overall Study|Protocol Violation|2|||
129926076|NCT03899259|467695176|FG000|Overall Study|Adverse Event|5|||
129926077|NCT03899259|467695177|FG001|Overall Study|Adverse Event|4|||
129926078|NCT03899259|467695178|FG002|Overall Study|Adverse Event|6|||
129926079|NCT03899259|467695176|FG000|Overall Study|Lack of Efficacy|5|||
129926080|NCT03899259|467695177|FG001|Overall Study|Lack of Efficacy|0|||
129926081|NCT03899259|467695178|FG002|Overall Study|Lack of Efficacy|2|||
129926082|NCT03899259|467695176|FG000|Overall Study|Pregnancy|3|||
129926083|NCT03899259|467695177|FG001|Overall Study|Pregnancy|0|||
130117443|NCT02961920|468390502|FG000|Overall Study|did not achive stydy protocol schedule|1|||
130117444|NCT02961920|468390503|FG001|Overall Study|did not achive stydy protocol schedule|1|||
130117445|NCT02232074|468390504|FG000|Overall Study|Withdrawal by Subject|5|||
130117446|NCT02232074|468390505|FG001|Overall Study|Withdrawal by Subject|3|||
130117447|NCT02232074|468390504|FG000|Overall Study|No legal concerns at baseline|36|||
130117448|NCT02232074|468390505|FG001|Overall Study|No legal concerns at baseline|41|||
130117449|NCT02232074|468390504|FG000|Overall Study|deemed ineligible|0|||
129926084|NCT03899259|467695178|FG002|Overall Study|Pregnancy|1|||
129926085|NCT03899259|467695176|FG000|Overall Study|Physician Decision|0|||
129926086|NCT03899259|467695177|FG001|Overall Study|Physician Decision|1|||
130117450|NCT02232074|468390505|FG001|Overall Study|deemed ineligible|1|||
130117451|NCT04480463|468390508|FG000|Overall Study|Death|0|||
130117452|NCT04480463|468390509|FG001|Overall Study|Death|1|||
129926087|NCT03899259|467695178|FG002|Overall Study|Physician Decision|0|||
129926088|NCT03899259|467695176|FG000|Overall Study|Protocol Deviation|1|||
129926089|NCT03899259|467695177|FG001|Overall Study|Protocol Deviation|1|||
129926090|NCT03899259|467695178|FG002|Overall Study|Protocol Deviation|1|||
129926091|NCT03899259|467695176|FG000|Overall Study|Withdrawal by Subject|8|||
129926092|NCT03899259|467695177|FG001|Overall Study|Withdrawal by Subject|10|||
129926093|NCT03899259|467695178|FG002|Overall Study|Withdrawal by Subject|12|||
129926094|NCT03899259|467695176|FG000|Overall Study|Lost to Follow-up|5|||
129926095|NCT03899259|467695177|FG001|Overall Study|Lost to Follow-up|6|||
129926096|NCT03899259|467695178|FG002|Overall Study|Lost to Follow-up|2|||
129926097|NCT03899259|467695176|FG000|Overall Study|Lack of Adherence|1|||
129926098|NCT03899259|467695177|FG001|Overall Study|Lack of Adherence|0|||
129926099|NCT03899259|467695178|FG002|Overall Study|Lack of Adherence|0|||
129926100|NCT03899259|467695176|FG000|Overall Study|Screen Failure|1|||
129926101|NCT03899259|467695177|FG001|Overall Study|Screen Failure|0|||
129926102|NCT03899259|467695178|FG002|Overall Study|Screen Failure|0|||
129926103|NCT03899259|467695176|FG000|Overall Study|Ongoing Study Participation|127|||
129926104|NCT03899259|467695177|FG001|Overall Study|Ongoing Study Participation|134|||
129926105|NCT03899259|467695178|FG002|Overall Study|Ongoing Study Participation|210|||
129926106|NCT01197378|467695179|FG000|Overall Study|Adverse Event|3|||
129926107|NCT01197378|467695179|FG000|Overall Study|Withdrawal by Subject|1|||
129926108|NCT01197378|467695179|FG000|Overall Study|Physician Decision|1|||
129926109|NCT01197378|467695179|FG000|Overall Study|Other|2|||
129926110|NCT05139810|467695181|FG000|Overall Study|Voluntary Withdrawal|2|||
129926111|NCT05139810|467695182|FG001|Overall Study|Voluntary Withdrawal|1|||
129926112|NCT05139810|467695183|FG002|Overall Study|Voluntary Withdrawal|0|||
129926113|NCT05139810|467695181|FG000|Overall Study|Pregnancy|1|||
129926114|NCT05139810|467695182|FG001|Overall Study|Pregnancy|0|||
129926115|NCT05139810|467695183|FG002|Overall Study|Pregnancy|0|||
129926116|NCT05139810|467695181|FG000|Overall Study|Roll Over to CS7|19|||
129926117|NCT05139810|467695182|FG001|Overall Study|Roll Over to CS7|44|||
129926118|NCT05139810|467695183|FG002|Overall Study|Roll Over to CS7|20|||
129926119|NCT05566639|467695186|FG000|Overall Study|Adverse Event|1|||
129926120|NCT05566639|467695187|FG001|Overall Study|Adverse Event|1|||
130117453|NCT04480463|468390508|FG000|Overall Study|Adverse Event|6|||
130117454|NCT04480463|468390509|FG001|Overall Study|Adverse Event|8|||
130117455|NCT04480463|468390508|FG000|Overall Study|Lost to Follow-up|3|||
130117456|NCT04480463|468390509|FG001|Overall Study|Lost to Follow-up|2|||
130117457|NCT04480463|468390508|FG000|Overall Study|Physician Decision|2|||
130117458|NCT04480463|468390509|FG001|Overall Study|Physician Decision|5|||
130117459|NCT04480463|468390508|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
130117460|NCT04480463|468390509|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
130117461|NCT04480463|468390508|FG000|Overall Study|Protocol Violation|2|||
130117462|NCT04480463|468390509|FG001|Overall Study|Protocol Violation|1|||
130117463|NCT04480463|468390508|FG000|Overall Study|Withdrawal by Subject|6|||
130117464|NCT04480463|468390509|FG001|Overall Study|Withdrawal by Subject|7|||
130117465|NCT04480463|468390508|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
130117466|NCT04480463|468390509|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
130117467|NCT04480463|468390508|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
130117468|NCT04480463|468390509|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
130117469|NCT04480463|468390508|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
130117470|NCT04480463|468390509|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
130117471|NCT04480463|468390508|FG000|Overall Study|Other|6|||
130117472|NCT04480463|468390509|FG001|Overall Study|Other|4|||
130117473|NCT01579474|468390511|FG000|Overall Study|Adverse Event|1|||
130117474|NCT01579474|468390512|FG001|Overall Study|Adverse Event|13|||
130117475|NCT01579474|468390513|FG002|Overall Study|Adverse Event|2|||
130117476|NCT01579474|468390514|FG003|Overall Study|Adverse Event|0|||
130117477|NCT01579474|468390515|FG004|Overall Study|Adverse Event|0|||
130117478|NCT01579474|468390516|FG005|Overall Study|Adverse Event|1|||
130117479|NCT01579474|468390511|FG000|Overall Study|Lack of Efficacy|1|||
130117480|NCT01579474|468390512|FG001|Overall Study|Lack of Efficacy|0|||
130117481|NCT01579474|468390513|FG002|Overall Study|Lack of Efficacy|0|||
130117482|NCT01579474|468390514|FG003|Overall Study|Lack of Efficacy|0|||
130117483|NCT01579474|468390515|FG004|Overall Study|Lack of Efficacy|1|||
130117484|NCT01579474|468390516|FG005|Overall Study|Lack of Efficacy|0|||
129926121|NCT05566639|467695186|FG000|Overall Study|Serious Adverse Event|1|||
129926122|NCT05566639|467695187|FG001|Overall Study|Serious Adverse Event|3|||
129926123|NCT05566639|467695186|FG000|Overall Study|Death|44|||
129926124|NCT05566639|467695187|FG001|Overall Study|Death|45|||
129926125|NCT05566639|467695186|FG000|Overall Study|Lost to Follow-up|467|||
129926126|NCT05566639|467695187|FG001|Overall Study|Lost to Follow-up|461|||
129926127|NCT05566639|467695186|FG000|Overall Study|Physician Decision|45|||
129926128|NCT05566639|467695187|FG001|Overall Study|Physician Decision|44|||
129926129|NCT05566639|467695186|FG000|Overall Study|Protocol Deviation|4|||
130117485|NCT01579474|468390511|FG000|Overall Study|Withdrawal by Subject|1|||
130117486|NCT01579474|468390512|FG001|Overall Study|Withdrawal by Subject|0|||
130117487|NCT01579474|468390513|FG002|Overall Study|Withdrawal by Subject|0|||
130117488|NCT01579474|468390514|FG003|Overall Study|Withdrawal by Subject|0|||
130117489|NCT01579474|468390515|FG004|Overall Study|Withdrawal by Subject|0|||
130117490|NCT01579474|468390516|FG005|Overall Study|Withdrawal by Subject|0|||
130117491|NCT02637076|468390517|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
130117492|NCT02637076|468390518|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
130117493|NCT02637076|468390517|FG000|Overall Study|Withdrawal by Subject|0|||
130117494|NCT02637076|468390518|FG001|Overall Study|Withdrawal by Subject|4|||
130117495|NCT00130520|468390519|FG000|Overall Study|Adverse Event|11|||
130117496|NCT00130520|468390519|FG000|Overall Study|Death|1|||
130117497|NCT00130520|468390519|FG000|Overall Study|Physician Decision|1|||
130117498|NCT00130520|468390519|FG000|Overall Study|Withdrawal by Subject|1|||
130117499|NCT00130520|468390519|FG000|Overall Study|Disease Progression|23|||
130117500|NCT00130520|468390519|FG000|Overall Study|Protocol non-compliance|1|||
130117501|NCT00130520|468390519|FG000|Overall Study|Did not meet re-treatment criteria|1|||
129926130|NCT05566639|467695187|FG001|Overall Study|Protocol Deviation|4|||
129926131|NCT05566639|467695186|FG000|Overall Study|Withdrawal by Subject|277|||
129926132|NCT05566639|467695187|FG001|Overall Study|Withdrawal by Subject|271|||
129926133|NCT05566639|467695186|FG000|Overall Study|Other Than Specified|52|||
129926134|NCT05566639|467695187|FG001|Overall Study|Other Than Specified|64|||
129926135|NCT04159415|467695189|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926136|NCT04159415|467695190|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926137|NCT04159415|467695191|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926138|NCT04159415|467695192|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926139|NCT04159415|467695193|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926140|NCT04159415|467695194|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926141|NCT04159415|467695195|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
129926142|NCT04159415|467695196|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
129926143|NCT03800654|467695197|FG000|Overall Study|Time constraints|3|||
129926144|NCT03800654|467695198|FG001|Overall Study|Time constraints|3|||
129926145|NCT03800654|467695199|FG002|Overall Study|Time constraints|3|||
129926146|NCT03800654|467695197|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
129926147|NCT03800654|467695198|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
129926148|NCT03800654|467695199|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
129926149|NCT03800654|467695197|FG000|Overall Study|Lost to Follow-up|2|||
129926150|NCT03800654|467695198|FG001|Overall Study|Lost to Follow-up|1|||
129926151|NCT03800654|467695199|FG002|Overall Study|Lost to Follow-up|6|||
129926152|NCT03800654|467695197|FG000|Overall Study|Medical Health Issue|0|||
129926153|NCT03800654|467695198|FG001|Overall Study|Medical Health Issue|0|||
129926154|NCT03800654|467695199|FG002|Overall Study|Medical Health Issue|1|||
129926155|NCT03800654|467695197|FG000|Overall Study|Personal Issues|0|||
129926156|NCT03800654|467695198|FG001|Overall Study|Personal Issues|2|||
129926157|NCT03800654|467695199|FG002|Overall Study|Personal Issues|0|||
129926158|NCT03800654|467695197|FG000|Overall Study|Protocol Violation|0|||
129926159|NCT03800654|467695198|FG001|Overall Study|Protocol Violation|1|||
129926160|NCT03800654|467695199|FG002|Overall Study|Protocol Violation|0|||
129926161|NCT06182033|467695200|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
129926162|NCT06182033|467695201|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
129926163|NCT06182033|467695200|FG000|Overall Study|Target child relocation|1|||
129926164|NCT06182033|467695201|FG001|Overall Study|Target child relocation|1|||
129926165|NCT06182033|467695200|FG000|Overall Study|Withdrawal by Subject|1|||
129926166|NCT06182033|467695201|FG001|Overall Study|Withdrawal by Subject|0|||
129926167|NCT02723591|467695202|FG000|Overall Study|Adverse Event|48|||
129926168|NCT02723591|467695203|FG001|Overall Study|Adverse Event|40|||
129926169|NCT02723591|467695202|FG000|Overall Study|Death|2|||
130117502|NCT01238848|468390521|FG000|Overall Study|Physician Decision|13|||
130117503|NCT01238848|468390522|FG001|Overall Study|Physician Decision|5|||
130117504|NCT00576901|468390524|FG000|Overall Study|Withdrawal by Subject|1|||
130117505|NCT00576901|468390524|FG000|Overall Study|Disease course|1|||
129926170|NCT02723591|467695203|FG001|Overall Study|Death|2|||
129926171|NCT02723591|467695202|FG000|Overall Study|Lack of Efficacy|4|||
129926172|NCT02723591|467695203|FG001|Overall Study|Lack of Efficacy|3|||
129926173|NCT02723591|467695202|FG000|Overall Study|Lost to Follow-up|1|||
129926174|NCT02723591|467695203|FG001|Overall Study|Lost to Follow-up|7|||
129926175|NCT02723591|467695202|FG000|Overall Study|Protocol Violation|20|||
129926176|NCT02723591|467695203|FG001|Overall Study|Protocol Violation|23|||
129926177|NCT02723591|467695202|FG000|Overall Study|Withdrawal by Subject|4|||
129926178|NCT02723591|467695203|FG001|Overall Study|Withdrawal by Subject|8|||
129926179|NCT02723591|467695202|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
129926180|NCT02723591|467695203|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
130117506|NCT00576901|468390524|FG000|Overall Study|Protocol Violation|1|||
129926181|NCT02723591|467695202|FG000|Overall Study|Miscellaneous|5|||
129926182|NCT02723591|467695203|FG001|Overall Study|Miscellaneous|6|||
129926189|NCT02151981|467695208|FG000|Overall Study|Death|184|||
129926190|NCT02151981|467695209|FG001|Overall Study|Death|88|||
129926191|NCT02151981|467695208|FG000|Overall Study|Lost to Follow-up|7|||
129926192|NCT02151981|467695209|FG001|Overall Study|Lost to Follow-up|1|||
129926193|NCT02151981|467695208|FG000|Overall Study|Withdrawal by Subject|27|||
129926194|NCT02151981|467695209|FG001|Overall Study|Withdrawal by Subject|21|||
129926195|NCT02151981|467695208|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129926196|NCT02151981|467695209|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129926197|NCT02151981|467695208|FG000|Overall Study|Other reasons|1|||
129926198|NCT02151981|467695209|FG001|Overall Study|Other reasons|2|||
129926199|NCT05446168|467695210|FG000|Overall Study|Physician Decision|0|||
129926200|NCT05446168|467695211|FG001|Overall Study|Physician Decision|1|||
129926201|NCT01946789|467695217|FG000|Overall Study|Death|0|||
129926202|NCT01946789|467695218|FG001|Overall Study|Death|2|||
129926203|NCT01946789|467695219|FG002|Overall Study|Death|1|||
129926204|NCT01946789|467695220|FG003|Overall Study|Death|1|||
129926205|NCT01946789|467695221|FG004|Overall Study|Death|1|||
129926206|NCT01946789|467695222|FG005|Overall Study|Death|1|||
129926207|NCT01946789|467695223|FG006|Overall Study|Death|3|||
129926208|NCT01946789|467695224|FG007|Overall Study|Death|1|||
129926209|NCT01946789|467695225|FG008|Overall Study|Death|2|||
129926210|NCT01946789|467695217|FG000|Overall Study|Progressive Disease|0|||
129926211|NCT01946789|467695218|FG001|Overall Study|Progressive Disease|0|||
129926212|NCT01946789|467695219|FG002|Overall Study|Progressive Disease|1|||
129926213|NCT01946789|467695220|FG003|Overall Study|Progressive Disease|0|||
129926214|NCT01946789|467695221|FG004|Overall Study|Progressive Disease|0|||
129926215|NCT01946789|467695222|FG005|Overall Study|Progressive Disease|2|||
129926216|NCT01946789|467695223|FG006|Overall Study|Progressive Disease|0|||
129926217|NCT01946789|467695224|FG007|Overall Study|Progressive Disease|0|||
129926218|NCT01946789|467695225|FG008|Overall Study|Progressive Disease|0|||
129926219|NCT01946789|467695217|FG000|Overall Study|Withdrawal by Subject|0|||
129926220|NCT01946789|467695218|FG001|Overall Study|Withdrawal by Subject|0|||
129926221|NCT01946789|467695219|FG002|Overall Study|Withdrawal by Subject|0|||
129926222|NCT01946789|467695220|FG003|Overall Study|Withdrawal by Subject|2|||
129926223|NCT01946789|467695221|FG004|Overall Study|Withdrawal by Subject|1|||
129926224|NCT01946789|467695222|FG005|Overall Study|Withdrawal by Subject|0|||
129926225|NCT01946789|467695223|FG006|Overall Study|Withdrawal by Subject|1|||
129926226|NCT01946789|467695224|FG007|Overall Study|Withdrawal by Subject|0|||
129926227|NCT01946789|467695225|FG008|Overall Study|Withdrawal by Subject|0|||
129926228|NCT05374798|467695226|FG000|Overall Study|Lost to Follow-up|2|||
129926229|NCT05374798|467695226|FG000|Overall Study|Withdrawal by Subject|2|||
129926230|NCT05374798|467695226|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
129926231|NCT01275677|467695227|FG000|Overall Study|Not at risk for recurrence.|1|||
129926232|NCT01275677|467695228|FG001|Overall Study|Not at risk for recurrence.|1|||
129926233|NCT01275677|467695227|FG000|Overall Study|No follow-up|26|||
129926234|NCT01275677|467695228|FG001|Overall Study|No follow-up|37|||
129926235|NCT01275677|467695227|FG000|Overall Study|No clinical follow up.|1|||
129926236|NCT01275677|467695228|FG001|Overall Study|No clinical follow up.|4|||
129926237|NCT04409353|467695236|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
129926238|NCT04409353|467695237|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
129926239|NCT04409353|467695238|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
129926240|NCT04409353|467695236|FG000|Overall Study|Lost to Follow-up|6|||
129926241|NCT04409353|467695237|FG001|Overall Study|Lost to Follow-up|8|||
129926242|NCT04409353|467695238|FG002|Overall Study|Lost to Follow-up|7|||
129926243|NCT04409353|467695236|FG000|Overall Study|Major surgery during participation window|4|||
129926244|NCT04409353|467695237|FG001|Overall Study|Major surgery during participation window|3|||
129926245|NCT04409353|467695238|FG002|Overall Study|Major surgery during participation window|3|||
129926246|NCT04409353|467695236|FG000|Overall Study|Life event occurred during participation window|3|||
129926247|NCT04409353|467695237|FG001|Overall Study|Life event occurred during participation window|2|||
129926248|NCT04409353|467695238|FG002|Overall Study|Life event occurred during participation window|4|||
129926249|NCT04409353|467695236|FG000|Overall Study|Lack of Efficacy|4|||
129926250|NCT04409353|467695237|FG001|Overall Study|Lack of Efficacy|1|||
129926251|NCT04409353|467695238|FG002|Overall Study|Lack of Efficacy|3|||
129926252|NCT04409353|467695236|FG000|Overall Study|Adverse Event|2|||
129926253|NCT04409353|467695237|FG001|Overall Study|Adverse Event|1|||
129926254|NCT04409353|467695238|FG002|Overall Study|Adverse Event|1|||
129926255|NCT04409353|467695236|FG000|Overall Study|Disease burden - unable to participate|0|||
129926256|NCT04409353|467695237|FG001|Overall Study|Disease burden - unable to participate|1|||
129926257|NCT04409353|467695238|FG002|Overall Study|Disease burden - unable to participate|1|||
130068988|NCT01432457|468207790|FG002|Overall Study|Lost to Follow-up|20|||
129926258|NCT04409353|467695236|FG000|Overall Study|Intervention too complicated|1|||
129926259|NCT04409353|467695237|FG001|Overall Study|Intervention too complicated|0|||
129926260|NCT04409353|467695238|FG002|Overall Study|Intervention too complicated|1|||
129926261|NCT04081103|467695239|FG000|Overall Study|Adverse Event|1|||
129926262|NCT04081103|467695240|FG001|Overall Study|Adverse Event|1|||
129926263|NCT04081103|467695241|FG002|Overall Study|Adverse Event|1|||
130068989|NCT01432457|468207788|FG000|Overall Study|Protocol Violation|3|||
130068990|NCT01432457|468207789|FG001|Overall Study|Protocol Violation|2|||
129926264|NCT04081103|467695239|FG000|Overall Study|Physician Decision|0|||
129926265|NCT04081103|467695240|FG001|Overall Study|Physician Decision|0|||
129926266|NCT04081103|467695241|FG002|Overall Study|Physician Decision|1|||
129926267|NCT03034356|467695242|FG000|Baseline|Lost to Follow-up|2|||
129926268|NCT03034356|467695243|FG001|Baseline|Lost to Follow-up|4|||
129926269|NCT03034356|467695242|FG000|Baseline|Withdrawal by Subject|2|||
129926270|NCT03034356|467695243|FG001|Baseline|Withdrawal by Subject|0|||
129926271|NCT03034356|467695242|FG000|Baseline|Physician Decision|0|||
129926272|NCT03034356|467695243|FG001|Baseline|Physician Decision|1|||
129926273|NCT03034356|467695242|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
129926274|NCT03034356|467695243|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
129926275|NCT03034356|467695242|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
129926276|NCT03034356|467695243|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
129926277|NCT03034356|467695242|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
129926278|NCT03034356|467695243|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
129926279|NCT03034356|467695242|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
129926280|NCT03034356|467695243|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
129926281|NCT03854227|467696805|FG000|Overall Study|Adverse Event|0|||
129926282|NCT03854227|467696806|FG001|Overall Study|Adverse Event|0|||
129926283|NCT03854227|467696807|FG002|Overall Study|Adverse Event|0|||
129926284|NCT03854227|467696808|FG003|Overall Study|Adverse Event|1|||
129926285|NCT03854227|467696809|FG004|Overall Study|Adverse Event|0|||
129926286|NCT03854227|467696810|FG005|Overall Study|Adverse Event|0|||
129926287|NCT03854227|467696811|FG006|Overall Study|Adverse Event|1|||
129926288|NCT03854227|467696812|FG007|Overall Study|Adverse Event|0|||
129926289|NCT03854227|467696813|FG008|Overall Study|Adverse Event|0|||
129926290|NCT03854227|467696814|FG009|Overall Study|Adverse Event|3|||
129926291|NCT03854227|467696815|FG010|Overall Study|Adverse Event|0|||
129926292|NCT03854227|467696816|FG011|Overall Study|Adverse Event|1|||
129926293|NCT03854227|467696805|FG000|Overall Study|Death|0|||
129926294|NCT03854227|467696806|FG001|Overall Study|Death|0|||
129926295|NCT03854227|467696807|FG002|Overall Study|Death|0|||
129926296|NCT03854227|467696808|FG003|Overall Study|Death|0|||
129926297|NCT03854227|467696809|FG004|Overall Study|Death|0|||
129926298|NCT03854227|467696810|FG005|Overall Study|Death|1|||
129926299|NCT03854227|467696811|FG006|Overall Study|Death|0|||
129926300|NCT03854227|467696812|FG007|Overall Study|Death|0|||
129926301|NCT03854227|467696813|FG008|Overall Study|Death|0|||
129926302|NCT03854227|467696814|FG009|Overall Study|Death|1|||
129926303|NCT03854227|467696815|FG010|Overall Study|Death|0|||
129926304|NCT03854227|467696816|FG011|Overall Study|Death|1|||
129926305|NCT03854227|467696805|FG000|Overall Study|Physician Decision|0|||
129926306|NCT03854227|467696806|FG001|Overall Study|Physician Decision|0|||
129926307|NCT03854227|467696807|FG002|Overall Study|Physician Decision|0|||
129926308|NCT03854227|467696808|FG003|Overall Study|Physician Decision|0|||
129926309|NCT03854227|467696809|FG004|Overall Study|Physician Decision|0|||
129926310|NCT03854227|467696810|FG005|Overall Study|Physician Decision|1|||
129926311|NCT03854227|467696811|FG006|Overall Study|Physician Decision|0|||
129926312|NCT03854227|467696812|FG007|Overall Study|Physician Decision|0|||
129926313|NCT03854227|467696813|FG008|Overall Study|Physician Decision|1|||
129926314|NCT03854227|467696814|FG009|Overall Study|Physician Decision|1|||
129926315|NCT03854227|467696815|FG010|Overall Study|Physician Decision|0|||
129926316|NCT03854227|467696816|FG011|Overall Study|Physician Decision|1|||
129926317|NCT03854227|467696805|FG000|Overall Study|Progressive disease|1|||
129926318|NCT03854227|467696806|FG001|Overall Study|Progressive disease|1|||
129926319|NCT03854227|467696807|FG002|Overall Study|Progressive disease|1|||
129926320|NCT03854227|467696808|FG003|Overall Study|Progressive disease|2|||
129926321|NCT03854227|467696809|FG004|Overall Study|Progressive disease|3|||
129926322|NCT03854227|467696810|FG005|Overall Study|Progressive disease|1|||
129926323|NCT03854227|467696811|FG006|Overall Study|Progressive disease|2|||
129926324|NCT03854227|467696812|FG007|Overall Study|Progressive disease|5|||
129926325|NCT03854227|467696813|FG008|Overall Study|Progressive disease|2|||
129926326|NCT03854227|467696814|FG009|Overall Study|Progressive disease|5|||
129926327|NCT03854227|467696815|FG010|Overall Study|Progressive disease|1|||
129926328|NCT03854227|467696816|FG011|Overall Study|Progressive disease|6|||
129926329|NCT03854227|467696805|FG000|Overall Study|Study terminated by sponsor|0|||
129926330|NCT03854227|467696806|FG001|Overall Study|Study terminated by sponsor|0|||
129926331|NCT03854227|467696807|FG002|Overall Study|Study terminated by sponsor|0|||
129926332|NCT03854227|467696808|FG003|Overall Study|Study terminated by sponsor|0|||
129926333|NCT03854227|467696809|FG004|Overall Study|Study terminated by sponsor|0|||
129926334|NCT03854227|467696810|FG005|Overall Study|Study terminated by sponsor|0|||
130068991|NCT01432457|468207790|FG002|Overall Study|Protocol Violation|6|||
129926335|NCT03854227|467696811|FG006|Overall Study|Study terminated by sponsor|0|||
129926336|NCT03854227|467696812|FG007|Overall Study|Study terminated by sponsor|0|||
129926337|NCT03854227|467696813|FG008|Overall Study|Study terminated by sponsor|0|||
129926338|NCT03854227|467696814|FG009|Overall Study|Study terminated by sponsor|1|||
129926339|NCT03854227|467696815|FG010|Overall Study|Study terminated by sponsor|0|||
129926340|NCT03854227|467696816|FG011|Overall Study|Study terminated by sponsor|0|||
129926341|NCT03854227|467696805|FG000|Overall Study|Withdrawal by Subject|0|||
129926342|NCT03854227|467696806|FG001|Overall Study|Withdrawal by Subject|0|||
129926343|NCT03854227|467696807|FG002|Overall Study|Withdrawal by Subject|1|||
129926344|NCT03854227|467696808|FG003|Overall Study|Withdrawal by Subject|0|||
129926345|NCT03854227|467696809|FG004|Overall Study|Withdrawal by Subject|0|||
129926346|NCT03854227|467696810|FG005|Overall Study|Withdrawal by Subject|0|||
129926347|NCT03854227|467696811|FG006|Overall Study|Withdrawal by Subject|0|||
129926348|NCT03854227|467696812|FG007|Overall Study|Withdrawal by Subject|0|||
129926349|NCT03854227|467696813|FG008|Overall Study|Withdrawal by Subject|0|||
129926350|NCT03854227|467696814|FG009|Overall Study|Withdrawal by Subject|1|||
129926351|NCT03854227|467696815|FG010|Overall Study|Withdrawal by Subject|1|||
129926352|NCT03854227|467696816|FG011|Overall Study|Withdrawal by Subject|0|||
129926353|NCT03854227|467696805|FG000|Overall Study|Disease relapse|0|||
129926354|NCT03854227|467696806|FG001|Overall Study|Disease relapse|0|||
129926355|NCT03854227|467696807|FG002|Overall Study|Disease relapse|0|||
129926356|NCT03854227|467696808|FG003|Overall Study|Disease relapse|0|||
129926357|NCT03854227|467696809|FG004|Overall Study|Disease relapse|0|||
129926358|NCT03854227|467696810|FG005|Overall Study|Disease relapse|0|||
129926359|NCT03854227|467696811|FG006|Overall Study|Disease relapse|0|||
129926360|NCT03854227|467696812|FG007|Overall Study|Disease relapse|0|||
129926361|NCT03854227|467696813|FG008|Overall Study|Disease relapse|1|||
129926362|NCT03854227|467696814|FG009|Overall Study|Disease relapse|0|||
129926363|NCT03854227|467696815|FG010|Overall Study|Disease relapse|0|||
129926364|NCT03854227|467696816|FG011|Overall Study|Disease relapse|0|||
129926365|NCT03854227|467696805|FG000|Overall Study|Global deterioration of health status|0|||
129926366|NCT03854227|467696806|FG001|Overall Study|Global deterioration of health status|0|||
129926367|NCT03854227|467696807|FG002|Overall Study|Global deterioration of health status|0|||
129926368|NCT03854227|467696808|FG003|Overall Study|Global deterioration of health status|0|||
129926369|NCT03854227|467696809|FG004|Overall Study|Global deterioration of health status|0|||
129926370|NCT03854227|467696810|FG005|Overall Study|Global deterioration of health status|1|||
129926371|NCT03854227|467696811|FG006|Overall Study|Global deterioration of health status|0|||
129926372|NCT03854227|467696812|FG007|Overall Study|Global deterioration of health status|1|||
129926373|NCT03854227|467696813|FG008|Overall Study|Global deterioration of health status|0|||
129926374|NCT03854227|467696814|FG009|Overall Study|Global deterioration of health status|0|||
129926375|NCT03854227|467696815|FG010|Overall Study|Global deterioration of health status|0|||
129926376|NCT03854227|467696816|FG011|Overall Study|Global deterioration of health status|0|||
129926377|NCT03854227|467696805|FG000|Overall Study|Refused further treatment|0|||
129926378|NCT03854227|467696806|FG001|Overall Study|Refused further treatment|0|||
129926379|NCT03854227|467696807|FG002|Overall Study|Refused further treatment|0|||
129926380|NCT03854227|467696808|FG003|Overall Study|Refused further treatment|0|||
129926381|NCT03854227|467696809|FG004|Overall Study|Refused further treatment|0|||
129926382|NCT03854227|467696810|FG005|Overall Study|Refused further treatment|0|||
129926383|NCT03854227|467696811|FG006|Overall Study|Refused further treatment|0|||
129926384|NCT03854227|467696812|FG007|Overall Study|Refused further treatment|0|||
129926385|NCT03854227|467696813|FG008|Overall Study|Refused further treatment|0|||
129926386|NCT03854227|467696814|FG009|Overall Study|Refused further treatment|1|||
129926387|NCT03854227|467696815|FG010|Overall Study|Refused further treatment|0|||
129926388|NCT03854227|467696816|FG011|Overall Study|Refused further treatment|1|||
129926389|NCT03854227|467696805|FG000|Overall Study|Other|0|||
129926390|NCT03854227|467696806|FG001|Overall Study|Other|0|||
129926391|NCT03854227|467696807|FG002|Overall Study|Other|0|||
129926392|NCT03854227|467696808|FG003|Overall Study|Other|0|||
129926393|NCT03854227|467696809|FG004|Overall Study|Other|0|||
129926394|NCT03854227|467696810|FG005|Overall Study|Other|0|||
129926395|NCT03854227|467696811|FG006|Overall Study|Other|0|||
129926396|NCT03854227|467696812|FG007|Overall Study|Other|0|||
129926397|NCT03854227|467696813|FG008|Overall Study|Other|1|||
129926398|NCT03854227|467696814|FG009|Overall Study|Other|1|||
129926399|NCT03854227|467696815|FG010|Overall Study|Other|0|||
129926400|NCT03854227|467696816|FG011|Overall Study|Other|0|||
129926401|NCT03668236|467696817|FG000|90-day Follow-up|Withdrawal by Subject|3|||
129926402|NCT03668236|467696818|FG001|90-day Follow-up|Withdrawal by Subject|2|||
129926403|NCT03668236|467696817|FG000|90-day Follow-up|Lost to Follow-up|3|||
129926404|NCT03668236|467696818|FG001|90-day Follow-up|Lost to Follow-up|1|||
129926405|NCT03668236|467696817|FG000|Baseline Characteristics|Lost to Follow-up|9|||
129926406|NCT03668236|467696818|FG001|Baseline Characteristics|Lost to Follow-up|5|||
129926407|NCT03668236|467696817|FG000|1-year Follow-up|Withdrawal by Subject|17|||
129926408|NCT03668236|467696818|FG001|1-year Follow-up|Withdrawal by Subject|15|||
129926409|NCT06132282|467696824|FG000|Overall Study|Lost to Follow-up|31|||
129926410|NCT04376502|467696830|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
129926411|NCT03748953|467696831|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
129926412|NCT03748953|467696832|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
129926413|NCT03748953|467696831|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
129926414|NCT03748953|467696832|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
129926415|NCT03748953|467696831|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
129926416|NCT03748953|467696832|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
129926417|NCT03748953|467696831|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
129926418|NCT03748953|467696832|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
129926419|NCT03748953|467696831|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
129926420|NCT03748953|467696832|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
129926421|NCT04119843|467696837|FG000|Overall Study|Adverse Event|3|||
129926422|NCT04119843|467696837|FG000|Overall Study|Death|1|||
129926423|NCT02841579|467696838|FG000|Overall Study|Death|1|||
129926424|NCT02841579|467696838|FG000|Overall Study|Adverse Event|1|||
129926425|NCT02841579|467696838|FG000|Overall Study|Lack of Efficacy|9|||
129926426|NCT01501955|467696842|FG000|Overall Study|Withdrawal by Subject|1|||
129926427|NCT01501955|467696843|FG001|Overall Study|Withdrawal by Subject|0|||
129926428|NCT01501955|467696842|FG000|Overall Study|Adverse Event|1|||
129926429|NCT01501955|467696843|FG001|Overall Study|Adverse Event|3|||
129926430|NCT05034328|467696844|FG000|Overall Study|Protocol Violation|1|||
129926431|NCT05034328|467696845|FG001|Overall Study|Protocol Violation|0|||
129926432|NCT05034328|467696844|FG000|Overall Study|Lost to Follow-up|0|||
129926433|NCT05034328|467696845|FG001|Overall Study|Lost to Follow-up|10|||
129926434|NCT03625167|467696850|FG000|Overall Study|Protocol Violation|5|||
129926435|NCT02969707|467696853|FG000|Overall Study|Withdrawal by Subject|6|||
129926436|NCT02969707|467696854|FG001|Overall Study|Withdrawal by Subject|5|||
129926437|NCT02969707|467696853|FG000|Overall Study|Severe anxiety|0|||
129926438|NCT02969707|467696854|FG001|Overall Study|Severe anxiety|1|||
129926439|NCT02969707|467696853|FG000|Overall Study|Positive toxicology screen|0|||
129926440|NCT02969707|467696854|FG001|Overall Study|Positive toxicology screen|2|||
129926441|NCT02969707|467696853|FG000|Overall Study|Claustrophobia|2|||
129926442|NCT02969707|467696854|FG001|Overall Study|Claustrophobia|2|||
129926443|NCT02969707|467696853|FG000|Overall Study|Non-compliance|1|||
129926444|NCT02969707|467696854|FG001|Overall Study|Non-compliance|2|||
129926445|NCT04979442|467696855|FG000|Overall Study|Death|43|||
129926446|NCT04979442|467696856|FG001|Overall Study|Death|30|||
129926447|NCT04979442|467696855|FG000|Overall Study|Withdrawal by Subject|8|||
129926448|NCT04979442|467696856|FG001|Overall Study|Withdrawal by Subject|13|||
129926449|NCT04979442|467696855|FG000|Overall Study|Physician Decision|1|||
129926450|NCT04979442|467696856|FG001|Overall Study|Physician Decision|1|||
129926451|NCT04979442|467696855|FG000|Overall Study|Lost to Follow-up|0|||
129926452|NCT04979442|467696856|FG001|Overall Study|Lost to Follow-up|2|||
129926453|NCT04979442|467696855|FG000|Overall Study|do not want to continue|0|||
129926454|NCT04979442|467696856|FG001|Overall Study|do not want to continue|1|||
129926455|NCT04314713|467696859|FG000|Overall Study|Lost to Follow-up|0|||
129926456|NCT04314713|467696860|FG001|Overall Study|Lost to Follow-up|0|||
129926457|NCT04314713|467696861|FG002|Overall Study|Lost to Follow-up|0|||
129926458|NCT04314713|467696862|FG003|Overall Study|Lost to Follow-up|1|||
129926459|NCT04314713|467696863|FG004|Overall Study|Lost to Follow-up|0|||
129926460|NCT04314713|467696864|FG005|Overall Study|Lost to Follow-up|0|||
129926461|NCT00248287|467696869|FG000|Overall Study|Adverse Event|11|||
129926462|NCT00248287|467696870|FG001|Overall Study|Adverse Event|10|||
129926463|NCT00248287|467696869|FG000|Overall Study|Death|1|||
129926464|NCT00248287|467696870|FG001|Overall Study|Death|0|||
129926465|NCT00248287|467696869|FG000|Overall Study|Lost to Follow-up|0|||
129926466|NCT00248287|467696870|FG001|Overall Study|Lost to Follow-up|1|||
129926467|NCT00248287|467696869|FG000|Overall Study|Investigator Request|4|||
129926468|NCT00248287|467696870|FG001|Overall Study|Investigator Request|3|||
129926469|NCT00248287|467696869|FG000|Overall Study|Patient Request|5|||
129926470|NCT00248287|467696870|FG001|Overall Study|Patient Request|3|||
129926471|NCT00248287|467696869|FG000|Overall Study|Other|3|||
129926472|NCT00248287|467696870|FG001|Overall Study|Other|2|||
129926473|NCT02714257|467696871|FG000|Overall Study|Withdrawal by Subject|6|||
129926474|NCT02714257|467696872|FG001|Overall Study|Withdrawal by Subject|11|||
129926475|NCT02714257|467696871|FG000|Overall Study|Death|3|||
129926476|NCT02714257|467696872|FG001|Overall Study|Death|4|||
129926477|NCT02714257|467696871|FG000|Overall Study|Lost to Follow-up|1|||
129926478|NCT02714257|467696872|FG001|Overall Study|Lost to Follow-up|6|||
129926479|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
129926480|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
129926481|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
129926482|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
129926483|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
130068992|NCT01432457|468207788|FG000|Overall Study|Withdrawal by Subject|6|||
130068993|NCT01432457|468207789|FG001|Overall Study|Withdrawal by Subject|11|||
129926484|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
130068994|NCT01432457|468207790|FG002|Overall Study|Withdrawal by Subject|9|||
129926485|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
129926486|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
129926487|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
129926488|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
129926489|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Other|3|||
129926490|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Other|3|||
129926491|NCT04103580|467696873|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
129926492|NCT04103580|467696874|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
129926493|NCT04103580|467696873|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
129926494|NCT04103580|467696874|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
129926495|NCT04103580|467696873|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
129926496|NCT04103580|467696874|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
129926497|NCT04103580|467696873|FG000|Phase 2 Bereavement|Other|8|||
129926498|NCT04103580|467696874|FG001|Phase 2 Bereavement|Other|6|||
129926499|NCT04145440|467696875|FG000|Overall Study|Physician Decision|3|||
129926500|NCT04145440|467696876|FG001|Overall Study|Physician Decision|0|||
129926501|NCT04145440|467696875|FG000|Overall Study|Use of prohibited therapy|2|||
129926502|NCT04145440|467696876|FG001|Overall Study|Use of prohibited therapy|3|||
129926503|NCT05297565|467696881|FG000|Overall Study|Other Reasons|0|||
129926504|NCT05297565|467696882|FG001|Overall Study|Other Reasons|1|||
129926505|NCT05297565|467696881|FG000|Overall Study|Physician Decision|0|||
129926506|NCT05297565|467696882|FG001|Overall Study|Physician Decision|1|||
129926507|NCT05297565|467696881|FG000|Overall Study|Disease recurrence|1|||
129926508|NCT05297565|467696882|FG001|Overall Study|Disease recurrence|0|||
129926509|NCT05670587|467696883|FG000|Overall Study|Withdrawal by Subject|3|||
129926510|NCT05940194|467696884|FG000|Overall Study|Adverse Event|0|||
129926511|NCT05940194|467696885|FG001|Overall Study|Adverse Event|1|||
129926512|NCT05940194|467696886|FG002|Overall Study|Adverse Event|0|||
129926513|NCT05940194|467696884|FG000|Overall Study|Migrated/Moved from the study area|2|||
129926514|NCT05940194|467696885|FG001|Overall Study|Migrated/Moved from the study area|2|||
129926515|NCT05940194|467696886|FG002|Overall Study|Migrated/Moved from the study area|4|||
129926516|NCT03235544|467696887|FG000|Overall Study|Death|11|||
129926517|NCT03235544|467696888|FG001|Overall Study|Death|31|||
129926518|NCT03235544|467696889|FG002|Overall Study|Death|19|||
129926519|NCT03235544|467696890|FG003|Overall Study|Death|34|||
129926520|NCT03235544|467696887|FG000|Overall Study|Lost to Follow-up|0|||
129926521|NCT03235544|467696888|FG001|Overall Study|Lost to Follow-up|1|||
129926522|NCT03235544|467696889|FG002|Overall Study|Lost to Follow-up|1|||
129926523|NCT03235544|467696890|FG003|Overall Study|Lost to Follow-up|1|||
129926524|NCT03235544|467696887|FG000|Overall Study|Withdrawal by Subject|0|||
129926525|NCT03235544|467696888|FG001|Overall Study|Withdrawal by Subject|3|||
129926526|NCT03235544|467696889|FG002|Overall Study|Withdrawal by Subject|1|||
129926527|NCT03235544|467696890|FG003|Overall Study|Withdrawal by Subject|5|||
129926528|NCT03235544|467696887|FG000|Overall Study|Disease Progression|0|||
129926529|NCT03235544|467696888|FG001|Overall Study|Disease Progression|1|||
129926530|NCT03235544|467696889|FG002|Overall Study|Disease Progression|0|||
129926531|NCT03235544|467696890|FG003|Overall Study|Disease Progression|2|||
129926532|NCT03235544|467696887|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
129926533|NCT03235544|467696888|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
129926534|NCT03235544|467696889|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
129926535|NCT03235544|467696890|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
129926536|NCT03235544|467696887|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
129926537|NCT03235544|467696888|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
129926538|NCT03235544|467696889|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
129926539|NCT03235544|467696890|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
129926540|NCT04830800|467696892|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
129926541|NCT04830800|467696893|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
129926542|NCT04830800|467696894|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
129926543|NCT04830800|467696895|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
129926544|NCT04830800|467696896|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
129926545|NCT03710603|467696899|FG000|Overall Study|Adverse Event|1|||
129926546|NCT03710603|467696900|FG001|Overall Study|Adverse Event|0|||
129926547|NCT03710603|467696899|FG000|Overall Study|Death|44|||
129926548|NCT03710603|467696900|FG001|Overall Study|Death|34|||
129926549|NCT03710603|467696899|FG000|Overall Study|Lost to Follow-up|3|||
129926550|NCT03710603|467696900|FG001|Overall Study|Lost to Follow-up|5|||
129926551|NCT03710603|467696899|FG000|Overall Study|Withdrawal by Subject|11|||
129926552|NCT03710603|467696900|FG001|Overall Study|Withdrawal by Subject|10|||
129926553|NCT01456949|467696901|FG000|Enrollment|PI death- incomplete data|6|||
129926554|NCT01456949|467696901|FG000|Enrollment|Death|1|||
129926555|NCT01456949|467696901|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
129926556|NCT01456949|467696901|FG000|Enrollment|Physician Decision|10|||
129926557|NCT01456949|467696901|FG000|Enrollment|Withdrawal by Subject|7|||
129926558|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
129926559|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
129926560|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
129926561|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
129926562|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
129926563|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
129926564|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
129926565|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
129926566|NCT02626533|467696902|FG000|Overall Study|Protocol Violation|14|||
129926567|NCT02626533|467696902|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
129926568|NCT02626533|467696902|FG000|Overall Study|Withdrawal by Subject|1|||
129926569|NCT04753697|467696903|FG000|Induction Phase|Withdrawal by Subject|12|||
129926570|NCT04753697|467696904|FG001|Induction Phase|Withdrawal by Subject|5|||
129926571|NCT04753697|467696905|FG002|Induction Phase|Withdrawal by Subject|6|||
129926572|NCT04753697|467696903|FG000|Induction Phase|Physician Decision|1|||
129926573|NCT04753697|467696904|FG001|Induction Phase|Physician Decision|0|||
129926574|NCT04753697|467696905|FG002|Induction Phase|Physician Decision|0|||
129926575|NCT04753697|467696903|FG000|Induction Phase|Lost to Follow-up|2|||
129926576|NCT04753697|467696904|FG001|Induction Phase|Lost to Follow-up|2|||
129926577|NCT04753697|467696905|FG002|Induction Phase|Lost to Follow-up|1|||
129926578|NCT04753697|467696903|FG000|Induction Phase|Lack of Efficacy|1|||
129926579|NCT04753697|467696904|FG001|Induction Phase|Lack of Efficacy|0|||
129926580|NCT04753697|467696905|FG002|Induction Phase|Lack of Efficacy|0|||
129926581|NCT04753697|467696903|FG000|Maintenance Phase|Physician Decision|0|||
129926582|NCT04753697|467696904|FG001|Maintenance Phase|Physician Decision|0|||
129926583|NCT04753697|467696905|FG002|Maintenance Phase|Physician Decision|1|||
129926584|NCT04753697|467696903|FG000|Maintenance Phase|Withdrawal by Subject|3|||
129926585|NCT04753697|467696904|FG001|Maintenance Phase|Withdrawal by Subject|4|||
129926586|NCT04753697|467696905|FG002|Maintenance Phase|Withdrawal by Subject|6|||
129926587|NCT04753697|467696903|FG000|Maintenance Phase|Lost to Follow-up|2|||
129926588|NCT04753697|467696904|FG001|Maintenance Phase|Lost to Follow-up|2|||
129926589|NCT04753697|467696905|FG002|Maintenance Phase|Lost to Follow-up|0|||
129926590|NCT04753697|467696903|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
129926591|NCT04753697|467696904|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
129926592|NCT04753697|467696905|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
129926593|NCT04753697|467696903|FG000|Maintenance Phase|Adverse Event|0|||
129926594|NCT04753697|467696904|FG001|Maintenance Phase|Adverse Event|1|||
129926595|NCT04753697|467696905|FG002|Maintenance Phase|Adverse Event|1|||
129926596|NCT04753697|467696903|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
129926597|NCT04753697|467696904|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
129926598|NCT04753697|467696905|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
129926599|NCT03701763|467696906|FG000|Placebo-controlled Phase|Adverse Event|1|||
129926600|NCT03701763|467696907|FG001|Placebo-controlled Phase|Adverse Event|5|||
129926601|NCT03701763|467696908|FG002|Placebo-controlled Phase|Adverse Event|0|||
129926602|NCT03701763|467696909|FG003|Placebo-controlled Phase|Adverse Event|0|||
129926603|NCT03701763|467696906|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
129926604|NCT03701763|467696907|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
129926605|NCT03701763|467696908|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
129926606|NCT03701763|467696909|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
129926607|NCT03701763|467696906|FG000|Placebo-controlled Phase|Miscellaneous|2|||
129926608|NCT03701763|467696907|FG001|Placebo-controlled Phase|Miscellaneous|0|||
129926609|NCT03701763|467696908|FG002|Placebo-controlled Phase|Miscellaneous|0|||
129926610|NCT03701763|467696909|FG003|Placebo-controlled Phase|Miscellaneous|0|||
129926611|NCT03701763|467696906|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
129926612|NCT03701763|467696907|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
129926613|NCT03701763|467696908|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
129926614|NCT03701763|467696909|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
129926615|NCT03701763|467696906|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
129926616|NCT03701763|467696907|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
129926617|NCT03701763|467696908|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
129926618|NCT03701763|467696909|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
129926619|NCT03701763|467696906|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
129926620|NCT03701763|467696907|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
129926621|NCT03701763|467696908|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
129926622|NCT03701763|467696909|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
129926623|NCT03701763|467696906|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
129926624|NCT03701763|467696907|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
129926625|NCT03701763|467696908|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
129926626|NCT03701763|467696909|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
129926627|NCT03701763|467696906|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
129926628|NCT03701763|467696907|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
129926629|NCT03701763|467696908|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
129926630|NCT03701763|467696909|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
129926631|NCT03701763|467696906|FG000|Apremilast Extension Phase|Adverse Event|0|||
129926632|NCT03701763|467696907|FG001|Apremilast Extension Phase|Adverse Event|0|||
129926633|NCT03701763|467696908|FG002|Apremilast Extension Phase|Adverse Event|3|||
129926634|NCT03701763|467696909|FG003|Apremilast Extension Phase|Adverse Event|1|||
129926635|NCT03701763|467696906|FG000|Apremilast Extension Phase|Miscellaneous|0|||
129926636|NCT03701763|467696907|FG001|Apremilast Extension Phase|Miscellaneous|0|||
129926637|NCT03701763|467696908|FG002|Apremilast Extension Phase|Miscellaneous|2|||
129926638|NCT03701763|467696909|FG003|Apremilast Extension Phase|Miscellaneous|1|||
129926639|NCT03701763|467696906|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
129926640|NCT03701763|467696907|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
129926641|NCT03701763|467696908|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
129926642|NCT03701763|467696909|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
129926643|NCT03701763|467696906|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
129926644|NCT03701763|467696907|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
129926645|NCT03701763|467696908|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
129926646|NCT03701763|467696909|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
129926647|NCT03701763|467696906|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
129926648|NCT03701763|467696907|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
129926649|NCT03701763|467696908|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
129926650|NCT03701763|467696909|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
129926651|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
129926652|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
129926653|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
129926654|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
129926655|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
129926656|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
129926657|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
129926658|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
129926659|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Other|0|||
129926660|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Other|0|||
129926661|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Other|1|||
129926662|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Other|0|||
129926663|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
129926664|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
129926665|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
129926666|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
129926667|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
129926668|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
129926669|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
129926670|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
129926671|NCT03511664|467696915|FG000|Overall Study|Death|457|||
129926672|NCT03511664|467696916|FG001|Overall Study|Death|201|||
129926673|NCT03511664|467696917|FG002|Overall Study|Death|21|||
129926674|NCT03511664|467696915|FG000|Overall Study|Withdrew consent|40|||
129926675|NCT03511664|467696916|FG001|Overall Study|Withdrew consent|63|||
129926676|NCT03511664|467696917|FG002|Overall Study|Withdrew consent|3|||
129926677|NCT03511664|467696915|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
129926678|NCT03511664|467696916|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
129926679|NCT03511664|467696917|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
129926680|NCT03511664|467696915|FG000|Overall Study|Lost to Follow-up|8|||
129926681|NCT03511664|467696916|FG001|Overall Study|Lost to Follow-up|5|||
129926682|NCT03511664|467696917|FG002|Overall Study|Lost to Follow-up|0|||
129926683|NCT03511664|467696915|FG000|Overall Study|Physician Decision|2|||
129926684|NCT03511664|467696916|FG001|Overall Study|Physician Decision|1|||
129926685|NCT03511664|467696917|FG002|Overall Study|Physician Decision|0|||
129926686|NCT03511664|467696915|FG000|Overall Study|Patient non-compliance|1|||
129926687|NCT03511664|467696916|FG001|Overall Study|Patient non-compliance|0|||
129926688|NCT03511664|467696917|FG002|Overall Study|Patient non-compliance|0|||
129926689|NCT02823145|467696922|FG000|Enrollment|Other|1|||
129926690|NCT02823145|467696923|FG001|Enrollment|Other|0|||
129926691|NCT02823145|467696922|FG000|Treatment|Adverse Event|0|||
129926692|NCT02823145|467696923|FG001|Treatment|Adverse Event|11|||
129926693|NCT02823145|467696922|FG000|Treatment|Death|0|||
129926694|NCT02823145|467696923|FG001|Treatment|Death|3|||
129926695|NCT02823145|467696922|FG000|Treatment|Family Decision|0|||
129926696|NCT02823145|467696923|FG001|Treatment|Family Decision|1|||
129926697|NCT02823145|467696922|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
129926698|NCT02823145|467696923|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
129926699|NCT02823145|467696922|FG000|Treatment|Lack of Efficacy|0|||
129926700|NCT02823145|467696923|FG001|Treatment|Lack of Efficacy|48|||
129926701|NCT02823145|467696922|FG000|Treatment|Non-Compliance With E-Diary|0|||
129926702|NCT02823145|467696923|FG001|Treatment|Non-Compliance With E-Diary|1|||
129926703|NCT02823145|467696922|FG000|Treatment|Physician Decision|0|||
129926704|NCT02823145|467696923|FG001|Treatment|Physician Decision|2|||
129926705|NCT02823145|467696922|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
129926706|NCT02823145|467696923|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
129926707|NCT02823145|467696922|FG000|Treatment|Subject needed to take prohibited medication|0|||
129926708|NCT02823145|467696923|FG001|Treatment|Subject needed to take prohibited medication|1|||
129926709|NCT02823145|467696922|FG000|Treatment|Subject transferred to direct access programme|0|||
129926710|NCT02823145|467696923|FG001|Treatment|Subject transferred to direct access programme|1|||
129926711|NCT02823145|467696922|FG000|Treatment|Switching to commercially available drug|0|||
129926712|NCT02823145|467696923|FG001|Treatment|Switching to commercially available drug|11|||
129926713|NCT02823145|467696922|FG000|Treatment|Transitioned to commercial supply of medication|0|||
129926714|NCT02823145|467696923|FG001|Treatment|Transitioned to commercial supply of medication|1|||
129926715|NCT02823145|467696922|FG000|Treatment|Withdrawal By Caregiver|0|||
129926716|NCT02823145|467696923|FG001|Treatment|Withdrawal By Caregiver|1|||
129926717|NCT02823145|467696922|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
129926718|NCT02823145|467696923|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
129926719|NCT02823145|467696922|FG000|Treatment|Withdrawal by Subject|0|||
129926720|NCT02823145|467696923|FG001|Treatment|Withdrawal by Subject|16|||
129926721|NCT02823145|467696922|FG000|Treatment|Reason unknown|0|||
129926722|NCT02823145|467696923|FG001|Treatment|Reason unknown|1|||
129926723|NCT05292391|467696924|FG000|Overall Study|Lost to Follow-up|0|||
129926724|NCT05292391|467696925|FG001|Overall Study|Lost to Follow-up|0|||
129926725|NCT05292391|467696926|FG002|Overall Study|Lost to Follow-up|0|||
129926726|NCT05292391|467696927|FG003|Overall Study|Lost to Follow-up|1|||
129926727|NCT05292391|467696928|FG004|Overall Study|Lost to Follow-up|0|||
129926728|NCT05809453|467698962|FG000|Overall Study|Withdrawal by Subject|1|||
129926729|NCT05809453|467698963|FG001|Overall Study|Withdrawal by Subject|0|||
129926730|NCT05809453|467698964|FG002|Overall Study|Withdrawal by Subject|0|||
129926731|NCT05809453|467698965|FG003|Overall Study|Withdrawal by Subject|0|||
129926732|NCT03287817|467698966|FG000|Overall Study|Progressive disease|4|||
129926733|NCT03287817|467698967|FG001|Overall Study|Progressive disease|2|||
129926734|NCT03287817|467698968|FG002|Overall Study|Progressive disease|3|||
129926735|NCT03287817|467698969|FG003|Overall Study|Progressive disease|10|||
129926736|NCT03287817|467698970|FG004|Overall Study|Progressive disease|8|||
129926737|NCT03287817|467698966|FG000|Overall Study|Death|0|||
129926738|NCT03287817|467698967|FG001|Overall Study|Death|0|||
129926739|NCT03287817|467698968|FG002|Overall Study|Death|2|||
129926740|NCT03287817|467698969|FG003|Overall Study|Death|3|||
129926741|NCT03287817|467698970|FG004|Overall Study|Death|4|||
129926742|NCT03287817|467698966|FG000|Overall Study|Physician Decision|0|||
129926743|NCT03287817|467698967|FG001|Overall Study|Physician Decision|0|||
129926744|NCT03287817|467698968|FG002|Overall Study|Physician Decision|0|||
129926745|NCT03287817|467698969|FG003|Overall Study|Physician Decision|1|||
129926746|NCT03287817|467698970|FG004|Overall Study|Physician Decision|0|||
129926747|NCT03287817|467698966|FG000|Overall Study|Withdrawal by Subject|0|||
129926748|NCT03287817|467698967|FG001|Overall Study|Withdrawal by Subject|0|||
129926749|NCT03287817|467698968|FG002|Overall Study|Withdrawal by Subject|0|||
129926750|NCT03287817|467698969|FG003|Overall Study|Withdrawal by Subject|0|||
129926751|NCT03287817|467698970|FG004|Overall Study|Withdrawal by Subject|4|||
129926752|NCT03257410|467698971|FG000|Overall Study|Adverse Event|2|||
129926753|NCT03257410|467698972|FG001|Overall Study|Adverse Event|3|||
129926754|NCT03257410|467698971|FG000|Overall Study|Protocol Violation|1|||
129926755|NCT03257410|467698972|FG001|Overall Study|Protocol Violation|2|||
129926756|NCT03257410|467698971|FG000|Overall Study|Lost to Follow-up|1|||
129926757|NCT03257410|467698972|FG001|Overall Study|Lost to Follow-up|0|||
129926758|NCT03257410|467698971|FG000|Overall Study|Withdrawal by Subject|1|||
129926759|NCT03257410|467698972|FG001|Overall Study|Withdrawal by Subject|2|||
129926760|NCT03257410|467698971|FG000|Overall Study|Physician Decision|1|||
129926761|NCT03257410|467698972|FG001|Overall Study|Physician Decision|1|||
129926762|NCT03257410|467698971|FG000|Overall Study|Renal transplantation|2|||
129926763|NCT03257410|467698972|FG001|Overall Study|Renal transplantation|0|||
129926764|NCT03257410|467698971|FG000|Overall Study|Switch to peritoneal dialysis|1|||
129926765|NCT03257410|467698972|FG001|Overall Study|Switch to peritoneal dialysis|0|||
129926766|NCT03257410|467698971|FG000|Overall Study|Death|3|||
129926767|NCT03257410|467698972|FG001|Overall Study|Death|2|||
129926768|NCT03257410|467698971|FG000|Overall Study|Change to another dialysis center|2|||
129926769|NCT03257410|467698972|FG001|Overall Study|Change to another dialysis center|2|||
129926770|NCT03257410|467698971|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
129926771|NCT03257410|467698972|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
129926772|NCT03257410|467698971|FG000|Overall Study|Miscellaneous|2|||
129926773|NCT03257410|467698972|FG001|Overall Study|Miscellaneous|2|||
129926774|NCT03257410|467698971|FG000|Overall Study|Other|0|||
129926775|NCT03257410|467698972|FG001|Overall Study|Other|1|||
129926776|NCT02276885|467698973|FG000|Overall Study|Withdrawal by Subject|2|||
129926777|NCT02276885|467698974|FG001|Overall Study|Withdrawal by Subject|0|||
129926778|NCT02276885|467698973|FG000|Overall Study|Lost to Follow-up|5|||
129926779|NCT02276885|467698974|FG001|Overall Study|Lost to Follow-up|2|||
129926780|NCT04171141|467698975|FG000|Overall Study|Adverse Event|0|||
129926781|NCT04171141|467698976|FG001|Overall Study|Adverse Event|0|||
129926782|NCT04171141|467698977|FG002|Overall Study|Adverse Event|2|||
129926783|NCT04171141|467698978|FG003|Overall Study|Adverse Event|0|||
129926784|NCT04171141|467698979|FG004|Overall Study|Adverse Event|0|||
129926785|NCT04171141|467698980|FG005|Overall Study|Adverse Event|0|||
129926786|NCT04171141|467698981|FG006|Overall Study|Adverse Event|0|||
129926787|NCT04171141|467698982|FG007|Overall Study|Adverse Event|0|||
129926788|NCT04171141|467698983|FG008|Overall Study|Adverse Event|0|||
129926789|NCT04171141|467698984|FG009|Overall Study|Adverse Event|0|||
129926790|NCT04171141|467698985|FG010|Overall Study|Adverse Event|0|||
129926791|NCT04171141|467698986|FG011|Overall Study|Adverse Event|0|||
129926792|NCT04171141|467698987|FG012|Overall Study|Adverse Event|0|||
129926793|NCT04171141|467698988|FG013|Overall Study|Adverse Event|2|||
129926794|NCT04171141|467698989|FG014|Overall Study|Adverse Event|0|||
129926795|NCT04171141|467698990|FG015|Overall Study|Adverse Event|0|||
129926796|NCT04171141|467698975|FG000|Overall Study|Physician Decision|0|||
129926797|NCT04171141|467698976|FG001|Overall Study|Physician Decision|0|||
129926798|NCT04171141|467698977|FG002|Overall Study|Physician Decision|0|||
129926799|NCT04171141|467698978|FG003|Overall Study|Physician Decision|0|||
129926800|NCT04171141|467698979|FG004|Overall Study|Physician Decision|1|||
129926801|NCT04171141|467698980|FG005|Overall Study|Physician Decision|0|||
129926802|NCT04171141|467698981|FG006|Overall Study|Physician Decision|0|||
129926803|NCT04171141|467698982|FG007|Overall Study|Physician Decision|0|||
129926804|NCT04171141|467698983|FG008|Overall Study|Physician Decision|0|||
129926805|NCT04171141|467698984|FG009|Overall Study|Physician Decision|0|||
129926806|NCT04171141|467698985|FG010|Overall Study|Physician Decision|0|||
129926807|NCT04171141|467698986|FG011|Overall Study|Physician Decision|0|||
129926808|NCT04171141|467698987|FG012|Overall Study|Physician Decision|0|||
129926809|NCT04171141|467698988|FG013|Overall Study|Physician Decision|0|||
129926810|NCT04171141|467698989|FG014|Overall Study|Physician Decision|0|||
129926811|NCT04171141|467698990|FG015|Overall Study|Physician Decision|1|||
129926812|NCT04171141|467698975|FG000|Overall Study|Progressive disease|2|||
129926813|NCT04171141|467698976|FG001|Overall Study|Progressive disease|3|||
129926814|NCT04171141|467698977|FG002|Overall Study|Progressive disease|4|||
129926815|NCT04171141|467698978|FG003|Overall Study|Progressive disease|7|||
129926816|NCT04171141|467698979|FG004|Overall Study|Progressive disease|1|||
129926817|NCT04171141|467698980|FG005|Overall Study|Progressive disease|8|||
129926818|NCT04171141|467698981|FG006|Overall Study|Progressive disease|4|||
129926819|NCT04171141|467698982|FG007|Overall Study|Progressive disease|6|||
129926820|NCT04171141|467698983|FG008|Overall Study|Progressive disease|7|||
129926821|NCT04171141|467698984|FG009|Overall Study|Progressive disease|3|||
129926822|NCT04171141|467698985|FG010|Overall Study|Progressive disease|4|||
129926823|NCT04171141|467698986|FG011|Overall Study|Progressive disease|3|||
129926824|NCT04171141|467698987|FG012|Overall Study|Progressive disease|4|||
129926825|NCT04171141|467698988|FG013|Overall Study|Progressive disease|2|||
129926826|NCT04171141|467698989|FG014|Overall Study|Progressive disease|4|||
129926827|NCT04171141|467698990|FG015|Overall Study|Progressive disease|1|||
129926828|NCT04171141|467698975|FG000|Overall Study|Withdrawal by Subject|0|||
129926829|NCT04171141|467698976|FG001|Overall Study|Withdrawal by Subject|0|||
129926830|NCT04171141|467698977|FG002|Overall Study|Withdrawal by Subject|0|||
129926831|NCT04171141|467698978|FG003|Overall Study|Withdrawal by Subject|1|||
129926832|NCT04171141|467698979|FG004|Overall Study|Withdrawal by Subject|0|||
129926833|NCT04171141|467698980|FG005|Overall Study|Withdrawal by Subject|0|||
129926834|NCT04171141|467698981|FG006|Overall Study|Withdrawal by Subject|1|||
129926835|NCT04171141|467698982|FG007|Overall Study|Withdrawal by Subject|0|||
129926836|NCT04171141|467698983|FG008|Overall Study|Withdrawal by Subject|0|||
129926837|NCT04171141|467698984|FG009|Overall Study|Withdrawal by Subject|1|||
129926838|NCT04171141|467698985|FG010|Overall Study|Withdrawal by Subject|0|||
129926839|NCT04171141|467698986|FG011|Overall Study|Withdrawal by Subject|0|||
129926840|NCT04171141|467698987|FG012|Overall Study|Withdrawal by Subject|0|||
129926841|NCT04171141|467698988|FG013|Overall Study|Withdrawal by Subject|0|||
129926842|NCT04171141|467698989|FG014|Overall Study|Withdrawal by Subject|0|||
129926843|NCT04171141|467698990|FG015|Overall Study|Withdrawal by Subject|0|||
129926844|NCT04171141|467698975|FG000|Overall Study|Global deterioration of health status|0|||
129926845|NCT04171141|467698976|FG001|Overall Study|Global deterioration of health status|0|||
129926846|NCT04171141|467698977|FG002|Overall Study|Global deterioration of health status|0|||
129926847|NCT04171141|467698978|FG003|Overall Study|Global deterioration of health status|1|||
129926848|NCT04171141|467698979|FG004|Overall Study|Global deterioration of health status|0|||
129926849|NCT04171141|467698980|FG005|Overall Study|Global deterioration of health status|2|||
129926850|NCT04171141|467698981|FG006|Overall Study|Global deterioration of health status|1|||
129926851|NCT04171141|467698982|FG007|Overall Study|Global deterioration of health status|0|||
129926852|NCT04171141|467698983|FG008|Overall Study|Global deterioration of health status|1|||
130068995|NCT01432457|468207788|FG000|Overall Study|Reasons not defined|2|||
129926853|NCT04171141|467698984|FG009|Overall Study|Global deterioration of health status|0|||
129926854|NCT04171141|467698985|FG010|Overall Study|Global deterioration of health status|0|||
129926855|NCT04171141|467698986|FG011|Overall Study|Global deterioration of health status|0|||
129926856|NCT04171141|467698987|FG012|Overall Study|Global deterioration of health status|0|||
129926857|NCT04171141|467698988|FG013|Overall Study|Global deterioration of health status|0|||
129926858|NCT04171141|467698989|FG014|Overall Study|Global deterioration of health status|1|||
129926859|NCT04171141|467698990|FG015|Overall Study|Global deterioration of health status|1|||
129926860|NCT03314454|467698993|FG000|Overall Study|Protocol Violation|1|||
129926861|NCT03652389|467698994|FG000|Overall Study|Lost to Follow-up|1|||
129926862|NCT03652389|467698995|FG001|Overall Study|Lost to Follow-up|5|||
129926863|NCT03652389|467698994|FG000|Overall Study|Withdrawal by Subject|5|||
129926864|NCT03652389|467698995|FG001|Overall Study|Withdrawal by Subject|1|||
129926865|NCT03652389|467698994|FG000|Overall Study|New diagnosis|2|||
129926866|NCT03652389|467698995|FG001|Overall Study|New diagnosis|0|||
129926867|NCT05496231|467699002|FG000|Overall Study|Adverse Event|1|||
129926868|NCT05496231|467699003|FG001|Overall Study|Adverse Event|1|||
129926869|NCT05496231|467699004|FG002|Overall Study|Adverse Event|0|||
129926870|NCT05496231|467699005|FG003|Overall Study|Adverse Event|4|||
129926871|NCT05496231|467699002|FG000|Overall Study|Withdrawal by Subject|5|||
129926872|NCT05496231|467699003|FG001|Overall Study|Withdrawal by Subject|5|||
129926873|NCT05496231|467699004|FG002|Overall Study|Withdrawal by Subject|4|||
129926874|NCT05496231|467699005|FG003|Overall Study|Withdrawal by Subject|11|||
129926875|NCT05496231|467699002|FG000|Overall Study|Migrated/moved from the study area|3|||
129926876|NCT05496231|467699003|FG001|Overall Study|Migrated/moved from the study area|5|||
129926877|NCT05496231|467699004|FG002|Overall Study|Migrated/moved from the study area|3|||
129926878|NCT05496231|467699005|FG003|Overall Study|Migrated/moved from the study area|3|||
129926879|NCT05496231|467699002|FG000|Overall Study|Lost to Follow-up|13|||
129926880|NCT05496231|467699003|FG001|Overall Study|Lost to Follow-up|6|||
129926881|NCT05496231|467699004|FG002|Overall Study|Lost to Follow-up|11|||
129926882|NCT05496231|467699005|FG003|Overall Study|Lost to Follow-up|6|||
129926883|NCT05496231|467699002|FG000|Overall Study|Other|9|||
129926884|NCT05496231|467699003|FG001|Overall Study|Other|7|||
129926885|NCT05496231|467699004|FG002|Overall Study|Other|7|||
129926886|NCT05496231|467699005|FG003|Overall Study|Other|8|||
129926887|NCT05029622|467699008|FG000|Overall Study|Lost to Follow-up|1|||
129926888|NCT05526430|467699013|FG000|Overall Study|Withdrawal by Subject|0|||
129926889|NCT05526430|467699014|FG001|Overall Study|Withdrawal by Subject|2|||
129926890|NCT05526430|467699015|FG002|Overall Study|Withdrawal by Subject|0|||
129926891|NCT05526430|467699016|FG003|Overall Study|Withdrawal by Subject|0|||
129926892|NCT03085810|467699017|FG000|Main Study|Withdrawal by Subject|77|||
129926893|NCT03085810|467699018|FG001|Main Study|Withdrawal by Subject|0|||
129926894|NCT03085810|467699019|FG002|Main Study|Withdrawal by Subject|0|||
129926895|NCT03085810|467699017|FG000|Main Study|Terminated By Sponsor|14|||
129926896|NCT03085810|467699018|FG001|Main Study|Terminated By Sponsor|0|||
129926897|NCT03085810|467699019|FG002|Main Study|Terminated By Sponsor|0|||
129926898|NCT03085810|467699017|FG000|Main Study|Protocol Violation|15|||
129926899|NCT03085810|467699018|FG001|Main Study|Protocol Violation|0|||
129926900|NCT03085810|467699019|FG002|Main Study|Protocol Violation|0|||
129926901|NCT03085810|467699017|FG000|Main Study|Physician Decision|13|||
129926902|NCT03085810|467699018|FG001|Main Study|Physician Decision|0|||
129926903|NCT03085810|467699019|FG002|Main Study|Physician Decision|0|||
129926904|NCT03085810|467699017|FG000|Main Study|Lost to Follow-up|17|||
129926905|NCT03085810|467699018|FG001|Main Study|Lost to Follow-up|0|||
129926906|NCT03085810|467699019|FG002|Main Study|Lost to Follow-up|0|||
129926907|NCT03085810|467699017|FG000|Main Study|Adverse Event|25|||
129926908|NCT03085810|467699018|FG001|Main Study|Adverse Event|0|||
129926909|NCT03085810|467699019|FG002|Main Study|Adverse Event|0|||
129926910|NCT03085810|467699017|FG000|Main Study|Pregnancy|7|||
129926911|NCT03085810|467699018|FG001|Main Study|Pregnancy|0|||
129926912|NCT03085810|467699019|FG002|Main Study|Pregnancy|0|||
129926913|NCT03085810|467699017|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
129926914|NCT03085810|467699018|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
129926915|NCT03085810|467699019|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
129926916|NCT03085810|467699017|FG000|Main Study|Lack of Efficacy|10|||
129926917|NCT03085810|467699018|FG001|Main Study|Lack of Efficacy|0|||
129926918|NCT03085810|467699019|FG002|Main Study|Lack of Efficacy|0|||
129926919|NCT03085810|467699017|FG000|Main Study|Death|12|||
129926920|NCT03085810|467699018|FG001|Main Study|Death|0|||
129926921|NCT03085810|467699019|FG002|Main Study|Death|0|||
129926922|NCT03085810|467699017|FG000|Main Study|Disease progression|1|||
129926923|NCT03085810|467699018|FG001|Main Study|Disease progression|0|||
129926924|NCT03085810|467699019|FG002|Main Study|Disease progression|0|||
129926925|NCT03085810|467699017|FG000|Main Study|Site Closure|3|||
129926926|NCT03085810|467699018|FG001|Main Study|Site Closure|0|||
129926927|NCT03085810|467699019|FG002|Main Study|Site Closure|0|||
129926928|NCT03085810|467699017|FG000|Main Study|Planned pregnancy|17|||
129926929|NCT03085810|467699018|FG001|Main Study|Planned pregnancy|0|||
129926930|NCT03085810|467699019|FG002|Main Study|Planned pregnancy|0|||
129926931|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
129926932|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
129926933|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
129926934|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
129926935|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
129926936|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
129926937|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
129926938|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
129926939|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
129926940|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
129926941|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
129926942|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
129926943|NCT05200403|467699022|FG000|Overall Study|Withdrawal by Subject|4|||
129926944|NCT05200403|467699023|FG001|Overall Study|Withdrawal by Subject|2|||
129926945|NCT05200403|467699024|FG002|Overall Study|Withdrawal by Subject|6|||
129926946|NCT01959607|467699025|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
129926947|NCT01959607|467699026|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
129926948|NCT01959607|467699027|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129926949|NCT01959607|467699028|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
129926950|NCT04054193|467699041|FG000|Cycle 1|Physician Decision|1|||
129926951|NCT04054193|467699041|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
129926952|NCT04054193|467699041|FG000|Cycle 1|Allocated but not treated|3|||
129926953|NCT04054193|467699041|FG000|Cycles 2-3|Physician Decision|2|||
129926954|NCT04054193|467699041|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
129926955|NCT04054193|467699041|FG000|Cycles 2-3|Various reasons|17|||
129926956|NCT02966873|467699042|FG000|Overall Study|Lost to Follow-up|16|||
129926957|NCT02966873|467699043|FG001|Overall Study|Lost to Follow-up|15|||
129926958|NCT03084536|467699044|FG000|Overall Study|Determined to be ineligible|0|||
129926959|NCT03084536|467699045|FG001|Overall Study|Determined to be ineligible|0|||
129926960|NCT03084536|467699046|FG002|Overall Study|Determined to be ineligible|16|||
129926961|NCT03084536|467699044|FG000|Overall Study|Withdrawal by Subject|0|||
129926962|NCT03084536|467699045|FG001|Overall Study|Withdrawal by Subject|0|||
129926963|NCT03084536|467699046|FG002|Overall Study|Withdrawal by Subject|4|||
129926964|NCT03084536|467699044|FG000|Overall Study|Physician Decision|0|||
129926965|NCT03084536|467699045|FG001|Overall Study|Physician Decision|0|||
129926966|NCT03084536|467699046|FG002|Overall Study|Physician Decision|3|||
129926967|NCT03084536|467699044|FG000|Overall Study|Death|0|||
129926968|NCT03084536|467699045|FG001|Overall Study|Death|0|||
129926969|NCT03084536|467699046|FG002|Overall Study|Death|1|||
129926970|NCT03084536|467699044|FG000|Overall Study|Lost to Follow-up|0|||
129926971|NCT03084536|467699045|FG001|Overall Study|Lost to Follow-up|0|||
129926972|NCT03084536|467699046|FG002|Overall Study|Lost to Follow-up|1|||
129926973|NCT03084536|467699044|FG000|Overall Study|Protocol Violation|0|||
129926974|NCT03084536|467699045|FG001|Overall Study|Protocol Violation|0|||
129926975|NCT03084536|467699046|FG002|Overall Study|Protocol Violation|1|||
129926976|NCT03084536|467699044|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
129926977|NCT03084536|467699045|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
129926978|NCT03084536|467699046|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
129926979|NCT05073458|467699049|FG000|24-week Double-blind Period|Adverse Event|1|||
129926980|NCT05073458|467699050|FG001|24-week Double-blind Period|Adverse Event|0|||
129926981|NCT05073458|467699049|FG000|24-week Double-blind Period|Physician Decision|1|||
129926982|NCT05073458|467699050|FG001|24-week Double-blind Period|Physician Decision|0|||
129926983|NCT05073458|467699049|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
129926984|NCT05073458|467699050|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
129926985|NCT05073458|467699049|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
129926986|NCT05073458|467699050|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
129926987|NCT05073458|467699049|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
129926988|NCT05073458|467699050|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
129926989|NCT05073458|467699049|FG000|24-week Open-label Period|Adverse Event|1|||
129926990|NCT05073458|467699050|FG001|24-week Open-label Period|Adverse Event|2|||
129926991|NCT04850898|467699061|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
129926992|NCT04850898|467699062|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
129926993|NCT03785964|467699064|FG000|Overall Study|Adverse Event|14|||
129926994|NCT03785964|467699065|FG001|Overall Study|Adverse Event|1|||
129926995|NCT03785964|467699064|FG000|Overall Study|Unqualified Clinical Progression|1|||
129926996|NCT03785964|467699065|FG001|Overall Study|Unqualified Clinical Progression|1|||
129926997|NCT03785964|467699064|FG000|Overall Study|Participant non-compliance|1|||
129926998|NCT03785964|467699065|FG001|Overall Study|Participant non-compliance|1|||
129926999|NCT03785964|467699064|FG000|Overall Study|Not treated|1|||
129927000|NCT03785964|467699065|FG001|Overall Study|Not treated|0|||
129927001|NCT03785964|467699064|FG000|Overall Study|Other reason|5|||
129927002|NCT03785964|467699065|FG001|Overall Study|Other reason|11|||
129927003|NCT03785964|467699064|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
129927004|NCT03785964|467699065|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
129927005|NCT04117347|467699072|FG000|Overall Study|Adverse Event|0|||
129927006|NCT04117347|467699073|FG001|Overall Study|Adverse Event|0|||
129927007|NCT04117347|467699074|FG002|Overall Study|Adverse Event|1|||
129927008|NCT04117347|467699072|FG000|Overall Study|No time for study|0|||
129927009|NCT04117347|467699073|FG001|Overall Study|No time for study|2|||
129927010|NCT04117347|467699074|FG002|Overall Study|No time for study|0|||
129927011|NCT04117347|467699072|FG000|Overall Study|Family emergency|1|||
129927012|NCT04117347|467699073|FG001|Overall Study|Family emergency|0|||
129927013|NCT04117347|467699074|FG002|Overall Study|Family emergency|0|||
129927014|NCT02505984|467699075|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
129927015|NCT02505984|467699076|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
129927016|NCT02505984|467699075|FG000|Overall Study|Unreliable self-report data|1|||
129927017|NCT02505984|467699076|FG001|Overall Study|Unreliable self-report data|0|||
129927018|NCT02505984|467699075|FG000|Overall Study|Study blind opened during assessment|0|||
129927019|NCT02505984|467699076|FG001|Overall Study|Study blind opened during assessment|1|||
129927020|NCT02505984|467699075|FG000|Overall Study|Noncompliance with study protocol|0|||
129927021|NCT02505984|467699076|FG001|Overall Study|Noncompliance with study protocol|1|||
129927022|NCT03687086|467699077|FG000|Overall Study|Withdrawal by Subject|3|||
129927023|NCT03687086|467699078|FG001|Overall Study|Withdrawal by Subject|4|||
129927024|NCT03687086|467699077|FG000|Overall Study|Lost to Follow-up|1|||
129927025|NCT03687086|467699078|FG001|Overall Study|Lost to Follow-up|1|||
129927026|NCT03687086|467699077|FG000|Overall Study|Death|1|||
129927027|NCT03687086|467699078|FG001|Overall Study|Death|0|||
129927028|NCT03687086|467699077|FG000|Overall Study|Incomplete assessment|0|||
129927029|NCT03687086|467699078|FG001|Overall Study|Incomplete assessment|2|||
129927030|NCT06473662|467699083|FG000|Overall Study|Withdrawal by Subject|1|||
129927031|NCT06473662|467699084|FG001|Overall Study|Withdrawal by Subject|6|||
129927032|NCT06473662|467699085|FG002|Overall Study|Withdrawal by Subject|5|||
129927033|NCT06473662|467699083|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
129927034|NCT06473662|467699084|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
129927035|NCT06473662|467699085|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
129927036|NCT06473662|467699083|FG000|Overall Study|Starting HbA1c below 7%|0|||
129927037|NCT06473662|467699084|FG001|Overall Study|Starting HbA1c below 7%|1|||
129927038|NCT06473662|467699085|FG002|Overall Study|Starting HbA1c below 7%|1|||
129927039|NCT06473662|467699083|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
129927040|NCT06473662|467699084|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
129927041|NCT06473662|467699085|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
129927042|NCT06473662|467699083|FG000|Overall Study|Did not take medication|2|||
129927043|NCT06473662|467699084|FG001|Overall Study|Did not take medication|3|||
129927044|NCT06473662|467699085|FG002|Overall Study|Did not take medication|2|||
129927045|NCT04515849|467699086|FG000|Overall Study|Adverse Event|0|||
129927046|NCT04515849|467699087|FG001|Overall Study|Adverse Event|0|||
129927047|NCT04515849|467699088|FG002|Overall Study|Adverse Event|0|||
129927048|NCT04515849|467699089|FG003|Overall Study|Adverse Event|1|||
129927049|NCT04515849|467699090|FG004|Overall Study|Adverse Event|2|||
129927050|NCT04515849|467699086|FG000|Overall Study|Death|2|||
129927051|NCT04515849|467699087|FG001|Overall Study|Death|0|||
129927052|NCT04515849|467699088|FG002|Overall Study|Death|0|||
129927053|NCT04515849|467699089|FG003|Overall Study|Death|0|||
129927054|NCT04515849|467699090|FG004|Overall Study|Death|0|||
129927055|NCT04515849|467699086|FG000|Overall Study|Other:family emergency|0|||
129927056|NCT04515849|467699087|FG001|Overall Study|Other:family emergency|0|||
129927057|NCT04515849|467699088|FG002|Overall Study|Other:family emergency|0|||
129927058|NCT04515849|467699089|FG003|Overall Study|Other:family emergency|1|||
129927059|NCT04515849|467699090|FG004|Overall Study|Other:family emergency|0|||
129927060|NCT04515849|467699086|FG000|Overall Study|Other:randomised by error|0|||
129927061|NCT04515849|467699087|FG001|Overall Study|Other:randomised by error|1|||
129927062|NCT04515849|467699088|FG002|Overall Study|Other:randomised by error|0|||
129927063|NCT04515849|467699089|FG003|Overall Study|Other:randomised by error|0|||
129927064|NCT04515849|467699090|FG004|Overall Study|Other:randomised by error|0|||
129927065|NCT04515849|467699086|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927066|NCT04515849|467699087|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927067|NCT04515849|467699088|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927068|NCT04515849|467699089|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
129927069|NCT04515849|467699090|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927070|NCT04515849|467699086|FG000|Overall Study|Physician Decision|0|||
129927071|NCT04515849|467699087|FG001|Overall Study|Physician Decision|1|||
129927072|NCT04515849|467699088|FG002|Overall Study|Physician Decision|0|||
129927073|NCT04515849|467699089|FG003|Overall Study|Physician Decision|0|||
129927074|NCT04515849|467699090|FG004|Overall Study|Physician Decision|0|||
129927075|NCT04515849|467699086|FG000|Overall Study|Withdrawal by Subject|1|||
129927076|NCT04515849|467699087|FG001|Overall Study|Withdrawal by Subject|2|||
129927077|NCT04515849|467699088|FG002|Overall Study|Withdrawal by Subject|1|||
129927078|NCT04515849|467699089|FG003|Overall Study|Withdrawal by Subject|0|||
129927079|NCT04515849|467699090|FG004|Overall Study|Withdrawal by Subject|0|||
129927080|NCT04577963|467699100|FG000|Part 2|Death|0|||
129927081|NCT04577963|467699101|FG001|Part 2|Death|1|||
129927082|NCT04577963|467699102|FG002|Part 2|Death|8|||
129927083|NCT04577963|467699103|FG003|Part 2|Death|0|||
129927084|NCT04577963|467699104|FG004|Part 2|Death|20|||
129927085|NCT04577963|467699100|FG000|Part 2|Lost to Follow-up|0|||
129927086|NCT04577963|467699101|FG001|Part 2|Lost to Follow-up|0|||
129927087|NCT04577963|467699102|FG002|Part 2|Lost to Follow-up|0|||
129927088|NCT04577963|467699103|FG003|Part 2|Lost to Follow-up|0|||
129927089|NCT04577963|467699104|FG004|Part 2|Lost to Follow-up|2|||
129927090|NCT04577963|467699100|FG000|Part 2|Withdrawal by Subject|0|||
129927091|NCT04577963|467699101|FG001|Part 2|Withdrawal by Subject|0|||
129927092|NCT04577963|467699102|FG002|Part 2|Withdrawal by Subject|0|||
129927093|NCT04577963|467699103|FG003|Part 2|Withdrawal by Subject|0|||
129927094|NCT04577963|467699104|FG004|Part 2|Withdrawal by Subject|10|||
129927095|NCT04577963|467699100|FG000|Part 2|Progressive disease|0|||
129927096|NCT04577963|467699101|FG001|Part 2|Progressive disease|0|||
129927097|NCT04577963|467699102|FG002|Part 2|Progressive disease|0|||
129927098|NCT04577963|467699103|FG003|Part 2|Progressive disease|0|||
129927099|NCT04577963|467699104|FG004|Part 2|Progressive disease|2|||
129927100|NCT04577963|467699100|FG000|Part 2|Investigator decision|0|||
129927101|NCT04577963|467699101|FG001|Part 2|Investigator decision|0|||
129927102|NCT04577963|467699102|FG002|Part 2|Investigator decision|0|||
129927103|NCT04577963|467699103|FG003|Part 2|Investigator decision|0|||
129927104|NCT04577963|467699104|FG004|Part 2|Investigator decision|1|||
129927105|NCT04577963|467699100|FG000|Part 2|Sponsor terminated study|0|||
129927106|NCT04577963|467699101|FG001|Part 2|Sponsor terminated study|0|||
129927107|NCT04577963|467699102|FG002|Part 2|Sponsor terminated study|3|||
129927108|NCT04577963|467699103|FG003|Part 2|Sponsor terminated study|1|||
129927109|NCT04577963|467699104|FG004|Part 2|Sponsor terminated study|4|||
129927110|NCT04857723|467699105|FG000|Overall Study|Withdrawal by Subject|2|||
129927111|NCT03221426|467699106|FG000|Overall Study|Ongoing in study|212|||
129927112|NCT03221426|467699107|FG001|Overall Study|Ongoing in study|193|||
129927113|NCT03221426|467699108|FG002|Overall Study|Ongoing in study|61|||
129927114|NCT03221426|467699109|FG003|Overall Study|Ongoing in study|55|||
129927115|NCT03221426|467699106|FG000|Overall Study|Withdrawal by Subject|12|||
129927116|NCT03221426|467699107|FG001|Overall Study|Withdrawal by Subject|4|||
129927117|NCT03221426|467699108|FG002|Overall Study|Withdrawal by Subject|2|||
129927118|NCT03221426|467699109|FG003|Overall Study|Withdrawal by Subject|3|||
129927119|NCT03221426|467699106|FG000|Overall Study|Lost to Follow-up|4|||
129927120|NCT03221426|467699107|FG001|Overall Study|Lost to Follow-up|1|||
129927121|NCT03221426|467699108|FG002|Overall Study|Lost to Follow-up|1|||
129927122|NCT03221426|467699109|FG003|Overall Study|Lost to Follow-up|0|||
129927123|NCT03221426|467699106|FG000|Overall Study|Death|174|||
129927124|NCT03221426|467699107|FG001|Overall Study|Death|204|||
129927125|NCT03221426|467699108|FG002|Overall Study|Death|36|||
129927126|NCT03221426|467699109|FG003|Overall Study|Death|45|||
129927127|NCT04858451|467700613|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
129927128|NCT04858451|467700614|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927129|NCT04858451|467700615|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927130|NCT04858451|467700616|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927131|NCT04858451|467700617|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927132|NCT04858451|467700618|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927133|NCT04858451|467700619|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927134|NCT04858451|467700620|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927135|NCT04858451|467700621|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927136|NCT04858451|467700613|FG000|Part 2|Discontinued|0|||
129927137|NCT04858451|467700614|FG001|Part 2|Discontinued|0|||
129927138|NCT04858451|467700615|FG002|Part 2|Discontinued|0|||
129927139|NCT04858451|467700616|FG003|Part 2|Discontinued|0|||
129927140|NCT04858451|467700617|FG004|Part 2|Discontinued|0|||
129927141|NCT04858451|467700618|FG005|Part 2|Discontinued|0|||
129927142|NCT04858451|467700619|FG006|Part 2|Discontinued|0|||
129927143|NCT04858451|467700620|FG007|Part 2|Discontinued|0|||
129927144|NCT04858451|467700621|FG008|Part 2|Discontinued|63|||
129927145|NCT04233216|467700623|FG000|Overall Study|Lost to Follow-up|1|||
129927146|NCT04233216|467700624|FG001|Overall Study|Lost to Follow-up|0|||
129927147|NCT04233216|467700625|FG002|Overall Study|Lost to Follow-up|2|||
129927148|NCT04233216|467700626|FG003|Overall Study|Lost to Follow-up|0|||
129927149|NCT04233216|467700623|FG000|Overall Study|Physician Decision|0|||
129927150|NCT04233216|467700624|FG001|Overall Study|Physician Decision|3|||
129927151|NCT04233216|467700625|FG002|Overall Study|Physician Decision|0|||
129927152|NCT04233216|467700626|FG003|Overall Study|Physician Decision|2|||
129927153|NCT04233216|467700623|FG000|Overall Study|Withdrawal by Subject|0|||
129927154|NCT04233216|467700624|FG001|Overall Study|Withdrawal by Subject|2|||
129927155|NCT04233216|467700625|FG002|Overall Study|Withdrawal by Subject|1|||
129927156|NCT04233216|467700626|FG003|Overall Study|Withdrawal by Subject|0|||
129927157|NCT02116530|467700640|FG000|Overall Study|Withdrawal by Subject|1|||
129927158|NCT02116530|467700641|FG001|Overall Study|Withdrawal by Subject|2|||
129927159|NCT02116530|467700640|FG000|Overall Study|Adverse Event|4|||
129927160|NCT02116530|467700641|FG001|Overall Study|Adverse Event|0|||
129927161|NCT02116530|467700640|FG000|Overall Study|Physician Decision|1|||
129927162|NCT02116530|467700641|FG001|Overall Study|Physician Decision|0|||
129927163|NCT02116530|467700640|FG000|Overall Study|Lost to Follow-up|1|||
129927164|NCT02116530|467700641|FG001|Overall Study|Lost to Follow-up|0|||
129927165|NCT02116530|467700640|FG000|Overall Study|Other Medical Problems|2|||
129927166|NCT02116530|467700641|FG001|Overall Study|Other Medical Problems|2|||
129927167|NCT03766685|467700642|FG000|Overall Study|Lost to Follow-up|1|||
129927168|NCT03766685|467700643|FG001|Overall Study|Lost to Follow-up|1|||
129927169|NCT03766685|467700644|FG002|Overall Study|Lost to Follow-up|0|||
129927170|NCT03766685|467700645|FG003|Overall Study|Lost to Follow-up|0|||
129927171|NCT03766685|467700642|FG000|Overall Study|Adverse Event, not fatal|0|||
129927172|NCT03766685|467700643|FG001|Overall Study|Adverse Event, not fatal|1|||
129927173|NCT03766685|467700644|FG002|Overall Study|Adverse Event, not fatal|0|||
129927174|NCT03766685|467700645|FG003|Overall Study|Adverse Event, not fatal|1|||
129927175|NCT03766685|467700642|FG000|Overall Study|Withdrawal by Subject|0|||
129927176|NCT03766685|467700643|FG001|Overall Study|Withdrawal by Subject|2|||
129927177|NCT03766685|467700644|FG002|Overall Study|Withdrawal by Subject|0|||
129927178|NCT03766685|467700645|FG003|Overall Study|Withdrawal by Subject|0|||
129927179|NCT03766685|467700642|FG000|Overall Study|Protocol Violation|0|||
129927180|NCT03766685|467700643|FG001|Overall Study|Protocol Violation|1|||
129927181|NCT03766685|467700644|FG002|Overall Study|Protocol Violation|0|||
129927182|NCT03766685|467700645|FG003|Overall Study|Protocol Violation|0|||
129927183|NCT03766685|467700642|FG000|Overall Study|Non-compliance|0|||
129927184|NCT03766685|467700643|FG001|Overall Study|Non-compliance|2|||
129927185|NCT03766685|467700644|FG002|Overall Study|Non-compliance|0|||
129927186|NCT03766685|467700645|FG003|Overall Study|Non-compliance|0|||
129927187|NCT02927236|467700650|FG000|Characterization Phase|Physician Decision|0|||
129927188|NCT02927236|467700651|FG001|Characterization Phase|Physician Decision|3|||
129927189|NCT02927236|467700652|FG002|Characterization Phase|Physician Decision|0|||
129927190|NCT02927236|467700653|FG003|Characterization Phase|Physician Decision|2|||
129927191|NCT02927236|467700650|FG000|Characterization Phase|Lost to Follow-up|0|||
129927192|NCT02927236|467700651|FG001|Characterization Phase|Lost to Follow-up|0|||
129927193|NCT02927236|467700652|FG002|Characterization Phase|Lost to Follow-up|0|||
129927194|NCT02927236|467700653|FG003|Characterization Phase|Lost to Follow-up|3|||
129927195|NCT02927236|467700650|FG000|Characterization Phase|Withdrawal by Subject|1|||
129927196|NCT02927236|467700651|FG001|Characterization Phase|Withdrawal by Subject|0|||
129927197|NCT02927236|467700652|FG002|Characterization Phase|Withdrawal by Subject|0|||
129927198|NCT02927236|467700653|FG003|Characterization Phase|Withdrawal by Subject|1|||
129927199|NCT02927236|467700650|FG000|Treatment Phase|Adverse Event|1|||
129927200|NCT02927236|467700651|FG001|Treatment Phase|Adverse Event|0|||
129927201|NCT02927236|467700652|FG002|Treatment Phase|Adverse Event|1|||
129927202|NCT02927236|467700653|FG003|Treatment Phase|Adverse Event|1|||
129927203|NCT02927236|467700650|FG000|Treatment Phase|Protocol Violation|3|||
129927204|NCT02927236|467700651|FG001|Treatment Phase|Protocol Violation|0|||
129927205|NCT02927236|467700652|FG002|Treatment Phase|Protocol Violation|0|||
129927206|NCT02927236|467700653|FG003|Treatment Phase|Protocol Violation|1|||
129927207|NCT02927236|467700650|FG000|Treatment Phase|Lost to Follow-up|1|||
129927208|NCT02927236|467700651|FG001|Treatment Phase|Lost to Follow-up|0|||
129927209|NCT02927236|467700652|FG002|Treatment Phase|Lost to Follow-up|0|||
129927210|NCT02927236|467700653|FG003|Treatment Phase|Lost to Follow-up|0|||
129927211|NCT02927236|467700650|FG000|Follow-up Phase|Lost to Follow-up|1|||
129927212|NCT02927236|467700651|FG001|Follow-up Phase|Lost to Follow-up|0|||
129927213|NCT02927236|467700652|FG002|Follow-up Phase|Lost to Follow-up|1|||
129927214|NCT02927236|467700653|FG003|Follow-up Phase|Lost to Follow-up|0|||
129927215|NCT03974178|467700656|FG000|Overall Study|Death|0|||
129927216|NCT03974178|467700657|FG001|Overall Study|Death|1|||
129927217|NCT04508309|467700658|FG000|Overall Study|Death|0|||
129927218|NCT04508309|467700659|FG001|Overall Study|Death|0|||
129927219|NCT04508309|467700660|FG002|Overall Study|Death|0|||
129927220|NCT04508309|467700661|FG003|Overall Study|Death|0|||
129927221|NCT04508309|467700662|FG004|Overall Study|Death|1|||
129927222|NCT04508309|467700658|FG000|Overall Study|Lost to Follow-up|0|||
129927223|NCT04508309|467700659|FG001|Overall Study|Lost to Follow-up|0|||
129927224|NCT04508309|467700660|FG002|Overall Study|Lost to Follow-up|1|||
129927225|NCT04508309|467700661|FG003|Overall Study|Lost to Follow-up|1|||
129927226|NCT04508309|467700662|FG004|Overall Study|Lost to Follow-up|0|||
129927227|NCT04508309|467700658|FG000|Overall Study|Withdrawal by Subject|0|||
129927228|NCT04508309|467700659|FG001|Overall Study|Withdrawal by Subject|0|||
129927229|NCT04508309|467700660|FG002|Overall Study|Withdrawal by Subject|0|||
129927230|NCT04508309|467700661|FG003|Overall Study|Withdrawal by Subject|0|||
129927231|NCT04508309|467700662|FG004|Overall Study|Withdrawal by Subject|1|||
129927232|NCT04914676|467700666|FG000|Overall Study|Study termination|3|||
129927233|NCT04914676|467700667|FG001|Overall Study|Study termination|0|||
129927234|NCT03240016|467700668|FG000|Overall Study|Adverse Event|9|||
129927235|NCT03240016|467700668|FG000|Overall Study|Withdrawal by Subject|7|||
129927236|NCT03240016|467700668|FG000|Overall Study|Death|1|||
129927237|NCT03240016|467700668|FG000|Overall Study|Physician Decision|2|||
129927238|NCT03913442|467700669|FG000|Overall Study|Adverse Event|0|||
129927239|NCT03913442|467700670|FG001|Overall Study|Adverse Event|3|||
129927240|NCT03913442|467700669|FG000|Overall Study|Withdrawal by Subject|5|||
129927241|NCT03913442|467700670|FG001|Overall Study|Withdrawal by Subject|5|||
129927242|NCT03913442|467700669|FG000|Overall Study|Terminations|2|||
129927243|NCT03913442|467700670|FG001|Overall Study|Terminations|1|||
129927244|NCT03913442|467700669|FG000|Overall Study|Lost to Follow-up|2|||
129927245|NCT03913442|467700670|FG001|Overall Study|Lost to Follow-up|2|||
129927246|NCT00950742|467700671|FG000|Overall Study|Other Adverse Event|1|||
129927247|NCT00950742|467700672|FG001|Overall Study|Other Adverse Event|0|||
129927248|NCT00950742|467700671|FG000|Overall Study|Withdrawal by Subject|3|||
129927249|NCT00950742|467700672|FG001|Overall Study|Withdrawal by Subject|0|||
129927250|NCT00950742|467700671|FG000|Overall Study|Progressive Disease|6|||
129927251|NCT00950742|467700672|FG001|Overall Study|Progressive Disease|2|||
129927252|NCT00950742|467700671|FG000|Overall Study|Dose limiting toxicity|6|||
129927253|NCT00950742|467700672|FG001|Overall Study|Dose limiting toxicity|0|||
129927254|NCT05436262|467700674|FG000|Pre-Randomization|Withdrawal by Subject|1|||
129927255|NCT05436262|467700675|FG001|Pre-Randomization|Withdrawal by Subject|0|||
129927256|NCT05436262|467700676|FG002|Pre-Randomization|Withdrawal by Subject|0|||
129927257|NCT05436262|467700674|FG000|Randomization|Withdrawal by Subject|0|||
129927258|NCT05436262|467700675|FG001|Randomization|Withdrawal by Subject|1|||
129927259|NCT05436262|467700676|FG002|Randomization|Withdrawal by Subject|0|||
129927260|NCT05299073|467700677|FG000|Overall Study|Withdrawal by Subject|0|||
129927261|NCT05299073|467700678|FG001|Overall Study|Withdrawal by Subject|0|||
129927262|NCT05299073|467700679|FG002|Overall Study|Withdrawal by Subject|1|||
129927263|NCT05299073|467700677|FG000|Overall Study|Adverse Event|0|||
129927264|NCT05299073|467700678|FG001|Overall Study|Adverse Event|1|||
129927265|NCT05299073|467700679|FG002|Overall Study|Adverse Event|0|||
129927266|NCT05299073|467700677|FG000|Overall Study|Lost to Follow-up|0|||
129927267|NCT05299073|467700678|FG001|Overall Study|Lost to Follow-up|1|||
129927268|NCT05299073|467700679|FG002|Overall Study|Lost to Follow-up|0|||
129927269|NCT00592852|467700680|FG000|Overall Study|Non-compliance|1|||
129927270|NCT00592852|467700680|FG000|Overall Study|Adverse Event|3|||
129927271|NCT00592852|467700680|FG000|Overall Study|Found ineligible|1|||
129927272|NCT00592852|467700680|FG000|Overall Study|Withdrawal by Subject|1|||
129927273|NCT05002088|467700682|FG000|Overall Study|Withdrawal by Subject|9|||
129927274|NCT05002088|467700683|FG001|Overall Study|Withdrawal by Subject|0|||
129927275|NCT05002088|467700682|FG000|Overall Study|Lost to Follow-up|0|||
129927276|NCT05002088|467700683|FG001|Overall Study|Lost to Follow-up|1|||
129927277|NCT05002088|467700682|FG000|Overall Study|Death|16|||
129927278|NCT05002088|467700683|FG001|Overall Study|Death|2|||
129927279|NCT05002088|467700682|FG000|Overall Study|Protocol Violation|25|||
129927280|NCT05002088|467700683|FG001|Overall Study|Protocol Violation|7|||
129927281|NCT04068181|467700684|FG000|Overall Study|Death|17|||
129927282|NCT04068181|467700685|FG001|Overall Study|Death|12|||
129927283|NCT04068181|467700686|FG002|Overall Study|Death|4|||
129927284|NCT04068181|467700687|FG003|Overall Study|Death|7|||
129927285|NCT04068181|467700684|FG000|Overall Study|Lost to Follow-up|1|||
129927286|NCT04068181|467700685|FG001|Overall Study|Lost to Follow-up|0|||
129927287|NCT04068181|467700686|FG002|Overall Study|Lost to Follow-up|0|||
129927288|NCT04068181|467700687|FG003|Overall Study|Lost to Follow-up|0|||
129927289|NCT04068181|467700684|FG000|Overall Study|Withdrawal of consent from study|3|||
129927290|NCT04068181|467700685|FG001|Overall Study|Withdrawal of consent from study|0|||
129927291|NCT04068181|467700686|FG002|Overall Study|Withdrawal of consent from study|0|||
129927292|NCT04068181|467700687|FG003|Overall Study|Withdrawal of consent from study|0|||
129927293|NCT04770402|467700688|FG000|Overall Study|Lost to Follow-up|1|||
129927294|NCT04770402|467700689|FG001|Overall Study|Lost to Follow-up|2|||
129927295|NCT04770402|467700688|FG000|Overall Study|Non-compliance|1|||
129927296|NCT04770402|467700689|FG001|Overall Study|Non-compliance|0|||
129927297|NCT04770402|467700688|FG000|Overall Study|Withdrawal by Subject|0|||
129927298|NCT04770402|467700689|FG001|Overall Study|Withdrawal by Subject|1|||
129927299|NCT05194956|467700691|FG000|Washout Period|Withdrawal by Subject|0|||
129927300|NCT05194956|467700692|FG001|Washout Period|Withdrawal by Subject|2|||
129927301|NCT03905798|467700713|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
129927302|NCT03463044|467700718|FG000|Overall Study|Lost to Follow-up|0|||
129927303|NCT03463044|467700719|FG001|Overall Study|Lost to Follow-up|0|||
129927304|NCT03463044|467700720|FG002|Overall Study|Lost to Follow-up|0|||
129927305|NCT03463044|467700721|FG003|Overall Study|Lost to Follow-up|0|||
129927306|NCT03463044|467700722|FG004|Overall Study|Lost to Follow-up|0|||
129927307|NCT03463044|467700723|FG005|Overall Study|Lost to Follow-up|0|||
129927308|NCT03463044|467700724|FG006|Overall Study|Lost to Follow-up|0|||
129927309|NCT03463044|467700725|FG007|Overall Study|Lost to Follow-up|1|||
129927310|NCT03463044|467700726|FG008|Overall Study|Lost to Follow-up|0|||
129927311|NCT05192109|467700727|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129927312|NCT05192109|467700728|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129927313|NCT05192109|467700729|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927314|NCT05192109|467700730|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927315|NCT05192109|467700727|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129927316|NCT05192109|467700728|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129927317|NCT05192109|467700729|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927318|NCT05192109|467700730|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927319|NCT04498390|467700731|FG000|Overall Study|Adverse Event|0|||
129927320|NCT04498390|467700732|FG001|Overall Study|Adverse Event|0|||
129927321|NCT04498390|467700733|FG002|Overall Study|Adverse Event|1|||
129927322|NCT04498390|467700734|FG003|Overall Study|Adverse Event|0|||
129927323|NCT04498390|467700735|FG004|Overall Study|Adverse Event|0|||
129927324|NCT04498390|467700731|FG000|Overall Study|Withdrawal by Subject|0|||
129927325|NCT04498390|467700732|FG001|Overall Study|Withdrawal by Subject|0|||
129927326|NCT04498390|467700733|FG002|Overall Study|Withdrawal by Subject|0|||
129927327|NCT04498390|467700734|FG003|Overall Study|Withdrawal by Subject|1|||
129927328|NCT04498390|467700735|FG004|Overall Study|Withdrawal by Subject|0|||
129927329|NCT03478956|467700736|FG000|Randomized Treatment Period|Adverse Event|1|||
129927330|NCT03478956|467700737|FG001|Randomized Treatment Period|Adverse Event|0|||
129927331|NCT03478956|467700738|FG002|Randomized Treatment Period|Adverse Event|0|||
129927332|NCT03478956|467700739|FG003|Randomized Treatment Period|Adverse Event|0|||
129927333|NCT03478956|467700736|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
129927334|NCT03478956|467700737|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
129927335|NCT03478956|467700738|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
129927336|NCT03478956|467700739|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
129927337|NCT03478956|467700736|FG000|Open Label Extension Period|Adverse Event|0|||
129927338|NCT03478956|467700737|FG001|Open Label Extension Period|Adverse Event|0|||
129927339|NCT03478956|467700738|FG002|Open Label Extension Period|Adverse Event|4|||
129927340|NCT03478956|467700739|FG003|Open Label Extension Period|Adverse Event|0|||
129927341|NCT03478956|467700736|FG000|Open Label Extension Period|Lack of Efficacy|0|||
129927342|NCT03478956|467700737|FG001|Open Label Extension Period|Lack of Efficacy|0|||
129927343|NCT03478956|467700738|FG002|Open Label Extension Period|Lack of Efficacy|8|||
129927344|NCT03478956|467700739|FG003|Open Label Extension Period|Lack of Efficacy|0|||
129927345|NCT03478956|467700736|FG000|Open Label Extension Period|Reason Not Provided|0|||
129927346|NCT03478956|467700737|FG001|Open Label Extension Period|Reason Not Provided|0|||
129927347|NCT03478956|467700738|FG002|Open Label Extension Period|Reason Not Provided|1|||
129927348|NCT03478956|467700739|FG003|Open Label Extension Period|Reason Not Provided|0|||
129927349|NCT03478956|467700736|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
129927350|NCT03478956|467700737|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
129927351|NCT03478956|467700738|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
129927352|NCT03478956|467700739|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
129927353|NCT03478956|467700736|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
129927354|NCT03478956|467700737|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
129927355|NCT03478956|467700738|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
129927356|NCT03478956|467700739|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
129927357|NCT03478956|467700736|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129927358|NCT03478956|467700737|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129927359|NCT03478956|467700738|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129927360|NCT03478956|467700739|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
129927361|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
129927362|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
129927363|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
129927364|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
129927365|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
129927366|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
129927367|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
129927368|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
129927369|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
129927370|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
129927371|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
129927372|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
129927373|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
129927374|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
129927375|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
129927376|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
129927377|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
129927378|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
129927379|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
129927380|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
129927381|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
129927382|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
129927383|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
129927384|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
129927385|NCT04800211|467700740|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
129927386|NCT04800211|467700741|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
129927387|NCT04800211|467700742|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
129927388|NCT04800211|467700740|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
129927389|NCT04800211|467700741|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
129927390|NCT04800211|467700742|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
129927391|NCT04800211|467700740|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
129927392|NCT04800211|467700741|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
129927393|NCT04800211|467700742|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
129927394|NCT05170841|467700743|FG000|Single Dose Phase|Adverse Event|1|||
129927395|NCT05170841|467700744|FG001|Single Dose Phase|Adverse Event|2|||
129927396|NCT05170841|467700745|FG002|Single Dose Phase|Adverse Event|0|||
129927397|NCT05170841|467700746|FG003|Single Dose Phase|Adverse Event|2|||
129927398|NCT05170841|467700743|FG000|Multiple Dose Phase|Adverse Event|1|||
129927399|NCT05170841|467700744|FG001|Multiple Dose Phase|Adverse Event|2|||
129927400|NCT05170841|467700745|FG002|Multiple Dose Phase|Adverse Event|1|||
129927401|NCT05170841|467700746|FG003|Multiple Dose Phase|Adverse Event|4|||
129927402|NCT05170841|467700743|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
129927403|NCT05170841|467700744|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
129927404|NCT05170841|467700745|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
129927405|NCT05170841|467700746|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
129927406|NCT04865289|467700747|FG000|Overall Study|Participant ongoing in study|47|||
129927407|NCT04865289|467700748|FG001|Overall Study|Participant ongoing in study|35|||
129927408|NCT04865289|467700747|FG000|Overall Study|Death|27|||
129927409|NCT04865289|467700748|FG001|Overall Study|Death|21|||
129927410|NCT02733159|467700751|FG000|Overall Study|Adverse Event|1|||
129927411|NCT02733159|467700751|FG000|Overall Study|Lack of disease progression|1|||
129927412|NCT06122194|467700752|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
129927413|NCT06122194|467700753|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
129927414|NCT06122194|467700754|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
129927415|NCT06122194|467700755|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
129927416|NCT02887521|467700762|FG000|Overall Study|Withdrawal by Subject|0|||
129927417|NCT02887521|467700763|FG001|Overall Study|Withdrawal by Subject|3|||
129927418|NCT02709161|467700766|FG000|Overall Study|Withdrawal by Subject|1|||
129927419|NCT02709161|467700767|FG001|Overall Study|Withdrawal by Subject|0|||
129927420|NCT02561247|467702783|FG000|Overall Study|Protocol Violation|1|||
129927421|NCT02561247|467702783|FG000|Overall Study|Withdrawal by Subject|1|||
129927422|NCT02561247|467702783|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
129927423|NCT03663569|467702784|FG000|Overall Study|Discontinuation of study|11|||
129927424|NCT03663569|467702784|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
129927425|NCT03663569|467702784|FG000|Overall Study|Deceased patient|6|||
129927426|NCT03663569|467702784|FG000|Overall Study|Lost to Follow-up|18|||
129927427|NCT03663569|467702784|FG000|Overall Study|Withdrawal of consent|5|||
129927428|NCT03663569|467702784|FG000|Overall Study|Patient's request|11|||
129927429|NCT03663569|467702784|FG000|Overall Study|Adverse Event|4|||
129927430|NCT03663569|467702784|FG000|Overall Study|Not come to second visit|3|||
129927431|NCT03663569|467702784|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
129927432|NCT03663569|467702784|FG000|Overall Study|Serious adverse event|1|||
129927433|NCT04298983|467702786|FG000|Overall Study|Adverse Event|4|||
129927434|NCT04298983|467702786|FG000|Overall Study|Lack of Efficacy|3|||
129927435|NCT04248725|467702787|FG000|Post-Treatment|Lost to Follow-up|6|||
129927436|NCT04248725|467702788|FG001|Post-Treatment|Lost to Follow-up|5|||
129927437|NCT04248725|467702787|FG000|6-Month Follow Up|Lost to Follow-up|9|||
129927438|NCT04248725|467702788|FG001|6-Month Follow Up|Lost to Follow-up|8|||
129927439|NCT03656510|467702790|FG000|Overall Study|Lost to Follow-up|1|||
129927440|NCT03656510|467702791|FG001|Overall Study|Lost to Follow-up|0|||
129927441|NCT03656510|467702792|FG002|Overall Study|Lost to Follow-up|0|||
129927442|NCT03656510|467702793|FG003|Overall Study|Lost to Follow-up|0|||
129927443|NCT03656510|467702794|FG004|Overall Study|Lost to Follow-up|0|||
129927444|NCT03656510|467702795|FG005|Overall Study|Lost to Follow-up|0|||
129927445|NCT03656510|467702790|FG000|Overall Study|Withdrawal by Subject|1|||
129927446|NCT03656510|467702791|FG001|Overall Study|Withdrawal by Subject|1|||
129927447|NCT03656510|467702792|FG002|Overall Study|Withdrawal by Subject|0|||
129927448|NCT03656510|467702793|FG003|Overall Study|Withdrawal by Subject|1|||
129927449|NCT03656510|467702794|FG004|Overall Study|Withdrawal by Subject|0|||
129927450|NCT03656510|467702795|FG005|Overall Study|Withdrawal by Subject|0|||
129927451|NCT03819153|467702800|FG000|Overall Study|Withdrawal by Subject|20|||
129927452|NCT03819153|467702801|FG001|Overall Study|Withdrawal by Subject|28|||
129927453|NCT03819153|467702800|FG000|Overall Study|Lost to Follow-up|23|||
129927454|NCT03819153|467702801|FG001|Overall Study|Lost to Follow-up|30|||
129927455|NCT05671653|467702802|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
129927456|NCT05671653|467702803|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
129927457|NCT05671653|467702804|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
129927458|NCT05671653|467702805|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
129927459|NCT05671653|467702806|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
129927460|NCT05671653|467702807|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
129927461|NCT05671653|467702808|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
129927462|NCT05671653|467702809|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
129927463|NCT05671653|467702810|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
129927464|NCT05671653|467702811|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
129927465|NCT05671653|467702812|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
129927466|NCT05671653|467702813|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
129927467|NCT05671653|467702814|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
129927468|NCT05671653|467702802|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927469|NCT05671653|467702803|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927470|NCT05671653|467702804|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927471|NCT05671653|467702805|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927472|NCT05671653|467702806|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927473|NCT05671653|467702807|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
129927474|NCT05671653|467702808|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927475|NCT05671653|467702809|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927476|NCT05671653|467702810|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927477|NCT05671653|467702811|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927478|NCT05671653|467702812|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927479|NCT05671653|467702813|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927480|NCT05671653|467702814|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927481|NCT05671653|467702802|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927482|NCT05671653|467702803|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927483|NCT05671653|467702804|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927484|NCT05671653|467702805|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927485|NCT05671653|467702806|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927486|NCT05671653|467702807|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
129927487|NCT05671653|467702808|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927488|NCT05671653|467702809|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927489|NCT05671653|467702810|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927490|NCT05671653|467702811|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927491|NCT05671653|467702812|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927492|NCT05671653|467702813|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927493|NCT05671653|467702814|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927494|NCT05671653|467702802|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927495|NCT05671653|467702803|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927496|NCT05671653|467702804|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927497|NCT05671653|467702805|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927498|NCT05671653|467702806|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927499|NCT05671653|467702807|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927500|NCT05671653|467702808|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927501|NCT05671653|467702809|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927502|NCT05671653|467702810|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
129927503|NCT05671653|467702811|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927504|NCT05671653|467702812|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927505|NCT05671653|467702813|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927506|NCT05671653|467702814|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927507|NCT05671653|467702802|FG000|Cohort 2 Period 2|Adverse Event|0|||
129927508|NCT05671653|467702803|FG001|Cohort 2 Period 2|Adverse Event|0|||
129927509|NCT05671653|467702804|FG002|Cohort 2 Period 2|Adverse Event|0|||
129927510|NCT05671653|467702805|FG003|Cohort 2 Period 2|Adverse Event|0|||
129927511|NCT05671653|467702806|FG004|Cohort 2 Period 2|Adverse Event|0|||
129927512|NCT05671653|467702807|FG005|Cohort 2 Period 2|Adverse Event|0|||
129927513|NCT05671653|467702808|FG006|Cohort 2 Period 2|Adverse Event|0|||
129927514|NCT05671653|467702809|FG007|Cohort 2 Period 2|Adverse Event|0|||
129927515|NCT05671653|467702810|FG008|Cohort 2 Period 2|Adverse Event|0|||
129927516|NCT05671653|467702811|FG009|Cohort 2 Period 2|Adverse Event|0|||
129927517|NCT05671653|467702812|FG010|Cohort 2 Period 2|Adverse Event|1|||
129927518|NCT05671653|467702813|FG011|Cohort 2 Period 2|Adverse Event|0|||
129927519|NCT05671653|467702814|FG012|Cohort 2 Period 2|Adverse Event|0|||
129927520|NCT05671653|467702802|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
129927521|NCT05671653|467702803|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
129927522|NCT05671653|467702804|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
129927523|NCT05671653|467702805|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
129927524|NCT05671653|467702806|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
129927525|NCT05671653|467702807|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
129927526|NCT05671653|467702808|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
129927527|NCT05671653|467702809|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
129927528|NCT05671653|467702810|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
129927529|NCT05671653|467702811|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
129927530|NCT05671653|467702812|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
129927531|NCT05671653|467702813|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
129927532|NCT05671653|467702814|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
129927533|NCT05671653|467702802|FG000|Cohort 2 Period 2|Pregnancy|0|||
129927534|NCT05671653|467702803|FG001|Cohort 2 Period 2|Pregnancy|0|||
129927535|NCT05671653|467702804|FG002|Cohort 2 Period 2|Pregnancy|0|||
129927536|NCT05671653|467702805|FG003|Cohort 2 Period 2|Pregnancy|0|||
130117507|NCT01755858|468390527|FG000|Overall Study|Adverse Event|1|||
129927537|NCT05671653|467702806|FG004|Cohort 2 Period 2|Pregnancy|0|||
129927538|NCT05671653|467702807|FG005|Cohort 2 Period 2|Pregnancy|0|||
129927539|NCT05671653|467702808|FG006|Cohort 2 Period 2|Pregnancy|0|||
129927540|NCT05671653|467702809|FG007|Cohort 2 Period 2|Pregnancy|0|||
129927541|NCT05671653|467702810|FG008|Cohort 2 Period 2|Pregnancy|0|||
129927542|NCT05671653|467702811|FG009|Cohort 2 Period 2|Pregnancy|0|||
129927543|NCT05671653|467702812|FG010|Cohort 2 Period 2|Pregnancy|1|||
129927544|NCT05671653|467702813|FG011|Cohort 2 Period 2|Pregnancy|0|||
129927545|NCT05671653|467702814|FG012|Cohort 2 Period 2|Pregnancy|0|||
129927546|NCT05671653|467702802|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927547|NCT05671653|467702803|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927548|NCT05671653|467702804|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927549|NCT05671653|467702805|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927550|NCT05671653|467702806|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927551|NCT05671653|467702807|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927552|NCT05671653|467702808|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927553|NCT05671653|467702809|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927554|NCT05671653|467702810|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927555|NCT05671653|467702811|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927556|NCT05671653|467702812|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
129927557|NCT05671653|467702813|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927558|NCT05671653|467702814|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927559|NCT05671653|467702802|FG000|Cohort 2 Period 2|Other|0|||
129927560|NCT05671653|467702803|FG001|Cohort 2 Period 2|Other|0|||
129927561|NCT05671653|467702804|FG002|Cohort 2 Period 2|Other|0|||
129927562|NCT05671653|467702805|FG003|Cohort 2 Period 2|Other|0|||
129927563|NCT05671653|467702806|FG004|Cohort 2 Period 2|Other|0|||
129927564|NCT05671653|467702807|FG005|Cohort 2 Period 2|Other|0|||
129927565|NCT05671653|467702808|FG006|Cohort 2 Period 2|Other|0|||
129927566|NCT05671653|467702809|FG007|Cohort 2 Period 2|Other|0|||
129927567|NCT05671653|467702810|FG008|Cohort 2 Period 2|Other|0|||
129927568|NCT05671653|467702811|FG009|Cohort 2 Period 2|Other|0|||
129927569|NCT05671653|467702812|FG010|Cohort 2 Period 2|Other|1|||
129927570|NCT05671653|467702813|FG011|Cohort 2 Period 2|Other|0|||
129927571|NCT05671653|467702814|FG012|Cohort 2 Period 2|Other|0|||
129927572|NCT05671653|467702802|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927573|NCT05671653|467702803|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927574|NCT05671653|467702804|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927575|NCT05671653|467702805|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927576|NCT05671653|467702806|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927577|NCT05671653|467702807|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927578|NCT05671653|467702808|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927579|NCT05671653|467702809|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927580|NCT05671653|467702810|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927581|NCT05671653|467702811|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927582|NCT05671653|467702812|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927583|NCT05671653|467702813|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
129927584|NCT05671653|467702814|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927585|NCT02305888|467702821|FG000|Overall Study|Lost to Follow-up|0|||
129927586|NCT02305888|467702822|FG001|Overall Study|Lost to Follow-up|0|||
129927587|NCT02305888|467702823|FG002|Overall Study|Lost to Follow-up|1|||
129927588|NCT02305888|467702821|FG000|Overall Study|Adverse Event|0|||
129927589|NCT02305888|467702822|FG001|Overall Study|Adverse Event|1|||
130117508|NCT01755858|468390528|FG001|Overall Study|Adverse Event|1|||
129927590|NCT02305888|467702823|FG002|Overall Study|Adverse Event|0|||
130117509|NCT02398188|468390529|FG000|Overall Study|Adverse Event|2|||
130117510|NCT02398188|468390530|FG001|Overall Study|Adverse Event|3|||
129927591|NCT06232590|467702824|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
129927592|NCT06232590|467702825|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
129927593|NCT05070728|467702829|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
129927594|NCT05070728|467702830|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
129927595|NCT02589795|467702838|FG000|Overall Study|Lost to Follow-up|1|||
129927596|NCT02589795|467702839|FG001|Overall Study|Lost to Follow-up|0|||
129927597|NCT02589795|467702840|FG002|Overall Study|Lost to Follow-up|0|||
129927598|NCT02589795|467702838|FG000|Overall Study|Withdrawal by Subject|0|||
129927599|NCT02589795|467702839|FG001|Overall Study|Withdrawal by Subject|0|||
129927600|NCT02589795|467702840|FG002|Overall Study|Withdrawal by Subject|2|||
129927601|NCT02589795|467702838|FG000|Overall Study|Protocol Violation|0|||
130117511|NCT02398188|468390529|FG000|Overall Study|Lost to Follow-up|5|||
129927602|NCT02589795|467702839|FG001|Overall Study|Protocol Violation|0|||
129927603|NCT02589795|467702840|FG002|Overall Study|Protocol Violation|1|||
129927604|NCT03599661|467702841|FG000|Overall Study|Lost to Follow-up|9|||
129927605|NCT04909801|467702844|FG000|Overall Study|Lack of Efficacy|2|||
129927606|NCT04909801|467702845|FG001|Overall Study|Lack of Efficacy|1|||
129927607|NCT04909801|467702844|FG000|Overall Study|Adverse Event|1|||
129927608|NCT04909801|467702845|FG001|Overall Study|Adverse Event|2|||
129927609|NCT04909801|467702844|FG000|Overall Study|Participant request to discontinue study treatment|1|||
129927610|NCT04909801|467702845|FG001|Overall Study|Participant request to discontinue study treatment|2|||
129927611|NCT04909801|467702844|FG000|Overall Study|Withdrawal by Subject|2|||
129927612|NCT04909801|467702845|FG001|Overall Study|Withdrawal by Subject|1|||
129927613|NCT04909801|467702844|FG000|Overall Study|other reasons|1|||
129927614|NCT04909801|467702845|FG001|Overall Study|other reasons|1|||
129927615|NCT04550221|467702848|FG000|Overall Study|Lost to Follow-up|0|||
129927616|NCT04550221|467702849|FG001|Overall Study|Lost to Follow-up|4|||
129927617|NCT04550221|467702848|FG000|Overall Study|Withdrawn|3|||
129927618|NCT04550221|467702849|FG001|Overall Study|Withdrawn|0|||
129927619|NCT04550221|467702848|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
129927620|NCT04550221|467702849|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
129927621|NCT04811040|467702850|FG000|Overall Study|Lost to Follow-up|2|||
129927622|NCT04811040|467702851|FG001|Overall Study|Lost to Follow-up|0|||
129927623|NCT04811040|467702852|FG002|Overall Study|Lost to Follow-up|0|||
129927624|NCT04811040|467702853|FG003|Overall Study|Lost to Follow-up|0|||
129927625|NCT04811040|467702850|FG000|Overall Study|Withdrew consent|1|||
129927626|NCT04811040|467702851|FG001|Overall Study|Withdrew consent|1|||
129927627|NCT04811040|467702852|FG002|Overall Study|Withdrew consent|0|||
129927628|NCT04811040|467702853|FG003|Overall Study|Withdrew consent|0|||
129927629|NCT05274074|467702854|FG000|Overall Study|Lost to Follow-up|2|||
129927630|NCT05274074|467702855|FG001|Overall Study|Lost to Follow-up|3|||
129927631|NCT05274074|467702854|FG000|Overall Study|Withdrawal by Subject|1|||
129927632|NCT05274074|467702855|FG001|Overall Study|Withdrawal by Subject|2|||
129927633|NCT01828099|467702865|FG000|Treatment Period|Adverse Event|24|||
129927634|NCT01828099|467702866|FG001|Treatment Period|Adverse Event|23|||
129927635|NCT01828099|467702865|FG000|Treatment Period|Death|10|||
129927636|NCT01828099|467702866|FG001|Treatment Period|Death|12|||
129927637|NCT01828099|467702865|FG000|Treatment Period|Lost to Follow-up|2|||
129927638|NCT01828099|467702866|FG001|Treatment Period|Lost to Follow-up|1|||
129927639|NCT01828099|467702865|FG000|Treatment Period|Non-compliance with study treatment|1|||
129927640|NCT01828099|467702866|FG001|Treatment Period|Non-compliance with study treatment|0|||
129927641|NCT01828099|467702865|FG000|Treatment Period|Physician Decision|17|||
129927642|NCT01828099|467702866|FG001|Treatment Period|Physician Decision|16|||
129927643|NCT01828099|467702865|FG000|Treatment Period|Progressive disease|99|||
129927644|NCT01828099|467702866|FG001|Treatment Period|Progressive disease|107|||
129927645|NCT01828099|467702865|FG000|Treatment Period|Subject/guardian decision|22|||
129927646|NCT01828099|467702866|FG001|Treatment Period|Subject/guardian decision|26|||
129927647|NCT01828099|467702865|FG000|Treatment Period|Study terminated by Sponsor|13|||
129927648|NCT01828099|467702866|FG001|Treatment Period|Study terminated by Sponsor|1|||
129927649|NCT01828099|467702865|FG000|Treatment Period|Protocol deviation|1|||
129927650|NCT01828099|467702866|FG001|Treatment Period|Protocol deviation|0|||
129927651|NCT01828099|467702865|FG000|Treatment Period|No longer requires treatment|0|||
129927652|NCT01828099|467702866|FG001|Treatment Period|No longer requires treatment|1|||
129927653|NCT01828099|467702865|FG000|Extension-treatment Phase|Adverse Event|0|||
130117512|NCT02398188|468390530|FG001|Overall Study|Lost to Follow-up|0|||
129927654|NCT01828099|467702866|FG001|Extension-treatment Phase|Adverse Event|17|||
129927655|NCT01828099|467702865|FG000|Extension-treatment Phase|Death|0|||
129927656|NCT01828099|467702866|FG001|Extension-treatment Phase|Death|11|||
129927657|NCT01828099|467702865|FG000|Extension-treatment Phase|Physician Decision|0|||
129927658|NCT01828099|467702866|FG001|Extension-treatment Phase|Physician Decision|5|||
129927659|NCT01828099|467702865|FG000|Extension-treatment Phase|Progressive disease|0|||
129927660|NCT01828099|467702866|FG001|Extension-treatment Phase|Progressive disease|54|||
129927661|NCT01828099|467702865|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
129927662|NCT01828099|467702866|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
129927663|NCT01828099|467702865|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
129927664|NCT01828099|467702866|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
129927665|NCT05934942|467702870|FG000|Run-in Period|Not treated|1|||
129927666|NCT05934942|467702870|FG000|Run-in Period|Withdrawal by Subject|1|||
129927667|NCT04362254|467702871|FG000|Overall Study|Adverse Event|1|||
129927668|NCT04362254|467702871|FG000|Overall Study|Protocol Violation|1|||
129927669|NCT04362254|467702871|FG000|Overall Study|Due to early termination of the trial|10|||
129927670|NCT04568434|467702872|FG000|Overall Study|Voluntary Withdrawal|0|||
129927671|NCT04568434|467702873|FG001|Overall Study|Voluntary Withdrawal|1|||
130117513|NCT02398188|468390529|FG000|Overall Study|Non-compliance|4|||
129927672|NCT04568434|467702874|FG002|Overall Study|Voluntary Withdrawal|1|||
130117514|NCT02398188|468390530|FG001|Overall Study|Non-compliance|4|||
129927673|NCT04568434|467702872|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
129927674|NCT04568434|467702873|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
129927675|NCT04568434|467702874|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
129927676|NCT04568434|467702872|FG000|Overall Study|Investigator Judgement|1|||
129927677|NCT04568434|467702873|FG001|Overall Study|Investigator Judgement|0|||
129927678|NCT04568434|467702874|FG002|Overall Study|Investigator Judgement|0|||
129927679|NCT05469464|467702875|FG000|Overall Study|Withdrawal by Subject|8|||
129927680|NCT05469464|467702876|FG001|Overall Study|Withdrawal by Subject|7|||
129927681|NCT05469464|467702877|FG002|Overall Study|Withdrawal by Subject|4|||
129927682|NCT05469464|467702878|FG003|Overall Study|Withdrawal by Subject|5|||
129927683|NCT05469464|467702875|FG000|Overall Study|Adverse Event|8|||
129927684|NCT05469464|467702876|FG001|Overall Study|Adverse Event|14|||
129927685|NCT05469464|467702877|FG002|Overall Study|Adverse Event|13|||
129927686|NCT05469464|467702878|FG003|Overall Study|Adverse Event|2|||
129927687|NCT05469464|467702875|FG000|Overall Study|Lost to Follow-up|2|||
129927688|NCT05469464|467702876|FG001|Overall Study|Lost to Follow-up|5|||
129927689|NCT05469464|467702877|FG002|Overall Study|Lost to Follow-up|3|||
129927690|NCT05469464|467702878|FG003|Overall Study|Lost to Follow-up|3|||
129927691|NCT05469464|467702875|FG000|Overall Study|Lack of Efficacy|4|||
129927692|NCT05469464|467702876|FG001|Overall Study|Lack of Efficacy|1|||
129927693|NCT05469464|467702877|FG002|Overall Study|Lack of Efficacy|2|||
129927694|NCT05469464|467702878|FG003|Overall Study|Lack of Efficacy|2|||
129927695|NCT05469464|467702875|FG000|Overall Study|Physician Decision|0|||
129927696|NCT05469464|467702876|FG001|Overall Study|Physician Decision|0|||
129927697|NCT05469464|467702877|FG002|Overall Study|Physician Decision|0|||
129927698|NCT05469464|467702878|FG003|Overall Study|Physician Decision|1|||
129927699|NCT00321048|467702879|FG000|Overall Study|Withdrawal by Subject|6|||
129927700|NCT00321048|467702880|FG001|Overall Study|Withdrawal by Subject|8|||
129927701|NCT04433208|467702881|FG000|Overall Study|Withdrawal by Subject|0|||
129927702|NCT04433208|467702882|FG001|Overall Study|Withdrawal by Subject|1|||
129927703|NCT04433208|467702883|FG002|Overall Study|Withdrawal by Subject|1|||
129927704|NCT04433208|467702884|FG003|Overall Study|Withdrawal by Subject|0|||
129927705|NCT04433208|467702885|FG004|Overall Study|Withdrawal by Subject|2|||
129927706|NCT04433208|467702886|FG005|Overall Study|Withdrawal by Subject|1|||
129927707|NCT04433208|467702881|FG000|Overall Study|Lost to Follow-up|0|||
129927708|NCT04433208|467702882|FG001|Overall Study|Lost to Follow-up|0|||
129927709|NCT04433208|467702883|FG002|Overall Study|Lost to Follow-up|0|||
129927710|NCT04433208|467702884|FG003|Overall Study|Lost to Follow-up|0|||
129927711|NCT04433208|467702885|FG004|Overall Study|Lost to Follow-up|0|||
129927712|NCT04433208|467702886|FG005|Overall Study|Lost to Follow-up|1|||
129927713|NCT05485779|467702887|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927714|NCT05485779|467702888|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927715|NCT05485779|467702889|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927716|NCT05485779|467702890|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927717|NCT05485779|467702891|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927718|NCT05485779|467702892|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927719|NCT05485779|467702893|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927720|NCT05485779|467702894|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
129927721|NCT05485779|467702895|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
129927722|NCT05485779|467702896|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927723|NCT05485779|467702897|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927724|NCT05485779|467702887|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927725|NCT05485779|467702888|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927726|NCT05485779|467702889|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927727|NCT05485779|467702890|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927728|NCT05485779|467702891|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927729|NCT05485779|467702892|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927730|NCT05485779|467702893|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927731|NCT05485779|467702894|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927732|NCT05485779|467702895|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927733|NCT05485779|467702896|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927734|NCT05485779|467702897|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
129927735|NCT05485779|467702887|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927736|NCT05485779|467702888|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927737|NCT05485779|467702889|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927738|NCT05485779|467702890|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
129927739|NCT05485779|467702891|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927740|NCT05485779|467702892|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927741|NCT05485779|467702893|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927742|NCT05485779|467702894|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
130068996|NCT01432457|468207789|FG001|Overall Study|Reasons not defined|3|||
129927743|NCT05485779|467702895|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927744|NCT05485779|467702896|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927745|NCT05485779|467702897|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927746|NCT05764525|467702900|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
129927747|NCT05764525|467702901|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
129927748|NCT05764525|467702900|FG000|Overall Study|Withdrawal by Subject|4|||
129927749|NCT05764525|467702901|FG001|Overall Study|Withdrawal by Subject|8|||
129927750|NCT05764525|467702900|FG000|Overall Study|Physician Decision|1|||
129927751|NCT05764525|467702901|FG001|Overall Study|Physician Decision|0|||
129927752|NCT03030261|467702903|FG000|Overall Study|Still receiving continuation therapy|5|||
129927753|NCT05370040|467702913|FG000|Overall Study|Lost to Follow-up|0|||
129927754|NCT05370040|467702914|FG001|Overall Study|Lost to Follow-up|0|||
129927755|NCT05370040|467702915|FG002|Overall Study|Lost to Follow-up|1|||
129927756|NCT05370040|467702916|FG003|Overall Study|Lost to Follow-up|0|||
129927757|NCT05370040|467702917|FG004|Overall Study|Lost to Follow-up|1|||
129927758|NCT05370040|467702918|FG005|Overall Study|Lost to Follow-up|0|||
129927759|NCT04971109|467702919|FG000|Overall Study|Adverse Event|4|||
129927760|NCT04971109|467702920|FG001|Overall Study|Adverse Event|3|||
129927761|NCT04971109|467702919|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
129927762|NCT04971109|467702920|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
129927763|NCT04971109|467702919|FG000|Overall Study|Lost to Follow-up|8|||
129927764|NCT04971109|467702920|FG001|Overall Study|Lost to Follow-up|2|||
129927765|NCT04971109|467702919|FG000|Overall Study|Physician Decision|5|||
129927766|NCT04971109|467702920|FG001|Overall Study|Physician Decision|0|||
129927767|NCT04971109|467702919|FG000|Overall Study|Protocol Violation|0|||
129927768|NCT04971109|467702920|FG001|Overall Study|Protocol Violation|1|||
129927769|NCT04971109|467702919|FG000|Overall Study|Withdrawal by Subject|18|||
129927770|NCT04971109|467702920|FG001|Overall Study|Withdrawal by Subject|3|||
129927771|NCT04971109|467702919|FG000|Overall Study|Subject was randomized in error|1|||
129927772|NCT04971109|467702920|FG001|Overall Study|Subject was randomized in error|0|||
129927773|NCT03910478|467702921|FG000|Overall Study|Death|13|||
129927774|NCT03910478|467702922|FG001|Overall Study|Death|6|||
129927775|NCT03910478|467702921|FG000|Overall Study|Withdrawal by Subject|23|||
129927776|NCT03910478|467702922|FG001|Overall Study|Withdrawal by Subject|2|||
129927777|NCT03910478|467702921|FG000|Overall Study|Physician Decision|5|||
129927778|NCT03910478|467702922|FG001|Overall Study|Physician Decision|0|||
129927779|NCT03910478|467702921|FG000|Overall Study|Protocol Violation|1|||
129927780|NCT03910478|467702922|FG001|Overall Study|Protocol Violation|0|||
129927781|NCT03910478|467702921|FG000|Overall Study|Failure to meet continuation criteria|2|||
129927782|NCT03910478|467702922|FG001|Overall Study|Failure to meet continuation criteria|0|||
129927783|NCT03910478|467702921|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
129927784|NCT03910478|467702922|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
129927785|NCT05293171|467702924|FG000|Washout 5 to 7 Days|Adverse Event|1|||
129927786|NCT05293171|467702925|FG001|Washout 5 to 7 Days|Adverse Event|1|||
129927787|NCT05293171|467702926|FG002|Washout 5 to 7 Days|Adverse Event|0|||
129927788|NCT05293171|467702927|FG003|Washout 5 to 7 Days|Adverse Event|0|||
129927789|NCT05293171|467702928|FG004|Washout 5 to 7 Days|Adverse Event|0|||
129927790|NCT05293171|467702929|FG005|Washout 5 to 7 Days|Adverse Event|0|||
129927791|NCT05293171|467702930|FG006|Washout 5 to 7 Days|Adverse Event|0|||
129927792|NCT05293171|467702931|FG007|Washout 5 to 7 Days|Adverse Event|0|||
129927793|NCT05293171|467702932|FG008|Washout 5 to 7 Days|Adverse Event|0|||
129927794|NCT05293171|467702933|FG009|Washout 5 to 7 Days|Adverse Event|0|||
129927795|NCT05293171|467702934|FG010|Washout 5 to 7 Days|Adverse Event|0|||
129927796|NCT05293171|467702935|FG011|Washout 5 to 7 Days|Adverse Event|0|||
129927797|NCT05293171|467702924|FG000|Washout 5 to 7 Days|Adverse Event|0|||
129927798|NCT05293171|467702925|FG001|Washout 5 to 7 Days|Adverse Event|0|||
129927799|NCT05293171|467702926|FG002|Washout 5 to 7 Days|Adverse Event|0|||
129927800|NCT05293171|467702927|FG003|Washout 5 to 7 Days|Adverse Event|0|||
129927801|NCT05293171|467702928|FG004|Washout 5 to 7 Days|Adverse Event|0|||
129927802|NCT05293171|467702929|FG005|Washout 5 to 7 Days|Adverse Event|1|||
129927803|NCT05293171|467702930|FG006|Washout 5 to 7 Days|Adverse Event|0|||
129927804|NCT05293171|467702931|FG007|Washout 5 to 7 Days|Adverse Event|0|||
129927805|NCT05293171|467702932|FG008|Washout 5 to 7 Days|Adverse Event|0|||
129927806|NCT05293171|467702933|FG009|Washout 5 to 7 Days|Adverse Event|0|||
129927807|NCT05293171|467702934|FG010|Washout 5 to 7 Days|Adverse Event|0|||
129927808|NCT05293171|467702935|FG011|Washout 5 to 7 Days|Adverse Event|0|||
129927809|NCT01712490|467702941|FG000|Overall Study|Ongoing|601|||
129927810|NCT01712490|467702942|FG001|Overall Study|Ongoing|586|||
129927811|NCT01712490|467702941|FG000|Overall Study|Other|11|||
129927812|NCT01712490|467702942|FG001|Overall Study|Other|11|||
129927813|NCT01712490|467702941|FG000|Overall Study|Withdrawal by Subject|36|||
129927814|NCT01712490|467702942|FG001|Overall Study|Withdrawal by Subject|44|||
129927815|NCT01712490|467702941|FG000|Overall Study|Lost to Follow-up|16|||
129927816|NCT01712490|467702942|FG001|Overall Study|Lost to Follow-up|29|||
129927817|NCT03987022|467702945|FG000|Overall Study|Lost to Follow-up|2|||
129927818|NCT03987022|467702946|FG001|Overall Study|Lost to Follow-up|2|||
129927819|NCT03987022|467702945|FG000|Overall Study|Withdrawal by Subject|1|||
129927820|NCT03987022|467702946|FG001|Overall Study|Withdrawal by Subject|0|||
129927821|NCT05123586|467702949|FG000|Overall Study|Physician Decision|1|||
129927822|NCT05123586|467702950|FG001|Overall Study|Physician Decision|1|||
129927823|NCT05123586|467702949|FG000|Overall Study|Withdrawal by Subject|0|||
129927824|NCT05123586|467702950|FG001|Overall Study|Withdrawal by Subject|3|||
129927825|NCT03734679|467702956|FG000|Overall Study|Missed Visit|1|||
129927826|NCT03626220|467702960|FG000|Overall Study|Withdrawal by Subject|2|||
129927827|NCT03626220|467702961|FG001|Overall Study|Withdrawal by Subject|0|||
129927828|NCT04231149|467704080|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927829|NCT04231149|467704081|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
129927830|NCT04231149|467704082|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927831|NCT04231149|467704083|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927832|NCT04231149|467704084|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927833|NCT05877976|467704085|FG000|Overall Study|Lost to Follow-up|31|||
129927834|NCT05622812|467704086|FG000|Overall Study|Withdrawal by Subject|1|||
129927835|NCT05622812|467704087|FG001|Overall Study|Withdrawal by Subject|4|||
129927836|NCT05622812|467704086|FG000|Overall Study|Lost to Follow-up|2|||
129927837|NCT05622812|467704087|FG001|Overall Study|Lost to Follow-up|1|||
129927838|NCT03916185|467704088|FG000|Overall Study|Lost to Follow-up|0|||
129927839|NCT03916185|467704089|FG001|Overall Study|Lost to Follow-up|1|||
129927840|NCT03916185|467704090|FG002|Overall Study|Lost to Follow-up|0|||
129927841|NCT03916185|467704091|FG003|Overall Study|Lost to Follow-up|0|||
129927842|NCT03916185|467704088|FG000|Overall Study|Moved|1|||
129927843|NCT03916185|467704089|FG001|Overall Study|Moved|0|||
129927844|NCT03916185|467704090|FG002|Overall Study|Moved|0|||
129927845|NCT03916185|467704091|FG003|Overall Study|Moved|1|||
129927846|NCT03916185|467704088|FG000|Overall Study|Not Able to Get to Clinic|1|||
129927847|NCT03916185|467704089|FG001|Overall Study|Not Able to Get to Clinic|0|||
129927848|NCT03916185|467704090|FG002|Overall Study|Not Able to Get to Clinic|0|||
129927849|NCT03916185|467704091|FG003|Overall Study|Not Able to Get to Clinic|0|||
129927850|NCT02844465|467704093|FG000|Overall Study|Screen Failure|36|||
129927851|NCT02844465|467704093|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
129927852|NCT02844465|467704093|FG000|Overall Study|Withdrawal by Subject|5|||
129927853|NCT02844465|467704093|FG000|Overall Study|Lost to Follow-up|1|||
129927854|NCT02844465|467704093|FG000|Overall Study|Retreatment|1|||
129927855|NCT02460458|467704094|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
129927856|NCT02460458|467704094|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
129927857|NCT02460458|467704094|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
129927858|NCT02460458|467704094|FG000|First Prospective Phase|Lost to Follow-up|84|||
129927859|NCT02460458|467704094|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
129927860|NCT03220035|467704095|FG000|Overall Study|Adverse Event|1|||
129927861|NCT03220035|467704095|FG000|Overall Study|Protocol Violation|1|||
129927862|NCT03220035|467704095|FG000|Overall Study|Progressive Disease|2|||
129927863|NCT02433379|467704096|FG000|Overall Study|Screen Failures|55|||
129927864|NCT02433379|467704096|FG000|Overall Study|Death|57|||
129927865|NCT02433379|467704096|FG000|Overall Study|Total Withdrawals|209|||
129927866|NCT01928394|467704101|FG000|Treatment Period|Disease progression|17|||
129927867|NCT01928394|467704102|FG001|Treatment Period|Disease progression|2|||
129927868|NCT01928394|467704103|FG002|Treatment Period|Disease progression|12|||
129927869|NCT01928394|467704104|FG003|Treatment Period|Disease progression|48|||
129927870|NCT01928394|467704105|FG004|Treatment Period|Disease progression|3|||
129927871|NCT01928394|467704106|FG005|Treatment Period|Disease progression|25|||
129927872|NCT01928394|467704107|FG006|Treatment Period|Disease progression|38|||
129927873|NCT01928394|467704108|FG007|Treatment Period|Disease progression|16|||
129927874|NCT01928394|467704109|FG008|Treatment Period|Disease progression|3|||
129927875|NCT01928394|467704110|FG009|Treatment Period|Disease progression|11|||
130068997|NCT01432457|468207790|FG002|Overall Study|Reasons not defined|4|||
130068998|NCT01432457|468207788|FG000|Overall Study|Did not take study drug|6|||
130068999|NCT01432457|468207789|FG001|Overall Study|Did not take study drug|6|||
130069000|NCT01432457|468207790|FG002|Overall Study|Did not take study drug|3|||
130069001|NCT02574481|468207791|FG000|Overall Study|Withdrawal by Subject|29|||
130069002|NCT02574481|468207792|FG001|Overall Study|Withdrawal by Subject|15|||
129927876|NCT01928394|467704111|FG010|Treatment Period|Disease progression|22|||
129927877|NCT01928394|467704112|FG011|Treatment Period|Disease progression|73|||
129927878|NCT01928394|467704113|FG012|Treatment Period|Disease progression|38|||
129927879|NCT01928394|467704114|FG013|Treatment Period|Disease progression|118|||
129927880|NCT01928394|467704115|FG014|Treatment Period|Disease progression|59|||
129927881|NCT01928394|467704116|FG015|Treatment Period|Disease progression|1|||
129927882|NCT01928394|467704117|FG016|Treatment Period|Disease progression|43|||
129927883|NCT01928394|467704118|FG017|Treatment Period|Disease progression|56|||
129927884|NCT01928394|467704119|FG018|Treatment Period|Disease progression|50|||
129927885|NCT01928394|467704120|FG019|Treatment Period|Disease progression|71|||
129927886|NCT01928394|467704121|FG020|Treatment Period|Disease progression|30|||
130069003|NCT02574481|468207793|FG002|Overall Study|Withdrawal by Subject|4|||
129927887|NCT01928394|467704122|FG021|Treatment Period|Disease progression|31|||
129927888|NCT01928394|467704123|FG022|Treatment Period|Disease progression|31|||
129927889|NCT01928394|467704101|FG000|Treatment Period|Study drug toxicity|1|||
129927890|NCT01928394|467704102|FG001|Treatment Period|Study drug toxicity|1|||
129927891|NCT01928394|467704103|FG002|Treatment Period|Study drug toxicity|3|||
129927892|NCT01928394|467704104|FG003|Treatment Period|Study drug toxicity|3|||
129927893|NCT01928394|467704105|FG004|Treatment Period|Study drug toxicity|0|||
129927894|NCT01928394|467704106|FG005|Treatment Period|Study drug toxicity|9|||
129927895|NCT01928394|467704107|FG006|Treatment Period|Study drug toxicity|7|||
129927896|NCT01928394|467704108|FG007|Treatment Period|Study drug toxicity|1|||
129927897|NCT01928394|467704109|FG008|Treatment Period|Study drug toxicity|0|||
129927898|NCT01928394|467704110|FG009|Treatment Period|Study drug toxicity|5|||
129927899|NCT01928394|467704111|FG010|Treatment Period|Study drug toxicity|2|||
129927900|NCT01928394|467704112|FG011|Treatment Period|Study drug toxicity|3|||
129927901|NCT01928394|467704113|FG012|Treatment Period|Study drug toxicity|7|||
129927902|NCT01928394|467704114|FG013|Treatment Period|Study drug toxicity|5|||
129927903|NCT01928394|467704115|FG014|Treatment Period|Study drug toxicity|12|||
129927904|NCT01928394|467704116|FG015|Treatment Period|Study drug toxicity|0|||
129927905|NCT01928394|467704117|FG016|Treatment Period|Study drug toxicity|3|||
129927906|NCT01928394|467704118|FG017|Treatment Period|Study drug toxicity|3|||
129927907|NCT01928394|467704119|FG018|Treatment Period|Study drug toxicity|12|||
129927908|NCT01928394|467704120|FG019|Treatment Period|Study drug toxicity|15|||
129927909|NCT01928394|467704121|FG020|Treatment Period|Study drug toxicity|4|||
129927910|NCT01928394|467704122|FG021|Treatment Period|Study drug toxicity|7|||
129927911|NCT01928394|467704123|FG022|Treatment Period|Study drug toxicity|4|||
129927912|NCT01928394|467704101|FG000|Treatment Period|AE unrelated to study drug|0|||
129927913|NCT01928394|467704102|FG001|Treatment Period|AE unrelated to study drug|0|||
129927914|NCT01928394|467704103|FG002|Treatment Period|AE unrelated to study drug|2|||
129927915|NCT01928394|467704104|FG003|Treatment Period|AE unrelated to study drug|3|||
129927916|NCT01928394|467704105|FG004|Treatment Period|AE unrelated to study drug|0|||
129927917|NCT01928394|467704106|FG005|Treatment Period|AE unrelated to study drug|5|||
129927918|NCT01928394|467704107|FG006|Treatment Period|AE unrelated to study drug|1|||
129927919|NCT01928394|467704108|FG007|Treatment Period|AE unrelated to study drug|0|||
129927920|NCT01928394|467704109|FG008|Treatment Period|AE unrelated to study drug|0|||
129927921|NCT01928394|467704110|FG009|Treatment Period|AE unrelated to study drug|2|||
129927922|NCT01928394|467704111|FG010|Treatment Period|AE unrelated to study drug|0|||
129927923|NCT01928394|467704112|FG011|Treatment Period|AE unrelated to study drug|12|||
129927924|NCT01928394|467704113|FG012|Treatment Period|AE unrelated to study drug|6|||
129927925|NCT01928394|467704114|FG013|Treatment Period|AE unrelated to study drug|13|||
129927926|NCT01928394|467704115|FG014|Treatment Period|AE unrelated to study drug|6|||
129927927|NCT01928394|467704116|FG015|Treatment Period|AE unrelated to study drug|1|||
129927928|NCT01928394|467704117|FG016|Treatment Period|AE unrelated to study drug|1|||
129927929|NCT01928394|467704118|FG017|Treatment Period|AE unrelated to study drug|6|||
129927930|NCT01928394|467704119|FG018|Treatment Period|AE unrelated to study drug|3|||
129927931|NCT01928394|467704120|FG019|Treatment Period|AE unrelated to study drug|5|||
129927932|NCT01928394|467704121|FG020|Treatment Period|AE unrelated to study drug|1|||
129927933|NCT01928394|467704122|FG021|Treatment Period|AE unrelated to study drug|1|||
129927934|NCT01928394|467704123|FG022|Treatment Period|AE unrelated to study drug|0|||
129927935|NCT01928394|467704101|FG000|Treatment Period|Participant request to stop therapy|0|||
129927936|NCT01928394|467704102|FG001|Treatment Period|Participant request to stop therapy|0|||
129927937|NCT01928394|467704103|FG002|Treatment Period|Participant request to stop therapy|0|||
129927938|NCT01928394|467704104|FG003|Treatment Period|Participant request to stop therapy|0|||
129927939|NCT01928394|467704105|FG004|Treatment Period|Participant request to stop therapy|0|||
129927940|NCT01928394|467704106|FG005|Treatment Period|Participant request to stop therapy|3|||
129927941|NCT01928394|467704107|FG006|Treatment Period|Participant request to stop therapy|3|||
129927942|NCT01928394|467704108|FG007|Treatment Period|Participant request to stop therapy|0|||
129927943|NCT01928394|467704109|FG008|Treatment Period|Participant request to stop therapy|0|||
129927944|NCT01928394|467704110|FG009|Treatment Period|Participant request to stop therapy|0|||
129927945|NCT01928394|467704111|FG010|Treatment Period|Participant request to stop therapy|3|||
129927946|NCT01928394|467704112|FG011|Treatment Period|Participant request to stop therapy|2|||
129927947|NCT01928394|467704113|FG012|Treatment Period|Participant request to stop therapy|1|||
129927948|NCT01928394|467704114|FG013|Treatment Period|Participant request to stop therapy|2|||
129927949|NCT01928394|467704115|FG014|Treatment Period|Participant request to stop therapy|4|||
129927950|NCT01928394|467704116|FG015|Treatment Period|Participant request to stop therapy|0|||
129927951|NCT01928394|467704117|FG016|Treatment Period|Participant request to stop therapy|1|||
129927952|NCT01928394|467704118|FG017|Treatment Period|Participant request to stop therapy|3|||
129927953|NCT01928394|467704119|FG018|Treatment Period|Participant request to stop therapy|1|||
129927954|NCT01928394|467704120|FG019|Treatment Period|Participant request to stop therapy|1|||
130069004|NCT02574481|468207794|FG003|Overall Study|Withdrawal by Subject|1|||
129927955|NCT01928394|467704121|FG020|Treatment Period|Participant request to stop therapy|3|||
129927956|NCT01928394|467704122|FG021|Treatment Period|Participant request to stop therapy|1|||
129927957|NCT01928394|467704123|FG022|Treatment Period|Participant request to stop therapy|3|||
129927958|NCT01928394|467704101|FG000|Treatment Period|Participant withdrew consent|0|||
129927959|NCT01928394|467704102|FG001|Treatment Period|Participant withdrew consent|0|||
129927960|NCT01928394|467704103|FG002|Treatment Period|Participant withdrew consent|1|||
129927961|NCT01928394|467704104|FG003|Treatment Period|Participant withdrew consent|1|||
129927962|NCT01928394|467704105|FG004|Treatment Period|Participant withdrew consent|0|||
129927963|NCT01928394|467704106|FG005|Treatment Period|Participant withdrew consent|1|||
129927964|NCT01928394|467704107|FG006|Treatment Period|Participant withdrew consent|0|||
129927965|NCT01928394|467704108|FG007|Treatment Period|Participant withdrew consent|1|||
129927966|NCT01928394|467704109|FG008|Treatment Period|Participant withdrew consent|0|||
129927967|NCT01928394|467704110|FG009|Treatment Period|Participant withdrew consent|0|||
129927968|NCT01928394|467704111|FG010|Treatment Period|Participant withdrew consent|1|||
129927969|NCT01928394|467704112|FG011|Treatment Period|Participant withdrew consent|1|||
129927970|NCT01928394|467704113|FG012|Treatment Period|Participant withdrew consent|1|||
129927971|NCT01928394|467704114|FG013|Treatment Period|Participant withdrew consent|0|||
129927972|NCT01928394|467704115|FG014|Treatment Period|Participant withdrew consent|2|||
129927973|NCT01928394|467704116|FG015|Treatment Period|Participant withdrew consent|0|||
129927974|NCT01928394|467704117|FG016|Treatment Period|Participant withdrew consent|2|||
129927975|NCT01928394|467704118|FG017|Treatment Period|Participant withdrew consent|1|||
129927976|NCT01928394|467704119|FG018|Treatment Period|Participant withdrew consent|1|||
129927977|NCT01928394|467704120|FG019|Treatment Period|Participant withdrew consent|1|||
129927978|NCT01928394|467704121|FG020|Treatment Period|Participant withdrew consent|0|||
129927979|NCT01928394|467704122|FG021|Treatment Period|Participant withdrew consent|2|||
129927980|NCT01928394|467704123|FG022|Treatment Period|Participant withdrew consent|0|||
129927981|NCT01928394|467704101|FG000|Treatment Period|Poor/non-compliance|0|||
129927982|NCT01928394|467704102|FG001|Treatment Period|Poor/non-compliance|0|||
129927983|NCT01928394|467704103|FG002|Treatment Period|Poor/non-compliance|0|||
129927984|NCT01928394|467704104|FG003|Treatment Period|Poor/non-compliance|1|||
129927985|NCT01928394|467704105|FG004|Treatment Period|Poor/non-compliance|0|||
129927986|NCT01928394|467704106|FG005|Treatment Period|Poor/non-compliance|0|||
129927987|NCT01928394|467704107|FG006|Treatment Period|Poor/non-compliance|0|||
129927988|NCT01928394|467704108|FG007|Treatment Period|Poor/non-compliance|0|||
129927989|NCT01928394|467704109|FG008|Treatment Period|Poor/non-compliance|0|||
129927990|NCT01928394|467704110|FG009|Treatment Period|Poor/non-compliance|0|||
129927991|NCT01928394|467704111|FG010|Treatment Period|Poor/non-compliance|0|||
129927992|NCT01928394|467704112|FG011|Treatment Period|Poor/non-compliance|0|||
129927993|NCT01928394|467704113|FG012|Treatment Period|Poor/non-compliance|1|||
129927994|NCT01928394|467704114|FG013|Treatment Period|Poor/non-compliance|0|||
129927995|NCT01928394|467704115|FG014|Treatment Period|Poor/non-compliance|1|||
129927996|NCT01928394|467704116|FG015|Treatment Period|Poor/non-compliance|0|||
129927997|NCT01928394|467704117|FG016|Treatment Period|Poor/non-compliance|0|||
129927998|NCT01928394|467704118|FG017|Treatment Period|Poor/non-compliance|1|||
129927999|NCT01928394|467704119|FG018|Treatment Period|Poor/non-compliance|0|||
129928000|NCT01928394|467704120|FG019|Treatment Period|Poor/non-compliance|1|||
129928001|NCT01928394|467704121|FG020|Treatment Period|Poor/non-compliance|0|||
129928002|NCT01928394|467704122|FG021|Treatment Period|Poor/non-compliance|0|||
129928003|NCT01928394|467704123|FG022|Treatment Period|Poor/non-compliance|0|||
129928004|NCT01928394|467704101|FG000|Treatment Period|other reason|0|||
129928005|NCT01928394|467704102|FG001|Treatment Period|other reason|0|||
129928006|NCT01928394|467704103|FG002|Treatment Period|other reason|0|||
129928007|NCT01928394|467704104|FG003|Treatment Period|other reason|0|||
129928008|NCT01928394|467704105|FG004|Treatment Period|other reason|0|||
129928009|NCT01928394|467704106|FG005|Treatment Period|other reason|0|||
129928010|NCT01928394|467704107|FG006|Treatment Period|other reason|0|||
129928011|NCT01928394|467704108|FG007|Treatment Period|other reason|0|||
129928012|NCT01928394|467704109|FG008|Treatment Period|other reason|0|||
129928013|NCT01928394|467704110|FG009|Treatment Period|other reason|0|||
129928014|NCT01928394|467704111|FG010|Treatment Period|other reason|1|||
129928015|NCT01928394|467704112|FG011|Treatment Period|other reason|1|||
129928016|NCT01928394|467704113|FG012|Treatment Period|other reason|1|||
129928017|NCT01928394|467704114|FG013|Treatment Period|other reason|0|||
129928018|NCT01928394|467704115|FG014|Treatment Period|other reason|1|||
129928019|NCT01928394|467704116|FG015|Treatment Period|other reason|0|||
129928020|NCT01928394|467704117|FG016|Treatment Period|other reason|0|||
129928021|NCT01928394|467704118|FG017|Treatment Period|other reason|0|||
129928022|NCT01928394|467704119|FG018|Treatment Period|other reason|2|||
129928023|NCT01928394|467704120|FG019|Treatment Period|other reason|2|||
129928024|NCT01928394|467704121|FG020|Treatment Period|other reason|0|||
129928025|NCT01928394|467704122|FG021|Treatment Period|other reason|0|||
129928026|NCT01928394|467704123|FG022|Treatment Period|other reason|0|||
129928027|NCT01928394|467704101|FG000|Treatment Period|Maximum clinical benefit|0|||
129928028|NCT01928394|467704102|FG001|Treatment Period|Maximum clinical benefit|0|||
129928029|NCT01928394|467704103|FG002|Treatment Period|Maximum clinical benefit|0|||
129928030|NCT01928394|467704104|FG003|Treatment Period|Maximum clinical benefit|0|||
129928031|NCT01928394|467704105|FG004|Treatment Period|Maximum clinical benefit|0|||
129928032|NCT01928394|467704106|FG005|Treatment Period|Maximum clinical benefit|0|||
129928033|NCT01928394|467704107|FG006|Treatment Period|Maximum clinical benefit|0|||
129928034|NCT01928394|467704108|FG007|Treatment Period|Maximum clinical benefit|0|||
129928035|NCT01928394|467704109|FG008|Treatment Period|Maximum clinical benefit|0|||
129928036|NCT01928394|467704110|FG009|Treatment Period|Maximum clinical benefit|0|||
129928037|NCT01928394|467704111|FG010|Treatment Period|Maximum clinical benefit|1|||
129928038|NCT01928394|467704112|FG011|Treatment Period|Maximum clinical benefit|1|||
129928039|NCT01928394|467704113|FG012|Treatment Period|Maximum clinical benefit|0|||
129928040|NCT01928394|467704114|FG013|Treatment Period|Maximum clinical benefit|0|||
129928041|NCT01928394|467704115|FG014|Treatment Period|Maximum clinical benefit|1|||
129928042|NCT01928394|467704116|FG015|Treatment Period|Maximum clinical benefit|0|||
129928043|NCT01928394|467704117|FG016|Treatment Period|Maximum clinical benefit|0|||
129928044|NCT01928394|467704118|FG017|Treatment Period|Maximum clinical benefit|1|||
129928045|NCT01928394|467704119|FG018|Treatment Period|Maximum clinical benefit|1|||
129928046|NCT01928394|467704120|FG019|Treatment Period|Maximum clinical benefit|0|||
129928047|NCT01928394|467704121|FG020|Treatment Period|Maximum clinical benefit|2|||
129928048|NCT01928394|467704122|FG021|Treatment Period|Maximum clinical benefit|0|||
129928049|NCT01928394|467704123|FG022|Treatment Period|Maximum clinical benefit|0|||
129928050|NCT01928394|467704101|FG000|Treatment Period|Lost to Follow-up|0|||
129928051|NCT01928394|467704102|FG001|Treatment Period|Lost to Follow-up|0|||
129928052|NCT01928394|467704103|FG002|Treatment Period|Lost to Follow-up|0|||
129928053|NCT01928394|467704104|FG003|Treatment Period|Lost to Follow-up|0|||
129928054|NCT01928394|467704105|FG004|Treatment Period|Lost to Follow-up|0|||
129928055|NCT01928394|467704106|FG005|Treatment Period|Lost to Follow-up|0|||
129928056|NCT01928394|467704107|FG006|Treatment Period|Lost to Follow-up|0|||
129928057|NCT01928394|467704108|FG007|Treatment Period|Lost to Follow-up|0|||
129928058|NCT01928394|467704109|FG008|Treatment Period|Lost to Follow-up|0|||
129928059|NCT01928394|467704110|FG009|Treatment Period|Lost to Follow-up|0|||
129928060|NCT01928394|467704111|FG010|Treatment Period|Lost to Follow-up|0|||
129928061|NCT01928394|467704112|FG011|Treatment Period|Lost to Follow-up|0|||
129928062|NCT01928394|467704113|FG012|Treatment Period|Lost to Follow-up|0|||
129928063|NCT01928394|467704114|FG013|Treatment Period|Lost to Follow-up|0|||
129928064|NCT01928394|467704115|FG014|Treatment Period|Lost to Follow-up|0|||
129928065|NCT01928394|467704116|FG015|Treatment Period|Lost to Follow-up|0|||
129928066|NCT01928394|467704117|FG016|Treatment Period|Lost to Follow-up|0|||
129928067|NCT01928394|467704118|FG017|Treatment Period|Lost to Follow-up|0|||
129928068|NCT01928394|467704119|FG018|Treatment Period|Lost to Follow-up|0|||
129928069|NCT01928394|467704120|FG019|Treatment Period|Lost to Follow-up|0|||
129928070|NCT01928394|467704121|FG020|Treatment Period|Lost to Follow-up|0|||
129928071|NCT01928394|467704122|FG021|Treatment Period|Lost to Follow-up|0|||
129928072|NCT01928394|467704123|FG022|Treatment Period|Lost to Follow-up|1|||
129928073|NCT01928394|467704101|FG000|Treatment Period|Death|0|||
129928074|NCT01928394|467704102|FG001|Treatment Period|Death|0|||
129928075|NCT01928394|467704103|FG002|Treatment Period|Death|0|||
129928076|NCT01928394|467704104|FG003|Treatment Period|Death|0|||
129928077|NCT01928394|467704105|FG004|Treatment Period|Death|0|||
129928078|NCT01928394|467704106|FG005|Treatment Period|Death|0|||
129928079|NCT01928394|467704107|FG006|Treatment Period|Death|0|||
129928080|NCT01928394|467704108|FG007|Treatment Period|Death|0|||
129928081|NCT01928394|467704109|FG008|Treatment Period|Death|0|||
129928082|NCT01928394|467704110|FG009|Treatment Period|Death|0|||
129928083|NCT01928394|467704111|FG010|Treatment Period|Death|0|||
129928084|NCT01928394|467704112|FG011|Treatment Period|Death|0|||
129928085|NCT01928394|467704113|FG012|Treatment Period|Death|0|||
129928086|NCT01928394|467704114|FG013|Treatment Period|Death|1|||
129928087|NCT01928394|467704115|FG014|Treatment Period|Death|2|||
129928088|NCT01928394|467704116|FG015|Treatment Period|Death|0|||
129928089|NCT01928394|467704117|FG016|Treatment Period|Death|0|||
129928090|NCT01928394|467704118|FG017|Treatment Period|Death|0|||
129928091|NCT01928394|467704119|FG018|Treatment Period|Death|0|||
129928092|NCT01928394|467704120|FG019|Treatment Period|Death|0|||
129928093|NCT01928394|467704121|FG020|Treatment Period|Death|0|||
129928094|NCT01928394|467704122|FG021|Treatment Period|Death|0|||
129928095|NCT01928394|467704123|FG022|Treatment Period|Death|0|||
129928096|NCT01928394|467704101|FG000|Follow-up Period|Participant withdrew consent|3|||
129928097|NCT01928394|467704102|FG001|Follow-up Period|Participant withdrew consent|0|||
129928098|NCT01928394|467704103|FG002|Follow-up Period|Participant withdrew consent|1|||
129928099|NCT01928394|467704104|FG003|Follow-up Period|Participant withdrew consent|4|||
129928100|NCT01928394|467704105|FG004|Follow-up Period|Participant withdrew consent|0|||
129928101|NCT01928394|467704106|FG005|Follow-up Period|Participant withdrew consent|2|||
129928102|NCT01928394|467704107|FG006|Follow-up Period|Participant withdrew consent|5|||
129928103|NCT01928394|467704108|FG007|Follow-up Period|Participant withdrew consent|1|||
129928104|NCT01928394|467704109|FG008|Follow-up Period|Participant withdrew consent|0|||
129928105|NCT01928394|467704110|FG009|Follow-up Period|Participant withdrew consent|0|||
129928106|NCT01928394|467704111|FG010|Follow-up Period|Participant withdrew consent|5|||
129928107|NCT01928394|467704112|FG011|Follow-up Period|Participant withdrew consent|8|||
129928108|NCT01928394|467704113|FG012|Follow-up Period|Participant withdrew consent|2|||
129928109|NCT01928394|467704114|FG013|Follow-up Period|Participant withdrew consent|12|||
129928110|NCT01928394|467704115|FG014|Follow-up Period|Participant withdrew consent|7|||
129928111|NCT01928394|467704116|FG015|Follow-up Period|Participant withdrew consent|0|||
129928112|NCT01928394|467704117|FG016|Follow-up Period|Participant withdrew consent|5|||
129928113|NCT01928394|467704118|FG017|Follow-up Period|Participant withdrew consent|3|||
129928114|NCT01928394|467704119|FG018|Follow-up Period|Participant withdrew consent|2|||
129928115|NCT01928394|467704120|FG019|Follow-up Period|Participant withdrew consent|7|||
129928116|NCT01928394|467704121|FG020|Follow-up Period|Participant withdrew consent|4|||
129928117|NCT01928394|467704122|FG021|Follow-up Period|Participant withdrew consent|6|||
129928118|NCT01928394|467704123|FG022|Follow-up Period|Participant withdrew consent|2|||
129928119|NCT01928394|467704101|FG000|Follow-up Period|Death|0|||
129928120|NCT01928394|467704102|FG001|Follow-up Period|Death|0|||
129928121|NCT01928394|467704103|FG002|Follow-up Period|Death|2|||
129928122|NCT01928394|467704104|FG003|Follow-up Period|Death|6|||
129928123|NCT01928394|467704105|FG004|Follow-up Period|Death|0|||
129928124|NCT01928394|467704106|FG005|Follow-up Period|Death|6|||
129928125|NCT01928394|467704107|FG006|Follow-up Period|Death|6|||
129928126|NCT01928394|467704108|FG007|Follow-up Period|Death|2|||
129928127|NCT01928394|467704109|FG008|Follow-up Period|Death|1|||
129928128|NCT01928394|467704110|FG009|Follow-up Period|Death|2|||
129928129|NCT01928394|467704111|FG010|Follow-up Period|Death|4|||
129928130|NCT01928394|467704112|FG011|Follow-up Period|Death|12|||
129928131|NCT01928394|467704113|FG012|Follow-up Period|Death|11|||
129928132|NCT01928394|467704114|FG013|Follow-up Period|Death|25|||
129928133|NCT01928394|467704115|FG014|Follow-up Period|Death|18|||
129928134|NCT01928394|467704116|FG015|Follow-up Period|Death|0|||
129928135|NCT01928394|467704117|FG016|Follow-up Period|Death|6|||
129928136|NCT01928394|467704118|FG017|Follow-up Period|Death|5|||
129928137|NCT01928394|467704119|FG018|Follow-up Period|Death|13|||
129928138|NCT01928394|467704120|FG019|Follow-up Period|Death|13|||
129928139|NCT01928394|467704121|FG020|Follow-up Period|Death|5|||
129928140|NCT01928394|467704122|FG021|Follow-up Period|Death|3|||
129928141|NCT01928394|467704123|FG022|Follow-up Period|Death|2|||
129928142|NCT01928394|467704101|FG000|Follow-up Period|other reason|0|||
129928143|NCT01928394|467704102|FG001|Follow-up Period|other reason|0|||
129928144|NCT01928394|467704103|FG002|Follow-up Period|other reason|0|||
129928145|NCT01928394|467704104|FG003|Follow-up Period|other reason|0|||
129928146|NCT01928394|467704105|FG004|Follow-up Period|other reason|0|||
129928147|NCT01928394|467704106|FG005|Follow-up Period|other reason|0|||
129928148|NCT01928394|467704107|FG006|Follow-up Period|other reason|1|||
129928149|NCT01928394|467704108|FG007|Follow-up Period|other reason|3|||
129928150|NCT01928394|467704109|FG008|Follow-up Period|other reason|0|||
129928151|NCT01928394|467704110|FG009|Follow-up Period|other reason|0|||
129928152|NCT01928394|467704111|FG010|Follow-up Period|other reason|2|||
129928153|NCT01928394|467704112|FG011|Follow-up Period|other reason|1|||
129928154|NCT01928394|467704113|FG012|Follow-up Period|other reason|0|||
129928155|NCT01928394|467704114|FG013|Follow-up Period|other reason|1|||
129928156|NCT01928394|467704115|FG014|Follow-up Period|other reason|4|||
129928157|NCT01928394|467704116|FG015|Follow-up Period|other reason|0|||
129928158|NCT01928394|467704117|FG016|Follow-up Period|other reason|2|||
129928159|NCT01928394|467704118|FG017|Follow-up Period|other reason|0|||
129928160|NCT01928394|467704119|FG018|Follow-up Period|other reason|1|||
129928161|NCT01928394|467704120|FG019|Follow-up Period|other reason|1|||
129928162|NCT01928394|467704121|FG020|Follow-up Period|other reason|0|||
129928163|NCT01928394|467704122|FG021|Follow-up Period|other reason|0|||
129928164|NCT01928394|467704123|FG022|Follow-up Period|other reason|1|||
129928165|NCT01928394|467704101|FG000|Follow-up Period|Lost to Follow-up|0|||
129928166|NCT01928394|467704102|FG001|Follow-up Period|Lost to Follow-up|0|||
129928167|NCT01928394|467704103|FG002|Follow-up Period|Lost to Follow-up|0|||
129928168|NCT01928394|467704104|FG003|Follow-up Period|Lost to Follow-up|0|||
129928169|NCT01928394|467704105|FG004|Follow-up Period|Lost to Follow-up|0|||
129928170|NCT01928394|467704106|FG005|Follow-up Period|Lost to Follow-up|0|||
129928171|NCT01928394|467704107|FG006|Follow-up Period|Lost to Follow-up|0|||
129928172|NCT01928394|467704108|FG007|Follow-up Period|Lost to Follow-up|0|||
129928173|NCT01928394|467704109|FG008|Follow-up Period|Lost to Follow-up|0|||
129928174|NCT01928394|467704110|FG009|Follow-up Period|Lost to Follow-up|0|||
129928175|NCT01928394|467704111|FG010|Follow-up Period|Lost to Follow-up|0|||
129928176|NCT01928394|467704112|FG011|Follow-up Period|Lost to Follow-up|1|||
129928177|NCT01928394|467704113|FG012|Follow-up Period|Lost to Follow-up|1|||
129928178|NCT01928394|467704114|FG013|Follow-up Period|Lost to Follow-up|0|||
129928179|NCT01928394|467704115|FG014|Follow-up Period|Lost to Follow-up|1|||
129928180|NCT01928394|467704116|FG015|Follow-up Period|Lost to Follow-up|0|||
129928181|NCT01928394|467704117|FG016|Follow-up Period|Lost to Follow-up|1|||
129928182|NCT01928394|467704118|FG017|Follow-up Period|Lost to Follow-up|0|||
129928183|NCT01928394|467704119|FG018|Follow-up Period|Lost to Follow-up|0|||
129928184|NCT01928394|467704120|FG019|Follow-up Period|Lost to Follow-up|0|||
129928185|NCT01928394|467704121|FG020|Follow-up Period|Lost to Follow-up|0|||
129928186|NCT01928394|467704122|FG021|Follow-up Period|Lost to Follow-up|0|||
129928187|NCT01928394|467704123|FG022|Follow-up Period|Lost to Follow-up|1|||
130069005|NCT02574481|468207791|FG000|Overall Study|Adverse Event|5|||
129928188|NCT04707625|467704124|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
129928189|NCT04471246|467704125|FG000|Overall Study|Lost to Follow-up|2|||
129928190|NCT04471246|467704126|FG001|Overall Study|Lost to Follow-up|2|||
129928191|NCT03334630|467704127|FG000|Overall Study|Withdrawal by Subject|7|||
129928192|NCT03334630|467704128|FG001|Overall Study|Withdrawal by Subject|7|||
129928193|NCT03334630|467704127|FG000|Overall Study|Lost to Follow-up|3|||
129928194|NCT03334630|467704128|FG001|Overall Study|Lost to Follow-up|1|||
129928195|NCT03334630|467704127|FG000|Overall Study|Adverse Event|0|||
129928196|NCT03334630|467704128|FG001|Overall Study|Adverse Event|1|||
129928197|NCT03334630|467704127|FG000|Overall Study|Physician Decision|1|||
129928198|NCT03334630|467704128|FG001|Overall Study|Physician Decision|1|||
129928199|NCT03334630|467704127|FG000|Overall Study|Enrollment closed|2|||
129928200|NCT03334630|467704128|FG001|Overall Study|Enrollment closed|1|||
129928201|NCT03334630|467704127|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
129928202|NCT03334630|467704128|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
129928203|NCT03334630|467704127|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
129928204|NCT03334630|467704128|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
129928205|NCT02724969|467704148|FG000|Overall Study|Lost to Follow-up|12|||
129928206|NCT02724969|467704149|FG001|Overall Study|Lost to Follow-up|6|||
129928207|NCT02724969|467704148|FG000|Overall Study|Withdrawal by Subject|3|||
129928208|NCT02724969|467704149|FG001|Overall Study|Withdrawal by Subject|3|||
129928209|NCT02724969|467704148|FG000|Overall Study|Infant demise|0|||
129928210|NCT02724969|467704149|FG001|Overall Study|Infant demise|2|||
129928211|NCT01346540|467704150|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
129928212|NCT01346540|467704151|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
129928213|NCT01346540|467704150|FG000|Overall Study|Adverse Event|0|||
129928214|NCT01346540|467704151|FG001|Overall Study|Adverse Event|4|||
129928215|NCT03362476|467704156|FG000|Overall Study|Withdrawal by Subject|0|||
129928216|NCT03362476|467704157|FG001|Overall Study|Withdrawal by Subject|1|||
129928217|NCT05147116|467704164|FG000|Overall Study|Withdrawal by Subject|0|||
129928218|NCT05147116|467704165|FG001|Overall Study|Withdrawal by Subject|1|||
129928219|NCT03672916|467704166|FG000|Overall Study|Death|6|||
129928220|NCT03672916|467704166|FG000|Overall Study|Lost to Follow-up|29|||
129928221|NCT03672916|467704166|FG000|Overall Study|Adverse Event|6|||
129928222|NCT03672916|467704166|FG000|Overall Study|Withdrawal by Subject|11|||
129928223|NCT04197336|467704167|FG000|Overall Study|Withdrawal by Subject|1|||
129928224|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
129928225|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
129928226|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
129928227|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
129928228|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
129928229|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
129928230|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
129928231|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Death|0|||
129928232|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Death|1|||
129928233|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Death|0|||
129928234|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Death|0|||
129928235|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Death|0|||
129928236|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Death|0|||
129928237|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Death|0|||
129928238|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
129928239|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928240|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928241|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928242|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928243|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928244|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928245|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928246|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
129928247|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928248|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928249|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928250|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928251|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928252|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Other|1|||
129928253|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Other|0|||
129928254|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Other|0|||
129928255|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Other|0|||
129928256|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Other|0|||
129928257|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Other|0|||
129928258|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Other|0|||
130069006|NCT02574481|468207792|FG001|Overall Study|Adverse Event|1|||
130069007|NCT02574481|468207793|FG002|Overall Study|Adverse Event|1|||
130069008|NCT02574481|468207794|FG003|Overall Study|Adverse Event|0|||
130069009|NCT02574481|468207791|FG000|Overall Study|Visit Missed|15|||
130069010|NCT02574481|468207792|FG001|Overall Study|Visit Missed|7|||
130069011|NCT02574481|468207793|FG002|Overall Study|Visit Missed|5|||
130069012|NCT02574481|468207794|FG003|Overall Study|Visit Missed|0|||
130069013|NCT02574481|468207791|FG000|Overall Study|Other|7|||
130069014|NCT02574481|468207792|FG001|Overall Study|Other|2|||
130069015|NCT02574481|468207793|FG002|Overall Study|Other|0|||
130069016|NCT02574481|468207794|FG003|Overall Study|Other|0|||
130069017|NCT02574481|468207791|FG000|Overall Study|Death|48|||
130069018|NCT02574481|468207792|FG001|Overall Study|Death|26|||
130069019|NCT02574481|468207793|FG002|Overall Study|Death|12|||
130069020|NCT02574481|468207794|FG003|Overall Study|Death|4|||
130069021|NCT02574481|468207791|FG000|Overall Study|Physician Decision|5|||
130069022|NCT02574481|468207792|FG001|Overall Study|Physician Decision|2|||
130069023|NCT02574481|468207793|FG002|Overall Study|Physician Decision|0|||
130069024|NCT02574481|468207794|FG003|Overall Study|Physician Decision|0|||
130069025|NCT02574481|468207791|FG000|Overall Study|Lost to Follow-up|5|||
130069026|NCT02574481|468207792|FG001|Overall Study|Lost to Follow-up|1|||
130069027|NCT02574481|468207793|FG002|Overall Study|Lost to Follow-up|3|||
130069028|NCT02574481|468207794|FG003|Overall Study|Lost to Follow-up|0|||
130069029|NCT04134728|468207795|FG000|Overall Study|Adverse Event|3|||
130069030|NCT04134728|468207796|FG001|Overall Study|Adverse Event|2|||
130069031|NCT04134728|468207797|FG002|Overall Study|Adverse Event|9|||
130069032|NCT04134728|468207798|FG003|Overall Study|Adverse Event|0|||
130069033|NCT04134728|468207799|FG004|Overall Study|Adverse Event|0|||
130069034|NCT04134728|468207800|FG005|Overall Study|Adverse Event|0|||
130069035|NCT04134728|468207795|FG000|Overall Study|Lack of Efficacy|3|||
130069036|NCT04134728|468207796|FG001|Overall Study|Lack of Efficacy|3|||
130069037|NCT04134728|468207797|FG002|Overall Study|Lack of Efficacy|1|||
130069038|NCT04134728|468207798|FG003|Overall Study|Lack of Efficacy|2|||
130069039|NCT04134728|468207799|FG004|Overall Study|Lack of Efficacy|0|||
130069040|NCT04134728|468207800|FG005|Overall Study|Lack of Efficacy|0|||
130069041|NCT04134728|468207795|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130069042|NCT04134728|468207796|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130069043|NCT04134728|468207797|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
130069044|NCT04134728|468207798|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130069045|NCT04134728|468207799|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130069046|NCT04134728|468207800|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130069047|NCT04134728|468207795|FG000|Overall Study|Protocol Deviation|0|||
130069048|NCT04134728|468207796|FG001|Overall Study|Protocol Deviation|0|||
130069049|NCT04134728|468207797|FG002|Overall Study|Protocol Deviation|1|||
130069050|NCT04134728|468207798|FG003|Overall Study|Protocol Deviation|0|||
130069051|NCT04134728|468207799|FG004|Overall Study|Protocol Deviation|0|||
130069052|NCT04134728|468207800|FG005|Overall Study|Protocol Deviation|0|||
130069053|NCT04134728|468207795|FG000|Overall Study|Informed Consent Withdrawn|3|||
130069054|NCT04134728|468207796|FG001|Overall Study|Informed Consent Withdrawn|6|||
130069055|NCT04134728|468207797|FG002|Overall Study|Informed Consent Withdrawn|8|||
130069056|NCT04134728|468207798|FG003|Overall Study|Informed Consent Withdrawn|1|||
130069057|NCT04134728|468207799|FG004|Overall Study|Informed Consent Withdrawn|1|||
130069058|NCT04134728|468207800|FG005|Overall Study|Informed Consent Withdrawn|0|||
130069059|NCT04134728|468207795|FG000|Overall Study|Physician Decision|2|||
130069060|NCT04134728|468207796|FG001|Overall Study|Physician Decision|0|||
130069061|NCT04134728|468207797|FG002|Overall Study|Physician Decision|0|||
130069062|NCT04134728|468207798|FG003|Overall Study|Physician Decision|0|||
130069063|NCT04134728|468207799|FG004|Overall Study|Physician Decision|0|||
130069064|NCT04134728|468207800|FG005|Overall Study|Physician Decision|0|||
130069065|NCT04134728|468207795|FG000|Overall Study|Lost to Follow-up|1|||
130069066|NCT04134728|468207796|FG001|Overall Study|Lost to Follow-up|2|||
130069067|NCT04134728|468207797|FG002|Overall Study|Lost to Follow-up|1|||
130069068|NCT04134728|468207798|FG003|Overall Study|Lost to Follow-up|0|||
130069069|NCT04134728|468207799|FG004|Overall Study|Lost to Follow-up|0|||
130069070|NCT04134728|468207800|FG005|Overall Study|Lost to Follow-up|1|||
130069071|NCT04134728|468207795|FG000|Overall Study|Investigator Site Closed|0|||
130069072|NCT04134728|468207796|FG001|Overall Study|Investigator Site Closed|1|||
130069073|NCT04134728|468207797|FG002|Overall Study|Investigator Site Closed|1|||
130069074|NCT04134728|468207798|FG003|Overall Study|Investigator Site Closed|0|||
130069075|NCT04134728|468207799|FG004|Overall Study|Investigator Site Closed|0|||
130069076|NCT04134728|468207800|FG005|Overall Study|Investigator Site Closed|0|||
130069077|NCT02905825|468207809|FG000|Overall Study|Protocol Violation|11|||
130069078|NCT02905825|468207809|FG000|Overall Study|Device Malfunction|1|||
130069079|NCT01281189|468207810|FG000|Overall Study|Adverse Event|7|||
130069080|NCT01281189|468207811|FG001|Overall Study|Adverse Event|9|||
130069081|NCT01281189|468207810|FG000|Overall Study|Lost to Follow-up|6|||
130069082|NCT01281189|468207811|FG001|Overall Study|Lost to Follow-up|4|||
130069083|NCT01281189|468207810|FG000|Overall Study|Withdrawal by Subject|21|||
130069084|NCT01281189|468207811|FG001|Overall Study|Withdrawal by Subject|24|||
129928259|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
129928260|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
129928261|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928262|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928263|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928264|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928265|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928266|NCT04585815|467704168|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928267|NCT04585815|467704169|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
129928268|NCT04585815|467704170|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928269|NCT04585815|467704171|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928270|NCT04585815|467704172|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928271|NCT04585815|467704173|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928272|NCT04585815|467704174|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928273|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
129928274|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
129928275|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
129928276|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
129928277|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
129928278|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
129928279|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
129928280|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Death|0|||
129928281|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Death|0|||
129928282|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Death|0|||
129928283|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Death|1|||
129928284|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Death|0|||
129928285|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Death|0|||
129928286|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Death|0|||
129928287|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928288|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928289|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928290|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
129928291|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928292|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
129928293|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928294|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928295|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928296|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928297|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
129928298|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928299|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928300|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928301|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928302|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928303|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928304|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928305|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928306|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928307|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
129928308|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
129928309|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
129928310|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
129928311|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
129928312|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
129928313|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
129928314|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
129928315|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
129928316|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
129928317|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
129928318|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
129928319|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
129928320|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
129928321|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
129928322|NCT04585815|467704168|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928323|NCT04585815|467704169|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928324|NCT04585815|467704170|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928325|NCT04585815|467704171|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928326|NCT04585815|467704172|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
130069085|NCT01281189|468207810|FG000|Overall Study|Physician Decision|2|||
129928327|NCT04585815|467704173|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
129928328|NCT04585815|467704174|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
129928329|NCT04585815|467704168|FG000|Sub-study B- Follow-up Phase|Death|0|||
129928330|NCT04585815|467704169|FG001|Sub-study B- Follow-up Phase|Death|0|||
129928331|NCT04585815|467704170|FG002|Sub-study B- Follow-up Phase|Death|1|||
129928332|NCT04585815|467704171|FG003|Sub-study B- Follow-up Phase|Death|3|||
129928333|NCT04585815|467704172|FG004|Sub-study B- Follow-up Phase|Death|0|||
129928334|NCT04585815|467704173|FG005|Sub-study B- Follow-up Phase|Death|0|||
129928335|NCT04585815|467704174|FG006|Sub-study B- Follow-up Phase|Death|1|||
129928336|NCT03571581|467704177|FG000|Overall Study|Death|2|||
129928337|NCT03571581|467704177|FG000|Overall Study|Withdrawal by Subject|2|||
129928338|NCT01309672|467704179|FG000|Overall Study|Lack of Efficacy|20|||
129928339|NCT01309672|467704179|FG000|Overall Study|Other|9|||
129928340|NCT01309672|467704179|FG000|Overall Study|Adverse Event|5|||
129928341|NCT01309672|467704179|FG000|Overall Study|Withdrawal by Subject|3|||
129928342|NCT05623228|467704180|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
129928343|NCT05623228|467704181|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928344|NCT05623228|467704182|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928345|NCT05623228|467704183|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928346|NCT05623228|467704184|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928347|NCT05623228|467704185|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928348|NCT05623228|467704186|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928349|NCT05623228|467704187|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928350|NCT05623228|467704180|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
129928351|NCT05623228|467704181|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928352|NCT05623228|467704182|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
129928353|NCT05623228|467704183|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
129928354|NCT05623228|467704184|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928355|NCT05623228|467704185|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928356|NCT05623228|467704186|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928357|NCT05623228|467704187|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928358|NCT04141891|467704189|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
129928359|NCT04141891|467704190|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
129928360|NCT04141891|467704189|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
129928361|NCT04141891|467704190|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
129928362|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
129928363|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
129928364|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
129928365|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
129928366|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
129928367|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
129928368|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
129928369|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
129928370|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
129928371|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
129928372|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
129928373|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
129928374|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
129928375|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
129928376|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
129928377|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
129928378|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
129928379|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
129928380|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
129928381|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
129928382|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
129928383|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
129928384|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
129928385|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
129928386|NCT04737330|467704191|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
129928387|NCT04737330|467704192|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
129928388|NCT04737330|467704191|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
129928389|NCT04737330|467704192|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
129928390|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
129928391|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
129928392|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
129928393|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
129928394|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
130117515|NCT02398188|468390529|FG000|Overall Study|Protocol Violation|6|||
130117516|NCT02398188|468390530|FG001|Overall Study|Protocol Violation|10|||
130117517|NCT02398188|468390529|FG000|Overall Study|Sponsor Decision|2|||
130117518|NCT02398188|468390530|FG001|Overall Study|Sponsor Decision|1|||
130117519|NCT02398188|468390529|FG000|Overall Study|Pregnancy|1|||
130117520|NCT02398188|468390530|FG001|Overall Study|Pregnancy|0|||
130117521|NCT02398188|468390529|FG000|Overall Study|Withdrawal by Subject|7|||
130117522|NCT02398188|468390530|FG001|Overall Study|Withdrawal by Subject|16|||
130117523|NCT00782509|468390531|FG000|Overall Study|Adverse Event|20|||
130117524|NCT00782509|468390532|FG001|Overall Study|Adverse Event|10|||
130117525|NCT00782509|468390533|FG002|Overall Study|Adverse Event|20|||
130117526|NCT00782509|468390531|FG000|Overall Study|Lost to Follow-up|1|||
130117527|NCT00782509|468390532|FG001|Overall Study|Lost to Follow-up|2|||
130117528|NCT00782509|468390533|FG002|Overall Study|Lost to Follow-up|3|||
130117529|NCT00782509|468390531|FG000|Overall Study|Withdrawal by Subject|3|||
130117530|NCT00782509|468390532|FG001|Overall Study|Withdrawal by Subject|5|||
130117531|NCT00782509|468390533|FG002|Overall Study|Withdrawal by Subject|8|||
130117532|NCT00782509|468390531|FG000|Overall Study|Non compliance with protocol|2|||
130117533|NCT00782509|468390532|FG001|Overall Study|Non compliance with protocol|0|||
130117534|NCT00782509|468390533|FG002|Overall Study|Non compliance with protocol|0|||
130117535|NCT00782509|468390531|FG000|Overall Study|Other reasons not stated above|5|||
130117536|NCT00782509|468390532|FG001|Overall Study|Other reasons not stated above|2|||
130117537|NCT00782509|468390533|FG002|Overall Study|Other reasons not stated above|3|||
130117538|NCT00782509|468390531|FG000|Overall Study|Lack of Efficacy|10|||
130117539|NCT00782509|468390532|FG001|Overall Study|Lack of Efficacy|5|||
130117540|NCT00782509|468390533|FG002|Overall Study|Lack of Efficacy|2|||
130117541|NCT01259869|468390534|FG000|Overall Study|Duplicated registration|1|||
130117542|NCT00175019|468390535|FG000|Overall Study|Adverse Event|54|||
130117543|NCT00175019|468390536|FG001|Overall Study|Adverse Event|22|||
130117544|NCT00175019|468390537|FG002|Overall Study|Adverse Event|2|||
130117545|NCT00175019|468390535|FG000|Overall Study|Protocol Violation|6|||
130117546|NCT00175019|468390536|FG001|Overall Study|Protocol Violation|3|||
130117547|NCT00175019|468390537|FG002|Overall Study|Protocol Violation|3|||
130117548|NCT00175019|468390535|FG000|Overall Study|Lost to Follow-up|42|||
130117549|NCT00175019|468390536|FG001|Overall Study|Lost to Follow-up|39|||
130117550|NCT00175019|468390537|FG002|Overall Study|Lost to Follow-up|9|||
130117551|NCT00175019|468390535|FG000|Overall Study|Did not continue under Amendment 4|1|||
130117552|NCT00175019|468390536|FG001|Overall Study|Did not continue under Amendment 4|1|||
130117553|NCT00175019|468390537|FG002|Overall Study|Did not continue under Amendment 4|2|||
130117554|NCT00175019|468390535|FG000|Overall Study|Personal Reason(s)|39|||
130117555|NCT00175019|468390536|FG001|Overall Study|Personal Reason(s)|31|||
130117556|NCT00175019|468390537|FG002|Overall Study|Personal Reason(s)|8|||
130117557|NCT00175019|468390535|FG000|Overall Study|Therapeutic Failure|10|||
130117558|NCT00175019|468390536|FG001|Overall Study|Therapeutic Failure|38|||
130117559|NCT00175019|468390537|FG002|Overall Study|Therapeutic Failure|22|||
130117560|NCT00175019|468390535|FG000|Overall Study|Gout Flare|2|||
130117561|NCT00175019|468390536|FG001|Overall Study|Gout Flare|3|||
130117562|NCT00175019|468390537|FG002|Overall Study|Gout Flare|0|||
130117563|NCT00175019|468390535|FG000|Overall Study|Reason Not Specified|40|||
130117564|NCT00175019|468390536|FG001|Overall Study|Reason Not Specified|34|||
130117565|NCT00175019|468390537|FG002|Overall Study|Reason Not Specified|11|||
130117566|NCT03209570|468390538|FG000|Overall Study|Death|1|||
130117567|NCT03209570|468390539|FG001|Overall Study|Death|0|||
130117568|NCT03209570|468390538|FG000|Overall Study|Incomplete Data|8|||
130117569|NCT03209570|468390539|FG001|Overall Study|Incomplete Data|10|||
130117570|NCT03209570|468390538|FG000|Overall Study|Protocol Violation|1|||
130117571|NCT03209570|468390539|FG001|Overall Study|Protocol Violation|0|||
130117572|NCT03209570|468390538|FG000|Overall Study|Withdrawal by Subject|0|||
130117573|NCT03209570|468390539|FG001|Overall Study|Withdrawal by Subject|3|||
130117574|NCT00220701|468390550|FG000|Overall Study|Lost to Follow-up|5|||
130117575|NCT00220701|468390551|FG001|Overall Study|Lost to Follow-up|4|||
130117576|NCT00755326|468390553|FG000|Overall Study|Lost to Follow-up|2|||
129928395|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
129928396|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
129928397|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
129928398|NCT01651403|467704197|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
130117577|NCT00755326|468390554|FG001|Overall Study|Lost to Follow-up|3|||
130117578|NCT04041570|468390560|FG000|Overall Study|Moved from Area|0|||
130117579|NCT04041570|468390561|FG001|Overall Study|Moved from Area|2|||
130117580|NCT01338636|468390562|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
130117581|NCT02385526|468390563|FG000|Overall Study|Withdrawal by Subject|0|||
130117582|NCT02385526|468390564|FG001|Overall Study|Withdrawal by Subject|2|||
130117583|NCT02385526|468390565|FG002|Overall Study|Withdrawal by Subject|0|||
130117584|NCT02385526|468390563|FG000|Overall Study|Lost to Follow-up|0|||
130117585|NCT02385526|468390564|FG001|Overall Study|Lost to Follow-up|1|||
130117586|NCT02385526|468390565|FG002|Overall Study|Lost to Follow-up|0|||
130117587|NCT02385526|468390563|FG000|Overall Study|Physician Decision|1|||
130117588|NCT02385526|468390564|FG001|Overall Study|Physician Decision|0|||
129928399|NCT01651403|467704198|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
129928400|NCT01651403|467704197|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
129928401|NCT01651403|467704198|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
129928402|NCT01651403|467704197|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
129928403|NCT01651403|467704198|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
129928404|NCT01651403|467704197|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
129928405|NCT01651403|467704198|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
129928406|NCT01651403|467704197|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
129928407|NCT01651403|467704198|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
129928408|NCT01651403|467704197|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
129928409|NCT01651403|467704198|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
129928410|NCT05090683|467704201|FG000|Overall Study|Lost to Follow-up|10|||
129928411|NCT05090683|467704202|FG001|Overall Study|Lost to Follow-up|2|||
129928412|NCT05090683|467704201|FG000|Overall Study|Withdrawal by Subject|15|||
129928413|NCT05090683|467704202|FG001|Overall Study|Withdrawal by Subject|0|||
129928414|NCT05299723|467705357|FG000|Overall Study|Withdrawal by Subject|0|||
129928415|NCT05299723|467705358|FG001|Overall Study|Withdrawal by Subject|2|||
129928416|NCT05299723|467705359|FG002|Overall Study|Withdrawal by Subject|0|||
129928417|NCT00696111|467705360|FG000|Overall Study|Withdrawal by Subject|17|||
129928418|NCT03952338|467705361|FG000|Overall Study|Lost to Follow-up|11|||
129928419|NCT03952338|467705362|FG001|Overall Study|Lost to Follow-up|17|||
129928420|NCT03952338|467705361|FG000|Overall Study|Withdrawal by Subject|1|||
129928421|NCT03952338|467705362|FG001|Overall Study|Withdrawal by Subject|1|||
129928422|NCT03952338|467705361|FG000|Overall Study|Protocol Violation|1|||
129928423|NCT03952338|467705362|FG001|Overall Study|Protocol Violation|0|||
129928424|NCT02593773|467705363|FG000|Overall Study|Voluntary Withdrawal|3|||
129928425|NCT02593773|467705363|FG000|Overall Study|Study Terminated by Sponsor|31|||
129928426|NCT02593773|467705363|FG000|Overall Study|Death|1|||
129928427|NCT05452460|467705365|FG000|Overall Study|Lost to Follow-up|3|||
129928428|NCT05452460|467705366|FG001|Overall Study|Lost to Follow-up|3|||
129928429|NCT05452460|467705365|FG000|Overall Study|Did not receive intervention|1|||
129928430|NCT05452460|467705366|FG001|Overall Study|Did not receive intervention|0|||
129928431|NCT04447040|467705369|FG000|Overall Study|Lost to Follow-up|2|||
129928432|NCT04447040|467705370|FG001|Overall Study|Lost to Follow-up|1|||
129928433|NCT04447040|467705371|FG002|Overall Study|Lost to Follow-up|3|||
129928434|NCT04447040|467705372|FG003|Overall Study|Lost to Follow-up|3|||
129928435|NCT04447040|467705373|FG004|Overall Study|Lost to Follow-up|1|||
129928436|NCT04447040|467705374|FG005|Overall Study|Lost to Follow-up|3|||
129928437|NCT04447040|467705369|FG000|Overall Study|Withdrawal by Subject|0|||
129928438|NCT04447040|467705370|FG001|Overall Study|Withdrawal by Subject|1|||
129928439|NCT04447040|467705371|FG002|Overall Study|Withdrawal by Subject|1|||
129928440|NCT04447040|467705372|FG003|Overall Study|Withdrawal by Subject|1|||
129928441|NCT04447040|467705373|FG004|Overall Study|Withdrawal by Subject|0|||
129928442|NCT04447040|467705374|FG005|Overall Study|Withdrawal by Subject|0|||
129928443|NCT01208662|467705375|FG000|Induction and Consolidation|Disease Progression|23|||
129928444|NCT01208662|467705376|FG001|Induction and Consolidation|Disease Progression|13|||
129928445|NCT01208662|467705377|FG002|Induction and Consolidation|Disease Progression|0|||
129928446|NCT01208662|467705375|FG000|Induction and Consolidation|Adverse Event|16|||
129928447|NCT01208662|467705376|FG001|Induction and Consolidation|Adverse Event|18|||
129928448|NCT01208662|467705377|FG002|Induction and Consolidation|Adverse Event|2|||
129928449|NCT01208662|467705375|FG000|Induction and Consolidation|MD or Participant Decision|16|||
129928450|NCT01208662|467705376|FG001|Induction and Consolidation|MD or Participant Decision|34|||
129928451|NCT01208662|467705377|FG002|Induction and Consolidation|MD or Participant Decision|4|||
129928452|NCT01208662|467705375|FG000|Induction and Consolidation|Death|1|||
129928453|NCT01208662|467705376|FG001|Induction and Consolidation|Death|3|||
129928454|NCT01208662|467705377|FG002|Induction and Consolidation|Death|1|||
129928455|NCT01208662|467705375|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
129928456|NCT01208662|467705376|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
129928457|NCT01208662|467705377|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
129928458|NCT01208662|467705375|FG000|Maintenance|Disease Progression|156|||
129928459|NCT01208662|467705376|FG001|Maintenance|Disease Progression|102|||
129928460|NCT01208662|467705377|FG002|Maintenance|Disease Progression|0|||
129928461|NCT01208662|467705375|FG000|Maintenance|Adverse Event|12|||
129928462|NCT01208662|467705376|FG001|Maintenance|Adverse Event|28|||
129928463|NCT01208662|467705377|FG002|Maintenance|Adverse Event|0|||
129928464|NCT01208662|467705375|FG000|Maintenance|MD or Participant Decision|24|||
129928465|NCT01208662|467705376|FG001|Maintenance|MD or Participant Decision|36|||
129928466|NCT01208662|467705377|FG002|Maintenance|MD or Participant Decision|0|||
129928467|NCT01208662|467705375|FG000|Maintenance|Death|0|||
129928468|NCT01208662|467705376|FG001|Maintenance|Death|3|||
129928469|NCT01208662|467705377|FG002|Maintenance|Death|0|||
129928470|NCT01208662|467705375|FG000|Maintenance|Discontinued for other reasons|21|||
129928471|NCT01208662|467705376|FG001|Maintenance|Discontinued for other reasons|31|||
129928472|NCT01208662|467705377|FG002|Maintenance|Discontinued for other reasons|0|||
129928473|NCT01208662|467705375|FG000|Maintenance|Still on Treatment|78|||
129928474|NCT01208662|467705376|FG001|Maintenance|Still on Treatment|89|||
129928475|NCT01208662|467705377|FG002|Maintenance|Still on Treatment|0|||
129928476|NCT04076618|467705378|FG000|Overall Study|Lost to Follow-up|2|||
129928477|NCT04076618|467705379|FG001|Overall Study|Lost to Follow-up|1|||
129928478|NCT04076618|467705380|FG002|Overall Study|Lost to Follow-up|3|||
129928479|NCT04076618|467705378|FG000|Overall Study|Withdrawal by Subject|3|||
129928480|NCT04076618|467705379|FG001|Overall Study|Withdrawal by Subject|1|||
129928481|NCT04076618|467705380|FG002|Overall Study|Withdrawal by Subject|2|||
129928482|NCT04076618|467705378|FG000|Overall Study|Relocated out of state|0|||
129928483|NCT04076618|467705379|FG001|Overall Study|Relocated out of state|2|||
129928484|NCT04076618|467705380|FG002|Overall Study|Relocated out of state|0|||
129928485|NCT04076618|467705378|FG000|Overall Study|COVID concerns|0|||
129928486|NCT04076618|467705379|FG001|Overall Study|COVID concerns|1|||
129928487|NCT04076618|467705380|FG002|Overall Study|COVID concerns|0|||
129928488|NCT04076618|467705378|FG000|Overall Study|Adverse Event|0|||
129928489|NCT04076618|467705379|FG001|Overall Study|Adverse Event|0|||
129928490|NCT04076618|467705380|FG002|Overall Study|Adverse Event|2|||
129928491|NCT03386578|467705387|FG000|PK Component|Lost to Follow-up|0|||
129928492|NCT03386578|467705388|FG001|PK Component|Lost to Follow-up|1|||
129928493|NCT03386578|467705389|FG002|PK Component|Lost to Follow-up|0|||
129928494|NCT03386578|467705390|FG003|PK Component|Lost to Follow-up|0|||
129928495|NCT03386578|467705391|FG004|PK Component|Lost to Follow-up|0|||
129928496|NCT03386578|467705392|FG005|PK Component|Lost to Follow-up|0|||
129928497|NCT03386578|467705393|FG006|PK Component|Lost to Follow-up|1|||
129928498|NCT03386578|467705394|FG007|PK Component|Lost to Follow-up|0|||
129928499|NCT03386578|467705395|FG008|PK Component|Lost to Follow-up|0|||
129928500|NCT03386578|467705396|FG009|PK Component|Lost to Follow-up|0|||
129928501|NCT03386578|467705387|FG000|PK Component|Stillbirth/Abortion|0|||
129928502|NCT03386578|467705388|FG001|PK Component|Stillbirth/Abortion|0|||
129928503|NCT03386578|467705389|FG002|PK Component|Stillbirth/Abortion|0|||
129928504|NCT03386578|467705390|FG003|PK Component|Stillbirth/Abortion|0|||
129928505|NCT03386578|467705391|FG004|PK Component|Stillbirth/Abortion|0|||
129928506|NCT03386578|467705392|FG005|PK Component|Stillbirth/Abortion|2|||
129928507|NCT03386578|467705393|FG006|PK Component|Stillbirth/Abortion|0|||
129928508|NCT03386578|467705394|FG007|PK Component|Stillbirth/Abortion|0|||
129928509|NCT03386578|467705395|FG008|PK Component|Stillbirth/Abortion|0|||
129928510|NCT03386578|467705396|FG009|PK Component|Stillbirth/Abortion|0|||
129928511|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928512|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928513|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
129928514|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
129928515|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928516|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928517|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928518|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
129928519|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
129928520|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928521|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928522|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928523|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
129928524|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
129928525|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928526|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928527|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928528|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
129928529|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
129928530|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928531|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Death|0|||
129928532|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Death|0|||
129928533|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Death|1|||
129928534|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Death|0|||
129928535|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Death|0|||
129928536|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Death|0|||
129928537|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Death|0|||
129928538|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Death|9|||
129928539|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Death|5|||
129928540|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Death|0|||
129928541|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928542|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928543|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928544|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
129928545|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
130069086|NCT01281189|468207811|FG001|Overall Study|Physician Decision|3|||
129928546|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928547|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928548|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928549|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
129928550|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928551|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928552|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928553|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928554|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928555|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928556|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928557|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928558|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
129928559|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
129928560|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928561|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928562|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928563|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928564|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928565|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928566|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928567|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928568|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
129928569|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
129928570|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928571|NCT05907174|467705397|FG000|3-Month Assessment|Withdrawal by Subject|0|||
129928572|NCT05907174|467705398|FG001|3-Month Assessment|Withdrawal by Subject|0|||
129928573|NCT05907174|467705399|FG002|3-Month Assessment|Withdrawal by Subject|0|||
129928574|NCT05907174|467705400|FG003|3-Month Assessment|Withdrawal by Subject|1|||
129928575|NCT05907174|467705397|FG000|3-Month Assessment|Lost to Follow-up|1|||
129928576|NCT05907174|467705398|FG001|3-Month Assessment|Lost to Follow-up|1|||
129928577|NCT05907174|467705399|FG002|3-Month Assessment|Lost to Follow-up|1|||
129928578|NCT05907174|467705400|FG003|3-Month Assessment|Lost to Follow-up|1|||
129928579|NCT05907174|467705397|FG000|6-Month Assessment|Death|0|||
129928580|NCT05907174|467705398|FG001|6-Month Assessment|Death|0|||
129928581|NCT05907174|467705399|FG002|6-Month Assessment|Death|3|||
129928582|NCT05907174|467705400|FG003|6-Month Assessment|Death|0|||
129928583|NCT05907174|467705397|FG000|6-Month Assessment|Withdrawal by Subject|0|||
129928584|NCT05907174|467705398|FG001|6-Month Assessment|Withdrawal by Subject|0|||
129928585|NCT05907174|467705399|FG002|6-Month Assessment|Withdrawal by Subject|1|||
129928586|NCT05907174|467705400|FG003|6-Month Assessment|Withdrawal by Subject|1|||
129928587|NCT05907174|467705397|FG000|6-Month Assessment|Lost to Follow-up|0|||
129928588|NCT05907174|467705398|FG001|6-Month Assessment|Lost to Follow-up|1|||
129928589|NCT05907174|467705399|FG002|6-Month Assessment|Lost to Follow-up|1|||
129928590|NCT05907174|467705400|FG003|6-Month Assessment|Lost to Follow-up|1|||
129928591|NCT05093842|467705401|FG000|Overall Study|Pregnancy loss|1|||
129928592|NCT05093842|467705402|FG001|Overall Study|Pregnancy loss|1|||
129928593|NCT05093842|467705401|FG000|Overall Study|Lost to Follow-up|6|||
129928594|NCT05093842|467705402|FG001|Overall Study|Lost to Follow-up|0|||
129928595|NCT05093842|467705401|FG000|Overall Study|Physician Decision|0|||
129928596|NCT05093842|467705402|FG001|Overall Study|Physician Decision|1|||
129928597|NCT04066205|467705403|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
129928598|NCT04066205|467705404|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
129928599|NCT04066205|467705403|FG000|T2 Immediate Post-Intervention|did not respond|5|||
129928600|NCT04066205|467705404|FG001|T2 Immediate Post-Intervention|did not respond|3|||
129928601|NCT04685135|467705411|FG000|Overall Study|Death|126|||
129928602|NCT04685135|467705412|FG001|Overall Study|Death|53|||
129928603|NCT04685135|467705411|FG000|Overall Study|Withdrawal by Subject|12|||
129928604|NCT04685135|467705412|FG001|Overall Study|Withdrawal by Subject|16|||
129928605|NCT05868382|467705418|FG000|Overall Study|Lost to Follow-up|5|||
129928606|NCT05868382|467705419|FG001|Overall Study|Lost to Follow-up|0|||
129928607|NCT05868382|467705420|FG002|Overall Study|Lost to Follow-up|6|||
129928608|NCT05868382|467705421|FG003|Overall Study|Lost to Follow-up|4|||
129928609|NCT05868382|467705422|FG004|Overall Study|Lost to Follow-up|2|||
129928610|NCT05868382|467705423|FG005|Overall Study|Lost to Follow-up|6|||
129928611|NCT05868382|467705418|FG000|Overall Study|Withdrawal by Subject|1|||
129928612|NCT05868382|467705419|FG001|Overall Study|Withdrawal by Subject|0|||
129928613|NCT05868382|467705420|FG002|Overall Study|Withdrawal by Subject|0|||
129928614|NCT05868382|467705421|FG003|Overall Study|Withdrawal by Subject|0|||
129928615|NCT05868382|467705422|FG004|Overall Study|Withdrawal by Subject|1|||
130069087|NCT01281189|468207810|FG000|Overall Study|Death|103|||
129928616|NCT05868382|467705423|FG005|Overall Study|Withdrawal by Subject|0|||
129928617|NCT01221948|467705433|FG000|Overall Study|Physician Decision|5|||
129928618|NCT01221948|467705433|FG000|Overall Study|Withdrawal by Subject|2|||
130069088|NCT01281189|468207811|FG001|Overall Study|Death|91|||
130069089|NCT01281189|468207810|FG000|Overall Study|Other|8|||
130069090|NCT01281189|468207811|FG001|Overall Study|Other|12|||
130069091|NCT05355818|468207812|FG000|Overall Study|Adverse Event|1|||
130069092|NCT05355818|468207813|FG001|Overall Study|Adverse Event|1|||
130069093|NCT05355818|468207812|FG000|Overall Study|Lack of Efficacy|2|||
130069094|NCT05355818|468207813|FG001|Overall Study|Lack of Efficacy|1|||
130069095|NCT05355818|468207812|FG000|Overall Study|Lost to Follow-up|0|||
130069096|NCT05355818|468207813|FG001|Overall Study|Lost to Follow-up|1|||
130069097|NCT01136746|468207816|FG000|Overall Study|Lost to Follow-up|0|||
130069098|NCT01136746|468207817|FG001|Overall Study|Lost to Follow-up|2|||
130069099|NCT01136746|468207816|FG000|Overall Study|Protocol Violation|2|||
130069100|NCT01136746|468207817|FG001|Overall Study|Protocol Violation|1|||
130069101|NCT01136746|468207816|FG000|Overall Study|Death|1|||
130069102|NCT01136746|468207817|FG001|Overall Study|Death|0|||
130069103|NCT00092677|468207827|FG000|Overall Study|Lost to Follow-up|0|||
130069104|NCT00092677|468207828|FG001|Overall Study|Lost to Follow-up|2|||
130069105|NCT00092677|468207827|FG000|Overall Study|Adminstrative|5|||
130069106|NCT00092677|468207828|FG001|Overall Study|Adminstrative|9|||
130069107|NCT01090102|468207829|FG000|First 12 Weeks|Withdrawal by Subject|1|||
130069108|NCT01090102|468207830|FG001|First 12 Weeks|Withdrawal by Subject|1|||
130069109|NCT01090102|468207829|FG000|First 12 Weeks|Adverse Event|2|||
130069110|NCT01090102|468207830|FG001|First 12 Weeks|Adverse Event|0|||
130069111|NCT01090102|468207829|FG000|First 12 Weeks|Death|1|||
130069112|NCT01090102|468207830|FG001|First 12 Weeks|Death|1|||
130069113|NCT01090102|468207829|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
130069114|NCT01090102|468207830|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
130069115|NCT01601704|468207831|FG000|Overall Study|Randomized but not dispensed study med|1|||
130069116|NCT01601704|468207832|FG001|Overall Study|Randomized but not dispensed study med|4|||
130069117|NCT00010803|468207833|FG000|Overall Study|Withdrawal by Subject|97|||
130069118|NCT00010803|468207834|FG001|Overall Study|Withdrawal by Subject|98|||
130069119|NCT01019252|468207835|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
130069120|NCT01019252|468207836|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
130069121|NCT01019252|468207835|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
130069122|NCT01019252|468207836|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
130069123|NCT01019252|468207835|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
130069124|NCT01019252|468207836|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
130069125|NCT01019252|468207835|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
130069126|NCT01019252|468207836|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
130069127|NCT02273037|468207837|FG000|Overall Study|Lost to Follow-up|1|||
130069128|NCT02273037|468207838|FG001|Overall Study|Lost to Follow-up|0|||
130069129|NCT02273037|468207837|FG000|Overall Study|Delivered before monitoring initiated|1|||
130069130|NCT02273037|468207838|FG001|Overall Study|Delivered before monitoring initiated|3|||
130069131|NCT02273037|468207837|FG000|Overall Study|Breech delivery|2|||
130069132|NCT02273037|468207838|FG001|Overall Study|Breech delivery|3|||
130069133|NCT02273037|468207837|FG000|Overall Study|Multiple delivery|2|||
130069134|NCT02273037|468207838|FG001|Overall Study|Multiple delivery|2|||
130069135|NCT02273037|468207837|FG000|Overall Study|Other complication|2|||
130069136|NCT02273037|468207838|FG001|Overall Study|Other complication|0|||
130069137|NCT03351478|468207839|FG000|Overall Study|At the subject's own request|11|||
130069138|NCT03351478|468207840|FG001|Overall Study|At the subject's own request|12|||
130069139|NCT03351478|468207841|FG002|Overall Study|At the subject's own request|5|||
130069140|NCT03351478|468207839|FG000|Overall Study|Adverse Event|1|||
130069141|NCT03351478|468207840|FG001|Overall Study|Adverse Event|2|||
130069142|NCT03351478|468207841|FG002|Overall Study|Adverse Event|1|||
130069143|NCT03351478|468207839|FG000|Overall Study|Poor compliance to protocol|1|||
130069144|NCT03351478|468207840|FG001|Overall Study|Poor compliance to protocol|0|||
130069145|NCT03351478|468207841|FG002|Overall Study|Poor compliance to protocol|0|||
130069146|NCT03351478|468207839|FG000|Overall Study|Reason not Specified|1|||
130069147|NCT03351478|468207840|FG001|Overall Study|Reason not Specified|3|||
130069148|NCT03351478|468207841|FG002|Overall Study|Reason not Specified|0|||
130069149|NCT03351478|468207839|FG000|Overall Study|Lost to Follow-up|0|||
130069150|NCT03351478|468207840|FG001|Overall Study|Lost to Follow-up|0|||
130069151|NCT03351478|468207841|FG002|Overall Study|Lost to Follow-up|1|||
130069152|NCT00985738|468207845|FG000|Overall Study|Study closed prematurely|8|||
130069153|NCT00985738|468207846|FG001|Overall Study|Study closed prematurely|8|||
130069154|NCT00510484|468207848|FG000|Wash-out Period|Adverse Event|0|||
130069155|NCT00510484|468207849|FG001|Wash-out Period|Adverse Event|1|||
130069156|NCT00762268|468207852|FG000|Overall Study|Withdrawal by Subject|3|||
130069157|NCT00762268|468207853|FG001|Overall Study|Withdrawal by Subject|3|||
130069158|NCT02533401|468207856|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
130069159|NCT02533401|468207856|FG000|Overall Study|Death|5|||
130069160|NCT02533401|468207856|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
129928619|NCT01221948|467705433|FG000|Overall Study|not disclosed|2|||
129928620|NCT01221948|467705433|FG000|Overall Study|Death|1|||
129928621|NCT01221948|467705433|FG000|Overall Study|Protocol Violation|4|||
129928622|NCT00746096|467705434|FG000|Overall Study|Adverse Event|1|||
129928623|NCT00746096|467705435|FG001|Overall Study|Adverse Event|0|||
129928624|NCT00746096|467705434|FG000|Overall Study|Withdrawal by Subject|5|||
129928625|NCT00746096|467705435|FG001|Overall Study|Withdrawal by Subject|1|||
129928626|NCT00746096|467705434|FG000|Overall Study|Lost to Follow-up|2|||
129928627|NCT00746096|467705435|FG001|Overall Study|Lost to Follow-up|1|||
129928628|NCT00746096|467705434|FG000|Overall Study|Protocol Violation|1|||
129928629|NCT00746096|467705435|FG001|Overall Study|Protocol Violation|0|||
129928630|NCT00746096|467705434|FG000|Overall Study|No study drug treatment|1|||
129928631|NCT00746096|467705435|FG001|Overall Study|No study drug treatment|1|||
129928632|NCT04295512|467705436|FG000|Overall Study|Lack of family response to schedule assessment|0|||
129928633|NCT04295512|467705437|FG001|Overall Study|Lack of family response to schedule assessment|0|||
129928634|NCT04295512|467705438|FG002|Overall Study|Lack of family response to schedule assessment|0|||
129928635|NCT04295512|467705439|FG003|Overall Study|Lack of family response to schedule assessment|2|||
129928636|NCT04295512|467705436|FG000|Overall Study|Therapist did not refer eligible family|7|||
129928637|NCT04295512|467705437|FG001|Overall Study|Therapist did not refer eligible family|7|||
129928638|NCT04295512|467705438|FG002|Overall Study|Therapist did not refer eligible family|0|||
129928639|NCT04295512|467705439|FG003|Overall Study|Therapist did not refer eligible family|0|||
129928640|NCT04587453|467705444|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
129928641|NCT04587453|467705445|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
129928642|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
129928643|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928644|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928645|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928646|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928647|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928648|NCT04625725|467705446|FG000|Provent Main Study|Withdrawal by Subject|242|||
129928649|NCT04625725|467705447|FG001|Provent Main Study|Withdrawal by Subject|144|||
129928650|NCT04625725|467705448|FG002|Provent Main Study|Withdrawal by Subject|0|||
129928651|NCT04625725|467705449|FG003|Provent Main Study|Withdrawal by Subject|0|||
129928652|NCT04625725|467705450|FG004|Provent Main Study|Withdrawal by Subject|0|||
129928653|NCT04625725|467705451|FG005|Provent Main Study|Withdrawal by Subject|0|||
129928654|NCT04625725|467705446|FG000|Provent Main Study|Physician Decision|5|||
129928655|NCT04625725|467705447|FG001|Provent Main Study|Physician Decision|0|||
129928656|NCT04625725|467705448|FG002|Provent Main Study|Physician Decision|0|||
129928657|NCT04625725|467705449|FG003|Provent Main Study|Physician Decision|0|||
129928658|NCT04625725|467705450|FG004|Provent Main Study|Physician Decision|0|||
129928659|NCT04625725|467705451|FG005|Provent Main Study|Physician Decision|0|||
129928660|NCT04625725|467705446|FG000|Provent Main Study|Protocol Violation|1|||
129928661|NCT04625725|467705447|FG001|Provent Main Study|Protocol Violation|0|||
129928662|NCT04625725|467705448|FG002|Provent Main Study|Protocol Violation|0|||
129928663|NCT04625725|467705449|FG003|Provent Main Study|Protocol Violation|0|||
129928664|NCT04625725|467705450|FG004|Provent Main Study|Protocol Violation|0|||
129928665|NCT04625725|467705451|FG005|Provent Main Study|Protocol Violation|0|||
129928666|NCT04625725|467705446|FG000|Provent Main Study|Lost to Follow-up|357|||
129928667|NCT04625725|467705447|FG001|Provent Main Study|Lost to Follow-up|200|||
129928668|NCT04625725|467705448|FG002|Provent Main Study|Lost to Follow-up|0|||
129928669|NCT04625725|467705449|FG003|Provent Main Study|Lost to Follow-up|0|||
129928670|NCT04625725|467705450|FG004|Provent Main Study|Lost to Follow-up|0|||
129928671|NCT04625725|467705451|FG005|Provent Main Study|Lost to Follow-up|0|||
129928672|NCT04625725|467705446|FG000|Provent Main Study|Death|22|||
129928673|NCT04625725|467705447|FG001|Provent Main Study|Death|10|||
129928674|NCT04625725|467705448|FG002|Provent Main Study|Death|0|||
129928675|NCT04625725|467705449|FG003|Provent Main Study|Death|0|||
129928676|NCT04625725|467705450|FG004|Provent Main Study|Death|0|||
129928677|NCT04625725|467705451|FG005|Provent Main Study|Death|0|||
129928678|NCT04625725|467705446|FG000|Provent Main Study|Adverse Event|2|||
129928679|NCT04625725|467705447|FG001|Provent Main Study|Adverse Event|1|||
129928680|NCT04625725|467705448|FG002|Provent Main Study|Adverse Event|0|||
129928681|NCT04625725|467705449|FG003|Provent Main Study|Adverse Event|0|||
129928682|NCT04625725|467705450|FG004|Provent Main Study|Adverse Event|0|||
129928683|NCT04625725|467705451|FG005|Provent Main Study|Adverse Event|0|||
130069161|NCT02533401|468207856|FG000|Overall Study|Lost to Follow-up|1|||
130069162|NCT02533401|468207856|FG000|Overall Study|Violation of Selection Criteria|1|||
130069163|NCT00150345|468207860|FG000|Overall Study|Death|5|||
129928684|NCT04625725|467705446|FG000|Provent Main Study|Participants dosed in sub-study|310|||
129928685|NCT04625725|467705447|FG001|Provent Main Study|Participants dosed in sub-study|193|||
129928686|NCT04625725|467705448|FG002|Provent Main Study|Participants dosed in sub-study|0|||
129928687|NCT04625725|467705449|FG003|Provent Main Study|Participants dosed in sub-study|0|||
129928688|NCT04625725|467705450|FG004|Provent Main Study|Participants dosed in sub-study|0|||
129928689|NCT04625725|467705451|FG005|Provent Main Study|Participants dosed in sub-study|0|||
129928690|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
129928691|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
129928692|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928693|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928694|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928695|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928696|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
129928697|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
129928698|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928699|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928700|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928701|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928702|NCT04625725|467705446|FG000|Provent Main Study|INCARCERATION|3|||
129928703|NCT04625725|467705447|FG001|Provent Main Study|INCARCERATION|0|||
129928704|NCT04625725|467705448|FG002|Provent Main Study|INCARCERATION|0|||
129928705|NCT04625725|467705449|FG003|Provent Main Study|INCARCERATION|0|||
129928706|NCT04625725|467705450|FG004|Provent Main Study|INCARCERATION|0|||
129928707|NCT04625725|467705451|FG005|Provent Main Study|INCARCERATION|0|||
129928708|NCT04625725|467705446|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
129928709|NCT04625725|467705447|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
129928710|NCT04625725|467705448|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928711|NCT04625725|467705449|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928712|NCT04625725|467705450|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928713|NCT04625725|467705451|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928714|NCT04625725|467705446|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
129928715|NCT04625725|467705447|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
129928716|NCT04625725|467705448|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928717|NCT04625725|467705449|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928718|NCT04625725|467705450|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928719|NCT04625725|467705451|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928720|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
129928721|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
129928722|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928723|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928724|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928725|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928726|NCT04625725|467705446|FG000|Provent Main Study|MISSING REASON|0|||
129928727|NCT04625725|467705447|FG001|Provent Main Study|MISSING REASON|1|||
129928728|NCT04625725|467705448|FG002|Provent Main Study|MISSING REASON|0|||
129928729|NCT04625725|467705449|FG003|Provent Main Study|MISSING REASON|0|||
129928730|NCT04625725|467705450|FG004|Provent Main Study|MISSING REASON|0|||
129928731|NCT04625725|467705451|FG005|Provent Main Study|MISSING REASON|0|||
129928732|NCT04625725|467705446|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928733|NCT04625725|467705447|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928734|NCT04625725|467705448|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928735|NCT04625725|467705449|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
129928736|NCT04625725|467705450|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928737|NCT04625725|467705451|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928738|NCT04625725|467705446|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928739|NCT04625725|467705447|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928740|NCT04625725|467705448|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
129928741|NCT04625725|467705449|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928742|NCT04625725|467705450|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928743|NCT04625725|467705451|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928744|NCT04625725|467705446|FG000|Provent Sub Study|Lost to Follow-up|0|||
129928745|NCT04625725|467705447|FG001|Provent Sub Study|Lost to Follow-up|0|||
129928746|NCT04625725|467705448|FG002|Provent Sub Study|Lost to Follow-up|20|||
129928747|NCT04625725|467705449|FG003|Provent Sub Study|Lost to Follow-up|10|||
129928748|NCT04625725|467705450|FG004|Provent Sub Study|Lost to Follow-up|6|||
129928749|NCT04625725|467705451|FG005|Provent Sub Study|Lost to Follow-up|4|||
129928750|NCT04625725|467705446|FG000|Provent Sub Study|Death|0|||
129928751|NCT04625725|467705447|FG001|Provent Sub Study|Death|0|||
129928752|NCT04625725|467705448|FG002|Provent Sub Study|Death|8|||
129928753|NCT04625725|467705449|FG003|Provent Sub Study|Death|5|||
129928754|NCT04625725|467705450|FG004|Provent Sub Study|Death|0|||
129928755|NCT04625725|467705451|FG005|Provent Sub Study|Death|1|||
129928756|NCT04625725|467705446|FG000|Provent Sub Study|Adverse Event|0|||
129928757|NCT04625725|467705447|FG001|Provent Sub Study|Adverse Event|0|||
129928758|NCT04625725|467705448|FG002|Provent Sub Study|Adverse Event|0|||
129928759|NCT04625725|467705449|FG003|Provent Sub Study|Adverse Event|0|||
129928760|NCT04625725|467705450|FG004|Provent Sub Study|Adverse Event|0|||
129928761|NCT04625725|467705451|FG005|Provent Sub Study|Adverse Event|1|||
129928762|NCT04625725|467705446|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928763|NCT04625725|467705447|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928764|NCT04625725|467705448|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928765|NCT04625725|467705449|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928766|NCT04625725|467705450|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
129928767|NCT04625725|467705451|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928768|NCT04625725|467705446|FG000|Provent Sub Study|Withdrawal by Subject|0|||
129928769|NCT04625725|467705447|FG001|Provent Sub Study|Withdrawal by Subject|0|||
129928770|NCT04625725|467705448|FG002|Provent Sub Study|Withdrawal by Subject|11|||
129928771|NCT04625725|467705449|FG003|Provent Sub Study|Withdrawal by Subject|13|||
129928772|NCT04625725|467705450|FG004|Provent Sub Study|Withdrawal by Subject|5|||
129928773|NCT04625725|467705451|FG005|Provent Sub Study|Withdrawal by Subject|6|||
129928774|NCT04625725|467705446|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928775|NCT04625725|467705447|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928776|NCT04625725|467705448|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928777|NCT04625725|467705449|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928778|NCT04625725|467705450|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928779|NCT04625725|467705451|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
129928780|NCT04032847|467705455|FG000|Overall Study|Study termination by sponsor|8|||
129928781|NCT04032847|467705456|FG001|Overall Study|Study termination by sponsor|0|||
129928782|NCT04032847|467705457|FG002|Overall Study|Study termination by sponsor|4|||
129928783|NCT04032847|467705455|FG000|Overall Study|Death|12|||
129928784|NCT04032847|467705456|FG001|Overall Study|Death|0|||
129928785|NCT04032847|467705457|FG002|Overall Study|Death|0|||
129928786|NCT04032847|467705455|FG000|Overall Study|Progressive disease|2|||
129928787|NCT04032847|467705456|FG001|Overall Study|Progressive disease|0|||
129928788|NCT04032847|467705457|FG002|Overall Study|Progressive disease|1|||
129928789|NCT03213665|467705458|FG000|Overall Study|Adverse Event|1|||
129928790|NCT03213665|467705458|FG000|Overall Study|Physician Decision|2|||
130117589|NCT02385526|468390565|FG002|Overall Study|Physician Decision|0|||
129928791|NCT03213665|467705458|FG000|Overall Study|Withdrawal by Subject|3|||
129928792|NCT03213665|467705458|FG000|Overall Study|Progressive Disease|13|||
129928793|NCT05873556|467705459|FG000|Overall Study|Lost to Follow-up|4|||
129928794|NCT05873556|467705460|FG001|Overall Study|Lost to Follow-up|1|||
129928795|NCT04689256|467705461|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
129928796|NCT04689256|467705462|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
129928797|NCT05104463|467705463|FG000|Overall Study|Adverse Event|1|||
129928798|NCT05104463|467705464|FG001|Overall Study|Adverse Event|1|||
129928799|NCT05104463|467705463|FG000|Overall Study|Lost to Follow-up|1|||
129928800|NCT05104463|467705464|FG001|Overall Study|Lost to Follow-up|1|||
129928801|NCT05104463|467705463|FG000|Overall Study|Physician Decision|1|||
129928802|NCT05104463|467705464|FG001|Overall Study|Physician Decision|0|||
129928803|NCT05104463|467705463|FG000|Overall Study|Protocol Violation|0|||
129928804|NCT05104463|467705464|FG001|Overall Study|Protocol Violation|2|||
129928805|NCT05104463|467705463|FG000|Overall Study|Withdrawal by Subject|1|||
129928806|NCT05104463|467705464|FG001|Overall Study|Withdrawal by Subject|1|||
129928807|NCT05267470|467705468|FG000|Overall Study|Decision by sponsor|0|||
129928808|NCT05267470|467705469|FG001|Overall Study|Decision by sponsor|3|||
129928809|NCT05267470|467705470|FG002|Overall Study|Decision by sponsor|19|||
129928810|NCT05267470|467705471|FG003|Overall Study|Decision by sponsor|7|||
129928811|NCT05267470|467705472|FG004|Overall Study|Decision by sponsor|3|||
129928812|NCT05267470|467705468|FG000|Overall Study|Withdrawal by Subject|1|||
129928813|NCT05267470|467705469|FG001|Overall Study|Withdrawal by Subject|1|||
129928814|NCT05267470|467705470|FG002|Overall Study|Withdrawal by Subject|2|||
129928815|NCT05267470|467705471|FG003|Overall Study|Withdrawal by Subject|2|||
129928816|NCT05267470|467705472|FG004|Overall Study|Withdrawal by Subject|0|||
129928817|NCT05267470|467705468|FG000|Overall Study|Death|3|||
129928818|NCT05267470|467705469|FG001|Overall Study|Death|5|||
129928819|NCT05267470|467705470|FG002|Overall Study|Death|8|||
129928820|NCT05267470|467705471|FG003|Overall Study|Death|18|||
129928821|NCT05267470|467705472|FG004|Overall Study|Death|1|||
129928822|NCT05267470|467705468|FG000|Overall Study|Lost to Follow-up|0|||
129928823|NCT05267470|467705469|FG001|Overall Study|Lost to Follow-up|0|||
129928824|NCT05267470|467705470|FG002|Overall Study|Lost to Follow-up|0|||
129928825|NCT05267470|467705471|FG003|Overall Study|Lost to Follow-up|1|||
129928826|NCT05267470|467705472|FG004|Overall Study|Lost to Follow-up|0|||
130117590|NCT02385526|468390563|FG000|Overall Study|Protocol Violation|1|||
129928827|NCT03381586|467705473|FG000|Overall Study|Adverse Event|1|||
129928828|NCT03381586|467705474|FG001|Overall Study|Adverse Event|1|||
129928829|NCT03381586|467705473|FG000|Overall Study|Protocol Violation|1|||
129928830|NCT03381586|467705474|FG001|Overall Study|Protocol Violation|0|||
130117591|NCT02385526|468390564|FG001|Overall Study|Protocol Violation|0|||
129928831|NCT03381586|467705473|FG000|Overall Study|Withdrawal by Subject|1|||
129928832|NCT03381586|467705474|FG001|Overall Study|Withdrawal by Subject|2|||
129928833|NCT04230681|467705475|FG000|Overall Study|Physician Decision|2|||
129928834|NCT04230681|467705476|FG001|Overall Study|Physician Decision|3|||
129928835|NCT04230681|467705475|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
129928836|NCT04230681|467705476|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
129928837|NCT04230681|467705475|FG000|Overall Study|IV inadvertently removed|0|||
129928838|NCT04230681|467705476|FG001|Overall Study|IV inadvertently removed|1|||
129979691|NCT03752970|467889435|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
129979692|NCT03752970|467889436|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
129979693|NCT03752970|467889437|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
129979694|NCT03752970|467889435|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
129979695|NCT03752970|467889436|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
129979696|NCT03752970|467889437|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
129979697|NCT01696045|467889440|FG000|Overall Study|Study drug toxicity|1|||
129979698|NCT01696045|467889441|FG001|Overall Study|Study drug toxicity|5|||
129979699|NCT01696045|467889440|FG000|Overall Study|Disease progression|2|||
129979700|NCT01696045|467889441|FG001|Overall Study|Disease progression|2|||
129979701|NCT00573859|467889442|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
129979702|NCT00573859|467889442|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
129979703|NCT03541200|467889451|FG000|Overall Study|Adverse Event|19|||
129979704|NCT03541200|467889451|FG000|Overall Study|Death|1|||
129979705|NCT03541200|467889451|FG000|Overall Study|Lost to Follow-up|10|||
129979706|NCT03541200|467889451|FG000|Overall Study|Physician Decision|1|||
129979707|NCT03541200|467889451|FG000|Overall Study|Protocol Violation|51|||
129979708|NCT03541200|467889451|FG000|Overall Study|Withdrawal by Subject|23|||
129979709|NCT03541200|467889451|FG000|Overall Study|other|8|||
129979710|NCT01283516|467889456|FG000|Overall Study|Adverse Event|0|||
129979711|NCT01283516|467889457|FG001|Overall Study|Adverse Event|0|||
129979712|NCT01283516|467889458|FG002|Overall Study|Adverse Event|0|||
129979713|NCT01283516|467889459|FG003|Overall Study|Adverse Event|0|||
129979714|NCT01283516|467889460|FG004|Overall Study|Adverse Event|0|||
129979715|NCT01283516|467889461|FG005|Overall Study|Adverse Event|0|||
129979716|NCT01283516|467889462|FG006|Overall Study|Adverse Event|2|||
129979717|NCT01283516|467889463|FG007|Overall Study|Adverse Event|0|||
129979718|NCT01283516|467889464|FG008|Overall Study|Adverse Event|28|||
129979719|NCT01283516|467889456|FG000|Overall Study|Death|0|||
129979720|NCT01283516|467889457|FG001|Overall Study|Death|0|||
129979721|NCT01283516|467889458|FG002|Overall Study|Death|0|||
129979722|NCT01283516|467889459|FG003|Overall Study|Death|0|||
129979723|NCT01283516|467889460|FG004|Overall Study|Death|0|||
129979724|NCT01283516|467889461|FG005|Overall Study|Death|1|||
129979725|NCT01283516|467889462|FG006|Overall Study|Death|0|||
129979726|NCT01283516|467889463|FG007|Overall Study|Death|1|||
129979727|NCT01283516|467889464|FG008|Overall Study|Death|12|||
129979728|NCT01283516|467889456|FG000|Overall Study|Disease Progression|2|||
129979729|NCT01283516|467889457|FG001|Overall Study|Disease Progression|2|||
129979730|NCT01283516|467889458|FG002|Overall Study|Disease Progression|3|||
129979731|NCT01283516|467889459|FG003|Overall Study|Disease Progression|3|||
129979732|NCT01283516|467889460|FG004|Overall Study|Disease Progression|13|||
129979733|NCT01283516|467889461|FG005|Overall Study|Disease Progression|8|||
129979734|NCT01283516|467889462|FG006|Overall Study|Disease Progression|6|||
129979735|NCT01283516|467889463|FG007|Overall Study|Disease Progression|3|||
129979736|NCT01283516|467889464|FG008|Overall Study|Disease Progression|139|||
129979737|NCT01283516|467889456|FG000|Overall Study|Withdrawal by Subject|0|||
129979738|NCT01283516|467889457|FG001|Overall Study|Withdrawal by Subject|0|||
129979739|NCT01283516|467889458|FG002|Overall Study|Withdrawal by Subject|0|||
129979740|NCT01283516|467889459|FG003|Overall Study|Withdrawal by Subject|0|||
129979741|NCT01283516|467889460|FG004|Overall Study|Withdrawal by Subject|1|||
129979742|NCT01283516|467889461|FG005|Overall Study|Withdrawal by Subject|0|||
129979743|NCT01283516|467889462|FG006|Overall Study|Withdrawal by Subject|1|||
129979744|NCT01283516|467889463|FG007|Overall Study|Withdrawal by Subject|0|||
129979745|NCT01283516|467889464|FG008|Overall Study|Withdrawal by Subject|36|||
129979746|NCT01283516|467889456|FG000|Overall Study|Administrative problems|0|||
129979747|NCT01283516|467889457|FG001|Overall Study|Administrative problems|0|||
129979748|NCT01283516|467889458|FG002|Overall Study|Administrative problems|0|||
129979749|NCT01283516|467889459|FG003|Overall Study|Administrative problems|0|||
129979750|NCT01283516|467889460|FG004|Overall Study|Administrative problems|0|||
129979751|NCT01283516|467889461|FG005|Overall Study|Administrative problems|1|||
129979752|NCT01283516|467889462|FG006|Overall Study|Administrative problems|1|||
129979753|NCT01283516|467889463|FG007|Overall Study|Administrative problems|1|||
129979754|NCT01283516|467889464|FG008|Overall Study|Administrative problems|39|||
129979755|NCT01283516|467889456|FG000|Overall Study|Lost to Follow-up|0|||
129979756|NCT01283516|467889457|FG001|Overall Study|Lost to Follow-up|0|||
129979757|NCT01283516|467889458|FG002|Overall Study|Lost to Follow-up|0|||
129979758|NCT01283516|467889459|FG003|Overall Study|Lost to Follow-up|0|||
129979759|NCT01283516|467889460|FG004|Overall Study|Lost to Follow-up|0|||
129928839|NCT05645757|467707809|FG000|Overall Study|Enrolled but treatment not administered|0|||
129928840|NCT05645757|467707810|FG001|Overall Study|Enrolled but treatment not administered|0|||
129928841|NCT05645757|467707811|FG002|Overall Study|Enrolled but treatment not administered|0|||
129928842|NCT05645757|467707812|FG003|Overall Study|Enrolled but treatment not administered|0|||
129928843|NCT05645757|467707813|FG004|Overall Study|Enrolled but treatment not administered|1|||
129928844|NCT05645757|467707814|FG005|Overall Study|Enrolled but treatment not administered|1|||
129928845|NCT05645757|467707815|FG006|Overall Study|Enrolled but treatment not administered|0|||
129928846|NCT05645757|467707816|FG007|Overall Study|Enrolled but treatment not administered|0|||
129928847|NCT00539591|467707817|FG000|Overall Study|Toxicity|3|||
129928848|NCT00539591|467707818|FG001|Overall Study|Toxicity|0|||
129928849|NCT00539591|467707819|FG002|Overall Study|Toxicity|0|||
129928850|NCT00539591|467707817|FG000|Overall Study|Disease progression|2|||
129928851|NCT00539591|467707818|FG001|Overall Study|Disease progression|2|||
129928852|NCT00539591|467707819|FG002|Overall Study|Disease progression|3|||
129928853|NCT02038777|467707822|FG000|Overall Study|Death|0|||
129928854|NCT02038777|467707823|FG001|Overall Study|Death|2|||
129928855|NCT02038777|467707824|FG002|Overall Study|Death|0|||
129928856|NCT02038777|467707825|FG003|Overall Study|Death|1|||
129928857|NCT02038777|467707826|FG004|Overall Study|Death|2|||
129928858|NCT02038777|467707827|FG005|Overall Study|Death|4|||
129928859|NCT02038777|467707828|FG006|Overall Study|Death|0|||
129928860|NCT02038777|467707829|FG007|Overall Study|Death|11|||
129928861|NCT02038777|467707822|FG000|Overall Study|Lost to Follow-up|0|||
129928862|NCT02038777|467707823|FG001|Overall Study|Lost to Follow-up|0|||
129928863|NCT02038777|467707824|FG002|Overall Study|Lost to Follow-up|0|||
129928864|NCT02038777|467707825|FG003|Overall Study|Lost to Follow-up|1|||
129928865|NCT02038777|467707826|FG004|Overall Study|Lost to Follow-up|0|||
129928866|NCT02038777|467707827|FG005|Overall Study|Lost to Follow-up|0|||
129928867|NCT02038777|467707828|FG006|Overall Study|Lost to Follow-up|0|||
129928868|NCT02038777|467707829|FG007|Overall Study|Lost to Follow-up|0|||
129928869|NCT02038777|467707822|FG000|Overall Study|Other|0|||
129928870|NCT02038777|467707823|FG001|Overall Study|Other|1|||
129928871|NCT02038777|467707824|FG002|Overall Study|Other|0|||
129928872|NCT02038777|467707825|FG003|Overall Study|Other|2|||
129928873|NCT02038777|467707826|FG004|Overall Study|Other|1|||
129928874|NCT02038777|467707827|FG005|Overall Study|Other|0|||
129928875|NCT02038777|467707828|FG006|Overall Study|Other|0|||
129928876|NCT02038777|467707829|FG007|Overall Study|Other|0|||
129928877|NCT02038777|467707822|FG000|Overall Study|Randomized but not treated|0|||
129928878|NCT02038777|467707823|FG001|Overall Study|Randomized but not treated|1|||
129928879|NCT02038777|467707824|FG002|Overall Study|Randomized but not treated|0|||
129928880|NCT02038777|467707825|FG003|Overall Study|Randomized but not treated|0|||
129928881|NCT02038777|467707826|FG004|Overall Study|Randomized but not treated|0|||
129928882|NCT02038777|467707827|FG005|Overall Study|Randomized but not treated|0|||
129928883|NCT02038777|467707828|FG006|Overall Study|Randomized but not treated|0|||
129928884|NCT02038777|467707829|FG007|Overall Study|Randomized but not treated|0|||
129928885|NCT02038777|467707822|FG000|Overall Study|Started Chemotherapy|1|||
129928886|NCT02038777|467707823|FG001|Overall Study|Started Chemotherapy|0|||
129928887|NCT02038777|467707824|FG002|Overall Study|Started Chemotherapy|3|||
129928888|NCT02038777|467707825|FG003|Overall Study|Started Chemotherapy|0|||
129928889|NCT02038777|467707826|FG004|Overall Study|Started Chemotherapy|0|||
129928890|NCT02038777|467707827|FG005|Overall Study|Started Chemotherapy|0|||
129928891|NCT02038777|467707828|FG006|Overall Study|Started Chemotherapy|0|||
129928892|NCT02038777|467707829|FG007|Overall Study|Started Chemotherapy|0|||
129928893|NCT02038777|467707822|FG000|Overall Study|participation terminated by sponsor|0|||
129928894|NCT02038777|467707823|FG001|Overall Study|participation terminated by sponsor|0|||
129928895|NCT02038777|467707824|FG002|Overall Study|participation terminated by sponsor|0|||
129928896|NCT02038777|467707825|FG003|Overall Study|participation terminated by sponsor|0|||
129928897|NCT02038777|467707826|FG004|Overall Study|participation terminated by sponsor|0|||
129928898|NCT02038777|467707827|FG005|Overall Study|participation terminated by sponsor|0|||
129928899|NCT02038777|467707828|FG006|Overall Study|participation terminated by sponsor|1|||
130117592|NCT02385526|468390565|FG002|Overall Study|Protocol Violation|0|||
130117593|NCT03532009|468390566|FG000|Overall Study|Other|1|||
130117594|NCT03532009|468390567|FG001|Overall Study|Other|1|||
129928900|NCT02038777|467707829|FG007|Overall Study|participation terminated by sponsor|1|||
129928901|NCT04299464|467707830|FG000|Overall Study|Adverse Event|1|||
129928902|NCT04299464|467707831|FG001|Overall Study|Adverse Event|0|||
129928903|NCT04299464|467707832|FG002|Overall Study|Adverse Event|2|||
129928904|NCT04299464|467707830|FG000|Overall Study|Non-compliance with Study Drug|1|||
129928905|NCT04299464|467707831|FG001|Overall Study|Non-compliance with Study Drug|0|||
129928906|NCT04299464|467707832|FG002|Overall Study|Non-compliance with Study Drug|0|||
129928907|NCT04299464|467707830|FG000|Overall Study|Reason not Specified|0|||
129928908|NCT04299464|467707831|FG001|Overall Study|Reason not Specified|1|||
129928909|NCT04299464|467707832|FG002|Overall Study|Reason not Specified|3|||
129928910|NCT04299464|467707830|FG000|Overall Study|Physician Decision|0|||
129928911|NCT04299464|467707831|FG001|Overall Study|Physician Decision|1|||
129928912|NCT04299464|467707832|FG002|Overall Study|Physician Decision|1|||
130117595|NCT03532009|468390566|FG000|Overall Study|Death|1|||
129928913|NCT04299464|467707830|FG000|Overall Study|Withdrawal by Subject|0|||
129928914|NCT04299464|467707831|FG001|Overall Study|Withdrawal by Subject|2|||
129928915|NCT04299464|467707832|FG002|Overall Study|Withdrawal by Subject|1|||
129928916|NCT04079218|467707833|FG000|Overall Study|Death|1|||
129928917|NCT04079218|467707834|FG001|Overall Study|Death|0|||
129928918|NCT04079218|467707833|FG000|Overall Study|Withdrawal by Subject|3|||
129928919|NCT04079218|467707834|FG001|Overall Study|Withdrawal by Subject|0|||
129928920|NCT04079218|467707833|FG000|Overall Study|Physician Decision|4|||
129928921|NCT04079218|467707834|FG001|Overall Study|Physician Decision|0|||
129928922|NCT04079218|467707833|FG000|Overall Study|Lost to Follow-up|0|||
129928923|NCT04079218|467707834|FG001|Overall Study|Lost to Follow-up|1|||
129928924|NCT02424617|467707837|FG000|Overall Study|Adverse Event|0|||
129928925|NCT02424617|467707838|FG001|Overall Study|Adverse Event|1|||
129928926|NCT02424617|467707839|FG002|Overall Study|Adverse Event|0|||
129928927|NCT02424617|467707840|FG003|Overall Study|Adverse Event|0|||
129928928|NCT02424617|467707837|FG000|Overall Study|Investigator Decision|0|||
129928929|NCT02424617|467707838|FG001|Overall Study|Investigator Decision|0|||
129928930|NCT02424617|467707839|FG002|Overall Study|Investigator Decision|0|||
129928931|NCT02424617|467707840|FG003|Overall Study|Investigator Decision|1|||
129928932|NCT02424617|467707837|FG000|Overall Study|Withdrawal by Subject|1|||
129928933|NCT02424617|467707838|FG001|Overall Study|Withdrawal by Subject|1|||
129928934|NCT02424617|467707839|FG002|Overall Study|Withdrawal by Subject|0|||
129928935|NCT02424617|467707840|FG003|Overall Study|Withdrawal by Subject|1|||
129928936|NCT02424617|467707837|FG000|Overall Study|Progressive Disease|7|||
129928937|NCT02424617|467707838|FG001|Overall Study|Progressive Disease|6|||
129928938|NCT02424617|467707839|FG002|Overall Study|Progressive Disease|11|||
129928939|NCT02424617|467707840|FG003|Overall Study|Progressive Disease|10|||
129928940|NCT02424617|467707837|FG000|Overall Study|Other|0|||
129928941|NCT02424617|467707838|FG001|Overall Study|Other|0|||
129928942|NCT02424617|467707839|FG002|Overall Study|Other|0|||
129928943|NCT02424617|467707840|FG003|Overall Study|Other|1|||
129928944|NCT02694822|467707841|FG000|Phase 1|Death|2|||
129928945|NCT02694822|467707842|FG001|Phase 1|Death|1|||
129928946|NCT02694822|467707843|FG002|Phase 1|Death|6|||
129928947|NCT02694822|467707844|FG003|Phase 1|Death|6|||
129928948|NCT02694822|467707845|FG004|Phase 1|Death|3|||
129928949|NCT02694822|467707846|FG005|Phase 1|Death|0|||
129928950|NCT02694822|467707841|FG000|Phase 1|Withdrawal by Subject|2|||
129928951|NCT02694822|467707842|FG001|Phase 1|Withdrawal by Subject|2|||
129928952|NCT02694822|467707843|FG002|Phase 1|Withdrawal by Subject|4|||
129928953|NCT02694822|467707844|FG003|Phase 1|Withdrawal by Subject|8|||
129928954|NCT02694822|467707845|FG004|Phase 1|Withdrawal by Subject|1|||
129928955|NCT02694822|467707846|FG005|Phase 1|Withdrawal by Subject|0|||
129928956|NCT02694822|467707841|FG000|Phase 2|Death|0|||
129928957|NCT02694822|467707842|FG001|Phase 2|Death|0|||
129928958|NCT02694822|467707843|FG002|Phase 2|Death|0|||
129928959|NCT02694822|467707844|FG003|Phase 2|Death|0|||
129928960|NCT02694822|467707845|FG004|Phase 2|Death|0|||
129928961|NCT02694822|467707846|FG005|Phase 2|Death|26|||
129928962|NCT02694822|467707841|FG000|Phase 2|Withdrawal by Subject|0|||
129928963|NCT02694822|467707842|FG001|Phase 2|Withdrawal by Subject|0|||
129928964|NCT02694822|467707843|FG002|Phase 2|Withdrawal by Subject|0|||
129928965|NCT02694822|467707844|FG003|Phase 2|Withdrawal by Subject|0|||
129928966|NCT02694822|467707845|FG004|Phase 2|Withdrawal by Subject|0|||
129928967|NCT02694822|467707846|FG005|Phase 2|Withdrawal by Subject|13|||
129928968|NCT02694822|467707841|FG000|Phase 2|Administrative Study Closure|0|||
129928969|NCT02694822|467707842|FG001|Phase 2|Administrative Study Closure|0|||
129928970|NCT02694822|467707843|FG002|Phase 2|Administrative Study Closure|0|||
129928971|NCT02694822|467707844|FG003|Phase 2|Administrative Study Closure|0|||
129928972|NCT02694822|467707845|FG004|Phase 2|Administrative Study Closure|0|||
129928973|NCT02694822|467707846|FG005|Phase 2|Administrative Study Closure|2|||
129928974|NCT02694822|467707841|FG000|Phase 2|Lost to Follow-up|0|||
129928975|NCT02694822|467707842|FG001|Phase 2|Lost to Follow-up|0|||
129928976|NCT02694822|467707843|FG002|Phase 2|Lost to Follow-up|0|||
129928977|NCT02694822|467707844|FG003|Phase 2|Lost to Follow-up|0|||
129928978|NCT02694822|467707845|FG004|Phase 2|Lost to Follow-up|0|||
129928979|NCT02694822|467707846|FG005|Phase 2|Lost to Follow-up|1|||
129928980|NCT02694822|467707841|FG000|Phase 2|Participant Transferred to Another Site|0|||
129928981|NCT02694822|467707842|FG001|Phase 2|Participant Transferred to Another Site|0|||
129928982|NCT02694822|467707843|FG002|Phase 2|Participant Transferred to Another Site|0|||
129928983|NCT02694822|467707844|FG003|Phase 2|Participant Transferred to Another Site|0|||
129928984|NCT02694822|467707845|FG004|Phase 2|Participant Transferred to Another Site|0|||
129928985|NCT02694822|467707846|FG005|Phase 2|Participant Transferred to Another Site|1|||
129928986|NCT01868997|467707849|FG000|Overall Study|Adverse Event|2|||
129928987|NCT01868997|467707850|FG001|Overall Study|Adverse Event|5|||
129928988|NCT01868997|467707849|FG000|Overall Study|Lack of Efficacy|2|||
129928989|NCT01868997|467707850|FG001|Overall Study|Lack of Efficacy|0|||
129928990|NCT01868997|467707849|FG000|Overall Study|Other|3|||
129928991|NCT01868997|467707850|FG001|Overall Study|Other|1|||
129928992|NCT01960452|467707851|FG000|Overall Study|Withdrawal by Subject|2|||
129928993|NCT01960452|467707852|FG001|Overall Study|Withdrawal by Subject|1|||
129928994|NCT01960452|467707851|FG000|Overall Study|Sleep apnea in Night 1|1|||
129928995|NCT01960452|467707852|FG001|Overall Study|Sleep apnea in Night 1|0|||
129928996|NCT01960452|467707851|FG000|Overall Study|Poor Sleep in Night 1|0|||
129928997|NCT01960452|467707852|FG001|Overall Study|Poor Sleep in Night 1|2|||
129928998|NCT01960452|467707851|FG000|Overall Study|No Sex/Age Match Night 1|1|||
129928999|NCT01960452|467707852|FG001|Overall Study|No Sex/Age Match Night 1|0|||
129929000|NCT01960452|467707851|FG000|Overall Study|No Sex/Age Match Night 2|0|||
129929001|NCT01960452|467707852|FG001|Overall Study|No Sex/Age Match Night 2|2|||
129929002|NCT01960452|467707851|FG000|Overall Study|Technical Difficulties Night 2|2|||
129929003|NCT01960452|467707852|FG001|Overall Study|Technical Difficulties Night 2|0|||
129929004|NCT02052882|467707863|FG000|Overall Study|Not treated|11|||
129929005|NCT02052882|467707863|FG000|Overall Study|Protocol Violation|1|||
129929006|NCT02052882|467707863|FG000|Overall Study|Inadequate testing|1|||
129929007|NCT04778397|467707864|FG000|Overall Study|Death|59|||
129929008|NCT04778397|467707865|FG001|Overall Study|Death|54|||
129929009|NCT04778397|467707866|FG002|Overall Study|Death|11|||
129929010|NCT04778397|467707867|FG003|Overall Study|Death|9|||
129929011|NCT04778397|467707864|FG000|Overall Study|Study Terminated by Sponsor|34|||
129929012|NCT04778397|467707865|FG001|Overall Study|Study Terminated by Sponsor|42|||
129929013|NCT04778397|467707866|FG002|Overall Study|Study Terminated by Sponsor|15|||
129929014|NCT04778397|467707867|FG003|Overall Study|Study Terminated by Sponsor|12|||
129929015|NCT04778397|467707864|FG000|Overall Study|Withdrew Consent|5|||
129929016|NCT04778397|467707865|FG001|Overall Study|Withdrew Consent|4|||
129929017|NCT04778397|467707866|FG002|Overall Study|Withdrew Consent|1|||
129929018|NCT04778397|467707867|FG003|Overall Study|Withdrew Consent|1|||
129929019|NCT04778397|467707864|FG000|Overall Study|Reason Not Specified|1|||
129929020|NCT04778397|467707865|FG001|Overall Study|Reason Not Specified|3|||
129929021|NCT04778397|467707866|FG002|Overall Study|Reason Not Specified|0|||
129929022|NCT04778397|467707867|FG003|Overall Study|Reason Not Specified|2|||
129929023|NCT04778397|467707864|FG000|Overall Study|Lost to Follow-up|2|||
129929024|NCT04778397|467707865|FG001|Overall Study|Lost to Follow-up|1|||
129929025|NCT04778397|467707866|FG002|Overall Study|Lost to Follow-up|0|||
129929026|NCT04778397|467707867|FG003|Overall Study|Lost to Follow-up|1|||
129929027|NCT03249090|467707868|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
129929028|NCT03249090|467707869|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
129929029|NCT03249090|467707868|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
129929030|NCT03249090|467707869|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
129929031|NCT03249090|467707868|FG000|3 Month Time Point|Voluntary withdrawal|6|||
129929032|NCT03249090|467707869|FG001|3 Month Time Point|Voluntary withdrawal|3|||
129929033|NCT03249090|467707868|FG000|3 Month Time Point|Changed oncology practice|4|||
129929034|NCT03249090|467707869|FG001|3 Month Time Point|Changed oncology practice|2|||
129929035|NCT03249090|467707868|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
129929036|NCT03249090|467707869|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
129929037|NCT03249090|467707868|FG000|12 Month Time Point|Voluntary withdrawal|35|||
129929038|NCT03249090|467707869|FG001|12 Month Time Point|Voluntary withdrawal|4|||
129929039|NCT03249090|467707868|FG000|12 Month Time Point|Changed oncology practice|20|||
129929040|NCT03249090|467707869|FG001|12 Month Time Point|Changed oncology practice|9|||
129929041|NCT04359654|467707873|FG000|Overall Study|Withdrawal by Subject|1|||
129929042|NCT04359654|467707874|FG001|Overall Study|Withdrawal by Subject|0|||
129929043|NCT04359654|467707873|FG000|Overall Study|Adverse Event|0|||
129929044|NCT04359654|467707874|FG001|Overall Study|Adverse Event|1|||
129929045|NCT04314778|467707875|FG000|Overall Study|Lost to Follow-up|5|||
129929046|NCT04314778|467707876|FG001|Overall Study|Lost to Follow-up|3|||
129929047|NCT04024020|467707879|FG000|Overall Study|Withdrawal by Subject|2|||
129929048|NCT04024020|467707880|FG001|Overall Study|Withdrawal by Subject|2|||
129929049|NCT05646355|467707881|FG000|Overall Study|Lost to Follow-up|1|||
129929050|NCT05646355|467707882|FG001|Overall Study|Lost to Follow-up|0|||
129929051|NCT05646355|467707881|FG000|Overall Study|translated materials not available for pilot|2|||
129929052|NCT05646355|467707882|FG001|Overall Study|translated materials not available for pilot|0|||
129929053|NCT05646355|467707881|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
129929054|NCT05646355|467707882|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
129929055|NCT03523572|467707883|FG000|Dose Escalation|Progressive disease|1|||
129929056|NCT03523572|467707884|FG001|Dose Escalation|Progressive disease|0|||
129929057|NCT03523572|467707885|FG002|Dose Escalation|Progressive disease|0|||
129929058|NCT03523572|467707886|FG003|Dose Escalation|Progressive disease|0|||
129929059|NCT03523572|467707887|FG004|Dose Escalation|Progressive disease|0|||
129929060|NCT03523572|467707888|FG005|Dose Escalation|Progressive disease|0|||
129929061|NCT03523572|467707883|FG000|Dose Escalation|Clinical Progression|0|||
129929062|NCT03523572|467707884|FG001|Dose Escalation|Clinical Progression|1|||
129929063|NCT03523572|467707885|FG002|Dose Escalation|Clinical Progression|0|||
129929064|NCT03523572|467707886|FG003|Dose Escalation|Clinical Progression|0|||
129929065|NCT03523572|467707887|FG004|Dose Escalation|Clinical Progression|0|||
129929066|NCT03523572|467707888|FG005|Dose Escalation|Clinical Progression|0|||
129929067|NCT03523572|467707883|FG000|Dose Escalation|Adverse Event|2|||
129929068|NCT03523572|467707884|FG001|Dose Escalation|Adverse Event|0|||
129929069|NCT03523572|467707885|FG002|Dose Escalation|Adverse Event|0|||
129929070|NCT03523572|467707886|FG003|Dose Escalation|Adverse Event|0|||
129929071|NCT03523572|467707887|FG004|Dose Escalation|Adverse Event|0|||
129929072|NCT03523572|467707888|FG005|Dose Escalation|Adverse Event|0|||
129929073|NCT03523572|467707883|FG000|Dose Escalation|Physician Decision|1|||
129929074|NCT03523572|467707884|FG001|Dose Escalation|Physician Decision|1|||
129929075|NCT03523572|467707885|FG002|Dose Escalation|Physician Decision|0|||
129929076|NCT03523572|467707886|FG003|Dose Escalation|Physician Decision|0|||
129929077|NCT03523572|467707887|FG004|Dose Escalation|Physician Decision|0|||
129929078|NCT03523572|467707888|FG005|Dose Escalation|Physician Decision|0|||
129929079|NCT03523572|467707883|FG000|Dose Expansion|Progressive Disease|0|||
129929080|NCT03523572|467707884|FG001|Dose Expansion|Progressive Disease|0|||
129929081|NCT03523572|467707885|FG002|Dose Expansion|Progressive Disease|9|||
129929082|NCT03523572|467707886|FG003|Dose Expansion|Progressive Disease|11|||
129929083|NCT03523572|467707887|FG004|Dose Expansion|Progressive Disease|15|||
129929084|NCT03523572|467707888|FG005|Dose Expansion|Progressive Disease|2|||
129929085|NCT03523572|467707883|FG000|Dose Expansion|Clinical Progression|0|||
129929086|NCT03523572|467707884|FG001|Dose Expansion|Clinical Progression|0|||
129929087|NCT03523572|467707885|FG002|Dose Expansion|Clinical Progression|2|||
129929088|NCT03523572|467707886|FG003|Dose Expansion|Clinical Progression|2|||
129929089|NCT03523572|467707887|FG004|Dose Expansion|Clinical Progression|2|||
129929090|NCT03523572|467707888|FG005|Dose Expansion|Clinical Progression|0|||
129929091|NCT03523572|467707883|FG000|Dose Expansion|Adverse Event|0|||
129929092|NCT03523572|467707884|FG001|Dose Expansion|Adverse Event|0|||
129929093|NCT03523572|467707885|FG002|Dose Expansion|Adverse Event|10|||
129929094|NCT03523572|467707886|FG003|Dose Expansion|Adverse Event|1|||
129929095|NCT03523572|467707887|FG004|Dose Expansion|Adverse Event|5|||
129929096|NCT03523572|467707888|FG005|Dose Expansion|Adverse Event|2|||
129929097|NCT03523572|467707883|FG000|Dose Expansion|Withdrawal by Subject|0|||
129929098|NCT03523572|467707884|FG001|Dose Expansion|Withdrawal by Subject|0|||
129929099|NCT03523572|467707885|FG002|Dose Expansion|Withdrawal by Subject|1|||
129929100|NCT03523572|467707886|FG003|Dose Expansion|Withdrawal by Subject|1|||
129929101|NCT03523572|467707887|FG004|Dose Expansion|Withdrawal by Subject|0|||
129929102|NCT03523572|467707888|FG005|Dose Expansion|Withdrawal by Subject|0|||
129929103|NCT03523572|467707883|FG000|Dose Expansion|Physician Decision|0|||
129929104|NCT03523572|467707884|FG001|Dose Expansion|Physician Decision|0|||
129929105|NCT03523572|467707885|FG002|Dose Expansion|Physician Decision|1|||
129929106|NCT03523572|467707886|FG003|Dose Expansion|Physician Decision|0|||
129929107|NCT03523572|467707887|FG004|Dose Expansion|Physician Decision|1|||
129929108|NCT03523572|467707888|FG005|Dose Expansion|Physician Decision|0|||
129929109|NCT03523572|467707883|FG000|Dose Expansion|Miscellaneous|0|||
129929110|NCT03523572|467707884|FG001|Dose Expansion|Miscellaneous|0|||
129929111|NCT03523572|467707885|FG002|Dose Expansion|Miscellaneous|0|||
129929112|NCT03523572|467707886|FG003|Dose Expansion|Miscellaneous|0|||
129929113|NCT03523572|467707887|FG004|Dose Expansion|Miscellaneous|3|||
129929114|NCT03523572|467707888|FG005|Dose Expansion|Miscellaneous|0|||
129929115|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929116|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929117|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929118|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
129929119|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
129929120|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929121|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
129929122|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929123|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
129929124|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
129929125|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
129929126|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
129929127|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
129929128|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
129929129|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
129929130|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
129929131|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929132|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929133|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929134|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929135|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929136|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
129929137|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
129929138|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929139|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929140|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929141|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929142|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929143|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929144|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929145|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929146|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
129929147|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
129929148|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
129929149|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
129929150|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
129929151|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
129929152|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
129929153|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
129929154|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
129929155|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
129929156|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
129929157|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
129929158|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
129929159|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
129929160|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
129929161|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
129929162|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
129929163|NCT02315703|467707891|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
129929164|NCT02315703|467707892|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
129929165|NCT02315703|467707893|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929166|NCT02315703|467707894|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929167|NCT02315703|467707895|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929168|NCT02315703|467707896|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929169|NCT02315703|467707897|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929170|NCT02315703|467707898|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929171|NCT02315703|467707891|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929172|NCT02315703|467707892|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
129929173|NCT02315703|467707893|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929174|NCT02315703|467707894|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929175|NCT02315703|467707895|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929176|NCT02315703|467707896|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929177|NCT02315703|467707897|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929178|NCT02315703|467707898|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929179|NCT02315703|467707891|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
129929180|NCT02315703|467707892|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
129929181|NCT02315703|467707893|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
129929182|NCT02315703|467707894|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
129929183|NCT02315703|467707895|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
129929184|NCT02315703|467707896|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
129929185|NCT02315703|467707897|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
129929186|NCT02315703|467707898|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
129929187|NCT03476343|467707900|FG000|Overall Study|Clinical exam moved to another scanner|7|||
129929188|NCT03476343|467707900|FG000|Overall Study|Clinical order cancelled|4|||
129929189|NCT03476343|467707900|FG000|Overall Study|Neonate did not settle down for the scan|1|||
129929190|NCT03088878|467707901|FG000|Overall Study|Adverse Event|0|||
129929191|NCT03088878|467707902|FG001|Overall Study|Adverse Event|0|||
129929192|NCT03088878|467707903|FG002|Overall Study|Adverse Event|0|||
129929193|NCT03088878|467707904|FG003|Overall Study|Adverse Event|0|||
129929194|NCT03088878|467707905|FG004|Overall Study|Adverse Event|4|||
129929195|NCT03088878|467707906|FG005|Overall Study|Adverse Event|2|||
129929196|NCT03088878|467707907|FG006|Overall Study|Adverse Event|1|||
129929197|NCT03088878|467707908|FG007|Overall Study|Adverse Event|0|||
129929198|NCT03088878|467707909|FG008|Overall Study|Adverse Event|0|||
129929199|NCT03088878|467707910|FG009|Overall Study|Adverse Event|0|||
129929200|NCT03088878|467707911|FG010|Overall Study|Adverse Event|0|||
129929201|NCT03088878|467707912|FG011|Overall Study|Adverse Event|0|||
129929202|NCT03088878|467707913|FG012|Overall Study|Adverse Event|5|||
129929203|NCT03088878|467707914|FG013|Overall Study|Adverse Event|3|||
129929204|NCT03088878|467707901|FG000|Overall Study|Clinical Progression|0|||
129929205|NCT03088878|467707902|FG001|Overall Study|Clinical Progression|0|||
129929206|NCT03088878|467707903|FG002|Overall Study|Clinical Progression|0|||
129929207|NCT03088878|467707904|FG003|Overall Study|Clinical Progression|0|||
129929208|NCT03088878|467707905|FG004|Overall Study|Clinical Progression|2|||
130069164|NCT00150345|468207861|FG001|Overall Study|Death|2|||
130069165|NCT00150345|468207860|FG000|Overall Study|Adverse Event|8|||
129929209|NCT03088878|467707906|FG005|Overall Study|Clinical Progression|0|||
129929210|NCT03088878|467707907|FG006|Overall Study|Clinical Progression|0|||
129929211|NCT03088878|467707908|FG007|Overall Study|Clinical Progression|0|||
129929212|NCT03088878|467707909|FG008|Overall Study|Clinical Progression|0|||
129929213|NCT03088878|467707910|FG009|Overall Study|Clinical Progression|0|||
129929214|NCT03088878|467707911|FG010|Overall Study|Clinical Progression|0|||
129929215|NCT03088878|467707912|FG011|Overall Study|Clinical Progression|0|||
129929216|NCT03088878|467707913|FG012|Overall Study|Clinical Progression|0|||
129929217|NCT03088878|467707914|FG013|Overall Study|Clinical Progression|0|||
129929218|NCT03088878|467707901|FG000|Overall Study|Death|0|||
129929219|NCT03088878|467707902|FG001|Overall Study|Death|0|||
129929220|NCT03088878|467707903|FG002|Overall Study|Death|0|||
129929221|NCT03088878|467707904|FG003|Overall Study|Death|0|||
129929222|NCT03088878|467707905|FG004|Overall Study|Death|2|||
129929223|NCT03088878|467707906|FG005|Overall Study|Death|0|||
129929224|NCT03088878|467707907|FG006|Overall Study|Death|0|||
129929225|NCT03088878|467707908|FG007|Overall Study|Death|0|||
129929226|NCT03088878|467707909|FG008|Overall Study|Death|0|||
129929227|NCT03088878|467707910|FG009|Overall Study|Death|0|||
129929228|NCT03088878|467707911|FG010|Overall Study|Death|0|||
129929229|NCT03088878|467707912|FG011|Overall Study|Death|1|||
129929230|NCT03088878|467707913|FG012|Overall Study|Death|0|||
129929231|NCT03088878|467707914|FG013|Overall Study|Death|0|||
129929232|NCT03088878|467707901|FG000|Overall Study|Disease Progression|1|||
129929233|NCT03088878|467707902|FG001|Overall Study|Disease Progression|2|||
129929234|NCT03088878|467707903|FG002|Overall Study|Disease Progression|3|||
129929235|NCT03088878|467707904|FG003|Overall Study|Disease Progression|0|||
129929236|NCT03088878|467707905|FG004|Overall Study|Disease Progression|3|||
129929237|NCT03088878|467707906|FG005|Overall Study|Disease Progression|0|||
129929238|NCT03088878|467707907|FG006|Overall Study|Disease Progression|0|||
129929239|NCT03088878|467707908|FG007|Overall Study|Disease Progression|0|||
129929240|NCT03088878|467707909|FG008|Overall Study|Disease Progression|0|||
129929241|NCT03088878|467707910|FG009|Overall Study|Disease Progression|0|||
129929242|NCT03088878|467707911|FG010|Overall Study|Disease Progression|0|||
129929243|NCT03088878|467707912|FG011|Overall Study|Disease Progression|0|||
129929244|NCT03088878|467707913|FG012|Overall Study|Disease Progression|1|||
129929245|NCT03088878|467707914|FG013|Overall Study|Disease Progression|1|||
129929246|NCT03088878|467707901|FG000|Overall Study|Initiation of Alternative Treatment|0|||
129929247|NCT03088878|467707902|FG001|Overall Study|Initiation of Alternative Treatment|0|||
129929248|NCT03088878|467707903|FG002|Overall Study|Initiation of Alternative Treatment|0|||
129929249|NCT03088878|467707904|FG003|Overall Study|Initiation of Alternative Treatment|1|||
129929250|NCT03088878|467707905|FG004|Overall Study|Initiation of Alternative Treatment|0|||
129929251|NCT03088878|467707906|FG005|Overall Study|Initiation of Alternative Treatment|0|||
129929252|NCT03088878|467707907|FG006|Overall Study|Initiation of Alternative Treatment|0|||
129929253|NCT03088878|467707908|FG007|Overall Study|Initiation of Alternative Treatment|1|||
129929254|NCT03088878|467707909|FG008|Overall Study|Initiation of Alternative Treatment|1|||
129929255|NCT03088878|467707910|FG009|Overall Study|Initiation of Alternative Treatment|0|||
129929256|NCT03088878|467707911|FG010|Overall Study|Initiation of Alternative Treatment|0|||
129929257|NCT03088878|467707912|FG011|Overall Study|Initiation of Alternative Treatment|0|||
129929258|NCT03088878|467707913|FG012|Overall Study|Initiation of Alternative Treatment|0|||
129929259|NCT03088878|467707914|FG013|Overall Study|Initiation of Alternative Treatment|0|||
129929260|NCT03088878|467707901|FG000|Overall Study|Withdrawal by Subject|0|||
129929261|NCT03088878|467707902|FG001|Overall Study|Withdrawal by Subject|0|||
129929262|NCT03088878|467707903|FG002|Overall Study|Withdrawal by Subject|0|||
129929263|NCT03088878|467707904|FG003|Overall Study|Withdrawal by Subject|1|||
129929264|NCT03088878|467707905|FG004|Overall Study|Withdrawal by Subject|4|||
129929265|NCT03088878|467707906|FG005|Overall Study|Withdrawal by Subject|1|||
129929266|NCT03088878|467707907|FG006|Overall Study|Withdrawal by Subject|1|||
129929267|NCT03088878|467707908|FG007|Overall Study|Withdrawal by Subject|0|||
129929268|NCT03088878|467707909|FG008|Overall Study|Withdrawal by Subject|1|||
129929269|NCT03088878|467707910|FG009|Overall Study|Withdrawal by Subject|2|||
129929270|NCT03088878|467707911|FG010|Overall Study|Withdrawal by Subject|0|||
129929271|NCT03088878|467707912|FG011|Overall Study|Withdrawal by Subject|2|||
129929272|NCT03088878|467707913|FG012|Overall Study|Withdrawal by Subject|1|||
129929273|NCT03088878|467707914|FG013|Overall Study|Withdrawal by Subject|0|||
130069166|NCT00150345|468207861|FG001|Overall Study|Adverse Event|6|||
129929274|NCT03088878|467707901|FG000|Overall Study|Terminated by Sponsor|2|||
129929275|NCT03088878|467707902|FG001|Overall Study|Terminated by Sponsor|1|||
129929276|NCT03088878|467707903|FG002|Overall Study|Terminated by Sponsor|0|||
129929277|NCT03088878|467707904|FG003|Overall Study|Terminated by Sponsor|1|||
129929278|NCT03088878|467707905|FG004|Overall Study|Terminated by Sponsor|6|||
129929279|NCT03088878|467707906|FG005|Overall Study|Terminated by Sponsor|0|||
129929280|NCT03088878|467707907|FG006|Overall Study|Terminated by Sponsor|0|||
129929281|NCT03088878|467707908|FG007|Overall Study|Terminated by Sponsor|0|||
129929282|NCT03088878|467707909|FG008|Overall Study|Terminated by Sponsor|0|||
129929283|NCT03088878|467707910|FG009|Overall Study|Terminated by Sponsor|0|||
129929284|NCT03088878|467707911|FG010|Overall Study|Terminated by Sponsor|3|||
129929285|NCT03088878|467707912|FG011|Overall Study|Terminated by Sponsor|13|||
129929286|NCT03088878|467707913|FG012|Overall Study|Terminated by Sponsor|2|||
129929287|NCT03088878|467707914|FG013|Overall Study|Terminated by Sponsor|1|||
129929288|NCT03088878|467707901|FG000|Overall Study|Completed 2 years of Treatment|0|||
129929289|NCT03088878|467707902|FG001|Overall Study|Completed 2 years of Treatment|0|||
129929290|NCT03088878|467707903|FG002|Overall Study|Completed 2 years of Treatment|0|||
129929291|NCT03088878|467707904|FG003|Overall Study|Completed 2 years of Treatment|0|||
129929292|NCT03088878|467707905|FG004|Overall Study|Completed 2 years of Treatment|0|||
129929293|NCT03088878|467707906|FG005|Overall Study|Completed 2 years of Treatment|0|||
129929294|NCT03088878|467707907|FG006|Overall Study|Completed 2 years of Treatment|1|||
129929295|NCT03088878|467707908|FG007|Overall Study|Completed 2 years of Treatment|0|||
129929296|NCT03088878|467707909|FG008|Overall Study|Completed 2 years of Treatment|0|||
129929297|NCT03088878|467707910|FG009|Overall Study|Completed 2 years of Treatment|1|||
129929298|NCT03088878|467707911|FG010|Overall Study|Completed 2 years of Treatment|0|||
129929299|NCT03088878|467707912|FG011|Overall Study|Completed 2 years of Treatment|0|||
129929300|NCT03088878|467707913|FG012|Overall Study|Completed 2 years of Treatment|8|||
129929301|NCT03088878|467707914|FG013|Overall Study|Completed 2 years of Treatment|3|||
129929302|NCT03088878|467707901|FG000|Overall Study|Physician Decision|0|||
129929303|NCT03088878|467707902|FG001|Overall Study|Physician Decision|0|||
129929304|NCT03088878|467707903|FG002|Overall Study|Physician Decision|0|||
129929305|NCT03088878|467707904|FG003|Overall Study|Physician Decision|0|||
129929306|NCT03088878|467707905|FG004|Overall Study|Physician Decision|0|||
129929307|NCT03088878|467707906|FG005|Overall Study|Physician Decision|0|||
129929308|NCT03088878|467707907|FG006|Overall Study|Physician Decision|0|||
129929309|NCT03088878|467707908|FG007|Overall Study|Physician Decision|2|||
129929310|NCT03088878|467707909|FG008|Overall Study|Physician Decision|1|||
129929311|NCT03088878|467707910|FG009|Overall Study|Physician Decision|0|||
129929312|NCT03088878|467707911|FG010|Overall Study|Physician Decision|0|||
129929313|NCT03088878|467707912|FG011|Overall Study|Physician Decision|0|||
129929314|NCT03088878|467707913|FG012|Overall Study|Physician Decision|0|||
129929315|NCT03088878|467707914|FG013|Overall Study|Physician Decision|1|||
129929316|NCT03088878|467707901|FG000|Overall Study|COVID Related noncompliance|0|||
129929317|NCT03088878|467707902|FG001|Overall Study|COVID Related noncompliance|0|||
129929318|NCT03088878|467707903|FG002|Overall Study|COVID Related noncompliance|0|||
129929319|NCT03088878|467707904|FG003|Overall Study|COVID Related noncompliance|0|||
129929320|NCT03088878|467707905|FG004|Overall Study|COVID Related noncompliance|0|||
129929321|NCT03088878|467707906|FG005|Overall Study|COVID Related noncompliance|0|||
129929322|NCT03088878|467707907|FG006|Overall Study|COVID Related noncompliance|0|||
129929323|NCT03088878|467707908|FG007|Overall Study|COVID Related noncompliance|0|||
129929324|NCT03088878|467707909|FG008|Overall Study|COVID Related noncompliance|0|||
129929325|NCT03088878|467707910|FG009|Overall Study|COVID Related noncompliance|0|||
129929326|NCT03088878|467707911|FG010|Overall Study|COVID Related noncompliance|0|||
129929327|NCT03088878|467707912|FG011|Overall Study|COVID Related noncompliance|0|||
129929328|NCT03088878|467707913|FG012|Overall Study|COVID Related noncompliance|0|||
129929329|NCT03088878|467707914|FG013|Overall Study|COVID Related noncompliance|1|||
129929330|NCT03088878|467707901|FG000|Overall Study|Drug or Study Noncompliance|0|||
129929331|NCT03088878|467707902|FG001|Overall Study|Drug or Study Noncompliance|0|||
129929332|NCT03088878|467707903|FG002|Overall Study|Drug or Study Noncompliance|0|||
129929333|NCT03088878|467707904|FG003|Overall Study|Drug or Study Noncompliance|0|||
129929334|NCT03088878|467707905|FG004|Overall Study|Drug or Study Noncompliance|0|||
129929335|NCT03088878|467707906|FG005|Overall Study|Drug or Study Noncompliance|0|||
129929336|NCT03088878|467707907|FG006|Overall Study|Drug or Study Noncompliance|0|||
129929337|NCT03088878|467707908|FG007|Overall Study|Drug or Study Noncompliance|0|||
129929338|NCT03088878|467707909|FG008|Overall Study|Drug or Study Noncompliance|0|||
129929339|NCT03088878|467707910|FG009|Overall Study|Drug or Study Noncompliance|0|||
129929340|NCT03088878|467707911|FG010|Overall Study|Drug or Study Noncompliance|0|||
129929341|NCT03088878|467707912|FG011|Overall Study|Drug or Study Noncompliance|0|||
129929342|NCT03088878|467707913|FG012|Overall Study|Drug or Study Noncompliance|1|||
129929343|NCT03088878|467707914|FG013|Overall Study|Drug or Study Noncompliance|0|||
129929344|NCT05216406|467707917|FG000|Overall Study|Lost to Follow-up|8|||
129929345|NCT05216406|467707918|FG001|Overall Study|Lost to Follow-up|9|||
129929346|NCT04690582|467707921|FG000|Overall Study|Withdrawal by Subject|6|||
129929347|NCT04690582|467707922|FG001|Overall Study|Withdrawal by Subject|4|||
129929348|NCT03711474|467707923|FG000|Overall Study|Physician Decision|2|||
129929349|NCT03711474|467707924|FG001|Overall Study|Physician Decision|0|||
129929350|NCT05974501|467707925|FG000|Overall Study|Physician Decision|0|||
129929351|NCT05974501|467707926|FG001|Overall Study|Physician Decision|1|||
129929352|NCT04270942|467707929|FG000|Overall Study|Death|1|||
129929353|NCT03625115|467707931|FG000|Overall Study|Withdrawal by Subject|4|||
129929354|NCT03625115|467707932|FG001|Overall Study|Withdrawal by Subject|7|||
129929355|NCT03625115|467707931|FG000|Overall Study|Lost to Follow-up|17|||
129929356|NCT03625115|467707932|FG001|Overall Study|Lost to Follow-up|24|||
129929357|NCT01236781|467707933|FG000|Overall Study|Ineligible|2|||
129929358|NCT01236781|467707934|FG001|Overall Study|Ineligible|1|||
129929359|NCT01236781|467707933|FG000|Overall Study|Did not complete study imaging|5|||
129929360|NCT01236781|467707934|FG001|Overall Study|Did not complete study imaging|0|||
129929361|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
129929362|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
129929363|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
129929364|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
129929365|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
129929366|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
129929367|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
129929368|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
129929369|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
129929370|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
129929371|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
129929372|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
129929373|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Death|4|||
129929374|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Death|4|||
129929375|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Death|3|||
129929376|NCT03756662|467707938|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
129929377|NCT03298451|467707945|FG000|Overall Study|Death|275|||
129929378|NCT03298451|467707946|FG001|Overall Study|Death|260|||
129929379|NCT03298451|467707947|FG002|Overall Study|Death|122|||
129929380|NCT03298451|467707948|FG003|Overall Study|Death|280|||
129929381|NCT03298451|467707945|FG000|Overall Study|Lost to Follow-up|1|||
129929382|NCT03298451|467707946|FG001|Overall Study|Lost to Follow-up|1|||
129929383|NCT03298451|467707947|FG002|Overall Study|Lost to Follow-up|0|||
129929384|NCT03298451|467707948|FG003|Overall Study|Lost to Follow-up|7|||
129929385|NCT03298451|467707945|FG000|Overall Study|Withdrawal by Subject|9|||
129929386|NCT03298451|467707946|FG001|Overall Study|Withdrawal by Subject|7|||
129929387|NCT03298451|467707947|FG002|Overall Study|Withdrawal by Subject|1|||
129929388|NCT03298451|467707948|FG003|Overall Study|Withdrawal by Subject|20|||
129929389|NCT04308681|467707953|FG000|Pre-Treatment|Not reported|1|||
129929390|NCT04308681|467707954|FG001|Pre-Treatment|Not reported|1|||
129929391|NCT04308681|467707955|FG002|Pre-Treatment|Not reported|0|||
129929392|NCT04308681|467707956|FG003|Pre-Treatment|Not reported|0|||
129929393|NCT04308681|467707957|FG004|Pre-Treatment|Not reported|0|||
129929394|NCT04308681|467707958|FG005|Pre-Treatment|Not reported|2|||
129929395|NCT04308681|467707959|FG006|Pre-Treatment|Not reported|0|||
129929396|NCT04308681|467707960|FG007|Pre-Treatment|Not reported|0|||
129929397|NCT04308681|467707953|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
129929398|NCT04308681|467707954|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
129929399|NCT04308681|467707955|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
129929400|NCT04308681|467707956|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
129929401|NCT04308681|467707957|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
129929402|NCT04308681|467707958|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
129929403|NCT04308681|467707959|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
129929404|NCT04308681|467707960|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
129929405|NCT04308681|467707953|FG000|Treatment up to Week 26|Other reasons|2|||
129929406|NCT04308681|467707954|FG001|Treatment up to Week 26|Other reasons|0|||
129929407|NCT04308681|467707955|FG002|Treatment up to Week 26|Other reasons|0|||
129929408|NCT04308681|467707956|FG003|Treatment up to Week 26|Other reasons|0|||
129929409|NCT04308681|467707957|FG004|Treatment up to Week 26|Other reasons|1|||
129929410|NCT04308681|467707958|FG005|Treatment up to Week 26|Other reasons|1|||
129929411|NCT04308681|467707959|FG006|Treatment up to Week 26|Other reasons|0|||
129929412|NCT04308681|467707960|FG007|Treatment up to Week 26|Other reasons|0|||
129929413|NCT04308681|467707953|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929414|NCT04308681|467707954|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
129929415|NCT04308681|467707955|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
129929416|NCT04308681|467707956|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929417|NCT04308681|467707957|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
129929418|NCT04308681|467707958|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929419|NCT04308681|467707959|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
129929420|NCT04308681|467707960|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929421|NCT04308681|467707953|FG000|Treatment up to Week 26|Adverse Event|6|||
129929422|NCT04308681|467707954|FG001|Treatment up to Week 26|Adverse Event|5|||
129929423|NCT04308681|467707955|FG002|Treatment up to Week 26|Adverse Event|5|||
129929424|NCT04308681|467707956|FG003|Treatment up to Week 26|Adverse Event|0|||
129929425|NCT04308681|467707957|FG004|Treatment up to Week 26|Adverse Event|6|||
129929426|NCT04308681|467707958|FG005|Treatment up to Week 26|Adverse Event|1|||
129929427|NCT04308681|467707959|FG006|Treatment up to Week 26|Adverse Event|0|||
129929428|NCT04308681|467707960|FG007|Treatment up to Week 26|Adverse Event|0|||
129929429|NCT04308681|467707953|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929430|NCT04308681|467707954|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
129929431|NCT04308681|467707955|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
129929432|NCT04308681|467707956|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929433|NCT04308681|467707957|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129979760|NCT01283516|467889461|FG005|Overall Study|Lost to Follow-up|0|||
129929434|NCT04308681|467707958|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929435|NCT04308681|467707959|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929436|NCT04308681|467707960|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929437|NCT04308681|467707953|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
129929438|NCT04308681|467707954|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
129929439|NCT04308681|467707955|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
129929440|NCT04308681|467707956|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
129929441|NCT04308681|467707957|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
129929442|NCT04308681|467707958|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
129929443|NCT04308681|467707959|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
129929444|NCT04308681|467707960|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
129929445|NCT04308681|467707953|FG000|OTE - 26 Weeks|Death|0|||
129929446|NCT04308681|467707954|FG001|OTE - 26 Weeks|Death|1|||
129929447|NCT04308681|467707955|FG002|OTE - 26 Weeks|Death|0|||
129929448|NCT04308681|467707956|FG003|OTE - 26 Weeks|Death|0|||
129929449|NCT04308681|467707957|FG004|OTE - 26 Weeks|Death|0|||
129929450|NCT04308681|467707958|FG005|OTE - 26 Weeks|Death|0|||
129929451|NCT04308681|467707959|FG006|OTE - 26 Weeks|Death|1|||
129929452|NCT04308681|467707960|FG007|OTE - 26 Weeks|Death|0|||
129929453|NCT04308681|467707953|FG000|OTE - 26 Weeks|Adverse Event|0|||
129929454|NCT04308681|467707954|FG001|OTE - 26 Weeks|Adverse Event|2|||
129929455|NCT04308681|467707955|FG002|OTE - 26 Weeks|Adverse Event|8|||
129929456|NCT04308681|467707956|FG003|OTE - 26 Weeks|Adverse Event|3|||
129929457|NCT04308681|467707957|FG004|OTE - 26 Weeks|Adverse Event|0|||
129929458|NCT04308681|467707958|FG005|OTE - 26 Weeks|Adverse Event|1|||
129929459|NCT04308681|467707959|FG006|OTE - 26 Weeks|Adverse Event|2|||
129929460|NCT04308681|467707960|FG007|OTE - 26 Weeks|Adverse Event|0|||
129929461|NCT04308681|467707953|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929462|NCT04308681|467707954|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
129929463|NCT04308681|467707955|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
129929464|NCT04308681|467707956|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929465|NCT04308681|467707957|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929466|NCT04308681|467707958|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
129929467|NCT04308681|467707959|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929468|NCT04308681|467707960|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929469|NCT05565820|467707961|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
129929470|NCT05565820|467707962|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
129929471|NCT05565820|467707961|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
129929472|NCT05565820|467707962|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
129929473|NCT03295721|467707965|FG000|Overall Study|Adverse Event|1|||
129929474|NCT03295721|467707966|FG001|Overall Study|Adverse Event|0|||
129929475|NCT03295721|467707967|FG002|Overall Study|Adverse Event|0|||
129929476|NCT03295721|467707965|FG000|Overall Study|Lost to Follow-up|1|||
129929477|NCT03295721|467707966|FG001|Overall Study|Lost to Follow-up|1|||
129929478|NCT03295721|467707967|FG002|Overall Study|Lost to Follow-up|1|||
129929479|NCT03295721|467707965|FG000|Overall Study|Withdrawal by Subject|1|||
129929480|NCT03295721|467707966|FG001|Overall Study|Withdrawal by Subject|0|||
129929481|NCT03295721|467707967|FG002|Overall Study|Withdrawal by Subject|1|||
129929482|NCT03295721|467707965|FG000|Overall Study|Death|0|||
129929483|NCT03295721|467707966|FG001|Overall Study|Death|0|||
129929484|NCT03295721|467707967|FG002|Overall Study|Death|1|||
129929485|NCT04786119|467707971|FG000|Overall Study|Withdrawal by Subject|2|||
129929486|NCT03325985|467707972|FG000|Overall Study|Lost to Follow-up|122|||
129929487|NCT03325985|467707973|FG001|Overall Study|Lost to Follow-up|26|||
129929488|NCT03325985|467707974|FG002|Overall Study|Lost to Follow-up|141|||
129929489|NCT03325985|467707975|FG003|Overall Study|Lost to Follow-up|28|||
129929490|NCT03325985|467707972|FG000|Overall Study|Death|99|||
129929491|NCT03325985|467707973|FG001|Overall Study|Death|36|||
129929492|NCT03325985|467707974|FG002|Overall Study|Death|94|||
130117596|NCT03532009|468390567|FG001|Overall Study|Death|1|||
130117597|NCT03532009|468390566|FG000|Overall Study|Withdrawal by Patient|0|||
130117598|NCT03532009|468390567|FG001|Overall Study|Withdrawal by Patient|2|||
130117599|NCT02035137|468390569|FG000|Overall Study|Physician Decision|0|||
129929493|NCT03325985|467707975|FG003|Overall Study|Death|32|||
129929494|NCT03056573|467707976|FG000|Overall Study|Death|2|||
129929495|NCT03056573|467707977|FG001|Overall Study|Death|4|||
129929496|NCT03056573|467707976|FG000|Overall Study|Withdrawal by Subject|2|||
129929497|NCT03056573|467707977|FG001|Overall Study|Withdrawal by Subject|0|||
129929498|NCT03056573|467707976|FG000|Overall Study|Lost to Follow-up|1|||
129929499|NCT03056573|467707977|FG001|Overall Study|Lost to Follow-up|1|||
129929500|NCT02684227|467707979|FG000|Overall Study|Adverse Event|1|||
129929501|NCT02684227|467707980|FG001|Overall Study|Adverse Event|7|||
129929502|NCT02684227|467707979|FG000|Overall Study|Death|0|||
129929503|NCT02684227|467707980|FG001|Overall Study|Death|2|||
129929504|NCT02684227|467707979|FG000|Overall Study|Withdrawal by Subject|0|||
129929505|NCT02684227|467707980|FG001|Overall Study|Withdrawal by Subject|1|||
129929506|NCT02684227|467707979|FG000|Overall Study|Progressive Disease|0|||
130117600|NCT02035137|468390570|FG001|Overall Study|Physician Decision|0|||
130117601|NCT02035137|468390571|FG002|Overall Study|Physician Decision|1|||
130117602|NCT02035137|468390569|FG000|Overall Study|Withdrawal by Subject|0|||
130117603|NCT02035137|468390570|FG001|Overall Study|Withdrawal by Subject|1|||
130117604|NCT02035137|468390571|FG002|Overall Study|Withdrawal by Subject|2|||
130117605|NCT02035137|468390569|FG000|Overall Study|Ineligible|0|||
130117606|NCT02035137|468390570|FG001|Overall Study|Ineligible|1|||
130117607|NCT02035137|468390571|FG002|Overall Study|Ineligible|2|||
130117608|NCT02035137|468390569|FG000|Overall Study|Disease progression prior to treatment start|2|||
130117609|NCT02035137|468390570|FG001|Overall Study|Disease progression prior to treatment start|0|||
130117610|NCT02035137|468390571|FG002|Overall Study|Disease progression prior to treatment start|0|||
130117611|NCT01006707|468390587|FG000|Study Session 1|Lost to Follow-up|2|||
130117612|NCT01006707|468390588|FG001|Study Session 1|Lost to Follow-up|0|||
130117613|NCT01006707|468390589|FG002|Study Session 1|Lost to Follow-up|0|||
130117614|NCT01006707|468390587|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
130117615|NCT01006707|468390588|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
130117616|NCT01006707|468390589|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
130117617|NCT02750306|468390590|FG000|Overall Study|Withdrawal by Subject|5|||
130117618|NCT02750306|468390591|FG001|Overall Study|Withdrawal by Subject|2|||
130117619|NCT02750306|468390590|FG000|Overall Study|Protocol Violation|1|||
130117620|NCT02750306|468390591|FG001|Overall Study|Protocol Violation|0|||
130117621|NCT02737306|468390592|FG000|Overall Study|Adverse Event|3|||
130117622|NCT02737306|468390593|FG001|Overall Study|Adverse Event|0|||
130117623|NCT02737306|468390592|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
130117624|NCT02737306|468390593|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
130117625|NCT05034731|468390594|FG000|Overall Study|Screen fail|1|||
130117626|NCT05034731|468390595|FG001|Overall Study|Screen fail|1|||
130117627|NCT00283686|468390597|FG000|Overall Study|Death|1|||
130117628|NCT00283686|468390598|FG001|Overall Study|Death|1|||
130117629|NCT00283686|468390599|FG002|Overall Study|Death|1|||
130117630|NCT00283686|468390600|FG003|Overall Study|Death|0|||
130117631|NCT00283686|468390597|FG000|Overall Study|Lost to Follow-up|21|||
130117632|NCT00283686|468390598|FG001|Overall Study|Lost to Follow-up|31|||
130117633|NCT00283686|468390599|FG002|Overall Study|Lost to Follow-up|26|||
130117634|NCT00283686|468390600|FG003|Overall Study|Lost to Follow-up|20|||
130117635|NCT00283686|468390597|FG000|Overall Study|Less than full participation|7|||
130117636|NCT00283686|468390598|FG001|Overall Study|Less than full participation|9|||
130117637|NCT00283686|468390599|FG002|Overall Study|Less than full participation|6|||
130117638|NCT00283686|468390600|FG003|Overall Study|Less than full participation|12|||
130117639|NCT02970669|468390601|FG000|Double-blind Period|Adverse Event|4|||
130117640|NCT02970669|468390602|FG001|Double-blind Period|Adverse Event|0|||
130117641|NCT02970669|468390601|FG000|Double-blind Period|Death|1|||
130117642|NCT02970669|468390602|FG001|Double-blind Period|Death|0|||
130117643|NCT02970669|468390601|FG000|Double-blind Period|Study terminated by sponsor|1|||
130117644|NCT02970669|468390602|FG001|Double-blind Period|Study terminated by sponsor|2|||
130117645|NCT02970669|468390601|FG000|Double-blind Period|Physician Decision|0|||
130117646|NCT02970669|468390602|FG001|Double-blind Period|Physician Decision|2|||
130117647|NCT02970669|468390601|FG000|Double-blind Period|Withdrawal by Subject|2|||
130117648|NCT02970669|468390602|FG001|Double-blind Period|Withdrawal by Subject|2|||
129929507|NCT02684227|467707980|FG001|Overall Study|Progressive Disease|2|||
130117649|NCT02970669|468390601|FG000|Open-label Period|Withdrawal by Subject|2|||
130117650|NCT02970669|468390602|FG001|Open-label Period|Withdrawal by Subject|2|||
130117651|NCT02970669|468390601|FG000|Open-label Period|Adverse Event|1|||
130117652|NCT02970669|468390602|FG001|Open-label Period|Adverse Event|0|||
130117653|NCT02970669|468390601|FG000|Open-label Period|Physician Decision|1|||
130117654|NCT02970669|468390602|FG001|Open-label Period|Physician Decision|0|||
130117655|NCT03521999|468390603|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
130117656|NCT03521999|468390604|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
130117657|NCT03521999|468390603|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
129929508|NCT03606408|467707981|FG000|Overall Study|Adverse Event|13|||
130117658|NCT03521999|468390604|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
130117659|NCT03521999|468390603|FG000|Completed 3 Month Follow up|Death|0|||
130117660|NCT03521999|468390604|FG001|Completed 3 Month Follow up|Death|1|||
130117661|NCT03521999|468390603|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
130117662|NCT03521999|468390604|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
130117663|NCT00467584|468390609|FG000|Overall Study|Withdrawal by Subject|4|||
130117664|NCT00467584|468390610|FG001|Overall Study|Withdrawal by Subject|5|||
130117665|NCT00467584|468390611|FG002|Overall Study|Withdrawal by Subject|1|||
130117666|NCT02292238|468390615|FG000|Overall Study|Protocol Violation|1|||
130117667|NCT02292238|468390616|FG001|Overall Study|Protocol Violation|2|||
130117668|NCT02292238|468390615|FG000|Overall Study|Withdrawal by Subject|2|||
129929509|NCT03606408|467707981|FG000|Overall Study|Withdrawal by Subject|7|||
129929510|NCT03606408|467707981|FG000|Overall Study|Physician Decision|4|||
130117669|NCT02292238|468390616|FG001|Overall Study|Withdrawal by Subject|1|||
130117670|NCT02292238|468390615|FG000|Overall Study|Lost to Follow-up|1|||
130117671|NCT02292238|468390616|FG001|Overall Study|Lost to Follow-up|0|||
130117672|NCT02292238|468390615|FG000|Overall Study|Physician Decision|0|||
130117673|NCT02292238|468390616|FG001|Overall Study|Physician Decision|1|||
129929511|NCT03606408|467707981|FG000|Overall Study|Lack of Efficacy|2|||
129929512|NCT03606408|467707981|FG000|Overall Study|Death|1|||
129929513|NCT03606408|467707981|FG000|Overall Study|new therapy for study indication|1|||
129929514|NCT03556293|467707982|FG000|Overall Study|Ineligible for analysis|1904|||
129929515|NCT03556293|467707983|FG001|Overall Study|Ineligible for analysis|1471|||
129929516|NCT03556293|467707984|FG002|Overall Study|Ineligible for analysis|1091|||
129929517|NCT03556293|467707985|FG003|Overall Study|Ineligible for analysis|1269|||
129929518|NCT05828017|467707988|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
129929519|NCT05012163|467707989|FG000|Overall Study|Protocol Violation|0|||
129929520|NCT05012163|467707990|FG001|Overall Study|Protocol Violation|0|||
129929521|NCT05012163|467707991|FG002|Overall Study|Protocol Violation|1|||
129929522|NCT05012163|467707992|FG003|Overall Study|Protocol Violation|1|||
129929523|NCT03213873|467707995|FG000|Overall Study|Withdrawal by Subject|8|||
129929524|NCT03213873|467707996|FG001|Overall Study|Withdrawal by Subject|9|||
129929525|NCT03213873|467707995|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
129929526|NCT03213873|467707996|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
129929527|NCT03213873|467707995|FG000|Overall Study|Lost to Follow-up|0|||
129929528|NCT03213873|467707996|FG001|Overall Study|Lost to Follow-up|2|||
129929529|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
129929530|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
129929531|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
129929532|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
129929533|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
129929534|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
129929535|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
129929536|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
129929537|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
129929538|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
129929539|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
129929540|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
129929541|NCT02852655|467708004|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
129929542|NCT02852655|467708005|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
129929543|NCT02852655|467708006|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
129929544|NCT02852655|467708004|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
129929545|NCT02852655|467708005|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
129929546|NCT02852655|467708006|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
129929547|NCT02852655|467708004|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
129929548|NCT02852655|467708005|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
129929549|NCT02852655|467708006|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
129929550|NCT02852655|467708004|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
129929551|NCT02852655|467708005|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
129929552|NCT02852655|467708006|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
129929553|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
129929554|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
129929555|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
129929556|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
129929557|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
129929558|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
129929559|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
129929560|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
129929561|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
129929562|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
129929563|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
129929564|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
129929565|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
129929566|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
129929567|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
129929568|NCT03924635|467709683|FG000|Overall Study|Withdrawal by Subject|2|||
129929569|NCT03924635|467709684|FG001|Overall Study|Withdrawal by Subject|4|||
129929570|NCT03676192|467709685|FG000|Induction Study Period|Adverse Event|21|||
129929571|NCT03676192|467709686|FG001|Induction Study Period|Adverse Event|20|||
129929572|NCT03676192|467709685|FG000|Induction Study Period|Death|23|||
129929573|NCT03676192|467709686|FG001|Induction Study Period|Death|20|||
129929574|NCT03676192|467709685|FG000|Induction Study Period|Lost to Follow-up|3|||
129929575|NCT03676192|467709686|FG001|Induction Study Period|Lost to Follow-up|3|||
129929576|NCT03676192|467709685|FG000|Induction Study Period|Physician Decision|6|||
130069167|NCT00150345|468207860|FG000|Overall Study|Lack of Efficacy|5|||
130117674|NCT01789320|468390617|FG000|Overall Study|Re-enrolled into study|1|||
130117675|NCT01789320|468390617|FG000|Overall Study|Lost to Follow-up|1|||
130117676|NCT02789111|468390622|FG000|Overall Study|Withdrawal by Subject|1|||
130117677|NCT02789111|468390623|FG001|Overall Study|Withdrawal by Subject|4|||
130117678|NCT00673790|468390626|FG000|Overall Study|Adverse Event|23|||
130117679|NCT00673790|468390627|FG001|Overall Study|Adverse Event|14|||
130117680|NCT00673790|468390628|FG002|Overall Study|Adverse Event|2|||
130117681|NCT00673790|468390626|FG000|Overall Study|Lack of Efficacy|2|||
130117682|NCT00673790|468390627|FG001|Overall Study|Lack of Efficacy|2|||
130117683|NCT00673790|468390628|FG002|Overall Study|Lack of Efficacy|2|||
130117684|NCT00673790|468390626|FG000|Overall Study|Protocol Violation|6|||
130117685|NCT00673790|468390627|FG001|Overall Study|Protocol Violation|9|||
130117686|NCT00673790|468390628|FG002|Overall Study|Protocol Violation|1|||
130117687|NCT00673790|468390626|FG000|Overall Study|Withdrawal by Subject|7|||
130117688|NCT00673790|468390627|FG001|Overall Study|Withdrawal by Subject|4|||
130117689|NCT00673790|468390628|FG002|Overall Study|Withdrawal by Subject|1|||
130117690|NCT00673790|468390626|FG000|Overall Study|Lost to Follow-up|6|||
130117691|NCT00673790|468390627|FG001|Overall Study|Lost to Follow-up|6|||
130117692|NCT00673790|468390628|FG002|Overall Study|Lost to Follow-up|5|||
130117693|NCT00673790|468390626|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
130117694|NCT00673790|468390627|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
130117695|NCT00673790|468390628|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
130117696|NCT00673790|468390626|FG000|Overall Study|Poor compliance|1|||
130117697|NCT00673790|468390627|FG001|Overall Study|Poor compliance|0|||
130117698|NCT00673790|468390628|FG002|Overall Study|Poor compliance|0|||
130117699|NCT00673790|468390626|FG000|Overall Study|Participated in two Nebivolol studies|0|||
130117700|NCT00673790|468390627|FG001|Overall Study|Participated in two Nebivolol studies|0|||
130117701|NCT00673790|468390628|FG002|Overall Study|Participated in two Nebivolol studies|1|||
130117702|NCT00673790|468390626|FG000|Overall Study|Unconfirmed pregnancy|0|||
130117703|NCT00673790|468390627|FG001|Overall Study|Unconfirmed pregnancy|1|||
130117704|NCT00673790|468390628|FG002|Overall Study|Unconfirmed pregnancy|0|||
130117705|NCT00673790|468390626|FG000|Overall Study|Randomization criteria not met|0|||
130117706|NCT00673790|468390627|FG001|Overall Study|Randomization criteria not met|1|||
130117707|NCT00673790|468390628|FG002|Overall Study|Randomization criteria not met|0|||
130117708|NCT00601484|468390632|FG000|Overall Study|Adverse Event|0|||
130117709|NCT00601484|468390633|FG001|Overall Study|Adverse Event|1|||
130117710|NCT00601484|468390632|FG000|Overall Study|Lost to Follow-up|4|||
130117711|NCT00601484|468390633|FG001|Overall Study|Lost to Follow-up|3|||
130117712|NCT00601484|468390632|FG000|Overall Study|Lack of Efficacy|0|||
130117713|NCT00601484|468390633|FG001|Overall Study|Lack of Efficacy|2|||
130117714|NCT00601484|468390632|FG000|Overall Study|Withdrawal by Subject|1|||
130117715|NCT00601484|468390633|FG001|Overall Study|Withdrawal by Subject|1|||
130117716|NCT00601484|468390632|FG000|Overall Study|Randomized, but not treated|0|||
130117717|NCT00601484|468390633|FG001|Overall Study|Randomized, but not treated|1|||
130117718|NCT01200394|468390634|FG000|Overall Study|Adverse Event|0|||
130117719|NCT01200394|468390635|FG001|Overall Study|Adverse Event|14|||
130117720|NCT01200394|468390634|FG000|Overall Study|Death|1|||
130117721|NCT01200394|468390635|FG001|Overall Study|Death|0|||
130117722|NCT01200394|468390634|FG000|Overall Study|Lost to Follow-up|0|||
130117723|NCT01200394|468390635|FG001|Overall Study|Lost to Follow-up|1|||
130117724|NCT01200394|468390634|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
130117725|NCT01200394|468390635|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
130117726|NCT01200394|468390634|FG000|Overall Study|Protocol Violation|0|||
130117727|NCT01200394|468390635|FG001|Overall Study|Protocol Violation|3|||
130117728|NCT01200394|468390634|FG000|Overall Study|Withdrawal by Subject|0|||
130117729|NCT01200394|468390635|FG001|Overall Study|Withdrawal by Subject|5|||
130117730|NCT01200394|468390634|FG000|Overall Study|Other|0|||
130117731|NCT01200394|468390635|FG001|Overall Study|Other|1|||
130117732|NCT01463683|468390639|FG000|Overall Study|Adverse Event|2|||
130117733|NCT01463683|468390640|FG001|Overall Study|Adverse Event|0|||
130117734|NCT01463683|468390641|FG002|Overall Study|Adverse Event|0|||
130117735|NCT01463683|468390639|FG000|Overall Study|Lost to Follow-up|10|||
130117736|NCT01463683|468390640|FG001|Overall Study|Lost to Follow-up|9|||
130117737|NCT01463683|468390641|FG002|Overall Study|Lost to Follow-up|7|||
130117738|NCT01463683|468390639|FG000|Overall Study|Physician Decision|0|||
130117739|NCT01463683|468390640|FG001|Overall Study|Physician Decision|3|||
130117740|NCT01463683|468390641|FG002|Overall Study|Physician Decision|1|||
130117741|NCT01463683|468390639|FG000|Overall Study|Pregnancy|2|||
130117742|NCT01463683|468390640|FG001|Overall Study|Pregnancy|2|||
130117743|NCT01463683|468390641|FG002|Overall Study|Pregnancy|1|||
130117744|NCT01463683|468390639|FG000|Overall Study|Withdrawal by Subject|5|||
130117745|NCT01463683|468390640|FG001|Overall Study|Withdrawal by Subject|17|||
130117746|NCT01463683|468390641|FG002|Overall Study|Withdrawal by Subject|2|||
130117747|NCT04345471|468390646|FG000|Overall Study|Adverse Event|8|||
130117748|NCT04345471|468390647|FG001|Overall Study|Adverse Event|5|||
130117749|NCT04345471|468390648|FG002|Overall Study|Adverse Event|6|||
130117750|NCT04345471|468390646|FG000|Overall Study|Lack of Efficacy|1|||
130117751|NCT04345471|468390647|FG001|Overall Study|Lack of Efficacy|1|||
129929577|NCT03676192|467709686|FG001|Induction Study Period|Physician Decision|3|||
129929578|NCT03676192|467709685|FG000|Induction Study Period|Progressive Disease|32|||
129929579|NCT03676192|467709686|FG001|Induction Study Period|Progressive Disease|21|||
129929580|NCT03676192|467709685|FG000|Induction Study Period|Protocol Violation|1|||
129929581|NCT03676192|467709686|FG001|Induction Study Period|Protocol Violation|2|||
129929582|NCT03676192|467709685|FG000|Induction Study Period|Withdrawal by Subject|20|||
129929583|NCT03676192|467709686|FG001|Induction Study Period|Withdrawal by Subject|15|||
129929584|NCT03209973|467709687|FG000|Overall Study|Withdrawal by Subject|7|||
129929585|NCT03209973|467709687|FG000|Overall Study|Lost to Follow-up|2|||
129929586|NCT03209973|467709687|FG000|Overall Study|Death|8|||
129929587|NCT03209973|467709687|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
129929588|NCT03209973|467709687|FG000|Overall Study|Sponsor Decision|18|||
129929589|NCT03209973|467709687|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
129929590|NCT03209973|467709687|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
129929591|NCT04766892|467709688|FG000|Overall Study|Withdrawal by Subject|1|||
129929592|NCT04766892|467709688|FG000|Overall Study|Lost to Follow-up|1|||
129929593|NCT04766892|467709688|FG000|Overall Study|Adverse Event|3|||
129929594|NCT04766892|467709688|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
129929595|NCT05906784|467709689|FG000|Overall Study|Lost to Follow-up|2|||
129929596|NCT05906784|467709690|FG001|Overall Study|Lost to Follow-up|1|||
129929597|NCT05906784|467709691|FG002|Overall Study|Lost to Follow-up|1|||
129929598|NCT05906784|467709692|FG003|Overall Study|Lost to Follow-up|1|||
129929599|NCT02668692|467709693|FG000|Overall Study|Adverse Event|1|||
129929600|NCT02668692|467709694|FG001|Overall Study|Adverse Event|0|||
129929601|NCT01627574|467709698|FG000|Overall Study|Withdrawal by Subject|8|||
129929602|NCT01627574|467709699|FG001|Overall Study|Withdrawal by Subject|5|||
129929603|NCT01627574|467709698|FG000|Overall Study|Lost to Follow-up|13|||
129929604|NCT01627574|467709699|FG001|Overall Study|Lost to Follow-up|13|||
129929605|NCT03308877|467709701|FG000|Overall Study|Lost to Follow-up|32|||
129929606|NCT03308877|467709702|FG001|Overall Study|Lost to Follow-up|28|||
129929607|NCT04677738|467709712|FG000|Overall Study|Withdrawal by Subject|4|||
129929608|NCT04677738|467709713|FG001|Overall Study|Withdrawal by Subject|2|||
129929609|NCT03519178|467709718|FG000|PF-06873600 Treatment|Adverse Event|0|||
129929610|NCT03519178|467709719|FG001|PF-06873600 Treatment|Adverse Event|0|||
129929611|NCT03519178|467709720|FG002|PF-06873600 Treatment|Adverse Event|0|||
129929612|NCT03519178|467709721|FG003|PF-06873600 Treatment|Adverse Event|0|||
129929613|NCT03519178|467709722|FG004|PF-06873600 Treatment|Adverse Event|0|||
129929614|NCT03519178|467709723|FG005|PF-06873600 Treatment|Adverse Event|0|||
129929615|NCT03519178|467709724|FG006|PF-06873600 Treatment|Adverse Event|0|||
129929616|NCT03519178|467709725|FG007|PF-06873600 Treatment|Adverse Event|2|||
129929617|NCT03519178|467709726|FG008|PF-06873600 Treatment|Adverse Event|1|||
129929618|NCT03519178|467709727|FG009|PF-06873600 Treatment|Adverse Event|0|||
129929619|NCT03519178|467709728|FG010|PF-06873600 Treatment|Adverse Event|0|||
129929620|NCT03519178|467709729|FG011|PF-06873600 Treatment|Adverse Event|0|||
129929621|NCT03519178|467709730|FG012|PF-06873600 Treatment|Adverse Event|1|||
129929622|NCT03519178|467709731|FG013|PF-06873600 Treatment|Adverse Event|3|||
129929623|NCT03519178|467709732|FG014|PF-06873600 Treatment|Adverse Event|2|||
129929624|NCT03519178|467709718|FG000|PF-06873600 Treatment|Death|0|||
129929625|NCT03519178|467709719|FG001|PF-06873600 Treatment|Death|0|||
129929626|NCT03519178|467709720|FG002|PF-06873600 Treatment|Death|0|||
129929627|NCT03519178|467709721|FG003|PF-06873600 Treatment|Death|0|||
130117752|NCT04345471|468390648|FG002|Overall Study|Lack of Efficacy|0|||
129929628|NCT03519178|467709722|FG004|PF-06873600 Treatment|Death|0|||
129929629|NCT03519178|467709723|FG005|PF-06873600 Treatment|Death|0|||
129929630|NCT03519178|467709724|FG006|PF-06873600 Treatment|Death|0|||
129929631|NCT03519178|467709725|FG007|PF-06873600 Treatment|Death|0|||
129929632|NCT03519178|467709726|FG008|PF-06873600 Treatment|Death|1|||
129929633|NCT03519178|467709727|FG009|PF-06873600 Treatment|Death|1|||
129929634|NCT03519178|467709728|FG010|PF-06873600 Treatment|Death|0|||
129929635|NCT03519178|467709729|FG011|PF-06873600 Treatment|Death|0|||
130117753|NCT04345471|468390646|FG000|Overall Study|Protocol Violation|0|||
130117754|NCT04345471|468390647|FG001|Overall Study|Protocol Violation|1|||
129929636|NCT03519178|467709730|FG012|PF-06873600 Treatment|Death|0|||
129929637|NCT03519178|467709731|FG013|PF-06873600 Treatment|Death|0|||
130117755|NCT04345471|468390648|FG002|Overall Study|Protocol Violation|2|||
129929638|NCT03519178|467709732|FG014|PF-06873600 Treatment|Death|1|||
129929639|NCT03519178|467709718|FG000|PF-06873600 Treatment|Physician Decision|0|||
129929640|NCT03519178|467709719|FG001|PF-06873600 Treatment|Physician Decision|0|||
129929641|NCT03519178|467709720|FG002|PF-06873600 Treatment|Physician Decision|0|||
129929642|NCT03519178|467709721|FG003|PF-06873600 Treatment|Physician Decision|0|||
129929643|NCT03519178|467709722|FG004|PF-06873600 Treatment|Physician Decision|0|||
129929644|NCT03519178|467709723|FG005|PF-06873600 Treatment|Physician Decision|0|||
129929645|NCT03519178|467709724|FG006|PF-06873600 Treatment|Physician Decision|0|||
129929646|NCT03519178|467709725|FG007|PF-06873600 Treatment|Physician Decision|1|||
129929647|NCT03519178|467709726|FG008|PF-06873600 Treatment|Physician Decision|0|||
129929648|NCT03519178|467709727|FG009|PF-06873600 Treatment|Physician Decision|0|||
130117756|NCT04345471|468390646|FG000|Overall Study|Withdrawal by Subject|10|||
130117757|NCT04345471|468390647|FG001|Overall Study|Withdrawal by Subject|5|||
130117758|NCT04345471|468390648|FG002|Overall Study|Withdrawal by Subject|10|||
130117759|NCT03896490|468390683|FG000|Overall Study|Withdrawal by Subject|1|||
130117760|NCT03896490|468390684|FG001|Overall Study|Withdrawal by Subject|1|||
130117761|NCT00003782|468390685|FG000|Overall Study|No follow up data|30|||
130117762|NCT00003782|468390686|FG001|Overall Study|No follow up data|31|||
130117763|NCT00003782|468390687|FG002|Overall Study|No follow up data|26|||
130117764|NCT01890707|468390688|FG000|Overall Study|Lost to Follow-up|1|||
130117765|NCT01890707|468390689|FG001|Overall Study|Lost to Follow-up|1|||
130117766|NCT01326026|468390691|FG000|Overall Study|Adverse Event|4|||
130117767|NCT01326026|468390692|FG001|Overall Study|Adverse Event|3|||
130117768|NCT01326026|468390691|FG000|Overall Study|Withdrawal Criteria|5|||
130117769|NCT01326026|468390692|FG001|Overall Study|Withdrawal Criteria|7|||
130117770|NCT01326026|468390691|FG000|Overall Study|Other|3|||
130117771|NCT01326026|468390692|FG001|Overall Study|Other|3|||
130117772|NCT05188521|468392325|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
130117773|NCT05188521|468392326|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
130117774|NCT01341639|468392327|FG000|Infant Series|Protocol Violation|1|||
130117775|NCT01341639|468392328|FG001|Infant Series|Protocol Violation|0|||
130117776|NCT01341639|468392327|FG000|Infant Series|Not Vaccinated|0|||
130117777|NCT01341639|468392328|FG001|Infant Series|Not Vaccinated|1|||
130117778|NCT01341639|468392327|FG000|Infant Series|Adverse Event|0|||
130117779|NCT01341639|468392328|FG001|Infant Series|Adverse Event|5|||
130117780|NCT01341639|468392327|FG000|Infant Series|Withdrawal by Subject|11|||
130117781|NCT01341639|468392328|FG001|Infant Series|Withdrawal by Subject|8|||
130117782|NCT01341639|468392327|FG000|Infant Series|Lost to Follow-up|0|||
130117783|NCT01341639|468392328|FG001|Infant Series|Lost to Follow-up|2|||
130117784|NCT01341639|468392327|FG000|Infant Series|Site 0048 Participants|17|||
130117785|NCT01341639|468392328|FG001|Infant Series|Site 0048 Participants|16|||
130117786|NCT01341639|468392327|FG000|Interim Period|Withdrawal by Subject|6|||
130117787|NCT01341639|468392328|FG001|Interim Period|Withdrawal by Subject|7|||
130117788|NCT01341639|468392327|FG000|Interim Period|Lost to Follow-up|2|||
130117789|NCT01341639|468392328|FG001|Interim Period|Lost to Follow-up|0|||
130117790|NCT01341639|468392327|FG000|Interim Period|Physician Decision|0|||
130117791|NCT01341639|468392328|FG001|Interim Period|Physician Decision|1|||
130117792|NCT01341639|468392327|FG000|Interim Period|Protocol Violation|0|||
130117793|NCT01341639|468392328|FG001|Interim Period|Protocol Violation|1|||
130117794|NCT01341639|468392327|FG000|Post-Treatment|Withdrawal by Subject|0|||
130117795|NCT01341639|468392328|FG001|Post-Treatment|Withdrawal by Subject|1|||
130117796|NCT01341639|468392327|FG000|Post-Treatment|Adverse Event|0|||
130117797|NCT01341639|468392328|FG001|Post-Treatment|Adverse Event|2|||
130117798|NCT04582266|468392329|FG000|Overall Study|Lost to Follow-up|7|||
130117799|NCT04582266|468392330|FG001|Overall Study|Lost to Follow-up|5|||
130117800|NCT04582266|468392329|FG000|Overall Study|Withdrawal by Subject|1|||
130117801|NCT04582266|468392330|FG001|Overall Study|Withdrawal by Subject|0|||
130117802|NCT04582266|468392329|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
130117803|NCT04582266|468392330|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
130117804|NCT01241461|468392331|FG000|Overall Study|Progressive Disease|3|||
130117805|NCT01241461|468392332|FG001|Overall Study|Progressive Disease|6|||
130117806|NCT01132118|468392333|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
130117807|NCT01132118|468392334|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
130117808|NCT01132118|468392333|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130117809|NCT01132118|468392334|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
130117810|NCT01132118|468392333|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
130117811|NCT01132118|468392334|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
130117812|NCT03705351|468392337|FG000|Overall Study|Study termination|3|||
130117813|NCT03705351|468392337|FG000|Overall Study|Death|1|||
130117814|NCT03705351|468392337|FG000|Overall Study|Lack of Efficacy|2|||
130117815|NCT03705351|468392337|FG000|Overall Study|Withdrawal by Subject|1|||
129929649|NCT03519178|467709728|FG010|PF-06873600 Treatment|Physician Decision|1|||
129929650|NCT03519178|467709729|FG011|PF-06873600 Treatment|Physician Decision|0|||
129929651|NCT03519178|467709730|FG012|PF-06873600 Treatment|Physician Decision|0|||
130117816|NCT01299038|468392345|FG000|Overall Study|Withdrawal by Subject|1|||
130117817|NCT01299038|468392346|FG001|Overall Study|Withdrawal by Subject|0|||
130117818|NCT00322556|468392347|FG000|Overall Study|Adverse Event|1|||
130117819|NCT00322556|468392347|FG000|Overall Study|Withdrawal by Subject|1|||
130117820|NCT00322556|468392347|FG000|Overall Study|Lost to Follow-up|3|||
130117821|NCT00322556|468392347|FG000|Overall Study|Other Reason|7|||
129929652|NCT03519178|467709731|FG013|PF-06873600 Treatment|Physician Decision|4|||
130117822|NCT00704418|468392348|FG000|Overall Study|Withdrawal by Subject|2|||
130117823|NCT00704418|468392349|FG001|Overall Study|Withdrawal by Subject|0|||
130117824|NCT00704418|468392348|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
130117825|NCT00704418|468392349|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
130117826|NCT02322879|468392350|FG000|First Intervention|Physician Decision|1|||
130117827|NCT02322879|468392351|FG001|First Intervention|Physician Decision|0|||
130117828|NCT02295774|468392352|FG000|Overall Study|Physician Decision|1|||
129929653|NCT03519178|467709732|FG014|PF-06873600 Treatment|Physician Decision|1|||
129929654|NCT03519178|467709718|FG000|PF-06873600 Treatment|Progressive disease|1|||
129929655|NCT03519178|467709719|FG001|PF-06873600 Treatment|Progressive disease|1|||
129929656|NCT03519178|467709720|FG002|PF-06873600 Treatment|Progressive disease|1|||
129929657|NCT03519178|467709721|FG003|PF-06873600 Treatment|Progressive disease|1|||
129929658|NCT03519178|467709722|FG004|PF-06873600 Treatment|Progressive disease|6|||
129929659|NCT03519178|467709723|FG005|PF-06873600 Treatment|Progressive disease|7|||
129929660|NCT03519178|467709724|FG006|PF-06873600 Treatment|Progressive disease|3|||
129929661|NCT03519178|467709725|FG007|PF-06873600 Treatment|Progressive disease|7|||
129929662|NCT03519178|467709726|FG008|PF-06873600 Treatment|Progressive disease|3|||
129929663|NCT03519178|467709727|FG009|PF-06873600 Treatment|Progressive disease|5|||
129929664|NCT03519178|467709728|FG010|PF-06873600 Treatment|Progressive disease|4|||
129929665|NCT03519178|467709729|FG011|PF-06873600 Treatment|Progressive disease|3|||
129929666|NCT03519178|467709730|FG012|PF-06873600 Treatment|Progressive disease|4|||
129929667|NCT03519178|467709731|FG013|PF-06873600 Treatment|Progressive disease|28|||
129929668|NCT03519178|467709732|FG014|PF-06873600 Treatment|Progressive disease|7|||
129929669|NCT03519178|467709718|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929670|NCT03519178|467709719|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929671|NCT03519178|467709720|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929672|NCT03519178|467709721|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929673|NCT03519178|467709722|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929674|NCT03519178|467709723|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929675|NCT03519178|467709724|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929676|NCT03519178|467709725|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929677|NCT03519178|467709726|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
129929678|NCT03519178|467709727|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929679|NCT03519178|467709728|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929680|NCT03519178|467709729|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929681|NCT03519178|467709730|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929682|NCT03519178|467709731|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929683|NCT03519178|467709732|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929684|NCT03519178|467709718|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
129929685|NCT03519178|467709719|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
129929686|NCT03519178|467709720|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
129929687|NCT03519178|467709721|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
129929688|NCT03519178|467709722|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
129929689|NCT03519178|467709723|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
129929690|NCT03519178|467709724|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
129929691|NCT03519178|467709725|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
129929692|NCT03519178|467709726|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
129929693|NCT03519178|467709727|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
129929694|NCT03519178|467709728|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
129929695|NCT03519178|467709729|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
129929696|NCT03519178|467709730|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
129929697|NCT03519178|467709731|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
129929698|NCT03519178|467709732|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
129929699|NCT03519178|467709718|FG000|PF-06873600 Treatment|Refused further treatment|0|||
129929700|NCT03519178|467709719|FG001|PF-06873600 Treatment|Refused further treatment|1|||
129929701|NCT03519178|467709720|FG002|PF-06873600 Treatment|Refused further treatment|0|||
129929702|NCT03519178|467709721|FG003|PF-06873600 Treatment|Refused further treatment|0|||
129929703|NCT03519178|467709722|FG004|PF-06873600 Treatment|Refused further treatment|1|||
129929704|NCT03519178|467709723|FG005|PF-06873600 Treatment|Refused further treatment|0|||
129929705|NCT03519178|467709724|FG006|PF-06873600 Treatment|Refused further treatment|0|||
129929706|NCT03519178|467709725|FG007|PF-06873600 Treatment|Refused further treatment|0|||
129929707|NCT03519178|467709726|FG008|PF-06873600 Treatment|Refused further treatment|0|||
129929708|NCT03519178|467709727|FG009|PF-06873600 Treatment|Refused further treatment|0|||
129929709|NCT03519178|467709728|FG010|PF-06873600 Treatment|Refused further treatment|0|||
129929710|NCT03519178|467709729|FG011|PF-06873600 Treatment|Refused further treatment|0|||
129929711|NCT03519178|467709730|FG012|PF-06873600 Treatment|Refused further treatment|0|||
129929712|NCT03519178|467709731|FG013|PF-06873600 Treatment|Refused further treatment|0|||
129929713|NCT03519178|467709732|FG014|PF-06873600 Treatment|Refused further treatment|1|||
129929714|NCT03519178|467709718|FG000|PF-06873600 Treatment|Other|0|||
130117829|NCT02295774|468392352|FG000|Overall Study|Withdrawal by Subject|2|||
130117830|NCT01673009|468392354|FG000|Overall Study|Physician Decision|5|||
129929715|NCT03519178|467709719|FG001|PF-06873600 Treatment|Other|0|||
129929716|NCT03519178|467709720|FG002|PF-06873600 Treatment|Other|0|||
129929717|NCT03519178|467709721|FG003|PF-06873600 Treatment|Other|0|||
129929718|NCT03519178|467709722|FG004|PF-06873600 Treatment|Other|0|||
129929719|NCT03519178|467709723|FG005|PF-06873600 Treatment|Other|0|||
130117831|NCT01673009|468392354|FG000|Overall Study|Withdrawal by Subject|8|||
129929720|NCT03519178|467709724|FG006|PF-06873600 Treatment|Other|0|||
129929721|NCT03519178|467709725|FG007|PF-06873600 Treatment|Other|0|||
129929722|NCT03519178|467709726|FG008|PF-06873600 Treatment|Other|1|||
129929723|NCT03519178|467709727|FG009|PF-06873600 Treatment|Other|0|||
129929724|NCT03519178|467709728|FG010|PF-06873600 Treatment|Other|0|||
129929725|NCT03519178|467709729|FG011|PF-06873600 Treatment|Other|0|||
129929726|NCT03519178|467709730|FG012|PF-06873600 Treatment|Other|0|||
129929727|NCT03519178|467709731|FG013|PF-06873600 Treatment|Other|1|||
129929728|NCT03519178|467709732|FG014|PF-06873600 Treatment|Other|3|||
129929729|NCT03519178|467709718|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
129929730|NCT03519178|467709719|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
129929731|NCT03519178|467709720|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
129929732|NCT03519178|467709721|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
129929733|NCT03519178|467709722|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
129929734|NCT03519178|467709723|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
129929735|NCT03519178|467709724|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
129929736|NCT03519178|467709725|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
129929737|NCT03519178|467709726|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
129929738|NCT03519178|467709727|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
129929739|NCT03519178|467709728|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
129929740|NCT03519178|467709729|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
129929741|NCT03519178|467709730|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
129929742|NCT03519178|467709731|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
129929743|NCT03519178|467709732|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
129929744|NCT03519178|467709718|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929745|NCT03519178|467709719|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929746|NCT03519178|467709720|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929747|NCT03519178|467709721|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929748|NCT03519178|467709722|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929749|NCT03519178|467709723|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929750|NCT03519178|467709724|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929751|NCT03519178|467709725|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929752|NCT03519178|467709726|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929753|NCT03519178|467709727|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929754|NCT03519178|467709728|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929755|NCT03519178|467709729|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929756|NCT03519178|467709730|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929757|NCT03519178|467709731|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
129929758|NCT03519178|467709732|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
129929759|NCT03519178|467709718|FG000|PF-06873600 Treatment|Ongoing|0|||
129929760|NCT03519178|467709719|FG001|PF-06873600 Treatment|Ongoing|0|||
129929761|NCT03519178|467709720|FG002|PF-06873600 Treatment|Ongoing|0|||
129929762|NCT03519178|467709721|FG003|PF-06873600 Treatment|Ongoing|0|||
129929763|NCT03519178|467709722|FG004|PF-06873600 Treatment|Ongoing|0|||
129929764|NCT03519178|467709723|FG005|PF-06873600 Treatment|Ongoing|0|||
129929765|NCT03519178|467709724|FG006|PF-06873600 Treatment|Ongoing|0|||
129929766|NCT03519178|467709725|FG007|PF-06873600 Treatment|Ongoing|0|||
129929767|NCT03519178|467709726|FG008|PF-06873600 Treatment|Ongoing|0|||
129929768|NCT03519178|467709727|FG009|PF-06873600 Treatment|Ongoing|0|||
129929769|NCT03519178|467709728|FG010|PF-06873600 Treatment|Ongoing|0|||
129929770|NCT03519178|467709729|FG011|PF-06873600 Treatment|Ongoing|0|||
129929771|NCT03519178|467709730|FG012|PF-06873600 Treatment|Ongoing|0|||
129929772|NCT03519178|467709731|FG013|PF-06873600 Treatment|Ongoing|1|||
129929773|NCT03519178|467709732|FG014|PF-06873600 Treatment|Ongoing|6|||
129929774|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929775|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929776|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929777|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929778|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929779|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929780|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929781|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929782|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929783|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929784|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929785|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929786|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929787|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
129929788|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929789|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Death|0|||
129929790|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Death|0|||
129929791|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Death|0|||
129929792|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Death|0|||
130117832|NCT02623959|468392357|FG000|Overall Study|Progression|0|||
130117833|NCT02623959|468392358|FG001|Overall Study|Progression|1|||
130117834|NCT00384033|468392365|FG000|Overall Study|Adverse Event|10|||
130117835|NCT00384033|468392366|FG001|Overall Study|Adverse Event|8|||
130117836|NCT00384033|468392367|FG002|Overall Study|Adverse Event|11|||
130117837|NCT00384033|468392368|FG003|Overall Study|Adverse Event|20|||
130117838|NCT00384033|468392365|FG000|Overall Study|Failed to return|1|||
130117839|NCT00384033|468392366|FG001|Overall Study|Failed to return|3|||
130117840|NCT00384033|468392367|FG002|Overall Study|Failed to return|2|||
130117841|NCT00384033|468392368|FG003|Overall Study|Failed to return|2|||
130117842|NCT00384033|468392365|FG000|Overall Study|Physician Decision|1|||
130117843|NCT00384033|468392366|FG001|Overall Study|Physician Decision|0|||
130117844|NCT00384033|468392367|FG002|Overall Study|Physician Decision|0|||
130117845|NCT00384033|468392368|FG003|Overall Study|Physician Decision|0|||
130117846|NCT00384033|468392365|FG000|Overall Study|Lost to Follow-up|6|||
130117847|NCT00384033|468392366|FG001|Overall Study|Lost to Follow-up|12|||
130117848|NCT00384033|468392367|FG002|Overall Study|Lost to Follow-up|7|||
130117849|NCT00384033|468392368|FG003|Overall Study|Lost to Follow-up|7|||
130117850|NCT00384033|468392365|FG000|Overall Study|Other|2|||
130117851|NCT00384033|468392366|FG001|Overall Study|Other|0|||
130117852|NCT00384033|468392367|FG002|Overall Study|Other|0|||
130117853|NCT00384033|468392368|FG003|Overall Study|Other|0|||
130117854|NCT00384033|468392365|FG000|Overall Study|Protocol Violation|5|||
130117855|NCT00384033|468392366|FG001|Overall Study|Protocol Violation|0|||
130117856|NCT00384033|468392367|FG002|Overall Study|Protocol Violation|5|||
129929793|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Death|0|||
129929794|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Death|0|||
129929795|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Death|0|||
129929796|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Death|0|||
129929797|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Death|0|||
129929798|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Death|1|||
129929799|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Death|0|||
129929800|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Death|0|||
129929801|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Death|0|||
129929802|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Death|0|||
129929803|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Death|1|||
129929804|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929805|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929806|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929807|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929808|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929809|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929810|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929811|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929812|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929813|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929814|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929815|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929816|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929817|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929818|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
129929819|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929820|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929821|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929822|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929823|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929824|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929825|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929826|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929827|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130117857|NCT00384033|468392368|FG003|Overall Study|Protocol Violation|6|||
130117858|NCT00384033|468392365|FG000|Overall Study|Withdrawal by Subject|6|||
130117859|NCT00384033|468392366|FG001|Overall Study|Withdrawal by Subject|2|||
130117860|NCT00384033|468392367|FG002|Overall Study|Withdrawal by Subject|5|||
130117861|NCT00384033|468392368|FG003|Overall Study|Withdrawal by Subject|2|||
130117862|NCT00384033|468392365|FG000|Overall Study|Lack of Efficacy|7|||
130117863|NCT00384033|468392366|FG001|Overall Study|Lack of Efficacy|3|||
130117864|NCT00384033|468392367|FG002|Overall Study|Lack of Efficacy|3|||
130117865|NCT00384033|468392368|FG003|Overall Study|Lack of Efficacy|1|||
130117866|NCT00384033|468392365|FG000|Overall Study|Randomized but not treated|3|||
129929828|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
130117867|NCT00384033|468392366|FG001|Overall Study|Randomized but not treated|7|||
130117868|NCT00384033|468392367|FG002|Overall Study|Randomized but not treated|10|||
129929829|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929830|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929831|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929832|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
129929833|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
129929834|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929835|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929836|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929837|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929838|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929839|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929840|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929841|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929842|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929843|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
129929844|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929845|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929846|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929847|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
129929848|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
129929849|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929850|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929851|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929852|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929853|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929854|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929855|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929856|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929857|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929858|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929859|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929860|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929861|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929862|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
129929863|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
129929864|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929865|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929866|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929867|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929868|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929869|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929870|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929871|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929872|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929873|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
129929874|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929875|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929876|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929877|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
129929878|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
129929879|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929880|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929881|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929882|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929883|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929884|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929885|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929886|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929887|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929888|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
129929889|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129979761|NCT01283516|467889462|FG006|Overall Study|Lost to Follow-up|0|||
130117869|NCT00384033|468392368|FG003|Overall Study|Randomized but not treated|2|||
130117870|NCT00290745|468392369|FG000|Overall Study|Withdrawal by Subject|4|||
130117871|NCT00290745|468392369|FG000|Overall Study|Physician Decision|2|||
130117872|NCT00290745|468392369|FG000|Overall Study|Surgery after 3 months for progression|3|||
130117873|NCT00290745|468392369|FG000|Overall Study|Baseline MRI not available|3|||
130117874|NCT03361423|468392370|FG000|Overall Study|Withdrawal by Subject|4|||
130117875|NCT03361423|468392371|FG001|Overall Study|Withdrawal by Subject|3|||
130117876|NCT03361423|468392370|FG000|Overall Study|Did not treat|19|||
130117877|NCT03361423|468392371|FG001|Overall Study|Did not treat|18|||
130117878|NCT03361423|468392370|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
130117879|NCT03361423|468392371|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
130117880|NCT03361423|468392370|FG000|Overall Study|Missing data|4|||
130117881|NCT03361423|468392371|FG001|Overall Study|Missing data|1|||
130117882|NCT01336894|468392372|FG000|Follow-up|Study terminated prematurely|2|||
130117883|NCT01336894|468392373|FG001|Follow-up|Study terminated prematurely|7|||
130117884|NCT03937466|468392374|FG000|Overall Study|not eligbile after the 2-week diary|9|||
130117885|NCT03937466|468392374|FG000|Overall Study|never returned their diary|6|||
130117886|NCT03937466|468392374|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
130117887|NCT03937466|468392374|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
130117888|NCT00622908|468392375|FG000|Overall Study|Protocol Violation|1|||
130117889|NCT00622908|468392376|FG001|Overall Study|Protocol Violation|0|||
130117890|NCT00622908|468392375|FG000|Overall Study|Adverse Event|0|||
130117891|NCT00622908|468392376|FG001|Overall Study|Adverse Event|1|||
130117892|NCT00622908|468392375|FG000|Overall Study|Lack of Efficacy|1|||
130117893|NCT00622908|468392376|FG001|Overall Study|Lack of Efficacy|7|||
130117894|NCT00622908|468392375|FG000|Overall Study|Lost to Follow-up|1|||
130117895|NCT00622908|468392376|FG001|Overall Study|Lost to Follow-up|0|||
130117896|NCT00622908|468392375|FG000|Overall Study|Refusal|0|||
130117897|NCT00622908|468392376|FG001|Overall Study|Refusal|1|||
130117898|NCT00622908|468392375|FG000|Overall Study|Termination by study sponser|0|||
130117899|NCT00622908|468392376|FG001|Overall Study|Termination by study sponser|1|||
130117900|NCT00113490|468392377|FG000|Overall Study|Withdrawal by Subject|1|||
130117901|NCT00113490|468392378|FG001|Overall Study|Withdrawal by Subject|3|||
130117902|NCT00113490|468392377|FG000|Overall Study|Lost to Follow-up|1|||
130117903|NCT00113490|468392378|FG001|Overall Study|Lost to Follow-up|0|||
130117904|NCT02162758|468392379|FG000|Overall Study|Study termination|0|||
130117905|NCT02162758|468392380|FG001|Overall Study|Study termination|1|||
130117906|NCT04471935|468392381|FG000|Overall Study|Withdrawal by Subject|1|||
130117907|NCT04471935|468392381|FG000|Overall Study|Deemed ineligible to participate|1|||
130117908|NCT01659567|468392384|FG000|Overall Study|Lack of Efficacy|22|||
130117909|NCT01659567|468392384|FG000|Overall Study|Switched to Pegferon|6|||
130117910|NCT01659567|468392384|FG000|Overall Study|Adverse Event|12|||
130117911|NCT01659567|468392384|FG000|Overall Study|Good result at early stage of treatment|5|||
130117912|NCT01659567|468392384|FG000|Overall Study|Withdrawal by Subject|64|||
130117913|NCT01659567|468392384|FG000|Overall Study|Progression of the main disease|1|||
130117914|NCT01659567|468392384|FG000|Overall Study|Other|13|||
130117915|NCT03019965|468392385|FG000|Overall Study|Withdrawal by Subject|1|||
130117916|NCT03019965|468392386|FG001|Overall Study|Withdrawal by Subject|0|||
130117917|NCT03019965|468392385|FG000|Overall Study|Protocol Violation|1|||
130117918|NCT03019965|468392386|FG001|Overall Study|Protocol Violation|3|||
130117919|NCT03019965|468392385|FG000|Overall Study|viral or fungal infection|3|||
130117920|NCT03019965|468392386|FG001|Overall Study|viral or fungal infection|4|||
130117921|NCT03019965|468392385|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
130117922|NCT03019965|468392386|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
130117923|NCT03019965|468392385|FG000|Overall Study|Physician Decision|1|||
130117924|NCT03019965|468392386|FG001|Overall Study|Physician Decision|1|||
130117925|NCT03213210|468392387|FG000|Overall Study|Lost to Follow-up|2|||
130117926|NCT03213210|468392387|FG000|Overall Study|Study termination|3|||
130117927|NCT01325207|468392395|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129929890|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929891|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929892|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
129929893|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929894|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
130117928|NCT01325207|468392396|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130117929|NCT01325207|468392397|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130117930|NCT01325207|468392398|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130117931|NCT01325207|468392399|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
130117932|NCT01325207|468392400|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
130117933|NCT01325207|468392395|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
130117934|NCT01325207|468392396|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
130117935|NCT01325207|468392397|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
129929895|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929896|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929897|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929898|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929899|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929900|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929901|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929902|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929903|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929904|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929905|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929906|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929907|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929908|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
129929909|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Other|0|||
129929910|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Other|0|||
129929911|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Other|0|||
129929912|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Other|0|||
129929913|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Other|0|||
129929914|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Other|0|||
129929915|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Other|0|||
129929916|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Other|0|||
129929917|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Other|0|||
129929918|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Other|0|||
129929919|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Other|0|||
129929920|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Other|0|||
129929921|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Other|0|||
129929922|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Other|1|||
129929923|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Other|3|||
129929924|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929925|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929926|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929927|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929928|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929929|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929930|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929931|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929932|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929933|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929934|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929935|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929936|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929937|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
129929938|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
129929939|NCT03519178|467709718|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
129929940|NCT03519178|467709719|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
129929941|NCT03519178|467709720|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
129929942|NCT03519178|467709721|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
129929943|NCT03519178|467709722|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
129929944|NCT03519178|467709723|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
129929945|NCT03519178|467709724|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
129929946|NCT03519178|467709725|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
129929947|NCT03519178|467709726|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
129929948|NCT03519178|467709727|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
129929949|NCT03519178|467709728|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
129929950|NCT03519178|467709729|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
129929951|NCT03519178|467709730|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
129929952|NCT03519178|467709731|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
129929953|NCT03519178|467709732|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
129929954|NCT03519178|467709718|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
129929955|NCT03519178|467709719|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
129929956|NCT03519178|467709720|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
129929957|NCT03519178|467709721|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
129929958|NCT03519178|467709722|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
129929959|NCT03519178|467709723|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
130117936|NCT01325207|468392398|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
129929960|NCT03519178|467709724|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
129929961|NCT03519178|467709725|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
129929962|NCT03519178|467709726|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
129929963|NCT03519178|467709727|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
129929964|NCT03519178|467709728|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
129929965|NCT03519178|467709729|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
129929966|NCT03519178|467709730|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
129929967|NCT03519178|467709731|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
129929968|NCT03519178|467709732|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
129929969|NCT03519178|467709718|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929970|NCT03519178|467709719|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929971|NCT03519178|467709720|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929972|NCT03519178|467709721|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929973|NCT03519178|467709722|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929974|NCT03519178|467709723|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929975|NCT03519178|467709724|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929976|NCT03519178|467709725|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929977|NCT03519178|467709726|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929978|NCT03519178|467709727|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929979|NCT03519178|467709728|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
129929980|NCT03519178|467709729|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929981|NCT03519178|467709730|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929982|NCT03519178|467709731|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929983|NCT03519178|467709732|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929984|NCT03519178|467709718|FG000|Follow-Up|Death|0|||
129929985|NCT03519178|467709719|FG001|Follow-Up|Death|0|||
129929986|NCT03519178|467709720|FG002|Follow-Up|Death|1|||
129929987|NCT03519178|467709721|FG003|Follow-Up|Death|0|||
129929988|NCT03519178|467709722|FG004|Follow-Up|Death|0|||
129929989|NCT03519178|467709723|FG005|Follow-Up|Death|0|||
129929990|NCT03519178|467709724|FG006|Follow-Up|Death|0|||
129929991|NCT03519178|467709725|FG007|Follow-Up|Death|0|||
129929992|NCT03519178|467709726|FG008|Follow-Up|Death|3|||
129929993|NCT03519178|467709727|FG009|Follow-Up|Death|1|||
129929994|NCT03519178|467709728|FG010|Follow-Up|Death|0|||
129929995|NCT03519178|467709729|FG011|Follow-Up|Death|0|||
129929996|NCT03519178|467709730|FG012|Follow-Up|Death|2|||
129929997|NCT03519178|467709731|FG013|Follow-Up|Death|0|||
129929998|NCT03519178|467709732|FG014|Follow-Up|Death|0|||
129929999|NCT03519178|467709718|FG000|Follow-Up|Lost to Follow-up|0|||
129930000|NCT03519178|467709719|FG001|Follow-Up|Lost to Follow-up|0|||
129930001|NCT03519178|467709720|FG002|Follow-Up|Lost to Follow-up|0|||
129930002|NCT03519178|467709721|FG003|Follow-Up|Lost to Follow-up|0|||
129930003|NCT03519178|467709722|FG004|Follow-Up|Lost to Follow-up|0|||
129930004|NCT03519178|467709723|FG005|Follow-Up|Lost to Follow-up|3|||
129930005|NCT03519178|467709724|FG006|Follow-Up|Lost to Follow-up|1|||
129930006|NCT03519178|467709725|FG007|Follow-Up|Lost to Follow-up|4|||
129930007|NCT03519178|467709726|FG008|Follow-Up|Lost to Follow-up|1|||
129930008|NCT03519178|467709727|FG009|Follow-Up|Lost to Follow-up|0|||
129930009|NCT03519178|467709728|FG010|Follow-Up|Lost to Follow-up|0|||
129930010|NCT03519178|467709729|FG011|Follow-Up|Lost to Follow-up|0|||
129930011|NCT03519178|467709730|FG012|Follow-Up|Lost to Follow-up|0|||
129930012|NCT03519178|467709731|FG013|Follow-Up|Lost to Follow-up|0|||
129930013|NCT03519178|467709732|FG014|Follow-Up|Lost to Follow-up|0|||
129930014|NCT03519178|467709718|FG000|Follow-Up|Withdrawal by Subject|1|||
129930015|NCT03519178|467709719|FG001|Follow-Up|Withdrawal by Subject|2|||
129930016|NCT03519178|467709720|FG002|Follow-Up|Withdrawal by Subject|2|||
129930017|NCT03519178|467709721|FG003|Follow-Up|Withdrawal by Subject|3|||
129930018|NCT03519178|467709722|FG004|Follow-Up|Withdrawal by Subject|5|||
129930019|NCT03519178|467709723|FG005|Follow-Up|Withdrawal by Subject|1|||
129930020|NCT03519178|467709724|FG006|Follow-Up|Withdrawal by Subject|2|||
129930021|NCT03519178|467709725|FG007|Follow-Up|Withdrawal by Subject|6|||
129930022|NCT03519178|467709726|FG008|Follow-Up|Withdrawal by Subject|5|||
129930023|NCT03519178|467709727|FG009|Follow-Up|Withdrawal by Subject|2|||
129930024|NCT03519178|467709728|FG010|Follow-Up|Withdrawal by Subject|3|||
129930025|NCT03519178|467709729|FG011|Follow-Up|Withdrawal by Subject|5|||
129930026|NCT03519178|467709730|FG012|Follow-Up|Withdrawal by Subject|2|||
129930027|NCT03519178|467709731|FG013|Follow-Up|Withdrawal by Subject|0|||
129930028|NCT03519178|467709732|FG014|Follow-Up|Withdrawal by Subject|0|||
129930029|NCT03519178|467709718|FG000|Follow-Up|Other|0|||
129930030|NCT03519178|467709719|FG001|Follow-Up|Other|0|||
129930031|NCT03519178|467709720|FG002|Follow-Up|Other|0|||
129930032|NCT03519178|467709721|FG003|Follow-Up|Other|0|||
129930033|NCT03519178|467709722|FG004|Follow-Up|Other|0|||
129930034|NCT03519178|467709723|FG005|Follow-Up|Other|0|||
129930035|NCT03519178|467709724|FG006|Follow-Up|Other|0|||
129930036|NCT03519178|467709725|FG007|Follow-Up|Other|1|||
129930037|NCT03519178|467709726|FG008|Follow-Up|Other|0|||
129930038|NCT03519178|467709727|FG009|Follow-Up|Other|0|||
129930039|NCT03519178|467709728|FG010|Follow-Up|Other|0|||
129930040|NCT03519178|467709729|FG011|Follow-Up|Other|0|||
129930041|NCT03519178|467709730|FG012|Follow-Up|Other|0|||
129930042|NCT03519178|467709731|FG013|Follow-Up|Other|0|||
129930043|NCT03519178|467709732|FG014|Follow-Up|Other|0|||
129930044|NCT03519178|467709718|FG000|Long-term Follow-up|Death|0|||
129930045|NCT03519178|467709719|FG001|Long-term Follow-up|Death|0|||
129930046|NCT03519178|467709720|FG002|Long-term Follow-up|Death|0|||
129930047|NCT03519178|467709721|FG003|Long-term Follow-up|Death|0|||
129930048|NCT03519178|467709722|FG004|Long-term Follow-up|Death|0|||
129930049|NCT03519178|467709723|FG005|Long-term Follow-up|Death|0|||
129930050|NCT03519178|467709724|FG006|Long-term Follow-up|Death|0|||
129930051|NCT03519178|467709725|FG007|Long-term Follow-up|Death|0|||
129930052|NCT03519178|467709726|FG008|Long-term Follow-up|Death|0|||
129930053|NCT03519178|467709727|FG009|Long-term Follow-up|Death|0|||
129930054|NCT03519178|467709728|FG010|Long-term Follow-up|Death|0|||
129930055|NCT03519178|467709729|FG011|Long-term Follow-up|Death|0|||
129930056|NCT03519178|467709730|FG012|Long-term Follow-up|Death|0|||
129930057|NCT03519178|467709731|FG013|Long-term Follow-up|Death|4|||
129930058|NCT03519178|467709732|FG014|Long-term Follow-up|Death|4|||
129930059|NCT03519178|467709718|FG000|Long-term Follow-up|Lost to Follow-up|0|||
129930060|NCT03519178|467709719|FG001|Long-term Follow-up|Lost to Follow-up|0|||
129930061|NCT03519178|467709720|FG002|Long-term Follow-up|Lost to Follow-up|0|||
129930062|NCT03519178|467709721|FG003|Long-term Follow-up|Lost to Follow-up|0|||
129930063|NCT03519178|467709722|FG004|Long-term Follow-up|Lost to Follow-up|0|||
129930064|NCT03519178|467709723|FG005|Long-term Follow-up|Lost to Follow-up|0|||
129930065|NCT03519178|467709724|FG006|Long-term Follow-up|Lost to Follow-up|0|||
129930066|NCT03519178|467709725|FG007|Long-term Follow-up|Lost to Follow-up|0|||
129930067|NCT03519178|467709726|FG008|Long-term Follow-up|Lost to Follow-up|0|||
129930068|NCT03519178|467709727|FG009|Long-term Follow-up|Lost to Follow-up|0|||
129930069|NCT03519178|467709728|FG010|Long-term Follow-up|Lost to Follow-up|0|||
129930070|NCT03519178|467709729|FG011|Long-term Follow-up|Lost to Follow-up|0|||
129930071|NCT03519178|467709730|FG012|Long-term Follow-up|Lost to Follow-up|0|||
129930072|NCT03519178|467709731|FG013|Long-term Follow-up|Lost to Follow-up|1|||
129930073|NCT03519178|467709732|FG014|Long-term Follow-up|Lost to Follow-up|1|||
129930074|NCT03519178|467709718|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
129930075|NCT03519178|467709719|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
129930076|NCT03519178|467709720|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
129930077|NCT03519178|467709721|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
129930078|NCT03519178|467709722|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
129930079|NCT03519178|467709723|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
129930080|NCT03519178|467709724|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
129930081|NCT03519178|467709725|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
129930082|NCT03519178|467709726|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
129930083|NCT03519178|467709727|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
129930084|NCT03519178|467709728|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
129930085|NCT03519178|467709729|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
129930086|NCT03519178|467709730|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
129930087|NCT03519178|467709731|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
129930088|NCT03519178|467709732|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
129930089|NCT03519178|467709718|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
129930090|NCT03519178|467709719|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
129930091|NCT03519178|467709720|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
129930092|NCT03519178|467709721|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
129930093|NCT03519178|467709722|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
129930094|NCT03519178|467709723|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
129930095|NCT03519178|467709724|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
129930096|NCT03519178|467709725|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
129930097|NCT03519178|467709726|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
129930098|NCT03519178|467709727|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
129930099|NCT03519178|467709728|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
129930100|NCT03519178|467709729|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
129930101|NCT03519178|467709730|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
129930102|NCT03519178|467709731|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
129930103|NCT03519178|467709732|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
129930104|NCT03519178|467709718|FG000|Long-term Follow-up|Other|0|||
130117937|NCT01325207|468392399|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
130117938|NCT01325207|468392400|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
129930105|NCT03519178|467709719|FG001|Long-term Follow-up|Other|0|||
129930106|NCT03519178|467709720|FG002|Long-term Follow-up|Other|0|||
129930107|NCT03519178|467709721|FG003|Long-term Follow-up|Other|0|||
129930108|NCT03519178|467709722|FG004|Long-term Follow-up|Other|0|||
129930109|NCT03519178|467709723|FG005|Long-term Follow-up|Other|0|||
129930110|NCT03519178|467709724|FG006|Long-term Follow-up|Other|0|||
129930111|NCT03519178|467709725|FG007|Long-term Follow-up|Other|0|||
129930112|NCT03519178|467709726|FG008|Long-term Follow-up|Other|0|||
129930113|NCT03519178|467709727|FG009|Long-term Follow-up|Other|0|||
130117939|NCT01325207|468392395|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130117940|NCT01325207|468392396|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130117941|NCT01325207|468392397|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130117942|NCT01325207|468392398|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
130117943|NCT01325207|468392399|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
130117944|NCT01325207|468392400|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
130117945|NCT01325207|468392395|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130117946|NCT01325207|468392396|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
130117947|NCT01325207|468392397|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130117948|NCT01325207|468392398|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130117949|NCT01325207|468392399|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130117950|NCT01325207|468392400|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
130117951|NCT01325207|468392395|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130117952|NCT01325207|468392396|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130117953|NCT01325207|468392397|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130117954|NCT01325207|468392398|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130117955|NCT01325207|468392399|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
130117956|NCT01325207|468392400|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
130117957|NCT01325207|468392395|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130117958|NCT01325207|468392396|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130117959|NCT01325207|468392397|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130117960|NCT01325207|468392398|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130117961|NCT01325207|468392399|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
130117962|NCT01325207|468392400|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
130117963|NCT01325207|468392395|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130117964|NCT01325207|468392396|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130117965|NCT01325207|468392397|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130117966|NCT01325207|468392398|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130117967|NCT01325207|468392399|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
130117968|NCT01325207|468392400|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
130117969|NCT00708422|468392401|FG000|Overall Study|Adverse Event|3|||
130117970|NCT00708422|468392402|FG001|Overall Study|Adverse Event|1|||
130117971|NCT00708422|468392401|FG000|Overall Study|Withdrawal by Subject|1|||
130117972|NCT00708422|468392402|FG001|Overall Study|Withdrawal by Subject|0|||
130117973|NCT01254409|468392403|FG000|Overall Study|Adverse Event|0|||
130117974|NCT01254409|468392404|FG001|Overall Study|Adverse Event|1|||
130117975|NCT01254409|468392405|FG002|Overall Study|Adverse Event|0|||
129930114|NCT03519178|467709728|FG010|Long-term Follow-up|Other|0|||
129930115|NCT03519178|467709729|FG011|Long-term Follow-up|Other|0|||
129930116|NCT03519178|467709730|FG012|Long-term Follow-up|Other|0|||
129930117|NCT03519178|467709731|FG013|Long-term Follow-up|Other|0|||
129930118|NCT03519178|467709732|FG014|Long-term Follow-up|Other|1|||
129930119|NCT03519178|467709718|FG000|Long-term Follow-up|Ongoing|0|||
129930120|NCT03519178|467709719|FG001|Long-term Follow-up|Ongoing|0|||
129930121|NCT03519178|467709720|FG002|Long-term Follow-up|Ongoing|0|||
129930122|NCT03519178|467709721|FG003|Long-term Follow-up|Ongoing|0|||
129930123|NCT03519178|467709722|FG004|Long-term Follow-up|Ongoing|0|||
129930124|NCT03519178|467709723|FG005|Long-term Follow-up|Ongoing|0|||
129930125|NCT03519178|467709724|FG006|Long-term Follow-up|Ongoing|0|||
129930126|NCT03519178|467709725|FG007|Long-term Follow-up|Ongoing|0|||
129930127|NCT03519178|467709726|FG008|Long-term Follow-up|Ongoing|0|||
129930128|NCT03519178|467709727|FG009|Long-term Follow-up|Ongoing|0|||
129930129|NCT03519178|467709728|FG010|Long-term Follow-up|Ongoing|0|||
129930130|NCT03519178|467709729|FG011|Long-term Follow-up|Ongoing|0|||
129930131|NCT03519178|467709730|FG012|Long-term Follow-up|Ongoing|0|||
129930132|NCT03519178|467709731|FG013|Long-term Follow-up|Ongoing|1|||
129930133|NCT03519178|467709732|FG014|Long-term Follow-up|Ongoing|0|||
129930134|NCT02240238|467709733|FG000|Phase 1|Adverse Event|0|||
130117976|NCT01254409|468392406|FG003|Overall Study|Adverse Event|0|||
130117977|NCT00299156|468392411|FG000|Period 2 (Randomized)|Screen Failure|0|||
130117978|NCT00299156|468392412|FG001|Period 2 (Randomized)|Screen Failure|1|||
129930135|NCT02240238|467709734|FG001|Phase 1|Adverse Event|0|||
129930136|NCT02240238|467709735|FG002|Phase 1|Adverse Event|0|||
129930137|NCT02240238|467709736|FG003|Phase 1|Adverse Event|0|||
129930138|NCT02240238|467709737|FG004|Phase 1|Adverse Event|0|||
130117979|NCT00299156|468392413|FG002|Period 2 (Randomized)|Screen Failure|0|||
130117980|NCT01166568|468392429|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
129930139|NCT02240238|467709738|FG005|Phase 1|Adverse Event|0|||
129930140|NCT02240238|467709739|FG006|Phase 1|Adverse Event|3|||
129930141|NCT02240238|467709740|FG007|Phase 1|Adverse Event|1|||
129930142|NCT02240238|467709741|FG008|Phase 1|Adverse Event|0|||
129930143|NCT02240238|467709742|FG009|Phase 1|Adverse Event|0|||
129930144|NCT02240238|467709743|FG010|Phase 1|Adverse Event|0|||
129930145|NCT02240238|467709744|FG011|Phase 1|Adverse Event|0|||
129930146|NCT02240238|467709733|FG000|Phase 1|Death|0|||
129930147|NCT02240238|467709734|FG001|Phase 1|Death|0|||
129930148|NCT02240238|467709735|FG002|Phase 1|Death|0|||
129930149|NCT02240238|467709736|FG003|Phase 1|Death|0|||
129930150|NCT02240238|467709737|FG004|Phase 1|Death|0|||
129930151|NCT02240238|467709738|FG005|Phase 1|Death|1|||
129930152|NCT02240238|467709739|FG006|Phase 1|Death|0|||
129930153|NCT02240238|467709740|FG007|Phase 1|Death|0|||
129930154|NCT02240238|467709741|FG008|Phase 1|Death|0|||
129930155|NCT02240238|467709742|FG009|Phase 1|Death|0|||
129930156|NCT02240238|467709743|FG010|Phase 1|Death|0|||
129930157|NCT02240238|467709744|FG011|Phase 1|Death|0|||
129930158|NCT02240238|467709733|FG000|Phase 1|Sponsor termination|0|||
129930159|NCT02240238|467709734|FG001|Phase 1|Sponsor termination|0|||
129930160|NCT02240238|467709735|FG002|Phase 1|Sponsor termination|0|||
129930161|NCT02240238|467709736|FG003|Phase 1|Sponsor termination|0|||
129930162|NCT02240238|467709737|FG004|Phase 1|Sponsor termination|0|||
129930163|NCT02240238|467709738|FG005|Phase 1|Sponsor termination|1|||
129930164|NCT02240238|467709739|FG006|Phase 1|Sponsor termination|0|||
129930165|NCT02240238|467709740|FG007|Phase 1|Sponsor termination|0|||
129930166|NCT02240238|467709741|FG008|Phase 1|Sponsor termination|0|||
129930167|NCT02240238|467709742|FG009|Phase 1|Sponsor termination|0|||
129930168|NCT02240238|467709743|FG010|Phase 1|Sponsor termination|0|||
129930169|NCT02240238|467709744|FG011|Phase 1|Sponsor termination|0|||
129930170|NCT02240238|467709733|FG000|Phase 1|Withdrawal by Subject|0|||
129930171|NCT02240238|467709734|FG001|Phase 1|Withdrawal by Subject|0|||
129930172|NCT02240238|467709735|FG002|Phase 1|Withdrawal by Subject|0|||
129930173|NCT02240238|467709736|FG003|Phase 1|Withdrawal by Subject|0|||
129930174|NCT02240238|467709737|FG004|Phase 1|Withdrawal by Subject|0|||
129930175|NCT02240238|467709738|FG005|Phase 1|Withdrawal by Subject|2|||
129930176|NCT02240238|467709739|FG006|Phase 1|Withdrawal by Subject|0|||
129930177|NCT02240238|467709740|FG007|Phase 1|Withdrawal by Subject|0|||
129930178|NCT02240238|467709741|FG008|Phase 1|Withdrawal by Subject|0|||
129930179|NCT02240238|467709742|FG009|Phase 1|Withdrawal by Subject|0|||
129930180|NCT02240238|467709743|FG010|Phase 1|Withdrawal by Subject|0|||
129930181|NCT02240238|467709744|FG011|Phase 1|Withdrawal by Subject|0|||
130069168|NCT00150345|468207861|FG001|Overall Study|Lack of Efficacy|4|||
130069169|NCT00150345|468207860|FG000|Overall Study|Withdrawal by Subject|3|||
130069170|NCT00150345|468207861|FG001|Overall Study|Withdrawal by Subject|4|||
130069171|NCT00150345|468207860|FG000|Overall Study|Laboratory abnormality|1|||
130069172|NCT00150345|468207861|FG001|Overall Study|Laboratory abnormality|2|||
130069173|NCT00150345|468207860|FG000|Overall Study|Other|12|||
130069174|NCT00150345|468207861|FG001|Overall Study|Other|14|||
130117981|NCT01166568|468392430|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
130117982|NCT01166568|468392431|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
130117983|NCT01166568|468392429|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
129930182|NCT02240238|467709733|FG000|Phase 1|Physician Decision|0|||
129930183|NCT02240238|467709734|FG001|Phase 1|Physician Decision|0|||
129930184|NCT02240238|467709735|FG002|Phase 1|Physician Decision|0|||
129930185|NCT02240238|467709736|FG003|Phase 1|Physician Decision|0|||
129930186|NCT02240238|467709737|FG004|Phase 1|Physician Decision|0|||
129930187|NCT02240238|467709738|FG005|Phase 1|Physician Decision|2|||
129930188|NCT02240238|467709739|FG006|Phase 1|Physician Decision|0|||
129930189|NCT02240238|467709740|FG007|Phase 1|Physician Decision|0|||
129930190|NCT02240238|467709741|FG008|Phase 1|Physician Decision|0|||
129930191|NCT02240238|467709742|FG009|Phase 1|Physician Decision|0|||
129930192|NCT02240238|467709743|FG010|Phase 1|Physician Decision|0|||
129930193|NCT02240238|467709744|FG011|Phase 1|Physician Decision|0|||
129930194|NCT02240238|467709733|FG000|Phase 2|Adverse Event|0|||
129930195|NCT02240238|467709734|FG001|Phase 2|Adverse Event|0|||
129930196|NCT02240238|467709735|FG002|Phase 2|Adverse Event|0|||
129930197|NCT02240238|467709736|FG003|Phase 2|Adverse Event|0|||
129930198|NCT02240238|467709737|FG004|Phase 2|Adverse Event|0|||
129930199|NCT02240238|467709738|FG005|Phase 2|Adverse Event|0|||
129930200|NCT02240238|467709739|FG006|Phase 2|Adverse Event|0|||
129930201|NCT02240238|467709740|FG007|Phase 2|Adverse Event|0|||
129930202|NCT02240238|467709741|FG008|Phase 2|Adverse Event|0|||
129930203|NCT02240238|467709742|FG009|Phase 2|Adverse Event|7|||
129930204|NCT02240238|467709743|FG010|Phase 2|Adverse Event|14|||
129930205|NCT02240238|467709744|FG011|Phase 2|Adverse Event|2|||
129930206|NCT02240238|467709733|FG000|Phase 2|Death|0|||
130069175|NCT01457924|468207868|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
130069176|NCT01457924|468207869|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
129930207|NCT02240238|467709734|FG001|Phase 2|Death|0|||
130069177|NCT01457924|468207870|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
129930208|NCT02240238|467709735|FG002|Phase 2|Death|0|||
129930209|NCT02240238|467709736|FG003|Phase 2|Death|0|||
129930210|NCT02240238|467709737|FG004|Phase 2|Death|0|||
129930211|NCT02240238|467709738|FG005|Phase 2|Death|0|||
129930212|NCT02240238|467709739|FG006|Phase 2|Death|0|||
129930213|NCT02240238|467709740|FG007|Phase 2|Death|0|||
129930214|NCT02240238|467709741|FG008|Phase 2|Death|0|||
129930215|NCT02240238|467709742|FG009|Phase 2|Death|3|||
129930216|NCT02240238|467709743|FG010|Phase 2|Death|2|||
129930217|NCT02240238|467709744|FG011|Phase 2|Death|1|||
129930218|NCT02240238|467709733|FG000|Phase 2|Disease progression|0|||
129930219|NCT02240238|467709734|FG001|Phase 2|Disease progression|0|||
129930220|NCT02240238|467709735|FG002|Phase 2|Disease progression|0|||
129930221|NCT02240238|467709736|FG003|Phase 2|Disease progression|0|||
129930222|NCT02240238|467709737|FG004|Phase 2|Disease progression|0|||
129930223|NCT02240238|467709738|FG005|Phase 2|Disease progression|0|||
129930224|NCT02240238|467709739|FG006|Phase 2|Disease progression|0|||
129930225|NCT02240238|467709740|FG007|Phase 2|Disease progression|0|||
129930226|NCT02240238|467709741|FG008|Phase 2|Disease progression|0|||
129930227|NCT02240238|467709742|FG009|Phase 2|Disease progression|5|||
129930228|NCT02240238|467709743|FG010|Phase 2|Disease progression|11|||
129930229|NCT02240238|467709744|FG011|Phase 2|Disease progression|1|||
129930230|NCT02240238|467709733|FG000|Phase 2|Withdrawal by Subject|0|||
129930231|NCT02240238|467709734|FG001|Phase 2|Withdrawal by Subject|0|||
129930232|NCT02240238|467709735|FG002|Phase 2|Withdrawal by Subject|0|||
129930233|NCT02240238|467709736|FG003|Phase 2|Withdrawal by Subject|0|||
129930234|NCT02240238|467709737|FG004|Phase 2|Withdrawal by Subject|0|||
129930235|NCT02240238|467709738|FG005|Phase 2|Withdrawal by Subject|0|||
129930236|NCT02240238|467709739|FG006|Phase 2|Withdrawal by Subject|0|||
129930237|NCT02240238|467709740|FG007|Phase 2|Withdrawal by Subject|0|||
129930238|NCT02240238|467709741|FG008|Phase 2|Withdrawal by Subject|0|||
129930239|NCT02240238|467709742|FG009|Phase 2|Withdrawal by Subject|1|||
129930240|NCT02240238|467709743|FG010|Phase 2|Withdrawal by Subject|1|||
129930241|NCT02240238|467709744|FG011|Phase 2|Withdrawal by Subject|0|||
129930242|NCT02240238|467709733|FG000|Phase 2|Physician Decision|0|||
129930243|NCT02240238|467709734|FG001|Phase 2|Physician Decision|0|||
129930244|NCT02240238|467709735|FG002|Phase 2|Physician Decision|0|||
129930245|NCT02240238|467709736|FG003|Phase 2|Physician Decision|0|||
129930246|NCT02240238|467709737|FG004|Phase 2|Physician Decision|0|||
129930247|NCT02240238|467709738|FG005|Phase 2|Physician Decision|0|||
129930248|NCT02240238|467709739|FG006|Phase 2|Physician Decision|0|||
129930249|NCT02240238|467709740|FG007|Phase 2|Physician Decision|0|||
129930250|NCT02240238|467709741|FG008|Phase 2|Physician Decision|0|||
129930251|NCT02240238|467709742|FG009|Phase 2|Physician Decision|1|||
129930252|NCT02240238|467709743|FG010|Phase 2|Physician Decision|3|||
129930253|NCT02240238|467709744|FG011|Phase 2|Physician Decision|0|||
129930254|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930255|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930256|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930257|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930258|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930259|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930260|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930261|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930262|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930263|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
129930264|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930265|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930266|NCT02240238|467709733|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930267|NCT02240238|467709734|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930268|NCT02240238|467709735|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930269|NCT02240238|467709736|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930270|NCT02240238|467709737|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930271|NCT02240238|467709738|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930272|NCT02240238|467709739|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930273|NCT02240238|467709740|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930274|NCT02240238|467709741|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930275|NCT02240238|467709742|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
129930276|NCT02240238|467709743|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930277|NCT02240238|467709744|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930278|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930279|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930280|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930281|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930282|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930283|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930284|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930285|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930286|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930287|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930288|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
129930289|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930290|NCT02240238|467709733|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930291|NCT02240238|467709734|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930292|NCT02240238|467709735|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930293|NCT02240238|467709736|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930294|NCT02240238|467709737|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930295|NCT02240238|467709738|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930296|NCT02240238|467709739|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930297|NCT02240238|467709740|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930298|NCT02240238|467709741|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930299|NCT02240238|467709742|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
130069178|NCT01457924|468207871|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
130069179|NCT01457924|468207872|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
130069180|NCT01457924|468207868|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130069181|NCT01457924|468207869|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130069182|NCT01457924|468207870|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130069183|NCT01457924|468207871|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
130069184|NCT01457924|468207872|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
130069185|NCT01457924|468207868|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
130069186|NCT01457924|468207869|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130069187|NCT01457924|468207870|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130069188|NCT01457924|468207871|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130069189|NCT01457924|468207872|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
130069190|NCT01457924|468207868|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
130069191|NCT01457924|468207869|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
130069192|NCT01457924|468207870|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
130069193|NCT01457924|468207871|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
130069194|NCT01457924|468207872|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
130069195|NCT01457924|468207868|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
130069196|NCT01457924|468207869|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
130069197|NCT01457924|468207870|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
130069198|NCT01457924|468207871|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
130069199|NCT01457924|468207872|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
130069200|NCT01457924|468207868|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
130069201|NCT01457924|468207869|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
130069202|NCT01457924|468207870|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
130069203|NCT01457924|468207871|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
130069204|NCT01457924|468207872|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
130069205|NCT01457924|468207868|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
130069206|NCT01457924|468207869|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
130069207|NCT01457924|468207870|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
130069208|NCT01457924|468207871|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
130069209|NCT01457924|468207872|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
130069210|NCT01457924|468207868|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
130069211|NCT01457924|468207869|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
130069212|NCT01457924|468207870|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
130069213|NCT01457924|468207871|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
130069214|NCT01457924|468207872|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
130069215|NCT01457924|468207868|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130069216|NCT01457924|468207869|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130069217|NCT01457924|468207870|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130069218|NCT01457924|468207871|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
130069219|NCT01457924|468207872|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
130069220|NCT01457924|468207868|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
130069221|NCT01457924|468207869|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
130069222|NCT01457924|468207870|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
130069223|NCT01457924|468207871|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
130069224|NCT01457924|468207872|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
130069225|NCT01457924|468207868|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
130069226|NCT01457924|468207869|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
130069227|NCT01457924|468207870|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
130069228|NCT01457924|468207871|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
130069229|NCT01457924|468207872|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
130117984|NCT01166568|468392430|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
130117985|NCT01166568|468392431|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
130117986|NCT01166568|468392429|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
130117987|NCT01166568|468392430|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
130117988|NCT01166568|468392431|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
130117989|NCT01654380|468392432|FG000|Part B, Period 1|Physician Decision|0|||
130117990|NCT01654380|468392433|FG001|Part B, Period 1|Physician Decision|0|||
130117991|NCT01654380|468392434|FG002|Part B, Period 1|Physician Decision|1|||
130117992|NCT01654380|468392435|FG003|Part B, Period 1|Physician Decision|0|||
130117993|NCT03335371|468392436|FG000|Overall Study|Lost to Follow-up|0|||
130117994|NCT03335371|468392437|FG001|Overall Study|Lost to Follow-up|0|||
130117995|NCT03335371|468392438|FG002|Overall Study|Lost to Follow-up|0|||
130117996|NCT03335371|468392439|FG003|Overall Study|Lost to Follow-up|0|||
130117997|NCT03335371|468392440|FG004|Overall Study|Lost to Follow-up|1|||
130117998|NCT03335371|468392436|FG000|Overall Study|Withdrawal by Subject|0|||
130117999|NCT03335371|468392437|FG001|Overall Study|Withdrawal by Subject|0|||
130118000|NCT03335371|468392438|FG002|Overall Study|Withdrawal by Subject|0|||
130118001|NCT03335371|468392439|FG003|Overall Study|Withdrawal by Subject|0|||
130118002|NCT03335371|468392440|FG004|Overall Study|Withdrawal by Subject|1|||
130118003|NCT03335371|468392436|FG000|Overall Study|Randomization Error|0|||
130118004|NCT03335371|468392437|FG001|Overall Study|Randomization Error|0|||
130118005|NCT03335371|468392438|FG002|Overall Study|Randomization Error|1|||
130118006|NCT03335371|468392439|FG003|Overall Study|Randomization Error|0|||
130118007|NCT03335371|468392440|FG004|Overall Study|Randomization Error|0|||
130118008|NCT00684671|468392441|FG000|Overall Study|Adverse Event|1|||
130118009|NCT00684671|468392442|FG001|Overall Study|Adverse Event|0|||
130118010|NCT00684671|468392443|FG002|Overall Study|Adverse Event|0|||
130118011|NCT00684671|468392441|FG000|Overall Study|Lost to Follow-up|1|||
130118012|NCT00684671|468392442|FG001|Overall Study|Lost to Follow-up|0|||
130118013|NCT00684671|468392443|FG002|Overall Study|Lost to Follow-up|0|||
130118014|NCT00684671|468392441|FG000|Overall Study|Alcoholic dependance|1|||
130118015|NCT00684671|468392442|FG001|Overall Study|Alcoholic dependance|0|||
130118016|NCT00684671|468392443|FG002|Overall Study|Alcoholic dependance|0|||
130118017|NCT01725451|468392445|FG000|Period 1|Withdrawal by Subject|1|||
130118018|NCT01725451|468392446|FG001|Period 1|Withdrawal by Subject|0|||
130118019|NCT01725451|468392447|FG002|Period 1|Withdrawal by Subject|0|||
130118020|NCT01725451|468392448|FG003|Period 1|Withdrawal by Subject|0|||
130118021|NCT01725451|468392445|FG000|Washout From Period 3|Protocol Violation|0|||
130118022|NCT01725451|468392446|FG001|Washout From Period 3|Protocol Violation|0|||
130118023|NCT01725451|468392447|FG002|Washout From Period 3|Protocol Violation|1|||
130118024|NCT01725451|468392448|FG003|Washout From Period 3|Protocol Violation|0|||
130118025|NCT01725451|468392445|FG000|Washout From Period 3|Adverse Event|0|||
130118026|NCT01725451|468392446|FG001|Washout From Period 3|Adverse Event|1|||
130118027|NCT01725451|468392447|FG002|Washout From Period 3|Adverse Event|0|||
129930300|NCT02240238|467709743|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
129930301|NCT02240238|467709744|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930302|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930303|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930304|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930305|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930306|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930307|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930308|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930309|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930310|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930311|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930312|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
129930313|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930314|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930315|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930316|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930317|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
130118028|NCT01725451|468392448|FG003|Washout From Period 3|Adverse Event|0|||
130118029|NCT01725451|468392445|FG000|Period 4|Adverse Event|0|||
130118030|NCT01725451|468392446|FG001|Period 4|Adverse Event|0|||
130118031|NCT01725451|468392447|FG002|Period 4|Adverse Event|1|||
130118032|NCT01725451|468392448|FG003|Period 4|Adverse Event|0|||
130118033|NCT01564758|468392449|FG000|Overall Study|Death|8|||
130118034|NCT01564758|468392449|FG000|Overall Study|Adverse Event|3|||
130118035|NCT01564758|468392449|FG000|Overall Study|Other|3|||
130118036|NCT00249821|468392450|FG000|Overall Study|Technical problem|0|||
130118037|NCT00249821|468392451|FG001|Overall Study|Technical problem|1|||
130118038|NCT02482571|468392452|FG000|Overall Study|Adverse Event|1|||
130118039|NCT02482571|468392452|FG000|Overall Study|Scanner or Respiract failure|3|||
129930318|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930319|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930320|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930321|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930322|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930323|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930324|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
129930325|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930326|NCT02240238|467709733|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930327|NCT02240238|467709734|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930328|NCT02240238|467709735|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930329|NCT02240238|467709736|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930330|NCT02240238|467709737|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930331|NCT02240238|467709738|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930332|NCT02240238|467709739|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930333|NCT02240238|467709740|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930334|NCT02240238|467709741|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930335|NCT02240238|467709742|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930336|NCT02240238|467709743|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
129930337|NCT02240238|467709744|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930338|NCT02240238|467709733|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930339|NCT02240238|467709734|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930340|NCT02240238|467709735|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930341|NCT02240238|467709736|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930342|NCT02240238|467709737|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930343|NCT02240238|467709738|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930344|NCT02240238|467709739|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930345|NCT02240238|467709740|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930346|NCT02240238|467709741|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930347|NCT02240238|467709742|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930348|NCT02240238|467709743|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930349|NCT02240238|467709744|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
129930350|NCT04797195|467709766|FG000|Overall Study|Death|8|||
129930351|NCT04797195|467709767|FG001|Overall Study|Death|15|||
129930352|NCT04797195|467709766|FG000|Overall Study|Change from PD|15|||
129930353|NCT04797195|467709767|FG001|Overall Study|Change from PD|15|||
129930354|NCT04797195|467709766|FG000|Overall Study|Withdrawal by Subject|3|||
129930355|NCT04797195|467709767|FG001|Overall Study|Withdrawal by Subject|2|||
129930356|NCT04101357|467709768|FG000|Overall Study|Death|1|||
129930357|NCT04101357|467709769|FG001|Overall Study|Death|1|||
129930358|NCT04101357|467709770|FG002|Overall Study|Death|1|||
129930359|NCT04101357|467709771|FG003|Overall Study|Death|2|||
129930360|NCT04101357|467709772|FG004|Overall Study|Death|4|||
129930361|NCT04101357|467709773|FG005|Overall Study|Death|11|||
129930362|NCT04101357|467709774|FG006|Overall Study|Death|4|||
129930363|NCT04101357|467709775|FG007|Overall Study|Death|4|||
129930364|NCT04101357|467709776|FG008|Overall Study|Death|5|||
129930365|NCT04101357|467709777|FG009|Overall Study|Death|2|||
129930366|NCT04101357|467709778|FG010|Overall Study|Death|3|||
129930367|NCT04101357|467709768|FG000|Overall Study|Trial closure|0|||
129930368|NCT04101357|467709769|FG001|Overall Study|Trial closure|0|||
129930369|NCT04101357|467709770|FG002|Overall Study|Trial closure|0|||
129930370|NCT04101357|467709771|FG003|Overall Study|Trial closure|0|||
130069230|NCT01457924|468207868|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
130069231|NCT01457924|468207869|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
130069232|NCT01457924|468207870|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
130069233|NCT01457924|468207871|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
130069234|NCT01457924|468207872|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
130069235|NCT01457924|468207868|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
130069236|NCT01457924|468207869|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
130069237|NCT01457924|468207870|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
130069238|NCT01457924|468207871|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
130069239|NCT01457924|468207872|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
130069240|NCT01438307|468207873|FG000|Overall Study|Death|1|||
130069241|NCT01438307|468207874|FG001|Overall Study|Death|1|||
130069242|NCT00973622|468207876|FG000|Overall Study|did not attend MRI|14|||
129930371|NCT04101357|467709772|FG004|Overall Study|Trial closure|0|||
129930372|NCT04101357|467709773|FG005|Overall Study|Trial closure|2|||
129930373|NCT04101357|467709774|FG006|Overall Study|Trial closure|2|||
129930374|NCT04101357|467709775|FG007|Overall Study|Trial closure|0|||
129930375|NCT04101357|467709776|FG008|Overall Study|Trial closure|0|||
129930376|NCT04101357|467709777|FG009|Overall Study|Trial closure|0|||
129930377|NCT04101357|467709778|FG010|Overall Study|Trial closure|1|||
129930378|NCT04101357|467709768|FG000|Overall Study|Lost to Follow-up|0|||
129930379|NCT04101357|467709769|FG001|Overall Study|Lost to Follow-up|0|||
129930380|NCT04101357|467709770|FG002|Overall Study|Lost to Follow-up|0|||
129930381|NCT04101357|467709771|FG003|Overall Study|Lost to Follow-up|1|||
129930382|NCT04101357|467709772|FG004|Overall Study|Lost to Follow-up|0|||
129930383|NCT04101357|467709773|FG005|Overall Study|Lost to Follow-up|0|||
129930384|NCT04101357|467709774|FG006|Overall Study|Lost to Follow-up|0|||
129930385|NCT04101357|467709775|FG007|Overall Study|Lost to Follow-up|1|||
129930386|NCT04101357|467709776|FG008|Overall Study|Lost to Follow-up|0|||
129930387|NCT04101357|467709777|FG009|Overall Study|Lost to Follow-up|0|||
129930388|NCT04101357|467709778|FG010|Overall Study|Lost to Follow-up|0|||
129930389|NCT04101357|467709768|FG000|Overall Study|Withdrawal by Subject|1|||
129930390|NCT04101357|467709769|FG001|Overall Study|Withdrawal by Subject|0|||
129930391|NCT04101357|467709770|FG002|Overall Study|Withdrawal by Subject|0|||
129930392|NCT04101357|467709771|FG003|Overall Study|Withdrawal by Subject|0|||
129930393|NCT04101357|467709772|FG004|Overall Study|Withdrawal by Subject|0|||
129930394|NCT04101357|467709773|FG005|Overall Study|Withdrawal by Subject|0|||
129930395|NCT04101357|467709774|FG006|Overall Study|Withdrawal by Subject|0|||
129930396|NCT04101357|467709775|FG007|Overall Study|Withdrawal by Subject|0|||
129930397|NCT04101357|467709776|FG008|Overall Study|Withdrawal by Subject|1|||
129930398|NCT04101357|467709777|FG009|Overall Study|Withdrawal by Subject|1|||
129930399|NCT04101357|467709778|FG010|Overall Study|Withdrawal by Subject|0|||
129930400|NCT04101357|467709768|FG000|Overall Study|Other|0|||
129930401|NCT04101357|467709769|FG001|Overall Study|Other|0|||
129930402|NCT04101357|467709770|FG002|Overall Study|Other|0|||
129930403|NCT04101357|467709771|FG003|Overall Study|Other|0|||
129930404|NCT04101357|467709772|FG004|Overall Study|Other|0|||
129930405|NCT04101357|467709773|FG005|Overall Study|Other|1|||
129930406|NCT04101357|467709774|FG006|Overall Study|Other|2|||
129930407|NCT04101357|467709775|FG007|Overall Study|Other|1|||
129930408|NCT04101357|467709776|FG008|Overall Study|Other|0|||
129930409|NCT04101357|467709777|FG009|Overall Study|Other|0|||
129930410|NCT04101357|467709778|FG010|Overall Study|Other|0|||
129930411|NCT04101357|467709768|FG000|Overall Study|Enrolled but not treated|0|||
129930412|NCT04101357|467709769|FG001|Overall Study|Enrolled but not treated|0|||
129930413|NCT04101357|467709770|FG002|Overall Study|Enrolled but not treated|0|||
129930414|NCT04101357|467709771|FG003|Overall Study|Enrolled but not treated|0|||
129930415|NCT04101357|467709772|FG004|Overall Study|Enrolled but not treated|0|||
129930416|NCT04101357|467709773|FG005|Overall Study|Enrolled but not treated|1|||
129930417|NCT04101357|467709774|FG006|Overall Study|Enrolled but not treated|1|||
129930418|NCT04101357|467709775|FG007|Overall Study|Enrolled but not treated|0|||
129930419|NCT04101357|467709776|FG008|Overall Study|Enrolled but not treated|0|||
129930420|NCT04101357|467709777|FG009|Overall Study|Enrolled but not treated|0|||
129930421|NCT04101357|467709778|FG010|Overall Study|Enrolled but not treated|0|||
129930422|NCT02497950|467709779|FG000|Overall Study|Death|209|||
129930423|NCT02497950|467709779|FG000|Overall Study|Transplanted|85|||
129930424|NCT02497950|467709779|FG000|Overall Study|Explanted|8|||
129930425|NCT02497950|467709779|FG000|Overall Study|Device Permanently Deactivated|4|||
129930426|NCT02497950|467709779|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
129930427|NCT02497950|467709779|FG000|Overall Study|Lost to Follow-up|6|||
129930428|NCT02497950|467709779|FG000|Overall Study|Withdrawal by Subject|2|||
129930429|NCT02497950|467709779|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
129930430|NCT02497950|467709779|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
129930431|NCT01009788|467709792|FG000|Overall Study|Withdrawal by Subject|1|||
129930432|NCT01009788|467709793|FG001|Overall Study|Withdrawal by Subject|0|||
129930433|NCT05586490|467709794|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930434|NCT05586490|467709795|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930435|NCT05586490|467709796|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
129930436|NCT05586490|467709797|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930437|NCT05586490|467709798|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930438|NCT05586490|467709794|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
129930439|NCT05586490|467709795|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930440|NCT05586490|467709796|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930441|NCT05586490|467709797|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930442|NCT05586490|467709798|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930443|NCT05586490|467709794|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
129930444|NCT05586490|467709795|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930445|NCT05586490|467709796|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930446|NCT05586490|467709797|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930447|NCT05586490|467709798|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930448|NCT05076266|467709799|FG000|Overall Study|Survey not complete - Participant refusal|2|||
129930449|NCT05076266|467709800|FG001|Overall Study|Survey not complete - Participant refusal|0|||
129930450|NCT04003246|467709803|FG000|Overall Study|Death|9|||
129930451|NCT04132518|467709813|FG000|Overall Study|Prematurely withdrawn from the study|0|||
129930452|NCT04132518|467709814|FG001|Overall Study|Prematurely withdrawn from the study|9|||
129930453|NCT04132518|467709815|FG002|Overall Study|Prematurely withdrawn from the study|1|||
129930454|NCT05524402|467709817|FG000|Overall Study|Withdrawal by Subject|3|||
129930455|NCT05524402|467709818|FG001|Overall Study|Withdrawal by Subject|1|||
129930456|NCT05524402|467709817|FG000|Overall Study|Lost to Follow-up|2|||
129930457|NCT05524402|467709818|FG001|Overall Study|Lost to Follow-up|1|||
129930458|NCT04544007|467709825|FG000|Overall Study|Withdrawal by Subject|1|||
129930459|NCT04544007|467709825|FG000|Overall Study|Confirmed Progressive Disease|1|||
129930460|NCT02988661|467709826|FG000|Overall Study|Death|2|||
129930461|NCT02988661|467709827|FG001|Overall Study|Death|18|||
129930462|NCT02988661|467709826|FG000|Overall Study|Lost to Follow-up|0|||
129930463|NCT02988661|467709827|FG001|Overall Study|Lost to Follow-up|33|||
129930464|NCT02988661|467709826|FG000|Overall Study|Withdrawal by Subject|0|||
129930465|NCT02988661|467709827|FG001|Overall Study|Withdrawal by Subject|6|||
129930466|NCT02988661|467709826|FG000|Overall Study|Unable to complete the 18-month survey|1|||
129930467|NCT02988661|467709827|FG001|Overall Study|Unable to complete the 18-month survey|27|||
129930468|NCT02413489|467709843|FG000|Overall Study|Death|11|||
129930469|NCT02413489|467709844|FG001|Overall Study|Death|3|||
129930470|NCT02413489|467709845|FG002|Overall Study|Death|4|||
129930471|NCT02413489|467709843|FG000|Overall Study|Withdrawal by Subject|2|||
129930472|NCT02413489|467709844|FG001|Overall Study|Withdrawal by Subject|0|||
129930473|NCT02413489|467709845|FG002|Overall Study|Withdrawal by Subject|0|||
129930474|NCT02413489|467709843|FG000|Overall Study|Study Terminated By Sponsor|2|||
129930475|NCT02413489|467709844|FG001|Overall Study|Study Terminated By Sponsor|13|||
129930476|NCT02413489|467709845|FG002|Overall Study|Study Terminated By Sponsor|1|||
129930477|NCT04294641|467711518|FG000|Overall Study|Screen failure|4|||
129930478|NCT04730739|467711520|FG000|Overall Study|Death|1|||
129930479|NCT04707469|467711523|FG000|Overall Study|Site closure|0|||
129930480|NCT04707469|467711524|FG001|Overall Study|Site closure|2|||
129930481|NCT04707469|467711525|FG002|Overall Study|Site closure|0|||
129930482|NCT04707469|467711523|FG000|Overall Study|Physician Decision|2|||
129930483|NCT04707469|467711524|FG001|Overall Study|Physician Decision|2|||
129930484|NCT04707469|467711525|FG002|Overall Study|Physician Decision|2|||
129930485|NCT04707469|467711523|FG000|Overall Study|Death|1|||
129930486|NCT04707469|467711524|FG001|Overall Study|Death|6|||
129930487|NCT04707469|467711525|FG002|Overall Study|Death|2|||
129930488|NCT04707469|467711523|FG000|Overall Study|Lost to Follow-up|9|||
129930489|NCT04707469|467711524|FG001|Overall Study|Lost to Follow-up|19|||
129930490|NCT04707469|467711525|FG002|Overall Study|Lost to Follow-up|14|||
129930491|NCT04707469|467711523|FG000|Overall Study|Withdrawal by Subject|17|||
129930492|NCT04707469|467711524|FG001|Overall Study|Withdrawal by Subject|16|||
129930493|NCT04707469|467711525|FG002|Overall Study|Withdrawal by Subject|12|||
129930494|NCT05218096|467711533|FG000|Primary Evaluation|Withdrawal by Subject|0|||
129930495|NCT05218096|467711534|FG001|Primary Evaluation|Withdrawal by Subject|0|||
129930496|NCT05218096|467711535|FG002|Primary Evaluation|Withdrawal by Subject|2|||
129930497|NCT05218096|467711536|FG003|Primary Evaluation|Withdrawal by Subject|0|||
129930498|NCT05218096|467711537|FG004|Primary Evaluation|Withdrawal by Subject|0|||
129930499|NCT05218096|467711533|FG000|Primary Evaluation|Physician Decision|1|||
129930500|NCT05218096|467711534|FG001|Primary Evaluation|Physician Decision|0|||
129930501|NCT05218096|467711535|FG002|Primary Evaluation|Physician Decision|0|||
129930502|NCT05218096|467711536|FG003|Primary Evaluation|Physician Decision|0|||
129930503|NCT05218096|467711537|FG004|Primary Evaluation|Physician Decision|0|||
129930504|NCT05218096|467711533|FG000|Extended Treatment|Clinical Deterioration|1|||
129930505|NCT05218096|467711534|FG001|Extended Treatment|Clinical Deterioration|1|||
129930506|NCT05218096|467711535|FG002|Extended Treatment|Clinical Deterioration|0|||
129930507|NCT05218096|467711536|FG003|Extended Treatment|Clinical Deterioration|0|||
130069243|NCT00973622|468207877|FG001|Overall Study|did not attend MRI|3|||
129930508|NCT05218096|467711537|FG004|Extended Treatment|Clinical Deterioration|0|||
129930509|NCT05218096|467711533|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
129930510|NCT05218096|467711534|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
129930511|NCT05218096|467711535|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
129930512|NCT05218096|467711536|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
129930513|NCT05218096|467711537|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
129930514|NCT05218096|467711533|FG000|Extended Treatment|Withdrawal by Subject|1|||
129930515|NCT05218096|467711534|FG001|Extended Treatment|Withdrawal by Subject|3|||
129930516|NCT05218096|467711535|FG002|Extended Treatment|Withdrawal by Subject|0|||
129930517|NCT05218096|467711536|FG003|Extended Treatment|Withdrawal by Subject|2|||
129930518|NCT05218096|467711537|FG004|Extended Treatment|Withdrawal by Subject|2|||
129930519|NCT05218096|467711533|FG000|Extended Treatment|Lack of Efficacy|3|||
129930520|NCT05218096|467711534|FG001|Extended Treatment|Lack of Efficacy|0|||
129930521|NCT05218096|467711535|FG002|Extended Treatment|Lack of Efficacy|0|||
129930522|NCT05218096|467711536|FG003|Extended Treatment|Lack of Efficacy|0|||
129930523|NCT05218096|467711537|FG004|Extended Treatment|Lack of Efficacy|0|||
129930524|NCT05218096|467711533|FG000|Extended Treatment|Physician Decision|0|||
129930525|NCT05218096|467711534|FG001|Extended Treatment|Physician Decision|1|||
129930526|NCT05218096|467711535|FG002|Extended Treatment|Physician Decision|0|||
129930527|NCT05218096|467711536|FG003|Extended Treatment|Physician Decision|0|||
129930528|NCT05218096|467711537|FG004|Extended Treatment|Physician Decision|0|||
129930529|NCT05218096|467711533|FG000|Open-label Extension|Adverse Event|1|||
129930530|NCT05218096|467711534|FG001|Open-label Extension|Adverse Event|0|||
129930531|NCT05218096|467711535|FG002|Open-label Extension|Adverse Event|0|||
129930532|NCT05218096|467711536|FG003|Open-label Extension|Adverse Event|0|||
129930533|NCT05218096|467711537|FG004|Open-label Extension|Adverse Event|1|||
129930534|NCT05218096|467711533|FG000|Open-label Extension|Pregnancy|0|||
129930535|NCT05218096|467711534|FG001|Open-label Extension|Pregnancy|0|||
129930536|NCT05218096|467711535|FG002|Open-label Extension|Pregnancy|0|||
129930537|NCT05218096|467711536|FG003|Open-label Extension|Pregnancy|0|||
129930538|NCT05218096|467711537|FG004|Open-label Extension|Pregnancy|1|||
129930539|NCT05218096|467711533|FG000|Open-label Extension|Lack of Efficacy|1|||
129930540|NCT05218096|467711534|FG001|Open-label Extension|Lack of Efficacy|2|||
129930541|NCT05218096|467711535|FG002|Open-label Extension|Lack of Efficacy|0|||
129930542|NCT05218096|467711536|FG003|Open-label Extension|Lack of Efficacy|0|||
129930543|NCT05218096|467711537|FG004|Open-label Extension|Lack of Efficacy|0|||
129930544|NCT05218096|467711533|FG000|Open-label Extension|Lost to Follow-up|1|||
129930545|NCT05218096|467711534|FG001|Open-label Extension|Lost to Follow-up|0|||
129930546|NCT05218096|467711535|FG002|Open-label Extension|Lost to Follow-up|0|||
129930547|NCT05218096|467711536|FG003|Open-label Extension|Lost to Follow-up|0|||
129930548|NCT05218096|467711537|FG004|Open-label Extension|Lost to Follow-up|0|||
129930549|NCT05218096|467711533|FG000|Open-label Extension|Death|0|||
129930550|NCT05218096|467711534|FG001|Open-label Extension|Death|0|||
129930551|NCT05218096|467711535|FG002|Open-label Extension|Death|0|||
129930552|NCT05218096|467711536|FG003|Open-label Extension|Death|1|||
129930553|NCT05218096|467711537|FG004|Open-label Extension|Death|0|||
129930554|NCT05218096|467711533|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
129930555|NCT05218096|467711534|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
129930556|NCT05218096|467711535|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
129930557|NCT05218096|467711536|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
129930558|NCT05218096|467711537|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
129930559|NCT05269966|467711540|FG000|Overall Study|Adverse Event|4|||
129930560|NCT05269966|467711540|FG000|Overall Study|Withdrawal by Subject|1|||
129930561|NCT05269966|467711540|FG000|Overall Study|Lost to Follow-up|4|||
129930562|NCT05269966|467711540|FG000|Overall Study|Physician Decision|1|||
129930563|NCT05863156|467711549|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
129930564|NCT05863156|467711550|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
129930565|NCT05863156|467711551|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
129930566|NCT04660539|467711554|FG000|Overall Study|Adverse Event|10|||
129930567|NCT04660539|467711554|FG000|Overall Study|Lack of Efficacy|4|||
129930568|NCT04660539|467711554|FG000|Overall Study|Lost to Follow-up|5|||
129930569|NCT04660539|467711554|FG000|Overall Study|Non-Compliance With Study Drug|3|||
129930570|NCT04660539|467711554|FG000|Overall Study|Reason not Specified|12|||
129930571|NCT04660539|467711554|FG000|Overall Study|Pregnancy|2|||
129930572|NCT04660539|467711554|FG000|Overall Study|Protocol Violation|2|||
129930573|NCT04660539|467711554|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
129930574|NCT04660539|467711554|FG000|Overall Study|Withdrawal by Subject|21|||
129930575|NCT03655028|467711557|FG000|12-weeks Follow up|Death|1|||
129930576|NCT03655028|467711558|FG001|12-weeks Follow up|Death|0|||
129930577|NCT03655028|467711557|FG000|12-weeks Follow up|Physician Decision|3|||
129930578|NCT03655028|467711558|FG001|12-weeks Follow up|Physician Decision|3|||
129930579|NCT03655028|467711557|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
129930580|NCT03655028|467711558|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
129930581|NCT03655028|467711557|FG000|12-weeks Follow up|Lost to Follow-up|4|||
129930582|NCT03655028|467711558|FG001|12-weeks Follow up|Lost to Follow-up|4|||
129930583|NCT03655028|467711557|FG000|24-weeks|Lost to Follow-up|1|||
129930584|NCT03655028|467711558|FG001|24-weeks|Lost to Follow-up|1|||
129930585|NCT03655028|467711557|FG000|24-weeks|Death|0|||
129930586|NCT03655028|467711558|FG001|24-weeks|Death|1|||
129930587|NCT03513302|467711559|FG000|First Intervention (14 Days)|Screen failure|15|||
129930588|NCT03513302|467711560|FG001|First Intervention (14 Days)|Screen failure|16|||
129930589|NCT05618587|467711561|FG000|Overall Study|Lost to Follow-up|2|||
129930590|NCT05618587|467711562|FG001|Overall Study|Lost to Follow-up|0|||
129930591|NCT05167864|467711563|FG000|Overall Study|Lost to Follow-up|7|||
129930592|NCT05167864|467711564|FG001|Overall Study|Lost to Follow-up|6|||
129930593|NCT05167864|467711565|FG002|Overall Study|Lost to Follow-up|7|||
129930594|NCT05167864|467711566|FG003|Overall Study|Lost to Follow-up|9|||
129930595|NCT03852550|467711567|FG000|Overall Study|Lost to Follow-up|4|||
129930596|NCT03852550|467711568|FG001|Overall Study|Lost to Follow-up|3|||
129930597|NCT03852550|467711567|FG000|Overall Study|Only parent outcomes completed|0|||
129930598|NCT03852550|467711568|FG001|Overall Study|Only parent outcomes completed|1|||
129930599|NCT03852550|467711567|FG000|Overall Study|Withdrawal by Subject|1|||
129930600|NCT03852550|467711568|FG001|Overall Study|Withdrawal by Subject|0|||
129930601|NCT05204654|467711569|FG000|Overall Study|Study terminated due to time restraint|2|||
130069244|NCT00973622|468207876|FG000|Overall Study|did not pass MRI screen|6|||
130069245|NCT00973622|468207877|FG001|Overall Study|did not pass MRI screen|0|||
130069246|NCT00973622|468207876|FG000|Overall Study|did not complete rTMS sessions|11|||
130069247|NCT00973622|468207877|FG001|Overall Study|did not complete rTMS sessions|2|||
130069248|NCT03814005|468207881|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
130069249|NCT03814005|468207882|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
130069250|NCT03814005|468207883|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
130069251|NCT03814005|468207881|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
130069252|NCT03814005|468207882|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
130069253|NCT03814005|468207883|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
130069254|NCT03814005|468207881|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
130069255|NCT03814005|468207882|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
130069256|NCT03814005|468207883|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
130069257|NCT03814005|468207881|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
130069258|NCT03814005|468207882|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
130069259|NCT03814005|468207883|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
130069260|NCT03814005|468207881|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
130069261|NCT03814005|468207882|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
130069262|NCT03814005|468207883|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
130069263|NCT03814005|468207881|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
130069264|NCT03814005|468207882|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
130069265|NCT03814005|468207883|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
130069266|NCT03395223|468207884|FG000|Overall Study|Lost to Follow-up|3|||
130069267|NCT03395223|468207884|FG000|Overall Study|Other|1|||
130069268|NCT01855945|468207890|FG000|Overall Study|Adverse Event|0|||
130069269|NCT01855945|468207891|FG001|Overall Study|Adverse Event|0|||
130118040|NCT02482571|468392452|FG000|Overall Study|Withdrawal by Subject|4|||
129930602|NCT05204654|467711570|FG001|Overall Study|Study terminated due to time restraint|2|||
129930603|NCT02296684|467711585|FG000|Overall Study|Withdrawal by Subject|0|||
129930604|NCT02296684|467711586|FG001|Overall Study|Withdrawal by Subject|1|||
129930605|NCT02296684|467711587|FG002|Overall Study|Withdrawal by Subject|1|||
129930606|NCT02296684|467711585|FG000|Overall Study|Death|2|||
129930607|NCT02296684|467711586|FG001|Overall Study|Death|0|||
129930608|NCT02296684|467711587|FG002|Overall Study|Death|0|||
129930609|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
129930610|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
129930611|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
129930612|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
129930613|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
129930614|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
129930615|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
129930616|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
129930617|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
129930618|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
129930619|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
129930620|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
129930621|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
129930622|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
129930623|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
129930624|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
129930625|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
129930626|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
129930627|NCT01254864|467711590|FG000|Randomization Phase|Adverse Event|0|||
129930628|NCT01254864|467711591|FG001|Randomization Phase|Adverse Event|5|||
129930629|NCT01254864|467711592|FG002|Randomization Phase|Adverse Event|17|||
129930630|NCT01254864|467711590|FG000|Randomization Phase|Death|0|||
129930631|NCT01254864|467711591|FG001|Randomization Phase|Death|1|||
129930632|NCT01254864|467711592|FG002|Randomization Phase|Death|0|||
130069270|NCT01855945|468207892|FG002|Overall Study|Adverse Event|0|||
130069271|NCT01855945|468207893|FG003|Overall Study|Adverse Event|0|||
130069272|NCT01855945|468207894|FG004|Overall Study|Adverse Event|0|||
130069273|NCT01855945|468207895|FG005|Overall Study|Adverse Event|0|||
129930633|NCT01254864|467711590|FG000|Randomization Phase|Lost to Follow-up|0|||
129930634|NCT01254864|467711591|FG001|Randomization Phase|Lost to Follow-up|0|||
130069274|NCT01855945|468207896|FG006|Overall Study|Adverse Event|1|||
129930635|NCT01254864|467711592|FG002|Randomization Phase|Lost to Follow-up|1|||
130118041|NCT01446913|468392453|FG000|Overall Study|Significant illness|1|||
130118042|NCT01446913|468392454|FG001|Overall Study|Significant illness|1|||
130118043|NCT01446913|468392455|FG002|Overall Study|Significant illness|1|||
129930636|NCT01254864|467711590|FG000|Randomization Phase|Physician Decision|0|||
129930637|NCT01254864|467711591|FG001|Randomization Phase|Physician Decision|20|||
129930638|NCT01254864|467711592|FG002|Randomization Phase|Physician Decision|25|||
129930639|NCT01254864|467711590|FG000|Randomization Phase|Withdrawal by Subject|0|||
129930640|NCT01254864|467711591|FG001|Randomization Phase|Withdrawal by Subject|4|||
129930641|NCT01254864|467711592|FG002|Randomization Phase|Withdrawal by Subject|2|||
129930642|NCT01254864|467711590|FG000|Randomization Phase|Non-Compliance|0|||
129930643|NCT01254864|467711591|FG001|Randomization Phase|Non-Compliance|1|||
129930644|NCT01254864|467711592|FG002|Randomization Phase|Non-Compliance|0|||
129930645|NCT01254864|467711590|FG000|Randomization Phase|Comorbidities|0|||
129930646|NCT01254864|467711591|FG001|Randomization Phase|Comorbidities|2|||
129930647|NCT01254864|467711592|FG002|Randomization Phase|Comorbidities|1|||
129930648|NCT01828112|467711595|FG000|Treatment Phase|Adverse Event|7|||
129930649|NCT01828112|467711596|FG001|Treatment Phase|Adverse Event|8|||
129930650|NCT01828112|467711597|FG002|Treatment Phase|Adverse Event|0|||
129930651|NCT01828112|467711595|FG000|Treatment Phase|Death|9|||
129930652|NCT01828112|467711596|FG001|Treatment Phase|Death|5|||
129930653|NCT01828112|467711597|FG002|Treatment Phase|Death|0|||
129930654|NCT01828112|467711595|FG000|Treatment Phase|No longer required treatment|0|||
129930655|NCT01828112|467711596|FG001|Treatment Phase|No longer required treatment|1|||
129930656|NCT01828112|467711597|FG002|Treatment Phase|No longer required treatment|0|||
129930657|NCT01828112|467711595|FG000|Treatment Phase|Physician Decision|6|||
129930658|NCT01828112|467711596|FG001|Treatment Phase|Physician Decision|7|||
129930659|NCT01828112|467711597|FG002|Treatment Phase|Physician Decision|0|||
129930660|NCT01828112|467711595|FG000|Treatment Phase|Pregnancy|1|||
129930661|NCT01828112|467711596|FG001|Treatment Phase|Pregnancy|0|||
129930662|NCT01828112|467711597|FG002|Treatment Phase|Pregnancy|0|||
129930663|NCT01828112|467711595|FG000|Treatment Phase|Progressive disease|79|||
129930664|NCT01828112|467711596|FG001|Treatment Phase|Progressive disease|87|||
129930665|NCT01828112|467711597|FG002|Treatment Phase|Progressive disease|0|||
129930666|NCT01828112|467711595|FG000|Treatment Phase|Study terminated by sponsor|1|||
129930667|NCT01828112|467711596|FG001|Treatment Phase|Study terminated by sponsor|0|||
129930668|NCT01828112|467711597|FG002|Treatment Phase|Study terminated by sponsor|0|||
129930669|NCT01828112|467711595|FG000|Treatment Phase|Subject/guardian decision|12|||
129930670|NCT01828112|467711596|FG001|Treatment Phase|Subject/guardian decision|8|||
129930671|NCT01828112|467711597|FG002|Treatment Phase|Subject/guardian decision|0|||
129930672|NCT01828112|467711595|FG000|Extension Treatment Phase|Adverse Event|0|||
129930673|NCT01828112|467711596|FG001|Extension Treatment Phase|Adverse Event|0|||
129930674|NCT01828112|467711597|FG002|Extension Treatment Phase|Adverse Event|6|||
129930675|NCT01828112|467711595|FG000|Extension Treatment Phase|Death|0|||
129930676|NCT01828112|467711596|FG001|Extension Treatment Phase|Death|0|||
129930677|NCT01828112|467711597|FG002|Extension Treatment Phase|Death|17|||
129930678|NCT01828112|467711595|FG000|Extension Treatment Phase|Physician Decision|0|||
129930679|NCT01828112|467711596|FG001|Extension Treatment Phase|Physician Decision|0|||
129930680|NCT01828112|467711597|FG002|Extension Treatment Phase|Physician Decision|5|||
129930681|NCT01828112|467711595|FG000|Extension Treatment Phase|Progressive disease|0|||
129930682|NCT01828112|467711596|FG001|Extension Treatment Phase|Progressive disease|0|||
129930683|NCT01828112|467711597|FG002|Extension Treatment Phase|Progressive disease|46|||
129930684|NCT01828112|467711595|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
129930685|NCT01828112|467711596|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
129930686|NCT01828112|467711597|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
129930687|NCT01828112|467711595|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
129930688|NCT01828112|467711596|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
129930689|NCT01828112|467711597|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
129930690|NCT02446236|467711607|FG000|Overall Study|Screen Failure|1|||
129930691|NCT02446236|467711608|FG001|Overall Study|Screen Failure|0|||
129930692|NCT02446236|467711609|FG002|Overall Study|Screen Failure|1|||
130069275|NCT01855945|468207897|FG007|Overall Study|Adverse Event|0|||
130069276|NCT01855945|468207898|FG008|Overall Study|Adverse Event|0|||
130069277|NCT01855945|468207899|FG009|Overall Study|Adverse Event|0|||
130069278|NCT01855945|468207900|FG010|Overall Study|Adverse Event|0|||
130069279|NCT01855945|468207901|FG011|Overall Study|Adverse Event|0|||
129930693|NCT02446236|467711607|FG000|Overall Study|Actively Receiving Therapy|0|||
130069280|NCT01855945|468207890|FG000|Overall Study|Death|0|||
130069281|NCT01855945|468207891|FG001|Overall Study|Death|0|||
130069282|NCT01855945|468207892|FG002|Overall Study|Death|0|||
130069283|NCT01855945|468207893|FG003|Overall Study|Death|0|||
130069284|NCT01855945|468207894|FG004|Overall Study|Death|0|||
129930694|NCT02446236|467711608|FG001|Overall Study|Actively Receiving Therapy|0|||
129930695|NCT02446236|467711609|FG002|Overall Study|Actively Receiving Therapy|1|||
130069285|NCT01855945|468207895|FG005|Overall Study|Death|0|||
130069286|NCT01855945|468207896|FG006|Overall Study|Death|2|||
130069287|NCT01855945|468207897|FG007|Overall Study|Death|0|||
130069288|NCT01855945|468207898|FG008|Overall Study|Death|0|||
129930696|NCT00429364|467711610|FG000|Overall Study|Withdrawal by Subject|11|||
129930697|NCT00429364|467711611|FG001|Overall Study|Withdrawal by Subject|5|||
129930698|NCT00429364|467711610|FG000|Overall Study|Physician Decision|4|||
129930699|NCT00429364|467711611|FG001|Overall Study|Physician Decision|2|||
129930700|NCT00429364|467711610|FG000|Overall Study|Lost to Follow-up|7|||
129930701|NCT00429364|467711611|FG001|Overall Study|Lost to Follow-up|6|||
129930702|NCT00429364|467711610|FG000|Overall Study|Death|0|||
129930703|NCT00429364|467711611|FG001|Overall Study|Death|1|||
129930704|NCT00429364|467711610|FG000|Overall Study|Underwent aortic root surgery|10|||
129930705|NCT00429364|467711611|FG001|Overall Study|Underwent aortic root surgery|18|||
129930706|NCT00429364|467711610|FG000|Overall Study|Pregnancy|0|||
129930707|NCT00429364|467711611|FG001|Overall Study|Pregnancy|1|||
129930708|NCT04871529|467711612|FG000|Overall Study|Withdrawal by Subject|0|||
129930709|NCT04871529|467711613|FG001|Overall Study|Withdrawal by Subject|1|||
129930710|NCT04871529|467711612|FG000|Overall Study|Death|0|||
129930711|NCT04871529|467711613|FG001|Overall Study|Death|1|||
129930712|NCT04871529|467711612|FG000|Overall Study|Not protocol specified|0|||
129930713|NCT04871529|467711613|FG001|Overall Study|Not protocol specified|1|||
129930714|NCT05184452|467711614|FG000|Overall Study|Lost to Follow-up|0|||
129930715|NCT05184452|467711615|FG001|Overall Study|Lost to Follow-up|0|||
129930716|NCT05184452|467711616|FG002|Overall Study|Lost to Follow-up|0|||
129930717|NCT05184452|467711617|FG003|Overall Study|Lost to Follow-up|0|||
129930718|NCT05184452|467711618|FG004|Overall Study|Lost to Follow-up|0|||
129930719|NCT05184452|467711619|FG005|Overall Study|Lost to Follow-up|2|||
129930720|NCT05184452|467711620|FG006|Overall Study|Lost to Follow-up|0|||
129930721|NCT05184452|467711621|FG007|Overall Study|Lost to Follow-up|0|||
129930722|NCT05184452|467711622|FG008|Overall Study|Lost to Follow-up|0|||
129930723|NCT05184452|467711623|FG009|Overall Study|Lost to Follow-up|1|||
129930724|NCT05184452|467711614|FG000|Overall Study|Withdrawal by Subject|0|||
129930725|NCT05184452|467711615|FG001|Overall Study|Withdrawal by Subject|0|||
129930726|NCT05184452|467711616|FG002|Overall Study|Withdrawal by Subject|0|||
129930727|NCT05184452|467711617|FG003|Overall Study|Withdrawal by Subject|0|||
129930728|NCT05184452|467711618|FG004|Overall Study|Withdrawal by Subject|0|||
129930729|NCT05184452|467711619|FG005|Overall Study|Withdrawal by Subject|1|||
129930730|NCT05184452|467711620|FG006|Overall Study|Withdrawal by Subject|0|||
129930731|NCT05184452|467711621|FG007|Overall Study|Withdrawal by Subject|0|||
129930732|NCT05184452|467711622|FG008|Overall Study|Withdrawal by Subject|0|||
129930733|NCT05184452|467711623|FG009|Overall Study|Withdrawal by Subject|1|||
129930734|NCT04428203|467711624|FG000|Overall Study|Adverse Event|1|||
129930735|NCT04428203|467711625|FG001|Overall Study|Adverse Event|0|||
129930736|NCT04428203|467711626|FG002|Overall Study|Adverse Event|0|||
129930737|NCT04428203|467711624|FG000|Overall Study|Withdrawal by Subject|1|||
129930738|NCT04428203|467711625|FG001|Overall Study|Withdrawal by Subject|0|||
129930739|NCT04428203|467711626|FG002|Overall Study|Withdrawal by Subject|1|||
129930740|NCT05280574|467711627|FG000|Overall Study|Withdrawal by Subject|0|||
129930741|NCT05280574|467711628|FG001|Overall Study|Withdrawal by Subject|2|||
129930742|NCT05280574|467711629|FG002|Overall Study|Withdrawal by Subject|0|||
129930743|NCT04056611|467711632|FG000|Overall Study|Physician Decision|1|||
129930744|NCT03733925|467711633|FG000|Overall Study|Lost to Follow-up|1|||
129930745|NCT03733925|467711633|FG000|Overall Study|Withdrawal by Subject|2|||
129930746|NCT03733925|467711633|FG000|Overall Study|Adverse Event|2|||
129930747|NCT03733925|467711633|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129930748|NCT02631746|467711634|FG000|Overall Study|Lack of Efficacy|3|||
129930749|NCT02224144|467711635|FG000|Overall Study|Lost to Follow-up|3|||
129930750|NCT02224144|467711636|FG001|Overall Study|Lost to Follow-up|1|||
129930751|NCT02224144|467711635|FG000|Overall Study|Death|2|||
129930752|NCT02224144|467711636|FG001|Overall Study|Death|0|||
129930753|NCT02224144|467711635|FG000|Overall Study|Withdrawal by Subject|0|||
129930754|NCT02224144|467711636|FG001|Overall Study|Withdrawal by Subject|1|||
129930755|NCT02780700|467711646|FG000|Overall Study|Progressive disease|1|||
129930756|NCT04086121|467711657|FG000|Overall Study|Other than listed|8|||
130069289|NCT01855945|468207899|FG009|Overall Study|Death|0|||
130069290|NCT01855945|468207900|FG010|Overall Study|Death|0|||
130069291|NCT01855945|468207901|FG011|Overall Study|Death|0|||
129930757|NCT04086121|467711657|FG000|Overall Study|Withdrawal by Subject|3|||
129930758|NCT04086121|467711657|FG000|Overall Study|Lost to Follow-up|2|||
129930759|NCT04086121|467711657|FG000|Overall Study|Adverse Event|1|||
129930760|NCT02834390|467711658|FG000|Induction Phase|Progressive disease|0|||
129930761|NCT02834390|467711659|FG001|Induction Phase|Progressive disease|1|||
130069292|NCT01855945|468207890|FG000|Overall Study|Lost to Follow-up|11|||
129930762|NCT02834390|467711658|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
129930763|NCT02834390|467711659|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
129930764|NCT02834390|467711658|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
129930765|NCT02834390|467711659|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
129930766|NCT02834390|467711658|FG000|Consolidation Phase|Physician Decision|1|||
129930767|NCT02834390|467711659|FG001|Consolidation Phase|Physician Decision|1|||
129930768|NCT03118518|467711660|FG000|Overall Study|Early Exit after treatment|2|||
129930769|NCT03118518|467711661|FG001|Overall Study|Early Exit after treatment|8|||
130118044|NCT01446913|468392453|FG000|Overall Study|Withdrawal by Subject|5|||
130118045|NCT01446913|468392454|FG001|Overall Study|Withdrawal by Subject|3|||
130118046|NCT01446913|468392455|FG002|Overall Study|Withdrawal by Subject|5|||
130118047|NCT01446913|468392453|FG000|Overall Study|Physician Decision|0|||
130118048|NCT01446913|468392454|FG001|Overall Study|Physician Decision|0|||
130118049|NCT01446913|468392455|FG002|Overall Study|Physician Decision|2|||
130118050|NCT01446913|468392453|FG000|Overall Study|Lost to Follow-up|3|||
130118051|NCT01446913|468392454|FG001|Overall Study|Lost to Follow-up|5|||
130118052|NCT01446913|468392455|FG002|Overall Study|Lost to Follow-up|3|||
130118053|NCT00814320|468392460|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
130118054|NCT00814320|468392461|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
130118055|NCT00814320|468392460|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
130118056|NCT00814320|468392461|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
130118057|NCT00814320|468392460|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
130118058|NCT00814320|468392461|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
130118059|NCT00814320|468392460|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
130118060|NCT00814320|468392461|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
130118061|NCT00814320|468392460|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
130118062|NCT00814320|468392461|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
130118063|NCT00814320|468392460|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
130118064|NCT00814320|468392461|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
130118065|NCT00814320|468392460|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
130118066|NCT00814320|468392461|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
130118067|NCT00814320|468392460|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
130118068|NCT00814320|468392461|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
130118069|NCT00814320|468392460|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
130118070|NCT00814320|468392461|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
130118071|NCT00814320|468392460|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
130118072|NCT00814320|468392461|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
130118073|NCT00491504|468392462|FG000|Overall Study|Adverse Event|0|||
130118074|NCT00491504|468392463|FG001|Overall Study|Adverse Event|1|||
130118075|NCT00491504|468392464|FG002|Overall Study|Adverse Event|0|||
130118076|NCT00491504|468392465|FG003|Overall Study|Adverse Event|0|||
130118077|NCT00491504|468392462|FG000|Overall Study|Withdrawal by Subject|0|||
130118078|NCT00491504|468392463|FG001|Overall Study|Withdrawal by Subject|0|||
130118079|NCT00491504|468392464|FG002|Overall Study|Withdrawal by Subject|1|||
130118080|NCT00491504|468392465|FG003|Overall Study|Withdrawal by Subject|2|||
130118081|NCT00491504|468392462|FG000|Overall Study|Protocol Violation|0|||
130118082|NCT00491504|468392463|FG001|Overall Study|Protocol Violation|0|||
130118083|NCT00491504|468392464|FG002|Overall Study|Protocol Violation|3|||
130118084|NCT00491504|468392465|FG003|Overall Study|Protocol Violation|2|||
130118085|NCT02041702|468392466|FG000|Overall Study|Lost to Follow-up|1|||
130118086|NCT02041702|468392467|FG001|Overall Study|Lost to Follow-up|6|||
130118087|NCT02041702|468392466|FG000|Overall Study|Death|4|||
130118088|NCT02041702|468392467|FG001|Overall Study|Death|0|||
130118089|NCT02041702|468392466|FG000|Overall Study|Withdrawal by Subject|4|||
130118090|NCT02041702|468392467|FG001|Overall Study|Withdrawal by Subject|3|||
130118091|NCT02041702|468392466|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
130118092|NCT02041702|468392467|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
130118093|NCT02041702|468392466|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
130118094|NCT02041702|468392467|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
130118095|NCT00717756|468392469|FG000|Overall Study|Withdrawal by Subject|1|||
130118096|NCT00745251|468392470|FG000|Overall Study|Adverse Event|1|||
130069293|NCT01855945|468207891|FG001|Overall Study|Lost to Follow-up|10|||
130069294|NCT01855945|468207892|FG002|Overall Study|Lost to Follow-up|7|||
130069295|NCT01855945|468207893|FG003|Overall Study|Lost to Follow-up|3|||
130069296|NCT01855945|468207894|FG004|Overall Study|Lost to Follow-up|0|||
130069297|NCT01855945|468207895|FG005|Overall Study|Lost to Follow-up|3|||
130069298|NCT01855945|468207896|FG006|Overall Study|Lost to Follow-up|4|||
130069299|NCT01855945|468207897|FG007|Overall Study|Lost to Follow-up|7|||
130069300|NCT01855945|468207898|FG008|Overall Study|Lost to Follow-up|2|||
130069301|NCT01855945|468207899|FG009|Overall Study|Lost to Follow-up|0|||
130069302|NCT01855945|468207900|FG010|Overall Study|Lost to Follow-up|0|||
130069303|NCT01855945|468207901|FG011|Overall Study|Lost to Follow-up|2|||
130069304|NCT01855945|468207890|FG000|Overall Study|Other - Unclassified|1|||
130069305|NCT01855945|468207891|FG001|Overall Study|Other - Unclassified|1|||
130069306|NCT01855945|468207892|FG002|Overall Study|Other - Unclassified|1|||
130069307|NCT01855945|468207893|FG003|Overall Study|Other - Unclassified|0|||
130069308|NCT01855945|468207894|FG004|Overall Study|Other - Unclassified|0|||
130069309|NCT01855945|468207895|FG005|Overall Study|Other - Unclassified|0|||
130069310|NCT01855945|468207896|FG006|Overall Study|Other - Unclassified|2|||
130069311|NCT01855945|468207897|FG007|Overall Study|Other - Unclassified|1|||
130069312|NCT01855945|468207898|FG008|Overall Study|Other - Unclassified|0|||
130069313|NCT01855945|468207899|FG009|Overall Study|Other - Unclassified|0|||
129930770|NCT03118518|467711660|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
129930771|NCT03118518|467711661|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
129930772|NCT02998528|467711667|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
129930773|NCT02998528|467711668|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
129930774|NCT02998528|467711669|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
129930775|NCT02998528|467711667|FG000|Randomization Period|Participant withdrew consent|0|||
129930776|NCT02998528|467711668|FG001|Randomization Period|Participant withdrew consent|3|||
129930777|NCT02998528|467711669|FG002|Randomization Period|Participant withdrew consent|0|||
129930778|NCT02998528|467711667|FG000|Randomization Period|Participant no longer meets study criteria|1|||
129930779|NCT02998528|467711668|FG001|Randomization Period|Participant no longer meets study criteria|3|||
129930780|NCT02998528|467711669|FG002|Randomization Period|Participant no longer meets study criteria|2|||
129930781|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
129930782|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
129930783|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
129930784|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
129930785|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
129930786|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
129930787|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
129930788|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
129930789|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
129930790|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
129930791|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
129930792|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
129930793|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
129930794|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
129930795|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
129930796|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Death|1|||
130069314|NCT01855945|468207900|FG010|Overall Study|Other - Unclassified|1|||
130069315|NCT01855945|468207901|FG011|Overall Study|Other - Unclassified|0|||
130069316|NCT01855945|468207890|FG000|Overall Study|Withdrawal by Subject|4|||
129930797|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Death|0|||
129930798|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Death|0|||
129930799|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
129930800|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
129930801|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
129930802|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
129930803|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
129930804|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
129930805|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
129930806|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
129930807|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
129930808|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
129930809|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
129930810|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
130069317|NCT01855945|468207891|FG001|Overall Study|Withdrawal by Subject|0|||
130069318|NCT01855945|468207892|FG002|Overall Study|Withdrawal by Subject|4|||
130069319|NCT01855945|468207893|FG003|Overall Study|Withdrawal by Subject|1|||
130069320|NCT01855945|468207894|FG004|Overall Study|Withdrawal by Subject|1|||
130069321|NCT01855945|468207895|FG005|Overall Study|Withdrawal by Subject|0|||
130069322|NCT01855945|468207896|FG006|Overall Study|Withdrawal by Subject|1|||
130069323|NCT01855945|468207897|FG007|Overall Study|Withdrawal by Subject|0|||
130069324|NCT01855945|468207898|FG008|Overall Study|Withdrawal by Subject|0|||
130069325|NCT01855945|468207899|FG009|Overall Study|Withdrawal by Subject|2|||
130069326|NCT01855945|468207900|FG010|Overall Study|Withdrawal by Subject|4|||
130069327|NCT01855945|468207901|FG011|Overall Study|Withdrawal by Subject|1|||
130069328|NCT01148693|468207902|FG000|Overall Study|Attempts for cannulation were failed|13|||
130069329|NCT01148693|468207903|FG001|Overall Study|Attempts for cannulation were failed|10|||
130069330|NCT01135017|468207904|FG000|Overall Study|Adverse Event|3|||
130069331|NCT01135017|468207905|FG001|Overall Study|Adverse Event|8|||
130069332|NCT01135017|468207904|FG000|Overall Study|Other than above|3|||
130069333|NCT01135017|468207905|FG001|Overall Study|Other than above|4|||
130069334|NCT01074658|468207907|FG000|Overall Study|No implant attempted|19|||
130069335|NCT01342952|468207908|FG000|Overall Study|Adverse Event|0|||
130069336|NCT01342952|468207909|FG001|Overall Study|Adverse Event|5|||
130069337|NCT01342952|468207910|FG002|Overall Study|Adverse Event|1|||
130069338|NCT01342952|468207911|FG003|Overall Study|Adverse Event|0|||
130069339|NCT01342952|468207908|FG000|Overall Study|Lost to Follow-up|0|||
130118097|NCT00745251|468392471|FG001|Overall Study|Adverse Event|2|||
129930811|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
129930812|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
129930813|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
129930814|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
129930815|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
129930816|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
129930817|NCT05660434|467711672|FG000|Overall Study|Never obtained study materials|2|||
129930818|NCT05660434|467711673|FG001|Overall Study|Never obtained study materials|1|||
129930819|NCT02575950|467711674|FG000|Overall Study|Withdrawal by Subject|0|||
129930820|NCT02575950|467711675|FG001|Overall Study|Withdrawal by Subject|0|||
129930821|NCT02575950|467711676|FG002|Overall Study|Withdrawal by Subject|0|||
129930822|NCT02575950|467711677|FG003|Overall Study|Withdrawal by Subject|2|||
129930823|NCT02575950|467711674|FG000|Overall Study|Lost to Follow-up|0|||
129930824|NCT02575950|467711675|FG001|Overall Study|Lost to Follow-up|1|||
129930825|NCT02575950|467711676|FG002|Overall Study|Lost to Follow-up|0|||
129930826|NCT02575950|467711677|FG003|Overall Study|Lost to Follow-up|3|||
129930827|NCT04271046|467711678|FG000|Overall Study|Death|0|||
129930828|NCT04271046|467711679|FG001|Overall Study|Death|2|||
129930829|NCT04271046|467711680|FG002|Overall Study|Death|0|||
129930830|NCT04271046|467711681|FG003|Overall Study|Death|2|||
129930831|NCT04271046|467711678|FG000|Overall Study|Lost to Follow-up|12|||
129930832|NCT04271046|467711679|FG001|Overall Study|Lost to Follow-up|12|||
129930833|NCT04271046|467711680|FG002|Overall Study|Lost to Follow-up|11|||
129930834|NCT04271046|467711681|FG003|Overall Study|Lost to Follow-up|11|||
129930835|NCT04271046|467711678|FG000|Overall Study|Patient with Dementia Died|2|||
129930836|NCT04271046|467711679|FG001|Overall Study|Patient with Dementia Died|0|||
129930837|NCT04271046|467711680|FG002|Overall Study|Patient with Dementia Died|2|||
129930838|NCT04271046|467711681|FG003|Overall Study|Patient with Dementia Died|0|||
129930839|NCT04271046|467711678|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
129930840|NCT04271046|467711679|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
129930841|NCT04271046|467711680|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
129930842|NCT04271046|467711681|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
129930843|NCT04797858|467713819|FG000|Overall Study|Withdrawal by Subject|0|||
129930844|NCT04797858|467713820|FG001|Overall Study|Withdrawal by Subject|1|||
129930845|NCT04797858|467713819|FG000|Overall Study|Excluded due to administrative error|7|||
129930846|NCT04797858|467713820|FG001|Overall Study|Excluded due to administrative error|8|||
129930847|NCT04826471|467713821|FG000|Overall Study|Lost to Follow-up|2|||
129930848|NCT04826471|467713821|FG000|Overall Study|Protocol Violation|3|||
129930849|NCT04826471|467713821|FG000|Overall Study|Withdrawal by Subject|1|||
129930850|NCT04414722|467713822|FG000|Overall Study|Lost to Follow-up|3|||
129930851|NCT04414722|467713823|FG001|Overall Study|Lost to Follow-up|4|||
129930852|NCT04414722|467713824|FG002|Overall Study|Lost to Follow-up|3|||
129930853|NCT04414722|467713825|FG003|Overall Study|Lost to Follow-up|2|||
129930854|NCT04414722|467713826|FG004|Overall Study|Lost to Follow-up|3|||
129930855|NCT04414722|467713822|FG000|Overall Study|Withdrawal by Subject|6|||
129930856|NCT04414722|467713823|FG001|Overall Study|Withdrawal by Subject|3|||
129930857|NCT04414722|467713824|FG002|Overall Study|Withdrawal by Subject|1|||
129930858|NCT04414722|467713825|FG003|Overall Study|Withdrawal by Subject|5|||
129930859|NCT04414722|467713826|FG004|Overall Study|Withdrawal by Subject|1|||
129930860|NCT04414722|467713822|FG000|Overall Study|Physician Decision|0|||
129930861|NCT04414722|467713823|FG001|Overall Study|Physician Decision|1|||
129930862|NCT04414722|467713824|FG002|Overall Study|Physician Decision|2|||
129930863|NCT04414722|467713825|FG003|Overall Study|Physician Decision|0|||
129930864|NCT04414722|467713826|FG004|Overall Study|Physician Decision|0|||
129930865|NCT04414722|467713822|FG000|Overall Study|Non-participatory|0|||
129930866|NCT04414722|467713823|FG001|Overall Study|Non-participatory|1|||
129930867|NCT04414722|467713824|FG002|Overall Study|Non-participatory|1|||
129930868|NCT04414722|467713825|FG003|Overall Study|Non-participatory|0|||
129930869|NCT04414722|467713826|FG004|Overall Study|Non-participatory|0|||
129930870|NCT04304144|467713827|FG000|DLT Observation Period|Physician Decision|0|||
129930871|NCT04304144|467713828|FG001|DLT Observation Period|Physician Decision|1|||
129930872|NCT04304144|467713829|FG002|DLT Observation Period|Physician Decision|0|||
129930873|NCT04304144|467713830|FG003|DLT Observation Period|Physician Decision|0|||
130069340|NCT01342952|468207909|FG001|Overall Study|Lost to Follow-up|2|||
130069341|NCT01342952|468207910|FG002|Overall Study|Lost to Follow-up|0|||
130069342|NCT01342952|468207911|FG003|Overall Study|Lost to Follow-up|0|||
129930874|NCT04304144|467713827|FG000|Continued Treatment Period|Adverse Event|0|||
129930875|NCT04304144|467713828|FG001|Continued Treatment Period|Adverse Event|1|||
129930876|NCT04304144|467713829|FG002|Continued Treatment Period|Adverse Event|0|||
129930877|NCT04304144|467713830|FG003|Continued Treatment Period|Adverse Event|0|||
129930878|NCT04304144|467713827|FG000|Continued Treatment Period|Death|0|||
129930879|NCT04304144|467713828|FG001|Continued Treatment Period|Death|0|||
129930880|NCT04304144|467713829|FG002|Continued Treatment Period|Death|1|||
129930881|NCT04304144|467713830|FG003|Continued Treatment Period|Death|2|||
129930882|NCT04304144|467713827|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
129930883|NCT04304144|467713828|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
129930884|NCT04304144|467713829|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
129930885|NCT04304144|467713830|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
129930886|NCT04304144|467713827|FG000|Continued Treatment Period|Other than specified|2|||
129930887|NCT04304144|467713828|FG001|Continued Treatment Period|Other than specified|0|||
129930888|NCT04304144|467713829|FG002|Continued Treatment Period|Other than specified|1|||
129930889|NCT04304144|467713830|FG003|Continued Treatment Period|Other than specified|1|||
130069343|NCT01342952|468207908|FG000|Overall Study|Withdrawal by Subject|1|||
130069344|NCT01342952|468207909|FG001|Overall Study|Withdrawal by Subject|1|||
130069345|NCT01342952|468207910|FG002|Overall Study|Withdrawal by Subject|0|||
130069346|NCT01342952|468207911|FG003|Overall Study|Withdrawal by Subject|0|||
130069347|NCT01342952|468207908|FG000|Overall Study|Physician Decision|3|||
130069348|NCT01342952|468207909|FG001|Overall Study|Physician Decision|3|||
130069349|NCT01342952|468207910|FG002|Overall Study|Physician Decision|1|||
130069350|NCT01342952|468207911|FG003|Overall Study|Physician Decision|0|||
130069351|NCT01162304|468207914|FG000|Overall Study|Beck scale to high|11|||
130069352|NCT03505749|468207917|FG000|Overall Study|Lost to Follow-up|7|||
130069353|NCT03505749|468207918|FG001|Overall Study|Lost to Follow-up|11|||
130069354|NCT03505749|468207917|FG000|Overall Study|Withdrawal by Subject|6|||
130069355|NCT03505749|468207918|FG001|Overall Study|Withdrawal by Subject|0|||
130069356|NCT03505749|468207917|FG000|Overall Study|Discharged from treatment|3|||
130069357|NCT03505749|468207918|FG001|Overall Study|Discharged from treatment|6|||
130069358|NCT03549117|468207922|FG000|Overall Study|Withdrawal by Subject|1|||
130069359|NCT03549117|468207923|FG001|Overall Study|Withdrawal by Subject|0|||
130069360|NCT00888615|468207924|FG000|Overall Study|No treatment|2|||
130069361|NCT02091921|468207927|FG000|Overall Study|Adverse Event|3|||
130069362|NCT03307629|468207928|FG000|Overall Study|Withdrawal by Subject|0|||
130069363|NCT03307629|468207929|FG001|Overall Study|Withdrawal by Subject|0|||
130069364|NCT03307629|468207930|FG002|Overall Study|Withdrawal by Subject|0|||
130069365|NCT03307629|468207931|FG003|Overall Study|Withdrawal by Subject|2|||
130069366|NCT03307629|468207928|FG000|Overall Study|Disease Progression|0|||
130069367|NCT03307629|468207929|FG001|Overall Study|Disease Progression|0|||
130069368|NCT03307629|468207930|FG002|Overall Study|Disease Progression|0|||
130069369|NCT03307629|468207931|FG003|Overall Study|Disease Progression|3|||
130069370|NCT03307629|468207928|FG000|Overall Study|Death|0|||
130069371|NCT03307629|468207929|FG001|Overall Study|Death|3|||
130069372|NCT03307629|468207930|FG002|Overall Study|Death|0|||
130069373|NCT03307629|468207931|FG003|Overall Study|Death|1|||
130069374|NCT00719953|468207936|FG000|Overall Study|Adverse Event|4|||
130069375|NCT01626989|468207937|FG000|Screening Period|Screen Failure|15|||
130069376|NCT01626989|468207938|FG001|Screening Period|Screen Failure|0|||
130069377|NCT01626989|468207939|FG002|Screening Period|Screen Failure|0|||
130069378|NCT01626989|468207937|FG000|Screening Period|Withdrawal by Subject|2|||
130069379|NCT01626989|468207938|FG001|Screening Period|Withdrawal by Subject|0|||
130069380|NCT01626989|468207939|FG002|Screening Period|Withdrawal by Subject|0|||
130069381|NCT02947022|468207943|FG000|Overall Study|Study Stopped|1|||
130069382|NCT01230749|468207944|FG000|Overall Study|Adverse Event|0|||
130069383|NCT01230749|468207945|FG001|Overall Study|Adverse Event|0|||
130069384|NCT01230749|468207946|FG002|Overall Study|Adverse Event|0|||
130069385|NCT01230749|468207947|FG003|Overall Study|Adverse Event|1|||
130069386|NCT01230749|468207944|FG000|Overall Study|Physician Decision|0|||
130069387|NCT01230749|468207945|FG001|Overall Study|Physician Decision|0|||
130069388|NCT01230749|468207946|FG002|Overall Study|Physician Decision|1|||
130069389|NCT01230749|468207947|FG003|Overall Study|Physician Decision|0|||
130069390|NCT01230749|468207944|FG000|Overall Study|Withdrawal by Subject|0|||
130069391|NCT01230749|468207945|FG001|Overall Study|Withdrawal by Subject|1|||
130069392|NCT01230749|468207946|FG002|Overall Study|Withdrawal by Subject|0|||
130069393|NCT01230749|468207947|FG003|Overall Study|Withdrawal by Subject|0|||
130069394|NCT01230749|468207944|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
130069395|NCT01230749|468207945|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
130069396|NCT01230749|468207946|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
130069397|NCT01230749|468207947|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
129930890|NCT05256654|467713831|FG000|Overall Study|Adverse Event|0|||
130069398|NCT03518034|468209468|FG000|Overall Study|Not Treated|5|||
130069399|NCT03518034|468209469|FG001|Overall Study|Not Treated|1|||
130069400|NCT03518034|468209468|FG000|Overall Study|Withdrawal by Subject|309|||
130069401|NCT03518034|468209469|FG001|Overall Study|Withdrawal by Subject|351|||
130069402|NCT03518034|468209468|FG000|Overall Study|Lost to Follow-up|446|||
130069403|NCT03518034|468209469|FG001|Overall Study|Lost to Follow-up|458|||
130069404|NCT03518034|468209468|FG000|Overall Study|Adverse Event|138|||
130069405|NCT03518034|468209469|FG001|Overall Study|Adverse Event|130|||
130069406|NCT03518034|468209468|FG000|Overall Study|Lack of Efficacy|11|||
130069407|NCT03518034|468209469|FG001|Overall Study|Lack of Efficacy|23|||
130069408|NCT03518034|468209468|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
130069409|NCT03518034|468209469|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
130069410|NCT03518034|468209468|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
130069411|NCT03518034|468209469|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
130118098|NCT00745251|468392470|FG000|Overall Study|Withdrawal by Subject|1|||
130118099|NCT00745251|468392471|FG001|Overall Study|Withdrawal by Subject|1|||
130118100|NCT02928848|468392472|FG000|Arm 2|Withdrawal by Subject|1|||
130118101|NCT02928848|468392473|FG001|Arm 2|Withdrawal by Subject|0|||
130118102|NCT00969332|468392474|FG000|Overall Study|Physician Decision|8|||
130118103|NCT00969332|468392474|FG000|Overall Study|Withdrawal by Subject|3|||
130118104|NCT02729896|468392476|FG000|Overall Study|Death|0|||
130118105|NCT02729896|468392477|FG001|Overall Study|Death|2|||
130118106|NCT02729896|468392478|FG002|Overall Study|Death|13|||
130118107|NCT02729896|468392476|FG000|Overall Study|Lost to Follow-up|0|||
130118108|NCT02729896|468392477|FG001|Overall Study|Lost to Follow-up|2|||
130118109|NCT02729896|468392478|FG002|Overall Study|Lost to Follow-up|3|||
130118110|NCT02729896|468392476|FG000|Overall Study|Other|0|||
130118111|NCT02729896|468392477|FG001|Overall Study|Other|2|||
130118112|NCT02729896|468392478|FG002|Overall Study|Other|0|||
130118113|NCT02729896|468392476|FG000|Overall Study|Physician Decision|1|||
130118114|NCT02729896|468392477|FG001|Overall Study|Physician Decision|2|||
130118115|NCT02729896|468392478|FG002|Overall Study|Physician Decision|3|||
130118116|NCT02729896|468392476|FG000|Overall Study|Progressive Disease|0|||
130118117|NCT02729896|468392477|FG001|Overall Study|Progressive Disease|1|||
130118118|NCT02729896|468392478|FG002|Overall Study|Progressive Disease|0|||
130118119|NCT02729896|468392476|FG000|Overall Study|Withdrawal by Subject|1|||
130118120|NCT02729896|468392477|FG001|Overall Study|Withdrawal by Subject|0|||
130118121|NCT02729896|468392478|FG002|Overall Study|Withdrawal by Subject|3|||
130118122|NCT00582309|468392479|FG000|Overall Study|Protocol Violation|0|||
130118123|NCT00582309|468392480|FG001|Overall Study|Protocol Violation|0|||
130118124|NCT00582309|468392481|FG002|Overall Study|Protocol Violation|2|||
130118125|NCT01618305|468392482|FG000|Overall Study|Death|0|||
130118126|NCT01618305|468392483|FG001|Overall Study|Death|1|||
130118127|NCT01618305|468392482|FG000|Overall Study|Lost to Follow-up|11|||
130118128|NCT01618305|468392483|FG001|Overall Study|Lost to Follow-up|7|||
130118129|NCT01618305|468392482|FG000|Overall Study|Protocol Violation|1|||
130118130|NCT01618305|468392483|FG001|Overall Study|Protocol Violation|0|||
130118131|NCT01618305|468392482|FG000|Overall Study|Withdrawal by Subject|3|||
130118132|NCT01618305|468392483|FG001|Overall Study|Withdrawal by Subject|2|||
130118133|NCT02708277|468392484|FG000|Overall Study|Lost to Follow-up|7|||
130118134|NCT02708277|468392485|FG001|Overall Study|Lost to Follow-up|4|||
130118135|NCT01058421|468392486|FG000|1 Month Outcomes|Death|10|||
130118136|NCT01058421|468392487|FG001|1 Month Outcomes|Death|6|||
130118137|NCT01058421|468392486|FG000|1 Month Outcomes|Lost to Follow-up|8|||
130118138|NCT01058421|468392487|FG001|1 Month Outcomes|Lost to Follow-up|7|||
130118139|NCT01058421|468392486|FG000|1 Month Outcomes|Remained in Hospital|5|||
130118140|NCT01058421|468392487|FG001|1 Month Outcomes|Remained in Hospital|12|||
130118141|NCT01058421|468392486|FG000|1 Month Outcomes|Remained in Other Facility|16|||
130118142|NCT01058421|468392487|FG001|1 Month Outcomes|Remained in Other Facility|17|||
130118143|NCT01058421|468392486|FG000|3 Month Outcomes|Death|3|||
130118144|NCT01058421|468392487|FG001|3 Month Outcomes|Death|5|||
130118145|NCT01058421|468392486|FG000|3 Month Outcomes|Lost to Follow-up|12|||
130118146|NCT01058421|468392487|FG001|3 Month Outcomes|Lost to Follow-up|11|||
130118147|NCT01058421|468392486|FG000|3 Month Outcomes|Remained in Hospital|0|||
130118148|NCT01058421|468392487|FG001|3 Month Outcomes|Remained in Hospital|2|||
130118149|NCT01058421|468392486|FG000|3 Month Outcomes|Remained in Other Facility|5|||
130118150|NCT01058421|468392487|FG001|3 Month Outcomes|Remained in Other Facility|8|||
130118151|NCT01058421|468392486|FG000|6 Month Outcomes|Death|2|||
130118152|NCT01058421|468392487|FG001|6 Month Outcomes|Death|2|||
130118153|NCT01058421|468392486|FG000|6 Month Outcomes|Lost to Follow-up|16|||
130118154|NCT01058421|468392487|FG001|6 Month Outcomes|Lost to Follow-up|21|||
130118155|NCT01058421|468392486|FG000|6 Month Outcomes|Remained in Other Facility|1|||
130118156|NCT01058421|468392487|FG001|6 Month Outcomes|Remained in Other Facility|3|||
130118157|NCT01960816|468392488|FG000|Overall Study|Lost to Follow-up|1|||
130118158|NCT01118728|468392489|FG000|Overall Study|Adverse Event|17|||
130118159|NCT01118728|468392489|FG000|Overall Study|Lack of Efficacy|27|||
130118160|NCT01118728|468392489|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
130118161|NCT01118728|468392489|FG000|Overall Study|Withdrawal by Subject|3|||
130118162|NCT01118728|468392489|FG000|Overall Study|Lost to Follow-up|4|||
130118163|NCT00385541|468392490|FG000|Overall Study|severe pain, clinician requested unblind|0|||
130118164|NCT00385541|468392491|FG001|Overall Study|severe pain, clinician requested unblind|1|||
130118165|NCT00929708|468392492|FG000|Overall Study|Protocol Violation|2|||
130118166|NCT00929708|468392493|FG001|Overall Study|Protocol Violation|1|||
130118167|NCT00929708|468392494|FG002|Overall Study|Protocol Violation|1|||
130118168|NCT00929708|468392495|FG003|Overall Study|Protocol Violation|1|||
130118169|NCT00929708|468392496|FG004|Overall Study|Protocol Violation|1|||
130118170|NCT00929708|468392492|FG000|Overall Study|Withdrawal by Subject|2|||
130118171|NCT00929708|468392493|FG001|Overall Study|Withdrawal by Subject|0|||
130118172|NCT00929708|468392494|FG002|Overall Study|Withdrawal by Subject|0|||
130118173|NCT00929708|468392495|FG003|Overall Study|Withdrawal by Subject|2|||
130118174|NCT00929708|468392496|FG004|Overall Study|Withdrawal by Subject|1|||
130118175|NCT00929708|468392492|FG000|Overall Study|Adverse Event|0|||
130118176|NCT00929708|468392493|FG001|Overall Study|Adverse Event|0|||
129930891|NCT05256654|467713832|FG001|Overall Study|Adverse Event|0|||
129930892|NCT05256654|467713833|FG002|Overall Study|Adverse Event|1|||
129930893|NCT05256654|467713834|FG003|Overall Study|Adverse Event|0|||
129930894|NCT05256654|467713831|FG000|Overall Study|Lost to Follow-up|0|||
129930895|NCT05256654|467713832|FG001|Overall Study|Lost to Follow-up|0|||
129930896|NCT05256654|467713833|FG002|Overall Study|Lost to Follow-up|0|||
129930897|NCT05256654|467713834|FG003|Overall Study|Lost to Follow-up|1|||
129930898|NCT05256654|467713831|FG000|Overall Study|Withdrawal by Subject|1|||
129930899|NCT05256654|467713832|FG001|Overall Study|Withdrawal by Subject|2|||
129930900|NCT05256654|467713833|FG002|Overall Study|Withdrawal by Subject|1|||
129930901|NCT05256654|467713834|FG003|Overall Study|Withdrawal by Subject|3|||
129930902|NCT05256654|467713831|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
129930903|NCT05256654|467713832|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
129930904|NCT05256654|467713833|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
129930905|NCT05256654|467713834|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
129930906|NCT05256654|467713831|FG000|Overall Study|Other|0|||
129930907|NCT05256654|467713832|FG001|Overall Study|Other|0|||
129930908|NCT05256654|467713833|FG002|Overall Study|Other|0|||
129930909|NCT05256654|467713834|FG003|Overall Study|Other|1|||
129930910|NCT03442309|467713841|FG000|Overall Study|Lost to Follow-up|1676|||
129930911|NCT03442309|467713842|FG001|Overall Study|Lost to Follow-up|1642|||
129930912|NCT04862416|467713843|FG000|Overall Study|Withdrawal by Subject|0|||
129930913|NCT04862416|467713844|FG001|Overall Study|Withdrawal by Subject|1|||
129930914|NCT04862416|467713845|FG002|Overall Study|Withdrawal by Subject|0|||
129930915|NCT04862416|467713846|FG003|Overall Study|Withdrawal by Subject|1|||
129930916|NCT04862416|467713847|FG004|Overall Study|Withdrawal by Subject|0|||
129930917|NCT04862416|467713848|FG005|Overall Study|Withdrawal by Subject|0|||
129930918|NCT04862416|467713849|FG006|Overall Study|Withdrawal by Subject|0|||
129930919|NCT04862416|467713850|FG007|Overall Study|Withdrawal by Subject|0|||
129930920|NCT05207956|467713851|FG000|Overall Study|Lost to follow up|1|||
129930921|NCT05207956|467713852|FG001|Overall Study|Lost to follow up|2|||
129930922|NCT05425420|467713868|FG000|Overall Study|Physician Decision|1|||
129930923|NCT05425420|467713868|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
129930924|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
129930925|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
129930926|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
129930927|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
129930928|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
129930929|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
129930930|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
129930931|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
129930932|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
129930933|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
129930934|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
129930935|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
129930936|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
129930937|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
129930938|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
129930939|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
129930940|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
129930941|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
129930942|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
129930943|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
129930944|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
129930945|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
129930946|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
129930947|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
129930948|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
129930949|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
129930950|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
129930951|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
130069412|NCT03518034|468209468|FG000|Overall Study|Other, Not Specified|84|||
130069413|NCT03518034|468209469|FG001|Overall Study|Other, Not Specified|53|||
130069414|NCT03518034|468209468|FG000|Overall Study|Reason Missing|2|||
130069415|NCT03518034|468209469|FG001|Overall Study|Reason Missing|3|||
130069416|NCT02227849|468209477|FG000|Overall Study|Adverse Event|4|||
130069417|NCT02227849|468209477|FG000|Overall Study|Physician Decision|1|||
129930952|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
129930953|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
129930954|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
129930955|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
130069418|NCT02227849|468209477|FG000|Overall Study|Withdrawal by Subject|3|||
130069419|NCT01590212|468209480|FG000|Overall Study|Withdrawal by Subject|2|||
130069420|NCT01590212|468209481|FG001|Overall Study|Withdrawal by Subject|2|||
130069421|NCT01590212|468209482|FG002|Overall Study|Withdrawal by Subject|2|||
130069422|NCT01590212|468209480|FG000|Overall Study|Lost to Follow-up|1|||
130069423|NCT01590212|468209481|FG001|Overall Study|Lost to Follow-up|2|||
130069424|NCT01590212|468209482|FG002|Overall Study|Lost to Follow-up|3|||
130069425|NCT04897594|468209484|FG000|Overall Study|Lost to Follow-up|0|||
130069426|NCT04897594|468209485|FG001|Overall Study|Lost to Follow-up|1|||
130069427|NCT04897594|468209486|FG002|Overall Study|Lost to Follow-up|1|||
130069428|NCT04897594|468209484|FG000|Overall Study|Sponsor Decision|0|||
130069429|NCT04897594|468209485|FG001|Overall Study|Sponsor Decision|0|||
130069430|NCT04897594|468209486|FG002|Overall Study|Sponsor Decision|1|||
130069431|NCT04897594|468209484|FG000|Overall Study|Withdrawal by Subject|1|||
130069432|NCT04897594|468209485|FG001|Overall Study|Withdrawal by Subject|0|||
130069433|NCT04897594|468209486|FG002|Overall Study|Withdrawal by Subject|1|||
130069434|NCT00636441|468209495|FG000|Overall Study|Adverse Event|0|||
130069435|NCT00636441|468209496|FG001|Overall Study|Adverse Event|1|||
130069436|NCT00636441|468209497|FG002|Overall Study|Adverse Event|1|||
130069437|NCT00636441|468209498|FG003|Overall Study|Adverse Event|0|||
130069438|NCT00636441|468209499|FG004|Overall Study|Adverse Event|0|||
130069439|NCT00636441|468209500|FG005|Overall Study|Adverse Event|1|||
130069440|NCT00636441|468209501|FG006|Overall Study|Adverse Event|0|||
130069441|NCT00636441|468209495|FG000|Overall Study|Late, ineligible|0|||
130069442|NCT00636441|468209496|FG001|Overall Study|Late, ineligible|0|||
130069443|NCT00636441|468209497|FG002|Overall Study|Late, ineligible|0|||
130069444|NCT00636441|468209498|FG003|Overall Study|Late, ineligible|0|||
130069445|NCT00636441|468209499|FG004|Overall Study|Late, ineligible|0|||
130069446|NCT00636441|468209500|FG005|Overall Study|Late, ineligible|0|||
130069447|NCT00636441|468209501|FG006|Overall Study|Late, ineligible|1|||
130069448|NCT00636441|468209495|FG000|Overall Study|Screen Failure|0|||
130069449|NCT00636441|468209496|FG001|Overall Study|Screen Failure|0|||
130069450|NCT00636441|468209497|FG002|Overall Study|Screen Failure|0|||
130069451|NCT00636441|468209498|FG003|Overall Study|Screen Failure|0|||
130069452|NCT00636441|468209499|FG004|Overall Study|Screen Failure|0|||
130069453|NCT00636441|468209500|FG005|Overall Study|Screen Failure|0|||
130069454|NCT00636441|468209501|FG006|Overall Study|Screen Failure|17|||
130069455|NCT00425100|468209502|FG000|Overall Study|Adverse Event|36|||
130069456|NCT00425100|468209502|FG000|Overall Study|Lack of Efficacy|4|||
130069457|NCT00425100|468209502|FG000|Overall Study|Lost to Follow-up|2|||
130069458|NCT00425100|468209502|FG000|Overall Study|Protocol Violation|4|||
130069459|NCT00425100|468209502|FG000|Overall Study|Withdrawal by Subject|7|||
130069460|NCT03495817|468209503|FG000|26 Week Open Label|Adverse Event|3|||
130069461|NCT03495817|468209503|FG000|26 Week Open Label|Withdrawal by Subject|4|||
130069462|NCT03495817|468209503|FG000|26 Week Open Label|Lost to Follow-up|1|||
130069463|NCT03495817|468209503|FG000|26 Week Extension|Lost to Follow-up|2|||
130069464|NCT04169061|468209505|FG000|Overall Study|Adverse Event|2|||
130069465|NCT04169061|468209505|FG000|Overall Study|Death|1|||
130069466|NCT04169061|468209505|FG000|Overall Study|Withdrawal by Subject|1|||
130069467|NCT04169061|468209505|FG000|Overall Study|Protocol Violation|1|||
130069468|NCT04585451|468209509|FG000|Overall Study|Withdrawal by Subject|26|||
130069469|NCT04585451|468209510|FG001|Overall Study|Withdrawal by Subject|0|||
130069470|NCT00326417|468209511|FG000|Overall Study|Withdrawal by Subject|0|||
130069471|NCT00326417|468209512|FG001|Overall Study|Withdrawal by Subject|0|||
130069472|NCT00326417|468209513|FG002|Overall Study|Withdrawal by Subject|1|||
130069473|NCT00326417|468209514|FG003|Overall Study|Withdrawal by Subject|0|||
130069474|NCT00326417|468209511|FG000|Overall Study|Arm Closed|7|||
130069475|NCT00326417|468209512|FG001|Overall Study|Arm Closed|0|||
130069476|NCT00326417|468209513|FG002|Overall Study|Arm Closed|0|||
130069477|NCT00326417|468209514|FG003|Overall Study|Arm Closed|3|||
130069478|NCT00326417|468209511|FG000|Overall Study|Death|7|||
130069479|NCT00326417|468209512|FG001|Overall Study|Death|0|||
130069480|NCT00326417|468209513|FG002|Overall Study|Death|0|||
130069481|NCT00326417|468209514|FG003|Overall Study|Death|0|||
130069482|NCT00844285|468209515|FG000|Overall Study|Other|0|||
130069483|NCT00844285|468209516|FG001|Overall Study|Other|1|||
130118177|NCT00929708|468392494|FG002|Overall Study|Adverse Event|0|||
130118178|NCT00929708|468392495|FG003|Overall Study|Adverse Event|0|||
130069484|NCT00844285|468209517|FG002|Overall Study|Other|0|||
130069485|NCT00844285|468209515|FG000|Overall Study|Other than specified|95|||
130069486|NCT00844285|468209516|FG001|Overall Study|Other than specified|129|||
130069487|NCT00844285|468209517|FG002|Overall Study|Other than specified|12|||
130069488|NCT00844285|468209515|FG000|Overall Study|Site closure|256|||
130069489|NCT00844285|468209516|FG001|Overall Study|Site closure|450|||
130069490|NCT00844285|468209517|FG002|Overall Study|Site closure|50|||
130069491|NCT00844285|468209515|FG000|Overall Study|Follow-up < 8 years|16|||
130069492|NCT00844285|468209516|FG001|Overall Study|Follow-up < 8 years|23|||
130069493|NCT00844285|468209517|FG002|Overall Study|Follow-up < 8 years|4|||
130069494|NCT00844285|468209515|FG000|Overall Study|Protocol Violation|26|||
130118179|NCT00929708|468392496|FG004|Overall Study|Adverse Event|3|||
130118180|NCT00929708|468392492|FG000|Overall Study|Physician Decision|0|||
130118181|NCT00929708|468392493|FG001|Overall Study|Physician Decision|2|||
130118182|NCT00929708|468392494|FG002|Overall Study|Physician Decision|2|||
129930956|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
129930957|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
129930958|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
129930959|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
129930960|NCT04571619|467713878|FG000|Phase 1|Death|22|||
129930961|NCT04571619|467713879|FG001|Phase 1|Death|18|||
129930962|NCT04571619|467713878|FG000|Phase 1|Withdrawal by Subject|7|||
129930963|NCT04571619|467713879|FG001|Phase 1|Withdrawal by Subject|2|||
129930964|NCT04571619|467713878|FG000|Phase 2|Death|13|||
129930965|NCT04571619|467713879|FG001|Phase 2|Death|16|||
129930966|NCT04571619|467713878|FG000|Phase 2|Withdrawal by Subject|6|||
129930967|NCT04571619|467713879|FG001|Phase 2|Withdrawal by Subject|4|||
129930968|NCT03505008|467713880|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
129930969|NCT03505008|467713881|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
129930970|NCT03505008|467713882|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
129930971|NCT03505008|467713883|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
129930972|NCT03505008|467713880|FG000|Before Week 24 Randomization|Adverse Event|10|||
129930973|NCT03505008|467713881|FG001|Before Week 24 Randomization|Adverse Event|0|||
129930974|NCT03505008|467713882|FG002|Before Week 24 Randomization|Adverse Event|0|||
129930975|NCT03505008|467713883|FG003|Before Week 24 Randomization|Adverse Event|0|||
129930976|NCT03505008|467713880|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
129930977|NCT03505008|467713881|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
129930978|NCT03505008|467713882|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
129930979|NCT03505008|467713883|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
129930980|NCT03505008|467713880|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
129930981|NCT03505008|467713881|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
129930982|NCT03505008|467713882|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
129930983|NCT03505008|467713883|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
129930984|NCT03505008|467713880|FG000|Before Week 24 Randomization|Physician Decision|2|||
129930985|NCT03505008|467713881|FG001|Before Week 24 Randomization|Physician Decision|0|||
129930986|NCT03505008|467713882|FG002|Before Week 24 Randomization|Physician Decision|0|||
129930987|NCT03505008|467713883|FG003|Before Week 24 Randomization|Physician Decision|0|||
129930988|NCT03505008|467713880|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
129930989|NCT03505008|467713881|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
129930990|NCT03505008|467713882|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
129930991|NCT03505008|467713883|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
129930992|NCT03505008|467713880|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
129930993|NCT03505008|467713881|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
129930994|NCT03505008|467713882|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
129930995|NCT03505008|467713883|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
129930996|NCT03505008|467713880|FG000|Before Week 24 Randomization|Complication|1|||
129930997|NCT03505008|467713881|FG001|Before Week 24 Randomization|Complication|0|||
129930998|NCT03505008|467713882|FG002|Before Week 24 Randomization|Complication|0|||
129930999|NCT03505008|467713883|FG003|Before Week 24 Randomization|Complication|0|||
129931000|NCT03505008|467713880|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
129931001|NCT03505008|467713881|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
129931002|NCT03505008|467713882|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
129931003|NCT03505008|467713883|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
129931004|NCT03505008|467713880|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
129931005|NCT03505008|467713881|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
129931006|NCT03505008|467713882|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
129931007|NCT03505008|467713883|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
129931008|NCT03505008|467713880|FG000|After Week 24 Randomization|Adverse Event|0|||
129931009|NCT03505008|467713881|FG001|After Week 24 Randomization|Adverse Event|1|||
129931010|NCT03505008|467713882|FG002|After Week 24 Randomization|Adverse Event|2|||
129931011|NCT03505008|467713883|FG003|After Week 24 Randomization|Adverse Event|2|||
129931012|NCT03505008|467713880|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
129931013|NCT03505008|467713881|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
129931014|NCT03505008|467713882|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
129931015|NCT03505008|467713883|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
129931016|NCT03505008|467713880|FG000|After Week 24 Randomization|Protocol Violation|0|||
129931017|NCT03505008|467713881|FG001|After Week 24 Randomization|Protocol Violation|0|||
129931018|NCT03505008|467713882|FG002|After Week 24 Randomization|Protocol Violation|1|||
129931019|NCT03505008|467713883|FG003|After Week 24 Randomization|Protocol Violation|0|||
129931020|NCT04741776|467713884|FG000|Overall Study|Withdrawal by Subject|7|||
129931021|NCT04741776|467713885|FG001|Overall Study|Withdrawal by Subject|10|||
129931022|NCT04741776|467713886|FG002|Overall Study|Withdrawal by Subject|10|||
129931023|NCT04741776|467713887|FG003|Overall Study|Withdrawal by Subject|17|||
129931024|NCT04741776|467713884|FG000|Overall Study|Death|0|||
129931025|NCT04741776|467713885|FG001|Overall Study|Death|0|||
129931026|NCT04741776|467713886|FG002|Overall Study|Death|1|||
129931027|NCT04741776|467713887|FG003|Overall Study|Death|0|||
129931028|NCT05069896|467713888|FG000|Overall Study|Adverse Event|0|||
129931029|NCT05069896|467713889|FG001|Overall Study|Adverse Event|1|||
129931030|NCT05069896|467713890|FG002|Overall Study|Adverse Event|1|||
129931031|NCT05069896|467713891|FG003|Overall Study|Adverse Event|0|||
129931032|NCT05069896|467713892|FG004|Overall Study|Adverse Event|0|||
129931033|NCT05069896|467713893|FG005|Overall Study|Adverse Event|0|||
129931034|NCT05069896|467713888|FG000|Overall Study|Lost to Follow-up|0|||
129931035|NCT05069896|467713889|FG001|Overall Study|Lost to Follow-up|0|||
129931036|NCT05069896|467713890|FG002|Overall Study|Lost to Follow-up|1|||
129931037|NCT05069896|467713891|FG003|Overall Study|Lost to Follow-up|0|||
129931038|NCT05069896|467713892|FG004|Overall Study|Lost to Follow-up|1|||
129931039|NCT05069896|467713893|FG005|Overall Study|Lost to Follow-up|2|||
129931040|NCT04068831|467713894|FG000|Overall Study|Disease Progression|10|||
129931041|NCT04068831|467713895|FG001|Overall Study|Disease Progression|8|||
129931042|NCT04820322|467713896|FG000|Overall Study|Adverse Event|1|||
129931043|NCT04820322|467713897|FG001|Overall Study|Adverse Event|0|||
129931044|NCT00323856|467713901|FG000|Overall Study|Withdrawal by Subject|1|||
129931045|NCT00323856|467713901|FG000|Overall Study|Was uncooperative and noncompliant|1|||
129931046|NCT00323856|467713901|FG000|Overall Study|Reason not specified|1|||
129931047|NCT00323856|467713901|FG000|Overall Study|Missing|2|||
129931048|NCT03156465|467713902|FG000|Overall Study|Withdrawal by Subject|2|||
129931049|NCT04580914|467713914|FG000|Overall Study|Withdrawal by Subject|6|||
129931050|NCT04580914|467713914|FG000|Overall Study|Lost to Follow-up|2|||
129931051|NCT03580356|467713916|FG000|Treatment Period|Withdrawal by Subject|13|||
129931052|NCT03580356|467713917|FG001|Treatment Period|Withdrawal by Subject|0|||
129931053|NCT03580356|467713918|FG002|Treatment Period|Withdrawal by Subject|13|||
129931054|NCT03580356|467713919|FG003|Treatment Period|Withdrawal by Subject|1|||
129931055|NCT03580356|467713920|FG004|Treatment Period|Withdrawal by Subject|17|||
129931056|NCT03580356|467713921|FG005|Treatment Period|Withdrawal by Subject|0|||
129931057|NCT03580356|467713922|FG006|Treatment Period|Withdrawal by Subject|5|||
129931058|NCT03580356|467713923|FG007|Treatment Period|Withdrawal by Subject|0|||
129931059|NCT03580356|467713916|FG000|Treatment Period|Adverse Event|10|||
129931060|NCT03580356|467713917|FG001|Treatment Period|Adverse Event|0|||
129931061|NCT03580356|467713918|FG002|Treatment Period|Adverse Event|13|||
129931062|NCT03580356|467713919|FG003|Treatment Period|Adverse Event|0|||
129931063|NCT03580356|467713920|FG004|Treatment Period|Adverse Event|5|||
129931064|NCT03580356|467713921|FG005|Treatment Period|Adverse Event|0|||
129931065|NCT03580356|467713922|FG006|Treatment Period|Adverse Event|8|||
129931066|NCT03580356|467713923|FG007|Treatment Period|Adverse Event|0|||
129931067|NCT03580356|467713916|FG000|Treatment Period|Protocol Violation|5|||
129931068|NCT03580356|467713917|FG001|Treatment Period|Protocol Violation|0|||
129931069|NCT03580356|467713918|FG002|Treatment Period|Protocol Violation|6|||
129931070|NCT03580356|467713919|FG003|Treatment Period|Protocol Violation|1|||
129931071|NCT03580356|467713920|FG004|Treatment Period|Protocol Violation|9|||
129931072|NCT03580356|467713921|FG005|Treatment Period|Protocol Violation|1|||
129931073|NCT03580356|467713922|FG006|Treatment Period|Protocol Violation|1|||
129931074|NCT03580356|467713923|FG007|Treatment Period|Protocol Violation|0|||
129931075|NCT03580356|467713916|FG000|Treatment Period|Lack of Efficacy|6|||
129931076|NCT03580356|467713917|FG001|Treatment Period|Lack of Efficacy|0|||
129931077|NCT03580356|467713918|FG002|Treatment Period|Lack of Efficacy|2|||
129931078|NCT03580356|467713919|FG003|Treatment Period|Lack of Efficacy|0|||
129931079|NCT03580356|467713920|FG004|Treatment Period|Lack of Efficacy|3|||
129931080|NCT03580356|467713921|FG005|Treatment Period|Lack of Efficacy|0|||
129931081|NCT03580356|467713922|FG006|Treatment Period|Lack of Efficacy|3|||
129931082|NCT03580356|467713923|FG007|Treatment Period|Lack of Efficacy|0|||
129931083|NCT03580356|467713916|FG000|Treatment Period|Pregnancy|1|||
129931084|NCT03580356|467713917|FG001|Treatment Period|Pregnancy|0|||
129931085|NCT03580356|467713918|FG002|Treatment Period|Pregnancy|7|||
129931086|NCT03580356|467713919|FG003|Treatment Period|Pregnancy|0|||
129931087|NCT03580356|467713920|FG004|Treatment Period|Pregnancy|2|||
129931088|NCT03580356|467713921|FG005|Treatment Period|Pregnancy|0|||
129931089|NCT03580356|467713922|FG006|Treatment Period|Pregnancy|1|||
129931090|NCT03580356|467713923|FG007|Treatment Period|Pregnancy|0|||
129931091|NCT03580356|467713916|FG000|Treatment Period|Physician Decision|2|||
129931092|NCT03580356|467713917|FG001|Treatment Period|Physician Decision|0|||
129931093|NCT03580356|467713918|FG002|Treatment Period|Physician Decision|1|||
129931094|NCT03580356|467713919|FG003|Treatment Period|Physician Decision|0|||
129931095|NCT03580356|467713920|FG004|Treatment Period|Physician Decision|4|||
129931096|NCT03580356|467713921|FG005|Treatment Period|Physician Decision|0|||
129931097|NCT03580356|467713922|FG006|Treatment Period|Physician Decision|2|||
129931098|NCT03580356|467713923|FG007|Treatment Period|Physician Decision|0|||
129931099|NCT03580356|467713916|FG000|Treatment Period|Lost to Follow-up|1|||
129931100|NCT03580356|467713917|FG001|Treatment Period|Lost to Follow-up|1|||
129931101|NCT03580356|467713918|FG002|Treatment Period|Lost to Follow-up|1|||
129931102|NCT03580356|467713919|FG003|Treatment Period|Lost to Follow-up|0|||
129931103|NCT03580356|467713920|FG004|Treatment Period|Lost to Follow-up|3|||
129931104|NCT03580356|467713921|FG005|Treatment Period|Lost to Follow-up|0|||
129931105|NCT03580356|467713922|FG006|Treatment Period|Lost to Follow-up|1|||
129931106|NCT03580356|467713923|FG007|Treatment Period|Lost to Follow-up|0|||
129931107|NCT03580356|467713916|FG000|Treatment Period|Death|0|||
129931108|NCT03580356|467713917|FG001|Treatment Period|Death|0|||
129931109|NCT03580356|467713918|FG002|Treatment Period|Death|1|||
129931110|NCT03580356|467713919|FG003|Treatment Period|Death|0|||
129931111|NCT03580356|467713920|FG004|Treatment Period|Death|0|||
129931112|NCT03580356|467713921|FG005|Treatment Period|Death|0|||
129931113|NCT03580356|467713922|FG006|Treatment Period|Death|0|||
129931114|NCT03580356|467713923|FG007|Treatment Period|Death|0|||
129931115|NCT03580356|467713916|FG000|Treatment Period|Technical problems|0|||
129931116|NCT03580356|467713917|FG001|Treatment Period|Technical problems|0|||
129931117|NCT03580356|467713918|FG002|Treatment Period|Technical problems|0|||
129931118|NCT03580356|467713919|FG003|Treatment Period|Technical problems|0|||
129931119|NCT03580356|467713920|FG004|Treatment Period|Technical problems|1|||
129931120|NCT03580356|467713921|FG005|Treatment Period|Technical problems|0|||
129931121|NCT03580356|467713922|FG006|Treatment Period|Technical problems|0|||
129931122|NCT03580356|467713923|FG007|Treatment Period|Technical problems|0|||
129931123|NCT03580356|467713916|FG000|Treatment Period|Misrandomized, no treatment|0|||
129931124|NCT03580356|467713917|FG001|Treatment Period|Misrandomized, no treatment|0|||
129931125|NCT03580356|467713918|FG002|Treatment Period|Misrandomized, no treatment|1|||
129931126|NCT03580356|467713919|FG003|Treatment Period|Misrandomized, no treatment|0|||
129931127|NCT03580356|467713920|FG004|Treatment Period|Misrandomized, no treatment|2|||
129931128|NCT03580356|467713921|FG005|Treatment Period|Misrandomized, no treatment|0|||
129931129|NCT03580356|467713922|FG006|Treatment Period|Misrandomized, no treatment|0|||
129931130|NCT03580356|467713923|FG007|Treatment Period|Misrandomized, no treatment|0|||
129931131|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
129931132|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
129931133|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
129931134|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
129931135|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
129931136|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
129931137|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
129931138|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
129931139|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
129931140|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931141|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
129931142|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931143|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
129931144|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931145|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931146|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931147|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
129931148|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
129931149|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
129931150|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
129931151|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
129931152|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
129931153|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
129931154|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
129931155|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931156|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130069495|NCT00844285|468209516|FG001|Overall Study|Protocol Violation|28|||
130069496|NCT00844285|468209517|FG002|Overall Study|Protocol Violation|54|||
130069497|NCT00844285|468209515|FG000|Overall Study|Death|22|||
130069498|NCT00844285|468209516|FG001|Overall Study|Death|21|||
130069499|NCT00844285|468209517|FG002|Overall Study|Death|8|||
130069500|NCT00844285|468209515|FG000|Overall Study|Withdrew Consent|344|||
130069501|NCT00844285|468209516|FG001|Overall Study|Withdrew Consent|466|||
129931157|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
129931158|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931159|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
129931160|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931161|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931162|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
130069502|NCT00844285|468209517|FG002|Overall Study|Withdrew Consent|70|||
129931163|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
129931164|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
129931165|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
129931166|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
130069503|NCT00844285|468209515|FG000|Overall Study|Lost to Follow-up|330|||
130069504|NCT00844285|468209516|FG001|Overall Study|Lost to Follow-up|486|||
129931167|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
129931168|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
129931169|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
129931170|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
129931171|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
129931172|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
129931173|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
129931174|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
129931175|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
129931176|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
129931177|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
129931178|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
129931179|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
129931180|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
129931181|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
129931182|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
129931183|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
129931184|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
129931185|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
129931186|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
129931187|NCT05715528|467713924|FG000|Overall Study|Randomized but never treated|11|||
129931188|NCT05715528|467713925|FG001|Overall Study|Randomized but never treated|13|||
129931189|NCT05715528|467713924|FG000|Overall Study|Withdrew consent|7|||
129931190|NCT05715528|467713925|FG001|Overall Study|Withdrew consent|15|||
129931191|NCT05715528|467713924|FG000|Overall Study|Lost to Follow-up|5|||
129931192|NCT05715528|467713925|FG001|Overall Study|Lost to Follow-up|13|||
129931193|NCT05715528|467713924|FG000|Overall Study|Investigator's discretion|3|||
129931194|NCT05715528|467713925|FG001|Overall Study|Investigator's discretion|1|||
129931195|NCT05715528|467713924|FG000|Overall Study|Protocol Violation|2|||
129931196|NCT05715528|467713925|FG001|Overall Study|Protocol Violation|0|||
129931197|NCT05715528|467713924|FG000|Overall Study|Non-compliance with study drug|0|||
129931198|NCT05715528|467713925|FG001|Overall Study|Non-compliance with study drug|1|||
129931199|NCT05035654|467713926|FG000|Overall Study|Physician Decision|0|||
129931200|NCT05035654|467713927|FG001|Overall Study|Physician Decision|1|||
129931201|NCT05035654|467713928|FG002|Overall Study|Physician Decision|0|||
129931202|NCT05035654|467713926|FG000|Overall Study|Adverse Event|0|||
129931203|NCT05035654|467713927|FG001|Overall Study|Adverse Event|1|||
129931204|NCT05035654|467713928|FG002|Overall Study|Adverse Event|0|||
129931205|NCT05035654|467713926|FG000|Overall Study|Withdrawal by Subject|0|||
129931206|NCT05035654|467713927|FG001|Overall Study|Withdrawal by Subject|0|||
129931207|NCT05035654|467713928|FG002|Overall Study|Withdrawal by Subject|4|||
129931208|NCT05035654|467713926|FG000|Overall Study|Bilateral Dislodgement|1|||
129931209|NCT05035654|467713927|FG001|Overall Study|Bilateral Dislodgement|0|||
129931210|NCT05035654|467713928|FG002|Overall Study|Bilateral Dislodgement|0|||
130069505|NCT00844285|468209517|FG002|Overall Study|Lost to Follow-up|74|||
130069506|NCT00555906|468209520|FG000|Phase 1|Objective Progression or Relapse|3|||
130069507|NCT00555906|468209521|FG001|Phase 1|Objective Progression or Relapse|5|||
130069508|NCT00555906|468209522|FG002|Phase 1|Objective Progression or Relapse|3|||
130069509|NCT00555906|468209523|FG003|Phase 1|Objective Progression or Relapse|1|||
129931253|NCT05856435|467713943|FG000|Overall Study|Lost to Follow-up|6|||
129931254|NCT02323880|467713944|FG000|Overall Study|Adverse Event|2|||
129931255|NCT02323880|467713945|FG001|Overall Study|Adverse Event|0|||
129931256|NCT02323880|467713946|FG002|Overall Study|Adverse Event|1|||
129931257|NCT02323880|467713947|FG003|Overall Study|Adverse Event|1|||
129931258|NCT02323880|467713948|FG004|Overall Study|Adverse Event|1|||
129931259|NCT02323880|467713949|FG005|Overall Study|Adverse Event|0|||
129931260|NCT02323880|467713950|FG006|Overall Study|Adverse Event|1|||
129931261|NCT02323880|467713951|FG007|Overall Study|Adverse Event|0|||
129931262|NCT02323880|467713944|FG000|Overall Study|Death|0|||
129931263|NCT02323880|467713945|FG001|Overall Study|Death|0|||
129931264|NCT02323880|467713946|FG002|Overall Study|Death|0|||
129931265|NCT02323880|467713947|FG003|Overall Study|Death|0|||
129931266|NCT02323880|467713948|FG004|Overall Study|Death|0|||
129931267|NCT02323880|467713949|FG005|Overall Study|Death|1|||
129931268|NCT02323880|467713950|FG006|Overall Study|Death|0|||
129931269|NCT02323880|467713951|FG007|Overall Study|Death|0|||
129931270|NCT02323880|467713944|FG000|Overall Study|Lack of Efficacy|4|||
129931271|NCT02323880|467713945|FG001|Overall Study|Lack of Efficacy|11|||
129931272|NCT02323880|467713946|FG002|Overall Study|Lack of Efficacy|5|||
129931273|NCT02323880|467713947|FG003|Overall Study|Lack of Efficacy|5|||
129931274|NCT02323880|467713948|FG004|Overall Study|Lack of Efficacy|4|||
129931275|NCT02323880|467713949|FG005|Overall Study|Lack of Efficacy|8|||
129931276|NCT02323880|467713950|FG006|Overall Study|Lack of Efficacy|4|||
129931277|NCT02323880|467713951|FG007|Overall Study|Lack of Efficacy|6|||
129931278|NCT02323880|467713944|FG000|Overall Study|Physician Decision|0|||
129931279|NCT02323880|467713945|FG001|Overall Study|Physician Decision|0|||
129931280|NCT02323880|467713946|FG002|Overall Study|Physician Decision|0|||
129931281|NCT02323880|467713947|FG003|Overall Study|Physician Decision|0|||
129931282|NCT02323880|467713948|FG004|Overall Study|Physician Decision|1|||
129931283|NCT02323880|467713949|FG005|Overall Study|Physician Decision|1|||
129931284|NCT02323880|467713950|FG006|Overall Study|Physician Decision|1|||
129931285|NCT02323880|467713951|FG007|Overall Study|Physician Decision|0|||
129931286|NCT02323880|467713944|FG000|Overall Study|Withdrawal by Subject|0|||
129931287|NCT02323880|467713945|FG001|Overall Study|Withdrawal by Subject|2|||
129931288|NCT02323880|467713946|FG002|Overall Study|Withdrawal by Subject|0|||
129931289|NCT02323880|467713947|FG003|Overall Study|Withdrawal by Subject|0|||
129931290|NCT02323880|467713948|FG004|Overall Study|Withdrawal by Subject|0|||
129931291|NCT02323880|467713949|FG005|Overall Study|Withdrawal by Subject|0|||
129931292|NCT02323880|467713950|FG006|Overall Study|Withdrawal by Subject|0|||
129931293|NCT02323880|467713951|FG007|Overall Study|Withdrawal by Subject|0|||
129931294|NCT04934072|467713953|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
129931295|NCT04934072|467713954|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
129931296|NCT04934072|467713955|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
129931297|NCT04934072|467713956|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
129931298|NCT04934072|467713957|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
129931299|NCT04934072|467713953|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
129931300|NCT04934072|467713954|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
129931301|NCT04934072|467713955|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
129931302|NCT04934072|467713956|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
129931303|NCT04934072|467713957|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
129931304|NCT04934072|467713953|FG000|Day 0 to Week 52|Other|3|||
129931305|NCT04934072|467713954|FG001|Day 0 to Week 52|Other|1|||
129931306|NCT04934072|467713955|FG002|Day 0 to Week 52|Other|0|||
129931307|NCT04934072|467713956|FG003|Day 0 to Week 52|Other|0|||
129931308|NCT04934072|467713957|FG004|Day 0 to Week 52|Other|0|||
129931309|NCT04934072|467713953|FG000|Day 0 to Week 52|Adverse Event|1|||
129931310|NCT04934072|467713954|FG001|Day 0 to Week 52|Adverse Event|3|||
129931311|NCT04934072|467713955|FG002|Day 0 to Week 52|Adverse Event|0|||
129931312|NCT04934072|467713956|FG003|Day 0 to Week 52|Adverse Event|0|||
129931313|NCT04934072|467713957|FG004|Day 0 to Week 52|Adverse Event|0|||
129931314|NCT04934072|467713953|FG000|Week 52 to Week 78|Adverse Event|0|||
129931315|NCT04934072|467713954|FG001|Week 52 to Week 78|Adverse Event|0|||
129931316|NCT04934072|467713955|FG002|Week 52 to Week 78|Adverse Event|0|||
129931317|NCT04934072|467713956|FG003|Week 52 to Week 78|Adverse Event|1|||
129931318|NCT04934072|467713957|FG004|Week 52 to Week 78|Adverse Event|1|||
129931319|NCT04934072|467713953|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
129931320|NCT04934072|467713954|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
129931321|NCT04934072|467713955|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
129931322|NCT04934072|467713956|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
129931323|NCT04934072|467713957|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
129931324|NCT04934072|467713953|FG000|Week 52 to Week 78|Other|0|||
129931325|NCT04934072|467713954|FG001|Week 52 to Week 78|Other|0|||
129931326|NCT04934072|467713955|FG002|Week 52 to Week 78|Other|1|||
129931327|NCT04934072|467713956|FG003|Week 52 to Week 78|Other|0|||
129931328|NCT04934072|467713957|FG004|Week 52 to Week 78|Other|0|||
129931329|NCT03213678|467713962|FG000|Overall Study|Death|1|||
129931330|NCT03213678|467713962|FG000|Overall Study|Physician Decision|1|||
129931331|NCT03213678|467713962|FG000|Overall Study|Progressive disease|16|||
129931332|NCT04218851|467713963|FG000|Overall Study|Death|1|||
129931333|NCT04218851|467713964|FG001|Overall Study|Death|3|||
129931334|NCT03174275|467713967|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
129931335|NCT03174275|467713967|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
129931336|NCT03174275|467713967|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
129931337|NCT03174275|467713967|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
129931338|NCT03174275|467713967|FG000|Adjuvant Chemotherapy|Progression|1|||
129931339|NCT03174275|467713967|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
129931340|NCT03174275|467713967|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
129931341|NCT03174275|467713967|FG000|Adjuvant Durvalumab|Progression|1|||
129931342|NCT03174275|467713967|FG000|Adjuvant Durvalumab|Adverse Event|3|||
129931343|NCT03174275|467713967|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
129931344|NCT03174275|467713967|FG000|Adjuvant Radiotherapy|Progression|1|||
129931345|NCT03174275|467713967|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
129931346|NCT05285137|467713968|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
129931347|NCT05285137|467713969|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
129931348|NCT05285137|467713970|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
129931349|NCT05285137|467713971|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
129931350|NCT05285137|467713972|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
129931351|NCT05285137|467713973|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
129931352|NCT05285137|467713974|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
129931353|NCT05285137|467713975|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
129931354|NCT05285137|467713976|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
129931355|NCT05285137|467713968|FG000|Overall Study|Lost to Follow-up|0|||
129931356|NCT05285137|467713969|FG001|Overall Study|Lost to Follow-up|0|||
129931357|NCT05285137|467713970|FG002|Overall Study|Lost to Follow-up|1|||
129931358|NCT05285137|467713971|FG003|Overall Study|Lost to Follow-up|3|||
129931359|NCT05285137|467713972|FG004|Overall Study|Lost to Follow-up|0|||
129931360|NCT05285137|467713973|FG005|Overall Study|Lost to Follow-up|0|||
129931361|NCT05285137|467713974|FG006|Overall Study|Lost to Follow-up|1|||
129931362|NCT05285137|467713975|FG007|Overall Study|Lost to Follow-up|0|||
129931363|NCT05285137|467713976|FG008|Overall Study|Lost to Follow-up|0|||
129931364|NCT05285137|467713968|FG000|Overall Study|Physician Decision|0|||
129931365|NCT05285137|467713969|FG001|Overall Study|Physician Decision|1|||
129931366|NCT05285137|467713970|FG002|Overall Study|Physician Decision|0|||
129931367|NCT05285137|467713971|FG003|Overall Study|Physician Decision|0|||
129931368|NCT05285137|467713972|FG004|Overall Study|Physician Decision|0|||
129931369|NCT05285137|467713973|FG005|Overall Study|Physician Decision|0|||
129931370|NCT05285137|467713974|FG006|Overall Study|Physician Decision|0|||
129931371|NCT05285137|467713975|FG007|Overall Study|Physician Decision|0|||
129931372|NCT05285137|467713976|FG008|Overall Study|Physician Decision|0|||
129931373|NCT05285137|467713968|FG000|Overall Study|Pregnancy|0|||
129931374|NCT05285137|467713969|FG001|Overall Study|Pregnancy|0|||
129931375|NCT05285137|467713970|FG002|Overall Study|Pregnancy|0|||
129931376|NCT05285137|467713971|FG003|Overall Study|Pregnancy|0|||
129931377|NCT05285137|467713972|FG004|Overall Study|Pregnancy|0|||
129931378|NCT05285137|467713973|FG005|Overall Study|Pregnancy|0|||
129931379|NCT05285137|467713974|FG006|Overall Study|Pregnancy|1|||
129931380|NCT05285137|467713975|FG007|Overall Study|Pregnancy|0|||
129931381|NCT05285137|467713976|FG008|Overall Study|Pregnancy|0|||
129931382|NCT05285137|467713968|FG000|Overall Study|Withdrawal by Subject|0|||
129931383|NCT05285137|467713969|FG001|Overall Study|Withdrawal by Subject|1|||
129931384|NCT05285137|467713970|FG002|Overall Study|Withdrawal by Subject|2|||
129931385|NCT05285137|467713971|FG003|Overall Study|Withdrawal by Subject|1|||
129931386|NCT05285137|467713972|FG004|Overall Study|Withdrawal by Subject|0|||
129931387|NCT05285137|467713973|FG005|Overall Study|Withdrawal by Subject|0|||
129931388|NCT05285137|467713974|FG006|Overall Study|Withdrawal by Subject|0|||
129931389|NCT05285137|467713975|FG007|Overall Study|Withdrawal by Subject|0|||
129931390|NCT05285137|467713976|FG008|Overall Study|Withdrawal by Subject|1|||
129931391|NCT01820611|467713977|FG000|Overall Study|Death|8|||
129931392|NCT01820611|467713977|FG000|Overall Study|Adverse Event|1|||
129931393|NCT01820611|467713977|FG000|Overall Study|Withdrawal by Subject|9|||
129931394|NCT03484819|467713978|FG000|Overall Study|Death|2|||
129931395|NCT03484819|467713978|FG000|Overall Study|Adverse Event|2|||
129931396|NCT03484819|467713978|FG000|Overall Study|Physician Decision|1|||
129931397|NCT03484819|467713978|FG000|Overall Study|Withdrawal by Subject|2|||
129931398|NCT03484819|467713978|FG000|Overall Study|Disease Progression|4|||
129931399|NCT03484819|467713978|FG000|Overall Study|Complicating Condition|1|||
129931400|NCT04456296|467713979|FG000|Overall Study|Withdrawal by Subject|14|||
129931401|NCT04456296|467713980|FG001|Overall Study|Withdrawal by Subject|21|||
129931402|NCT04456296|467713981|FG002|Overall Study|Withdrawal by Subject|21|||
129931403|NCT04456296|467713979|FG000|Overall Study|Adverse Event|2|||
129931404|NCT04456296|467713980|FG001|Overall Study|Adverse Event|2|||
129931405|NCT04456296|467713981|FG002|Overall Study|Adverse Event|2|||
129931406|NCT04456296|467713979|FG000|Overall Study|Death|1|||
129931407|NCT04456296|467713980|FG001|Overall Study|Death|0|||
129931408|NCT04456296|467713981|FG002|Overall Study|Death|0|||
129931409|NCT04456296|467713979|FG000|Overall Study|Lost to Follow-up|3|||
129931410|NCT04456296|467713980|FG001|Overall Study|Lost to Follow-up|5|||
129931411|NCT04456296|467713981|FG002|Overall Study|Lost to Follow-up|6|||
129931412|NCT04456296|467713979|FG000|Overall Study|Other than specified|0|||
129931413|NCT04456296|467713980|FG001|Overall Study|Other than specified|1|||
129931414|NCT04456296|467713981|FG002|Overall Study|Other than specified|4|||
129931415|NCT04456296|467713979|FG000|Overall Study|Randomized, not treated|2|||
129931416|NCT04456296|467713980|FG001|Overall Study|Randomized, not treated|1|||
129931417|NCT04456296|467713981|FG002|Overall Study|Randomized, not treated|0|||
129931418|NCT05736458|467713982|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
129931419|NCT05736458|467713983|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
129931420|NCT05736458|467713984|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
129931421|NCT05736458|467713982|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
129931422|NCT05736458|467713983|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
129931423|NCT05736458|467713984|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
129931424|NCT05736458|467713982|FG000|TMS/fMRI #1|Physician Decision|0|||
129931425|NCT05736458|467713983|FG001|TMS/fMRI #1|Physician Decision|0|||
129931426|NCT05736458|467713984|FG002|TMS/fMRI #1|Physician Decision|2|||
129931427|NCT05736458|467713982|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
129931428|NCT05736458|467713983|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
129931429|NCT05736458|467713984|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
129931430|NCT04247802|467713985|FG000|Overall Study|Withdrawal by Subject|1|||
129931431|NCT04247802|467713986|FG001|Overall Study|Withdrawal by Subject|3|||
129931432|NCT04247802|467713985|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
129931433|NCT04247802|467713986|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
129931434|NCT05962814|467713987|FG000|Overall Study|failed eligibility|1|||
129931435|NCT02865538|467713989|FG000|Overall Study|Withdrawal by Subject|0|||
129931436|NCT02865538|467713990|FG001|Overall Study|Withdrawal by Subject|0|||
129931437|NCT02865538|467713991|FG002|Overall Study|Withdrawal by Subject|1|||
129931438|NCT02865538|467713992|FG003|Overall Study|Withdrawal by Subject|0|||
129931439|NCT02865538|467713993|FG004|Overall Study|Withdrawal by Subject|0|||
129931440|NCT02865538|467713989|FG000|Overall Study|Lost to Follow-up|1|||
129931441|NCT02865538|467713990|FG001|Overall Study|Lost to Follow-up|0|||
129931442|NCT02865538|467713991|FG002|Overall Study|Lost to Follow-up|0|||
129931443|NCT02865538|467713992|FG003|Overall Study|Lost to Follow-up|0|||
129931444|NCT02865538|467713993|FG004|Overall Study|Lost to Follow-up|0|||
129931445|NCT03106740|467715136|FG000|Overall Study|Lost to Follow-up|2|||
129931446|NCT03106740|467715137|FG001|Overall Study|Lost to Follow-up|2|||
129931447|NCT03106740|467715136|FG000|Overall Study|Withdrawal by Subject|2|||
129931448|NCT03106740|467715137|FG001|Overall Study|Withdrawal by Subject|4|||
129931449|NCT03106740|467715136|FG000|Overall Study|Physician Decision|0|||
129931450|NCT03106740|467715137|FG001|Overall Study|Physician Decision|1|||
129931451|NCT03106740|467715136|FG000|Overall Study|Partial data|1|||
129931452|NCT03106740|467715137|FG001|Overall Study|Partial data|0|||
129931453|NCT04565990|467715138|FG000|Overall Study|Death|5|||
129931454|NCT04565990|467715138|FG000|Overall Study|Lost to Follow-up|1|||
129931455|NCT04565990|467715138|FG000|Overall Study|Withdrawal by Subject|1|||
129931456|NCT04862234|467715139|FG000|Overall Study|Surgery cancellation|1|||
129931457|NCT04862234|467715140|FG001|Overall Study|Surgery cancellation|2|||
129931458|NCT04862234|467715139|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
129931459|NCT04862234|467715140|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
129931460|NCT04862234|467715139|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
129931461|NCT04862234|467715140|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
129931462|NCT03292484|467715141|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
129931463|NCT03292484|467715141|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
129931464|NCT03292484|467715141|FG000|Overall Study|Protocol Violation|2|||
130118183|NCT00929708|468392495|FG003|Overall Study|Physician Decision|2|||
130118184|NCT00929708|468392496|FG004|Overall Study|Physician Decision|1|||
130118185|NCT00929708|468392492|FG000|Overall Study|Lost to Follow-up|0|||
130118186|NCT00929708|468392493|FG001|Overall Study|Lost to Follow-up|0|||
130118187|NCT00929708|468392494|FG002|Overall Study|Lost to Follow-up|0|||
130118188|NCT00929708|468392495|FG003|Overall Study|Lost to Follow-up|1|||
130118189|NCT00929708|468392496|FG004|Overall Study|Lost to Follow-up|0|||
130118190|NCT01893138|468392497|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130118191|NCT01893138|468392498|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130118192|NCT01893138|468392497|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
130118193|NCT01893138|468392498|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
130118194|NCT01893138|468392497|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
130118195|NCT01893138|468392498|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
130118196|NCT01893138|468392497|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
130118197|NCT01893138|468392498|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
130118198|NCT01893138|468392497|FG000|Open Label - Unblinded Period|Adverse Event|1|||
130118199|NCT01893138|468392498|FG001|Open Label - Unblinded Period|Adverse Event|0|||
130118200|NCT01628120|468394121|FG000|Overall Study|Withdrawal by Subject|7|||
130118201|NCT01628120|468394121|FG000|Overall Study|Adverse Event|12|||
130118202|NCT01628120|468394121|FG000|Overall Study|Lost to Follow-up|1|||
130118203|NCT01628120|468394121|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
130118204|NCT01628120|468394121|FG000|Overall Study|Non-compliant with Study Procedures|1|||
130118205|NCT01628120|468394121|FG000|Overall Study|Not Treated|3|||
130118206|NCT01628120|468394121|FG000|Overall Study|Sponsor Decision|5|||
130118207|NCT01628120|468394121|FG000|Overall Study|Switched Dialysis Method|2|||
130118208|NCT01628120|468394121|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
130118209|NCT01628120|468394121|FG000|Overall Study|Moved or Relocated|5|||
130118210|NCT01628120|468394121|FG000|Overall Study|Kidney Transplant|2|||
130118211|NCT01628120|468394121|FG000|Overall Study|Use of Standard of Care|1|||
130118212|NCT01075763|468394124|FG000|Overall Study|Lost to Follow-up|2|||
130118213|NCT01075763|468394125|FG001|Overall Study|Lost to Follow-up|1|||
130118214|NCT01075763|468394124|FG000|Overall Study|Lack of Efficacy|0|||
130118215|NCT01075763|468394125|FG001|Overall Study|Lack of Efficacy|1|||
130118216|NCT01075763|468394124|FG000|Overall Study|Withdrawal by Subject|2|||
130118217|NCT01075763|468394125|FG001|Overall Study|Withdrawal by Subject|2|||
130118218|NCT00586521|468394126|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
130118219|NCT03731182|468394133|FG000|Overall Study|Lost to Follow-up|2|||
130118220|NCT03731182|468394134|FG001|Overall Study|Lost to Follow-up|0|||
130118221|NCT03731182|468394133|FG000|Overall Study|Physician Decision|1|||
130118222|NCT03731182|468394134|FG001|Overall Study|Physician Decision|0|||
130118223|NCT03731182|468394133|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
130118224|NCT03731182|468394134|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130118225|NCT00582036|468394135|FG000|Overall Study|Withdrawal by Subject|0|||
130118226|NCT00582036|468394136|FG001|Overall Study|Withdrawal by Subject|1|||
130118227|NCT04161144|468394137|FG000|Overall Study|Withdrawal by Subject|0|||
130118228|NCT04161144|468394138|FG001|Overall Study|Withdrawal by Subject|1|||
130118229|NCT04161144|468394137|FG000|Overall Study|Protocol Violation|1|||
130118230|NCT04161144|468394138|FG001|Overall Study|Protocol Violation|0|||
130118231|NCT02207621|468394141|FG000|Overall Study|Adverse Event|71|||
130118232|NCT02207621|468394142|FG001|Overall Study|Adverse Event|15|||
130118233|NCT02207621|468394143|FG002|Overall Study|Adverse Event|132|||
130118234|NCT02207621|468394141|FG000|Overall Study|Withdrawal by Subject|9|||
130118235|NCT02207621|468394142|FG001|Overall Study|Withdrawal by Subject|9|||
130118236|NCT02207621|468394143|FG002|Overall Study|Withdrawal by Subject|13|||
130118237|NCT02207621|468394141|FG000|Overall Study|Non-Compliant|3|||
130118238|NCT02207621|468394142|FG001|Overall Study|Non-Compliant|3|||
130118239|NCT02207621|468394143|FG002|Overall Study|Non-Compliant|1|||
130118240|NCT02207621|468394141|FG000|Overall Study|Lost to Follow-up|1|||
130118241|NCT02207621|468394142|FG001|Overall Study|Lost to Follow-up|0|||
130118242|NCT02207621|468394143|FG002|Overall Study|Lost to Follow-up|3|||
130118243|NCT02207621|468394141|FG000|Overall Study|Lack of Efficacy|10|||
130118244|NCT02207621|468394142|FG001|Overall Study|Lack of Efficacy|2|||
130118245|NCT02207621|468394143|FG002|Overall Study|Lack of Efficacy|4|||
130118246|NCT02207621|468394141|FG000|Overall Study|Disallowed Concurrent Medication|2|||
130118247|NCT02207621|468394142|FG001|Overall Study|Disallowed Concurrent Medication|5|||
130118248|NCT02207621|468394143|FG002|Overall Study|Disallowed Concurrent Medication|2|||
129931465|NCT03292484|467715141|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
130118249|NCT02207621|468394141|FG000|Overall Study|Physician Decision|1|||
130118250|NCT02207621|468394142|FG001|Overall Study|Physician Decision|2|||
130118251|NCT02207621|468394143|FG002|Overall Study|Physician Decision|2|||
130118252|NCT02207621|468394141|FG000|Overall Study|Protocol Violation|4|||
130118253|NCT02207621|468394142|FG001|Overall Study|Protocol Violation|10|||
130118254|NCT02207621|468394143|FG002|Overall Study|Protocol Violation|6|||
130118255|NCT02207621|468394141|FG000|Overall Study|Death|2|||
130118256|NCT02207621|468394142|FG001|Overall Study|Death|0|||
130118257|NCT02207621|468394143|FG002|Overall Study|Death|0|||
130118258|NCT02207621|468394141|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
129931466|NCT03292484|467715141|FG000|Overall Study|Sponsor decision|349|||
129931467|NCT03292484|467715141|FG000|Overall Study|Lost to Follow-up|7|||
129931468|NCT03292484|467715141|FG000|Overall Study|Coronavirus Disease 2019|1|||
129931469|NCT03292484|467715141|FG000|Overall Study|Other|20|||
129931470|NCT05290493|467715142|FG000|Overall Study|Withdrawal by Subject|2|||
129931471|NCT05290493|467715143|FG001|Overall Study|Withdrawal by Subject|2|||
129931472|NCT05290493|467715142|FG000|Overall Study|Adverse Event|1|||
129931473|NCT05290493|467715143|FG001|Overall Study|Adverse Event|0|||
129931474|NCT04615273|467715147|FG000|Overall Study|Withdrawal by Subject|3|||
129931475|NCT04615273|467715148|FG001|Overall Study|Withdrawal by Subject|1|||
129931476|NCT04615273|467715149|FG002|Overall Study|Withdrawal by Subject|2|||
129931477|NCT04615273|467715147|FG000|Overall Study|Adverse Event|1|||
129931478|NCT04615273|467715148|FG001|Overall Study|Adverse Event|0|||
129931479|NCT04615273|467715149|FG002|Overall Study|Adverse Event|1|||
129931480|NCT04615273|467715147|FG000|Overall Study|Lost to Follow-up|0|||
129931481|NCT04615273|467715148|FG001|Overall Study|Lost to Follow-up|1|||
129931482|NCT04615273|467715149|FG002|Overall Study|Lost to Follow-up|0|||
129931483|NCT04615273|467715147|FG000|Overall Study|Physician Decision|0|||
129931484|NCT04615273|467715148|FG001|Overall Study|Physician Decision|0|||
129931485|NCT04615273|467715149|FG002|Overall Study|Physician Decision|1|||
129931486|NCT04615273|467715147|FG000|Overall Study|Other|0|||
129931487|NCT04615273|467715148|FG001|Overall Study|Other|1|||
129931488|NCT04615273|467715149|FG002|Overall Study|Other|0|||
129931489|NCT04615273|467715147|FG000|Overall Study|Randomized but not treated|1|||
129931490|NCT04615273|467715148|FG001|Overall Study|Randomized but not treated|3|||
129931491|NCT04615273|467715149|FG002|Overall Study|Randomized but not treated|1|||
129931492|NCT03677141|467715153|FG000|Overall Study|Death|2|||
129931493|NCT03677141|467715154|FG001|Overall Study|Death|1|||
129931494|NCT03677141|467715155|FG002|Overall Study|Death|6|||
129931495|NCT03677141|467715156|FG003|Overall Study|Death|9|||
129931496|NCT03677141|467715157|FG004|Overall Study|Death|5|||
129931497|NCT03677141|467715158|FG005|Overall Study|Death|3|||
129931498|NCT03677141|467715153|FG000|Overall Study|Lost to Follow-up|0|||
129931499|NCT03677141|467715154|FG001|Overall Study|Lost to Follow-up|0|||
129931500|NCT03677141|467715155|FG002|Overall Study|Lost to Follow-up|0|||
129931501|NCT03677141|467715156|FG003|Overall Study|Lost to Follow-up|2|||
129931502|NCT03677141|467715157|FG004|Overall Study|Lost to Follow-up|0|||
129931503|NCT03677141|467715158|FG005|Overall Study|Lost to Follow-up|0|||
129931504|NCT03677141|467715153|FG000|Overall Study|Screen failure or enrolled in error|0|||
129931505|NCT03677141|467715154|FG001|Overall Study|Screen failure or enrolled in error|0|||
130069510|NCT00555906|468209524|FG004|Phase 1|Objective Progression or Relapse|0|||
130069511|NCT00555906|468209520|FG000|Phase 1|Global Deterioration of Health Status|0|||
130069512|NCT00555906|468209521|FG001|Phase 1|Global Deterioration of Health Status|1|||
130069513|NCT00555906|468209522|FG002|Phase 1|Global Deterioration of Health Status|1|||
130069514|NCT00555906|468209523|FG003|Phase 1|Global Deterioration of Health Status|1|||
130069515|NCT00555906|468209524|FG004|Phase 1|Global Deterioration of Health Status|0|||
130069516|NCT00555906|468209520|FG000|Phase 1|Adverse Event|0|||
130069517|NCT00555906|468209521|FG001|Phase 1|Adverse Event|0|||
130069518|NCT00555906|468209522|FG002|Phase 1|Adverse Event|3|||
130069519|NCT00555906|468209523|FG003|Phase 1|Adverse Event|2|||
130069520|NCT00555906|468209524|FG004|Phase 1|Adverse Event|0|||
130069521|NCT00555906|468209520|FG000|Phase 1|Withdrawal by Subject|0|||
130069522|NCT00555906|468209521|FG001|Phase 1|Withdrawal by Subject|0|||
130069523|NCT00555906|468209522|FG002|Phase 1|Withdrawal by Subject|0|||
130069524|NCT00555906|468209523|FG003|Phase 1|Withdrawal by Subject|1|||
130069525|NCT00555906|468209524|FG004|Phase 1|Withdrawal by Subject|0|||
130069526|NCT00555906|468209520|FG000|Phase 2|Adverse Event|0|||
130069527|NCT00555906|468209521|FG001|Phase 2|Adverse Event|0|||
130069528|NCT00555906|468209522|FG002|Phase 2|Adverse Event|0|||
130069529|NCT00555906|468209523|FG003|Phase 2|Adverse Event|0|||
130069530|NCT00555906|468209524|FG004|Phase 2|Adverse Event|4|||
130069531|NCT00555906|468209520|FG000|Phase 2|Global Deterioration of Health Status|0|||
130069532|NCT00555906|468209521|FG001|Phase 2|Global Deterioration of Health Status|0|||
130069533|NCT00555906|468209522|FG002|Phase 2|Global Deterioration of Health Status|0|||
130069534|NCT00555906|468209523|FG003|Phase 2|Global Deterioration of Health Status|0|||
130069535|NCT00555906|468209524|FG004|Phase 2|Global Deterioration of Health Status|2|||
130069536|NCT00555906|468209520|FG000|Phase 2|Objective Progression or Relapse|0|||
129931506|NCT03677141|467715155|FG002|Overall Study|Screen failure or enrolled in error|0|||
129931507|NCT03677141|467715156|FG003|Overall Study|Screen failure or enrolled in error|0|||
129931508|NCT03677141|467715157|FG004|Overall Study|Screen failure or enrolled in error|2|||
129931509|NCT03677141|467715158|FG005|Overall Study|Screen failure or enrolled in error|0|||
129931510|NCT03677141|467715153|FG000|Overall Study|Physician Decision|0|||
129931511|NCT03677141|467715154|FG001|Overall Study|Physician Decision|0|||
129931512|NCT03677141|467715155|FG002|Overall Study|Physician Decision|0|||
129931513|NCT03677141|467715156|FG003|Overall Study|Physician Decision|0|||
129931514|NCT03677141|467715157|FG004|Overall Study|Physician Decision|1|||
129931515|NCT03677141|467715158|FG005|Overall Study|Physician Decision|0|||
130069537|NCT00555906|468209521|FG001|Phase 2|Objective Progression or Relapse|0|||
130069538|NCT00555906|468209522|FG002|Phase 2|Objective Progression or Relapse|0|||
130118259|NCT02207621|468394142|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
130118260|NCT02207621|468394143|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
130118261|NCT00958256|468394145|FG000|Overall Study|Adverse Event|3|||
130118262|NCT03036579|468394148|FG000|2 Years|Lost to Follow-up|1|||
130118263|NCT03036579|468394149|FG001|2 Years|Lost to Follow-up|0|||
130118264|NCT03036579|468394148|FG000|3 Years|Lost to Follow-up|0|||
130118265|NCT03036579|468394149|FG001|3 Years|Lost to Follow-up|1|||
130118266|NCT01090765|468394150|FG000|Overall Study|Patient withdrew consent|0|||
130118267|NCT01090765|468394151|FG001|Overall Study|Patient withdrew consent|0|||
130118268|NCT01090765|468394152|FG002|Overall Study|Patient withdrew consent|0|||
130118269|NCT01090765|468394153|FG003|Overall Study|Patient withdrew consent|0|||
130118270|NCT01090765|468394154|FG004|Overall Study|Patient withdrew consent|1|||
130118271|NCT01090765|468394155|FG005|Overall Study|Patient withdrew consent|1|||
129931516|NCT03677141|467715153|FG000|Overall Study|Withdrawal by Subject|0|||
129931517|NCT03677141|467715154|FG001|Overall Study|Withdrawal by Subject|0|||
129931518|NCT03677141|467715155|FG002|Overall Study|Withdrawal by Subject|1|||
130069539|NCT00555906|468209523|FG003|Phase 2|Objective Progression or Relapse|0|||
130069540|NCT00555906|468209524|FG004|Phase 2|Objective Progression or Relapse|16|||
130069541|NCT00555906|468209520|FG000|Phase 2|Withdrawal by Subject|0|||
130069542|NCT00555906|468209521|FG001|Phase 2|Withdrawal by Subject|0|||
130069543|NCT00555906|468209522|FG002|Phase 2|Withdrawal by Subject|0|||
130069544|NCT00555906|468209523|FG003|Phase 2|Withdrawal by Subject|0|||
130069545|NCT00555906|468209524|FG004|Phase 2|Withdrawal by Subject|2|||
130069546|NCT00555906|468209520|FG000|Phase 2|Other|0|||
130069547|NCT00555906|468209521|FG001|Phase 2|Other|0|||
130069548|NCT00555906|468209522|FG002|Phase 2|Other|0|||
130069549|NCT00555906|468209523|FG003|Phase 2|Other|0|||
130069550|NCT00555906|468209524|FG004|Phase 2|Other|6|||
130069551|NCT00555906|468209520|FG000|Phase 2|Randomized but not Treated|0|||
130069552|NCT00555906|468209521|FG001|Phase 2|Randomized but not Treated|0|||
130069553|NCT00555906|468209522|FG002|Phase 2|Randomized but not Treated|0|||
130069554|NCT00555906|468209523|FG003|Phase 2|Randomized but not Treated|0|||
130069555|NCT00555906|468209524|FG004|Phase 2|Randomized but not Treated|2|||
130069556|NCT03219567|468209525|FG000|Overall Study|Withdrawal by Subject|0|||
130069557|NCT03219567|468209526|FG001|Overall Study|Withdrawal by Subject|1|||
130069558|NCT02849626|468209527|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
130069559|NCT02849626|468209528|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
130069560|NCT02849626|468209529|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
130069561|NCT02849626|468209530|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
130069562|NCT02849626|468209527|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
130069563|NCT02849626|468209528|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
130069564|NCT02849626|468209529|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
130069565|NCT02849626|468209530|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
130069566|NCT02849626|468209527|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
130069567|NCT02849626|468209528|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
130069568|NCT02849626|468209529|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
130069569|NCT02849626|468209530|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
130069570|NCT02849626|468209527|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
130069571|NCT02849626|468209528|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
130069572|NCT02849626|468209529|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
130069573|NCT02849626|468209530|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
130069574|NCT02849626|468209527|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
130069575|NCT02849626|468209528|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
130069576|NCT02849626|468209529|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
130069577|NCT02849626|468209530|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
130069578|NCT02849626|468209527|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
130069579|NCT02849626|468209528|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
130069580|NCT02849626|468209529|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
130069581|NCT02849626|468209530|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
130069582|NCT02849626|468209527|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
130069583|NCT02849626|468209528|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
130069584|NCT02849626|468209529|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
130069585|NCT02849626|468209530|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
130069586|NCT02849626|468209527|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
130069587|NCT02849626|468209528|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
130069588|NCT02849626|468209529|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
130069589|NCT02849626|468209530|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
130069590|NCT02849626|468209527|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
130069591|NCT02849626|468209528|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
130118272|NCT01090765|468394150|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
129931519|NCT03677141|467715156|FG003|Overall Study|Withdrawal by Subject|1|||
130118273|NCT01090765|468394151|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
130118274|NCT01090765|468394152|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
129931520|NCT03677141|467715157|FG004|Overall Study|Withdrawal by Subject|1|||
129931521|NCT03677141|467715158|FG005|Overall Study|Withdrawal by Subject|0|||
129931522|NCT05838027|467715166|FG000|Overall Study|Lost to Follow-up|5|||
129931523|NCT05838027|467715167|FG001|Overall Study|Lost to Follow-up|1|||
129931524|NCT05838027|467715166|FG000|Overall Study|Withdrawal by Subject|1|||
129931525|NCT05838027|467715167|FG001|Overall Study|Withdrawal by Subject|0|||
129931526|NCT04599634|467715168|FG000|Overall Study|Dose limiting toxicity|0|||
129931527|NCT04599634|467715169|FG001|Overall Study|Dose limiting toxicity|0|||
129931528|NCT04599634|467715170|FG002|Overall Study|Dose limiting toxicity|2|||
129931529|NCT04599634|467715171|FG003|Overall Study|Dose limiting toxicity|0|||
129931530|NCT03714815|467715172|FG000|Overall Study|Physician Decision|2|||
129931531|NCT03714815|467715172|FG000|Overall Study|Withdrawal by Subject|2|||
129931532|NCT03714815|467715172|FG000|Overall Study|Death|11|||
129931533|NCT03276676|467715177|FG000|Overall Study|Withdrawal by Subject|2|||
129931534|NCT03276676|467715178|FG001|Overall Study|Withdrawal by Subject|1|||
129931535|NCT02962076|467715181|FG000|Overall Study|MHED tracer not available|5|||
129931536|NCT02962076|467715181|FG000|Overall Study|Protocol Violation|1|||
129931537|NCT02962076|467715181|FG000|Overall Study|Physician Decision|1|||
129931538|NCT04089865|467715182|FG000|Overall Study|Withdrawal by Subject|2|||
129931539|NCT04089865|467715183|FG001|Overall Study|Withdrawal by Subject|2|||
129931540|NCT04089865|467715184|FG002|Overall Study|Withdrawal by Subject|7|||
129931541|NCT04089865|467715185|FG003|Overall Study|Withdrawal by Subject|2|||
129931542|NCT03926130|467715186|FG000|Overall Study|Adverse Event|9|||
129931543|NCT03926130|467715187|FG001|Overall Study|Adverse Event|11|||
129931544|NCT03926130|467715188|FG002|Overall Study|Adverse Event|2|||
129931545|NCT03926130|467715189|FG003|Overall Study|Adverse Event|0|||
129931546|NCT03926130|467715186|FG000|Overall Study|Death|2|||
129931547|NCT03926130|467715187|FG001|Overall Study|Death|0|||
129931548|NCT03926130|467715188|FG002|Overall Study|Death|1|||
129931549|NCT03926130|467715189|FG003|Overall Study|Death|0|||
129931550|NCT03926130|467715186|FG000|Overall Study|Lack of Efficacy|14|||
129931551|NCT03926130|467715187|FG001|Overall Study|Lack of Efficacy|11|||
129931552|NCT03926130|467715188|FG002|Overall Study|Lack of Efficacy|7|||
129931553|NCT03926130|467715189|FG003|Overall Study|Lack of Efficacy|1|||
129931554|NCT03926130|467715186|FG000|Overall Study|Lost to Follow-up|0|||
129931555|NCT03926130|467715187|FG001|Overall Study|Lost to Follow-up|7|||
129931556|NCT03926130|467715188|FG002|Overall Study|Lost to Follow-up|1|||
129931557|NCT03926130|467715189|FG003|Overall Study|Lost to Follow-up|0|||
129931558|NCT03926130|467715186|FG000|Overall Study|As Reported by Investigator|2|||
129931559|NCT03926130|467715187|FG001|Overall Study|As Reported by Investigator|6|||
129931560|NCT03926130|467715188|FG002|Overall Study|As Reported by Investigator|6|||
129931561|NCT03926130|467715189|FG003|Overall Study|As Reported by Investigator|0|||
129931562|NCT03926130|467715186|FG000|Overall Study|Physician Decision|3|||
129931563|NCT03926130|467715187|FG001|Overall Study|Physician Decision|2|||
129931564|NCT03926130|467715188|FG002|Overall Study|Physician Decision|1|||
129931565|NCT03926130|467715189|FG003|Overall Study|Physician Decision|0|||
129931566|NCT03926130|467715186|FG000|Overall Study|Pregnancy|2|||
129931567|NCT03926130|467715187|FG001|Overall Study|Pregnancy|2|||
129931568|NCT03926130|467715188|FG002|Overall Study|Pregnancy|1|||
129931569|NCT03926130|467715189|FG003|Overall Study|Pregnancy|0|||
129931570|NCT03926130|467715186|FG000|Overall Study|Withdrawal by Subject|20|||
129931571|NCT03926130|467715187|FG001|Overall Study|Withdrawal by Subject|28|||
129931572|NCT03926130|467715188|FG002|Overall Study|Withdrawal by Subject|18|||
129931573|NCT03926130|467715189|FG003|Overall Study|Withdrawal by Subject|1|||
129931574|NCT03926130|467715186|FG000|Overall Study|Non-Compliance|1|||
129931575|NCT03926130|467715187|FG001|Overall Study|Non-Compliance|1|||
129931576|NCT03926130|467715188|FG002|Overall Study|Non-Compliance|0|||
129931577|NCT03926130|467715189|FG003|Overall Study|Non-Compliance|0|||
129931578|NCT03926130|467715186|FG000|Overall Study|Disposition Not Captured|0|||
129931579|NCT03926130|467715187|FG001|Overall Study|Disposition Not Captured|2|||
129931580|NCT03926130|467715188|FG002|Overall Study|Disposition Not Captured|1|||
129931581|NCT03926130|467715189|FG003|Overall Study|Disposition Not Captured|0|||
129931582|NCT03583333|467715190|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
129931583|NCT03583333|467715191|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
129931584|NCT03583333|467715190|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
129931585|NCT03583333|467715191|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
129931586|NCT03583333|467715190|FG000|Overall Study|Withdrawal by Subject|9|||
129931587|NCT03583333|467715191|FG001|Overall Study|Withdrawal by Subject|5|||
129931588|NCT03583333|467715190|FG000|Overall Study|Physician Decision|3|||
129931589|NCT03583333|467715191|FG001|Overall Study|Physician Decision|2|||
129931590|NCT03583333|467715190|FG000|Overall Study|Death|12|||
129931591|NCT03583333|467715191|FG001|Overall Study|Death|7|||
129931592|NCT03824366|467715199|FG000|Overall Study|Death|1|||
129931593|NCT03824366|467715199|FG000|Overall Study|Previously unidentified metal artifact|1|||
129931594|NCT03824366|467715199|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
129931595|NCT03824366|467715199|FG000|Overall Study|Withdrawal by Subject|1|||
129931596|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
129979762|NCT01283516|467889463|FG007|Overall Study|Lost to Follow-up|0|||
129931597|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
129931598|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931599|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931600|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931601|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931602|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931603|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931604|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931605|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931606|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931607|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931608|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931609|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
129931610|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931611|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931612|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931613|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931614|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931615|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931616|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931617|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931618|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931619|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931620|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
129931621|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
129931622|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931623|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931624|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931625|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931626|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931627|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931628|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931629|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931630|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931631|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931632|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931633|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
129931634|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931635|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931636|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931637|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931638|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931639|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931640|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931641|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931642|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931643|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931644|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931645|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
129931646|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931647|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931648|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931649|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931650|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931651|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931652|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931653|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931654|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931655|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931656|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931657|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
129931658|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931659|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931660|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931661|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931662|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931663|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931664|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931665|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931666|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931667|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931668|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931669|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931670|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
129931671|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931672|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
129931673|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931674|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931675|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931676|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931677|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931678|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931679|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931680|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931681|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931682|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
129931683|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
129931684|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
129931685|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931686|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931687|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931688|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931689|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931690|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931691|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931692|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931693|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931694|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931695|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
129931696|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
129931697|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931698|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931699|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931700|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931701|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931702|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931703|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931704|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931705|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931706|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
129931707|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
129931708|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
129931709|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931710|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931711|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931712|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931713|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931714|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931715|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931716|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931717|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931718|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
129931719|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
129931720|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
129931721|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931722|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931723|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130118275|NCT01090765|468394153|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
130118276|NCT01090765|468394154|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
130118277|NCT01090765|468394155|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
130118278|NCT01090765|468394150|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
130118279|NCT01090765|468394151|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
130118280|NCT01090765|468394152|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
130118281|NCT01090765|468394153|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
130118282|NCT01090765|468394154|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
130118283|NCT01090765|468394155|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
130118284|NCT00421174|468394159|FG000|Overall Study|Withdrawal by Subject|0|||
130118285|NCT00421174|468394160|FG001|Overall Study|Withdrawal by Subject|1|||
130118286|NCT00421174|468394159|FG000|Overall Study|Ineligible due to infection|2|||
130118287|NCT00421174|468394160|FG001|Overall Study|Ineligible due to infection|0|||
130118288|NCT00992407|468394161|FG000|Overall Study|Protocol Violation|2|||
130118289|NCT00992407|468394162|FG001|Overall Study|Protocol Violation|1|||
130118290|NCT00992407|468394161|FG000|Overall Study|Lost to Follow-up|3|||
130118291|NCT00992407|468394162|FG001|Overall Study|Lost to Follow-up|3|||
130118292|NCT00992407|468394161|FG000|Overall Study|Adverse Event|3|||
130118293|NCT00992407|468394162|FG001|Overall Study|Adverse Event|2|||
130118294|NCT00992407|468394161|FG000|Overall Study|protocol Violation & Adverse events|2|||
130118295|NCT00992407|468394162|FG001|Overall Study|protocol Violation & Adverse events|4|||
130118296|NCT00992407|468394161|FG000|Overall Study|Other|2|||
130118297|NCT00992407|468394162|FG001|Overall Study|Other|0|||
130118298|NCT00992407|468394161|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
130118299|NCT00992407|468394162|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
130118300|NCT00992407|468394161|FG000|Overall Study|Study medication not administered|17|||
130118301|NCT00992407|468394162|FG001|Overall Study|Study medication not administered|13|||
130118302|NCT02396381|468394163|FG000|Overall Study|Adverse Event|3|||
130118303|NCT02396381|468394164|FG001|Overall Study|Adverse Event|2|||
130118304|NCT02396381|468394163|FG000|Overall Study|Withdrawal by Subject|33|||
130118305|NCT02396381|468394164|FG001|Overall Study|Withdrawal by Subject|24|||
130118306|NCT02396381|468394163|FG000|Overall Study|Lost to Follow-up|49|||
130118307|NCT02396381|468394164|FG001|Overall Study|Lost to Follow-up|31|||
130118308|NCT02396381|468394163|FG000|Overall Study|Protocol Violation|1|||
130118309|NCT02396381|468394164|FG001|Overall Study|Protocol Violation|0|||
130118310|NCT02396381|468394163|FG000|Overall Study|Site terminated by sponsor|7|||
129931724|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931725|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
130118311|NCT02396381|468394164|FG001|Overall Study|Site terminated by sponsor|8|||
130118312|NCT02396381|468394163|FG000|Overall Study|Physician Decision|5|||
130118313|NCT02396381|468394164|FG001|Overall Study|Physician Decision|5|||
130118314|NCT02396381|468394163|FG000|Overall Study|Pregnancy|2|||
130118315|NCT02396381|468394164|FG001|Overall Study|Pregnancy|0|||
130118316|NCT02396381|468394163|FG000|Overall Study|Non-compliance with study procedures|1|||
130118317|NCT02396381|468394164|FG001|Overall Study|Non-compliance with study procedures|0|||
130118318|NCT02396381|468394163|FG000|Overall Study|Moved out of town/state|1|||
130118319|NCT02396381|468394164|FG001|Overall Study|Moved out of town/state|3|||
130118320|NCT02396381|468394163|FG000|Overall Study|Could not complete visit|1|||
130118321|NCT02396381|468394164|FG001|Overall Study|Could not complete visit|0|||
130118322|NCT02396381|468394163|FG000|Overall Study|Possible conflict of interest|1|||
130118323|NCT02396381|468394164|FG001|Overall Study|Possible conflict of interest|0|||
130118324|NCT02396381|468394163|FG000|Overall Study|Randomization/Screening Error|3|||
130118325|NCT02396381|468394164|FG001|Overall Study|Randomization/Screening Error|1|||
129931726|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931727|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931728|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931729|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931730|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931731|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931732|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
130118326|NCT00356200|468394166|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
130118327|NCT00356200|468394167|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
130118328|NCT00356200|468394166|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
130118329|NCT00356200|468394167|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
130118330|NCT01000337|468394171|FG000|Overall Study|Lost to Follow-up|4|||
130118331|NCT01000337|468394172|FG001|Overall Study|Lost to Follow-up|3|||
130118332|NCT02173704|468394173|FG000|Overall Study|Adverse Event|1|||
130118333|NCT02173704|468394174|FG001|Overall Study|Adverse Event|0|||
130118334|NCT02173704|468394173|FG000|Overall Study|Lost to Follow-up|1|||
130118335|NCT02173704|468394174|FG001|Overall Study|Lost to Follow-up|0|||
130118336|NCT02173704|468394173|FG000|Overall Study|Other|1|||
130118337|NCT02173704|468394174|FG001|Overall Study|Other|0|||
130118338|NCT02173704|468394173|FG000|Overall Study|Protocol Violation|1|||
130118339|NCT02173704|468394174|FG001|Overall Study|Protocol Violation|0|||
129931733|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
129931734|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
129931735|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
129931736|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
129931737|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931738|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931739|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931740|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931741|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931742|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
130069592|NCT02849626|468209529|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
130069593|NCT02849626|468209530|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
130069594|NCT02849626|468209527|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
130069595|NCT02849626|468209528|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
130069596|NCT02849626|468209529|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
130069597|NCT02849626|468209530|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
129931743|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931744|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931745|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
129931746|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
129931747|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
129931748|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
129931749|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931750|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931751|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931752|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931753|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931754|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931755|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931756|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931757|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
129931758|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931759|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
129931760|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931761|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931762|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931763|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931764|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931765|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931766|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931767|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931768|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931769|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
129931770|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931771|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
129931772|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
129931773|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931774|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931775|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931776|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931777|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931778|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931779|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931780|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931781|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
129931782|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
130069598|NCT02849626|468209527|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
130069599|NCT02849626|468209528|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
130069600|NCT02849626|468209529|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
130069601|NCT02849626|468209530|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
130069602|NCT01313208|468209531|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
130069603|NCT01313208|468209532|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
130069604|NCT01313208|468209531|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
130069605|NCT01313208|468209532|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
130069606|NCT01313208|468209531|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
130069607|NCT01313208|468209532|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
130069608|NCT01313208|468209531|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
129931783|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
129931784|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
129931785|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
130069609|NCT01313208|468209532|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
130069610|NCT01313208|468209531|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
129931786|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931787|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931788|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931789|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931790|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931791|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931792|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931793|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
129931794|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931795|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931796|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931797|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931798|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931799|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931800|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931801|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931802|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931803|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931804|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931805|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931806|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
129931807|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931808|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931809|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931810|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931811|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931812|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931813|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931814|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931815|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931816|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931817|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931818|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
129931819|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931820|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931821|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931822|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931823|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931824|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931825|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931826|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931827|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931828|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931829|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
129931830|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931831|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931832|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931833|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931834|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931835|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931836|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931837|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931838|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931839|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931840|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931841|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931842|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931843|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931844|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
129931845|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931846|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931847|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
130069611|NCT01313208|468209532|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
129931848|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931849|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931850|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931851|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931852|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931853|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931854|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931855|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931856|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931857|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
129931858|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
129931859|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
129931860|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931861|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931862|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931863|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931864|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931865|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931866|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931867|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931868|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931869|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
129931870|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
129931871|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
129931872|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931873|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931874|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931875|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931876|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931877|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931878|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931879|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931880|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931881|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931882|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
129931883|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931884|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931885|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931886|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931887|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931888|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931889|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931890|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931891|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931892|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931893|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931894|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931895|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
129931896|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931897|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931898|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931899|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931900|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931901|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931902|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931903|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931904|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931905|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931906|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129979763|NCT01283516|467889464|FG008|Overall Study|Lost to Follow-up|1|||
129931907|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
129931908|NCT03485729|467715222|FG000|Overall Study|Withdrawal by Subject|0|||
129931909|NCT03485729|467715223|FG001|Overall Study|Withdrawal by Subject|0|||
129931910|NCT03485729|467715224|FG002|Overall Study|Withdrawal by Subject|1|||
129931911|NCT03485729|467715222|FG000|Overall Study|Disease progression|8|||
129931912|NCT03485729|467715223|FG001|Overall Study|Disease progression|13|||
129931913|NCT03485729|467715224|FG002|Overall Study|Disease progression|1|||
129931914|NCT03485729|467715222|FG000|Overall Study|Hospice care|1|||
129931915|NCT03485729|467715223|FG001|Overall Study|Hospice care|0|||
129931916|NCT03485729|467715224|FG002|Overall Study|Hospice care|0|||
129931917|NCT03485729|467715222|FG000|Overall Study|Poor performance status|1|||
129931918|NCT03485729|467715223|FG001|Overall Study|Poor performance status|0|||
129931919|NCT03485729|467715224|FG002|Overall Study|Poor performance status|0|||
129931920|NCT03485729|467715222|FG000|Overall Study|Illness|0|||
129931921|NCT03485729|467715223|FG001|Overall Study|Illness|1|||
129931922|NCT03485729|467715224|FG002|Overall Study|Illness|0|||
129931923|NCT02997202|467715234|FG000|Overall Study|Miscellaneous|2|||
129931924|NCT02997202|467715235|FG001|Overall Study|Miscellaneous|2|||
129931925|NCT02997202|467715234|FG000|Overall Study|Withdrawal by Subject|8|||
129931926|NCT02997202|467715235|FG001|Overall Study|Withdrawal by Subject|12|||
129931927|NCT02997202|467715234|FG000|Overall Study|Lost to Follow-up|5|||
129931928|NCT02997202|467715235|FG001|Overall Study|Lost to Follow-up|3|||
129931929|NCT02997202|467715234|FG000|Overall Study|Death|41|||
129931930|NCT02997202|467715235|FG001|Overall Study|Death|45|||
129931931|NCT01199133|467715236|FG000|Year 1|Adverse Event|16|||
129931932|NCT01199133|467715237|FG001|Year 1|Adverse Event|4|||
129931933|NCT01199133|467715236|FG000|Year 1|Withdrawal by Subject|8|||
129931934|NCT01199133|467715237|FG001|Year 1|Withdrawal by Subject|4|||
129931935|NCT01199133|467715236|FG000|Year 1|Any other reason not above-mentioned|6|||
129931936|NCT01199133|467715237|FG001|Year 1|Any other reason not above-mentioned|7|||
129931937|NCT01199133|467715236|FG000|Year 2|Adverse Event|1|||
129931938|NCT01199133|467715237|FG001|Year 2|Adverse Event|0|||
129931939|NCT01199133|467715236|FG000|Year 2|Withdrawal by Subject|1|||
129931940|NCT01199133|467715237|FG001|Year 2|Withdrawal by Subject|1|||
129931941|NCT01199133|467715236|FG000|Year 2|Any other reason not above-mentioned|1|||
129931942|NCT01199133|467715237|FG001|Year 2|Any other reason not above-mentioned|2|||
129931943|NCT05013385|467715239|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
129931944|NCT01447719|467715244|FG000|Overall Study|Image acquisition failure|2|||
129931945|NCT01447719|467715244|FG000|Overall Study|Invalid image or not imaged|3|||
130069612|NCT01313208|468209531|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
130069613|NCT01313208|468209532|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
130069614|NCT01313208|468209531|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
130069615|NCT01313208|468209532|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
130069616|NCT01313208|468209531|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
130069617|NCT01313208|468209532|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
130069618|NCT01313208|468209531|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
130069619|NCT01313208|468209532|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
130069620|NCT01654523|468209533|FG000|Overall Study|Withdrawal by Subject|1|||
130069621|NCT01957787|468209534|FG000|Overall Study|Death|18|||
130069622|NCT01957787|468209534|FG000|Overall Study|Lost to Follow-up|3|||
130069623|NCT01957787|468209534|FG000|Overall Study|Withdrawal by Subject|3|||
130069624|NCT01957787|468209534|FG000|Overall Study|Entered Hospice or Similar Program|2|||
130069625|NCT01957787|468209534|FG000|Overall Study|Index Tumor(s) Resected|2|||
130069626|NCT01957787|468209534|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
129931946|NCT01447719|467715244|FG000|Overall Study|Subject still living at end of study|79|||
129931947|NCT01447719|467715244|FG000|Overall Study|Withdrawal by Subject|2|||
129931948|NCT01447719|467715244|FG000|Overall Study|Family withdrew autopsy consent|7|||
129931949|NCT05100628|467715245|FG000|Overall Study|Progressive Disease|1|||
129931950|NCT05100628|467715246|FG001|Overall Study|Progressive Disease|0|||
129931951|NCT05100628|467715247|FG002|Overall Study|Progressive Disease|0|||
129931952|NCT05100628|467715248|FG003|Overall Study|Progressive Disease|0|||
129931953|NCT05100628|467715245|FG000|Overall Study|Study Terminated by Sponsor|0|||
129931954|NCT05100628|467715246|FG001|Overall Study|Study Terminated by Sponsor|0|||
129931955|NCT05100628|467715247|FG002|Overall Study|Study Terminated by Sponsor|3|||
129931956|NCT05100628|467715248|FG003|Overall Study|Study Terminated by Sponsor|0|||
129931957|NCT05100628|467715245|FG000|Overall Study|unkown|0|||
130069627|NCT01957787|468209534|FG000|Overall Study|Local therapy, not cryoablation|6|||
130069628|NCT04176445|468209535|FG000|Overall Study|Adverse Event|0|||
129931958|NCT05100628|467715246|FG001|Overall Study|unkown|1|||
129931959|NCT05100628|467715247|FG002|Overall Study|unkown|0|||
129931960|NCT05100628|467715248|FG003|Overall Study|unkown|0|||
129931961|NCT05900154|467715251|FG000|Follow-Up Period|Lost to Follow-up|1|||
129931962|NCT05900154|467715252|FG001|Follow-Up Period|Lost to Follow-up|2|||
129931963|NCT05900154|467715253|FG002|Follow-Up Period|Lost to Follow-up|1|||
129931964|NCT05900154|467715254|FG003|Follow-Up Period|Lost to Follow-up|0|||
129931965|NCT05900154|467715255|FG004|Follow-Up Period|Lost to Follow-up|1|||
129931966|NCT05900154|467715256|FG005|Follow-Up Period|Lost to Follow-up|1|||
129931967|NCT02518048|467715263|FG000|Overall Study|Withdrawal by Subject|1|||
129931968|NCT05363163|467716608|FG000|Overall Study|Withdrawal by Subject|13|||
129931969|NCT03673501|467716611|FG000|Overall Study|Participants ongoing.|36|||
129931970|NCT03673501|467716612|FG001|Overall Study|Participants ongoing.|24|||
129931971|NCT04709419|467716613|FG000|Overall Study|Physician Decision|1|||
129931972|NCT04709419|467716614|FG001|Overall Study|Physician Decision|0|||
129931973|NCT05683340|467716615|FG000|Overall Study|Adverse Event|1|||
129931974|NCT05683340|467716616|FG001|Overall Study|Adverse Event|1|||
129931975|NCT05683340|467716615|FG000|Overall Study|Protocol Violation|1|||
129931976|NCT05683340|467716616|FG001|Overall Study|Protocol Violation|0|||
129931977|NCT05683340|467716615|FG000|Overall Study|Withdrawal by Subject|0|||
129931978|NCT05683340|467716616|FG001|Overall Study|Withdrawal by Subject|2|||
129931979|NCT02056834|467716617|FG000|Overall Study|Lost to Follow-up|7|||
129931980|NCT06106022|467716618|FG000|Overall Study|Lost to Follow-up|1|||
129931981|NCT06106022|467716619|FG001|Overall Study|Lost to Follow-up|0|||
129931982|NCT06106022|467716618|FG000|Overall Study|Voluntary Withdrawal|0|||
129931983|NCT06106022|467716619|FG001|Overall Study|Voluntary Withdrawal|2|||
129931984|NCT02839265|467716649|FG000|Overall Study|Screen Failure|2|||
129931985|NCT02839265|467716649|FG000|Overall Study|Death|1|||
129931986|NCT02839265|467716649|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
129931987|NCT03635424|467716650|FG000|Overall Study|Adverse Event|1|||
129931988|NCT03635424|467716650|FG000|Overall Study|Death|1|||
129931989|NCT03635424|467716650|FG000|Overall Study|Device not implanted|1|||
129931990|NCT05533190|467716653|FG000|Overall Study|Lost to Follow-up|19|||
129931991|NCT05533190|467716654|FG001|Overall Study|Lost to Follow-up|7|||
129931992|NCT05533190|467716653|FG000|Overall Study|Failed to download app|1|||
129931993|NCT05533190|467716654|FG001|Overall Study|Failed to download app|0|||
129931994|NCT05533190|467716653|FG000|Overall Study|Thought app was a scam|1|||
129931995|NCT05533190|467716654|FG001|Overall Study|Thought app was a scam|0|||
129931996|NCT05533190|467716653|FG000|Overall Study|Withdrawal by Subject|2|||
129931997|NCT05533190|467716654|FG001|Overall Study|Withdrawal by Subject|0|||
129931998|NCT04167553|467716658|FG000|Overall Study|Withdrawal by Subject|1|||
129931999|NCT04167553|467716659|FG001|Overall Study|Withdrawal by Subject|0|||
129932000|NCT04167553|467716660|FG002|Overall Study|Withdrawal by Subject|1|||
129932001|NCT04167553|467716661|FG003|Overall Study|Withdrawal by Subject|2|||
129932002|NCT04167553|467716662|FG004|Overall Study|Withdrawal by Subject|1|||
129932003|NCT04167553|467716663|FG005|Overall Study|Withdrawal by Subject|0|||
129932004|NCT04167553|467716664|FG006|Overall Study|Withdrawal by Subject|0|||
129932005|NCT04167553|467716658|FG000|Overall Study|Physician Decision|0|||
129932006|NCT04167553|467716659|FG001|Overall Study|Physician Decision|0|||
129932007|NCT04167553|467716660|FG002|Overall Study|Physician Decision|0|||
129932008|NCT04167553|467716661|FG003|Overall Study|Physician Decision|0|||
129932009|NCT04167553|467716662|FG004|Overall Study|Physician Decision|2|||
129932010|NCT04167553|467716663|FG005|Overall Study|Physician Decision|2|||
129932011|NCT04167553|467716664|FG006|Overall Study|Physician Decision|0|||
129932012|NCT04167553|467716658|FG000|Overall Study|Lost to Follow-up|0|||
129932013|NCT04167553|467716659|FG001|Overall Study|Lost to Follow-up|0|||
129932014|NCT04167553|467716660|FG002|Overall Study|Lost to Follow-up|2|||
129932015|NCT04167553|467716661|FG003|Overall Study|Lost to Follow-up|0|||
129932016|NCT04167553|467716662|FG004|Overall Study|Lost to Follow-up|0|||
129932017|NCT04167553|467716663|FG005|Overall Study|Lost to Follow-up|0|||
129932018|NCT04167553|467716664|FG006|Overall Study|Lost to Follow-up|0|||
129932019|NCT03858517|467716668|FG000|Overall Study|Adverse Event|1|||
129932020|NCT03858517|467716668|FG000|Overall Study|Lost to Follow-up|1|||
129932021|NCT03858517|467716668|FG000|Overall Study|removed for being incarcerated|1|||
129932022|NCT03858517|467716668|FG000|Overall Study|Sponsor Closure|48|||
129932023|NCT02828358|467716669|FG000|Overall Study|Physician Decision|7|||
129932024|NCT02828358|467716670|FG001|Overall Study|Physician Decision|1|||
129932025|NCT02828358|467716669|FG000|Overall Study|Treatment Failure|6|||
129932026|NCT02828358|467716670|FG001|Overall Study|Treatment Failure|0|||
129932027|NCT02828358|467716669|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
129932028|NCT02828358|467716670|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
129932029|NCT02828358|467716669|FG000|Overall Study|Refusal of further protocol therapy|2|||
129932030|NCT02828358|467716670|FG001|Overall Study|Refusal of further protocol therapy|0|||
129932031|NCT02828358|467716669|FG000|Overall Study|Relapse|25|||
129932032|NCT02828358|467716670|FG001|Overall Study|Relapse|0|||
129932033|NCT02828358|467716669|FG000|Overall Study|Still on therapy|5|||
129932034|NCT02828358|467716670|FG001|Overall Study|Still on therapy|0|||
129932035|NCT05172232|467716671|FG000|Overall Study|Lost to Follow-up|3|||
129932036|NCT01828021|467716672|FG000|Overall Study|Adverse Event|5|||
129932037|NCT01828021|467716672|FG000|Overall Study|Lack of Efficacy|17|||
129932038|NCT01828021|467716672|FG000|Overall Study|Withdrawal by Subject|2|||
129932039|NCT01828021|467716672|FG000|Overall Study|Ileal obstruction, unrelated|1|||
129932040|NCT03717935|467716678|FG000|Overall Study|Withdrawal by Subject|0|||
129932041|NCT03717935|467716679|FG001|Overall Study|Withdrawal by Subject|2|||
129932042|NCT02990338|467716680|FG000|Overall Study|Randomized and not treated|4|||
129932043|NCT02990338|467716681|FG001|Overall Study|Randomized and not treated|2|||
129932044|NCT02990338|467716680|FG000|Overall Study|Adverse Event|23|||
129932045|NCT02990338|467716681|FG001|Overall Study|Adverse Event|22|||
129932046|NCT02990338|467716680|FG000|Overall Study|Progressive disease|118|||
129932047|NCT02990338|467716681|FG001|Overall Study|Progressive disease|107|||
129932048|NCT02990338|467716680|FG000|Overall Study|Poor compliance to protocol|0|||
129932049|NCT02990338|467716681|FG001|Overall Study|Poor compliance to protocol|1|||
129932050|NCT02990338|467716680|FG000|Overall Study|Withdrawal by Subject|6|||
129932051|NCT02990338|467716681|FG001|Overall Study|Withdrawal by Subject|8|||
129932052|NCT02990338|467716680|FG000|Overall Study|Physician's decision|2|||
129932053|NCT02990338|467716681|FG001|Overall Study|Physician's decision|6|||
129932054|NCT02990338|467716680|FG000|Overall Study|Treatment extension study|0|||
129932055|NCT02990338|467716681|FG001|Overall Study|Treatment extension study|6|||
129932056|NCT02990338|467716680|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
129932057|NCT02990338|467716681|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
129932058|NCT02990338|467716680|FG000|Overall Study|Continue with therapy available commercially|0|||
129932059|NCT02990338|467716681|FG001|Overall Study|Continue with therapy available commercially|1|||
129932060|NCT04479761|467716683|FG000|Overall Study|could not perform the balance tasks|1|||
129932061|NCT04479761|467716684|FG001|Overall Study|could not perform the balance tasks|0|||
129932062|NCT04479761|467716685|FG002|Overall Study|could not perform the balance tasks|0|||
129932063|NCT04479761|467716683|FG000|Overall Study|Adverse Event|1|||
129932064|NCT04479761|467716684|FG001|Overall Study|Adverse Event|0|||
129932065|NCT04479761|467716685|FG002|Overall Study|Adverse Event|0|||
129932066|NCT04479761|467716683|FG000|Overall Study|one control did not meet screening criteria|0|||
129932067|NCT04479761|467716684|FG001|Overall Study|one control did not meet screening criteria|0|||
129932068|NCT04479761|467716685|FG002|Overall Study|one control did not meet screening criteria|1|||
129932069|NCT04479761|467716683|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
129932070|NCT04479761|467716684|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
129932071|NCT04479761|467716685|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
129932072|NCT04186819|467716686|FG000|Overall Study|Adverse Event|1|||
129932073|NCT04186819|467716686|FG000|Overall Study|Lost to Follow-up|1|||
129932074|NCT04186819|467716686|FG000|Overall Study|Opted for EBRT|1|||
129932075|NCT04186819|467716686|FG000|Overall Study|Opted SBRT|1|||
129932076|NCT04186819|467716686|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
129932077|NCT04186819|467716686|FG000|Overall Study|Physician Decision|1|||
129932078|NCT04186819|467716686|FG000|Overall Study|RP Delayed|1|||
129932079|NCT04186819|467716686|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
129932080|NCT04186819|467716686|FG000|Overall Study|Subject declined for financial reasons|1|||
129932081|NCT04186819|467716686|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
129932082|NCT04186819|467716686|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
129932083|NCT04186819|467716686|FG000|Overall Study|The subject opted for other treatment option|2|||
129932084|NCT04186819|467716686|FG000|Overall Study|The subject opted for other treatment options|1|||
129932085|NCT04186819|467716686|FG000|Overall Study|Withdrawal by Subject|3|||
129932086|NCT04186819|467716686|FG000|Overall Study|Reason not specified|1|||
129932087|NCT00631475|467716704|FG000|Overall Study|Death|18|||
129932088|NCT00631475|467716704|FG000|Overall Study|Adverse Event|14|||
129932089|NCT00631475|467716704|FG000|Overall Study|Withdrew consent|5|||
129932090|NCT00631475|467716704|FG000|Overall Study|Preparation for lung transplant|8|||
129932091|NCT00303459|467716705|FG000|Overall Study|Death|33|||
129932092|NCT00303459|467716706|FG001|Overall Study|Death|44|||
129932093|NCT00303459|467716705|FG000|Overall Study|Withdrawal of consent|32|||
129932094|NCT00303459|467716706|FG001|Overall Study|Withdrawal of consent|26|||
129932095|NCT00303459|467716705|FG000|Overall Study|Lost to Follow-up|5|||
129932096|NCT00303459|467716706|FG001|Overall Study|Lost to Follow-up|4|||
129932097|NCT00303459|467716705|FG000|Overall Study|Administrative reason|7|||
129932098|NCT00303459|467716706|FG001|Overall Study|Administrative reason|7|||
129932099|NCT00303459|467716705|FG000|Overall Study|Decision by the investigator|5|||
129932100|NCT00303459|467716706|FG001|Overall Study|Decision by the investigator|7|||
129932101|NCT00303459|467716705|FG000|Overall Study|Lung transplantation|1|||
129932102|NCT00303459|467716706|FG001|Overall Study|Lung transplantation|1|||
129932103|NCT04129554|467716707|FG000|Overall Study|Withdrawal by Subject|4|||
130069629|NCT04176445|468209536|FG001|Overall Study|Adverse Event|1|||
130069630|NCT04176445|468209535|FG000|Overall Study|change plans weaning after first intervention|0|||
130069631|NCT04176445|468209536|FG001|Overall Study|change plans weaning after first intervention|1|||
130069632|NCT04046341|468209538|FG000|Overall Study|Lost to Follow-up|2|||
130069633|NCT04046341|468209538|FG000|Overall Study|Withdrawal by Subject|1|||
130069634|NCT00405652|468209539|FG000|Overall Study|Adverse Event|4|||
130069635|NCT00435994|468209541|FG000|Overall Study|Lost to Follow-up|7|||
129932104|NCT04129554|467716708|FG001|Overall Study|Withdrawal by Subject|3|||
129932105|NCT04129554|467716707|FG000|Overall Study|Other|0|||
129932106|NCT04129554|467716708|FG001|Overall Study|Other|2|||
129932107|NCT01570361|467716709|FG000|Overall Study|Subject discontinued|1|||
129932108|NCT01570361|467716710|FG001|Overall Study|Subject discontinued|2|||
129932109|NCT01570361|467716709|FG000|Overall Study|Sponsor closing the study|51|||
129932110|NCT01570361|467716710|FG001|Overall Study|Sponsor closing the study|50|||
129932111|NCT01570361|467716709|FG000|Overall Study|Subject excluded|5|||
129932112|NCT01570361|467716710|FG001|Overall Study|Subject excluded|3|||
129932113|NCT01570361|467716709|FG000|Overall Study|Subject withdrew consent|14|||
129932114|NCT01570361|467716710|FG001|Overall Study|Subject withdrew consent|9|||
129932115|NCT01570361|467716709|FG000|Overall Study|Adverse Event|2|||
129932116|NCT01570361|467716710|FG001|Overall Study|Adverse Event|1|||
129932117|NCT01570361|467716709|FG000|Overall Study|Lost to Follow-up|4|||
129932118|NCT01570361|467716710|FG001|Overall Study|Lost to Follow-up|4|||
129932119|NCT01570361|467716709|FG000|Overall Study|Death|5|||
129932120|NCT01570361|467716710|FG001|Overall Study|Death|4|||
129932121|NCT01570361|467716709|FG000|Overall Study|Other|0|||
129932122|NCT01570361|467716710|FG001|Overall Study|Other|2|||
129932123|NCT02846545|467716713|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
129932124|NCT02846545|467716714|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
129932125|NCT02846545|467716713|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
129932126|NCT02846545|467716714|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
129932127|NCT02846545|467716713|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
129932128|NCT02846545|467716714|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
129932129|NCT02846545|467716713|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
129932130|NCT02846545|467716714|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
129932131|NCT02846545|467716713|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
129932132|NCT02846545|467716714|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
129932133|NCT03691298|467716717|FG000|Overall Study|Lost to Follow-up|8|||
129932134|NCT03691298|467716717|FG000|Overall Study|Sponsor terminated study|2|||
129932135|NCT02492711|467716721|FG000|Overall Study|Adverse Event|9|||
129932136|NCT02492711|467716722|FG001|Overall Study|Adverse Event|9|||
129932137|NCT02492711|467716723|FG002|Overall Study|Adverse Event|2|||
129932138|NCT02492711|467716721|FG000|Overall Study|Death|3|||
129932139|NCT02492711|467716722|FG001|Overall Study|Death|3|||
129932140|NCT02492711|467716723|FG002|Overall Study|Death|0|||
129932141|NCT02492711|467716721|FG000|Overall Study|Withdrawal by Subject|10|||
129932142|NCT02492711|467716722|FG001|Overall Study|Withdrawal by Subject|16|||
129932143|NCT02492711|467716723|FG002|Overall Study|Withdrawal by Subject|5|||
129932144|NCT02492711|467716721|FG000|Overall Study|Physician Decision|10|||
129932145|NCT02492711|467716722|FG001|Overall Study|Physician Decision|6|||
129932146|NCT02492711|467716723|FG002|Overall Study|Physician Decision|4|||
129932147|NCT02492711|467716721|FG000|Overall Study|Lost to Follow-up|0|||
129932148|NCT02492711|467716722|FG001|Overall Study|Lost to Follow-up|0|||
129932149|NCT02492711|467716723|FG002|Overall Study|Lost to Follow-up|1|||
129932150|NCT02492711|467716721|FG000|Overall Study|study treatment delay|2|||
129932151|NCT02492711|467716722|FG001|Overall Study|study treatment delay|1|||
129932152|NCT02492711|467716723|FG002|Overall Study|study treatment delay|0|||
129932153|NCT02492711|467716721|FG000|Overall Study|change in chemotherapy|0|||
129932154|NCT02492711|467716722|FG001|Overall Study|change in chemotherapy|1|||
129932155|NCT02492711|467716723|FG002|Overall Study|change in chemotherapy|0|||
129932156|NCT02492711|467716721|FG000|Overall Study|never treated|2|||
129932157|NCT02492711|467716722|FG001|Overall Study|never treated|4|||
129932158|NCT02492711|467716723|FG002|Overall Study|never treated|0|||
129932159|NCT02492711|467716721|FG000|Overall Study|Other|0|||
129932160|NCT02492711|467716722|FG001|Overall Study|Other|0|||
129932161|NCT02492711|467716723|FG002|Overall Study|Other|1|||
129932162|NCT03993392|467716730|FG000|Overall Study|Withdrawal by Subject|3|||
129932163|NCT03993392|467716730|FG000|Overall Study|Lost to Follow-up|2|||
129932164|NCT03993392|467716730|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
129932165|NCT05890105|467716734|FG000|Overall Study|Adverse Event|1|||
129932166|NCT05890105|467716735|FG001|Overall Study|Adverse Event|0|||
129932167|NCT05890105|467716736|FG002|Overall Study|Adverse Event|0|||
129932168|NCT05890105|467716734|FG000|Overall Study|Other|1|||
129932169|NCT05890105|467716735|FG001|Overall Study|Other|2|||
129932170|NCT05890105|467716736|FG002|Overall Study|Other|0|||
129932171|NCT04505410|467716737|FG000|Overall Study|Adverse Event|2|||
129932172|NCT04505410|467716738|FG001|Overall Study|Adverse Event|0|||
129932173|NCT04505410|467716737|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
129932174|NCT04505410|467716738|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
129932175|NCT04505410|467716737|FG000|Overall Study|did not want to follow diet|1|||
129932176|NCT04505410|467716738|FG001|Overall Study|did not want to follow diet|0|||
129932177|NCT04505410|467716737|FG000|Overall Study|flare up of ulcerative colitis|0|||
129932178|NCT04505410|467716738|FG001|Overall Study|flare up of ulcerative colitis|1|||
129932179|NCT04505410|467716737|FG000|Overall Study|Lost to Follow-up|0|||
130069636|NCT00435994|468209542|FG001|Overall Study|Lost to Follow-up|0|||
129932180|NCT04505410|467716738|FG001|Overall Study|Lost to Follow-up|2|||
129932181|NCT04505410|467716737|FG000|Overall Study|Lost to Follow-up|1|||
129932182|NCT04505410|467716738|FG001|Overall Study|Lost to Follow-up|0|||
129932183|NCT04505410|467716737|FG000|Overall Study|initiated another diet on their own|0|||
129932184|NCT04505410|467716738|FG001|Overall Study|initiated another diet on their own|2|||
129932185|NCT06262477|467718120|FG000|Overall Study|Withdrawal by Subject|1|||
129932186|NCT06262477|467718121|FG001|Overall Study|Withdrawal by Subject|0|||
129932187|NCT06262477|467718120|FG000|Overall Study|Adverse Event|0|||
129932188|NCT06262477|467718121|FG001|Overall Study|Adverse Event|1|||
129932189|NCT06262477|467718120|FG000|Overall Study|Lost to Follow-up|0|||
129932190|NCT06262477|467718121|FG001|Overall Study|Lost to Follow-up|1|||
129932191|NCT04183283|467718126|FG000|Period 1|Withdrawal by Subject|0|||
129932192|NCT04183283|467718127|FG001|Period 1|Withdrawal by Subject|1|||
129932193|NCT04183283|467718128|FG002|Period 1|Withdrawal by Subject|0|||
129932194|NCT04183283|467718129|FG003|Period 1|Withdrawal by Subject|0|||
129932195|NCT04183283|467718126|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
129932196|NCT04183283|467718127|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
129932197|NCT04183283|467718128|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
129932198|NCT04183283|467718129|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
129932199|NCT04999111|467718136|FG000|Overall Study|Lost to Follow-up|21|||
129932200|NCT04999111|467718137|FG001|Overall Study|Lost to Follow-up|16|||
129932201|NCT04999111|467718138|FG002|Overall Study|Lost to Follow-up|2|||
129932202|NCT04999111|467718139|FG003|Overall Study|Lost to Follow-up|26|||
129932203|NCT04999111|467718140|FG004|Overall Study|Lost to Follow-up|30|||
129932204|NCT04999111|467718141|FG005|Overall Study|Lost to Follow-up|6|||
129932205|NCT04999111|467718136|FG000|Overall Study|Physician Decision|1|||
129932206|NCT04999111|467718137|FG001|Overall Study|Physician Decision|3|||
129932207|NCT04999111|467718138|FG002|Overall Study|Physician Decision|0|||
129932208|NCT04999111|467718139|FG003|Overall Study|Physician Decision|1|||
129932209|NCT04999111|467718140|FG004|Overall Study|Physician Decision|2|||
129932210|NCT04999111|467718141|FG005|Overall Study|Physician Decision|0|||
129932211|NCT04999111|467718136|FG000|Overall Study|Withdrawal by Subject|23|||
129932212|NCT04999111|467718137|FG001|Overall Study|Withdrawal by Subject|29|||
129932213|NCT04999111|467718138|FG002|Overall Study|Withdrawal by Subject|15|||
129932214|NCT04999111|467718139|FG003|Overall Study|Withdrawal by Subject|30|||
129932215|NCT04999111|467718140|FG004|Overall Study|Withdrawal by Subject|35|||
129932216|NCT04999111|467718141|FG005|Overall Study|Withdrawal by Subject|10|||
129932217|NCT04999111|467718136|FG000|Overall Study|Other|6|||
129932218|NCT04999111|467718137|FG001|Overall Study|Other|6|||
129932219|NCT04999111|467718138|FG002|Overall Study|Other|3|||
129932220|NCT04999111|467718139|FG003|Overall Study|Other|8|||
129932221|NCT04999111|467718140|FG004|Overall Study|Other|8|||
129932222|NCT04999111|467718141|FG005|Overall Study|Other|5|||
129932223|NCT04999111|467718136|FG000|Overall Study|Non-compliance with study schedule|1|||
129932224|NCT04999111|467718137|FG001|Overall Study|Non-compliance with study schedule|0|||
129932225|NCT04999111|467718138|FG002|Overall Study|Non-compliance with study schedule|0|||
129932226|NCT04999111|467718139|FG003|Overall Study|Non-compliance with study schedule|1|||
129932227|NCT04999111|467718140|FG004|Overall Study|Non-compliance with study schedule|1|||
129932228|NCT04999111|467718141|FG005|Overall Study|Non-compliance with study schedule|1|||
129932229|NCT04999111|467718136|FG000|Overall Study|Randomized but not vaccinated|1|||
129932230|NCT04999111|467718137|FG001|Overall Study|Randomized but not vaccinated|2|||
129932231|NCT04999111|467718138|FG002|Overall Study|Randomized but not vaccinated|0|||
129932232|NCT04999111|467718139|FG003|Overall Study|Randomized but not vaccinated|3|||
129932233|NCT04999111|467718140|FG004|Overall Study|Randomized but not vaccinated|3|||
129932234|NCT04999111|467718141|FG005|Overall Study|Randomized but not vaccinated|0|||
129932235|NCT04999111|467718136|FG000|Overall Study|Adverse Event|1|||
129932236|NCT04999111|467718137|FG001|Overall Study|Adverse Event|1|||
129932237|NCT04999111|467718138|FG002|Overall Study|Adverse Event|0|||
129932238|NCT04999111|467718139|FG003|Overall Study|Adverse Event|0|||
129932239|NCT04999111|467718140|FG004|Overall Study|Adverse Event|0|||
129932240|NCT04999111|467718141|FG005|Overall Study|Adverse Event|0|||
129932241|NCT04999111|467718136|FG000|Overall Study|Initiated prohibited medication|0|||
129932242|NCT04999111|467718137|FG001|Overall Study|Initiated prohibited medication|0|||
129932243|NCT04999111|467718138|FG002|Overall Study|Initiated prohibited medication|0|||
129932244|NCT04999111|467718139|FG003|Overall Study|Initiated prohibited medication|0|||
129932245|NCT04999111|467718140|FG004|Overall Study|Initiated prohibited medication|1|||
129932246|NCT04999111|467718141|FG005|Overall Study|Initiated prohibited medication|0|||
129932247|NCT01314105|467718148|FG000|Overall Study|Progressive Disease|6|||
129932248|NCT01314105|467718149|FG001|Overall Study|Progressive Disease|10|||
130069637|NCT00435994|468209543|FG002|Overall Study|Lost to Follow-up|0|||
130069638|NCT03846219|468209547|FG000|Overall Study|Withdrawal by Subject|3|||
130069639|NCT03846219|468209548|FG001|Overall Study|Withdrawal by Subject|2|||
130069640|NCT03846219|468209549|FG002|Overall Study|Withdrawal by Subject|2|||
130069641|NCT03846219|468209547|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
130069642|NCT03846219|468209548|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
129932249|NCT01314105|467718148|FG000|Overall Study|Refused to continue taking medication|0|||
129932250|NCT01314105|467718149|FG001|Overall Study|Refused to continue taking medication|1|||
129932251|NCT01314105|467718148|FG000|Overall Study|Other Adverse Event|1|||
129932252|NCT01314105|467718149|FG001|Overall Study|Other Adverse Event|1|||
129932253|NCT03640286|467718155|FG000|Overall Study|Adverse Event|6|||
129932254|NCT03640286|467718156|FG001|Overall Study|Adverse Event|6|||
129932255|NCT03640286|467718155|FG000|Overall Study|Lost to Follow-up|3|||
129932256|NCT03640286|467718156|FG001|Overall Study|Lost to Follow-up|6|||
129932257|NCT03640286|467718155|FG000|Overall Study|Pregnancy|1|||
129932258|NCT03640286|467718156|FG001|Overall Study|Pregnancy|0|||
129932259|NCT03640286|467718155|FG000|Overall Study|Withdrawal by Subject|10|||
129932260|NCT03640286|467718156|FG001|Overall Study|Withdrawal by Subject|10|||
129932261|NCT03640286|467718155|FG000|Overall Study|Non-compliance|4|||
129932262|NCT03640286|467718156|FG001|Overall Study|Non-compliance|10|||
129932263|NCT03640286|467718155|FG000|Overall Study|Medication change|1|||
129932264|NCT03640286|467718156|FG001|Overall Study|Medication change|0|||
129932265|NCT03640286|467718155|FG000|Overall Study|Other|1|||
129932266|NCT03640286|467718156|FG001|Overall Study|Other|2|||
129932267|NCT03640286|467718155|FG000|Overall Study|Joined another lifestyle program|0|||
129932268|NCT03640286|467718156|FG001|Overall Study|Joined another lifestyle program|1|||
129932269|NCT05524116|467718157|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
129932270|NCT05524116|467718158|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
129932271|NCT05524116|467718157|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
129932272|NCT05524116|467718158|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
129932273|NCT05524116|467718157|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
129932274|NCT05524116|467718158|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
129932275|NCT05524116|467718157|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
129932276|NCT05524116|467718158|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
129932277|NCT05524116|467718157|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
129932278|NCT05524116|467718158|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
129932279|NCT03181516|467718159|FG000|Overall Study|Withdrawal by Subject|14|||
129932280|NCT03181516|467718160|FG001|Overall Study|Withdrawal by Subject|7|||
129932281|NCT03181516|467718159|FG000|Overall Study|Lost to Follow-up|2|||
129932282|NCT03181516|467718160|FG001|Overall Study|Lost to Follow-up|2|||
129932283|NCT05405985|467718161|FG000|Overall Study|Withdrawal by Subject|1|||
129932284|NCT05405985|467718162|FG001|Overall Study|Withdrawal by Subject|0|||
129932285|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
129932286|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
129932287|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
129932288|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
129932289|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
129932290|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
129932291|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
129932292|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
129932293|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
129932294|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
129932295|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
129932296|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
129932297|NCT04880733|467718163|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
129932298|NCT04880733|467718164|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
129932299|NCT04880733|467718165|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
129932300|NCT05552508|467718166|FG000|Overall Study|Adverse Event|3|||
129932301|NCT01917084|467718167|FG000|Overall Study|Withdrawal by Subject|1|||
129932302|NCT04451772|467718174|FG000|Overall Study|Adverse Event|1|||
129932303|NCT04451772|467718175|FG001|Overall Study|Adverse Event|0|||
129932304|NCT04451772|467718176|FG002|Overall Study|Adverse Event|1|||
129932305|NCT04451772|467718177|FG003|Overall Study|Adverse Event|1|||
129932306|NCT04451772|467718178|FG004|Overall Study|Adverse Event|0|||
129932307|NCT04451772|467718179|FG005|Overall Study|Adverse Event|3|||
129932308|NCT04451772|467718174|FG000|Overall Study|Withdrawal by Subject|2|||
129932309|NCT04451772|467718175|FG001|Overall Study|Withdrawal by Subject|7|||
129932310|NCT04451772|467718176|FG002|Overall Study|Withdrawal by Subject|2|||
129932311|NCT04451772|467718177|FG003|Overall Study|Withdrawal by Subject|1|||
129932312|NCT04451772|467718178|FG004|Overall Study|Withdrawal by Subject|1|||
129932313|NCT04451772|467718179|FG005|Overall Study|Withdrawal by Subject|0|||
129932314|NCT04451772|467718174|FG000|Overall Study|Other, not specified|1|||
129932315|NCT04451772|467718175|FG001|Overall Study|Other, not specified|2|||
129932316|NCT04451772|467718176|FG002|Overall Study|Other, not specified|1|||
129932317|NCT04451772|467718177|FG003|Overall Study|Other, not specified|0|||
129932318|NCT04451772|467718178|FG004|Overall Study|Other, not specified|0|||
129932319|NCT04451772|467718179|FG005|Overall Study|Other, not specified|1|||
129932320|NCT04451772|467718174|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
129932321|NCT04451772|467718175|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
129932322|NCT04451772|467718176|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
129932323|NCT04451772|467718177|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
129932324|NCT04451772|467718178|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
129932325|NCT04451772|467718179|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
130118340|NCT02173704|468394173|FG000|Overall Study|Withdrawal by Subject|9|||
130118341|NCT02173704|468394174|FG001|Overall Study|Withdrawal by Subject|4|||
130118342|NCT00419926|468394175|FG000|Overall Study|Withdrawal by Subject|7|||
130118343|NCT00419926|468394176|FG001|Overall Study|Withdrawal by Subject|3|||
130118344|NCT00419926|468394175|FG000|Overall Study|Administrative Problem|4|||
130118345|NCT00419926|468394176|FG001|Overall Study|Administrative Problem|4|||
130118346|NCT00419926|468394175|FG000|Overall Study|Lost to Follow-up|1|||
130118347|NCT00419926|468394176|FG001|Overall Study|Lost to Follow-up|2|||
130118348|NCT00419926|468394175|FG000|Overall Study|Death|2|||
130118349|NCT00419926|468394176|FG001|Overall Study|Death|1|||
130118350|NCT02374918|468394177|FG000|Overall Study|Protocol Violation|2|||
130118351|NCT02374918|468394178|FG001|Overall Study|Protocol Violation|0|||
130118352|NCT02374918|468394179|FG002|Overall Study|Protocol Violation|2|||
130118353|NCT02374918|468394180|FG003|Overall Study|Protocol Violation|1|||
130118354|NCT02374918|468394177|FG000|Overall Study|Withdrawal by Subject|1|||
130118355|NCT02374918|468394178|FG001|Overall Study|Withdrawal by Subject|1|||
130118356|NCT02374918|468394179|FG002|Overall Study|Withdrawal by Subject|1|||
130118357|NCT02374918|468394180|FG003|Overall Study|Withdrawal by Subject|0|||
130118358|NCT02374918|468394177|FG000|Overall Study|Lack of Efficacy|0|||
130118359|NCT02374918|468394178|FG001|Overall Study|Lack of Efficacy|0|||
130118360|NCT02374918|468394179|FG002|Overall Study|Lack of Efficacy|1|||
130118361|NCT02374918|468394180|FG003|Overall Study|Lack of Efficacy|1|||
130118362|NCT01180244|468394181|FG000|Overall Study|Lack of Efficacy|0|||
130118363|NCT01180244|468394182|FG001|Overall Study|Lack of Efficacy|7|||
130118364|NCT01180244|468394181|FG000|Overall Study|Physician Decision|3|||
130118365|NCT01180244|468394182|FG001|Overall Study|Physician Decision|0|||
130118366|NCT01180244|468394181|FG000|Overall Study|Adverse Event|1|||
130118367|NCT01180244|468394182|FG001|Overall Study|Adverse Event|0|||
130118368|NCT01180244|468394181|FG000|Overall Study|Withdrawal by Subject|0|||
130118369|NCT01180244|468394182|FG001|Overall Study|Withdrawal by Subject|1|||
130118370|NCT01180244|468394181|FG000|Overall Study|Protocol Violation|1|||
130118371|NCT01180244|468394182|FG001|Overall Study|Protocol Violation|0|||
130118372|NCT01180244|468394181|FG000|Overall Study|Lost to Follow-up|1|||
130118373|NCT01180244|468394182|FG001|Overall Study|Lost to Follow-up|0|||
130118374|NCT00729859|468394183|FG000|Overall Study|Adverse Event|0|||
130118375|NCT00729859|468394184|FG001|Overall Study|Adverse Event|1|||
130118376|NCT00729859|468394185|FG002|Overall Study|Adverse Event|0|||
130118377|NCT00729859|468394183|FG000|Overall Study|Withdrawal by Subject|0|||
130118378|NCT00729859|468394184|FG001|Overall Study|Withdrawal by Subject|1|||
130118379|NCT00729859|468394185|FG002|Overall Study|Withdrawal by Subject|0|||
130118380|NCT02623829|468394188|FG000|Overall Study|Lost to Follow-up|1|||
130118381|NCT02623829|468394189|FG001|Overall Study|Lost to Follow-up|1|||
130118382|NCT03349333|468394190|FG000|Overall Study|Progression of Disease|36|||
130118383|NCT03349333|468394190|FG000|Overall Study|Adverse Event|11|||
130118384|NCT03349333|468394190|FG000|Overall Study|Other|6|||
130118385|NCT03349333|468394190|FG000|Overall Study|Withdrawal by Subject|5|||
130118386|NCT03349333|468394190|FG000|Overall Study|Conditions interfere with participation|2|||
130118387|NCT03349333|468394190|FG000|Overall Study|Physician Decision|2|||
130118388|NCT03349333|468394190|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
130118389|NCT03349333|468394190|FG000|Overall Study|Patients in treatment less than 24 month|8|||
130118390|NCT00783796|468394191|FG000|Overall Study|Did not receive any stent|4|||
130118391|NCT00783796|468394191|FG000|Overall Study|Received non-XIENCE V stent|1|||
130118392|NCT00783796|468394191|FG000|Overall Study|Received commercial XIENCE V stent|1|||
130118393|NCT03267264|468394193|FG000|Overall Study|Withdrawal by Subject|1|||
130118394|NCT03267264|468394194|FG001|Overall Study|Withdrawal by Subject|0|||
130118395|NCT03267264|468394195|FG002|Overall Study|Withdrawal by Subject|2|||
130118396|NCT03267264|468394196|FG003|Overall Study|Withdrawal by Subject|4|||
130118397|NCT01766921|468394197|FG000|Overall Study|Administrative Reason|5|||
130118398|NCT01766921|468394198|FG001|Overall Study|Administrative Reason|5|||
130118399|NCT01766921|468394197|FG000|Overall Study|Death|1|||
130118400|NCT01766921|468394198|FG001|Overall Study|Death|1|||
129932326|NCT02278211|467718180|FG000|Overall Study|Unable to analyse PET scan|2|||
129932327|NCT05424380|467718181|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
130118401|NCT01766921|468394197|FG000|Overall Study|Lost to Follow-up|1|||
130118402|NCT01766921|468394198|FG001|Overall Study|Lost to Follow-up|3|||
130118403|NCT01766921|468394197|FG000|Overall Study|Unclassified|2|||
130118404|NCT01766921|468394198|FG001|Overall Study|Unclassified|2|||
130118405|NCT01766921|468394197|FG000|Overall Study|Protocol Violation|1|||
130118406|NCT01766921|468394198|FG001|Overall Study|Protocol Violation|1|||
130118407|NCT01766921|468394197|FG000|Overall Study|Withdrawal by Subject|14|||
130118408|NCT01766921|468394198|FG001|Overall Study|Withdrawal by Subject|5|||
130118409|NCT01915732|468394201|FG000|Overall Study|Withdrawal by Subject|18|||
130118410|NCT01915732|468394202|FG001|Overall Study|Withdrawal by Subject|18|||
130118411|NCT01915732|468394201|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
130118412|NCT01915732|468394202|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130118413|NCT01915732|468394201|FG000|Overall Study|Adverse Event|12|||
130118414|NCT01915732|468394202|FG001|Overall Study|Adverse Event|4|||
130118415|NCT01915732|468394201|FG000|Overall Study|Protocol Violation|5|||
130069643|NCT03846219|468209549|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
130069644|NCT03846219|468209547|FG000|Overall Study|Physician Decision|0|||
130069645|NCT03846219|468209548|FG001|Overall Study|Physician Decision|0|||
130069646|NCT03846219|468209549|FG002|Overall Study|Physician Decision|2|||
130069647|NCT05109702|468209550|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
130069648|NCT05109702|468209551|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
130069649|NCT05109702|468209552|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
130069650|NCT05109702|468209550|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
130069651|NCT05109702|468209551|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
130069652|NCT05109702|468209552|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
130069653|NCT05109702|468209550|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
130069654|NCT05109702|468209551|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
130069655|NCT05109702|468209552|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
130069656|NCT05109702|468209550|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
130069657|NCT05109702|468209551|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
130069658|NCT05109702|468209552|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
130069659|NCT05109702|468209550|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
130069660|NCT05109702|468209551|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
130069661|NCT05109702|468209552|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
130069662|NCT01392378|468209557|FG000|Infant Series|Adverse Event|0|||
130069663|NCT01392378|468209558|FG001|Infant Series|Adverse Event|0|||
130069664|NCT01392378|468209559|FG002|Infant Series|Adverse Event|0|||
130069665|NCT01392378|468209560|FG003|Infant Series|Adverse Event|1|||
130069666|NCT01392378|468209561|FG004|Infant Series|Adverse Event|0|||
130069667|NCT01392378|468209557|FG000|Infant Series|Lost to Follow-up|0|||
130069668|NCT01392378|468209558|FG001|Infant Series|Lost to Follow-up|0|||
130069669|NCT01392378|468209559|FG002|Infant Series|Lost to Follow-up|0|||
130069670|NCT01392378|468209560|FG003|Infant Series|Lost to Follow-up|1|||
130069671|NCT01392378|468209561|FG004|Infant Series|Lost to Follow-up|0|||
130069672|NCT01392378|468209557|FG000|Infant Series|Protocol Violation|0|||
130069673|NCT01392378|468209558|FG001|Infant Series|Protocol Violation|1|||
130069674|NCT01392378|468209559|FG002|Infant Series|Protocol Violation|0|||
130069675|NCT01392378|468209560|FG003|Infant Series|Protocol Violation|0|||
130069676|NCT01392378|468209561|FG004|Infant Series|Protocol Violation|0|||
130069677|NCT01392378|468209557|FG000|Infant Series|Withdrawal by Parent|4|||
130069678|NCT01392378|468209558|FG001|Infant Series|Withdrawal by Parent|1|||
130069679|NCT01392378|468209559|FG002|Infant Series|Withdrawal by Parent|0|||
130069680|NCT01392378|468209560|FG003|Infant Series|Withdrawal by Parent|0|||
130069681|NCT01392378|468209561|FG004|Infant Series|Withdrawal by Parent|0|||
130069682|NCT01392378|468209557|FG000|After Infant Series|Lost to Follow-up|0|||
130069683|NCT01392378|468209558|FG001|After Infant Series|Lost to Follow-up|0|||
130069684|NCT01392378|468209559|FG002|After Infant Series|Lost to Follow-up|1|||
130069685|NCT01392378|468209560|FG003|After Infant Series|Lost to Follow-up|0|||
130069686|NCT01392378|468209561|FG004|After Infant Series|Lost to Follow-up|0|||
130069687|NCT01392378|468209557|FG000|After Infant Series|Withdrawal by Parent|0|||
130069688|NCT01392378|468209558|FG001|After Infant Series|Withdrawal by Parent|1|||
130069689|NCT01392378|468209559|FG002|After Infant Series|Withdrawal by Parent|1|||
130069690|NCT01392378|468209560|FG003|After Infant Series|Withdrawal by Parent|0|||
130069691|NCT01392378|468209561|FG004|After Infant Series|Withdrawal by Parent|1|||
130069692|NCT01392378|468209557|FG000|Toddler Dose|Lost to Follow-up|0|||
130069693|NCT01392378|468209558|FG001|Toddler Dose|Lost to Follow-up|0|||
130069694|NCT01392378|468209559|FG002|Toddler Dose|Lost to Follow-up|0|||
130069695|NCT01392378|468209560|FG003|Toddler Dose|Lost to Follow-up|1|||
130069696|NCT01392378|468209561|FG004|Toddler Dose|Lost to Follow-up|0|||
130069697|NCT01392378|468209557|FG000|Toddler Dose|Withdrawal by Parent|0|||
130069698|NCT01392378|468209558|FG001|Toddler Dose|Withdrawal by Parent|1|||
130069699|NCT01392378|468209559|FG002|Toddler Dose|Withdrawal by Parent|0|||
130069700|NCT01392378|468209560|FG003|Toddler Dose|Withdrawal by Parent|1|||
130069701|NCT01392378|468209561|FG004|Toddler Dose|Withdrawal by Parent|1|||
130069702|NCT02322411|468209566|FG000|Overall Study|Lost to Follow-up|4|||
130069703|NCT02322411|468209567|FG001|Overall Study|Lost to Follow-up|7|||
130069704|NCT02322411|468209566|FG000|Overall Study|Withdrawal by Subject|1|||
130069705|NCT02322411|468209567|FG001|Overall Study|Withdrawal by Subject|0|||
130069706|NCT00788697|468209572|FG000|Overall Study|No study drug administered|12|||
130069707|NCT00788697|468209572|FG000|Overall Study|Training Patients|74|||
130069708|NCT00788697|468209572|FG000|Overall Study|no truth standard procedure available|5|||
130069709|NCT00788697|468209572|FG000|Overall Study|Technically inadequate truth standard|1|||
130069710|NCT00788697|468209572|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
130069711|NCT02671461|468209573|FG000|Treatment|Adverse Event|0|||
130069712|NCT02671461|468209574|FG001|Treatment|Adverse Event|0|||
130069713|NCT02671461|468209575|FG002|Treatment|Adverse Event|1|||
130069714|NCT02671461|468209573|FG000|Treatment|Administrative Reason by Sponsor|1|||
130069715|NCT02671461|468209574|FG001|Treatment|Administrative Reason by Sponsor|3|||
130069716|NCT02671461|468209575|FG002|Treatment|Administrative Reason by Sponsor|4|||
130069717|NCT02671461|468209573|FG000|Treatment|Randomized, not treated|1|||
130069718|NCT02671461|468209574|FG001|Treatment|Randomized, not treated|0|||
129932328|NCT05424380|467718182|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932329|NCT05424380|467718183|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932330|NCT05424380|467718184|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932331|NCT05424380|467718185|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932332|NCT05424380|467718186|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932333|NCT05424380|467718181|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
129932334|NCT05424380|467718182|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932335|NCT05424380|467718183|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932336|NCT05424380|467718184|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932337|NCT05424380|467718185|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932338|NCT05424380|467718186|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932339|NCT05424380|467718181|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
129932340|NCT05424380|467718182|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932341|NCT05424380|467718183|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932342|NCT05424380|467718184|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932343|NCT05424380|467718185|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932344|NCT05424380|467718186|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932345|NCT05424380|467718181|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932346|NCT05424380|467718182|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
129932347|NCT05424380|467718183|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932348|NCT05424380|467718184|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932349|NCT05424380|467718185|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932350|NCT05424380|467718186|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932351|NCT05424380|467718181|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932352|NCT05424380|467718182|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
129932353|NCT05424380|467718183|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932354|NCT05424380|467718184|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932355|NCT05424380|467718185|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932356|NCT05424380|467718186|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932357|NCT05424380|467718181|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932358|NCT05424380|467718182|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932359|NCT05424380|467718183|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
129932360|NCT05424380|467718184|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932361|NCT05424380|467718185|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932362|NCT05424380|467718186|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932363|NCT05424380|467718181|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932364|NCT05424380|467718182|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932365|NCT05424380|467718183|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
129932366|NCT05424380|467718184|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932367|NCT05424380|467718185|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932368|NCT05424380|467718186|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932369|NCT05424380|467718181|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932370|NCT05424380|467718182|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932371|NCT05424380|467718183|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
129932372|NCT05424380|467718184|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932373|NCT05424380|467718185|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932374|NCT05424380|467718186|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932375|NCT05424380|467718181|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932376|NCT05424380|467718182|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932377|NCT05424380|467718183|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932378|NCT05424380|467718184|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
129932379|NCT05424380|467718185|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932380|NCT05424380|467718186|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932381|NCT05424380|467718181|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932382|NCT05424380|467718182|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932383|NCT05424380|467718183|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932384|NCT05424380|467718184|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
129932385|NCT05424380|467718185|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932386|NCT05424380|467718186|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932387|NCT05424380|467718181|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932388|NCT05424380|467718182|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932389|NCT05424380|467718183|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932390|NCT05424380|467718184|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
129932391|NCT05424380|467718185|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932392|NCT05424380|467718186|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932393|NCT05424380|467718181|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932394|NCT05424380|467718182|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
130069719|NCT02671461|468209575|FG002|Treatment|Randomized, not treated|0|||
130118416|NCT01915732|468394202|FG001|Overall Study|Protocol Violation|5|||
130118417|NCT01915732|468394201|FG000|Overall Study|Lack of Efficacy|6|||
130118418|NCT01915732|468394202|FG001|Overall Study|Lack of Efficacy|11|||
130118419|NCT01915732|468394201|FG000|Overall Study|Lost to Follow-up|22|||
130118420|NCT01915732|468394202|FG001|Overall Study|Lost to Follow-up|26|||
130118421|NCT01915732|468394201|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
130118422|NCT01915732|468394202|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
130118423|NCT01915732|468394201|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
130118424|NCT01915732|468394202|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
130118425|NCT01915732|468394201|FG000|Overall Study|Drug Release Error|1|||
130118426|NCT01915732|468394202|FG001|Overall Study|Drug Release Error|0|||
130118427|NCT01915732|468394201|FG000|Overall Study|Recovered|1|||
130118428|NCT01915732|468394202|FG001|Overall Study|Recovered|0|||
130118429|NCT01915732|468394201|FG000|Overall Study|Pregnancy|1|||
130118430|NCT01915732|468394202|FG001|Overall Study|Pregnancy|0|||
130118431|NCT01915732|468394201|FG000|Overall Study|Poor Perceived Efficacy|1|||
130118432|NCT01915732|468394202|FG001|Overall Study|Poor Perceived Efficacy|0|||
130118433|NCT01915732|468394201|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
130118434|NCT01915732|468394202|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
130118435|NCT01915732|468394201|FG000|Overall Study|Got Well|0|||
130118436|NCT01915732|468394202|FG001|Overall Study|Got Well|1|||
130118437|NCT01915732|468394201|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
130118438|NCT01915732|468394202|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
130118439|NCT01915732|468394201|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
130118440|NCT01915732|468394202|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
130118441|NCT01915732|468394201|FG000|Overall Study|Job Transfer|0|||
130118442|NCT01915732|468394202|FG001|Overall Study|Job Transfer|1|||
130118443|NCT01915732|468394201|FG000|Overall Study|Improper Facial Procedure|0|||
130118444|NCT01915732|468394202|FG001|Overall Study|Improper Facial Procedure|1|||
130118445|NCT01915732|468394201|FG000|Overall Study|Poor Conscious Effect|0|||
130118446|NCT01915732|468394202|FG001|Overall Study|Poor Conscious Effect|1|||
130118447|NCT02015793|468394206|FG000|Overall Study|Adverse Event|3|||
130118448|NCT02015793|468394207|FG001|Overall Study|Adverse Event|3|||
130118449|NCT02015793|468394206|FG000|Overall Study|Withdrawal by Subject|1|||
130118450|NCT02015793|468394207|FG001|Overall Study|Withdrawal by Subject|1|||
130118451|NCT00437281|468394208|FG000|Overall Study|Adverse Event|0|||
130118452|NCT00437281|468394209|FG001|Overall Study|Adverse Event|0|||
130118453|NCT00437281|468394210|FG002|Overall Study|Adverse Event|0|||
130118454|NCT00437281|468394211|FG003|Overall Study|Adverse Event|1|||
130118455|NCT00437281|468394212|FG004|Overall Study|Adverse Event|0|||
130118456|NCT00437281|468394213|FG005|Overall Study|Adverse Event|1|||
130118457|NCT00437281|468394214|FG006|Overall Study|Adverse Event|0|||
130118458|NCT00437281|468394215|FG007|Overall Study|Adverse Event|0|||
130118459|NCT00437281|468394216|FG008|Overall Study|Adverse Event|0|||
130118460|NCT00437281|468394217|FG009|Overall Study|Adverse Event|1|||
130118461|NCT00437281|468394218|FG010|Overall Study|Adverse Event|0|||
130118462|NCT00437281|468394219|FG011|Overall Study|Adverse Event|0|||
130118463|NCT00437281|468394220|FG012|Overall Study|Adverse Event|0|||
130118464|NCT00437281|468394221|FG013|Overall Study|Adverse Event|1|||
130118465|NCT00437281|468394222|FG014|Overall Study|Adverse Event|1|||
130118466|NCT00437281|468394223|FG015|Overall Study|Adverse Event|0|||
130118467|NCT00437281|468394224|FG016|Overall Study|Adverse Event|0|||
130118468|NCT00437281|468394225|FG017|Overall Study|Adverse Event|0|||
130118469|NCT00437281|468394226|FG018|Overall Study|Adverse Event|1|||
130118470|NCT00437281|468394227|FG019|Overall Study|Adverse Event|0|||
130118471|NCT00437281|468394208|FG000|Overall Study|Lost to Follow-up|0|||
130118472|NCT00437281|468394209|FG001|Overall Study|Lost to Follow-up|0|||
130118473|NCT00437281|468394210|FG002|Overall Study|Lost to Follow-up|0|||
130118474|NCT00437281|468394211|FG003|Overall Study|Lost to Follow-up|0|||
130118475|NCT00437281|468394212|FG004|Overall Study|Lost to Follow-up|0|||
130118476|NCT00437281|468394213|FG005|Overall Study|Lost to Follow-up|0|||
130118477|NCT00437281|468394214|FG006|Overall Study|Lost to Follow-up|0|||
130118478|NCT00437281|468394215|FG007|Overall Study|Lost to Follow-up|0|||
130118479|NCT00437281|468394216|FG008|Overall Study|Lost to Follow-up|0|||
130118480|NCT00437281|468394217|FG009|Overall Study|Lost to Follow-up|0|||
130118481|NCT00437281|468394218|FG010|Overall Study|Lost to Follow-up|0|||
130118482|NCT00437281|468394219|FG011|Overall Study|Lost to Follow-up|0|||
130118483|NCT00437281|468394220|FG012|Overall Study|Lost to Follow-up|0|||
130118484|NCT00437281|468394221|FG013|Overall Study|Lost to Follow-up|0|||
130118485|NCT00437281|468394222|FG014|Overall Study|Lost to Follow-up|0|||
130118486|NCT00437281|468394223|FG015|Overall Study|Lost to Follow-up|0|||
130118487|NCT00437281|468394224|FG016|Overall Study|Lost to Follow-up|0|||
130118488|NCT00437281|468394225|FG017|Overall Study|Lost to Follow-up|0|||
130118489|NCT00437281|468394226|FG018|Overall Study|Lost to Follow-up|0|||
130118490|NCT00437281|468394227|FG019|Overall Study|Lost to Follow-up|1|||
130118491|NCT00947427|468394228|FG000|Overall Study|Withdrawal by Subject|1|||
130118492|NCT00947427|468394229|FG001|Overall Study|Withdrawal by Subject|3|||
130118493|NCT00947427|468394228|FG000|Overall Study|Protocol Violation|0|||
130118494|NCT00947427|468394229|FG001|Overall Study|Protocol Violation|1|||
130118495|NCT00601354|468394230|FG000|Overall Study|Lost to Follow-up|4|||
130118496|NCT00601354|468394231|FG001|Overall Study|Lost to Follow-up|5|||
130118497|NCT01862328|468394234|FG000|Overall Study|Progressive Disease|3|||
130118498|NCT01862328|468394235|FG001|Overall Study|Progressive Disease|11|||
130118499|NCT01862328|468394236|FG002|Overall Study|Progressive Disease|5|||
130118500|NCT01862328|468394237|FG003|Overall Study|Progressive Disease|6|||
130118501|NCT01862328|468394238|FG004|Overall Study|Progressive Disease|7|||
130118502|NCT01862328|468394239|FG005|Overall Study|Progressive Disease|4|||
130118503|NCT01862328|468394240|FG006|Overall Study|Progressive Disease|3|||
130118504|NCT01862328|468394234|FG000|Overall Study|Adverse Event|0|||
130118505|NCT01862328|468394235|FG001|Overall Study|Adverse Event|4|||
130118506|NCT01862328|468394236|FG002|Overall Study|Adverse Event|0|||
130118507|NCT01862328|468394237|FG003|Overall Study|Adverse Event|1|||
130118508|NCT01862328|468394238|FG004|Overall Study|Adverse Event|0|||
130118509|NCT01862328|468394239|FG005|Overall Study|Adverse Event|2|||
130118510|NCT01862328|468394240|FG006|Overall Study|Adverse Event|4|||
130118511|NCT01862328|468394234|FG000|Overall Study|Other|0|||
130118512|NCT01862328|468394235|FG001|Overall Study|Other|2|||
130118513|NCT01862328|468394236|FG002|Overall Study|Other|1|||
130118514|NCT01862328|468394237|FG003|Overall Study|Other|0|||
130118515|NCT01862328|468394238|FG004|Overall Study|Other|4|||
130118516|NCT01862328|468394239|FG005|Overall Study|Other|0|||
130118517|NCT01862328|468394240|FG006|Overall Study|Other|1|||
130118518|NCT01862328|468394234|FG000|Overall Study|Withdrawal by Subject|1|||
130118519|NCT01862328|468394235|FG001|Overall Study|Withdrawal by Subject|1|||
130118520|NCT01862328|468394236|FG002|Overall Study|Withdrawal by Subject|0|||
130118521|NCT01862328|468394237|FG003|Overall Study|Withdrawal by Subject|0|||
130118522|NCT01862328|468394238|FG004|Overall Study|Withdrawal by Subject|1|||
130118523|NCT01862328|468394239|FG005|Overall Study|Withdrawal by Subject|1|||
130069720|NCT02671461|468209573|FG000|Follow-up|Withdrawal by Subject|1|||
130069721|NCT02671461|468209574|FG001|Follow-up|Withdrawal by Subject|0|||
130069722|NCT02671461|468209575|FG002|Follow-up|Withdrawal by Subject|0|||
130069723|NCT02671461|468209573|FG000|Follow-up|Lost to Follow-up|0|||
130069724|NCT02671461|468209574|FG001|Follow-up|Lost to Follow-up|0|||
130069725|NCT02671461|468209575|FG002|Follow-up|Lost to Follow-up|1|||
130069726|NCT02671461|468209573|FG000|Follow-up|Administrative Reason by Sponsor|0|||
130069727|NCT02671461|468209574|FG001|Follow-up|Administrative Reason by Sponsor|1|||
130069728|NCT02671461|468209575|FG002|Follow-up|Administrative Reason by Sponsor|0|||
130069729|NCT01412060|468209576|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
130069730|NCT01412060|468209577|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
130069731|NCT01412060|468209578|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
130069732|NCT01412060|468209576|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
130069733|NCT01412060|468209577|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
130069734|NCT01412060|468209578|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
130069735|NCT01412060|468209576|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
130069736|NCT01412060|468209577|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
130069737|NCT01412060|468209578|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
130069738|NCT01412060|468209576|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
130069739|NCT01412060|468209577|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
130069740|NCT01412060|468209578|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
130069741|NCT01412060|468209576|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
130069742|NCT01412060|468209577|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
130069743|NCT01412060|468209578|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
130069744|NCT01412060|468209576|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
130069745|NCT01412060|468209577|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
130069746|NCT01412060|468209578|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
130069747|NCT01412060|468209576|FG000|Period Between RIP and SP|Adverse Event|4|||
130069748|NCT01412060|468209577|FG001|Period Between RIP and SP|Adverse Event|0|||
130069749|NCT01412060|468209578|FG002|Period Between RIP and SP|Adverse Event|0|||
130069750|NCT01412060|468209576|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
130069751|NCT01412060|468209577|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
130069752|NCT01412060|468209578|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
130069753|NCT01412060|468209576|FG000|Period Between RIP and SP|Protocol Violation|2|||
130069754|NCT01412060|468209577|FG001|Period Between RIP and SP|Protocol Violation|0|||
130069755|NCT01412060|468209578|FG002|Period Between RIP and SP|Protocol Violation|0|||
130069756|NCT01412060|468209576|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
130118524|NCT01862328|468394240|FG006|Overall Study|Withdrawal by Subject|1|||
130118525|NCT01862328|468394234|FG000|Overall Study|Symptomatic Deterioration|0|||
130118526|NCT01862328|468394235|FG001|Overall Study|Symptomatic Deterioration|0|||
130118527|NCT01862328|468394236|FG002|Overall Study|Symptomatic Deterioration|0|||
130069757|NCT01412060|468209577|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
130069758|NCT01412060|468209578|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
130118528|NCT01862328|468394237|FG003|Overall Study|Symptomatic Deterioration|0|||
130118529|NCT01862328|468394238|FG004|Overall Study|Symptomatic Deterioration|0|||
130118530|NCT01862328|468394239|FG005|Overall Study|Symptomatic Deterioration|0|||
130118531|NCT01862328|468394240|FG006|Overall Study|Symptomatic Deterioration|1|||
130118532|NCT00936975|468394241|FG000|Overall Study|Withdrawal by Subject|1|||
130118533|NCT00936975|468394241|FG000|Overall Study|Disease progression|3|||
130118534|NCT00936975|468394241|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
130118535|NCT04104646|468394243|FG000|Overall Study|Withdrawal by Subject|1|||
130118536|NCT04104646|468394244|FG001|Overall Study|Withdrawal by Subject|1|||
130118537|NCT04104646|468394243|FG000|Overall Study|Lost to Follow-up|1|||
130118538|NCT04104646|468394244|FG001|Overall Study|Lost to Follow-up|0|||
130118539|NCT04104646|468394243|FG000|Overall Study|Physician Decision|2|||
130118540|NCT04104646|468394244|FG001|Overall Study|Physician Decision|0|||
130118541|NCT01656889|468394245|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
130118542|NCT01656889|468394246|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
130118543|NCT01656889|468394245|FG000|Treatment Period, 12 Weeks|Death|0|||
130118544|NCT01656889|468394246|FG001|Treatment Period, 12 Weeks|Death|1|||
130118545|NCT01656889|468394245|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
130118546|NCT01656889|468394246|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
130118547|NCT01656889|468394245|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
130118548|NCT01656889|468394246|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
130118549|NCT01656889|468394245|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
130118550|NCT01656889|468394246|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
130118551|NCT01656889|468394245|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
130118552|NCT01656889|468394246|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
130118553|NCT01656889|468394245|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
130118554|NCT01656889|468394246|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
130118555|NCT01656889|468394245|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
130118556|NCT01656889|468394246|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
130118557|NCT01656889|468394245|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
130118558|NCT01656889|468394246|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
130118559|NCT01656889|468394245|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
130118560|NCT01656889|468394246|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
130118561|NCT02521948|468394247|FG000|Overall Study|Adverse Event|2|||
130118562|NCT02521948|468394247|FG000|Overall Study|Death|4|||
130118563|NCT02521948|468394247|FG000|Overall Study|Lost to Follow-up|1|||
130118564|NCT02521948|468394247|FG000|Overall Study|Did not attend one or both follow-ups|6|||
130118565|NCT02427607|468394248|FG000|Overall Study|Withdrawal by Subject|1|||
130118566|NCT00423800|468394249|FG000|Overall Study|Protocol Violation|0|||
130118567|NCT00423800|468394250|FG001|Overall Study|Protocol Violation|1|||
130118568|NCT04000009|468394251|FG000|Overall Study|Adverse Event|13|||
130118569|NCT04000009|468394251|FG000|Overall Study|Lack of Efficacy|7|||
130118570|NCT04000009|468394251|FG000|Overall Study|Lost to Follow-up|8|||
129932395|NCT05424380|467718183|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932396|NCT05424380|467718184|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932397|NCT05424380|467718185|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
130118571|NCT04000009|468394251|FG000|Overall Study|Noncompliance with study drug|4|||
130118572|NCT04000009|468394251|FG000|Overall Study|Physician Decision|1|||
130118573|NCT04000009|468394251|FG000|Overall Study|Use of prohibited medication|3|||
130118574|NCT04000009|468394251|FG000|Overall Study|Pregnancy|1|||
130118575|NCT04000009|468394251|FG000|Overall Study|Withdrawal by Subject|22|||
130118576|NCT04000009|468394251|FG000|Overall Study|Study terminated by sponsor|98|||
130118577|NCT04000009|468394251|FG000|Overall Study|Not further specified|8|||
130118578|NCT00679783|468394253|FG000|Overall Study|Adverse Event|0|||
130118579|NCT00679783|468394254|FG001|Overall Study|Adverse Event|0|||
130118580|NCT00679783|468394255|FG002|Overall Study|Adverse Event|0|||
130118581|NCT00679783|468394256|FG003|Overall Study|Adverse Event|3|||
130118582|NCT00679783|468394257|FG004|Overall Study|Adverse Event|0|||
130118583|NCT00679783|468394258|FG005|Overall Study|Adverse Event|0|||
130118584|NCT00679783|468394259|FG006|Overall Study|Adverse Event|1|||
130118585|NCT00679783|468394253|FG000|Overall Study|Lack of Efficacy|0|||
130118586|NCT00679783|468394254|FG001|Overall Study|Lack of Efficacy|1|||
130118587|NCT00679783|468394255|FG002|Overall Study|Lack of Efficacy|0|||
130118588|NCT00679783|468394256|FG003|Overall Study|Lack of Efficacy|2|||
130118589|NCT00679783|468394257|FG004|Overall Study|Lack of Efficacy|0|||
130118590|NCT00679783|468394258|FG005|Overall Study|Lack of Efficacy|0|||
130118591|NCT00679783|468394259|FG006|Overall Study|Lack of Efficacy|0|||
130118592|NCT00679783|468394253|FG000|Overall Study|Withdrawal by Subject|0|||
129932398|NCT05424380|467718186|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932399|NCT05424380|467718181|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932400|NCT05424380|467718182|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932401|NCT05424380|467718183|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
130118593|NCT00679783|468394254|FG001|Overall Study|Withdrawal by Subject|0|||
130118594|NCT00679783|468394255|FG002|Overall Study|Withdrawal by Subject|1|||
130118595|NCT00679783|468394256|FG003|Overall Study|Withdrawal by Subject|1|||
130118596|NCT00679783|468394257|FG004|Overall Study|Withdrawal by Subject|0|||
130118597|NCT00679783|468394258|FG005|Overall Study|Withdrawal by Subject|0|||
130118598|NCT00679783|468394259|FG006|Overall Study|Withdrawal by Subject|0|||
130118599|NCT00679783|468394253|FG000|Overall Study|Not Captured|0|||
130118600|NCT00679783|468394254|FG001|Overall Study|Not Captured|0|||
130118601|NCT00679783|468394255|FG002|Overall Study|Not Captured|0|||
130118602|NCT00679783|468394256|FG003|Overall Study|Not Captured|5|||
130118603|NCT00679783|468394257|FG004|Overall Study|Not Captured|0|||
130118604|NCT00679783|468394258|FG005|Overall Study|Not Captured|0|||
129932402|NCT05424380|467718184|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932403|NCT05424380|467718185|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
129932404|NCT05424380|467718186|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932405|NCT05424380|467718181|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932406|NCT05424380|467718182|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932407|NCT05424380|467718183|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932408|NCT05424380|467718184|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932409|NCT05424380|467718185|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
129932410|NCT05424380|467718186|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932411|NCT02909686|467718187|FG000|Overall Study|Physician Decision|3|||
129932412|NCT02909686|467718187|FG000|Overall Study|Withdrawal by Subject|2|||
129932413|NCT06037668|467718190|FG000|Overall Study|Lost to Follow-up|1|||
129932414|NCT06037668|467718191|FG001|Overall Study|Lost to Follow-up|1|||
129932415|NCT06037668|467718190|FG000|Overall Study|Protocol Violation|1|||
129932416|NCT06037668|467718191|FG001|Overall Study|Protocol Violation|0|||
129932417|NCT06037668|467718190|FG000|Overall Study|Withdrawal by Subject|1|||
129932418|NCT06037668|467718191|FG001|Overall Study|Withdrawal by Subject|0|||
129932419|NCT06037668|467718190|FG000|Overall Study|Other Study Discontinuation Reason|1|||
129932420|NCT06037668|467718191|FG001|Overall Study|Other Study Discontinuation Reason|0|||
129932421|NCT04804540|467718192|FG000|Overall Study|Adverse Event|26|||
129932422|NCT04804540|467718193|FG001|Overall Study|Adverse Event|13|||
129932423|NCT02473445|467718194|FG000|Overall Study|Withdrawal by Subject|2|||
129932424|NCT02473445|467718194|FG000|Overall Study|Sponsor Decision|20|||
129932425|NCT03015532|467718195|FG000|Overall Study|Adverse Event|0|||
129932426|NCT03015532|467718196|FG001|Overall Study|Adverse Event|0|||
129932427|NCT03015532|467718197|FG002|Overall Study|Adverse Event|0|||
129932428|NCT03015532|467718198|FG003|Overall Study|Adverse Event|0|||
129932429|NCT03015532|467718199|FG004|Overall Study|Adverse Event|0|||
129932430|NCT03015532|467718200|FG005|Overall Study|Adverse Event|2|||
129932431|NCT03015532|467718201|FG006|Overall Study|Adverse Event|1|||
129932432|NCT03015532|467718202|FG007|Overall Study|Adverse Event|0|||
129932433|NCT03015532|467718195|FG000|Overall Study|Withdrawal by Subject|0|||
129932434|NCT03015532|467718196|FG001|Overall Study|Withdrawal by Subject|0|||
129932435|NCT03015532|467718197|FG002|Overall Study|Withdrawal by Subject|0|||
129932436|NCT03015532|467718198|FG003|Overall Study|Withdrawal by Subject|0|||
129932437|NCT03015532|467718199|FG004|Overall Study|Withdrawal by Subject|0|||
129932438|NCT03015532|467718200|FG005|Overall Study|Withdrawal by Subject|0|||
129932439|NCT03015532|467718201|FG006|Overall Study|Withdrawal by Subject|1|||
129932440|NCT03015532|467718202|FG007|Overall Study|Withdrawal by Subject|0|||
130118605|NCT00679783|468394259|FG006|Overall Study|Not Captured|0|||
130118606|NCT00679783|468394253|FG000|Overall Study|Ongoing at data cut-off|2|||
129932441|NCT05970861|467718203|FG000|Overall Study|Physician Decision|4|||
129932442|NCT05970861|467718204|FG001|Overall Study|Physician Decision|4|||
129932443|NCT05970861|467718203|FG000|Overall Study|Lost to Follow-up|4|||
129932444|NCT05970861|467718204|FG001|Overall Study|Lost to Follow-up|3|||
129932445|NCT04629339|467718205|FG000|Overall Study|Death|1|||
129932446|NCT04629339|467718206|FG001|Overall Study|Death|0|||
129932447|NCT04629339|467718207|FG002|Overall Study|Death|2|||
129932448|NCT04629339|467718208|FG003|Overall Study|Death|2|||
129932449|NCT04629339|467718209|FG004|Overall Study|Death|0|||
129932450|NCT04629339|467718205|FG000|Overall Study|Disease Progression|0|||
129932451|NCT04629339|467718206|FG001|Overall Study|Disease Progression|0|||
130118607|NCT00679783|468394254|FG001|Overall Study|Ongoing at data cut-off|2|||
130118608|NCT00679783|468394255|FG002|Overall Study|Ongoing at data cut-off|0|||
130118609|NCT00679783|468394256|FG003|Overall Study|Ongoing at data cut-off|9|||
129932452|NCT04629339|467718207|FG002|Overall Study|Disease Progression|1|||
129932453|NCT04629339|467718208|FG003|Overall Study|Disease Progression|1|||
129932454|NCT04629339|467718209|FG004|Overall Study|Disease Progression|0|||
129932455|NCT04629339|467718205|FG000|Overall Study|Lost to Follow-up|0|||
129932456|NCT04629339|467718206|FG001|Overall Study|Lost to Follow-up|0|||
129932457|NCT04629339|467718207|FG002|Overall Study|Lost to Follow-up|0|||
129932458|NCT04629339|467718208|FG003|Overall Study|Lost to Follow-up|1|||
129932459|NCT04629339|467718209|FG004|Overall Study|Lost to Follow-up|0|||
129932460|NCT04629339|467718205|FG000|Overall Study|Physician Decision|0|||
129932461|NCT04629339|467718206|FG001|Overall Study|Physician Decision|1|||
129932462|NCT04629339|467718207|FG002|Overall Study|Physician Decision|0|||
129932463|NCT04629339|467718208|FG003|Overall Study|Physician Decision|0|||
129932464|NCT04629339|467718209|FG004|Overall Study|Physician Decision|0|||
130118610|NCT00679783|468394257|FG004|Overall Study|Ongoing at data cut-off|1|||
130118611|NCT00679783|468394258|FG005|Overall Study|Ongoing at data cut-off|0|||
130118612|NCT00679783|468394259|FG006|Overall Study|Ongoing at data cut-off|0|||
129932465|NCT04629339|467718205|FG000|Overall Study|Study Terminated by Sponsor|0|||
129932466|NCT04629339|467718206|FG001|Overall Study|Study Terminated by Sponsor|0|||
129932467|NCT04629339|467718207|FG002|Overall Study|Study Terminated by Sponsor|0|||
129932468|NCT04629339|467718208|FG003|Overall Study|Study Terminated by Sponsor|1|||
129932469|NCT04629339|467718209|FG004|Overall Study|Study Terminated by Sponsor|0|||
129932470|NCT04629339|467718205|FG000|Overall Study|Withdrawal by Subject|0|||
129932471|NCT04629339|467718206|FG001|Overall Study|Withdrawal by Subject|0|||
129932472|NCT04629339|467718207|FG002|Overall Study|Withdrawal by Subject|2|||
129932473|NCT04629339|467718208|FG003|Overall Study|Withdrawal by Subject|2|||
129932474|NCT04629339|467718209|FG004|Overall Study|Withdrawal by Subject|0|||
129932475|NCT03914469|467718210|FG000|Overall Study|Lost to Follow-up|1|||
129932476|NCT03914469|467718211|FG001|Overall Study|Lost to Follow-up|4|||
129932477|NCT04778410|467718212|FG000|Safety Run-in Period|Death|5|||
129932478|NCT04778410|467718213|FG001|Safety Run-in Period|Death|6|||
129932479|NCT04778410|467718214|FG002|Safety Run-in Period|Death|0|||
129932480|NCT04778410|467718215|FG003|Safety Run-in Period|Death|0|||
129932481|NCT04778410|467718216|FG004|Safety Run-in Period|Death|0|||
129932482|NCT04778410|467718217|FG005|Safety Run-in Period|Death|0|||
129932483|NCT04778410|467718212|FG000|Phase 2 Period|Death|0|||
129932484|NCT04778410|467718213|FG001|Phase 2 Period|Death|0|||
129932485|NCT04778410|467718214|FG002|Phase 2 Period|Death|0|||
129932486|NCT04778410|467718215|FG003|Phase 2 Period|Death|5|||
129932487|NCT04778410|467718216|FG004|Phase 2 Period|Death|18|||
129932488|NCT04778410|467718217|FG005|Phase 2 Period|Death|0|||
129932489|NCT04778410|467718212|FG000|Phase 2 Period|Lost to Follow-up|0|||
129932490|NCT04778410|467718213|FG001|Phase 2 Period|Lost to Follow-up|0|||
129932491|NCT04778410|467718214|FG002|Phase 2 Period|Lost to Follow-up|0|||
129932492|NCT04778410|467718215|FG003|Phase 2 Period|Lost to Follow-up|1|||
129932493|NCT04778410|467718216|FG004|Phase 2 Period|Lost to Follow-up|1|||
129932494|NCT04778410|467718217|FG005|Phase 2 Period|Lost to Follow-up|0|||
129932495|NCT04778410|467718212|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
129932496|NCT04778410|467718213|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
129932497|NCT04778410|467718214|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
129932498|NCT04778410|467718215|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
129932499|NCT04778410|467718216|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
129932500|NCT04778410|467718217|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
129932501|NCT04778410|467718212|FG000|Phase 2 Period|Withdrew Consent|0|||
129932502|NCT04778410|467718213|FG001|Phase 2 Period|Withdrew Consent|0|||
129932503|NCT04778410|467718214|FG002|Phase 2 Period|Withdrew Consent|0|||
129932504|NCT04778410|467718215|FG003|Phase 2 Period|Withdrew Consent|0|||
129932505|NCT04778410|467718216|FG004|Phase 2 Period|Withdrew Consent|2|||
129932506|NCT04778410|467718217|FG005|Phase 2 Period|Withdrew Consent|0|||
129932507|NCT03252288|467718222|FG000|Overall Study|Death|1|||
129932508|NCT03252288|467718223|FG001|Overall Study|Death|0|||
129932509|NCT03252288|467718224|FG002|Overall Study|Death|0|||
129932510|NCT03252288|467718222|FG000|Overall Study|Death|11|||
129932511|NCT03252288|467718223|FG001|Overall Study|Death|0|||
129932512|NCT03252288|467718224|FG002|Overall Study|Death|0|||
129932513|NCT03252288|467718222|FG000|Overall Study|Withdrawal by Subject|2|||
129932514|NCT03252288|467718223|FG001|Overall Study|Withdrawal by Subject|0|||
129932515|NCT03252288|467718224|FG002|Overall Study|Withdrawal by Subject|0|||
129932516|NCT03252288|467718222|FG000|Overall Study|Lost to Follow-up|79|||
129932517|NCT03252288|467718223|FG001|Overall Study|Lost to Follow-up|0|||
129932518|NCT03252288|467718224|FG002|Overall Study|Lost to Follow-up|0|||
129932519|NCT03252288|467718222|FG000|Overall Study|Loss of baseline data on tablets|6|||
129932520|NCT03252288|467718223|FG001|Overall Study|Loss of baseline data on tablets|0|||
129932521|NCT03252288|467718224|FG002|Overall Study|Loss of baseline data on tablets|0|||
129932522|NCT02542631|467718226|FG000|Overall Study|Adverse Event|1|||
129932523|NCT02542631|467718227|FG001|Overall Study|Adverse Event|1|||
129932524|NCT02542631|467718226|FG000|Overall Study|Sponsor Termination|1|||
129932525|NCT02542631|467718227|FG001|Overall Study|Sponsor Termination|0|||
129932526|NCT02542631|467718226|FG000|Overall Study|Withdrawal by Subject|11|||
129932527|NCT02542631|467718227|FG001|Overall Study|Withdrawal by Subject|16|||
129932528|NCT02542631|467718226|FG000|Overall Study|Protocol Violation|1|||
129932529|NCT02542631|467718227|FG001|Overall Study|Protocol Violation|1|||
129932530|NCT02542631|467718226|FG000|Overall Study|Physician Decision|6|||
129932531|NCT02542631|467718227|FG001|Overall Study|Physician Decision|4|||
129932532|NCT02542631|467718226|FG000|Overall Study|Lost to Follow-up|6|||
129932533|NCT02542631|467718227|FG001|Overall Study|Lost to Follow-up|5|||
129932534|NCT02542631|467718226|FG000|Overall Study|Death|1|||
129932535|NCT02542631|467718227|FG001|Overall Study|Death|2|||
129932536|NCT02542631|467718226|FG000|Overall Study|Other|2|||
129932537|NCT02542631|467718227|FG001|Overall Study|Other|1|||
129932538|NCT02542631|467718226|FG000|Overall Study|Used Prohibited Medication|2|||
129932539|NCT02542631|467718227|FG001|Overall Study|Used Prohibited Medication|1|||
129932540|NCT02938923|467718228|FG000|Overall Study|Death|1|||
129932541|NCT02938923|467718229|FG001|Overall Study|Death|0|||
129932542|NCT02938923|467718230|FG002|Overall Study|Death|0|||
129932543|NCT02938923|467718228|FG000|Overall Study|Physician Decision|0|||
129932544|NCT02938923|467718229|FG001|Overall Study|Physician Decision|2|||
129932545|NCT02938923|467718230|FG002|Overall Study|Physician Decision|0|||
129932546|NCT02938923|467718228|FG000|Overall Study|Withdrawal by Subject|0|||
129932547|NCT02938923|467718229|FG001|Overall Study|Withdrawal by Subject|1|||
129932548|NCT02938923|467718230|FG002|Overall Study|Withdrawal by Subject|1|||
129932549|NCT00721149|467718231|FG000|Overall Study|Physician Decision|1|||
129932550|NCT04583280|467718233|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
129932551|NCT04583280|467718234|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
129932552|NCT05158504|467718235|FG000|Overall Study|Lost to Follow-up|2|||
129932553|NCT05158504|467718236|FG001|Overall Study|Lost to Follow-up|3|||
129932554|NCT03606512|467718237|FG000|Overall Study|Lost to Follow-up|0|||
129932555|NCT03606512|467718238|FG001|Overall Study|Lost to Follow-up|1|||
129932556|NCT03606512|467718237|FG000|Overall Study|'moved from study area|0|||
129932557|NCT03606512|467718238|FG001|Overall Study|'moved from study area|1|||
129932558|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
129932559|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
129932560|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
129932561|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
129932562|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
129932563|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
129932564|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
129932565|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
129932566|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
129932567|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
129932568|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
129932569|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
129932570|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
129932571|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
129932572|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
129932573|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
129932574|NCT05513937|467718239|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
129932575|NCT05513937|467718240|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
129932576|NCT05513937|467718241|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
129932577|NCT05513937|467718242|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
129932578|NCT05513937|467718239|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
129932579|NCT05513937|467718240|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
129932580|NCT05513937|467718241|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
129932581|NCT05513937|467718242|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
129932582|NCT03245840|467718243|FG000|Overall Study|Adverse Event|6|||
129932583|NCT03245840|467718244|FG001|Overall Study|Adverse Event|0|||
129932584|NCT03245840|467718243|FG000|Overall Study|Death|2|||
129932585|NCT03245840|467718244|FG001|Overall Study|Death|0|||
129932586|NCT03245840|467718243|FG000|Overall Study|Withdrawal by Subject|31|||
129932587|NCT03245840|467718244|FG001|Overall Study|Withdrawal by Subject|1|||
129932588|NCT03245840|467718243|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129932589|NCT03245840|467718244|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129932590|NCT03245840|467718243|FG000|Overall Study|Physician Decision|4|||
129932591|NCT03245840|467718244|FG001|Overall Study|Physician Decision|1|||
129932592|NCT03245840|467718243|FG000|Overall Study|Study Terminated by Sponsor|56|||
129932593|NCT03245840|467718244|FG001|Overall Study|Study Terminated by Sponsor|6|||
129932594|NCT03245840|467718243|FG000|Overall Study|Site Terminated by Sponsor|4|||
129932595|NCT03245840|467718244|FG001|Overall Study|Site Terminated by Sponsor|0|||
129932596|NCT03245840|467718243|FG000|Overall Study|Lost to Follow-up|12|||
129932597|NCT03245840|467718244|FG001|Overall Study|Lost to Follow-up|2|||
129932598|NCT03245840|467718243|FG000|Overall Study|Pregnancy|2|||
129932599|NCT03245840|467718244|FG001|Overall Study|Pregnancy|0|||
129932600|NCT03245840|467718243|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129932601|NCT03245840|467718244|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129932602|NCT03245840|467718243|FG000|Overall Study|Not treated|1|||
129932603|NCT03245840|467718244|FG001|Overall Study|Not treated|1|||
129932604|NCT04109066|467718249|FG000|Pre-treatment|Participant withdrew consent|2|||
129932605|NCT04109066|467718250|FG001|Pre-treatment|Participant withdrew consent|0|||
129932606|NCT04109066|467718249|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
129932607|NCT04109066|467718250|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
129932608|NCT04109066|467718249|FG000|Treatment|Lack of Efficacy|2|||
129932609|NCT04109066|467718250|FG001|Treatment|Lack of Efficacy|4|||
129932610|NCT04109066|467718249|FG000|Treatment|Adverse Event|23|||
129932611|NCT04109066|467718250|FG001|Treatment|Adverse Event|7|||
129932612|NCT04109066|467718249|FG000|Treatment|Participant request to discontinue Study treatment|15|||
129932613|NCT04109066|467718250|FG001|Treatment|Participant request to discontinue Study treatment|14|||
129932614|NCT04109066|467718249|FG000|Treatment|Withdrawal by Subject|8|||
130118613|NCT01754259|468394260|FG000|Overall Study|Withdrawal by Subject|2|||
130118614|NCT01754259|468394261|FG001|Overall Study|Withdrawal by Subject|4|||
130118615|NCT01754259|468394260|FG000|Overall Study|Adverse Event|3|||
130118616|NCT01754259|468394261|FG001|Overall Study|Adverse Event|1|||
130118617|NCT01754259|468394260|FG000|Overall Study|Lost to Follow-up|0|||
130118618|NCT01754259|468394261|FG001|Overall Study|Lost to Follow-up|1|||
130118619|NCT00619385|468394262|FG000|Overall Study|Adverse Event|0|||
130118620|NCT00619385|468394263|FG001|Overall Study|Adverse Event|0|||
130118621|NCT00619385|468394264|FG002|Overall Study|Adverse Event|3|||
130118622|NCT00619385|468394262|FG000|Overall Study|Other|1|||
130118623|NCT00619385|468394263|FG001|Overall Study|Other|2|||
130118624|NCT00619385|468394264|FG002|Overall Study|Other|1|||
130118625|NCT00306384|468394267|FG000|Overall Study|Adverse Event|103|||
130118626|NCT00306384|468394268|FG001|Overall Study|Adverse Event|87|||
130118627|NCT00306384|468394269|FG002|Overall Study|Adverse Event|40|||
130118628|NCT00306384|468394267|FG000|Overall Study|Major protocol deviation|43|||
130118629|NCT00306384|468394268|FG001|Overall Study|Major protocol deviation|51|||
130118630|NCT00306384|468394269|FG002|Overall Study|Major protocol deviation|18|||
130118631|NCT00306384|468394267|FG000|Overall Study|Lost to Follow-up|57|||
130118632|NCT00306384|468394268|FG001|Overall Study|Lost to Follow-up|41|||
130118633|NCT00306384|468394269|FG002|Overall Study|Lost to Follow-up|35|||
130118634|NCT00306384|468394267|FG000|Overall Study|Voluntary withdrawal|199|||
130118635|NCT00306384|468394268|FG001|Overall Study|Voluntary withdrawal|187|||
130118636|NCT00306384|468394269|FG002|Overall Study|Voluntary withdrawal|91|||
130118637|NCT00306384|468394267|FG000|Overall Study|Study termination|1|||
130118638|NCT00306384|468394268|FG001|Overall Study|Study termination|0|||
130118639|NCT00306384|468394269|FG002|Overall Study|Study termination|1|||
130118640|NCT00306384|468394267|FG000|Overall Study|Pregnancy|3|||
130118641|NCT00306384|468394268|FG001|Overall Study|Pregnancy|1|||
130118642|NCT00306384|468394269|FG002|Overall Study|Pregnancy|1|||
130118643|NCT00306384|468394267|FG000|Overall Study|Lack of Efficacy|26|||
130118644|NCT00306384|468394268|FG001|Overall Study|Lack of Efficacy|40|||
130118645|NCT00306384|468394269|FG002|Overall Study|Lack of Efficacy|38|||
130118646|NCT00306384|468394267|FG000|Overall Study|Investigator discretion|28|||
130118647|NCT00306384|468394268|FG001|Overall Study|Investigator discretion|31|||
130118648|NCT00306384|468394269|FG002|Overall Study|Investigator discretion|21|||
130118649|NCT00306384|468394267|FG000|Overall Study|Other|80|||
130118650|NCT00306384|468394268|FG001|Overall Study|Other|70|||
130118651|NCT00306384|468394269|FG002|Overall Study|Other|32|||
130118652|NCT00306384|468394267|FG000|Overall Study|Site closure|2|||
130118653|NCT00306384|468394268|FG001|Overall Study|Site closure|0|||
130118654|NCT00306384|468394269|FG002|Overall Study|Site closure|0|||
130118655|NCT03850509|468394270|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
130118656|NCT03850509|468394271|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
130118657|NCT01565083|468394274|FG000|Overall Study|Withdrawal by Subject|6|||
130118658|NCT01565083|468394275|FG001|Overall Study|Withdrawal by Subject|4|||
130118659|NCT01565083|468394274|FG000|Overall Study|Lost to Follow-up|2|||
130118660|NCT01565083|468394275|FG001|Overall Study|Lost to Follow-up|7|||
130118661|NCT01565083|468394274|FG000|Overall Study|Death|22|||
130118662|NCT01565083|468394275|FG001|Overall Study|Death|23|||
130118663|NCT01565083|468394274|FG000|Overall Study|Other|3|||
130118664|NCT01565083|468394275|FG001|Overall Study|Other|5|||
130118665|NCT01379781|468395976|FG000|Overall Study|Lost to Follow-up|11|||
130118666|NCT01379781|468395977|FG001|Overall Study|Lost to Follow-up|8|||
130118667|NCT03329027|468395980|FG000|Overall Study|Lost to Follow-up|1|||
130118668|NCT03329027|468395981|FG001|Overall Study|Lost to Follow-up|0|||
130118669|NCT03329027|468395982|FG002|Overall Study|Lost to Follow-up|1|||
130118670|NCT03329027|468395980|FG000|Overall Study|Protocol Violation|9|||
130118671|NCT03329027|468395981|FG001|Overall Study|Protocol Violation|5|||
130118672|NCT03329027|468395982|FG002|Overall Study|Protocol Violation|7|||
130118673|NCT02761980|468395988|FG000|Overall Study|Adverse Event|4|||
130118674|NCT02761980|468395989|FG001|Overall Study|Adverse Event|6|||
130118675|NCT02761980|468395990|FG002|Overall Study|Adverse Event|5|||
130118676|NCT02761980|468395991|FG003|Overall Study|Adverse Event|6|||
130118677|NCT02761980|468395988|FG000|Overall Study|Withdrawal by Subject|0|||
129932615|NCT04109066|467718250|FG001|Treatment|Withdrawal by Subject|8|||
130118678|NCT02761980|468395989|FG001|Overall Study|Withdrawal by Subject|1|||
130118679|NCT02761980|468395990|FG002|Overall Study|Withdrawal by Subject|0|||
130118680|NCT02761980|468395991|FG003|Overall Study|Withdrawal by Subject|0|||
130118681|NCT02761980|468395988|FG000|Overall Study|Other|0|||
130118682|NCT02761980|468395989|FG001|Overall Study|Other|0|||
130118683|NCT02761980|468395990|FG002|Overall Study|Other|1|||
130118684|NCT02761980|468395991|FG003|Overall Study|Other|0|||
130118685|NCT01052116|468395992|FG000|Overall Study|Lost to Follow-up|11|||
130118686|NCT01052116|468395993|FG001|Overall Study|Lost to Follow-up|17|||
130118687|NCT01052116|468395992|FG000|Overall Study|Withdrawal by Subject|3|||
130118688|NCT01052116|468395993|FG001|Overall Study|Withdrawal by Subject|6|||
130118689|NCT01052116|468395992|FG000|Overall Study|Spirometry not performed|0|||
130118690|NCT01052116|468395993|FG001|Overall Study|Spirometry not performed|4|||
130118691|NCT01768858|468395994|FG000|Overall Study|Lost to Follow-up|9|||
130118692|NCT01768858|468395994|FG000|Overall Study|Lack of Efficacy|8|||
129932616|NCT04109066|467718249|FG000|Treatment|Death|3|||
129932617|NCT04109066|467718250|FG001|Treatment|Death|0|||
129932618|NCT04109066|467718249|FG000|Treatment|Participant no longer meets study criteria|2|||
129932619|NCT04109066|467718250|FG001|Treatment|Participant no longer meets study criteria|2|||
129932620|NCT04109066|467718249|FG000|Treatment|Administrative reasons by sponsor|2|||
129932621|NCT04109066|467718250|FG001|Treatment|Administrative reasons by sponsor|3|||
129932622|NCT04109066|467718249|FG000|Treatment|Other reasons|17|||
129932623|NCT04109066|467718250|FG001|Treatment|Other reasons|23|||
129932624|NCT04109066|467718249|FG000|Treatment|Disease Progression|4|||
129932625|NCT04109066|467718250|FG001|Treatment|Disease Progression|7|||
129932626|NCT04109066|467718249|FG000|Treatment|Study drug toxicity|12|||
129932627|NCT04109066|467718250|FG001|Treatment|Study drug toxicity|5|||
129932628|NCT04109066|467718249|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
129932629|NCT04109066|467718250|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
129932630|NCT04109066|467718249|FG000|Treatment|Disease Recurrence|0|||
129932631|NCT04109066|467718250|FG001|Treatment|Disease Recurrence|2|||
129932632|NCT04109066|467718249|FG000|Treatment|Not reported|4|||
129932633|NCT04109066|467718250|FG001|Treatment|Not reported|8|||
129932634|NCT01586910|467719277|FG000|Overall Study|Death|4|||
129932635|NCT01586910|467719278|FG001|Overall Study|Death|4|||
129932636|NCT01586910|467719277|FG000|Overall Study|Withdrawal by Subject|6|||
129932637|NCT01586910|467719278|FG001|Overall Study|Withdrawal by Subject|43|||
129932638|NCT01586910|467719277|FG000|Overall Study|Physician withdrew Subject|5|||
129932639|NCT01586910|467719278|FG001|Overall Study|Physician withdrew Subject|24|||
129932640|NCT01064440|467719279|FG000|Overall Study|Lost to Follow-up|1|||
129932641|NCT01064440|467719280|FG001|Overall Study|Lost to Follow-up|1|||
129932642|NCT01064440|467719281|FG002|Overall Study|Lost to Follow-up|1|||
129932643|NCT01064440|467719279|FG000|Overall Study|Non-compliance|0|||
129932644|NCT01064440|467719280|FG001|Overall Study|Non-compliance|1|||
129932645|NCT01064440|467719281|FG002|Overall Study|Non-compliance|0|||
129932646|NCT01064440|467719279|FG000|Overall Study|Death|1|||
129932647|NCT01064440|467719280|FG001|Overall Study|Death|0|||
129932648|NCT01064440|467719281|FG002|Overall Study|Death|1|||
129932649|NCT01064440|467719279|FG000|Overall Study|Withdrawal by Subject|0|||
129932650|NCT01064440|467719280|FG001|Overall Study|Withdrawal by Subject|1|||
129932651|NCT01064440|467719281|FG002|Overall Study|Withdrawal by Subject|1|||
129932652|NCT01064440|467719279|FG000|Overall Study|Other: amputation|1|||
129932653|NCT01064440|467719280|FG001|Overall Study|Other: amputation|0|||
129932654|NCT01064440|467719281|FG002|Overall Study|Other: amputation|0|||
129932655|NCT04108130|467719282|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
129932656|NCT04108130|467719283|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
129932657|NCT04108130|467719282|FG000|Overall Study|Consent Withdrawn|9|||
129932658|NCT04108130|467719283|FG001|Overall Study|Consent Withdrawn|6|||
129932659|NCT04108130|467719282|FG000|Overall Study|Surgery Cancelled|4|||
129932660|NCT04108130|467719283|FG001|Overall Study|Surgery Cancelled|4|||
129932661|NCT04108130|467719282|FG000|Overall Study|Found Ineligible for Study|4|||
129932662|NCT04108130|467719283|FG001|Overall Study|Found Ineligible for Study|3|||
129932663|NCT04108130|467719282|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
129932664|NCT04108130|467719283|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
129932665|NCT04108130|467719282|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
129932666|NCT04108130|467719283|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
129932667|NCT05507333|467719284|FG000|Overall Study|Protocol Violation|1|||
130069759|NCT01412060|468209576|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
130069760|NCT01412060|468209577|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
130069761|NCT01412060|468209578|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
130069762|NCT01412060|468209576|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
130069763|NCT01412060|468209577|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
130069764|NCT01412060|468209578|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
130069765|NCT01412060|468209576|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
130069766|NCT01412060|468209577|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
130069767|NCT01412060|468209578|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
130069768|NCT01412060|468209576|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
130069769|NCT01412060|468209577|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
130118693|NCT01768858|468395994|FG000|Overall Study|Serious Adverse Event|1|||
129932668|NCT02585323|467719285|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
129932669|NCT02585323|467719286|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
129932670|NCT02585323|467719285|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
129932671|NCT02585323|467719286|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
129932672|NCT02585323|467719285|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
129932673|NCT02585323|467719286|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
129932674|NCT02585323|467719285|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
129932675|NCT02585323|467719286|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
129932676|NCT01130883|467719287|FG000|Overall Study|Patient Noncompliance|6|||
129932677|NCT01130883|467719287|FG000|Overall Study|Reason Unknown|1|||
130069770|NCT01412060|468209578|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
130069771|NCT01412060|468209576|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
130069772|NCT01412060|468209577|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
130069773|NCT01412060|468209578|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
130069774|NCT01412060|468209576|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
130069775|NCT01412060|468209577|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
130069776|NCT01412060|468209578|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
130069777|NCT01412060|468209576|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
130069778|NCT01412060|468209577|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
130069779|NCT01412060|468209578|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
130069780|NCT01412060|468209576|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
130069781|NCT01412060|468209577|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
130069782|NCT01412060|468209578|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
130069783|NCT01412060|468209576|FG000|Period Between SP and DBP|Protocol Violation|2|||
130069784|NCT01412060|468209577|FG001|Period Between SP and DBP|Protocol Violation|0|||
130069785|NCT01412060|468209578|FG002|Period Between SP and DBP|Protocol Violation|0|||
130069786|NCT01412060|468209576|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
130069787|NCT01412060|468209577|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
130069788|NCT01412060|468209578|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
130069789|NCT01412060|468209576|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
130069790|NCT01412060|468209577|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
130069791|NCT01412060|468209578|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
130069792|NCT01412060|468209576|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
129932678|NCT01130883|467719287|FG000|Overall Study|Adverse Event|3|||
129932679|NCT03981926|467719296|FG000|Overall Study|Lost to Follow-up|5|||
129932680|NCT03981926|467719297|FG001|Overall Study|Lost to Follow-up|9|||
129932681|NCT05464069|467719298|FG000|Overall Study|Protocol Violation|3|||
129932682|NCT05464069|467719299|FG001|Overall Study|Protocol Violation|2|||
129932683|NCT05976334|467719300|FG000|Part B|Death|0|||
129932684|NCT05976334|467719301|FG001|Part B|Death|1|||
129932685|NCT05976334|467719300|FG000|Part B|Study Terminated by Sponsor|0|||
129932686|NCT05976334|467719301|FG001|Part B|Study Terminated by Sponsor|1|||
129932687|NCT05976334|467719300|FG000|Part B|Reason Not Specified|0|||
129932688|NCT05976334|467719301|FG001|Part B|Reason Not Specified|1|||
129932689|NCT02437136|467719304|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
129932690|NCT02437136|467719305|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932691|NCT02437136|467719306|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932692|NCT02437136|467719307|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932693|NCT02437136|467719308|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130069793|NCT01412060|468209577|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
130069794|NCT01412060|468209578|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
130069795|NCT01412060|468209576|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
130069796|NCT01412060|468209577|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
130069797|NCT01412060|468209578|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
130069798|NCT01412060|468209576|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
130069799|NCT01412060|468209577|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
130069800|NCT01412060|468209578|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
130069801|NCT01412060|468209576|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
130069802|NCT01412060|468209577|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
130069803|NCT01412060|468209578|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
130069804|NCT01412060|468209576|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
130069805|NCT01412060|468209577|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
130069806|NCT01412060|468209578|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
130069807|NCT01412060|468209576|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
130069808|NCT01412060|468209577|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
130069809|NCT01412060|468209578|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
130069810|NCT01412060|468209576|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
130069811|NCT01412060|468209577|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
130069812|NCT01412060|468209578|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
130069813|NCT01412060|468209576|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
130069814|NCT01412060|468209577|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
130069815|NCT01412060|468209578|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
130069816|NCT02713789|468209580|FG000|Overall Study|Lost to Follow-up|0|||
130069817|NCT02713789|468209581|FG001|Overall Study|Lost to Follow-up|1|||
130069818|NCT02713789|468209582|FG002|Overall Study|Lost to Follow-up|1|||
130069819|NCT00903370|468209583|FG000|Overall Study|Death|13|||
130069820|NCT00903370|468209584|FG001|Overall Study|Death|10|||
129932694|NCT02437136|467719309|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
130118694|NCT01768858|468395994|FG000|Overall Study|Participant moved to Germany|1|||
130118695|NCT01768858|468395994|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
130118696|NCT01768858|468395994|FG000|Overall Study|Exanthema|1|||
130118697|NCT01768858|468395994|FG000|Overall Study|Withdrawal by Subject|1|||
130118698|NCT02742090|468395995|FG000|Overall Study|Adverse Event|10|||
130118699|NCT02742090|468395995|FG000|Overall Study|Death|3|||
130118700|NCT02742090|468395995|FG000|Overall Study|Disease Progression|25|||
130118701|NCT02742090|468395995|FG000|Overall Study|Investigator's Decision|1|||
130118702|NCT02742090|468395995|FG000|Overall Study|Lost to Follow-up|1|||
130118703|NCT02742090|468395995|FG000|Overall Study|Non-compliance with Study|1|||
130118704|NCT02742090|468395995|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
130118705|NCT02742090|468395995|FG000|Overall Study|Withdrawal by Subject|4|||
130118706|NCT02742090|468395995|FG000|Overall Study|Reason Not Specified|1|||
130118707|NCT00836927|468395998|FG000|Overall Study|Progressive disease|2|||
130118708|NCT00836927|468395999|FG001|Overall Study|Progressive disease|0|||
130118709|NCT00836927|468396000|FG002|Overall Study|Progressive disease|0|||
130118710|NCT00836927|468396001|FG003|Overall Study|Progressive disease|1|||
130118711|NCT00836927|468396002|FG004|Overall Study|Progressive disease|1|||
130118712|NCT00836927|468395998|FG000|Overall Study|Withdrawal by Subject|1|||
130118713|NCT00836927|468395999|FG001|Overall Study|Withdrawal by Subject|0|||
130118714|NCT00836927|468396000|FG002|Overall Study|Withdrawal by Subject|0|||
130118715|NCT00836927|468396001|FG003|Overall Study|Withdrawal by Subject|0|||
130118716|NCT00836927|468396002|FG004|Overall Study|Withdrawal by Subject|0|||
130118717|NCT02192905|468396008|FG000|Overall Study|Lost to Follow-up|1|||
130118718|NCT04820842|468396010|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130118719|NCT04820842|468396011|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
130118720|NCT04820842|468396012|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
130118721|NCT04820842|468396013|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130118722|NCT04820842|468396014|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130118723|NCT04820842|468396015|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130118724|NCT04820842|468396016|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
130118725|NCT04820842|468396010|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
130118726|NCT04820842|468396011|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
130118727|NCT04820842|468396012|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
130118728|NCT04820842|468396013|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118729|NCT04820842|468396014|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118730|NCT04820842|468396015|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118731|NCT04820842|468396016|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118732|NCT04820842|468396010|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130118733|NCT04820842|468396011|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
130118734|NCT04820842|468396012|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130118735|NCT04820842|468396013|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130118736|NCT04820842|468396014|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130118737|NCT04820842|468396015|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130118738|NCT04820842|468396016|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
130118739|NCT04820842|468396010|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118740|NCT04820842|468396011|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118741|NCT04820842|468396012|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118742|NCT04820842|468396013|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
130118743|NCT04820842|468396014|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118744|NCT04820842|468396015|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
130118745|NCT04820842|468396016|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
130118746|NCT02688400|468396021|FG000|Overall Study|Protocol Violation|2|||
130118747|NCT02688400|468396022|FG001|Overall Study|Protocol Violation|5|||
130118748|NCT02688400|468396021|FG000|Overall Study|Lack of Efficacy|7|||
130118749|NCT02688400|468396022|FG001|Overall Study|Lack of Efficacy|7|||
130118750|NCT02688400|468396021|FG000|Overall Study|Adverse Event|21|||
130118751|NCT02688400|468396022|FG001|Overall Study|Adverse Event|12|||
130118752|NCT02688400|468396021|FG000|Overall Study|Withdrawal by Subject|15|||
130118753|NCT02688400|468396022|FG001|Overall Study|Withdrawal by Subject|13|||
130118754|NCT02688400|468396021|FG000|Overall Study|No study medication intake|1|||
130118755|NCT02688400|468396022|FG001|Overall Study|No study medication intake|4|||
129932695|NCT02437136|467719310|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932696|NCT02437136|467719304|FG000|Expansion (Phase 2)|Death|0|||
129932697|NCT02437136|467719305|FG001|Expansion (Phase 2)|Death|0|||
129932698|NCT02437136|467719306|FG002|Expansion (Phase 2)|Death|0|||
129932699|NCT02437136|467719307|FG003|Expansion (Phase 2)|Death|6|||
129932700|NCT02437136|467719308|FG004|Expansion (Phase 2)|Death|37|||
129932701|NCT02437136|467719309|FG005|Expansion (Phase 2)|Death|29|||
129932702|NCT02437136|467719310|FG006|Expansion (Phase 2)|Death|24|||
129932703|NCT02437136|467719304|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
129932704|NCT02437136|467719305|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
129932705|NCT02437136|467719306|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
129932706|NCT02437136|467719307|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
129932707|NCT02437136|467719308|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
129932708|NCT02437136|467719309|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
129932709|NCT02437136|467719310|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
129932710|NCT02437136|467719304|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
129932711|NCT02437136|467719305|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
129932712|NCT02437136|467719306|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
129932713|NCT02437136|467719307|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
129932714|NCT02437136|467719308|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
129932715|NCT02437136|467719309|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
129932716|NCT02437136|467719310|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
129932717|NCT04632225|467719317|FG000|Overall Study|Withdrawal by Subject|2|||
129932718|NCT04632225|467719318|FG001|Overall Study|Withdrawal by Subject|2|||
129932719|NCT05224544|467719326|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
129932720|NCT05224544|467719327|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
129932721|NCT00844415|467719328|FG000|Overall Study|Withdrawal by Subject|1|||
129932722|NCT03988621|467719332|FG000|Overall Study|Lost to Follow-up|16|||
129932723|NCT03988621|467719333|FG001|Overall Study|Lost to Follow-up|17|||
129932724|NCT03988621|467719332|FG000|Overall Study|Withdrawal by Subject|14|||
129932725|NCT03988621|467719333|FG001|Overall Study|Withdrawal by Subject|7|||
129932726|NCT03988621|467719332|FG000|Overall Study|Patient Lost to Follow Up|15|||
129932727|NCT03988621|467719333|FG001|Overall Study|Patient Lost to Follow Up|15|||
129932728|NCT03988621|467719332|FG000|Overall Study|Patient death|1|||
129932729|NCT03988621|467719333|FG001|Overall Study|Patient death|5|||
129932730|NCT04158739|467719336|FG000|Overall Study|Adverse Event|1|||
129932731|NCT04158739|467719337|FG001|Overall Study|Adverse Event|0|||
129932732|NCT04158739|467719336|FG000|Overall Study|Death|0|||
129932733|NCT04158739|467719337|FG001|Overall Study|Death|1|||
129932734|NCT04158739|467719336|FG000|Overall Study|Lack of Efficacy|3|||
129932735|NCT04158739|467719337|FG001|Overall Study|Lack of Efficacy|7|||
129932736|NCT04158739|467719336|FG000|Overall Study|Physician Decision|0|||
129932737|NCT04158739|467719337|FG001|Overall Study|Physician Decision|1|||
129932738|NCT04158739|467719336|FG000|Overall Study|Withdrawal by Subject|3|||
129932739|NCT04158739|467719337|FG001|Overall Study|Withdrawal by Subject|0|||
129932740|NCT00677365|467719338|FG000|Overall Study|Adverse Event|2|||
129932741|NCT00677365|467719339|FG001|Overall Study|Adverse Event|1|||
129932742|NCT00677365|467719340|FG002|Overall Study|Adverse Event|1|||
129932743|NCT00677365|467719341|FG003|Overall Study|Adverse Event|2|||
129932744|NCT00677365|467719338|FG000|Overall Study|Withdrawal by Subject|0|||
129932745|NCT00677365|467719339|FG001|Overall Study|Withdrawal by Subject|0|||
129932746|NCT00677365|467719340|FG002|Overall Study|Withdrawal by Subject|1|||
129932747|NCT00677365|467719341|FG003|Overall Study|Withdrawal by Subject|0|||
129932748|NCT00677365|467719338|FG000|Overall Study|Other reason|0|||
129932749|NCT00677365|467719339|FG001|Overall Study|Other reason|0|||
129932750|NCT00677365|467719340|FG002|Overall Study|Other reason|0|||
129932751|NCT00677365|467719341|FG003|Overall Study|Other reason|1|||
129932752|NCT01121588|467719342|FG000|Overall Study|Death|5|||
129932753|NCT01121588|467719343|FG001|Overall Study|Death|3|||
129932754|NCT01121588|467719344|FG002|Overall Study|Death|13|||
129932755|NCT01121588|467719342|FG000|Overall Study|Study Terminated by Sponsor|1|||
130069821|NCT00903370|468209583|FG000|Overall Study|Withdrawal by Subject|9|||
130069822|NCT00903370|468209584|FG001|Overall Study|Withdrawal by Subject|6|||
130069823|NCT00903370|468209583|FG000|Overall Study|Lost to Follow-up|6|||
130069824|NCT00903370|468209584|FG001|Overall Study|Lost to Follow-up|8|||
129932756|NCT01121588|467719343|FG001|Overall Study|Study Terminated by Sponsor|1|||
129932757|NCT01121588|467719344|FG002|Overall Study|Study Terminated by Sponsor|0|||
129932758|NCT01121588|467719342|FG000|Overall Study|Participant Refused Further Followup|2|||
129932759|NCT01121588|467719343|FG001|Overall Study|Participant Refused Further Followup|0|||
129932760|NCT01121588|467719344|FG002|Overall Study|Participant Refused Further Followup|2|||
129932761|NCT01121588|467719342|FG000|Overall Study|Lost to Follow-up|0|||
129932762|NCT01121588|467719343|FG001|Overall Study|Lost to Follow-up|1|||
129932763|NCT01121588|467719344|FG002|Overall Study|Lost to Follow-up|1|||
129932764|NCT01121588|467719342|FG000|Overall Study|Non-Specified Reasons|9|||
129932765|NCT01121588|467719343|FG001|Overall Study|Non-Specified Reasons|4|||
129932766|NCT01121588|467719344|FG002|Overall Study|Non-Specified Reasons|2|||
130069825|NCT00367432|468209585|FG000|First Period (16 Weeks)|Adverse Event|6|||
130069826|NCT00367432|468209586|FG001|First Period (16 Weeks)|Adverse Event|0|||
129932767|NCT03663205|467719347|FG000|Overall Study|Death|144|||
129932768|NCT03663205|467719348|FG001|Overall Study|Death|69|||
129932769|NCT03663205|467719347|FG000|Overall Study|Sponsor decision|53|||
129932770|NCT03663205|467719348|FG001|Overall Study|Sponsor decision|19|||
129932771|NCT03663205|467719347|FG000|Overall Study|Withdrawal by Subject|8|||
129932772|NCT03663205|467719348|FG001|Overall Study|Withdrawal by Subject|11|||
129932773|NCT03663205|467719347|FG000|Overall Study|Lost to Follow-up|7|||
129932774|NCT03663205|467719348|FG001|Overall Study|Lost to Follow-up|9|||
129932775|NCT03663205|467719347|FG000|Overall Study|Transferred to long term extension study|11|||
129932776|NCT03663205|467719348|FG001|Overall Study|Transferred to long term extension study|3|||
129932777|NCT02577354|467719349|FG000|Overall Study|Lack of Efficacy|4|||
129932778|NCT02577354|467719350|FG001|Overall Study|Lack of Efficacy|4|||
129932779|NCT02577354|467719349|FG000|Overall Study|Lost to Follow-up|3|||
129932780|NCT02577354|467719350|FG001|Overall Study|Lost to Follow-up|1|||
129932781|NCT02577354|467719349|FG000|Overall Study|Missed Visit|4|||
129932782|NCT02577354|467719350|FG001|Overall Study|Missed Visit|3|||
129932783|NCT02577354|467719349|FG000|Overall Study|Adverse Event|4|||
129932784|NCT02577354|467719350|FG001|Overall Study|Adverse Event|5|||
129932785|NCT04206787|467719351|FG000|Overall Study|Other than listed|2|||
129932786|NCT04206787|467719351|FG000|Overall Study|Investigator decision|1|||
129932787|NCT04206787|467719351|FG000|Overall Study|Death|25|||
129932788|NCT04206787|467719351|FG000|Overall Study|Lost to Follow-up|9|||
129932789|NCT04206787|467719351|FG000|Overall Study|Withdrawal of consent|9|||
129932790|NCT03367156|467719850|FG000|Overall Study|Lack of interest|3|||
129932791|NCT03367156|467719851|FG001|Overall Study|Lack of interest|1|||
129932792|NCT03367156|467719850|FG000|Overall Study|Death|2|||
129932793|NCT03367156|467719851|FG001|Overall Study|Death|0|||
129932794|NCT03367156|467719850|FG000|Overall Study|Lost to Follow-up|2|||
129932795|NCT03367156|467719851|FG001|Overall Study|Lost to Follow-up|1|||
129932796|NCT03367156|467719850|FG000|Overall Study|Became ineligible|1|||
129932797|NCT03367156|467719851|FG001|Overall Study|Became ineligible|2|||
129932798|NCT03367156|467719850|FG000|Overall Study|Hospitalization|1|||
129932799|NCT03367156|467719851|FG001|Overall Study|Hospitalization|0|||
129932800|NCT03367156|467719850|FG000|Overall Study|Concerned about Treatment|11|||
129932801|NCT03367156|467719851|FG001|Overall Study|Concerned about Treatment|3|||
129932802|NCT03367156|467719850|FG000|Overall Study|Started new treatment|4|||
129932803|NCT03367156|467719851|FG001|Overall Study|Started new treatment|1|||
129932804|NCT05507437|467719852|FG000|Overall Study|Withdrawal by Subject|1|||
129932805|NCT05507437|467719853|FG001|Overall Study|Withdrawal by Subject|1|||
129932806|NCT05507437|467719852|FG000|Overall Study|Death|3|||
129932807|NCT05507437|467719853|FG001|Overall Study|Death|0|||
129932808|NCT03972150|467719854|FG000|Overall Study|Adverse Event|0|||
129932809|NCT03972150|467719855|FG001|Overall Study|Adverse Event|1|||
129932810|NCT03972150|467719856|FG002|Overall Study|Adverse Event|1|||
129932811|NCT03972150|467719857|FG003|Overall Study|Adverse Event|0|||
129932812|NCT03972150|467719858|FG004|Overall Study|Adverse Event|0|||
129932813|NCT03972150|467719854|FG000|Overall Study|Progressive disease|3|||
129932814|NCT03972150|467719855|FG001|Overall Study|Progressive disease|5|||
129932815|NCT03972150|467719856|FG002|Overall Study|Progressive disease|2|||
129932816|NCT03972150|467719857|FG003|Overall Study|Progressive disease|2|||
129932817|NCT03972150|467719858|FG004|Overall Study|Progressive disease|3|||
129932818|NCT04136912|467719866|FG000|Overall Study|Operational reasons|0|||
129932819|NCT04136912|467719867|FG001|Overall Study|Operational reasons|0|||
129932820|NCT04136912|467719868|FG002|Overall Study|Operational reasons|2|||
129932821|NCT04526886|467719869|FG000|Overall Study|Physician Decision|4|||
129932822|NCT04282980|467719870|FG000|Overall Study|Remained on treatment|6|||
129932823|NCT04282980|467719870|FG000|Overall Study|Survival follow-up|11|||
129932824|NCT04282980|467719870|FG000|Overall Study|Withdrawal of informed consent|1|||
129932825|NCT04282980|467719870|FG000|Overall Study|Lost to Follow-up|1|||
129932826|NCT03571386|467719871|FG000|Overall Study|scheduling conflict|4|||
129932827|NCT03571386|467719872|FG001|Overall Study|scheduling conflict|0|||
129932828|NCT03571386|467719871|FG000|Overall Study|Withdrawal by Subject|15|||
129932829|NCT03571386|467719872|FG001|Overall Study|Withdrawal by Subject|5|||
129932830|NCT04311632|467719873|FG000|Overall Study|Withdrawal by Subject|0|||
129932831|NCT04311632|467719874|FG001|Overall Study|Withdrawal by Subject|0|||
129932832|NCT04311632|467719875|FG002|Overall Study|Withdrawal by Subject|1|||
129932833|NCT04605159|467719876|FG000|Overall Study|Adverse Event|6|||
129932834|NCT04605159|467719877|FG001|Overall Study|Adverse Event|3|||
129932835|NCT04605159|467719878|FG002|Overall Study|Adverse Event|21|||
129932836|NCT04605159|467719879|FG003|Overall Study|Adverse Event|4|||
129932837|NCT04605159|467719876|FG000|Overall Study|Lost to Follow-up|74|||
129932838|NCT04605159|467719877|FG001|Overall Study|Lost to Follow-up|45|||
129932839|NCT04605159|467719878|FG002|Overall Study|Lost to Follow-up|119|||
129932840|NCT04605159|467719879|FG003|Overall Study|Lost to Follow-up|80|||
129932841|NCT04605159|467719876|FG000|Overall Study|Protocol Violation|4|||
129932842|NCT04605159|467719877|FG001|Overall Study|Protocol Violation|5|||
129932843|NCT04605159|467719878|FG002|Overall Study|Protocol Violation|2|||
129932844|NCT04605159|467719879|FG003|Overall Study|Protocol Violation|0|||
129932845|NCT04605159|467719876|FG000|Overall Study|Withdrawal by Subject|66|||
129932846|NCT04605159|467719877|FG001|Overall Study|Withdrawal by Subject|37|||
129932847|NCT04605159|467719878|FG002|Overall Study|Withdrawal by Subject|68|||
129932848|NCT04605159|467719879|FG003|Overall Study|Withdrawal by Subject|50|||
129932849|NCT04605159|467719876|FG000|Overall Study|Migrated / moved from the study area|32|||
129932850|NCT04605159|467719877|FG001|Overall Study|Migrated / moved from the study area|22|||
129932851|NCT04605159|467719878|FG002|Overall Study|Migrated / moved from the study area|41|||
129932852|NCT04605159|467719879|FG003|Overall Study|Migrated / moved from the study area|21|||
129932853|NCT04605159|467719876|FG000|Overall Study|Other|1|||
129932854|NCT04605159|467719877|FG001|Overall Study|Other|2|||
129932855|NCT04605159|467719878|FG002|Overall Study|Other|7|||
129932856|NCT04605159|467719879|FG003|Overall Study|Other|3|||
129932857|NCT04881461|467719880|FG000|Overall Study|Adverse Event|2|||
129932858|NCT04881461|467719881|FG001|Overall Study|Adverse Event|4|||
129932859|NCT04881461|467719880|FG000|Overall Study|Withdrawal by Subject|19|||
129932860|NCT04881461|467719881|FG001|Overall Study|Withdrawal by Subject|19|||
129932861|NCT04881461|467719880|FG000|Overall Study|Lost to Follow-up|4|||
129932862|NCT04881461|467719881|FG001|Overall Study|Lost to Follow-up|4|||
129932863|NCT04881461|467719880|FG000|Overall Study|Lack of Efficacy|1|||
129932864|NCT04881461|467719881|FG001|Overall Study|Lack of Efficacy|0|||
129932865|NCT04881461|467719880|FG000|Overall Study|"Reason stated as other in CRF"|1|||
129932866|NCT04881461|467719881|FG001|Overall Study|"Reason stated as other in CRF"|2|||
129932867|NCT00450216|467719882|FG000|Overall Study|Adverse Event|38|||
129932868|NCT00450216|467719883|FG001|Overall Study|Adverse Event|23|||
129932869|NCT00450216|467719882|FG000|Overall Study|Withdrawal by Subject|48|||
129932870|NCT00450216|467719883|FG001|Overall Study|Withdrawal by Subject|26|||
129932871|NCT00450216|467719882|FG000|Overall Study|Lost to Follow-up|16|||
129932872|NCT00450216|467719883|FG001|Overall Study|Lost to Follow-up|9|||
129932873|NCT00450216|467719882|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
129932874|NCT00450216|467719883|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
129932875|NCT00450216|467719882|FG000|Overall Study|misc|21|||
129932876|NCT00450216|467719883|FG001|Overall Study|misc|20|||
129932877|NCT01475786|467719884|FG000|Overall Study|Adverse Event|0|||
129932878|NCT01475786|467719885|FG001|Overall Study|Adverse Event|1|||
129932879|NCT01475786|467719886|FG002|Overall Study|Adverse Event|0|||
129932880|NCT01475786|467719884|FG000|Overall Study|Lost to Follow-up|1|||
129932881|NCT01475786|467719885|FG001|Overall Study|Lost to Follow-up|2|||
129932882|NCT01475786|467719886|FG002|Overall Study|Lost to Follow-up|1|||
129932883|NCT01475786|467719884|FG000|Overall Study|Withdrawal by Subject|0|||
129932884|NCT01475786|467719885|FG001|Overall Study|Withdrawal by Subject|1|||
129932885|NCT01475786|467719886|FG002|Overall Study|Withdrawal by Subject|1|||
129932886|NCT01475786|467719884|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
129932887|NCT01475786|467719885|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
129932888|NCT01475786|467719886|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
129932889|NCT02039401|467719887|FG000|Overall Study|Adverse Event|0|||
129932890|NCT02039401|467719888|FG001|Overall Study|Adverse Event|1|||
129932891|NCT03057054|467719889|FG000|Overall Study|Death|4|||
129932892|NCT03057054|467719890|FG001|Overall Study|Death|4|||
129932893|NCT03057054|467719889|FG000|Overall Study|Withdrawal by Subject|6|||
129932894|NCT03057054|467719890|FG001|Overall Study|Withdrawal by Subject|3|||
129932895|NCT03057054|467719889|FG000|Overall Study|Ineligible|1|||
129932896|NCT03057054|467719890|FG001|Overall Study|Ineligible|1|||
129932897|NCT03734029|467719895|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
129932898|NCT03734029|467719896|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
129932899|NCT03734029|467719895|FG000|Overall Study|Adverse Event|60|||
130118756|NCT02688400|468396021|FG000|Overall Study|Lost to Follow-up|0|||
129932900|NCT03734029|467719896|FG001|Overall Study|Adverse Event|14|||
129932901|NCT03734029|467719895|FG000|Overall Study|Withdrawal by Subject|12|||
129932902|NCT03734029|467719896|FG001|Overall Study|Withdrawal by Subject|11|||
129932903|NCT03734029|467719895|FG000|Overall Study|Clinical progression by investigator|10|||
129932904|NCT03734029|467719896|FG001|Overall Study|Clinical progression by investigator|8|||
129932905|NCT03734029|467719895|FG000|Overall Study|Death|5|||
129932906|NCT03734029|467719896|FG001|Overall Study|Death|2|||
129932907|NCT03734029|467719895|FG000|Overall Study|Physician Decision|4|||
129932908|NCT03734029|467719896|FG001|Overall Study|Physician Decision|3|||
129932909|NCT03734029|467719895|FG000|Overall Study|Other|2|||
129932910|NCT03734029|467719896|FG001|Overall Study|Other|0|||
129932911|NCT03734029|467719895|FG000|Overall Study|Lost to Follow-up|0|||
129932912|NCT03734029|467719896|FG001|Overall Study|Lost to Follow-up|1|||
129932913|NCT03734029|467719895|FG000|Overall Study|Randomized, but not treated|2|||
129932914|NCT03734029|467719896|FG001|Overall Study|Randomized, but not treated|12|||
129932915|NCT05422885|467720954|FG000|Overall Study|Lost to Follow-up|1|||
129932916|NCT05422885|467720954|FG000|Overall Study|Withdrawal by Subject|2|||
129932917|NCT04084574|467720955|FG000|Overall Study|Lost to Follow-up|1|||
129932918|NCT04084574|467720956|FG001|Overall Study|Lost to Follow-up|0|||
129932919|NCT04084574|467720955|FG000|Overall Study|Physician Decision|1|||
129932920|NCT04084574|467720956|FG001|Overall Study|Physician Decision|0|||
129932921|NCT04084574|467720955|FG000|Overall Study|Relocated out of state|1|||
129932922|NCT04084574|467720956|FG001|Overall Study|Relocated out of state|0|||
130118757|NCT02688400|468396022|FG001|Overall Study|Lost to Follow-up|3|||
130118758|NCT02006706|468396024|FG000|Overall Study|Lost to Follow-up|1|||
130118759|NCT02848599|468396025|FG000|Overall Study|Protocol Violation|7|||
130118760|NCT02848599|468396026|FG001|Overall Study|Protocol Violation|9|||
130118761|NCT00635778|468396029|FG000|Overall Study|Adverse Event|1|||
130118762|NCT00635778|468396030|FG001|Overall Study|Adverse Event|0|||
130118763|NCT00635778|468396031|FG002|Overall Study|Adverse Event|0|||
130118764|NCT00635778|468396032|FG003|Overall Study|Adverse Event|3|||
130118765|NCT00635778|468396033|FG004|Overall Study|Adverse Event|3|||
130118766|NCT00635778|468396034|FG005|Overall Study|Adverse Event|6|||
130118767|NCT00635778|468396035|FG006|Overall Study|Adverse Event|1|||
130118768|NCT00635778|468396029|FG000|Overall Study|Withdrawal by Subject|0|||
130118769|NCT00635778|468396030|FG001|Overall Study|Withdrawal by Subject|0|||
130118770|NCT00635778|468396031|FG002|Overall Study|Withdrawal by Subject|0|||
130118771|NCT00635778|468396032|FG003|Overall Study|Withdrawal by Subject|1|||
130118772|NCT00635778|468396033|FG004|Overall Study|Withdrawal by Subject|0|||
130118773|NCT00635778|468396034|FG005|Overall Study|Withdrawal by Subject|1|||
130118774|NCT00635778|468396035|FG006|Overall Study|Withdrawal by Subject|1|||
130118775|NCT00635778|468396029|FG000|Overall Study|Progressive disease|0|||
130118776|NCT00635778|468396030|FG001|Overall Study|Progressive disease|3|||
130118777|NCT00635778|468396031|FG002|Overall Study|Progressive disease|3|||
130118778|NCT00635778|468396032|FG003|Overall Study|Progressive disease|4|||
130118779|NCT00635778|468396033|FG004|Overall Study|Progressive disease|5|||
130118780|NCT00635778|468396034|FG005|Overall Study|Progressive disease|14|||
130118781|NCT00635778|468396035|FG006|Overall Study|Progressive disease|4|||
130118782|NCT00812253|468396036|FG000|Overall Study|Withdrawal by Subject|3|||
130118783|NCT00812253|468396037|FG001|Overall Study|Withdrawal by Subject|2|||
130118784|NCT00812253|468396036|FG000|Overall Study|Protocol Violation|1|||
130118785|NCT00812253|468396037|FG001|Overall Study|Protocol Violation|1|||
130118786|NCT00812253|468396036|FG000|Overall Study|Lost to Follow-up|2|||
130118787|NCT00812253|468396037|FG001|Overall Study|Lost to Follow-up|0|||
130118788|NCT01884025|468396038|FG000|Overall Study|Lost to Follow-up|3|||
130118789|NCT01884025|468396039|FG001|Overall Study|Lost to Follow-up|4|||
130118790|NCT02918162|468396040|FG000|Overall Study|Withdrawal by Subject|1|||
130118791|NCT02918162|468396040|FG000|Overall Study|Omental Disease|1|||
130118792|NCT00395226|468396041|FG000|Overall Study|Adverse Event|4|||
130118793|NCT00395226|468396042|FG001|Overall Study|Adverse Event|3|||
130118794|NCT00395226|468396041|FG000|Overall Study|Withdrawal by Subject|0|||
130118795|NCT00395226|468396042|FG001|Overall Study|Withdrawal by Subject|1|||
130118796|NCT00395226|468396041|FG000|Overall Study|Lost to Follow-up|0|||
130118797|NCT00395226|468396042|FG001|Overall Study|Lost to Follow-up|1|||
130118798|NCT01612000|468396045|FG000|Overall Study|Lost to Follow-up|6|||
130118799|NCT01612000|468396046|FG001|Overall Study|Lost to Follow-up|4|||
130118800|NCT01612000|468396047|FG002|Overall Study|Lost to Follow-up|4|||
130118801|NCT01612000|468396048|FG003|Overall Study|Lost to Follow-up|8|||
130118802|NCT01612000|468396045|FG000|Overall Study|Physician Decision|0|||
130118803|NCT01612000|468396046|FG001|Overall Study|Physician Decision|0|||
130118804|NCT01612000|468396047|FG002|Overall Study|Physician Decision|1|||
130118805|NCT01612000|468396048|FG003|Overall Study|Physician Decision|0|||
130118806|NCT01612000|468396045|FG000|Overall Study|Withdrawal by Subject|3|||
130118807|NCT01612000|468396046|FG001|Overall Study|Withdrawal by Subject|1|||
129932923|NCT02944968|467720959|FG000|Overall Study|Subject excluded before study procedure|1|||
129932924|NCT02944968|467720959|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
129932925|NCT01385202|467720960|FG000|Overall Study|Lost to Follow-up|6|||
129932926|NCT01385202|467720960|FG000|Overall Study|Not Eligible|11|||
129932927|NCT01385202|467720960|FG000|Overall Study|Withdrawn|1|||
129932928|NCT02905331|467720961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
129932929|NCT02905331|467720962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
129932930|NCT02905331|467720963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
129932931|NCT02905331|467720961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
129932932|NCT02905331|467720962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
129932933|NCT02905331|467720963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
129932934|NCT02905331|467720961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
129932935|NCT02905331|467720962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
129932936|NCT02905331|467720963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
130118808|NCT01612000|468396047|FG002|Overall Study|Withdrawal by Subject|2|||
130118809|NCT01612000|468396048|FG003|Overall Study|Withdrawal by Subject|2|||
130118810|NCT02354586|468396050|FG000|Overall Study|Death|230|||
130118811|NCT02354586|468396050|FG000|Overall Study|Withdrawal by Subject|59|||
130118812|NCT02354586|468396050|FG000|Overall Study|Lost to Follow-up|11|||
130118813|NCT02354586|468396050|FG000|Overall Study|Sponsor decision|51|||
130118814|NCT02354586|468396050|FG000|Overall Study|Site closure|2|||
130118815|NCT02354586|468396050|FG000|Overall Study|Intercurrent illness|1|||
130118816|NCT02354586|468396050|FG000|Overall Study|Protocol Violation|3|||
130118817|NCT02354586|468396050|FG000|Overall Study|Physician Decision|13|||
130118818|NCT02354586|468396050|FG000|Overall Study|Lack of Efficacy|86|||
130118819|NCT02354586|468396050|FG000|Overall Study|Adverse Event|7|||
129932937|NCT02905331|467720961|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
129932938|NCT02905331|467720962|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
129932939|NCT02905331|467720963|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
129932940|NCT02905331|467720961|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
129932941|NCT02905331|467720962|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
129932942|NCT02905331|467720963|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
129932943|NCT03681262|467720964|FG000|Overall Study|Continuing on study|3|||
129932944|NCT03681262|467720965|FG001|Overall Study|Continuing on study|3|||
129932945|NCT03681262|467720964|FG000|Overall Study|Lost to Follow-up|1|||
129932946|NCT03681262|467720965|FG001|Overall Study|Lost to Follow-up|0|||
129932947|NCT04102111|467720966|FG000|Overall Study|Withdrawal by Subject|2|||
129932948|NCT04102111|467720967|FG001|Overall Study|Withdrawal by Subject|3|||
129932949|NCT04102111|467720966|FG000|Overall Study|Adverse Event|1|||
129932950|NCT04102111|467720967|FG001|Overall Study|Adverse Event|1|||
129932951|NCT04102111|467720966|FG000|Overall Study|Study terminated by sponsor|1|||
129932952|NCT04102111|467720967|FG001|Overall Study|Study terminated by sponsor|3|||
129932953|NCT02782676|467720968|FG000|Overall Study|Lost to Follow-up|0|||
129932954|NCT02782676|467720969|FG001|Overall Study|Lost to Follow-up|1|||
129932955|NCT03334695|467720970|FG000|Overall Study|Lost to Follow-up|3|||
129932956|NCT03334695|467720971|FG001|Overall Study|Lost to Follow-up|3|||
129932957|NCT03334695|467720970|FG000|Overall Study|Physician Decision|1|||
129932958|NCT03334695|467720971|FG001|Overall Study|Physician Decision|2|||
129932959|NCT03334695|467720970|FG000|Overall Study|Protocol Violation|0|||
129932960|NCT03334695|467720971|FG001|Overall Study|Protocol Violation|1|||
129932961|NCT02641730|467720972|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
129932962|NCT02641730|467720973|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129932963|NCT02641730|467720974|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129932964|NCT02641730|467720975|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
129932965|NCT02641730|467720976|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
129932966|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
129932967|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
129932968|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
129932969|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
129932970|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
129932971|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
129932972|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
129932973|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
129932974|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
129932975|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
129932976|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129932977|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129932978|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129932979|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
129932980|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
130069827|NCT00367432|468209585|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
130069828|NCT00367432|468209586|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
130069829|NCT00367432|468209585|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
130069830|NCT00367432|468209586|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
130069831|NCT00367432|468209585|FG000|First Period (16 Weeks)|Other Reason|2|||
130069832|NCT00367432|468209586|FG001|First Period (16 Weeks)|Other Reason|0|||
130069833|NCT00367432|468209585|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
130069834|NCT00367432|468209586|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
130069835|NCT00367432|468209585|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
130069836|NCT00367432|468209586|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
130069837|NCT00367432|468209585|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
130069838|NCT00367432|468209586|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
130069839|NCT00367432|468209585|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
130069840|NCT00367432|468209586|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
130069841|NCT00367432|468209585|FG000|Second Period (up to 54 Months)|Other Reason|6|||
130069842|NCT00367432|468209586|FG001|Second Period (up to 54 Months)|Other Reason|2|||
130069843|NCT00014911|468209587|FG000|Overall Study|Adverse Event|1|||
130069844|NCT00014911|468209587|FG000|Overall Study|Lost to Follow-up|1|||
130069845|NCT00014911|468209587|FG000|Overall Study|Withdrawal by Subject|6|||
130069846|NCT00014911|468209587|FG000|Overall Study|Unknown Reasons|2|||
129932981|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
129932982|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
129932983|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
129932984|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
129932985|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
129932986|NCT02641730|467720972|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
129932987|NCT02641730|467720973|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
129932988|NCT02641730|467720974|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
129932989|NCT02641730|467720975|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
129932990|NCT02641730|467720976|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
129932991|NCT02326974|467720981|FG000|Overall Study|Withdrawal by Subject|2|||
129932992|NCT02326974|467720981|FG000|Overall Study|failed heterogenity evaluation|5|||
129932993|NCT04173247|467720982|FG000|Overall Study|Withdrawal by Subject|0|||
129932994|NCT04173247|467720983|FG001|Overall Study|Withdrawal by Subject|2|||
129932995|NCT04173247|467720982|FG000|Overall Study|Death|1|||
129932996|NCT04173247|467720983|FG001|Overall Study|Death|0|||
129932997|NCT04173247|467720982|FG000|Overall Study|Physician Decision|1|||
129932998|NCT04173247|467720983|FG001|Overall Study|Physician Decision|0|||
129932999|NCT04924400|467720991|FG000|Overall Study|Lost to Follow-up|3|||
129933000|NCT04924400|467720992|FG001|Overall Study|Lost to Follow-up|0|||
129933001|NCT04424316|467720993|FG000|Overall Study|Adverse Event|0|||
129933002|NCT04424316|467720994|FG001|Overall Study|Adverse Event|1|||
129933003|NCT04424316|467720995|FG002|Overall Study|Adverse Event|0|||
129933004|NCT04424316|467720996|FG003|Overall Study|Adverse Event|0|||
129933005|NCT04424316|467720993|FG000|Overall Study|Death|1|||
129933006|NCT04424316|467720994|FG001|Overall Study|Death|0|||
129933007|NCT04424316|467720995|FG002|Overall Study|Death|8|||
129933008|NCT04424316|467720996|FG003|Overall Study|Death|14|||
129933009|NCT04424316|467720993|FG000|Overall Study|Lost to Follow-up|93|||
129933010|NCT04424316|467720994|FG001|Overall Study|Lost to Follow-up|88|||
129933011|NCT04424316|467720995|FG002|Overall Study|Lost to Follow-up|224|||
129933012|NCT04424316|467720996|FG003|Overall Study|Lost to Follow-up|211|||
129933013|NCT04424316|467720993|FG000|Overall Study|No longer met eligibility criteria|1|||
129933014|NCT04424316|467720994|FG001|Overall Study|No longer met eligibility criteria|0|||
129933015|NCT04424316|467720995|FG002|Overall Study|No longer met eligibility criteria|0|||
129933016|NCT04424316|467720996|FG003|Overall Study|No longer met eligibility criteria|0|||
129933017|NCT04424316|467720993|FG000|Overall Study|Other|15|||
129933018|NCT04424316|467720994|FG001|Overall Study|Other|11|||
129933019|NCT04424316|467720995|FG002|Overall Study|Other|34|||
129933020|NCT04424316|467720996|FG003|Overall Study|Other|45|||
129933021|NCT04424316|467720993|FG000|Overall Study|Physician Decision|1|||
129933022|NCT04424316|467720994|FG001|Overall Study|Physician Decision|0|||
129933023|NCT04424316|467720995|FG002|Overall Study|Physician Decision|1|||
129933024|NCT04424316|467720996|FG003|Overall Study|Physician Decision|1|||
129933025|NCT04424316|467720993|FG000|Overall Study|Protocol Violation|0|||
129933026|NCT04424316|467720994|FG001|Overall Study|Protocol Violation|1|||
129933027|NCT04424316|467720995|FG002|Overall Study|Protocol Violation|0|||
129933028|NCT04424316|467720996|FG003|Overall Study|Protocol Violation|0|||
129933029|NCT04424316|467720993|FG000|Overall Study|Withdrawal by Subject|71|||
129933030|NCT04424316|467720994|FG001|Overall Study|Withdrawal by Subject|77|||
129933031|NCT04424316|467720995|FG002|Overall Study|Withdrawal by Subject|0|||
129933032|NCT04424316|467720996|FG003|Overall Study|Withdrawal by Subject|0|||
129933033|NCT04424316|467720993|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129933034|NCT04424316|467720994|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129933035|NCT04424316|467720995|FG002|Overall Study|Withdrawal by parent/guardian|74|||
129933036|NCT04424316|467720996|FG003|Overall Study|Withdrawal by parent/guardian|81|||
129933037|NCT04424316|467720993|FG000|Overall Study|Randomized but not vaccinated|13|||
129933038|NCT04424316|467720994|FG001|Overall Study|Randomized but not vaccinated|21|||
129933039|NCT04424316|467720995|FG002|Overall Study|Randomized but not vaccinated|0|||
129933040|NCT04424316|467720996|FG003|Overall Study|Randomized but not vaccinated|0|||
129933041|NCT04424316|467720993|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
129933042|NCT04424316|467720994|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
129933043|NCT04424316|467720995|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
129933044|NCT04424316|467720996|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
129933045|NCT00412607|467720999|FG000|Overall Study|Withdrawal by Subject|9|||
129933046|NCT00412607|467720999|FG000|Overall Study|Lost to Follow-up|19|||
130118820|NCT00634907|468396051|FG000|Overall Study|Withdrawal by Subject|3|||
130118821|NCT00634907|468396052|FG001|Overall Study|Withdrawal by Subject|0|||
130118822|NCT00634907|468396051|FG000|Overall Study|Physician Decision|3|||
130118823|NCT00634907|468396052|FG001|Overall Study|Physician Decision|9|||
129933047|NCT00412607|467720999|FG000|Overall Study|Death|61|||
129933048|NCT00412607|467720999|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
129933049|NCT04707768|467721007|FG000|Overall Study|Adverse Event|9|||
129933050|NCT04707768|467721008|FG001|Overall Study|Adverse Event|18|||
129933051|NCT04707768|467721009|FG002|Overall Study|Adverse Event|3|||
129933052|NCT04707768|467721007|FG000|Overall Study|Investigator's Discretion|8|||
129933053|NCT04707768|467721008|FG001|Overall Study|Investigator's Discretion|4|||
129933054|NCT04707768|467721009|FG002|Overall Study|Investigator's Discretion|3|||
129933055|NCT04707768|467721007|FG000|Overall Study|Withdrawal by Subject|6|||
129933056|NCT04707768|467721008|FG001|Overall Study|Withdrawal by Subject|8|||
129933057|NCT04707768|467721009|FG002|Overall Study|Withdrawal by Subject|2|||
129933058|NCT04707768|467721007|FG000|Overall Study|Lack of Efficacy|1|||
129933059|NCT04707768|467721008|FG001|Overall Study|Lack of Efficacy|3|||
130118824|NCT00634907|468396051|FG000|Overall Study|Withdrawal by Subject|11|||
129933060|NCT04707768|467721009|FG002|Overall Study|Lack of Efficacy|0|||
130118825|NCT00634907|468396052|FG001|Overall Study|Withdrawal by Subject|8|||
130118826|NCT02419313|468396057|FG000|First Intervention|Lost to Follow-up|2|||
130118827|NCT02419313|468396058|FG001|First Intervention|Lost to Follow-up|0|||
130118828|NCT02419313|468396057|FG000|Second Intervention|Lost to Follow-up|1|||
130118829|NCT02419313|468396058|FG001|Second Intervention|Lost to Follow-up|0|||
130118830|NCT02540356|468396062|FG000|Overall Study|Terminated due to disease progression|1|||
130118831|NCT02540356|468396063|FG001|Overall Study|Terminated due to disease progression|0|||
130118832|NCT01513148|468396064|FG000|Overall Study|Protocol Violation|2|||
130118833|NCT01513148|468396065|FG001|Overall Study|Protocol Violation|2|||
130118834|NCT04652453|468396066|FG000|Overall Study|Death|8|||
130118835|NCT04652453|468396067|FG001|Overall Study|Death|2|||
130118836|NCT04652453|468396068|FG002|Overall Study|Death|0|||
130118837|NCT04652453|468396066|FG000|Overall Study|Hospice|5|||
130118838|NCT04652453|468396067|FG001|Overall Study|Hospice|5|||
130118839|NCT04652453|468396068|FG002|Overall Study|Hospice|0|||
130118840|NCT04652453|468396066|FG000|Overall Study|Withdrawal by Subject|2|||
130118841|NCT04652453|468396067|FG001|Overall Study|Withdrawal by Subject|0|||
130118842|NCT04652453|468396068|FG002|Overall Study|Withdrawal by Subject|0|||
130118843|NCT02978326|468396074|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
130118844|NCT02978326|468396075|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
130118845|NCT02978326|468396076|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
130118846|NCT02978326|468396074|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
130118847|NCT02978326|468396075|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
130118848|NCT02978326|468396076|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
130118849|NCT02978326|468396074|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
130118850|NCT02978326|468396075|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
130118851|NCT02978326|468396076|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
130118852|NCT02978326|468396074|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
130118853|NCT02978326|468396075|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
130118854|NCT02978326|468396076|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
130118855|NCT01411995|468396079|FG000|Overall Study|Failed IUD insertion|0|||
130118856|NCT01411995|468396080|FG001|Overall Study|Failed IUD insertion|1|||
130118857|NCT01937364|468396081|FG000|Overall Study|Adverse Event|2|||
130118858|NCT01937364|468396082|FG001|Overall Study|Adverse Event|1|||
130118859|NCT02974153|468396083|FG000|Overall Study|Adverse Event|6|||
130118860|NCT02974153|468396084|FG001|Overall Study|Adverse Event|0|||
130118861|NCT02974153|468396085|FG002|Overall Study|Adverse Event|1|||
130118862|NCT02974153|468396083|FG000|Overall Study|Lack of Efficacy|6|||
130118863|NCT02974153|468396084|FG001|Overall Study|Lack of Efficacy|5|||
130118864|NCT02974153|468396085|FG002|Overall Study|Lack of Efficacy|10|||
130118865|NCT02974153|468396083|FG000|Overall Study|Lost to Follow-up|9|||
130118866|NCT02974153|468396084|FG001|Overall Study|Lost to Follow-up|10|||
130118867|NCT02974153|468396085|FG002|Overall Study|Lost to Follow-up|17|||
130118868|NCT02974153|468396083|FG000|Overall Study|Physician Decision|0|||
130118869|NCT02974153|468396084|FG001|Overall Study|Physician Decision|2|||
129933061|NCT04707768|467721007|FG000|Overall Study|Lost to Follow-up|0|||
129933062|NCT04707768|467721008|FG001|Overall Study|Lost to Follow-up|0|||
129933063|NCT04707768|467721009|FG002|Overall Study|Lost to Follow-up|3|||
129933064|NCT04707768|467721007|FG000|Overall Study|Death|13|||
129933065|NCT04707768|467721008|FG001|Overall Study|Death|11|||
129933066|NCT04707768|467721009|FG002|Overall Study|Death|13|||
129933067|NCT04707768|467721007|FG000|Overall Study|Protocol Violation|2|||
129933068|NCT04707768|467721008|FG001|Overall Study|Protocol Violation|1|||
129933069|NCT04707768|467721009|FG002|Overall Study|Protocol Violation|0|||
129933070|NCT04707768|467721007|FG000|Overall Study|Non Compliance with Study Drug|1|||
129933071|NCT04707768|467721008|FG001|Overall Study|Non Compliance with Study Drug|0|||
129933072|NCT04707768|467721009|FG002|Overall Study|Non Compliance with Study Drug|0|||
130118870|NCT02974153|468396085|FG002|Overall Study|Physician Decision|1|||
130118871|NCT02974153|468396083|FG000|Overall Study|Withdrawal by Subject|9|||
130118872|NCT02974153|468396084|FG001|Overall Study|Withdrawal by Subject|16|||
129933073|NCT04707768|467721007|FG000|Overall Study|Transplant|4|||
129933074|NCT04707768|467721008|FG001|Overall Study|Transplant|4|||
129933075|NCT04707768|467721009|FG002|Overall Study|Transplant|8|||
129933076|NCT04707768|467721007|FG000|Overall Study|Other|9|||
130118873|NCT02974153|468396085|FG002|Overall Study|Withdrawal by Subject|11|||
129933077|NCT04707768|467721008|FG001|Overall Study|Other|5|||
129933078|NCT04707768|467721009|FG002|Overall Study|Other|2|||
130118874|NCT02974153|468396083|FG000|Overall Study|Study Burden|8|||
130118875|NCT02974153|468396084|FG001|Overall Study|Study Burden|7|||
130118876|NCT02974153|468396085|FG002|Overall Study|Study Burden|3|||
130118877|NCT02974153|468396083|FG000|Overall Study|Other|14|||
130118878|NCT02974153|468396084|FG001|Overall Study|Other|8|||
130118879|NCT02974153|468396085|FG002|Overall Study|Other|7|||
130118880|NCT02277769|468396086|FG000|Overall Study|Protocol Violation|3|||
130118881|NCT02277769|468396087|FG001|Overall Study|Protocol Violation|3|||
130118882|NCT02277769|468396088|FG002|Overall Study|Protocol Violation|5|||
130118883|NCT02277769|468396086|FG000|Overall Study|Lack of Efficacy|17|||
130118884|NCT02277769|468396087|FG001|Overall Study|Lack of Efficacy|0|||
129933079|NCT04078152|467721010|FG000|Overall Study|Other|83|||
129933080|NCT04078152|467721011|FG001|Overall Study|Other|22|||
129933081|NCT04078152|467721012|FG002|Overall Study|Other|25|||
129933082|NCT04078152|467721010|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
129933083|NCT04078152|467721011|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
129933084|NCT04078152|467721012|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
129933085|NCT04078152|467721010|FG000|Overall Study|Withdrawal by Subject|5|||
129933086|NCT04078152|467721011|FG001|Overall Study|Withdrawal by Subject|0|||
129933087|NCT04078152|467721012|FG002|Overall Study|Withdrawal by Subject|1|||
129933088|NCT04078152|467721010|FG000|Overall Study|Death|10|||
129933089|NCT04078152|467721011|FG001|Overall Study|Death|2|||
129933090|NCT04078152|467721012|FG002|Overall Study|Death|12|||
129933091|NCT04078152|467721010|FG000|Overall Study|Adverse Event|1|||
129933092|NCT04078152|467721011|FG001|Overall Study|Adverse Event|0|||
129933093|NCT04078152|467721012|FG002|Overall Study|Adverse Event|0|||
129933094|NCT02510235|467721013|FG000|Overall Study|Withdrawal by Subject|1|||
129933095|NCT02510235|467721014|FG001|Overall Study|Withdrawal by Subject|0|||
129933096|NCT03248479|467721015|FG000|Overall Study|Death|12|||
129933097|NCT03248479|467721016|FG001|Overall Study|Death|44|||
129933098|NCT03248479|467721017|FG002|Overall Study|Death|1|||
129933099|NCT03248479|467721018|FG003|Overall Study|Death|72|||
129933100|NCT03248479|467721019|FG004|Overall Study|Death|17|||
129933101|NCT03248479|467721020|FG005|Overall Study|Death|6|||
129933102|NCT03248479|467721021|FG006|Overall Study|Death|1|||
129933103|NCT03248479|467721022|FG007|Overall Study|Death|14|||
129933104|NCT03248479|467721023|FG008|Overall Study|Death|3|||
129933105|NCT03248479|467721024|FG009|Overall Study|Death|7|||
129933106|NCT03248479|467721025|FG010|Overall Study|Death|3|||
129933107|NCT03248479|467721026|FG011|Overall Study|Death|1|||
129933108|NCT03248479|467721027|FG012|Overall Study|Death|1|||
129933109|NCT03248479|467721015|FG000|Overall Study|Study terminated by sponsor|12|||
129933110|NCT03248479|467721016|FG001|Overall Study|Study terminated by sponsor|15|||
129933111|NCT03248479|467721017|FG002|Overall Study|Study terminated by sponsor|0|||
129933112|NCT03248479|467721018|FG003|Overall Study|Study terminated by sponsor|5|||
129933113|NCT03248479|467721019|FG004|Overall Study|Study terminated by sponsor|0|||
129933114|NCT03248479|467721020|FG005|Overall Study|Study terminated by sponsor|0|||
129933115|NCT03248479|467721021|FG006|Overall Study|Study terminated by sponsor|0|||
129933116|NCT03248479|467721022|FG007|Overall Study|Study terminated by sponsor|1|||
129933117|NCT03248479|467721023|FG008|Overall Study|Study terminated by sponsor|1|||
129933118|NCT03248479|467721024|FG009|Overall Study|Study terminated by sponsor|0|||
129933119|NCT03248479|467721025|FG010|Overall Study|Study terminated by sponsor|5|||
129933120|NCT03248479|467721026|FG011|Overall Study|Study terminated by sponsor|4|||
129933121|NCT03248479|467721027|FG012|Overall Study|Study terminated by sponsor|0|||
129933122|NCT03248479|467721015|FG000|Overall Study|Consent withdrawn|6|||
129933123|NCT03248479|467721016|FG001|Overall Study|Consent withdrawn|3|||
129933124|NCT03248479|467721017|FG002|Overall Study|Consent withdrawn|0|||
129933125|NCT03248479|467721018|FG003|Overall Study|Consent withdrawn|9|||
129933126|NCT03248479|467721019|FG004|Overall Study|Consent withdrawn|1|||
129933127|NCT03248479|467721020|FG005|Overall Study|Consent withdrawn|0|||
129933128|NCT03248479|467721021|FG006|Overall Study|Consent withdrawn|0|||
129933129|NCT03248479|467721022|FG007|Overall Study|Consent withdrawn|1|||
129933130|NCT03248479|467721023|FG008|Overall Study|Consent withdrawn|0|||
129933131|NCT03248479|467721024|FG009|Overall Study|Consent withdrawn|3|||
129933132|NCT03248479|467721025|FG010|Overall Study|Consent withdrawn|1|||
129933133|NCT03248479|467721026|FG011|Overall Study|Consent withdrawn|0|||
129933134|NCT03248479|467721027|FG012|Overall Study|Consent withdrawn|1|||
129933135|NCT03248479|467721015|FG000|Overall Study|Lost to Follow-up|2|||
129933136|NCT03248479|467721016|FG001|Overall Study|Lost to Follow-up|1|||
129933137|NCT03248479|467721017|FG002|Overall Study|Lost to Follow-up|0|||
129933138|NCT03248479|467721018|FG003|Overall Study|Lost to Follow-up|0|||
129933139|NCT03248479|467721019|FG004|Overall Study|Lost to Follow-up|0|||
129933140|NCT03248479|467721020|FG005|Overall Study|Lost to Follow-up|0|||
129933141|NCT03248479|467721021|FG006|Overall Study|Lost to Follow-up|0|||
129933142|NCT03248479|467721022|FG007|Overall Study|Lost to Follow-up|0|||
129933143|NCT03248479|467721023|FG008|Overall Study|Lost to Follow-up|0|||
129933144|NCT03248479|467721024|FG009|Overall Study|Lost to Follow-up|0|||
129933145|NCT03248479|467721025|FG010|Overall Study|Lost to Follow-up|0|||
129933146|NCT03248479|467721026|FG011|Overall Study|Lost to Follow-up|0|||
129933147|NCT03248479|467721027|FG012|Overall Study|Lost to Follow-up|1|||
129933148|NCT03248479|467721015|FG000|Overall Study|Not reported|0|||
129933149|NCT03248479|467721016|FG001|Overall Study|Not reported|0|||
129933150|NCT03248479|467721017|FG002|Overall Study|Not reported|0|||
129933151|NCT03248479|467721018|FG003|Overall Study|Not reported|1|||
129933152|NCT03248479|467721019|FG004|Overall Study|Not reported|1|||
129933153|NCT03248479|467721020|FG005|Overall Study|Not reported|0|||
129933154|NCT03248479|467721021|FG006|Overall Study|Not reported|0|||
129933155|NCT03248479|467721022|FG007|Overall Study|Not reported|1|||
129933156|NCT03248479|467721023|FG008|Overall Study|Not reported|1|||
129933157|NCT03248479|467721024|FG009|Overall Study|Not reported|0|||
129933158|NCT03248479|467721025|FG010|Overall Study|Not reported|0|||
129933159|NCT03248479|467721026|FG011|Overall Study|Not reported|0|||
129933160|NCT03248479|467721027|FG012|Overall Study|Not reported|0|||
129933161|NCT03735979|467721032|FG000|Overall Study|Lost to Follow-up|1|||
129933162|NCT03735979|467721033|FG001|Overall Study|Lost to Follow-up|12|||
129933163|NCT03735979|467721034|FG002|Overall Study|Lost to Follow-up|14|||
129933164|NCT03735979|467721032|FG000|Overall Study|Withdrawal by Subject|1|||
129933165|NCT03735979|467721033|FG001|Overall Study|Withdrawal by Subject|5|||
129933166|NCT03735979|467721034|FG002|Overall Study|Withdrawal by Subject|2|||
129933167|NCT03735979|467721032|FG000|Overall Study|Not due to the above reasons|1|||
129933168|NCT03735979|467721033|FG001|Overall Study|Not due to the above reasons|0|||
129933169|NCT03735979|467721034|FG002|Overall Study|Not due to the above reasons|0|||
129933170|NCT00319111|467721037|FG000|Overall Study|Adverse Event|20|||
129933171|NCT00319111|467721037|FG000|Overall Study|Withdrawal of consent|11|||
129933172|NCT00319111|467721037|FG000|Overall Study|Death|9|||
129933173|NCT00319111|467721037|FG000|Overall Study|Lack of clinical improvement|4|||
129933174|NCT00319111|467721037|FG000|Overall Study|Administrative|2|||
129933175|NCT00319111|467721037|FG000|Overall Study|Treatment failure|1|||
129933176|NCT04743973|467721038|FG000|Overall Study|Withdrawal by Subject|5|||
129933177|NCT05654662|467721039|FG000|Overall Study|Withdrawal by Subject|1|||
129933178|NCT05654662|467721040|FG001|Overall Study|Withdrawal by Subject|0|||
129933179|NCT05654662|467721039|FG000|Overall Study|A death in the family|1|||
129933180|NCT05654662|467721040|FG001|Overall Study|A death in the family|0|||
129933181|NCT03165955|467721041|FG000|Treatment|Withdrawal by Subject|3|||
129933182|NCT03165955|467721041|FG000|Treatment|Death|1|||
129933183|NCT03165955|467721041|FG000|Treatment|Adverse Event|1|||
129933184|NCT03165955|467721041|FG000|Treatment|Progressive disease|3|||
129933185|NCT04678856|467721042|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
129933186|NCT04678856|467721043|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
129933187|NCT04678856|467721042|FG000|Overall Study|Withdrawal by Subject|5|||
129933188|NCT04678856|467721043|FG001|Overall Study|Withdrawal by Subject|1|||
129933189|NCT05247034|467722460|FG000|Overall Study|Lost to Follow-up|3|||
129933190|NCT05247034|467722461|FG001|Overall Study|Lost to Follow-up|2|||
129933191|NCT05247034|467722460|FG000|Overall Study|Organizational problems when attending appointments|1|||
129933192|NCT05247034|467722461|FG001|Overall Study|Organizational problems when attending appointments|0|||
129933193|NCT04464564|467722462|FG000|Period A (Placebo lead-in)|Other|5|||
129933194|NCT04464564|467722463|FG001|Period A (Placebo lead-in)|Other|0|||
129933195|NCT04464564|467722464|FG002|Period A (Placebo lead-in)|Other|0|||
129933196|NCT04464564|467722465|FG003|Period A (Placebo lead-in)|Other|0|||
129933197|NCT04464564|467722462|FG000|Period B (Randomization Period)|Adverse Event|0|||
129933198|NCT04464564|467722463|FG001|Period B (Randomization Period)|Adverse Event|1|||
129933199|NCT04464564|467722464|FG002|Period B (Randomization Period)|Adverse Event|2|||
129933200|NCT04464564|467722465|FG003|Period B (Randomization Period)|Adverse Event|8|||
129933201|NCT04464564|467722462|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
129933202|NCT04464564|467722463|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
129933203|NCT04464564|467722464|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
129933204|NCT04464564|467722465|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
129933205|NCT04464564|467722462|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
129933206|NCT04464564|467722463|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
129933207|NCT04464564|467722464|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
129933208|NCT04464564|467722465|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
129933209|NCT04464564|467722462|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
129933210|NCT04464564|467722463|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
129933211|NCT04464564|467722464|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
129933212|NCT04464564|467722465|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
129933213|NCT04464564|467722462|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
129933214|NCT04464564|467722463|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
129933215|NCT04464564|467722464|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
129933216|NCT04464564|467722465|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
129933217|NCT04464564|467722462|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
129933218|NCT04464564|467722463|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
129933219|NCT04464564|467722464|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
129933220|NCT04464564|467722465|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
129933221|NCT04464564|467722462|FG000|Period B (Randomization Period)|Reason not Specified|0|||
129933222|NCT04464564|467722463|FG001|Period B (Randomization Period)|Reason not Specified|3|||
129933223|NCT04464564|467722464|FG002|Period B (Randomization Period)|Reason not Specified|3|||
129933224|NCT04464564|467722465|FG003|Period B (Randomization Period)|Reason not Specified|3|||
129933225|NCT03505710|467722466|FG000|Overall Study|Progressive Disease|24|||
130069847|NCT00014911|468209587|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
130069848|NCT01924299|468209588|FG000|Period 2|Withdrawal by Subject|1|||
129933226|NCT03505710|467722467|FG001|Overall Study|Progressive Disease|17|||
129933227|NCT03505710|467722468|FG002|Overall Study|Progressive Disease|43|||
130118885|NCT02277769|468396088|FG002|Overall Study|Lack of Efficacy|4|||
130118886|NCT02277769|468396086|FG000|Overall Study|Adverse Event|14|||
130118887|NCT02277769|468396087|FG001|Overall Study|Adverse Event|2|||
130118888|NCT02277769|468396088|FG002|Overall Study|Adverse Event|4|||
130118889|NCT02277769|468396086|FG000|Overall Study|Other than specified above|12|||
130118890|NCT02277769|468396087|FG001|Overall Study|Other than specified above|8|||
130118891|NCT02277769|468396088|FG002|Overall Study|Other than specified above|5|||
130118892|NCT00203307|468396089|FG000|First Intervention|Adverse Event|2|||
130118893|NCT00203307|468396090|FG001|First Intervention|Adverse Event|0|||
130118894|NCT03730103|468396091|FG000|Overall Study|Did not meet inclusion criteria|0|||
130118895|NCT03730103|468396092|FG001|Overall Study|Did not meet inclusion criteria|5|||
130118896|NCT01488578|468396093|FG000|Overall Study|Protocol Violation|1836|||
130118897|NCT02308111|468396094|FG000|Overall Study|Adverse Event|31|||
130118898|NCT02308111|468396095|FG001|Overall Study|Adverse Event|19|||
130118899|NCT02308111|468396094|FG000|Overall Study|Death|9|||
130118900|NCT02308111|468396095|FG001|Overall Study|Death|6|||
130118901|NCT02308111|468396094|FG000|Overall Study|Lost to Follow-up|2|||
130118902|NCT02308111|468396095|FG001|Overall Study|Lost to Follow-up|7|||
130118903|NCT02308111|468396094|FG000|Overall Study|Physician Decision|6|||
130118904|NCT02308111|468396095|FG001|Overall Study|Physician Decision|17|||
130118905|NCT02308111|468396094|FG000|Overall Study|Protocol Violation|0|||
130118906|NCT02308111|468396095|FG001|Overall Study|Protocol Violation|1|||
130118907|NCT02308111|468396094|FG000|Overall Study|Withdrawal by Subject|28|||
130118908|NCT02308111|468396095|FG001|Overall Study|Withdrawal by Subject|38|||
130118909|NCT02308111|468396094|FG000|Overall Study|Study Terminated by Sponsor|72|||
130118910|NCT02308111|468396095|FG001|Overall Study|Study Terminated by Sponsor|61|||
130118911|NCT02308111|468396094|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
130118912|NCT02308111|468396095|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
130118913|NCT02308111|468396094|FG000|Overall Study|Site Closure|3|||
130118914|NCT02308111|468396095|FG001|Overall Study|Site Closure|3|||
130118915|NCT02308111|468396094|FG000|Overall Study|Non-compliance with Study Drug|3|||
130118916|NCT02308111|468396095|FG001|Overall Study|Non-compliance with Study Drug|1|||
130118917|NCT02308111|468396094|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
130118918|NCT02308111|468396095|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
130118919|NCT02308111|468396094|FG000|Overall Study|Liver Transplant|3|||
130118920|NCT02308111|468396095|FG001|Overall Study|Liver Transplant|3|||
130118921|NCT02308111|468396094|FG000|Overall Study|Liver Transplant Waitlist|2|||
130118922|NCT02308111|468396095|FG001|Overall Study|Liver Transplant Waitlist|2|||
130118923|NCT02308111|468396094|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
130118924|NCT02308111|468396095|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
130118925|NCT03271528|468396096|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
130118926|NCT03271528|468396097|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
130118927|NCT03271528|468396096|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
130118928|NCT03271528|468396097|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
130118929|NCT03271528|468396096|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
130118930|NCT03271528|468396097|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
130118931|NCT03271528|468396096|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
130118932|NCT03271528|468396097|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
130118933|NCT03271528|468396096|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
130118934|NCT03271528|468396097|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
130118935|NCT03271528|468396096|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
130118936|NCT03271528|468396097|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
130118937|NCT03271528|468396096|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
130118938|NCT03271528|468396097|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
130118939|NCT01873859|468396102|FG000|Overall Study|Withdrawal by Subject|0|||
130118940|NCT01873859|468396103|FG001|Overall Study|Withdrawal by Subject|4|||
130118941|NCT03977584|468396104|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
130118942|NCT03977584|468396105|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
130118943|NCT03977584|468396106|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
130118944|NCT03504852|468396110|FG000|Overall Study|Withdrawal of informed consent|2|||
130118945|NCT03504852|468396111|FG001|Overall Study|Withdrawal of informed consent|1|||
130118946|NCT03504852|468396112|FG002|Overall Study|Withdrawal of informed consent|0|||
130118947|NCT03504852|468396110|FG000|Overall Study|Withdrawal by Subject|5|||
130118948|NCT03504852|468396111|FG001|Overall Study|Withdrawal by Subject|5|||
130118949|NCT03504852|468396112|FG002|Overall Study|Withdrawal by Subject|1|||
130118950|NCT03504852|468396110|FG000|Overall Study|Lost to Follow-up|4|||
130118951|NCT03504852|468396111|FG001|Overall Study|Lost to Follow-up|1|||
130118952|NCT03504852|468396112|FG002|Overall Study|Lost to Follow-up|0|||
130118953|NCT03504852|468396110|FG000|Overall Study|New therapy for study indication|1|||
130118954|NCT03504852|468396111|FG001|Overall Study|New therapy for study indication|0|||
130118955|NCT03504852|468396112|FG002|Overall Study|New therapy for study indication|0|||
129933228|NCT03505710|467722466|FG000|Overall Study|Clinical Progression|6|||
129933229|NCT03505710|467722467|FG001|Overall Study|Clinical Progression|8|||
129933230|NCT03505710|467722468|FG002|Overall Study|Clinical Progression|3|||
129933231|NCT03505710|467722466|FG000|Overall Study|Adverse Event|12|||
129933232|NCT03505710|467722467|FG001|Overall Study|Adverse Event|6|||
129933233|NCT03505710|467722468|FG002|Overall Study|Adverse Event|28|||
129933234|NCT03505710|467722466|FG000|Overall Study|Withdrawal by Subject|1|||
129933235|NCT03505710|467722467|FG001|Overall Study|Withdrawal by Subject|3|||
129933236|NCT03505710|467722468|FG002|Overall Study|Withdrawal by Subject|7|||
129933237|NCT03505710|467722466|FG000|Overall Study|Physician Decision|1|||
129933238|NCT03505710|467722467|FG001|Overall Study|Physician Decision|1|||
129933239|NCT03505710|467722468|FG002|Overall Study|Physician Decision|2|||
129933240|NCT03505710|467722466|FG000|Overall Study|Death|4|||
129933241|NCT03505710|467722467|FG001|Overall Study|Death|5|||
129933242|NCT03505710|467722468|FG002|Overall Study|Death|6|||
129933243|NCT03505710|467722466|FG000|Overall Study|Other Reasons|1|||
129933244|NCT03505710|467722467|FG001|Overall Study|Other Reasons|1|||
129933245|NCT03505710|467722468|FG002|Overall Study|Other Reasons|1|||
129933246|NCT03505710|467722466|FG000|Overall Study|Study Terminated by Sponsor|0|||
129933247|NCT03505710|467722467|FG001|Overall Study|Study Terminated by Sponsor|0|||
129933248|NCT03505710|467722468|FG002|Overall Study|Study Terminated by Sponsor|1|||
129933249|NCT00942877|467722473|FG000|Overall Study|Refused further treatment|1|||
129933250|NCT00942877|467722474|FG001|Overall Study|Refused further treatment|1|||
129933251|NCT00942877|467722473|FG000|Overall Study|Patient was not treated|1|||
129933252|NCT00942877|467722474|FG001|Overall Study|Patient was not treated|0|||
129933253|NCT00942877|467722473|FG000|Overall Study|Adverse Event|1|||
129933254|NCT00942877|467722474|FG001|Overall Study|Adverse Event|0|||
129933255|NCT00942877|467722473|FG000|Overall Study|Progressive disease|42|||
129933256|NCT00942877|467722474|FG001|Overall Study|Progressive disease|3|||
129933257|NCT02874742|467722476|FG000|Overall Study|Death|0|||
129933258|NCT02874742|467722477|FG001|Overall Study|Death|1|||
129933259|NCT02874742|467722478|FG002|Overall Study|Death|0|||
129933260|NCT02874742|467722476|FG000|Overall Study|Lost to Follow-up|5|||
129933261|NCT02874742|467722477|FG001|Overall Study|Lost to Follow-up|4|||
129933262|NCT02874742|467722478|FG002|Overall Study|Lost to Follow-up|1|||
129933263|NCT02874742|467722476|FG000|Overall Study|Withdrawal by Subject|17|||
129933264|NCT02874742|467722477|FG001|Overall Study|Withdrawal by Subject|8|||
129933265|NCT02874742|467722478|FG002|Overall Study|Withdrawal by Subject|0|||
129933266|NCT02874742|467722476|FG000|Overall Study|Other|4|||
129933267|NCT02874742|467722477|FG001|Overall Study|Other|1|||
129933268|NCT02874742|467722478|FG002|Overall Study|Other|0|||
129933269|NCT02874742|467722476|FG000|Overall Study|Progressive Disease|1|||
129933270|NCT02874742|467722477|FG001|Overall Study|Progressive Disease|0|||
129933271|NCT02874742|467722478|FG002|Overall Study|Progressive Disease|0|||
129933272|NCT02874742|467722476|FG000|Overall Study|Screen Failure|0|||
129933273|NCT02874742|467722477|FG001|Overall Study|Screen Failure|2|||
129933274|NCT02874742|467722478|FG002|Overall Study|Screen Failure|0|||
129933275|NCT00964392|467722479|FG000|Overall Study|Withdrawal by Subject|4|||
129933276|NCT00964392|467722480|FG001|Overall Study|Withdrawal by Subject|6|||
129933277|NCT00964392|467722479|FG000|Overall Study|Lost to Follow-up|4|||
129933278|NCT00964392|467722480|FG001|Overall Study|Lost to Follow-up|10|||
129933279|NCT00964392|467722479|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
129933280|NCT00964392|467722480|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
129933281|NCT00964392|467722479|FG000|Overall Study|Not completed|44|||
129933282|NCT00964392|467722480|FG001|Overall Study|Not completed|168|||
129933283|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
129933284|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
129933285|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
129933286|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
129933287|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
129933288|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
129933289|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
129933290|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
130069849|NCT01924299|468209589|FG001|Period 2|Withdrawal by Subject|0|||
130069850|NCT01924299|468209588|FG000|Period 2|Adverse Event|0|||
129933291|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
129933292|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
129933293|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
129933294|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
129933295|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
129933296|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
129933297|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
129933298|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
129933299|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
129933300|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
129933301|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
130069851|NCT01924299|468209589|FG001|Period 2|Adverse Event|1|||
129933302|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
129933303|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
129933304|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
129933305|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
129933306|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
129933307|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
129933308|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
129933309|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
129933310|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
129933311|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
129933312|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
129933313|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
129933314|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
129933315|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
129933316|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
129933317|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
129933318|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
129933319|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
129933320|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
129933321|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
129933322|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
129933323|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
129933324|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
129933325|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
129933326|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
129933327|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
129933328|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
129933329|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
129933330|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
129933331|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
129933332|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
129933333|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
129933334|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
129933335|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
129933336|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
129933337|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
129933338|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
129933339|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
129933340|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
129933341|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
129933342|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
129933343|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
129933344|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
129933345|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
129933346|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
129933347|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
129933348|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
129933349|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
129933350|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
129933351|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
130069852|NCT04199793|468209590|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
130069853|NCT04199793|468209591|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
130069854|NCT04199793|468209590|FG000|Overall Study|Withdrawal by Subject|1|||
130069855|NCT04199793|468209591|FG001|Overall Study|Withdrawal by Subject|1|||
130069856|NCT04179786|468209595|FG000|Overall Study|Withdrawal by Subject|8|||
130069857|NCT03310580|468209596|FG000|Overall Study|Adverse Event|0|||
130069858|NCT03310580|468209597|FG001|Overall Study|Adverse Event|1|||
130069859|NCT03310580|468209598|FG002|Overall Study|Adverse Event|0|||
130069860|NCT01999946|468209605|FG000|Overall Study|Participant not released from jail|2|||
130069861|NCT01999946|468209606|FG001|Overall Study|Participant not released from jail|2|||
130069862|NCT01999946|468209607|FG002|Overall Study|Participant not released from jail|0|||
130069863|NCT01999946|468209605|FG000|Overall Study|Not included in primary outcome analysis|0|||
130069864|NCT01999946|468209606|FG001|Overall Study|Not included in primary outcome analysis|0|||
130069865|NCT01999946|468209607|FG002|Overall Study|Not included in primary outcome analysis|79|||
129933352|NCT04055012|467722484|FG000|Overall Study|Withdrawal by Subject|1|||
129933353|NCT04055012|467722485|FG001|Overall Study|Withdrawal by Subject|3|||
129933354|NCT04055012|467722486|FG002|Overall Study|Withdrawal by Subject|1|||
129933355|NCT04055012|467722487|FG003|Overall Study|Withdrawal by Subject|0|||
129933356|NCT04055012|467722484|FG000|Overall Study|Metformin Recall|1|||
129933357|NCT04055012|467722485|FG001|Overall Study|Metformin Recall|1|||
129933358|NCT04055012|467722486|FG002|Overall Study|Metformin Recall|1|||
129933359|NCT04055012|467722487|FG003|Overall Study|Metformin Recall|0|||
129933360|NCT03884101|467722492|FG000|Overall Study|Participant Ongoing in Study|202|||
129933361|NCT03884101|467722493|FG001|Overall Study|Participant Ongoing in Study|186|||
129933362|NCT03884101|467722492|FG000|Overall Study|Death|212|||
129933363|NCT03884101|467722493|FG001|Overall Study|Death|224|||
129933364|NCT03884101|467722492|FG000|Overall Study|Lost to Follow-up|0|||
129933365|NCT03884101|467722493|FG001|Overall Study|Lost to Follow-up|1|||
129933366|NCT03884101|467722492|FG000|Overall Study|Withdrawal by Subject|6|||
129933367|NCT03884101|467722493|FG001|Overall Study|Withdrawal by Subject|11|||
129933368|NCT05070741|467722494|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
129933369|NCT03582033|467722497|FG000|Part A|Other|0|||
129933370|NCT03582033|467722498|FG001|Part A|Other|0|||
129933371|NCT03582033|467722499|FG002|Part A|Other|0|||
129933372|NCT03582033|467722500|FG003|Part A|Other|0|||
129933373|NCT03582033|467722501|FG004|Part A|Other|2|||
129933374|NCT03582033|467722502|FG005|Part A|Other|0|||
129933375|NCT03582033|467722503|FG006|Part A|Other|0|||
129933376|NCT03582033|467722504|FG007|Part A|Other|0|||
129933377|NCT03582033|467722505|FG008|Part A|Other|0|||
129933378|NCT03582033|467722506|FG009|Part A|Other|0|||
129933379|NCT03582033|467722497|FG000|Part A|Death|1|||
129933380|NCT03582033|467722498|FG001|Part A|Death|1|||
129933381|NCT03582033|467722499|FG002|Part A|Death|2|||
129933382|NCT03582033|467722500|FG003|Part A|Death|4|||
129933383|NCT03582033|467722501|FG004|Part A|Death|11|||
129933384|NCT03582033|467722502|FG005|Part A|Death|0|||
129933385|NCT03582033|467722503|FG006|Part A|Death|0|||
129933386|NCT03582033|467722504|FG007|Part A|Death|0|||
129933387|NCT03582033|467722505|FG008|Part A|Death|0|||
129933388|NCT03582033|467722506|FG009|Part A|Death|0|||
129933389|NCT03582033|467722497|FG000|Part A|Lost to Follow-up|0|||
129933390|NCT03582033|467722498|FG001|Part A|Lost to Follow-up|0|||
129933391|NCT03582033|467722499|FG002|Part A|Lost to Follow-up|0|||
129933392|NCT03582033|467722500|FG003|Part A|Lost to Follow-up|0|||
129933393|NCT03582033|467722501|FG004|Part A|Lost to Follow-up|1|||
129933394|NCT03582033|467722502|FG005|Part A|Lost to Follow-up|0|||
129933395|NCT03582033|467722503|FG006|Part A|Lost to Follow-up|0|||
129933396|NCT03582033|467722504|FG007|Part A|Lost to Follow-up|0|||
129933397|NCT03582033|467722505|FG008|Part A|Lost to Follow-up|0|||
129933398|NCT03582033|467722506|FG009|Part A|Lost to Follow-up|0|||
129933399|NCT03582033|467722497|FG000|Part A|Study terminated by sponsor|0|||
129933400|NCT03582033|467722498|FG001|Part A|Study terminated by sponsor|0|||
129933401|NCT03582033|467722499|FG002|Part A|Study terminated by sponsor|0|||
129933402|NCT03582033|467722500|FG003|Part A|Study terminated by sponsor|2|||
129933403|NCT03582033|467722501|FG004|Part A|Study terminated by sponsor|1|||
129933404|NCT03582033|467722502|FG005|Part A|Study terminated by sponsor|0|||
129933405|NCT03582033|467722503|FG006|Part A|Study terminated by sponsor|0|||
129933406|NCT03582033|467722504|FG007|Part A|Study terminated by sponsor|0|||
129933407|NCT03582033|467722505|FG008|Part A|Study terminated by sponsor|0|||
129933408|NCT03582033|467722506|FG009|Part A|Study terminated by sponsor|0|||
129933409|NCT03582033|467722497|FG000|Part A|Withdrawal by Subject|1|||
129933410|NCT03582033|467722498|FG001|Part A|Withdrawal by Subject|1|||
129933411|NCT03582033|467722499|FG002|Part A|Withdrawal by Subject|0|||
129933412|NCT03582033|467722500|FG003|Part A|Withdrawal by Subject|1|||
129933413|NCT03582033|467722501|FG004|Part A|Withdrawal by Subject|7|||
129933414|NCT03582033|467722502|FG005|Part A|Withdrawal by Subject|0|||
129933415|NCT03582033|467722503|FG006|Part A|Withdrawal by Subject|0|||
129933416|NCT03582033|467722504|FG007|Part A|Withdrawal by Subject|0|||
129933417|NCT03582033|467722505|FG008|Part A|Withdrawal by Subject|0|||
129933418|NCT03582033|467722506|FG009|Part A|Withdrawal by Subject|0|||
129933419|NCT03582033|467722497|FG000|Part B|Death|0|||
129933420|NCT03582033|467722498|FG001|Part B|Death|0|||
129933421|NCT03582033|467722499|FG002|Part B|Death|0|||
129933422|NCT03582033|467722500|FG003|Part B|Death|0|||
129933423|NCT03582033|467722501|FG004|Part B|Death|0|||
129933424|NCT03582033|467722502|FG005|Part B|Death|2|||
129933425|NCT03582033|467722503|FG006|Part B|Death|0|||
129933426|NCT03582033|467722504|FG007|Part B|Death|0|||
129933427|NCT03582033|467722505|FG008|Part B|Death|0|||
129933428|NCT03582033|467722506|FG009|Part B|Death|0|||
129933429|NCT03582033|467722497|FG000|Part B|Study terminated by sponsor|0|||
129933430|NCT03582033|467722498|FG001|Part B|Study terminated by sponsor|0|||
129933431|NCT03582033|467722499|FG002|Part B|Study terminated by sponsor|0|||
129933432|NCT03582033|467722500|FG003|Part B|Study terminated by sponsor|0|||
129933433|NCT03582033|467722501|FG004|Part B|Study terminated by sponsor|0|||
129933434|NCT03582033|467722502|FG005|Part B|Study terminated by sponsor|12|||
129933435|NCT03582033|467722503|FG006|Part B|Study terminated by sponsor|0|||
129933436|NCT03582033|467722504|FG007|Part B|Study terminated by sponsor|0|||
129933437|NCT03582033|467722505|FG008|Part B|Study terminated by sponsor|0|||
129933438|NCT03582033|467722506|FG009|Part B|Study terminated by sponsor|0|||
129933439|NCT03582033|467722497|FG000|Part B|Withdrawal by Subject|0|||
129933440|NCT03582033|467722498|FG001|Part B|Withdrawal by Subject|0|||
129933441|NCT03582033|467722499|FG002|Part B|Withdrawal by Subject|0|||
129933442|NCT03582033|467722500|FG003|Part B|Withdrawal by Subject|0|||
129933443|NCT03582033|467722501|FG004|Part B|Withdrawal by Subject|0|||
129933444|NCT03582033|467722502|FG005|Part B|Withdrawal by Subject|6|||
129933445|NCT03582033|467722503|FG006|Part B|Withdrawal by Subject|0|||
129933446|NCT03582033|467722504|FG007|Part B|Withdrawal by Subject|0|||
129933447|NCT03582033|467722505|FG008|Part B|Withdrawal by Subject|0|||
129933448|NCT03582033|467722506|FG009|Part B|Withdrawal by Subject|0|||
129933449|NCT03582033|467722497|FG000|Part C|Other|0|||
129933450|NCT03582033|467722498|FG001|Part C|Other|0|||
129933451|NCT03582033|467722499|FG002|Part C|Other|0|||
129933452|NCT03582033|467722500|FG003|Part C|Other|0|||
129933453|NCT03582033|467722501|FG004|Part C|Other|0|||
129933454|NCT03582033|467722502|FG005|Part C|Other|0|||
129933455|NCT03582033|467722503|FG006|Part C|Other|2|||
129933456|NCT03582033|467722504|FG007|Part C|Other|0|||
129933457|NCT03582033|467722505|FG008|Part C|Other|0|||
129933458|NCT03582033|467722506|FG009|Part C|Other|0|||
129933459|NCT03582033|467722497|FG000|Part C|Death|0|||
129933460|NCT03582033|467722498|FG001|Part C|Death|0|||
129933461|NCT03582033|467722499|FG002|Part C|Death|0|||
129933462|NCT03582033|467722500|FG003|Part C|Death|0|||
129933463|NCT03582033|467722501|FG004|Part C|Death|0|||
129933464|NCT03582033|467722502|FG005|Part C|Death|0|||
129933465|NCT03582033|467722503|FG006|Part C|Death|6|||
129933466|NCT03582033|467722504|FG007|Part C|Death|1|||
129933467|NCT03582033|467722505|FG008|Part C|Death|2|||
129933468|NCT03582033|467722506|FG009|Part C|Death|0|||
129933469|NCT03582033|467722497|FG000|Part C|Study terminated by sponsor|0|||
129933470|NCT03582033|467722498|FG001|Part C|Study terminated by sponsor|0|||
129933471|NCT03582033|467722499|FG002|Part C|Study terminated by sponsor|0|||
129933472|NCT03582033|467722500|FG003|Part C|Study terminated by sponsor|0|||
129933473|NCT03582033|467722501|FG004|Part C|Study terminated by sponsor|0|||
129933474|NCT03582033|467722502|FG005|Part C|Study terminated by sponsor|0|||
129933475|NCT03582033|467722503|FG006|Part C|Study terminated by sponsor|3|||
129933476|NCT03582033|467722504|FG007|Part C|Study terminated by sponsor|3|||
129933477|NCT03582033|467722505|FG008|Part C|Study terminated by sponsor|2|||
129933478|NCT03582033|467722506|FG009|Part C|Study terminated by sponsor|0|||
129933479|NCT03582033|467722497|FG000|Part C|Withdrawal by Subject|0|||
129933480|NCT03582033|467722498|FG001|Part C|Withdrawal by Subject|0|||
129933481|NCT03582033|467722499|FG002|Part C|Withdrawal by Subject|0|||
129933482|NCT03582033|467722500|FG003|Part C|Withdrawal by Subject|0|||
129933483|NCT03582033|467722501|FG004|Part C|Withdrawal by Subject|0|||
129933484|NCT03582033|467722502|FG005|Part C|Withdrawal by Subject|0|||
129933485|NCT03582033|467722503|FG006|Part C|Withdrawal by Subject|1|||
129933486|NCT03582033|467722504|FG007|Part C|Withdrawal by Subject|2|||
129933487|NCT03582033|467722505|FG008|Part C|Withdrawal by Subject|1|||
129933488|NCT03582033|467722506|FG009|Part C|Withdrawal by Subject|0|||
129933489|NCT03582033|467722497|FG000|Part D|Death|0|||
129933490|NCT03582033|467722498|FG001|Part D|Death|0|||
129933491|NCT03582033|467722499|FG002|Part D|Death|0|||
129933492|NCT03582033|467722500|FG003|Part D|Death|0|||
129933493|NCT03582033|467722501|FG004|Part D|Death|0|||
129933494|NCT03582033|467722502|FG005|Part D|Death|0|||
129933495|NCT03582033|467722503|FG006|Part D|Death|0|||
129933496|NCT03582033|467722504|FG007|Part D|Death|0|||
129933497|NCT03582033|467722505|FG008|Part D|Death|0|||
129933498|NCT03582033|467722506|FG009|Part D|Death|1|||
129933499|NCT03582033|467722497|FG000|Part D|Study terminated by sponsor|0|||
129933500|NCT03582033|467722498|FG001|Part D|Study terminated by sponsor|0|||
129933501|NCT03582033|467722499|FG002|Part D|Study terminated by sponsor|0|||
129933502|NCT03582033|467722500|FG003|Part D|Study terminated by sponsor|0|||
129933503|NCT03582033|467722501|FG004|Part D|Study terminated by sponsor|0|||
129933504|NCT03582033|467722502|FG005|Part D|Study terminated by sponsor|0|||
129933505|NCT03582033|467722503|FG006|Part D|Study terminated by sponsor|0|||
129933506|NCT03582033|467722504|FG007|Part D|Study terminated by sponsor|0|||
129933507|NCT03582033|467722505|FG008|Part D|Study terminated by sponsor|0|||
129933508|NCT03582033|467722506|FG009|Part D|Study terminated by sponsor|4|||
129933509|NCT04631016|467722509|FG000|Overall Study|Adverse Event|3|||
129933510|NCT04631016|467722510|FG001|Overall Study|Adverse Event|0|||
129933511|NCT04631016|467722509|FG000|Overall Study|Withdrawal by Subject|5|||
129933512|NCT04631016|467722510|FG001|Overall Study|Withdrawal by Subject|4|||
129933513|NCT04631016|467722509|FG000|Overall Study|Reason unspecified|1|||
129933514|NCT04631016|467722510|FG001|Overall Study|Reason unspecified|0|||
129933515|NCT04631016|467722509|FG000|Overall Study|Failure to meet randomization criteria|2|||
129933516|NCT04631016|467722510|FG001|Overall Study|Failure to meet randomization criteria|1|||
129933517|NCT03812614|467722511|FG000|Intervention|Withdrawal by Subject|7|||
129933518|NCT03812614|467722512|FG001|Intervention|Withdrawal by Subject|2|||
129933519|NCT03812614|467722513|FG002|Intervention|Withdrawal by Subject|7|||
129933520|NCT03812614|467722514|FG003|Intervention|Withdrawal by Subject|2|||
129933521|NCT03812614|467722511|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
129933522|NCT03812614|467722512|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
129933523|NCT03812614|467722513|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
129933524|NCT03812614|467722514|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
129933525|NCT03812614|467722511|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
129933526|NCT03812614|467722512|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
129933527|NCT03812614|467722513|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
129933528|NCT03812614|467722514|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
129933529|NCT03812614|467722511|FG000|6-month Follow-up|Lost to Follow-up|0|||
129933530|NCT03812614|467722512|FG001|6-month Follow-up|Lost to Follow-up|0|||
129933531|NCT03812614|467722513|FG002|6-month Follow-up|Lost to Follow-up|12|||
129933532|NCT03812614|467722514|FG003|6-month Follow-up|Lost to Follow-up|8|||
129933533|NCT03812614|467722511|FG000|12-month Follow-up|Lost to Follow-up|18|||
129933534|NCT03812614|467722512|FG001|12-month Follow-up|Lost to Follow-up|17|||
129933535|NCT03812614|467722513|FG002|12-month Follow-up|Lost to Follow-up|5|||
129933536|NCT03812614|467722514|FG003|12-month Follow-up|Lost to Follow-up|2|||
129933537|NCT05205161|467722515|FG000|Overall Study|Study terminated by sponsor|3|||
129933538|NCT05205161|467722516|FG001|Overall Study|Study terminated by sponsor|3|||
129933539|NCT05205161|467722517|FG002|Overall Study|Study terminated by sponsor|1|||
129933540|NCT05652010|467722518|FG000|First Intervention|Withdrawal by Subject|0|||
129933541|NCT05652010|467722519|FG001|First Intervention|Withdrawal by Subject|1|||
129933542|NCT05652010|467722518|FG000|Second Intervention|Withdrawal by Subject|1|||
129933543|NCT05652010|467722519|FG001|Second Intervention|Withdrawal by Subject|0|||
129933544|NCT05741294|467722520|FG000|Overall Study|Lost to Follow-up|3|||
129933545|NCT05741294|467722520|FG000|Overall Study|Protocol deviation|3|||
129933546|NCT05741294|467722520|FG000|Overall Study|Withdrawal by Subject|1|||
129933547|NCT04163991|467722521|FG000|Overall Study|Adverse Event|0|||
129933548|NCT04163991|467722522|FG001|Overall Study|Adverse Event|0|||
129933549|NCT04163991|467722523|FG002|Overall Study|Adverse Event|0|||
129933550|NCT04163991|467722524|FG003|Overall Study|Adverse Event|1|||
129933551|NCT04163991|467722525|FG004|Overall Study|Adverse Event|0|||
129933552|NCT04163991|467722521|FG000|Overall Study|Death|0|||
129933553|NCT04163991|467722522|FG001|Overall Study|Death|0|||
129933554|NCT04163991|467722523|FG002|Overall Study|Death|1|||
129933555|NCT04163991|467722524|FG003|Overall Study|Death|0|||
129933556|NCT04163991|467722525|FG004|Overall Study|Death|0|||
129933557|NCT04163991|467722521|FG000|Overall Study|Lost to Follow-up|0|||
129933558|NCT04163991|467722522|FG001|Overall Study|Lost to Follow-up|1|||
129933559|NCT04163991|467722523|FG002|Overall Study|Lost to Follow-up|0|||
129933560|NCT04163991|467722524|FG003|Overall Study|Lost to Follow-up|0|||
129933561|NCT04163991|467722525|FG004|Overall Study|Lost to Follow-up|0|||
129933562|NCT04163991|467722521|FG000|Overall Study|Withdrawal by Subject|1|||
129933563|NCT04163991|467722522|FG001|Overall Study|Withdrawal by Subject|1|||
129933564|NCT04163991|467722523|FG002|Overall Study|Withdrawal by Subject|3|||
129933565|NCT04163991|467722524|FG003|Overall Study|Withdrawal by Subject|1|||
129933566|NCT04163991|467722525|FG004|Overall Study|Withdrawal by Subject|1|||
129933567|NCT04163991|467722521|FG000|Overall Study|Other, Not Specified|0|||
129933568|NCT04163991|467722522|FG001|Overall Study|Other, Not Specified|1|||
129933569|NCT04163991|467722523|FG002|Overall Study|Other, Not Specified|1|||
129933570|NCT04163991|467722524|FG003|Overall Study|Other, Not Specified|1|||
129933571|NCT04163991|467722525|FG004|Overall Study|Other, Not Specified|0|||
129933572|NCT03372057|467722526|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
129933573|NCT03372057|467722527|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
129933574|NCT03372057|467722528|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
129933575|NCT03372057|467722526|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
129933576|NCT03372057|467722527|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
129933577|NCT03372057|467722528|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
129933578|NCT03372057|467722526|FG000|Dose Optimization Phase|Death|16|||
129933579|NCT03372057|467722527|FG001|Dose Optimization Phase|Death|11|||
129933580|NCT03372057|467722528|FG002|Dose Optimization Phase|Death|0|||
129933581|NCT03372057|467722526|FG000|Expansion Phase|Withdrawal by Subject|0|||
129933582|NCT03372057|467722527|FG001|Expansion Phase|Withdrawal by Subject|0|||
129933583|NCT03372057|467722528|FG002|Expansion Phase|Withdrawal by Subject|4|||
129933584|NCT03372057|467722526|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
129933585|NCT03372057|467722527|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
129933586|NCT03372057|467722528|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
129933587|NCT03372057|467722526|FG000|Expansion Phase|Death|0|||
129933588|NCT03372057|467722527|FG001|Expansion Phase|Death|0|||
130069866|NCT00355134|468211305|FG000|Core Phase|Withdrawal by Subject|35|||
129933589|NCT03372057|467722528|FG002|Expansion Phase|Death|78|||
129933590|NCT03372057|467722526|FG000|Expansion Phase|Progressive Disease|0|||
129933591|NCT03372057|467722527|FG001|Expansion Phase|Progressive Disease|0|||
129933592|NCT03372057|467722528|FG002|Expansion Phase|Progressive Disease|1|||
129933593|NCT03372057|467722526|FG000|Expansion Phase|Adverse Event|0|||
129933594|NCT03372057|467722527|FG001|Expansion Phase|Adverse Event|0|||
129933595|NCT03372057|467722528|FG002|Expansion Phase|Adverse Event|1|||
129933596|NCT05953740|467722529|FG000|Period 1|Physician Decision|0|||
129933597|NCT05953740|467722530|FG001|Period 1|Physician Decision|1|||
129933598|NCT05953740|467722531|FG002|Period 1|Physician Decision|0|||
129933599|NCT05953740|467722532|FG003|Period 1|Physician Decision|0|||
129933600|NCT05953740|467722533|FG004|Period 1|Physician Decision|0|||
129933601|NCT05953740|467722534|FG005|Period 1|Physician Decision|0|||
129933602|NCT05953740|467722535|FG006|Period 1|Physician Decision|0|||
129933603|NCT05953740|467722536|FG007|Period 1|Physician Decision|0|||
129933604|NCT05953740|467722529|FG000|Period 2|Withdrawal by Subject|0|||
129933605|NCT05953740|467722530|FG001|Period 2|Withdrawal by Subject|1|||
129933606|NCT05953740|467722531|FG002|Period 2|Withdrawal by Subject|1|||
129933607|NCT05953740|467722532|FG003|Period 2|Withdrawal by Subject|0|||
129933608|NCT05953740|467722533|FG004|Period 2|Withdrawal by Subject|0|||
129933609|NCT05953740|467722534|FG005|Period 2|Withdrawal by Subject|0|||
129933610|NCT05953740|467722535|FG006|Period 2|Withdrawal by Subject|0|||
129933611|NCT05953740|467722536|FG007|Period 2|Withdrawal by Subject|0|||
129933612|NCT03880955|467722537|FG000|Overall Study|Adverse Event|1|||
129933613|NCT03880955|467722537|FG000|Overall Study|Death|1|||
129933614|NCT03880955|467722537|FG000|Overall Study|Lost to Follow-up|12|||
129933615|NCT03880955|467722537|FG000|Overall Study|Withdrawal by Subject|4|||
129933616|NCT03880955|467722537|FG000|Overall Study|Missing- Study Site Closed|27|||
129933617|NCT04214418|467722540|FG000|Overall Study|Withdrawal by Subject|1|||
129933618|NCT04214418|467722541|FG001|Overall Study|Withdrawal by Subject|0|||
129933619|NCT04214418|467722542|FG002|Overall Study|Withdrawal by Subject|0|||
129933620|NCT04214418|467722543|FG003|Overall Study|Withdrawal by Subject|0|||
129933621|NCT04214418|467722544|FG004|Overall Study|Withdrawal by Subject|0|||
129933622|NCT04214418|467722545|FG005|Overall Study|Withdrawal by Subject|0|||
129933623|NCT04214418|467722540|FG000|Overall Study|Adverse Event|0|||
129933624|NCT04214418|467722541|FG001|Overall Study|Adverse Event|2|||
129933625|NCT04214418|467722542|FG002|Overall Study|Adverse Event|0|||
129933626|NCT04214418|467722543|FG003|Overall Study|Adverse Event|0|||
129933627|NCT04214418|467722544|FG004|Overall Study|Adverse Event|0|||
129933628|NCT04214418|467722545|FG005|Overall Study|Adverse Event|0|||
129933629|NCT04214418|467722540|FG000|Overall Study|Death|1|||
129933630|NCT04214418|467722541|FG001|Overall Study|Death|0|||
129933631|NCT04214418|467722542|FG002|Overall Study|Death|0|||
129933632|NCT04214418|467722543|FG003|Overall Study|Death|0|||
129933633|NCT04214418|467722544|FG004|Overall Study|Death|0|||
129933634|NCT04214418|467722545|FG005|Overall Study|Death|0|||
129933635|NCT04635059|467722546|FG000|Overall Study|Study terminated early.|4|||
129933636|NCT03011034|467722550|FG000|Overall Study|Adverse Event|1|||
129933637|NCT03011034|467722551|FG001|Overall Study|Adverse Event|0|||
129933638|NCT05123027|467722553|FG000|Overall Study|Lost to Follow-up|17|||
129933639|NCT05123027|467722554|FG001|Overall Study|Lost to Follow-up|22|||
129933640|NCT05123027|467722553|FG000|Overall Study|Incarceration|3|||
129933641|NCT05123027|467722554|FG001|Overall Study|Incarceration|4|||
129933642|NCT05123027|467722553|FG000|Overall Study|Death|2|||
129933643|NCT05123027|467722554|FG001|Overall Study|Death|2|||
129933644|NCT05123027|467722553|FG000|Overall Study|Other|2|||
129933645|NCT05123027|467722554|FG001|Overall Study|Other|0|||
129933646|NCT05112900|467722555|FG000|Overall Study|Withdrawal by Subject|960|||
129933647|NCT05112900|467722556|FG001|Overall Study|Withdrawal by Subject|921|||
129933648|NCT05112900|467722557|FG002|Overall Study|Withdrawal by Subject|968|||
129933649|NCT00626795|467722560|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
129933650|NCT00626795|467722561|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
129933651|NCT00626795|467722562|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
129933652|NCT00626795|467722560|FG000|Blinded Treatment|Lack of Efficacy|2|||
129933653|NCT00626795|467722561|FG001|Blinded Treatment|Lack of Efficacy|0|||
129933654|NCT00626795|467722562|FG002|Blinded Treatment|Lack of Efficacy|0|||
129933655|NCT00626795|467722560|FG000|Blinded Treatment|Unacceptable adverse event|0|||
129933656|NCT00626795|467722561|FG001|Blinded Treatment|Unacceptable adverse event|0|||
129933657|NCT00626795|467722562|FG002|Blinded Treatment|Unacceptable adverse event|1|||
129933658|NCT00626795|467722560|FG000|Blinded Treatment|Protocol Violation|0|||
129933659|NCT00626795|467722561|FG001|Blinded Treatment|Protocol Violation|1|||
129933660|NCT00626795|467722562|FG002|Blinded Treatment|Protocol Violation|1|||
129933661|NCT00626795|467722560|FG000|Blinded Treatment|Withdrawal by Subject|1|||
129933662|NCT00626795|467722561|FG001|Blinded Treatment|Withdrawal by Subject|1|||
129933663|NCT00626795|467722562|FG002|Blinded Treatment|Withdrawal by Subject|0|||
129933664|NCT00626795|467722560|FG000|Blinded Treatment|Other reasons|2|||
129933665|NCT00626795|467722561|FG001|Blinded Treatment|Other reasons|0|||
129933666|NCT00626795|467722562|FG002|Blinded Treatment|Other reasons|2|||
129933667|NCT00626795|467722560|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
129933668|NCT00626795|467722561|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
129933669|NCT00626795|467722562|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
129933670|NCT04499521|467722570|FG000|Overall Study|Disease Progression|1|||
129933671|NCT04499521|467722571|FG001|Overall Study|Disease Progression|0|||
129933672|NCT05525104|467722572|FG000|Overall Study|Failed caudal analgesia|1|||
129933673|NCT05525104|467722573|FG001|Overall Study|Failed caudal analgesia|3|||
129933674|NCT05525104|467722572|FG000|Overall Study|Premedication needed|0|||
129933675|NCT05525104|467722573|FG001|Overall Study|Premedication needed|1|||
129933676|NCT05525104|467722572|FG000|Overall Study|Protocol Violation|10|||
129933677|NCT05525104|467722573|FG001|Overall Study|Protocol Violation|0|||
129933678|NCT05525104|467722572|FG000|Overall Study|Cancelled operation|1|||
129933679|NCT05525104|467722573|FG001|Overall Study|Cancelled operation|0|||
129933680|NCT03990883|467722574|FG000|Blinded Treatment Phase|Adverse Event|1|||
129933681|NCT03990883|467722575|FG001|Blinded Treatment Phase|Adverse Event|1|||
129933682|NCT03990883|467722576|FG002|Blinded Treatment Phase|Adverse Event|0|||
129933683|NCT03990883|467722574|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
129933684|NCT03990883|467722575|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
129933685|NCT03990883|467722576|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
129933686|NCT03990883|467722574|FG000|Blinded Treatment Phase|Physician Decision|1|||
129933687|NCT03990883|467722575|FG001|Blinded Treatment Phase|Physician Decision|0|||
129933688|NCT03990883|467722576|FG002|Blinded Treatment Phase|Physician Decision|0|||
129933689|NCT03990883|467722574|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
129933690|NCT03990883|467722575|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
129933691|NCT03990883|467722576|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
129933692|NCT03990883|467722574|FG000|Blinded Treatment Phase|COVID-19|3|||
129933693|NCT03990883|467722575|FG001|Blinded Treatment Phase|COVID-19|2|||
129933694|NCT03990883|467722576|FG002|Blinded Treatment Phase|COVID-19|0|||
129933695|NCT03990883|467722574|FG000|Blinded Treatment Phase|Personal Reasons|6|||
129933696|NCT03990883|467722575|FG001|Blinded Treatment Phase|Personal Reasons|3|||
129933697|NCT03990883|467722576|FG002|Blinded Treatment Phase|Personal Reasons|0|||
129933698|NCT03990883|467722574|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
129933699|NCT03990883|467722575|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
129933700|NCT03990883|467722576|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
129933701|NCT03990883|467722574|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
129933702|NCT03990883|467722575|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
129933703|NCT03990883|467722576|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
129933704|NCT03990883|467722574|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
129933705|NCT03990883|467722575|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
129933706|NCT03990883|467722576|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
129933707|NCT04389957|467723821|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
129933708|NCT04389957|467723822|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
129933709|NCT04389957|467723823|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
129933710|NCT04389957|467723824|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
129933711|NCT04389957|467723825|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
129933712|NCT02095691|467723826|FG000|Overall Study|Physician Decision|1|||
129933713|NCT00887198|467723827|FG000|Randomized Period|Ongoing|42|||
129933714|NCT00887198|467723828|FG001|Randomized Period|Ongoing|0|||
129933715|NCT00887198|467723829|FG002|Randomized Period|Ongoing|0|||
129933716|NCT00887198|467723827|FG000|Randomized Period|Adverse Event|50|||
129933717|NCT00887198|467723828|FG001|Randomized Period|Adverse Event|33|||
129933718|NCT00887198|467723829|FG002|Randomized Period|Adverse Event|0|||
129933719|NCT00887198|467723827|FG000|Randomized Period|Lost to Follow-up|1|||
129933720|NCT00887198|467723828|FG001|Randomized Period|Lost to Follow-up|0|||
129933721|NCT00887198|467723829|FG002|Randomized Period|Lost to Follow-up|0|||
129933722|NCT00887198|467723827|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
129933723|NCT00887198|467723828|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
129933724|NCT00887198|467723829|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
129933725|NCT00887198|467723827|FG000|Randomized Period|Withdrawal by Subject|41|||
129933726|NCT00887198|467723828|FG001|Randomized Period|Withdrawal by Subject|56|||
129933727|NCT00887198|467723829|FG002|Randomized Period|Withdrawal by Subject|0|||
129933728|NCT00887198|467723827|FG000|Randomized Period|Progressive disease|366|||
129933729|NCT00887198|467723828|FG001|Randomized Period|Progressive disease|370|||
129933730|NCT00887198|467723829|FG002|Randomized Period|Progressive disease|0|||
129933731|NCT00887198|467723827|FG000|Randomized Period|Other|42|||
130069867|NCT00355134|468211306|FG001|Core Phase|Withdrawal by Subject|24|||
130069868|NCT00355134|468211307|FG002|Core Phase|Withdrawal by Subject|35|||
129933732|NCT00887198|467723828|FG001|Randomized Period|Other|30|||
129933733|NCT00887198|467723829|FG002|Randomized Period|Other|0|||
129933734|NCT00887198|467723827|FG000|Randomized Period|Randomized, Not treated|4|||
129933735|NCT00887198|467723828|FG001|Randomized Period|Randomized, Not treated|2|||
129933736|NCT00887198|467723829|FG002|Randomized Period|Randomized, Not treated|0|||
129933737|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
129933738|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
130069869|NCT00355134|468211308|FG003|Core Phase|Withdrawal by Subject|0|||
130069870|NCT00355134|468211309|FG004|Core Phase|Withdrawal by Subject|0|||
129933739|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
129933740|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
129933741|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
129933742|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
129933743|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
129933744|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
129933745|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
129933746|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
129933747|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
129933748|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
129933749|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
129933750|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
129933751|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
129933752|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Other|0|||
129933753|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Other|0|||
129933754|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Other|19|||
129933755|NCT05007080|467723830|FG000|Overall Study|Lost to Follow-up|0|||
129933756|NCT05007080|467723831|FG001|Overall Study|Lost to Follow-up|1|||
129933757|NCT05007080|467723832|FG002|Overall Study|Lost to Follow-up|0|||
129933758|NCT05007080|467723833|FG003|Overall Study|Lost to Follow-up|1|||
129933759|NCT05007080|467723834|FG004|Overall Study|Lost to Follow-up|1|||
129933760|NCT05007080|467723835|FG005|Overall Study|Lost to Follow-up|1|||
129933761|NCT05007080|467723830|FG000|Overall Study|Death|0|||
129933762|NCT05007080|467723831|FG001|Overall Study|Death|1|||
129933763|NCT05007080|467723832|FG002|Overall Study|Death|0|||
129933764|NCT05007080|467723833|FG003|Overall Study|Death|0|||
129933765|NCT05007080|467723834|FG004|Overall Study|Death|0|||
129933766|NCT05007080|467723835|FG005|Overall Study|Death|0|||
129933767|NCT05007080|467723830|FG000|Overall Study|Withdrawal by Subject|1|||
129933768|NCT05007080|467723831|FG001|Overall Study|Withdrawal by Subject|2|||
129933769|NCT05007080|467723832|FG002|Overall Study|Withdrawal by Subject|0|||
129933770|NCT05007080|467723833|FG003|Overall Study|Withdrawal by Subject|2|||
129933771|NCT05007080|467723834|FG004|Overall Study|Withdrawal by Subject|1|||
129933772|NCT05007080|467723835|FG005|Overall Study|Withdrawal by Subject|1|||
129933773|NCT05007080|467723830|FG000|Overall Study|Other|1|||
129933774|NCT05007080|467723831|FG001|Overall Study|Other|0|||
129933775|NCT05007080|467723832|FG002|Overall Study|Other|1|||
129933776|NCT05007080|467723833|FG003|Overall Study|Other|1|||
129933777|NCT05007080|467723834|FG004|Overall Study|Other|0|||
129933778|NCT05007080|467723835|FG005|Overall Study|Other|2|||
129933779|NCT05007080|467723830|FG000|Overall Study|Randomized not vaccinated|0|||
129933780|NCT05007080|467723831|FG001|Overall Study|Randomized not vaccinated|0|||
129933781|NCT05007080|467723832|FG002|Overall Study|Randomized not vaccinated|0|||
129933782|NCT05007080|467723833|FG003|Overall Study|Randomized not vaccinated|0|||
129933783|NCT05007080|467723834|FG004|Overall Study|Randomized not vaccinated|0|||
129933784|NCT05007080|467723835|FG005|Overall Study|Randomized not vaccinated|1|||
129933785|NCT00319046|467723836|FG000|Overall Study|withdrawal of subject's consent|7|||
129933786|NCT00319046|467723836|FG000|Overall Study|administrative reason|1|||
129933787|NCT05147584|467723837|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
129933788|NCT05460871|467723838|FG000|Overall Study|Withdrawal by Subject|1|||
129933789|NCT05460871|467723839|FG001|Overall Study|Withdrawal by Subject|2|||
129933790|NCT03498521|467723843|FG000|Overall Study|Death|191|||
129933791|NCT03498521|467723844|FG001|Overall Study|Death|64|||
129933792|NCT03498521|467723845|FG002|Overall Study|Death|72|||
129933793|NCT03498521|467723843|FG000|Overall Study|Exclusion criteria|1|||
129933794|NCT03498521|467723844|FG001|Overall Study|Exclusion criteria|0|||
130069871|NCT00355134|468211305|FG000|Core Phase|Adverse Event|28|||
130069872|NCT00355134|468211306|FG001|Core Phase|Adverse Event|22|||
129933795|NCT03498521|467723845|FG002|Overall Study|Exclusion criteria|0|||
129933796|NCT03498521|467723843|FG000|Overall Study|Lost to Follow-up|3|||
129933797|NCT03498521|467723844|FG001|Overall Study|Lost to Follow-up|3|||
129933798|NCT03498521|467723845|FG002|Overall Study|Lost to Follow-up|3|||
129933799|NCT03498521|467723843|FG000|Overall Study|No profile due to technical failure|1|||
129933800|NCT03498521|467723844|FG001|Overall Study|No profile due to technical failure|0|||
129933801|NCT03498521|467723845|FG002|Overall Study|No profile due to technical failure|0|||
129933802|NCT03498521|467723843|FG000|Overall Study|Physician Decision|0|||
129933803|NCT03498521|467723844|FG001|Overall Study|Physician Decision|1|||
129933804|NCT03498521|467723845|FG002|Overall Study|Physician Decision|0|||
129933805|NCT03498521|467723843|FG000|Overall Study|Withdrawal by Subject|9|||
129933806|NCT03498521|467723844|FG001|Overall Study|Withdrawal by Subject|6|||
129933807|NCT03498521|467723845|FG002|Overall Study|Withdrawal by Subject|2|||
129933808|NCT03498521|467723843|FG000|Overall Study|Study ongoing|121|||
129933809|NCT03498521|467723844|FG001|Overall Study|Study ongoing|36|||
129933810|NCT03498521|467723845|FG002|Overall Study|Study ongoing|15|||
129933811|NCT05830799|467723847|FG000|Overall Study|Withdrawal by Subject|1|||
129933812|NCT03652272|467723848|FG000|3 Month|Withdrawal by Subject|1|||
129933813|NCT03652272|467723849|FG001|3 Month|Withdrawal by Subject|1|||
129933814|NCT03652272|467723848|FG000|3 Month|Lost to Follow-up|16|||
129933815|NCT03652272|467723849|FG001|3 Month|Lost to Follow-up|14|||
129933816|NCT04214834|467723852|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
129933817|NCT04214834|467723853|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
129933818|NCT03370913|467723856|FG000|Overall Study|Death|1|||
129933819|NCT03370913|467723856|FG000|Overall Study|Lost to Follow-up|1|||
129933820|NCT04633538|467723857|FG000|Overall Study|Death|1|||
129933821|NCT04633538|467723857|FG000|Overall Study|Lost to Follow-up|3|||
129933822|NCT04633538|467723857|FG000|Overall Study|Withdrawal by Subject|1|||
129933823|NCT02938520|467723860|FG000|Overall Study|On-going at the time of analysis|258|||
129933824|NCT02938520|467723861|FG001|Overall Study|On-going at the time of analysis|261|||
129933825|NCT02938520|467723860|FG000|Overall Study|Physician Decision|2|||
129933826|NCT02938520|467723861|FG001|Overall Study|Physician Decision|5|||
129933827|NCT02938520|467723860|FG000|Overall Study|Lost to Follow-up|2|||
129933828|NCT02938520|467723861|FG001|Overall Study|Lost to Follow-up|2|||
129933829|NCT02938520|467723860|FG000|Overall Study|Withdrawal by Subject|7|||
129933830|NCT02938520|467723861|FG001|Overall Study|Withdrawal by Subject|7|||
129933831|NCT02938520|467723860|FG000|Overall Study|Protocol Violation|0|||
129933832|NCT02938520|467723861|FG001|Overall Study|Protocol Violation|1|||
129933833|NCT02938520|467723860|FG000|Overall Study|Lack of Efficacy|5|||
129933834|NCT02938520|467723861|FG001|Overall Study|Lack of Efficacy|3|||
129933835|NCT02938520|467723860|FG000|Overall Study|Adverse Event|9|||
129933836|NCT02938520|467723861|FG001|Overall Study|Adverse Event|4|||
129933837|NCT04675034|467723866|FG000|Overall Study|Lost to Follow-up|1|||
129933838|NCT04675034|467723867|FG001|Overall Study|Lost to Follow-up|1|||
129933839|NCT04675034|467723868|FG002|Overall Study|Lost to Follow-up|0|||
129933840|NCT04675034|467723869|FG003|Overall Study|Lost to Follow-up|2|||
129933841|NCT04675034|467723870|FG004|Overall Study|Lost to Follow-up|0|||
129933842|NCT04675034|467723866|FG000|Overall Study|Protocol Violation|1|||
129933843|NCT04675034|467723867|FG001|Overall Study|Protocol Violation|0|||
129933844|NCT04675034|467723868|FG002|Overall Study|Protocol Violation|0|||
129933845|NCT04675034|467723869|FG003|Overall Study|Protocol Violation|1|||
129933846|NCT04675034|467723870|FG004|Overall Study|Protocol Violation|3|||
129933847|NCT04675034|467723866|FG000|Overall Study|Withdrawal by Subject|9|||
129933848|NCT04675034|467723867|FG001|Overall Study|Withdrawal by Subject|3|||
129933849|NCT04675034|467723868|FG002|Overall Study|Withdrawal by Subject|4|||
129933850|NCT04675034|467723869|FG003|Overall Study|Withdrawal by Subject|8|||
129933851|NCT04675034|467723870|FG004|Overall Study|Withdrawal by Subject|6|||
129933852|NCT05008055|467723876|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
129933853|NCT05008055|467723877|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
129933854|NCT05008055|467723878|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
129933855|NCT04679389|467723881|FG000|Overall Study|Adverse Event|1|||
129933856|NCT04679389|467723882|FG001|Overall Study|Adverse Event|0|||
129933857|NCT04679389|467723881|FG000|Overall Study|Protocol Violation|2|||
129933858|NCT04679389|467723882|FG001|Overall Study|Protocol Violation|0|||
129933859|NCT04679389|467723881|FG000|Overall Study|Physician Decision|3|||
129933860|NCT04679389|467723882|FG001|Overall Study|Physician Decision|5|||
129933861|NCT04679389|467723881|FG000|Overall Study|Withdrawal by Subject|5|||
129933862|NCT04679389|467723882|FG001|Overall Study|Withdrawal by Subject|7|||
129933863|NCT01438853|467723893|FG000|Overall Study|Death|0|||
129933864|NCT01438853|467723894|FG001|Overall Study|Death|0|||
129933865|NCT01438853|467723895|FG002|Overall Study|Death|0|||
129933866|NCT01438853|467723896|FG003|Overall Study|Death|1|||
129933867|NCT01438853|467723893|FG000|Overall Study|Withdrawal by Subject|0|||
129933868|NCT01438853|467723894|FG001|Overall Study|Withdrawal by Subject|0|||
129933869|NCT01438853|467723895|FG002|Overall Study|Withdrawal by Subject|1|||
130069873|NCT00355134|468211307|FG002|Core Phase|Adverse Event|16|||
129933870|NCT01438853|467723896|FG003|Overall Study|Withdrawal by Subject|0|||
129933871|NCT02624050|467723897|FG000|Overall Study|Physician Decision|4|||
129933872|NCT02624050|467723898|FG001|Overall Study|Physician Decision|0|||
129933873|NCT02624050|467723897|FG000|Overall Study|Protocol Violation|2|||
129933874|NCT02624050|467723898|FG001|Overall Study|Protocol Violation|0|||
129933875|NCT03904576|467723899|FG000|Washout Period|Protocol Violation|1|||
129933876|NCT03904576|467723900|FG001|Washout Period|Protocol Violation|1|||
129933877|NCT03279978|467723902|FG000|Overall Study|Withdrawal by Subject|0|||
129933878|NCT03279978|467723903|FG001|Overall Study|Withdrawal by Subject|1|||
129933879|NCT03279978|467723904|FG002|Overall Study|Withdrawal by Subject|0|||
129933880|NCT03279978|467723905|FG003|Overall Study|Withdrawal by Subject|0|||
129933881|NCT03279978|467723906|FG004|Overall Study|Withdrawal by Subject|0|||
129933882|NCT03279978|467723907|FG005|Overall Study|Withdrawal by Subject|0|||
129933883|NCT03279978|467723908|FG006|Overall Study|Withdrawal by Subject|0|||
129933884|NCT03279978|467723909|FG007|Overall Study|Withdrawal by Subject|0|||
129933885|NCT03279978|467723910|FG008|Overall Study|Withdrawal by Subject|0|||
129933886|NCT03279978|467723911|FG009|Overall Study|Withdrawal by Subject|1|||
130069874|NCT00355134|468211308|FG003|Core Phase|Adverse Event|0|||
130069875|NCT00355134|468211309|FG004|Core Phase|Adverse Event|0|||
129933887|NCT03279978|467723902|FG000|Overall Study|Lost to Follow-up|1|||
130069876|NCT00355134|468211305|FG000|Core Phase|Lost to Follow-up|17|||
130069877|NCT00355134|468211306|FG001|Core Phase|Lost to Follow-up|13|||
130069878|NCT00355134|468211307|FG002|Core Phase|Lost to Follow-up|21|||
130069879|NCT00355134|468211308|FG003|Core Phase|Lost to Follow-up|0|||
130069880|NCT00355134|468211309|FG004|Core Phase|Lost to Follow-up|0|||
130069881|NCT00355134|468211305|FG000|Core Phase|Abnormal laboratory value(s)|19|||
130069882|NCT00355134|468211306|FG001|Core Phase|Abnormal laboratory value(s)|14|||
130069883|NCT00355134|468211307|FG002|Core Phase|Abnormal laboratory value(s)|2|||
130069884|NCT00355134|468211308|FG003|Core Phase|Abnormal laboratory value(s)|0|||
130069885|NCT00355134|468211309|FG004|Core Phase|Abnormal laboratory value(s)|0|||
130069886|NCT00355134|468211305|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
130069887|NCT00355134|468211306|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
130069888|NCT00355134|468211307|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
130069889|NCT00355134|468211308|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
130069890|NCT00355134|468211309|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
130069891|NCT00355134|468211305|FG000|Core Phase|Administrative problems|5|||
130069892|NCT00355134|468211306|FG001|Core Phase|Administrative problems|3|||
130069893|NCT00355134|468211307|FG002|Core Phase|Administrative problems|5|||
130069894|NCT00355134|468211308|FG003|Core Phase|Administrative problems|0|||
130069895|NCT00355134|468211309|FG004|Core Phase|Administrative problems|0|||
130069896|NCT00355134|468211305|FG000|Core Phase|Protocol Violation|3|||
130069897|NCT00355134|468211306|FG001|Core Phase|Protocol Violation|2|||
130069898|NCT00355134|468211307|FG002|Core Phase|Protocol Violation|2|||
130069899|NCT00355134|468211308|FG003|Core Phase|Protocol Violation|0|||
130069900|NCT00355134|468211309|FG004|Core Phase|Protocol Violation|0|||
130069901|NCT00355134|468211305|FG000|Core Phase|Abnormal test procedure result(s)|1|||
130069902|NCT00355134|468211306|FG001|Core Phase|Abnormal test procedure result(s)|2|||
130069903|NCT00355134|468211307|FG002|Core Phase|Abnormal test procedure result(s)|1|||
130069904|NCT00355134|468211308|FG003|Core Phase|Abnormal test procedure result(s)|0|||
130069905|NCT00355134|468211309|FG004|Core Phase|Abnormal test procedure result(s)|0|||
130069906|NCT00355134|468211305|FG000|Core Phase|Condition no longer requires study drug|1|||
130069907|NCT00355134|468211306|FG001|Core Phase|Condition no longer requires study drug|0|||
130069908|NCT00355134|468211307|FG002|Core Phase|Condition no longer requires study drug|1|||
130069909|NCT00355134|468211308|FG003|Core Phase|Condition no longer requires study drug|0|||
130069910|NCT00355134|468211309|FG004|Core Phase|Condition no longer requires study drug|0|||
130069911|NCT00355134|468211305|FG000|Extension Phase|Withdrawal by Subject|7|||
130069912|NCT00355134|468211306|FG001|Extension Phase|Withdrawal by Subject|11|||
130069913|NCT00355134|468211307|FG002|Extension Phase|Withdrawal by Subject|0|||
130069914|NCT00355134|468211308|FG003|Extension Phase|Withdrawal by Subject|7|||
130069915|NCT00355134|468211309|FG004|Extension Phase|Withdrawal by Subject|5|||
130069916|NCT00355134|468211305|FG000|Extension Phase|Adverse Event|13|||
130069917|NCT00355134|468211306|FG001|Extension Phase|Adverse Event|9|||
130069918|NCT00355134|468211307|FG002|Extension Phase|Adverse Event|0|||
130069919|NCT00355134|468211308|FG003|Extension Phase|Adverse Event|3|||
130069920|NCT00355134|468211309|FG004|Extension Phase|Adverse Event|5|||
130069921|NCT00355134|468211305|FG000|Extension Phase|Lost to Follow-up|2|||
130069922|NCT00355134|468211306|FG001|Extension Phase|Lost to Follow-up|6|||
130069923|NCT00355134|468211307|FG002|Extension Phase|Lost to Follow-up|0|||
130069924|NCT00355134|468211308|FG003|Extension Phase|Lost to Follow-up|2|||
130069925|NCT00355134|468211309|FG004|Extension Phase|Lost to Follow-up|4|||
130069926|NCT00355134|468211305|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
130069927|NCT00355134|468211306|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
130069928|NCT00355134|468211307|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
130069929|NCT00355134|468211308|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
130069930|NCT00355134|468211309|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
130069931|NCT00355134|468211305|FG000|Extension Phase|Administrative problems|2|||
130069932|NCT00355134|468211306|FG001|Extension Phase|Administrative problems|4|||
130069933|NCT00355134|468211307|FG002|Extension Phase|Administrative problems|0|||
130069934|NCT00355134|468211308|FG003|Extension Phase|Administrative problems|1|||
130069935|NCT00355134|468211309|FG004|Extension Phase|Administrative problems|1|||
130069936|NCT00355134|468211305|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
130069937|NCT00355134|468211306|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
130069938|NCT00355134|468211307|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
130069939|NCT00355134|468211308|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
130069940|NCT00355134|468211309|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
130069941|NCT00355134|468211305|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
130069942|NCT00355134|468211306|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
130069943|NCT00355134|468211307|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
130069944|NCT00355134|468211308|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
130069945|NCT00355134|468211309|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
130118956|NCT03504852|468396110|FG000|Overall Study|Lack of Efficacy|1|||
129933888|NCT03279978|467723903|FG001|Overall Study|Lost to Follow-up|0|||
130069946|NCT00355134|468211305|FG000|Extension Phase|Protocol Violation|0|||
130069947|NCT00355134|468211306|FG001|Extension Phase|Protocol Violation|0|||
130069948|NCT00355134|468211307|FG002|Extension Phase|Protocol Violation|0|||
130069949|NCT00355134|468211308|FG003|Extension Phase|Protocol Violation|1|||
130069950|NCT00355134|468211309|FG004|Extension Phase|Protocol Violation|0|||
130069951|NCT02848313|468211310|FG000|Overall Study|Adverse Event|1|||
130069952|NCT02848313|468211311|FG001|Overall Study|Adverse Event|2|||
130069953|NCT02848313|468211310|FG000|Overall Study|Lack of Efficacy|0|||
130069954|NCT02848313|468211311|FG001|Overall Study|Lack of Efficacy|1|||
130069955|NCT02848313|468211310|FG000|Overall Study|Withdrawal by Subject|1|||
130069956|NCT02848313|468211311|FG001|Overall Study|Withdrawal by Subject|1|||
130069957|NCT02848313|468211310|FG000|Overall Study|Lost to follow up|1|||
130069958|NCT02848313|468211311|FG001|Overall Study|Lost to follow up|0|||
130069959|NCT01544478|468211312|FG000|Overall Study|Adverse Event|1|||
130069960|NCT01544478|468211312|FG000|Overall Study|Death|1|||
130069961|NCT01544478|468211312|FG000|Overall Study|Lost to Follow-up|48|||
130069962|NCT01544478|468211312|FG000|Overall Study|Physician Decision|15|||
130069963|NCT01544478|468211312|FG000|Overall Study|Pregnancy|1|||
130069964|NCT01544478|468211312|FG000|Overall Study|Withdrawal by Subject|52|||
130069965|NCT03382262|468211316|FG000|Overall Study|Physician Decision|0|||
130069966|NCT03382262|468211317|FG001|Overall Study|Physician Decision|0|||
130069967|NCT03382262|468211318|FG002|Overall Study|Physician Decision|1|||
130069968|NCT03382262|468211319|FG003|Overall Study|Physician Decision|0|||
130069969|NCT03382262|468211316|FG000|Overall Study|Withdrawal by Subject|0|||
130069970|NCT03382262|468211317|FG001|Overall Study|Withdrawal by Subject|0|||
130069971|NCT03382262|468211318|FG002|Overall Study|Withdrawal by Subject|0|||
130069972|NCT03382262|468211319|FG003|Overall Study|Withdrawal by Subject|1|||
130069973|NCT02038790|468211321|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
130069974|NCT02038790|468211322|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
130069975|NCT00438464|468211326|FG000|Overall Study|Terminated Early|14|||
130069976|NCT00438464|468211327|FG001|Overall Study|Terminated Early|5|||
130069977|NCT00438464|468211326|FG000|Overall Study|Incomplete data submission|0|||
130069978|NCT00438464|468211327|FG001|Overall Study|Incomplete data submission|2|||
130069979|NCT03943446|468211329|FG000|Overall Study|Lost to Follow-up|0|||
130069980|NCT03943446|468211330|FG001|Overall Study|Lost to Follow-up|0|||
130069981|NCT03943446|468211331|FG002|Overall Study|Lost to Follow-up|1|||
130069982|NCT03943446|468211329|FG000|Overall Study|Withdrawal by Subject|1|||
130069983|NCT03943446|468211330|FG001|Overall Study|Withdrawal by Subject|1|||
130069984|NCT03943446|468211331|FG002|Overall Study|Withdrawal by Subject|2|||
130069985|NCT03943446|468211329|FG000|Overall Study|Study Terminated by Sponsor|1|||
130069986|NCT03943446|468211330|FG001|Overall Study|Study Terminated by Sponsor|2|||
130069987|NCT03943446|468211331|FG002|Overall Study|Study Terminated by Sponsor|1|||
130069988|NCT03943446|468211329|FG000|Overall Study|Reason not Specified|5|||
130069989|NCT03943446|468211330|FG001|Overall Study|Reason not Specified|1|||
130069990|NCT03943446|468211331|FG002|Overall Study|Reason not Specified|3|||
130069991|NCT04209530|468211334|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
130069992|NCT04209530|468211335|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
130069993|NCT04209530|468211334|FG000|Overall Study|Withdrawal by Subject|0|||
130069994|NCT04209530|468211335|FG001|Overall Study|Withdrawal by Subject|1|||
130069995|NCT03862495|468211338|FG000|Overall Study|Lost to Follow-up|37|||
130069996|NCT03862495|468211339|FG001|Overall Study|Lost to Follow-up|35|||
130069997|NCT00615914|468211340|FG000|Overall Study|Adverse Event|274|||
130069998|NCT00615914|468211340|FG000|Overall Study|Death|20|||
130069999|NCT00615914|468211340|FG000|Overall Study|Lack of Efficacy|59|||
130070000|NCT00615914|468211340|FG000|Overall Study|Lost to Follow-up|187|||
130070001|NCT00615914|468211340|FG000|Overall Study|Withdrawal by Subject|16|||
130070002|NCT00615914|468211340|FG000|Overall Study|Physician Decision|4|||
130070003|NCT00615914|468211340|FG000|Overall Study|No data was collected.|65|||
130070004|NCT00615914|468211340|FG000|Overall Study|No treatment|2|||
130070005|NCT00615914|468211340|FG000|Overall Study|Irregularly enrolled patients|10|||
130070006|NCT01467661|468211341|FG000|Overall Study|Adverse Event|16|||
130070007|NCT01467661|468211341|FG000|Overall Study|Withdrawal by Subject|1|||
130070008|NCT01467661|468211341|FG000|Overall Study|Lack of Efficacy|3|||
130070009|NCT01467661|468211341|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
130070010|NCT03673956|468211342|FG000|Overall Study|Lost to Follow-up|1|||
130070011|NCT03673956|468211343|FG001|Overall Study|Lost to Follow-up|0|||
130070012|NCT03673956|468211344|FG002|Overall Study|Lost to Follow-up|0|||
129933889|NCT03279978|467723904|FG002|Overall Study|Lost to Follow-up|1|||
129933890|NCT03279978|467723905|FG003|Overall Study|Lost to Follow-up|0|||
129933891|NCT03279978|467723906|FG004|Overall Study|Lost to Follow-up|0|||
129933892|NCT03279978|467723907|FG005|Overall Study|Lost to Follow-up|0|||
130070013|NCT03673956|468211345|FG003|Overall Study|Lost to Follow-up|0|||
129933893|NCT03279978|467723908|FG006|Overall Study|Lost to Follow-up|0|||
129933894|NCT03279978|467723909|FG007|Overall Study|Lost to Follow-up|0|||
130070014|NCT03673956|468211342|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
130118957|NCT03504852|468396111|FG001|Overall Study|Lack of Efficacy|2|||
130118958|NCT03504852|468396112|FG002|Overall Study|Lack of Efficacy|0|||
129933895|NCT03279978|467723910|FG008|Overall Study|Lost to Follow-up|0|||
129933896|NCT03279978|467723911|FG009|Overall Study|Lost to Follow-up|0|||
129933897|NCT03279978|467723902|FG000|Overall Study|Other than stated above|0|||
129933898|NCT03279978|467723903|FG001|Overall Study|Other than stated above|0|||
129933899|NCT03279978|467723904|FG002|Overall Study|Other than stated above|0|||
129933900|NCT03279978|467723905|FG003|Overall Study|Other than stated above|0|||
129933901|NCT03279978|467723906|FG004|Overall Study|Other than stated above|0|||
129933902|NCT03279978|467723907|FG005|Overall Study|Other than stated above|0|||
129933903|NCT03279978|467723908|FG006|Overall Study|Other than stated above|1|||
129933904|NCT03279978|467723909|FG007|Overall Study|Other than stated above|0|||
129933905|NCT03279978|467723910|FG008|Overall Study|Other than stated above|0|||
129933906|NCT03279978|467723911|FG009|Overall Study|Other than stated above|0|||
129933907|NCT04330040|467723912|FG000|Overall Study|Other: Adverse event|5|||
129933908|NCT04330040|467723913|FG001|Overall Study|Other: Adverse event|0|||
129933909|NCT04330040|467723914|FG002|Overall Study|Other: Adverse event|0|||
129933910|NCT04330040|467723912|FG000|Overall Study|Disease progression|38|||
129933911|NCT04330040|467723913|FG001|Overall Study|Disease progression|10|||
129933912|NCT04330040|467723914|FG002|Overall Study|Disease progression|0|||
129933913|NCT04330040|467723912|FG000|Overall Study|Physician Decision|5|||
129933914|NCT04330040|467723913|FG001|Overall Study|Physician Decision|3|||
129933915|NCT04330040|467723914|FG002|Overall Study|Physician Decision|0|||
129933916|NCT04330040|467723912|FG000|Overall Study|Lost to Follow-up|1|||
129933917|NCT04330040|467723913|FG001|Overall Study|Lost to Follow-up|1|||
129933918|NCT04330040|467723914|FG002|Overall Study|Lost to Follow-up|0|||
129933919|NCT04330040|467723912|FG000|Overall Study|Death|2|||
129933920|NCT04330040|467723913|FG001|Overall Study|Death|1|||
129933921|NCT04330040|467723914|FG002|Overall Study|Death|0|||
129933922|NCT04330040|467723912|FG000|Overall Study|Withdrawal by Subject|3|||
129933923|NCT04330040|467723913|FG001|Overall Study|Withdrawal by Subject|3|||
129933924|NCT04330040|467723914|FG002|Overall Study|Withdrawal by Subject|0|||
129933925|NCT04330040|467723912|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
129933926|NCT04330040|467723913|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
129933927|NCT04330040|467723914|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
129933928|NCT04330040|467723912|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
129933929|NCT04330040|467723913|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
129933930|NCT04330040|467723914|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
129933931|NCT04330040|467723912|FG000|Overall Study|Other: Disease progression|1|||
129933932|NCT04330040|467723913|FG001|Overall Study|Other: Disease progression|0|||
129933933|NCT04330040|467723914|FG002|Overall Study|Other: Disease progression|0|||
129933934|NCT04330040|467723912|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
129933935|NCT04330040|467723913|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
129933936|NCT04330040|467723914|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
129933937|NCT04330040|467723912|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
129933938|NCT04330040|467723913|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
129933939|NCT04330040|467723914|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
129933940|NCT04330040|467723912|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
129933941|NCT04330040|467723913|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
129933942|NCT04330040|467723914|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
129933943|NCT01756300|467723917|FG000|Overall Study|Death|1|||
129933944|NCT01756300|467723917|FG000|Overall Study|Withdrawal by Subject|1|||
129933945|NCT04427007|467724750|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
129933946|NCT04427007|467724751|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
129933947|NCT04633278|467724752|FG000|Overall Study|Adverse Event|1|||
129933948|NCT04633278|467724753|FG001|Overall Study|Adverse Event|0|||
129933949|NCT04633278|467724752|FG000|Overall Study|Withdrawal by Subject|1|||
129933950|NCT04633278|467724753|FG001|Overall Study|Withdrawal by Subject|0|||
129933951|NCT04633278|467724752|FG000|Overall Study|Death|11|||
129933952|NCT04633278|467724753|FG001|Overall Study|Death|7|||
129933953|NCT04633278|467724752|FG000|Overall Study|Sponsor Decision|3|||
129933954|NCT04633278|467724753|FG001|Overall Study|Sponsor Decision|0|||
129933955|NCT04633278|467724752|FG000|Overall Study|Not Listed|1|||
129933956|NCT04633278|467724753|FG001|Overall Study|Not Listed|0|||
129933957|NCT03636490|467724754|FG000|Overall Study|Dropped out or incomplete data|141|||
129933958|NCT02246127|467724755|FG000|First Course Treatment|Adverse Event|9|||
129933959|NCT02246127|467724756|FG001|First Course Treatment|Adverse Event|7|||
129933960|NCT02246127|467724755|FG000|First Course Treatment|Withdrawal by Subject|6|||
129933961|NCT02246127|467724756|FG001|First Course Treatment|Withdrawal by Subject|7|||
129933962|NCT02246127|467724755|FG000|First Course Treatment|Physician Decision|9|||
129933963|NCT02246127|467724756|FG001|First Course Treatment|Physician Decision|9|||
129933964|NCT02246127|467724755|FG000|First Course Treatment|Death|3|||
129933965|NCT02246127|467724756|FG001|First Course Treatment|Death|3|||
129933966|NCT02246127|467724755|FG000|First Course Treatment|Not reported reasons|6|||
130118959|NCT03504852|468396110|FG000|Overall Study|Death|0|||
129933967|NCT02246127|467724756|FG001|First Course Treatment|Not reported reasons|7|||
129933968|NCT02246127|467724755|FG000|First Course Treatment|Not treated|3|||
129933969|NCT02246127|467724756|FG001|First Course Treatment|Not treated|3|||
129933970|NCT06262347|467724762|FG000|Overall Study|Lost to Follow-up|4|||
129933971|NCT06262347|467724763|FG001|Overall Study|Lost to Follow-up|3|||
129933972|NCT06262347|467724762|FG000|Overall Study|Withdrawal by Subject|0|||
129933973|NCT06262347|467724763|FG001|Overall Study|Withdrawal by Subject|1|||
130118960|NCT03504852|468396111|FG001|Overall Study|Death|1|||
129933974|NCT06655818|467724776|FG000|Overall Study|Withdrawal by Subject|1|||
129933975|NCT04623775|467724787|FG000|Randomization|No Longer Meets Study Criteria|2|||
129933976|NCT04623775|467724788|FG001|Randomization|No Longer Meets Study Criteria|1|||
129933977|NCT04623775|467724789|FG002|Randomization|No Longer Meets Study Criteria|0|||
129933978|NCT04623775|467724790|FG003|Randomization|No Longer Meets Study Criteria|0|||
129933979|NCT04623775|467724787|FG000|Randomization|Withdrew Consent|0|||
129933980|NCT04623775|467724788|FG001|Randomization|Withdrew Consent|0|||
129933981|NCT04623775|467724789|FG002|Randomization|Withdrew Consent|0|||
129933982|NCT04623775|467724790|FG003|Randomization|Withdrew Consent|1|||
129933983|NCT04623775|467724787|FG000|Randomization|Other Reasons|0|||
129933984|NCT04623775|467724788|FG001|Randomization|Other Reasons|0|||
129933985|NCT04623775|467724789|FG002|Randomization|Other Reasons|0|||
129933986|NCT04623775|467724790|FG003|Randomization|Other Reasons|1|||
129933987|NCT04623775|467724787|FG000|Treatment Period|participant withdrew consent|4|||
129933988|NCT04623775|467724788|FG001|Treatment Period|participant withdrew consent|0|||
129933989|NCT04623775|467724789|FG002|Treatment Period|participant withdrew consent|1|||
129933990|NCT04623775|467724790|FG003|Treatment Period|participant withdrew consent|2|||
129933991|NCT04623775|467724787|FG000|Treatment Period|Death|3|||
129933992|NCT04623775|467724788|FG001|Treatment Period|Death|1|||
129933993|NCT04623775|467724789|FG002|Treatment Period|Death|4|||
129933994|NCT04623775|467724790|FG003|Treatment Period|Death|2|||
129933995|NCT04623775|467724787|FG000|Treatment Period|Lost to Follow-up|0|||
129933996|NCT04623775|467724788|FG001|Treatment Period|Lost to Follow-up|2|||
129933997|NCT04623775|467724789|FG002|Treatment Period|Lost to Follow-up|0|||
129933998|NCT04623775|467724790|FG003|Treatment Period|Lost to Follow-up|0|||
129933999|NCT04623775|467724787|FG000|Treatment Period|poor/non compliance|0|||
129934000|NCT04623775|467724788|FG001|Treatment Period|poor/non compliance|0|||
129934001|NCT04623775|467724789|FG002|Treatment Period|poor/non compliance|1|||
129934002|NCT04623775|467724790|FG003|Treatment Period|poor/non compliance|0|||
129934003|NCT04623775|467724787|FG000|Treatment Period|participant no longer meets study criteria|0|||
129934004|NCT04623775|467724788|FG001|Treatment Period|participant no longer meets study criteria|1|||
129934005|NCT04623775|467724789|FG002|Treatment Period|participant no longer meets study criteria|0|||
129934006|NCT04623775|467724790|FG003|Treatment Period|participant no longer meets study criteria|0|||
129934007|NCT04623775|467724787|FG000|Treatment Period|administrative reasons by sponsor|3|||
129934008|NCT04623775|467724788|FG001|Treatment Period|administrative reasons by sponsor|2|||
129934009|NCT04623775|467724789|FG002|Treatment Period|administrative reasons by sponsor|0|||
129934010|NCT04623775|467724790|FG003|Treatment Period|administrative reasons by sponsor|0|||
129934011|NCT04623775|467724787|FG000|Treatment Period|other reasons|2|||
129934012|NCT04623775|467724788|FG001|Treatment Period|other reasons|0|||
129934013|NCT04623775|467724789|FG002|Treatment Period|other reasons|1|||
129934014|NCT04623775|467724790|FG003|Treatment Period|other reasons|1|||
129934015|NCT04623775|467724787|FG000|Treatment Period|disease progression|40|||
129934016|NCT04623775|467724788|FG001|Treatment Period|disease progression|35|||
129934017|NCT04623775|467724789|FG002|Treatment Period|disease progression|63|||
129934018|NCT04623775|467724790|FG003|Treatment Period|disease progression|63|||
129934019|NCT04623775|467724787|FG000|Treatment Period|study drug toxicity|12|||
129934020|NCT04623775|467724788|FG001|Treatment Period|study drug toxicity|15|||
129934021|NCT04623775|467724789|FG002|Treatment Period|study drug toxicity|13|||
129934022|NCT04623775|467724790|FG003|Treatment Period|study drug toxicity|12|||
129934023|NCT04623775|467724787|FG000|Treatment Period|AE unrelated to study drug|4|||
129934024|NCT04623775|467724788|FG001|Treatment Period|AE unrelated to study drug|9|||
129934025|NCT04623775|467724789|FG002|Treatment Period|AE unrelated to study drug|12|||
129934026|NCT04623775|467724790|FG003|Treatment Period|AE unrelated to study drug|9|||
129934027|NCT04623775|467724787|FG000|Treatment Period|participant request to discontinue treatment|0|||
129934028|NCT04623775|467724788|FG001|Treatment Period|participant request to discontinue treatment|2|||
129934029|NCT04623775|467724789|FG002|Treatment Period|participant request to discontinue treatment|2|||
129934030|NCT04623775|467724790|FG003|Treatment Period|participant request to discontinue treatment|0|||
129934031|NCT04560179|467724799|FG000|Overall Study|Physician Decision|1|||
129934032|NCT04560179|467724800|FG001|Overall Study|Physician Decision|0|||
129934033|NCT04560179|467724801|FG002|Overall Study|Physician Decision|0|||
129934034|NCT04560179|467724802|FG003|Overall Study|Physician Decision|0|||
129934035|NCT04560179|467724803|FG004|Overall Study|Physician Decision|0|||
129934036|NCT04560179|467724799|FG000|Overall Study|Adverse Event|0|||
129934037|NCT04560179|467724800|FG001|Overall Study|Adverse Event|0|||
129934038|NCT04560179|467724801|FG002|Overall Study|Adverse Event|0|||
129934039|NCT04560179|467724802|FG003|Overall Study|Adverse Event|1|||
129934040|NCT04560179|467724803|FG004|Overall Study|Adverse Event|0|||
129934041|NCT04496752|467724806|FG000|Second Assessment|Lost to Follow-up|3|||
129934042|NCT04496752|467724807|FG001|Second Assessment|Lost to Follow-up|3|||
129934043|NCT04496752|467724806|FG000|Second Assessment|Adverse Event|2|||
129934044|NCT04496752|467724807|FG001|Second Assessment|Adverse Event|0|||
129934045|NCT04967599|467724810|FG000|Overall Study|Lost to Follow-up|35|||
129934046|NCT04967599|467724811|FG001|Overall Study|Lost to Follow-up|19|||
129934047|NCT04967599|467724812|FG002|Overall Study|Lost to Follow-up|23|||
129934048|NCT04369911|467724813|FG000|Overall Study|Lost to Follow-up|3|||
129934049|NCT04369911|467724814|FG001|Overall Study|Lost to Follow-up|3|||
129934050|NCT04369911|467724813|FG000|Overall Study|Withdrawal by Subject|1|||
129934051|NCT04369911|467724814|FG001|Overall Study|Withdrawal by Subject|2|||
129934052|NCT05451693|467724815|FG000|Overall Study|Withdrawal by Subject|1|||
129934053|NCT05451693|467724816|FG001|Overall Study|Withdrawal by Subject|1|||
129934054|NCT05541484|467724826|FG000|Overall Study|Withdrawal by Subject|1|||
129934055|NCT05541484|467724827|FG001|Overall Study|Withdrawal by Subject|0|||
129934056|NCT02919917|467724830|FG000|Overall Study|Withdrawal by Subject|4|||
129934057|NCT02919917|467724831|FG001|Overall Study|Withdrawal by Subject|8|||
129934058|NCT05215054|467724832|FG000|Overall Study|Lost to Follow-up|1|||
129934059|NCT05215054|467724833|FG001|Overall Study|Lost to Follow-up|1|||
129934060|NCT05215054|467724832|FG000|Overall Study|Protocol Violation|1|||
129934061|NCT05215054|467724833|FG001|Overall Study|Protocol Violation|1|||
129934062|NCT05215054|467724832|FG000|Overall Study|Withdrawal by Subject|4|||
129934063|NCT05215054|467724833|FG001|Overall Study|Withdrawal by Subject|4|||
129934064|NCT04159519|467724837|FG000|Overall Study|Adverse Event|1|||
129934065|NCT04159519|467724838|FG001|Overall Study|Adverse Event|1|||
129934066|NCT04159519|467724837|FG000|Overall Study|Lack of Efficacy|1|||
129934067|NCT04159519|467724838|FG001|Overall Study|Lack of Efficacy|0|||
129934068|NCT04159519|467724837|FG000|Overall Study|Discontinued from study|1|||
129934069|NCT04159519|467724838|FG001|Overall Study|Discontinued from study|0|||
129934070|NCT04159519|467724837|FG000|Overall Study|Protocol Violation|1|||
129934071|NCT04159519|467724838|FG001|Overall Study|Protocol Violation|1|||
129934072|NCT04159519|467724837|FG000|Overall Study|Withdrawal by Subject|4|||
129934073|NCT04159519|467724838|FG001|Overall Study|Withdrawal by Subject|4|||
129934074|NCT01651000|467724839|FG000|Overall Study|Adverse Event|2|||
129934075|NCT01651000|467724840|FG001|Overall Study|Adverse Event|8|||
129934076|NCT01651000|467724839|FG000|Overall Study|Lost to Follow-up|3|||
129934077|NCT01651000|467724840|FG001|Overall Study|Lost to Follow-up|2|||
129934078|NCT01651000|467724839|FG000|Overall Study|Protocol Violation|0|||
129934079|NCT01651000|467724840|FG001|Overall Study|Protocol Violation|3|||
129934080|NCT01651000|467724839|FG000|Overall Study|Withdrawal by Subject|2|||
129934081|NCT01651000|467724840|FG001|Overall Study|Withdrawal by Subject|10|||
129934082|NCT01651000|467724839|FG000|Overall Study|Subject noncompliance|0|||
129934083|NCT01651000|467724840|FG001|Overall Study|Subject noncompliance|3|||
129934084|NCT01651000|467724839|FG000|Overall Study|Lack of Efficacy|1|||
129934085|NCT01651000|467724840|FG001|Overall Study|Lack of Efficacy|1|||
129934086|NCT01651000|467724839|FG000|Overall Study|Physician Decision|1|||
129934087|NCT01651000|467724840|FG001|Overall Study|Physician Decision|0|||
129934088|NCT01651000|467724839|FG000|Overall Study|Administrative reason|1|||
129934089|NCT01651000|467724840|FG001|Overall Study|Administrative reason|0|||
129934090|NCT01651000|467724839|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
129934091|NCT01651000|467724840|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
129934092|NCT02765412|467724841|FG000|Overall Study|Death|482|||
129934093|NCT02765412|467724842|FG001|Overall Study|Death|855|||
129934094|NCT02163694|467725545|FG000|Overall Study|Adverse event- related to progression|4|||
129934095|NCT02163694|467725546|FG001|Overall Study|Adverse event- related to progression|10|||
129934096|NCT02163694|467725545|FG000|Overall Study|Adverse event- not related to progression|7|||
129934097|NCT02163694|467725546|FG001|Overall Study|Adverse event- not related to progression|22|||
129934098|NCT02163694|467725545|FG000|Overall Study|Withdrew consent|13|||
129934099|NCT02163694|467725546|FG001|Overall Study|Withdrew consent|28|||
129934100|NCT02163694|467725545|FG000|Overall Study|Lost to Follow-up|2|||
129934101|NCT02163694|467725546|FG001|Overall Study|Lost to Follow-up|2|||
130070015|NCT03673956|468211343|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
130070016|NCT03673956|468211344|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
130070017|NCT03673956|468211345|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
129934102|NCT02163694|467725545|FG000|Overall Study|Sponsor discontinued study|3|||
129934103|NCT02163694|467725546|FG001|Overall Study|Sponsor discontinued study|29|||
129934104|NCT02163694|467725545|FG000|Overall Study|Progressive disease per protocol|125|||
129934105|NCT02163694|467725546|FG001|Overall Study|Progressive disease per protocol|224|||
129934106|NCT02163694|467725545|FG000|Overall Study|Other, not specified|17|||
129934107|NCT02163694|467725546|FG001|Overall Study|Other, not specified|22|||
129934108|NCT02163694|467725545|FG000|Overall Study|Randomized but Not Treated|1|||
129934109|NCT02163694|467725546|FG001|Overall Study|Randomized but Not Treated|0|||
129934110|NCT02163694|467725545|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
129934111|NCT02163694|467725546|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
129934112|NCT06010836|467725549|FG000|Overall Study|Lost to Follow-up|2|||
129934113|NCT06010836|467725550|FG001|Overall Study|Lost to Follow-up|2|||
129934114|NCT06010836|467725549|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
129934115|NCT06010836|467725550|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
129934116|NCT06010836|467725549|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
129934117|NCT06010836|467725550|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
129934118|NCT06010836|467725549|FG000|Overall Study|Did not receive intervention discussion|0|||
129934119|NCT06010836|467725550|FG001|Overall Study|Did not receive intervention discussion|4|||
129934120|NCT04524689|467725551|FG000|Overall Study|Withdrawal by Subject|1|||
129934121|NCT04524689|467725552|FG001|Overall Study|Withdrawal by Subject|1|||
129934122|NCT04524689|467725553|FG002|Overall Study|Withdrawal by Subject|0|||
129934123|NCT04524689|467725554|FG003|Overall Study|Withdrawal by Subject|0|||
129934124|NCT04524689|467725555|FG004|Overall Study|Withdrawal by Subject|1|||
129934125|NCT04524689|467725556|FG005|Overall Study|Withdrawal by Subject|0|||
129934126|NCT04524689|467725551|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
129934127|NCT04524689|467725552|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
129934128|NCT04524689|467725553|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
129934129|NCT04524689|467725554|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
129934130|NCT04524689|467725555|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
129934131|NCT04524689|467725556|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
129934132|NCT04524689|467725551|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
129934133|NCT04524689|467725552|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
129934134|NCT04524689|467725553|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
129934135|NCT04524689|467725554|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
129934136|NCT04524689|467725555|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
129934137|NCT04524689|467725556|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
129934138|NCT03662022|467725559|FG000|Year 1 2019|prevalent case|83|||
129934139|NCT03662022|467725560|FG001|Year 1 2019|prevalent case|116|||
129934140|NCT03662022|467725561|FG002|Year 1 2019|prevalent case|158|||
129934141|NCT03662022|467725562|FG003|Year 1 2019|prevalent case|99|||
129934142|NCT03662022|467725559|FG000|Year 2 2020|incident case|18|||
129934143|NCT03662022|467725560|FG001|Year 2 2020|incident case|18|||
129934144|NCT03662022|467725561|FG002|Year 2 2020|incident case|16|||
129934145|NCT03662022|467725562|FG003|Year 2 2020|incident case|26|||
129934146|NCT03662022|467725559|FG000|Year 2 2020|other case|18|||
129934147|NCT03662022|467725560|FG001|Year 2 2020|other case|16|||
129934148|NCT03662022|467725561|FG002|Year 2 2020|other case|16|||
129934149|NCT03662022|467725562|FG003|Year 2 2020|other case|24|||
129934150|NCT03662022|467725559|FG000|Year 2 2020|Lost to Follow-up|1633|||
129934151|NCT03662022|467725560|FG001|Year 2 2020|Lost to Follow-up|1183|||
129934152|NCT03662022|467725561|FG002|Year 2 2020|Lost to Follow-up|1381|||
129934153|NCT03662022|467725562|FG003|Year 2 2020|Lost to Follow-up|2858|||
129934154|NCT03662022|467725559|FG000|Year 3 2021|incident case|24|||
129934155|NCT03662022|467725560|FG001|Year 3 2021|incident case|27|||
129934156|NCT03662022|467725561|FG002|Year 3 2021|incident case|24|||
129934157|NCT03662022|467725562|FG003|Year 3 2021|incident case|11|||
129934158|NCT03662022|467725559|FG000|Year 3 2021|other case|4|||
129934159|NCT03662022|467725560|FG001|Year 3 2021|other case|15|||
129934160|NCT03662022|467725561|FG002|Year 3 2021|other case|10|||
129934161|NCT03662022|467725562|FG003|Year 3 2021|other case|14|||
129934162|NCT03662022|467725559|FG000|Year 3 2021|Lost to Follow-up|179|||
129934163|NCT03662022|467725560|FG001|Year 3 2021|Lost to Follow-up|244|||
129934164|NCT03662022|467725561|FG002|Year 3 2021|Lost to Follow-up|480|||
129934165|NCT03662022|467725562|FG003|Year 3 2021|Lost to Follow-up|477|||
129934166|NCT03662022|467725559|FG000|Year 4 2022|incident case|25|||
129934167|NCT03662022|467725560|FG001|Year 4 2022|incident case|41|||
129934168|NCT03662022|467725561|FG002|Year 4 2022|incident case|28|||
129934169|NCT03662022|467725562|FG003|Year 4 2022|incident case|7|||
129934170|NCT03662022|467725559|FG000|Year 4 2022|other case|8|||
129934171|NCT03662022|467725560|FG001|Year 4 2022|other case|19|||
129934172|NCT03662022|467725561|FG002|Year 4 2022|other case|13|||
129934173|NCT03662022|467725562|FG003|Year 4 2022|other case|7|||
129934174|NCT03662022|467725559|FG000|Year 4 2022|Lost to Follow-up|986|||
129934175|NCT03662022|467725560|FG001|Year 4 2022|Lost to Follow-up|1079|||
129934176|NCT03662022|467725561|FG002|Year 4 2022|Lost to Follow-up|1236|||
129934177|NCT03662022|467725562|FG003|Year 4 2022|Lost to Follow-up|1826|||
129934178|NCT04490109|467725573|FG000|Overall Study|Lost to Follow-up|3|||
129934179|NCT04490109|467725574|FG001|Overall Study|Lost to Follow-up|10|||
129934180|NCT04490109|467725575|FG002|Overall Study|Lost to Follow-up|4|||
129934181|NCT04490109|467725573|FG000|Overall Study|Withdrawal by Subject|8|||
129934182|NCT04490109|467725574|FG001|Overall Study|Withdrawal by Subject|6|||
129934183|NCT04490109|467725575|FG002|Overall Study|Withdrawal by Subject|9|||
129934184|NCT04490109|467725573|FG000|Overall Study|Physician Decision|0|||
129934185|NCT04490109|467725574|FG001|Overall Study|Physician Decision|2|||
129934186|NCT04490109|467725575|FG002|Overall Study|Physician Decision|3|||
130118961|NCT03504852|468396112|FG002|Overall Study|Death|0|||
130118962|NCT03504852|468396110|FG000|Overall Study|Adverse Event|4|||
130118963|NCT03504852|468396111|FG001|Overall Study|Adverse Event|8|||
130118964|NCT03504852|468396112|FG002|Overall Study|Adverse Event|2|||
130118965|NCT01066052|468396113|FG000|Overall Study|Enrolled But Not Treated|3|||
130118966|NCT01066052|468396114|FG001|Overall Study|Enrolled But Not Treated|0|||
130118967|NCT01835145|468396115|FG000|Overall Study|Ineligible prior to treatment|1|||
130118968|NCT01835145|468396116|FG001|Overall Study|Ineligible prior to treatment|0|||
130118969|NCT01309919|468396137|FG000|Overall Study|Did not receive a postpartum IUD|17|||
130118970|NCT01309919|468396138|FG001|Overall Study|Did not receive a postpartum IUD|48|||
130118971|NCT00319449|468396139|FG000|Overall Study|Subject did not wish to continue|1|||
130118972|NCT00319449|468396140|FG001|Overall Study|Subject did not wish to continue|0|||
130118973|NCT00319449|468396139|FG000|Overall Study|Noncompliance with the protocol|1|||
130118974|NCT00319449|468396140|FG001|Overall Study|Noncompliance with the protocol|0|||
130118975|NCT02102490|468396141|FG000|Overall Study|Death|6|||
130118976|NCT02102490|468396141|FG000|Overall Study|Lost to Follow-up|1|||
130118977|NCT01346410|468396142|FG000|Overall Study|Death|1|||
130118978|NCT00979628|468396143|FG000|Overall Study|received regimen < 24 hours|7|||
130118979|NCT00979628|468396144|FG001|Overall Study|received regimen < 24 hours|6|||
130118980|NCT00979628|468396145|FG002|Overall Study|received regimen < 24 hours|5|||
130118981|NCT00979628|468396143|FG000|Overall Study|received steroids|1|||
129934187|NCT04490109|467725573|FG000|Overall Study|Adverse Event|2|||
129934188|NCT04490109|467725574|FG001|Overall Study|Adverse Event|1|||
129934189|NCT04490109|467725575|FG002|Overall Study|Adverse Event|0|||
129934190|NCT04490109|467725573|FG000|Overall Study|Significant Non-Compliance|2|||
129934191|NCT04490109|467725574|FG001|Overall Study|Significant Non-Compliance|4|||
129934192|NCT04490109|467725575|FG002|Overall Study|Significant Non-Compliance|4|||
129934193|NCT04490109|467725573|FG000|Overall Study|Significant Clinical Event|0|||
129934194|NCT04490109|467725574|FG001|Overall Study|Significant Clinical Event|1|||
129934195|NCT04490109|467725575|FG002|Overall Study|Significant Clinical Event|0|||
129934196|NCT04490109|467725573|FG000|Overall Study|Other Reason|4|||
129934197|NCT04490109|467725574|FG001|Overall Study|Other Reason|1|||
129934198|NCT04490109|467725575|FG002|Overall Study|Other Reason|1|||
129934199|NCT03817983|467725578|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
129934200|NCT03817983|467725579|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
129934201|NCT03817983|467725580|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
129934202|NCT03744676|467725581|FG000|Pre-Treatment Phase|Disease related complications|2|||
129934203|NCT03744676|467725581|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
129934204|NCT03744676|467725581|FG000|Pre-Treatment Phase|Death|7|||
129934205|NCT03744676|467725581|FG000|Pre-Treatment Phase|Other Reasons|7|||
129934206|NCT03744676|467725581|FG000|Treatment Phase|Participant withdrew consent|8|||
129934207|NCT03744676|467725581|FG000|Treatment Phase|Death|33|||
129934208|NCT03744676|467725581|FG000|Treatment Phase|other reasons|6|||
129934209|NCT03884439|467725588|FG000|Overall Study|No informed consent for publication of study results|38|||
129934210|NCT03884439|467725588|FG000|Overall Study|Contract violation/deficiency|7|||
129934211|NCT03547271|467725589|FG000|Overall Study|Adverse Event|1|||
129934212|NCT03547271|467725590|FG001|Overall Study|Adverse Event|1|||
129934213|NCT03547271|467725591|FG002|Overall Study|Adverse Event|0|||
129934214|NCT03547271|467725592|FG003|Overall Study|Adverse Event|0|||
129934215|NCT03547271|467725589|FG000|Overall Study|Protocol deviation|5|||
129934216|NCT03547271|467725590|FG001|Overall Study|Protocol deviation|7|||
129934217|NCT03547271|467725591|FG002|Overall Study|Protocol deviation|3|||
129934218|NCT03547271|467725592|FG003|Overall Study|Protocol deviation|0|||
129934219|NCT03547271|467725589|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
129934220|NCT03547271|467725590|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
129934221|NCT03547271|467725591|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129934222|NCT03547271|467725592|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
129934223|NCT03547271|467725589|FG000|Overall Study|Lost to Follow-up|3|||
129934224|NCT03547271|467725590|FG001|Overall Study|Lost to Follow-up|3|||
129934225|NCT03547271|467725591|FG002|Overall Study|Lost to Follow-up|1|||
129934226|NCT03547271|467725592|FG003|Overall Study|Lost to Follow-up|0|||
129934227|NCT03533257|467725598|FG000|Overall Study|Adverse Event|4|||
129934228|NCT03533257|467725599|FG001|Overall Study|Adverse Event|2|||
129934229|NCT03533257|467725598|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
129934230|NCT03533257|467725599|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
129934231|NCT03250676|467725600|FG000|Overall Study|Adverse Event|0|||
130118982|NCT00979628|468396144|FG001|Overall Study|received steroids|1|||
130118983|NCT00979628|468396145|FG002|Overall Study|received steroids|0|||
130118984|NCT00979628|468396143|FG000|Overall Study|transferred to ICU|1|||
129934232|NCT03250676|467725601|FG001|Overall Study|Adverse Event|0|||
129934233|NCT03250676|467725602|FG002|Overall Study|Adverse Event|0|||
129934234|NCT03250676|467725603|FG003|Overall Study|Adverse Event|1|||
129934235|NCT03250676|467725604|FG004|Overall Study|Adverse Event|2|||
129934236|NCT03250676|467725605|FG005|Overall Study|Adverse Event|9|||
129934237|NCT03250676|467725600|FG000|Overall Study|Withdrawal by Subject|1|||
130118985|NCT00979628|468396144|FG001|Overall Study|transferred to ICU|2|||
130118986|NCT00979628|468396145|FG002|Overall Study|transferred to ICU|1|||
129934238|NCT03250676|467725601|FG001|Overall Study|Withdrawal by Subject|0|||
129934239|NCT03250676|467725602|FG002|Overall Study|Withdrawal by Subject|0|||
129934240|NCT03250676|467725603|FG003|Overall Study|Withdrawal by Subject|1|||
129934241|NCT03250676|467725604|FG004|Overall Study|Withdrawal by Subject|1|||
129934242|NCT03250676|467725605|FG005|Overall Study|Withdrawal by Subject|2|||
129934243|NCT03250676|467725600|FG000|Overall Study|Physician Decision|0|||
129934244|NCT03250676|467725601|FG001|Overall Study|Physician Decision|0|||
129934245|NCT03250676|467725602|FG002|Overall Study|Physician Decision|0|||
129934246|NCT03250676|467725603|FG003|Overall Study|Physician Decision|2|||
129934247|NCT03250676|467725604|FG004|Overall Study|Physician Decision|0|||
129934248|NCT03250676|467725605|FG005|Overall Study|Physician Decision|3|||
129934249|NCT03250676|467725600|FG000|Overall Study|Withdrawal of consent|0|||
129934250|NCT03250676|467725601|FG001|Overall Study|Withdrawal of consent|0|||
129934251|NCT03250676|467725602|FG002|Overall Study|Withdrawal of consent|2|||
129934252|NCT03250676|467725603|FG003|Overall Study|Withdrawal of consent|0|||
129934253|NCT03250676|467725604|FG004|Overall Study|Withdrawal of consent|0|||
129934254|NCT03250676|467725605|FG005|Overall Study|Withdrawal of consent|2|||
129934255|NCT03250676|467725600|FG000|Overall Study|Other|1|||
129934256|NCT03250676|467725601|FG001|Overall Study|Other|0|||
129934257|NCT03250676|467725602|FG002|Overall Study|Other|0|||
129934258|NCT03250676|467725603|FG003|Overall Study|Other|0|||
129934259|NCT03250676|467725604|FG004|Overall Study|Other|0|||
129934260|NCT03250676|467725605|FG005|Overall Study|Other|0|||
129934261|NCT03250676|467725600|FG000|Overall Study|Disease progression|4|||
129934262|NCT03250676|467725601|FG001|Overall Study|Disease progression|12|||
129934263|NCT03250676|467725602|FG002|Overall Study|Disease progression|9|||
129934264|NCT03250676|467725603|FG003|Overall Study|Disease progression|7|||
129934265|NCT03250676|467725604|FG004|Overall Study|Disease progression|4|||
129934266|NCT03250676|467725605|FG005|Overall Study|Disease progression|88|||
129934267|NCT04780581|467725606|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
129934268|NCT04780581|467725607|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
129934269|NCT04780581|467725606|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
129934270|NCT04780581|467725607|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
129934271|NCT05267639|467726663|FG000|Overall Study|Withdrawal by Subject|1|||
129934272|NCT05267639|467726664|FG001|Overall Study|Withdrawal by Subject|0|||
129934273|NCT04244175|467726668|FG000|Overall Study|Adverse Event|3|||
129934274|NCT04244175|467726669|FG001|Overall Study|Adverse Event|2|||
129934275|NCT04244175|467726670|FG002|Overall Study|Adverse Event|5|||
129934276|NCT04244175|467726668|FG000|Overall Study|Lack of Efficacy|1|||
129934277|NCT04244175|467726669|FG001|Overall Study|Lack of Efficacy|0|||
129934278|NCT04244175|467726670|FG002|Overall Study|Lack of Efficacy|1|||
129934279|NCT04244175|467726668|FG000|Overall Study|Lost to Follow-up|1|||
129934280|NCT04244175|467726669|FG001|Overall Study|Lost to Follow-up|0|||
129934281|NCT04244175|467726670|FG002|Overall Study|Lost to Follow-up|0|||
129934282|NCT04244175|467726668|FG000|Overall Study|Non-compliance with study drug|1|||
129934283|NCT04244175|467726669|FG001|Overall Study|Non-compliance with study drug|0|||
129934284|NCT04244175|467726670|FG002|Overall Study|Non-compliance with study drug|1|||
129934285|NCT04244175|467726668|FG000|Overall Study|Protocol deviation|0|||
129934286|NCT04244175|467726669|FG001|Overall Study|Protocol deviation|1|||
129934287|NCT04244175|467726670|FG002|Overall Study|Protocol deviation|0|||
129934288|NCT04244175|467726668|FG000|Overall Study|Withdrawal by Subject|1|||
129934289|NCT04244175|467726669|FG001|Overall Study|Withdrawal by Subject|3|||
129934290|NCT04244175|467726670|FG002|Overall Study|Withdrawal by Subject|1|||
129934291|NCT04244175|467726668|FG000|Overall Study|Other, not specified|0|||
129934292|NCT04244175|467726669|FG001|Overall Study|Other, not specified|1|||
129934293|NCT04244175|467726670|FG002|Overall Study|Other, not specified|2|||
129934294|NCT04595331|467726671|FG000|Overall Study|Withdrawal by Subject|0|||
129934295|NCT04595331|467726672|FG001|Overall Study|Withdrawal by Subject|1|||
129934296|NCT04595331|467726671|FG000|Overall Study|Lost to Follow-up|0|||
129934297|NCT04595331|467726672|FG001|Overall Study|Lost to Follow-up|5|||
129934298|NCT04595331|467726671|FG000|Overall Study|Medical reason|0|||
129934299|NCT04595331|467726672|FG001|Overall Study|Medical reason|1|||
129934300|NCT03781089|467726673|FG000|Overall Study|Constipation|1|||
129934301|NCT03781089|467726674|FG001|Overall Study|Constipation|0|||
129934302|NCT03781089|467726673|FG000|Overall Study|Positive pregnancy test|0|||
129934303|NCT03781089|467726674|FG001|Overall Study|Positive pregnancy test|1|||
129934304|NCT05311176|467726675|FG000|Overall Study|Death|6|||
129934305|NCT05311176|467726675|FG000|Overall Study|Sponsor discontinued the study|1|||
129934306|NCT05836012|467726686|FG000|Overall Study|Lost to Follow-up|1|||
129934307|NCT05836012|467726687|FG001|Overall Study|Lost to Follow-up|0|||
129934308|NCT05836012|467726686|FG000|Overall Study|Withdrawal by Subject|1|||
129934309|NCT05836012|467726687|FG001|Overall Study|Withdrawal by Subject|3|||
129934310|NCT05836012|467726686|FG000|Overall Study|Reason not included in pre-specified categories|2|||
129934311|NCT05836012|467726687|FG001|Overall Study|Reason not included in pre-specified categories|1|||
129934312|NCT05454514|467726688|FG000|Overall Study|Withdrawal by Subject|4|||
129934313|NCT06065735|467726689|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
129934314|NCT06065735|467726690|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
129934315|NCT06065735|467726691|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
129934316|NCT06065735|467726689|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
129934317|NCT06065735|467726690|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
129934318|NCT06065735|467726691|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
129934319|NCT06065735|467726689|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
129934320|NCT06065735|467726690|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
129934321|NCT06065735|467726691|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
129934322|NCT06065735|467726689|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
129934323|NCT06065735|467726690|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
129934324|NCT06065735|467726691|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
129934325|NCT06065735|467726689|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
129934326|NCT06065735|467726690|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
129934327|NCT06065735|467726691|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
129934328|NCT03418740|467726692|FG000|Overall Study|Lost to Follow-up|13|||
129934329|NCT03418740|467726692|FG000|Overall Study|Scheduling Issues|7|||
129934330|NCT03418740|467726692|FG000|Overall Study|Withdrawal by Subject|2|||
129934331|NCT03418740|467726692|FG000|Overall Study|Unable to Continue Consent|1|||
129934332|NCT04157517|467726697|FG000|Overall Study|Death|1|||
129934333|NCT04157517|467726698|FG001|Overall Study|Death|2|||
129934334|NCT04157517|467726699|FG002|Overall Study|Death|2|||
129934335|NCT04157517|467726700|FG003|Overall Study|Death|3|||
129934336|NCT04157517|467726701|FG004|Overall Study|Death|3|||
129934337|NCT04157517|467726702|FG005|Overall Study|Death|4|||
129934338|NCT04157517|467726703|FG006|Overall Study|Death|1|||
129934339|NCT04157517|467726704|FG007|Overall Study|Death|2|||
129934340|NCT04157517|467726705|FG008|Overall Study|Death|4|||
129934341|NCT04157517|467726706|FG009|Overall Study|Death|0|||
129934342|NCT04157517|467726697|FG000|Overall Study|Withdrawal by Subject|1|||
129934343|NCT04157517|467726698|FG001|Overall Study|Withdrawal by Subject|1|||
129934344|NCT04157517|467726699|FG002|Overall Study|Withdrawal by Subject|1|||
129934345|NCT04157517|467726700|FG003|Overall Study|Withdrawal by Subject|0|||
129934346|NCT04157517|467726701|FG004|Overall Study|Withdrawal by Subject|0|||
129934347|NCT04157517|467726702|FG005|Overall Study|Withdrawal by Subject|1|||
129934348|NCT04157517|467726703|FG006|Overall Study|Withdrawal by Subject|0|||
129934349|NCT04157517|467726704|FG007|Overall Study|Withdrawal by Subject|0|||
129934350|NCT04157517|467726705|FG008|Overall Study|Withdrawal by Subject|1|||
129934351|NCT04157517|467726706|FG009|Overall Study|Withdrawal by Subject|0|||
129934352|NCT04157517|467726697|FG000|Overall Study|Other|1|||
129934353|NCT04157517|467726698|FG001|Overall Study|Other|0|||
129934354|NCT04157517|467726699|FG002|Overall Study|Other|0|||
129934355|NCT04157517|467726700|FG003|Overall Study|Other|0|||
129934356|NCT04157517|467726701|FG004|Overall Study|Other|0|||
129934357|NCT04157517|467726702|FG005|Overall Study|Other|1|||
129934358|NCT04157517|467726703|FG006|Overall Study|Other|2|||
129934359|NCT04157517|467726704|FG007|Overall Study|Other|7|||
129934360|NCT04157517|467726705|FG008|Overall Study|Other|7|||
129934361|NCT04157517|467726706|FG009|Overall Study|Other|0|||
129934362|NCT02933489|467726707|FG000|Overall Study|Ineligible|3|||
129934363|NCT02933489|467726708|FG001|Overall Study|Ineligible|3|||
129934364|NCT02933489|467726707|FG000|Overall Study|Withdrawal by Subject|27|||
129934365|NCT02933489|467726708|FG001|Overall Study|Withdrawal by Subject|18|||
129934366|NCT02933489|467726707|FG000|Overall Study|Unable to complete exams (other)|14|||
129934367|NCT02933489|467726708|FG001|Overall Study|Unable to complete exams (other)|7|||
129934368|NCT02461134|467726711|FG000|Overall Study|Adverse Event|1|||
129934369|NCT04761198|467726712|FG000|Overall Study|Progressive Disease|1|||
129934370|NCT04761198|467726713|FG001|Overall Study|Progressive Disease|0|||
129934371|NCT04761198|467726714|FG002|Overall Study|Progressive Disease|0|||
129934372|NCT04761198|467726715|FG003|Overall Study|Progressive Disease|1|||
129934373|NCT04761198|467726716|FG004|Overall Study|Progressive Disease|4|||
129934374|NCT04761198|467726717|FG005|Overall Study|Progressive Disease|1|||
129934375|NCT04761198|467726718|FG006|Overall Study|Progressive Disease|2|||
129934376|NCT04761198|467726712|FG000|Overall Study|Protocol Violation|0|||
129934377|NCT04761198|467726713|FG001|Overall Study|Protocol Violation|0|||
129934378|NCT04761198|467726714|FG002|Overall Study|Protocol Violation|0|||
129934379|NCT04761198|467726715|FG003|Overall Study|Protocol Violation|0|||
129934380|NCT04761198|467726716|FG004|Overall Study|Protocol Violation|1|||
129934381|NCT04761198|467726717|FG005|Overall Study|Protocol Violation|0|||
129934382|NCT04761198|467726718|FG006|Overall Study|Protocol Violation|0|||
129934383|NCT04761198|467726712|FG000|Overall Study|Death|2|||
129934384|NCT04761198|467726713|FG001|Overall Study|Death|1|||
129934385|NCT04761198|467726714|FG002|Overall Study|Death|2|||
129934386|NCT04761198|467726715|FG003|Overall Study|Death|5|||
129934387|NCT04761198|467726716|FG004|Overall Study|Death|14|||
129934388|NCT04761198|467726717|FG005|Overall Study|Death|2|||
129934389|NCT04761198|467726718|FG006|Overall Study|Death|5|||
129934390|NCT04761198|467726712|FG000|Overall Study|Lost to Follow-up|0|||
129934391|NCT04761198|467726713|FG001|Overall Study|Lost to Follow-up|0|||
129934392|NCT04761198|467726714|FG002|Overall Study|Lost to Follow-up|0|||
129934393|NCT04761198|467726715|FG003|Overall Study|Lost to Follow-up|0|||
129934394|NCT04761198|467726716|FG004|Overall Study|Lost to Follow-up|1|||
130070018|NCT00270998|468211346|FG000|3 Month Follow-up|Adverse Event|1|||
130070019|NCT00270998|468211347|FG001|3 Month Follow-up|Adverse Event|0|||
130070020|NCT00270998|468211348|FG002|3 Month Follow-up|Adverse Event|0|||
130070021|NCT00270998|468211346|FG000|3 Month Follow-up|Lack of Efficacy|1|||
130070022|NCT00270998|468211347|FG001|3 Month Follow-up|Lack of Efficacy|2|||
130070023|NCT00270998|468211348|FG002|3 Month Follow-up|Lack of Efficacy|1|||
130070024|NCT00270998|468211346|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
130070025|NCT00270998|468211347|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
130070026|NCT00270998|468211348|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
130070027|NCT00270998|468211346|FG000|3 Month Follow-up|Pessary did not fit|12|||
130070028|NCT00270998|468211347|FG001|3 Month Follow-up|Pessary did not fit|0|||
130070029|NCT00270998|468211348|FG002|3 Month Follow-up|Pessary did not fit|0|||
130070030|NCT00270998|468211346|FG000|3 Month Follow-up|Personal/family health|1|||
130070031|NCT00270998|468211347|FG001|3 Month Follow-up|Personal/family health|1|||
130070032|NCT00270998|468211348|FG002|3 Month Follow-up|Personal/family health|0|||
130070033|NCT00270998|468211346|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
130070034|NCT00270998|468211347|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
130070035|NCT00270998|468211348|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
130070036|NCT00270998|468211346|FG000|12 Month Follow-up|Lack of Efficacy|5|||
130070037|NCT00270998|468211347|FG001|12 Month Follow-up|Lack of Efficacy|4|||
130070038|NCT00270998|468211348|FG002|12 Month Follow-up|Lack of Efficacy|3|||
130070039|NCT00270998|468211346|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
130070040|NCT00270998|468211347|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
130070041|NCT00270998|468211348|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
130070042|NCT00270998|468211346|FG000|12 Month Follow-up|Pessary did not fit|1|||
130070043|NCT00270998|468211347|FG001|12 Month Follow-up|Pessary did not fit|0|||
130070044|NCT00270998|468211348|FG002|12 Month Follow-up|Pessary did not fit|0|||
130070045|NCT00270998|468211346|FG000|12 Month Follow-up|Personal/family health|0|||
130070046|NCT00270998|468211347|FG001|12 Month Follow-up|Personal/family health|5|||
130070047|NCT00270998|468211348|FG002|12 Month Follow-up|Personal/family health|1|||
130070048|NCT00270998|468211346|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
130070049|NCT00270998|468211347|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
130070050|NCT00270998|468211348|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
130070051|NCT00425113|468211349|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
130070052|NCT00425113|468211350|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
130070053|NCT00425113|468211349|FG000|Overall Study|diagnosis of abdominal TB|0|||
130070054|NCT00425113|468211350|FG001|Overall Study|diagnosis of abdominal TB|1|||
130070055|NCT00425113|468211349|FG000|Overall Study|missing study drug more than 14 days|0|||
130070056|NCT00425113|468211350|FG001|Overall Study|missing study drug more than 14 days|1|||
130070057|NCT00425113|468211349|FG000|Overall Study|Withdrawal by Subject|1|||
130070058|NCT00425113|468211350|FG001|Overall Study|Withdrawal by Subject|0|||
130070059|NCT01686958|468211354|FG000|Overall Study|Withdrawal by Subject|1|||
130070060|NCT01151540|468211359|FG000|Overall Study|Other|2|||
130070061|NCT01151540|468211359|FG000|Overall Study|Adverse event, non-fatal|4|||
130070062|NCT01151540|468211359|FG000|Overall Study|Withdrawal by Subject|7|||
130070063|NCT03094832|468211360|FG000|Overall Study|Lost to Follow-up|0|||
130070064|NCT03094832|468211361|FG001|Overall Study|Lost to Follow-up|0|||
130070065|NCT03094832|468211362|FG002|Overall Study|Lost to Follow-up|0|||
130070066|NCT03094832|468211363|FG003|Overall Study|Lost to Follow-up|1|||
130070067|NCT03094832|468211364|FG004|Overall Study|Lost to Follow-up|1|||
130070068|NCT03094832|468211360|FG000|Overall Study|Death|1|||
130070069|NCT03094832|468211361|FG001|Overall Study|Death|0|||
130070070|NCT03094832|468211362|FG002|Overall Study|Death|0|||
130070071|NCT03094832|468211363|FG003|Overall Study|Death|0|||
130070072|NCT03094832|468211364|FG004|Overall Study|Death|0|||
130070073|NCT03094832|468211360|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130070074|NCT03094832|468211361|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130070075|NCT03094832|468211362|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
130070076|NCT03094832|468211363|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130070077|NCT03094832|468211364|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130070078|NCT03094832|468211360|FG000|Overall Study|Other|13|||
130070079|NCT03094832|468211361|FG001|Overall Study|Other|20|||
130070080|NCT03094832|468211362|FG002|Overall Study|Other|1|||
130070081|NCT03094832|468211363|FG003|Overall Study|Other|7|||
130070082|NCT03094832|468211364|FG004|Overall Study|Other|1|||
130070083|NCT01998880|468211365|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
130070084|NCT01998880|468211366|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
130070085|NCT01998880|468211365|FG000|Overall Study|Disease Progression|1|||
129934395|NCT04761198|467726717|FG005|Overall Study|Lost to Follow-up|0|||
129934396|NCT04761198|467726718|FG006|Overall Study|Lost to Follow-up|0|||
129934397|NCT04761198|467726712|FG000|Overall Study|Withdrawal by Subject|2|||
129934398|NCT04761198|467726713|FG001|Overall Study|Withdrawal by Subject|0|||
129934399|NCT04761198|467726714|FG002|Overall Study|Withdrawal by Subject|1|||
129934400|NCT04761198|467726715|FG003|Overall Study|Withdrawal by Subject|0|||
129934401|NCT04761198|467726716|FG004|Overall Study|Withdrawal by Subject|2|||
129934402|NCT04761198|467726717|FG005|Overall Study|Withdrawal by Subject|0|||
130118987|NCT01736553|468396150|FG000|Overall Study|Death|12|||
130118988|NCT01736553|468396151|FG001|Overall Study|Death|0|||
129934403|NCT04761198|467726718|FG006|Overall Study|Withdrawal by Subject|1|||
129934404|NCT04761198|467726712|FG000|Overall Study|Study Terminated by Sponsor|6|||
129934405|NCT04761198|467726713|FG001|Overall Study|Study Terminated by Sponsor|0|||
129934406|NCT04761198|467726714|FG002|Overall Study|Study Terminated by Sponsor|5|||
129934407|NCT04761198|467726715|FG003|Overall Study|Study Terminated by Sponsor|3|||
129934408|NCT04761198|467726716|FG004|Overall Study|Study Terminated by Sponsor|10|||
129934409|NCT04761198|467726717|FG005|Overall Study|Study Terminated by Sponsor|1|||
129934410|NCT04761198|467726718|FG006|Overall Study|Study Terminated by Sponsor|2|||
129934411|NCT02994927|467726719|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129934412|NCT02994927|467726720|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129934413|NCT02994927|467726719|FG000|Overall Study|Did not meet eligibility criteria|0|||
129934414|NCT02994927|467726720|FG001|Overall Study|Did not meet eligibility criteria|1|||
129934415|NCT02994927|467726719|FG000|Overall Study|Physician Decision|4|||
129934416|NCT02994927|467726720|FG001|Overall Study|Physician Decision|3|||
129934417|NCT02994927|467726719|FG000|Overall Study|Death|4|||
129934418|NCT02994927|467726720|FG001|Overall Study|Death|2|||
129934419|NCT02994927|467726719|FG000|Overall Study|Adverse Event|2|||
129934420|NCT02994927|467726720|FG001|Overall Study|Adverse Event|1|||
129934421|NCT02994927|467726719|FG000|Overall Study|Withdrawal by Subject|3|||
129934422|NCT02994927|467726720|FG001|Overall Study|Withdrawal by Subject|6|||
129934423|NCT02994927|467726719|FG000|Overall Study|Lost to Follow-up|2|||
129934424|NCT02994927|467726720|FG001|Overall Study|Lost to Follow-up|1|||
129934425|NCT03493542|467726728|FG000|Base Study|Withdrawal by Subject|0|||
129934426|NCT03493542|467726729|FG001|Base Study|Withdrawal by Subject|4|||
129934427|NCT03493542|467726730|FG002|Base Study|Withdrawal by Subject|0|||
129934428|NCT03493542|467726728|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
129934429|NCT03493542|467726729|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
129934430|NCT03493542|467726730|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
129934431|NCT03493542|467726728|FG000|Extension Study|Withdrawal by Subject|0|||
129934432|NCT03493542|467726729|FG001|Extension Study|Withdrawal by Subject|0|||
129934433|NCT03493542|467726730|FG002|Extension Study|Withdrawal by Subject|25|||
129934434|NCT04093869|467726731|FG000|Overall Study|Death|0|||
129934435|NCT04093869|467726732|FG001|Overall Study|Death|1|||
129934436|NCT04093869|467726731|FG000|Overall Study|Withdrawal by Subject|1|||
129934437|NCT04093869|467726732|FG001|Overall Study|Withdrawal by Subject|0|||
129934438|NCT03587805|467726733|FG000|Overall Study|Adverse Event|72|||
129934439|NCT03587805|467726733|FG000|Overall Study|Death|1|||
129934440|NCT03587805|467726733|FG000|Overall Study|Lost to Follow-up|78|||
129934441|NCT03587805|467726733|FG000|Overall Study|Withdrawal by Subject|105|||
129934442|NCT03587805|467726733|FG000|Overall Study|Lack of Efficacy|119|||
129934443|NCT03587805|467726733|FG000|Overall Study|Reason unknown|26|||
129934444|NCT03587805|467726733|FG000|Overall Study|COVID_19 pandemic|4|||
129934445|NCT03587805|467726733|FG000|Overall Study|Various reasons|121|||
129934446|NCT03587805|467726733|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129934447|NCT03982186|467726734|FG000|Overall Study|Lost to Follow-up|0|||
129934448|NCT03982186|467726735|FG001|Overall Study|Lost to Follow-up|1|||
129934449|NCT03982186|467726736|FG002|Overall Study|Lost to Follow-up|2|||
129934450|NCT03982186|467726737|FG003|Overall Study|Lost to Follow-up|1|||
129934451|NCT03982186|467726738|FG004|Overall Study|Lost to Follow-up|1|||
129934452|NCT03982186|467726739|FG005|Overall Study|Lost to Follow-up|0|||
129934453|NCT03982186|467726734|FG000|Overall Study|Physician Decision|0|||
129934454|NCT03982186|467726735|FG001|Overall Study|Physician Decision|1|||
129934455|NCT03982186|467726736|FG002|Overall Study|Physician Decision|0|||
129934456|NCT03982186|467726737|FG003|Overall Study|Physician Decision|0|||
129934457|NCT03982186|467726738|FG004|Overall Study|Physician Decision|0|||
129934458|NCT03982186|467726739|FG005|Overall Study|Physician Decision|0|||
130118989|NCT01736553|468396150|FG000|Overall Study|Withdrawal by Subject|5|||
130118990|NCT01736553|468396151|FG001|Overall Study|Withdrawal by Subject|2|||
130118991|NCT01736553|468396150|FG000|Overall Study|Lost to Follow-up|2|||
130118992|NCT01736553|468396151|FG001|Overall Study|Lost to Follow-up|2|||
129934459|NCT03982186|467726734|FG000|Overall Study|Withdrawal by Subject|3|||
129934460|NCT03982186|467726735|FG001|Overall Study|Withdrawal by Subject|4|||
129934461|NCT03982186|467726736|FG002|Overall Study|Withdrawal by Subject|1|||
129934462|NCT03982186|467726737|FG003|Overall Study|Withdrawal by Subject|7|||
129934463|NCT03982186|467726738|FG004|Overall Study|Withdrawal by Subject|2|||
129934464|NCT03982186|467726739|FG005|Overall Study|Withdrawal by Subject|0|||
129934465|NCT03982186|467726734|FG000|Overall Study|Randomized and not treated|0|||
129934466|NCT03982186|467726735|FG001|Overall Study|Randomized and not treated|0|||
129934467|NCT03982186|467726736|FG002|Overall Study|Randomized and not treated|0|||
129934468|NCT03982186|467726737|FG003|Overall Study|Randomized and not treated|1|||
129934469|NCT03982186|467726738|FG004|Overall Study|Randomized and not treated|0|||
130118993|NCT02154529|468396152|FG000|Overall Study|Death|1|||
129934470|NCT03982186|467726739|FG005|Overall Study|Randomized and not treated|0|||
129934471|NCT05020353|467727234|FG000|Overall Study|Protocol Violation|7|||
129934472|NCT05020353|467727234|FG000|Overall Study|Withdrawal by Subject|33|||
129934473|NCT03417284|467727235|FG000|Overall Study|Inadequate supply on study drug|1|||
129934474|NCT03417284|467727236|FG001|Overall Study|Inadequate supply on study drug|0|||
129934475|NCT03417284|467727237|FG002|Overall Study|Inadequate supply on study drug|0|||
129934476|NCT03417284|467727238|FG003|Overall Study|Inadequate supply on study drug|0|||
129934477|NCT03417284|467727235|FG000|Overall Study|Disease Progression|0|||
129934478|NCT03417284|467727236|FG001|Overall Study|Disease Progression|0|||
129934479|NCT03417284|467727237|FG002|Overall Study|Disease Progression|1|||
129934480|NCT03417284|467727238|FG003|Overall Study|Disease Progression|0|||
129934481|NCT05132400|467727239|FG000|Overall Study|Withdrawal by Subject|14|||
129934482|NCT05132400|467727240|FG001|Overall Study|Withdrawal by Subject|8|||
129934483|NCT05132400|467727239|FG000|Overall Study|Lost to Follow-up|132|||
129934484|NCT05132400|467727240|FG001|Overall Study|Lost to Follow-up|121|||
129934485|NCT01880515|467727242|FG000|Overall Study|Lost to Follow-up|3|||
129934486|NCT01880515|467727243|FG001|Overall Study|Lost to Follow-up|2|||
129934487|NCT01880515|467727242|FG000|Overall Study|Disease Progression|5|||
129934488|NCT01880515|467727243|FG001|Overall Study|Disease Progression|7|||
129934489|NCT03333915|467727257|FG000|Overall Study|Lost to Follow-up|0|||
129934490|NCT03333915|467727258|FG001|Overall Study|Lost to Follow-up|0|||
129934491|NCT03333915|467727259|FG002|Overall Study|Lost to Follow-up|1|||
129934492|NCT03333915|467727260|FG003|Overall Study|Lost to Follow-up|0|||
129934493|NCT03333915|467727261|FG004|Overall Study|Lost to Follow-up|0|||
129934494|NCT03333915|467727257|FG000|Overall Study|Disease Progression|0|||
129934495|NCT03333915|467727258|FG001|Overall Study|Disease Progression|1|||
129934496|NCT03333915|467727259|FG002|Overall Study|Disease Progression|0|||
129934497|NCT03333915|467727260|FG003|Overall Study|Disease Progression|0|||
129934498|NCT03333915|467727261|FG004|Overall Study|Disease Progression|0|||
129934499|NCT03333915|467727257|FG000|Overall Study|Death|0|||
129934500|NCT03333915|467727258|FG001|Overall Study|Death|0|||
129934501|NCT03333915|467727259|FG002|Overall Study|Death|0|||
129934502|NCT03333915|467727260|FG003|Overall Study|Death|37|||
129934503|NCT03333915|467727261|FG004|Overall Study|Death|18|||
129934504|NCT03333915|467727257|FG000|Overall Study|Sponsor's Decision|0|||
129934505|NCT03333915|467727258|FG001|Overall Study|Sponsor's Decision|0|||
129934506|NCT03333915|467727259|FG002|Overall Study|Sponsor's Decision|0|||
129934507|NCT03333915|467727260|FG003|Overall Study|Sponsor's Decision|48|||
129934508|NCT03333915|467727261|FG004|Overall Study|Sponsor's Decision|4|||
129934509|NCT03333915|467727257|FG000|Overall Study|Withdrawal by Subject|0|||
129934510|NCT03333915|467727258|FG001|Overall Study|Withdrawal by Subject|0|||
129934511|NCT03333915|467727259|FG002|Overall Study|Withdrawal by Subject|0|||
129934512|NCT03333915|467727260|FG003|Overall Study|Withdrawal by Subject|5|||
129934513|NCT03333915|467727261|FG004|Overall Study|Withdrawal by Subject|1|||
129934514|NCT05785130|467727263|FG000|Overall Study|Withdrawal by Subject|1|||
129934515|NCT05785130|467727264|FG001|Overall Study|Withdrawal by Subject|0|||
129934516|NCT05785130|467727263|FG000|Overall Study|Lack of Efficacy|0|||
129934517|NCT05785130|467727264|FG001|Overall Study|Lack of Efficacy|1|||
129934518|NCT02532621|467727270|FG000|Overall Study|Death|3|||
129934519|NCT02532621|467727270|FG000|Overall Study|Lost to Follow-up|3|||
129934520|NCT02532621|467727270|FG000|Overall Study|Withdrawal by Subject|6|||
129934521|NCT02532621|467727270|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
129934522|NCT02532621|467727270|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
129934523|NCT03522298|467727271|FG000|Overall Study|Adverse Event|1|||
129934524|NCT03522298|467727272|FG001|Overall Study|Adverse Event|0|||
129934525|NCT03522298|467727273|FG002|Overall Study|Adverse Event|0|||
129934526|NCT03522298|467727274|FG003|Overall Study|Adverse Event|1|||
129934527|NCT03522298|467727271|FG000|Overall Study|Death|2|||
129934528|NCT03522298|467727272|FG001|Overall Study|Death|4|||
129934529|NCT03522298|467727273|FG002|Overall Study|Death|8|||
129934530|NCT03522298|467727274|FG003|Overall Study|Death|8|||
130070086|NCT01998880|468211366|FG001|Overall Study|Disease Progression|8|||
130070087|NCT01998880|468211365|FG000|Overall Study|Withdrew Consent|2|||
130070088|NCT01998880|468211366|FG001|Overall Study|Withdrew Consent|1|||
129934531|NCT03522298|467727271|FG000|Overall Study|Patient decision|0|||
129934532|NCT03522298|467727272|FG001|Overall Study|Patient decision|2|||
129934533|NCT03522298|467727273|FG002|Overall Study|Patient decision|2|||
130070089|NCT01998880|468211365|FG000|Overall Study|Death|3|||
129934534|NCT03522298|467727274|FG003|Overall Study|Patient decision|2|||
129934535|NCT04795245|467727277|FG000|Overall Study|Unkown reason|7|||
129934536|NCT04795245|467727277|FG000|Overall Study|Death|17|||
129934537|NCT04795245|467727277|FG000|Overall Study|Other than listed|19|||
129934538|NCT04795245|467727277|FG000|Overall Study|Adverse Event|143|||
129934539|NCT04795245|467727277|FG000|Overall Study|Progressive disease|512|||
129934540|NCT04795245|467727277|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
129934541|NCT01897441|467727278|FG000|Overall Study|Lost to Follow-up|0|||
129934542|NCT01897441|467727279|FG001|Overall Study|Lost to Follow-up|0|||
129934543|NCT01897441|467727280|FG002|Overall Study|Lost to Follow-up|1|||
129934544|NCT01897441|467727281|FG003|Overall Study|Lost to Follow-up|0|||
129934545|NCT01897441|467727282|FG004|Overall Study|Lost to Follow-up|0|||
130070090|NCT01998880|468211366|FG001|Overall Study|Death|6|||
129934546|NCT01897441|467727283|FG005|Overall Study|Lost to Follow-up|0|||
129934547|NCT01897441|467727278|FG000|Overall Study|Withdrawal by Subject|0|||
130118994|NCT02154529|468396153|FG001|Overall Study|Death|1|||
129934548|NCT01897441|467727279|FG001|Overall Study|Withdrawal by Subject|0|||
129934549|NCT01897441|467727280|FG002|Overall Study|Withdrawal by Subject|0|||
129934550|NCT01897441|467727281|FG003|Overall Study|Withdrawal by Subject|0|||
129934551|NCT01897441|467727282|FG004|Overall Study|Withdrawal by Subject|1|||
129934552|NCT01897441|467727283|FG005|Overall Study|Withdrawal by Subject|0|||
129934553|NCT01897441|467727278|FG000|Overall Study|Withdrawn by Provider|0|||
129934554|NCT01897441|467727279|FG001|Overall Study|Withdrawn by Provider|2|||
129934555|NCT01897441|467727280|FG002|Overall Study|Withdrawn by Provider|0|||
129934556|NCT01897441|467727281|FG003|Overall Study|Withdrawn by Provider|0|||
129934557|NCT01897441|467727282|FG004|Overall Study|Withdrawn by Provider|0|||
129934558|NCT01897441|467727283|FG005|Overall Study|Withdrawn by Provider|0|||
129934559|NCT02806726|467727289|FG000|Overall Study|Lost to Follow-up|1|||
129934560|NCT04281498|467727290|FG000|Overall Study|Progression of disease|1|||
129934561|NCT04281498|467727290|FG000|Overall Study|Planned SCT|1|||
129934562|NCT04281498|467727290|FG000|Overall Study|Alternative Treatment|1|||
129934563|NCT01527188|467727293|FG000|Overall Study|Adverse Event|5|||
129934564|NCT01527188|467727294|FG001|Overall Study|Adverse Event|5|||
129934565|NCT01527188|467727295|FG002|Overall Study|Adverse Event|11|||
129934566|NCT01527188|467727296|FG003|Overall Study|Adverse Event|0|||
129934567|NCT01527188|467727293|FG000|Overall Study|Withdrawal by Subject|3|||
129934568|NCT01527188|467727294|FG001|Overall Study|Withdrawal by Subject|6|||
129934569|NCT01527188|467727295|FG002|Overall Study|Withdrawal by Subject|4|||
129934570|NCT01527188|467727296|FG003|Overall Study|Withdrawal by Subject|4|||
129934571|NCT01527188|467727293|FG000|Overall Study|Any other reason not above-mentioned|6|||
129934572|NCT01527188|467727294|FG001|Overall Study|Any other reason not above-mentioned|7|||
129934573|NCT01527188|467727295|FG002|Overall Study|Any other reason not above-mentioned|8|||
129934574|NCT01527188|467727296|FG003|Overall Study|Any other reason not above-mentioned|8|||
129934575|NCT04626427|467727297|FG000|Overall Study|Death|1|||
129934576|NCT04626427|467727297|FG000|Overall Study|Withdrawal by Subject|1|||
129934577|NCT04626427|467727297|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
129934578|NCT04626427|467727297|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
129934579|NCT01265537|467727298|FG000|Overall Study|Adverse Event|2|||
129934580|NCT01265537|467727299|FG001|Overall Study|Adverse Event|1|||
129934581|NCT01265537|467727298|FG000|Overall Study|Physician Decision|0|||
129934582|NCT01265537|467727299|FG001|Overall Study|Physician Decision|1|||
129934583|NCT05866926|467727300|FG000|Overall Study|Death|16|||
129934584|NCT05866926|467727301|FG001|Overall Study|Death|9|||
129934585|NCT05866926|467727300|FG000|Overall Study|Lost to Follow-up|0|||
129934586|NCT05866926|467727301|FG001|Overall Study|Lost to Follow-up|1|||
129934587|NCT05866926|467727300|FG000|Overall Study|Adverse Event|1|||
129934588|NCT05866926|467727301|FG001|Overall Study|Adverse Event|0|||
129934589|NCT05866926|467727300|FG000|Overall Study|Withdrawal by Subject|5|||
129934590|NCT05866926|467727301|FG001|Overall Study|Withdrawal by Subject|1|||
129934591|NCT05866926|467727300|FG000|Overall Study|Disease progression|1|||
129934592|NCT05866926|467727301|FG001|Overall Study|Disease progression|0|||
129934593|NCT05866926|467727300|FG000|Overall Study|other causes|2|||
129934594|NCT05866926|467727301|FG001|Overall Study|other causes|1|||
129934595|NCT03635567|467727670|FG000|Overall Study|Lost to Follow-up|4|||
129934596|NCT03635567|467727671|FG001|Overall Study|Lost to Follow-up|1|||
129934597|NCT03635567|467727670|FG000|Overall Study|Withdrawal by Subject|11|||
129934598|NCT03635567|467727671|FG001|Overall Study|Withdrawal by Subject|16|||
129934599|NCT03635567|467727670|FG000|Overall Study|Sponsor Decision|99|||
129934600|NCT03635567|467727671|FG001|Overall Study|Sponsor Decision|57|||
129934601|NCT03635567|467727670|FG000|Overall Study|Death|194|||
129934602|NCT03635567|467727671|FG001|Overall Study|Death|235|||
129934603|NCT00942734|467727681|FG000|Overall Study|Adverse Event|2|||
129934604|NCT00942734|467727681|FG000|Overall Study|Protocol Violation|3|||
129934605|NCT00942734|467727681|FG000|Overall Study|Disease Progression|2|||
129934606|NCT00942734|467727681|FG000|Overall Study|Physician Decision|1|||
129934607|NCT03816397|467727682|FG000|Overall Study|Censored at interim analysis date.|13|||
129934608|NCT03816397|467727683|FG001|Overall Study|Censored at interim analysis date.|6|||
130070091|NCT01998880|468211365|FG000|Overall Study|Insufficient Therapeutic Response|1|||
130070092|NCT01998880|468211366|FG001|Overall Study|Insufficient Therapeutic Response|5|||
130070093|NCT01998880|468211365|FG000|Overall Study|Administrative/Other|1|||
129934609|NCT03816397|467727682|FG000|Overall Study|Withdrawal by Subject|1|||
129934610|NCT03816397|467727683|FG001|Overall Study|Withdrawal by Subject|1|||
129934611|NCT05985395|467727684|FG000|Overall Study|Physician Decision|2|||
129934612|NCT05985395|467727685|FG001|Overall Study|Physician Decision|1|||
129934613|NCT05985395|467727684|FG000|Overall Study|Withdrawal by Subject|1|||
129934614|NCT05985395|467727685|FG001|Overall Study|Withdrawal by Subject|0|||
129934615|NCT02777593|467727697|FG000|Overall Study|Still in study|1|||
129934616|NCT02777593|467727698|FG001|Overall Study|Still in study|32|||
129934617|NCT02777593|467727699|FG002|Overall Study|Still in study|3|||
129934618|NCT02777593|467727700|FG003|Overall Study|Still in study|6|||
129934619|NCT02777593|467727701|FG004|Overall Study|Still in study|5|||
129934620|NCT02777593|467727697|FG000|Overall Study|Death|21|||
130070094|NCT01998880|468211366|FG001|Overall Study|Administrative/Other|1|||
130118995|NCT02154529|468396154|FG002|Overall Study|Death|5|||
130118996|NCT02154529|468396155|FG003|Overall Study|Death|1|||
130118997|NCT02154529|468396152|FG000|Overall Study|Termination of study by sponsor|2|||
130118998|NCT02154529|468396153|FG001|Overall Study|Termination of study by sponsor|2|||
130118999|NCT02154529|468396154|FG002|Overall Study|Termination of study by sponsor|3|||
130119000|NCT02154529|468396155|FG003|Overall Study|Termination of study by sponsor|1|||
130119001|NCT02154529|468396152|FG000|Overall Study|Lost to Follow-up|1|||
130119002|NCT02154529|468396153|FG001|Overall Study|Lost to Follow-up|0|||
130119003|NCT02154529|468396154|FG002|Overall Study|Lost to Follow-up|0|||
130119004|NCT02154529|468396155|FG003|Overall Study|Lost to Follow-up|0|||
130119005|NCT00458302|468398273|FG000|Overall Study|Adverse Event|4|||
130119006|NCT00458302|468398274|FG001|Overall Study|Adverse Event|14|||
130119007|NCT00458302|468398273|FG000|Overall Study|Pregnancy|2|||
130119008|NCT00458302|468398274|FG001|Overall Study|Pregnancy|1|||
130119009|NCT00458302|468398273|FG000|Overall Study|Protocol Violation|0|||
130119010|NCT00458302|468398274|FG001|Overall Study|Protocol Violation|2|||
130119011|NCT00458302|468398273|FG000|Overall Study|Withdrawal by Subject|6|||
130119012|NCT00458302|468398274|FG001|Overall Study|Withdrawal by Subject|4|||
130119013|NCT00458302|468398273|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
130119014|NCT00458302|468398274|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
130119015|NCT00458302|468398273|FG000|Overall Study|Study Termination By Sponsor|1|||
130119016|NCT00458302|468398274|FG001|Overall Study|Study Termination By Sponsor|0|||
130119017|NCT00458302|468398273|FG000|Overall Study|Lost to Follow-up|2|||
130119018|NCT00458302|468398274|FG001|Overall Study|Lost to Follow-up|0|||
130119019|NCT00458302|468398273|FG000|Overall Study|Other|4|||
130119020|NCT00458302|468398274|FG001|Overall Study|Other|2|||
130119021|NCT02178709|468398276|FG000|Overall Study|Adverse Event|5|||
130119022|NCT02178709|468398276|FG000|Overall Study|Death|2|||
130119023|NCT02178709|468398276|FG000|Overall Study|Withdrawal by Subject|2|||
130119024|NCT02178709|468398276|FG000|Overall Study|Physician Decision|2|||
130119025|NCT02178709|468398276|FG000|Overall Study|Disease Progression|5|||
130119026|NCT02224456|468398277|FG000|Overall Study|Lack of Efficacy|1|||
130119027|NCT02224456|468398277|FG000|Overall Study|Lost to Follow-up|15|||
130119028|NCT02224456|468398277|FG000|Overall Study|Withdrawal by Subject|9|||
130119029|NCT02224456|468398277|FG000|Overall Study|Physician Decision|3|||
130119030|NCT02224456|468398277|FG000|Overall Study|Death|2|||
130119031|NCT02224456|468398277|FG000|Overall Study|Pregnancy|4|||
130119032|NCT02224456|468398277|FG000|Overall Study|Protocol Violation|1|||
130119033|NCT02224456|468398277|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
130119034|NCT02946385|468398278|FG000|Overall Study|Lost to Follow-up|0|||
130119035|NCT02946385|468398279|FG001|Overall Study|Lost to Follow-up|0|||
130119036|NCT02946385|468398280|FG002|Overall Study|Lost to Follow-up|3|||
130119037|NCT02946385|468398281|FG003|Overall Study|Lost to Follow-up|0|||
130119038|NCT02946385|468398282|FG004|Overall Study|Lost to Follow-up|2|||
130119039|NCT02946385|468398283|FG005|Overall Study|Lost to Follow-up|1|||
130119040|NCT01644890|468398284|FG000|Overall Study|Adverse Event|7|||
130119041|NCT01644890|468398285|FG001|Overall Study|Adverse Event|20|||
130119042|NCT01644890|468398284|FG000|Overall Study|Death|1|||
130119043|NCT01644890|468398285|FG001|Overall Study|Death|3|||
130119044|NCT01644890|468398284|FG000|Overall Study|Physician Decision|3|||
130119045|NCT01644890|468398285|FG001|Overall Study|Physician Decision|9|||
130119046|NCT01644890|468398284|FG000|Overall Study|Protocol Violation|6|||
130119047|NCT01644890|468398285|FG001|Overall Study|Protocol Violation|7|||
130119048|NCT01644890|468398284|FG000|Overall Study|Withdrawal by Subject|19|||
130119049|NCT01644890|468398285|FG001|Overall Study|Withdrawal by Subject|27|||
130119050|NCT01644890|468398284|FG000|Overall Study|Progression Disease|160|||
130119051|NCT01644890|468398285|FG001|Overall Study|Progression Disease|131|||
130119052|NCT01644890|468398284|FG000|Overall Study|Clinical Progression|6|||
130119053|NCT01644890|468398285|FG001|Overall Study|Clinical Progression|6|||
130119054|NCT01644890|468398284|FG000|Overall Study|> 28 days since last dose of study drug|6|||
130119055|NCT01644890|468398285|FG001|Overall Study|> 28 days since last dose of study drug|3|||
130119056|NCT01644890|468398284|FG000|Overall Study|Other|8|||
130119057|NCT01644890|468398285|FG001|Overall Study|Other|9|||
130119058|NCT01060670|468398286|FG000|Run In|screen failure|0|||
130119059|NCT01060670|468398287|FG001|Run In|screen failure|238|||
130119060|NCT04849988|468398290|FG000|Overall Study|Lack of Efficacy|3|||
130119061|NCT04849988|468398291|FG001|Overall Study|Lack of Efficacy|4|||
130119062|NCT04849988|468398292|FG002|Overall Study|Lack of Efficacy|1|||
130119063|NCT04849988|468398293|FG003|Overall Study|Lack of Efficacy|4|||
130119064|NCT04849988|468398290|FG000|Overall Study|Other reasons|1|||
130119065|NCT04849988|468398291|FG001|Overall Study|Other reasons|2|||
130119066|NCT04849988|468398292|FG002|Overall Study|Other reasons|2|||
130119067|NCT04849988|468398293|FG003|Overall Study|Other reasons|1|||
130119068|NCT02146430|468398298|FG000|Overall Study|Protocol Violation|5|||
130119069|NCT02146430|468398299|FG001|Overall Study|Protocol Violation|4|||
130119070|NCT02146430|468398300|FG002|Overall Study|Protocol Violation|8|||
130119071|NCT02146430|468398301|FG003|Overall Study|Protocol Violation|6|||
130119072|NCT02146430|468398298|FG000|Overall Study|Lack of Efficacy|13|||
130119073|NCT02146430|468398299|FG001|Overall Study|Lack of Efficacy|11|||
130119074|NCT02146430|468398300|FG002|Overall Study|Lack of Efficacy|8|||
129934621|NCT02777593|467727698|FG001|Overall Study|Death|28|||
129934622|NCT02777593|467727699|FG002|Overall Study|Death|0|||
129934623|NCT02777593|467727700|FG003|Overall Study|Death|5|||
129934624|NCT02777593|467727701|FG004|Overall Study|Death|0|||
129934625|NCT02777593|467727697|FG000|Overall Study|Withdrawal by Subject|8|||
129934626|NCT02777593|467727698|FG001|Overall Study|Withdrawal by Subject|4|||
129934627|NCT02777593|467727699|FG002|Overall Study|Withdrawal by Subject|1|||
129934628|NCT02777593|467727700|FG003|Overall Study|Withdrawal by Subject|1|||
129934629|NCT02777593|467727701|FG004|Overall Study|Withdrawal by Subject|0|||
129934630|NCT02777593|467727697|FG000|Overall Study|Lost to Follow-up|8|||
129934631|NCT02777593|467727698|FG001|Overall Study|Lost to Follow-up|16|||
130070095|NCT01998880|468211365|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
130070096|NCT01998880|468211366|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
130070097|NCT01998880|468211365|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
130070098|NCT01998880|468211366|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
130070099|NCT01998880|468211365|FG000|Overall Study|Did Not Receive Treatment|3|||
130070100|NCT01998880|468211366|FG001|Overall Study|Did Not Receive Treatment|2|||
130070101|NCT02248857|468211367|FG000|3 Month|Withdrawal by Subject|9|||
130070102|NCT02248857|468211368|FG001|3 Month|Withdrawal by Subject|3|||
130070103|NCT02248857|468211369|FG002|3 Month|Withdrawal by Subject|4|||
130070104|NCT02248857|468211367|FG000|3 Month|Unable to reach for 3 month|35|||
130070105|NCT02248857|468211368|FG001|3 Month|Unable to reach for 3 month|29|||
130070106|NCT02248857|468211369|FG002|3 Month|Unable to reach for 3 month|26|||
130070107|NCT02248857|468211367|FG000|3 Month|Partially completed, unable to finish|2|||
130070108|NCT02248857|468211368|FG001|3 Month|Partially completed, unable to finish|2|||
130070109|NCT02248857|468211369|FG002|3 Month|Partially completed, unable to finish|1|||
130070110|NCT02248857|468211367|FG000|6 Month|Lost to Follow-up|27|||
130070111|NCT02248857|468211368|FG001|6 Month|Lost to Follow-up|26|||
130070112|NCT02248857|468211369|FG002|6 Month|Lost to Follow-up|15|||
130070113|NCT02248857|468211367|FG000|6 Month|Partially completed, unable to finish|0|||
130070114|NCT02248857|468211368|FG001|6 Month|Partially completed, unable to finish|1|||
130070115|NCT02248857|468211369|FG002|6 Month|Partially completed, unable to finish|0|||
130070116|NCT02248857|468211367|FG000|6 Month|Withdrawal by Subject|0|||
130070117|NCT02248857|468211368|FG001|6 Month|Withdrawal by Subject|2|||
130070118|NCT02248857|468211369|FG002|6 Month|Withdrawal by Subject|2|||
130070119|NCT02248857|468211367|FG000|6 Month|Death|1|||
130070120|NCT02248857|468211368|FG001|6 Month|Death|0|||
130070121|NCT02248857|468211369|FG002|6 Month|Death|0|||
130070122|NCT02261883|468211370|FG000|Overall Study|Death|3|||
130070123|NCT02261883|468211371|FG001|Overall Study|Death|2|||
130070124|NCT02261883|468211370|FG000|Overall Study|Physician Decision|1|||
130070125|NCT02261883|468211371|FG001|Overall Study|Physician Decision|0|||
130070126|NCT02261883|468211370|FG000|Overall Study|Protocol Violation|1|||
130070127|NCT02261883|468211371|FG001|Overall Study|Protocol Violation|0|||
130070128|NCT02261883|468211370|FG000|Overall Study|Withdrawal by Subject|0|||
130070129|NCT02261883|468211371|FG001|Overall Study|Withdrawal by Subject|1|||
130070130|NCT02261883|468211370|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
130070131|NCT02261883|468211371|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
130070132|NCT00004732|468211372|FG000|Overall Study|Withdrawal by Subject|36|||
130070133|NCT00004732|468211373|FG001|Overall Study|Withdrawal by Subject|64|||
130070134|NCT00004732|468211372|FG000|Overall Study|Lost to Follow-up|33|||
130070135|NCT00004732|468211373|FG001|Overall Study|Lost to Follow-up|47|||
130070136|NCT02674685|468211377|FG000|Overall Study|Withdrawal by Subject|4|||
130070137|NCT05567393|468211382|FG000|Overall Study|Voluntary Withdrawal|0|||
130070138|NCT05567393|468211383|FG001|Overall Study|Voluntary Withdrawal|0|||
130070139|NCT05567393|468211384|FG002|Overall Study|Voluntary Withdrawal|0|||
130070140|NCT05567393|468211385|FG003|Overall Study|Voluntary Withdrawal|0|||
130070141|NCT05567393|468211386|FG004|Overall Study|Voluntary Withdrawal|0|||
130070142|NCT05567393|468211387|FG005|Overall Study|Voluntary Withdrawal|0|||
129934632|NCT02777593|467727699|FG002|Overall Study|Lost to Follow-up|5|||
129934633|NCT02777593|467727700|FG003|Overall Study|Lost to Follow-up|0|||
129934634|NCT02777593|467727701|FG004|Overall Study|Lost to Follow-up|1|||
130070143|NCT05567393|468211388|FG006|Overall Study|Voluntary Withdrawal|0|||
130070144|NCT05567393|468211389|FG007|Overall Study|Voluntary Withdrawal|0|||
130070145|NCT05567393|468211390|FG008|Overall Study|Voluntary Withdrawal|0|||
130070146|NCT05567393|468211391|FG009|Overall Study|Voluntary Withdrawal|0|||
130070147|NCT05567393|468211392|FG010|Overall Study|Voluntary Withdrawal|0|||
130070148|NCT05567393|468211393|FG011|Overall Study|Voluntary Withdrawal|0|||
130070149|NCT05567393|468211394|FG012|Overall Study|Voluntary Withdrawal|0|||
130070150|NCT05567393|468211395|FG013|Overall Study|Voluntary Withdrawal|1|||
130070151|NCT05567393|468211396|FG014|Overall Study|Voluntary Withdrawal|0|||
130070152|NCT05567393|468211397|FG015|Overall Study|Voluntary Withdrawal|0|||
130070153|NCT05567393|468211398|FG016|Overall Study|Voluntary Withdrawal|0|||
130070154|NCT05567393|468211399|FG017|Overall Study|Voluntary Withdrawal|0|||
130070155|NCT03820726|468211400|FG000|Overall Study|Other than listed|23|||
130070156|NCT03820726|468211400|FG000|Overall Study|Withdrawal by Subject|37|||
129934635|NCT02777593|467727697|FG000|Overall Study|Physician Decision|2|||
129934636|NCT02777593|467727698|FG001|Overall Study|Physician Decision|2|||
129934637|NCT02777593|467727699|FG002|Overall Study|Physician Decision|0|||
129934638|NCT02777593|467727700|FG003|Overall Study|Physician Decision|0|||
129934639|NCT02777593|467727701|FG004|Overall Study|Physician Decision|0|||
129934640|NCT02777593|467727697|FG000|Overall Study|Discontinued due to Other|1|||
129934641|NCT02777593|467727698|FG001|Overall Study|Discontinued due to Other|0|||
129934642|NCT02777593|467727699|FG002|Overall Study|Discontinued due to Other|0|||
129934643|NCT02777593|467727700|FG003|Overall Study|Discontinued due to Other|0|||
129934644|NCT02777593|467727701|FG004|Overall Study|Discontinued due to Other|0|||
129934645|NCT05485935|467727702|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
129934646|NCT05485935|467727703|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
129934647|NCT05485935|467727702|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
129934648|NCT05485935|467727703|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
129934649|NCT05485935|467727702|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
129934650|NCT05485935|467727703|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
129934651|NCT05485935|467727702|FG000|Period 2 (T2 and V3)|loss of contact|0|||
129934652|NCT05485935|467727703|FG001|Period 2 (T2 and V3)|loss of contact|1|||
129934653|NCT05129501|467727707|FG000|Overall Study|Lost to Follow-up|54|||
129934654|NCT05129501|467727708|FG001|Overall Study|Lost to Follow-up|41|||
129934655|NCT02325154|467727709|FG000|Overall Study|Physician Decision|1|||
129934656|NCT03782116|467727710|FG000|Completed Intervetion|Lost to Follow-up|11|||
129934657|NCT03782116|467727711|FG001|Completed Intervetion|Lost to Follow-up|7|||
129934658|NCT03782116|467727710|FG000|Completed Intervetion|Withdrawal by Subject|6|||
129934659|NCT03782116|467727711|FG001|Completed Intervetion|Withdrawal by Subject|5|||
129934660|NCT03782116|467727710|FG000|Included in Analysis|Protocol Violation|5|||
129934661|NCT03782116|467727711|FG001|Included in Analysis|Protocol Violation|5|||
129934662|NCT02611687|467728241|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
129934663|NCT02611687|467728242|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
129934664|NCT00447980|467728246|FG000|Overall Study|Withdrawal by Subject|1|||
129934665|NCT00447980|467728247|FG001|Overall Study|Withdrawal by Subject|1|||
129934666|NCT00447980|467728248|FG002|Overall Study|Withdrawal by Subject|4|||
129934667|NCT00447980|467728249|FG003|Overall Study|Withdrawal by Subject|4|||
129934668|NCT00447980|467728246|FG000|Overall Study|Lost to Follow-up|1|||
129934669|NCT00447980|467728247|FG001|Overall Study|Lost to Follow-up|1|||
129934670|NCT00447980|467728248|FG002|Overall Study|Lost to Follow-up|0|||
129934671|NCT00447980|467728249|FG003|Overall Study|Lost to Follow-up|0|||
129934672|NCT00447980|467728246|FG000|Overall Study|Did not proceed with surgery|3|||
129934673|NCT00447980|467728247|FG001|Overall Study|Did not proceed with surgery|3|||
129934674|NCT00447980|467728248|FG002|Overall Study|Did not proceed with surgery|2|||
129934675|NCT00447980|467728249|FG003|Overall Study|Did not proceed with surgery|2|||
129934676|NCT05157841|467728250|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
129934677|NCT05157841|467728251|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
129934678|NCT05157841|467728252|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
129934679|NCT05157841|467728250|FG000|Part A (14 Days)|Adverse Event|1|||
129934680|NCT05157841|467728251|FG001|Part A (14 Days)|Adverse Event|0|||
129934681|NCT05157841|467728252|FG002|Part A (14 Days)|Adverse Event|0|||
129934682|NCT05157841|467728250|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
129934683|NCT05157841|467728251|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
129934684|NCT05157841|467728252|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
129934685|NCT02076009|467728253|FG000|Overall Study|Death|172|||
129934686|NCT02076009|467728254|FG001|Overall Study|Death|153|||
129934687|NCT02076009|467728253|FG000|Overall Study|Withdrawal by Subject|16|||
129934688|NCT02076009|467728254|FG001|Overall Study|Withdrawal by Subject|12|||
129934689|NCT02076009|467728253|FG000|Overall Study|Lost to Follow-up|4|||
129934690|NCT02076009|467728254|FG001|Overall Study|Lost to Follow-up|2|||
129934691|NCT02076009|467728253|FG000|Overall Study|Progressive Disease|1|||
129934692|NCT02076009|467728254|FG001|Overall Study|Progressive Disease|0|||
129934693|NCT02076009|467728253|FG000|Overall Study|Physician Decision|0|||
129934694|NCT02076009|467728254|FG001|Overall Study|Physician Decision|1|||
129934695|NCT02076009|467728253|FG000|Overall Study|End of data collection|90|||
129934696|NCT02076009|467728254|FG001|Overall Study|End of data collection|118|||
129934697|NCT04165213|467728255|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
129934698|NCT04165213|467728256|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
129934699|NCT04165213|467728255|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
129934700|NCT04165213|467728256|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
129934701|NCT04165213|467728255|FG000|Clinician Enrollment|Termination from site|0|||
129934702|NCT04165213|467728256|FG001|Clinician Enrollment|Termination from site|1|||
129934703|NCT04165213|467728255|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
129934704|NCT04165213|467728256|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
129934705|NCT04165213|467728255|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
129934706|NCT04165213|467728256|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
129934707|NCT04165213|467728255|FG000|Caregiver Enrollment|Physician Decision|1|||
129934708|NCT04165213|467728256|FG001|Caregiver Enrollment|Physician Decision|0|||
129934709|NCT04165213|467728255|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
129934710|NCT04165213|467728256|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
129934711|NCT04165213|467728255|FG000|Caregiver Enrollment|PLWD death|2|||
129934712|NCT04165213|467728256|FG001|Caregiver Enrollment|PLWD death|0|||
129934713|NCT04165213|467728255|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
129934714|NCT04165213|467728256|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
129934715|NCT04165213|467728255|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
129934716|NCT04165213|467728256|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
129934717|NCT04165213|467728255|FG000|PLWD Enrollment|Lost to Follow-up|1|||
129934718|NCT04165213|467728256|FG001|PLWD Enrollment|Lost to Follow-up|1|||
129934719|NCT04165213|467728255|FG000|PLWD Enrollment|Physician Decision|1|||
129934720|NCT04165213|467728256|FG001|PLWD Enrollment|Physician Decision|0|||
129934721|NCT04165213|467728255|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
129934722|NCT04165213|467728256|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
129934723|NCT04165213|467728255|FG000|PLWD Enrollment|Death|2|||
129934724|NCT04165213|467728256|FG001|PLWD Enrollment|Death|0|||
129934725|NCT04165213|467728255|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
129934726|NCT04165213|467728256|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
129934727|NCT04933474|467728257|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
129934728|NCT04933474|467728258|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
129934729|NCT04933474|467728257|FG000|Overall Study|Lost to Follow-up|19|||
129934730|NCT04933474|467728258|FG001|Overall Study|Lost to Follow-up|9|||
129934731|NCT04933474|467728257|FG000|Overall Study|Life Burden - unable to participate|6|||
129934732|NCT04933474|467728258|FG001|Overall Study|Life Burden - unable to participate|2|||
129934733|NCT04933474|467728257|FG000|Overall Study|Disease Burden - unable to participate|4|||
129934734|NCT04933474|467728258|FG001|Overall Study|Disease Burden - unable to participate|1|||
129934735|NCT04933474|467728257|FG000|Overall Study|Surgery/Hospitalization|1|||
129934736|NCT04933474|467728258|FG001|Overall Study|Surgery/Hospitalization|2|||
129934737|NCT04933474|467728257|FG000|Overall Study|Dissatisfied with Intervention|1|||
129934738|NCT04933474|467728258|FG001|Overall Study|Dissatisfied with Intervention|1|||
129934739|NCT04933474|467728257|FG000|Overall Study|Withdrew interest in participation|1|||
129934740|NCT04933474|467728258|FG001|Overall Study|Withdrew interest in participation|0|||
129934741|NCT04933474|467728257|FG000|Overall Study|Had previously enrolled in the study|0|||
129934742|NCT04933474|467728258|FG001|Overall Study|Had previously enrolled in the study|1|||
129934743|NCT05988398|467728265|FG000|Overall Study|Lack of time|21|||
129934744|NCT05988398|467728266|FG001|Overall Study|Lack of time|0|||
129934745|NCT05988398|467728265|FG000|Overall Study|Absent from school|0|||
129934746|NCT05988398|467728266|FG001|Overall Study|Absent from school|38|||
129934747|NCT05988398|467728265|FG000|Overall Study|Chose not to participate|0|||
129934748|NCT05988398|467728266|FG001|Overall Study|Chose not to participate|42|||
129934749|NCT05988398|467728265|FG000|Overall Study|Other commitments (e.g., sports)|0|||
129934750|NCT05988398|467728266|FG001|Overall Study|Other commitments (e.g., sports)|25|||
129934751|NCT05718687|467728278|FG000|Overall Study|Withdrawal by Subject|3|||
129934752|NCT01220531|467728281|FG000|Overall Study|Death|7|||
129934753|NCT01220531|467728281|FG000|Overall Study|Lost to Follow-up|1|||
129934754|NCT00709956|467728282|FG000|Overall Study|Withdrawal by Subject|1|||
129934755|NCT00709956|467728283|FG001|Overall Study|Withdrawal by Subject|1|||
129934756|NCT00709956|467728282|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
129934757|NCT00709956|467728283|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
129934758|NCT03512301|467728904|FG000|Overall Study|Protocol Violation|2|||
129934759|NCT03512301|467728904|FG000|Overall Study|Did Not Qualify|3|||
129934760|NCT03512301|467728904|FG000|Overall Study|Age-ineligible|1|||
129934761|NCT03512301|467728904|FG000|Overall Study|Inadequate fluency with the English language|3|||
129934762|NCT03983382|467728905|FG000|Overall Study|Death|1|||
129934763|NCT03983382|467728905|FG000|Overall Study|Lost to Follow-up|3|||
129934764|NCT03983382|467728905|FG000|Overall Study|Physician Decision|2|||
129934765|NCT03983382|467728905|FG000|Overall Study|Withdrawal by Subject|10|||
129934766|NCT03983382|467728905|FG000|Overall Study|Change in cancer treatment|2|||
129934767|NCT04174170|467728906|FG000|Placebo Run-in Period|Not Randomized|38|||
129934768|NCT04174170|467728907|FG001|Placebo Run-in Period|Not Randomized|0|||
129934769|NCT04174170|467728908|FG002|Placebo Run-in Period|Not Randomized|0|||
129934770|NCT04174170|467728909|FG003|Placebo Run-in Period|Not Randomized|0|||
129934771|NCT04174170|467728906|FG000|Double Blind Treatment Period|Adverse Event|0|||
129934772|NCT04174170|467728907|FG001|Double Blind Treatment Period|Adverse Event|9|||
129934773|NCT04174170|467728908|FG002|Double Blind Treatment Period|Adverse Event|9|||
129934774|NCT04174170|467728909|FG003|Double Blind Treatment Period|Adverse Event|8|||
129934775|NCT04174170|467728906|FG000|Double Blind Treatment Period|Death|0|||
129934776|NCT04174170|467728907|FG001|Double Blind Treatment Period|Death|1|||
129934777|NCT04174170|467728908|FG002|Double Blind Treatment Period|Death|0|||
129934778|NCT04174170|467728909|FG003|Double Blind Treatment Period|Death|0|||
129934779|NCT04174170|467728906|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
129934780|NCT04174170|467728907|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
129934781|NCT04174170|467728908|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
129934782|NCT04174170|467728909|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
129934783|NCT04174170|467728906|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
129934784|NCT04174170|467728907|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
129934785|NCT04174170|467728908|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
129934786|NCT04174170|467728909|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
129934787|NCT04174170|467728906|FG000|Double Blind Treatment Period|Physician Decision|0|||
129934788|NCT04174170|467728907|FG001|Double Blind Treatment Period|Physician Decision|1|||
129934789|NCT04174170|467728908|FG002|Double Blind Treatment Period|Physician Decision|0|||
129934790|NCT04174170|467728909|FG003|Double Blind Treatment Period|Physician Decision|1|||
129934791|NCT04174170|467728906|FG000|Double Blind Treatment Period|Pregnancy|0|||
129934792|NCT04174170|467728907|FG001|Double Blind Treatment Period|Pregnancy|1|||
129934793|NCT04174170|467728908|FG002|Double Blind Treatment Period|Pregnancy|0|||
129934794|NCT04174170|467728909|FG003|Double Blind Treatment Period|Pregnancy|1|||
129934795|NCT04174170|467728906|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
129934796|NCT04174170|467728907|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
129934797|NCT04174170|467728908|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
129934798|NCT04174170|467728909|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
129934799|NCT04174170|467728906|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
129934800|NCT04174170|467728907|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
129934801|NCT04174170|467728908|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
129934802|NCT04174170|467728909|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
129934803|NCT04174170|467728906|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
129934804|NCT04174170|467728907|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
129934805|NCT04174170|467728908|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
129934806|NCT04174170|467728909|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
129934807|NCT04772534|467728917|FG000|Overall Study|Physician Decision|1|||
129934808|NCT04772534|467728918|FG001|Overall Study|Physician Decision|0|||
129934809|NCT04772534|467728919|FG002|Overall Study|Physician Decision|0|||
129934810|NCT04772534|467728917|FG000|Overall Study|Withdrawal by Subject|3|||
129934811|NCT04772534|467728918|FG001|Overall Study|Withdrawal by Subject|0|||
129934812|NCT04772534|467728919|FG002|Overall Study|Withdrawal by Subject|1|||
129934813|NCT03242915|467728926|FG000|Overall Study|Adverse Event|5|||
129934814|NCT03242915|467728927|FG001|Overall Study|Adverse Event|1|||
129934815|NCT03242915|467728926|FG000|Overall Study|Withdrawal by Subject|0|||
129934816|NCT03242915|467728927|FG001|Overall Study|Withdrawal by Subject|2|||
129934817|NCT03242915|467728926|FG000|Overall Study|Physician Decision|4|||
129934818|NCT03242915|467728927|FG001|Overall Study|Physician Decision|1|||
129934819|NCT04908930|467728936|FG000|Overall Study|Lost to Follow-up|1|||
129934820|NCT04908930|467728937|FG001|Overall Study|Lost to Follow-up|1|||
129934821|NCT04908930|467728938|FG002|Overall Study|Lost to Follow-up|0|||
129934822|NCT04908930|467728939|FG003|Overall Study|Lost to Follow-up|0|||
129934823|NCT04908930|467728940|FG004|Overall Study|Lost to Follow-up|0|||
129934824|NCT04908930|467728936|FG000|Overall Study|hardware in mouth|1|||
129934825|NCT04908930|467728937|FG001|Overall Study|hardware in mouth|1|||
129934826|NCT04908930|467728938|FG002|Overall Study|hardware in mouth|0|||
129934827|NCT04908930|467728939|FG003|Overall Study|hardware in mouth|0|||
129934828|NCT04908930|467728940|FG004|Overall Study|hardware in mouth|0|||
129934829|NCT04908930|467728936|FG000|Overall Study|wrong team|1|||
129934830|NCT04908930|467728937|FG001|Overall Study|wrong team|0|||
129934831|NCT04908930|467728938|FG002|Overall Study|wrong team|0|||
129934832|NCT04908930|467728939|FG003|Overall Study|wrong team|0|||
129934833|NCT04908930|467728940|FG004|Overall Study|wrong team|0|||
129934834|NCT04908930|467728936|FG000|Overall Study|quit team|2|||
129934835|NCT04908930|467728937|FG001|Overall Study|quit team|4|||
129934836|NCT04908930|467728938|FG002|Overall Study|quit team|0|||
129934837|NCT04908930|467728939|FG003|Overall Study|quit team|0|||
129934838|NCT04908930|467728940|FG004|Overall Study|quit team|0|||
129934839|NCT04908930|467728936|FG000|Overall Study|Withdrawal by Subject|1|||
129934840|NCT04908930|467728937|FG001|Overall Study|Withdrawal by Subject|2|||
129934841|NCT04908930|467728938|FG002|Overall Study|Withdrawal by Subject|0|||
129934842|NCT04908930|467728939|FG003|Overall Study|Withdrawal by Subject|0|||
129934843|NCT04908930|467728940|FG004|Overall Study|Withdrawal by Subject|0|||
129934844|NCT04908930|467728936|FG000|Overall Study|parent not liking program|0|||
129934845|NCT04908930|467728937|FG001|Overall Study|parent not liking program|1|||
129934846|NCT04908930|467728938|FG002|Overall Study|parent not liking program|0|||
129934847|NCT04908930|467728939|FG003|Overall Study|parent not liking program|0|||
129934848|NCT04908930|467728940|FG004|Overall Study|parent not liking program|0|||
129934849|NCT01499368|467728941|FG000|Overall Study|Did not meet I/E criteria|8|||
129934850|NCT01499368|467728942|FG001|Overall Study|Did not meet I/E criteria|4|||
129934851|NCT01499368|467728943|FG002|Overall Study|Did not meet I/E criteria|4|||
129934852|NCT01499368|467728941|FG000|Overall Study|Prohibited Concomitant medication|1|||
129934853|NCT01499368|467728942|FG001|Overall Study|Prohibited Concomitant medication|1|||
129934854|NCT01499368|467728943|FG002|Overall Study|Prohibited Concomitant medication|0|||
129934855|NCT01499368|467728941|FG000|Overall Study|Withdrawal by Subject|11|||
129934856|NCT01499368|467728942|FG001|Overall Study|Withdrawal by Subject|10|||
129934857|NCT01499368|467728943|FG002|Overall Study|Withdrawal by Subject|8|||
129934858|NCT01499368|467728941|FG000|Overall Study|Lost to Follow-up|3|||
129934859|NCT01499368|467728942|FG001|Overall Study|Lost to Follow-up|2|||
129934860|NCT01499368|467728943|FG002|Overall Study|Lost to Follow-up|5|||
129934861|NCT01499368|467728941|FG000|Overall Study|Adverse Event|4|||
129934862|NCT01499368|467728942|FG001|Overall Study|Adverse Event|0|||
129934863|NCT01499368|467728943|FG002|Overall Study|Adverse Event|2|||
129934864|NCT01499368|467728941|FG000|Overall Study|Physician Decision|0|||
129934865|NCT01499368|467728942|FG001|Overall Study|Physician Decision|1|||
129934866|NCT01499368|467728943|FG002|Overall Study|Physician Decision|0|||
129934867|NCT01499368|467728941|FG000|Overall Study|Deviation from visit window|0|||
129934868|NCT01499368|467728942|FG001|Overall Study|Deviation from visit window|0|||
129934869|NCT01499368|467728943|FG002|Overall Study|Deviation from visit window|1|||
129934870|NCT01499368|467728941|FG000|Overall Study|Error of Prescriptions|0|||
129934871|NCT01499368|467728942|FG001|Overall Study|Error of Prescriptions|0|||
129934872|NCT01499368|467728943|FG002|Overall Study|Error of Prescriptions|1|||
129934873|NCT03092674|467728944|FG000|Overall Study|Adverse Event or Side Effects|1|||
129934874|NCT03092674|467728945|FG001|Overall Study|Adverse Event or Side Effects|4|||
129934875|NCT03092674|467728946|FG002|Overall Study|Adverse Event or Side Effects|4|||
129934876|NCT03092674|467728944|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
129934877|NCT03092674|467728945|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
129934878|NCT03092674|467728946|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
129934879|NCT03092674|467728944|FG000|Overall Study|Progression/Relapse|5|||
129934880|NCT03092674|467728945|FG001|Overall Study|Progression/Relapse|4|||
129934881|NCT03092674|467728946|FG002|Overall Study|Progression/Relapse|8|||
129934882|NCT03092674|467728944|FG000|Overall Study|Death|4|||
129934883|NCT03092674|467728945|FG001|Overall Study|Death|8|||
129934884|NCT03092674|467728946|FG002|Overall Study|Death|2|||
129934885|NCT03092674|467728944|FG000|Overall Study|Other - Not Protocol Specified|11|||
129934886|NCT03092674|467728945|FG001|Overall Study|Other - Not Protocol Specified|8|||
129934887|NCT03092674|467728946|FG002|Overall Study|Other - Not Protocol Specified|8|||
129934888|NCT05771467|467728948|FG000|Overall Study|Lost to Follow-up|6|||
129934889|NCT05771467|467728949|FG001|Overall Study|Lost to Follow-up|3|||
129934890|NCT01553149|467728952|FG000|Overall Study|Adverse Event|0|||
129934891|NCT01553149|467728953|FG001|Overall Study|Adverse Event|9|||
129934892|NCT01553149|467728952|FG000|Overall Study|Physician Decision|5|||
129934893|NCT01553149|467728953|FG001|Overall Study|Physician Decision|10|||
129934894|NCT01553149|467728952|FG000|Overall Study|Ineligible|0|||
129934895|NCT01553149|467728953|FG001|Overall Study|Ineligible|1|||
129934896|NCT01105091|467728955|FG000|Overall Study|Death|2|||
129934897|NCT01105091|467728956|FG001|Overall Study|Death|0|||
129934898|NCT03008382|467728957|FG000|Overall Study|Withdrawal by Subject|2|||
129934899|NCT03008382|467728958|FG001|Overall Study|Withdrawal by Subject|5|||
129934900|NCT03008382|467728959|FG002|Overall Study|Withdrawal by Subject|2|||
129934901|NCT03008382|467728960|FG003|Overall Study|Withdrawal by Subject|0|||
129934902|NCT03008382|467728957|FG000|Overall Study|Protocol Violation|1|||
129934903|NCT03008382|467728958|FG001|Overall Study|Protocol Violation|0|||
129934904|NCT03008382|467728959|FG002|Overall Study|Protocol Violation|0|||
129934905|NCT03008382|467728960|FG003|Overall Study|Protocol Violation|0|||
129934906|NCT03008382|467728957|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
129934907|NCT03008382|467728958|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
129934908|NCT03008382|467728959|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
129934909|NCT03008382|467728960|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
129934910|NCT03008382|467728957|FG000|Overall Study|Lost to Follow-up|0|||
129934911|NCT03008382|467728958|FG001|Overall Study|Lost to Follow-up|0|||
129934912|NCT03008382|467728959|FG002|Overall Study|Lost to Follow-up|1|||
129934913|NCT03008382|467728960|FG003|Overall Study|Lost to Follow-up|0|||
129934914|NCT03008382|467728957|FG000|Overall Study|Screenfail|0|||
129934915|NCT03008382|467728958|FG001|Overall Study|Screenfail|0|||
129934916|NCT03008382|467728959|FG002|Overall Study|Screenfail|2|||
129934917|NCT03008382|467728960|FG003|Overall Study|Screenfail|0|||
129934918|NCT03215706|467728961|FG000|Randomization|Adverse Event unrelated to study drug|1|||
129934919|NCT03215706|467728962|FG001|Randomization|Adverse Event unrelated to study drug|0|||
129934920|NCT03215706|467728961|FG000|Randomization|participant withdrew consent|1|||
129934921|NCT03215706|467728962|FG001|Randomization|participant withdrew consent|3|||
129934922|NCT03215706|467728961|FG000|Randomization|no longer meets study criteria|1|||
129934923|NCT03215706|467728962|FG001|Randomization|no longer meets study criteria|4|||
129934924|NCT03215706|467728961|FG000|Randomization|other reasons|0|||
129934925|NCT03215706|467728962|FG001|Randomization|other reasons|2|||
129934926|NCT03215706|467728961|FG000|Treatment Period|Disease Progression|150|||
129934927|NCT03215706|467728962|FG001|Treatment Period|Disease Progression|142|||
129934928|NCT03215706|467728961|FG000|Treatment Period|Study Drug Toxicity|53|||
129934929|NCT03215706|467728962|FG001|Treatment Period|Study Drug Toxicity|21|||
129934930|NCT03215706|467728961|FG000|Treatment Period|Death|2|||
129934931|NCT03215706|467728962|FG001|Treatment Period|Death|1|||
129934932|NCT03215706|467728961|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
129934933|NCT03215706|467728962|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
129934934|NCT03215706|467728961|FG000|Treatment Period|Request to D/C treatment|1|||
130119075|NCT02146430|468398301|FG003|Overall Study|Lack of Efficacy|5|||
130119076|NCT02146430|468398298|FG000|Overall Study|Adverse Event|20|||
130119077|NCT02146430|468398299|FG001|Overall Study|Adverse Event|40|||
130119078|NCT02146430|468398300|FG002|Overall Study|Adverse Event|32|||
130119079|NCT02146430|468398301|FG003|Overall Study|Adverse Event|49|||
130119080|NCT02146430|468398298|FG000|Overall Study|Reason missing or not reported|2|||
130119081|NCT02146430|468398299|FG001|Overall Study|Reason missing or not reported|3|||
130119082|NCT02146430|468398300|FG002|Overall Study|Reason missing or not reported|4|||
130119083|NCT02146430|468398301|FG003|Overall Study|Reason missing or not reported|5|||
130119084|NCT02146430|468398298|FG000|Overall Study|Withdrawal by Subject|27|||
130119085|NCT02146430|468398299|FG001|Overall Study|Withdrawal by Subject|29|||
130119086|NCT02146430|468398300|FG002|Overall Study|Withdrawal by Subject|30|||
130119087|NCT02146430|468398301|FG003|Overall Study|Withdrawal by Subject|34|||
130119088|NCT01893905|468398302|FG000|Overall Study|Withdrawal by Subject|1|||
130119089|NCT01893905|468398303|FG001|Overall Study|Withdrawal by Subject|0|||
130119090|NCT01893905|468398302|FG000|Overall Study|Adverse Event|9|||
130119091|NCT01893905|468398303|FG001|Overall Study|Adverse Event|3|||
130119092|NCT01893905|468398302|FG000|Overall Study|Lack of Efficacy|5|||
130119093|NCT01893905|468398303|FG001|Overall Study|Lack of Efficacy|7|||
130119094|NCT01893905|468398302|FG000|Overall Study|Lost to Follow-up|1|||
130119095|NCT01893905|468398303|FG001|Overall Study|Lost to Follow-up|0|||
130119096|NCT01893905|468398302|FG000|Overall Study|Protocol Violation|6|||
130119097|NCT01893905|468398303|FG001|Overall Study|Protocol Violation|1|||
130119098|NCT01893905|468398302|FG000|Overall Study|Lack of adherence to treatment|2|||
130119099|NCT01893905|468398303|FG001|Overall Study|Lack of adherence to treatment|0|||
130119100|NCT01893905|468398302|FG000|Overall Study|Other reason|1|||
130119101|NCT01893905|468398303|FG001|Overall Study|Other reason|3|||
130119102|NCT03093324|468398304|FG000|Overall Study|Adverse Event|4|||
130119103|NCT03093324|468398305|FG001|Overall Study|Adverse Event|15|||
130119104|NCT03093324|468398304|FG000|Overall Study|Lost to Follow-up|1|||
130119105|NCT03093324|468398305|FG001|Overall Study|Lost to Follow-up|0|||
130119106|NCT03093324|468398304|FG000|Overall Study|Protocol Deviation|2|||
130119107|NCT03093324|468398305|FG001|Overall Study|Protocol Deviation|2|||
130119108|NCT03093324|468398304|FG000|Overall Study|Withdrawal by Subject|2|||
130119109|NCT03093324|468398305|FG001|Overall Study|Withdrawal by Subject|2|||
130119110|NCT00614055|468398309|FG000|Overall Study|Adverse Event|1|||
130119111|NCT00614055|468398310|FG001|Overall Study|Adverse Event|0|||
130119112|NCT00614055|468398311|FG002|Overall Study|Adverse Event|0|||
130119113|NCT00614055|468398309|FG000|Overall Study|Protocol Violation|2|||
130119114|NCT00614055|468398310|FG001|Overall Study|Protocol Violation|2|||
129934935|NCT03215706|467728962|FG001|Treatment Period|Request to D/C treatment|6|||
129934936|NCT03215706|467728961|FG000|Treatment Period|Participant withdrew consent|3|||
129934937|NCT03215706|467728962|FG001|Treatment Period|Participant withdrew consent|4|||
130119115|NCT00614055|468398311|FG002|Overall Study|Protocol Violation|1|||
130119116|NCT00614055|468398309|FG000|Overall Study|Lack of Efficacy|0|||
130119117|NCT00614055|468398310|FG001|Overall Study|Lack of Efficacy|0|||
130119118|NCT00614055|468398311|FG002|Overall Study|Lack of Efficacy|2|||
130119119|NCT00614055|468398309|FG000|Overall Study|Unclassified|1|||
130119120|NCT00614055|468398310|FG001|Overall Study|Unclassified|4|||
130119121|NCT00614055|468398311|FG002|Overall Study|Unclassified|2|||
130119122|NCT01691859|468398313|FG000|Overall Study|Adverse Event|19|||
130119123|NCT01691859|468398313|FG000|Overall Study|Lack of Efficacy|11|||
130119124|NCT01691859|468398313|FG000|Overall Study|Protocol Violation|4|||
130119125|NCT01691859|468398313|FG000|Overall Study|Product commercially available|221|||
130119126|NCT01691859|468398313|FG000|Overall Study|Study closed/terminated|50|||
130119127|NCT01691859|468398313|FG000|Overall Study|Lost to Follow-up|5|||
130119128|NCT01691859|468398313|FG000|Overall Study|Physician Decision|6|||
130119129|NCT01691859|468398313|FG000|Overall Study|Withdrawal by Subject|31|||
130119130|NCT01296932|468398314|FG000|Overall Study|Dose limiting toxicity|0|||
129934938|NCT03215706|467728961|FG000|Treatment Period|Lost to Follow-up|0|||
129934939|NCT03215706|467728962|FG001|Treatment Period|Lost to Follow-up|1|||
129934940|NCT03215706|467728961|FG000|Treatment Period|Other Reasons|4|||
129934941|NCT03215706|467728962|FG001|Treatment Period|Other Reasons|5|||
130119131|NCT01296932|468398315|FG001|Overall Study|Dose limiting toxicity|0|||
129934942|NCT03215706|467728961|FG000|Treatment Period|Ongoing in the treatment period|105|||
129934943|NCT03215706|467728962|FG001|Treatment Period|Ongoing in the treatment period|43|||
130119132|NCT01296932|468398316|FG002|Overall Study|Dose limiting toxicity|0|||
130119133|NCT01296932|468398317|FG003|Overall Study|Dose limiting toxicity|0|||
130119134|NCT01296932|468398318|FG004|Overall Study|Dose limiting toxicity|0|||
130119135|NCT01296932|468398319|FG005|Overall Study|Dose limiting toxicity|0|||
130119136|NCT01296932|468398320|FG006|Overall Study|Dose limiting toxicity|1|||
129934944|NCT00945724|467728963|FG000|Overall Study|Withdrawal by Subject|2|||
129934945|NCT00945724|467728963|FG000|Overall Study|Physician Decision|1|||
130119137|NCT01296932|468398321|FG007|Overall Study|Dose limiting toxicity|0|||
130119138|NCT01296932|468398322|FG008|Overall Study|Dose limiting toxicity|1|||
130119139|NCT01296932|468398314|FG000|Overall Study|Progressive disease|2|||
130119140|NCT01296932|468398315|FG001|Overall Study|Progressive disease|0|||
130119141|NCT01296932|468398316|FG002|Overall Study|Progressive disease|1|||
129934946|NCT00945724|467728963|FG000|Overall Study|Adverse Event|5|||
129934947|NCT00945724|467728963|FG000|Overall Study|Second malignancy|1|||
129934948|NCT04194450|467729573|FG000|Overall Study|not eligible|1|||
129934949|NCT04194450|467729574|FG001|Overall Study|not eligible|0|||
129934950|NCT03786926|467729584|FG000|Overall Study|Adverse Event|0|||
129934951|NCT03786926|467729585|FG001|Overall Study|Adverse Event|0|||
129934952|NCT03786926|467729586|FG002|Overall Study|Adverse Event|0|||
129934953|NCT03786926|467729587|FG003|Overall Study|Adverse Event|0|||
129934954|NCT03786926|467729588|FG004|Overall Study|Adverse Event|0|||
129934955|NCT03786926|467729589|FG005|Overall Study|Adverse Event|0|||
129934956|NCT03786926|467729590|FG006|Overall Study|Adverse Event|0|||
129934957|NCT03786926|467729591|FG007|Overall Study|Adverse Event|1|||
129934958|NCT03786926|467729592|FG008|Overall Study|Adverse Event|1|||
129934959|NCT03786926|467729593|FG009|Overall Study|Adverse Event|0|||
129934960|NCT03786926|467729594|FG010|Overall Study|Adverse Event|1|||
129934961|NCT03786926|467729584|FG000|Overall Study|Progressive disease|3|||
129934962|NCT03786926|467729585|FG001|Overall Study|Progressive disease|0|||
129934963|NCT03786926|467729586|FG002|Overall Study|Progressive disease|3|||
129934964|NCT03786926|467729587|FG003|Overall Study|Progressive disease|1|||
129934965|NCT03786926|467729588|FG004|Overall Study|Progressive disease|2|||
129934966|NCT03786926|467729589|FG005|Overall Study|Progressive disease|2|||
129934967|NCT03786926|467729590|FG006|Overall Study|Progressive disease|1|||
129934968|NCT03786926|467729591|FG007|Overall Study|Progressive disease|6|||
129934969|NCT03786926|467729592|FG008|Overall Study|Progressive disease|1|||
129934970|NCT03786926|467729593|FG009|Overall Study|Progressive disease|1|||
129934971|NCT03786926|467729594|FG010|Overall Study|Progressive disease|1|||
129934972|NCT03786926|467729584|FG000|Overall Study|Death|0|||
129934973|NCT03786926|467729585|FG001|Overall Study|Death|1|||
129934974|NCT03786926|467729586|FG002|Overall Study|Death|1|||
129934975|NCT03786926|467729587|FG003|Overall Study|Death|0|||
129934976|NCT03786926|467729588|FG004|Overall Study|Death|0|||
129934977|NCT03786926|467729589|FG005|Overall Study|Death|0|||
129934978|NCT03786926|467729590|FG006|Overall Study|Death|0|||
129934979|NCT03786926|467729591|FG007|Overall Study|Death|0|||
129934980|NCT03786926|467729592|FG008|Overall Study|Death|0|||
129934981|NCT03786926|467729593|FG009|Overall Study|Death|1|||
129934982|NCT03786926|467729594|FG010|Overall Study|Death|2|||
129934983|NCT03786926|467729584|FG000|Overall Study|Physician Decision|0|||
129934984|NCT03786926|467729585|FG001|Overall Study|Physician Decision|1|||
129934985|NCT03786926|467729586|FG002|Overall Study|Physician Decision|0|||
129934986|NCT03786926|467729587|FG003|Overall Study|Physician Decision|1|||
129934987|NCT03786926|467729588|FG004|Overall Study|Physician Decision|2|||
129934988|NCT03786926|467729589|FG005|Overall Study|Physician Decision|0|||
129934989|NCT03786926|467729590|FG006|Overall Study|Physician Decision|0|||
129934990|NCT03786926|467729591|FG007|Overall Study|Physician Decision|2|||
129934991|NCT03786926|467729592|FG008|Overall Study|Physician Decision|1|||
129934992|NCT03786926|467729593|FG009|Overall Study|Physician Decision|1|||
129934993|NCT03786926|467729594|FG010|Overall Study|Physician Decision|0|||
129934994|NCT03786926|467729584|FG000|Overall Study|Withdrawal by Subject|0|||
129934995|NCT03786926|467729585|FG001|Overall Study|Withdrawal by Subject|1|||
129934996|NCT03786926|467729586|FG002|Overall Study|Withdrawal by Subject|1|||
129934997|NCT03786926|467729587|FG003|Overall Study|Withdrawal by Subject|0|||
129934998|NCT03786926|467729588|FG004|Overall Study|Withdrawal by Subject|0|||
129934999|NCT03786926|467729589|FG005|Overall Study|Withdrawal by Subject|0|||
129935000|NCT03786926|467729590|FG006|Overall Study|Withdrawal by Subject|1|||
129935001|NCT03786926|467729591|FG007|Overall Study|Withdrawal by Subject|0|||
129935002|NCT03786926|467729592|FG008|Overall Study|Withdrawal by Subject|1|||
130070157|NCT03820726|468211400|FG000|Overall Study|Lost to Follow-up|3|||
130070158|NCT03820726|468211400|FG000|Overall Study|Protocol deviation|1|||
130070159|NCT03820726|468211400|FG000|Overall Study|Adverse Event|146|||
130070160|NCT03820726|468211400|FG000|Overall Study|Not treated|1|||
130070161|NCT00345540|468211405|FG000|Overall Study|Withdrawal by Subject|1|||
130070162|NCT01406652|468211406|FG000|Overall Study|Lost-to-follow-up|3|||
130070163|NCT01406652|468211407|FG001|Overall Study|Lost-to-follow-up|4|||
130070164|NCT01406652|468211406|FG000|Overall Study|Withdrawal by Subject|2|||
130119142|NCT01296932|468398317|FG003|Overall Study|Progressive disease|1|||
129935003|NCT03786926|467729593|FG009|Overall Study|Withdrawal by Subject|0|||
129935004|NCT03786926|467729594|FG010|Overall Study|Withdrawal by Subject|1|||
129935005|NCT03786926|467729584|FG000|Overall Study|Study terminated by Sponsor|0|||
129935006|NCT03786926|467729585|FG001|Overall Study|Study terminated by Sponsor|0|||
129935007|NCT03786926|467729586|FG002|Overall Study|Study terminated by Sponsor|0|||
129935008|NCT03786926|467729587|FG003|Overall Study|Study terminated by Sponsor|0|||
130070165|NCT01406652|468211407|FG001|Overall Study|Withdrawal by Subject|2|||
129935009|NCT03786926|467729588|FG004|Overall Study|Study terminated by Sponsor|1|||
129935010|NCT03786926|467729589|FG005|Overall Study|Study terminated by Sponsor|0|||
129935011|NCT03786926|467729590|FG006|Overall Study|Study terminated by Sponsor|0|||
129935012|NCT03786926|467729591|FG007|Overall Study|Study terminated by Sponsor|4|||
129935013|NCT03786926|467729592|FG008|Overall Study|Study terminated by Sponsor|0|||
129935014|NCT03786926|467729593|FG009|Overall Study|Study terminated by Sponsor|0|||
129935015|NCT03786926|467729594|FG010|Overall Study|Study terminated by Sponsor|0|||
129935016|NCT03786926|467729584|FG000|Overall Study|Anti-neoplasm treatment|0|||
129935017|NCT03786926|467729585|FG001|Overall Study|Anti-neoplasm treatment|0|||
129935018|NCT03786926|467729586|FG002|Overall Study|Anti-neoplasm treatment|0|||
129935019|NCT03786926|467729587|FG003|Overall Study|Anti-neoplasm treatment|0|||
129935020|NCT03786926|467729588|FG004|Overall Study|Anti-neoplasm treatment|1|||
129935021|NCT03786926|467729589|FG005|Overall Study|Anti-neoplasm treatment|0|||
129935022|NCT03786926|467729590|FG006|Overall Study|Anti-neoplasm treatment|1|||
129935023|NCT03786926|467729591|FG007|Overall Study|Anti-neoplasm treatment|0|||
129935024|NCT03786926|467729592|FG008|Overall Study|Anti-neoplasm treatment|0|||
129935025|NCT03786926|467729593|FG009|Overall Study|Anti-neoplasm treatment|0|||
129935026|NCT03786926|467729594|FG010|Overall Study|Anti-neoplasm treatment|0|||
129935027|NCT03786926|467729584|FG000|Overall Study|Other|0|||
129935028|NCT03786926|467729585|FG001|Overall Study|Other|0|||
129935029|NCT03786926|467729586|FG002|Overall Study|Other|0|||
129935030|NCT03786926|467729587|FG003|Overall Study|Other|1|||
129935031|NCT03786926|467729588|FG004|Overall Study|Other|0|||
129935032|NCT03786926|467729589|FG005|Overall Study|Other|1|||
129935033|NCT03786926|467729590|FG006|Overall Study|Other|0|||
129935034|NCT03786926|467729591|FG007|Overall Study|Other|0|||
129935035|NCT03786926|467729592|FG008|Overall Study|Other|2|||
129935036|NCT03786926|467729593|FG009|Overall Study|Other|0|||
129935037|NCT03786926|467729594|FG010|Overall Study|Other|0|||
129935038|NCT05875701|467729600|FG000|Overall Study|Lost to Follow-up|2|||
129935039|NCT05875701|467729601|FG001|Overall Study|Lost to Follow-up|0|||
129935040|NCT05875701|467729600|FG000|Overall Study|Withdrawal by Subject|1|||
129935041|NCT05875701|467729601|FG001|Overall Study|Withdrawal by Subject|1|||
129935042|NCT04408755|467729602|FG000|Period A (Placebo lead-in)|Other|11|||
129935043|NCT04408755|467729603|FG001|Period A (Placebo lead-in)|Other|0|||
129935044|NCT04408755|467729604|FG002|Period A (Placebo lead-in)|Other|0|||
129935045|NCT04408755|467729605|FG003|Period A (Placebo lead-in)|Other|0|||
129935046|NCT04408755|467729602|FG000|Period B (Randomization Period)|Adverse Event|0|||
129935047|NCT04408755|467729603|FG001|Period B (Randomization Period)|Adverse Event|3|||
129935048|NCT04408755|467729604|FG002|Period B (Randomization Period)|Adverse Event|0|||
129935049|NCT04408755|467729605|FG003|Period B (Randomization Period)|Adverse Event|1|||
129935050|NCT04408755|467729602|FG000|Period B (Randomization Period)|Death|0|||
129935051|NCT04408755|467729603|FG001|Period B (Randomization Period)|Death|0|||
129935052|NCT04408755|467729604|FG002|Period B (Randomization Period)|Death|1|||
129935053|NCT04408755|467729605|FG003|Period B (Randomization Period)|Death|0|||
129935054|NCT04408755|467729602|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
129935055|NCT04408755|467729603|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
129935056|NCT04408755|467729604|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
129935057|NCT04408755|467729605|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
129935058|NCT04408755|467729602|FG000|Period B (Randomization Period)|Physician Decision|0|||
129935059|NCT04408755|467729603|FG001|Period B (Randomization Period)|Physician Decision|0|||
129935060|NCT04408755|467729604|FG002|Period B (Randomization Period)|Physician Decision|1|||
129935061|NCT04408755|467729605|FG003|Period B (Randomization Period)|Physician Decision|0|||
129935062|NCT04408755|467729602|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
129935063|NCT04408755|467729603|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
129935064|NCT04408755|467729604|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
129935065|NCT04408755|467729605|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
129935066|NCT04408755|467729602|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
129935067|NCT04408755|467729603|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
129935068|NCT04408755|467729604|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
129935069|NCT04408755|467729605|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
129935070|NCT04408755|467729602|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
129935071|NCT04408755|467729603|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
129935072|NCT04408755|467729604|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
129935073|NCT04408755|467729605|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
129935074|NCT04408755|467729602|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
129935075|NCT04408755|467729603|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
129935076|NCT04408755|467729604|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
129935077|NCT04408755|467729605|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
129935078|NCT04408755|467729602|FG000|Period B (Randomization Period)|Reason not Specified|0|||
129935079|NCT04408755|467729603|FG001|Period B (Randomization Period)|Reason not Specified|1|||
129935080|NCT04408755|467729604|FG002|Period B (Randomization Period)|Reason not Specified|0|||
129935081|NCT04408755|467729605|FG003|Period B (Randomization Period)|Reason not Specified|2|||
129935082|NCT00308997|467729606|FG000|Overall Study|Subject feigned clinical data|0|||
129935083|NCT00308997|467729607|FG001|Overall Study|Subject feigned clinical data|1|||
129935084|NCT00308997|467729606|FG000|Overall Study|Unable to tolerate intervention|1|||
129935085|NCT00308997|467729607|FG001|Overall Study|Unable to tolerate intervention|0|||
129935086|NCT04490356|467729608|FG000|Overall Study|Lost to Follow-up|1|||
129935087|NCT03733626|467729609|FG000|Overall Study|Physician Decision|4|||
129935088|NCT03733626|467729610|FG001|Overall Study|Physician Decision|4|||
129935089|NCT04586244|467729613|FG000|Overall Study|Lost to Follow-up|1|||
129935090|NCT04586244|467729614|FG001|Overall Study|Lost to Follow-up|0|||
129935091|NCT04586244|467729615|FG002|Overall Study|Lost to Follow-up|0|||
129935092|NCT04586244|467729616|FG003|Overall Study|Lost to Follow-up|1|||
129935093|NCT04586244|467729617|FG004|Overall Study|Lost to Follow-up|0|||
129935094|NCT04586244|467729613|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935095|NCT04586244|467729614|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
129935096|NCT04586244|467729615|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935097|NCT04586244|467729616|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935098|NCT04586244|467729617|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935099|NCT04174560|467729622|FG000|Overall Study|Lost to Follow-up|1|||
129935100|NCT04174560|467729623|FG001|Overall Study|Lost to Follow-up|0|||
129935101|NCT04174560|467729624|FG002|Overall Study|Lost to Follow-up|0|||
129935102|NCT04174560|467729625|FG003|Overall Study|Lost to Follow-up|0|||
129935103|NCT04174560|467729622|FG000|Overall Study|Withdrawal by Subject|0|||
129935104|NCT04174560|467729623|FG001|Overall Study|Withdrawal by Subject|0|||
129935105|NCT04174560|467729624|FG002|Overall Study|Withdrawal by Subject|2|||
129935106|NCT04174560|467729625|FG003|Overall Study|Withdrawal by Subject|0|||
129935107|NCT05424718|467729626|FG000|Overall Study|Lost to Follow-up|5|||
129935108|NCT05424718|467729627|FG001|Overall Study|Lost to Follow-up|4|||
129935109|NCT04046549|467729628|FG000|Overall Study|Adverse Event|1|||
129935110|NCT04046549|467729628|FG000|Overall Study|Physician Decision|1|||
129935111|NCT04046549|467729628|FG000|Overall Study|Withdrawal by Subject|3|||
129935112|NCT04046549|467729628|FG000|Overall Study|Other, Not Specified|5|||
129935113|NCT03142009|467729629|FG000|Overall Study|Lost to Follow-up|45|||
129935114|NCT03142009|467729630|FG001|Overall Study|Lost to Follow-up|30|||
129935115|NCT03872466|467729631|FG000|Overall Study|Withdrawal by Subject|1|||
129935116|NCT03872466|467729632|FG001|Overall Study|Withdrawal by Subject|0|||
129935117|NCT03872466|467729631|FG000|Overall Study|Physician Decision|2|||
129935118|NCT03872466|467729632|FG001|Overall Study|Physician Decision|0|||
129935119|NCT01778686|467729633|FG000|Overall Study|Adverse Event|0|||
129935120|NCT01778686|467729634|FG001|Overall Study|Adverse Event|0|||
129935121|NCT01778686|467729635|FG002|Overall Study|Adverse Event|1|||
129935122|NCT06059443|467729636|FG000|Overall Study|Withdrawal by Subject|2|||
129935123|NCT06059443|467729637|FG001|Overall Study|Withdrawal by Subject|0|||
129935124|NCT06059443|467729636|FG000|Overall Study|Lost to Follow-up|2|||
129935125|NCT06059443|467729637|FG001|Overall Study|Lost to Follow-up|2|||
129935126|NCT00994643|467730232|FG000|Overall Study|Withdrawal by Subject|1|||
129935127|NCT05412004|467730233|FG000|Overall Study|Adverse Event|0|||
129935128|NCT05412004|467730234|FG001|Overall Study|Adverse Event|2|||
129935129|NCT05412004|467730235|FG002|Overall Study|Adverse Event|1|||
129935130|NCT05412004|467730236|FG003|Overall Study|Adverse Event|5|||
129935131|NCT05412004|467730233|FG000|Overall Study|Assigned Treatment by Mistake|5|||
129935132|NCT05412004|467730234|FG001|Overall Study|Assigned Treatment by Mistake|10|||
129935133|NCT05412004|467730235|FG002|Overall Study|Assigned Treatment by Mistake|2|||
129935134|NCT05412004|467730236|FG003|Overall Study|Assigned Treatment by Mistake|5|||
129935135|NCT05412004|467730233|FG000|Overall Study|Lost to Follow-up|3|||
129935136|NCT05412004|467730234|FG001|Overall Study|Lost to Follow-up|0|||
129935137|NCT05412004|467730235|FG002|Overall Study|Lost to Follow-up|0|||
129935138|NCT05412004|467730236|FG003|Overall Study|Lost to Follow-up|0|||
129935139|NCT05412004|467730233|FG000|Overall Study|Patient could not travel to site|0|||
129935140|NCT05412004|467730234|FG001|Overall Study|Patient could not travel to site|1|||
129935141|NCT05412004|467730235|FG002|Overall Study|Patient could not travel to site|0|||
129935142|NCT05412004|467730236|FG003|Overall Study|Patient could not travel to site|0|||
129935143|NCT05412004|467730233|FG000|Overall Study|Physician Decision|0|||
129935144|NCT05412004|467730234|FG001|Overall Study|Physician Decision|1|||
129935145|NCT05412004|467730235|FG002|Overall Study|Physician Decision|0|||
130070166|NCT01406652|468211406|FG000|Overall Study|Insufficient follow-up|5|||
130070167|NCT01406652|468211407|FG001|Overall Study|Insufficient follow-up|4|||
130070168|NCT01406652|468211406|FG000|Overall Study|Infection not sure|10|||
130070169|NCT01406652|468211407|FG001|Overall Study|Infection not sure|10|||
130070170|NCT00141037|468211408|FG000|Overall Study|Physician Decision|1|||
129935146|NCT05412004|467730236|FG003|Overall Study|Physician Decision|0|||
130070171|NCT00141037|468211409|FG001|Overall Study|Physician Decision|2|||
129935147|NCT05412004|467730233|FG000|Overall Study|Pregnancy|0|||
129935148|NCT05412004|467730234|FG001|Overall Study|Pregnancy|1|||
129935149|NCT05412004|467730235|FG002|Overall Study|Pregnancy|0|||
129935150|NCT05412004|467730236|FG003|Overall Study|Pregnancy|0|||
129935151|NCT05412004|467730233|FG000|Overall Study|Protocol Violation|1|||
129935152|NCT05412004|467730234|FG001|Overall Study|Protocol Violation|0|||
129935153|NCT05412004|467730235|FG002|Overall Study|Protocol Violation|0|||
130070172|NCT00141037|468211408|FG000|Overall Study|Lost to Follow-up|3|||
130070173|NCT00141037|468211409|FG001|Overall Study|Lost to Follow-up|1|||
129935154|NCT05412004|467730236|FG003|Overall Study|Protocol Violation|0|||
130070174|NCT00141037|468211408|FG000|Overall Study|Protocol Violation|0|||
130119143|NCT01296932|468398318|FG004|Overall Study|Progressive disease|2|||
130119144|NCT01296932|468398319|FG005|Overall Study|Progressive disease|3|||
130119145|NCT01296932|468398320|FG006|Overall Study|Progressive disease|1|||
130119146|NCT01296932|468398321|FG007|Overall Study|Progressive disease|0|||
130119147|NCT01296932|468398322|FG008|Overall Study|Progressive disease|0|||
130119148|NCT01296932|468398314|FG000|Overall Study|Withdrawal by Subject|0|||
130119149|NCT01296932|468398315|FG001|Overall Study|Withdrawal by Subject|0|||
130119150|NCT01296932|468398316|FG002|Overall Study|Withdrawal by Subject|1|||
130119151|NCT01296932|468398317|FG003|Overall Study|Withdrawal by Subject|1|||
130119152|NCT01296932|468398318|FG004|Overall Study|Withdrawal by Subject|0|||
129935155|NCT05412004|467730233|FG000|Overall Study|Withdrawal by Subject|4|||
129935156|NCT05412004|467730234|FG001|Overall Study|Withdrawal by Subject|19|||
129935157|NCT05412004|467730235|FG002|Overall Study|Withdrawal by Subject|4|||
129935158|NCT05412004|467730236|FG003|Overall Study|Withdrawal by Subject|14|||
129935159|NCT05412004|467730233|FG000|Overall Study|Screen Failure|0|||
129935160|NCT05412004|467730234|FG001|Overall Study|Screen Failure|0|||
129935161|NCT05412004|467730235|FG002|Overall Study|Screen Failure|0|||
129935162|NCT05412004|467730236|FG003|Overall Study|Screen Failure|1|||
129935163|NCT05412004|467730233|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
129935164|NCT05412004|467730234|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
129935165|NCT05412004|467730235|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
130070175|NCT00141037|468211409|FG001|Overall Study|Protocol Violation|2|||
130070176|NCT00141037|468211408|FG000|Overall Study|Withdrawal by Subject|2|||
130070177|NCT00141037|468211409|FG001|Overall Study|Withdrawal by Subject|1|||
130070178|NCT00141037|468211408|FG000|Overall Study|Other|0|||
130070179|NCT00141037|468211409|FG001|Overall Study|Other|1|||
130070180|NCT00141037|468211408|FG000|Overall Study|Moved from area|1|||
130070181|NCT00141037|468211409|FG001|Overall Study|Moved from area|7|||
130070182|NCT00141037|468211408|FG000|Overall Study|Graft Failure|3|||
130070183|NCT00141037|468211409|FG001|Overall Study|Graft Failure|4|||
130070184|NCT00260429|468211410|FG000|Overall Study|failure to follow appointments|1|||
130070185|NCT00260429|468211411|FG001|Overall Study|failure to follow appointments|0|||
130070186|NCT00260429|468211410|FG000|Overall Study|scheduled hand surgery|1|||
130070187|NCT00260429|468211411|FG001|Overall Study|scheduled hand surgery|0|||
130070188|NCT00861380|468211412|FG000|Overall Study|Withdrawal Information not recorded|8427|||
130070189|NCT00861380|468211413|FG001|Overall Study|Withdrawal Information not recorded|9112|||
130070190|NCT00861380|468211414|FG002|Overall Study|Withdrawal Information not recorded|8872|||
130070191|NCT00861380|468211415|FG003|Overall Study|Withdrawal Information not recorded|3689|||
130119153|NCT01296932|468398319|FG005|Overall Study|Withdrawal by Subject|0|||
130119154|NCT01296932|468398320|FG006|Overall Study|Withdrawal by Subject|3|||
129935166|NCT05412004|467730236|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
129935167|NCT00968149|467730237|FG000|Overall Study|Adverse Event|5|||
129935168|NCT00968149|467730238|FG001|Overall Study|Adverse Event|1|||
129935169|NCT00968149|467730237|FG000|Overall Study|Lack of Efficacy|0|||
129935170|NCT00968149|467730238|FG001|Overall Study|Lack of Efficacy|4|||
129935171|NCT00968149|467730237|FG000|Overall Study|Lost to Follow-up|0|||
129935172|NCT00968149|467730238|FG001|Overall Study|Lost to Follow-up|1|||
129935173|NCT00968149|467730237|FG000|Overall Study|Protocol Violation|4|||
129935174|NCT00968149|467730238|FG001|Overall Study|Protocol Violation|0|||
129935175|NCT00968149|467730237|FG000|Overall Study|Withdrawal by Subject|2|||
129935176|NCT00968149|467730238|FG001|Overall Study|Withdrawal by Subject|0|||
129935177|NCT03934931|467730239|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
129935178|NCT03934931|467730240|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
129935179|NCT03934931|467730241|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
129935180|NCT00495677|467730242|FG000|Stage 1 (25 Days)|Adverse Event|0|||
129935181|NCT00495677|467730243|FG001|Stage 1 (25 Days)|Adverse Event|0|||
129935182|NCT00495677|467730244|FG002|Stage 1 (25 Days)|Adverse Event|1|||
129935183|NCT00495677|467730245|FG003|Stage 1 (25 Days)|Adverse Event|0|||
129935184|NCT00495677|467730246|FG004|Stage 1 (25 Days)|Adverse Event|0|||
129935185|NCT00495677|467730247|FG005|Stage 1 (25 Days)|Adverse Event|0|||
129935186|NCT00495677|467730248|FG006|Stage 1 (25 Days)|Adverse Event|0|||
130070192|NCT00861380|468211416|FG004|Overall Study|Withdrawal Information not recorded|1812|||
130119155|NCT01296932|468398321|FG007|Overall Study|Withdrawal by Subject|0|||
130070193|NCT00861380|468211417|FG005|Overall Study|Withdrawal Information not recorded|6249|||
130070194|NCT00861380|468211418|FG006|Overall Study|Withdrawal Information not recorded|3020|||
129935187|NCT02231749|467730252|FG000|Overall Study|Disease progression|229|||
129935188|NCT02231749|467730253|FG001|Overall Study|Disease progression|297|||
129935189|NCT02231749|467730252|FG000|Overall Study|Study Drug Toxicity|134|||
129935190|NCT02231749|467730253|FG001|Overall Study|Study Drug Toxicity|63|||
129935191|NCT02231749|467730252|FG000|Overall Study|Death|1|||
129935192|NCT02231749|467730253|FG001|Overall Study|Death|1|||
129935193|NCT02231749|467730252|FG000|Overall Study|AE unrelated to Study drug|32|||
130070195|NCT00628758|468211419|FG000|Overall Study|Adverse Event|2|||
130119156|NCT01296932|468398322|FG008|Overall Study|Withdrawal by Subject|0|||
130119157|NCT01296932|468398314|FG000|Overall Study|Adverse Event|1|||
129935194|NCT02231749|467730253|FG001|Overall Study|AE unrelated to Study drug|31|||
129935195|NCT02231749|467730252|FG000|Overall Study|Participant's request to discontinue|10|||
129935196|NCT02231749|467730253|FG001|Overall Study|Participant's request to discontinue|21|||
129935197|NCT02231749|467730252|FG000|Overall Study|Participant withdrew Consent|8|||
129935198|NCT02231749|467730253|FG001|Overall Study|Participant withdrew Consent|15|||
129935199|NCT02231749|467730252|FG000|Overall Study|Lost to Follow-up|1|||
129935200|NCT02231749|467730253|FG001|Overall Study|Lost to Follow-up|2|||
129935201|NCT02231749|467730252|FG000|Overall Study|Maximum Clinical Benefit|5|||
129935202|NCT02231749|467730253|FG001|Overall Study|Maximum Clinical Benefit|8|||
129935203|NCT02231749|467730252|FG000|Overall Study|Poor/Non-Compliance|0|||
129935204|NCT02231749|467730253|FG001|Overall Study|Poor/Non-Compliance|3|||
129935205|NCT02231749|467730252|FG000|Overall Study|Pregnancy|1|||
129935206|NCT02231749|467730253|FG001|Overall Study|Pregnancy|0|||
129935207|NCT02231749|467730252|FG000|Overall Study|other|0|||
129935208|NCT02231749|467730253|FG001|Overall Study|other|8|||
129935209|NCT02231749|467730252|FG000|Overall Study|No longer meets Study Criteria|1|||
129935210|NCT02231749|467730253|FG001|Overall Study|No longer meets Study Criteria|0|||
129935211|NCT02989662|467730259|FG000|Overall Study|Lost to Follow-up|0|||
129935212|NCT02989662|467730260|FG001|Overall Study|Lost to Follow-up|0|||
129935213|NCT02989662|467730261|FG002|Overall Study|Lost to Follow-up|0|||
129935214|NCT02989662|467730262|FG003|Overall Study|Lost to Follow-up|2|||
129935215|NCT02989662|467730259|FG000|Overall Study|Physician Decision|3|||
129935216|NCT02989662|467730260|FG001|Overall Study|Physician Decision|0|||
129935217|NCT02989662|467730261|FG002|Overall Study|Physician Decision|0|||
129935218|NCT02989662|467730262|FG003|Overall Study|Physician Decision|0|||
129935219|NCT02989662|467730259|FG000|Overall Study|Withdrawal by Subject|1|||
129935220|NCT02989662|467730260|FG001|Overall Study|Withdrawal by Subject|0|||
129935221|NCT02989662|467730261|FG002|Overall Study|Withdrawal by Subject|0|||
129935222|NCT02989662|467730262|FG003|Overall Study|Withdrawal by Subject|0|||
129935223|NCT02726386|467730266|FG000|Overall Study|Adverse Event|17|||
129935224|NCT02726386|467730267|FG001|Overall Study|Adverse Event|20|||
129935225|NCT02726386|467730266|FG000|Overall Study|Withdrawal by Subject|14|||
129935226|NCT02726386|467730267|FG001|Overall Study|Withdrawal by Subject|28|||
129935227|NCT02726386|467730266|FG000|Overall Study|Other reasons|7|||
129935228|NCT02726386|467730267|FG001|Overall Study|Other reasons|8|||
129935229|NCT02951052|467730273|FG000|Overall Study|Adverse Event|13|||
129935230|NCT02951052|467730274|FG001|Overall Study|Adverse Event|5|||
129935231|NCT02951052|467730273|FG000|Overall Study|Withdrawal by Subject|1|||
129935232|NCT02951052|467730274|FG001|Overall Study|Withdrawal by Subject|5|||
129935233|NCT02951052|467730273|FG000|Overall Study|Physician Decision|2|||
129935234|NCT02951052|467730274|FG001|Overall Study|Physician Decision|0|||
129935235|NCT02951052|467730273|FG000|Overall Study|Lost to Follow-up|1|||
129935236|NCT02951052|467730274|FG001|Overall Study|Lost to Follow-up|1|||
129935237|NCT02951052|467730273|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
129935238|NCT02951052|467730274|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
129935239|NCT02951052|467730273|FG000|Overall Study|Protocol Violation|5|||
129935240|NCT02951052|467730274|FG001|Overall Study|Protocol Violation|3|||
129935241|NCT02951052|467730273|FG000|Overall Study|Lack of Efficacy|3|||
129935242|NCT02951052|467730274|FG001|Overall Study|Lack of Efficacy|4|||
129935243|NCT02951052|467730273|FG000|Overall Study|Ongoing|1|||
129935244|NCT02951052|467730274|FG001|Overall Study|Ongoing|0|||
129935245|NCT04644029|467731117|FG000|Overall Study|Death|1|||
129935246|NCT04644029|467731118|FG001|Overall Study|Death|0|||
129935247|NCT04644029|467731117|FG000|Overall Study|Physician Decision|1|||
129935248|NCT04644029|467731118|FG001|Overall Study|Physician Decision|2|||
129935249|NCT04644029|467731117|FG000|Overall Study|Withdrawal by Subject|21|||
129935250|NCT04644029|467731118|FG001|Overall Study|Withdrawal by Subject|19|||
129935251|NCT04644029|467731117|FG000|Overall Study|Lost to Follow-up|31|||
129935252|NCT04644029|467731118|FG001|Overall Study|Lost to Follow-up|34|||
129935253|NCT04644029|467731117|FG000|Overall Study|Study Terminated by Sponsor|308|||
129935254|NCT04644029|467731118|FG001|Overall Study|Study Terminated by Sponsor|309|||
129935255|NCT04644029|467731117|FG000|Overall Study|Randomized in Error|2|||
129935256|NCT04644029|467731118|FG001|Overall Study|Randomized in Error|1|||
129935257|NCT04644029|467731117|FG000|Overall Study|Other|0|||
129935258|NCT04644029|467731118|FG001|Overall Study|Other|1|||
129935259|NCT02720068|467731119|FG000|Overall Study|Adverse Event|0|||
129935260|NCT02720068|467731120|FG001|Overall Study|Adverse Event|0|||
129935261|NCT02720068|467731121|FG002|Overall Study|Adverse Event|0|||
129935262|NCT02720068|467731122|FG003|Overall Study|Adverse Event|0|||
129935263|NCT02720068|467731123|FG004|Overall Study|Adverse Event|0|||
130070196|NCT00628758|468211420|FG001|Overall Study|Adverse Event|3|||
129935264|NCT02720068|467731124|FG005|Overall Study|Adverse Event|0|||
129935265|NCT02720068|467731125|FG006|Overall Study|Adverse Event|0|||
129935266|NCT02720068|467731126|FG007|Overall Study|Adverse Event|0|||
129935267|NCT02720068|467731127|FG008|Overall Study|Adverse Event|0|||
129935268|NCT02720068|467731128|FG009|Overall Study|Adverse Event|0|||
129935269|NCT02720068|467731129|FG010|Overall Study|Adverse Event|0|||
129935270|NCT02720068|467731130|FG011|Overall Study|Adverse Event|1|||
129935271|NCT02720068|467731131|FG012|Overall Study|Adverse Event|0|||
129935272|NCT02720068|467731132|FG013|Overall Study|Adverse Event|0|||
129935273|NCT02720068|467731133|FG014|Overall Study|Adverse Event|0|||
129935274|NCT02720068|467731134|FG015|Overall Study|Adverse Event|0|||
129935275|NCT02720068|467731135|FG016|Overall Study|Adverse Event|0|||
129935276|NCT02720068|467731136|FG017|Overall Study|Adverse Event|0|||
129935277|NCT02720068|467731119|FG000|Overall Study|Death|1|||
129935278|NCT02720068|467731120|FG001|Overall Study|Death|3|||
129935279|NCT02720068|467731121|FG002|Overall Study|Death|2|||
129935280|NCT02720068|467731122|FG003|Overall Study|Death|1|||
129935281|NCT02720068|467731123|FG004|Overall Study|Death|2|||
129935282|NCT02720068|467731124|FG005|Overall Study|Death|1|||
129935283|NCT02720068|467731125|FG006|Overall Study|Death|2|||
129935284|NCT02720068|467731126|FG007|Overall Study|Death|2|||
129935285|NCT02720068|467731127|FG008|Overall Study|Death|3|||
129935286|NCT02720068|467731128|FG009|Overall Study|Death|1|||
129935287|NCT02720068|467731129|FG010|Overall Study|Death|20|||
129935288|NCT02720068|467731130|FG011|Overall Study|Death|166|||
129935289|NCT02720068|467731131|FG012|Overall Study|Death|34|||
129935290|NCT02720068|467731132|FG013|Overall Study|Death|30|||
129935291|NCT02720068|467731133|FG014|Overall Study|Death|45|||
129935292|NCT02720068|467731134|FG015|Overall Study|Death|16|||
129935293|NCT02720068|467731135|FG016|Overall Study|Death|20|||
129935294|NCT02720068|467731136|FG017|Overall Study|Death|28|||
129935295|NCT02720068|467731119|FG000|Overall Study|Lost to Follow-up|0|||
129935296|NCT02720068|467731120|FG001|Overall Study|Lost to Follow-up|0|||
129935297|NCT02720068|467731121|FG002|Overall Study|Lost to Follow-up|0|||
129935298|NCT02720068|467731122|FG003|Overall Study|Lost to Follow-up|0|||
129935299|NCT02720068|467731123|FG004|Overall Study|Lost to Follow-up|0|||
129935300|NCT02720068|467731124|FG005|Overall Study|Lost to Follow-up|0|||
129935301|NCT02720068|467731125|FG006|Overall Study|Lost to Follow-up|0|||
129935302|NCT02720068|467731126|FG007|Overall Study|Lost to Follow-up|0|||
129935303|NCT02720068|467731127|FG008|Overall Study|Lost to Follow-up|0|||
129935304|NCT02720068|467731128|FG009|Overall Study|Lost to Follow-up|0|||
129935305|NCT02720068|467731129|FG010|Overall Study|Lost to Follow-up|0|||
129935306|NCT02720068|467731130|FG011|Overall Study|Lost to Follow-up|1|||
129935307|NCT02720068|467731131|FG012|Overall Study|Lost to Follow-up|0|||
129935308|NCT02720068|467731132|FG013|Overall Study|Lost to Follow-up|1|||
129935309|NCT02720068|467731133|FG014|Overall Study|Lost to Follow-up|2|||
129935310|NCT02720068|467731134|FG015|Overall Study|Lost to Follow-up|0|||
129935311|NCT02720068|467731135|FG016|Overall Study|Lost to Follow-up|0|||
129935312|NCT02720068|467731136|FG017|Overall Study|Lost to Follow-up|1|||
129935313|NCT02720068|467731119|FG000|Overall Study|Physician Decision|0|||
129935314|NCT02720068|467731120|FG001|Overall Study|Physician Decision|0|||
129935315|NCT02720068|467731121|FG002|Overall Study|Physician Decision|0|||
129935316|NCT02720068|467731122|FG003|Overall Study|Physician Decision|1|||
129935317|NCT02720068|467731123|FG004|Overall Study|Physician Decision|0|||
129935318|NCT02720068|467731124|FG005|Overall Study|Physician Decision|0|||
129935319|NCT02720068|467731125|FG006|Overall Study|Physician Decision|0|||
129935320|NCT02720068|467731126|FG007|Overall Study|Physician Decision|0|||
129935321|NCT02720068|467731127|FG008|Overall Study|Physician Decision|0|||
129935322|NCT02720068|467731128|FG009|Overall Study|Physician Decision|0|||
129935323|NCT02720068|467731129|FG010|Overall Study|Physician Decision|0|||
129935324|NCT02720068|467731130|FG011|Overall Study|Physician Decision|1|||
129935325|NCT02720068|467731131|FG012|Overall Study|Physician Decision|0|||
129935326|NCT02720068|467731132|FG013|Overall Study|Physician Decision|0|||
129935327|NCT02720068|467731133|FG014|Overall Study|Physician Decision|0|||
129935328|NCT02720068|467731134|FG015|Overall Study|Physician Decision|0|||
129935329|NCT02720068|467731135|FG016|Overall Study|Physician Decision|0|||
129935330|NCT02720068|467731136|FG017|Overall Study|Physician Decision|1|||
129935331|NCT02720068|467731119|FG000|Overall Study|Progressive Disease|2|||
129935332|NCT02720068|467731120|FG001|Overall Study|Progressive Disease|3|||
129935333|NCT02720068|467731121|FG002|Overall Study|Progressive Disease|1|||
129935334|NCT02720068|467731122|FG003|Overall Study|Progressive Disease|1|||
129935335|NCT02720068|467731123|FG004|Overall Study|Progressive Disease|1|||
130119158|NCT01296932|468398315|FG001|Overall Study|Adverse Event|1|||
130119159|NCT01296932|468398316|FG002|Overall Study|Adverse Event|1|||
129935336|NCT02720068|467731124|FG005|Overall Study|Progressive Disease|2|||
129935337|NCT02720068|467731125|FG006|Overall Study|Progressive Disease|1|||
129935338|NCT02720068|467731126|FG007|Overall Study|Progressive Disease|1|||
129935339|NCT02720068|467731127|FG008|Overall Study|Progressive Disease|0|||
129935340|NCT02720068|467731128|FG009|Overall Study|Progressive Disease|1|||
129935341|NCT02720068|467731129|FG010|Overall Study|Progressive Disease|0|||
129935342|NCT02720068|467731130|FG011|Overall Study|Progressive Disease|4|||
129935343|NCT02720068|467731131|FG012|Overall Study|Progressive Disease|1|||
130119160|NCT01296932|468398317|FG003|Overall Study|Adverse Event|2|||
129935344|NCT02720068|467731132|FG013|Overall Study|Progressive Disease|0|||
129935345|NCT02720068|467731133|FG014|Overall Study|Progressive Disease|0|||
129935346|NCT02720068|467731134|FG015|Overall Study|Progressive Disease|0|||
129935347|NCT02720068|467731135|FG016|Overall Study|Progressive Disease|0|||
129935348|NCT02720068|467731136|FG017|Overall Study|Progressive Disease|0|||
129935349|NCT02720068|467731119|FG000|Overall Study|Sponsor Decision|0|||
129935350|NCT02720068|467731120|FG001|Overall Study|Sponsor Decision|0|||
130119161|NCT01296932|468398318|FG004|Overall Study|Adverse Event|1|||
129935351|NCT02720068|467731121|FG002|Overall Study|Sponsor Decision|0|||
129935352|NCT02720068|467731122|FG003|Overall Study|Sponsor Decision|0|||
129935353|NCT02720068|467731123|FG004|Overall Study|Sponsor Decision|0|||
129935354|NCT02720068|467731124|FG005|Overall Study|Sponsor Decision|0|||
129935355|NCT02720068|467731125|FG006|Overall Study|Sponsor Decision|0|||
129935356|NCT02720068|467731126|FG007|Overall Study|Sponsor Decision|0|||
129935357|NCT02720068|467731127|FG008|Overall Study|Sponsor Decision|0|||
129935358|NCT02720068|467731128|FG009|Overall Study|Sponsor Decision|0|||
129935359|NCT02720068|467731129|FG010|Overall Study|Sponsor Decision|0|||
129935360|NCT02720068|467731130|FG011|Overall Study|Sponsor Decision|6|||
129935361|NCT02720068|467731131|FG012|Overall Study|Sponsor Decision|3|||
129935362|NCT02720068|467731132|FG013|Overall Study|Sponsor Decision|2|||
129935363|NCT02720068|467731133|FG014|Overall Study|Sponsor Decision|4|||
129935364|NCT02720068|467731134|FG015|Overall Study|Sponsor Decision|4|||
129935365|NCT02720068|467731135|FG016|Overall Study|Sponsor Decision|0|||
129935366|NCT02720068|467731136|FG017|Overall Study|Sponsor Decision|8|||
129935367|NCT02720068|467731119|FG000|Overall Study|Withdrawal by Subject|0|||
129935368|NCT02720068|467731120|FG001|Overall Study|Withdrawal by Subject|0|||
129935369|NCT02720068|467731121|FG002|Overall Study|Withdrawal by Subject|0|||
129935370|NCT02720068|467731122|FG003|Overall Study|Withdrawal by Subject|0|||
129935371|NCT02720068|467731123|FG004|Overall Study|Withdrawal by Subject|0|||
129935372|NCT02720068|467731124|FG005|Overall Study|Withdrawal by Subject|0|||
129935373|NCT02720068|467731125|FG006|Overall Study|Withdrawal by Subject|0|||
129935374|NCT02720068|467731126|FG007|Overall Study|Withdrawal by Subject|0|||
129935375|NCT02720068|467731127|FG008|Overall Study|Withdrawal by Subject|0|||
129935376|NCT02720068|467731128|FG009|Overall Study|Withdrawal by Subject|1|||
129935377|NCT02720068|467731129|FG010|Overall Study|Withdrawal by Subject|0|||
129935378|NCT02720068|467731130|FG011|Overall Study|Withdrawal by Subject|27|||
129935379|NCT02720068|467731131|FG012|Overall Study|Withdrawal by Subject|2|||
129935380|NCT02720068|467731132|FG013|Overall Study|Withdrawal by Subject|8|||
129935381|NCT02720068|467731133|FG014|Overall Study|Withdrawal by Subject|7|||
129935382|NCT02720068|467731134|FG015|Overall Study|Withdrawal by Subject|0|||
129935383|NCT02720068|467731135|FG016|Overall Study|Withdrawal by Subject|0|||
129935384|NCT02720068|467731136|FG017|Overall Study|Withdrawal by Subject|2|||
129935385|NCT02720068|467731119|FG000|Overall Study|Protocol Violation|0|||
129935386|NCT02720068|467731120|FG001|Overall Study|Protocol Violation|0|||
129935387|NCT02720068|467731121|FG002|Overall Study|Protocol Violation|0|||
129935388|NCT02720068|467731122|FG003|Overall Study|Protocol Violation|0|||
129935389|NCT02720068|467731123|FG004|Overall Study|Protocol Violation|0|||
129935390|NCT02720068|467731124|FG005|Overall Study|Protocol Violation|0|||
129935391|NCT02720068|467731125|FG006|Overall Study|Protocol Violation|0|||
129935392|NCT02720068|467731126|FG007|Overall Study|Protocol Violation|0|||
129935393|NCT02720068|467731127|FG008|Overall Study|Protocol Violation|0|||
129935394|NCT02720068|467731128|FG009|Overall Study|Protocol Violation|0|||
129935395|NCT02720068|467731129|FG010|Overall Study|Protocol Violation|1|||
129935396|NCT02720068|467731130|FG011|Overall Study|Protocol Violation|0|||
129935397|NCT02720068|467731131|FG012|Overall Study|Protocol Violation|0|||
129935398|NCT02720068|467731132|FG013|Overall Study|Protocol Violation|0|||
129935399|NCT02720068|467731133|FG014|Overall Study|Protocol Violation|1|||
129935400|NCT02720068|467731134|FG015|Overall Study|Protocol Violation|0|||
129935401|NCT02720068|467731135|FG016|Overall Study|Protocol Violation|1|||
129935402|NCT02720068|467731136|FG017|Overall Study|Protocol Violation|0|||
129935403|NCT00113360|467731137|FG000|Overall Study|Adverse Event|3|||
129935404|NCT00113360|467731137|FG000|Overall Study|Subject required surgery|1|||
129935405|NCT00113360|467731137|FG000|Overall Study|Did not meet eligibility criteria|3|||
129935406|NCT02467270|467731152|FG000|Overall Study|Participants Never Treated|0|||
129935407|NCT02467270|467731153|FG001|Overall Study|Participants Never Treated|1|||
129935408|NCT02467270|467731154|FG002|Overall Study|Participants Never Treated|0|||
129935409|NCT02467270|467731152|FG000|Overall Study|Ongoing|50|||
129935410|NCT02467270|467731153|FG001|Overall Study|Ongoing|41|||
129935411|NCT02467270|467731154|FG002|Overall Study|Ongoing|43|||
129935412|NCT02467270|467731152|FG000|Overall Study|Adverse Event|16|||
129935413|NCT02467270|467731153|FG001|Overall Study|Adverse Event|15|||
129935414|NCT02467270|467731154|FG002|Overall Study|Adverse Event|14|||
129935415|NCT02467270|467731152|FG000|Overall Study|Progressive Disease|7|||
129935416|NCT02467270|467731153|FG001|Overall Study|Progressive Disease|7|||
129935417|NCT02467270|467731154|FG002|Overall Study|Progressive Disease|4|||
129935418|NCT02467270|467731152|FG000|Overall Study|Death|2|||
130070197|NCT00628758|468211419|FG000|Overall Study|Withdrawal by Subject|6|||
129935419|NCT02467270|467731153|FG001|Overall Study|Death|0|||
129935420|NCT02467270|467731154|FG002|Overall Study|Death|2|||
129935421|NCT02467270|467731152|FG000|Overall Study|Lack of Efficacy|12|||
129935422|NCT02467270|467731153|FG001|Overall Study|Lack of Efficacy|18|||
129935423|NCT02467270|467731154|FG002|Overall Study|Lack of Efficacy|23|||
129935424|NCT02467270|467731152|FG000|Overall Study|Non-compliance With Study Drug|0|||
129935425|NCT02467270|467731153|FG001|Overall Study|Non-compliance With Study Drug|2|||
129935426|NCT02467270|467731154|FG002|Overall Study|Non-compliance With Study Drug|1|||
129935427|NCT02467270|467731152|FG000|Overall Study|Lost to Follow-up|2|||
129935428|NCT02467270|467731153|FG001|Overall Study|Lost to Follow-up|1|||
129935429|NCT02467270|467731154|FG002|Overall Study|Lost to Follow-up|0|||
129935430|NCT02467270|467731152|FG000|Overall Study|Pregnancy|0|||
129935431|NCT02467270|467731153|FG001|Overall Study|Pregnancy|1|||
129935432|NCT02467270|467731154|FG002|Overall Study|Pregnancy|0|||
129935433|NCT02467270|467731152|FG000|Overall Study|Physician Decision|0|||
129935434|NCT02467270|467731153|FG001|Overall Study|Physician Decision|4|||
129935435|NCT02467270|467731154|FG002|Overall Study|Physician Decision|1|||
129935436|NCT02467270|467731152|FG000|Overall Study|Withdrawal by Subject|4|||
129935437|NCT02467270|467731153|FG001|Overall Study|Withdrawal by Subject|3|||
129935438|NCT02467270|467731154|FG002|Overall Study|Withdrawal by Subject|5|||
129935439|NCT02467270|467731152|FG000|Overall Study|Reason not Specified|1|||
129935440|NCT02467270|467731153|FG001|Overall Study|Reason not Specified|2|||
129935441|NCT02467270|467731154|FG002|Overall Study|Reason not Specified|1|||
129935442|NCT00739908|467731155|FG000|Overall Study|Adverse Event|5|||
129935443|NCT00739908|467731156|FG001|Overall Study|Adverse Event|6|||
129935444|NCT00739908|467731155|FG000|Overall Study|Withdrawal by Subject|4|||
129935445|NCT00739908|467731156|FG001|Overall Study|Withdrawal by Subject|2|||
129935446|NCT00739908|467731155|FG000|Overall Study|Lost to Follow-up|14|||
129935447|NCT00739908|467731156|FG001|Overall Study|Lost to Follow-up|9|||
129935448|NCT00739908|467731155|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
129935449|NCT00739908|467731156|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
129935450|NCT00739908|467731155|FG000|Overall Study|Non-Compliance With Study Medication|0|||
129935451|NCT00739908|467731156|FG001|Overall Study|Non-Compliance With Study Medication|3|||
129935452|NCT00739908|467731155|FG000|Overall Study|Lack of Efficacy|0|||
129935453|NCT00739908|467731156|FG001|Overall Study|Lack of Efficacy|1|||
129935454|NCT00739908|467731155|FG000|Overall Study|Relocation|0|||
129935455|NCT00739908|467731156|FG001|Overall Study|Relocation|1|||
129935456|NCT04129164|467731159|FG000|Overall Study|Non-compliance with procedures|0|||
129935457|NCT04129164|467731160|FG001|Overall Study|Non-compliance with procedures|0|||
129935458|NCT04129164|467731161|FG002|Overall Study|Non-compliance with procedures|2|||
129935459|NCT04129164|467731162|FG003|Overall Study|Non-compliance with procedures|0|||
129935460|NCT04129164|467731159|FG000|Overall Study|Adverse Event|0|||
129935461|NCT04129164|467731160|FG001|Overall Study|Adverse Event|0|||
129935462|NCT04129164|467731161|FG002|Overall Study|Adverse Event|2|||
129935463|NCT04129164|467731162|FG003|Overall Study|Adverse Event|0|||
129935464|NCT04129164|467731159|FG000|Overall Study|Pregnancy|0|||
129935465|NCT04129164|467731160|FG001|Overall Study|Pregnancy|0|||
129935466|NCT04129164|467731161|FG002|Overall Study|Pregnancy|0|||
129935467|NCT04129164|467731162|FG003|Overall Study|Pregnancy|1|||
129935468|NCT04129164|467731159|FG000|Overall Study|Withdrawal by Subject|3|||
129935469|NCT04129164|467731160|FG001|Overall Study|Withdrawal by Subject|2|||
129935470|NCT04129164|467731161|FG002|Overall Study|Withdrawal by Subject|4|||
129935471|NCT04129164|467731162|FG003|Overall Study|Withdrawal by Subject|6|||
129935472|NCT04129164|467731159|FG000|Overall Study|Death|0|||
129935473|NCT04129164|467731160|FG001|Overall Study|Death|1|||
129935474|NCT04129164|467731161|FG002|Overall Study|Death|0|||
129935475|NCT04129164|467731162|FG003|Overall Study|Death|0|||
129935476|NCT04129164|467731159|FG000|Overall Study|Lost to Follow-up|0|||
129935477|NCT04129164|467731160|FG001|Overall Study|Lost to Follow-up|1|||
129935478|NCT04129164|467731161|FG002|Overall Study|Lost to Follow-up|0|||
129935479|NCT04129164|467731162|FG003|Overall Study|Lost to Follow-up|0|||
129935480|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
129935481|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
129935482|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
129935483|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
129935484|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
129935485|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
129935486|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
129935487|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
129935488|NCT03868930|467731163|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
129935489|NCT03868930|467731164|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
129935490|NCT04227899|467731167|FG000|Overall Study|Withdrawal by Subject|6|||
129935491|NCT04227899|467731168|FG001|Overall Study|Withdrawal by Subject|3|||
129935492|NCT04227899|467731167|FG000|Overall Study|Death|12|||
129935493|NCT04227899|467731168|FG001|Overall Study|Death|6|||
129935494|NCT04227899|467731167|FG000|Overall Study|Lost to Follow-up|2|||
129935495|NCT04227899|467731168|FG001|Overall Study|Lost to Follow-up|1|||
129935496|NCT01773993|467731170|FG000|Overall Study|No Visit After Treatment|35|||
129935497|NCT04664881|467731171|FG000|Overall Study|Withdrawal by Subject|1|||
129935498|NCT04664881|467731172|FG001|Overall Study|Withdrawal by Subject|8|||
129935499|NCT04664881|467731171|FG000|Overall Study|Physician Decision|0|||
129935500|NCT04664881|467731172|FG001|Overall Study|Physician Decision|5|||
129935501|NCT04664881|467731171|FG000|Overall Study|Lost to Follow-up|1|||
129935502|NCT04664881|467731172|FG001|Overall Study|Lost to Follow-up|0|||
129935503|NCT00328783|467731175|FG000|Overall Study|Could not tolerate ABC|21|||
129935504|NCT00328783|467731175|FG000|Overall Study|No heart in RT field|4|||
130119162|NCT01296932|468398319|FG005|Overall Study|Adverse Event|0|||
129935505|NCT00328783|467731175|FG000|Overall Study|Withdrawal by Subject|1|||
129935506|NCT00357682|467731176|FG000|Overall Study|Did not receive allocated Treatment|10|||
129935507|NCT00357682|467731177|FG001|Overall Study|Did not receive allocated Treatment|9|||
129935508|NCT00357682|467731178|FG002|Overall Study|Did not receive allocated Treatment|9|||
129935509|NCT00357682|467731179|FG003|Overall Study|Did not receive allocated Treatment|10|||
129935510|NCT00357682|467731176|FG000|Overall Study|Withdrew consent|6|||
129935511|NCT00357682|467731177|FG001|Overall Study|Withdrew consent|6|||
129935512|NCT00357682|467731178|FG002|Overall Study|Withdrew consent|5|||
129935513|NCT00357682|467731179|FG003|Overall Study|Withdrew consent|5|||
129935514|NCT00357682|467731176|FG000|Overall Study|Lost to Follow-up|39|||
129935515|NCT00357682|467731177|FG001|Overall Study|Lost to Follow-up|33|||
129935516|NCT00357682|467731178|FG002|Overall Study|Lost to Follow-up|26|||
129935517|NCT00357682|467731179|FG003|Overall Study|Lost to Follow-up|35|||
129935518|NCT00357682|467731176|FG000|Overall Study|Adverse Event|24|||
129935519|NCT00357682|467731177|FG001|Overall Study|Adverse Event|32|||
129935520|NCT00357682|467731178|FG002|Overall Study|Adverse Event|22|||
129935521|NCT00357682|467731179|FG003|Overall Study|Adverse Event|27|||
129935522|NCT00357682|467731176|FG000|Overall Study|Physician Decision|32|||
129935523|NCT00357682|467731177|FG001|Overall Study|Physician Decision|20|||
129935524|NCT00357682|467731178|FG002|Overall Study|Physician Decision|24|||
129935525|NCT00357682|467731179|FG003|Overall Study|Physician Decision|30|||
129935526|NCT00357682|467731176|FG000|Overall Study|Patient decision|73|||
129935527|NCT00357682|467731177|FG001|Overall Study|Patient decision|80|||
129935528|NCT00357682|467731178|FG002|Overall Study|Patient decision|51|||
129935529|NCT00357682|467731179|FG003|Overall Study|Patient decision|59|||
129935530|NCT00357682|467731176|FG000|Overall Study|Other reason|157|||
129935531|NCT00357682|467731177|FG001|Overall Study|Other reason|130|||
129935532|NCT00357682|467731178|FG002|Overall Study|Other reason|114|||
129935533|NCT00357682|467731179|FG003|Overall Study|Other reason|99|||
129935534|NCT03201939|467731184|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
129935535|NCT03201939|467731185|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
129935536|NCT05707351|467731188|FG000|Overall Study|Withdrawal by Subject|2|||
129935537|NCT05707351|467731188|FG000|Overall Study|Reason Not Specified|1|||
129935538|NCT04012567|467731197|FG000|Overall Study|Lost to Follow-up|0|||
129935539|NCT04012567|467731198|FG001|Overall Study|Lost to Follow-up|1|||
129935540|NCT04012567|467731197|FG000|Overall Study|Withdrawal by Subject|1|||
129935541|NCT04012567|467731198|FG001|Overall Study|Withdrawal by Subject|0|||
129935542|NCT02206828|467731201|FG000|Overall Study|Lost to Follow-up|7|||
129935543|NCT05795153|467732204|FG000|Overall Study|Adverse Event|2|||
129935544|NCT05795153|467732204|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129935545|NCT05795153|467732204|FG000|Overall Study|Lost to Follow-up|1|||
129935546|NCT05795153|467732204|FG000|Overall Study|Subject decision|2|||
129935547|NCT05180539|467732205|FG000|Overall Study|Lost to Follow-up|27|||
129935548|NCT05180539|467732206|FG001|Overall Study|Lost to Follow-up|30|||
129935549|NCT02566889|467732209|FG000|Overall Study|Withdrawal by Subject|3|||
129935550|NCT02566889|467732210|FG001|Overall Study|Withdrawal by Subject|1|||
129935551|NCT02566889|467732209|FG000|Overall Study|Adverse Event|4|||
129935552|NCT02566889|467732210|FG001|Overall Study|Adverse Event|2|||
129935553|NCT02566889|467732209|FG000|Overall Study|Other|6|||
129935554|NCT02566889|467732210|FG001|Overall Study|Other|2|||
129935555|NCT04518943|467732211|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
129935556|NCT04518943|467732212|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
129935557|NCT04518943|467732213|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
129935558|NCT04518943|467732214|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
129935559|NCT04518943|467732215|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
129935560|NCT04518943|467732216|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
129935561|NCT04518943|467732217|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
129935562|NCT04518943|467732218|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
129935563|NCT04518943|467732219|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
129935564|NCT04518943|467732220|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
129935565|NCT04518943|467732221|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
129935566|NCT04518943|467732222|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
129935567|NCT04518943|467732223|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
129935568|NCT04518943|467732224|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
129935569|NCT04518943|467732225|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
129935570|NCT04518943|467732226|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
129935571|NCT03699163|467732228|FG000|Overall Study|Physician Decision|12|||
129935572|NCT03699163|467732229|FG001|Overall Study|Physician Decision|0|||
129935573|NCT03699163|467732228|FG000|Overall Study|failed QC measures|205|||
129935574|NCT03699163|467732229|FG001|Overall Study|failed QC measures|206|||
129935575|NCT03705793|467732230|FG000|Overall Study|Lost to Follow-up|3|||
129935576|NCT03705793|467732231|FG001|Overall Study|Lost to Follow-up|4|||
129935577|NCT03705793|467732230|FG000|Overall Study|Withdrawal by Subject|2|||
129935578|NCT03705793|467732231|FG001|Overall Study|Withdrawal by Subject|1|||
129935579|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Other|0|||
129935580|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Other|2|||
129935581|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Other|1|||
129935582|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Other|2|||
129935583|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Other|2|||
129935584|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Other|0|||
129935585|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Other|0|||
129935586|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Other|0|||
129935587|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Other|0|||
129935588|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Other|0|||
129935589|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Other|0|||
129935590|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Other|0|||
129935591|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Other|0|||
129935592|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Other|0|||
129935593|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Other|0|||
129935594|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Other|0|||
129935595|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Other|0|||
129935596|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
129935597|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
129935598|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
129935599|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
129935600|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
129935601|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
129935602|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935603|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935604|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935605|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935606|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935607|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935608|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935609|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935610|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935611|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935612|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935613|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935614|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
129935615|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
129935616|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935617|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
129935618|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
129935619|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935620|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935621|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935622|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935623|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935624|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935625|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935626|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935627|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935628|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935629|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935630|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Death|2|||
129935631|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Death|1|||
129935632|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Death|1|||
129935633|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Death|0|||
129935634|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Death|0|||
129935635|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Death|0|||
129935636|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Death|0|||
129935637|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Death|0|||
129935638|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Death|0|||
129935639|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Death|0|||
129935640|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Death|0|||
130119163|NCT01296932|468398320|FG006|Overall Study|Adverse Event|0|||
130119164|NCT01296932|468398321|FG007|Overall Study|Adverse Event|0|||
130119165|NCT01296932|468398322|FG008|Overall Study|Adverse Event|1|||
129935641|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Death|0|||
129935642|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Death|0|||
129935643|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Death|0|||
129935644|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Death|0|||
129935645|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Death|0|||
130119166|NCT01296932|468398314|FG000|Overall Study|Investigator decision|0|||
130119167|NCT01296932|468398315|FG001|Overall Study|Investigator decision|1|||
129935646|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Death|0|||
129935647|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935648|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
130119168|NCT01296932|468398316|FG002|Overall Study|Investigator decision|0|||
130119169|NCT01296932|468398317|FG003|Overall Study|Investigator decision|1|||
129935649|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
130070198|NCT00628758|468211420|FG001|Overall Study|Withdrawal by Subject|3|||
130070199|NCT00628758|468211419|FG000|Overall Study|Death|1|||
130070200|NCT00628758|468211420|FG001|Overall Study|Death|0|||
130070201|NCT00628758|468211419|FG000|Overall Study|Protocol Violation|5|||
130070202|NCT00628758|468211420|FG001|Overall Study|Protocol Violation|1|||
130070203|NCT00628758|468211419|FG000|Overall Study|Lost to Follow-up|25|||
130070204|NCT00628758|468211420|FG001|Overall Study|Lost to Follow-up|31|||
130070205|NCT00628758|468211419|FG000|Overall Study|Pregnancy|2|||
130070206|NCT00628758|468211420|FG001|Overall Study|Pregnancy|2|||
130070207|NCT00628758|468211419|FG000|Overall Study|Investigator Moved|3|||
130070208|NCT00628758|468211420|FG001|Overall Study|Investigator Moved|0|||
130070209|NCT00628758|468211419|FG000|Overall Study|Treatment Failure|0|||
130070210|NCT00628758|468211420|FG001|Overall Study|Treatment Failure|2|||
130070211|NCT00637377|468211421|FG000|Overall Study|Adverse Event|2|||
130070212|NCT00637377|468211422|FG001|Overall Study|Adverse Event|6|||
130070213|NCT00637377|468211423|FG002|Overall Study|Adverse Event|8|||
130070214|NCT00637377|468211424|FG003|Overall Study|Adverse Event|9|||
130070215|NCT00637377|468211421|FG000|Overall Study|Death|1|||
130070216|NCT00637377|468211422|FG001|Overall Study|Death|3|||
130070217|NCT00637377|468211423|FG002|Overall Study|Death|2|||
130070218|NCT00637377|468211424|FG003|Overall Study|Death|1|||
130070219|NCT00637377|468211421|FG000|Overall Study|Lack of Efficacy|0|||
130070220|NCT00637377|468211422|FG001|Overall Study|Lack of Efficacy|0|||
130070221|NCT00637377|468211423|FG002|Overall Study|Lack of Efficacy|1|||
130070222|NCT00637377|468211424|FG003|Overall Study|Lack of Efficacy|1|||
130070223|NCT00637377|468211421|FG000|Overall Study|Lost to Follow-up|4|||
130070224|NCT00637377|468211422|FG001|Overall Study|Lost to Follow-up|1|||
130070225|NCT00637377|468211423|FG002|Overall Study|Lost to Follow-up|2|||
130070226|NCT00637377|468211424|FG003|Overall Study|Lost to Follow-up|2|||
130070227|NCT00637377|468211421|FG000|Overall Study|Protocol Violation|2|||
129935650|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935651|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
129935652|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
129935653|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935654|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935655|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935656|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935657|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935658|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935659|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935660|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935661|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935662|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935663|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935664|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935665|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935666|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935667|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935668|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
129935669|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
129935670|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935671|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935672|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935673|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935674|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935675|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935676|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935677|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935678|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935679|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935680|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935681|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935682|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935683|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
129935684|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935685|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935686|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935687|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935688|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935689|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935690|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935691|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935692|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935693|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130070228|NCT00637377|468211422|FG001|Overall Study|Protocol Violation|1|||
129935694|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935695|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935696|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935697|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935698|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935699|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935700|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935701|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935702|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935703|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935704|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
129935705|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
129935706|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
129935707|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935708|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935709|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935710|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935711|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935712|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935713|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935714|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935715|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935716|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935717|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935718|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935719|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935720|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935721|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
129935722|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
129935723|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935724|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935725|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935726|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935727|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935728|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935729|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935730|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935731|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935732|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Death|0|||
129935733|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Death|0|||
129935734|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Death|0|||
129935735|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Death|0|||
129935736|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Death|0|||
129935737|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Death|0|||
129935738|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Death|1|||
129935739|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Death|6|||
129935740|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Death|0|||
129935741|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Death|0|||
129935742|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Death|0|||
129935743|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Death|0|||
129935744|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Death|0|||
129935745|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Death|0|||
129935746|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Death|0|||
129935747|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Death|0|||
129935748|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Death|0|||
129935749|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935750|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935751|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935752|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935753|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935754|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935755|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
129935756|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
129935757|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935758|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935759|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935760|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935761|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935762|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935763|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935764|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935765|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935766|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935767|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935768|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935769|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935770|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935771|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935772|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
129935773|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
129935774|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935775|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935776|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935777|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935778|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935779|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935780|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935781|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935782|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935783|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Other|0|||
129935784|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Other|0|||
129935785|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Other|0|||
129935786|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Other|0|||
129935787|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Other|0|||
129935788|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Other|0|||
129935789|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Other|1|||
129935790|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Other|7|||
129935791|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Other|0|||
129935792|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Other|0|||
129935793|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Other|0|||
129935794|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Other|0|||
129935795|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Other|0|||
129935796|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Other|0|||
129935797|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Other|0|||
129935798|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Other|0|||
129935799|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Other|0|||
129935800|NCT02719574|467732232|FG000|Phase 2|Protocol Defined Disease Progression|0|||
129935801|NCT02719574|467732233|FG001|Phase 2|Protocol Defined Disease Progression|0|||
129935802|NCT02719574|467732234|FG002|Phase 2|Protocol Defined Disease Progression|0|||
129935803|NCT02719574|467732235|FG003|Phase 2|Protocol Defined Disease Progression|0|||
129935804|NCT02719574|467732236|FG004|Phase 2|Protocol Defined Disease Progression|0|||
129935805|NCT02719574|467732237|FG005|Phase 2|Protocol Defined Disease Progression|0|||
129935806|NCT02719574|467732238|FG006|Phase 2|Protocol Defined Disease Progression|0|||
129935807|NCT02719574|467732239|FG007|Phase 2|Protocol Defined Disease Progression|0|||
129935808|NCT02719574|467732240|FG008|Phase 2|Protocol Defined Disease Progression|0|||
129935809|NCT02719574|467732241|FG009|Phase 2|Protocol Defined Disease Progression|65|||
129935810|NCT02719574|467732242|FG010|Phase 2|Protocol Defined Disease Progression|8|||
129935811|NCT02719574|467732243|FG011|Phase 2|Protocol Defined Disease Progression|2|||
129935812|NCT02719574|467732244|FG012|Phase 2|Protocol Defined Disease Progression|4|||
129935813|NCT02719574|467732245|FG013|Phase 2|Protocol Defined Disease Progression|9|||
129935814|NCT02719574|467732246|FG014|Phase 2|Protocol Defined Disease Progression|11|||
129935815|NCT02719574|467732247|FG015|Phase 2|Protocol Defined Disease Progression|3|||
129935816|NCT02719574|467732248|FG016|Phase 2|Protocol Defined Disease Progression|4|||
129935817|NCT02719574|467732232|FG000|Phase 2|Adverse Event|0|||
129935818|NCT02719574|467732233|FG001|Phase 2|Adverse Event|0|||
129935819|NCT02719574|467732234|FG002|Phase 2|Adverse Event|0|||
129935820|NCT02719574|467732235|FG003|Phase 2|Adverse Event|0|||
129935821|NCT02719574|467732236|FG004|Phase 2|Adverse Event|0|||
129935822|NCT02719574|467732237|FG005|Phase 2|Adverse Event|0|||
129935823|NCT02719574|467732238|FG006|Phase 2|Adverse Event|0|||
129935824|NCT02719574|467732239|FG007|Phase 2|Adverse Event|0|||
129935825|NCT02719574|467732240|FG008|Phase 2|Adverse Event|0|||
129935826|NCT02719574|467732241|FG009|Phase 2|Adverse Event|27|||
129935827|NCT02719574|467732242|FG010|Phase 2|Adverse Event|0|||
129935828|NCT02719574|467732243|FG011|Phase 2|Adverse Event|1|||
129935829|NCT02719574|467732244|FG012|Phase 2|Adverse Event|1|||
129935830|NCT02719574|467732245|FG013|Phase 2|Adverse Event|1|||
129935831|NCT02719574|467732246|FG014|Phase 2|Adverse Event|2|||
129935832|NCT02719574|467732247|FG015|Phase 2|Adverse Event|2|||
129935833|NCT02719574|467732248|FG016|Phase 2|Adverse Event|3|||
129935834|NCT02719574|467732232|FG000|Phase 2|Other|0|||
129935835|NCT02719574|467732233|FG001|Phase 2|Other|0|||
129935836|NCT02719574|467732234|FG002|Phase 2|Other|0|||
129935837|NCT02719574|467732235|FG003|Phase 2|Other|0|||
129935838|NCT02719574|467732236|FG004|Phase 2|Other|0|||
129935839|NCT02719574|467732237|FG005|Phase 2|Other|0|||
129935840|NCT02719574|467732238|FG006|Phase 2|Other|0|||
130070229|NCT00637377|468211423|FG002|Overall Study|Protocol Violation|1|||
129935841|NCT02719574|467732239|FG007|Phase 2|Other|0|||
129935842|NCT02719574|467732240|FG008|Phase 2|Other|0|||
129935843|NCT02719574|467732241|FG009|Phase 2|Other|20|||
129935844|NCT02719574|467732242|FG010|Phase 2|Other|7|||
129935845|NCT02719574|467732243|FG011|Phase 2|Other|0|||
129935846|NCT02719574|467732244|FG012|Phase 2|Other|5|||
129935847|NCT02719574|467732245|FG013|Phase 2|Other|7|||
129935848|NCT02719574|467732246|FG014|Phase 2|Other|0|||
129935849|NCT02719574|467732247|FG015|Phase 2|Other|1|||
129935850|NCT02719574|467732248|FG016|Phase 2|Other|4|||
129935851|NCT02719574|467732232|FG000|Phase 2|Transplant|0|||
129935852|NCT02719574|467732233|FG001|Phase 2|Transplant|0|||
129935853|NCT02719574|467732234|FG002|Phase 2|Transplant|0|||
129935854|NCT02719574|467732235|FG003|Phase 2|Transplant|0|||
129935855|NCT02719574|467732236|FG004|Phase 2|Transplant|0|||
129935856|NCT02719574|467732237|FG005|Phase 2|Transplant|0|||
129935857|NCT02719574|467732238|FG006|Phase 2|Transplant|0|||
129935858|NCT02719574|467732239|FG007|Phase 2|Transplant|0|||
129935859|NCT02719574|467732240|FG008|Phase 2|Transplant|0|||
129935860|NCT02719574|467732241|FG009|Phase 2|Transplant|15|||
129935861|NCT02719574|467732242|FG010|Phase 2|Transplant|2|||
129935862|NCT02719574|467732243|FG011|Phase 2|Transplant|0|||
129935863|NCT02719574|467732244|FG012|Phase 2|Transplant|6|||
129935864|NCT02719574|467732245|FG013|Phase 2|Transplant|1|||
129935865|NCT02719574|467732246|FG014|Phase 2|Transplant|1|||
129935866|NCT02719574|467732247|FG015|Phase 2|Transplant|0|||
129935867|NCT02719574|467732248|FG016|Phase 2|Transplant|0|||
129935868|NCT02719574|467732232|FG000|Phase 2|Death|0|||
129935869|NCT02719574|467732233|FG001|Phase 2|Death|0|||
130070230|NCT00637377|468211424|FG003|Overall Study|Protocol Violation|0|||
130070231|NCT00637377|468211421|FG000|Overall Study|Withdrawal by Subject|11|||
130070232|NCT00637377|468211422|FG001|Overall Study|Withdrawal by Subject|15|||
130070233|NCT00637377|468211423|FG002|Overall Study|Withdrawal by Subject|13|||
130070234|NCT00637377|468211424|FG003|Overall Study|Withdrawal by Subject|11|||
130070235|NCT00637377|468211421|FG000|Overall Study|Other (no further information available)|7|||
130070236|NCT00637377|468211422|FG001|Overall Study|Other (no further information available)|6|||
130070237|NCT00637377|468211423|FG002|Overall Study|Other (no further information available)|10|||
130070238|NCT00637377|468211424|FG003|Overall Study|Other (no further information available)|5|||
130070239|NCT01938001|468211425|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
130070240|NCT01938001|468211426|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
130070241|NCT01938001|468211425|FG000|Pre-Treatment|Death|1|||
130070242|NCT01938001|468211426|FG001|Pre-Treatment|Death|0|||
130070243|NCT01938001|468211425|FG000|Treatment|Death|2|||
130070244|NCT01938001|468211426|FG001|Treatment|Death|0|||
130070245|NCT01938001|468211425|FG000|Treatment|Adverse Event|14|||
130070246|NCT01938001|468211426|FG001|Treatment|Adverse Event|8|||
130070247|NCT01938001|468211425|FG000|Treatment|Progressive Disease|21|||
130070248|NCT01938001|468211426|FG001|Treatment|Progressive Disease|54|||
130070249|NCT01938001|468211425|FG000|Treatment|Withdrawal by Subject|13|||
130070250|NCT01938001|468211426|FG001|Treatment|Withdrawal by Subject|7|||
130070251|NCT01938001|468211425|FG000|Treatment|Other reasons|2|||
130070252|NCT01938001|468211426|FG001|Treatment|Other reasons|1|||
130070253|NCT02762708|468211427|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
130070254|NCT02762708|468211428|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
130070255|NCT02762708|468211429|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
130070256|NCT02762708|468211430|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
130070257|NCT01068717|468211437|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
130070258|NCT01068717|468211438|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
130070259|NCT01068717|468211439|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
130070260|NCT01068717|468211440|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
130070261|NCT01822223|468211441|FG000|Overall Study|Death|0|||
130070262|NCT01822223|468211442|FG001|Overall Study|Death|1|||
130070263|NCT04186663|468211445|FG000|Overall Study|Lost to Follow-up|1|||
130070264|NCT04186663|468211445|FG000|Overall Study|Unable to complete blood draw|3|||
130070265|NCT01184846|468211449|FG000|Overall Study|Adverse Event|2|||
130070266|NCT01184846|468211449|FG000|Overall Study|Insufficient response|1|||
130070267|NCT00892957|468211450|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
130070268|NCT00892957|468211451|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
130070269|NCT00892957|468211450|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
130070270|NCT00892957|468211451|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
130070271|NCT04876599|468211454|FG000|Overall Study|Missed|2|||
130070272|NCT04876599|468211455|FG001|Overall Study|Missed|0|||
129935870|NCT02719574|467732234|FG002|Phase 2|Death|0|||
129935871|NCT02719574|467732235|FG003|Phase 2|Death|0|||
129935872|NCT02719574|467732236|FG004|Phase 2|Death|0|||
129935873|NCT02719574|467732237|FG005|Phase 2|Death|0|||
129935874|NCT02719574|467732238|FG006|Phase 2|Death|0|||
130070273|NCT04876599|468211454|FG000|Overall Study|Declined|2|||
129935875|NCT02719574|467732239|FG007|Phase 2|Death|0|||
129935876|NCT02719574|467732240|FG008|Phase 2|Death|0|||
129935877|NCT02719574|467732241|FG009|Phase 2|Death|14|||
129935878|NCT02719574|467732242|FG010|Phase 2|Death|0|||
129935879|NCT02719574|467732243|FG011|Phase 2|Death|0|||
129935880|NCT02719574|467732244|FG012|Phase 2|Death|1|||
129935881|NCT02719574|467732245|FG013|Phase 2|Death|1|||
129935882|NCT02719574|467732246|FG014|Phase 2|Death|2|||
129935883|NCT02719574|467732247|FG015|Phase 2|Death|0|||
129935884|NCT02719574|467732248|FG016|Phase 2|Death|0|||
129935885|NCT02719574|467732232|FG000|Phase 2|Investigator Decision|0|||
129935886|NCT02719574|467732233|FG001|Phase 2|Investigator Decision|0|||
129935887|NCT02719574|467732234|FG002|Phase 2|Investigator Decision|0|||
129935888|NCT02719574|467732235|FG003|Phase 2|Investigator Decision|0|||
129935889|NCT02719574|467732236|FG004|Phase 2|Investigator Decision|0|||
129935890|NCT02719574|467732237|FG005|Phase 2|Investigator Decision|0|||
129935891|NCT02719574|467732238|FG006|Phase 2|Investigator Decision|0|||
129935892|NCT02719574|467732239|FG007|Phase 2|Investigator Decision|0|||
129935893|NCT02719574|467732240|FG008|Phase 2|Investigator Decision|0|||
129935894|NCT02719574|467732241|FG009|Phase 2|Investigator Decision|6|||
129935895|NCT02719574|467732242|FG010|Phase 2|Investigator Decision|1|||
129935896|NCT02719574|467732243|FG011|Phase 2|Investigator Decision|2|||
129935897|NCT02719574|467732244|FG012|Phase 2|Investigator Decision|3|||
129935898|NCT02719574|467732245|FG013|Phase 2|Investigator Decision|1|||
129935899|NCT02719574|467732246|FG014|Phase 2|Investigator Decision|3|||
129935900|NCT02719574|467732247|FG015|Phase 2|Investigator Decision|2|||
129935901|NCT02719574|467732248|FG016|Phase 2|Investigator Decision|0|||
129935902|NCT02719574|467732232|FG000|Phase 2|Withdrawal by Subject|0|||
129935903|NCT02719574|467732233|FG001|Phase 2|Withdrawal by Subject|0|||
129935904|NCT02719574|467732234|FG002|Phase 2|Withdrawal by Subject|0|||
129935905|NCT02719574|467732235|FG003|Phase 2|Withdrawal by Subject|0|||
129935906|NCT02719574|467732236|FG004|Phase 2|Withdrawal by Subject|0|||
129935907|NCT02719574|467732237|FG005|Phase 2|Withdrawal by Subject|0|||
129935908|NCT02719574|467732238|FG006|Phase 2|Withdrawal by Subject|0|||
129935909|NCT02719574|467732239|FG007|Phase 2|Withdrawal by Subject|0|||
129935910|NCT02719574|467732240|FG008|Phase 2|Withdrawal by Subject|0|||
129935911|NCT02719574|467732241|FG009|Phase 2|Withdrawal by Subject|5|||
129935912|NCT02719574|467732242|FG010|Phase 2|Withdrawal by Subject|0|||
129935913|NCT02719574|467732243|FG011|Phase 2|Withdrawal by Subject|0|||
129935914|NCT02719574|467732244|FG012|Phase 2|Withdrawal by Subject|0|||
129935915|NCT02719574|467732245|FG013|Phase 2|Withdrawal by Subject|1|||
129935916|NCT02719574|467732246|FG014|Phase 2|Withdrawal by Subject|1|||
129935917|NCT02719574|467732247|FG015|Phase 2|Withdrawal by Subject|2|||
129935918|NCT02719574|467732248|FG016|Phase 2|Withdrawal by Subject|0|||
129935919|NCT02719574|467732232|FG000|Phase 2|Protocol Violation|0|||
129935920|NCT02719574|467732233|FG001|Phase 2|Protocol Violation|0|||
129935921|NCT02719574|467732234|FG002|Phase 2|Protocol Violation|0|||
129935922|NCT02719574|467732235|FG003|Phase 2|Protocol Violation|0|||
129935923|NCT02719574|467732236|FG004|Phase 2|Protocol Violation|0|||
129935924|NCT02719574|467732237|FG005|Phase 2|Protocol Violation|0|||
129935925|NCT02719574|467732238|FG006|Phase 2|Protocol Violation|0|||
129935926|NCT02719574|467732239|FG007|Phase 2|Protocol Violation|0|||
129935927|NCT02719574|467732240|FG008|Phase 2|Protocol Violation|0|||
129935928|NCT02719574|467732241|FG009|Phase 2|Protocol Violation|1|||
129935929|NCT02719574|467732242|FG010|Phase 2|Protocol Violation|0|||
129935930|NCT02719574|467732243|FG011|Phase 2|Protocol Violation|0|||
129935931|NCT02719574|467732244|FG012|Phase 2|Protocol Violation|0|||
129935932|NCT02719574|467732245|FG013|Phase 2|Protocol Violation|0|||
129935933|NCT02719574|467732246|FG014|Phase 2|Protocol Violation|0|||
129935934|NCT02719574|467732247|FG015|Phase 2|Protocol Violation|0|||
129935935|NCT02719574|467732248|FG016|Phase 2|Protocol Violation|0|||
129935936|NCT03875313|467732257|FG000|Overall Study|Withdrawal by Subject|1|||
129935937|NCT03875313|467732258|FG001|Overall Study|Withdrawal by Subject|3|||
129935938|NCT03875313|467732259|FG002|Overall Study|Withdrawal by Subject|0|||
129935939|NCT03875313|467732260|FG003|Overall Study|Withdrawal by Subject|0|||
129935940|NCT03875313|467732261|FG004|Overall Study|Withdrawal by Subject|0|||
129935941|NCT03875313|467732257|FG000|Overall Study|Death|0|||
129935942|NCT03875313|467732258|FG001|Overall Study|Death|0|||
129935943|NCT03875313|467732259|FG002|Overall Study|Death|0|||
129935944|NCT03875313|467732260|FG003|Overall Study|Death|0|||
129935945|NCT03875313|467732261|FG004|Overall Study|Death|1|||
129935946|NCT03875313|467732257|FG000|Overall Study|Lost to Follow-up|0|||
129935947|NCT03875313|467732258|FG001|Overall Study|Lost to Follow-up|0|||
129935948|NCT03875313|467732259|FG002|Overall Study|Lost to Follow-up|0|||
129935949|NCT03875313|467732260|FG003|Overall Study|Lost to Follow-up|0|||
129935950|NCT03875313|467732261|FG004|Overall Study|Lost to Follow-up|1|||
129935951|NCT03875313|467732257|FG000|Overall Study|Study Termination by Sponsor|0|||
129935952|NCT03875313|467732258|FG001|Overall Study|Study Termination by Sponsor|1|||
129935953|NCT03875313|467732259|FG002|Overall Study|Study Termination by Sponsor|1|||
129935954|NCT03875313|467732260|FG003|Overall Study|Study Termination by Sponsor|0|||
129935955|NCT03875313|467732261|FG004|Overall Study|Study Termination by Sponsor|1|||
129935956|NCT03875313|467732257|FG000|Overall Study|New Anticancer Treatment|0|||
130070274|NCT04876599|468211455|FG001|Overall Study|Declined|3|||
130070275|NCT03175562|468211456|FG000|Overall Study|Adverse Event|1|||
130070276|NCT03175562|468211456|FG000|Overall Study|Lost to Follow-up|3|||
130070277|NCT03175562|468211456|FG000|Overall Study|Withdrawal by Subject|7|||
130070278|NCT03175562|468211456|FG000|Overall Study|Other (Not Specified)|5|||
130070279|NCT02146833|468211457|FG000|Overall Study|Death|10|||
130070280|NCT02146833|468211457|FG000|Overall Study|No longer consented to study treatment|1|||
130070281|NCT03700736|468211460|FG000|Overall Study|Pregnancy|1|||
130070282|NCT03700736|468211461|FG001|Overall Study|Pregnancy|1|||
130070283|NCT03700736|468211460|FG000|Overall Study|Withdrawal by Subject|2|||
130070284|NCT03700736|468211461|FG001|Overall Study|Withdrawal by Subject|6|||
130070285|NCT00642018|468211462|FG000|Overall Study|Adverse Event|11|||
130070286|NCT00642018|468211463|FG001|Overall Study|Adverse Event|36|||
130070287|NCT00642018|468211462|FG000|Overall Study|Withdrawal by Subject|4|||
130070288|NCT00642018|468211463|FG001|Overall Study|Withdrawal by Subject|10|||
130070289|NCT00642018|468211462|FG000|Overall Study|Progressive Disease|13|||
130070290|NCT00642018|468211463|FG001|Overall Study|Progressive Disease|18|||
130070291|NCT00642018|468211462|FG000|Overall Study|Physician Decision|0|||
130070292|NCT00642018|468211463|FG001|Overall Study|Physician Decision|10|||
130070293|NCT00642018|468211462|FG000|Overall Study|Protocol Violation|0|||
130070294|NCT00642018|468211463|FG001|Overall Study|Protocol Violation|1|||
130070295|NCT00642018|468211462|FG000|Overall Study|Death|0|||
130070296|NCT00642018|468211463|FG001|Overall Study|Death|3|||
130070297|NCT00642018|468211462|FG000|Overall Study|Entry Criteria Not Met|0|||
130070298|NCT00642018|468211463|FG001|Overall Study|Entry Criteria Not Met|1|||
130070299|NCT04126031|468211466|FG000|Part A|Withdrawal by Subject|0|||
130070300|NCT04126031|468211467|FG001|Part A|Withdrawal by Subject|0|||
130070301|NCT04126031|468211468|FG002|Part A|Withdrawal by Subject|1|||
130070302|NCT04126031|468211469|FG003|Part A|Withdrawal by Subject|0|||
130070303|NCT04126031|468211470|FG004|Part A|Withdrawal by Subject|0|||
130070304|NCT04126031|468211471|FG005|Part A|Withdrawal by Subject|0|||
130070305|NCT04126031|468211466|FG000|Part A|Other|1|||
130070306|NCT04126031|468211467|FG001|Part A|Other|0|||
130070307|NCT04126031|468211468|FG002|Part A|Other|0|||
130070308|NCT04126031|468211469|FG003|Part A|Other|0|||
130070309|NCT04126031|468211470|FG004|Part A|Other|0|||
130070310|NCT04126031|468211471|FG005|Part A|Other|0|||
130070311|NCT04126031|468211466|FG000|Part B|Adverse Event|0|||
130070312|NCT04126031|468211467|FG001|Part B|Adverse Event|0|||
130070313|NCT04126031|468211468|FG002|Part B|Adverse Event|0|||
130070314|NCT04126031|468211469|FG003|Part B|Adverse Event|0|||
130070315|NCT04126031|468211470|FG004|Part B|Adverse Event|0|||
130070316|NCT04126031|468211471|FG005|Part B|Adverse Event|2|||
130070317|NCT04126031|468211466|FG000|Part B|Pre-existing hypertransaminasemia|0|||
130070318|NCT04126031|468211467|FG001|Part B|Pre-existing hypertransaminasemia|0|||
130070319|NCT04126031|468211468|FG002|Part B|Pre-existing hypertransaminasemia|0|||
130070320|NCT04126031|468211469|FG003|Part B|Pre-existing hypertransaminasemia|0|||
130070321|NCT04126031|468211470|FG004|Part B|Pre-existing hypertransaminasemia|1|||
130070322|NCT04126031|468211471|FG005|Part B|Pre-existing hypertransaminasemia|0|||
130070323|NCT00617656|468211472|FG000|Overall Study|Inclusion error|4|||
130070324|NCT00617656|468211473|FG001|Overall Study|Inclusion error|4|||
130070325|NCT00617656|468211474|FG002|Overall Study|Inclusion error|0|||
130070326|NCT00617656|468211475|FG003|Overall Study|Inclusion error|0|||
130070327|NCT00617656|468211472|FG000|Overall Study|Missing data|44|||
130070328|NCT00617656|468211473|FG001|Overall Study|Missing data|30|||
130070329|NCT00617656|468211474|FG002|Overall Study|Missing data|13|||
130070330|NCT00617656|468211475|FG003|Overall Study|Missing data|6|||
130070331|NCT00617656|468211472|FG000|Overall Study|Withdrawal by Subject|0|||
130070332|NCT00617656|468211473|FG001|Overall Study|Withdrawal by Subject|2|||
130070333|NCT00617656|468211474|FG002|Overall Study|Withdrawal by Subject|0|||
130070334|NCT00617656|468211475|FG003|Overall Study|Withdrawal by Subject|0|||
130070335|NCT00131664|468211476|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
130070336|NCT00131664|468211477|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
130070337|NCT00131664|468211478|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
130070338|NCT00131664|468211479|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
130070339|NCT00131664|468211480|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
130070340|NCT00131664|468211481|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
130070341|NCT00131664|468211476|FG000|First Period (First 6 Months)|Death|0|||
130070342|NCT00131664|468211477|FG001|First Period (First 6 Months)|Death|1|||
130070343|NCT00131664|468211478|FG002|First Period (First 6 Months)|Death|0|||
130070344|NCT00131664|468211479|FG003|First Period (First 6 Months)|Death|0|||
130070345|NCT00131664|468211480|FG004|First Period (First 6 Months)|Death|0|||
130070346|NCT00131664|468211481|FG005|First Period (First 6 Months)|Death|0|||
130070347|NCT00131664|468211476|FG000|First Period (First 6 Months)|Protocol Violation|2|||
130070348|NCT00131664|468211477|FG001|First Period (First 6 Months)|Protocol Violation|2|||
130070349|NCT00131664|468211478|FG002|First Period (First 6 Months)|Protocol Violation|1|||
130070350|NCT00131664|468211479|FG003|First Period (First 6 Months)|Protocol Violation|0|||
130070351|NCT00131664|468211480|FG004|First Period (First 6 Months)|Protocol Violation|0|||
130070352|NCT00131664|468211481|FG005|First Period (First 6 Months)|Protocol Violation|0|||
130070353|NCT00131664|468211476|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
130070354|NCT00131664|468211477|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
130070355|NCT00131664|468211478|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
130070356|NCT00131664|468211479|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
130070357|NCT00131664|468211480|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
130070358|NCT00131664|468211481|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
130070359|NCT00131664|468211476|FG000|First Period (First 6 Months)|Adverse Event|9|||
130070360|NCT00131664|468211477|FG001|First Period (First 6 Months)|Adverse Event|4|||
130070361|NCT00131664|468211478|FG002|First Period (First 6 Months)|Adverse Event|5|||
130070362|NCT00131664|468211479|FG003|First Period (First 6 Months)|Adverse Event|0|||
130070363|NCT00131664|468211480|FG004|First Period (First 6 Months)|Adverse Event|0|||
130070364|NCT00131664|468211481|FG005|First Period (First 6 Months)|Adverse Event|0|||
130070365|NCT00131664|468211476|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
130070366|NCT00131664|468211477|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
130070367|NCT00131664|468211478|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130070368|NCT00131664|468211479|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130070369|NCT00131664|468211480|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130070370|NCT00131664|468211481|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
130070371|NCT00131664|468211476|FG000|First Period (First 6 Months)|Administrative reasons|2|||
130070372|NCT00131664|468211477|FG001|First Period (First 6 Months)|Administrative reasons|0|||
130070373|NCT00131664|468211478|FG002|First Period (First 6 Months)|Administrative reasons|5|||
130070374|NCT00131664|468211479|FG003|First Period (First 6 Months)|Administrative reasons|0|||
130070375|NCT00131664|468211480|FG004|First Period (First 6 Months)|Administrative reasons|0|||
130070376|NCT00131664|468211481|FG005|First Period (First 6 Months)|Administrative reasons|0|||
130070377|NCT00131664|468211476|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
130070378|NCT00131664|468211477|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
130070379|NCT00131664|468211478|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
130070380|NCT00131664|468211479|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
130070381|NCT00131664|468211480|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
130070382|NCT00131664|468211481|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
130070383|NCT00131664|468211476|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
130070384|NCT00131664|468211477|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
130070385|NCT00131664|468211478|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
130070386|NCT00131664|468211479|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
130070387|NCT00131664|468211480|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
130070388|NCT00131664|468211481|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
130070389|NCT00131664|468211476|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
130070390|NCT00131664|468211477|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130070391|NCT00131664|468211478|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130070392|NCT00131664|468211479|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130070393|NCT00131664|468211480|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130070394|NCT00131664|468211481|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
130070395|NCT00131664|468211476|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
130070396|NCT00131664|468211477|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
130070397|NCT00131664|468211478|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
130070398|NCT00131664|468211479|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
130070399|NCT00131664|468211480|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
130070400|NCT00131664|468211481|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
130070401|NCT00131664|468211476|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130070402|NCT00131664|468211477|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130070403|NCT00131664|468211478|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130070404|NCT00131664|468211479|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
130070405|NCT00131664|468211480|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130070406|NCT00131664|468211481|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
130070407|NCT00131664|468211476|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
130070408|NCT00131664|468211477|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
130070409|NCT00131664|468211478|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
130070410|NCT00131664|468211479|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
130070411|NCT00131664|468211480|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
130070412|NCT00131664|468211481|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
130070413|NCT00107172|468213446|FG000|Overall Study|Withdrawal by Subject|1|||
130070414|NCT00107172|468213447|FG001|Overall Study|Withdrawal by Subject|0|||
130070415|NCT00107172|468213446|FG000|Overall Study|Death|0|||
130070416|NCT00107172|468213447|FG001|Overall Study|Death|2|||
130070417|NCT00107172|468213446|FG000|Overall Study|Other Reason|4|||
130070418|NCT00107172|468213447|FG001|Overall Study|Other Reason|3|||
130070419|NCT02687711|468213448|FG000|Overall Study|Adverse Event|89|||
130070420|NCT02687711|468213448|FG000|Overall Study|Lack of Efficacy|70|||
130119170|NCT01296932|468398318|FG004|Overall Study|Investigator decision|0|||
129935957|NCT03875313|467732258|FG001|Overall Study|New Anticancer Treatment|1|||
129935958|NCT03875313|467732259|FG002|Overall Study|New Anticancer Treatment|2|||
129935959|NCT03875313|467732260|FG003|Overall Study|New Anticancer Treatment|1|||
129935960|NCT03875313|467732261|FG004|Overall Study|New Anticancer Treatment|0|||
129935961|NCT03875313|467732257|FG000|Overall Study|Other, Not Specified|2|||
129935962|NCT03875313|467732258|FG001|Overall Study|Other, Not Specified|11|||
129935963|NCT03875313|467732259|FG002|Overall Study|Other, Not Specified|3|||
130070421|NCT02687711|468213448|FG000|Overall Study|Lost to Follow-up|20|||
130070422|NCT02687711|468213448|FG000|Overall Study|Consent withdrawn|15|||
130070423|NCT02687711|468213448|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
130070424|NCT02687711|468213448|FG000|Overall Study|Too expensive|4|||
130070425|NCT02687711|468213448|FG000|Overall Study|Participant moved abroad|1|||
130070426|NCT02687711|468213448|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
130070427|NCT02687711|468213448|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
130070428|NCT02687711|468213448|FG000|Overall Study|Disliked taste|1|||
130070429|NCT02687711|468213448|FG000|Overall Study|Low mood|1|||
130070430|NCT02687711|468213448|FG000|Overall Study|Side effects|1|||
130070431|NCT02687711|468213448|FG000|Overall Study|Change of Hospital|1|||
130070432|NCT02687711|468213448|FG000|Overall Study|Liver Encephalopathy|1|||
130070433|NCT02687711|468213448|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
130070434|NCT02687711|468213448|FG000|Overall Study|Withdrawn due to intake interruption|1|||
130070435|NCT02687711|468213448|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
130070436|NCT02687711|468213448|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
130070437|NCT02687711|468213448|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
130070438|NCT03621189|468213449|FG000|Overall Study|Withdrawal by Subject|0|||
130070439|NCT03621189|468213450|FG001|Overall Study|Withdrawal by Subject|3|||
130070440|NCT03621189|468213449|FG000|Overall Study|Physician Decision|0|||
130070441|NCT03621189|468213450|FG001|Overall Study|Physician Decision|2|||
130070442|NCT03706040|468213453|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
130070443|NCT03706040|468213454|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
130070444|NCT03706040|468213455|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
130070445|NCT03706040|468213456|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
130070446|NCT03706040|468213457|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
130070447|NCT03706040|468213458|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
130070448|NCT03706040|468213459|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
130070449|NCT03706040|468213453|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
130070450|NCT03706040|468213454|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
130070451|NCT03706040|468213455|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
130070452|NCT03706040|468213456|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130070453|NCT03706040|468213457|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130070454|NCT03706040|468213458|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130070455|NCT03706040|468213459|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
130070456|NCT03706040|468213453|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
130070457|NCT03706040|468213454|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
130070458|NCT03706040|468213455|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
130070459|NCT03706040|468213456|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130070460|NCT03706040|468213457|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130070461|NCT03706040|468213458|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130070462|NCT03706040|468213459|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
130070463|NCT03706040|468213453|FG000|Period A (Week 0 to Week 16)|Other|2|||
130070464|NCT03706040|468213454|FG001|Period A (Week 0 to Week 16)|Other|0|||
130070465|NCT03706040|468213455|FG002|Period A (Week 0 to Week 16)|Other|2|||
130070466|NCT03706040|468213456|FG003|Period A (Week 0 to Week 16)|Other|0|||
130070467|NCT03706040|468213457|FG004|Period A (Week 0 to Week 16)|Other|0|||
130070468|NCT03706040|468213458|FG005|Period A (Week 0 to Week 16)|Other|0|||
130070469|NCT03706040|468213459|FG006|Period A (Week 0 to Week 16)|Other|0|||
130070470|NCT03706040|468213453|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
130070471|NCT03706040|468213454|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
130070472|NCT03706040|468213455|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
130070473|NCT03706040|468213456|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
130070474|NCT03706040|468213457|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
130070475|NCT03706040|468213458|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
130070476|NCT03706040|468213459|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
130070477|NCT03706040|468213453|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
130070478|NCT03706040|468213454|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
130070479|NCT03706040|468213455|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
130070480|NCT03706040|468213456|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
130119171|NCT01296932|468398319|FG005|Overall Study|Investigator decision|0|||
130119172|NCT01296932|468398320|FG006|Overall Study|Investigator decision|1|||
129935964|NCT03875313|467732260|FG003|Overall Study|Other, Not Specified|3|||
129935965|NCT03875313|467732261|FG004|Overall Study|Other, Not Specified|1|||
129935966|NCT03286114|467732266|FG000|Overall Study|Adverse Event|6|||
129935967|NCT03286114|467732266|FG000|Overall Study|Death|3|||
129935968|NCT01046825|467732267|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935969|NCT01046825|467732268|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
129935970|NCT01046825|467732269|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935971|NCT01046825|467732270|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935972|NCT01046825|467732271|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935973|NCT01046825|467732267|FG000|Overall Study|Physician Decision|0|||
129935974|NCT01046825|467732268|FG001|Overall Study|Physician Decision|1|||
129935975|NCT01046825|467732269|FG002|Overall Study|Physician Decision|2|||
129935976|NCT01046825|467732270|FG003|Overall Study|Physician Decision|0|||
129935977|NCT01046825|467732271|FG004|Overall Study|Physician Decision|0|||
129935978|NCT01046825|467732267|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935979|NCT01046825|467732268|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935980|NCT01046825|467732269|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
129935981|NCT01046825|467732270|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935982|NCT01046825|467732271|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935983|NCT01046825|467732267|FG000|Overall Study|Found to be ineligible|0|||
129935984|NCT01046825|467732268|FG001|Overall Study|Found to be ineligible|1|||
129935985|NCT01046825|467732269|FG002|Overall Study|Found to be ineligible|0|||
129935986|NCT01046825|467732270|FG003|Overall Study|Found to be ineligible|0|||
129935987|NCT01046825|467732271|FG004|Overall Study|Found to be ineligible|0|||
129935988|NCT01046825|467732267|FG000|Overall Study|Death|0|||
129935989|NCT01046825|467732268|FG001|Overall Study|Death|0|||
129935990|NCT01046825|467732269|FG002|Overall Study|Death|0|||
129935991|NCT01046825|467732270|FG003|Overall Study|Death|1|||
129935992|NCT01046825|467732271|FG004|Overall Study|Death|0|||
130070481|NCT03706040|468213457|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
130070482|NCT03706040|468213458|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
130070483|NCT03706040|468213459|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
130070484|NCT03706040|468213453|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130070485|NCT03706040|468213454|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130070486|NCT03706040|468213455|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130070487|NCT03706040|468213456|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130070488|NCT03706040|468213457|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
130070489|NCT03706040|468213458|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
130070490|NCT03706040|468213459|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
130070491|NCT03706040|468213453|FG000|Period B (Week 16 to Week 52)|Other|0|||
130070492|NCT03706040|468213454|FG001|Period B (Week 16 to Week 52)|Other|0|||
130070493|NCT03706040|468213455|FG002|Period B (Week 16 to Week 52)|Other|0|||
130070494|NCT03706040|468213456|FG003|Period B (Week 16 to Week 52)|Other|4|||
130070495|NCT03706040|468213457|FG004|Period B (Week 16 to Week 52)|Other|5|||
130070496|NCT03706040|468213458|FG005|Period B (Week 16 to Week 52)|Other|23|||
130070497|NCT03706040|468213459|FG006|Period B (Week 16 to Week 52)|Other|17|||
130070498|NCT03077243|468213460|FG000|Overall Study|Death|1|||
130070499|NCT03077243|468213461|FG001|Overall Study|Death|2|||
130070500|NCT03077243|468213462|FG002|Overall Study|Death|0|||
130070501|NCT03077243|468213463|FG003|Overall Study|Death|0|||
130070502|NCT03077243|468213460|FG000|Overall Study|Withdrawal by Subject|1|||
130070503|NCT03077243|468213461|FG001|Overall Study|Withdrawal by Subject|3|||
130070504|NCT03077243|468213462|FG002|Overall Study|Withdrawal by Subject|0|||
130070505|NCT03077243|468213463|FG003|Overall Study|Withdrawal by Subject|0|||
130070506|NCT03077243|468213460|FG000|Overall Study|Physician Decision|1|||
130070507|NCT03077243|468213461|FG001|Overall Study|Physician Decision|0|||
130070508|NCT03077243|468213462|FG002|Overall Study|Physician Decision|0|||
130070509|NCT03077243|468213463|FG003|Overall Study|Physician Decision|0|||
130070510|NCT03077243|468213460|FG000|Overall Study|Research at two study sites terminated early|0|||
130070511|NCT03077243|468213461|FG001|Overall Study|Research at two study sites terminated early|0|||
130070512|NCT03077243|468213462|FG002|Overall Study|Research at two study sites terminated early|0|||
130070513|NCT03077243|468213463|FG003|Overall Study|Research at two study sites terminated early|69|||
130070514|NCT00607919|468213464|FG000|Acute Phase|Adverse Event|9|||
130070515|NCT00607919|468213465|FG001|Acute Phase|Adverse Event|2|||
130070516|NCT00607919|468213464|FG000|Acute Phase|Entry Criteria Not Met|1|||
130070517|NCT00607919|468213465|FG001|Acute Phase|Entry Criteria Not Met|1|||
129935993|NCT01046825|467732267|FG000|Overall Study|Did not submit biology samples|0|||
129935994|NCT01046825|467732268|FG001|Overall Study|Did not submit biology samples|0|||
130070518|NCT00607919|468213464|FG000|Acute Phase|Lack of Efficacy|1|||
130070519|NCT00607919|468213465|FG001|Acute Phase|Lack of Efficacy|2|||
130070520|NCT00607919|468213464|FG000|Acute Phase|Lost to Follow-up|9|||
130070521|NCT00607919|468213465|FG001|Acute Phase|Lost to Follow-up|3|||
130070522|NCT00607919|468213464|FG000|Acute Phase|Parent/Caregiver Decision|6|||
130070523|NCT00607919|468213465|FG001|Acute Phase|Parent/Caregiver Decision|4|||
130070524|NCT00607919|468213464|FG000|Acute Phase|Protocol Violation|5|||
129935995|NCT01046825|467732269|FG002|Overall Study|Did not submit biology samples|0|||
129935996|NCT01046825|467732270|FG003|Overall Study|Did not submit biology samples|0|||
129935997|NCT01046825|467732271|FG004|Overall Study|Did not submit biology samples|13|||
129935998|NCT02075554|467732273|FG000|Overall Study|Lost to Follow-up|7|||
129935999|NCT02075554|467732273|FG000|Overall Study|Withdrawal by Subject|5|||
129936000|NCT02075554|467732273|FG000|Overall Study|Physician Decision|3|||
129936001|NCT04993677|467732280|FG000|Overall Study|Lost to Follow-up|1|||
129936002|NCT04993677|467732281|FG001|Overall Study|Lost to Follow-up|0|||
129936003|NCT04993677|467732282|FG002|Overall Study|Lost to Follow-up|0|||
129936004|NCT04993677|467732283|FG003|Overall Study|Lost to Follow-up|0|||
129936005|NCT04993677|467732280|FG000|Overall Study|Death|11|||
129936006|NCT04993677|467732281|FG001|Overall Study|Death|8|||
129936007|NCT04993677|467732282|FG002|Overall Study|Death|3|||
129936008|NCT04993677|467732283|FG003|Overall Study|Death|1|||
129936009|NCT04993677|467732280|FG000|Overall Study|Subject withdrawal of consent|4|||
129936010|NCT04993677|467732281|FG001|Overall Study|Subject withdrawal of consent|3|||
129936011|NCT04993677|467732282|FG002|Overall Study|Subject withdrawal of consent|0|||
129936012|NCT04993677|467732283|FG003|Overall Study|Subject withdrawal of consent|2|||
129936013|NCT04993677|467732280|FG000|Overall Study|Study termination by sponsor|3|||
129936014|NCT04993677|467732281|FG001|Overall Study|Study termination by sponsor|25|||
129936015|NCT04993677|467732282|FG002|Overall Study|Study termination by sponsor|3|||
129936016|NCT04993677|467732283|FG003|Overall Study|Study termination by sponsor|3|||
129936017|NCT04993677|467732280|FG000|Overall Study|Other|2|||
130070525|NCT00607919|468213465|FG001|Acute Phase|Protocol Violation|1|||
130070526|NCT00607919|468213464|FG000|Acute Phase|Withdrawal by Subject|3|||
130070527|NCT00607919|468213465|FG001|Acute Phase|Withdrawal by Subject|3|||
130070528|NCT00607919|468213464|FG000|Open-Label Phase|Adverse Event|1|||
130070529|NCT00607919|468213465|FG001|Open-Label Phase|Adverse Event|5|||
130070530|NCT00607919|468213464|FG000|Open-Label Phase|Lost to Follow-up|4|||
130070531|NCT00607919|468213465|FG001|Open-Label Phase|Lost to Follow-up|1|||
130070532|NCT00607919|468213464|FG000|Open-Label Phase|Protocol Violation|2|||
130070533|NCT00607919|468213465|FG001|Open-Label Phase|Protocol Violation|2|||
130070534|NCT00607919|468213464|FG000|Open-Label Phase|Withdrawal by Subject|2|||
130070535|NCT00607919|468213465|FG001|Open-Label Phase|Withdrawal by Subject|2|||
130070536|NCT00607919|468213464|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
130070537|NCT00607919|468213465|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
130070538|NCT02580240|468213478|FG000|Overall Study|Physician Decision|2|||
130070539|NCT02580240|468213479|FG001|Overall Study|Physician Decision|0|||
130070540|NCT02007252|468213482|FG000|Overall Study|Administrative problems|3|||
130070541|NCT02007252|468213483|FG001|Overall Study|Administrative problems|7|||
130070542|NCT02007252|468213482|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130070543|NCT02007252|468213483|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130070544|NCT02007252|468213482|FG000|Overall Study|Adverse Event|7|||
130070545|NCT02007252|468213483|FG001|Overall Study|Adverse Event|4|||
130070546|NCT02001688|468213484|FG000|Overall Study|Withdrawal by Subject|0|||
130070547|NCT02001688|468213485|FG001|Overall Study|Withdrawal by Subject|0|||
130070548|NCT02001688|468213486|FG002|Overall Study|Withdrawal by Subject|1|||
130070549|NCT02001688|468213484|FG000|Overall Study|Adverse Event|0|||
130070550|NCT02001688|468213485|FG001|Overall Study|Adverse Event|1|||
130070551|NCT02001688|468213486|FG002|Overall Study|Adverse Event|0|||
130070552|NCT01989754|468213487|FG000|Overall Study|Withdrawal by Subject|10|||
130070553|NCT01989754|468213488|FG001|Overall Study|Withdrawal by Subject|14|||
130070554|NCT01989754|468213487|FG000|Overall Study|Lost to Follow-up|28|||
130070555|NCT01989754|468213488|FG001|Overall Study|Lost to Follow-up|20|||
130070556|NCT01989754|468213487|FG000|Overall Study|Closed Site|1|||
130070557|NCT01989754|468213488|FG001|Overall Study|Closed Site|1|||
130070558|NCT05441540|468213489|FG000|Overall Study|Withdrawal by Subject|2|||
130070559|NCT00813917|468213490|FG000|Overall Study|Adverse Event|0|||
130070560|NCT00813917|468213491|FG001|Overall Study|Adverse Event|1|||
130070561|NCT00813917|468213490|FG000|Overall Study|Withdrawal by Subject|3|||
130070562|NCT00813917|468213491|FG001|Overall Study|Withdrawal by Subject|4|||
130070563|NCT00813917|468213490|FG000|Overall Study|Lost to Follow-up|3|||
130070564|NCT00813917|468213491|FG001|Overall Study|Lost to Follow-up|1|||
130070565|NCT00792701|468213495|FG000|Overall Study|Adverse Event|0|||
130070566|NCT00792701|468213496|FG001|Overall Study|Adverse Event|22|||
130070567|NCT00792701|468213495|FG000|Overall Study|Ineligible|1|||
130070568|NCT00792701|468213496|FG001|Overall Study|Ineligible|3|||
130070569|NCT00792701|468213495|FG000|Overall Study|Withdrawal by Subject|1|||
130070570|NCT00792701|468213496|FG001|Overall Study|Withdrawal by Subject|19|||
130070571|NCT00792701|468213495|FG000|Overall Study|Not protocol specified|17|||
130070572|NCT00792701|468213496|FG001|Overall Study|Not protocol specified|0|||
130119173|NCT01296932|468398321|FG007|Overall Study|Investigator decision|0|||
129936018|NCT04993677|467732281|FG001|Overall Study|Other|3|||
130070573|NCT02143141|468213503|FG000|Overall Study|pain scores at 24 hours not collected|1|||
130070574|NCT02143141|468213504|FG001|Overall Study|pain scores at 24 hours not collected|0|||
130070575|NCT00064077|468213505|FG000|Overall Study|Improper prior treatment|1|||
130070576|NCT00064077|468213506|FG001|Overall Study|Improper prior treatment|0|||
129936019|NCT04993677|467732282|FG002|Overall Study|Other|3|||
129936020|NCT04993677|467732283|FG003|Overall Study|Other|2|||
129936021|NCT00003222|467732286|FG000|Overall Study|Physician Decision|0|||
129936022|NCT00003222|467732287|FG001|Overall Study|Physician Decision|1|||
129936023|NCT04757753|467732288|FG000|Overall Study|Lost to Follow-up|7|||
129936024|NCT04757753|467732289|FG001|Overall Study|Lost to Follow-up|7|||
129936025|NCT04757753|467732288|FG000|Overall Study|Withdrawal by Subject|0|||
129936026|NCT04757753|467732289|FG001|Overall Study|Withdrawal by Subject|3|||
129936027|NCT04757753|467732288|FG000|Overall Study|Endodontic treatment failure|1|||
129936028|NCT04757753|467732289|FG001|Overall Study|Endodontic treatment failure|2|||
129936029|NCT04757753|467732288|FG000|Overall Study|Tooth fracture/extraction|3|||
129936030|NCT04757753|467732289|FG001|Overall Study|Tooth fracture/extraction|0|||
129936031|NCT01313559|467732290|FG000|Overall Study|Withdrawal by Subject|1|||
129936032|NCT01313559|467732291|FG001|Overall Study|Withdrawal by Subject|2|||
129936033|NCT01313559|467732290|FG000|Overall Study|Disease progression|1|||
129936034|NCT01313559|467732291|FG001|Overall Study|Disease progression|0|||
129936035|NCT01313559|467732290|FG000|Overall Study|Rising PSA|2|||
129936036|NCT01313559|467732291|FG001|Overall Study|Rising PSA|0|||
129936037|NCT02656706|467732293|FG000|Overall Study|Insurance Denial|1|||
129936038|NCT03725332|467732294|FG000|Overall Study|Adverse Event|5|||
129936039|NCT03725332|467732295|FG001|Overall Study|Adverse Event|10|||
129936040|NCT03725332|467732294|FG000|Overall Study|Death|1|||
129936041|NCT03725332|467732295|FG001|Overall Study|Death|3|||
129936042|NCT03725332|467732294|FG000|Overall Study|Lost to Follow-up|43|||
129936043|NCT03725332|467732295|FG001|Overall Study|Lost to Follow-up|122|||
129936044|NCT03725332|467732294|FG000|Overall Study|Withdrawal by Subject|0|||
129936045|NCT03725332|467732295|FG001|Overall Study|Withdrawal by Subject|1|||
129936046|NCT03725332|467732294|FG000|Overall Study|Duplicate enrollment|0|||
129936047|NCT03725332|467732295|FG001|Overall Study|Duplicate enrollment|1|||
129936048|NCT03725332|467732294|FG000|Overall Study|Did not consent|0|||
129936049|NCT03725332|467732295|FG001|Overall Study|Did not consent|1|||
129936050|NCT02701283|467732306|FG000|Overall Study|Death|25|||
129936051|NCT02701283|467732307|FG001|Overall Study|Death|29|||
129936052|NCT02701283|467732308|FG002|Overall Study|Death|19|||
129936053|NCT02701283|467732306|FG000|Overall Study|Lost to Follow-up|3|||
129936054|NCT02701283|467732307|FG001|Overall Study|Lost to Follow-up|8|||
129936055|NCT02701283|467732308|FG002|Overall Study|Lost to Follow-up|1|||
129936056|NCT02701283|467732306|FG000|Overall Study|Withdrawal by Subject|12|||
129936057|NCT02701283|467732307|FG001|Overall Study|Withdrawal by Subject|41|||
129936058|NCT02701283|467732308|FG002|Overall Study|Withdrawal by Subject|1|||
129936059|NCT02701283|467732306|FG000|Overall Study|Missed 2-year visit|22|||
129936060|NCT02701283|467732307|FG001|Overall Study|Missed 2-year visit|27|||
129936061|NCT02701283|467732308|FG002|Overall Study|Missed 2-year visit|0|||
129936062|NCT02701283|467732306|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
129936063|NCT02701283|467732307|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
129936064|NCT02701283|467732308|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
129936065|NCT04908514|467732314|FG000|Overall Study|Lost to Follow-up|2|||
129936066|NCT04908514|467732314|FG000|Overall Study|Withdrawal by Subject|1|||
129936067|NCT03248492|467732851|FG000|Overall Study|Progressive Disease|24|||
129936068|NCT03248492|467732852|FG001|Overall Study|Progressive Disease|23|||
129936069|NCT03248492|467732853|FG002|Overall Study|Progressive Disease|11|||
129936070|NCT03248492|467732854|FG003|Overall Study|Progressive Disease|66|||
129936071|NCT03248492|467732855|FG004|Overall Study|Progressive Disease|1|||
129936072|NCT03248492|467732851|FG000|Overall Study|Adverse Event|14|||
129936073|NCT03248492|467732852|FG001|Overall Study|Adverse Event|13|||
129936074|NCT03248492|467732853|FG002|Overall Study|Adverse Event|9|||
129936075|NCT03248492|467732854|FG003|Overall Study|Adverse Event|22|||
129936076|NCT03248492|467732855|FG004|Overall Study|Adverse Event|2|||
129936077|NCT03248492|467732851|FG000|Overall Study|Withdrawal by Subject|5|||
129936078|NCT03248492|467732852|FG001|Overall Study|Withdrawal by Subject|4|||
129936079|NCT03248492|467732853|FG002|Overall Study|Withdrawal by Subject|0|||
129936080|NCT03248492|467732854|FG003|Overall Study|Withdrawal by Subject|8|||
129936081|NCT03248492|467732855|FG004|Overall Study|Withdrawal by Subject|1|||
129936082|NCT03248492|467732851|FG000|Overall Study|Physician Decision|1|||
129936083|NCT03248492|467732852|FG001|Overall Study|Physician Decision|1|||
129936084|NCT03248492|467732853|FG002|Overall Study|Physician Decision|1|||
129936085|NCT03248492|467732854|FG003|Overall Study|Physician Decision|7|||
129936086|NCT03248492|467732855|FG004|Overall Study|Physician Decision|0|||
129936087|NCT03248492|467732851|FG000|Overall Study|Death|1|||
129936088|NCT03248492|467732852|FG001|Overall Study|Death|1|||
129936089|NCT03248492|467732853|FG002|Overall Study|Death|0|||
129936090|NCT03248492|467732854|FG003|Overall Study|Death|6|||
129936091|NCT03248492|467732855|FG004|Overall Study|Death|0|||
129936092|NCT03248492|467732851|FG000|Overall Study|Study Terminated by Sponsor|3|||
129936093|NCT03248492|467732852|FG001|Overall Study|Study Terminated by Sponsor|1|||
129936094|NCT03248492|467732853|FG002|Overall Study|Study Terminated by Sponsor|0|||
129936095|NCT03248492|467732854|FG003|Overall Study|Study Terminated by Sponsor|7|||
129936096|NCT03248492|467732855|FG004|Overall Study|Study Terminated by Sponsor|0|||
129936097|NCT03248492|467732851|FG000|Overall Study|Other|2|||
129936098|NCT03248492|467732852|FG001|Overall Study|Other|5|||
129936099|NCT03248492|467732853|FG002|Overall Study|Other|0|||
129936100|NCT03248492|467732854|FG003|Overall Study|Other|14|||
129936101|NCT03248492|467732855|FG004|Overall Study|Other|0|||
129936102|NCT03767335|467732856|FG000|Overall Study|Physician Decision|1|||
129936103|NCT03767335|467732857|FG001|Overall Study|Physician Decision|1|||
129936104|NCT03767335|467732858|FG002|Overall Study|Physician Decision|0|||
129936105|NCT03767335|467732856|FG000|Overall Study|Withdrawal by Subject|0|||
129936106|NCT03767335|467732857|FG001|Overall Study|Withdrawal by Subject|0|||
129936107|NCT03767335|467732858|FG002|Overall Study|Withdrawal by Subject|6|||
129936108|NCT03767335|467732856|FG000|Overall Study|Participant excluded from efficacy population|0|||
129936109|NCT03767335|467732857|FG001|Overall Study|Participant excluded from efficacy population|0|||
129936110|NCT03767335|467732858|FG002|Overall Study|Participant excluded from efficacy population|1|||
129936111|NCT03767335|467732856|FG000|Overall Study|Death|0|||
129936112|NCT03767335|467732857|FG001|Overall Study|Death|0|||
129936113|NCT03767335|467732858|FG002|Overall Study|Death|2|||
129936114|NCT03767335|467732856|FG000|Overall Study|Progressive Disease|2|||
129936115|NCT03767335|467732857|FG001|Overall Study|Progressive Disease|2|||
129936116|NCT03767335|467732858|FG002|Overall Study|Progressive Disease|2|||
129936117|NCT03767335|467732856|FG000|Overall Study|Disease progression needing additional medication|0|||
129936118|NCT03767335|467732857|FG001|Overall Study|Disease progression needing additional medication|0|||
129936119|NCT03767335|467732858|FG002|Overall Study|Disease progression needing additional medication|17|||
129936120|NCT03767335|467732856|FG000|Overall Study|Sponsor decision|0|||
129936121|NCT03767335|467732857|FG001|Overall Study|Sponsor decision|0|||
129936122|NCT03767335|467732858|FG002|Overall Study|Sponsor decision|2|||
129936123|NCT03767335|467732856|FG000|Overall Study|Other Medical Reasons|0|||
129936124|NCT03767335|467732857|FG001|Overall Study|Other Medical Reasons|0|||
129936125|NCT03767335|467732858|FG002|Overall Study|Other Medical Reasons|3|||
129936126|NCT03705390|467732859|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
129936127|NCT03705390|467732859|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
129936128|NCT04495621|467732861|FG000|Overall Study|Withdrawal by Subject|0|||
129936129|NCT04495621|467732862|FG001|Overall Study|Withdrawal by Subject|3|||
129936130|NCT04495621|467732861|FG000|Overall Study|Death|7|||
129936131|NCT04495621|467732862|FG001|Overall Study|Death|11|||
129936132|NCT04495621|467732861|FG000|Overall Study|Investigator Decision|0|||
129936133|NCT04495621|467732862|FG001|Overall Study|Investigator Decision|7|||
129936134|NCT04495621|467732861|FG000|Overall Study|Lost to Follow-up|0|||
129936135|NCT04495621|467732862|FG001|Overall Study|Lost to Follow-up|1|||
129936136|NCT01830595|467732871|FG000|First Period|Withdrawal by Subject|1|||
129936137|NCT01830595|467732872|FG001|First Period|Withdrawal by Subject|3|||
129936138|NCT01830595|467732871|FG000|Washout|Withdrawal by Subject|2|||
129936139|NCT01830595|467732872|FG001|Washout|Withdrawal by Subject|2|||
129936140|NCT05116774|467732877|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
129936141|NCT05116774|467732878|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
129936142|NCT05116774|467732877|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
129936143|NCT05116774|467732878|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
129936144|NCT05116774|467732877|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
129936145|NCT05116774|467732878|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
129936146|NCT05116774|467732877|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
129936147|NCT05116774|467732878|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
129936148|NCT03150862|467732879|FG000|Overall Study|Death|2|||
129936149|NCT03150862|467732880|FG001|Overall Study|Death|7|||
129936150|NCT03150862|467732881|FG002|Overall Study|Death|8|||
129936151|NCT03150862|467732882|FG003|Overall Study|Death|27|||
130070577|NCT00064077|468213507|FG002|Overall Study|Improper prior treatment|0|||
130070578|NCT00064077|468213508|FG003|Overall Study|Improper prior treatment|0|||
130070579|NCT00064077|468213505|FG000|Overall Study|Poor risk|2|||
130070580|NCT00064077|468213506|FG001|Overall Study|Poor risk|0|||
130070581|NCT00064077|468213507|FG002|Overall Study|Poor risk|1|||
129936152|NCT03150862|467732883|FG004|Overall Study|Death|4|||
129936153|NCT03150862|467732884|FG005|Overall Study|Death|8|||
129936154|NCT03150862|467732885|FG006|Overall Study|Death|6|||
129936155|NCT03150862|467732886|FG007|Overall Study|Death|21|||
129936156|NCT03150862|467732879|FG000|Overall Study|Withdrawal by Subject|1|||
129936157|NCT03150862|467732880|FG001|Overall Study|Withdrawal by Subject|1|||
129936158|NCT03150862|467732881|FG002|Overall Study|Withdrawal by Subject|0|||
129936159|NCT03150862|467732882|FG003|Overall Study|Withdrawal by Subject|3|||
129936160|NCT03150862|467732883|FG004|Overall Study|Withdrawal by Subject|1|||
129936161|NCT03150862|467732884|FG005|Overall Study|Withdrawal by Subject|1|||
129936162|NCT03150862|467732885|FG006|Overall Study|Withdrawal by Subject|1|||
129936163|NCT03150862|467732886|FG007|Overall Study|Withdrawal by Subject|3|||
129936164|NCT03150862|467732879|FG000|Overall Study|Lost to Follow-up|0|||
129936165|NCT03150862|467732880|FG001|Overall Study|Lost to Follow-up|0|||
129936166|NCT03150862|467732881|FG002|Overall Study|Lost to Follow-up|1|||
129936167|NCT03150862|467732882|FG003|Overall Study|Lost to Follow-up|0|||
130070582|NCT00064077|468213508|FG003|Overall Study|Poor risk|1|||
130070583|NCT00064077|468213505|FG000|Overall Study|Pathology|10|||
129936168|NCT03150862|467732883|FG004|Overall Study|Lost to Follow-up|0|||
129936169|NCT03150862|467732884|FG005|Overall Study|Lost to Follow-up|0|||
129936170|NCT03150862|467732885|FG006|Overall Study|Lost to Follow-up|0|||
129936171|NCT03150862|467732886|FG007|Overall Study|Lost to Follow-up|2|||
129936172|NCT03150862|467732879|FG000|Overall Study|Sponsor's decision|0|||
129936173|NCT03150862|467732880|FG001|Overall Study|Sponsor's decision|0|||
129936174|NCT03150862|467732881|FG002|Overall Study|Sponsor's decision|0|||
129936175|NCT03150862|467732882|FG003|Overall Study|Sponsor's decision|10|||
129936176|NCT03150862|467732883|FG004|Overall Study|Sponsor's decision|3|||
129936177|NCT03150862|467732884|FG005|Overall Study|Sponsor's decision|0|||
129936178|NCT03150862|467732885|FG006|Overall Study|Sponsor's decision|1|||
129936179|NCT03150862|467732886|FG007|Overall Study|Sponsor's decision|1|||
129936180|NCT03150862|467732879|FG000|Overall Study|Change in Methylation status|0|||
129936181|NCT03150862|467732880|FG001|Overall Study|Change in Methylation status|0|||
129936182|NCT03150862|467732881|FG002|Overall Study|Change in Methylation status|0|||
129936183|NCT03150862|467732882|FG003|Overall Study|Change in Methylation status|0|||
129936184|NCT03150862|467732883|FG004|Overall Study|Change in Methylation status|1|||
129936185|NCT03150862|467732884|FG005|Overall Study|Change in Methylation status|0|||
129936186|NCT03150862|467732885|FG006|Overall Study|Change in Methylation status|0|||
129936187|NCT03150862|467732886|FG007|Overall Study|Change in Methylation status|0|||
129936188|NCT03150862|467732879|FG000|Overall Study|Roll over in to Long Term Extension|0|||
129936189|NCT03150862|467732880|FG001|Overall Study|Roll over in to Long Term Extension|0|||
129936190|NCT03150862|467732881|FG002|Overall Study|Roll over in to Long Term Extension|0|||
129936191|NCT03150862|467732882|FG003|Overall Study|Roll over in to Long Term Extension|0|||
129936192|NCT03150862|467732883|FG004|Overall Study|Roll over in to Long Term Extension|0|||
129936193|NCT03150862|467732884|FG005|Overall Study|Roll over in to Long Term Extension|0|||
129936194|NCT03150862|467732885|FG006|Overall Study|Roll over in to Long Term Extension|0|||
129936195|NCT03150862|467732886|FG007|Overall Study|Roll over in to Long Term Extension|1|||
129936196|NCT03150862|467732879|FG000|Overall Study|Progressive Disease|0|||
129936197|NCT03150862|467732880|FG001|Overall Study|Progressive Disease|0|||
129936198|NCT03150862|467732881|FG002|Overall Study|Progressive Disease|0|||
129936199|NCT03150862|467732882|FG003|Overall Study|Progressive Disease|0|||
129936200|NCT03150862|467732883|FG004|Overall Study|Progressive Disease|0|||
129936201|NCT03150862|467732884|FG005|Overall Study|Progressive Disease|0|||
129936202|NCT03150862|467732885|FG006|Overall Study|Progressive Disease|0|||
129936203|NCT03150862|467732886|FG007|Overall Study|Progressive Disease|2|||
129936204|NCT04977583|467733387|FG000|Overall Study|Lost to Follow-up|8|||
129936205|NCT04977583|467733388|FG001|Overall Study|Lost to Follow-up|4|||
129936206|NCT04977583|467733389|FG002|Overall Study|Lost to Follow-up|13|||
129936207|NCT04977583|467733387|FG000|Overall Study|Withdrawal by Subject|3|||
129936208|NCT04977583|467733388|FG001|Overall Study|Withdrawal by Subject|2|||
129936209|NCT04977583|467733389|FG002|Overall Study|Withdrawal by Subject|1|||
129936210|NCT02422615|467733392|FG000|Treatment Period|Progressive disease|314|||
129936211|NCT02422615|467733393|FG001|Treatment Period|Progressive disease|200|||
129936212|NCT02422615|467733392|FG000|Treatment Period|Adverse Event|51|||
129936213|NCT02422615|467733393|FG001|Treatment Period|Adverse Event|9|||
129936214|NCT02422615|467733392|FG000|Treatment Period|Physician Decision|32|||
129936215|NCT02422615|467733393|FG001|Treatment Period|Physician Decision|8|||
129936216|NCT02422615|467733392|FG000|Treatment Period|Subject/guardian decision|38|||
129936217|NCT02422615|467733393|FG001|Treatment Period|Subject/guardian decision|8|||
129936218|NCT02422615|467733392|FG000|Treatment Period|Death|2|||
129936219|NCT02422615|467733393|FG001|Treatment Period|Death|1|||
129936220|NCT02422615|467733392|FG000|Treatment Period|Technical problems|0|||
129936221|NCT02422615|467733393|FG001|Treatment Period|Technical problems|1|||
129936222|NCT02422615|467733392|FG000|Treatment Period|Protocol deviation|1|||
129936223|NCT02422615|467733393|FG001|Treatment Period|Protocol deviation|1|||
129936224|NCT02422615|467733392|FG000|Treatment Period|Study terminated as per protocol|46|||
129936225|NCT02422615|467733393|FG001|Treatment Period|Study terminated as per protocol|14|||
129936226|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129936227|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129936228|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Death|2|||
130070584|NCT00064077|468213506|FG001|Overall Study|Pathology|7|||
130070585|NCT00064077|468213507|FG002|Overall Study|Pathology|3|||
130070586|NCT00064077|468213508|FG003|Overall Study|Pathology|4|||
130070587|NCT00064077|468213505|FG000|Overall Study|No surgery|0|||
129936229|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Death|1|||
129936230|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129936231|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129936232|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
129936233|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
129936234|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
129936235|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
129936236|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
129936237|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
130070588|NCT00064077|468213506|FG001|Overall Study|No surgery|0|||
129936238|NCT04121546|467733395|FG000|Overall Study|Lost to Follow-up|1|||
129936239|NCT04121546|467733396|FG001|Overall Study|Lost to Follow-up|3|||
129936240|NCT03653364|467733397|FG000|Overall Study|Withdrawal by Subject|1|||
129936241|NCT03653364|467733397|FG000|Overall Study|Enrolled in Error|1|||
129936242|NCT03653364|467733397|FG000|Overall Study|Death|1|||
129936243|NCT04940624|467733398|FG000|Overall Study|Adverse Event|4|||
129936244|NCT04940624|467733399|FG001|Overall Study|Adverse Event|11|||
129936245|NCT04940624|467733398|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129936246|NCT04940624|467733399|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129936247|NCT04940624|467733398|FG000|Overall Study|Physician Decision|1|||
129936248|NCT04940624|467733399|FG001|Overall Study|Physician Decision|0|||
129936249|NCT04940624|467733398|FG000|Overall Study|Lost to Follow-up|1|||
129936250|NCT04940624|467733399|FG001|Overall Study|Lost to Follow-up|0|||
129936251|NCT04940624|467733398|FG000|Overall Study|Reason Not Specified|1|||
129936252|NCT04940624|467733399|FG001|Overall Study|Reason Not Specified|0|||
129936253|NCT05714059|467733406|FG000|Overall Study|Withdrawal by Subject|2|||
129936254|NCT05714059|467733407|FG001|Overall Study|Withdrawal by Subject|2|||
129936255|NCT05714059|467733406|FG000|Overall Study|Adverse Event|0|||
129936256|NCT05714059|467733407|FG001|Overall Study|Adverse Event|1|||
129936257|NCT05714059|467733406|FG000|Overall Study|Lost to Follow-up|0|||
129936258|NCT05714059|467733407|FG001|Overall Study|Lost to Follow-up|1|||
129936259|NCT05714059|467733406|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
129936260|NCT05714059|467733407|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
129936261|NCT05714059|467733406|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
129936262|NCT05714059|467733407|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
129936263|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
129936264|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
129936265|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
129936266|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
129936267|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
129936268|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
129936269|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
129936270|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
129936271|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
129936272|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
129936273|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
129936274|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
129936275|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
129936276|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
129936277|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
129936278|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
129936279|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
129936280|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
129936281|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
129936282|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
129936283|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
129936284|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
129936285|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
129936286|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
129936287|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
129936288|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
129936289|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
129936290|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
129936291|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
129936292|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
129936293|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
129936294|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
129936295|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
129936296|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
129936297|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
129936298|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
129936299|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
129936300|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
129936301|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
129936302|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
129936303|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
129936304|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
129936305|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
129936306|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
129936307|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
129936308|NCT04755595|467733413|FG000|Overall Study|Lost to Follow-up|1|||
129936309|NCT00319696|467733414|FG000|Overall Study|Adverse Event|36|||
130119174|NCT01296932|468398322|FG008|Overall Study|Investigator decision|1|||
130119175|NCT01296932|468398314|FG000|Overall Study|No clinical benefit anymore|0|||
130119176|NCT01296932|468398315|FG001|Overall Study|No clinical benefit anymore|1|||
130119177|NCT01296932|468398316|FG002|Overall Study|No clinical benefit anymore|0|||
130119178|NCT01296932|468398317|FG003|Overall Study|No clinical benefit anymore|0|||
130119179|NCT01296932|468398318|FG004|Overall Study|No clinical benefit anymore|0|||
130119180|NCT01296932|468398319|FG005|Overall Study|No clinical benefit anymore|0|||
130119181|NCT01296932|468398320|FG006|Overall Study|No clinical benefit anymore|0|||
130119182|NCT01296932|468398321|FG007|Overall Study|No clinical benefit anymore|0|||
130119183|NCT01296932|468398322|FG008|Overall Study|No clinical benefit anymore|0|||
130119184|NCT01296932|468398314|FG000|Overall Study|Physician Decision|0|||
130119185|NCT01296932|468398315|FG001|Overall Study|Physician Decision|0|||
130119186|NCT01296932|468398316|FG002|Overall Study|Physician Decision|1|||
130119187|NCT01296932|468398317|FG003|Overall Study|Physician Decision|0|||
130119188|NCT01296932|468398318|FG004|Overall Study|Physician Decision|0|||
130119189|NCT01296932|468398319|FG005|Overall Study|Physician Decision|0|||
130119190|NCT01296932|468398320|FG006|Overall Study|Physician Decision|0|||
129936310|NCT00319696|467733414|FG000|Overall Study|withdrawal of consent|14|||
129936311|NCT00319696|467733414|FG000|Overall Study|administrative|7|||
129936312|NCT00319696|467733414|FG000|Overall Study|Lost to Follow-up|3|||
129936313|NCT03891758|467733416|FG000|Overall Study|Adverse Event|2|||
129936314|NCT03891758|467733417|FG001|Overall Study|Adverse Event|0|||
129936315|NCT03891758|467733416|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129936316|NCT03891758|467733417|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129936317|NCT05039021|467734107|FG000|Overall Study|Death|1|||
129936318|NCT05039021|467734107|FG000|Overall Study|Lost to Follow-up|3|||
129936319|NCT01639131|467734108|FG000|Overall Study|Disease Progression|6|||
129936320|NCT00686595|467734112|FG000|Overall Study|Adverse Event|3|||
129936321|NCT00686595|467734112|FG000|Overall Study|Protocol Violation|1|||
129936322|NCT00686595|467734112|FG000|Overall Study|Lost to Follow-up|1|||
129936323|NCT00686595|467734112|FG000|Overall Study|Lack of Efficacy|1|||
129936324|NCT00686595|467734112|FG000|Overall Study|Poor Compliance|1|||
129936325|NCT00087685|467734124|FG000|Overall Study|Adverse Event|5|||
129936326|NCT00087685|467734124|FG000|Overall Study|Non-Compliance|1|||
129936327|NCT00087685|467734124|FG000|Overall Study|Progressive Disease|5|||
129936328|NCT00087685|467734124|FG000|Overall Study|Withdrawal by Subject|3|||
129936329|NCT03213457|467734125|FG000|Screening Period|Withdrawal by Subject|0|||
129936330|NCT03213457|467734126|FG001|Screening Period|Withdrawal by Subject|1|||
129936331|NCT03213457|467734127|FG002|Screening Period|Withdrawal by Subject|0|||
129936332|NCT03213457|467734125|FG000|Screening Period|Other|1|||
129936333|NCT03213457|467734126|FG001|Screening Period|Other|0|||
129936334|NCT03213457|467734127|FG002|Screening Period|Other|0|||
129936335|NCT03213457|467734125|FG000|Double-Blind Period|Adverse Event|3|||
129936336|NCT03213457|467734126|FG001|Double-Blind Period|Adverse Event|2|||
129936337|NCT03213457|467734127|FG002|Double-Blind Period|Adverse Event|7|||
129936338|NCT03213457|467734125|FG000|Double-Blind Period|Withdrawal by Subject|14|||
129936339|NCT03213457|467734126|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129936340|NCT03213457|467734127|FG002|Double-Blind Period|Withdrawal by Subject|14|||
129936341|NCT03213457|467734125|FG000|Double-Blind Period|Lost to Follow-up|2|||
129936342|NCT03213457|467734126|FG001|Double-Blind Period|Lost to Follow-up|3|||
129936343|NCT03213457|467734127|FG002|Double-Blind Period|Lost to Follow-up|9|||
129936344|NCT03213457|467734125|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
129936345|NCT03213457|467734126|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
129936346|NCT03213457|467734127|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
129936347|NCT03213457|467734125|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
129936348|NCT03213457|467734126|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
129936349|NCT03213457|467734127|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
129936350|NCT03213457|467734125|FG000|Double-Blind Period|Pregnancy|5|||
129936351|NCT03213457|467734126|FG001|Double-Blind Period|Pregnancy|0|||
129936352|NCT03213457|467734127|FG002|Double-Blind Period|Pregnancy|0|||
129936353|NCT03213457|467734125|FG000|Double-Blind Period|Other|10|||
129936354|NCT03213457|467734126|FG001|Double-Blind Period|Other|3|||
129936355|NCT03213457|467734127|FG002|Double-Blind Period|Other|17|||
129936356|NCT03213457|467734125|FG000|Open-Label Period|Adverse Event|1|||
129936357|NCT03213457|467734126|FG001|Open-Label Period|Adverse Event|2|||
129936358|NCT03213457|467734127|FG002|Open-Label Period|Adverse Event|2|||
129936359|NCT03213457|467734125|FG000|Open-Label Period|Withdrawal by Subject|12|||
129936360|NCT03213457|467734126|FG001|Open-Label Period|Withdrawal by Subject|5|||
130119191|NCT01296932|468398321|FG007|Overall Study|Physician Decision|0|||
129936361|NCT03213457|467734127|FG002|Open-Label Period|Withdrawal by Subject|24|||
129936362|NCT03213457|467734125|FG000|Open-Label Period|Lost to Follow-up|1|||
129936363|NCT03213457|467734126|FG001|Open-Label Period|Lost to Follow-up|2|||
129936364|NCT03213457|467734127|FG002|Open-Label Period|Lost to Follow-up|8|||
129936365|NCT03213457|467734125|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
129936366|NCT03213457|467734126|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
129936367|NCT03213457|467734127|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
129936368|NCT03213457|467734125|FG000|Open-Label Period|Non-compliance with study procedures|1|||
129936369|NCT03213457|467734126|FG001|Open-Label Period|Non-compliance with study procedures|1|||
129936370|NCT03213457|467734127|FG002|Open-Label Period|Non-compliance with study procedures|2|||
129936371|NCT03213457|467734125|FG000|Open-Label Period|Exclusionary medications|0|||
129936372|NCT03213457|467734126|FG001|Open-Label Period|Exclusionary medications|0|||
129936373|NCT03213457|467734127|FG002|Open-Label Period|Exclusionary medications|1|||
129936374|NCT03213457|467734125|FG000|Open-Label Period|Other|1|||
129936375|NCT03213457|467734126|FG001|Open-Label Period|Other|1|||
129936376|NCT03213457|467734127|FG002|Open-Label Period|Other|6|||
129936377|NCT03213457|467734125|FG000|Follow-Up Period|Adverse Event|16|||
129936378|NCT03213457|467734126|FG001|Follow-Up Period|Adverse Event|8|||
129936379|NCT03213457|467734127|FG002|Follow-Up Period|Adverse Event|37|||
129936380|NCT03213457|467734125|FG000|Follow-Up Period|Withdrawal by Subject|18|||
129936381|NCT03213457|467734126|FG001|Follow-Up Period|Withdrawal by Subject|11|||
129936382|NCT03213457|467734127|FG002|Follow-Up Period|Withdrawal by Subject|55|||
129936383|NCT03213457|467734125|FG000|Follow-Up Period|Lost to Follow-up|28|||
129936384|NCT03213457|467734126|FG001|Follow-Up Period|Lost to Follow-up|15|||
129936385|NCT03213457|467734127|FG002|Follow-Up Period|Lost to Follow-up|50|||
129936386|NCT03213457|467734125|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
129936387|NCT03213457|467734126|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
129936388|NCT03213457|467734127|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
129936389|NCT03213457|467734125|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
129936390|NCT03213457|467734126|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
129936391|NCT03213457|467734127|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
129936392|NCT03213457|467734125|FG000|Follow-Up Period|Pregnancy|7|||
129936393|NCT03213457|467734126|FG001|Follow-Up Period|Pregnancy|0|||
129936394|NCT03213457|467734127|FG002|Follow-Up Period|Pregnancy|18|||
129936395|NCT03213457|467734125|FG000|Follow-Up Period|Exclusionary medications|1|||
129936396|NCT03213457|467734126|FG001|Follow-Up Period|Exclusionary medications|1|||
129936397|NCT03213457|467734127|FG002|Follow-Up Period|Exclusionary medications|5|||
129936398|NCT03213457|467734125|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
129936399|NCT03213457|467734126|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
129936400|NCT03213457|467734127|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
129936401|NCT03213457|467734125|FG000|Follow-Up Period|Other|14|||
129936402|NCT03213457|467734126|FG001|Follow-Up Period|Other|10|||
129936403|NCT03213457|467734127|FG002|Follow-Up Period|Other|31|||
129936404|NCT05934292|467734128|FG000|Overall Study|Lost to Follow-up|0|||
129936405|NCT05934292|467734129|FG001|Overall Study|Lost to Follow-up|0|||
129936406|NCT05934292|467734130|FG002|Overall Study|Lost to Follow-up|1|||
129936407|NCT05934292|467734131|FG003|Overall Study|Lost to Follow-up|0|||
129936408|NCT04479787|467734132|FG000|Through 6 Months|Withdrawal by Subject|16|||
129936409|NCT04479787|467734133|FG001|Through 6 Months|Withdrawal by Subject|14|||
130070589|NCT00064077|468213507|FG002|Overall Study|No surgery|1|||
130070590|NCT00064077|468213508|FG003|Overall Study|No surgery|0|||
130070591|NCT00064077|468213505|FG000|Overall Study|No tumor|0|||
130070592|NCT00064077|468213506|FG001|Overall Study|No tumor|0|||
130070593|NCT00064077|468213507|FG002|Overall Study|No tumor|1|||
130070594|NCT00064077|468213508|FG003|Overall Study|No tumor|0|||
130070595|NCT00064077|468213505|FG000|Overall Study|Other reasons|2|||
130070596|NCT00064077|468213506|FG001|Overall Study|Other reasons|2|||
130070597|NCT00064077|468213507|FG002|Overall Study|Other reasons|1|||
130070598|NCT00064077|468213508|FG003|Overall Study|Other reasons|2|||
130070599|NCT00879437|468213509|FG000|Overall Study|Protocol Violation|0|||
130070600|NCT00879437|468213510|FG001|Overall Study|Protocol Violation|1|||
130070601|NCT00879437|468213509|FG000|Overall Study|Death|1|||
130070602|NCT00879437|468213510|FG001|Overall Study|Death|0|||
130070603|NCT03000686|468213511|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
130070604|NCT03000686|468213512|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
130070605|NCT03000686|468213513|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
130070606|NCT03000686|468213514|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
129936410|NCT04479787|467734132|FG000|Through 6 Months|Unsuccessful Trial|17|||
129936411|NCT04479787|467734133|FG001|Through 6 Months|Unsuccessful Trial|0|||
129936412|NCT04479787|467734132|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
129936413|NCT04479787|467734133|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
130070607|NCT01112982|468213517|FG000|Overall Study|Withdrawal by Subject|1|||
130070608|NCT01112982|468213517|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
129936414|NCT04479787|467734132|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
129936415|NCT04479787|467734133|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
129936416|NCT04479787|467734132|FG000|Through 6 Months|Lost to Follow-up|3|||
129936417|NCT04479787|467734133|FG001|Through 6 Months|Lost to Follow-up|2|||
129936418|NCT04479787|467734132|FG000|Through 6 Months|Death|3|||
129936419|NCT04479787|467734133|FG001|Through 6 Months|Death|0|||
130070609|NCT00294684|468213518|FG000|Overall Study|Lost to Follow-up|5|||
130070610|NCT00294684|468213519|FG001|Overall Study|Lost to Follow-up|8|||
129936420|NCT04479787|467734132|FG000|Through 6 Months|Inclusion/Exclusion|2|||
129936421|NCT04479787|467734133|FG001|Through 6 Months|Inclusion/Exclusion|1|||
129936422|NCT04479787|467734132|FG000|Through 6 Months|Subject Became Pregnant|1|||
129936423|NCT04479787|467734133|FG001|Through 6 Months|Subject Became Pregnant|1|||
129936424|NCT04479787|467734132|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
129936425|NCT04479787|467734133|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
129936426|NCT04479787|467734132|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
129936427|NCT04479787|467734133|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
129936428|NCT04479787|467734132|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
129936429|NCT04479787|467734133|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
129936430|NCT04479787|467734132|FG000|After 6 Months|Withdrawal by Subject|3|||
129936431|NCT04479787|467734133|FG001|After 6 Months|Withdrawal by Subject|13|||
129936432|NCT04479787|467734132|FG000|After 6 Months|Unsuccessful Trial|0|||
129936433|NCT04479787|467734133|FG001|After 6 Months|Unsuccessful Trial|7|||
129936434|NCT04479787|467734132|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
129936435|NCT04479787|467734133|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
129936436|NCT04479787|467734132|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
129936437|NCT04479787|467734133|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
129936438|NCT04479787|467734132|FG000|After 6 Months|Death|2|||
129936439|NCT04479787|467734133|FG001|After 6 Months|Death|0|||
129936440|NCT04479787|467734132|FG000|After 6 Months|Lost to Follow-up|1|||
129936441|NCT04479787|467734133|FG001|After 6 Months|Lost to Follow-up|1|||
129936442|NCT04479787|467734132|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
129936443|NCT04479787|467734133|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
129936444|NCT04479787|467734132|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
129936445|NCT04479787|467734133|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
129936446|NCT04479787|467734132|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
129936447|NCT04479787|467734133|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
129936448|NCT04479787|467734132|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
129936449|NCT04479787|467734133|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
129936450|NCT04899674|467734134|FG000|Test|Adverse Event|1|||
129936451|NCT03774472|467734135|FG000|Overall Study|Physician Decision|1|||
129936452|NCT03774472|467734136|FG001|Overall Study|Physician Decision|0|||
129936453|NCT03774472|467734137|FG002|Overall Study|Physician Decision|0|||
129936454|NCT03774472|467734135|FG000|Overall Study|Progression prior to 4 weeks|0|||
129936455|NCT03774472|467734136|FG001|Overall Study|Progression prior to 4 weeks|1|||
129936456|NCT03774472|467734137|FG002|Overall Study|Progression prior to 4 weeks|0|||
129936457|NCT03774472|467734135|FG000|Overall Study|Withdrawal by Subject|0|||
129936458|NCT03774472|467734136|FG001|Overall Study|Withdrawal by Subject|1|||
129936459|NCT03774472|467734137|FG002|Overall Study|Withdrawal by Subject|0|||
129936460|NCT04059406|467734138|FG000|Overall Study|Early Treatment Termination|5|||
129936461|NCT04059406|467734139|FG001|Overall Study|Early Treatment Termination|5|||
129936462|NCT04059406|467734140|FG002|Overall Study|Early Treatment Termination|15|||
129936463|NCT05155306|467734141|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
129936464|NCT05155306|467734142|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
129936465|NCT05155306|467734143|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
129936466|NCT05155306|467734144|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
129936467|NCT05155306|467734141|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
129936468|NCT05155306|467734142|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
129936469|NCT05155306|467734143|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
129936470|NCT05155306|467734144|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
129936471|NCT05601882|467734147|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
129936472|NCT05601882|467734148|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
129936473|NCT05601882|467734149|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
129936474|NCT05601882|467734150|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
129936475|NCT05601882|467734147|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
129936476|NCT05601882|467734148|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
129936477|NCT05601882|467734149|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
129936478|NCT05601882|467734150|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
129936479|NCT05601882|467734147|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
129936480|NCT05601882|467734148|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
129936481|NCT05601882|467734149|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
129936482|NCT05601882|467734150|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
129936483|NCT05601882|467734147|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
129936484|NCT05601882|467734148|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
129936485|NCT05601882|467734149|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
129936486|NCT05601882|467734150|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
129936487|NCT05601882|467734147|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
129936488|NCT05601882|467734148|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
130070611|NCT00389441|468213520|FG000|Overall Study|Adverse Event|7|||
129936489|NCT05601882|467734149|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
129936490|NCT05601882|467734150|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
129936491|NCT05601882|467734147|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
129936492|NCT05601882|467734148|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
129936493|NCT05601882|467734149|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
129936494|NCT05601882|467734150|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
129936495|NCT04158141|467734151|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
129936496|NCT04158141|467734152|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
129936497|NCT04158141|467734153|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
129936498|NCT04158141|467734151|FG000|Step 1: Registration|Adverse Event|1|||
129936499|NCT04158141|467734152|FG001|Step 1: Registration|Adverse Event|0|||
129936500|NCT04158141|467734153|FG002|Step 1: Registration|Adverse Event|0|||
129936501|NCT04158141|467734151|FG000|Step 1: Registration|Withdrawal by Subject|1|||
129936502|NCT04158141|467734152|FG001|Step 1: Registration|Withdrawal by Subject|0|||
129936503|NCT04158141|467734153|FG002|Step 1: Registration|Withdrawal by Subject|0|||
129936504|NCT04158141|467734151|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
129936505|NCT04158141|467734152|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
129936506|NCT04158141|467734153|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
129936507|NCT04121741|467734157|FG000|Overall Study|Protocol Violation|1|||
129936508|NCT04121741|467734158|FG001|Overall Study|Protocol Violation|0|||
129936509|NCT04121741|467734159|FG002|Overall Study|Protocol Violation|0|||
129936510|NCT04121741|467734160|FG003|Overall Study|Protocol Violation|0|||
129936511|NCT04121741|467734161|FG004|Overall Study|Protocol Violation|0|||
129936512|NCT04121741|467734162|FG005|Overall Study|Protocol Violation|0|||
129936513|NCT03473223|467734163|FG000|Overall Study|Lost to Follow-up|1|||
129936514|NCT03473223|467734164|FG001|Overall Study|Lost to Follow-up|1|||
129936515|NCT03473223|467734163|FG000|Overall Study|Withdrawal by Subject|47|||
129936516|NCT03473223|467734164|FG001|Overall Study|Withdrawal by Subject|42|||
129936517|NCT03473223|467734163|FG000|Overall Study|Indirect contact|32|||
129936518|NCT03473223|467734164|FG001|Overall Study|Indirect contact|29|||
129936519|NCT03473223|467734163|FG000|Overall Study|Other (Not specified)|32|||
129936520|NCT03473223|467734164|FG001|Overall Study|Other (Not specified)|20|||
129936521|NCT00115934|467734165|FG000|Overall Study|Lost to Follow-up|1|||
129936522|NCT00115934|467734166|FG001|Overall Study|Lost to Follow-up|0|||
129936523|NCT00115934|467734165|FG000|Overall Study|Did not receive intervention|3|||
129936524|NCT00115934|467734166|FG001|Overall Study|Did not receive intervention|2|||
129936525|NCT05827068|467734170|FG000|Overall Study|Lost to Follow-up|1|||
129936526|NCT05827068|467734171|FG001|Overall Study|Lost to Follow-up|4|||
129936527|NCT05827068|467734172|FG002|Overall Study|Lost to Follow-up|1|||
129936528|NCT05827068|467734173|FG003|Overall Study|Lost to Follow-up|1|||
129936529|NCT05827068|467734174|FG004|Overall Study|Lost to Follow-up|2|||
129936530|NCT05827068|467734175|FG005|Overall Study|Lost to Follow-up|4|||
129936531|NCT05827068|467734176|FG006|Overall Study|Lost to Follow-up|1|||
129936532|NCT05827068|467734170|FG000|Overall Study|Withdrawal by Subject|4|||
129936533|NCT05827068|467734171|FG001|Overall Study|Withdrawal by Subject|0|||
129936534|NCT05827068|467734172|FG002|Overall Study|Withdrawal by Subject|1|||
129936535|NCT05827068|467734173|FG003|Overall Study|Withdrawal by Subject|2|||
129936536|NCT05827068|467734174|FG004|Overall Study|Withdrawal by Subject|3|||
129936537|NCT05827068|467734175|FG005|Overall Study|Withdrawal by Subject|0|||
129936538|NCT05827068|467734176|FG006|Overall Study|Withdrawal by Subject|1|||
129936539|NCT05827068|467734170|FG000|Overall Study|Physician Decision|0|||
129936540|NCT05827068|467734171|FG001|Overall Study|Physician Decision|0|||
129936541|NCT05827068|467734172|FG002|Overall Study|Physician Decision|0|||
130070612|NCT00389441|468213520|FG000|Overall Study|Death|4|||
130070613|NCT00389441|468213520|FG000|Overall Study|Lost to Follow-up|2|||
130070614|NCT00389441|468213520|FG000|Overall Study|Withdrawal by Subject|4|||
130070615|NCT00389441|468213520|FG000|Overall Study|Physician Decision|1|||
130070616|NCT00389441|468213520|FG000|Overall Study|Protocol Violation|1|||
130070617|NCT00389441|468213520|FG000|Overall Study|Global deterioration of health status|4|||
130070618|NCT00389441|468213520|FG000|Overall Study|Objective progression or relapse|26|||
130070619|NCT00389441|468213520|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
129936542|NCT05827068|467734173|FG003|Overall Study|Physician Decision|0|||
129936543|NCT05827068|467734174|FG004|Overall Study|Physician Decision|1|||
129936544|NCT05827068|467734175|FG005|Overall Study|Physician Decision|0|||
129936545|NCT05827068|467734176|FG006|Overall Study|Physician Decision|1|||
129936546|NCT05827068|467734170|FG000|Overall Study|Other Than Specified|0|||
129936547|NCT05827068|467734171|FG001|Overall Study|Other Than Specified|1|||
129936548|NCT05827068|467734172|FG002|Overall Study|Other Than Specified|0|||
129936549|NCT05827068|467734173|FG003|Overall Study|Other Than Specified|0|||
129936550|NCT05827068|467734174|FG004|Overall Study|Other Than Specified|0|||
129936551|NCT05827068|467734175|FG005|Overall Study|Other Than Specified|0|||
129936552|NCT05827068|467734176|FG006|Overall Study|Other Than Specified|0|||
129936553|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
129936554|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
130070620|NCT00389441|468213520|FG000|Overall Study|Clinical progression|1|||
130070621|NCT01981109|468213521|FG000|Overall Study|Death|36|||
130070622|NCT01981109|468213521|FG000|Overall Study|Withdrawal by Subject|40|||
130070623|NCT01981109|468213521|FG000|Overall Study|Lost to Follow-up|9|||
130070624|NCT01981109|468213521|FG000|Overall Study|No Discontinuation Documentation|37|||
130070625|NCT01981109|468213521|FG000|Overall Study|Study Termination|100|||
130070626|NCT01981109|468213521|FG000|Overall Study|No data available|2|||
130070627|NCT00126672|468213523|FG000|Overall Study|Adverse Event|4|||
130070628|NCT00126672|468213523|FG000|Overall Study|Lost to Follow-up|4|||
130070629|NCT01001234|468213529|FG000|Overall Study|Withdrawal by Subject|2|||
130070630|NCT01001234|468213530|FG001|Overall Study|Withdrawal by Subject|0|||
130070631|NCT01001234|468213531|FG002|Overall Study|Withdrawal by Subject|3|||
130070632|NCT01001234|468213532|FG003|Overall Study|Withdrawal by Subject|0|||
130070633|NCT01001234|468213533|FG004|Overall Study|Withdrawal by Subject|0|||
130070634|NCT01001234|468213529|FG000|Overall Study|Protocol Violation|34|||
130070635|NCT01001234|468213530|FG001|Overall Study|Protocol Violation|3|||
130070636|NCT01001234|468213531|FG002|Overall Study|Protocol Violation|19|||
130070637|NCT01001234|468213532|FG003|Overall Study|Protocol Violation|18|||
130070638|NCT01001234|468213533|FG004|Overall Study|Protocol Violation|0|||
130070639|NCT01001234|468213529|FG000|Overall Study|Lost to Follow-up|0|||
130070640|NCT01001234|468213530|FG001|Overall Study|Lost to Follow-up|0|||
130070641|NCT01001234|468213531|FG002|Overall Study|Lost to Follow-up|1|||
130070642|NCT01001234|468213532|FG003|Overall Study|Lost to Follow-up|2|||
130070643|NCT01001234|468213533|FG004|Overall Study|Lost to Follow-up|0|||
130070644|NCT01001234|468213529|FG000|Overall Study|Physician Decision|1|||
130070645|NCT01001234|468213530|FG001|Overall Study|Physician Decision|0|||
130070646|NCT01001234|468213531|FG002|Overall Study|Physician Decision|0|||
130070647|NCT01001234|468213532|FG003|Overall Study|Physician Decision|0|||
130070648|NCT01001234|468213533|FG004|Overall Study|Physician Decision|0|||
130070649|NCT01001234|468213529|FG000|Overall Study|Not Treated: Adverse Event|1|||
130070650|NCT01001234|468213530|FG001|Overall Study|Not Treated: Adverse Event|0|||
130070651|NCT01001234|468213531|FG002|Overall Study|Not Treated: Adverse Event|0|||
130070652|NCT01001234|468213532|FG003|Overall Study|Not Treated: Adverse Event|0|||
130070653|NCT01001234|468213533|FG004|Overall Study|Not Treated: Adverse Event|0|||
130070654|NCT01001234|468213529|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
130070655|NCT01001234|468213530|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
130070656|NCT01001234|468213531|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
130070657|NCT01001234|468213532|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
130070658|NCT01001234|468213533|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
130070659|NCT01001234|468213529|FG000|Overall Study|Not Treated: Protocol Violation|3|||
130070660|NCT01001234|468213530|FG001|Overall Study|Not Treated: Protocol Violation|0|||
130070661|NCT01001234|468213531|FG002|Overall Study|Not Treated: Protocol Violation|0|||
130070662|NCT01001234|468213532|FG003|Overall Study|Not Treated: Protocol Violation|0|||
130070663|NCT01001234|468213533|FG004|Overall Study|Not Treated: Protocol Violation|0|||
130070664|NCT01001234|468213529|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
130070665|NCT01001234|468213530|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
130070666|NCT01001234|468213531|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
130070667|NCT01001234|468213532|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
130070668|NCT01001234|468213533|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
130070669|NCT01001234|468213529|FG000|Overall Study|Not Treated: Pregnancy|3|||
130070670|NCT01001234|468213530|FG001|Overall Study|Not Treated: Pregnancy|0|||
130070671|NCT01001234|468213531|FG002|Overall Study|Not Treated: Pregnancy|0|||
130070672|NCT01001234|468213532|FG003|Overall Study|Not Treated: Pregnancy|0|||
130070673|NCT01001234|468213533|FG004|Overall Study|Not Treated: Pregnancy|0|||
130070674|NCT01001234|468213529|FG000|Overall Study|Not Treated: Physician Decision|37|||
130070675|NCT01001234|468213530|FG001|Overall Study|Not Treated: Physician Decision|4|||
130070676|NCT01001234|468213531|FG002|Overall Study|Not Treated: Physician Decision|0|||
130070677|NCT01001234|468213532|FG003|Overall Study|Not Treated: Physician Decision|0|||
130070678|NCT01001234|468213533|FG004|Overall Study|Not Treated: Physician Decision|0|||
130070679|NCT01001234|468213529|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
130070680|NCT01001234|468213530|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
130070681|NCT01001234|468213531|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
130070682|NCT01001234|468213532|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
130070683|NCT01001234|468213533|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
130070684|NCT02076334|468213535|FG000|Overall Study|Protocol Violation|1|||
130070685|NCT02076334|468213536|FG001|Overall Study|Protocol Violation|0|||
130070686|NCT02076334|468213537|FG002|Overall Study|Protocol Violation|0|||
130070687|NCT02076334|468213538|FG003|Overall Study|Protocol Violation|0|||
130070688|NCT02076334|468213535|FG000|Overall Study|Lost to Follow-up|0|||
130070689|NCT02076334|468213536|FG001|Overall Study|Lost to Follow-up|1|||
130070690|NCT02076334|468213537|FG002|Overall Study|Lost to Follow-up|1|||
130070691|NCT02076334|468213538|FG003|Overall Study|Lost to Follow-up|0|||
130070692|NCT02076334|468213535|FG000|Overall Study|muscle soreness|0|||
130070693|NCT02076334|468213536|FG001|Overall Study|muscle soreness|0|||
130070694|NCT02076334|468213537|FG002|Overall Study|muscle soreness|0|||
129936555|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
129936556|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
129936557|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
129936558|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
129936559|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
129936560|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
129936561|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
129936562|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
129936563|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Adverse Event|5|||
129936564|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Adverse Event|11|||
129936565|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
129936566|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
129936567|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Physician Decision|6|||
129936568|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Physician Decision|3|||
129936569|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Pregnancy|2|||
129936570|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Pregnancy|2|||
129936571|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
129936572|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
129936573|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
129936574|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
129936575|NCT03867201|467734177|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
129936576|NCT03867201|467734178|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
129936577|NCT03867201|467734177|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
129936578|NCT03867201|467734178|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
129936579|NCT04039113|467734181|FG000|Overall Study|Withdrawal by Subject|8|||
129936580|NCT04039113|467734182|FG001|Overall Study|Withdrawal by Subject|11|||
129936581|NCT04039113|467734181|FG000|Overall Study|Lost to Follow-up|1|||
129936582|NCT04039113|467734182|FG001|Overall Study|Lost to Follow-up|1|||
129936583|NCT04039113|467734181|FG000|Overall Study|Adverse Event|2|||
129936584|NCT04039113|467734182|FG001|Overall Study|Adverse Event|2|||
129936585|NCT04039113|467734181|FG000|Overall Study|Death|2|||
129936586|NCT04039113|467734182|FG001|Overall Study|Death|4|||
129936587|NCT04039113|467734181|FG000|Overall Study|Site Closure|6|||
129936588|NCT04039113|467734182|FG001|Overall Study|Site Closure|0|||
129936589|NCT04039113|467734181|FG000|Overall Study|Failure to meet randomisation criteria|4|||
129936590|NCT04039113|467734182|FG001|Overall Study|Failure to meet randomisation criteria|0|||
129936591|NCT01470144|467734183|FG000|Overall Study|Adverse Event|2|||
129936592|NCT01470144|467734183|FG000|Overall Study|Death|1|||
129936593|NCT01470144|467734183|FG000|Overall Study|Lung transplant|6|||
129936594|NCT01470144|467734183|FG000|Overall Study|Patient's and investigator's decision|1|||
129936595|NCT01596972|467734626|FG000|Overall Study|Physician Decision|1|||
129936596|NCT01596972|467734627|FG001|Overall Study|Physician Decision|9|||
129936597|NCT01596972|467734626|FG000|Overall Study|Lost to Follow-up|0|||
129936598|NCT01596972|467734627|FG001|Overall Study|Lost to Follow-up|4|||
129936599|NCT01596972|467734626|FG000|Overall Study|Withdrawal by Subject|0|||
129936600|NCT01596972|467734627|FG001|Overall Study|Withdrawal by Subject|1|||
129936601|NCT01260896|467734629|FG000|First Intervention|Withdrawn Due to Emesis|2|||
129936602|NCT01260896|467734630|FG001|First Intervention|Withdrawn Due to Emesis|0|||
129936603|NCT06688357|467734631|FG000|Overall Study|Adverse Event|0|||
129936604|NCT06688357|467734632|FG001|Overall Study|Adverse Event|1|||
129936605|NCT04018495|467734633|FG000|Overall Study|Physician Decision|1|||
129936606|NCT01084863|467734636|FG000|Main Study Treatment Period|Disease progression|11|||
129936607|NCT01084863|467734637|FG001|Main Study Treatment Period|Disease progression|7|||
129936608|NCT01084863|467734636|FG000|Main Study Treatment Period|Adverse Event|5|||
129936609|NCT01084863|467734637|FG001|Main Study Treatment Period|Adverse Event|3|||
129936610|NCT01084863|467734636|FG000|Main Study Treatment Period|Other Reason|0|||
130070695|NCT02076334|468213538|FG003|Overall Study|muscle soreness|1|||
130070696|NCT03379376|468213539|FG000|Overall Study|Lost to Follow-up|2|||
130070697|NCT03379376|468213539|FG000|Overall Study|Did not wish to complete follow up|1|||
130070698|NCT03379376|468213539|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
130070699|NCT03379376|468213539|FG000|Overall Study|Death|1|||
130070700|NCT01611298|468213540|FG000|Overall Study|Relapsed|2|||
130070701|NCT00753623|468213541|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
130070702|NCT00753623|468213542|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
130070703|NCT00753623|468213541|FG000|Phase I (14 Days)|Physician Decision|1|||
130070704|NCT00753623|468213542|FG001|Phase I (14 Days)|Physician Decision|2|||
130070705|NCT00753623|468213541|FG000|Phase I (14 Days)|Adverse Event|0|||
130070706|NCT00753623|468213542|FG001|Phase I (14 Days)|Adverse Event|1|||
130070707|NCT00753623|468213541|FG000|Washout (7 Days)|Physician Decision|1|||
130070708|NCT00753623|468213542|FG001|Washout (7 Days)|Physician Decision|0|||
130070709|NCT00753623|468213541|FG000|Phase II (14 Days)|Physician Decision|0|||
130070710|NCT00753623|468213542|FG001|Phase II (14 Days)|Physician Decision|1|||
130070711|NCT03332303|468213543|FG000|Overall Study|Participant did not dose|1|||
129936611|NCT01084863|467734637|FG001|Main Study Treatment Period|Other Reason|1|||
129936612|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
129936613|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
129936614|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
129936615|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
129936616|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
129936617|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
129936618|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
129936619|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
129936620|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Other|0|||
129936621|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Other|1|||
129936622|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
129936623|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
130070712|NCT03332303|468213544|FG001|Overall Study|Participant did not dose|2|||
130070713|NCT03332303|468213545|FG002|Overall Study|Participant did not dose|0|||
129936762|NCT03834740|467734644|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
129936763|NCT03834740|467734645|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
129936764|NCT03834740|467734646|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
129936765|NCT03275285|467734649|FG000|Overall Study|Ongoing|45|||
129936766|NCT03275285|467734650|FG001|Overall Study|Ongoing|69|||
129936767|NCT06191679|467734651|FG000|Baseline|Lost to Follow-up|1|||
129936768|NCT06191679|467734652|FG001|Baseline|Lost to Follow-up|0|||
129936769|NCT06191679|467734653|FG002|Baseline|Lost to Follow-up|1|||
129936770|NCT06191679|467734654|FG003|Baseline|Lost to Follow-up|0|||
129936771|NCT06191679|467734651|FG000|Allocation to Group|Withdrawal by Subject|0|||
129936772|NCT06191679|467734652|FG001|Allocation to Group|Withdrawal by Subject|1|||
129936773|NCT06191679|467734653|FG002|Allocation to Group|Withdrawal by Subject|2|||
129936774|NCT06191679|467734654|FG003|Allocation to Group|Withdrawal by Subject|0|||
129936775|NCT06191679|467734651|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
129936776|NCT06191679|467734652|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
129936777|NCT06191679|467734653|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
129936778|NCT06191679|467734654|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
129936779|NCT06191679|467734651|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
129936780|NCT06191679|467734652|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
129936781|NCT06191679|467734653|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
129936782|NCT06191679|467734654|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
129936783|NCT06191679|467734651|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
129936784|NCT06191679|467734652|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
129936785|NCT06191679|467734653|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
129936786|NCT06191679|467734654|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
129936787|NCT02500576|467734655|FG000|Overall Study|Adverse Event|0|||
129936788|NCT02500576|467734656|FG001|Overall Study|Adverse Event|1|||
129936789|NCT02500576|467734655|FG000|Overall Study|Death|2|||
129936790|NCT02500576|467734656|FG001|Overall Study|Death|1|||
129936791|NCT02500576|467734655|FG000|Overall Study|Lack of Efficacy|5|||
129936792|NCT02500576|467734656|FG001|Overall Study|Lack of Efficacy|5|||
129936793|NCT02500576|467734655|FG000|Overall Study|Withdrawal by Subject|1|||
129936794|NCT02500576|467734656|FG001|Overall Study|Withdrawal by Subject|1|||
129936795|NCT00353496|467734659|FG000|Overall Study|Adverse Event|1|||
129936796|NCT00353496|467734660|FG001|Overall Study|Adverse Event|0|||
129936797|NCT00353496|467734659|FG000|Overall Study|Protocol Violation|2|||
129936798|NCT00353496|467734660|FG001|Overall Study|Protocol Violation|2|||
129936799|NCT00353496|467734659|FG000|Overall Study|Withdrawal by Subject|3|||
129936800|NCT00353496|467734660|FG001|Overall Study|Withdrawal by Subject|4|||
129936801|NCT00353496|467734659|FG000|Overall Study|Physician Decision|6|||
129936802|NCT00353496|467734660|FG001|Overall Study|Physician Decision|9|||
129936803|NCT00353496|467734659|FG000|Overall Study|Not otherwise specified|4|||
129936804|NCT00353496|467734660|FG001|Overall Study|Not otherwise specified|2|||
129936805|NCT03997474|467734661|FG000|Overall Study|Death|6|||
129936806|NCT03997474|467734662|FG001|Overall Study|Death|2|||
129936807|NCT03997474|467734663|FG002|Overall Study|Death|1|||
129936808|NCT03997474|467734661|FG000|Overall Study|Physician Decision|2|||
129936809|NCT03997474|467734662|FG001|Overall Study|Physician Decision|0|||
129936810|NCT03997474|467734663|FG002|Overall Study|Physician Decision|0|||
129936811|NCT03997474|467734661|FG000|Overall Study|study terminated by sponsor|1|||
129936812|NCT03997474|467734662|FG001|Overall Study|study terminated by sponsor|0|||
129936813|NCT03997474|467734663|FG002|Overall Study|study terminated by sponsor|1|||
129936814|NCT04980300|467734665|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
129936815|NCT04980300|467734666|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
129936816|NCT04980300|467734665|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
129936817|NCT04980300|467734666|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
129936818|NCT04980300|467734665|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
129936819|NCT04980300|467734666|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
129936820|NCT04980300|467734665|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
129936821|NCT04980300|467734666|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
129936822|NCT03140670|467735523|FG000|Overall Study|Withdrawal by Subject|2|||
129936823|NCT03140670|467735523|FG000|Overall Study|Lost to Follow-up|1|||
129936824|NCT03140670|467735523|FG000|Overall Study|Physician Decision|1|||
129936825|NCT00220805|467735524|FG000|Overall Study|Adverse Event|1|||
129936826|NCT00220805|467735525|FG001|Overall Study|Adverse Event|3|||
129936827|NCT00220805|467735524|FG000|Overall Study|Withdrawal by Subject|3|||
129936828|NCT00220805|467735525|FG001|Overall Study|Withdrawal by Subject|0|||
129936829|NCT00220805|467735524|FG000|Overall Study|Lack of Efficacy|1|||
129936830|NCT00220805|467735525|FG001|Overall Study|Lack of Efficacy|0|||
129936831|NCT00220805|467735524|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
129936832|NCT00220805|467735525|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
129936833|NCT02325466|467735526|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
129936834|NCT02325466|467735527|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
129936835|NCT02325466|467735528|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
129936836|NCT02325466|467735526|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
129936837|NCT02325466|467735527|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
129936838|NCT02325466|467735528|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
129936839|NCT02325466|467735526|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
129936840|NCT02325466|467735527|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
129936841|NCT02325466|467735528|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
129936842|NCT02325466|467735526|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
129936843|NCT02325466|467735527|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
129936844|NCT02325466|467735528|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
129936845|NCT02325466|467735526|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
130070714|NCT03332303|468213543|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
130070715|NCT03332303|468213544|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
130070716|NCT03332303|468213545|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
130070717|NCT03332303|468213543|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
130070718|NCT03332303|468213544|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
130070719|NCT03332303|468213545|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
130070720|NCT03332303|468213543|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
130070721|NCT03332303|468213544|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
130070722|NCT03332303|468213545|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
130070723|NCT03332303|468213543|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
130070724|NCT03332303|468213544|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
130070725|NCT03332303|468213545|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
130070726|NCT03332303|468213543|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
130070727|NCT03332303|468213544|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
130070728|NCT03332303|468213545|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
130070729|NCT03332303|468213543|FG000|Overall Study|Participant had a significant protocol deviation|0|||
130070730|NCT03332303|468213544|FG001|Overall Study|Participant had a significant protocol deviation|1|||
130070731|NCT03332303|468213545|FG002|Overall Study|Participant had a significant protocol deviation|0|||
130070732|NCT01296698|468213546|FG000|Overall Study|Adverse Event|1|||
130070733|NCT01296698|468213547|FG001|Overall Study|Adverse Event|0|||
130070734|NCT01296698|468213546|FG000|Overall Study|Death|1|||
130070735|NCT01296698|468213547|FG001|Overall Study|Death|0|||
130070736|NCT01296698|468213546|FG000|Overall Study|Lost to Follow-up|19|||
130070737|NCT01296698|468213547|FG001|Overall Study|Lost to Follow-up|1|||
130070738|NCT01296698|468213546|FG000|Overall Study|Withdrawal by Subject|12|||
130070739|NCT01296698|468213547|FG001|Overall Study|Withdrawal by Subject|0|||
130070740|NCT01296698|468213546|FG000|Overall Study|Difficulty Contacting Subject|2|||
130070741|NCT01296698|468213547|FG001|Overall Study|Difficulty Contacting Subject|0|||
130070742|NCT01296698|468213546|FG000|Overall Study|Study Terminated by Sponsor|209|||
130119192|NCT01296932|468398322|FG008|Overall Study|Physician Decision|0|||
129936846|NCT02325466|467735527|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
129936847|NCT02325466|467735528|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
129936848|NCT02325466|467735526|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
129936849|NCT02325466|467735527|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
129936850|NCT02325466|467735528|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
129936851|NCT02325466|467735526|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
129936852|NCT02325466|467735527|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
129936853|NCT02325466|467735528|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
129936854|NCT02325466|467735526|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
130070743|NCT01296698|468213547|FG001|Overall Study|Study Terminated by Sponsor|12|||
130070744|NCT03639987|468213548|FG000|Overall Study|Study terminated by sponsor|26|||
130070745|NCT03639987|468213549|FG001|Overall Study|Study terminated by sponsor|25|||
130070746|NCT03639987|468213548|FG000|Overall Study|Lost to Follow-up|0|||
130070747|NCT03639987|468213549|FG001|Overall Study|Lost to Follow-up|1|||
130070748|NCT02559713|468213556|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
130070749|NCT02193828|468213561|FG000|Overall Study|Withdrawal by Subject|0|||
130070750|NCT02193828|468213562|FG001|Overall Study|Withdrawal by Subject|0|||
130070751|NCT02193828|468213563|FG002|Overall Study|Withdrawal by Subject|1|||
130070752|NCT02193828|468213564|FG003|Overall Study|Withdrawal by Subject|1|||
130070753|NCT00889681|468213565|FG000|Overall Study|Not meeting qualification Criteria|2|||
130070754|NCT00889681|468213565|FG000|Overall Study|Insurance disapproval|1|||
130070755|NCT01185704|468213566|FG000|Overall Study|Randomized but not treated|3|||
130070756|NCT01185704|468213567|FG001|Overall Study|Randomized but not treated|3|||
130070757|NCT01185704|468213566|FG000|Overall Study|Lack of ovarian response|5|||
130070758|NCT01185704|468213567|FG001|Overall Study|Lack of ovarian response|1|||
130070759|NCT01185704|468213566|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
130070760|NCT01185704|468213567|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
130070761|NCT01185704|468213566|FG000|Overall Study|Ectopic pregnancy|0|||
130070762|NCT01185704|468213567|FG001|Overall Study|Ectopic pregnancy|1|||
130070763|NCT02661464|468213571|FG000|Overall Study|Lost to Follow-up|28|||
130070764|NCT02661464|468213572|FG001|Overall Study|Lost to Follow-up|0|||
130070765|NCT02661464|468213573|FG002|Overall Study|Lost to Follow-up|0|||
130070766|NCT02661464|468213574|FG003|Overall Study|Lost to Follow-up|0|||
130070767|NCT02661464|468213571|FG000|Overall Study|Withdrawal by Subject|3|||
130070768|NCT02661464|468213572|FG001|Overall Study|Withdrawal by Subject|1|||
130070769|NCT02661464|468213573|FG002|Overall Study|Withdrawal by Subject|0|||
130070770|NCT02661464|468213574|FG003|Overall Study|Withdrawal by Subject|0|||
130070771|NCT02661464|468213571|FG000|Overall Study|Participants terminated prematurely|288|||
130070772|NCT02661464|468213572|FG001|Overall Study|Participants terminated prematurely|52|||
130070773|NCT02661464|468213573|FG002|Overall Study|Participants terminated prematurely|1|||
130070774|NCT02661464|468213574|FG003|Overall Study|Participants terminated prematurely|1|||
130070775|NCT02661464|468213571|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
130070776|NCT02661464|468213572|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
130070777|NCT02661464|468213573|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
130070778|NCT02661464|468213574|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
130070779|NCT03148756|468213575|FG000|Overall Study|Study Terminated|0|||
130070780|NCT03148756|468213576|FG001|Overall Study|Study Terminated|1|||
130070781|NCT02177175|468213581|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
130070782|NCT02177175|468213582|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
130070783|NCT01468701|468213584|FG000|Overall Study|Not eligible|91|||
130070784|NCT01468701|468213585|FG001|Overall Study|Not eligible|140|||
130070785|NCT01468701|468213586|FG002|Overall Study|Not eligible|29|||
130070786|NCT01468701|468213587|FG003|Overall Study|Not eligible|12|||
130070787|NCT01468701|468213588|FG004|Overall Study|Not eligible|22|||
130070788|NCT01468701|468213589|FG005|Overall Study|Not eligible|2|||
130070789|NCT01468701|468213590|FG006|Overall Study|Not eligible|39|||
130070790|NCT01468701|468213591|FG007|Overall Study|Not eligible|1|||
130070791|NCT01468701|468213592|FG008|Overall Study|Not eligible|40|||
130070792|NCT01468701|468213593|FG009|Overall Study|Not eligible|126|||
130070793|NCT01468701|468213594|FG010|Overall Study|Not eligible|39|||
130070794|NCT01468701|468213595|FG011|Overall Study|Not eligible|33|||
130070795|NCT01468701|468213596|FG012|Overall Study|Not eligible|1|||
130070796|NCT01468701|468213597|FG013|Overall Study|Not eligible|19|||
130070797|NCT01468701|468213598|FG014|Overall Study|Not eligible|1|||
130070798|NCT01468701|468213599|FG015|Overall Study|Not eligible|32|||
130070799|NCT01468701|468213600|FG016|Overall Study|Not eligible|0|||
130070800|NCT01468701|468213584|FG000|Overall Study|Lost to Follow-up|306|||
130070801|NCT01468701|468213585|FG001|Overall Study|Lost to Follow-up|0|||
130070802|NCT01468701|468213586|FG002|Overall Study|Lost to Follow-up|0|||
130070803|NCT01468701|468213587|FG003|Overall Study|Lost to Follow-up|0|||
130070804|NCT01468701|468213588|FG004|Overall Study|Lost to Follow-up|0|||
130070805|NCT01468701|468213589|FG005|Overall Study|Lost to Follow-up|0|||
130070806|NCT01468701|468213590|FG006|Overall Study|Lost to Follow-up|0|||
130070807|NCT01468701|468213591|FG007|Overall Study|Lost to Follow-up|0|||
130119193|NCT01296932|468398314|FG000|Overall Study|IV problems, administration not possible|0|||
130119194|NCT01296932|468398315|FG001|Overall Study|IV problems, administration not possible|0|||
130119195|NCT01296932|468398316|FG002|Overall Study|IV problems, administration not possible|1|||
130119196|NCT01296932|468398317|FG003|Overall Study|IV problems, administration not possible|0|||
130119197|NCT01296932|468398318|FG004|Overall Study|IV problems, administration not possible|0|||
130119198|NCT01296932|468398319|FG005|Overall Study|IV problems, administration not possible|0|||
130119199|NCT01296932|468398320|FG006|Overall Study|IV problems, administration not possible|0|||
130119200|NCT01296932|468398321|FG007|Overall Study|IV problems, administration not possible|0|||
130119201|NCT01296932|468398322|FG008|Overall Study|IV problems, administration not possible|0|||
130119202|NCT01296932|468398314|FG000|Overall Study|per protocol|0|||
130119203|NCT01296932|468398315|FG001|Overall Study|per protocol|0|||
130119204|NCT01296932|468398316|FG002|Overall Study|per protocol|1|||
130119205|NCT01296932|468398317|FG003|Overall Study|per protocol|1|||
130119206|NCT01296932|468398318|FG004|Overall Study|per protocol|0|||
130119207|NCT01296932|468398319|FG005|Overall Study|per protocol|0|||
130119208|NCT01296932|468398320|FG006|Overall Study|per protocol|0|||
130119209|NCT01296932|468398321|FG007|Overall Study|per protocol|0|||
130119210|NCT01296932|468398322|FG008|Overall Study|per protocol|0|||
130119211|NCT01296932|468398314|FG000|Overall Study|Low benefit and too many side effects|0|||
130119212|NCT01296932|468398315|FG001|Overall Study|Low benefit and too many side effects|0|||
130119213|NCT01296932|468398316|FG002|Overall Study|Low benefit and too many side effects|0|||
130119214|NCT01296932|468398317|FG003|Overall Study|Low benefit and too many side effects|0|||
130119215|NCT01296932|468398318|FG004|Overall Study|Low benefit and too many side effects|0|||
130119216|NCT01296932|468398319|FG005|Overall Study|Low benefit and too many side effects|0|||
130119217|NCT01296932|468398320|FG006|Overall Study|Low benefit and too many side effects|0|||
130119218|NCT01296932|468398321|FG007|Overall Study|Low benefit and too many side effects|1|||
130119219|NCT01296932|468398322|FG008|Overall Study|Low benefit and too many side effects|0|||
130119220|NCT01296932|468398314|FG000|Overall Study|No adequate treatment response|0|||
130119221|NCT01296932|468398315|FG001|Overall Study|No adequate treatment response|0|||
130119222|NCT01296932|468398316|FG002|Overall Study|No adequate treatment response|0|||
130119223|NCT01296932|468398317|FG003|Overall Study|No adequate treatment response|0|||
130119224|NCT01296932|468398318|FG004|Overall Study|No adequate treatment response|0|||
130119225|NCT01296932|468398319|FG005|Overall Study|No adequate treatment response|0|||
130119226|NCT01296932|468398320|FG006|Overall Study|No adequate treatment response|0|||
130119227|NCT01296932|468398321|FG007|Overall Study|No adequate treatment response|1|||
130119228|NCT01296932|468398322|FG008|Overall Study|No adequate treatment response|0|||
130119229|NCT01296932|468398314|FG000|Overall Study|Dosage already reduced, AE still present|0|||
130119230|NCT01296932|468398315|FG001|Overall Study|Dosage already reduced, AE still present|0|||
130119231|NCT01296932|468398316|FG002|Overall Study|Dosage already reduced, AE still present|0|||
130119232|NCT01296932|468398317|FG003|Overall Study|Dosage already reduced, AE still present|0|||
130119233|NCT01296932|468398318|FG004|Overall Study|Dosage already reduced, AE still present|0|||
130119234|NCT01296932|468398319|FG005|Overall Study|Dosage already reduced, AE still present|0|||
130119235|NCT01296932|468398320|FG006|Overall Study|Dosage already reduced, AE still present|0|||
130119236|NCT01296932|468398321|FG007|Overall Study|Dosage already reduced, AE still present|0|||
130119237|NCT01296932|468398322|FG008|Overall Study|Dosage already reduced, AE still present|1|||
130119238|NCT02352337|468398323|FG000|Overall Study|Patients never treated|4|||
130119239|NCT02352337|468398324|FG001|Overall Study|Patients never treated|1|||
130119240|NCT02352337|468398325|FG002|Overall Study|Patients never treated|2|||
130119241|NCT02458638|468398326|FG000|Overall Study|Death|309|||
130119242|NCT02458638|468398326|FG000|Overall Study|End of Cohort/End of Study|67|||
130119243|NCT02458638|468398326|FG000|Overall Study|Lost to Follow-up|31|||
130119244|NCT02458638|468398326|FG000|Overall Study|Other Reasons|4|||
130119245|NCT02458638|468398326|FG000|Overall Study|Physician Decision|1|||
130119246|NCT02458638|468398326|FG000|Overall Study|Withdrawal by Subject|47|||
130119247|NCT01829464|468398329|FG000|Overall Study|Adverse Event|1|||
130119248|NCT01829464|468398330|FG001|Overall Study|Adverse Event|0|||
129936855|NCT02325466|467735527|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
129936856|NCT02325466|467735528|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
129936857|NCT02325466|467735526|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
129936858|NCT02325466|467735527|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
129936859|NCT02325466|467735528|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
130119249|NCT01829464|468398331|FG002|Overall Study|Adverse Event|0|||
130119250|NCT01829464|468398329|FG000|Overall Study|Lost to Follow-up|0|||
130119251|NCT01829464|468398330|FG001|Overall Study|Lost to Follow-up|0|||
130119252|NCT01829464|468398331|FG002|Overall Study|Lost to Follow-up|1|||
130119253|NCT01829464|468398329|FG000|Overall Study|Withdrawal by Subject|2|||
130119254|NCT01829464|468398330|FG001|Overall Study|Withdrawal by Subject|0|||
130119255|NCT01829464|468398331|FG002|Overall Study|Withdrawal by Subject|0|||
130119256|NCT01829464|468398329|FG000|Overall Study|Study terminated by sponsor|25|||
129936860|NCT01105975|467735532|FG000|Overall Study|Adverse Event|2|||
129936861|NCT01105975|467735533|FG001|Overall Study|Adverse Event|1|||
129936862|NCT01105975|467735534|FG002|Overall Study|Adverse Event|5|||
129936863|NCT01105975|467735535|FG003|Overall Study|Adverse Event|1|||
129936864|NCT01105975|467735536|FG004|Overall Study|Adverse Event|0|||
129936865|NCT01105975|467735537|FG005|Overall Study|Adverse Event|1|||
129936866|NCT01105975|467735538|FG006|Overall Study|Adverse Event|2|||
129936867|NCT01105975|467735539|FG007|Overall Study|Adverse Event|4|||
129936868|NCT01105975|467735540|FG008|Overall Study|Adverse Event|1|||
129936869|NCT01105975|467735541|FG009|Overall Study|Adverse Event|4|||
129936870|NCT01105975|467735532|FG000|Overall Study|Withdrawal by Subject|2|||
129936871|NCT01105975|467735533|FG001|Overall Study|Withdrawal by Subject|2|||
129936872|NCT01105975|467735534|FG002|Overall Study|Withdrawal by Subject|2|||
129936873|NCT01105975|467735535|FG003|Overall Study|Withdrawal by Subject|0|||
129936874|NCT01105975|467735536|FG004|Overall Study|Withdrawal by Subject|4|||
129936875|NCT01105975|467735537|FG005|Overall Study|Withdrawal by Subject|1|||
129936876|NCT01105975|467735538|FG006|Overall Study|Withdrawal by Subject|2|||
129936877|NCT01105975|467735539|FG007|Overall Study|Withdrawal by Subject|1|||
129936878|NCT01105975|467735540|FG008|Overall Study|Withdrawal by Subject|0|||
129936879|NCT01105975|467735541|FG009|Overall Study|Withdrawal by Subject|3|||
129936880|NCT01105975|467735532|FG000|Overall Study|Lost to Follow-up|1|||
129936881|NCT01105975|467735533|FG001|Overall Study|Lost to Follow-up|0|||
129936882|NCT01105975|467735534|FG002|Overall Study|Lost to Follow-up|0|||
129936883|NCT01105975|467735535|FG003|Overall Study|Lost to Follow-up|1|||
129936884|NCT01105975|467735536|FG004|Overall Study|Lost to Follow-up|1|||
129936885|NCT01105975|467735537|FG005|Overall Study|Lost to Follow-up|0|||
129936886|NCT01105975|467735538|FG006|Overall Study|Lost to Follow-up|0|||
129936887|NCT01105975|467735539|FG007|Overall Study|Lost to Follow-up|0|||
129936888|NCT01105975|467735540|FG008|Overall Study|Lost to Follow-up|1|||
129936889|NCT01105975|467735541|FG009|Overall Study|Lost to Follow-up|0|||
129936890|NCT01105975|467735532|FG000|Overall Study|Physician Decision|0|||
129936891|NCT01105975|467735533|FG001|Overall Study|Physician Decision|0|||
129936892|NCT01105975|467735534|FG002|Overall Study|Physician Decision|0|||
129936893|NCT01105975|467735535|FG003|Overall Study|Physician Decision|0|||
129936894|NCT01105975|467735536|FG004|Overall Study|Physician Decision|0|||
129936895|NCT01105975|467735537|FG005|Overall Study|Physician Decision|0|||
129936896|NCT01105975|467735538|FG006|Overall Study|Physician Decision|2|||
129936897|NCT01105975|467735539|FG007|Overall Study|Physician Decision|0|||
129936898|NCT01105975|467735540|FG008|Overall Study|Physician Decision|0|||
129936899|NCT01105975|467735541|FG009|Overall Study|Physician Decision|0|||
129936900|NCT01105975|467735532|FG000|Overall Study|Protocol Violation|0|||
129936901|NCT01105975|467735533|FG001|Overall Study|Protocol Violation|2|||
129936902|NCT01105975|467735534|FG002|Overall Study|Protocol Violation|2|||
129936903|NCT01105975|467735535|FG003|Overall Study|Protocol Violation|0|||
129936904|NCT01105975|467735536|FG004|Overall Study|Protocol Violation|1|||
129936905|NCT01105975|467735537|FG005|Overall Study|Protocol Violation|1|||
129936906|NCT01105975|467735538|FG006|Overall Study|Protocol Violation|1|||
129936907|NCT01105975|467735539|FG007|Overall Study|Protocol Violation|1|||
129936908|NCT01105975|467735540|FG008|Overall Study|Protocol Violation|2|||
129936909|NCT01105975|467735541|FG009|Overall Study|Protocol Violation|2|||
129936910|NCT01105975|467735532|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936911|NCT01105975|467735533|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936912|NCT01105975|467735534|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129936913|NCT01105975|467735535|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936914|NCT01105975|467735536|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936915|NCT01105975|467735537|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
129936916|NCT01105975|467735538|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129936917|NCT01105975|467735539|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129936918|NCT01105975|467735540|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
129936919|NCT01105975|467735541|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936920|NCT00312208|467735545|FG000|Overall Study|Adverse Event|97|||
129936921|NCT00312208|467735546|FG001|Overall Study|Adverse Event|61|||
129936922|NCT00312208|467735545|FG000|Overall Study|Protocol Violation|5|||
129936923|NCT00312208|467735546|FG001|Overall Study|Protocol Violation|3|||
129936924|NCT00312208|467735545|FG000|Overall Study|Death|2|||
129936925|NCT00312208|467735546|FG001|Overall Study|Death|1|||
129936926|NCT00312208|467735545|FG000|Overall Study|Lack of Efficacy|7|||
129936927|NCT00312208|467735546|FG001|Overall Study|Lack of Efficacy|4|||
129936928|NCT00312208|467735545|FG000|Overall Study|Lost to Follow-up|3|||
129936929|NCT00312208|467735546|FG001|Overall Study|Lost to Follow-up|5|||
129936930|NCT00312208|467735545|FG000|Overall Study|Withdrawal by Subject|53|||
129936931|NCT00312208|467735546|FG001|Overall Study|Withdrawal by Subject|42|||
129936932|NCT00312208|467735545|FG000|Overall Study|Other|5|||
129936933|NCT00312208|467735546|FG001|Overall Study|Other|7|||
129936934|NCT02284113|467735547|FG000|Overall Study|Adverse Event|1|||
129936935|NCT02284113|467735548|FG001|Overall Study|Adverse Event|0|||
129936936|NCT02284113|467735547|FG000|Overall Study|non-compliance|0|||
129936937|NCT02284113|467735548|FG001|Overall Study|non-compliance|1|||
129936938|NCT02284113|467735547|FG000|Overall Study|Withdrawal by Subject|0|||
129936939|NCT02284113|467735548|FG001|Overall Study|Withdrawal by Subject|1|||
129936940|NCT02284113|467735547|FG000|Overall Study|not provided|0|||
129936941|NCT02284113|467735548|FG001|Overall Study|not provided|1|||
129936942|NCT02284113|467735547|FG000|Overall Study|surgery cancelled|2|||
129936943|NCT02284113|467735548|FG001|Overall Study|surgery cancelled|0|||
129936944|NCT03885232|467735551|FG000|Overall Study|Lost to Follow-up|74|||
129936945|NCT03885232|467735552|FG001|Overall Study|Lost to Follow-up|32|||
129936946|NCT03885232|467735551|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
129936947|NCT03885232|467735552|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
129936948|NCT01315132|467735555|FG000|Overall Study|not treated due to disease progression|1|||
129936949|NCT03840902|467735558|FG000|Overall Study|Randomized but not treated|1|||
129936950|NCT03840902|467735559|FG001|Overall Study|Randomized but not treated|1|||
129936951|NCT03660930|467735560|FG000|Overall Study|Adverse Event|0|||
129936952|NCT03660930|467735561|FG001|Overall Study|Adverse Event|0|||
129936953|NCT03660930|467735562|FG002|Overall Study|Adverse Event|0|||
129936954|NCT03660930|467735563|FG003|Overall Study|Adverse Event|2|||
129936955|NCT03660930|467735564|FG004|Overall Study|Adverse Event|0|||
129936956|NCT03660930|467735565|FG005|Overall Study|Adverse Event|1|||
129936957|NCT03660930|467735566|FG006|Overall Study|Adverse Event|0|||
129936958|NCT03660930|467735567|FG007|Overall Study|Adverse Event|0|||
129936959|NCT03660930|467735560|FG000|Overall Study|Withdrawal by Subject|0|||
129936960|NCT03660930|467735561|FG001|Overall Study|Withdrawal by Subject|0|||
129936961|NCT03660930|467735562|FG002|Overall Study|Withdrawal by Subject|0|||
129936962|NCT03660930|467735563|FG003|Overall Study|Withdrawal by Subject|0|||
129936963|NCT03660930|467735564|FG004|Overall Study|Withdrawal by Subject|0|||
129936964|NCT03660930|467735565|FG005|Overall Study|Withdrawal by Subject|1|||
129936965|NCT03660930|467735566|FG006|Overall Study|Withdrawal by Subject|0|||
129936966|NCT03660930|467735567|FG007|Overall Study|Withdrawal by Subject|0|||
129936967|NCT05018143|467735570|FG000|Overall Study|Lost to Follow-up|5|||
129936968|NCT05018143|467735571|FG001|Overall Study|Lost to Follow-up|4|||
129936969|NCT05018143|467735570|FG000|Overall Study|Withdrawal by Subject|0|||
129936970|NCT05018143|467735571|FG001|Overall Study|Withdrawal by Subject|1|||
129936971|NCT01208974|467735574|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
129936972|NCT01208974|467735575|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
129936973|NCT01208974|467735576|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
129936974|NCT01208974|467735577|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
129936975|NCT01208974|467735574|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
129936976|NCT01208974|467735575|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
129936977|NCT01208974|467735576|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
129936978|NCT01208974|467735577|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
129936979|NCT01208974|467735574|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
129936980|NCT01208974|467735575|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
129936981|NCT01208974|467735576|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
129936982|NCT01208974|467735577|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
129936983|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
129936984|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
129936985|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
129936986|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
129936987|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
129936988|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
129936989|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
129936990|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
129936991|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
129936992|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
129936993|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
129936994|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
129936995|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
129936996|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
129936997|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
129936998|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
129936999|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
129937000|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
129937001|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
129937002|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
129937003|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
129937004|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937005|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937006|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
130070808|NCT01468701|468213592|FG008|Overall Study|Lost to Follow-up|215|||
130070809|NCT01468701|468213593|FG009|Overall Study|Lost to Follow-up|309|||
130070810|NCT01468701|468213594|FG010|Overall Study|Lost to Follow-up|224|||
130070811|NCT01468701|468213595|FG011|Overall Study|Lost to Follow-up|212|||
130119257|NCT01829464|468398330|FG001|Overall Study|Study terminated by sponsor|28|||
130119258|NCT01829464|468398331|FG002|Overall Study|Study terminated by sponsor|25|||
130119259|NCT01829464|468398329|FG000|Overall Study|Lack of Efficacy|0|||
130119260|NCT01829464|468398330|FG001|Overall Study|Lack of Efficacy|1|||
130119261|NCT01829464|468398331|FG002|Overall Study|Lack of Efficacy|0|||
130119262|NCT01290263|468398336|FG000|Overall Study|Adverse Event|0|||
130119263|NCT01290263|468398337|FG001|Overall Study|Adverse Event|0|||
130119264|NCT01290263|468398338|FG002|Overall Study|Adverse Event|0|||
130119265|NCT01290263|468398339|FG003|Overall Study|Adverse Event|1|||
130119266|NCT01290263|468398340|FG004|Overall Study|Adverse Event|1|||
130119267|NCT01290263|468398336|FG000|Overall Study|Lack of Efficacy|8|||
130119268|NCT01290263|468398337|FG001|Overall Study|Lack of Efficacy|2|||
130119269|NCT01290263|468398338|FG002|Overall Study|Lack of Efficacy|7|||
130119270|NCT01290263|468398339|FG003|Overall Study|Lack of Efficacy|24|||
130119271|NCT01290263|468398340|FG004|Overall Study|Lack of Efficacy|33|||
130119272|NCT01290263|468398336|FG000|Overall Study|Withdrawal by Subject|3|||
130119273|NCT01290263|468398337|FG001|Overall Study|Withdrawal by Subject|1|||
130119274|NCT01290263|468398338|FG002|Overall Study|Withdrawal by Subject|0|||
130119275|NCT01290263|468398339|FG003|Overall Study|Withdrawal by Subject|1|||
130119276|NCT01290263|468398340|FG004|Overall Study|Withdrawal by Subject|2|||
130119277|NCT01290263|468398336|FG000|Overall Study|Participant Non-Compliance|0|||
130119278|NCT01290263|468398337|FG001|Overall Study|Participant Non-Compliance|0|||
130119279|NCT01290263|468398338|FG002|Overall Study|Participant Non-Compliance|0|||
130119280|NCT01290263|468398339|FG003|Overall Study|Participant Non-Compliance|1|||
130119281|NCT01290263|468398340|FG004|Overall Study|Participant Non-Compliance|1|||
130119282|NCT03738332|468398341|FG000|Overall Study|Withdrawal by Subject|1|||
130119283|NCT04700449|468398342|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
130119284|NCT04700449|468398343|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
130119285|NCT04700449|468398344|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
130119286|NCT04700449|468398345|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
130119287|NCT04700449|468398342|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
130119288|NCT04700449|468398343|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
130119289|NCT04700449|468398344|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
130119290|NCT04700449|468398345|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
130119291|NCT04700449|468398342|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
130119292|NCT04700449|468398343|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
130119293|NCT04700449|468398344|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
130119294|NCT04700449|468398345|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
130119295|NCT04700449|468398342|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
130119296|NCT04700449|468398343|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
130119297|NCT04700449|468398344|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129937007|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937008|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937009|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
129937010|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937011|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
129937012|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937013|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937014|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937015|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937016|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937017|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
129937018|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937019|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
130070812|NCT01468701|468213596|FG012|Overall Study|Lost to Follow-up|11|||
130070813|NCT01468701|468213597|FG013|Overall Study|Lost to Follow-up|164|||
130070814|NCT01468701|468213598|FG014|Overall Study|Lost to Follow-up|17|||
130070815|NCT01468701|468213599|FG015|Overall Study|Lost to Follow-up|127|||
130070816|NCT01468701|468213600|FG016|Overall Study|Lost to Follow-up|1|||
130070817|NCT01468701|468213584|FG000|Overall Study|Withdrawal by Subject|165|||
130070818|NCT01468701|468213585|FG001|Overall Study|Withdrawal by Subject|0|||
130070819|NCT01468701|468213586|FG002|Overall Study|Withdrawal by Subject|0|||
130070820|NCT01468701|468213587|FG003|Overall Study|Withdrawal by Subject|0|||
130070821|NCT01468701|468213588|FG004|Overall Study|Withdrawal by Subject|0|||
130070822|NCT01468701|468213589|FG005|Overall Study|Withdrawal by Subject|0|||
130070823|NCT01468701|468213590|FG006|Overall Study|Withdrawal by Subject|0|||
130070824|NCT01468701|468213591|FG007|Overall Study|Withdrawal by Subject|0|||
130070825|NCT01468701|468213592|FG008|Overall Study|Withdrawal by Subject|83|||
130070826|NCT01468701|468213593|FG009|Overall Study|Withdrawal by Subject|88|||
129937020|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937021|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937022|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937023|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
129937024|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
129937025|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937026|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937027|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937028|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937029|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937030|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937031|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
129937032|NCT03656718|467735578|FG000|Treatment Period Part C|Disease progression|0|||
129937033|NCT03656718|467735579|FG001|Treatment Period Part C|Disease progression|0|||
129937034|NCT03656718|467735580|FG002|Treatment Period Part C|Disease progression|0|||
129937035|NCT03656718|467735581|FG003|Treatment Period Part C|Disease progression|0|||
129937036|NCT03656718|467735582|FG004|Treatment Period Part C|Disease progression|12|||
129937037|NCT03656718|467735583|FG005|Treatment Period Part C|Disease progression|0|||
129937038|NCT03656718|467735584|FG006|Treatment Period Part C|Disease progression|0|||
129937039|NCT03656718|467735578|FG000|Treatment Period Part C|Death|0|||
129937040|NCT03656718|467735579|FG001|Treatment Period Part C|Death|0|||
129937041|NCT03656718|467735580|FG002|Treatment Period Part C|Death|0|||
129937042|NCT03656718|467735581|FG003|Treatment Period Part C|Death|0|||
129937043|NCT03656718|467735582|FG004|Treatment Period Part C|Death|1|||
129937044|NCT03656718|467735583|FG005|Treatment Period Part C|Death|0|||
129937045|NCT03656718|467735584|FG006|Treatment Period Part C|Death|0|||
129937046|NCT03656718|467735578|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937047|NCT03656718|467735579|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937048|NCT03656718|467735580|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937049|NCT03656718|467735581|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937050|NCT03656718|467735582|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
129937051|NCT03656718|467735583|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937052|NCT03656718|467735584|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937053|NCT03656718|467735578|FG000|Treatment Period Part C|Other reasons|0|||
129937054|NCT03656718|467735579|FG001|Treatment Period Part C|Other reasons|0|||
129937055|NCT03656718|467735580|FG002|Treatment Period Part C|Other reasons|0|||
129937056|NCT03656718|467735581|FG003|Treatment Period Part C|Other reasons|0|||
129937057|NCT03656718|467735582|FG004|Treatment Period Part C|Other reasons|1|||
129937058|NCT03656718|467735583|FG005|Treatment Period Part C|Other reasons|0|||
129937059|NCT03656718|467735584|FG006|Treatment Period Part C|Other reasons|0|||
129937060|NCT03656718|467735578|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
129937061|NCT03656718|467735579|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
129937062|NCT03656718|467735580|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
129937063|NCT03656718|467735581|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
129937064|NCT03656718|467735582|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
129937065|NCT03656718|467735583|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
129937066|NCT03656718|467735584|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
129937067|NCT03211247|467735585|FG000|Overall Study|Adverse Event|8|||
129937068|NCT03211247|467735586|FG001|Overall Study|Adverse Event|0|||
129937069|NCT03211247|467735587|FG002|Overall Study|Adverse Event|1|||
129937070|NCT03211247|467735588|FG003|Overall Study|Adverse Event|0|||
129937071|NCT03211247|467735589|FG004|Overall Study|Adverse Event|0|||
129937072|NCT03211247|467735585|FG000|Overall Study|Lost to Follow-up|2|||
129937073|NCT03211247|467735586|FG001|Overall Study|Lost to Follow-up|1|||
129937074|NCT03211247|467735587|FG002|Overall Study|Lost to Follow-up|0|||
129937075|NCT03211247|467735588|FG003|Overall Study|Lost to Follow-up|0|||
129937076|NCT03211247|467735589|FG004|Overall Study|Lost to Follow-up|0|||
129937077|NCT03211247|467735585|FG000|Overall Study|Physician Decision|1|||
129937078|NCT03211247|467735586|FG001|Overall Study|Physician Decision|2|||
129937079|NCT03211247|467735587|FG002|Overall Study|Physician Decision|0|||
129937080|NCT03211247|467735588|FG003|Overall Study|Physician Decision|0|||
129937081|NCT03211247|467735589|FG004|Overall Study|Physician Decision|0|||
129937082|NCT03211247|467735585|FG000|Overall Study|Non-compliance with study drug|2|||
130070827|NCT01468701|468213594|FG010|Overall Study|Withdrawal by Subject|100|||
129937083|NCT03211247|467735586|FG001|Overall Study|Non-compliance with study drug|0|||
129937084|NCT03211247|467735587|FG002|Overall Study|Non-compliance with study drug|0|||
129937085|NCT03211247|467735588|FG003|Overall Study|Non-compliance with study drug|0|||
129937086|NCT03211247|467735589|FG004|Overall Study|Non-compliance with study drug|0|||
130070828|NCT01468701|468213595|FG011|Overall Study|Withdrawal by Subject|114|||
130070829|NCT01468701|468213596|FG012|Overall Study|Withdrawal by Subject|9|||
130119298|NCT04700449|468398345|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
130119299|NCT04700449|468398342|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
130119300|NCT04700449|468398343|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
129937087|NCT03211247|467735585|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
129937088|NCT03211247|467735586|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
129937089|NCT03211247|467735587|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
129937090|NCT03211247|467735588|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
129937091|NCT03211247|467735589|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
129937092|NCT03211247|467735585|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
129937093|NCT03211247|467735586|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
129937094|NCT03211247|467735587|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
129937095|NCT03211247|467735588|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
130119301|NCT04700449|468398344|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
130119302|NCT04700449|468398345|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
130119303|NCT04700449|468398342|FG000|Stage 1: Double-Blind Period|Other|0|||
129937096|NCT03211247|467735589|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
129937097|NCT03211247|467735585|FG000|Overall Study|Protocol Violation|0|||
129937098|NCT03211247|467735586|FG001|Overall Study|Protocol Violation|1|||
129937099|NCT03211247|467735587|FG002|Overall Study|Protocol Violation|0|||
129937100|NCT03211247|467735588|FG003|Overall Study|Protocol Violation|0|||
129937101|NCT03211247|467735589|FG004|Overall Study|Protocol Violation|0|||
129937102|NCT03691493|467735592|FG000|Overall Study|Withdrawal by Subject|1|||
129937103|NCT01983683|467735593|FG000|Overall Study|Withdrawal by Subject|14|||
129937104|NCT01983683|467735594|FG001|Overall Study|Withdrawal by Subject|18|||
129937105|NCT01983683|467735593|FG000|Overall Study|Death|11|||
130119304|NCT04700449|468398343|FG001|Stage 1: Double-Blind Period|Other|0|||
130119305|NCT04700449|468398344|FG002|Stage 1: Double-Blind Period|Other|1|||
130119306|NCT04700449|468398345|FG003|Stage 1: Double-Blind Period|Other|0|||
130119307|NCT04700449|468398342|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
130119308|NCT04700449|468398343|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
130119309|NCT04700449|468398344|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
130119310|NCT04700449|468398345|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
130119311|NCT04700449|468398342|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
130119312|NCT04700449|468398343|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
130119313|NCT04700449|468398344|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
130119314|NCT04700449|468398345|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
130119315|NCT04700449|468398342|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
130119316|NCT04700449|468398343|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
130119317|NCT04700449|468398344|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
130119318|NCT04700449|468398345|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
130119319|NCT04700449|468398342|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
130119320|NCT04700449|468398343|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
130119321|NCT04700449|468398344|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
130119322|NCT04700449|468398345|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
130119323|NCT04700449|468398342|FG000|Stage 2 Sub-study 1|Other|1|||
130119324|NCT04700449|468398343|FG001|Stage 2 Sub-study 1|Other|2|||
130119325|NCT04700449|468398344|FG002|Stage 2 Sub-study 1|Other|0|||
130119326|NCT04700449|468398345|FG003|Stage 2 Sub-study 1|Other|0|||
130119327|NCT04700449|468398342|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
130119328|NCT04700449|468398343|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
130119329|NCT04700449|468398344|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
130119330|NCT04700449|468398345|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
130119331|NCT04700449|468398342|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
130119332|NCT04700449|468398343|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
130119333|NCT04700449|468398344|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
130119334|NCT04700449|468398345|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
129937106|NCT01983683|467735594|FG001|Overall Study|Death|15|||
129937107|NCT01983683|467735593|FG000|Overall Study|Physician Decision|8|||
129937108|NCT01983683|467735594|FG001|Overall Study|Physician Decision|9|||
129937109|NCT01983683|467735593|FG000|Overall Study|Lost to Follow-up|4|||
129937110|NCT01983683|467735594|FG001|Overall Study|Lost to Follow-up|8|||
129937111|NCT01983683|467735593|FG000|Overall Study|Sponsor Decision|1|||
129937112|NCT01983683|467735594|FG001|Overall Study|Sponsor Decision|1|||
130119335|NCT04700449|468398342|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
130119336|NCT04700449|468398343|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
130119337|NCT04700449|468398344|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
130119338|NCT04700449|468398345|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
130119339|NCT04700449|468398342|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129937113|NCT04882917|467735597|FG000|Overall Study|Adverse Event|0|||
129937114|NCT04882917|467735598|FG001|Overall Study|Adverse Event|1|||
129937115|NCT04882917|467735599|FG002|Overall Study|Adverse Event|2|||
129937116|NCT04882917|467735600|FG003|Overall Study|Adverse Event|2|||
130119340|NCT04700449|468398343|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
130119341|NCT04700449|468398344|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
130119342|NCT04700449|468398345|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
129937117|NCT04882917|467735597|FG000|Overall Study|Withdrawal by Subject|1|||
129937118|NCT04882917|467735598|FG001|Overall Study|Withdrawal by Subject|0|||
129937119|NCT04882917|467735599|FG002|Overall Study|Withdrawal by Subject|2|||
129937120|NCT04882917|467735600|FG003|Overall Study|Withdrawal by Subject|1|||
129937121|NCT04882917|467735597|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
129937122|NCT04882917|467735598|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
129937123|NCT04882917|467735599|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
129937124|NCT04882917|467735600|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
129937125|NCT00319020|467735602|FG000|Overall Study|Death|2|||
129937126|NCT00319020|467735603|FG001|Overall Study|Death|2|||
129937127|NCT00319020|467735602|FG000|Overall Study|Withdrawal by Subject|4|||
129937128|NCT00319020|467735603|FG001|Overall Study|Withdrawal by Subject|1|||
129937129|NCT00319020|467735602|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
129937130|NCT00319020|467735603|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
129937131|NCT00319020|467735602|FG000|Overall Study|Administrative reason|0|||
129937132|NCT00319020|467735603|FG001|Overall Study|Administrative reason|5|||
129937133|NCT00319020|467735602|FG000|Overall Study|Disease progression|0|||
129937134|NCT00319020|467735603|FG001|Overall Study|Disease progression|2|||
129937135|NCT00319020|467735602|FG000|Overall Study|Transplant|0|||
129937136|NCT00319020|467735603|FG001|Overall Study|Transplant|1|||
129937137|NCT00319020|467735602|FG000|Overall Study|Treatment failure|0|||
129937138|NCT00319020|467735603|FG001|Overall Study|Treatment failure|1|||
129937139|NCT00319020|467735602|FG000|Overall Study|Adverse Event|0|||
129937140|NCT00319020|467735603|FG001|Overall Study|Adverse Event|1|||
129937141|NCT04153890|467735607|FG000|Overall Study|Lost to Follow-up|9|||
129937142|NCT04153890|467735608|FG001|Overall Study|Lost to Follow-up|0|||
129937143|NCT04153890|467735609|FG002|Overall Study|Lost to Follow-up|9|||
129937144|NCT04153890|467735610|FG003|Overall Study|Lost to Follow-up|0|||
129937145|NCT04153890|467735607|FG000|Overall Study|Death|0|||
129937146|NCT04153890|467735608|FG001|Overall Study|Death|2|||
129937147|NCT04153890|467735609|FG002|Overall Study|Death|0|||
129937148|NCT04153890|467735610|FG003|Overall Study|Death|0|||
129937149|NCT04153890|467735607|FG000|Overall Study|Withdrawal by Subject|0|||
129937150|NCT04153890|467735608|FG001|Overall Study|Withdrawal by Subject|0|||
129937151|NCT04153890|467735609|FG002|Overall Study|Withdrawal by Subject|0|||
129937152|NCT04153890|467735610|FG003|Overall Study|Withdrawal by Subject|2|||
129937153|NCT05786612|467735611|FG000|Overall Study|Adverse Event|1|||
129937154|NCT05786612|467735612|FG001|Overall Study|Adverse Event|2|||
129937155|NCT05786612|467735611|FG000|Overall Study|one screening failure|0|||
129937156|NCT05786612|467735612|FG001|Overall Study|one screening failure|2|||
129937157|NCT03459196|467736848|FG000|Overall Study|Subject didn't receive study catheter|2|||
129937158|NCT01288443|467736850|FG000|Overall Study|Adverse Event|0|||
129937159|NCT01288443|467736851|FG001|Overall Study|Adverse Event|0|||
129937160|NCT01288443|467736852|FG002|Overall Study|Adverse Event|1|||
129937161|NCT01288443|467736853|FG003|Overall Study|Adverse Event|1|||
129937162|NCT01288443|467736854|FG004|Overall Study|Adverse Event|3|||
129937163|NCT01288443|467736855|FG005|Overall Study|Adverse Event|1|||
129937164|NCT01288443|467736850|FG000|Overall Study|Poor compliance to protocol|0|||
129937165|NCT01288443|467736851|FG001|Overall Study|Poor compliance to protocol|0|||
129937166|NCT01288443|467736852|FG002|Overall Study|Poor compliance to protocol|0|||
129937167|NCT01288443|467736853|FG003|Overall Study|Poor compliance to protocol|0|||
129937168|NCT01288443|467736854|FG004|Overall Study|Poor compliance to protocol|0|||
129937169|NCT01288443|467736855|FG005|Overall Study|Poor compliance to protocol|1|||
129937170|NCT01288443|467736850|FG000|Overall Study|Participant Moved|0|||
130070830|NCT01468701|468213597|FG013|Overall Study|Withdrawal by Subject|47|||
130070831|NCT01468701|468213598|FG014|Overall Study|Withdrawal by Subject|6|||
130070832|NCT01468701|468213599|FG015|Overall Study|Withdrawal by Subject|31|||
130070833|NCT01468701|468213600|FG016|Overall Study|Withdrawal by Subject|0|||
130070834|NCT01468701|468213584|FG000|Overall Study|Other reasons than listed|437|||
130070835|NCT01468701|468213585|FG001|Overall Study|Other reasons than listed|0|||
129937171|NCT01288443|467736851|FG001|Overall Study|Participant Moved|0|||
129937172|NCT01288443|467736852|FG002|Overall Study|Participant Moved|0|||
129937173|NCT01288443|467736853|FG003|Overall Study|Participant Moved|1|||
129937174|NCT01288443|467736854|FG004|Overall Study|Participant Moved|2|||
129937175|NCT01288443|467736855|FG005|Overall Study|Participant Moved|1|||
129937176|NCT01288443|467736850|FG000|Overall Study|Consent withdrawn by Participant|0|||
129937177|NCT01288443|467736851|FG001|Overall Study|Consent withdrawn by Participant|0|||
129937178|NCT01288443|467736852|FG002|Overall Study|Consent withdrawn by Participant|0|||
129937179|NCT01288443|467736853|FG003|Overall Study|Consent withdrawn by Participant|0|||
129937180|NCT01288443|467736854|FG004|Overall Study|Consent withdrawn by Participant|0|||
129937181|NCT01288443|467736855|FG005|Overall Study|Consent withdrawn by Participant|1|||
129937182|NCT01288443|467736850|FG000|Overall Study|Lost to Follow-up|0|||
129937183|NCT01288443|467736851|FG001|Overall Study|Lost to Follow-up|1|||
129937184|NCT01288443|467736852|FG002|Overall Study|Lost to Follow-up|0|||
129937185|NCT01288443|467736853|FG003|Overall Study|Lost to Follow-up|0|||
129937186|NCT01288443|467736854|FG004|Overall Study|Lost to Follow-up|0|||
129937187|NCT01288443|467736855|FG005|Overall Study|Lost to Follow-up|0|||
130070836|NCT01468701|468213586|FG002|Overall Study|Other reasons than listed|0|||
130070837|NCT01468701|468213587|FG003|Overall Study|Other reasons than listed|0|||
130070838|NCT01468701|468213588|FG004|Overall Study|Other reasons than listed|0|||
130070839|NCT01468701|468213589|FG005|Overall Study|Other reasons than listed|0|||
130070840|NCT01468701|468213590|FG006|Overall Study|Other reasons than listed|0|||
130070841|NCT01468701|468213591|FG007|Overall Study|Other reasons than listed|0|||
130070842|NCT01468701|468213592|FG008|Overall Study|Other reasons than listed|318|||
130070843|NCT01468701|468213593|FG009|Overall Study|Other reasons than listed|658|||
130070844|NCT01468701|468213594|FG010|Overall Study|Other reasons than listed|433|||
130070845|NCT01468701|468213595|FG011|Overall Study|Other reasons than listed|504|||
130070846|NCT01468701|468213596|FG012|Overall Study|Other reasons than listed|28|||
130070847|NCT01468701|468213597|FG013|Overall Study|Other reasons than listed|239|||
130070848|NCT01468701|468213598|FG014|Overall Study|Other reasons than listed|39|||
130070849|NCT01468701|468213599|FG015|Overall Study|Other reasons than listed|172|||
130070850|NCT01468701|468213600|FG016|Overall Study|Other reasons than listed|0|||
130070851|NCT01468701|468213584|FG000|Overall Study|No end of study case report form|0|||
130070852|NCT01468701|468213585|FG001|Overall Study|No end of study case report form|0|||
130070853|NCT01468701|468213586|FG002|Overall Study|No end of study case report form|0|||
130070854|NCT01468701|468213587|FG003|Overall Study|No end of study case report form|0|||
130070855|NCT01468701|468213588|FG004|Overall Study|No end of study case report form|0|||
130070856|NCT01468701|468213589|FG005|Overall Study|No end of study case report form|0|||
130070857|NCT01468701|468213590|FG006|Overall Study|No end of study case report form|0|||
130070858|NCT01468701|468213591|FG007|Overall Study|No end of study case report form|0|||
130070859|NCT01468701|468213592|FG008|Overall Study|No end of study case report form|4|||
130070860|NCT01468701|468213593|FG009|Overall Study|No end of study case report form|1|||
130070861|NCT01468701|468213594|FG010|Overall Study|No end of study case report form|2|||
130070862|NCT01468701|468213595|FG011|Overall Study|No end of study case report form|3|||
130070863|NCT01468701|468213596|FG012|Overall Study|No end of study case report form|0|||
130070864|NCT01468701|468213597|FG013|Overall Study|No end of study case report form|1|||
130070865|NCT01468701|468213598|FG014|Overall Study|No end of study case report form|0|||
130070866|NCT01468701|468213599|FG015|Overall Study|No end of study case report form|0|||
130070867|NCT01468701|468213600|FG016|Overall Study|No end of study case report form|0|||
130070868|NCT01468701|468213584|FG000|Overall Study|Not being followed up|0|||
130070869|NCT01468701|468213585|FG001|Overall Study|Not being followed up|4963|||
130070870|NCT01468701|468213586|FG002|Overall Study|Not being followed up|1755|||
130070871|NCT01468701|468213587|FG003|Overall Study|Not being followed up|703|||
130070872|NCT01468701|468213588|FG004|Overall Study|Not being followed up|1714|||
130070873|NCT01468701|468213589|FG005|Overall Study|Not being followed up|126|||
130070874|NCT01468701|468213590|FG006|Overall Study|Not being followed up|1170|||
130070875|NCT01468701|468213591|FG007|Overall Study|Not being followed up|4|||
130070876|NCT01468701|468213592|FG008|Overall Study|Not being followed up|0|||
130070877|NCT01468701|468213593|FG009|Overall Study|Not being followed up|0|||
130070878|NCT01468701|468213594|FG010|Overall Study|Not being followed up|0|||
130070879|NCT01468701|468213595|FG011|Overall Study|Not being followed up|0|||
130070880|NCT01468701|468213596|FG012|Overall Study|Not being followed up|0|||
130070881|NCT01468701|468213597|FG013|Overall Study|Not being followed up|0|||
130070882|NCT01468701|468213598|FG014|Overall Study|Not being followed up|0|||
130070883|NCT01468701|468213599|FG015|Overall Study|Not being followed up|0|||
130070884|NCT01468701|468213600|FG016|Overall Study|Not being followed up|0|||
130070885|NCT00719862|468213602|FG000|Overall Study|Adverse Event|1|||
130070886|NCT00719862|468213603|FG001|Overall Study|Adverse Event|2|||
130070887|NCT00719862|468213602|FG000|Overall Study|Lack of Efficacy|3|||
130070888|NCT00719862|468213603|FG001|Overall Study|Lack of Efficacy|0|||
130070889|NCT00719862|468213602|FG000|Overall Study|Non-Compliance|1|||
130070890|NCT00719862|468213603|FG001|Overall Study|Non-Compliance|0|||
130070891|NCT00719862|468213602|FG000|Overall Study|Withdrawal by Subject|1|||
130070892|NCT00719862|468213603|FG001|Overall Study|Withdrawal by Subject|0|||
130070893|NCT00719862|468213602|FG000|Overall Study|Lost to Follow-up|0|||
130070894|NCT00719862|468213603|FG001|Overall Study|Lost to Follow-up|1|||
130070895|NCT00719862|468213602|FG000|Overall Study|Other|2|||
130070896|NCT00719862|468213603|FG001|Overall Study|Other|3|||
130070897|NCT02483078|468213611|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
130070898|NCT02483078|468213612|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
130070899|NCT02483078|468213611|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
130070900|NCT02483078|468213612|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
130070901|NCT02483078|468213611|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130070902|NCT02483078|468213612|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
130070903|NCT02483078|468213611|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
130070904|NCT02483078|468213612|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
130070905|NCT02483078|468213611|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
130070906|NCT02483078|468213612|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
130070907|NCT02483078|468213611|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
130070908|NCT02483078|468213612|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
130070909|NCT02853032|468213613|FG000|Overall Study|Adverse Event|4|||
130070910|NCT02853032|468213614|FG001|Overall Study|Adverse Event|0|||
130070911|NCT02853032|468213613|FG000|Overall Study|Withdrawal by Subject|3|||
130070912|NCT02853032|468213614|FG001|Overall Study|Withdrawal by Subject|1|||
130070913|NCT02853032|468213613|FG000|Overall Study|Requested to withdraw from all treatment|2|||
130070914|NCT02853032|468213614|FG001|Overall Study|Requested to withdraw from all treatment|2|||
130070915|NCT00676208|468213615|FG000|Overall Study|Lost to Follow-up|0|||
130070916|NCT00676208|468213616|FG001|Overall Study|Lost to Follow-up|2|||
130070917|NCT00676208|468213615|FG000|Overall Study|Incomplete data|2|||
130070918|NCT00676208|468213616|FG001|Overall Study|Incomplete data|4|||
130070919|NCT03726333|468213617|FG000|Overall Study|Progressive Disease|0|||
130070920|NCT03726333|468213618|FG001|Overall Study|Progressive Disease|0|||
130070921|NCT03726333|468213619|FG002|Overall Study|Progressive Disease|1|||
130070922|NCT03726333|468213620|FG003|Overall Study|Progressive Disease|0|||
130070923|NCT03726333|468213621|FG004|Overall Study|Progressive Disease|0|||
130070924|NCT01410799|468213622|FG000|Overall Study|PI decision|13|||
130070925|NCT01946412|468213623|FG000|Overall Study|Adverse Event|1|||
130070926|NCT01946412|468213623|FG000|Overall Study|Non-Compliance|1|||
130070927|NCT01946412|468213623|FG000|Overall Study|Continued with commercial Kalydeco|2|||
130070928|NCT01946412|468213623|FG000|Overall Study|Difficulty in swallowing|1|||
130070929|NCT02688153|468215941|FG000|Overall Study|Death|7|||
130070930|NCT02688153|468215942|FG001|Overall Study|Death|5|||
130070931|NCT02688153|468215941|FG000|Overall Study|Withdrawal by Subject|4|||
130070932|NCT02688153|468215942|FG001|Overall Study|Withdrawal by Subject|2|||
130070933|NCT02688153|468215941|FG000|Overall Study|Valve Explant|1|||
130070934|NCT02688153|468215942|FG001|Overall Study|Valve Explant|0|||
130070935|NCT02688153|468215941|FG000|Overall Study|Conversion to Commercial Valve|3|||
130070936|NCT02688153|468215942|FG001|Overall Study|Conversion to Commercial Valve|0|||
130070937|NCT01102140|468215943|FG000|Overall Study|Lost to Follow-up|1|||
130070938|NCT01102140|468215944|FG001|Overall Study|Lost to Follow-up|0|||
130070939|NCT01102140|468215943|FG000|Overall Study|Investigator terminated study|2|||
130070940|NCT01102140|468215944|FG001|Overall Study|Investigator terminated study|2|||
130070941|NCT03682055|468215945|FG000|Overall Study|Lack of Efficacy|1|||
130070942|NCT03682055|468215946|FG001|Overall Study|Lack of Efficacy|2|||
130070943|NCT03682055|468215947|FG002|Overall Study|Lack of Efficacy|1|||
130070944|NCT03682055|468215948|FG003|Overall Study|Lack of Efficacy|2|||
130070945|NCT03682055|468215949|FG004|Overall Study|Lack of Efficacy|1|||
130070946|NCT03682055|468215950|FG005|Overall Study|Lack of Efficacy|3|||
130070947|NCT03682055|468215945|FG000|Overall Study|Withdrawal by Subject|0|||
130070948|NCT03682055|468215946|FG001|Overall Study|Withdrawal by Subject|0|||
130070949|NCT03682055|468215947|FG002|Overall Study|Withdrawal by Subject|0|||
130070950|NCT03682055|468215948|FG003|Overall Study|Withdrawal by Subject|0|||
130070951|NCT03682055|468215949|FG004|Overall Study|Withdrawal by Subject|0|||
130070952|NCT03682055|468215950|FG005|Overall Study|Withdrawal by Subject|1|||
130070953|NCT03682055|468215945|FG000|Overall Study|Termination of Study by Sponsor|0|||
130070954|NCT03682055|468215946|FG001|Overall Study|Termination of Study by Sponsor|0|||
130070955|NCT03682055|468215947|FG002|Overall Study|Termination of Study by Sponsor|0|||
130070956|NCT03682055|468215948|FG003|Overall Study|Termination of Study by Sponsor|0|||
130070957|NCT03682055|468215949|FG004|Overall Study|Termination of Study by Sponsor|0|||
130070958|NCT03682055|468215950|FG005|Overall Study|Termination of Study by Sponsor|3|||
130070959|NCT01135394|468215951|FG000|Screening|Lost to Follow-up|2|||
130070960|NCT01135394|468215951|FG000|Screening|Withdrawal by Subject|10|||
130070961|NCT01135394|468215951|FG000|Screening|Screening failure|16|||
130070962|NCT01135394|468215951|FG000|Screening|Physician Decision|5|||
130070963|NCT01135394|468215951|FG000|Baseline Assessment|Withdrawal by Subject|9|||
130070964|NCT01135394|468215951|FG000|Baseline Assessment|Physician Decision|3|||
130070965|NCT01135394|468215951|FG000|Baseline Assessment|Lost to Follow-up|2|||
130070966|NCT01135394|468215951|FG000|Baseline Assessment|Adverse Event|1|||
130070967|NCT01135394|468215951|FG000|Study Treatment|Withdrawal by Subject|1|||
130070968|NCT01135394|468215951|FG000|Study Treatment|Physician Decision|1|||
130070969|NCT01135394|468215951|FG000|Study Treatment|Adverse Event|2|||
130070970|NCT00191386|468215952|FG000|Overall Study|Adverse Event|16|||
130070971|NCT00191386|468215952|FG000|Overall Study|Lost to Follow-up|1|||
130070972|NCT00191386|468215952|FG000|Overall Study|Entry Criteria Exclusion|3|||
130070973|NCT00191386|468215952|FG000|Overall Study|Protocol Violation|18|||
130070974|NCT00191386|468215952|FG000|Overall Study|Withdrawal by Subject|96|||
130070975|NCT00191386|468215952|FG000|Overall Study|Physician Decision|11|||
130070976|NCT00191386|468215952|FG000|Overall Study|Lack of Efficacy|15|||
130070977|NCT00462488|468215953|FG000|Overall Study|Protocol Violation|1|||
130070978|NCT00462488|468215954|FG001|Overall Study|Protocol Violation|0|||
130070979|NCT00462488|468215953|FG000|Overall Study|Lack of Efficacy|19|||
130070980|NCT00462488|468215954|FG001|Overall Study|Lack of Efficacy|17|||
130070981|NCT01742091|468215957|FG000|Overall Study|Adverse Event|0|||
130070982|NCT01742091|468215958|FG001|Overall Study|Adverse Event|0|||
130070983|NCT01742091|468215959|FG002|Overall Study|Adverse Event|0|||
130070984|NCT01742091|468215960|FG003|Overall Study|Adverse Event|0|||
130070985|NCT01742091|468215961|FG004|Overall Study|Adverse Event|1|||
130070986|NCT01742091|468215962|FG005|Overall Study|Adverse Event|0|||
130070987|NCT01742091|468215957|FG000|Overall Study|Physician Decision|0|||
130119343|NCT04700449|468398342|FG000|Stage 2 Sub-study 2|Other|0|||
130119344|NCT04700449|468398343|FG001|Stage 2 Sub-study 2|Other|0|||
130119345|NCT04700449|468398344|FG002|Stage 2 Sub-study 2|Other|0|||
130119346|NCT04700449|468398345|FG003|Stage 2 Sub-study 2|Other|5|||
130119347|NCT02336737|468398346|FG000|Overall Study|Withdrawal by Subject|5|||
129937188|NCT01288443|467736850|FG000|Overall Study|Study drug auto-injector administration|0|||
129937189|NCT01288443|467736851|FG001|Overall Study|Study drug auto-injector administration|0|||
129937190|NCT01288443|467736852|FG002|Overall Study|Study drug auto-injector administration|0|||
129937191|NCT01288443|467736853|FG003|Overall Study|Study drug auto-injector administration|0|||
129937192|NCT01288443|467736854|FG004|Overall Study|Study drug auto-injector administration|1|||
129937193|NCT01288443|467736855|FG005|Overall Study|Study drug auto-injector administration|1|||
129937194|NCT01288443|467736850|FG000|Overall Study|Other than above|0|||
129937195|NCT01288443|467736851|FG001|Overall Study|Other than above|0|||
129937196|NCT01288443|467736852|FG002|Overall Study|Other than above|0|||
129937197|NCT01288443|467736853|FG003|Overall Study|Other than above|2|||
129937198|NCT01288443|467736854|FG004|Overall Study|Other than above|1|||
129937199|NCT01288443|467736855|FG005|Overall Study|Other than above|0|||
129937200|NCT01964300|467736857|FG000|Overall Study|Ineligible after enrollment|0|||
129937201|NCT01964300|467736858|FG001|Overall Study|Ineligible after enrollment|1|||
129937202|NCT01964300|467736857|FG000|Overall Study|Adverse Event|1|||
129937203|NCT01964300|467736858|FG001|Overall Study|Adverse Event|1|||
129937204|NCT01964300|467736857|FG000|Overall Study|Lack of Efficacy|3|||
129937205|NCT01964300|467736858|FG001|Overall Study|Lack of Efficacy|5|||
129937206|NCT01964300|467736857|FG000|Overall Study|Withdrawal by Subject|0|||
129937207|NCT01964300|467736858|FG001|Overall Study|Withdrawal by Subject|1|||
129937208|NCT01964300|467736857|FG000|Overall Study|To receive alternative therapy|1|||
129937209|NCT01964300|467736858|FG001|Overall Study|To receive alternative therapy|2|||
129937210|NCT01964300|467736857|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
129937211|NCT01964300|467736858|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
129937212|NCT01964300|467736857|FG000|Overall Study|Weight criteria not met|0|||
129937213|NCT01964300|467736858|FG001|Overall Study|Weight criteria not met|1|||
129937214|NCT02111096|467736859|FG000|Overall Study|Adverse Event|4|||
129937215|NCT02111096|467736860|FG001|Overall Study|Adverse Event|1|||
129937216|NCT02111096|467736861|FG002|Overall Study|Adverse Event|2|||
129937217|NCT02111096|467736859|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129937218|NCT02111096|467736860|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129937219|NCT02111096|467736861|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129937220|NCT02111096|467736859|FG000|Overall Study|Lost to Follow Up|1|||
129937221|NCT02111096|467736860|FG001|Overall Study|Lost to Follow Up|1|||
129937222|NCT02111096|467736861|FG002|Overall Study|Lost to Follow Up|1|||
129937223|NCT02111096|467736859|FG000|Overall Study|Physician Decision|0|||
129937224|NCT02111096|467736860|FG001|Overall Study|Physician Decision|1|||
129937225|NCT02111096|467736861|FG002|Overall Study|Physician Decision|0|||
129937226|NCT02111096|467736859|FG000|Overall Study|Protocol Violation|1|||
129937227|NCT02111096|467736860|FG001|Overall Study|Protocol Violation|0|||
129937228|NCT02111096|467736861|FG002|Overall Study|Protocol Violation|1|||
129937229|NCT02111096|467736859|FG000|Overall Study|Terminated by Sponsor|53|||
129937230|NCT02111096|467736860|FG001|Overall Study|Terminated by Sponsor|35|||
129937231|NCT02111096|467736861|FG002|Overall Study|Terminated by Sponsor|54|||
129937232|NCT02111096|467736859|FG000|Overall Study|Withdrawal by Subject|4|||
129937233|NCT02111096|467736860|FG001|Overall Study|Withdrawal by Subject|2|||
130119348|NCT02336737|468398346|FG000|Overall Study|Physician Decision|8|||
130119349|NCT02228382|468398347|FG000|Overall Study|Death|5|||
130119350|NCT02228382|468398348|FG001|Overall Study|Death|7|||
130119351|NCT02228382|468398349|FG002|Overall Study|Death|5|||
130119352|NCT02228382|468398350|FG003|Overall Study|Death|0|||
129937234|NCT02111096|467736861|FG002|Overall Study|Withdrawal by Subject|8|||
129937235|NCT03709706|467736862|FG000|Overall Study|Adverse Event|0|||
129937236|NCT03709706|467736863|FG001|Overall Study|Adverse Event|1|||
129937237|NCT03709706|467736862|FG000|Overall Study|Physician Decision|14|||
129937238|NCT03709706|467736863|FG001|Overall Study|Physician Decision|8|||
129937239|NCT03709706|467736862|FG000|Overall Study|Withdrawal by Subject|2|||
129937240|NCT03709706|467736863|FG001|Overall Study|Withdrawal by Subject|1|||
129937241|NCT03709706|467736862|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
129937242|NCT03709706|467736863|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
130119353|NCT02228382|468398351|FG004|Overall Study|Death|2|||
130119354|NCT02228382|468398347|FG000|Overall Study|Participant refused further follow-up|0|||
129937243|NCT04868617|467736864|FG000|Overall Study|Death|1|||
129937244|NCT04868617|467736865|FG001|Overall Study|Death|0|||
129937245|NCT04868617|467736864|FG000|Overall Study|Adverse Event|1|||
129937246|NCT04868617|467736865|FG001|Overall Study|Adverse Event|0|||
129937247|NCT04868617|467736864|FG000|Overall Study|Withdrawal by Subject|1|||
130119355|NCT02228382|468398348|FG001|Overall Study|Participant refused further follow-up|0|||
130119356|NCT02228382|468398349|FG002|Overall Study|Participant refused further follow-up|1|||
129937248|NCT04868617|467736865|FG001|Overall Study|Withdrawal by Subject|0|||
129937249|NCT04868617|467736864|FG000|Overall Study|Device deficiency|1|||
129937250|NCT04868617|467736865|FG001|Overall Study|Device deficiency|0|||
129937251|NCT03183050|467736866|FG000|Overall Study|Lost to Follow-up|23|||
129937252|NCT02797132|467736867|FG000|Part A (15 Days)|Adverse Event|1|||
129937253|NCT02797132|467736867|FG000|Part B (24 Weeks)|Adverse Event|3|||
129937254|NCT01970007|467736868|FG000|Overall Study|Death|5|||
129937255|NCT01970007|467736868|FG000|Overall Study|Withdrawal by Subject|23|||
129937256|NCT01970007|467736868|FG000|Overall Study|Lost to Follow-up|24|||
130070988|NCT01742091|468215958|FG001|Overall Study|Physician Decision|0|||
130070989|NCT01742091|468215959|FG002|Overall Study|Physician Decision|0|||
130070990|NCT01742091|468215960|FG003|Overall Study|Physician Decision|0|||
130070991|NCT01742091|468215961|FG004|Overall Study|Physician Decision|0|||
130070992|NCT01742091|468215962|FG005|Overall Study|Physician Decision|1|||
130070993|NCT01742091|468215957|FG000|Overall Study|Withdrawal by Subject|0|||
130070994|NCT01742091|468215958|FG001|Overall Study|Withdrawal by Subject|0|||
130070995|NCT01742091|468215959|FG002|Overall Study|Withdrawal by Subject|0|||
130070996|NCT01742091|468215960|FG003|Overall Study|Withdrawal by Subject|1|||
130070997|NCT01742091|468215961|FG004|Overall Study|Withdrawal by Subject|0|||
130070998|NCT01742091|468215962|FG005|Overall Study|Withdrawal by Subject|0|||
130070999|NCT01742091|468215957|FG000|Overall Study|Lost to Follow-up|0|||
130071000|NCT01742091|468215958|FG001|Overall Study|Lost to Follow-up|0|||
130071001|NCT01742091|468215959|FG002|Overall Study|Lost to Follow-up|0|||
130071002|NCT01742091|468215960|FG003|Overall Study|Lost to Follow-up|0|||
130071003|NCT01742091|468215961|FG004|Overall Study|Lost to Follow-up|0|||
130071004|NCT01742091|468215962|FG005|Overall Study|Lost to Follow-up|1|||
130071005|NCT00212758|468215966|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
130071006|NCT00212758|468215967|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
130071007|NCT00212758|468215966|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
130071008|NCT00212758|468215967|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
130071009|NCT03510910|468215968|FG000|Overall Study|Incomplete Survey|2|||
130071010|NCT03510910|468215969|FG001|Overall Study|Incomplete Survey|3|||
130071011|NCT01105936|468215970|FG000|Period 1|Adverse Event|0|||
130071012|NCT01105936|468215971|FG001|Period 1|Adverse Event|0|||
130071013|NCT01105936|468215972|FG002|Period 1|Adverse Event|0|||
130071014|NCT01105936|468215973|FG003|Period 1|Adverse Event|1|||
130071015|NCT01105936|468215970|FG000|Period 2|Adverse Event|1|||
130071016|NCT01105936|468215971|FG001|Period 2|Adverse Event|0|||
130071017|NCT01105936|468215972|FG002|Period 2|Adverse Event|0|||
130071018|NCT01105936|468215973|FG003|Period 2|Adverse Event|0|||
130071019|NCT01105936|468215970|FG000|Period 3|Protocol Violation|0|||
130071020|NCT01105936|468215971|FG001|Period 3|Protocol Violation|2|||
130071021|NCT01105936|468215972|FG002|Period 3|Protocol Violation|0|||
130071022|NCT01105936|468215973|FG003|Period 3|Protocol Violation|0|||
130071023|NCT01673490|468215974|FG000|Overall Study|Lost to Follow-up|1|||
130071024|NCT01673490|468215974|FG000|Overall Study|Adverse Event|3|||
130071025|NCT01673490|468215974|FG000|Overall Study|Withdrawal by Subject|3|||
130071026|NCT02940860|468215982|FG000|Overall Study|Non-serious AE|1|||
130071027|NCT02940860|468215983|FG001|Overall Study|Non-serious AE|2|||
130071028|NCT02940860|468215982|FG000|Overall Study|Serious AE|7|||
130071029|NCT02940860|468215983|FG001|Overall Study|Serious AE|3|||
130071030|NCT02940860|468215982|FG000|Overall Study|Withdrawal by Subject|19|||
130071031|NCT02940860|468215983|FG001|Overall Study|Withdrawal by Subject|9|||
130071032|NCT02940860|468215982|FG000|Overall Study|Lost to Follow-up|13|||
130071033|NCT02940860|468215983|FG001|Overall Study|Lost to Follow-up|7|||
130071034|NCT02940860|468215982|FG000|Overall Study|Physician Decision|5|||
130071035|NCT02940860|468215983|FG001|Overall Study|Physician Decision|3|||
130071036|NCT02940860|468215982|FG000|Overall Study|Sponsor Decision|0|||
130071037|NCT02940860|468215983|FG001|Overall Study|Sponsor Decision|1|||
130071038|NCT02940860|468215982|FG000|Overall Study|Protocol Violation|0|||
130071039|NCT02940860|468215983|FG001|Overall Study|Protocol Violation|2|||
130071040|NCT02940860|468215982|FG000|Overall Study|Death|3|||
130071041|NCT02940860|468215983|FG001|Overall Study|Death|2|||
130071042|NCT02940860|468215982|FG000|Overall Study|Moved, poor venous access, transport|6|||
130071043|NCT02940860|468215983|FG001|Overall Study|Moved, poor venous access, transport|4|||
130071044|NCT02940860|468215982|FG000|Overall Study|Not treated|2|||
129937257|NCT01970007|467736868|FG000|Overall Study|"Other endpoint"|3|||
130071045|NCT02940860|468215983|FG001|Overall Study|Not treated|2|||
130071046|NCT02715804|468215984|FG000|Overall Study|Death|222|||
130071047|NCT02715804|468215985|FG001|Overall Study|Death|106|||
130071048|NCT02715804|468215984|FG000|Overall Study|Withdrawal by Subject|5|||
130071049|NCT02715804|468215985|FG001|Overall Study|Withdrawal by Subject|4|||
130071050|NCT02715804|468215984|FG000|Overall Study|Other than specified|2|||
130071051|NCT02715804|468215985|FG001|Overall Study|Other than specified|3|||
130071052|NCT00948194|468215986|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
130071053|NCT00948194|468215987|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
130071054|NCT02431793|468215988|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
130071055|NCT02431793|468215989|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
130071056|NCT02431793|468215990|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
130071057|NCT02431793|468215988|FG000|Overall Study|Withdrawal by Subject|7|||
129937258|NCT00754065|467736872|FG000|Overall Study|Never received treatment|12|||
129937259|NCT00754065|467736873|FG001|Overall Study|Never received treatment|2|||
129937260|NCT00754065|467736872|FG000|Overall Study|Adverse Event|19|||
129937261|NCT00754065|467736873|FG001|Overall Study|Adverse Event|25|||
129937262|NCT00754065|467736872|FG000|Overall Study|Lost to Follow-up|7|||
129937263|NCT00754065|467736873|FG001|Overall Study|Lost to Follow-up|11|||
129937264|NCT00754065|467736872|FG000|Overall Study|Protocol Violation|12|||
129937265|NCT00754065|467736873|FG001|Overall Study|Protocol Violation|10|||
129937266|NCT00754065|467736872|FG000|Overall Study|Withdrawal by Subject|4|||
129937267|NCT00754065|467736873|FG001|Overall Study|Withdrawal by Subject|5|||
129937268|NCT00754065|467736872|FG000|Overall Study|Pregnancy|6|||
129937269|NCT00754065|467736873|FG001|Overall Study|Pregnancy|0|||
129937270|NCT00754065|467736872|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
129937271|NCT00754065|467736873|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
129937272|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
129937273|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
129937274|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
129937275|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
129937276|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
129937277|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
129937278|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
129937279|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
129937280|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
129937281|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
129937282|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
129937283|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
129937284|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
129937285|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
129937286|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
129937287|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
129937288|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
129937289|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
129937290|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
129937291|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
129937292|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
129937293|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
129937294|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
129937295|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
129937296|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
129937297|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
129937298|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
129937299|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
129937300|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
129937301|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
129937302|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
129937303|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
129937304|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
129937305|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
129937306|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
129937307|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
129937308|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
129937309|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
129937310|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
129937311|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
129937312|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
129937313|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
129937314|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
129937315|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
129937316|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
129937317|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
129937318|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
129937319|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
129937320|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
129937321|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
129937322|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
129937323|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
129937324|NCT00623194|467736878|FG000|Overall Study|Lack of Efficacy|1|||
129937325|NCT00623194|467736878|FG000|Overall Study|Protocol Violation|3|||
129937326|NCT00623194|467736878|FG000|Overall Study|Unclassified|1|||
129937327|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
129937328|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
129937329|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
129937330|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
129937331|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
129937332|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
129937333|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
129937334|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
129937335|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
129937336|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
129937337|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
129937338|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
129937339|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
129937340|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
129937341|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
129937342|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
129937343|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
129937344|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
129937345|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
129937346|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
129937347|NCT00943917|467736883|FG000|Stage I|Adverse Event|1|||
129937348|NCT00943917|467736884|FG001|Stage I|Adverse Event|2|||
129937349|NCT00943917|467736885|FG002|Stage I|Adverse Event|2|||
129937350|NCT00943917|467736886|FG003|Stage I|Adverse Event|0|||
129937351|NCT00943917|467736887|FG004|Stage I|Adverse Event|0|||
129937352|NCT00943917|467736888|FG005|Stage I|Adverse Event|0|||
129937353|NCT00943917|467736889|FG006|Stage I|Adverse Event|0|||
129937354|NCT00943917|467736890|FG007|Stage I|Adverse Event|0|||
129937355|NCT00943917|467736891|FG008|Stage I|Adverse Event|0|||
129937356|NCT00943917|467736892|FG009|Stage I|Adverse Event|0|||
129937357|NCT00943917|467736893|FG010|Stage I|Adverse Event|0|||
129937358|NCT00943917|467736894|FG011|Stage I|Adverse Event|0|||
129937359|NCT00943917|467736895|FG012|Stage I|Adverse Event|0|||
129937360|NCT00943917|467736896|FG013|Stage I|Adverse Event|0|||
129937361|NCT00943917|467736897|FG014|Stage I|Adverse Event|0|||
129937362|NCT00943917|467736883|FG000|Stage I|Lost to Follow-up|0|||
129937363|NCT00943917|467736884|FG001|Stage I|Lost to Follow-up|0|||
129937364|NCT00943917|467736885|FG002|Stage I|Lost to Follow-up|1|||
129937365|NCT00943917|467736886|FG003|Stage I|Lost to Follow-up|0|||
129937366|NCT00943917|467736887|FG004|Stage I|Lost to Follow-up|0|||
129937367|NCT00943917|467736888|FG005|Stage I|Lost to Follow-up|0|||
129937368|NCT00943917|467736889|FG006|Stage I|Lost to Follow-up|0|||
129937369|NCT00943917|467736890|FG007|Stage I|Lost to Follow-up|0|||
129937370|NCT00943917|467736891|FG008|Stage I|Lost to Follow-up|0|||
129937371|NCT00943917|467736892|FG009|Stage I|Lost to Follow-up|0|||
129937372|NCT00943917|467736893|FG010|Stage I|Lost to Follow-up|0|||
129937373|NCT00943917|467736894|FG011|Stage I|Lost to Follow-up|0|||
129937374|NCT00943917|467736895|FG012|Stage I|Lost to Follow-up|0|||
129937375|NCT00943917|467736896|FG013|Stage I|Lost to Follow-up|0|||
129937376|NCT00943917|467736897|FG014|Stage I|Lost to Follow-up|0|||
129937377|NCT00943917|467736883|FG000|Stage I|hyperglycemia|0|||
129937378|NCT00943917|467736884|FG001|Stage I|hyperglycemia|0|||
129937379|NCT00943917|467736885|FG002|Stage I|hyperglycemia|1|||
129937380|NCT00943917|467736886|FG003|Stage I|hyperglycemia|0|||
129937381|NCT00943917|467736887|FG004|Stage I|hyperglycemia|0|||
129937382|NCT00943917|467736888|FG005|Stage I|hyperglycemia|0|||
129937383|NCT00943917|467736889|FG006|Stage I|hyperglycemia|0|||
129937384|NCT00943917|467736890|FG007|Stage I|hyperglycemia|0|||
129937385|NCT00943917|467736891|FG008|Stage I|hyperglycemia|0|||
129937386|NCT00943917|467736892|FG009|Stage I|hyperglycemia|0|||
129937387|NCT00943917|467736893|FG010|Stage I|hyperglycemia|0|||
129937388|NCT00943917|467736894|FG011|Stage I|hyperglycemia|0|||
129937389|NCT00943917|467736895|FG012|Stage I|hyperglycemia|0|||
129937390|NCT00943917|467736896|FG013|Stage I|hyperglycemia|0|||
129937391|NCT00943917|467736897|FG014|Stage I|hyperglycemia|0|||
129937392|NCT00943917|467736883|FG000|Stage I|A1C elevation|1|||
129937393|NCT00943917|467736884|FG001|Stage I|A1C elevation|0|||
129937394|NCT00943917|467736885|FG002|Stage I|A1C elevation|0|||
129937395|NCT00943917|467736886|FG003|Stage I|A1C elevation|0|||
129937396|NCT00943917|467736887|FG004|Stage I|A1C elevation|0|||
129937397|NCT00943917|467736888|FG005|Stage I|A1C elevation|0|||
129937398|NCT00943917|467736889|FG006|Stage I|A1C elevation|0|||
129937399|NCT00943917|467736890|FG007|Stage I|A1C elevation|0|||
129937400|NCT00943917|467736891|FG008|Stage I|A1C elevation|0|||
129937401|NCT00943917|467736892|FG009|Stage I|A1C elevation|0|||
129937402|NCT00943917|467736893|FG010|Stage I|A1C elevation|0|||
129937403|NCT00943917|467736894|FG011|Stage I|A1C elevation|0|||
129937404|NCT00943917|467736895|FG012|Stage I|A1C elevation|0|||
129937405|NCT00943917|467736896|FG013|Stage I|A1C elevation|0|||
129937406|NCT00943917|467736897|FG014|Stage I|A1C elevation|0|||
130119357|NCT02228382|468398350|FG003|Overall Study|Participant refused further follow-up|0|||
130119358|NCT02228382|468398351|FG004|Overall Study|Participant refused further follow-up|0|||
130119359|NCT02228382|468398347|FG000|Overall Study|Study terminated by sponsor|3|||
130119360|NCT02228382|468398348|FG001|Overall Study|Study terminated by sponsor|5|||
130119361|NCT02228382|468398349|FG002|Overall Study|Study terminated by sponsor|7|||
130119362|NCT02228382|468398350|FG003|Overall Study|Study terminated by sponsor|0|||
130119363|NCT02228382|468398351|FG004|Overall Study|Study terminated by sponsor|0|||
130119364|NCT02228382|468398347|FG000|Overall Study|Lost to Follow-up|0|||
130119365|NCT02228382|468398348|FG001|Overall Study|Lost to Follow-up|0|||
130119366|NCT02228382|468398349|FG002|Overall Study|Lost to Follow-up|3|||
130119367|NCT02228382|468398350|FG003|Overall Study|Lost to Follow-up|1|||
130119368|NCT02228382|468398351|FG004|Overall Study|Lost to Follow-up|0|||
130119369|NCT02228382|468398347|FG000|Overall Study|Withdrawal by Subject|0|||
130119370|NCT02228382|468398348|FG001|Overall Study|Withdrawal by Subject|3|||
130119371|NCT02228382|468398349|FG002|Overall Study|Withdrawal by Subject|2|||
130119372|NCT02228382|468398350|FG003|Overall Study|Withdrawal by Subject|1|||
130119373|NCT02228382|468398351|FG004|Overall Study|Withdrawal by Subject|0|||
130119374|NCT02228382|468398347|FG000|Overall Study|Other|2|||
130119375|NCT02228382|468398348|FG001|Overall Study|Other|3|||
130119376|NCT02228382|468398349|FG002|Overall Study|Other|3|||
130119377|NCT02228382|468398350|FG003|Overall Study|Other|0|||
130119378|NCT02228382|468398351|FG004|Overall Study|Other|0|||
130119379|NCT02324465|468398352|FG000|Overall Study|device failure|0|||
130119380|NCT02324465|468398353|FG001|Overall Study|device failure|1|||
130119381|NCT02655237|468398354|FG000|Overall Study|Adverse Event|10|||
130119382|NCT02655237|468398355|FG001|Overall Study|Adverse Event|7|||
130119383|NCT02655237|468398354|FG000|Overall Study|Protocol Deviation|2|||
130119384|NCT02655237|468398355|FG001|Overall Study|Protocol Deviation|0|||
130119385|NCT02655237|468398354|FG000|Overall Study|Withdrawal by Participant|1|||
130119386|NCT02655237|468398355|FG001|Overall Study|Withdrawal by Participant|2|||
130119387|NCT02655237|468398354|FG000|Overall Study|Lack of Efficacy|0|||
130119388|NCT02655237|468398355|FG001|Overall Study|Lack of Efficacy|1|||
130119389|NCT02655237|468398354|FG000|Overall Study|Recovery Leading to Surgery|2|||
130119390|NCT02655237|468398355|FG001|Overall Study|Recovery Leading to Surgery|1|||
130119391|NCT02655237|468398354|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
130119392|NCT02655237|468398355|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
130119393|NCT02655237|468398354|FG000|Overall Study|Randomized but Not Treated|1|||
130119394|NCT02655237|468398355|FG001|Overall Study|Randomized but Not Treated|0|||
130119395|NCT02132247|468398356|FG000|Overall Study|Protocol Violation|1|||
130119396|NCT02132247|468398357|FG001|Overall Study|Protocol Violation|0|||
130119397|NCT03679741|468398360|FG000|Period 1|No longer meet eligibility criteria|1|||
130119398|NCT03679741|468398361|FG001|Period 1|No longer meet eligibility criteria|0|||
130119399|NCT03679741|468398360|FG000|Period 1|Lost to Follow-up|0|||
130119400|NCT03679741|468398361|FG001|Period 1|Lost to Follow-up|1|||
130119401|NCT03679741|468398360|FG000|Period 1|Adverse Event|1|||
130119402|NCT03679741|468398361|FG001|Period 1|Adverse Event|1|||
130119403|NCT03679741|468398360|FG000|Period 1|Withdrawal by Subject|0|||
130119404|NCT03679741|468398361|FG001|Period 1|Withdrawal by Subject|1|||
130119405|NCT03679741|468398360|FG000|Period 2|Adverse Event|2|||
130119406|NCT03679741|468398361|FG001|Period 2|Adverse Event|1|||
130119407|NCT03679741|468398360|FG000|Period 2|Withdrawal by Subject|1|||
130119408|NCT03679741|468398361|FG001|Period 2|Withdrawal by Subject|1|||
130119409|NCT00520741|468398362|FG000|Overall Study|Adverse Event|16|||
130119410|NCT00520741|468398363|FG001|Overall Study|Adverse Event|56|||
130119411|NCT00520741|468398362|FG000|Overall Study|Lack of Efficacy|11|||
130119412|NCT00520741|468398363|FG001|Overall Study|Lack of Efficacy|30|||
130119413|NCT00520741|468398362|FG000|Overall Study|Withdrawal by Subject|0|||
130119414|NCT00520741|468398363|FG001|Overall Study|Withdrawal by Subject|11|||
130119415|NCT00520741|468398362|FG000|Overall Study|Protocol Violation|2|||
129937407|NCT00943917|467736883|FG000|Stage I|Withdrawal by Subject|2|||
129937408|NCT00943917|467736884|FG001|Stage I|Withdrawal by Subject|1|||
129937409|NCT00943917|467736885|FG002|Stage I|Withdrawal by Subject|2|||
129937410|NCT00943917|467736886|FG003|Stage I|Withdrawal by Subject|0|||
130119416|NCT00520741|468398363|FG001|Overall Study|Protocol Violation|15|||
130119417|NCT00520741|468398362|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
130119418|NCT00520741|468398363|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
130119419|NCT00520741|468398362|FG000|Overall Study|Lost to Follow-up|4|||
130119420|NCT00520741|468398363|FG001|Overall Study|Lost to Follow-up|4|||
130119421|NCT00520741|468398362|FG000|Overall Study|Other reasons for premature termination|0|||
129937411|NCT00943917|467736887|FG004|Stage I|Withdrawal by Subject|0|||
129937412|NCT00943917|467736888|FG005|Stage I|Withdrawal by Subject|0|||
130119422|NCT00520741|468398363|FG001|Overall Study|Other reasons for premature termination|6|||
130119423|NCT02750761|468398365|FG000|Overall Study|Lost to Follow-up|0|||
130119424|NCT02750761|468398366|FG001|Overall Study|Lost to Follow-up|0|||
130119425|NCT02750761|468398367|FG002|Overall Study|Lost to Follow-up|1|||
130119426|NCT02750761|468398368|FG003|Overall Study|Lost to Follow-up|0|||
130119427|NCT02750761|468398369|FG004|Overall Study|Lost to Follow-up|0|||
130119428|NCT02750761|468398370|FG005|Overall Study|Lost to Follow-up|0|||
129937413|NCT00943917|467736889|FG006|Stage I|Withdrawal by Subject|0|||
129937414|NCT00943917|467736890|FG007|Stage I|Withdrawal by Subject|0|||
129937415|NCT00943917|467736891|FG008|Stage I|Withdrawal by Subject|0|||
129937416|NCT00943917|467736892|FG009|Stage I|Withdrawal by Subject|0|||
129937417|NCT00943917|467736893|FG010|Stage I|Withdrawal by Subject|0|||
129937418|NCT00943917|467736894|FG011|Stage I|Withdrawal by Subject|0|||
130071058|NCT02431793|468215989|FG001|Overall Study|Withdrawal by Subject|5|||
129937419|NCT00943917|467736895|FG012|Stage I|Withdrawal by Subject|0|||
129937420|NCT00943917|467736896|FG013|Stage I|Withdrawal by Subject|0|||
129937421|NCT00943917|467736897|FG014|Stage I|Withdrawal by Subject|0|||
129937422|NCT00943917|467736883|FG000|Stage II|Adverse Event|0|||
129937423|NCT00943917|467736884|FG001|Stage II|Adverse Event|0|||
129937424|NCT00943917|467736885|FG002|Stage II|Adverse Event|0|||
129937425|NCT00943917|467736886|FG003|Stage II|Adverse Event|0|||
129937426|NCT00943917|467736887|FG004|Stage II|Adverse Event|0|||
129937427|NCT00943917|467736888|FG005|Stage II|Adverse Event|1|||
129937428|NCT00943917|467736889|FG006|Stage II|Adverse Event|3|||
129937429|NCT00943917|467736890|FG007|Stage II|Adverse Event|0|||
129937430|NCT00943917|467736891|FG008|Stage II|Adverse Event|1|||
129937431|NCT00943917|467736892|FG009|Stage II|Adverse Event|0|||
129937432|NCT00943917|467736893|FG010|Stage II|Adverse Event|0|||
129937433|NCT00943917|467736894|FG011|Stage II|Adverse Event|0|||
129937434|NCT00943917|467736895|FG012|Stage II|Adverse Event|0|||
129937435|NCT00943917|467736896|FG013|Stage II|Adverse Event|0|||
129937436|NCT00943917|467736897|FG014|Stage II|Adverse Event|0|||
129937437|NCT00943917|467736883|FG000|Stage II|Withdrawal by Subject|0|||
129937438|NCT00943917|467736884|FG001|Stage II|Withdrawal by Subject|0|||
129937439|NCT00943917|467736885|FG002|Stage II|Withdrawal by Subject|0|||
129937440|NCT00943917|467736886|FG003|Stage II|Withdrawal by Subject|0|||
129937441|NCT00943917|467736887|FG004|Stage II|Withdrawal by Subject|0|||
129937442|NCT00943917|467736888|FG005|Stage II|Withdrawal by Subject|1|||
129937443|NCT00943917|467736889|FG006|Stage II|Withdrawal by Subject|0|||
129937444|NCT00943917|467736890|FG007|Stage II|Withdrawal by Subject|0|||
129937445|NCT00943917|467736891|FG008|Stage II|Withdrawal by Subject|0|||
129937446|NCT00943917|467736892|FG009|Stage II|Withdrawal by Subject|0|||
129937447|NCT00943917|467736893|FG010|Stage II|Withdrawal by Subject|0|||
129937448|NCT00943917|467736894|FG011|Stage II|Withdrawal by Subject|0|||
129937449|NCT00943917|467736895|FG012|Stage II|Withdrawal by Subject|0|||
129937450|NCT00943917|467736896|FG013|Stage II|Withdrawal by Subject|0|||
129937451|NCT00943917|467736897|FG014|Stage II|Withdrawal by Subject|0|||
129937452|NCT00943917|467736883|FG000|Stage II|Pregnancy|0|||
129937453|NCT00943917|467736884|FG001|Stage II|Pregnancy|0|||
129937454|NCT00943917|467736885|FG002|Stage II|Pregnancy|0|||
130071059|NCT02431793|468215990|FG002|Overall Study|Withdrawal by Subject|5|||
130071060|NCT02431793|468215988|FG000|Overall Study|Lost to Follow-up|101|||
129937455|NCT00943917|467736886|FG003|Stage II|Pregnancy|0|||
129937456|NCT00943917|467736887|FG004|Stage II|Pregnancy|0|||
129937457|NCT00943917|467736888|FG005|Stage II|Pregnancy|1|||
129937458|NCT00943917|467736889|FG006|Stage II|Pregnancy|0|||
129937459|NCT00943917|467736890|FG007|Stage II|Pregnancy|0|||
129937460|NCT00943917|467736891|FG008|Stage II|Pregnancy|0|||
129937461|NCT00943917|467736892|FG009|Stage II|Pregnancy|0|||
129937462|NCT00943917|467736893|FG010|Stage II|Pregnancy|0|||
129937463|NCT00943917|467736894|FG011|Stage II|Pregnancy|0|||
129937464|NCT00943917|467736895|FG012|Stage II|Pregnancy|0|||
129937465|NCT00943917|467736896|FG013|Stage II|Pregnancy|0|||
129937466|NCT00943917|467736897|FG014|Stage II|Pregnancy|0|||
129937467|NCT00943917|467736883|FG000|Stage II Continuation|Adverse Event|0|||
129937468|NCT00943917|467736884|FG001|Stage II Continuation|Adverse Event|0|||
129937469|NCT00943917|467736885|FG002|Stage II Continuation|Adverse Event|0|||
129937470|NCT00943917|467736886|FG003|Stage II Continuation|Adverse Event|0|||
129937471|NCT00943917|467736887|FG004|Stage II Continuation|Adverse Event|0|||
129937472|NCT00943917|467736888|FG005|Stage II Continuation|Adverse Event|0|||
129937473|NCT00943917|467736889|FG006|Stage II Continuation|Adverse Event|0|||
129937474|NCT00943917|467736890|FG007|Stage II Continuation|Adverse Event|0|||
130071061|NCT02431793|468215989|FG001|Overall Study|Lost to Follow-up|122|||
130071062|NCT02431793|468215990|FG002|Overall Study|Lost to Follow-up|104|||
130071063|NCT00233324|468215991|FG000|Main Study|Death|68|||
129937475|NCT00943917|467736891|FG008|Stage II Continuation|Adverse Event|0|||
129937476|NCT00943917|467736892|FG009|Stage II Continuation|Adverse Event|0|||
129937477|NCT00943917|467736893|FG010|Stage II Continuation|Adverse Event|0|||
129937478|NCT00943917|467736894|FG011|Stage II Continuation|Adverse Event|1|||
129937479|NCT00943917|467736895|FG012|Stage II Continuation|Adverse Event|2|||
129937480|NCT00943917|467736896|FG013|Stage II Continuation|Adverse Event|1|||
129937481|NCT00943917|467736897|FG014|Stage II Continuation|Adverse Event|1|||
129937482|NCT00943917|467736883|FG000|Stage II Continuation|Withdrawal by Subject|0|||
129937483|NCT00943917|467736884|FG001|Stage II Continuation|Withdrawal by Subject|0|||
129937484|NCT00943917|467736885|FG002|Stage II Continuation|Withdrawal by Subject|0|||
129937485|NCT00943917|467736886|FG003|Stage II Continuation|Withdrawal by Subject|0|||
129937486|NCT00943917|467736887|FG004|Stage II Continuation|Withdrawal by Subject|0|||
129937487|NCT00943917|467736888|FG005|Stage II Continuation|Withdrawal by Subject|0|||
130071064|NCT00233324|468215992|FG001|Main Study|Death|60|||
130119429|NCT01860976|468398371|FG000|Blinded Treatment|Adverse Event|1|||
130119430|NCT01860976|468398372|FG001|Blinded Treatment|Adverse Event|3|||
130119431|NCT01860976|468398371|FG000|Blinded Treatment|Lack of Efficacy|5|||
130119432|NCT01860976|468398372|FG001|Blinded Treatment|Lack of Efficacy|12|||
130119433|NCT01860976|468398371|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
130119434|NCT01860976|468398372|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
130119435|NCT01860976|468398371|FG000|Blinded Treatment|Withdrawal by Subject|3|||
130119436|NCT01860976|468398372|FG001|Blinded Treatment|Withdrawal by Subject|5|||
130119437|NCT01860976|468398371|FG000|Blinded Treatment|Subject no longer met criteria|1|||
130119438|NCT01860976|468398372|FG001|Blinded Treatment|Subject no longer met criteria|0|||
130119439|NCT01860976|468398371|FG000|Blinded Treatment|Entered Open-Label in error|0|||
130119440|NCT01860976|468398372|FG001|Blinded Treatment|Entered Open-Label in error|1|||
130119441|NCT01860976|468398371|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
130119442|NCT01860976|468398372|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
130119443|NCT01860976|468398371|FG000|Open-Label|Adverse Event|2|||
130119444|NCT01860976|468398372|FG001|Open-Label|Adverse Event|4|||
130119445|NCT01860976|468398371|FG000|Open-Label|Lack of Efficacy|16|||
130119446|NCT01860976|468398372|FG001|Open-Label|Lack of Efficacy|8|||
130119447|NCT01860976|468398371|FG000|Open-Label|Lost to Follow-up|1|||
130119448|NCT01860976|468398372|FG001|Open-Label|Lost to Follow-up|2|||
130119449|NCT01860976|468398371|FG000|Open-Label|Subject request discontinue treatment|4|||
130119450|NCT01860976|468398372|FG001|Open-Label|Subject request discontinue treatment|3|||
130119451|NCT01860976|468398371|FG000|Open-Label|Withdrawal by Subject|4|||
130119452|NCT01860976|468398372|FG001|Open-Label|Withdrawal by Subject|1|||
130119453|NCT01860976|468398371|FG000|Open-Label|Other Reasons|1|||
130119454|NCT01860976|468398372|FG001|Open-Label|Other Reasons|1|||
130119455|NCT01860976|468398371|FG000|Long Term Extension|Adverse Event|4|||
130119456|NCT01860976|468398372|FG001|Long Term Extension|Adverse Event|0|||
130119457|NCT01860976|468398371|FG000|Long Term Extension|Lack of Efficacy|2|||
130119458|NCT01860976|468398372|FG001|Long Term Extension|Lack of Efficacy|0|||
130119459|NCT01860976|468398371|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
130119460|NCT01860976|468398372|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
130119461|NCT01860976|468398371|FG000|Long Term Extension|Lost to Follow-up|2|||
130119462|NCT01860976|468398372|FG001|Long Term Extension|Lost to Follow-up|0|||
130119463|NCT01860976|468398371|FG000|Long Term Extension|subject withdrew consent|7|||
130119464|NCT01860976|468398372|FG001|Long Term Extension|subject withdrew consent|0|||
130119465|NCT02227862|468398373|FG000|Overall Study|Protocol Violation|7|||
130119466|NCT02227862|468398374|FG001|Overall Study|Protocol Violation|9|||
130119467|NCT02227862|468398373|FG000|Overall Study|Other|0|||
130119468|NCT02227862|468398374|FG001|Overall Study|Other|2|||
130119469|NCT02227862|468398373|FG000|Overall Study|Adverse Event|4|||
130119470|NCT02227862|468398374|FG001|Overall Study|Adverse Event|3|||
130119471|NCT02227862|468398373|FG000|Overall Study|Withdrawal by Subject|7|||
130119472|NCT02227862|468398374|FG001|Overall Study|Withdrawal by Subject|6|||
130119473|NCT02227862|468398373|FG000|Overall Study|Lost to Follow-up|1|||
130119474|NCT02227862|468398374|FG001|Overall Study|Lost to Follow-up|2|||
130119475|NCT02204371|468398382|FG000|Overall Study|Adverse Event|1|||
130119476|NCT00620763|468398385|FG000|Period: First Intervention|Withdrawal by Subject|0|||
130119477|NCT00620763|468398386|FG001|Period: First Intervention|Withdrawal by Subject|2|||
130119478|NCT00620763|468398385|FG000|Period: First Intervention|Protocol Violation|0|||
130119479|NCT00620763|468398386|FG001|Period: First Intervention|Protocol Violation|3|||
130119480|NCT00620763|468398385|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
130119481|NCT00620763|468398386|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
130119482|NCT00368966|468398390|FG000|Infant Series|Withdrawal by Subject|11|||
130119483|NCT00368966|468398391|FG001|Infant Series|Withdrawal by Subject|6|||
130119484|NCT00368966|468398390|FG000|Infant Series|Protocol Violation|2|||
130119485|NCT00368966|468398391|FG001|Infant Series|Protocol Violation|1|||
130119486|NCT00368966|468398390|FG000|Infant Series|Lost to Follow-up|2|||
130119487|NCT00368966|468398391|FG001|Infant Series|Lost to Follow-up|0|||
130119488|NCT00368966|468398390|FG000|Infant Series|Randomization error|0|||
130119489|NCT00368966|468398391|FG001|Infant Series|Randomization error|1|||
130119490|NCT00368966|468398390|FG000|Infant Series|Failed to meet eligibility criteria|0|||
130119491|NCT00368966|468398391|FG001|Infant Series|Failed to meet eligibility criteria|1|||
130119492|NCT00368966|468398390|FG000|Infant Series|Adverse Event|0|||
130119493|NCT00368966|468398391|FG001|Infant Series|Adverse Event|1|||
130119494|NCT00368966|468398390|FG000|Infant Series|Failed to return|1|||
130119495|NCT00368966|468398391|FG001|Infant Series|Failed to return|0|||
130119496|NCT00368966|468398390|FG000|After Infant|Failed to return|3|||
130119497|NCT00368966|468398391|FG001|After Infant|Failed to return|1|||
130119498|NCT00368966|468398390|FG000|After Infant|Adverse Event|1|||
130119499|NCT00368966|468398391|FG001|After Infant|Adverse Event|2|||
130119500|NCT00368966|468398390|FG000|After Infant|Withdrawal by Subject|1|||
130119501|NCT00368966|468398391|FG001|After Infant|Withdrawal by Subject|1|||
130119502|NCT00368966|468398390|FG000|After Infant|Death|1|||
130119503|NCT00368966|468398391|FG001|After Infant|Death|0|||
130119504|NCT00368966|468398390|FG000|After Infant|Lost to Follow-up|0|||
129937488|NCT00943917|467736889|FG006|Stage II Continuation|Withdrawal by Subject|0|||
129937489|NCT00943917|467736890|FG007|Stage II Continuation|Withdrawal by Subject|0|||
129937490|NCT00943917|467736891|FG008|Stage II Continuation|Withdrawal by Subject|0|||
129937491|NCT00943917|467736892|FG009|Stage II Continuation|Withdrawal by Subject|0|||
129937492|NCT00943917|467736893|FG010|Stage II Continuation|Withdrawal by Subject|0|||
129937493|NCT00943917|467736894|FG011|Stage II Continuation|Withdrawal by Subject|0|||
129937494|NCT00943917|467736895|FG012|Stage II Continuation|Withdrawal by Subject|0|||
129937495|NCT00943917|467736896|FG013|Stage II Continuation|Withdrawal by Subject|1|||
129937496|NCT00943917|467736897|FG014|Stage II Continuation|Withdrawal by Subject|3|||
129937497|NCT00943917|467736883|FG000|Stage II Continuation|Protocol Violation|0|||
129937498|NCT00943917|467736884|FG001|Stage II Continuation|Protocol Violation|0|||
129937499|NCT00943917|467736885|FG002|Stage II Continuation|Protocol Violation|0|||
129937500|NCT00943917|467736886|FG003|Stage II Continuation|Protocol Violation|0|||
129937501|NCT00943917|467736887|FG004|Stage II Continuation|Protocol Violation|0|||
129937502|NCT00943917|467736888|FG005|Stage II Continuation|Protocol Violation|0|||
129937503|NCT00943917|467736889|FG006|Stage II Continuation|Protocol Violation|0|||
129937504|NCT00943917|467736890|FG007|Stage II Continuation|Protocol Violation|0|||
129937505|NCT00943917|467736891|FG008|Stage II Continuation|Protocol Violation|0|||
129937506|NCT00943917|467736892|FG009|Stage II Continuation|Protocol Violation|1|||
129937507|NCT00943917|467736893|FG010|Stage II Continuation|Protocol Violation|0|||
129937508|NCT00943917|467736894|FG011|Stage II Continuation|Protocol Violation|1|||
129937509|NCT00943917|467736895|FG012|Stage II Continuation|Protocol Violation|0|||
129937510|NCT00943917|467736896|FG013|Stage II Continuation|Protocol Violation|0|||
129937511|NCT00943917|467736897|FG014|Stage II Continuation|Protocol Violation|0|||
129937512|NCT00943917|467736883|FG000|Stage II Continuation|hypoglycemia|0|||
129937513|NCT00943917|467736884|FG001|Stage II Continuation|hypoglycemia|0|||
129937514|NCT00943917|467736885|FG002|Stage II Continuation|hypoglycemia|0|||
129937515|NCT00943917|467736886|FG003|Stage II Continuation|hypoglycemia|0|||
129937516|NCT00943917|467736887|FG004|Stage II Continuation|hypoglycemia|0|||
129937517|NCT00943917|467736888|FG005|Stage II Continuation|hypoglycemia|0|||
129937518|NCT00943917|467736889|FG006|Stage II Continuation|hypoglycemia|0|||
129937519|NCT00943917|467736890|FG007|Stage II Continuation|hypoglycemia|0|||
129937520|NCT00943917|467736891|FG008|Stage II Continuation|hypoglycemia|0|||
129937521|NCT00943917|467736892|FG009|Stage II Continuation|hypoglycemia|0|||
129937522|NCT00943917|467736893|FG010|Stage II Continuation|hypoglycemia|0|||
129937523|NCT00943917|467736894|FG011|Stage II Continuation|hypoglycemia|0|||
129937524|NCT00943917|467736895|FG012|Stage II Continuation|hypoglycemia|1|||
130071065|NCT00233324|468215993|FG002|Main Study|Death|62|||
129937525|NCT00943917|467736896|FG013|Stage II Continuation|hypoglycemia|0|||
129937526|NCT00943917|467736897|FG014|Stage II Continuation|hypoglycemia|0|||
129937527|NCT00943917|467736883|FG000|Stage II Continuation|A1C elevation|0|||
129937528|NCT00943917|467736884|FG001|Stage II Continuation|A1C elevation|0|||
129937529|NCT00943917|467736885|FG002|Stage II Continuation|A1C elevation|0|||
129937530|NCT00943917|467736886|FG003|Stage II Continuation|A1C elevation|0|||
129937531|NCT00943917|467736887|FG004|Stage II Continuation|A1C elevation|0|||
129937532|NCT00943917|467736888|FG005|Stage II Continuation|A1C elevation|0|||
129937533|NCT00943917|467736889|FG006|Stage II Continuation|A1C elevation|0|||
129937534|NCT00943917|467736890|FG007|Stage II Continuation|A1C elevation|0|||
129937535|NCT00943917|467736891|FG008|Stage II Continuation|A1C elevation|0|||
129937536|NCT00943917|467736892|FG009|Stage II Continuation|A1C elevation|0|||
129937537|NCT00943917|467736893|FG010|Stage II Continuation|A1C elevation|0|||
129937538|NCT00943917|467736894|FG011|Stage II Continuation|A1C elevation|0|||
129937539|NCT00943917|467736895|FG012|Stage II Continuation|A1C elevation|0|||
129937540|NCT00943917|467736896|FG013|Stage II Continuation|A1C elevation|1|||
129937541|NCT00943917|467736897|FG014|Stage II Continuation|A1C elevation|0|||
129937542|NCT01171976|467736898|FG000|Overall Study|Protocol Violation|0|||
129937543|NCT01171976|467736899|FG001|Overall Study|Protocol Violation|0|||
129937544|NCT01171976|467736900|FG002|Overall Study|Protocol Violation|1|||
129937545|NCT01171976|467736898|FG000|Overall Study|Death|2|||
129937546|NCT01171976|467736899|FG001|Overall Study|Death|4|||
129937547|NCT01171976|467736900|FG002|Overall Study|Death|1|||
129937548|NCT01171976|467736898|FG000|Overall Study|Lost to Follow-up|4|||
129937549|NCT01171976|467736899|FG001|Overall Study|Lost to Follow-up|0|||
129937550|NCT01171976|467736900|FG002|Overall Study|Lost to Follow-up|2|||
129937551|NCT01171976|467736898|FG000|Overall Study|Withdrawal by Subject|1|||
129937552|NCT01171976|467736899|FG001|Overall Study|Withdrawal by Subject|5|||
130071066|NCT00233324|468215994|FG003|Main Study|Death|47|||
129937553|NCT01171976|467736900|FG002|Overall Study|Withdrawal by Subject|6|||
129937554|NCT01171976|467736898|FG000|Overall Study|Abnormal test result|1|||
129937555|NCT01171976|467736899|FG001|Overall Study|Abnormal test result|0|||
129937556|NCT01171976|467736900|FG002|Overall Study|Abnormal test result|0|||
130071067|NCT00233324|468215991|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
129937557|NCT01171976|467736898|FG000|Overall Study|Adverse Event|6|||
129937558|NCT01171976|467736899|FG001|Overall Study|Adverse Event|2|||
129937559|NCT01171976|467736900|FG002|Overall Study|Adverse Event|5|||
130071068|NCT00233324|468215992|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
130119505|NCT00368966|468398391|FG001|After Infant|Lost to Follow-up|1|||
130119506|NCT00368966|468398390|FG000|Toddler Dose|Withdrawal by Subject|1|||
130119507|NCT00368966|468398391|FG001|Toddler Dose|Withdrawal by Subject|1|||
130119508|NCT00368966|468398390|FG000|Toddler Dose|Lost to Follow-up|0|||
130119509|NCT00368966|468398391|FG001|Toddler Dose|Lost to Follow-up|2|||
130119510|NCT02866175|468398392|FG000|Overall Study|Adverse Event|56|||
130119511|NCT02866175|468398393|FG001|Overall Study|Adverse Event|54|||
130119512|NCT02866175|468398392|FG000|Overall Study|Withdrawal by Subject|31|||
130119513|NCT02866175|468398393|FG001|Overall Study|Withdrawal by Subject|52|||
130119514|NCT02866175|468398392|FG000|Overall Study|Death|30|||
130119515|NCT02866175|468398393|FG001|Overall Study|Death|23|||
130119516|NCT02866175|468398392|FG000|Overall Study|Other|7|||
130119517|NCT02866175|468398393|FG001|Overall Study|Other|14|||
130119518|NCT02866175|468398392|FG000|Overall Study|Progressive disease|1|||
130119519|NCT02866175|468398393|FG001|Overall Study|Progressive disease|1|||
130119520|NCT02866175|468398392|FG000|Overall Study|Lost to Follow-up|2|||
130119521|NCT02866175|468398393|FG001|Overall Study|Lost to Follow-up|0|||
130119522|NCT02866175|468398392|FG000|Overall Study|Lack of Efficacy|0|||
130119523|NCT02866175|468398393|FG001|Overall Study|Lack of Efficacy|1|||
130119524|NCT02866175|468398392|FG000|Overall Study|Physician Decision|3|||
130119525|NCT02866175|468398393|FG001|Overall Study|Physician Decision|15|||
130119526|NCT02866175|468398392|FG000|Overall Study|Did not receive treatment|5|||
130119527|NCT02866175|468398393|FG001|Overall Study|Did not receive treatment|15|||
130119528|NCT01694485|468398394|FG000|Overall Study|Withdrawal by Subject|20|||
130119529|NCT01694485|468398395|FG001|Overall Study|Withdrawal by Subject|6|||
130119530|NCT01694485|468398396|FG002|Overall Study|Withdrawal by Subject|7|||
130119531|NCT01694485|468398397|FG003|Overall Study|Withdrawal by Subject|25|||
130119532|NCT01694485|468398398|FG004|Overall Study|Withdrawal by Subject|18|||
130119533|NCT01694485|468398394|FG000|Overall Study|Sponsor Decision|3|||
130119534|NCT01694485|468398395|FG001|Overall Study|Sponsor Decision|0|||
130119535|NCT01694485|468398396|FG002|Overall Study|Sponsor Decision|0|||
130119536|NCT01694485|468398397|FG003|Overall Study|Sponsor Decision|2|||
130119537|NCT01694485|468398398|FG004|Overall Study|Sponsor Decision|0|||
130119538|NCT01694485|468398394|FG000|Overall Study|Lost to Follow-up|9|||
130119539|NCT01694485|468398395|FG001|Overall Study|Lost to Follow-up|1|||
130119540|NCT01694485|468398396|FG002|Overall Study|Lost to Follow-up|6|||
130119541|NCT01694485|468398397|FG003|Overall Study|Lost to Follow-up|10|||
130119542|NCT01694485|468398398|FG004|Overall Study|Lost to Follow-up|7|||
130119543|NCT01694485|468398394|FG000|Overall Study|Death|1|||
130119544|NCT01694485|468398395|FG001|Overall Study|Death|0|||
130119545|NCT01694485|468398396|FG002|Overall Study|Death|0|||
130119546|NCT01694485|468398397|FG003|Overall Study|Death|1|||
130119547|NCT01694485|468398398|FG004|Overall Study|Death|0|||
130119548|NCT01595009|468398399|FG000|Core|Patients completed per protocol|85|||
130119549|NCT01595009|468398400|FG001|Core|Patients completed per protocol|44|||
129937560|NCT02754596|467736904|FG000|Overall Study|Withdrawal by Subject|3|||
129937561|NCT02754596|467736905|FG001|Overall Study|Withdrawal by Subject|4|||
129937562|NCT02754596|467736906|FG002|Overall Study|Withdrawal by Subject|0|||
129937563|NCT02754596|467736904|FG000|Overall Study|Physician Decision|1|||
129937564|NCT02754596|467736905|FG001|Overall Study|Physician Decision|1|||
129937565|NCT02754596|467736906|FG002|Overall Study|Physician Decision|1|||
129937566|NCT02754596|467736904|FG000|Overall Study|Lost to Follow-up|1|||
129937567|NCT02754596|467736905|FG001|Overall Study|Lost to Follow-up|1|||
129937568|NCT02754596|467736906|FG002|Overall Study|Lost to Follow-up|2|||
129937569|NCT02754596|467736904|FG000|Overall Study|Death|0|||
129937570|NCT02754596|467736905|FG001|Overall Study|Death|2|||
129937571|NCT02754596|467736906|FG002|Overall Study|Death|0|||
129937572|NCT02754596|467736904|FG000|Overall Study|Adverse Event|1|||
129937573|NCT02754596|467736905|FG001|Overall Study|Adverse Event|0|||
129937574|NCT02754596|467736906|FG002|Overall Study|Adverse Event|1|||
129937575|NCT02754596|467736904|FG000|Overall Study|Other|1|||
129937576|NCT02754596|467736905|FG001|Overall Study|Other|0|||
129937577|NCT02754596|467736906|FG002|Overall Study|Other|0|||
129937578|NCT03357952|467736907|FG000|Overall Study|Withdrawal by Subject|0|||
129937579|NCT03357952|467736908|FG001|Overall Study|Withdrawal by Subject|1|||
129937580|NCT03357952|467736907|FG000|Overall Study|Sponsor Decision|9|||
129937581|NCT03357952|467736908|FG001|Overall Study|Sponsor Decision|0|||
129937582|NCT01371994|467736909|FG000|Overall Study|Adverse Event|3|||
130119550|NCT01595009|468398401|FG002|Core|Patients completed per protocol|0|||
130119551|NCT01595009|468398402|FG003|Core|Patients completed per protocol|0|||
130119552|NCT01595009|468398399|FG000|Core|Adverse Event|19|||
130119553|NCT01595009|468398400|FG001|Core|Adverse Event|23|||
129937583|NCT01371994|467736910|FG001|Overall Study|Adverse Event|6|||
129937584|NCT01371994|467736909|FG000|Overall Study|Lack of Efficacy|3|||
129937585|NCT01371994|467736910|FG001|Overall Study|Lack of Efficacy|0|||
130119554|NCT01595009|468398401|FG002|Core|Adverse Event|0|||
129937586|NCT01371994|467736909|FG000|Overall Study|Withdrawal by Subject|13|||
130119555|NCT01595009|468398402|FG003|Core|Adverse Event|0|||
130119556|NCT01595009|468398399|FG000|Core|Disease progression|14|||
130119557|NCT01595009|468398400|FG001|Core|Disease progression|26|||
130119558|NCT01595009|468398401|FG002|Core|Disease progression|0|||
129937587|NCT01371994|467736910|FG001|Overall Study|Withdrawal by Subject|7|||
129937588|NCT01371994|467736909|FG000|Overall Study|Lost to Follow-up|1|||
129937589|NCT01371994|467736910|FG001|Overall Study|Lost to Follow-up|1|||
129937590|NCT01371994|467736909|FG000|Overall Study|Protocol Violation|24|||
129937591|NCT01371994|467736910|FG001|Overall Study|Protocol Violation|17|||
129937592|NCT01371994|467736909|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
129937593|NCT01371994|467736910|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
129937594|NCT01371994|467736909|FG000|Overall Study|Physician Decision|1|||
129937595|NCT01371994|467736910|FG001|Overall Study|Physician Decision|1|||
129937596|NCT01371994|467736909|FG000|Overall Study|Miscellaneous Reasons|6|||
129937597|NCT01371994|467736910|FG001|Overall Study|Miscellaneous Reasons|4|||
129937598|NCT03280030|467736911|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
129937599|NCT03280030|467736912|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
129937600|NCT03280030|467736913|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
129937601|NCT03280030|467736911|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
129937602|NCT03280030|467736912|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
129937603|NCT03280030|467736913|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
129937604|NCT03280030|467736911|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
129937605|NCT03280030|467736912|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
129937606|NCT03280030|467736913|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
129937607|NCT03280030|467736911|FG000|Part 2 - Efficacy|Adverse Event|0|||
129937608|NCT03280030|467736912|FG001|Part 2 - Efficacy|Adverse Event|4|||
129937609|NCT03280030|467736913|FG002|Part 2 - Efficacy|Adverse Event|6|||
129937610|NCT03280030|467736911|FG000|Part 2 - Efficacy|Death|0|||
129937611|NCT03280030|467736912|FG001|Part 2 - Efficacy|Death|3|||
129937612|NCT03280030|467736913|FG002|Part 2 - Efficacy|Death|0|||
129937613|NCT03280030|467736911|FG000|Part 2 - Efficacy|Physician Decision|0|||
129937614|NCT03280030|467736912|FG001|Part 2 - Efficacy|Physician Decision|10|||
129937615|NCT03280030|467736913|FG002|Part 2 - Efficacy|Physician Decision|16|||
129937616|NCT03280030|467736911|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
129937617|NCT03280030|467736912|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
129937618|NCT03280030|467736913|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
129937619|NCT03280030|467736911|FG000|Part 2 - Efficacy|Progressive disease|0|||
129937620|NCT03280030|467736912|FG001|Part 2 - Efficacy|Progressive disease|7|||
129937621|NCT03280030|467736913|FG002|Part 2 - Efficacy|Progressive disease|5|||
129937622|NCT03222609|467736914|FG000|Overall Study|Withdrew consent|2|||
129937623|NCT03222609|467736915|FG001|Overall Study|Withdrew consent|3|||
129937624|NCT03222609|467736916|FG002|Overall Study|Withdrew consent|4|||
129937625|NCT03222609|467736917|FG003|Overall Study|Withdrew consent|2|||
129937626|NCT03222609|467736914|FG000|Overall Study|Lost to Follow-up|1|||
129937627|NCT03222609|467736915|FG001|Overall Study|Lost to Follow-up|0|||
129937628|NCT03222609|467736916|FG002|Overall Study|Lost to Follow-up|0|||
129937629|NCT03222609|467736917|FG003|Overall Study|Lost to Follow-up|0|||
129937630|NCT03222609|467736914|FG000|Overall Study|Death|16|||
129937631|NCT03222609|467736915|FG001|Overall Study|Death|13|||
129937632|NCT03222609|467736916|FG002|Overall Study|Death|9|||
129937633|NCT03222609|467736917|FG003|Overall Study|Death|6|||
129937634|NCT03222609|467736914|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
129937635|NCT03222609|467736915|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
129937636|NCT03222609|467736916|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
129937637|NCT03222609|467736917|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
129937638|NCT05521516|467736918|FG000|Overall Study|Withdrawal by Subject|1|||
129937639|NCT05521516|467736919|FG001|Overall Study|Withdrawal by Subject|1|||
129937640|NCT00545545|467736920|FG000|Overall Study|Progressive Neoplastic Disease|1|||
129937641|NCT00545545|467736921|FG001|Overall Study|Progressive Neoplastic Disease|5|||
129937642|NCT00545545|467736922|FG002|Overall Study|Progressive Neoplastic Disease|0|||
129937643|NCT00545545|467736923|FG003|Overall Study|Progressive Neoplastic Disease|4|||
129937644|NCT00545545|467736924|FG004|Overall Study|Progressive Neoplastic Disease|8|||
129937645|NCT00545545|467736925|FG005|Overall Study|Progressive Neoplastic Disease|7|||
129937646|NCT00545545|467736920|FG000|Overall Study|Withdrawal by Subject|0|||
129937647|NCT00545545|467736921|FG001|Overall Study|Withdrawal by Subject|1|||
129937648|NCT00545545|467736922|FG002|Overall Study|Withdrawal by Subject|0|||
129937649|NCT00545545|467736923|FG003|Overall Study|Withdrawal by Subject|0|||
129937650|NCT00545545|467736924|FG004|Overall Study|Withdrawal by Subject|0|||
129937651|NCT00545545|467736925|FG005|Overall Study|Withdrawal by Subject|0|||
129937652|NCT00545545|467736920|FG000|Overall Study|Physician Decision|1|||
129937653|NCT00545545|467736921|FG001|Overall Study|Physician Decision|0|||
129937654|NCT00545545|467736922|FG002|Overall Study|Physician Decision|0|||
129937655|NCT00545545|467736923|FG003|Overall Study|Physician Decision|0|||
129937656|NCT00545545|467736924|FG004|Overall Study|Physician Decision|0|||
129937657|NCT00545545|467736925|FG005|Overall Study|Physician Decision|1|||
129937658|NCT00545545|467736920|FG000|Overall Study|Irinotecan intolerance|1|||
129937659|NCT00545545|467736921|FG001|Overall Study|Irinotecan intolerance|1|||
129937660|NCT00545545|467736922|FG002|Overall Study|Irinotecan intolerance|0|||
129937661|NCT00545545|467736923|FG003|Overall Study|Irinotecan intolerance|0|||
129937662|NCT00545545|467736924|FG004|Overall Study|Irinotecan intolerance|0|||
129937663|NCT00545545|467736925|FG005|Overall Study|Irinotecan intolerance|0|||
129937664|NCT00545545|467736920|FG000|Overall Study|No target lesions to track post surgery|0|||
129937665|NCT00545545|467736921|FG001|Overall Study|No target lesions to track post surgery|0|||
129937666|NCT00545545|467736922|FG002|Overall Study|No target lesions to track post surgery|0|||
129937667|NCT00545545|467736923|FG003|Overall Study|No target lesions to track post surgery|0|||
129937668|NCT00545545|467736924|FG004|Overall Study|No target lesions to track post surgery|1|||
129937669|NCT00545545|467736925|FG005|Overall Study|No target lesions to track post surgery|1|||
129937670|NCT00227266|467736938|FG000|Overall Study|Withdrawal by Subject|0|||
129937671|NCT00227266|467736939|FG001|Overall Study|Withdrawal by Subject|0|||
129937672|NCT00227266|467736940|FG002|Overall Study|Withdrawal by Subject|1|||
129937673|NCT00227266|467736938|FG000|Overall Study|Protocol Violation|1|||
129937674|NCT00227266|467736939|FG001|Overall Study|Protocol Violation|0|||
129937675|NCT00227266|467736940|FG002|Overall Study|Protocol Violation|1|||
129937676|NCT00227266|467736938|FG000|Overall Study|Excessive weight gain|0|||
129937677|NCT00227266|467736939|FG001|Overall Study|Excessive weight gain|0|||
129937678|NCT00227266|467736940|FG002|Overall Study|Excessive weight gain|2|||
129937679|NCT02678689|467736941|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
129937680|NCT02678689|467736942|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
129937681|NCT03959423|467736946|FG000|Overall Study|Withdrawal by Subject|2|||
129937682|NCT03959423|467736947|FG001|Overall Study|Withdrawal by Subject|3|||
129937683|NCT03959423|467736946|FG000|Overall Study|Physician Decision|0|||
129937684|NCT03959423|467736947|FG001|Overall Study|Physician Decision|1|||
129937685|NCT03959423|467736946|FG000|Overall Study|Lost to Follow-up|1|||
129937686|NCT03959423|467736947|FG001|Overall Study|Lost to Follow-up|0|||
129937687|NCT03959423|467736946|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
129937688|NCT03959423|467736947|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129937689|NCT04926740|467736948|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
129937690|NCT04926740|467736949|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
129937691|NCT04926740|467736948|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
129937692|NCT04926740|467736949|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
129937693|NCT02549352|467736950|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
129937694|NCT02549352|467736951|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
129937695|NCT02549352|467736950|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
129937696|NCT02549352|467736951|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
129937697|NCT02549352|467736950|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
129937698|NCT02549352|467736951|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
129937699|NCT02549352|467736950|FG000|12-month Follow-up|Withdrawal by Subject|4|||
129937700|NCT02549352|467736951|FG001|12-month Follow-up|Withdrawal by Subject|5|||
129937701|NCT02549352|467736950|FG000|12-month Follow-up|Lost to Follow-up|3|||
129937702|NCT02549352|467736951|FG001|12-month Follow-up|Lost to Follow-up|2|||
129937703|NCT02549352|467736950|FG000|12-month Follow-up|Death|0|||
129937704|NCT02549352|467736951|FG001|12-month Follow-up|Death|1|||
129937705|NCT02549352|467736950|FG000|12-month Follow-up|Protocol Violation|0|||
129937706|NCT02549352|467736951|FG001|12-month Follow-up|Protocol Violation|1|||
129937707|NCT02549352|467736950|FG000|12-month Follow-up|Other|1|||
129937708|NCT02549352|467736951|FG001|12-month Follow-up|Other|3|||
129937709|NCT04530487|467738009|FG000|Overall Study|Death|1|||
129937710|NCT00146172|467738010|FG000|Overall Study|Adverse Event|0|||
129937711|NCT00146172|467738011|FG001|Overall Study|Adverse Event|0|||
129937712|NCT00146172|467738012|FG002|Overall Study|Adverse Event|1|||
129937713|NCT00146172|467738013|FG003|Overall Study|Adverse Event|1|||
129937714|NCT00146172|467738014|FG004|Overall Study|Adverse Event|0|||
129937715|NCT00146172|467738015|FG005|Overall Study|Adverse Event|2|||
129937716|NCT00146172|467738016|FG006|Overall Study|Adverse Event|3|||
129937717|NCT00146172|467738017|FG007|Overall Study|Adverse Event|10|||
129937718|NCT00146172|467738010|FG000|Overall Study|Lost to Follow-up|0|||
129937719|NCT00146172|467738011|FG001|Overall Study|Lost to Follow-up|0|||
129937720|NCT00146172|467738012|FG002|Overall Study|Lost to Follow-up|0|||
129937721|NCT00146172|467738013|FG003|Overall Study|Lost to Follow-up|0|||
129937722|NCT00146172|467738014|FG004|Overall Study|Lost to Follow-up|0|||
129937723|NCT00146172|467738015|FG005|Overall Study|Lost to Follow-up|0|||
129937724|NCT00146172|467738016|FG006|Overall Study|Lost to Follow-up|0|||
129937725|NCT00146172|467738017|FG007|Overall Study|Lost to Follow-up|1|||
129937726|NCT00146172|467738010|FG000|Overall Study|Disease Progression|2|||
129937727|NCT00146172|467738011|FG001|Overall Study|Disease Progression|4|||
129937728|NCT00146172|467738012|FG002|Overall Study|Disease Progression|2|||
129937729|NCT00146172|467738013|FG003|Overall Study|Disease Progression|5|||
129937730|NCT00146172|467738014|FG004|Overall Study|Disease Progression|2|||
129937731|NCT00146172|467738015|FG005|Overall Study|Disease Progression|2|||
129937732|NCT00146172|467738016|FG006|Overall Study|Disease Progression|1|||
129937733|NCT00146172|467738017|FG007|Overall Study|Disease Progression|22|||
129937734|NCT00146172|467738010|FG000|Overall Study|Death|0|||
129937735|NCT00146172|467738011|FG001|Overall Study|Death|0|||
129937736|NCT00146172|467738012|FG002|Overall Study|Death|0|||
129937737|NCT00146172|467738013|FG003|Overall Study|Death|0|||
129937738|NCT00146172|467738014|FG004|Overall Study|Death|0|||
129937739|NCT00146172|467738015|FG005|Overall Study|Death|0|||
129937740|NCT00146172|467738016|FG006|Overall Study|Death|1|||
129937741|NCT00146172|467738017|FG007|Overall Study|Death|0|||
129937742|NCT00146172|467738010|FG000|Overall Study|Physician Decision|0|||
129937743|NCT00146172|467738011|FG001|Overall Study|Physician Decision|0|||
129937744|NCT00146172|467738012|FG002|Overall Study|Physician Decision|0|||
129937745|NCT00146172|467738013|FG003|Overall Study|Physician Decision|0|||
129937746|NCT00146172|467738014|FG004|Overall Study|Physician Decision|0|||
129937747|NCT00146172|467738015|FG005|Overall Study|Physician Decision|0|||
129937748|NCT00146172|467738016|FG006|Overall Study|Physician Decision|0|||
129937749|NCT00146172|467738017|FG007|Overall Study|Physician Decision|1|||
129937750|NCT00146172|467738010|FG000|Overall Study|Withdrawal by Subject|0|||
129937751|NCT00146172|467738011|FG001|Overall Study|Withdrawal by Subject|0|||
129937752|NCT00146172|467738012|FG002|Overall Study|Withdrawal by Subject|0|||
129937753|NCT00146172|467738013|FG003|Overall Study|Withdrawal by Subject|0|||
129937754|NCT00146172|467738014|FG004|Overall Study|Withdrawal by Subject|0|||
129937755|NCT00146172|467738015|FG005|Overall Study|Withdrawal by Subject|1|||
129937756|NCT00146172|467738016|FG006|Overall Study|Withdrawal by Subject|1|||
129937757|NCT00146172|467738017|FG007|Overall Study|Withdrawal by Subject|4|||
129937758|NCT00146172|467738010|FG000|Overall Study|Symptomatic Deterioration|1|||
129937759|NCT00146172|467738011|FG001|Overall Study|Symptomatic Deterioration|0|||
129937760|NCT00146172|467738012|FG002|Overall Study|Symptomatic Deterioration|1|||
129937761|NCT00146172|467738013|FG003|Overall Study|Symptomatic Deterioration|0|||
129937762|NCT00146172|467738014|FG004|Overall Study|Symptomatic Deterioration|1|||
129937763|NCT00146172|467738015|FG005|Overall Study|Symptomatic Deterioration|2|||
129937764|NCT00146172|467738016|FG006|Overall Study|Symptomatic Deterioration|0|||
129937765|NCT00146172|467738017|FG007|Overall Study|Symptomatic Deterioration|2|||
129937766|NCT03876457|467738020|FG000|Overall Study|Lost to Follow-up|1|||
129937767|NCT03876457|467738021|FG001|Overall Study|Lost to Follow-up|3|||
129937768|NCT01184326|467738022|FG000|Overall Study|Adverse Event|1|||
129937769|NCT01184326|467738023|FG001|Overall Study|Adverse Event|2|||
129937770|NCT01184326|467738024|FG002|Overall Study|Adverse Event|0|||
129937771|NCT01184326|467738022|FG000|Overall Study|Death|0|||
129937772|NCT01184326|467738023|FG001|Overall Study|Death|0|||
129937773|NCT01184326|467738024|FG002|Overall Study|Death|1|||
129937774|NCT01184326|467738022|FG000|Overall Study|Withdrawal by Subject|0|||
129937775|NCT01184326|467738023|FG001|Overall Study|Withdrawal by Subject|0|||
129937776|NCT01184326|467738024|FG002|Overall Study|Withdrawal by Subject|1|||
129937777|NCT01184326|467738022|FG000|Overall Study|Physician Decision|1|||
129937778|NCT01184326|467738023|FG001|Overall Study|Physician Decision|1|||
129937779|NCT01184326|467738024|FG002|Overall Study|Physician Decision|0|||
129937780|NCT01184326|467738022|FG000|Overall Study|Disease Progression|1|||
129937781|NCT01184326|467738023|FG001|Overall Study|Disease Progression|3|||
129937782|NCT01184326|467738024|FG002|Overall Study|Disease Progression|12|||
129937783|NCT01036724|467738025|FG000|Overall Study|Adverse Event|1|||
129937784|NCT01036724|467738026|FG001|Overall Study|Adverse Event|2|||
129937785|NCT01036724|467738025|FG000|Overall Study|Lack of Efficacy|1|||
129937786|NCT01036724|467738026|FG001|Overall Study|Lack of Efficacy|1|||
129937787|NCT01036724|467738025|FG000|Overall Study|Protocol Violation|4|||
129937788|NCT01036724|467738026|FG001|Overall Study|Protocol Violation|5|||
129937789|NCT00557492|467738028|FG000|Overall Study|Change in health insurance|1|||
129937790|NCT01574716|467738029|FG000|Part 1|Death|3|||
129937791|NCT01574716|467738030|FG001|Part 1|Death|1|||
129937792|NCT01574716|467738031|FG002|Part 1|Death|8|||
129937793|NCT01574716|467738032|FG003|Part 1|Death|0|||
129937794|NCT01574716|467738033|FG004|Part 1|Death|0|||
129937795|NCT01574716|467738029|FG000|Part 1|Discontinuation of study by sponsor|0|||
130119559|NCT01595009|468398402|FG003|Core|Disease progression|0|||
130119560|NCT01595009|468398399|FG000|Core|Withdrawal by Subject|4|||
130119561|NCT01595009|468398400|FG001|Core|Withdrawal by Subject|17|||
130119562|NCT01595009|468398401|FG002|Core|Withdrawal by Subject|0|||
130119563|NCT01595009|468398402|FG003|Core|Withdrawal by Subject|0|||
130119564|NCT01595009|468398399|FG000|Core|Death|3|||
130119565|NCT01595009|468398400|FG001|Core|Death|6|||
130119566|NCT01595009|468398401|FG002|Core|Death|0|||
129937796|NCT01574716|467738030|FG001|Part 1|Discontinuation of study by sponsor|0|||
130119567|NCT01595009|468398402|FG003|Core|Death|0|||
130119568|NCT01595009|468398399|FG000|Core|Lost to Follow-up|1|||
130119569|NCT01595009|468398400|FG001|Core|Lost to Follow-up|2|||
129937797|NCT01574716|467738031|FG002|Part 1|Discontinuation of study by sponsor|1|||
129937798|NCT01574716|467738032|FG003|Part 1|Discontinuation of study by sponsor|0|||
129937799|NCT01574716|467738033|FG004|Part 1|Discontinuation of study by sponsor|0|||
129937800|NCT01574716|467738029|FG000|Part 1|Withdrawal by Subject|0|||
129937801|NCT01574716|467738030|FG001|Part 1|Withdrawal by Subject|2|||
129937802|NCT01574716|467738031|FG002|Part 1|Withdrawal by Subject|0|||
129937803|NCT01574716|467738032|FG003|Part 1|Withdrawal by Subject|0|||
129937804|NCT01574716|467738033|FG004|Part 1|Withdrawal by Subject|0|||
130119570|NCT01595009|468398401|FG002|Core|Lost to Follow-up|0|||
130119571|NCT01595009|468398402|FG003|Core|Lost to Follow-up|0|||
130119572|NCT01595009|468398399|FG000|Core|Protocol deviation|0|||
129937805|NCT01574716|467738029|FG000|Part 1|Lost to Follow-up|0|||
130119573|NCT01595009|468398400|FG001|Core|Protocol deviation|1|||
130119574|NCT01595009|468398401|FG002|Core|Protocol deviation|0|||
130119575|NCT01595009|468398402|FG003|Core|Protocol deviation|0|||
130119576|NCT01595009|468398399|FG000|Core|Administrative problems|0|||
130119577|NCT01595009|468398400|FG001|Core|Administrative problems|1|||
130119578|NCT01595009|468398401|FG002|Core|Administrative problems|0|||
130119579|NCT01595009|468398402|FG003|Core|Administrative problems|0|||
130119580|NCT01595009|468398399|FG000|Extension|Administrative problems|0|||
130119581|NCT01595009|468398400|FG001|Extension|Administrative problems|0|||
130119582|NCT01595009|468398401|FG002|Extension|Administrative problems|0|||
130119583|NCT01595009|468398402|FG003|Extension|Administrative problems|1|||
130119584|NCT01595009|468398399|FG000|Extension|Patients completed per protocol|0|||
130119585|NCT01595009|468398400|FG001|Extension|Patients completed per protocol|0|||
130119586|NCT01595009|468398401|FG002|Extension|Patients completed per protocol|0|||
130119587|NCT01595009|468398402|FG003|Extension|Patients completed per protocol|2|||
130119588|NCT01595009|468398399|FG000|Extension|Disease progression|0|||
130119589|NCT01595009|468398400|FG001|Extension|Disease progression|0|||
130119590|NCT01595009|468398401|FG002|Extension|Disease progression|4|||
130119591|NCT01595009|468398402|FG003|Extension|Disease progression|7|||
130119592|NCT01595009|468398399|FG000|Extension|Adverse Event|0|||
130119593|NCT01595009|468398400|FG001|Extension|Adverse Event|0|||
130119594|NCT01595009|468398401|FG002|Extension|Adverse Event|0|||
130119595|NCT01595009|468398402|FG003|Extension|Adverse Event|1|||
130119596|NCT02907203|468398403|FG000|Overall Study|Death|1|||
130119597|NCT02907203|468398403|FG000|Overall Study|Lost to Follow-up|3|||
130119598|NCT02907203|468398403|FG000|Overall Study|Withdrawal by Subject|3|||
130119599|NCT02907203|468398403|FG000|Overall Study|Surgical bypass|1|||
130119600|NCT04956666|468398405|FG000|Overall Study|Adverse Event|18|||
130119601|NCT04956666|468398405|FG000|Overall Study|Physician Decision|5|||
130119602|NCT00662025|468398409|FG000|Overall Study|Objective progression or relapse|51|||
130119603|NCT00662025|468398409|FG000|Overall Study|Adverse Event|7|||
130119604|NCT00662025|468398409|FG000|Overall Study|Withdrawal by Subject|1|||
130119605|NCT00662025|468398409|FG000|Overall Study|Results of other clinical study|2|||
130119606|NCT00662025|468398409|FG000|Overall Study|Target lesion cannot be evaluated|1|||
130119607|NCT00662025|468398409|FG000|Overall Study|Domestic circumstances|1|||
130119608|NCT00760383|468398410|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
130119609|NCT00760383|468398411|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
130119610|NCT00626925|468398412|FG000|Overall Study|Lost to Follow-up|1|||
130119611|NCT00626925|468398413|FG001|Overall Study|Lost to Follow-up|2|||
130119612|NCT00626925|468398412|FG000|Overall Study|relapse|1|||
130119613|NCT00626925|468398413|FG001|Overall Study|relapse|0|||
130119614|NCT00626925|468398412|FG000|Overall Study|Adverse effect|6|||
130119615|NCT00626925|468398413|FG001|Overall Study|Adverse effect|2|||
130119616|NCT00626925|468398412|FG000|Overall Study|Lack of Efficacy|1|||
130119617|NCT00626925|468398413|FG001|Overall Study|Lack of Efficacy|4|||
130119618|NCT00626925|468398412|FG000|Overall Study|Time constraints|3|||
130119619|NCT00626925|468398413|FG001|Overall Study|Time constraints|1|||
130119620|NCT01215942|468398418|FG000|Treatment Period|Adverse Event|15|||
130119621|NCT01215942|468398419|FG001|Treatment Period|Adverse Event|26|||
130119622|NCT01215942|468398418|FG000|Treatment Period|Death|2|||
130119623|NCT01215942|468398419|FG001|Treatment Period|Death|4|||
130119624|NCT01215942|468398418|FG000|Treatment Period|Lack of Efficacy|23|||
130119625|NCT01215942|468398419|FG001|Treatment Period|Lack of Efficacy|62|||
130119626|NCT01215942|468398418|FG000|Treatment Period|Lost to Follow-up|3|||
130119627|NCT01215942|468398419|FG001|Treatment Period|Lost to Follow-up|4|||
129937806|NCT01574716|467738030|FG001|Part 1|Lost to Follow-up|1|||
129937807|NCT01574716|467738031|FG002|Part 1|Lost to Follow-up|0|||
129937808|NCT01574716|467738032|FG003|Part 1|Lost to Follow-up|0|||
129937809|NCT01574716|467738033|FG004|Part 1|Lost to Follow-up|0|||
129937810|NCT01574716|467738029|FG000|Part 2|Progressive disease|0|||
129937811|NCT01574716|467738030|FG001|Part 2|Progressive disease|0|||
129937812|NCT01574716|467738031|FG002|Part 2|Progressive disease|0|||
129937813|NCT01574716|467738032|FG003|Part 2|Progressive disease|1|||
129937814|NCT01574716|467738033|FG004|Part 2|Progressive disease|0|||
129937815|NCT01574716|467738029|FG000|Part 2|Death|0|||
130119628|NCT01215942|468398418|FG000|Treatment Period|Withdrawal by Subject|17|||
130119629|NCT01215942|468398419|FG001|Treatment Period|Withdrawal by Subject|40|||
130119630|NCT01215942|468398418|FG000|Treatment Period|Physician Decision|5|||
130119631|NCT01215942|468398419|FG001|Treatment Period|Physician Decision|5|||
130119632|NCT01215942|468398418|FG000|Treatment Period|Protocol Violation|0|||
130119633|NCT01215942|468398419|FG001|Treatment Period|Protocol Violation|1|||
130119634|NCT01215942|468398418|FG000|Treatment Period|Sponsor Decision|349|||
130119635|NCT01215942|468398419|FG001|Treatment Period|Sponsor Decision|530|||
130119636|NCT01215942|468398418|FG000|Post-Treatment Follow-Up Period|Death|0|||
130119637|NCT01215942|468398419|FG001|Post-Treatment Follow-Up Period|Death|1|||
130119638|NCT01215942|468398418|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130119639|NCT01215942|468398419|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130119640|NCT01215942|468398418|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
130119641|NCT01215942|468398419|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
129937816|NCT01574716|467738030|FG001|Part 2|Death|0|||
129937817|NCT01574716|467738031|FG002|Part 2|Death|0|||
129937818|NCT01574716|467738032|FG003|Part 2|Death|76|||
129937819|NCT01574716|467738033|FG004|Part 2|Death|35|||
129937820|NCT01574716|467738029|FG000|Part 2|Discontinuation of study by sponsor|0|||
129937821|NCT01574716|467738030|FG001|Part 2|Discontinuation of study by sponsor|0|||
129937822|NCT01574716|467738031|FG002|Part 2|Discontinuation of study by sponsor|0|||
129937823|NCT01574716|467738032|FG003|Part 2|Discontinuation of study by sponsor|51|||
129937824|NCT01574716|467738033|FG004|Part 2|Discontinuation of study by sponsor|31|||
129937825|NCT01574716|467738029|FG000|Part 2|Withdrawal by Subject|0|||
129937826|NCT01574716|467738030|FG001|Part 2|Withdrawal by Subject|0|||
129937827|NCT01574716|467738031|FG002|Part 2|Withdrawal by Subject|0|||
129937828|NCT01574716|467738032|FG003|Part 2|Withdrawal by Subject|5|||
129937829|NCT01574716|467738033|FG004|Part 2|Withdrawal by Subject|4|||
129937830|NCT01574716|467738029|FG000|Part 2|Brain metastases|0|||
129937831|NCT01574716|467738030|FG001|Part 2|Brain metastases|0|||
129937832|NCT01574716|467738031|FG002|Part 2|Brain metastases|0|||
129937833|NCT01574716|467738032|FG003|Part 2|Brain metastases|1|||
129937834|NCT01574716|467738033|FG004|Part 2|Brain metastases|0|||
129937835|NCT01574716|467738029|FG000|Part 2|Lost to Follow-up|0|||
129937836|NCT01574716|467738030|FG001|Part 2|Lost to Follow-up|0|||
129937837|NCT01574716|467738031|FG002|Part 2|Lost to Follow-up|0|||
129937838|NCT01574716|467738032|FG003|Part 2|Lost to Follow-up|3|||
129937839|NCT01574716|467738033|FG004|Part 2|Lost to Follow-up|0|||
129937840|NCT02438137|467738034|FG000|Overall Study|Lost to Follow-up|3|||
129937841|NCT02438137|467738035|FG001|Overall Study|Lost to Follow-up|2|||
129937842|NCT02438137|467738034|FG000|Overall Study|Adverse Event|1|||
129937843|NCT02438137|467738035|FG001|Overall Study|Adverse Event|0|||
129937844|NCT02438137|467738034|FG000|Overall Study|Withdrawal by Subject|4|||
129937845|NCT02438137|467738035|FG001|Overall Study|Withdrawal by Subject|3|||
129937846|NCT02438137|467738034|FG000|Overall Study|Physician Decision|0|||
129937847|NCT02438137|467738035|FG001|Overall Study|Physician Decision|1|||
129937848|NCT01637402|467738037|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
129937849|NCT01637402|467738038|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
129937850|NCT01637402|467738037|FG000|Standard Dose Regimen|Adverse Event|1|||
129937851|NCT01637402|467738038|FG001|Standard Dose Regimen|Adverse Event|0|||
129937852|NCT01637402|467738037|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
129937853|NCT01637402|467738038|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
129937854|NCT01637402|467738037|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
129937855|NCT01637402|467738038|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
129937856|NCT01637402|467738037|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
129937857|NCT01637402|467738038|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
129937858|NCT01637402|467738037|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
129937859|NCT01637402|467738038|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
129937860|NCT02285270|467738039|FG000|Overall Study|Lost to Follow-up|1|||
129937861|NCT02285270|467738039|FG000|Overall Study|Physician Decision|3|||
129937862|NCT02285270|467738039|FG000|Overall Study|Determined to be ineligible|1|||
129937863|NCT03621735|467738040|FG000|Overall Study|Withdrawal by Subject|13|||
129937864|NCT03621735|467738041|FG001|Overall Study|Withdrawal by Subject|13|||
129937865|NCT01627561|467738047|FG000|Overall Study|Lost to Follow-up|1|||
129937866|NCT01627561|467738048|FG001|Overall Study|Lost to Follow-up|0|||
129937867|NCT01627561|467738047|FG000|Overall Study|Withdrawal by Subject|0|||
129937868|NCT01627561|467738048|FG001|Overall Study|Withdrawal by Subject|1|||
129937869|NCT01627561|467738047|FG000|Overall Study|Migrated/moved from study area|0|||
129937870|NCT01627561|467738048|FG001|Overall Study|Migrated/moved from study area|2|||
129937871|NCT00890591|467738050|FG000|Overall Study|Lack of Efficacy|20|||
129937872|NCT01579318|467738055|FG000|Overall Study|Disease Progression|1|||
129937873|NCT02347332|467738056|FG000|Overall Study|Not treated|5|||
129937874|NCT02347332|467738057|FG001|Overall Study|Not treated|2|||
130071069|NCT00233324|468215993|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
130071070|NCT00233324|468215994|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
129937875|NCT02347332|467738056|FG000|Overall Study|Progressive disease|141|||
129937876|NCT02347332|467738057|FG001|Overall Study|Progressive disease|159|||
129937877|NCT02347332|467738056|FG000|Overall Study|Adverse Event|50|||
129937878|NCT02347332|467738057|FG001|Overall Study|Adverse Event|41|||
129937879|NCT02347332|467738056|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
129937880|NCT02347332|467738057|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
129937881|NCT02347332|467738056|FG000|Overall Study|Protocol Violation|1|||
129937882|NCT02347332|467738057|FG001|Overall Study|Protocol Violation|1|||
129937883|NCT02347332|467738056|FG000|Overall Study|Lost to Follow-up|2|||
129937884|NCT02347332|467738057|FG001|Overall Study|Lost to Follow-up|1|||
129937885|NCT02347332|467738056|FG000|Overall Study|Physician Decision|4|||
129937886|NCT02347332|467738057|FG001|Overall Study|Physician Decision|3|||
129937887|NCT02347332|467738056|FG000|Overall Study|Withdrawal by Subject|20|||
129937888|NCT02347332|467738057|FG001|Overall Study|Withdrawal by Subject|14|||
129937889|NCT02347332|467738056|FG000|Overall Study|Protocol requirement|1|||
129937890|NCT02347332|467738057|FG001|Overall Study|Protocol requirement|1|||
129937891|NCT02347332|467738056|FG000|Overall Study|Switch Post-Trial program|0|||
129937892|NCT02347332|467738057|FG001|Overall Study|Switch Post-Trial program|1|||
129937893|NCT00112359|467738058|FG000|Overall Study|Unrelated adverse event|16|||
129937894|NCT00112359|467738059|FG001|Overall Study|Unrelated adverse event|8|||
129937895|NCT00112359|467738058|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
129937896|NCT00112359|467738059|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
129937897|NCT00112359|467738058|FG000|Overall Study|Related adverse event|5|||
129937898|NCT00112359|467738059|FG001|Overall Study|Related adverse event|3|||
129937899|NCT00112359|467738058|FG000|Overall Study|Lost to Follow-up|0|||
129937900|NCT00112359|467738059|FG001|Overall Study|Lost to Follow-up|1|||
129937901|NCT00112359|467738058|FG000|Overall Study|Personal/administrative|1|||
129937902|NCT00112359|467738059|FG001|Overall Study|Personal/administrative|1|||
129937903|NCT00112359|467738058|FG000|Overall Study|Other|3|||
129937904|NCT00112359|467738059|FG001|Overall Study|Other|0|||
129937905|NCT01988402|467738060|FG000|Overall Study|Adverse Event|1|||
129937906|NCT01988402|467738061|FG001|Overall Study|Adverse Event|2|||
129937907|NCT01988402|467738060|FG000|Overall Study|Withdrawal by Subject|1|||
129937908|NCT01988402|467738061|FG001|Overall Study|Withdrawal by Subject|0|||
129937909|NCT01961609|467738062|FG000|Initiation|Missing|3|||
129937910|NCT01961609|467738063|FG001|Initiation|Missing|2|||
129937911|NCT01961609|467738064|FG002|Initiation|Missing|0|||
129937912|NCT01961609|467738065|FG003|Initiation|Missing|0|||
129937913|NCT01961609|467738062|FG000|Initiation|Protocol deviation|1|||
129937914|NCT01961609|467738063|FG001|Initiation|Protocol deviation|0|||
129937915|NCT01961609|467738064|FG002|Initiation|Protocol deviation|0|||
129937916|NCT01961609|467738065|FG003|Initiation|Protocol deviation|0|||
129937917|NCT01961609|467738062|FG000|Initiation|Death|0|||
129937918|NCT01961609|467738063|FG001|Initiation|Death|1|||
129937919|NCT01961609|467738064|FG002|Initiation|Death|0|||
129937920|NCT01961609|467738065|FG003|Initiation|Death|0|||
129937921|NCT01961609|467738062|FG000|Initiation|Administrative problems|1|||
129937922|NCT01961609|467738063|FG001|Initiation|Administrative problems|0|||
129937923|NCT01961609|467738064|FG002|Initiation|Administrative problems|0|||
129937924|NCT01961609|467738065|FG003|Initiation|Administrative problems|0|||
129937925|NCT01961609|467738062|FG000|Initiation|Withdrawal by Subject|1|||
129937926|NCT01961609|467738063|FG001|Initiation|Withdrawal by Subject|2|||
129937927|NCT01961609|467738064|FG002|Initiation|Withdrawal by Subject|0|||
129937928|NCT01961609|467738065|FG003|Initiation|Withdrawal by Subject|0|||
129937929|NCT01961609|467738062|FG000|Initiation|Lack of Efficacy|2|||
129937930|NCT01961609|467738063|FG001|Initiation|Lack of Efficacy|1|||
129937931|NCT01961609|467738064|FG002|Initiation|Lack of Efficacy|0|||
129937932|NCT01961609|467738065|FG003|Initiation|Lack of Efficacy|0|||
129937933|NCT01961609|467738062|FG000|Initiation|Abnormal lab values|0|||
129937934|NCT01961609|467738063|FG001|Initiation|Abnormal lab values|1|||
129937935|NCT01961609|467738064|FG002|Initiation|Abnormal lab values|0|||
129937936|NCT01961609|467738065|FG003|Initiation|Abnormal lab values|0|||
129937937|NCT01961609|467738062|FG000|Initiation|Adverse Event|3|||
129937938|NCT01961609|467738063|FG001|Initiation|Adverse Event|5|||
129937939|NCT01961609|467738064|FG002|Initiation|Adverse Event|0|||
129937940|NCT01961609|467738065|FG003|Initiation|Adverse Event|0|||
129937941|NCT01961609|467738062|FG000|Initiation|Randomized but not treated|1|||
129937942|NCT01961609|467738063|FG001|Initiation|Randomized but not treated|1|||
129937943|NCT01961609|467738064|FG002|Initiation|Randomized but not treated|0|||
129937944|NCT01961609|467738065|FG003|Initiation|Randomized but not treated|0|||
129937945|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
129937946|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
129937947|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
129937948|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
129937949|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
129937950|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
129937951|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
129937952|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
129937953|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
129937954|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
129937955|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
129937956|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
129937957|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
129937958|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
129937959|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
129937960|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
129937961|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
129937962|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
129937963|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
129937964|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
129937965|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
129937966|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
130119642|NCT01215942|468398418|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
130119643|NCT01215942|468398419|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
130119644|NCT01215942|468398418|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
130119645|NCT01215942|468398419|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
130119646|NCT03305055|468398420|FG000|Overall Study|Withdrawal by Subject|0|||
130119647|NCT03305055|468398421|FG001|Overall Study|Withdrawal by Subject|1|||
130119648|NCT03305055|468398420|FG000|Overall Study|Adverse Event|1|||
130071071|NCT00233324|468215991|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
130071072|NCT00233324|468215992|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
130071073|NCT00233324|468215993|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
130071074|NCT00233324|468215994|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
130071075|NCT03170258|468216000|FG000|Overall Study|Physician Decision|4|||
130071076|NCT03170258|468216001|FG001|Overall Study|Physician Decision|0|||
130071077|NCT03170258|468216000|FG000|Overall Study|Equipment issues|1|||
130071078|NCT03170258|468216001|FG001|Overall Study|Equipment issues|0|||
130071079|NCT03170258|468216000|FG000|Overall Study|Medication|1|||
130071080|NCT03170258|468216001|FG001|Overall Study|Medication|0|||
130071081|NCT03170258|468216000|FG000|Overall Study|Sleep issues|1|||
130071082|NCT03170258|468216001|FG001|Overall Study|Sleep issues|0|||
130071083|NCT01563107|468216002|FG000|Overall Study|Physician Decision|0|||
130071084|NCT01563107|468216003|FG001|Overall Study|Physician Decision|1|||
130071085|NCT01563107|468216004|FG002|Overall Study|Physician Decision|1|||
130071086|NCT01563107|468216005|FG003|Overall Study|Physician Decision|3|||
130071087|NCT01563107|468216002|FG000|Overall Study|Withdrawal by Subject|1|||
130071088|NCT01563107|468216003|FG001|Overall Study|Withdrawal by Subject|2|||
130071089|NCT01563107|468216004|FG002|Overall Study|Withdrawal by Subject|1|||
130071090|NCT01563107|468216005|FG003|Overall Study|Withdrawal by Subject|2|||
130071091|NCT00247273|468216009|FG000|Overall Study|Adverse Event|85|||
130071092|NCT00247273|468216010|FG001|Overall Study|Adverse Event|80|||
130071093|NCT00247273|468216009|FG000|Overall Study|Physician Decision|6|||
130071094|NCT00247273|468216010|FG001|Overall Study|Physician Decision|3|||
130071095|NCT00247273|468216009|FG000|Overall Study|Lost to Follow-up|7|||
130071096|NCT00247273|468216010|FG001|Overall Study|Lost to Follow-up|7|||
130071097|NCT00247273|468216009|FG000|Overall Study|Withdrawal by Subject|46|||
130071098|NCT00247273|468216010|FG001|Overall Study|Withdrawal by Subject|47|||
130071099|NCT00247273|468216009|FG000|Overall Study|Did not take any study drug|2|||
130071100|NCT00247273|468216010|FG001|Overall Study|Did not take any study drug|0|||
130071101|NCT01419015|468216012|FG000|Overall Study|Death|2|||
130071102|NCT03276572|468216014|FG000|Overall Study|In follow-up|0|||
130071103|NCT03276572|468216015|FG001|Overall Study|In follow-up|0|||
130071104|NCT03276572|468216016|FG002|Overall Study|In follow-up|0|||
130071105|NCT03276572|468216017|FG003|Overall Study|In follow-up|0|||
130071106|NCT03276572|468216018|FG004|Overall Study|In follow-up|0|||
130071107|NCT03276572|468216019|FG005|Overall Study|In follow-up|1|||
130071108|NCT03276572|468216020|FG006|Overall Study|In follow-up|1|||
130071109|NCT03276572|468216014|FG000|Overall Study|Lost to Follow-up|0|||
130071110|NCT03276572|468216015|FG001|Overall Study|Lost to Follow-up|0|||
130071111|NCT03276572|468216016|FG002|Overall Study|Lost to Follow-up|0|||
130071112|NCT03276572|468216017|FG003|Overall Study|Lost to Follow-up|0|||
130071113|NCT03276572|468216018|FG004|Overall Study|Lost to Follow-up|0|||
130071114|NCT03276572|468216019|FG005|Overall Study|Lost to Follow-up|0|||
130071115|NCT03276572|468216020|FG006|Overall Study|Lost to Follow-up|1|||
130071116|NCT01527110|468216021|FG000|Overall Study|Adverse Event|1|||
130071117|NCT01709708|468216022|FG000|Overall Study|Protocol Violation|1|||
130071118|NCT01709708|468216023|FG001|Overall Study|Protocol Violation|2|||
130071119|NCT00527072|468216024|FG000|Overall Study|Adverse Event|13|||
130071120|NCT00527072|468216024|FG000|Overall Study|Lack of Efficacy|11|||
130071121|NCT00527072|468216024|FG000|Overall Study|Lost to Follow-up|3|||
130071122|NCT00527072|468216024|FG000|Overall Study|Protocol Violation|2|||
130071123|NCT00527072|468216024|FG000|Overall Study|Withdrawal by Subject|7|||
130071124|NCT02657434|468216025|FG000|Overall Study|Study Terminated By Sponsor|64|||
130071125|NCT02657434|468216026|FG001|Overall Study|Study Terminated By Sponsor|82|||
130071126|NCT02657434|468216025|FG000|Overall Study|Death|189|||
130071127|NCT02657434|468216026|FG001|Overall Study|Death|190|||
130071128|NCT02657434|468216025|FG000|Overall Study|Lost to Follow-up|2|||
130071129|NCT02657434|468216026|FG001|Overall Study|Lost to Follow-up|2|||
130071130|NCT02657434|468216025|FG000|Overall Study|Randomization by Error|2|||
130071131|NCT02657434|468216026|FG001|Overall Study|Randomization by Error|0|||
130071132|NCT02657434|468216025|FG000|Overall Study|Withdrawal by Subject|28|||
130071133|NCT02657434|468216026|FG001|Overall Study|Withdrawal by Subject|17|||
130071134|NCT02657434|468216025|FG000|Overall Study|Protocol Violation|1|||
130071135|NCT02657434|468216026|FG001|Overall Study|Protocol Violation|0|||
130071136|NCT02657434|468216025|FG000|Overall Study|Physician Decision|0|||
130071137|NCT02657434|468216026|FG001|Overall Study|Physician Decision|1|||
130071138|NCT01628393|468216029|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
130071139|NCT01628393|468216030|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129937967|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
129937968|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
129937969|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
129937970|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
129937971|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
129937972|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
129937973|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
129937974|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
130071140|NCT01628393|468216031|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130071141|NCT01628393|468216032|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130071142|NCT01628393|468216033|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
130071143|NCT01628393|468216029|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
130071144|NCT01628393|468216030|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
130071145|NCT01628393|468216031|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
130071146|NCT01628393|468216032|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
130071147|NCT01628393|468216033|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
130071148|NCT01628393|468216029|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
130071149|NCT01628393|468216030|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
130071150|NCT01628393|468216031|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
130071151|NCT01628393|468216032|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130071152|NCT01628393|468216033|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
130071153|NCT01628393|468216029|FG000|Blinded Active Extension Period|Adverse Event|0|||
130071154|NCT01628393|468216030|FG001|Blinded Active Extension Period|Adverse Event|1|||
130071155|NCT01628393|468216031|FG002|Blinded Active Extension Period|Adverse Event|0|||
130071156|NCT01628393|468216032|FG003|Blinded Active Extension Period|Adverse Event|2|||
130071157|NCT01628393|468216033|FG004|Blinded Active Extension Period|Adverse Event|2|||
130071158|NCT01628393|468216029|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
130071159|NCT01628393|468216030|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
130071160|NCT01628393|468216031|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
130071161|NCT01628393|468216032|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
130071162|NCT01628393|468216033|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
130071163|NCT01628393|468216029|FG000|Blinded Active Extension Period|Physician Decision|0|||
130071164|NCT01628393|468216030|FG001|Blinded Active Extension Period|Physician Decision|3|||
130071165|NCT01628393|468216031|FG002|Blinded Active Extension Period|Physician Decision|0|||
130071166|NCT01628393|468216032|FG003|Blinded Active Extension Period|Physician Decision|1|||
130071167|NCT01628393|468216033|FG004|Blinded Active Extension Period|Physician Decision|0|||
130071168|NCT01628393|468216029|FG000|Blinded Active Extension Period|Protocol Violation|0|||
130071169|NCT01628393|468216030|FG001|Blinded Active Extension Period|Protocol Violation|0|||
130071170|NCT01628393|468216031|FG002|Blinded Active Extension Period|Protocol Violation|2|||
130071171|NCT01628393|468216032|FG003|Blinded Active Extension Period|Protocol Violation|1|||
130071172|NCT01628393|468216033|FG004|Blinded Active Extension Period|Protocol Violation|0|||
130071173|NCT01628393|468216029|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
130071174|NCT01628393|468216030|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
130071175|NCT01628393|468216031|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
130071176|NCT01628393|468216032|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
130071177|NCT01628393|468216033|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
130071178|NCT01369225|468216041|FG000|Overall Study|Withdrawal by Subject|1|||
130071179|NCT01369225|468216042|FG001|Overall Study|Withdrawal by Subject|0|||
130071180|NCT01369225|468216043|FG002|Overall Study|Withdrawal by Subject|2|||
130071181|NCT01369225|468216044|FG003|Overall Study|Withdrawal by Subject|1|||
130071182|NCT01369225|468216045|FG004|Overall Study|Withdrawal by Subject|0|||
130071183|NCT01369225|468216046|FG005|Overall Study|Withdrawal by Subject|0|||
130071184|NCT01369225|468216041|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
130071185|NCT01369225|468216042|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
130071186|NCT01369225|468216043|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
130071187|NCT01369225|468216044|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
130071188|NCT01369225|468216045|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
130071189|NCT01369225|468216046|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
130071190|NCT01369225|468216041|FG000|Overall Study|Other|1|||
130071191|NCT01369225|468216042|FG001|Overall Study|Other|0|||
130071192|NCT01369225|468216043|FG002|Overall Study|Other|0|||
130071193|NCT01369225|468216044|FG003|Overall Study|Other|0|||
130071194|NCT01369225|468216045|FG004|Overall Study|Other|1|||
130071195|NCT01369225|468216046|FG005|Overall Study|Other|0|||
130071196|NCT01369225|468216041|FG000|Overall Study|Adverse Event|0|||
130071197|NCT01369225|468216042|FG001|Overall Study|Adverse Event|0|||
130071198|NCT01369225|468216043|FG002|Overall Study|Adverse Event|0|||
130071199|NCT01369225|468216044|FG003|Overall Study|Adverse Event|1|||
130071200|NCT01369225|468216045|FG004|Overall Study|Adverse Event|1|||
130071201|NCT01369225|468216046|FG005|Overall Study|Adverse Event|0|||
130071202|NCT00105183|468216047|FG000|Overall Study|Death|19|||
129937975|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
129937976|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
129937977|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
129937978|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
129937979|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
129937980|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
129937981|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
129937982|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
129937983|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
129937984|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
129937985|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
129937986|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
129937987|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
129937988|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
129937989|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
129937990|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
129937991|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
129937992|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
129937993|NCT01211184|467738068|FG000|Overall Study|Withdrawal by Subject|0|||
129937994|NCT01211184|467738069|FG001|Overall Study|Withdrawal by Subject|2|||
129937995|NCT01211184|467738070|FG002|Overall Study|Withdrawal by Subject|1|||
129937996|NCT04060212|467738071|FG000|Overall Study|Withdrawal by Subject|7|||
129937997|NCT02844439|467738073|FG000|Overall Study|Withdrawal by Subject|1|||
129937998|NCT02844439|467738073|FG000|Overall Study|Lost to Follow-up|2|||
129937999|NCT02844439|467738073|FG000|Overall Study|Termination by Sponsor|4|||
129938000|NCT02844439|467738073|FG000|Overall Study|Death|28|||
129938001|NCT02844439|467738073|FG000|Overall Study|Other|5|||
129938002|NCT03170648|467738078|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
129938003|NCT03170648|467738078|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
129938004|NCT03509909|467738079|FG000|Overall Study|Withdrawal by Subject|16|||
129938005|NCT03509909|467738080|FG001|Overall Study|Withdrawal by Subject|9|||
129938006|NCT03509909|467738079|FG000|Overall Study|Lost to Follow-up|3|||
129938007|NCT03509909|467738080|FG001|Overall Study|Lost to Follow-up|4|||
129938008|NCT03509909|467738079|FG000|Overall Study|Adverse Event|2|||
129938009|NCT03509909|467738080|FG001|Overall Study|Adverse Event|0|||
129938010|NCT03500549|467738081|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
129938011|NCT03500549|467738082|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
129938012|NCT03500549|467738081|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
129938013|NCT03500549|467738082|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
129938014|NCT02107261|467738083|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
129938015|NCT02107261|467738084|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
129938016|NCT02107261|467738083|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
129938017|NCT02107261|467738084|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
129938018|NCT04337931|467738086|FG000|Overall Study|Death|4|||
129938019|NCT04337931|467738087|FG001|Overall Study|Death|1|||
129938020|NCT04337931|467738088|FG002|Overall Study|Death|7|||
129938021|NCT04337931|467738086|FG000|Overall Study|Withdrawal by Subject|0|||
129938022|NCT04337931|467738087|FG001|Overall Study|Withdrawal by Subject|1|||
129938023|NCT04337931|467738088|FG002|Overall Study|Withdrawal by Subject|0|||
129938024|NCT04337931|467738086|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
129938025|NCT04337931|467738087|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
129938026|NCT04337931|467738088|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
129938027|NCT04337931|467738086|FG000|Overall Study|Study terminated by sponsor|3|||
129938028|NCT04337931|467738087|FG001|Overall Study|Study terminated by sponsor|6|||
129938029|NCT04337931|467738088|FG002|Overall Study|Study terminated by sponsor|2|||
129938030|NCT04337931|467738086|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
129938031|NCT04337931|467738087|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
129938032|NCT04337931|467738088|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
129938033|NCT04337931|467738086|FG000|Overall Study|Colorectal cancer treatment|1|||
129938034|NCT04337931|467738087|FG001|Overall Study|Colorectal cancer treatment|0|||
129938035|NCT04337931|467738088|FG002|Overall Study|Colorectal cancer treatment|0|||
129938036|NCT04337931|467738086|FG000|Overall Study|Participant decision|0|||
130071203|NCT00105183|468216048|FG001|Overall Study|Death|13|||
129938037|NCT04337931|467738087|FG001|Overall Study|Participant decision|1|||
129938038|NCT04337931|467738088|FG002|Overall Study|Participant decision|0|||
129938039|NCT04436289|467738089|FG000|Overall Study|Death prior to hospital discharge|8|||
129938040|NCT04436289|467738090|FG001|Overall Study|Death prior to hospital discharge|5|||
129938041|NCT04436289|467738091|FG002|Overall Study|Death prior to hospital discharge|0|||
129938042|NCT04436289|467738092|FG003|Overall Study|Death prior to hospital discharge|1|||
129938043|NCT04436289|467738089|FG000|Overall Study|Withdrawal by Subject|0|||
129938044|NCT04436289|467738090|FG001|Overall Study|Withdrawal by Subject|1|||
129938045|NCT04436289|467738091|FG002|Overall Study|Withdrawal by Subject|4|||
129938046|NCT04436289|467738092|FG003|Overall Study|Withdrawal by Subject|0|||
129938047|NCT04436289|467738089|FG000|Overall Study|Extended hospital stay|0|||
129938048|NCT04436289|467738090|FG001|Overall Study|Extended hospital stay|1|||
129938049|NCT04436289|467738091|FG002|Overall Study|Extended hospital stay|0|||
129938050|NCT04436289|467738092|FG003|Overall Study|Extended hospital stay|0|||
129938051|NCT04436289|467738089|FG000|Overall Study|Lost to Follow-up|0|||
129938052|NCT04436289|467738090|FG001|Overall Study|Lost to Follow-up|4|||
129938053|NCT04436289|467738091|FG002|Overall Study|Lost to Follow-up|1|||
129938054|NCT04436289|467738092|FG003|Overall Study|Lost to Follow-up|3|||
129938055|NCT02928172|467738093|FG000|Overall Study|Device did not record data|1|||
129938056|NCT04066075|467738094|FG000|Overall Study|Lost to Follow-up|3|||
129938057|NCT04066075|467738095|FG001|Overall Study|Lost to Follow-up|3|||
129938058|NCT04066075|467738094|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
129938059|NCT04066075|467738095|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
129938060|NCT04066075|467738094|FG000|Overall Study|Withdrawal by Subject|2|||
129938061|NCT04066075|467738095|FG001|Overall Study|Withdrawal by Subject|2|||
129938062|NCT00309166|467738096|FG000|Overall Study|Adverse event, non-fatal|1|||
129938063|NCT00309166|467738097|FG001|Overall Study|Adverse event, non-fatal|0|||
129938064|NCT00309166|467738096|FG000|Overall Study|Withdrawal by Subject|4|||
129938065|NCT00309166|467738097|FG001|Overall Study|Withdrawal by Subject|3|||
129938066|NCT05139992|467738100|FG000|Overall Study|Withdrawal by Subject|12|||
129938067|NCT05139992|467738100|FG000|Overall Study|Lost to Follow-up|6|||
129938068|NCT04305327|467738101|FG000|Overall Study|Study early termination|2|||
129938069|NCT04305327|467738102|FG001|Overall Study|Study early termination|5|||
129938070|NCT04305327|467738103|FG002|Overall Study|Study early termination|2|||
129938071|NCT04305327|467738104|FG003|Overall Study|Study early termination|2|||
129938072|NCT04305327|467738101|FG000|Overall Study|Withdrawal by Subject|0|||
129938073|NCT04305327|467738102|FG001|Overall Study|Withdrawal by Subject|1|||
129938074|NCT04305327|467738103|FG002|Overall Study|Withdrawal by Subject|0|||
129938075|NCT04305327|467738104|FG003|Overall Study|Withdrawal by Subject|0|||
129938076|NCT00747565|467738105|FG000|Overall Study|Withdrawal by Subject|10|||
129938077|NCT00747565|467738106|FG001|Overall Study|Withdrawal by Subject|6|||
129938078|NCT00747565|467738105|FG000|Overall Study|Lost to Follow-up|4|||
129938079|NCT00747565|467738106|FG001|Overall Study|Lost to Follow-up|1|||
129938080|NCT03777657|467738107|FG000|Overall Study|Death|397|||
129938081|NCT03777657|467738108|FG001|Overall Study|Death|431|||
129938082|NCT03777657|467738107|FG000|Overall Study|Study Closed by Sponsor|77|||
129938083|NCT03777657|467738108|FG001|Overall Study|Study Closed by Sponsor|38|||
129938084|NCT03777657|467738107|FG000|Overall Study|Withdrawal by Subject|20|||
129938085|NCT03777657|467738108|FG001|Overall Study|Withdrawal by Subject|17|||
129938086|NCT03777657|467738107|FG000|Overall Study|Lost to Follow-up|6|||
129938087|NCT03777657|467738108|FG001|Overall Study|Lost to Follow-up|10|||
129938088|NCT05464732|467738111|FG000|Overall Study|Lost to Follow-up|0|||
129938089|NCT05464732|467738112|FG001|Overall Study|Lost to Follow-up|1|||
129938090|NCT05464732|467738111|FG000|Overall Study|Adverse Event|1|||
129938091|NCT05464732|467738112|FG001|Overall Study|Adverse Event|0|||
129938092|NCT00593840|467738115|FG000|Overall Study|Withdrawal by Subject|1|||
129938093|NCT00655499|467739183|FG000|Overall Study|not eligible|4|||
129938094|NCT04213807|467739190|FG000|Overall Study|Physician Decision|0|||
129938095|NCT04213807|467739191|FG001|Overall Study|Physician Decision|0|||
129938096|NCT04213807|467739192|FG002|Overall Study|Physician Decision|1|||
129938097|NCT02185794|467739194|FG000|Overall Study|Enrolled but Never Dosed|1|||
129938098|NCT02185794|467739195|FG001|Overall Study|Enrolled but Never Dosed|6|||
129938099|NCT02185794|467739196|FG002|Overall Study|Enrolled but Never Dosed|3|||
129938100|NCT02185794|467739197|FG003|Overall Study|Enrolled but Never Dosed|1|||
129938101|NCT02185794|467739198|FG004|Overall Study|Enrolled but Never Dosed|1|||
129938102|NCT02185794|467739199|FG005|Overall Study|Enrolled but Never Dosed|0|||
129938103|NCT02185794|467739194|FG000|Overall Study|Investigator's Discretion|1|||
129938104|NCT02185794|467739195|FG001|Overall Study|Investigator's Discretion|0|||
129938105|NCT02185794|467739196|FG002|Overall Study|Investigator's Discretion|1|||
129938106|NCT02185794|467739197|FG003|Overall Study|Investigator's Discretion|2|||
129938107|NCT02185794|467739198|FG004|Overall Study|Investigator's Discretion|2|||
129938108|NCT02185794|467739199|FG005|Overall Study|Investigator's Discretion|15|||
129938109|NCT02185794|467739194|FG000|Overall Study|Withdrew Consent|2|||
129938110|NCT02185794|467739195|FG001|Overall Study|Withdrew Consent|5|||
129938111|NCT02185794|467739196|FG002|Overall Study|Withdrew Consent|10|||
129938112|NCT02185794|467739197|FG003|Overall Study|Withdrew Consent|2|||
129938113|NCT02185794|467739198|FG004|Overall Study|Withdrew Consent|0|||
129938114|NCT02185794|467739199|FG005|Overall Study|Withdrew Consent|0|||
129938115|NCT02185794|467739194|FG000|Overall Study|Lost to Follow-up|1|||
129938116|NCT02185794|467739195|FG001|Overall Study|Lost to Follow-up|2|||
129938117|NCT02185794|467739196|FG002|Overall Study|Lost to Follow-up|2|||
129938118|NCT02185794|467739197|FG003|Overall Study|Lost to Follow-up|3|||
129938119|NCT02185794|467739198|FG004|Overall Study|Lost to Follow-up|0|||
129938120|NCT02185794|467739199|FG005|Overall Study|Lost to Follow-up|1|||
129938121|NCT00777049|467739200|FG000|Overall Study|Withdrawal by Subject|1|||
129938122|NCT00777049|467739201|FG001|Overall Study|Withdrawal by Subject|0|||
130119649|NCT03305055|468398421|FG001|Overall Study|Adverse Event|1|||
130119650|NCT01047345|468398426|FG000|Base Study|Adverse Event|3|||
130119651|NCT01047345|468398427|FG001|Base Study|Adverse Event|0|||
130119652|NCT01047345|468398428|FG002|Base Study|Adverse Event|0|||
130119653|NCT01047345|468398426|FG000|Base Study|Lost to Follow-up|4|||
130119654|NCT01047345|468398427|FG001|Base Study|Lost to Follow-up|1|||
130119655|NCT01047345|468398428|FG002|Base Study|Lost to Follow-up|0|||
130119656|NCT01047345|468398426|FG000|Base Study|Protocol Violation|3|||
130119657|NCT01047345|468398427|FG001|Base Study|Protocol Violation|1|||
130119658|NCT01047345|468398428|FG002|Base Study|Protocol Violation|0|||
130119659|NCT01047345|468398426|FG000|Base Study|Withdrawal by Subject|12|||
130119660|NCT01047345|468398427|FG001|Base Study|Withdrawal by Subject|4|||
130119661|NCT01047345|468398428|FG002|Base Study|Withdrawal by Subject|0|||
130119662|NCT01047345|468398426|FG000|Extension|Withdrawal by Subject|0|||
130119663|NCT01047345|468398427|FG001|Extension|Withdrawal by Subject|0|||
130119664|NCT01047345|468398428|FG002|Extension|Withdrawal by Subject|1|||
130119665|NCT01047345|468398426|FG000|Extension|Lost to Follow-up|0|||
130119666|NCT01047345|468398427|FG001|Extension|Lost to Follow-up|0|||
130119667|NCT01047345|468398428|FG002|Extension|Lost to Follow-up|5|||
130119668|NCT01816477|468398429|FG000|Overall Study|Withdrawal by Subject|13|||
130119669|NCT01816477|468398430|FG001|Overall Study|Withdrawal by Subject|1|||
130119670|NCT01816477|468398429|FG000|Overall Study|Unable to tolerate catheter placement|3|||
130119671|NCT01816477|468398430|FG001|Overall Study|Unable to tolerate catheter placement|0|||
130119672|NCT00819247|468398433|FG000|Overall Study|Adverse Event|0|||
130119673|NCT00819247|468398434|FG001|Overall Study|Adverse Event|5|||
130119674|NCT00819247|468398435|FG002|Overall Study|Adverse Event|3|||
130119675|NCT00819247|468398433|FG000|Overall Study|Insufficient testosterone response|5|||
130119676|NCT00819247|468398434|FG001|Overall Study|Insufficient testosterone response|8|||
130119677|NCT00819247|468398435|FG002|Overall Study|Insufficient testosterone response|10|||
130119678|NCT00819247|468398433|FG000|Overall Study|Withdrawal by Subject|1|||
130119679|NCT00819247|468398434|FG001|Overall Study|Withdrawal by Subject|0|||
130119680|NCT00819247|468398435|FG002|Overall Study|Withdrawal by Subject|0|||
130119681|NCT00819247|468398433|FG000|Overall Study|Protocol Violation|1|||
130119682|NCT00819247|468398434|FG001|Overall Study|Protocol Violation|0|||
130119683|NCT00819247|468398435|FG002|Overall Study|Protocol Violation|1|||
130119684|NCT00819247|468398433|FG000|Overall Study|Mistakenly withdrawn|0|||
130119685|NCT00819247|468398434|FG001|Overall Study|Mistakenly withdrawn|1|||
130119686|NCT00819247|468398435|FG002|Overall Study|Mistakenly withdrawn|0|||
130119687|NCT00819247|468398433|FG000|Overall Study|Bad prostate-specific antigen response|3|||
130119688|NCT00819247|468398434|FG001|Overall Study|Bad prostate-specific antigen response|2|||
130119689|NCT00819247|468398435|FG002|Overall Study|Bad prostate-specific antigen response|0|||
130119690|NCT00819247|468398433|FG000|Overall Study|Other|1|||
130119691|NCT00819247|468398434|FG001|Overall Study|Other|0|||
130119692|NCT00819247|468398435|FG002|Overall Study|Other|0|||
130119693|NCT00282256|468398436|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
130119694|NCT00282256|468398436|FG000|Extension Treatment Period|Adverse Event|2|||
130119695|NCT02626949|468398441|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
130119696|NCT02626949|468398442|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
130119697|NCT02626949|468398441|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
130119698|NCT02626949|468398442|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
130119699|NCT02626949|468398441|FG000|Enrolled|Lost to Follow-up|7|||
130119700|NCT02626949|468398442|FG001|Enrolled|Lost to Follow-up|6|||
130119701|NCT02626949|468398441|FG000|Enrolled|Withdrawal by Subject|3|||
130119702|NCT02626949|468398442|FG001|Enrolled|Withdrawal by Subject|2|||
130119703|NCT00329602|468398444|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
130119704|NCT00329602|468398445|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
130119705|NCT00329602|468398446|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
130119706|NCT00329602|468398444|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
130119707|NCT00329602|468398445|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
130119708|NCT00329602|468398446|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
130119709|NCT00329602|468398444|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
130119710|NCT00329602|468398445|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
130119711|NCT00329602|468398446|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
130119712|NCT00329602|468398444|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
130119713|NCT00329602|468398445|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
130119714|NCT00329602|468398446|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
130119715|NCT00329602|468398444|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
130119716|NCT00329602|468398445|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
130119717|NCT00329602|468398446|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
130119718|NCT00329602|468398444|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
129938123|NCT00777049|467739200|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
129938124|NCT00777049|467739201|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
129938125|NCT00246805|467739202|FG000|Phase 1|Lost to Follow-up|1|||
129938126|NCT00246805|467739203|FG001|Phase 1|Lost to Follow-up|0|||
129938127|NCT00609869|467739204|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
129938128|NCT00609869|467739204|FG000|Overall Study|Severe hematologic toxicity|1|||
129938129|NCT00609869|467739204|FG000|Overall Study|Withdrawal by Subject|1|||
129938130|NCT00609869|467739204|FG000|Overall Study|Seizures|1|||
129938131|NCT00609869|467739204|FG000|Overall Study|Severe tumor flare reaction|1|||
129938132|NCT00609869|467739204|FG000|Overall Study|Hepatitis B infection|1|||
129938133|NCT00609869|467739204|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
129938134|NCT00609869|467739204|FG000|Overall Study|Mantle cell: not evaluable|4|||
129938135|NCT00724126|467739205|FG000|Overall Study|Adverse Event|2|||
129938136|NCT00724126|467739206|FG001|Overall Study|Adverse Event|0|||
129938137|NCT00724126|467739205|FG000|Overall Study|Withdrawal by Subject|8|||
129938138|NCT00724126|467739206|FG001|Overall Study|Withdrawal by Subject|6|||
129938139|NCT00724126|467739205|FG000|Overall Study|Lost to Follow-up|6|||
129938140|NCT00724126|467739206|FG001|Overall Study|Lost to Follow-up|6|||
129938141|NCT00724126|467739205|FG000|Overall Study|Noncompliance|2|||
129938142|NCT00724126|467739206|FG001|Overall Study|Noncompliance|1|||
129938143|NCT00724126|467739205|FG000|Overall Study|Subject randomized although ineligible|1|||
129938144|NCT00724126|467739206|FG001|Overall Study|Subject randomized although ineligible|1|||
129938145|NCT00724126|467739205|FG000|Overall Study|Subject had to leave vicinity of site|0|||
129938146|NCT00724126|467739206|FG001|Overall Study|Subject had to leave vicinity of site|1|||
129938147|NCT00739934|467739207|FG000|Voriconazole IV|Adverse Event|6|||
129938148|NCT00739934|467739207|FG000|Voriconazole Oral|Other|3|||
129938149|NCT02502526|467739210|FG000|Overall Study|Lost to Follow-up|2|||
129938150|NCT02502526|467739211|FG001|Overall Study|Lost to Follow-up|2|||
129938151|NCT02502526|467739212|FG002|Overall Study|Lost to Follow-up|3|||
129938152|NCT02502526|467739210|FG000|Overall Study|Withdrawal by Subject|0|||
129938153|NCT02502526|467739211|FG001|Overall Study|Withdrawal by Subject|1|||
129938154|NCT02502526|467739212|FG002|Overall Study|Withdrawal by Subject|1|||
129938155|NCT02502526|467739210|FG000|Overall Study|Disqualified due to cataract grading|0|||
129938156|NCT02502526|467739211|FG001|Overall Study|Disqualified due to cataract grading|0|||
129938157|NCT02502526|467739212|FG002|Overall Study|Disqualified due to cataract grading|1|||
129938158|NCT02502526|467739210|FG000|Overall Study|Enrollment suspension|4|||
129938159|NCT02502526|467739211|FG001|Overall Study|Enrollment suspension|1|||
129938160|NCT02502526|467739212|FG002|Overall Study|Enrollment suspension|1|||
129938161|NCT01342367|467739213|FG000|Overall Study|Death|1|||
129938162|NCT01342367|467739214|FG001|Overall Study|Death|0|||
129938163|NCT01342367|467739213|FG000|Overall Study|Withdrawal by Subject|1|||
129938164|NCT01342367|467739214|FG001|Overall Study|Withdrawal by Subject|2|||
129938165|NCT00571649|467739216|FG000|Treatment Period|Adverse Event|438|||
129938166|NCT00571649|467739217|FG001|Treatment Period|Adverse Event|385|||
129938167|NCT00571649|467739216|FG000|Treatment Period|Clinical endpoint reached|50|||
129938168|NCT00571649|467739217|FG001|Treatment Period|Clinical endpoint reached|56|||
129938169|NCT00571649|467739216|FG000|Treatment Period|Withdrawal by Subject|285|||
129938170|NCT00571649|467739217|FG001|Treatment Period|Withdrawal by Subject|255|||
129938171|NCT00571649|467739216|FG000|Treatment Period|Death|76|||
129938172|NCT00571649|467739217|FG001|Treatment Period|Death|59|||
129938173|NCT00571649|467739216|FG000|Treatment Period|Physician Decision|8|||
129938174|NCT00571649|467739217|FG001|Treatment Period|Physician Decision|9|||
129938175|NCT00571649|467739216|FG000|Treatment Period|Lost to Follow-up|43|||
129938176|NCT00571649|467739217|FG001|Treatment Period|Lost to Follow-up|41|||
129938177|NCT00571649|467739216|FG000|Treatment Period|Non-compliant with study medication|88|||
129938178|NCT00571649|467739217|FG001|Treatment Period|Non-compliant with study medication|89|||
129938179|NCT00571649|467739216|FG000|Treatment Period|Patient convenience|11|||
129938180|NCT00571649|467739217|FG001|Treatment Period|Patient convenience|13|||
129938181|NCT00571649|467739216|FG000|Treatment Period|Protocol Violation|90|||
129938182|NCT00571649|467739217|FG001|Treatment Period|Protocol Violation|92|||
129938183|NCT00571649|467739216|FG000|Treatment Period|Technical problems|3|||
129938184|NCT00571649|467739217|FG001|Treatment Period|Technical problems|5|||
129938185|NCT00571649|467739216|FG000|Follow-up Period|Adverse Event|46|||
129938186|NCT00571649|467739217|FG001|Follow-up Period|Adverse Event|40|||
129938187|NCT00571649|467739216|FG000|Follow-up Period|Clinical endpoint reached|5|||
129938188|NCT00571649|467739217|FG001|Follow-up Period|Clinical endpoint reached|2|||
129938189|NCT00571649|467739216|FG000|Follow-up Period|Withdrawal by Subject|119|||
129938190|NCT00571649|467739217|FG001|Follow-up Period|Withdrawal by Subject|115|||
129938191|NCT00571649|467739216|FG000|Follow-up Period|Death|132|||
129938192|NCT00571649|467739217|FG001|Follow-up Period|Death|133|||
129938193|NCT00571649|467739216|FG000|Follow-up Period|Physician Decision|7|||
129938194|NCT00571649|467739217|FG001|Follow-up Period|Physician Decision|13|||
129938195|NCT00571649|467739216|FG000|Follow-up Period|Lost to Follow-up|95|||
129938196|NCT00571649|467739217|FG001|Follow-up Period|Lost to Follow-up|92|||
129938197|NCT00571649|467739216|FG000|Follow-up Period|Patient convenience|136|||
129938198|NCT00571649|467739217|FG001|Follow-up Period|Patient convenience|121|||
129938199|NCT00571649|467739216|FG000|Follow-up Period|Protocol Violation|5|||
129938200|NCT00571649|467739217|FG001|Follow-up Period|Protocol Violation|12|||
129938201|NCT00582972|467739218|FG000|Overall Study|Protocol Violation|2|||
129938202|NCT01566890|467739221|FG000|Overall Study|Adverse Event|1|||
129938203|NCT01566890|467739222|FG001|Overall Study|Adverse Event|0|||
129938204|NCT01566890|467739223|FG002|Overall Study|Adverse Event|0|||
129938205|NCT01566890|467739224|FG003|Overall Study|Adverse Event|0|||
129938206|NCT01566890|467739225|FG004|Overall Study|Adverse Event|0|||
129938207|NCT01566890|467739221|FG000|Overall Study|Withdrawal by Subject|3|||
129938208|NCT01566890|467739222|FG001|Overall Study|Withdrawal by Subject|1|||
129938209|NCT01566890|467739223|FG002|Overall Study|Withdrawal by Subject|1|||
129938210|NCT01566890|467739224|FG003|Overall Study|Withdrawal by Subject|1|||
129938211|NCT01566890|467739225|FG004|Overall Study|Withdrawal by Subject|0|||
129938212|NCT01566890|467739221|FG000|Overall Study|Screen failure|6|||
129938213|NCT01566890|467739222|FG001|Overall Study|Screen failure|0|||
129938214|NCT01566890|467739223|FG002|Overall Study|Screen failure|1|||
129938215|NCT01566890|467739224|FG003|Overall Study|Screen failure|1|||
129938216|NCT01566890|467739225|FG004|Overall Study|Screen failure|0|||
129938217|NCT01566890|467739221|FG000|Overall Study|Incomplete CEU data|1|||
129938218|NCT01566890|467739222|FG001|Overall Study|Incomplete CEU data|3|||
129938219|NCT01566890|467739223|FG002|Overall Study|Incomplete CEU data|5|||
129938220|NCT01566890|467739224|FG003|Overall Study|Incomplete CEU data|8|||
129938221|NCT01566890|467739225|FG004|Overall Study|Incomplete CEU data|0|||
129938222|NCT01566890|467739221|FG000|Overall Study|Lost to Follow-up|0|||
129938223|NCT01566890|467739222|FG001|Overall Study|Lost to Follow-up|0|||
129938224|NCT01566890|467739223|FG002|Overall Study|Lost to Follow-up|4|||
129938225|NCT01566890|467739224|FG003|Overall Study|Lost to Follow-up|4|||
129938226|NCT01566890|467739225|FG004|Overall Study|Lost to Follow-up|0|||
129938227|NCT01566890|467739221|FG000|Overall Study|Other|0|||
129938228|NCT01566890|467739222|FG001|Overall Study|Other|0|||
129938229|NCT01566890|467739223|FG002|Overall Study|Other|0|||
129938230|NCT01566890|467739224|FG003|Overall Study|Other|0|||
129938231|NCT01566890|467739225|FG004|Overall Study|Other|7|||
129938232|NCT01421667|467739231|FG000|Overall Study|Withdrawal by Subject|0|||
129938233|NCT01421667|467739232|FG001|Overall Study|Withdrawal by Subject|1|||
129938234|NCT01421667|467739233|FG002|Overall Study|Withdrawal by Subject|2|||
129938235|NCT01421667|467739234|FG003|Overall Study|Withdrawal by Subject|1|||
129938236|NCT01421667|467739231|FG000|Overall Study|Lost to Follow-up|0|||
129938237|NCT01421667|467739232|FG001|Overall Study|Lost to Follow-up|1|||
129938238|NCT01421667|467739233|FG002|Overall Study|Lost to Follow-up|0|||
129938239|NCT01421667|467739234|FG003|Overall Study|Lost to Follow-up|0|||
129938240|NCT01387516|467739236|FG000|Overall Study|Lost to Follow-up|4|||
129938241|NCT01387516|467739237|FG001|Overall Study|Lost to Follow-up|4|||
129938242|NCT01387516|467739238|FG002|Overall Study|Lost to Follow-up|2|||
129938243|NCT01387516|467739239|FG003|Overall Study|Lost to Follow-up|3|||
129938244|NCT01387516|467739236|FG000|Overall Study|Withdrawal by Subject|1|||
129938245|NCT01387516|467739237|FG001|Overall Study|Withdrawal by Subject|1|||
129938246|NCT01387516|467739238|FG002|Overall Study|Withdrawal by Subject|2|||
129938247|NCT01387516|467739239|FG003|Overall Study|Withdrawal by Subject|0|||
129938248|NCT01387516|467739236|FG000|Overall Study|Death|0|||
129938249|NCT01387516|467739237|FG001|Overall Study|Death|0|||
129938250|NCT01387516|467739238|FG002|Overall Study|Death|0|||
129938251|NCT01387516|467739239|FG003|Overall Study|Death|1|||
129938252|NCT01738438|467739244|FG000|Overall Study|Disease Progression|32|||
129938253|NCT01738438|467739244|FG000|Overall Study|Adverse Event|3|||
129938254|NCT02016872|467739249|FG000|Overall Study|Withdrawal by Subject|10|||
129938255|NCT02016872|467739249|FG000|Overall Study|Death Progression|2|||
129938256|NCT02016872|467739249|FG000|Overall Study|No FMISO scan|1|||
129938257|NCT02016872|467739249|FG000|Overall Study|Ineligible|2|||
129938258|NCT02415127|467739250|FG000|Overall Study|Adverse Event|1|||
129938259|NCT02415127|467739251|FG001|Overall Study|Adverse Event|0|||
129938260|NCT03789110|467739252|FG000|Overall Study|Adverse Event|2|||
129938261|NCT03789110|467739252|FG000|Overall Study|Physician Decision|1|||
129938262|NCT03789110|467739252|FG000|Overall Study|Withdrawal by Subject|2|||
129938263|NCT03789110|467739252|FG000|Overall Study|Lack of Efficacy|22|||
129938264|NCT03789110|467739252|FG000|Overall Study|still on treatment|3|||
129938265|NCT02761187|467739253|FG000|Overall Study|Too ill to Participate|13|||
129938266|NCT02761187|467739254|FG001|Overall Study|Too ill to Participate|8|||
129938267|NCT02761187|467739253|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
129938268|NCT02761187|467739254|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
129938269|NCT02761187|467739253|FG000|Overall Study|Patient withdrew consent|64|||
129938270|NCT02761187|467739254|FG001|Overall Study|Patient withdrew consent|58|||
129938271|NCT02761187|467739253|FG000|Overall Study|Physician discretion|4|||
129938272|NCT02761187|467739254|FG001|Overall Study|Physician discretion|8|||
129938273|NCT02761187|467739253|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
129938274|NCT02761187|467739254|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
129938275|NCT02761187|467739253|FG000|Overall Study|On Hospice|20|||
129938276|NCT02761187|467739254|FG001|Overall Study|On Hospice|26|||
129938277|NCT02761187|467739253|FG000|Overall Study|Deceased|474|||
129938278|NCT02761187|467739254|FG001|Overall Study|Deceased|642|||
129938279|NCT02761187|467739253|FG000|Overall Study|Lost to Follow-up|73|||
129938280|NCT02761187|467739254|FG001|Overall Study|Lost to Follow-up|63|||
129938281|NCT02761187|467739253|FG000|Overall Study|Due to study discontinued at site|100|||
129938282|NCT02761187|467739254|FG001|Overall Study|Due to study discontinued at site|85|||
129938283|NCT02761187|467739253|FG000|Overall Study|Reason not Specified|1484|||
129938284|NCT02761187|467739254|FG001|Overall Study|Reason not Specified|937|||
129938285|NCT03978637|467739255|FG000|Overall Study|Death|0|||
129938286|NCT03978637|467739256|FG001|Overall Study|Death|2|||
129938287|NCT03978637|467739257|FG002|Overall Study|Death|2|||
129938288|NCT03978637|467739258|FG003|Overall Study|Death|0|||
129938289|NCT03978637|467739255|FG000|Overall Study|Withdrawal by Subject|0|||
129938290|NCT03978637|467739256|FG001|Overall Study|Withdrawal by Subject|0|||
129938291|NCT03978637|467739257|FG002|Overall Study|Withdrawal by Subject|1|||
129938292|NCT03978637|467739258|FG003|Overall Study|Withdrawal by Subject|0|||
129938293|NCT03978637|467739255|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
129938294|NCT03978637|467739256|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
129938295|NCT03978637|467739257|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
129938296|NCT03978637|467739258|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
129938297|NCT02307682|467739259|FG000|Overall Study|Adverse Event|9|||
129938298|NCT02307682|467739260|FG001|Overall Study|Adverse Event|8|||
129938299|NCT02307682|467739261|FG002|Overall Study|Adverse Event|12|||
129938300|NCT02307682|467739259|FG000|Overall Study|Lack of Efficacy|1|||
129938301|NCT02307682|467739260|FG001|Overall Study|Lack of Efficacy|0|||
129938302|NCT02307682|467739261|FG002|Overall Study|Lack of Efficacy|1|||
129938303|NCT02307682|467739259|FG000|Overall Study|Physician Decision|2|||
129938304|NCT02307682|467739260|FG001|Overall Study|Physician Decision|2|||
129938305|NCT02307682|467739261|FG002|Overall Study|Physician Decision|8|||
129938306|NCT02307682|467739259|FG000|Overall Study|Progressive Disease|1|||
129938307|NCT02307682|467739260|FG001|Overall Study|Progressive Disease|0|||
129938308|NCT02307682|467739261|FG002|Overall Study|Progressive Disease|0|||
129938309|NCT02307682|467739259|FG000|Overall Study|Withdrawal by Subject|26|||
129938310|NCT02307682|467739260|FG001|Overall Study|Withdrawal by Subject|34|||
129938311|NCT02307682|467739261|FG002|Overall Study|Withdrawal by Subject|23|||
129938312|NCT02307682|467739259|FG000|Overall Study|Death|9|||
129938313|NCT02307682|467739260|FG001|Overall Study|Death|7|||
129938314|NCT02307682|467739261|FG002|Overall Study|Death|12|||
129938315|NCT02307682|467739259|FG000|Overall Study|Lost to Follow-up|1|||
129938316|NCT02307682|467739260|FG001|Overall Study|Lost to Follow-up|5|||
129938317|NCT02307682|467739261|FG002|Overall Study|Lost to Follow-up|6|||
129938318|NCT02307682|467739259|FG000|Overall Study|Protocol Deviation|0|||
129938319|NCT02307682|467739260|FG001|Overall Study|Protocol Deviation|0|||
129938320|NCT02307682|467739261|FG002|Overall Study|Protocol Deviation|2|||
129938321|NCT02307682|467739259|FG000|Overall Study|Other|1|||
129938322|NCT02307682|467739260|FG001|Overall Study|Other|1|||
129938323|NCT02307682|467739261|FG002|Overall Study|Other|0|||
129938324|NCT05630833|467739263|FG000|Overall Study|Adverse Event|3|||
129938325|NCT05630833|467739264|FG001|Overall Study|Adverse Event|0|||
129938326|NCT05630833|467739263|FG000|Overall Study|Lack of Efficacy|0|||
129938327|NCT05630833|467739264|FG001|Overall Study|Lack of Efficacy|1|||
129938328|NCT05630833|467739263|FG000|Overall Study|Lost to Follow-up|1|||
129938329|NCT05630833|467739264|FG001|Overall Study|Lost to Follow-up|0|||
129938330|NCT05630833|467739263|FG000|Overall Study|Withdrawal by Subject|3|||
129938331|NCT05630833|467739264|FG001|Overall Study|Withdrawal by Subject|1|||
129938332|NCT03170349|467739266|FG000|From Implant to the 30-Day Visit|Death|1|||
129938333|NCT03170349|467739266|FG000|From 30-Day to 6-Month Visit|Death|3|||
129938334|NCT03170349|467739266|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
129938335|NCT03170349|467739266|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
129938336|NCT03170349|467739266|FG000|From 6-Month to 1-Year Visit|Death|6|||
129938337|NCT03170349|467739266|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
129938338|NCT03170349|467739266|FG000|From 1-Year to 2-Year Visit|Death|13|||
129938339|NCT03170349|467739266|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
129938340|NCT03170349|467739266|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
129938341|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Death|10|||
129938342|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
129938343|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
129938344|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
129938345|NCT04503681|467740765|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
129938346|NCT04503681|467740766|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
129938347|NCT01084694|467740773|FG000|Overall Study|Withdrawal by Subject|2|||
129938348|NCT01084694|467740774|FG001|Overall Study|Withdrawal by Subject|1|||
129938349|NCT01084694|467740773|FG000|Overall Study|Death|2|||
129938350|NCT01084694|467740774|FG001|Overall Study|Death|12|||
129938351|NCT01084694|467740773|FG000|Overall Study|eligibility not maintained|2|||
129938352|NCT01084694|467740774|FG001|Overall Study|eligibility not maintained|7|||
129938353|NCT00945321|467740777|FG000|Period 1|Adverse Event|0|||
129938354|NCT00945321|467740778|FG001|Period 1|Adverse Event|0|||
129938355|NCT00945321|467740779|FG002|Period 1|Adverse Event|0|||
129938356|NCT00945321|467740780|FG003|Period 1|Adverse Event|0|||
129938357|NCT00945321|467740781|FG004|Period 1|Adverse Event|1|||
130119719|NCT00329602|468398445|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
130119720|NCT00329602|468398446|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
130119721|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
130119722|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
130119723|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
130119724|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
130119725|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
130119726|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
130119727|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
130119728|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
130119729|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
130119730|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
130119731|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
130119732|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
130119733|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
130119734|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
130119735|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
130119736|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
130119737|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
130119738|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
130119739|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
130119740|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
130119741|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
130119742|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
130119743|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
130119744|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
130119745|NCT00455533|468398447|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
130119746|NCT00455533|468398448|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
130119747|NCT00455533|468398449|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
130119748|NCT00455533|468398447|FG000|Period Two: Randomized Period|Death|0|||
130119749|NCT00455533|468398448|FG001|Period Two: Randomized Period|Death|0|||
130119750|NCT00455533|468398449|FG002|Period Two: Randomized Period|Death|3|||
130119751|NCT00455533|468398447|FG000|Period Two: Randomized Period|Disease Progression|0|||
130119752|NCT00455533|468398448|FG001|Period Two: Randomized Period|Disease Progression|1|||
130119753|NCT00455533|468398449|FG002|Period Two: Randomized Period|Disease Progression|1|||
130119754|NCT00455533|468398447|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
130119755|NCT00455533|468398448|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
130119756|NCT00455533|468398449|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
130119757|NCT00455533|468398447|FG000|Period Two: Randomized Period|Other - need reasons|0|||
130119758|NCT00455533|468398448|FG001|Period Two: Randomized Period|Other - need reasons|1|||
130119759|NCT00455533|468398449|FG002|Period Two: Randomized Period|Other - need reasons|0|||
130119760|NCT00455533|468398447|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
130119761|NCT00455533|468398448|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
130119762|NCT00455533|468398449|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
130119763|NCT00455533|468398447|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
130119764|NCT00455533|468398448|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
130119765|NCT00455533|468398449|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
130119766|NCT02576990|468398454|FG000|Overall Study|Death|29|||
130119767|NCT02576990|468398455|FG001|Overall Study|Death|18|||
129938358|NCT00945321|467740782|FG005|Period 1|Adverse Event|0|||
129938359|NCT00945321|467740777|FG000|Period 4|Lost to Follow-up|0|||
129938360|NCT00945321|467740778|FG001|Period 4|Lost to Follow-up|0|||
129938361|NCT00945321|467740779|FG002|Period 4|Lost to Follow-up|0|||
129938362|NCT00945321|467740780|FG003|Period 4|Lost to Follow-up|0|||
129938363|NCT00945321|467740781|FG004|Period 4|Lost to Follow-up|0|||
129938364|NCT00945321|467740782|FG005|Period 4|Lost to Follow-up|1|||
129938365|NCT02633215|467740783|FG000|Overall Study|Lost to Follow-up|2|||
129938366|NCT02633215|467740784|FG001|Overall Study|Lost to Follow-up|3|||
129938367|NCT00692913|467740785|FG000|Overall Study|Adverse Event|8|||
129938368|NCT00692913|467740786|FG001|Overall Study|Adverse Event|4|||
129938369|NCT00692913|467740785|FG000|Overall Study|Lost to Follow-up|3|||
129938370|NCT00692913|467740786|FG001|Overall Study|Lost to Follow-up|5|||
129938371|NCT00692913|467740785|FG000|Overall Study|Physician Decision|2|||
129938372|NCT00692913|467740786|FG001|Overall Study|Physician Decision|0|||
129938373|NCT00692913|467740785|FG000|Overall Study|Protocol Violation|1|||
129938374|NCT00692913|467740786|FG001|Overall Study|Protocol Violation|1|||
129938375|NCT00692913|467740785|FG000|Overall Study|Withdrawal by Subject|15|||
129938376|NCT00692913|467740786|FG001|Overall Study|Withdrawal by Subject|20|||
129938377|NCT04017611|467740787|FG000|Overall Study|Withdrawn prior to completion|1|||
129938378|NCT02291913|467740796|FG000|Overall Study|Progressive Disease|32|||
129938379|NCT02291913|467740796|FG000|Overall Study|Adverse Event|11|||
129938380|NCT02291913|467740796|FG000|Overall Study|Death|2|||
129938381|NCT02291913|467740796|FG000|Overall Study|Physician Decision|1|||
129938382|NCT02291913|467740796|FG000|Overall Study|Withdrawal by Subject|1|||
129938383|NCT02291913|467740796|FG000|Overall Study|Protocol Violation|1|||
129938384|NCT02866942|467740797|FG000|Overall Study|Invalid consent|1|||
129938385|NCT01268306|467740800|FG000|Overall Study|Lost to Follow-up|1|||
129938386|NCT04334317|467740801|FG000|Overall Study|Adverse Event|1|||
129938387|NCT04334317|467740802|FG001|Overall Study|Adverse Event|2|||
129938388|NCT04334317|467740803|FG002|Overall Study|Adverse Event|0|||
129938389|NCT04334317|467740804|FG003|Overall Study|Adverse Event|0|||
129938390|NCT04334317|467740801|FG000|Overall Study|Protocol Deviation|0|||
129938391|NCT04334317|467740802|FG001|Overall Study|Protocol Deviation|1|||
129938392|NCT04334317|467740803|FG002|Overall Study|Protocol Deviation|0|||
129938393|NCT04334317|467740804|FG003|Overall Study|Protocol Deviation|0|||
129938394|NCT04334317|467740801|FG000|Overall Study|Withdrawal by Subject|2|||
129938395|NCT04334317|467740802|FG001|Overall Study|Withdrawal by Subject|2|||
129938396|NCT04334317|467740803|FG002|Overall Study|Withdrawal by Subject|0|||
129938397|NCT04334317|467740804|FG003|Overall Study|Withdrawal by Subject|0|||
129938398|NCT01128595|467740809|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129938399|NCT01128595|467740810|FG001|Treatment Period 3|Withdrawal by Subject|1|||
129938400|NCT01128595|467740811|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129938401|NCT01128595|467740812|FG003|Treatment Period 3|Withdrawal by Subject|0|||
129938402|NCT00605306|467740813|FG000|Overall Study|Adverse Event|0|||
129938403|NCT00605306|467740814|FG001|Overall Study|Adverse Event|1|||
129938404|NCT00372775|467740815|FG000|Overall Study|Adverse Event|8|||
129938405|NCT00372775|467740815|FG000|Overall Study|Death|15|||
129938406|NCT00372775|467740815|FG000|Overall Study|Objective progression or relapse|30|||
129938407|NCT00372775|467740815|FG000|Overall Study|Global deterioration of health status|6|||
129938408|NCT00372775|467740815|FG000|Overall Study|Withdrawal by Subject|1|||
129938409|NCT00372775|467740815|FG000|Overall Study|Other|1|||
129938410|NCT00372775|467740815|FG000|Overall Study|Not Treated|2|||
129938411|NCT02568215|467740817|FG000|Overall Study|Death|1|||
129938412|NCT02568215|467740818|FG001|Overall Study|Death|2|||
129938413|NCT02568215|467740819|FG002|Overall Study|Death|0|||
129938414|NCT02568215|467740817|FG000|Overall Study|Physician Decision|2|||
129938415|NCT02568215|467740818|FG001|Overall Study|Physician Decision|2|||
129938416|NCT02568215|467740819|FG002|Overall Study|Physician Decision|2|||
129938417|NCT02568215|467740817|FG000|Overall Study|Lost to Follow-up|29|||
129938418|NCT02568215|467740818|FG001|Overall Study|Lost to Follow-up|32|||
129938419|NCT02568215|467740819|FG002|Overall Study|Lost to Follow-up|41|||
129938420|NCT02568215|467740817|FG000|Overall Study|Withdrawal by Subject|21|||
129938421|NCT02568215|467740818|FG001|Overall Study|Withdrawal by Subject|19|||
129938422|NCT02568215|467740819|FG002|Overall Study|Withdrawal by Subject|22|||
129938423|NCT02568215|467740817|FG000|Overall Study|Protocol Violation|1|||
129938424|NCT02568215|467740818|FG001|Overall Study|Protocol Violation|1|||
129938425|NCT02568215|467740819|FG002|Overall Study|Protocol Violation|0|||
129938426|NCT02568215|467740817|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
129938427|NCT02568215|467740818|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
129938428|NCT02568215|467740819|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
129938429|NCT02568215|467740817|FG000|Overall Study|Other|0|||
129938430|NCT02568215|467740818|FG001|Overall Study|Other|1|||
129938431|NCT02568215|467740819|FG002|Overall Study|Other|4|||
129938432|NCT00336505|467740820|FG000|Overall Study|Adverse Event|10|||
129938433|NCT00336505|467740821|FG001|Overall Study|Adverse Event|9|||
129938434|NCT00336505|467740820|FG000|Overall Study|Lack of Efficacy|8|||
129938435|NCT00336505|467740821|FG001|Overall Study|Lack of Efficacy|4|||
129938436|NCT00336505|467740820|FG000|Overall Study|Lost to Follow-up|7|||
129938437|NCT00336505|467740821|FG001|Overall Study|Lost to Follow-up|4|||
129938438|NCT00336505|467740820|FG000|Overall Study|Withdrawal by Subject|5|||
129938439|NCT00336505|467740821|FG001|Overall Study|Withdrawal by Subject|3|||
129938440|NCT00336505|467740820|FG000|Overall Study|Other|7|||
129938441|NCT00336505|467740821|FG001|Overall Study|Other|7|||
130071204|NCT00105183|468216049|FG002|Overall Study|Death|15|||
129938442|NCT01092416|467740822|FG000|Enrollment|Atherectomy device not inserted|3|||
129938443|NCT01092416|467740822|FG000|30-Day Follow-up|Death|2|||
129938444|NCT01092416|467740822|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
129938445|NCT01092416|467740822|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
129938446|NCT01092416|467740822|FG000|12-Month Follow-up|Death|16|||
129938447|NCT01092416|467740822|FG000|12-Month Follow-up|Lost to Follow-up|4|||
129938448|NCT01092416|467740822|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
130071205|NCT00105183|468216047|FG000|Overall Study|Withdrawal by Subject|1|||
129938449|NCT01092416|467740822|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
129938450|NCT01092416|467740822|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
129938451|NCT00366249|467740823|FG000|Overall Study|Adverse Event|53|||
129938452|NCT00366249|467740824|FG001|Overall Study|Adverse Event|28|||
129938453|NCT00366249|467740823|FG000|Overall Study|Death|0|||
129938454|NCT00366249|467740824|FG001|Overall Study|Death|1|||
130071206|NCT00105183|468216048|FG001|Overall Study|Withdrawal by Subject|1|||
129938455|NCT00366249|467740823|FG000|Overall Study|Physician Decision|5|||
129938456|NCT00366249|467740824|FG001|Overall Study|Physician Decision|2|||
129938457|NCT00366249|467740823|FG000|Overall Study|Lost to Follow-up|2|||
129938458|NCT00366249|467740824|FG001|Overall Study|Lost to Follow-up|0|||
129938459|NCT00366249|467740823|FG000|Overall Study|Protocol Violation|1|||
129938460|NCT00366249|467740824|FG001|Overall Study|Protocol Violation|2|||
129938461|NCT00366249|467740823|FG000|Overall Study|Withdrawal by Subject|18|||
129938462|NCT00366249|467740824|FG001|Overall Study|Withdrawal by Subject|4|||
129938463|NCT00366249|467740823|FG000|Overall Study|Lack of Efficacy|21|||
129938464|NCT00366249|467740824|FG001|Overall Study|Lack of Efficacy|21|||
129938465|NCT00366249|467740823|FG000|Overall Study|Most due to osteomylitis status|31|||
129938466|NCT00366249|467740824|FG001|Overall Study|Most due to osteomylitis status|20|||
129938467|NCT01561300|467740825|FG000|Run in on Placebo|Adverse Event|1|||
129938468|NCT01561300|467740826|FG001|Run in on Placebo|Adverse Event|0|||
129938469|NCT01952366|467740828|FG000|Overall Study|Death|22|||
129938470|NCT01952366|467740828|FG000|Overall Study|Withdrawal by Subject|9|||
129938471|NCT04860505|467740829|FG000|Overall Study|Lost to Follow-up|2|||
129938472|NCT03066609|467740832|FG000|INDUCTION|Pregnancy|0|||
129938473|NCT03066609|467740833|FG001|INDUCTION|Pregnancy|0|||
129938474|NCT03066609|467740834|FG002|INDUCTION|Pregnancy|1|||
129938475|NCT03066609|467740835|FG003|INDUCTION|Pregnancy|0|||
129938476|NCT03066609|467740832|FG000|INDUCTION|Lack of Efficacy|0|||
129938477|NCT03066609|467740833|FG001|INDUCTION|Lack of Efficacy|0|||
129938478|NCT03066609|467740834|FG002|INDUCTION|Lack of Efficacy|1|||
129938479|NCT03066609|467740835|FG003|INDUCTION|Lack of Efficacy|0|||
129938480|NCT03066609|467740832|FG000|INDUCTION|Adverse Event|2|||
129938481|NCT03066609|467740833|FG001|INDUCTION|Adverse Event|2|||
129938482|NCT03066609|467740834|FG002|INDUCTION|Adverse Event|0|||
129938483|NCT03066609|467740835|FG003|INDUCTION|Adverse Event|0|||
129938484|NCT03066609|467740832|FG000|MAINTENANCE|Adverse Event|0|||
129938485|NCT03066609|467740833|FG001|MAINTENANCE|Adverse Event|0|||
129938486|NCT03066609|467740834|FG002|MAINTENANCE|Adverse Event|0|||
129938487|NCT03066609|467740835|FG003|MAINTENANCE|Adverse Event|1|||
129938488|NCT03066609|467740832|FG000|MAINTENANCE|Withdrawal by Subject|4|||
129938489|NCT03066609|467740833|FG001|MAINTENANCE|Withdrawal by Subject|2|||
129938490|NCT03066609|467740834|FG002|MAINTENANCE|Withdrawal by Subject|1|||
129938491|NCT03066609|467740835|FG003|MAINTENANCE|Withdrawal by Subject|1|||
129938492|NCT03066609|467740832|FG000|MAINTENANCE|Lost to Follow-up|0|||
129938493|NCT03066609|467740833|FG001|MAINTENANCE|Lost to Follow-up|1|||
129938494|NCT03066609|467740834|FG002|MAINTENANCE|Lost to Follow-up|1|||
129938495|NCT03066609|467740835|FG003|MAINTENANCE|Lost to Follow-up|0|||
129938496|NCT03066609|467740832|FG000|MAINTENANCE|Pregnancy|1|||
129938497|NCT03066609|467740833|FG001|MAINTENANCE|Pregnancy|0|||
129938498|NCT03066609|467740834|FG002|MAINTENANCE|Pregnancy|0|||
129938499|NCT03066609|467740835|FG003|MAINTENANCE|Pregnancy|0|||
129938500|NCT03066609|467740832|FG000|MAINTENANCE|Lack of Efficacy|2|||
129938501|NCT03066609|467740833|FG001|MAINTENANCE|Lack of Efficacy|1|||
129938502|NCT03066609|467740834|FG002|MAINTENANCE|Lack of Efficacy|0|||
129938503|NCT03066609|467740835|FG003|MAINTENANCE|Lack of Efficacy|1|||
129938504|NCT03066609|467740832|FG000|OVERALL STUDY|Adverse Event|2|||
129938505|NCT03066609|467740833|FG001|OVERALL STUDY|Adverse Event|2|||
129938506|NCT03066609|467740834|FG002|OVERALL STUDY|Adverse Event|0|||
129938507|NCT03066609|467740835|FG003|OVERALL STUDY|Adverse Event|1|||
129938508|NCT03066609|467740832|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
129938509|NCT03066609|467740833|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
129938510|NCT03066609|467740834|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
129938511|NCT03066609|467740835|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
129938512|NCT03066609|467740832|FG000|OVERALL STUDY|Lost to Follow-up|1|||
129938513|NCT03066609|467740833|FG001|OVERALL STUDY|Lost to Follow-up|1|||
129938514|NCT03066609|467740834|FG002|OVERALL STUDY|Lost to Follow-up|1|||
129938515|NCT03066609|467740835|FG003|OVERALL STUDY|Lost to Follow-up|1|||
129938516|NCT03066609|467740832|FG000|OVERALL STUDY|Pregnancy|1|||
129938517|NCT03066609|467740833|FG001|OVERALL STUDY|Pregnancy|0|||
129938518|NCT03066609|467740834|FG002|OVERALL STUDY|Pregnancy|1|||
129938519|NCT03066609|467740835|FG003|OVERALL STUDY|Pregnancy|0|||
129938520|NCT03066609|467740832|FG000|OVERALL STUDY|Lack of Efficacy|2|||
129938521|NCT03066609|467740833|FG001|OVERALL STUDY|Lack of Efficacy|1|||
129938522|NCT03066609|467740834|FG002|OVERALL STUDY|Lack of Efficacy|1|||
129938523|NCT03066609|467740835|FG003|OVERALL STUDY|Lack of Efficacy|1|||
129938524|NCT03066609|467740832|FG000|OVERALL STUDY|discontinued follow up|0|||
129938525|NCT03066609|467740833|FG001|OVERALL STUDY|discontinued follow up|2|||
129938526|NCT03066609|467740834|FG002|OVERALL STUDY|discontinued follow up|0|||
129938527|NCT03066609|467740835|FG003|OVERALL STUDY|discontinued follow up|0|||
129938528|NCT00293397|467740839|FG000|Overall Study|Death|2|||
129938529|NCT00822120|467740840|FG000|Initial Registration|Adverse Event|1|||
129938530|NCT00822120|467740841|FG001|Initial Registration|Adverse Event|0|||
129938531|NCT00822120|467740842|FG002|Initial Registration|Adverse Event|0|||
129938532|NCT00822120|467740843|FG003|Initial Registration|Adverse Event|0|||
129938533|NCT00822120|467740844|FG004|Initial Registration|Adverse Event|0|||
129938534|NCT00822120|467740845|FG005|Initial Registration|Adverse Event|0|||
129938535|NCT00822120|467740840|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
129938536|NCT00822120|467740841|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938537|NCT00822120|467740842|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938538|NCT00822120|467740843|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938539|NCT00822120|467740844|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938540|NCT00822120|467740845|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938541|NCT00822120|467740840|FG000|Initial Registration|Reasons not Protocol Specified|2|||
129938542|NCT00822120|467740841|FG001|Initial Registration|Reasons not Protocol Specified|0|||
129938543|NCT00822120|467740842|FG002|Initial Registration|Reasons not Protocol Specified|0|||
129938544|NCT00822120|467740843|FG003|Initial Registration|Reasons not Protocol Specified|0|||
129938545|NCT00822120|467740844|FG004|Initial Registration|Reasons not Protocol Specified|0|||
129938546|NCT00822120|467740845|FG005|Initial Registration|Reasons not Protocol Specified|0|||
129938547|NCT00822120|467740840|FG000|Initial Registration|Ineligible|22|||
129938548|NCT00822120|467740841|FG001|Initial Registration|Ineligible|1|||
129938549|NCT00822120|467740842|FG002|Initial Registration|Ineligible|0|||
129938550|NCT00822120|467740843|FG003|Initial Registration|Ineligible|0|||
129938551|NCT00822120|467740844|FG004|Initial Registration|Ineligible|0|||
129938552|NCT00822120|467740845|FG005|Initial Registration|Ineligible|0|||
129938553|NCT00822120|467740840|FG000|PET-directed Therapy|Adverse Event|0|||
129938554|NCT00822120|467740841|FG001|PET-directed Therapy|Adverse Event|0|||
129938555|NCT00822120|467740842|FG002|PET-directed Therapy|Adverse Event|0|||
129938556|NCT00822120|467740843|FG003|PET-directed Therapy|Adverse Event|1|||
129938557|NCT00822120|467740844|FG004|PET-directed Therapy|Adverse Event|0|||
129938558|NCT00822120|467740845|FG005|PET-directed Therapy|Adverse Event|0|||
129938559|NCT00822120|467740840|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938560|NCT00822120|467740841|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938561|NCT00822120|467740842|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938562|NCT00822120|467740843|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
129938563|NCT00822120|467740844|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938564|NCT00822120|467740845|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938565|NCT00822120|467740840|FG000|PET-directed Therapy|Death|0|||
129938566|NCT00822120|467740841|FG001|PET-directed Therapy|Death|0|||
129938567|NCT00822120|467740842|FG002|PET-directed Therapy|Death|0|||
129938568|NCT00822120|467740843|FG003|PET-directed Therapy|Death|2|||
129938569|NCT00822120|467740844|FG004|PET-directed Therapy|Death|0|||
129938570|NCT00822120|467740845|FG005|PET-directed Therapy|Death|0|||
129938571|NCT00822120|467740840|FG000|PET-directed Therapy|Protocol Violation|0|||
129938572|NCT00822120|467740841|FG001|PET-directed Therapy|Protocol Violation|0|||
129938573|NCT00822120|467740842|FG002|PET-directed Therapy|Protocol Violation|0|||
129938574|NCT00822120|467740843|FG003|PET-directed Therapy|Protocol Violation|6|||
129938575|NCT00822120|467740844|FG004|PET-directed Therapy|Protocol Violation|0|||
129938576|NCT00822120|467740845|FG005|PET-directed Therapy|Protocol Violation|0|||
129938577|NCT00503906|467740846|FG000|Overall Study|Withdrawal by Subject|1|||
129938578|NCT01324310|467740847|FG000|Overall Study|Adverse Event|1|||
129938579|NCT01324310|467740847|FG000|Overall Study|Disease Progression|1|||
129938580|NCT03170882|467740848|FG000|Overall Study|Death|17|||
129938581|NCT03170882|467740849|FG001|Overall Study|Death|29|||
129938582|NCT03170882|467740848|FG000|Overall Study|Lost to Follow-up|0|||
129938583|NCT03170882|467740849|FG001|Overall Study|Lost to Follow-up|1|||
129938584|NCT03170882|467740848|FG000|Overall Study|Withdrawal by Subject|4|||
129938585|NCT03170882|467740849|FG001|Overall Study|Withdrawal by Subject|7|||
129938586|NCT03170882|467740848|FG000|Overall Study|Reason not Specified|28|||
129938587|NCT03170882|467740849|FG001|Overall Study|Reason not Specified|36|||
129938588|NCT00622700|467740850|FG000|Core Treatment Period|Randomized but Not Treated|0|||
129938589|NCT00622700|467740851|FG001|Core Treatment Period|Randomized but Not Treated|2|||
129938590|NCT00622700|467740852|FG002|Core Treatment Period|Randomized but Not Treated|2|||
129938591|NCT00622700|467740853|FG003|Core Treatment Period|Randomized but Not Treated|0|||
129938592|NCT00622700|467740854|FG004|Core Treatment Period|Randomized but Not Treated|0|||
129938593|NCT00622700|467740855|FG005|Core Treatment Period|Randomized but Not Treated|0|||
129938594|NCT00622700|467740856|FG006|Core Treatment Period|Randomized but Not Treated|0|||
129938595|NCT00622700|467740850|FG000|Core Treatment Period|Adverse Event|18|||
129938596|NCT00622700|467740851|FG001|Core Treatment Period|Adverse Event|25|||
129938597|NCT00622700|467740852|FG002|Core Treatment Period|Adverse Event|18|||
129938598|NCT00622700|467740853|FG003|Core Treatment Period|Adverse Event|0|||
129938599|NCT00622700|467740854|FG004|Core Treatment Period|Adverse Event|0|||
129938600|NCT00622700|467740855|FG005|Core Treatment Period|Adverse Event|0|||
129938601|NCT00622700|467740856|FG006|Core Treatment Period|Adverse Event|0|||
129938602|NCT00622700|467740850|FG000|Core Treatment Period|Lack of Efficacy|19|||
129938603|NCT00622700|467740851|FG001|Core Treatment Period|Lack of Efficacy|6|||
129938604|NCT00622700|467740852|FG002|Core Treatment Period|Lack of Efficacy|12|||
129938605|NCT00622700|467740853|FG003|Core Treatment Period|Lack of Efficacy|0|||
130071207|NCT00105183|468216049|FG002|Overall Study|Withdrawal by Subject|4|||
130071208|NCT00105183|468216047|FG000|Overall Study|Physician Decision|1|||
129938606|NCT00622700|467740854|FG004|Core Treatment Period|Lack of Efficacy|0|||
130071209|NCT00105183|468216048|FG001|Overall Study|Physician Decision|2|||
129938607|NCT00622700|467740855|FG005|Core Treatment Period|Lack of Efficacy|0|||
129938608|NCT00622700|467740856|FG006|Core Treatment Period|Lack of Efficacy|0|||
129938609|NCT00622700|467740850|FG000|Core Treatment Period|Lost to Follow-up|1|||
129938610|NCT00622700|467740851|FG001|Core Treatment Period|Lost to Follow-up|1|||
129938611|NCT00622700|467740852|FG002|Core Treatment Period|Lost to Follow-up|1|||
129938612|NCT00622700|467740853|FG003|Core Treatment Period|Lost to Follow-up|0|||
129938613|NCT00622700|467740854|FG004|Core Treatment Period|Lost to Follow-up|0|||
129938614|NCT00622700|467740855|FG005|Core Treatment Period|Lost to Follow-up|0|||
129938615|NCT00622700|467740856|FG006|Core Treatment Period|Lost to Follow-up|0|||
129938616|NCT00622700|467740850|FG000|Core Treatment Period|Death|1|||
129938617|NCT00622700|467740851|FG001|Core Treatment Period|Death|0|||
129938618|NCT00622700|467740852|FG002|Core Treatment Period|Death|0|||
129938619|NCT00622700|467740853|FG003|Core Treatment Period|Death|0|||
129938620|NCT00622700|467740854|FG004|Core Treatment Period|Death|0|||
129938621|NCT00622700|467740855|FG005|Core Treatment Period|Death|0|||
129938622|NCT00622700|467740856|FG006|Core Treatment Period|Death|0|||
129938623|NCT00622700|467740850|FG000|Core Treatment Period|Progressive Disease|3|||
129938624|NCT00622700|467740851|FG001|Core Treatment Period|Progressive Disease|1|||
129938625|NCT00622700|467740852|FG002|Core Treatment Period|Progressive Disease|0|||
129938626|NCT00622700|467740853|FG003|Core Treatment Period|Progressive Disease|0|||
129938627|NCT00622700|467740854|FG004|Core Treatment Period|Progressive Disease|0|||
129938628|NCT00622700|467740855|FG005|Core Treatment Period|Progressive Disease|0|||
129938629|NCT00622700|467740856|FG006|Core Treatment Period|Progressive Disease|0|||
129938630|NCT00622700|467740850|FG000|Core Treatment Period|Withdrawal by Subject|12|||
129938631|NCT00622700|467740851|FG001|Core Treatment Period|Withdrawal by Subject|18|||
129938632|NCT00622700|467740852|FG002|Core Treatment Period|Withdrawal by Subject|15|||
129938633|NCT00622700|467740853|FG003|Core Treatment Period|Withdrawal by Subject|0|||
129938634|NCT00622700|467740854|FG004|Core Treatment Period|Withdrawal by Subject|0|||
129938635|NCT00622700|467740855|FG005|Core Treatment Period|Withdrawal by Subject|0|||
129938636|NCT00622700|467740856|FG006|Core Treatment Period|Withdrawal by Subject|0|||
129938637|NCT00622700|467740850|FG000|Core Treatment Period|Other than specified above|2|||
129938638|NCT00622700|467740851|FG001|Core Treatment Period|Other than specified above|2|||
129938639|NCT00622700|467740852|FG002|Core Treatment Period|Other than specified above|5|||
129938640|NCT00622700|467740853|FG003|Core Treatment Period|Other than specified above|0|||
129938641|NCT00622700|467740854|FG004|Core Treatment Period|Other than specified above|0|||
129938642|NCT00622700|467740855|FG005|Core Treatment Period|Other than specified above|0|||
129938643|NCT00622700|467740856|FG006|Core Treatment Period|Other than specified above|0|||
129938644|NCT00622700|467740850|FG000|Extension Treatment Period|Adverse Event|0|||
129938645|NCT00622700|467740851|FG001|Extension Treatment Period|Adverse Event|0|||
129938646|NCT00622700|467740852|FG002|Extension Treatment Period|Adverse Event|0|||
129938647|NCT00622700|467740853|FG003|Extension Treatment Period|Adverse Event|5|||
129938648|NCT00622700|467740854|FG004|Extension Treatment Period|Adverse Event|9|||
129938649|NCT00622700|467740855|FG005|Extension Treatment Period|Adverse Event|6|||
129938650|NCT00622700|467740856|FG006|Extension Treatment Period|Adverse Event|8|||
129938651|NCT00622700|467740850|FG000|Extension Treatment Period|Lack of Efficacy|0|||
129938652|NCT00622700|467740851|FG001|Extension Treatment Period|Lack of Efficacy|0|||
129938653|NCT00622700|467740852|FG002|Extension Treatment Period|Lack of Efficacy|0|||
129938654|NCT00622700|467740853|FG003|Extension Treatment Period|Lack of Efficacy|2|||
129938655|NCT00622700|467740854|FG004|Extension Treatment Period|Lack of Efficacy|8|||
129938656|NCT00622700|467740855|FG005|Extension Treatment Period|Lack of Efficacy|1|||
129938657|NCT00622700|467740856|FG006|Extension Treatment Period|Lack of Efficacy|9|||
129938658|NCT00622700|467740850|FG000|Extension Treatment Period|Protocol Violation|0|||
129938659|NCT00622700|467740851|FG001|Extension Treatment Period|Protocol Violation|0|||
129938660|NCT00622700|467740852|FG002|Extension Treatment Period|Protocol Violation|0|||
129938661|NCT00622700|467740853|FG003|Extension Treatment Period|Protocol Violation|0|||
129938662|NCT00622700|467740854|FG004|Extension Treatment Period|Protocol Violation|0|||
129938663|NCT00622700|467740855|FG005|Extension Treatment Period|Protocol Violation|2|||
129938664|NCT00622700|467740856|FG006|Extension Treatment Period|Protocol Violation|0|||
129938665|NCT00622700|467740850|FG000|Extension Treatment Period|Lost to Follow-up|0|||
129938666|NCT00622700|467740851|FG001|Extension Treatment Period|Lost to Follow-up|0|||
129938667|NCT00622700|467740852|FG002|Extension Treatment Period|Lost to Follow-up|0|||
129938668|NCT00622700|467740853|FG003|Extension Treatment Period|Lost to Follow-up|0|||
129938669|NCT00622700|467740854|FG004|Extension Treatment Period|Lost to Follow-up|1|||
129938670|NCT00622700|467740855|FG005|Extension Treatment Period|Lost to Follow-up|0|||
129938671|NCT00622700|467740856|FG006|Extension Treatment Period|Lost to Follow-up|0|||
130071210|NCT00105183|468216049|FG002|Overall Study|Physician Decision|3|||
130071211|NCT00105183|468216047|FG000|Overall Study|Lost to Follow-up|0|||
130071212|NCT00105183|468216048|FG001|Overall Study|Lost to Follow-up|1|||
129938672|NCT00622700|467740850|FG000|Extension Treatment Period|Progressive Disease|0|||
129938673|NCT00622700|467740851|FG001|Extension Treatment Period|Progressive Disease|0|||
129938674|NCT00622700|467740852|FG002|Extension Treatment Period|Progressive Disease|0|||
129938675|NCT00622700|467740853|FG003|Extension Treatment Period|Progressive Disease|1|||
130071213|NCT00105183|468216049|FG002|Overall Study|Lost to Follow-up|1|||
129938676|NCT00622700|467740854|FG004|Extension Treatment Period|Progressive Disease|2|||
129938677|NCT00622700|467740855|FG005|Extension Treatment Period|Progressive Disease|0|||
129938678|NCT00622700|467740856|FG006|Extension Treatment Period|Progressive Disease|2|||
129938679|NCT00622700|467740850|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
129938680|NCT00622700|467740851|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129938681|NCT00622700|467740852|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129938682|NCT00622700|467740853|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
129938683|NCT00622700|467740854|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
129938684|NCT00622700|467740855|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
129938685|NCT00622700|467740856|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
129938686|NCT00622700|467740850|FG000|Extension Treatment Period|Missing|0|||
129938687|NCT00622700|467740851|FG001|Extension Treatment Period|Missing|0|||
129938688|NCT00622700|467740852|FG002|Extension Treatment Period|Missing|0|||
129938689|NCT00622700|467740853|FG003|Extension Treatment Period|Missing|2|||
129938690|NCT00622700|467740854|FG004|Extension Treatment Period|Missing|3|||
129938691|NCT00622700|467740855|FG005|Extension Treatment Period|Missing|1|||
129938692|NCT00622700|467740856|FG006|Extension Treatment Period|Missing|0|||
129938693|NCT00622700|467740850|FG000|Extension Treatment Period|Other than specified above|0|||
129938694|NCT00622700|467740851|FG001|Extension Treatment Period|Other than specified above|0|||
129938695|NCT00622700|467740852|FG002|Extension Treatment Period|Other than specified above|0|||
129938696|NCT00622700|467740853|FG003|Extension Treatment Period|Other than specified above|0|||
129938697|NCT00622700|467740854|FG004|Extension Treatment Period|Other than specified above|0|||
129938698|NCT00622700|467740855|FG005|Extension Treatment Period|Other than specified above|1|||
129938699|NCT00622700|467740856|FG006|Extension Treatment Period|Other than specified above|1|||
129938700|NCT02787005|467740876|FG000|Overall Study|Adverse Event|24|||
129938701|NCT02787005|467740877|FG001|Overall Study|Adverse Event|9|||
129938702|NCT02787005|467740878|FG002|Overall Study|Adverse Event|9|||
129938703|NCT02787005|467740879|FG003|Overall Study|Adverse Event|7|||
129938704|NCT02787005|467740880|FG004|Overall Study|Adverse Event|2|||
129938705|NCT02787005|467740876|FG000|Overall Study|Death|100|||
129938706|NCT02787005|467740877|FG001|Overall Study|Death|53|||
129938707|NCT02787005|467740878|FG002|Overall Study|Death|48|||
129938708|NCT02787005|467740879|FG003|Overall Study|Death|69|||
129938709|NCT02787005|467740880|FG004|Overall Study|Death|38|||
129938710|NCT02787005|467740876|FG000|Overall Study|Sponsor Decision|7|||
129938711|NCT02787005|467740877|FG001|Overall Study|Sponsor Decision|4|||
129938712|NCT02787005|467740878|FG002|Overall Study|Sponsor Decision|0|||
129938713|NCT02787005|467740879|FG003|Overall Study|Sponsor Decision|4|||
129938714|NCT02787005|467740880|FG004|Overall Study|Sponsor Decision|5|||
129938715|NCT02787005|467740876|FG000|Overall Study|Withdrawal by Subject|2|||
129938716|NCT02787005|467740877|FG001|Overall Study|Withdrawal by Subject|1|||
129938717|NCT02787005|467740878|FG002|Overall Study|Withdrawal by Subject|1|||
129938718|NCT02787005|467740879|FG003|Overall Study|Withdrawal by Subject|0|||
129938719|NCT02787005|467740880|FG004|Overall Study|Withdrawal by Subject|1|||
129938720|NCT02787005|467740876|FG000|Overall Study|Screen Failure|0|||
129938721|NCT02787005|467740877|FG001|Overall Study|Screen Failure|2|||
129938722|NCT02787005|467740878|FG002|Overall Study|Screen Failure|0|||
129938723|NCT02787005|467740879|FG003|Overall Study|Screen Failure|0|||
129938724|NCT02787005|467740880|FG004|Overall Study|Screen Failure|1|||
129938725|NCT02787005|467740876|FG000|Overall Study|Lost to Follow-up|0|||
129938726|NCT02787005|467740877|FG001|Overall Study|Lost to Follow-up|0|||
129938727|NCT02787005|467740878|FG002|Overall Study|Lost to Follow-up|0|||
129938728|NCT02787005|467740879|FG003|Overall Study|Lost to Follow-up|1|||
129938729|NCT02787005|467740880|FG004|Overall Study|Lost to Follow-up|0|||
129938730|NCT05580003|467740881|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938731|NCT05580003|467740882|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938732|NCT05580003|467740883|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938733|NCT05580003|467740884|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938734|NCT05580003|467740885|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130071214|NCT00105183|468216047|FG000|Overall Study|Other reason|1|||
130071215|NCT00105183|468216048|FG001|Overall Study|Other reason|2|||
130071216|NCT00105183|468216049|FG002|Overall Study|Other reason|0|||
130071217|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
130071218|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
129938735|NCT05580003|467740886|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938736|NCT05580003|467740887|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
129938737|NCT05580003|467740888|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938738|NCT05580003|467740889|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938739|NCT05580003|467740890|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938740|NCT05580003|467740891|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938741|NCT05580003|467740892|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938742|NCT05580003|467740893|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119768|NCT02576990|468398454|FG000|Overall Study|Physician Decision|1|||
130119769|NCT02576990|468398455|FG001|Overall Study|Physician Decision|0|||
130119770|NCT02576990|468398454|FG000|Overall Study|Screen failure|2|||
130119771|NCT02576990|468398455|FG001|Overall Study|Screen failure|0|||
130119772|NCT02576990|468398454|FG000|Overall Study|Sponsor's decision|24|||
130119773|NCT02576990|468398455|FG001|Overall Study|Sponsor's decision|4|||
130119774|NCT02576990|468398454|FG000|Overall Study|Withdrawal by Subject|0|||
130119775|NCT02576990|468398455|FG001|Overall Study|Withdrawal by Subject|2|||
130119776|NCT02415959|468398456|FG000|Overall Study|Adverse Event|0|||
130119777|NCT02415959|468398457|FG001|Overall Study|Adverse Event|1|||
130119778|NCT02415959|468398458|FG002|Overall Study|Adverse Event|0|||
130119779|NCT02415959|468398459|FG003|Overall Study|Adverse Event|0|||
130119780|NCT02415959|468398460|FG004|Overall Study|Adverse Event|0|||
130119781|NCT02415959|468398456|FG000|Overall Study|Protocol Violation|0|||
130119782|NCT02415959|468398457|FG001|Overall Study|Protocol Violation|0|||
130119783|NCT02415959|468398458|FG002|Overall Study|Protocol Violation|0|||
130119784|NCT02415959|468398459|FG003|Overall Study|Protocol Violation|1|||
130119785|NCT02415959|468398460|FG004|Overall Study|Protocol Violation|0|||
130119786|NCT00911859|468398461|FG000|Treatment Period|Adverse Event|3|||
130119787|NCT00911859|468398462|FG001|Treatment Period|Adverse Event|3|||
130119788|NCT00911859|468398463|FG002|Treatment Period|Adverse Event|7|||
130119789|NCT00911859|468398461|FG000|Treatment Period|Death|1|||
130119790|NCT00911859|468398462|FG001|Treatment Period|Death|3|||
130119791|NCT00911859|468398463|FG002|Treatment Period|Death|5|||
130119792|NCT00911859|468398461|FG000|Treatment Period|Lack of Efficacy|1|||
130119793|NCT00911859|468398462|FG001|Treatment Period|Lack of Efficacy|7|||
130119794|NCT00911859|468398463|FG002|Treatment Period|Lack of Efficacy|5|||
130119795|NCT00911859|468398461|FG000|Treatment Period|Physician Decision|3|||
130119796|NCT00911859|468398462|FG001|Treatment Period|Physician Decision|3|||
130119797|NCT00911859|468398463|FG002|Treatment Period|Physician Decision|3|||
130119798|NCT00911859|468398461|FG000|Treatment Period|Withdrawal by Subject|0|||
130119799|NCT00911859|468398462|FG001|Treatment Period|Withdrawal by Subject|4|||
130119800|NCT00911859|468398463|FG002|Treatment Period|Withdrawal by Subject|5|||
130119801|NCT00911859|468398461|FG000|Treatment Period|Did not receive study treatment|0|||
130119802|NCT00911859|468398462|FG001|Treatment Period|Did not receive study treatment|1|||
130119803|NCT00911859|468398463|FG002|Treatment Period|Did not receive study treatment|0|||
130119804|NCT00911859|468398461|FG000|Maintainance Period|Lack of Efficacy|0|||
130119805|NCT00911859|468398462|FG001|Maintainance Period|Lack of Efficacy|0|||
130119806|NCT00911859|468398463|FG002|Maintainance Period|Lack of Efficacy|9|||
130119807|NCT00911859|468398461|FG000|Maintainance Period|Physician Decision|0|||
130119808|NCT00911859|468398462|FG001|Maintainance Period|Physician Decision|0|||
130119809|NCT00911859|468398463|FG002|Maintainance Period|Physician Decision|9|||
130119810|NCT00911859|468398461|FG000|Maintainance Period|Withdrawal by Subject|0|||
130119811|NCT00911859|468398462|FG001|Maintainance Period|Withdrawal by Subject|0|||
130119812|NCT00911859|468398463|FG002|Maintainance Period|Withdrawal by Subject|3|||
130119813|NCT00911859|468398461|FG000|Follow-up Period|Death|5|||
130119814|NCT00911859|468398462|FG001|Follow-up Period|Death|8|||
130119815|NCT00911859|468398463|FG002|Follow-up Period|Death|10|||
130119816|NCT00911859|468398461|FG000|Follow-up Period|Lost to Follow-up|1|||
130119817|NCT00911859|468398462|FG001|Follow-up Period|Lost to Follow-up|1|||
130119818|NCT00911859|468398463|FG002|Follow-up Period|Lost to Follow-up|0|||
129938743|NCT05580003|467740894|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938744|NCT05580003|467740895|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938745|NCT05580003|467740896|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938746|NCT05580003|467740897|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938747|NCT05580003|467740898|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938748|NCT05580003|467740899|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119819|NCT00911859|468398461|FG000|Follow-up Period|Withdrawal by Subject|0|||
130119820|NCT00911859|468398462|FG001|Follow-up Period|Withdrawal by Subject|4|||
130119821|NCT00911859|468398463|FG002|Follow-up Period|Withdrawal by Subject|4|||
130119822|NCT00911859|468398461|FG000|Follow-up Period|Study terminated by sponsor|5|||
130119823|NCT00911859|468398462|FG001|Follow-up Period|Study terminated by sponsor|33|||
130119824|NCT00911859|468398463|FG002|Follow-up Period|Study terminated by sponsor|27|||
130119825|NCT01048333|468398466|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129938749|NCT05580003|467740900|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938750|NCT05580003|467740901|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119826|NCT01048333|468398467|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
130119827|NCT01048333|468398468|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130119828|NCT01048333|468398469|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130119829|NCT01048333|468398470|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130119830|NCT01048333|468398471|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
130119831|NCT02456909|468398472|FG000|Overall Study|Did not receive allocated intervention|24|||
130119832|NCT02456909|468398473|FG001|Overall Study|Did not receive allocated intervention|26|||
130119833|NCT02456909|468398472|FG000|Overall Study|Did not complete the primary outcome|0|||
130119834|NCT02456909|468398473|FG001|Overall Study|Did not complete the primary outcome|1|||
129938751|NCT05580003|467740902|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938752|NCT05580003|467740903|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938753|NCT05580003|467740904|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938754|NCT05580003|467740905|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938755|NCT05580003|467740906|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938756|NCT05580003|467740907|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938757|NCT05580003|467740908|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938758|NCT05580003|467740881|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938759|NCT05580003|467740882|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938760|NCT05580003|467740883|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938761|NCT05580003|467740884|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938762|NCT05580003|467740885|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938763|NCT05580003|467740886|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
129938764|NCT05580003|467740887|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938765|NCT05580003|467740888|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938766|NCT05580003|467740889|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938767|NCT05580003|467740890|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938768|NCT05580003|467740891|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938769|NCT05580003|467740892|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938770|NCT05580003|467740893|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938771|NCT05580003|467740894|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938772|NCT05580003|467740895|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938773|NCT05580003|467740896|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938774|NCT05580003|467740897|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938775|NCT05580003|467740898|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938776|NCT05580003|467740899|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938777|NCT05580003|467740900|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938778|NCT05580003|467740901|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938779|NCT05580003|467740902|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938780|NCT05580003|467740903|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938781|NCT05580003|467740904|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938782|NCT05580003|467740905|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938783|NCT05580003|467740906|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938784|NCT05580003|467740907|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938785|NCT05580003|467740908|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
130071219|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
130071220|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
130071221|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
130071222|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
130071223|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
130071224|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
130071225|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
130071226|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
130071227|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130071228|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130071229|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130071230|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
130071231|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
130071232|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
130071233|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
130071234|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
130071235|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
130071236|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
130071237|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
130071238|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
130071239|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
130071240|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
130071241|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
130071242|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Other|1|||
129938786|NCT05580003|467740881|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938787|NCT05580003|467740882|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938788|NCT05580003|467740883|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938789|NCT05580003|467740884|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
129938790|NCT05580003|467740885|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938791|NCT05580003|467740886|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938792|NCT05580003|467740887|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938793|NCT05580003|467740888|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938794|NCT05580003|467740889|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938795|NCT05580003|467740890|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938796|NCT05580003|467740891|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938797|NCT05580003|467740892|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938798|NCT05580003|467740893|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938799|NCT05580003|467740894|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938800|NCT05580003|467740895|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938801|NCT05580003|467740896|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938802|NCT05580003|467740897|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938803|NCT05580003|467740898|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938804|NCT05580003|467740899|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938805|NCT05580003|467740900|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938806|NCT05580003|467740901|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938807|NCT05580003|467740902|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938808|NCT05580003|467740903|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938809|NCT05580003|467740904|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938810|NCT05580003|467740905|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938811|NCT05580003|467740906|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938812|NCT05580003|467740907|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938813|NCT05580003|467740908|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938814|NCT05580003|467740881|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938815|NCT05580003|467740882|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
129938816|NCT05580003|467740883|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938817|NCT05580003|467740884|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938818|NCT05580003|467740885|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938819|NCT05580003|467740886|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938820|NCT05580003|467740887|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938821|NCT05580003|467740888|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938822|NCT05580003|467740889|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938823|NCT05580003|467740890|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938824|NCT05580003|467740891|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938825|NCT05580003|467740892|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938826|NCT05580003|467740893|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938827|NCT05580003|467740894|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938828|NCT05580003|467740895|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938829|NCT05580003|467740896|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938830|NCT05580003|467740897|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938831|NCT05580003|467740898|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938832|NCT05580003|467740899|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938833|NCT05580003|467740900|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938834|NCT05580003|467740901|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938835|NCT05580003|467740902|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938836|NCT05580003|467740903|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938837|NCT05580003|467740904|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938838|NCT05580003|467740905|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938839|NCT05580003|467740906|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938840|NCT05580003|467740907|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938841|NCT05580003|467740908|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938842|NCT05580003|467740881|FG000|Part 2 (up to 10 Days)|Other|0|||
129938843|NCT05580003|467740882|FG001|Part 2 (up to 10 Days)|Other|0|||
129938844|NCT05580003|467740883|FG002|Part 2 (up to 10 Days)|Other|0|||
129938845|NCT05580003|467740884|FG003|Part 2 (up to 10 Days)|Other|0|||
129938846|NCT05580003|467740885|FG004|Part 2 (up to 10 Days)|Other|0|||
129938847|NCT05580003|467740886|FG005|Part 2 (up to 10 Days)|Other|0|||
129938848|NCT05580003|467740887|FG006|Part 2 (up to 10 Days)|Other|0|||
129938849|NCT05580003|467740888|FG007|Part 2 (up to 10 Days)|Other|0|||
129938850|NCT05580003|467740889|FG008|Part 2 (up to 10 Days)|Other|0|||
129938851|NCT05580003|467740890|FG009|Part 2 (up to 10 Days)|Other|1|||
129938852|NCT05580003|467740891|FG010|Part 2 (up to 10 Days)|Other|0|||
129938853|NCT05580003|467740892|FG011|Part 2 (up to 10 Days)|Other|0|||
129938854|NCT05580003|467740893|FG012|Part 2 (up to 10 Days)|Other|0|||
129938855|NCT05580003|467740894|FG013|Part 2 (up to 10 Days)|Other|0|||
129938856|NCT05580003|467740895|FG014|Part 2 (up to 10 Days)|Other|0|||
129938857|NCT05580003|467740896|FG015|Part 2 (up to 10 Days)|Other|0|||
129938858|NCT05580003|467740897|FG016|Part 2 (up to 10 Days)|Other|0|||
130071243|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Other|0|||
130071244|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Other|0|||
130071245|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Other|0|||
130071246|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Other|1|||
130094810|NCT03996694|468303848|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
129938859|NCT05580003|467740898|FG017|Part 2 (up to 10 Days)|Other|0|||
129938860|NCT05580003|467740899|FG018|Part 2 (up to 10 Days)|Other|0|||
129938861|NCT05580003|467740900|FG019|Part 2 (up to 10 Days)|Other|0|||
129938862|NCT05580003|467740901|FG020|Part 2 (up to 10 Days)|Other|0|||
129938863|NCT05580003|467740902|FG021|Part 2 (up to 10 Days)|Other|0|||
129938864|NCT05580003|467740903|FG022|Part 2 (up to 10 Days)|Other|0|||
129938865|NCT05580003|467740904|FG023|Part 2 (up to 10 Days)|Other|0|||
129938866|NCT05580003|467740905|FG024|Part 2 (up to 10 Days)|Other|0|||
129938867|NCT05580003|467740906|FG025|Part 2 (up to 10 Days)|Other|0|||
129938868|NCT05580003|467740907|FG026|Part 2 (up to 10 Days)|Other|0|||
129938869|NCT05580003|467740908|FG027|Part 2 (up to 10 Days)|Other|0|||
129938870|NCT05580003|467740881|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938871|NCT05580003|467740882|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938872|NCT05580003|467740883|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938873|NCT05580003|467740884|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938874|NCT05580003|467740885|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938875|NCT05580003|467740886|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938876|NCT05580003|467740887|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938877|NCT05580003|467740888|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938878|NCT05580003|467740889|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938879|NCT05580003|467740890|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938880|NCT05580003|467740891|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938881|NCT05580003|467740892|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938882|NCT05580003|467740893|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938883|NCT05580003|467740894|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938884|NCT05580003|467740895|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938885|NCT05580003|467740896|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938886|NCT05580003|467740897|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938887|NCT05580003|467740898|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938888|NCT05580003|467740899|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938889|NCT05580003|467740900|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
129938890|NCT05580003|467740901|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938891|NCT05580003|467740902|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938892|NCT05580003|467740903|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938893|NCT05580003|467740904|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938894|NCT05580003|467740905|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938895|NCT05580003|467740906|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938896|NCT05580003|467740907|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938897|NCT05580003|467740908|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938898|NCT05580003|467740881|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938899|NCT05580003|467740882|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938900|NCT05580003|467740883|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938901|NCT05580003|467740884|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938902|NCT05580003|467740885|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938903|NCT05580003|467740886|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938904|NCT05580003|467740887|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938905|NCT05580003|467740888|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938906|NCT05580003|467740889|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938907|NCT05580003|467740890|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938908|NCT05580003|467740891|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938909|NCT05580003|467740892|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938910|NCT05580003|467740893|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938911|NCT05580003|467740894|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938912|NCT05580003|467740895|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938913|NCT05580003|467740896|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938914|NCT05580003|467740897|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938915|NCT05580003|467740898|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938916|NCT05580003|467740899|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938917|NCT05580003|467740900|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938918|NCT05580003|467740901|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
129938919|NCT05580003|467740902|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938920|NCT05580003|467740903|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938921|NCT05580003|467740904|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938922|NCT05580003|467740905|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938923|NCT05580003|467740906|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938924|NCT05580003|467740907|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938925|NCT05580003|467740908|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938926|NCT05580003|467740881|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938927|NCT05580003|467740882|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938928|NCT05580003|467740883|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938929|NCT05580003|467740884|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938930|NCT05580003|467740885|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938931|NCT05580003|467740886|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938932|NCT05580003|467740887|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938933|NCT05580003|467740888|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938934|NCT05580003|467740889|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938935|NCT05580003|467740890|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938936|NCT05580003|467740891|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938937|NCT05580003|467740892|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938938|NCT05580003|467740893|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938939|NCT05580003|467740894|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938940|NCT05580003|467740895|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938941|NCT05580003|467740896|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938942|NCT05580003|467740897|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938943|NCT05580003|467740898|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938944|NCT05580003|467740899|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
130071247|NCT02980692|468216050|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
130071248|NCT02980692|468216051|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
130071249|NCT02980692|468216052|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
130071250|NCT02980692|468216053|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
130071251|NCT02980692|468216054|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
130071252|NCT02980692|468216050|FG000|Double-blind Follow-up Period|Adverse Event|0|||
130071253|NCT02980692|468216051|FG001|Double-blind Follow-up Period|Adverse Event|0|||
130071254|NCT02980692|468216052|FG002|Double-blind Follow-up Period|Adverse Event|0|||
130071255|NCT02980692|468216053|FG003|Double-blind Follow-up Period|Adverse Event|1|||
130071256|NCT02980692|468216054|FG004|Double-blind Follow-up Period|Adverse Event|1|||
130071257|NCT02980692|468216050|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
130071258|NCT02980692|468216051|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
130071259|NCT02980692|468216052|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
130071260|NCT02980692|468216053|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
130071261|NCT02980692|468216054|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
130071262|NCT02980692|468216050|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
130071263|NCT02980692|468216051|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
130071264|NCT02980692|468216052|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
130071265|NCT02980692|468216053|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
130071266|NCT02980692|468216054|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
130071267|NCT02980692|468216050|FG000|Double-blind Follow-up Period|Pregnancy|0|||
130071268|NCT02980692|468216051|FG001|Double-blind Follow-up Period|Pregnancy|0|||
130071269|NCT02980692|468216052|FG002|Double-blind Follow-up Period|Pregnancy|1|||
130071270|NCT02980692|468216053|FG003|Double-blind Follow-up Period|Pregnancy|1|||
130071271|NCT02980692|468216054|FG004|Double-blind Follow-up Period|Pregnancy|0|||
130071272|NCT02980692|468216050|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
130071273|NCT02980692|468216051|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
130071274|NCT02980692|468216052|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
130071275|NCT02980692|468216053|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
130071276|NCT02980692|468216054|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
130071277|NCT02980692|468216050|FG000|Double-blind Follow-up Period|Other|0|||
130071278|NCT02980692|468216051|FG001|Double-blind Follow-up Period|Other|0|||
130071279|NCT02980692|468216052|FG002|Double-blind Follow-up Period|Other|1|||
130071280|NCT02980692|468216053|FG003|Double-blind Follow-up Period|Other|1|||
130071281|NCT02980692|468216054|FG004|Double-blind Follow-up Period|Other|3|||
130071282|NCT00563368|468216058|FG000|Overall Study|Lost to Follow-up|14|||
130071283|NCT00563368|468216059|FG001|Overall Study|Lost to Follow-up|14|||
130071284|NCT00563368|468216060|FG002|Overall Study|Lost to Follow-up|12|||
130071285|NCT00563368|468216061|FG003|Overall Study|Lost to Follow-up|6|||
130071286|NCT00563368|468216062|FG004|Overall Study|Lost to Follow-up|9|||
130071287|NCT00563368|468216063|FG005|Overall Study|Lost to Follow-up|8|||
130071288|NCT00563368|468216064|FG006|Overall Study|Lost to Follow-up|9|||
130071289|NCT00563368|468216058|FG000|Overall Study|Adverse Event|3|||
130071290|NCT00563368|468216059|FG001|Overall Study|Adverse Event|4|||
130071291|NCT00563368|468216060|FG002|Overall Study|Adverse Event|5|||
130071292|NCT00563368|468216061|FG003|Overall Study|Adverse Event|9|||
130071293|NCT00563368|468216062|FG004|Overall Study|Adverse Event|6|||
130071294|NCT00563368|468216063|FG005|Overall Study|Adverse Event|10|||
130071295|NCT00563368|468216064|FG006|Overall Study|Adverse Event|17|||
130071296|NCT00563368|468216058|FG000|Overall Study|Withdrawal by Subject|11|||
130071297|NCT00563368|468216059|FG001|Overall Study|Withdrawal by Subject|6|||
130071298|NCT00563368|468216060|FG002|Overall Study|Withdrawal by Subject|5|||
129938945|NCT05580003|467740900|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938946|NCT05580003|467740901|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938947|NCT05580003|467740902|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
129938948|NCT05580003|467740903|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938949|NCT05580003|467740904|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938950|NCT05580003|467740905|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938951|NCT05580003|467740906|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938952|NCT05580003|467740907|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938953|NCT05580003|467740908|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938954|NCT05580003|467740881|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938955|NCT05580003|467740882|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938956|NCT05580003|467740883|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938957|NCT05580003|467740884|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938958|NCT05580003|467740885|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938959|NCT05580003|467740886|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938960|NCT05580003|467740887|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938961|NCT05580003|467740888|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938962|NCT05580003|467740889|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938963|NCT05580003|467740890|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938964|NCT05580003|467740891|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938965|NCT05580003|467740892|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938966|NCT05580003|467740893|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938967|NCT05580003|467740894|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938968|NCT05580003|467740895|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938969|NCT05580003|467740896|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938970|NCT05580003|467740897|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938971|NCT05580003|467740898|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938972|NCT05580003|467740899|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938973|NCT05580003|467740900|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938974|NCT05580003|467740901|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938975|NCT05580003|467740902|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938976|NCT05580003|467740903|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938977|NCT05580003|467740904|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938978|NCT05580003|467740905|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938979|NCT05580003|467740906|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938980|NCT05580003|467740907|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938981|NCT05580003|467740908|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
129938982|NCT05580003|467740881|FG000|Part 6 Period 2 (Day 1)|Other|0|||
129938983|NCT05580003|467740882|FG001|Part 6 Period 2 (Day 1)|Other|0|||
129938984|NCT05580003|467740883|FG002|Part 6 Period 2 (Day 1)|Other|0|||
129938985|NCT05580003|467740884|FG003|Part 6 Period 2 (Day 1)|Other|0|||
129938986|NCT05580003|467740885|FG004|Part 6 Period 2 (Day 1)|Other|0|||
129938987|NCT05580003|467740886|FG005|Part 6 Period 2 (Day 1)|Other|0|||
129938988|NCT05580003|467740887|FG006|Part 6 Period 2 (Day 1)|Other|0|||
129938989|NCT05580003|467740888|FG007|Part 6 Period 2 (Day 1)|Other|0|||
129938990|NCT05580003|467740889|FG008|Part 6 Period 2 (Day 1)|Other|0|||
129938991|NCT05580003|467740890|FG009|Part 6 Period 2 (Day 1)|Other|0|||
129938992|NCT05580003|467740891|FG010|Part 6 Period 2 (Day 1)|Other|0|||
129938993|NCT05580003|467740892|FG011|Part 6 Period 2 (Day 1)|Other|0|||
129938994|NCT05580003|467740893|FG012|Part 6 Period 2 (Day 1)|Other|0|||
129938995|NCT05580003|467740894|FG013|Part 6 Period 2 (Day 1)|Other|0|||
129938996|NCT05580003|467740895|FG014|Part 6 Period 2 (Day 1)|Other|0|||
129938997|NCT05580003|467740896|FG015|Part 6 Period 2 (Day 1)|Other|0|||
129938998|NCT05580003|467740897|FG016|Part 6 Period 2 (Day 1)|Other|0|||
129938999|NCT05580003|467740898|FG017|Part 6 Period 2 (Day 1)|Other|0|||
129939000|NCT05580003|467740899|FG018|Part 6 Period 2 (Day 1)|Other|0|||
129939001|NCT05580003|467740900|FG019|Part 6 Period 2 (Day 1)|Other|0|||
129939002|NCT05580003|467740901|FG020|Part 6 Period 2 (Day 1)|Other|0|||
129939003|NCT05580003|467740902|FG021|Part 6 Period 2 (Day 1)|Other|0|||
129939004|NCT05580003|467740903|FG022|Part 6 Period 2 (Day 1)|Other|0|||
129939005|NCT05580003|467740904|FG023|Part 6 Period 2 (Day 1)|Other|0|||
129939006|NCT05580003|467740905|FG024|Part 6 Period 2 (Day 1)|Other|1|||
129939007|NCT05580003|467740906|FG025|Part 6 Period 2 (Day 1)|Other|0|||
129939008|NCT05580003|467740907|FG026|Part 6 Period 2 (Day 1)|Other|0|||
129939009|NCT05580003|467740908|FG027|Part 6 Period 2 (Day 1)|Other|0|||
129939010|NCT02029235|467740909|FG000|Overall Study|Non-compliance with study meds or diary|4|||
129939011|NCT02029235|467740910|FG001|Overall Study|Non-compliance with study meds or diary|1|||
129939012|NCT00701701|467740911|FG000|Overall Study|Withdrawal by Subject|0|||
129939013|NCT00701701|467740912|FG001|Overall Study|Withdrawal by Subject|1|||
129939014|NCT00701701|467740911|FG000|Overall Study|Adverse Event|0|||
129939015|NCT00701701|467740912|FG001|Overall Study|Adverse Event|1|||
129939016|NCT00589875|467740913|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
129939017|NCT00589875|467740913|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
129939018|NCT03593226|467740930|FG000|Overall Study|Disease progression|6|||
129939019|NCT03593226|467740931|FG001|Overall Study|Disease progression|13|||
129939020|NCT03593226|467740932|FG002|Overall Study|Disease progression|5|||
129939021|NCT03593226|467740933|FG003|Overall Study|Disease progression|6|||
129939022|NCT03593226|467740930|FG000|Overall Study|Adverse Event|0|||
129939023|NCT03593226|467740931|FG001|Overall Study|Adverse Event|1|||
129939024|NCT03593226|467740932|FG002|Overall Study|Adverse Event|0|||
129939025|NCT03593226|467740933|FG003|Overall Study|Adverse Event|0|||
129939026|NCT03593226|467740930|FG000|Overall Study|Withdrawal by Subject|0|||
129939027|NCT03593226|467740931|FG001|Overall Study|Withdrawal by Subject|4|||
129939028|NCT03593226|467740932|FG002|Overall Study|Withdrawal by Subject|1|||
129939029|NCT03593226|467740933|FG003|Overall Study|Withdrawal by Subject|0|||
129939030|NCT03593226|467740930|FG000|Overall Study|Physician Decision|0|||
129939031|NCT03593226|467740931|FG001|Overall Study|Physician Decision|1|||
129939032|NCT03593226|467740932|FG002|Overall Study|Physician Decision|0|||
129939033|NCT03593226|467740933|FG003|Overall Study|Physician Decision|0|||
129939034|NCT03593226|467740930|FG000|Overall Study|Clinical disease progression|0|||
129939035|NCT03593226|467740931|FG001|Overall Study|Clinical disease progression|0|||
129939036|NCT03593226|467740932|FG002|Overall Study|Clinical disease progression|1|||
129939037|NCT03593226|467740933|FG003|Overall Study|Clinical disease progression|0|||
129939038|NCT04517435|467740934|FG000|Overall Study|Withdrawal by Subject|0|||
129939039|NCT04517435|467740935|FG001|Overall Study|Withdrawal by Subject|0|||
129939040|NCT04517435|467740936|FG002|Overall Study|Withdrawal by Subject|1|||
129939041|NCT04517435|467740934|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
129939042|NCT04517435|467740935|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
129939043|NCT04517435|467740936|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
129939044|NCT04057131|467740937|FG000|Overall Study|Protocol Violation|24|||
129939045|NCT03160885|467740938|FG000|Initial Treatment Period|Not dosed|2|||
129939046|NCT03160885|467740939|FG001|Initial Treatment Period|Not dosed|0|||
129939047|NCT03160885|467740940|FG002|Initial Treatment Period|Not dosed|0|||
129939048|NCT03160885|467740941|FG003|Initial Treatment Period|Not dosed|0|||
129939049|NCT03160885|467740942|FG004|Initial Treatment Period|Not dosed|0|||
129939050|NCT03160885|467740943|FG005|Initial Treatment Period|Not dosed|0|||
129939051|NCT03160885|467740944|FG006|Initial Treatment Period|Not dosed|0|||
129939052|NCT03160885|467740938|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
129939053|NCT03160885|467740939|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
129939054|NCT03160885|467740940|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939055|NCT03160885|467740941|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939056|NCT03160885|467740942|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939057|NCT03160885|467740943|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939058|NCT03160885|467740944|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939059|NCT03160885|467740938|FG000|Open-label Treatment|Not dosed|0|||
129939060|NCT03160885|467740939|FG001|Open-label Treatment|Not dosed|0|||
129939061|NCT03160885|467740940|FG002|Open-label Treatment|Not dosed|0|||
129939062|NCT03160885|467740941|FG003|Open-label Treatment|Not dosed|0|||
129939063|NCT03160885|467740942|FG004|Open-label Treatment|Not dosed|0|||
129939064|NCT03160885|467740943|FG005|Open-label Treatment|Not dosed|0|||
129939065|NCT03160885|467740944|FG006|Open-label Treatment|Not dosed|2|||
129939066|NCT03160885|467740938|FG000|Open-label Treatment|Discontinued IMP|0|||
129939067|NCT03160885|467740939|FG001|Open-label Treatment|Discontinued IMP|0|||
129939068|NCT03160885|467740940|FG002|Open-label Treatment|Discontinued IMP|0|||
129939069|NCT03160885|467740941|FG003|Open-label Treatment|Discontinued IMP|0|||
129939070|NCT03160885|467740942|FG004|Open-label Treatment|Discontinued IMP|0|||
129939071|NCT03160885|467740943|FG005|Open-label Treatment|Discontinued IMP|0|||
129939072|NCT03160885|467740944|FG006|Open-label Treatment|Discontinued IMP|131|||
129939073|NCT03160885|467740938|FG000|Open-label Treatment|Completed Week 50|0|||
129939074|NCT03160885|467740939|FG001|Open-label Treatment|Completed Week 50|0|||
129939075|NCT03160885|467740940|FG002|Open-label Treatment|Completed Week 50|0|||
129939076|NCT03160885|467740941|FG003|Open-label Treatment|Completed Week 50|0|||
129939077|NCT03160885|467740942|FG004|Open-label Treatment|Completed Week 50|0|||
129939078|NCT03160885|467740943|FG005|Open-label Treatment|Completed Week 50|0|||
129939079|NCT03160885|467740944|FG006|Open-label Treatment|Completed Week 50|4|||
129939080|NCT03160885|467740938|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939081|NCT03160885|467740939|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939082|NCT03160885|467740940|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939083|NCT03160885|467740941|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
129939084|NCT03160885|467740942|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939085|NCT03160885|467740943|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939086|NCT03160885|467740944|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939087|NCT03160885|467740938|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
129939088|NCT03160885|467740939|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
129939089|NCT03160885|467740940|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
129939090|NCT03160885|467740941|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
129939091|NCT03160885|467740942|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
129939092|NCT03160885|467740943|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
129939093|NCT03160885|467740944|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
129939094|NCT03160885|467740938|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129939095|NCT03160885|467740939|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129939096|NCT03160885|467740940|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
129939097|NCT03160885|467740941|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
129939098|NCT03160885|467740942|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
129939099|NCT03160885|467740943|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
129939100|NCT03160885|467740944|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129939101|NCT03160885|467740938|FG000|Maintenance Treatment Period|Completed Week 50|0|||
129939102|NCT03160885|467740939|FG001|Maintenance Treatment Period|Completed Week 50|0|||
129939103|NCT03160885|467740940|FG002|Maintenance Treatment Period|Completed Week 50|1|||
129939104|NCT03160885|467740941|FG003|Maintenance Treatment Period|Completed Week 50|0|||
129939105|NCT03160885|467740942|FG004|Maintenance Treatment Period|Completed Week 50|0|||
129939106|NCT03160885|467740943|FG005|Maintenance Treatment Period|Completed Week 50|0|||
129939107|NCT03160885|467740944|FG006|Maintenance Treatment Period|Completed Week 50|0|||
129939108|NCT05704725|467740947|FG000|Overall Study|Lost to Follow-up|0|||
129939109|NCT05704725|467740948|FG001|Overall Study|Lost to Follow-up|1|||
129939110|NCT05704725|467740947|FG000|Overall Study|Withdrawal by Subject|1|||
129939111|NCT05704725|467740948|FG001|Overall Study|Withdrawal by Subject|0|||
129939112|NCT04484623|467740949|FG000|Overall Study|Lost to Follow-up|0|||
129939113|NCT04484623|467740950|FG001|Overall Study|Lost to Follow-up|1|||
129939114|NCT04484623|467740949|FG000|Overall Study|Protocol Deviation|1|||
129939115|NCT04484623|467740950|FG001|Overall Study|Protocol Deviation|0|||
129939116|NCT04484623|467740949|FG000|Overall Study|Physician Decision|1|||
129939117|NCT04484623|467740950|FG001|Overall Study|Physician Decision|0|||
129939118|NCT04484623|467740949|FG000|Overall Study|Withdrawal by Subject|11|||
129939119|NCT04484623|467740950|FG001|Overall Study|Withdrawal by Subject|8|||
129939120|NCT04484623|467740949|FG000|Overall Study|Ongoing|94|||
129939121|NCT04484623|467740950|FG001|Overall Study|Ongoing|84|||
129939122|NCT04551066|467740951|FG000|Overall Study|Death|5|||
129939123|NCT04551066|467740952|FG001|Overall Study|Death|3|||
129939124|NCT04551066|467740951|FG000|Overall Study|Lost to Follow-up|1|||
129939125|NCT04551066|467740952|FG001|Overall Study|Lost to Follow-up|0|||
129939126|NCT04551066|467740951|FG000|Overall Study|Sponsor Decision|103|||
129939127|NCT04551066|467740952|FG001|Overall Study|Sponsor Decision|117|||
129939128|NCT04551066|467740951|FG000|Overall Study|Withdrawal by Subject|8|||
129939129|NCT04551066|467740952|FG001|Overall Study|Withdrawal by Subject|2|||
129939130|NCT04551066|467740951|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
129939131|NCT04551066|467740952|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
129939132|NCT04551066|467740951|FG000|Overall Study|Adverse Event|2|||
129939133|NCT04551066|467740952|FG001|Overall Study|Adverse Event|0|||
129939134|NCT04551066|467740951|FG000|Overall Study|Physician Decision|2|||
129939135|NCT04551066|467740952|FG001|Overall Study|Physician Decision|0|||
129939136|NCT04551066|467740951|FG000|Overall Study|Protocol Violation|1|||
129939137|NCT04551066|467740952|FG001|Overall Study|Protocol Violation|0|||
129939138|NCT04551066|467740951|FG000|Overall Study|Lack of Efficacy|0|||
129939139|NCT04551066|467740952|FG001|Overall Study|Lack of Efficacy|1|||
129939140|NCT04551066|467740951|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
129939141|NCT04551066|467740952|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
129939142|NCT05529992|467740953|FG000|Overall Study|Withdrawal by Subject|1|||
129939143|NCT00210106|467742333|FG000|Overall Study|Death|1|||
129939144|NCT00210106|467742333|FG000|Overall Study|Protocol Violation|13|||
129939145|NCT00065182|467742338|FG000|Overall Study|Adverse Event|24|||
130071299|NCT00563368|468216061|FG003|Overall Study|Withdrawal by Subject|7|||
130071300|NCT00563368|468216062|FG004|Overall Study|Withdrawal by Subject|8|||
130071301|NCT00563368|468216063|FG005|Overall Study|Withdrawal by Subject|5|||
130071302|NCT00563368|468216064|FG006|Overall Study|Withdrawal by Subject|4|||
130071303|NCT00563368|468216058|FG000|Overall Study|protocol non-compliance|1|||
130071304|NCT00563368|468216059|FG001|Overall Study|protocol non-compliance|1|||
130071305|NCT00563368|468216060|FG002|Overall Study|protocol non-compliance|2|||
130071306|NCT00563368|468216061|FG003|Overall Study|protocol non-compliance|1|||
129939146|NCT00065182|467742339|FG001|Overall Study|Adverse Event|17|||
129939147|NCT00065182|467742338|FG000|Overall Study|Lost to Follow-up|0|||
129939148|NCT00065182|467742339|FG001|Overall Study|Lost to Follow-up|4|||
130071307|NCT00563368|468216062|FG004|Overall Study|protocol non-compliance|0|||
129939149|NCT00065182|467742338|FG000|Overall Study|Protocol Violation|3|||
129939150|NCT00065182|467742339|FG001|Overall Study|Protocol Violation|4|||
129939151|NCT00065182|467742338|FG000|Overall Study|Serious adverse events (SAE)|1|||
129939152|NCT00065182|467742339|FG001|Overall Study|Serious adverse events (SAE)|0|||
129939153|NCT00065182|467742338|FG000|Overall Study|Sponsor Decision|11|||
129939154|NCT00065182|467742339|FG001|Overall Study|Sponsor Decision|7|||
129939155|NCT00065182|467742338|FG000|Overall Study|Withdrawal by Subject|8|||
129939156|NCT00065182|467742339|FG001|Overall Study|Withdrawal by Subject|3|||
129939157|NCT00065182|467742338|FG000|Overall Study|No clinical benefit|1|||
129939158|NCT00065182|467742339|FG001|Overall Study|No clinical benefit|0|||
129939159|NCT00065182|467742338|FG000|Overall Study|Death|0|||
129939160|NCT00065182|467742339|FG001|Overall Study|Death|1|||
129939161|NCT00065182|467742338|FG000|Overall Study|Decline in Status|0|||
129939162|NCT00065182|467742339|FG001|Overall Study|Decline in Status|1|||
129939163|NCT04876417|467742342|FG000|Overall Study|Lost to Follow-up|5|||
129939164|NCT04876417|467742343|FG001|Overall Study|Lost to Follow-up|8|||
129939165|NCT04876417|467742344|FG002|Overall Study|Lost to Follow-up|0|||
129939166|NCT04876417|467742345|FG003|Overall Study|Lost to Follow-up|0|||
129939167|NCT03801148|467742346|FG000|Period 1 (2 Days)|Adverse Event|1|||
129939168|NCT03801148|467742347|FG001|Period 1 (2 Days)|Adverse Event|1|||
129939169|NCT03801148|467742348|FG002|Period 1 (2 Days)|Adverse Event|0|||
129939170|NCT03801148|467742349|FG003|Period 1 (2 Days)|Adverse Event|0|||
129939171|NCT03801148|467742346|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129939172|NCT03801148|467742347|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129939173|NCT03801148|467742348|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129939174|NCT03801148|467742349|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
129939175|NCT03801148|467742346|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129939176|NCT03801148|467742347|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129939177|NCT03801148|467742348|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129939178|NCT03801148|467742349|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129939179|NCT03801148|467742346|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
129939180|NCT03801148|467742347|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
129939181|NCT03801148|467742348|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
129939182|NCT03801148|467742349|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
129939183|NCT00439270|467742350|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
129939184|NCT00439270|467742351|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
129939185|NCT00439270|467742352|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
129939186|NCT00439270|467742353|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
129939187|NCT00439270|467742354|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
129939188|NCT00439270|467742350|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939189|NCT00439270|467742351|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
129939190|NCT00439270|467742352|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939191|NCT00439270|467742353|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939192|NCT00439270|467742354|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939193|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
129939194|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
129939195|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
129939196|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
129939197|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
129939198|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939199|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939200|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939201|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
129939202|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939203|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939204|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939205|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939206|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
129939207|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939208|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939209|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939210|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939211|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
129939212|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939213|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129939214|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129939215|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129939216|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
129939217|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
130119835|NCT01497938|468398476|FG000|Overall Study|Adverse Event|0|||
130119836|NCT01497938|468398477|FG001|Overall Study|Adverse Event|1|||
129939218|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939219|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939220|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939221|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
129939222|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939223|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939224|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939225|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939226|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
130119837|NCT01497938|468398476|FG000|Overall Study|Physician Decision|0|||
129939227|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939228|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939229|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939230|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939231|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
129939232|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939233|NCT01750684|467742355|FG000|Overall Study|Death|1|||
129939234|NCT01750684|467742356|FG001|Overall Study|Death|0|||
129939235|NCT01750684|467742355|FG000|Overall Study|Non-compliance with Study Drug|0|||
129939236|NCT01750684|467742356|FG001|Overall Study|Non-compliance with Study Drug|1|||
129939237|NCT01750684|467742355|FG000|Overall Study|Withdrawn by Sponsor|0|||
129939238|NCT01750684|467742356|FG001|Overall Study|Withdrawn by Sponsor|1|||
129939239|NCT01750684|467742355|FG000|Overall Study|Protocol Violation|1|||
129939240|NCT01750684|467742356|FG001|Overall Study|Protocol Violation|0|||
129939241|NCT03478969|467742357|FG000|Overall Study|Withdrawal by Subject|4|||
129939242|NCT03478969|467742358|FG001|Overall Study|Withdrawal by Subject|7|||
129939243|NCT03478969|467742359|FG002|Overall Study|Withdrawal by Subject|6|||
129939244|NCT03478969|467742357|FG000|Overall Study|Adverse Event|2|||
129939245|NCT03478969|467742358|FG001|Overall Study|Adverse Event|0|||
129939246|NCT03478969|467742359|FG002|Overall Study|Adverse Event|1|||
129939247|NCT03478969|467742357|FG000|Overall Study|Pregnancy|1|||
129939248|NCT03478969|467742358|FG001|Overall Study|Pregnancy|0|||
129939249|NCT03478969|467742359|FG002|Overall Study|Pregnancy|0|||
129939250|NCT03478969|467742357|FG000|Overall Study|Personal Reasons|1|||
129939251|NCT03478969|467742358|FG001|Overall Study|Personal Reasons|0|||
129939252|NCT03478969|467742359|FG002|Overall Study|Personal Reasons|1|||
129939253|NCT03478969|467742357|FG000|Overall Study|Covid-19|1|||
129939254|NCT03478969|467742358|FG001|Overall Study|Covid-19|4|||
129939255|NCT03478969|467742359|FG002|Overall Study|Covid-19|3|||
129939256|NCT03478969|467742357|FG000|Overall Study|Multiple Reasons|0|||
129939257|NCT03478969|467742358|FG001|Overall Study|Multiple Reasons|1|||
129939258|NCT03478969|467742359|FG002|Overall Study|Multiple Reasons|1|||
129939259|NCT03478969|467742357|FG000|Overall Study|Eligibility Criteria|0|||
129939260|NCT03478969|467742358|FG001|Overall Study|Eligibility Criteria|0|||
129939261|NCT03478969|467742359|FG002|Overall Study|Eligibility Criteria|5|||
129939262|NCT03478969|467742357|FG000|Overall Study|Lost to Follow-up|0|||
129939263|NCT03478969|467742358|FG001|Overall Study|Lost to Follow-up|0|||
129939264|NCT03478969|467742359|FG002|Overall Study|Lost to Follow-up|1|||
129939265|NCT01185600|467742360|FG000|Overall Study|Adverse Event|1|||
129939266|NCT01185600|467742361|FG001|Overall Study|Adverse Event|1|||
129939267|NCT01185600|467742360|FG000|Overall Study|Death|0|||
129939268|NCT01185600|467742361|FG001|Overall Study|Death|1|||
129939269|NCT01185600|467742360|FG000|Overall Study|Lost to Follow-up|0|||
129939270|NCT01185600|467742361|FG001|Overall Study|Lost to Follow-up|5|||
129939271|NCT01185600|467742360|FG000|Overall Study|Physician Decision|29|||
130071308|NCT00563368|468216063|FG005|Overall Study|protocol non-compliance|1|||
130071309|NCT00563368|468216064|FG006|Overall Study|protocol non-compliance|3|||
130071310|NCT00563368|468216058|FG000|Overall Study|Pregnancy|1|||
129939272|NCT01185600|467742361|FG001|Overall Study|Physician Decision|35|||
129939273|NCT01185600|467742360|FG000|Overall Study|Withdrawal by Subject|1|||
129939274|NCT01185600|467742361|FG001|Overall Study|Withdrawal by Subject|1|||
129939275|NCT01185600|467742360|FG000|Overall Study|Hold by DSMB|1|||
129939276|NCT01185600|467742361|FG001|Overall Study|Hold by DSMB|2|||
129939277|NCT01436175|467742362|FG000|Overall Study|Adverse Event|111|||
129939278|NCT01436175|467742362|FG000|Overall Study|Protocol Violation|49|||
129939279|NCT01436175|467742362|FG000|Overall Study|Withdrawal by Subject|108|||
129939280|NCT01436175|467742362|FG000|Overall Study|Lost to Follow-up|89|||
129939281|NCT01436175|467742362|FG000|Overall Study|Lack of Efficacy|24|||
129939282|NCT01436175|467742362|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
129939283|NCT01436175|467742362|FG000|Overall Study|Other|826|||
129939284|NCT05405244|467742364|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
129939285|NCT05405244|467742365|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
129939286|NCT05405244|467742364|FG000|Washout (2 Weeks)|Adverse Event|2|||
129939287|NCT05405244|467742365|FG001|Washout (2 Weeks)|Adverse Event|0|||
129939288|NCT05405244|467742364|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
129939289|NCT05405244|467742365|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
129939290|NCT03418922|467742368|FG000|Overall Study|Withdrawal by Subject|0|||
129939291|NCT03418922|467742369|FG001|Overall Study|Withdrawal by Subject|2|||
129939292|NCT03418922|467742368|FG000|Overall Study|Adverse Event|2|||
129939293|NCT03418922|467742369|FG001|Overall Study|Adverse Event|2|||
129939294|NCT03418922|467742368|FG000|Overall Study|Death|0|||
129939295|NCT03418922|467742369|FG001|Overall Study|Death|1|||
129939296|NCT03418922|467742368|FG000|Overall Study|Physician Decision|0|||
129939297|NCT03418922|467742369|FG001|Overall Study|Physician Decision|1|||
129939298|NCT03577106|467742370|FG000|Overall Study|Withdrawal by Subject|3|||
129939299|NCT00640159|467742371|FG000|Overall Study|Lost to Follow-up|2|||
129939300|NCT01500200|467742372|FG000|Stage 1|Adverse Event|1|||
129939301|NCT01500200|467742373|FG001|Stage 1|Adverse Event|4|||
129939302|NCT01500200|467742374|FG002|Stage 1|Adverse Event|5|||
129939303|NCT01500200|467742375|FG003|Stage 1|Adverse Event|0|||
129939304|NCT01500200|467742376|FG004|Stage 1|Adverse Event|0|||
129939305|NCT01500200|467742377|FG005|Stage 1|Adverse Event|0|||
129939306|NCT01500200|467742372|FG000|Stage 1|Lost to Follow-up|2|||
129939307|NCT01500200|467742373|FG001|Stage 1|Lost to Follow-up|2|||
129939308|NCT01500200|467742374|FG002|Stage 1|Lost to Follow-up|1|||
129939309|NCT01500200|467742375|FG003|Stage 1|Lost to Follow-up|0|||
129939310|NCT01500200|467742376|FG004|Stage 1|Lost to Follow-up|0|||
129939311|NCT01500200|467742377|FG005|Stage 1|Lost to Follow-up|0|||
129939312|NCT01500200|467742372|FG000|Stage 1|Withdrawal by Subject|3|||
129939313|NCT01500200|467742373|FG001|Stage 1|Withdrawal by Subject|0|||
129939314|NCT01500200|467742374|FG002|Stage 1|Withdrawal by Subject|0|||
129939315|NCT01500200|467742375|FG003|Stage 1|Withdrawal by Subject|0|||
129939316|NCT01500200|467742376|FG004|Stage 1|Withdrawal by Subject|0|||
129939317|NCT01500200|467742377|FG005|Stage 1|Withdrawal by Subject|0|||
129939318|NCT01500200|467742372|FG000|Stage 1|Noncompliance with Study Drug|1|||
129939319|NCT01500200|467742373|FG001|Stage 1|Noncompliance with Study Drug|0|||
129939320|NCT01500200|467742374|FG002|Stage 1|Noncompliance with Study Drug|0|||
129939321|NCT01500200|467742375|FG003|Stage 1|Noncompliance with Study Drug|0|||
129939322|NCT01500200|467742376|FG004|Stage 1|Noncompliance with Study Drug|0|||
129939323|NCT01500200|467742377|FG005|Stage 1|Noncompliance with Study Drug|0|||
129939324|NCT01500200|467742372|FG000|Stage 1|Physician Decision|1|||
129939325|NCT01500200|467742373|FG001|Stage 1|Physician Decision|0|||
129939326|NCT01500200|467742374|FG002|Stage 1|Physician Decision|0|||
129939327|NCT01500200|467742375|FG003|Stage 1|Physician Decision|0|||
129939328|NCT01500200|467742376|FG004|Stage 1|Physician Decision|0|||
129939329|NCT01500200|467742377|FG005|Stage 1|Physician Decision|0|||
129939330|NCT01500200|467742372|FG000|Stage 2|Adverse Event|0|||
129939331|NCT01500200|467742373|FG001|Stage 2|Adverse Event|0|||
129939332|NCT01500200|467742374|FG002|Stage 2|Adverse Event|0|||
129939333|NCT01500200|467742375|FG003|Stage 2|Adverse Event|0|||
129939334|NCT01500200|467742376|FG004|Stage 2|Adverse Event|5|||
129939335|NCT01500200|467742377|FG005|Stage 2|Adverse Event|4|||
129939336|NCT00523419|467742379|FG000|Overall Study|Adverse Event|1|||
129939337|NCT00523419|467742379|FG000|Overall Study|Withdrawal by Subject|1|||
129939338|NCT00523419|467742379|FG000|Overall Study|Physician Decision|2|||
129939339|NCT00523419|467742379|FG000|Overall Study|Progressive Disease|22|||
129939340|NCT00523419|467742379|FG000|Overall Study|Death due to Study Disease|4|||
129939341|NCT00523419|467742379|FG000|Overall Study|Death due to Adverse Event|2|||
129939342|NCT01218009|467742380|FG000|Overall Study|Protocol Violation|2|||
129939343|NCT01218009|467742381|FG001|Overall Study|Protocol Violation|1|||
129939344|NCT01218009|467742380|FG000|Overall Study|Withdrawal by Subject|3|||
129939345|NCT01218009|467742381|FG001|Overall Study|Withdrawal by Subject|1|||
129939346|NCT01218009|467742380|FG000|Overall Study|Sponsor terminated study|161|||
129939347|NCT01218009|467742381|FG001|Overall Study|Sponsor terminated study|163|||
129939348|NCT00811941|467742382|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
129939349|NCT00811941|467742383|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
129939350|NCT00811941|467742382|FG000|All Treated Patients|Adverse Event|2|||
129939351|NCT00811941|467742383|FG001|All Treated Patients|Adverse Event|43|||
129939352|NCT00811941|467742382|FG000|All Treated Patients|Lack of Efficacy|2|||
129939353|NCT00811941|467742383|FG001|All Treated Patients|Lack of Efficacy|3|||
129939354|NCT00811941|467742382|FG000|All Treated Patients|Non-compliance|1|||
129939355|NCT00811941|467742383|FG001|All Treated Patients|Non-compliance|8|||
129939356|NCT00811941|467742382|FG000|All Treated Patients|Protocol Violation|5|||
129939357|NCT00811941|467742383|FG001|All Treated Patients|Protocol Violation|17|||
129939358|NCT00811941|467742382|FG000|All Treated Patients|Withdrawal by Subject|35|||
129939359|NCT00811941|467742383|FG001|All Treated Patients|Withdrawal by Subject|94|||
129939360|NCT00811941|467742382|FG000|All Treated Patients|Lost to Follow-up|3|||
129939361|NCT00811941|467742383|FG001|All Treated Patients|Lost to Follow-up|12|||
129939362|NCT00811941|467742382|FG000|All Treated Patients|Other Reason|4|||
129939363|NCT00811941|467742383|FG001|All Treated Patients|Other Reason|14|||
129939364|NCT03802994|467742384|FG000|Overall Study|Lost to Follow-up|0|||
129939365|NCT03802994|467742385|FG001|Overall Study|Lost to Follow-up|2|||
129939366|NCT03802994|467742386|FG002|Overall Study|Lost to Follow-up|3|||
129939367|NCT03802994|467742387|FG003|Overall Study|Lost to Follow-up|2|||
129939368|NCT03802994|467742388|FG004|Overall Study|Lost to Follow-up|2|||
129939369|NCT02646618|467742392|FG000|Overall Study|Lost to Follow-up|10|||
129939370|NCT02646618|467742393|FG001|Overall Study|Lost to Follow-up|14|||
129939371|NCT00390884|467742394|FG000|Overall Study|Withdrawal by Subject|2|||
129939372|NCT00390884|467742395|FG001|Overall Study|Withdrawal by Subject|2|||
129939373|NCT04035447|467742396|FG000|Treatment Period|Lost to Follow-up|6|||
129939374|NCT04035447|467742397|FG001|Treatment Period|Lost to Follow-up|5|||
129939375|NCT04035447|467742396|FG000|Treatment Period|Physician Decision|0|||
129939376|NCT04035447|467742397|FG001|Treatment Period|Physician Decision|2|||
129939377|NCT03304587|467742398|FG000|Overall Study|Headache after intervention|0|||
129939378|NCT03304587|467742399|FG001|Overall Study|Headache after intervention|1|||
129939379|NCT03304587|467742398|FG000|Overall Study|Withdrawal by Subject|1|||
129939380|NCT03304587|467742399|FG001|Overall Study|Withdrawal by Subject|0|||
130119838|NCT01497938|468398477|FG001|Overall Study|Physician Decision|1|||
130119839|NCT01497938|468398476|FG000|Overall Study|Withdrawal by Subject|4|||
129939381|NCT01458366|467742401|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
129939382|NCT01458366|467742402|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
129939383|NCT01458366|467742403|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
129939384|NCT01458366|467742404|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
129939385|NCT01458366|467742405|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
129939386|NCT01458366|467742401|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939387|NCT01458366|467742402|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939388|NCT01458366|467742403|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939389|NCT01458366|467742404|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939390|NCT01458366|467742405|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
129939391|NCT01753999|467742406|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
129939392|NCT01753999|467742407|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
129939393|NCT01753999|467742406|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
129939394|NCT01753999|467742407|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
129939395|NCT01753999|467742406|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
129939396|NCT01753999|467742407|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
129939397|NCT01753999|467742406|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
129939398|NCT01753999|467742407|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
129939399|NCT01753999|467742406|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
129939400|NCT01753999|467742407|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
129939401|NCT01753999|467742406|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
129939402|NCT01753999|467742407|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
129939403|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939404|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
129939405|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939406|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
129939407|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939408|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939409|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939410|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939411|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939412|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939413|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
129939414|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939415|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939416|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939417|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939418|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939419|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939420|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
129939421|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
129939422|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939423|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939424|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
129939425|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939426|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939427|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939428|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939429|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939430|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939431|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939432|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
129939433|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
129939434|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
129939435|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
129939436|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
129939437|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
129939438|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
129939439|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939440|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939441|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
129939442|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939443|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
129939444|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939445|NCT02392234|467742408|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
129939446|NCT02392234|467742409|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
130119840|NCT01497938|468398477|FG001|Overall Study|Withdrawal by Subject|0|||
129939447|NCT02392234|467742410|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939448|NCT02392234|467742411|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939449|NCT02392234|467742412|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939450|NCT02392234|467742413|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939451|NCT02052440|467742418|FG000|Overall Study|Withdrawal by Subject|0|||
129939452|NCT02052440|467742419|FG001|Overall Study|Withdrawal by Subject|1|||
129939453|NCT02130557|467742420|FG000|Overall Study|Withdrawal by Subject|12|||
129939454|NCT02130557|467742421|FG001|Overall Study|Withdrawal by Subject|12|||
129939455|NCT02130557|467742420|FG000|Overall Study|Investigator Request|0|||
129939456|NCT02130557|467742421|FG001|Overall Study|Investigator Request|2|||
129939457|NCT02130557|467742420|FG000|Overall Study|Deceased|14|||
129939458|NCT02130557|467742421|FG001|Overall Study|Deceased|14|||
130119841|NCT01497938|468398476|FG000|Overall Study|Device Violation|1|||
129939459|NCT02130557|467742420|FG000|Overall Study|Lost to Follow-up|6|||
129939460|NCT02130557|467742421|FG001|Overall Study|Lost to Follow-up|7|||
129939461|NCT02130557|467742420|FG000|Overall Study|Other|2|||
129939462|NCT02130557|467742421|FG001|Overall Study|Other|1|||
129939463|NCT02130557|467742420|FG000|Overall Study|Missing|2|||
129939464|NCT02130557|467742421|FG001|Overall Study|Missing|1|||
129939465|NCT02408887|467742422|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
129939466|NCT02408887|467742423|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
129939467|NCT02408887|467742422|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
129939468|NCT02408887|467742423|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
129939469|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129939470|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129939471|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129939472|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129939473|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129939474|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
129939475|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
129939476|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129939477|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
129939478|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
129939479|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
129939480|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
129939481|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
129939482|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
129939483|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
129939484|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
129939485|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
129939486|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
129939487|NCT03333109|467742425|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
129939488|NCT03333109|467742426|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
129939489|NCT03333109|467742427|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
129939490|NCT03333109|467742425|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
129939491|NCT03333109|467742426|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
129939492|NCT03333109|467742427|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
129939493|NCT02078648|467742430|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
129939494|NCT02078648|467742431|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
129939495|NCT02078648|467742430|FG000|Overall Study|Adverse Event|0|||
129939496|NCT02078648|467742431|FG001|Overall Study|Adverse Event|1|||
129939497|NCT02078648|467742430|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
129939498|NCT02078648|467742431|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
129939499|NCT02078648|467742430|FG000|Overall Study|Withdrawal by Subject|3|||
129939500|NCT02078648|467742431|FG001|Overall Study|Withdrawal by Subject|1|||
129939501|NCT02078648|467742430|FG000|Overall Study|Investigator Decision|5|||
129939502|NCT02078648|467742431|FG001|Overall Study|Investigator Decision|7|||
129939503|NCT02078648|467742430|FG000|Overall Study|Death|1|||
129939504|NCT02078648|467742431|FG001|Overall Study|Death|1|||
129939505|NCT02078648|467742430|FG000|Overall Study|Undefined|0|||
129939506|NCT02078648|467742431|FG001|Overall Study|Undefined|1|||
129939507|NCT04088227|467742432|FG000|Overall Study|Withdrawal by Subject|1|||
129939508|NCT04088227|467742433|FG001|Overall Study|Withdrawal by Subject|0|||
129939509|NCT04088227|467742432|FG000|Overall Study|Surgery postponed >5weeks|1|||
129939510|NCT04088227|467742433|FG001|Overall Study|Surgery postponed >5weeks|0|||
129939511|NCT01855750|467742434|FG000|Overall Study|Death|78|||
129939512|NCT01855750|467742435|FG001|Overall Study|Death|78|||
129939513|NCT01855750|467742434|FG000|Overall Study|Lost to Follow-up|9|||
129939514|NCT01855750|467742435|FG001|Overall Study|Lost to Follow-up|23|||
129939515|NCT01855750|467742434|FG000|Overall Study|Withdrawal by Subject|35|||
129939516|NCT01855750|467742435|FG001|Overall Study|Withdrawal by Subject|28|||
129939517|NCT01855750|467742434|FG000|Overall Study|Sponsor ends the study|297|||
129939518|NCT01855750|467742435|FG001|Overall Study|Sponsor ends the study|290|||
129939519|NCT04300023|467742436|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
129939520|NCT04300023|467742437|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
129939521|NCT05525572|467742438|FG000|Overall Study|Lost to Follow-up|2|||
129939522|NCT03425682|467742439|FG000|Overall Study|Lost to Follow-up|2|||
129939523|NCT03425682|467742440|FG001|Overall Study|Lost to Follow-up|4|||
129939524|NCT03425682|467742439|FG000|Overall Study|Withdrawal by Subject|0|||
129939525|NCT03425682|467742440|FG001|Overall Study|Withdrawal by Subject|3|||
129939526|NCT03425682|467742439|FG000|Overall Study|Subject did not meet I/E|4|||
129939527|NCT03425682|467742440|FG001|Overall Study|Subject did not meet I/E|10|||
129939528|NCT03277989|467742445|FG000|Overall Study|Lost to Follow-up|6|||
129939529|NCT03277989|467742445|FG000|Overall Study|Adverse Event|6|||
129939530|NCT03277989|467742445|FG000|Overall Study|Withdrawal by Subject|3|||
129939531|NCT03277989|467742445|FG000|Overall Study|Didn't Receive Study Device|7|||
129939532|NCT03277989|467742445|FG000|Overall Study|Site Closure|26|||
129939533|NCT03277989|467742445|FG000|Overall Study|Sponsor Closure|107|||
129939534|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
129939535|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
129939536|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
129939537|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
129939538|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
129939539|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
129939540|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
129939541|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
129939542|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
129939543|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
129939544|NCT03516942|467742449|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
129939545|NCT03516942|467742449|FG000|Registration Through Baseline Survey Com|Death|8|||
129939546|NCT03516942|467742449|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
129939547|NCT03516942|467742449|FG000|T0: Baseline|LOST|13|||
129939548|NCT03516942|467742449|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
129939549|NCT03516942|467742449|FG000|T1: 3 Months Survey|Death|10|||
129939550|NCT03516942|467742449|FG000|T1: 3 Months Survey|Lost|163|||
129939551|NCT03516942|467742449|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
129939552|NCT03516942|467742449|FG000|T2: 6 Month Survey|Death|14|||
129939553|NCT03516942|467742449|FG000|T2: 6 Month Survey|Lost|180|||
129939554|NCT03516942|467742449|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
129939555|NCT03516942|467742449|FG000|T3: 12 Month Survey|Death|19|||
129939556|NCT03516942|467742449|FG000|T3: 12 Month Survey|Lost|209|||
129939557|NCT05613907|467742450|FG000|Overall Study|Lost to Follow-up|5|||
129939558|NCT05613907|467742450|FG000|Overall Study|Death|3|||
129939559|NCT05613907|467742450|FG000|Overall Study|Withdrawal by Subject|2|||
129939560|NCT05349838|467742451|FG000|Overall Study|Virological Failure|1|||
129939561|NCT05349838|467742452|FG001|Overall Study|Virological Failure|2|||
129939562|NCT05349838|467742451|FG000|Overall Study|Withdrawal by Subject|2|||
129939563|NCT05349838|467742452|FG001|Overall Study|Withdrawal by Subject|3|||
129939564|NCT05349838|467742451|FG000|Overall Study|Adverse Event|3|||
129939565|NCT05349838|467742452|FG001|Overall Study|Adverse Event|1|||
129939566|NCT05349838|467742451|FG000|Overall Study|Lost to Follow-up|1|||
129939567|NCT05349838|467742452|FG001|Overall Study|Lost to Follow-up|2|||
129939568|NCT05349838|467742451|FG000|Overall Study|Other reasons|5|||
129939569|NCT05349838|467742452|FG001|Overall Study|Other reasons|1|||
129939570|NCT05071430|467742454|FG000|Overall Study|Adverse Event|1|||
129939571|NCT05071430|467742455|FG001|Overall Study|Adverse Event|2|||
129939572|NCT05071430|467742454|FG000|Overall Study|Lost to Follow-up|4|||
129939573|NCT05071430|467742455|FG001|Overall Study|Lost to Follow-up|4|||
129939574|NCT05071430|467742454|FG000|Overall Study|Protocol Violation|1|||
129939575|NCT05071430|467742455|FG001|Overall Study|Protocol Violation|0|||
129939576|NCT05071430|467742454|FG000|Overall Study|Withdrawal by Subject|3|||
129939577|NCT05071430|467742455|FG001|Overall Study|Withdrawal by Subject|2|||
129939578|NCT05071430|467742454|FG000|Overall Study|Other|1|||
129939579|NCT05071430|467742455|FG001|Overall Study|Other|1|||
129939580|NCT00490139|467742457|FG000|Overall Study|Lost to Follow-up|249|||
129939581|NCT00490139|467742458|FG001|Overall Study|Lost to Follow-up|216|||
129939582|NCT00490139|467742459|FG002|Overall Study|Lost to Follow-up|205|||
129939583|NCT00490139|467742460|FG003|Overall Study|Lost to Follow-up|229|||
129939584|NCT00490139|467742457|FG000|Overall Study|Withdrawal by Subject|333|||
129939585|NCT00490139|467742458|FG001|Overall Study|Withdrawal by Subject|322|||
129939586|NCT00490139|467742459|FG002|Overall Study|Withdrawal by Subject|396|||
129939587|NCT00490139|467742460|FG003|Overall Study|Withdrawal by Subject|295|||
129939588|NCT00490139|467742457|FG000|Overall Study|Patient did not sign ICF 12|169|||
129939589|NCT00490139|467742458|FG001|Overall Study|Patient did not sign ICF 12|176|||
129939590|NCT00490139|467742459|FG002|Overall Study|Patient did not sign ICF 12|139|||
129939591|NCT00490139|467742460|FG003|Overall Study|Patient did not sign ICF 12|167|||
129939592|NCT00490139|467742457|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
130119842|NCT01497938|468398477|FG001|Overall Study|Device Violation|0|||
130119843|NCT05200858|468398478|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
130119844|NCT05200858|468398479|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
130119845|NCT05200858|468398480|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
130119846|NCT05200858|468398481|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
130119847|NCT00313703|468400063|FG000|Overall Study|Lost to Follow-up|11|||
130119848|NCT00313703|468400064|FG001|Overall Study|Lost to Follow-up|2|||
130119849|NCT00313703|468400065|FG002|Overall Study|Lost to Follow-up|5|||
130119850|NCT00313703|468400066|FG003|Overall Study|Lost to Follow-up|12|||
130119851|NCT00101582|468400069|FG000|Overall Study|Ineligibility determined|0|||
130119852|NCT00101582|468400070|FG001|Overall Study|Ineligibility determined|1|||
130119853|NCT00101582|468400069|FG000|Overall Study|Adverse Event|1|||
130119854|NCT00101582|468400070|FG001|Overall Study|Adverse Event|4|||
130119855|NCT00101582|468400069|FG000|Overall Study|Withdrawal by Subject|6|||
130119856|NCT00101582|468400070|FG001|Overall Study|Withdrawal by Subject|4|||
130119857|NCT00101582|468400069|FG000|Overall Study|Physician Decision|1|||
130119858|NCT00101582|468400070|FG001|Overall Study|Physician Decision|0|||
130119859|NCT00101582|468400069|FG000|Overall Study|Death|3|||
130119860|NCT00101582|468400070|FG001|Overall Study|Death|5|||
130119861|NCT00101582|468400069|FG000|Overall Study|Other|0|||
130119862|NCT00101582|468400070|FG001|Overall Study|Other|1|||
130119863|NCT00056160|468400071|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
130119864|NCT00056160|468400072|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
130119865|NCT00056160|468400071|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
130119866|NCT00056160|468400072|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
130119867|NCT00056160|468400071|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
130119868|NCT00056160|468400072|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
130119869|NCT00056160|468400071|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
130119870|NCT00056160|468400072|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
130119871|NCT00056160|468400071|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
130119872|NCT00056160|468400072|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
130119873|NCT00056160|468400071|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
130119874|NCT00056160|468400072|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
130119875|NCT00056160|468400071|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
130119876|NCT00056160|468400072|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
130119877|NCT00056160|468400071|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
130119878|NCT00056160|468400072|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
130119879|NCT00056160|468400071|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
130119880|NCT00056160|468400072|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
130119881|NCT00056160|468400071|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
130119882|NCT00056160|468400072|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
130119883|NCT00056160|468400071|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
130119884|NCT00056160|468400072|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
130119885|NCT00056160|468400071|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
130119886|NCT00056160|468400072|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
130119887|NCT00056160|468400071|FG000|Final Follow-up|Transferred into expanded access study.|3|||
130119888|NCT00056160|468400072|FG001|Final Follow-up|Transferred into expanded access study.|0|||
130119889|NCT00056160|468400071|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
130119890|NCT00056160|468400072|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
130119891|NCT00056160|468400071|FG000|Final Follow-up|Adverse Event|1|||
130119892|NCT00056160|468400072|FG001|Final Follow-up|Adverse Event|0|||
130119893|NCT03312530|468400074|FG000|Overall Study|Death|5|||
130119894|NCT03312530|468400075|FG001|Overall Study|Death|5|||
130119895|NCT03312530|468400076|FG002|Overall Study|Death|4|||
130119896|NCT03312530|468400077|FG003|Overall Study|Death|10|||
130119897|NCT03312530|468400078|FG004|Overall Study|Death|8|||
130119898|NCT03312530|468400074|FG000|Overall Study|Lost to Follow-up|0|||
130119899|NCT03312530|468400075|FG001|Overall Study|Lost to Follow-up|0|||
130119900|NCT03312530|468400076|FG002|Overall Study|Lost to Follow-up|0|||
130119901|NCT03312530|468400077|FG003|Overall Study|Lost to Follow-up|1|||
130119902|NCT03312530|468400078|FG004|Overall Study|Lost to Follow-up|0|||
130119903|NCT03312530|468400074|FG000|Overall Study|Participant in another sponsor study.|0|||
130119904|NCT03312530|468400075|FG001|Overall Study|Participant in another sponsor study.|0|||
130119905|NCT03312530|468400076|FG002|Overall Study|Participant in another sponsor study.|0|||
130119906|NCT03312530|468400077|FG003|Overall Study|Participant in another sponsor study.|1|||
130119907|NCT03312530|468400078|FG004|Overall Study|Participant in another sponsor study.|0|||
130119908|NCT03312530|468400074|FG000|Overall Study|Study terminated by sponsor|1|||
130119909|NCT03312530|468400075|FG001|Overall Study|Study terminated by sponsor|0|||
130119910|NCT03312530|468400076|FG002|Overall Study|Study terminated by sponsor|2|||
130119911|NCT03312530|468400077|FG003|Overall Study|Study terminated by sponsor|3|||
130119912|NCT03312530|468400078|FG004|Overall Study|Study terminated by sponsor|7|||
130119913|NCT03312530|468400074|FG000|Overall Study|Withdrawal by Subject|0|||
130119914|NCT03312530|468400075|FG001|Overall Study|Withdrawal by Subject|1|||
130119915|NCT03312530|468400076|FG002|Overall Study|Withdrawal by Subject|0|||
129939593|NCT00490139|467742458|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
129939594|NCT00490139|467742459|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
129939595|NCT00490139|467742460|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
129939596|NCT00490139|467742457|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
129939597|NCT00490139|467742458|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
129939598|NCT00490139|467742459|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
129939599|NCT00490139|467742460|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
129939600|NCT00490139|467742457|FG000|Overall Study|Other reasons as defined per protocol|98|||
129939601|NCT00490139|467742458|FG001|Overall Study|Other reasons as defined per protocol|84|||
129939602|NCT00490139|467742459|FG002|Overall Study|Other reasons as defined per protocol|82|||
129939603|NCT00490139|467742460|FG003|Overall Study|Other reasons as defined per protocol|105|||
129939604|NCT02798471|467742461|FG000|Overall Study|Adverse Event|7|||
129939605|NCT02798471|467742462|FG001|Overall Study|Adverse Event|2|||
129939606|NCT02798471|467742461|FG000|Overall Study|Physician Decision|3|||
129939607|NCT02798471|467742462|FG001|Overall Study|Physician Decision|7|||
129939608|NCT02798471|467742461|FG000|Overall Study|Death|2|||
129939609|NCT02798471|467742462|FG001|Overall Study|Death|3|||
129939610|NCT02798471|467742461|FG000|Overall Study|Lost to Follow-up|0|||
129939611|NCT02798471|467742462|FG001|Overall Study|Lost to Follow-up|1|||
129939612|NCT02798471|467742461|FG000|Overall Study|Other|5|||
129939613|NCT02798471|467742462|FG001|Overall Study|Other|3|||
129939614|NCT02798471|467742461|FG000|Overall Study|Subject withdrew consent|0|||
129939615|NCT02798471|467742462|FG001|Overall Study|Subject withdrew consent|6|||
129939616|NCT02798471|467742461|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
129939617|NCT02798471|467742462|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
129939618|NCT02798471|467742461|FG000|Overall Study|Randomized, but not treated|0|||
129939619|NCT02798471|467742462|FG001|Overall Study|Randomized, but not treated|2|||
129939620|NCT03752684|467743825|FG000|Overall Study|Lost to Follow-up|4|||
129939621|NCT01982682|467743828|FG000|Overall Study|Physician Decision|1|||
129939622|NCT02760654|467743829|FG000|Overall Study|Lost to Follow-up|3|||
129939623|NCT02760654|467743830|FG001|Overall Study|Lost to Follow-up|3|||
129939624|NCT02760654|467743829|FG000|Overall Study|Withdrawal by Subject|4|||
129939625|NCT02760654|467743830|FG001|Overall Study|Withdrawal by Subject|3|||
129939626|NCT00754325|467743831|FG000|Initial Treatment|Continuing Active Treatment|4|||
129939627|NCT00754325|467743832|FG001|Initial Treatment|Continuing Active Treatment|5|||
129939628|NCT00754325|467743831|FG000|Initial Treatment|Adverse Event|7|||
129939629|NCT00754325|467743832|FG001|Initial Treatment|Adverse Event|6|||
129939630|NCT00754325|467743831|FG000|Initial Treatment|Withdrawal by Subject|2|||
129939631|NCT00754325|467743832|FG001|Initial Treatment|Withdrawal by Subject|2|||
129939632|NCT00754325|467743831|FG000|Initial Treatment|Physician Decision|2|||
129939633|NCT00754325|467743832|FG001|Initial Treatment|Physician Decision|0|||
129939634|NCT00754325|467743831|FG000|Initial Treatment|Sponsor Request|0|||
129939635|NCT00754325|467743832|FG001|Initial Treatment|Sponsor Request|1|||
129939636|NCT00754325|467743831|FG000|Initial Treatment|Disease Progression|35|||
129939637|NCT00754325|467743832|FG001|Initial Treatment|Disease Progression|35|||
129939638|NCT03442777|467743833|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
129939639|NCT03442777|467743834|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
129939640|NCT03442777|467743835|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
129939641|NCT02941549|467743836|FG000|Overall Study|Adverse Event|1|||
129939642|NCT02941549|467743837|FG001|Overall Study|Adverse Event|0|||
129939643|NCT02941549|467743838|FG002|Overall Study|Adverse Event|0|||
129939644|NCT02941549|467743836|FG000|Overall Study|Withdrawal by Subject|2|||
129939645|NCT02941549|467743837|FG001|Overall Study|Withdrawal by Subject|1|||
129939646|NCT02941549|467743838|FG002|Overall Study|Withdrawal by Subject|2|||
129939647|NCT03451422|467743839|FG000|Overall Study|Lost to Follow-up|0|||
129939648|NCT03451422|467743840|FG001|Overall Study|Lost to Follow-up|0|||
129939649|NCT03451422|467743841|FG002|Overall Study|Lost to Follow-up|0|||
129939650|NCT03451422|467743842|FG003|Overall Study|Lost to Follow-up|0|||
129939651|NCT03451422|467743843|FG004|Overall Study|Lost to Follow-up|0|||
129939652|NCT03451422|467743844|FG005|Overall Study|Lost to Follow-up|1|||
129939653|NCT03451422|467743839|FG000|Overall Study|Decision by sponsor|1|||
129939654|NCT03451422|467743840|FG001|Overall Study|Decision by sponsor|0|||
129939655|NCT03451422|467743841|FG002|Overall Study|Decision by sponsor|1|||
129939656|NCT03451422|467743842|FG003|Overall Study|Decision by sponsor|0|||
129939657|NCT03451422|467743843|FG004|Overall Study|Decision by sponsor|0|||
129939658|NCT03451422|467743844|FG005|Overall Study|Decision by sponsor|0|||
129939659|NCT03451422|467743839|FG000|Overall Study|Withdrawal by Subject|0|||
129939660|NCT03451422|467743840|FG001|Overall Study|Withdrawal by Subject|0|||
129939661|NCT03451422|467743841|FG002|Overall Study|Withdrawal by Subject|2|||
129939662|NCT03451422|467743842|FG003|Overall Study|Withdrawal by Subject|3|||
129939663|NCT03451422|467743843|FG004|Overall Study|Withdrawal by Subject|2|||
129939664|NCT03451422|467743844|FG005|Overall Study|Withdrawal by Subject|1|||
129939665|NCT03601715|467743845|FG000|Second Intervention|Lost to Follow-up|1|||
129939666|NCT03601715|467743846|FG001|Second Intervention|Lost to Follow-up|1|||
129939667|NCT03601715|467743847|FG002|Second Intervention|Lost to Follow-up|0|||
129939668|NCT00918333|467743850|FG000|Overall Study|Drug not taken per protocol|1|||
129939669|NCT00918333|467743851|FG001|Overall Study|Drug not taken per protocol|0|||
129939670|NCT00918333|467743850|FG000|Overall Study|Inadequate amount of drugs provided|1|||
129939671|NCT00918333|467743851|FG001|Overall Study|Inadequate amount of drugs provided|4|||
129939672|NCT00918333|467743850|FG000|Overall Study|Ineligible|1|||
129939673|NCT00918333|467743851|FG001|Overall Study|Ineligible|0|||
129939674|NCT00918333|467743850|FG000|Overall Study|Withdrawal by Subject|0|||
129939675|NCT00918333|467743851|FG001|Overall Study|Withdrawal by Subject|1|||
129939676|NCT01313884|467743853|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
129939677|NCT00263757|467743854|FG000|Overall Study|Withdrawal by Subject|5|||
129939678|NCT00263757|467743855|FG001|Overall Study|Withdrawal by Subject|4|||
129939679|NCT00263757|467743854|FG000|Overall Study|Screen failure|0|||
129939680|NCT00263757|467743855|FG001|Overall Study|Screen failure|1|||
129939681|NCT00263757|467743854|FG000|Overall Study|Adverse Event|3|||
129939682|NCT00263757|467743855|FG001|Overall Study|Adverse Event|3|||
129939683|NCT02964741|467743856|FG000|Overall Study|Protocol Violation|1|||
129939684|NCT02964741|467743857|FG001|Overall Study|Protocol Violation|0|||
129939685|NCT02964741|467743858|FG002|Overall Study|Protocol Violation|0|||
129939686|NCT02964741|467743856|FG000|Overall Study|Withdrawal by Subject|0|||
129939687|NCT02964741|467743857|FG001|Overall Study|Withdrawal by Subject|1|||
129939688|NCT02964741|467743858|FG002|Overall Study|Withdrawal by Subject|0|||
129939689|NCT02964741|467743856|FG000|Overall Study|claustrophobia|1|||
129939690|NCT02964741|467743857|FG001|Overall Study|claustrophobia|0|||
129939691|NCT02964741|467743858|FG002|Overall Study|claustrophobia|0|||
129939692|NCT01212744|467743871|FG000|Overall Study|Withdrawal by Subject|1|||
129939693|NCT02167451|467743872|FG000|Overall Study|Withdrawal by Subject|1|||
129939694|NCT01218659|467743873|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
129939695|NCT01218659|467743874|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
129939696|NCT01218659|467743875|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
129939697|NCT01218659|467743873|FG000|18-Month Randomized Period|Did not receive study drug|0|||
129939698|NCT01218659|467743874|FG001|18-Month Randomized Period|Did not receive study drug|3|||
129939699|NCT01218659|467743875|FG002|18-Month Randomized Period|Did not receive study drug|0|||
129939700|NCT01218659|467743873|FG000|12-Month OLE|Withdrawal by Subject|0|||
130071311|NCT00563368|468216059|FG001|Overall Study|Pregnancy|0|||
130071312|NCT00563368|468216060|FG002|Overall Study|Pregnancy|1|||
130071313|NCT00563368|468216061|FG003|Overall Study|Pregnancy|2|||
130071314|NCT00563368|468216062|FG004|Overall Study|Pregnancy|1|||
130071315|NCT00563368|468216063|FG005|Overall Study|Pregnancy|2|||
130071316|NCT00563368|468216064|FG006|Overall Study|Pregnancy|0|||
129939701|NCT01218659|467743874|FG001|12-Month OLE|Withdrawal by Subject|0|||
129939702|NCT01218659|467743875|FG002|12-Month OLE|Withdrawal by Subject|2|||
129939703|NCT01218659|467743873|FG000|12-Month OLE|Physician Decision|0|||
129939704|NCT01218659|467743874|FG001|12-Month OLE|Physician Decision|0|||
129939705|NCT01218659|467743875|FG002|12-Month OLE|Physician Decision|1|||
129939706|NCT01218659|467743873|FG000|12-Month OLE|Lost to Follow-up|0|||
129939707|NCT01218659|467743874|FG001|12-Month OLE|Lost to Follow-up|0|||
129939708|NCT01218659|467743875|FG002|12-Month OLE|Lost to Follow-up|1|||
129939709|NCT01218659|467743873|FG000|12-Month OLE|Pregnancy|0|||
129939710|NCT01218659|467743874|FG001|12-Month OLE|Pregnancy|0|||
129939711|NCT01218659|467743875|FG002|12-Month OLE|Pregnancy|1|||
129939712|NCT01218659|467743873|FG000|12-Month OLE|Lack of Efficacy|0|||
129939713|NCT01218659|467743874|FG001|12-Month OLE|Lack of Efficacy|0|||
129939714|NCT01218659|467743875|FG002|12-Month OLE|Lack of Efficacy|1|||
129939715|NCT01218659|467743873|FG000|12-Month OLE|Declined to participate in the OLE|0|||
129939716|NCT01218659|467743874|FG001|12-Month OLE|Declined to participate in the OLE|0|||
129939717|NCT01218659|467743875|FG002|12-Month OLE|Declined to participate in the OLE|4|||
129939718|NCT04191824|467743882|FG000|Overall Study|Death|13|||
130071317|NCT00563368|468216058|FG000|Overall Study|requirement for restricted medication|0|||
130071318|NCT00563368|468216059|FG001|Overall Study|requirement for restricted medication|0|||
130071319|NCT00563368|468216060|FG002|Overall Study|requirement for restricted medication|2|||
129939719|NCT04191824|467743883|FG001|Overall Study|Death|12|||
129939720|NCT04191824|467743882|FG000|Overall Study|Lost to Follow-up|456|||
129939721|NCT04191824|467743883|FG001|Overall Study|Lost to Follow-up|435|||
129939722|NCT04191824|467743882|FG000|Overall Study|Physician Decision|2|||
129939723|NCT04191824|467743883|FG001|Overall Study|Physician Decision|1|||
129939724|NCT04191824|467743882|FG000|Overall Study|Protocol Violation|0|||
129939725|NCT04191824|467743883|FG001|Overall Study|Protocol Violation|2|||
129939726|NCT04191824|467743882|FG000|Overall Study|Withdrawal by Subject|16|||
129939727|NCT04191824|467743883|FG001|Overall Study|Withdrawal by Subject|18|||
129939728|NCT04191824|467743882|FG000|Overall Study|Early site closure|24|||
129939729|NCT04191824|467743883|FG001|Overall Study|Early site closure|22|||
129939730|NCT01499849|467743889|FG000|Overall Study|Adverse Event|28|||
129939731|NCT01499849|467743890|FG001|Overall Study|Adverse Event|32|||
129939732|NCT01499849|467743889|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
130071320|NCT00563368|468216061|FG003|Overall Study|requirement for restricted medication|0|||
130119916|NCT03312530|468400077|FG003|Overall Study|Withdrawal by Subject|0|||
130119917|NCT03312530|468400078|FG004|Overall Study|Withdrawal by Subject|0|||
129939733|NCT01499849|467743890|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
129939734|NCT01499849|467743889|FG000|Overall Study|Withdrawal by Subject|43|||
129939735|NCT01499849|467743890|FG001|Overall Study|Withdrawal by Subject|43|||
129939736|NCT01499849|467743889|FG000|Overall Study|Death|5|||
129939737|NCT01499849|467743890|FG001|Overall Study|Death|7|||
129939738|NCT01499849|467743889|FG000|Overall Study|Disease Progression|11|||
129939739|NCT01499849|467743890|FG001|Overall Study|Disease Progression|10|||
129939740|NCT01499849|467743889|FG000|Overall Study|Protocol Violation|11|||
129939741|NCT01499849|467743890|FG001|Overall Study|Protocol Violation|11|||
129939742|NCT01499849|467743889|FG000|Overall Study|Physician Decision|20|||
129939743|NCT01499849|467743890|FG001|Overall Study|Physician Decision|19|||
129939744|NCT01499849|467743889|FG000|Overall Study|Lack of Efficacy|3|||
129939745|NCT01499849|467743890|FG001|Overall Study|Lack of Efficacy|4|||
129939746|NCT01499849|467743889|FG000|Overall Study|Lost to Follow-up|6|||
129939747|NCT01499849|467743890|FG001|Overall Study|Lost to Follow-up|3|||
129939748|NCT01499849|467743889|FG000|Overall Study|Other Reasons|27|||
129939749|NCT01499849|467743890|FG001|Overall Study|Other Reasons|30|||
129939750|NCT01437319|467743891|FG000|Phase I|Lost to Follow-up|2|||
129939751|NCT01437319|467743892|FG001|Phase I|Lost to Follow-up|0|||
129939752|NCT01437319|467743893|FG002|Phase I|Lost to Follow-up|0|||
129939753|NCT01437319|467743891|FG000|Phase I|Protocol Violation|1|||
129939754|NCT01437319|467743892|FG001|Phase I|Protocol Violation|0|||
129939755|NCT01437319|467743893|FG002|Phase I|Protocol Violation|0|||
129939756|NCT01437319|467743891|FG000|Phase I|Study related symptoms/complaints|27|||
129939757|NCT01437319|467743892|FG001|Phase I|Study related symptoms/complaints|0|||
129939758|NCT01437319|467743893|FG002|Phase I|Study related symptoms/complaints|0|||
129939759|NCT01437319|467743891|FG000|Phase I|Withdrawal by Subject|25|||
129939760|NCT01437319|467743892|FG001|Phase I|Withdrawal by Subject|0|||
129939761|NCT01437319|467743893|FG002|Phase I|Withdrawal by Subject|0|||
129939762|NCT01437319|467743891|FG000|Phase II|Withdrawal by Subject|0|||
129939763|NCT01437319|467743892|FG001|Phase II|Withdrawal by Subject|8|||
129939764|NCT01437319|467743893|FG002|Phase II|Withdrawal by Subject|16|||
129939765|NCT01437319|467743891|FG000|Phase II|Lost to Follow-up|0|||
129939766|NCT01437319|467743892|FG001|Phase II|Lost to Follow-up|7|||
129939767|NCT01437319|467743893|FG002|Phase II|Lost to Follow-up|2|||
129939768|NCT01437319|467743891|FG000|Phase II|Study related symptoms/complaints|0|||
129939769|NCT01437319|467743892|FG001|Phase II|Study related symptoms/complaints|28|||
129939770|NCT01437319|467743893|FG002|Phase II|Study related symptoms/complaints|19|||
129939771|NCT01437319|467743891|FG000|Phase II|Protocol Violation|0|||
129939772|NCT01437319|467743892|FG001|Phase II|Protocol Violation|1|||
129939773|NCT01437319|467743893|FG002|Phase II|Protocol Violation|0|||
129939774|NCT00174252|467743894|FG000|Overall Study|Protocol Violation|2|||
129939775|NCT03611556|467743897|FG000|Overall Study|Death|7|||
129939776|NCT03611556|467743898|FG001|Overall Study|Death|7|||
129939777|NCT03611556|467743899|FG002|Overall Study|Death|3|||
129939778|NCT03611556|467743900|FG003|Overall Study|Death|8|||
129939779|NCT03611556|467743901|FG004|Overall Study|Death|47|||
129939780|NCT03611556|467743902|FG005|Overall Study|Death|32|||
129939781|NCT03611556|467743903|FG006|Overall Study|Death|53|||
129939782|NCT03611556|467743897|FG000|Overall Study|Withdrawal by Subject|0|||
129939783|NCT03611556|467743898|FG001|Overall Study|Withdrawal by Subject|0|||
129939784|NCT03611556|467743899|FG002|Overall Study|Withdrawal by Subject|0|||
129939785|NCT03611556|467743900|FG003|Overall Study|Withdrawal by Subject|0|||
129939786|NCT03611556|467743901|FG004|Overall Study|Withdrawal by Subject|4|||
129939787|NCT03611556|467743902|FG005|Overall Study|Withdrawal by Subject|2|||
129939788|NCT03611556|467743903|FG006|Overall Study|Withdrawal by Subject|4|||
129939789|NCT03611556|467743897|FG000|Overall Study|Sponsor decision|0|||
129939790|NCT03611556|467743898|FG001|Overall Study|Sponsor decision|0|||
129939791|NCT03611556|467743899|FG002|Overall Study|Sponsor decision|0|||
129939792|NCT03611556|467743900|FG003|Overall Study|Sponsor decision|0|||
129939793|NCT03611556|467743901|FG004|Overall Study|Sponsor decision|9|||
129939794|NCT03611556|467743902|FG005|Overall Study|Sponsor decision|4|||
129939795|NCT03611556|467743903|FG006|Overall Study|Sponsor decision|12|||
129939796|NCT03611556|467743897|FG000|Overall Study|Reasons|0|||
129939797|NCT03611556|467743898|FG001|Overall Study|Reasons|0|||
130154857|NCT00958126|468526628|FG007|Overall Study|Moved away from study area|0|||
129939798|NCT03611556|467743899|FG002|Overall Study|Reasons|0|||
129939799|NCT03611556|467743900|FG003|Overall Study|Reasons|0|||
129939800|NCT03611556|467743901|FG004|Overall Study|Reasons|2|||
129939801|NCT03611556|467743902|FG005|Overall Study|Reasons|0|||
129939802|NCT03611556|467743903|FG006|Overall Study|Reasons|1|||
129939803|NCT02397096|467743904|FG000|Day 1 to Week 24|Adverse Event|7|||
129939804|NCT02397096|467743905|FG001|Day 1 to Week 24|Adverse Event|1|||
129939805|NCT02397096|467743904|FG000|Day 1 to Week 24|Death|1|||
129939806|NCT02397096|467743905|FG001|Day 1 to Week 24|Death|0|||
129939807|NCT02397096|467743904|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
129939808|NCT02397096|467743905|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
129939809|NCT02397096|467743904|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
129939810|NCT02397096|467743905|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
130119918|NCT03312530|468400074|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130119919|NCT03312530|468400075|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130119920|NCT03312530|468400076|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130119921|NCT03312530|468400077|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
130119922|NCT03312530|468400078|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
130119923|NCT04583579|468400079|FG000|Overall Study|Lost to Follow-up|4|||
130119924|NCT00278200|468400080|FG000|Overall Study|Death|1|||
130119925|NCT00278200|468400081|FG001|Overall Study|Death|3|||
130119926|NCT00278200|468400080|FG000|Overall Study|Physician Decision|0|||
130119927|NCT00278200|468400081|FG001|Overall Study|Physician Decision|1|||
130119928|NCT03519256|468400089|FG000|Overall Study|Disease recurrence|4|||
130119929|NCT03519256|468400090|FG001|Overall Study|Disease recurrence|4|||
130119930|NCT03519256|468400091|FG002|Overall Study|Disease recurrence|5|||
130119931|NCT03519256|468400092|FG003|Overall Study|Disease recurrence|2|||
130119932|NCT03519256|468400089|FG000|Overall Study|Study drug toxicity|0|||
130119933|NCT03519256|468400090|FG001|Overall Study|Study drug toxicity|2|||
130119934|NCT03519256|468400091|FG002|Overall Study|Study drug toxicity|5|||
130119935|NCT03519256|468400092|FG003|Overall Study|Study drug toxicity|2|||
130119936|NCT03519256|468400089|FG000|Overall Study|Adverse event unrelated to study drug|0|||
130119937|NCT03519256|468400090|FG001|Overall Study|Adverse event unrelated to study drug|1|||
130119938|NCT03519256|468400091|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130119939|NCT03519256|468400092|FG003|Overall Study|Adverse event unrelated to study drug|0|||
130119940|NCT03519256|468400089|FG000|Overall Study|Participant request to discontinue study treatment|0|||
130119941|NCT03519256|468400090|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130119942|NCT03519256|468400091|FG002|Overall Study|Participant request to discontinue study treatment|0|||
130119943|NCT03519256|468400092|FG003|Overall Study|Participant request to discontinue study treatment|2|||
130119944|NCT03519256|468400089|FG000|Overall Study|Other reasons|0|||
130119945|NCT03519256|468400090|FG001|Overall Study|Other reasons|0|||
130119946|NCT03519256|468400091|FG002|Overall Study|Other reasons|2|||
129939811|NCT02397096|467743904|FG000|Day 1 to Week 24|Physician Decision|2|||
129939812|NCT02397096|467743905|FG001|Day 1 to Week 24|Physician Decision|3|||
129939813|NCT02397096|467743904|FG000|Day 1 to Week 24|Protocol Violation|1|||
129939814|NCT02397096|467743905|FG001|Day 1 to Week 24|Protocol Violation|4|||
129939815|NCT02397096|467743904|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
129939816|NCT02397096|467743905|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
129939817|NCT02397096|467743904|FG000|Day 1 to Week 24|Randomized, not treated|3|||
129939818|NCT02397096|467743905|FG001|Day 1 to Week 24|Randomized, not treated|0|||
129939819|NCT02397096|467743904|FG000|Week 24 to Week 48|Adverse Event|6|||
129939820|NCT02397096|467743905|FG001|Week 24 to Week 48|Adverse Event|2|||
129939821|NCT02397096|467743904|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
129939822|NCT02397096|467743905|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
129939823|NCT02397096|467743904|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
129939824|NCT02397096|467743905|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
129939825|NCT02397096|467743904|FG000|Week 24 to Week 48|Physician Decision|2|||
129939826|NCT02397096|467743905|FG001|Week 24 to Week 48|Physician Decision|1|||
129939827|NCT02397096|467743904|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
129939828|NCT02397096|467743905|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
129939829|NCT02397096|467743904|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
129939830|NCT02397096|467743905|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
129939831|NCT02397096|467743904|FG000|Study Extension 1|Adverse Event|7|||
130071321|NCT00563368|468216062|FG004|Overall Study|requirement for restricted medication|0|||
130071322|NCT00563368|468216063|FG005|Overall Study|requirement for restricted medication|0|||
130071323|NCT00563368|468216064|FG006|Overall Study|requirement for restricted medication|0|||
130071324|NCT00563368|468216058|FG000|Overall Study|Other|5|||
130071325|NCT00563368|468216059|FG001|Overall Study|Other|5|||
130071326|NCT00563368|468216060|FG002|Overall Study|Other|3|||
130071327|NCT00563368|468216061|FG003|Overall Study|Other|4|||
130071328|NCT00563368|468216062|FG004|Overall Study|Other|4|||
130071329|NCT00563368|468216063|FG005|Overall Study|Other|4|||
130071330|NCT00563368|468216064|FG006|Overall Study|Other|0|||
130071331|NCT01156532|468216065|FG000|Overall Study|Family Reasons|1|||
130071332|NCT01156532|468216065|FG000|Overall Study|Lost to Follow-up|1|||
130071333|NCT01819506|468216066|FG000|Overall Study|Physician Decision|5|||
130071334|NCT01819506|468216067|FG001|Overall Study|Physician Decision|2|||
130071335|NCT01819506|468216066|FG000|Overall Study|Withdrawal by Subject|3|||
129939832|NCT02397096|467743905|FG001|Study Extension 1|Adverse Event|5|||
129939833|NCT02397096|467743904|FG000|Study Extension 1|Death|1|||
129939834|NCT02397096|467743905|FG001|Study Extension 1|Death|0|||
129939835|NCT02397096|467743904|FG000|Study Extension 1|Lack of Efficacy|2|||
129939836|NCT02397096|467743905|FG001|Study Extension 1|Lack of Efficacy|5|||
130071336|NCT01819506|468216067|FG001|Overall Study|Withdrawal by Subject|3|||
130071337|NCT00729326|468216072|FG000|Overall Study|Lost to Follow-up|2|||
130071338|NCT00729326|468216073|FG001|Overall Study|Lost to Follow-up|0|||
129939837|NCT02397096|467743904|FG000|Study Extension 1|Lost to Follow-up|2|||
129939838|NCT02397096|467743905|FG001|Study Extension 1|Lost to Follow-up|3|||
129939839|NCT02397096|467743904|FG000|Study Extension 1|Non-compliance with study drug|3|||
129939840|NCT02397096|467743905|FG001|Study Extension 1|Non-compliance with study drug|0|||
129939841|NCT02397096|467743904|FG000|Study Extension 1|Physician Decision|4|||
129939842|NCT02397096|467743905|FG001|Study Extension 1|Physician Decision|2|||
129939843|NCT02397096|467743904|FG000|Study Extension 1|Pregnancy|1|||
129939844|NCT02397096|467743905|FG001|Study Extension 1|Pregnancy|0|||
129939845|NCT02397096|467743904|FG000|Study Extension 1|Protocol Violation|0|||
129939846|NCT02397096|467743905|FG001|Study Extension 1|Protocol Violation|1|||
129939847|NCT02397096|467743904|FG000|Study Extension 1|Withdrawal by Subject|21|||
129939848|NCT02397096|467743905|FG001|Study Extension 1|Withdrawal by Subject|7|||
129939849|NCT02397096|467743904|FG000|Study Extension 2|Adverse Event|3|||
129939850|NCT02397096|467743905|FG001|Study Extension 2|Adverse Event|3|||
129939851|NCT02397096|467743904|FG000|Study Extension 2|Availability of study medication locally|152|||
129939852|NCT02397096|467743905|FG001|Study Extension 2|Availability of study medication locally|64|||
129939853|NCT02397096|467743904|FG000|Study Extension 2|Death|2|||
129939854|NCT02397096|467743905|FG001|Study Extension 2|Death|0|||
129939855|NCT02397096|467743904|FG000|Study Extension 2|Lack of Efficacy|1|||
129939856|NCT02397096|467743905|FG001|Study Extension 2|Lack of Efficacy|0|||
129939857|NCT02397096|467743904|FG000|Study Extension 2|Lost to Follow-up|2|||
129939858|NCT02397096|467743905|FG001|Study Extension 2|Lost to Follow-up|1|||
129939859|NCT02397096|467743904|FG000|Study Extension 2|Non-compliance with study drug|1|||
129939860|NCT02397096|467743905|FG001|Study Extension 2|Non-compliance with study drug|0|||
129939861|NCT02397096|467743904|FG000|Study Extension 2|Physician Decision|2|||
129939862|NCT02397096|467743905|FG001|Study Extension 2|Physician Decision|5|||
129939863|NCT02397096|467743904|FG000|Study Extension 2|Pregnancy|1|||
129939864|NCT02397096|467743905|FG001|Study Extension 2|Pregnancy|0|||
129939865|NCT02397096|467743904|FG000|Study Extension 2|Withdrawal by Subject|10|||
129939866|NCT02397096|467743905|FG001|Study Extension 2|Withdrawal by Subject|3|||
129939867|NCT02397096|467743904|FG000|Study Extension 3|Adverse Event|1|||
129939868|NCT02397096|467743905|FG001|Study Extension 3|Adverse Event|0|||
129939869|NCT02397096|467743904|FG000|Study Extension 3|Availability of study medication locally|11|||
129939870|NCT02397096|467743905|FG001|Study Extension 3|Availability of study medication locally|3|||
129939871|NCT02397096|467743904|FG000|Study Extension 3|Lost to Follow-up|1|||
129939872|NCT02397096|467743905|FG001|Study Extension 3|Lost to Follow-up|0|||
129939873|NCT02397096|467743904|FG000|Study Extension 3|Withdrawal by Subject|2|||
129939874|NCT02397096|467743905|FG001|Study Extension 3|Withdrawal by Subject|1|||
129939875|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
129939876|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
129939877|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
129939878|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
129939879|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
129939880|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
129939881|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
129939882|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
129939883|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
129939884|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
129939885|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
129939886|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
129939887|NCT03488719|467743914|FG000|Overall Study|Adverse Event|0|||
129939888|NCT03488719|467743915|FG001|Overall Study|Adverse Event|4|||
129939889|NCT03488719|467743916|FG002|Overall Study|Adverse Event|2|||
129939890|NCT03488719|467743914|FG000|Overall Study|Other|0|||
129939891|NCT03488719|467743915|FG001|Overall Study|Other|0|||
129939892|NCT03488719|467743916|FG002|Overall Study|Other|5|||
129939893|NCT03477175|467743919|FG000|Overall Study|Unable to travel due to COVID-19|0|||
129939894|NCT03477175|467743920|FG001|Overall Study|Unable to travel due to COVID-19|1|||
129939895|NCT03477175|467743919|FG000|Overall Study|Physician Decision|1|||
129939896|NCT03477175|467743920|FG001|Overall Study|Physician Decision|0|||
129939897|NCT03477175|467743919|FG000|Overall Study|Transitioned to commercial drug|6|||
129939898|NCT03477175|467743920|FG001|Overall Study|Transitioned to commercial drug|6|||
129939899|NCT03477175|467743919|FG000|Overall Study|Lost to Follow-up|1|||
129939900|NCT03477175|467743920|FG001|Overall Study|Lost to Follow-up|1|||
129939901|NCT03477175|467743919|FG000|Overall Study|Withdrawal by Subject|3|||
129939902|NCT03477175|467743920|FG001|Overall Study|Withdrawal by Subject|1|||
129939903|NCT03477175|467743919|FG000|Overall Study|Adverse Event|1|||
129939904|NCT03477175|467743920|FG001|Overall Study|Adverse Event|5|||
129939905|NCT03477175|467743919|FG000|Overall Study|Disease Progression|7|||
129939906|NCT03477175|467743920|FG001|Overall Study|Disease Progression|7|||
129939907|NCT01675492|467743921|FG000|Overall Study|study completed early - product approval|42|||
129939908|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939909|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939910|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939911|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
129939912|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939913|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939914|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939915|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939916|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939917|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939918|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
129939919|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939920|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939921|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
129939922|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939923|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939924|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939925|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939926|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939927|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939928|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Death|1|||
129939929|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Death|2|||
129939930|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Death|3|||
129939931|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Death|5|||
129939932|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Death|4|||
129939933|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Death|0|||
129939934|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Death|0|||
129939935|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Death|0|||
129939936|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Death|0|||
129939937|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Death|0|||
129939938|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939939|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
129939940|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939941|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939942|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
129939943|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939944|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939945|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939946|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939947|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939948|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
129939949|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939950|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939951|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939952|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
129939953|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939954|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939955|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939956|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939957|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939958|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939959|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939960|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939961|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939962|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939963|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
129939964|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939965|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939966|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939967|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939968|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939969|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939970|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939971|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939972|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939973|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939974|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
129939975|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939976|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939977|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939978|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939979|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939980|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939981|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939982|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939983|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
129939984|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
129939985|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939986|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939987|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939988|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939989|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939990|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939991|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939992|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939993|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
129939994|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939995|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939996|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939997|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939998|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129939999|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940000|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940001|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940002|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940003|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940004|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940005|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
129940006|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
129940007|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
129940008|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940009|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940010|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940011|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940012|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940013|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940014|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940015|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940016|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
129940017|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
129940018|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940019|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940020|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940021|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940022|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940023|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940024|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940025|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940026|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940027|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
129940028|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940029|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940030|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940031|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940032|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940033|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940034|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940035|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
130119947|NCT03519256|468400092|FG003|Overall Study|Other reasons|0|||
130119948|NCT03519256|468400089|FG000|Overall Study|Disease progression|6|||
130119949|NCT03519256|468400090|FG001|Overall Study|Disease progression|3|||
130119950|NCT03519256|468400091|FG002|Overall Study|Disease progression|2|||
130119951|NCT03519256|468400092|FG003|Overall Study|Disease progression|1|||
130119952|NCT03519256|468400089|FG000|Overall Study|Lost to Follow-up|0|||
130119953|NCT03519256|468400090|FG001|Overall Study|Lost to Follow-up|1|||
130119954|NCT03519256|468400091|FG002|Overall Study|Lost to Follow-up|0|||
130119955|NCT03519256|468400092|FG003|Overall Study|Lost to Follow-up|0|||
130119956|NCT05431153|468400093|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119957|NCT05431153|468400094|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119958|NCT05431153|468400095|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119959|NCT05431153|468400096|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119960|NCT05431153|468400097|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
130119961|NCT05431153|468400098|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
130119962|NCT04828161|468400099|FG000|Overall Study|Withdrawal by Subject|0|||
130119963|NCT04828161|468400100|FG001|Overall Study|Withdrawal by Subject|3|||
130119964|NCT04828161|468400101|FG002|Overall Study|Withdrawal by Subject|3|||
130119965|NCT04828161|468400102|FG003|Overall Study|Withdrawal by Subject|4|||
130119966|NCT04828161|468400099|FG000|Overall Study|Lost to Follow-up|1|||
130119967|NCT04828161|468400100|FG001|Overall Study|Lost to Follow-up|4|||
130119968|NCT04828161|468400101|FG002|Overall Study|Lost to Follow-up|2|||
130119969|NCT04828161|468400102|FG003|Overall Study|Lost to Follow-up|2|||
130119970|NCT04828161|468400099|FG000|Overall Study|Other|2|||
129940036|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
129940037|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940038|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940039|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940040|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940041|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940042|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940043|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940044|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940045|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
129940046|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940047|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
129940048|NCT02751528|467743932|FG000|Overall Study|Withdrawal by Subject|1|||
129940049|NCT02751528|467743932|FG000|Overall Study|Adverse Event|1|||
129940050|NCT04218357|467743933|FG000|1st Allocation|Withdrawal by Subject|1|||
129940051|NCT04218357|467743934|FG001|1st Allocation|Withdrawal by Subject|0|||
129940052|NCT01958021|467743935|FG000|Treatment|Progressive disease|206|||
129940053|NCT01958021|467743936|FG001|Treatment|Progressive disease|265|||
129940054|NCT01958021|467743935|FG000|Treatment|Adverse Event|38|||
129940055|NCT01958021|467743936|FG001|Treatment|Adverse Event|10|||
129940056|NCT01958021|467743935|FG000|Treatment|Subject/guardian decision|29|||
129940057|NCT01958021|467743936|FG001|Treatment|Subject/guardian decision|25|||
129940058|NCT01958021|467743935|FG000|Treatment|Physician Decision|28|||
129940059|NCT01958021|467743936|FG001|Treatment|Physician Decision|21|||
129940060|NCT01958021|467743935|FG000|Treatment|Death|6|||
129940061|NCT01958021|467743936|FG001|Treatment|Death|1|||
129940062|NCT01958021|467743935|FG000|Treatment|Protocol deviation|3|||
129940063|NCT01958021|467743936|FG001|Treatment|Protocol deviation|1|||
129940064|NCT01958021|467743935|FG000|Treatment|Sponsor decision|24|||
129940065|NCT01958021|467743936|FG001|Treatment|Sponsor decision|11|||
129940066|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129940067|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129940068|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Death|1|||
129940069|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Death|0|||
129940070|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
129940071|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129940072|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129940073|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129940074|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
129940075|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129940076|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
129940077|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
129940078|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
129940079|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
130119971|NCT04828161|468400100|FG001|Overall Study|Other|0|||
130119972|NCT04828161|468400101|FG002|Overall Study|Other|2|||
130119973|NCT04828161|468400102|FG003|Overall Study|Other|0|||
130119974|NCT04828161|468400099|FG000|Overall Study|Death|0|||
130119975|NCT04828161|468400100|FG001|Overall Study|Death|0|||
129940080|NCT02488408|467743938|FG000|Part A|Adverse Event|2|||
129940081|NCT02488408|467743939|FG001|Part A|Adverse Event|0|||
129940082|NCT02488408|467743940|FG002|Part A|Adverse Event|0|||
129940083|NCT02488408|467743941|FG003|Part A|Adverse Event|0|||
129940084|NCT02488408|467743942|FG004|Part A|Adverse Event|0|||
129940085|NCT02488408|467743943|FG005|Part A|Adverse Event|0|||
129940086|NCT02488408|467743944|FG006|Part A|Adverse Event|0|||
129940087|NCT02488408|467743945|FG007|Part A|Adverse Event|0|||
129940088|NCT02488408|467743946|FG008|Part A|Adverse Event|0|||
129940089|NCT02488408|467743947|FG009|Part A|Adverse Event|0|||
129940090|NCT02488408|467743938|FG000|Part A|Death|1|||
129940091|NCT02488408|467743939|FG001|Part A|Death|5|||
129940092|NCT02488408|467743940|FG002|Part A|Death|0|||
129940093|NCT02488408|467743941|FG003|Part A|Death|0|||
129940094|NCT02488408|467743942|FG004|Part A|Death|3|||
129940095|NCT02488408|467743943|FG005|Part A|Death|0|||
129940096|NCT02488408|467743944|FG006|Part A|Death|0|||
129940097|NCT02488408|467743945|FG007|Part A|Death|0|||
129940098|NCT02488408|467743946|FG008|Part A|Death|0|||
129940099|NCT02488408|467743947|FG009|Part A|Death|0|||
129940100|NCT02488408|467743938|FG000|Part A|Disease Progression|2|||
129940101|NCT02488408|467743939|FG001|Part A|Disease Progression|8|||
129940102|NCT02488408|467743940|FG002|Part A|Disease Progression|2|||
129940103|NCT02488408|467743941|FG003|Part A|Disease Progression|3|||
129940104|NCT02488408|467743942|FG004|Part A|Disease Progression|4|||
129940105|NCT02488408|467743943|FG005|Part A|Disease Progression|0|||
129940106|NCT02488408|467743944|FG006|Part A|Disease Progression|0|||
129940107|NCT02488408|467743945|FG007|Part A|Disease Progression|0|||
129940108|NCT02488408|467743946|FG008|Part A|Disease Progression|0|||
129940109|NCT02488408|467743947|FG009|Part A|Disease Progression|0|||
129940110|NCT02488408|467743938|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
129940111|NCT02488408|467743939|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
129940112|NCT02488408|467743940|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
129940113|NCT02488408|467743941|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
129940114|NCT02488408|467743942|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
129940115|NCT02488408|467743943|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
129940116|NCT02488408|467743944|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
129940117|NCT02488408|467743945|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
129940118|NCT02488408|467743946|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
129940119|NCT02488408|467743947|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
129940120|NCT02488408|467743938|FG000|Part A|Investigator Decision|0|||
129940121|NCT02488408|467743939|FG001|Part A|Investigator Decision|1|||
129940122|NCT02488408|467743940|FG002|Part A|Investigator Decision|1|||
129940123|NCT02488408|467743941|FG003|Part A|Investigator Decision|0|||
129940124|NCT02488408|467743942|FG004|Part A|Investigator Decision|0|||
129940125|NCT02488408|467743943|FG005|Part A|Investigator Decision|0|||
129940126|NCT02488408|467743944|FG006|Part A|Investigator Decision|0|||
129940127|NCT02488408|467743945|FG007|Part A|Investigator Decision|0|||
129940128|NCT02488408|467743946|FG008|Part A|Investigator Decision|0|||
129940129|NCT02488408|467743947|FG009|Part A|Investigator Decision|0|||
129940130|NCT02488408|467743938|FG000|Part A|Withdrawal by Subject|0|||
129940131|NCT02488408|467743939|FG001|Part A|Withdrawal by Subject|0|||
129940132|NCT02488408|467743940|FG002|Part A|Withdrawal by Subject|2|||
129940133|NCT02488408|467743941|FG003|Part A|Withdrawal by Subject|0|||
129940134|NCT02488408|467743942|FG004|Part A|Withdrawal by Subject|0|||
129940135|NCT02488408|467743943|FG005|Part A|Withdrawal by Subject|0|||
129940136|NCT02488408|467743944|FG006|Part A|Withdrawal by Subject|0|||
129940137|NCT02488408|467743945|FG007|Part A|Withdrawal by Subject|0|||
129940138|NCT02488408|467743946|FG008|Part A|Withdrawal by Subject|0|||
129940139|NCT02488408|467743947|FG009|Part A|Withdrawal by Subject|0|||
129940140|NCT02488408|467743938|FG000|Part A|Other|1|||
129940141|NCT02488408|467743939|FG001|Part A|Other|0|||
129940142|NCT02488408|467743940|FG002|Part A|Other|0|||
129940143|NCT02488408|467743941|FG003|Part A|Other|0|||
129940144|NCT02488408|467743942|FG004|Part A|Other|0|||
129940145|NCT02488408|467743943|FG005|Part A|Other|0|||
129940146|NCT02488408|467743944|FG006|Part A|Other|0|||
129940147|NCT02488408|467743945|FG007|Part A|Other|0|||
129940148|NCT02488408|467743946|FG008|Part A|Other|0|||
129940149|NCT02488408|467743947|FG009|Part A|Other|0|||
129940150|NCT02488408|467743938|FG000|Part B|Adverse Event|0|||
130071339|NCT00729326|468216072|FG000|Overall Study|Physician Decision|0|||
129940151|NCT02488408|467743939|FG001|Part B|Adverse Event|0|||
129940152|NCT02488408|467743940|FG002|Part B|Adverse Event|0|||
129940153|NCT02488408|467743941|FG003|Part B|Adverse Event|0|||
129940154|NCT02488408|467743942|FG004|Part B|Adverse Event|0|||
129940155|NCT02488408|467743943|FG005|Part B|Adverse Event|2|||
129940156|NCT02488408|467743944|FG006|Part B|Adverse Event|2|||
129940157|NCT02488408|467743945|FG007|Part B|Adverse Event|7|||
129940158|NCT02488408|467743946|FG008|Part B|Adverse Event|2|||
129940159|NCT02488408|467743947|FG009|Part B|Adverse Event|2|||
129940160|NCT02488408|467743938|FG000|Part B|Death|0|||
129940161|NCT02488408|467743939|FG001|Part B|Death|0|||
129940162|NCT02488408|467743940|FG002|Part B|Death|0|||
129940163|NCT02488408|467743941|FG003|Part B|Death|0|||
129940164|NCT02488408|467743942|FG004|Part B|Death|0|||
129940165|NCT02488408|467743943|FG005|Part B|Death|3|||
129940166|NCT02488408|467743944|FG006|Part B|Death|1|||
129940167|NCT02488408|467743945|FG007|Part B|Death|2|||
129940168|NCT02488408|467743946|FG008|Part B|Death|2|||
129940169|NCT02488408|467743947|FG009|Part B|Death|2|||
129940170|NCT02488408|467743938|FG000|Part B|Death due to Disease Progression|0|||
129940171|NCT02488408|467743939|FG001|Part B|Death due to Disease Progression|0|||
129940172|NCT02488408|467743940|FG002|Part B|Death due to Disease Progression|0|||
129940173|NCT02488408|467743941|FG003|Part B|Death due to Disease Progression|0|||
129940174|NCT02488408|467743942|FG004|Part B|Death due to Disease Progression|0|||
129940175|NCT02488408|467743943|FG005|Part B|Death due to Disease Progression|2|||
129940176|NCT02488408|467743944|FG006|Part B|Death due to Disease Progression|2|||
129940177|NCT02488408|467743945|FG007|Part B|Death due to Disease Progression|1|||
129940178|NCT02488408|467743946|FG008|Part B|Death due to Disease Progression|1|||
129940179|NCT02488408|467743947|FG009|Part B|Death due to Disease Progression|1|||
129940180|NCT02488408|467743938|FG000|Part B|Disease Progression|0|||
129940181|NCT02488408|467743939|FG001|Part B|Disease Progression|0|||
129940182|NCT02488408|467743940|FG002|Part B|Disease Progression|0|||
129940183|NCT02488408|467743941|FG003|Part B|Disease Progression|0|||
129940184|NCT02488408|467743942|FG004|Part B|Disease Progression|0|||
129940185|NCT02488408|467743943|FG005|Part B|Disease Progression|6|||
129940186|NCT02488408|467743944|FG006|Part B|Disease Progression|9|||
129940187|NCT02488408|467743945|FG007|Part B|Disease Progression|7|||
129940188|NCT02488408|467743946|FG008|Part B|Disease Progression|9|||
129940189|NCT02488408|467743947|FG009|Part B|Disease Progression|11|||
129940190|NCT02488408|467743938|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
129940191|NCT02488408|467743939|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
129940192|NCT02488408|467743940|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
129940193|NCT02488408|467743941|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
129940194|NCT02488408|467743942|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
129940195|NCT02488408|467743943|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
129940196|NCT02488408|467743944|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
129940197|NCT02488408|467743945|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
129940198|NCT02488408|467743946|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
129940199|NCT02488408|467743947|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
129940200|NCT02488408|467743938|FG000|Part B|Investigator Decision|0|||
129940201|NCT02488408|467743939|FG001|Part B|Investigator Decision|0|||
130071340|NCT00729326|468216073|FG001|Overall Study|Physician Decision|1|||
130071341|NCT00729326|468216072|FG000|Overall Study|Protocol Violation|3|||
130071342|NCT00729326|468216073|FG001|Overall Study|Protocol Violation|2|||
130071343|NCT00729326|468216072|FG000|Overall Study|Subject Decision|4|||
130071344|NCT00729326|468216073|FG001|Overall Study|Subject Decision|4|||
130071345|NCT00729326|468216072|FG000|Overall Study|Sponsor Decision|1|||
130071346|NCT00729326|468216073|FG001|Overall Study|Sponsor Decision|2|||
130071347|NCT01235728|468216074|FG000|Overall Study|Protocol Violation|0|||
130071348|NCT01235728|468216075|FG001|Overall Study|Protocol Violation|0|||
130071349|NCT01235728|468216076|FG002|Overall Study|Protocol Violation|0|||
130071350|NCT01235728|468216077|FG003|Overall Study|Protocol Violation|1|||
130071351|NCT01235728|468216078|FG004|Overall Study|Protocol Violation|0|||
130071352|NCT01235728|468216079|FG005|Overall Study|Protocol Violation|0|||
130071353|NCT01235728|468216080|FG006|Overall Study|Protocol Violation|0|||
130071354|NCT01235728|468216081|FG007|Overall Study|Protocol Violation|0|||
130071355|NCT01419080|468216084|FG000|Overall Study|Withdrawal by Subject|75|||
130071356|NCT01419080|468216084|FG000|Overall Study|Death|30|||
130071357|NCT01419080|468216084|FG000|Overall Study|Lost to Follow-up|23|||
130071358|NCT01419080|468216084|FG000|Overall Study|Too Ill|3|||
130071359|NCT03199638|468216088|FG000|Overall Study|inability to drink glutamine during regularly|0|||
130071360|NCT03199638|468216089|FG001|Overall Study|inability to drink glutamine during regularly|2|||
130071361|NCT01575899|468216090|FG000|Overall Study|Lost to Follow-up|3|||
130071362|NCT01575899|468216091|FG001|Overall Study|Lost to Follow-up|4|||
130071363|NCT01575899|468216092|FG002|Overall Study|Lost to Follow-up|2|||
130071364|NCT01575899|468216090|FG000|Overall Study|Protocol Violation|2|||
130071365|NCT01575899|468216091|FG001|Overall Study|Protocol Violation|1|||
130071366|NCT01575899|468216092|FG002|Overall Study|Protocol Violation|0|||
130071367|NCT02807844|468216093|FG000|Overall Study|Physician Decision|0|||
130071368|NCT02807844|468216094|FG001|Overall Study|Physician Decision|0|||
130071369|NCT02807844|468216095|FG002|Overall Study|Physician Decision|0|||
129940202|NCT02488408|467743940|FG002|Part B|Investigator Decision|0|||
130071370|NCT02807844|468216096|FG003|Overall Study|Physician Decision|0|||
130071371|NCT02807844|468216097|FG004|Overall Study|Physician Decision|0|||
130071372|NCT02807844|468216098|FG005|Overall Study|Physician Decision|0|||
130071373|NCT02807844|468216099|FG006|Overall Study|Physician Decision|3|||
130071374|NCT02807844|468216100|FG007|Overall Study|Physician Decision|0|||
129940203|NCT02488408|467743941|FG003|Part B|Investigator Decision|0|||
129940204|NCT02488408|467743942|FG004|Part B|Investigator Decision|0|||
129940205|NCT02488408|467743943|FG005|Part B|Investigator Decision|0|||
129940206|NCT02488408|467743944|FG006|Part B|Investigator Decision|1|||
130071375|NCT02807844|468216101|FG008|Overall Study|Physician Decision|1|||
130071376|NCT02807844|468216102|FG009|Overall Study|Physician Decision|2|||
130071377|NCT02807844|468216093|FG000|Overall Study|Death|0|||
130071378|NCT02807844|468216094|FG001|Overall Study|Death|0|||
130071379|NCT02807844|468216095|FG002|Overall Study|Death|2|||
129940207|NCT02488408|467743945|FG007|Part B|Investigator Decision|0|||
129940208|NCT02488408|467743946|FG008|Part B|Investigator Decision|2|||
129940209|NCT02488408|467743947|FG009|Part B|Investigator Decision|1|||
129940210|NCT05886777|467743950|FG000|Overall Study|Lost to Follow-up|1|||
129940211|NCT05886777|467743951|FG001|Overall Study|Lost to Follow-up|0|||
129940212|NCT05886777|467743952|FG002|Overall Study|Lost to Follow-up|2|||
129940213|NCT05886777|467743953|FG003|Overall Study|Lost to Follow-up|1|||
129940214|NCT05886777|467743954|FG004|Overall Study|Lost to Follow-up|0|||
129940215|NCT05886777|467743955|FG005|Overall Study|Lost to Follow-up|2|||
129940216|NCT05886777|467743956|FG006|Overall Study|Lost to Follow-up|0|||
129940217|NCT05886777|467743950|FG000|Overall Study|Other|0|||
129940218|NCT05886777|467743951|FG001|Overall Study|Other|2|||
129940219|NCT05886777|467743952|FG002|Overall Study|Other|1|||
129940220|NCT05886777|467743953|FG003|Overall Study|Other|0|||
129940221|NCT05886777|467743954|FG004|Overall Study|Other|0|||
129940222|NCT05886777|467743955|FG005|Overall Study|Other|0|||
129940223|NCT05886777|467743956|FG006|Overall Study|Other|0|||
129940224|NCT05886777|467743950|FG000|Overall Study|Withdrawal by Subject|1|||
129940225|NCT05886777|467743951|FG001|Overall Study|Withdrawal by Subject|0|||
129940226|NCT05886777|467743952|FG002|Overall Study|Withdrawal by Subject|1|||
129940227|NCT05886777|467743953|FG003|Overall Study|Withdrawal by Subject|4|||
129940228|NCT05886777|467743954|FG004|Overall Study|Withdrawal by Subject|3|||
129940229|NCT05886777|467743955|FG005|Overall Study|Withdrawal by Subject|1|||
129940230|NCT05886777|467743956|FG006|Overall Study|Withdrawal by Subject|1|||
129940231|NCT05886777|467743950|FG000|Overall Study|Protocol Violation|0|||
130071380|NCT02807844|468216096|FG003|Overall Study|Death|4|||
130071381|NCT02807844|468216097|FG004|Overall Study|Death|1|||
130071382|NCT02807844|468216098|FG005|Overall Study|Death|2|||
130071383|NCT02807844|468216099|FG006|Overall Study|Death|1|||
130071384|NCT02807844|468216100|FG007|Overall Study|Death|2|||
130071385|NCT02807844|468216101|FG008|Overall Study|Death|0|||
130071386|NCT02807844|468216102|FG009|Overall Study|Death|1|||
130071387|NCT02807844|468216093|FG000|Overall Study|Withdrawal by Subject|0|||
130071388|NCT02807844|468216094|FG001|Overall Study|Withdrawal by Subject|0|||
130071389|NCT02807844|468216095|FG002|Overall Study|Withdrawal by Subject|2|||
130071390|NCT02807844|468216096|FG003|Overall Study|Withdrawal by Subject|1|||
130071391|NCT02807844|468216097|FG004|Overall Study|Withdrawal by Subject|1|||
130071392|NCT02807844|468216098|FG005|Overall Study|Withdrawal by Subject|0|||
130071393|NCT02807844|468216099|FG006|Overall Study|Withdrawal by Subject|1|||
130071394|NCT02807844|468216100|FG007|Overall Study|Withdrawal by Subject|0|||
130071395|NCT02807844|468216101|FG008|Overall Study|Withdrawal by Subject|0|||
130071396|NCT02807844|468216102|FG009|Overall Study|Withdrawal by Subject|0|||
130071397|NCT02807844|468216093|FG000|Overall Study|Progressive disease|5|||
130071398|NCT02807844|468216094|FG001|Overall Study|Progressive disease|12|||
130071399|NCT02807844|468216095|FG002|Overall Study|Progressive disease|8|||
130071400|NCT02807844|468216096|FG003|Overall Study|Progressive disease|8|||
130071401|NCT02807844|468216097|FG004|Overall Study|Progressive disease|3|||
130071402|NCT02807844|468216098|FG005|Overall Study|Progressive disease|8|||
130071403|NCT02807844|468216099|FG006|Overall Study|Progressive disease|14|||
130071404|NCT02807844|468216100|FG007|Overall Study|Progressive disease|17|||
130071405|NCT02807844|468216101|FG008|Overall Study|Progressive disease|19|||
130071406|NCT02807844|468216102|FG009|Overall Study|Progressive disease|15|||
130071407|NCT02807844|468216093|FG000|Overall Study|Adverse Event|1|||
130071408|NCT02807844|468216094|FG001|Overall Study|Adverse Event|0|||
130071409|NCT02807844|468216095|FG002|Overall Study|Adverse Event|0|||
130071410|NCT02807844|468216096|FG003|Overall Study|Adverse Event|0|||
130071411|NCT02807844|468216097|FG004|Overall Study|Adverse Event|1|||
130071412|NCT02807844|468216098|FG005|Overall Study|Adverse Event|1|||
130071413|NCT02807844|468216099|FG006|Overall Study|Adverse Event|1|||
130071414|NCT02807844|468216100|FG007|Overall Study|Adverse Event|1|||
130071415|NCT02807844|468216101|FG008|Overall Study|Adverse Event|1|||
130071416|NCT02807844|468216102|FG009|Overall Study|Adverse Event|2|||
130071417|NCT04294095|468216103|FG000|Overall Study|Adverse Event|1|||
130071418|NCT04294095|468216104|FG001|Overall Study|Adverse Event|0|||
130071419|NCT03205982|468216109|FG000|Overall Study|Lost to Follow-up|20|||
130071420|NCT03205982|468216110|FG001|Overall Study|Lost to Follow-up|19|||
130071421|NCT03205982|468216109|FG000|Overall Study|Withdrawal by Subject|4|||
130071422|NCT03205982|468216110|FG001|Overall Study|Withdrawal by Subject|3|||
130071423|NCT03205982|468216109|FG000|Overall Study|Withdrawal by PI|0|||
130071424|NCT03205982|468216110|FG001|Overall Study|Withdrawal by PI|1|||
130071425|NCT00994162|468216111|FG000|Overall Study|Withdrawal by Subject|1|||
130071426|NCT00994162|468216111|FG000|Overall Study|Lost to Follow-up|2|||
129940232|NCT05886777|467743951|FG001|Overall Study|Protocol Violation|0|||
129940233|NCT05886777|467743952|FG002|Overall Study|Protocol Violation|1|||
129940234|NCT05886777|467743953|FG003|Overall Study|Protocol Violation|0|||
129940235|NCT05886777|467743954|FG004|Overall Study|Protocol Violation|0|||
130071427|NCT00994162|468216111|FG000|Overall Study|Product Complaint|1|||
130071428|NCT00994162|468216111|FG000|Overall Study|Poor Compliance|5|||
130071429|NCT00994162|468216111|FG000|Overall Study|Lack of Response|3|||
130071430|NCT00994162|468216111|FG000|Overall Study|Discharged from Hospital|4|||
130119976|NCT04828161|468400101|FG002|Overall Study|Death|0|||
129940236|NCT05886777|467743955|FG005|Overall Study|Protocol Violation|0|||
129940237|NCT05886777|467743956|FG006|Overall Study|Protocol Violation|0|||
129940238|NCT05886777|467743950|FG000|Overall Study|No longer met eligibility criteria|0|||
129940239|NCT05886777|467743951|FG001|Overall Study|No longer met eligibility criteria|1|||
129940240|NCT05886777|467743952|FG002|Overall Study|No longer met eligibility criteria|0|||
129940241|NCT05886777|467743953|FG003|Overall Study|No longer met eligibility criteria|0|||
129940242|NCT05886777|467743954|FG004|Overall Study|No longer met eligibility criteria|0|||
129940243|NCT05886777|467743955|FG005|Overall Study|No longer met eligibility criteria|0|||
129940244|NCT05886777|467743956|FG006|Overall Study|No longer met eligibility criteria|0|||
129940245|NCT03664804|467743958|FG000|Overall Study|Withdrawal by Subject|7|||
129940246|NCT04701203|467743959|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
129940247|NCT04701203|467743960|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
129940248|NCT04701203|467743961|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
129940249|NCT04701203|467743959|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
129940250|NCT04701203|467743960|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
129940251|NCT04701203|467743961|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
129940252|NCT04701203|467743959|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
129940253|NCT04701203|467743960|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
129940254|NCT04701203|467743961|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
129940255|NCT04701203|467743959|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
129940256|NCT04701203|467743960|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
129940257|NCT04701203|467743961|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
129940258|NCT06140290|467743963|FG000|Period 1|Adverse Event|1|||
129940259|NCT06140290|467743964|FG001|Period 1|Adverse Event|0|||
129940260|NCT06140290|467743963|FG000|Period 2|Assigned but not treated|0|||
129940261|NCT06140290|467743964|FG001|Period 2|Assigned but not treated|1|||
129940262|NCT06140290|467743963|FG000|Period 2|Withdrawal by Subject|0|||
129940263|NCT06140290|467743964|FG001|Period 2|Withdrawal by Subject|1|||
129940264|NCT05293717|467743965|FG000|Overall Study|Physician Decision|1|||
129940265|NCT03762850|467745390|FG000|Overall Study|Death|0|||
129940266|NCT03762850|467745391|FG001|Overall Study|Death|1|||
129940267|NCT03762850|467745390|FG000|Overall Study|Lost to Follow-up|0|||
129940268|NCT03762850|467745391|FG001|Overall Study|Lost to Follow-up|1|||
129940269|NCT03762850|467745390|FG000|Overall Study|Physician Decision|0|||
129940270|NCT03762850|467745391|FG001|Overall Study|Physician Decision|1|||
129940271|NCT03762850|467745390|FG000|Overall Study|Withdrawal by Subject|4|||
129940272|NCT03762850|467745391|FG001|Overall Study|Withdrawal by Subject|9|||
129940273|NCT03083366|467745392|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
129940274|NCT03083366|467745393|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
129940275|NCT03083366|467745392|FG000|Enrollment Period|Lack of Efficacy|1|||
129940276|NCT03083366|467745393|FG001|Enrollment Period|Lack of Efficacy|0|||
129940277|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940278|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940279|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
129940280|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
129940281|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940282|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
129940283|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940284|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
129940285|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
129940286|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
129940287|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Death|0|||
129940288|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Death|0|||
129940289|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Death|0|||
129940290|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Death|0|||
129940291|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Death|0|||
129940292|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Death|0|||
129940293|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Death|0|||
129940294|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Death|0|||
129940295|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Death|1|||
129940296|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Death|0|||
129940297|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
129940298|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
130071431|NCT00994162|468216111|FG000|Overall Study|Death|2|||
130071432|NCT00994162|468216111|FG000|Overall Study|Care Transferred to Another Physician|2|||
129940299|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
129940300|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940301|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940302|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940303|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940304|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940305|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
129940306|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940307|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940308|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940309|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940310|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940311|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
129940312|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940313|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940314|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940315|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
129940316|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
129940317|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940318|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940319|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940320|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
129940321|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940322|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940323|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940324|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940325|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940326|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940327|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
129940328|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
129940329|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
129940330|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
129940331|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
129940332|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
129940333|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
129940334|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
129940335|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
129940336|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
129940337|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940338|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940339|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940340|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940341|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940342|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940343|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940344|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
129940345|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940346|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940347|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940348|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
129940349|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
129940350|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940351|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940352|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940353|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940354|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940355|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
129940356|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940357|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940358|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
129940359|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
129940360|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
129940361|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940362|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940363|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940364|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940365|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940366|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
129940367|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
129940368|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
130119977|NCT04828161|468400102|FG003|Overall Study|Death|2|||
130119978|NCT00135707|468400111|FG000|Overall Study|Lost to Follow-up|94|||
129940369|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
130119979|NCT00135707|468400112|FG001|Overall Study|Lost to Follow-up|89|||
130119980|NCT00135707|468400111|FG000|Overall Study|Withdrawal by Subject|0|||
129940370|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
130119981|NCT00135707|468400112|FG001|Overall Study|Withdrawal by Subject|1|||
130119982|NCT00135707|468400111|FG000|Overall Study|Institutional review board request|1|||
129940371|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
129940372|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
129940373|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
129940374|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
129940375|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
129940376|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
129940377|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
129940378|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
129940379|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
129940380|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
129940381|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
129940382|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940383|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
129940384|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940385|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940386|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940387|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
129940388|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
129940389|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
129940390|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
129940391|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
129940392|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other|1|||
129940393|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other|0|||
129940394|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other|0|||
129940395|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other|0|||
129940396|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other|0|||
129940397|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
129940398|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
129940399|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
129940400|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
129940401|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
129940402|NCT03352713|467745418|FG000|Overall Study|Lost to Follow-up|8|||
129940403|NCT03352713|467745418|FG000|Overall Study|Withdrawn by investigator|5|||
129940404|NCT03352713|467745418|FG000|Overall Study|Completed 0 EMAs|8|||
129940405|NCT03352713|467745418|FG000|Overall Study|Device incompatible/stolen|5|||
129940406|NCT01812759|467745419|FG000|Overall Study|Physician Decision|0|||
129940407|NCT01812759|467745420|FG001|Overall Study|Physician Decision|0|||
129940408|NCT01812759|467745421|FG002|Overall Study|Physician Decision|1|||
129940409|NCT00536120|467745422|FG000|Overall Study|Lost to Follow-up|1|||
129940410|NCT00536120|467745423|FG001|Overall Study|Lost to Follow-up|0|||
129940411|NCT00536120|467745422|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
129940412|NCT00536120|467745423|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
129940413|NCT00536120|467745422|FG000|Overall Study|Non-compliance|1|||
129940414|NCT00536120|467745423|FG001|Overall Study|Non-compliance|0|||
129940415|NCT00536120|467745422|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
129940416|NCT00536120|467745423|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
129940417|NCT00536120|467745422|FG000|Overall Study|Steroid Use|0|||
129940418|NCT00536120|467745423|FG001|Overall Study|Steroid Use|2|||
129940419|NCT00536120|467745422|FG000|Overall Study|Missed Study Visit|0|||
129940420|NCT00536120|467745423|FG001|Overall Study|Missed Study Visit|1|||
129940421|NCT02722434|467745424|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
129940422|NCT02722434|467745425|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
129940423|NCT02722434|467745424|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
129940424|NCT02722434|467745425|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
129940425|NCT00360269|467745426|FG000|Overall Study|Lost to Follow-up|7|||
129940426|NCT00360269|467745427|FG001|Overall Study|Lost to Follow-up|9|||
129940427|NCT00360269|467745426|FG000|Overall Study|Physician Decision|1|||
129940428|NCT00360269|467745427|FG001|Overall Study|Physician Decision|2|||
129940429|NCT00360269|467745426|FG000|Overall Study|Adverse Event|1|||
129940430|NCT00360269|467745427|FG001|Overall Study|Adverse Event|0|||
129940431|NCT00360269|467745426|FG000|Overall Study|Withdrawal by Subject|1|||
129940432|NCT00360269|467745427|FG001|Overall Study|Withdrawal by Subject|1|||
129940433|NCT00048932|467745430|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
129940434|NCT00048932|467745431|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
129940435|NCT00048932|467745432|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
129940436|NCT00048932|467745430|FG000|Double Blind Period (DB)|Adverse Event|51|||
129940437|NCT00048932|467745431|FG001|Double Blind Period (DB)|Adverse Event|19|||
129940438|NCT00048932|467745432|FG002|Double Blind Period (DB)|Adverse Event|0|||
129940439|NCT00048932|467745430|FG000|Double Blind Period (DB)|Death|5|||
129940440|NCT00048932|467745431|FG001|Double Blind Period (DB)|Death|3|||
129940441|NCT00048932|467745432|FG002|Double Blind Period (DB)|Death|0|||
129940442|NCT00048932|467745430|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
129940443|NCT00048932|467745431|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
129940444|NCT00048932|467745432|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
129940445|NCT00048932|467745430|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
129940446|NCT00048932|467745431|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
129940447|NCT00048932|467745432|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
129940448|NCT00048932|467745430|FG000|Double Blind Period (DB)|Relocation|1|||
129940449|NCT00048932|467745431|FG001|Double Blind Period (DB)|Relocation|0|||
129940450|NCT00048932|467745432|FG002|Double Blind Period (DB)|Relocation|0|||
129940451|NCT00048932|467745430|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
129940452|NCT00048932|467745431|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
129940453|NCT00048932|467745432|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
129940454|NCT00048932|467745430|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
129940455|NCT00048932|467745431|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
129940456|NCT00048932|467745432|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
129940457|NCT00048932|467745430|FG000|Double Blind Period (DB)|Pregnancy|1|||
129940458|NCT00048932|467745431|FG001|Double Blind Period (DB)|Pregnancy|0|||
129940459|NCT00048932|467745432|FG002|Double Blind Period (DB)|Pregnancy|0|||
129940460|NCT00048932|467745430|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
129940461|NCT00048932|467745431|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
129940462|NCT00048932|467745432|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
129940463|NCT00048932|467745430|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
129940464|NCT00048932|467745431|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
129940465|NCT00048932|467745432|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
129940466|NCT00048932|467745430|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
129940467|NCT00048932|467745431|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
129940468|NCT00048932|467745432|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
129940469|NCT00048932|467745430|FG000|Open Label Period (OL)|Death|0|||
129940470|NCT00048932|467745431|FG001|Open Label Period (OL)|Death|0|||
129940471|NCT00048932|467745432|FG002|Open Label Period (OL)|Death|25|||
129940472|NCT00048932|467745430|FG000|Open Label Period (OL)|Adverse Event|0|||
129940473|NCT00048932|467745431|FG001|Open Label Period (OL)|Adverse Event|0|||
129940474|NCT00048932|467745432|FG002|Open Label Period (OL)|Adverse Event|103|||
129940475|NCT00048932|467745430|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
129940476|NCT00048932|467745431|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
129940477|NCT00048932|467745432|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
129940478|NCT00048932|467745430|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
129940479|NCT00048932|467745431|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
129940480|NCT00048932|467745432|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
129940481|NCT00048932|467745430|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
129940482|NCT00048932|467745431|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
129940483|NCT00048932|467745432|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
129940484|NCT00048932|467745430|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
129940485|NCT00048932|467745431|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
129940486|NCT00048932|467745432|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
129940487|NCT00048932|467745430|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
129940488|NCT00048932|467745431|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
129940489|NCT00048932|467745432|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
129940490|NCT00048932|467745430|FG000|Open Label Period (OL)|Pregnancy|0|||
129940491|NCT00048932|467745431|FG001|Open Label Period (OL)|Pregnancy|0|||
129940492|NCT00048932|467745432|FG002|Open Label Period (OL)|Pregnancy|6|||
129940493|NCT00048932|467745430|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
129940494|NCT00048932|467745431|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
129940495|NCT00048932|467745432|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
129940496|NCT00048932|467745430|FG000|Open Label Period (OL)|Investigator Retiring|0|||
129940497|NCT00048932|467745431|FG001|Open Label Period (OL)|Investigator Retiring|0|||
129940498|NCT00048932|467745432|FG002|Open Label Period (OL)|Investigator Retiring|2|||
129940499|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
129940500|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
129940501|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
129940502|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Relocated|0|||
129940503|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Relocated|0|||
129940504|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Relocated|6|||
130071433|NCT00994162|468216111|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
130071434|NCT00994162|468216111|FG000|Overall Study|Physician Decision|2|||
129940505|NCT00048932|467745430|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
129940506|NCT00048932|467745431|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
129940507|NCT00048932|467745432|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
129940508|NCT00048932|467745430|FG000|Open Label Period (OL)|Site Closure|0|||
129940509|NCT00048932|467745431|FG001|Open Label Period (OL)|Site Closure|0|||
129940510|NCT00048932|467745432|FG002|Open Label Period (OL)|Site Closure|3|||
129940511|NCT00048932|467745430|FG000|Open Label Period (OL)|Trial Terminated|0|||
129940512|NCT00048932|467745431|FG001|Open Label Period (OL)|Trial Terminated|0|||
130071435|NCT00994162|468216111|FG000|Overall Study|Surrounding Wound Erythematous|1|||
129940513|NCT00048932|467745432|FG002|Open Label Period (OL)|Trial Terminated|1|||
129940514|NCT00048932|467745430|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
129940515|NCT00048932|467745431|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
129940516|NCT00048932|467745432|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
129940517|NCT00048932|467745430|FG000|Open Label Period (OL)|Patient Decision|0|||
129940518|NCT00048932|467745431|FG001|Open Label Period (OL)|Patient Decision|0|||
129940519|NCT00048932|467745432|FG002|Open Label Period (OL)|Patient Decision|4|||
129940520|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
129940521|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
129940522|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
129940523|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
129940524|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
129940525|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
129940526|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
129940527|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
129940528|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
129940529|NCT00048932|467745430|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
129940530|NCT00048932|467745431|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
129940531|NCT00048932|467745432|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
129940532|NCT00048932|467745430|FG000|Open Label Period (OL)|Investigator Decision|0|||
129940533|NCT00048932|467745431|FG001|Open Label Period (OL)|Investigator Decision|0|||
129940534|NCT00048932|467745432|FG002|Open Label Period (OL)|Investigator Decision|4|||
129940535|NCT00048932|467745430|FG000|Open Label Period (OL)|Site Staff Issues|0|||
129940536|NCT00048932|467745431|FG001|Open Label Period (OL)|Site Staff Issues|0|||
129940537|NCT00048932|467745432|FG002|Open Label Period (OL)|Site Staff Issues|2|||
129940538|NCT00048932|467745430|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
129940539|NCT00048932|467745431|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
129940540|NCT00048932|467745432|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
129940541|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Surgery|0|||
129940542|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Surgery|0|||
129940543|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Surgery|1|||
129940544|NCT02232737|467745433|FG000|Overall Study|Lost to Follow-up|18|||
129940545|NCT02232737|467745434|FG001|Overall Study|Lost to Follow-up|28|||
129940546|NCT02232737|467745435|FG002|Overall Study|Lost to Follow-up|33|||
129940547|NCT02232737|467745433|FG000|Overall Study|Personal reasons|7|||
129940548|NCT02232737|467745434|FG001|Overall Study|Personal reasons|8|||
129940549|NCT02232737|467745435|FG002|Overall Study|Personal reasons|14|||
129940550|NCT02232737|467745433|FG000|Overall Study|Adverse Event|6|||
129940551|NCT02232737|467745434|FG001|Overall Study|Adverse Event|3|||
129940552|NCT02232737|467745435|FG002|Overall Study|Adverse Event|8|||
129940553|NCT02232737|467745433|FG000|Overall Study|Incarcerated|2|||
129940554|NCT02232737|467745434|FG001|Overall Study|Incarcerated|1|||
129940555|NCT02232737|467745435|FG002|Overall Study|Incarcerated|2|||
129940556|NCT02232737|467745433|FG000|Overall Study|Withdrawal by Subject|0|||
129940557|NCT02232737|467745434|FG001|Overall Study|Withdrawal by Subject|1|||
129940558|NCT02232737|467745435|FG002|Overall Study|Withdrawal by Subject|2|||
129940559|NCT02232737|467745433|FG000|Overall Study|Death|0|||
129940560|NCT02232737|467745434|FG001|Overall Study|Death|1|||
129940561|NCT02232737|467745435|FG002|Overall Study|Death|1|||
129940562|NCT02232737|467745433|FG000|Overall Study|Physician Decision|1|||
129940563|NCT02232737|467745434|FG001|Overall Study|Physician Decision|3|||
129940564|NCT02232737|467745435|FG002|Overall Study|Physician Decision|1|||
129940565|NCT02232737|467745433|FG000|Overall Study|Protocol Violation|1|||
129940566|NCT02232737|467745434|FG001|Overall Study|Protocol Violation|0|||
129940567|NCT02232737|467745435|FG002|Overall Study|Protocol Violation|1|||
129940568|NCT02232737|467745433|FG000|Overall Study|Reason unknown|1|||
129940569|NCT02232737|467745434|FG001|Overall Study|Reason unknown|0|||
129940570|NCT02232737|467745435|FG002|Overall Study|Reason unknown|0|||
129940571|NCT04559698|467745436|FG000|Overall Study|Lost to Follow-up|14|||
129940572|NCT04559698|467745437|FG001|Overall Study|Lost to Follow-up|15|||
129940573|NCT04559698|467745436|FG000|Overall Study|Withdrawal by Subject|0|||
129940574|NCT04559698|467745437|FG001|Overall Study|Withdrawal by Subject|1|||
129940575|NCT04989816|467745438|FG000|Overall Study|Death|77|||
129940576|NCT04989816|467745438|FG000|Overall Study|Lost to Follow-up|3|||
130119983|NCT00135707|468400112|FG001|Overall Study|Institutional review board request|0|||
129940577|NCT03437733|467745439|FG000|Overall Study|Eligibility criteria not met|0|||
129940578|NCT03437733|467745440|FG001|Overall Study|Eligibility criteria not met|3|||
129940579|NCT00786864|467745441|FG000|Overall Study|Lost to Follow-up|0|||
129940580|NCT00786864|467745442|FG001|Overall Study|Lost to Follow-up|1|||
129940581|NCT00786864|467745441|FG000|Overall Study|Sustained serious back injury|1|||
129940582|NCT00786864|467745442|FG001|Overall Study|Sustained serious back injury|0|||
129940583|NCT01641900|467745446|FG000|Overall Study|Withdrawal by Subject|2|||
130119984|NCT03093454|468400113|FG000|Overall Study|Withdrawal by Subject|1|||
130119985|NCT03093454|468400114|FG001|Overall Study|Withdrawal by Subject|1|||
129940584|NCT01641900|467745447|FG001|Overall Study|Withdrawal by Subject|2|||
129940585|NCT03220724|467745453|FG000|Overall Study|Lost to Follow-up|2|||
129940586|NCT03220724|467745454|FG001|Overall Study|Lost to Follow-up|2|||
129940587|NCT03220724|467745455|FG002|Overall Study|Lost to Follow-up|0|||
129940588|NCT03220724|467745456|FG003|Overall Study|Lost to Follow-up|3|||
129940589|NCT03220724|467745457|FG004|Overall Study|Lost to Follow-up|1|||
129940590|NCT03220724|467745458|FG005|Overall Study|Lost to Follow-up|0|||
129940591|NCT03220724|467745459|FG006|Overall Study|Lost to Follow-up|2|||
129940592|NCT03220724|467745460|FG007|Overall Study|Lost to Follow-up|1|||
129940593|NCT03220724|467745461|FG008|Overall Study|Lost to Follow-up|0|||
129940594|NCT03220724|467745453|FG000|Overall Study|Withdrawal by Subject|1|||
129940595|NCT03220724|467745454|FG001|Overall Study|Withdrawal by Subject|0|||
129940596|NCT03220724|467745455|FG002|Overall Study|Withdrawal by Subject|1|||
129940597|NCT03220724|467745456|FG003|Overall Study|Withdrawal by Subject|0|||
129940598|NCT03220724|467745457|FG004|Overall Study|Withdrawal by Subject|0|||
129940599|NCT03220724|467745458|FG005|Overall Study|Withdrawal by Subject|0|||
129940600|NCT03220724|467745459|FG006|Overall Study|Withdrawal by Subject|0|||
129940601|NCT03220724|467745460|FG007|Overall Study|Withdrawal by Subject|0|||
129940602|NCT03220724|467745461|FG008|Overall Study|Withdrawal by Subject|0|||
129940603|NCT02463448|467745462|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
129940604|NCT02463448|467745462|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
129940605|NCT02463448|467745462|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
129940606|NCT02463448|467745462|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
129940607|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
129940608|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
129940609|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
129940610|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
129940611|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
129940612|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
129940613|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
129940614|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
129940615|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
129940616|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
129940617|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
129940618|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
129940619|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
129940620|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
129940621|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
129940622|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
129940623|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
129940624|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
129940625|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
129940626|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
129940627|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
129940628|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
129940629|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
129940630|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
129940631|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
129940632|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
129940633|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
129940634|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
129940635|NCT00857766|467745468|FG000|Overall Study|Adverse Event|13|||
129940636|NCT00857766|467745469|FG001|Overall Study|Adverse Event|12|||
129940637|NCT00857766|467745468|FG000|Overall Study|Protocol Violation|11|||
129940638|NCT00857766|467745469|FG001|Overall Study|Protocol Violation|11|||
129940639|NCT00857766|467745468|FG000|Overall Study|Lost to Follow-up|1|||
129940640|NCT00857766|467745469|FG001|Overall Study|Lost to Follow-up|0|||
129940641|NCT00857766|467745468|FG000|Overall Study|Investigator Discretion|2|||
130071436|NCT00994162|468216111|FG000|Overall Study|Machine Losing Vaccum|1|||
130071437|NCT00994162|468216111|FG000|Overall Study|Patient Lived Too Far Away|1|||
130071438|NCT00994162|468216111|FG000|Overall Study|Above Knee Amputation|1|||
130071439|NCT00994162|468216111|FG000|Overall Study|Reason Not Reported By Site|1|||
130071440|NCT01425749|468216112|FG000|Overall Study|progression of melanoma|0|||
129940642|NCT00857766|467745469|FG001|Overall Study|Investigator Discretion|3|||
129940643|NCT00857766|467745468|FG000|Overall Study|Participant Withdrew Consent|4|||
129940644|NCT00857766|467745469|FG001|Overall Study|Participant Withdrew Consent|4|||
129940645|NCT01640951|467745470|FG000|Overall Study|Adverse Event|8|||
129940646|NCT01640951|467745471|FG001|Overall Study|Adverse Event|3|||
129940647|NCT01640951|467745472|FG002|Overall Study|Adverse Event|10|||
129940648|NCT01640951|467745473|FG003|Overall Study|Adverse Event|6|||
129940649|NCT01640951|467745474|FG004|Overall Study|Adverse Event|1|||
130071441|NCT01425749|468216113|FG001|Overall Study|progression of melanoma|1|||
129940650|NCT01640951|467745475|FG005|Overall Study|Adverse Event|11|||
129940651|NCT01640951|467745476|FG006|Overall Study|Adverse Event|1|||
129940652|NCT01640951|467745477|FG007|Overall Study|Adverse Event|3|||
129940653|NCT01640951|467745470|FG000|Overall Study|Lack of Efficacy|20|||
129940654|NCT01640951|467745471|FG001|Overall Study|Lack of Efficacy|1|||
129940655|NCT01640951|467745472|FG002|Overall Study|Lack of Efficacy|7|||
129940656|NCT01640951|467745473|FG003|Overall Study|Lack of Efficacy|14|||
129940657|NCT01640951|467745474|FG004|Overall Study|Lack of Efficacy|0|||
129940658|NCT01640951|467745475|FG005|Overall Study|Lack of Efficacy|6|||
129940659|NCT01640951|467745476|FG006|Overall Study|Lack of Efficacy|5|||
129940660|NCT01640951|467745477|FG007|Overall Study|Lack of Efficacy|6|||
129940661|NCT01640951|467745470|FG000|Overall Study|Lost to Follow-up|1|||
129940662|NCT01640951|467745471|FG001|Overall Study|Lost to Follow-up|0|||
129940663|NCT01640951|467745472|FG002|Overall Study|Lost to Follow-up|6|||
129940664|NCT01640951|467745473|FG003|Overall Study|Lost to Follow-up|2|||
129940665|NCT01640951|467745474|FG004|Overall Study|Lost to Follow-up|2|||
129940666|NCT01640951|467745475|FG005|Overall Study|Lost to Follow-up|3|||
129940667|NCT01640951|467745476|FG006|Overall Study|Lost to Follow-up|1|||
129940668|NCT01640951|467745477|FG007|Overall Study|Lost to Follow-up|1|||
129940669|NCT01640951|467745470|FG000|Overall Study|Non-compliance with study treatment|0|||
129940670|NCT01640951|467745471|FG001|Overall Study|Non-compliance with study treatment|0|||
129940671|NCT01640951|467745472|FG002|Overall Study|Non-compliance with study treatment|1|||
129940672|NCT01640951|467745473|FG003|Overall Study|Non-compliance with study treatment|1|||
129940673|NCT01640951|467745474|FG004|Overall Study|Non-compliance with study treatment|1|||
129940674|NCT01640951|467745475|FG005|Overall Study|Non-compliance with study treatment|4|||
129940675|NCT01640951|467745476|FG006|Overall Study|Non-compliance with study treatment|1|||
129940676|NCT01640951|467745477|FG007|Overall Study|Non-compliance with study treatment|0|||
129940677|NCT01640951|467745470|FG000|Overall Study|Physician Decision|2|||
129940678|NCT01640951|467745471|FG001|Overall Study|Physician Decision|5|||
129940679|NCT01640951|467745472|FG002|Overall Study|Physician Decision|2|||
129940680|NCT01640951|467745473|FG003|Overall Study|Physician Decision|2|||
129940681|NCT01640951|467745474|FG004|Overall Study|Physician Decision|2|||
129940682|NCT01640951|467745475|FG005|Overall Study|Physician Decision|3|||
129940683|NCT01640951|467745476|FG006|Overall Study|Physician Decision|3|||
129940684|NCT01640951|467745477|FG007|Overall Study|Physician Decision|0|||
129940685|NCT01640951|467745470|FG000|Overall Study|Pregnancy|3|||
129940686|NCT01640951|467745471|FG001|Overall Study|Pregnancy|0|||
129940687|NCT01640951|467745472|FG002|Overall Study|Pregnancy|0|||
129940688|NCT01640951|467745473|FG003|Overall Study|Pregnancy|4|||
129940689|NCT01640951|467745474|FG004|Overall Study|Pregnancy|0|||
129940690|NCT01640951|467745475|FG005|Overall Study|Pregnancy|0|||
129940691|NCT01640951|467745476|FG006|Overall Study|Pregnancy|2|||
129940692|NCT01640951|467745477|FG007|Overall Study|Pregnancy|0|||
129940693|NCT01640951|467745470|FG000|Overall Study|Protocol Deviation|0|||
129940694|NCT01640951|467745471|FG001|Overall Study|Protocol Deviation|1|||
129940695|NCT01640951|467745472|FG002|Overall Study|Protocol Deviation|2|||
129940696|NCT01640951|467745473|FG003|Overall Study|Protocol Deviation|1|||
129940697|NCT01640951|467745474|FG004|Overall Study|Protocol Deviation|0|||
129940698|NCT01640951|467745475|FG005|Overall Study|Protocol Deviation|1|||
129940699|NCT01640951|467745476|FG006|Overall Study|Protocol Deviation|0|||
129940700|NCT01640951|467745477|FG007|Overall Study|Protocol Deviation|0|||
129940701|NCT01640951|467745470|FG000|Overall Study|Subject/Guardian decision|12|||
129940702|NCT01640951|467745471|FG001|Overall Study|Subject/Guardian decision|4|||
129940703|NCT01640951|467745472|FG002|Overall Study|Subject/Guardian decision|13|||
129940704|NCT01640951|467745473|FG003|Overall Study|Subject/Guardian decision|15|||
129940705|NCT01640951|467745474|FG004|Overall Study|Subject/Guardian decision|7|||
129940706|NCT01640951|467745475|FG005|Overall Study|Subject/Guardian decision|19|||
129940707|NCT01640951|467745476|FG006|Overall Study|Subject/Guardian decision|5|||
130071442|NCT01293084|468216114|FG000|Overall Study|Physician Decision|3|||
130071443|NCT01293084|468216114|FG000|Overall Study|Withdrawal by Subject|2|||
130071444|NCT02096042|468216115|FG000|Overall Study|Disease Progression|1|||
129940708|NCT01640951|467745477|FG007|Overall Study|Subject/Guardian decision|4|||
129940709|NCT01640951|467745470|FG000|Overall Study|Death|0|||
129940710|NCT01640951|467745471|FG001|Overall Study|Death|1|||
129940711|NCT01640951|467745472|FG002|Overall Study|Death|1|||
129940712|NCT01640951|467745473|FG003|Overall Study|Death|0|||
129940713|NCT01640951|467745474|FG004|Overall Study|Death|0|||
129940714|NCT01640951|467745475|FG005|Overall Study|Death|0|||
129940715|NCT01640951|467745476|FG006|Overall Study|Death|0|||
129940716|NCT01640951|467745477|FG007|Overall Study|Death|2|||
129940717|NCT03355573|467745478|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
129940718|NCT03355573|467745478|FG000|Overall Study|Sponsor's decision|1|||
129940719|NCT03355573|467745478|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
129940720|NCT03355573|467745478|FG000|Overall Study|PI's decision|2|||
129940721|NCT03355573|467745478|FG000|Overall Study|Withdrawal by Subject|23|||
129940722|NCT03355573|467745478|FG000|Overall Study|Lost to Follow-up|4|||
129940723|NCT03355573|467745478|FG000|Overall Study|Lack of Efficacy|2|||
129940724|NCT03355573|467745478|FG000|Overall Study|Adverse Event, non-fatal|17|||
129940725|NCT03355573|467745478|FG000|Overall Study|Adverse Event, serious fatal|2|||
129940726|NCT01536093|467745481|FG000|Overall Study|Death|1|||
129940727|NCT01536093|467745482|FG001|Overall Study|Death|2|||
129940728|NCT01536093|467745481|FG000|Overall Study|absence of maternal colostrum|2|||
129940729|NCT01536093|467745482|FG001|Overall Study|absence of maternal colostrum|0|||
129940730|NCT01536093|467745481|FG000|Overall Study|Withdrawal by Subject|0|||
129940731|NCT01536093|467745482|FG001|Overall Study|Withdrawal by Subject|1|||
129940732|NCT02406092|467745483|FG000|Overall Study|Screen failure|10|||
129940733|NCT02406092|467745484|FG001|Overall Study|Screen failure|7|||
129940734|NCT02406092|467745483|FG000|Overall Study|Death|22|||
129940735|NCT02406092|467745484|FG001|Overall Study|Death|5|||
129940736|NCT02406092|467745483|FG000|Overall Study|Lost to Follow-up|4|||
129940737|NCT02406092|467745484|FG001|Overall Study|Lost to Follow-up|1|||
129940738|NCT02406092|467745483|FG000|Overall Study|Adverse Event|1|||
129940739|NCT02406092|467745484|FG001|Overall Study|Adverse Event|0|||
129940740|NCT02406092|467745483|FG000|Overall Study|Withdrawal by Subject|1|||
129940741|NCT02406092|467745484|FG001|Overall Study|Withdrawal by Subject|0|||
129940742|NCT03631407|467745485|FG000|Overall Study|Withdrawal by Subject|3|||
129940743|NCT03631407|467745486|FG001|Overall Study|Withdrawal by Subject|2|||
129940744|NCT03631407|467745485|FG000|Overall Study|Sponsor Decision|0|||
129940745|NCT03631407|467745486|FG001|Overall Study|Sponsor Decision|2|||
129940746|NCT03631407|467745485|FG000|Overall Study|Death|16|||
129940747|NCT03631407|467745486|FG001|Overall Study|Death|16|||
129940748|NCT03631407|467745485|FG000|Overall Study|Randomized by mistake without study treatment|1|||
129940749|NCT03631407|467745486|FG001|Overall Study|Randomized by mistake without study treatment|0|||
129940750|NCT00942266|467745487|FG000|Overall Study|Withdrawal by Subject|1|||
129940751|NCT00942266|467745488|FG001|Overall Study|Withdrawal by Subject|0|||
129940752|NCT00942266|467745487|FG000|Overall Study|Adverse Event|2|||
129940753|NCT00942266|467745488|FG001|Overall Study|Adverse Event|1|||
129940754|NCT00942266|467745487|FG000|Overall Study|Disease Progression|38|||
129940755|NCT00942266|467745488|FG001|Overall Study|Disease Progression|11|||
129940756|NCT00942266|467745487|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
129940757|NCT00942266|467745488|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
129940758|NCT00942266|467745487|FG000|Overall Study|Intercurrent illness|0|||
129940759|NCT00942266|467745488|FG001|Overall Study|Intercurrent illness|1|||
129940760|NCT00942266|467745487|FG000|Overall Study|Physician Decision|2|||
129940761|NCT00942266|467745488|FG001|Overall Study|Physician Decision|0|||
129940762|NCT00942266|467745487|FG000|Overall Study|medical deterioration (pneumonia)|0|||
129940763|NCT00942266|467745488|FG001|Overall Study|medical deterioration (pneumonia)|1|||
129940764|NCT00756574|467745494|FG000|Overall Study|Withdrawal by Subject|9|||
129940765|NCT00756574|467745495|FG001|Overall Study|Withdrawal by Subject|7|||
129940766|NCT00756574|467745494|FG000|Overall Study|Lost to Follow-up|4|||
129940767|NCT00756574|467745495|FG001|Overall Study|Lost to Follow-up|4|||
129940768|NCT04795167|467745496|FG000|Overall Study|Death|1|||
129940769|NCT04795167|467745497|FG001|Overall Study|Death|18|||
129940770|NCT04795167|467745498|FG002|Overall Study|Death|1|||
129940771|NCT04795167|467745496|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
129940772|NCT04795167|467745497|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
129940773|NCT04795167|467745498|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
129940774|NCT03598907|467745507|FG000|Overall Study|Physician Decision|14|||
129940775|NCT03598907|467745508|FG001|Overall Study|Physician Decision|19|||
129940776|NCT05025384|467745509|FG000|Overall Study|Physician Decision|5|||
129940777|NCT05025384|467745510|FG001|Overall Study|Physician Decision|6|||
129940778|NCT03610581|467745511|FG000|Overall Study|Study terminated by sponsor|2|||
129940779|NCT03610581|467745512|FG001|Overall Study|Study terminated by sponsor|0|||
129940780|NCT03610581|467745511|FG000|Overall Study|Other|0|||
129940781|NCT03610581|467745512|FG001|Overall Study|Other|1|||
129940782|NCT03610581|467745511|FG000|Overall Study|Withdrawal by Subject|1|||
129940783|NCT03610581|467745512|FG001|Overall Study|Withdrawal by Subject|0|||
129940784|NCT00748709|467745521|FG000|Overall Study|Progressive disease|15|||
129940785|NCT00748709|467745521|FG000|Overall Study|Drug reducing Toxity|2|||
130071445|NCT02096042|468216116|FG001|Overall Study|Disease Progression|0|||
130071446|NCT02096042|468216117|FG002|Overall Study|Disease Progression|0|||
130071447|NCT02983799|468216118|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
129940786|NCT00748709|467745521|FG000|Overall Study|Other Adverse Event|1|||
129940787|NCT00748709|467745521|FG000|Overall Study|Withdrawal by Subject|1|||
129940788|NCT00748709|467745521|FG000|Overall Study|Other Reasons|1|||
129940789|NCT05485805|467745526|FG000|Overall Study|Withdrawal by Subject|1|||
129940790|NCT05485805|467745527|FG001|Overall Study|Withdrawal by Subject|2|||
129940791|NCT05485805|467745528|FG002|Overall Study|Withdrawal by Subject|2|||
129940792|NCT05485805|467745529|FG003|Overall Study|Withdrawal by Subject|0|||
129940793|NCT05485805|467745530|FG004|Overall Study|Withdrawal by Subject|2|||
129940794|NCT05485805|467745526|FG000|Overall Study|Adverse Event|0|||
129940795|NCT05485805|467745527|FG001|Overall Study|Adverse Event|1|||
129940796|NCT05485805|467745528|FG002|Overall Study|Adverse Event|0|||
129940797|NCT05485805|467745529|FG003|Overall Study|Adverse Event|0|||
129940798|NCT05485805|467745530|FG004|Overall Study|Adverse Event|0|||
129940799|NCT05485805|467745526|FG000|Overall Study|Lost to Follow-up|1|||
129940800|NCT05485805|467745527|FG001|Overall Study|Lost to Follow-up|1|||
129940801|NCT05485805|467745528|FG002|Overall Study|Lost to Follow-up|3|||
129940802|NCT05485805|467745529|FG003|Overall Study|Lost to Follow-up|1|||
129940803|NCT05485805|467745530|FG004|Overall Study|Lost to Follow-up|0|||
129940804|NCT00092534|467746733|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
129940805|NCT00092534|467746734|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
129940806|NCT00092534|467746735|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129940807|NCT00092534|467746736|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129940808|NCT00092534|467746737|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129940809|NCT00092534|467746733|FG000|Base Study Vaccination Period|Adverse Event|3|||
129940810|NCT00092534|467746734|FG001|Base Study Vaccination Period|Adverse Event|1|||
129940811|NCT00092534|467746735|FG002|Base Study Vaccination Period|Adverse Event|0|||
129940812|NCT00092534|467746736|FG003|Base Study Vaccination Period|Adverse Event|0|||
129940813|NCT00092534|467746737|FG004|Base Study Vaccination Period|Adverse Event|0|||
129940814|NCT00092534|467746733|FG000|Base Study Vaccination Period|Death|5|||
129940815|NCT00092534|467746734|FG001|Base Study Vaccination Period|Death|4|||
129940816|NCT00092534|467746735|FG002|Base Study Vaccination Period|Death|0|||
129940817|NCT00092534|467746736|FG003|Base Study Vaccination Period|Death|0|||
129940818|NCT00092534|467746737|FG004|Base Study Vaccination Period|Death|0|||
129940819|NCT00092534|467746733|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
129940820|NCT00092534|467746734|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
129940821|NCT00092534|467746735|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
129940822|NCT00092534|467746736|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
129940823|NCT00092534|467746737|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129940824|NCT00092534|467746733|FG000|Base Study Vaccination Period|Physician Decision|1|||
129940825|NCT00092534|467746734|FG001|Base Study Vaccination Period|Physician Decision|0|||
129940826|NCT00092534|467746735|FG002|Base Study Vaccination Period|Physician Decision|0|||
129940827|NCT00092534|467746736|FG003|Base Study Vaccination Period|Physician Decision|0|||
129940828|NCT00092534|467746737|FG004|Base Study Vaccination Period|Physician Decision|0|||
129940829|NCT00092534|467746733|FG000|Base Study Vaccination Period|Pregnancy|9|||
129940830|NCT00092534|467746734|FG001|Base Study Vaccination Period|Pregnancy|7|||
129940831|NCT00092534|467746735|FG002|Base Study Vaccination Period|Pregnancy|0|||
129940832|NCT00092534|467746736|FG003|Base Study Vaccination Period|Pregnancy|0|||
129940833|NCT00092534|467746737|FG004|Base Study Vaccination Period|Pregnancy|0|||
129940834|NCT00092534|467746733|FG000|Base Study Vaccination Period|Protocol Violation|2|||
129940835|NCT00092534|467746734|FG001|Base Study Vaccination Period|Protocol Violation|1|||
129940836|NCT00092534|467746735|FG002|Base Study Vaccination Period|Protocol Violation|0|||
129940837|NCT00092534|467746736|FG003|Base Study Vaccination Period|Protocol Violation|0|||
129940838|NCT00092534|467746737|FG004|Base Study Vaccination Period|Protocol Violation|0|||
129940839|NCT00092534|467746733|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
129940840|NCT00092534|467746734|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
129940841|NCT00092534|467746735|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
129940842|NCT00092534|467746736|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
129940843|NCT00092534|467746737|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129940844|NCT00092534|467746733|FG000|Base Study Vaccination Period|Moved|14|||
129940845|NCT00092534|467746734|FG001|Base Study Vaccination Period|Moved|12|||
129940846|NCT00092534|467746735|FG002|Base Study Vaccination Period|Moved|0|||
129940847|NCT00092534|467746736|FG003|Base Study Vaccination Period|Moved|0|||
129940848|NCT00092534|467746737|FG004|Base Study Vaccination Period|Moved|0|||
129940849|NCT00092534|467746733|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
129940850|NCT00092534|467746734|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940851|NCT00092534|467746735|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940852|NCT00092534|467746736|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940853|NCT00092534|467746737|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940854|NCT00092534|467746733|FG000|Base Study Vaccination Period|Travel|1|||
129940855|NCT00092534|467746734|FG001|Base Study Vaccination Period|Travel|0|||
129940856|NCT00092534|467746735|FG002|Base Study Vaccination Period|Travel|0|||
129940857|NCT00092534|467746736|FG003|Base Study Vaccination Period|Travel|0|||
129940858|NCT00092534|467746737|FG004|Base Study Vaccination Period|Travel|0|||
130119986|NCT03093454|468400113|FG000|Overall Study|Scheduling conflict|3|||
130119987|NCT03093454|468400114|FG001|Overall Study|Scheduling conflict|1|||
129940859|NCT00092534|467746733|FG000|Base Study Vaccination Period|Site Closed|0|||
129940860|NCT00092534|467746734|FG001|Base Study Vaccination Period|Site Closed|1|||
129940861|NCT00092534|467746735|FG002|Base Study Vaccination Period|Site Closed|0|||
129940862|NCT00092534|467746736|FG003|Base Study Vaccination Period|Site Closed|0|||
129940863|NCT00092534|467746737|FG004|Base Study Vaccination Period|Site Closed|0|||
129940864|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Adverse Event|2|||
129940865|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Adverse Event|4|||
130119988|NCT03093454|468400113|FG000|Overall Study|Physician Decision|2|||
130119989|NCT03093454|468400114|FG001|Overall Study|Physician Decision|1|||
129940866|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Adverse Event|0|||
130119990|NCT04540497|468400118|FG000|Overall Study|Adverse Event|0|||
130119991|NCT04540497|468400119|FG001|Overall Study|Adverse Event|2|||
129940867|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Adverse Event|0|||
129940868|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Adverse Event|0|||
129940869|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Death|2|||
129940870|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Death|1|||
129940871|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Death|0|||
129940872|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Death|0|||
129940873|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Death|0|||
129940874|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
129940875|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
129940876|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
129940877|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
129940878|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
129940879|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Pregnancy|6|||
129940880|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Pregnancy|10|||
129940881|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Pregnancy|0|||
129940882|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Pregnancy|0|||
129940883|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Pregnancy|0|||
129940884|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
129940885|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
129940886|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
129940887|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
129940888|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
129940889|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
129940890|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
129940891|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
129940892|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
129940893|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
129940894|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Moved|62|||
129940895|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Moved|58|||
129940896|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Moved|0|||
129940897|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Moved|0|||
129940898|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Moved|0|||
129940899|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Travel|10|||
129940900|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Travel|7|||
129940901|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Travel|0|||
129940902|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Travel|0|||
129940903|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Travel|0|||
129940904|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Site Closed|0|||
129940905|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Site Closed|2|||
129940906|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Site Closed|0|||
129940907|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Site Closed|0|||
129940908|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Site Closed|0|||
129940909|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
129940910|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
129940911|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
129940912|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
129940913|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
129940914|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
129940915|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
129940916|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
129940917|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
129940918|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
129940919|NCT00092534|467746733|FG000|Base Study EXT|Lost to Follow-up|0|||
129940920|NCT00092534|467746734|FG001|Base Study EXT|Lost to Follow-up|0|||
129940921|NCT00092534|467746735|FG002|Base Study EXT|Lost to Follow-up|41|||
129940922|NCT00092534|467746736|FG003|Base Study EXT|Lost to Follow-up|0|||
129940923|NCT00092534|467746737|FG004|Base Study EXT|Lost to Follow-up|0|||
129940924|NCT00092534|467746733|FG000|Base Study EXT|Physician Decision|0|||
129940925|NCT00092534|467746734|FG001|Base Study EXT|Physician Decision|0|||
129940926|NCT00092534|467746735|FG002|Base Study EXT|Physician Decision|1|||
129940927|NCT00092534|467746736|FG003|Base Study EXT|Physician Decision|0|||
129940928|NCT00092534|467746737|FG004|Base Study EXT|Physician Decision|0|||
129940929|NCT00092534|467746733|FG000|Base Study EXT|Pregnancy|0|||
129940930|NCT00092534|467746734|FG001|Base Study EXT|Pregnancy|0|||
129940931|NCT00092534|467746735|FG002|Base Study EXT|Pregnancy|12|||
129940932|NCT00092534|467746736|FG003|Base Study EXT|Pregnancy|0|||
129940933|NCT00092534|467746737|FG004|Base Study EXT|Pregnancy|0|||
129940934|NCT00092534|467746733|FG000|Base Study EXT|Withdrawal by Subject|0|||
129940935|NCT00092534|467746734|FG001|Base Study EXT|Withdrawal by Subject|0|||
129940936|NCT00092534|467746735|FG002|Base Study EXT|Withdrawal by Subject|18|||
129940937|NCT00092534|467746736|FG003|Base Study EXT|Withdrawal by Subject|0|||
129940938|NCT00092534|467746737|FG004|Base Study EXT|Withdrawal by Subject|0|||
129940939|NCT00092534|467746733|FG000|Base Study EXT|Participant moved|0|||
129940940|NCT00092534|467746734|FG001|Base Study EXT|Participant moved|0|||
130071448|NCT02983799|468216119|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
130119992|NCT04540497|468400118|FG000|Overall Study|Lost to Follow-up|1|||
129940941|NCT00092534|467746735|FG002|Base Study EXT|Participant moved|6|||
129940942|NCT00092534|467746736|FG003|Base Study EXT|Participant moved|0|||
129940943|NCT00092534|467746737|FG004|Base Study EXT|Participant moved|0|||
129940944|NCT00092534|467746733|FG000|Base Study EXT|Travel|0|||
129940945|NCT00092534|467746734|FG001|Base Study EXT|Travel|0|||
129940946|NCT00092534|467746735|FG002|Base Study EXT|Travel|2|||
129940947|NCT00092534|467746736|FG003|Base Study EXT|Travel|0|||
129940948|NCT00092534|467746737|FG004|Base Study EXT|Travel|0|||
129940949|NCT00092534|467746733|FG000|Base Study EXT|Site closed|0|||
129940950|NCT00092534|467746734|FG001|Base Study EXT|Site closed|0|||
129940951|NCT00092534|467746735|FG002|Base Study EXT|Site closed|21|||
129940952|NCT00092534|467746736|FG003|Base Study EXT|Site closed|0|||
129940953|NCT00092534|467746737|FG004|Base Study EXT|Site closed|0|||
129940954|NCT00092534|467746733|FG000|Base Study EXT|Study ended|0|||
129940955|NCT00092534|467746734|FG001|Base Study EXT|Study ended|0|||
129940956|NCT00092534|467746735|FG002|Base Study EXT|Study ended|29|||
129940957|NCT00092534|467746736|FG003|Base Study EXT|Study ended|0|||
129940958|NCT00092534|467746737|FG004|Base Study EXT|Study ended|0|||
129940959|NCT00092534|467746733|FG000|Base Study EXT|Protocol Violation|0|||
129940960|NCT00092534|467746734|FG001|Base Study EXT|Protocol Violation|0|||
129940961|NCT00092534|467746735|FG002|Base Study EXT|Protocol Violation|15|||
129940962|NCT00092534|467746736|FG003|Base Study EXT|Protocol Violation|0|||
129940963|NCT00092534|467746737|FG004|Base Study EXT|Protocol Violation|0|||
129940964|NCT00092534|467746733|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940965|NCT00092534|467746734|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940966|NCT00092534|467746735|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940967|NCT00092534|467746736|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
129940968|NCT00092534|467746737|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940969|NCT03002194|467746738|FG000|Overall Study|Lost to Follow-up|6|||
129940970|NCT03002194|467746738|FG000|Overall Study|Adverse Event|1|||
129940971|NCT03002194|467746738|FG000|Overall Study|Lack of Efficacy|1|||
129940972|NCT03002194|467746738|FG000|Overall Study|Withdrawal by Subject|2|||
129940973|NCT02200705|467746748|FG000|Overall Study|Excluded|12|||
129940974|NCT02200705|467746748|FG000|Overall Study|Death|21|||
129940975|NCT02200705|467746748|FG000|Overall Study|Withdrawal by Subject|22|||
129940976|NCT02200705|467746748|FG000|Overall Study|Lost to Follow-up|13|||
129940977|NCT02200705|467746748|FG000|Overall Study|Physician Decision|5|||
129940978|NCT02200705|467746748|FG000|Overall Study|Adverse Event|2|||
129940979|NCT04162210|467746753|FG000|Overall Study|Lost to Follow-up|4|||
129940980|NCT04162210|467746754|FG001|Overall Study|Lost to Follow-up|1|||
129940981|NCT04162210|467746753|FG000|Overall Study|Withdrawal by Subject|17|||
129940982|NCT04162210|467746754|FG001|Overall Study|Withdrawal by Subject|9|||
129940983|NCT04162210|467746753|FG000|Overall Study|Ongoing|113|||
129940984|NCT04162210|467746754|FG001|Overall Study|Ongoing|59|||
129940985|NCT00371345|467746756|FG000|Overall Study|Disease Progression|21|||
129940986|NCT00371345|467746757|FG001|Overall Study|Disease Progression|35|||
129940987|NCT00371345|467746756|FG000|Overall Study|Study Drug Toxicity|1|||
129940988|NCT00371345|467746757|FG001|Overall Study|Study Drug Toxicity|7|||
129940989|NCT00371345|467746756|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
129940990|NCT00371345|467746757|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
129940991|NCT00371345|467746756|FG000|Overall Study|Participant Request|1|||
129940992|NCT00371345|467746757|FG001|Overall Study|Participant Request|1|||
129940993|NCT00371345|467746756|FG000|Overall Study|Participant Withdrew Consent|0|||
129940994|NCT00371345|467746757|FG001|Overall Study|Participant Withdrew Consent|1|||
129940995|NCT00442104|467746762|FG000|Overall Study|Adverse Event|5|||
129940996|NCT00442104|467746762|FG000|Overall Study|Death|2|||
129940997|NCT00442104|467746762|FG000|Overall Study|Lost to Follow-up|3|||
129940998|NCT00442104|467746762|FG000|Overall Study|Withdrawal by Subject|5|||
129940999|NCT00442104|467746762|FG000|Overall Study|Insufficient Clinical Response|10|||
129941000|NCT00442104|467746762|FG000|Overall Study|Other|21|||
129941001|NCT00442104|467746762|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
129941002|NCT00713596|467746763|FG000|Overall Study|Study was terminated|2|||
129941003|NCT00713596|467746764|FG001|Overall Study|Study was terminated|3|||
129941004|NCT00713596|467746765|FG002|Overall Study|Study was terminated|2|||
129941005|NCT04545619|467746766|FG000|Overall Study|due to equipment challenges|1|||
130119993|NCT04540497|468400119|FG001|Overall Study|Lost to Follow-up|0|||
129941006|NCT00463229|467746775|FG000|Overall Study|Lost to Follow-up|5|||
129941007|NCT00463229|467746776|FG001|Overall Study|Lost to Follow-up|7|||
129941008|NCT00463229|467746775|FG000|Overall Study|Death|4|||
129941009|NCT00463229|467746776|FG001|Overall Study|Death|3|||
129941010|NCT01932970|467746777|FG000|Overall Study|Withdrawal by Subject|5|||
129941011|NCT01932970|467746777|FG000|Overall Study|Death|1|||
129941012|NCT01932970|467746777|FG000|Overall Study|Lost to Follow-up|2|||
129941013|NCT01932970|467746777|FG000|Overall Study|Protocol Specified Criteria|10|||
129941014|NCT01359150|467746778|FG000|Overall Study|Lack of Efficacy|1|||
129941015|NCT01359150|467746779|FG001|Overall Study|Lack of Efficacy|1|||
129941016|NCT01359150|467746778|FG000|Overall Study|Withdrawal by Subject|1|||
129941017|NCT01359150|467746779|FG001|Overall Study|Withdrawal by Subject|1|||
129941018|NCT01359150|467746778|FG000|Overall Study|Adverse Event|4|||
129941019|NCT01359150|467746779|FG001|Overall Study|Adverse Event|3|||
129941020|NCT01359150|467746778|FG000|Overall Study|Other|1|||
129941021|NCT01359150|467746779|FG001|Overall Study|Other|0|||
129941022|NCT01787032|467746786|FG000|Overall Study|Protocol Violation|0|||
129941023|NCT01787032|467746787|FG001|Overall Study|Protocol Violation|0|||
129941024|NCT01787032|467746788|FG002|Overall Study|Protocol Violation|0|||
129941025|NCT01787032|467746789|FG003|Overall Study|Protocol Violation|0|||
129941026|NCT01787032|467746790|FG004|Overall Study|Protocol Violation|1|||
129941027|NCT01787032|467746791|FG005|Overall Study|Protocol Violation|1|||
129941028|NCT00776009|467746792|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
129941029|NCT00776009|467746793|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
129941030|NCT00776009|467746794|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
129941031|NCT00776009|467746795|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
129941032|NCT00776009|467746796|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
129941033|NCT00776009|467746797|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
129941034|NCT00776009|467746792|FG000|Period 1: First Intervention|Protocol Violation|0|||
129941035|NCT00776009|467746793|FG001|Period 1: First Intervention|Protocol Violation|1|||
129941036|NCT00776009|467746794|FG002|Period 1: First Intervention|Protocol Violation|0|||
129941037|NCT00776009|467746795|FG003|Period 1: First Intervention|Protocol Violation|0|||
129941038|NCT00776009|467746796|FG004|Period 1: First Intervention|Protocol Violation|1|||
129941039|NCT00776009|467746797|FG005|Period 1: First Intervention|Protocol Violation|0|||
129941040|NCT00776009|467746792|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941041|NCT00776009|467746793|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941042|NCT00776009|467746794|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941043|NCT00776009|467746795|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941044|NCT00776009|467746796|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941045|NCT00776009|467746797|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
129941046|NCT00776009|467746792|FG000|Period 2: Second Intervention|Protocol Violation|1|||
129941047|NCT00776009|467746793|FG001|Period 2: Second Intervention|Protocol Violation|0|||
129941048|NCT00776009|467746794|FG002|Period 2: Second Intervention|Protocol Violation|1|||
129941049|NCT00776009|467746795|FG003|Period 2: Second Intervention|Protocol Violation|0|||
129941050|NCT00776009|467746796|FG004|Period 2: Second Intervention|Protocol Violation|0|||
129941051|NCT00776009|467746797|FG005|Period 2: Second Intervention|Protocol Violation|0|||
129941052|NCT00776009|467746792|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
129941053|NCT00776009|467746793|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941054|NCT00776009|467746794|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941055|NCT00776009|467746795|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941056|NCT00776009|467746796|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941057|NCT00776009|467746797|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941058|NCT04971733|467746798|FG000|Overall Study|Adverse Event|1|||
129941059|NCT04971733|467746799|FG001|Overall Study|Adverse Event|1|||
129941060|NCT04971733|467746798|FG000|Overall Study|Subject choice|2|||
129941061|NCT04971733|467746799|FG001|Overall Study|Subject choice|0|||
129941062|NCT04971733|467746798|FG000|Overall Study|Withdrawal by Subject|1|||
129941063|NCT04971733|467746799|FG001|Overall Study|Withdrawal by Subject|0|||
129941064|NCT04971733|467746798|FG000|Overall Study|Other|1|||
129941065|NCT04971733|467746799|FG001|Overall Study|Other|0|||
129941066|NCT02816398|467746802|FG000|Overall Study|Death|5|||
129941067|NCT02816398|467746802|FG000|Overall Study|Lack of Efficacy|8|||
129941068|NCT02816398|467746802|FG000|Overall Study|Lost to Follow-up|1|||
129941069|NCT01593020|467746806|FG000|Overall Study|Adverse Event|1|||
129941070|NCT01593020|467746807|FG001|Overall Study|Adverse Event|1|||
129941071|NCT01593020|467746806|FG000|Overall Study|Death|0|||
129941072|NCT01593020|467746807|FG001|Overall Study|Death|1|||
129941073|NCT01593020|467746806|FG000|Overall Study|Ineligible|1|||
129941074|NCT01593020|467746807|FG001|Overall Study|Ineligible|0|||
129941075|NCT02972359|467746816|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
129941076|NCT02972359|467746816|FG000|Overall Study|Lack of Efficacy|1|||
129941077|NCT02972359|467746816|FG000|Overall Study|Adverse Event|4|||
129941078|NCT02972359|467746816|FG000|Overall Study|Death|1|||
130071449|NCT02983799|468216120|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
129941079|NCT02972359|467746816|FG000|Overall Study|Withdrawal by Subject|30|||
129941080|NCT02972359|467746816|FG000|Overall Study|Protocol Violation|1|||
129941081|NCT02972359|467746816|FG000|Overall Study|Lost to Follow-up|26|||
129941082|NCT02972359|467746816|FG000|Overall Study|Other reasons|5|||
129941083|NCT02972359|467746816|FG000|Overall Study|Missing|1|||
129941084|NCT02063659|467746817|FG000|Double-Blind Treatment Period|Adverse Event|1|||
129941085|NCT02063659|467746818|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129941086|NCT02063659|467746819|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129941087|NCT02063659|467746820|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129941088|NCT02063659|467746817|FG000|Double-Blind Treatment Period|Physician Decision|1|||
129941089|NCT02063659|467746818|FG001|Double-Blind Treatment Period|Physician Decision|0|||
129941090|NCT02063659|467746819|FG002|Double-Blind Treatment Period|Physician Decision|0|||
130071450|NCT02983799|468216121|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
129941091|NCT02063659|467746820|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129941092|NCT02063659|467746817|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
129941093|NCT02063659|467746818|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
129941094|NCT02063659|467746819|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
129941095|NCT02063659|467746820|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
129941096|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
129941097|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
129941098|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
129941099|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
129941100|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129941101|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129941102|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129941103|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
129941104|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129941105|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129941106|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129941107|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
129941108|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
129941109|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
129941110|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
129941111|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
129941112|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129941113|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129941114|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129941115|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
129941116|NCT01532999|467746821|FG000|Overall Study|Lost to Follow-up|14|||
129941117|NCT01532999|467746822|FG001|Overall Study|Lost to Follow-up|8|||
129941118|NCT01532999|467746821|FG000|Overall Study|Physician Decision|1|||
129941119|NCT01532999|467746822|FG001|Overall Study|Physician Decision|2|||
129941120|NCT01532999|467746821|FG000|Overall Study|Withdrawal by Subject|5|||
129941121|NCT01532999|467746822|FG001|Overall Study|Withdrawal by Subject|0|||
129941122|NCT01532999|467746821|FG000|Overall Study|Relocated|2|||
129941123|NCT01532999|467746822|FG001|Overall Study|Relocated|0|||
129941124|NCT01532999|467746821|FG000|Overall Study|should not have been randomized|1|||
129941125|NCT01532999|467746822|FG001|Overall Study|should not have been randomized|0|||
129941126|NCT01532999|467746821|FG000|Overall Study|substantial noncompliance|2|||
129941127|NCT01532999|467746822|FG001|Overall Study|substantial noncompliance|0|||
129941128|NCT01532999|467746821|FG000|Overall Study|no show for week 9 assessments|6|||
129941129|NCT01532999|467746822|FG001|Overall Study|no show for week 9 assessments|4|||
129941130|NCT01532999|467746821|FG000|Overall Study|Adverse Event|0|||
129941131|NCT01532999|467746822|FG001|Overall Study|Adverse Event|1|||
129941132|NCT01532999|467746821|FG000|Overall Study|incarcerated|0|||
129941133|NCT01532999|467746822|FG001|Overall Study|incarcerated|1|||
129941134|NCT01532999|467746821|FG000|Overall Study|New job|0|||
129941135|NCT01532999|467746822|FG001|Overall Study|New job|2|||
129941136|NCT05251363|467746825|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
129941137|NCT05251363|467746825|FG000|Overall Study After Implant Period|Death|9|||
129941138|NCT05251363|467746825|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
129941139|NCT05251363|467746825|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
129941140|NCT05251363|467746825|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
129941141|NCT05251363|467746825|FG000|Overall Study After Implant Period|Physician Decision|1|||
129941142|NCT05251363|467746825|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
129941143|NCT03835754|467746828|FG000|Overall Study|Death|4|||
129941144|NCT02830204|467746829|FG000|Overall Study|Death|9|||
129941145|NCT02830204|467746829|FG000|Overall Study|Withdrawal by Subject|1|||
129941146|NCT04686266|467746833|FG000|Overall Study|Withdrawal by Subject|0|||
129941147|NCT04686266|467746834|FG001|Overall Study|Withdrawal by Subject|1|||
129941148|NCT04445831|467746835|FG000|Overall Study|Withdrawal by Subject|2|||
130119994|NCT04540497|468400118|FG000|Overall Study|Withdrawal by Subject|1|||
130119995|NCT04540497|468400119|FG001|Overall Study|Withdrawal by Subject|1|||
130119996|NCT04540497|468400118|FG000|Overall Study|Miscellaneous|2|||
129941149|NCT04445831|467746836|FG001|Overall Study|Withdrawal by Subject|1|||
129941150|NCT04445831|467746837|FG002|Overall Study|Withdrawal by Subject|1|||
129941151|NCT04445831|467746838|FG003|Overall Study|Withdrawal by Subject|0|||
129941152|NCT04445831|467746839|FG004|Overall Study|Withdrawal by Subject|0|||
129941153|NCT04445831|467746840|FG005|Overall Study|Withdrawal by Subject|0|||
129941154|NCT04445831|467746841|FG006|Overall Study|Withdrawal by Subject|0|||
129941155|NCT04445831|467746835|FG000|Overall Study|Subject withdrawal by caregiver|0|||
129941156|NCT04445831|467746836|FG001|Overall Study|Subject withdrawal by caregiver|1|||
129941157|NCT04445831|467746837|FG002|Overall Study|Subject withdrawal by caregiver|0|||
130119997|NCT04540497|468400119|FG001|Overall Study|Miscellaneous|1|||
130119998|NCT02524379|468400124|FG000|Overall Study|Death|1|||
129941158|NCT04445831|467746838|FG003|Overall Study|Subject withdrawal by caregiver|0|||
129941159|NCT04445831|467746839|FG004|Overall Study|Subject withdrawal by caregiver|0|||
129941160|NCT04445831|467746840|FG005|Overall Study|Subject withdrawal by caregiver|0|||
129941161|NCT04445831|467746841|FG006|Overall Study|Subject withdrawal by caregiver|0|||
129941162|NCT04306367|467746846|FG000|Overall Study|Progression of Disease|9|||
129941163|NCT04306367|467746846|FG000|Overall Study|Adverse Event|3|||
129941164|NCT04306367|467746846|FG000|Overall Study|Withdrawal by Subject|1|||
129941165|NCT04912856|467746849|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
129941166|NCT04912856|467746850|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
129941167|NCT04912856|467746849|FG000|Overall Study|Not reported in synoptic CSR.|0|||
129941168|NCT04912856|467746850|FG001|Overall Study|Not reported in synoptic CSR.|1|||
129941169|NCT05470114|467746859|FG000|Overall Study|Withdrawal by Subject|1|||
129941170|NCT05470114|467746860|FG001|Overall Study|Withdrawal by Subject|0|||
129941171|NCT05470114|467746859|FG000|Overall Study|Lost to Follow-up|1|||
129941172|NCT05470114|467746860|FG001|Overall Study|Lost to Follow-up|0|||
129941173|NCT01563185|467746861|FG000|Overall Study|Withdrawal by Subject|1|||
129941174|NCT01563185|467746861|FG000|Overall Study|Non-Compliance with study drug|1|||
129941175|NCT05864209|467748292|FG000|Overall Study|Lost to Follow-up|2|||
129941176|NCT05864209|467748293|FG001|Overall Study|Lost to Follow-up|3|||
129941177|NCT06056310|467748296|FG000|Overall Study|Other Reasons|2|||
129941178|NCT06056310|467748296|FG000|Overall Study|Sponsor Request|16|||
129941179|NCT05029284|467748299|FG000|Overall Study|Lost to Follow-up|1|||
129941180|NCT04001829|467748300|FG000|Overall Study|Never start protocol therapy|5|||
129941181|NCT04001829|467748301|FG001|Overall Study|Never start protocol therapy|5|||
129941182|NCT04001829|467748300|FG000|Overall Study|Adverse Event|11|||
129941183|NCT04001829|467748301|FG001|Overall Study|Adverse Event|7|||
129941184|NCT04001829|467748300|FG000|Overall Study|Alternative therapy|1|||
129941185|NCT04001829|467748301|FG001|Overall Study|Alternative therapy|2|||
129941186|NCT04001829|467748300|FG000|Overall Study|Disease progression/relapse|2|||
129941187|NCT04001829|467748301|FG001|Overall Study|Disease progression/relapse|1|||
129941188|NCT04001829|467748300|FG000|Overall Study|Other complicating disease|1|||
129941189|NCT04001829|467748301|FG001|Overall Study|Other complicating disease|0|||
129941190|NCT04001829|467748300|FG000|Overall Study|Withdrawal by Subject|1|||
129941191|NCT04001829|467748301|FG001|Overall Study|Withdrawal by Subject|4|||
129941192|NCT04001829|467748300|FG000|Overall Study|Ineligible|2|||
129941193|NCT04001829|467748301|FG001|Overall Study|Ineligible|2|||
129941194|NCT04001829|467748300|FG000|Overall Study|Reason missing due to delinquent data|1|||
129941195|NCT04001829|467748301|FG001|Overall Study|Reason missing due to delinquent data|0|||
129941196|NCT00985088|467748304|FG000|Overall Study|Serious Adverse Event|1|||
129941197|NCT00985088|467748305|FG001|Overall Study|Serious Adverse Event|1|||
129941198|NCT00985088|467748306|FG002|Overall Study|Serious Adverse Event|0|||
129941199|NCT00985088|467748307|FG003|Overall Study|Serious Adverse Event|0|||
129941200|NCT00985088|467748308|FG004|Overall Study|Serious Adverse Event|0|||
129941201|NCT00985088|467748309|FG005|Overall Study|Serious Adverse Event|0|||
129941202|NCT00985088|467748310|FG006|Overall Study|Serious Adverse Event|0|||
129941203|NCT00985088|467748311|FG007|Overall Study|Serious Adverse Event|1|||
129941204|NCT00985088|467748304|FG000|Overall Study|Adverse Event|0|||
129941205|NCT00985088|467748305|FG001|Overall Study|Adverse Event|0|||
129941206|NCT00985088|467748306|FG002|Overall Study|Adverse Event|1|||
129941207|NCT00985088|467748307|FG003|Overall Study|Adverse Event|0|||
129941208|NCT00985088|467748308|FG004|Overall Study|Adverse Event|0|||
129941209|NCT00985088|467748309|FG005|Overall Study|Adverse Event|0|||
129941210|NCT00985088|467748310|FG006|Overall Study|Adverse Event|0|||
129941211|NCT00985088|467748311|FG007|Overall Study|Adverse Event|0|||
129941212|NCT00985088|467748304|FG000|Overall Study|Withdrawal by Subject|4|||
129941213|NCT00985088|467748305|FG001|Overall Study|Withdrawal by Subject|0|||
129941214|NCT00985088|467748306|FG002|Overall Study|Withdrawal by Subject|0|||
129941215|NCT00985088|467748307|FG003|Overall Study|Withdrawal by Subject|1|||
129941216|NCT00985088|467748308|FG004|Overall Study|Withdrawal by Subject|3|||
129941217|NCT00985088|467748309|FG005|Overall Study|Withdrawal by Subject|2|||
129941218|NCT00985088|467748310|FG006|Overall Study|Withdrawal by Subject|1|||
129941219|NCT00985088|467748311|FG007|Overall Study|Withdrawal by Subject|2|||
129941220|NCT00985088|467748304|FG000|Overall Study|Migrated/moved from study area|0|||
129941221|NCT00985088|467748305|FG001|Overall Study|Migrated/moved from study area|0|||
129941222|NCT00985088|467748306|FG002|Overall Study|Migrated/moved from study area|1|||
129941223|NCT00985088|467748307|FG003|Overall Study|Migrated/moved from study area|0|||
129941224|NCT00985088|467748308|FG004|Overall Study|Migrated/moved from study area|0|||
129941225|NCT00985088|467748309|FG005|Overall Study|Migrated/moved from study area|0|||
129941226|NCT00985088|467748310|FG006|Overall Study|Migrated/moved from study area|0|||
129941227|NCT00985088|467748311|FG007|Overall Study|Migrated/moved from study area|1|||
129941228|NCT00985088|467748304|FG000|Overall Study|Lost to Follow-up|6|||
129941229|NCT00985088|467748305|FG001|Overall Study|Lost to Follow-up|1|||
129941230|NCT00985088|467748306|FG002|Overall Study|Lost to Follow-up|2|||
129941231|NCT00985088|467748307|FG003|Overall Study|Lost to Follow-up|6|||
129941232|NCT00985088|467748308|FG004|Overall Study|Lost to Follow-up|6|||
129941233|NCT00985088|467748309|FG005|Overall Study|Lost to Follow-up|5|||
129941234|NCT00985088|467748310|FG006|Overall Study|Lost to Follow-up|3|||
129941235|NCT00985088|467748311|FG007|Overall Study|Lost to Follow-up|2|||
129941236|NCT01737398|467748312|FG000|Overall Study|Adverse event or SAE|16|||
129941237|NCT01737398|467748313|FG001|Overall Study|Adverse event or SAE|1|||
129941238|NCT01737398|467748312|FG000|Overall Study|Stopping rule met|2|||
129941239|NCT01737398|467748313|FG001|Overall Study|Stopping rule met|1|||
129941240|NCT01737398|467748312|FG000|Overall Study|Voluntary withdrawal|2|||
129941241|NCT01737398|467748313|FG001|Overall Study|Voluntary withdrawal|3|||
129941242|NCT01737398|467748312|FG000|Overall Study|Ineligibility|1|||
129941243|NCT01737398|467748313|FG001|Overall Study|Ineligibility|0|||
129941244|NCT01737398|467748312|FG000|Overall Study|Liver transplant|1|||
129941245|NCT01737398|467748313|FG001|Overall Study|Liver transplant|0|||
129941246|NCT01737398|467748312|FG000|Overall Study|Disease progression|2|||
129941247|NCT01737398|467748313|FG001|Overall Study|Disease progression|3|||
129941248|NCT01737398|467748312|FG000|Overall Study|Sponsor's decision|2|||
129941249|NCT01737398|467748313|FG001|Overall Study|Sponsor's decision|0|||
129941250|NCT05250115|467748314|FG000|Overall Study|Premature study end|40|||
129941251|NCT05250115|467748314|FG000|Overall Study|Adverse Event|8|||
129941252|NCT05250115|467748314|FG000|Overall Study|Lost to Follow-up|7|||
129941253|NCT05250115|467748314|FG000|Overall Study|Withdrawal by Subject|6|||
129941254|NCT05250115|467748314|FG000|Overall Study|Withdrawal of informed consent|1|||
129941255|NCT05250115|467748314|FG000|Overall Study|Other|7|||
129941256|NCT01478594|467748321|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
129941257|NCT01478594|467748322|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
129941258|NCT01478594|467748321|FG000|Overall Study|Death|45|||
129941259|NCT01478594|467748322|FG001|Overall Study|Death|18|||
129941260|NCT01478594|467748321|FG000|Overall Study|Lost to Follow-up|3|||
129941261|NCT01478594|467748322|FG001|Overall Study|Lost to Follow-up|1|||
129941262|NCT01478594|467748321|FG000|Overall Study|Withdrawal by Subject|9|||
129941263|NCT01478594|467748322|FG001|Overall Study|Withdrawal by Subject|3|||
129941264|NCT01478594|467748321|FG000|Overall Study|Study Closed by Sponsor|8|||
129941265|NCT01478594|467748322|FG001|Overall Study|Study Closed by Sponsor|5|||
129941266|NCT04885998|467748323|FG000|Overall Study|Withdrawal by Subject|0|||
129941267|NCT04885998|467748324|FG001|Overall Study|Withdrawal by Subject|2|||
129941268|NCT04885998|467748325|FG002|Overall Study|Withdrawal by Subject|0|||
129941269|NCT04885998|467748326|FG003|Overall Study|Withdrawal by Subject|3|||
129941270|NCT04885998|467748323|FG000|Overall Study|Lost to Follow-up|1|||
129941271|NCT04885998|467748324|FG001|Overall Study|Lost to Follow-up|1|||
129941272|NCT04885998|467748325|FG002|Overall Study|Lost to Follow-up|0|||
129941273|NCT04885998|467748326|FG003|Overall Study|Lost to Follow-up|0|||
129941274|NCT04885998|467748323|FG000|Overall Study|Death|2|||
129941275|NCT04885998|467748324|FG001|Overall Study|Death|1|||
129941276|NCT04885998|467748325|FG002|Overall Study|Death|2|||
129941277|NCT04885998|467748326|FG003|Overall Study|Death|2|||
129941278|NCT04885998|467748323|FG000|Overall Study|Decision by sponsor|1|||
129941279|NCT04885998|467748324|FG001|Overall Study|Decision by sponsor|1|||
129941280|NCT04885998|467748325|FG002|Overall Study|Decision by sponsor|0|||
129941281|NCT04885998|467748326|FG003|Overall Study|Decision by sponsor|0|||
129941282|NCT03712371|467748328|FG000|Overall Study|Lack of Efficacy|0|||
129941283|NCT03712371|467748329|FG001|Overall Study|Lack of Efficacy|0|||
129941284|NCT03712371|467748330|FG002|Overall Study|Lack of Efficacy|0|||
129941285|NCT03712371|467748331|FG003|Overall Study|Lack of Efficacy|1|||
129941286|NCT02788981|467748334|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
129941287|NCT02788981|467748335|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
129941288|NCT04250194|467748336|FG000|Overall Study|Declined to schedule biopsy|6|||
129941289|NCT04250194|467748337|FG001|Overall Study|Declined to schedule biopsy|10|||
129941290|NCT04250194|467748336|FG000|Overall Study|Medically Unfit for Biopsy|2|||
129941291|NCT04250194|467748337|FG001|Overall Study|Medically Unfit for Biopsy|1|||
129941292|NCT04250194|467748336|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
129941293|NCT04250194|467748337|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
129941294|NCT04250194|467748336|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
129941295|NCT04250194|467748337|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
130071451|NCT02983799|468216122|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
130071452|NCT02983799|468216118|FG000|Overall Study|Death|20|||
129941296|NCT04250194|467748336|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
129941297|NCT04250194|467748337|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
129941298|NCT03113409|467748342|FG000|Overall Study|Withdrawal by Subject|5|||
129941299|NCT03113409|467748343|FG001|Overall Study|Withdrawal by Subject|0|||
129941300|NCT03113409|467748344|FG002|Overall Study|Withdrawal by Subject|0|||
129941301|NCT02040870|467748345|FG000|Overall Study|Completed treatment phase|6|||
129941302|NCT02040870|467748345|FG000|Overall Study|Adverse Event|7|||
129941303|NCT02040870|467748345|FG000|Overall Study|Progressive disease|58|||
129941304|NCT02040870|467748345|FG000|Overall Study|Physician Decision|6|||
129941305|NCT02040870|467748345|FG000|Overall Study|Subject/guardian decision|10|||
129941306|NCT02040870|467748345|FG000|Overall Study|Lost to Follow-up|3|||
129941307|NCT02040870|467748345|FG000|Overall Study|Death|13|||
129941308|NCT02275611|467748348|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
129941309|NCT02275611|467748349|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
129941310|NCT02275611|467748350|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
129941311|NCT02275611|467748351|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
129941312|NCT01759862|467748357|FG000|Overall Study|Physician Decision|3|||
129941313|NCT01759862|467748358|FG001|Overall Study|Physician Decision|1|||
129941314|NCT01759862|467748357|FG000|Overall Study|Adverse Event|0|||
129941315|NCT01759862|467748358|FG001|Overall Study|Adverse Event|1|||
129941316|NCT03041233|467748361|FG000|Overall Study|Death|5|||
129941317|NCT03041233|467748361|FG000|Overall Study|Physician Decision|1|||
129941318|NCT03041233|467748361|FG000|Overall Study|Lost to Follow-up|16|||
129941319|NCT03041233|467748361|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
129941320|NCT03041233|467748361|FG000|Overall Study|Sponsor Request|1|||
129941321|NCT03041233|467748361|FG000|Overall Study|Duplicate subject|1|||
129941322|NCT03041233|467748361|FG000|Overall Study|Re-ablation|1|||
129941323|NCT03516812|467748364|FG000|Overall Study|Adverse Event|4|||
129941324|NCT03516812|467748364|FG000|Overall Study|Lack of Efficacy|2|||
129941325|NCT03890289|467748365|FG000|Overall Study|Adverse Event|1|||
129941326|NCT03890289|467748365|FG000|Overall Study|Physician Decision|1|||
129941327|NCT03890289|467748365|FG000|Overall Study|Lack of Efficacy|2|||
129941328|NCT01588951|467748369|FG000|Overall Study|Ineligible in retrospect|0|||
129941329|NCT01588951|467748370|FG001|Overall Study|Ineligible in retrospect|0|||
129941330|NCT01588951|467748371|FG002|Overall Study|Ineligible in retrospect|1|||
129941331|NCT02628626|467748372|FG000|Overall Study|Withdrawal by Subject|2|||
129941332|NCT02628626|467748373|FG001|Overall Study|Withdrawal by Subject|2|||
129941333|NCT01400958|467748376|FG000|Overall Study|Physician Decision|0|||
129941334|NCT01400958|467748377|FG001|Overall Study|Physician Decision|1|||
129941335|NCT01400958|467748376|FG000|Overall Study|Withdrawal by Subject|0|||
129941336|NCT01400958|467748377|FG001|Overall Study|Withdrawal by Subject|1|||
129941337|NCT01400958|467748376|FG000|Overall Study|Adverse Event|1|||
129941338|NCT01400958|467748377|FG001|Overall Study|Adverse Event|0|||
129941339|NCT00914966|467748378|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
129941340|NCT00914966|467748378|FG000|Step 1: 1500 Units|Physician Decision|1|||
129941341|NCT00914966|467748378|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
129941342|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941343|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
129941344|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941345|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941346|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941347|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941348|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
129941349|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941350|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941351|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941352|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941353|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941354|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941355|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941356|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
129941357|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941358|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941359|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941360|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
129941361|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
129941362|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
129941363|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
129941364|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
129941365|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
129941366|NCT04021862|467748379|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941367|NCT04021862|467748380|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941368|NCT04021862|467748381|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941369|NCT04021862|467748382|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
129941370|NCT04021862|467748383|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941371|NCT04021862|467748384|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941372|NCT01690624|467748385|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
129941373|NCT01690624|467748386|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
129941374|NCT01690624|467748387|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
129941375|NCT01690624|467748388|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
129941376|NCT01690624|467748385|FG000|Overall Study|Adverse event (other than DLT)|3|||
129941377|NCT01690624|467748386|FG001|Overall Study|Adverse event (other than DLT)|1|||
129941378|NCT01690624|467748387|FG002|Overall Study|Adverse event (other than DLT)|1|||
129941379|NCT01690624|467748388|FG003|Overall Study|Adverse event (other than DLT)|1|||
129941380|NCT01690624|467748385|FG000|Overall Study|Withdrawal by Subject|0|||
129941381|NCT01690624|467748386|FG001|Overall Study|Withdrawal by Subject|0|||
129941382|NCT01690624|467748387|FG002|Overall Study|Withdrawal by Subject|1|||
129941383|NCT01690624|467748388|FG003|Overall Study|Withdrawal by Subject|0|||
129941384|NCT01690624|467748385|FG000|Overall Study|Sponsor is ending trial|0|||
129941385|NCT01690624|467748386|FG001|Overall Study|Sponsor is ending trial|0|||
129941386|NCT01690624|467748387|FG002|Overall Study|Sponsor is ending trial|0|||
129941387|NCT01690624|467748388|FG003|Overall Study|Sponsor is ending trial|1|||
129941388|NCT01690624|467748385|FG000|Overall Study|Physician Decision|0|||
129941389|NCT01690624|467748386|FG001|Overall Study|Physician Decision|0|||
129941390|NCT01690624|467748387|FG002|Overall Study|Physician Decision|0|||
129941391|NCT01690624|467748388|FG003|Overall Study|Physician Decision|1|||
129941392|NCT01690624|467748385|FG000|Overall Study|Withdrawal by Subject|0|||
129941393|NCT01690624|467748386|FG001|Overall Study|Withdrawal by Subject|1|||
129941394|NCT01690624|467748387|FG002|Overall Study|Withdrawal by Subject|0|||
129941395|NCT01690624|467748388|FG003|Overall Study|Withdrawal by Subject|0|||
129941396|NCT01690624|467748385|FG000|Overall Study|Lack of Efficacy|1|||
129941397|NCT01690624|467748386|FG001|Overall Study|Lack of Efficacy|1|||
129941398|NCT01690624|467748387|FG002|Overall Study|Lack of Efficacy|3|||
129941399|NCT01690624|467748388|FG003|Overall Study|Lack of Efficacy|0|||
129941400|NCT02517268|467748390|FG000|Overall Study|Withdrawal by Subject|1|||
129941401|NCT02517268|467748391|FG001|Overall Study|Withdrawal by Subject|0|||
129941402|NCT04649047|467748398|FG000|Overall Study|Withdrawal by Subject|3|||
129941403|NCT00719888|467748399|FG000|Overall Study|Death|24|||
129941404|NCT00719888|467748400|FG001|Overall Study|Death|9|||
129941405|NCT00719888|467748399|FG000|Overall Study|Relapse|8|||
129941406|NCT00719888|467748400|FG001|Overall Study|Relapse|3|||
129941407|NCT00719888|467748399|FG000|Overall Study|Physician Decision|1|||
129941408|NCT00719888|467748400|FG001|Overall Study|Physician Decision|0|||
129941409|NCT00719888|467748399|FG000|Overall Study|Withdrawal by Subject|1|||
129941410|NCT00719888|467748400|FG001|Overall Study|Withdrawal by Subject|0|||
129941411|NCT05037513|467748401|FG000|Intervention Period|Lost to Follow-up|1|||
129941412|NCT05037513|467748402|FG001|Intervention Period|Lost to Follow-up|2|||
129941413|NCT05037513|467748401|FG000|Follow Up Period|Lost to Follow-up|16|||
129941414|NCT05037513|467748402|FG001|Follow Up Period|Lost to Follow-up|21|||
129941415|NCT05037513|467748401|FG000|Follow Up Period|Death|0|||
129941416|NCT05037513|467748402|FG001|Follow Up Period|Death|1|||
129941417|NCT05037513|467748401|FG000|Follow Up Period|Incarcerated|4|||
129941418|NCT05037513|467748402|FG001|Follow Up Period|Incarcerated|2|||
129941419|NCT03773107|467748403|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
129941420|NCT03773107|467748404|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
129941421|NCT03773107|467748405|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
129941422|NCT03773107|467748406|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
129941423|NCT02328014|467749730|FG000|Overall Study|Adverse Event|1|||
129941424|NCT02328014|467749731|FG001|Overall Study|Adverse Event|0|||
129941425|NCT02328014|467749732|FG002|Overall Study|Adverse Event|0|||
129941426|NCT02328014|467749733|FG003|Overall Study|Adverse Event|1|||
129941427|NCT02328014|467749730|FG000|Overall Study|Death|0|||
129941428|NCT02328014|467749731|FG001|Overall Study|Death|0|||
129941429|NCT02328014|467749732|FG002|Overall Study|Death|0|||
129941430|NCT02328014|467749733|FG003|Overall Study|Death|4|||
129941431|NCT02328014|467749730|FG000|Overall Study|Physician Decision|0|||
129941432|NCT02328014|467749731|FG001|Overall Study|Physician Decision|0|||
129941433|NCT02328014|467749732|FG002|Overall Study|Physician Decision|0|||
129941434|NCT02328014|467749733|FG003|Overall Study|Physician Decision|1|||
129941435|NCT02328014|467749730|FG000|Overall Study|Disease Progression|1|||
129941436|NCT02328014|467749731|FG001|Overall Study|Disease Progression|0|||
129941437|NCT02328014|467749732|FG002|Overall Study|Disease Progression|1|||
129941438|NCT02328014|467749733|FG003|Overall Study|Disease Progression|3|||
129941439|NCT02328014|467749730|FG000|Overall Study|Study Terminated by Sponsor|4|||
129941440|NCT02328014|467749731|FG001|Overall Study|Study Terminated by Sponsor|1|||
129941441|NCT02328014|467749732|FG002|Overall Study|Study Terminated by Sponsor|1|||
129941442|NCT02328014|467749733|FG003|Overall Study|Study Terminated by Sponsor|0|||
129941443|NCT02328014|467749730|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
129941444|NCT02328014|467749731|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
129941445|NCT02328014|467749732|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
129941446|NCT02328014|467749733|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
129941447|NCT02328014|467749730|FG000|Overall Study|Withdrawal by Subject|0|||
129941448|NCT02328014|467749731|FG001|Overall Study|Withdrawal by Subject|0|||
129941449|NCT02328014|467749732|FG002|Overall Study|Withdrawal by Subject|0|||
129941450|NCT02328014|467749733|FG003|Overall Study|Withdrawal by Subject|1|||
129941451|NCT01274338|467749734|FG000|Overall Study|Lack of Efficacy|72|||
129941452|NCT01274338|467749735|FG001|Overall Study|Lack of Efficacy|108|||
129941453|NCT01274338|467749736|FG002|Overall Study|Lack of Efficacy|116|||
129941454|NCT01274338|467749737|FG003|Overall Study|Lack of Efficacy|0|||
129941455|NCT01274338|467749738|FG004|Overall Study|Lack of Efficacy|0|||
129941456|NCT01274338|467749739|FG005|Overall Study|Lack of Efficacy|0|||
129941457|NCT01274338|467749734|FG000|Overall Study|Adverse Event|272|||
129941458|NCT01274338|467749735|FG001|Overall Study|Adverse Event|105|||
129941459|NCT01274338|467749736|FG002|Overall Study|Adverse Event|180|||
129941460|NCT01274338|467749737|FG003|Overall Study|Adverse Event|1|||
129941461|NCT01274338|467749738|FG004|Overall Study|Adverse Event|0|||
129941462|NCT01274338|467749739|FG005|Overall Study|Adverse Event|0|||
129941463|NCT01274338|467749734|FG000|Overall Study|Death|8|||
129941464|NCT01274338|467749735|FG001|Overall Study|Death|1|||
129941465|NCT01274338|467749736|FG002|Overall Study|Death|0|||
129941466|NCT01274338|467749737|FG003|Overall Study|Death|0|||
129941467|NCT01274338|467749738|FG004|Overall Study|Death|0|||
129941468|NCT01274338|467749739|FG005|Overall Study|Death|0|||
129941469|NCT01274338|467749734|FG000|Overall Study|Withdrawal by Subject|27|||
129941470|NCT01274338|467749735|FG001|Overall Study|Withdrawal by Subject|99|||
129941471|NCT01274338|467749736|FG002|Overall Study|Withdrawal by Subject|17|||
129941472|NCT01274338|467749737|FG003|Overall Study|Withdrawal by Subject|0|||
129941473|NCT01274338|467749738|FG004|Overall Study|Withdrawal by Subject|0|||
129941474|NCT01274338|467749739|FG005|Overall Study|Withdrawal by Subject|0|||
129941475|NCT01274338|467749734|FG000|Overall Study|Did not start treatment|8|||
129941476|NCT01274338|467749735|FG001|Overall Study|Did not start treatment|116|||
129941477|NCT01274338|467749736|FG002|Overall Study|Did not start treatment|7|||
129941478|NCT01274338|467749737|FG003|Overall Study|Did not start treatment|0|||
129941479|NCT01274338|467749738|FG004|Overall Study|Did not start treatment|0|||
129941480|NCT01274338|467749739|FG005|Overall Study|Did not start treatment|0|||
129941481|NCT01274338|467749734|FG000|Overall Study|Alternative therapy|0|||
129941482|NCT01274338|467749735|FG001|Overall Study|Alternative therapy|1|||
129941483|NCT01274338|467749736|FG002|Overall Study|Alternative therapy|0|||
129941484|NCT01274338|467749737|FG003|Overall Study|Alternative therapy|0|||
129941485|NCT01274338|467749738|FG004|Overall Study|Alternative therapy|0|||
129941486|NCT01274338|467749739|FG005|Overall Study|Alternative therapy|0|||
129941487|NCT01274338|467749734|FG000|Overall Study|Other complicating diseases|0|||
129941488|NCT01274338|467749735|FG001|Overall Study|Other complicating diseases|3|||
129941489|NCT01274338|467749736|FG002|Overall Study|Other complicating diseases|1|||
129941490|NCT01274338|467749737|FG003|Overall Study|Other complicating diseases|0|||
129941491|NCT01274338|467749738|FG004|Overall Study|Other complicating diseases|0|||
129941492|NCT01274338|467749739|FG005|Overall Study|Other complicating diseases|0|||
129941493|NCT01274338|467749734|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
129941494|NCT01274338|467749735|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941495|NCT01274338|467749736|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941496|NCT01274338|467749737|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941497|NCT01274338|467749738|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941498|NCT01274338|467749739|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941499|NCT01274338|467749734|FG000|Overall Study|Pregnancy|0|||
129941500|NCT01274338|467749735|FG001|Overall Study|Pregnancy|0|||
129941501|NCT01274338|467749736|FG002|Overall Study|Pregnancy|1|||
129941502|NCT01274338|467749737|FG003|Overall Study|Pregnancy|0|||
129941503|NCT01274338|467749738|FG004|Overall Study|Pregnancy|0|||
129941504|NCT01274338|467749739|FG005|Overall Study|Pregnancy|0|||
129941505|NCT01274338|467749734|FG000|Overall Study|Reason not reported|12|||
129941506|NCT01274338|467749735|FG001|Overall Study|Reason not reported|21|||
129941507|NCT01274338|467749736|FG002|Overall Study|Reason not reported|3|||
129941508|NCT01274338|467749737|FG003|Overall Study|Reason not reported|0|||
129941509|NCT01274338|467749738|FG004|Overall Study|Reason not reported|1|||
129941510|NCT01274338|467749739|FG005|Overall Study|Reason not reported|0|||
129941511|NCT05422339|467749740|FG000|Overall Study|Withdrawal by Subject|17|||
129941512|NCT05422339|467749741|FG001|Overall Study|Withdrawal by Subject|15|||
129941513|NCT03678688|467749748|FG000|Overall Study|Reason not Specified|0|||
130071453|NCT02983799|468216119|FG001|Overall Study|Death|5|||
130071454|NCT02983799|468216120|FG002|Overall Study|Death|23|||
130071455|NCT02983799|468216121|FG003|Overall Study|Death|47|||
130071456|NCT02983799|468216122|FG004|Overall Study|Death|7|||
129941514|NCT03678688|467749749|FG001|Overall Study|Reason not Specified|0|||
130071457|NCT02983799|468216118|FG000|Overall Study|Withdrawal by Subject|1|||
130071458|NCT02983799|468216119|FG001|Overall Study|Withdrawal by Subject|0|||
130071459|NCT02983799|468216120|FG002|Overall Study|Withdrawal by Subject|3|||
129941515|NCT03678688|467749750|FG002|Overall Study|Reason not Specified|3|||
129941516|NCT03678688|467749751|FG003|Overall Study|Reason not Specified|0|||
129941517|NCT03678688|467749752|FG004|Overall Study|Reason not Specified|1|||
129941518|NCT03678688|467749753|FG005|Overall Study|Reason not Specified|0|||
129941519|NCT03678688|467749754|FG006|Overall Study|Reason not Specified|0|||
129941520|NCT03678688|467749755|FG007|Overall Study|Reason not Specified|0|||
129941521|NCT03678688|467749756|FG008|Overall Study|Reason not Specified|0|||
129941522|NCT03678688|467749748|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
129941523|NCT03678688|467749749|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
129941524|NCT03678688|467749750|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
130119999|NCT01521559|468400127|FG000|Overall Study|Adverse Event|0|||
130120000|NCT01521559|468400128|FG001|Overall Study|Adverse Event|4|||
130120001|NCT01521559|468400127|FG000|Overall Study|Death|1|||
130120002|NCT01521559|468400128|FG001|Overall Study|Death|0|||
130120003|NCT01521559|468400127|FG000|Overall Study|Withdrawal by Subject|9|||
130120004|NCT01521559|468400128|FG001|Overall Study|Withdrawal by Subject|11|||
130120005|NCT01521559|468400127|FG000|Overall Study|Lost to Follow-up|3|||
130120006|NCT01521559|468400128|FG001|Overall Study|Lost to Follow-up|1|||
130120007|NCT01521559|468400127|FG000|Overall Study|Protocol Violation|1|||
130120008|NCT01521559|468400128|FG001|Overall Study|Protocol Violation|0|||
130120009|NCT01521559|468400127|FG000|Overall Study|Other|1|||
130120010|NCT01521559|468400128|FG001|Overall Study|Other|2|||
130120011|NCT00275002|468400130|FG000|Overall Study|Death|1|||
129941525|NCT03678688|467749751|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
129941526|NCT03678688|467749752|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
129941527|NCT03678688|467749753|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
129941528|NCT03678688|467749754|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
129941529|NCT03678688|467749755|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
129941530|NCT03678688|467749756|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
129941531|NCT03678688|467749748|FG000|Overall Study|Covid Related Adverse Event|0|||
129941532|NCT03678688|467749749|FG001|Overall Study|Covid Related Adverse Event|0|||
129941533|NCT03678688|467749750|FG002|Overall Study|Covid Related Adverse Event|0|||
129941534|NCT03678688|467749751|FG003|Overall Study|Covid Related Adverse Event|0|||
129941535|NCT03678688|467749752|FG004|Overall Study|Covid Related Adverse Event|0|||
129941536|NCT03678688|467749753|FG005|Overall Study|Covid Related Adverse Event|3|||
129941537|NCT03678688|467749754|FG006|Overall Study|Covid Related Adverse Event|1|||
130071460|NCT02983799|468216121|FG003|Overall Study|Withdrawal by Subject|4|||
130071461|NCT02983799|468216122|FG004|Overall Study|Withdrawal by Subject|1|||
130071462|NCT02983799|468216118|FG000|Overall Study|Protocol Violation|0|||
130071463|NCT02983799|468216119|FG001|Overall Study|Protocol Violation|1|||
130071464|NCT02983799|468216120|FG002|Overall Study|Protocol Violation|0|||
130071465|NCT02983799|468216121|FG003|Overall Study|Protocol Violation|0|||
130071466|NCT02983799|468216122|FG004|Overall Study|Protocol Violation|1|||
130071467|NCT02983799|468216118|FG000|Overall Study|Lost to Follow-up|1|||
130071468|NCT02983799|468216119|FG001|Overall Study|Lost to Follow-up|0|||
130071469|NCT02983799|468216120|FG002|Overall Study|Lost to Follow-up|1|||
130071470|NCT02983799|468216121|FG003|Overall Study|Lost to Follow-up|0|||
130071471|NCT02983799|468216122|FG004|Overall Study|Lost to Follow-up|0|||
130071472|NCT00631540|468216137|FG000|Overall Study|Withdrawal by Subject|5|||
130071473|NCT00631540|468216137|FG000|Overall Study|Death|4|||
130071474|NCT00631540|468216137|FG000|Overall Study|Lost to Follow-up|2|||
130071475|NCT00631540|468216137|FG000|Overall Study|Core Lab Data Unavailable|3|||
130071476|NCT00970268|468216143|FG000|Overall Study|Withdrawal by Subject|12|||
130071477|NCT00970268|468216144|FG001|Overall Study|Withdrawal by Subject|19|||
130071478|NCT00970268|468216143|FG000|Overall Study|Adverse Event|15|||
130071479|NCT00970268|468216144|FG001|Overall Study|Adverse Event|12|||
130071480|NCT00970268|468216143|FG000|Overall Study|Lack of Efficacy|3|||
130071481|NCT00970268|468216144|FG001|Overall Study|Lack of Efficacy|6|||
130071482|NCT00970268|468216143|FG000|Overall Study|Protocol Violation|4|||
130071483|NCT00970268|468216144|FG001|Overall Study|Protocol Violation|7|||
130071484|NCT00970268|468216143|FG000|Overall Study|Other Reason|3|||
130071485|NCT00970268|468216144|FG001|Overall Study|Other Reason|1|||
130071486|NCT00970268|468216143|FG000|Overall Study|COPD Exacerbation|4|||
130071487|NCT00970268|468216144|FG001|Overall Study|COPD Exacerbation|2|||
130071488|NCT00970268|468216143|FG000|Overall Study|Lost to Follow-up|1|||
130071489|NCT00970268|468216144|FG001|Overall Study|Lost to Follow-up|2|||
130071490|NCT00970268|468216143|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
130071491|NCT00970268|468216144|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
130071492|NCT03136367|468216146|FG000|T1 Consultation|discontinued mistakenly included|2|||
130071493|NCT03136367|468216147|FG001|T1 Consultation|discontinued mistakenly included|6|||
130071494|NCT03136367|468216148|FG002|T1 Consultation|discontinued mistakenly included|1|||
130071495|NCT03136367|468216146|FG000|T1 Consultation|Discontinued other|0|||
130071496|NCT03136367|468216147|FG001|T1 Consultation|Discontinued other|1|||
130071497|NCT03136367|468216148|FG002|T1 Consultation|Discontinued other|0|||
130071498|NCT03136367|468216146|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
130071499|NCT03136367|468216147|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
130120012|NCT00275002|468400131|FG001|Overall Study|Death|0|||
130120013|NCT00275002|468400130|FG000|Overall Study|Disease progression|21|||
129941538|NCT03678688|467749755|FG007|Overall Study|Covid Related Adverse Event|1|||
129941539|NCT03678688|467749756|FG008|Overall Study|Covid Related Adverse Event|0|||
130071500|NCT03136367|468216148|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
130071501|NCT03136367|468216146|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
130071502|NCT03136367|468216147|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
129941540|NCT03678688|467749748|FG000|Overall Study|Physician Decision|0|||
130120014|NCT00275002|468400131|FG001|Overall Study|Disease progression|15|||
130120015|NCT00275002|468400130|FG000|Overall Study|Adverse Event|0|||
130120016|NCT00275002|468400131|FG001|Overall Study|Adverse Event|1|||
130120017|NCT00576381|468400138|FG000|Overall Study|Reoperation|3|||
129941541|NCT03678688|467749749|FG001|Overall Study|Physician Decision|0|||
129941542|NCT03678688|467749750|FG002|Overall Study|Physician Decision|0|||
129941543|NCT03678688|467749751|FG003|Overall Study|Physician Decision|0|||
129941544|NCT03678688|467749752|FG004|Overall Study|Physician Decision|0|||
129941545|NCT03678688|467749753|FG005|Overall Study|Physician Decision|1|||
129941546|NCT03678688|467749754|FG006|Overall Study|Physician Decision|0|||
129941547|NCT03678688|467749755|FG007|Overall Study|Physician Decision|0|||
129941548|NCT03678688|467749756|FG008|Overall Study|Physician Decision|0|||
129941549|NCT03678688|467749748|FG000|Overall Study|Withdrawal by Subject|0|||
129941550|NCT03678688|467749749|FG001|Overall Study|Withdrawal by Subject|0|||
129941551|NCT03678688|467749750|FG002|Overall Study|Withdrawal by Subject|0|||
129941552|NCT03678688|467749751|FG003|Overall Study|Withdrawal by Subject|0|||
129941553|NCT03678688|467749752|FG004|Overall Study|Withdrawal by Subject|0|||
129941554|NCT03678688|467749753|FG005|Overall Study|Withdrawal by Subject|0|||
129941555|NCT03678688|467749754|FG006|Overall Study|Withdrawal by Subject|2|||
129941556|NCT03678688|467749755|FG007|Overall Study|Withdrawal by Subject|1|||
129941557|NCT03678688|467749756|FG008|Overall Study|Withdrawal by Subject|0|||
129941558|NCT01278030|467749763|FG000|Overall Study|Withdrawal by Subject|8|||
129941559|NCT01278030|467749764|FG001|Overall Study|Withdrawal by Subject|4|||
129941560|NCT00458783|467749766|FG000|Overall Study|Protocol Violation|1228|||
129941561|NCT00458783|467749767|FG001|Overall Study|Protocol Violation|1220|||
129941562|NCT04401267|467749769|FG000|Overall Study|Death|0|||
129941563|NCT04401267|467749770|FG001|Overall Study|Death|1|||
129941564|NCT04401267|467749769|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
129941565|NCT04401267|467749770|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
129941566|NCT04401267|467749769|FG000|Overall Study|Found to be Ineligible|1|||
129941567|NCT04401267|467749770|FG001|Overall Study|Found to be Ineligible|0|||
129941568|NCT03214081|467749771|FG000|Overall Study|Case Report Forms Uncollected|9|||
129941569|NCT03214081|467749771|FG000|Overall Study|Protocol Deviation|54|||
129941570|NCT02962284|467749772|FG000|Overall Study|Death|2|||
129941571|NCT02962284|467749773|FG001|Overall Study|Death|0|||
129941572|NCT02962284|467749772|FG000|Overall Study|Progressive disease|2|||
129941573|NCT02962284|467749773|FG001|Overall Study|Progressive disease|3|||
129941574|NCT02962284|467749772|FG000|Overall Study|Withdrawal by Subject|1|||
129941575|NCT02962284|467749773|FG001|Overall Study|Withdrawal by Subject|0|||
129941576|NCT05815342|467749774|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
129941577|NCT05815342|467749774|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
129941578|NCT05815342|467749774|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
129941579|NCT05815342|467749774|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
129941580|NCT05815342|467749774|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
129941581|NCT00345046|467749777|FG000|Overall Study|Protocol Violation|1|||
129941582|NCT00345046|467749778|FG001|Overall Study|Protocol Violation|1|||
129941583|NCT00345046|467749779|FG002|Overall Study|Protocol Violation|2|||
129941584|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
129941585|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
129941586|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
129941587|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Death|0|||
129941588|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Death|2|||
129941589|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Death|1|||
129941590|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
129941591|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
129941592|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
129941593|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
129941594|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
129941595|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
129941596|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
129941597|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
129941598|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
129941599|NCT00790569|467749780|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
129941600|NCT00790569|467749781|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
129941601|NCT00790569|467749782|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
129941602|NCT03244800|467749784|FG000|Overall Study|Adverse Event|0|||
129941603|NCT03244800|467749785|FG001|Overall Study|Adverse Event|1|||
129941604|NCT03244800|467749786|FG002|Overall Study|Adverse Event|0|||
129941605|NCT03244800|467749787|FG003|Overall Study|Adverse Event|1|||
130071503|NCT03136367|468216148|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
130071504|NCT03136367|468216146|FG000|T2 Post-consultation|Discontinued other|0|||
129941606|NCT03244800|467749784|FG000|Overall Study|Withdrew treatment|0|||
129941607|NCT03244800|467749785|FG001|Overall Study|Withdrew treatment|0|||
129941608|NCT03244800|467749786|FG002|Overall Study|Withdrew treatment|0|||
129941609|NCT03244800|467749787|FG003|Overall Study|Withdrew treatment|1|||
129941610|NCT02362035|467749788|FG000|Overall Study|Death|67|||
129941611|NCT02362035|467749788|FG000|Overall Study|Lost to Follow-up|3|||
129941612|NCT02362035|467749788|FG000|Overall Study|Adverse Event|1|||
129941613|NCT02362035|467749788|FG000|Overall Study|Physician Decision|1|||
129941614|NCT02362035|467749788|FG000|Overall Study|Subject started another cancer therapy|10|||
129941615|NCT02362035|467749788|FG000|Overall Study|Study terminated by sponsor|45|||
129941616|NCT02362035|467749788|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
129941617|NCT02362035|467749788|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
129941618|NCT02362035|467749788|FG000|Overall Study|Disease progression|11|||
129941619|NCT02362035|467749788|FG000|Overall Study|Withdrawal by Subject|20|||
129941620|NCT00229658|467749791|FG000|Overall Study|Administrative|2|||
129941621|NCT00229658|467749792|FG001|Overall Study|Administrative|1|||
129941622|NCT00229658|467749791|FG000|Overall Study|Investigator decision|13|||
129941623|NCT00229658|467749792|FG001|Overall Study|Investigator decision|10|||
129941624|NCT00229658|467749791|FG000|Overall Study|Other|80|||
129941625|NCT00229658|467749792|FG001|Overall Study|Other|60|||
129941626|NCT00229658|467749791|FG000|Overall Study|Lost to Follow-up|82|||
129941627|NCT00229658|467749792|FG001|Overall Study|Lost to Follow-up|55|||
129941628|NCT00229658|467749791|FG000|Overall Study|Serious Adverse Event|2|||
129941629|NCT00229658|467749792|FG001|Overall Study|Serious Adverse Event|2|||
129941630|NCT00229658|467749791|FG000|Overall Study|Withdrawal of consent|46|||
129941631|NCT00229658|467749792|FG001|Overall Study|Withdrawal of consent|39|||
129941632|NCT00249769|467749793|FG000|Overall Study|Withdrawal by Subject|1|||
129941633|NCT00249769|467749794|FG001|Overall Study|Withdrawal by Subject|10|||
129941634|NCT00249769|467749795|FG002|Overall Study|Withdrawal by Subject|6|||
129941635|NCT00249769|467749793|FG000|Overall Study|Migration from Study Area|1|||
130071505|NCT03136367|468216147|FG001|T2 Post-consultation|Discontinued other|2|||
130071506|NCT03136367|468216148|FG002|T2 Post-consultation|Discontinued other|6|||
130071507|NCT03136367|468216146|FG000|T2 Post-consultation|Discontinued transferred care|0|||
130071508|NCT03136367|468216147|FG001|T2 Post-consultation|Discontinued transferred care|0|||
130071509|NCT03136367|468216148|FG002|T2 Post-consultation|Discontinued transferred care|3|||
130071510|NCT03136367|468216146|FG000|T2 Post-consultation|Discontinued lost contact|0|||
130071511|NCT03136367|468216147|FG001|T2 Post-consultation|Discontinued lost contact|1|||
130071512|NCT03136367|468216148|FG002|T2 Post-consultation|Discontinued lost contact|0|||
130071513|NCT03136367|468216146|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
130071514|NCT03136367|468216147|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
130120018|NCT00576381|468400138|FG000|Overall Study|Adverse Event|4|||
130120019|NCT01031537|468400142|FG000|Overall Study|medical reasons not related to study|3|||
130120020|NCT01031537|468400142|FG000|Overall Study|Lack of Efficacy|1|||
130120021|NCT01031537|468400142|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
130120022|NCT01031537|468400142|FG000|Overall Study|moved, met exclusion criteria|10|||
130120023|NCT01031537|468400142|FG000|Overall Study|Withdrawal by Subject|5|||
130120024|NCT01031537|468400142|FG000|Overall Study|PI removal, no longer met eligibility|12|||
130120025|NCT01506947|468400146|FG000|Overall Study|Lost to Follow-up|7|||
130120026|NCT01506947|468400146|FG000|Overall Study|Adverse Event|5|||
130120027|NCT01506947|468400146|FG000|Overall Study|Death|1|||
130120028|NCT01506947|468400146|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
130120029|NCT01700621|468400147|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
130120030|NCT01700621|468400148|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
130120031|NCT01700621|468400147|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
129941636|NCT00249769|467749794|FG001|Overall Study|Migration from Study Area|3|||
129941637|NCT00249769|467749795|FG002|Overall Study|Migration from Study Area|14|||
129941638|NCT00249769|467749793|FG000|Overall Study|Miscellaneous|0|||
129941639|NCT00249769|467749794|FG001|Overall Study|Miscellaneous|2|||
129941640|NCT00249769|467749795|FG002|Overall Study|Miscellaneous|2|||
129941641|NCT00249769|467749793|FG000|Overall Study|Adverse Event|0|||
129941642|NCT00249769|467749794|FG001|Overall Study|Adverse Event|0|||
129941643|NCT00249769|467749795|FG002|Overall Study|Adverse Event|1|||
129941644|NCT00249769|467749793|FG000|Overall Study|Physician Decision|0|||
129941645|NCT00249769|467749794|FG001|Overall Study|Physician Decision|0|||
129941646|NCT00249769|467749795|FG002|Overall Study|Physician Decision|2|||
129941647|NCT00249769|467749793|FG000|Overall Study|Lost to Follow-up|0|||
129941648|NCT00249769|467749794|FG001|Overall Study|Lost to Follow-up|0|||
129941649|NCT00249769|467749795|FG002|Overall Study|Lost to Follow-up|3|||
129941650|NCT01953224|467749796|FG000|Overall Study|Lost to Follow-up|1|||
129941651|NCT01953224|467749797|FG001|Overall Study|Lost to Follow-up|1|||
129941652|NCT01953224|467749796|FG000|Overall Study|Withdrawal by Subject|1|||
129941653|NCT01953224|467749797|FG001|Overall Study|Withdrawal by Subject|2|||
129941654|NCT03229408|467749798|FG000|Overall Study|Withdrawal by Subject|4|||
129941655|NCT03229408|467749799|FG001|Overall Study|Withdrawal by Subject|1|||
129941656|NCT03229408|467749798|FG000|Overall Study|Adverse Event|2|||
129941657|NCT03229408|467749799|FG001|Overall Study|Adverse Event|0|||
129941658|NCT03229408|467749798|FG000|Overall Study|Pregnancy|0|||
130071515|NCT03136367|468216148|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
130071516|NCT03136367|468216146|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
130120032|NCT01700621|468400148|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
129941659|NCT03229408|467749799|FG001|Overall Study|Pregnancy|1|||
129941660|NCT03229408|467749798|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
130154858|NCT00958126|468526621|FG000|Overall Study|Lost to Follow-up|1|||
130120033|NCT01700621|468400147|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
130120034|NCT01700621|468400148|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
130120035|NCT02166697|468400149|FG000|Overall Study|Protocol Violation|347|||
130120036|NCT02720510|468400153|FG000|Overall Study|Study Terminated by the sponsor|2|||
130120037|NCT02720510|468400154|FG001|Overall Study|Study Terminated by the sponsor|0|||
130120038|NCT02720510|468400153|FG000|Overall Study|Adverse Event|0|||
130120039|NCT02720510|468400154|FG001|Overall Study|Adverse Event|1|||
130120040|NCT02720510|468400153|FG000|Overall Study|Physician Decision|1|||
130120041|NCT02720510|468400154|FG001|Overall Study|Physician Decision|2|||
130120042|NCT01618266|468400164|FG000|Overall Study|Lost to Follow-up|9|||
130120043|NCT01618266|468400164|FG000|Overall Study|Treatment satisfaction|10|||
130120044|NCT01618266|468400164|FG000|Overall Study|Other reasons|11|||
130120045|NCT01618266|468400164|FG000|Overall Study|Lack of Efficacy|23|||
130120046|NCT01618266|468400164|FG000|Overall Study|Protocol Violation|43|||
130120047|NCT02985151|468400165|FG000|Original Randomization|Withdrawal by Subject|0|||
130120048|NCT02985151|468400166|FG001|Original Randomization|Withdrawal by Subject|1|||
130120049|NCT03522948|468400175|FG000|Overall Study|Lost to Follow-up|1|||
130120050|NCT00084084|468400176|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
130120051|NCT00084084|468400176|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
130120052|NCT01802879|468400177|FG000|Overall Study|Administrative problems|2|||
130120053|NCT01802879|468400177|FG000|Overall Study|Disease progression|6|||
130120054|NCT02187042|468400178|FG000|Overall Study|Death|1|||
130120055|NCT02187042|468400179|FG001|Overall Study|Death|1|||
130120056|NCT02187042|468400178|FG000|Overall Study|Toxicity|6|||
130120057|NCT02187042|468400179|FG001|Overall Study|Toxicity|5|||
130120058|NCT02187042|468400178|FG000|Overall Study|Participant choice|1|||
130120059|NCT02187042|468400179|FG001|Overall Study|Participant choice|0|||
130120060|NCT02187042|468400178|FG000|Overall Study|Doctor choice|1|||
130120061|NCT02187042|468400179|FG001|Overall Study|Doctor choice|0|||
130120062|NCT02187042|468400178|FG000|Overall Study|Progressive disease|4|||
130120063|NCT02187042|468400179|FG001|Overall Study|Progressive disease|8|||
130120064|NCT00108732|468400180|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
130120065|NCT00108732|468400180|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
130120066|NCT00108732|468400180|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
130120067|NCT00108732|468400180|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
130120068|NCT00108732|468400180|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
130120069|NCT00108732|468400180|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
130120070|NCT00108732|468400180|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
130120071|NCT02116803|468400182|FG000|Overall Study|Adverse Event|2|||
130120072|NCT02116803|468400183|FG001|Overall Study|Adverse Event|1|||
130120073|NCT02116803|468400182|FG000|Overall Study|Physician Decision|1|||
130120074|NCT02116803|468400183|FG001|Overall Study|Physician Decision|0|||
130120075|NCT02116803|468400182|FG000|Overall Study|Progressive disease|4|||
130120076|NCT02116803|468400183|FG001|Overall Study|Progressive disease|0|||
130120077|NCT02116803|468400182|FG000|Overall Study|Study terminated by sponsor|2|||
130120078|NCT02116803|468400183|FG001|Overall Study|Study terminated by sponsor|1|||
130120079|NCT02116803|468400182|FG000|Overall Study|Death|1|||
130120080|NCT02116803|468400183|FG001|Overall Study|Death|0|||
130120081|NCT00698685|468400186|FG000|Overall Study|Sister withdrew as donor|1|||
130120082|NCT00698685|468400186|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
130120083|NCT01457053|468400188|FG000|Overall Study|Unable to undergo selected treatment|1|||
130120084|NCT01457053|468400189|FG001|Overall Study|Unable to undergo selected treatment|1|||
130120085|NCT02799602|468400190|FG000|Overall Study|Protocol Violation|1|||
130120086|NCT02799602|468400191|FG001|Overall Study|Protocol Violation|0|||
130120087|NCT02799602|468400190|FG000|Overall Study|Physician Decision|5|||
129941661|NCT03229408|467749799|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
129941662|NCT04541589|467749800|FG000|Treatment Period|Adverse Event|8|||
129941663|NCT04541589|467749801|FG001|Treatment Period|Adverse Event|2|||
129941664|NCT04541589|467749800|FG000|Treatment Period|Physician Decision|3|||
129941665|NCT04541589|467749801|FG001|Treatment Period|Physician Decision|1|||
129941666|NCT04541589|467749800|FG000|Treatment Period|Subject decision|7|||
129941667|NCT04541589|467749801|FG001|Treatment Period|Subject decision|4|||
129941668|NCT04541589|467749800|FG000|Treatment Period|Withdrawal by Subject|1|||
129941669|NCT04541589|467749801|FG001|Treatment Period|Withdrawal by Subject|0|||
129941670|NCT04541589|467749800|FG000|Safety Follow-up Period|Adverse Event|2|||
130120088|NCT02799602|468400191|FG001|Overall Study|Physician Decision|6|||
130120089|NCT02799602|468400190|FG000|Overall Study|Lost to Follow-up|4|||
130120090|NCT02799602|468400191|FG001|Overall Study|Lost to Follow-up|2|||
130120091|NCT02799602|468400190|FG000|Overall Study|Additional primary malignancy|11|||
130120092|NCT02799602|468400191|FG001|Overall Study|Additional primary malignancy|6|||
130120093|NCT02799602|468400190|FG000|Overall Study|Non-compliance with study drug|14|||
130120094|NCT02799602|468400191|FG001|Overall Study|Non-compliance with study drug|12|||
130120095|NCT02799602|468400190|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
130120096|NCT02799602|468400191|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
130120097|NCT02799602|468400190|FG000|Overall Study|Withdrawal by Subject|26|||
130120098|NCT02799602|468400191|FG001|Overall Study|Withdrawal by Subject|40|||
130120099|NCT02799602|468400190|FG000|Overall Study|Progressive disease - clinical progression|131|||
130120100|NCT02799602|468400191|FG001|Overall Study|Progressive disease - clinical progression|276|||
130120101|NCT02799602|468400190|FG000|Overall Study|Progressive disease - radiological progression|90|||
130120102|NCT02799602|468400191|FG001|Overall Study|Progressive disease - radiological progression|133|||
130120103|NCT02799602|468400190|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
130120104|NCT02799602|468400191|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
130120105|NCT02799602|468400190|FG000|Overall Study|Death|9|||
130120106|NCT02799602|468400191|FG001|Overall Study|Death|5|||
130120107|NCT02799602|468400190|FG000|Overall Study|Other|287|||
130120108|NCT02799602|468400191|FG001|Overall Study|Other|118|||
130120109|NCT02799602|468400190|FG000|Overall Study|Study drug never administered|0|||
130120110|NCT02799602|468400191|FG001|Overall Study|Study drug never administered|3|||
130120111|NCT00634179|468400199|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
130120112|NCT00767325|468400202|FG000|Overall Study|Lack of Efficacy|2|||
130120113|NCT00767325|468400202|FG000|Overall Study|Adverse Event|7|||
130120114|NCT00767325|468400202|FG000|Overall Study|Lost to Follow-up|3|||
130120115|NCT00767325|468400202|FG000|Overall Study|No longer met study criteria|2|||
130120116|NCT00767325|468400202|FG000|Overall Study|Missed visit due to family reasons|1|||
130120117|NCT03538756|468400203|FG000|Long-Term Follow-up|Adverse Event|0|||
130120118|NCT03538756|468400204|FG001|Long-Term Follow-up|Adverse Event|0|||
130120119|NCT03538756|468400205|FG002|Long-Term Follow-up|Adverse Event|6|||
130120120|NCT03538756|468400203|FG000|Long-Term Follow-up|Death|0|||
130120121|NCT03538756|468400204|FG001|Long-Term Follow-up|Death|0|||
130120122|NCT03538756|468400205|FG002|Long-Term Follow-up|Death|1|||
130120123|NCT03538756|468400203|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
130120124|NCT03538756|468400204|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
130120125|NCT03538756|468400205|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
130120126|NCT03538756|468400203|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
130120127|NCT03538756|468400204|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
130120128|NCT03538756|468400205|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
130120129|NCT03538756|468400203|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
130120130|NCT03538756|468400204|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
130120131|NCT03538756|468400205|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
130120132|NCT00752856|468400206|FG000|Overall Study|randomized but did not do viral kinetics|0|||
130120133|NCT00752856|468400207|FG001|Overall Study|randomized but did not do viral kinetics|1|||
130120134|NCT03131999|468400208|FG000|Overall Study|Withdrawal by Subject|0|||
130120135|NCT03131999|468400209|FG001|Overall Study|Withdrawal by Subject|1|||
130120136|NCT00996736|468400215|FG000|Overall Study|Death|1|||
130120137|NCT00996736|468400216|FG001|Overall Study|Death|1|||
130120138|NCT00996736|468400215|FG000|Overall Study|Lost to Follow-up|15|||
130120139|NCT00996736|468400216|FG001|Overall Study|Lost to Follow-up|14|||
130120140|NCT00996736|468400215|FG000|Overall Study|Visit not within 3-month window|5|||
130120141|NCT00996736|468400216|FG001|Overall Study|Visit not within 3-month window|3|||
130120142|NCT02688608|468400217|FG000|Overall Study|Lost to Follow-up|1|||
130120143|NCT00365352|468400218|FG000|Overall Study|Adverse Event|6|||
130120144|NCT00365352|468400219|FG001|Overall Study|Adverse Event|7|||
130120145|NCT00365352|468400220|FG002|Overall Study|Adverse Event|8|||
130120146|NCT00365352|468400218|FG000|Overall Study|Participant Withdrew Consent|8|||
130120147|NCT00365352|468400219|FG001|Overall Study|Participant Withdrew Consent|3|||
130120148|NCT00365352|468400220|FG002|Overall Study|Participant Withdrew Consent|4|||
130120149|NCT00365352|468400218|FG000|Overall Study|Lack of Efficacy|3|||
130120150|NCT00365352|468400219|FG001|Overall Study|Lack of Efficacy|0|||
130120151|NCT00365352|468400220|FG002|Overall Study|Lack of Efficacy|0|||
130120152|NCT00365352|468400218|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
130120153|NCT00365352|468400219|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
130120154|NCT00365352|468400220|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
130120155|NCT00365352|468400218|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
130120156|NCT00365352|468400219|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
130120157|NCT00365352|468400220|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
130120158|NCT00365352|468400218|FG000|Overall Study|Lost to Follow-up|1|||
130120159|NCT00365352|468400219|FG001|Overall Study|Lost to Follow-up|1|||
130120160|NCT00365352|468400220|FG002|Overall Study|Lost to Follow-up|0|||
130120161|NCT00365352|468400218|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
130120162|NCT00365352|468400219|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
130120163|NCT00365352|468400220|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
130120164|NCT02109133|468400225|FG000|Overall Study|Lost to Follow-up|1|||
130120165|NCT02109133|468400226|FG001|Overall Study|Lost to Follow-up|0|||
130120166|NCT00409578|468400227|FG000|Overall Study|Adverse Event|27|||
130120167|NCT00409578|468400228|FG001|Overall Study|Adverse Event|37|||
130120168|NCT00409578|468400229|FG002|Overall Study|Adverse Event|25|||
130120169|NCT00409578|468400230|FG003|Overall Study|Adverse Event|33|||
130120170|NCT00409578|468400227|FG000|Overall Study|Abnormal laboratory value(s)|2|||
130120171|NCT00409578|468400228|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129941671|NCT04541589|467749801|FG001|Safety Follow-up Period|Adverse Event|1|||
129941672|NCT04541589|467749800|FG000|Safety Follow-up Period|Physician Decision|1|||
129941673|NCT04541589|467749801|FG001|Safety Follow-up Period|Physician Decision|0|||
129941674|NCT04541589|467749800|FG000|Safety Follow-up Period|Subject decision|5|||
129941675|NCT04541589|467749801|FG001|Safety Follow-up Period|Subject decision|3|||
129941676|NCT04541589|467749800|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
129941677|NCT04541589|467749801|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
129941678|NCT03745313|467749802|FG000|At 30 Days Follow-up|Death|2|||
129941679|NCT03745313|467749802|FG000|At 6 Months Follow-up|Death|1|||
129941680|NCT03745313|467749802|FG000|At 6 Months Follow-up|Missed Visit|1|||
129941681|NCT03745313|467749802|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
129941682|NCT03745313|467749802|FG000|At 1 Year Follow-up|Death|2|||
129941683|NCT03745313|467749802|FG000|At 1 Year Follow-up|Missed Visit|2|||
129941684|NCT03745313|467749802|FG000|At 2 Year Follow-up|Missed Visit|1|||
129941685|NCT03389802|467749805|FG000|Overall Study|Lack of Efficacy|3|||
129941686|NCT03389802|467749806|FG001|Overall Study|Lack of Efficacy|3|||
129941687|NCT03389802|467749807|FG002|Overall Study|Lack of Efficacy|13|||
129941688|NCT03389802|467749808|FG003|Overall Study|Lack of Efficacy|6|||
129941689|NCT03389802|467749809|FG004|Overall Study|Lack of Efficacy|1|||
129941690|NCT03389802|467749805|FG000|Overall Study|Adverse Event|0|||
129941691|NCT03389802|467749806|FG001|Overall Study|Adverse Event|0|||
129941692|NCT03389802|467749807|FG002|Overall Study|Adverse Event|1|||
129941693|NCT03389802|467749808|FG003|Overall Study|Adverse Event|0|||
129941694|NCT03389802|467749809|FG004|Overall Study|Adverse Event|4|||
129941695|NCT03389802|467749805|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
129941696|NCT03389802|467749806|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
129941697|NCT03389802|467749807|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
129941698|NCT03389802|467749808|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
129941699|NCT03389802|467749809|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
129941700|NCT02426138|467749810|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129941701|NCT02426138|467749811|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129941702|NCT00274261|467749812|FG000|Overall Study|Adverse Event|19|||
129941703|NCT00274261|467749813|FG001|Overall Study|Adverse Event|11|||
129941704|NCT00274261|467749812|FG000|Overall Study|Pregnancy|114|||
129941705|NCT00274261|467749813|FG001|Overall Study|Pregnancy|83|||
129941706|NCT00274261|467749812|FG000|Overall Study|Withdrawal by Subject|179|||
129941707|NCT00274261|467749813|FG001|Overall Study|Withdrawal by Subject|126|||
129941708|NCT00274261|467749812|FG000|Overall Study|Protocol Violation|71|||
129941709|NCT00274261|467749813|FG001|Overall Study|Protocol Violation|42|||
129941710|NCT00274261|467749812|FG000|Overall Study|Lost to Follow-up|106|||
129941711|NCT00274261|467749813|FG001|Overall Study|Lost to Follow-up|75|||
129941712|NCT03362190|467749822|FG000|Overall Study|Adverse Event|0|||
129941713|NCT03362190|467749823|FG001|Overall Study|Adverse Event|0|||
129941714|NCT03362190|467749824|FG002|Overall Study|Adverse Event|0|||
129941715|NCT03362190|467749825|FG003|Overall Study|Adverse Event|1|||
129941716|NCT03362190|467749822|FG000|Overall Study|Withdrawal by Subject|0|||
129941717|NCT03362190|467749823|FG001|Overall Study|Withdrawal by Subject|0|||
129941718|NCT03362190|467749824|FG002|Overall Study|Withdrawal by Subject|0|||
129941719|NCT03362190|467749825|FG003|Overall Study|Withdrawal by Subject|1|||
129941720|NCT00687219|467749826|FG000|Overall Study|Adverse Event|8|||
129941721|NCT00687219|467749826|FG000|Overall Study|Discontinuance criteria met|7|||
129941722|NCT00687219|467749826|FG000|Overall Study|HCV-RNA positive conversion|34|||
129941723|NCT00687219|467749826|FG000|Overall Study|Withdrawal by Subject|1|||
129941724|NCT00687219|467749826|FG000|Overall Study|Lack of Efficacy|1|||
129941725|NCT01367236|467749827|FG000|Overall Study|Withdrawal by Subject|3|||
129941726|NCT01367236|467749828|FG001|Overall Study|Withdrawal by Subject|1|||
129941727|NCT02350634|467749831|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
129941728|NCT04827732|467749840|FG000|Overall Study|Did not start treatment|0|||
129941729|NCT04827732|467749841|FG001|Overall Study|Did not start treatment|1|||
129941730|NCT04827732|467749842|FG002|Overall Study|Did not start treatment|0|||
129941731|NCT04827732|467749843|FG003|Overall Study|Did not start treatment|1|||
129941732|NCT03414684|467749845|FG000|First-course Treatment|Complete response|0|||
129941733|NCT03414684|467749846|FG001|First-course Treatment|Complete response|1|||
129941734|NCT03414684|467749845|FG000|First-course Treatment|Intercurrent illness|1|||
129941735|NCT03414684|467749846|FG001|First-course Treatment|Intercurrent illness|0|||
129941736|NCT03414684|467749845|FG000|First-course Treatment|Progressive Disease|31|||
129941737|NCT03414684|467749846|FG001|First-course Treatment|Progressive Disease|32|||
129941738|NCT03414684|467749845|FG000|First-course Treatment|Adverse Event|1|||
129941739|NCT03414684|467749846|FG001|First-course Treatment|Adverse Event|2|||
129941740|NCT03414684|467749845|FG000|First-course Treatment|Physician Decision|0|||
129941741|NCT03414684|467749846|FG001|First-course Treatment|Physician Decision|1|||
129941742|NCT03414684|467749845|FG000|First-course Treatment|Withdrawal by Subject|0|||
129941743|NCT03414684|467749846|FG001|First-course Treatment|Withdrawal by Subject|1|||
129941744|NCT03414684|467749845|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
129941745|NCT03414684|467749846|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
129941746|NCT03414684|467749845|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
129941747|NCT03414684|467749846|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
129941748|NCT03414684|467749845|FG000|First-course Treatment|Still on treatment|3|||
129941749|NCT03414684|467749846|FG001|First-course Treatment|Still on treatment|0|||
129941750|NCT03414684|467749845|FG000|First-course Treatment|Never started protocol therapy|2|||
129941751|NCT03414684|467749846|FG001|First-course Treatment|Never started protocol therapy|1|||
129941752|NCT03414684|467749845|FG000|Crossover Treatment|Progressive disease|0|||
129941753|NCT03414684|467749846|FG001|Crossover Treatment|Progressive disease|12|||
129941754|NCT03414684|467749845|FG000|Crossover Treatment|Adverse Event|0|||
129941755|NCT03414684|467749846|FG001|Crossover Treatment|Adverse Event|3|||
129941756|NCT03414684|467749845|FG000|Crossover Treatment|Physician Decision|0|||
129941757|NCT03414684|467749846|FG001|Crossover Treatment|Physician Decision|1|||
129941758|NCT03414684|467749845|FG000|Crossover Treatment|Still on treatment|0|||
129941759|NCT03414684|467749846|FG001|Crossover Treatment|Still on treatment|2|||
129941760|NCT04038580|467749847|FG000|Washout 1|Death|0|||
129941761|NCT04038580|467749848|FG001|Washout 1|Death|0|||
129941762|NCT04038580|467749849|FG002|Washout 1|Death|0|||
129941763|NCT04038580|467749850|FG003|Washout 1|Death|1|||
129941764|NCT04038580|467749851|FG004|Washout 1|Death|0|||
129941765|NCT04038580|467749852|FG005|Washout 1|Death|0|||
129941766|NCT04038580|467749847|FG000|Washout 1|Withdrawal by Subject|0|||
129941767|NCT04038580|467749848|FG001|Washout 1|Withdrawal by Subject|0|||
129941768|NCT04038580|467749849|FG002|Washout 1|Withdrawal by Subject|0|||
129941769|NCT04038580|467749850|FG003|Washout 1|Withdrawal by Subject|0|||
129941770|NCT04038580|467749851|FG004|Washout 1|Withdrawal by Subject|1|||
129941771|NCT04038580|467749852|FG005|Washout 1|Withdrawal by Subject|0|||
129941772|NCT04038580|467749847|FG000|Wash-out 2|Withdrawal by Subject|1|||
129941773|NCT04038580|467749848|FG001|Wash-out 2|Withdrawal by Subject|0|||
129941774|NCT04038580|467749849|FG002|Wash-out 2|Withdrawal by Subject|0|||
129941775|NCT04038580|467749850|FG003|Wash-out 2|Withdrawal by Subject|2|||
129941776|NCT04038580|467749851|FG004|Wash-out 2|Withdrawal by Subject|0|||
129941777|NCT04038580|467749852|FG005|Wash-out 2|Withdrawal by Subject|1|||
129941778|NCT04038580|467749847|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
129941779|NCT04038580|467749848|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
129941780|NCT04038580|467749849|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
129941781|NCT04038580|467749850|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
129941782|NCT04038580|467749851|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
129941783|NCT04038580|467749852|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
129941784|NCT04038580|467749847|FG000|Wash-out 3|Withdrawal by Subject|1|||
129941785|NCT04038580|467749848|FG001|Wash-out 3|Withdrawal by Subject|0|||
129941786|NCT04038580|467749849|FG002|Wash-out 3|Withdrawal by Subject|2|||
129941787|NCT04038580|467749850|FG003|Wash-out 3|Withdrawal by Subject|0|||
129941788|NCT04038580|467749851|FG004|Wash-out 3|Withdrawal by Subject|0|||
129941789|NCT04038580|467749852|FG005|Wash-out 3|Withdrawal by Subject|0|||
129941790|NCT04577651|467749857|FG000|Overall Study|Screen Failure|7|||
129941791|NCT04577651|467749857|FG000|Overall Study|Adverse Event|1|||
129941792|NCT04577651|467749857|FG000|Overall Study|Death|1|||
129941793|NCT04577651|467749857|FG000|Overall Study|Physician Decision|1|||
129941794|NCT04577651|467749857|FG000|Overall Study|Withdrawal by Subject|3|||
129941795|NCT02278796|467750687|FG000|Overall Study|Death|2|||
129941796|NCT02278796|467750688|FG001|Overall Study|Death|3|||
129941797|NCT00357994|467750689|FG000|Overall Study|Adverse Event|1|||
129941798|NCT00357994|467750690|FG001|Overall Study|Adverse Event|2|||
129941799|NCT00357994|467750689|FG000|Overall Study|Lack of Efficacy|0|||
129941800|NCT00357994|467750690|FG001|Overall Study|Lack of Efficacy|1|||
129941801|NCT00357994|467750689|FG000|Overall Study|Protocol Violation|1|||
129941802|NCT00357994|467750690|FG001|Overall Study|Protocol Violation|0|||
129941803|NCT01613417|467750691|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
129941804|NCT01613417|467750692|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
129941805|NCT00512252|467750693|FG000|Overall Study|Lost to Follow-up|0|||
129941806|NCT00512252|467750694|FG001|Overall Study|Lost to Follow-up|0|||
129941807|NCT00512252|467750695|FG002|Overall Study|Lost to Follow-up|1|||
129941808|NCT00512252|467750693|FG000|Overall Study|Protocol Violation|0|||
129941809|NCT00512252|467750694|FG001|Overall Study|Protocol Violation|0|||
129941810|NCT00512252|467750695|FG002|Overall Study|Protocol Violation|1|||
129941811|NCT00512252|467750693|FG000|Overall Study|Death|0|||
129941812|NCT00512252|467750694|FG001|Overall Study|Death|0|||
129941813|NCT00512252|467750695|FG002|Overall Study|Death|1|||
129941814|NCT00705406|467750696|FG000|Overall Study|Lost to Follow-up|3|||
129941815|NCT00705406|467750697|FG001|Overall Study|Lost to Follow-up|3|||
129941816|NCT00705406|467750696|FG000|Overall Study|Did not receive study drug|1|||
129941817|NCT00705406|467750697|FG001|Overall Study|Did not receive study drug|2|||
129941818|NCT02357966|467750698|FG000|Overall Study|Death|0|||
129941819|NCT02357966|467750699|FG001|Overall Study|Death|0|||
129941820|NCT02357966|467750700|FG002|Overall Study|Death|1|||
129941821|NCT02357966|467750701|FG003|Overall Study|Death|0|||
129941822|NCT02357966|467750702|FG004|Overall Study|Death|2|||
129941823|NCT02357966|467750703|FG005|Overall Study|Death|0|||
129941824|NCT02357966|467750698|FG000|Overall Study|Physician Decision|1|||
129941825|NCT02357966|467750699|FG001|Overall Study|Physician Decision|0|||
129941826|NCT02357966|467750700|FG002|Overall Study|Physician Decision|0|||
129941827|NCT02357966|467750701|FG003|Overall Study|Physician Decision|0|||
129941828|NCT02357966|467750702|FG004|Overall Study|Physician Decision|1|||
129941829|NCT02357966|467750703|FG005|Overall Study|Physician Decision|0|||
129941830|NCT04652726|467750710|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
129941831|NCT04652726|467750711|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
129941832|NCT04652726|467750712|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
129941833|NCT04652726|467750710|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
129941834|NCT04652726|467750711|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
129941835|NCT04652726|467750712|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
129941836|NCT02157116|467750713|FG000|Overall Study|Withdrawal by Subject|4|||
129941837|NCT02157116|467750713|FG000|Overall Study|Physician Decision|3|||
129941838|NCT02157116|467750713|FG000|Overall Study|Failed Screening|2|||
129941839|NCT00093496|467750714|FG000|Overall Study|Protocol Violation|1|||
129941840|NCT00093496|467750715|FG001|Overall Study|Protocol Violation|3|||
129941841|NCT05014412|467750718|FG000|Overall Study|Death|11|||
129941842|NCT05014412|467750719|FG001|Overall Study|Death|7|||
129941843|NCT05014412|467750720|FG002|Overall Study|Death|4|||
129941844|NCT05014412|467750721|FG003|Overall Study|Death|7|||
129941845|NCT05014412|467750718|FG000|Overall Study|Withdrawal by Subject|1|||
129941846|NCT05014412|467750719|FG001|Overall Study|Withdrawal by Subject|1|||
129941847|NCT05014412|467750720|FG002|Overall Study|Withdrawal by Subject|1|||
129941848|NCT05014412|467750721|FG003|Overall Study|Withdrawal by Subject|2|||
129941849|NCT05014412|467750718|FG000|Overall Study|Ongoing|21|||
129941850|NCT05014412|467750719|FG001|Overall Study|Ongoing|4|||
129941851|NCT05014412|467750720|FG002|Overall Study|Ongoing|6|||
129941852|NCT05014412|467750721|FG003|Overall Study|Ongoing|20|||
129941853|NCT02101775|467750722|FG000|Overall Study|Adverse Event|4|||
129941854|NCT02101775|467750723|FG001|Overall Study|Adverse Event|0|||
129941855|NCT02101775|467750724|FG002|Overall Study|Adverse Event|0|||
129941856|NCT02101775|467750722|FG000|Overall Study|Admission to Hospital|0|||
129941857|NCT02101775|467750723|FG001|Overall Study|Admission to Hospital|1|||
129941858|NCT02101775|467750724|FG002|Overall Study|Admission to Hospital|0|||
129941859|NCT01886872|467750727|FG000|Overall Study|Ineligible|7|||
129941860|NCT01886872|467750728|FG001|Overall Study|Ineligible|4|||
129941861|NCT01886872|467750729|FG002|Overall Study|Ineligible|12|||
129941862|NCT04941482|467750730|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
129941863|NCT04941482|467750731|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
129941864|NCT04200664|467750732|FG000|Overall Study|Withdrawal by Subject|1|||
129941865|NCT04200664|467750733|FG001|Overall Study|Withdrawal by Subject|0|||
129941866|NCT04200664|467750734|FG002|Overall Study|Withdrawal by Subject|0|||
129941867|NCT02744066|467750739|FG000|Overall Study|Withdrawal by parent|0|||
129941868|NCT02744066|467750740|FG001|Overall Study|Withdrawal by parent|1|||
129941869|NCT02744066|467750739|FG000|Overall Study|Discharged from NICU prior to completion|0|||
129941870|NCT02744066|467750740|FG001|Overall Study|Discharged from NICU prior to completion|4|||
129941871|NCT02454959|467750741|FG000|Overall Study|Protocol-Specified Criteria|3|||
129941872|NCT02454959|467750741|FG000|Overall Study|Physician Decision|1|||
129941873|NCT02454959|467750741|FG000|Overall Study|Withdrawal by Subject|3|||
129941874|NCT02454959|467750741|FG000|Overall Study|Adverse Event|2|||
129941875|NCT04745676|467750742|FG000|Overall Study|Death|1|||
129941876|NCT04745676|467750743|FG001|Overall Study|Death|0|||
129941877|NCT04745676|467750744|FG002|Overall Study|Death|0|||
129941878|NCT05810285|467750756|FG000|Overall Study|Death|4|||
129941879|NCT05810285|467750757|FG001|Overall Study|Death|21|||
129941880|NCT05810285|467750756|FG000|Overall Study|Adverse Event|18|||
129941881|NCT05810285|467750757|FG001|Overall Study|Adverse Event|16|||
129941882|NCT03945773|467752084|FG000|Overall Study|Consent Withdrawn|1|||
129941883|NCT03945773|467752085|FG001|Overall Study|Consent Withdrawn|1|||
129941884|NCT03945773|467752084|FG000|Overall Study|Lost to Follow-up|1|||
129941885|NCT03945773|467752085|FG001|Overall Study|Lost to Follow-up|0|||
129941886|NCT03945773|467752084|FG000|Overall Study|Death|46|||
129941887|NCT03945773|467752085|FG001|Overall Study|Death|22|||
129941888|NCT03945773|467752084|FG000|Overall Study|Physician Decision|1|||
129941889|NCT03945773|467752085|FG001|Overall Study|Physician Decision|0|||
129941890|NCT03945773|467752084|FG000|Overall Study|Other|1|||
129941891|NCT03945773|467752085|FG001|Overall Study|Other|0|||
129941892|NCT03945773|467752084|FG000|Overall Study|Ongoing at the time of DCO|4|||
129941893|NCT03945773|467752085|FG001|Overall Study|Ongoing at the time of DCO|3|||
129941894|NCT01372085|467752092|FG000|Washout Period 2|Physician Decision|0|||
129941895|NCT01372085|467752093|FG001|Washout Period 2|Physician Decision|0|||
129941896|NCT01372085|467752094|FG002|Washout Period 2|Physician Decision|0|||
129941897|NCT01372085|467752095|FG003|Washout Period 2|Physician Decision|0|||
129941898|NCT01372085|467752096|FG004|Washout Period 2|Physician Decision|1|||
129941899|NCT01372085|467752097|FG005|Washout Period 2|Physician Decision|0|||
129941900|NCT01372085|467752098|FG006|Washout Period 2|Physician Decision|0|||
129941901|NCT01372085|467752099|FG007|Washout Period 2|Physician Decision|0|||
129941902|NCT01372085|467752100|FG008|Washout Period 2|Physician Decision|0|||
129941903|NCT01372085|467752101|FG009|Washout Period 2|Physician Decision|0|||
129941904|NCT01372085|467752092|FG000|Washout Period 3|Withdrawal by Subject|0|||
129941905|NCT01372085|467752093|FG001|Washout Period 3|Withdrawal by Subject|0|||
129941906|NCT01372085|467752094|FG002|Washout Period 3|Withdrawal by Subject|0|||
129941907|NCT01372085|467752095|FG003|Washout Period 3|Withdrawal by Subject|0|||
129941908|NCT01372085|467752096|FG004|Washout Period 3|Withdrawal by Subject|0|||
129941909|NCT01372085|467752097|FG005|Washout Period 3|Withdrawal by Subject|2|||
129941910|NCT01372085|467752098|FG006|Washout Period 3|Withdrawal by Subject|0|||
129941911|NCT01372085|467752099|FG007|Washout Period 3|Withdrawal by Subject|0|||
129941912|NCT01372085|467752100|FG008|Washout Period 3|Withdrawal by Subject|0|||
129941913|NCT01372085|467752101|FG009|Washout Period 3|Withdrawal by Subject|0|||
129941914|NCT02824198|467752102|FG000|Overall Study|Non-compliance with the protocol|5|||
129941915|NCT02824198|467752103|FG001|Overall Study|Non-compliance with the protocol|1|||
129941916|NCT02824198|467752102|FG000|Overall Study|Lost to Follow-up|5|||
129941917|NCT02824198|467752103|FG001|Overall Study|Lost to Follow-up|2|||
129941918|NCT02824198|467752102|FG000|Overall Study|Withdrawal by Subject|5|||
130071517|NCT03136367|468216147|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
130071518|NCT03136367|468216148|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
129941919|NCT02824198|467752103|FG001|Overall Study|Withdrawal by Subject|0|||
129941920|NCT01079806|467752106|FG000|Day 1 to Week 96|Adverse Event|0|||
129941921|NCT01079806|467752107|FG001|Day 1 to Week 96|Adverse Event|3|||
129941922|NCT01079806|467752106|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
129941923|NCT01079806|467752107|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
129941924|NCT01079806|467752106|FG000|Day 1 to Week 96|Pregnancy|0|||
129941925|NCT01079806|467752107|FG001|Day 1 to Week 96|Pregnancy|1|||
129941926|NCT01079806|467752106|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
129941927|NCT01079806|467752107|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
129941928|NCT01079806|467752106|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
129941929|NCT01079806|467752107|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
129941930|NCT01079806|467752106|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
129941931|NCT01079806|467752107|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
129941932|NCT01079806|467752106|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
129941933|NCT01079806|467752107|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
129941934|NCT01079806|467752106|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
129941935|NCT01079806|467752107|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
129941936|NCT01079806|467752106|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
129941937|NCT01079806|467752107|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
129941938|NCT01079806|467752106|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
129941939|NCT01079806|467752107|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
129941940|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
129941941|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
129941942|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
129941943|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
129941944|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
129941945|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
129941946|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
129941947|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
129941948|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129941949|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
129941950|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
129941951|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
129941952|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129941953|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129941954|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
129941955|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
129941956|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
129941957|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
129941958|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
129941959|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
129941960|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
129941961|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
129941962|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
129941963|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
129941964|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
129941965|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
129941966|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
129941967|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
129941968|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
129941969|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
130120172|NCT00409578|468400229|FG002|Overall Study|Abnormal laboratory value(s)|2|||
130120173|NCT00409578|468400230|FG003|Overall Study|Abnormal laboratory value(s)|4|||
130120174|NCT00409578|468400227|FG000|Overall Study|Lack of Efficacy|0|||
130120175|NCT00409578|468400228|FG001|Overall Study|Lack of Efficacy|0|||
130120176|NCT00409578|468400229|FG002|Overall Study|Lack of Efficacy|0|||
130120177|NCT00409578|468400230|FG003|Overall Study|Lack of Efficacy|2|||
130120178|NCT00409578|468400227|FG000|Overall Study|Subject no longer requires study drug|0|||
130120179|NCT00409578|468400228|FG001|Overall Study|Subject no longer requires study drug|0|||
130120180|NCT00409578|468400229|FG002|Overall Study|Subject no longer requires study drug|0|||
129941970|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941971|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941972|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941973|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941974|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941975|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941976|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941977|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941978|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941979|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129941980|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129941981|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
129941982|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941983|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941984|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941985|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941986|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941987|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
129941988|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941989|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
129941990|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
129941991|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
129941992|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
129941993|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
129941994|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
129941995|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
129941996|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
129941997|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
129941998|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
129941999|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
129942000|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
129942001|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
129942002|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
129942003|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
129942004|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
129942005|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
129942006|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
129942007|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
129942008|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
129942009|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
129942010|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942011|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
129942012|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942013|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942014|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942015|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942016|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942017|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942018|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
129942019|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942020|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
129942021|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
129942022|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942023|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942024|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
129942025|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
129942026|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942027|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942028|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
129942029|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942030|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942031|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
129942032|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
129942033|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
129942034|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
129942035|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
129942036|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
130120181|NCT00409578|468400230|FG003|Overall Study|Subject no longer requires study drug|1|||
130120182|NCT00409578|468400227|FG000|Overall Study|Withdrawal by Subject|8|||
130120183|NCT00409578|468400228|FG001|Overall Study|Withdrawal by Subject|15|||
130120184|NCT00409578|468400229|FG002|Overall Study|Withdrawal by Subject|16|||
130120185|NCT00409578|468400230|FG003|Overall Study|Withdrawal by Subject|17|||
130120186|NCT00409578|468400227|FG000|Overall Study|Lost to Follow-up|2|||
130120187|NCT00409578|468400228|FG001|Overall Study|Lost to Follow-up|0|||
130120188|NCT00409578|468400229|FG002|Overall Study|Lost to Follow-up|2|||
129942037|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
129942038|NCT01779700|467752115|FG000|Overall Study|Adverse Event|4|||
129942039|NCT01779700|467752116|FG001|Overall Study|Adverse Event|3|||
129942040|NCT01779700|467752115|FG000|Overall Study|Withdrawal by Subject|0|||
129942041|NCT01779700|467752116|FG001|Overall Study|Withdrawal by Subject|2|||
129942042|NCT00019604|467752117|FG000|Overall Study|Death|1|||
129942043|NCT00019604|467752117|FG000|Overall Study|Progressive disease|23|||
129942044|NCT00019604|467752117|FG000|Overall Study|Refused treatment|1|||
129942045|NCT00019604|467752117|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
129942046|NCT00019604|467752117|FG000|Overall Study|Going to have liver transplant|1|||
129942047|NCT00019604|467752117|FG000|Overall Study|Move to a different study|1|||
129942048|NCT00019604|467752117|FG000|Overall Study|Non compliant on systemic CH|1|||
129942049|NCT00019604|467752117|FG000|Overall Study|Non compliant|1|||
129942050|NCT00019604|467752117|FG000|Overall Study|Resectable disease|1|||
129942051|NCT00019604|467752117|FG000|Overall Study|Started new chemo regimen|1|||
129942052|NCT00019604|467752117|FG000|Overall Study|Pt going to immunotherapy study|1|||
129942053|NCT00019604|467752117|FG000|Overall Study|Too much disease|1|||
129942054|NCT00019604|467752117|FG000|Overall Study|Unable to evaluate|1|||
129942055|NCT00019604|467752117|FG000|Overall Study|Details for other not available|4|||
129942056|NCT00734578|467752120|FG000|Overall Study|Adverse Event|4|||
129942057|NCT00734578|467752121|FG001|Overall Study|Adverse Event|6|||
129942058|NCT00734578|467752122|FG002|Overall Study|Adverse Event|1|||
129942059|NCT00734578|467752120|FG000|Overall Study|Protocol Violation|8|||
129942060|NCT00734578|467752121|FG001|Overall Study|Protocol Violation|6|||
129942061|NCT00734578|467752122|FG002|Overall Study|Protocol Violation|3|||
129942062|NCT00734578|467752120|FG000|Overall Study|Withdrawal by Subject|7|||
129942063|NCT00734578|467752121|FG001|Overall Study|Withdrawal by Subject|8|||
129942064|NCT00734578|467752122|FG002|Overall Study|Withdrawal by Subject|11|||
129942065|NCT00734578|467752120|FG000|Overall Study|Lost to Follow-up|9|||
129942066|NCT00734578|467752121|FG001|Overall Study|Lost to Follow-up|3|||
129942067|NCT00734578|467752122|FG002|Overall Study|Lost to Follow-up|5|||
129942068|NCT00734578|467752120|FG000|Overall Study|Lack of Efficacy|3|||
129942069|NCT00734578|467752121|FG001|Overall Study|Lack of Efficacy|2|||
129942070|NCT00734578|467752122|FG002|Overall Study|Lack of Efficacy|5|||
129942071|NCT00734578|467752120|FG000|Overall Study|Randomized in error|1|||
129942072|NCT00734578|467752121|FG001|Overall Study|Randomized in error|0|||
129942073|NCT00734578|467752122|FG002|Overall Study|Randomized in error|0|||
129942074|NCT00734578|467752120|FG000|Overall Study|Exclusion criteria|1|||
129942075|NCT00734578|467752121|FG001|Overall Study|Exclusion criteria|0|||
129942076|NCT00734578|467752122|FG002|Overall Study|Exclusion criteria|0|||
129942077|NCT02085941|467752126|FG000|Overall Study|Lack of Efficacy|1|||
129942078|NCT02085941|467752127|FG001|Overall Study|Lack of Efficacy|0|||
129942079|NCT02085941|467752126|FG000|Overall Study|Death|6|||
129942080|NCT02085941|467752127|FG001|Overall Study|Death|1|||
129942081|NCT02085941|467752126|FG000|Overall Study|Lost to Follow-up|1|||
129942082|NCT02085941|467752127|FG001|Overall Study|Lost to Follow-up|0|||
129942083|NCT02085941|467752126|FG000|Overall Study|Physician Decision|0|||
129942084|NCT02085941|467752127|FG001|Overall Study|Physician Decision|2|||
129942085|NCT03499964|467752128|FG000|Overall Study|Lack of Efficacy|6|||
129942086|NCT03499964|467752129|FG001|Overall Study|Lack of Efficacy|26|||
129942087|NCT03499964|467752128|FG000|Overall Study|Adverse Event|1|||
129942088|NCT03499964|467752129|FG001|Overall Study|Adverse Event|0|||
129942089|NCT03499964|467752128|FG000|Overall Study|Death|1|||
130120189|NCT00409578|468400230|FG003|Overall Study|Lost to Follow-up|2|||
129942090|NCT03499964|467752129|FG001|Overall Study|Death|0|||
129942091|NCT03499964|467752128|FG000|Overall Study|Withdrawal by Subject|2|||
129942092|NCT03499964|467752129|FG001|Overall Study|Withdrawal by Subject|1|||
129942093|NCT03499964|467752128|FG000|Overall Study|Lost to Follow-up|1|||
129942094|NCT03499964|467752129|FG001|Overall Study|Lost to Follow-up|0|||
129942095|NCT03274076|467752132|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
129942096|NCT03274076|467752133|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
129942097|NCT03274076|467752134|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
129942098|NCT03274076|467752135|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
129942099|NCT03274076|467752132|FG000|24 Weeks Open Label|Adverse Event|0|||
129942100|NCT03274076|467752133|FG001|24 Weeks Open Label|Adverse Event|0|||
129942101|NCT03274076|467752134|FG002|24 Weeks Open Label|Adverse Event|2|||
129942102|NCT03274076|467752135|FG003|24 Weeks Open Label|Adverse Event|0|||
129942103|NCT03274076|467752132|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
129942104|NCT03274076|467752133|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
129942105|NCT03274076|467752134|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
129942106|NCT03274076|467752135|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
129942107|NCT00975585|467752136|FG000|Overall Study|Adverse Event|0|||
129942108|NCT00975585|467752137|FG001|Overall Study|Adverse Event|4|||
129942109|NCT00975585|467752136|FG000|Overall Study|Lost to Follow-up|3|||
129942110|NCT00975585|467752137|FG001|Overall Study|Lost to Follow-up|5|||
129942111|NCT00975585|467752136|FG000|Overall Study|Withdrawal by Subject|2|||
129942112|NCT00975585|467752137|FG001|Overall Study|Withdrawal by Subject|1|||
129942113|NCT00975585|467752136|FG000|Overall Study|Lens issue|2|||
129942114|NCT00975585|467752137|FG001|Overall Study|Lens issue|2|||
129942115|NCT00795184|467752138|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
129942116|NCT00795184|467752139|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
129942117|NCT00683800|467752141|FG000|Overall Study|Adverse Event|195|||
129942118|NCT00683800|467752142|FG001|Overall Study|Adverse Event|102|||
129942119|NCT00683800|467752141|FG000|Overall Study|Death|0|||
129942120|NCT00683800|467752142|FG001|Overall Study|Death|1|||
129942121|NCT00683800|467752141|FG000|Overall Study|Lost to Follow-up|57|||
129942122|NCT00683800|467752142|FG001|Overall Study|Lost to Follow-up|44|||
129942123|NCT00683800|467752141|FG000|Overall Study|Other|5|||
129942124|NCT00683800|467752142|FG001|Overall Study|Other|2|||
129942125|NCT00683800|467752141|FG000|Overall Study|Protocol Violation|13|||
129942126|NCT00683800|467752142|FG001|Overall Study|Protocol Violation|16|||
129942127|NCT00683800|467752141|FG000|Overall Study|Withdrawal by Subject|66|||
129942128|NCT00683800|467752142|FG001|Overall Study|Withdrawal by Subject|64|||
129942129|NCT00683800|467752141|FG000|Overall Study|Lack of Efficacy|61|||
129942130|NCT00683800|467752142|FG001|Overall Study|Lack of Efficacy|104|||
129942131|NCT00683800|467752141|FG000|Overall Study|Randomized, not treated|35|||
129942132|NCT00683800|467752142|FG001|Overall Study|Randomized, not treated|33|||
129942133|NCT00205179|467752145|FG000|Overall Study|Death|0|||
129942134|NCT00205179|467752146|FG001|Overall Study|Death|2|||
129942135|NCT00205179|467752145|FG000|Overall Study|Physician Decision|1|||
129942136|NCT00205179|467752146|FG001|Overall Study|Physician Decision|1|||
129942137|NCT00205179|467752145|FG000|Overall Study|Adverse Event|1|||
129942138|NCT00205179|467752146|FG001|Overall Study|Adverse Event|1|||
129942139|NCT00586313|467752147|FG000|Overall Study|Lack of Efficacy|2|||
129942140|NCT02079649|467752150|FG000|Overall Study|Lost to Follow-up|0|||
129942141|NCT02079649|467752151|FG001|Overall Study|Lost to Follow-up|0|||
129942142|NCT02079649|467752152|FG002|Overall Study|Lost to Follow-up|0|||
129942143|NCT02079649|467752153|FG003|Overall Study|Lost to Follow-up|1|||
129942144|NCT02079649|467752150|FG000|Overall Study|Withdrawal by Subject|0|||
129942145|NCT02079649|467752151|FG001|Overall Study|Withdrawal by Subject|0|||
129942146|NCT02079649|467752152|FG002|Overall Study|Withdrawal by Subject|0|||
129942147|NCT02079649|467752153|FG003|Overall Study|Withdrawal by Subject|1|||
129942148|NCT02079649|467752150|FG000|Overall Study|Randomization error (prior to treatment)|1|||
129942149|NCT02079649|467752151|FG001|Overall Study|Randomization error (prior to treatment)|0|||
129942150|NCT02079649|467752152|FG002|Overall Study|Randomization error (prior to treatment)|1|||
129942151|NCT02079649|467752153|FG003|Overall Study|Randomization error (prior to treatment)|0|||
129942152|NCT01953692|467752156|FG000|Overall Study|Adverse Event|5|||
129942153|NCT01953692|467752157|FG001|Overall Study|Adverse Event|2|||
129942154|NCT01953692|467752158|FG002|Overall Study|Adverse Event|4|||
129942155|NCT01953692|467752159|FG003|Overall Study|Adverse Event|2|||
129942156|NCT01953692|467752160|FG004|Overall Study|Adverse Event|1|||
129942157|NCT01953692|467752161|FG005|Overall Study|Adverse Event|2|||
129942158|NCT01953692|467752162|FG006|Overall Study|Adverse Event|0|||
129942159|NCT01953692|467752163|FG007|Overall Study|Adverse Event|0|||
129942160|NCT01953692|467752164|FG008|Overall Study|Adverse Event|0|||
129942161|NCT01953692|467752156|FG000|Overall Study|Clinical Progression|0|||
129942162|NCT01953692|467752157|FG001|Overall Study|Clinical Progression|15|||
129942163|NCT01953692|467752158|FG002|Overall Study|Clinical Progression|7|||
129942164|NCT01953692|467752159|FG003|Overall Study|Clinical Progression|5|||
129942165|NCT01953692|467752160|FG004|Overall Study|Clinical Progression|0|||
129942166|NCT01953692|467752161|FG005|Overall Study|Clinical Progression|7|||
129942167|NCT01953692|467752162|FG006|Overall Study|Clinical Progression|20|||
129942168|NCT01953692|467752163|FG007|Overall Study|Clinical Progression|3|||
129942169|NCT01953692|467752164|FG008|Overall Study|Clinical Progression|3|||
129942170|NCT01953692|467752156|FG000|Overall Study|Death|5|||
129942171|NCT01953692|467752157|FG001|Overall Study|Death|0|||
129942172|NCT01953692|467752158|FG002|Overall Study|Death|2|||
129942173|NCT01953692|467752159|FG003|Overall Study|Death|2|||
129942174|NCT01953692|467752160|FG004|Overall Study|Death|1|||
129942175|NCT01953692|467752161|FG005|Overall Study|Death|3|||
129942176|NCT01953692|467752162|FG006|Overall Study|Death|6|||
129942177|NCT01953692|467752163|FG007|Overall Study|Death|2|||
129942178|NCT01953692|467752164|FG008|Overall Study|Death|1|||
129942179|NCT01953692|467752156|FG000|Overall Study|Excluded Medication|1|||
129942180|NCT01953692|467752157|FG001|Overall Study|Excluded Medication|0|||
129942181|NCT01953692|467752158|FG002|Overall Study|Excluded Medication|0|||
129942182|NCT01953692|467752159|FG003|Overall Study|Excluded Medication|0|||
129942183|NCT01953692|467752160|FG004|Overall Study|Excluded Medication|0|||
129942184|NCT01953692|467752161|FG005|Overall Study|Excluded Medication|0|||
129942185|NCT01953692|467752162|FG006|Overall Study|Excluded Medication|0|||
129942186|NCT01953692|467752163|FG007|Overall Study|Excluded Medication|0|||
129942187|NCT01953692|467752164|FG008|Overall Study|Excluded Medication|0|||
129942188|NCT01953692|467752156|FG000|Overall Study|Lost to Follow-up|1|||
129942189|NCT01953692|467752157|FG001|Overall Study|Lost to Follow-up|0|||
129942190|NCT01953692|467752158|FG002|Overall Study|Lost to Follow-up|3|||
129942191|NCT01953692|467752159|FG003|Overall Study|Lost to Follow-up|1|||
129942192|NCT01953692|467752160|FG004|Overall Study|Lost to Follow-up|0|||
129942193|NCT01953692|467752161|FG005|Overall Study|Lost to Follow-up|1|||
129942194|NCT01953692|467752162|FG006|Overall Study|Lost to Follow-up|0|||
129942195|NCT01953692|467752163|FG007|Overall Study|Lost to Follow-up|0|||
129942196|NCT01953692|467752164|FG008|Overall Study|Lost to Follow-up|0|||
129942197|NCT01953692|467752156|FG000|Overall Study|Physician Decision|11|||
129942198|NCT01953692|467752157|FG001|Overall Study|Physician Decision|4|||
129942199|NCT01953692|467752158|FG002|Overall Study|Physician Decision|2|||
129942200|NCT01953692|467752159|FG003|Overall Study|Physician Decision|2|||
129942201|NCT01953692|467752160|FG004|Overall Study|Physician Decision|1|||
129942202|NCT01953692|467752161|FG005|Overall Study|Physician Decision|2|||
129942203|NCT01953692|467752162|FG006|Overall Study|Physician Decision|4|||
129942204|NCT01953692|467752163|FG007|Overall Study|Physician Decision|1|||
129942205|NCT01953692|467752164|FG008|Overall Study|Physician Decision|0|||
129942206|NCT01953692|467752156|FG000|Overall Study|Protocol Violation|0|||
129942207|NCT01953692|467752157|FG001|Overall Study|Protocol Violation|2|||
129942208|NCT01953692|467752158|FG002|Overall Study|Protocol Violation|1|||
129942209|NCT01953692|467752159|FG003|Overall Study|Protocol Violation|0|||
129942210|NCT01953692|467752160|FG004|Overall Study|Protocol Violation|0|||
129942211|NCT01953692|467752161|FG005|Overall Study|Protocol Violation|0|||
129942212|NCT01953692|467752162|FG006|Overall Study|Protocol Violation|0|||
129942213|NCT01953692|467752163|FG007|Overall Study|Protocol Violation|1|||
129942214|NCT01953692|467752164|FG008|Overall Study|Protocol Violation|0|||
129942215|NCT01953692|467752156|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942216|NCT01953692|467752157|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942217|NCT01953692|467752158|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942218|NCT01953692|467752159|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942219|NCT01953692|467752160|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942220|NCT01953692|467752161|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942221|NCT01953692|467752162|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942222|NCT01953692|467752163|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
129942223|NCT01953692|467752164|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942224|NCT01953692|467752156|FG000|Overall Study|Withdrawal by Subject|4|||
129942225|NCT01953692|467752157|FG001|Overall Study|Withdrawal by Subject|2|||
129942226|NCT01953692|467752158|FG002|Overall Study|Withdrawal by Subject|1|||
129942227|NCT01953692|467752159|FG003|Overall Study|Withdrawal by Subject|2|||
129942228|NCT01953692|467752160|FG004|Overall Study|Withdrawal by Subject|0|||
129942229|NCT01953692|467752161|FG005|Overall Study|Withdrawal by Subject|3|||
129942230|NCT01953692|467752162|FG006|Overall Study|Withdrawal by Subject|2|||
129942231|NCT01953692|467752163|FG007|Overall Study|Withdrawal by Subject|1|||
129942232|NCT01953692|467752164|FG008|Overall Study|Withdrawal by Subject|1|||
129942233|NCT01328496|467752173|FG000|Overall Study|Significant Change in Health Status|1|||
129942234|NCT01328496|467752174|FG001|Overall Study|Significant Change in Health Status|0|||
129942235|NCT05966155|467752175|FG000|Overall Study|Death|1|||
129942236|NCT05966155|467752176|FG001|Overall Study|Death|2|||
129942237|NCT05966155|467752175|FG000|Overall Study|Lost to Follow-up|63|||
129942238|NCT05966155|467752176|FG001|Overall Study|Lost to Follow-up|67|||
129942239|NCT05966155|467752175|FG000|Overall Study|Protocol Violation|1|||
129942240|NCT05966155|467752176|FG001|Overall Study|Protocol Violation|0|||
129942241|NCT05966155|467752175|FG000|Overall Study|Withdrawal by Subject|8|||
129942242|NCT05966155|467752176|FG001|Overall Study|Withdrawal by Subject|9|||
129942243|NCT05966155|467752175|FG000|Overall Study|Enrolled Erroneously|0|||
129942244|NCT05966155|467752176|FG001|Overall Study|Enrolled Erroneously|1|||
129942245|NCT05966155|467752175|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
129942246|NCT05966155|467752176|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
129942247|NCT02743819|467752177|FG000|Overall Study|Lack of Efficacy|5|||
129942248|NCT02743819|467752177|FG000|Overall Study|Death|2|||
129942249|NCT02743819|467752177|FG000|Overall Study|Adverse Event|1|||
129942250|NCT03582475|467752188|FG000|Treatment Period|Withdrawal by Subject|0|||
129942251|NCT03582475|467752189|FG001|Treatment Period|Withdrawal by Subject|1|||
129942252|NCT03582475|467752188|FG000|Follow-up Period|Withdrawal by Subject|0|||
129942253|NCT03582475|467752189|FG001|Follow-up Period|Withdrawal by Subject|1|||
129942254|NCT01706159|467752190|FG000|Overall Study|Withdrawal Criteria|2|||
129942255|NCT01706159|467752191|FG001|Overall Study|Withdrawal Criteria|1|||
129942256|NCT01706159|467752190|FG000|Overall Study|Unclassified|6|||
129942257|NCT01706159|467752191|FG001|Overall Study|Unclassified|1|||
129942258|NCT00553332|467752196|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
129942259|NCT03775486|467752197|FG000|Initial Therapy Phase|Other reason provided|0|||
129942260|NCT03775486|467752198|FG001|Initial Therapy Phase|Other reason provided|15|||
129942261|NCT03775486|467752197|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
129942262|NCT03775486|467752198|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
129942263|NCT03775486|467752197|FG000|Initial Therapy Phase|Protocol Violation|0|||
129942264|NCT03775486|467752198|FG001|Initial Therapy Phase|Protocol Violation|2|||
129942265|NCT03775486|467752197|FG000|Initial Therapy Phase|Adverse Event|0|||
129942266|NCT03775486|467752198|FG001|Initial Therapy Phase|Adverse Event|34|||
129942267|NCT03775486|467752197|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
129942268|NCT03775486|467752198|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
129942269|NCT03775486|467752197|FG000|Maintenance Phase|Withdrawal by Subject|13|||
129942270|NCT03775486|467752198|FG001|Maintenance Phase|Withdrawal by Subject|12|||
129942271|NCT03775486|467752197|FG000|Maintenance Phase|Death|44|||
129942272|NCT03775486|467752198|FG001|Maintenance Phase|Death|45|||
129942273|NCT02235298|467752200|FG000|Overall Study|Lost to Follow-up|6|||
129942274|NCT02235298|467752201|FG001|Overall Study|Lost to Follow-up|5|||
129942275|NCT02235298|467752200|FG000|Overall Study|Adverse Event|2|||
129942276|NCT02235298|467752201|FG001|Overall Study|Adverse Event|2|||
129942277|NCT02235298|467752200|FG000|Overall Study|Withdrawal by Subject|0|||
129942278|NCT02235298|467752201|FG001|Overall Study|Withdrawal by Subject|1|||
129942279|NCT03102034|467752202|FG000|Overall Study|Withdrawal by Subject|1|||
129942280|NCT03102034|467752203|FG001|Overall Study|Withdrawal by Subject|0|||
129942281|NCT01701401|467752206|FG000|Overall Study|Randomized But Not Treated|3|||
129942282|NCT01701401|467752207|FG001|Overall Study|Randomized But Not Treated|1|||
129942283|NCT01701401|467752208|FG002|Overall Study|Randomized But Not Treated|0|||
129942284|NCT01701401|467752209|FG003|Overall Study|Randomized But Not Treated|1|||
129942285|NCT01701401|467752206|FG000|Overall Study|Lost to Follow-up|5|||
129942286|NCT01701401|467752207|FG001|Overall Study|Lost to Follow-up|5|||
129942287|NCT01701401|467752208|FG002|Overall Study|Lost to Follow-up|1|||
129942288|NCT01701401|467752209|FG003|Overall Study|Lost to Follow-up|3|||
129942289|NCT01701401|467752206|FG000|Overall Study|Withdrew Consent|0|||
129942290|NCT01701401|467752207|FG001|Overall Study|Withdrew Consent|3|||
129942291|NCT01701401|467752208|FG002|Overall Study|Withdrew Consent|1|||
129942292|NCT01701401|467752209|FG003|Overall Study|Withdrew Consent|2|||
129942293|NCT01701401|467752206|FG000|Overall Study|Lack of Efficacy|1|||
129942294|NCT01701401|467752207|FG001|Overall Study|Lack of Efficacy|0|||
129942295|NCT01701401|467752208|FG002|Overall Study|Lack of Efficacy|2|||
129942296|NCT01701401|467752209|FG003|Overall Study|Lack of Efficacy|0|||
129942297|NCT01701401|467752206|FG000|Overall Study|Adverse Event|1|||
129942298|NCT01701401|467752207|FG001|Overall Study|Adverse Event|0|||
129942299|NCT01701401|467752208|FG002|Overall Study|Adverse Event|0|||
129942300|NCT01701401|467752209|FG003|Overall Study|Adverse Event|0|||
129942301|NCT01701401|467752206|FG000|Overall Study|Protocol Violation|0|||
129942302|NCT01701401|467752207|FG001|Overall Study|Protocol Violation|0|||
129942303|NCT01701401|467752208|FG002|Overall Study|Protocol Violation|1|||
129942304|NCT01701401|467752209|FG003|Overall Study|Protocol Violation|0|||
129942305|NCT05325294|467752212|FG000|Overall Study|Adverse Event|3|||
129942306|NCT05325294|467752213|FG001|Overall Study|Adverse Event|3|||
129942307|NCT05325294|467752212|FG000|Overall Study|Physician Decision|0|||
129942308|NCT05325294|467752213|FG001|Overall Study|Physician Decision|1|||
129942309|NCT05325294|467752212|FG000|Overall Study|Withdrawal by Subject|0|||
129942310|NCT05325294|467752213|FG001|Overall Study|Withdrawal by Subject|3|||
129942311|NCT05325294|467752212|FG000|Overall Study|Lost to Follow-up|1|||
129942312|NCT05325294|467752213|FG001|Overall Study|Lost to Follow-up|0|||
129942313|NCT05325294|467752212|FG000|Overall Study|Sponsor Request|0|||
129942314|NCT05325294|467752213|FG001|Overall Study|Sponsor Request|2|||
129942315|NCT00647387|467752214|FG000|Overall Study|Lost to Follow-up|6|||
129942316|NCT00647387|467752214|FG000|Overall Study|Unsuccessful implant|5|||
129942317|NCT00647387|467752214|FG000|Overall Study|Device explanted|3|||
129942318|NCT00647387|467752214|FG000|Overall Study|Other Reason|3|||
129942319|NCT00647387|467752214|FG000|Overall Study|Death|2|||
129942320|NCT02969356|467752215|FG000|Overall Study|Adverse Event|7|||
129942321|NCT02969356|467752215|FG000|Overall Study|Consent withdrawn|2|||
129942322|NCT02969356|467752215|FG000|Overall Study|Lost to Follow-up|3|||
129942323|NCT02969356|467752215|FG000|Overall Study|Did not need to be reinjected|6|||
129942324|NCT02969356|467752215|FG000|Overall Study|Personal reasons|5|||
129942325|NCT03147287|467752216|FG000|Overall Study|Randomized Not Treated|2|||
129942326|NCT03147287|467752217|FG001|Overall Study|Randomized Not Treated|1|||
129942327|NCT03147287|467752218|FG002|Overall Study|Randomized Not Treated|1|||
129942328|NCT03147287|467752216|FG000|Overall Study|Progressive Disease RECIST|31|||
129942329|NCT03147287|467752217|FG001|Overall Study|Progressive Disease RECIST|72|||
129942330|NCT03147287|467752218|FG002|Overall Study|Progressive Disease RECIST|32|||
129942331|NCT03147287|467752216|FG000|Overall Study|Progressive Disease not RECIST|13|||
129942332|NCT03147287|467752217|FG001|Overall Study|Progressive Disease not RECIST|21|||
129942333|NCT03147287|467752218|FG002|Overall Study|Progressive Disease not RECIST|13|||
129942334|NCT03147287|467752216|FG000|Overall Study|Physician Decision|1|||
129942335|NCT03147287|467752217|FG001|Overall Study|Physician Decision|2|||
129942336|NCT03147287|467752218|FG002|Overall Study|Physician Decision|1|||
129942337|NCT03147287|467752216|FG000|Overall Study|Intercurrent illness|0|||
129942338|NCT03147287|467752217|FG001|Overall Study|Intercurrent illness|1|||
129942339|NCT03147287|467752218|FG002|Overall Study|Intercurrent illness|0|||
129942340|NCT03147287|467752216|FG000|Overall Study|Withdrawal by Subject|2|||
129942341|NCT03147287|467752217|FG001|Overall Study|Withdrawal by Subject|3|||
129942342|NCT03147287|467752218|FG002|Overall Study|Withdrawal by Subject|2|||
129942343|NCT03147287|467752216|FG000|Overall Study|Patient Non-Compliance|0|||
129942344|NCT03147287|467752217|FG001|Overall Study|Patient Non-Compliance|2|||
129942345|NCT03147287|467752218|FG002|Overall Study|Patient Non-Compliance|0|||
129942346|NCT03147287|467752216|FG000|Overall Study|Patient moved|0|||
129942347|NCT03147287|467752217|FG001|Overall Study|Patient moved|1|||
129942348|NCT03147287|467752218|FG002|Overall Study|Patient moved|0|||
129942349|NCT03147287|467752216|FG000|Overall Study|Arm A crossover without PD|1|||
129942350|NCT03147287|467752217|FG001|Overall Study|Arm A crossover without PD|0|||
129942351|NCT03147287|467752218|FG002|Overall Study|Arm A crossover without PD|0|||
129942352|NCT03147287|467752216|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
129942353|NCT03147287|467752217|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
129942354|NCT03147287|467752218|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
129942355|NCT01970878|467753271|FG000|Overall Study|Withdrawal by Subject|11|||
129942356|NCT01970878|467753272|FG001|Overall Study|Withdrawal by Subject|10|||
129942357|NCT01970878|467753273|FG002|Overall Study|Withdrawal by Subject|14|||
129942358|NCT01970878|467753274|FG003|Overall Study|Withdrawal by Subject|7|||
129942359|NCT01970878|467753271|FG000|Overall Study|Lost to Follow-up|1|||
129942360|NCT01970878|467753272|FG001|Overall Study|Lost to Follow-up|3|||
129942361|NCT01970878|467753273|FG002|Overall Study|Lost to Follow-up|2|||
129942362|NCT01970878|467753274|FG003|Overall Study|Lost to Follow-up|4|||
129942363|NCT01970878|467753271|FG000|Overall Study|Administrative Reasons|1|||
129942364|NCT01970878|467753272|FG001|Overall Study|Administrative Reasons|0|||
129942365|NCT01970878|467753273|FG002|Overall Study|Administrative Reasons|0|||
129942366|NCT01970878|467753274|FG003|Overall Study|Administrative Reasons|4|||
129942367|NCT01970878|467753271|FG000|Overall Study|Lack of Efficacy|2|||
129942368|NCT01970878|467753272|FG001|Overall Study|Lack of Efficacy|1|||
129942369|NCT01970878|467753273|FG002|Overall Study|Lack of Efficacy|2|||
129942370|NCT01970878|467753274|FG003|Overall Study|Lack of Efficacy|0|||
129942371|NCT01970878|467753271|FG000|Overall Study|Adverse Event|12|||
129942372|NCT01970878|467753272|FG001|Overall Study|Adverse Event|7|||
129942373|NCT01970878|467753273|FG002|Overall Study|Adverse Event|4|||
129942374|NCT01970878|467753274|FG003|Overall Study|Adverse Event|3|||
129942375|NCT01970878|467753271|FG000|Overall Study|Protocol Specified Criteria|10|||
129942376|NCT01970878|467753272|FG001|Overall Study|Protocol Specified Criteria|4|||
129942377|NCT01970878|467753273|FG002|Overall Study|Protocol Specified Criteria|3|||
129942378|NCT01970878|467753274|FG003|Overall Study|Protocol Specified Criteria|6|||
129942379|NCT01970878|467753271|FG000|Overall Study|Physician Decision|0|||
129942380|NCT01970878|467753272|FG001|Overall Study|Physician Decision|1|||
129942381|NCT01970878|467753273|FG002|Overall Study|Physician Decision|1|||
129942382|NCT01970878|467753274|FG003|Overall Study|Physician Decision|0|||
129942383|NCT01970878|467753271|FG000|Overall Study|No Completion Status|0|||
129942384|NCT01970878|467753272|FG001|Overall Study|No Completion Status|1|||
129942385|NCT01970878|467753273|FG002|Overall Study|No Completion Status|0|||
129942386|NCT01970878|467753274|FG003|Overall Study|No Completion Status|0|||
129942387|NCT04926857|467753275|FG000|Overall Study|Withdrawal by Subject|40|||
129942388|NCT04926857|467753275|FG000|Overall Study|Death|9|||
129942389|NCT04926857|467753275|FG000|Overall Study|Study product no longer in use|44|||
129942390|NCT04926857|467753275|FG000|Overall Study|Inadequate data to address primary objective|16|||
130071519|NCT03136367|468216146|FG000|T3 1 Week After Surgery|other discontinued|2|||
130071520|NCT03136367|468216147|FG001|T3 1 Week After Surgery|other discontinued|4|||
130071521|NCT03136367|468216148|FG002|T3 1 Week After Surgery|other discontinued|3|||
130071522|NCT03136367|468216146|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
129942391|NCT00089609|467753278|FG000|Overall Study|Withdrawal by Subject|3|||
129942392|NCT00089609|467753279|FG001|Overall Study|Withdrawal by Subject|1|||
129942393|NCT00747006|467753281|FG000|Overall Study|Adverse Event|1|||
129942394|NCT00747006|467753282|FG001|Overall Study|Adverse Event|0|||
129942395|NCT00747006|467753283|FG002|Overall Study|Adverse Event|0|||
129942396|NCT00747006|467753281|FG000|Overall Study|Lost to Follow-up|0|||
129942397|NCT00747006|467753282|FG001|Overall Study|Lost to Follow-up|1|||
129942398|NCT00747006|467753283|FG002|Overall Study|Lost to Follow-up|0|||
129942399|NCT00747006|467753281|FG000|Overall Study|Physician Decision|2|||
129942400|NCT00747006|467753282|FG001|Overall Study|Physician Decision|0|||
129942401|NCT00747006|467753283|FG002|Overall Study|Physician Decision|1|||
129942402|NCT03689946|467753284|FG000|Overall Study|Withdrawal by Subject|3|||
129942403|NCT03689946|467753284|FG000|Overall Study|Lost to Follow-up|3|||
129942404|NCT03689946|467753284|FG000|Overall Study|Data corruption|2|||
129942405|NCT04608409|467753287|FG000|Overall Study|Physician Decision|1|||
129942406|NCT04608409|467753288|FG001|Overall Study|Physician Decision|1|||
129942407|NCT04608409|467753289|FG002|Overall Study|Physician Decision|2|||
129942408|NCT00599196|467753290|FG000|Overall Study|Lack of Efficacy|22|||
129942409|NCT00599196|467753290|FG000|Overall Study|Adverse Event|93|||
129942410|NCT00599196|467753290|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
129942411|NCT00599196|467753290|FG000|Overall Study|Subject withdrew consent|43|||
129942412|NCT00599196|467753290|FG000|Overall Study|Study ended per sponsor|197|||
129942413|NCT00599196|467753290|FG000|Overall Study|Lost to Follow-up|17|||
129942414|NCT00599196|467753290|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
129942415|NCT00599196|467753290|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
129942416|NCT00599196|467753290|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
129942417|NCT00599196|467753290|FG000|Overall Study|Other: Pt Moved To Australia|1|||
129942418|NCT00599196|467753290|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
129942419|NCT00599196|467753290|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
129942420|NCT04497415|467753308|FG000|Overall Study|Lost to Follow-up|43|||
129942421|NCT04497415|467753309|FG001|Overall Study|Lost to Follow-up|27|||
129942422|NCT00853580|467753313|FG000|Overall Study|Lost to Follow-up|3|||
129942423|NCT00853580|467753314|FG001|Overall Study|Lost to Follow-up|5|||
129942424|NCT00853580|467753313|FG000|Overall Study|Protocol Violation|2|||
129942425|NCT00853580|467753314|FG001|Overall Study|Protocol Violation|1|||
129942426|NCT00853580|467753313|FG000|Overall Study|Withdrawal by Subject|2|||
129942427|NCT00853580|467753314|FG001|Overall Study|Withdrawal by Subject|8|||
129942428|NCT00853580|467753313|FG000|Overall Study|Commenced contraindicated therapy|0|||
129942429|NCT00853580|467753314|FG001|Overall Study|Commenced contraindicated therapy|2|||
129942430|NCT01700205|467753315|FG000|Overall Study|Withdrawal by Subject|13|||
129942431|NCT01700205|467753316|FG001|Overall Study|Withdrawal by Subject|13|||
129942432|NCT01700205|467753315|FG000|Overall Study|Protocol Violation|2|||
129942433|NCT01700205|467753316|FG001|Overall Study|Protocol Violation|2|||
129942434|NCT00388726|467753319|FG000|Overall Study|Adverse Event|50|||
129942435|NCT00388726|467753320|FG001|Overall Study|Adverse Event|24|||
129942436|NCT00388726|467753319|FG000|Overall Study|Progressive Disease|336|||
129942437|NCT00388726|467753320|FG001|Overall Study|Progressive Disease|153|||
129942438|NCT00388726|467753319|FG000|Overall Study|Clinical Progression|61|||
129942439|NCT00388726|467753320|FG001|Overall Study|Clinical Progression|36|||
129942440|NCT00388726|467753319|FG000|Overall Study|Withdrawal by Subject|10|||
129942441|NCT00388726|467753320|FG001|Overall Study|Withdrawal by Subject|7|||
129942442|NCT00388726|467753319|FG000|Overall Study|Administrative|6|||
129942443|NCT00388726|467753320|FG001|Overall Study|Administrative|9|||
129942444|NCT00388726|467753319|FG000|Overall Study|Physician Decision|18|||
129942445|NCT00388726|467753320|FG001|Overall Study|Physician Decision|13|||
129942446|NCT00388726|467753319|FG000|Overall Study|Death|3|||
129942447|NCT00388726|467753320|FG001|Overall Study|Death|2|||
129942448|NCT02022670|467753321|FG000|Overall Study|Adverse Event|1|||
129942449|NCT02022670|467753322|FG001|Overall Study|Adverse Event|0|||
129942450|NCT02022670|467753323|FG002|Overall Study|Adverse Event|1|||
129942451|NCT04638816|467753324|FG000|Overall Study|Withdrawal by Subject|0|||
129942452|NCT04638816|467753325|FG001|Overall Study|Withdrawal by Subject|1|||
129942453|NCT04638816|467753324|FG000|Overall Study|Lost to Follow-up|0|||
129942454|NCT04638816|467753325|FG001|Overall Study|Lost to Follow-up|1|||
129942455|NCT02251652|467753326|FG000|Overall Study|Withdrawal by Subject|1|||
129942456|NCT00983294|467753331|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
129942457|NCT00983294|467753331|FG000|Colchicine With Azithromycin|Adverse Event|1|||
129942458|NCT00853593|467753338|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
129942459|NCT00853593|467753338|FG000|Overall Study|Model 4396 lead not attempted|29|||
129942460|NCT00853593|467753338|FG000|Overall Study|Implant not attempted|4|||
129942461|NCT00600353|467753344|FG000|Overall Study|history of malignancy within 5 years|1|||
129942462|NCT00600353|467753345|FG001|Overall Study|history of malignancy within 5 years|0|||
129942463|NCT00600353|467753344|FG000|Overall Study|History of prepartive regimen|0|||
129942464|NCT00600353|467753345|FG001|Overall Study|History of prepartive regimen|1|||
129942465|NCT03683576|467753347|FG000|Overall Study|Withdrawal by Subject|2|||
129942466|NCT03683576|467753348|FG001|Overall Study|Withdrawal by Subject|0|||
129942467|NCT03683576|467753349|FG002|Overall Study|Withdrawal by Subject|8|||
129942468|NCT03683576|467753350|FG003|Overall Study|Withdrawal by Subject|3|||
129942469|NCT03683576|467753347|FG000|Overall Study|Adverse Event|3|||
129942470|NCT03683576|467753348|FG001|Overall Study|Adverse Event|0|||
129942471|NCT03683576|467753349|FG002|Overall Study|Adverse Event|0|||
129942472|NCT03683576|467753350|FG003|Overall Study|Adverse Event|4|||
129942473|NCT03683576|467753347|FG000|Overall Study|Lack of Efficacy|1|||
129942474|NCT03683576|467753348|FG001|Overall Study|Lack of Efficacy|0|||
129942475|NCT03683576|467753349|FG002|Overall Study|Lack of Efficacy|1|||
129942476|NCT03683576|467753350|FG003|Overall Study|Lack of Efficacy|1|||
129942477|NCT03683576|467753347|FG000|Overall Study|Lost to Follow-up|0|||
129942478|NCT03683576|467753348|FG001|Overall Study|Lost to Follow-up|1|||
129942479|NCT03683576|467753349|FG002|Overall Study|Lost to Follow-up|2|||
129942480|NCT03683576|467753350|FG003|Overall Study|Lost to Follow-up|0|||
129942481|NCT03683576|467753347|FG000|Overall Study|Other, Not Specified|0|||
129942482|NCT03683576|467753348|FG001|Overall Study|Other, Not Specified|2|||
129942483|NCT03683576|467753349|FG002|Overall Study|Other, Not Specified|0|||
129942484|NCT03683576|467753350|FG003|Overall Study|Other, Not Specified|0|||
129942485|NCT03683576|467753347|FG000|Overall Study|Protocol Violation|0|||
129942486|NCT03683576|467753348|FG001|Overall Study|Protocol Violation|1|||
129942487|NCT03683576|467753349|FG002|Overall Study|Protocol Violation|1|||
129942488|NCT03683576|467753350|FG003|Overall Study|Protocol Violation|0|||
129942489|NCT01827839|467753351|FG000|Overall Study|Adverse Event|1|||
129942490|NCT01827839|467753351|FG000|Overall Study|Consent Withdrawal|2|||
129942491|NCT03611075|467753355|FG000|Overall Study|Physician Decision|0|||
129942492|NCT03611075|467753356|FG001|Overall Study|Physician Decision|1|||
129942493|NCT03611075|467753357|FG002|Overall Study|Physician Decision|1|||
129942494|NCT03611075|467753358|FG003|Overall Study|Physician Decision|0|||
129942495|NCT03611075|467753359|FG004|Overall Study|Physician Decision|0|||
129942496|NCT03611075|467753360|FG005|Overall Study|Physician Decision|0|||
129942497|NCT03611075|467753361|FG006|Overall Study|Physician Decision|0|||
129942498|NCT03611075|467753362|FG007|Overall Study|Physician Decision|0|||
129942499|NCT03611075|467753363|FG008|Overall Study|Physician Decision|0|||
129942500|NCT03611075|467753355|FG000|Overall Study|Lost to Follow-up|1|||
129942501|NCT03611075|467753356|FG001|Overall Study|Lost to Follow-up|0|||
129942502|NCT03611075|467753357|FG002|Overall Study|Lost to Follow-up|0|||
129942503|NCT03611075|467753358|FG003|Overall Study|Lost to Follow-up|2|||
129942504|NCT03611075|467753359|FG004|Overall Study|Lost to Follow-up|0|||
129942505|NCT03611075|467753360|FG005|Overall Study|Lost to Follow-up|0|||
129942506|NCT03611075|467753361|FG006|Overall Study|Lost to Follow-up|0|||
129942507|NCT03611075|467753362|FG007|Overall Study|Lost to Follow-up|0|||
129942508|NCT03611075|467753363|FG008|Overall Study|Lost to Follow-up|0|||
129942509|NCT03611075|467753355|FG000|Overall Study|Withdrawal by Subject|0|||
129942510|NCT03611075|467753356|FG001|Overall Study|Withdrawal by Subject|1|||
129942511|NCT03611075|467753357|FG002|Overall Study|Withdrawal by Subject|1|||
129942512|NCT03611075|467753358|FG003|Overall Study|Withdrawal by Subject|1|||
129942513|NCT03611075|467753359|FG004|Overall Study|Withdrawal by Subject|0|||
129942514|NCT03611075|467753360|FG005|Overall Study|Withdrawal by Subject|0|||
129942515|NCT03611075|467753361|FG006|Overall Study|Withdrawal by Subject|1|||
129942516|NCT03611075|467753362|FG007|Overall Study|Withdrawal by Subject|0|||
129942517|NCT03611075|467753363|FG008|Overall Study|Withdrawal by Subject|0|||
129942518|NCT03611075|467753355|FG000|Overall Study|Reason unknown|0|||
129942519|NCT03611075|467753356|FG001|Overall Study|Reason unknown|0|||
129942520|NCT03611075|467753357|FG002|Overall Study|Reason unknown|0|||
129942521|NCT03611075|467753358|FG003|Overall Study|Reason unknown|1|||
129942522|NCT03611075|467753359|FG004|Overall Study|Reason unknown|0|||
129942523|NCT03611075|467753360|FG005|Overall Study|Reason unknown|0|||
129942524|NCT03611075|467753361|FG006|Overall Study|Reason unknown|1|||
129942525|NCT03611075|467753362|FG007|Overall Study|Reason unknown|0|||
129942526|NCT03611075|467753363|FG008|Overall Study|Reason unknown|0|||
129942527|NCT00676091|467753364|FG000|Infant Series|Parent or legal guardian request|10|||
129942528|NCT00676091|467753365|FG001|Infant Series|Parent or legal guardian request|8|||
129942529|NCT00676091|467753364|FG000|Infant Series|Protocol Violation|6|||
129942530|NCT00676091|467753365|FG001|Infant Series|Protocol Violation|3|||
129942531|NCT00676091|467753364|FG000|Infant Series|Adverse Event|2|||
129942532|NCT00676091|467753365|FG001|Infant Series|Adverse Event|3|||
129942533|NCT00676091|467753364|FG000|Infant Series|Failed to return|1|||
130071523|NCT03136367|468216147|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
130071524|NCT03136367|468216148|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
130071525|NCT03136367|468216146|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
130071526|NCT03136367|468216147|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
130071527|NCT03136367|468216148|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
130071528|NCT03136367|468216146|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
129942534|NCT00676091|467753365|FG001|Infant Series|Failed to return|3|||
129942535|NCT00676091|467753364|FG000|Infant Series|Lost to Follow-up|1|||
129942536|NCT00676091|467753365|FG001|Infant Series|Lost to Follow-up|0|||
130071529|NCT03136367|468216147|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
130071530|NCT03136367|468216148|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
129942537|NCT00676091|467753364|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
129942538|NCT00676091|467753365|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
129942539|NCT00676091|467753364|FG000|After Infant Series|Adverse Event|0|||
129942540|NCT00676091|467753365|FG001|After Infant Series|Adverse Event|1|||
129942541|NCT00676091|467753364|FG000|After Infant Series|Protocol Violation|0|||
129942542|NCT00676091|467753365|FG001|After Infant Series|Protocol Violation|1|||
129942543|NCT00676091|467753364|FG000|After Infant Series|Failed to return|1|||
129942544|NCT00676091|467753365|FG001|After Infant Series|Failed to return|1|||
129942545|NCT00676091|467753364|FG000|Toddler Dose|Failed to return|2|||
129942546|NCT00676091|467753365|FG001|Toddler Dose|Failed to return|0|||
130071531|NCT03136367|468216146|FG000|T4 12 Weeks After Surgery|Death|0|||
130120190|NCT00409578|468400227|FG000|Overall Study|Administrative problems|8|||
130120191|NCT00409578|468400228|FG001|Overall Study|Administrative problems|9|||
130120192|NCT00409578|468400229|FG002|Overall Study|Administrative problems|2|||
130120193|NCT00409578|468400230|FG003|Overall Study|Administrative problems|4|||
129942547|NCT00676091|467753364|FG000|Toddler Dose|Parent or legal guardian request|1|||
129942548|NCT00676091|467753365|FG001|Toddler Dose|Parent or legal guardian request|0|||
129942549|NCT05366751|467753369|FG000|Overall Study|Adverse Event|25|||
129942550|NCT05366751|467753369|FG000|Overall Study|Physician Decision|3|||
130120194|NCT00409578|468400227|FG000|Overall Study|Death|2|||
130120195|NCT00409578|468400228|FG001|Overall Study|Death|4|||
130120196|NCT00409578|468400229|FG002|Overall Study|Death|4|||
130120197|NCT00409578|468400230|FG003|Overall Study|Death|2|||
130120198|NCT00409578|468400227|FG000|Overall Study|Protocol Violation|3|||
130120199|NCT00409578|468400228|FG001|Overall Study|Protocol Violation|2|||
130120200|NCT00409578|468400229|FG002|Overall Study|Protocol Violation|3|||
130120201|NCT00409578|468400230|FG003|Overall Study|Protocol Violation|1|||
130120202|NCT00409578|468400227|FG000|Overall Study|Missing|0|||
130120203|NCT00409578|468400228|FG001|Overall Study|Missing|1|||
129942551|NCT05366751|467753369|FG000|Overall Study|Lost to Follow-up|2|||
129942552|NCT05366751|467753369|FG000|Overall Study|Withdrawal by Subject|14|||
129942553|NCT05366751|467753369|FG000|Overall Study|Study Terminated by Sponsor|50|||
129942554|NCT05366751|467753369|FG000|Overall Study|Site Terminated by Sponsor|3|||
129942555|NCT00491894|467753375|FG000|Overall Study|Adverse Event|14|||
129942556|NCT00491894|467753375|FG000|Overall Study|Withdrawal by Subject|5|||
129942557|NCT00491894|467753375|FG000|Overall Study|Death|3|||
129942558|NCT00491894|467753375|FG000|Overall Study|Lost to Follow-up|3|||
129942559|NCT00491894|467753375|FG000|Overall Study|Lack of Efficacy|2|||
129942560|NCT00491894|467753375|FG000|Overall Study|Other-Failed to meet any criteria|2|||
129942561|NCT00491894|467753375|FG000|Overall Study|Physician Decision|2|||
129942562|NCT00491894|467753375|FG000|Overall Study|Protocol Violation|2|||
129942563|NCT00491894|467753375|FG000|Overall Study|Other-Intake of prohibited medication|1|||
129942564|NCT04172675|467755107|FG000|Overall Study|Withdrawal by Subject|7|||
129942565|NCT04172675|467755108|FG001|Overall Study|Withdrawal by Subject|5|||
129942566|NCT04172675|467755109|FG002|Overall Study|Withdrawal by Subject|1|||
129942567|NCT04172675|467755110|FG003|Overall Study|Withdrawal by Subject|4|||
129942568|NCT05349721|467755111|FG000|Part A (24 Weeks)|Adverse Event|9|||
129942569|NCT05349721|467755112|FG001|Part A (24 Weeks)|Adverse Event|2|||
129942570|NCT05349721|467755111|FG000|Part A (24 Weeks)|Death|8|||
129942571|NCT05349721|467755112|FG001|Part A (24 Weeks)|Death|3|||
129942572|NCT05349721|467755111|FG000|Part A (24 Weeks)|Disease Progression|1|||
129942573|NCT05349721|467755112|FG001|Part A (24 Weeks)|Disease Progression|1|||
129942574|NCT05349721|467755111|FG000|Part A (24 Weeks)|Screen Failure|2|||
129942575|NCT05349721|467755112|FG001|Part A (24 Weeks)|Screen Failure|0|||
129942576|NCT05349721|467755111|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
129942577|NCT05349721|467755112|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
129942578|NCT05349721|467755111|FG000|Part A (24 Weeks)|Other Than Specified|5|||
129942579|NCT05349721|467755112|FG001|Part A (24 Weeks)|Other Than Specified|1|||
129942580|NCT05349721|467755111|FG000|Part B (28 Weeks)|Adverse Event|3|||
129942581|NCT05349721|467755112|FG001|Part B (28 Weeks)|Adverse Event|0|||
129942582|NCT05349721|467755111|FG000|Part B (28 Weeks)|Death|21|||
129942583|NCT05349721|467755112|FG001|Part B (28 Weeks)|Death|11|||
129942584|NCT05349721|467755111|FG000|Part B (28 Weeks)|Disease Progression|2|||
129942585|NCT05349721|467755112|FG001|Part B (28 Weeks)|Disease Progression|1|||
129942586|NCT05349721|467755111|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
129942587|NCT05349721|467755112|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
129942588|NCT05349721|467755111|FG000|Part B (28 Weeks)|Physician Decision|1|||
129942589|NCT05349721|467755112|FG001|Part B (28 Weeks)|Physician Decision|0|||
129942590|NCT05349721|467755111|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
129942591|NCT05349721|467755112|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
129942592|NCT05349721|467755111|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
129942593|NCT05349721|467755112|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
129942594|NCT05349721|467755111|FG000|Part B (28 Weeks)|Other Than Specified|4|||
129942595|NCT05349721|467755112|FG001|Part B (28 Weeks)|Other Than Specified|2|||
129942596|NCT05349721|467755111|FG000|Part C (108 Weeks)|Death|0|||
130120204|NCT00409578|468400229|FG002|Overall Study|Missing|0|||
129942597|NCT05349721|467755112|FG001|Part C (108 Weeks)|Death|1|||
129942598|NCT05349721|467755111|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
129942599|NCT05349721|467755112|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
129942600|NCT05349721|467755111|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
130120205|NCT00409578|468400230|FG003|Overall Study|Missing|1|||
129942601|NCT05349721|467755112|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
129942602|NCT05349721|467755111|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
129942603|NCT05349721|467755112|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
129942604|NCT03070392|467755113|FG000|Overall Study|Not Treated|7|||
129942605|NCT03070392|467755114|FG001|Overall Study|Not Treated|0|||
130120206|NCT01691508|468402280|FG000|Overall Study|Adverse Event|3|||
130120207|NCT01691508|468402281|FG001|Overall Study|Adverse Event|3|||
130120208|NCT01691508|468402280|FG000|Overall Study|Withdrawal by Subject|1|||
130154859|NCT00958126|468526622|FG001|Overall Study|Lost to Follow-up|5|||
129942606|NCT03070392|467755115|FG002|Overall Study|Not Treated|3|||
129942607|NCT03070392|467755116|FG003|Overall Study|Not Treated|12|||
129942608|NCT03070392|467755113|FG000|Overall Study|Death|3|||
129942609|NCT03070392|467755114|FG001|Overall Study|Death|0|||
129942610|NCT03070392|467755115|FG002|Overall Study|Death|0|||
129942611|NCT03070392|467755116|FG003|Overall Study|Death|1|||
129942612|NCT03070392|467755113|FG000|Overall Study|Withdrawal by Subject|7|||
129942613|NCT03070392|467755114|FG001|Overall Study|Withdrawal by Subject|0|||
129942614|NCT03070392|467755115|FG002|Overall Study|Withdrawal by Subject|0|||
129942615|NCT03070392|467755116|FG003|Overall Study|Withdrawal by Subject|3|||
129942616|NCT03070392|467755113|FG000|Overall Study|Physician Decision|1|||
129942617|NCT03070392|467755114|FG001|Overall Study|Physician Decision|0|||
129942618|NCT03070392|467755115|FG002|Overall Study|Physician Decision|0|||
129942619|NCT03070392|467755116|FG003|Overall Study|Physician Decision|2|||
129942620|NCT03070392|467755113|FG000|Overall Study|Progressive Disease|154|||
129942621|NCT03070392|467755114|FG001|Overall Study|Progressive Disease|6|||
129942622|NCT03070392|467755115|FG002|Overall Study|Progressive Disease|2|||
129942623|NCT03070392|467755116|FG003|Overall Study|Progressive Disease|70|||
129942624|NCT03070392|467755113|FG000|Overall Study|Adverse Event|6|||
129942625|NCT03070392|467755114|FG001|Overall Study|Adverse Event|1|||
129942626|NCT03070392|467755115|FG002|Overall Study|Adverse Event|1|||
129942627|NCT03070392|467755116|FG003|Overall Study|Adverse Event|3|||
129942628|NCT03070392|467755113|FG000|Overall Study|Alternate anticancer treatment|1|||
129942629|NCT03070392|467755114|FG001|Overall Study|Alternate anticancer treatment|0|||
129942630|NCT03070392|467755115|FG002|Overall Study|Alternate anticancer treatment|0|||
129942631|NCT03070392|467755116|FG003|Overall Study|Alternate anticancer treatment|1|||
129942632|NCT03070392|467755113|FG000|Overall Study|Ongoing|73|||
129942633|NCT03070392|467755114|FG001|Overall Study|Ongoing|0|||
129942634|NCT03070392|467755115|FG002|Overall Study|Ongoing|0|||
129942635|NCT03070392|467755116|FG003|Overall Study|Ongoing|11|||
129942636|NCT02972034|467755117|FG000|Overall Study|Death|11|||
129942637|NCT02972034|467755118|FG001|Overall Study|Death|1|||
129942638|NCT02972034|467755119|FG002|Overall Study|Death|3|||
129942639|NCT02972034|467755120|FG003|Overall Study|Death|3|||
129942640|NCT02972034|467755121|FG004|Overall Study|Death|2|||
129942641|NCT02972034|467755122|FG005|Overall Study|Death|2|||
129942642|NCT02972034|467755123|FG006|Overall Study|Death|3|||
129942643|NCT02972034|467755124|FG007|Overall Study|Death|4|||
129942644|NCT02972034|467755125|FG008|Overall Study|Death|8|||
129942645|NCT02972034|467755126|FG009|Overall Study|Death|11|||
129942646|NCT02972034|467755127|FG010|Overall Study|Death|3|||
129942647|NCT02972034|467755128|FG011|Overall Study|Death|2|||
129942648|NCT02972034|467755129|FG012|Overall Study|Death|11|||
129942649|NCT02972034|467755130|FG013|Overall Study|Death|10|||
129942650|NCT02972034|467755131|FG014|Overall Study|Death|9|||
129942651|NCT02972034|467755117|FG000|Overall Study|Lost to Follow-up|0|||
129942652|NCT02972034|467755118|FG001|Overall Study|Lost to Follow-up|0|||
129942653|NCT02972034|467755119|FG002|Overall Study|Lost to Follow-up|0|||
129942654|NCT02972034|467755120|FG003|Overall Study|Lost to Follow-up|0|||
129942655|NCT02972034|467755121|FG004|Overall Study|Lost to Follow-up|1|||
129942656|NCT02972034|467755122|FG005|Overall Study|Lost to Follow-up|0|||
129942657|NCT02972034|467755123|FG006|Overall Study|Lost to Follow-up|0|||
129942658|NCT02972034|467755124|FG007|Overall Study|Lost to Follow-up|1|||
129942659|NCT02972034|467755125|FG008|Overall Study|Lost to Follow-up|0|||
129942660|NCT02972034|467755126|FG009|Overall Study|Lost to Follow-up|0|||
129942661|NCT02972034|467755127|FG010|Overall Study|Lost to Follow-up|0|||
129942662|NCT02972034|467755128|FG011|Overall Study|Lost to Follow-up|0|||
129942663|NCT02972034|467755129|FG012|Overall Study|Lost to Follow-up|0|||
129942664|NCT02972034|467755130|FG013|Overall Study|Lost to Follow-up|0|||
129942665|NCT02972034|467755131|FG014|Overall Study|Lost to Follow-up|1|||
130120209|NCT01691508|468402281|FG001|Overall Study|Withdrawal by Subject|0|||
130120210|NCT00623103|468402290|FG000|Overall Study|Adverse Event|70|||
129942666|NCT02972034|467755117|FG000|Overall Study|Physician Decision|0|||
129942667|NCT02972034|467755118|FG001|Overall Study|Physician Decision|0|||
130120211|NCT00623103|468402291|FG001|Overall Study|Adverse Event|60|||
130120212|NCT00623103|468402290|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130120213|NCT00623103|468402291|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
129942668|NCT02972034|467755119|FG002|Overall Study|Physician Decision|0|||
129942669|NCT02972034|467755120|FG003|Overall Study|Physician Decision|0|||
129942670|NCT02972034|467755121|FG004|Overall Study|Physician Decision|0|||
129942671|NCT02972034|467755122|FG005|Overall Study|Physician Decision|0|||
129942672|NCT02972034|467755123|FG006|Overall Study|Physician Decision|0|||
129942673|NCT02972034|467755124|FG007|Overall Study|Physician Decision|1|||
129942674|NCT02972034|467755125|FG008|Overall Study|Physician Decision|0|||
129942675|NCT02972034|467755126|FG009|Overall Study|Physician Decision|0|||
129942676|NCT02972034|467755127|FG010|Overall Study|Physician Decision|1|||
129942677|NCT02972034|467755128|FG011|Overall Study|Physician Decision|0|||
129942678|NCT02972034|467755129|FG012|Overall Study|Physician Decision|0|||
129942679|NCT02972034|467755130|FG013|Overall Study|Physician Decision|0|||
129942680|NCT02972034|467755131|FG014|Overall Study|Physician Decision|0|||
129942681|NCT02972034|467755117|FG000|Overall Study|Sponsor Decision|0|||
129942682|NCT02972034|467755118|FG001|Overall Study|Sponsor Decision|0|||
129942683|NCT02972034|467755119|FG002|Overall Study|Sponsor Decision|0|||
129942684|NCT02972034|467755120|FG003|Overall Study|Sponsor Decision|1|||
129942685|NCT02972034|467755121|FG004|Overall Study|Sponsor Decision|0|||
129942686|NCT02972034|467755122|FG005|Overall Study|Sponsor Decision|0|||
129942687|NCT02972034|467755123|FG006|Overall Study|Sponsor Decision|1|||
129942688|NCT02972034|467755124|FG007|Overall Study|Sponsor Decision|1|||
129942689|NCT02972034|467755125|FG008|Overall Study|Sponsor Decision|1|||
129942690|NCT02972034|467755126|FG009|Overall Study|Sponsor Decision|2|||
129942691|NCT02972034|467755127|FG010|Overall Study|Sponsor Decision|2|||
129942692|NCT02972034|467755128|FG011|Overall Study|Sponsor Decision|0|||
129942693|NCT02972034|467755129|FG012|Overall Study|Sponsor Decision|1|||
129942694|NCT02972034|467755130|FG013|Overall Study|Sponsor Decision|0|||
129942695|NCT02972034|467755131|FG014|Overall Study|Sponsor Decision|1|||
129942696|NCT02972034|467755117|FG000|Overall Study|Withdrawal by Subject|3|||
129942697|NCT02972034|467755118|FG001|Overall Study|Withdrawal by Subject|0|||
129942698|NCT02972034|467755119|FG002|Overall Study|Withdrawal by Subject|0|||
129942699|NCT02972034|467755120|FG003|Overall Study|Withdrawal by Subject|0|||
129942700|NCT02972034|467755121|FG004|Overall Study|Withdrawal by Subject|1|||
129942701|NCT02972034|467755122|FG005|Overall Study|Withdrawal by Subject|1|||
129942702|NCT02972034|467755123|FG006|Overall Study|Withdrawal by Subject|0|||
129942703|NCT02972034|467755124|FG007|Overall Study|Withdrawal by Subject|0|||
129942704|NCT02972034|467755125|FG008|Overall Study|Withdrawal by Subject|1|||
129942705|NCT02972034|467755126|FG009|Overall Study|Withdrawal by Subject|1|||
129942706|NCT02972034|467755127|FG010|Overall Study|Withdrawal by Subject|2|||
129942707|NCT02972034|467755128|FG011|Overall Study|Withdrawal by Subject|1|||
129942708|NCT02972034|467755129|FG012|Overall Study|Withdrawal by Subject|1|||
129942709|NCT02972034|467755130|FG013|Overall Study|Withdrawal by Subject|1|||
129942710|NCT02972034|467755131|FG014|Overall Study|Withdrawal by Subject|0|||
129942711|NCT02972034|467755117|FG000|Overall Study|Screen Failure|0|||
129942712|NCT02972034|467755118|FG001|Overall Study|Screen Failure|0|||
129942713|NCT02972034|467755119|FG002|Overall Study|Screen Failure|0|||
129942714|NCT02972034|467755120|FG003|Overall Study|Screen Failure|0|||
129942715|NCT02972034|467755121|FG004|Overall Study|Screen Failure|0|||
129942716|NCT02972034|467755122|FG005|Overall Study|Screen Failure|0|||
129942717|NCT02972034|467755123|FG006|Overall Study|Screen Failure|0|||
129942718|NCT02972034|467755124|FG007|Overall Study|Screen Failure|0|||
129942719|NCT02972034|467755125|FG008|Overall Study|Screen Failure|0|||
129942720|NCT02972034|467755126|FG009|Overall Study|Screen Failure|0|||
129942721|NCT02972034|467755127|FG010|Overall Study|Screen Failure|0|||
129942722|NCT02972034|467755128|FG011|Overall Study|Screen Failure|0|||
129942723|NCT02972034|467755129|FG012|Overall Study|Screen Failure|1|||
129942724|NCT02972034|467755130|FG013|Overall Study|Screen Failure|0|||
129942725|NCT02972034|467755131|FG014|Overall Study|Screen Failure|0|||
129942726|NCT03861052|467755132|FG000|Overall Study|Adverse Event|1|||
129942727|NCT03861052|467755133|FG001|Overall Study|Adverse Event|1|||
129942728|NCT03861052|467755134|FG002|Overall Study|Adverse Event|2|||
129942729|NCT03861052|467755135|FG003|Overall Study|Adverse Event|4|||
129942730|NCT03861052|467755132|FG000|Overall Study|Lost to Follow-up|0|||
129942731|NCT03861052|467755133|FG001|Overall Study|Lost to Follow-up|0|||
129942732|NCT03861052|467755134|FG002|Overall Study|Lost to Follow-up|0|||
129942733|NCT03861052|467755135|FG003|Overall Study|Lost to Follow-up|1|||
129942734|NCT03861052|467755132|FG000|Overall Study|Physician Decision|0|||
129942735|NCT03861052|467755133|FG001|Overall Study|Physician Decision|1|||
129942736|NCT03861052|467755134|FG002|Overall Study|Physician Decision|0|||
129942737|NCT03861052|467755135|FG003|Overall Study|Physician Decision|0|||
129942738|NCT03861052|467755132|FG000|Overall Study|Withdrawal by Subject|2|||
129942739|NCT03861052|467755133|FG001|Overall Study|Withdrawal by Subject|5|||
129942740|NCT03861052|467755134|FG002|Overall Study|Withdrawal by Subject|3|||
129942741|NCT03861052|467755135|FG003|Overall Study|Withdrawal by Subject|0|||
129942742|NCT03861052|467755132|FG000|Overall Study|Relocation to other city|1|||
129942743|NCT03861052|467755133|FG001|Overall Study|Relocation to other city|0|||
129942744|NCT03861052|467755134|FG002|Overall Study|Relocation to other city|0|||
129942745|NCT03861052|467755135|FG003|Overall Study|Relocation to other city|0|||
129942746|NCT00378898|467755136|FG000|Overall Study|Withdrawal by Subject|10|||
129942747|NCT00378898|467755137|FG001|Overall Study|Withdrawal by Subject|5|||
129942748|NCT00378898|467755136|FG000|Overall Study|Protocol Violation|1|||
129942749|NCT00378898|467755137|FG001|Overall Study|Protocol Violation|1|||
129942750|NCT02534233|467755140|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
129942751|NCT03136159|467755141|FG000|Overall Study|chorioamnionitis|2|||
129942752|NCT03136159|467755142|FG001|Overall Study|chorioamnionitis|0|||
129942753|NCT03136159|467755141|FG000|Overall Study|vertical skin incision|1|||
129942754|NCT03136159|467755142|FG001|Overall Study|vertical skin incision|0|||
129942755|NCT03136159|467755141|FG000|Overall Study|additional dressing|1|||
129942756|NCT03136159|467755142|FG001|Overall Study|additional dressing|0|||
129942757|NCT03136159|467755141|FG000|Overall Study|never got dressing placed|1|||
130120214|NCT00623103|468402290|FG000|Overall Study|Withdrawal by Subject|18|||
129942758|NCT03136159|467755142|FG001|Overall Study|never got dressing placed|0|||
130120215|NCT00623103|468402291|FG001|Overall Study|Withdrawal by Subject|24|||
129942759|NCT03823703|467755143|FG000|Overall Study|Sponsor request|0|||
129942760|NCT03823703|467755144|FG001|Overall Study|Sponsor request|3|||
129942761|NCT03823703|467755145|FG002|Overall Study|Sponsor request|4|||
129942762|NCT03823703|467755143|FG000|Overall Study|Adverse Event|3|||
129942763|NCT03823703|467755144|FG001|Overall Study|Adverse Event|1|||
129942764|NCT03823703|467755145|FG002|Overall Study|Adverse Event|0|||
129942765|NCT03823703|467755143|FG000|Overall Study|Withdrawal by Subject|0|||
129942766|NCT03823703|467755144|FG001|Overall Study|Withdrawal by Subject|1|||
129942767|NCT03823703|467755145|FG002|Overall Study|Withdrawal by Subject|0|||
129942768|NCT03137459|467755146|FG000|2-month Assessment|Withdrawal by Subject|13|||
129942769|NCT03137459|467755147|FG001|2-month Assessment|Withdrawal by Subject|3|||
129942770|NCT03137459|467755146|FG000|2-month Assessment|Unable to reach|42|||
129942771|NCT03137459|467755147|FG001|2-month Assessment|Unable to reach|32|||
129942772|NCT03137459|467755146|FG000|2-month Assessment|Refused assessment|7|||
129942773|NCT03137459|467755147|FG001|2-month Assessment|Refused assessment|5|||
129942774|NCT03137459|467755146|FG000|2-month Assessment|Acutely ill|6|||
129942775|NCT03137459|467755147|FG001|2-month Assessment|Acutely ill|2|||
129942776|NCT03137459|467755146|FG000|4-month Assessment|Death|4|||
129942777|NCT03137459|467755147|FG001|4-month Assessment|Death|2|||
129942778|NCT03137459|467755146|FG000|4-month Assessment|Withdrawal by Subject|4|||
129942779|NCT03137459|467755147|FG001|4-month Assessment|Withdrawal by Subject|2|||
129942780|NCT03137459|467755146|FG000|4-month Assessment|Unable to reach|44|||
129942781|NCT03137459|467755147|FG001|4-month Assessment|Unable to reach|29|||
129942782|NCT03137459|467755146|FG000|4-month Assessment|Refused assessment|24|||
129942783|NCT03137459|467755147|FG001|4-month Assessment|Refused assessment|10|||
129942784|NCT03137459|467755146|FG000|4-month Assessment|Acutely ill|2|||
129942785|NCT03137459|467755147|FG001|4-month Assessment|Acutely ill|3|||
129942786|NCT03137459|467755146|FG000|6-months|Lost to Follow-up|14|||
129942787|NCT03137459|467755147|FG001|6-months|Lost to Follow-up|11|||
129942788|NCT03137459|467755146|FG000|6-months|Death|0|||
129942789|NCT03137459|467755147|FG001|6-months|Death|2|||
129942790|NCT03137459|467755146|FG000|6-months|Refused assessment|6|||
129942791|NCT03137459|467755147|FG001|6-months|Refused assessment|3|||
129942792|NCT03137459|467755146|FG000|6-months|Acutely ill|1|||
129942793|NCT03137459|467755147|FG001|6-months|Acutely ill|1|||
129942794|NCT01732757|467755148|FG000|Overall Study|Lost to Follow-up|1|||
129942795|NCT01732757|467755149|FG001|Overall Study|Lost to Follow-up|0|||
129942796|NCT01732757|467755150|FG002|Overall Study|Lost to Follow-up|0|||
129942797|NCT00925548|467755151|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
129942798|NCT00925548|467755152|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
129942799|NCT04921358|467755153|FG000|Overall Study|Withdrawal by Subject|6|||
129942800|NCT04921358|467755154|FG001|Overall Study|Withdrawal by Subject|13|||
129942801|NCT04921358|467755153|FG000|Overall Study|Lost to Follow-up|3|||
129942802|NCT04921358|467755154|FG001|Overall Study|Lost to Follow-up|6|||
129942803|NCT04921358|467755153|FG000|Overall Study|Study Terminated by Sponsor|86|||
129942804|NCT04921358|467755154|FG001|Overall Study|Study Terminated by Sponsor|89|||
129942805|NCT04921358|467755153|FG000|Overall Study|Death|92|||
129942806|NCT04921358|467755154|FG001|Overall Study|Death|82|||
129942807|NCT02372799|467755159|FG000|Treatment Period|Adverse Event|3|||
129942808|NCT02372799|467755160|FG001|Treatment Period|Adverse Event|10|||
129942809|NCT02372799|467755161|FG002|Treatment Period|Adverse Event|6|||
129942810|NCT02372799|467755159|FG000|Treatment Period|Insufficient therapeutic response|2|||
129942811|NCT02372799|467755160|FG001|Treatment Period|Insufficient therapeutic response|2|||
129942812|NCT02372799|467755161|FG002|Treatment Period|Insufficient therapeutic response|0|||
129942813|NCT02372799|467755159|FG000|Treatment Period|Withdrawal by Subject|10|||
129942814|NCT02372799|467755160|FG001|Treatment Period|Withdrawal by Subject|10|||
129942815|NCT02372799|467755161|FG002|Treatment Period|Withdrawal by Subject|2|||
130071532|NCT03136367|468216147|FG001|T4 12 Weeks After Surgery|Death|1|||
130071533|NCT03136367|468216148|FG002|T4 12 Weeks After Surgery|Death|3|||
130071534|NCT03136367|468216146|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
130071535|NCT03136367|468216147|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
130071536|NCT03136367|468216148|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
130071537|NCT03136367|468216146|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
130071538|NCT03136367|468216147|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
130071539|NCT03136367|468216148|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
130071540|NCT03136367|468216146|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
130071541|NCT03136367|468216147|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
130071542|NCT03136367|468216148|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
130071543|NCT03136367|468216146|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
130071544|NCT03136367|468216147|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
130071545|NCT03136367|468216148|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
129942816|NCT02372799|467755159|FG000|Treatment Period|Lost to Follow-up|11|||
129942817|NCT02372799|467755160|FG001|Treatment Period|Lost to Follow-up|5|||
129942818|NCT02372799|467755161|FG002|Treatment Period|Lost to Follow-up|3|||
130120216|NCT00623103|468402290|FG000|Overall Study|Lost to Follow-up|4|||
129942819|NCT02372799|467755159|FG000|Treatment Period|Protocol Violation|3|||
129942820|NCT02372799|467755160|FG001|Treatment Period|Protocol Violation|0|||
129942821|NCT02372799|467755161|FG002|Treatment Period|Protocol Violation|0|||
129942822|NCT02372799|467755159|FG000|Treatment Period|Non-compliance with study drug|4|||
129942823|NCT02372799|467755160|FG001|Treatment Period|Non-compliance with study drug|4|||
129942824|NCT02372799|467755161|FG002|Treatment Period|Non-compliance with study drug|4|||
129942825|NCT02372799|467755159|FG000|Treatment Period|Miscellaneous Reasons|1|||
129942826|NCT02372799|467755160|FG001|Treatment Period|Miscellaneous Reasons|1|||
129942827|NCT02372799|467755161|FG002|Treatment Period|Miscellaneous Reasons|0|||
129942828|NCT02372799|467755159|FG000|Down-taper Period|Lost to Follow-up|1|||
129942829|NCT02372799|467755160|FG001|Down-taper Period|Lost to Follow-up|2|||
129942830|NCT02372799|467755161|FG002|Down-taper Period|Lost to Follow-up|2|||
129942831|NCT00491400|467755162|FG000|Overall Study|Withdrawal by Subject|5|||
129942832|NCT00491400|467755163|FG001|Overall Study|Withdrawal by Subject|4|||
129942833|NCT00745875|467755164|FG000|Overall Study|Continuing study treatment|4|||
129942834|NCT00745875|467755165|FG001|Overall Study|Continuing study treatment|4|||
129942835|NCT01256359|467755168|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
129942836|NCT01256359|467755169|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
129942837|NCT01256359|467755168|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
129942838|NCT01256359|467755169|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
129942839|NCT02000752|467755170|FG000|Overall Study|Dystocic delivery|19|||
129942840|NCT02000752|467755171|FG001|Overall Study|Dystocic delivery|8|||
129942841|NCT02000752|467755170|FG000|Overall Study|Shift Changes|12|||
129942842|NCT02000752|467755171|FG001|Overall Study|Shift Changes|5|||
129942843|NCT04693637|467755172|FG000|Overall Study|Death|4|||
129942844|NCT04693637|467755172|FG000|Overall Study|Withdrawal by Subject|3|||
129942845|NCT04693637|467755172|FG000|Overall Study|Physician Decision|2|||
129942846|NCT04693637|467755172|FG000|Overall Study|Lost to Follow-up|1|||
129942847|NCT01728324|467755194|FG000|Termination of DBV|Adverse Event|14|||
129942848|NCT01728324|467755195|FG001|Termination of DBV|Adverse Event|13|||
129942849|NCT01728324|467755196|FG002|Termination of DBV|Adverse Event|4|||
129942850|NCT01728324|467755194|FG000|Termination of DBV|Lack of Efficacy|14|||
129942851|NCT01728324|467755195|FG001|Termination of DBV|Lack of Efficacy|12|||
129942852|NCT01728324|467755196|FG002|Termination of DBV|Lack of Efficacy|8|||
129942853|NCT01728324|467755194|FG000|Termination of DBV|Withdrawal by Subject|9|||
129942854|NCT01728324|467755195|FG001|Termination of DBV|Withdrawal by Subject|6|||
129942855|NCT01728324|467755196|FG002|Termination of DBV|Withdrawal by Subject|2|||
129942856|NCT01728324|467755194|FG000|Termination of DBV|Other than stated|1|||
129942857|NCT01728324|467755195|FG001|Termination of DBV|Other than stated|3|||
129942858|NCT01728324|467755196|FG002|Termination of DBV|Other than stated|0|||
129942859|NCT01728324|467755194|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
129942860|NCT01728324|467755195|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
129942861|NCT01728324|467755196|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
129942862|NCT01728324|467755194|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
129942863|NCT01728324|467755195|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
129942864|NCT01728324|467755196|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
129942865|NCT01728324|467755194|FG000|Termination of FDV|Adverse Event|14|||
129942866|NCT01728324|467755195|FG001|Termination of FDV|Adverse Event|13|||
129942867|NCT01728324|467755196|FG002|Termination of FDV|Adverse Event|4|||
129942868|NCT01728324|467755194|FG000|Termination of FDV|Lack of Efficacy|14|||
129942869|NCT01728324|467755195|FG001|Termination of FDV|Lack of Efficacy|12|||
129942870|NCT01728324|467755196|FG002|Termination of FDV|Lack of Efficacy|8|||
129942871|NCT01728324|467755194|FG000|Termination of FDV|Withdrawal by Subject|9|||
129942872|NCT01728324|467755195|FG001|Termination of FDV|Withdrawal by Subject|6|||
129942873|NCT01728324|467755196|FG002|Termination of FDV|Withdrawal by Subject|2|||
129942874|NCT01728324|467755194|FG000|Termination of FDV|Other than stated|1|||
129942875|NCT01728324|467755195|FG001|Termination of FDV|Other than stated|3|||
129942876|NCT01728324|467755196|FG002|Termination of FDV|Other than stated|0|||
129942877|NCT01728324|467755194|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
129942878|NCT01728324|467755195|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
129942879|NCT01728324|467755196|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
129942880|NCT01728324|467755194|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
129942881|NCT01728324|467755195|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
129942882|NCT01728324|467755196|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
129942883|NCT01728324|467755194|FG000|Termination of RBV|Adverse Event|15|||
129942884|NCT01728324|467755195|FG001|Termination of RBV|Adverse Event|16|||
129942885|NCT01728324|467755196|FG002|Termination of RBV|Adverse Event|5|||
129942886|NCT01728324|467755194|FG000|Termination of RBV|Lack of Efficacy|14|||
129942887|NCT01728324|467755195|FG001|Termination of RBV|Lack of Efficacy|11|||
129942888|NCT01728324|467755196|FG002|Termination of RBV|Lack of Efficacy|7|||
129942889|NCT01728324|467755194|FG000|Termination of RBV|Withdrawal by Subject|9|||
129942890|NCT01728324|467755195|FG001|Termination of RBV|Withdrawal by Subject|5|||
129942891|NCT01728324|467755196|FG002|Termination of RBV|Withdrawal by Subject|2|||
129942892|NCT01728324|467755194|FG000|Termination of RBV|Other than stated|1|||
129942893|NCT01728324|467755195|FG001|Termination of RBV|Other than stated|3|||
129942894|NCT01728324|467755196|FG002|Termination of RBV|Other than stated|1|||
129942895|NCT01728324|467755194|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
129942896|NCT01728324|467755195|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
129942897|NCT01728324|467755196|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
129942898|NCT01728324|467755194|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
129942899|NCT01728324|467755195|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
129942900|NCT01728324|467755196|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
129942901|NCT03057600|467755197|FG000|Overall Study|Adverse Event|0|||
129942902|NCT03057600|467755198|FG001|Overall Study|Adverse Event|0|||
129942903|NCT03057600|467755199|FG002|Overall Study|Adverse Event|4|||
129942904|NCT03057600|467755200|FG003|Overall Study|Adverse Event|0|||
129942905|NCT03057600|467755197|FG000|Overall Study|Radiologic Disease Progression|8|||
129942906|NCT03057600|467755198|FG001|Overall Study|Radiologic Disease Progression|7|||
129942907|NCT03057600|467755199|FG002|Overall Study|Radiologic Disease Progression|13|||
129942908|NCT03057600|467755200|FG003|Overall Study|Radiologic Disease Progression|10|||
130120217|NCT00623103|468402291|FG001|Overall Study|Lost to Follow-up|1|||
130120218|NCT00623103|468402290|FG000|Overall Study|Administrative problems|2|||
130120219|NCT00623103|468402291|FG001|Overall Study|Administrative problems|4|||
130120220|NCT00623103|468402290|FG000|Overall Study|Death|11|||
130120221|NCT00623103|468402291|FG001|Overall Study|Death|11|||
130120222|NCT00623103|468402290|FG000|Overall Study|Protocol deviation|2|||
129942909|NCT03057600|467755197|FG000|Overall Study|Symptomatic Deterioration|0|||
129942910|NCT03057600|467755198|FG001|Overall Study|Symptomatic Deterioration|1|||
129942911|NCT03057600|467755199|FG002|Overall Study|Symptomatic Deterioration|1|||
129942912|NCT03057600|467755200|FG003|Overall Study|Symptomatic Deterioration|0|||
129942913|NCT03057600|467755197|FG000|Overall Study|Investigator Decision|0|||
129942914|NCT03057600|467755198|FG001|Overall Study|Investigator Decision|0|||
129942915|NCT03057600|467755199|FG002|Overall Study|Investigator Decision|1|||
129942916|NCT03057600|467755200|FG003|Overall Study|Investigator Decision|0|||
129942917|NCT03057600|467755197|FG000|Overall Study|Study Termination by Sponsor|0|||
129942918|NCT03057600|467755198|FG001|Overall Study|Study Termination by Sponsor|0|||
129942919|NCT03057600|467755199|FG002|Overall Study|Study Termination by Sponsor|0|||
129942920|NCT03057600|467755200|FG003|Overall Study|Study Termination by Sponsor|2|||
129942921|NCT03057600|467755197|FG000|Overall Study|Withdrawal by Subject|0|||
129942922|NCT03057600|467755198|FG001|Overall Study|Withdrawal by Subject|1|||
130071546|NCT03136367|468216146|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
130071547|NCT03136367|468216147|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
130071548|NCT03136367|468216148|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
130071549|NCT03136367|468216146|FG000|T5 1 Year After Surgery|Death|0|||
130071550|NCT03136367|468216147|FG001|T5 1 Year After Surgery|Death|0|||
130071551|NCT03136367|468216148|FG002|T5 1 Year After Surgery|Death|1|||
130071552|NCT03136367|468216146|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
130071553|NCT03136367|468216147|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
130071554|NCT03136367|468216148|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
130071555|NCT03136367|468216146|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
130071556|NCT03136367|468216147|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
130071557|NCT03136367|468216148|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
130071558|NCT03136367|468216146|FG000|T5 1 Year After Surgery|study ended before due|31|||
130071559|NCT03136367|468216147|FG001|T5 1 Year After Surgery|study ended before due|103|||
130071560|NCT03136367|468216148|FG002|T5 1 Year After Surgery|study ended before due|110|||
130071561|NCT03136367|468216146|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
130071562|NCT03136367|468216147|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
130071563|NCT03136367|468216148|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
130071564|NCT05200455|468216149|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
130071565|NCT01602549|468216150|FG000|Overall Study|Protocol Violation|0|||
130071566|NCT01602549|468216151|FG001|Overall Study|Protocol Violation|1|||
130071567|NCT01602549|468216150|FG000|Overall Study|Withdrawal by Subject|1|||
130071568|NCT01602549|468216151|FG001|Overall Study|Withdrawal by Subject|0|||
130071569|NCT03750240|468218055|FG000|Overall Study|Technical Difficulties|2|||
130071570|NCT00927758|468218056|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130071571|NCT00927758|468218057|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130120223|NCT00623103|468402291|FG001|Overall Study|Protocol deviation|1|||
130120224|NCT01966042|468402299|FG000|Overall Study|Death|2|||
130071572|NCT00927758|468218058|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130071573|NCT00927758|468218059|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
130071574|NCT00927758|468218060|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
130071575|NCT00927758|468218061|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
130120225|NCT00625807|468402300|FG000|Overall Study|schedule conflict|2|||
129942923|NCT03057600|467755199|FG002|Overall Study|Withdrawal by Subject|0|||
129942924|NCT03057600|467755200|FG003|Overall Study|Withdrawal by Subject|0|||
129942925|NCT03057600|467755197|FG000|Overall Study|Other, Not Specified|1|||
129942926|NCT03057600|467755198|FG001|Overall Study|Other, Not Specified|1|||
129942927|NCT03057600|467755199|FG002|Overall Study|Other, Not Specified|1|||
129942928|NCT03057600|467755200|FG003|Overall Study|Other, Not Specified|1|||
129942929|NCT01170208|467755201|FG000|Overall Study|Withdrawal by Subject|5|||
129942930|NCT01170208|467755202|FG001|Overall Study|Withdrawal by Subject|0|||
129942931|NCT01170208|467755203|FG002|Overall Study|Withdrawal by Subject|1|||
129942932|NCT01170208|467755201|FG000|Overall Study|Protocol Violation|1|||
129942933|NCT01170208|467755202|FG001|Overall Study|Protocol Violation|0|||
129942934|NCT01170208|467755203|FG002|Overall Study|Protocol Violation|1|||
129942935|NCT03335488|467755210|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
129942936|NCT03335488|467755211|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
129942937|NCT03335488|467755210|FG000|Safety Extension Period|Adverse Event|1|||
129942938|NCT03335488|467755211|FG001|Safety Extension Period|Adverse Event|0|||
129942939|NCT03335488|467755210|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
129942940|NCT03335488|467755211|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
129942941|NCT02113449|467755212|FG000|Overall Study|Adverse Event|4|||
129942942|NCT01160354|467755215|FG000|Overall Study|Death|0|||
129942943|NCT01160354|467755216|FG001|Overall Study|Death|1|||
129942944|NCT01160354|467755217|FG002|Overall Study|Death|1|||
129942945|NCT01822756|467755218|FG000|Overall Study|Adverse Event|0|||
129942946|NCT01822756|467755219|FG001|Overall Study|Adverse Event|0|||
129942947|NCT01822756|467755220|FG002|Overall Study|Adverse Event|0|||
129942948|NCT01822756|467755221|FG003|Overall Study|Adverse Event|2|||
129942949|NCT01822756|467755222|FG004|Overall Study|Adverse Event|0|||
129942950|NCT01822756|467755218|FG000|Overall Study|Disease progression|11|||
129942951|NCT01822756|467755219|FG001|Overall Study|Disease progression|1|||
129942952|NCT01822756|467755220|FG002|Overall Study|Disease progression|7|||
129942953|NCT01822756|467755221|FG003|Overall Study|Disease progression|2|||
129942954|NCT01822756|467755222|FG004|Overall Study|Disease progression|6|||
129942955|NCT01822756|467755218|FG000|Overall Study|Death|2|||
129942956|NCT01822756|467755219|FG001|Overall Study|Death|2|||
129942957|NCT01822756|467755220|FG002|Overall Study|Death|1|||
129942958|NCT01822756|467755221|FG003|Overall Study|Death|0|||
129942959|NCT01822756|467755222|FG004|Overall Study|Death|0|||
129942960|NCT01822756|467755218|FG000|Overall Study|Lost to Follow-up|1|||
129942961|NCT01822756|467755219|FG001|Overall Study|Lost to Follow-up|0|||
129942962|NCT01822756|467755220|FG002|Overall Study|Lost to Follow-up|1|||
129942963|NCT01822756|467755221|FG003|Overall Study|Lost to Follow-up|0|||
129942964|NCT01822756|467755222|FG004|Overall Study|Lost to Follow-up|1|||
129942965|NCT01822756|467755218|FG000|Overall Study|Physician Decision|0|||
129942966|NCT01822756|467755219|FG001|Overall Study|Physician Decision|1|||
129942967|NCT01822756|467755220|FG002|Overall Study|Physician Decision|0|||
129942968|NCT01822756|467755221|FG003|Overall Study|Physician Decision|0|||
129942969|NCT01822756|467755222|FG004|Overall Study|Physician Decision|0|||
129942970|NCT01822756|467755218|FG000|Overall Study|disease progression & patient preference|2|||
129942971|NCT01822756|467755219|FG001|Overall Study|disease progression & patient preference|0|||
129942972|NCT01822756|467755220|FG002|Overall Study|disease progression & patient preference|1|||
129942973|NCT01822756|467755221|FG003|Overall Study|disease progression & patient preference|0|||
129942974|NCT01822756|467755222|FG004|Overall Study|disease progression & patient preference|0|||
129942975|NCT00614614|467755227|FG000|Primary Vaccination Phase|Adverse Event|6|||
129942976|NCT00614614|467755228|FG001|Primary Vaccination Phase|Adverse Event|0|||
129942977|NCT00614614|467755229|FG002|Primary Vaccination Phase|Adverse Event|0|||
129942978|NCT00614614|467755230|FG003|Primary Vaccination Phase|Adverse Event|0|||
129942979|NCT00614614|467755231|FG004|Primary Vaccination Phase|Adverse Event|0|||
129942980|NCT00614614|467755227|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
129942981|NCT00614614|467755228|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
129942982|NCT00614614|467755229|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
129942983|NCT00614614|467755230|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
129942984|NCT00614614|467755231|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
129942985|NCT00614614|467755227|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
129942986|NCT00614614|467755228|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
129942987|NCT00614614|467755229|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
129942988|NCT00614614|467755230|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
130071576|NCT00927758|468218056|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
130071577|NCT00927758|468218057|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
130071578|NCT00927758|468218058|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
130071579|NCT00927758|468218059|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
130071580|NCT00927758|468218060|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
130071581|NCT00927758|468218061|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
130120226|NCT00625807|468402301|FG001|Overall Study|schedule conflict|8|||
129942989|NCT00614614|467755231|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
129942990|NCT00614614|467755227|FG000|Primary Vaccination Phase|Protocol Violation|9|||
129942991|NCT00614614|467755228|FG001|Primary Vaccination Phase|Protocol Violation|3|||
129942992|NCT00614614|467755229|FG002|Primary Vaccination Phase|Protocol Violation|0|||
129942993|NCT00614614|467755230|FG003|Primary Vaccination Phase|Protocol Violation|0|||
130071582|NCT00439725|468218063|FG000|Treatment Period|Withdrawal by Subject|22|||
130071583|NCT00439725|468218064|FG001|Treatment Period|Withdrawal by Subject|19|||
130071584|NCT00439725|468218063|FG000|Treatment Period|Study terminated by sponsor|156|||
130071585|NCT00439725|468218064|FG001|Treatment Period|Study terminated by sponsor|148|||
130071586|NCT00439725|468218063|FG000|Treatment Period|Site closed by investigator|1|||
130071587|NCT00439725|468218064|FG001|Treatment Period|Site closed by investigator|2|||
130071588|NCT00439725|468218063|FG000|Treatment Period|Adverse Event|39|||
130071589|NCT00439725|468218064|FG001|Treatment Period|Adverse Event|18|||
130071590|NCT00439725|468218063|FG000|Treatment Period|Physician Decision|1|||
130071591|NCT00439725|468218064|FG001|Treatment Period|Physician Decision|1|||
130071592|NCT00439725|468218063|FG000|Treatment Period|Protocol Violation|2|||
130071593|NCT00439725|468218064|FG001|Treatment Period|Protocol Violation|1|||
130071594|NCT00439725|468218063|FG000|Treatment Period|Clinical endpoint reached|6|||
130071595|NCT00439725|468218064|FG001|Treatment Period|Clinical endpoint reached|50|||
130071596|NCT00439725|468218063|FG000|Treatment Period|Technical problems|1|||
130071597|NCT00439725|468218064|FG001|Treatment Period|Technical problems|0|||
130071598|NCT00439725|468218063|FG000|Treatment Period|Lost to Follow-up|1|||
130071599|NCT00439725|468218064|FG001|Treatment Period|Lost to Follow-up|1|||
130071600|NCT00439725|468218063|FG000|Treatment Period|Participant convenience|1|||
130071601|NCT00439725|468218064|FG001|Treatment Period|Participant convenience|0|||
130071602|NCT00439725|468218063|FG000|Treatment Period|Protocol driven decision point|1|||
130071603|NCT00439725|468218064|FG001|Treatment Period|Protocol driven decision point|1|||
130071604|NCT00439725|468218063|FG000|Treatment Period|Death|1|||
130071605|NCT00439725|468218064|FG001|Treatment Period|Death|1|||
130071606|NCT00439725|468218063|FG000|Treatment Period|Participant did not receive treatment|4|||
130120227|NCT02224391|468402302|FG000|Overall Study|Lost to Follow-up|26|||
130120228|NCT02224391|468402303|FG001|Overall Study|Lost to Follow-up|19|||
129942994|NCT00614614|467755231|FG004|Primary Vaccination Phase|Protocol Violation|0|||
129942995|NCT00614614|467755227|FG000|Primary Vaccination Phase|Other|4|||
129942996|NCT00614614|467755228|FG001|Primary Vaccination Phase|Other|0|||
129942997|NCT00614614|467755229|FG002|Primary Vaccination Phase|Other|0|||
129942998|NCT00614614|467755230|FG003|Primary Vaccination Phase|Other|0|||
129942999|NCT00614614|467755231|FG004|Primary Vaccination Phase|Other|0|||
129943000|NCT00614614|467755227|FG000|Booster Vaccination Phase|Adverse Event|0|||
129943001|NCT00614614|467755228|FG001|Booster Vaccination Phase|Adverse Event|0|||
129943002|NCT00614614|467755229|FG002|Booster Vaccination Phase|Adverse Event|1|||
129943003|NCT00614614|467755230|FG003|Booster Vaccination Phase|Adverse Event|1|||
129943004|NCT00614614|467755231|FG004|Booster Vaccination Phase|Adverse Event|0|||
129943005|NCT00614614|467755227|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
129943006|NCT00614614|467755228|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129943007|NCT00614614|467755229|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
129943008|NCT00614614|467755230|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
129943009|NCT00614614|467755231|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
129943010|NCT00614614|467755227|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
129943011|NCT00614614|467755228|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
129943012|NCT00614614|467755229|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
129943013|NCT00614614|467755230|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
129943014|NCT00614614|467755231|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
129943015|NCT00614614|467755227|FG000|Booster Vaccination Phase|Protocol Violation|0|||
129943016|NCT00614614|467755228|FG001|Booster Vaccination Phase|Protocol Violation|0|||
129943017|NCT00614614|467755229|FG002|Booster Vaccination Phase|Protocol Violation|2|||
129943018|NCT00614614|467755230|FG003|Booster Vaccination Phase|Protocol Violation|3|||
129943019|NCT00614614|467755231|FG004|Booster Vaccination Phase|Protocol Violation|0|||
129943020|NCT00614614|467755227|FG000|Booster Vaccination Phase|Other|0|||
129943021|NCT00614614|467755228|FG001|Booster Vaccination Phase|Other|1|||
129943022|NCT00614614|467755229|FG002|Booster Vaccination Phase|Other|3|||
129943023|NCT00614614|467755230|FG003|Booster Vaccination Phase|Other|2|||
129943024|NCT00614614|467755231|FG004|Booster Vaccination Phase|Other|1|||
129943025|NCT00933270|467755232|FG000|Overall Study|Withdrawal by Subject|26|||
129943026|NCT00933270|467755232|FG000|Overall Study|Insufficient Follow-up|10|||
129943027|NCT00933270|467755232|FG000|Overall Study|Lost to Follow-up|14|||
129943028|NCT00933270|467755232|FG000|Overall Study|Adverse Event|1|||
129943029|NCT00933270|467755232|FG000|Overall Study|Missed Visit|2|||
129943030|NCT00933270|467755232|FG000|Overall Study|Death|24|||
129943031|NCT00933270|467755232|FG000|Overall Study|Moved or would not return|10|||
129943032|NCT01000805|467755233|FG000|Overall Study|Adverse Event|21|||
130071607|NCT00439725|468218064|FG001|Treatment Period|Participant did not receive treatment|4|||
130071608|NCT00439725|468218063|FG000|Observational Period|Withdrawal by Subject|2|||
130071609|NCT00439725|468218064|FG001|Observational Period|Withdrawal by Subject|2|||
130071610|NCT00439725|468218063|FG000|Observational Period|Lost to Follow-up|0|||
130071611|NCT00439725|468218064|FG001|Observational Period|Lost to Follow-up|1|||
130071612|NCT00439725|468218063|FG000|Observational Period|Death|0|||
129943033|NCT01000805|467755234|FG001|Overall Study|Adverse Event|9|||
129943034|NCT01000805|467755233|FG000|Overall Study|Lack of Efficacy|5|||
129943035|NCT01000805|467755234|FG001|Overall Study|Lack of Efficacy|16|||
129943036|NCT01000805|467755233|FG000|Overall Study|Lost to Follow-up|16|||
129943037|NCT01000805|467755234|FG001|Overall Study|Lost to Follow-up|21|||
129943038|NCT01000805|467755233|FG000|Overall Study|Physician Decision|0|||
129943039|NCT01000805|467755234|FG001|Overall Study|Physician Decision|1|||
129943040|NCT01000805|467755233|FG000|Overall Study|Protocol Violation|12|||
129943041|NCT01000805|467755234|FG001|Overall Study|Protocol Violation|8|||
129943042|NCT01000805|467755233|FG000|Overall Study|Withdrawal by Subject|16|||
129943043|NCT01000805|467755234|FG001|Overall Study|Withdrawal by Subject|6|||
129943044|NCT01000805|467755233|FG000|Overall Study|Sponsor Decision|0|||
129943045|NCT01000805|467755234|FG001|Overall Study|Sponsor Decision|1|||
129943046|NCT00989196|467755235|FG000|Treatment Period|Lost to Follow-up|1|||
129943047|NCT00989196|467755236|FG001|Treatment Period|Lost to Follow-up|0|||
129943048|NCT03476798|467755239|FG000|Overall Study|Death|1|||
129943049|NCT03476798|467755239|FG000|Overall Study|Withdrawal by Subject|2|||
129943050|NCT03476798|467755239|FG000|Overall Study|Protocol Violation|2|||
129943051|NCT05824559|467755240|FG000|Overall Study|Adverse Event|2|||
129943052|NCT05824559|467755240|FG000|Overall Study|Physician Decision|2|||
129943053|NCT05824559|467755240|FG000|Overall Study|Progressive Disease|16|||
129943054|NCT05824559|467755240|FG000|Overall Study|Study Terminated by Sponsor|1|||
129943055|NCT05824559|467755240|FG000|Overall Study|Withdrawal by Subject|2|||
129943056|NCT02409680|467755245|FG000|Overall Study|Lost to Follow-up|15|||
129943057|NCT02409680|467755246|FG001|Overall Study|Lost to Follow-up|30|||
129943058|NCT03343704|467755252|FG000|Overall Study|Refused to complete follow up|0|||
129943059|NCT03343704|467755253|FG001|Overall Study|Refused to complete follow up|1|||
129943060|NCT03343704|467755252|FG000|Overall Study|Death|0|||
129943061|NCT03343704|467755253|FG001|Overall Study|Death|1|||
129943062|NCT03343704|467755252|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
129943063|NCT03343704|467755253|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
129943064|NCT03789656|467755254|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
129943065|NCT03789656|467755255|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
129943066|NCT03789656|467755256|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
129943067|NCT03789656|467755257|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
129943068|NCT03789656|467755258|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
129943069|NCT03789656|467755254|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943070|NCT03789656|467755255|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943071|NCT03789656|467755256|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
129943072|NCT03789656|467755257|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943073|NCT03789656|467755258|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943074|NCT03789656|467755254|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
129943075|NCT03789656|467755255|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943076|NCT03789656|467755256|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943077|NCT03789656|467755257|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943078|NCT03789656|467755258|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943079|NCT03789656|467755254|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
129943080|NCT03789656|467755255|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943081|NCT03789656|467755256|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943082|NCT03789656|467755257|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943083|NCT03789656|467755258|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943084|NCT02434328|467755266|FG000|Overall Study|Adverse Event|9|||
129943085|NCT02434328|467755267|FG001|Overall Study|Adverse Event|4|||
129943086|NCT02434328|467755266|FG000|Overall Study|Lack of Efficacy|0|||
129943087|NCT02434328|467755267|FG001|Overall Study|Lack of Efficacy|2|||
129943088|NCT02434328|467755266|FG000|Overall Study|Physician Decision|0|||
129943089|NCT02434328|467755267|FG001|Overall Study|Physician Decision|1|||
129943090|NCT02434328|467755266|FG000|Overall Study|Withdrawal by Subject|12|||
129943091|NCT02434328|467755267|FG001|Overall Study|Withdrawal by Subject|21|||
129943092|NCT02434328|467755266|FG000|Overall Study|Death|4|||
129943093|NCT02434328|467755267|FG001|Overall Study|Death|7|||
129943094|NCT02434328|467755266|FG000|Overall Study|Lost to Follow-up|1|||
129943095|NCT02434328|467755267|FG001|Overall Study|Lost to Follow-up|6|||
129943096|NCT02434328|467755266|FG000|Overall Study|Other|4|||
129943097|NCT02434328|467755267|FG001|Overall Study|Other|1|||
129943098|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
129943099|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
129943100|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
129943101|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
129943102|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
129943103|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
129943104|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
129943105|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
129943106|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
129943107|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
130071613|NCT00439725|468218064|FG001|Observational Period|Death|2|||
129943108|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
129943109|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943110|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943111|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943112|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943113|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Disease progression|0|||
129943114|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Disease progression|1|||
129943115|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Disease progression|1|||
129943116|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Disease progression|0|||
129943117|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Disease progression|0|||
129943118|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
129943119|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
129943120|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
129943121|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
129943122|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
129943123|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943124|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943125|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943126|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
129943127|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943128|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943129|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943130|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943131|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
130071614|NCT00439725|468218063|FG000|Observational Period|Study termination by sponsor|1|||
130071615|NCT00439725|468218064|FG001|Observational Period|Study termination by sponsor|1|||
129943132|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943133|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
129943134|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
129943135|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
129943136|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
129943137|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
129943138|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Death|0|||
129943139|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Death|0|||
129943140|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Death|0|||
129943141|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Death|1|||
129943142|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Death|1|||
129943143|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943144|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943145|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943146|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943147|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
129943148|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943149|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943150|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943151|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943152|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
129943153|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943154|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943155|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943156|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
130071616|NCT00439725|468218063|FG000|Observational Period|Clinical endpoint reached|3|||
130071617|NCT00439725|468218064|FG001|Observational Period|Clinical endpoint reached|1|||
129943157|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943158|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
129943159|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
129943160|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
130071618|NCT00439725|468218063|FG000|Observational Period|Technical problems|1|||
130071619|NCT00439725|468218064|FG001|Observational Period|Technical problems|0|||
130071620|NCT00439725|468218063|FG000|Observational Period|Participant convenience|1|||
130071621|NCT00439725|468218064|FG001|Observational Period|Participant convenience|0|||
130071622|NCT00379236|468218065|FG000|Double-blind|Adverse Event|11|||
130071623|NCT00379236|468218066|FG001|Double-blind|Adverse Event|6|||
130071624|NCT00379236|468218067|FG002|Double-blind|Adverse Event|0|||
130071625|NCT00379236|468218065|FG000|Double-blind|Protocol Violation|3|||
129943161|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
129943162|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
129943163|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
129943164|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
129943165|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
129943166|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
129943167|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
129943168|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
129943169|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
129943170|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
129943171|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
129943172|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
129943173|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
129943174|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
129943175|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
129943176|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
129943177|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
129943178|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
129943179|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
129943180|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
129943181|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
129943182|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
129943183|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
129943184|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
129943185|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
129943186|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
129943187|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
129943188|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
129943189|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
129943190|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
129943191|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
129943192|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
129943193|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
129943194|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
129943195|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
129943196|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
129943197|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
129943198|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
129943199|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
129943200|NCT05432986|467755280|FG000|Overall Study|Withdrawal by Subject|2|||
129943201|NCT05432986|467755280|FG000|Overall Study|incomplete measurement|7|||
129943202|NCT03009344|467756652|FG000|Overall Study|Lack of Efficacy|5|||
129943203|NCT03009344|467756652|FG000|Overall Study|Withdrawal by Subject|1|||
129943204|NCT03009344|467756652|FG000|Overall Study|Adverse Event|1|||
129943205|NCT03116464|467756653|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
129943206|NCT00597376|467756654|FG000|Overall Study|Withdrawal by Subject|4|||
129943207|NCT00597376|467756655|FG001|Overall Study|Withdrawal by Subject|3|||
129943208|NCT00597376|467756654|FG000|Overall Study|Adverse Event|4|||
129943209|NCT00597376|467756655|FG001|Overall Study|Adverse Event|1|||
129943210|NCT01532648|467756658|FG000|Overall Study|Lost to Follow-up|3|||
129943211|NCT01532648|467756659|FG001|Overall Study|Lost to Follow-up|4|||
129943212|NCT01532648|467756658|FG000|Overall Study|Lack of Efficacy|4|||
129943213|NCT01532648|467756659|FG001|Overall Study|Lack of Efficacy|1|||
129943214|NCT01532648|467756658|FG000|Overall Study|Protocol Violation|1|||
129943215|NCT01532648|467756659|FG001|Overall Study|Protocol Violation|1|||
129943216|NCT01532648|467756658|FG000|Overall Study|Adverse Event|12|||
129943217|NCT01532648|467756659|FG001|Overall Study|Adverse Event|9|||
129943218|NCT01532648|467756658|FG000|Overall Study|Withdrawal by Subject|16|||
129943219|NCT01532648|467756659|FG001|Overall Study|Withdrawal by Subject|2|||
129943220|NCT01583166|467756660|FG000|Overall Study|Withdrawal by Subject|4|||
129943221|NCT01583166|467756661|FG001|Overall Study|Withdrawal by Subject|6|||
129943222|NCT04652869|467756666|FG000|Overall Study|Withdrawal by Subject|0|||
129943223|NCT04652869|467756667|FG001|Overall Study|Withdrawal by Subject|2|||
129943224|NCT04652869|467756668|FG002|Overall Study|Withdrawal by Subject|0|||
129943225|NCT01833455|467756669|FG000|Overall Study|Withdrawal by Subject|1|||
129943226|NCT01833455|467756670|FG001|Overall Study|Withdrawal by Subject|0|||
129943227|NCT00562094|467756671|FG000|Overall Study|Lost to Follow-up|62|||
129943228|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
129943229|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
129943230|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
129943231|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
129943232|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
129943233|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
129943234|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
129943235|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
129943236|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
129943237|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
129943238|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
129943239|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
129943240|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Other|1|||
129943241|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Other|0|||
129943242|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Other|0|||
129943243|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
129943244|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
129943245|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
129943246|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
129943247|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
129943248|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
129943249|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
129943250|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
129943251|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
129943252|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
129943253|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
129943254|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
129943255|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
129943256|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
129943257|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
129943258|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
129943259|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
129943260|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
129943261|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Other|1|||
129943262|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Other|0|||
129943263|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Other|0|||
129943264|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
129943265|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
129943266|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
129943267|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
129943268|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
129943269|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
129943270|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
129943271|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
129943272|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
129943273|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
129943274|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
129943275|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
129943276|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
129943277|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
129943278|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
129943279|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
129943280|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
129943281|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
129943282|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Other|30|||
129943283|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Other|0|||
129943284|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Other|0|||
129943285|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
129943286|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
129943287|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
129943288|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
129943289|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
129943290|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
129943291|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Adverse Event|0|||
129943292|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Adverse Event|7|||
129943293|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Adverse Event|2|||
129943294|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Failed to return|0|||
129943295|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Failed to return|2|||
129943296|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Failed to return|2|||
129943297|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
129943298|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
129943299|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
129943300|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
129943301|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
129943302|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
129943303|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Other|0|||
129943304|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Other|2|||
129943305|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Other|0|||
129943306|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
129943307|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
129943308|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
129943309|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
129943310|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
129943311|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
129943312|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
129943313|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
129943314|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
129943315|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
129943316|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
129943317|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
129943318|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
129943319|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
129943320|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
129943321|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
129943322|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
129943323|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
129943324|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
129943325|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
129943326|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
129943327|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
129943328|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
129943329|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
129943330|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
129943331|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
129943332|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
129943333|NCT01555138|467756677|FG000|Overall Study|Death|0|||
129943334|NCT01555138|467756678|FG001|Overall Study|Death|1|||
129943335|NCT01555138|467756677|FG000|Overall Study|Lost to Follow-up|1|||
129943336|NCT01555138|467756678|FG001|Overall Study|Lost to Follow-up|0|||
129943337|NCT01555138|467756677|FG000|Overall Study|Abnormal Lab reults|1|||
129943338|NCT01555138|467756678|FG001|Overall Study|Abnormal Lab reults|3|||
129943339|NCT01555138|467756677|FG000|Overall Study|Lack of Efficacy|2|||
129943340|NCT01555138|467756678|FG001|Overall Study|Lack of Efficacy|2|||
129943341|NCT01555138|467756677|FG000|Overall Study|Protocol Violation|5|||
129943342|NCT01555138|467756678|FG001|Overall Study|Protocol Violation|3|||
129943343|NCT01555138|467756677|FG000|Overall Study|Administrative problems|8|||
129943344|NCT01555138|467756678|FG001|Overall Study|Administrative problems|0|||
129943345|NCT01555138|467756677|FG000|Overall Study|Withdrawal by Subject|16|||
129943346|NCT01555138|467756678|FG001|Overall Study|Withdrawal by Subject|15|||
129943347|NCT01555138|467756677|FG000|Overall Study|Adverse Event|14|||
129943348|NCT01555138|467756678|FG001|Overall Study|Adverse Event|14|||
129943349|NCT03883828|467756679|FG000|Overall Study|Did not start radiotherapy|1|||
129943350|NCT03883828|467756680|FG001|Overall Study|Did not start radiotherapy|2|||
129943351|NCT04938453|467756684|FG000|Washout Period 1|Adverse Event|1|||
129943352|NCT04938453|467756685|FG001|Washout Period 1|Adverse Event|0|||
129943353|NCT04938453|467756684|FG000|Washout Period 1|Physician Decision|0|||
129943354|NCT04938453|467756685|FG001|Washout Period 1|Physician Decision|1|||
129943355|NCT02095145|467756690|FG000|Overall Study|Withdrawal by Subject|1|||
129943356|NCT02095145|467756691|FG001|Overall Study|Withdrawal by Subject|0|||
129943357|NCT04237792|467756695|FG000|Treatment (Day 1)|Adverse Event|1|||
129943358|NCT04237792|467756696|FG001|Treatment (Day 1)|Adverse Event|0|||
129943359|NCT04237792|467756697|FG002|Treatment (Day 1)|Adverse Event|0|||
129943360|NCT04237792|467756698|FG003|Treatment (Day 1)|Adverse Event|0|||
129943361|NCT04237792|467756699|FG004|Treatment (Day 1)|Adverse Event|1|||
129943362|NCT04237792|467756700|FG005|Treatment (Day 1)|Adverse Event|1|||
129943363|NCT04237792|467756695|FG000|Treatment (Day 1)|Other|0|||
129943364|NCT04237792|467756696|FG001|Treatment (Day 1)|Other|0|||
129943365|NCT04237792|467756697|FG002|Treatment (Day 1)|Other|1|||
129943366|NCT04237792|467756698|FG003|Treatment (Day 1)|Other|0|||
129943367|NCT04237792|467756699|FG004|Treatment (Day 1)|Other|0|||
129943368|NCT04237792|467756700|FG005|Treatment (Day 1)|Other|1|||
129943369|NCT04237792|467756695|FG000|Treatment (Day 1)|Not treated|1|||
129943370|NCT04237792|467756696|FG001|Treatment (Day 1)|Not treated|1|||
129943371|NCT04237792|467756697|FG002|Treatment (Day 1)|Not treated|2|||
129943372|NCT04237792|467756698|FG003|Treatment (Day 1)|Not treated|1|||
129943373|NCT04237792|467756699|FG004|Treatment (Day 1)|Not treated|0|||
129943374|NCT04237792|467756700|FG005|Treatment (Day 1)|Not treated|1|||
129943375|NCT05553366|467756702|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
129943376|NCT05553366|467756703|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
129943377|NCT05553366|467756704|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
129943378|NCT05553366|467756702|FG000|Overall Study|Lost to Follow-up|3|||
129943379|NCT05553366|467756703|FG001|Overall Study|Lost to Follow-up|3|||
129943380|NCT05553366|467756704|FG002|Overall Study|Lost to Follow-up|3|||
129943381|NCT05553366|467756702|FG000|Overall Study|Other non-compliance|1|||
129943382|NCT05553366|467756703|FG001|Overall Study|Other non-compliance|1|||
129943383|NCT05553366|467756704|FG002|Overall Study|Other non-compliance|0|||
129943384|NCT05553366|467756702|FG000|Overall Study|Randomized but not dosed|0|||
129943385|NCT05553366|467756703|FG001|Overall Study|Randomized but not dosed|0|||
129943386|NCT05553366|467756704|FG002|Overall Study|Randomized but not dosed|2|||
129943387|NCT02022657|467756708|FG000|Overall Study|Withdrawal by Subject|2|||
129943388|NCT02022657|467756709|FG001|Overall Study|Withdrawal by Subject|0|||
129943389|NCT02022657|467756710|FG002|Overall Study|Withdrawal by Subject|1|||
129943390|NCT02022657|467756711|FG003|Overall Study|Withdrawal by Subject|0|||
129943391|NCT02022657|467756712|FG004|Overall Study|Withdrawal by Subject|0|||
129943392|NCT02022657|467756713|FG005|Overall Study|Withdrawal by Subject|0|||
129943393|NCT02022657|467756708|FG000|Overall Study|Physician Decision|0|||
129943394|NCT02022657|467756709|FG001|Overall Study|Physician Decision|0|||
129943395|NCT02022657|467756710|FG002|Overall Study|Physician Decision|0|||
129943396|NCT02022657|467756711|FG003|Overall Study|Physician Decision|0|||
129943397|NCT02022657|467756712|FG004|Overall Study|Physician Decision|0|||
129943398|NCT02022657|467756713|FG005|Overall Study|Physician Decision|1|||
129943399|NCT03739866|467756715|FG000|Overall Study|Lost to Follow-up|0|||
129943400|NCT03739866|467756716|FG001|Overall Study|Lost to Follow-up|0|||
129943401|NCT03739866|467756717|FG002|Overall Study|Lost to Follow-up|0|||
129943402|NCT03739866|467756718|FG003|Overall Study|Lost to Follow-up|1|||
129943403|NCT03739866|467756719|FG004|Overall Study|Lost to Follow-up|0|||
129943404|NCT03739866|467756720|FG005|Overall Study|Lost to Follow-up|0|||
129943405|NCT03739866|467756721|FG006|Overall Study|Lost to Follow-up|0|||
129943406|NCT03739866|467756722|FG007|Overall Study|Lost to Follow-up|0|||
129943407|NCT03739866|467756715|FG000|Overall Study|Enrolled but not treated|0|||
129943408|NCT03739866|467756716|FG001|Overall Study|Enrolled but not treated|0|||
129943409|NCT03739866|467756717|FG002|Overall Study|Enrolled but not treated|1|||
129943410|NCT03739866|467756718|FG003|Overall Study|Enrolled but not treated|0|||
129943411|NCT03739866|467756719|FG004|Overall Study|Enrolled but not treated|1|||
129943412|NCT03739866|467756720|FG005|Overall Study|Enrolled but not treated|0|||
129943413|NCT03739866|467756721|FG006|Overall Study|Enrolled but not treated|0|||
129943414|NCT03739866|467756722|FG007|Overall Study|Enrolled but not treated|0|||
129943415|NCT01034306|467756723|FG000|Overall Study|Adverse Event|1|||
129943416|NCT01034306|467756724|FG001|Overall Study|Adverse Event|0|||
129943417|NCT01034306|467756723|FG000|Overall Study|Lost to Follow-up|0|||
129943418|NCT01034306|467756724|FG001|Overall Study|Lost to Follow-up|1|||
129943419|NCT01034306|467756723|FG000|Overall Study|Withdrawal by Subject|2|||
129943420|NCT01034306|467756724|FG001|Overall Study|Withdrawal by Subject|2|||
129943421|NCT01034306|467756723|FG000|Overall Study|hospitalized and decided to stop|1|||
129943422|NCT01034306|467756724|FG001|Overall Study|hospitalized and decided to stop|0|||
129943423|NCT01034306|467756723|FG000|Overall Study|Noncomplience|1|||
129943424|NCT01034306|467756724|FG001|Overall Study|Noncomplience|0|||
129943425|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
129943426|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
129943427|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
129943428|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
129943429|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
129943430|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
129943431|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
129943432|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
129943433|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
129943434|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
129943435|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
129943436|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
129943437|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
129943438|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
129943439|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Death|1|||
129943440|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Death|0|||
129943441|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
129943442|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
129943443|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
129943444|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
129943445|NCT01968967|467756731|FG000|Treatment Period|Other|22|||
129943446|NCT01968967|467756732|FG001|Treatment Period|Other|22|||
129943447|NCT01968967|467756733|FG002|Treatment Period|Other|0|||
129943448|NCT01968967|467756734|FG003|Treatment Period|Other|0|||
129943449|NCT01968967|467756735|FG004|Treatment Period|Other|0|||
129943450|NCT01968967|467756731|FG000|Treatment Period|Withdrawal by Subject|71|||
129943451|NCT01968967|467756732|FG001|Treatment Period|Withdrawal by Subject|61|||
129943452|NCT01968967|467756733|FG002|Treatment Period|Withdrawal by Subject|0|||
129943453|NCT01968967|467756734|FG003|Treatment Period|Withdrawal by Subject|0|||
129943454|NCT01968967|467756735|FG004|Treatment Period|Withdrawal by Subject|0|||
129943455|NCT01968967|467756731|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
129943456|NCT01968967|467756732|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
129943457|NCT01968967|467756733|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
129943458|NCT01968967|467756734|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
129943459|NCT01968967|467756735|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
129943460|NCT01968967|467756731|FG000|Treatment Period|Lost to Follow-up|26|||
129943461|NCT01968967|467756732|FG001|Treatment Period|Lost to Follow-up|31|||
129943462|NCT01968967|467756733|FG002|Treatment Period|Lost to Follow-up|0|||
129943463|NCT01968967|467756734|FG003|Treatment Period|Lost to Follow-up|0|||
129943464|NCT01968967|467756735|FG004|Treatment Period|Lost to Follow-up|0|||
129943465|NCT01968967|467756731|FG000|Treatment Period|Protocol Violation|1|||
129943466|NCT01968967|467756732|FG001|Treatment Period|Protocol Violation|2|||
129943467|NCT01968967|467756733|FG002|Treatment Period|Protocol Violation|0|||
129943468|NCT01968967|467756734|FG003|Treatment Period|Protocol Violation|0|||
129943469|NCT01968967|467756735|FG004|Treatment Period|Protocol Violation|0|||
129943470|NCT01968967|467756731|FG000|Treatment Period|Adverse Event|9|||
129943471|NCT01968967|467756732|FG001|Treatment Period|Adverse Event|8|||
129943472|NCT01968967|467756733|FG002|Treatment Period|Adverse Event|0|||
129943473|NCT01968967|467756734|FG003|Treatment Period|Adverse Event|0|||
129943474|NCT01968967|467756735|FG004|Treatment Period|Adverse Event|0|||
129943475|NCT01968967|467756731|FG000|Treatment Period|Death|9|||
129943476|NCT01968967|467756732|FG001|Treatment Period|Death|2|||
129943477|NCT01968967|467756733|FG002|Treatment Period|Death|0|||
129943478|NCT01968967|467756734|FG003|Treatment Period|Death|0|||
129943479|NCT01968967|467756735|FG004|Treatment Period|Death|0|||
129943480|NCT01968967|467756731|FG000|Treatment Period|Randomized Not Treated|6|||
129943481|NCT01968967|467756732|FG001|Treatment Period|Randomized Not Treated|5|||
129943482|NCT01968967|467756733|FG002|Treatment Period|Randomized Not Treated|0|||
129943483|NCT01968967|467756734|FG003|Treatment Period|Randomized Not Treated|0|||
129943484|NCT01968967|467756735|FG004|Treatment Period|Randomized Not Treated|0|||
129943485|NCT01968967|467756731|FG000|Extension Period|Withdrew Consent|0|||
129943486|NCT01968967|467756732|FG001|Extension Period|Withdrew Consent|0|||
129943487|NCT01968967|467756733|FG002|Extension Period|Withdrew Consent|2|||
129943488|NCT01968967|467756734|FG003|Extension Period|Withdrew Consent|0|||
129943489|NCT01968967|467756735|FG004|Extension Period|Withdrew Consent|5|||
129943490|NCT03489369|467756736|FG000|Overall Study|Documented Progressive Disease|3|||
129943491|NCT03489369|467756737|FG001|Overall Study|Documented Progressive Disease|2|||
129943492|NCT03489369|467756738|FG002|Overall Study|Documented Progressive Disease|3|||
129943493|NCT03489369|467756739|FG003|Overall Study|Documented Progressive Disease|6|||
129943494|NCT03489369|467756736|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
129943495|NCT03489369|467756737|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
129943496|NCT03489369|467756738|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
129943497|NCT03489369|467756739|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
129943498|NCT00109031|467756745|FG000|Overall Study|Adverse Event|0|||
129943499|NCT00109031|467756746|FG001|Overall Study|Adverse Event|0|||
129943500|NCT00109031|467756747|FG002|Overall Study|Adverse Event|1|||
129943501|NCT00109031|467756748|FG003|Overall Study|Adverse Event|0|||
129943502|NCT00109031|467756745|FG000|Overall Study|Withdrawal by Subject|0|||
129943503|NCT00109031|467756746|FG001|Overall Study|Withdrawal by Subject|1|||
129943504|NCT00109031|467756747|FG002|Overall Study|Withdrawal by Subject|0|||
129943505|NCT00109031|467756748|FG003|Overall Study|Withdrawal by Subject|0|||
129943506|NCT00109031|467756745|FG000|Overall Study|Physician Decision|0|||
129943507|NCT00109031|467756746|FG001|Overall Study|Physician Decision|1|||
129943508|NCT00109031|467756747|FG002|Overall Study|Physician Decision|0|||
129943509|NCT00109031|467756748|FG003|Overall Study|Physician Decision|0|||
129943510|NCT00109031|467756745|FG000|Overall Study|Protocol Violation|0|||
129943511|NCT00109031|467756746|FG001|Overall Study|Protocol Violation|0|||
129943512|NCT00109031|467756747|FG002|Overall Study|Protocol Violation|1|||
129943513|NCT00109031|467756748|FG003|Overall Study|Protocol Violation|0|||
129943514|NCT03697603|467756749|FG000|Overall Study|Adverse Event|3|||
129943515|NCT03697603|467756750|FG001|Overall Study|Adverse Event|18|||
129943516|NCT03697603|467756751|FG002|Overall Study|Adverse Event|3|||
129943517|NCT03697603|467756749|FG000|Overall Study|Physician Decision|1|||
129943518|NCT03697603|467756750|FG001|Overall Study|Physician Decision|0|||
129943519|NCT03697603|467756751|FG002|Overall Study|Physician Decision|2|||
129943520|NCT03697603|467756749|FG000|Overall Study|Protocol Violation|3|||
129943521|NCT03697603|467756750|FG001|Overall Study|Protocol Violation|8|||
129943522|NCT03697603|467756751|FG002|Overall Study|Protocol Violation|5|||
129943523|NCT03697603|467756749|FG000|Overall Study|Withdrawal by Subject|5|||
129943524|NCT03697603|467756750|FG001|Overall Study|Withdrawal by Subject|1|||
129943525|NCT03697603|467756751|FG002|Overall Study|Withdrawal by Subject|1|||
129943526|NCT03697603|467756749|FG000|Overall Study|Protocol Violation|0|||
129943527|NCT03697603|467756750|FG001|Overall Study|Protocol Violation|0|||
129943528|NCT03697603|467756751|FG002|Overall Study|Protocol Violation|1|||
129943529|NCT02309294|467756754|FG000|Overall Study|Withdrawal by Subject|2|||
129943530|NCT03520036|467756755|FG000|Overall Study|Adverse Event|1|||
129943531|NCT03520036|467756756|FG001|Overall Study|Adverse Event|2|||
129943532|NCT03520036|467756757|FG002|Overall Study|Adverse Event|0|||
129943533|NCT03520036|467756755|FG000|Overall Study|Protocol Violation|1|||
129943534|NCT03520036|467756756|FG001|Overall Study|Protocol Violation|0|||
129943535|NCT03520036|467756757|FG002|Overall Study|Protocol Violation|0|||
129943536|NCT03520036|467756755|FG000|Overall Study|Withdrawal by Subject|0|||
129943537|NCT03520036|467756756|FG001|Overall Study|Withdrawal by Subject|1|||
129943538|NCT03520036|467756757|FG002|Overall Study|Withdrawal by Subject|4|||
129943539|NCT03520036|467756755|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
129943540|NCT03520036|467756756|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
129943541|NCT03520036|467756757|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
129943542|NCT00467272|467756760|FG000|Overall Study|Pneumonia|2|||
129943543|NCT00467272|467756760|FG000|Overall Study|Thrombophlebitis|1|||
129943544|NCT05426109|467756761|FG000|Overall Study|Withdrawal by Subject|0|||
129943545|NCT05426109|467756762|FG001|Overall Study|Withdrawal by Subject|1|||
129943546|NCT05212285|467756763|FG000|Overall Study|Lack of Efficacy|12|||
129943547|NCT05212285|467756764|FG001|Overall Study|Lack of Efficacy|8|||
129943548|NCT05212285|467756763|FG000|Overall Study|Withdrawal by Subject|8|||
129943549|NCT05212285|467756764|FG001|Overall Study|Withdrawal by Subject|1|||
129943550|NCT05212285|467756763|FG000|Overall Study|Lost to Follow-up|13|||
129943551|NCT05212285|467756764|FG001|Overall Study|Lost to Follow-up|1|||
129943552|NCT05212285|467756763|FG000|Overall Study|miss data|21|||
129943553|NCT05212285|467756764|FG001|Overall Study|miss data|2|||
129943554|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
129943555|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
129943556|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
129943557|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
129943558|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
129943559|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
129943560|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
129943561|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
129943562|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
129943563|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
129943564|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
129943565|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
129943566|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
129943567|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
129943568|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
129943569|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
129943570|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
129943571|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
129943572|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
129943573|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
129943574|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
129943575|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
129943576|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
129943577|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
129943578|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
129943579|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
129943580|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
129943581|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
129943582|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
129943583|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
129943584|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
129943585|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
129943586|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
129943587|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
129943588|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
129943589|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
129943590|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
129943591|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
129943592|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
129943593|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
129943594|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
129943595|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
129943596|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
129943597|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
129943598|NCT03924869|467756770|FG000|Overall Study|Death|66|||
129943599|NCT03924869|467756771|FG001|Overall Study|Death|53|||
129943600|NCT03924869|467756770|FG000|Overall Study|Lost to Follow-up|2|||
129943601|NCT03924869|467756771|FG001|Overall Study|Lost to Follow-up|0|||
129943602|NCT03924869|467756770|FG000|Overall Study|Physician Decision|0|||
129943603|NCT03924869|467756771|FG001|Overall Study|Physician Decision|3|||
129943604|NCT03924869|467756770|FG000|Overall Study|Withdrawal by Subject|5|||
129943605|NCT03924869|467756771|FG001|Overall Study|Withdrawal by Subject|1|||
129943606|NCT03924869|467756770|FG000|Overall Study|Participants Ongoing|154|||
129943607|NCT03924869|467756771|FG001|Overall Study|Participants Ongoing|164|||
129943608|NCT02542943|467756772|FG000|Overall Study|Lost to Follow-up|1|||
129943609|NCT02542943|467756773|FG001|Overall Study|Lost to Follow-up|0|||
129943610|NCT02542943|467756774|FG002|Overall Study|Lost to Follow-up|0|||
129943611|NCT02542943|467756772|FG000|Overall Study|Withdrawal by Subject|0|||
129943612|NCT02542943|467756773|FG001|Overall Study|Withdrawal by Subject|1|||
129943613|NCT02542943|467756774|FG002|Overall Study|Withdrawal by Subject|0|||
129943614|NCT05865392|467756783|FG000|Overall Study|Withdrawal by Subject|4|||
129943615|NCT05865392|467756784|FG001|Overall Study|Withdrawal by Subject|0|||
129943616|NCT05865392|467756783|FG000|Overall Study|Didn't meet inclusion criteria|4|||
129943617|NCT05865392|467756784|FG001|Overall Study|Didn't meet inclusion criteria|0|||
129943618|NCT02637063|467758048|FG000|Overall Study|Lost to Follow-up|3|||
129943619|NCT02637063|467758049|FG001|Overall Study|Lost to Follow-up|2|||
129943620|NCT02637063|467758050|FG002|Overall Study|Lost to Follow-up|3|||
129943621|NCT02637063|467758048|FG000|Overall Study|Withdrawal by Subject|2|||
129943622|NCT02637063|467758049|FG001|Overall Study|Withdrawal by Subject|2|||
129943623|NCT02637063|467758050|FG002|Overall Study|Withdrawal by Subject|3|||
129943624|NCT02310581|467758051|FG000|Overall Study|Adverse Event|1|||
129943625|NCT02310581|467758052|FG001|Overall Study|Adverse Event|1|||
129943626|NCT02310581|467758053|FG002|Overall Study|Adverse Event|1|||
129943627|NCT02310581|467758054|FG003|Overall Study|Adverse Event|0|||
129943628|NCT02310581|467758051|FG000|Overall Study|Withdrawal by Subject|2|||
129943629|NCT02310581|467758052|FG001|Overall Study|Withdrawal by Subject|1|||
129943630|NCT02310581|467758053|FG002|Overall Study|Withdrawal by Subject|0|||
129943631|NCT02310581|467758054|FG003|Overall Study|Withdrawal by Subject|1|||
129943632|NCT01673594|467758055|FG000|Overall Study|Adverse Event|3|||
129943633|NCT01673594|467758056|FG001|Overall Study|Adverse Event|1|||
129943634|NCT01673594|467758055|FG000|Overall Study|Lost to Follow-up|1|||
129943635|NCT01673594|467758056|FG001|Overall Study|Lost to Follow-up|0|||
129943636|NCT01673594|467758055|FG000|Overall Study|Physician Decision|2|||
129943637|NCT01673594|467758056|FG001|Overall Study|Physician Decision|4|||
129943638|NCT01673594|467758055|FG000|Overall Study|Withdrawal by Subject|0|||
129943639|NCT01673594|467758056|FG001|Overall Study|Withdrawal by Subject|1|||
129943640|NCT04658784|467758057|FG000|6-month Follow-up|Lost to Follow-up|2|||
129943641|NCT04658784|467758058|FG001|6-month Follow-up|Lost to Follow-up|5|||
129943642|NCT00454194|467758064|FG000|Overall Study|Adverse Event|7|||
129943643|NCT00454194|467758065|FG001|Overall Study|Adverse Event|2|||
129943644|NCT00454194|467758064|FG000|Overall Study|Withdrawal by Subject|12|||
129943645|NCT00454194|467758065|FG001|Overall Study|Withdrawal by Subject|8|||
129943646|NCT00454194|467758064|FG000|Overall Study|Other Medical Problems|1|||
130071626|NCT00379236|468218066|FG001|Double-blind|Protocol Violation|3|||
130071627|NCT00379236|468218067|FG002|Double-blind|Protocol Violation|0|||
129943647|NCT00454194|467758065|FG001|Overall Study|Other Medical Problems|2|||
129943648|NCT00454194|467758064|FG000|Overall Study|Other Unspecified Reason|2|||
129943649|NCT00454194|467758065|FG001|Overall Study|Other Unspecified Reason|2|||
129943650|NCT02827201|467758066|FG000|Overall Study|Death|1|||
129943651|NCT02827201|467758067|FG001|Overall Study|Death|2|||
130071628|NCT00379236|468218065|FG000|Double-blind|Withdrawal by Subject|12|||
130071629|NCT00379236|468218066|FG001|Double-blind|Withdrawal by Subject|13|||
130071630|NCT00379236|468218067|FG002|Double-blind|Withdrawal by Subject|0|||
130071631|NCT00379236|468218065|FG000|Double-blind|Lost to Follow-up|4|||
130071632|NCT00379236|468218066|FG001|Double-blind|Lost to Follow-up|3|||
130071633|NCT00379236|468218067|FG002|Double-blind|Lost to Follow-up|0|||
129943652|NCT02827201|467758066|FG000|Overall Study|Patients not treated|1|||
129943653|NCT02827201|467758067|FG001|Overall Study|Patients not treated|1|||
129943654|NCT03345979|467758068|FG000|Overall Study|Withdrawal by Subject|20|||
129943655|NCT03345979|467758069|FG001|Overall Study|Withdrawal by Subject|31|||
129943656|NCT03345979|467758068|FG000|Overall Study|Adverse Event|10|||
129943657|NCT03345979|467758069|FG001|Overall Study|Adverse Event|11|||
129943658|NCT03345979|467758068|FG000|Overall Study|Lost to Follow-up|8|||
129943659|NCT03345979|467758069|FG001|Overall Study|Lost to Follow-up|9|||
129943660|NCT03345979|467758068|FG000|Overall Study|Lack of Efficacy|4|||
130071634|NCT00379236|468218065|FG000|Double-blind|Use of exclusionary medication|1|||
129943661|NCT03345979|467758069|FG001|Overall Study|Lack of Efficacy|2|||
129943662|NCT03345979|467758068|FG000|Overall Study|Protocol Violation|1|||
129943663|NCT03345979|467758069|FG001|Overall Study|Protocol Violation|3|||
129943664|NCT03345979|467758068|FG000|Overall Study|Physician Decision|0|||
129943665|NCT03345979|467758069|FG001|Overall Study|Physician Decision|2|||
129943666|NCT00620854|467758070|FG000|Washout 1|Withdrawal by Subject|0|||
129943667|NCT00620854|467758071|FG001|Washout 1|Withdrawal by Subject|0|||
129943668|NCT00620854|467758072|FG002|Washout 1|Withdrawal by Subject|1|||
129943669|NCT00620854|467758073|FG003|Washout 1|Withdrawal by Subject|1|||
129943670|NCT00620854|467758074|FG004|Washout 1|Withdrawal by Subject|0|||
129943671|NCT00620854|467758075|FG005|Washout 1|Withdrawal by Subject|0|||
129943672|NCT00487240|467758076|FG000|Overall Study|Withdrawal by Subject|12|||
129943673|NCT00487240|467758077|FG001|Overall Study|Withdrawal by Subject|6|||
129943674|NCT00487240|467758076|FG000|Overall Study|Lost to Follow-up|7|||
129943675|NCT00487240|467758077|FG001|Overall Study|Lost to Follow-up|6|||
129943676|NCT00487240|467758076|FG000|Overall Study|Adverse Event|0|||
129943677|NCT00487240|467758077|FG001|Overall Study|Adverse Event|4|||
129943678|NCT00487240|467758076|FG000|Overall Study|Protocol Violation|5|||
129943679|NCT00487240|467758077|FG001|Overall Study|Protocol Violation|5|||
129943680|NCT00487240|467758076|FG000|Overall Study|Entry Criteria Not Met|3|||
129943681|NCT00487240|467758077|FG001|Overall Study|Entry Criteria Not Met|4|||
129943682|NCT00487240|467758076|FG000|Overall Study|Sponsor Decision|2|||
129943683|NCT00487240|467758077|FG001|Overall Study|Sponsor Decision|1|||
129943684|NCT00487240|467758076|FG000|Overall Study|Physician Decision|2|||
129943685|NCT00487240|467758077|FG001|Overall Study|Physician Decision|0|||
129943686|NCT00999596|467758080|FG000|Overall Study|Statistical population not required|101|||
129943687|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
129943688|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
129943689|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Death|2|||
129943690|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
129943691|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
129943692|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
129943693|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
129943694|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Death|1|||
129943695|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
129943696|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
129943697|NCT02630186|467758082|FG000|Overall Study|Withdrawal by Subject|1|||
129943698|NCT00439218|467758085|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
129943699|NCT03176407|467758086|FG000|Overall Study|Protocol Violation|1|||
129943700|NCT03176407|467758086|FG000|Overall Study|human failure|1|||
129943701|NCT03176407|467758086|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
129943702|NCT01428583|467758089|FG000|Overall Study|Adverse Event|75|||
129943703|NCT01428583|467758089|FG000|Overall Study|Withdrawal by Subject|51|||
129943704|NCT01428583|467758089|FG000|Overall Study|Lack of Efficacy|37|||
129943705|NCT01428583|467758089|FG000|Overall Study|Lost to Follow-up|17|||
129943706|NCT01428583|467758089|FG000|Overall Study|Death|1|||
129943707|NCT01428583|467758089|FG000|Overall Study|Pregnancy|1|||
129943708|NCT01428583|467758089|FG000|Overall Study|Protocol Violation|1|||
129943709|NCT01428583|467758089|FG000|Overall Study|Physician Decision|12|||
129943710|NCT01428583|467758089|FG000|Overall Study|Non-compliant|25|||
129943711|NCT01428583|467758089|FG000|Overall Study|Confirmed positive urine drug test|8|||
129943712|NCT01428583|467758089|FG000|Overall Study|Sponsor's request|3|||
129943713|NCT01428583|467758089|FG000|Overall Study|Other|6|||
129943714|NCT00670488|467758090|FG000|Overall Study|Adverse Event|0|||
129943715|NCT00670488|467758091|FG001|Overall Study|Adverse Event|7|||
129943716|NCT00670488|467758092|FG002|Overall Study|Adverse Event|0|||
129943717|NCT00670488|467758093|FG003|Overall Study|Adverse Event|3|||
129943718|NCT00670488|467758094|FG004|Overall Study|Adverse Event|1|||
129943719|NCT00670488|467758095|FG005|Overall Study|Adverse Event|1|||
129943720|NCT00670488|467758096|FG006|Overall Study|Adverse Event|5|||
129943721|NCT00670488|467758097|FG007|Overall Study|Adverse Event|1|||
129943722|NCT00670488|467758098|FG008|Overall Study|Adverse Event|0|||
130154860|NCT00958126|468526623|FG002|Overall Study|Lost to Follow-up|9|||
129943723|NCT00670488|467758099|FG009|Overall Study|Adverse Event|1|||
129943724|NCT00670488|467758090|FG000|Overall Study|Physician Decision|1|||
129943725|NCT00670488|467758091|FG001|Overall Study|Physician Decision|9|||
129943726|NCT00670488|467758092|FG002|Overall Study|Physician Decision|0|||
129943727|NCT00670488|467758093|FG003|Overall Study|Physician Decision|1|||
129943728|NCT00670488|467758094|FG004|Overall Study|Physician Decision|0|||
129943729|NCT00670488|467758095|FG005|Overall Study|Physician Decision|0|||
129943730|NCT00670488|467758096|FG006|Overall Study|Physician Decision|0|||
129943731|NCT00670488|467758097|FG007|Overall Study|Physician Decision|0|||
129943732|NCT00670488|467758098|FG008|Overall Study|Physician Decision|0|||
129943733|NCT00670488|467758099|FG009|Overall Study|Physician Decision|0|||
129943734|NCT00670488|467758090|FG000|Overall Study|Progressive Disease|2|||
129943735|NCT00670488|467758091|FG001|Overall Study|Progressive Disease|41|||
129943736|NCT00670488|467758092|FG002|Overall Study|Progressive Disease|3|||
129943737|NCT00670488|467758093|FG003|Overall Study|Progressive Disease|2|||
129943738|NCT00670488|467758094|FG004|Overall Study|Progressive Disease|2|||
129943739|NCT00670488|467758095|FG005|Overall Study|Progressive Disease|4|||
129943740|NCT00670488|467758096|FG006|Overall Study|Progressive Disease|11|||
129943741|NCT00670488|467758097|FG007|Overall Study|Progressive Disease|2|||
129943742|NCT00670488|467758098|FG008|Overall Study|Progressive Disease|2|||
129943743|NCT00670488|467758099|FG009|Overall Study|Progressive Disease|1|||
129943744|NCT00670488|467758090|FG000|Overall Study|Withdrawal by Subject|0|||
129943745|NCT00670488|467758091|FG001|Overall Study|Withdrawal by Subject|1|||
129943746|NCT00670488|467758092|FG002|Overall Study|Withdrawal by Subject|0|||
129943747|NCT00670488|467758093|FG003|Overall Study|Withdrawal by Subject|1|||
129943748|NCT00670488|467758094|FG004|Overall Study|Withdrawal by Subject|0|||
129943749|NCT00670488|467758095|FG005|Overall Study|Withdrawal by Subject|0|||
129943750|NCT00670488|467758096|FG006|Overall Study|Withdrawal by Subject|1|||
129943751|NCT00670488|467758097|FG007|Overall Study|Withdrawal by Subject|0|||
129943752|NCT00670488|467758098|FG008|Overall Study|Withdrawal by Subject|1|||
129943753|NCT00670488|467758099|FG009|Overall Study|Withdrawal by Subject|0|||
129943754|NCT01124045|467758104|FG000|Overall Study|Lost to Follow-up|0|||
129943755|NCT01124045|467758105|FG001|Overall Study|Lost to Follow-up|1|||
129943756|NCT01124045|467758104|FG000|Overall Study|Physician Decision|0|||
129943757|NCT01124045|467758105|FG001|Overall Study|Physician Decision|2|||
129943758|NCT03205566|467758110|FG000|Phase 1|Protocol Violation|1|||
129943759|NCT03205566|467758111|FG001|Phase 1|Protocol Violation|1|||
129943760|NCT00836498|467758112|FG000|Overall Study|Adverse Event|1|||
129943761|NCT00836498|467758113|FG001|Overall Study|Adverse Event|0|||
129943762|NCT00836498|467758112|FG000|Overall Study|Lost to Follow-up|1|||
129943763|NCT00836498|467758113|FG001|Overall Study|Lost to Follow-up|0|||
129943764|NCT00836498|467758112|FG000|Overall Study|Withdrawal by Subject|2|||
129943765|NCT00836498|467758113|FG001|Overall Study|Withdrawal by Subject|1|||
129943766|NCT03418545|467758114|FG000|Overall Study|Withdrawal by Participant|2|||
129943767|NCT03418545|467758115|FG001|Overall Study|Withdrawal by Participant|4|||
129943768|NCT03418545|467758114|FG000|Overall Study|Lost to Follow-up|3|||
129943769|NCT03418545|467758115|FG001|Overall Study|Lost to Follow-up|5|||
129943770|NCT03418545|467758114|FG000|Overall Study|Reason Not Specified|0|||
129943771|NCT03418545|467758115|FG001|Overall Study|Reason Not Specified|1|||
129943772|NCT03418545|467758114|FG000|Overall Study|Missing Completion Status|0|||
129943773|NCT03418545|467758115|FG001|Overall Study|Missing Completion Status|1|||
129943774|NCT02384382|467758121|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
129943775|NCT02384382|467758121|FG000|Overall Study|Death|1|||
129943776|NCT02384382|467758121|FG000|Overall Study|Adverse Event|1|||
129943777|NCT02384382|467758121|FG000|Overall Study|Disease progression|16|||
129943778|NCT03567616|467758127|FG000|Overall Study|Disease progression|4|||
129943779|NCT03567616|467758127|FG000|Overall Study|Withdrawal by Subject|1|||
129943780|NCT03567616|467758127|FG000|Overall Study|Physician Decision|1|||
129943781|NCT03567616|467758127|FG000|Overall Study|Death|1|||
129943782|NCT03567616|467758127|FG000|Overall Study|Adverse Event|1|||
129943783|NCT01074242|467758128|FG000|Overall Study|Case report before date of contract|40|||
129943784|NCT01074242|467758128|FG000|Overall Study|Lost to Follow-up|1|||
129943785|NCT01074242|467758128|FG000|Overall Study|Case report unclear|6|||
129943786|NCT01074242|467758128|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
129943787|NCT01074242|467758128|FG000|Overall Study|Duplicate Case Report Form|5|||
129943788|NCT01957163|467758134|FG000|Overall Study|Adverse Event|5|||
129943789|NCT01957163|467758135|FG001|Overall Study|Adverse Event|2|||
129943790|NCT01957163|467758136|FG002|Overall Study|Adverse Event|4|||
129943791|NCT01957163|467758134|FG000|Overall Study|Lack of Efficacy|5|||
129943792|NCT01957163|467758135|FG001|Overall Study|Lack of Efficacy|4|||
129943793|NCT01957163|467758136|FG002|Overall Study|Lack of Efficacy|9|||
129943794|NCT01957163|467758134|FG000|Overall Study|Protocol Violation|1|||
129943795|NCT01957163|467758135|FG001|Overall Study|Protocol Violation|2|||
129943796|NCT01957163|467758136|FG002|Overall Study|Protocol Violation|0|||
129943797|NCT01957163|467758134|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
129943798|NCT01957163|467758135|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
129943799|NCT01957163|467758136|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
130071635|NCT00379236|468218066|FG001|Double-blind|Use of exclusionary medication|2|||
130071636|NCT00379236|468218067|FG002|Double-blind|Use of exclusionary medication|0|||
129943800|NCT01957163|467758134|FG000|Overall Study|Lost to Follow-up|0|||
129943801|NCT01957163|467758135|FG001|Overall Study|Lost to Follow-up|1|||
129943802|NCT01957163|467758136|FG002|Overall Study|Lost to Follow-up|0|||
129943803|NCT01957163|467758134|FG000|Overall Study|Withdrawal by Subject|4|||
129943804|NCT01957163|467758135|FG001|Overall Study|Withdrawal by Subject|2|||
129943805|NCT01957163|467758136|FG002|Overall Study|Withdrawal by Subject|4|||
129943806|NCT01065779|467758139|FG000|Overall Study|Duplicate Investigation|1|||
129943807|NCT01065779|467758139|FG000|Overall Study|Investigation Before Contract Date|37|||
129943808|NCT01065779|467758139|FG000|Overall Study|Non-enrollment Period Administration|10|||
129943809|NCT01065779|467758139|FG000|Overall Study|Not Administered With Study Drug|17|||
129943810|NCT01065779|467758139|FG000|Overall Study|Failed to Follow-up|10|||
130071637|NCT00379236|468218065|FG000|Double-blind|Other|3|||
129943811|NCT01065779|467758139|FG000|Overall Study|Inclusion Criteria Violation|7|||
129943812|NCT02630966|467758140|FG000|Overall Study|Adverse Event|1|||
129943813|NCT02630966|467758141|FG001|Overall Study|Adverse Event|3|||
129943814|NCT02630966|467758140|FG000|Overall Study|Significant Protocol Deviation|0|||
129943815|NCT02630966|467758141|FG001|Overall Study|Significant Protocol Deviation|2|||
129943816|NCT02630966|467758140|FG000|Overall Study|Voluntary Withdrawal|1|||
129943817|NCT02630966|467758141|FG001|Overall Study|Voluntary Withdrawal|1|||
129943818|NCT02630966|467758140|FG000|Overall Study|Lack of Efficacy|0|||
129943819|NCT02630966|467758141|FG001|Overall Study|Lack of Efficacy|2|||
129943820|NCT00641537|467758142|FG000|96-week Period|Adverse Event|0|||
129943821|NCT00641537|467758143|FG001|96-week Period|Adverse Event|1|||
129943822|NCT00641537|467758144|FG002|96-week Period|Adverse Event|3|||
129943823|NCT00641537|467758145|FG003|96-week Period|Adverse Event|0|||
129943824|NCT00641537|467758146|FG004|96-week Period|Adverse Event|2|||
129943825|NCT00641537|467758147|FG005|96-week Period|Adverse Event|0|||
129943826|NCT00641537|467758148|FG006|96-week Period|Adverse Event|0|||
129943827|NCT00641537|467758149|FG007|96-week Period|Adverse Event|0|||
129943828|NCT00641537|467758142|FG000|96-week Period|Lost to Follow-up|3|||
129943829|NCT00641537|467758143|FG001|96-week Period|Lost to Follow-up|1|||
129943830|NCT00641537|467758144|FG002|96-week Period|Lost to Follow-up|2|||
129943831|NCT00641537|467758145|FG003|96-week Period|Lost to Follow-up|2|||
129943832|NCT00641537|467758146|FG004|96-week Period|Lost to Follow-up|4|||
129943833|NCT00641537|467758147|FG005|96-week Period|Lost to Follow-up|0|||
129943834|NCT00641537|467758148|FG006|96-week Period|Lost to Follow-up|1|||
129943835|NCT00641537|467758149|FG007|96-week Period|Lost to Follow-up|0|||
129943836|NCT00641537|467758142|FG000|96-week Period|Protocol Violation|0|||
129943837|NCT00641537|467758143|FG001|96-week Period|Protocol Violation|1|||
129943838|NCT00641537|467758144|FG002|96-week Period|Protocol Violation|0|||
129943839|NCT00641537|467758145|FG003|96-week Period|Protocol Violation|1|||
129943840|NCT00641537|467758146|FG004|96-week Period|Protocol Violation|0|||
129943841|NCT00641537|467758147|FG005|96-week Period|Protocol Violation|1|||
129943842|NCT00641537|467758148|FG006|96-week Period|Protocol Violation|0|||
129943843|NCT00641537|467758149|FG007|96-week Period|Protocol Violation|0|||
129943844|NCT00641537|467758142|FG000|96-week Period|Death|2|||
129943845|NCT00641537|467758143|FG001|96-week Period|Death|0|||
129943846|NCT00641537|467758144|FG002|96-week Period|Death|1|||
129943847|NCT00641537|467758145|FG003|96-week Period|Death|0|||
129943848|NCT00641537|467758146|FG004|96-week Period|Death|0|||
129943849|NCT00641537|467758147|FG005|96-week Period|Death|0|||
129943850|NCT00641537|467758148|FG006|96-week Period|Death|0|||
129943851|NCT00641537|467758149|FG007|96-week Period|Death|0|||
129943852|NCT00641537|467758142|FG000|96-week Period|Other|4|||
129943853|NCT00641537|467758143|FG001|96-week Period|Other|7|||
129943854|NCT00641537|467758144|FG002|96-week Period|Other|14|||
129943855|NCT00641537|467758145|FG003|96-week Period|Other|9|||
129943856|NCT00641537|467758146|FG004|96-week Period|Other|11|||
129943857|NCT00641537|467758147|FG005|96-week Period|Other|6|||
129943858|NCT00641537|467758148|FG006|96-week Period|Other|4|||
129943859|NCT00641537|467758149|FG007|96-week Period|Other|6|||
129943860|NCT00641537|467758142|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
129943861|NCT00641537|467758143|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
129943862|NCT00641537|467758144|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
129943863|NCT00641537|467758145|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
129943864|NCT00641537|467758146|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
129943865|NCT00641537|467758147|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
129943866|NCT00641537|467758148|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
129943867|NCT00641537|467758149|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
129943868|NCT00641537|467758142|FG000|24-Week Supplemental Follow-up Period|Other|0|||
129943869|NCT00641537|467758143|FG001|24-Week Supplemental Follow-up Period|Other|2|||
129943870|NCT00641537|467758144|FG002|24-Week Supplemental Follow-up Period|Other|2|||
129943871|NCT00641537|467758145|FG003|24-Week Supplemental Follow-up Period|Other|1|||
129943872|NCT00641537|467758146|FG004|24-Week Supplemental Follow-up Period|Other|3|||
129943873|NCT00641537|467758147|FG005|24-Week Supplemental Follow-up Period|Other|0|||
129943874|NCT00641537|467758148|FG006|24-Week Supplemental Follow-up Period|Other|1|||
129943875|NCT00641537|467758149|FG007|24-Week Supplemental Follow-up Period|Other|1|||
129943876|NCT01801007|467758150|FG000|Overall Study|Adverse Event|2|||
129943877|NCT01801007|467758150|FG000|Overall Study|Lost to Follow-up|4|||
130071638|NCT00379236|468218066|FG001|Double-blind|Other|7|||
130071639|NCT00379236|468218067|FG002|Double-blind|Other|0|||
129943878|NCT01801007|467758150|FG000|Overall Study|Withdrawal by Subject|5|||
129943879|NCT00665392|467758151|FG000|Overall Study|not treated|1|||
129943880|NCT01321073|467758157|FG000|Overall Study|Did not attempt implant|4|||
129943881|NCT01321073|467758157|FG000|Overall Study|Death|3|||
129943882|NCT05352230|467758166|FG000|First Intervention (3 Months)|study terminated|2|||
129943883|NCT05352230|467758167|FG001|First Intervention (3 Months)|study terminated|2|||
129943884|NCT02686658|467758168|FG000|Overall Study|Adverse Event|0|||
129943885|NCT02686658|467758169|FG001|Overall Study|Adverse Event|0|||
129943886|NCT02686658|467758170|FG002|Overall Study|Adverse Event|1|||
129943887|NCT02686658|467758171|FG003|Overall Study|Adverse Event|1|||
129943888|NCT02686658|467758172|FG004|Overall Study|Adverse Event|2|||
129943889|NCT02686658|467758173|FG005|Overall Study|Adverse Event|1|||
130071640|NCT00379236|468218065|FG000|Double-blind|Data could not be retrieved|2|||
129943890|NCT02686658|467758168|FG000|Overall Study|Investigator decision|0|||
129943891|NCT02686658|467758169|FG001|Overall Study|Investigator decision|0|||
129943892|NCT02686658|467758170|FG002|Overall Study|Investigator decision|0|||
129943893|NCT02686658|467758171|FG003|Overall Study|Investigator decision|1|||
129943894|NCT02686658|467758172|FG004|Overall Study|Investigator decision|2|||
129943895|NCT02686658|467758173|FG005|Overall Study|Investigator decision|1|||
129943896|NCT02686658|467758168|FG000|Overall Study|Sponsor decision|1|||
129943897|NCT02686658|467758169|FG001|Overall Study|Sponsor decision|2|||
129943898|NCT02686658|467758170|FG002|Overall Study|Sponsor decision|1|||
129943899|NCT02686658|467758171|FG003|Overall Study|Sponsor decision|5|||
129943900|NCT02686658|467758172|FG004|Overall Study|Sponsor decision|13|||
129943901|NCT02686658|467758173|FG005|Overall Study|Sponsor decision|2|||
129943902|NCT02686658|467758168|FG000|Overall Study|Lost to Follow-up|0|||
129943903|NCT02686658|467758169|FG001|Overall Study|Lost to Follow-up|0|||
129943904|NCT02686658|467758170|FG002|Overall Study|Lost to Follow-up|2|||
129943905|NCT02686658|467758171|FG003|Overall Study|Lost to Follow-up|0|||
129943906|NCT02686658|467758172|FG004|Overall Study|Lost to Follow-up|0|||
129943907|NCT02686658|467758173|FG005|Overall Study|Lost to Follow-up|1|||
129943908|NCT02686658|467758168|FG000|Overall Study|Death|1|||
129943909|NCT02686658|467758169|FG001|Overall Study|Death|0|||
129943910|NCT02686658|467758170|FG002|Overall Study|Death|0|||
129943911|NCT02686658|467758171|FG003|Overall Study|Death|1|||
129943912|NCT02686658|467758172|FG004|Overall Study|Death|1|||
129943913|NCT02686658|467758173|FG005|Overall Study|Death|1|||
129943914|NCT02686658|467758168|FG000|Overall Study|Withdrawal by Subject|2|||
129943915|NCT02686658|467758169|FG001|Overall Study|Withdrawal by Subject|5|||
129943916|NCT02686658|467758170|FG002|Overall Study|Withdrawal by Subject|4|||
129943917|NCT02686658|467758171|FG003|Overall Study|Withdrawal by Subject|4|||
129943918|NCT02686658|467758172|FG004|Overall Study|Withdrawal by Subject|17|||
129943919|NCT02686658|467758173|FG005|Overall Study|Withdrawal by Subject|8|||
129943920|NCT02686658|467758168|FG000|Overall Study|Placed in hospice care|0|||
129943921|NCT02686658|467758169|FG001|Overall Study|Placed in hospice care|0|||
129943922|NCT02686658|467758170|FG002|Overall Study|Placed in hospice care|1|||
129943923|NCT02686658|467758171|FG003|Overall Study|Placed in hospice care|0|||
129943924|NCT02686658|467758172|FG004|Overall Study|Placed in hospice care|0|||
129943925|NCT02686658|467758173|FG005|Overall Study|Placed in hospice care|0|||
129943926|NCT02686658|467758168|FG000|Overall Study|Participant non-compliance|0|||
129943927|NCT02686658|467758169|FG001|Overall Study|Participant non-compliance|0|||
129943928|NCT02686658|467758170|FG002|Overall Study|Participant non-compliance|0|||
129943929|NCT02686658|467758171|FG003|Overall Study|Participant non-compliance|0|||
129943930|NCT02686658|467758172|FG004|Overall Study|Participant non-compliance|0|||
129943931|NCT02686658|467758173|FG005|Overall Study|Participant non-compliance|1|||
129943932|NCT02686658|467758168|FG000|Overall Study|Concern over coronavirus disease care|0|||
129943933|NCT02686658|467758169|FG001|Overall Study|Concern over coronavirus disease care|0|||
129943934|NCT02686658|467758170|FG002|Overall Study|Concern over coronavirus disease care|0|||
129943935|NCT02686658|467758171|FG003|Overall Study|Concern over coronavirus disease care|0|||
129943936|NCT02686658|467758172|FG004|Overall Study|Concern over coronavirus disease care|2|||
129943937|NCT02686658|467758173|FG005|Overall Study|Concern over coronavirus disease care|1|||
129943938|NCT00570505|467758174|FG000|Overall Study|Adverse Event|7|||
130071641|NCT00379236|468218066|FG001|Double-blind|Data could not be retrieved|2|||
130071642|NCT00379236|468218067|FG002|Double-blind|Data could not be retrieved|0|||
129943939|NCT00570505|467758174|FG000|Overall Study|Withdrawal by Subject|7|||
129943940|NCT00570505|467758174|FG000|Overall Study|Lost to Follow-up|23|||
129943941|NCT00570505|467758174|FG000|Overall Study|Other loss to follow-up|4|||
129943942|NCT04224272|467758175|FG000|Part 1 - Dose Finding|Death|4|||
129943943|NCT04224272|467758175|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
129943944|NCT04224272|467758175|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
129943945|NCT04224272|467758175|FG000|Part 2 - Dose Expansion|Death|10|||
129943946|NCT04224272|467758175|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
129943947|NCT02556918|467760090|FG000|Overall Study|Protocol Violation|5|||
129943948|NCT02556918|467760091|FG001|Overall Study|Protocol Violation|6|||
129943949|NCT02556918|467760090|FG000|Overall Study|Withdrawal by Subject|4|||
129943950|NCT02556918|467760091|FG001|Overall Study|Withdrawal by Subject|4|||
129943951|NCT00551421|467760102|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
129943952|NCT02634307|467760112|FG000|Overall Study|Adverse Event|50|||
129943953|NCT02634307|467760113|FG001|Overall Study|Adverse Event|24|||
129943954|NCT02634307|467760114|FG002|Overall Study|Adverse Event|14|||
129943955|NCT02634307|467760112|FG000|Overall Study|Lost to Follow-up|21|||
130071643|NCT00379236|468218065|FG000|Open-label Extension|Adverse Event|0|||
129943956|NCT02634307|467760113|FG001|Overall Study|Lost to Follow-up|5|||
129943957|NCT02634307|467760114|FG002|Overall Study|Lost to Follow-up|6|||
129943958|NCT02634307|467760112|FG000|Overall Study|Pregnancy|5|||
129943959|NCT02634307|467760113|FG001|Overall Study|Pregnancy|1|||
129943960|NCT02634307|467760114|FG002|Overall Study|Pregnancy|3|||
129943961|NCT02634307|467760112|FG000|Overall Study|Withdrawal by Subject|38|||
129943962|NCT02634307|467760113|FG001|Overall Study|Withdrawal by Subject|24|||
129943963|NCT02634307|467760114|FG002|Overall Study|Withdrawal by Subject|18|||
129943964|NCT02634307|467760112|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129943965|NCT02634307|467760113|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129943966|NCT02634307|467760114|FG002|Overall Study|Non-Compliance with Study Drug|2|||
129943967|NCT02634307|467760112|FG000|Overall Study|Lack of Efficacy|1|||
129943968|NCT02634307|467760113|FG001|Overall Study|Lack of Efficacy|5|||
129943969|NCT02634307|467760114|FG002|Overall Study|Lack of Efficacy|3|||
129943970|NCT02634307|467760112|FG000|Overall Study|Physician Decision|7|||
129943971|NCT02634307|467760113|FG001|Overall Study|Physician Decision|5|||
129943972|NCT02634307|467760114|FG002|Overall Study|Physician Decision|5|||
129943973|NCT02634307|467760112|FG000|Overall Study|Reason not Specified|3|||
129943974|NCT02634307|467760113|FG001|Overall Study|Reason not Specified|5|||
129943975|NCT02634307|467760114|FG002|Overall Study|Reason not Specified|10|||
129943976|NCT02698475|467760115|FG000|Main Study Period|Lack of Efficacy|1|||
129943977|NCT02698475|467760115|FG000|Main Study Period|Protocol Violation|2|||
129943978|NCT02698475|467760115|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
129943979|NCT02698475|467760115|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
129943980|NCT02698475|467760115|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
129943981|NCT02698475|467760115|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
129943982|NCT02698475|467760115|FG000|Long-Term Extension Period|Other|1|||
129943983|NCT02132949|467760116|FG000|Overall Study|Death|7|||
129943984|NCT02132949|467760117|FG001|Overall Study|Death|13|||
129943985|NCT02132949|467760116|FG000|Overall Study|Lost to Follow-up|14|||
129943986|NCT02132949|467760117|FG001|Overall Study|Lost to Follow-up|4|||
129943987|NCT02132949|467760116|FG000|Overall Study|Withdrawal by Subject|6|||
129943988|NCT02132949|467760117|FG001|Overall Study|Withdrawal by Subject|5|||
129943989|NCT02132949|467760116|FG000|Overall Study|Noncompliance|5|||
129943990|NCT02132949|467760117|FG001|Overall Study|Noncompliance|1|||
129943991|NCT02132949|467760116|FG000|Overall Study|Physician Decision|3|||
129943992|NCT02132949|467760117|FG001|Overall Study|Physician Decision|1|||
129943993|NCT02132949|467760116|FG000|Overall Study|Disease Progression|3|||
129943994|NCT02132949|467760117|FG001|Overall Study|Disease Progression|0|||
129943995|NCT02132949|467760116|FG000|Overall Study|Adverse Event|2|||
129943996|NCT02132949|467760117|FG001|Overall Study|Adverse Event|1|||
129943997|NCT02132949|467760116|FG000|Overall Study|Withdrew Prior to Treatment|1|||
129943998|NCT02132949|467760117|FG001|Overall Study|Withdrew Prior to Treatment|2|||
129943999|NCT02132949|467760116|FG000|Overall Study|Reason Unspecified|0|||
129944000|NCT02132949|467760117|FG001|Overall Study|Reason Unspecified|1|||
129944001|NCT02148705|467760125|FG000|Overall Study|Death|2|||
129944002|NCT02148705|467760126|FG001|Overall Study|Death|0|||
129944003|NCT02148705|467760127|FG002|Overall Study|Death|0|||
129944004|NCT02148705|467760125|FG000|Overall Study|Lost to Follow-up|13|||
129944005|NCT02148705|467760126|FG001|Overall Study|Lost to Follow-up|4|||
129944006|NCT02148705|467760127|FG002|Overall Study|Lost to Follow-up|10|||
129944007|NCT02148705|467760125|FG000|Overall Study|Withdrawal by Subject|3|||
129944008|NCT02148705|467760126|FG001|Overall Study|Withdrawal by Subject|0|||
129944009|NCT02148705|467760127|FG002|Overall Study|Withdrawal by Subject|2|||
129944010|NCT02148705|467760125|FG000|Overall Study|Not Treated|0|||
129944011|NCT02148705|467760126|FG001|Overall Study|Not Treated|1|||
129944012|NCT02148705|467760127|FG002|Overall Study|Not Treated|5|||
129944013|NCT01737021|467760128|FG000|Overall Study|Lost to Follow-up|5|||
129944014|NCT01737021|467760129|FG001|Overall Study|Lost to Follow-up|3|||
129944015|NCT03865732|467760131|FG000|Overall Study|Adverse Event|0|||
129944016|NCT03865732|467760132|FG001|Overall Study|Adverse Event|1|||
129944017|NCT03392194|467760133|FG000|Overall Study|Withdrawal by Subject|1|||
129944018|NCT03392194|467760134|FG001|Overall Study|Withdrawal by Subject|2|||
129944019|NCT03392194|467760133|FG000|Overall Study|Conflicts with personal schedule|1|||
129944020|NCT03392194|467760134|FG001|Overall Study|Conflicts with personal schedule|0|||
129944021|NCT01019135|467760136|FG000|Overall Study|Did not receive allocated intervention|12|||
129944022|NCT01019135|467760137|FG001|Overall Study|Did not receive allocated intervention|6|||
129944023|NCT01019135|467760138|FG002|Overall Study|Did not receive allocated intervention|25|||
129944024|NCT01019135|467760136|FG000|Overall Study|Did not attend CR|8|||
129944025|NCT01019135|467760137|FG001|Overall Study|Did not attend CR|13|||
129944026|NCT01019135|467760138|FG002|Overall Study|Did not attend CR|6|||
129944027|NCT05124210|467760139|FG000|Overall Study|Lost to Follow-up|1|||
129944028|NCT05124210|467760140|FG001|Overall Study|Lost to Follow-up|0|||
129944029|NCT05124210|467760139|FG000|Overall Study|Withdrawal by Subject|1|||
129944030|NCT05124210|467760140|FG001|Overall Study|Withdrawal by Subject|0|||
129944031|NCT00768755|467760143|FG000|Phase 1|Death|6|||
129944032|NCT00768755|467760144|FG001|Phase 1|Death|0|||
129944033|NCT00768755|467760145|FG002|Phase 1|Death|0|||
129944034|NCT00768755|467760146|FG003|Phase 1|Death|0|||
129944035|NCT00768755|467760143|FG000|Phase 1|Other|4|||
129944036|NCT00768755|467760144|FG001|Phase 1|Other|0|||
129944037|NCT00768755|467760145|FG002|Phase 1|Other|0|||
129944038|NCT00768755|467760146|FG003|Phase 1|Other|0|||
129944039|NCT00768755|467760143|FG000|Phase 2|Death|0|||
129944040|NCT00768755|467760144|FG001|Phase 2|Death|37|||
129944041|NCT00768755|467760145|FG002|Phase 2|Death|48|||
129944042|NCT00768755|467760146|FG003|Phase 2|Death|31|||
129944043|NCT00768755|467760143|FG000|Phase 2|Protocol Violation|0|||
129944044|NCT00768755|467760144|FG001|Phase 2|Protocol Violation|2|||
129944045|NCT00768755|467760145|FG002|Phase 2|Protocol Violation|0|||
129944046|NCT00768755|467760146|FG003|Phase 2|Protocol Violation|1|||
129944047|NCT00768755|467760143|FG000|Phase 2|Lost to Follow-up|0|||
129944048|NCT00768755|467760144|FG001|Phase 2|Lost to Follow-up|1|||
129944049|NCT00768755|467760145|FG002|Phase 2|Lost to Follow-up|1|||
129944050|NCT00768755|467760146|FG003|Phase 2|Lost to Follow-up|4|||
129944051|NCT00768755|467760143|FG000|Phase 2|Withdrawal by Subject|0|||
129944052|NCT00768755|467760144|FG001|Phase 2|Withdrawal by Subject|1|||
129944053|NCT00768755|467760145|FG002|Phase 2|Withdrawal by Subject|0|||
129944054|NCT00768755|467760146|FG003|Phase 2|Withdrawal by Subject|1|||
129944055|NCT00768755|467760143|FG000|Phase 2|Other|0|||
129944056|NCT00768755|467760144|FG001|Phase 2|Other|1|||
129944057|NCT00768755|467760145|FG002|Phase 2|Other|2|||
129944058|NCT00768755|467760146|FG003|Phase 2|Other|4|||
129944059|NCT00768755|467760143|FG000|Phase 2|Study Terminated by Sponsor|0|||
129944060|NCT00768755|467760144|FG001|Phase 2|Study Terminated by Sponsor|13|||
129944061|NCT00768755|467760145|FG002|Phase 2|Study Terminated by Sponsor|7|||
129944062|NCT00768755|467760146|FG003|Phase 2|Study Terminated by Sponsor|14|||
129944063|NCT00768755|467760143|FG000|Phase 2|Randomized but not treated|0|||
129944064|NCT00768755|467760144|FG001|Phase 2|Randomized but not treated|0|||
129944065|NCT00768755|467760145|FG002|Phase 2|Randomized but not treated|0|||
129944066|NCT00768755|467760146|FG003|Phase 2|Randomized but not treated|2|||
129944067|NCT00310037|467760147|FG000|Overall Study|Adverse Event|7|||
129944068|NCT00310037|467760148|FG001|Overall Study|Adverse Event|14|||
129944069|NCT00310037|467760147|FG000|Overall Study|Withdrawal by Subject|4|||
129944070|NCT00310037|467760148|FG001|Overall Study|Withdrawal by Subject|3|||
129944071|NCT00310037|467760147|FG000|Overall Study|Progression|6|||
129944072|NCT00310037|467760148|FG001|Overall Study|Progression|0|||
129944073|NCT00310037|467760147|FG000|Overall Study|Non-protocol treatment|1|||
129944074|NCT00310037|467760148|FG001|Overall Study|Non-protocol treatment|0|||
129944075|NCT01530334|467760152|FG000|Overall Study|Adverse Event|3|||
129944076|NCT01530334|467760152|FG000|Overall Study|unknown reason|1|||
129944077|NCT01530334|467760152|FG000|Overall Study|Progressive disease|47|||
129944078|NCT01485887|467760153|FG000|Overall Study|Withdrawal by Subject|2|||
129944079|NCT01485887|467760153|FG000|Overall Study|Adverse Event|8|||
129944080|NCT01485887|467760153|FG000|Overall Study|Deterioration of primary disease|1|||
129944081|NCT01485887|467760153|FG000|Overall Study|Primary disease markedly improved|1|||
129944082|NCT00659373|467760154|FG000|Overall Study|Withdrawal by Subject|3|||
129944083|NCT00659373|467760155|FG001|Overall Study|Withdrawal by Subject|5|||
129944084|NCT00659373|467760154|FG000|Overall Study|Assessment Missed|2|||
129944085|NCT00659373|467760155|FG001|Overall Study|Assessment Missed|2|||
129944086|NCT02382640|467760156|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
129944087|NCT02382640|467760157|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
129944088|NCT02382640|467760158|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
129944089|NCT02382640|467760159|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
130071644|NCT00379236|468218066|FG001|Open-label Extension|Adverse Event|0|||
130071645|NCT00379236|468218067|FG002|Open-label Extension|Adverse Event|13|||
130071646|NCT00379236|468218065|FG000|Open-label Extension|Protocol Violation|0|||
130071647|NCT00379236|468218066|FG001|Open-label Extension|Protocol Violation|0|||
130071648|NCT00379236|468218067|FG002|Open-label Extension|Protocol Violation|7|||
130071649|NCT00379236|468218065|FG000|Open-label Extension|Withdrawal by Subject|0|||
130071650|NCT00379236|468218066|FG001|Open-label Extension|Withdrawal by Subject|0|||
130071651|NCT00379236|468218067|FG002|Open-label Extension|Withdrawal by Subject|13|||
130071652|NCT00379236|468218065|FG000|Open-label Extension|Lost to Follow-up|0|||
130120229|NCT02224391|468402302|FG000|Overall Study|Withdrawal by Subject|6|||
130120230|NCT02224391|468402303|FG001|Overall Study|Withdrawal by Subject|5|||
130120231|NCT01974895|468402305|FG000|Overall Study|Protocol Violation|1|||
130120232|NCT01974895|468402306|FG001|Overall Study|Protocol Violation|0|||
130071653|NCT00379236|468218066|FG001|Open-label Extension|Lost to Follow-up|0|||
130071654|NCT00379236|468218067|FG002|Open-label Extension|Lost to Follow-up|12|||
130071655|NCT00379236|468218065|FG000|Open-label Extension|Use of exclusionary medication|0|||
130071656|NCT00379236|468218066|FG001|Open-label Extension|Use of exclusionary medication|0|||
129944090|NCT03162614|467760162|FG000|Overall Study|Lost to Follow-up|2|||
129944091|NCT03162614|467760163|FG001|Overall Study|Lost to Follow-up|1|||
129944092|NCT03162614|467760164|FG002|Overall Study|Lost to Follow-up|1|||
129944093|NCT03162614|467760165|FG003|Overall Study|Lost to Follow-up|1|||
129944094|NCT03162614|467760166|FG004|Overall Study|Lost to Follow-up|2|||
129944095|NCT03162614|467760167|FG005|Overall Study|Lost to Follow-up|0|||
129944096|NCT03162614|467760162|FG000|Overall Study|Protocol Violation|0|||
129944097|NCT03162614|467760163|FG001|Overall Study|Protocol Violation|1|||
129944098|NCT03162614|467760164|FG002|Overall Study|Protocol Violation|0|||
129944099|NCT03162614|467760165|FG003|Overall Study|Protocol Violation|1|||
130071657|NCT00379236|468218067|FG002|Open-label Extension|Use of exclusionary medication|3|||
130071658|NCT00379236|468218065|FG000|Open-label Extension|Other|0|||
130071659|NCT00379236|468218066|FG001|Open-label Extension|Other|0|||
129944100|NCT03162614|467760166|FG004|Overall Study|Protocol Violation|0|||
129944101|NCT03162614|467760167|FG005|Overall Study|Protocol Violation|0|||
129944102|NCT03162614|467760162|FG000|Overall Study|Withdrawal by Subject|2|||
129944103|NCT03162614|467760163|FG001|Overall Study|Withdrawal by Subject|1|||
129944104|NCT03162614|467760164|FG002|Overall Study|Withdrawal by Subject|1|||
129944105|NCT03162614|467760165|FG003|Overall Study|Withdrawal by Subject|1|||
129944106|NCT03162614|467760166|FG004|Overall Study|Withdrawal by Subject|0|||
129944107|NCT03162614|467760167|FG005|Overall Study|Withdrawal by Subject|0|||
129944108|NCT03162614|467760162|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
129944109|NCT03162614|467760163|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
129944110|NCT03162614|467760164|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
129944111|NCT03162614|467760165|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
129944112|NCT03162614|467760166|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
129944113|NCT03162614|467760167|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
129944114|NCT05270460|467760170|FG000|Overall Study|Adverse Event|0|||
129944115|NCT05270460|467760171|FG001|Overall Study|Adverse Event|1|||
129944116|NCT05270460|467760172|FG002|Overall Study|Adverse Event|0|||
129944117|NCT05270460|467760170|FG000|Overall Study|Early Termination|0|||
129944118|NCT05270460|467760171|FG001|Overall Study|Early Termination|1|||
129944119|NCT05270460|467760172|FG002|Overall Study|Early Termination|0|||
129944120|NCT00380250|467760173|FG000|Overall Study|Withdrawal by Subject|39|||
129944121|NCT00380250|467760174|FG001|Overall Study|Withdrawal by Subject|28|||
129944122|NCT00380250|467760173|FG000|Overall Study|Adverse Event|20|||
129944123|NCT00380250|467760174|FG001|Overall Study|Adverse Event|9|||
129944124|NCT00380250|467760173|FG000|Overall Study|Lack of Efficacy|10|||
129944125|NCT00380250|467760174|FG001|Overall Study|Lack of Efficacy|8|||
129944126|NCT00380250|467760173|FG000|Overall Study|Protocol Violation|15|||
129944127|NCT00380250|467760174|FG001|Overall Study|Protocol Violation|5|||
129944128|NCT00380250|467760173|FG000|Overall Study|Lost to Follow-up|14|||
129944129|NCT00380250|467760174|FG001|Overall Study|Lost to Follow-up|5|||
129944130|NCT00380250|467760173|FG000|Overall Study|Physician Decision|1|||
129944131|NCT00380250|467760174|FG001|Overall Study|Physician Decision|0|||
129944132|NCT00243867|467760175|FG000|Overall Study|Adverse Event|24|||
129944133|NCT00243867|467760176|FG001|Overall Study|Adverse Event|34|||
129944134|NCT00243867|467760175|FG000|Overall Study|Lack of Efficacy|115|||
129944135|NCT00243867|467760176|FG001|Overall Study|Lack of Efficacy|78|||
129944136|NCT00243867|467760175|FG000|Overall Study|Withdrawal by Subject|11|||
129944137|NCT00243867|467760176|FG001|Overall Study|Withdrawal by Subject|23|||
129944138|NCT00243867|467760175|FG000|Overall Study|Lost to Follow-up|2|||
129944139|NCT00243867|467760176|FG001|Overall Study|Lost to Follow-up|1|||
129944140|NCT00243867|467760175|FG000|Overall Study|Physician Decision|2|||
129944141|NCT00243867|467760176|FG001|Overall Study|Physician Decision|7|||
129944142|NCT00243867|467760175|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
129944143|NCT00243867|467760176|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
129944144|NCT01638000|467760177|FG000|Overall Study|Randomized but Never Received Drug|7|||
129944145|NCT01638000|467760178|FG001|Overall Study|Randomized but Never Received Drug|10|||
129944146|NCT01638000|467760177|FG000|Overall Study|Adverse Event|14|||
129944147|NCT01638000|467760178|FG001|Overall Study|Adverse Event|16|||
129944148|NCT01638000|467760177|FG000|Overall Study|Lack of Efficacy|5|||
129944149|NCT01638000|467760178|FG001|Overall Study|Lack of Efficacy|6|||
129944150|NCT01638000|467760177|FG000|Overall Study|Protocol Violation|11|||
129944151|NCT01638000|467760178|FG001|Overall Study|Protocol Violation|13|||
129944152|NCT01638000|467760177|FG000|Overall Study|Withdrawal by Subject|21|||
129944153|NCT01638000|467760178|FG001|Overall Study|Withdrawal by Subject|24|||
129944154|NCT01638000|467760177|FG000|Overall Study|Miscellaneous|2|||
129944155|NCT01638000|467760178|FG001|Overall Study|Miscellaneous|2|||
129944156|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944157|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944158|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
129944159|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944160|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944161|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
129944162|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
129944163|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
129944164|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
129944165|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
129944166|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944167|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
129944168|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944169|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944170|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944171|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
129944172|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
129944173|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
129944174|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
130120233|NCT01974895|468402305|FG000|Overall Study|Lost to Follow-up|4|||
130120234|NCT01974895|468402306|FG001|Overall Study|Lost to Follow-up|6|||
130120235|NCT01974895|468402305|FG000|Overall Study|Withdrawal by Subject|0|||
130120236|NCT01974895|468402306|FG001|Overall Study|Withdrawal by Subject|1|||
130120237|NCT01974895|468402305|FG000|Overall Study|Other (Missed Visit)|1|||
130120238|NCT01974895|468402306|FG001|Overall Study|Other (Missed Visit)|0|||
130120239|NCT01974895|468402305|FG000|Overall Study|Other (Reason unknown)|9|||
130120240|NCT01974895|468402306|FG001|Overall Study|Other (Reason unknown)|8|||
130120241|NCT01984242|468402307|FG000|Overall Study|Death|52|||
130120242|NCT01984242|468402308|FG001|Overall Study|Death|50|||
130120243|NCT01984242|468402309|FG002|Overall Study|Death|52|||
130120244|NCT01984242|468402307|FG000|Overall Study|Withdrawal by Subject|5|||
130120245|NCT01984242|468402308|FG001|Overall Study|Withdrawal by Subject|3|||
130120246|NCT01984242|468402309|FG002|Overall Study|Withdrawal by Subject|10|||
130120247|NCT01984242|468402307|FG000|Overall Study|Physician Decision|0|||
130120248|NCT01984242|468402308|FG001|Overall Study|Physician Decision|0|||
130120249|NCT01984242|468402309|FG002|Overall Study|Physician Decision|1|||
130120250|NCT01984242|468402307|FG000|Overall Study|Lost to Follow-up|4|||
130120251|NCT01984242|468402308|FG001|Overall Study|Lost to Follow-up|0|||
130120252|NCT01984242|468402309|FG002|Overall Study|Lost to Follow-up|3|||
130120253|NCT01984242|468402307|FG000|Overall Study|Sponsor Decision|1|||
130120254|NCT01984242|468402308|FG001|Overall Study|Sponsor Decision|0|||
130120255|NCT01984242|468402309|FG002|Overall Study|Sponsor Decision|0|||
130120256|NCT01984242|468402307|FG000|Overall Study|Non-Compliance|1|||
130120257|NCT01984242|468402308|FG001|Overall Study|Non-Compliance|0|||
130120258|NCT01984242|468402309|FG002|Overall Study|Non-Compliance|0|||
130120259|NCT01984242|468402307|FG000|Overall Study|Study terminated by Sponsor|38|||
130120260|NCT01984242|468402308|FG001|Overall Study|Study terminated by Sponsor|50|||
130120261|NCT01984242|468402309|FG002|Overall Study|Study terminated by Sponsor|34|||
130120262|NCT01984242|468402307|FG000|Overall Study|Disease Progression|0|||
130120263|NCT01984242|468402308|FG001|Overall Study|Disease Progression|0|||
130120264|NCT01984242|468402309|FG002|Overall Study|Disease Progression|1|||
130120265|NCT04543136|468402312|FG000|Overall Study|Withdrawal by Subject|0|||
130120266|NCT04543136|468402313|FG001|Overall Study|Withdrawal by Subject|1|||
130120267|NCT04543136|468402314|FG002|Overall Study|Withdrawal by Subject|0|||
130120268|NCT04543136|468402315|FG003|Overall Study|Withdrawal by Subject|1|||
130120269|NCT04543136|468402316|FG004|Overall Study|Withdrawal by Subject|0|||
130120270|NCT04543136|468402317|FG005|Overall Study|Withdrawal by Subject|0|||
130120271|NCT01626079|468402320|FG000|Overall Study|Death|167|||
130120272|NCT01626079|468402321|FG001|Overall Study|Death|192|||
130120273|NCT01626079|468402322|FG002|Overall Study|Death|39|||
130120274|NCT01626079|468402320|FG000|Overall Study|Withdrawal by Subject|23|||
130120275|NCT01626079|468402321|FG001|Overall Study|Withdrawal by Subject|37|||
130120276|NCT01626079|468402322|FG002|Overall Study|Withdrawal by Subject|5|||
130120277|NCT01626079|468402320|FG000|Overall Study|Lost to Follow-up|7|||
130120278|NCT01626079|468402321|FG001|Overall Study|Lost to Follow-up|4|||
130120279|NCT01626079|468402322|FG002|Overall Study|Lost to Follow-up|2|||
130120280|NCT01626079|468402320|FG000|Overall Study|Missed Visits|1|||
130120281|NCT01626079|468402321|FG001|Overall Study|Missed Visits|4|||
130120282|NCT01626079|468402322|FG002|Overall Study|Missed Visits|6|||
130120283|NCT02430870|468402323|FG000|Part 2|Voluntary Withdrawal|0|||
130120284|NCT02430870|468402324|FG001|Part 2|Voluntary Withdrawal|0|||
130120285|NCT02430870|468402325|FG002|Part 2|Voluntary Withdrawal|0|||
129944175|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
129944176|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944177|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944178|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
129944179|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944180|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944181|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
129944182|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
129944183|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
129944184|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
129944185|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
130120286|NCT02430870|468402326|FG003|Part 2|Voluntary Withdrawal|0|||
130120287|NCT02430870|468402327|FG004|Part 2|Voluntary Withdrawal|0|||
130120288|NCT02430870|468402328|FG005|Part 2|Voluntary Withdrawal|0|||
130120289|NCT02430870|468402329|FG006|Part 2|Voluntary Withdrawal|1|||
129944186|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
129944187|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
130120290|NCT02430870|468402330|FG007|Part 2|Voluntary Withdrawal|0|||
130120291|NCT02430870|468402323|FG000|Part 2|Other Reason Not Specified|0|||
129944188|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
130120292|NCT02430870|468402324|FG001|Part 2|Other Reason Not Specified|0|||
130120293|NCT02430870|468402325|FG002|Part 2|Other Reason Not Specified|0|||
130120294|NCT02430870|468402326|FG003|Part 2|Other Reason Not Specified|0|||
130120295|NCT02430870|468402327|FG004|Part 2|Other Reason Not Specified|0|||
130120296|NCT02430870|468402328|FG005|Part 2|Other Reason Not Specified|0|||
130120297|NCT02430870|468402329|FG006|Part 2|Other Reason Not Specified|0|||
130120298|NCT02430870|468402330|FG007|Part 2|Other Reason Not Specified|1|||
130120299|NCT03982433|468402331|FG000|Overall Study|Lost to Follow-up|1|||
130120300|NCT00865709|468402332|FG000|Treatment|Adverse Event|9|||
130120301|NCT00865709|468402333|FG001|Treatment|Adverse Event|6|||
129944189|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
129944190|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
129944191|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
129944192|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944193|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944194|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944195|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944196|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
129944197|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
129944198|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
129944199|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
129944200|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
129944201|NCT01683409|467760181|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944202|NCT01683409|467760182|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944203|NCT01683409|467760183|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944204|NCT01683409|467760184|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944205|NCT01683409|467760185|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
129944206|NCT01683409|467760181|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944207|NCT01683409|467760182|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944208|NCT01683409|467760183|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
129944209|NCT01683409|467760184|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944210|NCT01683409|467760185|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944211|NCT04218864|467760186|FG000|Overall Study|Lost to Follow-up|8|||
129944212|NCT04218864|467760187|FG001|Overall Study|Lost to Follow-up|4|||
129944213|NCT04218864|467760186|FG000|Overall Study|Withdrawal by Subject|1|||
129944214|NCT04218864|467760187|FG001|Overall Study|Withdrawal by Subject|3|||
129944215|NCT01227421|467760189|FG000|Overall Study|Lost to Follow-up|6|||
129944216|NCT01227421|467760190|FG001|Overall Study|Lost to Follow-up|7|||
129944217|NCT01227421|467760191|FG002|Overall Study|Lost to Follow-up|5|||
129944218|NCT01227421|467760189|FG000|Overall Study|Adverse Event|2|||
129944219|NCT01227421|467760190|FG001|Overall Study|Adverse Event|7|||
129944220|NCT01227421|467760191|FG002|Overall Study|Adverse Event|2|||
129944221|NCT01227421|467760189|FG000|Overall Study|Withdrawal by Subject|1|||
129944222|NCT01227421|467760190|FG001|Overall Study|Withdrawal by Subject|2|||
129944223|NCT01227421|467760191|FG002|Overall Study|Withdrawal by Subject|1|||
129944224|NCT01227421|467760189|FG000|Overall Study|Protocol Violation|1|||
129944225|NCT01227421|467760190|FG001|Overall Study|Protocol Violation|1|||
129944226|NCT01227421|467760191|FG002|Overall Study|Protocol Violation|2|||
129944227|NCT01227421|467760189|FG000|Overall Study|Randomized in error|1|||
129944228|NCT01227421|467760190|FG001|Overall Study|Randomized in error|1|||
129944229|NCT01227421|467760191|FG002|Overall Study|Randomized in error|0|||
129944230|NCT02499328|467760192|FG000|Overall Study|Withdrawal by Subject|1|||
129944231|NCT02499328|467760193|FG001|Overall Study|Withdrawal by Subject|1|||
129944232|NCT02499328|467760194|FG002|Overall Study|Withdrawal by Subject|5|||
129944233|NCT02499328|467760195|FG003|Overall Study|Withdrawal by Subject|3|||
129944234|NCT02499328|467760196|FG004|Overall Study|Withdrawal by Subject|5|||
129944235|NCT02499328|467760197|FG005|Overall Study|Withdrawal by Subject|0|||
129944236|NCT02499328|467760198|FG006|Overall Study|Withdrawal by Subject|0|||
129944237|NCT02499328|467760199|FG007|Overall Study|Withdrawal by Subject|0|||
129944238|NCT02499328|467760200|FG008|Overall Study|Withdrawal by Subject|2|||
129944239|NCT02499328|467760201|FG009|Overall Study|Withdrawal by Subject|2|||
130071660|NCT00379236|468218067|FG002|Open-label Extension|Other|7|||
130071661|NCT04914819|468218068|FG000|Overall Study|Pregnancy|3|||
130071662|NCT04914819|468218069|FG001|Overall Study|Pregnancy|1|||
130071663|NCT04914819|468218068|FG000|Overall Study|Discontinued study|4|||
130071664|NCT04914819|468218069|FG001|Overall Study|Discontinued study|1|||
130071665|NCT04914819|468218068|FG000|Overall Study|Lost to Follow-up|7|||
130071666|NCT04914819|468218069|FG001|Overall Study|Lost to Follow-up|0|||
130071667|NCT04038385|468218070|FG000|Overall Study|Completed baseline assessment only|7|||
130120302|NCT00865709|468402332|FG000|Treatment|Withdrawal by Subject|10|||
129944240|NCT02499328|467760202|FG010|Overall Study|Withdrawal by Subject|0|||
129944241|NCT02499328|467760203|FG011|Overall Study|Withdrawal by Subject|3|||
129944242|NCT02499328|467760204|FG012|Overall Study|Withdrawal by Subject|7|||
129944243|NCT02499328|467760205|FG013|Overall Study|Withdrawal by Subject|3|||
129944244|NCT02499328|467760206|FG014|Overall Study|Withdrawal by Subject|1|||
130071668|NCT04038385|468218071|FG001|Overall Study|Completed baseline assessment only|4|||
129944245|NCT02499328|467760207|FG015|Overall Study|Withdrawal by Subject|0|||
130071669|NCT04038385|468218070|FG000|Overall Study|Moved out of area|4|||
130120303|NCT00865709|468402333|FG001|Treatment|Withdrawal by Subject|7|||
130120304|NCT00865709|468402332|FG000|Treatment|Physician Decision|3|||
129944246|NCT02499328|467760208|FG016|Overall Study|Withdrawal by Subject|0|||
129944247|NCT02499328|467760209|FG017|Overall Study|Withdrawal by Subject|3|||
129944248|NCT02499328|467760210|FG018|Overall Study|Withdrawal by Subject|0|||
129944249|NCT02499328|467760192|FG000|Overall Study|Lost to Follow-up|0|||
129944250|NCT02499328|467760193|FG001|Overall Study|Lost to Follow-up|1|||
129944251|NCT02499328|467760194|FG002|Overall Study|Lost to Follow-up|1|||
129944252|NCT02499328|467760195|FG003|Overall Study|Lost to Follow-up|2|||
129944253|NCT02499328|467760196|FG004|Overall Study|Lost to Follow-up|0|||
129944254|NCT02499328|467760197|FG005|Overall Study|Lost to Follow-up|0|||
129944255|NCT02499328|467760198|FG006|Overall Study|Lost to Follow-up|0|||
129944256|NCT02499328|467760199|FG007|Overall Study|Lost to Follow-up|2|||
129944257|NCT02499328|467760200|FG008|Overall Study|Lost to Follow-up|3|||
129944258|NCT02499328|467760201|FG009|Overall Study|Lost to Follow-up|0|||
129944259|NCT02499328|467760202|FG010|Overall Study|Lost to Follow-up|0|||
129944260|NCT02499328|467760203|FG011|Overall Study|Lost to Follow-up|0|||
129944261|NCT02499328|467760204|FG012|Overall Study|Lost to Follow-up|0|||
129944262|NCT02499328|467760205|FG013|Overall Study|Lost to Follow-up|0|||
129944263|NCT02499328|467760206|FG014|Overall Study|Lost to Follow-up|0|||
129944264|NCT02499328|467760207|FG015|Overall Study|Lost to Follow-up|0|||
129944265|NCT02499328|467760208|FG016|Overall Study|Lost to Follow-up|0|||
129944266|NCT02499328|467760209|FG017|Overall Study|Lost to Follow-up|0|||
129944267|NCT02499328|467760210|FG018|Overall Study|Lost to Follow-up|1|||
129944268|NCT02499328|467760192|FG000|Overall Study|Death|0|||
129944269|NCT02499328|467760193|FG001|Overall Study|Death|3|||
129944270|NCT02499328|467760194|FG002|Overall Study|Death|3|||
129944271|NCT02499328|467760195|FG003|Overall Study|Death|2|||
129944272|NCT02499328|467760196|FG004|Overall Study|Death|4|||
129944273|NCT02499328|467760197|FG005|Overall Study|Death|7|||
129944274|NCT02499328|467760198|FG006|Overall Study|Death|3|||
129944275|NCT02499328|467760199|FG007|Overall Study|Death|0|||
129944276|NCT02499328|467760200|FG008|Overall Study|Death|2|||
129944277|NCT02499328|467760201|FG009|Overall Study|Death|6|||
129944278|NCT02499328|467760202|FG010|Overall Study|Death|6|||
129944279|NCT02499328|467760203|FG011|Overall Study|Death|20|||
129944280|NCT02499328|467760204|FG012|Overall Study|Death|9|||
129944281|NCT02499328|467760205|FG013|Overall Study|Death|7|||
129944282|NCT02499328|467760206|FG014|Overall Study|Death|3|||
129944283|NCT02499328|467760207|FG015|Overall Study|Death|1|||
129944284|NCT02499328|467760208|FG016|Overall Study|Death|1|||
129944285|NCT02499328|467760209|FG017|Overall Study|Death|16|||
129944286|NCT02499328|467760210|FG018|Overall Study|Death|5|||
129944287|NCT02499328|467760192|FG000|Overall Study|"Other"|2|||
129944288|NCT02499328|467760193|FG001|Overall Study|"Other"|2|||
129944289|NCT02499328|467760194|FG002|Overall Study|"Other"|1|||
129944290|NCT02499328|467760195|FG003|Overall Study|"Other"|3|||
129944291|NCT02499328|467760196|FG004|Overall Study|"Other"|6|||
129944292|NCT02499328|467760197|FG005|Overall Study|"Other"|2|||
129944293|NCT02499328|467760198|FG006|Overall Study|"Other"|3|||
129944294|NCT02499328|467760199|FG007|Overall Study|"Other"|4|||
129944295|NCT02499328|467760200|FG008|Overall Study|"Other"|6|||
129944296|NCT02499328|467760201|FG009|Overall Study|"Other"|16|||
129944297|NCT02499328|467760202|FG010|Overall Study|"Other"|13|||
129944298|NCT02499328|467760203|FG011|Overall Study|"Other"|31|||
129944299|NCT02499328|467760204|FG012|Overall Study|"Other"|8|||
129944300|NCT02499328|467760205|FG013|Overall Study|"Other"|7|||
129944301|NCT02499328|467760206|FG014|Overall Study|"Other"|6|||
129944302|NCT02499328|467760207|FG015|Overall Study|"Other"|0|||
129944303|NCT02499328|467760208|FG016|Overall Study|"Other"|0|||
129944304|NCT02499328|467760209|FG017|Overall Study|"Other"|34|||
129944305|NCT02499328|467760210|FG018|Overall Study|"Other"|43|||
129944306|NCT02499328|467760192|FG000|Overall Study|Disease Progression|0|||
129944307|NCT02499328|467760193|FG001|Overall Study|Disease Progression|0|||
129944308|NCT02499328|467760194|FG002|Overall Study|Disease Progression|0|||
129944309|NCT02499328|467760195|FG003|Overall Study|Disease Progression|0|||
129944310|NCT02499328|467760196|FG004|Overall Study|Disease Progression|0|||
129944311|NCT02499328|467760197|FG005|Overall Study|Disease Progression|0|||
129944312|NCT02499328|467760198|FG006|Overall Study|Disease Progression|1|||
129944313|NCT02499328|467760199|FG007|Overall Study|Disease Progression|0|||
129944314|NCT02499328|467760200|FG008|Overall Study|Disease Progression|1|||
129944315|NCT02499328|467760201|FG009|Overall Study|Disease Progression|0|||
129944316|NCT02499328|467760202|FG010|Overall Study|Disease Progression|1|||
130071670|NCT04038385|468218071|FG001|Overall Study|Moved out of area|2|||
130071671|NCT04038385|468218070|FG000|Overall Study|Discontinued study involvement|6|||
129944317|NCT02499328|467760203|FG011|Overall Study|Disease Progression|0|||
129944318|NCT02499328|467760204|FG012|Overall Study|Disease Progression|0|||
129944319|NCT02499328|467760205|FG013|Overall Study|Disease Progression|0|||
129944320|NCT02499328|467760206|FG014|Overall Study|Disease Progression|0|||
129944321|NCT02499328|467760207|FG015|Overall Study|Disease Progression|0|||
129944322|NCT02499328|467760208|FG016|Overall Study|Disease Progression|0|||
129944323|NCT02499328|467760209|FG017|Overall Study|Disease Progression|2|||
129944324|NCT02499328|467760210|FG018|Overall Study|Disease Progression|0|||
129944325|NCT02499328|467760192|FG000|Overall Study|Adverse Event|1|||
129944326|NCT02499328|467760193|FG001|Overall Study|Adverse Event|0|||
129944327|NCT02499328|467760194|FG002|Overall Study|Adverse Event|0|||
129944328|NCT02499328|467760195|FG003|Overall Study|Adverse Event|1|||
129944329|NCT02499328|467760196|FG004|Overall Study|Adverse Event|0|||
129944330|NCT02499328|467760197|FG005|Overall Study|Adverse Event|0|||
129944331|NCT02499328|467760198|FG006|Overall Study|Adverse Event|0|||
129944332|NCT02499328|467760199|FG007|Overall Study|Adverse Event|0|||
129944333|NCT02499328|467760200|FG008|Overall Study|Adverse Event|0|||
129944334|NCT02499328|467760201|FG009|Overall Study|Adverse Event|0|||
129944335|NCT02499328|467760202|FG010|Overall Study|Adverse Event|0|||
129944336|NCT02499328|467760203|FG011|Overall Study|Adverse Event|0|||
129944337|NCT02499328|467760204|FG012|Overall Study|Adverse Event|1|||
129944338|NCT02499328|467760205|FG013|Overall Study|Adverse Event|0|||
129944339|NCT02499328|467760206|FG014|Overall Study|Adverse Event|0|||
129944340|NCT02499328|467760207|FG015|Overall Study|Adverse Event|0|||
129944341|NCT02499328|467760208|FG016|Overall Study|Adverse Event|0|||
129944342|NCT02499328|467760209|FG017|Overall Study|Adverse Event|0|||
129944343|NCT02499328|467760210|FG018|Overall Study|Adverse Event|0|||
129944344|NCT00145470|467760211|FG000|Overall Study|Adverse Event|19|||
129944345|NCT00145470|467760212|FG001|Overall Study|Adverse Event|25|||
129944346|NCT00145470|467760211|FG000|Overall Study|Lack of Efficacy|27|||
129944347|NCT00145470|467760212|FG001|Overall Study|Lack of Efficacy|13|||
129944348|NCT00145470|467760211|FG000|Overall Study|Withdrawal by Subject|36|||
129944349|NCT00145470|467760212|FG001|Overall Study|Withdrawal by Subject|34|||
129944350|NCT00145470|467760211|FG000|Overall Study|Lost to Follow-up|21|||
129944351|NCT00145470|467760212|FG001|Overall Study|Lost to Follow-up|17|||
129944352|NCT00145470|467760211|FG000|Overall Study|Reason Not Reported|9|||
129944353|NCT00145470|467760212|FG001|Overall Study|Reason Not Reported|9|||
129944354|NCT04602728|467760214|FG000|Overall Study|Lost to Follow-up|4|||
129944355|NCT04602728|467760215|FG001|Overall Study|Lost to Follow-up|4|||
129944356|NCT04447027|467760218|FG000|Dose Escalation|Withdrawal by Subject|1|||
129944357|NCT04447027|467760219|FG001|Dose Escalation|Withdrawal by Subject|4|||
129944358|NCT04447027|467760220|FG002|Dose Escalation|Withdrawal by Subject|3|||
129944359|NCT04447027|467760221|FG003|Dose Escalation|Withdrawal by Subject|3|||
129944360|NCT04447027|467760222|FG004|Dose Escalation|Withdrawal by Subject|1|||
129944361|NCT04447027|467760223|FG005|Dose Escalation|Withdrawal by Subject|0|||
129944362|NCT04447027|467760224|FG006|Dose Escalation|Withdrawal by Subject|0|||
129944363|NCT04447027|467760225|FG007|Dose Escalation|Withdrawal by Subject|0|||
129944364|NCT04447027|467760226|FG008|Dose Escalation|Withdrawal by Subject|0|||
129944365|NCT04447027|467760218|FG000|Dose Escalation|Refused further treatment|0|||
129944366|NCT04447027|467760219|FG001|Dose Escalation|Refused further treatment|1|||
129944367|NCT04447027|467760220|FG002|Dose Escalation|Refused further treatment|1|||
129944368|NCT04447027|467760221|FG003|Dose Escalation|Refused further treatment|0|||
129944369|NCT04447027|467760222|FG004|Dose Escalation|Refused further treatment|0|||
129944370|NCT04447027|467760223|FG005|Dose Escalation|Refused further treatment|0|||
129944371|NCT04447027|467760224|FG006|Dose Escalation|Refused further treatment|0|||
129944372|NCT04447027|467760225|FG007|Dose Escalation|Refused further treatment|0|||
129944373|NCT04447027|467760226|FG008|Dose Escalation|Refused further treatment|0|||
129944374|NCT04447027|467760218|FG000|Dose Expansion|Withdrawal by Subject|0|||
129944375|NCT04447027|467760219|FG001|Dose Expansion|Withdrawal by Subject|0|||
129944376|NCT04447027|467760220|FG002|Dose Expansion|Withdrawal by Subject|0|||
129944377|NCT04447027|467760221|FG003|Dose Expansion|Withdrawal by Subject|0|||
129944378|NCT04447027|467760222|FG004|Dose Expansion|Withdrawal by Subject|0|||
129944379|NCT04447027|467760223|FG005|Dose Expansion|Withdrawal by Subject|2|||
129944380|NCT04447027|467760224|FG006|Dose Expansion|Withdrawal by Subject|0|||
129944381|NCT04447027|467760225|FG007|Dose Expansion|Withdrawal by Subject|2|||
129944382|NCT04447027|467760226|FG008|Dose Expansion|Withdrawal by Subject|0|||
129944383|NCT02831049|467760227|FG000|Overall Study|Lost to Follow-up|0|||
129944384|NCT02831049|467760228|FG001|Overall Study|Lost to Follow-up|0|||
129944385|NCT02831049|467760229|FG002|Overall Study|Lost to Follow-up|1|||
129944386|NCT02831049|467760227|FG000|Overall Study|Withdrawal by Subject|0|||
129944387|NCT02831049|467760228|FG001|Overall Study|Withdrawal by Subject|1|||
129944388|NCT02831049|467760229|FG002|Overall Study|Withdrawal by Subject|1|||
129944389|NCT02831049|467760227|FG000|Overall Study|Pandemic shutdown|1|||
129944390|NCT02831049|467760228|FG001|Overall Study|Pandemic shutdown|0|||
130071672|NCT04038385|468218071|FG001|Overall Study|Discontinued study involvement|1|||
130071673|NCT01625611|468218072|FG000|Overall Study|No adlib drinks Lab 1|3|||
130071674|NCT01625611|468218073|FG001|Overall Study|No adlib drinks Lab 1|0|||
130071675|NCT01625611|468218072|FG000|Overall Study|Technical issues with PET|1|||
130071676|NCT01625611|468218073|FG001|Overall Study|Technical issues with PET|0|||
130071677|NCT01625611|468218072|FG000|Overall Study|Unable to complete study procedures|1|||
129944391|NCT02831049|467760229|FG002|Overall Study|Pandemic shutdown|0|||
129944392|NCT02609048|467760230|FG000|Overall Study|Adverse Event|3|||
129944393|NCT02609048|467760231|FG001|Overall Study|Adverse Event|0|||
129944394|NCT02609048|467760232|FG002|Overall Study|Adverse Event|0|||
129944395|NCT02609048|467760230|FG000|Overall Study|Randomized but never treated|1|||
129944396|NCT02609048|467760231|FG001|Overall Study|Randomized but never treated|1|||
129944397|NCT02609048|467760232|FG002|Overall Study|Randomized but never treated|1|||
129944398|NCT02609048|467760230|FG000|Overall Study|Withdrawal of informed consent|1|||
130071678|NCT01625611|468218073|FG001|Overall Study|Unable to complete study procedures|0|||
130071679|NCT01625611|468218072|FG000|Overall Study|Withdrawal by Subject|3|||
130071680|NCT01625611|468218073|FG001|Overall Study|Withdrawal by Subject|0|||
130071681|NCT01998958|468218074|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071682|NCT01998958|468218075|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
130071683|NCT01998958|468218076|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071684|NCT01998958|468218077|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071685|NCT01998958|468218078|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071686|NCT01998958|468218079|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071687|NCT01998958|468218080|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071688|NCT01998958|468218081|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071689|NCT01998958|468218082|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071690|NCT01998958|468218083|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071691|NCT01998958|468218084|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071692|NCT01998958|468218085|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071693|NCT01998958|468218086|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071694|NCT01998958|468218087|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130120305|NCT00865709|468402333|FG001|Treatment|Physician Decision|2|||
130120306|NCT00865709|468402332|FG000|Treatment|Surgery|8|||
129944399|NCT02609048|467760231|FG001|Overall Study|Withdrawal of informed consent|0|||
129944400|NCT02609048|467760232|FG002|Overall Study|Withdrawal of informed consent|0|||
129944401|NCT02609048|467760230|FG000|Overall Study|Reason not specified|6|||
129944402|NCT02609048|467760231|FG001|Overall Study|Reason not specified|9|||
130120307|NCT00865709|468402333|FG001|Treatment|Surgery|3|||
130120308|NCT00429923|468402334|FG000|Overall Study|Adverse Event|0|||
130120309|NCT00429923|468402335|FG001|Overall Study|Adverse Event|2|||
130120310|NCT00429923|468402336|FG002|Overall Study|Adverse Event|3|||
130120311|NCT00429923|468402334|FG000|Overall Study|Lack of Efficacy|4|||
130120312|NCT00429923|468402335|FG001|Overall Study|Lack of Efficacy|1|||
130120313|NCT00429923|468402336|FG002|Overall Study|Lack of Efficacy|33|||
130120314|NCT00429923|468402334|FG000|Overall Study|Lost to Follow-up|0|||
130120315|NCT00429923|468402335|FG001|Overall Study|Lost to Follow-up|0|||
130120316|NCT00429923|468402336|FG002|Overall Study|Lost to Follow-up|2|||
130120317|NCT00429923|468402334|FG000|Overall Study|Withdrew Consent|1|||
130120318|NCT00429923|468402335|FG001|Overall Study|Withdrew Consent|0|||
130120319|NCT00429923|468402336|FG002|Overall Study|Withdrew Consent|1|||
130120320|NCT00429923|468402334|FG000|Overall Study|Early Termination|0|||
130120321|NCT00429923|468402335|FG001|Overall Study|Early Termination|1|||
129944403|NCT02609048|467760232|FG002|Overall Study|Reason not specified|9|||
129944404|NCT02485925|467760233|FG000|Overall Study|Withdrawal by Subject|3|||
129944405|NCT02485925|467760233|FG000|Overall Study|Death|1|||
129944406|NCT02485925|467760233|FG000|Overall Study|Lost to Follow-up|11|||
129944407|NCT05995977|467760234|FG000|Overall Study|Withdrawal by Subject|1|||
129944408|NCT05995977|467760235|FG001|Overall Study|Withdrawal by Subject|4|||
129944409|NCT05995977|467760234|FG000|Overall Study|Lost to Follow-up|2|||
129944410|NCT05995977|467760235|FG001|Overall Study|Lost to Follow-up|0|||
129944411|NCT04181788|467760236|FG000|TREATMENT|Adverse Event|0|||
129944412|NCT04181788|467760237|FG001|TREATMENT|Adverse Event|2|||
129944413|NCT04181788|467760238|FG002|TREATMENT|Adverse Event|1|||
129944414|NCT04181788|467760239|FG003|TREATMENT|Adverse Event|0|||
129944415|NCT04181788|467760240|FG004|TREATMENT|Adverse Event|1|||
129944416|NCT04181788|467760241|FG005|TREATMENT|Adverse Event|3|||
129944417|NCT04181788|467760236|FG000|TREATMENT|Death|0|||
129944418|NCT04181788|467760237|FG001|TREATMENT|Death|0|||
129944419|NCT04181788|467760238|FG002|TREATMENT|Death|0|||
129944420|NCT04181788|467760239|FG003|TREATMENT|Death|0|||
129944421|NCT04181788|467760240|FG004|TREATMENT|Death|8|||
129944422|NCT04181788|467760241|FG005|TREATMENT|Death|8|||
129944423|NCT04181788|467760236|FG000|TREATMENT|Physician Decision|0|||
129944424|NCT04181788|467760237|FG001|TREATMENT|Physician Decision|0|||
129944425|NCT04181788|467760238|FG002|TREATMENT|Physician Decision|0|||
129944426|NCT04181788|467760239|FG003|TREATMENT|Physician Decision|0|||
129944427|NCT04181788|467760240|FG004|TREATMENT|Physician Decision|0|||
129944428|NCT04181788|467760241|FG005|TREATMENT|Physician Decision|1|||
129944429|NCT04181788|467760236|FG000|TREATMENT|Progressive disease|3|||
130071695|NCT01998958|468218088|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071696|NCT01998958|468218089|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071697|NCT01998958|468218090|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130120322|NCT00429923|468402336|FG002|Overall Study|Early Termination|0|||
130120323|NCT04799158|468402343|FG000|Run-In Period|Adverse Event|6|||
129944430|NCT04181788|467760237|FG001|TREATMENT|Progressive disease|3|||
129944431|NCT04181788|467760238|FG002|TREATMENT|Progressive disease|5|||
129944432|NCT04181788|467760239|FG003|TREATMENT|Progressive disease|7|||
129944433|NCT04181788|467760240|FG004|TREATMENT|Progressive disease|20|||
129944434|NCT04181788|467760241|FG005|TREATMENT|Progressive disease|38|||
129944435|NCT04181788|467760236|FG000|TREATMENT|Global deterioration of health status|0|||
129944436|NCT04181788|467760237|FG001|TREATMENT|Global deterioration of health status|2|||
130120324|NCT04799158|468402344|FG001|Run-In Period|Adverse Event|0|||
129944437|NCT04181788|467760238|FG002|TREATMENT|Global deterioration of health status|0|||
129944438|NCT04181788|467760239|FG003|TREATMENT|Global deterioration of health status|0|||
129944439|NCT04181788|467760240|FG004|TREATMENT|Global deterioration of health status|2|||
129944440|NCT04181788|467760241|FG005|TREATMENT|Global deterioration of health status|8|||
129944441|NCT04181788|467760236|FG000|TREATMENT|Withdrawal by Subject|1|||
129944442|NCT04181788|467760237|FG001|TREATMENT|Withdrawal by Subject|2|||
129944443|NCT04181788|467760238|FG002|TREATMENT|Withdrawal by Subject|0|||
129944444|NCT04181788|467760239|FG003|TREATMENT|Withdrawal by Subject|0|||
129944445|NCT04181788|467760240|FG004|TREATMENT|Withdrawal by Subject|3|||
129944446|NCT04181788|467760241|FG005|TREATMENT|Withdrawal by Subject|5|||
129944447|NCT04181788|467760236|FG000|TREATMENT|Other unspecified|0|||
129944448|NCT04181788|467760237|FG001|TREATMENT|Other unspecified|0|||
129944449|NCT04181788|467760238|FG002|TREATMENT|Other unspecified|0|||
129944450|NCT04181788|467760239|FG003|TREATMENT|Other unspecified|0|||
129944451|NCT04181788|467760240|FG004|TREATMENT|Other unspecified|0|||
129944452|NCT04181788|467760241|FG005|TREATMENT|Other unspecified|2|||
129944453|NCT04181788|467760236|FG000|TREATMENT|Ongoing|0|||
129944454|NCT04181788|467760237|FG001|TREATMENT|Ongoing|3|||
129944455|NCT04181788|467760238|FG002|TREATMENT|Ongoing|0|||
129944456|NCT04181788|467760239|FG003|TREATMENT|Ongoing|5|||
129944457|NCT04181788|467760240|FG004|TREATMENT|Ongoing|7|||
129944458|NCT04181788|467760241|FG005|TREATMENT|Ongoing|15|||
129944459|NCT04181788|467760236|FG000|FOLLOW-UP|Death|0|||
129944460|NCT04181788|467760237|FG001|FOLLOW-UP|Death|0|||
129944461|NCT04181788|467760238|FG002|FOLLOW-UP|Death|1|||
129944462|NCT04181788|467760239|FG003|FOLLOW-UP|Death|2|||
129944463|NCT04181788|467760240|FG004|FOLLOW-UP|Death|8|||
129944464|NCT04181788|467760241|FG005|FOLLOW-UP|Death|20|||
129944465|NCT04181788|467760236|FG000|FOLLOW-UP|Lost to Follow-up|0|||
129944466|NCT04181788|467760237|FG001|FOLLOW-UP|Lost to Follow-up|0|||
129944467|NCT04181788|467760238|FG002|FOLLOW-UP|Lost to Follow-up|0|||
129944468|NCT04181788|467760239|FG003|FOLLOW-UP|Lost to Follow-up|0|||
129944469|NCT04181788|467760240|FG004|FOLLOW-UP|Lost to Follow-up|0|||
129944470|NCT04181788|467760241|FG005|FOLLOW-UP|Lost to Follow-up|2|||
129944471|NCT04181788|467760236|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
129944472|NCT04181788|467760237|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
129944473|NCT04181788|467760238|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
129944474|NCT04181788|467760239|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
129944475|NCT04181788|467760240|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
129944476|NCT04181788|467760241|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
129944477|NCT04181788|467760236|FG000|FOLLOW-UP|Other unspecified|0|||
129944478|NCT04181788|467760237|FG001|FOLLOW-UP|Other unspecified|1|||
129944479|NCT04181788|467760238|FG002|FOLLOW-UP|Other unspecified|0|||
129944480|NCT04181788|467760239|FG003|FOLLOW-UP|Other unspecified|0|||
129944481|NCT04181788|467760240|FG004|FOLLOW-UP|Other unspecified|0|||
129944482|NCT04181788|467760241|FG005|FOLLOW-UP|Other unspecified|3|||
129944483|NCT04181788|467760236|FG000|FOLLOW-UP|Ongoing|0|||
129944484|NCT04181788|467760237|FG001|FOLLOW-UP|Ongoing|0|||
129944485|NCT04181788|467760238|FG002|FOLLOW-UP|Ongoing|1|||
129944486|NCT04181788|467760239|FG003|FOLLOW-UP|Ongoing|3|||
129944487|NCT04181788|467760240|FG004|FOLLOW-UP|Ongoing|2|||
129944488|NCT04181788|467760241|FG005|FOLLOW-UP|Ongoing|2|||
129944489|NCT04937504|467760242|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
129944490|NCT04937504|467760243|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
129944491|NCT04937504|467760242|FG000|9 Months Assessment|Lost to Follow-up|3|||
129944492|NCT04937504|467760243|FG001|9 Months Assessment|Lost to Follow-up|2|||
129944493|NCT04186247|467760244|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
129944494|NCT04186247|467760245|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944495|NCT04186247|467760246|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944496|NCT04186247|467760247|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944497|NCT04186247|467760248|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944498|NCT03662659|467760249|FG000|Pre-treatment|Participant no longer met study criteria|1|||
129944499|NCT03662659|467760250|FG001|Pre-treatment|Participant no longer met study criteria|1|||
129944500|NCT03662659|467760249|FG000|Pre-treatment|Other reasons|1|||
129944501|NCT03662659|467760250|FG001|Pre-treatment|Other reasons|0|||
129944502|NCT03662659|467760249|FG000|Treatment|Completed Treatment|0|||
129944503|NCT03662659|467760250|FG001|Treatment|Completed Treatment|2|||
129944504|NCT03662659|467760249|FG000|Treatment|Disease Progression|85|||
130071698|NCT01998958|468218091|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129944505|NCT03662659|467760250|FG001|Treatment|Disease Progression|97|||
129944506|NCT03662659|467760249|FG000|Treatment|Study Drug Toxicity|19|||
129944507|NCT03662659|467760250|FG001|Treatment|Study Drug Toxicity|9|||
129944508|NCT03662659|467760249|FG000|Treatment|Death|11|||
129944509|NCT03662659|467760250|FG001|Treatment|Death|9|||
129944510|NCT03662659|467760249|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
129944511|NCT03662659|467760250|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
129944512|NCT03662659|467760249|FG000|Treatment|Withdrawal by Subject|1|||
129944513|NCT03662659|467760250|FG001|Treatment|Withdrawal by Subject|1|||
129944514|NCT03662659|467760249|FG000|Treatment|Poor/Non-compliance|1|||
129944515|NCT03662659|467760250|FG001|Treatment|Poor/Non-compliance|0|||
129944516|NCT03662659|467760249|FG000|Treatment|Participant no longer meets study criteria|1|||
129944517|NCT03662659|467760250|FG001|Treatment|Participant no longer meets study criteria|0|||
129944518|NCT03662659|467760249|FG000|Treatment|Other reasons|10|||
129944519|NCT03662659|467760250|FG001|Treatment|Other reasons|8|||
129944520|NCT03662659|467760249|FG000|Treatment|Administrative reasons by sponsor|1|||
129944521|NCT03662659|467760250|FG001|Treatment|Administrative reasons by sponsor|0|||
129944522|NCT03662659|467760249|FG000|Treatment|maximum clinical benefit|0|||
129944523|NCT03662659|467760250|FG001|Treatment|maximum clinical benefit|2|||
129944524|NCT04118894|467760252|FG000|Overall Study|Lost to Follow-up|21|||
129944525|NCT04118894|467760252|FG000|Overall Study|Withdrawal by Subject|10|||
129944526|NCT04118894|467760252|FG000|Overall Study|Adverse Event|4|||
129944527|NCT04323800|467761730|FG000|Overall Study|Withdrawal by Subject|4|||
129944528|NCT04323800|467761731|FG001|Overall Study|Withdrawal by Subject|4|||
129944529|NCT04323800|467761730|FG000|Overall Study|Incomplete transfusion|1|||
129944530|NCT04323800|467761731|FG001|Overall Study|Incomplete transfusion|0|||
129944531|NCT04323800|467761730|FG000|Overall Study|Other|0|||
129944532|NCT04323800|467761731|FG001|Overall Study|Other|1|||
129944533|NCT04323800|467761730|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
129944534|NCT04323800|467761731|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
129944535|NCT00489554|467761732|FG000|Overall Study|Adverse Event|2|||
129944536|NCT00489554|467761732|FG000|Overall Study|Withdrawal by Subject|1|||
129944537|NCT00489554|467761732|FG000|Overall Study|Lost to Follow-up|1|||
129944538|NCT06571695|467761733|FG000|Overall Study|Lost to Follow-up|1|||
129944539|NCT06571695|467761734|FG001|Overall Study|Lost to Follow-up|6|||
129944540|NCT01380145|467761735|FG000|Overall Study|Progressive disease|4|||
129944541|NCT02038049|467761740|FG000|Overall Study|Lost to Follow-up|1|||
129944542|NCT02038049|467761741|FG001|Overall Study|Lost to Follow-up|0|||
129944543|NCT02771366|467761742|FG000|Period 1|Withdrawal by Subject|0|||
129944544|NCT02771366|467761743|FG001|Period 1|Withdrawal by Subject|2|||
129944545|NCT02771366|467761742|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
129944546|NCT02771366|467761743|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
129944547|NCT01808534|467761744|FG000|Overall Study|Disease progression|3|||
129944548|NCT01808534|467761744|FG000|Overall Study|Physician Decision|1|||
129944549|NCT01823224|467761745|FG000|Overall Study|Lost to Follow-up|5|||
129944550|NCT01823224|467761746|FG001|Overall Study|Lost to Follow-up|6|||
129944551|NCT01823224|467761745|FG000|Overall Study|didn't qualify|1|||
129944552|NCT01823224|467761746|FG001|Overall Study|didn't qualify|2|||
129944553|NCT01823224|467761745|FG000|Overall Study|pharmacy error|0|||
129944554|NCT01823224|467761746|FG001|Overall Study|pharmacy error|1|||
129944555|NCT01823224|467761745|FG000|Overall Study|missed med dose|0|||
129944556|NCT01823224|467761746|FG001|Overall Study|missed med dose|1|||
129944557|NCT01823224|467761745|FG000|Overall Study|Withdrawal by Subject|0|||
129944558|NCT01823224|467761746|FG001|Overall Study|Withdrawal by Subject|1|||
129944559|NCT03737110|467761754|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
129944560|NCT03737110|467761755|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
129944561|NCT03737110|467761756|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
129944562|NCT03737110|467761757|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
129944563|NCT03737110|467761758|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
129944564|NCT03737110|467761759|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
129944565|NCT03737110|467761754|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
129944566|NCT03737110|467761755|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944567|NCT03737110|467761756|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944568|NCT03737110|467761757|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944569|NCT03737110|467761758|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944570|NCT03737110|467761759|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944571|NCT03737110|467761754|FG000|Run-in (RI) Period|Adverse Event|4|||
129944572|NCT03737110|467761755|FG001|Run-in (RI) Period|Adverse Event|0|||
129944573|NCT03737110|467761756|FG002|Run-in (RI) Period|Adverse Event|0|||
129944574|NCT03737110|467761757|FG003|Run-in (RI) Period|Adverse Event|0|||
129944575|NCT03737110|467761758|FG004|Run-in (RI) Period|Adverse Event|0|||
129944576|NCT03737110|467761759|FG005|Run-in (RI) Period|Adverse Event|0|||
129944577|NCT03737110|467761754|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944578|NCT03737110|467761755|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
129979764|NCT01204710|467889468|FG000|Randomization Treatment|Lost to Follow-up|1|||
129979765|NCT01204710|467889469|FG001|Randomization Treatment|Lost to Follow-up|0|||
129979766|NCT01204710|467889468|FG000|Randomization Treatment|Withdrawal by Subject|6|||
129979767|NCT01204710|467889469|FG001|Randomization Treatment|Withdrawal by Subject|5|||
129979768|NCT01204710|467889468|FG000|Randomization Treatment|Physician Decision|3|||
129979769|NCT01204710|467889469|FG001|Randomization Treatment|Physician Decision|2|||
129979770|NCT01204710|467889468|FG000|Randomization Treatment|Entry criteria not met|0|||
129979771|NCT01204710|467889469|FG001|Randomization Treatment|Entry criteria not met|1|||
129979772|NCT01204710|467889468|FG000|Randomization Treatment|Adverse Event|4|||
129979773|NCT01204710|467889469|FG001|Randomization Treatment|Adverse Event|2|||
129979774|NCT01204710|467889468|FG000|Randomization Treatment|Sponsor Decision|0|||
129979775|NCT01204710|467889469|FG001|Randomization Treatment|Sponsor Decision|1|||
129979776|NCT01204710|467889468|FG000|Randomization Treatment|Worsening of General condition|0|||
130071699|NCT01998958|468218092|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071700|NCT01998958|468218093|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071701|NCT01998958|468218094|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071702|NCT01998958|468218095|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071703|NCT01998958|468218096|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071704|NCT01998958|468218097|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071705|NCT01998958|468218098|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071706|NCT01998958|468218099|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071707|NCT01998958|468218100|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071708|NCT01998958|468218101|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071709|NCT01998958|468218102|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071710|NCT01998958|468218103|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071711|NCT01998958|468218104|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
130071712|NCT01998958|468218105|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129944579|NCT03737110|467761756|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944580|NCT03737110|467761757|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944581|NCT03737110|467761758|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944582|NCT03737110|467761759|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944583|NCT03737110|467761754|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944584|NCT03737110|467761755|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944585|NCT03737110|467761756|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
129944586|NCT03737110|467761757|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944587|NCT03737110|467761758|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944588|NCT03737110|467761759|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944589|NCT03737110|467761754|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944590|NCT03737110|467761755|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944591|NCT03737110|467761756|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944592|NCT03737110|467761757|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
129944593|NCT03737110|467761758|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944594|NCT03737110|467761759|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944595|NCT03737110|467761754|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944596|NCT03737110|467761755|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944597|NCT03737110|467761756|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944598|NCT03737110|467761757|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
129944599|NCT03737110|467761758|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944600|NCT03737110|467761759|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
129944601|NCT03737110|467761754|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944602|NCT03737110|467761755|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944603|NCT03737110|467761756|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944604|NCT03737110|467761757|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944605|NCT03737110|467761758|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
129944606|NCT03737110|467761759|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944607|NCT02575365|467761770|FG000|Overall Study|Lost to Follow-up|4|||
129944608|NCT00273052|467761781|FG000|Overall Study|Withdrawal by Subject|16|||
129944609|NCT00273052|467761782|FG001|Overall Study|Withdrawal by Subject|19|||
129944610|NCT00273052|467761781|FG000|Overall Study|Adverse Event|21|||
129944611|NCT00273052|467761782|FG001|Overall Study|Adverse Event|19|||
129944612|NCT00273052|467761781|FG000|Overall Study|Protocol Violation|14|||
129944613|NCT00273052|467761782|FG001|Overall Study|Protocol Violation|18|||
129944614|NCT00273052|467761781|FG000|Overall Study|Lost to Follow-up|7|||
129944615|NCT00273052|467761782|FG001|Overall Study|Lost to Follow-up|25|||
129944616|NCT00273052|467761781|FG000|Overall Study|Lack of Efficacy|6|||
129944617|NCT00273052|467761782|FG001|Overall Study|Lack of Efficacy|4|||
129944618|NCT00273052|467761781|FG000|Overall Study|Non-Compliance|3|||
129944619|NCT00273052|467761782|FG001|Overall Study|Non-Compliance|1|||
129944620|NCT00273052|467761781|FG000|Overall Study|Other|2|||
129944621|NCT00273052|467761782|FG001|Overall Study|Other|0|||
129944622|NCT00273052|467761781|FG000|Overall Study|Worsening serum lipid levels|0|||
129944623|NCT00273052|467761782|FG001|Overall Study|Worsening serum lipid levels|2|||
129944624|NCT01951703|467761785|FG000|First Intervention|Withdrawal by Subject|1|||
129944625|NCT01951703|467761786|FG001|First Intervention|Withdrawal by Subject|0|||
129944626|NCT01951703|467761785|FG000|First Intervention|Subject was not compliant|1|||
129944627|NCT01951703|467761786|FG001|First Intervention|Subject was not compliant|1|||
130071713|NCT01998958|468218074|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071714|NCT01998958|468218075|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
129944628|NCT01951703|467761785|FG000|First Intervention|Physician Decision|1|||
130071715|NCT01998958|468218076|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071716|NCT01998958|468218077|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944629|NCT01951703|467761786|FG001|First Intervention|Physician Decision|0|||
129944630|NCT01951703|467761785|FG000|Second Intervention|Protocol Violation|0|||
129944631|NCT01951703|467761786|FG001|Second Intervention|Protocol Violation|1|||
129944632|NCT01951703|467761785|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
129944633|NCT01951703|467761786|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
129944634|NCT01009645|467761787|FG000|Overall Study|Lost to Follow-up|2|||
129944635|NCT01009645|467761788|FG001|Overall Study|Lost to Follow-up|8|||
129944636|NCT01009645|467761789|FG002|Overall Study|Lost to Follow-up|4|||
129944637|NCT01009645|467761790|FG003|Overall Study|Lost to Follow-up|5|||
129944638|NCT02708498|467761791|FG000|Overall Study|Death|20|||
129944639|NCT02708498|467761792|FG001|Overall Study|Death|19|||
129944640|NCT02708498|467761793|FG002|Overall Study|Death|0|||
129944641|NCT02708498|467761794|FG003|Overall Study|Death|0|||
129944642|NCT02708498|467761795|FG004|Overall Study|Death|1|||
129944643|NCT02708498|467761796|FG005|Overall Study|Death|0|||
129944644|NCT02708498|467761797|FG006|Overall Study|Death|0|||
129944645|NCT02708498|467761798|FG007|Overall Study|Death|0|||
129944646|NCT02708498|467761791|FG000|Overall Study|Unknown reason, missing data|0|||
129944647|NCT02708498|467761792|FG001|Overall Study|Unknown reason, missing data|0|||
129944648|NCT02708498|467761793|FG002|Overall Study|Unknown reason, missing data|62|||
129944649|NCT02708498|467761794|FG003|Overall Study|Unknown reason, missing data|51|||
129944650|NCT02708498|467761795|FG004|Overall Study|Unknown reason, missing data|195|||
129944651|NCT02708498|467761796|FG005|Overall Study|Unknown reason, missing data|132|||
129944652|NCT02708498|467761797|FG006|Overall Study|Unknown reason, missing data|0|||
129944653|NCT02708498|467761798|FG007|Overall Study|Unknown reason, missing data|0|||
129944654|NCT03052517|467761799|FG000|Overall Study|Study Terminated By Sponsor|928|||
129944655|NCT03052517|467761800|FG001|Overall Study|Study Terminated By Sponsor|938|||
129944656|NCT03052517|467761801|FG002|Overall Study|Study Terminated By Sponsor|296|||
129944657|NCT03052517|467761799|FG000|Overall Study|Subject/Guardian Decision|50|||
129944658|NCT03052517|467761800|FG001|Overall Study|Subject/Guardian Decision|45|||
129944659|NCT03052517|467761801|FG002|Overall Study|Subject/Guardian Decision|22|||
129944660|NCT03052517|467761799|FG000|Overall Study|Lack of Efficacy|23|||
129944661|NCT03052517|467761800|FG001|Overall Study|Lack of Efficacy|14|||
129944662|NCT03052517|467761801|FG002|Overall Study|Lack of Efficacy|7|||
129944663|NCT03052517|467761799|FG000|Overall Study|Adverse Event|6|||
129944664|NCT03052517|467761800|FG001|Overall Study|Adverse Event|5|||
129944665|NCT03052517|467761801|FG002|Overall Study|Adverse Event|0|||
129944666|NCT03052517|467761799|FG000|Overall Study|Physician Decision|4|||
129944667|NCT03052517|467761800|FG001|Overall Study|Physician Decision|5|||
129944668|NCT03052517|467761801|FG002|Overall Study|Physician Decision|1|||
129944669|NCT03052517|467761799|FG000|Overall Study|Death|3|||
129944670|NCT03052517|467761800|FG001|Overall Study|Death|0|||
129944671|NCT03052517|467761801|FG002|Overall Study|Death|1|||
129944672|NCT03052517|467761799|FG000|Overall Study|Lost to Follow-up|2|||
129944673|NCT03052517|467761800|FG001|Overall Study|Lost to Follow-up|4|||
129944674|NCT03052517|467761801|FG002|Overall Study|Lost to Follow-up|0|||
129944675|NCT03052517|467761799|FG000|Overall Study|Pregnancy|1|||
129944676|NCT03052517|467761800|FG001|Overall Study|Pregnancy|0|||
129944677|NCT03052517|467761801|FG002|Overall Study|Pregnancy|1|||
129944678|NCT03052517|467761799|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
129944679|NCT03052517|467761800|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
129944680|NCT03052517|467761801|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
129944681|NCT03052517|467761799|FG000|Overall Study|Technical Problems|0|||
129944682|NCT03052517|467761800|FG001|Overall Study|Technical Problems|1|||
129944683|NCT03052517|467761801|FG002|Overall Study|Technical Problems|0|||
129944684|NCT04803734|467761802|FG000|Overall Study|Withdrawal by Subject|0|||
129944685|NCT04803734|467761803|FG001|Overall Study|Withdrawal by Subject|1|||
129944686|NCT04803734|467761802|FG000|Overall Study|Protocol Violation|0|||
129944687|NCT04803734|467761803|FG001|Overall Study|Protocol Violation|1|||
129944688|NCT01640288|467761804|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
129944689|NCT01640288|467761805|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
130071717|NCT01998958|468218078|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071718|NCT01998958|468218079|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071719|NCT01998958|468218080|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944690|NCT01640288|467761804|FG000|Overall Study|Screen Failure|20|||
129944691|NCT01640288|467761805|FG001|Overall Study|Screen Failure|18|||
129944692|NCT01640288|467761804|FG000|Overall Study|Withdrawn by PI|5|||
129944693|NCT01640288|467761805|FG001|Overall Study|Withdrawn by PI|0|||
129944694|NCT01640288|467761804|FG000|Overall Study|Withdrawal by Subject|1|||
129944695|NCT01640288|467761805|FG001|Overall Study|Withdrawal by Subject|0|||
129944696|NCT00195819|467761808|FG000|Double-Blind|Withdrawal by Subject|1|||
129944697|NCT00195819|467761809|FG001|Double-Blind|Withdrawal by Subject|0|||
129944698|NCT00195819|467761808|FG000|Double-Blind|Moved|1|||
129944699|NCT00195819|467761809|FG001|Double-Blind|Moved|0|||
129944700|NCT00195819|467761808|FG000|Open-label|Adverse Event|0|||
129944701|NCT00195819|467761809|FG001|Open-label|Adverse Event|9|||
129944702|NCT00195819|467761808|FG000|Open-label|Lack of Efficacy|0|||
129944703|NCT00195819|467761809|FG001|Open-label|Lack of Efficacy|2|||
129944704|NCT00195819|467761808|FG000|Open-label|Pregnancy|0|||
129944705|NCT00195819|467761809|FG001|Open-label|Pregnancy|1|||
129944706|NCT00195819|467761808|FG000|Open-label|Protocol Violation|0|||
129944707|NCT00195819|467761809|FG001|Open-label|Protocol Violation|2|||
129944708|NCT00195819|467761808|FG000|Open-label|Moved|0|||
129944709|NCT00195819|467761809|FG001|Open-label|Moved|1|||
129944710|NCT00195819|467761808|FG000|Open-label|Withdrawal by Subject|0|||
129944711|NCT00195819|467761809|FG001|Open-label|Withdrawal by Subject|5|||
129944712|NCT03298087|467761810|FG000|Overall Study|Withdrawal by Subject|4|||
129944713|NCT03781375|467761815|FG000|Double-blind Phase|Adverse Event|0|||
129944714|NCT03781375|467761816|FG001|Double-blind Phase|Adverse Event|1|||
129944715|NCT03781375|467761815|FG000|Double-blind Phase|Lack of Response|6|||
129944716|NCT03781375|467761816|FG001|Double-blind Phase|Lack of Response|2|||
129944717|NCT03781375|467761815|FG000|Double-blind Phase|Other|1|||
129944718|NCT03781375|467761816|FG001|Double-blind Phase|Other|3|||
129944719|NCT03781375|467761815|FG000|Open-label Phase|Protocol Issues|0|||
129944720|NCT03781375|467761816|FG001|Open-label Phase|Protocol Issues|1|||
129944721|NCT03781375|467761815|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
129944722|NCT03781375|467761816|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
129944723|NCT03781375|467761815|FG000|Open-label Phase|Other|2|||
129944724|NCT03781375|467761816|FG001|Open-label Phase|Other|2|||
129944725|NCT03184987|467761820|FG000|Overall Study|Withdrawal by Subject|0|||
129944726|NCT03184987|467761821|FG001|Overall Study|Withdrawal by Subject|1|||
129944727|NCT03184987|467761822|FG002|Overall Study|Withdrawal by Subject|2|||
129944728|NCT03184987|467761820|FG000|Overall Study|Physician Decision|0|||
129944729|NCT03184987|467761821|FG001|Overall Study|Physician Decision|0|||
129944730|NCT03184987|467761822|FG002|Overall Study|Physician Decision|1|||
129944731|NCT03184987|467761820|FG000|Overall Study|Adverse Event|1|||
129944732|NCT03184987|467761821|FG001|Overall Study|Adverse Event|0|||
129944733|NCT03184987|467761822|FG002|Overall Study|Adverse Event|1|||
129944734|NCT02203799|467761823|FG000|Overall Study|Withdrawal by Subject|3|||
129944735|NCT00681109|467761824|FG000|Overall Study|Lost to Follow-up|2|||
129944736|NCT00681109|467761825|FG001|Overall Study|Lost to Follow-up|6|||
129944737|NCT00681109|467761826|FG002|Overall Study|Lost to Follow-up|0|||
129944738|NCT04660799|467761827|FG000|Overall Study|Progressive Disease|1|||
129944739|NCT04660799|467761828|FG001|Overall Study|Progressive Disease|1|||
129944740|NCT04660799|467761827|FG000|Overall Study|Death|2|||
129944741|NCT04660799|467761828|FG001|Overall Study|Death|1|||
129944742|NCT04660799|467761827|FG000|Overall Study|Adverse Event|2|||
129944743|NCT04660799|467761828|FG001|Overall Study|Adverse Event|1|||
129944744|NCT04660799|467761827|FG000|Overall Study|Withdrawal by Subject|2|||
129944745|NCT04660799|467761828|FG001|Overall Study|Withdrawal by Subject|5|||
129944746|NCT02106884|467761829|FG000|Overall Study|Change of diagnosis/exclusion|0|||
129944747|NCT02106884|467761830|FG001|Overall Study|Change of diagnosis/exclusion|1|||
129944748|NCT02161458|467761831|FG000|Overall Study|Withdrawal by Subject|0|||
129944749|NCT02161458|467761832|FG001|Overall Study|Withdrawal by Subject|4|||
129944750|NCT02161458|467761833|FG002|Overall Study|Withdrawal by Subject|4|||
129944751|NCT02161458|467761834|FG003|Overall Study|Withdrawal by Subject|0|||
129944752|NCT02161458|467761831|FG000|Overall Study|Lost to Follow-up|0|||
129944753|NCT02161458|467761832|FG001|Overall Study|Lost to Follow-up|2|||
129944754|NCT02161458|467761833|FG002|Overall Study|Lost to Follow-up|1|||
129944755|NCT02161458|467761834|FG003|Overall Study|Lost to Follow-up|0|||
129944756|NCT01560429|467761837|FG000|Overall Study|Protocol Violation|3|||
129944757|NCT01560429|467761838|FG001|Overall Study|Protocol Violation|6|||
129944758|NCT00391170|467761847|FG000|Overall Study|Withdrawal by Subject|1|||
129944759|NCT00391170|467761848|FG001|Overall Study|Withdrawal by Subject|0|||
129944760|NCT00391170|467761847|FG000|Overall Study|Adverse Event|3|||
129944761|NCT00391170|467761848|FG001|Overall Study|Adverse Event|2|||
129944762|NCT00391170|467761847|FG000|Overall Study|Physician Decision|2|||
130071720|NCT01998958|468218081|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071721|NCT01998958|468218082|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071722|NCT01998958|468218083|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071723|NCT01998958|468218084|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071724|NCT01998958|468218085|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071725|NCT01998958|468218086|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944763|NCT00391170|467761848|FG001|Overall Study|Physician Decision|2|||
129944764|NCT03035942|467761851|FG000|Overall Study|Adverse Event|8|||
129944765|NCT03035942|467761852|FG001|Overall Study|Adverse Event|4|||
129944766|NCT03035942|467761853|FG002|Overall Study|Adverse Event|5|||
129944767|NCT02091752|467761854|FG000|Overall Study|Study terminated by Sponsor|2|||
129944768|NCT02091752|467761854|FG000|Overall Study|Adverse Event|1|||
129944769|NCT04029090|467761855|FG000|Overall Study|Protocol Violation|1|||
129944770|NCT04029090|467761856|FG001|Overall Study|Protocol Violation|0|||
129944771|NCT04029090|467761857|FG002|Overall Study|Protocol Violation|0|||
130071726|NCT01998958|468218087|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944772|NCT04029090|467761855|FG000|Overall Study|Withdrawal by Subject|0|||
129944773|NCT04029090|467761856|FG001|Overall Study|Withdrawal by Subject|1|||
129944774|NCT04029090|467761857|FG002|Overall Study|Withdrawal by Subject|0|||
129944775|NCT02157948|467761858|FG000|Overall Study|Withdrawal by Subject|4|||
129944776|NCT02157948|467761859|FG001|Overall Study|Withdrawal by Subject|5|||
129944777|NCT02157948|467761858|FG000|Overall Study|Lost to Follow-up|3|||
129944778|NCT02157948|467761859|FG001|Overall Study|Lost to Follow-up|2|||
129944779|NCT02157948|467761858|FG000|Overall Study|Protocol Specified Criteria|2|||
129944780|NCT02157948|467761859|FG001|Overall Study|Protocol Specified Criteria|1|||
129944781|NCT02157948|467761858|FG000|Overall Study|Decision by Sponsor|0|||
129944782|NCT02157948|467761859|FG001|Overall Study|Decision by Sponsor|1|||
129944783|NCT01604824|467761860|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944784|NCT01604824|467761861|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944785|NCT01604824|467761862|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944786|NCT01604824|467761863|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944787|NCT01604824|467761864|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
129944788|NCT01604824|467761865|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944789|NCT01604824|467761860|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944790|NCT01604824|467761861|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944791|NCT01604824|467761862|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944792|NCT01604824|467761863|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944793|NCT01604824|467761864|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
129944794|NCT01604824|467761865|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944795|NCT06269003|467761878|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
129944796|NCT06269003|467761879|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
129944797|NCT06269003|467761880|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
129944798|NCT06269003|467761881|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
129944799|NCT01567852|467762841|FG000|Overall Study|Withdrawal by Subject|3|||
129944800|NCT01567852|467762842|FG001|Overall Study|Withdrawal by Subject|6|||
129944801|NCT01567852|467762841|FG000|Overall Study|ECT discontinued|1|||
129944802|NCT01567852|467762842|FG001|Overall Study|ECT discontinued|1|||
129944803|NCT02713594|467762843|FG000|Overall Study|Withdrawal by Subject|32|||
129944804|NCT02713594|467762844|FG001|Overall Study|Withdrawal by Subject|22|||
129944805|NCT02713594|467762843|FG000|Overall Study|Lost to Follow-up|358|||
129944806|NCT02713594|467762844|FG001|Overall Study|Lost to Follow-up|374|||
129944807|NCT00670449|467762845|FG000|Overall Study|Adverse Event|6|||
129944808|NCT00670449|467762846|FG001|Overall Study|Adverse Event|2|||
129944809|NCT00670449|467762847|FG002|Overall Study|Adverse Event|8|||
129944810|NCT00670449|467762848|FG003|Overall Study|Adverse Event|5|||
129944811|NCT00670449|467762845|FG000|Overall Study|Protocol Deviation|1|||
129944812|NCT00670449|467762846|FG001|Overall Study|Protocol Deviation|2|||
129944813|NCT00670449|467762847|FG002|Overall Study|Protocol Deviation|0|||
129944814|NCT00670449|467762848|FG003|Overall Study|Protocol Deviation|1|||
129944815|NCT00670449|467762845|FG000|Overall Study|Administrative Problems|0|||
129944816|NCT00670449|467762846|FG001|Overall Study|Administrative Problems|2|||
129944817|NCT00670449|467762847|FG002|Overall Study|Administrative Problems|0|||
129944818|NCT00670449|467762848|FG003|Overall Study|Administrative Problems|1|||
129944819|NCT00670449|467762845|FG000|Overall Study|Subject Withdrew Consent|0|||
129944820|NCT00670449|467762846|FG001|Overall Study|Subject Withdrew Consent|2|||
129944821|NCT00670449|467762847|FG002|Overall Study|Subject Withdrew Consent|0|||
129944822|NCT00670449|467762848|FG003|Overall Study|Subject Withdrew Consent|1|||
129944823|NCT00670449|467762845|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
129944824|NCT00670449|467762846|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129944825|NCT00670449|467762847|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129944826|NCT00670449|467762848|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129944827|NCT00670449|467762845|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
129944828|NCT00670449|467762846|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
129944829|NCT00670449|467762847|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129944830|NCT00670449|467762848|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
129944831|NCT04809623|467762849|FG000|Overall Study|Study Terminated by Sponsor|1|||
129944832|NCT04809623|467762850|FG001|Overall Study|Study Terminated by Sponsor|0|||
129944833|NCT02660086|467762853|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
129944834|NCT02660086|467762854|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
129944835|NCT02660086|467762853|FG000|Overall Study- 12-month|Left full-time employment|12|||
129944836|NCT02660086|467762854|FG001|Overall Study- 12-month|Left full-time employment|20|||
129944837|NCT02660086|467762853|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
129944838|NCT02660086|467762854|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
129944839|NCT02660086|467762853|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
129944840|NCT02660086|467762854|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
129944841|NCT02660086|467762853|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
129944842|NCT02660086|467762854|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
129944843|NCT02660086|467762853|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
129944844|NCT02660086|467762854|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
129944845|NCT01214200|467762858|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
129944846|NCT01214200|467762858|FG000|Overall Study|Withdrawal by Subject|2|||
129944847|NCT00667017|467762859|FG000|Overall Study|Withdrawal by Subject|1|||
129944848|NCT02605174|467762863|FG000|Overall Study|Adverse Event|0|||
129944849|NCT02605174|467762864|FG001|Overall Study|Adverse Event|0|||
129944850|NCT02605174|467762865|FG002|Overall Study|Adverse Event|1|||
129944851|NCT02605174|467762866|FG003|Overall Study|Adverse Event|0|||
129944852|NCT02605174|467762867|FG004|Overall Study|Adverse Event|4|||
129944853|NCT02605174|467762868|FG005|Overall Study|Adverse Event|0|||
129944854|NCT02605174|467762869|FG006|Overall Study|Adverse Event|0|||
129944855|NCT02605174|467762863|FG000|Overall Study|Lost to Follow-up|20|||
129944856|NCT02605174|467762864|FG001|Overall Study|Lost to Follow-up|7|||
129944857|NCT02605174|467762865|FG002|Overall Study|Lost to Follow-up|27|||
129944858|NCT02605174|467762866|FG003|Overall Study|Lost to Follow-up|10|||
129944859|NCT02605174|467762867|FG004|Overall Study|Lost to Follow-up|20|||
129944860|NCT02605174|467762868|FG005|Overall Study|Lost to Follow-up|10|||
129944861|NCT02605174|467762869|FG006|Overall Study|Lost to Follow-up|29|||
129944862|NCT02605174|467762863|FG000|Overall Study|Protocol Violation|10|||
129944863|NCT02605174|467762864|FG001|Overall Study|Protocol Violation|4|||
129944864|NCT02605174|467762865|FG002|Overall Study|Protocol Violation|14|||
129944865|NCT02605174|467762866|FG003|Overall Study|Protocol Violation|6|||
129944866|NCT02605174|467762867|FG004|Overall Study|Protocol Violation|7|||
129944867|NCT02605174|467762868|FG005|Overall Study|Protocol Violation|7|||
129944868|NCT02605174|467762869|FG006|Overall Study|Protocol Violation|12|||
129944869|NCT02605174|467762863|FG000|Overall Study|Pregnancy|1|||
129944870|NCT02605174|467762864|FG001|Overall Study|Pregnancy|0|||
129944871|NCT02605174|467762865|FG002|Overall Study|Pregnancy|0|||
129944872|NCT02605174|467762866|FG003|Overall Study|Pregnancy|2|||
129944873|NCT02605174|467762867|FG004|Overall Study|Pregnancy|0|||
129944874|NCT02605174|467762868|FG005|Overall Study|Pregnancy|0|||
129944875|NCT02605174|467762869|FG006|Overall Study|Pregnancy|0|||
129944876|NCT02605174|467762863|FG000|Overall Study|Withdrawal by Subject|9|||
129944877|NCT02605174|467762864|FG001|Overall Study|Withdrawal by Subject|6|||
129944878|NCT02605174|467762865|FG002|Overall Study|Withdrawal by Subject|14|||
129944879|NCT02605174|467762866|FG003|Overall Study|Withdrawal by Subject|11|||
129944880|NCT02605174|467762867|FG004|Overall Study|Withdrawal by Subject|6|||
129944881|NCT02605174|467762868|FG005|Overall Study|Withdrawal by Subject|4|||
129944882|NCT02605174|467762869|FG006|Overall Study|Withdrawal by Subject|15|||
129944883|NCT02605174|467762863|FG000|Overall Study|Physician Decision|2|||
129944884|NCT02605174|467762864|FG001|Overall Study|Physician Decision|0|||
129944885|NCT02605174|467762865|FG002|Overall Study|Physician Decision|0|||
129944886|NCT02605174|467762866|FG003|Overall Study|Physician Decision|0|||
129944887|NCT02605174|467762867|FG004|Overall Study|Physician Decision|0|||
129944888|NCT02605174|467762868|FG005|Overall Study|Physician Decision|0|||
129944889|NCT02605174|467762869|FG006|Overall Study|Physician Decision|3|||
129944890|NCT02605174|467762863|FG000|Overall Study|Randomization Failure|22|||
129944891|NCT02605174|467762864|FG001|Overall Study|Randomization Failure|6|||
129944892|NCT02605174|467762865|FG002|Overall Study|Randomization Failure|20|||
129944893|NCT02605174|467762866|FG003|Overall Study|Randomization Failure|7|||
129944894|NCT02605174|467762867|FG004|Overall Study|Randomization Failure|16|||
129944895|NCT02605174|467762868|FG005|Overall Study|Randomization Failure|11|||
129944896|NCT02605174|467762869|FG006|Overall Study|Randomization Failure|30|||
129944897|NCT03041090|467762870|FG000|Overall Study|technical error|0|||
129944898|NCT03041090|467762871|FG001|Overall Study|technical error|3|||
129944899|NCT03292406|467762872|FG000|Overall Study|Progressive Disease|6|||
129944900|NCT03292406|467762873|FG001|Overall Study|Progressive Disease|3|||
129944901|NCT03292406|467762874|FG002|Overall Study|Progressive Disease|4|||
129944902|NCT03292406|467762872|FG000|Overall Study|Adverse Event|7|||
129944903|NCT03292406|467762873|FG001|Overall Study|Adverse Event|1|||
129944904|NCT03292406|467762874|FG002|Overall Study|Adverse Event|4|||
130071727|NCT01998958|468218088|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944905|NCT03292406|467762872|FG000|Overall Study|Withdrawal by Subject|0|||
129944906|NCT03292406|467762873|FG001|Overall Study|Withdrawal by Subject|7|||
129944907|NCT03292406|467762874|FG002|Overall Study|Withdrawal by Subject|2|||
129944908|NCT03292406|467762872|FG000|Overall Study|Protocol Violation|0|||
129944909|NCT03292406|467762873|FG001|Overall Study|Protocol Violation|1|||
129944910|NCT03292406|467762874|FG002|Overall Study|Protocol Violation|1|||
129944911|NCT03292406|467762872|FG000|Overall Study|Other|0|||
129944912|NCT03292406|467762873|FG001|Overall Study|Other|1|||
129944913|NCT03292406|467762874|FG002|Overall Study|Other|2|||
129944914|NCT00047385|467762875|FG000|Overall Study|Death before any screening|2|||
129944915|NCT00047385|467762876|FG001|Overall Study|Death before any screening|5|||
129944916|NCT00047385|467762875|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
129944917|NCT00047385|467762876|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
129944918|NCT00047385|467762875|FG000|Overall Study|Eligible for screening but had no screen|260|||
129944919|NCT00047385|467762876|FG001|Overall Study|Eligible for screening but had no screen|492|||
129944920|NCT03490032|467762877|FG000|Overall Study|family issue (child custody)|1|||
129944921|NCT03490032|467762878|FG001|Overall Study|family issue (child custody)|0|||
129944922|NCT03490032|467762879|FG002|Overall Study|family issue (child custody)|0|||
130071728|NCT01998958|468218089|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944923|NCT02224755|467762880|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
129944924|NCT02224755|467762881|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
129944925|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Death|103|||
129944926|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Death|98|||
129944927|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
129944928|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
129944929|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
129944930|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
130071729|NCT01998958|468218090|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071730|NCT01998958|468218091|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944931|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
129944932|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
129944933|NCT01852045|467762882|FG000|Overall Study|Adverse Event|1|||
129944934|NCT01852045|467762883|FG001|Overall Study|Adverse Event|0|||
129944935|NCT01852045|467762884|FG002|Overall Study|Adverse Event|0|||
129944936|NCT01852045|467762882|FG000|Overall Study|Lack of Efficacy|3|||
129944937|NCT01852045|467762883|FG001|Overall Study|Lack of Efficacy|0|||
129944938|NCT01852045|467762884|FG002|Overall Study|Lack of Efficacy|0|||
129944939|NCT01852045|467762882|FG000|Overall Study|Lost to Follow-up|0|||
129944940|NCT01852045|467762883|FG001|Overall Study|Lost to Follow-up|1|||
129944941|NCT01852045|467762884|FG002|Overall Study|Lost to Follow-up|1|||
129944942|NCT01852045|467762882|FG000|Overall Study|Withdrawal by Subject|1|||
129944943|NCT01852045|467762883|FG001|Overall Study|Withdrawal by Subject|0|||
129944944|NCT01852045|467762884|FG002|Overall Study|Withdrawal by Subject|1|||
129944945|NCT01852045|467762882|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129944946|NCT01852045|467762883|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129944947|NCT01852045|467762884|FG002|Overall Study|Other Miscellaneous Reasons|2|||
129944948|NCT02736188|467762885|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
129944949|NCT02736188|467762885|FG000|Overall Study|Adverse Event|1|||
129944950|NCT02736188|467762885|FG000|Overall Study|Withdrawal by Subject|1|||
129944951|NCT02736188|467762885|FG000|Overall Study|Other|6|||
129944952|NCT02007070|467762887|FG000|Overall Study|Adverse Event|4|||
129944953|NCT02007070|467762887|FG000|Overall Study|Clinical Progression|4|||
129944954|NCT02007070|467762887|FG000|Overall Study|Death|1|||
129944955|NCT02007070|467762887|FG000|Overall Study|Protocol Violation|2|||
129944956|NCT02007070|467762887|FG000|Overall Study|Physician Decision|1|||
129944957|NCT02007070|467762887|FG000|Overall Study|Progressive Disease|21|||
129944958|NCT01629589|467762890|FG000|Overall Study|Protocol Violation|4|||
129944959|NCT01629589|467762891|FG001|Overall Study|Protocol Violation|2|||
129944960|NCT01629589|467762890|FG000|Overall Study|Lost to Follow-up|2|||
129944961|NCT01629589|467762891|FG001|Overall Study|Lost to Follow-up|1|||
129944962|NCT01629589|467762890|FG000|Overall Study|Withdrawal by Subject|2|||
129944963|NCT01629589|467762891|FG001|Overall Study|Withdrawal by Subject|3|||
129944964|NCT01629589|467762890|FG000|Overall Study|Did not receive study vaccine|0|||
129944965|NCT01629589|467762891|FG001|Overall Study|Did not receive study vaccine|1|||
129944966|NCT01303510|467762892|FG000|Overall Study|Lost to Follow-up|1|||
129944967|NCT01303510|467762893|FG001|Overall Study|Lost to Follow-up|0|||
129944968|NCT00822900|467762894|FG000|Overall Study|Withdrawal by Subject|14|||
129944969|NCT00822900|467762895|FG001|Overall Study|Withdrawal by Subject|14|||
129944970|NCT00822900|467762894|FG000|Overall Study|Lost to Follow-up|9|||
129944971|NCT00822900|467762895|FG001|Overall Study|Lost to Follow-up|9|||
129944972|NCT00822900|467762894|FG000|Overall Study|Death|83|||
129944973|NCT00822900|467762895|FG001|Overall Study|Death|69|||
129944974|NCT00822900|467762894|FG000|Overall Study|Became a ward of the state|2|||
130071731|NCT01998958|468218092|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944975|NCT00822900|467762895|FG001|Overall Study|Became a ward of the state|1|||
129944976|NCT02095678|467762896|FG000|Overall Study|Withdrawal by Subject|0|||
129944977|NCT02095678|467762897|FG001|Overall Study|Withdrawal by Subject|1|||
129944978|NCT02095678|467762896|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
129944979|NCT02095678|467762897|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
129944980|NCT02095678|467762896|FG000|Overall Study|lesion impacted by previous treatment|1|||
129944981|NCT02095678|467762897|FG001|Overall Study|lesion impacted by previous treatment|1|||
129944982|NCT02095678|467762896|FG000|Overall Study|No Confirmed Diagnosis|0|||
129944983|NCT02095678|467762897|FG001|Overall Study|No Confirmed Diagnosis|3|||
129944984|NCT02095678|467762896|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
129944985|NCT02095678|467762897|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
130071732|NCT01998958|468218093|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944986|NCT02095678|467762896|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
129944987|NCT02095678|467762897|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
130071733|NCT01998958|468218094|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944988|NCT00701415|467762898|FG000|Overall Study|Adverse Event|0|||
129944989|NCT00701415|467762899|FG001|Overall Study|Adverse Event|1|||
130071734|NCT01998958|468218095|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071735|NCT01998958|468218096|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129944990|NCT00701415|467762898|FG000|Overall Study|Social/family issues and needle phobia|1|||
129944991|NCT00701415|467762899|FG001|Overall Study|Social/family issues and needle phobia|0|||
129944992|NCT02066636|467762900|FG000|Overall Study|Disease progression|51|||
129944993|NCT02066636|467762901|FG001|Overall Study|Disease progression|60|||
129944994|NCT02066636|467762902|FG002|Overall Study|Disease progression|700|||
129944995|NCT02066636|467762900|FG000|Overall Study|Study drug toxicity|13|||
129944996|NCT02066636|467762901|FG001|Overall Study|Study drug toxicity|2|||
129944997|NCT02066636|467762902|FG002|Overall Study|Study drug toxicity|58|||
129944998|NCT02066636|467762900|FG000|Overall Study|Death|4|||
129944999|NCT02066636|467762901|FG001|Overall Study|Death|2|||
129945000|NCT02066636|467762902|FG002|Overall Study|Death|158|||
129945001|NCT02066636|467762900|FG000|Overall Study|Adverse event unrelated to study drug|6|||
129945002|NCT02066636|467762901|FG001|Overall Study|Adverse event unrelated to study drug|4|||
129945003|NCT02066636|467762902|FG002|Overall Study|Adverse event unrelated to study drug|45|||
129945004|NCT02066636|467762900|FG000|Overall Study|Participant request to discontinue treatment|12|||
129945005|NCT02066636|467762901|FG001|Overall Study|Participant request to discontinue treatment|12|||
129945006|NCT02066636|467762902|FG002|Overall Study|Participant request to discontinue treatment|70|||
129945007|NCT02066636|467762900|FG000|Overall Study|Participant withdrew consent|10|||
129945008|NCT02066636|467762901|FG001|Overall Study|Participant withdrew consent|18|||
129945009|NCT02066636|467762902|FG002|Overall Study|Participant withdrew consent|61|||
129945010|NCT02066636|467762900|FG000|Overall Study|Lost to Follow-up|0|||
129945011|NCT02066636|467762901|FG001|Overall Study|Lost to Follow-up|2|||
129945012|NCT02066636|467762902|FG002|Overall Study|Lost to Follow-up|2|||
129945013|NCT02066636|467762900|FG000|Overall Study|Maximum clinical benefit|2|||
129945014|NCT02066636|467762901|FG001|Overall Study|Maximum clinical benefit|2|||
129945015|NCT02066636|467762902|FG002|Overall Study|Maximum clinical benefit|3|||
129945016|NCT02066636|467762900|FG000|Overall Study|Poor/non-compliance|2|||
129945017|NCT02066636|467762901|FG001|Overall Study|Poor/non-compliance|1|||
129945018|NCT02066636|467762902|FG002|Overall Study|Poor/non-compliance|1|||
129945019|NCT02066636|467762900|FG000|Overall Study|Participant no loner meets study criteria|3|||
129945020|NCT02066636|467762901|FG001|Overall Study|Participant no loner meets study criteria|2|||
129945021|NCT02066636|467762902|FG002|Overall Study|Participant no loner meets study criteria|28|||
129945022|NCT02066636|467762900|FG000|Overall Study|Administrative reasons by sponsor|8|||
129945023|NCT02066636|467762901|FG001|Overall Study|Administrative reasons by sponsor|5|||
129945024|NCT02066636|467762902|FG002|Overall Study|Administrative reasons by sponsor|0|||
129945025|NCT02066636|467762900|FG000|Overall Study|Other reasons|16|||
129945026|NCT02066636|467762901|FG001|Overall Study|Other reasons|15|||
129945027|NCT02066636|467762902|FG002|Overall Study|Other reasons|50|||
129945028|NCT00705159|467762906|FG000|Overall Study|Withdrawal by Subject|0|||
129945029|NCT00705159|467762907|FG001|Overall Study|Withdrawal by Subject|1|||
129945030|NCT00705159|467762908|FG002|Overall Study|Withdrawal by Subject|1|||
129945031|NCT00705159|467762909|FG003|Overall Study|Withdrawal by Subject|1|||
129945032|NCT00705159|467762906|FG000|Overall Study|Protocol Violation|0|||
129945033|NCT00705159|467762907|FG001|Overall Study|Protocol Violation|1|||
129945034|NCT00705159|467762908|FG002|Overall Study|Protocol Violation|0|||
129945035|NCT00705159|467762909|FG003|Overall Study|Protocol Violation|0|||
129945036|NCT00705159|467762906|FG000|Overall Study|Adverse Event|0|||
129945037|NCT00705159|467762907|FG001|Overall Study|Adverse Event|0|||
129945038|NCT00705159|467762908|FG002|Overall Study|Adverse Event|1|||
129945039|NCT00705159|467762909|FG003|Overall Study|Adverse Event|0|||
129945040|NCT00705159|467762906|FG000|Overall Study|Lost to Follow-up|0|||
129945041|NCT00705159|467762907|FG001|Overall Study|Lost to Follow-up|0|||
129945042|NCT00705159|467762908|FG002|Overall Study|Lost to Follow-up|3|||
129945043|NCT00705159|467762909|FG003|Overall Study|Lost to Follow-up|2|||
130120325|NCT04799158|468402345|FG002|Run-In Period|Adverse Event|0|||
130120326|NCT04799158|468402346|FG003|Run-In Period|Adverse Event|0|||
130120327|NCT04799158|468402347|FG004|Run-In Period|Adverse Event|0|||
130120328|NCT04799158|468402343|FG000|Run-In Period|Lost to Follow-up|4|||
130120329|NCT04799158|468402344|FG001|Run-In Period|Lost to Follow-up|0|||
129945044|NCT00705159|467762906|FG000|Overall Study|Screen Failure|0|||
129945045|NCT00705159|467762907|FG001|Overall Study|Screen Failure|0|||
129945046|NCT00705159|467762908|FG002|Overall Study|Screen Failure|0|||
129945047|NCT00705159|467762909|FG003|Overall Study|Screen Failure|1|||
129945048|NCT03026166|467762910|FG000|Overall Study|Death|22|||
129945049|NCT03026166|467762911|FG001|Overall Study|Death|7|||
129945050|NCT03026166|467762910|FG000|Overall Study|Physician Decision|2|||
129945051|NCT03026166|467762911|FG001|Overall Study|Physician Decision|0|||
130120330|NCT04799158|468402345|FG002|Run-In Period|Lost to Follow-up|0|||
129945052|NCT03026166|467762910|FG000|Overall Study|Withdrawal by Subject|1|||
129945053|NCT03026166|467762911|FG001|Overall Study|Withdrawal by Subject|2|||
129945054|NCT03026166|467762910|FG000|Overall Study|Lost to Follow-up|1|||
129945055|NCT03026166|467762911|FG001|Overall Study|Lost to Follow-up|0|||
129945056|NCT03026166|467762910|FG000|Overall Study|Study Terminated by Sponsor|3|||
129945057|NCT03026166|467762911|FG001|Overall Study|Study Terminated by Sponsor|3|||
129945058|NCT03026166|467762910|FG000|Overall Study|Other|1|||
129945059|NCT03026166|467762911|FG001|Overall Study|Other|0|||
129945060|NCT01989104|467762914|FG000|Overall Study|Withdrawal by Subject|3|||
129945061|NCT01989104|467762915|FG001|Overall Study|Withdrawal by Subject|0|||
129945062|NCT01989104|467762916|FG002|Overall Study|Withdrawal by Subject|0|||
129945063|NCT01989104|467762917|FG003|Overall Study|Withdrawal by Subject|0|||
129945064|NCT01989104|467762918|FG004|Overall Study|Withdrawal by Subject|0|||
129945065|NCT02833948|467762921|FG000|Overall Study|Death|2|||
129945066|NCT02833948|467762922|FG001|Overall Study|Death|3|||
129945067|NCT02833948|467762921|FG000|Overall Study|were not scanned|8|||
129945068|NCT02833948|467762922|FG001|Overall Study|were not scanned|13|||
129945069|NCT02833948|467762921|FG000|Overall Study|scans could not be evaluated|5|||
129945070|NCT02833948|467762922|FG001|Overall Study|scans could not be evaluated|2|||
129945071|NCT03539055|467762926|FG000|Overall Study|Death|4|||
129945072|NCT03539055|467762926|FG000|Overall Study|Lost to Follow-up|1|||
129945073|NCT03539055|467762926|FG000|Overall Study|Withdrawal by Subject|2|||
129945074|NCT03539055|467762926|FG000|Overall Study|Screen Fail|7|||
129945075|NCT03539055|467762926|FG000|Overall Study|Drug Intolerance|2|||
129945076|NCT04821271|467762927|FG000|Period 1|Withdrawal by Subject|2|||
129945077|NCT04821271|467762928|FG001|Period 1|Withdrawal by Subject|0|||
129945078|NCT04076059|467762929|FG000|Double Blind Phase|Progressive disease|22|||
129945079|NCT04076059|467762930|FG001|Double Blind Phase|Progressive disease|26|||
129945080|NCT04076059|467762931|FG002|Double Blind Phase|Progressive disease|0|||
129945081|NCT04076059|467762929|FG000|Double Blind Phase|Withdrawal by Subject|4|||
129945082|NCT04076059|467762930|FG001|Double Blind Phase|Withdrawal by Subject|11|||
129945083|NCT04076059|467762931|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129945084|NCT04076059|467762929|FG000|Double Blind Phase|Death|1|||
129945085|NCT04076059|467762930|FG001|Double Blind Phase|Death|1|||
129945086|NCT04076059|467762931|FG002|Double Blind Phase|Death|0|||
129945087|NCT04076059|467762929|FG000|Double Blind Phase|Lost to Follow-up|1|||
129945088|NCT04076059|467762930|FG001|Double Blind Phase|Lost to Follow-up|0|||
129945089|NCT04076059|467762931|FG002|Double Blind Phase|Lost to Follow-up|0|||
129945090|NCT04076059|467762929|FG000|Double Blind Phase|Adverse Event|5|||
129945091|NCT04076059|467762930|FG001|Double Blind Phase|Adverse Event|1|||
129945092|NCT04076059|467762931|FG002|Double Blind Phase|Adverse Event|0|||
129945093|NCT04076059|467762929|FG000|Double Blind Phase|Ongoing Participants|82|||
129945094|NCT04076059|467762930|FG001|Double Blind Phase|Ongoing Participants|18|||
129945095|NCT04076059|467762931|FG002|Double Blind Phase|Ongoing Participants|0|||
129945096|NCT04076059|467762929|FG000|Double Blind Phase|Miscellaneous|3|||
129945097|NCT04076059|467762930|FG001|Double Blind Phase|Miscellaneous|1|||
129945098|NCT04076059|467762931|FG002|Double Blind Phase|Miscellaneous|0|||
129945099|NCT04076059|467762929|FG000|Double Blind Phase|Protocol Deviation|1|||
129945100|NCT04076059|467762930|FG001|Double Blind Phase|Protocol Deviation|1|||
129945101|NCT04076059|467762931|FG002|Double Blind Phase|Protocol Deviation|0|||
129945102|NCT04076059|467762929|FG000|Double Blind Phase|Did not take study drug|1|||
129945103|NCT04076059|467762930|FG001|Double Blind Phase|Did not take study drug|1|||
129945104|NCT04076059|467762931|FG002|Double Blind Phase|Did not take study drug|0|||
129945105|NCT04076059|467762929|FG000|Open Label Phase|Progressive disease|0|||
129945106|NCT04076059|467762930|FG001|Open Label Phase|Progressive disease|0|||
129945107|NCT04076059|467762931|FG002|Open Label Phase|Progressive disease|7|||
129945108|NCT04076059|467762929|FG000|Open Label Phase|Withdrawal by Subject|0|||
129945109|NCT04076059|467762930|FG001|Open Label Phase|Withdrawal by Subject|0|||
129945110|NCT04076059|467762931|FG002|Open Label Phase|Withdrawal by Subject|3|||
129945111|NCT04076059|467762929|FG000|Open Label Phase|Death|0|||
129945112|NCT04076059|467762930|FG001|Open Label Phase|Death|0|||
129945113|NCT04076059|467762931|FG002|Open Label Phase|Death|2|||
129945114|NCT04076059|467762929|FG000|Open Label Phase|Ongoing Participants|0|||
129945115|NCT04076059|467762930|FG001|Open Label Phase|Ongoing Participants|0|||
129945116|NCT04076059|467762931|FG002|Open Label Phase|Ongoing Participants|11|||
129945117|NCT04535414|467762939|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
129945118|NCT04535414|467762940|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
129945119|NCT04535414|467762939|FG000|Overall Study|Cancelled appointment|1|||
129945120|NCT04535414|467762940|FG001|Overall Study|Cancelled appointment|0|||
129945121|NCT04535414|467762939|FG000|Overall Study|cancelled - food in stomach|2|||
129945122|NCT04535414|467762940|FG001|Overall Study|cancelled - food in stomach|0|||
129945123|NCT04535414|467762939|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
129945124|NCT04535414|467762940|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
129945125|NCT04535414|467762939|FG000|Overall Study|Withdrawal by Subject|0|||
129945126|NCT04535414|467762940|FG001|Overall Study|Withdrawal by Subject|1|||
129945127|NCT00949117|467764077|FG000|Overall Study|Lack of Efficacy|2|||
129945128|NCT00949117|467764078|FG001|Overall Study|Lack of Efficacy|3|||
129945129|NCT00949117|467764077|FG000|Overall Study|Protocol Violation|1|||
129945130|NCT00949117|467764078|FG001|Overall Study|Protocol Violation|1|||
129945131|NCT00949117|467764077|FG000|Overall Study|Adverse Event|0|||
129945132|NCT00949117|467764078|FG001|Overall Study|Adverse Event|1|||
129945133|NCT00799409|467764079|FG000|Overall Study|Withdrawal by Subject|1|||
129945134|NCT00799409|467764080|FG001|Overall Study|Withdrawal by Subject|0|||
129945135|NCT00799409|467764081|FG002|Overall Study|Withdrawal by Subject|0|||
129945136|NCT00799409|467764079|FG000|Overall Study|Lost to Follow-up|1|||
129945137|NCT00799409|467764080|FG001|Overall Study|Lost to Follow-up|0|||
129945138|NCT00799409|467764081|FG002|Overall Study|Lost to Follow-up|0|||
129945139|NCT00799409|467764079|FG000|Overall Study|Optimal Dose Not Achieved|2|||
129945140|NCT00799409|467764080|FG001|Overall Study|Optimal Dose Not Achieved|0|||
129945141|NCT00799409|467764081|FG002|Overall Study|Optimal Dose Not Achieved|0|||
129945142|NCT00799409|467764079|FG000|Overall Study|Failure to follow study protocol)|1|||
129945143|NCT00799409|467764080|FG001|Overall Study|Failure to follow study protocol)|0|||
129945144|NCT00799409|467764081|FG002|Overall Study|Failure to follow study protocol)|0|||
129945145|NCT00799409|467764079|FG000|Overall Study|Did not attend lab school day 1|1|||
129945146|NCT00799409|467764080|FG001|Overall Study|Did not attend lab school day 1|0|||
129945147|NCT00799409|467764081|FG002|Overall Study|Did not attend lab school day 1|0|||
129945148|NCT00799409|467764079|FG000|Overall Study|medication compliance|1|||
129945149|NCT00799409|467764080|FG001|Overall Study|medication compliance|0|||
129945150|NCT00799409|467764081|FG002|Overall Study|medication compliance|0|||
129945151|NCT03964974|467764082|FG000|Overall Study|Lost to Follow-up|3|||
129945152|NCT03964974|467764083|FG001|Overall Study|Lost to Follow-up|2|||
129945153|NCT03964974|467764082|FG000|Overall Study|Withdrawal by Subject|0|||
129945154|NCT03964974|467764083|FG001|Overall Study|Withdrawal by Subject|3|||
129945155|NCT01719172|467764084|FG000|Overall Study|Lost to Follow-up|1|||
129945156|NCT01719172|467764084|FG000|Overall Study|Death|1|||
129945157|NCT00587171|467764085|FG000|Overall Study|Lost to Follow-up|1|||
130071736|NCT01998958|468218097|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071737|NCT01998958|468218098|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071738|NCT01998958|468218099|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071739|NCT01998958|468218100|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071740|NCT01998958|468218101|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071741|NCT01998958|468218102|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071742|NCT01998958|468218103|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071743|NCT01998958|468218104|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071744|NCT01998958|468218105|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
130071745|NCT01998958|468218074|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
130071746|NCT01998958|468218075|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
130071747|NCT01998958|468218076|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
130071748|NCT01998958|468218077|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
130071749|NCT01998958|468218078|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
130071750|NCT01998958|468218079|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
130071751|NCT01998958|468218080|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
130071752|NCT01998958|468218081|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
130071753|NCT01998958|468218082|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
130071754|NCT01998958|468218083|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
130071755|NCT01998958|468218084|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
130071756|NCT01998958|468218085|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
130071757|NCT01998958|468218086|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
130071758|NCT01998958|468218087|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
130071759|NCT01998958|468218088|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
130071760|NCT01998958|468218089|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
130071761|NCT01998958|468218090|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
130071762|NCT01998958|468218091|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
130071763|NCT01998958|468218092|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
130071764|NCT01998958|468218093|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
130071765|NCT01998958|468218094|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
130071766|NCT01998958|468218095|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
130071767|NCT01998958|468218096|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
130071768|NCT01998958|468218097|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
130071769|NCT01998958|468218098|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
130071770|NCT01998958|468218099|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
130071771|NCT01998958|468218100|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
130071772|NCT01998958|468218101|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
130071773|NCT01998958|468218102|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
130071774|NCT01998958|468218103|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
130071775|NCT01998958|468218104|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
130071776|NCT01998958|468218105|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
130071777|NCT01998958|468218074|FG000|Period 1 (Panel A and B)|Other|1|||
130071778|NCT01998958|468218075|FG001|Period 1 (Panel A and B)|Other|0|||
129945158|NCT00587171|467764086|FG001|Overall Study|Lost to Follow-up|1|||
129945159|NCT01148017|467764087|FG000|Overall Study|Withdrawal by Subject|31|||
129945160|NCT01148017|467764088|FG001|Overall Study|Withdrawal by Subject|14|||
130071779|NCT01998958|468218076|FG002|Period 1 (Panel A and B)|Other|0|||
130071780|NCT01998958|468218077|FG003|Period 1 (Panel A and B)|Other|0|||
130071781|NCT01998958|468218078|FG004|Period 1 (Panel A and B)|Other|0|||
130071782|NCT01998958|468218079|FG005|Period 1 (Panel A and B)|Other|0|||
130071783|NCT01998958|468218080|FG006|Period 1 (Panel A and B)|Other|0|||
130071784|NCT01998958|468218081|FG007|Period 1 (Panel A and B)|Other|0|||
130071785|NCT01998958|468218082|FG008|Period 1 (Panel A and B)|Other|0|||
129945161|NCT01148017|467764089|FG002|Overall Study|Withdrawal by Subject|0|||
129945162|NCT01148017|467764090|FG003|Overall Study|Withdrawal by Subject|0|||
129945163|NCT01148017|467764087|FG000|Overall Study|Lost to Follow-up|23|||
129945164|NCT01148017|467764088|FG001|Overall Study|Lost to Follow-up|10|||
129945165|NCT01148017|467764089|FG002|Overall Study|Lost to Follow-up|0|||
129945166|NCT01148017|467764090|FG003|Overall Study|Lost to Follow-up|0|||
129945167|NCT01148017|467764087|FG000|Overall Study|Inappropriate enrollment|1|||
129945168|NCT01148017|467764088|FG001|Overall Study|Inappropriate enrollment|0|||
129945169|NCT01148017|467764089|FG002|Overall Study|Inappropriate enrollment|0|||
129945170|NCT01148017|467764090|FG003|Overall Study|Inappropriate enrollment|0|||
129945171|NCT01148017|467764087|FG000|Overall Study|Administrative reason|22|||
129945172|NCT01148017|467764088|FG001|Overall Study|Administrative reason|9|||
129945173|NCT01148017|467764089|FG002|Overall Study|Administrative reason|0|||
129945174|NCT01148017|467764090|FG003|Overall Study|Administrative reason|0|||
129945175|NCT01148017|467764087|FG000|Overall Study|Unable to classify|3|||
129945176|NCT01148017|467764088|FG001|Overall Study|Unable to classify|1|||
129945177|NCT01148017|467764089|FG002|Overall Study|Unable to classify|0|||
129945178|NCT01148017|467764090|FG003|Overall Study|Unable to classify|0|||
129945179|NCT01848483|467764091|FG000|Overall Study|Death|2|||
129945180|NCT01848483|467764092|FG001|Overall Study|Death|1|||
129945181|NCT01848483|467764091|FG000|Overall Study|Lost to Follow-up|6|||
129945182|NCT01848483|467764092|FG001|Overall Study|Lost to Follow-up|8|||
129945183|NCT01848483|467764091|FG000|Overall Study|Withdrawal by Subject|1|||
129945184|NCT01848483|467764092|FG001|Overall Study|Withdrawal by Subject|0|||
129945185|NCT01848483|467764091|FG000|Overall Study|Incarceration|2|||
129945186|NCT01848483|467764092|FG001|Overall Study|Incarceration|2|||
129945187|NCT04250636|467764095|FG000|Overall Study|Lost to Follow-up|2|||
129945188|NCT01779050|467764097|FG000|Overall Study|Withdrawal by Subject|1|||
129945189|NCT01779050|467764098|FG001|Overall Study|Withdrawal by Subject|0|||
129945190|NCT02202317|467764099|FG000|Overall Study|Lost to Follow-up|1|||
129945191|NCT01353274|467764100|FG000|Overall Study|No case report form (CRF) collected|28|||
129945192|NCT01409837|467764101|FG000|Overall Study|Withdrawal by Subject|2|||
129945193|NCT01409837|467764102|FG001|Overall Study|Withdrawal by Subject|1|||
129945194|NCT01409837|467764101|FG000|Overall Study|Lost to Follow-up|1|||
129945195|NCT01409837|467764102|FG001|Overall Study|Lost to Follow-up|0|||
129945196|NCT01409837|467764101|FG000|Overall Study|Physician Decision|0|||
129945197|NCT01409837|467764102|FG001|Overall Study|Physician Decision|1|||
129945198|NCT03960645|467764103|FG000|Overall Study|Protocol Violation|1|||
129945199|NCT03960645|467764104|FG001|Overall Study|Protocol Violation|0|||
129945200|NCT00022672|467764106|FG000|Main Phase: 24 Months|Adverse Event|6|||
129945201|NCT00022672|467764107|FG001|Main Phase: 24 Months|Adverse Event|0|||
129945202|NCT00022672|467764106|FG000|Main Phase: 24 Months|Death|0|||
129945203|NCT00022672|467764107|FG001|Main Phase: 24 Months|Death|3|||
129945204|NCT00022672|467764106|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
129945205|NCT00022672|467764107|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
129945206|NCT00022672|467764106|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
129945207|NCT00022672|467764107|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
129945208|NCT00022672|467764106|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
129945209|NCT00022672|467764107|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
129945210|NCT00022672|467764106|FG000|Main Phase: 24 Months|Refused Treatment|3|||
129945211|NCT00022672|467764107|FG001|Main Phase: 24 Months|Refused Treatment|4|||
129945212|NCT00022672|467764106|FG000|Main Phase: 24 Months|Failure to Return|1|||
129945213|NCT00022672|467764107|FG001|Main Phase: 24 Months|Failure to Return|1|||
129945214|NCT00022672|467764106|FG000|Main Phase: 24 Months|Other|1|||
129945215|NCT00022672|467764107|FG001|Main Phase: 24 Months|Other|0|||
129945216|NCT00022672|467764106|FG000|Extension Phase|Adverse Event|1|||
129945217|NCT00022672|467764107|FG001|Extension Phase|Adverse Event|3|||
129945218|NCT00022672|467764106|FG000|Extension Phase|Death|0|||
129945219|NCT00022672|467764107|FG001|Extension Phase|Death|1|||
129945220|NCT00022672|467764106|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
129945221|NCT00022672|467764107|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
129945222|NCT00022672|467764106|FG000|Extension Phase|Refused Treatment|0|||
129945223|NCT00022672|467764107|FG001|Extension Phase|Refused Treatment|2|||
129945224|NCT00022672|467764106|FG000|Extension Phase|Other|1|||
129945225|NCT00022672|467764107|FG001|Extension Phase|Other|1|||
129945226|NCT00403494|467764108|FG000|Overall Study|Adverse Event|10|||
129945227|NCT00403494|467764109|FG001|Overall Study|Adverse Event|8|||
129945228|NCT00403494|467764108|FG000|Overall Study|Withdrew Consent|3|||
129945229|NCT00403494|467764109|FG001|Overall Study|Withdrew Consent|2|||
129945230|NCT00403494|467764108|FG000|Overall Study|Inappropriately enrolled|0|||
129945231|NCT00403494|467764109|FG001|Overall Study|Inappropriately enrolled|1|||
129945232|NCT00403494|467764108|FG000|Overall Study|Lost to Follow-up|0|||
129945233|NCT00403494|467764109|FG001|Overall Study|Lost to Follow-up|2|||
129945234|NCT00403494|467764108|FG000|Overall Study|Protocol noncompliance|0|||
129945235|NCT00403494|467764109|FG001|Overall Study|Protocol noncompliance|1|||
129945236|NCT00403494|467764108|FG000|Overall Study|Death|1|||
129945237|NCT00403494|467764109|FG001|Overall Study|Death|0|||
129945238|NCT00403494|467764108|FG000|Overall Study|Sponsor Request|1|||
129945239|NCT00403494|467764109|FG001|Overall Study|Sponsor Request|0|||
129945240|NCT00703092|467764110|FG000|Overall Study|Withdrawal by Subject|2|||
129945241|NCT02309515|467764111|FG000|Overall Study|Withdrawal by Subject|0|||
129945242|NCT02309515|467764112|FG001|Overall Study|Withdrawal by Subject|1|||
129945243|NCT04070105|467764116|FG000|Overall Study|Lost to Follow-up|0|||
129945244|NCT04070105|467764117|FG001|Overall Study|Lost to Follow-up|0|||
129945245|NCT04070105|467764118|FG002|Overall Study|Lost to Follow-up|0|||
129945246|NCT04070105|467764119|FG003|Overall Study|Lost to Follow-up|0|||
129945247|NCT04070105|467764120|FG004|Overall Study|Lost to Follow-up|0|||
129945248|NCT04070105|467764121|FG005|Overall Study|Lost to Follow-up|1|||
129945249|NCT05260437|467764127|FG000|Overall Study|Lost to Follow-up|5|||
129945250|NCT05260437|467764128|FG001|Overall Study|Lost to Follow-up|2|||
129945251|NCT05260437|467764129|FG002|Overall Study|Lost to Follow-up|1|||
129945252|NCT05260437|467764130|FG003|Overall Study|Lost to Follow-up|2|||
129945253|NCT05260437|467764131|FG004|Overall Study|Lost to Follow-up|2|||
129945254|NCT05260437|467764127|FG000|Overall Study|Withdrawal by Subject|3|||
129945255|NCT05260437|467764128|FG001|Overall Study|Withdrawal by Subject|0|||
129945256|NCT05260437|467764129|FG002|Overall Study|Withdrawal by Subject|4|||
129945257|NCT05260437|467764130|FG003|Overall Study|Withdrawal by Subject|5|||
129945258|NCT05260437|467764131|FG004|Overall Study|Withdrawal by Subject|0|||
129945259|NCT05260437|467764127|FG000|Overall Study|Vaccine Not Administered|0|||
129945260|NCT05260437|467764128|FG001|Overall Study|Vaccine Not Administered|1|||
129945261|NCT05260437|467764129|FG002|Overall Study|Vaccine Not Administered|0|||
129945262|NCT05260437|467764130|FG003|Overall Study|Vaccine Not Administered|0|||
129945263|NCT05260437|467764131|FG004|Overall Study|Vaccine Not Administered|0|||
129945264|NCT00910962|467764132|FG000|Overall Study|Adverse Event|5|||
129945265|NCT00910962|467764133|FG001|Overall Study|Adverse Event|20|||
129945266|NCT00910962|467764134|FG002|Overall Study|Adverse Event|17|||
129945267|NCT00910962|467764132|FG000|Overall Study|Protocol Violation|1|||
129945268|NCT00910962|467764133|FG001|Overall Study|Protocol Violation|3|||
129945269|NCT00910962|467764134|FG002|Overall Study|Protocol Violation|3|||
129945270|NCT00910962|467764132|FG000|Overall Study|Lost to Follow-up|0|||
129945271|NCT00910962|467764133|FG001|Overall Study|Lost to Follow-up|3|||
129945272|NCT00910962|467764134|FG002|Overall Study|Lost to Follow-up|1|||
129945273|NCT00910962|467764132|FG000|Overall Study|Physician Decision|0|||
129945274|NCT00910962|467764133|FG001|Overall Study|Physician Decision|6|||
129945275|NCT00910962|467764134|FG002|Overall Study|Physician Decision|6|||
129945276|NCT00910962|467764132|FG000|Overall Study|Withdrawal by Subject|25|||
129945277|NCT00910962|467764133|FG001|Overall Study|Withdrawal by Subject|32|||
129945278|NCT00910962|467764134|FG002|Overall Study|Withdrawal by Subject|32|||
129945279|NCT00910962|467764132|FG000|Overall Study|Reached defined stopping criteria|12|||
129945280|NCT00910962|467764133|FG001|Overall Study|Reached defined stopping criteria|14|||
129945281|NCT00910962|467764134|FG002|Overall Study|Reached defined stopping criteria|17|||
129945282|NCT01858688|467764135|FG000|Overall Study|Withdrawal by Subject|8|||
129945283|NCT01858688|467764135|FG000|Overall Study|Participant began another therapy|3|||
129945284|NCT01858688|467764135|FG000|Overall Study|Physician Decision|2|||
129945285|NCT01858688|467764135|FG000|Overall Study|Progressive Disease|2|||
129945286|NCT01858688|467764135|FG000|Overall Study|Reason not reproted|5|||
129945287|NCT01999335|467764136|FG000|Overall Study|Discontinued before receiving treatment|0|||
129945288|NCT01999335|467764137|FG001|Overall Study|Discontinued before receiving treatment|0|||
129945289|NCT01999335|467764138|FG002|Overall Study|Discontinued before receiving treatment|0|||
129945290|NCT01999335|467764139|FG003|Overall Study|Discontinued before receiving treatment|0|||
129945291|NCT01999335|467764140|FG004|Overall Study|Discontinued before receiving treatment|2|||
129945292|NCT00787176|467764141|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
129945293|NCT00787176|467764142|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
129945294|NCT00787176|467764143|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
129945295|NCT00787176|467764144|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
129945296|NCT01220999|467764154|FG000|Overall Study|Progressive disease|0|||
129945297|NCT01220999|467764155|FG001|Overall Study|Progressive disease|0|||
129945298|NCT01220999|467764156|FG002|Overall Study|Progressive disease|1|||
129945299|NCT01220999|467764157|FG003|Overall Study|Progressive disease|0|||
129945300|NCT01220999|467764158|FG004|Overall Study|Progressive disease|0|||
129945301|NCT03861234|467764159|FG000|Overall Study|Not treated|0|||
129945302|NCT03861234|467764160|FG001|Overall Study|Not treated|0|||
129945303|NCT03861234|467764161|FG002|Overall Study|Not treated|0|||
129945304|NCT03861234|467764162|FG003|Overall Study|Not treated|0|||
129945305|NCT03861234|467764163|FG004|Overall Study|Not treated|0|||
129945306|NCT03861234|467764164|FG005|Overall Study|Not treated|1|||
129945307|NCT03861234|467764165|FG006|Overall Study|Not treated|0|||
129945308|NCT03861234|467764166|FG007|Overall Study|Not treated|0|||
129945309|NCT03861234|467764159|FG000|Overall Study|Adverse Event|0|||
129945310|NCT03861234|467764160|FG001|Overall Study|Adverse Event|0|||
129945311|NCT03861234|467764161|FG002|Overall Study|Adverse Event|0|||
129945312|NCT03861234|467764162|FG003|Overall Study|Adverse Event|0|||
129945313|NCT03861234|467764163|FG004|Overall Study|Adverse Event|0|||
129945314|NCT03861234|467764164|FG005|Overall Study|Adverse Event|1|||
129945315|NCT03861234|467764165|FG006|Overall Study|Adverse Event|0|||
129945316|NCT03861234|467764166|FG007|Overall Study|Adverse Event|0|||
130071786|NCT01998958|468218083|FG009|Period 1 (Panel A and B)|Other|0|||
130071787|NCT01998958|468218084|FG010|Period 1 (Panel A and B)|Other|0|||
129945317|NCT03861234|467764159|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
129945318|NCT03861234|467764160|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
129945319|NCT03861234|467764161|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
129945320|NCT03861234|467764162|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
129945321|NCT03861234|467764163|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
129945322|NCT03861234|467764164|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
129945323|NCT03861234|467764165|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
129945324|NCT03861234|467764166|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
129945325|NCT03861234|467764159|FG000|Overall Study|As per sponsor decision|0|||
129945326|NCT03861234|467764160|FG001|Overall Study|As per sponsor decision|0|||
129945327|NCT03861234|467764161|FG002|Overall Study|As per sponsor decision|0|||
129945328|NCT03861234|467764162|FG003|Overall Study|As per sponsor decision|0|||
129945329|NCT03861234|467764163|FG004|Overall Study|As per sponsor decision|0|||
129945330|NCT03861234|467764164|FG005|Overall Study|As per sponsor decision|0|||
129945331|NCT03861234|467764165|FG006|Overall Study|As per sponsor decision|1|||
129945332|NCT03861234|467764166|FG007|Overall Study|As per sponsor decision|0|||
129945333|NCT03861234|467764159|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
129945334|NCT03861234|467764160|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
129945335|NCT03861234|467764161|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
129945336|NCT03861234|467764162|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
129945337|NCT03861234|467764163|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
129945338|NCT03861234|467764164|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
129945339|NCT03861234|467764165|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
129945340|NCT03861234|467764166|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
129945341|NCT02852824|467764167|FG000|Overall Study|Withdrawal by Subject|1|||
129945342|NCT02852824|467764168|FG001|Overall Study|Withdrawal by Subject|0|||
129945343|NCT02852824|467764169|FG002|Overall Study|Withdrawal by Subject|0|||
129945344|NCT02852824|467764170|FG003|Overall Study|Withdrawal by Subject|0|||
129945345|NCT02852824|467764171|FG004|Overall Study|Withdrawal by Subject|0|||
129945346|NCT02852824|467764172|FG005|Overall Study|Withdrawal by Subject|0|||
129945347|NCT02852824|467764173|FG006|Overall Study|Withdrawal by Subject|0|||
129945348|NCT02852824|467764167|FG000|Overall Study|Adverse Event|0|||
129945349|NCT02852824|467764168|FG001|Overall Study|Adverse Event|0|||
129945350|NCT02852824|467764169|FG002|Overall Study|Adverse Event|0|||
129945351|NCT02852824|467764170|FG003|Overall Study|Adverse Event|0|||
129945352|NCT02852824|467764171|FG004|Overall Study|Adverse Event|2|||
129945353|NCT02852824|467764172|FG005|Overall Study|Adverse Event|0|||
129945354|NCT02852824|467764173|FG006|Overall Study|Adverse Event|0|||
129945355|NCT03775213|467764174|FG000|Overall Study|Withdrawal by Subject|51|||
129945356|NCT03775213|467764175|FG001|Overall Study|Withdrawal by Subject|53|||
129945357|NCT03775213|467764174|FG000|Overall Study|Incomplete Survey|7|||
129945358|NCT03775213|467764175|FG001|Overall Study|Incomplete Survey|7|||
129945359|NCT00786188|467764176|FG000|Overall Study|Adverse Event|3|||
129945360|NCT00786188|467764177|FG001|Overall Study|Adverse Event|1|||
129945361|NCT00786188|467764176|FG000|Overall Study|Withdrawal by Subject|2|||
129945362|NCT00786188|467764177|FG001|Overall Study|Withdrawal by Subject|0|||
129945363|NCT02521493|467764181|FG000|Overall Study|Death|3|||
129945364|NCT02521493|467764182|FG001|Overall Study|Death|4|||
129945365|NCT02521493|467764183|FG002|Overall Study|Death|1|||
129945366|NCT02521493|467764181|FG000|Overall Study|Physician Decision|19|||
129945367|NCT02521493|467764182|FG001|Overall Study|Physician Decision|1|||
129945368|NCT02521493|467764183|FG002|Overall Study|Physician Decision|2|||
129945369|NCT02521493|467764181|FG000|Overall Study|Withdrawal by Subject|3|||
129945370|NCT02521493|467764182|FG001|Overall Study|Withdrawal by Subject|0|||
129945371|NCT02521493|467764183|FG002|Overall Study|Withdrawal by Subject|0|||
129945372|NCT02521493|467764181|FG000|Overall Study|Ineligible|0|||
129945373|NCT02521493|467764182|FG001|Overall Study|Ineligible|1|||
129945374|NCT02521493|467764183|FG002|Overall Study|Ineligible|0|||
129945375|NCT02521493|467764181|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
129945376|NCT02521493|467764182|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
129945377|NCT02521493|467764183|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
129945378|NCT02521493|467764181|FG000|Overall Study|No MRD result|0|||
130071788|NCT01998958|468218085|FG011|Period 1 (Panel A and B)|Other|0|||
130071789|NCT01998958|468218086|FG012|Period 1 (Panel A and B)|Other|0|||
130071790|NCT01998958|468218087|FG013|Period 1 (Panel A and B)|Other|0|||
129945379|NCT02521493|467764182|FG001|Overall Study|No MRD result|0|||
129945380|NCT02521493|467764183|FG002|Overall Study|No MRD result|4|||
129945381|NCT01218594|467764184|FG000|Overall Study|Death|1|||
129945382|NCT01218594|467764184|FG000|Overall Study|Withdrawal by Subject|3|||
129945383|NCT01218594|467764184|FG000|Overall Study|Adverse Event|2|||
129945384|NCT01218594|467764184|FG000|Overall Study|Physician Decision|6|||
129945385|NCT04748341|467764185|FG000|Overall Study|Lost to Follow-up|1|||
129945386|NCT04748341|467764186|FG001|Overall Study|Lost to Follow-up|1|||
129945387|NCT00452114|467764188|FG000|Overall Study|Physician Decision|3|||
130071791|NCT01998958|468218088|FG014|Period 1 (Panel A and B)|Other|0|||
129945388|NCT00452114|467764189|FG001|Overall Study|Physician Decision|3|||
129945389|NCT02334215|467764190|FG000|Overall Study|Death|1|||
129945390|NCT02334215|467764191|FG001|Overall Study|Death|1|||
129945391|NCT02334215|467764192|FG002|Overall Study|Death|0|||
129945392|NCT02334215|467764190|FG000|Overall Study|Lost to Follow-up|1|||
129945393|NCT02334215|467764191|FG001|Overall Study|Lost to Follow-up|0|||
129945394|NCT02334215|467764192|FG002|Overall Study|Lost to Follow-up|4|||
129945395|NCT02334215|467764190|FG000|Overall Study|Withdrawal by Subject|2|||
129945396|NCT02334215|467764191|FG001|Overall Study|Withdrawal by Subject|2|||
129945397|NCT02334215|467764192|FG002|Overall Study|Withdrawal by Subject|1|||
129945398|NCT02334215|467764190|FG000|Overall Study|Not released from incarceration on time|3|||
129945399|NCT02334215|467764191|FG001|Overall Study|Not released from incarceration on time|3|||
129945400|NCT02334215|467764192|FG002|Overall Study|Not released from incarceration on time|3|||
129945401|NCT02334215|467764190|FG000|Overall Study|Incarcerated|0|||
129945402|NCT02334215|467764191|FG001|Overall Study|Incarcerated|0|||
129945403|NCT02334215|467764192|FG002|Overall Study|Incarcerated|7|||
129945404|NCT03905642|467764193|FG000|Overall Study|Withdrawal by Subject|3|||
129945405|NCT03905642|467764193|FG000|Overall Study|Pregnancy|1|||
129945406|NCT03905642|467764193|FG000|Overall Study|Adverse Event|1|||
129945407|NCT03905642|467764193|FG000|Overall Study|Lack of Efficacy|1|||
129945408|NCT03905642|467764193|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
129945409|NCT03769090|467766298|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
129945410|NCT03769090|467766299|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
129945411|NCT03769090|467766300|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
129945412|NCT03769090|467766298|FG000|Overall Study|Withdrawal by Subject|52|||
129945413|NCT03769090|467766299|FG001|Overall Study|Withdrawal by Subject|62|||
129945414|NCT03769090|467766300|FG002|Overall Study|Withdrawal by Subject|74|||
129945415|NCT03769090|467766298|FG000|Overall Study|Death|4|||
129945416|NCT03769090|467766299|FG001|Overall Study|Death|2|||
129945417|NCT03769090|467766300|FG002|Overall Study|Death|2|||
129945418|NCT03769090|467766298|FG000|Overall Study|Adverse Event|7|||
129945419|NCT03769090|467766299|FG001|Overall Study|Adverse Event|7|||
129945420|NCT03769090|467766300|FG002|Overall Study|Adverse Event|8|||
129945421|NCT03769090|467766298|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
129945422|NCT03769090|467766299|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
129945423|NCT03769090|467766300|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
129945424|NCT03769090|467766298|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
129945425|NCT03769090|467766299|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
129945426|NCT03769090|467766300|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
129945427|NCT03769090|467766298|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
129945428|NCT03769090|467766299|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
129945429|NCT03769090|467766300|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
129945430|NCT03769090|467766298|FG000|Overall Study|Protocol Violation|5|||
129945431|NCT03769090|467766299|FG001|Overall Study|Protocol Violation|6|||
129945432|NCT03769090|467766300|FG002|Overall Study|Protocol Violation|8|||
129945433|NCT03769090|467766298|FG000|Overall Study|Pregnancy|1|||
129945434|NCT03769090|467766299|FG001|Overall Study|Pregnancy|0|||
129945435|NCT03769090|467766300|FG002|Overall Study|Pregnancy|3|||
129945436|NCT03769090|467766298|FG000|Overall Study|Lost to Follow-up|19|||
129945437|NCT03769090|467766299|FG001|Overall Study|Lost to Follow-up|25|||
129945438|NCT03769090|467766300|FG002|Overall Study|Lost to Follow-up|21|||
129945439|NCT03769090|467766298|FG000|Overall Study|Condition under investigation worsened|2|||
129945440|NCT03769090|467766299|FG001|Overall Study|Condition under investigation worsened|0|||
129945441|NCT03769090|467766300|FG002|Overall Study|Condition under investigation worsened|1|||
129945442|NCT03769090|467766298|FG000|Overall Study|Lack of Efficacy|1|||
129945443|NCT03769090|467766299|FG001|Overall Study|Lack of Efficacy|2|||
129945444|NCT03769090|467766300|FG002|Overall Study|Lack of Efficacy|2|||
129945445|NCT03769090|467766298|FG000|Overall Study|Other reasons|8|||
129945446|NCT03769090|467766299|FG001|Overall Study|Other reasons|12|||
129945447|NCT03769090|467766300|FG002|Overall Study|Other reasons|15|||
129945448|NCT02014402|467766304|FG000|Overall Study|Adverse Event|1|||
129945449|NCT02014402|467766305|FG001|Overall Study|Adverse Event|0|||
129945450|NCT02014402|467766306|FG002|Overall Study|Adverse Event|0|||
129945451|NCT02014402|467766307|FG003|Overall Study|Adverse Event|0|||
129945452|NCT02014402|467766304|FG000|Overall Study|Withdrawal by Subject|1|||
130071792|NCT01998958|468218089|FG015|Period 1 (Panel A and B)|Other|0|||
129945453|NCT02014402|467766305|FG001|Overall Study|Withdrawal by Subject|2|||
129945454|NCT02014402|467766306|FG002|Overall Study|Withdrawal by Subject|2|||
129945455|NCT02014402|467766307|FG003|Overall Study|Withdrawal by Subject|1|||
129945456|NCT02014402|467766304|FG000|Overall Study|Subject did not have transportation|0|||
129945457|NCT02014402|467766305|FG001|Overall Study|Subject did not have transportation|1|||
129945458|NCT02014402|467766306|FG002|Overall Study|Subject did not have transportation|0|||
129945459|NCT02014402|467766307|FG003|Overall Study|Subject did not have transportation|0|||
129945460|NCT02014402|467766304|FG000|Overall Study|Lost to Follow-up|0|||
129945461|NCT02014402|467766305|FG001|Overall Study|Lost to Follow-up|0|||
129945462|NCT02014402|467766306|FG002|Overall Study|Lost to Follow-up|1|||
129945463|NCT02014402|467766307|FG003|Overall Study|Lost to Follow-up|2|||
129945464|NCT00443820|467766308|FG000|Overall Study|Adverse Event|1|||
129945465|NCT00443820|467766309|FG001|Overall Study|Adverse Event|1|||
129945466|NCT00443820|467766310|FG002|Overall Study|Adverse Event|0|||
129945467|NCT00443820|467766311|FG003|Overall Study|Adverse Event|0|||
129945468|NCT00443820|467766308|FG000|Overall Study|Lack of Efficacy|3|||
129945469|NCT00443820|467766309|FG001|Overall Study|Lack of Efficacy|2|||
129945470|NCT00443820|467766310|FG002|Overall Study|Lack of Efficacy|1|||
129945471|NCT00443820|467766311|FG003|Overall Study|Lack of Efficacy|1|||
129945472|NCT00443820|467766308|FG000|Overall Study|Protocol Violation|2|||
129945473|NCT00443820|467766309|FG001|Overall Study|Protocol Violation|1|||
129945474|NCT00443820|467766310|FG002|Overall Study|Protocol Violation|2|||
129945475|NCT00443820|467766311|FG003|Overall Study|Protocol Violation|1|||
129945476|NCT00443820|467766308|FG000|Overall Study|Withdrawal by Subject|6|||
129945477|NCT00443820|467766309|FG001|Overall Study|Withdrawal by Subject|7|||
129945478|NCT00443820|467766310|FG002|Overall Study|Withdrawal by Subject|8|||
129945479|NCT00443820|467766311|FG003|Overall Study|Withdrawal by Subject|9|||
129945480|NCT00443820|467766308|FG000|Overall Study|Lost to Follow-up|9|||
129945481|NCT00443820|467766309|FG001|Overall Study|Lost to Follow-up|8|||
129945482|NCT00443820|467766310|FG002|Overall Study|Lost to Follow-up|6|||
129945483|NCT00443820|467766311|FG003|Overall Study|Lost to Follow-up|5|||
129945484|NCT00443820|467766308|FG000|Overall Study|Administrative problems|0|||
129945485|NCT00443820|467766309|FG001|Overall Study|Administrative problems|0|||
129945486|NCT00443820|467766310|FG002|Overall Study|Administrative problems|0|||
129945487|NCT00443820|467766311|FG003|Overall Study|Administrative problems|1|||
129945488|NCT00443820|467766308|FG000|Overall Study|Death|0|||
129945489|NCT00443820|467766309|FG001|Overall Study|Death|0|||
129945490|NCT00443820|467766310|FG002|Overall Study|Death|1|||
129945491|NCT00443820|467766311|FG003|Overall Study|Death|0|||
129945492|NCT04633200|467766312|FG000|Overall Study|Lost to Follow-up|3|||
129945493|NCT04633200|467766313|FG001|Overall Study|Lost to Follow-up|5|||
129945494|NCT03493282|467766314|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
129945495|NCT03493282|467766315|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
129945496|NCT03493282|467766316|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
129945497|NCT03493282|467766314|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
129945498|NCT03493282|467766315|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
129945499|NCT03493282|467766316|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
129945500|NCT01523392|467766317|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129945501|NCT01523392|467766318|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129945502|NCT01523392|467766317|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
129945503|NCT01523392|467766318|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
129945504|NCT01523392|467766317|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
129945505|NCT01523392|467766318|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
129945506|NCT00671853|467766320|FG000|Overall Study|Lack of Efficacy|3|||
129945507|NCT00671853|467766321|FG001|Overall Study|Lack of Efficacy|7|||
129945508|NCT00671853|467766320|FG000|Overall Study|Adverse Event|7|||
129945509|NCT00671853|467766321|FG001|Overall Study|Adverse Event|1|||
129945510|NCT00671853|467766320|FG000|Overall Study|Withdrawal by Subject|1|||
129945511|NCT00671853|467766321|FG001|Overall Study|Withdrawal by Subject|5|||
129945512|NCT00671853|467766320|FG000|Overall Study|Lost to Follow-up|8|||
129945513|NCT00671853|467766321|FG001|Overall Study|Lost to Follow-up|8|||
129945514|NCT00671853|467766320|FG000|Overall Study|Physician Decision|0|||
129945515|NCT00671853|467766321|FG001|Overall Study|Physician Decision|2|||
129945516|NCT00671853|467766320|FG000|Overall Study|Non-adherence with study procedures|1|||
129945517|NCT00671853|467766321|FG001|Overall Study|Non-adherence with study procedures|4|||
129945518|NCT01332266|467766323|FG000|Phase 1b|Death|3|||
129945519|NCT01332266|467766324|FG001|Phase 1b|Death|3|||
129945520|NCT01332266|467766325|FG002|Phase 1b|Death|2|||
129945521|NCT01332266|467766326|FG003|Phase 1b|Death|0|||
129945522|NCT01332266|467766327|FG004|Phase 1b|Death|0|||
129945523|NCT01332266|467766323|FG000|Phase 1b|Lost to Follow-up|0|||
129945524|NCT01332266|467766324|FG001|Phase 1b|Lost to Follow-up|1|||
129945525|NCT01332266|467766325|FG002|Phase 1b|Lost to Follow-up|0|||
129945526|NCT01332266|467766326|FG003|Phase 1b|Lost to Follow-up|0|||
130071793|NCT01998958|468218090|FG016|Period 1 (Panel A and B)|Other|0|||
129945527|NCT01332266|467766327|FG004|Phase 1b|Lost to Follow-up|0|||
129945528|NCT01332266|467766323|FG000|Phase 1b|Withdrawal by Subject|1|||
129945529|NCT01332266|467766324|FG001|Phase 1b|Withdrawal by Subject|1|||
129945530|NCT01332266|467766325|FG002|Phase 1b|Withdrawal by Subject|1|||
129945531|NCT01332266|467766326|FG003|Phase 1b|Withdrawal by Subject|0|||
129945532|NCT01332266|467766327|FG004|Phase 1b|Withdrawal by Subject|0|||
129945533|NCT01332266|467766323|FG000|Phase 2|Death|0|||
129945534|NCT01332266|467766324|FG001|Phase 2|Death|0|||
129945535|NCT01332266|467766325|FG002|Phase 2|Death|0|||
129945536|NCT01332266|467766326|FG003|Phase 2|Death|33|||
129945537|NCT01332266|467766327|FG004|Phase 2|Death|36|||
129945538|NCT01332266|467766323|FG000|Phase 2|Lost to Follow-up|0|||
129945539|NCT01332266|467766324|FG001|Phase 2|Lost to Follow-up|0|||
129945540|NCT01332266|467766325|FG002|Phase 2|Lost to Follow-up|0|||
129945541|NCT01332266|467766326|FG003|Phase 2|Lost to Follow-up|2|||
129945542|NCT01332266|467766327|FG004|Phase 2|Lost to Follow-up|0|||
129945543|NCT01332266|467766323|FG000|Phase 2|Physician Decision|0|||
129945544|NCT01332266|467766324|FG001|Phase 2|Physician Decision|0|||
129945545|NCT01332266|467766325|FG002|Phase 2|Physician Decision|0|||
129945546|NCT01332266|467766326|FG003|Phase 2|Physician Decision|3|||
129945547|NCT01332266|467766327|FG004|Phase 2|Physician Decision|1|||
129945548|NCT01332266|467766323|FG000|Phase 2|Symptomatic deterioration|0|||
129945549|NCT01332266|467766324|FG001|Phase 2|Symptomatic deterioration|0|||
129945550|NCT01332266|467766325|FG002|Phase 2|Symptomatic deterioration|0|||
129945551|NCT01332266|467766326|FG003|Phase 2|Symptomatic deterioration|0|||
129945552|NCT01332266|467766327|FG004|Phase 2|Symptomatic deterioration|1|||
129945553|NCT01332266|467766323|FG000|Phase 2|Progression Disease|0|||
129945554|NCT01332266|467766324|FG001|Phase 2|Progression Disease|0|||
129945555|NCT01332266|467766325|FG002|Phase 2|Progression Disease|0|||
129945556|NCT01332266|467766326|FG003|Phase 2|Progression Disease|2|||
129945557|NCT01332266|467766327|FG004|Phase 2|Progression Disease|1|||
129945558|NCT01332266|467766323|FG000|Phase 2|Withdrawal by Subject|0|||
129945559|NCT01332266|467766324|FG001|Phase 2|Withdrawal by Subject|0|||
129945560|NCT01332266|467766325|FG002|Phase 2|Withdrawal by Subject|0|||
129945561|NCT01332266|467766326|FG003|Phase 2|Withdrawal by Subject|2|||
129945562|NCT01332266|467766327|FG004|Phase 2|Withdrawal by Subject|2|||
129945563|NCT02128269|467766334|FG000|Treatment Period|Adverse Event|1|||
129945564|NCT02128269|467766334|FG000|Treatment Period|Physician Decision|1|||
129945565|NCT00878189|467766335|FG000|Overall Study|Death|0|||
129945566|NCT00878189|467766336|FG001|Overall Study|Death|1|||
129945567|NCT00878189|467766337|FG002|Overall Study|Death|0|||
129945568|NCT00878189|467766338|FG003|Overall Study|Death|1|||
129945569|NCT00878189|467766339|FG004|Overall Study|Death|0|||
129945570|NCT00878189|467766340|FG005|Overall Study|Death|0|||
129945571|NCT00878189|467766341|FG006|Overall Study|Death|0|||
129945572|NCT00878189|467766342|FG007|Overall Study|Death|0|||
129945573|NCT00878189|467766343|FG008|Overall Study|Death|1|||
129945574|NCT00878189|467766335|FG000|Overall Study|Participant Refused to Follow-up|0|||
129945575|NCT00878189|467766336|FG001|Overall Study|Participant Refused to Follow-up|0|||
129945576|NCT00878189|467766337|FG002|Overall Study|Participant Refused to Follow-up|0|||
129945577|NCT00878189|467766338|FG003|Overall Study|Participant Refused to Follow-up|0|||
129945578|NCT00878189|467766339|FG004|Overall Study|Participant Refused to Follow-up|0|||
129945579|NCT00878189|467766340|FG005|Overall Study|Participant Refused to Follow-up|4|||
129945580|NCT00878189|467766341|FG006|Overall Study|Participant Refused to Follow-up|0|||
129945581|NCT00878189|467766342|FG007|Overall Study|Participant Refused to Follow-up|0|||
129945582|NCT00878189|467766343|FG008|Overall Study|Participant Refused to Follow-up|0|||
129945583|NCT00878189|467766335|FG000|Overall Study|Other|3|||
129945584|NCT00878189|467766336|FG001|Overall Study|Other|2|||
129945585|NCT00878189|467766337|FG002|Overall Study|Other|4|||
129945586|NCT00878189|467766338|FG003|Overall Study|Other|7|||
129945587|NCT00878189|467766339|FG004|Overall Study|Other|4|||
129945588|NCT00878189|467766340|FG005|Overall Study|Other|18|||
129945589|NCT00878189|467766341|FG006|Overall Study|Other|15|||
129945590|NCT00878189|467766342|FG007|Overall Study|Other|3|||
129945591|NCT00878189|467766343|FG008|Overall Study|Other|4|||
129945592|NCT00878189|467766335|FG000|Overall Study|Lost to Follow-up|0|||
129945593|NCT00878189|467766336|FG001|Overall Study|Lost to Follow-up|0|||
129945594|NCT00878189|467766337|FG002|Overall Study|Lost to Follow-up|0|||
129945595|NCT00878189|467766338|FG003|Overall Study|Lost to Follow-up|0|||
129945596|NCT00878189|467766339|FG004|Overall Study|Lost to Follow-up|0|||
129945597|NCT00878189|467766340|FG005|Overall Study|Lost to Follow-up|1|||
129945598|NCT00878189|467766341|FG006|Overall Study|Lost to Follow-up|1|||
129945599|NCT00878189|467766342|FG007|Overall Study|Lost to Follow-up|0|||
129945600|NCT00878189|467766343|FG008|Overall Study|Lost to Follow-up|0|||
129945601|NCT00878189|467766335|FG000|Overall Study|Objection Progression or Relapse|0|||
129945602|NCT00878189|467766336|FG001|Overall Study|Objection Progression or Relapse|0|||
129945603|NCT00878189|467766337|FG002|Overall Study|Objection Progression or Relapse|0|||
129945604|NCT00878189|467766338|FG003|Overall Study|Objection Progression or Relapse|0|||
129945605|NCT00878189|467766339|FG004|Overall Study|Objection Progression or Relapse|0|||
129945606|NCT00878189|467766340|FG005|Overall Study|Objection Progression or Relapse|0|||
129945607|NCT00878189|467766341|FG006|Overall Study|Objection Progression or Relapse|0|||
129945608|NCT00878189|467766342|FG007|Overall Study|Objection Progression or Relapse|0|||
129945609|NCT00878189|467766343|FG008|Overall Study|Objection Progression or Relapse|3|||
129945610|NCT01021748|467766344|FG000|Overall Study|Adverse Event|2|||
129945611|NCT01021748|467766345|FG001|Overall Study|Adverse Event|1|||
129945612|NCT01021748|467766346|FG002|Overall Study|Adverse Event|2|||
129945613|NCT01021748|467766347|FG003|Overall Study|Adverse Event|0|||
129945614|NCT01021748|467766348|FG004|Overall Study|Adverse Event|2|||
129945615|NCT01021748|467766349|FG005|Overall Study|Adverse Event|0|||
129945616|NCT01021748|467766350|FG006|Overall Study|Adverse Event|1|||
129945617|NCT01021748|467766351|FG007|Overall Study|Adverse Event|0|||
129945618|NCT01021748|467766352|FG008|Overall Study|Adverse Event|7|||
129945619|NCT01021748|467766344|FG000|Overall Study|Physician Decision|1|||
129945620|NCT01021748|467766345|FG001|Overall Study|Physician Decision|0|||
129945621|NCT01021748|467766346|FG002|Overall Study|Physician Decision|1|||
130071794|NCT01998958|468218091|FG017|Period 1 (Panel A and B)|Other|0|||
130071795|NCT01998958|468218092|FG018|Period 1 (Panel A and B)|Other|0|||
130071796|NCT01998958|468218093|FG019|Period 1 (Panel A and B)|Other|0|||
130071797|NCT01998958|468218094|FG020|Period 1 (Panel A and B)|Other|0|||
130071798|NCT01998958|468218095|FG021|Period 1 (Panel A and B)|Other|0|||
130071799|NCT01998958|468218096|FG022|Period 1 (Panel A and B)|Other|0|||
130071800|NCT01998958|468218097|FG023|Period 1 (Panel A and B)|Other|0|||
130071801|NCT01998958|468218098|FG024|Period 1 (Panel A and B)|Other|0|||
130071802|NCT01998958|468218099|FG025|Period 1 (Panel A and B)|Other|0|||
130071803|NCT01998958|468218100|FG026|Period 1 (Panel A and B)|Other|0|||
130071804|NCT01998958|468218101|FG027|Period 1 (Panel A and B)|Other|0|||
130071805|NCT01998958|468218102|FG028|Period 1 (Panel A and B)|Other|0|||
130071806|NCT01998958|468218103|FG029|Period 1 (Panel A and B)|Other|0|||
130071807|NCT01998958|468218104|FG030|Period 1 (Panel A and B)|Other|0|||
130071808|NCT01998958|468218105|FG031|Period 1 (Panel A and B)|Other|0|||
130071809|NCT01998958|468218074|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
130071810|NCT01998958|468218075|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
130071811|NCT01998958|468218076|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
130071812|NCT01998958|468218077|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
130071813|NCT01998958|468218078|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
130071814|NCT01998958|468218079|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
130071815|NCT01998958|468218080|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
130071816|NCT01998958|468218081|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
130071817|NCT01998958|468218082|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
130071818|NCT01998958|468218083|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
130071819|NCT01998958|468218084|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
130071820|NCT01998958|468218085|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
130071821|NCT01998958|468218086|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
130071822|NCT01998958|468218087|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
129945622|NCT01021748|467766347|FG003|Overall Study|Physician Decision|1|||
129945623|NCT01021748|467766348|FG004|Overall Study|Physician Decision|0|||
129945624|NCT01021748|467766349|FG005|Overall Study|Physician Decision|0|||
129945625|NCT01021748|467766350|FG006|Overall Study|Physician Decision|1|||
129945626|NCT01021748|467766351|FG007|Overall Study|Physician Decision|1|||
129945627|NCT01021748|467766352|FG008|Overall Study|Physician Decision|2|||
129945628|NCT01021748|467766344|FG000|Overall Study|Progressive Disease|3|||
129945629|NCT01021748|467766345|FG001|Overall Study|Progressive Disease|3|||
129945630|NCT01021748|467766346|FG002|Overall Study|Progressive Disease|4|||
129945631|NCT01021748|467766347|FG003|Overall Study|Progressive Disease|6|||
129945632|NCT01021748|467766348|FG004|Overall Study|Progressive Disease|7|||
129945633|NCT01021748|467766349|FG005|Overall Study|Progressive Disease|3|||
129945634|NCT01021748|467766350|FG006|Overall Study|Progressive Disease|0|||
129945635|NCT01021748|467766351|FG007|Overall Study|Progressive Disease|5|||
129945636|NCT01021748|467766352|FG008|Overall Study|Progressive Disease|6|||
129945637|NCT01021748|467766344|FG000|Overall Study|Withdrawal by Subject|0|||
129945638|NCT01021748|467766345|FG001|Overall Study|Withdrawal by Subject|0|||
129945639|NCT01021748|467766346|FG002|Overall Study|Withdrawal by Subject|0|||
129945640|NCT01021748|467766347|FG003|Overall Study|Withdrawal by Subject|0|||
129945641|NCT01021748|467766348|FG004|Overall Study|Withdrawal by Subject|0|||
129945642|NCT01021748|467766349|FG005|Overall Study|Withdrawal by Subject|0|||
129945643|NCT01021748|467766350|FG006|Overall Study|Withdrawal by Subject|1|||
129945644|NCT01021748|467766351|FG007|Overall Study|Withdrawal by Subject|0|||
129945645|NCT01021748|467766352|FG008|Overall Study|Withdrawal by Subject|1|||
129945646|NCT01021748|467766344|FG000|Overall Study|Not Treated|0|||
129945647|NCT01021748|467766345|FG001|Overall Study|Not Treated|1|||
129945648|NCT01021748|467766346|FG002|Overall Study|Not Treated|0|||
129945649|NCT01021748|467766347|FG003|Overall Study|Not Treated|0|||
129945650|NCT01021748|467766348|FG004|Overall Study|Not Treated|0|||
129945651|NCT01021748|467766349|FG005|Overall Study|Not Treated|0|||
129945652|NCT01021748|467766350|FG006|Overall Study|Not Treated|0|||
129945653|NCT01021748|467766351|FG007|Overall Study|Not Treated|0|||
129945654|NCT01021748|467766352|FG008|Overall Study|Not Treated|0|||
129945655|NCT01829711|467766357|FG000|Overall Study|Lost to Follow-up|2|||
129945656|NCT01829711|467766357|FG000|Overall Study|Withdrawal by Subject|3|||
129945657|NCT01829711|467766357|FG000|Overall Study|Death|4|||
130071823|NCT01998958|468218088|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
130071824|NCT01998958|468218089|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
130071825|NCT01998958|468218090|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
130071826|NCT01998958|468218091|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
130071827|NCT01998958|468218092|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
130071828|NCT01998958|468218093|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
129945658|NCT01829711|467766357|FG000|Overall Study|Started new therapies|17|||
129945659|NCT01829711|467766357|FG000|Overall Study|Adverse Event|3|||
129945660|NCT01829711|467766357|FG000|Overall Study|Due to progression of disease|13|||
129945661|NCT01829711|467766357|FG000|Overall Study|Due to lack of response|1|||
129945662|NCT01480258|467766358|FG000|Infant Series|Protocol Violation|2|||
129945663|NCT01480258|467766359|FG001|Infant Series|Protocol Violation|0|||
129945664|NCT01480258|467766358|FG000|Infant Series|Physician Decision|0|||
130071829|NCT01998958|468218094|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
130071830|NCT01998958|468218095|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
130071831|NCT01998958|468218096|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
130071832|NCT01998958|468218097|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
130071833|NCT01998958|468218098|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
129945665|NCT01480258|467766359|FG001|Infant Series|Physician Decision|1|||
129945666|NCT01480258|467766358|FG000|Infant Series|Not Vaccinated|3|||
129945667|NCT01480258|467766359|FG001|Infant Series|Not Vaccinated|0|||
129945668|NCT01480258|467766358|FG000|Infant Series|Adverse Event|1|||
129945669|NCT01480258|467766359|FG001|Infant Series|Adverse Event|1|||
129945670|NCT01480258|467766358|FG000|Infant Series|Withdrawal by Subject|1|||
129945671|NCT01480258|467766359|FG001|Infant Series|Withdrawal by Subject|6|||
129945672|NCT01480258|467766358|FG000|Interim Period|Lost to Follow-up|0|||
129945673|NCT01480258|467766359|FG001|Interim Period|Lost to Follow-up|2|||
129945674|NCT01480258|467766358|FG000|Interim Period|Physician Decision|1|||
129945675|NCT01480258|467766359|FG001|Interim Period|Physician Decision|0|||
129945676|NCT01480258|467766358|FG000|Interim Period|Protocol Violation|0|||
129945677|NCT01480258|467766359|FG001|Interim Period|Protocol Violation|1|||
129945678|NCT01480258|467766358|FG000|Interim Period|Withdrawal by Subject|9|||
130071834|NCT01998958|468218099|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
129945679|NCT01480258|467766359|FG001|Interim Period|Withdrawal by Subject|6|||
129945680|NCT03316170|467766362|FG000|Overall Study|Death|1|||
129945681|NCT03316170|467766363|FG001|Overall Study|Death|0|||
129945682|NCT03316170|467766362|FG000|Overall Study|Lost to Follow-up|6|||
129945683|NCT03316170|467766363|FG001|Overall Study|Lost to Follow-up|7|||
129945684|NCT02169414|467766364|FG000|Overall Study|Withdrawal by Subject|1|||
129945685|NCT02169414|467766365|FG001|Overall Study|Withdrawal by Subject|0|||
129945686|NCT02169414|467766366|FG002|Overall Study|Withdrawal by Subject|0|||
129945687|NCT02169414|467766367|FG003|Overall Study|Withdrawal by Subject|0|||
129945688|NCT02169414|467766364|FG000|Overall Study|Adverse Event|0|||
129945689|NCT02169414|467766365|FG001|Overall Study|Adverse Event|1|||
129945690|NCT02169414|467766366|FG002|Overall Study|Adverse Event|0|||
129945691|NCT02169414|467766367|FG003|Overall Study|Adverse Event|0|||
129945692|NCT03374254|467766368|FG000|Overall Study|Death|5|||
129945693|NCT03374254|467766369|FG001|Overall Study|Death|16|||
129945694|NCT03374254|467766370|FG002|Overall Study|Death|13|||
129945695|NCT03374254|467766371|FG003|Overall Study|Death|11|||
129945696|NCT03374254|467766372|FG004|Overall Study|Death|9|||
129945697|NCT03374254|467766373|FG005|Overall Study|Death|12|||
129945698|NCT03374254|467766374|FG006|Overall Study|Death|11|||
129945699|NCT03374254|467766375|FG007|Overall Study|Death|6|||
129945700|NCT03374254|467766376|FG008|Overall Study|Death|7|||
129945701|NCT03374254|467766368|FG000|Overall Study|Lost to Follow-up|0|||
129945702|NCT03374254|467766369|FG001|Overall Study|Lost to Follow-up|0|||
129945703|NCT03374254|467766370|FG002|Overall Study|Lost to Follow-up|0|||
129945704|NCT03374254|467766371|FG003|Overall Study|Lost to Follow-up|0|||
129945705|NCT03374254|467766372|FG004|Overall Study|Lost to Follow-up|0|||
129945706|NCT03374254|467766373|FG005|Overall Study|Lost to Follow-up|0|||
129945707|NCT03374254|467766374|FG006|Overall Study|Lost to Follow-up|2|||
129945708|NCT03374254|467766375|FG007|Overall Study|Lost to Follow-up|0|||
129945709|NCT03374254|467766376|FG008|Overall Study|Lost to Follow-up|0|||
129945710|NCT03374254|467766368|FG000|Overall Study|Sponsor Decision|1|||
129945711|NCT03374254|467766369|FG001|Overall Study|Sponsor Decision|0|||
129945712|NCT03374254|467766370|FG002|Overall Study|Sponsor Decision|2|||
129945713|NCT03374254|467766371|FG003|Overall Study|Sponsor Decision|3|||
129945714|NCT03374254|467766372|FG004|Overall Study|Sponsor Decision|2|||
129945715|NCT03374254|467766373|FG005|Overall Study|Sponsor Decision|3|||
129945716|NCT03374254|467766374|FG006|Overall Study|Sponsor Decision|3|||
129945717|NCT03374254|467766375|FG007|Overall Study|Sponsor Decision|3|||
129945718|NCT03374254|467766376|FG008|Overall Study|Sponsor Decision|4|||
129945719|NCT03374254|467766368|FG000|Overall Study|Withdrawal by Subject|0|||
129945720|NCT03374254|467766369|FG001|Overall Study|Withdrawal by Subject|0|||
129945721|NCT03374254|467766370|FG002|Overall Study|Withdrawal by Subject|0|||
129945722|NCT03374254|467766371|FG003|Overall Study|Withdrawal by Subject|2|||
129945723|NCT03374254|467766372|FG004|Overall Study|Withdrawal by Subject|0|||
129945724|NCT03374254|467766373|FG005|Overall Study|Withdrawal by Subject|1|||
129945725|NCT03374254|467766374|FG006|Overall Study|Withdrawal by Subject|0|||
129945726|NCT03374254|467766375|FG007|Overall Study|Withdrawal by Subject|0|||
129945727|NCT03374254|467766376|FG008|Overall Study|Withdrawal by Subject|0|||
130071835|NCT01998958|468218100|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
129945728|NCT00749944|467766379|FG000|Overall Study|Lost to Follow-up|2|||
129945729|NCT00749944|467766380|FG001|Overall Study|Lost to Follow-up|1|||
129945730|NCT00749944|467766379|FG000|Overall Study|Other|1|||
129945731|NCT00749944|467766380|FG001|Overall Study|Other|0|||
129945732|NCT00749944|467766379|FG000|Overall Study|Withdrawal by Subject|2|||
129945733|NCT00749944|467766380|FG001|Overall Study|Withdrawal by Subject|0|||
129945734|NCT00624377|467766383|FG000|Overall Study|Lost to Follow-up|355|||
129945735|NCT00624377|467766383|FG000|Overall Study|Withdrawal by Subject|100|||
130071836|NCT01998958|468218101|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
130071837|NCT01998958|468218102|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
129945736|NCT00624377|467766383|FG000|Overall Study|Adverse Event|14|||
129945737|NCT00624377|467766383|FG000|Overall Study|Other|91|||
129945738|NCT00624377|467766383|FG000|Overall Study|Non-evaluable population|84|||
129945739|NCT02404441|467766387|FG000|Phase 1 Part|Adverse Event|1|||
129945740|NCT02404441|467766388|FG001|Phase 1 Part|Adverse Event|0|||
129945741|NCT02404441|467766389|FG002|Phase 1 Part|Adverse Event|0|||
129945742|NCT02404441|467766390|FG003|Phase 1 Part|Adverse Event|0|||
129945743|NCT02404441|467766391|FG004|Phase 1 Part|Adverse Event|0|||
129945744|NCT02404441|467766392|FG005|Phase 1 Part|Adverse Event|0|||
129945745|NCT02404441|467766393|FG006|Phase 1 Part|Adverse Event|0|||
129945746|NCT02404441|467766394|FG007|Phase 1 Part|Adverse Event|0|||
129945747|NCT02404441|467766395|FG008|Phase 1 Part|Adverse Event|0|||
129945748|NCT02404441|467766396|FG009|Phase 1 Part|Adverse Event|0|||
130071838|NCT01998958|468218103|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
130071839|NCT01998958|468218104|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
130071840|NCT01998958|468218105|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
130071841|NCT01998958|468218074|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071842|NCT01998958|468218075|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071843|NCT01998958|468218076|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071844|NCT01998958|468218077|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071845|NCT01998958|468218078|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130120331|NCT04799158|468402346|FG003|Run-In Period|Lost to Follow-up|0|||
130120332|NCT04799158|468402347|FG004|Run-In Period|Lost to Follow-up|0|||
130120333|NCT04799158|468402343|FG000|Run-In Period|Significant Protocol Deviation|1|||
129945749|NCT02404441|467766387|FG000|Phase 1 Part|Physician Decision|0|||
129945750|NCT02404441|467766388|FG001|Phase 1 Part|Physician Decision|1|||
129945751|NCT02404441|467766389|FG002|Phase 1 Part|Physician Decision|0|||
129945752|NCT02404441|467766390|FG003|Phase 1 Part|Physician Decision|0|||
129945753|NCT02404441|467766391|FG004|Phase 1 Part|Physician Decision|0|||
129945754|NCT02404441|467766392|FG005|Phase 1 Part|Physician Decision|0|||
129945755|NCT02404441|467766393|FG006|Phase 1 Part|Physician Decision|0|||
129945756|NCT02404441|467766394|FG007|Phase 1 Part|Physician Decision|0|||
129945757|NCT02404441|467766395|FG008|Phase 1 Part|Physician Decision|0|||
129945758|NCT02404441|467766396|FG009|Phase 1 Part|Physician Decision|0|||
129945759|NCT02404441|467766387|FG000|Phase 1 Part|Progressive Disease|14|||
129945760|NCT02404441|467766388|FG001|Phase 1 Part|Progressive Disease|11|||
129945761|NCT02404441|467766389|FG002|Phase 1 Part|Progressive Disease|7|||
129945762|NCT02404441|467766390|FG003|Phase 1 Part|Progressive Disease|6|||
129945763|NCT02404441|467766391|FG004|Phase 1 Part|Progressive Disease|9|||
129945764|NCT02404441|467766392|FG005|Phase 1 Part|Progressive Disease|0|||
129945765|NCT02404441|467766393|FG006|Phase 1 Part|Progressive Disease|0|||
129945766|NCT02404441|467766394|FG007|Phase 1 Part|Progressive Disease|0|||
129945767|NCT02404441|467766395|FG008|Phase 1 Part|Progressive Disease|0|||
129945768|NCT02404441|467766396|FG009|Phase 1 Part|Progressive Disease|0|||
129945769|NCT02404441|467766387|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
129945770|NCT02404441|467766388|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
129945771|NCT02404441|467766389|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
129945772|NCT02404441|467766390|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
129945773|NCT02404441|467766391|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
129945774|NCT02404441|467766392|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
129945775|NCT02404441|467766393|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
129945776|NCT02404441|467766394|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
129945777|NCT02404441|467766395|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
129945778|NCT02404441|467766396|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
129945779|NCT02404441|467766387|FG000|Phase 1 Part|Death|1|||
129945780|NCT02404441|467766388|FG001|Phase 1 Part|Death|1|||
129945781|NCT02404441|467766389|FG002|Phase 1 Part|Death|1|||
129945782|NCT02404441|467766390|FG003|Phase 1 Part|Death|0|||
129945783|NCT02404441|467766391|FG004|Phase 1 Part|Death|1|||
129945784|NCT02404441|467766392|FG005|Phase 1 Part|Death|0|||
129945785|NCT02404441|467766393|FG006|Phase 1 Part|Death|0|||
129945786|NCT02404441|467766394|FG007|Phase 1 Part|Death|0|||
129945787|NCT02404441|467766395|FG008|Phase 1 Part|Death|0|||
130071846|NCT01998958|468218079|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071847|NCT01998958|468218080|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071848|NCT01998958|468218081|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071849|NCT01998958|468218082|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129945788|NCT02404441|467766396|FG009|Phase 1 Part|Death|0|||
129945789|NCT02404441|467766387|FG000|Phase 2 Part|Adverse Event|0|||
129945790|NCT02404441|467766388|FG001|Phase 2 Part|Adverse Event|0|||
129945791|NCT02404441|467766389|FG002|Phase 2 Part|Adverse Event|0|||
129945792|NCT02404441|467766390|FG003|Phase 2 Part|Adverse Event|0|||
129945793|NCT02404441|467766391|FG004|Phase 2 Part|Adverse Event|0|||
129945794|NCT02404441|467766392|FG005|Phase 2 Part|Adverse Event|2|||
129945795|NCT02404441|467766393|FG006|Phase 2 Part|Adverse Event|3|||
129945796|NCT02404441|467766394|FG007|Phase 2 Part|Adverse Event|3|||
129945797|NCT02404441|467766395|FG008|Phase 2 Part|Adverse Event|6|||
130071850|NCT01998958|468218083|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129945798|NCT02404441|467766396|FG009|Phase 2 Part|Adverse Event|1|||
129945799|NCT02404441|467766387|FG000|Phase 2 Part|Physician Decision|0|||
129945800|NCT02404441|467766388|FG001|Phase 2 Part|Physician Decision|0|||
129945801|NCT02404441|467766389|FG002|Phase 2 Part|Physician Decision|0|||
129945802|NCT02404441|467766390|FG003|Phase 2 Part|Physician Decision|0|||
129945803|NCT02404441|467766391|FG004|Phase 2 Part|Physician Decision|0|||
129945804|NCT02404441|467766392|FG005|Phase 2 Part|Physician Decision|7|||
129945805|NCT02404441|467766393|FG006|Phase 2 Part|Physician Decision|9|||
129945806|NCT02404441|467766394|FG007|Phase 2 Part|Physician Decision|2|||
129945807|NCT02404441|467766395|FG008|Phase 2 Part|Physician Decision|1|||
129945808|NCT02404441|467766396|FG009|Phase 2 Part|Physician Decision|3|||
129945809|NCT02404441|467766387|FG000|Phase 2 Part|Progressive disease|0|||
129945810|NCT02404441|467766388|FG001|Phase 2 Part|Progressive disease|0|||
129945811|NCT02404441|467766389|FG002|Phase 2 Part|Progressive disease|0|||
129945812|NCT02404441|467766390|FG003|Phase 2 Part|Progressive disease|0|||
129945813|NCT02404441|467766391|FG004|Phase 2 Part|Progressive disease|0|||
129945814|NCT02404441|467766392|FG005|Phase 2 Part|Progressive disease|43|||
129945815|NCT02404441|467766393|FG006|Phase 2 Part|Progressive disease|32|||
129945816|NCT02404441|467766394|FG007|Phase 2 Part|Progressive disease|31|||
129945817|NCT02404441|467766395|FG008|Phase 2 Part|Progressive disease|39|||
129945818|NCT02404441|467766396|FG009|Phase 2 Part|Progressive disease|27|||
129945819|NCT02404441|467766387|FG000|Phase 2 Part|Subject/guardian decision|0|||
129945820|NCT02404441|467766388|FG001|Phase 2 Part|Subject/guardian decision|0|||
129945821|NCT02404441|467766389|FG002|Phase 2 Part|Subject/guardian decision|0|||
129945822|NCT02404441|467766390|FG003|Phase 2 Part|Subject/guardian decision|0|||
129945823|NCT02404441|467766391|FG004|Phase 2 Part|Subject/guardian decision|0|||
129945824|NCT02404441|467766392|FG005|Phase 2 Part|Subject/guardian decision|3|||
129945825|NCT02404441|467766393|FG006|Phase 2 Part|Subject/guardian decision|9|||
129945826|NCT02404441|467766394|FG007|Phase 2 Part|Subject/guardian decision|0|||
129945827|NCT02404441|467766395|FG008|Phase 2 Part|Subject/guardian decision|3|||
129945828|NCT02404441|467766396|FG009|Phase 2 Part|Subject/guardian decision|2|||
129945829|NCT02404441|467766387|FG000|Phase 2 Part|Death|0|||
129945830|NCT02404441|467766388|FG001|Phase 2 Part|Death|0|||
129945831|NCT02404441|467766389|FG002|Phase 2 Part|Death|0|||
129945832|NCT02404441|467766390|FG003|Phase 2 Part|Death|0|||
129945833|NCT02404441|467766391|FG004|Phase 2 Part|Death|0|||
129945834|NCT02404441|467766392|FG005|Phase 2 Part|Death|4|||
129945835|NCT02404441|467766393|FG006|Phase 2 Part|Death|8|||
129945836|NCT02404441|467766394|FG007|Phase 2 Part|Death|4|||
129945837|NCT02404441|467766395|FG008|Phase 2 Part|Death|10|||
129945838|NCT02404441|467766396|FG009|Phase 2 Part|Death|9|||
129945839|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945840|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945841|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945842|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
129945843|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945844|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945845|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945846|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945847|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
129945848|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945849|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945850|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945851|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945852|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945853|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Death|1|||
129945854|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Death|2|||
129945855|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Death|0|||
129945856|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Death|1|||
129945857|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Death|0|||
129945858|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Death|0|||
129945859|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Death|0|||
129945860|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
129945861|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
129945862|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
129945863|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
129945864|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
129945865|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
129945866|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
129945867|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945868|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
129945869|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945870|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945871|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945872|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945873|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945874|NCT02234141|467766397|FG000|Long-Term Treatment Period|Death|0|||
129945875|NCT02234141|467766398|FG001|Long-Term Treatment Period|Death|0|||
129945876|NCT02234141|467766399|FG002|Long-Term Treatment Period|Death|0|||
129945877|NCT02234141|467766400|FG003|Long-Term Treatment Period|Death|0|||
129945878|NCT02234141|467766401|FG004|Long-Term Treatment Period|Death|0|||
129945879|NCT02234141|467766402|FG005|Long-Term Treatment Period|Death|1|||
129945880|NCT02234141|467766403|FG006|Long-Term Treatment Period|Death|0|||
129945881|NCT02234141|467766397|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
129945882|NCT02234141|467766398|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
129945883|NCT02234141|467766399|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
129945884|NCT02234141|467766400|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
129945885|NCT02234141|467766401|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
129945886|NCT02234141|467766402|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
129945887|NCT02234141|467766403|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
129945888|NCT02234141|467766397|FG000|Long-Term Treatment Period|Adverse Event|4|||
129945889|NCT02234141|467766398|FG001|Long-Term Treatment Period|Adverse Event|0|||
129945890|NCT02234141|467766399|FG002|Long-Term Treatment Period|Adverse Event|5|||
129945891|NCT02234141|467766400|FG003|Long-Term Treatment Period|Adverse Event|0|||
129945892|NCT02234141|467766401|FG004|Long-Term Treatment Period|Adverse Event|1|||
129945893|NCT02234141|467766402|FG005|Long-Term Treatment Period|Adverse Event|1|||
129945894|NCT02234141|467766403|FG006|Long-Term Treatment Period|Adverse Event|1|||
129945895|NCT02234141|467766397|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
129945896|NCT02234141|467766398|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
129945897|NCT02234141|467766399|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
129945898|NCT02234141|467766400|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
129945899|NCT02234141|467766401|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
129945900|NCT02234141|467766402|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
129945901|NCT02234141|467766403|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
129945902|NCT02234141|467766397|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
129945903|NCT02234141|467766398|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
129945904|NCT02234141|467766399|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
129945905|NCT02234141|467766400|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
129945906|NCT02234141|467766401|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
129945907|NCT02234141|467766402|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
129945908|NCT02234141|467766403|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
129945909|NCT00895245|467766404|FG000|Overall Study|Lack of Efficacy|6|||
129945910|NCT04248868|467766405|FG000|Overall Study|Death|1|||
129945911|NCT04248868|467766405|FG000|Overall Study|Lost to Follow-up|3|||
129945912|NCT04248868|467766405|FG000|Overall Study|Protocol Violation|2|||
129945913|NCT02706483|467766408|FG000|Overall Study|Adverse Event|97|||
129945914|NCT02706483|467766408|FG000|Overall Study|Death|1|||
129945915|NCT02706483|467766408|FG000|Overall Study|Lack of Efficacy|39|||
129945916|NCT02706483|467766408|FG000|Overall Study|Lost to Follow-up|101|||
129945917|NCT02706483|467766408|FG000|Overall Study|Non-compliance with study drug|15|||
129945918|NCT02706483|467766408|FG000|Overall Study|Physician Decision|6|||
129945919|NCT02706483|467766408|FG000|Overall Study|Pregnancy|6|||
129945920|NCT02706483|467766408|FG000|Overall Study|Protocol Violation|18|||
129945921|NCT02706483|467766408|FG000|Overall Study|Withdrawal by Subject|136|||
129945922|NCT02706483|467766408|FG000|Overall Study|Non-compliance with visits|6|||
129945923|NCT02706483|467766408|FG000|Overall Study|Site closure|4|||
129945924|NCT02706483|467766408|FG000|Overall Study|Subject moved|1|||
129945925|NCT03131713|467766409|FG000|Overall Study|Lost to Follow-up|5|||
129945926|NCT03131713|467766410|FG001|Overall Study|Lost to Follow-up|0|||
129945927|NCT02208843|467766411|FG000|Overall Study|Clinical symptoms of progression|2|||
129945928|NCT02208843|467766411|FG000|Overall Study|Progression disease according to RECIST|24|||
129945929|NCT02208843|467766411|FG000|Overall Study|Adverse Event|12|||
129945930|NCT02208843|467766411|FG000|Overall Study|Protocol Violation|1|||
129945931|NCT02208843|467766411|FG000|Overall Study|Withdrawal by Subject|1|||
129945932|NCT02208843|467766411|FG000|Overall Study|Switched to commercial afatinib|20|||
129945933|NCT01976507|467766412|FG000|Overall Study|Adverse Event|6|||
129945934|NCT01976507|467766412|FG000|Overall Study|ablation not done, drug not given|1|||
129945935|NCT01972776|467766413|FG000|Part 1|Withdrawal by Subject|0|||
129945936|NCT01972776|467766414|FG001|Part 1|Withdrawal by Subject|0|||
129945937|NCT01972776|467766415|FG002|Part 1|Withdrawal by Subject|1|||
129945938|NCT01972776|467766416|FG003|Part 1|Withdrawal by Subject|0|||
129945939|NCT01972776|467766417|FG004|Part 1|Withdrawal by Subject|0|||
129945940|NCT01972776|467766418|FG005|Part 1|Withdrawal by Subject|0|||
129945941|NCT01972776|467766413|FG000|Part 1|Adverse Event|0|||
129945942|NCT01972776|467766414|FG001|Part 1|Adverse Event|0|||
129945943|NCT01972776|467766415|FG002|Part 1|Adverse Event|1|||
129945944|NCT01972776|467766416|FG003|Part 1|Adverse Event|1|||
129945945|NCT01972776|467766417|FG004|Part 1|Adverse Event|0|||
129945946|NCT01972776|467766418|FG005|Part 1|Adverse Event|0|||
129945947|NCT01972776|467766413|FG000|Part 2|Adverse Event|0|||
129945948|NCT01972776|467766414|FG001|Part 2|Adverse Event|0|||
129945949|NCT01972776|467766415|FG002|Part 2|Adverse Event|0|||
129945950|NCT01972776|467766416|FG003|Part 2|Adverse Event|0|||
129945951|NCT01972776|467766417|FG004|Part 2|Adverse Event|3|||
129945952|NCT01972776|467766418|FG005|Part 2|Adverse Event|0|||
129945953|NCT01972776|467766413|FG000|Part 2|Administrative problems|0|||
129945954|NCT01972776|467766414|FG001|Part 2|Administrative problems|0|||
129945955|NCT01972776|467766415|FG002|Part 2|Administrative problems|0|||
129945956|NCT01972776|467766416|FG003|Part 2|Administrative problems|0|||
129945957|NCT01972776|467766417|FG004|Part 2|Administrative problems|10|||
129945958|NCT01972776|467766418|FG005|Part 2|Administrative problems|7|||
129945959|NCT00089791|467766422|FG000|Overall Study|Physician Decision|6|||
129945960|NCT00089791|467766423|FG001|Overall Study|Physician Decision|3|||
129945961|NCT00089791|467766422|FG000|Overall Study|Adverse Event|81|||
129945962|NCT00089791|467766423|FG001|Overall Study|Adverse Event|93|||
129945963|NCT00089791|467766422|FG000|Overall Study|Withdrawal by Subject|403|||
129945964|NCT00089791|467766423|FG001|Overall Study|Withdrawal by Subject|344|||
129945965|NCT00089791|467766422|FG000|Overall Study|Death|78|||
129945966|NCT00089791|467766423|FG001|Overall Study|Death|62|||
129945967|NCT00089791|467766422|FG000|Overall Study|Disease progression|7|||
129945968|NCT00089791|467766423|FG001|Overall Study|Disease progression|3|||
129945969|NCT00089791|467766422|FG000|Overall Study|Ineligibility determined|12|||
129945970|NCT00089791|467766423|FG001|Overall Study|Ineligibility determined|9|||
129945971|NCT00089791|467766422|FG000|Overall Study|Lost to Follow-up|57|||
129945972|NCT00089791|467766423|FG001|Overall Study|Lost to Follow-up|57|||
129945973|NCT00089791|467766422|FG000|Overall Study|Noncompliance|17|||
129945974|NCT00089791|467766423|FG001|Overall Study|Noncompliance|13|||
129945975|NCT00089791|467766422|FG000|Overall Study|Other|20|||
129945976|NCT00089791|467766423|FG001|Overall Study|Other|32|||
129945977|NCT00089791|467766422|FG000|Overall Study|Protocol deviation|12|||
130120334|NCT04799158|468402344|FG001|Run-In Period|Significant Protocol Deviation|0|||
130120335|NCT04799158|468402345|FG002|Run-In Period|Significant Protocol Deviation|0|||
130120336|NCT04799158|468402346|FG003|Run-In Period|Significant Protocol Deviation|0|||
130120337|NCT04799158|468402347|FG004|Run-In Period|Significant Protocol Deviation|0|||
130120338|NCT04799158|468402343|FG000|Run-In Period|Withdrawal by Subject|11|||
130120339|NCT04799158|468402344|FG001|Run-In Period|Withdrawal by Subject|0|||
130120340|NCT04799158|468402345|FG002|Run-In Period|Withdrawal by Subject|0|||
130120341|NCT04799158|468402346|FG003|Run-In Period|Withdrawal by Subject|0|||
130120342|NCT04799158|468402347|FG004|Run-In Period|Withdrawal by Subject|0|||
130120343|NCT04799158|468402343|FG000|Run-In Period|Miscellaneous|3|||
130120344|NCT04799158|468402344|FG001|Run-In Period|Miscellaneous|0|||
130120345|NCT04799158|468402345|FG002|Run-In Period|Miscellaneous|0|||
130120346|NCT04799158|468402346|FG003|Run-In Period|Miscellaneous|0|||
130120347|NCT04799158|468402347|FG004|Run-In Period|Miscellaneous|0|||
130120348|NCT04799158|468402343|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
130120349|NCT04799158|468402344|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129945978|NCT00089791|467766423|FG001|Overall Study|Protocol deviation|10|||
129945979|NCT00089791|467766422|FG000|Overall Study|Requirement for alternative therapy|7|||
129945980|NCT00089791|467766423|FG001|Overall Study|Requirement for alternative therapy|4|||
129945981|NCT00148122|467766424|FG000|Overall Study|Withdrawal by Subject|2|||
129945982|NCT03042767|467766425|FG000|Overall Study|Lost to Follow-up|1|||
129945983|NCT03042767|467766426|FG001|Overall Study|Lost to Follow-up|2|||
129945984|NCT01543204|467766427|FG000|Overall Study|Non-compliance|1|||
129945985|NCT01543204|467766427|FG000|Overall Study|Adverse Event|1|||
129945986|NCT01543204|467766427|FG000|Overall Study|Withdrawal by Subject|4|||
129945987|NCT01543204|467766427|FG000|Overall Study|Requirement for Alternative Therapy|1|||
129945988|NCT01543204|467766427|FG000|Overall Study|Lost to Follow-up|1|||
129945989|NCT02449902|467766431|FG000|Overall Study|Adverse Event|0|||
129945990|NCT02449902|467766432|FG001|Overall Study|Adverse Event|1|||
129945991|NCT02449902|467766431|FG000|Overall Study|Withdrawal by Subject|0|||
129945992|NCT02449902|467766432|FG001|Overall Study|Withdrawal by Subject|1|||
129945993|NCT02362789|467766433|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
129945994|NCT02362789|467766434|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
130120350|NCT04799158|468402345|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
130120351|NCT04799158|468402346|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129945995|NCT02362789|467766435|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
129945996|NCT02362789|467766433|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
129945997|NCT02362789|467766434|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
129945998|NCT02362789|467766435|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
129945999|NCT02362789|467766433|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
129946000|NCT02362789|467766434|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
129946001|NCT02362789|467766435|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
129946002|NCT02362789|467766433|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
129946003|NCT02362789|467766434|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
129946004|NCT02362789|467766435|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
129946005|NCT02362789|467766433|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
129946006|NCT02362789|467766434|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
130120352|NCT04799158|468402347|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129946007|NCT02362789|467766435|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
129946008|NCT03326856|467766436|FG000|Overall Study|Lost to Follow-up|1|||
129946009|NCT03326856|467766437|FG001|Overall Study|Lost to Follow-up|1|||
129946010|NCT03326856|467766438|FG002|Overall Study|Lost to Follow-up|0|||
129946011|NCT03326856|467766439|FG003|Overall Study|Lost to Follow-up|0|||
129946012|NCT03326856|467766440|FG004|Overall Study|Lost to Follow-up|0|||
129946013|NCT02037568|467766441|FG000|Overall Study|Withdrawal by Subject|17|||
129946014|NCT02037568|467766442|FG001|Overall Study|Withdrawal by Subject|24|||
129946015|NCT02037568|467766441|FG000|Overall Study|Lost to Follow-up|16|||
129946016|NCT02037568|467766442|FG001|Overall Study|Lost to Follow-up|13|||
129946017|NCT02037568|467766441|FG000|Overall Study|Screen Failure|3|||
129946018|NCT02037568|467766442|FG001|Overall Study|Screen Failure|1|||
129946019|NCT02037568|467766441|FG000|Overall Study|Patient did not receive transplant|0|||
129946020|NCT02037568|467766442|FG001|Overall Study|Patient did not receive transplant|1|||
129946021|NCT00721734|467766446|FG000|Overall Study|Progressive Disease|3|||
129946022|NCT00721734|467766447|FG001|Overall Study|Progressive Disease|10|||
129946023|NCT00721734|467766448|FG002|Overall Study|Progressive Disease|4|||
129946024|NCT00721734|467766449|FG003|Overall Study|Progressive Disease|5|||
129946025|NCT00721734|467766450|FG004|Overall Study|Progressive Disease|2|||
129946026|NCT00721734|467766446|FG000|Overall Study|Adverse Event|3|||
129946027|NCT00721734|467766447|FG001|Overall Study|Adverse Event|1|||
129946028|NCT00721734|467766448|FG002|Overall Study|Adverse Event|4|||
129946029|NCT00721734|467766449|FG003|Overall Study|Adverse Event|0|||
129946030|NCT00721734|467766450|FG004|Overall Study|Adverse Event|3|||
129946031|NCT00721734|467766446|FG000|Overall Study|Withdrawal by Subject|2|||
129946032|NCT00721734|467766447|FG001|Overall Study|Withdrawal by Subject|1|||
129946033|NCT00721734|467766448|FG002|Overall Study|Withdrawal by Subject|0|||
129946034|NCT00721734|467766449|FG003|Overall Study|Withdrawal by Subject|0|||
129946035|NCT00721734|467766450|FG004|Overall Study|Withdrawal by Subject|1|||
129946036|NCT00721734|467766446|FG000|Overall Study|Other|0|||
129946037|NCT00721734|467766447|FG001|Overall Study|Other|0|||
129946038|NCT00721734|467766448|FG002|Overall Study|Other|0|||
129946039|NCT00721734|467766449|FG003|Overall Study|Other|1|||
129946040|NCT00721734|467766450|FG004|Overall Study|Other|0|||
129946041|NCT00621842|467766451|FG000|Overall Study|Adverse Event|6|||
129946042|NCT00621842|467766451|FG000|Overall Study|Withdrawal by Subject|7|||
129946043|NCT00621842|467766451|FG000|Overall Study|Protocol Violation|4|||
129946044|NCT00621842|467766451|FG000|Overall Study|Lack of Efficacy|2|||
129946045|NCT01989689|467766453|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
129946046|NCT01989689|467766454|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
129946047|NCT01989689|467766453|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
129946048|NCT01989689|467766454|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
130071851|NCT01998958|468218084|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071852|NCT01998958|468218085|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071853|NCT01998958|468218086|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071854|NCT01998958|468218087|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071855|NCT01998958|468218088|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
130071856|NCT01998958|468218089|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071857|NCT01998958|468218090|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071858|NCT01998958|468218091|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071859|NCT01998958|468218092|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
130071860|NCT01998958|468218093|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071861|NCT01998958|468218094|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071862|NCT01998958|468218095|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071863|NCT01998958|468218096|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071864|NCT01998958|468218097|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071865|NCT01998958|468218098|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071866|NCT01998958|468218099|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129946049|NCT00526994|467766455|FG000|Overall Study|Lost to Follow-up|98|||
129946050|NCT00526994|467766456|FG001|Overall Study|Lost to Follow-up|108|||
129946051|NCT00526994|467766457|FG002|Overall Study|Lost to Follow-up|96|||
129946052|NCT00526994|467766455|FG000|Overall Study|Death|4|||
129946053|NCT00526994|467766456|FG001|Overall Study|Death|3|||
130071867|NCT01998958|468218100|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071868|NCT01998958|468218101|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071869|NCT01998958|468218102|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130071870|NCT01998958|468218103|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
130154861|NCT00958126|468526624|FG003|Overall Study|Lost to Follow-up|8|||
129946054|NCT00526994|467766457|FG002|Overall Study|Death|3|||
129946055|NCT00526994|467766455|FG000|Overall Study|Withdrawal by Subject|2|||
129946056|NCT00526994|467766456|FG001|Overall Study|Withdrawal by Subject|7|||
129946057|NCT00526994|467766457|FG002|Overall Study|Withdrawal by Subject|5|||
129946058|NCT00526994|467766455|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
129946059|NCT00526994|467766456|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
129946060|NCT00526994|467766457|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
129946061|NCT03938272|467766458|FG000|Overall Study|Withdrawal by Subject|1|||
129946062|NCT03938272|467766459|FG001|Overall Study|Withdrawal by Subject|0|||
129946063|NCT03938272|467766458|FG000|Overall Study|Physician Decision|0|||
129946064|NCT03938272|467766459|FG001|Overall Study|Physician Decision|2|||
129946065|NCT03938272|467766458|FG000|Overall Study|Study termination by sponsor|10|||
129946066|NCT03938272|467766459|FG001|Overall Study|Study termination by sponsor|8|||
129946067|NCT03692871|467766463|FG000|Overall Study|Death|1|||
129946068|NCT03692871|467766464|FG001|Overall Study|Death|1|||
129946069|NCT03692871|467766463|FG000|Overall Study|Lost to Follow-up|24|||
129946070|NCT03692871|467766464|FG001|Overall Study|Lost to Follow-up|9|||
129946071|NCT03692871|467766463|FG000|Overall Study|Physician Decision|22|||
129946072|NCT03692871|467766464|FG001|Overall Study|Physician Decision|7|||
129946073|NCT03692871|467766463|FG000|Overall Study|Protocol Deviation|1|||
129946074|NCT03692871|467766464|FG001|Overall Study|Protocol Deviation|0|||
129946075|NCT03692871|467766463|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
129946076|NCT03692871|467766464|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
129946077|NCT02644122|467766465|FG000|Overall Study|Withdrawal by Subject|1|||
129946078|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
129946079|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
129946080|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
129946081|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
129946082|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
129946083|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
129946084|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
129946085|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
129946086|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
129946087|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
129946088|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
129946089|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
129946090|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
129946091|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
129946092|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
129946093|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
129946094|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
129946095|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
129946096|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
129946097|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
129946098|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
129946099|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
129946100|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
129946101|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
129946102|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
129946103|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
129946104|NCT00680771|467766470|FG000|Overall Study|Withdrawal by Subject|1|||
129946105|NCT00680771|467766471|FG001|Overall Study|Withdrawal by Subject|0|||
129946106|NCT00680771|467766470|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
129946107|NCT00680771|467766471|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
129946108|NCT00680771|467766470|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
129946109|NCT00680771|467766471|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
129946110|NCT01316913|467766472|FG000|Overall Study|Adverse Event|17|||
129946111|NCT01316913|467766473|FG001|Overall Study|Adverse Event|20|||
129946112|NCT01316913|467766474|FG002|Overall Study|Adverse Event|15|||
129946113|NCT01316913|467766475|FG003|Overall Study|Adverse Event|11|||
129946114|NCT01316913|467766472|FG000|Overall Study|Lack of Efficacy|22|||
129946115|NCT01316913|467766473|FG001|Overall Study|Lack of Efficacy|12|||
129946116|NCT01316913|467766474|FG002|Overall Study|Lack of Efficacy|9|||
129946117|NCT01316913|467766475|FG003|Overall Study|Lack of Efficacy|13|||
129946118|NCT01316913|467766472|FG000|Overall Study|Protocol Violation|1|||
129946119|NCT01316913|467766473|FG001|Overall Study|Protocol Violation|4|||
129946120|NCT01316913|467766474|FG002|Overall Study|Protocol Violation|4|||
129946121|NCT01316913|467766475|FG003|Overall Study|Protocol Violation|1|||
129946122|NCT01316913|467766472|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
129946123|NCT01316913|467766473|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
129946124|NCT01316913|467766474|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
129946125|NCT01316913|467766475|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
129946126|NCT01316913|467766472|FG000|Overall Study|Lost to Follow-up|0|||
129946127|NCT01316913|467766473|FG001|Overall Study|Lost to Follow-up|1|||
129946128|NCT01316913|467766474|FG002|Overall Study|Lost to Follow-up|0|||
129946129|NCT01316913|467766475|FG003|Overall Study|Lost to Follow-up|2|||
129946130|NCT01316913|467766472|FG000|Overall Study|Withdrawal by Subject|10|||
129946131|NCT01316913|467766473|FG001|Overall Study|Withdrawal by Subject|9|||
129946132|NCT01316913|467766474|FG002|Overall Study|Withdrawal by Subject|10|||
129946133|NCT01316913|467766475|FG003|Overall Study|Withdrawal by Subject|6|||
129946134|NCT01668719|467766476|FG000|Phase I|On treatment|1|||
129946135|NCT01668719|467766477|FG001|Phase I|On treatment|0|||
129946136|NCT01668719|467766478|FG002|Phase I|On treatment|0|||
129946137|NCT01668719|467766476|FG000|Phase I|Adverse Event|2|||
129946138|NCT01668719|467766477|FG001|Phase I|Adverse Event|0|||
129946139|NCT01668719|467766478|FG002|Phase I|Adverse Event|0|||
129946140|NCT01668719|467766476|FG000|Phase I|Progression/relapse|1|||
129946141|NCT01668719|467766477|FG001|Phase I|Progression/relapse|0|||
129946142|NCT01668719|467766478|FG002|Phase I|Progression/relapse|0|||
129946143|NCT01668719|467766476|FG000|Phase I|not protocol specified|2|||
129946144|NCT01668719|467766477|FG001|Phase I|not protocol specified|0|||
129946145|NCT01668719|467766478|FG002|Phase I|not protocol specified|0|||
129946146|NCT01668719|467766476|FG000|Phase II|On treatment|0|||
129946147|NCT01668719|467766477|FG001|Phase II|On treatment|4|||
129946148|NCT01668719|467766478|FG002|Phase II|On treatment|3|||
129946149|NCT01668719|467766476|FG000|Phase II|Adverse Event|0|||
129946150|NCT01668719|467766477|FG001|Phase II|Adverse Event|18|||
129946151|NCT01668719|467766478|FG002|Phase II|Adverse Event|18|||
129946152|NCT01668719|467766476|FG000|Phase II|Refusal unrelated to adverse event|0|||
129946153|NCT01668719|467766477|FG001|Phase II|Refusal unrelated to adverse event|4|||
129946154|NCT01668719|467766478|FG002|Phase II|Refusal unrelated to adverse event|1|||
129946155|NCT01668719|467766476|FG000|Phase II|Progression/relapse|0|||
129946156|NCT01668719|467766477|FG001|Phase II|Progression/relapse|13|||
129946157|NCT01668719|467766478|FG002|Phase II|Progression/relapse|17|||
129946158|NCT01668719|467766476|FG000|Phase II|Death|0|||
129946159|NCT01668719|467766477|FG001|Phase II|Death|0|||
129946160|NCT01668719|467766478|FG002|Phase II|Death|2|||
129946161|NCT01668719|467766476|FG000|Phase II|not protocol specified|0|||
129946162|NCT01668719|467766477|FG001|Phase II|not protocol specified|13|||
129946163|NCT01668719|467766478|FG002|Phase II|not protocol specified|7|||
129946164|NCT02060487|467766479|FG000|Overall Study|Other|1|||
129946165|NCT02060487|467766480|FG001|Overall Study|Other|2|||
129946166|NCT02060487|467766481|FG002|Overall Study|Other|1|||
129946167|NCT02060487|467766479|FG000|Overall Study|Lack of Efficacy|0|||
129946168|NCT02060487|467766480|FG001|Overall Study|Lack of Efficacy|1|||
129946169|NCT02060487|467766481|FG002|Overall Study|Lack of Efficacy|0|||
129946170|NCT02060487|467766479|FG000|Overall Study|Withdrawal by Subject|3|||
129946171|NCT02060487|467766480|FG001|Overall Study|Withdrawal by Subject|10|||
129946172|NCT02060487|467766481|FG002|Overall Study|Withdrawal by Subject|4|||
129946173|NCT02060487|467766479|FG000|Overall Study|Study Terminated By Sponsor|87|||
129946174|NCT02060487|467766480|FG001|Overall Study|Study Terminated By Sponsor|89|||
129946175|NCT02060487|467766481|FG002|Overall Study|Study Terminated By Sponsor|100|||
129946176|NCT02060487|467766479|FG000|Overall Study|Randomized in error|1|||
129946177|NCT02060487|467766480|FG001|Overall Study|Randomized in error|0|||
129946178|NCT02060487|467766481|FG002|Overall Study|Randomized in error|0|||
129946179|NCT02060487|467766479|FG000|Overall Study|Protocol Violation|0|||
129946180|NCT02060487|467766480|FG001|Overall Study|Protocol Violation|1|||
129946181|NCT02060487|467766481|FG002|Overall Study|Protocol Violation|1|||
129946182|NCT02060487|467766479|FG000|Overall Study|Lost to Follow-up|3|||
129946183|NCT02060487|467766480|FG001|Overall Study|Lost to Follow-up|0|||
129946184|NCT02060487|467766481|FG002|Overall Study|Lost to Follow-up|2|||
129946185|NCT02060487|467766479|FG000|Overall Study|Death|34|||
129946186|NCT02060487|467766480|FG001|Overall Study|Death|25|||
129946187|NCT02060487|467766481|FG002|Overall Study|Death|19|||
129946188|NCT02060487|467766479|FG000|Overall Study|Adverse Event|0|||
129946189|NCT02060487|467766480|FG001|Overall Study|Adverse Event|0|||
129946190|NCT02060487|467766481|FG002|Overall Study|Adverse Event|1|||
129946191|NCT00875706|467766482|FG000|Overall Study|Withdrawal by Subject|1|||
129946192|NCT00875706|467766483|FG001|Overall Study|Withdrawal by Subject|0|||
129946193|NCT00875706|467766484|FG002|Overall Study|Withdrawal by Subject|0|||
129946194|NCT02950961|467766486|FG000|Overall Study|Study had to stop due to COVID.|7|||
129946195|NCT02241785|467766489|FG000|Overall Study|Sponsor Termination|43|||
129946196|NCT02241785|467766489|FG000|Overall Study|Withdrawal by Subject|1|||
129946197|NCT02241785|467766489|FG000|Overall Study|Lost to Follow-up|2|||
129946198|NCT02241785|467766489|FG000|Overall Study|Adverse Event|1|||
129946199|NCT03055988|467766490|FG000|Period 1|Adverse Event|0|||
129946200|NCT03055988|467766491|FG001|Period 1|Adverse Event|1|||
129946201|NCT03055988|467766490|FG000|Period 1|Lost to Follow-up|1|||
129946202|NCT03055988|467766491|FG001|Period 1|Lost to Follow-up|0|||
129946203|NCT03055988|467766490|FG000|Period 1|Withdrawal by Subject|0|||
129946204|NCT03055988|467766491|FG001|Period 1|Withdrawal by Subject|4|||
129946205|NCT03055988|467766490|FG000|Period 2|Adverse Event|0|||
129946206|NCT03055988|467766491|FG001|Period 2|Adverse Event|1|||
129946207|NCT03055988|467766490|FG000|Period 2|Other than listed|1|||
129946208|NCT03055988|467766491|FG001|Period 2|Other than listed|1|||
129946209|NCT00845520|467766492|FG000|Overall Study|Death|1|||
129946210|NCT00845520|467766493|FG001|Overall Study|Death|2|||
129946211|NCT00845520|467766494|FG002|Overall Study|Death|0|||
129946212|NCT00845520|467766492|FG000|Overall Study|Lost to Follow-up|1|||
129946213|NCT00845520|467766493|FG001|Overall Study|Lost to Follow-up|0|||
129946214|NCT00845520|467766494|FG002|Overall Study|Lost to Follow-up|0|||
129946215|NCT00845520|467766492|FG000|Overall Study|Adverse Event|0|||
129946216|NCT00845520|467766493|FG001|Overall Study|Adverse Event|0|||
129946217|NCT00845520|467766494|FG002|Overall Study|Adverse Event|1|||
129946218|NCT01736475|467766495|FG000|Overall Study|Adverse Event|4|||
129946219|NCT01736475|467766496|FG001|Overall Study|Adverse Event|0|||
129946220|NCT01736475|467766495|FG000|Overall Study|Withdrawal by Subject|2|||
129946221|NCT01736475|467766496|FG001|Overall Study|Withdrawal by Subject|0|||
129946222|NCT01736475|467766495|FG000|Overall Study|Protocol Violation|4|||
129946223|NCT01736475|467766496|FG001|Overall Study|Protocol Violation|0|||
129946224|NCT01736475|467766495|FG000|Overall Study|Other - Screen failure|1|||
129946225|NCT01736475|467766496|FG001|Overall Study|Other - Screen failure|0|||
129946226|NCT01736475|467766495|FG000|Overall Study|Other - Surgical procedure|1|||
129946227|NCT01736475|467766496|FG001|Overall Study|Other - Surgical procedure|0|||
129946228|NCT02807857|467766497|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
129946229|NCT02807857|467766497|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
129946230|NCT02807857|467766497|FG000|Follow-Up Set|Withdrawal by Subject|8|||
129946231|NCT02807857|467766497|FG000|Follow-Up Set|Lost to Follow-up|7|||
129946232|NCT02807857|467766497|FG000|Follow-Up Set|Physician Decision|6|||
129946233|NCT02807857|467766497|FG000|Follow-Up Set|Adverse Event|3|||
129946234|NCT02807857|467766497|FG000|Follow-Up Set|Death|27|||
129946235|NCT02807857|467766497|FG000|Follow-Up Set|Relocation|2|||
129946236|NCT01190124|467768447|FG000|Overall Study|Death|3|||
129946237|NCT01190124|467768448|FG001|Overall Study|Death|0|||
129946238|NCT01190124|467768449|FG002|Overall Study|Death|0|||
129946239|NCT01190124|467768447|FG000|Overall Study|Therapeutic Failure|12|||
129946240|NCT01190124|467768448|FG001|Overall Study|Therapeutic Failure|0|||
129946241|NCT01190124|467768449|FG002|Overall Study|Therapeutic Failure|1|||
129946242|NCT01190124|467768447|FG000|Overall Study|Lost to Follow-up|2|||
129946243|NCT01190124|467768448|FG001|Overall Study|Lost to Follow-up|0|||
129946244|NCT01190124|467768449|FG002|Overall Study|Lost to Follow-up|0|||
129946245|NCT00070707|467768450|FG000|Overall Study|Adverse Event|1|||
129946246|NCT00070707|467768451|FG001|Overall Study|Adverse Event|2|||
129946247|NCT00070707|467768450|FG000|Overall Study|Lack of Efficacy|4|||
129946248|NCT00070707|467768451|FG001|Overall Study|Lack of Efficacy|1|||
129946249|NCT00070707|467768450|FG000|Overall Study|Protocol Violation|8|||
129946250|NCT00070707|467768451|FG001|Overall Study|Protocol Violation|4|||
129946251|NCT00070707|467768450|FG000|Overall Study|Unrelated to Study Medication|1|||
129946252|NCT00070707|467768451|FG001|Overall Study|Unrelated to Study Medication|0|||
129946253|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
129946254|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
129946255|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
129946256|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
129946257|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
129946258|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
129946259|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
129946260|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
129946261|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
129946262|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
129946263|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
129946264|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
129946265|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
129946266|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
129946267|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
129946268|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
129946269|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
129946270|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
129946271|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
129946272|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
129946273|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
129946274|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
129946275|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
129946276|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
129946277|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
129946278|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
129946279|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
129946280|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
129946281|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
129946282|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
129946283|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
129946284|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
129946285|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
129946286|NCT02236611|467768456|FG000|Overall Study|Adverse Event|10|||
129946287|NCT02236611|467768457|FG001|Overall Study|Adverse Event|16|||
129946288|NCT02236611|467768456|FG000|Overall Study|Lack of Efficacy|4|||
129946289|NCT02236611|467768457|FG001|Overall Study|Lack of Efficacy|7|||
129946290|NCT02236611|467768456|FG000|Overall Study|Lost to Follow-up|0|||
129946291|NCT02236611|467768457|FG001|Overall Study|Lost to Follow-up|2|||
129946292|NCT02236611|467768456|FG000|Overall Study|Protocol deviation|3|||
129946293|NCT02236611|467768457|FG001|Overall Study|Protocol deviation|5|||
129946294|NCT02236611|467768456|FG000|Overall Study|Withdrew consent|9|||
129946295|NCT02236611|467768457|FG001|Overall Study|Withdrew consent|4|||
129946296|NCT01450007|467768458|FG000|Overall Study|Late exclusion before treatment|2|||
129946297|NCT01450007|467768459|FG001|Overall Study|Late exclusion before treatment|3|||
129946298|NCT01450007|467768460|FG002|Overall Study|Late exclusion before treatment|2|||
129946299|NCT01450007|467768458|FG000|Overall Study|Protocol Violation|0|||
129946300|NCT01450007|467768459|FG001|Overall Study|Protocol Violation|1|||
129946301|NCT01450007|467768460|FG002|Overall Study|Protocol Violation|1|||
129946302|NCT01450007|467768458|FG000|Overall Study|Adverse Event|0|||
129946303|NCT01450007|467768459|FG001|Overall Study|Adverse Event|1|||
129946304|NCT01450007|467768460|FG002|Overall Study|Adverse Event|0|||
129946305|NCT03851094|467768462|FG000|Overall Study|Withdrawal by Subject|0|||
129946306|NCT03851094|467768463|FG001|Overall Study|Withdrawal by Subject|1|||
129946307|NCT03851094|467768462|FG000|Overall Study|Participant lost device|0|||
129946308|NCT03851094|467768463|FG001|Overall Study|Participant lost device|1|||
129946309|NCT03851094|467768462|FG000|Overall Study|Participant returned device|0|||
129946310|NCT03851094|467768463|FG001|Overall Study|Participant returned device|2|||
129946311|NCT01536704|467768464|FG000|Washout Period 1|Withdrawal by Subject|1|||
129946312|NCT01536704|467768465|FG001|Washout Period 1|Withdrawal by Subject|2|||
129946313|NCT01536704|467768466|FG002|Washout Period 1|Withdrawal by Subject|0|||
129946314|NCT01536704|467768467|FG003|Washout Period 1|Withdrawal by Subject|0|||
129946315|NCT01536704|467768464|FG000|Washout Period 2|Adverse Event|1|||
129946316|NCT01536704|467768465|FG001|Washout Period 2|Adverse Event|0|||
129946317|NCT01536704|467768466|FG002|Washout Period 2|Adverse Event|0|||
129946318|NCT01536704|467768467|FG003|Washout Period 2|Adverse Event|0|||
129946319|NCT01536704|467768464|FG000|Washout Period 2|Withdrawal by Subject|0|||
129946320|NCT01536704|467768465|FG001|Washout Period 2|Withdrawal by Subject|0|||
129946321|NCT01536704|467768466|FG002|Washout Period 2|Withdrawal by Subject|0|||
129946322|NCT01536704|467768467|FG003|Washout Period 2|Withdrawal by Subject|1|||
129946323|NCT01536704|467768464|FG000|Period 3|Adverse Event|0|||
129946324|NCT01536704|467768465|FG001|Period 3|Adverse Event|0|||
129946325|NCT01536704|467768466|FG002|Period 3|Adverse Event|0|||
129946326|NCT01536704|467768467|FG003|Period 3|Adverse Event|1|||
129946327|NCT01536704|467768464|FG000|Washout Period 3|Adverse Event|0|||
129946328|NCT01536704|467768465|FG001|Washout Period 3|Adverse Event|0|||
129946329|NCT01536704|467768466|FG002|Washout Period 3|Adverse Event|1|||
129946330|NCT01536704|467768467|FG003|Washout Period 3|Adverse Event|0|||
129946331|NCT02392507|467768468|FG000|Induction Regimen|Death|3|||
129946332|NCT02392507|467768468|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
129946333|NCT02392507|467768468|FG000|Induction Regimen|Physician Decision|1|||
129946334|NCT02392507|467768468|FG000|Induction Regimen|Withdrawal by Subject|2|||
129946335|NCT02392507|467768468|FG000|Maintenance Regimen|Death|1|||
129946336|NCT02392507|467768468|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
129946337|NCT00240994|467768469|FG000|Overall Study|Lost to Follow-up|1|||
129946338|NCT00240994|467768469|FG000|Overall Study|Protocol Violation|1|||
129946339|NCT00240994|467768469|FG000|Overall Study|Graft failure|1|||
129946340|NCT00923078|467768473|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
129946341|NCT00923078|467768474|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
129946342|NCT00923078|467768475|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
129946343|NCT00923078|467768473|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
129946344|NCT00923078|467768474|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
129946345|NCT00923078|467768475|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
129946346|NCT03547154|467768486|FG000|Overall Study|Disease Progression/Recurrence|6|||
129946347|NCT03547154|467768487|FG001|Overall Study|Disease Progression/Recurrence|14|||
129946348|NCT03547154|467768486|FG000|Overall Study|Adverse Event|26|||
129946349|NCT03547154|467768487|FG001|Overall Study|Adverse Event|31|||
129946350|NCT03547154|467768486|FG000|Overall Study|Protocol Violation|6|||
129946351|NCT03547154|467768487|FG001|Overall Study|Protocol Violation|1|||
129946352|NCT03547154|467768486|FG000|Overall Study|Physician Decision|4|||
129946353|NCT03547154|467768487|FG001|Overall Study|Physician Decision|3|||
129946354|NCT03547154|467768486|FG000|Overall Study|Insufficient Therapeutic Response|13|||
129946355|NCT03547154|467768487|FG001|Overall Study|Insufficient Therapeutic Response|10|||
129946356|NCT03547154|467768486|FG000|Overall Study|Withdrawal by Subject|10|||
129946357|NCT03547154|467768487|FG001|Overall Study|Withdrawal by Subject|6|||
129946358|NCT03547154|467768486|FG000|Overall Study|Not Selected|0|||
129946359|NCT03547154|467768487|FG001|Overall Study|Not Selected|1|||
129946360|NCT03547154|467768486|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
129946361|NCT03547154|467768487|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
129946362|NCT04679675|467768488|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
129979777|NCT01204710|467889469|FG001|Randomization Treatment|Worsening of General condition|1|||
129946363|NCT04679675|467768489|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
129946364|NCT04679675|467768490|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
129946365|NCT04679675|467768491|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
129946366|NCT04679675|467768488|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
129946367|NCT04679675|467768489|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
129946368|NCT04679675|467768490|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
129946369|NCT04679675|467768491|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
129946370|NCT03259568|467768492|FG000|Overall Study|Participant performance was low|3|||
129946371|NCT01794299|467768502|FG000|Overall Study|ATIR manufacturing not possible|1|||
129946372|NCT01794299|467768502|FG000|Overall Study|Death|14|||
129946373|NCT01794299|467768502|FG000|Overall Study|Graft failure|1|||
129946374|NCT01794299|467768502|FG000|Overall Study|ATIR batch rejected|2|||
129946375|NCT01794299|467768502|FG000|Overall Study|Relapse|2|||
129946376|NCT01794299|467768502|FG000|Overall Study|Discontinued from active follow-up|1|||
129946377|NCT01794299|467768502|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
129946378|NCT01029704|467768503|FG000|Overall Study|Adverse Event|0|||
129946379|NCT01029704|467768504|FG001|Overall Study|Adverse Event|0|||
129946380|NCT01029704|467768505|FG002|Overall Study|Adverse Event|0|||
129946381|NCT01029704|467768506|FG003|Overall Study|Adverse Event|0|||
129946382|NCT01029704|467768507|FG004|Overall Study|Adverse Event|0|||
129946383|NCT01029704|467768508|FG005|Overall Study|Adverse Event|0|||
129946384|NCT01029704|467768509|FG006|Overall Study|Adverse Event|1|||
129946385|NCT01029704|467768510|FG007|Overall Study|Adverse Event|1|||
129946386|NCT01029704|467768511|FG008|Overall Study|Adverse Event|0|||
129946387|NCT01029704|467768503|FG000|Overall Study|Withdrawal by Subject|0|||
129946388|NCT01029704|467768504|FG001|Overall Study|Withdrawal by Subject|0|||
129946389|NCT01029704|467768505|FG002|Overall Study|Withdrawal by Subject|0|||
129946390|NCT01029704|467768506|FG003|Overall Study|Withdrawal by Subject|0|||
129946391|NCT01029704|467768507|FG004|Overall Study|Withdrawal by Subject|2|||
129946392|NCT01029704|467768508|FG005|Overall Study|Withdrawal by Subject|1|||
129946393|NCT01029704|467768509|FG006|Overall Study|Withdrawal by Subject|1|||
129946394|NCT01029704|467768510|FG007|Overall Study|Withdrawal by Subject|1|||
129946395|NCT01029704|467768511|FG008|Overall Study|Withdrawal by Subject|0|||
129946396|NCT01029704|467768503|FG000|Overall Study|Lost to Follow-up|0|||
129946397|NCT01029704|467768504|FG001|Overall Study|Lost to Follow-up|0|||
129946398|NCT01029704|467768505|FG002|Overall Study|Lost to Follow-up|0|||
129946399|NCT01029704|467768506|FG003|Overall Study|Lost to Follow-up|0|||
129946400|NCT01029704|467768507|FG004|Overall Study|Lost to Follow-up|0|||
129946401|NCT01029704|467768508|FG005|Overall Study|Lost to Follow-up|0|||
129946402|NCT01029704|467768509|FG006|Overall Study|Lost to Follow-up|1|||
129946403|NCT01029704|467768510|FG007|Overall Study|Lost to Follow-up|1|||
129946404|NCT01029704|467768511|FG008|Overall Study|Lost to Follow-up|1|||
129946405|NCT01029704|467768503|FG000|Overall Study|Lack of Efficacy|0|||
129946406|NCT01029704|467768504|FG001|Overall Study|Lack of Efficacy|0|||
129946407|NCT01029704|467768505|FG002|Overall Study|Lack of Efficacy|0|||
129946408|NCT01029704|467768506|FG003|Overall Study|Lack of Efficacy|0|||
129946409|NCT01029704|467768507|FG004|Overall Study|Lack of Efficacy|2|||
129946410|NCT01029704|467768508|FG005|Overall Study|Lack of Efficacy|3|||
129946411|NCT01029704|467768509|FG006|Overall Study|Lack of Efficacy|1|||
129946412|NCT01029704|467768510|FG007|Overall Study|Lack of Efficacy|2|||
129946413|NCT01029704|467768511|FG008|Overall Study|Lack of Efficacy|0|||
129946414|NCT01029704|467768503|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
129946415|NCT01029704|467768504|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
129946416|NCT01029704|467768505|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
129946417|NCT01029704|467768506|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
129946418|NCT01029704|467768507|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
129946419|NCT01029704|467768508|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
129946420|NCT01029704|467768509|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
129946421|NCT01029704|467768510|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
129946422|NCT01029704|467768511|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
129946423|NCT03006393|467768512|FG000|Overall Study|Withdrawal by Subject|1|||
129946424|NCT03006393|467768513|FG001|Overall Study|Withdrawal by Subject|1|||
129946425|NCT03006393|467768512|FG000|Overall Study|Pregnancy|0|||
129946426|NCT03006393|467768513|FG001|Overall Study|Pregnancy|1|||
129946427|NCT03006393|467768512|FG000|Overall Study|Lost to Follow-up|0|||
129946428|NCT03006393|467768513|FG001|Overall Study|Lost to Follow-up|1|||
129946429|NCT01365546|467768514|FG000|Overall Study|Withdrawal by Subject|1|||
129946430|NCT01365546|467768514|FG000|Overall Study|Screen failure|9|||
129946431|NCT01365546|467768514|FG000|Overall Study|Study termination|1|||
129946432|NCT00472082|467768515|FG000|Overall Study|Study prematurely terminated|5|||
129946433|NCT03200574|467768523|FG000|Overall Study|Death|4|||
129946434|NCT03200574|467768523|FG000|Overall Study|Withdrawal by Subject|8|||
129946435|NCT03200574|467768523|FG000|Overall Study|Long-Term need for anticoagulation|1|||
129946436|NCT03200574|467768523|FG000|Overall Study|Relocation|2|||
129946437|NCT03200574|467768523|FG000|Overall Study|Lost to Follow-up|2|||
129946438|NCT04183491|467768524|FG000|Overall Study|Withdrawal by Subject|0|||
129946439|NCT04183491|467768525|FG001|Overall Study|Withdrawal by Subject|0|||
129946440|NCT04183491|467768526|FG002|Overall Study|Withdrawal by Subject|1|||
129946441|NCT04183491|467768527|FG003|Overall Study|Withdrawal by Subject|0|||
129946442|NCT04183491|467768528|FG004|Overall Study|Withdrawal by Subject|0|||
129946443|NCT04183491|467768529|FG005|Overall Study|Withdrawal by Subject|1|||
129946444|NCT04183491|467768530|FG006|Overall Study|Withdrawal by Subject|0|||
129946445|NCT00068107|467768533|FG000|Overall Study|end-stage renal disease|6|||
129946446|NCT00068107|467768533|FG000|Overall Study|Death|2|||
129946447|NCT00068107|467768533|FG000|Overall Study|Withdrawal by Subject|1|||
129946448|NCT01419184|467768536|FG000|Overall Study|Site data not available|3|||
129946449|NCT01419184|467768537|FG001|Overall Study|Site data not available|2|||
129946450|NCT01419184|467768536|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
129946451|NCT01419184|467768537|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
129946452|NCT01419184|467768536|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
129946453|NCT01419184|467768537|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
129946454|NCT01419184|467768536|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
129946455|NCT01419184|467768537|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
129946456|NCT01419184|467768536|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
129946457|NCT01419184|467768537|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
129946458|NCT01419184|467768536|FG000|Overall Study|Participant randomized, not treated|1|||
129946459|NCT01419184|467768537|FG001|Overall Study|Participant randomized, not treated|0|||
129946460|NCT03989232|467768540|FG000|Overall Study|Lost to Follow-up|3|||
129946461|NCT03989232|467768541|FG001|Overall Study|Lost to Follow-up|10|||
129946462|NCT03989232|467768540|FG000|Overall Study|Withdrawal by Subject|6|||
129946463|NCT03989232|467768541|FG001|Overall Study|Withdrawal by Subject|6|||
129946464|NCT03989232|467768540|FG000|Overall Study|Death|1|||
129946465|NCT03989232|467768541|FG001|Overall Study|Death|2|||
129946466|NCT02691702|467768548|FG000|Overall Study|Adverse Event|1|||
129946467|NCT02691702|467768549|FG001|Overall Study|Adverse Event|0|||
129946468|NCT02691702|467768550|FG002|Overall Study|Adverse Event|0|||
129946469|NCT02691702|467768551|FG003|Overall Study|Adverse Event|0|||
129946470|NCT02691702|467768552|FG004|Overall Study|Adverse Event|0|||
129946471|NCT02691702|467768553|FG005|Overall Study|Adverse Event|0|||
129946472|NCT02691702|467768554|FG006|Overall Study|Adverse Event|0|||
129946473|NCT02691702|467768555|FG007|Overall Study|Adverse Event|0|||
129946474|NCT02691702|467768556|FG008|Overall Study|Adverse Event|1|||
129946475|NCT02691702|467768557|FG009|Overall Study|Adverse Event|0|||
129946476|NCT02691702|467768558|FG010|Overall Study|Adverse Event|1|||
129946477|NCT02691702|467768548|FG000|Overall Study|Lost to Follow-up|0|||
129946478|NCT02691702|467768549|FG001|Overall Study|Lost to Follow-up|0|||
129946479|NCT02691702|467768550|FG002|Overall Study|Lost to Follow-up|1|||
129946480|NCT02691702|467768551|FG003|Overall Study|Lost to Follow-up|0|||
129946481|NCT02691702|467768552|FG004|Overall Study|Lost to Follow-up|0|||
129946482|NCT02691702|467768553|FG005|Overall Study|Lost to Follow-up|2|||
129946483|NCT02691702|467768554|FG006|Overall Study|Lost to Follow-up|0|||
129946484|NCT02691702|467768555|FG007|Overall Study|Lost to Follow-up|0|||
129946485|NCT02691702|467768556|FG008|Overall Study|Lost to Follow-up|0|||
129946486|NCT02691702|467768557|FG009|Overall Study|Lost to Follow-up|0|||
129946487|NCT02691702|467768558|FG010|Overall Study|Lost to Follow-up|1|||
129946488|NCT02691702|467768548|FG000|Overall Study|Withdrawal by Subject|1|||
129946489|NCT02691702|467768549|FG001|Overall Study|Withdrawal by Subject|1|||
129946490|NCT02691702|467768550|FG002|Overall Study|Withdrawal by Subject|0|||
129946491|NCT02691702|467768551|FG003|Overall Study|Withdrawal by Subject|0|||
129946492|NCT02691702|467768552|FG004|Overall Study|Withdrawal by Subject|0|||
129946493|NCT02691702|467768553|FG005|Overall Study|Withdrawal by Subject|1|||
129946494|NCT02691702|467768554|FG006|Overall Study|Withdrawal by Subject|2|||
129946495|NCT02691702|467768555|FG007|Overall Study|Withdrawal by Subject|0|||
129946496|NCT02691702|467768556|FG008|Overall Study|Withdrawal by Subject|0|||
129946497|NCT02691702|467768557|FG009|Overall Study|Withdrawal by Subject|0|||
129946498|NCT02691702|467768558|FG010|Overall Study|Withdrawal by Subject|0|||
130071871|NCT01998958|468218104|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129946499|NCT02691702|467768548|FG000|Overall Study|Other|0|||
129946500|NCT02691702|467768549|FG001|Overall Study|Other|0|||
129946501|NCT02691702|467768550|FG002|Overall Study|Other|0|||
129946502|NCT02691702|467768551|FG003|Overall Study|Other|0|||
129946503|NCT02691702|467768552|FG004|Overall Study|Other|0|||
129946504|NCT02691702|467768553|FG005|Overall Study|Other|0|||
129946505|NCT02691702|467768554|FG006|Overall Study|Other|1|||
129946506|NCT02691702|467768555|FG007|Overall Study|Other|0|||
129946507|NCT02691702|467768556|FG008|Overall Study|Other|1|||
129946508|NCT02691702|467768557|FG009|Overall Study|Other|0|||
130071872|NCT01998958|468218105|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129946509|NCT02691702|467768558|FG010|Overall Study|Other|0|||
129946510|NCT02691702|467768548|FG000|Overall Study|Protocol Violation|0|||
129946511|NCT02691702|467768549|FG001|Overall Study|Protocol Violation|0|||
129946512|NCT02691702|467768550|FG002|Overall Study|Protocol Violation|0|||
129946513|NCT02691702|467768551|FG003|Overall Study|Protocol Violation|0|||
129946514|NCT02691702|467768552|FG004|Overall Study|Protocol Violation|0|||
129946515|NCT02691702|467768553|FG005|Overall Study|Protocol Violation|0|||
129946516|NCT02691702|467768554|FG006|Overall Study|Protocol Violation|0|||
129946517|NCT02691702|467768555|FG007|Overall Study|Protocol Violation|0|||
129946518|NCT02691702|467768556|FG008|Overall Study|Protocol Violation|0|||
129946519|NCT02691702|467768557|FG009|Overall Study|Protocol Violation|2|||
129946520|NCT02691702|467768558|FG010|Overall Study|Protocol Violation|0|||
129946521|NCT05169684|467768559|FG000|Overall Study|Adverse Event|1|||
129946522|NCT05169684|467768560|FG001|Overall Study|Adverse Event|3|||
129946523|NCT05169684|467768559|FG000|Overall Study|Physician Decision|0|||
129946524|NCT05169684|467768560|FG001|Overall Study|Physician Decision|1|||
129946525|NCT05169684|467768559|FG000|Overall Study|Progressive Disease|1|||
129946526|NCT05169684|467768560|FG001|Overall Study|Progressive Disease|1|||
129946527|NCT05169684|467768559|FG000|Overall Study|Participant request to discontinue treatment|0|||
129946528|NCT05169684|467768560|FG001|Overall Study|Participant request to discontinue treatment|1|||
129946529|NCT05169684|467768559|FG000|Overall Study|Other Reason|0|||
129946530|NCT05169684|467768560|FG001|Overall Study|Other Reason|1|||
129946531|NCT05484661|467768561|FG000|Overall Study|Withdrawal by Subject|1|||
129946532|NCT05484661|467768562|FG001|Overall Study|Withdrawal by Subject|0|||
129946533|NCT03205488|467768568|FG000|Overall Study|Adverse Event|1|||
129946534|NCT03205488|467768569|FG001|Overall Study|Adverse Event|2|||
129946535|NCT03205488|467768570|FG002|Overall Study|Adverse Event|4|||
129946536|NCT03205488|467768568|FG000|Overall Study|Protocol Violation|0|||
129946537|NCT03205488|467768569|FG001|Overall Study|Protocol Violation|0|||
129946538|NCT03205488|467768570|FG002|Overall Study|Protocol Violation|1|||
129946539|NCT01856569|467768571|FG000|Overall Study|Other|1|||
129946540|NCT01856569|467768571|FG000|Overall Study|Changed Site/Structure|1|||
129946541|NCT01856569|467768571|FG000|Overall Study|Lost to Follow-up|3|||
129946542|NCT01856569|467768571|FG000|Overall Study|Did not met inclusion criteria|8|||
129946543|NCT03652610|467768572|FG000|Overall Study|Lost to Follow-up|1|||
129946544|NCT03652610|467768573|FG001|Overall Study|Lost to Follow-up|0|||
129946545|NCT03652610|467768572|FG000|Overall Study|Withdrawal by Subject|3|||
129946546|NCT03652610|467768573|FG001|Overall Study|Withdrawal by Subject|5|||
129946547|NCT00326183|467768574|FG000|Overall Study|Lost to Follow-up|104|||
129946548|NCT00326183|467768575|FG001|Overall Study|Lost to Follow-up|56|||
129946549|NCT00326183|467768574|FG000|Overall Study|Protocol Violation|6|||
129946550|NCT00326183|467768575|FG001|Overall Study|Protocol Violation|3|||
129946551|NCT00326183|467768574|FG000|Overall Study|Withdrawal by Subject|35|||
129946552|NCT00326183|467768575|FG001|Overall Study|Withdrawal by Subject|7|||
129946553|NCT00326183|467768574|FG000|Overall Study|Subject Moved|7|||
129946554|NCT00326183|467768575|FG001|Overall Study|Subject Moved|4|||
129946555|NCT00326183|467768574|FG000|Overall Study|Other|47|||
129946556|NCT00326183|467768575|FG001|Overall Study|Other|13|||
129946557|NCT00326183|467768574|FG000|Overall Study|Adverse Event|1|||
129946558|NCT00326183|467768575|FG001|Overall Study|Adverse Event|0|||
129946559|NCT02279732|467768577|FG000|Overall Study|Death|23|||
129946560|NCT02279732|467768578|FG001|Overall Study|Death|20|||
129946561|NCT02279732|467768577|FG000|Overall Study|Disease Progression|13|||
129946562|NCT02279732|467768578|FG001|Overall Study|Disease Progression|3|||
129946563|NCT02279732|467768577|FG000|Overall Study|Withdrawal by Subject|2|||
129946564|NCT02279732|467768578|FG001|Overall Study|Withdrawal by Subject|7|||
129946565|NCT02279732|467768577|FG000|Overall Study|Adverse Event|1|||
129946566|NCT02279732|467768578|FG001|Overall Study|Adverse Event|2|||
129946567|NCT02279732|467768577|FG000|Overall Study|Administrative Reason By Sponsor|0|||
129946568|NCT02279732|467768578|FG001|Overall Study|Administrative Reason By Sponsor|2|||
129946569|NCT02279732|467768577|FG000|Overall Study|Study Drug Toxicity|2|||
129946570|NCT02279732|467768578|FG001|Overall Study|Study Drug Toxicity|0|||
129946571|NCT02279732|467768577|FG000|Overall Study|Lost to Follow-up|0|||
129946572|NCT02279732|467768578|FG001|Overall Study|Lost to Follow-up|1|||
129946573|NCT02279732|467768577|FG000|Overall Study|Maximum Clinical Benefit|1|||
129946574|NCT02279732|467768578|FG001|Overall Study|Maximum Clinical Benefit|0|||
129946575|NCT02279732|467768577|FG000|Overall Study|Subject Requested to Discontinue|0|||
129946576|NCT02279732|467768578|FG001|Overall Study|Subject Requested to Discontinue|1|||
129946577|NCT02279732|467768577|FG000|Overall Study|Other|53|||
129946578|NCT02279732|467768578|FG001|Overall Study|Other|67|||
129946579|NCT02279732|467768577|FG000|Overall Study|Other|3|||
129946580|NCT02279732|467768578|FG001|Overall Study|Other|3|||
129946581|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
129946582|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
129946583|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
129946584|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
129946585|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
129946586|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
129946587|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
129946588|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
129946589|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Death|41|||
130154862|NCT00958126|468526625|FG004|Overall Study|Lost to Follow-up|0|||
129946590|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Death|33|||
129946591|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Death|0|||
129946592|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Death|0|||
129946593|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
129946594|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
129946595|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
129946596|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
129946597|NCT02970318|467768579|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
129946598|NCT02970318|467768580|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
129946599|NCT02970318|467768581|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
129946600|NCT02970318|467768582|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
129946601|NCT02970318|467768579|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
129946602|NCT02970318|467768580|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
129946603|NCT02970318|467768581|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
129946604|NCT02970318|467768582|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
129946605|NCT02970318|467768579|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
129946606|NCT02970318|467768580|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
129946607|NCT02970318|467768581|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
129946608|NCT02970318|467768582|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
129946609|NCT00824408|467768583|FG000|Run-in Phase|Progressive disease|4|||
129946610|NCT00824408|467768584|FG001|Run-in Phase|Progressive disease|4|||
129946611|NCT00824408|467768585|FG002|Run-in Phase|Progressive disease|0|||
129946612|NCT00824408|467768586|FG003|Run-in Phase|Progressive disease|0|||
129946613|NCT00824408|467768587|FG004|Run-in Phase|Progressive disease|0|||
129946614|NCT00824408|467768583|FG000|Run-in Phase|Adverse Event|1|||
129946615|NCT00824408|467768584|FG001|Run-in Phase|Adverse Event|1|||
129946616|NCT00824408|467768585|FG002|Run-in Phase|Adverse Event|0|||
129946617|NCT00824408|467768586|FG003|Run-in Phase|Adverse Event|0|||
129946618|NCT00824408|467768587|FG004|Run-in Phase|Adverse Event|0|||
129946619|NCT00824408|467768583|FG000|Run-in Phase|Refused to continue medication|1|||
129946620|NCT00824408|467768584|FG001|Run-in Phase|Refused to continue medication|0|||
129946621|NCT00824408|467768585|FG002|Run-in Phase|Refused to continue medication|0|||
129946622|NCT00824408|467768586|FG003|Run-in Phase|Refused to continue medication|0|||
129946623|NCT00824408|467768587|FG004|Run-in Phase|Refused to continue medication|0|||
129946624|NCT00824408|467768583|FG000|Run-in Phase|Other reason not defined above|0|||
129946625|NCT00824408|467768584|FG001|Run-in Phase|Other reason not defined above|1|||
129946626|NCT00824408|467768585|FG002|Run-in Phase|Other reason not defined above|0|||
129946627|NCT00824408|467768586|FG003|Run-in Phase|Other reason not defined above|0|||
129946628|NCT00824408|467768587|FG004|Run-in Phase|Other reason not defined above|0|||
129946629|NCT00824408|467768583|FG000|Randomized Phase|Not treated|0|||
129946630|NCT00824408|467768584|FG001|Randomized Phase|Not treated|0|||
129946631|NCT00824408|467768585|FG002|Randomized Phase|Not treated|1|||
129946632|NCT00824408|467768586|FG003|Randomized Phase|Not treated|1|||
129946633|NCT00824408|467768587|FG004|Randomized Phase|Not treated|1|||
129946634|NCT00824408|467768583|FG000|Randomized Phase|Progressive disease|0|||
129946635|NCT00824408|467768584|FG001|Randomized Phase|Progressive disease|0|||
129946636|NCT00824408|467768585|FG002|Randomized Phase|Progressive disease|25|||
129946637|NCT00824408|467768586|FG003|Randomized Phase|Progressive disease|36|||
129946638|NCT00824408|467768587|FG004|Randomized Phase|Progressive disease|34|||
129946639|NCT00824408|467768583|FG000|Randomized Phase|Adverse Event|0|||
129946640|NCT00824408|467768584|FG001|Randomized Phase|Adverse Event|0|||
129946641|NCT00824408|467768585|FG002|Randomized Phase|Adverse Event|4|||
129946642|NCT00824408|467768586|FG003|Randomized Phase|Adverse Event|5|||
129946643|NCT00824408|467768587|FG004|Randomized Phase|Adverse Event|5|||
129946644|NCT00824408|467768583|FG000|Randomized Phase|Refused to continue medication|0|||
129946645|NCT00824408|467768584|FG001|Randomized Phase|Refused to continue medication|0|||
129946646|NCT00824408|467768585|FG002|Randomized Phase|Refused to continue medication|2|||
129946647|NCT00824408|467768586|FG003|Randomized Phase|Refused to continue medication|2|||
129946648|NCT00824408|467768587|FG004|Randomized Phase|Refused to continue medication|2|||
129946649|NCT00824408|467768583|FG000|Randomized Phase|Other reason not defined above|0|||
129946650|NCT00824408|467768584|FG001|Randomized Phase|Other reason not defined above|0|||
129946651|NCT00824408|467768585|FG002|Randomized Phase|Other reason not defined above|4|||
129946652|NCT00824408|467768586|FG003|Randomized Phase|Other reason not defined above|2|||
129946653|NCT00824408|467768587|FG004|Randomized Phase|Other reason not defined above|4|||
129946654|NCT01263496|467768596|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
129946655|NCT01263496|467768597|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946656|NCT01263496|467768598|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946657|NCT01263496|467768599|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946658|NCT01263496|467768600|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946659|NCT01263496|467768601|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946660|NCT01263496|467768602|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946661|NCT01263496|467768603|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946662|NCT01263496|467768604|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946663|NCT01263496|467768596|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946664|NCT01263496|467768597|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946665|NCT01263496|467768598|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946666|NCT01263496|467768599|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
129946667|NCT01263496|467768600|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
129946668|NCT01263496|467768601|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946669|NCT01263496|467768602|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946670|NCT01263496|467768603|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946671|NCT01263496|467768604|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946672|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
129946673|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
129946674|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
129946675|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
129946676|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
129946677|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
129946678|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
129946679|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
129946680|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
129946681|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946682|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
129946683|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946684|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946685|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946686|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946687|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946688|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946689|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946690|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946691|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129946692|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129946693|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129946694|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
129946695|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946696|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946697|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129946698|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946699|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
129946700|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
129946701|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
129946702|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129946703|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
129946704|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129946705|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129946706|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129946707|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129946708|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946709|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946710|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946711|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946712|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946713|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946714|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946715|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
129946716|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946717|NCT02915783|467768605|FG000|Overall Study|Death|21|||
129946718|NCT02915783|467768605|FG000|Overall Study|Lost to Follow-up|1|||
129946719|NCT02915783|467768605|FG000|Overall Study|Withdrawal by Subject|2|||
129946720|NCT01528605|467768606|FG000|Overall Study|Lost to Follow-up|1|||
129946721|NCT01528605|467768607|FG001|Overall Study|Lost to Follow-up|0|||
129946722|NCT01528605|467768608|FG002|Overall Study|Lost to Follow-up|1|||
129946723|NCT01528605|467768609|FG003|Overall Study|Lost to Follow-up|1|||
130071873|NCT01998958|468218074|FG000|Open Label Phase (Optional)|Adverse Event|0|||
130071874|NCT01998958|468218075|FG001|Open Label Phase (Optional)|Adverse Event|0|||
130071875|NCT01998958|468218076|FG002|Open Label Phase (Optional)|Adverse Event|0|||
130071876|NCT01998958|468218077|FG003|Open Label Phase (Optional)|Adverse Event|0|||
129946724|NCT01528605|467768610|FG004|Overall Study|Lost to Follow-up|0|||
129946725|NCT01528605|467768611|FG005|Overall Study|Lost to Follow-up|0|||
129946726|NCT01528605|467768606|FG000|Overall Study|Death|1|||
129946727|NCT01528605|467768607|FG001|Overall Study|Death|0|||
129946728|NCT01528605|467768608|FG002|Overall Study|Death|0|||
129946729|NCT01528605|467768609|FG003|Overall Study|Death|0|||
129946730|NCT01528605|467768610|FG004|Overall Study|Death|0|||
129946731|NCT01528605|467768611|FG005|Overall Study|Death|0|||
129946732|NCT01075152|467768617|FG000|Overall Study|Withdrawal by Subject|1|||
129946733|NCT01075152|467768618|FG001|Overall Study|Withdrawal by Subject|0|||
129946734|NCT01668355|467770049|FG000|Overall Study|Death|3|||
129946735|NCT01668355|467770050|FG001|Overall Study|Death|1|||
129946736|NCT01668355|467770049|FG000|Overall Study|Withdrawal by Subject|6|||
129946737|NCT01668355|467770050|FG001|Overall Study|Withdrawal by Subject|1|||
129946738|NCT00535626|467770051|FG000|Overall Study|Death|15|||
129946739|NCT00535626|467770051|FG000|Overall Study|Lost to Follow-up|29|||
129946740|NCT00535626|467770051|FG000|Overall Study|Withdrawal by Subject|20|||
129946741|NCT00535626|467770051|FG000|Overall Study|Removal/revision of study component|8|||
129946742|NCT00535626|467770051|FG000|Overall Study|Subject terminated|31|||
129946743|NCT00535626|467770051|FG000|Overall Study|Unable to return|2|||
129946744|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
129946745|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
129946746|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
129946747|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
129946748|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
129946749|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
129946750|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
129946751|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
129946752|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
129946753|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
129946754|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
129946755|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
129946756|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
129946757|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
129946758|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
129946759|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
129946760|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
129946761|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
129946762|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
129946763|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
129946764|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
129946765|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
129946766|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
129946767|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
129946768|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
129946769|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
129946770|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
129946771|NCT02710669|467770055|FG000|Overall Study|Physician Decision|2|||
129946772|NCT02710669|467770056|FG001|Overall Study|Physician Decision|1|||
129946773|NCT02710669|467770057|FG002|Overall Study|Physician Decision|0|||
129946774|NCT02710669|467770055|FG000|Overall Study|Institutional delays (including COVID)|2|||
129946775|NCT02710669|467770056|FG001|Overall Study|Institutional delays (including COVID)|2|||
129946776|NCT02710669|467770057|FG002|Overall Study|Institutional delays (including COVID)|0|||
129946777|NCT02710669|467770055|FG000|Overall Study|arrived in afib/aflutter|10|||
129946778|NCT02710669|467770056|FG001|Overall Study|arrived in afib/aflutter|8|||
129946779|NCT02710669|467770057|FG002|Overall Study|arrived in afib/aflutter|2|||
129946780|NCT00731692|467770060|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
130120353|NCT04799158|468402343|FG000|On-Demand Treatment Period|Adverse Event|0|||
129946781|NCT00731692|467770061|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
129946782|NCT00731692|467770062|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
129946783|NCT00731692|467770060|FG000|Core Study (36 Months)|Physician Decision|1|||
129946784|NCT00731692|467770061|FG001|Core Study (36 Months)|Physician Decision|0|||
129946785|NCT00731692|467770062|FG002|Core Study (36 Months)|Physician Decision|2|||
129946786|NCT00731692|467770060|FG000|Core Study (36 Months)|Death|2|||
130120354|NCT04799158|468402344|FG001|On-Demand Treatment Period|Adverse Event|1|||
130120355|NCT04799158|468402345|FG002|On-Demand Treatment Period|Adverse Event|0|||
129946787|NCT00731692|467770061|FG001|Core Study (36 Months)|Death|1|||
129946788|NCT00731692|467770062|FG002|Core Study (36 Months)|Death|2|||
129946789|NCT00731692|467770060|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
129946790|NCT00731692|467770061|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
129946791|NCT00731692|467770062|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
129946792|NCT00731692|467770060|FG000|Core Study (36 Months)|Administrative|2|||
129946793|NCT00731692|467770061|FG001|Core Study (36 Months)|Administrative|2|||
129946794|NCT00731692|467770062|FG002|Core Study (36 Months)|Administrative|6|||
129946795|NCT00731692|467770060|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
129946796|NCT00731692|467770061|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
129946797|NCT00731692|467770062|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
129946798|NCT00731692|467770060|FG000|Core Study (36 Months)|Protocol Violation|4|||
129946799|NCT00731692|467770061|FG001|Core Study (36 Months)|Protocol Violation|5|||
129946800|NCT00731692|467770062|FG002|Core Study (36 Months)|Protocol Violation|8|||
130120356|NCT04799158|468402346|FG003|On-Demand Treatment Period|Adverse Event|0|||
130120357|NCT04799158|468402347|FG004|On-Demand Treatment Period|Adverse Event|1|||
130120358|NCT04799158|468402343|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
130120359|NCT04799158|468402344|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
130120360|NCT04799158|468402345|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
130120361|NCT04799158|468402346|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
130120362|NCT04799158|468402347|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
130120363|NCT04799158|468402343|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130120364|NCT04799158|468402344|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130120365|NCT04799158|468402345|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130120366|NCT04799158|468402346|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
130120367|NCT04799158|468402347|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
130120368|NCT04799158|468402343|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
130120369|NCT04799158|468402344|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
130120370|NCT04799158|468402345|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
130120371|NCT04799158|468402346|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
130120372|NCT04799158|468402347|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
130120373|NCT04799158|468402343|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
129946801|NCT00731692|467770060|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
129946802|NCT00731692|467770061|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
129946803|NCT00731692|467770062|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
129946804|NCT00731692|467770060|FG000|Core Study (36 Months)|Adverse Event|25|||
129946805|NCT00731692|467770061|FG001|Core Study (36 Months)|Adverse Event|28|||
129946806|NCT00731692|467770062|FG002|Core Study (36 Months)|Adverse Event|29|||
130120374|NCT04799158|468402344|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
130120375|NCT04799158|468402345|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
130120376|NCT04799158|468402346|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
130120377|NCT04799158|468402347|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
130120378|NCT04799158|468402343|FG000|On-Demand Treatment Period|Miscellaneous|0|||
129946807|NCT00731692|467770060|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
129946808|NCT00731692|467770061|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
130071877|NCT01998958|468218078|FG004|Open Label Phase (Optional)|Adverse Event|0|||
130071878|NCT01998958|468218079|FG005|Open Label Phase (Optional)|Adverse Event|0|||
130071879|NCT01998958|468218080|FG006|Open Label Phase (Optional)|Adverse Event|0|||
129946809|NCT00731692|467770062|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
129946810|NCT00731692|467770060|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
129946811|NCT00731692|467770061|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
129946812|NCT00731692|467770062|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
129946813|NCT00731692|467770060|FG000|Extension Phase|Abnormal test procedure|0|||
129946814|NCT00731692|467770061|FG001|Extension Phase|Abnormal test procedure|0|||
129946815|NCT00731692|467770062|FG002|Extension Phase|Abnormal test procedure|1|||
129946816|NCT00731692|467770060|FG000|Extension Phase|Abnormal lab values|0|||
129946817|NCT00731692|467770061|FG001|Extension Phase|Abnormal lab values|0|||
130071880|NCT01998958|468218081|FG007|Open Label Phase (Optional)|Adverse Event|0|||
130071881|NCT01998958|468218082|FG008|Open Label Phase (Optional)|Adverse Event|0|||
130071882|NCT01998958|468218083|FG009|Open Label Phase (Optional)|Adverse Event|0|||
130071883|NCT01998958|468218084|FG010|Open Label Phase (Optional)|Adverse Event|0|||
129946818|NCT00731692|467770062|FG002|Extension Phase|Abnormal lab values|1|||
129946819|NCT00731692|467770060|FG000|Extension Phase|Lost to Follow-up|0|||
129946820|NCT00731692|467770061|FG001|Extension Phase|Lost to Follow-up|1|||
129946821|NCT00731692|467770062|FG002|Extension Phase|Lost to Follow-up|4|||
130071884|NCT01998958|468218085|FG011|Open Label Phase (Optional)|Adverse Event|0|||
130120379|NCT04799158|468402344|FG001|On-Demand Treatment Period|Miscellaneous|0|||
129946822|NCT00731692|467770060|FG000|Extension Phase|Withdrawal by Subject|4|||
129946823|NCT00731692|467770061|FG001|Extension Phase|Withdrawal by Subject|5|||
129946824|NCT00731692|467770062|FG002|Extension Phase|Withdrawal by Subject|3|||
130071885|NCT01998958|468218086|FG012|Open Label Phase (Optional)|Adverse Event|0|||
130071886|NCT01998958|468218087|FG013|Open Label Phase (Optional)|Adverse Event|0|||
129946825|NCT00731692|467770060|FG000|Extension Phase|Adverse Event|1|||
129946826|NCT00731692|467770061|FG001|Extension Phase|Adverse Event|1|||
129946827|NCT00731692|467770062|FG002|Extension Phase|Adverse Event|15|||
130071887|NCT01998958|468218088|FG014|Open Label Phase (Optional)|Adverse Event|0|||
130120380|NCT04799158|468402345|FG002|On-Demand Treatment Period|Miscellaneous|0|||
130120381|NCT04799158|468402346|FG003|On-Demand Treatment Period|Miscellaneous|0|||
129946828|NCT03332589|467770063|FG000|Overall Study|Lack of Efficacy|2|||
129946829|NCT03332589|467770064|FG001|Overall Study|Lack of Efficacy|0|||
129946830|NCT03332589|467770065|FG002|Overall Study|Lack of Efficacy|0|||
129946831|NCT03332589|467770063|FG000|Overall Study|Adverse Event|1|||
129946832|NCT03332589|467770064|FG001|Overall Study|Adverse Event|0|||
129946833|NCT03332589|467770065|FG002|Overall Study|Adverse Event|0|||
129946834|NCT03332589|467770063|FG000|Overall Study|Death|1|||
129946835|NCT03332589|467770064|FG001|Overall Study|Death|0|||
129946836|NCT03332589|467770065|FG002|Overall Study|Death|0|||
129946837|NCT00108355|467770070|FG000|Overall Study|Peritonitis at index paracentesis|1|||
129946838|NCT00108355|467770071|FG001|Overall Study|Peritonitis at index paracentesis|1|||
129946839|NCT00108355|467770070|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
129946840|NCT00108355|467770071|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
129946841|NCT02002689|467770076|FG000|Overall Study|Disease Progression|7|||
129946842|NCT02002689|467770076|FG000|Overall Study|Adverse Event|3|||
129946843|NCT00087516|467770077|FG000|Overall Study|Adverse Event|10|||
129946844|NCT00087516|467770078|FG001|Overall Study|Adverse Event|10|||
129946845|NCT00087516|467770079|FG002|Overall Study|Adverse Event|3|||
129946846|NCT00087516|467770080|FG003|Overall Study|Adverse Event|6|||
129946847|NCT00087516|467770077|FG000|Overall Study|Lack of Efficacy|82|||
129946848|NCT00087516|467770078|FG001|Overall Study|Lack of Efficacy|80|||
129946849|NCT00087516|467770079|FG002|Overall Study|Lack of Efficacy|39|||
129946850|NCT00087516|467770080|FG003|Overall Study|Lack of Efficacy|29|||
129946851|NCT00087516|467770077|FG000|Overall Study|Lost to Follow-up|8|||
129946852|NCT00087516|467770078|FG001|Overall Study|Lost to Follow-up|6|||
129946853|NCT00087516|467770079|FG002|Overall Study|Lost to Follow-up|5|||
129946854|NCT00087516|467770080|FG003|Overall Study|Lost to Follow-up|5|||
129946855|NCT00087516|467770077|FG000|Overall Study|Protocol Violation|4|||
129946856|NCT00087516|467770078|FG001|Overall Study|Protocol Violation|8|||
129946857|NCT00087516|467770079|FG002|Overall Study|Protocol Violation|3|||
129946858|NCT00087516|467770080|FG003|Overall Study|Protocol Violation|6|||
129946859|NCT00087516|467770077|FG000|Overall Study|Withdrawal by Subject|16|||
129946860|NCT00087516|467770078|FG001|Overall Study|Withdrawal by Subject|27|||
129946861|NCT00087516|467770079|FG002|Overall Study|Withdrawal by Subject|11|||
129946862|NCT00087516|467770080|FG003|Overall Study|Withdrawal by Subject|12|||
129946863|NCT00087516|467770077|FG000|Overall Study|Site terminated|0|||
129946864|NCT00087516|467770078|FG001|Overall Study|Site terminated|2|||
129946865|NCT00087516|467770079|FG002|Overall Study|Site terminated|1|||
129946866|NCT00087516|467770080|FG003|Overall Study|Site terminated|0|||
129946867|NCT00087516|467770077|FG000|Overall Study|Protocol specified discontinuation|35|||
129946868|NCT00087516|467770078|FG001|Overall Study|Protocol specified discontinuation|33|||
129946869|NCT00087516|467770079|FG002|Overall Study|Protocol specified discontinuation|33|||
129946870|NCT00087516|467770080|FG003|Overall Study|Protocol specified discontinuation|26|||
129946871|NCT00087516|467770077|FG000|Overall Study|Patient moved|3|||
129946872|NCT00087516|467770078|FG001|Overall Study|Patient moved|2|||
129946873|NCT00087516|467770079|FG002|Overall Study|Patient moved|1|||
129946874|NCT00087516|467770080|FG003|Overall Study|Patient moved|0|||
129946875|NCT00087516|467770077|FG000|Overall Study|Patient was non-compliant|3|||
129946876|NCT00087516|467770078|FG001|Overall Study|Patient was non-compliant|1|||
129946877|NCT00087516|467770079|FG002|Overall Study|Patient was non-compliant|0|||
129946878|NCT00087516|467770080|FG003|Overall Study|Patient was non-compliant|0|||
129946879|NCT00087516|467770077|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
129946880|NCT00087516|467770078|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
129946881|NCT00087516|467770079|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
129946882|NCT00087516|467770080|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
129946883|NCT00087516|467770077|FG000|Overall Study|Other|0|||
129946884|NCT00087516|467770078|FG001|Overall Study|Other|0|||
129946885|NCT00087516|467770079|FG002|Overall Study|Other|1|||
129946886|NCT00087516|467770080|FG003|Overall Study|Other|0|||
129946887|NCT01128959|467770085|FG000|Lead in Period|Adverse Event|3|||
129946888|NCT01128959|467770085|FG000|Treatment Period|Adverse Event|3|||
129946889|NCT01128959|467770085|FG000|Treatment Period|Withdrawal by Subject|1|||
129946890|NCT02338999|467770086|FG000|First Intervention|Withdrawal by Subject|3|||
129946891|NCT02338999|467770087|FG001|First Intervention|Withdrawal by Subject|1|||
129946892|NCT02338999|467770086|FG000|Washout Period|Withdrawal by Subject|0|||
129946893|NCT02338999|467770087|FG001|Washout Period|Withdrawal by Subject|2|||
129946894|NCT02338999|467770086|FG000|Second Intervention|Withdrawal by Subject|0|||
129946895|NCT02338999|467770087|FG001|Second Intervention|Withdrawal by Subject|2|||
129946896|NCT02701296|467770088|FG000|Overall Study|Incomplete Data|0|||
129946897|NCT02701296|467770089|FG001|Overall Study|Incomplete Data|2|||
129946898|NCT00569166|467770090|FG000|Overall Study|Withdrawal by Subject|7|||
129946899|NCT00569166|467770091|FG001|Overall Study|Withdrawal by Subject|5|||
129946900|NCT00569166|467770092|FG002|Overall Study|Withdrawal by Subject|3|||
129946901|NCT00569166|467770090|FG000|Overall Study|Lost to Follow-up|2|||
129946902|NCT00569166|467770091|FG001|Overall Study|Lost to Follow-up|1|||
129946903|NCT00569166|467770092|FG002|Overall Study|Lost to Follow-up|1|||
129946904|NCT05005247|467770093|FG000|Overall Study|Withdrawal by Subject|0|||
129946905|NCT05005247|467770094|FG001|Overall Study|Withdrawal by Subject|1|||
129946906|NCT05005247|467770095|FG002|Overall Study|Withdrawal by Subject|0|||
129946907|NCT00308308|467770096|FG000|Overall Study|Adverse Event|17|||
129946908|NCT00308308|467770097|FG001|Overall Study|Adverse Event|2|||
129946909|NCT00308308|467770096|FG000|Overall Study|Lost to Follow-up|5|||
129946910|NCT00308308|467770097|FG001|Overall Study|Lost to Follow-up|5|||
129946911|NCT00308308|467770096|FG000|Overall Study|Physician Decision|15|||
129946912|NCT00308308|467770097|FG001|Overall Study|Physician Decision|7|||
129946913|NCT00308308|467770096|FG000|Overall Study|Protocol Violation|3|||
129946914|NCT00308308|467770097|FG001|Overall Study|Protocol Violation|14|||
129946915|NCT00308308|467770096|FG000|Overall Study|Withdrawal by Subject|47|||
129946916|NCT00308308|467770097|FG001|Overall Study|Withdrawal by Subject|19|||
129946917|NCT00308308|467770096|FG000|Overall Study|Various|7|||
129946918|NCT00308308|467770097|FG001|Overall Study|Various|5|||
129946919|NCT00308308|467770096|FG000|Overall Study|Randomized but not dosed|8|||
129946920|NCT00308308|467770097|FG001|Overall Study|Randomized but not dosed|16|||
129946921|NCT00308308|467770096|FG000|Overall Study|Other|1|||
129946922|NCT00308308|467770097|FG001|Overall Study|Other|0|||
129946923|NCT01802333|467770098|FG000|Overall Study|Ineligible|2|||
129946924|NCT01802333|467770099|FG001|Overall Study|Ineligible|6|||
129946925|NCT01802333|467770100|FG002|Overall Study|Ineligible|8|||
129946926|NCT01802333|467770098|FG000|Overall Study|Adverse Event|1|||
129946927|NCT01802333|467770099|FG001|Overall Study|Adverse Event|8|||
129946928|NCT01802333|467770100|FG002|Overall Study|Adverse Event|8|||
129946929|NCT01802333|467770098|FG000|Overall Study|Withdrawal by Subject|6|||
129946930|NCT01802333|467770099|FG001|Overall Study|Withdrawal by Subject|6|||
129946931|NCT01802333|467770100|FG002|Overall Study|Withdrawal by Subject|5|||
129946932|NCT01802333|467770098|FG000|Overall Study|Progression/relapse|1|||
129946933|NCT01802333|467770099|FG001|Overall Study|Progression/relapse|3|||
129946934|NCT01802333|467770100|FG002|Overall Study|Progression/relapse|0|||
129946935|NCT01802333|467770098|FG000|Overall Study|Death|7|||
129946936|NCT01802333|467770099|FG001|Overall Study|Death|14|||
129946937|NCT01802333|467770100|FG002|Overall Study|Death|13|||
129946938|NCT01802333|467770098|FG000|Overall Study|Other - not protocol specified|32|||
129946939|NCT01802333|467770099|FG001|Overall Study|Other - not protocol specified|22|||
129946940|NCT01802333|467770100|FG002|Overall Study|Other - not protocol specified|24|||
129946941|NCT01802333|467770098|FG000|Overall Study|Did not start treatment|0|||
130071888|NCT01998958|468218089|FG015|Open Label Phase (Optional)|Adverse Event|0|||
129946942|NCT01802333|467770099|FG001|Overall Study|Did not start treatment|2|||
129946943|NCT01802333|467770100|FG002|Overall Study|Did not start treatment|5|||
129946944|NCT01947491|467770102|FG000|Overall Study|Lost to Follow-up|5|||
129946945|NCT01947491|467770103|FG001|Overall Study|Lost to Follow-up|3|||
129946946|NCT01947491|467770104|FG002|Overall Study|Lost to Follow-up|1|||
130071889|NCT01998958|468218090|FG016|Open Label Phase (Optional)|Adverse Event|0|||
130071890|NCT01998958|468218091|FG017|Open Label Phase (Optional)|Adverse Event|0|||
130071891|NCT01998958|468218092|FG018|Open Label Phase (Optional)|Adverse Event|0|||
130071892|NCT01998958|468218093|FG019|Open Label Phase (Optional)|Adverse Event|0|||
130071893|NCT01998958|468218094|FG020|Open Label Phase (Optional)|Adverse Event|0|||
130071894|NCT01998958|468218095|FG021|Open Label Phase (Optional)|Adverse Event|0|||
130071895|NCT01998958|468218096|FG022|Open Label Phase (Optional)|Adverse Event|0|||
130071896|NCT01998958|468218097|FG023|Open Label Phase (Optional)|Adverse Event|1|||
130071897|NCT01998958|468218098|FG024|Open Label Phase (Optional)|Adverse Event|0|||
130071898|NCT01998958|468218099|FG025|Open Label Phase (Optional)|Adverse Event|0|||
130071899|NCT01998958|468218100|FG026|Open Label Phase (Optional)|Adverse Event|0|||
130071900|NCT01998958|468218101|FG027|Open Label Phase (Optional)|Adverse Event|0|||
130071901|NCT01998958|468218102|FG028|Open Label Phase (Optional)|Adverse Event|0|||
130071902|NCT01998958|468218103|FG029|Open Label Phase (Optional)|Adverse Event|0|||
130071903|NCT01998958|468218104|FG030|Open Label Phase (Optional)|Adverse Event|0|||
130071904|NCT01998958|468218105|FG031|Open Label Phase (Optional)|Adverse Event|0|||
130071905|NCT01998958|468218074|FG000|Open Label Phase (Optional)|Other|0|||
130071906|NCT01998958|468218075|FG001|Open Label Phase (Optional)|Other|0|||
130071907|NCT01998958|468218076|FG002|Open Label Phase (Optional)|Other|0|||
130071908|NCT01998958|468218077|FG003|Open Label Phase (Optional)|Other|0|||
130071909|NCT01998958|468218078|FG004|Open Label Phase (Optional)|Other|0|||
130071910|NCT01998958|468218079|FG005|Open Label Phase (Optional)|Other|0|||
130071911|NCT01998958|468218080|FG006|Open Label Phase (Optional)|Other|0|||
130071912|NCT01998958|468218081|FG007|Open Label Phase (Optional)|Other|0|||
130071913|NCT01998958|468218082|FG008|Open Label Phase (Optional)|Other|0|||
130071914|NCT01998958|468218083|FG009|Open Label Phase (Optional)|Other|0|||
130071915|NCT01998958|468218084|FG010|Open Label Phase (Optional)|Other|0|||
129946947|NCT01947491|467770105|FG003|Overall Study|Lost to Follow-up|2|||
129946948|NCT01947491|467770102|FG000|Overall Study|Lack of Efficacy|1|||
129946949|NCT01947491|467770103|FG001|Overall Study|Lack of Efficacy|0|||
129946950|NCT01947491|467770104|FG002|Overall Study|Lack of Efficacy|0|||
129946951|NCT01947491|467770105|FG003|Overall Study|Lack of Efficacy|1|||
129946952|NCT01947491|467770102|FG000|Overall Study|Protocol Violation|1|||
129946953|NCT01947491|467770103|FG001|Overall Study|Protocol Violation|0|||
129946954|NCT01947491|467770104|FG002|Overall Study|Protocol Violation|0|||
129946955|NCT01947491|467770105|FG003|Overall Study|Protocol Violation|0|||
129946956|NCT01947491|467770102|FG000|Overall Study|Withdrawal by Subject|1|||
129946957|NCT01947491|467770103|FG001|Overall Study|Withdrawal by Subject|1|||
129946958|NCT01947491|467770104|FG002|Overall Study|Withdrawal by Subject|1|||
129946959|NCT01947491|467770105|FG003|Overall Study|Withdrawal by Subject|0|||
129946960|NCT01947491|467770102|FG000|Overall Study|Worsening of condition|0|||
129946961|NCT01947491|467770103|FG001|Overall Study|Worsening of condition|1|||
129946962|NCT01947491|467770104|FG002|Overall Study|Worsening of condition|0|||
129946963|NCT01947491|467770105|FG003|Overall Study|Worsening of condition|0|||
129946964|NCT01947491|467770102|FG000|Overall Study|Adverse Event|0|||
129946965|NCT01947491|467770103|FG001|Overall Study|Adverse Event|1|||
129946966|NCT01947491|467770104|FG002|Overall Study|Adverse Event|0|||
129946967|NCT01947491|467770105|FG003|Overall Study|Adverse Event|2|||
129946968|NCT02067663|467770106|FG000|Overall Study|Lost to Follow-up|13|||
129946969|NCT02067663|467770107|FG001|Overall Study|Lost to Follow-up|14|||
129946970|NCT03137784|467770108|FG000|Overall Study|Adverse Event|1|||
129946971|NCT03137784|467770109|FG001|Overall Study|Adverse Event|1|||
129946972|NCT03137784|467770110|FG002|Overall Study|Adverse Event|0|||
129946973|NCT03137784|467770111|FG003|Overall Study|Adverse Event|0|||
129946974|NCT03137784|467770112|FG004|Overall Study|Adverse Event|0|||
129946975|NCT03137784|467770113|FG005|Overall Study|Adverse Event|0|||
129946976|NCT03137784|467770108|FG000|Overall Study|Subject/guardian decision|1|||
129946977|NCT03137784|467770109|FG001|Overall Study|Subject/guardian decision|0|||
129946978|NCT03137784|467770110|FG002|Overall Study|Subject/guardian decision|0|||
129946979|NCT03137784|467770111|FG003|Overall Study|Subject/guardian decision|0|||
129946980|NCT03137784|467770112|FG004|Overall Study|Subject/guardian decision|0|||
129946981|NCT03137784|467770113|FG005|Overall Study|Subject/guardian decision|0|||
129946982|NCT03137784|467770108|FG000|Overall Study|Non-compliance with study treatment|0|||
129946983|NCT03137784|467770109|FG001|Overall Study|Non-compliance with study treatment|0|||
129946984|NCT03137784|467770110|FG002|Overall Study|Non-compliance with study treatment|0|||
129946985|NCT03137784|467770111|FG003|Overall Study|Non-compliance with study treatment|0|||
129946986|NCT03137784|467770112|FG004|Overall Study|Non-compliance with study treatment|1|||
129946987|NCT03137784|467770113|FG005|Overall Study|Non-compliance with study treatment|0|||
129946988|NCT01437540|467770114|FG000|Overall Study|Not listed below|7|||
129946989|NCT01437540|467770115|FG001|Overall Study|Not listed below|6|||
129946990|NCT01437540|467770114|FG000|Overall Study|COPD exacerbation|13|||
129946991|NCT01437540|467770115|FG001|Overall Study|COPD exacerbation|3|||
129946992|NCT01437540|467770114|FG000|Overall Study|Lost to Follow-up|3|||
129946993|NCT01437540|467770115|FG001|Overall Study|Lost to Follow-up|5|||
129946994|NCT01437540|467770114|FG000|Overall Study|Lack of Efficacy|23|||
129946995|NCT01437540|467770115|FG001|Overall Study|Lack of Efficacy|11|||
129946996|NCT01437540|467770114|FG000|Overall Study|Protocol Violation|24|||
129946997|NCT01437540|467770115|FG001|Overall Study|Protocol Violation|12|||
129946998|NCT01437540|467770114|FG000|Overall Study|Adverse Event|26|||
129946999|NCT01437540|467770115|FG001|Overall Study|Adverse Event|13|||
129947000|NCT01437540|467770114|FG000|Overall Study|Withdrawal by Subject|31|||
129947001|NCT01437540|467770115|FG001|Overall Study|Withdrawal by Subject|15|||
129947002|NCT03142932|467770116|FG000|Overall Study|Lost to Follow-up|2|||
129947003|NCT03142932|467770117|FG001|Overall Study|Lost to Follow-up|11|||
129947004|NCT00929526|467770118|FG000|Overall Study|Withdrawal by Subject|1|||
129947005|NCT00929526|467770119|FG001|Overall Study|Withdrawal by Subject|11|||
129947006|NCT00929526|467770118|FG000|Overall Study|Lost to Follow-up|8|||
129947007|NCT00929526|467770119|FG001|Overall Study|Lost to Follow-up|12|||
129947008|NCT00929526|467770118|FG000|Overall Study|Other|8|||
129947009|NCT00929526|467770119|FG001|Overall Study|Other|6|||
129947010|NCT02547974|467770120|FG000|Overall Study|Withdrawal by Subject|1|||
129947011|NCT02547974|467770121|FG001|Overall Study|Withdrawal by Subject|0|||
129947012|NCT02547974|467770122|FG002|Overall Study|Withdrawal by Subject|0|||
129947013|NCT02547974|467770123|FG003|Overall Study|Withdrawal by Subject|0|||
129947014|NCT01393600|467770124|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
129947015|NCT01393600|467770125|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
129947016|NCT01393600|467770126|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
129947017|NCT01393600|467770127|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
129947018|NCT01393600|467770124|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
129947019|NCT01393600|467770125|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
129947020|NCT01393600|467770126|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
129947021|NCT01393600|467770127|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
129947022|NCT01393600|467770124|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
129947023|NCT01393600|467770125|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
129947024|NCT01393600|467770126|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
129947025|NCT01393600|467770127|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
129947026|NCT01393600|467770124|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
129947027|NCT01393600|467770125|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
129947028|NCT01393600|467770126|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
129947029|NCT01393600|467770127|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
129947030|NCT01393600|467770124|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
129947031|NCT01393600|467770125|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
129947032|NCT01393600|467770126|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
129947033|NCT01393600|467770127|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
129947034|NCT01393600|467770124|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
129947035|NCT01393600|467770125|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
129947036|NCT01393600|467770126|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
129947037|NCT01393600|467770127|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
129947038|NCT01393600|467770124|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
129947039|NCT01393600|467770125|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
129947040|NCT01393600|467770126|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
129947041|NCT01393600|467770127|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
129947042|NCT04766996|467770128|FG000|Overall Study|Withdrawal by Subject|1|||
129947043|NCT04766996|467770129|FG001|Overall Study|Withdrawal by Subject|0|||
129947044|NCT04766996|467770130|FG002|Overall Study|Withdrawal by Subject|13|||
129947045|NCT02988713|467770134|FG000|Overall Study|Withdrawal by Subject|1|||
129947046|NCT02988713|467770134|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
129947047|NCT01918033|467770135|FG000|Overall Study|Adverse Event|1|||
129947048|NCT01918033|467770136|FG001|Overall Study|Adverse Event|0|||
129947049|NCT01918033|467770137|FG002|Overall Study|Adverse Event|2|||
129947050|NCT01918033|467770135|FG000|Overall Study|Lost to Follow-up|0|||
129947051|NCT01918033|467770136|FG001|Overall Study|Lost to Follow-up|1|||
129947052|NCT01918033|467770137|FG002|Overall Study|Lost to Follow-up|0|||
129947053|NCT01918033|467770135|FG000|Overall Study|Protocol Violation|2|||
129947054|NCT01918033|467770136|FG001|Overall Study|Protocol Violation|0|||
129947055|NCT01918033|467770137|FG002|Overall Study|Protocol Violation|1|||
129947056|NCT01918033|467770135|FG000|Overall Study|Withdrawal by Subject|2|||
129947057|NCT01918033|467770136|FG001|Overall Study|Withdrawal by Subject|1|||
129947058|NCT01918033|467770137|FG002|Overall Study|Withdrawal by Subject|0|||
129947059|NCT00761267|467770146|FG000|Overall Study|Death|1|||
129947060|NCT00761267|467770147|FG001|Overall Study|Death|2|||
129947061|NCT00761267|467770148|FG002|Overall Study|Death|5|||
129947062|NCT00761267|467770146|FG000|Overall Study|Lost to Follow-up|0|||
129947063|NCT00761267|467770147|FG001|Overall Study|Lost to Follow-up|0|||
129947064|NCT00761267|467770148|FG002|Overall Study|Lost to Follow-up|1|||
129947065|NCT00761267|467770146|FG000|Overall Study|Randomized but not treated|1|||
129947066|NCT00761267|467770147|FG001|Overall Study|Randomized but not treated|1|||
129947067|NCT00761267|467770148|FG002|Overall Study|Randomized but not treated|0|||
129947068|NCT00761267|467770146|FG000|Overall Study|Withdrawal by Subject|0|||
129947069|NCT00761267|467770147|FG001|Overall Study|Withdrawal by Subject|1|||
129947070|NCT00761267|467770148|FG002|Overall Study|Withdrawal by Subject|0|||
129947071|NCT02538094|467770156|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
129947072|NCT02538094|467770157|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
129947073|NCT02538094|467770156|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
129947074|NCT02538094|467770157|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
129947075|NCT03288506|467770158|FG000|Overall Study|Withdrawal by Subject|52|||
129947076|NCT01323790|467770159|FG000|Overall Study|Other|3|||
129947077|NCT01323790|467770160|FG001|Overall Study|Other|2|||
129947078|NCT01323790|467770161|FG002|Overall Study|Other|1|||
129947079|NCT01323790|467770159|FG000|Overall Study|Lost to Follow-up|11|||
129947080|NCT01323790|467770160|FG001|Overall Study|Lost to Follow-up|9|||
129947081|NCT01323790|467770161|FG002|Overall Study|Lost to Follow-up|9|||
129947082|NCT01323790|467770159|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
129947083|NCT01323790|467770160|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
129947084|NCT01323790|467770161|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
129947085|NCT01323790|467770159|FG000|Overall Study|Lack of Efficacy|3|||
129947086|NCT01323790|467770160|FG001|Overall Study|Lack of Efficacy|0|||
129947087|NCT01323790|467770161|FG002|Overall Study|Lack of Efficacy|3|||
129947088|NCT01323790|467770159|FG000|Overall Study|Adverse Event|11|||
129947089|NCT01323790|467770160|FG001|Overall Study|Adverse Event|24|||
129947090|NCT01323790|467770161|FG002|Overall Study|Adverse Event|12|||
129947091|NCT01323790|467770159|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129947092|NCT01323790|467770160|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129947093|NCT01323790|467770161|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
129947094|NCT01323790|467770159|FG000|Overall Study|Withdrawal by Subject|23|||
129947095|NCT01323790|467770160|FG001|Overall Study|Withdrawal by Subject|20|||
129947096|NCT01323790|467770161|FG002|Overall Study|Withdrawal by Subject|13|||
129947097|NCT01323790|467770159|FG000|Overall Study|Did Not Receive Treatment|2|||
129947098|NCT01323790|467770160|FG001|Overall Study|Did Not Receive Treatment|0|||
129947099|NCT01323790|467770161|FG002|Overall Study|Did Not Receive Treatment|1|||
129947100|NCT01323790|467770159|FG000|Overall Study|Severe non-compliance with protocol|2|||
129947101|NCT01323790|467770160|FG001|Overall Study|Severe non-compliance with protocol|2|||
129947102|NCT01323790|467770161|FG002|Overall Study|Severe non-compliance with protocol|2|||
129947103|NCT01880736|467770162|FG000|Overall Study|Adverse Event|0|||
129947104|NCT01880736|467770163|FG001|Overall Study|Adverse Event|0|||
130071916|NCT01998958|468218085|FG011|Open Label Phase (Optional)|Other|0|||
130071917|NCT01998958|468218086|FG012|Open Label Phase (Optional)|Other|0|||
129947105|NCT01880736|467770164|FG002|Overall Study|Adverse Event|0|||
129947106|NCT01880736|467770165|FG003|Overall Study|Adverse Event|1|||
129947107|NCT01880736|467770162|FG000|Overall Study|Withdrawal Criteria|1|||
129947108|NCT01880736|467770163|FG001|Overall Study|Withdrawal Criteria|2|||
129947109|NCT01880736|467770164|FG002|Overall Study|Withdrawal Criteria|1|||
129947110|NCT01880736|467770165|FG003|Overall Study|Withdrawal Criteria|5|||
129947111|NCT00266656|467770169|FG000|Overall Study|Death|1|||
129947112|NCT00266656|467770170|FG001|Overall Study|Death|0|||
129947113|NCT00266656|467770169|FG000|Overall Study|Lost to Follow-up|4|||
129947114|NCT00266656|467770170|FG001|Overall Study|Lost to Follow-up|1|||
129947115|NCT00266656|467770169|FG000|Overall Study|Withdrawal by Subject|4|||
129947116|NCT00266656|467770170|FG001|Overall Study|Withdrawal by Subject|2|||
129947117|NCT00266656|467770169|FG000|Overall Study|Did Not Reach Final Height|4|||
129947118|NCT00266656|467770170|FG001|Overall Study|Did Not Reach Final Height|8|||
129947119|NCT00266656|467770169|FG000|Overall Study|Parent/Caregiver Decision|1|||
129947120|NCT00266656|467770170|FG001|Overall Study|Parent/Caregiver Decision|2|||
129947121|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
129947122|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
129947123|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
129947124|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
129947125|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
129947126|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
129947127|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
129947128|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
129947129|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
129947130|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
129947131|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
129947132|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
129947133|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
129947134|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
129947135|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
129947136|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
129947137|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
129947138|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
129947139|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
129947140|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
129947141|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
129947142|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
129947143|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
129947144|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
129947145|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
129947146|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
129947147|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
129947148|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
129947149|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
129947150|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
129947151|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
129947152|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
129947153|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
129947154|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
129947155|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
129947156|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
129947157|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
129947158|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
129947159|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
129947160|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
129947161|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
129947162|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
129947163|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
129947164|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
129947165|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
129947166|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
129947167|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
129947168|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
129947169|NCT01915914|467770175|FG000|Acute Phase|Withdrawal by Subject|4|||
129947170|NCT01915914|467770176|FG001|Acute Phase|Withdrawal by Subject|0|||
129947171|NCT01915914|467770177|FG002|Acute Phase|Withdrawal by Subject|0|||
129947172|NCT01915914|467770178|FG003|Acute Phase|Withdrawal by Subject|0|||
129947173|NCT01915914|467770175|FG000|Acute Phase|Lost to Follow-up|4|||
129947174|NCT01915914|467770176|FG001|Acute Phase|Lost to Follow-up|0|||
129947175|NCT01915914|467770177|FG002|Acute Phase|Lost to Follow-up|0|||
129947176|NCT01915914|467770178|FG003|Acute Phase|Lost to Follow-up|0|||
129947177|NCT01915914|467770175|FG000|Acute Phase|Physician Decision|1|||
129947178|NCT01915914|467770176|FG001|Acute Phase|Physician Decision|0|||
129947179|NCT01915914|467770177|FG002|Acute Phase|Physician Decision|0|||
129947180|NCT01915914|467770178|FG003|Acute Phase|Physician Decision|0|||
129947181|NCT01915914|467770175|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
129947182|NCT01915914|467770176|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
129947183|NCT01915914|467770177|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
129947184|NCT01915914|467770178|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
129947185|NCT01915914|467770175|FG000|Acute Phase|"Not Achieved treatment success"|1|||
129947186|NCT01915914|467770176|FG001|Acute Phase|"Not Achieved treatment success"|0|||
129947187|NCT01915914|467770177|FG002|Acute Phase|"Not Achieved treatment success"|0|||
129947188|NCT01915914|467770178|FG003|Acute Phase|"Not Achieved treatment success"|0|||
129947189|NCT01915914|467770175|FG000|Acute Phase|Missing|1|||
129947190|NCT01915914|467770176|FG001|Acute Phase|Missing|0|||
129947191|NCT01915914|467770177|FG002|Acute Phase|Missing|0|||
129947192|NCT01915914|467770178|FG003|Acute Phase|Missing|0|||
129947193|NCT01915914|467770175|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129947194|NCT01915914|467770176|FG001|Maintenance Phase|Withdrawal by Subject|1|||
129947195|NCT01915914|467770177|FG002|Maintenance Phase|Withdrawal by Subject|1|||
129947196|NCT01915914|467770178|FG003|Maintenance Phase|Withdrawal by Subject|0|||
129947197|NCT01915914|467770175|FG000|Maintenance Phase|Lost to Follow-up|0|||
129947198|NCT01915914|467770176|FG001|Maintenance Phase|Lost to Follow-up|4|||
129947199|NCT01915914|467770177|FG002|Maintenance Phase|Lost to Follow-up|1|||
129947200|NCT01915914|467770178|FG003|Maintenance Phase|Lost to Follow-up|0|||
129947201|NCT01915914|467770175|FG000|Maintenance Phase|Missing|0|||
129947202|NCT01915914|467770176|FG001|Maintenance Phase|Missing|1|||
129947203|NCT01915914|467770177|FG002|Maintenance Phase|Missing|0|||
129947204|NCT01915914|467770178|FG003|Maintenance Phase|Missing|0|||
129947205|NCT01915914|467770175|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129947206|NCT01915914|467770176|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129947207|NCT01915914|467770177|FG002|Follow-up Phase|Withdrawal by Subject|0|||
129947208|NCT01915914|467770178|FG003|Follow-up Phase|Withdrawal by Subject|1|||
129947209|NCT01915914|467770175|FG000|Follow-up Phase|Physician Decision|0|||
129947210|NCT01915914|467770176|FG001|Follow-up Phase|Physician Decision|0|||
129947211|NCT01915914|467770177|FG002|Follow-up Phase|Physician Decision|0|||
129947212|NCT01915914|467770178|FG003|Follow-up Phase|Physician Decision|1|||
129947213|NCT02432274|467770179|FG000|Overall Study|Death|2|||
129947214|NCT02432274|467770180|FG001|Overall Study|Death|6|||
129947215|NCT02432274|467770181|FG002|Overall Study|Death|7|||
129947216|NCT02432274|467770182|FG003|Overall Study|Death|0|||
129947217|NCT02432274|467770183|FG004|Overall Study|Death|27|||
129947218|NCT02432274|467770184|FG005|Overall Study|Death|7|||
129947219|NCT02432274|467770185|FG006|Overall Study|Death|9|||
129947220|NCT02432274|467770186|FG007|Overall Study|Death|14|||
129947221|NCT02432274|467770179|FG000|Overall Study|Withdrawal of Consent|0|||
129947222|NCT02432274|467770180|FG001|Overall Study|Withdrawal of Consent|0|||
129947223|NCT02432274|467770181|FG002|Overall Study|Withdrawal of Consent|0|||
129947224|NCT02432274|467770182|FG003|Overall Study|Withdrawal of Consent|0|||
129947225|NCT02432274|467770183|FG004|Overall Study|Withdrawal of Consent|2|||
129947226|NCT02432274|467770184|FG005|Overall Study|Withdrawal of Consent|0|||
129947227|NCT02432274|467770185|FG006|Overall Study|Withdrawal of Consent|1|||
129947228|NCT02432274|467770186|FG007|Overall Study|Withdrawal of Consent|2|||
129947229|NCT00116649|467770187|FG000|Overall Study|Adverse Event|20|||
129947230|NCT00116649|467770187|FG000|Overall Study|Lack of Efficacy|1|||
129947231|NCT00116649|467770187|FG000|Overall Study|Lost to Follow-up|32|||
129947232|NCT00116649|467770187|FG000|Overall Study|Withdrawal by Subject|68|||
129947233|NCT00116649|467770187|FG000|Overall Study|Local Skin Reaction|9|||
129947234|NCT00116649|467770187|FG000|Overall Study|Various Reasons|18|||
129947235|NCT00116649|467770187|FG000|Overall Study|Protocol Specified|7|||
129947236|NCT00513071|467770188|FG000|Overall Study|Adverse Event|1|||
129947237|NCT00513071|467770188|FG000|Overall Study|Withdrawal by Subject|1|||
129947238|NCT00513071|467770188|FG000|Overall Study|Physician Decision|3|||
129947239|NCT00667732|467770189|FG000|Run -In (8 Weeks)|Adverse Event|4|||
129947240|NCT00667732|467770190|FG001|Run -In (8 Weeks)|Adverse Event|0|||
129947241|NCT00667732|467770191|FG002|Run -In (8 Weeks)|Adverse Event|0|||
129947242|NCT00667732|467770189|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
129947243|NCT00667732|467770190|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
129947244|NCT00667732|467770191|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
129947245|NCT00667732|467770189|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
129947246|NCT00667732|467770190|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
129947247|NCT00667732|467770191|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
129947248|NCT01240590|467770192|FG000|Phase I|Refused further treatment|0|||
129947249|NCT01240590|467770193|FG001|Phase I|Refused further treatment|0|||
129947250|NCT01240590|467770194|FG002|Phase I|Refused further treatment|3|||
129947251|NCT01240590|467770195|FG003|Phase I|Refused further treatment|0|||
129947252|NCT01240590|467770196|FG004|Phase I|Refused further treatment|0|||
129947253|NCT01240590|467770192|FG000|Phase II|Refused further treatment|0|||
129947254|NCT01240590|467770193|FG001|Phase II|Refused further treatment|0|||
129947255|NCT01240590|467770194|FG002|Phase II|Refused further treatment|0|||
129947256|NCT01240590|467770195|FG003|Phase II|Refused further treatment|2|||
129947257|NCT01240590|467770196|FG004|Phase II|Refused further treatment|1|||
129947258|NCT02659540|467770199|FG000|Overall Study|Adverse Event|3|||
129947259|NCT02659540|467770200|FG001|Overall Study|Adverse Event|2|||
129947260|NCT02659540|467770199|FG000|Overall Study|Death|1|||
129947261|NCT02659540|467770200|FG001|Overall Study|Death|0|||
129947262|NCT02659540|467770199|FG000|Overall Study|Progressive disease|2|||
129947263|NCT02659540|467770200|FG001|Overall Study|Progressive disease|6|||
129947264|NCT02106325|467770203|FG000|Phase 1|Lost to Follow-up|2|||
129947265|NCT02106325|467770204|FG001|Phase 1|Lost to Follow-up|2|||
129947266|NCT02106325|467770203|FG000|Phase 2|Lost to Follow-up|2|||
129947267|NCT02106325|467770204|FG001|Phase 2|Lost to Follow-up|3|||
129947268|NCT02106325|467770203|FG000|Phase 3|Lost to Follow-up|2|||
129947269|NCT02106325|467770204|FG001|Phase 3|Lost to Follow-up|1|||
129947270|NCT03890484|467770205|FG000|Overall Study|Lost to Follow-up|1|||
129947271|NCT03890484|467770206|FG001|Overall Study|Lost to Follow-up|1|||
129947272|NCT00824850|467770208|FG000|Overall Study|Withdrawal by Subject|0|||
129947273|NCT00824850|467770209|FG001|Overall Study|Withdrawal by Subject|1|||
129947274|NCT04820491|467770210|FG000|Overall Study|Withdrawal by Subject|1|||
129947275|NCT04820491|467770211|FG001|Overall Study|Withdrawal by Subject|0|||
129947276|NCT01377844|467772058|FG000|Overall Study|Withdrawal by Subject|25|||
129947277|NCT01377844|467772059|FG001|Overall Study|Withdrawal by Subject|28|||
129947278|NCT01377844|467772058|FG000|Overall Study|Protocol Violation|2|||
129947279|NCT01377844|467772059|FG001|Overall Study|Protocol Violation|3|||
129947280|NCT01377844|467772058|FG000|Overall Study|Adverse Event|3|||
129947281|NCT01377844|467772059|FG001|Overall Study|Adverse Event|0|||
129947282|NCT01377844|467772058|FG000|Overall Study|Physician Decision|6|||
129947283|NCT01377844|467772059|FG001|Overall Study|Physician Decision|3|||
129947284|NCT01377844|467772058|FG000|Overall Study|Study terminated by Sponsor|0|||
129947285|NCT01377844|467772059|FG001|Overall Study|Study terminated by Sponsor|1|||
129947286|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
129947287|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129947288|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129947289|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129947290|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
129947291|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129947292|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129947293|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129947294|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
129947295|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129947296|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129947297|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129947298|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
129947299|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129947300|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129947301|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129947302|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
129947303|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129947304|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129947305|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129947306|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
129947307|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
130071918|NCT01998958|468218087|FG013|Open Label Phase (Optional)|Other|0|||
130071919|NCT01998958|468218088|FG014|Open Label Phase (Optional)|Other|0|||
130071920|NCT01998958|468218089|FG015|Open Label Phase (Optional)|Other|0|||
130071921|NCT01998958|468218090|FG016|Open Label Phase (Optional)|Other|0|||
130071922|NCT01998958|468218091|FG017|Open Label Phase (Optional)|Other|0|||
130071923|NCT01998958|468218092|FG018|Open Label Phase (Optional)|Other|0|||
129947308|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129947309|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129947310|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
129947311|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129947312|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129947313|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129947314|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
129947315|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
129947316|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
129947317|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
129947318|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
130071924|NCT01998958|468218093|FG019|Open Label Phase (Optional)|Other|0|||
130071925|NCT01998958|468218094|FG020|Open Label Phase (Optional)|Other|0|||
129947319|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
129947320|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
129947321|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
129947322|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129947323|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
129947324|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
129947325|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
129947326|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129947327|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129947328|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129947329|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129947330|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
129947331|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129947332|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
129947333|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129947334|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
129947335|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
129947336|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
129947337|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
129947338|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129947339|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129947340|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
129947341|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
129947342|NCT02065895|467772066|FG000|Overall Study|Protocol Violation|1|||
129947343|NCT02065895|467772067|FG001|Overall Study|Protocol Violation|0|||
129947344|NCT02065895|467772068|FG002|Overall Study|Protocol Violation|0|||
129947345|NCT02065895|467772069|FG003|Overall Study|Protocol Violation|1|||
129947346|NCT02065895|467772070|FG004|Overall Study|Protocol Violation|0|||
129947347|NCT02065895|467772071|FG005|Overall Study|Protocol Violation|0|||
129947348|NCT02065895|467772066|FG000|Overall Study|Scheduling conflicts|0|||
129947349|NCT02065895|467772067|FG001|Overall Study|Scheduling conflicts|1|||
129947350|NCT02065895|467772068|FG002|Overall Study|Scheduling conflicts|0|||
129947351|NCT02065895|467772069|FG003|Overall Study|Scheduling conflicts|0|||
129947352|NCT02065895|467772070|FG004|Overall Study|Scheduling conflicts|0|||
129947353|NCT02065895|467772071|FG005|Overall Study|Scheduling conflicts|0|||
129947354|NCT03469258|467772072|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
129947355|NCT03403036|467772077|FG000|Overall Study|Lack of Efficacy|5|||
129947356|NCT00484198|467772080|FG000|Overall Study|Participant Withdrew Consent|12|||
129947357|NCT00484198|467772081|FG001|Overall Study|Participant Withdrew Consent|21|||
129947358|NCT00484198|467772082|FG002|Overall Study|Participant Withdrew Consent|47|||
129947359|NCT00484198|467772083|FG003|Overall Study|Participant Withdrew Consent|59|||
129947360|NCT00484198|467772080|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
129947361|NCT00484198|467772081|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
129947362|NCT00484198|467772082|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
129947363|NCT00484198|467772083|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
129947364|NCT00484198|467772080|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
129947365|NCT00484198|467772081|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
129947366|NCT00484198|467772082|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
129947367|NCT00484198|467772083|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
129947368|NCT00484198|467772080|FG000|Overall Study|Adverse Event|3|||
129947369|NCT00484198|467772081|FG001|Overall Study|Adverse Event|11|||
129947370|NCT00484198|467772082|FG002|Overall Study|Adverse Event|32|||
129947371|NCT00484198|467772083|FG003|Overall Study|Adverse Event|31|||
129947372|NCT00484198|467772080|FG000|Overall Study|Protocol Violation|0|||
129947373|NCT00484198|467772081|FG001|Overall Study|Protocol Violation|5|||
129947374|NCT00484198|467772082|FG002|Overall Study|Protocol Violation|6|||
129947375|NCT00484198|467772083|FG003|Overall Study|Protocol Violation|8|||
129947376|NCT00484198|467772080|FG000|Overall Study|Other|7|||
129947377|NCT00484198|467772081|FG001|Overall Study|Other|10|||
129947378|NCT00484198|467772082|FG002|Overall Study|Other|31|||
129947379|NCT00484198|467772083|FG003|Overall Study|Other|28|||
129947380|NCT02958553|467772084|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
129947381|NCT02958553|467772084|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
129947382|NCT03340961|467772085|FG000|Overall Study|Adverse Event|1|||
129947383|NCT03340961|467772086|FG001|Overall Study|Adverse Event|3|||
129947384|NCT03340961|467772087|FG002|Overall Study|Adverse Event|2|||
130071926|NCT01998958|468218095|FG021|Open Label Phase (Optional)|Other|0|||
130071927|NCT01998958|468218096|FG022|Open Label Phase (Optional)|Other|5|||
129947385|NCT03340961|467772088|FG003|Overall Study|Adverse Event|4|||
130071928|NCT01998958|468218097|FG023|Open Label Phase (Optional)|Other|1|||
130071929|NCT01998958|468218098|FG024|Open Label Phase (Optional)|Other|0|||
129947386|NCT03340961|467772085|FG000|Overall Study|Lost to Follow-up|0|||
130071930|NCT01998958|468218099|FG025|Open Label Phase (Optional)|Other|0|||
130071931|NCT01998958|468218100|FG026|Open Label Phase (Optional)|Other|0|||
130071932|NCT01998958|468218101|FG027|Open Label Phase (Optional)|Other|0|||
130071933|NCT01998958|468218102|FG028|Open Label Phase (Optional)|Other|0|||
130071934|NCT01998958|468218103|FG029|Open Label Phase (Optional)|Other|0|||
130071935|NCT01998958|468218104|FG030|Open Label Phase (Optional)|Other|0|||
130071936|NCT01998958|468218105|FG031|Open Label Phase (Optional)|Other|0|||
130071937|NCT01998958|468218074|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071938|NCT01998958|468218075|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071939|NCT01998958|468218076|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
129947387|NCT03340961|467772086|FG001|Overall Study|Lost to Follow-up|1|||
129947388|NCT03340961|467772087|FG002|Overall Study|Lost to Follow-up|0|||
129947389|NCT03340961|467772088|FG003|Overall Study|Lost to Follow-up|1|||
129947390|NCT03340961|467772085|FG000|Overall Study|Withdrawal by Subject|3|||
129947391|NCT03340961|467772086|FG001|Overall Study|Withdrawal by Subject|2|||
129947392|NCT03340961|467772087|FG002|Overall Study|Withdrawal by Subject|4|||
129947393|NCT03340961|467772088|FG003|Overall Study|Withdrawal by Subject|7|||
129947394|NCT03340961|467772085|FG000|Overall Study|Use of prohibited treatment|0|||
129947395|NCT03340961|467772086|FG001|Overall Study|Use of prohibited treatment|3|||
129947396|NCT03340961|467772087|FG002|Overall Study|Use of prohibited treatment|2|||
129947397|NCT03340961|467772088|FG003|Overall Study|Use of prohibited treatment|4|||
129947398|NCT03340961|467772085|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
129947399|NCT03340961|467772086|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
129947400|NCT03340961|467772087|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
129947401|NCT03340961|467772088|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
129947402|NCT03340961|467772085|FG000|Overall Study|Subject developed an exclusion criterion|0|||
129947403|NCT03340961|467772086|FG001|Overall Study|Subject developed an exclusion criterion|1|||
129947404|NCT03340961|467772087|FG002|Overall Study|Subject developed an exclusion criterion|0|||
129947405|NCT03340961|467772088|FG003|Overall Study|Subject developed an exclusion criterion|0|||
129947406|NCT03340961|467772085|FG000|Overall Study|Protocol Violation|1|||
129947407|NCT03340961|467772086|FG001|Overall Study|Protocol Violation|0|||
129947408|NCT03340961|467772087|FG002|Overall Study|Protocol Violation|1|||
129947409|NCT03340961|467772088|FG003|Overall Study|Protocol Violation|0|||
129947410|NCT03340961|467772085|FG000|Overall Study|Adverse Event|1|||
129947411|NCT03340961|467772086|FG001|Overall Study|Adverse Event|1|||
129947412|NCT03340961|467772087|FG002|Overall Study|Adverse Event|0|||
129947413|NCT03340961|467772088|FG003|Overall Study|Adverse Event|0|||
129947414|NCT03340961|467772085|FG000|Overall Study|Lack of Efficacy|0|||
129947415|NCT03340961|467772086|FG001|Overall Study|Lack of Efficacy|0|||
129947416|NCT03340961|467772087|FG002|Overall Study|Lack of Efficacy|0|||
129947417|NCT03340961|467772088|FG003|Overall Study|Lack of Efficacy|1|||
129947418|NCT01686152|467772089|FG000|Overall Study|Withdrawal by Subject|11|||
129947419|NCT01686152|467772090|FG001|Overall Study|Withdrawal by Subject|11|||
129947420|NCT01686152|467772091|FG002|Overall Study|Withdrawal by Subject|3|||
129947421|NCT01686152|467772089|FG000|Overall Study|Drug Code Unblinded|0|||
129947422|NCT01686152|467772090|FG001|Overall Study|Drug Code Unblinded|1|||
129947423|NCT01686152|467772091|FG002|Overall Study|Drug Code Unblinded|0|||
129947424|NCT01686152|467772089|FG000|Overall Study|Protocol Violation|6|||
129947425|NCT01686152|467772090|FG001|Overall Study|Protocol Violation|1|||
129947426|NCT01686152|467772091|FG002|Overall Study|Protocol Violation|0|||
129947427|NCT01686152|467772089|FG000|Overall Study|Adverse Event|12|||
129947428|NCT01686152|467772090|FG001|Overall Study|Adverse Event|11|||
129947429|NCT01686152|467772091|FG002|Overall Study|Adverse Event|0|||
129947430|NCT01686152|467772089|FG000|Overall Study|Lack of Efficacy|0|||
129947431|NCT01686152|467772090|FG001|Overall Study|Lack of Efficacy|0|||
129947432|NCT01686152|467772091|FG002|Overall Study|Lack of Efficacy|1|||
129947433|NCT01686152|467772089|FG000|Overall Study|IP Non-compliance|5|||
129947434|NCT01686152|467772090|FG001|Overall Study|IP Non-compliance|5|||
129947435|NCT01686152|467772091|FG002|Overall Study|IP Non-compliance|0|||
129947436|NCT01686152|467772089|FG000|Overall Study|Lost to Follow-up|7|||
129947437|NCT01686152|467772090|FG001|Overall Study|Lost to Follow-up|6|||
129947438|NCT01686152|467772091|FG002|Overall Study|Lost to Follow-up|5|||
129947439|NCT01853384|467772092|FG000|Randomized|Adverse Event|5|||
129947440|NCT01853384|467772093|FG001|Randomized|Adverse Event|3|||
129947441|NCT01853384|467772092|FG000|Randomized|Death|1|||
129947442|NCT01853384|467772093|FG001|Randomized|Death|2|||
129947443|NCT01853384|467772092|FG000|Randomized|Lost to Follow-up|1|||
129947444|NCT01853384|467772093|FG001|Randomized|Lost to Follow-up|1|||
129947445|NCT01853384|467772092|FG000|Randomized|Withdrawal by Subject|5|||
129947446|NCT01853384|467772093|FG001|Randomized|Withdrawal by Subject|3|||
129947447|NCT01853384|467772092|FG000|Randomized|Sponsor Decision|47|||
129947448|NCT01853384|467772093|FG001|Randomized|Sponsor Decision|34|||
129947449|NCT01853384|467772092|FG000|Randomized|Other|3|||
129947450|NCT01853384|467772093|FG001|Randomized|Other|3|||
129947451|NCT01853384|467772092|FG000|Completed Follow up Visit 1|Early Termination|13|||
129947452|NCT01853384|467772093|FG001|Completed Follow up Visit 1|Early Termination|9|||
129947453|NCT01853384|467772092|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
129947454|NCT01853384|467772093|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
129947455|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Adverse Event|1|||
129947456|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Adverse Event|0|||
129947457|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
129947458|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
129947459|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Death|1|||
129947460|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Death|0|||
129947461|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
129947462|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
129947463|NCT00704340|467772094|FG000|Overall Study|Lost to Follow-up|2|||
129947464|NCT00704340|467772095|FG001|Overall Study|Lost to Follow-up|1|||
129947465|NCT00704340|467772094|FG000|Overall Study|Death|0|||
129947466|NCT00704340|467772095|FG001|Overall Study|Death|1|||
129947467|NCT04311983|467772096|FG000|Overall Study|Lost to Follow-up|421|||
129947468|NCT04311983|467772097|FG001|Overall Study|Lost to Follow-up|456|||
129947469|NCT04311983|467772096|FG000|Overall Study|Incomplete survey|7|||
129947470|NCT04311983|467772097|FG001|Overall Study|Incomplete survey|9|||
129947471|NCT04311983|467772096|FG000|Overall Study|Death|1|||
129947472|NCT04311983|467772097|FG001|Overall Study|Death|0|||
129947473|NCT01205126|467772099|FG000|Titration Phase|Adverse Event|5|||
129947474|NCT01205126|467772100|FG001|Titration Phase|Adverse Event|3|||
129947475|NCT01205126|467772099|FG000|Titration Phase|Withdrawal by Subject|5|||
129947476|NCT01205126|467772100|FG001|Titration Phase|Withdrawal by Subject|5|||
129947477|NCT01205126|467772099|FG000|Titration Phase|Lost to Follow-up|2|||
129947478|NCT01205126|467772100|FG001|Titration Phase|Lost to Follow-up|2|||
129947479|NCT01205126|467772099|FG000|Titration Phase|No stable titration dose|1|||
129947480|NCT01205126|467772100|FG001|Titration Phase|No stable titration dose|0|||
129947481|NCT01205126|467772099|FG000|Titration Phase|More than maximum dosage required|2|||
129947482|NCT01205126|467772100|FG001|Titration Phase|More than maximum dosage required|3|||
129947483|NCT01205126|467772099|FG000|Titration Phase|Other|8|||
129947484|NCT01205126|467772100|FG001|Titration Phase|Other|6|||
129947485|NCT01205126|467772099|FG000|Between Titration & Maintenance Phase|Other|0|||
129947486|NCT01205126|467772100|FG001|Between Titration & Maintenance Phase|Other|4|||
129947487|NCT01205126|467772099|FG000|Maintenance Phase|Adverse Event|3|||
129947488|NCT01205126|467772100|FG001|Maintenance Phase|Adverse Event|7|||
129947489|NCT01205126|467772099|FG000|Maintenance Phase|Death|4|||
129947490|NCT01205126|467772100|FG001|Maintenance Phase|Death|4|||
129947491|NCT01205126|467772099|FG000|Maintenance Phase|More than the maximum dosage required|5|||
129947492|NCT01205126|467772100|FG001|Maintenance Phase|More than the maximum dosage required|5|||
129947493|NCT01205126|467772099|FG000|Maintenance Phase|Prohibited drugs used|1|||
129947494|NCT01205126|467772100|FG001|Maintenance Phase|Prohibited drugs used|0|||
129947495|NCT01205126|467772099|FG000|Maintenance Phase|Other|11|||
129947496|NCT01205126|467772100|FG001|Maintenance Phase|Other|8|||
129947497|NCT01205126|467772099|FG000|Maintenance Phase|Lost to Follow-up|5|||
129947498|NCT01205126|467772100|FG001|Maintenance Phase|Lost to Follow-up|5|||
129947499|NCT01205126|467772099|FG000|Maintenance Phase|Withdrawal by Subject|8|||
129947500|NCT01205126|467772100|FG001|Maintenance Phase|Withdrawal by Subject|11|||
129947501|NCT00486954|467772101|FG000|Pilot Part|Adverse Event|4|||
129947502|NCT00486954|467772102|FG001|Pilot Part|Adverse Event|0|||
129947503|NCT00486954|467772103|FG002|Pilot Part|Adverse Event|5|||
129947504|NCT00486954|467772104|FG003|Pilot Part|Adverse Event|0|||
129947505|NCT00486954|467772105|FG004|Pilot Part|Adverse Event|0|||
129947506|NCT00486954|467772101|FG000|Pilot Part|Disease Progression|2|||
129947507|NCT00486954|467772102|FG001|Pilot Part|Disease Progression|0|||
129947508|NCT00486954|467772103|FG002|Pilot Part|Disease Progression|1|||
129947509|NCT00486954|467772104|FG003|Pilot Part|Disease Progression|0|||
129947510|NCT00486954|467772105|FG004|Pilot Part|Disease Progression|0|||
129947511|NCT00486954|467772101|FG000|Randomized Part|Lost to Follow-up|0|||
129947512|NCT00486954|467772102|FG001|Randomized Part|Lost to Follow-up|0|||
129947513|NCT00486954|467772103|FG002|Randomized Part|Lost to Follow-up|0|||
129947514|NCT00486954|467772104|FG003|Randomized Part|Lost to Follow-up|0|||
129947515|NCT00486954|467772105|FG004|Randomized Part|Lost to Follow-up|1|||
129947516|NCT00486954|467772101|FG000|Randomized Part|Withdrawal by Subject|0|||
129947517|NCT00486954|467772102|FG001|Randomized Part|Withdrawal by Subject|0|||
129947518|NCT00486954|467772103|FG002|Randomized Part|Withdrawal by Subject|0|||
129947519|NCT00486954|467772104|FG003|Randomized Part|Withdrawal by Subject|1|||
129947520|NCT00486954|467772105|FG004|Randomized Part|Withdrawal by Subject|0|||
129947521|NCT00486954|467772101|FG000|Randomized Part|Sponsor Terminated Study|0|||
129947522|NCT00486954|467772102|FG001|Randomized Part|Sponsor Terminated Study|0|||
129947523|NCT00486954|467772103|FG002|Randomized Part|Sponsor Terminated Study|0|||
129947524|NCT00486954|467772104|FG003|Randomized Part|Sponsor Terminated Study|19|||
129947525|NCT00486954|467772105|FG004|Randomized Part|Sponsor Terminated Study|13|||
129947526|NCT00638456|467772108|FG000|Overall Study|Withdrawal by Subject|6|||
129947527|NCT00638456|467772109|FG001|Overall Study|Withdrawal by Subject|2|||
129947528|NCT03236779|467772110|FG000|Overall Study|Lost to Follow-up|13|||
129947529|NCT03236779|467772111|FG001|Overall Study|Lost to Follow-up|21|||
129947530|NCT01836523|467772112|FG000|Overall Study|Adverse Event|15|||
129947531|NCT01836523|467772113|FG001|Overall Study|Adverse Event|41|||
129947532|NCT01836523|467772114|FG002|Overall Study|Adverse Event|49|||
129947533|NCT01836523|467772115|FG003|Overall Study|Adverse Event|14|||
129947534|NCT01836523|467772112|FG000|Overall Study|Protocol Violation|6|||
129947535|NCT01836523|467772113|FG001|Overall Study|Protocol Violation|3|||
129947536|NCT01836523|467772114|FG002|Overall Study|Protocol Violation|2|||
129947537|NCT01836523|467772115|FG003|Overall Study|Protocol Violation|4|||
129947538|NCT01836523|467772112|FG000|Overall Study|Met Withdrawal Criteria|13|||
129947539|NCT01836523|467772113|FG001|Overall Study|Met Withdrawal Criteria|13|||
129947540|NCT01836523|467772114|FG002|Overall Study|Met Withdrawal Criteria|21|||
129947541|NCT01836523|467772115|FG003|Overall Study|Met Withdrawal Criteria|27|||
129947542|NCT01836523|467772112|FG000|Overall Study|Unclassified|17|||
129947543|NCT01836523|467772113|FG001|Overall Study|Unclassified|28|||
129947544|NCT01836523|467772114|FG002|Overall Study|Unclassified|19|||
129947545|NCT01836523|467772115|FG003|Overall Study|Unclassified|29|||
129947546|NCT00813709|467772118|FG000|Double Blind Period|Adverse Event|4|||
129947547|NCT00813709|467772119|FG001|Double Blind Period|Adverse Event|1|||
129947548|NCT00813709|467772120|FG002|Double Blind Period|Adverse Event|4|||
129947549|NCT00813709|467772121|FG003|Double Blind Period|Adverse Event|0|||
129947550|NCT00813709|467772122|FG004|Double Blind Period|Adverse Event|0|||
129947551|NCT00813709|467772123|FG005|Double Blind Period|Adverse Event|0|||
129947552|NCT00813709|467772118|FG000|Double Blind Period|Lost to Follow-up|3|||
129947553|NCT00813709|467772119|FG001|Double Blind Period|Lost to Follow-up|2|||
129947554|NCT00813709|467772120|FG002|Double Blind Period|Lost to Follow-up|2|||
129947555|NCT00813709|467772121|FG003|Double Blind Period|Lost to Follow-up|0|||
129947556|NCT00813709|467772122|FG004|Double Blind Period|Lost to Follow-up|0|||
129947557|NCT00813709|467772123|FG005|Double Blind Period|Lost to Follow-up|0|||
129947558|NCT00813709|467772118|FG000|Double Blind Period|Switched to open label phase|9|||
129947559|NCT00813709|467772119|FG001|Double Blind Period|Switched to open label phase|26|||
129947560|NCT00813709|467772120|FG002|Double Blind Period|Switched to open label phase|18|||
129947561|NCT00813709|467772121|FG003|Double Blind Period|Switched to open label phase|0|||
129947562|NCT00813709|467772122|FG004|Double Blind Period|Switched to open label phase|0|||
129947563|NCT00813709|467772123|FG005|Double Blind Period|Switched to open label phase|0|||
129947564|NCT00813709|467772118|FG000|Double Blind Period|Randomized but not treated|1|||
129947565|NCT00813709|467772119|FG001|Double Blind Period|Randomized but not treated|3|||
129947566|NCT00813709|467772120|FG002|Double Blind Period|Randomized but not treated|1|||
129947567|NCT00813709|467772121|FG003|Double Blind Period|Randomized but not treated|0|||
129947568|NCT00813709|467772122|FG004|Double Blind Period|Randomized but not treated|0|||
129947569|NCT00813709|467772123|FG005|Double Blind Period|Randomized but not treated|0|||
129947570|NCT00813709|467772118|FG000|Double Blind Period|Other|14|||
129947571|NCT00813709|467772119|FG001|Double Blind Period|Other|9|||
129947572|NCT00813709|467772120|FG002|Double Blind Period|Other|6|||
129947573|NCT00813709|467772121|FG003|Double Blind Period|Other|0|||
129947574|NCT00813709|467772122|FG004|Double Blind Period|Other|0|||
129947575|NCT00813709|467772123|FG005|Double Blind Period|Other|0|||
129947576|NCT00813709|467772118|FG000|Open Label Period|Adverse Event|0|||
129947577|NCT00813709|467772119|FG001|Open Label Period|Adverse Event|0|||
129947578|NCT00813709|467772120|FG002|Open Label Period|Adverse Event|0|||
129947579|NCT00813709|467772121|FG003|Open Label Period|Adverse Event|5|||
129947580|NCT00813709|467772122|FG004|Open Label Period|Adverse Event|4|||
129947581|NCT00813709|467772123|FG005|Open Label Period|Adverse Event|3|||
129947582|NCT00813709|467772118|FG000|Open Label Period|Lack of Efficacy|0|||
129947583|NCT00813709|467772119|FG001|Open Label Period|Lack of Efficacy|0|||
129947584|NCT00813709|467772120|FG002|Open Label Period|Lack of Efficacy|0|||
129947585|NCT00813709|467772121|FG003|Open Label Period|Lack of Efficacy|3|||
129947586|NCT00813709|467772122|FG004|Open Label Period|Lack of Efficacy|1|||
129947587|NCT00813709|467772123|FG005|Open Label Period|Lack of Efficacy|1|||
129947588|NCT00813709|467772118|FG000|Open Label Period|Randomized but not treated|0|||
129947589|NCT00813709|467772119|FG001|Open Label Period|Randomized but not treated|0|||
129947590|NCT00813709|467772120|FG002|Open Label Period|Randomized but not treated|0|||
129947591|NCT00813709|467772121|FG003|Open Label Period|Randomized but not treated|1|||
129947592|NCT00813709|467772122|FG004|Open Label Period|Randomized but not treated|0|||
129947593|NCT00813709|467772123|FG005|Open Label Period|Randomized but not treated|1|||
129947594|NCT00813709|467772118|FG000|Open Label Period|Other|0|||
129947595|NCT00813709|467772119|FG001|Open Label Period|Other|0|||
129947596|NCT00813709|467772120|FG002|Open Label Period|Other|0|||
129947597|NCT00813709|467772121|FG003|Open Label Period|Other|11|||
129947598|NCT00813709|467772122|FG004|Open Label Period|Other|5|||
129947599|NCT00813709|467772123|FG005|Open Label Period|Other|6|||
129947600|NCT00603798|467772127|FG000|Overall Study|Adverse Event|4|||
129947601|NCT00603798|467772128|FG001|Overall Study|Adverse Event|2|||
129947602|NCT00603798|467772129|FG002|Overall Study|Adverse Event|1|||
129947603|NCT00603798|467772127|FG000|Overall Study|Withdrawal by Subject|4|||
129947604|NCT00603798|467772128|FG001|Overall Study|Withdrawal by Subject|3|||
129947605|NCT00603798|467772129|FG002|Overall Study|Withdrawal by Subject|4|||
129947606|NCT00603798|467772127|FG000|Overall Study|Lost to Follow-up|1|||
129947607|NCT00603798|467772128|FG001|Overall Study|Lost to Follow-up|0|||
129947608|NCT00603798|467772129|FG002|Overall Study|Lost to Follow-up|1|||
129947609|NCT00603798|467772127|FG000|Overall Study|Non-compliance with study procedures|0|||
130154863|NCT00958126|468526626|FG005|Overall Study|Lost to Follow-up|0|||
129947610|NCT00603798|467772128|FG001|Overall Study|Non-compliance with study procedures|1|||
129947611|NCT00603798|467772129|FG002|Overall Study|Non-compliance with study procedures|0|||
129947612|NCT00603798|467772127|FG000|Overall Study|Not due to AE|1|||
129947613|NCT00603798|467772128|FG001|Overall Study|Not due to AE|1|||
129947614|NCT00603798|467772129|FG002|Overall Study|Not due to AE|4|||
129947615|NCT02245620|467772130|FG000|Overall Study|Physician Decision|1|||
129947616|NCT02245620|467772131|FG001|Overall Study|Physician Decision|1|||
129947617|NCT01102426|467772132|FG000|Overall Study|Randomized but not treated|4|||
129947618|NCT01102426|467772133|FG001|Overall Study|Randomized but not treated|1|||
129947619|NCT01102426|467772132|FG000|Overall Study|Adverse Events (treatment-related)|15|||
129947620|NCT01102426|467772133|FG001|Overall Study|Adverse Events (treatment-related)|8|||
129947621|NCT01102426|467772132|FG000|Overall Study|Physician Decision|9|||
129947622|NCT01102426|467772133|FG001|Overall Study|Physician Decision|6|||
129947623|NCT01102426|467772132|FG000|Overall Study|Progressive Disease|85|||
129947624|NCT01102426|467772133|FG001|Overall Study|Progressive Disease|44|||
129947625|NCT01102426|467772132|FG000|Overall Study|Adverse Events (unrelated to|9|||
129947626|NCT01102426|467772133|FG001|Overall Study|Adverse Events (unrelated to|1|||
129947627|NCT01102426|467772132|FG000|Overall Study|Patient Refusal|24|||
129947628|NCT01102426|467772133|FG001|Overall Study|Patient Refusal|12|||
129947629|NCT01102426|467772132|FG000|Overall Study|Death (due to adverse events|0|||
129947630|NCT01102426|467772133|FG001|Overall Study|Death (due to adverse events|1|||
129947631|NCT01102426|467772132|FG000|Overall Study|Death (non-related to the study|19|||
129947632|NCT01102426|467772133|FG001|Overall Study|Death (non-related to the study|8|||
129947633|NCT00889863|467772134|FG000|Part I: Open Label|Death|1|||
129947634|NCT00889863|467772135|FG001|Part I: Open Label|Death|0|||
129947635|NCT00889863|467772134|FG000|Part I: Open Label|Adverse Event|4|||
129947636|NCT00889863|467772135|FG001|Part I: Open Label|Adverse Event|0|||
129947637|NCT00889863|467772134|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
129947638|NCT00889863|467772135|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
129947639|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
129947640|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
129947641|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
129947642|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
129947643|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
129947644|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
129947645|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
129947646|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
129947647|NCT04361617|467772136|FG000|Overall Study|Withdrawal by Subject|0|||
129947648|NCT04361617|467772137|FG001|Overall Study|Withdrawal by Subject|1|||
129947649|NCT01393964|467772138|FG000|Overall Study|Disease Progression|4|||
129947650|NCT01393964|467772139|FG001|Overall Study|Disease Progression|3|||
129947651|NCT01393964|467772140|FG002|Overall Study|Disease Progression|5|||
129947652|NCT01393964|467772138|FG000|Overall Study|Study drug toxicity|1|||
129947653|NCT01393964|467772139|FG001|Overall Study|Study drug toxicity|0|||
129947654|NCT01393964|467772140|FG002|Overall Study|Study drug toxicity|0|||
129947655|NCT01393964|467772138|FG000|Overall Study|Withdrawal by Subject|0|||
129947656|NCT01393964|467772139|FG001|Overall Study|Withdrawal by Subject|0|||
129947657|NCT01393964|467772140|FG002|Overall Study|Withdrawal by Subject|1|||
129947658|NCT01393964|467772138|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129947659|NCT01393964|467772139|FG001|Overall Study|Adverse event unrelated to study drug|3|||
129947660|NCT01393964|467772140|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129947661|NCT01393964|467772138|FG000|Overall Study|Subject request stop study treatment|0|||
129947662|NCT01393964|467772139|FG001|Overall Study|Subject request stop study treatment|1|||
129947663|NCT01393964|467772140|FG002|Overall Study|Subject request stop study treatment|0|||
129947664|NCT01393964|467772138|FG000|Overall Study|Subject decided to move to transplant|1|||
129947665|NCT01393964|467772139|FG001|Overall Study|Subject decided to move to transplant|0|||
129947666|NCT01393964|467772140|FG002|Overall Study|Subject decided to move to transplant|0|||
129947667|NCT01393964|467772138|FG000|Overall Study|Subject switched to commercial supply|1|||
129947668|NCT01393964|467772139|FG001|Overall Study|Subject switched to commercial supply|0|||
129947669|NCT01393964|467772140|FG002|Overall Study|Subject switched to commercial supply|2|||
129947670|NCT01393964|467772138|FG000|Overall Study|Subject plateaued in terms of effect|1|||
129947671|NCT01393964|467772139|FG001|Overall Study|Subject plateaued in terms of effect|0|||
129947672|NCT01393964|467772140|FG002|Overall Study|Subject plateaued in terms of effect|0|||
129947673|NCT01393964|467772138|FG000|Overall Study|Investigator removed subject from study|0|||
129947674|NCT01393964|467772139|FG001|Overall Study|Investigator removed subject from study|1|||
129947675|NCT01393964|467772140|FG002|Overall Study|Investigator removed subject from study|0|||
129947676|NCT01393964|467772138|FG000|Overall Study|Subject converted to roll-over study|0|||
129947677|NCT01393964|467772139|FG001|Overall Study|Subject converted to roll-over study|1|||
130071940|NCT01998958|468218077|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071941|NCT01998958|468218078|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071942|NCT01998958|468218079|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
130120382|NCT04799158|468402347|FG004|On-Demand Treatment Period|Miscellaneous|1|||
129947678|NCT01393964|467772140|FG002|Overall Study|Subject converted to roll-over study|0|||
129947679|NCT01393964|467772138|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
129947680|NCT01393964|467772139|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
129947681|NCT01393964|467772140|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
129947682|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
129947683|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
129947684|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947685|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947686|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947687|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947688|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947689|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
129947690|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
129947691|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947692|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947693|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947694|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947695|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947696|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
129947697|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
129947698|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947699|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947700|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947701|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947702|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947703|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947704|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
129947705|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947706|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947707|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947708|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947709|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947710|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
129947711|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
129947712|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947713|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947714|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947715|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947716|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947717|NCT03136861|467772141|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947718|NCT03136861|467772142|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947719|NCT03136861|467772143|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947720|NCT03136861|467772144|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
129947721|NCT03136861|467772145|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
129947722|NCT03136861|467772146|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947723|NCT03136861|467772147|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
129947724|NCT03136861|467772141|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947725|NCT03136861|467772142|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947726|NCT03136861|467772143|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
129947727|NCT03136861|467772144|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947728|NCT03136861|467772145|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947729|NCT03136861|467772146|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947730|NCT03136861|467772147|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947731|NCT03136861|467772141|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947732|NCT03136861|467772142|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947733|NCT03136861|467772143|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
129947734|NCT03136861|467772144|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947735|NCT03136861|467772145|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947736|NCT03136861|467772146|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947737|NCT03136861|467772147|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947738|NCT01584648|467772150|FG000|Overall Study|Death|136|||
129947739|NCT01584648|467772151|FG001|Overall Study|Death|146|||
130120383|NCT03922477|468402348|FG000|Overall Study|Death|9|||
129947740|NCT01584648|467772150|FG000|Overall Study|Lost to Follow-up|9|||
129947741|NCT01584648|467772151|FG001|Overall Study|Lost to Follow-up|9|||
129947742|NCT01584648|467772150|FG000|Overall Study|Investigator discretion|3|||
129947743|NCT01584648|467772151|FG001|Overall Study|Investigator discretion|2|||
129947744|NCT01584648|467772150|FG000|Overall Study|Withdrew consent|13|||
129947745|NCT01584648|467772151|FG001|Overall Study|Withdrew consent|4|||
129947746|NCT01584648|467772150|FG000|Overall Study|Study closed/terminated|50|||
129947747|NCT01584648|467772151|FG001|Overall Study|Study closed/terminated|23|||
129947748|NCT01584648|467772150|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
129947749|NCT01584648|467772151|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
129947750|NCT05376397|467772154|FG000|Overall Study|Lost to Follow-up|1|||
129947751|NCT01328756|467772155|FG000|Overall Study|Protocol Violation|4|||
129947752|NCT01328756|467772155|FG000|Overall Study|Adverse Event|39|||
129947753|NCT01328756|467772155|FG000|Overall Study|Lack of Efficacy|5|||
129947754|NCT01328756|467772155|FG000|Overall Study|Withdrawal by Subject|41|||
129947755|NCT01328756|467772155|FG000|Overall Study|Lost to Follow-up|5|||
129947756|NCT01328756|467772155|FG000|Overall Study|Other|29|||
129947757|NCT04492475|467772159|FG000|Overall Study|Enrolled but not treated|8|||
129947758|NCT04492475|467772160|FG001|Overall Study|Enrolled but not treated|8|||
129947759|NCT04492475|467772159|FG000|Overall Study|Withdrawal by Subject|4|||
129947760|NCT04492475|467772160|FG001|Overall Study|Withdrawal by Subject|0|||
129947761|NCT04492475|467772159|FG000|Overall Study|Became ineligible after enrollment|2|||
129947762|NCT04492475|467772160|FG001|Overall Study|Became ineligible after enrollment|0|||
129947763|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
129947764|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
129947765|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
129947766|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
129947767|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
129947768|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
129947769|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Adverse Event|6|||
129947770|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Adverse Event|4|||
129947771|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Adverse Event|8|||
129947772|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
129947773|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
129947774|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
129947775|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
129947776|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
129947777|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
129947778|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
129947779|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
129947780|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
129947781|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
129947782|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
129947783|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
129947784|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
129947785|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
129947786|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
129947787|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
129947788|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
129947789|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
129947790|NCT01860079|467772167|FG000|Overall Study|Physician Decision|14|||
129947791|NCT01860079|467772168|FG001|Overall Study|Physician Decision|22|||
129947792|NCT04867382|467772169|FG000|Overall Study|Did not complete the survey|2|||
129947793|NCT04867382|467772170|FG001|Overall Study|Did not complete the survey|1|||
129947794|NCT05445557|467772174|FG000|Double Blind Part|Lost to Follow-up|1|||
129947795|NCT00428714|467772184|FG000|Overall Study|Progressive Disease|28|||
129947796|NCT00428714|467772185|FG001|Overall Study|Progressive Disease|36|||
129947797|NCT00428714|467772184|FG000|Overall Study|Withdrawal by Subject|0|||
129947798|NCT00428714|467772185|FG001|Overall Study|Withdrawal by Subject|3|||
129947799|NCT00428714|467772184|FG000|Overall Study|Adverse Event|0|||
129947800|NCT00428714|467772185|FG001|Overall Study|Adverse Event|2|||
129947801|NCT00428714|467772184|FG000|Overall Study|Physician Decision|1|||
129947802|NCT00428714|467772185|FG001|Overall Study|Physician Decision|1|||
129947803|NCT00428714|467772184|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
129947804|NCT00428714|467772185|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
130120384|NCT03922477|468402348|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
129947805|NCT00428714|467772184|FG000|Overall Study|Death due to other then PD|1|||
129947806|NCT00428714|467772185|FG001|Overall Study|Death due to other then PD|0|||
129947807|NCT01681511|467772186|FG000|Overall Study|No Treatment Received|1|||
129947808|NCT01681511|467772187|FG001|Overall Study|No Treatment Received|3|||
129947809|NCT01681511|467772186|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
129947810|NCT01681511|467772187|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
129947811|NCT01681511|467772186|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
129947812|NCT01681511|467772187|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
129947813|NCT01681511|467772186|FG000|Overall Study|No Daily Urine Sample Collected|0|||
129947814|NCT01681511|467772187|FG001|Overall Study|No Daily Urine Sample Collected|1|||
129947815|NCT01681511|467772186|FG000|Overall Study|No post-catheter sample collected|11|||
129947816|NCT01681511|467772187|FG001|Overall Study|No post-catheter sample collected|4|||
129947817|NCT01156675|467772188|FG000|Overall Study|Death|5|||
129947818|NCT01156675|467772189|FG001|Overall Study|Death|3|||
129947819|NCT01156675|467772190|FG002|Overall Study|Death|0|||
129947820|NCT01156675|467772188|FG000|Overall Study|No data|29|||
129947821|NCT01156675|467772189|FG001|Overall Study|No data|22|||
129947822|NCT01156675|467772190|FG002|Overall Study|No data|2|||
129947823|NCT02326220|467772204|FG000|Double-blind Treatment Period|Adverse Event|1|||
129947824|NCT02326220|467772205|FG001|Double-blind Treatment Period|Adverse Event|2|||
129947825|NCT02326220|467772206|FG002|Double-blind Treatment Period|Adverse Event|0|||
129947826|NCT02326220|467772204|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129947827|NCT02326220|467772205|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129947828|NCT02326220|467772206|FG002|Double-blind Treatment Period|Protocol Violation|0|||
129947829|NCT02326220|467772204|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129947830|NCT02326220|467772205|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129947831|NCT02326220|467772206|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129947832|NCT02326220|467772204|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129947833|NCT02326220|467772205|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129947834|NCT02326220|467772206|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
129947835|NCT02326220|467772204|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129947836|NCT02326220|467772205|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129947837|NCT02326220|467772206|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
129947838|NCT02114515|467772208|FG000|Overall Study|Lost to Follow-up|52|||
129947839|NCT02114515|467772209|FG001|Overall Study|Lost to Follow-up|55|||
129947840|NCT02114515|467772208|FG000|Overall Study|Death|12|||
129947841|NCT02114515|467772209|FG001|Overall Study|Death|12|||
129947842|NCT02114515|467772208|FG000|Overall Study|Withdrawal by Subject|4|||
129947843|NCT02114515|467772209|FG001|Overall Study|Withdrawal by Subject|22|||
129947844|NCT02114515|467772208|FG000|Overall Study|Other|65|||
129947845|NCT02114515|467772209|FG001|Overall Study|Other|61|||
129947846|NCT02699099|467772210|FG000|Overall Study|Adverse Event|1|||
129947847|NCT02699099|467772211|FG001|Overall Study|Adverse Event|0|||
129947848|NCT02699099|467772212|FG002|Overall Study|Adverse Event|2|||
129947849|NCT02699099|467772210|FG000|Overall Study|Lost to Follow-up|0|||
129947850|NCT02699099|467772211|FG001|Overall Study|Lost to Follow-up|1|||
129947851|NCT02699099|467772212|FG002|Overall Study|Lost to Follow-up|0|||
129947852|NCT02699099|467772210|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
129947853|NCT02699099|467772211|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129947854|NCT02699099|467772212|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
129947855|NCT02144285|467772215|FG000|Overall Study|Withdrawal by Subject|0|||
129947856|NCT02144285|467772216|FG001|Overall Study|Withdrawal by Subject|0|||
129947857|NCT02144285|467772217|FG002|Overall Study|Withdrawal by Subject|0|||
129947858|NCT02144285|467772218|FG003|Overall Study|Withdrawal by Subject|0|||
129947859|NCT02144285|467772219|FG004|Overall Study|Withdrawal by Subject|1|||
129947860|NCT02144285|467772220|FG005|Overall Study|Withdrawal by Subject|0|||
129947861|NCT02144285|467772221|FG006|Overall Study|Withdrawal by Subject|0|||
129947862|NCT02144285|467772222|FG007|Overall Study|Withdrawal by Subject|0|||
129947863|NCT02144285|467772223|FG008|Overall Study|Withdrawal by Subject|0|||
129947864|NCT02144285|467772224|FG009|Overall Study|Withdrawal by Subject|0|||
129947865|NCT05184062|467772226|FG000|Overall Study|Lost to Follow-up|5|||
129947866|NCT05184062|467772227|FG001|Overall Study|Lost to Follow-up|1|||
129947867|NCT05184062|467772226|FG000|Overall Study|Withdrawal by Subject|1|||
129947868|NCT05184062|467772227|FG001|Overall Study|Withdrawal by Subject|0|||
130071943|NCT01998958|468218080|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071944|NCT01998958|468218081|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
129947869|NCT03659136|467772232|FG000|Overall Study|Not treated|2|||
130071945|NCT01998958|468218082|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
129947870|NCT03659136|467772233|FG001|Overall Study|Not treated|0|||
129947871|NCT03659136|467772232|FG000|Overall Study|Covid-19 related|1|||
129947872|NCT03659136|467772233|FG001|Overall Study|Covid-19 related|1|||
129947873|NCT03659136|467772232|FG000|Overall Study|Withdrawal by Subject|1|||
129947874|NCT03659136|467772233|FG001|Overall Study|Withdrawal by Subject|6|||
129947875|NCT03659136|467772232|FG000|Overall Study|Adverse Event|4|||
129947876|NCT03659136|467772233|FG001|Overall Study|Adverse Event|6|||
129947877|NCT03659136|467772232|FG000|Overall Study|Progressive disease|37|||
129947878|NCT03659136|467772233|FG001|Overall Study|Progressive disease|31|||
129947879|NCT03659136|467772232|FG000|Overall Study|Study closure|2|||
129947880|NCT03659136|467772233|FG001|Overall Study|Study closure|2|||
129947881|NCT03659136|467772232|FG000|Overall Study|Sponsor decision/recommendation|3|||
129947882|NCT03659136|467772233|FG001|Overall Study|Sponsor decision/recommendation|2|||
129947883|NCT03659136|467772232|FG000|Overall Study|Switched to other drug/therapy|2|||
130071946|NCT01998958|468218083|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
129947884|NCT03659136|467772233|FG001|Overall Study|Switched to other drug/therapy|2|||
129947885|NCT03659136|467772232|FG000|Overall Study|Lack of clinical benefit|0|||
129947886|NCT03659136|467772233|FG001|Overall Study|Lack of clinical benefit|1|||
129947887|NCT03786471|467772234|FG000|Overall Study|Death|254|||
129947888|NCT03786471|467772235|FG001|Overall Study|Death|223|||
129947889|NCT03786471|467772236|FG002|Overall Study|Death|37|||
129947890|NCT03786471|467772234|FG000|Overall Study|Lost to Follow-up|63|||
129947891|NCT03786471|467772235|FG001|Overall Study|Lost to Follow-up|50|||
129947892|NCT03786471|467772236|FG002|Overall Study|Lost to Follow-up|15|||
129947893|NCT03786471|467772234|FG000|Overall Study|Withdrawal by Subject|99|||
129947894|NCT03786471|467772235|FG001|Overall Study|Withdrawal by Subject|81|||
129947895|NCT03786471|467772236|FG002|Overall Study|Withdrawal by Subject|11|||
129947896|NCT00747149|467773957|FG000|Overall Study|Adverse Event|0|||
129947897|NCT00747149|467773958|FG001|Overall Study|Adverse Event|15|||
129947898|NCT00747149|467773957|FG000|Overall Study|Lost to Follow-up|0|||
129947899|NCT00747149|467773958|FG001|Overall Study|Lost to Follow-up|10|||
129947900|NCT00747149|467773957|FG000|Overall Study|Withdrawal by Subject|0|||
129947901|NCT00747149|467773958|FG001|Overall Study|Withdrawal by Subject|6|||
129947902|NCT00747149|467773957|FG000|Overall Study|Did not receive treatment|0|||
129947903|NCT00747149|467773958|FG001|Overall Study|Did not receive treatment|1|||
129947904|NCT00747149|467773957|FG000|Overall Study|Incorrect enrollment|0|||
129947905|NCT00747149|467773958|FG001|Overall Study|Incorrect enrollment|6|||
129947906|NCT00747149|467773957|FG000|Overall Study|Severe non-compliance to protocol|0|||
129947907|NCT00747149|467773958|FG001|Overall Study|Severe non-compliance to protocol|1|||
129947908|NCT00747149|467773957|FG000|Overall Study|Not reported|1|||
129947909|NCT00747149|467773958|FG001|Overall Study|Not reported|4|||
129947910|NCT01276509|467773961|FG000|Overall Study|Adverse Event|9|||
129947911|NCT01276509|467773962|FG001|Overall Study|Adverse Event|8|||
129947912|NCT01276509|467773963|FG002|Overall Study|Adverse Event|4|||
129947913|NCT01276509|467773964|FG003|Overall Study|Adverse Event|3|||
129947914|NCT01276509|467773961|FG000|Overall Study|Lack of Efficacy|2|||
129947915|NCT01276509|467773962|FG001|Overall Study|Lack of Efficacy|1|||
129947916|NCT01276509|467773963|FG002|Overall Study|Lack of Efficacy|1|||
129947917|NCT01276509|467773964|FG003|Overall Study|Lack of Efficacy|2|||
129947918|NCT01276509|467773961|FG000|Overall Study|Pregnancy|1|||
129947919|NCT01276509|467773962|FG001|Overall Study|Pregnancy|0|||
129947920|NCT01276509|467773963|FG002|Overall Study|Pregnancy|0|||
129947921|NCT01276509|467773964|FG003|Overall Study|Pregnancy|0|||
129947922|NCT01276509|467773961|FG000|Overall Study|Withdrawal by Subject|1|||
129947923|NCT01276509|467773962|FG001|Overall Study|Withdrawal by Subject|2|||
129947924|NCT01276509|467773963|FG002|Overall Study|Withdrawal by Subject|0|||
129947925|NCT01276509|467773964|FG003|Overall Study|Withdrawal by Subject|0|||
129947926|NCT01276509|467773961|FG000|Overall Study|Other|0|||
129947927|NCT01276509|467773962|FG001|Overall Study|Other|1|||
129947928|NCT01276509|467773963|FG002|Overall Study|Other|0|||
129947929|NCT01276509|467773964|FG003|Overall Study|Other|0|||
129947930|NCT02196259|467773968|FG000|Overall Study|Researcher choice|0|||
129947931|NCT02196259|467773969|FG001|Overall Study|Researcher choice|0|||
129947932|NCT02196259|467773970|FG002|Overall Study|Researcher choice|1|||
129947933|NCT02196259|467773968|FG000|Overall Study|Partial data analysis|0|||
129947934|NCT02196259|467773969|FG001|Overall Study|Partial data analysis|3|||
129947935|NCT02196259|467773970|FG002|Overall Study|Partial data analysis|0|||
129947936|NCT02830893|467773971|FG000|Overall Study|Relocation to out of the country|1|||
129947937|NCT02830893|467773972|FG001|Overall Study|Relocation to out of the country|0|||
129947938|NCT02830893|467773971|FG000|Overall Study|Lost to Follow-up|0|||
129947939|NCT02830893|467773972|FG001|Overall Study|Lost to Follow-up|2|||
129947940|NCT02830893|467773971|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
129947941|NCT02830893|467773972|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
129947942|NCT00215943|467773973|FG000|Overall Study|Disease Progression|3|||
129947943|NCT00215943|467773974|FG001|Overall Study|Disease Progression|5|||
129947944|NCT00215943|467773973|FG000|Overall Study|Alternate therapy|0|||
129947945|NCT00215943|467773974|FG001|Overall Study|Alternate therapy|1|||
129947946|NCT00215943|467773973|FG000|Overall Study|Adverse Event|3|||
129947947|NCT00215943|467773974|FG001|Overall Study|Adverse Event|6|||
129947948|NCT00215943|467773973|FG000|Overall Study|Other disease|0|||
129947949|NCT00215943|467773974|FG001|Overall Study|Other disease|1|||
129947950|NCT00215943|467773973|FG000|Overall Study|Other complications|3|||
129947951|NCT00215943|467773974|FG001|Overall Study|Other complications|1|||
129947952|NCT00647699|467773975|FG000|Overall Study|Lost to Follow-up|5|||
129947953|NCT00647699|467773976|FG001|Overall Study|Lost to Follow-up|4|||
129947954|NCT00647699|467773975|FG000|Overall Study|Withdrawal by Subject|3|||
129947955|NCT00647699|467773976|FG001|Overall Study|Withdrawal by Subject|8|||
129947956|NCT00413283|467773977|FG000|Overall Study|Withdrawal by Subject|1|||
129947957|NCT00413283|467773978|FG001|Overall Study|Withdrawal by Subject|0|||
129947958|NCT00413283|467773979|FG002|Overall Study|Withdrawal by Subject|0|||
129947959|NCT00413283|467773980|FG003|Overall Study|Withdrawal by Subject|1|||
129947960|NCT00413283|467773977|FG000|Overall Study|Death|0|||
129947961|NCT00413283|467773978|FG001|Overall Study|Death|0|||
129947962|NCT00413283|467773979|FG002|Overall Study|Death|1|||
129947963|NCT00413283|467773980|FG003|Overall Study|Death|1|||
129947964|NCT00413283|467773977|FG000|Overall Study|Adverse Event|0|||
129947965|NCT00413283|467773978|FG001|Overall Study|Adverse Event|0|||
129947966|NCT00413283|467773979|FG002|Overall Study|Adverse Event|0|||
129947967|NCT00413283|467773980|FG003|Overall Study|Adverse Event|1|||
129947968|NCT00413283|467773977|FG000|Overall Study|Ineligibility determined|0|||
129947969|NCT00413283|467773978|FG001|Overall Study|Ineligibility determined|0|||
129947970|NCT00413283|467773979|FG002|Overall Study|Ineligibility determined|0|||
129947971|NCT00413283|467773980|FG003|Overall Study|Ineligibility determined|1|||
129947972|NCT00413283|467773977|FG000|Overall Study|Protocol deviation|0|||
129947973|NCT00413283|467773978|FG001|Overall Study|Protocol deviation|1|||
129947974|NCT00413283|467773979|FG002|Overall Study|Protocol deviation|0|||
129947975|NCT00413283|467773980|FG003|Overall Study|Protocol deviation|0|||
129947976|NCT00413283|467773977|FG000|Overall Study|Requirement for alternative therapy|0|||
129947977|NCT00413283|467773978|FG001|Overall Study|Requirement for alternative therapy|2|||
129947978|NCT00413283|467773979|FG002|Overall Study|Requirement for alternative therapy|0|||
129947979|NCT00413283|467773980|FG003|Overall Study|Requirement for alternative therapy|0|||
129947980|NCT00413283|467773977|FG000|Overall Study|Other|0|||
129947981|NCT00413283|467773978|FG001|Overall Study|Other|0|||
129947982|NCT00413283|467773979|FG002|Overall Study|Other|1|||
129947983|NCT00413283|467773980|FG003|Overall Study|Other|0|||
129947984|NCT02354417|467773981|FG000|Overall Study|Physician Decision|1|||
129947985|NCT00246129|467773982|FG000|Overall Study|Lost to Follow-up|1|||
129947986|NCT00246129|467773983|FG001|Overall Study|Lost to Follow-up|0|||
129947987|NCT00246129|467773982|FG000|Overall Study|Death|2|||
129947988|NCT00246129|467773983|FG001|Overall Study|Death|1|||
129947989|NCT00246129|467773982|FG000|Overall Study|suffered primary non-function|1|||
129947990|NCT00246129|467773983|FG001|Overall Study|suffered primary non-function|0|||
129947991|NCT00246129|467773982|FG000|Overall Study|grafts failed|3|||
129947992|NCT00246129|467773983|FG001|Overall Study|grafts failed|1|||
129947993|NCT00403845|467773993|FG000|Treatment Period 1|Subject withdrew consent|1|||
129947994|NCT00403845|467773994|FG001|Treatment Period 1|Subject withdrew consent|0|||
129947995|NCT00403845|467773995|FG002|Treatment Period 1|Subject withdrew consent|0|||
129947996|NCT00403845|467773996|FG003|Treatment Period 1|Subject withdrew consent|0|||
129947997|NCT00403845|467773993|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
129947998|NCT00403845|467773994|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
129947999|NCT00403845|467773995|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
129948000|NCT00403845|467773996|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
129948001|NCT00403845|467773993|FG000|Treatment Period 2|Subject withdrew consent|1|||
129948002|NCT00403845|467773994|FG001|Treatment Period 2|Subject withdrew consent|0|||
129948003|NCT00403845|467773995|FG002|Treatment Period 2|Subject withdrew consent|0|||
129948004|NCT00403845|467773996|FG003|Treatment Period 2|Subject withdrew consent|0|||
129948005|NCT00403845|467773993|FG000|Treatment Period 3|Subject withdrew consent|0|||
129948006|NCT00403845|467773994|FG001|Treatment Period 3|Subject withdrew consent|0|||
129948007|NCT00403845|467773995|FG002|Treatment Period 3|Subject withdrew consent|0|||
129948008|NCT00403845|467773996|FG003|Treatment Period 3|Subject withdrew consent|1|||
129948009|NCT00403845|467773993|FG000|Treatment Period 3|Adverse Event|0|||
129948010|NCT00403845|467773994|FG001|Treatment Period 3|Adverse Event|0|||
129948011|NCT00403845|467773995|FG002|Treatment Period 3|Adverse Event|0|||
129948012|NCT00403845|467773996|FG003|Treatment Period 3|Adverse Event|1|||
129948013|NCT00805792|467773997|FG000|Overall Study|Death|3|||
129948014|NCT00805792|467773997|FG000|Overall Study|Lost to Follow-up|2|||
129948015|NCT00578344|467773998|FG000|Overall Study|Insurance problems|1|||
129948016|NCT00578344|467773998|FG000|Overall Study|Graft failure|1|||
129948017|NCT02935673|467773999|FG000|Overall Study|Adverse Event|0|||
129948018|NCT02935673|467774000|FG001|Overall Study|Adverse Event|1|||
129948019|NCT02935673|467774001|FG002|Overall Study|Adverse Event|0|||
129948020|NCT02935673|467773999|FG000|Overall Study|Withdrawal by Subject|1|||
129948021|NCT02935673|467774000|FG001|Overall Study|Withdrawal by Subject|2|||
129948022|NCT02935673|467774001|FG002|Overall Study|Withdrawal by Subject|0|||
129948023|NCT04328467|467774003|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
129948024|NCT04328467|467774004|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
129948025|NCT04328467|467774005|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
129948026|NCT02753075|467774008|FG000|Overall Study|Adverse Event|2|||
129948027|NCT02753075|467774009|FG001|Overall Study|Adverse Event|1|||
129948028|NCT02753075|467774010|FG002|Overall Study|Adverse Event|0|||
129948029|NCT02753075|467774008|FG000|Overall Study|Lost to Follow-up|2|||
129948030|NCT02753075|467774009|FG001|Overall Study|Lost to Follow-up|0|||
129948031|NCT02753075|467774010|FG002|Overall Study|Lost to Follow-up|0|||
129948032|NCT02753075|467774008|FG000|Overall Study|Withdrawal of Consent|1|||
129948033|NCT02753075|467774009|FG001|Overall Study|Withdrawal of Consent|1|||
129948034|NCT02753075|467774010|FG002|Overall Study|Withdrawal of Consent|3|||
129948035|NCT02753075|467774008|FG000|Overall Study|Physician Decision|3|||
129948036|NCT02753075|467774009|FG001|Overall Study|Physician Decision|1|||
129948037|NCT02753075|467774010|FG002|Overall Study|Physician Decision|0|||
129948038|NCT02152384|467774011|FG000|Period 1|Withdrawal by Subject|0|||
129948039|NCT02152384|467774012|FG001|Period 1|Withdrawal by Subject|1|||
129948040|NCT02152384|467774011|FG000|Period 1|Adverse Event|1|||
129948041|NCT02152384|467774012|FG001|Period 1|Adverse Event|1|||
129948042|NCT03265132|467774021|FG000|Overall Study|Adverse Event|0|||
129948043|NCT03265132|467774022|FG001|Overall Study|Adverse Event|1|||
129948044|NCT03265132|467774021|FG000|Overall Study|Lack of Efficacy|0|||
129948045|NCT03265132|467774022|FG001|Overall Study|Lack of Efficacy|2|||
130071947|NCT01998958|468218084|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071948|NCT01998958|468218085|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071949|NCT01998958|468218086|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071950|NCT01998958|468218087|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071951|NCT01998958|468218088|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071952|NCT01998958|468218089|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071953|NCT01998958|468218090|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071954|NCT01998958|468218091|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071955|NCT01998958|468218092|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071956|NCT01998958|468218093|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071957|NCT01998958|468218094|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071958|NCT01998958|468218095|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071959|NCT01998958|468218096|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
129948046|NCT03265132|467774021|FG000|Overall Study|Progressive disease|0|||
129948047|NCT03265132|467774022|FG001|Overall Study|Progressive disease|2|||
129948048|NCT03265132|467774021|FG000|Overall Study|Withdrawal by Subject|0|||
129948049|NCT03265132|467774022|FG001|Overall Study|Withdrawal by Subject|1|||
129948050|NCT00088166|467774023|FG000|Overall Study|Adverse Event|11|||
129948051|NCT00088166|467774024|FG001|Overall Study|Adverse Event|9|||
129948052|NCT00088166|467774023|FG000|Overall Study|Death|3|||
129948053|NCT00088166|467774024|FG001|Overall Study|Death|1|||
129948054|NCT00088166|467774023|FG000|Overall Study|Lost to Follow-up|0|||
129948055|NCT00088166|467774024|FG001|Overall Study|Lost to Follow-up|1|||
129948056|NCT00088166|467774023|FG000|Overall Study|Physician Decision|4|||
129948057|NCT00088166|467774024|FG001|Overall Study|Physician Decision|1|||
129948058|NCT00088166|467774023|FG000|Overall Study|Protocol Violation|1|||
129948059|NCT00088166|467774024|FG001|Overall Study|Protocol Violation|5|||
129948060|NCT00088166|467774023|FG000|Overall Study|Patient deterioration|29|||
129948061|NCT00088166|467774024|FG001|Overall Study|Patient deterioration|39|||
129948062|NCT00088166|467774023|FG000|Overall Study|Withdrawal by Subject|5|||
129948063|NCT00088166|467774024|FG001|Overall Study|Withdrawal by Subject|5|||
129948064|NCT02671266|467774025|FG000|Overall Study|Withdrawal by Subject|1|||
129948065|NCT02671266|467774026|FG001|Overall Study|Withdrawal by Subject|1|||
129948066|NCT00666705|467774027|FG000|Overall Study|Withdrawal by Subject|1|||
129948067|NCT00687297|467774028|FG000|Randomization|Withdrawal by Subject|2|||
129948068|NCT00687297|467774029|FG001|Randomization|Withdrawal by Subject|0|||
129948069|NCT00687297|467774028|FG000|Randomization|Withdrew before treatment, ineligible|1|||
129948070|NCT00687297|467774029|FG001|Randomization|Withdrew before treatment, ineligible|1|||
129948071|NCT00687297|467774028|FG000|Induction|Withdrawal by Subject|4|||
129948072|NCT00687297|467774029|FG001|Induction|Withdrawal by Subject|4|||
129948073|NCT00687297|467774028|FG000|Induction|Adverse Event|16|||
129948074|NCT00687297|467774029|FG001|Induction|Adverse Event|15|||
129948075|NCT00687297|467774028|FG000|Induction|Death|7|||
129948076|NCT00687297|467774029|FG001|Induction|Death|11|||
129948077|NCT00687297|467774028|FG000|Induction|Lack of Efficacy|17|||
129948078|NCT00687297|467774029|FG001|Induction|Lack of Efficacy|21|||
129948079|NCT00687297|467774028|FG000|Induction|Ineligible|0|||
129948080|NCT00687297|467774029|FG001|Induction|Ineligible|1|||
129948081|NCT00687297|467774028|FG000|Induction|Patient Noncompliance|1|||
129948082|NCT00687297|467774029|FG001|Induction|Patient Noncompliance|0|||
129948083|NCT00687297|467774028|FG000|Induction|Physician Decision|0|||
129948084|NCT00687297|467774029|FG001|Induction|Physician Decision|2|||
129948085|NCT00687297|467774028|FG000|Induction|Other|0|||
129948086|NCT00687297|467774029|FG001|Induction|Other|1|||
129948087|NCT01109979|467774030|FG000|Overall Study|Physician Decision|2|||
130071960|NCT01998958|468218097|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071961|NCT01998958|468218098|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
129948088|NCT01109979|467774031|FG001|Overall Study|Physician Decision|0|||
129948089|NCT01109979|467774030|FG000|Overall Study|Withdrawal by Subject|0|||
129948090|NCT01109979|467774031|FG001|Overall Study|Withdrawal by Subject|1|||
129948091|NCT01228734|467774032|FG000|Overall Study|Randomized, but not treated|0|||
129948092|NCT01228734|467774033|FG001|Overall Study|Randomized, but not treated|4|||
129948093|NCT03128099|467774034|FG000|Overall Study|High dose task was too long|0|||
129948094|NCT03128099|467774035|FG001|Overall Study|High dose task was too long|4|||
130071962|NCT01998958|468218099|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071963|NCT01998958|468218100|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
129948095|NCT03128099|467774036|FG002|Overall Study|High dose task was too long|0|||
129948096|NCT03128099|467774034|FG000|Overall Study|Participant got a full time job.|1|||
129948097|NCT03128099|467774035|FG001|Overall Study|Participant got a full time job.|0|||
129948098|NCT03128099|467774036|FG002|Overall Study|Participant got a full time job.|0|||
129948099|NCT03128099|467774034|FG000|Overall Study|Became homeless and lost contact|1|||
129948100|NCT03128099|467774035|FG001|Overall Study|Became homeless and lost contact|0|||
129948101|NCT03128099|467774036|FG002|Overall Study|Became homeless and lost contact|0|||
129948102|NCT03128099|467774034|FG000|Overall Study|Did not complete all the assessments|0|||
129948103|NCT03128099|467774035|FG001|Overall Study|Did not complete all the assessments|0|||
129948104|NCT03128099|467774036|FG002|Overall Study|Did not complete all the assessments|1|||
129948105|NCT03456856|467774037|FG000|Overall Study|Lost to Follow-up|2|||
129948106|NCT03456856|467774037|FG000|Overall Study|Withdrawal by Subject|1|||
129948107|NCT02542696|467774042|FG000|Overall Study|Adverse Event|167|||
129948108|NCT02542696|467774042|FG000|Overall Study|Lack of Efficacy|26|||
129948109|NCT02542696|467774042|FG000|Overall Study|Lost to Follow-up|6|||
129948110|NCT02542696|467774042|FG000|Overall Study|Withdrawal by Subject|104|||
129948111|NCT02542696|467774042|FG000|Overall Study|Protocol Violation|5|||
129948112|NCT02542696|467774042|FG000|Overall Study|Death|8|||
129948113|NCT02542696|467774042|FG000|Overall Study|DECREASED OFF TIME|1|||
129948114|NCT02542696|467774042|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
129948115|NCT02542696|467774042|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
129948116|NCT02542696|467774042|FG000|Overall Study|MEDICAL HISTORY|1|||
129948117|NCT02542696|467774042|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
129948118|NCT02542696|467774042|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
129948119|NCT02542696|467774042|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
129948120|NCT02542696|467774042|FG000|Overall Study|SPONSOR DECISION|3|||
129948121|NCT02542696|467774042|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
129948122|NCT02542696|467774042|FG000|Overall Study|SUBJECT DECISION|2|||
129948123|NCT02137785|467774046|FG000|Overall Study|Lost to Follow-up|1|||
129948124|NCT02137785|467774047|FG001|Overall Study|Lost to Follow-up|0|||
129948125|NCT02137785|467774046|FG000|Overall Study|Withdrawal by Subject|1|||
129948126|NCT02137785|467774047|FG001|Overall Study|Withdrawal by Subject|4|||
129948127|NCT02137785|467774046|FG000|Overall Study|subject moved out of state|1|||
129948128|NCT02137785|467774047|FG001|Overall Study|subject moved out of state|0|||
129948129|NCT03390166|467774048|FG000|Overall Study|Death|0|||
129948130|NCT03390166|467774049|FG001|Overall Study|Death|1|||
129948131|NCT03390166|467774048|FG000|Overall Study|Lost to Follow-up|6|||
129948132|NCT03390166|467774049|FG001|Overall Study|Lost to Follow-up|4|||
129948133|NCT03390166|467774048|FG000|Overall Study|Physician Decision|2|||
129948134|NCT03390166|467774049|FG001|Overall Study|Physician Decision|1|||
129948135|NCT03390166|467774048|FG000|Overall Study|Move from study area|3|||
129948136|NCT03390166|467774049|FG001|Overall Study|Move from study area|2|||
129948137|NCT03390166|467774048|FG000|Overall Study|To militarycamp for conscript|1|||
129948138|NCT03390166|467774049|FG001|Overall Study|To militarycamp for conscript|0|||
129948139|NCT03390166|467774048|FG000|Overall Study|To drug therapy course|0|||
129948140|NCT03390166|467774049|FG001|Overall Study|To drug therapy course|1|||
129948141|NCT03390166|467774048|FG000|Overall Study|Move to work oversea|0|||
129948142|NCT03390166|467774049|FG001|Overall Study|Move to work oversea|1|||
129948143|NCT01137682|467774050|FG000|Overall Study|Adverse Event-CORE|2|||
129948144|NCT01137682|467774051|FG001|Overall Study|Adverse Event-CORE|4|||
129948145|NCT01137682|467774052|FG002|Overall Study|Adverse Event-CORE|0|||
129948146|NCT01137682|467774050|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
129948147|NCT01137682|467774051|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
129948148|NCT01137682|467774052|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
129948149|NCT01137682|467774050|FG000|Overall Study|Administrative problems-CORE|2|||
129948150|NCT01137682|467774051|FG001|Overall Study|Administrative problems-CORE|1|||
129948151|NCT01137682|467774052|FG002|Overall Study|Administrative problems-CORE|0|||
129948152|NCT01137682|467774050|FG000|Overall Study|Protocol Violation-CORE|0|||
129948153|NCT01137682|467774051|FG001|Overall Study|Protocol Violation-CORE|1|||
129948154|NCT01137682|467774052|FG002|Overall Study|Protocol Violation-CORE|1|||
129948155|NCT01137682|467774050|FG000|Overall Study|Adverse Event-Extension|4|||
129948156|NCT01137682|467774051|FG001|Overall Study|Adverse Event-Extension|8|||
129948157|NCT01137682|467774052|FG002|Overall Study|Adverse Event-Extension|7|||
129948158|NCT01137682|467774050|FG000|Overall Study|Lack of Efficacy-Extension|15|||
129948159|NCT01137682|467774051|FG001|Overall Study|Lack of Efficacy-Extension|9|||
130071964|NCT01998958|468218101|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
129948160|NCT01137682|467774052|FG002|Overall Study|Lack of Efficacy-Extension|13|||
130071965|NCT01998958|468218102|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071966|NCT01998958|468218103|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071967|NCT01998958|468218104|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
129948161|NCT01137682|467774050|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
129948162|NCT01137682|467774051|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
129948163|NCT01137682|467774052|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
129948164|NCT01137682|467774050|FG000|Overall Study|Lost to Follow Up-Extension|0|||
129948165|NCT01137682|467774051|FG001|Overall Study|Lost to Follow Up-Extension|1|||
129948166|NCT01137682|467774052|FG002|Overall Study|Lost to Follow Up-Extension|0|||
130071968|NCT01998958|468218105|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
130071969|NCT01998958|468218074|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948167|NCT01137682|467774050|FG000|Overall Study|Administrative problems-Extension|0|||
129948168|NCT01137682|467774051|FG001|Overall Study|Administrative problems-Extension|2|||
129948169|NCT01137682|467774052|FG002|Overall Study|Administrative problems-Extension|0|||
129948170|NCT01137682|467774050|FG000|Overall Study|Death-Extension|2|||
129948171|NCT01137682|467774051|FG001|Overall Study|Death-Extension|0|||
129948172|NCT01137682|467774052|FG002|Overall Study|Death-Extension|0|||
129948173|NCT01137682|467774050|FG000|Overall Study|Protocol Violation-Extension|2|||
129948174|NCT01137682|467774051|FG001|Overall Study|Protocol Violation-Extension|1|||
129948175|NCT01137682|467774052|FG002|Overall Study|Protocol Violation-Extension|0|||
129948176|NCT01137682|467774050|FG000|Overall Study|Did not enter extension|2|||
129948177|NCT01137682|467774051|FG001|Overall Study|Did not enter extension|3|||
129948178|NCT01137682|467774052|FG002|Overall Study|Did not enter extension|2|||
129948179|NCT01137682|467774050|FG000|Overall Study|Did not receive treatment in extension|0|||
129948180|NCT01137682|467774051|FG001|Overall Study|Did not receive treatment in extension|0|||
129948181|NCT01137682|467774052|FG002|Overall Study|Did not receive treatment in extension|1|||
129948182|NCT04421456|467774054|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
129948183|NCT04421456|467774055|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
129948184|NCT04421456|467774056|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
129948185|NCT04421456|467774054|FG000|Randomized Treatment Period|Adverse Event|0|||
129948186|NCT04421456|467774055|FG001|Randomized Treatment Period|Adverse Event|1|||
129948187|NCT04421456|467774056|FG002|Randomized Treatment Period|Adverse Event|0|||
129948188|NCT04421456|467774054|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
129948189|NCT04421456|467774055|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
129948190|NCT04421456|467774056|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
129948191|NCT04421456|467774054|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
129948192|NCT04421456|467774055|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
129948193|NCT04421456|467774056|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
129948194|NCT04421456|467774054|FG000|Randomized Treatment Period|Participant non-compliance|1|||
129948195|NCT04421456|467774055|FG001|Randomized Treatment Period|Participant non-compliance|1|||
129948196|NCT04421456|467774056|FG002|Randomized Treatment Period|Participant non-compliance|2|||
129948197|NCT04421456|467774054|FG000|Randomized Treatment Period|Other|0|||
129948198|NCT04421456|467774055|FG001|Randomized Treatment Period|Other|1|||
129948199|NCT04421456|467774056|FG002|Randomized Treatment Period|Other|3|||
129948200|NCT00274287|467774057|FG000|Overall Study|Withdrawal by Subject|1|||
129948201|NCT00274287|467774057|FG000|Overall Study|subject non-compliance|1|||
129948202|NCT04617847|467774058|FG000|Overall Study|Withdrawal by Subject|1|||
129948203|NCT04617847|467774059|FG001|Overall Study|Withdrawal by Subject|0|||
129948204|NCT04617847|467774058|FG000|Overall Study|Adverse Event|0|||
129948205|NCT04617847|467774059|FG001|Overall Study|Adverse Event|2|||
129948206|NCT04617847|467774058|FG000|Overall Study|Death|0|||
129948207|NCT04617847|467774059|FG001|Overall Study|Death|1|||
129948208|NCT04617847|467774058|FG000|Overall Study|Termination of Study by Sponsor|2|||
129948209|NCT04617847|467774059|FG001|Overall Study|Termination of Study by Sponsor|21|||
129948210|NCT00244751|467774060|FG000|Overall Study|Adverse Event|7|||
129948211|NCT00244751|467774061|FG001|Overall Study|Adverse Event|7|||
129948212|NCT00244751|467774062|FG002|Overall Study|Adverse Event|5|||
129948213|NCT00244751|467774060|FG000|Overall Study|Lost to Follow-up|0|||
129948214|NCT00244751|467774061|FG001|Overall Study|Lost to Follow-up|1|||
129948215|NCT00244751|467774062|FG002|Overall Study|Lost to Follow-up|0|||
129948216|NCT00244751|467774060|FG000|Overall Study|Protocol Violation|1|||
129948217|NCT00244751|467774061|FG001|Overall Study|Protocol Violation|0|||
129948218|NCT00244751|467774062|FG002|Overall Study|Protocol Violation|1|||
129948219|NCT00244751|467774060|FG000|Overall Study|Withdrawal by Subject|7|||
129948220|NCT00244751|467774061|FG001|Overall Study|Withdrawal by Subject|5|||
129948221|NCT00244751|467774062|FG002|Overall Study|Withdrawal by Subject|3|||
129948222|NCT00244751|467774060|FG000|Overall Study|Elevated liver enzymes|1|||
129948223|NCT00244751|467774061|FG001|Overall Study|Elevated liver enzymes|0|||
129948224|NCT00244751|467774062|FG002|Overall Study|Elevated liver enzymes|0|||
129948225|NCT00244751|467774060|FG000|Overall Study|Lack of compliance with protocol|0|||
129948226|NCT00244751|467774061|FG001|Overall Study|Lack of compliance with protocol|1|||
129948227|NCT00244751|467774062|FG002|Overall Study|Lack of compliance with protocol|0|||
129948228|NCT00244751|467774060|FG000|Overall Study|Safety reasons|0|||
129948229|NCT00244751|467774061|FG001|Overall Study|Safety reasons|1|||
129948230|NCT00244751|467774062|FG002|Overall Study|Safety reasons|0|||
129948231|NCT00244751|467774060|FG000|Overall Study|Participant randomized by mistake|0|||
129948232|NCT00244751|467774061|FG001|Overall Study|Participant randomized by mistake|0|||
129948233|NCT00244751|467774062|FG002|Overall Study|Participant randomized by mistake|1|||
129948234|NCT02206607|467774065|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
129948235|NCT02206607|467774066|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
129948236|NCT02206607|467774067|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
129948237|NCT02206607|467774068|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
129948238|NCT02206607|467774069|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
129948239|NCT02206607|467774065|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
129948240|NCT02206607|467774066|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
129948241|NCT02206607|467774067|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
129948242|NCT02206607|467774068|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
129948243|NCT02206607|467774069|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
129948244|NCT04085614|467774070|FG000|Overall Study|Protocol Violation|9|||
129948245|NCT04085614|467774071|FG001|Overall Study|Protocol Violation|6|||
129948246|NCT02399449|467774072|FG000|Overall Study|Withdrawal by Subject|3|||
129948247|NCT02399449|467774073|FG001|Overall Study|Withdrawal by Subject|9|||
129948248|NCT02399449|467774072|FG000|Overall Study|Physician Decision|0|||
129948249|NCT02399449|467774073|FG001|Overall Study|Physician Decision|1|||
129948250|NCT02516202|467774074|FG000|Overall Study|Withdrawal by Subject|1|||
129948251|NCT02516202|467774075|FG001|Overall Study|Withdrawal by Subject|0|||
129948252|NCT02516202|467774076|FG002|Overall Study|Withdrawal by Subject|1|||
129948253|NCT02516202|467774074|FG000|Overall Study|Lost to Follow-up|1|||
129948254|NCT02516202|467774075|FG001|Overall Study|Lost to Follow-up|1|||
129948255|NCT02516202|467774076|FG002|Overall Study|Lost to Follow-up|1|||
129948256|NCT02516202|467774074|FG000|Overall Study|Stopped Follow-up|0|||
129948257|NCT02516202|467774075|FG001|Overall Study|Stopped Follow-up|0|||
129948258|NCT02516202|467774076|FG002|Overall Study|Stopped Follow-up|1|||
129948259|NCT00337610|467774077|FG000|Overall Study|Adverse Event|2|||
129948260|NCT00337610|467774078|FG001|Overall Study|Adverse Event|2|||
129948261|NCT00337610|467774077|FG000|Overall Study|Death|0|||
129948262|NCT00337610|467774078|FG001|Overall Study|Death|1|||
129948263|NCT00337610|467774077|FG000|Overall Study|Lack of Efficacy|6|||
129948264|NCT00337610|467774078|FG001|Overall Study|Lack of Efficacy|3|||
129948265|NCT00337610|467774077|FG000|Overall Study|Lost to Follow-up|3|||
129948266|NCT00337610|467774078|FG001|Overall Study|Lost to Follow-up|3|||
129948267|NCT00337610|467774077|FG000|Overall Study|Withdrawal by Subject|6|||
129948268|NCT00337610|467774078|FG001|Overall Study|Withdrawal by Subject|5|||
129948269|NCT03979040|467774079|FG000|Overall Study|Withdrawal by Subject|24|||
129948270|NCT03979040|467774080|FG001|Overall Study|Withdrawal by Subject|32|||
129948271|NCT03979040|467774079|FG000|Overall Study|randomized but never started treatment|32|||
129948272|NCT03979040|467774080|FG001|Overall Study|randomized but never started treatment|39|||
129948273|NCT03979040|467774079|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
129948274|NCT03979040|467774080|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
129948275|NCT03541369|467774083|FG000|Overall Study|Death|0|||
129948276|NCT03541369|467774084|FG001|Overall Study|Death|0|||
129948277|NCT03541369|467774085|FG002|Overall Study|Death|0|||
129948278|NCT03541369|467774086|FG003|Overall Study|Death|0|||
129948279|NCT03541369|467774087|FG004|Overall Study|Death|1|||
129948280|NCT03541369|467774088|FG005|Overall Study|Death|1|||
129948281|NCT03541369|467774089|FG006|Overall Study|Death|0|||
129948282|NCT03541369|467774090|FG007|Overall Study|Death|2|||
129948283|NCT03541369|467774091|FG008|Overall Study|Death|1|||
129948284|NCT03541369|467774092|FG009|Overall Study|Death|2|||
129948285|NCT03541369|467774093|FG010|Overall Study|Death|1|||
129948286|NCT03541369|467774094|FG011|Overall Study|Death|0|||
129948287|NCT03541369|467774095|FG012|Overall Study|Death|2|||
129948288|NCT03541369|467774096|FG013|Overall Study|Death|1|||
129948289|NCT03541369|467774097|FG014|Overall Study|Death|1|||
129948290|NCT03541369|467774098|FG015|Overall Study|Death|1|||
129948291|NCT03541369|467774099|FG016|Overall Study|Death|0|||
129948292|NCT03541369|467774100|FG017|Overall Study|Death|1|||
129948293|NCT03541369|467774083|FG000|Overall Study|Decision by sponsor|0|||
129948294|NCT03541369|467774084|FG001|Overall Study|Decision by sponsor|0|||
129948295|NCT03541369|467774085|FG002|Overall Study|Decision by sponsor|0|||
129948296|NCT03541369|467774086|FG003|Overall Study|Decision by sponsor|1|||
129948297|NCT03541369|467774087|FG004|Overall Study|Decision by sponsor|0|||
129948298|NCT03541369|467774088|FG005|Overall Study|Decision by sponsor|2|||
129948299|NCT03541369|467774089|FG006|Overall Study|Decision by sponsor|0|||
129948300|NCT03541369|467774090|FG007|Overall Study|Decision by sponsor|1|||
129948301|NCT03541369|467774091|FG008|Overall Study|Decision by sponsor|2|||
130120385|NCT03922477|468402348|FG000|Overall Study|Physician Decision|1|||
129948302|NCT03541369|467774092|FG009|Overall Study|Decision by sponsor|0|||
129948303|NCT03541369|467774093|FG010|Overall Study|Decision by sponsor|0|||
129948304|NCT03541369|467774094|FG011|Overall Study|Decision by sponsor|0|||
129948305|NCT03541369|467774095|FG012|Overall Study|Decision by sponsor|2|||
129948306|NCT03541369|467774096|FG013|Overall Study|Decision by sponsor|2|||
129948307|NCT03541369|467774097|FG014|Overall Study|Decision by sponsor|0|||
129948308|NCT03541369|467774098|FG015|Overall Study|Decision by sponsor|1|||
129948309|NCT03541369|467774099|FG016|Overall Study|Decision by sponsor|1|||
129948310|NCT03541369|467774100|FG017|Overall Study|Decision by sponsor|1|||
129948311|NCT03541369|467774083|FG000|Overall Study|Withdrawal by Subject|0|||
129948312|NCT03541369|467774084|FG001|Overall Study|Withdrawal by Subject|0|||
129948313|NCT03541369|467774085|FG002|Overall Study|Withdrawal by Subject|0|||
129948314|NCT03541369|467774086|FG003|Overall Study|Withdrawal by Subject|0|||
129948315|NCT03541369|467774087|FG004|Overall Study|Withdrawal by Subject|0|||
129948316|NCT03541369|467774088|FG005|Overall Study|Withdrawal by Subject|0|||
129948317|NCT03541369|467774089|FG006|Overall Study|Withdrawal by Subject|1|||
129948318|NCT03541369|467774090|FG007|Overall Study|Withdrawal by Subject|0|||
129948319|NCT03541369|467774091|FG008|Overall Study|Withdrawal by Subject|0|||
129948320|NCT03541369|467774092|FG009|Overall Study|Withdrawal by Subject|0|||
129948321|NCT03541369|467774093|FG010|Overall Study|Withdrawal by Subject|0|||
129948322|NCT03541369|467774094|FG011|Overall Study|Withdrawal by Subject|1|||
129948323|NCT03541369|467774095|FG012|Overall Study|Withdrawal by Subject|0|||
129948324|NCT03541369|467774096|FG013|Overall Study|Withdrawal by Subject|0|||
129948325|NCT03541369|467774097|FG014|Overall Study|Withdrawal by Subject|3|||
129948326|NCT03541369|467774098|FG015|Overall Study|Withdrawal by Subject|0|||
129948327|NCT03541369|467774099|FG016|Overall Study|Withdrawal by Subject|4|||
129948328|NCT03541369|467774100|FG017|Overall Study|Withdrawal by Subject|2|||
129948329|NCT03541369|467774083|FG000|Overall Study|Lost to Follow-up|0|||
129948330|NCT03541369|467774084|FG001|Overall Study|Lost to Follow-up|0|||
129948331|NCT03541369|467774085|FG002|Overall Study|Lost to Follow-up|0|||
129948332|NCT03541369|467774086|FG003|Overall Study|Lost to Follow-up|0|||
129948333|NCT03541369|467774087|FG004|Overall Study|Lost to Follow-up|1|||
129948334|NCT03541369|467774088|FG005|Overall Study|Lost to Follow-up|0|||
129948335|NCT03541369|467774089|FG006|Overall Study|Lost to Follow-up|0|||
129948336|NCT03541369|467774090|FG007|Overall Study|Lost to Follow-up|0|||
129948337|NCT03541369|467774091|FG008|Overall Study|Lost to Follow-up|1|||
129948338|NCT03541369|467774092|FG009|Overall Study|Lost to Follow-up|0|||
129948339|NCT03541369|467774093|FG010|Overall Study|Lost to Follow-up|0|||
129948340|NCT03541369|467774094|FG011|Overall Study|Lost to Follow-up|0|||
129948341|NCT03541369|467774095|FG012|Overall Study|Lost to Follow-up|1|||
129948342|NCT03541369|467774096|FG013|Overall Study|Lost to Follow-up|0|||
129948343|NCT03541369|467774097|FG014|Overall Study|Lost to Follow-up|0|||
129948344|NCT03541369|467774098|FG015|Overall Study|Lost to Follow-up|0|||
129948345|NCT03541369|467774099|FG016|Overall Study|Lost to Follow-up|0|||
129948346|NCT03541369|467774100|FG017|Overall Study|Lost to Follow-up|0|||
129948347|NCT01079949|467774103|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
129948348|NCT01079949|467774104|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
129948349|NCT01079949|467774103|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
129948350|NCT01079949|467774104|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
129948351|NCT01079949|467774103|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
129948352|NCT01079949|467774104|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
129948353|NCT01079949|467774103|FG000|Overall Study|Randomized but not treated|1|||
129948354|NCT01079949|467774104|FG001|Overall Study|Randomized but not treated|0|||
129948355|NCT01529632|467774105|FG000|Overall Study|Administrative problem|2|||
129948356|NCT01529632|467774106|FG001|Overall Study|Administrative problem|1|||
129948357|NCT01529632|467774105|FG000|Overall Study|Protocol Violation|0|||
129948358|NCT01529632|467774106|FG001|Overall Study|Protocol Violation|1|||
129948359|NCT01529632|467774105|FG000|Overall Study|Adverse Event|1|||
129948360|NCT01529632|467774106|FG001|Overall Study|Adverse Event|1|||
129948361|NCT04369664|467775363|FG000|Overall Study|Physician Decision|1|||
129948362|NCT04369664|467775364|FG001|Overall Study|Physician Decision|0|||
129948363|NCT05522777|467775367|FG000|Overall Study|Lack of Efficacy|1|||
129948364|NCT05522777|467775367|FG000|Overall Study|Withdrawal by Subject|1|||
129948365|NCT05487300|467775370|FG000|Overall Study|Withdrawal by Subject|1|||
129948366|NCT05487300|467775371|FG001|Overall Study|Withdrawal by Subject|0|||
129948367|NCT01286311|467775373|FG000|Overall Study|Physician did not want outreach sent|14|||
129948368|NCT01286311|467775374|FG001|Overall Study|Physician did not want outreach sent|0|||
129948369|NCT00990184|467775375|FG000|Overall Study|Physician Decision|1|||
129948370|NCT01655498|467775376|FG000|Overall Study|Unrelated health issue|2|||
129948371|NCT01655498|467775376|FG000|Overall Study|Protocol Violation|2|||
129948372|NCT01655498|467775376|FG000|Overall Study|Withdrawal by Subject|1|||
129948373|NCT00930644|467775379|FG000|Overall Study|Withdrawal by Subject|4|||
129948374|NCT00930644|467775379|FG000|Overall Study|Physician Decision|2|||
129948375|NCT00930644|467775379|FG000|Overall Study|Death|1|||
129948376|NCT00930644|467775379|FG000|Overall Study|Adverse Event|16|||
129948377|NCT03909100|467775382|FG000|Overall Study|Protocol Deviation|2|||
129948378|NCT03909100|467775382|FG000|Overall Study|Technical Problems|4|||
130071970|NCT01998958|468218075|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948379|NCT03909100|467775382|FG000|Overall Study|Withdrawal by Subject|4|||
129948380|NCT03909100|467775382|FG000|Overall Study|Lost to Follow-up|1|||
129948381|NCT03909100|467775382|FG000|Overall Study|Reason not Specified|4|||
129948382|NCT00807599|467775383|FG000|Overall Study|Not treated on protocol study|0|||
129948383|NCT00807599|467775384|FG001|Overall Study|Not treated on protocol study|0|||
129948384|NCT00807599|467775385|FG002|Overall Study|Not treated on protocol study|2|||
129948385|NCT00807599|467775383|FG000|Overall Study|Adverse Event|0|||
129948386|NCT00807599|467775384|FG001|Overall Study|Adverse Event|0|||
129948387|NCT00807599|467775385|FG002|Overall Study|Adverse Event|5|||
129948388|NCT00807599|467775383|FG000|Overall Study|Inadequate response to induction|0|||
129948389|NCT00807599|467775384|FG001|Overall Study|Inadequate response to induction|0|||
129948390|NCT00807599|467775385|FG002|Overall Study|Inadequate response to induction|9|||
129948391|NCT00807599|467775383|FG000|Overall Study|Withdrawal by Subject|0|||
129948392|NCT00807599|467775384|FG001|Overall Study|Withdrawal by Subject|0|||
129948393|NCT00807599|467775385|FG002|Overall Study|Withdrawal by Subject|1|||
129948394|NCT01670877|467775387|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948395|NCT01670877|467775388|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
129948396|NCT01670877|467775389|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948397|NCT01670877|467775390|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948398|NCT01670877|467775391|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948399|NCT01670877|467775392|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948400|NCT01670877|467775387|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948401|NCT01670877|467775388|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948402|NCT01670877|467775389|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
129948403|NCT01670877|467775390|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948404|NCT01670877|467775391|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948405|NCT01670877|467775392|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948406|NCT01670877|467775387|FG000|Part I and Part 2|Grade 2 vomiting|0|||
129948407|NCT01670877|467775388|FG001|Part I and Part 2|Grade 2 vomiting|0|||
129948408|NCT01670877|467775389|FG002|Part I and Part 2|Grade 2 vomiting|0|||
129948409|NCT01670877|467775390|FG003|Part I and Part 2|Grade 2 vomiting|1|||
129948410|NCT01670877|467775391|FG004|Part I and Part 2|Grade 2 vomiting|0|||
129948411|NCT01670877|467775392|FG005|Part I and Part 2|Grade 2 vomiting|0|||
129948412|NCT01670877|467775387|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948413|NCT01670877|467775388|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948414|NCT01670877|467775389|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948415|NCT01670877|467775390|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
129948416|NCT01670877|467775391|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948417|NCT01670877|467775392|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948418|NCT01670877|467775387|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948419|NCT01670877|467775388|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948420|NCT01670877|467775389|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948421|NCT01670877|467775390|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
129948422|NCT01670877|467775391|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948423|NCT01670877|467775392|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948424|NCT02825550|467775394|FG000|Overall Study|Physician Decision|1|||
129948425|NCT03349476|467775398|FG000|Overall Study|Physician Decision|3|||
129948426|NCT00795639|467775399|FG000|Overall Study|Death|1|||
129948427|NCT00795639|467775400|FG001|Overall Study|Death|6|||
129948428|NCT00795639|467775399|FG000|Overall Study|Withdrawal by Subject|1|||
129948429|NCT00795639|467775400|FG001|Overall Study|Withdrawal by Subject|3|||
129948430|NCT00795639|467775399|FG000|Overall Study|Pregnancy|1|||
129948431|NCT00795639|467775400|FG001|Overall Study|Pregnancy|0|||
129948432|NCT00795639|467775399|FG000|Overall Study|Adverse Event|5|||
129948433|NCT00795639|467775400|FG001|Overall Study|Adverse Event|2|||
129948434|NCT00795639|467775399|FG000|Overall Study|Other|0|||
129948435|NCT00795639|467775400|FG001|Overall Study|Other|2|||
129948436|NCT00795639|467775399|FG000|Overall Study|Terminated by sponsor|13|||
129948437|NCT00795639|467775400|FG001|Overall Study|Terminated by sponsor|12|||
129948438|NCT00795639|467775399|FG000|Overall Study|Randomized and not treated|0|||
129948439|NCT00795639|467775400|FG001|Overall Study|Randomized and not treated|1|||
129948440|NCT00879710|467775407|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
129948441|NCT00879710|467775408|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
129948442|NCT00879710|467775409|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
129948443|NCT00879710|467775410|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
129948444|NCT00879710|467775407|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
129948445|NCT00879710|467775408|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
129948446|NCT00879710|467775409|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
129948447|NCT00879710|467775410|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
129948448|NCT00696241|467775412|FG000|Overall Study|Adverse Event|11|||
129948449|NCT00696241|467775413|FG001|Overall Study|Adverse Event|3|||
129948450|NCT00696241|467775414|FG002|Overall Study|Adverse Event|6|||
129948451|NCT00696241|467775415|FG003|Overall Study|Adverse Event|4|||
129948452|NCT00696241|467775416|FG004|Overall Study|Adverse Event|5|||
129948453|NCT00696241|467775412|FG000|Overall Study|Protocol Violation|1|||
129948454|NCT00696241|467775413|FG001|Overall Study|Protocol Violation|1|||
129948455|NCT00696241|467775414|FG002|Overall Study|Protocol Violation|2|||
129948456|NCT00696241|467775415|FG003|Overall Study|Protocol Violation|0|||
129948457|NCT00696241|467775416|FG004|Overall Study|Protocol Violation|3|||
129948458|NCT00696241|467775412|FG000|Overall Study|Lost to Follow-up|1|||
129948459|NCT00696241|467775413|FG001|Overall Study|Lost to Follow-up|4|||
129948460|NCT00696241|467775414|FG002|Overall Study|Lost to Follow-up|1|||
129948461|NCT00696241|467775415|FG003|Overall Study|Lost to Follow-up|2|||
129948462|NCT00696241|467775416|FG004|Overall Study|Lost to Follow-up|0|||
130154864|NCT00958126|468526627|FG006|Overall Study|Lost to Follow-up|0|||
129948463|NCT00696241|467775412|FG000|Overall Study|Withdrawal by Subject|4|||
129948464|NCT00696241|467775413|FG001|Overall Study|Withdrawal by Subject|8|||
129948465|NCT00696241|467775414|FG002|Overall Study|Withdrawal by Subject|6|||
129948466|NCT00696241|467775415|FG003|Overall Study|Withdrawal by Subject|1|||
129948467|NCT00696241|467775416|FG004|Overall Study|Withdrawal by Subject|0|||
129948468|NCT00696241|467775412|FG000|Overall Study|Lack of Efficacy|1|||
129948469|NCT00696241|467775413|FG001|Overall Study|Lack of Efficacy|5|||
129948470|NCT00696241|467775414|FG002|Overall Study|Lack of Efficacy|4|||
129948471|NCT00696241|467775415|FG003|Overall Study|Lack of Efficacy|5|||
129948472|NCT00696241|467775416|FG004|Overall Study|Lack of Efficacy|3|||
129948473|NCT00696241|467775412|FG000|Overall Study|Other|6|||
129948474|NCT00696241|467775413|FG001|Overall Study|Other|1|||
129948475|NCT00696241|467775414|FG002|Overall Study|Other|5|||
129948476|NCT00696241|467775415|FG003|Overall Study|Other|2|||
129948477|NCT00696241|467775416|FG004|Overall Study|Other|1|||
129948478|NCT02102724|467775425|FG000|Overall Study|Lost to Follow-up|1|||
129948479|NCT02102724|467775426|FG001|Overall Study|Lost to Follow-up|0|||
129948480|NCT02102724|467775425|FG000|Overall Study|surgery for brain aneurysm|1|||
129948481|NCT02102724|467775426|FG001|Overall Study|surgery for brain aneurysm|1|||
129948482|NCT02203513|467775427|FG000|Overall Study|Refused further treatment|2|||
129948483|NCT02203513|467775428|FG001|Overall Study|Refused further treatment|0|||
129948484|NCT02203513|467775429|FG002|Overall Study|Refused further treatment|1|||
129948485|NCT02203513|467775430|FG003|Overall Study|Refused further treatment|0|||
129948486|NCT02203513|467775431|FG004|Overall Study|Refused further treatment|0|||
129948487|NCT02203513|467775427|FG000|Overall Study|Switched to alternative treatment|3|||
129948488|NCT02203513|467775428|FG001|Overall Study|Switched to alternative treatment|4|||
129948489|NCT02203513|467775429|FG002|Overall Study|Switched to alternative treatment|0|||
129948490|NCT02203513|467775430|FG003|Overall Study|Switched to alternative treatment|0|||
129948491|NCT02203513|467775431|FG004|Overall Study|Switched to alternative treatment|4|||
129948492|NCT02203513|467775427|FG000|Overall Study|Did not receive investigational product (IP)|0|||
129948493|NCT02203513|467775428|FG001|Overall Study|Did not receive investigational product (IP)|1|||
129948494|NCT02203513|467775429|FG002|Overall Study|Did not receive investigational product (IP)|0|||
129948495|NCT02203513|467775430|FG003|Overall Study|Did not receive investigational product (IP)|0|||
129948496|NCT02203513|467775431|FG004|Overall Study|Did not receive investigational product (IP)|0|||
129948497|NCT02203513|467775427|FG000|Overall Study|Death (unrelated to study therapy)|1|||
129948498|NCT02203513|467775428|FG001|Overall Study|Death (unrelated to study therapy)|3|||
129948499|NCT02203513|467775429|FG002|Overall Study|Death (unrelated to study therapy)|1|||
129948500|NCT02203513|467775430|FG003|Overall Study|Death (unrelated to study therapy)|0|||
129948501|NCT02203513|467775431|FG004|Overall Study|Death (unrelated to study therapy)|2|||
129948502|NCT02203513|467775427|FG000|Overall Study|Lost to Follow-up|0|||
129948503|NCT02203513|467775428|FG001|Overall Study|Lost to Follow-up|0|||
129948504|NCT02203513|467775429|FG002|Overall Study|Lost to Follow-up|1|||
129948505|NCT02203513|467775430|FG003|Overall Study|Lost to Follow-up|1|||
129948506|NCT02203513|467775431|FG004|Overall Study|Lost to Follow-up|0|||
129948507|NCT02008916|467775432|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
129948508|NCT02008916|467775433|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
129948509|NCT02008916|467775434|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
129948510|NCT02008916|467775432|FG000|Week 16 - 156|Adverse Event|4|||
129948511|NCT02008916|467775433|FG001|Week 16 - 156|Adverse Event|2|||
129948512|NCT02008916|467775434|FG002|Week 16 - 156|Adverse Event|3|||
129948513|NCT02008916|467775432|FG000|Week 16 - 156|Withdrawal by Subject|7|||
129948514|NCT02008916|467775433|FG001|Week 16 - 156|Withdrawal by Subject|3|||
129948515|NCT02008916|467775434|FG002|Week 16 - 156|Withdrawal by Subject|5|||
129948516|NCT02008916|467775432|FG000|Week 16 - 156|No longer requires treatment|0|||
129948517|NCT02008916|467775433|FG001|Week 16 - 156|No longer requires treatment|1|||
129948518|NCT02008916|467775434|FG002|Week 16 - 156|No longer requires treatment|0|||
129948519|NCT02008916|467775432|FG000|Week 16 - 156|Lost to Follow-up|5|||
129948520|NCT02008916|467775433|FG001|Week 16 - 156|Lost to Follow-up|0|||
129948521|NCT02008916|467775434|FG002|Week 16 - 156|Lost to Follow-up|0|||
129948522|NCT02008916|467775432|FG000|Week 16 - 156|Lack of Efficacy|3|||
129948523|NCT02008916|467775433|FG001|Week 16 - 156|Lack of Efficacy|5|||
129948524|NCT02008916|467775434|FG002|Week 16 - 156|Lack of Efficacy|2|||
129948525|NCT02008916|467775432|FG000|Week 16 - 156|Pregnancy|0|||
129948526|NCT02008916|467775433|FG001|Week 16 - 156|Pregnancy|1|||
129948527|NCT02008916|467775434|FG002|Week 16 - 156|Pregnancy|0|||
130071971|NCT01998958|468218076|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948528|NCT02008916|467775432|FG000|Week 16 - 156|Physician Decision|0|||
130071972|NCT01998958|468218077|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948529|NCT02008916|467775433|FG001|Week 16 - 156|Physician Decision|1|||
129948530|NCT02008916|467775434|FG002|Week 16 - 156|Physician Decision|0|||
129948531|NCT03803475|467775435|FG000|Overall Study|Physician Decision|1|||
129948532|NCT02513667|467775436|FG000|Overall Study|Withdrawal by Subject|0|||
130071973|NCT01998958|468218078|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071974|NCT01998958|468218079|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948533|NCT02513667|467775437|FG001|Overall Study|Withdrawal by Subject|1|||
129948534|NCT03347396|467775438|FG000|Part A (26 Weeks)|Adverse Event|1|||
129948535|NCT03347396|467775439|FG001|Part A (26 Weeks)|Adverse Event|0|||
129948536|NCT03347396|467775438|FG000|Part A (26 Weeks)|Death|0|||
129948537|NCT03347396|467775439|FG001|Part A (26 Weeks)|Death|1|||
129948538|NCT03347396|467775438|FG000|Part B (149 Weeks)|Adverse Event|1|||
129948539|NCT03347396|467775439|FG001|Part B (149 Weeks)|Adverse Event|1|||
129948540|NCT03347396|467775438|FG000|Part B (149 Weeks)|Death|1|||
129948541|NCT03347396|467775439|FG001|Part B (149 Weeks)|Death|0|||
129948542|NCT00392197|467775441|FG000|Overall Study|Adverse Event|4|||
129948543|NCT00392197|467775442|FG001|Overall Study|Adverse Event|12|||
129948544|NCT00392197|467775441|FG000|Overall Study|Lack of Efficacy|3|||
129948545|NCT00392197|467775442|FG001|Overall Study|Lack of Efficacy|4|||
129948546|NCT00392197|467775441|FG000|Overall Study|Lost to Follow-up|0|||
129948547|NCT00392197|467775442|FG001|Overall Study|Lost to Follow-up|1|||
129948548|NCT00392197|467775441|FG000|Overall Study|Physician Decision|3|||
129948549|NCT00392197|467775442|FG001|Overall Study|Physician Decision|2|||
129948550|NCT00392197|467775441|FG000|Overall Study|Protocol Violation|7|||
129948551|NCT00392197|467775442|FG001|Overall Study|Protocol Violation|5|||
129948552|NCT00392197|467775441|FG000|Overall Study|Withdrawal by Subject|4|||
129948553|NCT00392197|467775442|FG001|Overall Study|Withdrawal by Subject|6|||
129948554|NCT03060525|467775443|FG000|Overall Study|moved out of state|1|||
129948555|NCT03060525|467775444|FG001|Overall Study|moved out of state|1|||
129948556|NCT03060525|467775445|FG002|Overall Study|moved out of state|1|||
129948557|NCT03060525|467775446|FG003|Overall Study|moved out of state|1|||
129948558|NCT03060525|467775443|FG000|Overall Study|unable to meet time commitment required of study|2|||
129948559|NCT03060525|467775444|FG001|Overall Study|unable to meet time commitment required of study|3|||
129948560|NCT03060525|467775445|FG002|Overall Study|unable to meet time commitment required of study|3|||
129948561|NCT03060525|467775446|FG003|Overall Study|unable to meet time commitment required of study|1|||
129948562|NCT03060525|467775443|FG000|Overall Study|no longer interested in doing intervention|0|||
129948563|NCT03060525|467775444|FG001|Overall Study|no longer interested in doing intervention|0|||
129948564|NCT03060525|467775445|FG002|Overall Study|no longer interested in doing intervention|0|||
129948565|NCT03060525|467775446|FG003|Overall Study|no longer interested in doing intervention|1|||
129948566|NCT00912964|467775447|FG000|Overall Study|Eligibility criterion not met|1|||
129948567|NCT00912964|467775448|FG001|Overall Study|Eligibility criterion not met|1|||
129948568|NCT00912964|467775449|FG002|Overall Study|Eligibility criterion not met|0|||
129948569|NCT00912964|467775447|FG000|Overall Study|Adverse Event|15|||
129948570|NCT00912964|467775448|FG001|Overall Study|Adverse Event|18|||
129948571|NCT00912964|467775449|FG002|Overall Study|Adverse Event|12|||
129948572|NCT00912964|467775447|FG000|Overall Study|Lack of Efficacy|11|||
129948573|NCT00912964|467775448|FG001|Overall Study|Lack of Efficacy|4|||
129948574|NCT00912964|467775449|FG002|Overall Study|Lack of Efficacy|3|||
129948575|NCT00912964|467775447|FG000|Overall Study|Withdrawal by Subject|20|||
129948576|NCT00912964|467775448|FG001|Overall Study|Withdrawal by Subject|12|||
129948577|NCT00912964|467775449|FG002|Overall Study|Withdrawal by Subject|18|||
129948578|NCT00912964|467775447|FG000|Overall Study|Lost to Follow-up|4|||
129948579|NCT00912964|467775448|FG001|Overall Study|Lost to Follow-up|3|||
129948580|NCT00912964|467775449|FG002|Overall Study|Lost to Follow-up|3|||
129948581|NCT00912964|467775447|FG000|Overall Study|Protocol Violation|5|||
129948582|NCT00912964|467775448|FG001|Overall Study|Protocol Violation|3|||
129948583|NCT00912964|467775449|FG002|Overall Study|Protocol Violation|8|||
129948584|NCT00912964|467775447|FG000|Overall Study|Taking exclusionary medications|7|||
129948585|NCT00912964|467775448|FG001|Overall Study|Taking exclusionary medications|4|||
129948586|NCT00912964|467775449|FG002|Overall Study|Taking exclusionary medications|8|||
129948587|NCT00912964|467775447|FG000|Overall Study|Medical History|1|||
129948588|NCT00912964|467775448|FG001|Overall Study|Medical History|0|||
129948589|NCT00912964|467775449|FG002|Overall Study|Medical History|0|||
129948590|NCT00912964|467775447|FG000|Overall Study|Non-compliance with study procedures|2|||
129948591|NCT00912964|467775448|FG001|Overall Study|Non-compliance with study procedures|0|||
129948592|NCT00912964|467775449|FG002|Overall Study|Non-compliance with study procedures|0|||
129948593|NCT00912964|467775447|FG000|Overall Study|Violation of exclusion criterion|0|||
129948594|NCT00912964|467775448|FG001|Overall Study|Violation of exclusion criterion|0|||
129948595|NCT00912964|467775449|FG002|Overall Study|Violation of exclusion criterion|2|||
129948596|NCT00912964|467775447|FG000|Overall Study|Randomized but never received study drug|0|||
129948597|NCT00912964|467775448|FG001|Overall Study|Randomized but never received study drug|1|||
129948598|NCT00912964|467775449|FG002|Overall Study|Randomized but never received study drug|0|||
129948599|NCT00090519|467775450|FG000|Overall Study|Adverse Event|5|||
129948600|NCT00090519|467775451|FG001|Overall Study|Adverse Event|4|||
129948601|NCT00090519|467775450|FG000|Overall Study|Death|9|||
129948602|NCT00090519|467775451|FG001|Overall Study|Death|9|||
129948603|NCT00090519|467775450|FG000|Overall Study|Lost to Follow-up|26|||
129948604|NCT00090519|467775451|FG001|Overall Study|Lost to Follow-up|29|||
129948605|NCT00090519|467775450|FG000|Overall Study|Withdrawal by Subject|28|||
129948606|NCT00090519|467775451|FG001|Overall Study|Withdrawal by Subject|29|||
129948607|NCT00090519|467775450|FG000|Overall Study|Physician Decision|2|||
129948608|NCT00090519|467775451|FG001|Overall Study|Physician Decision|3|||
129948609|NCT00090519|467775450|FG000|Overall Study|Sponsor Decision|3|||
129948610|NCT00090519|467775451|FG001|Overall Study|Sponsor Decision|1|||
129948611|NCT02161146|467775454|FG000|Overall Study|Adverse Event|1|||
129948612|NCT02161146|467775455|FG001|Overall Study|Adverse Event|1|||
129948613|NCT02161146|467775456|FG002|Overall Study|Adverse Event|0|||
130071975|NCT01998958|468218080|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071976|NCT01998958|468218081|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071977|NCT01998958|468218082|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071978|NCT01998958|468218083|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071979|NCT01998958|468218084|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071980|NCT01998958|468218085|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071981|NCT01998958|468218086|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071982|NCT01998958|468218087|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071983|NCT01998958|468218088|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071984|NCT01998958|468218089|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071985|NCT01998958|468218090|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071986|NCT01998958|468218091|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071987|NCT01998958|468218092|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071988|NCT01998958|468218093|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071989|NCT01998958|468218094|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071990|NCT01998958|468218095|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
130071991|NCT01998958|468218096|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
130071992|NCT01998958|468218097|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071993|NCT01998958|468218098|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071994|NCT01998958|468218099|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948614|NCT02161146|467775457|FG003|Overall Study|Adverse Event|1|||
129948615|NCT02161146|467775458|FG004|Overall Study|Adverse Event|0|||
129948616|NCT02161146|467775454|FG000|Overall Study|Lost to Follow-up|0|||
129948617|NCT02161146|467775455|FG001|Overall Study|Lost to Follow-up|1|||
129948618|NCT02161146|467775456|FG002|Overall Study|Lost to Follow-up|0|||
129948619|NCT02161146|467775457|FG003|Overall Study|Lost to Follow-up|0|||
129948620|NCT02161146|467775458|FG004|Overall Study|Lost to Follow-up|0|||
129948621|NCT02161146|467775454|FG000|Overall Study|Personal Reasons|0|||
129948622|NCT02161146|467775455|FG001|Overall Study|Personal Reasons|1|||
129948623|NCT02161146|467775456|FG002|Overall Study|Personal Reasons|0|||
129948624|NCT02161146|467775457|FG003|Overall Study|Personal Reasons|2|||
129948625|NCT02161146|467775458|FG004|Overall Study|Personal Reasons|1|||
129948626|NCT02161146|467775454|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129948627|NCT02161146|467775455|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129948628|NCT02161146|467775456|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129948629|NCT02161146|467775457|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129948630|NCT02161146|467775458|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129948631|NCT02189759|467775461|FG000|Overall Study|Lost to Follow-up|0|||
129948632|NCT02189759|467775462|FG001|Overall Study|Lost to Follow-up|0|||
129948633|NCT02189759|467775463|FG002|Overall Study|Lost to Follow-up|2|||
129948634|NCT02189759|467775464|FG003|Overall Study|Lost to Follow-up|5|||
129948635|NCT01294644|467775471|FG000|Overall Study|Adverse Event|2|||
129948636|NCT01294644|467775472|FG001|Overall Study|Adverse Event|0|||
129948637|NCT01294644|467775473|FG002|Overall Study|Adverse Event|1|||
129948638|NCT01294644|467775471|FG000|Overall Study|Withdrawal by Subject|3|||
129948639|NCT01294644|467775472|FG001|Overall Study|Withdrawal by Subject|7|||
129948640|NCT01294644|467775473|FG002|Overall Study|Withdrawal by Subject|4|||
129948641|NCT01294644|467775471|FG000|Overall Study|Lost to Follow-up|3|||
129948642|NCT01294644|467775472|FG001|Overall Study|Lost to Follow-up|2|||
129948643|NCT01294644|467775473|FG002|Overall Study|Lost to Follow-up|5|||
129948644|NCT01294644|467775471|FG000|Overall Study|Miscellaneous Reason|2|||
129948645|NCT01294644|467775472|FG001|Overall Study|Miscellaneous Reason|1|||
129948646|NCT01294644|467775473|FG002|Overall Study|Miscellaneous Reason|4|||
129948647|NCT01986348|467775474|FG000|Overall Study|Death|8|||
129948648|NCT01986348|467775475|FG001|Overall Study|Death|22|||
129948649|NCT01986348|467775476|FG002|Overall Study|Death|10|||
129948650|NCT01986348|467775477|FG003|Overall Study|Death|21|||
129948651|NCT01986348|467775474|FG000|Overall Study|Lost to Follow-up|0|||
129948652|NCT01986348|467775475|FG001|Overall Study|Lost to Follow-up|0|||
129948653|NCT01986348|467775476|FG002|Overall Study|Lost to Follow-up|0|||
129948654|NCT01986348|467775477|FG003|Overall Study|Lost to Follow-up|2|||
129948655|NCT01986348|467775474|FG000|Overall Study|Physician Decision|0|||
129948656|NCT01986348|467775475|FG001|Overall Study|Physician Decision|0|||
129948657|NCT01986348|467775476|FG002|Overall Study|Physician Decision|0|||
129948658|NCT01986348|467775477|FG003|Overall Study|Physician Decision|1|||
129948659|NCT01986348|467775474|FG000|Overall Study|Progressive Disease|0|||
129948660|NCT01986348|467775475|FG001|Overall Study|Progressive Disease|0|||
130071995|NCT01998958|468218100|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071996|NCT01998958|468218101|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
129948661|NCT01986348|467775476|FG002|Overall Study|Progressive Disease|2|||
129948662|NCT01986348|467775477|FG003|Overall Study|Progressive Disease|0|||
129948663|NCT01986348|467775474|FG000|Overall Study|Withdrawal by Participant|0|||
129948664|NCT01986348|467775475|FG001|Overall Study|Withdrawal by Participant|1|||
129948665|NCT01986348|467775476|FG002|Overall Study|Withdrawal by Participant|2|||
129948666|NCT01986348|467775477|FG003|Overall Study|Withdrawal by Participant|1|||
129948667|NCT01986348|467775474|FG000|Overall Study|Study Terminated by Sponsor|0|||
129948668|NCT01986348|467775475|FG001|Overall Study|Study Terminated by Sponsor|0|||
130120386|NCT03922477|468402348|FG000|Overall Study|Withdrawal by Subject|2|||
129948669|NCT01986348|467775476|FG002|Overall Study|Study Terminated by Sponsor|0|||
129948670|NCT01986348|467775477|FG003|Overall Study|Study Terminated by Sponsor|3|||
129948671|NCT01986348|467775474|FG000|Overall Study|Other-unspecified|0|||
129948672|NCT01986348|467775475|FG001|Overall Study|Other-unspecified|1|||
129948673|NCT01986348|467775476|FG002|Overall Study|Other-unspecified|0|||
129948674|NCT01986348|467775477|FG003|Overall Study|Other-unspecified|2|||
129948675|NCT02548585|467775478|FG000|Overall Study|Withdrawal by Subject|0|||
129948676|NCT02548585|467775479|FG001|Overall Study|Withdrawal by Subject|0|||
129948677|NCT02548585|467775480|FG002|Overall Study|Withdrawal by Subject|0|||
129948678|NCT02548585|467775481|FG003|Overall Study|Withdrawal by Subject|0|||
129948679|NCT02548585|467775482|FG004|Overall Study|Withdrawal by Subject|0|||
129948680|NCT02548585|467775483|FG005|Overall Study|Withdrawal by Subject|1|||
129948681|NCT02548585|467775484|FG006|Overall Study|Withdrawal by Subject|0|||
129948682|NCT02548585|467775478|FG000|Overall Study|Lost to Follow-up|1|||
129948683|NCT02548585|467775479|FG001|Overall Study|Lost to Follow-up|0|||
129948684|NCT02548585|467775480|FG002|Overall Study|Lost to Follow-up|0|||
129948685|NCT02548585|467775481|FG003|Overall Study|Lost to Follow-up|0|||
129948686|NCT02548585|467775482|FG004|Overall Study|Lost to Follow-up|0|||
129948687|NCT02548585|467775483|FG005|Overall Study|Lost to Follow-up|0|||
129948688|NCT02548585|467775484|FG006|Overall Study|Lost to Follow-up|0|||
129948689|NCT02548585|467775478|FG000|Overall Study|Other|1|||
129948690|NCT02548585|467775479|FG001|Overall Study|Other|0|||
129948691|NCT02548585|467775480|FG002|Overall Study|Other|0|||
129948692|NCT02548585|467775481|FG003|Overall Study|Other|2|||
129948693|NCT02548585|467775482|FG004|Overall Study|Other|3|||
129948694|NCT02548585|467775483|FG005|Overall Study|Other|0|||
129948695|NCT02548585|467775484|FG006|Overall Study|Other|1|||
129948696|NCT02548585|467775478|FG000|Overall Study|Randomized but not treated|0|||
129948697|NCT02548585|467775479|FG001|Overall Study|Randomized but not treated|0|||
129948698|NCT02548585|467775480|FG002|Overall Study|Randomized but not treated|0|||
129948699|NCT02548585|467775481|FG003|Overall Study|Randomized but not treated|0|||
129948700|NCT02548585|467775482|FG004|Overall Study|Randomized but not treated|0|||
129948701|NCT02548585|467775483|FG005|Overall Study|Randomized but not treated|1|||
129948702|NCT02548585|467775484|FG006|Overall Study|Randomized but not treated|0|||
129948703|NCT03242863|467775485|FG000|Study Week 1|Withdrawal by Subject|0|||
129948704|NCT03242863|467775486|FG001|Study Week 1|Withdrawal by Subject|1|||
129948705|NCT03242863|467775487|FG002|Study Week 1|Withdrawal by Subject|0|||
129948706|NCT03242863|467775488|FG003|Study Week 1|Withdrawal by Subject|0|||
129948707|NCT03242863|467775489|FG004|Study Week 1|Withdrawal by Subject|3|||
129948708|NCT03242863|467775490|FG005|Study Week 1|Withdrawal by Subject|0|||
129948709|NCT04919499|467775495|FG000|Overall Study|Adverse Event|0|||
129948710|NCT04919499|467775496|FG001|Overall Study|Adverse Event|0|||
129948711|NCT04919499|467775497|FG002|Overall Study|Adverse Event|0|||
129948712|NCT04919499|467775498|FG003|Overall Study|Adverse Event|0|||
129948713|NCT04919499|467775499|FG004|Overall Study|Adverse Event|2|||
129948714|NCT04919499|467775495|FG000|Overall Study|Not treated|0|||
129948715|NCT04919499|467775496|FG001|Overall Study|Not treated|0|||
129948716|NCT04919499|467775497|FG002|Overall Study|Not treated|0|||
129948717|NCT04919499|467775498|FG003|Overall Study|Not treated|1|||
129948718|NCT04919499|467775499|FG004|Overall Study|Not treated|0|||
129948719|NCT03840200|467777375|FG000|Overall Study|Death|6|||
129948720|NCT03840200|467777376|FG001|Overall Study|Death|3|||
129948721|NCT03840200|467777377|FG002|Overall Study|Death|6|||
129948722|NCT03840200|467777378|FG003|Overall Study|Death|10|||
129948723|NCT03840200|467777375|FG000|Overall Study|Reason Not Specified|2|||
129948724|NCT03840200|467777376|FG001|Overall Study|Reason Not Specified|2|||
129948725|NCT03840200|467777377|FG002|Overall Study|Reason Not Specified|1|||
129948726|NCT03840200|467777378|FG003|Overall Study|Reason Not Specified|15|||
129948727|NCT03840200|467777375|FG000|Overall Study|Physician Decision|0|||
129948728|NCT03840200|467777376|FG001|Overall Study|Physician Decision|0|||
129948729|NCT03840200|467777377|FG002|Overall Study|Physician Decision|0|||
129948730|NCT03840200|467777378|FG003|Overall Study|Physician Decision|2|||
129948731|NCT03840200|467777375|FG000|Overall Study|Progressive Disease|0|||
129948732|NCT03840200|467777376|FG001|Overall Study|Progressive Disease|0|||
130120387|NCT03387098|468402356|FG000|Overall Study|progressive disease|1|||
129948733|NCT03840200|467777377|FG002|Overall Study|Progressive Disease|0|||
129948734|NCT03840200|467777378|FG003|Overall Study|Progressive Disease|1|||
130120388|NCT03387098|468402356|FG000|Overall Study|Withdrawal by Subject|2|||
130120389|NCT03387098|468402356|FG000|Overall Study|study terminated by sponsor|1|||
129948735|NCT03840200|467777375|FG000|Overall Study|Withdrawal by Subject|0|||
129948736|NCT03840200|467777376|FG001|Overall Study|Withdrawal by Subject|1|||
129948737|NCT03840200|467777377|FG002|Overall Study|Withdrawal by Subject|0|||
129948738|NCT03840200|467777378|FG003|Overall Study|Withdrawal by Subject|2|||
129948739|NCT05006703|467777379|FG000|Overall Study|Withdrawal by Subject|1|||
129948740|NCT05006703|467777380|FG001|Overall Study|Withdrawal by Subject|0|||
129948741|NCT05006703|467777379|FG000|Overall Study|Lost to Follow-up|13|||
129948742|NCT05006703|467777380|FG001|Overall Study|Lost to Follow-up|5|||
130120390|NCT00662129|468402357|FG000|Overall Study|Protocol Violation|1|||
130120391|NCT00662129|468402357|FG000|Overall Study|Cancel prior to beginning treatment|1|||
129948743|NCT04620733|467777383|FG000|Overall Study|Adverse Event|4|||
129948744|NCT04620733|467777384|FG001|Overall Study|Adverse Event|3|||
129948745|NCT04620733|467777383|FG000|Overall Study|Withdrawal by Subject|2|||
129948746|NCT04620733|467777384|FG001|Overall Study|Withdrawal by Subject|5|||
129948747|NCT04620733|467777383|FG000|Overall Study|Lost to Follow-up|1|||
129948748|NCT04620733|467777384|FG001|Overall Study|Lost to Follow-up|1|||
129948749|NCT04620733|467777383|FG000|Overall Study|Protocol Deviation|1|||
129948750|NCT04620733|467777384|FG001|Overall Study|Protocol Deviation|1|||
129948751|NCT04620733|467777383|FG000|Overall Study|Reason Not Specified|0|||
129948752|NCT04620733|467777384|FG001|Overall Study|Reason Not Specified|1|||
129948753|NCT00264576|467777387|FG000|Overall Study|Lost to Follow-up|1|||
129948754|NCT00264576|467777388|FG001|Overall Study|Lost to Follow-up|1|||
129948755|NCT04783389|467777389|FG000|Overall Study|Withdrawal by Subject|2|||
129948756|NCT04783389|467777390|FG001|Overall Study|Withdrawal by Subject|0|||
129948757|NCT04783389|467777391|FG002|Overall Study|Withdrawal by Subject|0|||
129948758|NCT04783389|467777389|FG000|Overall Study|Termination of Study by Sponsor|10|||
129948759|NCT04783389|467777390|FG001|Overall Study|Termination of Study by Sponsor|12|||
129948760|NCT04783389|467777391|FG002|Overall Study|Termination of Study by Sponsor|14|||
129948761|NCT02164578|467777392|FG000|Treatment Period|Withdrawal by Subject|3|||
129948762|NCT02164578|467777393|FG001|Treatment Period|Withdrawal by Subject|3|||
129948763|NCT02164578|467777392|FG000|Treatment Period|Adverse Event|13|||
129948764|NCT02164578|467777393|FG001|Treatment Period|Adverse Event|6|||
129948765|NCT02164578|467777392|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
129948766|NCT02164578|467777393|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
129948767|NCT02164578|467777392|FG000|Treatment Period|Protocol Violation|0|||
129948768|NCT02164578|467777393|FG001|Treatment Period|Protocol Violation|2|||
129948769|NCT02164578|467777392|FG000|Extension Period|Withdrawal by Subject|2|||
129948770|NCT02164578|467777393|FG001|Extension Period|Withdrawal by Subject|0|||
129948771|NCT02164578|467777392|FG000|Extension Period|Adverse Event|4|||
129948772|NCT02164578|467777393|FG001|Extension Period|Adverse Event|0|||
129948773|NCT02164578|467777392|FG000|Extension Period|Expiry of study medication|1|||
129948774|NCT02164578|467777393|FG001|Extension Period|Expiry of study medication|0|||
129948775|NCT02164578|467777392|FG000|Extension Period|Protocol Violation|0|||
129948776|NCT02164578|467777393|FG001|Extension Period|Protocol Violation|1|||
129948777|NCT02507297|467777394|FG000|Overall Study|Withdrawal by Subject|1|||
129948778|NCT02507297|467777395|FG001|Overall Study|Withdrawal by Subject|0|||
129948779|NCT02507297|467777394|FG000|Overall Study|Lost to Follow-up|0|||
129948780|NCT02507297|467777395|FG001|Overall Study|Lost to Follow-up|1|||
129948781|NCT02489799|467777396|FG000|Overall Study|Lost to Follow-up|4|||
129948782|NCT02489799|467777397|FG001|Overall Study|Lost to Follow-up|1|||
129948783|NCT02489799|467777396|FG000|Overall Study|Failure to Maintain Eligibility|4|||
129948784|NCT02489799|467777397|FG001|Overall Study|Failure to Maintain Eligibility|6|||
129948785|NCT02489799|467777396|FG000|Overall Study|Withdrawal by Subject|1|||
129948786|NCT02489799|467777397|FG001|Overall Study|Withdrawal by Subject|1|||
129948787|NCT02489799|467777396|FG000|Overall Study|Death|0|||
129948788|NCT02489799|467777397|FG001|Overall Study|Death|1|||
129948789|NCT04909593|467777398|FG000|Overall Study|Withdrawal by Subject|1|||
129948790|NCT01018992|467777399|FG000|Overall Study|Adverse Event|8|||
129948791|NCT01018992|467777400|FG001|Overall Study|Adverse Event|3|||
129948792|NCT01018992|467777399|FG000|Overall Study|Withdrawal by Subject|3|||
129948793|NCT01018992|467777400|FG001|Overall Study|Withdrawal by Subject|8|||
129948794|NCT01018992|467777399|FG000|Overall Study|Protocol Violation|0|||
129948795|NCT01018992|467777400|FG001|Overall Study|Protocol Violation|4|||
129948796|NCT01018992|467777399|FG000|Overall Study|Lost to Follow-up|5|||
129948797|NCT01018992|467777400|FG001|Overall Study|Lost to Follow-up|1|||
129948798|NCT03029585|467777401|FG000|Overall Study|Death|1|||
129948799|NCT03029585|467777402|FG001|Overall Study|Death|1|||
129948800|NCT03029585|467777401|FG000|Overall Study|Withdrawal by Subject|1|||
129948801|NCT03029585|467777402|FG001|Overall Study|Withdrawal by Subject|0|||
129948802|NCT01241448|467777403|FG000|Overall Study|Adverse Event|1|||
129948803|NCT01241448|467777404|FG001|Overall Study|Adverse Event|0|||
129948804|NCT01241448|467777405|FG002|Overall Study|Adverse Event|2|||
129948805|NCT01241448|467777406|FG003|Overall Study|Adverse Event|2|||
129948806|NCT01241448|467777403|FG000|Overall Study|Lost to Follow-up|2|||
129948807|NCT01241448|467777404|FG001|Overall Study|Lost to Follow-up|1|||
129948808|NCT01241448|467777405|FG002|Overall Study|Lost to Follow-up|1|||
129948809|NCT01241448|467777406|FG003|Overall Study|Lost to Follow-up|1|||
129948810|NCT01241448|467777403|FG000|Overall Study|Physician Decision|0|||
129948811|NCT01241448|467777404|FG001|Overall Study|Physician Decision|2|||
129948812|NCT01241448|467777405|FG002|Overall Study|Physician Decision|0|||
129948813|NCT01241448|467777406|FG003|Overall Study|Physician Decision|0|||
129948814|NCT01241448|467777403|FG000|Overall Study|Protocol Violation|10|||
129948815|NCT01241448|467777404|FG001|Overall Study|Protocol Violation|5|||
129948816|NCT01241448|467777405|FG002|Overall Study|Protocol Violation|3|||
129948817|NCT01241448|467777406|FG003|Overall Study|Protocol Violation|6|||
129948818|NCT01241448|467777403|FG000|Overall Study|Sponsor Decision|17|||
129948819|NCT01241448|467777404|FG001|Overall Study|Sponsor Decision|14|||
129948820|NCT01241448|467777405|FG002|Overall Study|Sponsor Decision|12|||
129948821|NCT01241448|467777406|FG003|Overall Study|Sponsor Decision|6|||
129948822|NCT01241448|467777403|FG000|Overall Study|Withdrawal by Subject|4|||
129948823|NCT01241448|467777404|FG001|Overall Study|Withdrawal by Subject|5|||
129948824|NCT01241448|467777405|FG002|Overall Study|Withdrawal by Subject|3|||
129948825|NCT01241448|467777406|FG003|Overall Study|Withdrawal by Subject|6|||
129948826|NCT01241448|467777403|FG000|Overall Study|Excluded due to data integrity issues|3|||
130071997|NCT01998958|468218102|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071998|NCT01998958|468218103|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
130071999|NCT01998958|468218104|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
130072000|NCT01998958|468218105|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
130072001|NCT01998958|468218074|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072002|NCT01998958|468218075|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072003|NCT01998958|468218076|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072004|NCT01998958|468218077|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072005|NCT01998958|468218078|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072006|NCT01998958|468218079|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072007|NCT01998958|468218080|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072008|NCT01998958|468218081|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072009|NCT01998958|468218082|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072010|NCT01998958|468218083|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072011|NCT01998958|468218084|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072012|NCT01998958|468218085|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072013|NCT01998958|468218086|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072014|NCT01998958|468218087|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072015|NCT01998958|468218088|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072016|NCT01998958|468218089|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072017|NCT01998958|468218090|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072018|NCT01998958|468218091|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072019|NCT01998958|468218092|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072020|NCT01998958|468218093|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072021|NCT01998958|468218094|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072022|NCT01998958|468218095|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
130072023|NCT01998958|468218096|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
130072024|NCT01998958|468218097|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
130072025|NCT01998958|468218098|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072026|NCT01998958|468218099|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072027|NCT01998958|468218100|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072028|NCT01998958|468218101|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072029|NCT01998958|468218102|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072030|NCT01998958|468218103|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072031|NCT01998958|468218104|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130120392|NCT00662129|468402357|FG000|Overall Study|Ineligible|1|||
130120393|NCT02153736|468402358|FG000|Overall Study|Lost to Follow-up|1|||
129948827|NCT01241448|467777404|FG001|Overall Study|Excluded due to data integrity issues|2|||
129948828|NCT01241448|467777405|FG002|Overall Study|Excluded due to data integrity issues|2|||
129948829|NCT01241448|467777406|FG003|Overall Study|Excluded due to data integrity issues|2|||
129948830|NCT02092285|467777407|FG000|Induction Phase|Adverse Event|7|||
129948831|NCT02092285|467777407|FG000|Induction Phase|Physician Decision|4|||
129948832|NCT02092285|467777407|FG000|Induction Phase|Pregnancy|1|||
129948833|NCT02092285|467777407|FG000|Induction Phase|Relapse/Recurrence|7|||
129948834|NCT02092285|467777407|FG000|Induction Phase|Withdrawal by Subject|2|||
129948835|NCT02092285|467777407|FG000|Induction Phase|Lack of Efficacy|14|||
129948836|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
129948837|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
129948838|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
129948839|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
129948840|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
129948841|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
129948842|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
129948843|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
129948844|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
129948845|NCT01825785|467777408|FG000|Overall Study|Adverse Event|0|||
129948846|NCT01825785|467777409|FG001|Overall Study|Adverse Event|0|||
129948847|NCT01825785|467777410|FG002|Overall Study|Adverse Event|0|||
129948848|NCT01825785|467777411|FG003|Overall Study|Adverse Event|0|||
129948849|NCT01825785|467777412|FG004|Overall Study|Adverse Event|1|||
129948850|NCT01825785|467777413|FG005|Overall Study|Adverse Event|0|||
129948851|NCT01825785|467777414|FG006|Overall Study|Adverse Event|0|||
130072032|NCT01998958|468218105|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
130072033|NCT00445341|468218106|FG000|Overall Study|refused further treatment|1|||
130072034|NCT00445341|468218106|FG000|Overall Study|taken off treatment too early|1|||
130120394|NCT02153736|468402359|FG001|Overall Study|Lost to Follow-up|0|||
129948852|NCT01825785|467777408|FG000|Overall Study|Withdrawal by Subject|0|||
129948853|NCT01825785|467777409|FG001|Overall Study|Withdrawal by Subject|0|||
129948854|NCT01825785|467777410|FG002|Overall Study|Withdrawal by Subject|0|||
129948855|NCT01825785|467777411|FG003|Overall Study|Withdrawal by Subject|0|||
129948856|NCT01825785|467777412|FG004|Overall Study|Withdrawal by Subject|1|||
129948857|NCT01825785|467777413|FG005|Overall Study|Withdrawal by Subject|1|||
129948858|NCT01825785|467777414|FG006|Overall Study|Withdrawal by Subject|0|||
129948859|NCT01304940|467777416|FG000|Overall Study|not meet symptom severity requirement|3|||
129948860|NCT01304940|467777417|FG001|Overall Study|not meet symptom severity requirement|0|||
129948861|NCT00278395|467777420|FG000|Overall Study|Adverse Event|2|||
129948862|NCT00278395|467777420|FG000|Overall Study|Nonevaluable|1|||
129948863|NCT03740737|467777421|FG000|Overall Study|Protocol deviation|13|||
129948864|NCT03740737|467777422|FG001|Overall Study|Protocol deviation|0|||
129948865|NCT03740737|467777421|FG000|Overall Study|Adverse Event|2|||
129948866|NCT03740737|467777422|FG001|Overall Study|Adverse Event|0|||
129948867|NCT03740737|467777421|FG000|Overall Study|Lost to Follow-up|1|||
129948868|NCT03740737|467777422|FG001|Overall Study|Lost to Follow-up|0|||
129948869|NCT03740737|467777421|FG000|Overall Study|Randomization failure|1|||
129948870|NCT03740737|467777422|FG001|Overall Study|Randomization failure|0|||
129948871|NCT03740737|467777421|FG000|Overall Study|Participant withdrew consent|1|||
129948872|NCT03740737|467777422|FG001|Overall Study|Participant withdrew consent|0|||
129948873|NCT03740737|467777421|FG000|Overall Study|Participant withdrew from trial|2|||
129948874|NCT03740737|467777422|FG001|Overall Study|Participant withdrew from trial|1|||
129948875|NCT01381549|467777429|FG000|Overall Study|Ineligible: No organisms isolated|0|||
129948876|NCT01381549|467777430|FG001|Overall Study|Ineligible: No organisms isolated|0|||
129948877|NCT01381549|467777431|FG002|Overall Study|Ineligible: No organisms isolated|1|||
129948878|NCT02981953|467777432|FG000|Overall Study|Death|9|||
129948879|NCT02981953|467777432|FG000|Overall Study|Withdrawal by Subject|1|||
129948880|NCT02981953|467777432|FG000|Overall Study|Withdrawal to non-compliance|1|||
129948881|NCT02889900|467777435|FG000|Overall Study|Adverse Event|11|||
129948882|NCT02889900|467777435|FG000|Overall Study|Condition under investigation worsened|32|||
129948883|NCT02889900|467777435|FG000|Overall Study|Other|5|||
129948884|NCT02889900|467777435|FG000|Overall Study|Withdrawal by Subject|7|||
129948885|NCT02889900|467777435|FG000|Overall Study|Not treated|2|||
129948886|NCT01416285|467777437|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
129948887|NCT01416285|467777438|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
129948888|NCT02784834|467777446|FG000|Overall Study|Lack of Efficacy|1|||
129948889|NCT01090739|467777447|FG000|Enrollment|Withdrawal by Subject|24|||
129948890|NCT01090739|467777447|FG000|Enrollment|Protocol Violation|14|||
129948891|NCT01090739|467777447|FG000|Enrollment|Lost to Follow-up|5|||
129948892|NCT01090739|467777447|FG000|Enrollment|Physician Decision|5|||
129948893|NCT01090739|467777447|FG000|Enrollment|Sponsor termination of site|4|||
129948894|NCT01090739|467777447|FG000|Enrollment|Study implant limit reached|2|||
129948895|NCT01090739|467777447|FG000|Enrollment|Adverse Event|1|||
129948896|NCT01090739|467777447|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
129948897|NCT01090739|467777447|FG000|12 Month Follow-up|Lost to Follow-up|1|||
129948898|NCT01090739|467777447|FG000|12 Month Follow-up|Physician Decision|1|||
129948899|NCT01090739|467777447|FG000|12 Month Follow-up|Death|1|||
129948900|NCT01090739|467777447|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
129948901|NCT01090739|467777447|FG000|24 Month Follow-up|Lost to Follow-up|1|||
129948902|NCT01090739|467777447|FG000|24 Month Follow-up|Death|1|||
129948903|NCT01090739|467777447|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
129948904|NCT01090739|467777447|FG000|36 Month Follow-up|Visit still pending|17|||
129948905|NCT00441168|467777448|FG000|Treatment Period|Death|3|||
129948906|NCT00441168|467777449|FG001|Treatment Period|Death|0|||
129948907|NCT00441168|467777448|FG000|Treatment Period|Adverse Event|1|||
129948908|NCT00441168|467777449|FG001|Treatment Period|Adverse Event|2|||
129948909|NCT00441168|467777448|FG000|Treatment Period|Progressive Disease|0|||
129948910|NCT00441168|467777449|FG001|Treatment Period|Progressive Disease|2|||
129948911|NCT00441168|467777448|FG000|Treatment Period|Protocol Violation|0|||
129948912|NCT00441168|467777449|FG001|Treatment Period|Protocol Violation|1|||
130072035|NCT00968708|468218113|FG000|Overall Study|Adverse Event|169|||
130072036|NCT00968708|468218114|FG001|Overall Study|Adverse Event|150|||
130072037|NCT00968708|468218113|FG000|Overall Study|Major Protocol Deviation|0|||
129948913|NCT00441168|467777448|FG000|Treatment Period|Lost to Follow-up|0|||
129948914|NCT00441168|467777449|FG001|Treatment Period|Lost to Follow-up|1|||
129948915|NCT00441168|467777448|FG000|Treatment Period|Withdrawal by Subject|3|||
129948916|NCT00441168|467777449|FG001|Treatment Period|Withdrawal by Subject|0|||
129948917|NCT00441168|467777448|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
129948918|NCT00441168|467777449|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
129948919|NCT00441168|467777448|FG000|Treatment Period|refractory disease|1|||
129948920|NCT00441168|467777449|FG001|Treatment Period|refractory disease|0|||
129948921|NCT00441168|467777448|FG000|Follow-up Period|Death|3|||
130072038|NCT00968708|468218114|FG001|Overall Study|Major Protocol Deviation|1|||
130072039|NCT00968708|468218113|FG000|Overall Study|Lost to Follow-up|19|||
129948922|NCT00441168|467777449|FG001|Follow-up Period|Death|0|||
129948923|NCT00441168|467777448|FG000|Follow-up Period|Lost to Follow-up|5|||
129948924|NCT00441168|467777449|FG001|Follow-up Period|Lost to Follow-up|6|||
129948925|NCT00441168|467777448|FG000|Follow-up Period|Withdrawal by Subject|3|||
129948926|NCT00441168|467777449|FG001|Follow-up Period|Withdrawal by Subject|0|||
129948927|NCT00441168|467777448|FG000|Follow-up Period|Other|1|||
129948928|NCT00441168|467777449|FG001|Follow-up Period|Other|3|||
129948929|NCT03693989|467777450|FG000|Overall Study|Protocol Violation|3|||
129948930|NCT03693989|467777451|FG001|Overall Study|Protocol Violation|4|||
129948931|NCT03146845|467777452|FG000|Overall Study|Reference ulcer healed|1|||
129948932|NCT03146845|467777453|FG001|Overall Study|Reference ulcer healed|0|||
129948933|NCT03146845|467777452|FG000|Overall Study|Physician Decision|1|||
129948934|NCT03146845|467777453|FG001|Overall Study|Physician Decision|0|||
129948935|NCT03146845|467777452|FG000|Overall Study|Adverse Event|1|||
129948936|NCT03146845|467777453|FG001|Overall Study|Adverse Event|0|||
129948937|NCT03146845|467777452|FG000|Overall Study|Withdrawal by Subject|2|||
129948938|NCT03146845|467777453|FG001|Overall Study|Withdrawal by Subject|0|||
129948939|NCT03146845|467777452|FG000|Overall Study|Noncompliance|0|||
129948940|NCT03146845|467777453|FG001|Overall Study|Noncompliance|1|||
129948941|NCT03146845|467777452|FG000|Overall Study|Protocol Violation|0|||
129948942|NCT03146845|467777453|FG001|Overall Study|Protocol Violation|2|||
129948943|NCT03146845|467777452|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
129948944|NCT03146845|467777453|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
129948945|NCT00113529|467777456|FG000|Overall Study|Adverse Event|4|||
129948946|NCT00113529|467777456|FG000|Overall Study|Lack of Efficacy|20|||
129948947|NCT00113529|467777456|FG000|Overall Study|Decision of sponsor|6|||
129948948|NCT00113529|467777456|FG000|Overall Study|Withdrawal by Subject|4|||
129948949|NCT01535261|467777457|FG000|Overall Study|Physician Decision|8|||
129948950|NCT01535261|467777457|FG000|Overall Study|Protocol Violation|3|||
129948951|NCT01535261|467777457|FG000|Overall Study|Death|5|||
129948952|NCT01535261|467777457|FG000|Overall Study|Lost to Follow-up|8|||
129948953|NCT01535261|467777457|FG000|Overall Study|Withdrawal by Subject|14|||
129948954|NCT01535261|467777457|FG000|Overall Study|Adverse Event|12|||
129948955|NCT01757288|467777460|FG000|Overall Study|Consent withdrawal|0|||
129948956|NCT01757288|467777461|FG001|Overall Study|Consent withdrawal|4|||
129948957|NCT01757288|467777462|FG002|Overall Study|Consent withdrawal|4|||
129948958|NCT01757288|467777460|FG000|Overall Study|Patient off study, IRB hold.|0|||
129948959|NCT01757288|467777461|FG001|Overall Study|Patient off study, IRB hold.|0|||
129948960|NCT01757288|467777462|FG002|Overall Study|Patient off study, IRB hold.|1|||
129948961|NCT01757288|467777460|FG000|Overall Study|Patient death prior to starting treatment|0|||
129948962|NCT01757288|467777461|FG001|Overall Study|Patient death prior to starting treatment|0|||
129948963|NCT01757288|467777462|FG002|Overall Study|Patient death prior to starting treatment|1|||
129948964|NCT01757288|467777460|FG000|Overall Study|Wrong medication administered|0|||
129948965|NCT01757288|467777461|FG001|Overall Study|Wrong medication administered|1|||
129948966|NCT01757288|467777462|FG002|Overall Study|Wrong medication administered|0|||
129948967|NCT01757288|467777460|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
129948968|NCT01757288|467777461|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
129948969|NCT01757288|467777462|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
129948970|NCT01757288|467777460|FG000|Overall Study|Not meeting protocol constraints|0|||
129948971|NCT01757288|467777461|FG001|Overall Study|Not meeting protocol constraints|1|||
129948972|NCT01757288|467777462|FG002|Overall Study|Not meeting protocol constraints|1|||
129948973|NCT01757288|467777460|FG000|Overall Study|Multiple missed appointments|0|||
129948974|NCT01757288|467777461|FG001|Overall Study|Multiple missed appointments|1|||
129948975|NCT01757288|467777462|FG002|Overall Study|Multiple missed appointments|0|||
129948976|NCT01757288|467777460|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
129948977|NCT01757288|467777461|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
129948978|NCT01757288|467777462|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
129948979|NCT01757288|467777460|FG000|Overall Study|>2 weeks treatment break|0|||
129948980|NCT01757288|467777461|FG001|Overall Study|>2 weeks treatment break|0|||
129948981|NCT01757288|467777462|FG002|Overall Study|>2 weeks treatment break|1|||
129948982|NCT00042939|467777463|FG000|Overall Study|Adverse Event|6|||
129948983|NCT00042939|467777464|FG001|Overall Study|Adverse Event|7|||
129948984|NCT00042939|467777463|FG000|Overall Study|Death|3|||
129948985|NCT00042939|467777464|FG001|Overall Study|Death|2|||
129948986|NCT00042939|467777463|FG000|Overall Study|Withdrawal by Subject|3|||
129948987|NCT00042939|467777464|FG001|Overall Study|Withdrawal by Subject|4|||
129948988|NCT00042939|467777463|FG000|Overall Study|Other disease|1|||
129948989|NCT00042939|467777464|FG001|Overall Study|Other disease|0|||
129948990|NCT00042939|467777463|FG000|Overall Study|Ineligible|2|||
129948991|NCT00042939|467777464|FG001|Overall Study|Ineligible|2|||
129948992|NCT00042939|467777463|FG000|Overall Study|Deterioration of health|3|||
129948993|NCT00042939|467777464|FG001|Overall Study|Deterioration of health|4|||
129948994|NCT00042939|467777463|FG000|Overall Study|QOL diminished|1|||
129948995|NCT00042939|467777464|FG001|Overall Study|QOL diminished|0|||
129948996|NCT00042939|467777463|FG000|Overall Study|Rising ca 19-9|1|||
129948997|NCT00042939|467777464|FG001|Overall Study|Rising ca 19-9|0|||
129948998|NCT00042939|467777463|FG000|Overall Study|Patient non-compliance|1|||
129948999|NCT00042939|467777464|FG001|Overall Study|Patient non-compliance|0|||
129949000|NCT00042939|467777463|FG000|Overall Study|Still on treatment|1|||
129949001|NCT00042939|467777464|FG001|Overall Study|Still on treatment|0|||
129949002|NCT00042939|467777463|FG000|Overall Study|Treatment break > 4 weeks|0|||
129949003|NCT00042939|467777464|FG001|Overall Study|Treatment break > 4 weeks|1|||
129949004|NCT00042939|467777463|FG000|Overall Study|Did not start treatment|2|||
129949005|NCT00042939|467777464|FG001|Overall Study|Did not start treatment|1|||
129949006|NCT02525744|467777465|FG000|Period 1|Physician Decision|0|||
129949007|NCT02525744|467777466|FG001|Period 1|Physician Decision|0|||
129949008|NCT02525744|467777467|FG002|Period 1|Physician Decision|1|||
129949009|NCT02525744|467777468|FG003|Period 1|Physician Decision|0|||
129949010|NCT02525744|467777465|FG000|Period 3|Adverse Event|0|||
129949011|NCT02525744|467777466|FG001|Period 3|Adverse Event|1|||
129949012|NCT02525744|467777467|FG002|Period 3|Adverse Event|0|||
129949013|NCT02525744|467777468|FG003|Period 3|Adverse Event|0|||
129949014|NCT02525744|467777465|FG000|Period 4|Withdrawal by Subject|1|||
129949015|NCT02525744|467777466|FG001|Period 4|Withdrawal by Subject|0|||
129949016|NCT02525744|467777467|FG002|Period 4|Withdrawal by Subject|0|||
129949017|NCT02525744|467777468|FG003|Period 4|Withdrawal by Subject|0|||
129949018|NCT02525744|467777465|FG000|Period 5|Physician Decision|1|||
129949019|NCT02525744|467777466|FG001|Period 5|Physician Decision|0|||
129949020|NCT02525744|467777467|FG002|Period 5|Physician Decision|0|||
129949021|NCT02525744|467777468|FG003|Period 5|Physician Decision|0|||
129949022|NCT01777932|467777469|FG000|Overall Study|Disease progression|136|||
129949023|NCT01777932|467777469|FG000|Overall Study|Death|3|||
129949024|NCT01777932|467777469|FG000|Overall Study|Adverse Event|34|||
129949025|NCT01777932|467777469|FG000|Overall Study|Lost to Follow-up|3|||
129949026|NCT01777932|467777469|FG000|Overall Study|Investigator decision|10|||
129949027|NCT01777932|467777469|FG000|Overall Study|Reimbursement limit|9|||
129949028|NCT01777932|467777469|FG000|Overall Study|Patient refused further treatment|10|||
129949029|NCT02514824|467777474|FG000|Overall Study|Withdrawal by Subject|1|||
129949030|NCT02514824|467777475|FG001|Overall Study|Withdrawal by Subject|0|||
129949031|NCT02514824|467777476|FG002|Overall Study|Withdrawal by Subject|0|||
129949032|NCT02514824|467777477|FG003|Overall Study|Withdrawal by Subject|0|||
129949033|NCT02514824|467777474|FG000|Overall Study|Dose-Limiting Toxicity|0|||
129949034|NCT02514824|467777475|FG001|Overall Study|Dose-Limiting Toxicity|1|||
129949035|NCT02514824|467777476|FG002|Overall Study|Dose-Limiting Toxicity|0|||
129949036|NCT02514824|467777477|FG003|Overall Study|Dose-Limiting Toxicity|0|||
129949037|NCT01930188|467777478|FG000|Overall Study|unclassified|4|||
129949038|NCT01930188|467777479|FG001|Overall Study|unclassified|5|||
129949039|NCT01930188|467777480|FG002|Overall Study|unclassified|3|||
129949040|NCT01930188|467777478|FG000|Overall Study|Missing follow-up information|2|||
129949041|NCT01930188|467777479|FG001|Overall Study|Missing follow-up information|2|||
129949042|NCT01930188|467777480|FG002|Overall Study|Missing follow-up information|3|||
129949043|NCT01930188|467777478|FG000|Overall Study|Lost to Follow-up|5|||
129949044|NCT01930188|467777479|FG001|Overall Study|Lost to Follow-up|2|||
129949045|NCT01930188|467777480|FG002|Overall Study|Lost to Follow-up|2|||
129949046|NCT01930188|467777478|FG000|Overall Study|Death|2|||
129949047|NCT01930188|467777479|FG001|Overall Study|Death|1|||
129949048|NCT01930188|467777480|FG002|Overall Study|Death|3|||
129949049|NCT01930188|467777478|FG000|Overall Study|Withdrawal by Subject|9|||
129949050|NCT01930188|467777479|FG001|Overall Study|Withdrawal by Subject|11|||
129949051|NCT01930188|467777480|FG002|Overall Study|Withdrawal by Subject|8|||
129949052|NCT03150589|467777481|FG000|Overall Study|Withdrawal by Subject|16|||
129949053|NCT03150589|467777482|FG001|Overall Study|Withdrawal by Subject|9|||
129949054|NCT03150589|467777481|FG000|Overall Study|Adverse Event|7|||
129949055|NCT03150589|467777482|FG001|Overall Study|Adverse Event|6|||
129949056|NCT03150589|467777481|FG000|Overall Study|Protocol Violation|4|||
129949057|NCT03150589|467777482|FG001|Overall Study|Protocol Violation|3|||
129949058|NCT03150589|467777481|FG000|Overall Study|Lost to Follow-up|3|||
129949059|NCT03150589|467777482|FG001|Overall Study|Lost to Follow-up|3|||
129949060|NCT03150589|467777481|FG000|Overall Study|Death|2|||
129949061|NCT03150589|467777482|FG001|Overall Study|Death|3|||
129949062|NCT03150589|467777481|FG000|Overall Study|IP non-compliance and other reasons|12|||
129949063|NCT03150589|467777482|FG001|Overall Study|IP non-compliance and other reasons|3|||
129949064|NCT01020435|467777485|FG000|Overall Study|Lost to Follow-up|0|||
129949065|NCT01020435|467777486|FG001|Overall Study|Lost to Follow-up|1|||
129949066|NCT01000649|467777487|FG000|Overall Study|Adverse Event|5|||
129949067|NCT01000649|467777488|FG001|Overall Study|Adverse Event|1|||
130072040|NCT00968708|468218114|FG001|Overall Study|Lost to Follow-up|11|||
130072041|NCT00968708|468218113|FG000|Overall Study|Voluntary Withdrawal|104|||
129949068|NCT01000649|467777489|FG002|Overall Study|Adverse Event|2|||
129949069|NCT01000649|467777490|FG003|Overall Study|Adverse Event|4|||
129949070|NCT01000649|467777487|FG000|Overall Study|Lost to Follow-up|0|||
129949071|NCT01000649|467777488|FG001|Overall Study|Lost to Follow-up|2|||
129949072|NCT01000649|467777489|FG002|Overall Study|Lost to Follow-up|0|||
129949073|NCT01000649|467777490|FG003|Overall Study|Lost to Follow-up|2|||
129949074|NCT00346398|467777491|FG000|Overall Study|Lost to Follow-up|3|||
130072042|NCT00968708|468218114|FG001|Overall Study|Voluntary Withdrawal|101|||
129949075|NCT00346398|467777492|FG001|Overall Study|Lost to Follow-up|0|||
129949076|NCT00346398|467777491|FG000|Overall Study|Withdrawal by Subject|0|||
129949077|NCT00346398|467777492|FG001|Overall Study|Withdrawal by Subject|2|||
129949078|NCT02607956|467777493|FG000|Double-Blinded Phase|Withdrew Consent|17|||
129949079|NCT02607956|467777494|FG001|Double-Blinded Phase|Withdrew Consent|19|||
129949080|NCT02607956|467777495|FG002|Double-Blinded Phase|Withdrew Consent|0|||
129949081|NCT02607956|467777496|FG003|Double-Blinded Phase|Withdrew Consent|0|||
129949082|NCT02607956|467777493|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
129949083|NCT02607956|467777494|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
129949084|NCT02607956|467777495|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
129949085|NCT02607956|467777496|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
129949086|NCT02607956|467777493|FG000|Double-Blinded Phase|Randomized but never treated|7|||
129949087|NCT02607956|467777494|FG001|Double-Blinded Phase|Randomized but never treated|5|||
129949088|NCT02607956|467777495|FG002|Double-Blinded Phase|Randomized but never treated|0|||
129949089|NCT02607956|467777496|FG003|Double-Blinded Phase|Randomized but never treated|0|||
129949090|NCT02607956|467777493|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
129949091|NCT02607956|467777494|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
129949092|NCT02607956|467777495|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
129949093|NCT02607956|467777496|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
129949094|NCT02607956|467777493|FG000|Double-Blinded Phase|Death|4|||
129949095|NCT02607956|467777494|FG001|Double-Blinded Phase|Death|4|||
129949096|NCT02607956|467777495|FG002|Double-Blinded Phase|Death|0|||
129949097|NCT02607956|467777496|FG003|Double-Blinded Phase|Death|0|||
129949098|NCT02607956|467777493|FG000|Double-Blinded Phase|Adverse Event|4|||
129949099|NCT02607956|467777494|FG001|Double-Blinded Phase|Adverse Event|3|||
129949100|NCT02607956|467777495|FG002|Double-Blinded Phase|Adverse Event|0|||
129949101|NCT02607956|467777496|FG003|Double-Blinded Phase|Adverse Event|0|||
129949102|NCT02607956|467777493|FG000|Double-Blinded Phase|Protocol Violation|3|||
129949103|NCT02607956|467777494|FG001|Double-Blinded Phase|Protocol Violation|1|||
129949104|NCT02607956|467777495|FG002|Double-Blinded Phase|Protocol Violation|0|||
129949105|NCT02607956|467777496|FG003|Double-Blinded Phase|Protocol Violation|0|||
129949106|NCT02607956|467777493|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
129949107|NCT02607956|467777494|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
129949108|NCT02607956|467777495|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
129949109|NCT02607956|467777496|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
129949110|NCT02607956|467777493|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
129949111|NCT02607956|467777494|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
129949112|NCT02607956|467777495|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
129949113|NCT02607956|467777496|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
129949114|NCT02607956|467777493|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129949115|NCT02607956|467777494|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129949116|NCT02607956|467777495|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
129949117|NCT02607956|467777496|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
129949118|NCT02607956|467777493|FG000|Open-Label Extension Phase|Death|0|||
129949119|NCT02607956|467777494|FG001|Open-Label Extension Phase|Death|0|||
129949120|NCT02607956|467777495|FG002|Open-Label Extension Phase|Death|1|||
129949121|NCT02607956|467777496|FG003|Open-Label Extension Phase|Death|3|||
129949122|NCT02607956|467777493|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
129949123|NCT02607956|467777494|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
129949124|NCT02607956|467777495|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
129949125|NCT02607956|467777496|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
129949126|NCT02607956|467777493|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
129949127|NCT02607956|467777494|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
129949128|NCT02607956|467777495|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
129949129|NCT02607956|467777496|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
129949130|NCT02607956|467777493|FG000|Open-Label Extension Phase|Protocol Violation|0|||
130072043|NCT00968708|468218113|FG000|Overall Study|Investigator Discretion|0|||
130072044|NCT00968708|468218114|FG001|Overall Study|Investigator Discretion|1|||
130072045|NCT00968708|468218113|FG000|Overall Study|Other|26|||
129949131|NCT02607956|467777494|FG001|Open-Label Extension Phase|Protocol Violation|0|||
129949132|NCT02607956|467777495|FG002|Open-Label Extension Phase|Protocol Violation|0|||
129949133|NCT02607956|467777496|FG003|Open-Label Extension Phase|Protocol Violation|2|||
129949134|NCT02607956|467777493|FG000|Open-Label Extension Phase|Pregnancy|0|||
130072046|NCT00968708|468218114|FG001|Overall Study|Other|34|||
130072047|NCT03407170|468218115|FG000|Overall Study|Adverse Event|1|||
130072048|NCT01851863|468218120|FG000|Overall Study|Did not receive study medication|2|||
129949135|NCT02607956|467777494|FG001|Open-Label Extension Phase|Pregnancy|0|||
129949136|NCT02607956|467777495|FG002|Open-Label Extension Phase|Pregnancy|0|||
130072049|NCT01851863|468218121|FG001|Overall Study|Did not receive study medication|5|||
130072050|NCT01851863|468218122|FG002|Overall Study|Did not receive study medication|3|||
130072051|NCT01851863|468218123|FG003|Overall Study|Did not receive study medication|0|||
130072052|NCT01851863|468218120|FG000|Overall Study|Lost to Follow-up|3|||
130072053|NCT01851863|468218121|FG001|Overall Study|Lost to Follow-up|4|||
130072054|NCT01851863|468218122|FG002|Overall Study|Lost to Follow-up|2|||
130072055|NCT01851863|468218123|FG003|Overall Study|Lost to Follow-up|3|||
130072056|NCT03238352|468218124|FG000|Overall Study|Lost to Follow-up|0|||
130072057|NCT03238352|468218125|FG001|Overall Study|Lost to Follow-up|2|||
130072058|NCT03238352|468218126|FG002|Overall Study|Lost to Follow-up|1|||
130072059|NCT03238352|468218124|FG000|Overall Study|Withdrawal by Subject|0|||
130072060|NCT03238352|468218125|FG001|Overall Study|Withdrawal by Subject|1|||
130072061|NCT03238352|468218126|FG002|Overall Study|Withdrawal by Subject|0|||
130072062|NCT00928512|468218127|FG000|Overall Study|Adverse Event|4|||
130072063|NCT00928512|468218128|FG001|Overall Study|Adverse Event|3|||
130072064|NCT00928512|468218129|FG002|Overall Study|Adverse Event|2|||
130072065|NCT00928512|468218130|FG003|Overall Study|Adverse Event|8|||
130072066|NCT00928512|468218131|FG004|Overall Study|Adverse Event|6|||
130072067|NCT00928512|468218127|FG000|Overall Study|Lack of Efficacy|2|||
130072068|NCT00928512|468218128|FG001|Overall Study|Lack of Efficacy|0|||
130072069|NCT00928512|468218129|FG002|Overall Study|Lack of Efficacy|4|||
130072070|NCT00928512|468218130|FG003|Overall Study|Lack of Efficacy|7|||
130072071|NCT00928512|468218131|FG004|Overall Study|Lack of Efficacy|3|||
130072072|NCT00928512|468218127|FG000|Overall Study|Protocol Violation|0|||
130072073|NCT00928512|468218128|FG001|Overall Study|Protocol Violation|1|||
130072074|NCT00928512|468218129|FG002|Overall Study|Protocol Violation|0|||
130072075|NCT00928512|468218130|FG003|Overall Study|Protocol Violation|1|||
130072076|NCT00928512|468218131|FG004|Overall Study|Protocol Violation|3|||
130072077|NCT00928512|468218127|FG000|Overall Study|Withdrawal by Subject|3|||
130072078|NCT00928512|468218128|FG001|Overall Study|Withdrawal by Subject|0|||
130072079|NCT00928512|468218129|FG002|Overall Study|Withdrawal by Subject|3|||
130072080|NCT00928512|468218130|FG003|Overall Study|Withdrawal by Subject|4|||
130072081|NCT00928512|468218131|FG004|Overall Study|Withdrawal by Subject|0|||
130072082|NCT00928512|468218127|FG000|Overall Study|Lost to Follow-up|1|||
130072083|NCT00928512|468218128|FG001|Overall Study|Lost to Follow-up|1|||
130072084|NCT00928512|468218129|FG002|Overall Study|Lost to Follow-up|2|||
130072085|NCT00928512|468218130|FG003|Overall Study|Lost to Follow-up|1|||
130072086|NCT00928512|468218131|FG004|Overall Study|Lost to Follow-up|3|||
130072087|NCT00928512|468218127|FG000|Overall Study|Administrative Problems|0|||
130072088|NCT00928512|468218128|FG001|Overall Study|Administrative Problems|1|||
130072089|NCT00928512|468218129|FG002|Overall Study|Administrative Problems|0|||
130072090|NCT00928512|468218130|FG003|Overall Study|Administrative Problems|0|||
130072091|NCT00928512|468218131|FG004|Overall Study|Administrative Problems|0|||
130072092|NCT01963780|468218132|FG000|Overall Study|Death|7|||
130072093|NCT04153929|468218133|FG000|Overall Study|Other than listed|2|||
130072094|NCT04153929|468218134|FG001|Overall Study|Other than listed|2|||
130072095|NCT04153929|468218135|FG002|Overall Study|Other than listed|0|||
130072096|NCT04153929|468218136|FG003|Overall Study|Other than listed|1|||
130072097|NCT04153929|468218137|FG004|Overall Study|Other than listed|0|||
130072098|NCT04153929|468218138|FG005|Overall Study|Other than listed|2|||
130072099|NCT04153929|468218139|FG006|Overall Study|Other than listed|2|||
130072100|NCT04153929|468218140|FG007|Overall Study|Other than listed|1|||
130120395|NCT02153736|468402358|FG000|Overall Study|Medical status change made ineligible|1|||
130120396|NCT02153736|468402359|FG001|Overall Study|Medical status change made ineligible|0|||
129949137|NCT02607956|467777496|FG003|Open-Label Extension Phase|Pregnancy|1|||
129949138|NCT00103857|467777497|FG000|54-Week Base Study|Adverse Event|12|||
129949139|NCT00103857|467777498|FG001|54-Week Base Study|Adverse Event|9|||
129949140|NCT00103857|467777499|FG002|54-Week Base Study|Adverse Event|11|||
129949141|NCT00103857|467777500|FG003|54-Week Base Study|Adverse Event|6|||
129949142|NCT00103857|467777501|FG004|54-Week Base Study|Adverse Event|5|||
129949143|NCT00103857|467777502|FG005|54-Week Base Study|Adverse Event|11|||
129949144|NCT00103857|467777503|FG006|54-Week Base Study|Adverse Event|3|||
129949145|NCT00103857|467777497|FG000|54-Week Base Study|Death|0|||
129949146|NCT00103857|467777498|FG001|54-Week Base Study|Death|0|||
129949147|NCT00103857|467777499|FG002|54-Week Base Study|Death|0|||
129949148|NCT00103857|467777500|FG003|54-Week Base Study|Death|0|||
129949149|NCT00103857|467777501|FG004|54-Week Base Study|Death|1|||
130072101|NCT04153929|468218133|FG000|Overall Study|Lost to Follow-up|2|||
129949150|NCT00103857|467777502|FG005|54-Week Base Study|Death|1|||
130072102|NCT04153929|468218134|FG001|Overall Study|Lost to Follow-up|1|||
130072103|NCT04153929|468218135|FG002|Overall Study|Lost to Follow-up|0|||
130072104|NCT04153929|468218136|FG003|Overall Study|Lost to Follow-up|1|||
130072105|NCT04153929|468218137|FG004|Overall Study|Lost to Follow-up|1|||
130072106|NCT04153929|468218138|FG005|Overall Study|Lost to Follow-up|0|||
130072107|NCT04153929|468218139|FG006|Overall Study|Lost to Follow-up|0|||
130072108|NCT04153929|468218140|FG007|Overall Study|Lost to Follow-up|0|||
129949151|NCT00103857|467777503|FG006|54-Week Base Study|Death|0|||
129949152|NCT00103857|467777497|FG000|54-Week Base Study|Lack of Efficacy|11|||
129949153|NCT00103857|467777498|FG001|54-Week Base Study|Lack of Efficacy|14|||
130072109|NCT04153929|468218133|FG000|Overall Study|Withdrawal by Subject|3|||
130072110|NCT04153929|468218134|FG001|Overall Study|Withdrawal by Subject|1|||
130072111|NCT04153929|468218135|FG002|Overall Study|Withdrawal by Subject|0|||
130072112|NCT04153929|468218136|FG003|Overall Study|Withdrawal by Subject|3|||
130120397|NCT02153736|468402358|FG000|Overall Study|Death|0|||
129949154|NCT00103857|467777499|FG002|54-Week Base Study|Lack of Efficacy|8|||
129949155|NCT00103857|467777500|FG003|54-Week Base Study|Lack of Efficacy|4|||
129949156|NCT00103857|467777501|FG004|54-Week Base Study|Lack of Efficacy|3|||
129949157|NCT00103857|467777502|FG005|54-Week Base Study|Lack of Efficacy|14|||
129949158|NCT00103857|467777503|FG006|54-Week Base Study|Lack of Efficacy|19|||
129949159|NCT00103857|467777497|FG000|54-Week Base Study|Lost to Follow-up|5|||
129949160|NCT00103857|467777498|FG001|54-Week Base Study|Lost to Follow-up|4|||
129949161|NCT00103857|467777499|FG002|54-Week Base Study|Lost to Follow-up|7|||
129949162|NCT00103857|467777500|FG003|54-Week Base Study|Lost to Follow-up|5|||
129949163|NCT00103857|467777501|FG004|54-Week Base Study|Lost to Follow-up|10|||
129949164|NCT00103857|467777502|FG005|54-Week Base Study|Lost to Follow-up|9|||
129949165|NCT00103857|467777503|FG006|54-Week Base Study|Lost to Follow-up|3|||
129949166|NCT00103857|467777497|FG000|54-Week Base Study|Physician Decision|1|||
129949167|NCT00103857|467777498|FG001|54-Week Base Study|Physician Decision|1|||
129949168|NCT00103857|467777499|FG002|54-Week Base Study|Physician Decision|0|||
129949169|NCT00103857|467777500|FG003|54-Week Base Study|Physician Decision|0|||
129949170|NCT00103857|467777501|FG004|54-Week Base Study|Physician Decision|1|||
129949171|NCT00103857|467777502|FG005|54-Week Base Study|Physician Decision|0|||
129949172|NCT00103857|467777503|FG006|54-Week Base Study|Physician Decision|0|||
129949173|NCT00103857|467777497|FG000|54-Week Base Study|Pregnancy|1|||
129949174|NCT00103857|467777498|FG001|54-Week Base Study|Pregnancy|0|||
129949175|NCT00103857|467777499|FG002|54-Week Base Study|Pregnancy|0|||
129949176|NCT00103857|467777500|FG003|54-Week Base Study|Pregnancy|0|||
129949177|NCT00103857|467777501|FG004|54-Week Base Study|Pregnancy|1|||
129949178|NCT00103857|467777502|FG005|54-Week Base Study|Pregnancy|0|||
129949179|NCT00103857|467777503|FG006|54-Week Base Study|Pregnancy|1|||
129949180|NCT00103857|467777497|FG000|54-Week Base Study|Protocol Violation|6|||
129949181|NCT00103857|467777498|FG001|54-Week Base Study|Protocol Violation|4|||
129949182|NCT00103857|467777499|FG002|54-Week Base Study|Protocol Violation|2|||
129949183|NCT00103857|467777500|FG003|54-Week Base Study|Protocol Violation|4|||
129949184|NCT00103857|467777501|FG004|54-Week Base Study|Protocol Violation|0|||
129949185|NCT00103857|467777502|FG005|54-Week Base Study|Protocol Violation|3|||
129949186|NCT00103857|467777503|FG006|54-Week Base Study|Protocol Violation|3|||
129949187|NCT00103857|467777497|FG000|54-Week Base Study|Withdrawal by Subject|17|||
129949188|NCT00103857|467777498|FG001|54-Week Base Study|Withdrawal by Subject|16|||
129949189|NCT00103857|467777499|FG002|54-Week Base Study|Withdrawal by Subject|16|||
129949190|NCT00103857|467777500|FG003|54-Week Base Study|Withdrawal by Subject|15|||
129949191|NCT00103857|467777501|FG004|54-Week Base Study|Withdrawal by Subject|10|||
129949192|NCT00103857|467777502|FG005|54-Week Base Study|Withdrawal by Subject|15|||
129949193|NCT00103857|467777503|FG006|54-Week Base Study|Withdrawal by Subject|4|||
129949194|NCT00103857|467777497|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
129949195|NCT00103857|467777498|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
129949196|NCT00103857|467777499|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
129949197|NCT00103857|467777500|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
129949198|NCT00103857|467777501|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
129949199|NCT00103857|467777502|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
129949200|NCT00103857|467777503|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
129949201|NCT00103857|467777497|FG000|54-Week Base Study|patient moved|0|||
129949202|NCT00103857|467777498|FG001|54-Week Base Study|patient moved|1|||
129949203|NCT00103857|467777499|FG002|54-Week Base Study|patient moved|1|||
129949204|NCT00103857|467777500|FG003|54-Week Base Study|patient moved|2|||
129949205|NCT00103857|467777501|FG004|54-Week Base Study|patient moved|3|||
129949206|NCT00103857|467777502|FG005|54-Week Base Study|patient moved|1|||
129949207|NCT00103857|467777503|FG006|54-Week Base Study|patient moved|0|||
129949208|NCT00103857|467777497|FG000|54-Week Base Study|non-compliance with study procedures|1|||
129949209|NCT00103857|467777498|FG001|54-Week Base Study|non-compliance with study procedures|2|||
129949210|NCT00103857|467777499|FG002|54-Week Base Study|non-compliance with study procedures|0|||
129949211|NCT00103857|467777500|FG003|54-Week Base Study|non-compliance with study procedures|0|||
129949212|NCT00103857|467777501|FG004|54-Week Base Study|non-compliance with study procedures|0|||
129949213|NCT00103857|467777502|FG005|54-Week Base Study|non-compliance with study procedures|2|||
129949214|NCT00103857|467777503|FG006|54-Week Base Study|non-compliance with study procedures|0|||
129949215|NCT00103857|467777497|FG000|54-Week Base Study|patient incarcerated|0|||
129949216|NCT00103857|467777498|FG001|54-Week Base Study|patient incarcerated|0|||
129949217|NCT00103857|467777499|FG002|54-Week Base Study|patient incarcerated|0|||
129949218|NCT00103857|467777500|FG003|54-Week Base Study|patient incarcerated|0|||
129949219|NCT00103857|467777501|FG004|54-Week Base Study|patient incarcerated|1|||
129949220|NCT00103857|467777502|FG005|54-Week Base Study|patient incarcerated|1|||
129949221|NCT00103857|467777503|FG006|54-Week Base Study|patient incarcerated|0|||
129949222|NCT00103857|467777497|FG000|54-Week Base Study|laboratory reporting error|0|||
129949223|NCT00103857|467777498|FG001|54-Week Base Study|laboratory reporting error|0|||
129949224|NCT00103857|467777499|FG002|54-Week Base Study|laboratory reporting error|0|||
129949225|NCT00103857|467777500|FG003|54-Week Base Study|laboratory reporting error|0|||
129949226|NCT00103857|467777501|FG004|54-Week Base Study|laboratory reporting error|1|||
129949227|NCT00103857|467777502|FG005|54-Week Base Study|laboratory reporting error|0|||
130072113|NCT04153929|468218137|FG004|Overall Study|Withdrawal by Subject|1|||
130072114|NCT04153929|468218138|FG005|Overall Study|Withdrawal by Subject|0|||
130072115|NCT04153929|468218139|FG006|Overall Study|Withdrawal by Subject|1|||
130072116|NCT04153929|468218140|FG007|Overall Study|Withdrawal by Subject|0|||
130072117|NCT04153929|468218133|FG000|Overall Study|Protocol Violation|0|||
130072118|NCT04153929|468218134|FG001|Overall Study|Protocol Violation|0|||
130072119|NCT04153929|468218135|FG002|Overall Study|Protocol Violation|0|||
130120398|NCT02153736|468402359|FG001|Overall Study|Death|1|||
130120399|NCT02153736|468402358|FG000|Overall Study|Withdrawal by Subject|0|||
130120400|NCT02153736|468402359|FG001|Overall Study|Withdrawal by Subject|1|||
130120401|NCT01485536|468402365|FG000|Overall Study|Withdrawal by Subject|3|||
130120402|NCT01485536|468402365|FG000|Overall Study|Adverse Event|1|||
130120403|NCT00720122|468402371|FG000|Overall Study|Lost to Follow-up|1|||
130120404|NCT00720122|468402371|FG000|Overall Study|Physician Decision|1|||
130120405|NCT00720122|468402371|FG000|Overall Study|Withdrawal by Subject|7|||
130120406|NCT03072459|468402372|FG000|Overall Study|Device revised/removed|1|||
130120407|NCT03072459|468402372|FG000|Overall Study|Subject not able to return|1|||
130120408|NCT02579096|468402373|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
130120409|NCT02579096|468402374|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
130120410|NCT02579096|468402373|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
129949228|NCT00103857|467777503|FG006|54-Week Base Study|laboratory reporting error|0|||
129949229|NCT00103857|467777497|FG000|54-Week Base Study|site error|0|||
129949230|NCT00103857|467777498|FG001|54-Week Base Study|site error|0|||
129949231|NCT00103857|467777499|FG002|54-Week Base Study|site error|0|||
129949232|NCT00103857|467777500|FG003|54-Week Base Study|site error|0|||
129949233|NCT00103857|467777501|FG004|54-Week Base Study|site error|0|||
129949234|NCT00103857|467777502|FG005|54-Week Base Study|site error|1|||
129949235|NCT00103857|467777503|FG006|54-Week Base Study|site error|0|||
129949236|NCT00103857|467777497|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
129949237|NCT00103857|467777498|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949238|NCT00103857|467777499|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949239|NCT00103857|467777500|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949240|NCT00103857|467777501|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949241|NCT00103857|467777502|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949242|NCT00103857|467777503|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949243|NCT00103857|467777497|FG000|50-Week Extension Study|Adverse Event|2|||
129949244|NCT00103857|467777498|FG001|50-Week Extension Study|Adverse Event|3|||
129949245|NCT00103857|467777499|FG002|50-Week Extension Study|Adverse Event|2|||
129949246|NCT00103857|467777500|FG003|50-Week Extension Study|Adverse Event|0|||
129949247|NCT00103857|467777501|FG004|50-Week Extension Study|Adverse Event|1|||
129949248|NCT00103857|467777502|FG005|50-Week Extension Study|Adverse Event|1|||
129949249|NCT00103857|467777503|FG006|50-Week Extension Study|Adverse Event|0|||
129949250|NCT00103857|467777497|FG000|50-Week Extension Study|Death|0|||
129949251|NCT00103857|467777498|FG001|50-Week Extension Study|Death|0|||
129949252|NCT00103857|467777499|FG002|50-Week Extension Study|Death|0|||
129949253|NCT00103857|467777500|FG003|50-Week Extension Study|Death|1|||
129949254|NCT00103857|467777501|FG004|50-Week Extension Study|Death|0|||
129949255|NCT00103857|467777502|FG005|50-Week Extension Study|Death|1|||
129949256|NCT00103857|467777503|FG006|50-Week Extension Study|Death|0|||
129949257|NCT00103857|467777497|FG000|50-Week Extension Study|Lack of Efficacy|26|||
129949258|NCT00103857|467777498|FG001|50-Week Extension Study|Lack of Efficacy|15|||
129949259|NCT00103857|467777499|FG002|50-Week Extension Study|Lack of Efficacy|13|||
129949260|NCT00103857|467777500|FG003|50-Week Extension Study|Lack of Efficacy|16|||
129949261|NCT00103857|467777501|FG004|50-Week Extension Study|Lack of Efficacy|8|||
129949262|NCT00103857|467777502|FG005|50-Week Extension Study|Lack of Efficacy|8|||
129949263|NCT00103857|467777503|FG006|50-Week Extension Study|Lack of Efficacy|0|||
129949264|NCT00103857|467777497|FG000|50-Week Extension Study|Lost to Follow-up|4|||
129949265|NCT00103857|467777498|FG001|50-Week Extension Study|Lost to Follow-up|0|||
129949266|NCT00103857|467777499|FG002|50-Week Extension Study|Lost to Follow-up|1|||
130120411|NCT02579096|468402374|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
130120412|NCT02579096|468402373|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
130072120|NCT04153929|468218136|FG003|Overall Study|Protocol Violation|0|||
130120413|NCT02579096|468402374|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
130072121|NCT04153929|468218137|FG004|Overall Study|Protocol Violation|0|||
130072122|NCT04153929|468218138|FG005|Overall Study|Protocol Violation|0|||
129949267|NCT00103857|467777500|FG003|50-Week Extension Study|Lost to Follow-up|4|||
129949268|NCT00103857|467777501|FG004|50-Week Extension Study|Lost to Follow-up|3|||
129949269|NCT00103857|467777502|FG005|50-Week Extension Study|Lost to Follow-up|3|||
129949270|NCT00103857|467777503|FG006|50-Week Extension Study|Lost to Follow-up|0|||
129949271|NCT00103857|467777497|FG000|50-Week Extension Study|Physician Decision|0|||
130072123|NCT04153929|468218139|FG006|Overall Study|Protocol Violation|1|||
130072124|NCT04153929|468218140|FG007|Overall Study|Protocol Violation|2|||
130120414|NCT02579096|468402373|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
130120415|NCT02579096|468402374|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
130120416|NCT02579096|468402373|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
130120417|NCT02579096|468402374|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
129949272|NCT00103857|467777498|FG001|50-Week Extension Study|Physician Decision|1|||
129949273|NCT00103857|467777499|FG002|50-Week Extension Study|Physician Decision|1|||
129949274|NCT00103857|467777500|FG003|50-Week Extension Study|Physician Decision|0|||
129949275|NCT00103857|467777501|FG004|50-Week Extension Study|Physician Decision|0|||
129949276|NCT00103857|467777502|FG005|50-Week Extension Study|Physician Decision|0|||
129949277|NCT00103857|467777503|FG006|50-Week Extension Study|Physician Decision|0|||
129949278|NCT00103857|467777497|FG000|50-Week Extension Study|Pregnancy|0|||
129949279|NCT00103857|467777498|FG001|50-Week Extension Study|Pregnancy|0|||
129949280|NCT00103857|467777499|FG002|50-Week Extension Study|Pregnancy|1|||
129949281|NCT00103857|467777500|FG003|50-Week Extension Study|Pregnancy|0|||
129949282|NCT00103857|467777501|FG004|50-Week Extension Study|Pregnancy|1|||
129949283|NCT00103857|467777502|FG005|50-Week Extension Study|Pregnancy|0|||
129949284|NCT00103857|467777503|FG006|50-Week Extension Study|Pregnancy|0|||
129949285|NCT00103857|467777497|FG000|50-Week Extension Study|Protocol Violation|1|||
129949286|NCT00103857|467777498|FG001|50-Week Extension Study|Protocol Violation|1|||
129949287|NCT00103857|467777499|FG002|50-Week Extension Study|Protocol Violation|1|||
129949288|NCT00103857|467777500|FG003|50-Week Extension Study|Protocol Violation|2|||
129949289|NCT00103857|467777501|FG004|50-Week Extension Study|Protocol Violation|0|||
129949290|NCT00103857|467777502|FG005|50-Week Extension Study|Protocol Violation|1|||
129949291|NCT00103857|467777503|FG006|50-Week Extension Study|Protocol Violation|0|||
129949292|NCT00103857|467777497|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
129949293|NCT00103857|467777498|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
129949294|NCT00103857|467777499|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
129949295|NCT00103857|467777500|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
129949296|NCT00103857|467777501|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
129949297|NCT00103857|467777502|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
129949298|NCT00103857|467777503|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
129949299|NCT00103857|467777497|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
129949300|NCT00103857|467777498|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
129949301|NCT00103857|467777499|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
129949302|NCT00103857|467777500|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
129949303|NCT00103857|467777501|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
129949304|NCT00103857|467777502|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
129949305|NCT00103857|467777503|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
129949306|NCT00103857|467777497|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
129949307|NCT00103857|467777498|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
129949308|NCT00103857|467777499|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
129949309|NCT00103857|467777500|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
129949310|NCT00103857|467777501|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
129949311|NCT00103857|467777502|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
129949312|NCT00103857|467777503|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
129949313|NCT00103857|467777497|FG000|50-Week Extension Study|patient moved|0|||
129949314|NCT00103857|467777498|FG001|50-Week Extension Study|patient moved|0|||
129949315|NCT00103857|467777499|FG002|50-Week Extension Study|patient moved|1|||
129949316|NCT00103857|467777500|FG003|50-Week Extension Study|patient moved|2|||
129949317|NCT00103857|467777501|FG004|50-Week Extension Study|patient moved|0|||
129949318|NCT00103857|467777502|FG005|50-Week Extension Study|patient moved|0|||
129949319|NCT00103857|467777503|FG006|50-Week Extension Study|patient moved|0|||
129949320|NCT00103857|467777497|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949321|NCT00103857|467777498|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949322|NCT00103857|467777499|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
129949323|NCT00103857|467777500|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949324|NCT00103857|467777501|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949325|NCT00103857|467777502|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949326|NCT00103857|467777503|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949327|NCT00103857|467777497|FG000|50-Week Extension Study|reason unspecified|0|||
130072125|NCT04153929|468218133|FG000|Overall Study|Adverse Event|3|||
130072126|NCT04153929|468218134|FG001|Overall Study|Adverse Event|5|||
130072127|NCT04153929|468218135|FG002|Overall Study|Adverse Event|5|||
130072128|NCT04153929|468218136|FG003|Overall Study|Adverse Event|11|||
130072129|NCT04153929|468218137|FG004|Overall Study|Adverse Event|15|||
129949328|NCT00103857|467777498|FG001|50-Week Extension Study|reason unspecified|0|||
129949329|NCT00103857|467777499|FG002|50-Week Extension Study|reason unspecified|0|||
129949330|NCT00103857|467777500|FG003|50-Week Extension Study|reason unspecified|0|||
129949331|NCT00103857|467777501|FG004|50-Week Extension Study|reason unspecified|1|||
129949332|NCT00103857|467777502|FG005|50-Week Extension Study|reason unspecified|0|||
129949333|NCT00103857|467777503|FG006|50-Week Extension Study|reason unspecified|0|||
129949334|NCT01005914|467777504|FG000|Overall Study|Adverse Event|4|||
129949335|NCT01005914|467777504|FG000|Overall Study|Death|4|||
130072130|NCT04153929|468218138|FG005|Overall Study|Adverse Event|4|||
129949336|NCT01005914|467777504|FG000|Overall Study|Lack of Efficacy|1|||
129949337|NCT01005914|467777504|FG000|Overall Study|Withdrawal by Subject|1|||
129949338|NCT01240785|467777506|FG000|Overall Study|Lost to Follow-up|1|||
129949339|NCT01240785|467777507|FG001|Overall Study|Lost to Follow-up|0|||
129949340|NCT01240785|467777506|FG000|Overall Study|Protocol Violation|0|||
129949341|NCT01240785|467777507|FG001|Overall Study|Protocol Violation|3|||
129949342|NCT02132195|467777510|FG000|Initial Assignment|Relapsed|14|||
129949343|NCT02132195|467777511|FG001|Initial Assignment|Relapsed|0|||
129949344|NCT02132195|467777512|FG002|Initial Assignment|Relapsed|0|||
129949345|NCT02132195|467777510|FG000|Rescue Therapy|Relapsed|0|||
129949346|NCT02132195|467777511|FG001|Rescue Therapy|Relapsed|0|||
129949347|NCT02132195|467777512|FG002|Rescue Therapy|Relapsed|7|||
129949348|NCT02132195|467777510|FG000|Rescue Therapy|Physician Decision|0|||
129949349|NCT02132195|467777511|FG001|Rescue Therapy|Physician Decision|0|||
129949350|NCT02132195|467777512|FG002|Rescue Therapy|Physician Decision|1|||
129949351|NCT02132195|467777510|FG000|Rescue Therapy|Withdrawal by Subject|0|||
129949352|NCT02132195|467777511|FG001|Rescue Therapy|Withdrawal by Subject|0|||
129949353|NCT02132195|467777512|FG002|Rescue Therapy|Withdrawal by Subject|1|||
129949354|NCT02132195|467777510|FG000|Rescue Therapy|Adverse Event|0|||
129949355|NCT02132195|467777511|FG001|Rescue Therapy|Adverse Event|0|||
129949356|NCT02132195|467777512|FG002|Rescue Therapy|Adverse Event|2|||
129949357|NCT03065400|467777513|FG000|Overall Study|Adverse Event|1|||
129949358|NCT03065400|467777513|FG000|Overall Study|Physician Decision|3|||
129949359|NCT03065400|467777513|FG000|Overall Study|Withdrawal by Subject|1|||
129949360|NCT03065400|467777513|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
129949361|NCT03072862|467777514|FG000|Overall Study|Withdrawal by Subject|4|||
129949362|NCT03072862|467777514|FG000|Overall Study|Lost to Follow-up|6|||
129949363|NCT03072862|467777514|FG000|Overall Study|Protocol Violation|4|||
129949364|NCT03072862|467777514|FG000|Overall Study|Physician Decision|2|||
129949365|NCT03072862|467777514|FG000|Overall Study|Death|1|||
129949366|NCT03072862|467777514|FG000|Overall Study|Adverse Event|1|||
129949367|NCT02613403|467777522|FG000|Overall Study|Lost to Follow-up|0|||
129949368|NCT02613403|467777523|FG001|Overall Study|Lost to Follow-up|1|||
129949369|NCT02613403|467777524|FG002|Overall Study|Lost to Follow-up|0|||
129949370|NCT02613403|467777525|FG003|Overall Study|Lost to Follow-up|0|||
129949371|NCT02613403|467777526|FG004|Overall Study|Lost to Follow-up|0|||
129949372|NCT02613403|467777522|FG000|Overall Study|Withdrawal by Subject|2|||
129949373|NCT02613403|467777523|FG001|Overall Study|Withdrawal by Subject|0|||
129949374|NCT02613403|467777524|FG002|Overall Study|Withdrawal by Subject|0|||
129949375|NCT02613403|467777525|FG003|Overall Study|Withdrawal by Subject|0|||
129949376|NCT02613403|467777526|FG004|Overall Study|Withdrawal by Subject|0|||
129949377|NCT01147471|467777527|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
129949378|NCT01147471|467777528|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
129949379|NCT01147471|467777527|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
129949380|NCT01147471|467777528|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
129949381|NCT01147471|467777527|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
129949382|NCT01147471|467777528|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
129949383|NCT01147471|467777527|FG000|3 Month Follow Up|Lost to Follow-up|1|||
129949384|NCT01147471|467777528|FG001|3 Month Follow Up|Lost to Follow-up|1|||
129949385|NCT01147471|467777527|FG000|3 Month Follow Up|Physician Decision|0|||
129949386|NCT01147471|467777528|FG001|3 Month Follow Up|Physician Decision|1|||
129949387|NCT01147471|467777527|FG000|6 Month Follow Up|Lost to Follow-up|4|||
129949388|NCT01147471|467777528|FG001|6 Month Follow Up|Lost to Follow-up|2|||
129949389|NCT00800176|467777529|FG000|Overall Study|Adverse Event|2|||
129949390|NCT00800176|467777530|FG001|Overall Study|Adverse Event|1|||
129949391|NCT00800176|467777531|FG002|Overall Study|Adverse Event|0|||
129949392|NCT00800176|467777532|FG003|Overall Study|Adverse Event|2|||
129949393|NCT00800176|467777533|FG004|Overall Study|Adverse Event|1|||
129949394|NCT00800176|467777534|FG005|Overall Study|Adverse Event|1|||
129949395|NCT00800176|467777529|FG000|Overall Study|Refused treatment|3|||
129949396|NCT00800176|467777530|FG001|Overall Study|Refused treatment|2|||
129949397|NCT00800176|467777531|FG002|Overall Study|Refused treatment|0|||
130072131|NCT04153929|468218139|FG006|Overall Study|Adverse Event|8|||
130072132|NCT04153929|468218140|FG007|Overall Study|Adverse Event|2|||
129949398|NCT00800176|467777532|FG003|Overall Study|Refused treatment|0|||
129949399|NCT00800176|467777533|FG004|Overall Study|Refused treatment|1|||
129949400|NCT00800176|467777534|FG005|Overall Study|Refused treatment|4|||
129949401|NCT00800176|467777529|FG000|Overall Study|Failure to return|3|||
129949402|NCT00800176|467777530|FG001|Overall Study|Failure to return|3|||
129949403|NCT00800176|467777531|FG002|Overall Study|Failure to return|0|||
129949404|NCT00800176|467777532|FG003|Overall Study|Failure to return|2|||
129949405|NCT00800176|467777533|FG004|Overall Study|Failure to return|0|||
129949406|NCT00800176|467777534|FG005|Overall Study|Failure to return|0|||
129949407|NCT00800176|467777529|FG000|Overall Study|Other|1|||
129949408|NCT00800176|467777530|FG001|Overall Study|Other|0|||
129949409|NCT00800176|467777531|FG002|Overall Study|Other|0|||
129949410|NCT00800176|467777532|FG003|Overall Study|Other|0|||
129949411|NCT00800176|467777533|FG004|Overall Study|Other|2|||
129949412|NCT00800176|467777534|FG005|Overall Study|Other|0|||
129949413|NCT02188459|467777540|FG000|Overall Study|Lost to Follow-up|3|||
129949414|NCT02188459|467777541|FG001|Overall Study|Lost to Follow-up|4|||
129949415|NCT02188459|467777540|FG000|Overall Study|Early Termination|0|||
129949416|NCT02188459|467777541|FG001|Overall Study|Early Termination|3|||
129949417|NCT02612285|467777542|FG000|Overall Study|Withdrawal by Subject|1|||
129949418|NCT00805441|467777543|FG000|Overall Study|Adverse Event|5|||
129949419|NCT00805441|467777544|FG001|Overall Study|Adverse Event|2|||
129949420|NCT00805441|467777543|FG000|Overall Study|Lack of Efficacy|0|||
129949421|NCT00805441|467777544|FG001|Overall Study|Lack of Efficacy|2|||
129949422|NCT00805441|467777543|FG000|Overall Study|Protocol Violation|4|||
129949423|NCT00805441|467777544|FG001|Overall Study|Protocol Violation|8|||
129949424|NCT00805441|467777543|FG000|Overall Study|Lost to Follow-up|10|||
129949425|NCT00805441|467777544|FG001|Overall Study|Lost to Follow-up|13|||
129949426|NCT00805441|467777543|FG000|Overall Study|Withdrawal by Subject|15|||
129949427|NCT00805441|467777544|FG001|Overall Study|Withdrawal by Subject|9|||
129949428|NCT00805441|467777543|FG000|Overall Study|Physician Decision|0|||
129949429|NCT00805441|467777544|FG001|Overall Study|Physician Decision|1|||
129949430|NCT00805441|467777543|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
129949431|NCT00805441|467777544|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
129949432|NCT02935894|467777546|FG000|Overall Study|Subject dismissed|1|||
129949433|NCT01898299|467777549|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
129949434|NCT01898299|467777550|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
129949435|NCT02340806|467777551|FG000|Overall Study|Protocol Violation|2|||
129949436|NCT02340806|467777552|FG001|Overall Study|Protocol Violation|0|||
129949437|NCT02340806|467777551|FG000|Overall Study|epidural catheter replaced|2|||
129949438|NCT02340806|467777552|FG001|Overall Study|epidural catheter replaced|1|||
129949439|NCT02340806|467777551|FG000|Overall Study|history of chronic pain medication|1|||
129949440|NCT02340806|467777552|FG001|Overall Study|history of chronic pain medication|0|||
129949441|NCT02340806|467777551|FG000|Overall Study|re-dose < 90 min of CSE|1|||
129949442|NCT02340806|467777552|FG001|Overall Study|re-dose < 90 min of CSE|3|||
129949443|NCT00452452|467777553|FG000|Overall Study|Protocol Violation|0|||
129949444|NCT00452452|467777554|FG001|Overall Study|Protocol Violation|0|||
129949445|NCT00452452|467777555|FG002|Overall Study|Protocol Violation|1|||
129949446|NCT00452452|467777553|FG000|Overall Study|Withdrawal by Subject|1|||
129949447|NCT00452452|467777554|FG001|Overall Study|Withdrawal by Subject|0|||
129949448|NCT00452452|467777555|FG002|Overall Study|Withdrawal by Subject|0|||
129949449|NCT00452452|467777553|FG000|Overall Study|Lost to Follow-up|1|||
129949450|NCT00452452|467777554|FG001|Overall Study|Lost to Follow-up|0|||
129949451|NCT00452452|467777555|FG002|Overall Study|Lost to Follow-up|0|||
129949452|NCT02659059|467779086|FG000|Overall Study|Other reasons|6|||
129949453|NCT02659059|467779087|FG001|Overall Study|Other reasons|1|||
129949454|NCT02659059|467779086|FG000|Overall Study|Disease Progression|143|||
129949455|NCT02659059|467779087|FG001|Overall Study|Disease Progression|16|||
129949456|NCT02659059|467779086|FG000|Overall Study|Study Drug toxicity|56|||
129949457|NCT02659059|467779087|FG001|Overall Study|Study Drug toxicity|9|||
129949458|NCT02659059|467779086|FG000|Overall Study|Death|3|||
129949459|NCT02659059|467779087|FG001|Overall Study|Death|1|||
129949460|NCT02659059|467779086|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
129949461|NCT02659059|467779087|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
129949462|NCT02659059|467779086|FG000|Overall Study|Participant request to discontinue study treatment|5|||
129949463|NCT02659059|467779087|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129949464|NCT02659059|467779086|FG000|Overall Study|Participant withdrew consent|6|||
129949465|NCT02659059|467779087|FG001|Overall Study|Participant withdrew consent|1|||
129949466|NCT03976102|467779090|FG000|Overall Study|Withdrawal by Subject|4|||
129949467|NCT03976102|467779091|FG001|Overall Study|Withdrawal by Subject|4|||
129949468|NCT03976102|467779090|FG000|Overall Study|Adverse Event|2|||
129949469|NCT03976102|467779091|FG001|Overall Study|Adverse Event|4|||
129949470|NCT03976102|467779090|FG000|Overall Study|Not related to Covid-19|9|||
129949471|NCT03976102|467779091|FG001|Overall Study|Not related to Covid-19|13|||
129949472|NCT03976102|467779090|FG000|Overall Study|Lost to Follow-up|0|||
129949473|NCT03976102|467779091|FG001|Overall Study|Lost to Follow-up|2|||
129949474|NCT03976102|467779090|FG000|Overall Study|Death|3|||
129949475|NCT03976102|467779091|FG001|Overall Study|Death|2|||
129949476|NCT03976102|467779090|FG000|Overall Study|Physician Decision|1|||
129949477|NCT03976102|467779091|FG001|Overall Study|Physician Decision|1|||
129949478|NCT00092456|467779092|FG000|Overall Study|Adverse Event|0|||
129949479|NCT00092456|467779093|FG001|Overall Study|Adverse Event|0|||
129949480|NCT00092456|467779094|FG002|Overall Study|Adverse Event|1|||
129949481|NCT00092456|467779095|FG003|Overall Study|Adverse Event|1|||
129949482|NCT00092456|467779092|FG000|Overall Study|Lost to Follow-up|2|||
129949483|NCT00092456|467779093|FG001|Overall Study|Lost to Follow-up|2|||
129949484|NCT00092456|467779094|FG002|Overall Study|Lost to Follow-up|1|||
129949485|NCT00092456|467779095|FG003|Overall Study|Lost to Follow-up|2|||
129949486|NCT00092456|467779092|FG000|Overall Study|Protocol Violation|5|||
129949487|NCT00092456|467779093|FG001|Overall Study|Protocol Violation|7|||
129949488|NCT00092456|467779094|FG002|Overall Study|Protocol Violation|8|||
129949489|NCT00092456|467779095|FG003|Overall Study|Protocol Violation|6|||
129949490|NCT00092456|467779092|FG000|Overall Study|Withdrawal by Subject|13|||
129949491|NCT00092456|467779093|FG001|Overall Study|Withdrawal by Subject|5|||
129949492|NCT00092456|467779094|FG002|Overall Study|Withdrawal by Subject|16|||
129949493|NCT00092456|467779095|FG003|Overall Study|Withdrawal by Subject|6|||
129949494|NCT00092456|467779092|FG000|Overall Study|Moved|1|||
129949495|NCT00092456|467779093|FG001|Overall Study|Moved|1|||
129949496|NCT00092456|467779094|FG002|Overall Study|Moved|0|||
129949497|NCT00092456|467779095|FG003|Overall Study|Moved|1|||
129949498|NCT00092456|467779092|FG000|Overall Study|Other|4|||
129949499|NCT00092456|467779093|FG001|Overall Study|Other|2|||
129949500|NCT00092456|467779094|FG002|Overall Study|Other|3|||
129949501|NCT00092456|467779095|FG003|Overall Study|Other|0|||
129949502|NCT02121808|467779098|FG000|Overall Study|Technical problem|3|||
129949503|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
129949504|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
129949505|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
129949506|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
129949507|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
129949508|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
129949509|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
129949510|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
129949511|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
129949512|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
129949513|NCT05066230|467779099|FG000|After Week 48|Adverse Event|1|||
129949514|NCT05066230|467779100|FG001|After Week 48|Adverse Event|0|||
129949515|NCT05066230|467779099|FG000|After Week 48|Non-compliance with study schedule|1|||
129949516|NCT05066230|467779100|FG001|After Week 48|Non-compliance with study schedule|0|||
129949517|NCT05066230|467779099|FG000|After Week 48|Withdrawal by Subject|0|||
129949518|NCT05066230|467779100|FG001|After Week 48|Withdrawal by Subject|1|||
129949519|NCT05066230|467779099|FG000|After Week 48|Lost to Follow-up|3|||
129949520|NCT05066230|467779100|FG001|After Week 48|Lost to Follow-up|3|||
129949521|NCT05066230|467779099|FG000|After Week 48|Sponsor Request|115|||
129949522|NCT05066230|467779100|FG001|After Week 48|Sponsor Request|111|||
129949523|NCT03924193|467779101|FG000|Overall Study|Adverse Event|10|||
129949524|NCT03924193|467779102|FG001|Overall Study|Adverse Event|0|||
130072133|NCT04153929|468218133|FG000|Overall Study|Not treated|1|||
130072134|NCT04153929|468218134|FG001|Overall Study|Not treated|0|||
130072135|NCT04153929|468218135|FG002|Overall Study|Not treated|0|||
130072136|NCT04153929|468218136|FG003|Overall Study|Not treated|0|||
130072137|NCT04153929|468218137|FG004|Overall Study|Not treated|0|||
130072138|NCT04153929|468218138|FG005|Overall Study|Not treated|0|||
130072139|NCT04153929|468218139|FG006|Overall Study|Not treated|1|||
130072140|NCT04153929|468218140|FG007|Overall Study|Not treated|0|||
130072141|NCT04083794|468218141|FG000|Overall Study|Lost to Follow-up|9|||
130072142|NCT03383614|468218142|FG000|Overall Study|Withdrawal by Subject|0|||
130072143|NCT03383614|468218143|FG001|Overall Study|Withdrawal by Subject|1|||
130072144|NCT03383614|468218144|FG002|Overall Study|Withdrawal by Subject|0|||
130072145|NCT03383614|468218145|FG003|Overall Study|Withdrawal by Subject|0|||
130072146|NCT01202760|468218150|FG000|Overall Study|Entry Criteria Not Met|0|||
130072147|NCT01202760|468218151|FG001|Overall Study|Entry Criteria Not Met|3|||
130072148|NCT01202760|468218152|FG002|Overall Study|Entry Criteria Not Met|1|||
130072149|NCT01202760|468218150|FG000|Overall Study|Adverse Event|11|||
130072150|NCT01202760|468218151|FG001|Overall Study|Adverse Event|9|||
130072151|NCT01202760|468218152|FG002|Overall Study|Adverse Event|10|||
130072152|NCT01202760|468218150|FG000|Overall Study|Death|2|||
130072153|NCT01202760|468218151|FG001|Overall Study|Death|1|||
130072154|NCT01202760|468218152|FG002|Overall Study|Death|0|||
130072155|NCT01202760|468218150|FG000|Overall Study|Lack of Efficacy|6|||
129949525|NCT03924193|467779103|FG002|Overall Study|Adverse Event|10|||
129949526|NCT03924193|467779101|FG000|Overall Study|Withdrawal by Subject|5|||
129949527|NCT03924193|467779102|FG001|Overall Study|Withdrawal by Subject|10|||
129949528|NCT03924193|467779103|FG002|Overall Study|Withdrawal by Subject|2|||
130072156|NCT01202760|468218151|FG001|Overall Study|Lack of Efficacy|8|||
130072157|NCT01202760|468218152|FG002|Overall Study|Lack of Efficacy|7|||
130072158|NCT01202760|468218150|FG000|Overall Study|Lost to Follow-up|0|||
130072159|NCT01202760|468218151|FG001|Overall Study|Lost to Follow-up|2|||
129949529|NCT01322386|467779107|FG000|Overall Study|Protocol Violation|0|||
129949530|NCT01322386|467779108|FG001|Overall Study|Protocol Violation|1|||
129949531|NCT01322386|467779107|FG000|Overall Study|Physician Decision|0|||
129949532|NCT01322386|467779108|FG001|Overall Study|Physician Decision|1|||
129949533|NCT02291861|467779109|FG000|Overall Study|Adverse Event|2|||
129949534|NCT02291861|467779110|FG001|Overall Study|Adverse Event|4|||
130072160|NCT01202760|468218152|FG002|Overall Study|Lost to Follow-up|1|||
130072161|NCT01202760|468218150|FG000|Overall Study|Parent / Caregiver Decision|0|||
130072162|NCT01202760|468218151|FG001|Overall Study|Parent / Caregiver Decision|1|||
130072163|NCT01202760|468218152|FG002|Overall Study|Parent / Caregiver Decision|0|||
129949535|NCT02291861|467779111|FG002|Overall Study|Adverse Event|1|||
130072164|NCT01202760|468218150|FG000|Overall Study|Withdrawal by Subject|17|||
129949536|NCT02291861|467779112|FG003|Overall Study|Adverse Event|2|||
129949537|NCT02291861|467779109|FG000|Overall Study|Death|0|||
129949538|NCT02291861|467779110|FG001|Overall Study|Death|0|||
129949539|NCT02291861|467779111|FG002|Overall Study|Death|1|||
129949540|NCT02291861|467779112|FG003|Overall Study|Death|1|||
129949541|NCT02291861|467779109|FG000|Overall Study|Protocol Violation|1|||
129949542|NCT02291861|467779110|FG001|Overall Study|Protocol Violation|0|||
129949543|NCT02291861|467779111|FG002|Overall Study|Protocol Violation|0|||
129949544|NCT02291861|467779112|FG003|Overall Study|Protocol Violation|1|||
129949545|NCT02291861|467779109|FG000|Overall Study|Withdrawal by Subject|1|||
129949546|NCT02291861|467779110|FG001|Overall Study|Withdrawal by Subject|2|||
129949547|NCT02291861|467779111|FG002|Overall Study|Withdrawal by Subject|1|||
129949548|NCT02291861|467779112|FG003|Overall Study|Withdrawal by Subject|4|||
129949549|NCT02291861|467779109|FG000|Overall Study|Noncompliance|1|||
129949550|NCT02291861|467779110|FG001|Overall Study|Noncompliance|1|||
129949551|NCT02291861|467779111|FG002|Overall Study|Noncompliance|2|||
129949552|NCT02291861|467779112|FG003|Overall Study|Noncompliance|1|||
129949553|NCT02291861|467779109|FG000|Overall Study|Lost to Follow-up|2|||
129949554|NCT02291861|467779110|FG001|Overall Study|Lost to Follow-up|1|||
129949555|NCT02291861|467779111|FG002|Overall Study|Lost to Follow-up|4|||
129949556|NCT02291861|467779112|FG003|Overall Study|Lost to Follow-up|0|||
129949557|NCT02291861|467779109|FG000|Overall Study|Other|0|||
129949558|NCT02291861|467779110|FG001|Overall Study|Other|0|||
129949559|NCT02291861|467779111|FG002|Overall Study|Other|0|||
129949560|NCT02291861|467779112|FG003|Overall Study|Other|1|||
129949561|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
129949562|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
129949563|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
129949564|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
129949565|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Death|0|||
129949566|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Death|0|||
129949567|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Death|1|||
129949568|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Death|0|||
129949569|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
129949570|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
129949571|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
129949572|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
129949573|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129949574|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
129949575|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129949576|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
129949577|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
129949578|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
129949579|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
129949580|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
129949581|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
129949582|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
129949583|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
129949584|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
129949585|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
129949586|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
129949587|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
129949588|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
129949589|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Other|2|||
129949590|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Other|0|||
129949591|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Other|0|||
129949592|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Other|0|||
129949593|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
129949594|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
129949595|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
129949596|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
129949597|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
129949598|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
130072165|NCT01202760|468218151|FG001|Overall Study|Withdrawal by Subject|18|||
130072166|NCT01202760|468218152|FG002|Overall Study|Withdrawal by Subject|14|||
129949599|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
129949600|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
129949601|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
129949602|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
129949603|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
129949604|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
129949605|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
129949606|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
129949607|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
129949608|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
129949609|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Death|0|||
129949610|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Death|0|||
129949611|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Death|1|||
129949612|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Death|1|||
129949613|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
129949614|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
129949615|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
129949616|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
129949617|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
129949618|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
129949619|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
129949620|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
129949621|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
129949622|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
129949623|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
129949624|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
129949625|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Other|1|||
129949626|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Other|0|||
129949627|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Other|1|||
129949628|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Other|0|||
129949629|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
129949630|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
129949631|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
129949632|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
129949633|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
129949634|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
129949635|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
129949636|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
129949637|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
129949638|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
129949639|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
129949640|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
129949641|NCT02410278|467779127|FG000|Run-in Period|Adverse Event|5|||
129949642|NCT02410278|467779128|FG001|Run-in Period|Adverse Event|0|||
129949643|NCT02410278|467779129|FG002|Run-in Period|Adverse Event|0|||
129949644|NCT02410278|467779127|FG000|Run-in Period|GSRS Threshold Not Met|30|||
129949645|NCT02410278|467779128|FG001|Run-in Period|GSRS Threshold Not Met|0|||
129949646|NCT02410278|467779129|FG002|Run-in Period|GSRS Threshold Not Met|0|||
129949647|NCT02410278|467779127|FG000|Run-in Period|Lost to Follow-up|1|||
129949648|NCT02410278|467779128|FG001|Run-in Period|Lost to Follow-up|0|||
129949649|NCT02410278|467779129|FG002|Run-in Period|Lost to Follow-up|0|||
129949650|NCT02410278|467779127|FG000|Run-in Period|Withdrawal by Subject|1|||
129949651|NCT02410278|467779128|FG001|Run-in Period|Withdrawal by Subject|0|||
129949652|NCT02410278|467779129|FG002|Run-in Period|Withdrawal by Subject|0|||
129949653|NCT02410278|467779127|FG000|Run-in Period|Pregnancy|1|||
129949654|NCT02410278|467779128|FG001|Run-in Period|Pregnancy|0|||
129949655|NCT02410278|467779129|FG002|Run-in Period|Pregnancy|0|||
129949656|NCT02410278|467779127|FG000|Study Treatment Period|Adverse Event|0|||
129949657|NCT02410278|467779128|FG001|Study Treatment Period|Adverse Event|6|||
129949658|NCT02410278|467779129|FG002|Study Treatment Period|Adverse Event|3|||
129949659|NCT02410278|467779127|FG000|Study Treatment Period|Physician Decision|0|||
129949660|NCT02410278|467779128|FG001|Study Treatment Period|Physician Decision|0|||
129949661|NCT02410278|467779129|FG002|Study Treatment Period|Physician Decision|1|||
129949662|NCT02410278|467779127|FG000|Study Treatment Period|Withdrawal by Subject|0|||
129949663|NCT02410278|467779128|FG001|Study Treatment Period|Withdrawal by Subject|1|||
129949664|NCT02410278|467779129|FG002|Study Treatment Period|Withdrawal by Subject|0|||
129949665|NCT02410278|467779127|FG000|Study Treatment Period|Other|0|||
129949666|NCT02410278|467779128|FG001|Study Treatment Period|Other|3|||
129949667|NCT02410278|467779129|FG002|Study Treatment Period|Other|0|||
129949668|NCT02410278|467779127|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
129949669|NCT02410278|467779128|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
129949670|NCT02410278|467779129|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
129949671|NCT03695185|467779130|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
129949672|NCT03695185|467779130|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
129949673|NCT03695185|467779130|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
130072167|NCT01202760|468218150|FG000|Overall Study|Physician Decision|0|||
130072168|NCT01202760|468218151|FG001|Overall Study|Physician Decision|1|||
129949674|NCT03695185|467779130|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
129949675|NCT03695185|467779130|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
129949676|NCT03695185|467779130|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
129949677|NCT02584257|467779131|FG000|Period 1|Withdrawal by Subject|0|||
129949678|NCT02584257|467779132|FG001|Period 1|Withdrawal by Subject|0|||
129949679|NCT02584257|467779133|FG002|Period 1|Withdrawal by Subject|0|||
130072169|NCT01202760|468218152|FG002|Overall Study|Physician Decision|0|||
129949680|NCT02584257|467779134|FG003|Period 1|Withdrawal by Subject|0|||
129949681|NCT02584257|467779135|FG004|Period 1|Withdrawal by Subject|0|||
129949682|NCT02584257|467779136|FG005|Period 1|Withdrawal by Subject|0|||
129949683|NCT02584257|467779137|FG006|Period 1|Withdrawal by Subject|1|||
129949684|NCT02584257|467779138|FG007|Period 1|Withdrawal by Subject|0|||
129949685|NCT02584257|467779139|FG008|Period 1|Withdrawal by Subject|0|||
129949686|NCT02584257|467779131|FG000|Period 2|Physician Decision|1|||
129949687|NCT02584257|467779132|FG001|Period 2|Physician Decision|0|||
129949688|NCT02584257|467779133|FG002|Period 2|Physician Decision|0|||
129949689|NCT02584257|467779134|FG003|Period 2|Physician Decision|0|||
129949690|NCT02584257|467779135|FG004|Period 2|Physician Decision|0|||
129949691|NCT02584257|467779136|FG005|Period 2|Physician Decision|0|||
129949692|NCT02584257|467779137|FG006|Period 2|Physician Decision|0|||
129949693|NCT02584257|467779138|FG007|Period 2|Physician Decision|0|||
129949694|NCT02584257|467779139|FG008|Period 2|Physician Decision|0|||
129949695|NCT02584257|467779131|FG000|Period 2|Adverse Event|0|||
129949696|NCT02584257|467779132|FG001|Period 2|Adverse Event|1|||
129949697|NCT02584257|467779133|FG002|Period 2|Adverse Event|0|||
129949698|NCT02584257|467779134|FG003|Period 2|Adverse Event|0|||
129949699|NCT02584257|467779135|FG004|Period 2|Adverse Event|0|||
129949700|NCT02584257|467779136|FG005|Period 2|Adverse Event|0|||
129949701|NCT02584257|467779137|FG006|Period 2|Adverse Event|0|||
129949702|NCT02584257|467779138|FG007|Period 2|Adverse Event|0|||
129949703|NCT02584257|467779139|FG008|Period 2|Adverse Event|0|||
129949704|NCT01912599|467779147|FG000|Overall Study|Withdrawal by Subject|0|||
129949705|NCT01912599|467779148|FG001|Overall Study|Withdrawal by Subject|1|||
129949706|NCT03386344|467779150|FG000|Overall Study|Adverse Event|6|||
129949707|NCT03386344|467779151|FG001|Overall Study|Adverse Event|3|||
129949708|NCT03386344|467779152|FG002|Overall Study|Adverse Event|1|||
129949709|NCT03386344|467779150|FG000|Overall Study|Poor Compliance to Protocol|0|||
129949710|NCT03386344|467779151|FG001|Overall Study|Poor Compliance to Protocol|1|||
129949711|NCT03386344|467779152|FG002|Overall Study|Poor Compliance to Protocol|0|||
129949712|NCT03386344|467779150|FG000|Overall Study|Study Terminated by Sponsor|101|||
129949713|NCT03386344|467779151|FG001|Overall Study|Study Terminated by Sponsor|102|||
129949714|NCT03386344|467779152|FG002|Overall Study|Study Terminated by Sponsor|106|||
129949715|NCT03386344|467779150|FG000|Overall Study|Lost to Follow-up|3|||
129949716|NCT03386344|467779151|FG001|Overall Study|Lost to Follow-up|2|||
129949717|NCT03386344|467779152|FG002|Overall Study|Lost to Follow-up|1|||
129949718|NCT03386344|467779150|FG000|Overall Study|At the Participant's own Request|7|||
129949719|NCT03386344|467779151|FG001|Overall Study|At the Participant's own Request|7|||
129949720|NCT03386344|467779152|FG002|Overall Study|At the Participant's own Request|8|||
129949721|NCT03386344|467779150|FG000|Overall Study|Reason not Specified|0|||
129949722|NCT03386344|467779151|FG001|Overall Study|Reason not Specified|1|||
129949723|NCT03386344|467779152|FG002|Overall Study|Reason not Specified|0|||
129949724|NCT01280721|467779155|FG000|Overall Study|Adverse Event|4|||
129949725|NCT01280721|467779155|FG000|Overall Study|Physician Decision|3|||
129949726|NCT01280721|467779155|FG000|Overall Study|Withdrawal by Subject|6|||
129949727|NCT01280721|467779155|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
129949728|NCT01280721|467779155|FG000|Overall Study|No tolerability for the lowest dose|2|||
129949729|NCT01180400|467779156|FG000|Overall Study|Withdrawal by Subject|5|||
129949730|NCT01180400|467779157|FG001|Overall Study|Withdrawal by Subject|6|||
129949731|NCT01180400|467779156|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129949732|NCT01180400|467779157|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
129949733|NCT01180400|467779156|FG000|Overall Study|Adverse Event|12|||
129949734|NCT01180400|467779157|FG001|Overall Study|Adverse Event|10|||
129949735|NCT01180400|467779156|FG000|Overall Study|Severe non-compliance to protocol|1|||
129949736|NCT01180400|467779157|FG001|Overall Study|Severe non-compliance to protocol|2|||
129949737|NCT01180400|467779156|FG000|Overall Study|Condition under investigation worsened|2|||
129949738|NCT01180400|467779157|FG001|Overall Study|Condition under investigation worsened|1|||
129949739|NCT01180400|467779156|FG000|Overall Study|Lack of Efficacy|2|||
129949740|NCT01180400|467779157|FG001|Overall Study|Lack of Efficacy|0|||
129949741|NCT01180400|467779156|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129949742|NCT01180400|467779157|FG001|Overall Study|Study-specific withdrawal criteria|2|||
129949743|NCT01180400|467779156|FG000|Overall Study|Lost to Follow-up|2|||
129949744|NCT01180400|467779157|FG001|Overall Study|Lost to Follow-up|3|||
129949745|NCT01180400|467779156|FG000|Overall Study|Other|0|||
129949746|NCT01180400|467779157|FG001|Overall Study|Other|1|||
130120418|NCT02579096|468402373|FG000|Phase 2, Weeks 25 - 48|Death|2|||
129949747|NCT00963924|467779158|FG000|Overall Study|Adverse Event|1|||
129949748|NCT00963924|467779159|FG001|Overall Study|Adverse Event|0|||
129949749|NCT00963924|467779158|FG000|Overall Study|Withdrawal by Subject|0|||
129949750|NCT00963924|467779159|FG001|Overall Study|Withdrawal by Subject|1|||
129949751|NCT00963924|467779158|FG000|Overall Study|Changed antipsychotic|0|||
129949752|NCT00963924|467779159|FG001|Overall Study|Changed antipsychotic|1|||
129949753|NCT00963924|467779158|FG000|Overall Study|Lost to Follow-up|0|||
129949754|NCT00963924|467779159|FG001|Overall Study|Lost to Follow-up|1|||
129949755|NCT03031782|467779164|FG000|Treatment Period 1|Lack of Efficacy|3|||
129949756|NCT03031782|467779165|FG001|Treatment Period 1|Lack of Efficacy|0|||
129949757|NCT03031782|467779166|FG002|Treatment Period 1|Lack of Efficacy|0|||
129949758|NCT03031782|467779167|FG003|Treatment Period 1|Lack of Efficacy|0|||
129949759|NCT03031782|467779168|FG004|Treatment Period 1|Lack of Efficacy|0|||
129949760|NCT03031782|467779164|FG000|Treatment Period 2|Physician Decision|0|||
129949761|NCT03031782|467779165|FG001|Treatment Period 2|Physician Decision|1|||
129949762|NCT03031782|467779166|FG002|Treatment Period 2|Physician Decision|0|||
129949763|NCT03031782|467779167|FG003|Treatment Period 2|Physician Decision|0|||
129949764|NCT03031782|467779168|FG004|Treatment Period 2|Physician Decision|3|||
129949765|NCT03031782|467779164|FG000|Treatment Period 2|Lack of Efficacy|0|||
129949766|NCT03031782|467779165|FG001|Treatment Period 2|Lack of Efficacy|1|||
129949767|NCT03031782|467779166|FG002|Treatment Period 2|Lack of Efficacy|0|||
129949768|NCT03031782|467779167|FG003|Treatment Period 2|Lack of Efficacy|0|||
129949769|NCT03031782|467779168|FG004|Treatment Period 2|Lack of Efficacy|1|||
129949770|NCT03031782|467779164|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129949771|NCT03031782|467779165|FG001|Treatment Period 2|Withdrawal by Subject|3|||
129949772|NCT03031782|467779166|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129949773|NCT03031782|467779167|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129949774|NCT03031782|467779168|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129949775|NCT03031782|467779164|FG000|Treatment Period 2|Adverse Event|0|||
129949776|NCT03031782|467779165|FG001|Treatment Period 2|Adverse Event|1|||
129949777|NCT03031782|467779166|FG002|Treatment Period 2|Adverse Event|2|||
129949778|NCT03031782|467779167|FG003|Treatment Period 2|Adverse Event|0|||
129949779|NCT03031782|467779168|FG004|Treatment Period 2|Adverse Event|0|||
129949780|NCT03031782|467779164|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129949781|NCT03031782|467779165|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129949782|NCT03031782|467779166|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129949783|NCT03031782|467779167|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129949784|NCT03031782|467779168|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129949785|NCT02170207|467779171|FG000|Overall Study|Case report forms unavailable|5|||
129949786|NCT00886834|467779172|FG000|Overall Study|Protocol Violation|0|||
129949787|NCT00886834|467779173|FG001|Overall Study|Protocol Violation|3|||
129949788|NCT03122860|467779174|FG000|Overall Study|Discontinued Before Treatment|1|||
129949789|NCT03122860|467779175|FG001|Overall Study|Discontinued Before Treatment|1|||
129949790|NCT03122860|467779176|FG002|Overall Study|Discontinued Before Treatment|2|||
129949791|NCT03122860|467779177|FG003|Overall Study|Discontinued Before Treatment|0|||
129949792|NCT03122860|467779178|FG004|Overall Study|Discontinued Before Treatment|1|||
129949793|NCT03122860|467779179|FG005|Overall Study|Discontinued Before Treatment|0|||
129949794|NCT03122860|467779174|FG000|Overall Study|Adverse Event|1|||
129949795|NCT03122860|467779175|FG001|Overall Study|Adverse Event|0|||
129949796|NCT03122860|467779176|FG002|Overall Study|Adverse Event|1|||
129949797|NCT03122860|467779177|FG003|Overall Study|Adverse Event|1|||
129949798|NCT03122860|467779178|FG004|Overall Study|Adverse Event|0|||
129949799|NCT03122860|467779179|FG005|Overall Study|Adverse Event|0|||
129949800|NCT03122860|467779174|FG000|Overall Study|Lost to Follow-up|5|||
129949801|NCT03122860|467779175|FG001|Overall Study|Lost to Follow-up|2|||
129949802|NCT03122860|467779176|FG002|Overall Study|Lost to Follow-up|3|||
129949803|NCT03122860|467779177|FG003|Overall Study|Lost to Follow-up|3|||
129949804|NCT03122860|467779178|FG004|Overall Study|Lost to Follow-up|5|||
129949805|NCT03122860|467779179|FG005|Overall Study|Lost to Follow-up|4|||
129949806|NCT03122860|467779174|FG000|Overall Study|Subject Non-Compliance|0|||
129949807|NCT03122860|467779175|FG001|Overall Study|Subject Non-Compliance|0|||
129949808|NCT03122860|467779176|FG002|Overall Study|Subject Non-Compliance|1|||
129949809|NCT03122860|467779177|FG003|Overall Study|Subject Non-Compliance|0|||
129949810|NCT03122860|467779178|FG004|Overall Study|Subject Non-Compliance|0|||
129949811|NCT03122860|467779179|FG005|Overall Study|Subject Non-Compliance|0|||
129949812|NCT03122860|467779174|FG000|Overall Study|Withdrawal by Subject|3|||
129949813|NCT03122860|467779175|FG001|Overall Study|Withdrawal by Subject|2|||
129949814|NCT03122860|467779176|FG002|Overall Study|Withdrawal by Subject|5|||
129949815|NCT03122860|467779177|FG003|Overall Study|Withdrawal by Subject|7|||
129949816|NCT03122860|467779178|FG004|Overall Study|Withdrawal by Subject|9|||
129949817|NCT03122860|467779179|FG005|Overall Study|Withdrawal by Subject|8|||
129949818|NCT01138657|467779180|FG000|Overall Study|Adverse Event|3|||
129949819|NCT01138657|467779181|FG001|Overall Study|Adverse Event|10|||
129949820|NCT01138657|467779180|FG000|Overall Study|Lack of Efficacy|2|||
129949821|NCT01138657|467779181|FG001|Overall Study|Lack of Efficacy|1|||
129949822|NCT01138657|467779180|FG000|Overall Study|Lost to Follow-up|0|||
129949823|NCT01138657|467779181|FG001|Overall Study|Lost to Follow-up|3|||
129949824|NCT01138657|467779180|FG000|Overall Study|Miscellaneous Reasons|3|||
129949825|NCT01138657|467779181|FG001|Overall Study|Miscellaneous Reasons|4|||
129949826|NCT03875729|467779182|FG000|Overall Study|Adverse Event|0|||
129949827|NCT03875729|467779183|FG001|Overall Study|Adverse Event|5|||
129949828|NCT03875729|467779182|FG000|Overall Study|Withdrawal by Subject|8|||
129949829|NCT03875729|467779183|FG001|Overall Study|Withdrawal by Subject|11|||
129949830|NCT03875729|467779182|FG000|Overall Study|Pregnancy|0|||
129949831|NCT03875729|467779183|FG001|Overall Study|Pregnancy|1|||
129949832|NCT03875729|467779182|FG000|Overall Study|Lost to Follow-up|0|||
129949833|NCT03875729|467779183|FG001|Overall Study|Lost to Follow-up|5|||
129949834|NCT03875729|467779182|FG000|Overall Study|Personal reasons|2|||
129949835|NCT03875729|467779183|FG001|Overall Study|Personal reasons|0|||
129949836|NCT00529529|467779190|FG000|Overall Study|Adverse Event|12|||
129949837|NCT00529529|467779191|FG001|Overall Study|Adverse Event|17|||
130072170|NCT01202760|468218150|FG000|Overall Study|Protocol Violation|7|||
130072171|NCT01202760|468218151|FG001|Overall Study|Protocol Violation|5|||
130072172|NCT01202760|468218152|FG002|Overall Study|Protocol Violation|2|||
130072173|NCT01202760|468218150|FG000|Overall Study|Sponsor Decision|4|||
130072174|NCT01202760|468218151|FG001|Overall Study|Sponsor Decision|4|||
130072175|NCT01202760|468218152|FG002|Overall Study|Sponsor Decision|0|||
130072176|NCT00871572|468218153|FG000|Overall Study|Adverse Event|0|||
130072177|NCT00871572|468218154|FG001|Overall Study|Adverse Event|2|||
130072178|NCT00871572|468218155|FG002|Overall Study|Adverse Event|0|||
130072179|NCT00871572|468218156|FG003|Overall Study|Adverse Event|3|||
130072180|NCT00871572|468218153|FG000|Overall Study|Investigator Decision|0|||
130072181|NCT00871572|468218154|FG001|Overall Study|Investigator Decision|1|||
130072182|NCT00871572|468218155|FG002|Overall Study|Investigator Decision|0|||
130072183|NCT00871572|468218156|FG003|Overall Study|Investigator Decision|1|||
130072184|NCT00871572|468218153|FG000|Overall Study|Lost to Follow-up|0|||
130072185|NCT00871572|468218154|FG001|Overall Study|Lost to Follow-up|1|||
130072186|NCT00871572|468218155|FG002|Overall Study|Lost to Follow-up|0|||
130072187|NCT00871572|468218156|FG003|Overall Study|Lost to Follow-up|1|||
130072188|NCT00871572|468218153|FG000|Overall Study|Protocol Violation|0|||
130072189|NCT00871572|468218154|FG001|Overall Study|Protocol Violation|0|||
130072190|NCT00871572|468218155|FG002|Overall Study|Protocol Violation|1|||
130072191|NCT00871572|468218156|FG003|Overall Study|Protocol Violation|1|||
130072192|NCT00871572|468218153|FG000|Overall Study|Sponsor Decision|1|||
130072193|NCT00871572|468218154|FG001|Overall Study|Sponsor Decision|0|||
130072194|NCT00871572|468218155|FG002|Overall Study|Sponsor Decision|0|||
130072195|NCT00871572|468218156|FG003|Overall Study|Sponsor Decision|0|||
130072196|NCT00871572|468218153|FG000|Overall Study|Withdrawal by Subject|1|||
130072197|NCT00871572|468218154|FG001|Overall Study|Withdrawal by Subject|2|||
130072198|NCT00871572|468218155|FG002|Overall Study|Withdrawal by Subject|3|||
130072199|NCT00871572|468218156|FG003|Overall Study|Withdrawal by Subject|1|||
130072200|NCT04354155|468218159|FG000|Overall Study|Withdrawal by Subject|1|||
130072201|NCT04354155|468218159|FG000|Overall Study|Did not meet criteria for study intervention|1|||
129949838|NCT00529529|467779192|FG002|Overall Study|Adverse Event|8|||
129949839|NCT00529529|467779190|FG000|Overall Study|Subject withdrew consent|12|||
129949840|NCT00529529|467779191|FG001|Overall Study|Subject withdrew consent|9|||
129949841|NCT00529529|467779192|FG002|Overall Study|Subject withdrew consent|12|||
129949842|NCT00529529|467779190|FG000|Overall Study|Protocol deviation|8|||
129949843|NCT00529529|467779191|FG001|Overall Study|Protocol deviation|12|||
129949844|NCT00529529|467779192|FG002|Overall Study|Protocol deviation|5|||
129949845|NCT00529529|467779190|FG000|Overall Study|Lost to Follow-up|5|||
129949846|NCT00529529|467779191|FG001|Overall Study|Lost to Follow-up|3|||
129949847|NCT00529529|467779192|FG002|Overall Study|Lost to Follow-up|1|||
129949848|NCT00529529|467779190|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129949849|NCT00529529|467779191|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129949850|NCT00529529|467779192|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129949851|NCT00529529|467779190|FG000|Overall Study|Death|2|||
129949852|NCT00529529|467779191|FG001|Overall Study|Death|0|||
129949853|NCT00529529|467779192|FG002|Overall Study|Death|0|||
129949854|NCT00529529|467779190|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129949855|NCT00529529|467779191|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129949856|NCT00529529|467779192|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129949857|NCT00529529|467779190|FG000|Overall Study|Administrative problems|1|||
129949858|NCT00529529|467779191|FG001|Overall Study|Administrative problems|0|||
129949859|NCT00529529|467779192|FG002|Overall Study|Administrative problems|3|||
129949860|NCT00237809|467779195|FG000|Overall Study|Lost to Follow-up|11|||
129949861|NCT00237809|467779196|FG001|Overall Study|Lost to Follow-up|10|||
129949862|NCT00237809|467779197|FG002|Overall Study|Lost to Follow-up|9|||
129949863|NCT00237809|467779198|FG003|Overall Study|Lost to Follow-up|9|||
129949864|NCT02291549|467779201|FG000|Overall Study|Lost to Follow-up|1|||
129949865|NCT02291549|467779202|FG001|Overall Study|Lost to Follow-up|0|||
129949866|NCT02291549|467779201|FG000|Overall Study|Withdrawal by Subject|0|||
129949867|NCT02291549|467779202|FG001|Overall Study|Withdrawal by Subject|1|||
130072202|NCT00187889|468218160|FG000|Overall Study|Withdrawal by Subject|6|||
130072203|NCT00187889|468218161|FG001|Overall Study|Withdrawal by Subject|4|||
130072204|NCT03097029|468218166|FG000|Overall Study|Withdrawal by Subject|1|||
130072205|NCT00709124|468218168|FG000|Overall Study|Death|3|||
130072206|NCT00709124|468218169|FG001|Overall Study|Death|1|||
130072207|NCT00709124|468218168|FG000|Overall Study|encephalopathy; can't do assessment|1|||
130072208|NCT00709124|468218169|FG001|Overall Study|encephalopathy; can't do assessment|0|||
129949868|NCT02978716|467779204|FG000|Overall Study|Death|25|||
129949869|NCT02978716|467779205|FG001|Overall Study|Death|13|||
129949870|NCT02978716|467779206|FG002|Overall Study|Death|20|||
129949871|NCT02978716|467779204|FG000|Overall Study|Lost to Follow-up|0|||
130072209|NCT00373490|468218170|FG000|Overall Study|Adverse Event|0|||
130072210|NCT00373490|468218171|FG001|Overall Study|Adverse Event|1|||
129949872|NCT02978716|467779205|FG001|Overall Study|Lost to Follow-up|0|||
129949873|NCT02978716|467779206|FG002|Overall Study|Lost to Follow-up|1|||
129949874|NCT02978716|467779204|FG000|Overall Study|Withdrawal by Subject|6|||
129949875|NCT02978716|467779205|FG001|Overall Study|Withdrawal by Subject|4|||
129949876|NCT02978716|467779206|FG002|Overall Study|Withdrawal by Subject|5|||
129949877|NCT02978716|467779204|FG000|Overall Study|Sponsor terminated|2|||
129949878|NCT02978716|467779205|FG001|Overall Study|Sponsor terminated|13|||
129949879|NCT02978716|467779206|FG002|Overall Study|Sponsor terminated|9|||
129949880|NCT02978716|467779204|FG000|Overall Study|Other|1|||
129949881|NCT02978716|467779205|FG001|Overall Study|Other|3|||
129949882|NCT02978716|467779206|FG002|Overall Study|Other|0|||
129949883|NCT00960206|467779207|FG000|Overall Study|Death|7|||
129949884|NCT00960206|467779208|FG001|Overall Study|Death|4|||
129949885|NCT00960206|467779209|FG002|Overall Study|Death|1|||
129949886|NCT00960206|467779207|FG000|Overall Study|Unwilling/Unable to return|1|||
129949887|NCT00960206|467779208|FG001|Overall Study|Unwilling/Unable to return|2|||
129949888|NCT00960206|467779209|FG002|Overall Study|Unwilling/Unable to return|0|||
129949889|NCT00960206|467779207|FG000|Overall Study|Lost to Follow-up|8|||
129949890|NCT00960206|467779208|FG001|Overall Study|Lost to Follow-up|14|||
129949891|NCT00960206|467779209|FG002|Overall Study|Lost to Follow-up|8|||
129949892|NCT00960206|467779207|FG000|Overall Study|Withdrawal by Subject|2|||
129949893|NCT00960206|467779208|FG001|Overall Study|Withdrawal by Subject|4|||
129949894|NCT00960206|467779209|FG002|Overall Study|Withdrawal by Subject|0|||
129949895|NCT00960206|467779207|FG000|Overall Study|Revision of study component|2|||
129949896|NCT00960206|467779208|FG001|Overall Study|Revision of study component|2|||
129949897|NCT00960206|467779209|FG002|Overall Study|Revision of study component|2|||
129949898|NCT00960206|467779207|FG000|Overall Study|Missing 10 year data|20|||
129949899|NCT00960206|467779208|FG001|Overall Study|Missing 10 year data|1|||
129949900|NCT00960206|467779209|FG002|Overall Study|Missing 10 year data|1|||
129949901|NCT02470806|467779210|FG000|Overall Study|Lost to Follow-up|1|||
129949902|NCT02470806|467779211|FG001|Overall Study|Lost to Follow-up|1|||
129949903|NCT02470806|467779210|FG000|Overall Study|Adverse Event|5|||
129949904|NCT02470806|467779211|FG001|Overall Study|Adverse Event|2|||
129949905|NCT02470806|467779210|FG000|Overall Study|Protocol Violation|4|||
129949906|NCT02470806|467779211|FG001|Overall Study|Protocol Violation|11|||
129949907|NCT02470806|467779210|FG000|Overall Study|Physician Decision|0|||
129949908|NCT02470806|467779211|FG001|Overall Study|Physician Decision|3|||
130072211|NCT00373490|468218170|FG000|Overall Study|Lack of Efficacy|9|||
130072212|NCT00373490|468218171|FG001|Overall Study|Lack of Efficacy|4|||
130072213|NCT00373490|468218170|FG000|Overall Study|Withdrawal by Subject|0|||
130072214|NCT00373490|468218171|FG001|Overall Study|Withdrawal by Subject|1|||
130072215|NCT00108953|468218178|FG000|Follow-up|Death|18|||
130072216|NCT00108953|468218179|FG001|Follow-up|Death|26|||
130072217|NCT00108953|468218178|FG000|Follow-up|Lost to Follow-up|1|||
130072218|NCT00108953|468218179|FG001|Follow-up|Lost to Follow-up|1|||
130072219|NCT00108953|468218178|FG000|Follow-up|Study terminated by sponsor|10|||
130072220|NCT00108953|468218179|FG001|Follow-up|Study terminated by sponsor|6|||
130072221|NCT02999100|468218185|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
130072222|NCT02999100|468218186|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
130072223|NCT02999100|468218187|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
130072224|NCT02999100|468218188|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
130072225|NCT02999100|468218189|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
130072226|NCT02999100|468218190|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
130072227|NCT02999100|468218185|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130072228|NCT02999100|468218186|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130072229|NCT02999100|468218187|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130072230|NCT02999100|468218188|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
130072231|NCT02999100|468218189|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129949909|NCT02470806|467779210|FG000|Overall Study|Withdrawal by Subject|3|||
129949910|NCT02470806|467779211|FG001|Overall Study|Withdrawal by Subject|10|||
129949911|NCT02470806|467779210|FG000|Overall Study|Lack of Efficacy|5|||
129949912|NCT02470806|467779211|FG001|Overall Study|Lack of Efficacy|15|||
129949913|NCT03075878|467779215|FG000|Overall Study|Physician Decision|1|||
129949914|NCT00853957|467779220|FG000|Overall Study|Adverse Event|9|||
129949915|NCT00853957|467779221|FG001|Overall Study|Adverse Event|3|||
129949916|NCT00853957|467779220|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129949917|NCT00853957|467779221|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130072232|NCT02999100|468218190|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
130072233|NCT02999100|468218185|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129949918|NCT00853957|467779220|FG000|Overall Study|Subject withdrew consent|4|||
129949919|NCT00853957|467779221|FG001|Overall Study|Subject withdrew consent|5|||
129949920|NCT00853957|467779220|FG000|Overall Study|Lost to Follow-up|1|||
129949921|NCT00853957|467779221|FG001|Overall Study|Lost to Follow-up|6|||
129949922|NCT00853957|467779220|FG000|Overall Study|Protocol deviation|0|||
129949923|NCT00853957|467779221|FG001|Overall Study|Protocol deviation|3|||
129949924|NCT02158806|467779222|FG000|Overall Study|Death|2|||
129949925|NCT02158806|467779223|FG001|Overall Study|Death|0|||
130072234|NCT02999100|468218186|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129949926|NCT02158806|467779222|FG000|Overall Study|Withdrawal by Subject|2|||
129949927|NCT02158806|467779223|FG001|Overall Study|Withdrawal by Subject|0|||
129949928|NCT02158806|467779222|FG000|Overall Study|Lost to Follow-up|0|||
129949929|NCT02158806|467779223|FG001|Overall Study|Lost to Follow-up|3|||
129949930|NCT02158806|467779222|FG000|Overall Study|Moved out of area|0|||
129949931|NCT02158806|467779223|FG001|Overall Study|Moved out of area|1|||
129949932|NCT02158806|467779222|FG000|Overall Study|Transferred to palliative care|0|||
129949933|NCT02158806|467779223|FG001|Overall Study|Transferred to palliative care|1|||
129949934|NCT03070301|467779224|FG000|Overall Study|Progression of disease|16|||
129949935|NCT03070301|467779224|FG000|Overall Study|Physician Decision|3|||
129949936|NCT03070301|467779224|FG000|Overall Study|Withdrawal by Subject|1|||
129949937|NCT04520256|467779228|FG000|Overall Study|Lost to Follow-up|6|||
129949938|NCT04520256|467779229|FG001|Overall Study|Lost to Follow-up|4|||
129949939|NCT04520256|467779230|FG002|Overall Study|Lost to Follow-up|2|||
129949940|NCT04520256|467779231|FG003|Overall Study|Lost to Follow-up|3|||
129949941|NCT04520256|467779232|FG004|Overall Study|Lost to Follow-up|6|||
129949942|NCT04520256|467779233|FG005|Overall Study|Lost to Follow-up|6|||
129949943|NCT04520256|467779234|FG006|Overall Study|Lost to Follow-up|4|||
129949944|NCT04520256|467779235|FG007|Overall Study|Lost to Follow-up|6|||
129949945|NCT04520256|467779236|FG008|Overall Study|Lost to Follow-up|1|||
129949946|NCT04520256|467779237|FG009|Overall Study|Lost to Follow-up|3|||
129949947|NCT04520256|467779238|FG010|Overall Study|Lost to Follow-up|3|||
129949948|NCT04520256|467779239|FG011|Overall Study|Lost to Follow-up|2|||
129949949|NCT04520256|467779240|FG012|Overall Study|Lost to Follow-up|5|||
129949950|NCT04520256|467779241|FG013|Overall Study|Lost to Follow-up|3|||
129949951|NCT04520256|467779242|FG014|Overall Study|Lost to Follow-up|3|||
129949952|NCT04520256|467779243|FG015|Overall Study|Lost to Follow-up|6|||
129949953|NCT04520256|467779244|FG016|Overall Study|Lost to Follow-up|6|||
129949954|NCT04520256|467779245|FG017|Overall Study|Lost to Follow-up|4|||
129949955|NCT04520256|467779246|FG018|Overall Study|Lost to Follow-up|3|||
129949956|NCT04520256|467779247|FG019|Overall Study|Lost to Follow-up|3|||
129949957|NCT04520256|467779248|FG020|Overall Study|Lost to Follow-up|7|||
129949958|NCT04520256|467779249|FG021|Overall Study|Lost to Follow-up|3|||
129949959|NCT04520256|467779250|FG022|Overall Study|Lost to Follow-up|3|||
129949960|NCT04520256|467779251|FG023|Overall Study|Lost to Follow-up|8|||
129949961|NCT04520256|467779252|FG024|Overall Study|Lost to Follow-up|5|||
129949962|NCT04520256|467779253|FG025|Overall Study|Lost to Follow-up|4|||
129949963|NCT04520256|467779254|FG026|Overall Study|Lost to Follow-up|3|||
129949964|NCT04520256|467779255|FG027|Overall Study|Lost to Follow-up|4|||
129949965|NCT04520256|467779256|FG028|Overall Study|Lost to Follow-up|3|||
129949966|NCT04520256|467779257|FG029|Overall Study|Lost to Follow-up|4|||
129949967|NCT04520256|467779258|FG030|Overall Study|Lost to Follow-up|4|||
129949968|NCT04520256|467779259|FG031|Overall Study|Lost to Follow-up|4|||
129949969|NCT02880293|467781015|FG000|Overall Study|Inevaluable|5|||
129949970|NCT00451906|467781024|FG000|Overall Study|Adverse Event|515|||
129949971|NCT00451906|467781024|FG000|Overall Study|Lost to Follow-up|31|||
129949972|NCT00451906|467781024|FG000|Overall Study|Withdrawal by Subject|111|||
129949973|NCT00451906|467781024|FG000|Overall Study|Protocol Violation|21|||
129949974|NCT00451906|467781024|FG000|Overall Study|Progressive disease|1328|||
129949975|NCT00451906|467781024|FG000|Overall Study|Termination of the study|108|||
129949976|NCT00451906|467781024|FG000|Overall Study|Other Reasons|121|||
129949977|NCT00451906|467781024|FG000|Overall Study|Did not complete final visit|4|||
130072235|NCT02999100|468218187|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
129949978|NCT03072238|467781029|FG000|Overall Study|Withdrawal by Subject|44|||
129949979|NCT03072238|467781030|FG001|Overall Study|Withdrawal by Subject|64|||
129949980|NCT03072238|467781029|FG000|Overall Study|Lost to Follow-up|14|||
129949981|NCT03072238|467781030|FG001|Overall Study|Lost to Follow-up|5|||
129949982|NCT03072238|467781029|FG000|Overall Study|Physician Decision|4|||
129949983|NCT03072238|467781030|FG001|Overall Study|Physician Decision|6|||
129949984|NCT03072238|467781029|FG000|Overall Study|Death|351|||
129949985|NCT03072238|467781030|FG001|Overall Study|Death|318|||
129949986|NCT03072238|467781029|FG000|Overall Study|Progressive Disease|3|||
129949987|NCT03072238|467781030|FG001|Overall Study|Progressive Disease|4|||
129949988|NCT03072238|467781029|FG000|Overall Study|Reason Not Specified|138|||
129949989|NCT03072238|467781030|FG001|Overall Study|Reason Not Specified|150|||
129949990|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
130072236|NCT02999100|468218188|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130072237|NCT02999100|468218189|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130072238|NCT02999100|468218190|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
130072239|NCT01125293|468218191|FG000|Overall Study|Disease Progression|1|||
129949991|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
129949992|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
129949993|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
129949994|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
129949995|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
129949996|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
129949997|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
129949998|NCT01863368|467781036|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
129949999|NCT01863368|467781037|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
129950000|NCT01863368|467781036|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
129950001|NCT01863368|467781037|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
129950002|NCT00307489|467781038|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
129950003|NCT00307489|467781039|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
129950004|NCT00307489|467781038|FG000|Baseline Through Week 48|Physician Decision|1|||
129950005|NCT00307489|467781039|FG001|Baseline Through Week 48|Physician Decision|0|||
129950006|NCT00307489|467781038|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
129950007|NCT00307489|467781039|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
129950008|NCT00307489|467781038|FG000|Week 48 Through Week 168|Adverse Event|1|||
129950009|NCT00307489|467781039|FG001|Week 48 Through Week 168|Adverse Event|0|||
129950010|NCT00307489|467781038|FG000|Week 48 Through Week 168|Physician Decision|1|||
129950011|NCT00307489|467781039|FG001|Week 48 Through Week 168|Physician Decision|0|||
129950012|NCT00307489|467781038|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
129950013|NCT00307489|467781039|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
129950014|NCT00307489|467781038|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
129950015|NCT00307489|467781039|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
129950016|NCT00307489|467781038|FG000|Week 48 Through Week 168|Death|0|||
129950017|NCT00307489|467781039|FG001|Week 48 Through Week 168|Death|1|||
129950018|NCT00307489|467781038|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
129950019|NCT00307489|467781039|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
129950020|NCT00307489|467781038|FG000|Week 48 Through Week 168|Seroconversion|1|||
129950021|NCT00307489|467781039|FG001|Week 48 Through Week 168|Seroconversion|0|||
129950022|NCT02165202|467781040|FG000|Oral Phase|Refused further participation|5|||
129950023|NCT02165202|467781041|FG001|Oral Phase|Refused further participation|1|||
129950024|NCT02165202|467781040|FG000|Oral Phase|Study product Related Toxicity|1|||
129950025|NCT02165202|467781041|FG001|Oral Phase|Study product Related Toxicity|0|||
129950026|NCT02165202|467781040|FG000|Oral Phase|Unable to contact Participant|1|||
129950027|NCT02165202|467781041|FG001|Oral Phase|Unable to contact Participant|1|||
129950028|NCT02165202|467781040|FG000|Oral Phase|Clinical reasons|1|||
129950029|NCT02165202|467781041|FG001|Oral Phase|Clinical reasons|0|||
129950030|NCT02165202|467781040|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
129950031|NCT02165202|467781041|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
129950032|NCT02165202|467781040|FG000|Oral Phase|CMC advised termination|1|||
129950033|NCT02165202|467781041|FG001|Oral Phase|CMC advised termination|0|||
129950034|NCT02165202|467781040|FG000|Oral Phase|Relocated, no follow-up planned|1|||
129950035|NCT02165202|467781041|FG001|Oral Phase|Relocated, no follow-up planned|0|||
129950036|NCT02165202|467781040|FG000|Oral Phase|Abnormal EKG|0|||
129950037|NCT02165202|467781041|FG001|Oral Phase|Abnormal EKG|1|||
129950038|NCT02165202|467781040|FG000|Injection Phase|Abnormal Lab Value|5|||
129950039|NCT02165202|467781041|FG001|Injection Phase|Abnormal Lab Value|1|||
129950040|NCT02165202|467781040|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
129950041|NCT02165202|467781041|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
129950042|NCT02165202|467781040|FG000|Injection Phase|Unable to attend within Visit Window|1|||
129950043|NCT02165202|467781041|FG001|Injection Phase|Unable to attend within Visit Window|0|||
129950044|NCT02165202|467781040|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
129950045|NCT02165202|467781041|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
129950046|NCT02165202|467781040|FG000|Injection Phase|End of Study|2|||
129950047|NCT02165202|467781041|FG001|Injection Phase|End of Study|1|||
129950048|NCT02165202|467781040|FG000|Injection Phase|Study Product related Toxicity|1|||
129950049|NCT02165202|467781041|FG001|Injection Phase|Study Product related Toxicity|0|||
129950050|NCT02165202|467781040|FG000|Injection Phase|No longer interested|0|||
129950051|NCT02165202|467781041|FG001|Injection Phase|No longer interested|1|||
129950052|NCT02165202|467781040|FG000|Injection Phase|Participant unwilling to comply|1|||
129950053|NCT02165202|467781041|FG001|Injection Phase|Participant unwilling to comply|0|||
129950054|NCT01072149|467781047|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950055|NCT01072149|467781048|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950056|NCT01072149|467781049|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129950057|NCT01072149|467781050|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950058|NCT01072149|467781051|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950059|NCT01072149|467781052|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950060|NCT01072149|467781053|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950061|NCT01072149|467781054|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950062|NCT01072149|467781055|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950063|NCT01072149|467781056|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950064|NCT01072149|467781057|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950065|NCT01072149|467781058|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950066|NCT01072149|467781059|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950067|NCT01072149|467781060|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950068|NCT01072149|467781061|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950069|NCT01072149|467781062|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950070|NCT01072149|467781063|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950071|NCT01072149|467781064|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950072|NCT01072149|467781047|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950073|NCT01072149|467781048|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950074|NCT01072149|467781049|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950075|NCT01072149|467781050|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950076|NCT01072149|467781051|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950077|NCT01072149|467781052|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950078|NCT01072149|467781053|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950079|NCT01072149|467781054|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950080|NCT01072149|467781055|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950081|NCT01072149|467781056|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950082|NCT01072149|467781057|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950083|NCT01072149|467781058|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950084|NCT01072149|467781059|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950085|NCT01072149|467781060|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950086|NCT01072149|467781061|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950087|NCT01072149|467781062|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950088|NCT01072149|467781063|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950089|NCT01072149|467781064|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
129950090|NCT01072149|467781047|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950091|NCT01072149|467781048|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950092|NCT01072149|467781049|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950093|NCT01072149|467781050|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950094|NCT01072149|467781051|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950095|NCT01072149|467781052|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950096|NCT01072149|467781053|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950097|NCT01072149|467781054|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950098|NCT01072149|467781055|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950099|NCT01072149|467781056|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950100|NCT01072149|467781057|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
129950101|NCT01072149|467781058|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950102|NCT01072149|467781059|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950103|NCT01072149|467781060|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950104|NCT01072149|467781061|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950105|NCT01072149|467781062|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950106|NCT01072149|467781063|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950107|NCT01072149|467781064|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950108|NCT01072149|467781047|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950109|NCT01072149|467781048|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
129950110|NCT01072149|467781049|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950111|NCT01072149|467781050|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950112|NCT01072149|467781051|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950113|NCT01072149|467781052|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950114|NCT01072149|467781053|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950115|NCT01072149|467781054|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950116|NCT01072149|467781055|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950117|NCT01072149|467781056|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950118|NCT01072149|467781057|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950119|NCT01072149|467781058|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950120|NCT01072149|467781059|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950121|NCT01072149|467781060|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950122|NCT01072149|467781061|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950123|NCT01072149|467781062|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950124|NCT01072149|467781063|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950125|NCT01072149|467781064|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950126|NCT01072149|467781047|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950127|NCT01072149|467781048|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950128|NCT01072149|467781049|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
129950129|NCT01072149|467781050|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950130|NCT01072149|467781051|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950131|NCT01072149|467781052|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950132|NCT01072149|467781053|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950133|NCT01072149|467781054|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950134|NCT01072149|467781055|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950135|NCT01072149|467781056|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950136|NCT01072149|467781057|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950137|NCT01072149|467781058|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950138|NCT01072149|467781059|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950139|NCT01072149|467781060|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950140|NCT01072149|467781061|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950141|NCT01072149|467781062|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950142|NCT01072149|467781063|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950143|NCT01072149|467781064|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950144|NCT01072149|467781047|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950145|NCT01072149|467781048|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950146|NCT01072149|467781049|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950147|NCT01072149|467781050|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950148|NCT01072149|467781051|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950149|NCT01072149|467781052|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950150|NCT01072149|467781053|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950151|NCT01072149|467781054|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
129950152|NCT01072149|467781055|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950153|NCT01072149|467781056|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950154|NCT01072149|467781057|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950155|NCT01072149|467781058|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950156|NCT01072149|467781059|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950157|NCT01072149|467781060|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950158|NCT01072149|467781061|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950159|NCT01072149|467781062|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950160|NCT01072149|467781063|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950161|NCT01072149|467781064|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950162|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
129950163|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
129950164|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
129950165|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
129950166|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
129950167|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
129950168|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
129950169|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
129950170|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
129950171|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
129950172|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
129950173|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
129950174|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
129950175|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
129950176|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
129950177|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
129950178|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
129950179|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
129950180|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950181|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950182|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950183|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950184|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950185|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950186|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950187|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950188|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950189|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950190|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
130072240|NCT01125293|468218192|FG001|Overall Study|Disease Progression|3|||
130072241|NCT01125293|468218193|FG002|Overall Study|Disease Progression|4|||
130072242|NCT01125293|468218194|FG003|Overall Study|Disease Progression|3|||
130072243|NCT01125293|468218195|FG004|Overall Study|Disease Progression|5|||
130072244|NCT01125293|468218196|FG005|Overall Study|Disease Progression|12|||
130072245|NCT01125293|468218191|FG000|Overall Study|Adverse Event|1|||
130072246|NCT01125293|468218192|FG001|Overall Study|Adverse Event|0|||
129950191|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950192|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950193|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950194|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950195|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
129950196|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950197|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950198|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
130072247|NCT01125293|468218193|FG002|Overall Study|Adverse Event|0|||
130072248|NCT01125293|468218194|FG003|Overall Study|Adverse Event|0|||
130072249|NCT01125293|468218195|FG004|Overall Study|Adverse Event|2|||
130072250|NCT01125293|468218196|FG005|Overall Study|Adverse Event|8|||
129950199|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
129950200|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
129950201|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
129950202|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
129950203|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
129950204|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
129950205|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
129950206|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
129950207|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
129950208|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
129950209|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
129950210|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
129950211|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
129950212|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
129950213|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
129950214|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
129950215|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
129950216|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950217|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950218|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950219|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950220|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950221|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950222|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950223|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950224|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950225|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950226|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950227|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950228|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
129950229|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950230|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950231|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950232|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950233|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950234|NCT01072149|467781047|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950235|NCT01072149|467781048|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950236|NCT01072149|467781049|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
129950237|NCT01072149|467781050|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950238|NCT01072149|467781051|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950239|NCT01072149|467781052|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950240|NCT01072149|467781053|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950241|NCT01072149|467781054|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950242|NCT01072149|467781055|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950243|NCT01072149|467781056|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950244|NCT01072149|467781057|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950245|NCT01072149|467781058|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950246|NCT01072149|467781059|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950247|NCT01072149|467781060|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
129950248|NCT01072149|467781061|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950249|NCT01072149|467781062|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950250|NCT01072149|467781063|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950251|NCT01072149|467781064|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950252|NCT00080119|467781065|FG000|Overall Study|Discontinued because of study closure|0|||
129950253|NCT00080119|467781066|FG001|Overall Study|Discontinued because of study closure|0|||
129950254|NCT00080119|467781067|FG002|Overall Study|Discontinued because of study closure|130|||
129950255|NCT00080119|467781068|FG003|Overall Study|Discontinued because of study closure|141|||
129950256|NCT00080119|467781065|FG000|Overall Study|Unable to get to clinic|24|||
129950257|NCT00080119|467781066|FG001|Overall Study|Unable to get to clinic|24|||
129950258|NCT00080119|467781067|FG002|Overall Study|Unable to get to clinic|7|||
129950259|NCT00080119|467781068|FG003|Overall Study|Unable to get to clinic|1|||
129950260|NCT00080119|467781065|FG000|Overall Study|Consent withdrawn|13|||
129950261|NCT00080119|467781066|FG001|Overall Study|Consent withdrawn|17|||
129950262|NCT00080119|467781067|FG002|Overall Study|Consent withdrawn|4|||
130072251|NCT01125293|468218191|FG000|Overall Study|Symptomatic Deterioration|1|||
130072252|NCT01125293|468218192|FG001|Overall Study|Symptomatic Deterioration|0|||
130072253|NCT01125293|468218193|FG002|Overall Study|Symptomatic Deterioration|0|||
129950263|NCT00080119|467781068|FG003|Overall Study|Consent withdrawn|6|||
129950264|NCT00080119|467781065|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
130072254|NCT01125293|468218194|FG003|Overall Study|Symptomatic Deterioration|0|||
130072255|NCT01125293|468218195|FG004|Overall Study|Symptomatic Deterioration|0|||
129950265|NCT00080119|467781066|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
129950266|NCT00080119|467781067|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
129950267|NCT00080119|467781068|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
129950268|NCT00080119|467781065|FG000|Overall Study|Lost to Follow-up|16|||
129950269|NCT00080119|467781066|FG001|Overall Study|Lost to Follow-up|19|||
129950270|NCT00080119|467781067|FG002|Overall Study|Lost to Follow-up|19|||
129950271|NCT00080119|467781068|FG003|Overall Study|Lost to Follow-up|14|||
129950272|NCT01919489|467781069|FG000|Overall Study|Rejected the need of injections|4|||
129950273|NCT01919489|467781070|FG001|Overall Study|Rejected the need of injections|7|||
129950274|NCT01919489|467781069|FG000|Overall Study|Adverse Event|10|||
129950275|NCT01919489|467781070|FG001|Overall Study|Adverse Event|0|||
129950276|NCT01919489|467781069|FG000|Overall Study|Hospital readmission|2|||
129950277|NCT01919489|467781070|FG001|Overall Study|Hospital readmission|9|||
129950278|NCT01919489|467781069|FG000|Overall Study|Death|2|||
129950279|NCT01919489|467781070|FG001|Overall Study|Death|1|||
129950280|NCT01919489|467781069|FG000|Overall Study|Lost to Follow-up|38|||
129950281|NCT01919489|467781070|FG001|Overall Study|Lost to Follow-up|27|||
129950282|NCT00871494|467781072|FG000|Overall Study|Protocol Violation|5|||
129950283|NCT00871494|467781072|FG000|Overall Study|Lack of Efficacy|4|||
129950284|NCT00871494|467781072|FG000|Overall Study|Adverse Event|4|||
129950285|NCT00871494|467781072|FG000|Overall Study|Lost to Follow-up|1|||
129950286|NCT01133678|467781077|FG000|Overall Study|Death|1|||
129950287|NCT01133678|467781078|FG001|Overall Study|Death|1|||
129950288|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
129950289|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950290|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950291|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950292|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950293|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Adverse Event|0|||
129950294|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Adverse Event|1|||
129950295|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Adverse Event|1|||
129950296|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Adverse Event|0|||
129950297|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Adverse Event|0|||
129950298|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
129950299|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950300|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950301|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950302|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950303|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Physician Decision|1|||
129950304|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Physician Decision|0|||
129950305|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Physician Decision|0|||
129950306|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Physician Decision|0|||
129950307|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Physician Decision|0|||
129950308|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
129950309|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
129950310|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
129950311|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
129950312|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
129950313|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Ongoing|0|||
129950314|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Ongoing|0|||
129950315|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Ongoing|1|||
129950316|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Ongoing|0|||
129950317|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Ongoing|0|||
129950318|NCT00446095|467781079|FG000|Phase I (28 Days)|Adverse Event|0|||
129950319|NCT00446095|467781080|FG001|Phase I (28 Days)|Adverse Event|0|||
129950320|NCT00446095|467781081|FG002|Phase I (28 Days)|Adverse Event|0|||
129950321|NCT00446095|467781082|FG003|Phase I (28 Days)|Adverse Event|1|||
129950322|NCT00446095|467781083|FG004|Phase I (28 Days)|Adverse Event|0|||
129950323|NCT00446095|467781079|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
129950324|NCT00446095|467781080|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
130072256|NCT01125293|468218196|FG005|Overall Study|Symptomatic Deterioration|0|||
129950325|NCT00446095|467781081|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
129950326|NCT00446095|467781082|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
129950327|NCT00446095|467781083|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
129950328|NCT02574286|467781084|FG000|Overall Study|Adverse Event|3|||
129950329|NCT02574286|467781084|FG000|Overall Study|Withdrawal by Subject|2|||
129950330|NCT02764320|467781085|FG000|Overall Study|Withdrawal by Subject|35|||
130072257|NCT01125293|468218191|FG000|Overall Study|Death|0|||
130072258|NCT01125293|468218192|FG001|Overall Study|Death|0|||
129950331|NCT02764320|467781086|FG001|Overall Study|Withdrawal by Subject|38|||
130072259|NCT01125293|468218193|FG002|Overall Study|Death|0|||
129950332|NCT02764320|467781085|FG000|Overall Study|Protocol Violation|11|||
129950333|NCT02764320|467781086|FG001|Overall Study|Protocol Violation|6|||
129950334|NCT02764320|467781085|FG000|Overall Study|Adverse Event|2|||
129950335|NCT02764320|467781086|FG001|Overall Study|Adverse Event|0|||
129950336|NCT02764320|467781085|FG000|Overall Study|Health Issues unable to continue|2|||
129950337|NCT02764320|467781086|FG001|Overall Study|Health Issues unable to continue|0|||
129950338|NCT02764320|467781085|FG000|Overall Study|Did not meet inclusion criteria|1|||
130072260|NCT01125293|468218194|FG003|Overall Study|Death|0|||
130072261|NCT01125293|468218195|FG004|Overall Study|Death|1|||
130072262|NCT01125293|468218196|FG005|Overall Study|Death|0|||
130072263|NCT01125293|468218191|FG000|Overall Study|Withdrawal by Subject|0|||
130072264|NCT01125293|468218192|FG001|Overall Study|Withdrawal by Subject|0|||
130072265|NCT01125293|468218193|FG002|Overall Study|Withdrawal by Subject|0|||
130072266|NCT01125293|468218194|FG003|Overall Study|Withdrawal by Subject|0|||
130072267|NCT01125293|468218195|FG004|Overall Study|Withdrawal by Subject|2|||
130072268|NCT01125293|468218196|FG005|Overall Study|Withdrawal by Subject|1|||
130072269|NCT01125293|468218191|FG000|Overall Study|Physician Decision|0|||
130072270|NCT01125293|468218192|FG001|Overall Study|Physician Decision|0|||
130072271|NCT01125293|468218193|FG002|Overall Study|Physician Decision|0|||
130072272|NCT01125293|468218194|FG003|Overall Study|Physician Decision|0|||
130072273|NCT01125293|468218195|FG004|Overall Study|Physician Decision|0|||
130072274|NCT01125293|468218196|FG005|Overall Study|Physician Decision|2|||
130072275|NCT02224638|468218197|FG000|Overall Study|Adverse Event|1|||
130072276|NCT02224638|468218198|FG001|Overall Study|Adverse Event|1|||
130072277|NCT01270958|468218201|FG000|Overall Study|Lost to Follow-up|2|||
130072278|NCT01270958|468218201|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
130072279|NCT01455415|468218207|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
130072280|NCT01455415|468218208|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
130072281|NCT01455415|468218207|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
130072282|NCT01455415|468218208|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
130072283|NCT01455415|468218207|FG000|Period 1|Drug Error not Associated to AE|0|||
130072284|NCT01455415|468218208|FG001|Period 1|Drug Error not Associated to AE|1|||
130072285|NCT01455415|468218207|FG000|Period 1|AE Not Related to Study Drug|2|||
130072286|NCT01455415|468218208|FG001|Period 1|AE Not Related to Study Drug|6|||
130072287|NCT01455415|468218207|FG000|Period 1|Withdrawal by Subject|4|||
130072288|NCT01455415|468218208|FG001|Period 1|Withdrawal by Subject|5|||
130072289|NCT01455415|468218207|FG000|Period 1|Unspecified Reason|1|||
130072290|NCT01455415|468218208|FG001|Period 1|Unspecified Reason|1|||
130072291|NCT01455415|468218207|FG000|Period 1|Protocol Violation|0|||
130072292|NCT01455415|468218208|FG001|Period 1|Protocol Violation|2|||
130072293|NCT01455415|468218207|FG000|Washout|AE Related to Study Drug|2|||
130072294|NCT01455415|468218208|FG001|Washout|AE Related to Study Drug|0|||
130072295|NCT01455415|468218207|FG000|Washout|Lost to Follow-up|1|||
130072296|NCT01455415|468218208|FG001|Washout|Lost to Follow-up|0|||
130072297|NCT01455415|468218207|FG000|Washout|Drug Error not Associated to AE|2|||
130072298|NCT01455415|468218208|FG001|Washout|Drug Error not Associated to AE|1|||
130072299|NCT01455415|468218207|FG000|Washout|AE Not Related to Study Drug|2|||
130072300|NCT01455415|468218208|FG001|Washout|AE Not Related to Study Drug|3|||
130072301|NCT01455415|468218207|FG000|Washout|Unspecified Reason|1|||
130072302|NCT01455415|468218208|FG001|Washout|Unspecified Reason|2|||
130072303|NCT01455415|468218207|FG000|Washout|Protocol Violation|0|||
130072304|NCT01455415|468218208|FG001|Washout|Protocol Violation|1|||
130072305|NCT01455415|468218207|FG000|Period 2|AE Related to Study Drug|1|||
130072306|NCT01455415|468218208|FG001|Period 2|AE Related to Study Drug|2|||
130072307|NCT01455415|468218207|FG000|Period 2|Lost to Follow-up|2|||
130072308|NCT01455415|468218208|FG001|Period 2|Lost to Follow-up|1|||
130072309|NCT01455415|468218207|FG000|Period 2|AE Not Related to Study Drug|2|||
130072310|NCT01455415|468218208|FG001|Period 2|AE Not Related to Study Drug|1|||
130072311|NCT01455415|468218207|FG000|Period 2|Lack of Efficacy|2|||
130072312|NCT01455415|468218208|FG001|Period 2|Lack of Efficacy|0|||
130072313|NCT01455415|468218207|FG000|Period 2|Withdrawal by Subject|2|||
130072314|NCT01455415|468218208|FG001|Period 2|Withdrawal by Subject|3|||
130072315|NCT01455415|468218207|FG000|Period 2|Unspecified Reason|2|||
130072316|NCT01455415|468218208|FG001|Period 2|Unspecified Reason|3|||
130072317|NCT01455415|468218207|FG000|Period 2|Protocol Violation|2|||
130072318|NCT01455415|468218208|FG001|Period 2|Protocol Violation|0|||
130072319|NCT01455415|468218207|FG000|Follow-up|AE Related to Study Drug|0|||
130072320|NCT01455415|468218208|FG001|Follow-up|AE Related to Study Drug|1|||
130072321|NCT01455415|468218207|FG000|Follow-up|Lack of Efficacy|0|||
130072322|NCT01455415|468218208|FG001|Follow-up|Lack of Efficacy|1|||
130072323|NCT01455415|468218207|FG000|Follow-up|Withdrawal by Subject|2|||
130120419|NCT02579096|468402374|FG001|Phase 2, Weeks 25 - 48|Death|4|||
130072324|NCT01455415|468218208|FG001|Follow-up|Withdrawal by Subject|0|||
130072325|NCT01455415|468218207|FG000|Follow-up|Unspecified Reason|1|||
130072326|NCT01455415|468218208|FG001|Follow-up|Unspecified Reason|0|||
130072327|NCT00587301|468218209|FG000|Overall Study|Screen Failure|9|||
130072328|NCT00587301|468218209|FG000|Overall Study|Lost to Follow-up|22|||
130072329|NCT00587301|468218209|FG000|Overall Study|Withdrawal by Subject|7|||
130072330|NCT00587301|468218209|FG000|Overall Study|Protocol Violation|7|||
130120420|NCT02579096|468402373|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
130072331|NCT02758613|468218211|FG000|Treatment|Physician and Sponsor Decision|1|||
130072332|NCT02758613|468218212|FG001|Treatment|Physician and Sponsor Decision|0|||
130072333|NCT02758613|468218213|FG002|Treatment|Physician and Sponsor Decision|0|||
130072334|NCT02758613|468218214|FG003|Treatment|Physician and Sponsor Decision|0|||
130072335|NCT02758613|468218211|FG000|Treatment|Withdrawal by Subject|1|||
130154865|NCT00958126|468526628|FG007|Overall Study|Lost to Follow-up|0|||
130072336|NCT02758613|468218212|FG001|Treatment|Withdrawal by Subject|0|||
130072337|NCT02758613|468218213|FG002|Treatment|Withdrawal by Subject|1|||
130072338|NCT02758613|468218214|FG003|Treatment|Withdrawal by Subject|0|||
130072339|NCT01496274|468218215|FG000|Overall Study|Protocol Violation|0|||
130072340|NCT01496274|468218216|FG001|Overall Study|Protocol Violation|1|||
130072341|NCT01496274|468218215|FG000|Overall Study|Adverse Event|1|||
130072342|NCT01496274|468218216|FG001|Overall Study|Adverse Event|1|||
130072343|NCT01496274|468218215|FG000|Overall Study|Withdrawal by Subject|2|||
130072344|NCT01496274|468218216|FG001|Overall Study|Withdrawal by Subject|0|||
130072345|NCT01496274|468218215|FG000|Overall Study|Lost to Follow-up|0|||
130072346|NCT01496274|468218216|FG001|Overall Study|Lost to Follow-up|3|||
130072347|NCT00351819|468218217|FG000|Overall Study|Lost to Follow-up|4|||
130072348|NCT00351819|468218218|FG001|Overall Study|Lost to Follow-up|4|||
130072349|NCT00351819|468218217|FG000|Overall Study|Withdrawal by Subject|0|||
130072350|NCT00351819|468218218|FG001|Overall Study|Withdrawal by Subject|4|||
130072351|NCT00351819|468218217|FG000|Overall Study|Elevated PSA|1|||
130072352|NCT00351819|468218218|FG001|Overall Study|Elevated PSA|1|||
130072353|NCT00351819|468218217|FG000|Overall Study|Traumatic ankle fracture|1|||
130072354|NCT00351819|468218218|FG001|Overall Study|Traumatic ankle fracture|0|||
130072355|NCT00351819|468218217|FG000|Overall Study|Unprofessional behavior|1|||
130072356|NCT00351819|468218218|FG001|Overall Study|Unprofessional behavior|0|||
130072357|NCT00351819|468218217|FG000|Overall Study|Non-compliance|0|||
130072358|NCT00351819|468218218|FG001|Overall Study|Non-compliance|1|||
130072359|NCT00351819|468218217|FG000|Overall Study|Incarcerated|0|||
130072360|NCT00351819|468218218|FG001|Overall Study|Incarcerated|1|||
130072361|NCT00351819|468218217|FG000|Overall Study|Enrolled in another trial|0|||
130072362|NCT00351819|468218218|FG001|Overall Study|Enrolled in another trial|1|||
130072363|NCT02910219|468218219|FG000|Overall Study|Withdrawal by Subject|1|||
130072364|NCT02910219|468218220|FG001|Overall Study|Withdrawal by Subject|1|||
130072365|NCT01015820|468218221|FG000|Overall Study|Suboptimal measurements|1|||
130072366|NCT01015820|468218222|FG001|Overall Study|Suboptimal measurements|0|||
130072367|NCT00701441|468218223|FG000|Overall Study|failure in cpap compliance|0|||
130072368|NCT00701441|468218224|FG001|Overall Study|failure in cpap compliance|4|||
130072369|NCT01313078|468218226|FG000|Overall Study|Death|1|||
130072370|NCT01313078|468218226|FG000|Overall Study|Discontinued study drug|1|||
130072371|NCT01313078|468218226|FG000|Overall Study|Withdrawal by Subject|1|||
130072372|NCT01225172|468218228|FG000|Overall Study|Subject decision to stop|1|||
130072373|NCT01225172|468218229|FG001|Overall Study|Subject decision to stop|0|||
130072374|NCT01225172|468218228|FG000|Overall Study|Subject request to discontinue treatment|3|||
130072375|NCT01225172|468218229|FG001|Overall Study|Subject request to discontinue treatment|1|||
130072376|NCT01225172|468218228|FG000|Overall Study|Subject no longer meets study criteria|1|||
130072377|NCT01225172|468218229|FG001|Overall Study|Subject no longer meets study criteria|0|||
130072378|NCT01225172|468218228|FG000|Overall Study|Withdrawal by Subject|1|||
130072379|NCT01225172|468218229|FG001|Overall Study|Withdrawal by Subject|0|||
130072380|NCT02679781|468218230|FG000|Overall Study|Lost to Follow-up|1|||
130072381|NCT02679781|468218231|FG001|Overall Study|Lost to Follow-up|2|||
130072382|NCT02679781|468218230|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
130072383|NCT02679781|468218231|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
130072384|NCT04209400|468218232|FG000|Overall Study|Withdrawal by Subject|0|||
130072385|NCT04209400|468218233|FG001|Overall Study|Withdrawal by Subject|1|||
130072386|NCT00795509|468218234|FG000|Overall Study|Protocol Violation|31|||
130072387|NCT01375647|468220865|FG000|Overall Study|Lost to Follow-up|3|||
130072388|NCT01375647|468220866|FG001|Overall Study|Lost to Follow-up|3|||
130072389|NCT01375647|468220867|FG002|Overall Study|Lost to Follow-up|7|||
130072390|NCT01375647|468220868|FG003|Overall Study|Lost to Follow-up|10|||
130072391|NCT01375647|468220865|FG000|Overall Study|Death|1|||
130072392|NCT01375647|468220866|FG001|Overall Study|Death|2|||
130072393|NCT01375647|468220867|FG002|Overall Study|Death|1|||
130072394|NCT01375647|468220868|FG003|Overall Study|Death|0|||
130072395|NCT01375647|468220865|FG000|Overall Study|Withdrawal by Subject|17|||
130120421|NCT02579096|468402374|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
130120422|NCT02579096|468402373|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
130120423|NCT02579096|468402374|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
130120424|NCT02579096|468402373|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
130120425|NCT02579096|468402374|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
130120426|NCT02579096|468402373|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
130072396|NCT01375647|468220866|FG001|Overall Study|Withdrawal by Subject|20|||
130072397|NCT01375647|468220867|FG002|Overall Study|Withdrawal by Subject|26|||
130072398|NCT01375647|468220868|FG003|Overall Study|Withdrawal by Subject|14|||
130072399|NCT01375647|468220865|FG000|Overall Study|Physician Decision|1|||
130072400|NCT01375647|468220866|FG001|Overall Study|Physician Decision|0|||
130072401|NCT01375647|468220867|FG002|Overall Study|Physician Decision|0|||
130072402|NCT01375647|468220868|FG003|Overall Study|Physician Decision|0|||
130072403|NCT03366844|468220869|FG000|Overall Study|Physician Decision|1|||
130072404|NCT03366844|468220869|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
130120427|NCT02579096|468402374|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
130072405|NCT02088541|468220874|FG000|Overall Study|Adverse Event|3|||
130072406|NCT02088541|468220875|FG001|Overall Study|Adverse Event|0|||
130072407|NCT02088541|468220876|FG002|Overall Study|Adverse Event|3|||
130072408|NCT02088541|468220877|FG003|Overall Study|Adverse Event|3|||
130072409|NCT02088541|468220878|FG004|Overall Study|Adverse Event|0|||
130072410|NCT02088541|468220874|FG000|Overall Study|Death|51|||
130072411|NCT02088541|468220875|FG001|Overall Study|Death|21|||
130072412|NCT02088541|468220876|FG002|Overall Study|Death|85|||
130072413|NCT02088541|468220877|FG003|Overall Study|Death|28|||
130072414|NCT02088541|468220878|FG004|Overall Study|Death|38|||
130072415|NCT02088541|468220874|FG000|Overall Study|Lost to Follow-up|2|||
130072416|NCT02088541|468220875|FG001|Overall Study|Lost to Follow-up|0|||
130072417|NCT02088541|468220876|FG002|Overall Study|Lost to Follow-up|1|||
130072418|NCT02088541|468220877|FG003|Overall Study|Lost to Follow-up|0|||
130072419|NCT02088541|468220878|FG004|Overall Study|Lost to Follow-up|0|||
130072420|NCT02088541|468220874|FG000|Overall Study|Physician Decision|2|||
130072421|NCT02088541|468220875|FG001|Overall Study|Physician Decision|1|||
130072422|NCT02088541|468220876|FG002|Overall Study|Physician Decision|2|||
130072423|NCT02088541|468220877|FG003|Overall Study|Physician Decision|0|||
130072424|NCT02088541|468220878|FG004|Overall Study|Physician Decision|2|||
130072425|NCT02088541|468220874|FG000|Overall Study|Disease progression|7|||
130072426|NCT02088541|468220875|FG001|Overall Study|Disease progression|1|||
130072427|NCT02088541|468220876|FG002|Overall Study|Disease progression|2|||
130072428|NCT02088541|468220877|FG003|Overall Study|Disease progression|3|||
130072429|NCT02088541|468220878|FG004|Overall Study|Disease progression|1|||
130072430|NCT02088541|468220874|FG000|Overall Study|Study terminated by sponsor|1|||
130072431|NCT02088541|468220875|FG001|Overall Study|Study terminated by sponsor|1|||
130072432|NCT02088541|468220876|FG002|Overall Study|Study terminated by sponsor|12|||
130072433|NCT02088541|468220877|FG003|Overall Study|Study terminated by sponsor|2|||
130072434|NCT02088541|468220878|FG004|Overall Study|Study terminated by sponsor|6|||
130072435|NCT02088541|468220874|FG000|Overall Study|Withdrawal by Subject|3|||
130072436|NCT02088541|468220875|FG001|Overall Study|Withdrawal by Subject|2|||
130072437|NCT02088541|468220876|FG002|Overall Study|Withdrawal by Subject|9|||
130072438|NCT02088541|468220877|FG003|Overall Study|Withdrawal by Subject|7|||
130072439|NCT02088541|468220878|FG004|Overall Study|Withdrawal by Subject|10|||
130072440|NCT02088541|468220874|FG000|Overall Study|Other|2|||
130072441|NCT02088541|468220875|FG001|Overall Study|Other|1|||
130072442|NCT02088541|468220876|FG002|Overall Study|Other|3|||
130072443|NCT02088541|468220877|FG003|Overall Study|Other|1|||
130072444|NCT02088541|468220878|FG004|Overall Study|Other|1|||
130072445|NCT00323310|468220880|FG000|Overall Study|Withdrawal by Subject|1|||
130072446|NCT00323310|468220880|FG000|Overall Study|a parent refused blood draw|1|||
130072447|NCT00323310|468220880|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
130072448|NCT03984812|468220881|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072449|NCT03984812|468220882|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072450|NCT03984812|468220883|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
130072451|NCT03984812|468220884|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072452|NCT03984812|468220885|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072453|NCT03984812|468220886|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072454|NCT03984812|468220887|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072455|NCT03984812|468220888|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072456|NCT03984812|468220889|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072457|NCT03984812|468220890|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129950339|NCT02764320|467781086|FG001|Overall Study|Did not meet inclusion criteria|0|||
129950340|NCT02764320|467781085|FG000|Overall Study|Subject moved|0|||
129950341|NCT02764320|467781086|FG001|Overall Study|Subject moved|2|||
129950342|NCT02764320|467781085|FG000|Overall Study|Overused medication unavailable|0|||
129950343|NCT02764320|467781086|FG001|Overall Study|Overused medication unavailable|1|||
129950344|NCT02764320|467781085|FG000|Overall Study|Seeking care outside site|0|||
129950345|NCT02764320|467781086|FG001|Overall Study|Seeking care outside site|1|||
129950346|NCT02764320|467781085|FG000|Overall Study|Technology barriers|0|||
129950347|NCT02764320|467781086|FG001|Overall Study|Technology barriers|1|||
129950348|NCT01280656|467781087|FG000|Overall Study|Adverse Event|1|||
129950349|NCT01280656|467781088|FG001|Overall Study|Adverse Event|14|||
129950350|NCT01280656|467781089|FG002|Overall Study|Adverse Event|13|||
129950351|NCT01280656|467781087|FG000|Overall Study|Lack of Efficacy|1|||
129950352|NCT01280656|467781088|FG001|Overall Study|Lack of Efficacy|22|||
129950353|NCT01280656|467781089|FG002|Overall Study|Lack of Efficacy|38|||
130072458|NCT03984812|468220891|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
130072459|NCT02707601|468220894|FG000|Overall Study|Death|0|||
130072460|NCT02707601|468220895|FG001|Overall Study|Death|1|||
130072461|NCT02707601|468220894|FG000|Overall Study|Lack of Efficacy|0|||
130072462|NCT02707601|468220895|FG001|Overall Study|Lack of Efficacy|1|||
130072463|NCT02707601|468220894|FG000|Overall Study|Investigator's Discretion|1|||
130072464|NCT02707601|468220895|FG001|Overall Study|Investigator's Discretion|0|||
130072465|NCT02707601|468220894|FG000|Overall Study|Withdrew Consent|0|||
129950354|NCT01280656|467781087|FG000|Overall Study|Treatment shortening (RGT)|0|||
129950355|NCT01280656|467781088|FG001|Overall Study|Treatment shortening (RGT)|4|||
130072466|NCT02707601|468220895|FG001|Overall Study|Withdrew Consent|1|||
130072467|NCT02707601|468220894|FG000|Overall Study|Lost to Follow-up|1|||
130072468|NCT02707601|468220895|FG001|Overall Study|Lost to Follow-up|1|||
130072469|NCT02707601|468220894|FG000|Overall Study|Participants Randomized but Not Treated|2|||
130072470|NCT02707601|468220895|FG001|Overall Study|Participants Randomized but Not Treated|0|||
130072471|NCT03907969|468220897|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
130072472|NCT03907969|468220898|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
130072473|NCT03907969|468220899|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
130072474|NCT03907969|468220900|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
130072475|NCT03907969|468220901|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
130072476|NCT03907969|468220902|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
130072477|NCT03907969|468220903|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
130072478|NCT03907969|468220904|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
130072479|NCT03907969|468220905|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
130072480|NCT03907969|468220906|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
130072481|NCT03907969|468220907|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
130072482|NCT03907969|468220897|FG000|Monotherapy Part A|Progressive Disease|0|||
130072483|NCT03907969|468220898|FG001|Monotherapy Part A|Progressive Disease|1|||
130072484|NCT03907969|468220899|FG002|Monotherapy Part A|Progressive Disease|0|||
130072485|NCT03907969|468220900|FG003|Monotherapy Part A|Progressive Disease|0|||
130072486|NCT03907969|468220901|FG004|Monotherapy Part A|Progressive Disease|0|||
130072487|NCT03907969|468220902|FG005|Monotherapy Part A|Progressive Disease|1|||
130072488|NCT03907969|468220903|FG006|Monotherapy Part A|Progressive Disease|2|||
130072489|NCT03907969|468220904|FG007|Monotherapy Part A|Progressive Disease|0|||
130072490|NCT03907969|468220905|FG008|Monotherapy Part A|Progressive Disease|0|||
130072491|NCT03907969|468220906|FG009|Monotherapy Part A|Progressive Disease|0|||
130072492|NCT03907969|468220907|FG010|Monotherapy Part A|Progressive Disease|0|||
130072493|NCT03907969|468220897|FG000|Monotherapy Part A|Death|0|||
130072494|NCT03907969|468220898|FG001|Monotherapy Part A|Death|0|||
130072495|NCT03907969|468220899|FG002|Monotherapy Part A|Death|1|||
130072496|NCT03907969|468220900|FG003|Monotherapy Part A|Death|1|||
130072497|NCT03907969|468220901|FG004|Monotherapy Part A|Death|0|||
130072498|NCT03907969|468220902|FG005|Monotherapy Part A|Death|1|||
130072499|NCT03907969|468220903|FG006|Monotherapy Part A|Death|0|||
130072500|NCT03907969|468220904|FG007|Monotherapy Part A|Death|0|||
130072501|NCT03907969|468220905|FG008|Monotherapy Part A|Death|0|||
130072502|NCT03907969|468220906|FG009|Monotherapy Part A|Death|0|||
130072503|NCT03907969|468220907|FG010|Monotherapy Part A|Death|0|||
130072504|NCT03907969|468220897|FG000|Combination Therapy Part A|Adverse Event|0|||
130072505|NCT03907969|468220898|FG001|Combination Therapy Part A|Adverse Event|0|||
130072506|NCT03907969|468220899|FG002|Combination Therapy Part A|Adverse Event|0|||
130072507|NCT03907969|468220900|FG003|Combination Therapy Part A|Adverse Event|0|||
130072508|NCT03907969|468220901|FG004|Combination Therapy Part A|Adverse Event|0|||
130072509|NCT03907969|468220902|FG005|Combination Therapy Part A|Adverse Event|0|||
130072510|NCT03907969|468220903|FG006|Combination Therapy Part A|Adverse Event|0|||
130072511|NCT03907969|468220904|FG007|Combination Therapy Part A|Adverse Event|0|||
130072512|NCT03907969|468220905|FG008|Combination Therapy Part A|Adverse Event|0|||
130072513|NCT03907969|468220906|FG009|Combination Therapy Part A|Adverse Event|1|||
130072514|NCT03907969|468220907|FG010|Combination Therapy Part A|Adverse Event|1|||
130072515|NCT03907969|468220897|FG000|Combination Therapy Part A|Progressive disease|0|||
130072516|NCT03907969|468220898|FG001|Combination Therapy Part A|Progressive disease|0|||
130072517|NCT03907969|468220899|FG002|Combination Therapy Part A|Progressive disease|0|||
130072518|NCT03907969|468220900|FG003|Combination Therapy Part A|Progressive disease|0|||
130072519|NCT03907969|468220901|FG004|Combination Therapy Part A|Progressive disease|0|||
130072520|NCT03907969|468220902|FG005|Combination Therapy Part A|Progressive disease|0|||
130072521|NCT03907969|468220903|FG006|Combination Therapy Part A|Progressive disease|0|||
130072522|NCT03907969|468220904|FG007|Combination Therapy Part A|Progressive disease|1|||
130072523|NCT03907969|468220905|FG008|Combination Therapy Part A|Progressive disease|0|||
130072524|NCT03907969|468220906|FG009|Combination Therapy Part A|Progressive disease|2|||
130072525|NCT03907969|468220907|FG010|Combination Therapy Part A|Progressive disease|3|||
130072526|NCT03907969|468220897|FG000|Combination Therapy Part A|Death|0|||
130072527|NCT03907969|468220898|FG001|Combination Therapy Part A|Death|0|||
130072528|NCT03907969|468220899|FG002|Combination Therapy Part A|Death|0|||
130072529|NCT03907969|468220900|FG003|Combination Therapy Part A|Death|0|||
130072530|NCT03907969|468220901|FG004|Combination Therapy Part A|Death|0|||
130072531|NCT03907969|468220902|FG005|Combination Therapy Part A|Death|0|||
130072532|NCT03907969|468220903|FG006|Combination Therapy Part A|Death|0|||
130072533|NCT03907969|468220904|FG007|Combination Therapy Part A|Death|0|||
130072534|NCT03907969|468220905|FG008|Combination Therapy Part A|Death|1|||
129950356|NCT01280656|467781089|FG002|Overall Study|Treatment shortening (RGT)|5|||
130072535|NCT03907969|468220906|FG009|Combination Therapy Part A|Death|0|||
129950357|NCT01280656|467781087|FG000|Overall Study|Other|1|||
130072536|NCT03907969|468220907|FG010|Combination Therapy Part A|Death|1|||
130072537|NCT03907969|468220897|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
130072538|NCT03907969|468220898|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
130072539|NCT03907969|468220899|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
130072540|NCT03907969|468220900|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
130072541|NCT03907969|468220901|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
130072542|NCT03907969|468220902|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
130072543|NCT03907969|468220903|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
130072544|NCT03907969|468220904|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
130072545|NCT03907969|468220905|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
130072546|NCT03907969|468220906|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
130072547|NCT03907969|468220907|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
130072548|NCT03907969|468220897|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
130072549|NCT03907969|468220898|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
130072550|NCT03907969|468220899|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
130072551|NCT03907969|468220900|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
130072552|NCT03907969|468220901|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
130072553|NCT03907969|468220902|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
130072554|NCT03907969|468220903|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
130072555|NCT03907969|468220904|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
130072556|NCT03907969|468220905|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
130072557|NCT03907969|468220906|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
130072558|NCT03907969|468220907|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
130072559|NCT03907969|468220897|FG000|Combination Therapy Part A|Physician Decision|0|||
130072560|NCT03907969|468220898|FG001|Combination Therapy Part A|Physician Decision|0|||
130072561|NCT03907969|468220899|FG002|Combination Therapy Part A|Physician Decision|0|||
130072562|NCT03907969|468220900|FG003|Combination Therapy Part A|Physician Decision|0|||
130072563|NCT03907969|468220901|FG004|Combination Therapy Part A|Physician Decision|0|||
130072564|NCT03907969|468220902|FG005|Combination Therapy Part A|Physician Decision|0|||
130072565|NCT03907969|468220903|FG006|Combination Therapy Part A|Physician Decision|0|||
130072566|NCT03907969|468220904|FG007|Combination Therapy Part A|Physician Decision|1|||
130072567|NCT03907969|468220905|FG008|Combination Therapy Part A|Physician Decision|0|||
130072568|NCT03907969|468220906|FG009|Combination Therapy Part A|Physician Decision|0|||
130072569|NCT03907969|468220907|FG010|Combination Therapy Part A|Physician Decision|1|||
130072570|NCT00666536|468220908|FG000|Overall Study|Adverse Event|9|||
130072571|NCT00666536|468220909|FG001|Overall Study|Adverse Event|19|||
130072572|NCT00666536|468220908|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130072573|NCT00666536|468220909|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130072574|NCT00666536|468220908|FG000|Overall Study|Protocol deviation(s)|8|||
130072575|NCT00666536|468220909|FG001|Overall Study|Protocol deviation(s)|6|||
130072576|NCT00666536|468220908|FG000|Overall Study|Withdrawal by Subject|10|||
130072577|NCT00666536|468220909|FG001|Overall Study|Withdrawal by Subject|9|||
130072578|NCT00666536|468220908|FG000|Overall Study|Lost to Follow-up|4|||
130072579|NCT00666536|468220909|FG001|Overall Study|Lost to Follow-up|3|||
130072580|NCT00608881|468220917|FG000|Overall Study|Death|22|||
130072581|NCT00608881|468220918|FG001|Overall Study|Death|13|||
130072582|NCT00608881|468220917|FG000|Overall Study|Adverse Event|5|||
130072583|NCT00608881|468220918|FG001|Overall Study|Adverse Event|3|||
130072584|NCT00608881|468220917|FG000|Overall Study|Lost to Follow-up|28|||
130072585|NCT00608881|468220918|FG001|Overall Study|Lost to Follow-up|14|||
130072586|NCT00608881|468220917|FG000|Overall Study|Withdrawal by Subject|18|||
130072587|NCT00608881|468220918|FG001|Overall Study|Withdrawal by Subject|29|||
130072588|NCT00608881|468220917|FG000|Overall Study|Physician Decision|5|||
130072589|NCT00608881|468220918|FG001|Overall Study|Physician Decision|5|||
130072590|NCT00608881|468220917|FG000|Overall Study|Institutionalized|1|||
130072591|NCT00608881|468220918|FG001|Overall Study|Institutionalized|2|||
130072592|NCT00511108|468220920|FG000|Overall Study|Adverse Event|2|||
130072593|NCT00511108|468220921|FG001|Overall Study|Adverse Event|0|||
130072594|NCT00511108|468220922|FG002|Overall Study|Adverse Event|1|||
130072595|NCT00511108|468220923|FG003|Overall Study|Adverse Event|2|||
130072596|NCT00511108|468220920|FG000|Overall Study|Lost to Follow-up|0|||
130072597|NCT00511108|468220921|FG001|Overall Study|Lost to Follow-up|2|||
130072598|NCT00511108|468220922|FG002|Overall Study|Lost to Follow-up|1|||
130072599|NCT00511108|468220923|FG003|Overall Study|Lost to Follow-up|0|||
130072600|NCT00511108|468220920|FG000|Overall Study|Physician Decision|0|||
129950358|NCT01280656|467781088|FG001|Overall Study|Other|7|||
129950359|NCT01280656|467781089|FG002|Overall Study|Other|7|||
129950360|NCT01405508|467781090|FG000|Overall Study|AE, non-serious non-fatal|1|||
130072601|NCT00511108|468220921|FG001|Overall Study|Physician Decision|0|||
130072602|NCT00511108|468220922|FG002|Overall Study|Physician Decision|0|||
130072603|NCT00511108|468220923|FG003|Overall Study|Physician Decision|1|||
130072604|NCT00511108|468220920|FG000|Overall Study|Withdrawal by Subject|4|||
130072605|NCT00511108|468220921|FG001|Overall Study|Withdrawal by Subject|0|||
130072606|NCT00511108|468220922|FG002|Overall Study|Withdrawal by Subject|3|||
130072607|NCT00511108|468220923|FG003|Overall Study|Withdrawal by Subject|2|||
130072608|NCT02147691|468220926|FG000|Overall Study|Withdrawal by Subject|2|||
130072609|NCT02147691|468220927|FG001|Overall Study|Withdrawal by Subject|0|||
130072610|NCT02147691|468220926|FG000|Overall Study|Adverse Event|2|||
130072611|NCT02147691|468220927|FG001|Overall Study|Adverse Event|0|||
130072612|NCT02147691|468220926|FG000|Overall Study|Lost to Follow-up|0|||
130072613|NCT02147691|468220927|FG001|Overall Study|Lost to Follow-up|1|||
130072614|NCT02954952|468220928|FG000|Overall Study|Withdrawal by Subject|1|||
130072615|NCT02954952|468220929|FG001|Overall Study|Withdrawal by Subject|0|||
130072616|NCT02954952|468220930|FG002|Overall Study|Withdrawal by Subject|0|||
130072617|NCT02954952|468220928|FG000|Overall Study|No data collected|0|||
130072618|NCT02954952|468220929|FG001|Overall Study|No data collected|1|||
130072619|NCT02954952|468220930|FG002|Overall Study|No data collected|0|||
130072620|NCT01392742|468220933|FG000|Overall Study|Premature study termination|42|||
130072621|NCT01392742|468220933|FG000|Overall Study|Failure to return|35|||
130072622|NCT01392742|468220933|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
130072623|NCT01392742|468220933|FG000|Overall Study|Lost to Follow-up|34|||
130072624|NCT01392742|468220933|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
130072625|NCT01392742|468220933|FG000|Overall Study|ITR and Protocol deviation|1|||
130072626|NCT01392742|468220933|FG000|Overall Study|Adverse event/intercurrent illness|17|||
130072627|NCT01392742|468220933|FG000|Overall Study|Protocol Violation|14|||
130072628|NCT01392742|468220933|FG000|Overall Study|Other|3|||
130072629|NCT01392742|468220933|FG000|Overall Study|Missing information|13|||
130072630|NCT04179032|468220934|FG000|Part B (Up to Week 52)|Adverse Event|1|||
130072631|NCT04179032|468220934|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
130072632|NCT04179032|468220934|FG000|Access Extension Phase|Ongoing|11|||
130072633|NCT02432703|468220935|FG000|Overall Study|Adverse Event|1|||
130072634|NCT02432703|468220936|FG001|Overall Study|Adverse Event|4|||
130072635|NCT02432703|468220935|FG000|Overall Study|Lack of Efficacy|1|||
130072636|NCT02432703|468220936|FG001|Overall Study|Lack of Efficacy|0|||
130072637|NCT02432703|468220935|FG000|Overall Study|Lost to Follow-up|5|||
130072638|NCT02432703|468220936|FG001|Overall Study|Lost to Follow-up|3|||
130072639|NCT02432703|468220935|FG000|Overall Study|Withdrawal by Subject|9|||
130072640|NCT02432703|468220936|FG001|Overall Study|Withdrawal by Subject|6|||
130072641|NCT02432703|468220935|FG000|Overall Study|Other|6|||
130072642|NCT02432703|468220936|FG001|Overall Study|Other|5|||
130072643|NCT00724815|468220937|FG000|Overall Study|Randomized, not treated|31|||
130072644|NCT00724815|468220938|FG001|Overall Study|Randomized, not treated|30|||
130072645|NCT00724815|468220937|FG000|Overall Study|Adverse Event|5|||
130072646|NCT00724815|468220938|FG001|Overall Study|Adverse Event|3|||
130072647|NCT00724815|468220937|FG000|Overall Study|Lost to Follow-up|4|||
130072648|NCT00724815|468220938|FG001|Overall Study|Lost to Follow-up|1|||
130072649|NCT00724815|468220937|FG000|Overall Study|Other Various|3|||
130072650|NCT00724815|468220938|FG001|Overall Study|Other Various|5|||
130072651|NCT00810043|468220939|FG000|Overall Study|Withdrawal by Subject|1|||
130072652|NCT00810043|468220940|FG001|Overall Study|Withdrawal by Subject|0|||
130072653|NCT00810043|468220941|FG002|Overall Study|Withdrawal by Subject|2|||
130072654|NCT00810043|468220939|FG000|Overall Study|Lost to Follow-up|1|||
130072655|NCT00810043|468220940|FG001|Overall Study|Lost to Follow-up|0|||
130072656|NCT00810043|468220941|FG002|Overall Study|Lost to Follow-up|0|||
130072657|NCT00810043|468220939|FG000|Overall Study|Physician Decision|0|||
130072658|NCT00810043|468220940|FG001|Overall Study|Physician Decision|0|||
130072659|NCT00810043|468220941|FG002|Overall Study|Physician Decision|2|||
130072660|NCT00810043|468220939|FG000|Overall Study|Death|2|||
130072661|NCT00810043|468220940|FG001|Overall Study|Death|0|||
130072662|NCT00810043|468220941|FG002|Overall Study|Death|0|||
130072663|NCT00810043|468220939|FG000|Overall Study|Unrelated medical problem|0|||
130072664|NCT00810043|468220940|FG001|Overall Study|Unrelated medical problem|1|||
130072665|NCT00810043|468220941|FG002|Overall Study|Unrelated medical problem|0|||
130072666|NCT00810043|468220939|FG000|Overall Study|Non-medical problem|0|||
130072667|NCT00810043|468220940|FG001|Overall Study|Non-medical problem|0|||
130072668|NCT00810043|468220941|FG002|Overall Study|Non-medical problem|1|||
130120428|NCT02579096|468402373|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
129950361|NCT01405508|467781091|FG001|Overall Study|AE, non-serious non-fatal|1|||
129950362|NCT01405508|467781092|FG002|Overall Study|AE, non-serious non-fatal|0|||
129950363|NCT01405508|467781093|FG003|Overall Study|AE, non-serious non-fatal|0|||
129950364|NCT00476957|467781094|FG000|Overall Study|Lost to Follow-up|176|||
129950365|NCT00476957|467781095|FG001|Overall Study|Lost to Follow-up|193|||
129950366|NCT02159352|467781096|FG000|Overall Study|Adverse Event|3|||
129950367|NCT02159352|467781097|FG001|Overall Study|Adverse Event|1|||
129950368|NCT02159352|467781096|FG000|Overall Study|Withdrawal by Subject|0|||
129950369|NCT02159352|467781097|FG001|Overall Study|Withdrawal by Subject|1|||
130072669|NCT00810043|468220939|FG000|Overall Study|No longer met enrollment criteria|0|||
129950370|NCT01916109|467781102|FG000|Overall Study|Withdrawal by Subject|1|||
129950371|NCT00636168|467781103|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
130072670|NCT00810043|468220940|FG001|Overall Study|No longer met enrollment criteria|0|||
130072671|NCT00810043|468220941|FG002|Overall Study|No longer met enrollment criteria|3|||
130072672|NCT01359046|468220942|FG000|Overall Study|Did not receive allocated intervention|6|||
130072673|NCT01359046|468220943|FG001|Overall Study|Did not receive allocated intervention|6|||
130072674|NCT01359046|468220942|FG000|Overall Study|Physician Decision|1|||
130072675|NCT01359046|468220943|FG001|Overall Study|Physician Decision|11|||
130072676|NCT04539262|468220947|FG000|Overall Study|Adverse Event|0|||
130072677|NCT04539262|468220948|FG001|Overall Study|Adverse Event|0|||
129950372|NCT00636168|467781104|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
129950373|NCT00636168|467781103|FG000|Randomized to Study Drug|Adverse Event|1|||
129950374|NCT00636168|467781104|FG001|Randomized to Study Drug|Adverse Event|0|||
129950375|NCT00636168|467781103|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
129950376|NCT00636168|467781104|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
129950377|NCT00636168|467781103|FG000|Treated With Study Drug|Recurrence of disease|135|||
129950378|NCT00636168|467781104|FG001|Treated With Study Drug|Recurrence of disease|282|||
129950379|NCT00636168|467781103|FG000|Treated With Study Drug|Adverse Event|250|||
129950380|NCT00636168|467781104|FG001|Treated With Study Drug|Adverse Event|22|||
129950381|NCT00636168|467781103|FG000|Treated With Study Drug|Participant withdrew consent|16|||
129950382|NCT00636168|467781104|FG001|Treated With Study Drug|Participant withdrew consent|21|||
129950383|NCT00636168|467781103|FG000|Treated With Study Drug|Poor/non-compliance|1|||
129950384|NCT00636168|467781104|FG001|Treated With Study Drug|Poor/non-compliance|3|||
129950385|NCT00636168|467781103|FG000|Treated With Study Drug|Death|3|||
129950386|NCT00636168|467781104|FG001|Treated With Study Drug|Death|0|||
129950387|NCT00636168|467781103|FG000|Treated With Study Drug|Pregnancy|1|||
129950388|NCT00636168|467781104|FG001|Treated With Study Drug|Pregnancy|0|||
129950389|NCT00636168|467781103|FG000|Treated With Study Drug|No longer meets study criteria|1|||
129950390|NCT00636168|467781104|FG001|Treated With Study Drug|No longer meets study criteria|0|||
129950391|NCT00636168|467781103|FG000|Treated With Study Drug|Other reason|1|||
129950392|NCT00636168|467781104|FG001|Treated With Study Drug|Other reason|3|||
129950393|NCT00636168|467781103|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
129950394|NCT00636168|467781104|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
129950395|NCT00636168|467781103|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
129950396|NCT00636168|467781104|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
129950397|NCT00636168|467781103|FG000|Long Term Follow-Up|Death|8|||
129950398|NCT00636168|467781104|FG001|Long Term Follow-Up|Death|9|||
129950399|NCT02707952|467781105|FG000|Overall Study|Adverse Event|1|||
129950400|NCT02707952|467781106|FG001|Overall Study|Adverse Event|0|||
129950401|NCT02707952|467781107|FG002|Overall Study|Adverse Event|0|||
129950402|NCT02707952|467781108|FG003|Overall Study|Adverse Event|0|||
129950403|NCT02707952|467781105|FG000|Overall Study|Lost to Follow-up|1|||
129950404|NCT02707952|467781106|FG001|Overall Study|Lost to Follow-up|0|||
129950405|NCT02707952|467781107|FG002|Overall Study|Lost to Follow-up|0|||
129950406|NCT02707952|467781108|FG003|Overall Study|Lost to Follow-up|0|||
129950407|NCT02707952|467781105|FG000|Overall Study|Withdrawal by Subject|0|||
129950408|NCT02707952|467781106|FG001|Overall Study|Withdrawal by Subject|1|||
129950409|NCT02707952|467781107|FG002|Overall Study|Withdrawal by Subject|2|||
129950410|NCT02707952|467781108|FG003|Overall Study|Withdrawal by Subject|0|||
129950411|NCT02006641|467781109|FG000|Overall Study|Withdrawal before treatment|2|||
129950412|NCT02006641|467781110|FG001|Overall Study|Withdrawal before treatment|5|||
129950413|NCT02006641|467781111|FG002|Overall Study|Withdrawal before treatment|3|||
129950414|NCT02006641|467781109|FG000|Overall Study|Adverse Event|15|||
129950415|NCT02006641|467781110|FG001|Overall Study|Adverse Event|11|||
129950416|NCT02006641|467781111|FG002|Overall Study|Adverse Event|15|||
129950417|NCT02006641|467781109|FG000|Overall Study|Protocol Violation|0|||
129950418|NCT02006641|467781110|FG001|Overall Study|Protocol Violation|2|||
129950419|NCT02006641|467781111|FG002|Overall Study|Protocol Violation|2|||
129950420|NCT02006641|467781109|FG000|Overall Study|Lost to Follow-up|0|||
129950421|NCT02006641|467781110|FG001|Overall Study|Lost to Follow-up|1|||
129950422|NCT02006641|467781111|FG002|Overall Study|Lost to Follow-up|0|||
129950423|NCT02006641|467781109|FG000|Overall Study|Withdrawal by Subject|7|||
129950424|NCT02006641|467781110|FG001|Overall Study|Withdrawal by Subject|12|||
129950425|NCT02006641|467781111|FG002|Overall Study|Withdrawal by Subject|11|||
129950426|NCT02006641|467781109|FG000|Overall Study|Other reason: patient didn't show up|1|||
129950427|NCT02006641|467781110|FG001|Overall Study|Other reason: patient didn't show up|0|||
129950428|NCT02006641|467781111|FG002|Overall Study|Other reason: patient didn't show up|0|||
129950429|NCT02006641|467781109|FG000|Overall Study|Other reason:patient didn't want to come|0|||
129950430|NCT02006641|467781110|FG001|Overall Study|Other reason:patient didn't want to come|0|||
129950431|NCT02006641|467781111|FG002|Overall Study|Other reason:patient didn't want to come|1|||
129950432|NCT02006641|467781109|FG000|Overall Study|Other reason: patient has moved|1|||
129950433|NCT02006641|467781110|FG001|Overall Study|Other reason: patient has moved|0|||
129950434|NCT02006641|467781111|FG002|Overall Study|Other reason: patient has moved|1|||
129950435|NCT02006641|467781109|FG000|Overall Study|Other reason: caregiver in hospital|0|||
129950436|NCT02006641|467781110|FG001|Overall Study|Other reason: caregiver in hospital|1|||
129950437|NCT02006641|467781111|FG002|Overall Study|Other reason: caregiver in hospital|0|||
129950438|NCT02006641|467781109|FG000|Overall Study|Other reason: patient's wife has died|0|||
129950439|NCT02006641|467781110|FG001|Overall Study|Other reason: patient's wife has died|0|||
129950440|NCT02006641|467781111|FG002|Overall Study|Other reason: patient's wife has died|1|||
129950441|NCT02006641|467781109|FG000|Overall Study|Other reason: hospitalisation|0|||
129950442|NCT02006641|467781110|FG001|Overall Study|Other reason: hospitalisation|1|||
129950443|NCT02006641|467781111|FG002|Overall Study|Other reason: hospitalisation|0|||
129950444|NCT02006641|467781109|FG000|Overall Study|Other reason: caregiver impossibility|0|||
130072678|NCT04539262|468220949|FG002|Overall Study|Adverse Event|1|||
130072679|NCT04539262|468220950|FG003|Overall Study|Adverse Event|0|||
130072680|NCT04539262|468220951|FG004|Overall Study|Adverse Event|0|||
130072681|NCT04539262|468220952|FG005|Overall Study|Adverse Event|0|||
130072682|NCT04539262|468220953|FG006|Overall Study|Adverse Event|0|||
130072683|NCT04539262|468220954|FG007|Overall Study|Adverse Event|0|||
130072684|NCT04539262|468220947|FG000|Overall Study|Withdrew Consent|0|||
130072685|NCT04539262|468220948|FG001|Overall Study|Withdrew Consent|0|||
130072686|NCT04539262|468220949|FG002|Overall Study|Withdrew Consent|0|||
130072687|NCT04539262|468220950|FG003|Overall Study|Withdrew Consent|1|||
130072688|NCT04539262|468220951|FG004|Overall Study|Withdrew Consent|0|||
130072689|NCT04539262|468220952|FG005|Overall Study|Withdrew Consent|0|||
130072690|NCT04539262|468220953|FG006|Overall Study|Withdrew Consent|0|||
130072691|NCT04539262|468220954|FG007|Overall Study|Withdrew Consent|0|||
130072692|NCT04539262|468220947|FG000|Overall Study|Randomized, Not treated|0|||
130072693|NCT04539262|468220948|FG001|Overall Study|Randomized, Not treated|1|||
130072694|NCT04539262|468220949|FG002|Overall Study|Randomized, Not treated|0|||
130072695|NCT04539262|468220950|FG003|Overall Study|Randomized, Not treated|0|||
130072696|NCT04539262|468220951|FG004|Overall Study|Randomized, Not treated|0|||
130072697|NCT04539262|468220952|FG005|Overall Study|Randomized, Not treated|0|||
130072698|NCT04539262|468220953|FG006|Overall Study|Randomized, Not treated|1|||
130072699|NCT04539262|468220954|FG007|Overall Study|Randomized, Not treated|0|||
130072700|NCT01061567|468220961|FG000|Overall Study|Adverse Event|32|||
130072701|NCT01061567|468220961|FG000|Overall Study|Death|2|||
130072702|NCT01061567|468220961|FG000|Overall Study|Lack of Efficacy|3|||
130072703|NCT01061567|468220961|FG000|Overall Study|Lost to Follow-up|24|||
130072704|NCT01061567|468220961|FG000|Overall Study|Protocol Violation|1|||
130072705|NCT01061567|468220961|FG000|Overall Study|Withdrawal by Subject|11|||
130072706|NCT01061567|468220961|FG000|Overall Study|Other reason than stated above|3|||
130072707|NCT01831804|468220962|FG000|Overall Study|Adverse Event|0|||
130072708|NCT01831804|468220963|FG001|Overall Study|Adverse Event|0|||
130072709|NCT01831804|468220964|FG002|Overall Study|Adverse Event|0|||
130072710|NCT01831804|468220965|FG003|Overall Study|Adverse Event|0|||
130072711|NCT01831804|468220966|FG004|Overall Study|Adverse Event|0|||
130072712|NCT01831804|468220967|FG005|Overall Study|Adverse Event|0|||
130072713|NCT01831804|468220968|FG006|Overall Study|Adverse Event|1|||
130072714|NCT01831804|468220969|FG007|Overall Study|Adverse Event|0|||
130072715|NCT01831804|468220970|FG008|Overall Study|Adverse Event|1|||
130072716|NCT01831804|468220962|FG000|Overall Study|Protocol Violation|0|||
130072717|NCT01831804|468220963|FG001|Overall Study|Protocol Violation|0|||
130072718|NCT01831804|468220964|FG002|Overall Study|Protocol Violation|2|||
130072719|NCT01831804|468220965|FG003|Overall Study|Protocol Violation|0|||
130072720|NCT01831804|468220966|FG004|Overall Study|Protocol Violation|0|||
130072721|NCT01831804|468220967|FG005|Overall Study|Protocol Violation|0|||
130072722|NCT01831804|468220968|FG006|Overall Study|Protocol Violation|0|||
130072723|NCT01831804|468220969|FG007|Overall Study|Protocol Violation|0|||
130072724|NCT01831804|468220970|FG008|Overall Study|Protocol Violation|0|||
130072725|NCT01831804|468220962|FG000|Overall Study|Protocol defined stopping criteria|1|||
130072726|NCT01831804|468220963|FG001|Overall Study|Protocol defined stopping criteria|1|||
130072727|NCT01831804|468220964|FG002|Overall Study|Protocol defined stopping criteria|3|||
130072728|NCT01831804|468220965|FG003|Overall Study|Protocol defined stopping criteria|0|||
130072729|NCT01831804|468220966|FG004|Overall Study|Protocol defined stopping criteria|1|||
130072730|NCT01831804|468220967|FG005|Overall Study|Protocol defined stopping criteria|0|||
130072731|NCT01831804|468220968|FG006|Overall Study|Protocol defined stopping criteria|0|||
130072732|NCT01831804|468220969|FG007|Overall Study|Protocol defined stopping criteria|0|||
130072733|NCT01831804|468220970|FG008|Overall Study|Protocol defined stopping criteria|0|||
130072734|NCT01831804|468220962|FG000|Overall Study|Lost to Follow-up|0|||
130120429|NCT02579096|468402374|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
130120430|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Death|3|||
130120431|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Death|2|||
130120432|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
130120433|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
129950445|NCT02006641|467781110|FG001|Overall Study|Other reason: caregiver impossibility|0|||
129950446|NCT02006641|467781111|FG002|Overall Study|Other reason: caregiver impossibility|1|||
129950447|NCT02006641|467781109|FG000|Overall Study|Other reason: protocol non-compliance|0|||
129950448|NCT02006641|467781110|FG001|Overall Study|Other reason: protocol non-compliance|0|||
130072735|NCT01831804|468220963|FG001|Overall Study|Lost to Follow-up|0|||
130072736|NCT01831804|468220964|FG002|Overall Study|Lost to Follow-up|1|||
130072737|NCT01831804|468220965|FG003|Overall Study|Lost to Follow-up|0|||
130072738|NCT01831804|468220966|FG004|Overall Study|Lost to Follow-up|0|||
130072739|NCT01831804|468220967|FG005|Overall Study|Lost to Follow-up|0|||
130072740|NCT01831804|468220968|FG006|Overall Study|Lost to Follow-up|0|||
130072741|NCT01831804|468220969|FG007|Overall Study|Lost to Follow-up|0|||
130072742|NCT01831804|468220970|FG008|Overall Study|Lost to Follow-up|1|||
130072743|NCT01831804|468220962|FG000|Overall Study|Investigator discretion|0|||
130072744|NCT01831804|468220963|FG001|Overall Study|Investigator discretion|0|||
130072745|NCT01831804|468220964|FG002|Overall Study|Investigator discretion|0|||
130120434|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
130072746|NCT01831804|468220965|FG003|Overall Study|Investigator discretion|0|||
130072747|NCT01831804|468220966|FG004|Overall Study|Investigator discretion|1|||
130072748|NCT01831804|468220967|FG005|Overall Study|Investigator discretion|0|||
130072749|NCT01831804|468220968|FG006|Overall Study|Investigator discretion|0|||
130072750|NCT01831804|468220969|FG007|Overall Study|Investigator discretion|1|||
130072751|NCT01831804|468220970|FG008|Overall Study|Investigator discretion|0|||
130072752|NCT01831804|468220962|FG000|Overall Study|Withdrew Consent|0|||
130072753|NCT01831804|468220963|FG001|Overall Study|Withdrew Consent|1|||
130072754|NCT01831804|468220964|FG002|Overall Study|Withdrew Consent|0|||
130072755|NCT01831804|468220965|FG003|Overall Study|Withdrew Consent|0|||
130072756|NCT01831804|468220966|FG004|Overall Study|Withdrew Consent|0|||
130072757|NCT01831804|468220967|FG005|Overall Study|Withdrew Consent|0|||
130072758|NCT01831804|468220968|FG006|Overall Study|Withdrew Consent|0|||
130072759|NCT01831804|468220969|FG007|Overall Study|Withdrew Consent|2|||
130072760|NCT01831804|468220970|FG008|Overall Study|Withdrew Consent|0|||
130072761|NCT00268463|468220973|FG000|Overall Study|study terminated due to low accrual|10|||
130072762|NCT00268463|468220974|FG001|Overall Study|study terminated due to low accrual|12|||
130072763|NCT02920450|468220975|FG000|Overall Study|Death|1|||
130072764|NCT02920450|468220976|FG001|Overall Study|Death|0|||
130072765|NCT02920450|468220977|FG002|Overall Study|Death|0|||
130072766|NCT02920450|468220978|FG003|Overall Study|Death|0|||
130072767|NCT02920450|468220975|FG000|Overall Study|Withdrawal by Subject|1|||
130072768|NCT02920450|468220976|FG001|Overall Study|Withdrawal by Subject|0|||
130072769|NCT02920450|468220977|FG002|Overall Study|Withdrawal by Subject|0|||
130072770|NCT02920450|468220978|FG003|Overall Study|Withdrawal by Subject|0|||
130072771|NCT00291187|468220979|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
130072772|NCT00291187|468220980|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
130072773|NCT00291187|468220981|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
130072774|NCT00291187|468220982|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
130072775|NCT02443805|468220988|FG000|Overall Study|Adverse Event|100|||
130072776|NCT02443805|468220989|FG001|Overall Study|Adverse Event|18|||
130072777|NCT02443805|468220988|FG000|Overall Study|Withdrawal by Subject|73|||
130072778|NCT02443805|468220989|FG001|Overall Study|Withdrawal by Subject|74|||
130072779|NCT02443805|468220988|FG000|Overall Study|Lost to Follow-up|19|||
130072780|NCT02443805|468220989|FG001|Overall Study|Lost to Follow-up|14|||
130072781|NCT02443805|468220988|FG000|Overall Study|Pregnancy|6|||
130072782|NCT02443805|468220989|FG001|Overall Study|Pregnancy|5|||
130072783|NCT02443805|468220988|FG000|Overall Study|Protocol Violation|2|||
130072784|NCT02443805|468220989|FG001|Overall Study|Protocol Violation|4|||
130072785|NCT02443805|468220988|FG000|Overall Study|Lack of Efficacy|1|||
130072786|NCT02443805|468220989|FG001|Overall Study|Lack of Efficacy|1|||
130072787|NCT02443805|468220988|FG000|Overall Study|Non-compliance with study drug|6|||
130072788|NCT02443805|468220989|FG001|Overall Study|Non-compliance with study drug|4|||
130072789|NCT02443805|468220988|FG000|Overall Study|Withdrawal by parent/guardian|3|||
130072790|NCT02443805|468220989|FG001|Overall Study|Withdrawal by parent/guardian|5|||
130072791|NCT02443805|468220988|FG000|Overall Study|Any other reason not above-mentioned|3|||
130072792|NCT02443805|468220989|FG001|Overall Study|Any other reason not above-mentioned|2|||
130072793|NCT04362813|468220990|FG000|Overall Study|Death|12|||
130072794|NCT04362813|468220991|FG001|Overall Study|Death|16|||
130072795|NCT04362813|468220990|FG000|Overall Study|Withdrawal by Subject|3|||
130072796|NCT04362813|468220991|FG001|Overall Study|Withdrawal by Subject|1|||
130072797|NCT04362813|468220990|FG000|Overall Study|Protocol Violation|0|||
130072798|NCT04362813|468220991|FG001|Overall Study|Protocol Violation|3|||
130072799|NCT04362813|468220990|FG000|Overall Study|Lost to Follow-up|1|||
130072800|NCT04362813|468220991|FG001|Overall Study|Lost to Follow-up|1|||
130072801|NCT04362813|468220990|FG000|Overall Study|Enrolled but did not receive treatment|2|||
130072802|NCT04362813|468220991|FG001|Overall Study|Enrolled but did not receive treatment|4|||
130072803|NCT00961116|468220992|FG000|Washout Period of 7 Days|Adverse Event|1|||
130072804|NCT00961116|468220993|FG001|Washout Period of 7 Days|Adverse Event|1|||
130072805|NCT00961116|468220992|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
130072806|NCT00961116|468220993|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129950449|NCT02006641|467781111|FG002|Overall Study|Other reason: protocol non-compliance|1|||
129950450|NCT01287832|467781112|FG000|Overall Study|Adverse Event|1|||
130072807|NCT00961116|468220992|FG000|Washout Period of 7 Days|Protocol Violation|0|||
130072808|NCT00961116|468220993|FG001|Washout Period of 7 Days|Protocol Violation|1|||
130072809|NCT02708966|468220994|FG000|Overall Study|Lost to Follow-up|2|||
130072810|NCT02708966|468220995|FG001|Overall Study|Lost to Follow-up|2|||
130072811|NCT01732107|468220998|FG000|Overall Study|Adverse Event|2|||
130072812|NCT01732107|468220998|FG000|Overall Study|Disease Progression|8|||
130072813|NCT01732107|468220998|FG000|Overall Study|Physician Decision|1|||
130072814|NCT01732107|468220998|FG000|Overall Study|Withdrawal by Subject|2|||
130072815|NCT02023268|468220999|FG000|Overall Study|Lack of Efficacy|0|||
130072816|NCT02023268|468221000|FG001|Overall Study|Lack of Efficacy|1|||
130072817|NCT02023268|468220999|FG000|Overall Study|Adverse Event|0|||
130072818|NCT02023268|468221000|FG001|Overall Study|Adverse Event|2|||
130072819|NCT02023268|468220999|FG000|Overall Study|Withdrawal by Subject|0|||
130072820|NCT02023268|468221000|FG001|Overall Study|Withdrawal by Subject|1|||
130072821|NCT00615459|468221001|FG000|Period I|Adverse Event|2|||
130072822|NCT00615459|468221002|FG001|Period I|Adverse Event|0|||
130072823|NCT00615459|468221003|FG002|Period I|Adverse Event|1|||
130072824|NCT00615459|468221004|FG003|Period I|Adverse Event|0|||
130072825|NCT00615459|468221001|FG000|Period I|Subject withdrew consent|1|||
130072826|NCT00615459|468221002|FG001|Period I|Subject withdrew consent|0|||
130072827|NCT00615459|468221003|FG002|Period I|Subject withdrew consent|0|||
130072828|NCT00615459|468221004|FG003|Period I|Subject withdrew consent|1|||
130072829|NCT00615459|468221001|FG000|Period I|Abnormal test procedure results|1|||
130072830|NCT00615459|468221002|FG001|Period I|Abnormal test procedure results|1|||
130072831|NCT00615459|468221003|FG002|Period I|Abnormal test procedure results|1|||
130072832|NCT00615459|468221004|FG003|Period I|Abnormal test procedure results|0|||
130072833|NCT00615459|468221001|FG000|Period II|Adverse Event|1|||
130072834|NCT00615459|468221002|FG001|Period II|Adverse Event|0|||
130072835|NCT00615459|468221003|FG002|Period II|Adverse Event|0|||
130072836|NCT00615459|468221004|FG003|Period II|Adverse Event|0|||
130072837|NCT00615459|468221001|FG000|Period II|Lost to Follow-up|0|||
130072838|NCT00615459|468221002|FG001|Period II|Lost to Follow-up|0|||
130072839|NCT00615459|468221003|FG002|Period II|Lost to Follow-up|0|||
130072840|NCT00615459|468221004|FG003|Period II|Lost to Follow-up|1|||
130072841|NCT00615459|468221001|FG000|Period III|Adverse Event|0|||
130072842|NCT00615459|468221002|FG001|Period III|Adverse Event|1|||
130072843|NCT00615459|468221003|FG002|Period III|Adverse Event|0|||
130072844|NCT00615459|468221004|FG003|Period III|Adverse Event|0|||
130072845|NCT00615459|468221001|FG000|Period III|Administrative problems|0|||
130072846|NCT00615459|468221002|FG001|Period III|Administrative problems|1|||
130072847|NCT00615459|468221003|FG002|Period III|Administrative problems|1|||
130072848|NCT00615459|468221004|FG003|Period III|Administrative problems|0|||
130072849|NCT00615459|468221001|FG000|Period III|Unsatisfactory therapeutic effect|0|||
130072850|NCT00615459|468221002|FG001|Period III|Unsatisfactory therapeutic effect|1|||
130072851|NCT00615459|468221003|FG002|Period III|Unsatisfactory therapeutic effect|0|||
130072852|NCT00615459|468221004|FG003|Period III|Unsatisfactory therapeutic effect|0|||
130072853|NCT01975675|468221005|FG000|Overall Study|Death|0|||
130072854|NCT01975675|468221006|FG001|Overall Study|Death|1|||
130072855|NCT01975675|468221007|FG002|Overall Study|Death|0|||
130072856|NCT01975675|468221008|FG003|Overall Study|Death|0|||
130072857|NCT00224003|468221009|FG000|Overall Study|Adverse Event|1|||
130072858|NCT00224003|468221009|FG000|Overall Study|Protocol Violation|2|||
130072859|NCT00224003|468221009|FG000|Overall Study|Withdrawal by Subject|1|||
130072860|NCT00224003|468221009|FG000|Overall Study|unk|3|||
130072861|NCT00753688|468221010|FG000|Overall Study|Death|102|||
130072862|NCT00753688|468221011|FG001|Overall Study|Death|203|||
130072863|NCT00753688|468221010|FG000|Overall Study|Missing|4|||
130072864|NCT00753688|468221011|FG001|Overall Study|Missing|9|||
130072865|NCT00753688|468221010|FG000|Overall Study|Participant Withdrew Consent|2|||
130072866|NCT00753688|468221011|FG001|Overall Study|Participant Withdrew Consent|2|||
130072867|NCT00753688|468221010|FG000|Overall Study|Ongoing - in Follow-up|15|||
130072868|NCT00753688|468221011|FG001|Overall Study|Ongoing - in Follow-up|31|||
130072869|NCT00753688|468221010|FG000|Overall Study|Adverse Event|0|||
130072870|NCT00753688|468221011|FG001|Overall Study|Adverse Event|1|||
130072871|NCT03595384|468221012|FG000|Overall Study|Other time commitments|8|||
130072872|NCT03595384|468221012|FG000|Overall Study|Changes to session time|7|||
130072873|NCT03595384|468221012|FG000|Overall Study|Relocation out of country|1|||
130072874|NCT00293241|468221013|FG000|Overall Study|Lost to Follow-up|9|||
130072875|NCT00293241|468221014|FG001|Overall Study|Lost to Follow-up|16|||
130072876|NCT00293241|468221013|FG000|Overall Study|Physician Decision|23|||
130072877|NCT00293241|468221014|FG001|Overall Study|Physician Decision|17|||
130072878|NCT00293241|468221013|FG000|Overall Study|Withdrawal by Subject|4|||
130072879|NCT00293241|468221014|FG001|Overall Study|Withdrawal by Subject|8|||
130072880|NCT03803202|468221015|FG000|Overall Study|Other|0|||
130072881|NCT03803202|468221016|FG001|Overall Study|Other|1|||
130072882|NCT03803202|468221017|FG002|Overall Study|Other|0|||
129950451|NCT01287832|467781113|FG001|Overall Study|Adverse Event|0|||
129950452|NCT01287832|467781112|FG000|Overall Study|Death|0|||
130072883|NCT03803202|468221018|FG003|Overall Study|Other|0|||
130072884|NCT03803202|468221019|FG004|Overall Study|Other|0|||
130072885|NCT03803202|468221020|FG005|Overall Study|Other|0|||
130072886|NCT03803202|468221021|FG006|Overall Study|Other|0|||
130072887|NCT03803202|468221022|FG007|Overall Study|Other|0|||
130072888|NCT03803202|468221023|FG008|Overall Study|Other|0|||
130072889|NCT03803202|468221015|FG000|Overall Study|Death|0|||
130072890|NCT03803202|468221016|FG001|Overall Study|Death|0|||
130072891|NCT03803202|468221017|FG002|Overall Study|Death|0|||
130072892|NCT03803202|468221018|FG003|Overall Study|Death|0|||
130072893|NCT03803202|468221019|FG004|Overall Study|Death|0|||
130072894|NCT03803202|468221020|FG005|Overall Study|Death|1|||
130072895|NCT03803202|468221021|FG006|Overall Study|Death|0|||
130072896|NCT03803202|468221022|FG007|Overall Study|Death|0|||
130072897|NCT03803202|468221023|FG008|Overall Study|Death|0|||
130072898|NCT03803202|468221015|FG000|Overall Study|Withdrawal by Subject|0|||
130072899|NCT03803202|468221016|FG001|Overall Study|Withdrawal by Subject|0|||
130072900|NCT03803202|468221017|FG002|Overall Study|Withdrawal by Subject|1|||
130072901|NCT03803202|468221018|FG003|Overall Study|Withdrawal by Subject|0|||
130072902|NCT03803202|468221019|FG004|Overall Study|Withdrawal by Subject|0|||
130072903|NCT03803202|468221020|FG005|Overall Study|Withdrawal by Subject|0|||
130072904|NCT03803202|468221021|FG006|Overall Study|Withdrawal by Subject|0|||
130072905|NCT03803202|468221022|FG007|Overall Study|Withdrawal by Subject|1|||
130072906|NCT03803202|468221023|FG008|Overall Study|Withdrawal by Subject|0|||
130072907|NCT03803202|468221015|FG000|Overall Study|Lost to Follow-up|0|||
130072908|NCT03803202|468221016|FG001|Overall Study|Lost to Follow-up|0|||
130072909|NCT03803202|468221017|FG002|Overall Study|Lost to Follow-up|0|||
130072910|NCT03803202|468221018|FG003|Overall Study|Lost to Follow-up|1|||
130072911|NCT03803202|468221019|FG004|Overall Study|Lost to Follow-up|1|||
130072912|NCT03803202|468221020|FG005|Overall Study|Lost to Follow-up|0|||
130072913|NCT03803202|468221021|FG006|Overall Study|Lost to Follow-up|1|||
130072914|NCT03803202|468221022|FG007|Overall Study|Lost to Follow-up|0|||
130072915|NCT03803202|468221023|FG008|Overall Study|Lost to Follow-up|0|||
130072916|NCT00659126|468221028|FG000|Overall Study|Adverse Event|2|||
130072917|NCT00659126|468221029|FG001|Overall Study|Adverse Event|2|||
130072918|NCT00659126|468221028|FG000|Overall Study|Screen failure|1|||
130072919|NCT00659126|468221029|FG001|Overall Study|Screen failure|1|||
130072920|NCT00659126|468221028|FG000|Overall Study|Technical problems with MRI|0|||
130072921|NCT00659126|468221029|FG001|Overall Study|Technical problems with MRI|1|||
130072922|NCT02633046|468221032|FG000|Overall Study|Adverse Event|8|||
130072923|NCT02633046|468221032|FG000|Overall Study|Physician Decision|7|||
130072924|NCT02633046|468221032|FG000|Overall Study|Withdrawal by Subject|8|||
130072925|NCT02633046|468221032|FG000|Overall Study|Increased proteinuria|2|||
130072926|NCT02633046|468221032|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
130072927|NCT02633046|468221032|FG000|Overall Study|Mutual decision patient and physician|1|||
130072928|NCT00418717|468221043|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
130072929|NCT00418717|468221043|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
130072930|NCT00719537|468221046|FG000|Overall Study|Withdrawal by Subject|1|||
130072931|NCT00719537|468221047|FG001|Overall Study|Withdrawal by Subject|0|||
130072932|NCT00719537|468221046|FG000|Overall Study|Lost to Follow-up|0|||
130072933|NCT00719537|468221047|FG001|Overall Study|Lost to Follow-up|1|||
130072934|NCT01041404|468221056|FG000|Overall Study|Adverse Event|45|||
130072935|NCT01041404|468221057|FG001|Overall Study|Adverse Event|35|||
130072936|NCT01041404|468221056|FG000|Overall Study|Lack of Efficacy|200|||
130072937|NCT01041404|468221057|FG001|Overall Study|Lack of Efficacy|210|||
130072938|NCT01041404|468221056|FG000|Overall Study|Violation of Selection Criteria|0|||
130072939|NCT01041404|468221057|FG001|Overall Study|Violation of Selection Criteria|1|||
130072940|NCT01041404|468221056|FG000|Overall Study|Protocol Violation|4|||
130072941|NCT01041404|468221057|FG001|Overall Study|Protocol Violation|0|||
130072942|NCT01041404|468221056|FG000|Overall Study|Withdrawal by Subject|29|||
130072943|NCT01041404|468221057|FG001|Overall Study|Withdrawal by Subject|23|||
130072944|NCT01041404|468221056|FG000|Overall Study|Failure to Return|1|||
130072945|NCT01041404|468221057|FG001|Overall Study|Failure to Return|2|||
130072946|NCT01041404|468221056|FG000|Overall Study|Other|11|||
130072947|NCT01041404|468221057|FG001|Overall Study|Other|23|||
130072948|NCT00383708|468221058|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
130072949|NCT00383708|468221058|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
130072950|NCT00383708|468221058|FG000|Run-in Period|Protocol Violation|4|||
130072951|NCT00383708|468221058|FG000|Run-in Period|Adverse Event|2|||
130072952|NCT00383708|468221058|FG000|Run-in Period|Claustrophobia|1|||
130072953|NCT00383708|468221058|FG000|Co-administration Period|Adverse Event|5|||
130072954|NCT01576406|468221060|FG000|Overall Study|Lost to Follow-up|1|||
130072955|NCT01576406|468221061|FG001|Overall Study|Lost to Follow-up|2|||
130072956|NCT01576406|468221062|FG002|Overall Study|Lost to Follow-up|0|||
130072957|NCT01576406|468221063|FG003|Overall Study|Lost to Follow-up|0|||
130072958|NCT01576406|468221064|FG004|Overall Study|Lost to Follow-up|0|||
130072959|NCT01576406|468221065|FG005|Overall Study|Lost to Follow-up|0|||
130072960|NCT01576406|468221060|FG000|Overall Study|Death|3|||
130072961|NCT01576406|468221061|FG001|Overall Study|Death|4|||
130072962|NCT01576406|468221062|FG002|Overall Study|Death|8|||
130072963|NCT01576406|468221063|FG003|Overall Study|Death|5|||
130072964|NCT01576406|468221064|FG004|Overall Study|Death|7|||
130072965|NCT01576406|468221065|FG005|Overall Study|Death|9|||
130072966|NCT01576406|468221060|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130072967|NCT01576406|468221061|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130072968|NCT01576406|468221062|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
130072969|NCT01576406|468221063|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
130072970|NCT01576406|468221064|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130072971|NCT01576406|468221065|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
130072972|NCT01576406|468221060|FG000|Overall Study|Withdrawal the consent|2|||
130072973|NCT01576406|468221061|FG001|Overall Study|Withdrawal the consent|2|||
130072974|NCT01576406|468221062|FG002|Overall Study|Withdrawal the consent|5|||
130072975|NCT01576406|468221063|FG003|Overall Study|Withdrawal the consent|1|||
130072976|NCT01576406|468221064|FG004|Overall Study|Withdrawal the consent|1|||
130072977|NCT01576406|468221065|FG005|Overall Study|Withdrawal the consent|3|||
130072978|NCT01576406|468221060|FG000|Overall Study|Other|0|||
130072979|NCT01576406|468221061|FG001|Overall Study|Other|0|||
130072980|NCT01576406|468221062|FG002|Overall Study|Other|2|||
130072981|NCT01576406|468221063|FG003|Overall Study|Other|2|||
130072982|NCT01576406|468221064|FG004|Overall Study|Other|0|||
130072983|NCT01576406|468221065|FG005|Overall Study|Other|0|||
130072984|NCT00669032|468221068|FG000|Overall Study|Lost to Follow-up|6|||
130072985|NCT00669032|468221069|FG001|Overall Study|Lost to Follow-up|5|||
130072986|NCT00669032|468221068|FG000|Overall Study|Lack of Efficacy|8|||
130072987|NCT00669032|468221069|FG001|Overall Study|Lack of Efficacy|19|||
130072988|NCT00669032|468221068|FG000|Overall Study|Withdrawal by Subject|12|||
130072989|NCT00669032|468221069|FG001|Overall Study|Withdrawal by Subject|13|||
130072990|NCT00669032|468221068|FG000|Overall Study|Adverse Event|12|||
130072991|NCT00669032|468221069|FG001|Overall Study|Adverse Event|16|||
130072992|NCT00669032|468221068|FG000|Overall Study|Physician Decision|1|||
130072993|NCT00669032|468221069|FG001|Overall Study|Physician Decision|1|||
130072994|NCT00669032|468221068|FG000|Overall Study|No fulfilment of the selection criteria|5|||
130072995|NCT00669032|468221069|FG001|Overall Study|No fulfilment of the selection criteria|5|||
130072996|NCT01607073|468221070|FG000|Overall Study|Adverse Event|1|||
130072997|NCT03627494|468221071|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
130072998|NCT03627494|468221072|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
130072999|NCT03627494|468221073|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
130073000|NCT03627494|468221074|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073001|NCT03627494|468221075|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073002|NCT03627494|468221076|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073003|NCT03627494|468221077|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073004|NCT03627494|468221078|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073005|NCT03627494|468221079|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073006|NCT03627494|468221080|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073007|NCT03627494|468221081|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073008|NCT03627494|468221082|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
130073009|NCT03627494|468221071|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073010|NCT03627494|468221072|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073011|NCT03627494|468221073|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073012|NCT03627494|468221074|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073013|NCT03627494|468221075|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073014|NCT03627494|468221076|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073015|NCT03627494|468221077|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073016|NCT03627494|468221078|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073017|NCT03627494|468221079|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
130073018|NCT03627494|468221080|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073019|NCT03627494|468221081|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073020|NCT03627494|468221082|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
130073021|NCT03627494|468221071|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073022|NCT03627494|468221072|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073023|NCT03627494|468221073|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073024|NCT03627494|468221074|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073025|NCT03627494|468221075|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073026|NCT03627494|468221076|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073027|NCT03627494|468221077|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073028|NCT03627494|468221078|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073029|NCT03627494|468221079|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073030|NCT03627494|468221080|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
130073031|NCT03627494|468221081|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
130073032|NCT03627494|468221082|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
130073033|NCT00446641|468222711|FG000|Overall Study|Withdrawal by Subject|8|||
130073034|NCT00446641|468222712|FG001|Overall Study|Withdrawal by Subject|3|||
130073035|NCT00446641|468222711|FG000|Overall Study|poor compliance|8|||
130073036|NCT00446641|468222712|FG001|Overall Study|poor compliance|6|||
130073037|NCT00446641|468222711|FG000|Overall Study|Lost to Follow-up|1|||
130073038|NCT00446641|468222712|FG001|Overall Study|Lost to Follow-up|1|||
130073039|NCT00063986|468222713|FG000|Overall Study|Withdrawal by Subject|1|||
130073040|NCT00063986|468222713|FG000|Overall Study|Ineligible|1|||
130073041|NCT00063986|468222713|FG000|Overall Study|Intra-operatively ineligible|4|||
130073042|NCT04839393|468222714|FG000|Overall Study|Adverse Event|0|||
130073043|NCT04839393|468222715|FG001|Overall Study|Adverse Event|0|||
130073044|NCT04839393|468222716|FG002|Overall Study|Adverse Event|2|||
130073045|NCT04839393|468222714|FG000|Overall Study|Withdrawal by participant|0|||
130073046|NCT04839393|468222715|FG001|Overall Study|Withdrawal by participant|0|||
130073047|NCT04839393|468222716|FG002|Overall Study|Withdrawal by participant|1|||
130073048|NCT00633893|468222717|FG000|Overall Study|Death|1|||
130073049|NCT00633893|468222718|FG001|Overall Study|Death|3|||
130073050|NCT00633893|468222719|FG002|Overall Study|Death|9|||
130073051|NCT00633893|468222717|FG000|Overall Study|Adverse Event|65|||
130073052|NCT00633893|468222718|FG001|Overall Study|Adverse Event|58|||
130073053|NCT00633893|468222719|FG002|Overall Study|Adverse Event|126|||
130073054|NCT00633893|468222717|FG000|Overall Study|Withdrawal by Subject|7|||
130073055|NCT00633893|468222718|FG001|Overall Study|Withdrawal by Subject|12|||
130073056|NCT00633893|468222719|FG002|Overall Study|Withdrawal by Subject|6|||
130073057|NCT00633893|468222717|FG000|Overall Study|Lost to Follow-up|2|||
130073058|NCT00633893|468222718|FG001|Overall Study|Lost to Follow-up|4|||
130073059|NCT00633893|468222719|FG002|Overall Study|Lost to Follow-up|8|||
130073060|NCT00633893|468222717|FG000|Overall Study|Poor/non-compliance|5|||
130073061|NCT00633893|468222718|FG001|Overall Study|Poor/non-compliance|12|||
130073062|NCT00633893|468222719|FG002|Overall Study|Poor/non-compliance|3|||
130073063|NCT00633893|468222717|FG000|Overall Study|Pregnancy|2|||
130073064|NCT00633893|468222718|FG001|Overall Study|Pregnancy|1|||
130073065|NCT00633893|468222719|FG002|Overall Study|Pregnancy|1|||
130073066|NCT00633893|468222717|FG000|Overall Study|Not meet/no longer meets criteria|4|||
130073067|NCT00633893|468222718|FG001|Overall Study|Not meet/no longer meets criteria|6|||
130073068|NCT00633893|468222719|FG002|Overall Study|Not meet/no longer meets criteria|4|||
130073069|NCT00633893|468222717|FG000|Overall Study|Other|28|||
130073070|NCT00633893|468222718|FG001|Overall Study|Other|33|||
130073071|NCT00633893|468222719|FG002|Overall Study|Other|31|||
130073072|NCT05091918|468222720|FG000|Overall Study|Adverse Event|1|||
130073073|NCT05091918|468222720|FG000|Overall Study|Withdrawal by Subject|81|||
130073074|NCT03210220|468222721|FG000|Overall Study|Physician Decision|1|||
130073075|NCT03210220|468222722|FG001|Overall Study|Physician Decision|0|||
130073076|NCT02911519|468222723|FG000|Overall Study|Lost to Follow-up|2|||
130073077|NCT02911519|468222724|FG001|Overall Study|Lost to Follow-up|2|||
130073078|NCT02911519|468222723|FG000|Overall Study|Death|0|||
130073079|NCT02911519|468222724|FG001|Overall Study|Death|2|||
130073080|NCT00653328|468222725|FG000|Overall Study|Withdrawal by Subject|1|||
130073081|NCT00653328|468222725|FG000|Overall Study|Adverse Event|2|||
130073082|NCT00653328|468222725|FG000|Overall Study|Disease progression|10|||
130073083|NCT00653328|468222725|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
130073084|NCT00839436|468222728|FG000|Overall Study|Developed exclusionary condition|1|||
130073085|NCT00839436|468222729|FG001|Overall Study|Developed exclusionary condition|0|||
130073086|NCT00839436|468222730|FG002|Overall Study|Developed exclusionary condition|0|||
130073087|NCT00839436|468222728|FG000|Overall Study|Withdrawal by Subject|0|||
130073088|NCT00839436|468222729|FG001|Overall Study|Withdrawal by Subject|1|||
130073089|NCT00839436|468222730|FG002|Overall Study|Withdrawal by Subject|0|||
130073090|NCT00839436|468222728|FG000|Overall Study|Study drug no longer available|0|||
130073091|NCT00839436|468222729|FG001|Overall Study|Study drug no longer available|0|||
130073092|NCT00839436|468222730|FG002|Overall Study|Study drug no longer available|1|||
130073093|NCT00407550|468222731|FG000|Overall Study|Adverse Event|0|||
130073094|NCT00407550|468222732|FG001|Overall Study|Adverse Event|1|||
130073095|NCT00407550|468222731|FG000|Overall Study|Withdrawal by Subject|0|||
130073096|NCT00407550|468222732|FG001|Overall Study|Withdrawal by Subject|2|||
130073097|NCT00407550|468222731|FG000|Overall Study|Death|1|||
130073098|NCT00407550|468222732|FG001|Overall Study|Death|0|||
130073099|NCT00407550|468222731|FG000|Overall Study|Insurance or Other medical condition|2|||
130073100|NCT00407550|468222732|FG001|Overall Study|Insurance or Other medical condition|1|||
130073101|NCT01444898|468222734|FG000|Overall Study|Withdrawal by Subject|1|||
130073102|NCT02580591|468222736|FG000|Overall Study|Adverse Event|0|||
130073103|NCT02580591|468222737|FG001|Overall Study|Adverse Event|1|||
130073104|NCT02580591|468222738|FG002|Overall Study|Adverse Event|2|||
130073105|NCT02580591|468222739|FG003|Overall Study|Adverse Event|5|||
130073106|NCT02580591|468222736|FG000|Overall Study|Protocol Violation|3|||
130073107|NCT02580591|468222737|FG001|Overall Study|Protocol Violation|2|||
130073108|NCT02580591|468222738|FG002|Overall Study|Protocol Violation|1|||
130073109|NCT02580591|468222739|FG003|Overall Study|Protocol Violation|1|||
130073110|NCT02580591|468222736|FG000|Overall Study|Lost to Follow-up|5|||
130073111|NCT02580591|468222737|FG001|Overall Study|Lost to Follow-up|3|||
130073112|NCT02580591|468222738|FG002|Overall Study|Lost to Follow-up|3|||
129950453|NCT01287832|467781113|FG001|Overall Study|Death|1|||
130073113|NCT02580591|468222739|FG003|Overall Study|Lost to Follow-up|1|||
130073114|NCT02580591|468222736|FG000|Overall Study|Withdrawal by Subject|6|||
130073115|NCT02580591|468222737|FG001|Overall Study|Withdrawal by Subject|1|||
130073116|NCT02580591|468222738|FG002|Overall Study|Withdrawal by Subject|2|||
130073117|NCT02580591|468222739|FG003|Overall Study|Withdrawal by Subject|3|||
130073118|NCT02580591|468222736|FG000|Overall Study|Not treated|1|||
130073119|NCT02580591|468222737|FG001|Overall Study|Not treated|1|||
130073120|NCT02580591|468222738|FG002|Overall Study|Not treated|0|||
130073121|NCT02580591|468222739|FG003|Overall Study|Not treated|0|||
130073122|NCT02580591|468222736|FG000|Overall Study|Other than specified|3|||
130073123|NCT02580591|468222737|FG001|Overall Study|Other than specified|2|||
130073124|NCT02580591|468222738|FG002|Overall Study|Other than specified|5|||
130073125|NCT02580591|468222739|FG003|Overall Study|Other than specified|2|||
130073126|NCT00561340|468222743|FG000|Overall Study|refused to drink pediasure|6|||
130073127|NCT00561340|468222744|FG001|Overall Study|refused to drink pediasure|0|||
130073128|NCT03051217|468222745|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
130073129|NCT03051217|468222746|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130073130|NCT03051217|468222747|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130073131|NCT03051217|468222748|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130073132|NCT03051217|468222749|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130073133|NCT03051217|468222750|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130073134|NCT03051217|468222751|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130073135|NCT03051217|468222745|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130073136|NCT03051217|468222746|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
130073137|NCT03051217|468222747|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130073138|NCT03051217|468222748|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130073139|NCT03051217|468222749|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130073140|NCT03051217|468222750|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130073141|NCT03051217|468222751|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
130073142|NCT03051217|468222745|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130073143|NCT03051217|468222746|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130073144|NCT03051217|468222747|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
130073145|NCT03051217|468222748|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130073146|NCT03051217|468222749|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130073147|NCT03051217|468222750|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130073148|NCT03051217|468222751|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130073149|NCT03051217|468222745|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
130073150|NCT03051217|468222746|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
130073151|NCT03051217|468222747|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
130073152|NCT03051217|468222748|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
130073153|NCT03051217|468222749|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
130073154|NCT03051217|468222750|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
130073155|NCT03051217|468222751|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
130073156|NCT03051217|468222745|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130073157|NCT03051217|468222746|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130073158|NCT03051217|468222747|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130073159|NCT03051217|468222748|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
130073160|NCT03051217|468222749|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130073161|NCT03051217|468222750|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130073162|NCT03051217|468222751|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
130073163|NCT03051217|468222745|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130073164|NCT03051217|468222746|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130073165|NCT03051217|468222747|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130073166|NCT03051217|468222748|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
130073167|NCT03051217|468222749|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130073168|NCT03051217|468222750|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130073169|NCT03051217|468222751|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
130073170|NCT03051217|468222745|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130073171|NCT03051217|468222746|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130073172|NCT03051217|468222747|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130073173|NCT03051217|468222748|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130073174|NCT03051217|468222749|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
130073175|NCT03051217|468222750|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130073176|NCT03051217|468222751|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
130073177|NCT03051217|468222745|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130073178|NCT03051217|468222746|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130073179|NCT03051217|468222747|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130073180|NCT03051217|468222748|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130073181|NCT03051217|468222749|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130073182|NCT03051217|468222750|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
130073183|NCT03051217|468222751|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
130073184|NCT00641706|468222752|FG000|Overall Study|Adverse Event|2|||
130073185|NCT00641706|468222753|FG001|Overall Study|Adverse Event|1|||
130073186|NCT00641706|468222752|FG000|Overall Study|Withdrawal by Subject|6|||
130073187|NCT00641706|468222753|FG001|Overall Study|Withdrawal by Subject|1|||
129950454|NCT04749797|467781115|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
129950455|NCT04749797|467781116|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
129950456|NCT04749797|467781117|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
129950457|NCT01441596|467781118|FG000|Overall Study|Other reason not defined below|0|||
130073188|NCT00641706|468222752|FG000|Overall Study|Clinical Decline|1|||
130073189|NCT00641706|468222753|FG001|Overall Study|Clinical Decline|0|||
130073190|NCT00641706|468222752|FG000|Overall Study|Lead Investigator Decision|0|||
130073191|NCT00641706|468222753|FG001|Overall Study|Lead Investigator Decision|1|||
130073192|NCT00109772|468222754|FG000|Double-blind Treatment|Adverse Event|14|||
129950458|NCT01441596|467781119|FG001|Overall Study|Other reason not defined below|2|||
130073193|NCT00109772|468222755|FG001|Double-blind Treatment|Adverse Event|5|||
130073194|NCT00109772|468222754|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130073195|NCT00109772|468222755|FG001|Double-blind Treatment|Lack of Efficacy|0|||
130073196|NCT00109772|468222754|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
130073197|NCT00109772|468222755|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
130073198|NCT00109772|468222754|FG000|Double-blind Treatment|Lost to Follow-up|2|||
130073199|NCT00109772|468222755|FG001|Double-blind Treatment|Lost to Follow-up|3|||
130073200|NCT00109772|468222754|FG000|Double-blind Treatment|Protocol Violation|0|||
130073201|NCT00109772|468222755|FG001|Double-blind Treatment|Protocol Violation|1|||
130073202|NCT00109772|468222754|FG000|Double-blind Treatment|Other|0|||
130073203|NCT00109772|468222755|FG001|Double-blind Treatment|Other|4|||
130073204|NCT00109772|468222754|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
130073205|NCT00109772|468222755|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
130073206|NCT00109772|468222754|FG000|Open-label Extension|Adverse Event|10|||
130073207|NCT00109772|468222755|FG001|Open-label Extension|Adverse Event|19|||
130073208|NCT00109772|468222754|FG000|Open-label Extension|Lack of Efficacy|19|||
130073209|NCT00109772|468222755|FG001|Open-label Extension|Lack of Efficacy|11|||
130073210|NCT00109772|468222754|FG000|Open-label Extension|Withdrawal by Subject|9|||
130073211|NCT00109772|468222755|FG001|Open-label Extension|Withdrawal by Subject|6|||
130073212|NCT00109772|468222754|FG000|Open-label Extension|Lost to Follow-up|1|||
130073213|NCT00109772|468222755|FG001|Open-label Extension|Lost to Follow-up|0|||
130073214|NCT00109772|468222754|FG000|Open-label Extension|Death|0|||
130073215|NCT00109772|468222755|FG001|Open-label Extension|Death|1|||
130073216|NCT00109772|468222754|FG000|Open-label Extension|Protocol Violation|2|||
130073217|NCT00109772|468222755|FG001|Open-label Extension|Protocol Violation|2|||
130073218|NCT00109772|468222754|FG000|Open-label Extension|Other|4|||
130073219|NCT00109772|468222755|FG001|Open-label Extension|Other|10|||
130073220|NCT00282568|468222760|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
130073221|NCT00282568|468222760|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
130073222|NCT00282568|468222760|FG000|Extended Treatment Period|Adverse Event|17|||
130073223|NCT00282568|468222760|FG000|Extended Treatment Period|Non-compliance|4|||
130073224|NCT00282568|468222760|FG000|Extended Treatment Period|Physician Decision|1|||
130073225|NCT00282568|468222760|FG000|Extended Treatment Period|Lost to Follow-up|2|||
130073226|NCT03006926|468222761|FG000|Overall Study|Adverse Event|0|||
130073227|NCT03006926|468222762|FG001|Overall Study|Adverse Event|27|||
130073228|NCT03006926|468222761|FG000|Overall Study|Withdrawal by Subject|0|||
130073229|NCT03006926|468222762|FG001|Overall Study|Withdrawal by Subject|1|||
130073230|NCT03006926|468222761|FG000|Overall Study|Radiological Disease Progression|0|||
130073231|NCT03006926|468222762|FG001|Overall Study|Radiological Disease Progression|52|||
130073232|NCT03006926|468222761|FG000|Overall Study|Clinical Disease Progression|0|||
130073233|NCT03006926|468222762|FG001|Overall Study|Clinical Disease Progression|10|||
130073234|NCT03006926|468222761|FG000|Overall Study|Other|0|||
130073235|NCT03006926|468222762|FG001|Overall Study|Other|8|||
130073236|NCT03725293|468222769|FG000|Overall Study|Physician Decision|9|||
130073237|NCT03725293|468222770|FG001|Overall Study|Physician Decision|6|||
130073238|NCT03725293|468222769|FG000|Overall Study|alternative vascular access needs|1|||
130073239|NCT03725293|468222770|FG001|Overall Study|alternative vascular access needs|2|||
130073240|NCT03725293|468222769|FG000|Overall Study|venous anatomy screen failures|2|||
130073241|NCT03725293|468222770|FG001|Overall Study|venous anatomy screen failures|1|||
130073242|NCT01057862|468222771|FG000|Overall Study|Withdrawal by Subject|1|||
130073243|NCT01057862|468222772|FG001|Overall Study|Withdrawal by Subject|2|||
130073244|NCT00415584|468222773|FG000|Overall Study|Withdrawal by Subject|1|||
130073245|NCT00802867|468222774|FG000|Overall Study|Lost to Follow-up|6|||
130073246|NCT00802867|468222774|FG000|Overall Study|Protocol Violation|6|||
130073247|NCT00802867|468222774|FG000|Overall Study|Withdrawal by Subject|1|||
130073248|NCT04075396|468222775|FG000|Overall Study|Death|11|||
130073249|NCT04075396|468222776|FG001|Overall Study|Death|9|||
130073250|NCT04075396|468222775|FG000|Overall Study|Withdrawal by Subject|1|||
130073251|NCT04075396|468222776|FG001|Overall Study|Withdrawal by Subject|2|||
130073252|NCT04075396|468222775|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
130073253|NCT04075396|468222776|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
130073254|NCT04075396|468222775|FG000|Overall Study|Enrolled but not-treated|0|||
130073255|NCT04075396|468222776|FG001|Overall Study|Enrolled but not-treated|1|||
130073256|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
130073257|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
130073258|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
130073259|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
130073260|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
130073261|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
130073262|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
130073263|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
130073264|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
130073265|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
130073266|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
130073267|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
130073268|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
130073269|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
130073270|NCT03434041|468222777|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
130073271|NCT03434041|468222778|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
130073272|NCT03434041|468222777|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
130073273|NCT03434041|468222778|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
130073274|NCT03434041|468222777|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
130073275|NCT03434041|468222778|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
130073276|NCT03434041|468222777|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
130073277|NCT03434041|468222778|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
130073278|NCT03363165|468222785|FG000|3-month Follow-up|Death|0|||
130073279|NCT03363165|468222786|FG001|3-month Follow-up|Death|1|||
130073280|NCT03363165|468222785|FG000|6-month Follow-up|Death|0|||
130073281|NCT03363165|468222786|FG001|6-month Follow-up|Death|1|||
130073282|NCT03363165|468222785|FG000|6-month Follow-up|Withdrawal by Subject|1|||
130073283|NCT03363165|468222786|FG001|6-month Follow-up|Withdrawal by Subject|1|||
130073284|NCT03363165|468222785|FG000|12-month Follow-up|Death|1|||
130073285|NCT03363165|468222786|FG001|12-month Follow-up|Death|1|||
130073286|NCT03363165|468222785|FG000|12-month Follow-up|Withdrawal by Subject|1|||
130073287|NCT03363165|468222786|FG001|12-month Follow-up|Withdrawal by Subject|1|||
130073288|NCT02255760|468222787|FG000|Overall Study|Lost to Follow-up|0|||
130073289|NCT02255760|468222788|FG001|Overall Study|Lost to Follow-up|1|||
130073290|NCT02255760|468222789|FG002|Overall Study|Lost to Follow-up|0|||
130073291|NCT02255760|468222790|FG003|Overall Study|Lost to Follow-up|0|||
130073292|NCT02255760|468222791|FG004|Overall Study|Lost to Follow-up|0|||
130073293|NCT00618813|468222792|FG000|Overall Study|Lack of Efficacy|1|||
130073294|NCT00618813|468222792|FG000|Overall Study|Physician Decision|2|||
130073295|NCT00618813|468222792|FG000|Overall Study|Withdrawal by Subject|1|||
130073296|NCT00003838|468222793|FG000|Overall Study|Death|0|||
130073297|NCT00003838|468222794|FG001|Overall Study|Death|12|||
130073298|NCT00003838|468222795|FG002|Overall Study|Death|7|||
130073299|NCT00003838|468222793|FG000|Overall Study|Lost to Follow-up|0|||
130073300|NCT00003838|468222794|FG001|Overall Study|Lost to Follow-up|1|||
130073301|NCT00003838|468222795|FG002|Overall Study|Lost to Follow-up|1|||
130073302|NCT00003838|468222793|FG000|Overall Study|Disease Progression|0|||
130073303|NCT00003838|468222794|FG001|Overall Study|Disease Progression|12|||
130073304|NCT00003838|468222795|FG002|Overall Study|Disease Progression|0|||
130073305|NCT01809197|468222796|FG000|Overall Study|Lost to Follow-up|4|||
130073306|NCT01809197|468222797|FG001|Overall Study|Lost to Follow-up|2|||
130073307|NCT01809197|468222796|FG000|Overall Study|Adverse Event|2|||
130073308|NCT01809197|468222797|FG001|Overall Study|Adverse Event|3|||
130073309|NCT01809197|468222796|FG000|Overall Study|Failed slit lamp exam|1|||
130073310|NCT01809197|468222797|FG001|Overall Study|Failed slit lamp exam|0|||
130073311|NCT01809197|468222796|FG000|Overall Study|Non-Compliance|1|||
130073312|NCT01809197|468222797|FG001|Overall Study|Non-Compliance|1|||
130073313|NCT01809197|468222796|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
130073314|NCT01809197|468222797|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
130073315|NCT01809197|468222796|FG000|Overall Study|Withdrawal by Subject|1|||
130073316|NCT01809197|468222797|FG001|Overall Study|Withdrawal by Subject|1|||
130073317|NCT01809197|468222796|FG000|Overall Study|Product not available|0|||
130073318|NCT01809197|468222797|FG001|Overall Study|Product not available|1|||
130073319|NCT00770224|468222798|FG000|Step 1: Induction|Adverse Event|3|||
130073320|NCT00770224|468222799|FG001|Step 1: Induction|Adverse Event|0|||
130073321|NCT00770224|468222798|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
130073322|NCT00770224|468222799|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
130073323|NCT00770224|468222798|FG000|Step 1: Induction|Other reason not protocol specified|2|||
130073324|NCT00770224|468222799|FG001|Step 1: Induction|Other reason not protocol specified|0|||
130073325|NCT00770224|468222798|FG000|Step 1: Induction|Ineligible|2|||
130073326|NCT00770224|468222799|FG001|Step 1: Induction|Ineligible|0|||
130073327|NCT00770224|468222798|FG000|Step 1: Induction|No protocol treatment given|1|||
130073328|NCT00770224|468222799|FG001|Step 1: Induction|No protocol treatment given|0|||
130073329|NCT00770224|468222798|FG000|Step 2: Maintenance|Adverse Event|0|||
130073330|NCT00770224|468222799|FG001|Step 2: Maintenance|Adverse Event|10|||
130073331|NCT00770224|468222798|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
130073332|NCT00770224|468222799|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
130073333|NCT00770224|468222798|FG000|Step 2: Maintenance|Progression/relapse|0|||
130073334|NCT00770224|468222799|FG001|Step 2: Maintenance|Progression/relapse|1|||
130073335|NCT00770224|468222798|FG000|Step 2: Maintenance|Death|0|||
130073336|NCT00770224|468222799|FG001|Step 2: Maintenance|Death|2|||
130073337|NCT00770224|468222798|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
130073338|NCT00770224|468222799|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
129950459|NCT01441596|467781120|FG002|Overall Study|Other reason not defined below|1|||
129950460|NCT01441596|467781118|FG000|Overall Study|Withdrawal by Subject|4|||
129950461|NCT01441596|467781119|FG001|Overall Study|Withdrawal by Subject|0|||
129950462|NCT01441596|467781120|FG002|Overall Study|Withdrawal by Subject|2|||
129950463|NCT01441596|467781118|FG000|Overall Study|Not treated|0|||
129950464|NCT01441596|467781119|FG001|Overall Study|Not treated|1|||
129950465|NCT01441596|467781120|FG002|Overall Study|Not treated|1|||
129950466|NCT00871715|467781123|FG000|Overall Study|Withdrawal by Subject|6|||
129950467|NCT00871715|467781124|FG001|Overall Study|Withdrawal by Subject|10|||
129950468|NCT00871715|467781125|FG002|Overall Study|Withdrawal by Subject|15|||
129950469|NCT00871715|467781123|FG000|Overall Study|Physician Decision|6|||
129950470|NCT00871715|467781124|FG001|Overall Study|Physician Decision|0|||
129950471|NCT00871715|467781125|FG002|Overall Study|Physician Decision|2|||
129950472|NCT00871715|467781123|FG000|Overall Study|Lost to Follow-up|3|||
129950473|NCT00871715|467781124|FG001|Overall Study|Lost to Follow-up|6|||
129950474|NCT00871715|467781125|FG002|Overall Study|Lost to Follow-up|9|||
129950475|NCT03015220|467781128|FG000|Overall Study|Withdrawal by Subject|3|||
129950476|NCT03015220|467781129|FG001|Overall Study|Withdrawal by Subject|2|||
129950477|NCT03015220|467781130|FG002|Overall Study|Withdrawal by Subject|2|||
129950478|NCT03015220|467781131|FG003|Overall Study|Withdrawal by Subject|2|||
129950479|NCT03015220|467781128|FG000|Overall Study|Lost to Follow-up|0|||
129950480|NCT03015220|467781129|FG001|Overall Study|Lost to Follow-up|0|||
129950481|NCT03015220|467781130|FG002|Overall Study|Lost to Follow-up|1|||
129950482|NCT03015220|467781131|FG003|Overall Study|Lost to Follow-up|0|||
129950483|NCT01670526|467781133|FG000|Overall Study|Withdrawal by Subject|3|||
129950484|NCT01670526|467781134|FG001|Overall Study|Withdrawal by Subject|1|||
129950485|NCT01670526|467781133|FG000|Overall Study|Lost to Follow-up|9|||
129950486|NCT01670526|467781134|FG001|Overall Study|Lost to Follow-up|5|||
129950487|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
129950488|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
129950489|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
129950490|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
129950491|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
129950492|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
129950493|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
129950494|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
129950495|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
129950496|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
129950497|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
129950498|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
129950499|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
129950500|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
129950501|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
129950502|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
129950503|NCT01697956|467781139|FG000|Overall Study|Protocol Violation|1|||
129950504|NCT01697956|467781140|FG001|Overall Study|Protocol Violation|1|||
129950505|NCT01970527|467781141|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
129950506|NCT01970527|467781142|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
129950507|NCT01970527|467781141|FG000|Treatment|Disease progression|0|||
129950508|NCT01970527|467781142|FG001|Treatment|Disease progression|1|||
129950509|NCT01970527|467781141|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
129950510|NCT01970527|467781142|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
129950511|NCT01970527|467781141|FG000|Treatment|Death|0|||
129950512|NCT01970527|467781142|FG001|Treatment|Death|1|||
129950513|NCT01970527|467781141|FG000|Follow-up Clinic Visit|Disease progression|1|||
129950514|NCT01970527|467781142|FG001|Follow-up Clinic Visit|Disease progression|1|||
129950515|NCT01970527|467781141|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
129950516|NCT01970527|467781142|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
129950517|NCT01970527|467781141|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
129950518|NCT01970527|467781142|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
129950519|NCT01964547|467781143|FG000|Overall Study|Adverse Event|8|||
129950520|NCT01964547|467781144|FG001|Overall Study|Adverse Event|2|||
129950521|NCT01964547|467781143|FG000|Overall Study|Withdrawal by Subject|4|||
129950522|NCT01964547|467781144|FG001|Overall Study|Withdrawal by Subject|7|||
129950523|NCT01964547|467781143|FG000|Overall Study|Lost to Follow-up|0|||
129950524|NCT01964547|467781144|FG001|Overall Study|Lost to Follow-up|1|||
129950525|NCT01964547|467781143|FG000|Overall Study|Withdrawal by Investigator|0|||
130073339|NCT00770224|468222798|FG000|Step 2: Maintenance|Ineligible|0|||
130073340|NCT00770224|468222799|FG001|Step 2: Maintenance|Ineligible|2|||
129950526|NCT01964547|467781144|FG001|Overall Study|Withdrawal by Investigator|1|||
129950527|NCT01115309|467781145|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
129950528|NCT01115309|467781145|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
129950529|NCT01115309|467781145|FG000|Long-term Follow-up|Lost to Follow-up|6|||
129950530|NCT04447287|467781146|FG000|Period 1: Run-in Period|Adverse Event|3|||
129950531|NCT04447287|467781147|FG001|Period 1: Run-in Period|Adverse Event|0|||
130073341|NCT01040845|468222800|FG000|Overall Study|Withdrawal by Subject|1|||
130073342|NCT01040845|468222801|FG001|Overall Study|Withdrawal by Subject|1|||
130073343|NCT01040845|468222800|FG000|Overall Study|Physician Decision|1|||
130073344|NCT01040845|468222801|FG001|Overall Study|Physician Decision|0|||
130073345|NCT02260388|468222802|FG000|Overall Study|Lost to Follow-up|2|||
130073346|NCT02260388|468222803|FG001|Overall Study|Lost to Follow-up|8|||
130073347|NCT02260388|468222804|FG002|Overall Study|Lost to Follow-up|3|||
130073348|NCT02260388|468222805|FG003|Overall Study|Lost to Follow-up|4|||
130073349|NCT02959190|468222806|FG000|Open Label|Adverse Event|5|||
130073350|NCT02959190|468222807|FG001|Open Label|Adverse Event|7|||
130073351|NCT02959190|468222808|FG002|Open Label|Adverse Event|3|||
130073352|NCT02959190|468222809|FG003|Open Label|Adverse Event|4|||
130073353|NCT02959190|468222806|FG000|Open Label|Pregnancy|0|||
130073354|NCT02959190|468222807|FG001|Open Label|Pregnancy|1|||
130073355|NCT02959190|468222808|FG002|Open Label|Pregnancy|0|||
130073356|NCT02959190|468222809|FG003|Open Label|Pregnancy|0|||
130073357|NCT02959190|468222806|FG000|Open Label|Withdrawal by Subject|2|||
130073358|NCT02959190|468222807|FG001|Open Label|Withdrawal by Subject|8|||
130073359|NCT02959190|468222808|FG002|Open Label|Withdrawal by Subject|0|||
130073360|NCT02959190|468222809|FG003|Open Label|Withdrawal by Subject|0|||
130073361|NCT02959190|468222806|FG000|Open Label|Physician Decision|0|||
130073362|NCT02959190|468222807|FG001|Open Label|Physician Decision|0|||
130073363|NCT02959190|468222808|FG002|Open Label|Physician Decision|1|||
130073364|NCT02959190|468222809|FG003|Open Label|Physician Decision|0|||
130073365|NCT02959190|468222806|FG000|Open Label|Protocol Violation|0|||
130073366|NCT02959190|468222807|FG001|Open Label|Protocol Violation|0|||
130073367|NCT02959190|468222808|FG002|Open Label|Protocol Violation|0|||
130073368|NCT02959190|468222809|FG003|Open Label|Protocol Violation|2|||
130073369|NCT02959190|468222806|FG000|Post Treatment Follow Up|Adverse Event|1|||
130073370|NCT02959190|468222807|FG001|Post Treatment Follow Up|Adverse Event|1|||
130073371|NCT02959190|468222808|FG002|Post Treatment Follow Up|Adverse Event|0|||
130073372|NCT02959190|468222809|FG003|Post Treatment Follow Up|Adverse Event|0|||
130073373|NCT02959190|468222806|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
130073374|NCT02959190|468222807|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
130073375|NCT02959190|468222808|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
130073376|NCT02959190|468222809|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
130073377|NCT01235507|468222811|FG000|Overall Study|Adverse Event|1|||
130073378|NCT01235507|468222811|FG000|Overall Study|Withdrawal by Subject|1|||
130073379|NCT02228564|468222818|FG000|Overall Study|Withdrawal by Subject|10|||
130073380|NCT02228564|468222818|FG000|Overall Study|Death|11|||
130073381|NCT02228564|468222818|FG000|Overall Study|Physician Decision|5|||
130073382|NCT02228564|468222818|FG000|Overall Study|Lost to Follow-up|17|||
130073383|NCT02228564|468222818|FG000|Overall Study|Other|6|||
130073384|NCT02925312|468222821|FG000|Overall Study|Lost to Follow-up|25|||
130073385|NCT02925312|468222822|FG001|Overall Study|Lost to Follow-up|0|||
130073386|NCT02925312|468222821|FG000|Overall Study|Adverse Event|2|||
130073387|NCT02925312|468222822|FG001|Overall Study|Adverse Event|0|||
130073388|NCT02142504|468222823|FG000|Overall Study|Protocol Violation|2|||
130073389|NCT02142504|468222824|FG001|Overall Study|Protocol Violation|1|||
130073390|NCT02142504|468222825|FG002|Overall Study|Protocol Violation|2|||
130073391|NCT02142504|468222823|FG000|Overall Study|Adverse Event|2|||
130073392|NCT02142504|468222824|FG001|Overall Study|Adverse Event|3|||
130073393|NCT02142504|468222825|FG002|Overall Study|Adverse Event|4|||
130073394|NCT02142504|468222823|FG000|Overall Study|Lost to Follow-up|12|||
130073395|NCT02142504|468222824|FG001|Overall Study|Lost to Follow-up|19|||
130073396|NCT02142504|468222825|FG002|Overall Study|Lost to Follow-up|17|||
130073397|NCT02142504|468222823|FG000|Overall Study|Withdrawal by Subject|7|||
130073398|NCT02142504|468222824|FG001|Overall Study|Withdrawal by Subject|9|||
130120435|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
130120436|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
130120437|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
130073399|NCT02142504|468222825|FG002|Overall Study|Withdrawal by Subject|11|||
130073400|NCT02142504|468222823|FG000|Overall Study|Pregnancy|4|||
130073401|NCT02142504|468222824|FG001|Overall Study|Pregnancy|4|||
130073402|NCT02142504|468222825|FG002|Overall Study|Pregnancy|2|||
130073403|NCT02142504|468222823|FG000|Overall Study|Physician Decision|0|||
130073404|NCT02142504|468222824|FG001|Overall Study|Physician Decision|1|||
130073405|NCT02142504|468222825|FG002|Overall Study|Physician Decision|3|||
130073406|NCT02142504|468222823|FG000|Overall Study|Reason Not Specified|4|||
130073407|NCT02142504|468222824|FG001|Overall Study|Reason Not Specified|5|||
130073408|NCT02142504|468222825|FG002|Overall Study|Reason Not Specified|4|||
130073409|NCT01998399|468222826|FG000|Overall Study|Lost to Follow-up|1|||
130073410|NCT01998399|468222827|FG001|Overall Study|Lost to Follow-up|3|||
130073411|NCT01998399|468222826|FG000|Overall Study|Death|4|||
130073412|NCT01998399|468222827|FG001|Overall Study|Death|2|||
130073413|NCT01998399|468222826|FG000|Overall Study|Study stopped before dosing completed|3|||
130073414|NCT01998399|468222827|FG001|Overall Study|Study stopped before dosing completed|3|||
130073415|NCT01998399|468222826|FG000|Overall Study|Withdrawal by Subject|0|||
130073416|NCT01998399|468222827|FG001|Overall Study|Withdrawal by Subject|1|||
130073417|NCT04114539|468222831|FG000|Overall Study|Adverse Event|14|||
130120438|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
130073418|NCT04114539|468222831|FG000|Overall Study|Lost to Follow-up|2|||
130073419|NCT04114539|468222831|FG000|Overall Study|Non-compliance with Protocol|2|||
130073420|NCT04114539|468222831|FG000|Overall Study|Non-compliance with Study Drug|1|||
130073421|NCT04114539|468222831|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
130073422|NCT04114539|468222831|FG000|Overall Study|Withdrew consent|10|||
130073423|NCT04114539|468222831|FG000|Overall Study|Others not specified|5|||
130073424|NCT04114539|468222831|FG000|Overall Study|Investigator Decision|2|||
130073425|NCT00376246|468222832|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
130073426|NCT00376246|468222833|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
130073427|NCT00376246|468222832|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
130073428|NCT00376246|468222833|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130073429|NCT00376246|468222832|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
130073430|NCT00376246|468222833|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130073431|NCT01142193|468222839|FG000|Overall Study|Adverse Event|12|||
130073432|NCT01142193|468222840|FG001|Overall Study|Adverse Event|4|||
130073433|NCT01142193|468222839|FG000|Overall Study|Lack of Efficacy|2|||
130073434|NCT01142193|468222840|FG001|Overall Study|Lack of Efficacy|1|||
130073435|NCT01142193|468222839|FG000|Overall Study|Physician Decision|1|||
130073436|NCT01142193|468222840|FG001|Overall Study|Physician Decision|1|||
130073437|NCT01142193|468222839|FG000|Overall Study|Withdrawal by Subject|4|||
130073438|NCT01142193|468222840|FG001|Overall Study|Withdrawal by Subject|3|||
130073439|NCT01142193|468222839|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
130073440|NCT01142193|468222840|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
130073441|NCT01142193|468222839|FG000|Overall Study|Other|1|||
130073442|NCT01142193|468222840|FG001|Overall Study|Other|2|||
130073443|NCT03549429|468222843|FG000|Overall Study|Protocol Violation|5|||
130073444|NCT03549429|468222844|FG001|Overall Study|Protocol Violation|3|||
130073445|NCT01459068|468222845|FG000|Overall Study|Withdrawal by Subject|8|||
130073446|NCT01459068|468222846|FG001|Overall Study|Withdrawal by Subject|18|||
130073447|NCT01459068|468222845|FG000|Overall Study|Lost to Follow-up|31|||
130073448|NCT01459068|468222846|FG001|Overall Study|Lost to Follow-up|15|||
130073449|NCT01459068|468222845|FG000|Overall Study|Death|0|||
130073450|NCT01459068|468222846|FG001|Overall Study|Death|1|||
130073451|NCT00196196|468222849|FG000|Overall Study|Withdrawal by Subject|2|||
130073452|NCT00196196|468222849|FG000|Overall Study|Did not have required condition (hydroce|5|||
130073453|NCT01601470|468222850|FG000|Period 2 - LCZ696|Physician Decision|1|||
130073454|NCT01203787|468222851|FG000|Overall Study|Death|12|||
130073455|NCT01203787|468222852|FG001|Overall Study|Death|10|||
130073456|NCT01203787|468222851|FG000|Overall Study|Withdrawal by Subject|6|||
130073457|NCT01203787|468222852|FG001|Overall Study|Withdrawal by Subject|2|||
130073458|NCT01203787|468222851|FG000|Overall Study|Lost to Follow-up|2|||
130073459|NCT01203787|468222852|FG001|Overall Study|Lost to Follow-up|0|||
130073460|NCT01203787|468222851|FG000|Overall Study|Adverse Event|11|||
130073461|NCT01203787|468222852|FG001|Overall Study|Adverse Event|15|||
130073462|NCT03404518|468222853|FG000|Overall Study|Lost to Follow-up|28|||
130073463|NCT03404518|468222854|FG001|Overall Study|Lost to Follow-up|30|||
130073464|NCT03404518|468222853|FG000|Overall Study|Protocol Violation|13|||
130073465|NCT03404518|468222854|FG001|Overall Study|Protocol Violation|6|||
130073466|NCT01079195|468222855|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
130073467|NCT01079195|468222855|FG000|Overall Study|No Documentation Available|437|||
130073468|NCT01079195|468222855|FG000|Overall Study|Adverse Event|157|||
130073469|NCT01079195|468222855|FG000|Overall Study|Reason Unknown|39|||
130073470|NCT01079195|468222855|FG000|Overall Study|Withdrawal by Subject|18|||
130073471|NCT01079195|468222855|FG000|Overall Study|Financial Reasons|15|||
130073472|NCT01079195|468222855|FG000|Overall Study|Lack of Effectiveness|12|||
130073473|NCT01079195|468222855|FG000|Overall Study|Physician Decision|4|||
130073474|NCT01079195|468222855|FG000|Overall Study|Improved Status of Participant|4|||
130073475|NCT01079195|468222855|FG000|Overall Study|No Follow-up Documentation Available|4|||
130073476|NCT01079195|468222855|FG000|Overall Study|Non-compliance|2|||
130073477|NCT03693404|468222860|FG000|Overall Study|Withdrawal by Subject|1|||
130073478|NCT03693404|468222861|FG001|Overall Study|Withdrawal by Subject|0|||
130073479|NCT03693404|468222860|FG000|Overall Study|Lost to Follow-up|0|||
130120439|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
130120440|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
129950532|NCT04447287|467781148|FG002|Period 1: Run-in Period|Adverse Event|0|||
129950533|NCT04447287|467781146|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
130073480|NCT03693404|468222861|FG001|Overall Study|Lost to Follow-up|5|||
130073481|NCT03693404|468222860|FG000|Overall Study|Excluded from Analysis|0|||
130073482|NCT03693404|468222861|FG001|Overall Study|Excluded from Analysis|1|||
130073483|NCT02079519|468222862|FG000|Overall Study|Disease Progression|9|||
130073484|NCT02079519|468222862|FG000|Overall Study|Adverse Event|1|||
130073485|NCT01685203|468222864|FG000|Overall Study|Lost to Follow-up|3|||
130073486|NCT01685203|468222865|FG001|Overall Study|Lost to Follow-up|3|||
130073487|NCT01685203|468222866|FG002|Overall Study|Lost to Follow-up|0|||
130073488|NCT01685203|468222867|FG003|Overall Study|Lost to Follow-up|1|||
130073489|NCT01685203|468222868|FG004|Overall Study|Lost to Follow-up|0|||
130073490|NCT01685203|468222869|FG005|Overall Study|Lost to Follow-up|0|||
130073491|NCT01685203|468222870|FG006|Overall Study|Lost to Follow-up|0|||
130073492|NCT01685203|468222864|FG000|Overall Study|Adverse Event|0|||
130073493|NCT01685203|468222865|FG001|Overall Study|Adverse Event|0|||
130073494|NCT01685203|468222866|FG002|Overall Study|Adverse Event|0|||
130073495|NCT01685203|468222867|FG003|Overall Study|Adverse Event|0|||
130073496|NCT01685203|468222868|FG004|Overall Study|Adverse Event|0|||
130073497|NCT01685203|468222869|FG005|Overall Study|Adverse Event|2|||
130073498|NCT01685203|468222870|FG006|Overall Study|Adverse Event|0|||
130073499|NCT01685203|468222864|FG000|Overall Study|Adverse event and withdrew consent|1|||
130073500|NCT01685203|468222865|FG001|Overall Study|Adverse event and withdrew consent|0|||
130073501|NCT01685203|468222866|FG002|Overall Study|Adverse event and withdrew consent|0|||
130073502|NCT01685203|468222867|FG003|Overall Study|Adverse event and withdrew consent|0|||
130073503|NCT01685203|468222868|FG004|Overall Study|Adverse event and withdrew consent|0|||
130073504|NCT01685203|468222869|FG005|Overall Study|Adverse event and withdrew consent|0|||
130073505|NCT01685203|468222870|FG006|Overall Study|Adverse event and withdrew consent|0|||
130073506|NCT01685203|468222864|FG000|Overall Study|Patient's decision|0|||
130073507|NCT01685203|468222865|FG001|Overall Study|Patient's decision|0|||
130073508|NCT01685203|468222866|FG002|Overall Study|Patient's decision|0|||
130073509|NCT01685203|468222867|FG003|Overall Study|Patient's decision|0|||
130073510|NCT01685203|468222868|FG004|Overall Study|Patient's decision|0|||
130073511|NCT01685203|468222869|FG005|Overall Study|Patient's decision|1|||
130073512|NCT01685203|468222870|FG006|Overall Study|Patient's decision|0|||
130073513|NCT00318370|468222871|FG000|Period 1|Lack of Efficacy|5|||
130073514|NCT00318370|468222872|FG001|Period 1|Lack of Efficacy|0|||
130073515|NCT00318370|468222873|FG002|Period 1|Lack of Efficacy|0|||
130073516|NCT00318370|468222871|FG000|Period 1|Physician Decision|1|||
130073517|NCT00318370|468222872|FG001|Period 1|Physician Decision|0|||
130073518|NCT00318370|468222873|FG002|Period 1|Physician Decision|0|||
130073519|NCT00318370|468222871|FG000|Period 1|Withdrawal by Subject|1|||
130073520|NCT00318370|468222872|FG001|Period 1|Withdrawal by Subject|0|||
130073521|NCT00318370|468222873|FG002|Period 1|Withdrawal by Subject|0|||
130073522|NCT00318370|468222871|FG000|Period 2|Adverse Event|0|||
130073523|NCT00318370|468222872|FG001|Period 2|Adverse Event|3|||
130073524|NCT00318370|468222873|FG002|Period 2|Adverse Event|0|||
130073525|NCT00318370|468222871|FG000|Period 2|Lack of Efficacy|0|||
130073526|NCT00318370|468222872|FG001|Period 2|Lack of Efficacy|5|||
130073527|NCT00318370|468222873|FG002|Period 2|Lack of Efficacy|0|||
130073528|NCT00318370|468222871|FG000|Period 2|Physician Decision|0|||
130073529|NCT00318370|468222872|FG001|Period 2|Physician Decision|1|||
130073530|NCT00318370|468222873|FG002|Period 2|Physician Decision|0|||
130073531|NCT00318370|468222871|FG000|Period 2|Withdrawal by Subject|0|||
130073532|NCT00318370|468222872|FG001|Period 2|Withdrawal by Subject|1|||
130073533|NCT00318370|468222873|FG002|Period 2|Withdrawal by Subject|0|||
130073534|NCT00318370|468222871|FG000|Period 2|Other|0|||
130073535|NCT00318370|468222872|FG001|Period 2|Other|1|||
130073536|NCT00318370|468222873|FG002|Period 2|Other|0|||
130073537|NCT00318370|468222871|FG000|Period 3|Adverse Event|0|||
130073538|NCT00318370|468222872|FG001|Period 3|Adverse Event|0|||
130073539|NCT00318370|468222873|FG002|Period 3|Adverse Event|1|||
130073540|NCT00318370|468222871|FG000|Period 3|Lack of Efficacy|0|||
130073541|NCT00318370|468222872|FG001|Period 3|Lack of Efficacy|0|||
130073542|NCT00318370|468222873|FG002|Period 3|Lack of Efficacy|24|||
130073543|NCT00318370|468222871|FG000|Period 3|Death|0|||
130073544|NCT00318370|468222872|FG001|Period 3|Death|0|||
130073545|NCT00318370|468222873|FG002|Period 3|Death|1|||
130073546|NCT00318370|468222871|FG000|Period 3|Physician Decision|0|||
130073547|NCT00318370|468222872|FG001|Period 3|Physician Decision|0|||
130073548|NCT00318370|468222873|FG002|Period 3|Physician Decision|1|||
130073549|NCT00318370|468222871|FG000|Period 3|Withdrawal by Subject|0|||
130073550|NCT00318370|468222872|FG001|Period 3|Withdrawal by Subject|0|||
130073551|NCT00318370|468222873|FG002|Period 3|Withdrawal by Subject|3|||
130073552|NCT00318370|468222871|FG000|Period 3|Other|0|||
130073553|NCT00318370|468222872|FG001|Period 3|Other|0|||
130073554|NCT00318370|468222873|FG002|Period 3|Other|3|||
130120441|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
130073555|NCT01750840|468222874|FG000|Overall Study|Lost to Follow-up|4|||
130073556|NCT03565991|468224632|FG000|Overall Study|Other|11|||
130073557|NCT03565991|468224633|FG001|Overall Study|Other|0|||
130073558|NCT03565991|468224632|FG000|Overall Study|Global deterioration of health status|14|||
130073559|NCT03565991|468224633|FG001|Overall Study|Global deterioration of health status|4|||
130073560|NCT03565991|468224632|FG000|Overall Study|Withdrawal by Subject|2|||
130073561|NCT03565991|468224633|FG001|Overall Study|Withdrawal by Subject|6|||
130073562|NCT03565991|468224632|FG000|Overall Study|Progressive disease|121|||
130073563|NCT03565991|468224633|FG001|Overall Study|Progressive disease|29|||
130073564|NCT03565991|468224632|FG000|Overall Study|Death|3|||
130073565|NCT03565991|468224633|FG001|Overall Study|Death|0|||
130073566|NCT03565991|468224632|FG000|Overall Study|Adverse Event|7|||
130073567|NCT03565991|468224633|FG001|Overall Study|Adverse Event|2|||
130073568|NCT00784459|468224634|FG000|Overall Study|Adverse Event|0|||
130073569|NCT00784459|468224635|FG001|Overall Study|Adverse Event|2|||
130073570|NCT02741310|468224648|FG000|Overall Study|Sponsor Decision|2|||
130073571|NCT02741310|468224649|FG001|Overall Study|Sponsor Decision|2|||
130073572|NCT00239356|468224650|FG000|Overall Study|Lack of Efficacy|1|||
130073573|NCT00239356|468224651|FG001|Overall Study|Lack of Efficacy|0|||
130073574|NCT00239356|468224650|FG000|Overall Study|Adverse Event|6|||
130073575|NCT00239356|468224651|FG001|Overall Study|Adverse Event|0|||
130073576|NCT00239356|468224650|FG000|Overall Study|Withdrawal by Subject|15|||
130073577|NCT00239356|468224651|FG001|Overall Study|Withdrawal by Subject|6|||
130073578|NCT00239356|468224650|FG000|Overall Study|Lost to Follow-up|3|||
130073579|NCT00239356|468224651|FG001|Overall Study|Lost to Follow-up|0|||
130073580|NCT00239356|468224650|FG000|Overall Study|poor/non-compliance|2|||
130073581|NCT00239356|468224651|FG001|Overall Study|poor/non-compliance|0|||
130073582|NCT00239356|468224650|FG000|Overall Study|Pregnancy|1|||
130073583|NCT00239356|468224651|FG001|Overall Study|Pregnancy|0|||
130073584|NCT00239356|468224650|FG000|Overall Study|Administrative reason|0|||
130073585|NCT00239356|468224651|FG001|Overall Study|Administrative reason|1|||
130073586|NCT00239356|468224650|FG000|Overall Study|Drug available on market|11|||
130073587|NCT00239356|468224651|FG001|Overall Study|Drug available on market|2|||
130073588|NCT02044822|468224652|FG000|Overall Study|Study Terminated by Sponsor|77|||
130073589|NCT02044822|468224652|FG000|Overall Study|Investigator's Discretion|10|||
130073590|NCT02044822|468224652|FG000|Overall Study|Withdrew Consent|3|||
130073591|NCT02044822|468224652|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
130073592|NCT02044822|468224652|FG000|Overall Study|Lost to Follow-up|1|||
130073593|NCT03417505|468224655|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
130073594|NCT03417505|468224656|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
130073595|NCT01237223|468224663|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
130073596|NCT01237223|468224664|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130073597|NCT01237223|468224665|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130073598|NCT01237223|468224666|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130073599|NCT01237223|468224667|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130073600|NCT01237223|468224668|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
130073601|NCT01237223|468224663|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
130073602|NCT01237223|468224664|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130073603|NCT01237223|468224665|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130073604|NCT01237223|468224666|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130073605|NCT01237223|468224667|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130073606|NCT01237223|468224668|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
130073607|NCT01237223|468224663|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
130073608|NCT01237223|468224664|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130073609|NCT01237223|468224665|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130073610|NCT01237223|468224666|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130073611|NCT01237223|468224667|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130073612|NCT01237223|468224668|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
130073613|NCT01237223|468224663|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
130073614|NCT01237223|468224664|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130073615|NCT01237223|468224665|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130073616|NCT01237223|468224666|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130073617|NCT01237223|468224667|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130073618|NCT01237223|468224668|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
130073619|NCT01237223|468224663|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
130073620|NCT01237223|468224664|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130073621|NCT01237223|468224665|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130073622|NCT01237223|468224666|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130073623|NCT01237223|468224667|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130073624|NCT01237223|468224668|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
130073625|NCT01237223|468224663|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
130073626|NCT01237223|468224664|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
130073627|NCT01237223|468224665|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
130073628|NCT01237223|468224666|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
130073629|NCT01237223|468224667|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
130073630|NCT01237223|468224668|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
130073631|NCT01237223|468224663|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
130073632|NCT01237223|468224664|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
130073633|NCT01237223|468224665|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
129950534|NCT04447287|467781147|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
130073634|NCT01237223|468224666|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
130073635|NCT01237223|468224667|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
130073636|NCT01237223|468224668|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
130073637|NCT01237223|468224663|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
130073638|NCT01237223|468224664|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
130073639|NCT01237223|468224665|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
130073640|NCT01237223|468224666|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
130073641|NCT01237223|468224667|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
130073642|NCT01237223|468224668|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
130073643|NCT01237223|468224663|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130073644|NCT01237223|468224664|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130073645|NCT01237223|468224665|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130073646|NCT01237223|468224666|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130073647|NCT01237223|468224667|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
130073648|NCT01237223|468224668|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
130073649|NCT01237223|468224663|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
130073650|NCT01237223|468224664|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130073651|NCT01237223|468224665|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130073652|NCT01237223|468224666|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
130073653|NCT01237223|468224667|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130073654|NCT01237223|468224668|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
130073655|NCT00443846|468224673|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
130073656|NCT00443846|468224674|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
130073657|NCT00443846|468224673|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
130073658|NCT00443846|468224674|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
130073659|NCT00443846|468224673|FG000|Overall Study|Adverse Event|0|||
130073660|NCT00443846|468224674|FG001|Overall Study|Adverse Event|1|||
130073661|NCT00443846|468224673|FG000|Overall Study|Personal reason|8|||
130073662|NCT00443846|468224674|FG001|Overall Study|Personal reason|3|||
130073663|NCT00443846|468224673|FG000|Overall Study|Lost to Follow-up|1|||
130073664|NCT00443846|468224674|FG001|Overall Study|Lost to Follow-up|2|||
130073665|NCT01266070|468224675|FG000|Overall Study|Adverse Event|3|||
130073666|NCT01266070|468224675|FG000|Overall Study|Protocol Violation|1|||
130073667|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
130073668|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
130073669|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
130073670|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
130073671|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
130073672|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130073673|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
130073674|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130073675|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130073676|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
130073677|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130073678|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
130073679|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130073680|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130073681|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
130073682|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
130073683|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
130073684|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
130073685|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
130073686|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
130073687|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
130073688|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
130073689|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
130073690|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
130073691|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
130073692|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
130073693|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
130073694|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
130073695|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
130073696|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
130073697|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
130120442|NCT02579096|468402373|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
130120443|NCT02579096|468402374|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
130120444|NCT02275364|468402375|FG000|Period 1|Withdrawal by Subject|1|||
129950535|NCT04447287|467781148|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
129950536|NCT04447287|467781146|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
129950537|NCT04447287|467781147|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
129950538|NCT04447287|467781148|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
129950539|NCT02147093|467781151|FG000|Period 1|Lost to Follow-up|0|||
129950540|NCT02147093|467781152|FG001|Period 1|Lost to Follow-up|1|||
129950541|NCT02147093|467781151|FG000|Period 2|Protocol Violation|2|||
129950542|NCT02147093|467781152|FG001|Period 2|Protocol Violation|0|||
129950543|NCT03246724|467781153|FG000|Overall Study|Withdrawal by Subject|5|||
129950544|NCT03246724|467781154|FG001|Overall Study|Withdrawal by Subject|2|||
129950545|NCT03246724|467781155|FG002|Overall Study|Withdrawal by Subject|4|||
129950546|NCT03246724|467781156|FG003|Overall Study|Withdrawal by Subject|2|||
129950547|NCT03246724|467781153|FG000|Overall Study|Ineligible on day of surgery|7|||
129950548|NCT03246724|467781154|FG001|Overall Study|Ineligible on day of surgery|2|||
129950549|NCT03246724|467781155|FG002|Overall Study|Ineligible on day of surgery|0|||
129950550|NCT03246724|467781156|FG003|Overall Study|Ineligible on day of surgery|3|||
129950551|NCT03246724|467781153|FG000|Overall Study|Study completed before surgical date|2|||
129950552|NCT03246724|467781154|FG001|Overall Study|Study completed before surgical date|1|||
129950553|NCT03246724|467781155|FG002|Overall Study|Study completed before surgical date|8|||
129950554|NCT03246724|467781156|FG003|Overall Study|Study completed before surgical date|1|||
129950555|NCT03246724|467781153|FG000|Overall Study|Transferred to other arm|0|||
129950556|NCT03246724|467781154|FG001|Overall Study|Transferred to other arm|0|||
129950557|NCT03246724|467781155|FG002|Overall Study|Transferred to other arm|1|||
129950558|NCT03246724|467781156|FG003|Overall Study|Transferred to other arm|0|||
129950559|NCT03246724|467781153|FG000|Overall Study|Unable to obtain medication timely|0|||
129950560|NCT03246724|467781154|FG001|Overall Study|Unable to obtain medication timely|2|||
129950561|NCT03246724|467781155|FG002|Overall Study|Unable to obtain medication timely|2|||
129950562|NCT03246724|467781156|FG003|Overall Study|Unable to obtain medication timely|1|||
129950563|NCT03246724|467781153|FG000|Overall Study|Re-consented to participate|0|||
129950564|NCT03246724|467781154|FG001|Overall Study|Re-consented to participate|0|||
129950565|NCT03246724|467781155|FG002|Overall Study|Re-consented to participate|0|||
129950566|NCT03246724|467781156|FG003|Overall Study|Re-consented to participate|1|||
129950567|NCT00655824|467781157|FG000|Overall Study|Adverse Event|3|||
129950568|NCT00655824|467781157|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
129950569|NCT00655824|467781157|FG000|Overall Study|Protocol Violation|1|||
129950570|NCT00655824|467781157|FG000|Overall Study|Withdrawal by Subject|4|||
129950571|NCT00655824|467781157|FG000|Overall Study|Deterioration of Trial Disease|2|||
129950572|NCT01662505|467781164|FG000|Overall Study|Progressive disease|6|||
129950573|NCT01662505|467781165|FG001|Overall Study|Progressive disease|1|||
129950574|NCT01662505|467781166|FG002|Overall Study|Progressive disease|5|||
129950575|NCT01662505|467781164|FG000|Overall Study|Refused cont. medication|0|||
129950576|NCT01662505|467781165|FG001|Overall Study|Refused cont. medication|0|||
129950577|NCT01662505|467781166|FG002|Overall Study|Refused cont. medication|1|||
129950578|NCT01662505|467781164|FG000|Overall Study|Not specified above|1|||
129950579|NCT01662505|467781165|FG001|Overall Study|Not specified above|3|||
129950580|NCT01662505|467781166|FG002|Overall Study|Not specified above|2|||
129950581|NCT02255474|467781167|FG000|Overall Study|Lost to Follow-up|1|||
129950582|NCT02255474|467781168|FG001|Overall Study|Lost to Follow-up|1|||
129950583|NCT02255474|467781169|FG002|Overall Study|Lost to Follow-up|3|||
129950584|NCT02255474|467781167|FG000|Overall Study|Withdrawal by Subject|1|||
129950585|NCT02255474|467781168|FG001|Overall Study|Withdrawal by Subject|1|||
129950586|NCT02255474|467781169|FG002|Overall Study|Withdrawal by Subject|0|||
129950587|NCT01229176|467781170|FG000|Overall Study|Withdrawal by Subject|0|||
129950588|NCT01229176|467781171|FG001|Overall Study|Withdrawal by Subject|0|||
129950589|NCT01229176|467781172|FG002|Overall Study|Withdrawal by Subject|0|||
129950590|NCT01229176|467781173|FG003|Overall Study|Withdrawal by Subject|1|||
129950591|NCT01229176|467781174|FG004|Overall Study|Withdrawal by Subject|1|||
129950592|NCT01229176|467781175|FG005|Overall Study|Withdrawal by Subject|1|||
129950593|NCT01229176|467781176|FG006|Overall Study|Withdrawal by Subject|0|||
129950594|NCT01229176|467781177|FG007|Overall Study|Withdrawal by Subject|1|||
129950595|NCT01229176|467781170|FG000|Overall Study|Lost to Follow-up|0|||
129950596|NCT01229176|467781171|FG001|Overall Study|Lost to Follow-up|3|||
129950597|NCT01229176|467781172|FG002|Overall Study|Lost to Follow-up|0|||
129950598|NCT01229176|467781173|FG003|Overall Study|Lost to Follow-up|0|||
129950599|NCT01229176|467781174|FG004|Overall Study|Lost to Follow-up|1|||
130073698|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
130073699|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
130073700|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
130073701|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
130073702|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
129950600|NCT01229176|467781175|FG005|Overall Study|Lost to Follow-up|1|||
129950601|NCT01229176|467781176|FG006|Overall Study|Lost to Follow-up|0|||
129950602|NCT01229176|467781177|FG007|Overall Study|Lost to Follow-up|2|||
130120445|NCT02275364|468402376|FG001|Period 1|Withdrawal by Subject|0|||
130073703|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
130073704|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
130073705|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
130073706|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
130073707|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
130073708|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
130073709|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
130073710|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
130073711|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
130073712|NCT03689972|468224676|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
130073713|NCT03689972|468224677|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
130073714|NCT03689972|468224678|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
130073715|NCT03689972|468224679|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
130073716|NCT03689972|468224680|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
130073717|NCT03689972|468224676|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130073718|NCT03689972|468224677|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130073719|NCT03689972|468224678|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
130073720|NCT03689972|468224679|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130073721|NCT03689972|468224680|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
130073722|NCT03689972|468224676|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130073723|NCT03689972|468224677|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130073724|NCT03689972|468224678|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
130073725|NCT03689972|468224679|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130073726|NCT03689972|468224680|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
130073727|NCT03689972|468224676|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130073728|NCT03689972|468224677|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130073729|NCT03689972|468224678|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
130073730|NCT03689972|468224679|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130073731|NCT03689972|468224680|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
130073732|NCT03689972|468224676|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
130073733|NCT03689972|468224677|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
130073734|NCT03689972|468224678|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
130073735|NCT03689972|468224679|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
130073736|NCT03689972|468224680|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
130073737|NCT03689972|468224676|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
130073738|NCT03689972|468224677|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
130073739|NCT03689972|468224678|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
130120446|NCT02275364|468402375|FG000|Period 1|Other reason|1|||
130073740|NCT03689972|468224679|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
130073741|NCT03689972|468224680|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
130073742|NCT03689972|468224676|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
130073743|NCT03689972|468224677|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
130073744|NCT03689972|468224678|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
130073745|NCT03689972|468224679|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
130073746|NCT03689972|468224680|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
130073747|NCT03689972|468224676|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130073748|NCT03689972|468224677|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130073749|NCT03689972|468224678|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130073750|NCT03689972|468224679|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
130073751|NCT03689972|468224680|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
130073752|NCT03689972|468224676|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
130073753|NCT03689972|468224677|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
130073754|NCT03689972|468224678|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
130073755|NCT03689972|468224679|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
130073756|NCT03689972|468224680|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
130073757|NCT03689972|468224676|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130073758|NCT03689972|468224677|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130073759|NCT03689972|468224678|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130073760|NCT03689972|468224679|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
130073761|NCT03689972|468224680|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
130073762|NCT01838213|468224681|FG000|Overall Study|Ineligible|166|||
130073763|NCT01838213|468224682|FG001|Overall Study|Ineligible|191|||
130120447|NCT02275364|468402376|FG001|Period 1|Other reason|0|||
129950603|NCT00882050|467781183|FG000|Overall Study|Physician Decision|1|||
129950604|NCT00882050|467781184|FG001|Overall Study|Physician Decision|0|||
130073764|NCT00990249|468224685|FG000|Overall Study|Disease Progression|8|||
130073765|NCT00990249|468224685|FG000|Overall Study|Non-Compliance|1|||
130073766|NCT00990249|468224685|FG000|Overall Study|Death|2|||
130073767|NCT00990249|468224685|FG000|Overall Study|Not treated|2|||
130073768|NCT01548417|468224686|FG000|Overall Study|Withdrawal by Subject|0|||
130073769|NCT01548417|468224687|FG001|Overall Study|Withdrawal by Subject|2|||
130073770|NCT04583969|468224688|FG000|Overall Study|Death|31|||
130073771|NCT04583969|468224689|FG001|Overall Study|Death|38|||
130073772|NCT04583969|468224688|FG000|Overall Study|Lost to Follow-up|16|||
130073773|NCT04583969|468224689|FG001|Overall Study|Lost to Follow-up|13|||
130073774|NCT04583969|468224688|FG000|Overall Study|Protocol Violation|1|||
130073775|NCT04583969|468224689|FG001|Overall Study|Protocol Violation|0|||
130073776|NCT04583969|468224688|FG000|Overall Study|Withdrawal by Subject|3|||
130073777|NCT04583969|468224689|FG001|Overall Study|Withdrawal by Subject|3|||
130073778|NCT04583969|468224688|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
130073779|NCT04583969|468224689|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
130073780|NCT04583969|468224688|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
130073781|NCT04583969|468224689|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
130073782|NCT04583969|468224688|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
130073783|NCT04583969|468224689|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
130073784|NCT04583969|468224688|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
130073785|NCT04583969|468224689|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
130073786|NCT04583969|468224688|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
130073787|NCT04583969|468224689|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
130073788|NCT04397796|468224690|FG000|Overall Study|Death|3|||
130073789|NCT04397796|468224691|FG001|Overall Study|Death|1|||
130073790|NCT02640755|468224692|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
130073791|NCT02640755|468224693|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
130073792|NCT02640755|468224692|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
130073793|NCT02640755|468224693|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
130073794|NCT02640755|468224692|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
130073795|NCT02640755|468224693|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
130073796|NCT01484561|468224705|FG000|Overall Study|Lack of Efficacy|3|||
130073797|NCT01484561|468224706|FG001|Overall Study|Lack of Efficacy|1|||
130073798|NCT01484561|468224705|FG000|Overall Study|Lost to Follow-up|1|||
130073799|NCT01484561|468224706|FG001|Overall Study|Lost to Follow-up|0|||
130073800|NCT01484561|468224705|FG000|Overall Study|Withdrawal by Subject|3|||
130073801|NCT01484561|468224706|FG001|Overall Study|Withdrawal by Subject|0|||
130073802|NCT01484561|468224705|FG000|Overall Study|Other|1|||
130073803|NCT01484561|468224706|FG001|Overall Study|Other|1|||
130073804|NCT01484561|468224705|FG000|Overall Study|Adverse Event|1|||
130073805|NCT01484561|468224706|FG001|Overall Study|Adverse Event|4|||
130073806|NCT03371251|468224715|FG000|Overall Study|Withdrawal by Subject|1|||
130073807|NCT03371251|468224716|FG001|Overall Study|Withdrawal by Subject|0|||
130073808|NCT03371251|468224717|FG002|Overall Study|Withdrawal by Subject|1|||
130073809|NCT03371251|468224718|FG003|Overall Study|Withdrawal by Subject|0|||
130073810|NCT03371251|468224719|FG004|Overall Study|Withdrawal by Subject|2|||
130073811|NCT03371251|468224720|FG005|Overall Study|Withdrawal by Subject|2|||
130073812|NCT03371251|468224715|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
130073813|NCT03371251|468224716|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
130073814|NCT03371251|468224717|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
130073815|NCT03371251|468224718|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
130073816|NCT03371251|468224719|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
130073817|NCT03371251|468224720|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
130073818|NCT03371251|468224715|FG000|Overall Study|Adverse Event|0|||
130073819|NCT03371251|468224716|FG001|Overall Study|Adverse Event|0|||
130073820|NCT03371251|468224717|FG002|Overall Study|Adverse Event|0|||
130073821|NCT03371251|468224718|FG003|Overall Study|Adverse Event|0|||
130073822|NCT03371251|468224719|FG004|Overall Study|Adverse Event|1|||
130073823|NCT03371251|468224720|FG005|Overall Study|Adverse Event|0|||
130073824|NCT03371251|468224715|FG000|Overall Study|Decision by Sponsor|0|||
130073825|NCT03371251|468224716|FG001|Overall Study|Decision by Sponsor|0|||
130073826|NCT03371251|468224717|FG002|Overall Study|Decision by Sponsor|0|||
130073827|NCT03371251|468224718|FG003|Overall Study|Decision by Sponsor|0|||
130073828|NCT03371251|468224719|FG004|Overall Study|Decision by Sponsor|2|||
130073829|NCT03371251|468224720|FG005|Overall Study|Decision by Sponsor|0|||
130073830|NCT00114218|468224721|FG000|Overall Study|Wrong Cell Type|2|||
130073831|NCT00114218|468224721|FG000|Overall Study|Wrong Primary|1|||
130073832|NCT00114218|468224721|FG000|Overall Study|Never Treated|1|||
130073833|NCT01505114|468224722|FG000|Overall Study|Withdrawal by Subject|5|||
130073834|NCT01505114|468224723|FG001|Overall Study|Withdrawal by Subject|4|||
130073835|NCT01505114|468224724|FG002|Overall Study|Withdrawal by Subject|4|||
129950605|NCT00882050|467781185|FG002|Overall Study|Physician Decision|0|||
129950606|NCT02367794|467781186|FG000|Overall Study|Death|252|||
129950607|NCT02367794|467781187|FG001|Overall Study|Death|245|||
129950608|NCT02367794|467781188|FG002|Overall Study|Death|243|||
129950609|NCT02367794|467781186|FG000|Overall Study|Lost to Follow-up|1|||
129950610|NCT02367794|467781187|FG001|Overall Study|Lost to Follow-up|2|||
129950611|NCT02367794|467781188|FG002|Overall Study|Lost to Follow-up|2|||
129950612|NCT02367794|467781186|FG000|Overall Study|Physician Decision|0|||
129950613|NCT02367794|467781187|FG001|Overall Study|Physician Decision|5|||
129950614|NCT02367794|467781188|FG002|Overall Study|Physician Decision|3|||
129950615|NCT02367794|467781186|FG000|Overall Study|Protocol Violation|1|||
129950616|NCT02367794|467781187|FG001|Overall Study|Protocol Violation|0|||
129950617|NCT02367794|467781188|FG002|Overall Study|Protocol Violation|1|||
129950618|NCT02367794|467781186|FG000|Overall Study|Withdrawal by Subject|25|||
129950619|NCT02367794|467781187|FG001|Overall Study|Withdrawal by Subject|12|||
129950620|NCT02367794|467781188|FG002|Overall Study|Withdrawal by Subject|20|||
129950621|NCT02367794|467781186|FG000|Overall Study|Brain metastasis|1|||
129950622|NCT02367794|467781187|FG001|Overall Study|Brain metastasis|0|||
129950623|NCT02367794|467781188|FG002|Overall Study|Brain metastasis|0|||
129950624|NCT02367794|467781186|FG000|Overall Study|Randomized in error|0|||
129950625|NCT02367794|467781187|FG001|Overall Study|Randomized in error|0|||
129950626|NCT02367794|467781188|FG002|Overall Study|Randomized in error|1|||
129950627|NCT02367794|467781186|FG000|Overall Study|Patient unable to receive carboplatin|0|||
129950628|NCT02367794|467781187|FG001|Overall Study|Patient unable to receive carboplatin|0|||
129950629|NCT02367794|467781188|FG002|Overall Study|Patient unable to receive carboplatin|1|||
129950630|NCT02367794|467781186|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
129950631|NCT02367794|467781187|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
129950632|NCT02367794|467781188|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
129950633|NCT02367794|467781186|FG000|Overall Study|Adverse Event|0|||
129950634|NCT02367794|467781187|FG001|Overall Study|Adverse Event|0|||
129950635|NCT02367794|467781188|FG002|Overall Study|Adverse Event|2|||
129950636|NCT02367794|467781186|FG000|Overall Study|Study Terminated By Sponsor|0|||
129950637|NCT02367794|467781187|FG001|Overall Study|Study Terminated By Sponsor|1|||
129950638|NCT02367794|467781188|FG002|Overall Study|Study Terminated By Sponsor|1|||
129950639|NCT02367794|467781186|FG000|Overall Study|Moved to Roll-Over Study|0|||
129950640|NCT02367794|467781187|FG001|Overall Study|Moved to Roll-Over Study|15|||
129950641|NCT02367794|467781188|FG002|Overall Study|Moved to Roll-Over Study|13|||
129950642|NCT02367794|467781186|FG000|Overall Study|Sponsor Request|60|||
129950643|NCT02367794|467781187|FG001|Overall Study|Sponsor Request|57|||
129950644|NCT02367794|467781188|FG002|Overall Study|Sponsor Request|45|||
129950645|NCT02367794|467781186|FG000|Overall Study|Moved into PTAP Study|0|||
129950646|NCT02367794|467781187|FG001|Overall Study|Moved into PTAP Study|2|||
129950647|NCT02367794|467781188|FG002|Overall Study|Moved into PTAP Study|3|||
129950648|NCT02367794|467781186|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
129950649|NCT02367794|467781187|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
129950650|NCT02367794|467781188|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
129950651|NCT02367794|467781186|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
129950652|NCT02367794|467781187|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
129950653|NCT02367794|467781188|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
129950654|NCT02367794|467781186|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
129950655|NCT02367794|467781187|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
129950656|NCT02367794|467781188|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
129950657|NCT02367794|467781186|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
129950658|NCT02367794|467781187|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
129950659|NCT02367794|467781188|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
129950660|NCT02010684|467781189|FG000|Overall Study|Lost to Follow-up|8|||
129950661|NCT02010684|467781190|FG001|Overall Study|Lost to Follow-up|18|||
129950662|NCT02010684|467781189|FG000|Overall Study|Withdrawal by Subject|4|||
129950663|NCT02010684|467781190|FG001|Overall Study|Withdrawal by Subject|5|||
129950664|NCT00091572|467781195|FG000|Overall Study|Lost to Follow-up|1|||
129950665|NCT00091572|467781196|FG001|Overall Study|Lost to Follow-up|1|||
129950666|NCT00091572|467781195|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
129950667|NCT00091572|467781196|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
129950668|NCT00091572|467781195|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
129950669|NCT00091572|467781196|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
129950670|NCT00091572|467781195|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
129950671|NCT00091572|467781196|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
129950672|NCT00091572|467781195|FG000|Overall Study|Other Reason|6|||
129950673|NCT00091572|467781196|FG001|Overall Study|Other Reason|13|||
129950674|NCT00091572|467781195|FG000|Overall Study|Ongoing (still on treatment)|8|||
129950675|NCT00091572|467781196|FG001|Overall Study|Ongoing (still on treatment)|12|||
129950676|NCT00091572|467781195|FG000|Overall Study|Major Protocol Violation|2|||
130073836|NCT01505114|468224725|FG003|Overall Study|Withdrawal by Subject|7|||
130073837|NCT01505114|468224722|FG000|Overall Study|Death|1|||
130073838|NCT01505114|468224723|FG001|Overall Study|Death|0|||
129950677|NCT00091572|467781196|FG001|Overall Study|Major Protocol Violation|0|||
129950678|NCT00091572|467781195|FG000|Overall Study|Toxicity (Related AE)|53|||
129950679|NCT00091572|467781196|FG001|Overall Study|Toxicity (Related AE)|9|||
129950680|NCT02942771|467781198|FG000|Overall Study|Adverse Event|1|||
129950681|NCT02942771|467781199|FG001|Overall Study|Adverse Event|0|||
129950682|NCT02942771|467781200|FG002|Overall Study|Adverse Event|0|||
129950683|NCT02942771|467781201|FG003|Overall Study|Adverse Event|0|||
129950684|NCT02942771|467781202|FG004|Overall Study|Adverse Event|2|||
129950685|NCT02942771|467781198|FG000|Overall Study|Lost to Follow-up|1|||
129950686|NCT02942771|467781199|FG001|Overall Study|Lost to Follow-up|0|||
129950687|NCT02942771|467781200|FG002|Overall Study|Lost to Follow-up|0|||
129950688|NCT02942771|467781201|FG003|Overall Study|Lost to Follow-up|0|||
129950689|NCT02942771|467781202|FG004|Overall Study|Lost to Follow-up|0|||
129950690|NCT02942771|467781198|FG000|Overall Study|Withdrawal by Subject|1|||
129950691|NCT02942771|467781199|FG001|Overall Study|Withdrawal by Subject|0|||
129950692|NCT02942771|467781200|FG002|Overall Study|Withdrawal by Subject|0|||
129950693|NCT02942771|467781201|FG003|Overall Study|Withdrawal by Subject|0|||
129950694|NCT02942771|467781202|FG004|Overall Study|Withdrawal by Subject|2|||
129950695|NCT01186809|467781206|FG000|Overall Study|Death|30|||
129950696|NCT04895085|467781207|FG000|Overall Study|Death|1|||
129950697|NCT04895085|467781207|FG000|Overall Study|Withdrawal by Subject|1|||
129950698|NCT04895085|467781207|FG000|Overall Study|No longer eligible: Moved from area|1|||
129950699|NCT01159600|467781212|FG000|Overall Study|Not treated|0|||
129950700|NCT01159600|467781213|FG001|Overall Study|Not treated|0|||
129950701|NCT01159600|467781214|FG002|Overall Study|Not treated|1|||
129950702|NCT01159600|467781215|FG003|Overall Study|Not treated|0|||
129950703|NCT01159600|467781216|FG004|Overall Study|Not treated|0|||
129950704|NCT01159600|467781217|FG005|Overall Study|Not treated|1|||
129950705|NCT01159600|467781218|FG006|Overall Study|Not treated|2|||
129950706|NCT01159600|467781219|FG007|Overall Study|Not treated|2|||
129950707|NCT01159600|467781212|FG000|Overall Study|Adverse Event|7|||
129950708|NCT01159600|467781213|FG001|Overall Study|Adverse Event|2|||
129950709|NCT01159600|467781214|FG002|Overall Study|Adverse Event|5|||
129950710|NCT01159600|467781215|FG003|Overall Study|Adverse Event|1|||
129950711|NCT01159600|467781216|FG004|Overall Study|Adverse Event|8|||
129950712|NCT01159600|467781217|FG005|Overall Study|Adverse Event|6|||
129950713|NCT01159600|467781218|FG006|Overall Study|Adverse Event|7|||
129950714|NCT01159600|467781219|FG007|Overall Study|Adverse Event|5|||
129950715|NCT01159600|467781212|FG000|Overall Study|Lack of Efficacy|0|||
129950716|NCT01159600|467781213|FG001|Overall Study|Lack of Efficacy|0|||
129950717|NCT01159600|467781214|FG002|Overall Study|Lack of Efficacy|0|||
129950718|NCT01159600|467781215|FG003|Overall Study|Lack of Efficacy|0|||
129950719|NCT01159600|467781216|FG004|Overall Study|Lack of Efficacy|2|||
129950720|NCT01159600|467781217|FG005|Overall Study|Lack of Efficacy|0|||
129950721|NCT01159600|467781218|FG006|Overall Study|Lack of Efficacy|0|||
129950722|NCT01159600|467781219|FG007|Overall Study|Lack of Efficacy|1|||
129950723|NCT01159600|467781212|FG000|Overall Study|Non compliant with protocol|2|||
129950724|NCT01159600|467781213|FG001|Overall Study|Non compliant with protocol|1|||
129950725|NCT01159600|467781214|FG002|Overall Study|Non compliant with protocol|0|||
129950726|NCT01159600|467781215|FG003|Overall Study|Non compliant with protocol|0|||
129950727|NCT01159600|467781216|FG004|Overall Study|Non compliant with protocol|2|||
129950728|NCT01159600|467781217|FG005|Overall Study|Non compliant with protocol|0|||
129950729|NCT01159600|467781218|FG006|Overall Study|Non compliant with protocol|2|||
129950730|NCT01159600|467781219|FG007|Overall Study|Non compliant with protocol|0|||
129950731|NCT01159600|467781212|FG000|Overall Study|Lost to Follow-up|2|||
129950732|NCT01159600|467781213|FG001|Overall Study|Lost to Follow-up|3|||
129950733|NCT01159600|467781214|FG002|Overall Study|Lost to Follow-up|4|||
129950734|NCT01159600|467781215|FG003|Overall Study|Lost to Follow-up|3|||
129950735|NCT01159600|467781216|FG004|Overall Study|Lost to Follow-up|3|||
129950736|NCT01159600|467781217|FG005|Overall Study|Lost to Follow-up|0|||
129950737|NCT01159600|467781218|FG006|Overall Study|Lost to Follow-up|3|||
129950738|NCT01159600|467781219|FG007|Overall Study|Lost to Follow-up|2|||
129950739|NCT01159600|467781212|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
129950740|NCT01159600|467781213|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
129950741|NCT01159600|467781214|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
129950742|NCT01159600|467781215|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
129950743|NCT01159600|467781216|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
129950744|NCT01159600|467781217|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
129950745|NCT01159600|467781218|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
129950746|NCT01159600|467781219|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
129950747|NCT01159600|467781212|FG000|Overall Study|Other reason not defined above|3|||
129950748|NCT01159600|467781213|FG001|Overall Study|Other reason not defined above|0|||
129950749|NCT01159600|467781214|FG002|Overall Study|Other reason not defined above|4|||
130120448|NCT02097121|468402381|FG000|Overall Study|Other, not specified|4|||
129950750|NCT01159600|467781215|FG003|Overall Study|Other reason not defined above|2|||
129950751|NCT01159600|467781216|FG004|Overall Study|Other reason not defined above|5|||
129950752|NCT01159600|467781217|FG005|Overall Study|Other reason not defined above|7|||
130073839|NCT01505114|468224724|FG002|Overall Study|Death|0|||
130073840|NCT01505114|468224725|FG003|Overall Study|Death|1|||
130073841|NCT01505114|468224722|FG000|Overall Study|unable to adhere to visit schedule|3|||
130073842|NCT01505114|468224723|FG001|Overall Study|unable to adhere to visit schedule|2|||
130073843|NCT01505114|468224724|FG002|Overall Study|unable to adhere to visit schedule|3|||
130073844|NCT01505114|468224725|FG003|Overall Study|unable to adhere to visit schedule|3|||
130073845|NCT01505114|468224722|FG000|Overall Study|Lost to Follow-up|11|||
130073846|NCT01505114|468224723|FG001|Overall Study|Lost to Follow-up|5|||
130073847|NCT01505114|468224724|FG002|Overall Study|Lost to Follow-up|8|||
130073848|NCT01505114|468224725|FG003|Overall Study|Lost to Follow-up|7|||
130073849|NCT01505114|468224722|FG000|Overall Study|relocated|4|||
130073850|NCT01505114|468224723|FG001|Overall Study|relocated|2|||
130073851|NCT01505114|468224724|FG002|Overall Study|relocated|2|||
130073852|NCT01505114|468224725|FG003|Overall Study|relocated|3|||
130073853|NCT01505114|468224722|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
130073854|NCT01505114|468224723|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
130073855|NCT01505114|468224724|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
130073856|NCT01505114|468224725|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
130073857|NCT01505114|468224722|FG000|Overall Study|staff safety concerns|0|||
130073858|NCT01505114|468224723|FG001|Overall Study|staff safety concerns|0|||
130073859|NCT01505114|468224724|FG002|Overall Study|staff safety concerns|0|||
130073860|NCT01505114|468224725|FG003|Overall Study|staff safety concerns|1|||
130073861|NCT01505114|468224722|FG000|Overall Study|investigator decision|1|||
130073862|NCT01505114|468224723|FG001|Overall Study|investigator decision|0|||
130073863|NCT01505114|468224724|FG002|Overall Study|investigator decision|1|||
130073864|NCT01505114|468224725|FG003|Overall Study|investigator decision|0|||
130073865|NCT03168555|468224726|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
130073866|NCT03168555|468224726|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
130073867|NCT03168555|468224726|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
130073868|NCT03168555|468224726|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
130073869|NCT04445688|468224731|FG000|Washout (One Week)|Adverse Event|2|||
130073870|NCT04445688|468224731|FG000|Washout (One Week)|Withdrawal by Subject|1|||
130073871|NCT02017704|468224735|FG000|Overall Study|Withdrawal by Subject|2|||
130073872|NCT02017704|468224736|FG001|Overall Study|Withdrawal by Subject|0|||
130073873|NCT01587274|468224737|FG000|Overall Study|Lost to Follow-up|4|||
130073874|NCT01587274|468224738|FG001|Overall Study|Lost to Follow-up|5|||
130073875|NCT01587274|468224739|FG002|Overall Study|Lost to Follow-up|3|||
130073876|NCT00918346|468224740|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
130073877|NCT00918346|468224741|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
130073878|NCT02475629|468224742|FG000|Overall Study|Adverse Event|1|||
130073879|NCT02475629|468224742|FG000|Overall Study|Death|4|||
130073880|NCT02475629|468224742|FG000|Overall Study|Physician Decision|1|||
130073881|NCT02475629|468224742|FG000|Overall Study|Withdrawal by Subject|1|||
130073882|NCT02475629|468224742|FG000|Overall Study|Lost to Follow-up|1|||
130073883|NCT02475629|468224742|FG000|Overall Study|Subject non-compliance|1|||
130073884|NCT01000025|468224755|FG000|Overall Study|Adverse Event|43|||
130073885|NCT01000025|468224756|FG001|Overall Study|Adverse Event|2|||
130073886|NCT01000025|468224755|FG000|Overall Study|Withdrawal by Subject|13|||
130073887|NCT01000025|468224756|FG001|Overall Study|Withdrawal by Subject|8|||
130073888|NCT01000025|468224755|FG000|Overall Study|Death|23|||
130073889|NCT01000025|468224756|FG001|Overall Study|Death|13|||
130073890|NCT01000025|468224755|FG000|Overall Study|Lack of Efficacy|363|||
130073891|NCT01000025|468224756|FG001|Overall Study|Lack of Efficacy|208|||
130073892|NCT01000025|468224755|FG000|Overall Study|Intercurrent Illness|26|||
130073893|NCT01000025|468224756|FG001|Overall Study|Intercurrent Illness|7|||
130073894|NCT00422669|468224757|FG000|Overall Study|The study was terminated early.|98|||
130073895|NCT00422669|468224758|FG001|Overall Study|The study was terminated early.|100|||
130073896|NCT00422669|468224759|FG002|Overall Study|The study was terminated early.|7|||
130073897|NCT02738580|468224760|FG000|Overall Study|Adverse Event|1|||
130073898|NCT02738580|468224761|FG001|Overall Study|Adverse Event|0|||
130073899|NCT02738580|468224760|FG000|Overall Study|Lack of Efficacy|3|||
130073900|NCT02738580|468224761|FG001|Overall Study|Lack of Efficacy|2|||
130073901|NCT02738580|468224760|FG000|Overall Study|Withdrawal by Subject|0|||
130073902|NCT02738580|468224761|FG001|Overall Study|Withdrawal by Subject|1|||
130073903|NCT02738580|468224760|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
130073904|NCT02738580|468224761|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
130073905|NCT02565615|468224762|FG000|Overall Study|Death|0|||
130073906|NCT02565615|468224763|FG001|Overall Study|Death|1|||
130073907|NCT02565615|468224764|FG002|Overall Study|Death|0|||
130073908|NCT02565615|468224765|FG003|Overall Study|Death|0|||
130073909|NCT02565615|468224766|FG004|Overall Study|Death|4|||
130073910|NCT02565615|468224762|FG000|Overall Study|Not willing to participate in study|2|||
130073911|NCT02565615|468224763|FG001|Overall Study|Not willing to participate in study|21|||
129950753|NCT01159600|467781218|FG006|Overall Study|Other reason not defined above|3|||
130073912|NCT02565615|468224764|FG002|Overall Study|Not willing to participate in study|0|||
130073913|NCT02565615|468224765|FG003|Overall Study|Not willing to participate in study|1|||
129950754|NCT01159600|467781219|FG007|Overall Study|Other reason not defined above|3|||
129950755|NCT04433091|467781220|FG000|Overall Study|Lost to Follow-up|1|||
129950756|NCT04433091|467781221|FG001|Overall Study|Lost to Follow-up|0|||
129950757|NCT04433091|467781220|FG000|Overall Study|Withdrawn .|2|||
129950758|NCT04433091|467781221|FG001|Overall Study|Withdrawn .|4|||
129950759|NCT04097535|467781222|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
129950760|NCT04820023|467782934|FG000|Overall Study|Death|0|||
129950761|NCT04820023|467782935|FG001|Overall Study|Death|0|||
129950762|NCT04820023|467782936|FG002|Overall Study|Death|0|||
129950763|NCT04820023|467782937|FG003|Overall Study|Death|0|||
129950764|NCT04820023|467782938|FG004|Overall Study|Death|0|||
129950765|NCT04820023|467782939|FG005|Overall Study|Death|0|||
129950766|NCT04820023|467782940|FG006|Overall Study|Death|1|||
129950767|NCT04820023|467782941|FG007|Overall Study|Death|0|||
129950768|NCT04820023|467782942|FG008|Overall Study|Death|1|||
129950769|NCT04820023|467782934|FG000|Overall Study|Withdrawal by Subject|1|||
129950770|NCT04820023|467782935|FG001|Overall Study|Withdrawal by Subject|2|||
129950771|NCT04820023|467782936|FG002|Overall Study|Withdrawal by Subject|2|||
129950772|NCT04820023|467782937|FG003|Overall Study|Withdrawal by Subject|1|||
129950773|NCT04820023|467782938|FG004|Overall Study|Withdrawal by Subject|4|||
129950774|NCT04820023|467782939|FG005|Overall Study|Withdrawal by Subject|3|||
129950775|NCT04820023|467782940|FG006|Overall Study|Withdrawal by Subject|3|||
129950776|NCT04820023|467782941|FG007|Overall Study|Withdrawal by Subject|6|||
129950777|NCT04820023|467782942|FG008|Overall Study|Withdrawal by Subject|5|||
129950778|NCT04820023|467782934|FG000|Overall Study|Progressive Disease|3|||
129950779|NCT04820023|467782935|FG001|Overall Study|Progressive Disease|0|||
129950780|NCT04820023|467782936|FG002|Overall Study|Progressive Disease|2|||
129950781|NCT04820023|467782937|FG003|Overall Study|Progressive Disease|2|||
129950782|NCT04820023|467782938|FG004|Overall Study|Progressive Disease|2|||
129950783|NCT04820023|467782939|FG005|Overall Study|Progressive Disease|0|||
129950784|NCT04820023|467782940|FG006|Overall Study|Progressive Disease|1|||
129950785|NCT04820023|467782941|FG007|Overall Study|Progressive Disease|1|||
129950786|NCT04820023|467782942|FG008|Overall Study|Progressive Disease|0|||
129950787|NCT04820023|467782934|FG000|Overall Study|New anti-cancer therapy|0|||
129950788|NCT04820023|467782935|FG001|Overall Study|New anti-cancer therapy|0|||
129950789|NCT04820023|467782936|FG002|Overall Study|New anti-cancer therapy|0|||
129950790|NCT04820023|467782937|FG003|Overall Study|New anti-cancer therapy|0|||
129950791|NCT04820023|467782938|FG004|Overall Study|New anti-cancer therapy|2|||
129950792|NCT04820023|467782939|FG005|Overall Study|New anti-cancer therapy|0|||
129950793|NCT04820023|467782940|FG006|Overall Study|New anti-cancer therapy|0|||
129950794|NCT04820023|467782941|FG007|Overall Study|New anti-cancer therapy|0|||
129950795|NCT04820023|467782942|FG008|Overall Study|New anti-cancer therapy|0|||
129950796|NCT04820023|467782934|FG000|Overall Study|Other|0|||
129950797|NCT04820023|467782935|FG001|Overall Study|Other|1|||
129950798|NCT04820023|467782936|FG002|Overall Study|Other|0|||
129950799|NCT04820023|467782937|FG003|Overall Study|Other|0|||
129950800|NCT04820023|467782938|FG004|Overall Study|Other|0|||
129950801|NCT04820023|467782939|FG005|Overall Study|Other|0|||
129950802|NCT04820023|467782940|FG006|Overall Study|Other|0|||
129950803|NCT04820023|467782941|FG007|Overall Study|Other|2|||
129950804|NCT04820023|467782942|FG008|Overall Study|Other|0|||
129950805|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
129950806|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
129950807|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
130120449|NCT02097121|468402382|FG001|Overall Study|Other, not specified|2|||
130120450|NCT02097121|468402383|FG002|Overall Study|Other, not specified|3|||
130120451|NCT02097121|468402381|FG000|Overall Study|Lack of Efficacy|2|||
130120452|NCT02097121|468402382|FG001|Overall Study|Lack of Efficacy|1|||
130120453|NCT02097121|468402383|FG002|Overall Study|Lack of Efficacy|3|||
130120454|NCT02097121|468402381|FG000|Overall Study|Withdrawal by Subject|0|||
130120455|NCT02097121|468402382|FG001|Overall Study|Withdrawal by Subject|1|||
129950808|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
129950809|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
129950810|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
129950811|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
129950812|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
129950813|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
129950814|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
129950815|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
129950816|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
129950817|NCT01020487|467782943|FG000|Part 2 Open-label Period|Adverse Event|0|||
129950818|NCT01020487|467782944|FG001|Part 2 Open-label Period|Adverse Event|4|||
129950819|NCT01020487|467782945|FG002|Part 2 Open-label Period|Adverse Event|1|||
129950820|NCT02400749|467782948|FG000|Week 0 -16|Withdrawal by Subject|5|||
129950821|NCT02400749|467782949|FG001|Week 0 -16|Withdrawal by Subject|5|||
130120456|NCT02097121|468402383|FG002|Overall Study|Withdrawal by Subject|2|||
130073914|NCT02565615|468224766|FG004|Overall Study|Not willing to participate in study|169|||
130073915|NCT02565615|468224762|FG000|Overall Study|Lost to Follow-up|0|||
130073916|NCT02565615|468224763|FG001|Overall Study|Lost to Follow-up|4|||
130073917|NCT02565615|468224764|FG002|Overall Study|Lost to Follow-up|0|||
130073918|NCT02565615|468224765|FG003|Overall Study|Lost to Follow-up|1|||
130073919|NCT02565615|468224766|FG004|Overall Study|Lost to Follow-up|765|||
130073920|NCT02565615|468224762|FG000|Overall Study|Not meeting eligibility criteria|0|||
130073921|NCT02565615|468224763|FG001|Overall Study|Not meeting eligibility criteria|7|||
130073922|NCT02565615|468224764|FG002|Overall Study|Not meeting eligibility criteria|0|||
130073923|NCT02565615|468224765|FG003|Overall Study|Not meeting eligibility criteria|0|||
130073924|NCT02565615|468224766|FG004|Overall Study|Not meeting eligibility criteria|25|||
130073925|NCT02565615|468224762|FG000|Overall Study|Reason not defined|0|||
130073926|NCT02565615|468224763|FG001|Overall Study|Reason not defined|2|||
130073927|NCT02565615|468224764|FG002|Overall Study|Reason not defined|0|||
130073928|NCT02565615|468224765|FG003|Overall Study|Reason not defined|1|||
130073929|NCT02565615|468224766|FG004|Overall Study|Reason not defined|62|||
130073930|NCT02565615|468224762|FG000|Overall Study|Adverse Event|1|||
130073931|NCT02565615|468224763|FG001|Overall Study|Adverse Event|1|||
130073932|NCT02565615|468224764|FG002|Overall Study|Adverse Event|0|||
130073933|NCT02565615|468224765|FG003|Overall Study|Adverse Event|0|||
130073934|NCT02565615|468224766|FG004|Overall Study|Adverse Event|9|||
130073935|NCT02565615|468224762|FG000|Overall Study|Untreated|0|||
130073936|NCT02565615|468224763|FG001|Overall Study|Untreated|0|||
130073937|NCT02565615|468224764|FG002|Overall Study|Untreated|0|||
130073938|NCT02565615|468224765|FG003|Overall Study|Untreated|0|||
130073939|NCT02565615|468224766|FG004|Overall Study|Untreated|567|||
130073940|NCT01250756|468224770|FG000|Infant Series|Withdrawal by Subject|4|||
130073941|NCT01250756|468224771|FG001|Infant Series|Withdrawal by Subject|5|||
130073942|NCT01250756|468224770|FG000|Infant Series|Randomized, Not Vaccinated|2|||
130073943|NCT01250756|468224771|FG001|Infant Series|Randomized, Not Vaccinated|2|||
130073944|NCT01250756|468224770|FG000|Infant Series|Other|22|||
130073945|NCT01250756|468224771|FG001|Infant Series|Other|0|||
130073946|NCT01250756|468224770|FG000|After Infant Series|Adverse Event|5|||
130073947|NCT01250756|468224771|FG001|After Infant Series|Adverse Event|2|||
130073948|NCT01250756|468224770|FG000|After Infant Series|Withdrawal by Subject|4|||
130073949|NCT01250756|468224771|FG001|After Infant Series|Withdrawal by Subject|1|||
130073950|NCT01250756|468224770|FG000|After Infant Series|Other|2|||
130073951|NCT01250756|468224771|FG001|After Infant Series|Other|1|||
130073952|NCT01250756|468224770|FG000|Toddler Dose|Adverse Event|0|||
130073953|NCT01250756|468224771|FG001|Toddler Dose|Adverse Event|1|||
130073954|NCT01250756|468224770|FG000|After Toddler Dose|Adverse Event|0|||
130073955|NCT01250756|468224771|FG001|After Toddler Dose|Adverse Event|1|||
130073956|NCT01815580|468224773|FG000|Overall Study|Lost to Follow-up|4|||
130073957|NCT01815580|468224774|FG001|Overall Study|Lost to Follow-up|7|||
130073958|NCT01815580|468224773|FG000|Overall Study|Withdrawal by Subject|3|||
130073959|NCT01815580|468224774|FG001|Overall Study|Withdrawal by Subject|4|||
130073960|NCT01815580|468224773|FG000|Overall Study|Excluded from analysis|5|||
130073961|NCT01815580|468224774|FG001|Overall Study|Excluded from analysis|4|||
130073962|NCT00617591|468224775|FG000|Overall Study|Withdrew consent during Induction|4|||
130073963|NCT00617591|468224775|FG000|Overall Study|Withdrew consent during Maintenance|6|||
130073964|NCT01072448|468224782|FG000|Overall Study|Adverse Event|9|||
130073965|NCT01072448|468224783|FG001|Overall Study|Adverse Event|10|||
130073966|NCT01072448|468224782|FG000|Overall Study|Subject withdrew consent|4|||
130073967|NCT01072448|468224783|FG001|Overall Study|Subject withdrew consent|9|||
130073968|NCT01072448|468224782|FG000|Overall Study|Protocol deviation|3|||
130073969|NCT01072448|468224783|FG001|Overall Study|Protocol deviation|4|||
130073970|NCT01072448|468224782|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130073971|NCT01072448|468224783|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130073972|NCT01072448|468224782|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130073973|NCT01072448|468224783|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130073974|NCT01072448|468224782|FG000|Overall Study|Lost to Follow-up|1|||
130073975|NCT01072448|468224783|FG001|Overall Study|Lost to Follow-up|1|||
130073976|NCT01072448|468224782|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130073977|NCT01072448|468224783|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130073978|NCT01072448|468224782|FG000|Overall Study|Death|0|||
130073979|NCT01072448|468224783|FG001|Overall Study|Death|2|||
130073980|NCT01400139|468224784|FG000|HYD Core Study|Adverse Event|210|||
130073981|NCT01400139|468224784|FG000|HYD Core Study|Lack of Efficacy|59|||
130073982|NCT01400139|468224784|FG000|HYD Core Study|Withdrawal by Subject|114|||
130073983|NCT01400139|468224784|FG000|HYD Core Study|Lost to Follow-up|39|||
130073984|NCT01400139|468224784|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
130120457|NCT02097121|468402381|FG000|Overall Study|Adverse Event|0|||
130073985|NCT01400139|468224784|FG000|HYD Core Study|Administrative|56|||
130073986|NCT01400139|468224784|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
130073987|NCT01400139|468224784|FG000|HYD Extension Period|Adverse Event|8|||
130073988|NCT01400139|468224784|FG000|HYD Extension Period|Withdrawal by Subject|5|||
130073989|NCT01400139|468224784|FG000|HYD Extension Period|Administrative|10|||
130073990|NCT00249795|468224785|FG000|Overall Study|Not treated|16|||
129950822|NCT02400749|467782948|FG000|Week 0 -16|Adverse Event|3|||
129950823|NCT02400749|467782949|FG001|Week 0 -16|Adverse Event|1|||
129950824|NCT02400749|467782948|FG000|Week 0 -16|Lost to Follow-up|2|||
129950825|NCT02400749|467782949|FG001|Week 0 -16|Lost to Follow-up|0|||
129950826|NCT02400749|467782948|FG000|Week 0 -16|Protocol Violation|1|||
129950827|NCT02400749|467782949|FG001|Week 0 -16|Protocol Violation|0|||
129950828|NCT02400749|467782948|FG000|Week 17 - 32|Withdrawal by Subject|3|||
129950829|NCT02400749|467782949|FG001|Week 17 - 32|Withdrawal by Subject|2|||
129950830|NCT02400749|467782948|FG000|Week 17 - 32|Adverse Event|2|||
129950831|NCT02400749|467782949|FG001|Week 17 - 32|Adverse Event|1|||
129950832|NCT04425252|467782952|FG000|Overall Study|Withdrawal by Subject|2|||
129950833|NCT04425252|467782953|FG001|Overall Study|Withdrawal by Subject|1|||
129950834|NCT04425252|467782952|FG000|Overall Study|Lost to Follow-up|1|||
129950835|NCT04425252|467782953|FG001|Overall Study|Lost to Follow-up|0|||
129950836|NCT04425252|467782952|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
129950837|NCT04425252|467782953|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
129950838|NCT04025762|467782958|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
129950839|NCT04025762|467782959|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
129950840|NCT01975701|467782969|FG000|Overall Study|Lost to Follow-up|1|||
129950841|NCT01975701|467782969|FG000|Overall Study|Death|23|||
129950842|NCT01975701|467782969|FG000|Overall Study|Physician Decision|1|||
129950843|NCT02446015|467782972|FG000|Overall Study|Adverse Event|0|||
129950844|NCT02446015|467782973|FG001|Overall Study|Adverse Event|1|||
129950845|NCT02446015|467782972|FG000|Overall Study|Withdrawal by Subject|1|||
129950846|NCT02446015|467782973|FG001|Overall Study|Withdrawal by Subject|0|||
129950847|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
129950848|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
129950849|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
129950850|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
129950851|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Adverse Event|7|||
129950852|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Adverse Event|8|||
129950853|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Adverse Event|8|||
129950854|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Adverse Event|9|||
129950855|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
129950856|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
129950857|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
129950858|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
129950859|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
129950860|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
129950861|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
129950862|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
129950863|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Pregnancy|0|||
129950864|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Pregnancy|2|||
129950865|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Pregnancy|2|||
129950866|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Pregnancy|0|||
129950867|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Non-compliance|1|||
129950868|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Non-compliance|0|||
129950869|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Non-compliance|0|||
129950870|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Non-compliance|3|||
129950871|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Other|3|||
129950872|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Other|0|||
129950873|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Other|3|||
129950874|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Other|2|||
129950875|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
129950876|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
129950877|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
129950878|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
129950879|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
129950880|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
129950881|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
130073991|NCT00249795|468224786|FG001|Overall Study|Not treated|14|||
130073992|NCT00249795|468224785|FG000|Overall Study|Symptomatic hypotension|127|||
130073993|NCT00249795|468224786|FG001|Overall Study|Symptomatic hypotension|64|||
129950882|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
129950883|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
129950884|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
129950885|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
129950886|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
129950887|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
129950888|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
129950889|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
129950890|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
129950891|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
129950892|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
129950893|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
129950894|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
129950895|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
129950896|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
129950897|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
129950898|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
129950899|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
129950900|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
129950901|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
129950902|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
129950903|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
129950904|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
129950905|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
129950906|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
129950907|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
129950908|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
129950909|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
129950910|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
129950911|NCT01768572|467782982|FG000|Overall Study|Adverse Event|7|||
129950912|NCT01768572|467782983|FG001|Overall Study|Adverse Event|8|||
129950913|NCT01768572|467782984|FG002|Overall Study|Adverse Event|4|||
129950914|NCT01768572|467782982|FG000|Overall Study|Lack of Efficacy|1|||
129950915|NCT01768572|467782983|FG001|Overall Study|Lack of Efficacy|3|||
129950916|NCT01768572|467782984|FG002|Overall Study|Lack of Efficacy|1|||
129950917|NCT01768572|467782982|FG000|Overall Study|Other, Not due to an adverse event|1|||
129950918|NCT01768572|467782983|FG001|Overall Study|Other, Not due to an adverse event|1|||
129950919|NCT01768572|467782984|FG002|Overall Study|Other, Not due to an adverse event|1|||
129950920|NCT01215253|467782985|FG000|Overall Study|Withdrawal by Subject|57|||
129950921|NCT01215253|467782986|FG001|Overall Study|Withdrawal by Subject|35|||
129950922|NCT01215253|467782985|FG000|Overall Study|Physician Decision|9|||
129950923|NCT01215253|467782986|FG001|Overall Study|Physician Decision|12|||
129950924|NCT01215253|467782985|FG000|Overall Study|Lost to Follow-up|6|||
129950925|NCT01215253|467782986|FG001|Overall Study|Lost to Follow-up|4|||
129950926|NCT01215253|467782985|FG000|Overall Study|Other|14|||
129950927|NCT01215253|467782986|FG001|Overall Study|Other|12|||
129950928|NCT03761849|467782993|FG000|Overall Study|transferred to OpenLabelExtension|35|||
129950929|NCT03761849|467782994|FG001|Overall Study|transferred to OpenLabelExtension|34|||
129950930|NCT03761849|467782995|FG002|Overall Study|transferred to OpenLabelExtension|36|||
129950931|NCT03761849|467782996|FG003|Overall Study|transferred to OpenLabelExtension|0|||
129950932|NCT03761849|467782997|FG004|Overall Study|transferred to OpenLabelExtension|0|||
129950933|NCT03761849|467782998|FG005|Overall Study|transferred to OpenLabelExtension|0|||
129950934|NCT03761849|467782993|FG000|Overall Study|Adverse Event|1|||
129950935|NCT03761849|467782994|FG001|Overall Study|Adverse Event|0|||
129950936|NCT03761849|467782995|FG002|Overall Study|Adverse Event|0|||
129950937|NCT03761849|467782996|FG003|Overall Study|Adverse Event|0|||
129950938|NCT03761849|467782997|FG004|Overall Study|Adverse Event|2|||
129950939|NCT03761849|467782998|FG005|Overall Study|Adverse Event|3|||
129950940|NCT03761849|467782993|FG000|Overall Study|Withdrawal by Subject|0|||
129950941|NCT03761849|467782994|FG001|Overall Study|Withdrawal by Subject|0|||
129950942|NCT03761849|467782995|FG002|Overall Study|Withdrawal by Subject|0|||
129950943|NCT03761849|467782996|FG003|Overall Study|Withdrawal by Subject|41|||
129950944|NCT03761849|467782997|FG004|Overall Study|Withdrawal by Subject|43|||
129950945|NCT03761849|467782998|FG005|Overall Study|Withdrawal by Subject|35|||
129950946|NCT03761849|467782993|FG000|Overall Study|Lost to Follow-up|0|||
129950947|NCT03761849|467782994|FG001|Overall Study|Lost to Follow-up|1|||
129950948|NCT03761849|467782995|FG002|Overall Study|Lost to Follow-up|0|||
129950949|NCT03761849|467782996|FG003|Overall Study|Lost to Follow-up|2|||
129950950|NCT03761849|467782997|FG004|Overall Study|Lost to Follow-up|4|||
129950951|NCT03761849|467782998|FG005|Overall Study|Lost to Follow-up|5|||
129950952|NCT03761849|467782993|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
129950953|NCT03761849|467782994|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
129950954|NCT03761849|467782995|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
129950955|NCT03761849|467782996|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
129950956|NCT03761849|467782997|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
129950957|NCT03761849|467782998|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
129950958|NCT03761849|467782993|FG000|Overall Study|Physician Decision|0|||
129950959|NCT03761849|467782994|FG001|Overall Study|Physician Decision|0|||
129950960|NCT03761849|467782995|FG002|Overall Study|Physician Decision|0|||
129950961|NCT03761849|467782996|FG003|Overall Study|Physician Decision|1|||
129950962|NCT03761849|467782997|FG004|Overall Study|Physician Decision|4|||
129950963|NCT03761849|467782998|FG005|Overall Study|Physician Decision|4|||
130073994|NCT00249795|468224785|FG000|Overall Study|Other Serious Adverse Event|84|||
130073995|NCT00249795|468224786|FG001|Overall Study|Other Serious Adverse Event|93|||
130073996|NCT00249795|468224785|FG000|Overall Study|Qualifying condition not present|26|||
130073997|NCT00249795|468224786|FG001|Overall Study|Qualifying condition not present|29|||
130073998|NCT00249795|468224785|FG000|Overall Study|Withdrawal by Subject|678|||
130073999|NCT00249795|468224786|FG001|Overall Study|Withdrawal by Subject|742|||
130074000|NCT00249795|468224785|FG000|Overall Study|Thromboembolic / outcome event|39|||
130074001|NCT00249795|468224786|FG001|Overall Study|Thromboembolic / outcome event|45|||
130074002|NCT00249795|468224785|FG000|Overall Study|Oral anticoagulant required|2|||
130074003|NCT00249795|468224786|FG001|Overall Study|Oral anticoagulant required|0|||
130074004|NCT00249795|468224785|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
130074005|NCT00249795|468224786|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
130074006|NCT00249795|468224785|FG000|Overall Study|Non-compliance|71|||
130074007|NCT00249795|468224786|FG001|Overall Study|Non-compliance|69|||
130074008|NCT00249795|468224785|FG000|Overall Study|Study drug intolerance|3|||
130074009|NCT00249795|468224786|FG001|Overall Study|Study drug intolerance|3|||
130074010|NCT00249795|468224785|FG000|Overall Study|Other adverse events (non-serious)|188|||
130074011|NCT00249795|468224786|FG001|Overall Study|Other adverse events (non-serious)|159|||
130074012|NCT00249795|468224785|FG000|Overall Study|Physician withdrew consent|71|||
130074013|NCT00249795|468224786|FG001|Overall Study|Physician withdrew consent|63|||
130074014|NCT00249795|468224785|FG000|Overall Study|Surgery / procedure|4|||
130074015|NCT00249795|468224786|FG001|Overall Study|Surgery / procedure|5|||
130074016|NCT00249795|468224785|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
130074017|NCT00249795|468224786|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
130074018|NCT00249795|468224785|FG000|Overall Study|Lightheadedness / dizziness|15|||
130074019|NCT00249795|468224786|FG001|Overall Study|Lightheadedness / dizziness|11|||
130074020|NCT00249795|468224785|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
130074021|NCT00249795|468224786|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
130074022|NCT00249795|468224785|FG000|Overall Study|Other contraindicated medication|1|||
130074023|NCT00249795|468224786|FG001|Overall Study|Other contraindicated medication|1|||
130074024|NCT00249795|468224785|FG000|Overall Study|Event related to cardiac condition|17|||
130074025|NCT00249795|468224786|FG001|Overall Study|Event related to cardiac condition|16|||
130074026|NCT00249795|468224785|FG000|Overall Study|Patient not wish to continue after May08|4|||
130074027|NCT00249795|468224786|FG001|Overall Study|Patient not wish to continue after May08|6|||
130074028|NCT00249795|468224785|FG000|Overall Study|Site not agree to continue after May08|1|||
130074029|NCT00249795|468224786|FG001|Overall Study|Site not agree to continue after May08|1|||
130074030|NCT00249795|468224785|FG000|Overall Study|Lost to Follow-up|0|||
130074031|NCT00249795|468224786|FG001|Overall Study|Lost to Follow-up|2|||
130074032|NCT00249795|468224785|FG000|Overall Study|Missing|0|||
130074033|NCT00249795|468224786|FG001|Overall Study|Missing|1|||
130074034|NCT02460978|468224788|FG000|Overall Study|Adverse Event|17|||
130074035|NCT02460978|468224789|FG001|Overall Study|Adverse Event|11|||
130074036|NCT02460978|468224790|FG002|Overall Study|Adverse Event|11|||
130074037|NCT02460978|468224788|FG000|Overall Study|Withdrawal by Subject|5|||
130074038|NCT02460978|468224789|FG001|Overall Study|Withdrawal by Subject|5|||
130074039|NCT02460978|468224790|FG002|Overall Study|Withdrawal by Subject|14|||
130074040|NCT02460978|468224788|FG000|Overall Study|Lost to Follow-up|2|||
130074041|NCT02460978|468224789|FG001|Overall Study|Lost to Follow-up|3|||
130074042|NCT02460978|468224790|FG002|Overall Study|Lost to Follow-up|1|||
130074043|NCT02460978|468224788|FG000|Overall Study|Protocol Violation|1|||
130074044|NCT02460978|468224789|FG001|Overall Study|Protocol Violation|1|||
130074045|NCT02460978|468224790|FG002|Overall Study|Protocol Violation|1|||
130074046|NCT02460978|468224788|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
130074047|NCT02460978|468224789|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
130074048|NCT02460978|468224790|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
130074049|NCT02460978|468224788|FG000|Overall Study|Pregnancy|0|||
130074050|NCT02460978|468224789|FG001|Overall Study|Pregnancy|0|||
130074051|NCT02460978|468224790|FG002|Overall Study|Pregnancy|2|||
130074052|NCT00588523|468224794|FG000|Overall Study|Not treated|3|||
130074053|NCT03032510|468224795|FG000|Overall Study|Adverse Event|5|||
130074054|NCT03032510|468224796|FG001|Overall Study|Adverse Event|2|||
130074055|NCT03032510|468224795|FG000|Overall Study|Lost to Follow-up|8|||
130074056|NCT03032510|468224796|FG001|Overall Study|Lost to Follow-up|7|||
130074057|NCT03032510|468224795|FG000|Overall Study|Withdrawal by Subject|8|||
130074058|NCT03032510|468224796|FG001|Overall Study|Withdrawal by Subject|7|||
130074059|NCT03032510|468224795|FG000|Overall Study|Subject noncompliance|4|||
130074060|NCT03032510|468224796|FG001|Overall Study|Subject noncompliance|2|||
130074061|NCT03032510|468224795|FG000|Overall Study|Physician Decision|2|||
130074062|NCT03032510|468224796|FG001|Overall Study|Physician Decision|0|||
130074063|NCT01176240|468224804|FG000|Study 306A|Lack of Efficacy|2|||
130074064|NCT01176240|468224805|FG001|Study 306A|Lack of Efficacy|1|||
130074065|NCT01176240|468224804|FG000|Study 306A|Protocol Violation|0|||
130074066|NCT01176240|468224805|FG001|Study 306A|Protocol Violation|1|||
130074067|NCT01176240|468224804|FG000|Study 306A|Withdrawal by Subject|0|||
130074068|NCT01176240|468224805|FG001|Study 306A|Withdrawal by Subject|1|||
130074069|NCT01176240|468224804|FG000|Study 306A|Stop due to diverse problems|1|||
130074070|NCT01176240|468224805|FG001|Study 306A|Stop due to diverse problems|0|||
130074071|NCT01176240|468224804|FG000|Study 306B|Lack of Efficacy|5|||
130074072|NCT01176240|468224805|FG001|Study 306B|Lack of Efficacy|3|||
130074073|NCT01176240|468224804|FG000|Study 306B|Adverse Event|10|||
130074074|NCT01176240|468224805|FG001|Study 306B|Adverse Event|5|||
130074075|NCT01176240|468224804|FG000|Study 306B|Protocol Violation|2|||
130074076|NCT01176240|468224805|FG001|Study 306B|Protocol Violation|3|||
130074077|NCT01176240|468224804|FG000|Study 306B|Withdrawal by Subject|4|||
130074078|NCT01176240|468224805|FG001|Study 306B|Withdrawal by Subject|1|||
130074079|NCT01176240|468224804|FG000|Study 306B|Physician Decision|2|||
130074080|NCT01176240|468224805|FG001|Study 306B|Physician Decision|1|||
130074081|NCT01176240|468224804|FG000|Study 306B|Supine Hypertension|1|||
130074082|NCT01176240|468224805|FG001|Study 306B|Supine Hypertension|2|||
130074083|NCT01176240|468224804|FG000|Study 306B|Lost to Follow-up|0|||
130074084|NCT01176240|468224805|FG001|Study 306B|Lost to Follow-up|1|||
130074085|NCT01176240|468224804|FG000|Study 306B|withdrew prior to dosing|2|||
130074086|NCT01176240|468224805|FG001|Study 306B|withdrew prior to dosing|1|||
130074087|NCT00807014|468224811|FG000|Overall Study|Participant Considered Disease Cured|13|||
130074088|NCT00807014|468224812|FG001|Overall Study|Participant Considered Disease Cured|2|||
130074089|NCT00807014|468224811|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
130074090|NCT00807014|468224812|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
130074091|NCT00807014|468224811|FG000|Overall Study|Protocol Violation|2|||
130074092|NCT00807014|468224812|FG001|Overall Study|Protocol Violation|8|||
130074093|NCT00807014|468224811|FG000|Overall Study|Adverse Event|0|||
130074094|NCT00807014|468224812|FG001|Overall Study|Adverse Event|2|||
130074095|NCT00807014|468224811|FG000|Overall Study|Lost to Follow-up|9|||
130074096|NCT00807014|468224812|FG001|Overall Study|Lost to Follow-up|7|||
130074097|NCT00807014|468224811|FG000|Overall Study|Recovery|1|||
130074098|NCT00807014|468224812|FG001|Overall Study|Recovery|0|||
130074099|NCT00807014|468224811|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
130074100|NCT00807014|468224812|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
130074101|NCT00651313|468224813|FG000|Overall Study|Adverse Event|0|||
130074102|NCT00651313|468224814|FG001|Overall Study|Adverse Event|1|||
130074103|NCT00651313|468224813|FG000|Overall Study|Withdrawal by Subject|3|||
130074104|NCT00651313|468224814|FG001|Overall Study|Withdrawal by Subject|1|||
130074105|NCT00651313|468224813|FG000|Overall Study|Lost to Follow-up|1|||
130074106|NCT00651313|468224814|FG001|Overall Study|Lost to Follow-up|1|||
130074107|NCT00651313|468224813|FG000|Overall Study|Adminstrative Discontinuation|2|||
130074108|NCT00651313|468224814|FG001|Overall Study|Adminstrative Discontinuation|3|||
130074109|NCT02650895|468224815|FG000|Overall Study|Withdrawal by Subject|0|||
130074110|NCT02650895|468224816|FG001|Overall Study|Withdrawal by Subject|1|||
130074111|NCT02650895|468224817|FG002|Overall Study|Withdrawal by Subject|0|||
130074112|NCT02650895|468224818|FG003|Overall Study|Withdrawal by Subject|0|||
130074113|NCT02650895|468224819|FG004|Overall Study|Withdrawal by Subject|0|||
130074114|NCT02650895|468224820|FG005|Overall Study|Withdrawal by Subject|0|||
130074115|NCT00981682|468224821|FG000|Overall Study|Adverse Event|48|||
130074116|NCT00981682|468224821|FG000|Overall Study|Withdrawal by Subject|52|||
130074117|NCT00981682|468224821|FG000|Overall Study|Lost to Follow-up|14|||
130074118|NCT00981682|468224821|FG000|Overall Study|Lack of Efficacy|13|||
130074119|NCT00981682|468224821|FG000|Overall Study|Protocol Violation|6|||
130074120|NCT00981682|468224821|FG000|Overall Study|administrative|9|||
130074121|NCT03906136|468226713|FG000|Overall Study|Adverse Event|1|||
130074122|NCT03906136|468226714|FG001|Overall Study|Adverse Event|0|||
130074123|NCT03906136|468226713|FG000|Overall Study|Lost to Follow-up|7|||
130074124|NCT03906136|468226714|FG001|Overall Study|Lost to Follow-up|4|||
130074125|NCT03906136|468226713|FG000|Overall Study|Physician Decision|1|||
130074126|NCT03906136|468226714|FG001|Overall Study|Physician Decision|0|||
130074127|NCT03906136|468226713|FG000|Overall Study|Withdrawal by Subject|3|||
130074128|NCT03906136|468226714|FG001|Overall Study|Withdrawal by Subject|7|||
130074129|NCT02371980|468226718|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
130074130|NCT02371980|468226719|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
130074131|NCT02371980|468226720|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
130074132|NCT02371980|468226721|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
130074133|NCT02371980|468226722|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
130074134|NCT02371980|468226718|FG000|Open-label Period|Significant Protocol Deviation|19|||
130074135|NCT02371980|468226719|FG001|Open-label Period|Significant Protocol Deviation|0|||
130074136|NCT02371980|468226720|FG002|Open-label Period|Significant Protocol Deviation|0|||
130074137|NCT02371980|468226721|FG003|Open-label Period|Significant Protocol Deviation|0|||
130074138|NCT02371980|468226722|FG004|Open-label Period|Significant Protocol Deviation|0|||
130074139|NCT02371980|468226718|FG000|Open-label Period|Noncompliance with Study Drug|10|||
130074140|NCT02371980|468226719|FG001|Open-label Period|Noncompliance with Study Drug|0|||
130074141|NCT02371980|468226720|FG002|Open-label Period|Noncompliance with Study Drug|0|||
130074142|NCT02371980|468226721|FG003|Open-label Period|Noncompliance with Study Drug|0|||
130074143|NCT02371980|468226722|FG004|Open-label Period|Noncompliance with Study Drug|0|||
130074144|NCT02371980|468226718|FG000|Open-label Period|Lost to Follow-up|55|||
130074145|NCT02371980|468226719|FG001|Open-label Period|Lost to Follow-up|0|||
130074146|NCT02371980|468226720|FG002|Open-label Period|Lost to Follow-up|0|||
130074147|NCT02371980|468226721|FG003|Open-label Period|Lost to Follow-up|0|||
130074148|NCT02371980|468226722|FG004|Open-label Period|Lost to Follow-up|0|||
130074149|NCT02371980|468226718|FG000|Open-label Period|Voluntary Withdrawal|91|||
130074150|NCT02371980|468226719|FG001|Open-label Period|Voluntary Withdrawal|0|||
130074151|NCT02371980|468226720|FG002|Open-label Period|Voluntary Withdrawal|0|||
130074152|NCT02371980|468226721|FG003|Open-label Period|Voluntary Withdrawal|0|||
130074153|NCT02371980|468226722|FG004|Open-label Period|Voluntary Withdrawal|0|||
130074154|NCT02371980|468226718|FG000|Open-label Period|Pregnancy|1|||
130074155|NCT02371980|468226719|FG001|Open-label Period|Pregnancy|0|||
130074156|NCT02371980|468226720|FG002|Open-label Period|Pregnancy|0|||
130074157|NCT02371980|468226721|FG003|Open-label Period|Pregnancy|0|||
130074158|NCT02371980|468226722|FG004|Open-label Period|Pregnancy|0|||
130074159|NCT02371980|468226718|FG000|Open-label Period|Lack of Efficacy|116|||
130120458|NCT02097121|468402382|FG001|Overall Study|Adverse Event|1|||
130120459|NCT02097121|468402383|FG002|Overall Study|Adverse Event|0|||
130120460|NCT02097121|468402381|FG000|Overall Study|Lost to Follow-up|1|||
130120461|NCT02097121|468402382|FG001|Overall Study|Lost to Follow-up|1|||
130120462|NCT02097121|468402383|FG002|Overall Study|Lost to Follow-up|2|||
130120463|NCT00661999|468402384|FG000|Overall Study|Adverse Event|11|||
130120464|NCT00661999|468402385|FG001|Overall Study|Adverse Event|5|||
130120465|NCT00661999|468402386|FG002|Overall Study|Adverse Event|8|||
130120466|NCT00661999|468402384|FG000|Overall Study|Death|8|||
130120467|NCT00661999|468402385|FG001|Overall Study|Death|6|||
130120468|NCT00661999|468402386|FG002|Overall Study|Death|3|||
130120469|NCT00661999|468402384|FG000|Overall Study|Other Reasons|5|||
130120470|NCT00661999|468402385|FG001|Overall Study|Other Reasons|12|||
130120471|NCT00661999|468402386|FG002|Overall Study|Other Reasons|23|||
130120472|NCT00661999|468402384|FG000|Overall Study|Withdrawal by Subject|30|||
130120473|NCT00661999|468402385|FG001|Overall Study|Withdrawal by Subject|23|||
130120474|NCT00661999|468402386|FG002|Overall Study|Withdrawal by Subject|14|||
130120475|NCT00661999|468402384|FG000|Overall Study|Alternative Treatment|1|||
130120476|NCT00661999|468402385|FG001|Overall Study|Alternative Treatment|0|||
130120477|NCT00661999|468402386|FG002|Overall Study|Alternative Treatment|0|||
130120478|NCT00661999|468402384|FG000|Overall Study|Other Medical Problems|4|||
130120479|NCT00661999|468402385|FG001|Overall Study|Other Medical Problems|4|||
130120480|NCT00661999|468402386|FG002|Overall Study|Other Medical Problems|9|||
130120481|NCT03066999|468402387|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
130120482|NCT03066999|468402388|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
130120483|NCT00510510|468402389|FG000|Overall Study|Adverse Event|4|||
129950964|NCT03761849|467782993|FG000|Overall Study|Death|0|||
129950965|NCT03761849|467782994|FG001|Overall Study|Death|0|||
129950966|NCT03761849|467782995|FG002|Overall Study|Death|0|||
129950967|NCT03761849|467782996|FG003|Overall Study|Death|1|||
129950968|NCT03761849|467782997|FG004|Overall Study|Death|1|||
129950969|NCT03761849|467782998|FG005|Overall Study|Death|3|||
129950970|NCT03761849|467782993|FG000|Overall Study|Protocol Violation|0|||
129950971|NCT03761849|467782994|FG001|Overall Study|Protocol Violation|0|||
129950972|NCT03761849|467782995|FG002|Overall Study|Protocol Violation|0|||
129950973|NCT03761849|467782996|FG003|Overall Study|Protocol Violation|2|||
129950974|NCT03761849|467782997|FG004|Overall Study|Protocol Violation|2|||
130120484|NCT00510510|468402390|FG001|Overall Study|Adverse Event|3|||
130120485|NCT00510510|468402391|FG002|Overall Study|Adverse Event|6|||
130120486|NCT00510510|468402389|FG000|Overall Study|Lack of Efficacy|0|||
130120487|NCT00510510|468402390|FG001|Overall Study|Lack of Efficacy|1|||
130120488|NCT00510510|468402391|FG002|Overall Study|Lack of Efficacy|1|||
130120489|NCT00510510|468402389|FG000|Overall Study|Subjects no longer requires study drug|0|||
130120490|NCT00510510|468402390|FG001|Overall Study|Subjects no longer requires study drug|0|||
130120491|NCT00510510|468402391|FG002|Overall Study|Subjects no longer requires study drug|2|||
130120492|NCT00510510|468402389|FG000|Overall Study|Withdrawal by Subject|1|||
130120493|NCT00510510|468402390|FG001|Overall Study|Withdrawal by Subject|2|||
130120494|NCT00510510|468402391|FG002|Overall Study|Withdrawal by Subject|3|||
129950975|NCT03761849|467782998|FG005|Overall Study|Protocol Violation|1|||
129950976|NCT03761849|467782993|FG000|Overall Study|Participant could not come to site|0|||
129950977|NCT03761849|467782994|FG001|Overall Study|Participant could not come to site|0|||
129950978|NCT03761849|467782995|FG002|Overall Study|Participant could not come to site|0|||
130074160|NCT02371980|468226719|FG001|Open-label Period|Lack of Efficacy|0|||
130074161|NCT02371980|468226720|FG002|Open-label Period|Lack of Efficacy|0|||
130074162|NCT02371980|468226721|FG003|Open-label Period|Lack of Efficacy|0|||
130120495|NCT00510510|468402389|FG000|Overall Study|Lost to Follow-up|0|||
130120496|NCT00510510|468402390|FG001|Overall Study|Lost to Follow-up|0|||
130120497|NCT00510510|468402391|FG002|Overall Study|Lost to Follow-up|1|||
130120498|NCT00510510|468402389|FG000|Overall Study|Protocol Violation|0|||
130120499|NCT00510510|468402390|FG001|Overall Study|Protocol Violation|3|||
130120500|NCT00510510|468402391|FG002|Overall Study|Protocol Violation|4|||
130120501|NCT03595657|468402392|FG000|Overall Study|Adverse Event|14|||
130120502|NCT03595657|468402392|FG000|Overall Study|Death|1|||
130120503|NCT03595657|468402392|FG000|Overall Study|Lack of Efficacy|40|||
129950979|NCT03761849|467782996|FG003|Overall Study|Participant could not come to site|0|||
129950980|NCT03761849|467782997|FG004|Overall Study|Participant could not come to site|1|||
129950981|NCT03761849|467782998|FG005|Overall Study|Participant could not come to site|0|||
129950982|NCT03761849|467782993|FG000|Overall Study|SF- safety Finding|0|||
129950983|NCT03761849|467782994|FG001|Overall Study|SF- safety Finding|0|||
129950984|NCT03761849|467782995|FG002|Overall Study|SF- safety Finding|0|||
129950985|NCT03761849|467782996|FG003|Overall Study|SF- safety Finding|0|||
129950986|NCT03761849|467782997|FG004|Overall Study|SF- safety Finding|0|||
129950987|NCT03761849|467782998|FG005|Overall Study|SF- safety Finding|1|||
129950988|NCT03761849|467782993|FG000|Overall Study|Patient did not attend visit|0|||
129950989|NCT03761849|467782994|FG001|Overall Study|Patient did not attend visit|0|||
129950990|NCT03761849|467782995|FG002|Overall Study|Patient did not attend visit|0|||
129950991|NCT03761849|467782996|FG003|Overall Study|Patient did not attend visit|0|||
129950992|NCT03761849|467782997|FG004|Overall Study|Patient did not attend visit|0|||
129950993|NCT03761849|467782998|FG005|Overall Study|Patient did not attend visit|1|||
129950994|NCT03840993|467782999|FG000|Overall Study|Adverse Event|1|||
129950995|NCT03840993|467783000|FG001|Overall Study|Adverse Event|0|||
129950996|NCT03840993|467782999|FG000|Overall Study|Lost to Follow-up|4|||
129950997|NCT03840993|467783000|FG001|Overall Study|Lost to Follow-up|0|||
129950998|NCT03840993|467782999|FG000|Overall Study|Physician Decision|0|||
129950999|NCT03840993|467783000|FG001|Overall Study|Physician Decision|1|||
129951000|NCT03840993|467782999|FG000|Overall Study|Pregnancy|0|||
129951001|NCT03840993|467783000|FG001|Overall Study|Pregnancy|1|||
129951002|NCT03840993|467782999|FG000|Overall Study|Withdrawal by Subject|1|||
129951003|NCT03840993|467783000|FG001|Overall Study|Withdrawal by Subject|3|||
129951004|NCT03840993|467782999|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
129951005|NCT03840993|467783000|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
129951006|NCT01540474|467783001|FG000|Vaccination Period|Lost to Follow-up|0|||
129951007|NCT01540474|467783002|FG001|Vaccination Period|Lost to Follow-up|1|||
129951008|NCT01540474|467783003|FG002|Vaccination Period|Lost to Follow-up|0|||
129951009|NCT01540474|467783004|FG003|Vaccination Period|Lost to Follow-up|0|||
129951010|NCT00857311|467783005|FG000|Overall Study|Lost to Follow-up|1|||
129951011|NCT00857311|467783006|FG001|Overall Study|Lost to Follow-up|0|||
129951012|NCT00857311|467783007|FG002|Overall Study|Lost to Follow-up|0|||
129951013|NCT00857311|467783008|FG003|Overall Study|Lost to Follow-up|0|||
129951014|NCT02005484|467783011|FG000|Overall Study|Death|1|||
129951015|NCT02005484|467783011|FG000|Overall Study|Disease progression|1|||
129951016|NCT02005484|467783011|FG000|Overall Study|Changed to a Different Study|1|||
129951017|NCT02005484|467783011|FG000|Overall Study|Sponsor decision|1|||
129951018|NCT01129011|467783012|FG000|Overall Study|Adverse Event|20|||
129951019|NCT01129011|467783013|FG001|Overall Study|Adverse Event|30|||
129951020|NCT01129011|467783012|FG000|Overall Study|Withdrawal by Subject|24|||
129951021|NCT01129011|467783013|FG001|Overall Study|Withdrawal by Subject|8|||
129951022|NCT01129011|467783012|FG000|Overall Study|Lost to Follow-up|6|||
129951023|NCT01129011|467783013|FG001|Overall Study|Lost to Follow-up|7|||
129951024|NCT01129011|467783012|FG000|Overall Study|Duodenal Ulcer|2|||
129951025|NCT01129011|467783013|FG001|Overall Study|Duodenal Ulcer|8|||
129951026|NCT01129011|467783012|FG000|Overall Study|misc|7|||
129951027|NCT01129011|467783013|FG001|Overall Study|misc|4|||
129951028|NCT02823574|467783017|FG000|Randomization|Disease Progression|0|||
129951029|NCT02823574|467783018|FG001|Randomization|Disease Progression|0|||
129951030|NCT02823574|467783019|FG002|Randomization|Disease Progression|1|||
129951031|NCT02823574|467783020|FG003|Randomization|Disease Progression|0|||
129951032|NCT02823574|467783017|FG000|Randomization|AE unrelated to Study Drug|1|||
129951033|NCT02823574|467783018|FG001|Randomization|AE unrelated to Study Drug|0|||
129951034|NCT02823574|467783019|FG002|Randomization|AE unrelated to Study Drug|0|||
129951035|NCT02823574|467783020|FG003|Randomization|AE unrelated to Study Drug|0|||
129951036|NCT02823574|467783017|FG000|Treatment Period|Poor/Non Compliance|1|||
129951037|NCT02823574|467783018|FG001|Treatment Period|Poor/Non Compliance|0|||
129951038|NCT02823574|467783019|FG002|Treatment Period|Poor/Non Compliance|0|||
129951039|NCT02823574|467783020|FG003|Treatment Period|Poor/Non Compliance|1|||
129951040|NCT02823574|467783017|FG000|Treatment Period|Maximum Clinical Benefit|8|||
129951041|NCT02823574|467783018|FG001|Treatment Period|Maximum Clinical Benefit|4|||
129951042|NCT02823574|467783019|FG002|Treatment Period|Maximum Clinical Benefit|7|||
129951043|NCT02823574|467783020|FG003|Treatment Period|Maximum Clinical Benefit|1|||
129951044|NCT02823574|467783017|FG000|Treatment Period|Lost to Follow-up|1|||
129951045|NCT02823574|467783018|FG001|Treatment Period|Lost to Follow-up|1|||
129951046|NCT02823574|467783019|FG002|Treatment Period|Lost to Follow-up|0|||
129951047|NCT02823574|467783020|FG003|Treatment Period|Lost to Follow-up|0|||
129951048|NCT02823574|467783017|FG000|Treatment Period|Participant withdrew consent|4|||
129951049|NCT02823574|467783018|FG001|Treatment Period|Participant withdrew consent|0|||
129951050|NCT02823574|467783019|FG002|Treatment Period|Participant withdrew consent|0|||
129951051|NCT02823574|467783020|FG003|Treatment Period|Participant withdrew consent|1|||
129951052|NCT02823574|467783017|FG000|Treatment Period|Participant request to discontinue|5|||
129951053|NCT02823574|467783018|FG001|Treatment Period|Participant request to discontinue|0|||
129951054|NCT02823574|467783019|FG002|Treatment Period|Participant request to discontinue|3|||
130074163|NCT02371980|468226722|FG004|Open-label Period|Lack of Efficacy|0|||
130074164|NCT02371980|468226718|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
130074165|NCT02371980|468226719|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
130074166|NCT02371980|468226720|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
130074167|NCT02371980|468226721|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
130074168|NCT02371980|468226722|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
130074169|NCT02371980|468226718|FG000|Open-label Period|Reason not Specified|9|||
130074170|NCT02371980|468226719|FG001|Open-label Period|Reason not Specified|0|||
130074171|NCT02371980|468226720|FG002|Open-label Period|Reason not Specified|0|||
130074172|NCT02371980|468226721|FG003|Open-label Period|Reason not Specified|0|||
130074173|NCT02371980|468226722|FG004|Open-label Period|Reason not Specified|0|||
130074174|NCT02371980|468226718|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
130074175|NCT02371980|468226719|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
130074176|NCT02371980|468226720|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
130074177|NCT02371980|468226721|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
130074178|NCT02371980|468226722|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
130074179|NCT02371980|468226718|FG000|Double-blind Period|Significant Protocol Deviation|0|||
130074180|NCT02371980|468226719|FG001|Double-blind Period|Significant Protocol Deviation|2|||
130074181|NCT02371980|468226720|FG002|Double-blind Period|Significant Protocol Deviation|7|||
130074182|NCT02371980|468226721|FG003|Double-blind Period|Significant Protocol Deviation|3|||
130074183|NCT02371980|468226722|FG004|Double-blind Period|Significant Protocol Deviation|3|||
130074184|NCT02371980|468226718|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
130074185|NCT02371980|468226719|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
130074186|NCT02371980|468226720|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
130074187|NCT02371980|468226721|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
130074188|NCT02371980|468226722|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
130074189|NCT02371980|468226718|FG000|Double-blind Period|Lost to Follow-up|0|||
130074190|NCT02371980|468226719|FG001|Double-blind Period|Lost to Follow-up|8|||
130074191|NCT02371980|468226720|FG002|Double-blind Period|Lost to Follow-up|8|||
130074192|NCT02371980|468226721|FG003|Double-blind Period|Lost to Follow-up|6|||
130074193|NCT02371980|468226722|FG004|Double-blind Period|Lost to Follow-up|5|||
130074194|NCT02371980|468226718|FG000|Double-blind Period|Voluntary Withdrawal|0|||
130074195|NCT02371980|468226719|FG001|Double-blind Period|Voluntary Withdrawal|12|||
130074196|NCT02371980|468226720|FG002|Double-blind Period|Voluntary Withdrawal|8|||
130074197|NCT02371980|468226721|FG003|Double-blind Period|Voluntary Withdrawal|9|||
130074198|NCT02371980|468226722|FG004|Double-blind Period|Voluntary Withdrawal|11|||
130074199|NCT02371980|468226718|FG000|Double-blind Period|Relapse|0|||
130074200|NCT02371980|468226719|FG001|Double-blind Period|Relapse|50|||
130074201|NCT02371980|468226720|FG002|Double-blind Period|Relapse|25|||
130074202|NCT02371980|468226721|FG003|Double-blind Period|Relapse|25|||
129951055|NCT02823574|467783020|FG003|Treatment Period|Participant request to discontinue|2|||
129951056|NCT02823574|467783017|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
129951057|NCT02823574|467783018|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
129951058|NCT02823574|467783019|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
129951059|NCT02823574|467783020|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
129951060|NCT02823574|467783017|FG000|Treatment Period|Study Drug Toxicity|11|||
129951061|NCT02823574|467783018|FG001|Treatment Period|Study Drug Toxicity|2|||
129951062|NCT02823574|467783019|FG002|Treatment Period|Study Drug Toxicity|14|||
129951063|NCT02823574|467783020|FG003|Treatment Period|Study Drug Toxicity|4|||
129951064|NCT02823574|467783017|FG000|Treatment Period|Disease Progression|113|||
129951065|NCT02823574|467783018|FG001|Treatment Period|Disease Progression|64|||
129951066|NCT02823574|467783019|FG002|Treatment Period|Disease Progression|82|||
129951067|NCT02823574|467783020|FG003|Treatment Period|Disease Progression|43|||
129951068|NCT02823574|467783017|FG000|Treatment Period|Other reasons|5|||
129951069|NCT02823574|467783018|FG001|Treatment Period|Other reasons|9|||
129951070|NCT02823574|467783019|FG002|Treatment Period|Other reasons|3|||
129951071|NCT02823574|467783020|FG003|Treatment Period|Other reasons|6|||
129951072|NCT02823574|467783017|FG000|Treatment Period|Participant no longer meets study criteria|0|||
129951073|NCT02823574|467783018|FG001|Treatment Period|Participant no longer meets study criteria|0|||
129951074|NCT02823574|467783019|FG002|Treatment Period|Participant no longer meets study criteria|1|||
129951075|NCT02823574|467783020|FG003|Treatment Period|Participant no longer meets study criteria|0|||
129951076|NCT02823574|467783017|FG000|Treatment Period|Death|0|||
129951077|NCT02823574|467783018|FG001|Treatment Period|Death|0|||
129951078|NCT02823574|467783019|FG002|Treatment Period|Death|3|||
129951079|NCT02823574|467783020|FG003|Treatment Period|Death|1|||
130074203|NCT02371980|468226722|FG004|Double-blind Period|Relapse|26|||
129951080|NCT00590759|467783021|FG000|Overall Study|Death|52|||
129951081|NCT00590759|467783021|FG000|Overall Study|Lost to Follow-up|28|||
130074204|NCT02371980|468226718|FG000|Double-blind Period|Reason not Specified|0|||
130074205|NCT02371980|468226719|FG001|Double-blind Period|Reason not Specified|3|||
130074206|NCT02371980|468226720|FG002|Double-blind Period|Reason not Specified|3|||
130074207|NCT02371980|468226721|FG003|Double-blind Period|Reason not Specified|2|||
130120504|NCT03595657|468402392|FG000|Overall Study|Withdrawal by Subject|10|||
130120505|NCT03595657|468402392|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
130120506|NCT03595657|468402392|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
130120507|NCT01361126|468402393|FG000|Overall Study|Sponsor decision|0|||
130120508|NCT01361126|468402394|FG001|Overall Study|Sponsor decision|2|||
130120509|NCT00663871|468402396|FG000|Overall Study|Lost to Follow-up|5|||
130120510|NCT00663871|468402397|FG001|Overall Study|Lost to Follow-up|5|||
130120511|NCT00663871|468402396|FG000|Overall Study|Withdrawal by Subject|5|||
130074208|NCT02371980|468226722|FG004|Double-blind Period|Reason not Specified|1|||
130074209|NCT02371980|468226718|FG000|Double-blind Period|Missing|0|||
130074210|NCT02371980|468226719|FG001|Double-blind Period|Missing|1|||
130074211|NCT02371980|468226720|FG002|Double-blind Period|Missing|0|||
130074212|NCT02371980|468226721|FG003|Double-blind Period|Missing|0|||
130074213|NCT02371980|468226722|FG004|Double-blind Period|Missing|0|||
130074214|NCT01826448|468226724|FG000|Overall Study|Adverse Event|1|||
130074215|NCT01826448|468226725|FG001|Overall Study|Adverse Event|3|||
130074216|NCT01826448|468226724|FG000|Overall Study|Disease progression|2|||
130074217|NCT01826448|468226725|FG001|Overall Study|Disease progression|4|||
130074218|NCT01826448|468226724|FG000|Overall Study|Withdrawal by Subject|1|||
130074219|NCT01826448|468226725|FG001|Overall Study|Withdrawal by Subject|0|||
130074220|NCT01826448|468226724|FG000|Overall Study|Physician Decision|0|||
130074221|NCT01826448|468226725|FG001|Overall Study|Physician Decision|1|||
130074222|NCT01826448|468226724|FG000|Overall Study|2 active cancers|0|||
130074223|NCT01826448|468226725|FG001|Overall Study|2 active cancers|1|||
130074224|NCT00790218|468226726|FG000|Overall Study|Death|1|||
130074225|NCT00790218|468226727|FG001|Overall Study|Death|0|||
130074226|NCT00790218|468226728|FG002|Overall Study|Death|0|||
130074227|NCT03424044|468226730|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074228|NCT03424044|468226731|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074229|NCT03424044|468226732|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
130074230|NCT03424044|468226733|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074231|NCT03424044|468226734|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074232|NCT03424044|468226735|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074233|NCT03424044|468226736|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074234|NCT03424044|468226737|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074235|NCT03424044|468226738|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
130074236|NCT03424044|468226730|FG000|First Intervention (76 Hours)|Adverse Event|0|||
130074237|NCT03424044|468226731|FG001|First Intervention (76 Hours)|Adverse Event|0|||
130074238|NCT03424044|468226732|FG002|First Intervention (76 Hours)|Adverse Event|0|||
130074239|NCT03424044|468226733|FG003|First Intervention (76 Hours)|Adverse Event|0|||
130074240|NCT03424044|468226734|FG004|First Intervention (76 Hours)|Adverse Event|1|||
130074241|NCT03424044|468226735|FG005|First Intervention (76 Hours)|Adverse Event|0|||
130074242|NCT03424044|468226736|FG006|First Intervention (76 Hours)|Adverse Event|0|||
130074243|NCT03424044|468226737|FG007|First Intervention (76 Hours)|Adverse Event|0|||
130074244|NCT03424044|468226738|FG008|First Intervention (76 Hours)|Adverse Event|0|||
130074245|NCT03424044|468226730|FG000|First Intervention (76 Hours)|device issues|0|||
130074246|NCT03424044|468226731|FG001|First Intervention (76 Hours)|device issues|0|||
130074247|NCT03424044|468226732|FG002|First Intervention (76 Hours)|device issues|0|||
130074248|NCT03424044|468226733|FG003|First Intervention (76 Hours)|device issues|0|||
130074249|NCT03424044|468226734|FG004|First Intervention (76 Hours)|device issues|0|||
130074250|NCT03424044|468226735|FG005|First Intervention (76 Hours)|device issues|0|||
130074251|NCT03424044|468226736|FG006|First Intervention (76 Hours)|device issues|1|||
130074252|NCT03424044|468226737|FG007|First Intervention (76 Hours)|device issues|1|||
130074253|NCT03424044|468226738|FG008|First Intervention (76 Hours)|device issues|1|||
130074254|NCT03424044|468226730|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
130120512|NCT00663871|468402397|FG001|Overall Study|Withdrawal by Subject|2|||
130120513|NCT04094870|468402398|FG000|Overall Study|Lost to Follow-up|1|||
130074255|NCT03424044|468226731|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
130074256|NCT03424044|468226732|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
130074257|NCT03424044|468226733|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
130074258|NCT03424044|468226734|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
130074259|NCT03424044|468226735|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
130074260|NCT03424044|468226736|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
130074261|NCT03424044|468226737|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
130074262|NCT03424044|468226738|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
130074263|NCT03424044|468226730|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074264|NCT03424044|468226731|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074265|NCT03424044|468226732|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074266|NCT03424044|468226733|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
130074267|NCT03424044|468226734|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130120514|NCT04094870|468402399|FG001|Overall Study|Lost to Follow-up|1|||
130120515|NCT03384745|468402402|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130074268|NCT03424044|468226735|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074269|NCT03424044|468226736|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074270|NCT03424044|468226737|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074271|NCT03424044|468226738|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
130074272|NCT02971007|468226741|FG000|Overall Study|Adverse Event|1|||
130074273|NCT02971007|468226742|FG001|Overall Study|Adverse Event|0|||
130074274|NCT02971007|468226743|FG002|Overall Study|Adverse Event|0|||
130074275|NCT02971007|468226741|FG000|Overall Study|Lost to Follow-up|0|||
130074276|NCT02971007|468226742|FG001|Overall Study|Lost to Follow-up|1|||
130074277|NCT02971007|468226743|FG002|Overall Study|Lost to Follow-up|1|||
130074278|NCT02971007|468226741|FG000|Overall Study|Withdrawal by Subject|0|||
130074279|NCT02971007|468226742|FG001|Overall Study|Withdrawal by Subject|1|||
130074280|NCT02971007|468226743|FG002|Overall Study|Withdrawal by Subject|0|||
130074281|NCT02971007|468226741|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
130074282|NCT02971007|468226742|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
130074283|NCT02971007|468226743|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
130074284|NCT02971007|468226741|FG000|Overall Study|Patient discontinued study drug|0|||
130074285|NCT02971007|468226742|FG001|Overall Study|Patient discontinued study drug|1|||
130074286|NCT02971007|468226743|FG002|Overall Study|Patient discontinued study drug|0|||
130074287|NCT00402285|468226746|FG000|Overall Study|insufficient RNA quality|7|||
130074288|NCT00402285|468226747|FG001|Overall Study|insufficient RNA quality|6|||
130074289|NCT00402285|468226748|FG002|Overall Study|insufficient RNA quality|2|||
130074290|NCT02431702|468226751|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
130074291|NCT02431702|468226752|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130074292|NCT02431702|468226753|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130074293|NCT02431702|468226754|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130074294|NCT02431702|468226755|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130074295|NCT02431702|468226756|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130074296|NCT02431702|468226757|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
130074297|NCT02431702|468226751|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
130074298|NCT02431702|468226752|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130074299|NCT02431702|468226753|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130074300|NCT02431702|468226754|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130074301|NCT02431702|468226755|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130074302|NCT02431702|468226756|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
130074303|NCT02431702|468226757|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
130074304|NCT02431702|468226751|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
130074305|NCT02431702|468226752|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130074306|NCT02431702|468226753|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130074307|NCT02431702|468226754|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130074308|NCT02431702|468226755|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130074309|NCT02431702|468226756|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
130074310|NCT02431702|468226757|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
130074311|NCT02431702|468226751|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
130074312|NCT02431702|468226752|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130074313|NCT02431702|468226753|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130074314|NCT02431702|468226754|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130074315|NCT02431702|468226755|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130074316|NCT02431702|468226756|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
130074317|NCT02431702|468226757|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
130074318|NCT02431702|468226751|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
130074319|NCT02431702|468226752|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130074320|NCT02431702|468226753|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130074321|NCT02431702|468226754|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130074322|NCT02431702|468226755|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130074323|NCT02431702|468226756|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130074324|NCT02431702|468226757|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
130074325|NCT02431702|468226751|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130074326|NCT02431702|468226752|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
130074327|NCT02431702|468226753|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
130074328|NCT02431702|468226754|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130074329|NCT02431702|468226755|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130074330|NCT02431702|468226756|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130074331|NCT02431702|468226757|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
130074332|NCT02431702|468226751|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130074333|NCT02431702|468226752|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
130074334|NCT02431702|468226753|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
130074335|NCT02431702|468226754|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
129951082|NCT00417885|467783022|FG000|Overall Study|Adverse Event|1|||
129951083|NCT00417885|467783022|FG000|Overall Study|Objective Progression or Relapse|3|||
129951084|NCT00417885|467783022|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
129951085|NCT01190436|467783023|FG000|Overall Study|Lost to Follow-up|35|||
129951086|NCT01190436|467783023|FG000|Overall Study|Other|4|||
129951087|NCT02721147|467783024|FG000|Overall Study|Lost to Follow-up|2|||
129951088|NCT02721147|467783025|FG001|Overall Study|Lost to Follow-up|0|||
129951089|NCT02721147|467783026|FG002|Overall Study|Lost to Follow-up|0|||
129951090|NCT01722097|467783028|FG000|Overall Study|Patient sheets not returned|6|||
129951091|NCT01722097|467783029|FG001|Overall Study|Patient sheets not returned|5|||
129951092|NCT02009332|467783030|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951093|NCT02009332|467783031|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
129951094|NCT02009332|467783032|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951095|NCT02009332|467783033|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951096|NCT02009332|467783034|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951097|NCT02009332|467783035|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951098|NCT02009332|467783030|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951099|NCT02009332|467783031|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951100|NCT02009332|467783032|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951101|NCT02009332|467783033|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951102|NCT02009332|467783034|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
129951103|NCT02009332|467783035|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951104|NCT02009332|467783030|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951105|NCT02009332|467783031|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951106|NCT02009332|467783032|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951107|NCT02009332|467783033|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951108|NCT02009332|467783034|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951109|NCT02009332|467783035|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
129951110|NCT00248794|467783037|FG000|Overall Study|Lost to Follow-up|6|||
129951111|NCT00248794|467783038|FG001|Overall Study|Lost to Follow-up|8|||
129951112|NCT00248794|467783039|FG002|Overall Study|Lost to Follow-up|3|||
129951113|NCT03449979|467783040|FG000|Overall Study|Technical difficulty|0|||
129951114|NCT03449979|467783041|FG001|Overall Study|Technical difficulty|0|||
129951115|NCT03449979|467783042|FG002|Overall Study|Technical difficulty|0|||
129951116|NCT03449979|467783043|FG003|Overall Study|Technical difficulty|1|||
129951117|NCT02632747|467783044|FG000|Wash-out Period|Adverse Event|1|||
129951118|NCT02632747|467783045|FG001|Wash-out Period|Adverse Event|0|||
129951119|NCT02069379|467783046|FG000|Baseline Measurements|Lost to Follow-up|1|||
129951120|NCT02069379|467783047|FG001|Baseline Measurements|Lost to Follow-up|0|||
129951121|NCT02069379|467783048|FG002|Baseline Measurements|Lost to Follow-up|0|||
129951122|NCT02069379|467783049|FG003|Baseline Measurements|Lost to Follow-up|0|||
129951123|NCT02069379|467783046|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
129951124|NCT02069379|467783047|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
129951125|NCT02069379|467783048|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
129951126|NCT02069379|467783049|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
129951127|NCT02069379|467783046|FG000|First Treatment Arm|Lost to Follow-up|0|||
129951128|NCT02069379|467783047|FG001|First Treatment Arm|Lost to Follow-up|1|||
129951129|NCT02069379|467783048|FG002|First Treatment Arm|Lost to Follow-up|1|||
129951130|NCT02069379|467783049|FG003|First Treatment Arm|Lost to Follow-up|0|||
129951131|NCT02069379|467783046|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
129951132|NCT02069379|467783047|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
129951133|NCT02069379|467783048|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
129951134|NCT02069379|467783049|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
129951135|NCT02069379|467783046|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
129951136|NCT02069379|467783047|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
129951137|NCT02069379|467783048|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
129951138|NCT02069379|467783049|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
129951139|NCT02069379|467783046|FG000|Second Treatment Arm|Lost to Follow-up|0|||
129951140|NCT02069379|467783047|FG001|Second Treatment Arm|Lost to Follow-up|0|||
129951141|NCT02069379|467783048|FG002|Second Treatment Arm|Lost to Follow-up|1|||
130074336|NCT02431702|468226755|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130074337|NCT02431702|468226756|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130074338|NCT02431702|468226757|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
130074339|NCT02431702|468226751|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130074340|NCT02431702|468226752|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
129951142|NCT02069379|467783049|FG003|Second Treatment Arm|Lost to Follow-up|0|||
129951143|NCT00700999|467783052|FG000|Overall Study|Lost to Follow-up|7|||
129951144|NCT00700999|467783053|FG001|Overall Study|Lost to Follow-up|7|||
129951145|NCT00700999|467783052|FG000|Overall Study|Excluded - did not meet study criteria|0|||
129951146|NCT00700999|467783053|FG001|Overall Study|Excluded - did not meet study criteria|1|||
129951147|NCT00700999|467783052|FG000|Overall Study|Withdrawal by Subject|8|||
130074341|NCT02431702|468226753|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
130074342|NCT02431702|468226754|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130074343|NCT02431702|468226755|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130074344|NCT02431702|468226756|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130074345|NCT02431702|468226757|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
130074346|NCT02431702|468226751|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130074347|NCT02431702|468226752|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
130074348|NCT02431702|468226753|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130074349|NCT02431702|468226754|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130074350|NCT02431702|468226755|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130074351|NCT02431702|468226756|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130074352|NCT02431702|468226757|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
130074353|NCT02431702|468226751|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
130074354|NCT02431702|468226752|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
130074355|NCT02431702|468226753|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
130074356|NCT02431702|468226754|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
130074357|NCT02431702|468226755|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
130074358|NCT02431702|468226756|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
130074359|NCT02431702|468226757|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
130074360|NCT02431702|468226751|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130074361|NCT02431702|468226752|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130074362|NCT02431702|468226753|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
130074363|NCT02431702|468226754|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130074364|NCT02431702|468226755|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130074365|NCT02431702|468226756|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130074366|NCT02431702|468226757|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
130074367|NCT02431702|468226751|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130074368|NCT02431702|468226752|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130074369|NCT02431702|468226753|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129951148|NCT00700999|467783053|FG001|Overall Study|Withdrawal by Subject|1|||
129951149|NCT03481725|467783054|FG000|Overall Study|Withdrawal by Subject|1|||
130074370|NCT02431702|468226754|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
130074371|NCT02431702|468226755|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
130074372|NCT02431702|468226756|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130074373|NCT02431702|468226757|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
130074374|NCT02431702|468226751|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130074375|NCT02431702|468226752|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130074376|NCT02431702|468226753|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130074377|NCT02431702|468226754|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
130074378|NCT02431702|468226755|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130074379|NCT02431702|468226756|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
130074380|NCT02431702|468226757|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
130074381|NCT02431702|468226751|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130074382|NCT02431702|468226752|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130074383|NCT02431702|468226753|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130074384|NCT02431702|468226754|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
130074385|NCT02431702|468226755|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
130074386|NCT02431702|468226756|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
130074387|NCT02431702|468226757|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
130074388|NCT02431702|468226751|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
130074389|NCT02431702|468226752|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
130074390|NCT02431702|468226753|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
130074391|NCT02431702|468226754|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
130074392|NCT02431702|468226755|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
130074393|NCT02431702|468226756|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
130074394|NCT02431702|468226757|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
130074395|NCT02009930|468226758|FG000|Overall Study|withdrawn|5|||
130074396|NCT02959970|468226764|FG000|Overall Study|Adverse Event|1|||
130074397|NCT02959970|468226765|FG001|Overall Study|Adverse Event|0|||
130074398|NCT02959970|468226764|FG000|Overall Study|Withdrawal by Subject|0|||
130074399|NCT02959970|468226765|FG001|Overall Study|Withdrawal by Subject|2|||
130074400|NCT02959970|468226764|FG000|Overall Study|Lost to Follow-up|1|||
130074401|NCT02959970|468226765|FG001|Overall Study|Lost to Follow-up|5|||
130074402|NCT00693420|468226768|FG000|Overall Study|Adverse Event|4|||
130074403|NCT00693420|468226769|FG001|Overall Study|Adverse Event|4|||
130074404|NCT00693420|468226768|FG000|Overall Study|Lost to Follow-up|0|||
129951150|NCT03481725|467783055|FG001|Overall Study|Withdrawal by Subject|0|||
129951151|NCT03651271|467783056|FG000|Overall Study|Death|4|||
129951152|NCT03651271|467783057|FG001|Overall Study|Death|37|||
129951153|NCT03651271|467783058|FG002|Overall Study|Death|0|||
129951154|NCT03651271|467783059|FG003|Overall Study|Death|2|||
129951155|NCT03651271|467783060|FG004|Overall Study|Death|6|||
129951156|NCT03651271|467783056|FG000|Overall Study|Lost to Follow-up|1|||
129951157|NCT03651271|467783057|FG001|Overall Study|Lost to Follow-up|5|||
129951158|NCT03651271|467783058|FG002|Overall Study|Lost to Follow-up|0|||
129951159|NCT03651271|467783059|FG003|Overall Study|Lost to Follow-up|1|||
129951160|NCT03651271|467783060|FG004|Overall Study|Lost to Follow-up|0|||
129951161|NCT03651271|467783056|FG000|Overall Study|Physician Decision|0|||
129951162|NCT03651271|467783057|FG001|Overall Study|Physician Decision|2|||
129951163|NCT03651271|467783058|FG002|Overall Study|Physician Decision|0|||
129951164|NCT03651271|467783059|FG003|Overall Study|Physician Decision|0|||
129951165|NCT03651271|467783060|FG004|Overall Study|Physician Decision|0|||
129951166|NCT03651271|467783056|FG000|Overall Study|Withdrawal by Subject|1|||
129951167|NCT03651271|467783057|FG001|Overall Study|Withdrawal by Subject|15|||
129951168|NCT03651271|467783058|FG002|Overall Study|Withdrawal by Subject|0|||
129951169|NCT03651271|467783059|FG003|Overall Study|Withdrawal by Subject|0|||
129951170|NCT03651271|467783060|FG004|Overall Study|Withdrawal by Subject|1|||
129951171|NCT03651271|467783056|FG000|Overall Study|Patient medically unable to continue|0|||
129951172|NCT03651271|467783057|FG001|Overall Study|Patient medically unable to continue|0|||
129951173|NCT03651271|467783058|FG002|Overall Study|Patient medically unable to continue|0|||
129951174|NCT03651271|467783059|FG003|Overall Study|Patient medically unable to continue|1|||
129951175|NCT03651271|467783060|FG004|Overall Study|Patient medically unable to continue|0|||
129951176|NCT03444155|467783063|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
129951177|NCT03444155|467783064|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
129951178|NCT02877680|467783069|FG000|Overall Study|Lost to Follow-up|1|||
129951179|NCT02877680|467783070|FG001|Overall Study|Lost to Follow-up|1|||
129951180|NCT02991118|467783077|FG000|Overall Study|Death|3|||
129951181|NCT02991118|467783078|FG001|Overall Study|Death|8|||
129951182|NCT02991118|467783077|FG000|Overall Study|Protocol Violation|0|||
129951183|NCT02991118|467783078|FG001|Overall Study|Protocol Violation|3|||
129951184|NCT02991118|467783077|FG000|Overall Study|Physician Decision|0|||
129951185|NCT02991118|467783078|FG001|Overall Study|Physician Decision|1|||
129951186|NCT02991118|467783077|FG000|Overall Study|Moved out of the country|0|||
129951187|NCT02991118|467783078|FG001|Overall Study|Moved out of the country|1|||
129951188|NCT02991118|467783077|FG000|Overall Study|Adverse Event|2|||
129951189|NCT02991118|467783078|FG001|Overall Study|Adverse Event|2|||
129951190|NCT02991118|467783077|FG000|Overall Study|Withdrawal by Subject|1|||
129951191|NCT02991118|467783078|FG001|Overall Study|Withdrawal by Subject|7|||
129951192|NCT02991118|467783077|FG000|Overall Study|Could not attend study visits|0|||
129951193|NCT02991118|467783078|FG001|Overall Study|Could not attend study visits|1|||
129951194|NCT02991118|467783077|FG000|Overall Study|Lost to Follow-up|1|||
129951195|NCT02991118|467783078|FG001|Overall Study|Lost to Follow-up|9|||
129951196|NCT00595959|467783079|FG000|Overall Study|Withdrawal by Subject|1|||
129951197|NCT00595959|467783079|FG000|Overall Study|Lost to Follow-up|1|||
129951198|NCT05700851|467783085|FG000|Overall Study|Received a kidney transplant|1|||
129951199|NCT05700851|467783085|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
129951200|NCT05700851|467783085|FG000|Overall Study|Withdrawal by Subject|1|||
129951201|NCT00589628|467783086|FG000|Overall Study|Lost to Follow-up|0|||
129951202|NCT00589628|467783087|FG001|Overall Study|Lost to Follow-up|1|||
129951203|NCT00736502|467783095|FG000|Overall Study|Adverse Event|22|||
129951204|NCT00736502|467783095|FG000|Overall Study|Lack of Efficacy|16|||
129951205|NCT00736502|467783095|FG000|Overall Study|Lost to Follow-up|27|||
129951206|NCT03032198|467783096|FG000|Overall Study|Screen Fail|1|||
129951207|NCT03100370|467783097|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951208|NCT03100370|467783098|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951209|NCT03100370|467783099|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951210|NCT03100370|467783100|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129951211|NCT03100370|467783101|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951212|NCT03100370|467783102|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951213|NCT01307800|467783103|FG000|Overall Study|Adverse Event|9|||
129951214|NCT01307800|467783104|FG001|Overall Study|Adverse Event|8|||
129951215|NCT01307800|467783105|FG002|Overall Study|Adverse Event|10|||
129951216|NCT01307800|467783106|FG003|Overall Study|Adverse Event|14|||
129951217|NCT01307800|467783103|FG000|Overall Study|Entry Criteria Not Met|0|||
129951218|NCT01307800|467783104|FG001|Overall Study|Entry Criteria Not Met|0|||
129951219|NCT01307800|467783105|FG002|Overall Study|Entry Criteria Not Met|0|||
129951220|NCT01307800|467783106|FG003|Overall Study|Entry Criteria Not Met|2|||
129951221|NCT01307800|467783103|FG000|Overall Study|Lost to Follow-up|5|||
129951222|NCT01307800|467783104|FG001|Overall Study|Lost to Follow-up|6|||
129951223|NCT01307800|467783105|FG002|Overall Study|Lost to Follow-up|2|||
129951224|NCT01307800|467783106|FG003|Overall Study|Lost to Follow-up|8|||
129951225|NCT01307800|467783103|FG000|Overall Study|Perceived Lack of Efficacy|24|||
129951226|NCT01307800|467783104|FG001|Overall Study|Perceived Lack of Efficacy|23|||
130074405|NCT00693420|468226769|FG001|Overall Study|Lost to Follow-up|3|||
130074406|NCT00693420|468226768|FG000|Overall Study|Withdrawal by Subject|1|||
130074407|NCT00693420|468226769|FG001|Overall Study|Withdrawal by Subject|0|||
130074408|NCT00693420|468226768|FG000|Overall Study|Protocol Violation|0|||
130074409|NCT00693420|468226769|FG001|Overall Study|Protocol Violation|2|||
130074410|NCT00693420|468226768|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
130074411|NCT00693420|468226769|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
130074412|NCT00693420|468226768|FG000|Overall Study|Personal Reasons|1|||
130074413|NCT00693420|468226769|FG001|Overall Study|Personal Reasons|4|||
130074414|NCT03250624|468226775|FG000|Overall Study|Lack of Efficacy|1|||
130074415|NCT03250624|468226776|FG001|Overall Study|Lack of Efficacy|4|||
130074416|NCT03250624|468226775|FG000|Overall Study|Adverse Event|0|||
130074417|NCT03250624|468226776|FG001|Overall Study|Adverse Event|1|||
130074418|NCT03250624|468226775|FG000|Overall Study|Other|1|||
130074419|NCT03250624|468226776|FG001|Overall Study|Other|2|||
130074420|NCT00509028|468226780|FG000|Overall Study|Adverse Event|2|||
130074421|NCT00509028|468226781|FG001|Overall Study|Adverse Event|0|||
130074422|NCT00509028|468226780|FG000|Overall Study|Withdrawal by Subject|4|||
130074423|NCT00509028|468226781|FG001|Overall Study|Withdrawal by Subject|3|||
130074424|NCT00509028|468226780|FG000|Overall Study|Lost to Follow-up|0|||
130074425|NCT00509028|468226781|FG001|Overall Study|Lost to Follow-up|1|||
130074426|NCT00509028|468226780|FG000|Overall Study|Protocol Violation|4|||
130074427|NCT00509028|468226781|FG001|Overall Study|Protocol Violation|2|||
130074428|NCT00509028|468226780|FG000|Overall Study|Non-compliance|2|||
130074429|NCT00509028|468226781|FG001|Overall Study|Non-compliance|1|||
130074430|NCT00948428|468226782|FG000|Overall Study|Withdrawal by Subject|6|||
130074431|NCT00948428|468226783|FG001|Overall Study|Withdrawal by Subject|12|||
130074432|NCT00948428|468226784|FG002|Overall Study|Withdrawal by Subject|7|||
130074433|NCT00948428|468226782|FG000|Overall Study|Adverse Event|6|||
130074434|NCT00948428|468226783|FG001|Overall Study|Adverse Event|3|||
130074435|NCT00948428|468226784|FG002|Overall Study|Adverse Event|0|||
130074436|NCT00948428|468226782|FG000|Overall Study|Lost to Follow-up|2|||
130074437|NCT00948428|468226783|FG001|Overall Study|Lost to Follow-up|1|||
130074438|NCT00948428|468226784|FG002|Overall Study|Lost to Follow-up|1|||
130074439|NCT00948428|468226782|FG000|Overall Study|Death|2|||
130074440|NCT00948428|468226783|FG001|Overall Study|Death|0|||
130074441|NCT00948428|468226784|FG002|Overall Study|Death|0|||
130074442|NCT00948428|468226782|FG000|Overall Study|Intercurrent Illness|1|||
130074443|NCT00948428|468226783|FG001|Overall Study|Intercurrent Illness|0|||
130074444|NCT00948428|468226784|FG002|Overall Study|Intercurrent Illness|0|||
130074445|NCT00948428|468226782|FG000|Overall Study|Non-compliance|1|||
130074446|NCT00948428|468226783|FG001|Overall Study|Non-compliance|2|||
130074447|NCT00948428|468226784|FG002|Overall Study|Non-compliance|0|||
130074448|NCT02408484|468226785|FG000|Overall Study|Withdrawal by Subject|3|||
130074449|NCT02408484|468226785|FG000|Overall Study|Not treated during study period|1|||
130074450|NCT02471586|468226786|FG000|Overall Study|Lost to Follow-up|3|||
130074451|NCT02471586|468226787|FG001|Overall Study|Lost to Follow-up|8|||
130074452|NCT02471586|468226788|FG002|Overall Study|Lost to Follow-up|4|||
130074453|NCT02471586|468226786|FG000|Overall Study|Death|2|||
130074454|NCT02471586|468226787|FG001|Overall Study|Death|2|||
130074455|NCT02471586|468226788|FG002|Overall Study|Death|0|||
130120516|NCT03384745|468402403|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130120517|NCT03384745|468402404|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
130120518|NCT03384745|468402405|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
130120519|NCT03384745|468402406|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130120520|NCT03384745|468402407|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
130120521|NCT03384745|468402402|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130120522|NCT03384745|468402403|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130074456|NCT00441727|468226791|FG000|Overall Study|Protocol Violation|19|||
130074457|NCT00441727|468226792|FG001|Overall Study|Protocol Violation|28|||
130074458|NCT00441727|468226793|FG002|Overall Study|Protocol Violation|32|||
130074459|NCT00441727|468226791|FG000|Overall Study|Adverse Event|26|||
130074460|NCT00441727|468226792|FG001|Overall Study|Adverse Event|33|||
130074461|NCT00441727|468226793|FG002|Overall Study|Adverse Event|28|||
130074462|NCT00441727|468226791|FG000|Overall Study|Lack of Efficacy|7|||
130074463|NCT00441727|468226792|FG001|Overall Study|Lack of Efficacy|8|||
130074464|NCT00441727|468226793|FG002|Overall Study|Lack of Efficacy|48|||
130074465|NCT00441727|468226791|FG000|Overall Study|Withdrawal by Subject|40|||
130074466|NCT00441727|468226792|FG001|Overall Study|Withdrawal by Subject|34|||
130074467|NCT00441727|468226793|FG002|Overall Study|Withdrawal by Subject|47|||
130074468|NCT00441727|468226791|FG000|Overall Study|Lost to Follow-up|5|||
130074469|NCT00441727|468226792|FG001|Overall Study|Lost to Follow-up|6|||
130074470|NCT00441727|468226793|FG002|Overall Study|Lost to Follow-up|5|||
130074471|NCT00441727|468226791|FG000|Overall Study|Safety Reasons|3|||
130074472|NCT00441727|468226792|FG001|Overall Study|Safety Reasons|1|||
130074473|NCT00441727|468226793|FG002|Overall Study|Safety Reasons|3|||
130074474|NCT00441727|468226791|FG000|Overall Study|Various reason specified|6|||
130074475|NCT00441727|468226792|FG001|Overall Study|Various reason specified|8|||
130074476|NCT00441727|468226793|FG002|Overall Study|Various reason specified|5|||
130074477|NCT03235726|468226796|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074478|NCT03235726|468226797|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074479|NCT03235726|468226798|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074480|NCT03235726|468226799|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074481|NCT03235726|468226800|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
130074482|NCT03235726|468226801|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074483|NCT03235726|468226802|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074484|NCT03235726|468226803|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074485|NCT03235726|468226804|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074486|NCT03235726|468226805|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
130074487|NCT03235726|468226796|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074488|NCT03235726|468226797|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074489|NCT03235726|468226798|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074490|NCT03235726|468226799|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074491|NCT03235726|468226800|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
130074492|NCT03235726|468226801|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074493|NCT03235726|468226802|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074494|NCT03235726|468226803|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074495|NCT03235726|468226804|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074496|NCT03235726|468226805|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
130074497|NCT03135262|468226809|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
130074498|NCT03135262|468226810|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130074499|NCT03135262|468226811|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130074500|NCT03135262|468226812|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130074501|NCT03135262|468226813|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
130074502|NCT03135262|468226809|FG000|Overall Study|Progression of disease|0|||
130074503|NCT03135262|468226810|FG001|Overall Study|Progression of disease|0|||
130074504|NCT03135262|468226811|FG002|Overall Study|Progression of disease|0|||
130074505|NCT03135262|468226812|FG003|Overall Study|Progression of disease|1|||
130074506|NCT03135262|468226813|FG004|Overall Study|Progression of disease|0|||
130074507|NCT03135262|468226809|FG000|Overall Study|Death|6|||
130074508|NCT03135262|468226810|FG001|Overall Study|Death|2|||
130074509|NCT03135262|468226811|FG002|Overall Study|Death|2|||
130074510|NCT03135262|468226812|FG003|Overall Study|Death|2|||
130074511|NCT03135262|468226813|FG004|Overall Study|Death|0|||
130074512|NCT03135262|468226809|FG000|Overall Study|Withdrawal by Subject|0|||
130074513|NCT03135262|468226810|FG001|Overall Study|Withdrawal by Subject|0|||
130074514|NCT03135262|468226811|FG002|Overall Study|Withdrawal by Subject|1|||
130074515|NCT03135262|468226812|FG003|Overall Study|Withdrawal by Subject|0|||
130074516|NCT03135262|468226813|FG004|Overall Study|Withdrawal by Subject|1|||
130074517|NCT03135262|468226809|FG000|Overall Study|Study terminated by sponsor|2|||
130074518|NCT03135262|468226810|FG001|Overall Study|Study terminated by sponsor|4|||
130074519|NCT03135262|468226811|FG002|Overall Study|Study terminated by sponsor|4|||
130074520|NCT03135262|468226812|FG003|Overall Study|Study terminated by sponsor|3|||
130074521|NCT03135262|468226813|FG004|Overall Study|Study terminated by sponsor|0|||
130074522|NCT01675141|468226814|FG000|Overall Study|Lenalidomide outside NIH|3|||
130074523|NCT01675141|468226814|FG000|Overall Study|Withdrawal by Subject|3|||
130074524|NCT01675141|468226814|FG000|Overall Study|Physician Decision|4|||
130074525|NCT01675141|468226814|FG000|Overall Study|No treatment, per protocol|1|||
130074526|NCT01599806|468226819|FG000|Overall Study|Lost to Follow-up|20|||
130074527|NCT01599806|468226820|FG001|Overall Study|Lost to Follow-up|20|||
130120523|NCT03384745|468402404|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130074528|NCT01599806|468226819|FG000|Overall Study|Withdrawal by Subject|12|||
130074529|NCT01599806|468226820|FG001|Overall Study|Withdrawal by Subject|12|||
130074530|NCT01599806|468226819|FG000|Overall Study|Other Eligibility criteria|11|||
130074531|NCT01599806|468226820|FG001|Overall Study|Other Eligibility criteria|9|||
130074532|NCT00391807|468226823|FG000|Overall Study|Did not receive study medication|23|||
130074533|NCT00391807|468226823|FG000|Overall Study|Adverse Event|177|||
130074534|NCT00391807|468226823|FG000|Overall Study|Pregnancy|25|||
130074535|NCT00391807|468226823|FG000|Overall Study|Lost to Follow-up|227|||
130074536|NCT00391807|468226823|FG000|Overall Study|Withdrawal by Subject|147|||
130074537|NCT00391807|468226823|FG000|Overall Study|Protocol Violation|20|||
130074538|NCT00391807|468226823|FG000|Overall Study|Various|96|||
130074539|NCT02417064|468226832|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
130074540|NCT02417064|468226833|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
130074541|NCT02417064|468226834|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
130074542|NCT02417064|468226832|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
129951227|NCT01307800|467783105|FG002|Overall Study|Perceived Lack of Efficacy|20|||
129951228|NCT01307800|467783106|FG003|Overall Study|Perceived Lack of Efficacy|33|||
129951229|NCT01307800|467783103|FG000|Overall Study|Protocol Violation|0|||
129951230|NCT01307800|467783104|FG001|Overall Study|Protocol Violation|3|||
129951231|NCT01307800|467783105|FG002|Overall Study|Protocol Violation|4|||
129951232|NCT01307800|467783106|FG003|Overall Study|Protocol Violation|5|||
129951233|NCT01307800|467783103|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
129951234|NCT01307800|467783104|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
129951235|NCT01307800|467783105|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
129951236|NCT01307800|467783106|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
129951237|NCT01307800|467783103|FG000|Overall Study|Sponsor Decision|6|||
129951238|NCT01307800|467783104|FG001|Overall Study|Sponsor Decision|9|||
129951239|NCT01307800|467783105|FG002|Overall Study|Sponsor Decision|12|||
129951240|NCT01307800|467783106|FG003|Overall Study|Sponsor Decision|28|||
129951241|NCT01307800|467783103|FG000|Overall Study|Withdrawal by Subject|10|||
129951242|NCT01307800|467783104|FG001|Overall Study|Withdrawal by Subject|11|||
129951243|NCT01307800|467783105|FG002|Overall Study|Withdrawal by Subject|8|||
129951244|NCT01307800|467783106|FG003|Overall Study|Withdrawal by Subject|15|||
129951245|NCT01307800|467783103|FG000|Overall Study|Participant Moved|0|||
129951246|NCT01307800|467783104|FG001|Overall Study|Participant Moved|2|||
129951247|NCT01307800|467783105|FG002|Overall Study|Participant Moved|1|||
129951248|NCT01307800|467783106|FG003|Overall Study|Participant Moved|3|||
129951249|NCT00689351|467783107|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
129951250|NCT00689351|467783108|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
129951251|NCT00689351|467783107|FG000|Infant Series of Dosing|Adverse Event|1|||
129951252|NCT00689351|467783108|FG001|Infant Series of Dosing|Adverse Event|0|||
129951253|NCT00689351|467783107|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
129951254|NCT00689351|467783108|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
129951255|NCT00689351|467783107|FG000|After Infant Series|Parent/legal guardian request|1|||
129951256|NCT00689351|467783108|FG001|After Infant Series|Parent/legal guardian request|0|||
129951257|NCT01766206|467783109|FG000|Overall Study|Withdrawal by Subject|22|||
129951258|NCT01766206|467783109|FG000|Overall Study|Lost to Follow-up|10|||
129951259|NCT01766206|467783109|FG000|Overall Study|Inappropriate enrollment|18|||
129951260|NCT01766206|467783109|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
129951261|NCT01884571|467783112|FG000|Overall Study|Adverse Event|1|||
129951262|NCT01884571|467783112|FG000|Overall Study|Death|2|||
129951263|NCT01884571|467783112|FG000|Overall Study|Withdrawal by Subject|2|||
129951264|NCT01884571|467783112|FG000|Overall Study|Disease progression|3|||
129951265|NCT03978130|467784771|FG000|Overall Study|Lost to Follow-up|13|||
129951266|NCT03978130|467784772|FG001|Overall Study|Lost to Follow-up|14|||
129951267|NCT03978130|467784771|FG000|Overall Study|Withdrawal by Subject|12|||
129951268|NCT03978130|467784772|FG001|Overall Study|Withdrawal by Subject|2|||
129951269|NCT03978130|467784771|FG000|Overall Study|Adverse Event|2|||
129951270|NCT03978130|467784772|FG001|Overall Study|Adverse Event|1|||
129951271|NCT01562275|467784773|FG000|Stage 1|Adverse Event|0|||
129951272|NCT01562275|467784774|FG001|Stage 1|Adverse Event|0|||
129951273|NCT01562275|467784775|FG002|Stage 1|Adverse Event|0|||
129951274|NCT01562275|467784776|FG003|Stage 1|Adverse Event|1|||
129951275|NCT01562275|467784777|FG004|Stage 1|Adverse Event|1|||
129951276|NCT01562275|467784778|FG005|Stage 1|Adverse Event|0|||
129951277|NCT01562275|467784779|FG006|Stage 1|Adverse Event|0|||
129951278|NCT01562275|467784780|FG007|Stage 1|Adverse Event|0|||
129951279|NCT01562275|467784781|FG008|Stage 1|Adverse Event|0|||
129951280|NCT01562275|467784782|FG009|Stage 1|Adverse Event|1|||
129951281|NCT01562275|467784783|FG010|Stage 1|Adverse Event|0|||
129951282|NCT01562275|467784784|FG011|Stage 1|Adverse Event|0|||
129951283|NCT01562275|467784785|FG012|Stage 1|Adverse Event|0|||
129951284|NCT01562275|467784773|FG000|Stage 1|Death|1|||
130074543|NCT02417064|468226833|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
129951285|NCT01562275|467784774|FG001|Stage 1|Death|0|||
129951286|NCT01562275|467784775|FG002|Stage 1|Death|0|||
129951287|NCT01562275|467784776|FG003|Stage 1|Death|0|||
129951288|NCT01562275|467784777|FG004|Stage 1|Death|0|||
129951289|NCT01562275|467784778|FG005|Stage 1|Death|0|||
129951290|NCT01562275|467784779|FG006|Stage 1|Death|0|||
129951291|NCT01562275|467784780|FG007|Stage 1|Death|0|||
129951292|NCT01562275|467784781|FG008|Stage 1|Death|0|||
129951293|NCT01562275|467784782|FG009|Stage 1|Death|0|||
129951294|NCT01562275|467784783|FG010|Stage 1|Death|0|||
129951295|NCT01562275|467784784|FG011|Stage 1|Death|0|||
129951296|NCT01562275|467784785|FG012|Stage 1|Death|0|||
129951297|NCT01562275|467784773|FG000|Stage 1|Non Compliance|0|||
129951298|NCT01562275|467784774|FG001|Stage 1|Non Compliance|0|||
129951299|NCT01562275|467784775|FG002|Stage 1|Non Compliance|1|||
129951300|NCT01562275|467784776|FG003|Stage 1|Non Compliance|0|||
129951301|NCT01562275|467784777|FG004|Stage 1|Non Compliance|0|||
129951302|NCT01562275|467784778|FG005|Stage 1|Non Compliance|0|||
129951303|NCT01562275|467784779|FG006|Stage 1|Non Compliance|0|||
129951304|NCT01562275|467784780|FG007|Stage 1|Non Compliance|0|||
129951305|NCT01562275|467784781|FG008|Stage 1|Non Compliance|0|||
130074544|NCT02417064|468226834|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
129951306|NCT01562275|467784782|FG009|Stage 1|Non Compliance|0|||
129951307|NCT01562275|467784783|FG010|Stage 1|Non Compliance|0|||
129951308|NCT01562275|467784784|FG011|Stage 1|Non Compliance|0|||
129951309|NCT01562275|467784785|FG012|Stage 1|Non Compliance|0|||
129951310|NCT01562275|467784773|FG000|Stage 1|Physician Decision|0|||
129951311|NCT01562275|467784774|FG001|Stage 1|Physician Decision|0|||
129951312|NCT01562275|467784775|FG002|Stage 1|Physician Decision|0|||
129951313|NCT01562275|467784776|FG003|Stage 1|Physician Decision|0|||
129951314|NCT01562275|467784777|FG004|Stage 1|Physician Decision|1|||
129951315|NCT01562275|467784778|FG005|Stage 1|Physician Decision|0|||
129951316|NCT01562275|467784779|FG006|Stage 1|Physician Decision|1|||
129951317|NCT01562275|467784780|FG007|Stage 1|Physician Decision|0|||
129951318|NCT01562275|467784781|FG008|Stage 1|Physician Decision|1|||
129951319|NCT01562275|467784782|FG009|Stage 1|Physician Decision|0|||
129951320|NCT01562275|467784783|FG010|Stage 1|Physician Decision|0|||
129951321|NCT01562275|467784784|FG011|Stage 1|Physician Decision|0|||
129951322|NCT01562275|467784785|FG012|Stage 1|Physician Decision|0|||
129951323|NCT01562275|467784773|FG000|Stage 1|Progression of Disease|2|||
129951324|NCT01562275|467784774|FG001|Stage 1|Progression of Disease|6|||
129951325|NCT01562275|467784775|FG002|Stage 1|Progression of Disease|2|||
129951326|NCT01562275|467784776|FG003|Stage 1|Progression of Disease|1|||
129951327|NCT01562275|467784777|FG004|Stage 1|Progression of Disease|2|||
129951328|NCT01562275|467784778|FG005|Stage 1|Progression of Disease|4|||
129951329|NCT01562275|467784779|FG006|Stage 1|Progression of Disease|1|||
129951330|NCT01562275|467784780|FG007|Stage 1|Progression of Disease|7|||
129951331|NCT01562275|467784781|FG008|Stage 1|Progression of Disease|2|||
129951332|NCT01562275|467784782|FG009|Stage 1|Progression of Disease|5|||
129951333|NCT01562275|467784783|FG010|Stage 1|Progression of Disease|3|||
129951334|NCT01562275|467784784|FG011|Stage 1|Progression of Disease|0|||
129951335|NCT01562275|467784785|FG012|Stage 1|Progression of Disease|0|||
129951336|NCT01562275|467784773|FG000|Stage 1|Withdrawal by Subject|0|||
129951337|NCT01562275|467784774|FG001|Stage 1|Withdrawal by Subject|1|||
129951338|NCT01562275|467784775|FG002|Stage 1|Withdrawal by Subject|0|||
129951339|NCT01562275|467784776|FG003|Stage 1|Withdrawal by Subject|2|||
129951340|NCT01562275|467784777|FG004|Stage 1|Withdrawal by Subject|0|||
129951341|NCT01562275|467784778|FG005|Stage 1|Withdrawal by Subject|0|||
129951342|NCT01562275|467784779|FG006|Stage 1|Withdrawal by Subject|1|||
129951343|NCT01562275|467784780|FG007|Stage 1|Withdrawal by Subject|0|||
129951344|NCT01562275|467784781|FG008|Stage 1|Withdrawal by Subject|0|||
129951345|NCT01562275|467784782|FG009|Stage 1|Withdrawal by Subject|1|||
129951346|NCT01562275|467784783|FG010|Stage 1|Withdrawal by Subject|0|||
129951347|NCT01562275|467784784|FG011|Stage 1|Withdrawal by Subject|0|||
129951348|NCT01562275|467784785|FG012|Stage 1|Withdrawal by Subject|0|||
129951349|NCT01562275|467784773|FG000|Stage 2|Death|0|||
129951350|NCT01562275|467784774|FG001|Stage 2|Death|0|||
129951351|NCT01562275|467784775|FG002|Stage 2|Death|0|||
129951352|NCT01562275|467784776|FG003|Stage 2|Death|0|||
129951353|NCT01562275|467784777|FG004|Stage 2|Death|0|||
129951354|NCT01562275|467784778|FG005|Stage 2|Death|0|||
129951355|NCT01562275|467784779|FG006|Stage 2|Death|0|||
129951356|NCT01562275|467784780|FG007|Stage 2|Death|0|||
129951357|NCT01562275|467784781|FG008|Stage 2|Death|0|||
129951358|NCT01562275|467784782|FG009|Stage 2|Death|0|||
129951359|NCT01562275|467784783|FG010|Stage 2|Death|0|||
129951360|NCT01562275|467784784|FG011|Stage 2|Death|2|||
129951361|NCT01562275|467784785|FG012|Stage 2|Death|1|||
129951362|NCT01562275|467784773|FG000|Stage 2|Progression of Disease|0|||
129951363|NCT01562275|467784774|FG001|Stage 2|Progression of Disease|0|||
129951364|NCT01562275|467784775|FG002|Stage 2|Progression of Disease|0|||
129951365|NCT01562275|467784776|FG003|Stage 2|Progression of Disease|0|||
129951366|NCT01562275|467784777|FG004|Stage 2|Progression of Disease|0|||
129951367|NCT01562275|467784778|FG005|Stage 2|Progression of Disease|0|||
129951368|NCT01562275|467784779|FG006|Stage 2|Progression of Disease|0|||
129951369|NCT01562275|467784780|FG007|Stage 2|Progression of Disease|0|||
129951370|NCT01562275|467784781|FG008|Stage 2|Progression of Disease|0|||
129951371|NCT01562275|467784782|FG009|Stage 2|Progression of Disease|0|||
129951372|NCT01562275|467784783|FG010|Stage 2|Progression of Disease|0|||
129951373|NCT01562275|467784784|FG011|Stage 2|Progression of Disease|12|||
129951374|NCT01562275|467784785|FG012|Stage 2|Progression of Disease|4|||
129951375|NCT00515112|467784787|FG000|Overall Study|Death|0|||
129951376|NCT00515112|467784788|FG001|Overall Study|Death|1|||
129951377|NCT00515112|467784787|FG000|Overall Study|The study was terminated|3|||
129951378|NCT00515112|467784788|FG001|Overall Study|The study was terminated|2|||
129951379|NCT01279447|467784789|FG000|Overall Study|Lost to Follow-up|3|||
129951380|NCT01279447|467784790|FG001|Overall Study|Lost to Follow-up|1|||
129951381|NCT01131325|467784791|FG000|Overall Study|Adverse Event|1|||
129951382|NCT01131325|467784791|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
129951383|NCT02213094|467784792|FG000|Overall Study|Adverse Event|1|||
129951384|NCT02213094|467784793|FG001|Overall Study|Adverse Event|0|||
129951385|NCT00988429|467784794|FG000|Overall Study|Adverse Event|9|||
129951386|NCT00988429|467784795|FG001|Overall Study|Adverse Event|21|||
129951387|NCT00988429|467784796|FG002|Overall Study|Adverse Event|45|||
129951388|NCT00988429|467784794|FG000|Overall Study|Lack of Efficacy|0|||
129951389|NCT00988429|467784795|FG001|Overall Study|Lack of Efficacy|0|||
129951390|NCT00988429|467784796|FG002|Overall Study|Lack of Efficacy|1|||
129951391|NCT00988429|467784794|FG000|Overall Study|Non-Compliance with Study Drug|5|||
129951392|NCT00988429|467784795|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129951393|NCT00988429|467784796|FG002|Overall Study|Non-Compliance with Study Drug|3|||
129951394|NCT00988429|467784794|FG000|Overall Study|Physician Decision|1|||
129951395|NCT00988429|467784795|FG001|Overall Study|Physician Decision|0|||
129951396|NCT00988429|467784796|FG002|Overall Study|Physician Decision|3|||
129951397|NCT00988429|467784794|FG000|Overall Study|Pregnancy|2|||
129951398|NCT00988429|467784795|FG001|Overall Study|Pregnancy|1|||
129951399|NCT00988429|467784796|FG002|Overall Study|Pregnancy|0|||
129951400|NCT00988429|467784794|FG000|Overall Study|Protocol Violation|4|||
129951401|NCT00988429|467784795|FG001|Overall Study|Protocol Violation|3|||
129951402|NCT00988429|467784796|FG002|Overall Study|Protocol Violation|3|||
129951403|NCT00988429|467784794|FG000|Overall Study|Withdrawal by Subject|7|||
129951404|NCT00988429|467784795|FG001|Overall Study|Withdrawal by Subject|7|||
129951405|NCT00988429|467784796|FG002|Overall Study|Withdrawal by Subject|12|||
129951406|NCT00988429|467784794|FG000|Overall Study|Administrative Reasons|1|||
129951407|NCT00988429|467784795|FG001|Overall Study|Administrative Reasons|2|||
129951408|NCT00988429|467784796|FG002|Overall Study|Administrative Reasons|1|||
129951409|NCT00988429|467784794|FG000|Overall Study|other reasons|8|||
129951410|NCT00988429|467784795|FG001|Overall Study|other reasons|8|||
129951411|NCT00988429|467784796|FG002|Overall Study|other reasons|1|||
129951412|NCT02964234|467784797|FG000|Overall Study|Lost to Follow-up|22|||
129951413|NCT02964234|467784798|FG001|Overall Study|Lost to Follow-up|13|||
129951414|NCT01074229|467784799|FG000|Overall Study|Lost to Follow-up|1|||
129951415|NCT01074229|467784800|FG001|Overall Study|Lost to Follow-up|0|||
129951416|NCT01074229|467784801|FG002|Overall Study|Lost to Follow-up|0|||
129951417|NCT01074229|467784799|FG000|Overall Study|Change to open surgical procedure|1|||
129951418|NCT01074229|467784800|FG001|Overall Study|Change to open surgical procedure|3|||
129951419|NCT01074229|467784801|FG002|Overall Study|Change to open surgical procedure|4|||
129951420|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
129951421|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
129951422|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
129951423|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
129951424|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
129951425|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
129951426|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
129951427|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
129951428|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
129951429|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
129951430|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
129951431|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
129951432|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
129951433|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
129951434|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Death|8|||
129951435|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
129951436|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
129951437|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
129951438|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
129951439|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951440|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951441|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951442|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951443|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951444|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951445|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951446|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951447|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951448|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951449|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951450|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951451|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951452|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951453|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951454|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951455|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951456|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951457|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951458|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951459|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
130074545|NCT02417064|468226832|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
130074546|NCT02417064|468226833|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
130074547|NCT02417064|468226834|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
130074548|NCT02417064|468226832|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
130074549|NCT02417064|468226833|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
130074550|NCT02417064|468226834|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
130074551|NCT02417064|468226832|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
130074552|NCT02417064|468226833|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
130074553|NCT02417064|468226834|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
130074554|NCT02417064|468226832|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
130074555|NCT02417064|468226833|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
130074556|NCT02417064|468226834|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
130074557|NCT02417064|468226832|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
130074558|NCT02417064|468226833|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
130074559|NCT02417064|468226834|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
130074560|NCT02417064|468226832|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
130074561|NCT02417064|468226833|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
130074562|NCT02417064|468226834|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
130074563|NCT02417064|468226832|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
130074564|NCT02417064|468226833|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
130074565|NCT02417064|468226834|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
130074566|NCT02417064|468226832|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
130074567|NCT02417064|468226833|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
130074568|NCT02417064|468226834|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
130074569|NCT02417064|468226832|FG000|Follow-up Phase (24 Weeks)|Other|2|||
130074570|NCT02417064|468226833|FG001|Follow-up Phase (24 Weeks)|Other|2|||
130074571|NCT02417064|468226834|FG002|Follow-up Phase (24 Weeks)|Other|3|||
130074572|NCT01585168|468226835|FG000|Overall Study|Lost to Follow-up|3|||
130074573|NCT01585168|468226836|FG001|Overall Study|Lost to Follow-up|1|||
130074574|NCT01585168|468226837|FG002|Overall Study|Lost to Follow-up|1|||
130074575|NCT01585168|468226838|FG003|Overall Study|Lost to Follow-up|1|||
130074576|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
130074577|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
130074578|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
130074579|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
130074580|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
130074581|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
130074582|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
130074583|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
130074584|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
130074585|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
130074586|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
130074587|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
130074588|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
130074589|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
130074590|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
130074591|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
130074592|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
130074593|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
130074594|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
130074595|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
130074596|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
130074597|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
130074598|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
130074599|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
130074600|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Other|0|||
130074601|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Other|1|||
130074602|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Other|0|||
130074603|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Other|0|||
130074604|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
130074605|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
130074606|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
130074607|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
130074608|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
130074609|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
130074610|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
130074611|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
130074612|NCT01194414|468226839|FG000|24 Weeks Double Blind Period|Death|0|||
129951460|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951461|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951462|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
129951463|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951464|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
129951465|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951466|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951467|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951468|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951469|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951470|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951471|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951472|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951473|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951474|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951475|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951476|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951477|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951478|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951479|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951480|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951481|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951482|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
129951483|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951484|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951485|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951486|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951487|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951488|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951489|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951490|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951491|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951492|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951493|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951494|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951495|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
129951496|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
129951497|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
129951498|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
129951499|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
129951500|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
129951501|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
129951502|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
129951503|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951504|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951505|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951506|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951507|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951508|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951509|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951510|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951511|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951512|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951513|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951514|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951515|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951516|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951517|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951518|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951519|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951520|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951521|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951522|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
129951523|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
129951524|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
129951525|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951526|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951527|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
130074613|NCT01194414|468226840|FG001|24 Weeks Double Blind Period|Death|1|||
130074614|NCT01194414|468226841|FG002|24 Weeks Double Blind Period|Death|0|||
130074615|NCT01194414|468226842|FG003|24 Weeks Double Blind Period|Death|0|||
130074616|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
130074617|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
130074618|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
130074619|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
130074620|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
130074621|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
130074622|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
130074623|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
130074624|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
130074625|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
130074626|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
130074627|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
130074628|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
130074629|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
130074630|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
130074631|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
130074632|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
130074633|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
130074634|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
130074635|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
130074636|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
130074637|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
130074638|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
130074639|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
130074640|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Other|2|||
130074641|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Other|1|||
130074642|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Other|0|||
130074643|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Other|0|||
130074644|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
130074645|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
130074646|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
130074647|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
130074648|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
130074649|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
129951528|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951529|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951530|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951531|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951532|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951533|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951534|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951535|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951536|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951537|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951538|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951539|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951540|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951541|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
129951542|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951543|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
129951544|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951545|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951546|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951547|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951548|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951549|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951550|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951551|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951552|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
130074650|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
130074651|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
130074652|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
130074653|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
130074654|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
130074655|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
130074656|NCT01194414|468226839|FG000|72 Weeks Open Label Extension|Death|1|||
130074657|NCT01194414|468226840|FG001|72 Weeks Open Label Extension|Death|2|||
130074658|NCT01194414|468226841|FG002|72 Weeks Open Label Extension|Death|0|||
130074659|NCT01194414|468226842|FG003|72 Weeks Open Label Extension|Death|2|||
130074660|NCT04737759|468226844|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
130074661|NCT04737759|468226845|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
130074662|NCT04737759|468226844|FG000|Overall Study|Death|2|||
130074663|NCT04737759|468226845|FG001|Overall Study|Death|0|||
130074664|NCT04737759|468226844|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
130074665|NCT04737759|468226845|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
130074666|NCT04737759|468226844|FG000|Overall Study|Lost to Follow-up|4|||
130074667|NCT04737759|468226845|FG001|Overall Study|Lost to Follow-up|12|||
130074668|NCT01749800|468226849|FG000|Overall Study|not meeting inclusion criteria|3|||
130074669|NCT01749800|468226850|FG001|Overall Study|not meeting inclusion criteria|0|||
130074670|NCT01749800|468226851|FG002|Overall Study|not meeting inclusion criteria|0|||
130074671|NCT01749800|468226849|FG000|Overall Study|Withdrawal by Subject|0|||
130074672|NCT01749800|468226850|FG001|Overall Study|Withdrawal by Subject|1|||
130074673|NCT01749800|468226851|FG002|Overall Study|Withdrawal by Subject|0|||
130074674|NCT01451398|468226853|FG000|Overall Study|Adverse Event|7|||
130074675|NCT01451398|468226854|FG001|Overall Study|Adverse Event|9|||
130074676|NCT01451398|468226853|FG000|Overall Study|Protocol Violation|1|||
130074677|NCT01451398|468226854|FG001|Overall Study|Protocol Violation|2|||
130074678|NCT01451398|468226853|FG000|Overall Study|Physician Decision|1|||
130074679|NCT01451398|468226854|FG001|Overall Study|Physician Decision|1|||
130074680|NCT01451398|468226853|FG000|Overall Study|Withdrawal by Subject|10|||
130074681|NCT01451398|468226854|FG001|Overall Study|Withdrawal by Subject|14|||
130074682|NCT01451398|468226853|FG000|Overall Study|Lost to Follow-up|6|||
130074683|NCT01451398|468226854|FG001|Overall Study|Lost to Follow-up|4|||
130074684|NCT01451398|468226853|FG000|Overall Study|Non-compliance with study drug|1|||
130074685|NCT01451398|468226854|FG001|Overall Study|Non-compliance with study drug|3|||
130074686|NCT01451398|468226853|FG000|Overall Study|Non-compliance with protocol|1|||
130074687|NCT01451398|468226854|FG001|Overall Study|Non-compliance with protocol|1|||
130074688|NCT01451398|468226853|FG000|Overall Study|Moved out of country|0|||
130074689|NCT01451398|468226854|FG001|Overall Study|Moved out of country|1|||
130074690|NCT01451398|468226853|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
130074691|NCT01451398|468226854|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
130074692|NCT01451398|468226853|FG000|Overall Study|Lack of Efficacy|0|||
130074693|NCT01451398|468226854|FG001|Overall Study|Lack of Efficacy|1|||
130074694|NCT04423757|468226858|FG000|Overall Study|Adverse Event|2|||
130074695|NCT04423757|468226859|FG001|Overall Study|Adverse Event|0|||
130074696|NCT04423757|468226858|FG000|Overall Study|Not treated|1|||
130074697|NCT04423757|468226859|FG001|Overall Study|Not treated|1|||
130074698|NCT02709109|468226860|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
130074699|NCT02709109|468226861|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
130074700|NCT02709109|468226862|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
130074701|NCT02709109|468226863|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
130074702|NCT02709109|468226860|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
130074703|NCT02709109|468226861|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
130074704|NCT02709109|468226862|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
130074705|NCT02709109|468226863|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
130074706|NCT02709109|468226860|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
130074707|NCT02709109|468226861|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
130074708|NCT02709109|468226862|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
130074709|NCT02709109|468226863|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
130074710|NCT02709109|468226860|FG000|Washout Period (28 Days)|Other|2|||
130074711|NCT02709109|468226861|FG001|Washout Period (28 Days)|Other|2|||
130074712|NCT02709109|468226862|FG002|Washout Period (28 Days)|Other|3|||
130074713|NCT02709109|468226863|FG003|Washout Period (28 Days)|Other|0|||
130074714|NCT02709109|468226860|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
130074715|NCT02709109|468226861|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
130074716|NCT02709109|468226862|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
130074717|NCT02709109|468226863|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
130074718|NCT02709109|468226860|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
130074719|NCT02709109|468226861|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
130074720|NCT02709109|468226862|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
130074721|NCT02709109|468226863|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
130074722|NCT02709109|468226860|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
130074723|NCT02709109|468226861|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
130074724|NCT02709109|468226862|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
130074725|NCT02709109|468226863|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
130074726|NCT02709109|468226860|FG000|Treatment Period 2 (28 Days)|Other|0|||
130074727|NCT02709109|468226861|FG001|Treatment Period 2 (28 Days)|Other|0|||
130074728|NCT02709109|468226862|FG002|Treatment Period 2 (28 Days)|Other|1|||
130074729|NCT02709109|468226863|FG003|Treatment Period 2 (28 Days)|Other|0|||
130074730|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
130074731|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
130074732|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
130074733|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
130074734|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
130074735|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
130074736|NCT00996593|468226864|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
130074737|NCT00996593|468226864|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
130074738|NCT00996593|468226864|FG000|Long-Term Follow-Up|Site Closed|1|||
130074739|NCT02810951|468226865|FG000|Overall Study|Adverse Event|1|||
130074740|NCT01928082|468226866|FG000|Overall Study|Study terminated.|1|||
130074741|NCT05563714|468226867|FG000|Overall Study|Death|2|||
130074742|NCT05563714|468226868|FG001|Overall Study|Death|2|||
130074743|NCT05563714|468226869|FG002|Overall Study|Death|0|||
130074744|NCT05563714|468226870|FG003|Overall Study|Death|0|||
130074745|NCT05563714|468226867|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
130074746|NCT05563714|468226868|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
130074747|NCT05563714|468226869|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
130074748|NCT05563714|468226870|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
130074749|NCT05563714|468226867|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
130074750|NCT05563714|468226868|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
130074751|NCT05563714|468226869|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
130074752|NCT05563714|468226870|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
130074753|NCT05563714|468226867|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
130074754|NCT05563714|468226868|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
130074755|NCT05563714|468226869|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
130074756|NCT05563714|468226870|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
130074757|NCT05563714|468226867|FG000|Overall Study|Lost to Follow-up|22|||
130074758|NCT05563714|468226868|FG001|Overall Study|Lost to Follow-up|19|||
130074759|NCT05563714|468226869|FG002|Overall Study|Lost to Follow-up|0|||
130074760|NCT05563714|468226870|FG003|Overall Study|Lost to Follow-up|0|||
130074761|NCT01610206|468226876|FG000|Overall Study|Adverse Event|10|||
130074762|NCT01610206|468226877|FG001|Overall Study|Adverse Event|30|||
130074763|NCT00166517|468226878|FG000|Overall Study|Lost to Follow-up|1|||
130074764|NCT00166517|468226879|FG001|Overall Study|Lost to Follow-up|0|||
130074765|NCT00166517|468226878|FG000|Overall Study|Protocol Violation|4|||
130074766|NCT00166517|468226879|FG001|Overall Study|Protocol Violation|1|||
130074767|NCT00166517|468226878|FG000|Overall Study|Withdrawal by Subject|0|||
130074768|NCT00166517|468226879|FG001|Overall Study|Withdrawal by Subject|1|||
130074769|NCT02186561|468226880|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
130074770|NCT02186561|468226880|FG000|Enrollment|Enrollment Cap Reached|5|||
130074771|NCT02186561|468226880|FG000|Enrollment|Insurance Denial|2|||
130074772|NCT02186561|468226880|FG000|Enrollment|Withdrawal by Subject|2|||
130074773|NCT02186561|468226880|FG000|Enrollment|Investigator Withdrew Consent|1|||
130074774|NCT02186561|468226880|FG000|30-Day Post Index Procedure Visit|Death|1|||
130074775|NCT02186561|468226880|FG000|1- Year Post Index Procedure Visit|Death|1|||
130074776|NCT02186561|468226880|FG000|1- Year Post Index Procedure Visit|Missed|1|||
130074777|NCT04285853|468226881|FG000|Overall Study|Withdrawal by Subject|1|||
130074778|NCT04285853|468226882|FG001|Overall Study|Withdrawal by Subject|0|||
130074779|NCT04285853|468226881|FG000|Overall Study|Lost to Follow-up|9|||
130074780|NCT04285853|468226882|FG001|Overall Study|Lost to Follow-up|5|||
130074781|NCT01731990|468229400|FG000|Overall Study|Adverse Event|1|||
130074782|NCT01731990|468229401|FG001|Overall Study|Adverse Event|5|||
130074783|NCT01731990|468229400|FG000|Overall Study|Withdrawal by Subject|1|||
130074784|NCT01731990|468229401|FG001|Overall Study|Withdrawal by Subject|1|||
130074785|NCT01731990|468229400|FG000|Overall Study|Protocol deviation|1|||
130074786|NCT01731990|468229401|FG001|Overall Study|Protocol deviation|2|||
130074787|NCT01731990|468229400|FG000|Overall Study|Death|1|||
130074788|NCT01731990|468229401|FG001|Overall Study|Death|0|||
130074789|NCT01280812|468229402|FG000|Overall Study|Withdrawal by Subject|2|||
130074790|NCT01280812|468229403|FG001|Overall Study|Withdrawal by Subject|1|||
130074791|NCT01280812|468229404|FG002|Overall Study|Withdrawal by Subject|0|||
130074792|NCT01280812|468229402|FG000|Overall Study|Lost to Follow-up|1|||
130074793|NCT01280812|468229403|FG001|Overall Study|Lost to Follow-up|1|||
130074794|NCT01280812|468229404|FG002|Overall Study|Lost to Follow-up|1|||
130074795|NCT04483544|468229405|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
130074796|NCT04483544|468229405|FG000|Post-Treatment|Admitted to hospice|2|||
130074797|NCT04483544|468229405|FG000|Post-Treatment|Study terminated|3|||
130074798|NCT01131078|468229412|FG000|Overall Study|Adverse Event|22|||
130074799|NCT01131078|468229413|FG001|Overall Study|Adverse Event|12|||
130074800|NCT01131078|468229414|FG002|Overall Study|Adverse Event|17|||
130074801|NCT01131078|468229412|FG000|Overall Study|Progressive Disease|58|||
130074802|NCT01131078|468229413|FG001|Overall Study|Progressive Disease|77|||
130074803|NCT01131078|468229414|FG002|Overall Study|Progressive Disease|71|||
129951553|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951554|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951555|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951556|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951557|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951558|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951559|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951560|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951561|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
129951562|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
129951563|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951564|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951565|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951566|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951567|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951568|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951569|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951570|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951571|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951572|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951573|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951574|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951575|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951576|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951577|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951578|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951579|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
129951580|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951581|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951582|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951583|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951584|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951585|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951586|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951587|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951588|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951589|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951590|NCT01587703|467784805|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951591|NCT01587703|467784806|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951592|NCT01587703|467784807|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951593|NCT01587703|467784808|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951594|NCT01587703|467784809|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951595|NCT01587703|467784810|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951596|NCT01587703|467784811|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951597|NCT01587703|467784812|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951598|NCT01587703|467784813|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951599|NCT01587703|467784814|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951600|NCT01587703|467784815|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951601|NCT01587703|467784816|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951602|NCT01587703|467784817|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951603|NCT01587703|467784818|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
130074804|NCT01131078|468229412|FG000|Overall Study|Protocol Violation|1|||
130074805|NCT01131078|468229413|FG001|Overall Study|Protocol Violation|0|||
130074806|NCT01131078|468229414|FG002|Overall Study|Protocol Violation|0|||
130074807|NCT01131078|468229412|FG000|Overall Study|Lost to Follow-up|1|||
130074808|NCT01131078|468229413|FG001|Overall Study|Lost to Follow-up|1|||
130074809|NCT01131078|468229414|FG002|Overall Study|Lost to Follow-up|1|||
130074810|NCT01131078|468229412|FG000|Overall Study|Withdrawal by Subject|2|||
130074811|NCT01131078|468229413|FG001|Overall Study|Withdrawal by Subject|4|||
130074812|NCT01131078|468229414|FG002|Overall Study|Withdrawal by Subject|3|||
130074813|NCT01131078|468229412|FG000|Overall Study|Non-compliance|3|||
130074814|NCT01131078|468229413|FG001|Overall Study|Non-compliance|0|||
130074815|NCT01131078|468229414|FG002|Overall Study|Non-compliance|0|||
130074816|NCT01131078|468229412|FG000|Overall Study|Physician Decision|10|||
130074817|NCT01131078|468229413|FG001|Overall Study|Physician Decision|6|||
130074818|NCT01131078|468229414|FG002|Overall Study|Physician Decision|8|||
130074819|NCT01131078|468229412|FG000|Overall Study|Death|4|||
130074820|NCT01131078|468229413|FG001|Overall Study|Death|0|||
130074821|NCT01131078|468229414|FG002|Overall Study|Death|2|||
130074822|NCT01131078|468229412|FG000|Overall Study|Other|0|||
130074823|NCT01131078|468229413|FG001|Overall Study|Other|1|||
130074824|NCT01131078|468229414|FG002|Overall Study|Other|0|||
130074825|NCT01685060|468229420|FG000|Overall Study|Rollover patients|16|||
130074826|NCT01685060|468229420|FG000|Overall Study|Adverse Event|12|||
130074827|NCT01685060|468229420|FG000|Overall Study|Progressive disease|69|||
130074828|NCT01685060|468229420|FG000|Overall Study|Physician Decision|14|||
130074829|NCT01685060|468229420|FG000|Overall Study|Subject/guardian decision|20|||
130074830|NCT01685060|468229420|FG000|Overall Study|Lost to Follow-up|1|||
130074831|NCT01685060|468229420|FG000|Overall Study|Death|8|||
130074832|NCT03597503|468229421|FG000|Overall Study|Withdrawal by Subject|0|||
130074833|NCT03597503|468229422|FG001|Overall Study|Withdrawal by Subject|2|||
130074834|NCT03597503|468229421|FG000|Overall Study|Lost to Follow-up|1|||
130074835|NCT03597503|468229422|FG001|Overall Study|Lost to Follow-up|2|||
130074836|NCT03597503|468229421|FG000|Overall Study|Protocol Violation|1|||
130074837|NCT03597503|468229422|FG001|Overall Study|Protocol Violation|0|||
130074838|NCT00937326|468229426|FG000|Overall Study|Adverse Event|0|||
130074839|NCT00937326|468229427|FG001|Overall Study|Adverse Event|3|||
130074840|NCT00937326|468229428|FG002|Overall Study|Adverse Event|1|||
130074841|NCT00937326|468229429|FG003|Overall Study|Adverse Event|1|||
130074842|NCT00937326|468229430|FG004|Overall Study|Adverse Event|2|||
130074843|NCT00937326|468229426|FG000|Overall Study|Death|0|||
130074844|NCT00937326|468229427|FG001|Overall Study|Death|0|||
130074845|NCT00937326|468229428|FG002|Overall Study|Death|1|||
130074846|NCT00937326|468229429|FG003|Overall Study|Death|0|||
130074847|NCT00937326|468229430|FG004|Overall Study|Death|0|||
130074848|NCT00937326|468229426|FG000|Overall Study|Withdrawal by Subject|3|||
130074849|NCT00937326|468229427|FG001|Overall Study|Withdrawal by Subject|4|||
130074850|NCT00937326|468229428|FG002|Overall Study|Withdrawal by Subject|1|||
130074851|NCT00937326|468229429|FG003|Overall Study|Withdrawal by Subject|4|||
130074852|NCT00937326|468229430|FG004|Overall Study|Withdrawal by Subject|3|||
130074853|NCT00937326|468229426|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130074854|NCT00937326|468229427|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130074855|NCT00937326|468229428|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
130074856|NCT00937326|468229429|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130074857|NCT00937326|468229430|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
130074858|NCT02578992|468229431|FG000|Overall Study|equipment not available or malfunction|3|||
130074859|NCT02578992|468229432|FG001|Overall Study|equipment not available or malfunction|3|||
130074860|NCT00086385|468229435|FG000|Overall Study|Death|2|||
130074861|NCT00086385|468229436|FG001|Overall Study|Death|2|||
130074862|NCT00086385|468229437|FG002|Overall Study|Death|1|||
130074863|NCT00086385|468229438|FG003|Overall Study|Death|1|||
130074864|NCT00880100|468229443|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
130074865|NCT00880100|468229443|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
130074866|NCT00880100|468229443|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
130074867|NCT02443155|468229444|FG000|Overall Study|Adverse Event|3|||
130074868|NCT02443155|468229445|FG001|Overall Study|Adverse Event|4|||
130074869|NCT02443155|468229446|FG002|Overall Study|Adverse Event|1|||
130074870|NCT02443155|468229447|FG003|Overall Study|Adverse Event|2|||
130074871|NCT02443155|468229444|FG000|Overall Study|Unclassified|0|||
130074872|NCT02443155|468229445|FG001|Overall Study|Unclassified|0|||
130074873|NCT02443155|468229446|FG002|Overall Study|Unclassified|2|||
130074874|NCT02443155|468229447|FG003|Overall Study|Unclassified|1|||
130074875|NCT02443155|468229444|FG000|Overall Study|Withdrawal by Subject|4|||
130074876|NCT02443155|468229445|FG001|Overall Study|Withdrawal by Subject|7|||
130074877|NCT02443155|468229446|FG002|Overall Study|Withdrawal by Subject|3|||
130074878|NCT02443155|468229447|FG003|Overall Study|Withdrawal by Subject|9|||
130074879|NCT02443155|468229444|FG000|Overall Study|Pregnancy|3|||
130074880|NCT02443155|468229445|FG001|Overall Study|Pregnancy|1|||
130074881|NCT02443155|468229446|FG002|Overall Study|Pregnancy|1|||
130074882|NCT02443155|468229447|FG003|Overall Study|Pregnancy|2|||
130074883|NCT02443155|468229444|FG000|Overall Study|Lost to Follow-up|1|||
130074884|NCT02443155|468229445|FG001|Overall Study|Lost to Follow-up|2|||
130074885|NCT02443155|468229446|FG002|Overall Study|Lost to Follow-up|0|||
130074886|NCT02443155|468229447|FG003|Overall Study|Lost to Follow-up|1|||
130074887|NCT02443155|468229444|FG000|Overall Study|Protocol Violation|1|||
130074888|NCT02443155|468229445|FG001|Overall Study|Protocol Violation|0|||
130074889|NCT02443155|468229446|FG002|Overall Study|Protocol Violation|1|||
130074890|NCT02443155|468229447|FG003|Overall Study|Protocol Violation|1|||
130074891|NCT02443155|468229444|FG000|Overall Study|Death|0|||
130074892|NCT02443155|468229445|FG001|Overall Study|Death|0|||
130074893|NCT02443155|468229446|FG002|Overall Study|Death|1|||
130074894|NCT02443155|468229447|FG003|Overall Study|Death|0|||
130074895|NCT00405275|468229451|FG000|Overall Study|Death|1|||
130074896|NCT00405275|468229452|FG001|Overall Study|Death|0|||
130074897|NCT00405275|468229451|FG000|Overall Study|Lost to Follow-up|5|||
130074898|NCT00405275|468229452|FG001|Overall Study|Lost to Follow-up|1|||
130074899|NCT00405275|468229451|FG000|Overall Study|Withdrawal by Subject|7|||
130074900|NCT00405275|468229452|FG001|Overall Study|Withdrawal by Subject|9|||
130074901|NCT00405275|468229451|FG000|Overall Study|Unwilling to continue|10|||
130074902|NCT00405275|468229452|FG001|Overall Study|Unwilling to continue|9|||
130074903|NCT00731666|468229453|FG000|Overall Study|Adverse Event|2|||
130074904|NCT00731666|468229453|FG000|Overall Study|Lost to Follow-up|8|||
130074905|NCT00731666|468229453|FG000|Overall Study|Withdrawal by Subject|2|||
130074906|NCT02853123|468229454|FG000|Treatment Period 1|Adverse Event|0|||
129951604|NCT01587703|467784819|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951605|NCT01587703|467784820|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951606|NCT01587703|467784821|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951607|NCT01587703|467784822|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951608|NCT01587703|467784823|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
129951609|NCT01587703|467784805|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951610|NCT01587703|467784806|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951611|NCT01587703|467784807|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951612|NCT01587703|467784808|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951613|NCT01587703|467784809|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951614|NCT01587703|467784810|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951615|NCT01587703|467784811|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951616|NCT01587703|467784812|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951617|NCT01587703|467784813|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951618|NCT01587703|467784814|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951619|NCT01587703|467784815|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951620|NCT01587703|467784816|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951621|NCT01587703|467784817|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951622|NCT01587703|467784818|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951623|NCT01587703|467784819|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951624|NCT01587703|467784820|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951625|NCT01587703|467784821|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951626|NCT01587703|467784822|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
129951627|NCT01587703|467784823|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
129951628|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951629|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951630|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951631|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951632|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951633|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951634|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951635|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951636|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951637|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951638|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951639|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951640|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951641|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951642|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
130074907|NCT02853123|468229455|FG001|Treatment Period 1|Adverse Event|3|||
130074908|NCT02853123|468229454|FG000|Washout Period|Worsening of COPD|0|||
130074909|NCT02853123|468229455|FG001|Washout Period|Worsening of COPD|3|||
130074910|NCT02853123|468229454|FG000|Washout Period|Adverse Event|1|||
129951643|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
130074911|NCT02853123|468229455|FG001|Washout Period|Adverse Event|0|||
130074912|NCT02809118|468229458|FG000|Overall Study|Withdrawal by Subject|0|||
130074913|NCT02809118|468229459|FG001|Overall Study|Withdrawal by Subject|1|||
130074914|NCT02809118|468229460|FG002|Overall Study|Withdrawal by Subject|1|||
130074915|NCT01235338|468229461|FG000|Overall Study|Adverse Event|3|||
130074916|NCT01235338|468229462|FG001|Overall Study|Adverse Event|2|||
130074917|NCT01235338|468229461|FG000|Overall Study|Protocol Violation|1|||
130074918|NCT01235338|468229462|FG001|Overall Study|Protocol Violation|1|||
130074919|NCT01235338|468229461|FG000|Overall Study|Withdrawal by Subject|5|||
130074920|NCT01235338|468229462|FG001|Overall Study|Withdrawal by Subject|0|||
130074921|NCT01235338|468229461|FG000|Overall Study|Exclusion criteria violations|1|||
130074922|NCT01235338|468229462|FG001|Overall Study|Exclusion criteria violations|1|||
130074923|NCT01235338|468229461|FG000|Overall Study|Positive drug screen|0|||
130074924|NCT01235338|468229462|FG001|Overall Study|Positive drug screen|1|||
130074925|NCT01235338|468229461|FG000|Overall Study|Prohibited meds|1|||
130074926|NCT01235338|468229462|FG001|Overall Study|Prohibited meds|0|||
130074927|NCT05283499|468229466|FG000|Overall Study|Did not receive intervention|1|||
130074928|NCT05283499|468229467|FG001|Overall Study|Did not receive intervention|2|||
130074929|NCT05516134|468229475|FG000|Overall Study|Lost to Follow-up|1|||
130074930|NCT05516134|468229476|FG001|Overall Study|Lost to Follow-up|0|||
130074931|NCT05516134|468229477|FG002|Overall Study|Lost to Follow-up|0|||
130074932|NCT03805971|468229478|FG000|Overall Study|Withdrawal by Subject|1|||
130074933|NCT03805971|468229478|FG000|Overall Study|Protocol Violation|2|||
130074934|NCT00254163|468229479|FG000|Overall Study|Adverse Event|29|||
130074935|NCT00254163|468229480|FG001|Overall Study|Adverse Event|26|||
130074936|NCT00254163|468229479|FG000|Overall Study|Patient request/withdrew consent|6|||
130074937|NCT00254163|468229480|FG001|Overall Study|Patient request/withdrew consent|4|||
130074938|NCT00254163|468229479|FG000|Overall Study|Investigator request|1|||
130074939|NCT00254163|468229480|FG001|Overall Study|Investigator request|3|||
130074940|NCT00254163|468229479|FG000|Overall Study|Failed entry|1|||
130074941|NCT00254163|468229480|FG001|Overall Study|Failed entry|3|||
130074942|NCT00254163|468229479|FG000|Overall Study|Progressive disease|0|||
130074943|NCT00254163|468229480|FG001|Overall Study|Progressive disease|1|||
130074944|NCT00254163|468229479|FG000|Overall Study|Death|0|||
130074945|NCT00254163|468229480|FG001|Overall Study|Death|1|||
130074946|NCT00254163|468229479|FG000|Overall Study|Other|8|||
130074947|NCT00254163|468229480|FG001|Overall Study|Other|8|||
130074948|NCT00517413|468229486|FG000|Overall Study|Adverse Event|7|||
130074949|NCT00517413|468229486|FG000|Overall Study|Death|13|||
130074950|NCT00517413|468229486|FG000|Overall Study|Protocol Violation|15|||
130074951|NCT00517413|468229486|FG000|Overall Study|Withdrawal by Subject|2|||
130074952|NCT00517413|468229486|FG000|Overall Study|Failure to return|1|||
130074953|NCT00517413|468229486|FG000|Overall Study|Other-Reasons|23|||
130074954|NCT01510028|468229487|FG000|Overall Study|Lack of Efficacy|1|||
130074955|NCT01510028|468229488|FG001|Overall Study|Lack of Efficacy|0|||
130074956|NCT01510028|468229489|FG002|Overall Study|Lack of Efficacy|0|||
130074957|NCT01510028|468229490|FG003|Overall Study|Lack of Efficacy|0|||
130074958|NCT01355497|468229491|FG000|Overall Study|Death|19|||
130074959|NCT01355497|468229492|FG001|Overall Study|Death|18|||
130074960|NCT01355497|468229491|FG000|Overall Study|Lost to Follow-up|3|||
130074961|NCT01355497|468229492|FG001|Overall Study|Lost to Follow-up|0|||
130074962|NCT01355497|468229491|FG000|Overall Study|Protocol Violation|0|||
130074963|NCT01355497|468229492|FG001|Overall Study|Protocol Violation|1|||
130074964|NCT01355497|468229491|FG000|Overall Study|other-not provided|9|||
130074965|NCT01355497|468229492|FG001|Overall Study|other-not provided|4|||
130074966|NCT01355497|468229491|FG000|Overall Study|Withdrawal by Subject|12|||
130074967|NCT01355497|468229492|FG001|Overall Study|Withdrawal by Subject|20|||
130074968|NCT01355497|468229491|FG000|Overall Study|noncompliance|1|||
130074969|NCT01355497|468229492|FG001|Overall Study|noncompliance|2|||
130074970|NCT01355497|468229491|FG000|Overall Study|progressive disease|11|||
130074971|NCT01355497|468229492|FG001|Overall Study|progressive disease|8|||
130074972|NCT01355497|468229491|FG000|Overall Study|Adverse Event|11|||
130074973|NCT01355497|468229492|FG001|Overall Study|Adverse Event|10|||
130074974|NCT01784211|468229500|FG000|Part A (Days 1-15)|Adverse Event|1|||
130074975|NCT01784211|468229501|FG001|Part A (Days 1-15)|Adverse Event|1|||
130074976|NCT01784211|468229502|FG002|Part A (Days 1-15)|Adverse Event|0|||
130074977|NCT01784211|468229503|FG003|Part A (Days 1-15)|Adverse Event|0|||
130074978|NCT01784211|468229504|FG004|Part A (Days 1-15)|Adverse Event|0|||
130074979|NCT01784211|468229505|FG005|Part A (Days 1-15)|Adverse Event|0|||
130074980|NCT01784211|468229500|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
130074981|NCT01784211|468229501|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
130074982|NCT01784211|468229502|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
130074983|NCT01784211|468229503|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
130074984|NCT01784211|468229504|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
130074985|NCT01784211|468229505|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
130074986|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
130074987|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
130074988|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
130074989|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
130074990|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
130074991|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
130074992|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
130074993|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
130074994|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
130074995|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
130074996|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
130074997|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
130074998|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
130074999|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
130075000|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
130075001|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
130075002|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
130075003|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
130075004|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
130075005|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
130075006|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
130075007|NCT01001572|468229506|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
130075008|NCT01001572|468229507|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
130075009|NCT01001572|468229508|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
130075010|NCT01001572|468229506|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130075011|NCT01001572|468229507|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
130075012|NCT01001572|468229508|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
130075013|NCT01001572|468229506|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130075014|NCT01001572|468229507|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
130075015|NCT01001572|468229508|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
130075016|NCT01001572|468229506|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
130075017|NCT01001572|468229507|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
130075018|NCT01001572|468229508|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
130075019|NCT01001572|468229506|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
130075020|NCT01001572|468229507|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
130075021|NCT01001572|468229508|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
130075022|NCT01001572|468229506|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
130075023|NCT01001572|468229507|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
130075024|NCT01001572|468229508|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
129951644|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951645|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951646|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951647|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951648|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951649|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951650|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951651|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951652|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951653|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951654|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951655|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951656|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951657|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951658|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
129951659|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951660|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951661|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
129951662|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951663|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951664|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951665|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951666|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951667|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951668|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951669|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951670|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951671|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951672|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951673|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951674|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951675|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951676|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951677|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
129951678|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
129951679|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
130075025|NCT01001572|468229506|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130075026|NCT01001572|468229507|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130075027|NCT01001572|468229508|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130075028|NCT01094808|468229509|FG000|Overall Study|Withdrawal by Subject|1|||
130075029|NCT01094808|468229510|FG001|Overall Study|Withdrawal by Subject|1|||
130075030|NCT01094808|468229511|FG002|Overall Study|Withdrawal by Subject|0|||
130075031|NCT00369278|468229512|FG000|Overall Study|Adverse Event|14|||
130075032|NCT00369278|468229513|FG001|Overall Study|Adverse Event|11|||
130075033|NCT00369278|468229512|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130075034|NCT00369278|468229513|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
130075035|NCT00369278|468229512|FG000|Overall Study|Protocol Violation|2|||
130075036|NCT00369278|468229513|FG001|Overall Study|Protocol Violation|1|||
129951680|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
129951681|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
129951682|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
129951683|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951684|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951685|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951686|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951687|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951688|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951689|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951690|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951691|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951692|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951693|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951694|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951695|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951696|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
129951697|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
129951698|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
129951699|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
129951700|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
129951701|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
129951702|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951703|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951704|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951705|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951706|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951707|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951708|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951709|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951710|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951711|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951712|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951713|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951714|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951715|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
129951716|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951717|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951718|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951719|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951720|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951721|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951722|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951723|NCT01799993|467784828|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
129951724|NCT01799993|467784829|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
129951725|NCT01799993|467784828|FG000|Overall Study|Death|61|||
129951726|NCT01799993|467784829|FG001|Overall Study|Death|45|||
129951727|NCT01799993|467784828|FG000|Overall Study|Withdrawal by Subject|23|||
129951728|NCT01799993|467784829|FG001|Overall Study|Withdrawal by Subject|24|||
129951729|NCT01799993|467784828|FG000|Overall Study|Lost to Follow-up|5|||
129951730|NCT01799993|467784829|FG001|Overall Study|Lost to Follow-up|8|||
129951731|NCT01799993|467784828|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
129951732|NCT01799993|467784829|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
129951733|NCT01799993|467784828|FG000|Overall Study|Protocol driven decision point|0|||
129951734|NCT01799993|467784829|FG001|Overall Study|Protocol driven decision point|3|||
129951735|NCT01799993|467784828|FG000|Overall Study|Protocol Violation|1|||
130075037|NCT00369278|468229512|FG000|Overall Study|Withdrawal by Subject|2|||
130075038|NCT00369278|468229513|FG001|Overall Study|Withdrawal by Subject|2|||
130075039|NCT00369278|468229512|FG000|Overall Study|Lost to Follow-up|1|||
130075040|NCT00369278|468229513|FG001|Overall Study|Lost to Follow-up|0|||
130075041|NCT00369278|468229512|FG000|Overall Study|Graft loss|1|||
130075042|NCT00369278|468229513|FG001|Overall Study|Graft loss|2|||
130075043|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Death|3|||
130075044|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Death|0|||
130075045|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Death|0|||
130075046|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Death|0|||
130075047|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Death|0|||
130075048|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
130075049|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
130075050|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
130075051|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
130075052|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
130075053|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130075054|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
130075055|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
130075056|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130075057|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
130075058|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Other|0|||
130075059|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Other|0|||
130075060|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Other|1|||
130075061|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Other|0|||
130075062|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Other|0|||
130075063|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
130075064|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
130075065|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
130075066|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
130075067|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
130075068|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
130075069|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
130075070|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
130075071|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
130075072|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
130075073|NCT01224106|468229514|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130075074|NCT01224106|468229515|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130075075|NCT01224106|468229516|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130075076|NCT01224106|468229517|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130075077|NCT01224106|468229518|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130075078|NCT01224106|468229514|FG000|Open-Label Extension (OLE) Phase|Death|0|||
130075079|NCT01224106|468229515|FG001|Open-Label Extension (OLE) Phase|Death|0|||
130075080|NCT01224106|468229516|FG002|Open-Label Extension (OLE) Phase|Death|0|||
130075081|NCT01224106|468229517|FG003|Open-Label Extension (OLE) Phase|Death|1|||
130075082|NCT01224106|468229518|FG004|Open-Label Extension (OLE) Phase|Death|3|||
130075083|NCT01224106|468229514|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130075084|NCT01224106|468229515|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130075085|NCT01224106|468229516|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
130075086|NCT01224106|468229517|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
130075087|NCT01224106|468229518|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
130075088|NCT01224106|468229514|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
130075089|NCT01224106|468229515|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
130075090|NCT01224106|468229516|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
130075091|NCT01224106|468229517|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
130075092|NCT01224106|468229518|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
130075093|NCT01224106|468229514|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
130075094|NCT01224106|468229515|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
130075095|NCT01224106|468229516|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
130075096|NCT01224106|468229517|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
130075097|NCT01224106|468229518|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
130075098|NCT01224106|468229514|FG000|Open-Label Extension (OLE) Phase|Other|0|||
130075099|NCT01224106|468229515|FG001|Open-Label Extension (OLE) Phase|Other|0|||
130075100|NCT01224106|468229516|FG002|Open-Label Extension (OLE) Phase|Other|0|||
130075101|NCT01224106|468229517|FG003|Open-Label Extension (OLE) Phase|Other|5|||
130075102|NCT01224106|468229518|FG004|Open-Label Extension (OLE) Phase|Other|3|||
130075103|NCT00446797|468229519|FG000|Overall Study|Lack of Efficacy|0|||
130120524|NCT03384745|468402405|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
130075104|NCT00446797|468229520|FG001|Overall Study|Lack of Efficacy|2|||
130075105|NCT00446797|468229519|FG000|Overall Study|Lost to Follow-up|5|||
130075106|NCT00446797|468229520|FG001|Overall Study|Lost to Follow-up|3|||
130075107|NCT00446797|468229519|FG000|Overall Study|Withdrawal by Subject|2|||
130075108|NCT00446797|468229520|FG001|Overall Study|Withdrawal by Subject|2|||
130075109|NCT00446797|468229519|FG000|Overall Study|Protocol Violation|1|||
130075110|NCT00446797|468229520|FG001|Overall Study|Protocol Violation|3|||
130075111|NCT00446797|468229519|FG000|Overall Study|subject entered at another site|0|||
130075112|NCT00446797|468229520|FG001|Overall Study|subject entered at another site|1|||
130075113|NCT00446797|468229519|FG000|Overall Study|did not meet entrance criteria|0|||
130075114|NCT00446797|468229520|FG001|Overall Study|did not meet entrance criteria|1|||
130075115|NCT03551626|468229527|FG000|Overall Study|Adverse Event|88|||
130075116|NCT03551626|468229527|FG000|Overall Study|Disease relapse|18|||
130075117|NCT03551626|468229527|FG000|Overall Study|Withdrawal of informed consent|6|||
130075118|NCT03551626|468229527|FG000|Overall Study|Patient decision|5|||
130075119|NCT03551626|468229527|FG000|Overall Study|Physician Decision|4|||
130075120|NCT03551626|468229527|FG000|Overall Study|Lost to Follow-up|3|||
129951736|NCT01799993|467784829|FG001|Overall Study|Protocol Violation|1|||
129951737|NCT01799993|467784828|FG000|Overall Study|Deterioration of general conditions|2|||
129951738|NCT01799993|467784829|FG001|Overall Study|Deterioration of general conditions|0|||
129951739|NCT01799993|467784828|FG000|Overall Study|Screen failure|0|||
129951740|NCT01799993|467784829|FG001|Overall Study|Screen failure|1|||
129951741|NCT01799993|467784828|FG000|Overall Study|Adverse Event|1|||
129951742|NCT01799993|467784829|FG001|Overall Study|Adverse Event|0|||
129951743|NCT01799993|467784828|FG000|Overall Study|Lack of Efficacy|1|||
129951744|NCT01799993|467784829|FG001|Overall Study|Lack of Efficacy|0|||
129951745|NCT01799993|467784828|FG000|Overall Study|Recovery|0|||
129951746|NCT01799993|467784829|FG001|Overall Study|Recovery|1|||
129951747|NCT01799993|467784828|FG000|Overall Study|Logistical difficulties|1|||
129951748|NCT01799993|467784829|FG001|Overall Study|Logistical difficulties|0|||
129951749|NCT01799993|467784828|FG000|Overall Study|Protocol deviation|1|||
129951750|NCT01799993|467784829|FG001|Overall Study|Protocol deviation|0|||
129951751|NCT01799993|467784828|FG000|Overall Study|Non-compliance with medical device|1|||
129951752|NCT01799993|467784829|FG001|Overall Study|Non-compliance with medical device|0|||
129951753|NCT01799993|467784828|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129951754|NCT01799993|467784829|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129951755|NCT01799993|467784828|FG000|Overall Study|Other|1|||
129951756|NCT01799993|467784829|FG001|Overall Study|Other|0|||
129951757|NCT01799993|467784828|FG000|Overall Study|Subject didn't return for follow-up|0|||
129951758|NCT01799993|467784829|FG001|Overall Study|Subject didn't return for follow-up|1|||
129951759|NCT04271254|467784830|FG000|Overall Study|Withdrawal by Subject|3|||
129951760|NCT04410445|467784831|FG000|Overall Study|Lost to Follow-up|3|||
129951761|NCT04410445|467784832|FG001|Overall Study|Lost to Follow-up|9|||
129951762|NCT04410445|467784831|FG000|Overall Study|Withdrawal by Subject|27|||
129951763|NCT04410445|467784832|FG001|Overall Study|Withdrawal by Subject|15|||
129951764|NCT01320683|467784833|FG000|Overall Study|Positive antibody response|1|||
129951765|NCT01123356|467784834|FG000|Overall Study|Adverse Event|2|||
129951766|NCT01123356|467784834|FG000|Overall Study|Lack of Efficacy|4|||
129951767|NCT01123356|467784834|FG000|Overall Study|Withdrawal by Subject|1|||
129951768|NCT00759681|467784835|FG000|Overall Study|Death|2|||
129951769|NCT00759681|467784836|FG001|Overall Study|Death|5|||
129951770|NCT00759681|467784835|FG000|Overall Study|Lost to Follow-up|8|||
129951771|NCT00759681|467784836|FG001|Overall Study|Lost to Follow-up|5|||
129951772|NCT00476151|467784837|FG000|Overall Study|Adverse Event|0|||
129951773|NCT00476151|467784838|FG001|Overall Study|Adverse Event|2|||
129951774|NCT00476151|467784837|FG000|Overall Study|Protocol Violation|1|||
129951775|NCT00476151|467784838|FG001|Overall Study|Protocol Violation|3|||
129951776|NCT00476151|467784837|FG000|Overall Study|Withdrawal by Subject|2|||
129951777|NCT00476151|467784838|FG001|Overall Study|Withdrawal by Subject|0|||
129951778|NCT00476151|467784837|FG000|Overall Study|Physician Decision|0|||
129951779|NCT00476151|467784838|FG001|Overall Study|Physician Decision|2|||
129951780|NCT01113541|467784845|FG000|Overall Study|Withdrawal by Subject|1|||
129951781|NCT01113541|467784845|FG000|Overall Study|Protocol Violation|1|||
129951782|NCT01113541|467784845|FG000|Overall Study|Study Terminated by Sponsor|7|||
129951783|NCT01113541|467784845|FG000|Overall Study|Adverse Event|4|||
129951784|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
129951785|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
129951786|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130075121|NCT03551626|468229527|FG000|Overall Study|Pregnancy|1|||
129951787|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951788|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951789|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951790|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
130075122|NCT03551626|468229527|FG000|Overall Study|Protocol deviation|1|||
130075123|NCT03551626|468229527|FG000|Overall Study|Technical problems|1|||
129951791|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
129951792|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
129951793|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
129951794|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951795|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951796|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951797|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951798|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
129951799|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951800|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
129951801|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951802|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951803|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951804|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951805|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951806|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
129951807|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951808|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951809|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951810|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951811|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951812|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
129951813|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
129951814|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
129951815|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951816|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951817|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951818|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951819|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
129951820|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
129951821|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
129951822|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951823|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951824|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951825|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951826|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951827|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951828|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951829|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951830|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951831|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
129951832|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951833|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951834|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951835|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951836|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
129951837|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951838|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
129951839|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
129951840|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129951841|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129951842|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129951843|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
129951844|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
129951845|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
129951846|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
129951847|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951848|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951849|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951850|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
129951851|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951852|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
129951853|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
129951854|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951855|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951856|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951857|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
129951858|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951859|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951860|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
129951861|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951862|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951863|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951864|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951865|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951866|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
129951867|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951868|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129951869|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129951870|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129951871|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
129951872|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
129951873|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
129951874|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
129951875|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951876|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951877|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951878|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
129951879|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
129951880|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
129951881|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
130075124|NCT02133001|468229528|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
130075125|NCT02133001|468229529|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
130075126|NCT02133001|468229528|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
130075127|NCT02133001|468229529|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
130075128|NCT02133001|468229528|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
130075129|NCT02133001|468229529|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
130075130|NCT02133001|468229528|FG000|Double Blind (Day 1-25)|Other|2|||
130075131|NCT02133001|468229529|FG001|Double Blind (Day 1-25)|Other|2|||
130075132|NCT02133001|468229528|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
130075133|NCT02133001|468229529|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
130075134|NCT02133001|468229528|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
130075135|NCT02133001|468229529|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
130075136|NCT02133001|468229528|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
130075137|NCT02133001|468229529|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
130075138|NCT02133001|468229528|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
130075139|NCT02133001|468229529|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
130075140|NCT04211961|468229530|FG000|Overall Study|Death|0|||
130075141|NCT04211961|468229531|FG001|Overall Study|Death|1|||
130075142|NCT04211961|468229530|FG000|Overall Study|Lost to Follow-up|0|||
130075143|NCT04211961|468229531|FG001|Overall Study|Lost to Follow-up|1|||
130075144|NCT04211961|468229530|FG000|Overall Study|Withdrawal by Subject|0|||
130075145|NCT04211961|468229531|FG001|Overall Study|Withdrawal by Subject|1|||
130075146|NCT02498392|468229536|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
130075147|NCT02498392|468229537|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
130075148|NCT02498392|468229536|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
130075149|NCT02498392|468229537|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
130075150|NCT02498392|468229536|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
130075151|NCT02498392|468229537|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
130075152|NCT02498392|468229536|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
130075153|NCT02498392|468229537|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
130075154|NCT02498392|468229536|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
130075155|NCT02498392|468229537|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
130075156|NCT02498392|468229536|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
130075157|NCT02498392|468229537|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
130075158|NCT05784129|468229538|FG000|Overall Study|Study terminated by sponsor|2|||
130075159|NCT05784129|468229539|FG001|Overall Study|Study terminated by sponsor|2|||
130075160|NCT01156363|468229540|FG000|Overall Study|Adverse Event|6|||
130075161|NCT01156363|468229540|FG000|Overall Study|Insufficient Therapeutic Response|5|||
130075162|NCT01156363|468229540|FG000|Overall Study|Failure to Return|1|||
130075163|NCT01156363|468229540|FG000|Overall Study|Refused Treatment|4|||
130075164|NCT01156363|468229540|FG000|Overall Study|Other|6|||
130075165|NCT02873208|468229543|FG000|Overall Study|Withdrawal by Subject|36|||
130075166|NCT02873208|468229543|FG000|Overall Study|Lost to Follow-up|22|||
129951882|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
129951883|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
130075167|NCT02873208|468229543|FG000|Overall Study|Adverse Event|15|||
130075168|NCT02873208|468229543|FG000|Overall Study|Non-compliance with study drug|12|||
130075169|NCT02873208|468229543|FG000|Overall Study|Protocol Violation|8|||
130075170|NCT02873208|468229543|FG000|Overall Study|Pregnancy|2|||
130075171|NCT02873208|468229543|FG000|Overall Study|Incarceration|1|||
130075172|NCT02873208|468229543|FG000|Overall Study|Lack of Efficacy|1|||
130075173|NCT02873208|468229543|FG000|Overall Study|Physician Decision|1|||
130075174|NCT04080752|468229544|FG000|Overall Study|Adverse Event|2|||
130075175|NCT04080752|468229545|FG001|Overall Study|Adverse Event|3|||
130075176|NCT04080752|468229544|FG000|Overall Study|Lack of Efficacy|1|||
130075177|NCT04080752|468229545|FG001|Overall Study|Lack of Efficacy|0|||
130075178|NCT04080752|468229544|FG000|Overall Study|Lost to Follow-up|1|||
130075179|NCT04080752|468229545|FG001|Overall Study|Lost to Follow-up|0|||
130075180|NCT04080752|468229544|FG000|Overall Study|Pregnancy|0|||
130075181|NCT04080752|468229545|FG001|Overall Study|Pregnancy|1|||
130075182|NCT04080752|468229544|FG000|Overall Study|Withdrawal by Subject|7|||
130075183|NCT04080752|468229545|FG001|Overall Study|Withdrawal by Subject|0|||
130075184|NCT04080752|468229544|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130075185|NCT04080752|468229545|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130075186|NCT04080752|468229544|FG000|Overall Study|Other|2|||
130075187|NCT04080752|468229545|FG001|Overall Study|Other|1|||
130075188|NCT01192100|468229546|FG000|Overall Study|Withdrawal by Subject|0|||
130075189|NCT01192100|468229547|FG001|Overall Study|Withdrawal by Subject|0|||
130075190|NCT01192100|468229548|FG002|Overall Study|Withdrawal by Subject|0|||
130075191|NCT01192100|468229549|FG003|Overall Study|Withdrawal by Subject|0|||
130075192|NCT01192100|468229550|FG004|Overall Study|Withdrawal by Subject|1|||
130075193|NCT01192100|468229551|FG005|Overall Study|Withdrawal by Subject|0|||
130075194|NCT01192100|468229546|FG000|Overall Study|Protocol Violation|0|||
130075195|NCT01192100|468229547|FG001|Overall Study|Protocol Violation|0|||
130075196|NCT01192100|468229548|FG002|Overall Study|Protocol Violation|0|||
130075197|NCT01192100|468229549|FG003|Overall Study|Protocol Violation|1|||
130075198|NCT01192100|468229550|FG004|Overall Study|Protocol Violation|0|||
130075199|NCT01192100|468229551|FG005|Overall Study|Protocol Violation|0|||
130075200|NCT04685538|468229552|FG000|Overall Study|Adverse Event|0|||
130075201|NCT04685538|468229553|FG001|Overall Study|Adverse Event|1|||
130075202|NCT04685538|468229552|FG000|Overall Study|Lost to Follow-up|0|||
130075203|NCT04685538|468229553|FG001|Overall Study|Lost to Follow-up|2|||
130075204|NCT01421069|468229554|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
130075205|NCT01421069|468229554|FG000|Parent Study|Failed to return|3|||
130075206|NCT01421069|468229554|FG000|Parent Study|Withdrawal by Subject|1|||
130075207|NCT01421069|468229554|FG000|Parent Study|Lost to Follow-up|2|||
130075208|NCT01421069|468229554|FG000|Parent Study|Lack of Efficacy|1|||
130075209|NCT01421069|468229554|FG000|Overall Period for Extension Study|Other|2|||
130075210|NCT01421069|468229554|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
130075211|NCT01421069|468229554|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
130075212|NCT01421069|468229554|FG000|Overall Period for Extension Study|Pregnancy|1|||
130075213|NCT01421069|468229554|FG000|Overall Period for Extension Study|Adverse Event|1|||
130075214|NCT01421069|468229554|FG000|Overall Period for Extension Study|Protocol Violation|1|||
130075215|NCT01421069|468229554|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
130075216|NCT01421069|468229554|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
130075217|NCT01421069|468229554|FG000|Active Treatment Period|Other|1|||
130075218|NCT01421069|468229554|FG000|Active Treatment Period|No longer willing to participate in study|8|||
130075219|NCT01421069|468229554|FG000|Active Treatment Period|Insufficient clinical response|1|||
130075220|NCT01421069|468229554|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
130075221|NCT01421069|468229554|FG000|Active Treatment Period|Pregnancy|1|||
130075222|NCT01421069|468229554|FG000|Active Treatment Period|Adverse Event|1|||
130075223|NCT01421069|468229554|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
130075224|NCT01421069|468229554|FG000|Active Treatment Period|Enrolled in observational period|29|||
130075225|NCT01421069|468229554|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
130075226|NCT01421069|468229554|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
130075227|NCT01421069|468229554|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
130075228|NCT01421069|468229554|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
130075229|NCT01421069|468229554|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
130075230|NCT01421069|468229554|FG000|2b. Retreatment Period|Protocol Violation|1|||
130075231|NCT01421069|468229554|FG000|Observational Period|Other|1|||
130075232|NCT01421069|468229554|FG000|Observational Period|No longer willing to participate in study|4|||
130120525|NCT03384745|468402406|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
130120526|NCT03384745|468402407|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
130075233|NCT01421069|468229554|FG000|Observational Period|Lost to Follow-up|3|||
130075234|NCT01641081|468229555|FG000|Period 1|Sponsor request (potential unblinding)|0|||
130075235|NCT01641081|468229556|FG001|Period 1|Sponsor request (potential unblinding)|0|||
130075236|NCT01641081|468229557|FG002|Period 1|Sponsor request (potential unblinding)|0|||
130075237|NCT01641081|468229558|FG003|Period 1|Sponsor request (potential unblinding)|0|||
130075238|NCT01641081|468229559|FG004|Period 1|Sponsor request (potential unblinding)|0|||
130075239|NCT01641081|468229560|FG005|Period 1|Sponsor request (potential unblinding)|0|||
130075240|NCT01641081|468229561|FG006|Period 1|Sponsor request (potential unblinding)|1|||
130075241|NCT01641081|468229562|FG007|Period 1|Sponsor request (potential unblinding)|0|||
130075242|NCT01641081|468229563|FG008|Period 1|Sponsor request (potential unblinding)|0|||
130075243|NCT01641081|468229564|FG009|Period 1|Sponsor request (potential unblinding)|0|||
130075244|NCT01641081|468229555|FG000|Period 1|Protocol Violation|0|||
130075245|NCT01641081|468229556|FG001|Period 1|Protocol Violation|0|||
130075246|NCT01641081|468229557|FG002|Period 1|Protocol Violation|0|||
130075247|NCT01641081|468229558|FG003|Period 1|Protocol Violation|0|||
130075248|NCT01641081|468229559|FG004|Period 1|Protocol Violation|1|||
130075249|NCT01641081|468229560|FG005|Period 1|Protocol Violation|0|||
130075250|NCT01641081|468229561|FG006|Period 1|Protocol Violation|0|||
130075251|NCT01641081|468229562|FG007|Period 1|Protocol Violation|1|||
130075252|NCT01641081|468229563|FG008|Period 1|Protocol Violation|0|||
130075253|NCT01641081|468229564|FG009|Period 1|Protocol Violation|0|||
130075254|NCT01641081|468229555|FG000|Period 1|Adverse Event|1|||
130075255|NCT01641081|468229556|FG001|Period 1|Adverse Event|0|||
130075256|NCT01641081|468229557|FG002|Period 1|Adverse Event|0|||
130075257|NCT01641081|468229558|FG003|Period 1|Adverse Event|0|||
130075258|NCT01641081|468229559|FG004|Period 1|Adverse Event|0|||
130075259|NCT01641081|468229560|FG005|Period 1|Adverse Event|0|||
130075260|NCT01641081|468229561|FG006|Period 1|Adverse Event|0|||
130075261|NCT01641081|468229562|FG007|Period 1|Adverse Event|2|||
130075262|NCT01641081|468229563|FG008|Period 1|Adverse Event|0|||
130075263|NCT01641081|468229564|FG009|Period 1|Adverse Event|0|||
130075264|NCT01641081|468229555|FG000|Period 2|Adverse Event|0|||
130075265|NCT01641081|468229556|FG001|Period 2|Adverse Event|0|||
130075266|NCT01641081|468229557|FG002|Period 2|Adverse Event|0|||
130075267|NCT01641081|468229558|FG003|Period 2|Adverse Event|0|||
130075268|NCT01641081|468229559|FG004|Period 2|Adverse Event|0|||
130075269|NCT01641081|468229560|FG005|Period 2|Adverse Event|1|||
130075270|NCT01641081|468229561|FG006|Period 2|Adverse Event|0|||
130075271|NCT01641081|468229562|FG007|Period 2|Adverse Event|0|||
130075272|NCT01641081|468229563|FG008|Period 2|Adverse Event|0|||
130075273|NCT01641081|468229564|FG009|Period 2|Adverse Event|0|||
130075274|NCT01641081|468229555|FG000|Period 2|Withdrawal by Subject|0|||
130075275|NCT01641081|468229556|FG001|Period 2|Withdrawal by Subject|0|||
130075276|NCT01641081|468229557|FG002|Period 2|Withdrawal by Subject|0|||
130075277|NCT01641081|468229558|FG003|Period 2|Withdrawal by Subject|1|||
130075278|NCT01641081|468229559|FG004|Period 2|Withdrawal by Subject|0|||
130075279|NCT01641081|468229560|FG005|Period 2|Withdrawal by Subject|0|||
130075280|NCT01641081|468229561|FG006|Period 2|Withdrawal by Subject|2|||
130075281|NCT01641081|468229562|FG007|Period 2|Withdrawal by Subject|0|||
130075282|NCT01641081|468229563|FG008|Period 2|Withdrawal by Subject|0|||
130075283|NCT01641081|468229564|FG009|Period 2|Withdrawal by Subject|0|||
130075284|NCT01641081|468229555|FG000|Period 2|Protocol Violation|1|||
130075285|NCT01641081|468229556|FG001|Period 2|Protocol Violation|0|||
130075286|NCT01641081|468229557|FG002|Period 2|Protocol Violation|0|||
130075287|NCT01641081|468229558|FG003|Period 2|Protocol Violation|0|||
130075288|NCT01641081|468229559|FG004|Period 2|Protocol Violation|0|||
130075289|NCT01641081|468229560|FG005|Period 2|Protocol Violation|0|||
130075290|NCT01641081|468229561|FG006|Period 2|Protocol Violation|0|||
130075291|NCT01641081|468229562|FG007|Period 2|Protocol Violation|0|||
130075292|NCT01641081|468229563|FG008|Period 2|Protocol Violation|0|||
130075293|NCT01641081|468229564|FG009|Period 2|Protocol Violation|0|||
130075294|NCT01641081|468229555|FG000|Period 3|Adverse Event|0|||
130075295|NCT01641081|468229556|FG001|Period 3|Adverse Event|0|||
130075296|NCT01641081|468229557|FG002|Period 3|Adverse Event|1|||
130075297|NCT01641081|468229558|FG003|Period 3|Adverse Event|0|||
130075298|NCT01641081|468229559|FG004|Period 3|Adverse Event|0|||
130075299|NCT01641081|468229560|FG005|Period 3|Adverse Event|0|||
130075300|NCT01641081|468229561|FG006|Period 3|Adverse Event|0|||
130075301|NCT01641081|468229562|FG007|Period 3|Adverse Event|0|||
130075302|NCT01641081|468229563|FG008|Period 3|Adverse Event|0|||
130075303|NCT01641081|468229564|FG009|Period 3|Adverse Event|0|||
130075304|NCT01641081|468229555|FG000|Period 3|Withdrawal by Subject|0|||
130075305|NCT01641081|468229556|FG001|Period 3|Withdrawal by Subject|0|||
130075306|NCT01641081|468229557|FG002|Period 3|Withdrawal by Subject|0|||
130075307|NCT01641081|468229558|FG003|Period 3|Withdrawal by Subject|0|||
130075308|NCT01641081|468229559|FG004|Period 3|Withdrawal by Subject|0|||
130075309|NCT01641081|468229560|FG005|Period 3|Withdrawal by Subject|0|||
130075310|NCT01641081|468229561|FG006|Period 3|Withdrawal by Subject|0|||
130075311|NCT01641081|468229562|FG007|Period 3|Withdrawal by Subject|0|||
130075312|NCT01641081|468229563|FG008|Period 3|Withdrawal by Subject|1|||
130075313|NCT01641081|468229564|FG009|Period 3|Withdrawal by Subject|0|||
130075314|NCT01641081|468229555|FG000|Period 4|Adverse Event|0|||
130075315|NCT01641081|468229556|FG001|Period 4|Adverse Event|1|||
130075316|NCT01641081|468229557|FG002|Period 4|Adverse Event|0|||
130075317|NCT01641081|468229558|FG003|Period 4|Adverse Event|1|||
130075318|NCT01641081|468229559|FG004|Period 4|Adverse Event|0|||
130075319|NCT01641081|468229560|FG005|Period 4|Adverse Event|0|||
130075320|NCT01641081|468229561|FG006|Period 4|Adverse Event|0|||
130075321|NCT01641081|468229562|FG007|Period 4|Adverse Event|0|||
130075322|NCT01641081|468229563|FG008|Period 4|Adverse Event|0|||
130075323|NCT01641081|468229564|FG009|Period 4|Adverse Event|0|||
130075324|NCT01641081|468229555|FG000|Period 5|Adverse Event|0|||
130075325|NCT01641081|468229556|FG001|Period 5|Adverse Event|0|||
130075326|NCT01641081|468229557|FG002|Period 5|Adverse Event|2|||
130075327|NCT01641081|468229558|FG003|Period 5|Adverse Event|0|||
130075328|NCT01641081|468229559|FG004|Period 5|Adverse Event|0|||
130075329|NCT01641081|468229560|FG005|Period 5|Adverse Event|0|||
130075330|NCT01641081|468229561|FG006|Period 5|Adverse Event|0|||
130075331|NCT01641081|468229562|FG007|Period 5|Adverse Event|0|||
130075332|NCT01641081|468229563|FG008|Period 5|Adverse Event|0|||
130075333|NCT01641081|468229564|FG009|Period 5|Adverse Event|0|||
130075334|NCT01095666|468229565|FG000|Overall Study|Lack of Efficacy|0|||
130075335|NCT01095666|468229566|FG001|Overall Study|Lack of Efficacy|0|||
130075336|NCT01095666|468229567|FG002|Overall Study|Lack of Efficacy|1|||
130075337|NCT01095666|468229565|FG000|Overall Study|Adverse Event|2|||
130075338|NCT01095666|468229566|FG001|Overall Study|Adverse Event|1|||
130075339|NCT01095666|468229567|FG002|Overall Study|Adverse Event|3|||
130075340|NCT01095666|468229565|FG000|Overall Study|Lost to Follow-up|2|||
130075341|NCT01095666|468229566|FG001|Overall Study|Lost to Follow-up|2|||
130075342|NCT01095666|468229567|FG002|Overall Study|Lost to Follow-up|0|||
130075343|NCT01095666|468229565|FG000|Overall Study|Withdrawal by Subject|6|||
130075344|NCT01095666|468229566|FG001|Overall Study|Withdrawal by Subject|6|||
130075345|NCT01095666|468229567|FG002|Overall Study|Withdrawal by Subject|1|||
130075346|NCT01095666|468229565|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
130075347|NCT01095666|468229566|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
130075348|NCT01095666|468229567|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
130075349|NCT02917629|468229574|FG000|Overall Study|Withdrawal by Subject|0|||
130075350|NCT02917629|468229575|FG001|Overall Study|Withdrawal by Subject|1|||
130075351|NCT00718523|468229576|FG000|Overall Study|Withdrawal by Subject|5|||
130075352|NCT00718523|468229577|FG001|Overall Study|Withdrawal by Subject|7|||
130075353|NCT00718523|468229576|FG000|Overall Study|Death|13|||
130075354|NCT00718523|468229577|FG001|Overall Study|Death|17|||
130075355|NCT03136484|468229578|FG000|Overall Study|Withdrawal by Subject|19|||
130075356|NCT03136484|468229579|FG001|Overall Study|Withdrawal by Subject|14|||
130075357|NCT03136484|468229578|FG000|Overall Study|Lost to Follow-up|7|||
130075358|NCT03136484|468229579|FG001|Overall Study|Lost to Follow-up|8|||
130075359|NCT03136484|468229578|FG000|Overall Study|Death|1|||
130075360|NCT03136484|468229579|FG001|Overall Study|Death|0|||
130075361|NCT05041062|468229582|FG000|Overall Study|Adverse Event|2|||
130075362|NCT01802515|468229587|FG000|Overall Study|Withdrawal by Subject|3|||
130075363|NCT01802515|468229588|FG001|Overall Study|Withdrawal by Subject|0|||
130075364|NCT01802515|468229589|FG002|Overall Study|Withdrawal by Subject|0|||
130075365|NCT03038672|468231600|FG000|Initial Treatment|Unacceptable chemistry|0|||
130075366|NCT03038672|468231601|FG001|Initial Treatment|Unacceptable chemistry|1|||
130075367|NCT03038672|468231600|FG000|Initial Treatment|Progression prior to treatment|1|||
130075368|NCT03038672|468231601|FG001|Initial Treatment|Progression prior to treatment|0|||
130075369|NCT03038672|468231600|FG000|Initial Treatment|No treatment per protocol|1|||
130075370|NCT03038672|468231601|FG001|Initial Treatment|No treatment per protocol|0|||
130075371|NCT01696396|468231602|FG000|Overall Study|Withdrawal by Subject|19|||
130075372|NCT01696396|468231603|FG001|Overall Study|Withdrawal by Subject|5|||
130075373|NCT01696396|468231604|FG002|Overall Study|Withdrawal by Subject|19|||
130075374|NCT01696396|468231605|FG003|Overall Study|Withdrawal by Subject|11|||
130075375|NCT01696396|468231602|FG000|Overall Study|Decision by Sponsor|3|||
130075376|NCT01696396|468231603|FG001|Overall Study|Decision by Sponsor|1|||
130075377|NCT01696396|468231604|FG002|Overall Study|Decision by Sponsor|2|||
130075378|NCT01696396|468231605|FG003|Overall Study|Decision by Sponsor|2|||
130075379|NCT01696396|468231602|FG000|Overall Study|Lost to Follow-up|9|||
130075380|NCT01696396|468231603|FG001|Overall Study|Lost to Follow-up|1|||
130075381|NCT01696396|468231604|FG002|Overall Study|Lost to Follow-up|4|||
130075382|NCT01696396|468231605|FG003|Overall Study|Lost to Follow-up|1|||
130075383|NCT01696396|468231602|FG000|Overall Study|Death|0|||
130075384|NCT01696396|468231603|FG001|Overall Study|Death|0|||
130075385|NCT01696396|468231604|FG002|Overall Study|Death|1|||
130075386|NCT01696396|468231605|FG003|Overall Study|Death|0|||
130075387|NCT02712008|468231611|FG000|Baseline (Day 1) up to Week 12|Death|3|||
130075388|NCT02712008|468231612|FG001|Baseline (Day 1) up to Week 12|Death|0|||
130075389|NCT02712008|468231613|FG002|Baseline (Day 1) up to Week 12|Death|0|||
130075390|NCT02712008|468231614|FG003|Baseline (Day 1) up to Week 12|Death|0|||
130075391|NCT02712008|468231615|FG004|Baseline (Day 1) up to Week 12|Death|0|||
130075392|NCT02712008|468231616|FG005|Baseline (Day 1) up to Week 12|Death|0|||
130075393|NCT02712008|468231617|FG006|Baseline (Day 1) up to Week 12|Death|0|||
130075394|NCT02712008|468231618|FG007|Baseline (Day 1) up to Week 12|Death|0|||
130075395|NCT02712008|468231611|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130075396|NCT02712008|468231612|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
130075397|NCT02712008|468231613|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
130075398|NCT02712008|468231614|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130075399|NCT02712008|468231615|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130075400|NCT02712008|468231616|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130075401|NCT02712008|468231617|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130075402|NCT02712008|468231618|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
130075403|NCT02712008|468231611|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
130075404|NCT02712008|468231612|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130075405|NCT02712008|468231613|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
130075406|NCT02712008|468231614|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130075407|NCT02712008|468231615|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130075408|NCT02712008|468231616|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130075409|NCT02712008|468231617|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130075410|NCT02712008|468231618|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
130075411|NCT02712008|468231611|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075412|NCT02712008|468231612|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075413|NCT02712008|468231613|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
130075414|NCT02712008|468231614|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075415|NCT02712008|468231615|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075416|NCT02712008|468231616|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075417|NCT02712008|468231617|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075418|NCT02712008|468231618|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
130075419|NCT02712008|468231611|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075420|NCT02712008|468231612|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
130075421|NCT02712008|468231613|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075422|NCT02712008|468231614|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075423|NCT02712008|468231615|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075424|NCT02712008|468231616|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075425|NCT02712008|468231617|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075426|NCT02712008|468231618|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
130075427|NCT02712008|468231611|FG000|From Week 12 up to Week 36|Adverse Event|0|||
130075428|NCT02712008|468231612|FG001|From Week 12 up to Week 36|Adverse Event|0|||
130075429|NCT02712008|468231613|FG002|From Week 12 up to Week 36|Adverse Event|0|||
130075430|NCT02712008|468231614|FG003|From Week 12 up to Week 36|Adverse Event|0|||
130075431|NCT02712008|468231615|FG004|From Week 12 up to Week 36|Adverse Event|1|||
130075432|NCT02712008|468231616|FG005|From Week 12 up to Week 36|Adverse Event|0|||
130075433|NCT02712008|468231617|FG006|From Week 12 up to Week 36|Adverse Event|0|||
130075434|NCT02712008|468231618|FG007|From Week 12 up to Week 36|Adverse Event|2|||
130075435|NCT02712008|468231611|FG000|From Week 12 up to Week 36|Death|1|||
130075436|NCT02712008|468231612|FG001|From Week 12 up to Week 36|Death|0|||
130075437|NCT02712008|468231613|FG002|From Week 12 up to Week 36|Death|0|||
130075438|NCT02712008|468231614|FG003|From Week 12 up to Week 36|Death|0|||
130075439|NCT02712008|468231615|FG004|From Week 12 up to Week 36|Death|0|||
130075440|NCT02712008|468231616|FG005|From Week 12 up to Week 36|Death|0|||
130075441|NCT02712008|468231617|FG006|From Week 12 up to Week 36|Death|1|||
130075442|NCT02712008|468231618|FG007|From Week 12 up to Week 36|Death|0|||
130075443|NCT02712008|468231611|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
130075444|NCT02712008|468231612|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
130075445|NCT02712008|468231613|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
130075446|NCT02712008|468231614|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
130075447|NCT02712008|468231615|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
130075448|NCT02712008|468231616|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
130075449|NCT02712008|468231617|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
130075450|NCT02712008|468231618|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
130075451|NCT02712008|468231611|FG000|From Week 12 up to Week 36|Physician Decision|0|||
130120527|NCT03384745|468402402|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
130120528|NCT03384745|468402403|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
130120529|NCT03384745|468402404|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
130120530|NCT03384745|468402405|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
130120531|NCT03384745|468402406|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
130120532|NCT03384745|468402407|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
130120533|NCT03384745|468402402|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130075452|NCT02712008|468231612|FG001|From Week 12 up to Week 36|Physician Decision|0|||
130075453|NCT02712008|468231613|FG002|From Week 12 up to Week 36|Physician Decision|0|||
130075454|NCT02712008|468231614|FG003|From Week 12 up to Week 36|Physician Decision|1|||
130075455|NCT02712008|468231615|FG004|From Week 12 up to Week 36|Physician Decision|1|||
130075456|NCT02712008|468231616|FG005|From Week 12 up to Week 36|Physician Decision|0|||
130075457|NCT02712008|468231617|FG006|From Week 12 up to Week 36|Physician Decision|0|||
130075458|NCT02712008|468231618|FG007|From Week 12 up to Week 36|Physician Decision|0|||
130075459|NCT02712008|468231611|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130075460|NCT02712008|468231612|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130075461|NCT02712008|468231613|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130075462|NCT02712008|468231614|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130075463|NCT02712008|468231615|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130075464|NCT02712008|468231616|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
130120534|NCT03384745|468402403|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130075465|NCT02712008|468231617|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
130075466|NCT02712008|468231618|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
130075467|NCT00959894|468231619|FG000|Overall Study|Lost to Follow-up|10|||
130075468|NCT00959894|468231619|FG000|Overall Study|Adverse Event|3|||
130075469|NCT00959894|468231619|FG000|Overall Study|Withdrawal by Subject|1|||
130075470|NCT00959894|468231619|FG000|Overall Study|Need for contraindicated medication|1|||
130075471|NCT00959894|468231619|FG000|Overall Study|Subject moved out of town|1|||
130075472|NCT00653068|468231620|FG000|Overall Study|Death|9|||
130075473|NCT00653068|468231620|FG000|Overall Study|Lack of Efficacy|34|||
130075474|NCT00653068|468231620|FG000|Overall Study|Physician Decision|4|||
130075475|NCT00653068|468231620|FG000|Overall Study|Withdrawal by Subject|1|||
130075476|NCT00653068|468231620|FG000|Overall Study|Ineligible|2|||
130075477|NCT01305941|468231621|FG000|Overall Study|Adverse Event|6|||
130075478|NCT01305941|468231621|FG000|Overall Study|Clinical decline|2|||
130075479|NCT01305941|468231621|FG000|Overall Study|Withdrawal by Subject|1|||
130075480|NCT01305941|468231621|FG000|Overall Study|Death|1|||
130075481|NCT00608244|468231626|FG000|Overall Study|Adverse Event|1|||
130075482|NCT00608244|468231626|FG000|Overall Study|Low trough levels|1|||
130075483|NCT02944513|468231631|FG000|Overall Study|Withdrawal by Subject|4|||
130075484|NCT02944513|468231632|FG001|Overall Study|Withdrawal by Subject|1|||
130075485|NCT00106249|468231633|FG000|Overall Study|Lost to Follow-up|3|||
130075486|NCT00106249|468231634|FG001|Overall Study|Lost to Follow-up|2|||
130075487|NCT01929018|468231639|FG000|Overall Study|Lost to Follow-up|1|||
130075488|NCT01929018|468231640|FG001|Overall Study|Lost to Follow-up|0|||
130075489|NCT01929018|468231639|FG000|Overall Study|Hospitalization|0|||
130075490|NCT01929018|468231640|FG001|Overall Study|Hospitalization|1|||
130075491|NCT04882072|468231641|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
130075492|NCT04882072|468231642|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
130075493|NCT04882072|468231641|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
130075494|NCT04882072|468231642|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
130075495|NCT04882072|468231641|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
130075496|NCT04882072|468231642|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
130075497|NCT03097133|468231643|FG000|Overall Study|Lost to Follow-up|3|||
130075498|NCT03097133|468231644|FG001|Overall Study|Lost to Follow-up|2|||
130075499|NCT03097133|468231643|FG000|Overall Study|Withdrawal by Subject|2|||
130075500|NCT03097133|468231644|FG001|Overall Study|Withdrawal by Subject|5|||
130075501|NCT03097133|468231643|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
130075502|NCT03097133|468231644|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
130075503|NCT03097133|468231643|FG000|Overall Study|Other|3|||
130075504|NCT03097133|468231644|FG001|Overall Study|Other|2|||
130075505|NCT03097133|468231643|FG000|Overall Study|Adverse Event|1|||
130075506|NCT03097133|468231644|FG001|Overall Study|Adverse Event|0|||
130075507|NCT00841672|468231650|FG000|Overall Study|Adverse Event|7|||
130075508|NCT00841672|468231651|FG001|Overall Study|Adverse Event|16|||
130075509|NCT00841672|468231650|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130075510|NCT00841672|468231651|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130075511|NCT00841672|468231650|FG000|Overall Study|Subject withdrew consent|2|||
130075512|NCT00841672|468231651|FG001|Overall Study|Subject withdrew consent|4|||
130075513|NCT00841672|468231650|FG000|Overall Study|Lost to Follow-up|1|||
130075514|NCT00841672|468231651|FG001|Overall Study|Lost to Follow-up|1|||
130075515|NCT00841672|468231650|FG000|Overall Study|Administrative problems|9|||
130075516|NCT00841672|468231651|FG001|Overall Study|Administrative problems|9|||
130075517|NCT00841672|468231650|FG000|Overall Study|Misrandomized|1|||
130075518|NCT00841672|468231651|FG001|Overall Study|Misrandomized|0|||
130075519|NCT00841672|468231650|FG000|Overall Study|Protocol Deviation|0|||
130075520|NCT00841672|468231651|FG001|Overall Study|Protocol Deviation|1|||
130120535|NCT03384745|468402404|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
130120536|NCT03384745|468402405|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130120537|NCT03384745|468402406|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130075521|NCT00741260|468231656|FG000|Overall Study|Disease Progression|3|||
130075522|NCT00741260|468231657|FG001|Overall Study|Disease Progression|5|||
130075523|NCT00741260|468231658|FG002|Overall Study|Disease Progression|3|||
130075524|NCT00741260|468231659|FG003|Overall Study|Disease Progression|3|||
130075525|NCT00741260|468231660|FG004|Overall Study|Disease Progression|5|||
130075526|NCT00741260|468231661|FG005|Overall Study|Disease Progression|37|||
130075527|NCT00741260|468231662|FG006|Overall Study|Disease Progression|4|||
130075528|NCT00741260|468231656|FG000|Overall Study|Death|0|||
130075529|NCT00741260|468231657|FG001|Overall Study|Death|1|||
130075530|NCT00741260|468231658|FG002|Overall Study|Death|0|||
130075531|NCT00741260|468231659|FG003|Overall Study|Death|1|||
130075532|NCT00741260|468231660|FG004|Overall Study|Death|2|||
130075533|NCT00741260|468231661|FG005|Overall Study|Death|2|||
130075534|NCT00741260|468231662|FG006|Overall Study|Death|1|||
130075535|NCT00741260|468231656|FG000|Overall Study|Withdrawal by Subject|0|||
130075536|NCT00741260|468231657|FG001|Overall Study|Withdrawal by Subject|0|||
130075537|NCT00741260|468231658|FG002|Overall Study|Withdrawal by Subject|0|||
130075538|NCT00741260|468231659|FG003|Overall Study|Withdrawal by Subject|0|||
130075539|NCT00741260|468231660|FG004|Overall Study|Withdrawal by Subject|1|||
130075540|NCT00741260|468231661|FG005|Overall Study|Withdrawal by Subject|3|||
130075541|NCT00741260|468231662|FG006|Overall Study|Withdrawal by Subject|1|||
130075542|NCT00741260|468231656|FG000|Overall Study|Physician Decision|1|||
130075543|NCT00741260|468231657|FG001|Overall Study|Physician Decision|1|||
130075544|NCT00741260|468231658|FG002|Overall Study|Physician Decision|0|||
130075545|NCT00741260|468231659|FG003|Overall Study|Physician Decision|0|||
130075546|NCT00741260|468231660|FG004|Overall Study|Physician Decision|0|||
130075547|NCT00741260|468231661|FG005|Overall Study|Physician Decision|0|||
130075548|NCT00741260|468231662|FG006|Overall Study|Physician Decision|0|||
130075549|NCT00741260|468231656|FG000|Overall Study|Other|2|||
130075550|NCT00741260|468231657|FG001|Overall Study|Other|1|||
130075551|NCT00741260|468231658|FG002|Overall Study|Other|1|||
130075552|NCT00741260|468231659|FG003|Overall Study|Other|2|||
130075553|NCT00741260|468231660|FG004|Overall Study|Other|1|||
130075554|NCT00741260|468231661|FG005|Overall Study|Other|3|||
130075555|NCT00741260|468231662|FG006|Overall Study|Other|1|||
130075556|NCT02427100|468231663|FG000|Overall Study|Lost to Follow-up|0|||
130075557|NCT02427100|468231664|FG001|Overall Study|Lost to Follow-up|2|||
130075558|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
130075559|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
130075560|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
130075561|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
130075562|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
130075563|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
130075564|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
130075565|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
130075566|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130075567|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130075568|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130075569|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130075570|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130075571|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
130075572|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
130075573|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
130075574|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
130075575|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
130075576|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
130075577|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
130075578|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
130075579|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
130075580|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130075581|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130075582|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130075583|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130075584|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130075585|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
130075586|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
130075587|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130075588|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130075589|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130075590|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130075591|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130075592|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
130075593|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
130075594|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130075595|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130075596|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130075597|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130075598|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130075599|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
130075600|NCT02120352|468231665|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
130075601|NCT02120352|468231666|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
130075602|NCT02120352|468231667|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
130075603|NCT02120352|468231668|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
130075604|NCT02120352|468231669|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
130075605|NCT02120352|468231670|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
130075606|NCT02120352|468231671|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
130075607|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130075608|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
130075609|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
130075610|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
130075611|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130075612|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130075613|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
130075614|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130075615|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
130075616|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130075617|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
130075618|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130075619|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130075620|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
130075621|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130075622|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
130075623|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
130075624|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130075625|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130075626|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130075627|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
130075628|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130075629|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130075630|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
130075631|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
130075632|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130075633|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130075634|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
130075635|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130075636|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130075637|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130075638|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
130075639|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130075640|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130075641|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
130075642|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130075643|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
130075644|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
130075645|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
130075646|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130075647|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130075648|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
130075649|NCT02120352|468231665|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130075650|NCT02120352|468231666|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
130075651|NCT02120352|468231667|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130075652|NCT02120352|468231668|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130075653|NCT02120352|468231669|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130075654|NCT02120352|468231670|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130075655|NCT02120352|468231671|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
130075656|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
130075657|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
130075658|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
130075659|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
130075660|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
130075661|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
130075662|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
130075663|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130075664|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130075665|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130075666|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130075667|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
130075668|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130075669|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
130075670|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130075671|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
130075672|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
130120538|NCT03384745|468402407|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
130120539|NCT03384745|468402402|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130120540|NCT03384745|468402403|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129951884|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
129951885|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
129951886|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
129951887|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
129951888|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
129951889|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
129951890|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
129951891|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
129951892|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
129951893|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
129951894|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
129951895|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
129951896|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
129951897|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
129951898|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
129951899|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
129951900|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
129951901|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
129951902|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
129951903|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
129951904|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
129951905|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
129951906|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
129951907|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
129951908|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
129951909|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
129951910|NCT02309892|467784857|FG000|Overall Study|Physician Decision|1|||
129951911|NCT02309892|467784858|FG001|Overall Study|Physician Decision|0|||
129951912|NCT02309892|467784859|FG002|Overall Study|Physician Decision|0|||
129951913|NCT02309892|467784860|FG003|Overall Study|Physician Decision|0|||
129951914|NCT02309892|467784861|FG004|Overall Study|Physician Decision|0|||
129951915|NCT02309892|467784862|FG005|Overall Study|Physician Decision|0|||
129951916|NCT02309892|467784863|FG006|Overall Study|Physician Decision|0|||
129951917|NCT02309892|467784857|FG000|Overall Study|Adverse Event|1|||
129951918|NCT02309892|467784858|FG001|Overall Study|Adverse Event|0|||
129951919|NCT02309892|467784859|FG002|Overall Study|Adverse Event|1|||
129951920|NCT02309892|467784860|FG003|Overall Study|Adverse Event|0|||
129951921|NCT02309892|467784861|FG004|Overall Study|Adverse Event|0|||
129951922|NCT02309892|467784862|FG005|Overall Study|Adverse Event|0|||
129951923|NCT02309892|467784863|FG006|Overall Study|Adverse Event|0|||
129951924|NCT02309892|467784857|FG000|Overall Study|Progressive Disease|0|||
129951925|NCT02309892|467784858|FG001|Overall Study|Progressive Disease|1|||
129951926|NCT02309892|467784859|FG002|Overall Study|Progressive Disease|0|||
129951927|NCT02309892|467784860|FG003|Overall Study|Progressive Disease|0|||
129951928|NCT02309892|467784861|FG004|Overall Study|Progressive Disease|1|||
129951929|NCT02309892|467784862|FG005|Overall Study|Progressive Disease|0|||
129951930|NCT02309892|467784863|FG006|Overall Study|Progressive Disease|0|||
129951931|NCT02309892|467784857|FG000|Overall Study|Death|0|||
129951932|NCT02309892|467784858|FG001|Overall Study|Death|0|||
129951933|NCT02309892|467784859|FG002|Overall Study|Death|0|||
129951934|NCT02309892|467784860|FG003|Overall Study|Death|0|||
129951935|NCT02309892|467784861|FG004|Overall Study|Death|0|||
129951936|NCT02309892|467784862|FG005|Overall Study|Death|1|||
129951937|NCT02309892|467784863|FG006|Overall Study|Death|0|||
129951938|NCT03262389|467784864|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
129951939|NCT03262389|467784864|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
129951940|NCT03262389|467784864|FG000|Overall Study|opted out of PET/MR|1|||
129951941|NCT01052272|467784865|FG000|Overall Study|Death|0|||
129951942|NCT01052272|467784866|FG001|Overall Study|Death|0|||
129951943|NCT01052272|467784867|FG002|Overall Study|Death|1|||
129951944|NCT01052272|467784868|FG003|Overall Study|Death|1|||
129951945|NCT01052272|467784865|FG000|Overall Study|Physician Decision|0|||
129951946|NCT01052272|467784866|FG001|Overall Study|Physician Decision|1|||
130075673|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130075674|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
129951947|NCT01052272|467784867|FG002|Overall Study|Physician Decision|0|||
129951948|NCT01052272|467784868|FG003|Overall Study|Physician Decision|0|||
129951949|NCT01052272|467784865|FG000|Overall Study|patient refuses follow-up|5|||
129951950|NCT01052272|467784866|FG001|Overall Study|patient refuses follow-up|4|||
129951951|NCT01052272|467784867|FG002|Overall Study|patient refuses follow-up|2|||
129951952|NCT01052272|467784868|FG003|Overall Study|patient refuses follow-up|4|||
129951953|NCT01052272|467784865|FG000|Overall Study|Withdrawal by Subject|0|||
129951954|NCT01052272|467784866|FG001|Overall Study|Withdrawal by Subject|2|||
130075675|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130075676|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
130075677|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130075678|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
130075679|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
130075680|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130075681|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
130075682|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130075683|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
130075684|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130075685|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
130075686|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
130075687|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130075688|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
130075689|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130075690|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
130075691|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130075692|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
130075693|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
130075694|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130075695|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130075696|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130075697|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
130075698|NCT02120352|468231665|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
130075699|NCT02120352|468231666|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
130075700|NCT02120352|468231667|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
130075701|NCT02120352|468231668|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
130075702|NCT02120352|468231669|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
130075703|NCT02120352|468231670|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
130075704|NCT02120352|468231671|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
130075705|NCT02120352|468231665|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130075706|NCT02120352|468231666|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130075707|NCT02120352|468231667|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130075708|NCT02120352|468231668|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130075709|NCT02120352|468231669|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130075710|NCT02120352|468231670|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
130075711|NCT02120352|468231671|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
130075712|NCT00842361|468231673|FG000|Overall Study|Protocol Violation|1|||
130075713|NCT00842361|468231674|FG001|Overall Study|Protocol Violation|0|||
130075714|NCT00842361|468231673|FG000|Overall Study|Unclassified|0|||
130075715|NCT00842361|468231674|FG001|Overall Study|Unclassified|2|||
130075716|NCT03094611|468231675|FG000|Overall Study|Lack of Efficacy|1|||
130075717|NCT03094611|468231675|FG000|Overall Study|Stem Cell Transplant|1|||
130075718|NCT02023112|468231685|FG000|Overall Study|Withdrawal by Subject|2|||
130075719|NCT02023112|468231686|FG001|Overall Study|Withdrawal by Subject|1|||
130075720|NCT00981747|468231690|FG000|Losartan|Withdrawal by Subject|1|||
130075721|NCT00981747|468231690|FG000|Losartan|Death|1|||
130075722|NCT00981747|468231690|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
130075723|NCT01814826|468231693|FG000|Overall Study|Other|3|||
130075724|NCT01814826|468231694|FG001|Overall Study|Other|5|||
130075725|NCT01814826|468231695|FG002|Overall Study|Other|0|||
130075726|NCT01814826|468231693|FG000|Overall Study|Death|29|||
130075727|NCT01814826|468231694|FG001|Overall Study|Death|24|||
130075728|NCT01814826|468231695|FG002|Overall Study|Death|3|||
130075729|NCT03034057|468231696|FG000|Overall Study|Withdrawal by Subject|10|||
130075730|NCT03034057|468231696|FG000|Overall Study|Protocol Violation|1|||
130075731|NCT03034057|468231696|FG000|Overall Study|Not defined|2|||
130075732|NCT03034057|468231696|FG000|Overall Study|Lost to Follow-up|19|||
130075733|NCT03034057|468231696|FG000|Overall Study|Adverse Event|22|||
130075734|NCT03034057|468231696|FG000|Overall Study|Medication error without associated AE|1|||
130075735|NCT03339401|468231697|FG000|Overall Study|Death|2|||
130075736|NCT03339401|468231698|FG001|Overall Study|Death|1|||
130075737|NCT03339401|468231697|FG000|Overall Study|Withdrawal by Subject|2|||
130075738|NCT03339401|468231698|FG001|Overall Study|Withdrawal by Subject|0|||
130120541|NCT03384745|468402404|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130120542|NCT03384745|468402405|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
130075739|NCT03339401|468231697|FG000|Overall Study|Study terminated|4|||
130075740|NCT03339401|468231698|FG001|Overall Study|Study terminated|3|||
130075741|NCT03339401|468231697|FG000|Overall Study|Investigator Decision|1|||
130075742|NCT03339401|468231698|FG001|Overall Study|Investigator Decision|0|||
130120543|NCT03384745|468402406|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
130075743|NCT03271307|468231699|FG000|Overall Study|Lost to Follow-up|0|||
130075744|NCT03271307|468231700|FG001|Overall Study|Lost to Follow-up|0|||
130075745|NCT03271307|468231701|FG002|Overall Study|Lost to Follow-up|0|||
130075746|NCT03271307|468231702|FG003|Overall Study|Lost to Follow-up|28|||
130075747|NCT03271307|468231703|FG004|Overall Study|Lost to Follow-up|91|||
130075748|NCT03365947|468231704|FG000|Overall Study|Lost to Follow-up|0|||
130075749|NCT03365947|468231705|FG001|Overall Study|Lost to Follow-up|0|||
130075750|NCT03365947|468231706|FG002|Overall Study|Lost to Follow-up|0|||
130075751|NCT03365947|468231707|FG003|Overall Study|Lost to Follow-up|0|||
130075752|NCT03365947|468231708|FG004|Overall Study|Lost to Follow-up|0|||
130075753|NCT03365947|468231709|FG005|Overall Study|Lost to Follow-up|1|||
130075754|NCT03365947|468231710|FG006|Overall Study|Lost to Follow-up|0|||
130075755|NCT03365947|468231711|FG007|Overall Study|Lost to Follow-up|0|||
130075756|NCT03365947|468231712|FG008|Overall Study|Lost to Follow-up|0|||
130075757|NCT03365947|468231713|FG009|Overall Study|Lost to Follow-up|0|||
130075758|NCT03365947|468231714|FG010|Overall Study|Lost to Follow-up|0|||
130075759|NCT03365947|468231715|FG011|Overall Study|Lost to Follow-up|0|||
130075760|NCT03365947|468231716|FG012|Overall Study|Lost to Follow-up|0|||
130075761|NCT03365947|468231717|FG013|Overall Study|Lost to Follow-up|0|||
130075762|NCT03365947|468231718|FG014|Overall Study|Lost to Follow-up|0|||
130075763|NCT03365947|468231719|FG015|Overall Study|Lost to Follow-up|0|||
130075764|NCT03365947|468231720|FG016|Overall Study|Lost to Follow-up|0|||
130075765|NCT03365947|468231721|FG017|Overall Study|Lost to Follow-up|0|||
130075766|NCT03365947|468231722|FG018|Overall Study|Lost to Follow-up|0|||
130075767|NCT01042938|468231723|FG000|Overall Study|Withdrawal by Subject|1|||
130075768|NCT01042938|468231724|FG001|Overall Study|Withdrawal by Subject|1|||
130075769|NCT01042938|468231723|FG000|Overall Study|Protocol Violation|1|||
130075770|NCT01042938|468231724|FG001|Overall Study|Protocol Violation|1|||
130075771|NCT01042938|468231723|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
130075772|NCT01042938|468231724|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
130075773|NCT03997760|468231727|FG000|Overall Study|Protocol Deviation|0|||
130075774|NCT03997760|468231728|FG001|Overall Study|Protocol Deviation|1|||
130075775|NCT03997760|468231729|FG002|Overall Study|Protocol Deviation|0|||
130075776|NCT03997760|468231730|FG003|Overall Study|Protocol Deviation|0|||
130075777|NCT00856986|468231731|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
130075778|NCT00856986|468231732|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
130075779|NCT00856986|468231733|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
130075780|NCT00856986|468231734|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
130075781|NCT00856986|468231735|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
130075782|NCT00856986|468231731|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130075783|NCT00856986|468231732|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130075784|NCT00856986|468231733|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130075785|NCT00856986|468231734|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
130075786|NCT00856986|468231735|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
130075787|NCT00856986|468231731|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130075788|NCT00856986|468231732|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130075789|NCT00856986|468231733|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130075790|NCT00856986|468231734|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
130075791|NCT00856986|468231735|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
130075792|NCT00856986|468231731|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130075793|NCT00856986|468231732|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130075794|NCT00856986|468231733|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130075795|NCT00856986|468231734|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
130075796|NCT00856986|468231735|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
130075797|NCT00856986|468231731|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130075798|NCT00856986|468231732|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130075799|NCT00856986|468231733|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130075800|NCT00856986|468231734|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
130075801|NCT00856986|468231735|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
130075802|NCT00856986|468231731|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
130075803|NCT00856986|468231732|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
130075804|NCT00856986|468231733|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
130075805|NCT00856986|468231734|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
130075806|NCT00856986|468231735|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
130075807|NCT00856986|468231731|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
130075808|NCT00856986|468231732|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
130075809|NCT00856986|468231733|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
130075810|NCT00856986|468231734|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
130075811|NCT00856986|468231735|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
130075812|NCT00856986|468231731|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
130075813|NCT00856986|468231732|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
130075814|NCT00856986|468231733|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
130075815|NCT00856986|468231734|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
130075816|NCT00856986|468231735|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
130075817|NCT00856986|468231731|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
130075818|NCT00856986|468231732|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
130075819|NCT00856986|468231733|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
130075820|NCT00856986|468231734|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
130075821|NCT00856986|468231735|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
130075822|NCT00856986|468231731|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
130075823|NCT00856986|468231732|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
130075824|NCT00856986|468231733|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
130075825|NCT00856986|468231734|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
130075826|NCT00856986|468231735|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
130075827|NCT00856986|468231731|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
130075828|NCT00856986|468231732|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
130075829|NCT00856986|468231733|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
130075830|NCT00856986|468231734|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
130075831|NCT00856986|468231735|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
130075832|NCT00856986|468231731|FG000|Main Period, Weeks 0-26|Unclassified|7|||
130075833|NCT00856986|468231732|FG001|Main Period, Weeks 0-26|Unclassified|6|||
130075834|NCT00856986|468231733|FG002|Main Period, Weeks 0-26|Unclassified|7|||
130075835|NCT00856986|468231734|FG003|Main Period, Weeks 0-26|Unclassified|0|||
130075836|NCT00856986|468231735|FG004|Main Period, Weeks 0-26|Unclassified|0|||
130075837|NCT00856986|468231731|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
130075838|NCT00856986|468231732|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
130075839|NCT00856986|468231733|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
130075840|NCT00856986|468231734|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
130075841|NCT00856986|468231735|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
130075842|NCT00856986|468231731|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
130075843|NCT00856986|468231732|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
130075844|NCT00856986|468231733|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
130075845|NCT00856986|468231734|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
130075846|NCT00856986|468231735|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
130075847|NCT00856986|468231731|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
130075848|NCT00856986|468231732|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
130075849|NCT00856986|468231733|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
130075850|NCT00856986|468231734|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
130075851|NCT00856986|468231735|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
130075852|NCT00856986|468231731|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
130075853|NCT00856986|468231732|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
130075854|NCT00856986|468231733|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
130075855|NCT00856986|468231734|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
130075856|NCT00856986|468231735|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
130075857|NCT00856986|468231731|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
130075858|NCT00856986|468231732|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
130075859|NCT00856986|468231733|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
130075860|NCT00856986|468231734|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
130075861|NCT00856986|468231735|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
130075862|NCT00856986|468231731|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
130075863|NCT00856986|468231732|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
130075864|NCT00856986|468231733|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
130075865|NCT00856986|468231734|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
130075866|NCT00856986|468231735|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
130075867|NCT01915095|468231736|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
130075868|NCT01915095|468231737|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
130075869|NCT01915095|468231738|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
130075870|NCT01915095|468231739|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
130075871|NCT01915095|468231740|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
130075872|NCT02067533|468231743|FG000|Overall Study|Lost to Follow-up|4|||
130075873|NCT02067533|468231744|FG001|Overall Study|Lost to Follow-up|2|||
130075874|NCT02999191|468231746|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
130075875|NCT02999191|468231747|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
130075876|NCT02999191|468231748|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
130075877|NCT02896192|468231750|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
130075878|NCT02896192|468231750|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
130075879|NCT02896192|468231750|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
130075880|NCT00479167|468231755|FG000|Overall Study|Withdrawal by Subject|1|||
130075881|NCT01997281|468231760|FG000|Overall Study|Withdrawal by Subject|1|||
130075882|NCT01997281|468231761|FG001|Overall Study|Withdrawal by Subject|0|||
130075883|NCT00560794|468231762|FG000|Overall Study|Adverse Event|2|||
130075884|NCT00560794|468231762|FG000|Overall Study|Patient was not Compliant|1|||
130075885|NCT00560794|468231762|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
130075886|NCT00560794|468231762|FG000|Overall Study|Hematological Relapse|1|||
130075887|NCT00560794|468231762|FG000|Overall Study|Received Bone Marrow Transplant|6|||
130075888|NCT04857892|468231763|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
130075889|NCT04857892|468231764|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130075890|NCT04857892|468231765|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130075891|NCT04857892|468231766|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130075892|NCT04857892|468231767|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
130075893|NCT04857892|468231763|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
130075894|NCT04857892|468231764|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
130075895|NCT04857892|468231765|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
130075896|NCT04857892|468231766|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
130075897|NCT04857892|468231767|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
130075898|NCT04857892|468231763|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130075899|NCT04857892|468231764|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130075900|NCT04857892|468231765|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130075901|NCT04857892|468231766|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
130075902|NCT04857892|468231767|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
130075903|NCT02384993|468231772|FG000|Overall Study|Adverse Event|0|||
130075904|NCT02384993|468231773|FG001|Overall Study|Adverse Event|1|||
130075905|NCT01199198|468233249|FG000|Overall Study|Adverse Event|3|||
130075906|NCT01199198|468233250|FG001|Overall Study|Adverse Event|0|||
130075907|NCT01199198|468233249|FG000|Overall Study|Lost to Follow-up|1|||
130075908|NCT01199198|468233250|FG001|Overall Study|Lost to Follow-up|5|||
130075909|NCT01199198|468233249|FG000|Overall Study|Withdrawal by Subject|1|||
130075910|NCT01199198|468233250|FG001|Overall Study|Withdrawal by Subject|2|||
130075911|NCT01199198|468233249|FG000|Overall Study|ICU Transfer|1|||
130075912|NCT01199198|468233250|FG001|Overall Study|ICU Transfer|2|||
130075913|NCT01199198|468233249|FG000|Overall Study|Hospice-care transfer|1|||
130075914|NCT01199198|468233250|FG001|Overall Study|Hospice-care transfer|2|||
130075915|NCT02892734|468233251|FG000|Treatment on Study|Progressive Disease|2|||
130075916|NCT02892734|468233251|FG000|Follow up for 2 Years|Death|2|||
130075917|NCT02892734|468233251|FG000|Follow up for 2 Years|Study closed early|1|||
130075918|NCT02043509|468233252|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
130075919|NCT02043509|468233253|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
130075920|NCT02043509|468233252|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
130075921|NCT02043509|468233253|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
130075922|NCT02043509|468233252|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
130075923|NCT02043509|468233253|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
130075924|NCT02043509|468233252|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
130075925|NCT02043509|468233253|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
130075926|NCT02000219|468233257|FG000|14-Week Study Period|Physician Decision|1|||
130075927|NCT02000219|468233257|FG000|14-Week Study Period|Adverse Event|1|||
130075928|NCT02000219|468233257|FG000|14-Week Study Period|Underwent transplantation|1|||
130075929|NCT02000219|468233257|FG000|Continuation Period|Withdrawal by Subject|1|||
130075930|NCT02000219|468233257|FG000|Continuation Period|Had liver transplant|2|||
130075931|NCT02000219|468233257|FG000|Continuation Period|Non-compliance with study drug|2|||
130075932|NCT00608894|468233261|FG000|Overall Study|Withdrawal by Subject|0|||
130075933|NCT00608894|468233262|FG001|Overall Study|Withdrawal by Subject|2|||
130075934|NCT01376388|468233270|FG000|Overall Study|Adverse Event|13|||
130075935|NCT01376388|468233270|FG000|Overall Study|Lack of Efficacy|2|||
130075936|NCT01376388|468233270|FG000|Overall Study|Withdrawal by Subject|3|||
130075937|NCT01495689|468233283|FG000|Overall Study|Death|0|||
130075938|NCT01495689|468233284|FG001|Overall Study|Death|1|||
130075939|NCT01495689|468233283|FG000|Overall Study|Withdrawal by Subject|3|||
130075940|NCT01495689|468233284|FG001|Overall Study|Withdrawal by Subject|0|||
130075941|NCT01495689|468233283|FG000|Overall Study|Lost to Follow-up|7|||
130075942|NCT01495689|468233284|FG001|Overall Study|Lost to Follow-up|6|||
130075943|NCT00524043|468233285|FG000|Overall Study|Lack of Efficacy|15|||
130075944|NCT00524043|468233286|FG001|Overall Study|Lack of Efficacy|13|||
130075945|NCT00524043|468233287|FG002|Overall Study|Lack of Efficacy|14|||
130075946|NCT00524043|468233285|FG000|Overall Study|Withdrawal by Subject|5|||
130075947|NCT00524043|468233286|FG001|Overall Study|Withdrawal by Subject|7|||
130075948|NCT00524043|468233287|FG002|Overall Study|Withdrawal by Subject|7|||
130075949|NCT00524043|468233285|FG000|Overall Study|Adverse Event|5|||
130075950|NCT00524043|468233286|FG001|Overall Study|Adverse Event|2|||
130075951|NCT00524043|468233287|FG002|Overall Study|Adverse Event|7|||
130075952|NCT00524043|468233285|FG000|Overall Study|Lost to Follow-up|3|||
130075953|NCT00524043|468233286|FG001|Overall Study|Lost to Follow-up|5|||
130075954|NCT00524043|468233287|FG002|Overall Study|Lost to Follow-up|3|||
130075955|NCT00524043|468233285|FG000|Overall Study|Various (eg, incarceration)|2|||
130075956|NCT00524043|468233286|FG001|Overall Study|Various (eg, incarceration)|1|||
130075957|NCT00524043|468233287|FG002|Overall Study|Various (eg, incarceration)|0|||
130075958|NCT01843205|468233292|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
130075959|NCT01843205|468233293|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
130075960|NCT00606177|468233294|FG000|Overall Study|Adverse Event|9|||
130075961|NCT00606177|468233295|FG001|Overall Study|Adverse Event|5|||
130075962|NCT00606177|468233294|FG000|Overall Study|Lack of Efficacy|3|||
129951955|NCT01052272|467784867|FG002|Overall Study|Withdrawal by Subject|3|||
129951956|NCT01052272|467784868|FG003|Overall Study|Withdrawal by Subject|2|||
129951957|NCT01052272|467784865|FG000|Overall Study|placed in long-term care|0|||
129951958|NCT01052272|467784866|FG001|Overall Study|placed in long-term care|0|||
129951959|NCT01052272|467784867|FG002|Overall Study|placed in long-term care|1|||
129951960|NCT01052272|467784868|FG003|Overall Study|placed in long-term care|0|||
129951961|NCT01052272|467784865|FG000|Overall Study|decline in health|0|||
129951962|NCT01052272|467784866|FG001|Overall Study|decline in health|0|||
129951963|NCT01052272|467784867|FG002|Overall Study|decline in health|1|||
129951964|NCT01052272|467784868|FG003|Overall Study|decline in health|0|||
129951965|NCT04739306|467784869|FG000|Main Study Period|Adverse Event|6|||
129951966|NCT04739306|467784870|FG001|Main Study Period|Adverse Event|7|||
129951967|NCT04739306|467784869|FG000|Main Study Period|Lost to Follow-up|4|||
129951968|NCT04739306|467784870|FG001|Main Study Period|Lost to Follow-up|6|||
129951969|NCT04739306|467784869|FG000|Main Study Period|Physician Decision|1|||
129951970|NCT04739306|467784870|FG001|Main Study Period|Physician Decision|1|||
129951971|NCT04739306|467784869|FG000|Main Study Period|Withdrawal by Subject|8|||
129951972|NCT04739306|467784870|FG001|Main Study Period|Withdrawal by Subject|6|||
129951973|NCT04739306|467784869|FG000|Main Study Period|Protocol Violation|0|||
129951974|NCT04739306|467784870|FG001|Main Study Period|Protocol Violation|1|||
129951975|NCT04739306|467784869|FG000|Main Study Period|War in Ukraine|1|||
129951976|NCT04739306|467784870|FG001|Main Study Period|War in Ukraine|1|||
129951977|NCT01077284|467784871|FG000|Overall Study|Adverse Event|2|||
129951978|NCT01077284|467784872|FG001|Overall Study|Adverse Event|0|||
129951979|NCT01077284|467784873|FG002|Overall Study|Adverse Event|1|||
129951980|NCT01077284|467784871|FG000|Overall Study|Lost to Follow-up|1|||
129951981|NCT01077284|467784872|FG001|Overall Study|Lost to Follow-up|2|||
129951982|NCT01077284|467784873|FG002|Overall Study|Lost to Follow-up|0|||
129951983|NCT01077284|467784871|FG000|Overall Study|Withdrawal by Subject|2|||
129951984|NCT01077284|467784872|FG001|Overall Study|Withdrawal by Subject|3|||
129951985|NCT01077284|467784873|FG002|Overall Study|Withdrawal by Subject|1|||
129951986|NCT01077284|467784871|FG000|Overall Study|Other|0|||
129951987|NCT01077284|467784872|FG001|Overall Study|Other|0|||
129951988|NCT01077284|467784873|FG002|Overall Study|Other|1|||
129951989|NCT00096278|467784874|FG000|Overall Study|No follow-up data|15|||
129951990|NCT00096278|467784875|FG001|Overall Study|No follow-up data|18|||
129951991|NCT00096278|467784874|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
129951992|NCT00096278|467784875|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
129951993|NCT01894620|467784878|FG000|Overall Study|Withdrawal by Subject|0|||
129951994|NCT01894620|467784879|FG001|Overall Study|Withdrawal by Subject|1|||
129951995|NCT05104242|467784880|FG000|Overall Study|Withdrawal by Subject|1|||
129951996|NCT05104242|467784881|FG001|Overall Study|Withdrawal by Subject|5|||
129951997|NCT05104242|467784880|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
129951998|NCT05104242|467784881|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
129951999|NCT01864200|467784882|FG000|Overall Study|Lost to Follow-up|1|||
129952000|NCT01864200|467784883|FG001|Overall Study|Lost to Follow-up|3|||
129952001|NCT01864200|467784882|FG000|Overall Study|Protocol Violation|1|||
129952002|NCT01864200|467784883|FG001|Overall Study|Protocol Violation|0|||
129952003|NCT02077374|467784884|FG000|Overall Study|Withdrawal by Subject|0|||
129952004|NCT02077374|467784885|FG001|Overall Study|Withdrawal by Subject|1|||
129952005|NCT02077374|467784884|FG000|Overall Study|Protocol Violation|0|||
129952006|NCT02077374|467784885|FG001|Overall Study|Protocol Violation|1|||
129952007|NCT00424476|467784887|FG000|Overall Study|Withdrawal by Subject|7|||
129952008|NCT00424476|467784888|FG001|Overall Study|Withdrawal by Subject|6|||
129952009|NCT00424476|467784889|FG002|Overall Study|Withdrawal by Subject|3|||
129952010|NCT00424476|467784887|FG000|Overall Study|Adverse Event|19|||
129952011|NCT00424476|467784888|FG001|Overall Study|Adverse Event|16|||
129952012|NCT00424476|467784889|FG002|Overall Study|Adverse Event|15|||
129952013|NCT00424476|467784887|FG000|Overall Study|Lack of Efficacy|16|||
129952014|NCT00424476|467784888|FG001|Overall Study|Lack of Efficacy|12|||
129952015|NCT00424476|467784889|FG002|Overall Study|Lack of Efficacy|12|||
129952016|NCT00424476|467784887|FG000|Overall Study|Lack of Compliance|1|||
129952017|NCT00424476|467784888|FG001|Overall Study|Lack of Compliance|1|||
129952018|NCT00424476|467784889|FG002|Overall Study|Lack of Compliance|1|||
129952019|NCT00424476|467784887|FG000|Overall Study|Lost to Follow-up|4|||
129952020|NCT00424476|467784888|FG001|Overall Study|Lost to Follow-up|6|||
129952021|NCT00424476|467784889|FG002|Overall Study|Lost to Follow-up|3|||
129952022|NCT00424476|467784887|FG000|Overall Study|Protocol Violation|7|||
129952023|NCT00424476|467784888|FG001|Overall Study|Protocol Violation|2|||
129952024|NCT00424476|467784889|FG002|Overall Study|Protocol Violation|3|||
129952025|NCT00424476|467784887|FG000|Overall Study|Physician Decision|3|||
129952026|NCT00424476|467784888|FG001|Overall Study|Physician Decision|2|||
129952027|NCT00424476|467784889|FG002|Overall Study|Physician Decision|3|||
129952028|NCT00424476|467784887|FG000|Overall Study|Other|4|||
129952029|NCT00424476|467784888|FG001|Overall Study|Other|3|||
129952030|NCT00424476|467784889|FG002|Overall Study|Other|9|||
129952031|NCT00657709|467784890|FG000|Overall Study|AE or Death|7|||
129952032|NCT00657709|467784891|FG001|Overall Study|AE or Death|7|||
130075963|NCT00606177|468233295|FG001|Overall Study|Lack of Efficacy|7|||
130075964|NCT00606177|468233294|FG000|Overall Study|Physician Decision|1|||
130075965|NCT00606177|468233295|FG001|Overall Study|Physician Decision|0|||
130075966|NCT00606177|468233294|FG000|Overall Study|Protocol Violation|1|||
130075967|NCT00606177|468233295|FG001|Overall Study|Protocol Violation|4|||
130075968|NCT00606177|468233294|FG000|Overall Study|Withdrawal by Subject|5|||
130075969|NCT00606177|468233295|FG001|Overall Study|Withdrawal by Subject|6|||
130075970|NCT00606177|468233294|FG000|Overall Study|Progression to depressive phase|6|||
130075971|NCT00606177|468233295|FG001|Overall Study|Progression to depressive phase|1|||
130075972|NCT00606177|468233294|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
130075973|NCT00606177|468233295|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
130075974|NCT00606177|468233294|FG000|Overall Study|Change of residence or other commitments|1|||
130075975|NCT00606177|468233295|FG001|Overall Study|Change of residence or other commitments|1|||
130075976|NCT00136357|468233296|FG000|Overall Study|Withdrawal by Subject|3|||
130075977|NCT00136357|468233297|FG001|Overall Study|Withdrawal by Subject|2|||
130075978|NCT00216086|468233303|FG000|Overall Study|Protocol Violation|1|||
130075979|NCT00216086|468233303|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
130075980|NCT00216086|468233303|FG000|Overall Study|Social Reasons|2|||
130075981|NCT02025530|468233304|FG000|Overall Study|No longer met elligibility criteria|5|||
130075982|NCT02025530|468233305|FG001|Overall Study|No longer met elligibility criteria|1|||
130075983|NCT01017549|468233308|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
130075984|NCT01017549|468233308|FG000|One-year Follow-up|Lost to Follow-up|2|||
130075985|NCT01017549|468233308|FG000|One-year Follow-up|Withdrawal by Subject|5|||
130075986|NCT01017549|468233308|FG000|5 Year Follow-up|Lost to Follow-up|9|||
130075987|NCT01017549|468233308|FG000|5 Year Follow-up|Mastectomy|3|||
130075988|NCT02728206|468233310|FG000|Overall Study|Death|1|||
130075989|NCT02773368|468233311|FG000|Overall Study|Lost to Follow-up|4|||
130075990|NCT02773368|468233312|FG001|Overall Study|Lost to Follow-up|1|||
130075991|NCT02773368|468233311|FG000|Overall Study|Withdrawal by Subject|5|||
130075992|NCT02773368|468233312|FG001|Overall Study|Withdrawal by Subject|1|||
130075993|NCT02773368|468233311|FG000|Overall Study|Unclassified|1|||
130075994|NCT02773368|468233312|FG001|Overall Study|Unclassified|1|||
130075995|NCT02773368|468233311|FG000|Overall Study|Missing|0|||
130075996|NCT02773368|468233312|FG001|Overall Study|Missing|1|||
130075997|NCT02635867|468233315|FG000|Overall Study|Lost to Follow-up|4|||
130075998|NCT02635867|468233316|FG001|Overall Study|Lost to Follow-up|3|||
130075999|NCT02635867|468233317|FG002|Overall Study|Lost to Follow-up|3|||
130076000|NCT02635867|468233318|FG003|Overall Study|Lost to Follow-up|4|||
130076001|NCT02635867|468233319|FG004|Overall Study|Lost to Follow-up|1|||
130076002|NCT02918318|468233320|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
130076003|NCT02918318|468233321|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
130076004|NCT02918318|468233322|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
130076005|NCT02918318|468233323|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
130076006|NCT02918318|468233324|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
130076007|NCT02918318|468233320|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130076008|NCT02918318|468233321|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130076009|NCT02918318|468233322|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130076010|NCT02918318|468233323|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
130076011|NCT02918318|468233324|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
130076012|NCT02918318|468233320|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130076013|NCT02918318|468233321|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130076014|NCT02918318|468233322|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130076015|NCT02918318|468233323|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
130076016|NCT02918318|468233324|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
130076017|NCT02918318|468233320|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
130076018|NCT02918318|468233321|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
130076019|NCT02918318|468233322|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
130076020|NCT02918318|468233323|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
130076021|NCT02918318|468233324|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
130076022|NCT02918318|468233320|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130076023|NCT02918318|468233321|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130076024|NCT02918318|468233322|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130076025|NCT02918318|468233323|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
130120544|NCT03384745|468402407|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
130120545|NCT03384745|468402402|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130120546|NCT03384745|468402403|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130120547|NCT03384745|468402404|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130120548|NCT03384745|468402405|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130120549|NCT03384745|468402406|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
130076026|NCT02918318|468233324|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
130076027|NCT02918318|468233320|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
130076028|NCT02918318|468233321|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
130076029|NCT02918318|468233322|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
130076030|NCT02918318|468233323|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
130076031|NCT02918318|468233324|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
130076032|NCT02918318|468233320|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130076033|NCT02918318|468233321|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130076034|NCT02918318|468233322|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130076035|NCT02918318|468233323|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
130076036|NCT02918318|468233324|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
130076037|NCT02918318|468233320|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
130076038|NCT02918318|468233321|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
130076039|NCT02918318|468233322|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
130076040|NCT02918318|468233323|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
130076041|NCT02918318|468233324|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
130076042|NCT02918318|468233320|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
130076043|NCT02918318|468233321|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
130076044|NCT02918318|468233322|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
130076045|NCT02918318|468233323|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
130076046|NCT02918318|468233324|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
130076047|NCT02918318|468233320|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
130076048|NCT02918318|468233321|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
130076049|NCT02918318|468233322|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
130076050|NCT02918318|468233323|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
130076051|NCT02918318|468233324|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
130076052|NCT02918318|468233320|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130076053|NCT02918318|468233321|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130076054|NCT02918318|468233322|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130076055|NCT02918318|468233323|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
130076056|NCT02918318|468233324|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
130076057|NCT02918318|468233320|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130076058|NCT02918318|468233321|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130076059|NCT02918318|468233322|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130076060|NCT02918318|468233323|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
130076061|NCT02918318|468233324|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
130076062|NCT01782885|468233325|FG000|Overall Study|Lost to Follow-up|4|||
130076063|NCT01782885|468233326|FG001|Overall Study|Lost to Follow-up|6|||
130076064|NCT03447821|468233327|FG000|Overall Study|Withdrawal by Subject|1|||
130076065|NCT03447821|468233328|FG001|Overall Study|Withdrawal by Subject|1|||
130076066|NCT03447821|468233329|FG002|Overall Study|Withdrawal by Subject|0|||
130076067|NCT03447821|468233327|FG000|Overall Study|Lost to Follow-up|0|||
130076068|NCT03447821|468233328|FG001|Overall Study|Lost to Follow-up|0|||
129952033|NCT00657709|467784892|FG002|Overall Study|AE or Death|6|||
129952034|NCT00657709|467784893|FG003|Overall Study|AE or Death|7|||
129952035|NCT00657709|467784894|FG004|Overall Study|AE or Death|1|||
129952036|NCT00657709|467784890|FG000|Overall Study|Withdrawal by Subject|7|||
129952037|NCT00657709|467784891|FG001|Overall Study|Withdrawal by Subject|15|||
129952038|NCT00657709|467784892|FG002|Overall Study|Withdrawal by Subject|15|||
129952039|NCT00657709|467784893|FG003|Overall Study|Withdrawal by Subject|5|||
129952040|NCT00657709|467784894|FG004|Overall Study|Withdrawal by Subject|9|||
129952041|NCT00657709|467784890|FG000|Overall Study|Lost to Follow-up|9|||
129952042|NCT00657709|467784891|FG001|Overall Study|Lost to Follow-up|9|||
129952043|NCT00657709|467784892|FG002|Overall Study|Lost to Follow-up|7|||
129952044|NCT00657709|467784893|FG003|Overall Study|Lost to Follow-up|1|||
129952045|NCT00657709|467784894|FG004|Overall Study|Lost to Follow-up|21|||
129952046|NCT00657709|467784890|FG000|Overall Study|Protocol Violation|0|||
129952047|NCT00657709|467784891|FG001|Overall Study|Protocol Violation|2|||
129952048|NCT00657709|467784892|FG002|Overall Study|Protocol Violation|0|||
129952049|NCT00657709|467784893|FG003|Overall Study|Protocol Violation|1|||
129952050|NCT00657709|467784894|FG004|Overall Study|Protocol Violation|2|||
129952051|NCT00409747|467784895|FG000|Overall Study|Withdrawal by Subject|1|||
129952052|NCT02555397|467784898|FG000|Overall Study|Withdrawal by Subject|1|||
130076069|NCT03447821|468233329|FG002|Overall Study|Lost to Follow-up|1|||
130076070|NCT00329784|468233332|FG000|Overall Study|Lost to Follow-up|0|||
130076071|NCT00329784|468233333|FG001|Overall Study|Lost to Follow-up|1|||
130076072|NCT00329784|468233334|FG002|Overall Study|Lost to Follow-up|0|||
129952053|NCT02555397|467784899|FG001|Overall Study|Withdrawal by Subject|0|||
129952054|NCT02555397|467784900|FG002|Overall Study|Withdrawal by Subject|0|||
129952055|NCT02555397|467784901|FG003|Overall Study|Withdrawal by Subject|0|||
129952056|NCT02555397|467784902|FG004|Overall Study|Withdrawal by Subject|0|||
129952057|NCT00632736|467784906|FG000|Overall Study|Adverse Event|104|||
129952058|NCT00632736|467784906|FG000|Overall Study|Lost to Follow-up|15|||
129952059|NCT00632736|467784906|FG000|Overall Study|Protocol Violation|14|||
129952060|NCT00632736|467784906|FG000|Overall Study|Withdrawal by Subject|99|||
129952061|NCT00632736|467784906|FG000|Overall Study|Lack of Efficacy|5|||
130076073|NCT00329784|468233335|FG003|Overall Study|Lost to Follow-up|0|||
130076074|NCT00329784|468233332|FG000|Overall Study|Withdrawal by Subject|4|||
130076075|NCT00329784|468233333|FG001|Overall Study|Withdrawal by Subject|2|||
130076076|NCT00329784|468233334|FG002|Overall Study|Withdrawal by Subject|0|||
130076077|NCT00329784|468233335|FG003|Overall Study|Withdrawal by Subject|0|||
130076078|NCT00329784|468233332|FG000|Overall Study|Other|1|||
130076079|NCT00329784|468233333|FG001|Overall Study|Other|2|||
130076080|NCT00329784|468233334|FG002|Overall Study|Other|0|||
130076081|NCT00329784|468233335|FG003|Overall Study|Other|0|||
130076082|NCT00045630|468233343|FG000|Overall Study|Adverse Event|1|||
130076083|NCT00045630|468233343|FG000|Overall Study|Refusal unrelated to adverse event|1|||
130076084|NCT00045630|468233343|FG000|Overall Study|Progression/relapse|1|||
130076085|NCT00045630|468233343|FG000|Overall Study|Death|1|||
130076086|NCT00045630|468233343|FG000|Overall Study|Ineligible|2|||
130076087|NCT00924729|468233344|FG000|Overall Study|insufficient volume for analysis|1|||
130076088|NCT00924729|468233345|FG001|Overall Study|insufficient volume for analysis|0|||
130076089|NCT00924729|468233344|FG000|Overall Study|Protocol Violation|1|||
130076090|NCT00924729|468233345|FG001|Overall Study|Protocol Violation|0|||
130076091|NCT01929707|468233346|FG000|Intervention Period 1|Lost to Follow-up|0|||
130076092|NCT01929707|468233347|FG001|Intervention Period 1|Lost to Follow-up|0|||
130076093|NCT01929707|468233348|FG002|Intervention Period 1|Lost to Follow-up|0|||
130076094|NCT01929707|468233349|FG003|Intervention Period 1|Lost to Follow-up|1|||
130076095|NCT01929707|468233350|FG004|Intervention Period 1|Lost to Follow-up|0|||
130076096|NCT01929707|468233351|FG005|Intervention Period 1|Lost to Follow-up|0|||
130076097|NCT01929707|468233352|FG006|Intervention Period 1|Lost to Follow-up|0|||
130076098|NCT01929707|468233353|FG007|Intervention Period 1|Lost to Follow-up|0|||
130076099|NCT01929707|468233346|FG000|Intervention Period 1|Withdrawal by Subject|0|||
130076100|NCT01929707|468233347|FG001|Intervention Period 1|Withdrawal by Subject|0|||
130076101|NCT01929707|468233348|FG002|Intervention Period 1|Withdrawal by Subject|0|||
130076102|NCT01929707|468233349|FG003|Intervention Period 1|Withdrawal by Subject|2|||
130076103|NCT01929707|468233350|FG004|Intervention Period 1|Withdrawal by Subject|0|||
130076104|NCT01929707|468233351|FG005|Intervention Period 1|Withdrawal by Subject|0|||
130076105|NCT01929707|468233352|FG006|Intervention Period 1|Withdrawal by Subject|0|||
130076106|NCT01929707|468233353|FG007|Intervention Period 1|Withdrawal by Subject|0|||
130076107|NCT01929707|468233346|FG000|Intervention Period 2|Withdrawal by Subject|0|||
130076108|NCT01929707|468233347|FG001|Intervention Period 2|Withdrawal by Subject|0|||
130076109|NCT01929707|468233348|FG002|Intervention Period 2|Withdrawal by Subject|0|||
130076110|NCT01929707|468233349|FG003|Intervention Period 2|Withdrawal by Subject|0|||
130076111|NCT01929707|468233350|FG004|Intervention Period 2|Withdrawal by Subject|0|||
130076112|NCT01929707|468233351|FG005|Intervention Period 2|Withdrawal by Subject|2|||
130076113|NCT01929707|468233352|FG006|Intervention Period 2|Withdrawal by Subject|0|||
130076114|NCT01929707|468233353|FG007|Intervention Period 2|Withdrawal by Subject|0|||
130076115|NCT00437203|468233354|FG000|Overall Study|Death|0|||
130076116|NCT00437203|468233355|FG001|Overall Study|Death|0|||
130076117|NCT00437203|468233356|FG002|Overall Study|Death|1|||
130076118|NCT00437203|468233357|FG003|Overall Study|Death|0|||
130076119|NCT00437203|468233358|FG004|Overall Study|Death|0|||
130076120|NCT00437203|468233359|FG005|Overall Study|Death|0|||
130076121|NCT00437203|468233360|FG006|Overall Study|Death|0|||
130076122|NCT00437203|468233361|FG007|Overall Study|Death|1|||
130076123|NCT00437203|468233362|FG008|Overall Study|Death|0|||
130076124|NCT00437203|468233363|FG009|Overall Study|Death|1|||
130076125|NCT00437203|468233354|FG000|Overall Study|Adverse Event|1|||
130076126|NCT00437203|468233355|FG001|Overall Study|Adverse Event|1|||
130076127|NCT00437203|468233356|FG002|Overall Study|Adverse Event|0|||
130076128|NCT00437203|468233357|FG003|Overall Study|Adverse Event|0|||
130076129|NCT00437203|468233358|FG004|Overall Study|Adverse Event|0|||
130076130|NCT00437203|468233359|FG005|Overall Study|Adverse Event|0|||
130076131|NCT00437203|468233360|FG006|Overall Study|Adverse Event|0|||
130076132|NCT00437203|468233361|FG007|Overall Study|Adverse Event|1|||
130076133|NCT00437203|468233362|FG008|Overall Study|Adverse Event|0|||
130076134|NCT00437203|468233363|FG009|Overall Study|Adverse Event|1|||
130076135|NCT00437203|468233354|FG000|Overall Study|Study terminated by sponsor|0|||
130076136|NCT00437203|468233355|FG001|Overall Study|Study terminated by sponsor|0|||
130076137|NCT00437203|468233356|FG002|Overall Study|Study terminated by sponsor|0|||
130076138|NCT00437203|468233357|FG003|Overall Study|Study terminated by sponsor|0|||
130076139|NCT00437203|468233358|FG004|Overall Study|Study terminated by sponsor|0|||
130076140|NCT00437203|468233359|FG005|Overall Study|Study terminated by sponsor|0|||
130120550|NCT03384745|468402407|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
130120551|NCT03384745|468402402|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130120552|NCT03384745|468402403|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130076141|NCT00437203|468233360|FG006|Overall Study|Study terminated by sponsor|0|||
130076142|NCT00437203|468233361|FG007|Overall Study|Study terminated by sponsor|0|||
130076143|NCT00437203|468233362|FG008|Overall Study|Study terminated by sponsor|1|||
130076144|NCT00437203|468233363|FG009|Overall Study|Study terminated by sponsor|0|||
130076145|NCT00437203|468233354|FG000|Overall Study|Objective progression or relapse|5|||
130076146|NCT00437203|468233355|FG001|Overall Study|Objective progression or relapse|6|||
130076147|NCT00437203|468233356|FG002|Overall Study|Objective progression or relapse|2|||
130076148|NCT00437203|468233357|FG003|Overall Study|Objective progression or relapse|3|||
130076149|NCT00437203|468233358|FG004|Overall Study|Objective progression or relapse|3|||
130076150|NCT00437203|468233359|FG005|Overall Study|Objective progression or relapse|3|||
130076151|NCT00437203|468233360|FG006|Overall Study|Objective progression or relapse|6|||
130076152|NCT00437203|468233361|FG007|Overall Study|Objective progression or relapse|1|||
130076153|NCT00437203|468233362|FG008|Overall Study|Objective progression or relapse|2|||
130076154|NCT00437203|468233363|FG009|Overall Study|Objective progression or relapse|2|||
130076155|NCT00437203|468233354|FG000|Overall Study|Other|0|||
130076156|NCT00437203|468233355|FG001|Overall Study|Other|1|||
130076157|NCT00437203|468233356|FG002|Overall Study|Other|0|||
130076158|NCT00437203|468233357|FG003|Overall Study|Other|0|||
130076159|NCT00437203|468233358|FG004|Overall Study|Other|0|||
130076160|NCT00437203|468233359|FG005|Overall Study|Other|0|||
130076161|NCT00437203|468233360|FG006|Overall Study|Other|1|||
130076162|NCT00437203|468233361|FG007|Overall Study|Other|0|||
130076163|NCT00437203|468233362|FG008|Overall Study|Other|0|||
130076164|NCT00437203|468233363|FG009|Overall Study|Other|0|||
130076165|NCT01449955|468233364|FG000|Overall Study|Withdrawal by Subject|1|||
130076166|NCT01449955|468233365|FG001|Overall Study|Withdrawal by Subject|2|||
130076167|NCT04018612|468233372|FG000|Overall Study|Withdrawal by Subject|1|||
130076168|NCT04018612|468233373|FG001|Overall Study|Withdrawal by Subject|0|||
130076169|NCT04018612|468233374|FG002|Overall Study|Withdrawal by Subject|1|||
130076170|NCT00361218|468233375|FG000|Overall Study|Lost to Follow-up|11|||
130076171|NCT00361218|468233375|FG000|Overall Study|Personal Reasons|7|||
130076172|NCT00361218|468233375|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
130076173|NCT02671760|468233376|FG000|Overall Study|Lost to Follow-up|0|||
130076174|NCT02671760|468233377|FG001|Overall Study|Lost to Follow-up|1|||
130076175|NCT02671760|468233378|FG002|Overall Study|Lost to Follow-up|0|||
130076176|NCT02566109|468233379|FG000|Overall Study|Withdrawal by Subject|1|||
130076177|NCT01906476|468233380|FG000|Overall Study|Lost to Follow-up|17|||
130076178|NCT01906476|468233381|FG001|Overall Study|Lost to Follow-up|16|||
130076179|NCT01993667|468233382|FG000|Overall Study|Insufficient data to analyze|16|||
130076180|NCT01993667|468233383|FG001|Overall Study|Insufficient data to analyze|16|||
130076181|NCT01993667|468233382|FG000|Overall Study|Insufficient altitude reached|3|||
130076182|NCT01993667|468233383|FG001|Overall Study|Insufficient altitude reached|1|||
130076183|NCT01993667|468233382|FG000|Overall Study|Lost to Follow-up|2|||
130076184|NCT01993667|468233383|FG001|Overall Study|Lost to Follow-up|2|||
130076185|NCT01931150|468233384|FG000|Overall Study|Withdrawal by Subject|1|||
130076186|NCT01931150|468233385|FG001|Overall Study|Withdrawal by Subject|2|||
130076187|NCT01570309|468233388|FG000|Overall Study|Withdrawal by Subject|3|||
130076188|NCT01570309|468233389|FG001|Overall Study|Withdrawal by Subject|3|||
130076189|NCT00368472|468233391|FG000|Overall Study|Adverse Event|22|||
130076190|NCT00368472|468233391|FG000|Overall Study|Medication non-compliance|4|||
130076191|NCT00368472|468233391|FG000|Overall Study|Protocol Violation|2|||
130076192|NCT00368472|468233391|FG000|Overall Study|Request of Investigator or Sponsor|3|||
130076193|NCT00368472|468233391|FG000|Overall Study|Withdrawal by Subject|40|||
130076194|NCT00368472|468233391|FG000|Overall Study|Diary non-compliance|1|||
130076195|NCT00368472|468233391|FG000|Overall Study|Other|32|||
130076196|NCT00368472|468233391|FG000|Overall Study|Missing Final Disposition Date|1|||
130076197|NCT03619837|468233395|FG000|Screening|received organs from HCV-negative donors|47|||
130076198|NCT03619837|468233395|FG000|Screening|died on the wait-list|2|||
130076199|NCT03619837|468233395|FG000|Screening|remained on the wait list|40|||
130076200|NCT03619837|468233395|FG000|Screening|didn't meet eligibility criteria|3|||
130076201|NCT03619837|468233395|FG000|Screening|withdrew consent|2|||
130076202|NCT03619837|468233395|FG000|Screening|never listed for HCV-viremic donor|1|||
130076203|NCT03619837|468233395|FG000|Screening|developed exclusion criteria|2|||
130076204|NCT03619837|468233395|FG000|Screening|excluded by the investigator due to non-compliance|1|||
130076205|NCT04095793|468233396|FG000|Overall Study|Adverse Event|3|||
130076206|NCT04095793|468233396|FG000|Overall Study|Study Terminated by Sponsor|103|||
130076207|NCT04095793|468233396|FG000|Overall Study|Withdrawal by Subject|4|||
130076208|NCT00044213|468233397|FG000|Overall Study|Withdrawal by Subject|50|||
130076209|NCT00044213|468233398|FG001|Overall Study|Withdrawal by Subject|65|||
130076210|NCT00044213|468233399|FG002|Overall Study|Withdrawal by Subject|91|||
130076211|NCT00044213|468233400|FG003|Overall Study|Withdrawal by Subject|83|||
130076212|NCT00044213|468233397|FG000|Overall Study|Death|42|||
130076213|NCT00044213|468233398|FG001|Overall Study|Death|42|||
130076214|NCT00044213|468233399|FG002|Overall Study|Death|42|||
130076215|NCT00044213|468233400|FG003|Overall Study|Death|49|||
130076216|NCT00044213|468233397|FG000|Overall Study|Lost to Follow-up|8|||
130076217|NCT00044213|468233398|FG001|Overall Study|Lost to Follow-up|5|||
130076218|NCT00044213|468233399|FG002|Overall Study|Lost to Follow-up|5|||
130076219|NCT00044213|468233400|FG003|Overall Study|Lost to Follow-up|4|||
130076220|NCT01927068|468233405|FG000|Overall Study|Death|37|||
130076221|NCT01927068|468233406|FG001|Overall Study|Death|3|||
130076222|NCT01927068|468233405|FG000|Overall Study|Withdrawal by Subject|50|||
130076223|NCT01927068|468233406|FG001|Overall Study|Withdrawal by Subject|3|||
130076224|NCT01927068|468233405|FG000|Overall Study|Lost to Follow-up|10|||
130076225|NCT01927068|468233406|FG001|Overall Study|Lost to Follow-up|2|||
130076226|NCT01927068|468233405|FG000|Overall Study|Physician Decision|9|||
130076227|NCT01927068|468233406|FG001|Overall Study|Physician Decision|0|||
130076228|NCT01927068|468233405|FG000|Overall Study|Missed last follow-up visit|2|||
130076229|NCT01927068|468233406|FG001|Overall Study|Missed last follow-up visit|0|||
130076230|NCT00880607|468233407|FG000|Overall Study|Physician Decision|2|||
130076231|NCT00880607|468233408|FG001|Overall Study|Physician Decision|2|||
130076232|NCT00880607|468233407|FG000|Overall Study|Protocol Violation|2|||
130076233|NCT00880607|468233408|FG001|Overall Study|Protocol Violation|1|||
130076234|NCT00880607|468233407|FG000|Overall Study|surgery did not extend past L1 level|3|||
130076235|NCT00880607|468233408|FG001|Overall Study|surgery did not extend past L1 level|0|||
130076236|NCT02963766|468233410|FG000|Double-Blind Period|Adverse Event|1|||
130076237|NCT02963766|468233411|FG001|Double-Blind Period|Adverse Event|0|||
130076238|NCT02963766|468233412|FG002|Double-Blind Period|Adverse Event|1|||
130076239|NCT02963766|468233410|FG000|Double-Blind Period|Physician Decision|1|||
130076240|NCT02963766|468233411|FG001|Double-Blind Period|Physician Decision|0|||
130076241|NCT02963766|468233412|FG002|Double-Blind Period|Physician Decision|0|||
130076242|NCT02963766|468233410|FG000|Double-Blind Period|Withdrawal by Subject|1|||
130076243|NCT02963766|468233411|FG001|Double-Blind Period|Withdrawal by Subject|1|||
130076244|NCT02963766|468233412|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130076245|NCT02963766|468233410|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
130076246|NCT02963766|468233411|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
130076247|NCT02963766|468233412|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
130076248|NCT02963766|468233410|FG000|Double-Blind Period|Protocol Violation|1|||
130076249|NCT02963766|468233411|FG001|Double-Blind Period|Protocol Violation|0|||
130076250|NCT02963766|468233412|FG002|Double-Blind Period|Protocol Violation|0|||
130076251|NCT02963766|468233410|FG000|Double-Blind Period|Lost to Follow-up|0|||
130076252|NCT02963766|468233411|FG001|Double-Blind Period|Lost to Follow-up|1|||
130076253|NCT02963766|468233412|FG002|Double-Blind Period|Lost to Follow-up|0|||
130076254|NCT02963766|468233410|FG000|Open Label Extension (OLE)|Physician Decision|1|||
130076255|NCT02963766|468233411|FG001|Open Label Extension (OLE)|Physician Decision|2|||
130076256|NCT02963766|468233412|FG002|Open Label Extension (OLE)|Physician Decision|2|||
130076257|NCT02963766|468233410|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
130076258|NCT02963766|468233411|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
130076259|NCT02963766|468233412|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
130076260|NCT00499460|468233413|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
130076261|NCT00499460|468233414|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
130076262|NCT00499460|468233413|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
130076263|NCT00499460|468233414|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
130076264|NCT00499460|468233413|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
130076265|NCT00499460|468233414|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
130076266|NCT03938636|468235309|FG000|Overall Study|Protocol Violation|0|||
130076267|NCT03938636|468235310|FG001|Overall Study|Protocol Violation|1|||
130076268|NCT03938636|468235311|FG002|Overall Study|Protocol Violation|1|||
130076269|NCT03938636|468235309|FG000|Overall Study|Subject withdrew due to death in family|0|||
130076270|NCT03938636|468235310|FG001|Overall Study|Subject withdrew due to death in family|1|||
130076271|NCT03938636|468235311|FG002|Overall Study|Subject withdrew due to death in family|0|||
130076272|NCT03938636|468235309|FG000|Overall Study|Missed visit|0|||
130076273|NCT03938636|468235310|FG001|Overall Study|Missed visit|1|||
130076274|NCT03938636|468235311|FG002|Overall Study|Missed visit|0|||
130076275|NCT03938636|468235309|FG000|Overall Study|Adverse Event|0|||
130076276|NCT03938636|468235310|FG001|Overall Study|Adverse Event|0|||
130076277|NCT03938636|468235311|FG002|Overall Study|Adverse Event|1|||
130076278|NCT03938636|468235309|FG000|Overall Study|Lost to Follow-up|0|||
130076279|NCT03938636|468235310|FG001|Overall Study|Lost to Follow-up|0|||
130076280|NCT03938636|468235311|FG002|Overall Study|Lost to Follow-up|1|||
130076281|NCT01100658|468235312|FG000|Overall Study|Withdrawal by Subject|1|||
130076282|NCT00711412|468235313|FG000|Induction Treatment|Death|2|||
130076283|NCT00711412|468235313|FG000|Induction Treatment|Adverse Event|1|||
130076284|NCT00711412|468235313|FG000|Induction Treatment|Other|1|||
130120553|NCT03384745|468402404|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
129952062|NCT00632736|467784906|FG000|Overall Study|Sponsor terminated study|5|||
130120554|NCT03384745|468402405|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
130120555|NCT03384745|468402406|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130076285|NCT00711412|468235313|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
130076286|NCT00711412|468235313|FG000|Evaluated for Combination Treatment|Death|1|||
130076287|NCT00711412|468235313|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
130076288|NCT00711412|468235313|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
130076289|NCT00711412|468235313|FG000|Combination Treatment|Progressive Disease|1|||
130076290|NCT00711412|468235313|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
130076291|NCT00711412|468235313|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
130076292|NCT00711412|468235313|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
129952063|NCT00632736|467784906|FG000|Overall Study|Non-compliance|10|||
130076293|NCT00711412|468235313|FG000|Evaluation for Response and Surgery|Death|1|||
130076294|NCT00711412|468235313|FG000|Survival Follow up Until Death|Other|12|||
130076295|NCT00420342|468235317|FG000|Overall Study|Lost to Follow-up|1|||
130076296|NCT00420342|468235318|FG001|Overall Study|Lost to Follow-up|0|||
130076297|NCT00420342|468235319|FG002|Overall Study|Lost to Follow-up|1|||
130076298|NCT00420342|468235317|FG000|Overall Study|Withdrawal by Subject|0|||
130076299|NCT00420342|468235318|FG001|Overall Study|Withdrawal by Subject|2|||
130076300|NCT00420342|468235319|FG002|Overall Study|Withdrawal by Subject|0|||
130076301|NCT04072575|468235320|FG000|Overall Study|Physician Decision|1|||
130076302|NCT04072575|468235320|FG000|Overall Study|Adverse Event|7|||
130076303|NCT04072575|468235320|FG000|Overall Study|Withdrawal by Subject|14|||
130076304|NCT04072575|468235320|FG000|Overall Study|Other|2|||
130076305|NCT02473289|468235321|FG000|Overall Study|Adverse Event|2|||
130076306|NCT02473289|468235322|FG001|Overall Study|Adverse Event|3|||
130076307|NCT02473289|468235321|FG000|Overall Study|Lost to Follow-up|1|||
130076308|NCT02473289|468235322|FG001|Overall Study|Lost to Follow-up|1|||
130076309|NCT02473289|468235321|FG000|Overall Study|Protocol Violation|0|||
130076310|NCT02473289|468235322|FG001|Overall Study|Protocol Violation|1|||
130076311|NCT02473289|468235321|FG000|Overall Study|Withdrawal of consent|6|||
130076312|NCT02473289|468235322|FG001|Overall Study|Withdrawal of consent|7|||
130076313|NCT02473289|468235321|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
130076314|NCT02473289|468235322|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
130076315|NCT02473289|468235321|FG000|Overall Study|Other|2|||
130076316|NCT02473289|468235322|FG001|Overall Study|Other|0|||
130076317|NCT02244619|468235323|FG000|Overall Study|Did not receive study intervention|8|||
130076318|NCT02244619|468235324|FG001|Overall Study|Did not receive study intervention|21|||
130076319|NCT03285490|468235326|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
130076320|NCT03285490|468235327|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
130076321|NCT03285490|468235326|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
130076322|NCT03285490|468235327|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
130076323|NCT03745989|468235328|FG000|Overall Study|Death|3|||
130076324|NCT03745989|468235329|FG001|Overall Study|Death|7|||
130076325|NCT03745989|468235330|FG002|Overall Study|Death|4|||
130076326|NCT03745989|468235328|FG000|Overall Study|Lost to Follow-up|0|||
130076327|NCT03745989|468235329|FG001|Overall Study|Lost to Follow-up|2|||
130076328|NCT03745989|468235330|FG002|Overall Study|Lost to Follow-up|0|||
130076329|NCT03745989|468235328|FG000|Overall Study|Sponsor Decision|0|||
130076330|NCT03745989|468235329|FG001|Overall Study|Sponsor Decision|2|||
130076331|NCT03745989|468235330|FG002|Overall Study|Sponsor Decision|8|||
130076332|NCT03745989|468235328|FG000|Overall Study|Withdrawal by Subject|0|||
130076333|NCT03745989|468235329|FG001|Overall Study|Withdrawal by Subject|1|||
130076334|NCT03745989|468235330|FG002|Overall Study|Withdrawal by Subject|3|||
130076335|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
130076336|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
130076337|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
130076338|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
130076339|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
130076340|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
130076341|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
130076342|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
130076343|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
130076344|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
130076345|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
130076346|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
130076347|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
130076348|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
130076349|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
130076350|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
130076351|NCT01291511|468235334|FG000|Cross-Titration and Stabilization Phase|Death|1|||
130076352|NCT01291511|468235335|FG001|Cross-Titration and Stabilization Phase|Death|0|||
130076353|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
130076354|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
130076355|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
130076356|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
130076357|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
130076358|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
130076359|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
130076360|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
130076361|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
130076362|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
129952064|NCT00632736|467784906|FG000|Overall Study|Other|16|||
130076363|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
130076364|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
130076365|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
130076366|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
130076367|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
130076368|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
130076369|NCT01291511|468235334|FG000|Double-blind Relapse Prevention Phase|Death|1|||
130076370|NCT01291511|468235335|FG001|Double-blind Relapse Prevention Phase|Death|0|||
130076371|NCT00047008|468235337|FG000|Overall Study|Withdrawn consent|2|||
130076372|NCT00047008|468235338|FG001|Overall Study|Withdrawn consent|3|||
130076373|NCT00047008|468235337|FG000|Overall Study|Ineligible|9|||
130076374|NCT00047008|468235338|FG001|Overall Study|Ineligible|8|||
130076375|NCT00429572|468235339|FG000|Overall Study|Disease progression|1|||
130076376|NCT01366534|468235341|FG000|Overall Study|Lost to Follow-up|1|||
130076377|NCT01366534|468235342|FG001|Overall Study|Lost to Follow-up|0|||
130076378|NCT01366534|468235343|FG002|Overall Study|Lost to Follow-up|0|||
130076379|NCT01366534|468235341|FG000|Overall Study|Migrated|1|||
130076380|NCT01366534|468235342|FG001|Overall Study|Migrated|1|||
130076381|NCT01366534|468235343|FG002|Overall Study|Migrated|0|||
130076382|NCT01366534|468235341|FG000|Overall Study|Declined challenged|0|||
130076383|NCT01366534|468235342|FG001|Overall Study|Declined challenged|1|||
130076384|NCT01366534|468235343|FG002|Overall Study|Declined challenged|0|||
130076385|NCT02565576|468235345|FG000|Overall Study|abnormal lab value|2|||
130076386|NCT02565576|468235346|FG001|Overall Study|abnormal lab value|0|||
130076387|NCT02565576|468235345|FG000|Overall Study|subject / guardian decision|1|||
130076388|NCT02565576|468235346|FG001|Overall Study|subject / guardian decision|3|||
130076389|NCT02565576|468235345|FG000|Overall Study|Lost to Follow-up|1|||
130076390|NCT02565576|468235346|FG001|Overall Study|Lost to Follow-up|0|||
130076391|NCT02565576|468235345|FG000|Overall Study|Death|0|||
130076392|NCT02565576|468235346|FG001|Overall Study|Death|2|||
130076393|NCT02565576|468235345|FG000|Overall Study|Adverse Event|1|||
130076394|NCT02565576|468235346|FG001|Overall Study|Adverse Event|0|||
130076395|NCT01408732|468235347|FG000|Overall Study|Withdrawal by Subject|2|||
130076396|NCT01408732|468235348|FG001|Overall Study|Withdrawal by Subject|2|||
130076397|NCT00424099|468235349|FG000|Overall Study|Adverse Event|0|||
130076398|NCT00424099|468235350|FG001|Overall Study|Adverse Event|1|||
130076399|NCT00424099|468235351|FG002|Overall Study|Adverse Event|1|||
130076400|NCT00424099|468235352|FG003|Overall Study|Adverse Event|0|||
130076401|NCT00424099|468235349|FG000|Overall Study|Death|0|||
130076402|NCT00424099|468235350|FG001|Overall Study|Death|1|||
130076403|NCT00424099|468235351|FG002|Overall Study|Death|0|||
130076404|NCT00424099|468235352|FG003|Overall Study|Death|0|||
130076405|NCT00424099|468235349|FG000|Overall Study|Illness|2|||
130076406|NCT00424099|468235350|FG001|Overall Study|Illness|0|||
130076407|NCT00424099|468235351|FG002|Overall Study|Illness|1|||
130076408|NCT00424099|468235352|FG003|Overall Study|Illness|4|||
130076409|NCT00424099|468235349|FG000|Overall Study|Lost to Follow-up|0|||
130076410|NCT00424099|468235350|FG001|Overall Study|Lost to Follow-up|0|||
130076411|NCT00424099|468235351|FG002|Overall Study|Lost to Follow-up|3|||
130076412|NCT00424099|468235352|FG003|Overall Study|Lost to Follow-up|0|||
130076413|NCT00424099|468235349|FG000|Overall Study|Hospitalized|1|||
130076414|NCT00424099|468235350|FG001|Overall Study|Hospitalized|2|||
130076415|NCT00424099|468235351|FG002|Overall Study|Hospitalized|1|||
130076416|NCT00424099|468235352|FG003|Overall Study|Hospitalized|3|||
130076417|NCT00424099|468235349|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
130076418|NCT00424099|468235350|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
130076419|NCT00424099|468235351|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
130076420|NCT00424099|468235352|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
130076421|NCT00424099|468235349|FG000|Overall Study|Withdrawal by Subject|1|||
130076422|NCT00424099|468235350|FG001|Overall Study|Withdrawal by Subject|9|||
130076423|NCT00424099|468235351|FG002|Overall Study|Withdrawal by Subject|4|||
130076424|NCT00424099|468235352|FG003|Overall Study|Withdrawal by Subject|6|||
130076425|NCT00424099|468235349|FG000|Overall Study|Physician Decision|0|||
130076426|NCT00424099|468235350|FG001|Overall Study|Physician Decision|0|||
130076427|NCT00424099|468235351|FG002|Overall Study|Physician Decision|1|||
130076428|NCT00424099|468235352|FG003|Overall Study|Physician Decision|0|||
130076429|NCT00424099|468235349|FG000|Overall Study|Missing|0|||
130076430|NCT00424099|468235350|FG001|Overall Study|Missing|0|||
130076431|NCT00424099|468235351|FG002|Overall Study|Missing|1|||
130076432|NCT00424099|468235352|FG003|Overall Study|Missing|0|||
130076433|NCT03345342|468235353|FG000|Open-Label Phase|Adverse Event|30|||
130076434|NCT03345342|468235354|FG001|Open-Label Phase|Adverse Event|0|||
130076435|NCT03345342|468235355|FG002|Open-Label Phase|Adverse Event|0|||
130076436|NCT03345342|468235356|FG003|Open-Label Phase|Adverse Event|0|||
130076437|NCT03345342|468235357|FG004|Open-Label Phase|Adverse Event|0|||
130076438|NCT03345342|468235353|FG000|Open-Label Phase|Death|1|||
130076439|NCT03345342|468235354|FG001|Open-Label Phase|Death|0|||
130076440|NCT03345342|468235355|FG002|Open-Label Phase|Death|0|||
130076441|NCT03345342|468235356|FG003|Open-Label Phase|Death|0|||
130076442|NCT03345342|468235357|FG004|Open-Label Phase|Death|0|||
130076443|NCT03345342|468235353|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
130076444|NCT03345342|468235354|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
130076445|NCT03345342|468235355|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
130076446|NCT03345342|468235356|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
130076447|NCT03345342|468235357|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
130076448|NCT03345342|468235353|FG000|Open-Label Phase|Lack of Efficacy|6|||
130076449|NCT03345342|468235354|FG001|Open-Label Phase|Lack of Efficacy|0|||
130076450|NCT03345342|468235355|FG002|Open-Label Phase|Lack of Efficacy|0|||
130076451|NCT03345342|468235356|FG003|Open-Label Phase|Lack of Efficacy|0|||
130076452|NCT03345342|468235357|FG004|Open-Label Phase|Lack of Efficacy|0|||
130076453|NCT03345342|468235353|FG000|Open-Label Phase|Lost to Follow-up|9|||
130076454|NCT03345342|468235354|FG001|Open-Label Phase|Lost to Follow-up|0|||
130076455|NCT03345342|468235355|FG002|Open-Label Phase|Lost to Follow-up|0|||
130076456|NCT03345342|468235356|FG003|Open-Label Phase|Lost to Follow-up|0|||
130076457|NCT03345342|468235357|FG004|Open-Label Phase|Lost to Follow-up|0|||
130076458|NCT03345342|468235353|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
130076459|NCT03345342|468235354|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
130076460|NCT03345342|468235355|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
130076461|NCT03345342|468235356|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
130076462|NCT03345342|468235357|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
130076463|NCT03345342|468235353|FG000|Open-Label Phase|Physician Decision|4|||
130076464|NCT03345342|468235354|FG001|Open-Label Phase|Physician Decision|0|||
130076465|NCT03345342|468235355|FG002|Open-Label Phase|Physician Decision|0|||
130076466|NCT03345342|468235356|FG003|Open-Label Phase|Physician Decision|0|||
130076467|NCT03345342|468235357|FG004|Open-Label Phase|Physician Decision|0|||
130076468|NCT03345342|468235353|FG000|Open-Label Phase|Protocol Violation|8|||
130076469|NCT03345342|468235354|FG001|Open-Label Phase|Protocol Violation|0|||
130076470|NCT03345342|468235355|FG002|Open-Label Phase|Protocol Violation|0|||
130076471|NCT03345342|468235356|FG003|Open-Label Phase|Protocol Violation|0|||
130076472|NCT03345342|468235357|FG004|Open-Label Phase|Protocol Violation|0|||
130076473|NCT03345342|468235353|FG000|Open-Label Phase|Withdrawal by Subject|57|||
130076474|NCT03345342|468235354|FG001|Open-Label Phase|Withdrawal by Subject|0|||
130076475|NCT03345342|468235355|FG002|Open-Label Phase|Withdrawal by Subject|0|||
130076476|NCT03345342|468235356|FG003|Open-Label Phase|Withdrawal by Subject|0|||
130076477|NCT03345342|468235357|FG004|Open-Label Phase|Withdrawal by Subject|0|||
130076478|NCT03345342|468235353|FG000|Open-Label Phase|Other|15|||
130076479|NCT03345342|468235354|FG001|Open-Label Phase|Other|0|||
130076480|NCT03345342|468235355|FG002|Open-Label Phase|Other|0|||
130076481|NCT03345342|468235356|FG003|Open-Label Phase|Other|0|||
130076482|NCT03345342|468235357|FG004|Open-Label Phase|Other|0|||
130076483|NCT03345342|468235353|FG000|Double-Blind Phase|Adverse Event|0|||
130076484|NCT03345342|468235354|FG001|Double-Blind Phase|Adverse Event|1|||
130076485|NCT03345342|468235355|FG002|Double-Blind Phase|Adverse Event|6|||
130076486|NCT03345342|468235356|FG003|Double-Blind Phase|Adverse Event|0|||
130076487|NCT03345342|468235357|FG004|Double-Blind Phase|Adverse Event|0|||
130076488|NCT03345342|468235353|FG000|Double-Blind Phase|Death|0|||
130076489|NCT03345342|468235354|FG001|Double-Blind Phase|Death|2|||
130076490|NCT03345342|468235355|FG002|Double-Blind Phase|Death|1|||
130076491|NCT03345342|468235356|FG003|Double-Blind Phase|Death|0|||
130076492|NCT03345342|468235357|FG004|Double-Blind Phase|Death|0|||
130076493|NCT03345342|468235353|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
130076494|NCT03345342|468235354|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
130076495|NCT03345342|468235355|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
130076496|NCT03345342|468235356|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
130076497|NCT03345342|468235357|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
130076498|NCT03345342|468235353|FG000|Double-Blind Phase|Lost to Follow-up|0|||
130076499|NCT03345342|468235354|FG001|Double-Blind Phase|Lost to Follow-up|1|||
130076500|NCT03345342|468235355|FG002|Double-Blind Phase|Lost to Follow-up|7|||
130076501|NCT03345342|468235356|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130120556|NCT03384745|468402407|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
130076502|NCT03345342|468235357|FG004|Double-Blind Phase|Lost to Follow-up|0|||
130076503|NCT03345342|468235353|FG000|Double-Blind Phase|Physician Decision|0|||
130076504|NCT03345342|468235354|FG001|Double-Blind Phase|Physician Decision|1|||
130076505|NCT03345342|468235355|FG002|Double-Blind Phase|Physician Decision|4|||
130076506|NCT03345342|468235356|FG003|Double-Blind Phase|Physician Decision|0|||
130076507|NCT03345342|468235357|FG004|Double-Blind Phase|Physician Decision|0|||
130076508|NCT03345342|468235353|FG000|Double-Blind Phase|Protocol Violation|0|||
130076509|NCT03345342|468235354|FG001|Double-Blind Phase|Protocol Violation|0|||
130076510|NCT03345342|468235355|FG002|Double-Blind Phase|Protocol Violation|1|||
130076511|NCT03345342|468235356|FG003|Double-Blind Phase|Protocol Violation|0|||
130076512|NCT03345342|468235357|FG004|Double-Blind Phase|Protocol Violation|0|||
130076513|NCT03345342|468235353|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
130076514|NCT03345342|468235354|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
130076515|NCT03345342|468235355|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
129952065|NCT02312258|467784907|FG000|Overall Study|Lost to Follow-up|8|||
129952066|NCT02312258|467784908|FG001|Overall Study|Lost to Follow-up|8|||
129952067|NCT02312258|467784907|FG000|Overall Study|Withdrawal by Patient|49|||
129952068|NCT02312258|467784908|FG001|Overall Study|Withdrawal by Patient|76|||
129952069|NCT02312258|467784907|FG000|Overall Study|Reason not Specified|107|||
129952070|NCT02312258|467784908|FG001|Overall Study|Reason not Specified|159|||
129952071|NCT02312258|467784907|FG000|Overall Study|Missing|2|||
129952072|NCT02312258|467784908|FG001|Overall Study|Missing|1|||
129952073|NCT02312258|467784907|FG000|Overall Study|Death|115|||
129952074|NCT02312258|467784908|FG001|Overall Study|Death|181|||
129952075|NCT02892019|467784915|FG000|Overall Study|randomized but not treated|0|||
129952076|NCT02892019|467784916|FG001|Overall Study|randomized but not treated|1|||
129952077|NCT02892019|467784915|FG000|Overall Study|Withdrawal by Subject|0|||
129952078|NCT02892019|467784916|FG001|Overall Study|Withdrawal by Subject|1|||
129952079|NCT02892019|467784915|FG000|Overall Study|Adverse Event|1|||
129952080|NCT02892019|467784916|FG001|Overall Study|Adverse Event|1|||
129952081|NCT01313663|467784917|FG000|Overall Study|Study Closed/Terminated|2|||
129952082|NCT01313663|467784918|FG001|Overall Study|Study Closed/Terminated|4|||
129952083|NCT01313663|467784917|FG000|Overall Study|Lost to Follow-up|0|||
129952084|NCT01313663|467784918|FG001|Overall Study|Lost to Follow-up|1|||
129952085|NCT01313663|467784917|FG000|Overall Study|Physician Decision|0|||
129952086|NCT01313663|467784918|FG001|Overall Study|Physician Decision|2|||
129952087|NCT01313663|467784917|FG000|Overall Study|Withdrawal by Subject|2|||
129952088|NCT01313663|467784918|FG001|Overall Study|Withdrawal by Subject|1|||
129952089|NCT00946998|467786833|FG000|Overall Study|Exited prior to first outcome assessment|5|||
129952090|NCT00946998|467786834|FG001|Overall Study|Exited prior to first outcome assessment|3|||
129952091|NCT04049578|467786837|FG000|Overall Study|Physician Decision|1|||
129952092|NCT00304278|467786841|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
129952093|NCT00304278|467786841|FG000|Overall Study|PT had medical condition preventing TX|1|||
129952094|NCT01945593|467786842|FG000|Overall Study|Adverse Event|0|||
129952095|NCT01945593|467786843|FG001|Overall Study|Adverse Event|0|||
129952096|NCT01945593|467786844|FG002|Overall Study|Adverse Event|0|||
129952097|NCT01945593|467786845|FG003|Overall Study|Adverse Event|5|||
129952098|NCT01945593|467786842|FG000|Overall Study|Physician Decision|0|||
129952099|NCT01945593|467786843|FG001|Overall Study|Physician Decision|0|||
129952100|NCT01945593|467786844|FG002|Overall Study|Physician Decision|1|||
129952101|NCT01945593|467786845|FG003|Overall Study|Physician Decision|1|||
129952102|NCT01945593|467786842|FG000|Overall Study|Withdrawal by Subject|0|||
129952103|NCT01945593|467786843|FG001|Overall Study|Withdrawal by Subject|2|||
129952104|NCT01945593|467786844|FG002|Overall Study|Withdrawal by Subject|0|||
129952105|NCT01945593|467786845|FG003|Overall Study|Withdrawal by Subject|4|||
129952106|NCT01945593|467786842|FG000|Overall Study|Protocol Violation|0|||
129952107|NCT01945593|467786843|FG001|Overall Study|Protocol Violation|2|||
129952108|NCT01945593|467786844|FG002|Overall Study|Protocol Violation|1|||
129952109|NCT01945593|467786845|FG003|Overall Study|Protocol Violation|3|||
129952110|NCT01945593|467786842|FG000|Overall Study|Death|0|||
129952111|NCT01945593|467786843|FG001|Overall Study|Death|0|||
129952112|NCT01945593|467786844|FG002|Overall Study|Death|1|||
129952113|NCT01945593|467786845|FG003|Overall Study|Death|0|||
129952114|NCT01945593|467786842|FG000|Overall Study|Other: Terminated|0|||
129952115|NCT01945593|467786843|FG001|Overall Study|Other: Terminated|0|||
129952116|NCT01945593|467786844|FG002|Overall Study|Other: Terminated|0|||
129952117|NCT01945593|467786845|FG003|Overall Study|Other: Terminated|1|||
129952118|NCT01945593|467786842|FG000|Overall Study|Other: Surgical Procedure|0|||
129952119|NCT01945593|467786843|FG001|Overall Study|Other: Surgical Procedure|2|||
129952120|NCT01945593|467786844|FG002|Overall Study|Other: Surgical Procedure|0|||
129952121|NCT01945593|467786845|FG003|Overall Study|Other: Surgical Procedure|6|||
129952122|NCT01945593|467786842|FG000|Overall Study|Other: Screen Failure|0|||
129952123|NCT01945593|467786843|FG001|Overall Study|Other: Screen Failure|2|||
129952124|NCT01945593|467786844|FG002|Overall Study|Other: Screen Failure|0|||
129952125|NCT01945593|467786845|FG003|Overall Study|Other: Screen Failure|0|||
129952126|NCT00507429|467786846|FG000|Treatment Phase|Disease Progression|12|||
129952127|NCT00507429|467786847|FG001|Treatment Phase|Disease Progression|5|||
129952128|NCT00507429|467786846|FG000|Treatment Phase|Adverse Event|12|||
129952129|NCT00507429|467786847|FG001|Treatment Phase|Adverse Event|5|||
129952130|NCT00507429|467786846|FG000|Treatment Phase|Withdrawal by Subject|3|||
129952131|NCT00507429|467786847|FG001|Treatment Phase|Withdrawal by Subject|3|||
129952132|NCT00507429|467786846|FG000|Treatment Phase|Physician Decision|4|||
129952133|NCT00507429|467786847|FG001|Treatment Phase|Physician Decision|2|||
129952134|NCT00507429|467786846|FG000|Treatment Phase|Other|6|||
129952135|NCT00507429|467786847|FG001|Treatment Phase|Other|3|||
129952136|NCT00507429|467786846|FG000|Maintenance Phase|Progressive Disease|14|||
129952137|NCT00507429|467786847|FG001|Maintenance Phase|Progressive Disease|0|||
129952138|NCT00608959|467786848|FG000|Part 1|Did not meet eligibility criteria|1|||
129952139|NCT01005602|467786849|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
129952140|NCT01005602|467786850|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
129952141|NCT01248715|467786851|FG000|Overall Study|Not influenza positive|501|||
129952142|NCT01248715|467786852|FG001|Overall Study|Not influenza positive|510|||
129952143|NCT03409276|467786858|FG000|Overall Study|Withdrawal by Subject|0|||
130076516|NCT03345342|468235356|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
130076517|NCT03345342|468235357|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
130076518|NCT03345342|468235353|FG000|Double-Blind Phase|Other|0|||
130076519|NCT03345342|468235354|FG001|Double-Blind Phase|Other|1|||
130076520|NCT03345342|468235355|FG002|Double-Blind Phase|Other|3|||
130076521|NCT03345342|468235356|FG003|Double-Blind Phase|Other|0|||
130076522|NCT03345342|468235357|FG004|Double-Blind Phase|Other|0|||
130076523|NCT03345342|468235353|FG000|Follow-Up Phase|Adverse Event|0|||
130076524|NCT03345342|468235354|FG001|Follow-Up Phase|Adverse Event|0|||
130076525|NCT03345342|468235355|FG002|Follow-Up Phase|Adverse Event|0|||
130076526|NCT03345342|468235356|FG003|Follow-Up Phase|Adverse Event|0|||
130076527|NCT03345342|468235357|FG004|Follow-Up Phase|Adverse Event|4|||
130076528|NCT03345342|468235353|FG000|Follow-Up Phase|Lost to Follow-up|0|||
130076529|NCT03345342|468235354|FG001|Follow-Up Phase|Lost to Follow-up|0|||
130076530|NCT03345342|468235355|FG002|Follow-Up Phase|Lost to Follow-up|0|||
130076531|NCT03345342|468235356|FG003|Follow-Up Phase|Lost to Follow-up|0|||
130076532|NCT03345342|468235357|FG004|Follow-Up Phase|Lost to Follow-up|6|||
130076533|NCT03345342|468235353|FG000|Follow-Up Phase|Physician Decision|0|||
130076534|NCT03345342|468235354|FG001|Follow-Up Phase|Physician Decision|0|||
130076535|NCT03345342|468235355|FG002|Follow-Up Phase|Physician Decision|0|||
130076536|NCT03345342|468235356|FG003|Follow-Up Phase|Physician Decision|0|||
130076537|NCT03345342|468235357|FG004|Follow-Up Phase|Physician Decision|5|||
130076538|NCT03345342|468235353|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130076539|NCT03345342|468235354|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
130076540|NCT03345342|468235355|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
130076541|NCT03345342|468235356|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
130076542|NCT03345342|468235357|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
130076543|NCT03345342|468235353|FG000|Follow-Up Phase|Other|0|||
130076544|NCT03345342|468235354|FG001|Follow-Up Phase|Other|0|||
130076545|NCT03345342|468235355|FG002|Follow-Up Phase|Other|0|||
130076546|NCT03345342|468235356|FG003|Follow-Up Phase|Other|3|||
130076547|NCT03345342|468235357|FG004|Follow-Up Phase|Other|1|||
130076548|NCT03981744|468235362|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
130076549|NCT03981744|468235363|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
130076550|NCT03981744|468235364|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
130076551|NCT03981744|468235365|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
130076552|NCT03981744|468235362|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
130076553|NCT03981744|468235363|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
130076554|NCT03981744|468235364|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
130076555|NCT03981744|468235365|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
130076556|NCT03981744|468235362|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
130076557|NCT03981744|468235363|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
130076558|NCT03981744|468235364|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
130076559|NCT03981744|468235365|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
130076560|NCT02782104|468235366|FG000|Overall Study|Other|215|||
130076561|NCT02782104|468235366|FG000|Overall Study|Induction Day 28 Non Responder|9|||
130076562|NCT02782104|468235366|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130076563|NCT02782104|468235366|FG000|Overall Study|Death|8|||
130076564|NCT02782104|468235366|FG000|Overall Study|Pregnancy|6|||
130076565|NCT02782104|468235366|FG000|Overall Study|Withdrawal by Subject|63|||
130076566|NCT02782104|468235366|FG000|Overall Study|Protocol Violation|7|||
130076567|NCT02782104|468235366|FG000|Overall Study|Lack of Efficacy|61|||
130076568|NCT02782104|468235366|FG000|Overall Study|Lost to Follow-up|23|||
130076569|NCT02782104|468235366|FG000|Overall Study|Adverse Event|74|||
130076570|NCT03185819|468235367|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
130076571|NCT03185819|468235368|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
130076572|NCT03185819|468235369|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
130076573|NCT03185819|468235370|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
130076574|NCT03185819|468235367|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
130076575|NCT03185819|468235368|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
130076576|NCT03185819|468235369|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
130076577|NCT03185819|468235370|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
130076578|NCT03185819|468235367|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
130076579|NCT03185819|468235368|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
130076580|NCT03185819|468235369|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
130076581|NCT03185819|468235370|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
130076582|NCT03185819|468235367|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
130076583|NCT03185819|468235368|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
130076584|NCT03185819|468235369|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
130076585|NCT03185819|468235370|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
130076586|NCT03185819|468235367|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
130076587|NCT03185819|468235368|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
130076588|NCT03185819|468235369|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
130076589|NCT03185819|468235370|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
130076590|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
130076591|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
130076592|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
130076593|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
130076594|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
130076595|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
130076596|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
130076597|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
130076598|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
130076599|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
130076600|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
130076601|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
130076602|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
130076603|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
130076604|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
130076605|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
130076606|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
130076607|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
130076608|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
130076609|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
130076610|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
130076611|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
130076612|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
130076613|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
130076614|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
130076615|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
130076616|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
130076617|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
130076618|NCT03185819|468235367|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
130076619|NCT03185819|468235368|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
130076620|NCT03185819|468235369|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
130076621|NCT03185819|468235370|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
130076622|NCT02438787|468235371|FG000|Overall Study|Adverse Event|1|||
130076623|NCT02438787|468235372|FG001|Overall Study|Adverse Event|0|||
130076624|NCT02438787|468235373|FG002|Overall Study|Adverse Event|2|||
130076625|NCT02438787|468235371|FG000|Overall Study|Lack of Efficacy|1|||
130076626|NCT02438787|468235372|FG001|Overall Study|Lack of Efficacy|2|||
130076627|NCT02438787|468235373|FG002|Overall Study|Lack of Efficacy|0|||
130076628|NCT02438787|468235371|FG000|Overall Study|Lost to Follow-up|0|||
130076629|NCT02438787|468235372|FG001|Overall Study|Lost to Follow-up|1|||
130076630|NCT02438787|468235373|FG002|Overall Study|Lost to Follow-up|0|||
130076631|NCT02438787|468235371|FG000|Overall Study|Protocol Violation|0|||
130076632|NCT02438787|468235372|FG001|Overall Study|Protocol Violation|0|||
130076633|NCT02438787|468235373|FG002|Overall Study|Protocol Violation|1|||
130076634|NCT02438787|468235371|FG000|Overall Study|Withdrawal by Subject|15|||
130076635|NCT02438787|468235372|FG001|Overall Study|Withdrawal by Subject|7|||
130076636|NCT02438787|468235373|FG002|Overall Study|Withdrawal by Subject|10|||
130076637|NCT02438787|468235371|FG000|Overall Study|Study discontinued by sponsor|64|||
130076638|NCT02438787|468235372|FG001|Overall Study|Study discontinued by sponsor|72|||
130076639|NCT02438787|468235373|FG002|Overall Study|Study discontinued by sponsor|69|||
130076640|NCT02438787|468235371|FG000|Overall Study|Other|0|||
130076641|NCT02438787|468235372|FG001|Overall Study|Other|1|||
130076642|NCT02438787|468235373|FG002|Overall Study|Other|0|||
130076643|NCT02438787|468235371|FG000|Overall Study|Site terminated by sponsor|0|||
130076644|NCT02438787|468235372|FG001|Overall Study|Site terminated by sponsor|0|||
130076645|NCT02438787|468235373|FG002|Overall Study|Site terminated by sponsor|1|||
130076646|NCT03375203|468235374|FG000|Overall Study|Protocol Violation|0|||
130076647|NCT03375203|468235375|FG001|Overall Study|Protocol Violation|0|||
130076648|NCT03375203|468235376|FG002|Overall Study|Protocol Violation|1|||
130076649|NCT03375203|468235377|FG003|Overall Study|Protocol Violation|0|||
130076650|NCT03375203|468235378|FG004|Overall Study|Protocol Violation|0|||
130076651|NCT03375203|468235374|FG000|Overall Study|Adverse Event|2|||
130076652|NCT03375203|468235375|FG001|Overall Study|Adverse Event|3|||
130076653|NCT03375203|468235376|FG002|Overall Study|Adverse Event|0|||
130076654|NCT03375203|468235377|FG003|Overall Study|Adverse Event|2|||
129952144|NCT03409276|467786859|FG001|Overall Study|Withdrawal by Subject|0|||
129952145|NCT03409276|467786860|FG002|Overall Study|Withdrawal by Subject|0|||
129952146|NCT03409276|467786861|FG003|Overall Study|Withdrawal by Subject|0|||
129952147|NCT03409276|467786862|FG004|Overall Study|Withdrawal by Subject|1|||
129952148|NCT03409276|467786858|FG000|Overall Study|Lost to Follow-up|0|||
129952149|NCT03409276|467786859|FG001|Overall Study|Lost to Follow-up|0|||
129952150|NCT03409276|467786860|FG002|Overall Study|Lost to Follow-up|0|||
130076655|NCT03375203|468235378|FG004|Overall Study|Adverse Event|2|||
130076656|NCT03375203|468235374|FG000|Overall Study|Withdrawal by Subject|3|||
130076657|NCT03375203|468235375|FG001|Overall Study|Withdrawal by Subject|0|||
130076658|NCT03375203|468235376|FG002|Overall Study|Withdrawal by Subject|1|||
130076659|NCT03375203|468235377|FG003|Overall Study|Withdrawal by Subject|0|||
130076660|NCT03375203|468235378|FG004|Overall Study|Withdrawal by Subject|2|||
130076661|NCT03375203|468235374|FG000|Overall Study|Non-compliance with study drug|1|||
130076662|NCT03375203|468235375|FG001|Overall Study|Non-compliance with study drug|0|||
130076663|NCT03375203|468235376|FG002|Overall Study|Non-compliance with study drug|0|||
130076664|NCT03375203|468235377|FG003|Overall Study|Non-compliance with study drug|0|||
130076665|NCT03375203|468235378|FG004|Overall Study|Non-compliance with study drug|0|||
130076666|NCT03375203|468235374|FG000|Overall Study|Randomized, not treated.|0|||
130076667|NCT03375203|468235375|FG001|Overall Study|Randomized, not treated.|1|||
130076668|NCT03375203|468235376|FG002|Overall Study|Randomized, not treated.|0|||
130076669|NCT03375203|468235377|FG003|Overall Study|Randomized, not treated.|0|||
130076670|NCT03375203|468235378|FG004|Overall Study|Randomized, not treated.|0|||
130076671|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
130076672|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
130076673|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
130076674|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
130076675|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
130076676|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
130076677|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
130076678|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
130076679|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
130076680|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
130076681|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
130076682|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
130076683|NCT03321526|468235379|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
130076684|NCT03321526|468235380|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
130076685|NCT03321526|468235379|FG000|Follow-up Phase (2 Weeks)|Other|24|||
130076686|NCT03321526|468235380|FG001|Follow-up Phase (2 Weeks)|Other|24|||
130076687|NCT01989572|468235384|FG000|Overall Study|Lack of Efficacy|35|||
130076688|NCT01989572|468235385|FG001|Overall Study|Lack of Efficacy|48|||
130076689|NCT01989572|468235386|FG002|Overall Study|Lack of Efficacy|48|||
130076690|NCT01989572|468235387|FG003|Overall Study|Lack of Efficacy|43|||
130076691|NCT01989572|468235388|FG004|Overall Study|Lack of Efficacy|71|||
130076692|NCT01989572|468235389|FG005|Overall Study|Lack of Efficacy|79|||
130076693|NCT01989572|468235384|FG000|Overall Study|Adverse Event|2|||
130076694|NCT01989572|468235385|FG001|Overall Study|Adverse Event|1|||
130076695|NCT01989572|468235386|FG002|Overall Study|Adverse Event|3|||
130076696|NCT01989572|468235387|FG003|Overall Study|Adverse Event|0|||
130076697|NCT01989572|468235388|FG004|Overall Study|Adverse Event|3|||
130076698|NCT01989572|468235389|FG005|Overall Study|Adverse Event|0|||
130076699|NCT01989572|468235384|FG000|Overall Study|Death|0|||
130076700|NCT01989572|468235385|FG001|Overall Study|Death|0|||
130076701|NCT01989572|468235386|FG002|Overall Study|Death|0|||
130076702|NCT01989572|468235387|FG003|Overall Study|Death|0|||
130076703|NCT01989572|468235388|FG004|Overall Study|Death|1|||
130076704|NCT01989572|468235389|FG005|Overall Study|Death|0|||
130076705|NCT01989572|468235384|FG000|Overall Study|Withdrawal by Subject|4|||
130076706|NCT01989572|468235385|FG001|Overall Study|Withdrawal by Subject|1|||
130076707|NCT01989572|468235386|FG002|Overall Study|Withdrawal by Subject|5|||
130076708|NCT01989572|468235387|FG003|Overall Study|Withdrawal by Subject|1|||
130076709|NCT01989572|468235388|FG004|Overall Study|Withdrawal by Subject|12|||
130076710|NCT01989572|468235389|FG005|Overall Study|Withdrawal by Subject|4|||
130076711|NCT01989572|468235384|FG000|Overall Study|complicating disease|1|||
130076712|NCT01989572|468235385|FG001|Overall Study|complicating disease|1|||
130076713|NCT01989572|468235386|FG002|Overall Study|complicating disease|2|||
130076714|NCT01989572|468235387|FG003|Overall Study|complicating disease|0|||
130076715|NCT01989572|468235388|FG004|Overall Study|complicating disease|1|||
130076716|NCT01989572|468235389|FG005|Overall Study|complicating disease|0|||
130076717|NCT01989572|468235384|FG000|Overall Study|error|2|||
130076718|NCT01989572|468235385|FG001|Overall Study|error|1|||
130076719|NCT01989572|468235386|FG002|Overall Study|error|1|||
130076720|NCT01989572|468235387|FG003|Overall Study|error|1|||
129952151|NCT03409276|467786861|FG003|Overall Study|Lost to Follow-up|2|||
130076721|NCT01989572|468235388|FG004|Overall Study|error|1|||
130076722|NCT01989572|468235389|FG005|Overall Study|error|1|||
129952152|NCT03409276|467786862|FG004|Overall Study|Lost to Follow-up|2|||
130076723|NCT01989572|468235384|FG000|Overall Study|maximum dose reached|0|||
130120557|NCT03384745|468402402|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
130120558|NCT03384745|468402403|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
130120559|NCT03384745|468402404|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
130120560|NCT03384745|468402405|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
130120561|NCT03384745|468402406|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
130120562|NCT03384745|468402407|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
130120563|NCT03384745|468402402|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
130120564|NCT03384745|468402403|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
130120565|NCT03384745|468402404|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
130120566|NCT03384745|468402405|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
130120567|NCT03384745|468402406|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
130120568|NCT03384745|468402407|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
130120569|NCT03384745|468402402|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130120570|NCT03384745|468402403|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130120571|NCT03384745|468402404|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130120572|NCT03384745|468402405|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
130076724|NCT01989572|468235385|FG001|Overall Study|maximum dose reached|1|||
130076725|NCT01989572|468235386|FG002|Overall Study|maximum dose reached|0|||
130076726|NCT01989572|468235387|FG003|Overall Study|maximum dose reached|0|||
130076727|NCT01989572|468235388|FG004|Overall Study|maximum dose reached|1|||
130076728|NCT01989572|468235389|FG005|Overall Study|maximum dose reached|0|||
130076729|NCT01989572|468235384|FG000|Overall Study|unknown/not specify|3|||
130076730|NCT01989572|468235385|FG001|Overall Study|unknown/not specify|4|||
130076731|NCT01989572|468235386|FG002|Overall Study|unknown/not specify|1|||
130076732|NCT01989572|468235387|FG003|Overall Study|unknown/not specify|3|||
130076733|NCT01989572|468235388|FG004|Overall Study|unknown/not specify|3|||
130076734|NCT01989572|468235389|FG005|Overall Study|unknown/not specify|5|||
130076735|NCT01989572|468235384|FG000|Overall Study|not start protocol therapy|5|||
130076736|NCT01989572|468235385|FG001|Overall Study|not start protocol therapy|1|||
130076737|NCT01989572|468235386|FG002|Overall Study|not start protocol therapy|2|||
130076738|NCT01989572|468235387|FG003|Overall Study|not start protocol therapy|3|||
130076739|NCT01989572|468235388|FG004|Overall Study|not start protocol therapy|4|||
130076740|NCT01989572|468235389|FG005|Overall Study|not start protocol therapy|18|||
130076741|NCT01989572|468235384|FG000|Overall Study|alternative therapy|3|||
130076742|NCT01989572|468235385|FG001|Overall Study|alternative therapy|0|||
130076743|NCT01989572|468235386|FG002|Overall Study|alternative therapy|0|||
130076744|NCT01989572|468235387|FG003|Overall Study|alternative therapy|0|||
130076745|NCT01989572|468235388|FG004|Overall Study|alternative therapy|1|||
130076746|NCT01989572|468235389|FG005|Overall Study|alternative therapy|3|||
130076747|NCT00732641|468235390|FG000|Overall Study|Relapse or Progressive Disease|65|||
130076748|NCT00732641|468235391|FG001|Overall Study|Relapse or Progressive Disease|101|||
130076749|NCT00732641|468235390|FG000|Overall Study|Serious Adverse Events|12|||
130076750|NCT00732641|468235391|FG001|Overall Study|Serious Adverse Events|3|||
130076751|NCT00732641|468235390|FG000|Overall Study|Physician Decision|6|||
130076752|NCT00732641|468235391|FG001|Overall Study|Physician Decision|0|||
130076753|NCT00732641|468235390|FG000|Overall Study|Withdrawal by Subject|4|||
130076754|NCT00732641|468235391|FG001|Overall Study|Withdrawal by Subject|2|||
130076755|NCT00732641|468235390|FG000|Overall Study|Unable to Complete|1|||
130076756|NCT00732641|468235391|FG001|Overall Study|Unable to Complete|1|||
130076757|NCT00732641|468235390|FG000|Overall Study|Other|18|||
130076758|NCT00732641|468235391|FG001|Overall Study|Other|5|||
130076759|NCT02910089|468235392|FG000|Overall Study|Lost insurance eligibility|22|||
130076760|NCT02910089|468235393|FG001|Overall Study|Lost insurance eligibility|16|||
130076761|NCT00732238|468235394|FG000|Overall Study|Bacteremia|4|||
130076762|NCT00732238|468235395|FG001|Overall Study|Bacteremia|1|||
130076763|NCT00732238|468235394|FG000|Overall Study|Asymptomatic bacteriuria|1|||
130076764|NCT00732238|468235395|FG001|Overall Study|Asymptomatic bacteriuria|0|||
130120573|NCT03384745|468402406|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130120574|NCT03384745|468402407|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
130120575|NCT03384745|468402402|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
130120576|NCT03384745|468402403|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
130076765|NCT02280096|468235396|FG000|Overall Study|Pregnancy|1|||
130076766|NCT02280096|468235397|FG001|Overall Study|Pregnancy|0|||
130076767|NCT02280096|468235396|FG000|Overall Study|Functional neurological disorder|1|||
130076768|NCT02280096|468235397|FG001|Overall Study|Functional neurological disorder|0|||
130076769|NCT02280096|468235396|FG000|Overall Study|Lack of attachment|0|||
130076770|NCT02280096|468235397|FG001|Overall Study|Lack of attachment|1|||
130120577|NCT03384745|468402404|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
130076771|NCT02939976|468235400|FG000|Overall Study|Lost to Follow-up|7|||
130076772|NCT02939976|468235401|FG001|Overall Study|Lost to Follow-up|1|||
130076773|NCT02939976|468235402|FG002|Overall Study|Lost to Follow-up|1|||
130076774|NCT02939976|468235403|FG003|Overall Study|Lost to Follow-up|2|||
130076775|NCT02939976|468235400|FG000|Overall Study|Withdrawal by Subject|4|||
130076776|NCT02939976|468235401|FG001|Overall Study|Withdrawal by Subject|0|||
130076777|NCT02939976|468235402|FG002|Overall Study|Withdrawal by Subject|2|||
130076778|NCT02939976|468235403|FG003|Overall Study|Withdrawal by Subject|4|||
130076779|NCT02939976|468235400|FG000|Overall Study|Due to early study closure|4|||
130076780|NCT02939976|468235401|FG001|Overall Study|Due to early study closure|3|||
130076781|NCT02939976|468235402|FG002|Overall Study|Due to early study closure|2|||
130076782|NCT02939976|468235403|FG003|Overall Study|Due to early study closure|3|||
130076783|NCT00246376|468235404|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
130076784|NCT00246376|468235405|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
130076785|NCT00246376|468235406|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
130076786|NCT00246376|468235407|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
130076787|NCT00246376|468235408|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
130076788|NCT00246376|468235404|FG000|Overall Study|Adverse Event|2|||
130076789|NCT00246376|468235405|FG001|Overall Study|Adverse Event|3|||
130076790|NCT00246376|468235406|FG002|Overall Study|Adverse Event|1|||
130076791|NCT00246376|468235407|FG003|Overall Study|Adverse Event|3|||
130076792|NCT00246376|468235408|FG004|Overall Study|Adverse Event|1|||
130076793|NCT00246376|468235404|FG000|Overall Study|Lost to Follow-up|2|||
130076794|NCT00246376|468235405|FG001|Overall Study|Lost to Follow-up|11|||
130076795|NCT00246376|468235406|FG002|Overall Study|Lost to Follow-up|11|||
130076796|NCT00246376|468235407|FG003|Overall Study|Lost to Follow-up|16|||
130076797|NCT00246376|468235408|FG004|Overall Study|Lost to Follow-up|13|||
130076798|NCT01872897|468235409|FG000|Overall Study|Withdrawal by Subject|1|||
130076799|NCT01872897|468235410|FG001|Overall Study|Withdrawal by Subject|0|||
130076800|NCT02418585|468235413|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
130076801|NCT02418585|468235414|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
130076802|NCT02418585|468235413|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
130076803|NCT02418585|468235414|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
130076804|NCT02418585|468235413|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
130076805|NCT02418585|468235414|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
130076806|NCT02418585|468235413|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
130076807|NCT02418585|468235414|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
130076808|NCT02418585|468235413|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
130076809|NCT02418585|468235414|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
130076810|NCT02418585|468235413|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
130076811|NCT02418585|468235414|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
130076812|NCT02418585|468235413|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
130076813|NCT02418585|468235414|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
130076814|NCT02418585|468235413|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
130076815|NCT02418585|468235414|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
130076816|NCT02418585|468235413|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
130076817|NCT02418585|468235414|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
130076818|NCT02418585|468235413|FG000|Follow-up Phase (24 Weeks)|Other|3|||
130076819|NCT02418585|468235414|FG001|Follow-up Phase (24 Weeks)|Other|2|||
130076820|NCT02040857|468235415|FG000|Overall Study|Adverse Event|14|||
130076821|NCT02040857|468235415|FG000|Overall Study|Physician Decision|5|||
130076822|NCT02040857|468235415|FG000|Overall Study|Withdrawal by Subject|31|||
130076823|NCT02040857|468235415|FG000|Overall Study|patient non-compliance|3|||
130076824|NCT02040857|468235415|FG000|Overall Study|Lost to Follow-up|2|||
130076825|NCT02040857|468235415|FG000|Overall Study|recurrence|4|||
130076826|NCT02040857|468235415|FG000|Overall Study|ineligible|1|||
130076827|NCT04159701|468235416|FG000|Period 1: Treatment Period|Pregnancy|1|||
130076828|NCT04159701|468235417|FG001|Period 1: Treatment Period|Pregnancy|0|||
130076829|NCT04159701|468235416|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
130076830|NCT04159701|468235417|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
130076831|NCT04159701|468235416|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
130076832|NCT04159701|468235417|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
130076833|NCT04159701|468235416|FG000|Washout Period|site terminated by sponsor|0|||
130076834|NCT04159701|468235417|FG001|Washout Period|site terminated by sponsor|1|||
130076835|NCT04159701|468235416|FG000|Washout Period|study terminated by sponsor|10|||
130076836|NCT04159701|468235417|FG001|Washout Period|study terminated by sponsor|3|||
130076837|NCT04159701|468235416|FG000|Washout Period|Withdrawal by Subject|1|||
130076838|NCT04159701|468235417|FG001|Washout Period|Withdrawal by Subject|0|||
130076839|NCT04159701|468235416|FG000|Washout Period|Inadvertent Enrollment|1|||
130076840|NCT04159701|468235417|FG001|Washout Period|Inadvertent Enrollment|0|||
130076841|NCT04159701|468235416|FG000|Washout Period|Miscellaneous|1|||
130076842|NCT04159701|468235417|FG001|Washout Period|Miscellaneous|0|||
130076843|NCT04159701|468235416|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
130076844|NCT04159701|468235417|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
130076845|NCT04159701|468235416|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
130076846|NCT04159701|468235417|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
130076847|NCT04159701|468235416|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
130076848|NCT04159701|468235417|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
130076849|NCT04159701|468235416|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
130120578|NCT03384745|468402405|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
130120579|NCT03384745|468402406|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
130120580|NCT03384745|468402407|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
130120581|NCT02984683|468402410|FG000|Overall Study|Adverse Event|3|||
130120582|NCT02984683|468402411|FG001|Overall Study|Adverse Event|3|||
130120583|NCT02984683|468402410|FG000|Overall Study|Withdrawal by Subject|1|||
130120584|NCT02984683|468402411|FG001|Overall Study|Withdrawal by Subject|0|||
130120585|NCT02984683|468402410|FG000|Overall Study|Disease progression|7|||
130120586|NCT02984683|468402411|FG001|Overall Study|Disease progression|9|||
130120587|NCT02742181|468402412|FG000|Overall Study|Physician Decision|1|||
130120588|NCT02742181|468402413|FG001|Overall Study|Physician Decision|0|||
130120589|NCT02739984|468402414|FG000|Overall Study|Sponsor Decision|1|||
130120590|NCT02739984|468402415|FG001|Overall Study|Sponsor Decision|0|||
130120591|NCT02739984|468402414|FG000|Overall Study|Withdrawal by Subject|1|||
130120592|NCT02739984|468402415|FG001|Overall Study|Withdrawal by Subject|1|||
130120593|NCT02739984|468402414|FG000|Overall Study|Death|0|||
130120594|NCT02739984|468402415|FG001|Overall Study|Death|1|||
130120595|NCT02739984|468402414|FG000|Overall Study|Lost to Follow-up|3|||
130120596|NCT02739984|468402415|FG001|Overall Study|Lost to Follow-up|0|||
130120597|NCT02260492|468402416|FG000|Overall Study|Adverse Event|6|||
130120598|NCT02260492|468402417|FG001|Overall Study|Adverse Event|1|||
130120599|NCT02260492|468402418|FG002|Overall Study|Adverse Event|2|||
130120600|NCT02260492|468402416|FG000|Overall Study|Death|0|||
130120601|NCT02260492|468402417|FG001|Overall Study|Death|1|||
130120602|NCT02260492|468402418|FG002|Overall Study|Death|0|||
130120603|NCT02260492|468402416|FG000|Overall Study|Lost to Follow-up|12|||
130120604|NCT02260492|468402417|FG001|Overall Study|Lost to Follow-up|9|||
130120605|NCT02260492|468402418|FG002|Overall Study|Lost to Follow-up|0|||
130120606|NCT02260492|468402416|FG000|Overall Study|Physician Decision|2|||
130120607|NCT02260492|468402417|FG001|Overall Study|Physician Decision|0|||
130120608|NCT02260492|468402418|FG002|Overall Study|Physician Decision|1|||
130120609|NCT02260492|468402416|FG000|Overall Study|Withdrawal by Subject|3|||
130120610|NCT02260492|468402417|FG001|Overall Study|Withdrawal by Subject|2|||
130120611|NCT02260492|468402418|FG002|Overall Study|Withdrawal by Subject|2|||
130120612|NCT02309099|468404741|FG000|Overall Study|Adverse Event|2|||
130120613|NCT02309099|468404742|FG001|Overall Study|Adverse Event|0|||
130120614|NCT02016300|468404743|FG000|Overall Study|Lost to Follow-up|0|||
130120615|NCT02016300|468404744|FG001|Overall Study|Lost to Follow-up|3|||
130120616|NCT06165744|468404745|FG000|Overall Study|Non device-related adverse event|1|||
130120617|NCT05456529|468404746|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
130120618|NCT05456529|468404746|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
130120619|NCT05456529|468404746|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
130120620|NCT05456529|468404746|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
130120621|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
129952153|NCT03605745|467786864|FG000|Overall Study|Study was terminated for business reasons|47|||
129952154|NCT03344458|467786868|FG000|Overall Study|Physician Decision|1|||
129952155|NCT03344458|467786868|FG000|Overall Study|Withdrawal by Subject|16|||
129952156|NCT03344458|467786868|FG000|Overall Study|Other reasons|10|||
129952157|NCT03344458|467786868|FG000|Overall Study|Lost to Follow-up|9|||
129952158|NCT03344458|467786868|FG000|Overall Study|Protocol Violation|3|||
129952159|NCT03884478|467786869|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
129952160|NCT03884478|467786870|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
129952161|NCT03884478|467786871|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
129952162|NCT03884478|467786869|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
129952163|NCT03884478|467786870|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
129952164|NCT03884478|467786871|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
129952165|NCT03884478|467786869|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
129952166|NCT03884478|467786870|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
129952167|NCT03884478|467786871|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
129952168|NCT03884478|467786869|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
129952169|NCT03884478|467786870|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
129952170|NCT03884478|467786871|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
130120622|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
130120623|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Physician Decision|2|||
129952171|NCT01807234|467786874|FG000|Overall Study|Lost to Follow-up|2|||
129952172|NCT01807234|467786875|FG001|Overall Study|Lost to Follow-up|5|||
129952173|NCT01807234|467786876|FG002|Overall Study|Lost to Follow-up|1|||
130120624|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
130120625|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
130120626|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
130120627|NCT05456529|468404746|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
130120628|NCT00797108|468404747|FG000|Overall Study|Adverse Event|1|||
130120629|NCT00797108|468404748|FG001|Overall Study|Adverse Event|0|||
130120630|NCT00797108|468404749|FG002|Overall Study|Adverse Event|3|||
129952174|NCT01807234|467786877|FG003|Overall Study|Lost to Follow-up|1|||
129952175|NCT01807234|467786878|FG004|Overall Study|Lost to Follow-up|1|||
129952176|NCT01807234|467786879|FG005|Overall Study|Lost to Follow-up|2|||
129952177|NCT01807234|467786874|FG000|Overall Study|Withdrawal by Subject|3|||
129952178|NCT01807234|467786875|FG001|Overall Study|Withdrawal by Subject|1|||
129952179|NCT01807234|467786876|FG002|Overall Study|Withdrawal by Subject|1|||
129952180|NCT01807234|467786877|FG003|Overall Study|Withdrawal by Subject|1|||
129952181|NCT01807234|467786878|FG004|Overall Study|Withdrawal by Subject|2|||
129952182|NCT01807234|467786879|FG005|Overall Study|Withdrawal by Subject|1|||
129952183|NCT01807234|467786874|FG000|Overall Study|Lack of Efficacy|0|||
129952184|NCT01807234|467786875|FG001|Overall Study|Lack of Efficacy|0|||
129952185|NCT01807234|467786876|FG002|Overall Study|Lack of Efficacy|0|||
129952186|NCT01807234|467786877|FG003|Overall Study|Lack of Efficacy|0|||
129952187|NCT01807234|467786878|FG004|Overall Study|Lack of Efficacy|1|||
129952188|NCT01807234|467786879|FG005|Overall Study|Lack of Efficacy|1|||
130076850|NCT04159701|468235417|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
130076851|NCT04159701|468235416|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
130076852|NCT04159701|468235417|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
130076853|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
130076854|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
130076855|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
130076856|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
130076857|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
130076858|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
130076859|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
130076860|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
130076861|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
130076862|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
130076863|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
130076864|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
130076865|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
130076866|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
130076867|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
130076868|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
130076869|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
130076870|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
130076871|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
130076872|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
130076873|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
130076874|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
130076875|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
130076876|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
130076877|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
130076878|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
130076879|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
130076880|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
130076881|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
130076882|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
130076883|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
130076884|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
130076885|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
130076886|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
130076887|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
130076888|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
130076889|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
130076890|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
130076891|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
130076892|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
130076893|NCT03605836|468235418|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
130076894|NCT03605836|468235419|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
130076895|NCT03605836|468235420|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
130076896|NCT03605836|468235421|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
130076897|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
129952189|NCT00538629|467786880|FG000|Overall Study|At subject's request|1|||
129952190|NCT00538629|467786880|FG000|Overall Study|Adverse Event|2|||
129952191|NCT00538629|467786880|FG000|Overall Study|Lack of Efficacy|12|||
129952192|NCT00538629|467786880|FG000|Overall Study|Lost to Follow-up|6|||
130120631|NCT00797108|468404747|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
129952193|NCT00538629|467786880|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
129952194|NCT04454125|467786881|FG000|Overall Study|Lost to Follow-up|0|||
129952195|NCT04454125|467786882|FG001|Overall Study|Lost to Follow-up|1|||
129952196|NCT00555620|467786888|FG000|Overall Study|Death|0|||
129952197|NCT00555620|467786889|FG001|Overall Study|Death|1|||
129952198|NCT00555620|467786890|FG002|Overall Study|Death|0|||
129952199|NCT00555620|467786891|FG003|Overall Study|Death|0|||
129952200|NCT00555620|467786892|FG004|Overall Study|Death|0|||
129952201|NCT00555620|467786893|FG005|Overall Study|Death|1|||
129952202|NCT00555620|467786888|FG000|Overall Study|Study terminated by sponsor|0|||
129952203|NCT00555620|467786889|FG001|Overall Study|Study terminated by sponsor|0|||
129952204|NCT00555620|467786890|FG002|Overall Study|Study terminated by sponsor|1|||
129952205|NCT00555620|467786891|FG003|Overall Study|Study terminated by sponsor|0|||
129952206|NCT00555620|467786892|FG004|Overall Study|Study terminated by sponsor|0|||
129952207|NCT00555620|467786893|FG005|Overall Study|Study terminated by sponsor|0|||
129952208|NCT00555620|467786888|FG000|Overall Study|Adverse Event|0|||
129952209|NCT00555620|467786889|FG001|Overall Study|Adverse Event|0|||
129952210|NCT00555620|467786890|FG002|Overall Study|Adverse Event|1|||
129952211|NCT00555620|467786891|FG003|Overall Study|Adverse Event|5|||
129952212|NCT00555620|467786892|FG004|Overall Study|Adverse Event|0|||
129952213|NCT00555620|467786893|FG005|Overall Study|Adverse Event|1|||
129952214|NCT00555620|467786888|FG000|Overall Study|Objective progression or relapse|6|||
129952215|NCT00555620|467786889|FG001|Overall Study|Objective progression or relapse|5|||
129952216|NCT00555620|467786890|FG002|Overall Study|Objective progression or relapse|12|||
129952217|NCT00555620|467786891|FG003|Overall Study|Objective progression or relapse|17|||
129952218|NCT00555620|467786892|FG004|Overall Study|Objective progression or relapse|3|||
129952219|NCT00555620|467786893|FG005|Overall Study|Objective progression or relapse|16|||
129952220|NCT00555620|467786888|FG000|Overall Study|Participant refused treatment|0|||
129952221|NCT00555620|467786889|FG001|Overall Study|Participant refused treatment|1|||
129952222|NCT00555620|467786890|FG002|Overall Study|Participant refused treatment|1|||
129952223|NCT00555620|467786891|FG003|Overall Study|Participant refused treatment|0|||
129952224|NCT00555620|467786892|FG004|Overall Study|Participant refused treatment|0|||
129952225|NCT00555620|467786893|FG005|Overall Study|Participant refused treatment|1|||
129952226|NCT00555620|467786888|FG000|Overall Study|Other|0|||
129952227|NCT00555620|467786889|FG001|Overall Study|Other|0|||
129952228|NCT00555620|467786890|FG002|Overall Study|Other|0|||
129952229|NCT00555620|467786891|FG003|Overall Study|Other|1|||
129952230|NCT00555620|467786892|FG004|Overall Study|Other|0|||
129952231|NCT00555620|467786893|FG005|Overall Study|Other|3|||
129952232|NCT00828139|467786894|FG000|Overall Study|Adverse Event|8|||
129952233|NCT00828139|467786895|FG001|Overall Study|Adverse Event|1|||
129952234|NCT00828139|467786896|FG002|Overall Study|Adverse Event|10|||
129952235|NCT00828139|467786897|FG003|Overall Study|Adverse Event|5|||
129952236|NCT00828139|467786894|FG000|Overall Study|Death|2|||
129952237|NCT00828139|467786895|FG001|Overall Study|Death|1|||
129952238|NCT00828139|467786896|FG002|Overall Study|Death|0|||
129952239|NCT00828139|467786897|FG003|Overall Study|Death|2|||
129952240|NCT00828139|467786894|FG000|Overall Study|Refusal unrelated to toxicity|3|||
129952241|NCT00828139|467786895|FG001|Overall Study|Refusal unrelated to toxicity|4|||
129952242|NCT00828139|467786896|FG002|Overall Study|Refusal unrelated to toxicity|5|||
129952243|NCT00828139|467786897|FG003|Overall Study|Refusal unrelated to toxicity|3|||
129952244|NCT00828139|467786894|FG000|Overall Study|Disease Progression|24|||
129952245|NCT00828139|467786895|FG001|Overall Study|Disease Progression|33|||
129952246|NCT00828139|467786896|FG002|Overall Study|Disease Progression|35|||
129952247|NCT00828139|467786897|FG003|Overall Study|Disease Progression|39|||
129952248|NCT00828139|467786894|FG000|Overall Study|Other|4|||
129952249|NCT00828139|467786895|FG001|Overall Study|Other|2|||
129952250|NCT00828139|467786896|FG002|Overall Study|Other|5|||
129952251|NCT00828139|467786897|FG003|Overall Study|Other|2|||
129952252|NCT01714947|467786898|FG000|Part B|Progressive Disease|3|||
129952253|NCT01922102|467786899|FG000|Overall Study|Withdrawal by Subject|7|||
129952254|NCT01922102|467786900|FG001|Overall Study|Withdrawal by Subject|3|||
129952255|NCT01922102|467786901|FG002|Overall Study|Withdrawal by Subject|7|||
129952256|NCT01922102|467786899|FG000|Overall Study|Physician Decision|0|||
129952257|NCT01922102|467786900|FG001|Overall Study|Physician Decision|2|||
129952258|NCT01922102|467786901|FG002|Overall Study|Physician Decision|1|||
129952259|NCT01922102|467786899|FG000|Overall Study|Adverse Event|1|||
129952260|NCT01922102|467786900|FG001|Overall Study|Adverse Event|2|||
129952261|NCT01922102|467786901|FG002|Overall Study|Adverse Event|0|||
129952262|NCT01922102|467786899|FG000|Overall Study|Lost to Follow-up|1|||
130120632|NCT00797108|468404748|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
130120633|NCT00797108|468404749|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
129952263|NCT01922102|467786900|FG001|Overall Study|Lost to Follow-up|0|||
129952264|NCT01922102|467786901|FG002|Overall Study|Lost to Follow-up|0|||
129952265|NCT01922102|467786899|FG000|Overall Study|Administrative problems|0|||
129952266|NCT01922102|467786900|FG001|Overall Study|Administrative problems|2|||
129952267|NCT01922102|467786901|FG002|Overall Study|Administrative problems|0|||
129952268|NCT05203822|467786902|FG000|Overall Study|Adverse Event|1|||
129952269|NCT05203822|467786902|FG000|Overall Study|Withdrawal by Subject|1|||
129952270|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
129952271|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
129952272|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
129952273|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
129952274|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
129952275|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
129952276|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
129952277|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
129952278|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
129952279|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
129952280|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
129952281|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
129952282|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
129952283|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
129952284|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
129952285|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
129952286|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
129952287|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
129952288|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
129952289|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
129952290|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
129952291|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
129952292|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
129952293|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
129952294|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
129952295|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
129952296|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
129952297|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
129952298|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
129952299|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
129952300|NCT01767376|467786911|FG000|Overall Study|Lost to Follow-up|3|||
129952301|NCT01767376|467786912|FG001|Overall Study|Lost to Follow-up|2|||
129952302|NCT01767376|467786913|FG002|Overall Study|Lost to Follow-up|0|||
129952303|NCT01767376|467786911|FG000|Overall Study|Withdrawal by Subject|1|||
129952304|NCT01767376|467786912|FG001|Overall Study|Withdrawal by Subject|1|||
129952305|NCT01767376|467786913|FG002|Overall Study|Withdrawal by Subject|0|||
129952306|NCT04175834|467786915|FG000|Overall Study|Withdrawal by Subject|1|||
129952307|NCT04175834|467786916|FG001|Overall Study|Withdrawal by Subject|0|||
129952308|NCT03209492|467786919|FG000|Overall Study|Case Report Forms Uncollected|5|||
129952309|NCT01762345|467786920|FG000|Overall Study|Adverse Event|5|||
129952310|NCT01762345|467786920|FG000|Overall Study|Protocol Violation|2|||
129952311|NCT02379078|467786921|FG000|Overall Study|Lost to Follow-up|33|||
129952312|NCT02379078|467786922|FG001|Overall Study|Lost to Follow-up|30|||
129952313|NCT02379078|467786921|FG000|Overall Study|Withdrawal by Subject|6|||
129952314|NCT02379078|467786922|FG001|Overall Study|Withdrawal by Subject|5|||
129952315|NCT04908488|467786923|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
129952316|NCT04908488|467786924|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
129952317|NCT04908488|467786923|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
129952318|NCT04908488|467786924|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
129952319|NCT02959866|467786929|FG000|Overall Study|Withdrawal by Subject|1|||
129952320|NCT00952523|467786930|FG000|Overall Study|Withdrawal by Subject|7|||
129952321|NCT01029925|467786931|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
129952322|NCT01029925|467786931|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
129952323|NCT01029925|467786931|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
129952324|NCT05265247|467786932|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
129952325|NCT05265247|467786933|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
129952326|NCT05265247|467786932|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
129952327|NCT05265247|467786933|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
129952328|NCT05265247|467786932|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
129952329|NCT05265247|467786933|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
129952330|NCT01721109|467786936|FG000|Overall Study|Lack of Efficacy|1|||
129952331|NCT01721109|467786936|FG000|Overall Study|Non- Compliance with Study Drug|3|||
129952332|NCT01721109|467786936|FG000|Overall Study|Withdrew Consent|1|||
129952333|NCT01721109|467786936|FG000|Overall Study|Lost to Follow-up|2|||
129952334|NCT00134056|467786937|FG000|Randomization|Not eligible for assigned treatment|22|||
129952335|NCT00134056|467786938|FG001|Randomization|Not eligible for assigned treatment|20|||
129952336|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
129952337|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
129952338|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
129952339|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
129952340|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
129952341|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
129952342|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
129952343|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
129952344|NCT00321555|467786943|FG000|Overall Study|Developed antibodies|1|||
129952345|NCT00321555|467786943|FG000|Overall Study|Switched to alternative treatment|3|||
129952346|NCT00321555|467786943|FG000|Overall Study|Physician Decision|1|||
129952347|NCT00321555|467786943|FG000|Overall Study|Disease progression on study|1|||
129952348|NCT00537914|467786944|FG000|Overall Study|Death|1|||
129952349|NCT00537914|467786944|FG000|Overall Study|Adverse Event|7|||
129952350|NCT00537914|467786944|FG000|Overall Study|Treatment failure|10|||
129952351|NCT00537914|467786944|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
129952352|NCT00537914|467786944|FG000|Overall Study|Lost to Follow-up|19|||
129952353|NCT00537914|467786944|FG000|Overall Study|Withdrawal of informed consent|59|||
129952354|NCT01468597|467786945|FG000|Overall Study|Found ineligible|17|||
129952355|NCT01468597|467786945|FG000|Overall Study|concomitant valves|12|||
129952356|NCT01468597|467786945|FG000|Overall Study|off-pump CABG|1|||
129952357|NCT01468597|467786945|FG000|Overall Study|no platelet function data|5|||
129952358|NCT02260154|467786946|FG000|Overall Study|Screening failure|2|||
129952359|NCT02561195|467786948|FG000|Vaccination 1 to 3|Adverse Event|4|||
129952360|NCT02561195|467786949|FG001|Vaccination 1 to 3|Adverse Event|5|||
129952361|NCT02561195|467786950|FG002|Vaccination 1 to 3|Adverse Event|0|||
129952362|NCT02561195|467786951|FG003|Vaccination 1 to 3|Adverse Event|3|||
129952363|NCT02561195|467786952|FG004|Vaccination 1 to 3|Adverse Event|4|||
129952364|NCT02561195|467786953|FG005|Vaccination 1 to 3|Adverse Event|0|||
129952365|NCT02561195|467786954|FG006|Vaccination 1 to 3|Adverse Event|0|||
129952366|NCT02561195|467786955|FG007|Vaccination 1 to 3|Adverse Event|0|||
129952367|NCT02561195|467786956|FG008|Vaccination 1 to 3|Adverse Event|0|||
129952368|NCT02561195|467786957|FG009|Vaccination 1 to 3|Adverse Event|0|||
129952369|NCT02561195|467786958|FG010|Vaccination 1 to 3|Adverse Event|0|||
129952370|NCT02561195|467786959|FG011|Vaccination 1 to 3|Adverse Event|0|||
129952371|NCT02561195|467786960|FG012|Vaccination 1 to 3|Adverse Event|0|||
129952372|NCT02561195|467786961|FG013|Vaccination 1 to 3|Adverse Event|0|||
129952373|NCT02561195|467786948|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
129952374|NCT02561195|467786949|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
129952375|NCT02561195|467786950|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
129952376|NCT02561195|467786951|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
129952377|NCT02561195|467786952|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
129952378|NCT02561195|467786953|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
129952379|NCT02561195|467786954|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
129952380|NCT02561195|467786955|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
129952381|NCT02561195|467786956|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
129952382|NCT02561195|467786957|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
129952383|NCT02561195|467786958|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
129952384|NCT02561195|467786959|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
129952385|NCT02561195|467786960|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
129952386|NCT02561195|467786961|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
129952387|NCT02561195|467786948|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952388|NCT02561195|467786949|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
129952389|NCT02561195|467786950|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952390|NCT02561195|467786951|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
129952391|NCT02561195|467786952|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
129952392|NCT02561195|467786953|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
129952393|NCT02561195|467786954|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952394|NCT02561195|467786955|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952395|NCT02561195|467786956|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952396|NCT02561195|467786957|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952397|NCT02561195|467786958|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952398|NCT02561195|467786959|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952399|NCT02561195|467786960|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
130120634|NCT00797108|468404747|FG000|Overall Study|Global Deterioration of Health Status|0|||
129952400|NCT02561195|467786961|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952401|NCT02561195|467786948|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
129952402|NCT02561195|467786949|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
129952403|NCT02561195|467786950|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
129952404|NCT02561195|467786951|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
129952405|NCT02561195|467786952|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
130120635|NCT00797108|468404748|FG001|Overall Study|Global Deterioration of Health Status|1|||
129952406|NCT02561195|467786953|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
129952407|NCT02561195|467786954|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
129952408|NCT02561195|467786955|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
129952409|NCT02561195|467786956|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
129952410|NCT02561195|467786957|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
129952411|NCT02561195|467786958|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
129952412|NCT02561195|467786959|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
129952413|NCT02561195|467786960|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
129952414|NCT02561195|467786961|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
129952415|NCT02561195|467786948|FG000|Vaccination 1 to 3|Other|7|||
129952416|NCT02561195|467786949|FG001|Vaccination 1 to 3|Other|3|||
129952417|NCT02561195|467786950|FG002|Vaccination 1 to 3|Other|1|||
129952418|NCT02561195|467786951|FG003|Vaccination 1 to 3|Other|7|||
129952419|NCT02561195|467786952|FG004|Vaccination 1 to 3|Other|5|||
129952420|NCT02561195|467786953|FG005|Vaccination 1 to 3|Other|1|||
129952421|NCT02561195|467786954|FG006|Vaccination 1 to 3|Other|0|||
129952422|NCT02561195|467786955|FG007|Vaccination 1 to 3|Other|0|||
129952423|NCT02561195|467786956|FG008|Vaccination 1 to 3|Other|0|||
129952424|NCT02561195|467786957|FG009|Vaccination 1 to 3|Other|0|||
129952425|NCT02561195|467786958|FG010|Vaccination 1 to 3|Other|0|||
129952426|NCT02561195|467786959|FG011|Vaccination 1 to 3|Other|0|||
129952427|NCT02561195|467786960|FG012|Vaccination 1 to 3|Other|0|||
129952428|NCT02561195|467786961|FG013|Vaccination 1 to 3|Other|0|||
130120636|NCT00797108|468404749|FG002|Overall Study|Global Deterioration of Health Status|0|||
130120637|NCT00797108|468404747|FG000|Overall Study|Lack of Efficacy|1|||
130120638|NCT00797108|468404748|FG001|Overall Study|Lack of Efficacy|0|||
130120639|NCT00797108|468404749|FG002|Overall Study|Lack of Efficacy|1|||
130120640|NCT00797108|468404747|FG000|Overall Study|Other|0|||
130120641|NCT00797108|468404748|FG001|Overall Study|Other|0|||
130120642|NCT00797108|468404749|FG002|Overall Study|Other|2|||
130120643|NCT00797108|468404747|FG000|Overall Study|Randomized but not Treated|2|||
130120644|NCT00797108|468404748|FG001|Overall Study|Randomized but not Treated|0|||
130120645|NCT00797108|468404749|FG002|Overall Study|Randomized but not Treated|0|||
130120646|NCT02518113|468404750|FG000|Overall Study|Adverse Event|1|||
130120647|NCT02518113|468404751|FG001|Overall Study|Adverse Event|0|||
130120648|NCT02518113|468404752|FG002|Overall Study|Adverse Event|1|||
130120649|NCT02518113|468404753|FG003|Overall Study|Adverse Event|0|||
130120650|NCT02518113|468404750|FG000|Overall Study|Death|1|||
130120651|NCT02518113|468404751|FG001|Overall Study|Death|2|||
129952429|NCT02561195|467786948|FG000|Vaccination 1 to 3|Protocol Violation|1|||
129952430|NCT02561195|467786949|FG001|Vaccination 1 to 3|Protocol Violation|0|||
129952431|NCT02561195|467786950|FG002|Vaccination 1 to 3|Protocol Violation|1|||
129952432|NCT02561195|467786951|FG003|Vaccination 1 to 3|Protocol Violation|2|||
129952433|NCT02561195|467786952|FG004|Vaccination 1 to 3|Protocol Violation|5|||
129952434|NCT02561195|467786953|FG005|Vaccination 1 to 3|Protocol Violation|2|||
130076898|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
130076899|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
130076900|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
130076901|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
130076902|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
130076903|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
130076904|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
130076905|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
130076906|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
130076907|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
130076908|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
130076909|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
130076910|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
130076911|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
130076912|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
130076913|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
130120652|NCT02518113|468404752|FG002|Overall Study|Death|0|||
130120653|NCT02518113|468404753|FG003|Overall Study|Death|0|||
130120654|NCT02518113|468404750|FG000|Overall Study|Physician Decision|0|||
130120655|NCT02518113|468404751|FG001|Overall Study|Physician Decision|1|||
130120656|NCT02518113|468404752|FG002|Overall Study|Physician Decision|0|||
130120657|NCT02518113|468404753|FG003|Overall Study|Physician Decision|0|||
130120658|NCT02518113|468404750|FG000|Overall Study|Progressive Disease|1|||
130120659|NCT02518113|468404751|FG001|Overall Study|Progressive Disease|2|||
130120660|NCT02518113|468404752|FG002|Overall Study|Progressive Disease|3|||
129952435|NCT02561195|467786954|FG006|Vaccination 1 to 3|Protocol Violation|0|||
129952436|NCT02561195|467786955|FG007|Vaccination 1 to 3|Protocol Violation|0|||
130120661|NCT02518113|468404753|FG003|Overall Study|Progressive Disease|0|||
129952437|NCT02561195|467786956|FG008|Vaccination 1 to 3|Protocol Violation|0|||
129952438|NCT02561195|467786957|FG009|Vaccination 1 to 3|Protocol Violation|0|||
130076914|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
130076915|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
130076916|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
130076917|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
130076918|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
130076919|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
130076920|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
130076921|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
130076922|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
130076923|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
130076924|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
130076925|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
130076926|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
130076927|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
130076928|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
130076929|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
130076930|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
130076931|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
130076932|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
130076933|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
130076934|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
130076935|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
130076936|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
130076937|NCT03605836|468235418|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
130076938|NCT03605836|468235419|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
130076939|NCT03605836|468235420|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
130076940|NCT03605836|468235421|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
130120662|NCT02270736|468404754|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130120663|NCT02270736|468404755|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
130120664|NCT02270736|468404756|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130120665|NCT02270736|468404757|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130120666|NCT02270736|468404758|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
130120667|NCT02270736|468404754|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
130120668|NCT02270736|468404755|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
130120669|NCT02270736|468404756|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
130120670|NCT02270736|468404757|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
130120671|NCT02270736|468404758|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
130120672|NCT02270736|468404754|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130120673|NCT02270736|468404755|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
130120674|NCT02270736|468404756|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130120675|NCT02270736|468404757|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130120676|NCT02270736|468404758|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
130120677|NCT02270736|468404754|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130120678|NCT02270736|468404755|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130120679|NCT02270736|468404756|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
130120680|NCT02270736|468404757|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130120681|NCT02270736|468404758|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
130120682|NCT02270736|468404754|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130120683|NCT02270736|468404755|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130120684|NCT02270736|468404756|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130120685|NCT02270736|468404757|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
130120686|NCT02270736|468404758|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
130120687|NCT02270736|468404754|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130120688|NCT02270736|468404755|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130120689|NCT02270736|468404756|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130120690|NCT02270736|468404757|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
130120691|NCT02270736|468404758|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
130120692|NCT02270736|468404754|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130120693|NCT02270736|468404755|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130120694|NCT02270736|468404756|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130120695|NCT02270736|468404757|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
130120696|NCT02270736|468404758|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
130120697|NCT02270736|468404754|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130076941|NCT02057068|468235428|FG000|Overall Study|Withdrawal by Subject|2|||
130120698|NCT02270736|468404755|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130120699|NCT02270736|468404756|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130076942|NCT02057068|468235429|FG001|Overall Study|Withdrawal by Subject|2|||
130076943|NCT02057068|468235428|FG000|Overall Study|Caregiver (CG) Health|0|||
130076944|NCT02057068|468235429|FG001|Overall Study|Caregiver (CG) Health|2|||
130076945|NCT02057068|468235428|FG000|Overall Study|Carepartner (CP) Health|4|||
130076946|NCT02057068|468235429|FG001|Overall Study|Carepartner (CP) Health|2|||
130076947|NCT02057068|468235428|FG000|Overall Study|Lost to Follow-up|2|||
130076948|NCT02057068|468235429|FG001|Overall Study|Lost to Follow-up|2|||
130076949|NCT00865046|468235430|FG000|Overall Study|Lost to Follow-up|1|||
130076950|NCT00865046|468235431|FG001|Overall Study|Lost to Follow-up|4|||
130076951|NCT00865046|468235432|FG002|Overall Study|Lost to Follow-up|0|||
130076952|NCT00865046|468235430|FG000|Overall Study|Death|0|||
130076953|NCT00865046|468235431|FG001|Overall Study|Death|1|||
130076954|NCT00865046|468235432|FG002|Overall Study|Death|1|||
130076955|NCT00865046|468235430|FG000|Overall Study|Withdrawal by Subject|5|||
130076956|NCT00865046|468235431|FG001|Overall Study|Withdrawal by Subject|0|||
130076957|NCT00865046|468235432|FG002|Overall Study|Withdrawal by Subject|0|||
130076958|NCT02977507|468235435|FG000|Overall Study|Protocol Deviation|1|||
130076959|NCT02977507|468235436|FG001|Overall Study|Protocol Deviation|0|||
130076960|NCT02977507|468235435|FG000|Overall Study|Lost to Follow-up|1|||
130076961|NCT02977507|468235436|FG001|Overall Study|Lost to Follow-up|0|||
130076962|NCT00633360|468235439|FG000|Overall Study|Lost to Follow-up|1|||
130076963|NCT00633360|468235440|FG001|Overall Study|Lost to Follow-up|1|||
130076964|NCT00633360|468235439|FG000|Overall Study|Adverse Event|3|||
130076965|NCT00633360|468235440|FG001|Overall Study|Adverse Event|1|||
130076966|NCT00633360|468235439|FG000|Overall Study|Protocol Violation|0|||
130076967|NCT00633360|468235440|FG001|Overall Study|Protocol Violation|1|||
130076968|NCT00481988|468235441|FG000|Overall Study|Withdrawal by Subject|1|||
130076969|NCT00481988|468235442|FG001|Overall Study|Withdrawal by Subject|1|||
130076970|NCT00654420|468235443|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
130076971|NCT00654420|468235444|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
130076972|NCT00654420|468235445|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
130076973|NCT00654420|468235446|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
130076974|NCT00654420|468235443|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
130076975|NCT00654420|468235444|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
130076976|NCT00654420|468235445|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
130076977|NCT00654420|468235446|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
130076978|NCT00654420|468235443|FG000|Phase II|Adverse Event|0|||
130076979|NCT00654420|468235444|FG001|Phase II|Adverse Event|0|||
130076980|NCT00654420|468235445|FG002|Phase II|Adverse Event|3|||
130076981|NCT00654420|468235446|FG003|Phase II|Adverse Event|3|||
130076982|NCT00654420|468235443|FG000|Phase II|Lost to Follow-up|0|||
130076983|NCT00654420|468235444|FG001|Phase II|Lost to Follow-up|0|||
130076984|NCT00654420|468235445|FG002|Phase II|Lost to Follow-up|0|||
130076985|NCT00654420|468235446|FG003|Phase II|Lost to Follow-up|1|||
130076986|NCT00654420|468235443|FG000|Phase II|Physician Decision|0|||
130076987|NCT00654420|468235444|FG001|Phase II|Physician Decision|0|||
130076988|NCT00654420|468235445|FG002|Phase II|Physician Decision|0|||
130076989|NCT00654420|468235446|FG003|Phase II|Physician Decision|4|||
130076990|NCT00654420|468235443|FG000|Phase II|Progressive Disease|0|||
130076991|NCT00654420|468235444|FG001|Phase II|Progressive Disease|0|||
130076992|NCT00654420|468235445|FG002|Phase II|Progressive Disease|29|||
130076993|NCT00654420|468235446|FG003|Phase II|Progressive Disease|29|||
130076994|NCT00654420|468235443|FG000|Phase II|Withdrawal by Subject|0|||
130076995|NCT00654420|468235444|FG001|Phase II|Withdrawal by Subject|0|||
130076996|NCT00654420|468235445|FG002|Phase II|Withdrawal by Subject|4|||
130076997|NCT00654420|468235446|FG003|Phase II|Withdrawal by Subject|1|||
130076998|NCT00654420|468235443|FG000|Phase II|Missing Disposition Record|0|||
130076999|NCT00654420|468235444|FG001|Phase II|Missing Disposition Record|0|||
130077000|NCT00654420|468235445|FG002|Phase II|Missing Disposition Record|1|||
130077001|NCT00654420|468235446|FG003|Phase II|Missing Disposition Record|0|||
130077002|NCT00610207|468235448|FG000|Overall Study|Lost to Follow-up|3|||
130077003|NCT02465489|468235451|FG000|Overall Study|Adverse Event|5|||
130077004|NCT00471276|468235452|FG000|Overall Study|Death|2|||
130077005|NCT00471276|468235452|FG000|Overall Study|Adverse Event|16|||
130077006|NCT00471276|468235452|FG000|Overall Study|Protocol Violation|1|||
130077007|NCT00471276|468235452|FG000|Overall Study|Objective progression or relapse|54|||
130077008|NCT00471276|468235452|FG000|Overall Study|Global deterioration of health status|1|||
130077009|NCT00471276|468235452|FG000|Overall Study|Other|3|||
130077010|NCT00471276|468235452|FG000|Overall Study|Refused treatment|6|||
130077011|NCT00701103|468235453|FG000|Overall Study|Adverse Event|0|||
130077012|NCT00701103|468235454|FG001|Overall Study|Adverse Event|0|||
130077013|NCT00701103|468235455|FG002|Overall Study|Adverse Event|1|||
130077014|NCT00701103|468235456|FG003|Overall Study|Adverse Event|1|||
130077015|NCT00701103|468235457|FG004|Overall Study|Adverse Event|0|||
130077016|NCT00701103|468235458|FG005|Overall Study|Adverse Event|1|||
130077017|NCT00701103|468235459|FG006|Overall Study|Adverse Event|1|||
130077018|NCT00701103|468235460|FG007|Overall Study|Adverse Event|0|||
130077019|NCT00701103|468235461|FG008|Overall Study|Adverse Event|0|||
130077020|NCT00701103|468235462|FG009|Overall Study|Adverse Event|2|||
130077021|NCT00701103|468235463|FG010|Overall Study|Adverse Event|0|||
130077022|NCT00701103|468235453|FG000|Overall Study|Progressive Disease|5|||
130077023|NCT00701103|468235454|FG001|Overall Study|Progressive Disease|2|||
130077024|NCT00701103|468235455|FG002|Overall Study|Progressive Disease|6|||
130077025|NCT00701103|468235456|FG003|Overall Study|Progressive Disease|5|||
130077026|NCT00701103|468235457|FG004|Overall Study|Progressive Disease|6|||
130077027|NCT00701103|468235458|FG005|Overall Study|Progressive Disease|5|||
130077028|NCT00701103|468235459|FG006|Overall Study|Progressive Disease|7|||
130077029|NCT00701103|468235460|FG007|Overall Study|Progressive Disease|7|||
130077030|NCT00701103|468235461|FG008|Overall Study|Progressive Disease|8|||
130077031|NCT00701103|468235462|FG009|Overall Study|Progressive Disease|8|||
130077032|NCT00701103|468235463|FG010|Overall Study|Progressive Disease|11|||
130077033|NCT00701103|468235453|FG000|Overall Study|Withdrawal by Subject|0|||
130077034|NCT00701103|468235454|FG001|Overall Study|Withdrawal by Subject|1|||
130077035|NCT00701103|468235455|FG002|Overall Study|Withdrawal by Subject|1|||
130077036|NCT00701103|468235456|FG003|Overall Study|Withdrawal by Subject|0|||
130077037|NCT00701103|468235457|FG004|Overall Study|Withdrawal by Subject|0|||
130077038|NCT00701103|468235458|FG005|Overall Study|Withdrawal by Subject|0|||
130077039|NCT00701103|468235459|FG006|Overall Study|Withdrawal by Subject|0|||
130077040|NCT00701103|468235460|FG007|Overall Study|Withdrawal by Subject|0|||
130077041|NCT00701103|468235461|FG008|Overall Study|Withdrawal by Subject|0|||
130077042|NCT00701103|468235462|FG009|Overall Study|Withdrawal by Subject|0|||
130077043|NCT00701103|468235463|FG010|Overall Study|Withdrawal by Subject|0|||
130077044|NCT00701103|468235453|FG000|Overall Study|Other|0|||
130077045|NCT00701103|468235454|FG001|Overall Study|Other|0|||
130077046|NCT00701103|468235455|FG002|Overall Study|Other|0|||
130077047|NCT00701103|468235456|FG003|Overall Study|Other|0|||
130077048|NCT00701103|468235457|FG004|Overall Study|Other|0|||
130077049|NCT00701103|468235458|FG005|Overall Study|Other|0|||
130077050|NCT00701103|468235459|FG006|Overall Study|Other|0|||
130077051|NCT00701103|468235460|FG007|Overall Study|Other|0|||
130077052|NCT00701103|468235461|FG008|Overall Study|Other|1|||
130077053|NCT00701103|468235462|FG009|Overall Study|Other|1|||
130077054|NCT00701103|468235463|FG010|Overall Study|Other|0|||
130077055|NCT00179517|468235464|FG000|Overall Study|Withdrawal by Subject|2|||
130077056|NCT00179517|468235465|FG001|Overall Study|Withdrawal by Subject|1|||
130077057|NCT00431496|468235466|FG000|Overall Study|Adverse Event|3|||
130077058|NCT00431496|468235466|FG000|Overall Study|Lost to Follow-up|1|||
130077059|NCT00431496|468235466|FG000|Overall Study|Withdrawal by Subject|2|||
130077060|NCT00431496|468235466|FG000|Overall Study|Protocol-specified criteria|5|||
130077061|NCT01390038|468235467|FG000|Overall Study|Death|1|||
130077062|NCT01390038|468235467|FG000|Overall Study|Lost to Follow-up|1|||
130077063|NCT01390038|468235467|FG000|Overall Study|Withdrawal by Subject|4|||
130077064|NCT01390038|468235467|FG000|Overall Study|Simpliciti System Removal|2|||
130077065|NCT00814307|468235469|FG000|Overall Study|Randomized but not treated|1|||
130077066|NCT00814307|468235470|FG001|Overall Study|Randomized but not treated|0|||
130077067|NCT00814307|468235471|FG002|Overall Study|Randomized but not treated|0|||
130077068|NCT00814307|468235472|FG003|Overall Study|Randomized but not treated|0|||
130077069|NCT00814307|468235469|FG000|Overall Study|Adverse Event|3|||
130077070|NCT00814307|468235470|FG001|Overall Study|Adverse Event|9|||
130077071|NCT00814307|468235471|FG002|Overall Study|Adverse Event|3|||
130077072|NCT00814307|468235472|FG003|Overall Study|Adverse Event|2|||
130077073|NCT00814307|468235469|FG000|Overall Study|Lack of Efficacy|1|||
130077074|NCT00814307|468235470|FG001|Overall Study|Lack of Efficacy|1|||
130077075|NCT00814307|468235471|FG002|Overall Study|Lack of Efficacy|3|||
130077076|NCT00814307|468235472|FG003|Overall Study|Lack of Efficacy|4|||
130077077|NCT00814307|468235469|FG000|Overall Study|Other|1|||
130077078|NCT00814307|468235470|FG001|Overall Study|Other|2|||
130077079|NCT00814307|468235471|FG002|Overall Study|Other|0|||
130077080|NCT00814307|468235472|FG003|Overall Study|Other|1|||
130077081|NCT00814307|468235469|FG000|Overall Study|Protocol Violation|2|||
130077082|NCT00814307|468235470|FG001|Overall Study|Protocol Violation|8|||
130077083|NCT00814307|468235471|FG002|Overall Study|Protocol Violation|1|||
130077084|NCT00814307|468235472|FG003|Overall Study|Protocol Violation|1|||
130077085|NCT00814307|468235469|FG000|Overall Study|Withdrawal by Subject|4|||
130077086|NCT00814307|468235470|FG001|Overall Study|Withdrawal by Subject|6|||
130077087|NCT00814307|468235471|FG002|Overall Study|Withdrawal by Subject|0|||
130077088|NCT00814307|468235472|FG003|Overall Study|Withdrawal by Subject|2|||
130077089|NCT00814307|468235469|FG000|Overall Study|Death|0|||
130077090|NCT00814307|468235470|FG001|Overall Study|Death|1|||
130077091|NCT00814307|468235471|FG002|Overall Study|Death|0|||
130077092|NCT00814307|468235472|FG003|Overall Study|Death|0|||
130077093|NCT02290340|468235474|FG000|Overall Study|Lost to Follow-up|0|||
130077094|NCT02290340|468235475|FG001|Overall Study|Lost to Follow-up|0|||
130077095|NCT02290340|468235476|FG002|Overall Study|Lost to Follow-up|0|||
130077096|NCT02290340|468235477|FG003|Overall Study|Lost to Follow-up|1|||
130077097|NCT02290340|468235474|FG000|Overall Study|Withdrawal by Subject|1|||
130077098|NCT02290340|468235475|FG001|Overall Study|Withdrawal by Subject|0|||
130077099|NCT02290340|468235476|FG002|Overall Study|Withdrawal by Subject|0|||
130077100|NCT02290340|468235477|FG003|Overall Study|Withdrawal by Subject|0|||
130077101|NCT02290340|468235474|FG000|Overall Study|Other|1|||
129952439|NCT02561195|467786958|FG010|Vaccination 1 to 3|Protocol Violation|0|||
129952440|NCT02561195|467786959|FG011|Vaccination 1 to 3|Protocol Violation|0|||
129952441|NCT02561195|467786960|FG012|Vaccination 1 to 3|Protocol Violation|0|||
129952442|NCT02561195|467786961|FG013|Vaccination 1 to 3|Protocol Violation|0|||
129952443|NCT02561195|467786948|FG000|Vaccination 1 to 3|Death|2|||
129952444|NCT02561195|467786949|FG001|Vaccination 1 to 3|Death|1|||
129952445|NCT02561195|467786950|FG002|Vaccination 1 to 3|Death|0|||
129952446|NCT02561195|467786951|FG003|Vaccination 1 to 3|Death|2|||
129952447|NCT02561195|467786952|FG004|Vaccination 1 to 3|Death|0|||
129952448|NCT02561195|467786953|FG005|Vaccination 1 to 3|Death|0|||
129952449|NCT02561195|467786954|FG006|Vaccination 1 to 3|Death|0|||
129952450|NCT02561195|467786955|FG007|Vaccination 1 to 3|Death|0|||
129952451|NCT02561195|467786956|FG008|Vaccination 1 to 3|Death|0|||
129952452|NCT02561195|467786957|FG009|Vaccination 1 to 3|Death|0|||
129952453|NCT02561195|467786958|FG010|Vaccination 1 to 3|Death|0|||
129952454|NCT02561195|467786959|FG011|Vaccination 1 to 3|Death|0|||
129952455|NCT02561195|467786960|FG012|Vaccination 1 to 3|Death|0|||
129952456|NCT02561195|467786961|FG013|Vaccination 1 to 3|Death|0|||
129952457|NCT02561195|467786948|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
129952458|NCT02561195|467786949|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
129952459|NCT02561195|467786950|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
129952460|NCT02561195|467786951|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
129952461|NCT02561195|467786952|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
129952462|NCT02561195|467786953|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952463|NCT02561195|467786954|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952464|NCT02561195|467786955|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952465|NCT02561195|467786956|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952466|NCT02561195|467786957|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952467|NCT02561195|467786958|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952468|NCT02561195|467786959|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952469|NCT02561195|467786960|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952470|NCT02561195|467786961|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952471|NCT02561195|467786948|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
129952472|NCT02561195|467786949|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
129952473|NCT02561195|467786950|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
129952474|NCT02561195|467786951|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
129952475|NCT02561195|467786952|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
129952476|NCT02561195|467786953|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
129952477|NCT02561195|467786954|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
129952478|NCT02561195|467786955|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
129952479|NCT02561195|467786956|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
129952480|NCT02561195|467786957|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
129952481|NCT02561195|467786958|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
129952482|NCT02561195|467786959|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
129952483|NCT02561195|467786960|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
129952484|NCT02561195|467786961|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
129952485|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952486|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952487|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952488|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952489|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952490|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952491|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952492|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952493|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
129952494|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
129952495|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
129952496|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
129952497|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
129952498|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952499|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952500|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952501|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952502|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952503|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
130077102|NCT02290340|468235475|FG001|Overall Study|Other|0|||
129952504|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952505|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952506|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952507|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952508|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
130077103|NCT02290340|468235476|FG002|Overall Study|Other|0|||
129952509|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
130077104|NCT02290340|468235477|FG003|Overall Study|Other|1|||
129952510|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
130077105|NCT04315298|468237869|FG000|Overall Study|Withdrawal by Subject|0|||
130077106|NCT04315298|468237870|FG001|Overall Study|Withdrawal by Subject|0|||
130077107|NCT04315298|468237871|FG002|Overall Study|Withdrawal by Subject|0|||
130077108|NCT04315298|468237872|FG003|Overall Study|Withdrawal by Subject|2|||
130077109|NCT04315298|468237873|FG004|Overall Study|Withdrawal by Subject|2|||
130077110|NCT04315298|468237874|FG005|Overall Study|Withdrawal by Subject|2|||
130077111|NCT04315298|468237875|FG006|Overall Study|Withdrawal by Subject|0|||
130077112|NCT04315298|468237876|FG007|Overall Study|Withdrawal by Subject|1|||
130077113|NCT04315298|468237877|FG008|Overall Study|Withdrawal by Subject|1|||
130077114|NCT04315298|468237878|FG009|Overall Study|Withdrawal by Subject|1|||
130077115|NCT04315298|468237879|FG010|Overall Study|Withdrawal by Subject|0|||
130077116|NCT04315298|468237880|FG011|Overall Study|Withdrawal by Subject|0|||
130077117|NCT04315298|468237881|FG012|Overall Study|Withdrawal by Subject|0|||
130077118|NCT04315298|468237882|FG013|Overall Study|Withdrawal by Subject|0|||
130077119|NCT04315298|468237883|FG014|Overall Study|Withdrawal by Subject|0|||
130077120|NCT04315298|468237884|FG015|Overall Study|Withdrawal by Subject|0|||
130077121|NCT04315298|468237885|FG016|Overall Study|Withdrawal by Subject|0|||
130077122|NCT04315298|468237886|FG017|Overall Study|Withdrawal by Subject|0|||
130077123|NCT04315298|468237887|FG018|Overall Study|Withdrawal by Subject|0|||
130077124|NCT04315298|468237869|FG000|Overall Study|Physician Decision|0|||
130077125|NCT04315298|468237870|FG001|Overall Study|Physician Decision|0|||
130077126|NCT04315298|468237871|FG002|Overall Study|Physician Decision|0|||
130077127|NCT04315298|468237872|FG003|Overall Study|Physician Decision|0|||
130077128|NCT04315298|468237873|FG004|Overall Study|Physician Decision|1|||
130077129|NCT04315298|468237874|FG005|Overall Study|Physician Decision|0|||
130077130|NCT04315298|468237875|FG006|Overall Study|Physician Decision|0|||
130077131|NCT04315298|468237876|FG007|Overall Study|Physician Decision|0|||
130077132|NCT04315298|468237877|FG008|Overall Study|Physician Decision|0|||
130077133|NCT04315298|468237878|FG009|Overall Study|Physician Decision|0|||
130077134|NCT04315298|468237879|FG010|Overall Study|Physician Decision|0|||
130077135|NCT04315298|468237880|FG011|Overall Study|Physician Decision|0|||
130077136|NCT04315298|468237881|FG012|Overall Study|Physician Decision|0|||
130077137|NCT04315298|468237882|FG013|Overall Study|Physician Decision|0|||
130077138|NCT04315298|468237883|FG014|Overall Study|Physician Decision|0|||
130077139|NCT04315298|468237884|FG015|Overall Study|Physician Decision|0|||
130077140|NCT04315298|468237885|FG016|Overall Study|Physician Decision|0|||
130077141|NCT04315298|468237886|FG017|Overall Study|Physician Decision|0|||
130077142|NCT04315298|468237887|FG018|Overall Study|Physician Decision|0|||
130077143|NCT04315298|468237869|FG000|Overall Study|Lost to Follow-up|5|||
130077144|NCT04315298|468237870|FG001|Overall Study|Lost to Follow-up|10|||
130077145|NCT04315298|468237871|FG002|Overall Study|Lost to Follow-up|6|||
130077146|NCT04315298|468237872|FG003|Overall Study|Lost to Follow-up|8|||
130077147|NCT04315298|468237873|FG004|Overall Study|Lost to Follow-up|12|||
130077148|NCT04315298|468237874|FG005|Overall Study|Lost to Follow-up|13|||
130077149|NCT04315298|468237875|FG006|Overall Study|Lost to Follow-up|9|||
130077150|NCT04315298|468237876|FG007|Overall Study|Lost to Follow-up|16|||
130077151|NCT04315298|468237877|FG008|Overall Study|Lost to Follow-up|14|||
130077152|NCT04315298|468237878|FG009|Overall Study|Lost to Follow-up|0|||
130077153|NCT04315298|468237879|FG010|Overall Study|Lost to Follow-up|2|||
130077154|NCT04315298|468237880|FG011|Overall Study|Lost to Follow-up|1|||
130077155|NCT04315298|468237881|FG012|Overall Study|Lost to Follow-up|0|||
130077156|NCT04315298|468237882|FG013|Overall Study|Lost to Follow-up|0|||
130077157|NCT04315298|468237883|FG014|Overall Study|Lost to Follow-up|0|||
130077158|NCT04315298|468237884|FG015|Overall Study|Lost to Follow-up|2|||
130077159|NCT04315298|468237885|FG016|Overall Study|Lost to Follow-up|0|||
130077160|NCT04315298|468237886|FG017|Overall Study|Lost to Follow-up|0|||
130077161|NCT04315298|468237887|FG018|Overall Study|Lost to Follow-up|0|||
130077162|NCT04315298|468237869|FG000|Overall Study|Death|24|||
130077163|NCT04315298|468237870|FG001|Overall Study|Death|60|||
130077164|NCT04315298|468237871|FG002|Overall Study|Death|49|||
130077165|NCT04315298|468237872|FG003|Overall Study|Death|59|||
130077166|NCT04315298|468237873|FG004|Overall Study|Death|70|||
130077167|NCT04315298|468237874|FG005|Overall Study|Death|114|||
130077168|NCT04315298|468237875|FG006|Overall Study|Death|9|||
130077169|NCT04315298|468237876|FG007|Overall Study|Death|12|||
130077170|NCT04315298|468237877|FG008|Overall Study|Death|21|||
130077171|NCT04315298|468237878|FG009|Overall Study|Death|16|||
130077172|NCT04315298|468237879|FG010|Overall Study|Death|40|||
130077173|NCT04315298|468237880|FG011|Overall Study|Death|40|||
130077174|NCT04315298|468237881|FG012|Overall Study|Death|3|||
130077175|NCT04315298|468237882|FG013|Overall Study|Death|4|||
130077176|NCT04315298|468237883|FG014|Overall Study|Death|6|||
130077177|NCT04315298|468237884|FG015|Overall Study|Death|4|||
130077178|NCT04315298|468237885|FG016|Overall Study|Death|3|||
130077179|NCT04315298|468237886|FG017|Overall Study|Death|1|||
130077180|NCT04315298|468237887|FG018|Overall Study|Death|0|||
130077181|NCT00736385|468237888|FG000|Overall Study|Withdrawal by Subject|2|||
130077182|NCT00736385|468237889|FG001|Overall Study|Withdrawal by Subject|2|||
130077183|NCT00736385|468237888|FG000|Overall Study|Adverse Event|0|||
130077184|NCT00736385|468237889|FG001|Overall Study|Adverse Event|1|||
130077185|NCT01183104|468237890|FG000|Overall Study|Adverse Event|8|||
129952511|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952512|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
129952513|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Death|0|||
129952514|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Death|0|||
129952515|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Death|0|||
129952516|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Death|0|||
129952517|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Death|0|||
129952518|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Death|0|||
129952519|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Death|0|||
129952520|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Death|0|||
129952521|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Death|0|||
129952522|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Death|1|||
129952523|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Death|0|||
129952524|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Death|0|||
129952525|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Death|0|||
129952526|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Death|0|||
129952527|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952528|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952529|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952530|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952531|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952532|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952533|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952534|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952535|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952536|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952537|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
129952538|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952539|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
129952540|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952541|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952542|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952543|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952544|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952545|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952546|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952547|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952548|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952549|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952550|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952551|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952552|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
129952553|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
129952554|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
129952555|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Other|0|||
129952556|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Other|0|||
129952557|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Other|0|||
129952558|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Other|0|||
129952559|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Other|0|||
129952560|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Other|0|||
129952561|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Other|0|||
129952562|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Other|0|||
129952563|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Other|0|||
129952564|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Other|0|||
129952565|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Other|2|||
129952566|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Other|2|||
129952567|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Other|1|||
129952568|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Other|0|||
129952569|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952570|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952571|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952572|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952573|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952574|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952575|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
129952576|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952577|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952578|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
130120700|NCT02270736|468404757|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
130120701|NCT02270736|468404758|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
130120702|NCT02270736|468404754|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130120703|NCT02270736|468404755|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130120704|NCT02270736|468404756|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130120705|NCT02270736|468404757|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
130120706|NCT02270736|468404758|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
130120707|NCT01631864|468404759|FG000|Overall Study|Withdrawal by Subject|0|||
130120708|NCT01631864|468404760|FG001|Overall Study|Withdrawal by Subject|1|||
130120709|NCT01631864|468404759|FG000|Overall Study|Adverse Event|2|||
130120710|NCT01631864|468404760|FG001|Overall Study|Adverse Event|3|||
130120711|NCT03702621|468404783|FG000|Overall Study|Physician Decision|6|||
130120712|NCT03702621|468404784|FG001|Overall Study|Physician Decision|6|||
130120713|NCT00527423|468404785|FG000|Overall Study|Protocol Violation|1|||
130120714|NCT00527423|468404785|FG000|Overall Study|Adverse Event|5|||
130120715|NCT00527423|468404785|FG000|Overall Study|Physician Decision|4|||
130120716|NCT00527423|468404785|FG000|Overall Study|Withdrawal by Subject|10|||
130120717|NCT00527423|468404785|FG000|Overall Study|Lost to Follow-up|4|||
130120718|NCT00527423|468404785|FG000|Overall Study|OTHER|4|||
130120719|NCT00527423|468404785|FG000|Overall Study|Death|9|||
130120720|NCT03194464|468404787|FG000|Overall Study|data not usable|2|||
130120721|NCT03103100|468404788|FG000|Overall Study|Adverse Event|1|||
130120722|NCT03103100|468404789|FG001|Overall Study|Adverse Event|0|||
130120723|NCT03103100|468404790|FG002|Overall Study|Adverse Event|0|||
129952579|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
129952580|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
130077186|NCT01183104|468237891|FG001|Overall Study|Adverse Event|6|||
130077187|NCT01183104|468237890|FG000|Overall Study|Death|0|||
130077188|NCT01183104|468237891|FG001|Overall Study|Death|1|||
130077189|NCT01183104|468237890|FG000|Overall Study|Lost to Follow-up|14|||
130077190|NCT01183104|468237891|FG001|Overall Study|Lost to Follow-up|7|||
130077191|NCT01183104|468237890|FG000|Overall Study|Physician Decision|5|||
130077192|NCT01183104|468237891|FG001|Overall Study|Physician Decision|8|||
130077193|NCT01183104|468237890|FG000|Overall Study|Withdrawal by Subject|6|||
130077194|NCT01183104|468237891|FG001|Overall Study|Withdrawal by Subject|11|||
130077195|NCT01183104|468237890|FG000|Overall Study|Nonparticipation in Extension Study|39|||
130077196|NCT01183104|468237891|FG001|Overall Study|Nonparticipation in Extension Study|50|||
130077197|NCT01183104|468237890|FG000|Overall Study|Did not receive study drug|5|||
130077198|NCT01183104|468237891|FG001|Overall Study|Did not receive study drug|9|||
130077199|NCT03267511|468237892|FG000|Overall Study|Lost to Follow-up|0|||
130077200|NCT03267511|468237893|FG001|Overall Study|Lost to Follow-up|0|||
130120724|NCT03103100|468404788|FG000|Overall Study|Physician Decision|1|||
129952581|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952582|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
129952583|NCT03905512|467786962|FG000|Overall Study|Withdrawal by Subject|9|||
129952584|NCT03905512|467786963|FG001|Overall Study|Withdrawal by Subject|8|||
129952585|NCT03905512|467786962|FG000|Overall Study|Adverse Event|1|||
129952586|NCT03905512|467786963|FG001|Overall Study|Adverse Event|2|||
129952587|NCT03905512|467786962|FG000|Overall Study|Lost to Follow-up|4|||
129952588|NCT03905512|467786963|FG001|Overall Study|Lost to Follow-up|3|||
129952589|NCT03905512|467786962|FG000|Overall Study|Other than Specified|7|||
129952590|NCT03905512|467786963|FG001|Overall Study|Other than Specified|4|||
129952591|NCT00866619|467786964|FG000|Overall Study|Adverse Event|112|||
129952592|NCT00866619|467786965|FG001|Overall Study|Adverse Event|106|||
129952593|NCT00866619|467786966|FG002|Overall Study|Adverse Event|47|||
129952594|NCT00866619|467786967|FG003|Overall Study|Adverse Event|44|||
129952595|NCT00866619|467786964|FG000|Overall Study|Protocol Violation|2|||
129952596|NCT00866619|467786965|FG001|Overall Study|Protocol Violation|39|||
129952597|NCT00866619|467786966|FG002|Overall Study|Protocol Violation|2|||
129952598|NCT00866619|467786967|FG003|Overall Study|Protocol Violation|17|||
129952599|NCT00866619|467786964|FG000|Overall Study|Withdrawal by Subject|587|||
129952600|NCT00866619|467786965|FG001|Overall Study|Withdrawal by Subject|295|||
129952601|NCT00866619|467786966|FG002|Overall Study|Withdrawal by Subject|272|||
129952602|NCT00866619|467786967|FG003|Overall Study|Withdrawal by Subject|144|||
130077201|NCT03267511|468237894|FG002|Overall Study|Lost to Follow-up|0|||
130120725|NCT03103100|468404789|FG001|Overall Study|Physician Decision|0|||
130120726|NCT03103100|468404790|FG002|Overall Study|Physician Decision|2|||
129952603|NCT00866619|467786964|FG000|Overall Study|Lost to Follow-up|1145|||
129952604|NCT00866619|467786965|FG001|Overall Study|Lost to Follow-up|830|||
129952605|NCT00866619|467786966|FG002|Overall Study|Lost to Follow-up|568|||
129952606|NCT00866619|467786967|FG003|Overall Study|Lost to Follow-up|425|||
130077202|NCT03267511|468237895|FG003|Overall Study|Lost to Follow-up|1|||
130077203|NCT01594749|468237896|FG000|Overall Study|Adverse Event|2|||
130077204|NCT01594749|468237897|FG001|Overall Study|Adverse Event|1|||
130077205|NCT01594749|468237896|FG000|Overall Study|Withdrawal by Subject|2|||
130120727|NCT00436007|468404793|FG000|Overall Study|Withdrawal by Subject|5|||
129952607|NCT03560206|467786968|FG000|Overall Study|Lost to Follow-up|19|||
130077206|NCT01594749|468237897|FG001|Overall Study|Withdrawal by Subject|2|||
130077207|NCT01594749|468237896|FG000|Overall Study|Protocol Violation|2|||
130077208|NCT01594749|468237897|FG001|Overall Study|Protocol Violation|0|||
130077209|NCT01594749|468237896|FG000|Overall Study|Physician Decision|1|||
130077210|NCT01594749|468237897|FG001|Overall Study|Physician Decision|1|||
130077211|NCT01594749|468237896|FG000|Overall Study|Non-compliance with Protocol|0|||
130077212|NCT01594749|468237897|FG001|Overall Study|Non-compliance with Protocol|1|||
130077213|NCT01594749|468237896|FG000|Overall Study|Lost to Follow-up|1|||
130077214|NCT01594749|468237897|FG001|Overall Study|Lost to Follow-up|0|||
130077215|NCT01594749|468237896|FG000|Overall Study|Death|9|||
130077216|NCT01594749|468237897|FG001|Overall Study|Death|3|||
130077217|NCT01594749|468237896|FG000|Overall Study|Not Treated|4|||
130077218|NCT01594749|468237897|FG001|Overall Study|Not Treated|10|||
130077219|NCT01594749|468237896|FG000|Overall Study|Lost Source Documentation|1|||
130077220|NCT01594749|468237897|FG001|Overall Study|Lost Source Documentation|0|||
130077221|NCT00364351|468237898|FG000|Overall Study|Adverse Event|90|||
130077222|NCT00364351|468237899|FG001|Overall Study|Adverse Event|44|||
130077223|NCT00364351|468237898|FG000|Overall Study|Condition under investigation worsened|469|||
130077224|NCT00364351|468237899|FG001|Overall Study|Condition under investigation worsened|497|||
130077225|NCT00364351|468237898|FG000|Overall Study|Prohibited concomitant medication|0|||
130077226|NCT00364351|468237899|FG001|Overall Study|Prohibited concomitant medication|2|||
130077227|NCT00364351|468237898|FG000|Overall Study|Lost to Follow-up|1|||
130077228|NCT00364351|468237899|FG001|Overall Study|Lost to Follow-up|1|||
130077229|NCT00364351|468237898|FG000|Overall Study|Withdrawal by Subject|30|||
130077230|NCT00364351|468237899|FG001|Overall Study|Withdrawal by Subject|29|||
130077231|NCT00364351|468237898|FG000|Overall Study|Incorrect enrollment|1|||
130077232|NCT00364351|468237899|FG001|Overall Study|Incorrect enrollment|1|||
130077233|NCT00364351|468237898|FG000|Overall Study|Sponsor decision|1|||
130077234|NCT00364351|468237899|FG001|Overall Study|Sponsor decision|0|||
130077235|NCT00364351|468237898|FG000|Overall Study|Poor treatment compliance|0|||
130077236|NCT00364351|468237899|FG001|Overall Study|Poor treatment compliance|3|||
130077237|NCT00364351|468237898|FG000|Overall Study|Investigator error|0|||
130077238|NCT00364351|468237899|FG001|Overall Study|Investigator error|2|||
130077239|NCT00364351|468237898|FG000|Overall Study|Patient could not travel to site|0|||
130077240|NCT00364351|468237899|FG001|Overall Study|Patient could not travel to site|1|||
130077241|NCT00364351|468237898|FG000|Overall Study|Randomised treatment not started|0|||
130077242|NCT00364351|468237899|FG001|Overall Study|Randomised treatment not started|3|||
130077243|NCT00922974|468237900|FG000|Phase II Component|Protocol Violation|2|||
130077244|NCT00922974|468237901|FG001|Phase II Component|Protocol Violation|0|||
130077245|NCT00922974|468237900|FG000|Phase II Component|Not evaluable for treatment review|5|||
130077246|NCT00922974|468237901|FG001|Phase II Component|Not evaluable for treatment review|0|||
130077247|NCT00922974|468237900|FG000|Phase III Component|Protocol Violation|8|||
130077248|NCT00922974|468237901|FG001|Phase III Component|Protocol Violation|6|||
130077249|NCT02177786|468237902|FG000|Overall Study|Withdrew Consent|2|||
130077250|NCT02177786|468237903|FG001|Overall Study|Withdrew Consent|6|||
130077251|NCT02177786|468237904|FG002|Overall Study|Withdrew Consent|9|||
130077252|NCT02177786|468237905|FG003|Overall Study|Withdrew Consent|5|||
130077253|NCT02177786|468237902|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
130077254|NCT02177786|468237903|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
130077255|NCT02177786|468237904|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
130077256|NCT02177786|468237905|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
130077257|NCT02177786|468237902|FG000|Overall Study|Adverse Event|1|||
130077258|NCT02177786|468237903|FG001|Overall Study|Adverse Event|1|||
130077259|NCT02177786|468237904|FG002|Overall Study|Adverse Event|2|||
130077260|NCT02177786|468237905|FG003|Overall Study|Adverse Event|3|||
130077261|NCT02177786|468237902|FG000|Overall Study|Death|1|||
130077262|NCT02177786|468237903|FG001|Overall Study|Death|1|||
130077263|NCT02177786|468237904|FG002|Overall Study|Death|1|||
130077264|NCT02177786|468237905|FG003|Overall Study|Death|1|||
130077265|NCT02177786|468237902|FG000|Overall Study|Lost to Follow-up|0|||
130077266|NCT02177786|468237903|FG001|Overall Study|Lost to Follow-up|0|||
130077267|NCT02177786|468237904|FG002|Overall Study|Lost to Follow-up|2|||
130077268|NCT02177786|468237905|FG003|Overall Study|Lost to Follow-up|2|||
130077269|NCT02177786|468237902|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130077270|NCT02177786|468237903|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130077271|NCT02177786|468237904|FG002|Overall Study|Non-Compliance with Study Drug|0|||
130077272|NCT02177786|468237905|FG003|Overall Study|Non-Compliance with Study Drug|1|||
130077273|NCT02177786|468237902|FG000|Overall Study|Protocol Violation|0|||
130077274|NCT02177786|468237903|FG001|Overall Study|Protocol Violation|0|||
130077275|NCT02177786|468237904|FG002|Overall Study|Protocol Violation|2|||
130077276|NCT02177786|468237905|FG003|Overall Study|Protocol Violation|0|||
130077277|NCT02177786|468237902|FG000|Overall Study|Progressive Disease|0|||
130077278|NCT02177786|468237903|FG001|Overall Study|Progressive Disease|1|||
130077279|NCT02177786|468237904|FG002|Overall Study|Progressive Disease|0|||
130077280|NCT02177786|468237905|FG003|Overall Study|Progressive Disease|0|||
130077281|NCT02177786|468237902|FG000|Overall Study|Missing study completion status|0|||
130077282|NCT02177786|468237903|FG001|Overall Study|Missing study completion status|1|||
130077283|NCT02177786|468237904|FG002|Overall Study|Missing study completion status|0|||
130077284|NCT02177786|468237905|FG003|Overall Study|Missing study completion status|0|||
130077285|NCT03950440|468237906|FG000|Overall Study|Death|8|||
130077286|NCT03950440|468237907|FG001|Overall Study|Death|2|||
130077287|NCT03950440|468237908|FG002|Overall Study|Death|1|||
130077288|NCT00439309|468237909|FG000|Follow-Up|Death|1|||
130077289|NCT00439309|468237910|FG001|Follow-Up|Death|0|||
130077290|NCT00439309|468237909|FG000|Follow-Up|Lost to Follow-up|2|||
130077291|NCT00439309|468237910|FG001|Follow-Up|Lost to Follow-up|0|||
130077292|NCT00439309|468237909|FG000|Follow-Up|Withdrawal by Subject|0|||
130077293|NCT00439309|468237910|FG001|Follow-Up|Withdrawal by Subject|1|||
130077294|NCT00439309|468237909|FG000|Follow-Up|Late response by subject|0|||
130077295|NCT00439309|468237910|FG001|Follow-Up|Late response by subject|1|||
130077296|NCT00430027|468237911|FG000|Overall Study|Study terminated|8|||
130077297|NCT01957215|468237912|FG000|Overall Study|Adverse Event|2|||
130077298|NCT01957215|468237913|FG001|Overall Study|Adverse Event|2|||
130077299|NCT01957215|468237912|FG000|Overall Study|Lost to Follow-up|3|||
130077300|NCT01957215|468237913|FG001|Overall Study|Lost to Follow-up|3|||
130077301|NCT01957215|468237912|FG000|Overall Study|Protocol Violation|1|||
130077302|NCT01957215|468237913|FG001|Overall Study|Protocol Violation|2|||
130077303|NCT01957215|468237912|FG000|Overall Study|Withdrawal by Subject|7|||
130077304|NCT01957215|468237913|FG001|Overall Study|Withdrawal by Subject|5|||
130077305|NCT01977040|468237914|FG000|Overall Study|Vasa previa not confirmed|2|||
130077306|NCT00634751|468237920|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
130077307|NCT00634751|468237921|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
130077308|NCT00634751|468237922|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
130077309|NCT00634751|468237923|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
130077310|NCT00634751|468237920|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
130077311|NCT00634751|468237921|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
130077312|NCT00634751|468237922|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
130077313|NCT00634751|468237923|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
130077314|NCT00634751|468237920|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
130077315|NCT00634751|468237921|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
130077316|NCT00634751|468237922|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
130077317|NCT00634751|468237923|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
130077318|NCT04402385|468237926|FG000|Overall Study|Withdrawal by Subject|4|||
130077319|NCT04402385|468237927|FG001|Overall Study|Withdrawal by Subject|4|||
130077320|NCT04402385|468237926|FG000|Overall Study|Lost to Follow-up|1|||
130077321|NCT04402385|468237927|FG001|Overall Study|Lost to Follow-up|1|||
130077322|NCT04402385|468237926|FG000|Overall Study|Physician Decision|0|||
130077323|NCT04402385|468237927|FG001|Overall Study|Physician Decision|1|||
130077324|NCT00088595|468237928|FG000|Overall Study|Adverse Event|11|||
130077325|NCT00088595|468237928|FG000|Overall Study|Withdrawal by Subject|8|||
130077326|NCT00088595|468237928|FG000|Overall Study|Ongoing (After Core)|7|||
130077327|NCT00088595|468237928|FG000|Overall Study|New Cancer Therapy|2|||
130077328|NCT01308853|468237934|FG000|Overall Study|Adverse Event|1|||
130077329|NCT01308853|468237934|FG000|Overall Study|Lost to Follow-up|2|||
130077330|NCT01308853|468237934|FG000|Overall Study|Insertion of permanent implants|1|||
130077331|NCT01473355|468237938|FG000|Overall Study|Protocol Violation|2|||
130077332|NCT01473355|468237938|FG000|Overall Study|Adverse Event|2|||
130077333|NCT01473355|468237938|FG000|Overall Study|Lost to Follow-up|2|||
130077334|NCT01119963|468237939|FG000|Overall Study|Lost to Follow-up|1|||
130077335|NCT01119963|468237940|FG001|Overall Study|Lost to Follow-up|1|||
130077336|NCT02603172|468237941|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077337|NCT02603172|468237942|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077338|NCT02603172|468237943|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
130077339|NCT02603172|468237944|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077340|NCT02603172|468237945|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077341|NCT02603172|468237946|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077342|NCT02603172|468237947|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077343|NCT02603172|468237948|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
130077344|NCT01047436|468237949|FG000|Overall Study|Protocol Violation|1|||
130077345|NCT01047436|468237950|FG001|Overall Study|Protocol Violation|0|||
130077346|NCT00939341|468237951|FG000|Overall Study|Adverse Event|15|||
130077347|NCT00939341|468237951|FG000|Overall Study|Pregnancy|1|||
130077348|NCT00939341|468237951|FG000|Overall Study|Lost to Follow-up|23|||
130077349|NCT00939341|468237951|FG000|Overall Study|Withdrawal by Subject|13|||
130077350|NCT00939341|468237951|FG000|Overall Study|Protocol Violation|6|||
130077351|NCT00939341|468237951|FG000|Overall Study|Incorrect enrolment|8|||
130077352|NCT03377452|468237952|FG000|Overall Study|Refused assessment|0|||
130077353|NCT03377452|468237953|FG001|Overall Study|Refused assessment|2|||
130077354|NCT03377452|468237952|FG000|Overall Study|Lost to Follow-up|5|||
130077355|NCT03377452|468237953|FG001|Overall Study|Lost to Follow-up|4|||
130077356|NCT00796003|468237955|FG000|Overall Study|Disease Progression|2|||
130077357|NCT00796003|468237956|FG001|Overall Study|Disease Progression|13|||
130077358|NCT00796003|468237955|FG000|Overall Study|Adverse Event|1|||
130077359|NCT00796003|468237956|FG001|Overall Study|Adverse Event|7|||
130077360|NCT00796003|468237955|FG000|Overall Study|Specified organ function not met|0|||
130077361|NCT00796003|468237956|FG001|Overall Study|Specified organ function not met|1|||
130077362|NCT00796003|468237955|FG000|Overall Study|Physician Decision|0|||
130077363|NCT00796003|468237956|FG001|Overall Study|Physician Decision|4|||
130077364|NCT00796003|468237955|FG000|Overall Study|Withdrawal by Subject|0|||
130077365|NCT00796003|468237956|FG001|Overall Study|Withdrawal by Subject|1|||
130077366|NCT00796003|468237955|FG000|Overall Study|Other|0|||
130077367|NCT00796003|468237956|FG001|Overall Study|Other|1|||
130077368|NCT00796003|468237955|FG000|Overall Study|Participants Not treated|0|||
130077369|NCT00796003|468237956|FG001|Overall Study|Participants Not treated|2|||
130077370|NCT05179057|468237957|FG000|Overall Study|Adverse Event|3|||
130077371|NCT05179057|468237958|FG001|Overall Study|Adverse Event|2|||
130077372|NCT05179057|468237957|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
130077373|NCT05179057|468237958|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
130077374|NCT05179057|468237957|FG000|Overall Study|Study terminated|13|||
130077375|NCT05179057|468237958|FG001|Overall Study|Study terminated|7|||
130077376|NCT05179057|468237957|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
130077377|NCT05179057|468237958|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
130077378|NCT05179057|468237957|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
130077379|NCT05179057|468237958|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
130077380|NCT02437162|468237959|FG000|Overall Study|Protocol Violation|0|||
130077381|NCT02437162|468237960|FG001|Overall Study|Protocol Violation|1|||
130077382|NCT02437162|468237961|FG002|Overall Study|Protocol Violation|0|||
130077383|NCT02437162|468237959|FG000|Overall Study|Randomized but not treated|0|||
130077384|NCT02437162|468237960|FG001|Overall Study|Randomized but not treated|0|||
130077385|NCT02437162|468237961|FG002|Overall Study|Randomized but not treated|1|||
130077386|NCT02437162|468237959|FG000|Overall Study|Study discontinued by Sponsor|93|||
130077387|NCT02437162|468237960|FG001|Overall Study|Study discontinued by Sponsor|98|||
130077388|NCT02437162|468237961|FG002|Overall Study|Study discontinued by Sponsor|97|||
130077389|NCT02437162|468237959|FG000|Overall Study|Withdrawal by Subject|13|||
130077390|NCT02437162|468237960|FG001|Overall Study|Withdrawal by Subject|7|||
130077391|NCT02437162|468237961|FG002|Overall Study|Withdrawal by Subject|9|||
130077392|NCT02437162|468237959|FG000|Overall Study|Adverse Event|0|||
130077393|NCT02437162|468237960|FG001|Overall Study|Adverse Event|1|||
130120728|NCT00436007|468404794|FG001|Overall Study|Withdrawal by Subject|3|||
130120729|NCT00436007|468404795|FG002|Overall Study|Withdrawal by Subject|4|||
130120730|NCT00436007|468404793|FG000|Overall Study|Lost to Follow-up|14|||
130120731|NCT00436007|468404794|FG001|Overall Study|Lost to Follow-up|10|||
129952608|NCT03560206|467786969|FG001|Overall Study|Lost to Follow-up|11|||
129952609|NCT03560206|467786968|FG000|Overall Study|Withdrawal by Subject|2|||
129952610|NCT03560206|467786969|FG001|Overall Study|Withdrawal by Subject|4|||
129952611|NCT03560206|467786968|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
129952612|NCT03560206|467786969|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
129952613|NCT03560206|467786968|FG000|Overall Study|Busy schedule|14|||
129952614|NCT03560206|467786969|FG001|Overall Study|Busy schedule|2|||
129952615|NCT03560206|467786968|FG000|Overall Study|patients' new health condition such as cancer|10|||
129952616|NCT03560206|467786969|FG001|Overall Study|patients' new health condition such as cancer|1|||
129952617|NCT01199302|467786975|FG000|Overall Study|Adverse Event|1|||
129952618|NCT01199302|467786976|FG001|Overall Study|Adverse Event|1|||
129952619|NCT01199302|467786977|FG002|Overall Study|Adverse Event|2|||
129952620|NCT01199302|467786978|FG003|Overall Study|Adverse Event|0|||
129952621|NCT01199302|467786975|FG000|Overall Study|Withdrawal by Subject|2|||
129952622|NCT01199302|467786976|FG001|Overall Study|Withdrawal by Subject|2|||
129952623|NCT01199302|467786977|FG002|Overall Study|Withdrawal by Subject|3|||
129952624|NCT01199302|467786978|FG003|Overall Study|Withdrawal by Subject|0|||
129952625|NCT01199302|467786975|FG000|Overall Study|Disease Progression|3|||
129952626|NCT01199302|467786976|FG001|Overall Study|Disease Progression|4|||
129952627|NCT01199302|467786977|FG002|Overall Study|Disease Progression|4|||
129952628|NCT01199302|467786978|FG003|Overall Study|Disease Progression|2|||
129952629|NCT01199302|467786975|FG000|Overall Study|Study Termination|13|||
129952630|NCT01199302|467786976|FG001|Overall Study|Study Termination|8|||
129952631|NCT01199302|467786977|FG002|Overall Study|Study Termination|11|||
129952632|NCT01199302|467786978|FG003|Overall Study|Study Termination|9|||
129952633|NCT01199302|467786975|FG000|Overall Study|Lost to Follow-up|0|||
129952634|NCT01199302|467786976|FG001|Overall Study|Lost to Follow-up|1|||
129952635|NCT01199302|467786977|FG002|Overall Study|Lost to Follow-up|0|||
129952636|NCT01199302|467786978|FG003|Overall Study|Lost to Follow-up|0|||
130077394|NCT02437162|468237961|FG002|Overall Study|Adverse Event|0|||
130077395|NCT02437162|468237959|FG000|Overall Study|Lost to Follow-up|1|||
130077396|NCT02437162|468237960|FG001|Overall Study|Lost to Follow-up|0|||
130077397|NCT02437162|468237961|FG002|Overall Study|Lost to Follow-up|1|||
130077398|NCT02437162|468237959|FG000|Overall Study|Death|0|||
130077399|NCT02437162|468237960|FG001|Overall Study|Death|1|||
130077400|NCT02437162|468237961|FG002|Overall Study|Death|0|||
130077401|NCT02437162|468237959|FG000|Overall Study|Other|0|||
130077402|NCT02437162|468237960|FG001|Overall Study|Other|0|||
129952637|NCT01199302|467786975|FG000|Overall Study|Other|1|||
129952638|NCT01199302|467786976|FG001|Overall Study|Other|0|||
129952639|NCT01199302|467786977|FG002|Overall Study|Other|0|||
129952640|NCT01199302|467786978|FG003|Overall Study|Other|0|||
129952641|NCT01634165|467786981|FG000|Period 2|Adverse Event|0|||
129952642|NCT01634165|467786982|FG001|Period 2|Adverse Event|1|||
129952643|NCT01634165|467786983|FG002|Period 2|Adverse Event|0|||
129952644|NCT01634165|467786984|FG003|Period 2|Adverse Event|0|||
129952645|NCT03820024|467786985|FG000|Overall Study|Physician Decision|1|||
129952646|NCT03820024|467786986|FG001|Overall Study|Physician Decision|2|||
129952647|NCT00760877|467788311|FG000|Overall Study|Protocol Violation|1|||
129952648|NCT00760877|467788312|FG001|Overall Study|Protocol Violation|0|||
129952649|NCT00760877|467788311|FG000|Overall Study|Non-compliance with protocol treatment|2|||
129952650|NCT00760877|467788312|FG001|Overall Study|Non-compliance with protocol treatment|1|||
129952651|NCT00760877|467788311|FG000|Overall Study|Pregnancy|1|||
129952652|NCT00760877|467788312|FG001|Overall Study|Pregnancy|4|||
129952653|NCT00760877|467788311|FG000|Overall Study|Death|2|||
129952654|NCT00760877|467788312|FG001|Overall Study|Death|1|||
129952655|NCT00760877|467788311|FG000|Overall Study|Withdrawal by Subject|7|||
129952656|NCT00760877|467788312|FG001|Overall Study|Withdrawal by Subject|3|||
129952657|NCT00760877|467788311|FG000|Overall Study|Adverse Event|19|||
129952658|NCT00760877|467788312|FG001|Overall Study|Adverse Event|12|||
129952659|NCT00760877|467788311|FG000|Overall Study|Participant diagnosed with AML|0|||
129952660|NCT00760877|467788312|FG001|Overall Study|Participant diagnosed with AML|1|||
129952661|NCT00760877|467788311|FG000|Overall Study|Participant not eligible to cross-over|0|||
129952662|NCT00760877|467788312|FG001|Overall Study|Participant not eligible to cross-over|1|||
129952663|NCT00760877|467788311|FG000|Overall Study|Physician Decision|1|||
129952664|NCT00760877|467788312|FG001|Overall Study|Physician Decision|2|||
129952665|NCT00760877|467788311|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
129952666|NCT00760877|467788312|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
129952667|NCT00760877|467788311|FG000|Overall Study|Treatment failure|1|||
129952668|NCT00760877|467788312|FG001|Overall Study|Treatment failure|0|||
129952669|NCT00711555|467788315|FG000|Overall Study|Adverse Event|3|||
129952670|NCT05379400|467788317|FG000|Overall Study|Lost to Follow-up|1|||
129952671|NCT05379400|467788318|FG001|Overall Study|Lost to Follow-up|1|||
129952672|NCT04914897|467788320|FG000|Overall Study|Withdrawal by Subject|3|||
129952673|NCT04914897|467788321|FG001|Overall Study|Withdrawal by Subject|1|||
129952674|NCT04914897|467788322|FG002|Overall Study|Withdrawal by Subject|1|||
129952675|NCT04914897|467788323|FG003|Overall Study|Withdrawal by Subject|1|||
129952676|NCT04914897|467788320|FG000|Overall Study|Poor compliance to protocol|0|||
129952677|NCT04914897|467788321|FG001|Overall Study|Poor compliance to protocol|0|||
129952678|NCT04914897|467788322|FG002|Overall Study|Poor compliance to protocol|1|||
130077403|NCT02437162|468237961|FG002|Overall Study|Other|1|||
130077404|NCT04338321|468237962|FG000|Overall Study|Adverse Event|4|||
130077405|NCT04338321|468237963|FG001|Overall Study|Adverse Event|10|||
130077406|NCT04338321|468237962|FG000|Overall Study|Death|1|||
130077407|NCT04338321|468237963|FG001|Overall Study|Death|1|||
130077408|NCT04338321|468237962|FG000|Overall Study|Lost to Follow-up|4|||
130077409|NCT04338321|468237963|FG001|Overall Study|Lost to Follow-up|9|||
129952679|NCT04914897|467788323|FG003|Overall Study|Poor compliance to protocol|0|||
129952680|NCT04914897|467788320|FG000|Overall Study|Progressive disease|5|||
129952681|NCT04914897|467788321|FG001|Overall Study|Progressive disease|14|||
129952682|NCT04914897|467788322|FG002|Overall Study|Progressive disease|30|||
129952683|NCT04914897|467788323|FG003|Overall Study|Progressive disease|21|||
129952684|NCT04914897|467788320|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129952685|NCT04914897|467788321|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
129952686|NCT04914897|467788322|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
129952687|NCT04914897|467788323|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
129952688|NCT04914897|467788320|FG000|Overall Study|Other|1|||
129952689|NCT04914897|467788321|FG001|Overall Study|Other|0|||
130077410|NCT04338321|468237962|FG000|Overall Study|Withdrawal by Subject|45|||
129952690|NCT04914897|467788322|FG002|Overall Study|Other|0|||
129952691|NCT04914897|467788323|FG003|Overall Study|Other|1|||
129952692|NCT03141177|467788324|FG000|Overall Study|Death|62|||
129952693|NCT03141177|467788325|FG001|Overall Study|Death|13|||
129952694|NCT03141177|467788326|FG002|Overall Study|Death|84|||
129952695|NCT03141177|467788324|FG000|Overall Study|Participant withdrew consent|9|||
129952696|NCT03141177|467788325|FG001|Overall Study|Participant withdrew consent|2|||
129952697|NCT03141177|467788326|FG002|Overall Study|Participant withdrew consent|13|||
129952698|NCT03141177|467788324|FG000|Overall Study|Not reported|1|||
129952699|NCT03141177|467788325|FG001|Overall Study|Not reported|0|||
129952700|NCT03141177|467788326|FG002|Overall Study|Not reported|1|||
129952701|NCT03141177|467788324|FG000|Overall Study|Lost to Follow-up|2|||
129952702|NCT03141177|467788325|FG001|Overall Study|Lost to Follow-up|1|||
129952703|NCT03141177|467788326|FG002|Overall Study|Lost to Follow-up|1|||
130077411|NCT04338321|468237963|FG001|Overall Study|Withdrawal by Subject|69|||
130077412|NCT04338321|468237962|FG000|Overall Study|Physician Decision|5|||
130077413|NCT04338321|468237963|FG001|Overall Study|Physician Decision|9|||
129952704|NCT03141177|467788324|FG000|Overall Study|Other reasons|4|||
129952705|NCT03141177|467788325|FG001|Overall Study|Other reasons|0|||
129952706|NCT03141177|467788326|FG002|Overall Study|Other reasons|11|||
129952707|NCT03141177|467788324|FG000|Overall Study|Participants did not start treatment period|3|||
129952708|NCT03141177|467788325|FG001|Overall Study|Participants did not start treatment period|0|||
129952709|NCT03141177|467788326|FG002|Overall Study|Participants did not start treatment period|8|||
129952710|NCT03020914|467788329|FG000|Overall Study|Surgery Cancelled|1|||
129952711|NCT03020914|467788330|FG001|Overall Study|Surgery Cancelled|0|||
129952712|NCT00409006|467788335|FG000|Overall Study|Death|15|||
129952713|NCT00409006|467788336|FG001|Overall Study|Death|6|||
129952714|NCT00409006|467788335|FG000|Overall Study|Lost to Follow-up|1|||
129952715|NCT00409006|467788336|FG001|Overall Study|Lost to Follow-up|2|||
129952716|NCT00409006|467788335|FG000|Overall Study|Withdrawal by Subject|3|||
129952717|NCT00409006|467788336|FG001|Overall Study|Withdrawal by Subject|2|||
129952718|NCT00409006|467788335|FG000|Overall Study|Physician Decision|1|||
129952719|NCT00409006|467788336|FG001|Overall Study|Physician Decision|2|||
129952720|NCT03696342|467788340|FG000|Overall Study|Lost to Follow-up|1|||
129952721|NCT03696342|467788341|FG001|Overall Study|Lost to Follow-up|0|||
129952722|NCT01877720|467788347|FG000|Overall Study|Adverse Event|1|||
129952723|NCT01877720|467788348|FG001|Overall Study|Adverse Event|0|||
129952724|NCT00447499|467788349|FG000|Overall Study|Adverse Event|1|||
129952725|NCT00447499|467788349|FG000|Overall Study|Patient Decision|4|||
129952726|NCT00447499|467788349|FG000|Overall Study|Sponsor Decision|1|||
129952727|NCT00447499|467788349|FG000|Overall Study|Physician Decision|1|||
129952728|NCT02068352|467788350|FG000|Overall Study|Lost to Follow-up|0|||
129952729|NCT02068352|467788351|FG001|Overall Study|Lost to Follow-up|2|||
129952730|NCT02068352|467788352|FG002|Overall Study|Lost to Follow-up|0|||
129952731|NCT02068352|467788350|FG000|Overall Study|Adverse Event|4|||
129952732|NCT02068352|467788351|FG001|Overall Study|Adverse Event|2|||
129952733|NCT02068352|467788352|FG002|Overall Study|Adverse Event|7|||
129952734|NCT02068352|467788350|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
129952735|NCT02068352|467788351|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
129952736|NCT02068352|467788352|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
129952737|NCT02068352|467788350|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
129952738|NCT02068352|467788351|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
129952739|NCT02068352|467788352|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
129952740|NCT02068352|467788350|FG000|Overall Study|Protocol Deviation|0|||
129952741|NCT02068352|467788351|FG001|Overall Study|Protocol Deviation|0|||
129952742|NCT02068352|467788352|FG002|Overall Study|Protocol Deviation|1|||
129952743|NCT00946088|467788353|FG000|Overall Study|Withdrawal by Subject|0|||
129952744|NCT00946088|467788354|FG001|Overall Study|Withdrawal by Subject|1|||
129952745|NCT01322347|467788355|FG000|Overall Study|Adverse Event|7|||
129952746|NCT01322347|467788356|FG001|Overall Study|Adverse Event|2|||
129952747|NCT01322347|467788355|FG000|Overall Study|Death|5|||
129952748|NCT01322347|467788356|FG001|Overall Study|Death|3|||
129952749|NCT01322347|467788355|FG000|Overall Study|Physician Decision|2|||
129952750|NCT01322347|467788356|FG001|Overall Study|Physician Decision|1|||
129952751|NCT01322347|467788355|FG000|Overall Study|Protocol Violation|5|||
129952752|NCT01322347|467788356|FG001|Overall Study|Protocol Violation|2|||
129952753|NCT01322347|467788355|FG000|Overall Study|Withdrawal by Subject|1|||
129952754|NCT01322347|467788356|FG001|Overall Study|Withdrawal by Subject|4|||
129952755|NCT01322347|467788355|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
129952756|NCT01322347|467788356|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
129952757|NCT01322347|467788355|FG000|Overall Study|blood transfusion|5|||
129952758|NCT01322347|467788356|FG001|Overall Study|blood transfusion|5|||
129952759|NCT01322347|467788355|FG000|Overall Study|sponsor decision|1|||
129952760|NCT01322347|467788356|FG001|Overall Study|sponsor decision|3|||
129952761|NCT01322347|467788355|FG000|Overall Study|ineligible|6|||
129952762|NCT01322347|467788356|FG001|Overall Study|ineligible|3|||
129952763|NCT01322347|467788355|FG000|Overall Study|kidney transplant|3|||
129952764|NCT01322347|467788356|FG001|Overall Study|kidney transplant|1|||
129952765|NCT01322347|467788355|FG000|Overall Study|study drug withheld > 12 wks|0|||
129952766|NCT01322347|467788356|FG001|Overall Study|study drug withheld > 12 wks|1|||
129952767|NCT01322347|467788355|FG000|Overall Study|moved/changed dialysis|2|||
129952768|NCT01322347|467788356|FG001|Overall Study|moved/changed dialysis|4|||
129952769|NCT04883541|467788357|FG000|Overall Study|Not attending regular yoga class|16|||
129952770|NCT04883541|467788358|FG001|Overall Study|Not attending regular yoga class|0|||
129952771|NCT04883541|467788357|FG000|Overall Study|Not attending the pregnancy school|0|||
129952772|NCT04883541|467788358|FG001|Overall Study|Not attending the pregnancy school|9|||
130077414|NCT04338321|468237962|FG000|Overall Study|Other|3|||
130077415|NCT04338321|468237963|FG001|Overall Study|Other|10|||
130077416|NCT03107793|468237964|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
130077417|NCT03107793|468237965|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
130077418|NCT03107793|468237966|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
130077419|NCT03107793|468237967|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
130077420|NCT03107793|468237968|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129952773|NCT01369147|467788360|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
129952774|NCT01369147|467788361|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
129952775|NCT01369147|467788362|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
129952776|NCT00648895|467788368|FG000|Overall Study|Lack of Efficacy|0|||
129952777|NCT00648895|467788369|FG001|Overall Study|Lack of Efficacy|1|||
129952778|NCT02865083|467788370|FG000|Overall Study|Early Termination|3|||
129952779|NCT02865083|467788371|FG001|Overall Study|Early Termination|1|||
129952780|NCT04626128|467788372|FG000|Overall Study|Withdrawal by Subject|0|||
129952781|NCT04626128|467788373|FG001|Overall Study|Withdrawal by Subject|1|||
129952782|NCT04626128|467788374|FG002|Overall Study|Withdrawal by Subject|0|||
129952783|NCT04626128|467788375|FG003|Overall Study|Withdrawal by Subject|0|||
129952784|NCT01182285|467788376|FG000|First Intervention Week 1-10|Disease progression|1|||
129952785|NCT01182285|467788377|FG001|First Intervention Week 1-10|Disease progression|0|||
129952786|NCT01182285|467788378|FG002|First Intervention Week 1-10|Disease progression|0|||
129952787|NCT01182285|467788376|FG000|First Intervention Week 1-10|Adverse Event|1|||
129952788|NCT01182285|467788377|FG001|First Intervention Week 1-10|Adverse Event|0|||
129952789|NCT01182285|467788378|FG002|First Intervention Week 1-10|Adverse Event|0|||
129952790|NCT01182285|467788376|FG000|First Intervention Week 1-10|Non-compliance|1|||
129952791|NCT01182285|467788377|FG001|First Intervention Week 1-10|Non-compliance|0|||
129952792|NCT01182285|467788378|FG002|First Intervention Week 1-10|Non-compliance|0|||
129952793|NCT01182285|467788376|FG000|Third Intervention Week 11-52|Disease Progression|0|||
129952794|NCT01182285|467788377|FG001|Third Intervention Week 11-52|Disease Progression|0|||
129952795|NCT01182285|467788378|FG002|Third Intervention Week 11-52|Disease Progression|6|||
129952796|NCT01182285|467788376|FG000|Third Intervention Week 11-52|Other|0|||
129952797|NCT01182285|467788377|FG001|Third Intervention Week 11-52|Other|0|||
129952798|NCT01182285|467788378|FG002|Third Intervention Week 11-52|Other|2|||
129952799|NCT00841321|467788379|FG000|Overall Study|Lost to Follow-up|1|||
129952800|NCT00841321|467788380|FG001|Overall Study|Lost to Follow-up|1|||
129952801|NCT00841321|467788379|FG000|Overall Study|Adverse Event|0|||
129952802|NCT00841321|467788380|FG001|Overall Study|Adverse Event|2|||
129952803|NCT00379210|467788383|FG000|Overall Study|Withdrawal by Subject|10|||
129952804|NCT00379210|467788384|FG001|Overall Study|Withdrawal by Subject|7|||
129952805|NCT01358175|467788385|FG000|Overall Study|Death|1|||
129952806|NCT01358175|467788386|FG001|Overall Study|Death|0|||
129952807|NCT01358175|467788387|FG002|Overall Study|Death|1|||
129952808|NCT01358175|467788385|FG000|Overall Study|Withdrawal by Subject|9|||
129952809|NCT01358175|467788386|FG001|Overall Study|Withdrawal by Subject|5|||
129952810|NCT01358175|467788387|FG002|Overall Study|Withdrawal by Subject|10|||
129952811|NCT01358175|467788385|FG000|Overall Study|Technical issues|0|||
129952812|NCT01358175|467788386|FG001|Overall Study|Technical issues|1|||
129952813|NCT01358175|467788387|FG002|Overall Study|Technical issues|0|||
129952814|NCT01358175|467788385|FG000|Overall Study|Pregnancy|0|||
129952815|NCT01358175|467788386|FG001|Overall Study|Pregnancy|1|||
129952816|NCT01358175|467788387|FG002|Overall Study|Pregnancy|0|||
129952817|NCT01358175|467788385|FG000|Overall Study|Physician Decision|1|||
129952818|NCT01358175|467788386|FG001|Overall Study|Physician Decision|0|||
129952819|NCT01358175|467788387|FG002|Overall Study|Physician Decision|0|||
129952820|NCT01358175|467788385|FG000|Overall Study|Non Compliance with Study Treatment|0|||
129952821|NCT01358175|467788386|FG001|Overall Study|Non Compliance with Study Treatment|1|||
129952822|NCT01358175|467788387|FG002|Overall Study|Non Compliance with Study Treatment|1|||
129952823|NCT01358175|467788385|FG000|Overall Study|Lost to Follow-up|1|||
129952824|NCT01358175|467788386|FG001|Overall Study|Lost to Follow-up|1|||
129952825|NCT01358175|467788387|FG002|Overall Study|Lost to Follow-up|3|||
129952826|NCT01358175|467788385|FG000|Overall Study|Lack of Efficacy|3|||
129952827|NCT01358175|467788386|FG001|Overall Study|Lack of Efficacy|8|||
129952828|NCT01358175|467788387|FG002|Overall Study|Lack of Efficacy|6|||
129952829|NCT01358175|467788385|FG000|Overall Study|Adverse Event|6|||
129952830|NCT01358175|467788386|FG001|Overall Study|Adverse Event|11|||
129952831|NCT01358175|467788387|FG002|Overall Study|Adverse Event|11|||
129952832|NCT01525875|467788388|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
129952833|NCT01525875|467788389|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
129952834|NCT01525875|467788388|FG000|Open-label Period|Lost to Follow-up|0|||
129952835|NCT01525875|467788389|FG001|Open-label Period|Lost to Follow-up|2|||
129952836|NCT05072795|467788390|FG000|Overall Study|Lost to Follow-up|5|||
129952837|NCT00821093|467788393|FG000|Overall Study|Adverse Event|20|||
129952838|NCT00821093|467788394|FG001|Overall Study|Adverse Event|12|||
129952839|NCT00821093|467788393|FG000|Overall Study|Withdrawal by Subject|9|||
129952840|NCT00821093|467788394|FG001|Overall Study|Withdrawal by Subject|13|||
129952841|NCT00821093|467788393|FG000|Overall Study|Lost to Follow-up|9|||
129952842|NCT00821093|467788394|FG001|Overall Study|Lost to Follow-up|3|||
129952843|NCT00821093|467788393|FG000|Overall Study|Protocol deviation|3|||
129952844|NCT00821093|467788394|FG001|Overall Study|Protocol deviation|6|||
129952845|NCT00821093|467788393|FG000|Overall Study|Abnormal laboratory value(s)|2|||
129952846|NCT00821093|467788394|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129952847|NCT00821093|467788393|FG000|Overall Study|Lack of Efficacy|2|||
129952848|NCT00821093|467788394|FG001|Overall Study|Lack of Efficacy|2|||
129952849|NCT00821093|467788393|FG000|Overall Study|Death|2|||
129952850|NCT00821093|467788394|FG001|Overall Study|Death|1|||
129952851|NCT00821093|467788393|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129952852|NCT00821093|467788394|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129952853|NCT00821093|467788393|FG000|Overall Study|Administrative problems|1|||
129952854|NCT00821093|467788394|FG001|Overall Study|Administrative problems|2|||
129952855|NCT01107912|467788395|FG000|Period 1|Adverse Event|0|||
130077421|NCT03107793|468237964|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
130077422|NCT03107793|468237965|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
130077423|NCT03107793|468237966|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
130077424|NCT03107793|468237967|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
130077425|NCT03107793|468237968|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
130077426|NCT03107793|468237964|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
130077427|NCT03107793|468237965|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
130077428|NCT03107793|468237966|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
130077429|NCT03107793|468237967|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
130077430|NCT03107793|468237968|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
130077431|NCT03107793|468237964|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
130077432|NCT03107793|468237965|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130077433|NCT03107793|468237966|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130077434|NCT03107793|468237967|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130077435|NCT03107793|468237968|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
130077436|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130077437|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
130077438|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
130077439|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130077440|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
130077441|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130077442|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
130077443|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
130077444|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130077445|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
130077446|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130077447|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130077448|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
130077449|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130077450|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
130077451|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130077452|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
130077453|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
130077454|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130077455|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
130077456|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
130077457|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
130077458|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
130077459|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
130077460|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
130077461|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
130077462|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
130077463|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
130077464|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
130077465|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
130077466|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130077467|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
130077468|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130077469|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
130077470|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129952856|NCT01107912|467788396|FG001|Period 1|Adverse Event|0|||
129952857|NCT01107912|467788397|FG002|Period 1|Adverse Event|0|||
129952858|NCT01107912|467788398|FG003|Period 1|Adverse Event|0|||
129952859|NCT01107912|467788399|FG004|Period 1|Adverse Event|2|||
130077471|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
130077472|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
130077473|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
130077474|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
130077475|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
130077476|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
129952860|NCT01107912|467788400|FG005|Period 1|Adverse Event|0|||
129952861|NCT01107912|467788395|FG000|Period 1|Physician Decision|0|||
129952862|NCT01107912|467788396|FG001|Period 1|Physician Decision|0|||
130077477|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130077478|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
130077479|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130077480|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
130077481|NCT03107793|468237964|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130077482|NCT03107793|468237965|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
130077483|NCT03107793|468237966|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
130077484|NCT03107793|468237967|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130077485|NCT03107793|468237968|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
130077486|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
130077487|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
130077488|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
130077489|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
130077490|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
130077491|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130077492|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130077493|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130077494|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
130077495|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
130077496|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
130077497|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
130077498|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
130077499|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
130077500|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
130077501|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Death|0|||
130077502|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Death|0|||
130077503|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Death|0|||
130077504|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Death|0|||
130077505|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Death|1|||
130077506|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130077507|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130077508|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130077509|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
130077510|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
130077511|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
130077512|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
130077513|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
130077514|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
130077515|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
130077516|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
130077517|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
130077518|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
130077519|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
130077520|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
130077521|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130077522|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130077523|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130077524|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
130077525|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
130077526|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130077527|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130077528|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130077529|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
130077530|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
130077531|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Other|0|||
130077532|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Other|0|||
130077533|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Other|0|||
130077534|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Other|1|||
130077535|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Other|3|||
130077536|NCT03107793|468237964|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
130077537|NCT03107793|468237965|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
130077538|NCT03107793|468237966|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
129952863|NCT01107912|467788397|FG002|Period 1|Physician Decision|0|||
129952864|NCT01107912|467788398|FG003|Period 1|Physician Decision|0|||
130077539|NCT03107793|468237967|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
130077540|NCT03107793|468237968|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
130077541|NCT03146403|468237969|FG000|Overall Study|Withdrawal by Subject|0|||
130077542|NCT03146403|468237970|FG001|Overall Study|Withdrawal by Subject|3|||
130077543|NCT03146403|468237969|FG000|Overall Study|Lost to Follow-up|2|||
130077544|NCT03146403|468237970|FG001|Overall Study|Lost to Follow-up|0|||
130077545|NCT04599972|468237975|FG000|Overall Study|Withdrawal by Subject|6|||
130077546|NCT04599972|468237976|FG001|Overall Study|Withdrawal by Subject|1|||
130077547|NCT04599972|468237975|FG000|Overall Study|Adverse Event|1|||
130077548|NCT04599972|468237976|FG001|Overall Study|Adverse Event|1|||
130077549|NCT04599972|468237975|FG000|Overall Study|Lost to Follow-up|1|||
130077550|NCT04599972|468237976|FG001|Overall Study|Lost to Follow-up|6|||
130077551|NCT04599972|468237975|FG000|Overall Study|Protocol Violation|1|||
130077552|NCT04599972|468237976|FG001|Overall Study|Protocol Violation|0|||
130077553|NCT04599972|468237975|FG000|Overall Study|Other reason|1|||
130077554|NCT04599972|468237976|FG001|Overall Study|Other reason|0|||
130077555|NCT01594411|468237979|FG000|Overall Study|Lost to Follow-up|2|||
130077556|NCT04449276|468237980|FG000|Overall Study|Adverse Event|1|||
130077557|NCT04449276|468237981|FG001|Overall Study|Adverse Event|2|||
130077558|NCT04449276|468237982|FG002|Overall Study|Adverse Event|0|||
130077559|NCT04449276|468237983|FG003|Overall Study|Adverse Event|0|||
130077560|NCT04449276|468237984|FG004|Overall Study|Adverse Event|2|||
130077561|NCT04449276|468237985|FG005|Overall Study|Adverse Event|0|||
130077562|NCT04449276|468237986|FG006|Overall Study|Adverse Event|0|||
130077563|NCT04449276|468237987|FG007|Overall Study|Adverse Event|1|||
130077564|NCT04449276|468237980|FG000|Overall Study|Withdrawal by Subject|2|||
130077565|NCT04449276|468237981|FG001|Overall Study|Withdrawal by Subject|0|||
130077566|NCT04449276|468237982|FG002|Overall Study|Withdrawal by Subject|0|||
130077567|NCT04449276|468237983|FG003|Overall Study|Withdrawal by Subject|1|||
130077568|NCT04449276|468237984|FG004|Overall Study|Withdrawal by Subject|0|||
130077569|NCT04449276|468237985|FG005|Overall Study|Withdrawal by Subject|0|||
130077570|NCT04449276|468237986|FG006|Overall Study|Withdrawal by Subject|0|||
130077571|NCT04449276|468237987|FG007|Overall Study|Withdrawal by Subject|0|||
130120732|NCT00436007|468404795|FG002|Overall Study|Lost to Follow-up|13|||
130120733|NCT00436007|468404793|FG000|Overall Study|Physician Decision|0|||
130120734|NCT00436007|468404794|FG001|Overall Study|Physician Decision|0|||
130120735|NCT00436007|468404795|FG002|Overall Study|Physician Decision|2|||
130120736|NCT00436007|468404793|FG000|Overall Study|Death|0|||
130120737|NCT00436007|468404794|FG001|Overall Study|Death|1|||
130120738|NCT00436007|468404795|FG002|Overall Study|Death|3|||
130120739|NCT00436007|468404793|FG000|Overall Study|Other|0|||
130120740|NCT00436007|468404794|FG001|Overall Study|Other|0|||
130120741|NCT00436007|468404795|FG002|Overall Study|Other|1|||
130120742|NCT01957488|468404797|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
130120743|NCT01957488|468404798|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
130120744|NCT01957488|468404799|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
130120745|NCT01957488|468404800|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
130120746|NCT01957488|468404801|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
130120747|NCT01957488|468404802|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
130120748|NCT01957488|468404797|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
130120749|NCT01957488|468404798|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
130120750|NCT01957488|468404799|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
130120751|NCT01957488|468404800|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
130120752|NCT01957488|468404801|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
130120753|NCT01957488|468404802|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
130120754|NCT01957488|468404797|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
130120755|NCT01957488|468404798|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
130120756|NCT01957488|468404799|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
130120757|NCT01957488|468404800|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
130120758|NCT01957488|468404801|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
130120759|NCT01957488|468404802|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
130120760|NCT01957488|468404797|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130120761|NCT01957488|468404798|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130120762|NCT01957488|468404799|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
130120763|NCT01957488|468404800|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130120764|NCT01957488|468404801|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
130120765|NCT01957488|468404802|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
130077572|NCT04449276|468237980|FG000|Overall Study|Other|0|||
130077573|NCT04449276|468237981|FG001|Overall Study|Other|2|||
130077574|NCT04449276|468237982|FG002|Overall Study|Other|3|||
130077575|NCT04449276|468237983|FG003|Overall Study|Other|2|||
130077576|NCT04449276|468237984|FG004|Overall Study|Other|0|||
130077577|NCT04449276|468237985|FG005|Overall Study|Other|0|||
130077578|NCT04449276|468237986|FG006|Overall Study|Other|0|||
130120766|NCT01957488|468404797|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130120767|NCT01957488|468404798|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130120768|NCT01957488|468404799|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130077579|NCT04449276|468237987|FG007|Overall Study|Other|1|||
130077580|NCT01614795|468237988|FG000|Overall Study|Adverse Event|0|||
130077581|NCT01614795|468237989|FG001|Overall Study|Adverse Event|0|||
130077582|NCT01614795|468237990|FG002|Overall Study|Adverse Event|1|||
130077583|NCT01614795|468237991|FG003|Overall Study|Adverse Event|1|||
130077584|NCT01614795|468237988|FG000|Overall Study|Lack of Efficacy|10|||
130077585|NCT01614795|468237989|FG001|Overall Study|Lack of Efficacy|10|||
130077586|NCT01614795|468237990|FG002|Overall Study|Lack of Efficacy|9|||
130077587|NCT01614795|468237991|FG003|Overall Study|Lack of Efficacy|8|||
130077588|NCT01614795|468237988|FG000|Overall Study|Physician Decision|1|||
130077589|NCT01614795|468237989|FG001|Overall Study|Physician Decision|0|||
130077590|NCT01614795|468237990|FG002|Overall Study|Physician Decision|1|||
130077591|NCT01614795|468237991|FG003|Overall Study|Physician Decision|1|||
130077592|NCT01614795|468237988|FG000|Overall Study|Withdrawal by Subject|0|||
130077593|NCT01614795|468237989|FG001|Overall Study|Withdrawal by Subject|1|||
130077594|NCT01614795|468237990|FG002|Overall Study|Withdrawal by Subject|0|||
130077595|NCT01614795|468237991|FG003|Overall Study|Withdrawal by Subject|2|||
130077596|NCT01614795|468237988|FG000|Overall Study|Ineligible|0|||
130077597|NCT01614795|468237989|FG001|Overall Study|Ineligible|1|||
130077598|NCT01614795|468237990|FG002|Overall Study|Ineligible|0|||
130077599|NCT01614795|468237991|FG003|Overall Study|Ineligible|0|||
130077600|NCT00910728|468237992|FG000|Overall Study|Lack of Efficacy|2|||
130077601|NCT00910728|468237993|FG001|Overall Study|Lack of Efficacy|3|||
130077602|NCT00910728|468237994|FG002|Overall Study|Lack of Efficacy|1|||
130077603|NCT00910728|468237995|FG003|Overall Study|Lack of Efficacy|2|||
130077604|NCT00910728|468237996|FG004|Overall Study|Lack of Efficacy|1|||
130077605|NCT00910728|468237997|FG005|Overall Study|Lack of Efficacy|0|||
130077606|NCT00910728|468237998|FG006|Overall Study|Lack of Efficacy|2|||
130077607|NCT00910728|468237999|FG007|Overall Study|Lack of Efficacy|2|||
130077608|NCT00910728|468238000|FG008|Overall Study|Lack of Efficacy|2|||
130077609|NCT00910728|468237992|FG000|Overall Study|Withdrawal by Subject|0|||
130077610|NCT00910728|468237993|FG001|Overall Study|Withdrawal by Subject|0|||
130077611|NCT00910728|468237994|FG002|Overall Study|Withdrawal by Subject|0|||
130077612|NCT00910728|468237995|FG003|Overall Study|Withdrawal by Subject|0|||
130077613|NCT00910728|468237996|FG004|Overall Study|Withdrawal by Subject|3|||
130077614|NCT00910728|468237997|FG005|Overall Study|Withdrawal by Subject|1|||
130077615|NCT00910728|468237998|FG006|Overall Study|Withdrawal by Subject|2|||
130077616|NCT00910728|468237999|FG007|Overall Study|Withdrawal by Subject|0|||
130077617|NCT00910728|468238000|FG008|Overall Study|Withdrawal by Subject|0|||
130077618|NCT00910728|468237992|FG000|Overall Study|(not specified)|2|||
130077619|NCT00910728|468237993|FG001|Overall Study|(not specified)|0|||
130077620|NCT00910728|468237994|FG002|Overall Study|(not specified)|1|||
130077621|NCT00910728|468237995|FG003|Overall Study|(not specified)|0|||
130077622|NCT00910728|468237996|FG004|Overall Study|(not specified)|1|||
130077623|NCT00910728|468237997|FG005|Overall Study|(not specified)|0|||
129952865|NCT01107912|467788399|FG004|Period 1|Physician Decision|1|||
129952866|NCT01107912|467788400|FG005|Period 1|Physician Decision|0|||
129952867|NCT01107912|467788395|FG000|Period 1|Withdrawal by Subject|1|||
129952868|NCT01107912|467788396|FG001|Period 1|Withdrawal by Subject|0|||
129952869|NCT01107912|467788397|FG002|Period 1|Withdrawal by Subject|0|||
129952870|NCT01107912|467788398|FG003|Period 1|Withdrawal by Subject|0|||
129952871|NCT01107912|467788399|FG004|Period 1|Withdrawal by Subject|0|||
129952872|NCT01107912|467788400|FG005|Period 1|Withdrawal by Subject|0|||
129952873|NCT01107912|467788395|FG000|Period 2|Physician Decision|0|||
129952874|NCT01107912|467788396|FG001|Period 2|Physician Decision|0|||
129952875|NCT01107912|467788397|FG002|Period 2|Physician Decision|1|||
129952876|NCT01107912|467788398|FG003|Period 2|Physician Decision|0|||
129952877|NCT01107912|467788399|FG004|Period 2|Physician Decision|0|||
129952878|NCT01107912|467788400|FG005|Period 2|Physician Decision|0|||
129952879|NCT01107912|467788395|FG000|Period 3|Adverse Event|0|||
129952880|NCT01107912|467788396|FG001|Period 3|Adverse Event|1|||
129952881|NCT01107912|467788397|FG002|Period 3|Adverse Event|1|||
129952882|NCT01107912|467788398|FG003|Period 3|Adverse Event|0|||
129952883|NCT01107912|467788399|FG004|Period 3|Adverse Event|0|||
129952884|NCT01107912|467788400|FG005|Period 3|Adverse Event|0|||
130077624|NCT00910728|468237998|FG006|Overall Study|(not specified)|0|||
130077625|NCT00910728|468237999|FG007|Overall Study|(not specified)|0|||
130077626|NCT00910728|468238000|FG008|Overall Study|(not specified)|0|||
130077627|NCT00910728|468237992|FG000|Overall Study|Adverse Event|2|||
130077628|NCT00910728|468237993|FG001|Overall Study|Adverse Event|0|||
130077629|NCT00910728|468237994|FG002|Overall Study|Adverse Event|1|||
129952885|NCT01107912|467788395|FG000|Period 3|Withdrawal by Subject|0|||
129952886|NCT01107912|467788396|FG001|Period 3|Withdrawal by Subject|0|||
129952887|NCT01107912|467788397|FG002|Period 3|Withdrawal by Subject|0|||
129952888|NCT01107912|467788398|FG003|Period 3|Withdrawal by Subject|1|||
129952889|NCT01107912|467788399|FG004|Period 3|Withdrawal by Subject|0|||
129952890|NCT01107912|467788400|FG005|Period 3|Withdrawal by Subject|0|||
130077630|NCT00910728|468237995|FG003|Overall Study|Adverse Event|1|||
130077631|NCT00910728|468237996|FG004|Overall Study|Adverse Event|0|||
130077632|NCT00910728|468237997|FG005|Overall Study|Adverse Event|0|||
130077633|NCT00910728|468237998|FG006|Overall Study|Adverse Event|2|||
130077634|NCT00910728|468237999|FG007|Overall Study|Adverse Event|1|||
130077635|NCT00910728|468238000|FG008|Overall Study|Adverse Event|1|||
130077636|NCT00023712|468238001|FG000|Overall Study|Not platinum sensitive|1|||
130077637|NCT00023712|468238002|FG001|Overall Study|Not platinum sensitive|0|||
130077638|NCT00023712|468238001|FG000|Overall Study|Never treated|1|||
130077639|NCT00023712|468238002|FG001|Overall Study|Never treated|1|||
130077640|NCT01810380|468238003|FG000|Overall Study|Randomised not treated|2|||
130077641|NCT01810380|468238004|FG001|Overall Study|Randomised not treated|1|||
130077642|NCT01810380|468238005|FG002|Overall Study|Randomised not treated|1|||
130077643|NCT01810380|468238003|FG000|Overall Study|Adverse Event|11|||
130077644|NCT01810380|468238004|FG001|Overall Study|Adverse Event|14|||
130077645|NCT01810380|468238005|FG002|Overall Study|Adverse Event|4|||
130077646|NCT01810380|468238003|FG000|Overall Study|Lack of Efficacy|24|||
130077647|NCT01810380|468238004|FG001|Overall Study|Lack of Efficacy|10|||
130077648|NCT01810380|468238005|FG002|Overall Study|Lack of Efficacy|11|||
130077649|NCT01810380|468238003|FG000|Overall Study|Protocol Violation|1|||
130077650|NCT01810380|468238004|FG001|Overall Study|Protocol Violation|0|||
130077651|NCT01810380|468238005|FG002|Overall Study|Protocol Violation|1|||
130077652|NCT01810380|468238003|FG000|Overall Study|Withdrawal by Subject|6|||
130077653|NCT01810380|468238004|FG001|Overall Study|Withdrawal by Subject|0|||
130077654|NCT01810380|468238005|FG002|Overall Study|Withdrawal by Subject|6|||
130077655|NCT01810380|468238003|FG000|Overall Study|Administrative or other reasons|11|||
130077656|NCT01810380|468238004|FG001|Overall Study|Administrative or other reasons|13|||
130077657|NCT01810380|468238005|FG002|Overall Study|Administrative or other reasons|9|||
130077658|NCT00251589|468238008|FG000|Overall Study|Adverse Event|5|||
130077659|NCT00251589|468238009|FG001|Overall Study|Adverse Event|1|||
130077660|NCT00251589|468238010|FG002|Overall Study|Adverse Event|2|||
130077661|NCT00251589|468238011|FG003|Overall Study|Adverse Event|1|||
130077662|NCT00251589|468238008|FG000|Overall Study|Withdrawal by Subject|1|||
130077663|NCT00251589|468238009|FG001|Overall Study|Withdrawal by Subject|1|||
130077664|NCT00251589|468238010|FG002|Overall Study|Withdrawal by Subject|0|||
130077665|NCT00251589|468238011|FG003|Overall Study|Withdrawal by Subject|0|||
130077666|NCT00251589|468238008|FG000|Overall Study|Discontinued due to progressive disease|9|||
130077667|NCT00251589|468238009|FG001|Overall Study|Discontinued due to progressive disease|1|||
130077668|NCT00251589|468238010|FG002|Overall Study|Discontinued due to progressive disease|0|||
130077669|NCT00251589|468238011|FG003|Overall Study|Discontinued due to progressive disease|1|||
130077670|NCT02571972|468238014|FG000|Overall Study|Protocol Violation|2|||
130077671|NCT02571972|468238014|FG000|Overall Study|Withdrawal by Subject|2|||
130077672|NCT03039192|468238017|FG000|Overall Study|Lost to Follow-up|4|||
130077673|NCT03039192|468238018|FG001|Overall Study|Lost to Follow-up|4|||
130077674|NCT03039192|468238017|FG000|Overall Study|Adverse event, serious fatal|0|||
130077675|NCT03039192|468238018|FG001|Overall Study|Adverse event, serious fatal|1|||
130077676|NCT03039192|468238017|FG000|Overall Study|Adverse event, non-fatal|0|||
130077677|NCT03039192|468238018|FG001|Overall Study|Adverse event, non-fatal|2|||
130077678|NCT03039192|468238017|FG000|Overall Study|Withdrawal by Subject|6|||
130077679|NCT03039192|468238018|FG001|Overall Study|Withdrawal by Subject|9|||
130077680|NCT03039192|468238017|FG000|Overall Study|Discontinued from treatment phase|19|||
130077681|NCT03039192|468238018|FG001|Overall Study|Discontinued from treatment phase|12|||
130077682|NCT03039192|468238017|FG000|Overall Study|Other|3|||
130077683|NCT03039192|468238018|FG001|Overall Study|Other|2|||
130077684|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Adverse Event|22|||
130077685|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Adverse Event|0|||
130077686|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
130077687|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
130077688|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
130077689|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
130077690|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
130077691|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
130077692|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
130077693|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
130077694|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
130077695|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
130077696|NCT02493868|468238019|FG000|Induction Phase: DE Participants|Other|8|||
130077697|NCT02493868|468238020|FG001|Induction Phase: DE Participants|Other|0|||
130077698|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
130077699|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
130077700|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
130077701|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
130077702|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
130077703|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
130077704|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
130077705|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
130077706|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
130077707|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
130077708|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
130077709|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
130077710|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
130077711|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
130077712|NCT02493868|468238019|FG000|Optimization Phase: DE+TE Participants|Other|10|||
130077713|NCT02493868|468238020|FG001|Optimization Phase: DE+TE Participants|Other|2|||
130077714|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
130077715|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
130077716|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
130077717|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
130077718|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
130077719|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
130077720|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
130077721|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
130077722|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
130077723|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
130077724|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
130077725|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
130077726|NCT02493868|468238019|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
130077727|NCT02493868|468238020|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
130077728|NCT02493868|468238019|FG000|Follow-up Phase|Lost to Follow-up|1|||
130077729|NCT02493868|468238020|FG001|Follow-up Phase|Lost to Follow-up|0|||
130077730|NCT02493868|468238019|FG000|Follow-up Phase|Withdrawal by Subject|3|||
130077731|NCT02493868|468238020|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130077732|NCT02493868|468238019|FG000|Follow-up Phase|Investigator Decision|5|||
130077733|NCT02493868|468238020|FG001|Follow-up Phase|Investigator Decision|1|||
130077734|NCT02493868|468238019|FG000|Follow-up Phase|Other|2|||
130077735|NCT02493868|468238020|FG001|Follow-up Phase|Other|1|||
130077736|NCT02407236|468238021|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
130077737|NCT02407236|468238022|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
130077738|NCT02407236|468238023|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
130077739|NCT02407236|468238024|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
130077740|NCT02407236|468238025|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
130077741|NCT02407236|468238026|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
130077742|NCT02407236|468238027|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
130077743|NCT02407236|468238028|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
130077744|NCT02407236|468238029|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
130077745|NCT02407236|468238030|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
130077746|NCT02407236|468238031|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
130077747|NCT02407236|468238032|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
130077748|NCT02407236|468238033|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
130077749|NCT02407236|468238021|FG000|Induction Study (8 Weeks)|Death|0|||
130077750|NCT02407236|468238022|FG001|Induction Study (8 Weeks)|Death|0|||
130077751|NCT02407236|468238023|FG002|Induction Study (8 Weeks)|Death|1|||
130077752|NCT02407236|468238024|FG003|Induction Study (8 Weeks)|Death|0|||
130077753|NCT02407236|468238025|FG004|Induction Study (8 Weeks)|Death|0|||
130077754|NCT02407236|468238026|FG005|Induction Study (8 Weeks)|Death|0|||
130077755|NCT02407236|468238027|FG006|Induction Study (8 Weeks)|Death|0|||
130077756|NCT02407236|468238028|FG007|Induction Study (8 Weeks)|Death|0|||
130077757|NCT02407236|468238029|FG008|Induction Study (8 Weeks)|Death|0|||
130120769|NCT01957488|468404800|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130120770|NCT01957488|468404801|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
130120771|NCT01957488|468404802|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
130120772|NCT01957488|468404797|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
130077758|NCT02407236|468238030|FG009|Induction Study (8 Weeks)|Death|0|||
130077759|NCT02407236|468238031|FG010|Induction Study (8 Weeks)|Death|0|||
130077760|NCT02407236|468238032|FG011|Induction Study (8 Weeks)|Death|0|||
130077761|NCT02407236|468238033|FG012|Induction Study (8 Weeks)|Death|0|||
130077762|NCT02407236|468238021|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
130077763|NCT02407236|468238022|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
130077764|NCT02407236|468238023|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
130077765|NCT02407236|468238024|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077766|NCT02407236|468238025|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077767|NCT02407236|468238026|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077768|NCT02407236|468238027|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077769|NCT02407236|468238028|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077770|NCT02407236|468238029|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077771|NCT02407236|468238030|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077772|NCT02407236|468238031|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077773|NCT02407236|468238032|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077774|NCT02407236|468238033|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
130077775|NCT02407236|468238021|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077776|NCT02407236|468238022|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077777|NCT02407236|468238023|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
130077778|NCT02407236|468238024|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077779|NCT02407236|468238025|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077780|NCT02407236|468238026|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077781|NCT02407236|468238027|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077782|NCT02407236|468238028|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077783|NCT02407236|468238029|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077784|NCT02407236|468238030|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077785|NCT02407236|468238031|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077786|NCT02407236|468238032|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077787|NCT02407236|468238033|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
130077788|NCT02407236|468238021|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
130077789|NCT02407236|468238022|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
130077790|NCT02407236|468238023|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
130077791|NCT02407236|468238024|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
130077792|NCT02407236|468238025|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
130077793|NCT02407236|468238026|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
130077794|NCT02407236|468238027|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
130077795|NCT02407236|468238028|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
130077796|NCT02407236|468238029|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
130077797|NCT02407236|468238030|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
130077798|NCT02407236|468238031|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
130077799|NCT02407236|468238032|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
130077800|NCT02407236|468238033|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
130077801|NCT02407236|468238021|FG000|Induction Study (8 Weeks)|Other|2|||
130077802|NCT02407236|468238022|FG001|Induction Study (8 Weeks)|Other|1|||
130077803|NCT02407236|468238023|FG002|Induction Study (8 Weeks)|Other|5|||
130077804|NCT02407236|468238024|FG003|Induction Study (8 Weeks)|Other|0|||
130077805|NCT02407236|468238025|FG004|Induction Study (8 Weeks)|Other|0|||
130077806|NCT02407236|468238026|FG005|Induction Study (8 Weeks)|Other|0|||
130077807|NCT02407236|468238027|FG006|Induction Study (8 Weeks)|Other|0|||
130077808|NCT02407236|468238028|FG007|Induction Study (8 Weeks)|Other|0|||
130077809|NCT02407236|468238029|FG008|Induction Study (8 Weeks)|Other|0|||
130077810|NCT02407236|468238030|FG009|Induction Study (8 Weeks)|Other|0|||
130077811|NCT02407236|468238031|FG010|Induction Study (8 Weeks)|Other|0|||
130077812|NCT02407236|468238032|FG011|Induction Study (8 Weeks)|Other|0|||
130077813|NCT02407236|468238033|FG012|Induction Study (8 Weeks)|Other|0|||
130077814|NCT02407236|468238021|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077815|NCT02407236|468238022|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077816|NCT02407236|468238023|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077817|NCT02407236|468238024|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
130077818|NCT02407236|468238025|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
130077819|NCT02407236|468238026|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
130077820|NCT02407236|468238027|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
130077821|NCT02407236|468238028|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
130077822|NCT02407236|468238029|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077823|NCT02407236|468238030|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077824|NCT02407236|468238031|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077825|NCT02407236|468238032|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077826|NCT02407236|468238033|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
130077827|NCT02407236|468238021|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077828|NCT02407236|468238022|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077829|NCT02407236|468238023|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077830|NCT02407236|468238024|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
130077831|NCT02407236|468238025|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
130077832|NCT02407236|468238026|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
130077833|NCT02407236|468238027|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
130077834|NCT02407236|468238028|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
130077835|NCT02407236|468238029|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077836|NCT02407236|468238030|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077837|NCT02407236|468238031|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077838|NCT02407236|468238032|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077839|NCT02407236|468238033|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
130077840|NCT02407236|468238021|FG000|Maintenance Study (44 Weeks)|Other|0|||
130077841|NCT02407236|468238022|FG001|Maintenance Study (44 Weeks)|Other|0|||
130077842|NCT02407236|468238023|FG002|Maintenance Study (44 Weeks)|Other|0|||
130077843|NCT02407236|468238024|FG003|Maintenance Study (44 Weeks)|Other|5|||
130077844|NCT02407236|468238025|FG004|Maintenance Study (44 Weeks)|Other|7|||
130077845|NCT02407236|468238026|FG005|Maintenance Study (44 Weeks)|Other|8|||
130077846|NCT02407236|468238027|FG006|Maintenance Study (44 Weeks)|Other|4|||
130077847|NCT02407236|468238028|FG007|Maintenance Study (44 Weeks)|Other|6|||
130077848|NCT02407236|468238029|FG008|Maintenance Study (44 Weeks)|Other|0|||
130077849|NCT02407236|468238030|FG009|Maintenance Study (44 Weeks)|Other|0|||
130077850|NCT02407236|468238031|FG010|Maintenance Study (44 Weeks)|Other|0|||
130077851|NCT02407236|468238032|FG011|Maintenance Study (44 Weeks)|Other|0|||
130077852|NCT02407236|468238033|FG012|Maintenance Study (44 Weeks)|Other|0|||
130077853|NCT02407236|468238021|FG000|Maintenance Study (44 Weeks)|Death|0|||
130077854|NCT02407236|468238022|FG001|Maintenance Study (44 Weeks)|Death|0|||
130077855|NCT02407236|468238023|FG002|Maintenance Study (44 Weeks)|Death|0|||
130077856|NCT02407236|468238024|FG003|Maintenance Study (44 Weeks)|Death|0|||
130077857|NCT02407236|468238025|FG004|Maintenance Study (44 Weeks)|Death|0|||
130077858|NCT02407236|468238026|FG005|Maintenance Study (44 Weeks)|Death|0|||
130077859|NCT02407236|468238027|FG006|Maintenance Study (44 Weeks)|Death|0|||
130077860|NCT02407236|468238028|FG007|Maintenance Study (44 Weeks)|Death|1|||
130077861|NCT02407236|468238029|FG008|Maintenance Study (44 Weeks)|Death|0|||
130077862|NCT02407236|468238030|FG009|Maintenance Study (44 Weeks)|Death|0|||
130077863|NCT02407236|468238031|FG010|Maintenance Study (44 Weeks)|Death|0|||
130077864|NCT02407236|468238032|FG011|Maintenance Study (44 Weeks)|Death|0|||
130077865|NCT02407236|468238033|FG012|Maintenance Study (44 Weeks)|Death|0|||
130077866|NCT02407236|468238021|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077867|NCT02407236|468238022|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077868|NCT02407236|468238023|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077869|NCT02407236|468238024|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077870|NCT02407236|468238025|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077871|NCT02407236|468238026|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077872|NCT02407236|468238027|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077873|NCT02407236|468238028|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
130077874|NCT02407236|468238029|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
130077875|NCT02407236|468238030|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
130077876|NCT02407236|468238031|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
130077877|NCT02407236|468238032|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
130077878|NCT02407236|468238033|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
130077879|NCT02407236|468238021|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077880|NCT02407236|468238022|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077881|NCT02407236|468238023|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077882|NCT02407236|468238024|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077883|NCT02407236|468238025|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077884|NCT02407236|468238026|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077885|NCT02407236|468238027|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077886|NCT02407236|468238028|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077887|NCT02407236|468238029|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077888|NCT02407236|468238030|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077889|NCT02407236|468238031|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
130077890|NCT02407236|468238032|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077891|NCT02407236|468238033|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
130077892|NCT02407236|468238021|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077893|NCT02407236|468238022|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077894|NCT02407236|468238023|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077895|NCT02407236|468238024|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077896|NCT02407236|468238025|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077897|NCT02407236|468238026|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077898|NCT02407236|468238027|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077899|NCT02407236|468238028|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
130077900|NCT02407236|468238029|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
130077901|NCT02407236|468238030|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
130077902|NCT02407236|468238031|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
130077903|NCT02407236|468238032|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
130077904|NCT02407236|468238033|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
130077905|NCT02407236|468238021|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
130077906|NCT02407236|468238022|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
130077907|NCT02407236|468238023|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
130077908|NCT02407236|468238024|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
130077909|NCT02407236|468238025|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
130077910|NCT02407236|468238026|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
130077911|NCT02407236|468238027|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
130077912|NCT02407236|468238028|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
130077913|NCT02407236|468238029|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
130077914|NCT02407236|468238030|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
130077915|NCT02407236|468238031|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
130077916|NCT02407236|468238032|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
130077917|NCT02407236|468238033|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
130077918|NCT00643448|468238035|FG000|Overall Study|Lack of Efficacy|2|||
130077919|NCT00643448|468238036|FG001|Overall Study|Lack of Efficacy|0|||
130077920|NCT00643448|468238037|FG002|Overall Study|Lack of Efficacy|4|||
130077921|NCT00643448|468238035|FG000|Overall Study|Adverse Event|2|||
130077922|NCT00643448|468238036|FG001|Overall Study|Adverse Event|2|||
130077923|NCT00643448|468238037|FG002|Overall Study|Adverse Event|2|||
130077924|NCT00643448|468238035|FG000|Overall Study|QTcF>550 ms|0|||
130077925|NCT00643448|468238036|FG001|Overall Study|QTcF>550 ms|3|||
130077926|NCT00643448|468238037|FG002|Overall Study|QTcF>550 ms|0|||
130077927|NCT05166603|468238038|FG000|Overall Study|Withdrawal by Subject|68|||
130077928|NCT05166603|468238039|FG001|Overall Study|Withdrawal by Subject|0|||
130077929|NCT00777257|468239531|FG000|Overall Study|Adverse Event|3|||
130077930|NCT00777257|468239532|FG001|Overall Study|Adverse Event|1|||
130077931|NCT00777257|468239533|FG002|Overall Study|Adverse Event|0|||
130077932|NCT00777257|468239531|FG000|Overall Study|Lost to Follow-up|3|||
130077933|NCT00777257|468239532|FG001|Overall Study|Lost to Follow-up|3|||
130077934|NCT00777257|468239533|FG002|Overall Study|Lost to Follow-up|2|||
130077935|NCT00777257|468239531|FG000|Overall Study|Protocol Violation|2|||
130077936|NCT00777257|468239532|FG001|Overall Study|Protocol Violation|2|||
130077937|NCT00777257|468239533|FG002|Overall Study|Protocol Violation|2|||
130077938|NCT00777257|468239531|FG000|Overall Study|Withdrawal by Subject|3|||
130077939|NCT00777257|468239532|FG001|Overall Study|Withdrawal by Subject|6|||
130077940|NCT00777257|468239533|FG002|Overall Study|Withdrawal by Subject|5|||
130077941|NCT00098865|468239534|FG000|Overall Study|Progressive Disease|6|||
130077942|NCT00098865|468239534|FG000|Overall Study|Adverse Event|2|||
130077943|NCT00098865|468239534|FG000|Overall Study|Alternative Therapy|1|||
130077944|NCT00688623|468239536|FG000|Overall Study|Adverse Event|22|||
130077945|NCT00688623|468239536|FG000|Overall Study|abnormal lab value|1|||
130077946|NCT00688623|468239536|FG000|Overall Study|Withdrawal by Subject|4|||
130077947|NCT00688623|468239536|FG000|Overall Study|Death|3|||
130077948|NCT00688623|468239536|FG000|Overall Study|disease progression|23|||
130077949|NCT00688623|468239536|FG000|Overall Study|Protocol Violation|2|||
130077950|NCT02667236|468239537|FG000|Overall Study|Adverse Event|1|||
130077951|NCT02667236|468239538|FG001|Overall Study|Adverse Event|1|||
130077952|NCT02667236|468239537|FG000|Overall Study|Withdrawal by Subject|2|||
130077953|NCT02667236|468239538|FG001|Overall Study|Withdrawal by Subject|0|||
130077954|NCT00464620|468239539|FG000|Overall Study|Physician Decision|1|||
130077955|NCT00464620|468239540|FG001|Overall Study|Physician Decision|0|||
130077956|NCT00464620|468239541|FG002|Overall Study|Physician Decision|0|||
130077957|NCT00464620|468239539|FG000|Overall Study|Withdrawal by Subject|1|||
130077958|NCT00464620|468239540|FG001|Overall Study|Withdrawal by Subject|0|||
130077959|NCT00464620|468239541|FG002|Overall Study|Withdrawal by Subject|3|||
130077960|NCT00464620|468239539|FG000|Overall Study|Ineligible sarcoma subtype|0|||
130077961|NCT00464620|468239540|FG001|Overall Study|Ineligible sarcoma subtype|2|||
130077962|NCT00464620|468239541|FG002|Overall Study|Ineligible sarcoma subtype|2|||
130077963|NCT00464620|468239539|FG000|Overall Study|Use of prohibited concomitant medication|0|||
130077964|NCT00464620|468239540|FG001|Overall Study|Use of prohibited concomitant medication|0|||
130077965|NCT00464620|468239541|FG002|Overall Study|Use of prohibited concomitant medication|2|||
130077966|NCT04984876|468239542|FG000|Overall Study|Subject decision|2|||
130077967|NCT04984876|468239543|FG001|Overall Study|Subject decision|10|||
130077968|NCT04984876|468239544|FG002|Overall Study|Subject decision|3|||
130077969|NCT04984876|468239545|FG003|Overall Study|Subject decision|3|||
130077970|NCT04984876|468239546|FG004|Overall Study|Subject decision|3|||
130077971|NCT04984876|468239547|FG005|Overall Study|Subject decision|0|||
130077972|NCT04984876|468239542|FG000|Overall Study|Guardian decision|0|||
130077973|NCT04984876|468239543|FG001|Overall Study|Guardian decision|1|||
130077974|NCT04984876|468239544|FG002|Overall Study|Guardian decision|0|||
130077975|NCT04984876|468239545|FG003|Overall Study|Guardian decision|2|||
130077976|NCT04984876|468239546|FG004|Overall Study|Guardian decision|0|||
130077977|NCT04984876|468239547|FG005|Overall Study|Guardian decision|1|||
130077978|NCT04984876|468239542|FG000|Overall Study|Lost to Follow-up|0|||
130077979|NCT04984876|468239543|FG001|Overall Study|Lost to Follow-up|0|||
129952891|NCT01124916|467788404|FG000|Overall Study|Lost to Follow-up|3|||
129952892|NCT01124916|467788405|FG001|Overall Study|Lost to Follow-up|2|||
129952893|NCT01901302|467788406|FG000|Overall Study|Adverse Event|2|||
130077980|NCT04984876|468239544|FG002|Overall Study|Lost to Follow-up|1|||
130077981|NCT04984876|468239545|FG003|Overall Study|Lost to Follow-up|1|||
130077982|NCT04984876|468239546|FG004|Overall Study|Lost to Follow-up|0|||
130077983|NCT04984876|468239547|FG005|Overall Study|Lost to Follow-up|0|||
130077984|NCT04984876|468239542|FG000|Overall Study|Physician Decision|1|||
130077985|NCT04984876|468239543|FG001|Overall Study|Physician Decision|0|||
130077986|NCT04984876|468239544|FG002|Overall Study|Physician Decision|0|||
130077987|NCT04984876|468239545|FG003|Overall Study|Physician Decision|1|||
130077988|NCT04984876|468239546|FG004|Overall Study|Physician Decision|0|||
130077989|NCT04984876|468239547|FG005|Overall Study|Physician Decision|0|||
130077990|NCT04984876|468239542|FG000|Overall Study|Adverse Event|0|||
130077991|NCT04984876|468239543|FG001|Overall Study|Adverse Event|0|||
130077992|NCT04984876|468239544|FG002|Overall Study|Adverse Event|1|||
130077993|NCT04984876|468239545|FG003|Overall Study|Adverse Event|0|||
130077994|NCT04984876|468239546|FG004|Overall Study|Adverse Event|0|||
130077995|NCT04984876|468239547|FG005|Overall Study|Adverse Event|0|||
130077996|NCT03654560|468239550|FG000|Overall Study|Death|3|||
130077997|NCT03654560|468239551|FG001|Overall Study|Death|1|||
130077998|NCT03654560|468239550|FG000|Overall Study|Lost to Follow-up|1|||
130077999|NCT03654560|468239551|FG001|Overall Study|Lost to Follow-up|0|||
130078000|NCT00209092|468239552|FG000|Overall Study|Progression of disease|7|||
130078001|NCT00209092|468239553|FG001|Overall Study|Progression of disease|1|||
130078002|NCT00209092|468239552|FG000|Overall Study|Adverse Event|0|||
130078003|NCT00209092|468239553|FG001|Overall Study|Adverse Event|1|||
130078004|NCT00209092|468239552|FG000|Overall Study|Withdrawal by Subject|1|||
130078005|NCT00209092|468239553|FG001|Overall Study|Withdrawal by Subject|0|||
130078006|NCT02436915|468239556|FG000|Overall Study|Withdrawal by Subject|0|||
130078007|NCT02436915|468239557|FG001|Overall Study|Withdrawal by Subject|1|||
130078008|NCT01117181|468239564|FG000|Overall Study|Lost to Follow-up|1|||
130078009|NCT01117181|468239565|FG001|Overall Study|Lost to Follow-up|0|||
130078010|NCT01117181|468239564|FG000|Overall Study|Withdrawal by Subject|0|||
130078011|NCT01117181|468239565|FG001|Overall Study|Withdrawal by Subject|2|||
130078012|NCT01518309|468239566|FG000|Overall Study|Adverse Event|6|||
130078013|NCT01518309|468239566|FG000|Overall Study|Death|6|||
130078014|NCT01518309|468239566|FG000|Overall Study|Lack of Efficacy|7|||
130078015|NCT01518309|468239566|FG000|Overall Study|Withdrawal by Subject|6|||
130078016|NCT01518309|468239566|FG000|Overall Study|Physician Decision|3|||
130078017|NCT01518309|468239566|FG000|Overall Study|Sponsor Decision|2|||
130078018|NCT01518309|468239566|FG000|Overall Study|Not in Predefined Categories|9|||
130078019|NCT00863317|468239567|FG000|Overall Study|Lost to Follow-up|8|||
130078020|NCT00863317|468239568|FG001|Overall Study|Lost to Follow-up|9|||
130078021|NCT00038142|468239571|FG000|Overall Study|Ineligible|1|||
130078022|NCT00038142|468239572|FG001|Overall Study|Ineligible|0|||
130078023|NCT00038142|468239571|FG000|Overall Study|Progressive Disease|11|||
130078024|NCT00038142|468239572|FG001|Overall Study|Progressive Disease|7|||
130078025|NCT00038142|468239571|FG000|Overall Study|Death|1|||
130078026|NCT00038142|468239572|FG001|Overall Study|Death|0|||
130078027|NCT00038142|468239571|FG000|Overall Study|Adverse Event|1|||
130078028|NCT00038142|468239572|FG001|Overall Study|Adverse Event|0|||
130078029|NCT00038142|468239571|FG000|Overall Study|Unknown Reason|8|||
130078030|NCT00038142|468239572|FG001|Overall Study|Unknown Reason|0|||
130078031|NCT00809614|468239579|FG000|Overall Study|Lack of Efficacy|2|||
130078032|NCT00809614|468239580|FG001|Overall Study|Lack of Efficacy|3|||
130078033|NCT00809614|468239579|FG000|Overall Study|Withdrawal by Subject|1|||
130078034|NCT00809614|468239580|FG001|Overall Study|Withdrawal by Subject|1|||
130078035|NCT01080625|468239581|FG000|Overall Study|Physician Decision|0|||
130078036|NCT01080625|468239582|FG001|Overall Study|Physician Decision|2|||
130120773|NCT01957488|468404798|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
130120774|NCT01957488|468404799|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
129952894|NCT01901302|467788407|FG001|Overall Study|Adverse Event|1|||
129952895|NCT01901302|467788406|FG000|Overall Study|Lack of Efficacy|0|||
129952896|NCT01901302|467788407|FG001|Overall Study|Lack of Efficacy|2|||
129952897|NCT01901302|467788406|FG000|Overall Study|Study Terminated by Sponsor|23|||
130078037|NCT01080625|468239583|FG002|Overall Study|Physician Decision|1|||
130078038|NCT00364832|468239587|FG000|Core Period|Early Withdrawals|2|||
130078039|NCT00364832|468239588|FG001|Core Period|Early Withdrawals|2|||
130078040|NCT00364832|468239589|FG002|Core Period|Early Withdrawals|1|||
130078041|NCT00364832|468239590|FG003|Core Period|Early Withdrawals|1|||
130078042|NCT00364832|468239591|FG004|Core Period|Early Withdrawals|0|||
130078043|NCT00364832|468239592|FG005|Core Period|Early Withdrawals|0|||
130078044|NCT00364832|468239593|FG006|Core Period|Early Withdrawals|4|||
130078045|NCT00364832|468239594|FG007|Core Period|Early Withdrawals|1|||
130078046|NCT00364832|468239595|FG008|Core Period|Early Withdrawals|0|||
130078047|NCT00364832|468239596|FG009|Core Period|Early Withdrawals|0|||
130120775|NCT01957488|468404800|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
130120776|NCT01957488|468404801|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
129952898|NCT01901302|467788407|FG001|Overall Study|Study Terminated by Sponsor|20|||
130078048|NCT00364832|468239597|FG010|Core Period|Early Withdrawals|0|||
130078049|NCT00364832|468239598|FG011|Core Period|Early Withdrawals|0|||
130078050|NCT00364832|468239587|FG000|Extension Year 1|Early Withdrawals|0|||
130078051|NCT00364832|468239588|FG001|Extension Year 1|Early Withdrawals|0|||
130078052|NCT00364832|468239589|FG002|Extension Year 1|Early Withdrawals|0|||
130078053|NCT00364832|468239590|FG003|Extension Year 1|Early Withdrawals|0|||
130078054|NCT00364832|468239591|FG004|Extension Year 1|Early Withdrawals|0|||
130078055|NCT00364832|468239592|FG005|Extension Year 1|Early Withdrawals|0|||
130078056|NCT00364832|468239593|FG006|Extension Year 1|Early Withdrawals|0|||
130078057|NCT00364832|468239594|FG007|Extension Year 1|Early Withdrawals|0|||
130078058|NCT00364832|468239595|FG008|Extension Year 1|Early Withdrawals|0|||
130078059|NCT00364832|468239596|FG009|Extension Year 1|Early Withdrawals|4|||
130078060|NCT00364832|468239597|FG010|Extension Year 1|Early Withdrawals|2|||
129952899|NCT01901302|467788406|FG000|Overall Study|Withdrawal by Subject|2|||
129952900|NCT01901302|467788407|FG001|Overall Study|Withdrawal by Subject|0|||
129952901|NCT01536795|467788416|FG000|Overall Study|Lost to Follow-up|0|||
129952902|NCT01536795|467788417|FG001|Overall Study|Lost to Follow-up|2|||
129952903|NCT01536795|467788416|FG000|Overall Study|Lack of Efficacy|1|||
130120777|NCT01957488|468404802|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
130120778|NCT01957488|468404797|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
130120779|NCT01957488|468404798|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129952904|NCT01536795|467788417|FG001|Overall Study|Lack of Efficacy|0|||
129952905|NCT01699178|467788418|FG000|Overall Study|Adverse Event|1|||
129952906|NCT01699178|467788419|FG001|Overall Study|Adverse Event|5|||
129952907|NCT01699178|467788418|FG000|Overall Study|Lost to Follow-up|1|||
129952908|NCT01699178|467788419|FG001|Overall Study|Lost to Follow-up|6|||
129952909|NCT01699178|467788418|FG000|Overall Study|Non-compliance with Study Drug|3|||
129952910|NCT01699178|467788419|FG001|Overall Study|Non-compliance with Study Drug|1|||
129952911|NCT01699178|467788418|FG000|Overall Study|Physician Decision|1|||
129952912|NCT01699178|467788419|FG001|Overall Study|Physician Decision|0|||
129952913|NCT01699178|467788418|FG000|Overall Study|Withdrawal by Subject|4|||
129952914|NCT01699178|467788419|FG001|Overall Study|Withdrawal by Subject|12|||
129952915|NCT01699178|467788418|FG000|Overall Study|Hematocrit >54%|1|||
129952916|NCT01699178|467788419|FG001|Overall Study|Hematocrit >54%|1|||
129952917|NCT01699178|467788418|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
129952918|NCT01699178|467788419|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
129952919|NCT01699178|467788418|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
129952920|NCT01699178|467788419|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
129952921|NCT02066389|467788424|FG000|Overall Study|Adverse Event|1|||
129952922|NCT02066389|467788425|FG001|Overall Study|Adverse Event|1|||
129952923|NCT02066389|467788426|FG002|Overall Study|Adverse Event|1|||
129952924|NCT02066389|467788427|FG003|Overall Study|Adverse Event|1|||
129952925|NCT02066389|467788428|FG004|Overall Study|Adverse Event|5|||
129952926|NCT02066389|467788429|FG005|Overall Study|Adverse Event|1|||
129952927|NCT02066389|467788424|FG000|Overall Study|Withdrawal by Subject|4|||
129952928|NCT02066389|467788425|FG001|Overall Study|Withdrawal by Subject|0|||
129952929|NCT02066389|467788426|FG002|Overall Study|Withdrawal by Subject|5|||
129952930|NCT02066389|467788427|FG003|Overall Study|Withdrawal by Subject|1|||
129952931|NCT02066389|467788428|FG004|Overall Study|Withdrawal by Subject|1|||
129952932|NCT02066389|467788429|FG005|Overall Study|Withdrawal by Subject|2|||
129952933|NCT02066389|467788424|FG000|Overall Study|Lost to Follow-up|0|||
129952934|NCT02066389|467788425|FG001|Overall Study|Lost to Follow-up|0|||
129952935|NCT02066389|467788426|FG002|Overall Study|Lost to Follow-up|0|||
129952936|NCT02066389|467788427|FG003|Overall Study|Lost to Follow-up|1|||
129952937|NCT02066389|467788428|FG004|Overall Study|Lost to Follow-up|1|||
129952938|NCT02066389|467788429|FG005|Overall Study|Lost to Follow-up|1|||
129952939|NCT02066389|467788424|FG000|Overall Study|Randomized in Error|0|||
129952940|NCT02066389|467788425|FG001|Overall Study|Randomized in Error|0|||
129952941|NCT02066389|467788426|FG002|Overall Study|Randomized in Error|0|||
129952942|NCT02066389|467788427|FG003|Overall Study|Randomized in Error|0|||
129952943|NCT02066389|467788428|FG004|Overall Study|Randomized in Error|0|||
129952944|NCT02066389|467788429|FG005|Overall Study|Randomized in Error|1|||
129952945|NCT01755598|467788432|FG000|Overall Study|Other|109|||
129952946|NCT01755598|467788433|FG001|Overall Study|Other|109|||
129952947|NCT01755598|467788432|FG000|Overall Study|Lost to Follow-up|32|||
129952948|NCT01755598|467788433|FG001|Overall Study|Lost to Follow-up|43|||
129952949|NCT01755598|467788432|FG000|Overall Study|Migrated/moved from study area|76|||
129952950|NCT01755598|467788433|FG001|Overall Study|Migrated/moved from study area|65|||
129952951|NCT01755598|467788432|FG000|Overall Study|Withdrawal by Subject|22|||
129952952|NCT01755598|467788433|FG001|Overall Study|Withdrawal by Subject|31|||
129952953|NCT01755598|467788432|FG000|Overall Study|Protocol Violation|7|||
129952954|NCT01755598|467788433|FG001|Overall Study|Protocol Violation|7|||
129952955|NCT01755598|467788432|FG000|Overall Study|Adverse Event|19|||
129952956|NCT01755598|467788433|FG001|Overall Study|Adverse Event|28|||
129952957|NCT02924051|467788434|FG000|Overall Study|Withdrawal by Subject|1|||
129952958|NCT02924051|467788435|FG001|Overall Study|Withdrawal by Subject|9|||
129952959|NCT03547167|467788438|FG000|Overall Study|Withdrawal by Subject|34|||
129952960|NCT03547167|467788439|FG001|Overall Study|Withdrawal by Subject|12|||
129952961|NCT03547167|467788438|FG000|Overall Study|Screen Failure|0|||
129952962|NCT03547167|467788439|FG001|Overall Study|Screen Failure|1|||
129952963|NCT03547167|467788438|FG000|Overall Study|Lost to Follow-up|59|||
129952964|NCT03547167|467788439|FG001|Overall Study|Lost to Follow-up|15|||
129952965|NCT03547167|467788438|FG000|Overall Study|Death|4|||
129952966|NCT03547167|467788439|FG001|Overall Study|Death|2|||
129952967|NCT00645411|467788440|FG000|Overall Study|Adverse Event|0|||
129952968|NCT00645411|467788441|FG001|Overall Study|Adverse Event|0|||
130120780|NCT01957488|468404799|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
129952969|NCT00645411|467788442|FG002|Overall Study|Adverse Event|0|||
129952970|NCT00645411|467788443|FG003|Overall Study|Adverse Event|2|||
129952971|NCT00645411|467788440|FG000|Overall Study|Withdrawal by Subject|2|||
129952972|NCT00645411|467788441|FG001|Overall Study|Withdrawal by Subject|1|||
129952973|NCT00645411|467788442|FG002|Overall Study|Withdrawal by Subject|19|||
129952974|NCT00645411|467788443|FG003|Overall Study|Withdrawal by Subject|21|||
129952975|NCT00645411|467788440|FG000|Overall Study|Lost to Follow-up|10|||
129952976|NCT00645411|467788441|FG001|Overall Study|Lost to Follow-up|5|||
129952977|NCT00645411|467788442|FG002|Overall Study|Lost to Follow-up|124|||
129952978|NCT00645411|467788443|FG003|Overall Study|Lost to Follow-up|75|||
129952979|NCT00645411|467788440|FG000|Overall Study|Protocol Violation|1|||
129952980|NCT00645411|467788441|FG001|Overall Study|Protocol Violation|0|||
129952981|NCT00645411|467788442|FG002|Overall Study|Protocol Violation|1|||
129952982|NCT00645411|467788443|FG003|Overall Study|Protocol Violation|0|||
129952983|NCT00645411|467788440|FG000|Overall Study|Inappropriate enrollment|0|||
129952984|NCT00645411|467788441|FG001|Overall Study|Inappropriate enrollment|0|||
129952985|NCT00645411|467788442|FG002|Overall Study|Inappropriate enrollment|4|||
129952986|NCT00645411|467788443|FG003|Overall Study|Inappropriate enrollment|1|||
129952987|NCT00645411|467788440|FG000|Overall Study|Unable to classify|0|||
129952988|NCT00645411|467788441|FG001|Overall Study|Unable to classify|0|||
129952989|NCT00645411|467788442|FG002|Overall Study|Unable to classify|3|||
129952990|NCT00645411|467788443|FG003|Overall Study|Unable to classify|4|||
129952991|NCT03987074|467788445|FG000|Overall Study|Withdrew Consent|1|||
129952992|NCT03987074|467788446|FG001|Overall Study|Withdrew Consent|1|||
129952993|NCT03987074|467788447|FG002|Overall Study|Withdrew Consent|0|||
129952994|NCT03987074|467788448|FG003|Overall Study|Withdrew Consent|2|||
129952995|NCT03987074|467788449|FG004|Overall Study|Withdrew Consent|1|||
129952996|NCT03987074|467788445|FG000|Overall Study|Adverse Event|2|||
129952997|NCT03987074|467788446|FG001|Overall Study|Adverse Event|1|||
129952998|NCT03987074|467788447|FG002|Overall Study|Adverse Event|0|||
129952999|NCT03987074|467788448|FG003|Overall Study|Adverse Event|0|||
129953000|NCT03987074|467788449|FG004|Overall Study|Adverse Event|1|||
129953001|NCT03987074|467788445|FG000|Overall Study|Lost to Follow-up|0|||
129953002|NCT03987074|467788446|FG001|Overall Study|Lost to Follow-up|0|||
129953003|NCT03987074|467788447|FG002|Overall Study|Lost to Follow-up|1|||
129953004|NCT03987074|467788448|FG003|Overall Study|Lost to Follow-up|1|||
129953005|NCT03987074|467788449|FG004|Overall Study|Lost to Follow-up|0|||
129953006|NCT03987074|467788445|FG000|Overall Study|Investigator's Discretion|0|||
129953007|NCT03987074|467788446|FG001|Overall Study|Investigator's Discretion|0|||
129953008|NCT03987074|467788447|FG002|Overall Study|Investigator's Discretion|0|||
129953009|NCT03987074|467788448|FG003|Overall Study|Investigator's Discretion|1|||
129953010|NCT03987074|467788449|FG004|Overall Study|Investigator's Discretion|0|||
129953011|NCT01334606|467788454|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
129953012|NCT02674399|467788455|FG000|Overall Study|Lost to Follow-up|2|||
129953013|NCT02674399|467788456|FG001|Overall Study|Lost to Follow-up|0|||
129953014|NCT02138838|467788457|FG000|Overall Study|Study Closure|7|||
129953015|NCT02138838|467788458|FG001|Overall Study|Study Closure|6|||
129953016|NCT02138838|467788457|FG000|Overall Study|Withdrawal by Subject|1|||
129953017|NCT02138838|467788458|FG001|Overall Study|Withdrawal by Subject|5|||
129953018|NCT02993926|467788461|FG000|Enantone Treatment Phase|Adverse Event|1|||
129953019|NCT02993926|467788462|FG001|Enantone Treatment Phase|Adverse Event|0|||
129953020|NCT02993926|467788463|FG002|Enantone Treatment Phase|Adverse Event|0|||
129953021|NCT02993926|467788461|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
129953022|NCT02993926|467788462|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
129953023|NCT02993926|467788463|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
129953024|NCT02993926|467788461|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
129953025|NCT02993926|467788462|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
129953026|NCT02993926|467788463|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
129953027|NCT02993926|467788461|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
129953028|NCT02993926|467788462|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
129953029|NCT02993926|467788463|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
129953030|NCT01084772|467788465|FG000|Baseline|Withdrawal by Subject|7|||
129953031|NCT01084772|467788466|FG001|Baseline|Withdrawal by Subject|6|||
129953032|NCT01084772|467788465|FG000|3 Months|Death|1|||
129953033|NCT01084772|467788466|FG001|3 Months|Death|0|||
129953034|NCT01084772|467788465|FG000|3 Months|Study Termination|2|||
129953035|NCT01084772|467788466|FG001|3 Months|Study Termination|2|||
129953036|NCT01084772|467788465|FG000|1 Year|Withdrawal by Subject|0|||
129953037|NCT01084772|467788466|FG001|1 Year|Withdrawal by Subject|1|||
129953038|NCT01084772|467788465|FG000|1 Year|Lost to Follow-up|3|||
129953039|NCT01084772|467788466|FG001|1 Year|Lost to Follow-up|0|||
129953040|NCT01084772|467788465|FG000|1 Year|Study Termination|0|||
129953041|NCT01084772|467788466|FG001|1 Year|Study Termination|7|||
129953042|NCT01084772|467788465|FG000|2 Years|Withdrawal by Subject|1|||
129953043|NCT01084772|467788466|FG001|2 Years|Withdrawal by Subject|0|||
129953044|NCT01084772|467788465|FG000|2 Years|Lost to Follow-up|5|||
129953045|NCT01084772|467788466|FG001|2 Years|Lost to Follow-up|2|||
129953046|NCT01084772|467788465|FG000|2 Years|Study Termination|3|||
129953047|NCT01084772|467788466|FG001|2 Years|Study Termination|2|||
129953048|NCT01867307|467788467|FG000|Overall Study|Protocol Violation|2|||
129953049|NCT01867307|467788468|FG001|Overall Study|Protocol Violation|0|||
129953050|NCT01867307|467788467|FG000|Overall Study|Other Adverse Event|1|||
130078061|NCT00364832|468239598|FG011|Extension Year 1|Early Withdrawals|10|||
130078062|NCT00364832|468239587|FG000|Extension Year 2|Early Withdrawals|0|||
130078063|NCT00364832|468239588|FG001|Extension Year 2|Early Withdrawals|0|||
130078064|NCT00364832|468239589|FG002|Extension Year 2|Early Withdrawals|0|||
130078065|NCT00364832|468239590|FG003|Extension Year 2|Early Withdrawals|0|||
130078066|NCT00364832|468239591|FG004|Extension Year 2|Early Withdrawals|0|||
130078067|NCT00364832|468239592|FG005|Extension Year 2|Early Withdrawals|0|||
130078068|NCT00364832|468239593|FG006|Extension Year 2|Early Withdrawals|0|||
130078069|NCT00364832|468239594|FG007|Extension Year 2|Early Withdrawals|0|||
130078070|NCT00364832|468239595|FG008|Extension Year 2|Early Withdrawals|0|||
130078071|NCT00364832|468239596|FG009|Extension Year 2|Early Withdrawals|5|||
130078072|NCT00364832|468239597|FG010|Extension Year 2|Early Withdrawals|5|||
130078073|NCT00364832|468239598|FG011|Extension Year 2|Early Withdrawals|3|||
130078074|NCT02658149|468239600|FG000|Overall Study|Physician Decision|1|||
130078075|NCT02658149|468239601|FG001|Overall Study|Physician Decision|0|||
130078076|NCT01440972|468239604|FG000|Overall Study|Withdrawal by Subject|3|||
130078077|NCT01440972|468239605|FG001|Overall Study|Withdrawal by Subject|2|||
130078078|NCT04222673|468239606|FG000|Overall Study|Lost to Follow-up|5|||
130078079|NCT00068822|468239607|FG000|First Randomized Intervention|Lost to Follow-up|1|||
130078080|NCT00068822|468239608|FG001|First Randomized Intervention|Lost to Follow-up|2|||
130078081|NCT00735072|468239612|FG000|Overall Study|interrupted study med during ARV change|1|||
130078082|NCT00735072|468239613|FG001|Overall Study|interrupted study med during ARV change|0|||
130078083|NCT00735072|468239612|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
130078084|NCT00735072|468239613|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
130078085|NCT00911144|468239614|FG000|Overall Study|Withdrawal by Subject|16|||
130078086|NCT00911144|468239615|FG001|Overall Study|Withdrawal by Subject|5|||
130078087|NCT01024920|468239620|FG000|Overall Study|Progressive disease|47|||
130078088|NCT01024920|468239621|FG001|Overall Study|Progressive disease|25|||
130078089|NCT01024920|468239620|FG000|Overall Study|Adverse Event|8|||
130078090|NCT01024920|468239621|FG001|Overall Study|Adverse Event|4|||
130078091|NCT01024920|468239620|FG000|Overall Study|Lost to Follow-up|0|||
130078092|NCT01024920|468239621|FG001|Overall Study|Lost to Follow-up|1|||
130078093|NCT01024920|468239620|FG000|Overall Study|Patient refusal to continue|4|||
130078094|NCT01024920|468239621|FG001|Overall Study|Patient refusal to continue|0|||
130078095|NCT01024920|468239620|FG000|Overall Study|Other than listed|5|||
130078096|NCT01024920|468239621|FG001|Overall Study|Other than listed|1|||
130078097|NCT01024920|468239620|FG000|Overall Study|Not treated|3|||
130078098|NCT01024920|468239621|FG001|Overall Study|Not treated|0|||
130078099|NCT01024920|468239620|FG000|Overall Study|Protocol Violation|0|||
130078100|NCT01024920|468239621|FG001|Overall Study|Protocol Violation|1|||
130078101|NCT01098032|468239622|FG000|Overall Study|Withdrawal by Subject|1|||
130078102|NCT01098032|468239623|FG001|Overall Study|Withdrawal by Subject|1|||
130078103|NCT02182999|468239627|FG000|Overall Study|Adverse Event|4|||
130078104|NCT02182999|468239628|FG001|Overall Study|Adverse Event|3|||
130078105|NCT02182999|468239627|FG000|Overall Study|Physician Decision|1|||
129953051|NCT01867307|467788468|FG001|Overall Study|Other Adverse Event|3|||
129953052|NCT00518206|467788469|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
129953053|NCT00518206|467788470|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
129953054|NCT00518206|467788469|FG000|Overall Study|Withdrawal by Subject|2|||
129953055|NCT00518206|467788470|FG001|Overall Study|Withdrawal by Subject|0|||
129953056|NCT00518206|467788469|FG000|Overall Study|Drug Supply Issue|1|||
129953057|NCT00518206|467788470|FG001|Overall Study|Drug Supply Issue|0|||
129953058|NCT00518206|467788469|FG000|Overall Study|Reason Unknown|1|||
129953059|NCT00518206|467788470|FG001|Overall Study|Reason Unknown|0|||
129953060|NCT00518206|467788469|FG000|Overall Study|Completion Status Unknown|1|||
129953061|NCT00518206|467788470|FG001|Overall Study|Completion Status Unknown|0|||
129953062|NCT05356130|467789833|FG000|Overall Study|Withdrawal by Subject|0|||
130078106|NCT02182999|468239628|FG001|Overall Study|Physician Decision|0|||
130078107|NCT02252588|468239630|FG000|Overall Study|Withdrawal by Subject|4|||
130078108|NCT02252588|468239631|FG001|Overall Study|Withdrawal by Subject|0|||
130078109|NCT03039790|468239632|FG000|Overall Study|Lost to Follow-up|2|||
130078110|NCT03039790|468239633|FG001|Overall Study|Lost to Follow-up|0|||
130078111|NCT03039790|468239634|FG002|Overall Study|Lost to Follow-up|1|||
130078112|NCT03039790|468239635|FG003|Overall Study|Lost to Follow-up|1|||
130078113|NCT03039790|468239636|FG004|Overall Study|Lost to Follow-up|0|||
130078114|NCT03039790|468239637|FG005|Overall Study|Lost to Follow-up|1|||
129953063|NCT05356130|467789834|FG001|Overall Study|Withdrawal by Subject|0|||
129953064|NCT05356130|467789835|FG002|Overall Study|Withdrawal by Subject|3|||
129953065|NCT00228813|467789836|FG000|Overall Study|Death|4|||
130078115|NCT03039790|468239638|FG006|Overall Study|Lost to Follow-up|1|||
130078116|NCT03039790|468239639|FG007|Overall Study|Lost to Follow-up|1|||
130078117|NCT03039790|468239640|FG008|Overall Study|Lost to Follow-up|0|||
130078118|NCT03039790|468239641|FG009|Overall Study|Lost to Follow-up|1|||
130078119|NCT03039790|468239642|FG010|Overall Study|Lost to Follow-up|1|||
130078120|NCT03039790|468239643|FG011|Overall Study|Lost to Follow-up|0|||
130078121|NCT03039790|468239644|FG012|Overall Study|Lost to Follow-up|1|||
130078122|NCT03039790|468239645|FG013|Overall Study|Lost to Follow-up|0|||
129953066|NCT00668746|467789837|FG000|Overall Study|Lost to Follow-up|2|||
129953067|NCT00668746|467789838|FG001|Overall Study|Lost to Follow-up|1|||
129953068|NCT02109172|467789839|FG000|Overall Study|Withdrawal by Subject|1|||
129953069|NCT02109172|467789840|FG001|Overall Study|Withdrawal by Subject|0|||
129953070|NCT02109172|467789841|FG002|Overall Study|Withdrawal by Subject|0|||
129953071|NCT02109172|467789842|FG003|Overall Study|Withdrawal by Subject|1|||
129953072|NCT02109172|467789843|FG004|Overall Study|Withdrawal by Subject|0|||
129953073|NCT02109172|467789844|FG005|Overall Study|Withdrawal by Subject|0|||
129953074|NCT02109172|467789839|FG000|Overall Study|Adverse Event|0|||
129953075|NCT02109172|467789840|FG001|Overall Study|Adverse Event|0|||
129953076|NCT02109172|467789841|FG002|Overall Study|Adverse Event|1|||
129953077|NCT02109172|467789842|FG003|Overall Study|Adverse Event|0|||
129953078|NCT02109172|467789843|FG004|Overall Study|Adverse Event|0|||
129953079|NCT02109172|467789844|FG005|Overall Study|Adverse Event|1|||
129953080|NCT02109172|467789839|FG000|Overall Study|Death|0|||
129953081|NCT02109172|467789840|FG001|Overall Study|Death|0|||
129953082|NCT02109172|467789841|FG002|Overall Study|Death|0|||
129953083|NCT02109172|467789842|FG003|Overall Study|Death|0|||
129953084|NCT02109172|467789843|FG004|Overall Study|Death|1|||
129953085|NCT02109172|467789844|FG005|Overall Study|Death|0|||
130078123|NCT03039790|468239646|FG014|Overall Study|Lost to Follow-up|3|||
130078124|NCT03039790|468239647|FG015|Overall Study|Lost to Follow-up|1|||
130078125|NCT03039790|468239648|FG016|Overall Study|Lost to Follow-up|2|||
130078126|NCT03039790|468239649|FG017|Overall Study|Lost to Follow-up|2|||
130078127|NCT03039790|468239650|FG018|Overall Study|Lost to Follow-up|1|||
130078128|NCT03039790|468239651|FG019|Overall Study|Lost to Follow-up|3|||
130078129|NCT03039790|468239632|FG000|Overall Study|Withdrawal of Consent|1|||
130078130|NCT03039790|468239633|FG001|Overall Study|Withdrawal of Consent|0|||
130078131|NCT03039790|468239634|FG002|Overall Study|Withdrawal of Consent|0|||
130078132|NCT03039790|468239635|FG003|Overall Study|Withdrawal of Consent|1|||
130078133|NCT03039790|468239636|FG004|Overall Study|Withdrawal of Consent|0|||
130078134|NCT03039790|468239637|FG005|Overall Study|Withdrawal of Consent|0|||
130078135|NCT03039790|468239638|FG006|Overall Study|Withdrawal of Consent|0|||
130078136|NCT03039790|468239639|FG007|Overall Study|Withdrawal of Consent|0|||
130078137|NCT03039790|468239640|FG008|Overall Study|Withdrawal of Consent|0|||
130078138|NCT03039790|468239641|FG009|Overall Study|Withdrawal of Consent|1|||
130078139|NCT03039790|468239642|FG010|Overall Study|Withdrawal of Consent|0|||
130078140|NCT03039790|468239643|FG011|Overall Study|Withdrawal of Consent|0|||
130078141|NCT03039790|468239644|FG012|Overall Study|Withdrawal of Consent|2|||
130078142|NCT03039790|468239645|FG013|Overall Study|Withdrawal of Consent|0|||
130078143|NCT03039790|468239646|FG014|Overall Study|Withdrawal of Consent|1|||
130078144|NCT03039790|468239647|FG015|Overall Study|Withdrawal of Consent|5|||
130078145|NCT03039790|468239648|FG016|Overall Study|Withdrawal of Consent|3|||
130078146|NCT03039790|468239649|FG017|Overall Study|Withdrawal of Consent|0|||
130078147|NCT03039790|468239650|FG018|Overall Study|Withdrawal of Consent|2|||
130078148|NCT03039790|468239651|FG019|Overall Study|Withdrawal of Consent|5|||
130078149|NCT03039790|468239632|FG000|Overall Study|Death|0|||
130078150|NCT03039790|468239633|FG001|Overall Study|Death|0|||
130078151|NCT03039790|468239634|FG002|Overall Study|Death|0|||
130078152|NCT03039790|468239635|FG003|Overall Study|Death|0|||
130078153|NCT03039790|468239636|FG004|Overall Study|Death|0|||
130078154|NCT03039790|468239637|FG005|Overall Study|Death|0|||
130078155|NCT03039790|468239638|FG006|Overall Study|Death|0|||
130078156|NCT03039790|468239639|FG007|Overall Study|Death|0|||
130078157|NCT03039790|468239640|FG008|Overall Study|Death|0|||
130078158|NCT03039790|468239641|FG009|Overall Study|Death|0|||
130078159|NCT03039790|468239642|FG010|Overall Study|Death|0|||
130078160|NCT03039790|468239643|FG011|Overall Study|Death|0|||
130078161|NCT03039790|468239644|FG012|Overall Study|Death|0|||
130078162|NCT03039790|468239645|FG013|Overall Study|Death|0|||
130078163|NCT03039790|468239646|FG014|Overall Study|Death|0|||
130078164|NCT03039790|468239647|FG015|Overall Study|Death|1|||
130120781|NCT01957488|468404800|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
129953086|NCT05361304|467789852|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
129953087|NCT05361304|467789853|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
129953088|NCT05361304|467789852|FG000|Overall Study|COVID-19 Related|1|||
129953089|NCT05361304|467789853|FG001|Overall Study|COVID-19 Related|2|||
130078165|NCT03039790|468239648|FG016|Overall Study|Death|3|||
130078166|NCT03039790|468239649|FG017|Overall Study|Death|0|||
130078167|NCT03039790|468239650|FG018|Overall Study|Death|2|||
130078168|NCT03039790|468239651|FG019|Overall Study|Death|0|||
129953090|NCT05361304|467789852|FG000|Overall Study|Withdrawal by Subject|1|||
129953091|NCT05361304|467789853|FG001|Overall Study|Withdrawal by Subject|0|||
129953092|NCT01816165|467789854|FG000|Overall Study|Adverse Event|1|||
129953093|NCT01816165|467789855|FG001|Overall Study|Adverse Event|0|||
130078169|NCT03039790|468239632|FG000|Overall Study|Reason, not Specified|1|||
130078170|NCT03039790|468239633|FG001|Overall Study|Reason, not Specified|0|||
130078171|NCT03039790|468239634|FG002|Overall Study|Reason, not Specified|0|||
130078172|NCT03039790|468239635|FG003|Overall Study|Reason, not Specified|0|||
130078173|NCT03039790|468239636|FG004|Overall Study|Reason, not Specified|0|||
130078174|NCT03039790|468239637|FG005|Overall Study|Reason, not Specified|0|||
130078175|NCT03039790|468239638|FG006|Overall Study|Reason, not Specified|0|||
130078176|NCT03039790|468239639|FG007|Overall Study|Reason, not Specified|0|||
130078177|NCT03039790|468239640|FG008|Overall Study|Reason, not Specified|0|||
130078178|NCT03039790|468239641|FG009|Overall Study|Reason, not Specified|0|||
130078179|NCT03039790|468239642|FG010|Overall Study|Reason, not Specified|0|||
130078180|NCT03039790|468239643|FG011|Overall Study|Reason, not Specified|0|||
130078181|NCT03039790|468239644|FG012|Overall Study|Reason, not Specified|0|||
130078182|NCT03039790|468239645|FG013|Overall Study|Reason, not Specified|0|||
130078183|NCT03039790|468239646|FG014|Overall Study|Reason, not Specified|0|||
130078184|NCT03039790|468239647|FG015|Overall Study|Reason, not Specified|0|||
130078185|NCT03039790|468239648|FG016|Overall Study|Reason, not Specified|2|||
130078186|NCT03039790|468239649|FG017|Overall Study|Reason, not Specified|0|||
130078187|NCT03039790|468239650|FG018|Overall Study|Reason, not Specified|1|||
130078188|NCT03039790|468239651|FG019|Overall Study|Reason, not Specified|0|||
130078189|NCT02972593|468239652|FG000|Overall Study|Lost to Follow-up|19|||
130078190|NCT02972593|468239653|FG001|Overall Study|Lost to Follow-up|15|||
130078191|NCT02972593|468239652|FG000|Overall Study|Protocol Violation|1|||
130078192|NCT02972593|468239653|FG001|Overall Study|Protocol Violation|0|||
129953094|NCT01816165|467789856|FG002|Overall Study|Adverse Event|0|||
129953095|NCT01816165|467789857|FG003|Overall Study|Adverse Event|0|||
129953096|NCT03960437|467789859|FG000|Overall Study|Removed by PI|4|||
129953097|NCT03960437|467789859|FG000|Overall Study|Lost to Follow-up|2|||
129953098|NCT03960437|467789859|FG000|Overall Study|Withdrawal by Subject|1|||
129953099|NCT03960437|467789859|FG000|Overall Study|Death|2|||
129953100|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Adverse Event|0|||
129953101|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Adverse Event|0|||
129953102|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Adverse Event|0|||
129953103|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Adverse Event|5|||
129953104|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Adverse Event|0|||
129953105|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Death|0|||
129953106|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Death|0|||
129953107|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Death|0|||
129953108|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Death|1|||
129953109|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Death|0|||
129953110|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Disease Progression|1|||
129953111|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Disease Progression|1|||
129953112|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Disease Progression|0|||
129953113|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Disease Progression|10|||
129953114|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Disease Progression|1|||
129953115|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Other|0|||
129953116|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Other|0|||
129953117|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Other|0|||
129953118|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Other|1|||
129953119|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Other|0|||
129953120|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Adverse Event|0|||
129953121|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Adverse Event|0|||
129953122|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Adverse Event|0|||
129953123|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Adverse Event|1|||
129953124|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Adverse Event|0|||
129953125|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Death|0|||
129953126|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Death|0|||
129953127|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Death|0|||
129953128|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Death|1|||
129953129|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Death|1|||
129953130|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Disease Progression|0|||
129953131|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Disease Progression|2|||
129953132|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Disease Progression|2|||
129953133|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Disease Progression|17|||
129953134|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Disease Progression|1|||
129953135|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953136|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953137|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953138|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
129953139|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953140|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Other|1|||
129953141|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Other|0|||
129953142|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Other|0|||
129953143|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Other|3|||
129953144|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Other|0|||
129953145|NCT00267956|467789867|FG000|Controlled Period|Adverse Event|4|||
129953146|NCT00267956|467789868|FG001|Controlled Period|Adverse Event|1|||
129953147|NCT00267956|467789869|FG002|Controlled Period|Adverse Event|0|||
129953148|NCT00267956|467789870|FG003|Controlled Period|Adverse Event|0|||
129953149|NCT00267956|467789867|FG000|Controlled Period|Lack of Efficacy|4|||
129953150|NCT00267956|467789868|FG001|Controlled Period|Lack of Efficacy|2|||
129953151|NCT00267956|467789869|FG002|Controlled Period|Lack of Efficacy|0|||
129953152|NCT00267956|467789870|FG003|Controlled Period|Lack of Efficacy|0|||
130078193|NCT00693693|468239654|FG000|Overall Study|Lost to Follow-up|1|||
130078194|NCT00693693|468239655|FG001|Overall Study|Lost to Follow-up|1|||
130078195|NCT00693693|468239656|FG002|Overall Study|Lost to Follow-up|2|||
130078196|NCT00638690|468239665|FG000|Overall Study|Death|655|||
130078197|NCT00638690|468239666|FG001|Overall Study|Death|335|||
130078198|NCT00638690|468239665|FG000|Overall Study|Withdrawal by Subject|22|||
130078199|NCT00638690|468239666|FG001|Overall Study|Withdrawal by Subject|5|||
130078200|NCT00638690|468239665|FG000|Overall Study|Lost to Follow-up|4|||
130078201|NCT00638690|468239666|FG001|Overall Study|Lost to Follow-up|2|||
130078202|NCT00621244|468239672|FG000|Overall Study|Withdrawal by Subject|7|||
130078203|NCT00621244|468239673|FG001|Overall Study|Withdrawal by Subject|3|||
130078204|NCT00621244|468239674|FG002|Overall Study|Withdrawal by Subject|3|||
130078205|NCT00621244|468239675|FG003|Overall Study|Withdrawal by Subject|3|||
130078206|NCT00621244|468239672|FG000|Overall Study|Disease progression|44|||
130078207|NCT00621244|468239673|FG001|Overall Study|Disease progression|20|||
130078208|NCT00621244|468239674|FG002|Overall Study|Disease progression|20|||
130078209|NCT00621244|468239675|FG003|Overall Study|Disease progression|15|||
130078210|NCT00621244|468239672|FG000|Overall Study|Death|3|||
130078211|NCT00621244|468239673|FG001|Overall Study|Death|3|||
130078212|NCT00621244|468239674|FG002|Overall Study|Death|1|||
130078213|NCT00621244|468239675|FG003|Overall Study|Death|1|||
130078214|NCT00621244|468239672|FG000|Overall Study|Adverse Event|27|||
130078215|NCT00621244|468239673|FG001|Overall Study|Adverse Event|7|||
130078216|NCT00621244|468239674|FG002|Overall Study|Adverse Event|9|||
130078217|NCT00621244|468239675|FG003|Overall Study|Adverse Event|2|||
130078218|NCT00621244|468239672|FG000|Overall Study|Administrative problems|5|||
130078219|NCT00621244|468239673|FG001|Overall Study|Administrative problems|1|||
130078220|NCT00621244|468239674|FG002|Overall Study|Administrative problems|0|||
130078221|NCT00621244|468239675|FG003|Overall Study|Administrative problems|2|||
130078222|NCT00565812|468239688|FG000|Overall Study|Death|2|||
130078223|NCT00565812|468239689|FG001|Overall Study|Death|1|||
130078224|NCT00565812|468239690|FG002|Overall Study|Death|3|||
130078225|NCT00565812|468239688|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
130078226|NCT00565812|468239689|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
130078227|NCT00565812|468239690|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
130078228|NCT00565812|468239688|FG000|Overall Study|Lost to Follow-up|10|||
130078229|NCT00565812|468239689|FG001|Overall Study|Lost to Follow-up|8|||
130078230|NCT00565812|468239690|FG002|Overall Study|Lost to Follow-up|8|||
130078231|NCT00565812|468239688|FG000|Overall Study|Withdrawal by Subject|58|||
130078232|NCT00565812|468239689|FG001|Overall Study|Withdrawal by Subject|47|||
130078233|NCT00565812|468239690|FG002|Overall Study|Withdrawal by Subject|48|||
130078234|NCT00565812|468239688|FG000|Overall Study|Work Schedule|5|||
130078235|NCT00565812|468239689|FG001|Overall Study|Work Schedule|3|||
130078236|NCT00565812|468239690|FG002|Overall Study|Work Schedule|1|||
130078237|NCT00565812|468239688|FG000|Overall Study|Protocol Violation|2|||
130078238|NCT00565812|468239689|FG001|Overall Study|Protocol Violation|6|||
130078239|NCT00565812|468239690|FG002|Overall Study|Protocol Violation|4|||
130078240|NCT00565812|468239688|FG000|Overall Study|Adverse Event|41|||
130078241|NCT00565812|468239689|FG001|Overall Study|Adverse Event|54|||
130078242|NCT00565812|468239690|FG002|Overall Study|Adverse Event|40|||
130078243|NCT00565812|468239688|FG000|Overall Study|Jury Duty|1|||
130078244|NCT00565812|468239689|FG001|Overall Study|Jury Duty|0|||
130078245|NCT00565812|468239690|FG002|Overall Study|Jury Duty|0|||
130078246|NCT00565812|468239688|FG000|Overall Study|Relocated Out of Area|5|||
130078247|NCT00565812|468239689|FG001|Overall Study|Relocated Out of Area|8|||
130078248|NCT00565812|468239690|FG002|Overall Study|Relocated Out of Area|9|||
130078249|NCT00565812|468239688|FG000|Overall Study|Sponsor Decision|1|||
130078250|NCT00565812|468239689|FG001|Overall Study|Sponsor Decision|5|||
130078251|NCT00565812|468239690|FG002|Overall Study|Sponsor Decision|1|||
130078252|NCT00565812|468239688|FG000|Overall Study|Domestic Reasons|7|||
130078253|NCT00565812|468239689|FG001|Overall Study|Domestic Reasons|1|||
130078254|NCT00565812|468239690|FG002|Overall Study|Domestic Reasons|3|||
130078255|NCT00565812|468239688|FG000|Overall Study|Research Site Closure|6|||
130078256|NCT00565812|468239689|FG001|Overall Study|Research Site Closure|1|||
130078257|NCT00565812|468239690|FG002|Overall Study|Research Site Closure|8|||
130078258|NCT00565812|468239688|FG000|Overall Study|Surgical Intervention|0|||
130078259|NCT00565812|468239689|FG001|Overall Study|Surgical Intervention|1|||
130078260|NCT00565812|468239690|FG002|Overall Study|Surgical Intervention|2|||
130078261|NCT00565812|468239688|FG000|Overall Study|Low Compliance|1|||
130078262|NCT00565812|468239689|FG001|Overall Study|Low Compliance|0|||
130078263|NCT00565812|468239690|FG002|Overall Study|Low Compliance|1|||
130078264|NCT00565812|468239688|FG000|Overall Study|Follow-up Visit Not Completed|2|||
130078265|NCT00565812|468239689|FG001|Overall Study|Follow-up Visit Not Completed|0|||
130078266|NCT00565812|468239690|FG002|Overall Study|Follow-up Visit Not Completed|1|||
130078267|NCT00565812|468239688|FG000|Overall Study|Physician Decision|2|||
130078268|NCT00565812|468239689|FG001|Overall Study|Physician Decision|0|||
130078269|NCT00565812|468239690|FG002|Overall Study|Physician Decision|0|||
130078270|NCT04968353|468239691|FG000|Overall Study|Non-compliance|1|||
130078271|NCT04968353|468239692|FG001|Overall Study|Non-compliance|0|||
130078272|NCT04968353|468239693|FG002|Overall Study|Non-compliance|2|||
130078273|NCT04968353|468239694|FG003|Overall Study|Non-compliance|0|||
130078274|NCT02033850|468239699|FG000|Overall Study|Death|1|||
130078275|NCT02033850|468239700|FG001|Overall Study|Death|0|||
130078276|NCT02033850|468239699|FG000|Overall Study|unrelated medical reason|1|||
130078277|NCT02033850|468239700|FG001|Overall Study|unrelated medical reason|1|||
130078278|NCT03215667|468239701|FG000|Overall Study|Physician Decision|4|||
130078279|NCT00614991|468239704|FG000|Overall Study|Adverse Event|3|||
130078280|NCT00614991|468239705|FG001|Overall Study|Adverse Event|3|||
130078281|NCT00614991|468239706|FG002|Overall Study|Adverse Event|0|||
130078282|NCT00614991|468239707|FG003|Overall Study|Adverse Event|0|||
130078283|NCT00614991|468239708|FG004|Overall Study|Adverse Event|1|||
130078284|NCT00614991|468239709|FG005|Overall Study|Adverse Event|0|||
130078285|NCT03209362|468239712|FG000|Overall Study|Adverse Event|0|||
130078286|NCT03209362|468239713|FG001|Overall Study|Adverse Event|1|||
130078287|NCT03209362|468239712|FG000|Overall Study|Lost to Follow-up|0|||
130078288|NCT03209362|468239713|FG001|Overall Study|Lost to Follow-up|1|||
130078289|NCT03209362|468239712|FG000|Overall Study|Withdrawal by Subject|2|||
130078290|NCT03209362|468239713|FG001|Overall Study|Withdrawal by Subject|0|||
130078291|NCT03209362|468239712|FG000|Overall Study|Other|0|||
130078292|NCT03209362|468239713|FG001|Overall Study|Other|1|||
130078293|NCT02204410|468241987|FG000|Overall Study|Lost to Follow-up|5|||
130078294|NCT02204410|468241987|FG000|Overall Study|Physician Decision|2|||
130078295|NCT02204410|468241987|FG000|Overall Study|Protocol Violation|1|||
130078296|NCT02204410|468241987|FG000|Overall Study|Withdrawal by Subject|3|||
130078297|NCT01462045|468241990|FG000|Overall Study|Family matter|0|||
130078298|NCT01462045|468241991|FG001|Overall Study|Family matter|1|||
130078299|NCT01462045|468241992|FG002|Overall Study|Family matter|0|||
130078300|NCT02579863|468241993|FG000|Overall Study|Final Disposition Unknown|2|||
130078301|NCT02579863|468241994|FG001|Overall Study|Final Disposition Unknown|1|||
130078302|NCT02579863|468241993|FG000|Overall Study|Adverse Event|18|||
130078303|NCT02579863|468241994|FG001|Overall Study|Adverse Event|11|||
130078304|NCT02579863|468241993|FG000|Overall Study|Death|31|||
130078305|NCT02579863|468241994|FG001|Overall Study|Death|29|||
130078306|NCT02579863|468241993|FG000|Overall Study|Lost to Follow-up|2|||
130078307|NCT02579863|468241994|FG001|Overall Study|Lost to Follow-up|1|||
130078308|NCT02579863|468241993|FG000|Overall Study|Physician Decision|1|||
130078309|NCT02579863|468241994|FG001|Overall Study|Physician Decision|2|||
130078310|NCT02579863|468241993|FG000|Overall Study|Screen Failure|0|||
130078311|NCT02579863|468241994|FG001|Overall Study|Screen Failure|2|||
130078312|NCT02579863|468241993|FG000|Overall Study|Study Terminated at Selected Sites|82|||
130078313|NCT02579863|468241994|FG001|Overall Study|Study Terminated at Selected Sites|88|||
130078314|NCT02579863|468241993|FG000|Overall Study|Withdrawal by Subject|20|||
130078315|NCT02579863|468241994|FG001|Overall Study|Withdrawal by Subject|20|||
130078316|NCT01804842|468242002|FG000|Overall Study|Adverse Event|1|||
130078317|NCT01804842|468242003|FG001|Overall Study|Adverse Event|1|||
130078318|NCT01804842|468242004|FG002|Overall Study|Adverse Event|0|||
130078319|NCT01804842|468242002|FG000|Overall Study|Lost to Follow-up|1|||
130078320|NCT01804842|468242003|FG001|Overall Study|Lost to Follow-up|0|||
130078321|NCT01804842|468242004|FG002|Overall Study|Lost to Follow-up|0|||
130078322|NCT01804842|468242002|FG000|Overall Study|Non-Compliance|1|||
130078323|NCT01804842|468242003|FG001|Overall Study|Non-Compliance|1|||
130078324|NCT01804842|468242004|FG002|Overall Study|Non-Compliance|0|||
130078325|NCT01804842|468242002|FG000|Overall Study|Personal Reason|0|||
130078326|NCT01804842|468242003|FG001|Overall Study|Personal Reason|0|||
130078327|NCT01804842|468242004|FG002|Overall Study|Personal Reason|1|||
130078328|NCT03887052|468242006|FG000|Overall Study|Adverse Event|2|||
130078329|NCT03887052|468242006|FG000|Overall Study|Physician Decision|2|||
130078330|NCT03887052|468242006|FG000|Overall Study|Withdrawal by Subject|3|||
130078331|NCT03887052|468242006|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
130078332|NCT03887052|468242006|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
130078333|NCT03933215|468242007|FG000|Overall Study|Other|6|||
130120782|NCT01957488|468404801|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
130078334|NCT03933215|468242007|FG000|Overall Study|Sponsor decision|5|||
130078335|NCT03933215|468242007|FG000|Overall Study|Protocol Violation|5|||
130078336|NCT03933215|468242007|FG000|Overall Study|Withdrawal by Subject|6|||
130078337|NCT03933215|468242007|FG000|Overall Study|Lost to Follow-up|6|||
130078338|NCT03933215|468242007|FG000|Overall Study|Enrolled but not treated|38|||
130078339|NCT04097028|468242008|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
130078340|NCT04097028|468242008|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
130078341|NCT04097028|468242008|FG000|Overall Study|Disease Progression prior to Surgery|2|||
130078342|NCT04097028|468242008|FG000|Overall Study|Adverse Event prior to Surgery|1|||
130078343|NCT02352090|468242009|FG000|Overall Study|general malaise|1|||
130078344|NCT02352090|468242010|FG001|Overall Study|general malaise|0|||
130078345|NCT02352090|468242011|FG002|Overall Study|general malaise|0|||
130078346|NCT02352090|468242009|FG000|Overall Study|non-specified mild side-effects|0|||
130078347|NCT02352090|468242010|FG001|Overall Study|non-specified mild side-effects|0|||
130078348|NCT02352090|468242011|FG002|Overall Study|non-specified mild side-effects|2|||
130078349|NCT01678313|468242012|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
130078350|NCT01678313|468242013|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
130078351|NCT01678313|468242012|FG000|Completed the 3-month Therapy|Physician Decision|3|||
130078352|NCT01678313|468242013|FG001|Completed the 3-month Therapy|Physician Decision|4|||
130078353|NCT01678313|468242012|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
130078354|NCT01678313|468242013|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
129953153|NCT00267956|467789867|FG000|Controlled Period|Lost to Follow-up|2|||
129953154|NCT00267956|467789868|FG001|Controlled Period|Lost to Follow-up|0|||
129953155|NCT00267956|467789869|FG002|Controlled Period|Lost to Follow-up|0|||
129953156|NCT00267956|467789870|FG003|Controlled Period|Lost to Follow-up|0|||
129953157|NCT00267956|467789867|FG000|Controlled Period|Withdrew consent|3|||
129953158|NCT00267956|467789868|FG001|Controlled Period|Withdrew consent|1|||
129953159|NCT00267956|467789869|FG002|Controlled Period|Withdrew consent|0|||
129953160|NCT00267956|467789870|FG003|Controlled Period|Withdrew consent|0|||
129953161|NCT00267956|467789867|FG000|After Controlled Period|Adverse Event|0|||
129953162|NCT00267956|467789868|FG001|After Controlled Period|Adverse Event|0|||
129953163|NCT00267956|467789869|FG002|After Controlled Period|Adverse Event|2|||
129953164|NCT00267956|467789870|FG003|After Controlled Period|Adverse Event|1|||
129953165|NCT00267956|467789867|FG000|After Controlled Period|Lack of Efficacy|0|||
129953166|NCT00267956|467789868|FG001|After Controlled Period|Lack of Efficacy|0|||
129953167|NCT00267956|467789869|FG002|After Controlled Period|Lack of Efficacy|1|||
129953168|NCT00267956|467789870|FG003|After Controlled Period|Lack of Efficacy|1|||
129953169|NCT00267956|467789867|FG000|After Controlled Period|Lost to Follow-up|0|||
129953170|NCT00267956|467789868|FG001|After Controlled Period|Lost to Follow-up|0|||
129953171|NCT00267956|467789869|FG002|After Controlled Period|Lost to Follow-up|1|||
129953172|NCT00267956|467789870|FG003|After Controlled Period|Lost to Follow-up|0|||
129953173|NCT00267956|467789867|FG000|After Controlled Period|Withdrew consent|0|||
129953174|NCT00267956|467789868|FG001|After Controlled Period|Withdrew consent|0|||
129953175|NCT00267956|467789869|FG002|After Controlled Period|Withdrew consent|1|||
129953176|NCT00267956|467789870|FG003|After Controlled Period|Withdrew consent|0|||
129953177|NCT01263223|467789871|FG000|Period 2|Withdrawal by Subject|0|||
129953178|NCT01263223|467789872|FG001|Period 2|Withdrawal by Subject|1|||
129953179|NCT01263223|467789871|FG000|7-day Follow-up|Withdrawal by Subject|0|||
129953180|NCT01263223|467789872|FG001|7-day Follow-up|Withdrawal by Subject|1|||
129953181|NCT01263223|467789871|FG000|7-day Follow-up|Lost to Follow-up|1|||
129953182|NCT01263223|467789872|FG001|7-day Follow-up|Lost to Follow-up|0|||
129953183|NCT02246647|467789873|FG000|Overall Study|Withdrawal by Subject|1|||
129953184|NCT02246647|467789874|FG001|Overall Study|Withdrawal by Subject|1|||
129953185|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
129953186|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
129953187|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
129953188|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
129953189|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
129953190|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
129953191|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
129953192|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
129953193|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Death|3|||
129953194|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
129953195|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
129953196|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
129953197|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
129953198|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|other|3|||
129953199|NCT03184519|467789876|FG000|Overall Study|Lost to Follow-up|6|||
129953200|NCT03184519|467789876|FG000|Overall Study|Physician Decision|21|||
129953201|NCT04239911|467789877|FG000|Overall Study|Lost to Follow-up|2|||
129953202|NCT04239911|467789878|FG001|Overall Study|Lost to Follow-up|1|||
129953203|NCT00584909|467789884|FG000|Overall Study|Adverse Event|4|||
129953204|NCT03345407|467789885|FG000|Overall Study|Withdrawal by Subject|11|||
129953205|NCT03345407|467789886|FG001|Overall Study|Withdrawal by Subject|1|||
129953206|NCT03345407|467789887|FG002|Overall Study|Withdrawal by Subject|5|||
129953207|NCT03345407|467789888|FG003|Overall Study|Withdrawal by Subject|6|||
129953208|NCT03345407|467789889|FG004|Overall Study|Withdrawal by Subject|3|||
129953209|NCT03345407|467789890|FG005|Overall Study|Withdrawal by Subject|6|||
129953210|NCT03345407|467789891|FG006|Overall Study|Withdrawal by Subject|16|||
129953211|NCT03345407|467789885|FG000|Overall Study|Physician Decision|3|||
129953212|NCT03345407|467789886|FG001|Overall Study|Physician Decision|1|||
129953213|NCT03345407|467789887|FG002|Overall Study|Physician Decision|0|||
129953214|NCT03345407|467789888|FG003|Overall Study|Physician Decision|0|||
130078355|NCT01678313|468242012|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
129953215|NCT03345407|467789889|FG004|Overall Study|Physician Decision|1|||
129953216|NCT03345407|467789890|FG005|Overall Study|Physician Decision|2|||
129953217|NCT03345407|467789891|FG006|Overall Study|Physician Decision|3|||
129953218|NCT03345407|467789885|FG000|Overall Study|Lost to Follow-up|2|||
129953219|NCT03345407|467789886|FG001|Overall Study|Lost to Follow-up|0|||
129953220|NCT03345407|467789887|FG002|Overall Study|Lost to Follow-up|1|||
129953221|NCT03345407|467789888|FG003|Overall Study|Lost to Follow-up|0|||
130078356|NCT01678313|468242013|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
130078357|NCT00981292|468242016|FG000|Day 1|Protocol Violation|1|||
130078358|NCT00981292|468242017|FG001|Day 1|Protocol Violation|0|||
130078359|NCT00981292|468242018|FG002|Day 1|Protocol Violation|0|||
130078360|NCT00981292|468242019|FG003|Day 1|Protocol Violation|0|||
130078361|NCT00981292|468242020|FG004|Day 1|Protocol Violation|0|||
130078362|NCT00981292|468242021|FG005|Day 1|Protocol Violation|2|||
130078363|NCT00981292|468242016|FG000|Day 2|Protocol Violation|2|||
130078364|NCT00981292|468242017|FG001|Day 2|Protocol Violation|0|||
130078365|NCT00981292|468242018|FG002|Day 2|Protocol Violation|0|||
130078366|NCT00981292|468242019|FG003|Day 2|Protocol Violation|0|||
130078367|NCT00981292|468242020|FG004|Day 2|Protocol Violation|0|||
130078368|NCT00981292|468242021|FG005|Day 2|Protocol Violation|0|||
130078369|NCT00981292|468242016|FG000|Day 3|Protocol Violation|0|||
130078370|NCT00981292|468242017|FG001|Day 3|Protocol Violation|0|||
130078371|NCT00981292|468242018|FG002|Day 3|Protocol Violation|0|||
130078372|NCT00981292|468242019|FG003|Day 3|Protocol Violation|0|||
130078373|NCT00981292|468242020|FG004|Day 3|Protocol Violation|0|||
130078374|NCT00981292|468242021|FG005|Day 3|Protocol Violation|1|||
130078375|NCT01131130|468242022|FG000|Period 1 - Baseline|Pregnancy|1|||
130078376|NCT01131130|468242022|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
130078377|NCT03464136|468242023|FG000|Overall Study|Lost to Follow-up|5|||
130078378|NCT03464136|468242024|FG001|Overall Study|Lost to Follow-up|8|||
130078379|NCT03464136|468242023|FG000|Overall Study|Withdrawal by Subject|16|||
130078380|NCT03464136|468242024|FG001|Overall Study|Withdrawal by Subject|13|||
130078381|NCT03464136|468242023|FG000|Overall Study|Death|1|||
130078382|NCT03464136|468242024|FG001|Overall Study|Death|0|||
130078383|NCT03464136|468242023|FG000|Overall Study|Other|8|||
130078384|NCT03464136|468242024|FG001|Overall Study|Other|4|||
130078385|NCT03412565|468242025|FG000|Overall Study|Lost to Follow-up|0|||
130078386|NCT03412565|468242026|FG001|Overall Study|Lost to Follow-up|0|||
130078387|NCT03412565|468242027|FG002|Overall Study|Lost to Follow-up|1|||
130078388|NCT03412565|468242028|FG003|Overall Study|Lost to Follow-up|0|||
130078389|NCT03412565|468242025|FG000|Overall Study|Physician Decision|0|||
130078390|NCT03412565|468242026|FG001|Overall Study|Physician Decision|0|||
130078391|NCT03412565|468242027|FG002|Overall Study|Physician Decision|0|||
130078392|NCT03412565|468242028|FG003|Overall Study|Physician Decision|1|||
130078393|NCT03412565|468242025|FG000|Overall Study|Withdrawal by Subject|0|||
130078394|NCT03412565|468242026|FG001|Overall Study|Withdrawal by Subject|4|||
130078395|NCT03412565|468242027|FG002|Overall Study|Withdrawal by Subject|5|||
130078396|NCT03412565|468242028|FG003|Overall Study|Withdrawal by Subject|5|||
130078397|NCT03412565|468242025|FG000|Overall Study|Death|1|||
130078398|NCT03412565|468242026|FG001|Overall Study|Death|3|||
130078399|NCT03412565|468242027|FG002|Overall Study|Death|4|||
130078400|NCT03412565|468242028|FG003|Overall Study|Death|5|||
130078401|NCT03412565|468242025|FG000|Overall Study|Data collection ended|0|||
130078402|NCT03412565|468242026|FG001|Overall Study|Data collection ended|41|||
130078403|NCT03412565|468242027|FG002|Overall Study|Data collection ended|41|||
130078404|NCT03412565|468242028|FG003|Overall Study|Data collection ended|40|||
130078405|NCT03277105|468242029|FG000|Overall Study|Death|129|||
130078406|NCT03277105|468242030|FG001|Overall Study|Death|124|||
130078407|NCT03277105|468242029|FG000|Overall Study|Lost to Follow-up|2|||
130078408|NCT03277105|468242030|FG001|Overall Study|Lost to Follow-up|4|||
130078409|NCT03277105|468242029|FG000|Overall Study|Withdrawal by Subject|10|||
130078410|NCT03277105|468242030|FG001|Overall Study|Withdrawal by Subject|10|||
130078411|NCT03277105|468242029|FG000|Overall Study|Other|118|||
130078412|NCT03277105|468242030|FG001|Overall Study|Other|125|||
130078413|NCT01849562|468242037|FG000|Overall Study|Lost to Follow-up|1|||
130078414|NCT01849562|468242038|FG001|Overall Study|Lost to Follow-up|0|||
130078415|NCT01849562|468242039|FG002|Overall Study|Lost to Follow-up|0|||
130078416|NCT01849562|468242037|FG000|Overall Study|Non-compliance with Study Drug|1|||
130078417|NCT01849562|468242038|FG001|Overall Study|Non-compliance with Study Drug|0|||
130078418|NCT01849562|468242039|FG002|Overall Study|Non-compliance with Study Drug|0|||
130078419|NCT00498368|468242049|FG000|Overall Study|Withdrawal by Subject|3|||
130078420|NCT00498368|468242050|FG001|Overall Study|Withdrawal by Subject|2|||
130120783|NCT01957488|468404802|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
130078421|NCT02266004|468242051|FG000|Overall Study|unrelated adverse event|1|||
130078422|NCT02266004|468242051|FG000|Overall Study|Physician Decision|1|||
130078423|NCT00537771|468242056|FG000|Overall Study|Withdrawal by Subject|6|||
130078424|NCT00537771|468242057|FG001|Overall Study|Withdrawal by Subject|23|||
130078425|NCT00537771|468242056|FG000|Overall Study|Adverse Event|8|||
130120784|NCT01957488|468404797|FG000|Test Period 2 (2 Weeks)|Other|1|||
130078426|NCT00537771|468242057|FG001|Overall Study|Adverse Event|15|||
130078427|NCT00537771|468242056|FG000|Overall Study|Lost to Follow-up|9|||
130078428|NCT00537771|468242057|FG001|Overall Study|Lost to Follow-up|15|||
130078429|NCT00537771|468242056|FG000|Overall Study|Protocol Violation|2|||
130078430|NCT00537771|468242057|FG001|Overall Study|Protocol Violation|6|||
130078431|NCT00537771|468242056|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
130078432|NCT00537771|468242057|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130078433|NCT02736929|468242059|FG000|Main Study|Lost to Follow-up|7|||
130078434|NCT02736929|468242060|FG001|Main Study|Lost to Follow-up|1|||
130078435|NCT02736929|468242061|FG002|Main Study|Lost to Follow-up|0|||
130078436|NCT02736929|468242059|FG000|Main Study|Withdrawal by Subject|1|||
130078437|NCT02736929|468242060|FG001|Main Study|Withdrawal by Subject|1|||
130078438|NCT02736929|468242061|FG002|Main Study|Withdrawal by Subject|0|||
130078439|NCT02736929|468242059|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
130078440|NCT02736929|468242060|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
130078441|NCT02736929|468242061|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
130078442|NCT01347073|468242067|FG000|Overall Study|Adverse Event|1|||
130078443|NCT01347073|468242067|FG000|Overall Study|Liver Transplant|1|||
130078444|NCT01690988|468242074|FG000|Overall Study|Withdrawal by Subject|2|||
130078445|NCT01690988|468242075|FG001|Overall Study|Withdrawal by Subject|2|||
130078446|NCT01690988|468242076|FG002|Overall Study|Withdrawal by Subject|3|||
130078447|NCT01690988|468242074|FG000|Overall Study|Physician Decision|0|||
130078448|NCT01690988|468242075|FG001|Overall Study|Physician Decision|0|||
130078449|NCT01690988|468242076|FG002|Overall Study|Physician Decision|1|||
130078450|NCT01690988|468242074|FG000|Overall Study|Operation Cancelled|1|||
130078451|NCT01690988|468242075|FG001|Overall Study|Operation Cancelled|1|||
130078452|NCT01690988|468242076|FG002|Overall Study|Operation Cancelled|0|||
130078453|NCT01690988|468242074|FG000|Overall Study|Determined ineligible|1|||
130078454|NCT01690988|468242075|FG001|Overall Study|Determined ineligible|0|||
130078455|NCT01690988|468242076|FG002|Overall Study|Determined ineligible|0|||
130078456|NCT01690988|468242074|FG000|Overall Study|Death|1|||
130078457|NCT01690988|468242075|FG001|Overall Study|Death|1|||
130078458|NCT01690988|468242076|FG002|Overall Study|Death|1|||
130078459|NCT01690988|468242074|FG000|Overall Study|Sedated|1|||
130078460|NCT01690988|468242075|FG001|Overall Study|Sedated|1|||
130078461|NCT01690988|468242076|FG002|Overall Study|Sedated|2|||
130078462|NCT00372489|468242079|FG000|Overall Study|Adverse Event|18|||
130078463|NCT00372489|468242079|FG000|Overall Study|Lack of Efficacy|1|||
130078464|NCT00372489|468242079|FG000|Overall Study|Lost to Follow-up|3|||
130078465|NCT00372489|468242079|FG000|Overall Study|Physician Decision|3|||
130078466|NCT00372489|468242079|FG000|Overall Study|Withdrawal by Subject|5|||
130078467|NCT00372489|468242079|FG000|Overall Study|Patient Relocation|2|||
130078468|NCT00372489|468242079|FG000|Overall Study|Renal transplant|6|||
130078469|NCT00372489|468242079|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
130078470|NCT00552344|468242084|FG000|Overall Study|Lack of Efficacy|55|||
130078471|NCT00552344|468242084|FG000|Overall Study|Loss of efficacy|75|||
130078472|NCT00552344|468242084|FG000|Overall Study|Lost to Follow-up|8|||
130078473|NCT00552344|468242084|FG000|Overall Study|Withdrawal by Subject|48|||
130078474|NCT00552344|468242084|FG000|Overall Study|SAE, non-fatal|6|||
130078475|NCT00552344|468242084|FG000|Overall Study|AE, non-serious non-fatal|38|||
130078476|NCT00552344|468242084|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
130078477|NCT00552344|468242084|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
130078478|NCT00552344|468242084|FG000|Overall Study|Other Reason|22|||
130078479|NCT01662986|468242085|FG000|Overall Study|Adverse Event|5|||
130078480|NCT01662986|468242086|FG001|Overall Study|Adverse Event|4|||
130078481|NCT01662986|468242085|FG000|Overall Study|Protocol Violation|2|||
130078482|NCT01662986|468242086|FG001|Overall Study|Protocol Violation|3|||
130078483|NCT01662986|468242085|FG000|Overall Study|Lost to Follow-up|5|||
130078484|NCT01662986|468242086|FG001|Overall Study|Lost to Follow-up|4|||
130078485|NCT01662986|468242085|FG000|Overall Study|Withdrawal by Subject|2|||
130078486|NCT01662986|468242086|FG001|Overall Study|Withdrawal by Subject|2|||
130078487|NCT01662986|468242085|FG000|Overall Study|Not Treated|1|||
130078488|NCT01662986|468242086|FG001|Overall Study|Not Treated|0|||
130078489|NCT01662986|468242085|FG000|Overall Study|Other than stated above|3|||
130078490|NCT01662986|468242086|FG001|Overall Study|Other than stated above|0|||
130078491|NCT01512693|468242089|FG000|Overall Study|Withdrawal by Subject|0|||
130078492|NCT01512693|468242090|FG001|Overall Study|Withdrawal by Subject|1|||
130078493|NCT04731922|468242091|FG000|Overall Study|Adverse Event|0|||
130078494|NCT04731922|468242092|FG001|Overall Study|Adverse Event|0|||
130078495|NCT04731922|468242093|FG002|Overall Study|Adverse Event|0|||
130078496|NCT04731922|468242094|FG003|Overall Study|Adverse Event|0|||
130078497|NCT04731922|468242095|FG004|Overall Study|Adverse Event|0|||
130078498|NCT04731922|468242096|FG005|Overall Study|Adverse Event|0|||
130078499|NCT04731922|468242097|FG006|Overall Study|Adverse Event|0|||
130078500|NCT04731922|468242098|FG007|Overall Study|Adverse Event|0|||
130078501|NCT04731922|468242099|FG008|Overall Study|Adverse Event|0|||
130078502|NCT04731922|468242100|FG009|Overall Study|Adverse Event|0|||
130078503|NCT04731922|468242101|FG010|Overall Study|Adverse Event|1|||
130078504|NCT04731922|468242102|FG011|Overall Study|Adverse Event|0|||
130078505|NCT04731922|468242103|FG012|Overall Study|Adverse Event|0|||
130078506|NCT04731922|468242104|FG013|Overall Study|Adverse Event|0|||
130078507|NCT04731922|468242105|FG014|Overall Study|Adverse Event|0|||
130078508|NCT04731922|468242106|FG015|Overall Study|Adverse Event|0|||
130078509|NCT04731922|468242107|FG016|Overall Study|Adverse Event|0|||
130078510|NCT04731922|468242091|FG000|Overall Study|Lost to Follow-up|0|||
130078511|NCT04731922|468242092|FG001|Overall Study|Lost to Follow-up|0|||
130120785|NCT01957488|468404798|FG001|Test Period 2 (2 Weeks)|Other|0|||
130078512|NCT04731922|468242093|FG002|Overall Study|Lost to Follow-up|0|||
130078513|NCT04731922|468242094|FG003|Overall Study|Lost to Follow-up|1|||
130078514|NCT04731922|468242095|FG004|Overall Study|Lost to Follow-up|0|||
130078515|NCT04731922|468242096|FG005|Overall Study|Lost to Follow-up|1|||
130078516|NCT04731922|468242097|FG006|Overall Study|Lost to Follow-up|0|||
130078517|NCT04731922|468242098|FG007|Overall Study|Lost to Follow-up|0|||
130078518|NCT04731922|468242099|FG008|Overall Study|Lost to Follow-up|0|||
130078519|NCT04731922|468242100|FG009|Overall Study|Lost to Follow-up|0|||
130078520|NCT04731922|468242101|FG010|Overall Study|Lost to Follow-up|0|||
130078521|NCT04731922|468242102|FG011|Overall Study|Lost to Follow-up|0|||
130078522|NCT04731922|468242103|FG012|Overall Study|Lost to Follow-up|0|||
130078523|NCT04731922|468242104|FG013|Overall Study|Lost to Follow-up|0|||
130078524|NCT04731922|468242105|FG014|Overall Study|Lost to Follow-up|0|||
130078525|NCT04731922|468242106|FG015|Overall Study|Lost to Follow-up|0|||
130078526|NCT04731922|468242107|FG016|Overall Study|Lost to Follow-up|0|||
130078527|NCT04731922|468242091|FG000|Overall Study|Withdrawal by Subject|1|||
130078528|NCT04731922|468242092|FG001|Overall Study|Withdrawal by Subject|0|||
130078529|NCT04731922|468242093|FG002|Overall Study|Withdrawal by Subject|0|||
130078530|NCT04731922|468242094|FG003|Overall Study|Withdrawal by Subject|0|||
130078531|NCT04731922|468242095|FG004|Overall Study|Withdrawal by Subject|1|||
130078532|NCT04731922|468242096|FG005|Overall Study|Withdrawal by Subject|0|||
130078533|NCT04731922|468242097|FG006|Overall Study|Withdrawal by Subject|1|||
130078534|NCT04731922|468242098|FG007|Overall Study|Withdrawal by Subject|0|||
130078535|NCT04731922|468242099|FG008|Overall Study|Withdrawal by Subject|0|||
130078536|NCT04731922|468242100|FG009|Overall Study|Withdrawal by Subject|0|||
130078537|NCT04731922|468242101|FG010|Overall Study|Withdrawal by Subject|0|||
130078538|NCT04731922|468242102|FG011|Overall Study|Withdrawal by Subject|0|||
130078539|NCT04731922|468242103|FG012|Overall Study|Withdrawal by Subject|0|||
130078540|NCT04731922|468242104|FG013|Overall Study|Withdrawal by Subject|1|||
130078541|NCT04731922|468242105|FG014|Overall Study|Withdrawal by Subject|0|||
130078542|NCT04731922|468242106|FG015|Overall Study|Withdrawal by Subject|0|||
130078543|NCT04731922|468242107|FG016|Overall Study|Withdrawal by Subject|0|||
130078544|NCT04731922|468242091|FG000|Overall Study|Other|0|||
130078545|NCT04731922|468242092|FG001|Overall Study|Other|0|||
130078546|NCT04731922|468242093|FG002|Overall Study|Other|0|||
130078547|NCT04731922|468242094|FG003|Overall Study|Other|0|||
130078548|NCT04731922|468242095|FG004|Overall Study|Other|0|||
130078549|NCT04731922|468242096|FG005|Overall Study|Other|0|||
130078550|NCT04731922|468242097|FG006|Overall Study|Other|1|||
130078551|NCT04731922|468242098|FG007|Overall Study|Other|0|||
130078552|NCT04731922|468242099|FG008|Overall Study|Other|0|||
130078553|NCT04731922|468242100|FG009|Overall Study|Other|0|||
130078554|NCT04731922|468242101|FG010|Overall Study|Other|0|||
130078555|NCT04731922|468242102|FG011|Overall Study|Other|0|||
130078556|NCT04731922|468242103|FG012|Overall Study|Other|0|||
130078557|NCT04731922|468242104|FG013|Overall Study|Other|0|||
130078558|NCT04731922|468242105|FG014|Overall Study|Other|0|||
130078559|NCT04731922|468242106|FG015|Overall Study|Other|0|||
130078560|NCT04731922|468242107|FG016|Overall Study|Other|0|||
130078561|NCT02343952|468242110|FG000|Study Treatment|Disease Progression|23|||
130078562|NCT02343952|468242110|FG000|Study Treatment|Death|3|||
130078563|NCT02343952|468242110|FG000|Study Treatment|Adverse Event|19|||
130078564|NCT02343952|468242110|FG000|Study Treatment|Withdrawal by Subject|7|||
130078565|NCT02343952|468242110|FG000|Study Treatment|other complicating Diseases|1|||
130078566|NCT02343952|468242110|FG000|Follow up|Withdrawal by Subject|3|||
130078567|NCT02343952|468242110|FG000|Follow up|Death|33|||
130078568|NCT02343952|468242110|FG000|Follow up|Patient does not meet eligibility for study.|1|||
130078569|NCT02343952|468242110|FG000|Follow up|Research department closed by the practice.|5|||
130078570|NCT02343952|468242110|FG000|Follow up|Patient went home to Russia|1|||
130078571|NCT02343952|468242110|FG000|Follow up|Disease Progression|1|||
130078572|NCT02343952|468242110|FG000|Follow up|study terminated|1|||
130078573|NCT00845845|468242114|FG000|Overall Study|Lost to Follow-up|0|||
130078574|NCT00845845|468242115|FG001|Overall Study|Lost to Follow-up|4|||
130078575|NCT02820038|468242117|FG000|Overall Study|Lost to Follow-up|7|||
130078576|NCT02820038|468242118|FG001|Overall Study|Lost to Follow-up|11|||
130078577|NCT02820038|468242119|FG002|Overall Study|Lost to Follow-up|2|||
130078578|NCT02820038|468242120|FG003|Overall Study|Lost to Follow-up|9|||
129953222|NCT03345407|467789889|FG004|Overall Study|Lost to Follow-up|1|||
130078579|NCT02820038|468242117|FG000|Overall Study|Withdrawal by Subject|3|||
130078580|NCT02820038|468242118|FG001|Overall Study|Withdrawal by Subject|14|||
130078581|NCT02820038|468242119|FG002|Overall Study|Withdrawal by Subject|3|||
129953223|NCT03345407|467789890|FG005|Overall Study|Lost to Follow-up|2|||
129953224|NCT03345407|467789891|FG006|Overall Study|Lost to Follow-up|3|||
130078582|NCT02820038|468242120|FG003|Overall Study|Withdrawal by Subject|13|||
130078583|NCT02623699|468242121|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078584|NCT02623699|468242122|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
130078585|NCT02623699|468242123|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078586|NCT02623699|468242124|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078587|NCT02623699|468242125|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078588|NCT02623699|468242126|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078589|NCT02623699|468242127|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078590|NCT02623699|468242128|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129953225|NCT03345407|467789885|FG000|Overall Study|Protocol-defined stopping criteria|9|||
129953226|NCT03345407|467789886|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130078591|NCT02623699|468242129|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078592|NCT02623699|468242130|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078593|NCT02623699|468242131|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078594|NCT02623699|468242132|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
130078595|NCT02623699|468242121|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078596|NCT02623699|468242122|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078597|NCT02623699|468242123|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078598|NCT02623699|468242124|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078599|NCT02623699|468242125|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078600|NCT02623699|468242126|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078601|NCT02623699|468242127|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
130078602|NCT02623699|468242128|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078603|NCT02623699|468242129|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078604|NCT02623699|468242130|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078605|NCT02623699|468242131|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078606|NCT02623699|468242132|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
130078607|NCT02623699|468242121|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078608|NCT02623699|468242122|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078609|NCT02623699|468242123|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078610|NCT02623699|468242124|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078611|NCT02623699|468242125|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078612|NCT02623699|468242126|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
130078613|NCT02623699|468242127|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078614|NCT02623699|468242128|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078615|NCT02623699|468242129|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078616|NCT02623699|468242130|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078617|NCT02623699|468242131|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078618|NCT02623699|468242132|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
130078619|NCT02623699|468242121|FG000|Part B (Up to 289 Days)|Death|0|||
130078620|NCT02623699|468242122|FG001|Part B (Up to 289 Days)|Death|0|||
130078621|NCT02623699|468242123|FG002|Part B (Up to 289 Days)|Death|0|||
130078622|NCT02623699|468242124|FG003|Part B (Up to 289 Days)|Death|0|||
129953227|NCT03345407|467789887|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129953228|NCT03345407|467789888|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130078623|NCT02623699|468242125|FG004|Part B (Up to 289 Days)|Death|0|||
130078624|NCT02623699|468242126|FG005|Part B (Up to 289 Days)|Death|1|||
130078625|NCT02623699|468242127|FG006|Part B (Up to 289 Days)|Death|1|||
130078626|NCT02623699|468242128|FG007|Part B (Up to 289 Days)|Death|0|||
130078627|NCT02623699|468242129|FG008|Part B (Up to 289 Days)|Death|1|||
130078628|NCT02623699|468242130|FG009|Part B (Up to 289 Days)|Death|0|||
130078629|NCT02623699|468242131|FG010|Part B (Up to 289 Days)|Death|0|||
130078630|NCT02623699|468242132|FG011|Part B (Up to 289 Days)|Death|0|||
130078631|NCT02623699|468242121|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
130078632|NCT02623699|468242122|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
130078633|NCT02623699|468242123|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
130078634|NCT02623699|468242124|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
130078635|NCT02623699|468242125|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
130078636|NCT02623699|468242126|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
130078637|NCT02623699|468242127|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
130078638|NCT02623699|468242128|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
130078639|NCT02623699|468242129|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
130078640|NCT02623699|468242130|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
130078641|NCT02623699|468242131|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
130078642|NCT02623699|468242132|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
130078643|NCT02623699|468242121|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078644|NCT02623699|468242122|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078645|NCT02623699|468242123|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078646|NCT02623699|468242124|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078647|NCT02623699|468242125|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078648|NCT02623699|468242126|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129953229|NCT03345407|467789889|FG004|Overall Study|Protocol-defined stopping criteria|2|||
130078649|NCT02623699|468242127|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078650|NCT02623699|468242128|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078651|NCT02623699|468242129|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129953230|NCT03345407|467789890|FG005|Overall Study|Protocol-defined stopping criteria|1|||
129953231|NCT03345407|467789891|FG006|Overall Study|Protocol-defined stopping criteria|1|||
130078652|NCT02623699|468242130|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
130078653|NCT02623699|468242131|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
130120786|NCT01957488|468404799|FG002|Test Period 2 (2 Weeks)|Other|0|||
130078654|NCT02623699|468242132|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
130078655|NCT02623699|468242121|FG000|Part C (Up to 236 Days)|Death|0|||
130078656|NCT02623699|468242122|FG001|Part C (Up to 236 Days)|Death|0|||
130078657|NCT02623699|468242123|FG002|Part C (Up to 236 Days)|Death|0|||
130078658|NCT02623699|468242124|FG003|Part C (Up to 236 Days)|Death|0|||
130078659|NCT02623699|468242125|FG004|Part C (Up to 236 Days)|Death|0|||
130078660|NCT02623699|468242126|FG005|Part C (Up to 236 Days)|Death|0|||
130078661|NCT02623699|468242127|FG006|Part C (Up to 236 Days)|Death|0|||
130078662|NCT02623699|468242128|FG007|Part C (Up to 236 Days)|Death|0|||
130078663|NCT02623699|468242129|FG008|Part C (Up to 236 Days)|Death|0|||
130078664|NCT02623699|468242130|FG009|Part C (Up to 236 Days)|Death|0|||
130078665|NCT02623699|468242131|FG010|Part C (Up to 236 Days)|Death|0|||
130078666|NCT02623699|468242132|FG011|Part C (Up to 236 Days)|Death|1|||
130078667|NCT02623699|468242121|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
130078668|NCT02623699|468242122|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
130078669|NCT02623699|468242123|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
130078670|NCT02623699|468242124|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
130078671|NCT02623699|468242125|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
130078672|NCT02623699|468242126|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
130078673|NCT02623699|468242127|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
130078674|NCT02623699|468242128|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
130078675|NCT02623699|468242129|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
130078676|NCT02623699|468242130|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
130078677|NCT02623699|468242131|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
130078678|NCT02623699|468242132|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
130078679|NCT00033371|468242133|FG000|Overall Study|Adverse Event|1|||
130078680|NCT00033371|468242134|FG001|Overall Study|Adverse Event|5|||
130078681|NCT00033371|468242133|FG000|Overall Study|Lost to Follow-up|2|||
130078682|NCT00033371|468242134|FG001|Overall Study|Lost to Follow-up|1|||
130078683|NCT00033371|468242133|FG000|Overall Study|Withdrawal by Subject|3|||
130078684|NCT00033371|468242134|FG001|Overall Study|Withdrawal by Subject|3|||
130078685|NCT00033371|468242133|FG000|Overall Study|Disease Progression|0|||
130078686|NCT00033371|468242134|FG001|Overall Study|Disease Progression|1|||
130078687|NCT00899678|468242135|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
130078688|NCT00899678|468242136|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
130078689|NCT00899678|468242137|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
130078690|NCT00899678|468242135|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
130078691|NCT00899678|468242136|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
130078692|NCT00899678|468242137|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
130078693|NCT00899678|468242135|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
130078694|NCT00899678|468242136|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
130078695|NCT00899678|468242137|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
130078696|NCT00899678|468242135|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
130078697|NCT00899678|468242136|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
130078698|NCT00899678|468242137|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
130078699|NCT00899678|468242135|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
130078700|NCT00899678|468242136|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
130078701|NCT00899678|468242137|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
130078702|NCT00899678|468242135|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
130078703|NCT00899678|468242136|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
130078704|NCT00899678|468242137|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
130078705|NCT00899678|468242135|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
130078706|NCT00899678|468242136|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
130078707|NCT00899678|468242137|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
130078708|NCT00899678|468242135|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
130078709|NCT00899678|468242136|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
130078710|NCT00899678|468242137|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
130078711|NCT00899678|468242135|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
130078712|NCT00899678|468242136|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
130078713|NCT00899678|468242137|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
130078714|NCT03799627|468242142|FG000|Overall Study|Adverse Event|1|||
130078715|NCT03799627|468242143|FG001|Overall Study|Adverse Event|2|||
130078716|NCT03799627|468242144|FG002|Overall Study|Adverse Event|0|||
130078717|NCT03799627|468242145|FG003|Overall Study|Adverse Event|0|||
130078718|NCT03799627|468242146|FG004|Overall Study|Adverse Event|2|||
130078719|NCT03799627|468242147|FG005|Overall Study|Adverse Event|5|||
130078720|NCT03799627|468242148|FG006|Overall Study|Adverse Event|0|||
130078721|NCT03799627|468242149|FG007|Overall Study|Adverse Event|2|||
130078722|NCT03799627|468242150|FG008|Overall Study|Adverse Event|0|||
130078723|NCT03799627|468242142|FG000|Overall Study|Physician Decision|2|||
130078724|NCT03799627|468242143|FG001|Overall Study|Physician Decision|2|||
130078725|NCT03799627|468242144|FG002|Overall Study|Physician Decision|0|||
130078726|NCT03799627|468242145|FG003|Overall Study|Physician Decision|0|||
130078727|NCT03799627|468242146|FG004|Overall Study|Physician Decision|2|||
130078728|NCT03799627|468242147|FG005|Overall Study|Physician Decision|2|||
130078729|NCT03799627|468242148|FG006|Overall Study|Physician Decision|0|||
130078730|NCT03799627|468242149|FG007|Overall Study|Physician Decision|0|||
130078731|NCT03799627|468242150|FG008|Overall Study|Physician Decision|0|||
130078732|NCT03799627|468242142|FG000|Overall Study|Withdrawal by Subject|1|||
130078733|NCT03799627|468242143|FG001|Overall Study|Withdrawal by Subject|1|||
130078734|NCT03799627|468242144|FG002|Overall Study|Withdrawal by Subject|0|||
130078735|NCT03799627|468242145|FG003|Overall Study|Withdrawal by Subject|2|||
130078736|NCT03799627|468242146|FG004|Overall Study|Withdrawal by Subject|0|||
130078737|NCT03799627|468242147|FG005|Overall Study|Withdrawal by Subject|3|||
130078738|NCT03799627|468242148|FG006|Overall Study|Withdrawal by Subject|0|||
130078739|NCT03799627|468242149|FG007|Overall Study|Withdrawal by Subject|0|||
130078740|NCT03799627|468242150|FG008|Overall Study|Withdrawal by Subject|0|||
130078741|NCT03799627|468242142|FG000|Overall Study|Lack of Efficacy|0|||
130078742|NCT03799627|468242143|FG001|Overall Study|Lack of Efficacy|0|||
130078743|NCT03799627|468242144|FG002|Overall Study|Lack of Efficacy|0|||
130078744|NCT03799627|468242145|FG003|Overall Study|Lack of Efficacy|1|||
130078745|NCT03799627|468242146|FG004|Overall Study|Lack of Efficacy|0|||
130078746|NCT03799627|468242147|FG005|Overall Study|Lack of Efficacy|0|||
130078747|NCT03799627|468242148|FG006|Overall Study|Lack of Efficacy|0|||
130078748|NCT03799627|468242149|FG007|Overall Study|Lack of Efficacy|0|||
130078749|NCT03799627|468242150|FG008|Overall Study|Lack of Efficacy|0|||
130078750|NCT03799627|468242142|FG000|Overall Study|Lost to Follow-up|0|||
130078751|NCT03799627|468242143|FG001|Overall Study|Lost to Follow-up|0|||
130078752|NCT03799627|468242144|FG002|Overall Study|Lost to Follow-up|0|||
130078753|NCT03799627|468242145|FG003|Overall Study|Lost to Follow-up|0|||
130078754|NCT03799627|468242146|FG004|Overall Study|Lost to Follow-up|0|||
130078755|NCT03799627|468242147|FG005|Overall Study|Lost to Follow-up|0|||
130078756|NCT03799627|468242148|FG006|Overall Study|Lost to Follow-up|1|||
130078757|NCT03799627|468242149|FG007|Overall Study|Lost to Follow-up|0|||
130078758|NCT03799627|468242150|FG008|Overall Study|Lost to Follow-up|1|||
130078759|NCT03799627|468242142|FG000|Overall Study|Death|0|||
130078760|NCT03799627|468242143|FG001|Overall Study|Death|0|||
130078761|NCT03799627|468242144|FG002|Overall Study|Death|0|||
130078762|NCT03799627|468242145|FG003|Overall Study|Death|1|||
130078763|NCT03799627|468242146|FG004|Overall Study|Death|0|||
130078764|NCT03799627|468242147|FG005|Overall Study|Death|0|||
130078765|NCT03799627|468242148|FG006|Overall Study|Death|0|||
130078766|NCT03799627|468242149|FG007|Overall Study|Death|0|||
130078767|NCT03799627|468242150|FG008|Overall Study|Death|0|||
130078768|NCT03799627|468242142|FG000|Overall Study|Study Drug Put on Hold|1|||
130078769|NCT03799627|468242143|FG001|Overall Study|Study Drug Put on Hold|0|||
130078770|NCT03799627|468242144|FG002|Overall Study|Study Drug Put on Hold|0|||
130078771|NCT03799627|468242145|FG003|Overall Study|Study Drug Put on Hold|0|||
130078772|NCT03799627|468242146|FG004|Overall Study|Study Drug Put on Hold|0|||
130078773|NCT03799627|468242147|FG005|Overall Study|Study Drug Put on Hold|0|||
130078774|NCT03799627|468242148|FG006|Overall Study|Study Drug Put on Hold|0|||
130078775|NCT03799627|468242149|FG007|Overall Study|Study Drug Put on Hold|0|||
130078776|NCT03799627|468242150|FG008|Overall Study|Study Drug Put on Hold|0|||
130078777|NCT03799627|468242142|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
130078778|NCT03799627|468242143|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
130078779|NCT03799627|468242144|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
130078780|NCT03799627|468242145|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
130078781|NCT03799627|468242146|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
130078782|NCT03799627|468242147|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
130078783|NCT03799627|468242148|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
130078784|NCT03799627|468242149|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
130078785|NCT03799627|468242150|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
130078786|NCT03799627|468242142|FG000|Overall Study|Kidney Transplantation|1|||
130078787|NCT03799627|468242143|FG001|Overall Study|Kidney Transplantation|0|||
130078788|NCT03799627|468242144|FG002|Overall Study|Kidney Transplantation|0|||
130078789|NCT03799627|468242145|FG003|Overall Study|Kidney Transplantation|1|||
130078790|NCT03799627|468242146|FG004|Overall Study|Kidney Transplantation|1|||
129953232|NCT03345407|467789885|FG000|Overall Study|Protocol Violation|2|||
129953233|NCT03345407|467789886|FG001|Overall Study|Protocol Violation|0|||
130078791|NCT03799627|468242147|FG005|Overall Study|Kidney Transplantation|0|||
130078792|NCT03799627|468242148|FG006|Overall Study|Kidney Transplantation|0|||
130078793|NCT03799627|468242149|FG007|Overall Study|Kidney Transplantation|0|||
130078794|NCT03799627|468242150|FG008|Overall Study|Kidney Transplantation|0|||
130078795|NCT03799627|468242142|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
130078796|NCT03799627|468242143|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
130078797|NCT03799627|468242144|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
130078798|NCT03799627|468242145|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
130078799|NCT03799627|468242146|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
130078800|NCT03799627|468242147|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
130078801|NCT03799627|468242148|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
130078802|NCT03799627|468242149|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
130078803|NCT03799627|468242150|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
130078804|NCT03799627|468242142|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078805|NCT03799627|468242143|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
130078806|NCT03799627|468242144|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078807|NCT03799627|468242145|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078808|NCT03799627|468242146|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078809|NCT03799627|468242147|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078810|NCT03799627|468242148|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078811|NCT03799627|468242149|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078812|NCT03799627|468242150|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
130078813|NCT03799627|468242142|FG000|Overall Study|Met Exclusion Criteria|0|||
130078814|NCT03799627|468242143|FG001|Overall Study|Met Exclusion Criteria|0|||
130078815|NCT03799627|468242144|FG002|Overall Study|Met Exclusion Criteria|0|||
130078816|NCT03799627|468242145|FG003|Overall Study|Met Exclusion Criteria|1|||
130078817|NCT03799627|468242146|FG004|Overall Study|Met Exclusion Criteria|0|||
130078818|NCT03799627|468242147|FG005|Overall Study|Met Exclusion Criteria|0|||
130078819|NCT03799627|468242148|FG006|Overall Study|Met Exclusion Criteria|0|||
130078820|NCT03799627|468242149|FG007|Overall Study|Met Exclusion Criteria|0|||
130078821|NCT03799627|468242150|FG008|Overall Study|Met Exclusion Criteria|0|||
130078822|NCT03799627|468242142|FG000|Overall Study|Investigational Product Noncompliance|0|||
130078823|NCT03799627|468242143|FG001|Overall Study|Investigational Product Noncompliance|0|||
130078824|NCT03799627|468242144|FG002|Overall Study|Investigational Product Noncompliance|0|||
130078825|NCT03799627|468242145|FG003|Overall Study|Investigational Product Noncompliance|1|||
130078826|NCT03799627|468242146|FG004|Overall Study|Investigational Product Noncompliance|0|||
130078827|NCT03799627|468242147|FG005|Overall Study|Investigational Product Noncompliance|0|||
130078828|NCT03799627|468242148|FG006|Overall Study|Investigational Product Noncompliance|0|||
130078829|NCT03799627|468242149|FG007|Overall Study|Investigational Product Noncompliance|0|||
130078830|NCT03799627|468242150|FG008|Overall Study|Investigational Product Noncompliance|0|||
130078831|NCT03799627|468242142|FG000|Overall Study|Participant Relocation|0|||
130078832|NCT03799627|468242143|FG001|Overall Study|Participant Relocation|0|||
130078833|NCT03799627|468242144|FG002|Overall Study|Participant Relocation|0|||
130078834|NCT03799627|468242145|FG003|Overall Study|Participant Relocation|1|||
130078835|NCT03799627|468242146|FG004|Overall Study|Participant Relocation|0|||
130078836|NCT03799627|468242147|FG005|Overall Study|Participant Relocation|1|||
130078837|NCT03799627|468242148|FG006|Overall Study|Participant Relocation|0|||
130078838|NCT03799627|468242149|FG007|Overall Study|Participant Relocation|0|||
130078839|NCT03799627|468242150|FG008|Overall Study|Participant Relocation|0|||
130078840|NCT03799627|468242142|FG000|Overall Study|Eurofin Issue|0|||
130078841|NCT03799627|468242143|FG001|Overall Study|Eurofin Issue|0|||
130078842|NCT03799627|468242144|FG002|Overall Study|Eurofin Issue|0|||
130078843|NCT03799627|468242145|FG003|Overall Study|Eurofin Issue|0|||
130078844|NCT03799627|468242146|FG004|Overall Study|Eurofin Issue|1|||
130078845|NCT03799627|468242147|FG005|Overall Study|Eurofin Issue|0|||
130078846|NCT03799627|468242148|FG006|Overall Study|Eurofin Issue|0|||
130078847|NCT03799627|468242149|FG007|Overall Study|Eurofin Issue|0|||
130078848|NCT03799627|468242150|FG008|Overall Study|Eurofin Issue|0|||
130078849|NCT03799627|468242142|FG000|Overall Study|Noncompliance with Site Instructions|0|||
130078850|NCT03799627|468242143|FG001|Overall Study|Noncompliance with Site Instructions|0|||
130078851|NCT03799627|468242144|FG002|Overall Study|Noncompliance with Site Instructions|0|||
130078852|NCT03799627|468242145|FG003|Overall Study|Noncompliance with Site Instructions|0|||
130078853|NCT03799627|468242146|FG004|Overall Study|Noncompliance with Site Instructions|1|||
130078854|NCT03799627|468242147|FG005|Overall Study|Noncompliance with Site Instructions|0|||
130078855|NCT03799627|468242148|FG006|Overall Study|Noncompliance with Site Instructions|0|||
130078856|NCT03799627|468242149|FG007|Overall Study|Noncompliance with Site Instructions|0|||
130078857|NCT03799627|468242150|FG008|Overall Study|Noncompliance with Site Instructions|0|||
130078858|NCT03799627|468242142|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078859|NCT03799627|468242143|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078860|NCT03799627|468242144|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078861|NCT03799627|468242145|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078862|NCT03799627|468242146|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
130078863|NCT03799627|468242147|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078864|NCT03799627|468242148|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078865|NCT03799627|468242149|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078866|NCT03799627|468242150|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
130078867|NCT03799627|468242142|FG000|Overall Study|Changes In Hemoglobin Values|1|||
130078868|NCT03799627|468242143|FG001|Overall Study|Changes In Hemoglobin Values|2|||
130078869|NCT03799627|468242144|FG002|Overall Study|Changes In Hemoglobin Values|1|||
130120787|NCT01957488|468404800|FG003|Test Period 2 (2 Weeks)|Other|0|||
130120788|NCT01957488|468404801|FG004|Test Period 2 (2 Weeks)|Other|0|||
130120789|NCT01957488|468404802|FG005|Test Period 2 (2 Weeks)|Other|0|||
130078870|NCT03799627|468242145|FG003|Overall Study|Changes In Hemoglobin Values|0|||
130078871|NCT03799627|468242146|FG004|Overall Study|Changes In Hemoglobin Values|0|||
130078872|NCT03799627|468242147|FG005|Overall Study|Changes In Hemoglobin Values|2|||
130078873|NCT03799627|468242148|FG006|Overall Study|Changes In Hemoglobin Values|1|||
130078874|NCT03799627|468242149|FG007|Overall Study|Changes In Hemoglobin Values|0|||
130078875|NCT03799627|468242150|FG008|Overall Study|Changes In Hemoglobin Values|1|||
130078876|NCT01922739|468242153|FG000|Titration/Adjustment Period|Adverse Event|3|||
130078877|NCT01922739|468242153|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
130078878|NCT01922739|468242153|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
130078879|NCT01922739|468242153|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
130078880|NCT01922739|468242153|FG000|Open-label Treatment Period|Adverse Event|6|||
130078881|NCT01922739|468242153|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
130078882|NCT01922739|468242153|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
130078883|NCT01922739|468242153|FG000|Open-label Treatment Period|Protocol Violation|5|||
130078884|NCT01922739|468242153|FG000|Open-label Treatment Period|Pregnancy|1|||
130078885|NCT01922739|468242153|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
130078886|NCT01922739|468242153|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
130078887|NCT01922739|468242153|FG000|Open-label Treatment Period|Physician Decision|1|||
130078888|NCT01922739|468242153|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
130078889|NCT03148795|468242156|FG000|Overall Study|Progressive Disease|1|||
130078890|NCT04489940|468242157|FG000|Overall Study|Other|2|||
130078891|NCT04489940|468242157|FG000|Overall Study|Withdrawal by Subject|2|||
130078892|NCT04489940|468242157|FG000|Overall Study|Death|5|||
130078893|NCT04489940|468242157|FG000|Overall Study|Lost to Follow-up|1|||
130078894|NCT02725268|468242158|FG000|Overall Study|Death|58|||
130078895|NCT02725268|468242159|FG001|Overall Study|Death|59|||
130078896|NCT02725268|468242160|FG002|Overall Study|Death|30|||
130078897|NCT02725268|468242161|FG003|Overall Study|Death|16|||
130078898|NCT02725268|468242158|FG000|Overall Study|Lost to Follow-up|4|||
130078899|NCT02725268|468242159|FG001|Overall Study|Lost to Follow-up|3|||
130078900|NCT02725268|468242160|FG002|Overall Study|Lost to Follow-up|0|||
130078901|NCT02725268|468242161|FG003|Overall Study|Lost to Follow-up|1|||
130078902|NCT02725268|468242158|FG000|Overall Study|Site Terminated by Sponsor|0|||
130078903|NCT02725268|468242159|FG001|Overall Study|Site Terminated by Sponsor|1|||
130078904|NCT02725268|468242160|FG002|Overall Study|Site Terminated by Sponsor|0|||
130078905|NCT02725268|468242161|FG003|Overall Study|Site Terminated by Sponsor|0|||
130078906|NCT02725268|468242158|FG000|Overall Study|Withdrawal by Subject|8|||
130078907|NCT02725268|468242159|FG001|Overall Study|Withdrawal by Subject|6|||
130078908|NCT02725268|468242160|FG002|Overall Study|Withdrawal by Subject|8|||
130078909|NCT02725268|468242161|FG003|Overall Study|Withdrawal by Subject|1|||
130078910|NCT02725268|468242158|FG000|Overall Study|Reason not Specified|2|||
130078911|NCT02725268|468242159|FG001|Overall Study|Reason not Specified|1|||
130078912|NCT02725268|468242160|FG002|Overall Study|Reason not Specified|0|||
130078913|NCT02725268|468242161|FG003|Overall Study|Reason not Specified|0|||
130078914|NCT04498468|468242162|FG000|Overall Study|Lost to Follow-up|3|||
130078915|NCT04973085|468242169|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
130078916|NCT04973085|468242170|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
130078917|NCT02224274|468242171|FG000|Overall Study|Death|1|||
130078918|NCT02224274|468242172|FG001|Overall Study|Death|0|||
130078919|NCT01976624|468242173|FG000|Overall Study|Participants contraindicated|2|||
130078920|NCT01976624|468242173|FG000|Overall Study|Participants age less than 19 years|12|||
130078921|NCT03074318|468242181|FG000|Overall Study|Adverse Event|0|||
130078922|NCT03074318|468242182|FG001|Overall Study|Adverse Event|1|||
130078923|NCT03074318|468242183|FG002|Overall Study|Adverse Event|1|||
130078924|NCT03074318|468242184|FG003|Overall Study|Adverse Event|1|||
130078925|NCT03074318|468242181|FG000|Overall Study|Death|1|||
130078926|NCT03074318|468242182|FG001|Overall Study|Death|0|||
130078927|NCT03074318|468242183|FG002|Overall Study|Death|0|||
130078928|NCT03074318|468242184|FG003|Overall Study|Death|0|||
130078929|NCT03074318|468242181|FG000|Overall Study|Withdrawal by Subject|1|||
130078930|NCT03074318|468242182|FG001|Overall Study|Withdrawal by Subject|2|||
130078931|NCT03074318|468242183|FG002|Overall Study|Withdrawal by Subject|2|||
130078932|NCT03074318|468242184|FG003|Overall Study|Withdrawal by Subject|4|||
130078933|NCT03074318|468242181|FG000|Overall Study|Trial Closure|2|||
130078934|NCT03074318|468242182|FG001|Overall Study|Trial Closure|2|||
130078935|NCT03074318|468242183|FG002|Overall Study|Trial Closure|3|||
130078936|NCT03074318|468242184|FG003|Overall Study|Trial Closure|11|||
129953234|NCT03345407|467789887|FG002|Overall Study|Protocol Violation|0|||
129953235|NCT03345407|467789888|FG003|Overall Study|Protocol Violation|0|||
130078937|NCT01627782|468242187|FG000|Overall Study|Adverse Event|1|||
130078938|NCT01627782|468242188|FG001|Overall Study|Adverse Event|2|||
130078939|NCT01627782|468242189|FG002|Overall Study|Adverse Event|0|||
130078940|NCT01627782|468242190|FG003|Overall Study|Adverse Event|1|||
130078941|NCT01627782|468242187|FG000|Overall Study|Lack of Efficacy|11|||
130078942|NCT01627782|468242188|FG001|Overall Study|Lack of Efficacy|1|||
130078943|NCT01627782|468242189|FG002|Overall Study|Lack of Efficacy|15|||
130078944|NCT01627782|468242190|FG003|Overall Study|Lack of Efficacy|2|||
130078945|NCT01627782|468242187|FG000|Overall Study|Protocol Violation|1|||
130078946|NCT01627782|468242188|FG001|Overall Study|Protocol Violation|0|||
130120790|NCT01957488|468404797|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130078947|NCT01627782|468242189|FG002|Overall Study|Protocol Violation|0|||
130120791|NCT01957488|468404798|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
130120792|NCT01957488|468404799|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130120793|NCT01957488|468404800|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130120794|NCT01957488|468404801|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130120795|NCT01957488|468404802|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
130120796|NCT01957488|468404797|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
130120797|NCT01957488|468404798|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
130120798|NCT01957488|468404799|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
130120799|NCT01957488|468404800|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
130120800|NCT01957488|468404801|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
130120801|NCT01957488|468404802|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
130120802|NCT01957488|468404797|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130120803|NCT01957488|468404798|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130120804|NCT01957488|468404799|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130120805|NCT01957488|468404800|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130120806|NCT01957488|468404801|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
130120807|NCT01957488|468404802|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
130120808|NCT01957488|468404797|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
129953236|NCT03345407|467789889|FG004|Overall Study|Protocol Violation|1|||
129953237|NCT03345407|467789890|FG005|Overall Study|Protocol Violation|0|||
129953238|NCT03345407|467789891|FG006|Overall Study|Protocol Violation|3|||
129953239|NCT03345407|467789885|FG000|Overall Study|Lack of Efficacy|1|||
129953240|NCT03345407|467789886|FG001|Overall Study|Lack of Efficacy|1|||
129953241|NCT03345407|467789887|FG002|Overall Study|Lack of Efficacy|1|||
129953242|NCT03345407|467789888|FG003|Overall Study|Lack of Efficacy|1|||
129953243|NCT03345407|467789889|FG004|Overall Study|Lack of Efficacy|1|||
129953244|NCT03345407|467789890|FG005|Overall Study|Lack of Efficacy|0|||
129953245|NCT03345407|467789891|FG006|Overall Study|Lack of Efficacy|3|||
129953246|NCT03345407|467789885|FG000|Overall Study|Adverse Event|4|||
129953247|NCT03345407|467789886|FG001|Overall Study|Adverse Event|0|||
129953248|NCT03345407|467789887|FG002|Overall Study|Adverse Event|5|||
129953249|NCT03345407|467789888|FG003|Overall Study|Adverse Event|4|||
129953250|NCT03345407|467789889|FG004|Overall Study|Adverse Event|6|||
129953251|NCT03345407|467789890|FG005|Overall Study|Adverse Event|5|||
129953252|NCT03345407|467789891|FG006|Overall Study|Adverse Event|16|||
129953253|NCT02092909|467789894|FG000|Overall Study|Adverse Event|0|||
129953254|NCT02092909|467789895|FG001|Overall Study|Adverse Event|0|||
129953255|NCT02092909|467789896|FG002|Overall Study|Adverse Event|4|||
129953256|NCT02092909|467789897|FG003|Overall Study|Adverse Event|2|||
129953257|NCT02092909|467789894|FG000|Overall Study|Lack of Efficacy|0|||
129953258|NCT02092909|467789895|FG001|Overall Study|Lack of Efficacy|2|||
129953259|NCT02092909|467789896|FG002|Overall Study|Lack of Efficacy|1|||
129953260|NCT02092909|467789897|FG003|Overall Study|Lack of Efficacy|0|||
129953261|NCT02092909|467789894|FG000|Overall Study|Withdrawal by Subject|0|||
129953262|NCT02092909|467789895|FG001|Overall Study|Withdrawal by Subject|0|||
129953263|NCT02092909|467789896|FG002|Overall Study|Withdrawal by Subject|2|||
129953264|NCT02092909|467789897|FG003|Overall Study|Withdrawal by Subject|1|||
129953265|NCT02092909|467789894|FG000|Overall Study|Study terminated by Sponsor|0|||
129953266|NCT02092909|467789895|FG001|Overall Study|Study terminated by Sponsor|0|||
129953267|NCT02092909|467789896|FG002|Overall Study|Study terminated by Sponsor|0|||
129953268|NCT02092909|467789897|FG003|Overall Study|Study terminated by Sponsor|2|||
129953269|NCT02092909|467789894|FG000|Overall Study|Miscellaneous|1|||
129953270|NCT02092909|467789895|FG001|Overall Study|Miscellaneous|1|||
129953271|NCT02092909|467789896|FG002|Overall Study|Miscellaneous|2|||
129953272|NCT02092909|467789897|FG003|Overall Study|Miscellaneous|1|||
129953273|NCT00901459|467789900|FG000|Overall Study|Withdrawal by Subject|6|||
129953274|NCT04765046|467789901|FG000|Overall Study|Screen Failure|2|||
129953275|NCT04765046|467789901|FG000|Overall Study|Withdrawal by Subject|4|||
129953276|NCT04765046|467789901|FG000|Overall Study|Physician Decision|4|||
129953277|NCT04765046|467789901|FG000|Overall Study|Surgery Cancelled|8|||
129953278|NCT00753896|467789906|FG000|Overall Study|Adverse Event|4|||
129953279|NCT00753896|467789906|FG000|Overall Study|Death|1|||
129953280|NCT00753896|467789906|FG000|Overall Study|Lost to Follow-up|2|||
129953281|NCT00753896|467789906|FG000|Overall Study|Protocol Violation|1|||
129953282|NCT00753896|467789906|FG000|Overall Study|Withdrawal by Subject|4|||
129953283|NCT00753896|467789906|FG000|Overall Study|Entry Criteria Not Met|4|||
129953284|NCT00848198|467789908|FG000|Overall Study|Incomplete Case Report Forms|15|||
129953285|NCT03708744|467789912|FG000|Overall Study|Withdrawal by Subject|0|||
129953286|NCT03708744|467789913|FG001|Overall Study|Withdrawal by Subject|0|||
129953287|NCT03708744|467789914|FG002|Overall Study|Withdrawal by Subject|1|||
129953288|NCT03708744|467789915|FG003|Overall Study|Withdrawal by Subject|0|||
129953289|NCT03529942|467789916|FG000|Overall Study|Withdrawal by Subject|13|||
130120809|NCT01957488|468404798|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129953290|NCT03529942|467789916|FG000|Overall Study|Physician Decision|1|||
129953291|NCT03529942|467789916|FG000|Overall Study|Lost to Follow-up|7|||
129953292|NCT03529942|467789916|FG000|Overall Study|Needle inserted but no drug administered|1|||
130078948|NCT01627782|468242190|FG003|Overall Study|Protocol Violation|0|||
130078949|NCT01627782|468242187|FG000|Overall Study|Withdrawal by Subject|2|||
130078950|NCT01627782|468242188|FG001|Overall Study|Withdrawal by Subject|1|||
130078951|NCT01627782|468242189|FG002|Overall Study|Withdrawal by Subject|0|||
130078952|NCT01627782|468242190|FG003|Overall Study|Withdrawal by Subject|0|||
130078953|NCT01627782|468242187|FG000|Overall Study|Other|0|||
130078954|NCT01627782|468242188|FG001|Overall Study|Other|2|||
130078955|NCT01627782|468242189|FG002|Overall Study|Other|0|||
130078956|NCT01627782|468242190|FG003|Overall Study|Other|3|||
130078957|NCT01627782|468242187|FG000|Overall Study|Randomized But Not Treated|1|||
130078958|NCT01627782|468242188|FG001|Overall Study|Randomized But Not Treated|0|||
130078959|NCT01627782|468242189|FG002|Overall Study|Randomized But Not Treated|0|||
130078960|NCT01627782|468242190|FG003|Overall Study|Randomized But Not Treated|0|||
130078961|NCT02177812|468242191|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130078962|NCT02177812|468242192|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130078963|NCT02177812|468242193|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130078964|NCT02177812|468242194|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130078965|NCT02177812|468242195|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130078966|NCT02177812|468242196|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
130078967|NCT02177812|468242197|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
130078968|NCT02177812|468242198|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
130078969|NCT02177812|468242199|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
130078970|NCT02177812|468242191|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078971|NCT02177812|468242192|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078972|NCT02177812|468242193|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078973|NCT02177812|468242194|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078974|NCT02177812|468242195|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078975|NCT02177812|468242196|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
130078976|NCT02177812|468242197|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
130078977|NCT02177812|468242198|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078978|NCT02177812|468242199|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
130078979|NCT02177812|468242191|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130078980|NCT02177812|468242192|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130078981|NCT02177812|468242193|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130078982|NCT02177812|468242194|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130078983|NCT02177812|468242195|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130078984|NCT02177812|468242196|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130078985|NCT02177812|468242197|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
130078986|NCT02177812|468242198|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
130078987|NCT02177812|468242199|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
130078988|NCT00089999|468242200|FG000|Overall Study|Adverse Event|4|||
130078989|NCT00089999|468242201|FG001|Overall Study|Adverse Event|7|||
130078990|NCT00089999|468242200|FG000|Overall Study|Withdrawal by Subject|0|||
130078991|NCT00089999|468242201|FG001|Overall Study|Withdrawal by Subject|4|||
130078992|NCT00089999|468242200|FG000|Overall Study|Lost to Follow-up|2|||
130078993|NCT00089999|468242201|FG001|Overall Study|Lost to Follow-up|1|||
130078994|NCT00089999|468242200|FG000|Overall Study|Radiological Progression of Cancer|52|||
130078995|NCT00089999|468242201|FG001|Overall Study|Radiological Progression of Cancer|44|||
130078996|NCT00089999|468242200|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
130078997|NCT00089999|468242201|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
130078998|NCT00089999|468242200|FG000|Overall Study|Death|3|||
130078999|NCT00089999|468242201|FG001|Overall Study|Death|3|||
130079000|NCT00089999|468242200|FG000|Overall Study|Poor General Condition|1|||
130079001|NCT00089999|468242201|FG001|Overall Study|Poor General Condition|0|||
130079002|NCT00089999|468242200|FG000|Overall Study|Clinical Progression|1|||
130079003|NCT00089999|468242201|FG001|Overall Study|Clinical Progression|2|||
130079004|NCT00089999|468242200|FG000|Overall Study|Physician Decision|2|||
130079005|NCT00089999|468242201|FG001|Overall Study|Physician Decision|2|||
130079006|NCT00089999|468242200|FG000|Overall Study|Patient Underwent Surgery|2|||
130079007|NCT00089999|468242201|FG001|Overall Study|Patient Underwent Surgery|0|||
130120810|NCT01957488|468404799|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129953293|NCT03529942|467789916|FG000|Overall Study|Personal reasons|1|||
129953294|NCT04930263|467789917|FG000|Overall Study|Withdrawal by Subject|3|||
130079008|NCT00089999|468242200|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
130079009|NCT00089999|468242201|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
130079010|NCT01167153|468242202|FG000|Overall Study|Non-effective therapy|1|||
130079011|NCT01167153|468242203|FG001|Overall Study|Non-effective therapy|4|||
130079012|NCT01167153|468242202|FG000|Overall Study|AE including clinical laboratory AE|2|||
130079013|NCT01167153|468242203|FG001|Overall Study|AE including clinical laboratory AE|8|||
130079014|NCT01167153|468242202|FG000|Overall Study|Hypotension|1|||
130079015|NCT01167153|468242203|FG001|Overall Study|Hypotension|0|||
130079016|NCT01167153|468242202|FG000|Overall Study|Lost to Follow-up|7|||
130079017|NCT01167153|468242203|FG001|Overall Study|Lost to Follow-up|9|||
130120811|NCT01957488|468404800|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130120812|NCT01957488|468404801|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129953295|NCT04930263|467789918|FG001|Overall Study|Withdrawal by Subject|5|||
129953296|NCT01989156|467789921|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
129953297|NCT01989156|467789922|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
129953298|NCT01989156|467789923|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
129953299|NCT01989156|467789921|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
129953300|NCT01989156|467789922|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
129953301|NCT01989156|467789923|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
129953302|NCT01989156|467789921|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
129953303|NCT01989156|467789922|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
129953304|NCT01989156|467789923|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
129953305|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
129953306|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
129953307|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
129953308|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
129953309|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
129953310|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
129953311|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
129953312|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
129953313|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
129953314|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
129953315|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
129953316|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
129953317|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
129953318|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
129953319|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
129953320|NCT00850993|467789926|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
129953321|NCT00850993|467789927|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
129953322|NCT00850993|467789928|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
129953323|NCT00850993|467789929|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
129953324|NCT03839355|467789930|FG000|Overall Study|Withdrawal by Subject|1|||
129953325|NCT03839355|467789931|FG001|Overall Study|Withdrawal by Subject|0|||
129953326|NCT02009865|467789946|FG000|Overall Study|Adverse Event|0|||
129953327|NCT02009865|467789947|FG001|Overall Study|Adverse Event|2|||
129953328|NCT02009865|467789946|FG000|Overall Study|Protocol Violation|0|||
129953329|NCT02009865|467789947|FG001|Overall Study|Protocol Violation|2|||
129953330|NCT02009865|467789946|FG000|Overall Study|Withdrawal by Subject|1|||
129953331|NCT02009865|467789947|FG001|Overall Study|Withdrawal by Subject|1|||
129953332|NCT01760876|467789948|FG000|Overall Study|Non-cardiac death (head injury)|1|||
129953333|NCT01760876|467789948|FG000|Overall Study|Carcinoma of prostate|1|||
129953334|NCT01760876|467789948|FG000|Overall Study|Impaired renal function|1|||
129953335|NCT01760876|467789948|FG000|Overall Study|Major depression|1|||
129953336|NCT01760876|467789948|FG000|Overall Study|Very poor baseline OCT quality|2|||
129953337|NCT01517282|467789949|FG000|Overall Study|Consent withdrawn|0|||
129953338|NCT01517282|467789950|FG001|Overall Study|Consent withdrawn|1|||
129953339|NCT01517282|467789951|FG002|Overall Study|Consent withdrawn|1|||
129953340|NCT01517282|467789952|FG003|Overall Study|Consent withdrawn|1|||
129953341|NCT01517282|467789949|FG000|Overall Study|Physician Decision|1|||
129953342|NCT01517282|467789950|FG001|Overall Study|Physician Decision|0|||
129953343|NCT01517282|467789951|FG002|Overall Study|Physician Decision|0|||
129953344|NCT01517282|467789952|FG003|Overall Study|Physician Decision|0|||
129953345|NCT00525915|467789953|FG000|Overall Study|Non-Compliance|0|||
129953346|NCT00525915|467789954|FG001|Overall Study|Non-Compliance|1|||
129953347|NCT00525915|467789953|FG000|Overall Study|Disease Progression|5|||
129953348|NCT00525915|467789954|FG001|Overall Study|Disease Progression|6|||
129953349|NCT00525915|467789953|FG000|Overall Study|Withdrawal by Subject|1|||
129953350|NCT00525915|467789954|FG001|Overall Study|Withdrawal by Subject|0|||
129953351|NCT00525915|467789953|FG000|Overall Study|Refused Surgery|1|||
129953352|NCT00525915|467789954|FG001|Overall Study|Refused Surgery|2|||
129953353|NCT00525915|467789953|FG000|Overall Study|Unrelated illness|1|||
129953354|NCT00525915|467789954|FG001|Overall Study|Unrelated illness|0|||
129953355|NCT02332889|467789958|FG000|Overall Study|Physician Decision|1|||
129953356|NCT04198428|467790833|FG000|Overall Study|Withdrawal by Subject|150|||
129953357|NCT04198428|467790834|FG001|Overall Study|Withdrawal by Subject|156|||
129953358|NCT02011568|467790835|FG000|Overall Study|Withdrawal by Subject|8|||
129953359|NCT02011568|467790836|FG001|Overall Study|Withdrawal by Subject|10|||
129953360|NCT02011568|467790835|FG000|Overall Study|Physician Decision|1|||
129953361|NCT02011568|467790836|FG001|Overall Study|Physician Decision|3|||
129953362|NCT02409732|467790838|FG000|Overall Study|Withdrawal by Subject|4|||
129953363|NCT02409732|467790838|FG000|Overall Study|Lost to Follow-up|2|||
129953364|NCT00376259|467790839|FG000|Overall Study|Sponsor request - study termination|21|||
129953365|NCT00376259|467790840|FG001|Overall Study|Sponsor request - study termination|21|||
129953366|NCT00376259|467790839|FG000|Overall Study|Patient request|1|||
130079018|NCT01167153|468242202|FG000|Overall Study|Non-compliance to concomitant medication|0|||
130079019|NCT01167153|468242203|FG001|Overall Study|Non-compliance to concomitant medication|2|||
130079020|NCT01167153|468242202|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
130079021|NCT01167153|468242203|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
130079022|NCT01167153|468242202|FG000|Overall Study|Withdrawal consent|1|||
130079023|NCT01167153|468242203|FG001|Overall Study|Withdrawal consent|1|||
130079024|NCT01167153|468242202|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
130079025|NCT01167153|468242203|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
130079026|NCT01004159|468243581|FG000|Overall Study|Adverse Event|2|||
130079027|NCT01004159|468243581|FG000|Overall Study|Disease Progression|18|||
130079028|NCT00444951|468243585|FG000|Overall Study|Lost to Follow-up|1|||
130079029|NCT00444951|468243586|FG001|Overall Study|Lost to Follow-up|1|||
130079030|NCT00444951|468243587|FG002|Overall Study|Lost to Follow-up|0|||
130079031|NCT00444951|468243585|FG000|Overall Study|Withdrawal by Subject|4|||
130079032|NCT00444951|468243586|FG001|Overall Study|Withdrawal by Subject|5|||
130079033|NCT00444951|468243587|FG002|Overall Study|Withdrawal by Subject|3|||
130079034|NCT01998906|468243588|FG000|Overall Study|Participants ongoing in follow-up|77|||
130079035|NCT01998906|468243589|FG001|Overall Study|Participants ongoing in follow-up|60|||
130079036|NCT01998906|468243590|FG002|Overall Study|Participants ongoing in follow-up|58|||
130079037|NCT01998906|468243588|FG000|Overall Study|Death|21|||
130079038|NCT01998906|468243589|FG001|Overall Study|Death|30|||
130079039|NCT01998906|468243590|FG002|Overall Study|Death|17|||
130120813|NCT01957488|468404802|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
130120814|NCT01957488|468404797|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130120815|NCT01957488|468404798|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
130120816|NCT01957488|468404799|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130120817|NCT01957488|468404800|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130120818|NCT01957488|468404801|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130120819|NCT01957488|468404802|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
130120820|NCT01439165|468404803|FG000|Overall Study|Protocol Violation|3|||
130120821|NCT01439165|468404804|FG001|Overall Study|Protocol Violation|0|||
129953367|NCT00376259|467790840|FG001|Overall Study|Patient request|0|||
129953368|NCT01012999|467790841|FG000|Overall Study|Protocol Violation|1|||
130120822|NCT01439165|468404803|FG000|Overall Study|Lost to Follow-up|11|||
130120823|NCT01439165|468404804|FG001|Overall Study|Lost to Follow-up|1|||
130120824|NCT01439165|468404803|FG000|Overall Study|Withdrawal by Subject|7|||
130120825|NCT01439165|468404804|FG001|Overall Study|Withdrawal by Subject|1|||
130120826|NCT00810368|468404805|FG000|Overall Study|Lost to Follow-up|4|||
130120827|NCT00810368|468404806|FG001|Overall Study|Lost to Follow-up|2|||
130120828|NCT00810368|468404805|FG000|Overall Study|Lack of Efficacy|2|||
130120829|NCT00810368|468404806|FG001|Overall Study|Lack of Efficacy|0|||
130120830|NCT02433678|468404807|FG000|Overall Study|Lost to Follow-up|1|||
130120831|NCT02433678|468404808|FG001|Overall Study|Lost to Follow-up|2|||
130120832|NCT03365375|468404809|FG000|Overall Study|Withdrawal by Subject|0|||
130120833|NCT03365375|468404810|FG001|Overall Study|Withdrawal by Subject|1|||
129953369|NCT02069366|467790842|FG000|Overall Study|Lost to Follow-up|0|||
129953370|NCT02069366|467790843|FG001|Overall Study|Lost to Follow-up|0|||
129953371|NCT02069366|467790844|FG002|Overall Study|Lost to Follow-up|1|||
129953372|NCT02069366|467790845|FG003|Overall Study|Lost to Follow-up|0|||
129953373|NCT02069366|467790846|FG004|Overall Study|Lost to Follow-up|0|||
129953374|NCT02069366|467790847|FG005|Overall Study|Lost to Follow-up|2|||
129953375|NCT02069366|467790842|FG000|Overall Study|Protocol Violation|0|||
129953376|NCT02069366|467790843|FG001|Overall Study|Protocol Violation|0|||
129953377|NCT02069366|467790844|FG002|Overall Study|Protocol Violation|1|||
129953378|NCT02069366|467790845|FG003|Overall Study|Protocol Violation|0|||
129953379|NCT02069366|467790846|FG004|Overall Study|Protocol Violation|0|||
129953380|NCT02069366|467790847|FG005|Overall Study|Protocol Violation|0|||
129953381|NCT02069366|467790842|FG000|Overall Study|Withdrawal by Subject|1|||
129953382|NCT02069366|467790843|FG001|Overall Study|Withdrawal by Subject|0|||
129953383|NCT02069366|467790844|FG002|Overall Study|Withdrawal by Subject|1|||
129953384|NCT02069366|467790845|FG003|Overall Study|Withdrawal by Subject|2|||
129953385|NCT02069366|467790846|FG004|Overall Study|Withdrawal by Subject|0|||
130079040|NCT01998906|468243588|FG000|Overall Study|Lack of Efficacy|10|||
130079041|NCT01998906|468243589|FG001|Overall Study|Lack of Efficacy|9|||
130079042|NCT01998906|468243590|FG002|Overall Study|Lack of Efficacy|8|||
130079043|NCT01998906|468243588|FG000|Overall Study|Failure to return|0|||
130079044|NCT01998906|468243589|FG001|Overall Study|Failure to return|2|||
130079045|NCT01998906|468243590|FG002|Overall Study|Failure to return|4|||
130120834|NCT03365375|468404809|FG000|Overall Study|Lost to Follow-up|0|||
130120835|NCT03365375|468404810|FG001|Overall Study|Lost to Follow-up|4|||
130120836|NCT00266409|468404814|FG000|Overall Study|Lack of Efficacy|2|||
130120837|NCT00266409|468404815|FG001|Overall Study|Lack of Efficacy|6|||
130120838|NCT00266409|468404816|FG002|Overall Study|Lack of Efficacy|1|||
129953386|NCT02069366|467790847|FG005|Overall Study|Withdrawal by Subject|0|||
129953387|NCT02256553|467790848|FG000|Period I|Adverse Event|5|||
129953388|NCT02256553|467790848|FG000|Period I|Protocol Violation|1|||
130079046|NCT01998906|468243588|FG000|Overall Study|Violation of Selection Criteria|0|||
130079047|NCT01998906|468243589|FG001|Overall Study|Violation of Selection Criteria|0|||
129953389|NCT02256553|467790848|FG000|Period II|Adverse Event|1|||
129953390|NCT02256553|467790848|FG000|Period II|Subject Moved|1|||
129953391|NCT02256553|467790848|FG000|Period III|Adverse Event|3|||
129953392|NCT03436797|467790849|FG000|Main Study|Withdrawal by Subject|2|||
129953393|NCT03436797|467790849|FG000|Main Study|Adverse Event|4|||
129953394|NCT03436797|467790849|FG000|Main Study|Lost to Follow-up|1|||
129953395|NCT03436797|467790849|FG000|Main Study|Death|1|||
129953396|NCT03436797|467790849|FG000|Main Study|Non-Specific|2|||
130120839|NCT00266409|468404817|FG003|Overall Study|Lack of Efficacy|2|||
130120840|NCT00266409|468404814|FG000|Overall Study|Adverse Event|7|||
130120841|NCT00266409|468404815|FG001|Overall Study|Adverse Event|2|||
130120842|NCT00266409|468404816|FG002|Overall Study|Adverse Event|1|||
130120843|NCT00266409|468404817|FG003|Overall Study|Adverse Event|1|||
130120844|NCT00266409|468404814|FG000|Overall Study|Lost to Follow-up|18|||
130120845|NCT00266409|468404815|FG001|Overall Study|Lost to Follow-up|21|||
129953397|NCT03436797|467790849|FG000|Extended Dosing|Patient decision|1|||
129953398|NCT01951105|467790852|FG000|Overall Study|Adverse Event|0|||
129953399|NCT01951105|467790853|FG001|Overall Study|Adverse Event|5|||
129953400|NCT01951105|467790854|FG002|Overall Study|Adverse Event|0|||
129953401|NCT01951105|467790852|FG000|Overall Study|Lost to Follow-up|0|||
129953402|NCT01951105|467790853|FG001|Overall Study|Lost to Follow-up|1|||
129953403|NCT01951105|467790854|FG002|Overall Study|Lost to Follow-up|0|||
129953404|NCT01951105|467790852|FG000|Overall Study|Protocol Violation|1|||
129953405|NCT01951105|467790853|FG001|Overall Study|Protocol Violation|1|||
129953406|NCT01951105|467790854|FG002|Overall Study|Protocol Violation|1|||
129953407|NCT01951105|467790852|FG000|Overall Study|Withdrawal by Subject|0|||
129953408|NCT01951105|467790853|FG001|Overall Study|Withdrawal by Subject|3|||
129953409|NCT01951105|467790854|FG002|Overall Study|Withdrawal by Subject|1|||
129953410|NCT01601821|467790855|FG000|Overall Study|Death|2|||
129953411|NCT01601821|467790856|FG001|Overall Study|Death|5|||
129953412|NCT01601821|467790855|FG000|Overall Study|Protocol Violation|2|||
129953413|NCT01601821|467790856|FG001|Overall Study|Protocol Violation|2|||
129953414|NCT01601821|467790855|FG000|Overall Study|Lost to Follow-up|6|||
129953415|NCT01601821|467790856|FG001|Overall Study|Lost to Follow-up|14|||
129953416|NCT01601821|467790855|FG000|Overall Study|Withdrawal by Subject|1|||
129953417|NCT01601821|467790856|FG001|Overall Study|Withdrawal by Subject|0|||
129953418|NCT01601821|467790855|FG000|Overall Study|Graft Loss|6|||
129953419|NCT01601821|467790856|FG001|Overall Study|Graft Loss|6|||
129953420|NCT01601821|467790855|FG000|Overall Study|Study Events|7|||
129953421|NCT01601821|467790856|FG001|Overall Study|Study Events|1|||
129953422|NCT01601821|467790855|FG000|Overall Study|Other|5|||
129953423|NCT01601821|467790856|FG001|Overall Study|Other|1|||
129953424|NCT02469155|467790857|FG000|Overall Study|Adverse Event|6|||
129953425|NCT02469155|467790858|FG001|Overall Study|Adverse Event|0|||
130079048|NCT01998906|468243590|FG002|Overall Study|Violation of Selection Criteria|1|||
130079049|NCT01998906|468243588|FG000|Overall Study|Withdrawal by Subject|1|||
130079050|NCT01998906|468243589|FG001|Overall Study|Withdrawal by Subject|4|||
130079051|NCT01998906|468243590|FG002|Overall Study|Withdrawal by Subject|3|||
130079052|NCT01998906|468243588|FG000|Overall Study|Administrative/Other|2|||
130079053|NCT01998906|468243589|FG001|Overall Study|Administrative/Other|1|||
130120846|NCT00266409|468404816|FG002|Overall Study|Lost to Follow-up|6|||
129953426|NCT02469155|467790859|FG002|Overall Study|Adverse Event|1|||
129953427|NCT02469155|467790860|FG003|Overall Study|Adverse Event|10|||
129953428|NCT02469155|467790857|FG000|Overall Study|Lack of Efficacy|13|||
129953429|NCT02469155|467790858|FG001|Overall Study|Lack of Efficacy|10|||
129953430|NCT02469155|467790859|FG002|Overall Study|Lack of Efficacy|10|||
129953431|NCT02469155|467790860|FG003|Overall Study|Lack of Efficacy|8|||
130120847|NCT00266409|468404817|FG003|Overall Study|Lost to Follow-up|8|||
129953432|NCT02469155|467790857|FG000|Overall Study|Death|0|||
129953433|NCT02469155|467790858|FG001|Overall Study|Death|0|||
129953434|NCT02469155|467790859|FG002|Overall Study|Death|0|||
129953435|NCT02469155|467790860|FG003|Overall Study|Death|1|||
129953436|NCT02469155|467790857|FG000|Overall Study|Lost to Follow-up|5|||
129953437|NCT02469155|467790858|FG001|Overall Study|Lost to Follow-up|2|||
129953438|NCT02469155|467790859|FG002|Overall Study|Lost to Follow-up|7|||
129953439|NCT02469155|467790860|FG003|Overall Study|Lost to Follow-up|2|||
129953440|NCT02469155|467790857|FG000|Overall Study|Physician Decision|0|||
129953441|NCT02469155|467790858|FG001|Overall Study|Physician Decision|0|||
130120848|NCT00266409|468404814|FG000|Overall Study|Withdrawal by Subject|6|||
130120849|NCT00266409|468404815|FG001|Overall Study|Withdrawal by Subject|10|||
130120850|NCT00266409|468404816|FG002|Overall Study|Withdrawal by Subject|3|||
129953442|NCT02469155|467790859|FG002|Overall Study|Physician Decision|1|||
129953443|NCT02469155|467790860|FG003|Overall Study|Physician Decision|0|||
129953444|NCT02469155|467790857|FG000|Overall Study|Withdrawal by Subject|34|||
130079054|NCT01998906|468243590|FG002|Overall Study|Administrative/Other|3|||
130079055|NCT01998906|468243588|FG000|Overall Study|Other|3|||
130079056|NCT01998906|468243589|FG001|Overall Study|Other|8|||
129953445|NCT02469155|467790858|FG001|Overall Study|Withdrawal by Subject|30|||
129953446|NCT02469155|467790859|FG002|Overall Study|Withdrawal by Subject|20|||
129953447|NCT02469155|467790860|FG003|Overall Study|Withdrawal by Subject|37|||
129953448|NCT02469155|467790857|FG000|Overall Study|Other|3|||
130079057|NCT01998906|468243590|FG002|Overall Study|Other|4|||
130079058|NCT02828644|468243593|FG000|Overall Study|Lost to Follow-up|23|||
130079059|NCT02828644|468243594|FG001|Overall Study|Lost to Follow-up|22|||
130079060|NCT06048809|468243599|FG000|Overall Study|Adverse Event|2|||
130079061|NCT06048809|468243600|FG001|Overall Study|Adverse Event|0|||
130079062|NCT06048809|468243599|FG000|Overall Study|Withdrawal by Subject|1|||
130079063|NCT06048809|468243600|FG001|Overall Study|Withdrawal by Subject|1|||
130079064|NCT02158728|468243601|FG000|Overall Study|no procedure according to CIP done|3|||
130079065|NCT02158728|468243601|FG000|Overall Study|no qualified dataset|24|||
130079066|NCT03878160|468243607|FG000|Overall Study|Lost to Follow-up|1|||
130079067|NCT03878160|468243608|FG001|Overall Study|Lost to Follow-up|1|||
130079068|NCT03878160|468243609|FG002|Overall Study|Lost to Follow-up|1|||
130079069|NCT03878160|468243607|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
130079070|NCT03878160|468243608|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
130079071|NCT03878160|468243609|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
130079072|NCT00589602|468243615|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
130079073|NCT03687827|468243622|FG000|Treatment Period 1|Death|0|||
130079074|NCT03687827|468243623|FG001|Treatment Period 1|Death|1|||
130079075|NCT03687827|468243622|FG000|Treatment Period 1|Lost to Follow-up|2|||
130079076|NCT03687827|468243623|FG001|Treatment Period 1|Lost to Follow-up|2|||
130079077|NCT03687827|468243622|FG000|Treatment Period 1|Physician Decision|5|||
130079078|NCT03687827|468243623|FG001|Treatment Period 1|Physician Decision|2|||
130079079|NCT03687827|468243622|FG000|Treatment Period 1|Withdrawal by Subject|7|||
130079080|NCT03687827|468243623|FG001|Treatment Period 1|Withdrawal by Subject|3|||
130079081|NCT03687827|468243622|FG000|Treatment Period 2|Physician Decision|4|||
130079082|NCT03687827|468243623|FG001|Treatment Period 2|Physician Decision|1|||
130079083|NCT03687827|468243622|FG000|Treatment Period 2|Withdrawal by Subject|1|||
130079084|NCT03687827|468243623|FG001|Treatment Period 2|Withdrawal by Subject|2|||
130079085|NCT00285649|468243626|FG000|Overall Study|Lost to Follow-up|6|||
130079086|NCT00285649|468243627|FG001|Overall Study|Lost to Follow-up|4|||
130079087|NCT00285649|468243628|FG002|Overall Study|Lost to Follow-up|4|||
130079088|NCT00285649|468243626|FG000|Overall Study|Withdrawal by Subject|3|||
130079089|NCT00285649|468243627|FG001|Overall Study|Withdrawal by Subject|2|||
130079090|NCT00285649|468243628|FG002|Overall Study|Withdrawal by Subject|2|||
130079091|NCT03342404|468243629|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
130079092|NCT03342404|468243630|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
130079093|NCT03342404|468243629|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
130079094|NCT03342404|468243630|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
130079095|NCT03342404|468243629|FG000|Blinded Treatment Phase|Adverse Event|5|||
130079096|NCT03342404|468243630|FG001|Blinded Treatment Phase|Adverse Event|4|||
130079097|NCT03342404|468243629|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
130079098|NCT03342404|468243630|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
130079099|NCT03342404|468243629|FG000|Blinded Treatment Phase|Other reasons|1|||
130079100|NCT03342404|468243630|FG001|Blinded Treatment Phase|Other reasons|0|||
130079101|NCT03342404|468243629|FG000|Blinded Treatment Phase|Physician Decision|1|||
130079102|NCT03342404|468243630|FG001|Blinded Treatment Phase|Physician Decision|0|||
130079103|NCT03342404|468243629|FG000|Blinded Treatment Phase|Death|1|||
130079104|NCT03342404|468243630|FG001|Blinded Treatment Phase|Death|0|||
130079105|NCT03342404|468243629|FG000|Open-Label Phase|Lost to Follow-up|0|||
130079106|NCT03342404|468243630|FG001|Open-Label Phase|Lost to Follow-up|1|||
130079107|NCT03342404|468243629|FG000|Open-Label Phase|Other reasons|0|||
130079108|NCT03342404|468243630|FG001|Open-Label Phase|Other reasons|1|||
130079109|NCT03342404|468243629|FG000|Open-Label Phase|Adverse Event|0|||
130079110|NCT03342404|468243630|FG001|Open-Label Phase|Adverse Event|3|||
130079111|NCT03342404|468243629|FG000|Open-Label Phase|Withdrawal by Subject|0|||
130079112|NCT03342404|468243630|FG001|Open-Label Phase|Withdrawal by Subject|6|||
130079113|NCT01855425|468243631|FG000|Overall Study|Physician Decision|20|||
130079114|NCT03748420|468243633|FG000|Overall Study|No 12 month medication adherence data available|0|||
130079115|NCT03748420|468243634|FG001|Overall Study|No 12 month medication adherence data available|1|||
130079116|NCT03748420|468243633|FG000|Overall Study|Death|24|||
130079117|NCT03748420|468243634|FG001|Overall Study|Death|28|||
130079118|NCT03748420|468243633|FG000|Overall Study|Lost to Follow-up|231|||
130079119|NCT03748420|468243634|FG001|Overall Study|Lost to Follow-up|230|||
130079120|NCT00373880|468243635|FG000|Overall Study|Physician Decision|3|||
130079121|NCT00373880|468243635|FG000|Overall Study|Arrested|1|||
130079122|NCT00373880|468243635|FG000|Overall Study|Protocol Violation|14|||
130079123|NCT01925014|468243637|FG000|Overall Study|Inappropriate enrollment|4|||
130079124|NCT01925014|468243638|FG001|Overall Study|Inappropriate enrollment|6|||
130079125|NCT01925014|468243637|FG000|Overall Study|Withdrawal by Subject|5|||
130079126|NCT01925014|468243638|FG001|Overall Study|Withdrawal by Subject|13|||
130079127|NCT03696576|468243646|FG000|Overall Study|Soreness of throat after therapy|1|||
130079128|NCT03696576|468243647|FG001|Overall Study|Soreness of throat after therapy|1|||
130079129|NCT03696576|468243646|FG000|Overall Study|Lost to Follow-up|2|||
130079130|NCT03696576|468243647|FG001|Overall Study|Lost to Follow-up|4|||
130079131|NCT00312728|468243648|FG000|Overall Study|Progressive disease|53|||
130079132|NCT00312728|468243648|FG000|Overall Study|Adverse Event|32|||
129953449|NCT02469155|467790858|FG001|Overall Study|Other|3|||
129953450|NCT02469155|467790859|FG002|Overall Study|Other|2|||
129953451|NCT02469155|467790860|FG003|Overall Study|Other|10|||
129953452|NCT02469155|467790857|FG000|Overall Study|Protocol Violation|0|||
129953453|NCT02469155|467790858|FG001|Overall Study|Protocol Violation|1|||
129953454|NCT02469155|467790859|FG002|Overall Study|Protocol Violation|0|||
129953455|NCT02469155|467790860|FG003|Overall Study|Protocol Violation|1|||
129953456|NCT00442559|467790861|FG000|Overall Study|Lost to Follow-up|32|||
129953457|NCT00442559|467790862|FG001|Overall Study|Lost to Follow-up|34|||
129953458|NCT00442559|467790861|FG000|Overall Study|Protocol Violation|1|||
129953459|NCT00442559|467790862|FG001|Overall Study|Protocol Violation|1|||
129953460|NCT00442559|467790861|FG000|Overall Study|Withdrawal by Subject|1|||
129953461|NCT00442559|467790862|FG001|Overall Study|Withdrawal by Subject|0|||
129953462|NCT02604199|467790872|FG000|Overall Study|Pregnancy|0|||
129953463|NCT02604199|467790873|FG001|Overall Study|Pregnancy|0|||
129953464|NCT02604199|467790874|FG002|Overall Study|Pregnancy|0|||
129953465|NCT02604199|467790875|FG003|Overall Study|Pregnancy|1|||
129953466|NCT02604199|467790872|FG000|Overall Study|Study terminated by sponsor|0|||
129953467|NCT02604199|467790873|FG001|Overall Study|Study terminated by sponsor|2|||
129953468|NCT02604199|467790874|FG002|Overall Study|Study terminated by sponsor|0|||
129953469|NCT02604199|467790875|FG003|Overall Study|Study terminated by sponsor|2|||
129953470|NCT02604199|467790872|FG000|Overall Study|Withdrawal by Subject|0|||
129953471|NCT02604199|467790873|FG001|Overall Study|Withdrawal by Subject|1|||
129953472|NCT02604199|467790874|FG002|Overall Study|Withdrawal by Subject|0|||
129953473|NCT02604199|467790875|FG003|Overall Study|Withdrawal by Subject|0|||
129953474|NCT02812706|467790876|FG000|Phase 1|Adverse Event|0|||
129953475|NCT02812706|467790877|FG001|Phase 1|Adverse Event|2|||
129953476|NCT02812706|467790878|FG002|Phase 1|Adverse Event|0|||
129953477|NCT02812706|467790876|FG000|Phase 1|Progressive disease|3|||
129953478|NCT02812706|467790877|FG001|Phase 1|Progressive disease|3|||
129953479|NCT02812706|467790878|FG002|Phase 1|Progressive disease|0|||
129953480|NCT02812706|467790876|FG000|Phase 2|Adverse Event|0|||
129953481|NCT02812706|467790877|FG001|Phase 2|Adverse Event|0|||
129953482|NCT02812706|467790878|FG002|Phase 2|Adverse Event|2|||
129953483|NCT02812706|467790876|FG000|Phase 2|Progressive disease|0|||
129953484|NCT02812706|467790877|FG001|Phase 2|Progressive disease|0|||
129953485|NCT02812706|467790878|FG002|Phase 2|Progressive disease|22|||
129953486|NCT02812706|467790876|FG000|Phase 2|Other-Unspecified|0|||
129953487|NCT02812706|467790877|FG001|Phase 2|Other-Unspecified|0|||
129953488|NCT02812706|467790878|FG002|Phase 2|Other-Unspecified|4|||
129953489|NCT04362176|467790884|FG000|Overall Study|Lost to Follow-up|5|||
129953490|NCT04362176|467790885|FG001|Overall Study|Lost to Follow-up|8|||
129953491|NCT04362176|467790884|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
129953492|NCT04362176|467790885|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
129953493|NCT00742560|467790886|FG000|Overall Study|Adverse Event|0|||
129953494|NCT00742560|467790887|FG001|Overall Study|Adverse Event|0|||
129953495|NCT00742560|467790888|FG002|Overall Study|Adverse Event|1|||
129953496|NCT00742560|467790889|FG003|Overall Study|Adverse Event|1|||
129953497|NCT00742560|467790890|FG004|Overall Study|Adverse Event|1|||
129953498|NCT00742560|467790886|FG000|Overall Study|Death|0|||
129953499|NCT00742560|467790887|FG001|Overall Study|Death|2|||
129953500|NCT00742560|467790888|FG002|Overall Study|Death|0|||
129953501|NCT00742560|467790889|FG003|Overall Study|Death|2|||
129953502|NCT00742560|467790890|FG004|Overall Study|Death|3|||
129953503|NCT00742560|467790886|FG000|Overall Study|Subject's Decision|1|||
129953504|NCT00742560|467790887|FG001|Overall Study|Subject's Decision|0|||
129953505|NCT00742560|467790888|FG002|Overall Study|Subject's Decision|2|||
130079133|NCT00312728|468243648|FG000|Overall Study|Withdrawal by Subject|10|||
130079134|NCT00312728|468243648|FG000|Overall Study|Required non-protocol cancer treatment|2|||
130079135|NCT00312728|468243648|FG000|Overall Study|Protocol Violation|2|||
130079136|NCT00312728|468243648|FG000|Overall Study|Other|10|||
130079137|NCT00312728|468243648|FG000|Overall Study|Other|1|||
130079138|NCT01634100|468243651|FG000|Overall Study|Withdrawal by Subject|1|||
130079139|NCT01634100|468243652|FG001|Overall Study|Withdrawal by Subject|0|||
130079140|NCT01634100|468243653|FG002|Overall Study|Withdrawal by Subject|1|||
130079141|NCT01634100|468243654|FG003|Overall Study|Withdrawal by Subject|0|||
130079142|NCT01634100|468243655|FG004|Overall Study|Withdrawal by Subject|0|||
129953506|NCT00742560|467790889|FG003|Overall Study|Subject's Decision|3|||
129953507|NCT00742560|467790890|FG004|Overall Study|Subject's Decision|3|||
129953508|NCT00742560|467790886|FG000|Overall Study|Investigator's Decision|0|||
129953509|NCT00742560|467790887|FG001|Overall Study|Investigator's Decision|0|||
129953510|NCT00742560|467790888|FG002|Overall Study|Investigator's Decision|4|||
129953511|NCT00742560|467790889|FG003|Overall Study|Investigator's Decision|1|||
129953512|NCT00742560|467790890|FG004|Overall Study|Investigator's Decision|0|||
129953513|NCT00742560|467790886|FG000|Overall Study|Disease Progression|1|||
129953514|NCT00742560|467790887|FG001|Overall Study|Disease Progression|0|||
129953515|NCT00742560|467790888|FG002|Overall Study|Disease Progression|5|||
129953516|NCT00742560|467790889|FG003|Overall Study|Disease Progression|17|||
129953517|NCT00742560|467790890|FG004|Overall Study|Disease Progression|16|||
130079143|NCT01634100|468243656|FG005|Overall Study|Withdrawal by Subject|0|||
130079144|NCT01487863|468243664|FG000|Overall Study|Death|19|||
130079145|NCT01487863|468243665|FG001|Overall Study|Death|19|||
130079146|NCT00486889|468243666|FG000|Overall Study|Death|3|||
130079147|NCT00486889|468243666|FG000|Overall Study|Non-compliant|2|||
130079148|NCT00486889|468243666|FG000|Overall Study|Withdrawal by Subject|6|||
130079149|NCT00893763|468243667|FG000|Overall Study|extubated|110|||
130079150|NCT00893763|468243668|FG001|Overall Study|extubated|110|||
130079151|NCT01975376|468243669|FG000|Overall Study|Adverse Event|5|||
130079152|NCT01975376|468243670|FG001|Overall Study|Adverse Event|5|||
130079153|NCT01975376|468243669|FG000|Overall Study|Death|65|||
130079154|NCT01975376|468243670|FG001|Overall Study|Death|72|||
130079155|NCT01975376|468243669|FG000|Overall Study|Lost to Follow-up|70|||
130079156|NCT01975376|468243670|FG001|Overall Study|Lost to Follow-up|66|||
130079157|NCT01975376|468243669|FG000|Overall Study|Withdrew consent|68|||
130079158|NCT01975376|468243670|FG001|Overall Study|Withdrew consent|62|||
130079159|NCT01975376|468243669|FG000|Overall Study|Other|2|||
130079160|NCT01975376|468243670|FG001|Overall Study|Other|4|||
130079161|NCT01975376|468243669|FG000|Overall Study|Randomized, Not Treated|16|||
130079162|NCT01975376|468243670|FG001|Overall Study|Randomized, Not Treated|8|||
130079163|NCT01819194|468243675|FG000|Overall Study|Loss of study articles|2|||
130079164|NCT01448707|468243676|FG000|Overall Study|Adverse Event|3|||
130079165|NCT01448707|468243677|FG001|Overall Study|Adverse Event|1|||
130079166|NCT01448707|468243676|FG000|Overall Study|Lost to Follow-up|2|||
130079167|NCT01448707|468243677|FG001|Overall Study|Lost to Follow-up|6|||
130079168|NCT01448707|468243676|FG000|Overall Study|Withdrawal by Subject|6|||
130079169|NCT01448707|468243677|FG001|Overall Study|Withdrawal by Subject|7|||
130079170|NCT01448707|468243676|FG000|Overall Study|Other|7|||
130079171|NCT01448707|468243677|FG001|Overall Study|Other|4|||
130079172|NCT00441480|468243680|FG000|Overall Study|Protocol Violation|1|||
130079173|NCT00441480|468243681|FG001|Overall Study|Protocol Violation|1|||
130079174|NCT00441480|468243680|FG000|Overall Study|Withdrawal by Subject|2|||
130079175|NCT00441480|468243681|FG001|Overall Study|Withdrawal by Subject|3|||
130079176|NCT02699125|468243684|FG000|Placebo|Lost to Follow-up|2|||
130079177|NCT02699125|468243685|FG001|Placebo|Lost to Follow-up|0|||
130079178|NCT02699125|468243684|FG000|Placebo|Protocol Violation|1|||
130079179|NCT02699125|468243685|FG001|Placebo|Protocol Violation|0|||
130079180|NCT02699125|468243684|FG000|Placebo|Withdrawal by Subject|0|||
130079181|NCT02699125|468243685|FG001|Placebo|Withdrawal by Subject|4|||
130079182|NCT02699125|468243684|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
130079183|NCT02699125|468243685|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
130079184|NCT03796195|468243688|FG000|Overall Study|Study closed early|1|||
130079185|NCT02092324|468243691|FG000|Overall Study|Adverse Event|1|||
130079186|NCT02092324|468243691|FG000|Overall Study|Lack of Efficacy|6|||
130079187|NCT02092324|468243691|FG000|Overall Study|Proceed to Transplant|3|||
130079188|NCT02092324|468243691|FG000|Overall Study|Physician Decision|7|||
130079189|NCT02092324|468243691|FG000|Overall Study|Misdiagnosis|2|||
130079190|NCT01039428|468243692|FG000|Overall Study|Protocol Violation|1|||
130079191|NCT01039428|468243693|FG001|Overall Study|Protocol Violation|0|||
130079192|NCT01039428|468243692|FG000|Overall Study|Withdrawal by Subject|1|||
130079193|NCT01039428|468243693|FG001|Overall Study|Withdrawal by Subject|0|||
130079194|NCT00441012|468243694|FG000|Overall Study|Adverse Event|0|||
130079195|NCT00441012|468243695|FG001|Overall Study|Adverse Event|1|||
130079196|NCT00441012|468243694|FG000|Overall Study|Lost to Follow-up|3|||
130079197|NCT00441012|468243695|FG001|Overall Study|Lost to Follow-up|3|||
130079198|NCT00441012|468243694|FG000|Overall Study|Protocol Violation|10|||
130079199|NCT00441012|468243695|FG001|Overall Study|Protocol Violation|9|||
130079200|NCT00441012|468243694|FG000|Overall Study|Withdrawal by Subject|4|||
130079201|NCT00441012|468243695|FG001|Overall Study|Withdrawal by Subject|0|||
130079202|NCT00441012|468243694|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
130079203|NCT00441012|468243695|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
130079204|NCT00262314|468243700|FG000|Overall Study|Changing physicians|38|||
130079205|NCT00262314|468243700|FG000|Overall Study|Death|12|||
130079206|NCT00262314|468243700|FG000|Overall Study|Patient's decision|92|||
130079207|NCT00262314|468243700|FG000|Overall Study|Other|95|||
130079208|NCT00262314|468243700|FG000|Overall Study|Lost to Follow-up|70|||
130079209|NCT00262314|468243700|FG000|Overall Study|Administrative withdrawal|30|||
130079210|NCT05104749|468243701|FG000|Overall Study|Lost to Follow-up|2|||
130079211|NCT05104749|468243702|FG001|Overall Study|Lost to Follow-up|3|||
130079212|NCT03964493|468243703|FG000|Overall Study|Withdrawal by Subject|4|||
130079213|NCT03964493|468243704|FG001|Overall Study|Withdrawal by Subject|1|||
130079214|NCT03964493|468243703|FG000|Overall Study|Lost to Follow-up|13|||
130079215|NCT03964493|468243704|FG001|Overall Study|Lost to Follow-up|4|||
130079216|NCT02470429|468243705|FG000|Overall Study|Adverse Event|1|||
130079217|NCT02470429|468243706|FG001|Overall Study|Adverse Event|0|||
130079218|NCT02470429|468243705|FG000|Overall Study|Withdrawal by Subject|1|||
130079219|NCT02470429|468243706|FG001|Overall Study|Withdrawal by Subject|0|||
130079220|NCT01300767|468243707|FG000|Overall Study|Discomfort|2|||
130079221|NCT01300767|468243707|FG000|Overall Study|Biomicroscopy|1|||
130079222|NCT01300767|468243707|FG000|Overall Study|Unacceptable fit|1|||
130079223|NCT00398138|468243708|FG000|Overall Study|Adverse Event|2|||
130079224|NCT00117572|468243710|FG000|Overall Study|Site withdrew before starting treatment|2|||
129953518|NCT00742560|467790886|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
129953519|NCT00742560|467790887|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
129953520|NCT00742560|467790888|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
129953521|NCT00742560|467790889|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
129953522|NCT00742560|467790890|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
129953523|NCT00742560|467790886|FG000|Overall Study|Other|0|||
129953524|NCT00742560|467790887|FG001|Overall Study|Other|1|||
129953525|NCT00742560|467790888|FG002|Overall Study|Other|8|||
129953526|NCT00742560|467790889|FG003|Overall Study|Other|9|||
129953527|NCT00742560|467790890|FG004|Overall Study|Other|9|||
129953528|NCT00742560|467790886|FG000|Overall Study|MIssing|0|||
129953529|NCT00742560|467790887|FG001|Overall Study|MIssing|0|||
129953530|NCT00742560|467790888|FG002|Overall Study|MIssing|0|||
129953531|NCT00742560|467790889|FG003|Overall Study|MIssing|0|||
129953532|NCT00742560|467790890|FG004|Overall Study|MIssing|1|||
129953533|NCT01426217|467790891|FG000|Overall Study|lost sample|8|||
129953534|NCT01426217|467790892|FG001|Overall Study|lost sample|14|||
129953535|NCT01812837|467790893|FG000|Overall Study|Lost to Follow-up|1|||
129953536|NCT01812837|467790894|FG001|Overall Study|Lost to Follow-up|1|||
129953537|NCT01812837|467790895|FG002|Overall Study|Lost to Follow-up|0|||
129953538|NCT01812837|467790893|FG000|Overall Study|Protocol Violation|1|||
129953539|NCT01812837|467790894|FG001|Overall Study|Protocol Violation|0|||
129953540|NCT01812837|467790895|FG002|Overall Study|Protocol Violation|0|||
129953541|NCT00658632|467790896|FG000|Overall Study|Adverse Event|13|||
129953542|NCT00658632|467790897|FG001|Overall Study|Adverse Event|11|||
129953543|NCT00658632|467790896|FG000|Overall Study|Lost to Follow-up|25|||
129953544|NCT00658632|467790897|FG001|Overall Study|Lost to Follow-up|23|||
129953545|NCT00658632|467790896|FG000|Overall Study|Withdrawal by Subject|10|||
129953546|NCT00658632|467790897|FG001|Overall Study|Withdrawal by Subject|7|||
129953547|NCT00658632|467790896|FG000|Overall Study|Lack of Efficacy|0|||
129953548|NCT00658632|467790897|FG001|Overall Study|Lack of Efficacy|1|||
129953549|NCT00658632|467790896|FG000|Overall Study|Withdrawal of consent|8|||
129953550|NCT00658632|467790897|FG001|Overall Study|Withdrawal of consent|14|||
129953551|NCT00658632|467790896|FG000|Overall Study|Pregnancy|1|||
129953552|NCT00658632|467790897|FG001|Overall Study|Pregnancy|1|||
129953553|NCT00658632|467790896|FG000|Overall Study|Other|7|||
129953554|NCT00658632|467790897|FG001|Overall Study|Other|8|||
129953555|NCT04501614|467790898|FG000|Overall Study|Study Terminated by Sponsor|6|||
129953556|NCT04501614|467790899|FG001|Overall Study|Study Terminated by Sponsor|3|||
129953557|NCT04501614|467790898|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
129953558|NCT04501614|467790899|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
129953559|NCT04529941|467790900|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
129953560|NCT04529941|467790901|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
129953561|NCT02991456|467790904|FG000|Overall Study|Adverse Event|2|||
129953562|NCT02991456|467790905|FG001|Overall Study|Adverse Event|0|||
129953563|NCT02991456|467790904|FG000|Overall Study|Lost to Follow-up|0|||
129953564|NCT02991456|467790905|FG001|Overall Study|Lost to Follow-up|2|||
129953565|NCT02991456|467790904|FG000|Overall Study|Withdrawal by Subject|1|||
129953566|NCT02991456|467790905|FG001|Overall Study|Withdrawal by Subject|0|||
129953567|NCT04016415|467790906|FG000|Overall Study|Adverse Event|2|||
129953568|NCT04016415|467790907|FG001|Overall Study|Adverse Event|1|||
129953569|NCT04016415|467790906|FG000|Overall Study|Lost to Follow-up|6|||
129953570|NCT04016415|467790907|FG001|Overall Study|Lost to Follow-up|2|||
129953571|NCT04016415|467790906|FG000|Overall Study|Physician Decision|5|||
129953572|NCT04016415|467790907|FG001|Overall Study|Physician Decision|1|||
129953573|NCT04016415|467790906|FG000|Overall Study|Pregnancy|0|||
129953574|NCT04016415|467790907|FG001|Overall Study|Pregnancy|1|||
129953575|NCT04016415|467790906|FG000|Overall Study|Withdrawal by Subject|24|||
129953576|NCT04016415|467790907|FG001|Overall Study|Withdrawal by Subject|27|||
129953577|NCT04016415|467790906|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
129953578|NCT04016415|467790907|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
129953579|NCT05615870|467790908|FG000|Overall Study|Lost to Follow-up|10|||
129953580|NCT05615870|467790909|FG001|Overall Study|Lost to Follow-up|13|||
129953581|NCT05615870|467790908|FG000|Overall Study|Physician Decision|2|||
130120851|NCT00266409|468404817|FG003|Overall Study|Withdrawal by Subject|9|||
130120852|NCT00266409|468404814|FG000|Overall Study|Protocol Violation|5|||
130120853|NCT00266409|468404815|FG001|Overall Study|Protocol Violation|3|||
129953582|NCT05615870|467790909|FG001|Overall Study|Physician Decision|0|||
129953583|NCT05615870|467790908|FG000|Overall Study|Withdrawal by Subject|0|||
129953584|NCT05615870|467790909|FG001|Overall Study|Withdrawal by Subject|2|||
129953585|NCT05615870|467790908|FG000|Overall Study|Protocol Violation|0|||
129953586|NCT05615870|467790909|FG001|Overall Study|Protocol Violation|3|||
129953587|NCT05615870|467790908|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
129953588|NCT05615870|467790909|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
129953589|NCT05615870|467790908|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
129953590|NCT05615870|467790909|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
130079225|NCT00117572|468243711|FG001|Overall Study|Site withdrew before starting treatment|3|||
130079226|NCT00117572|468243710|FG000|Overall Study|Withdrawal by Subject|3|||
130079227|NCT00117572|468243711|FG001|Overall Study|Withdrawal by Subject|3|||
130079228|NCT00117572|468243710|FG000|Overall Study|Protocol Violation|1|||
130079229|NCT00117572|468243711|FG001|Overall Study|Protocol Violation|0|||
130079230|NCT00887068|468243712|FG000|Overall Study|Withdrawal by Subject|2|||
130079231|NCT00887068|468243713|FG001|Overall Study|Withdrawal by Subject|0|||
130079232|NCT00887068|468243712|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
130079233|NCT00887068|468243713|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
130079234|NCT01387594|468243714|FG000|Overall Study|Withdrawal by Subject|0|||
130079235|NCT01387594|468243715|FG001|Overall Study|Withdrawal by Subject|2|||
130079236|NCT01387594|468243714|FG000|Overall Study|Lost to Follow-up|0|||
130079237|NCT01387594|468243715|FG001|Overall Study|Lost to Follow-up|1|||
130079238|NCT03277794|468243720|FG000|Overall Study|Lost to Follow-up|2|||
130079239|NCT03277794|468243721|FG001|Overall Study|Lost to Follow-up|4|||
130079240|NCT03277794|468243720|FG000|Overall Study|Withdrew due to high acuity|1|||
130079241|NCT03277794|468243721|FG001|Overall Study|Withdrew due to high acuity|0|||
130079242|NCT03039569|468243726|FG000|Overall Study|Lost to Follow-up|5|||
130079243|NCT03039569|468243727|FG001|Overall Study|Lost to Follow-up|4|||
130079244|NCT02254304|468243728|FG000|Overall Study|Adverse Event|2|||
130079245|NCT02254304|468243729|FG001|Overall Study|Adverse Event|1|||
130079246|NCT02254304|468243728|FG000|Overall Study|Lost to Follow-up|2|||
130079247|NCT02254304|468243729|FG001|Overall Study|Lost to Follow-up|2|||
130079248|NCT02254304|468243728|FG000|Overall Study|Protocol Violation|1|||
130079249|NCT02254304|468243729|FG001|Overall Study|Protocol Violation|0|||
130079250|NCT02254304|468243728|FG000|Overall Study|Withdrawal by Subject|3|||
130079251|NCT02254304|468243729|FG001|Overall Study|Withdrawal by Subject|0|||
130079252|NCT02254304|468243728|FG000|Overall Study|Injection site pain and Injection fear|1|||
130079253|NCT02254304|468243729|FG001|Overall Study|Injection site pain and Injection fear|0|||
130079254|NCT02254304|468243728|FG000|Overall Study|Personal causes|4|||
130079255|NCT02254304|468243729|FG001|Overall Study|Personal causes|1|||
130079256|NCT02254304|468243728|FG000|Overall Study|Personal decision|1|||
130079257|NCT02254304|468243729|FG001|Overall Study|Personal decision|0|||
130079258|NCT04507360|468245226|FG000|Week 1|Lost to Follow-up|0|||
130079259|NCT04507360|468245227|FG001|Week 1|Lost to Follow-up|0|||
130079260|NCT04507360|468245228|FG002|Week 1|Lost to Follow-up|0|||
130079261|NCT04507360|468245229|FG003|Week 1|Lost to Follow-up|0|||
130079262|NCT04507360|468245230|FG004|Week 1|Lost to Follow-up|0|||
130079263|NCT04507360|468245231|FG005|Week 1|Lost to Follow-up|0|||
130079264|NCT04507360|468245232|FG006|Week 1|Lost to Follow-up|0|||
130079265|NCT04507360|468245233|FG007|Week 1|Lost to Follow-up|0|||
130079266|NCT04507360|468245234|FG008|Week 1|Lost to Follow-up|72|||
130079267|NCT04507360|468245235|FG009|Week 1|Lost to Follow-up|22|||
130079268|NCT04507360|468245236|FG010|Week 1|Lost to Follow-up|10|||
130079269|NCT04507360|468245226|FG000|Week 2|Lost to Follow-up|0|||
130079270|NCT04507360|468245227|FG001|Week 2|Lost to Follow-up|0|||
130079271|NCT04507360|468245228|FG002|Week 2|Lost to Follow-up|0|||
130079272|NCT04507360|468245229|FG003|Week 2|Lost to Follow-up|0|||
130079273|NCT04507360|468245230|FG004|Week 2|Lost to Follow-up|0|||
130079274|NCT04507360|468245231|FG005|Week 2|Lost to Follow-up|0|||
130079275|NCT04507360|468245232|FG006|Week 2|Lost to Follow-up|0|||
130079276|NCT04507360|468245233|FG007|Week 2|Lost to Follow-up|0|||
130079277|NCT04507360|468245234|FG008|Week 2|Lost to Follow-up|121|||
130079278|NCT04507360|468245235|FG009|Week 2|Lost to Follow-up|85|||
130079279|NCT04507360|468245236|FG010|Week 2|Lost to Follow-up|82|||
130079280|NCT04507360|468245226|FG000|Week 3|Lost to Follow-up|0|||
130079281|NCT04507360|468245227|FG001|Week 3|Lost to Follow-up|0|||
130079282|NCT04507360|468245228|FG002|Week 3|Lost to Follow-up|0|||
130079283|NCT04507360|468245229|FG003|Week 3|Lost to Follow-up|0|||
130079284|NCT04507360|468245230|FG004|Week 3|Lost to Follow-up|0|||
130079285|NCT04507360|468245231|FG005|Week 3|Lost to Follow-up|0|||
130079286|NCT04507360|468245232|FG006|Week 3|Lost to Follow-up|0|||
130079287|NCT04507360|468245233|FG007|Week 3|Lost to Follow-up|0|||
130079288|NCT04507360|468245234|FG008|Week 3|Lost to Follow-up|123|||
130079289|NCT04507360|468245235|FG009|Week 3|Lost to Follow-up|92|||
130079290|NCT04507360|468245236|FG010|Week 3|Lost to Follow-up|84|||
130079291|NCT04507360|468245226|FG000|Week 4|Lost to Follow-up|0|||
130079292|NCT04507360|468245227|FG001|Week 4|Lost to Follow-up|0|||
130079293|NCT04507360|468245228|FG002|Week 4|Lost to Follow-up|0|||
130079294|NCT04507360|468245229|FG003|Week 4|Lost to Follow-up|0|||
130079295|NCT04507360|468245230|FG004|Week 4|Lost to Follow-up|0|||
130079296|NCT04507360|468245231|FG005|Week 4|Lost to Follow-up|0|||
130079297|NCT04507360|468245232|FG006|Week 4|Lost to Follow-up|0|||
130079298|NCT04507360|468245233|FG007|Week 4|Lost to Follow-up|0|||
130079299|NCT04507360|468245234|FG008|Week 4|Lost to Follow-up|131|||
130079300|NCT04507360|468245235|FG009|Week 4|Lost to Follow-up|115|||
130079301|NCT04507360|468245236|FG010|Week 4|Lost to Follow-up|102|||
130079302|NCT04507360|468245226|FG000|Week 5|Lost to Follow-up|0|||
130079303|NCT04507360|468245227|FG001|Week 5|Lost to Follow-up|0|||
130079304|NCT04507360|468245228|FG002|Week 5|Lost to Follow-up|0|||
130079305|NCT04507360|468245229|FG003|Week 5|Lost to Follow-up|0|||
130079306|NCT04507360|468245230|FG004|Week 5|Lost to Follow-up|0|||
130079307|NCT04507360|468245231|FG005|Week 5|Lost to Follow-up|0|||
130079308|NCT04507360|468245232|FG006|Week 5|Lost to Follow-up|0|||
130079309|NCT04507360|468245233|FG007|Week 5|Lost to Follow-up|0|||
130079310|NCT04507360|468245234|FG008|Week 5|Lost to Follow-up|103|||
130079311|NCT04507360|468245235|FG009|Week 5|Lost to Follow-up|135|||
130079312|NCT04507360|468245236|FG010|Week 5|Lost to Follow-up|143|||
130079313|NCT04507360|468245226|FG000|Week 8|Lost to Follow-up|0|||
130079314|NCT04507360|468245227|FG001|Week 8|Lost to Follow-up|0|||
130079315|NCT04507360|468245228|FG002|Week 8|Lost to Follow-up|0|||
130079316|NCT04507360|468245229|FG003|Week 8|Lost to Follow-up|0|||
130079317|NCT04507360|468245230|FG004|Week 8|Lost to Follow-up|0|||
130079318|NCT04507360|468245231|FG005|Week 8|Lost to Follow-up|0|||
130079319|NCT04507360|468245232|FG006|Week 8|Lost to Follow-up|0|||
130079320|NCT04507360|468245233|FG007|Week 8|Lost to Follow-up|0|||
130079321|NCT04507360|468245234|FG008|Week 8|Lost to Follow-up|139|||
130079322|NCT04507360|468245235|FG009|Week 8|Lost to Follow-up|145|||
130079323|NCT04507360|468245236|FG010|Week 8|Lost to Follow-up|152|||
130079324|NCT03050307|468245237|FG000|Overall Study|Adverse Event|4|||
130079325|NCT03050307|468245238|FG001|Overall Study|Adverse Event|2|||
130079326|NCT03050307|468245237|FG000|Overall Study|Significant Protocol Deviation|0|||
130079327|NCT03050307|468245238|FG001|Overall Study|Significant Protocol Deviation|1|||
130079328|NCT03050307|468245237|FG000|Overall Study|Lost to Follow-up|0|||
130079329|NCT03050307|468245238|FG001|Overall Study|Lost to Follow-up|1|||
130079330|NCT03050307|468245237|FG000|Overall Study|Voluntary Withdrawal|3|||
130079331|NCT03050307|468245238|FG001|Overall Study|Voluntary Withdrawal|4|||
130079332|NCT03050307|468245237|FG000|Overall Study|Reason not Specified|1|||
130079333|NCT03050307|468245238|FG001|Overall Study|Reason not Specified|1|||
130079334|NCT02973997|468245239|FG000|Overall Study|Withdrawal by Subject|4|||
130079335|NCT02973997|468245240|FG001|Overall Study|Withdrawal by Subject|0|||
130079336|NCT02973997|468245239|FG000|Overall Study|Adverse Event|4|||
130079337|NCT02973997|468245240|FG001|Overall Study|Adverse Event|1|||
130079338|NCT02973997|468245239|FG000|Overall Study|Disease Progression|11|||
130079339|NCT02973997|468245240|FG001|Overall Study|Disease Progression|20|||
130079340|NCT02973997|468245239|FG000|Overall Study|Alternative Therapy|3|||
130079341|NCT02973997|468245240|FG001|Overall Study|Alternative Therapy|0|||
130079342|NCT02973997|468245239|FG000|Overall Study|Other complicating disease|0|||
130079343|NCT02973997|468245240|FG001|Overall Study|Other complicating disease|1|||
130079344|NCT02973997|468245239|FG000|Overall Study|Death|0|||
130079345|NCT02973997|468245240|FG001|Overall Study|Death|1|||
130079346|NCT02996110|468245247|FG000|Pre-Treatment|Other Reasons|0|||
130079347|NCT02996110|468245248|FG001|Pre-Treatment|Other Reasons|1|||
130079348|NCT02996110|468245249|FG002|Pre-Treatment|Other Reasons|0|||
130079349|NCT02996110|468245250|FG003|Pre-Treatment|Other Reasons|0|||
130079350|NCT02996110|468245251|FG004|Pre-Treatment|Other Reasons|1|||
130079351|NCT02996110|468245247|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
130079352|NCT02996110|468245248|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
130079353|NCT02996110|468245249|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
130079354|NCT02996110|468245250|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
130079355|NCT02996110|468245251|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
130079356|NCT02996110|468245247|FG000|Track 1|Disease Progression|15|||
130079357|NCT02996110|468245248|FG001|Track 1|Disease Progression|17|||
130079358|NCT02996110|468245249|FG002|Track 1|Disease Progression|0|||
130079359|NCT02996110|468245250|FG003|Track 1|Disease Progression|0|||
130079360|NCT02996110|468245251|FG004|Track 1|Disease Progression|0|||
130079361|NCT02996110|468245247|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
130079362|NCT02996110|468245248|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
130120854|NCT00266409|468404816|FG002|Overall Study|Protocol Violation|4|||
130120855|NCT00266409|468404817|FG003|Overall Study|Protocol Violation|2|||
130120856|NCT00266409|468404814|FG000|Overall Study|Other|7|||
129953591|NCT05615870|467790908|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
129953592|NCT05615870|467790909|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
129953593|NCT00070317|467790910|FG000|Overall Study|Inevaluable (Never Treated)|1|||
129953594|NCT00070317|467790910|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
129953595|NCT00070317|467790910|FG000|Overall Study|Ineligible required test not done|1|||
129953596|NCT00070317|467790910|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
129953597|NCT00070317|467790910|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
129953598|NCT01885559|467790911|FG000|Overall Study|Lost to Follow-up|15|||
130079363|NCT02996110|468245249|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
130079364|NCT02996110|468245250|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
130079365|NCT02996110|468245251|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
130079366|NCT02996110|468245247|FG000|Track 1|Study Drug Toxicity|5|||
130079367|NCT02996110|468245248|FG001|Track 1|Study Drug Toxicity|3|||
130079368|NCT02996110|468245249|FG002|Track 1|Study Drug Toxicity|0|||
130079369|NCT02996110|468245250|FG003|Track 1|Study Drug Toxicity|0|||
130079370|NCT02996110|468245251|FG004|Track 1|Study Drug Toxicity|0|||
130079371|NCT02996110|468245247|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
130079372|NCT02996110|468245248|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130079373|NCT02996110|468245249|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130079374|NCT02996110|468245250|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130079375|NCT02996110|468245251|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
130079376|NCT02996110|468245247|FG000|Track 1|Administrative Reason by Sponsor|0|||
130079377|NCT02996110|468245248|FG001|Track 1|Administrative Reason by Sponsor|1|||
130079378|NCT02996110|468245249|FG002|Track 1|Administrative Reason by Sponsor|0|||
130079379|NCT02996110|468245250|FG003|Track 1|Administrative Reason by Sponsor|0|||
130079380|NCT02996110|468245251|FG004|Track 1|Administrative Reason by Sponsor|0|||
130079381|NCT02996110|468245247|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
130079382|NCT02996110|468245248|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
130079383|NCT02996110|468245249|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
130079384|NCT02996110|468245250|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
130079385|NCT02996110|468245251|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
130079386|NCT02996110|468245247|FG000|Track 2|Disease Progression|33|||
130079387|NCT02996110|468245248|FG001|Track 2|Disease Progression|26|||
130079388|NCT02996110|468245249|FG002|Track 2|Disease Progression|19|||
130079389|NCT02996110|468245250|FG003|Track 2|Disease Progression|16|||
130079390|NCT02996110|468245251|FG004|Track 2|Disease Progression|15|||
130079391|NCT02996110|468245247|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
130079392|NCT02996110|468245248|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
130079393|NCT02996110|468245249|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
130079394|NCT02996110|468245250|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
130079395|NCT02996110|468245251|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
130079396|NCT02996110|468245247|FG000|Track 2|Death|0|||
130079397|NCT02996110|468245248|FG001|Track 2|Death|0|||
130079398|NCT02996110|468245249|FG002|Track 2|Death|1|||
130079399|NCT02996110|468245250|FG003|Track 2|Death|0|||
130079400|NCT02996110|468245251|FG004|Track 2|Death|1|||
130079401|NCT02996110|468245247|FG000|Track 2|Study Drug Toxicity|4|||
130079402|NCT02996110|468245248|FG001|Track 2|Study Drug Toxicity|1|||
130079403|NCT02996110|468245249|FG002|Track 2|Study Drug Toxicity|4|||
130079404|NCT02996110|468245250|FG003|Track 2|Study Drug Toxicity|1|||
130079405|NCT02996110|468245251|FG004|Track 2|Study Drug Toxicity|0|||
130079406|NCT02996110|468245247|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
130079407|NCT02996110|468245248|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
130079408|NCT02996110|468245249|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
130079409|NCT02996110|468245250|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
130079410|NCT02996110|468245251|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
130079411|NCT02996110|468245247|FG000|Track 2|Participant Withdrew Consent|1|||
130079412|NCT02996110|468245248|FG001|Track 2|Participant Withdrew Consent|2|||
130079413|NCT02996110|468245249|FG002|Track 2|Participant Withdrew Consent|3|||
130079414|NCT02996110|468245250|FG003|Track 2|Participant Withdrew Consent|1|||
130079415|NCT02996110|468245251|FG004|Track 2|Participant Withdrew Consent|1|||
130079416|NCT02996110|468245247|FG000|Track 2|Other Reasons|0|||
130079417|NCT02996110|468245248|FG001|Track 2|Other Reasons|0|||
130079418|NCT02996110|468245249|FG002|Track 2|Other Reasons|1|||
130079419|NCT02996110|468245250|FG003|Track 2|Other Reasons|0|||
130079420|NCT02996110|468245251|FG004|Track 2|Other Reasons|1|||
130079421|NCT01938391|468245252|FG000|6 Month Follow up|Withdrawal by Subject|1|||
130079422|NCT01938391|468245252|FG000|12 Month Follow up|Physician Decision|1|||
130079423|NCT01938391|468245252|FG000|12 Month Follow up|Withdrawal by Subject|1|||
130079424|NCT01077193|468245253|FG000|Overall Study|Lost to Follow-up|1|||
130079425|NCT01077193|468245253|FG000|Overall Study|Withdrawal by Subject|2|||
130079426|NCT01077193|468245253|FG000|Overall Study|Lack of Efficacy|1|||
130079427|NCT01077193|468245253|FG000|Overall Study|Study Terminated by Sponsor|40|||
130079428|NCT01536418|468245264|FG000|Overall Study|Protocol Violation|2|||
130079429|NCT01536418|468245265|FG001|Overall Study|Protocol Violation|3|||
130079430|NCT01536418|468245264|FG000|Overall Study|Physician Decision|1|||
130079431|NCT01536418|468245265|FG001|Overall Study|Physician Decision|3|||
130079432|NCT01536418|468245264|FG000|Overall Study|Study closed/terminated|41|||
130079433|NCT01536418|468245265|FG001|Overall Study|Study closed/terminated|37|||
130079434|NCT01536418|468245264|FG000|Overall Study|Lack of Efficacy|10|||
129953599|NCT01885559|467790912|FG001|Overall Study|Lost to Follow-up|16|||
129953600|NCT01885559|467790911|FG000|Overall Study|Less than full participation|9|||
130079435|NCT01536418|468245265|FG001|Overall Study|Lack of Efficacy|16|||
130079436|NCT01536418|468245264|FG000|Overall Study|Adverse Event|9|||
130079437|NCT01536418|468245265|FG001|Overall Study|Adverse Event|4|||
130079438|NCT01536418|468245264|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
130079439|NCT01536418|468245265|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
129953601|NCT01885559|467790912|FG001|Overall Study|Less than full participation|19|||
130079440|NCT01536418|468245264|FG000|Overall Study|Withdrawal by Subject|5|||
130079441|NCT01536418|468245265|FG001|Overall Study|Withdrawal by Subject|3|||
130079442|NCT01899768|468245266|FG000|Part A|Adverse Event|2|||
129953602|NCT01885559|467790911|FG000|Overall Study|Protocol Violation|0|||
130079443|NCT01899768|468245266|FG000|Part A|Withdrawal by Subject|1|||
130079444|NCT01899768|468245266|FG000|Part B|Adverse Event|1|||
130079445|NCT01899768|468245266|FG000|Part B|Withdrawal by Subject|1|||
129953603|NCT01885559|467790912|FG001|Overall Study|Protocol Violation|1|||
129953604|NCT00738400|467790918|FG000|Overall Study|Adverse Event|3|||
129953605|NCT00738400|467790919|FG001|Overall Study|Adverse Event|1|||
130079446|NCT02203916|468245267|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130079447|NCT02203916|468245268|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
130079448|NCT02203916|468245269|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
130079449|NCT02203916|468245267|FG000|Overall Study|Major Protocol Deviation|1|||
130079450|NCT02203916|468245268|FG001|Overall Study|Major Protocol Deviation|1|||
130079451|NCT02203916|468245269|FG002|Overall Study|Major Protocol Deviation|0|||
130079452|NCT02203916|468245267|FG000|Overall Study|Lost to Follow-up|0|||
130079453|NCT02203916|468245268|FG001|Overall Study|Lost to Follow-up|1|||
130079454|NCT02203916|468245269|FG002|Overall Study|Lost to Follow-up|0|||
130079455|NCT02203916|468245267|FG000|Overall Study|Voluntary Withdrawal|3|||
130079456|NCT02203916|468245268|FG001|Overall Study|Voluntary Withdrawal|3|||
130079457|NCT02203916|468245269|FG002|Overall Study|Voluntary Withdrawal|8|||
130079458|NCT02203916|468245267|FG000|Overall Study|Lack of Efficacy|3|||
130079459|NCT02203916|468245268|FG001|Overall Study|Lack of Efficacy|0|||
130079460|NCT02203916|468245269|FG002|Overall Study|Lack of Efficacy|0|||
130079461|NCT02203916|468245267|FG000|Overall Study|Reason Not Specified|0|||
130079462|NCT02203916|468245268|FG001|Overall Study|Reason Not Specified|2|||
130079463|NCT02203916|468245269|FG002|Overall Study|Reason Not Specified|1|||
130079464|NCT04043416|468245271|FG000|Washout|Change in health condition|0|||
130079465|NCT04043416|468245272|FG001|Washout|Change in health condition|1|||
130079466|NCT03236506|468245273|FG000|Overall Study|Death|1|||
130079467|NCT03236506|468245274|FG001|Overall Study|Death|1|||
130079468|NCT03236506|468245275|FG002|Overall Study|Death|1|||
130079469|NCT03236506|468245273|FG000|Overall Study|Withdrawal by Subject|3|||
130079470|NCT03236506|468245274|FG001|Overall Study|Withdrawal by Subject|3|||
130079471|NCT03236506|468245275|FG002|Overall Study|Withdrawal by Subject|4|||
130079472|NCT03236506|468245273|FG000|Overall Study|Did not initiate treatment|2|||
130079473|NCT03236506|468245274|FG001|Overall Study|Did not initiate treatment|1|||
130079474|NCT03236506|468245275|FG002|Overall Study|Did not initiate treatment|2|||
130079475|NCT00414973|468245276|FG000|Overall Study|Withdrawal by Subject|14|||
130079476|NCT00414973|468245277|FG001|Overall Study|Withdrawal by Subject|4|||
130079477|NCT00414973|468245278|FG002|Overall Study|Withdrawal by Subject|1|||
130079478|NCT00414973|468245279|FG003|Overall Study|Withdrawal by Subject|0|||
130079479|NCT00414973|468245276|FG000|Overall Study|Adverse Event|10|||
130079480|NCT00414973|468245277|FG001|Overall Study|Adverse Event|0|||
130079481|NCT00414973|468245278|FG002|Overall Study|Adverse Event|1|||
130079482|NCT00414973|468245279|FG003|Overall Study|Adverse Event|0|||
130079483|NCT00414973|468245276|FG000|Overall Study|Protocol Violation|3|||
130079484|NCT00414973|468245277|FG001|Overall Study|Protocol Violation|4|||
130079485|NCT00414973|468245278|FG002|Overall Study|Protocol Violation|0|||
130079486|NCT00414973|468245279|FG003|Overall Study|Protocol Violation|0|||
130079487|NCT00414973|468245276|FG000|Overall Study|Lost to Follow-up|0|||
130079488|NCT00414973|468245277|FG001|Overall Study|Lost to Follow-up|2|||
130079489|NCT00414973|468245278|FG002|Overall Study|Lost to Follow-up|0|||
130079490|NCT00414973|468245279|FG003|Overall Study|Lost to Follow-up|0|||
130079491|NCT00414973|468245276|FG000|Overall Study|Sponsor Decision|1|||
130079492|NCT00414973|468245277|FG001|Overall Study|Sponsor Decision|0|||
130079493|NCT00414973|468245278|FG002|Overall Study|Sponsor Decision|0|||
130079494|NCT00414973|468245279|FG003|Overall Study|Sponsor Decision|0|||
130079495|NCT00414973|468245276|FG000|Overall Study|Death|0|||
130079496|NCT00414973|468245277|FG001|Overall Study|Death|0|||
130079497|NCT00414973|468245278|FG002|Overall Study|Death|1|||
130079498|NCT00414973|468245279|FG003|Overall Study|Death|0|||
130120857|NCT00266409|468404815|FG001|Overall Study|Other|4|||
129953606|NCT00738400|467790918|FG000|Overall Study|Withdrawal by Subject|0|||
129953607|NCT00738400|467790919|FG001|Overall Study|Withdrawal by Subject|1|||
130079499|NCT01466062|468245280|FG000|Overall Study|Adverse Event|1|||
130079500|NCT01466062|468245280|FG000|Overall Study|Withdrawal by Subject|1|||
130079501|NCT02865928|468245281|FG000|Overall Study|Withdrawal by Subject|1|||
130079502|NCT02865928|468245282|FG001|Overall Study|Withdrawal by Subject|0|||
130079503|NCT02865928|468245281|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
130079504|NCT02865928|468245282|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
130079505|NCT02865928|468245281|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
130079506|NCT02865928|468245282|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
130079507|NCT03152110|468245291|FG000|Overall Study|Withdrawal by Subject|3|||
130079508|NCT00850135|468245295|FG000|Overall Study|Physician Decision|1|||
130079509|NCT04259346|468245296|FG000|Overall Study|Lost to Follow-up|1|||
130079510|NCT04259346|468245297|FG001|Overall Study|Lost to Follow-up|3|||
130079511|NCT04259346|468245296|FG000|Overall Study|Protocol Violation|1|||
130079512|NCT04259346|468245297|FG001|Overall Study|Protocol Violation|0|||
130079513|NCT04259346|468245296|FG000|Overall Study|Withdrawal by Subject|1|||
130079514|NCT04259346|468245297|FG001|Overall Study|Withdrawal by Subject|0|||
129953608|NCT00738400|467790918|FG000|Overall Study|Lack of Efficacy|0|||
130120858|NCT00266409|468404816|FG002|Overall Study|Other|2|||
130120859|NCT00266409|468404817|FG003|Overall Study|Other|0|||
130120860|NCT00635154|468404821|FG000|Overall Study|Alternative Treatment|8|||
130120861|NCT00635154|468404821|FG000|Overall Study|Other|4|||
130120862|NCT00635154|468404821|FG000|Overall Study|Still on treatment|21|||
130120863|NCT01399736|468404822|FG000|Overall Study|Withdrawal by Subject|4|||
130120864|NCT01399736|468404823|FG001|Overall Study|Withdrawal by Subject|2|||
130120865|NCT01399736|468404822|FG000|Overall Study|Lost to Follow-up|0|||
129953609|NCT00738400|467790919|FG001|Overall Study|Lack of Efficacy|1|||
129953610|NCT00738400|467790918|FG000|Overall Study|Lost to Follow-up|0|||
129953611|NCT00738400|467790919|FG001|Overall Study|Lost to Follow-up|3|||
129953612|NCT00738400|467790918|FG000|Overall Study|Protocol Violation|1|||
129953613|NCT00738400|467790919|FG001|Overall Study|Protocol Violation|0|||
129953614|NCT00738400|467790918|FG000|Overall Study|Non-compliant with study medication|0|||
129953615|NCT00738400|467790919|FG001|Overall Study|Non-compliant with study medication|1|||
129953616|NCT03138499|467790920|FG000|Overall Study|Lost to Follow-up|1|||
129953617|NCT03138499|467790921|FG001|Overall Study|Lost to Follow-up|0|||
129953618|NCT03138499|467790920|FG000|Overall Study|Participants withdrew consent|1|||
129953619|NCT03138499|467790921|FG001|Overall Study|Participants withdrew consent|0|||
129953620|NCT03138499|467790920|FG000|Overall Study|Participant discontinued study before treatment|0|||
129953621|NCT03138499|467790921|FG001|Overall Study|Participant discontinued study before treatment|1|||
129953622|NCT03138499|467790920|FG000|Overall Study|Disease Progression|2|||
129953623|NCT03138499|467790921|FG001|Overall Study|Disease Progression|6|||
129953624|NCT03138499|467790920|FG000|Overall Study|Study drug toxicity|2|||
129953625|NCT03138499|467790921|FG001|Overall Study|Study drug toxicity|2|||
129953626|NCT03138499|467790920|FG000|Overall Study|Participant request to discontinue study treatment|1|||
129953627|NCT03138499|467790921|FG001|Overall Study|Participant request to discontinue study treatment|1|||
129953628|NCT03138499|467790920|FG000|Overall Study|Other reasons|2|||
129953629|NCT03138499|467790921|FG001|Overall Study|Other reasons|0|||
129953630|NCT02312245|467790922|FG000|Overall Study|Death|0|||
129953631|NCT02312245|467790923|FG001|Overall Study|Death|0|||
129953632|NCT02312245|467790924|FG002|Overall Study|Death|0|||
129953633|NCT02312245|467790925|FG003|Overall Study|Death|1|||
129953634|NCT02312245|467790922|FG000|Overall Study|Withdrawal by Subject|1|||
129953635|NCT02312245|467790923|FG001|Overall Study|Withdrawal by Subject|1|||
129953636|NCT02312245|467790924|FG002|Overall Study|Withdrawal by Subject|0|||
129953637|NCT02312245|467790925|FG003|Overall Study|Withdrawal by Subject|2|||
129953638|NCT02312245|467790922|FG000|Overall Study|Alternative Therapy|1|||
129953639|NCT02312245|467790923|FG001|Overall Study|Alternative Therapy|0|||
129953640|NCT02312245|467790924|FG002|Overall Study|Alternative Therapy|0|||
129953641|NCT02312245|467790925|FG003|Overall Study|Alternative Therapy|0|||
129953642|NCT02312245|467790922|FG000|Overall Study|Progression|0|||
129953643|NCT02312245|467790923|FG001|Overall Study|Progression|0|||
129953644|NCT02312245|467790924|FG002|Overall Study|Progression|0|||
129953645|NCT02312245|467790925|FG003|Overall Study|Progression|5|||
129953646|NCT02312245|467790922|FG000|Overall Study|Patient went to hospice|0|||
129953647|NCT02312245|467790923|FG001|Overall Study|Patient went to hospice|0|||
129953648|NCT02312245|467790924|FG002|Overall Study|Patient went to hospice|0|||
129953649|NCT02312245|467790925|FG003|Overall Study|Patient went to hospice|1|||
129953650|NCT02312245|467790922|FG000|Overall Study|Ineligible|1|||
129953651|NCT02312245|467790923|FG001|Overall Study|Ineligible|0|||
129953652|NCT02312245|467790924|FG002|Overall Study|Ineligible|0|||
129953653|NCT02312245|467790925|FG003|Overall Study|Ineligible|0|||
129953654|NCT00508144|467790926|FG000|Overall Study|Not eligible|6|||
129953655|NCT00508144|467790926|FG000|Overall Study|Death|5|||
129953656|NCT01661972|467790927|FG000|Overall Study|Adverse Event|1|||
129953657|NCT01661972|467790928|FG001|Overall Study|Adverse Event|2|||
129953658|NCT01661972|467790927|FG000|Overall Study|Death during Treatment period|1|||
129953659|NCT01661972|467790928|FG001|Overall Study|Death during Treatment period|1|||
129953660|NCT01661972|467790927|FG000|Overall Study|Withdrawal by Subject|0|||
129953661|NCT01661972|467790928|FG001|Overall Study|Withdrawal by Subject|1|||
130120866|NCT01399736|468404823|FG001|Overall Study|Lost to Follow-up|2|||
130120867|NCT03500484|468404824|FG000|Overall Study|Adverse Event|2|||
129953662|NCT03556891|467790934|FG000|Initial Pivotal Study|Adverse Event|4|||
129953663|NCT03556891|467790934|FG000|Initial Pivotal Study|MRI Need|3|||
129953664|NCT03556891|467790934|FG000|Initial Pivotal Study|Device Failure|1|||
129953665|NCT03556891|467790934|FG000|Initial Pivotal Study|Death|1|||
129953666|NCT03556891|467790934|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
129953667|NCT03556891|467790934|FG000|Initial Pivotal Study|Missing at random|1|||
129953668|NCT03556891|467790934|FG000|Initial Pivotal Study|Missing due to COVID|1|||
129953669|NCT03556891|467790934|FG000|Initial Pivotal Study|Protocol Violation|1|||
129953670|NCT05927753|467791830|FG000|Overall Study|Withdrawal by Subject|0|||
129953671|NCT05927753|467791831|FG001|Overall Study|Withdrawal by Subject|2|||
129953672|NCT05927753|467791830|FG000|Overall Study|Physician Decision|0|||
129953673|NCT05927753|467791831|FG001|Overall Study|Physician Decision|1|||
129953674|NCT05381948|467791833|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
129953675|NCT05381948|467791834|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
130120868|NCT03500484|468404825|FG001|Overall Study|Adverse Event|0|||
129953676|NCT05381948|467791835|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
129953677|NCT05381948|467791833|FG000|Overall Study|Adverse Event: Non-ocular|0|||
129953678|NCT05381948|467791834|FG001|Overall Study|Adverse Event: Non-ocular|1|||
129953679|NCT05381948|467791835|FG002|Overall Study|Adverse Event: Non-ocular|0|||
129953680|NCT05381948|467791833|FG000|Overall Study|Lost to Follow-up|1|||
129953681|NCT05381948|467791834|FG001|Overall Study|Lost to Follow-up|0|||
129953682|NCT05381948|467791835|FG002|Overall Study|Lost to Follow-up|0|||
129953683|NCT05381948|467791833|FG000|Overall Study|Protocol Deviation|0|||
129953684|NCT05381948|467791834|FG001|Overall Study|Protocol Deviation|2|||
129953685|NCT05381948|467791835|FG002|Overall Study|Protocol Deviation|0|||
129953686|NCT05381948|467791833|FG000|Overall Study|Withdrawal by Subject|1|||
129953687|NCT05381948|467791834|FG001|Overall Study|Withdrawal by Subject|0|||
129953688|NCT05381948|467791835|FG002|Overall Study|Withdrawal by Subject|1|||
129953689|NCT05381948|467791833|FG000|Overall Study|Death|0|||
129953690|NCT05381948|467791834|FG001|Overall Study|Death|2|||
129953691|NCT05381948|467791835|FG002|Overall Study|Death|0|||
129953692|NCT05381948|467791833|FG000|Overall Study|Discontinued study without receiving study drug|0|||
129953693|NCT05381948|467791834|FG001|Overall Study|Discontinued study without receiving study drug|0|||
129953694|NCT05381948|467791835|FG002|Overall Study|Discontinued study without receiving study drug|1|||
129953695|NCT04649359|467791839|FG000|Overall Study|Withdrawal by Subject|7|||
129953696|NCT04649359|467791840|FG001|Overall Study|Withdrawal by Subject|7|||
129953697|NCT04649359|467791839|FG000|Overall Study|Death|41|||
129953698|NCT04649359|467791840|FG001|Overall Study|Death|26|||
129953699|NCT04649359|467791839|FG000|Overall Study|Ongoing in the study|75|||
129953700|NCT04649359|467791840|FG001|Overall Study|Ongoing in the study|31|||
129953701|NCT04751929|467791841|FG000|Overall Study|Withdrawal by Subject|2|||
129953702|NCT04751929|467791842|FG001|Overall Study|Withdrawal by Subject|0|||
129953703|NCT04751929|467791843|FG002|Overall Study|Withdrawal by Subject|0|||
129953704|NCT04751929|467791844|FG003|Overall Study|Withdrawal by Subject|0|||
129953705|NCT04751929|467791841|FG000|Overall Study|Rising PSA|0|||
129953706|NCT04751929|467791842|FG001|Overall Study|Rising PSA|1|||
129953707|NCT04751929|467791843|FG002|Overall Study|Rising PSA|0|||
129953708|NCT04751929|467791844|FG003|Overall Study|Rising PSA|0|||
129953709|NCT04751929|467791841|FG000|Overall Study|Adverse Event|1|||
129953710|NCT04751929|467791842|FG001|Overall Study|Adverse Event|2|||
129953711|NCT04751929|467791843|FG002|Overall Study|Adverse Event|0|||
129953712|NCT04751929|467791844|FG003|Overall Study|Adverse Event|0|||
129953713|NCT04751929|467791841|FG000|Overall Study|Progressive Disease|3|||
129953714|NCT04751929|467791842|FG001|Overall Study|Progressive Disease|4|||
129953715|NCT04751929|467791843|FG002|Overall Study|Progressive Disease|4|||
129953716|NCT04751929|467791844|FG003|Overall Study|Progressive Disease|0|||
129953717|NCT04751929|467791841|FG000|Overall Study|Death|1|||
129953718|NCT04751929|467791842|FG001|Overall Study|Death|1|||
129953719|NCT04751929|467791843|FG002|Overall Study|Death|0|||
129953720|NCT04751929|467791844|FG003|Overall Study|Death|0|||
129953721|NCT04175392|467791848|FG000|Overall Study|Withdrawal by Subject|3|||
129953722|NCT04175392|467791849|FG001|Overall Study|Withdrawal by Subject|2|||
129953723|NCT02727998|467791850|FG000|Overall Study|Lost to Follow-up|3|||
129953724|NCT02727998|467791851|FG001|Overall Study|Lost to Follow-up|3|||
129953725|NCT02727998|467791850|FG000|Overall Study|Withdrawal by Subject|0|||
129953726|NCT02727998|467791851|FG001|Overall Study|Withdrawal by Subject|1|||
129953727|NCT02105688|467791852|FG000|Part A: Double-Blind|Adverse Event|1|||
129953728|NCT02105688|467791853|FG001|Part A: Double-Blind|Adverse Event|0|||
129953729|NCT02105688|467791852|FG000|Part A: Double-Blind|Death|0|||
129953730|NCT02105688|467791853|FG001|Part A: Double-Blind|Death|1|||
129953731|NCT02105688|467791852|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
129953732|NCT02105688|467791853|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
129953733|NCT02105688|467791852|FG000|Part A: Double-Blind|Physician Decision|0|||
129953734|NCT02105688|467791853|FG001|Part A: Double-Blind|Physician Decision|1|||
129953735|NCT02105688|467791852|FG000|Part A: Double-Blind|Status Unknown|0|||
129953736|NCT02105688|467791853|FG001|Part A: Double-Blind|Status Unknown|2|||
129953737|NCT02105688|467791852|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
129953738|NCT02105688|467791853|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
129953739|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Death|2|||
129953740|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Death|1|||
129953741|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
129953742|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
129953743|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
129953744|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
129953745|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Physician Decision|3|||
129953746|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Physician Decision|1|||
129953747|NCT02062827|467791857|FG000|Overall Study|Death|1|||
129953748|NCT02062827|467791858|FG001|Overall Study|Death|0|||
129953749|NCT02062827|467791859|FG002|Overall Study|Death|0|||
129953750|NCT02062827|467791860|FG003|Overall Study|Death|0|||
129953751|NCT02062827|467791861|FG004|Overall Study|Death|0|||
129953752|NCT02062827|467791862|FG005|Overall Study|Death|0|||
130079515|NCT04259346|468245296|FG000|Overall Study|Adverse Event|1|||
130079516|NCT04259346|468245297|FG001|Overall Study|Adverse Event|1|||
130079517|NCT00623766|468245301|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
130079518|NCT00623766|468245302|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
130079519|NCT00623766|468245301|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
130079520|NCT00623766|468245302|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
130079521|NCT00623766|468245301|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
130079522|NCT00623766|468245302|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
130079523|NCT00623766|468245301|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
130079524|NCT00623766|468245302|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
130079525|NCT00623766|468245301|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
130079526|NCT00623766|468245302|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
130079527|NCT00422903|468245311|FG000|Overall Study|Disease Progression|3|||
130079528|NCT00422903|468245312|FG001|Overall Study|Disease Progression|1|||
130079529|NCT00422903|468245311|FG000|Overall Study|Adverse Event|0|||
130079530|NCT00422903|468245312|FG001|Overall Study|Adverse Event|2|||
130079531|NCT00422903|468245311|FG000|Overall Study|Informed Consent Withdrawn|1|||
130079532|NCT00422903|468245312|FG001|Overall Study|Informed Consent Withdrawn|2|||
130079533|NCT00422240|468245320|FG000|Overall Study|Lack of Efficacy|1|||
130079534|NCT00422240|468245321|FG001|Overall Study|Lack of Efficacy|2|||
130079535|NCT00422240|468245322|FG002|Overall Study|Lack of Efficacy|0|||
130079536|NCT00422240|468245323|FG003|Overall Study|Lack of Efficacy|1|||
130079537|NCT00422240|468245320|FG000|Overall Study|Adverse Event|11|||
130079538|NCT00422240|468245321|FG001|Overall Study|Adverse Event|4|||
130079539|NCT00422240|468245322|FG002|Overall Study|Adverse Event|5|||
130079540|NCT00422240|468245323|FG003|Overall Study|Adverse Event|2|||
130079541|NCT00422240|468245320|FG000|Overall Study|Subject request|21|||
130079542|NCT00422240|468245321|FG001|Overall Study|Subject request|17|||
130079543|NCT00422240|468245322|FG002|Overall Study|Subject request|18|||
130079544|NCT00422240|468245323|FG003|Overall Study|Subject request|30|||
130079545|NCT00422240|468245320|FG000|Overall Study|Protocol Violation|0|||
130079546|NCT00422240|468245321|FG001|Overall Study|Protocol Violation|1|||
130079547|NCT00422240|468245322|FG002|Overall Study|Protocol Violation|0|||
130079548|NCT00422240|468245323|FG003|Overall Study|Protocol Violation|1|||
130079549|NCT00422240|468245320|FG000|Overall Study|Lost to Follow-up|31|||
130079550|NCT00422240|468245321|FG001|Overall Study|Lost to Follow-up|32|||
130079551|NCT00422240|468245322|FG002|Overall Study|Lost to Follow-up|19|||
130079552|NCT00422240|468245323|FG003|Overall Study|Lost to Follow-up|34|||
130079553|NCT00422240|468245320|FG000|Overall Study|Other|1|||
130079554|NCT00422240|468245321|FG001|Overall Study|Other|0|||
130079555|NCT00422240|468245322|FG002|Overall Study|Other|0|||
130079556|NCT00422240|468245323|FG003|Overall Study|Other|1|||
130079557|NCT00422240|468245320|FG000|Overall Study|Pregnancy|3|||
130079558|NCT00422240|468245321|FG001|Overall Study|Pregnancy|1|||
130079559|NCT00422240|468245322|FG002|Overall Study|Pregnancy|1|||
130079560|NCT00422240|468245323|FG003|Overall Study|Pregnancy|2|||
130079561|NCT01624467|468245324|FG000|Overall Study|Withdrawal by Subject|2|||
130079562|NCT01624467|468245324|FG000|Overall Study|Lost to Follow-up|1|||
130079563|NCT01624467|468245324|FG000|Overall Study|Adverse Event|7|||
130079564|NCT01624467|468245324|FG000|Overall Study|Progressive Disease|19|||
130079565|NCT01624467|468245324|FG000|Overall Study|Per Sponsor Requirement|1|||
130079566|NCT01624467|468245324|FG000|Overall Study|Subject Withdrew from Treatment|1|||
130079567|NCT02201472|468245325|FG000|Overall Study|Lack of Efficacy|2|||
130079568|NCT01188811|468245333|FG000|Overall Study|Withdrawal by Subject|0|||
130079569|NCT01188811|468245334|FG001|Overall Study|Withdrawal by Subject|2|||
130079570|NCT01188811|468245333|FG000|Overall Study|Adverse Event|6|||
130079571|NCT01188811|468245334|FG001|Overall Study|Adverse Event|0|||
130079572|NCT01602744|468245335|FG000|Overall Study|Death|17|||
130079573|NCT01602744|468245336|FG001|Overall Study|Death|15|||
130079574|NCT01602744|468245335|FG000|Overall Study|Lost to Follow-up|13|||
130079575|NCT01602744|468245336|FG001|Overall Study|Lost to Follow-up|8|||
130079576|NCT03418376|468245337|FG000|Overall Study|Musculoskeletal injury|1|||
130079577|NCT03418376|468245338|FG001|Overall Study|Musculoskeletal injury|2|||
130079578|NCT03418376|468245339|FG002|Overall Study|Musculoskeletal injury|1|||
130079579|NCT03418376|468245340|FG003|Overall Study|Musculoskeletal injury|0|||
130079580|NCT03418376|468245337|FG000|Overall Study|Personal reasons|0|||
130079581|NCT03418376|468245338|FG001|Overall Study|Personal reasons|2|||
130079582|NCT03418376|468245339|FG002|Overall Study|Personal reasons|2|||
130079583|NCT03418376|468245340|FG003|Overall Study|Personal reasons|1|||
130079584|NCT03418376|468245337|FG000|Overall Study|Exacerbation|0|||
130079585|NCT03418376|468245338|FG001|Overall Study|Exacerbation|1|||
130079586|NCT03418376|468245339|FG002|Overall Study|Exacerbation|0|||
130079587|NCT03418376|468245340|FG003|Overall Study|Exacerbation|0|||
130079588|NCT04350372|468245345|FG000|Overall Study|Death|1|||
130079589|NCT00901394|468245346|FG000|Overall Study|Physician Decision|1|||
130079590|NCT00901394|468245347|FG001|Overall Study|Physician Decision|1|||
130079591|NCT00901394|468245348|FG002|Overall Study|Physician Decision|2|||
130079592|NCT03864627|468245351|FG000|Overall Study|Adverse Event|0|||
130079593|NCT03864627|468245352|FG001|Overall Study|Adverse Event|1|||
129953753|NCT02062827|467791863|FG006|Overall Study|Death|0|||
129953754|NCT02062827|467791864|FG007|Overall Study|Death|0|||
129953755|NCT02062827|467791857|FG000|Overall Study|Withdrawal by Subject|3|||
129953756|NCT02062827|467791858|FG001|Overall Study|Withdrawal by Subject|1|||
129953757|NCT02062827|467791859|FG002|Overall Study|Withdrawal by Subject|1|||
129953758|NCT02062827|467791860|FG003|Overall Study|Withdrawal by Subject|2|||
129953759|NCT02062827|467791861|FG004|Overall Study|Withdrawal by Subject|6|||
129953760|NCT02062827|467791862|FG005|Overall Study|Withdrawal by Subject|0|||
129953761|NCT02062827|467791863|FG006|Overall Study|Withdrawal by Subject|5|||
129953762|NCT02062827|467791864|FG007|Overall Study|Withdrawal by Subject|0|||
129953763|NCT02062827|467791857|FG000|Overall Study|Screen Fail|0|||
129953764|NCT02062827|467791858|FG001|Overall Study|Screen Fail|0|||
129953765|NCT02062827|467791859|FG002|Overall Study|Screen Fail|0|||
130120869|NCT03500484|468404824|FG000|Overall Study|Physician Decision|1|||
130120870|NCT03500484|468404825|FG001|Overall Study|Physician Decision|0|||
129953766|NCT02062827|467791860|FG003|Overall Study|Screen Fail|0|||
129953767|NCT02062827|467791861|FG004|Overall Study|Screen Fail|0|||
129953768|NCT02062827|467791862|FG005|Overall Study|Screen Fail|0|||
129953769|NCT02062827|467791863|FG006|Overall Study|Screen Fail|0|||
129953770|NCT02062827|467791864|FG007|Overall Study|Screen Fail|8|||
129953771|NCT03166215|467791865|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
129953772|NCT03166215|467791866|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
129953773|NCT03166215|467791867|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
129953774|NCT03166215|467791865|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
129953775|NCT03166215|467791866|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
129953776|NCT03166215|467791867|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
129953777|NCT00288353|467791869|FG000|Overall Study|Lack of Efficacy|2|||
129953778|NCT00288353|467791870|FG001|Overall Study|Lack of Efficacy|2|||
129953779|NCT00288353|467791869|FG000|Overall Study|Withdrawal by Subject|5|||
129953780|NCT00288353|467791870|FG001|Overall Study|Withdrawal by Subject|5|||
129953781|NCT05008224|467791871|FG000|Overall Study|Death|3|||
129953782|NCT05008224|467791871|FG000|Overall Study|Lost to Follow-up|2|||
129953783|NCT05008224|467791871|FG000|Overall Study|Did Not Continue on Extension Study|39|||
129953784|NCT05008224|467791871|FG000|Overall Study|Transferred to Extension Study|100|||
129953785|NCT05008224|467791871|FG000|Overall Study|Withdrawal by Subject|2|||
130120871|NCT03500484|468404824|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
130120872|NCT03500484|468404825|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
130120873|NCT02795104|468404826|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
130120874|NCT02795104|468404827|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
130120875|NCT02795104|468404828|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
130120876|NCT02795104|468404826|FG000|Overall Study|Withdrawal by Subject|0|||
129953786|NCT05234632|467791872|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
129953787|NCT05234632|467791873|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
129953788|NCT05234632|467791872|FG000|Overall Study|Withdrawal by Subject|2|||
129953789|NCT05234632|467791873|FG001|Overall Study|Withdrawal by Subject|0|||
129953790|NCT05234632|467791872|FG000|Overall Study|Adverse Event|0|||
129953791|NCT05234632|467791873|FG001|Overall Study|Adverse Event|4|||
129953792|NCT05234632|467791872|FG000|Overall Study|Physician Decision|1|||
129953793|NCT05234632|467791873|FG001|Overall Study|Physician Decision|1|||
129953794|NCT05234632|467791872|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
129953795|NCT05234632|467791873|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
129953796|NCT05234632|467791872|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
129953797|NCT05234632|467791873|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
129953798|NCT04985604|467791874|FG000|Overall Study|Death|4|||
129953799|NCT04985604|467791875|FG001|Overall Study|Death|6|||
129953800|NCT04985604|467791874|FG000|Overall Study|Withdrawal by Subject|0|||
129953801|NCT04985604|467791875|FG001|Overall Study|Withdrawal by Subject|1|||
129953802|NCT02282761|467791876|FG000|Overall Study|Death|0|||
129953803|NCT02282761|467791877|FG001|Overall Study|Death|0|||
130120877|NCT02795104|468404827|FG001|Overall Study|Withdrawal by Subject|2|||
130120878|NCT02795104|468404828|FG002|Overall Study|Withdrawal by Subject|0|||
130120879|NCT02795104|468404826|FG000|Overall Study|Lost to Follow-up|0|||
130120880|NCT02795104|468404827|FG001|Overall Study|Lost to Follow-up|0|||
130120881|NCT02795104|468404828|FG002|Overall Study|Lost to Follow-up|1|||
130120882|NCT00948675|468404829|FG000|Overall Study|Lost to Follow-up|1|||
129953804|NCT02282761|467791878|FG002|Overall Study|Death|1|||
129953805|NCT02282761|467791876|FG000|Overall Study|Adverse Event|6|||
129953806|NCT02282761|467791877|FG001|Overall Study|Adverse Event|2|||
129953807|NCT02282761|467791878|FG002|Overall Study|Adverse Event|0|||
129953808|NCT02282761|467791876|FG000|Overall Study|Lack of Efficacy|11|||
129953809|NCT02282761|467791877|FG001|Overall Study|Lack of Efficacy|6|||
129953810|NCT02282761|467791878|FG002|Overall Study|Lack of Efficacy|17|||
129953811|NCT02282761|467791876|FG000|Overall Study|Lost to Follow-up|2|||
129953812|NCT02282761|467791877|FG001|Overall Study|Lost to Follow-up|2|||
129953813|NCT02282761|467791878|FG002|Overall Study|Lost to Follow-up|1|||
129953814|NCT02282761|467791876|FG000|Overall Study|Physician Decision|0|||
130079594|NCT03864627|468245351|FG000|Overall Study|Lack of Efficacy|0|||
130079595|NCT03864627|468245352|FG001|Overall Study|Lack of Efficacy|1|||
130079596|NCT03864627|468245351|FG000|Overall Study|Lost to Follow-up|0|||
130079597|NCT03864627|468245352|FG001|Overall Study|Lost to Follow-up|1|||
130079598|NCT03864627|468245351|FG000|Overall Study|Withdrawal by Subject|4|||
130079599|NCT03864627|468245352|FG001|Overall Study|Withdrawal by Subject|8|||
130079600|NCT03864627|468245351|FG000|Overall Study|Study terminated by sponsor|0|||
130079601|NCT03864627|468245352|FG001|Overall Study|Study terminated by sponsor|1|||
130079602|NCT01388491|468245354|FG000|Overall Study|Adverse Event|10|||
130079603|NCT01388491|468245355|FG001|Overall Study|Adverse Event|9|||
130079604|NCT01388491|468245354|FG000|Overall Study|Sponsor Request|9|||
130079605|NCT01388491|468245355|FG001|Overall Study|Sponsor Request|7|||
130079606|NCT01388491|468245354|FG000|Overall Study|Withdrawal by Subject|6|||
130079607|NCT01388491|468245355|FG001|Overall Study|Withdrawal by Subject|10|||
130079608|NCT01388491|468245354|FG000|Overall Study|Lost to Follow-up|4|||
130079609|NCT01388491|468245355|FG001|Overall Study|Lost to Follow-up|3|||
130079610|NCT01388491|468245354|FG000|Overall Study|Protocol Violation|2|||
130079611|NCT01388491|468245355|FG001|Overall Study|Protocol Violation|0|||
130079612|NCT01388491|468245354|FG000|Overall Study|Noncompliance|2|||
130079613|NCT01388491|468245355|FG001|Overall Study|Noncompliance|0|||
130079614|NCT01388491|468245354|FG000|Overall Study|Pregnancy|1|||
130079615|NCT01388491|468245355|FG001|Overall Study|Pregnancy|0|||
130079616|NCT00412113|468245357|FG000|Overall Study|Adverse Event|11|||
130079617|NCT00412113|468245358|FG001|Overall Study|Adverse Event|15|||
130079618|NCT00412113|468245357|FG000|Overall Study|did not receive treatment|1|||
130079619|NCT00412113|468245358|FG001|Overall Study|did not receive treatment|0|||
130079620|NCT01190020|468245363|FG000|Overall Study|Adverse Event|2|||
130079621|NCT01190020|468245364|FG001|Overall Study|Adverse Event|0|||
130079622|NCT01190020|468245363|FG000|Overall Study|Lost to Follow-up|2|||
130079623|NCT01190020|468245364|FG001|Overall Study|Lost to Follow-up|0|||
130079624|NCT01190020|468245363|FG000|Overall Study|Withdrawal by Subject|3|||
130079625|NCT01190020|468245364|FG001|Overall Study|Withdrawal by Subject|0|||
130079626|NCT00796224|468245365|FG000|Overall Study|Adverse Event|1|||
130120883|NCT00948675|468404830|FG001|Overall Study|Lost to Follow-up|0|||
130120884|NCT00536575|468404833|FG000|Overall Study|Withdrawal by Subject|1|||
129953815|NCT02282761|467791877|FG001|Overall Study|Physician Decision|0|||
129953816|NCT02282761|467791878|FG002|Overall Study|Physician Decision|2|||
129953817|NCT02282761|467791876|FG000|Overall Study|Withdrawal by Subject|8|||
129953818|NCT02282761|467791877|FG001|Overall Study|Withdrawal by Subject|10|||
129953819|NCT02282761|467791878|FG002|Overall Study|Withdrawal by Subject|16|||
129953820|NCT02282761|467791876|FG000|Overall Study|Other|3|||
129953821|NCT02282761|467791877|FG001|Overall Study|Other|2|||
129953822|NCT02282761|467791878|FG002|Overall Study|Other|1|||
129953823|NCT02632045|467791879|FG000|Overall Study|Withdrawal by Subject|1|||
129953824|NCT02632045|467791880|FG001|Overall Study|Withdrawal by Subject|2|||
129953825|NCT05878522|467791881|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953826|NCT05878522|467791882|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953827|NCT05878522|467791883|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953828|NCT05878522|467791884|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953829|NCT05878522|467791885|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953830|NCT05878522|467791886|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953831|NCT05878522|467791887|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953832|NCT05878522|467791888|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953833|NCT05878522|467791889|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
129953834|NCT05878522|467791890|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953835|NCT05878522|467791891|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953836|NCT05878522|467791892|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953837|NCT05878522|467791881|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
129953838|NCT05878522|467791882|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953839|NCT05878522|467791883|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953840|NCT05878522|467791884|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130079627|NCT00796224|468245366|FG001|Overall Study|Adverse Event|0|||
130079628|NCT00796224|468245365|FG000|Overall Study|Protocol Violation|0|||
130079629|NCT00796224|468245366|FG001|Overall Study|Protocol Violation|1|||
130079630|NCT04195750|468245367|FG000|Overall Study|Death|245|||
129953841|NCT05878522|467791885|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953842|NCT05878522|467791886|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953843|NCT05878522|467791887|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130079631|NCT04195750|468245368|FG001|Overall Study|Death|253|||
130079632|NCT04195750|468245369|FG002|Overall Study|Death|5|||
130079633|NCT04195750|468245367|FG000|Overall Study|Physician Decision|0|||
130079634|NCT04195750|468245368|FG001|Overall Study|Physician Decision|1|||
130120885|NCT00536575|468404833|FG000|Overall Study|Death|1|||
129953844|NCT05878522|467791888|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
130079635|NCT04195750|468245369|FG002|Overall Study|Physician Decision|0|||
129953845|NCT05878522|467791889|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953846|NCT05878522|467791890|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
129953847|NCT05878522|467791891|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953848|NCT05878522|467791892|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953849|NCT05878522|467791881|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953850|NCT05878522|467791882|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
129953851|NCT05878522|467791883|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953852|NCT05878522|467791884|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
129953853|NCT05878522|467791885|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953854|NCT05878522|467791886|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953855|NCT05878522|467791887|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953856|NCT05878522|467791888|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953857|NCT05878522|467791889|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953858|NCT05878522|467791890|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953859|NCT05878522|467791891|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953860|NCT05878522|467791892|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
130079636|NCT04195750|468245367|FG000|Overall Study|Withdrawal by Subject|9|||
130079637|NCT04195750|468245368|FG001|Overall Study|Withdrawal by Subject|8|||
130079638|NCT04195750|468245369|FG002|Overall Study|Withdrawal by Subject|0|||
130079639|NCT04195750|468245367|FG000|Overall Study|Ongoing|120|||
130079640|NCT04195750|468245368|FG001|Overall Study|Ongoing|110|||
130079641|NCT04195750|468245369|FG002|Overall Study|Ongoing|4|||
130079642|NCT03782376|468245370|FG000|Overall Study|Lost to Follow-up|2|||
130079643|NCT03782376|468245371|FG001|Overall Study|Lost to Follow-up|2|||
130079644|NCT03782376|468245370|FG000|Overall Study|Withdrawal by Subject|7|||
130079645|NCT03782376|468245371|FG001|Overall Study|Withdrawal by Subject|11|||
130079646|NCT03782376|468245370|FG000|Overall Study|Death|1|||
130079647|NCT03782376|468245371|FG001|Overall Study|Death|0|||
130079648|NCT03782376|468245370|FG000|Overall Study|Other|16|||
130079649|NCT03782376|468245371|FG001|Overall Study|Other|17|||
130079650|NCT03559192|468245372|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
130079651|NCT03559192|468245373|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
130079652|NCT03559192|468245374|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
130079653|NCT03559192|468245372|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
130079654|NCT03559192|468245373|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
130079655|NCT03559192|468245374|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
130079656|NCT03559192|468245372|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
130079657|NCT03559192|468245373|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
130079658|NCT03559192|468245374|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
130079659|NCT03559192|468245372|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
130079660|NCT03559192|468245373|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
130079661|NCT03559192|468245374|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
130079662|NCT03559192|468245372|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
130079663|NCT03559192|468245373|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
130079664|NCT03559192|468245374|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
130079665|NCT03559192|468245372|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
130079666|NCT03559192|468245373|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
130079667|NCT03559192|468245374|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
130079668|NCT03559192|468245372|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
130079669|NCT03559192|468245373|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
130079670|NCT03559192|468245374|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
130079671|NCT03559192|468245372|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
130079672|NCT03559192|468245373|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
130079673|NCT03559192|468245374|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
130079674|NCT03559192|468245372|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
130079675|NCT03559192|468245373|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
130079676|NCT03559192|468245374|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
130079677|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
130079678|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
130079679|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Death|0|||
130079680|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Death|4|||
130079681|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
130079682|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
130079683|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
130079684|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
130079685|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
130079686|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
130120886|NCT00927810|468404837|FG000|Overall Study|Withdrawal by Subject|0|||
129953861|NCT05878522|467791881|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130120887|NCT00927810|468404838|FG001|Overall Study|Withdrawal by Subject|3|||
130120888|NCT00927810|468404839|FG002|Overall Study|Withdrawal by Subject|0|||
130079687|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
130079688|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
130079689|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
130079690|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
130079691|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Other|4|||
130079692|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Other|3|||
130079693|NCT03517722|468245375|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
130079694|NCT03517722|468245376|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
130079695|NCT03517722|468245375|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
130079696|NCT03517722|468245376|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
130079697|NCT03517722|468245375|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
130079698|NCT03517722|468245376|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
130079699|NCT03517722|468245375|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
130079700|NCT03517722|468245376|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
130079701|NCT03517722|468245375|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
130079702|NCT03517722|468245376|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
130079703|NCT02422186|468245377|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
130079704|NCT02422186|468245378|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
130079705|NCT02422186|468245377|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
130079706|NCT02422186|468245378|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
130079707|NCT02422186|468245377|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
130079708|NCT02422186|468245378|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
130079709|NCT02422186|468245377|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
130079710|NCT02422186|468245378|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
130079711|NCT02422186|468245377|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
130079712|NCT02422186|468245378|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
130079713|NCT02422186|468245377|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
130079714|NCT02422186|468245378|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
130079715|NCT02422186|468245377|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
130079716|NCT02422186|468245378|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
130079717|NCT02422186|468245377|FG000|Follow-up Phase (2 Weeks)|Other|3|||
130079718|NCT02422186|468245378|FG001|Follow-up Phase (2 Weeks)|Other|0|||
130079719|NCT03573804|468245379|FG000|Overall Study|claustrophobia or MRI table problems|10|||
130079720|NCT03399786|468245382|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
130079721|NCT03399786|468245383|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130079722|NCT03399786|468245384|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130079723|NCT03399786|468245385|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130079724|NCT03399786|468245382|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
130079725|NCT03399786|468245383|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
130079726|NCT03399786|468245384|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
130079727|NCT03399786|468245385|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
130079728|NCT03399786|468245382|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
130079729|NCT03399786|468245383|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
130079730|NCT03399786|468245384|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
130079731|NCT03399786|468245385|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
130079732|NCT01673373|468247609|FG000|Overall Study|Death|2|||
130079733|NCT01572844|468247610|FG000|Overall Study|Physician Decision|1|||
130079734|NCT01572844|468247611|FG001|Overall Study|Physician Decision|1|||
130079735|NCT00366444|468247613|FG000|Overall Study|Withdrawal by Subject|1|||
130079736|NCT00366444|468247614|FG001|Overall Study|Withdrawal by Subject|1|||
130079737|NCT00366444|468247613|FG000|Overall Study|Lack of Efficacy|0|||
130079738|NCT00366444|468247614|FG001|Overall Study|Lack of Efficacy|1|||
130079739|NCT05171816|468247615|FG000|Overall Study|Death|18|||
130079740|NCT05171816|468247616|FG001|Overall Study|Death|16|||
130079741|NCT04667949|468247617|FG000|Overall Study|Adverse Event|0|||
130079742|NCT04667949|468247618|FG001|Overall Study|Adverse Event|2|||
130079743|NCT04667949|468247617|FG000|Overall Study|Lost to Follow-up|0|||
130079744|NCT04667949|468247618|FG001|Overall Study|Lost to Follow-up|1|||
130079745|NCT04667949|468247617|FG000|Overall Study|Physician Decision|0|||
130079746|NCT04667949|468247618|FG001|Overall Study|Physician Decision|2|||
130079747|NCT04667949|468247617|FG000|Overall Study|Subject decision|1|||
130079748|NCT04667949|468247618|FG001|Overall Study|Subject decision|7|||
130079749|NCT02000622|468247621|FG000|Overall Study|Withdrawal by Subject|5|||
130079750|NCT02000622|468247622|FG001|Overall Study|Withdrawal by Subject|7|||
130079751|NCT02000622|468247621|FG000|Overall Study|Lost to Follow-up|4|||
130079752|NCT02000622|468247622|FG001|Overall Study|Lost to Follow-up|0|||
130079753|NCT02000622|468247621|FG000|Overall Study|Death|159|||
130079754|NCT02000622|468247622|FG001|Overall Study|Death|73|||
130120889|NCT00927810|468404840|FG003|Overall Study|Withdrawal by Subject|1|||
130120890|NCT00927810|468404837|FG000|Overall Study|Lost to Follow-up|0|||
130079755|NCT02000622|468247621|FG000|Overall Study|Withdrawn due to site closure|1|||
130079756|NCT02000622|468247622|FG001|Overall Study|Withdrawn due to site closure|0|||
130079757|NCT01405027|468247626|FG000|Overall Study|Withdrawn consent|3|||
130079758|NCT01405027|468247627|FG001|Overall Study|Withdrawn consent|0|||
130079759|NCT01405027|468247626|FG000|Overall Study|Lost to Follow-up|16|||
130079760|NCT01405027|468247627|FG001|Overall Study|Lost to Follow-up|24|||
130079761|NCT01405027|468247626|FG000|Overall Study|Investigator judgement|0|||
130079762|NCT01405027|468247627|FG001|Overall Study|Investigator judgement|2|||
130079763|NCT01405027|468247626|FG000|Overall Study|Death|1|||
130079764|NCT01405027|468247627|FG001|Overall Study|Death|0|||
130079765|NCT01405027|468247626|FG000|Overall Study|Other or Unknown|12|||
130079766|NCT01405027|468247627|FG001|Overall Study|Other or Unknown|25|||
130079767|NCT03671148|468247633|FG000|Overall Study|Adverse Event|3|||
130079768|NCT03671148|468247634|FG001|Overall Study|Adverse Event|2|||
130079769|NCT03671148|468247633|FG000|Overall Study|Withdrawal by Subject|8|||
130079770|NCT03671148|468247634|FG001|Overall Study|Withdrawal by Subject|2|||
130079771|NCT03671148|468247633|FG000|Overall Study|Lost to Follow-up|1|||
130079772|NCT03671148|468247634|FG001|Overall Study|Lost to Follow-up|2|||
130079773|NCT03671148|468247633|FG000|Overall Study|Lack of Efficacy|7|||
130079774|NCT03671148|468247634|FG001|Overall Study|Lack of Efficacy|2|||
130079775|NCT03671148|468247633|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
130079776|NCT03671148|468247634|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
130079777|NCT03671148|468247633|FG000|Overall Study|Other|1|||
130079778|NCT03671148|468247634|FG001|Overall Study|Other|0|||
130079779|NCT03671148|468247633|FG000|Overall Study|Incomplete Randomization Visit|1|||
130079780|NCT03671148|468247634|FG001|Overall Study|Incomplete Randomization Visit|0|||
130079781|NCT02234050|468247635|FG000|Overall Study|Lack of Efficacy|38|||
130079782|NCT02234050|468247636|FG001|Overall Study|Lack of Efficacy|22|||
130079783|NCT02234050|468247635|FG000|Overall Study|Adverse Event|13|||
130079784|NCT02234050|468247636|FG001|Overall Study|Adverse Event|1|||
130079785|NCT02234050|468247635|FG000|Overall Study|Withdrawal by Subject|4|||
130079786|NCT02234050|468247636|FG001|Overall Study|Withdrawal by Subject|2|||
130079787|NCT02234050|468247635|FG000|Overall Study|Sponsor's decision|6|||
130079788|NCT02234050|468247636|FG001|Overall Study|Sponsor's decision|0|||
130079789|NCT02365506|468247638|FG000|Overall Study|Investigator's Discretion|0|||
130079790|NCT02365506|468247639|FG001|Overall Study|Investigator's Discretion|0|||
130079791|NCT02365506|468247640|FG002|Overall Study|Investigator's Discretion|1|||
130079792|NCT01680991|468247641|FG000|Overall Study|Adverse Event|1|||
130079793|NCT01680991|468247642|FG001|Overall Study|Adverse Event|0|||
130079794|NCT01680991|468247643|FG002|Overall Study|Adverse Event|0|||
130079795|NCT01680991|468247641|FG000|Overall Study|Death|1|||
130079796|NCT01680991|468247642|FG001|Overall Study|Death|0|||
130079797|NCT01680991|468247643|FG002|Overall Study|Death|1|||
130079798|NCT01680991|468247641|FG000|Overall Study|Protocol Violation|0|||
130079799|NCT01680991|468247642|FG001|Overall Study|Protocol Violation|1|||
130079800|NCT01680991|468247643|FG002|Overall Study|Protocol Violation|0|||
130079801|NCT01680991|468247641|FG000|Overall Study|Withdrawal by Subject|5|||
130079802|NCT01680991|468247642|FG001|Overall Study|Withdrawal by Subject|1|||
130079803|NCT01680991|468247643|FG002|Overall Study|Withdrawal by Subject|0|||
130079804|NCT01680991|468247641|FG000|Overall Study|Progressive disease (PD)|0|||
130079805|NCT01680991|468247642|FG001|Overall Study|Progressive disease (PD)|10|||
130079806|NCT01680991|468247643|FG002|Overall Study|Progressive disease (PD)|0|||
130079807|NCT01680991|468247641|FG000|Overall Study|Physician Decision|0|||
130079808|NCT01680991|468247642|FG001|Overall Study|Physician Decision|7|||
130079809|NCT01680991|468247643|FG002|Overall Study|Physician Decision|2|||
130079810|NCT01680991|468247641|FG000|Overall Study|Bad physical condition|0|||
130079811|NCT01680991|468247642|FG001|Overall Study|Bad physical condition|0|||
130079812|NCT01680991|468247643|FG002|Overall Study|Bad physical condition|1|||
130079813|NCT01680991|468247641|FG000|Overall Study|PD confirmed in other hospital|1|||
130079814|NCT01680991|468247642|FG001|Overall Study|PD confirmed in other hospital|0|||
130079815|NCT01680991|468247643|FG002|Overall Study|PD confirmed in other hospital|0|||
130079816|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
130079817|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
130079818|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Death|1|||
130079819|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Death|1|||
130079820|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
130079821|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
130079822|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
130079823|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
130079824|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
130079825|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
130079826|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
130079827|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
130079828|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
129953862|NCT05878522|467791882|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
130079829|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
130079830|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
130079831|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
130079832|NCT03728881|468247644|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
130079833|NCT03728881|468247645|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
130079834|NCT03728881|468247644|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
130079835|NCT03728881|468247645|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
130079836|NCT03728881|468247644|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
130079837|NCT03728881|468247645|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
130079838|NCT06073054|468247646|FG000|Overall Study|Withdrawal by Subject|2|||
130079839|NCT03149029|468247647|FG000|Overall Study|Adverse Event|2|||
130079840|NCT03149029|468247648|FG001|Overall Study|Adverse Event|0|||
130079841|NCT00413777|468247653|FG000|Fixed-dose Period|Lost to Follow-up|1|||
130079842|NCT00413777|468247654|FG001|Fixed-dose Period|Lost to Follow-up|1|||
130079843|NCT00413777|468247653|FG000|Fixed-dose Period|Adverse Event|2|||
130079844|NCT00413777|468247654|FG001|Fixed-dose Period|Adverse Event|1|||
130079845|NCT00413777|468247653|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
130079846|NCT00413777|468247654|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
130079847|NCT00413777|468247653|FG000|Fixed-dose Period|Withdrew Consent|0|||
130079848|NCT00413777|468247654|FG001|Fixed-dose Period|Withdrew Consent|1|||
130079849|NCT05505734|468247655|FG000|Overall Study|Withdrawal by Subject|51|||
130079850|NCT05505734|468247656|FG001|Overall Study|Withdrawal by Subject|64|||
130079851|NCT05505734|468247655|FG000|Overall Study|Adverse Event|6|||
130079852|NCT05505734|468247656|FG001|Overall Study|Adverse Event|20|||
130079853|NCT05505734|468247655|FG000|Overall Study|Protocol Violation|8|||
130079854|NCT05505734|468247656|FG001|Overall Study|Protocol Violation|15|||
130079855|NCT05505734|468247655|FG000|Overall Study|Lack of therapeutic response|0|||
130079856|NCT05505734|468247656|FG001|Overall Study|Lack of therapeutic response|1|||
130079857|NCT05505734|468247655|FG000|Overall Study|Lost to Follow-up|247|||
130079858|NCT05505734|468247656|FG001|Overall Study|Lost to Follow-up|237|||
130079859|NCT05505734|468247655|FG000|Overall Study|Physician Decision|22|||
130079860|NCT05505734|468247656|FG001|Overall Study|Physician Decision|13|||
130079861|NCT05505734|468247655|FG000|Overall Study|Death|2|||
130079862|NCT05505734|468247656|FG001|Overall Study|Death|1|||
130079863|NCT05505734|468247655|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130079864|NCT05505734|468247656|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129953863|NCT05878522|467791883|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953864|NCT05878522|467791884|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953865|NCT05878522|467791885|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
129953866|NCT05878522|467791886|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953867|NCT05878522|467791887|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953868|NCT05878522|467791888|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953869|NCT05878522|467791889|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953870|NCT05878522|467791890|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953871|NCT05878522|467791891|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953872|NCT05878522|467791892|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953873|NCT05263492|467791893|FG000|Overall Study|Adverse Event|1|||
129953874|NCT05263492|467791893|FG000|Overall Study|Disease progression during active treatment|3|||
129953875|NCT03345420|467791896|FG000|Overall Study|Withdrawal by Subject|1|||
129953876|NCT02252172|467791897|FG000|Overall Study|Lost to Follow-up|3|||
129953877|NCT02252172|467791898|FG001|Overall Study|Lost to Follow-up|1|||
129953878|NCT02252172|467791897|FG000|Overall Study|Ongoing|276|||
129953879|NCT02252172|467791898|FG001|Overall Study|Ongoing|298|||
129953880|NCT05216835|467791899|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953881|NCT05216835|467791900|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
130079865|NCT05505734|468247655|FG000|Overall Study|Pregnancy|1|||
130079866|NCT05505734|468247656|FG001|Overall Study|Pregnancy|0|||
130079867|NCT05505734|468247655|FG000|Overall Study|Other|17|||
130079868|NCT05505734|468247656|FG001|Overall Study|Other|13|||
129953882|NCT05216835|467791901|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953883|NCT05216835|467791902|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953884|NCT05216835|467791903|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
129953885|NCT05216835|467791904|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
129953886|NCT05216835|467791905|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
129953887|NCT05216835|467791906|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
129953888|NCT05216835|467791899|FG000|Overall Study|Death|0|||
129953889|NCT05216835|467791900|FG001|Overall Study|Death|0|||
129953890|NCT05216835|467791901|FG002|Overall Study|Death|0|||
130079869|NCT00764322|468247657|FG000|Overall Study|Withdrawal by Subject|11|||
130079870|NCT00764322|468247657|FG000|Overall Study|No CYP2D6 genotyping|9|||
130079871|NCT02348840|468247679|FG000|Overall Study|Withdrawal by Subject|2|||
130079872|NCT02348840|468247680|FG001|Overall Study|Withdrawal by Subject|1|||
130079873|NCT02348840|468247681|FG002|Overall Study|Withdrawal by Subject|0|||
129953891|NCT05216835|467791902|FG003|Overall Study|Death|1|||
130079874|NCT02348840|468247682|FG003|Overall Study|Withdrawal by Subject|0|||
130079875|NCT01600105|468247683|FG000|Total Participants|Withdrawal by Subject|1|||
130079876|NCT01600105|468247684|FG001|Total Participants|Withdrawal by Subject|0|||
130079877|NCT01600105|468247683|FG000|Total Participants|No images in PACS|10|||
130079878|NCT01600105|468247684|FG001|Total Participants|No images in PACS|0|||
130079879|NCT01600105|468247683|FG000|Total Participants|Insufficient image quality|30|||
130079880|NCT01600105|468247684|FG001|Total Participants|Insufficient image quality|10|||
130079881|NCT01600105|468247683|FG000|Sub Study I|Insufficient image quality|0|||
130079882|NCT01600105|468247684|FG001|Sub Study I|Insufficient image quality|10|||
130079883|NCT01600105|468247683|FG000|Sub Study II|Withdrawal by Subject|1|||
130079884|NCT01600105|468247684|FG001|Sub Study II|Withdrawal by Subject|0|||
130079885|NCT01600105|468247683|FG000|Sub Study II|No images in PACS|1|||
130079886|NCT01600105|468247684|FG001|Sub Study II|No images in PACS|0|||
130079887|NCT01600105|468247683|FG000|Sub Study II|Insufficient image quality|3|||
130079888|NCT01600105|468247684|FG001|Sub Study II|Insufficient image quality|0|||
130079889|NCT01600105|468247683|FG000|Sub Study III|Insufficient image quality|5|||
130079890|NCT01600105|468247684|FG001|Sub Study III|Insufficient image quality|0|||
130079891|NCT01600105|468247683|FG000|Sub Study V|Poor Image Quality|2|||
130079892|NCT01600105|468247684|FG001|Sub Study V|Poor Image Quality|0|||
130079893|NCT01263444|468247685|FG000|Overall Study|Adverse Event|8|||
130079894|NCT01263444|468247685|FG000|Overall Study|Withdrawal by Subject|1|||
130079895|NCT01263444|468247685|FG000|Overall Study|Protocol Violation|1|||
130079896|NCT04007367|468247687|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
130079897|NCT04007367|468247688|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
130079898|NCT04007367|468247689|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
130079899|NCT04007367|468247687|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
130079900|NCT04007367|468247688|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
130079901|NCT04007367|468247689|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
130079902|NCT04007367|468247687|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
130079903|NCT04007367|468247688|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
130079904|NCT04007367|468247689|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
130079905|NCT04007367|468247687|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
130079906|NCT04007367|468247688|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
130079907|NCT04007367|468247689|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
130079908|NCT04007367|468247687|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
130079909|NCT04007367|468247688|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
130079910|NCT04007367|468247689|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
130079911|NCT01764022|468247690|FG000|Overall Study|Death|3|||
130079912|NCT01764022|468247691|FG001|Overall Study|Death|5|||
130079913|NCT01764022|468247690|FG000|Overall Study|Withdrawal by Subject|2|||
130079914|NCT01764022|468247691|FG001|Overall Study|Withdrawal by Subject|6|||
130079915|NCT01764022|468247690|FG000|Overall Study|Lack of Efficacy|0|||
130079916|NCT01764022|468247691|FG001|Overall Study|Lack of Efficacy|1|||
130079917|NCT01764022|468247690|FG000|Overall Study|Physician Decision|0|||
130079918|NCT01764022|468247691|FG001|Overall Study|Physician Decision|2|||
130079919|NCT01764022|468247690|FG000|Overall Study|Lost to Follow-up|2|||
130079920|NCT01764022|468247691|FG001|Overall Study|Lost to Follow-up|0|||
130079921|NCT01764022|468247690|FG000|Overall Study|Protocol Violation|1|||
130079922|NCT01764022|468247691|FG001|Overall Study|Protocol Violation|0|||
130079923|NCT00338806|468247693|FG000|Acute Phase|Withdrawal by Subject|0|||
130079924|NCT00338806|468247694|FG001|Acute Phase|Withdrawal by Subject|1|||
130079925|NCT00338806|468247693|FG000|Follow-up|Lost to Follow-up|1|||
130079926|NCT00338806|468247694|FG001|Follow-up|Lost to Follow-up|3|||
130079927|NCT00744991|468247695|FG000|Overall Study|Progressive Disease|11|||
130079928|NCT00744991|468247695|FG000|Overall Study|Withdrawal by Subject|8|||
130079929|NCT00744991|468247695|FG000|Overall Study|Physician Decision|3|||
130079930|NCT00744991|468247695|FG000|Overall Study|Adverse Event|2|||
130079931|NCT00744991|468247695|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
130079932|NCT00085644|468247701|FG000|Double-Blind Period|Adverse Event|5|||
130079933|NCT00085644|468247702|FG001|Double-Blind Period|Adverse Event|2|||
130079934|NCT00085644|468247703|FG002|Double-Blind Period|Adverse Event|0|||
130079935|NCT00085644|468247701|FG000|Double-Blind Period|Withdrawal by Subject|3|||
129953892|NCT05216835|467791903|FG004|Overall Study|Death|1|||
129953893|NCT05216835|467791904|FG005|Overall Study|Death|1|||
129953894|NCT05216835|467791905|FG006|Overall Study|Death|1|||
129953895|NCT05216835|467791906|FG007|Overall Study|Death|1|||
130079936|NCT00085644|468247702|FG001|Double-Blind Period|Withdrawal by Subject|0|||
130079937|NCT00085644|468247703|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130079938|NCT00085644|468247701|FG000|Double-Blind Period|Lost to Follow-up|2|||
130079939|NCT00085644|468247702|FG001|Double-Blind Period|Lost to Follow-up|1|||
130079940|NCT00085644|468247703|FG002|Double-Blind Period|Lost to Follow-up|0|||
130079941|NCT00085644|468247701|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
129953896|NCT05216835|467791899|FG000|Overall Study|Physician Decision|0|||
130079942|NCT00085644|468247702|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
130079943|NCT00085644|468247703|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
130120891|NCT00927810|468404838|FG001|Overall Study|Lost to Follow-up|2|||
130120892|NCT00927810|468404839|FG002|Overall Study|Lost to Follow-up|1|||
130120893|NCT00927810|468404840|FG003|Overall Study|Lost to Follow-up|1|||
130120894|NCT00927810|468404837|FG000|Overall Study|Death|0|||
130120895|NCT00927810|468404838|FG001|Overall Study|Death|2|||
130120896|NCT00927810|468404839|FG002|Overall Study|Death|0|||
130120897|NCT00927810|468404840|FG003|Overall Study|Death|0|||
130120898|NCT00927810|468404837|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130120899|NCT00927810|468404838|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130120900|NCT00927810|468404839|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130120901|NCT00927810|468404840|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130120902|NCT00198029|468404844|FG000|Overall Study|Withdrawal by Subject|4|||
130120903|NCT04128007|468404845|FG000|Overall Study|Withdrawal by Subject|9|||
130120904|NCT04128007|468404846|FG001|Overall Study|Withdrawal by Subject|6|||
130120905|NCT04128007|468404845|FG000|Overall Study|Protocol Violation|1|||
130120906|NCT04128007|468404846|FG001|Overall Study|Protocol Violation|0|||
130120907|NCT04128007|468404845|FG000|Overall Study|Lost to Follow-up|8|||
130120908|NCT04128007|468404846|FG001|Overall Study|Lost to Follow-up|7|||
130120909|NCT04128007|468404845|FG000|Overall Study|Adverse Event|5|||
130120910|NCT04128007|468404846|FG001|Overall Study|Adverse Event|2|||
130120911|NCT04128007|468404845|FG000|Overall Study|Not reported|0|||
130120912|NCT04128007|468404846|FG001|Overall Study|Not reported|2|||
129953897|NCT05216835|467791900|FG001|Overall Study|Physician Decision|0|||
129953898|NCT05216835|467791901|FG002|Overall Study|Physician Decision|0|||
129953899|NCT05216835|467791902|FG003|Overall Study|Physician Decision|0|||
129953900|NCT05216835|467791903|FG004|Overall Study|Physician Decision|0|||
129953901|NCT05216835|467791904|FG005|Overall Study|Physician Decision|1|||
129953902|NCT05216835|467791905|FG006|Overall Study|Physician Decision|1|||
129953903|NCT05216835|467791906|FG007|Overall Study|Physician Decision|0|||
129953904|NCT05216835|467791899|FG000|Overall Study|Study terminated by Sponsor|0|||
130079944|NCT00085644|468247701|FG000|Double-Blind Period|Contemplating pregnancy|1|||
130079945|NCT00085644|468247702|FG001|Double-Blind Period|Contemplating pregnancy|0|||
130079946|NCT00085644|468247703|FG002|Double-Blind Period|Contemplating pregnancy|0|||
130079947|NCT00085644|468247701|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
130079948|NCT00085644|468247702|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
130079949|NCT00085644|468247703|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
130079950|NCT00085644|468247701|FG000|Open-Label Period|Adverse Event|0|||
130079951|NCT00085644|468247702|FG001|Open-Label Period|Adverse Event|0|||
130079952|NCT00085644|468247703|FG002|Open-Label Period|Adverse Event|38|||
130079953|NCT00085644|468247701|FG000|Open-Label Period|Withdrawal by Subject|0|||
130079954|NCT00085644|468247702|FG001|Open-Label Period|Withdrawal by Subject|0|||
130079955|NCT00085644|468247703|FG002|Open-Label Period|Withdrawal by Subject|29|||
130079956|NCT00085644|468247701|FG000|Open-Label Period|Lost to Follow-up|0|||
130079957|NCT00085644|468247702|FG001|Open-Label Period|Lost to Follow-up|0|||
130079958|NCT00085644|468247703|FG002|Open-Label Period|Lost to Follow-up|13|||
130079959|NCT00085644|468247701|FG000|Open-Label Period|Lack of Efficacy|0|||
130079960|NCT00085644|468247702|FG001|Open-Label Period|Lack of Efficacy|0|||
130079961|NCT00085644|468247703|FG002|Open-Label Period|Lack of Efficacy|15|||
130079962|NCT00085644|468247701|FG000|Open-Label Period|Pregnancy|0|||
130079963|NCT00085644|468247702|FG001|Open-Label Period|Pregnancy|0|||
130079964|NCT00085644|468247703|FG002|Open-Label Period|Pregnancy|3|||
130079965|NCT00085644|468247701|FG000|Open-Label Period|Contemplating pregnancy|0|||
130079966|NCT00085644|468247702|FG001|Open-Label Period|Contemplating pregnancy|0|||
130079967|NCT00085644|468247703|FG002|Open-Label Period|Contemplating pregnancy|3|||
130079968|NCT00085644|468247701|FG000|Open-Label Period|Protocol Violation|0|||
130079969|NCT00085644|468247702|FG001|Open-Label Period|Protocol Violation|0|||
130079970|NCT00085644|468247703|FG002|Open-Label Period|Protocol Violation|4|||
130079971|NCT00085644|468247701|FG000|Open-Label Period|Personal reason|0|||
130079972|NCT00085644|468247702|FG001|Open-Label Period|Personal reason|0|||
130079973|NCT00085644|468247703|FG002|Open-Label Period|Personal reason|4|||
130079974|NCT03330106|468247704|FG000|Part A|Withdrawal by Subject|1|||
130079975|NCT03330106|468247705|FG001|Part A|Withdrawal by Subject|1|||
130079976|NCT03330106|468247706|FG002|Part A|Withdrawal by Subject|0|||
130079977|NCT03330106|468247707|FG003|Part A|Withdrawal by Subject|0|||
130079978|NCT03330106|468247704|FG000|Part A|Death|2|||
130079979|NCT03330106|468247705|FG001|Part A|Death|1|||
130079980|NCT03330106|468247706|FG002|Part A|Death|0|||
130079981|NCT03330106|468247707|FG003|Part A|Death|0|||
130079982|NCT03330106|468247704|FG000|Part A|Adverse Event|0|||
130120913|NCT04117607|468404847|FG000|Overall Study|Early Termination|0|||
130120914|NCT04117607|468404848|FG001|Overall Study|Early Termination|1|||
130120915|NCT04117607|468404849|FG002|Overall Study|Early Termination|0|||
130120916|NCT04117607|468404850|FG003|Overall Study|Early Termination|0|||
130120917|NCT04117607|468404851|FG004|Overall Study|Early Termination|0|||
130120918|NCT04117607|468404852|FG005|Overall Study|Early Termination|0|||
130120919|NCT04117607|468404853|FG006|Overall Study|Early Termination|1|||
130120920|NCT04117607|468404854|FG007|Overall Study|Early Termination|0|||
130120921|NCT04117607|468404855|FG008|Overall Study|Early Termination|0|||
129953905|NCT05216835|467791900|FG001|Overall Study|Study terminated by Sponsor|0|||
129953906|NCT05216835|467791901|FG002|Overall Study|Study terminated by Sponsor|0|||
130079983|NCT03330106|468247705|FG001|Part A|Adverse Event|1|||
130079984|NCT03330106|468247706|FG002|Part A|Adverse Event|0|||
130079985|NCT03330106|468247707|FG003|Part A|Adverse Event|0|||
130079986|NCT03330106|468247704|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
130079987|NCT03330106|468247705|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
130079988|NCT03330106|468247706|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
130079989|NCT03330106|468247707|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
130079990|NCT03330106|468247704|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
130079991|NCT03330106|468247705|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
130079992|NCT03330106|468247706|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
130079993|NCT03330106|468247707|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
130079994|NCT03330106|468247704|FG000|Part A|Progressive Disease|0|||
130079995|NCT03330106|468247705|FG001|Part A|Progressive Disease|1|||
130079996|NCT03330106|468247706|FG002|Part A|Progressive Disease|0|||
130079997|NCT03330106|468247707|FG003|Part A|Progressive Disease|0|||
130079998|NCT03330106|468247704|FG000|Part B|Lost to Follow-up|0|||
130079999|NCT03330106|468247705|FG001|Part B|Lost to Follow-up|0|||
130080000|NCT03330106|468247706|FG002|Part B|Lost to Follow-up|0|||
130080001|NCT03330106|468247707|FG003|Part B|Lost to Follow-up|1|||
130080002|NCT03330106|468247704|FG000|Part B|Withdrawal by Subject|0|||
130080003|NCT03330106|468247705|FG001|Part B|Withdrawal by Subject|0|||
130080004|NCT03330106|468247706|FG002|Part B|Withdrawal by Subject|4|||
130080005|NCT03330106|468247707|FG003|Part B|Withdrawal by Subject|0|||
130080006|NCT03330106|468247704|FG000|Part B|Death|0|||
130080007|NCT03330106|468247705|FG001|Part B|Death|0|||
130080008|NCT03330106|468247706|FG002|Part B|Death|2|||
130080009|NCT03330106|468247707|FG003|Part B|Death|0|||
130080010|NCT03330106|468247704|FG000|Part B|Clinical Progression|0|||
130080011|NCT03330106|468247705|FG001|Part B|Clinical Progression|0|||
130080012|NCT03330106|468247706|FG002|Part B|Clinical Progression|1|||
130080013|NCT03330106|468247707|FG003|Part B|Clinical Progression|1|||
130080014|NCT03330106|468247704|FG000|Part B|Symptomatic Deterioration|0|||
130080015|NCT03330106|468247705|FG001|Part B|Symptomatic Deterioration|0|||
130080016|NCT03330106|468247706|FG002|Part B|Symptomatic Deterioration|0|||
130080017|NCT03330106|468247707|FG003|Part B|Symptomatic Deterioration|1|||
130080018|NCT03330106|468247704|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
130080019|NCT03330106|468247705|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
130080020|NCT03330106|468247706|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
130080021|NCT03330106|468247707|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
130080022|NCT03330106|468247704|FG000|Part B|Progressive Disease|0|||
130080023|NCT03330106|468247705|FG001|Part B|Progressive Disease|0|||
130080024|NCT03330106|468247706|FG002|Part B|Progressive Disease|11|||
130080025|NCT03330106|468247707|FG003|Part B|Progressive Disease|4|||
130080026|NCT03198728|468247708|FG000|Overall Study|Adverse Event|10|||
130080027|NCT03198728|468247709|FG001|Overall Study|Adverse Event|5|||
130080028|NCT03198728|468247708|FG000|Overall Study|Lost to Follow-up|21|||
130080029|NCT03198728|468247709|FG001|Overall Study|Lost to Follow-up|7|||
130080030|NCT03198728|468247708|FG000|Overall Study|Physician Decision|7|||
130080031|NCT03198728|468247709|FG001|Overall Study|Physician Decision|2|||
130080032|NCT03198728|468247708|FG000|Overall Study|Withdrawal by Subject|14|||
130080033|NCT03198728|468247709|FG001|Overall Study|Withdrawal by Subject|10|||
130080034|NCT04051944|468247713|FG000|Overall Study|Study ending|1|||
130080035|NCT04051944|468247714|FG001|Overall Study|Study ending|1|||
130080036|NCT04051944|468247713|FG000|Overall Study|Early study termination by participant|1|||
130080037|NCT04051944|468247714|FG001|Overall Study|Early study termination by participant|0|||
130080038|NCT04051944|468247713|FG000|Overall Study|Withdrawal by Subject|2|||
130080039|NCT04051944|468247714|FG001|Overall Study|Withdrawal by Subject|2|||
130080040|NCT04051944|468247713|FG000|Overall Study|Lack of Efficacy|3|||
130080041|NCT04051944|468247714|FG001|Overall Study|Lack of Efficacy|0|||
130080042|NCT04051944|468247713|FG000|Overall Study|Adverse event, non- fatal|1|||
130080043|NCT04051944|468247714|FG001|Overall Study|Adverse event, non- fatal|1|||
130080044|NCT02139280|468247715|FG000|Overall Study|No longer eligible|2|||
130080045|NCT02139280|468247716|FG001|Overall Study|No longer eligible|0|||
130080046|NCT00736450|468247717|FG000|Overall Study|Not ABC gene eligible|19|||
130080047|NCT00736450|468247717|FG000|Overall Study|Withdrawal by Subject|5|||
130080048|NCT00736450|468247717|FG000|Overall Study|Physician Decision|1|||
130080049|NCT04157751|468247718|FG000|Overall Study|Withdrawal by Subject|12|||
130080050|NCT04157751|468247719|FG001|Overall Study|Withdrawal by Subject|17|||
129953907|NCT05216835|467791902|FG003|Overall Study|Study terminated by Sponsor|0|||
130080051|NCT04157751|468247718|FG000|Overall Study|Lost to Follow-up|6|||
130080052|NCT04157751|468247719|FG001|Overall Study|Lost to Follow-up|2|||
130080053|NCT04157751|468247718|FG000|Overall Study|Adverse Event|34|||
130080054|NCT04157751|468247719|FG001|Overall Study|Adverse Event|23|||
130080055|NCT04157751|468247718|FG000|Overall Study|Not treated|1|||
130080056|NCT04157751|468247719|FG001|Overall Study|Not treated|5|||
130080057|NCT04157751|468247718|FG000|Overall Study|Other reason not stated above|10|||
130080058|NCT04157751|468247719|FG001|Overall Study|Other reason not stated above|10|||
130080059|NCT01947894|468247732|FG000|Overall Study|Other|3|||
130080060|NCT01947894|468247733|FG001|Overall Study|Other|4|||
130080061|NCT01947894|468247734|FG002|Overall Study|Other|3|||
130080062|NCT01947894|468247732|FG000|Overall Study|Withdrawal by Subject|12|||
130080063|NCT01947894|468247733|FG001|Overall Study|Withdrawal by Subject|4|||
130080064|NCT01947894|468247734|FG002|Overall Study|Withdrawal by Subject|1|||
130080065|NCT01947894|468247732|FG000|Overall Study|Death|12|||
130080066|NCT01947894|468247733|FG001|Overall Study|Death|1|||
130080067|NCT01947894|468247734|FG002|Overall Study|Death|0|||
130080068|NCT01947894|468247732|FG000|Overall Study|Physician Decision|2|||
130080069|NCT01947894|468247733|FG001|Overall Study|Physician Decision|0|||
130080070|NCT01947894|468247734|FG002|Overall Study|Physician Decision|0|||
130080071|NCT01947894|468247732|FG000|Overall Study|Adverse Event|5|||
130080072|NCT01947894|468247733|FG001|Overall Study|Adverse Event|1|||
130080073|NCT01947894|468247734|FG002|Overall Study|Adverse Event|0|||
130080074|NCT01947894|468247732|FG000|Overall Study|Switched to other growth hormone brand|53|||
130080075|NCT01947894|468247733|FG001|Overall Study|Switched to other growth hormone brand|8|||
130080076|NCT01947894|468247734|FG002|Overall Study|Switched to other growth hormone brand|23|||
130080077|NCT01302691|468247735|FG000|Overall Study|Adverse Event|2|||
130080078|NCT01302691|468247736|FG001|Overall Study|Adverse Event|0|||
130080079|NCT01302691|468247735|FG000|Overall Study|Death|0|||
130080080|NCT01302691|468247736|FG001|Overall Study|Death|1|||
130080081|NCT01302691|468247735|FG000|Overall Study|Lost to Follow-up|1|||
130080082|NCT01302691|468247736|FG001|Overall Study|Lost to Follow-up|0|||
130080083|NCT01302691|468247735|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
130080084|NCT01302691|468247736|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
130080085|NCT01302691|468247735|FG000|Overall Study|Physician Decision|0|||
130080086|NCT01302691|468247736|FG001|Overall Study|Physician Decision|1|||
130080087|NCT01302691|468247735|FG000|Overall Study|Protocol Violation|1|||
130080088|NCT01302691|468247736|FG001|Overall Study|Protocol Violation|0|||
130080089|NCT03446612|468247737|FG000|Overall Study|Protocol defined stopping criteria|0|||
130080090|NCT03446612|468247738|FG001|Overall Study|Protocol defined stopping criteria|1|||
130080091|NCT01437267|468247740|FG000|Overall Study|Withdrawal by Subject|0|||
130080092|NCT01437267|468247741|FG001|Overall Study|Withdrawal by Subject|0|||
130080093|NCT01437267|468247742|FG002|Overall Study|Withdrawal by Subject|0|||
130080094|NCT01437267|468247743|FG003|Overall Study|Withdrawal by Subject|1|||
130080095|NCT01437267|468247744|FG004|Overall Study|Withdrawal by Subject|0|||
130080096|NCT01437267|468247745|FG005|Overall Study|Withdrawal by Subject|0|||
130080097|NCT01437267|468247740|FG000|Overall Study|Protocol Violation|0|||
130080098|NCT01437267|468247741|FG001|Overall Study|Protocol Violation|1|||
130080099|NCT01437267|468247742|FG002|Overall Study|Protocol Violation|0|||
130080100|NCT01437267|468247743|FG003|Overall Study|Protocol Violation|0|||
130080101|NCT01437267|468247744|FG004|Overall Study|Protocol Violation|0|||
130080102|NCT01437267|468247745|FG005|Overall Study|Protocol Violation|0|||
130080103|NCT03934203|468247748|FG000|Overall Study|Adverse Event|0|||
130080104|NCT03934203|468247749|FG001|Overall Study|Adverse Event|0|||
130080105|NCT03934203|468247750|FG002|Overall Study|Adverse Event|1|||
130080106|NCT03934203|468247751|FG003|Overall Study|Adverse Event|0|||
130080107|NCT03934203|468247752|FG004|Overall Study|Adverse Event|1|||
130080108|NCT03934203|468247753|FG005|Overall Study|Adverse Event|0|||
130080109|NCT03934203|468247754|FG006|Overall Study|Adverse Event|2|||
130080110|NCT03934203|468247755|FG007|Overall Study|Adverse Event|0|||
130080111|NCT03934203|468247756|FG008|Overall Study|Adverse Event|0|||
130080112|NCT03934203|468247757|FG009|Overall Study|Adverse Event|0|||
130080113|NCT03934203|468247758|FG010|Overall Study|Adverse Event|0|||
130080114|NCT03934203|468247759|FG011|Overall Study|Adverse Event|0|||
130080115|NCT03934203|468247760|FG012|Overall Study|Adverse Event|0|||
130120922|NCT04117607|468404856|FG009|Overall Study|Early Termination|0|||
130120923|NCT04117607|468404857|FG010|Overall Study|Early Termination|0|||
129953908|NCT05216835|467791903|FG004|Overall Study|Study terminated by Sponsor|0|||
129953909|NCT05216835|467791904|FG005|Overall Study|Study terminated by Sponsor|0|||
129953910|NCT05216835|467791905|FG006|Overall Study|Study terminated by Sponsor|0|||
129953911|NCT05216835|467791906|FG007|Overall Study|Study terminated by Sponsor|1|||
129953912|NCT05216835|467791899|FG000|Overall Study|Withdrawal by Subject|1|||
129953913|NCT05216835|467791900|FG001|Overall Study|Withdrawal by Subject|0|||
129953914|NCT05216835|467791901|FG002|Overall Study|Withdrawal by Subject|1|||
129953915|NCT05216835|467791902|FG003|Overall Study|Withdrawal by Subject|0|||
129953916|NCT05216835|467791903|FG004|Overall Study|Withdrawal by Subject|1|||
129953917|NCT05216835|467791904|FG005|Overall Study|Withdrawal by Subject|0|||
129953918|NCT05216835|467791905|FG006|Overall Study|Withdrawal by Subject|0|||
130080116|NCT03934203|468247761|FG013|Overall Study|Adverse Event|1|||
130080117|NCT03934203|468247762|FG014|Overall Study|Adverse Event|0|||
130080118|NCT00333970|468247763|FG000|Overall Study|Withdrawal by Subject|13|||
130080119|NCT00333970|468247764|FG001|Overall Study|Withdrawal by Subject|7|||
130120924|NCT04117607|468404858|FG011|Overall Study|Early Termination|0|||
129953919|NCT05216835|467791906|FG007|Overall Study|Withdrawal by Subject|1|||
130080120|NCT00608842|468247765|FG000|Overall Study|Participant's Request|0|||
130080121|NCT00608842|468247766|FG001|Overall Study|Participant's Request|1|||
130080122|NCT00608842|468247767|FG002|Overall Study|Participant's Request|2|||
130080123|NCT00608842|468247768|FG003|Overall Study|Participant's Request|1|||
130080124|NCT00608842|468247765|FG000|Overall Study|Lost to Follow-up|1|||
130080125|NCT00608842|468247766|FG001|Overall Study|Lost to Follow-up|0|||
130080126|NCT00608842|468247767|FG002|Overall Study|Lost to Follow-up|0|||
130080127|NCT00608842|468247768|FG003|Overall Study|Lost to Follow-up|0|||
130080128|NCT04445051|468247769|FG000|Overall Study|Adverse Event|0|||
130080129|NCT04445051|468247770|FG001|Overall Study|Adverse Event|0|||
130080130|NCT04445051|468247771|FG002|Overall Study|Adverse Event|1|||
130080131|NCT04445051|468247772|FG003|Overall Study|Adverse Event|0|||
130080132|NCT04445051|468247773|FG004|Overall Study|Adverse Event|0|||
130080133|NCT04445051|468247774|FG005|Overall Study|Adverse Event|0|||
130080134|NCT03924427|468247780|FG000|Overall Study|Adverse Event|4|||
130080135|NCT03924427|468247780|FG000|Overall Study|Lack of Efficacy|1|||
130080136|NCT03924427|468247780|FG000|Overall Study|Withdrawal by Subject|1|||
130080137|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
130080138|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
130080139|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
130080140|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
130080141|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
130080142|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
130080143|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
130080144|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
130080145|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
130080146|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
130080147|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
130080148|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
130080149|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
130080150|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
130080151|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
130080152|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130080153|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
130080154|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130080155|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130080156|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
130080157|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
130080158|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130080159|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130080160|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130080161|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
130080162|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130080163|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
130080164|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130080165|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130080166|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
130080167|NCT04757376|468247781|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
130080168|NCT04757376|468247782|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
130080169|NCT04757376|468247783|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
130080170|NCT04757376|468247784|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
130080171|NCT04757376|468247785|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
130080172|NCT04757376|468247781|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130080173|NCT04757376|468247782|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130080174|NCT04757376|468247783|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
130080175|NCT04757376|468247784|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130080176|NCT04757376|468247785|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
130080177|NCT01307046|468247786|FG000|Overall Study|Adverse Event|3|||
130080178|NCT01307046|468247787|FG001|Overall Study|Adverse Event|3|||
130080179|NCT01307046|468247786|FG000|Overall Study|Lack of Efficacy|0|||
129953920|NCT05216835|467791899|FG000|Overall Study|Other|0|||
129953921|NCT05216835|467791900|FG001|Overall Study|Other|1|||
129953922|NCT05216835|467791901|FG002|Overall Study|Other|0|||
129953923|NCT05216835|467791902|FG003|Overall Study|Other|0|||
130080180|NCT01307046|468247787|FG001|Overall Study|Lack of Efficacy|2|||
130080181|NCT01307046|468247786|FG000|Overall Study|Physician Decision|2|||
130080182|NCT01307046|468247787|FG001|Overall Study|Physician Decision|0|||
130080183|NCT01307046|468247786|FG000|Overall Study|Withdrawal by Subject|1|||
130080184|NCT01307046|468247787|FG001|Overall Study|Withdrawal by Subject|1|||
130080185|NCT01307046|468247786|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
130080186|NCT01307046|468247787|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
130080187|NCT01307046|468247786|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
130080188|NCT01307046|468247787|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
130080189|NCT01365091|468247790|FG000|Period 1|Adverse Event|1|||
130080190|NCT01365091|468247791|FG001|Period 1|Adverse Event|0|||
130080191|NCT01365091|468247792|FG002|Period 1|Adverse Event|2|||
130080192|NCT01365091|468247793|FG003|Period 1|Adverse Event|3|||
130080193|NCT01365091|468247790|FG000|Period 1|Positive test result for drugs of abuse|1|||
130080194|NCT01365091|468247791|FG001|Period 1|Positive test result for drugs of abuse|0|||
130080195|NCT01365091|468247792|FG002|Period 1|Positive test result for drugs of abuse|0|||
130080196|NCT01365091|468247793|FG003|Period 1|Positive test result for drugs of abuse|0|||
130080197|NCT01365091|468247790|FG000|Period 1|No longer met study criteria|0|||
130080198|NCT01365091|468247791|FG001|Period 1|No longer met study criteria|1|||
130080199|NCT01365091|468247792|FG002|Period 1|No longer met study criteria|0|||
130080200|NCT01365091|468247793|FG003|Period 1|No longer met study criteria|0|||
130080201|NCT01365091|468247790|FG000|Period 1|Withdrawal by Subject|0|||
130080202|NCT01365091|468247791|FG001|Period 1|Withdrawal by Subject|1|||
130080203|NCT01365091|468247792|FG002|Period 1|Withdrawal by Subject|0|||
130080204|NCT01365091|468247793|FG003|Period 1|Withdrawal by Subject|0|||
130080205|NCT01365091|468247790|FG000|Period 1|Personal reasons|0|||
130080206|NCT01365091|468247791|FG001|Period 1|Personal reasons|0|||
130080207|NCT01365091|468247792|FG002|Period 1|Personal reasons|1|||
130080208|NCT01365091|468247793|FG003|Period 1|Personal reasons|0|||
130080209|NCT01365091|468247790|FG000|Period 2|Withdrawal by Subject|1|||
130080210|NCT01365091|468247791|FG001|Period 2|Withdrawal by Subject|0|||
130080211|NCT01365091|468247792|FG002|Period 2|Withdrawal by Subject|0|||
130080212|NCT01365091|468247793|FG003|Period 2|Withdrawal by Subject|0|||
130080213|NCT01365091|468247790|FG000|Period 2|Adverse Event|0|||
130080214|NCT01365091|468247791|FG001|Period 2|Adverse Event|0|||
130080215|NCT01365091|468247792|FG002|Period 2|Adverse Event|1|||
130080216|NCT01365091|468247793|FG003|Period 2|Adverse Event|0|||
130080217|NCT02569398|468247794|FG000|Overall Study|Adverse Event|0|||
130080218|NCT02569398|468247795|FG001|Overall Study|Adverse Event|1|||
130080219|NCT02569398|468247796|FG002|Overall Study|Adverse Event|6|||
130080220|NCT02569398|468247794|FG000|Overall Study|Withdrawal by Subject|43|||
130080221|NCT02569398|468247795|FG001|Overall Study|Withdrawal by Subject|43|||
130080222|NCT02569398|468247796|FG002|Overall Study|Withdrawal by Subject|30|||
130080223|NCT02569398|468247794|FG000|Overall Study|Study terminated by sponsor|130|||
130080224|NCT02569398|468247795|FG001|Overall Study|Study terminated by sponsor|131|||
130080225|NCT02569398|468247796|FG002|Overall Study|Study terminated by sponsor|134|||
130080226|NCT02569398|468247794|FG000|Overall Study|Other|12|||
130080227|NCT02569398|468247795|FG001|Overall Study|Other|14|||
130080228|NCT02569398|468247796|FG002|Overall Study|Other|13|||
130080229|NCT02116361|468247799|FG000|Overall Study|Pregnancy|0|||
130080230|NCT02116361|468247800|FG001|Overall Study|Pregnancy|0|||
130080231|NCT02116361|468247801|FG002|Overall Study|Pregnancy|0|||
130080232|NCT02116361|468247802|FG003|Overall Study|Pregnancy|1|||
130080233|NCT02116361|468247799|FG000|Overall Study|Protocol Violation|1|||
130080234|NCT02116361|468247800|FG001|Overall Study|Protocol Violation|0|||
130080235|NCT02116361|468247801|FG002|Overall Study|Protocol Violation|0|||
130080236|NCT02116361|468247802|FG003|Overall Study|Protocol Violation|2|||
130080237|NCT02116361|468247799|FG000|Overall Study|Physician Decision|2|||
130080238|NCT02116361|468247800|FG001|Overall Study|Physician Decision|3|||
130080239|NCT02116361|468247801|FG002|Overall Study|Physician Decision|0|||
130080240|NCT02116361|468247802|FG003|Overall Study|Physician Decision|0|||
130080241|NCT02116361|468247799|FG000|Overall Study|Adverse Event|1|||
130080242|NCT02116361|468247800|FG001|Overall Study|Adverse Event|0|||
130080243|NCT02116361|468247801|FG002|Overall Study|Adverse Event|0|||
129953924|NCT05216835|467791903|FG004|Overall Study|Other|0|||
129953925|NCT05216835|467791904|FG005|Overall Study|Other|0|||
129953926|NCT05216835|467791905|FG006|Overall Study|Other|0|||
129953927|NCT05216835|467791906|FG007|Overall Study|Other|0|||
130080244|NCT02116361|468247802|FG003|Overall Study|Adverse Event|3|||
130080245|NCT02116361|468247799|FG000|Overall Study|Other Reasons|3|||
130080246|NCT02116361|468247800|FG001|Overall Study|Other Reasons|3|||
130080247|NCT02116361|468247801|FG002|Overall Study|Other Reasons|3|||
130080248|NCT02116361|468247802|FG003|Overall Study|Other Reasons|3|||
130080249|NCT02116361|468247799|FG000|Overall Study|Lack of Efficacy|5|||
130080250|NCT02116361|468247800|FG001|Overall Study|Lack of Efficacy|7|||
130080251|NCT02116361|468247801|FG002|Overall Study|Lack of Efficacy|4|||
130080252|NCT02116361|468247802|FG003|Overall Study|Lack of Efficacy|3|||
130080253|NCT02116361|468247799|FG000|Overall Study|Lost to Follow-up|4|||
130080254|NCT02116361|468247800|FG001|Overall Study|Lost to Follow-up|5|||
130080255|NCT02116361|468247801|FG002|Overall Study|Lost to Follow-up|7|||
130080256|NCT02116361|468247802|FG003|Overall Study|Lost to Follow-up|5|||
130080257|NCT02116361|468247799|FG000|Overall Study|Personal Reasons|6|||
130080258|NCT02116361|468247800|FG001|Overall Study|Personal Reasons|6|||
130080259|NCT02116361|468247801|FG002|Overall Study|Personal Reasons|4|||
130080260|NCT02116361|468247802|FG003|Overall Study|Personal Reasons|9|||
130080261|NCT02116361|468247799|FG000|Overall Study|Investigator Decision - Relapse|9|||
130080262|NCT02116361|468247800|FG001|Overall Study|Investigator Decision - Relapse|7|||
130080263|NCT02116361|468247801|FG002|Overall Study|Investigator Decision - Relapse|8|||
130080264|NCT02116361|468247802|FG003|Overall Study|Investigator Decision - Relapse|5|||
130080265|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
130080266|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
130080267|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
130080268|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
130080269|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
130080270|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
130080271|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130080272|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
130080273|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
130080274|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
130080275|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
130080276|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
130080277|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
130080278|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130080279|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130080280|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
130080281|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
130080282|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
130080283|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
130080284|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
130080285|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
130080286|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
130080287|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
130080288|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
130080289|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
130080290|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130080291|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
130080292|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
130080293|NCT03227224|468247803|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
130080294|NCT03227224|468247804|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
130080295|NCT03227224|468247805|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
130080296|NCT03227224|468247806|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
130080297|NCT03227224|468247803|FG000|Follow-up Phase (2 Weeks)|Other|4|||
130080298|NCT03227224|468247804|FG001|Follow-up Phase (2 Weeks)|Other|4|||
130080299|NCT03227224|468247805|FG002|Follow-up Phase (2 Weeks)|Other|6|||
130080300|NCT03227224|468247806|FG003|Follow-up Phase (2 Weeks)|Other|3|||
130080301|NCT02406027|468247807|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130080302|NCT02406027|468247808|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
130080303|NCT02406027|468247809|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
130080304|NCT02406027|468247810|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130080305|NCT02406027|468247811|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130080306|NCT02406027|468247812|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130080307|NCT02406027|468247813|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
130080308|NCT02406027|468247807|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
130080309|NCT02406027|468247808|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130080310|NCT02406027|468247809|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
130080311|NCT02406027|468247810|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130080312|NCT02406027|468247811|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
129953928|NCT05179603|467791907|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129953929|NCT05179603|467791907|FG000|Overall Study|Withdrawal by Subject|1|||
130080313|NCT02406027|468247812|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130080314|NCT02406027|468247813|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
130080315|NCT02406027|468247807|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
130080316|NCT02406027|468247808|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
129953930|NCT05179603|467791907|FG000|Overall Study|Progressive disease|4|||
130080317|NCT02406027|468247809|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
130080318|NCT02406027|468247810|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130080319|NCT02406027|468247811|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130080320|NCT02406027|468247812|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130080321|NCT02406027|468247813|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
130080322|NCT02406027|468247807|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
130080323|NCT02406027|468247808|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130080324|NCT02406027|468247809|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
130080325|NCT02406027|468247810|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130080326|NCT02406027|468247811|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130080327|NCT02406027|468247812|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130080328|NCT02406027|468247813|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
130080329|NCT02406027|468247807|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
130080330|NCT02406027|468247808|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
130080331|NCT02406027|468247809|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
130080332|NCT02406027|468247810|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
130080333|NCT02406027|468247811|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
130080334|NCT02406027|468247812|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
130080335|NCT02406027|468247813|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
130080336|NCT02406027|468247807|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
130080337|NCT02406027|468247808|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
130080338|NCT02406027|468247809|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
130080339|NCT02406027|468247810|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
130080340|NCT02406027|468247811|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
130080341|NCT02406027|468247812|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
130080342|NCT02406027|468247813|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
129953931|NCT05179603|467791907|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
129953932|NCT04551053|467791910|FG000|Overall Study|Death|10|||
129953933|NCT04551053|467791911|FG001|Overall Study|Death|9|||
129953934|NCT04551053|467791910|FG000|Overall Study|Lost to Follow-up|0|||
129953935|NCT04551053|467791911|FG001|Overall Study|Lost to Follow-up|2|||
129953936|NCT04551053|467791910|FG000|Overall Study|Study Terminated by Sponsor|57|||
129953937|NCT04551053|467791911|FG001|Overall Study|Study Terminated by Sponsor|65|||
129953938|NCT04551053|467791910|FG000|Overall Study|Withdrawal by Subject|12|||
129953939|NCT04551053|467791911|FG001|Overall Study|Withdrawal by Subject|5|||
129953940|NCT04551053|467791910|FG000|Overall Study|Adverse Event|2|||
129953941|NCT04551053|467791911|FG001|Overall Study|Adverse Event|0|||
129953942|NCT04551053|467791910|FG000|Overall Study|Lack of Efficacy|2|||
129953943|NCT04551053|467791911|FG001|Overall Study|Lack of Efficacy|1|||
129953944|NCT04551053|467791910|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
129953945|NCT04551053|467791911|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
129953946|NCT04551053|467791910|FG000|Overall Study|Splenapendectomi|1|||
129953947|NCT04551053|467791911|FG001|Overall Study|Splenapendectomi|0|||
129953948|NCT04551053|467791910|FG000|Overall Study|Medical Decision|1|||
129953949|NCT04551053|467791911|FG001|Overall Study|Medical Decision|1|||
129953950|NCT05740371|467791912|FG000|Overall Study|Death|1|||
129953951|NCT03019289|467791913|FG000|Overall Study|Adverse Event|1|||
129953952|NCT03019289|467791914|FG001|Overall Study|Adverse Event|0|||
129953953|NCT03019289|467791915|FG002|Overall Study|Adverse Event|0|||
129953954|NCT03019289|467791916|FG003|Overall Study|Adverse Event|0|||
129953955|NCT03019289|467791917|FG004|Overall Study|Adverse Event|0|||
129953956|NCT03019289|467791918|FG005|Overall Study|Adverse Event|0|||
129953957|NCT03019289|467791919|FG006|Overall Study|Adverse Event|0|||
129953958|NCT03019289|467791920|FG007|Overall Study|Adverse Event|0|||
129953959|NCT03019289|467791921|FG008|Overall Study|Adverse Event|1|||
129953960|NCT03019289|467791913|FG000|Overall Study|Other|1|||
129953961|NCT03019289|467791914|FG001|Overall Study|Other|0|||
129953962|NCT03019289|467791915|FG002|Overall Study|Other|0|||
129953963|NCT03019289|467791916|FG003|Overall Study|Other|0|||
129953964|NCT03019289|467791917|FG004|Overall Study|Other|0|||
129953965|NCT03019289|467791918|FG005|Overall Study|Other|0|||
129953966|NCT03019289|467791919|FG006|Overall Study|Other|0|||
129953967|NCT03019289|467791920|FG007|Overall Study|Other|0|||
129953968|NCT03019289|467791921|FG008|Overall Study|Other|0|||
129953969|NCT02389894|467791922|FG000|Overall Study|Death|4|||
129953970|NCT02389894|467791923|FG001|Overall Study|Death|5|||
129953971|NCT02389894|467791924|FG002|Overall Study|Death|3|||
129953972|NCT02389894|467791922|FG000|Overall Study|Withdrawal by Subject|2|||
129953973|NCT02389894|467791923|FG001|Overall Study|Withdrawal by Subject|4|||
129953974|NCT02389894|467791924|FG002|Overall Study|Withdrawal by Subject|5|||
130120925|NCT04117607|468404859|FG012|Overall Study|Early Termination|0|||
130120926|NCT04117607|468404860|FG013|Overall Study|Early Termination|0|||
130120927|NCT00814463|468404862|FG000|Overall Study|Lost to Follow-up|1|||
129953975|NCT02389894|467791922|FG000|Overall Study|Lost to Follow-up|2|||
129953976|NCT02389894|467791923|FG001|Overall Study|Lost to Follow-up|1|||
129953977|NCT02389894|467791924|FG002|Overall Study|Lost to Follow-up|1|||
130080343|NCT02406027|468247807|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130080344|NCT02406027|468247808|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130080345|NCT02406027|468247809|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130080346|NCT02406027|468247810|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
130080347|NCT02406027|468247811|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
130080348|NCT02406027|468247812|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
130080349|NCT02406027|468247813|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
130080350|NCT02406027|468247807|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
130080351|NCT02406027|468247808|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
130080352|NCT02406027|468247809|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
130080353|NCT02406027|468247810|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
130080354|NCT02406027|468247811|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
130080355|NCT02406027|468247812|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
130080356|NCT02406027|468247813|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
130080357|NCT02406027|468247807|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130080358|NCT02406027|468247808|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130080359|NCT02406027|468247809|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130080360|NCT02406027|468247810|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130080361|NCT02406027|468247811|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130080362|NCT02406027|468247812|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
130080363|NCT02406027|468247813|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
130080364|NCT02406027|468247807|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130080365|NCT02406027|468247808|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130080366|NCT02406027|468247809|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130080367|NCT02406027|468247810|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130080368|NCT02406027|468247811|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
130080369|NCT02406027|468247812|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130080370|NCT02406027|468247813|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
130080371|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
130080372|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
130080373|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
130080374|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
130080375|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Other|13|||
130080376|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
130080377|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
130080378|NCT02497287|468247814|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
130080379|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
130080380|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
130080381|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
130080382|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
130080383|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
130080384|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
130080385|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
130080386|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
130080387|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
130080388|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
130080389|NCT02497287|468247814|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
130080390|NCT02497287|468247814|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
130080391|NCT02497287|468247814|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
130080392|NCT02497287|468247814|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
130080393|NCT02497287|468247814|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
130080394|NCT02497287|468247814|FG000|Follow-up Phase (4 Week)|Other|1|||
130080395|NCT01226472|468247815|FG000|Overall Study|Progressive Disease|1|||
130080396|NCT00952419|468247816|FG000|Overall Study|Adverse Event|2|||
130080397|NCT00952419|468247817|FG001|Overall Study|Adverse Event|0|||
130080398|NCT00952419|468247818|FG002|Overall Study|Adverse Event|0|||
130080399|NCT00952419|468247816|FG000|Overall Study|Protocol Violation|3|||
130080400|NCT00952419|468247817|FG001|Overall Study|Protocol Violation|7|||
130080401|NCT00952419|468247818|FG002|Overall Study|Protocol Violation|0|||
130080402|NCT00952419|468247816|FG000|Overall Study|Withdrawal by Subject|1|||
130080403|NCT00952419|468247817|FG001|Overall Study|Withdrawal by Subject|3|||
130080404|NCT00952419|468247818|FG002|Overall Study|Withdrawal by Subject|0|||
130080405|NCT04888507|468249406|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
130080406|NCT00636155|468249407|FG000|Overall Study|Adverse Event|8|||
130080407|NCT00636155|468249407|FG000|Overall Study|Lack of Efficacy|1|||
130080408|NCT00636155|468249407|FG000|Overall Study|Withdrawal by Subject|3|||
130080409|NCT00636155|468249407|FG000|Overall Study|Stem cell transplant|1|||
130080410|NCT00636155|468249407|FG000|Overall Study|Physician Decision|5|||
130080411|NCT00400946|468249408|FG000|Overall Study|Ineligible|0|||
130080412|NCT00400946|468249409|FG001|Overall Study|Ineligible|0|||
130080413|NCT00400946|468249410|FG002|Overall Study|Ineligible|0|||
130080414|NCT00400946|468249411|FG003|Overall Study|Ineligible|5|||
130080415|NCT00400946|468249412|FG004|Overall Study|Ineligible|1|||
130080416|NCT00400946|468249408|FG000|Overall Study|Induction Failure|0|||
130080417|NCT00400946|468249409|FG001|Overall Study|Induction Failure|0|||
130080418|NCT00400946|468249410|FG002|Overall Study|Induction Failure|0|||
130080419|NCT00400946|468249411|FG003|Overall Study|Induction Failure|11|||
130080420|NCT00400946|468249412|FG004|Overall Study|Induction Failure|8|||
130080421|NCT00400946|468249408|FG000|Overall Study|Induction Death|0|||
130080422|NCT00400946|468249409|FG001|Overall Study|Induction Death|0|||
130080423|NCT00400946|468249410|FG002|Overall Study|Induction Death|0|||
130080424|NCT00400946|468249411|FG003|Overall Study|Induction Death|13|||
130080425|NCT00400946|468249412|FG004|Overall Study|Induction Death|3|||
130080426|NCT00400946|468249408|FG000|Overall Study|Lost to Follow-up|1|||
130080427|NCT00400946|468249409|FG001|Overall Study|Lost to Follow-up|1|||
130080428|NCT00400946|468249410|FG002|Overall Study|Lost to Follow-up|0|||
130080429|NCT00400946|468249411|FG003|Overall Study|Lost to Follow-up|0|||
130080430|NCT00400946|468249412|FG004|Overall Study|Lost to Follow-up|1|||
130080431|NCT00400946|468249408|FG000|Overall Study|Remission Death|1|||
130080432|NCT00400946|468249409|FG001|Overall Study|Remission Death|1|||
130080433|NCT00400946|468249410|FG002|Overall Study|Remission Death|0|||
130080434|NCT00400946|468249411|FG003|Overall Study|Remission Death|0|||
130080435|NCT00400946|468249412|FG004|Overall Study|Remission Death|1|||
130080436|NCT00400946|468249408|FG000|Overall Study|Relapse|9|||
130080437|NCT00400946|468249409|FG001|Overall Study|Relapse|2|||
130080438|NCT00400946|468249410|FG002|Overall Study|Relapse|1|||
130080439|NCT00400946|468249411|FG003|Overall Study|Relapse|1|||
130080440|NCT00400946|468249412|FG004|Overall Study|Relapse|5|||
130080441|NCT00400946|468249408|FG000|Overall Study|Transplant in CR1|0|||
130080442|NCT00400946|468249409|FG001|Overall Study|Transplant in CR1|0|||
130080443|NCT00400946|468249410|FG002|Overall Study|Transplant in CR1|0|||
130080444|NCT00400946|468249411|FG003|Overall Study|Transplant in CR1|10|||
130080445|NCT00400946|468249412|FG004|Overall Study|Transplant in CR1|1|||
130080446|NCT00400946|468249408|FG000|Overall Study|Withdrawal by Subject|2|||
130080447|NCT00400946|468249409|FG001|Overall Study|Withdrawal by Subject|5|||
130080448|NCT00400946|468249410|FG002|Overall Study|Withdrawal by Subject|1|||
130080449|NCT00400946|468249411|FG003|Overall Study|Withdrawal by Subject|5|||
130080450|NCT00400946|468249412|FG004|Overall Study|Withdrawal by Subject|8|||
130080451|NCT00400946|468249408|FG000|Overall Study|Clinical|1|||
130080452|NCT00400946|468249409|FG001|Overall Study|Clinical|2|||
130080453|NCT00400946|468249410|FG002|Overall Study|Clinical|0|||
130080454|NCT00400946|468249411|FG003|Overall Study|Clinical|2|||
130080455|NCT00400946|468249412|FG004|Overall Study|Clinical|9|||
130080456|NCT00400946|468249408|FG000|Overall Study|Other|0|||
130080457|NCT00400946|468249409|FG001|Overall Study|Other|0|||
130080458|NCT00400946|468249410|FG002|Overall Study|Other|0|||
130080459|NCT00400946|468249411|FG003|Overall Study|Other|0|||
130080460|NCT00400946|468249412|FG004|Overall Study|Other|1|||
130080461|NCT05643170|468249413|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
130080462|NCT05643170|468249413|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
130080463|NCT01432756|468249414|FG000|Overall Study|Lost to Follow-up|1|||
130080464|NCT01432756|468249415|FG001|Overall Study|Lost to Follow-up|0|||
130080465|NCT01432756|468249416|FG002|Overall Study|Lost to Follow-up|2|||
130080466|NCT01432756|468249417|FG003|Overall Study|Lost to Follow-up|1|||
130080467|NCT05426460|468249427|FG000|Overall Study|Protocol Violation|1|||
130080468|NCT05426460|468249428|FG001|Overall Study|Protocol Violation|1|||
130080469|NCT05426460|468249429|FG002|Overall Study|Protocol Violation|1|||
130080470|NCT05426460|468249430|FG003|Overall Study|Protocol Violation|0|||
130080471|NCT01431521|468249434|FG000|Overall Study|Withdrawal by Subject|0|||
130080472|NCT01431521|468249435|FG001|Overall Study|Withdrawal by Subject|0|||
130080473|NCT01431521|468249436|FG002|Overall Study|Withdrawal by Subject|1|||
130080474|NCT01431521|468249437|FG003|Overall Study|Withdrawal by Subject|0|||
130080475|NCT01320033|468249438|FG000|Overall Study|Lack of Efficacy|0|||
130080476|NCT01320033|468249439|FG001|Overall Study|Lack of Efficacy|0|||
130080477|NCT01320033|468249440|FG002|Overall Study|Lack of Efficacy|1|||
130080478|NCT01320033|468249438|FG000|Overall Study|Adverse Event|9|||
130080479|NCT01320033|468249439|FG001|Overall Study|Adverse Event|7|||
130080480|NCT01320033|468249440|FG002|Overall Study|Adverse Event|8|||
130080481|NCT01320033|468249438|FG000|Overall Study|Withdrawal by Subject|22|||
130080482|NCT01320033|468249439|FG001|Overall Study|Withdrawal by Subject|23|||
130080483|NCT01320033|468249440|FG002|Overall Study|Withdrawal by Subject|23|||
130080484|NCT01320033|468249438|FG000|Overall Study|Protocol Violation|3|||
130080485|NCT01320033|468249439|FG001|Overall Study|Protocol Violation|5|||
130080486|NCT01320033|468249440|FG002|Overall Study|Protocol Violation|3|||
130080487|NCT01320033|468249438|FG000|Overall Study|Lost to Follow-up|22|||
130080488|NCT01320033|468249439|FG001|Overall Study|Lost to Follow-up|26|||
130080489|NCT01320033|468249440|FG002|Overall Study|Lost to Follow-up|17|||
130080490|NCT01320033|468249438|FG000|Overall Study|Other|2|||
130080491|NCT01320033|468249439|FG001|Overall Study|Other|3|||
129953978|NCT01549951|467791925|FG000|Overall Study|Adverse Event|15|||
129953979|NCT01549951|467791925|FG000|Overall Study|Withdrawal by Subject|2|||
129953980|NCT01549951|467791925|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
129953981|NCT01549951|467791925|FG000|Overall Study|Progressive disease|29|||
129953982|NCT01549951|467791925|FG000|Overall Study|Symptomatic deterioration|1|||
129953983|NCT01549951|467791925|FG000|Overall Study|Other|2|||
129953984|NCT01123200|467791926|FG000|Overall Study|Withdrawal by Subject|1|||
129953985|NCT02819141|467791927|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
129953986|NCT02819141|467791928|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
129953987|NCT02101554|467792539|FG000|Overall Study|Protocol Violation|0|||
129953988|NCT02101554|467792540|FG001|Overall Study|Protocol Violation|1|||
129953989|NCT02101554|467792541|FG002|Overall Study|Protocol Violation|0|||
129953990|NCT02101554|467792539|FG000|Overall Study|Insufficient Clinical Response|0|||
129953991|NCT02101554|467792540|FG001|Overall Study|Insufficient Clinical Response|2|||
129953992|NCT02101554|467792541|FG002|Overall Study|Insufficient Clinical Response|0|||
129953993|NCT02101554|467792539|FG000|Overall Study|Adverse Event|2|||
129953994|NCT02101554|467792540|FG001|Overall Study|Adverse Event|1|||
129953995|NCT02101554|467792541|FG002|Overall Study|Adverse Event|1|||
129953996|NCT02101554|467792539|FG000|Overall Study|Lost to Follow-up|0|||
129953997|NCT02101554|467792540|FG001|Overall Study|Lost to Follow-up|1|||
129953998|NCT02101554|467792541|FG002|Overall Study|Lost to Follow-up|0|||
129953999|NCT02101554|467792539|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
129954000|NCT02101554|467792540|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
129954001|NCT02101554|467792541|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
129954002|NCT01075815|467792543|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
129954003|NCT01075815|467792544|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
129954004|NCT01075815|467792543|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
129954005|NCT01075815|467792544|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
129954006|NCT01075815|467792543|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
129954007|NCT01075815|467792544|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
129954008|NCT03503188|467792545|FG000|Overall Study|Non eligible in the sub study|0|||
129954009|NCT03503188|467792546|FG001|Overall Study|Non eligible in the sub study|1|||
129954010|NCT03747575|467792553|FG000|Overall Study|Withdrawal by Subject|6|||
129954011|NCT03747575|467792554|FG001|Overall Study|Withdrawal by Subject|3|||
129954012|NCT03747575|467792553|FG000|Overall Study|Lost to Follow-up|3|||
129954013|NCT03747575|467792554|FG001|Overall Study|Lost to Follow-up|3|||
129954014|NCT03747575|467792553|FG000|Overall Study|Adverse Event|0|||
129954015|NCT03747575|467792554|FG001|Overall Study|Adverse Event|1|||
129954016|NCT01052714|467792560|FG000|Overall Study|Adverse Event|6|||
129954017|NCT01052714|467792561|FG001|Overall Study|Adverse Event|3|||
129954018|NCT01052714|467792562|FG002|Overall Study|Adverse Event|0|||
129954019|NCT01052714|467792560|FG000|Overall Study|Death|1|||
129954020|NCT01052714|467792561|FG001|Overall Study|Death|2|||
129954021|NCT01052714|467792562|FG002|Overall Study|Death|0|||
129954022|NCT01052714|467792560|FG000|Overall Study|Lost to Follow-up|2|||
129954023|NCT01052714|467792561|FG001|Overall Study|Lost to Follow-up|3|||
129954024|NCT01052714|467792562|FG002|Overall Study|Lost to Follow-up|0|||
129954025|NCT01052714|467792560|FG000|Overall Study|Physician Decision|9|||
129954026|NCT01052714|467792561|FG001|Overall Study|Physician Decision|9|||
129954027|NCT01052714|467792562|FG002|Overall Study|Physician Decision|1|||
129954028|NCT01052714|467792560|FG000|Overall Study|Withdrawal by Subject|7|||
129954029|NCT01052714|467792561|FG001|Overall Study|Withdrawal by Subject|12|||
129954030|NCT01052714|467792562|FG002|Overall Study|Withdrawal by Subject|1|||
129954031|NCT03689452|467792565|FG000|Overall Study|Lost to Follow-up|1|||
129954032|NCT03689452|467792566|FG001|Overall Study|Lost to Follow-up|1|||
129954033|NCT02676778|467792568|FG000|Overall Study|Disease Progression|7|||
129954034|NCT02676778|467792569|FG001|Overall Study|Disease Progression|3|||
129954035|NCT02676778|467792570|FG002|Overall Study|Disease Progression|1|||
129954036|NCT02676778|467792568|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
129954037|NCT02676778|467792569|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
129954038|NCT02676778|467792570|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
129954039|NCT02676778|467792568|FG000|Overall Study|Withdrawal by Subject|3|||
129954040|NCT02676778|467792569|FG001|Overall Study|Withdrawal by Subject|2|||
129954041|NCT02676778|467792570|FG002|Overall Study|Withdrawal by Subject|0|||
129954042|NCT02676778|467792568|FG000|Overall Study|Other|4|||
129954043|NCT02676778|467792569|FG001|Overall Study|Other|3|||
129954044|NCT02676778|467792570|FG002|Overall Study|Other|0|||
129954045|NCT02676778|467792568|FG000|Overall Study|Adverse Event|2|||
129954046|NCT02676778|467792569|FG001|Overall Study|Adverse Event|3|||
129954047|NCT02676778|467792570|FG002|Overall Study|Adverse Event|0|||
129954048|NCT00732498|467792571|FG000|Overall Study|Ineligible|1|||
129954049|NCT00732498|467792571|FG000|Overall Study|Adverse Event|2|||
129954050|NCT00732498|467792571|FG000|Overall Study|Physician Decision|3|||
129954051|NCT03214198|467792579|FG000|Overall Study|Case Report Forms Uncollected|18|||
129954052|NCT03214198|467792579|FG000|Overall Study|Protocol Deviation|18|||
129954053|NCT04295499|467792580|FG000|Overall Study|moving out of state|1|||
129954054|NCT04295499|467792581|FG001|Overall Study|moving out of state|0|||
130080492|NCT01320033|468249440|FG002|Overall Study|Other|1|||
130080493|NCT00963469|468249441|FG000|Overall Study|Adverse Event|15|||
130080494|NCT00963469|468249442|FG001|Overall Study|Adverse Event|11|||
130080495|NCT00963469|468249443|FG002|Overall Study|Adverse Event|1|||
130080496|NCT00963469|468249441|FG000|Overall Study|Lack of Efficacy|10|||
130080497|NCT00963469|468249442|FG001|Overall Study|Lack of Efficacy|7|||
130080498|NCT00963469|468249443|FG002|Overall Study|Lack of Efficacy|2|||
130080499|NCT00963469|468249441|FG000|Overall Study|Lost to Follow-up|1|||
130080500|NCT00963469|468249442|FG001|Overall Study|Lost to Follow-up|1|||
130080501|NCT00963469|468249443|FG002|Overall Study|Lost to Follow-up|0|||
130080502|NCT00963469|468249441|FG000|Overall Study|Protocol Violation|5|||
130080503|NCT00963469|468249442|FG001|Overall Study|Protocol Violation|5|||
130080504|NCT00963469|468249443|FG002|Overall Study|Protocol Violation|3|||
130080505|NCT00963469|468249441|FG000|Overall Study|Withdrawal by Subject|4|||
130080506|NCT00963469|468249442|FG001|Overall Study|Withdrawal by Subject|1|||
130080507|NCT00963469|468249443|FG002|Overall Study|Withdrawal by Subject|1|||
130080508|NCT00963469|468249441|FG000|Overall Study|Pre-randomization Adverse Event|1|||
130080509|NCT00963469|468249442|FG001|Overall Study|Pre-randomization Adverse Event|2|||
130080510|NCT00963469|468249443|FG002|Overall Study|Pre-randomization Adverse Event|0|||
130080511|NCT00963469|468249441|FG000|Overall Study|Moved|1|||
130080512|NCT00963469|468249442|FG001|Overall Study|Moved|0|||
130080513|NCT00963469|468249443|FG002|Overall Study|Moved|0|||
130080514|NCT00963469|468249441|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
130080515|NCT00963469|468249442|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
130080516|NCT00963469|468249443|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
130080517|NCT04960202|468249461|FG000|Overall Study|Other|5|||
130080518|NCT04960202|468249462|FG001|Overall Study|Other|0|||
130080519|NCT04960202|468249461|FG000|Overall Study|Withdrawal by Subject|37|||
130080520|NCT04960202|468249462|FG001|Overall Study|Withdrawal by Subject|43|||
130080521|NCT04960202|468249461|FG000|Overall Study|Lost to Follow-up|20|||
130080522|NCT04960202|468249462|FG001|Overall Study|Lost to Follow-up|16|||
130080523|NCT04960202|468249461|FG000|Overall Study|Death|0|||
130080524|NCT04960202|468249462|FG001|Overall Study|Death|15|||
130080525|NCT03558828|468249466|FG000|Overall Study|Lost to Follow-up|4|||
130080526|NCT03558828|468249467|FG001|Overall Study|Lost to Follow-up|3|||
130080527|NCT03558828|468249468|FG002|Overall Study|Lost to Follow-up|3|||
130080528|NCT03558828|468249469|FG003|Overall Study|Lost to Follow-up|5|||
130080529|NCT03558828|468249470|FG004|Overall Study|Lost to Follow-up|2|||
130080530|NCT03558828|468249471|FG005|Overall Study|Lost to Follow-up|3|||
130080531|NCT03558828|468249466|FG000|Overall Study|dropped before the intervention|1|||
130080532|NCT03558828|468249467|FG001|Overall Study|dropped before the intervention|1|||
130080533|NCT03558828|468249468|FG002|Overall Study|dropped before the intervention|0|||
130080534|NCT03558828|468249469|FG003|Overall Study|dropped before the intervention|0|||
130080535|NCT03558828|468249470|FG004|Overall Study|dropped before the intervention|0|||
130080536|NCT03558828|468249471|FG005|Overall Study|dropped before the intervention|0|||
130080537|NCT00378534|468249472|FG000|Overall Study|Participants did not receive transplant|3|||
130080538|NCT00378534|468249473|FG001|Overall Study|Participants did not receive transplant|0|||
130080539|NCT04969900|468249474|FG000|Overall Study|Physician Decision|1|||
130080540|NCT04969900|468249475|FG001|Overall Study|Physician Decision|1|||
130080541|NCT04969900|468249474|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
130080542|NCT04969900|468249475|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
130080543|NCT00673816|468249480|FG000|Overall Study|Adverse Event|1|||
130080544|NCT00673816|468249480|FG000|Overall Study|Withdrawal by Subject|1|||
130080545|NCT01852591|468249482|FG000|Overall Study|Withdrawal by Subject|2|||
130080546|NCT01852591|468249482|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
130080547|NCT03774875|468249483|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
130080548|NCT03774875|468249484|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
130080549|NCT03774875|468249483|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
130080550|NCT03774875|468249484|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
130080551|NCT03774875|468249483|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
130080552|NCT03774875|468249484|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
130080553|NCT03774875|468249483|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
130080554|NCT03774875|468249484|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
130080555|NCT03774875|468249483|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
130080556|NCT03774875|468249484|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
130080557|NCT03774875|468249483|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
130080558|NCT03774875|468249484|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
130080559|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
130080560|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
130080561|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
130080562|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
130080563|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
130120928|NCT01265784|468404864|FG000|Overall Study|Lost to Follow-up|5|||
129954055|NCT04295499|467792580|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
129954056|NCT04295499|467792581|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
129954057|NCT03122548|467792582|FG000|Overall Study|Death|2|||
129954058|NCT03122548|467792582|FG000|Overall Study|Progression - subject went into hospice|1|||
129954059|NCT03122548|467792582|FG000|Overall Study|Study Terminated by Sponsor|2|||
129954060|NCT04448561|467792588|FG000|Overall Study|Noncompliance|1|||
129954061|NCT04448561|467792589|FG001|Overall Study|Noncompliance|0|||
129954062|NCT01730118|467793957|FG000|Dose Escalation|Death on study|5|||
129954063|NCT01730118|467793958|FG001|Dose Escalation|Death on study|7|||
129954064|NCT01730118|467793959|FG002|Dose Escalation|Death on study|2|||
129954065|NCT01730118|467793960|FG003|Dose Escalation|Death on study|6|||
129954066|NCT01730118|467793961|FG004|Dose Escalation|Death on study|0|||
129954067|NCT01730118|467793962|FG005|Dose Escalation|Death on study|0|||
129954068|NCT01730118|467793963|FG006|Dose Escalation|Death on study|0|||
129954069|NCT01730118|467793957|FG000|Dose Escalation|Died before treatment|0|||
129954070|NCT01730118|467793958|FG001|Dose Escalation|Died before treatment|0|||
129954071|NCT01730118|467793959|FG002|Dose Escalation|Died before treatment|0|||
129954072|NCT01730118|467793960|FG003|Dose Escalation|Died before treatment|0|||
129954073|NCT01730118|467793961|FG004|Dose Escalation|Died before treatment|0|||
129954074|NCT01730118|467793962|FG005|Dose Escalation|Died before treatment|0|||
129954075|NCT01730118|467793963|FG006|Dose Escalation|Died before treatment|1|||
129954076|NCT01730118|467793957|FG000|Dose Escalation|Chose to start a different treatment|1|||
129954077|NCT01730118|467793958|FG001|Dose Escalation|Chose to start a different treatment|0|||
129954078|NCT01730118|467793959|FG002|Dose Escalation|Chose to start a different treatment|0|||
129954079|NCT01730118|467793960|FG003|Dose Escalation|Chose to start a different treatment|0|||
129954080|NCT01730118|467793961|FG004|Dose Escalation|Chose to start a different treatment|0|||
129954081|NCT01730118|467793962|FG005|Dose Escalation|Chose to start a different treatment|0|||
129954082|NCT01730118|467793963|FG006|Dose Escalation|Chose to start a different treatment|0|||
129954083|NCT01730118|467793957|FG000|Dose Escalation|Withdrawal by Subject|0|||
129954084|NCT01730118|467793958|FG001|Dose Escalation|Withdrawal by Subject|0|||
129954085|NCT01730118|467793959|FG002|Dose Escalation|Withdrawal by Subject|1|||
129954086|NCT01730118|467793960|FG003|Dose Escalation|Withdrawal by Subject|0|||
129954087|NCT01730118|467793961|FG004|Dose Escalation|Withdrawal by Subject|0|||
129954088|NCT01730118|467793962|FG005|Dose Escalation|Withdrawal by Subject|0|||
129954089|NCT01730118|467793963|FG006|Dose Escalation|Withdrawal by Subject|0|||
129954090|NCT01730118|467793957|FG000|Dose Escalation|Disease progression prior to treatment|0|||
129954091|NCT01730118|467793958|FG001|Dose Escalation|Disease progression prior to treatment|0|||
129954092|NCT01730118|467793959|FG002|Dose Escalation|Disease progression prior to treatment|0|||
129954093|NCT01730118|467793960|FG003|Dose Escalation|Disease progression prior to treatment|0|||
129954094|NCT01730118|467793961|FG004|Dose Escalation|Disease progression prior to treatment|0|||
129954095|NCT01730118|467793962|FG005|Dose Escalation|Disease progression prior to treatment|0|||
129954096|NCT01730118|467793963|FG006|Dose Escalation|Disease progression prior to treatment|1|||
129954097|NCT01730118|467793957|FG000|Dose Expansion|Death|0|||
129954098|NCT01730118|467793958|FG001|Dose Expansion|Death|0|||
129954099|NCT01730118|467793959|FG002|Dose Expansion|Death|0|||
129954100|NCT01730118|467793960|FG003|Dose Expansion|Death|0|||
129954101|NCT01730118|467793961|FG004|Dose Expansion|Death|1|||
129954102|NCT01730118|467793962|FG005|Dose Expansion|Death|0|||
129954103|NCT01730118|467793963|FG006|Dose Expansion|Death|0|||
129954104|NCT01730118|467793957|FG000|Dose Expansion|Other medical condition|0|||
129954105|NCT01730118|467793958|FG001|Dose Expansion|Other medical condition|0|||
129954106|NCT01730118|467793959|FG002|Dose Expansion|Other medical condition|0|||
129954107|NCT01730118|467793960|FG003|Dose Expansion|Other medical condition|0|||
129954108|NCT01730118|467793961|FG004|Dose Expansion|Other medical condition|1|||
129954109|NCT01730118|467793962|FG005|Dose Expansion|Other medical condition|0|||
129954110|NCT01730118|467793963|FG006|Dose Expansion|Other medical condition|0|||
129954111|NCT01730118|467793957|FG000|Dose Expansion|Withdrawal by Subject|0|||
129954112|NCT01730118|467793958|FG001|Dose Expansion|Withdrawal by Subject|0|||
129954113|NCT01730118|467793959|FG002|Dose Expansion|Withdrawal by Subject|0|||
129954114|NCT01730118|467793960|FG003|Dose Expansion|Withdrawal by Subject|0|||
129954115|NCT01730118|467793961|FG004|Dose Expansion|Withdrawal by Subject|1|||
129954116|NCT01730118|467793962|FG005|Dose Expansion|Withdrawal by Subject|0|||
129954117|NCT01730118|467793963|FG006|Dose Expansion|Withdrawal by Subject|0|||
129954118|NCT01730118|467793957|FG000|Dose Expansion|Disease progression|0|||
129954119|NCT01730118|467793958|FG001|Dose Expansion|Disease progression|0|||
129954120|NCT01730118|467793959|FG002|Dose Expansion|Disease progression|0|||
129954121|NCT01730118|467793960|FG003|Dose Expansion|Disease progression|0|||
129954122|NCT01730118|467793961|FG004|Dose Expansion|Disease progression|0|||
129954123|NCT01730118|467793962|FG005|Dose Expansion|Disease progression|1|||
129954124|NCT01730118|467793963|FG006|Dose Expansion|Disease progression|0|||
129954125|NCT01730118|467793957|FG000|Dose Expansion|Inability to return|0|||
129954126|NCT01730118|467793958|FG001|Dose Expansion|Inability to return|0|||
129954127|NCT01730118|467793959|FG002|Dose Expansion|Inability to return|0|||
129954128|NCT01730118|467793960|FG003|Dose Expansion|Inability to return|0|||
130080564|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
130080565|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
130080566|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
130080567|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
130080568|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
130080569|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
130080570|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
130080571|NCT03774875|468249483|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
130080572|NCT03774875|468249484|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
130080573|NCT04088331|468249487|FG000|Overall Study|Lost to Follow-up|3|||
130080574|NCT04088331|468249487|FG000|Overall Study|Withdrawal by Subject|7|||
130080575|NCT04088331|468249487|FG000|Overall Study|Adverse Event|4|||
130080576|NCT03233308|468249492|FG000|Overall Study|Adverse Event|1|||
130080577|NCT03233308|468249492|FG000|Overall Study|Protocol Violation|1|||
130080578|NCT00976963|468249500|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
130080579|NCT00976963|468249501|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
130080580|NCT00976963|468249500|FG000|Overall Study|administrative error|1|||
130080581|NCT00976963|468249501|FG001|Overall Study|administrative error|0|||
130080582|NCT00976963|468249500|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
130080583|NCT00976963|468249501|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
130080584|NCT02756845|468249504|FG000|Overall Study|Death|12|||
130080585|NCT02756845|468249505|FG001|Overall Study|Death|2|||
130080586|NCT02756845|468249504|FG000|Overall Study|Withdrawal by Subject|1|||
130080587|NCT02756845|468249505|FG001|Overall Study|Withdrawal by Subject|0|||
130080588|NCT01688999|468249508|FG000|Overall Study|Withdrawal by Subject|5|||
130080589|NCT01688999|468249509|FG001|Overall Study|Withdrawal by Subject|1|||
130080590|NCT01688999|468249510|FG002|Overall Study|Withdrawal by Subject|1|||
130080591|NCT01688999|468249508|FG000|Overall Study|Adverse Event|2|||
130080592|NCT01688999|468249509|FG001|Overall Study|Adverse Event|0|||
130080593|NCT01688999|468249510|FG002|Overall Study|Adverse Event|2|||
130080594|NCT01688999|468249508|FG000|Overall Study|Ineligible/Not treated|1|||
130080595|NCT01688999|468249509|FG001|Overall Study|Ineligible/Not treated|0|||
130080596|NCT01688999|468249510|FG002|Overall Study|Ineligible/Not treated|0|||
130080597|NCT02768103|468249511|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
130080598|NCT03369704|468249512|FG000|Treatment Epoch|technical problems|1|||
130080599|NCT03369704|468249513|FG001|Treatment Epoch|technical problems|0|||
130080600|NCT03369704|468249512|FG000|Treatment Epoch|Protocol Violation|1|||
130080601|NCT03369704|468249513|FG001|Treatment Epoch|Protocol Violation|0|||
130080602|NCT03369704|468249512|FG000|Treatment Epoch|Lost to Follow-up|0|||
130080603|NCT03369704|468249513|FG001|Treatment Epoch|Lost to Follow-up|1|||
130080604|NCT03369704|468249512|FG000|Treatment Epoch|Lack of Efficacy|0|||
130080605|NCT03369704|468249513|FG001|Treatment Epoch|Lack of Efficacy|2|||
130080606|NCT03369704|468249512|FG000|Treatment Epoch|Adverse Event|2|||
130080607|NCT03369704|468249513|FG001|Treatment Epoch|Adverse Event|0|||
130080608|NCT03369704|468249512|FG000|Follow-up Epoch|Lost to Follow-up|1|||
130080609|NCT03369704|468249513|FG001|Follow-up Epoch|Lost to Follow-up|0|||
130080610|NCT02148952|468249517|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
130080611|NCT02148952|468249518|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
130080612|NCT02148952|468249517|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
130080613|NCT02148952|468249518|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
130080614|NCT02148952|468249517|FG000|Follow-Up|Lost to Follow-up|219|||
130080615|NCT02148952|468249518|FG001|Follow-Up|Lost to Follow-up|231|||
130080616|NCT02148952|468249517|FG000|Follow-Up|Withdrawal by Subject|46|||
130080617|NCT02148952|468249518|FG001|Follow-Up|Withdrawal by Subject|48|||
130080618|NCT01025232|468249519|FG000|Overall Study|Study drug no longer available|3|||
130080619|NCT01025232|468249520|FG001|Overall Study|Study drug no longer available|6|||
130080620|NCT02324049|468249522|FG000|Part C|Study terminated|11|||
130080621|NCT00423592|468249524|FG000|Overall Study|Adverse Event (through Week 12)|2|||
130080622|NCT00423592|468249524|FG000|Overall Study|Adverse Event (post Week 12)|5|||
130080623|NCT00149890|468249528|FG000|Overall Study|Adverse Event|1|||
130080624|NCT00149890|468249529|FG001|Overall Study|Adverse Event|8|||
130080625|NCT00149890|468249528|FG000|Overall Study|Lack of Efficacy|8|||
130080626|NCT00149890|468249529|FG001|Overall Study|Lack of Efficacy|9|||
130080627|NCT00149890|468249528|FG000|Overall Study|Protocol Violation|1|||
130080628|NCT00149890|468249529|FG001|Overall Study|Protocol Violation|0|||
130080629|NCT00149890|468249528|FG000|Overall Study|Lost to Follow-up|1|||
130080630|NCT00149890|468249529|FG001|Overall Study|Lost to Follow-up|0|||
130080631|NCT00149890|468249528|FG000|Overall Study|Graft Loss|2|||
130080632|NCT00149890|468249529|FG001|Overall Study|Graft Loss|1|||
130080633|NCT01894776|468249530|FG000|Overall Study|Withdrawal by Subject|1|||
130080634|NCT02485860|468249531|FG000|Overall Study|Lost to Follow-up|4|||
130080635|NCT02485860|468249532|FG001|Overall Study|Lost to Follow-up|1|||
130080636|NCT02485860|468249531|FG000|Overall Study|Physician Decision|1|||
130080637|NCT02485860|468249532|FG001|Overall Study|Physician Decision|2|||
130080638|NCT02485860|468249531|FG000|Overall Study|Health context (COVID-19)|1|||
130080639|NCT02485860|468249532|FG001|Overall Study|Health context (COVID-19)|0|||
130080640|NCT03325010|468249536|FG000|Overall Study|Adverse Event|3|||
130080641|NCT03325010|468249537|FG001|Overall Study|Adverse Event|8|||
130080642|NCT03325010|468249536|FG000|Overall Study|Protocol Violation|1|||
130080643|NCT03325010|468249537|FG001|Overall Study|Protocol Violation|8|||
130080644|NCT03325010|468249536|FG000|Overall Study|Withdrawal by Subject|1|||
130080645|NCT03325010|468249537|FG001|Overall Study|Withdrawal by Subject|3|||
130080646|NCT03325010|468249536|FG000|Overall Study|Lost to Follow-up|1|||
130080647|NCT03325010|468249537|FG001|Overall Study|Lost to Follow-up|0|||
130080648|NCT03325010|468249536|FG000|Overall Study|Physician Decision|1|||
130080649|NCT03325010|468249537|FG001|Overall Study|Physician Decision|1|||
130080650|NCT03325010|468249536|FG000|Overall Study|Lack of Efficacy|2|||
130080651|NCT03325010|468249537|FG001|Overall Study|Lack of Efficacy|0|||
129954129|NCT01730118|467793961|FG004|Dose Expansion|Inability to return|0|||
129954130|NCT01730118|467793962|FG005|Dose Expansion|Inability to return|1|||
129954131|NCT01730118|467793963|FG006|Dose Expansion|Inability to return|0|||
129954132|NCT01730118|467793957|FG000|Dose Expansion|Physician Decision|0|||
129954133|NCT01730118|467793958|FG001|Dose Expansion|Physician Decision|0|||
129954134|NCT01730118|467793959|FG002|Dose Expansion|Physician Decision|0|||
129954135|NCT01730118|467793960|FG003|Dose Expansion|Physician Decision|0|||
129954136|NCT01730118|467793961|FG004|Dose Expansion|Physician Decision|0|||
129954137|NCT01730118|467793962|FG005|Dose Expansion|Physician Decision|1|||
129954138|NCT01730118|467793963|FG006|Dose Expansion|Physician Decision|0|||
129954139|NCT00489489|467793965|FG000|Overall Study|Not treated due to protocol violation|0|||
129954140|NCT00489489|467793966|FG001|Overall Study|Not treated due to protocol violation|1|||
129954141|NCT00489489|467793967|FG002|Overall Study|Not treated due to protocol violation|1|||
129954142|NCT00489489|467793965|FG000|Overall Study|Adverse Event|1|||
129954143|NCT00489489|467793966|FG001|Overall Study|Adverse Event|1|||
129954144|NCT00489489|467793967|FG002|Overall Study|Adverse Event|1|||
129954145|NCT00489489|467793965|FG000|Overall Study|Protocol Violation|1|||
129954146|NCT00489489|467793966|FG001|Overall Study|Protocol Violation|0|||
129954147|NCT00489489|467793967|FG002|Overall Study|Protocol Violation|1|||
129954148|NCT00489489|467793965|FG000|Overall Study|Progressive disease|0|||
129954149|NCT00489489|467793966|FG001|Overall Study|Progressive disease|1|||
129954150|NCT00489489|467793967|FG002|Overall Study|Progressive disease|0|||
129954151|NCT00489489|467793965|FG000|Overall Study|Participant did not wish to continue|1|||
129954152|NCT00489489|467793966|FG001|Overall Study|Participant did not wish to continue|1|||
129954153|NCT00489489|467793967|FG002|Overall Study|Participant did not wish to continue|0|||
129954154|NCT00489489|467793965|FG000|Overall Study|Other than above|0|||
129954155|NCT00489489|467793966|FG001|Overall Study|Other than above|1|||
129954156|NCT00489489|467793967|FG002|Overall Study|Other than above|0|||
129954157|NCT04851587|467793970|FG000|Overall Study|Lost to Follow-up|18|||
129954158|NCT01350102|467793974|FG000|Overall Study|Adverse Event|0|||
129954159|NCT01350102|467793975|FG001|Overall Study|Adverse Event|0|||
129954160|NCT01350102|467793976|FG002|Overall Study|Adverse Event|1|||
129954161|NCT01350102|467793977|FG003|Overall Study|Adverse Event|0|||
129954162|NCT04523571|467793978|FG000|Received 2 Doses|Withdrawal by Subject|0|||
129954163|NCT04523571|467793979|FG001|Received 2 Doses|Withdrawal by Subject|0|||
129954164|NCT04523571|467793980|FG002|Received 2 Doses|Withdrawal by Subject|0|||
129954165|NCT04523571|467793981|FG003|Received 2 Doses|Withdrawal by Subject|1|||
129954166|NCT04523571|467793982|FG004|Received 2 Doses|Withdrawal by Subject|1|||
129954167|NCT04523571|467793983|FG005|Received 2 Doses|Withdrawal by Subject|0|||
129954168|NCT04523571|467793978|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
129954169|NCT04523571|467793979|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954170|NCT04523571|467793980|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
129954171|NCT04523571|467793981|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954172|NCT04523571|467793982|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954173|NCT04523571|467793983|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954174|NCT04523571|467793978|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954175|NCT04523571|467793979|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954176|NCT04523571|467793980|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
130080652|NCT03073200|468249542|FG000|Double Blind Treatment Period|Protocol Violation|1|||
130080653|NCT03073200|468249543|FG001|Double Blind Treatment Period|Protocol Violation|0|||
130080654|NCT03073200|468249544|FG002|Double Blind Treatment Period|Protocol Violation|0|||
130080655|NCT03073200|468249545|FG003|Double Blind Treatment Period|Protocol Violation|0|||
130080656|NCT03073200|468249546|FG004|Double Blind Treatment Period|Protocol Violation|0|||
129954177|NCT04523571|467793981|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954178|NCT04523571|467793982|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954179|NCT04523571|467793983|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
129954180|NCT04523571|467793978|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130080657|NCT03073200|468249547|FG005|Double Blind Treatment Period|Protocol Violation|0|||
130080658|NCT03073200|468249548|FG006|Double Blind Treatment Period|Protocol Violation|0|||
130080659|NCT03073200|468249549|FG007|Double Blind Treatment Period|Protocol Violation|0|||
130080660|NCT03073200|468249550|FG008|Double Blind Treatment Period|Protocol Violation|0|||
130080661|NCT03073200|468249551|FG009|Double Blind Treatment Period|Protocol Violation|0|||
130080662|NCT03073200|468249552|FG010|Double Blind Treatment Period|Protocol Violation|0|||
130080663|NCT03073200|468249553|FG011|Double Blind Treatment Period|Protocol Violation|0|||
130080664|NCT03073200|468249554|FG012|Double Blind Treatment Period|Protocol Violation|0|||
130080665|NCT03073200|468249555|FG013|Double Blind Treatment Period|Protocol Violation|0|||
130080666|NCT03073200|468249556|FG014|Double Blind Treatment Period|Protocol Violation|0|||
130080667|NCT03073200|468249542|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080668|NCT03073200|468249543|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
130080669|NCT03073200|468249544|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080670|NCT03073200|468249545|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080671|NCT03073200|468249546|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080672|NCT03073200|468249547|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080673|NCT03073200|468249548|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080674|NCT03073200|468249549|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080675|NCT03073200|468249550|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080676|NCT03073200|468249551|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080677|NCT03073200|468249552|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080678|NCT03073200|468249553|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080679|NCT03073200|468249554|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080680|NCT03073200|468249555|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080681|NCT03073200|468249556|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
130080682|NCT03073200|468249542|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
130080683|NCT03073200|468249543|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080684|NCT03073200|468249544|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080685|NCT03073200|468249545|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080686|NCT03073200|468249546|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080687|NCT03073200|468249547|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080688|NCT03073200|468249548|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080689|NCT03073200|468249549|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080690|NCT03073200|468249550|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080691|NCT03073200|468249551|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080692|NCT03073200|468249552|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080693|NCT03073200|468249553|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080694|NCT03073200|468249554|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080695|NCT03073200|468249555|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080696|NCT03073200|468249556|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
130080697|NCT03073200|468249542|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080698|NCT03073200|468249543|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080699|NCT03073200|468249544|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080700|NCT03073200|468249545|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
130080701|NCT03073200|468249546|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
130080702|NCT03073200|468249547|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080703|NCT03073200|468249548|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080704|NCT03073200|468249549|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080705|NCT03073200|468249550|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080706|NCT03073200|468249551|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080707|NCT03073200|468249552|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080708|NCT03073200|468249553|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080709|NCT03073200|468249554|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080710|NCT03073200|468249555|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080711|NCT03073200|468249556|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
130080712|NCT03073200|468249542|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
130080713|NCT03073200|468249543|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
130080714|NCT03073200|468249544|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
130080715|NCT03073200|468249545|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
130080716|NCT03073200|468249546|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
130080717|NCT03073200|468249547|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
130080718|NCT03073200|468249548|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
130080719|NCT03073200|468249549|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
130080720|NCT03073200|468249550|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
130080721|NCT03073200|468249551|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
129954181|NCT04523571|467793979|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130080722|NCT03073200|468249552|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
130080723|NCT03073200|468249553|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
130080724|NCT03073200|468249554|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
130080725|NCT03073200|468249555|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
130080726|NCT03073200|468249556|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
130080727|NCT03073200|468249542|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080728|NCT03073200|468249543|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080729|NCT03073200|468249544|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080730|NCT03073200|468249545|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080731|NCT03073200|468249546|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
130080732|NCT03073200|468249547|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080733|NCT03073200|468249548|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080734|NCT03073200|468249549|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080735|NCT03073200|468249550|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080736|NCT03073200|468249551|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080737|NCT03073200|468249552|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080738|NCT03073200|468249553|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080739|NCT03073200|468249554|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080740|NCT03073200|468249555|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080741|NCT03073200|468249556|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
130080742|NCT03073200|468249542|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080743|NCT03073200|468249543|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080744|NCT03073200|468249544|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080745|NCT03073200|468249545|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
130080746|NCT03073200|468249546|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
130080747|NCT03073200|468249547|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080748|NCT03073200|468249548|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080749|NCT03073200|468249549|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080750|NCT03073200|468249550|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080751|NCT03073200|468249551|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080752|NCT03073200|468249552|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080753|NCT03073200|468249553|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080754|NCT03073200|468249554|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080755|NCT03073200|468249555|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080756|NCT03073200|468249556|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
130080757|NCT03073200|468249542|FG000|Extension Period|Lost to Follow-up|0|||
130080758|NCT03073200|468249543|FG001|Extension Period|Lost to Follow-up|0|||
130080759|NCT03073200|468249544|FG002|Extension Period|Lost to Follow-up|0|||
130080760|NCT03073200|468249545|FG003|Extension Period|Lost to Follow-up|0|||
130080761|NCT03073200|468249546|FG004|Extension Period|Lost to Follow-up|0|||
130080762|NCT03073200|468249547|FG005|Extension Period|Lost to Follow-up|0|||
130080763|NCT03073200|468249548|FG006|Extension Period|Lost to Follow-up|1|||
130080764|NCT03073200|468249549|FG007|Extension Period|Lost to Follow-up|1|||
130080765|NCT03073200|468249550|FG008|Extension Period|Lost to Follow-up|0|||
130080766|NCT03073200|468249551|FG009|Extension Period|Lost to Follow-up|0|||
130080767|NCT03073200|468249552|FG010|Extension Period|Lost to Follow-up|0|||
130080768|NCT03073200|468249553|FG011|Extension Period|Lost to Follow-up|0|||
130080769|NCT03073200|468249554|FG012|Extension Period|Lost to Follow-up|0|||
130080770|NCT03073200|468249555|FG013|Extension Period|Lost to Follow-up|0|||
130080771|NCT03073200|468249556|FG014|Extension Period|Lost to Follow-up|0|||
130080772|NCT03073200|468249542|FG000|Extension Period|Sponsor Decision|0|||
130080773|NCT03073200|468249543|FG001|Extension Period|Sponsor Decision|0|||
130080774|NCT03073200|468249544|FG002|Extension Period|Sponsor Decision|0|||
130080775|NCT03073200|468249545|FG003|Extension Period|Sponsor Decision|0|||
130080776|NCT03073200|468249546|FG004|Extension Period|Sponsor Decision|0|||
130080777|NCT03073200|468249547|FG005|Extension Period|Sponsor Decision|0|||
130080778|NCT03073200|468249548|FG006|Extension Period|Sponsor Decision|0|||
130080779|NCT03073200|468249549|FG007|Extension Period|Sponsor Decision|0|||
130080780|NCT03073200|468249550|FG008|Extension Period|Sponsor Decision|1|||
130080781|NCT03073200|468249551|FG009|Extension Period|Sponsor Decision|0|||
130080782|NCT03073200|468249552|FG010|Extension Period|Sponsor Decision|0|||
130080783|NCT03073200|468249553|FG011|Extension Period|Sponsor Decision|0|||
130080784|NCT03073200|468249554|FG012|Extension Period|Sponsor Decision|0|||
130080785|NCT03073200|468249555|FG013|Extension Period|Sponsor Decision|0|||
130080786|NCT03073200|468249556|FG014|Extension Period|Sponsor Decision|0|||
130080787|NCT03073200|468249542|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
130080788|NCT03073200|468249543|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
130080789|NCT03073200|468249544|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
130080790|NCT03073200|468249545|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
130080791|NCT03073200|468249546|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
130080792|NCT03073200|468249547|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
130080793|NCT03073200|468249548|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
130080794|NCT03073200|468249549|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
130080795|NCT03073200|468249550|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
130080796|NCT03073200|468249551|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
130080797|NCT03073200|468249552|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
130080798|NCT03073200|468249553|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
130080799|NCT03073200|468249554|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
130080800|NCT03073200|468249555|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
130080801|NCT03073200|468249556|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
130080802|NCT03073200|468249542|FG000|Extension Period|Withdrawal by Subject|0|||
130080803|NCT03073200|468249543|FG001|Extension Period|Withdrawal by Subject|0|||
130080804|NCT03073200|468249544|FG002|Extension Period|Withdrawal by Subject|0|||
130080805|NCT03073200|468249545|FG003|Extension Period|Withdrawal by Subject|0|||
130080806|NCT03073200|468249546|FG004|Extension Period|Withdrawal by Subject|0|||
130080807|NCT03073200|468249547|FG005|Extension Period|Withdrawal by Subject|0|||
130080808|NCT03073200|468249548|FG006|Extension Period|Withdrawal by Subject|1|||
130080809|NCT03073200|468249549|FG007|Extension Period|Withdrawal by Subject|2|||
130080810|NCT03073200|468249550|FG008|Extension Period|Withdrawal by Subject|0|||
130080811|NCT03073200|468249551|FG009|Extension Period|Withdrawal by Subject|0|||
130080812|NCT03073200|468249552|FG010|Extension Period|Withdrawal by Subject|0|||
130080813|NCT03073200|468249553|FG011|Extension Period|Withdrawal by Subject|0|||
130080814|NCT03073200|468249554|FG012|Extension Period|Withdrawal by Subject|0|||
130080815|NCT03073200|468249555|FG013|Extension Period|Withdrawal by Subject|0|||
130080816|NCT03073200|468249556|FG014|Extension Period|Withdrawal by Subject|0|||
130080817|NCT03073200|468249542|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080818|NCT03073200|468249543|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080819|NCT03073200|468249544|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080820|NCT03073200|468249545|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080821|NCT03073200|468249546|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080822|NCT03073200|468249547|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080823|NCT03073200|468249548|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080824|NCT03073200|468249549|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080825|NCT03073200|468249550|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080826|NCT03073200|468249551|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080827|NCT03073200|468249552|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080828|NCT03073200|468249553|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
130080829|NCT03073200|468249554|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080830|NCT03073200|468249555|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080831|NCT03073200|468249556|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
130080832|NCT03073200|468249542|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080833|NCT03073200|468249543|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080834|NCT03073200|468249544|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080835|NCT03073200|468249545|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080836|NCT03073200|468249546|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080837|NCT03073200|468249547|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080838|NCT03073200|468249548|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080839|NCT03073200|468249549|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129954182|NCT04523571|467793980|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
130080840|NCT03073200|468249550|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080841|NCT03073200|468249551|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080842|NCT03073200|468249552|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080843|NCT03073200|468249553|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
130080844|NCT03073200|468249554|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080845|NCT03073200|468249555|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080846|NCT03073200|468249556|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
130080847|NCT03073200|468249542|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080848|NCT03073200|468249543|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080849|NCT03073200|468249544|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080850|NCT03073200|468249545|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080851|NCT03073200|468249546|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080852|NCT03073200|468249547|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080853|NCT03073200|468249548|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080854|NCT03073200|468249549|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080855|NCT03073200|468249550|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080856|NCT03073200|468249551|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080857|NCT03073200|468249552|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
130080858|NCT03073200|468249553|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
130080859|NCT03073200|468249554|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129954183|NCT04523571|467793981|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
129954184|NCT04523571|467793982|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
129954185|NCT04523571|467793983|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
129954186|NCT04385849|467793985|FG000|Overall Study|Lost to Follow-up|1|||
129954187|NCT04385849|467793986|FG001|Overall Study|Lost to Follow-up|0|||
129954188|NCT01375777|467793987|FG000|Overall Study|Withdrawal by Subject|0|||
129954189|NCT01375777|467793988|FG001|Overall Study|Withdrawal by Subject|2|||
129954190|NCT01375777|467793989|FG002|Overall Study|Withdrawal by Subject|1|||
129954191|NCT01375777|467793990|FG003|Overall Study|Withdrawal by Subject|0|||
129954192|NCT01375777|467793991|FG004|Overall Study|Withdrawal by Subject|1|||
129954193|NCT01375777|467793992|FG005|Overall Study|Withdrawal by Subject|1|||
129954194|NCT01375777|467793993|FG006|Overall Study|Withdrawal by Subject|1|||
129954195|NCT01375777|467793994|FG007|Overall Study|Withdrawal by Subject|2|||
129954196|NCT01375777|467793995|FG008|Overall Study|Withdrawal by Subject|1|||
129954197|NCT01375777|467793987|FG000|Overall Study|Lost to Follow-up|1|||
129954198|NCT01375777|467793988|FG001|Overall Study|Lost to Follow-up|0|||
129954199|NCT01375777|467793989|FG002|Overall Study|Lost to Follow-up|0|||
129954200|NCT01375777|467793990|FG003|Overall Study|Lost to Follow-up|0|||
129954201|NCT01375777|467793991|FG004|Overall Study|Lost to Follow-up|0|||
129954202|NCT01375777|467793992|FG005|Overall Study|Lost to Follow-up|0|||
129954203|NCT01375777|467793993|FG006|Overall Study|Lost to Follow-up|1|||
129954204|NCT01375777|467793994|FG007|Overall Study|Lost to Follow-up|0|||
129954205|NCT01375777|467793995|FG008|Overall Study|Lost to Follow-up|0|||
129954206|NCT01375777|467793987|FG000|Overall Study|Other|1|||
129954207|NCT01375777|467793988|FG001|Overall Study|Other|1|||
129954208|NCT01375777|467793989|FG002|Overall Study|Other|0|||
129954209|NCT01375777|467793990|FG003|Overall Study|Other|0|||
129954210|NCT01375777|467793991|FG004|Overall Study|Other|0|||
129954211|NCT01375777|467793992|FG005|Overall Study|Other|0|||
129954212|NCT01375777|467793993|FG006|Overall Study|Other|0|||
129954213|NCT01375777|467793994|FG007|Overall Study|Other|0|||
129954214|NCT01375777|467793995|FG008|Overall Study|Other|1|||
129954215|NCT05878990|467793996|FG000|Overall Study|Lost to Follow-up|7|||
129954216|NCT05878990|467793996|FG000|Overall Study|Withdrawal by Subject|1|||
129954217|NCT01838499|467793999|FG000|Overall Study|Protocol Violation|0|||
129954218|NCT01838499|467794000|FG001|Overall Study|Protocol Violation|1|||
129954219|NCT01838499|467793999|FG000|Overall Study|Lost to Follow-up|2|||
129954220|NCT01838499|467794000|FG001|Overall Study|Lost to Follow-up|4|||
129954221|NCT01838499|467793999|FG000|Overall Study|Lack of Efficacy|1|||
129954222|NCT01838499|467794000|FG001|Overall Study|Lack of Efficacy|2|||
129954223|NCT01838499|467793999|FG000|Overall Study|Adverse Event|2|||
129954224|NCT01838499|467794000|FG001|Overall Study|Adverse Event|1|||
129954225|NCT01838499|467793999|FG000|Overall Study|Withdrawal by Subject|19|||
129954226|NCT01838499|467794000|FG001|Overall Study|Withdrawal by Subject|9|||
129954227|NCT01136733|467794001|FG000|Phase 1b|Adverse Event|0|||
129954228|NCT01136733|467794002|FG001|Phase 1b|Adverse Event|3|||
129954229|NCT01136733|467794003|FG002|Phase 1b|Adverse Event|1|||
129954230|NCT01136733|467794004|FG003|Phase 1b|Adverse Event|0|||
129954231|NCT01136733|467794005|FG004|Phase 1b|Adverse Event|0|||
129954232|NCT01136733|467794006|FG005|Phase 1b|Adverse Event|0|||
129954233|NCT01136733|467794007|FG006|Phase 1b|Adverse Event|0|||
129954234|NCT01136733|467794001|FG000|Phase 1b|Participant Choice|0|||
129954235|NCT01136733|467794002|FG001|Phase 1b|Participant Choice|0|||
129954236|NCT01136733|467794003|FG002|Phase 1b|Participant Choice|1|||
129954237|NCT01136733|467794004|FG003|Phase 1b|Participant Choice|0|||
129954238|NCT01136733|467794005|FG004|Phase 1b|Participant Choice|0|||
129954239|NCT01136733|467794006|FG005|Phase 1b|Participant Choice|0|||
129954240|NCT01136733|467794007|FG006|Phase 1b|Participant Choice|0|||
129954241|NCT01136733|467794001|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
129954242|NCT01136733|467794002|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
129954243|NCT01136733|467794003|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
129954244|NCT01136733|467794004|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
129954245|NCT01136733|467794005|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
129954246|NCT01136733|467794006|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
129954247|NCT01136733|467794007|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
129954248|NCT01136733|467794001|FG000|Phase 1b|Clinical Progression|1|||
129954249|NCT01136733|467794002|FG001|Phase 1b|Clinical Progression|1|||
129954250|NCT01136733|467794003|FG002|Phase 1b|Clinical Progression|0|||
129954251|NCT01136733|467794004|FG003|Phase 1b|Clinical Progression|0|||
129954252|NCT01136733|467794005|FG004|Phase 1b|Clinical Progression|0|||
129954253|NCT01136733|467794006|FG005|Phase 1b|Clinical Progression|0|||
129954254|NCT01136733|467794007|FG006|Phase 1b|Clinical Progression|0|||
129954255|NCT01136733|467794001|FG000|Phase 2|Disease Progression|0|||
129954256|NCT01136733|467794002|FG001|Phase 2|Disease Progression|0|||
129954257|NCT01136733|467794003|FG002|Phase 2|Disease Progression|0|||
129954258|NCT01136733|467794004|FG003|Phase 2|Disease Progression|0|||
129954259|NCT01136733|467794005|FG004|Phase 2|Disease Progression|30|||
129954260|NCT01136733|467794006|FG005|Phase 2|Disease Progression|32|||
129954261|NCT01136733|467794007|FG006|Phase 2|Disease Progression|38|||
129954262|NCT01136733|467794001|FG000|Phase 2|Adverse Event|0|||
130080860|NCT03073200|468249555|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080861|NCT03073200|468249556|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
130080862|NCT03073200|468249542|FG000|Randomized Withdrawal Period|Adverse Event|0|||
130080863|NCT03073200|468249543|FG001|Randomized Withdrawal Period|Adverse Event|0|||
130080864|NCT03073200|468249544|FG002|Randomized Withdrawal Period|Adverse Event|0|||
130080865|NCT03073200|468249545|FG003|Randomized Withdrawal Period|Adverse Event|0|||
130080866|NCT03073200|468249546|FG004|Randomized Withdrawal Period|Adverse Event|0|||
130080867|NCT03073200|468249547|FG005|Randomized Withdrawal Period|Adverse Event|0|||
130080868|NCT03073200|468249548|FG006|Randomized Withdrawal Period|Adverse Event|0|||
130080869|NCT03073200|468249549|FG007|Randomized Withdrawal Period|Adverse Event|0|||
130080870|NCT03073200|468249550|FG008|Randomized Withdrawal Period|Adverse Event|0|||
130080871|NCT03073200|468249551|FG009|Randomized Withdrawal Period|Adverse Event|0|||
130080872|NCT03073200|468249552|FG010|Randomized Withdrawal Period|Adverse Event|1|||
130080873|NCT03073200|468249553|FG011|Randomized Withdrawal Period|Adverse Event|0|||
130080874|NCT03073200|468249554|FG012|Randomized Withdrawal Period|Adverse Event|0|||
130080875|NCT03073200|468249555|FG013|Randomized Withdrawal Period|Adverse Event|0|||
130080876|NCT03073200|468249556|FG014|Randomized Withdrawal Period|Adverse Event|0|||
130080877|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080878|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080879|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080880|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080881|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080882|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080883|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080884|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080885|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080886|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080887|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080888|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080889|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080890|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
130080891|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
130080892|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080893|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080894|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080895|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080896|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080897|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080898|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080899|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080900|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080901|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080902|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080903|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080904|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080905|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130080906|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130080907|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080908|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080909|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080910|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080911|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080912|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080913|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080914|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080915|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080916|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080917|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080918|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080919|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080920|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
130080921|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
130080922|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080923|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080924|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080925|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080926|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130120929|NCT01265784|468404865|FG001|Overall Study|Lost to Follow-up|3|||
130080927|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080928|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080929|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080930|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080931|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080932|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080933|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080934|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080935|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
130080936|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130080937|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080938|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080939|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080940|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080941|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080942|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080943|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080944|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080945|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080946|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080947|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080948|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080949|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080950|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
130080951|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
130080952|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080953|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080954|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080955|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080956|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080957|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080958|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080959|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080960|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080961|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080962|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080963|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080964|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080965|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
130080966|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
130080967|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080968|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080969|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080970|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080971|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080972|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080973|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080974|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080975|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080976|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080977|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080978|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080979|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080980|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
130080981|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130080982|NCT03073200|468249542|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080983|NCT03073200|468249543|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080984|NCT03073200|468249544|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080985|NCT03073200|468249545|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080986|NCT03073200|468249546|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080987|NCT03073200|468249547|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080988|NCT03073200|468249548|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080989|NCT03073200|468249549|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129954263|NCT01136733|467794002|FG001|Phase 2|Adverse Event|0|||
129954264|NCT01136733|467794003|FG002|Phase 2|Adverse Event|0|||
129954265|NCT01136733|467794004|FG003|Phase 2|Adverse Event|0|||
129954266|NCT01136733|467794005|FG004|Phase 2|Adverse Event|11|||
129954267|NCT01136733|467794006|FG005|Phase 2|Adverse Event|13|||
129954268|NCT01136733|467794007|FG006|Phase 2|Adverse Event|5|||
129954269|NCT01136733|467794001|FG000|Phase 2|Participant Choice|0|||
129954270|NCT01136733|467794002|FG001|Phase 2|Participant Choice|0|||
129954271|NCT01136733|467794003|FG002|Phase 2|Participant Choice|0|||
129954272|NCT01136733|467794004|FG003|Phase 2|Participant Choice|0|||
129954273|NCT01136733|467794005|FG004|Phase 2|Participant Choice|3|||
129954274|NCT01136733|467794006|FG005|Phase 2|Participant Choice|0|||
129954275|NCT01136733|467794007|FG006|Phase 2|Participant Choice|1|||
129954276|NCT01136733|467794001|FG000|Phase 2|Administrative-Withdrew Consent|0|||
129954277|NCT01136733|467794002|FG001|Phase 2|Administrative-Withdrew Consent|0|||
129954278|NCT01136733|467794003|FG002|Phase 2|Administrative-Withdrew Consent|0|||
129954279|NCT01136733|467794004|FG003|Phase 2|Administrative-Withdrew Consent|0|||
129954280|NCT01136733|467794005|FG004|Phase 2|Administrative-Withdrew Consent|1|||
129954281|NCT01136733|467794006|FG005|Phase 2|Administrative-Withdrew Consent|0|||
129954282|NCT01136733|467794007|FG006|Phase 2|Administrative-Withdrew Consent|0|||
129954283|NCT01136733|467794001|FG000|Phase 2|Other|0|||
129954284|NCT01136733|467794002|FG001|Phase 2|Other|0|||
130080990|NCT03073200|468249550|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130120930|NCT01265784|468404866|FG002|Overall Study|Lost to Follow-up|2|||
130120931|NCT01265784|468404864|FG000|Overall Study|Withdrawal by Subject|0|||
130120932|NCT01265784|468404865|FG001|Overall Study|Withdrawal by Subject|5|||
130120933|NCT01265784|468404866|FG002|Overall Study|Withdrawal by Subject|0|||
130120934|NCT01265784|468404864|FG000|Overall Study|Physician Decision|1|||
130080991|NCT03073200|468249551|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080992|NCT03073200|468249552|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080993|NCT03073200|468249553|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080994|NCT03073200|468249554|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080995|NCT03073200|468249555|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
130080996|NCT03073200|468249556|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
130080997|NCT05116683|468249559|FG000|Overall Study|Physician Decision|4|||
130080998|NCT01474889|468249561|FG000|Overall Study|Physician Decision|1|||
130080999|NCT01474889|468249562|FG001|Overall Study|Physician Decision|0|||
130081000|NCT01474889|468249563|FG002|Overall Study|Physician Decision|0|||
130081001|NCT01474889|468249561|FG000|Overall Study|Did not meet inclusion|1|||
130081002|NCT01474889|468249562|FG001|Overall Study|Did not meet inclusion|0|||
130081003|NCT01474889|468249563|FG002|Overall Study|Did not meet inclusion|0|||
130081004|NCT01474889|468249561|FG000|Overall Study|Withdrawal by Subject|0|||
130081005|NCT01474889|468249562|FG001|Overall Study|Withdrawal by Subject|1|||
130081006|NCT01474889|468249563|FG002|Overall Study|Withdrawal by Subject|0|||
130081007|NCT03935594|468249567|FG000|Overall Study|Physician Decision|3|||
130081008|NCT01435122|468249568|FG000|Overall Study|Early withdrawal due to toxicity|8|||
130081009|NCT03954704|468249569|FG000|Overall Study|Death|1|||
130081010|NCT03954704|468249570|FG001|Overall Study|Death|1|||
130081011|NCT03954704|468249571|FG002|Overall Study|Death|1|||
130081012|NCT03954704|468249572|FG003|Overall Study|Death|3|||
130081013|NCT03954704|468249573|FG004|Overall Study|Death|2|||
130081014|NCT03954704|468249574|FG005|Overall Study|Death|2|||
130120935|NCT01265784|468404865|FG001|Overall Study|Physician Decision|0|||
130120936|NCT01265784|468404866|FG002|Overall Study|Physician Decision|1|||
130081015|NCT03954704|468249575|FG006|Overall Study|Death|0|||
130081016|NCT03954704|468249569|FG000|Overall Study|Withdrew Consent|0|||
130081017|NCT03954704|468249570|FG001|Overall Study|Withdrew Consent|0|||
130081018|NCT03954704|468249571|FG002|Overall Study|Withdrew Consent|1|||
130081019|NCT03954704|468249572|FG003|Overall Study|Withdrew Consent|0|||
130081020|NCT03954704|468249573|FG004|Overall Study|Withdrew Consent|0|||
130081021|NCT03954704|468249574|FG005|Overall Study|Withdrew Consent|1|||
130081022|NCT03954704|468249575|FG006|Overall Study|Withdrew Consent|0|||
130081023|NCT03954704|468249569|FG000|Overall Study|Lost to Follow-up|0|||
130081024|NCT03954704|468249570|FG001|Overall Study|Lost to Follow-up|0|||
130081025|NCT03954704|468249571|FG002|Overall Study|Lost to Follow-up|0|||
130120937|NCT01265784|468404864|FG000|Overall Study|Adverse Event|1|||
130081026|NCT03954704|468249572|FG003|Overall Study|Lost to Follow-up|0|||
130120938|NCT01265784|468404865|FG001|Overall Study|Adverse Event|0|||
129954285|NCT01136733|467794003|FG002|Phase 2|Other|0|||
129954286|NCT01136733|467794004|FG003|Phase 2|Other|0|||
129954287|NCT01136733|467794005|FG004|Phase 2|Other|6|||
129954288|NCT01136733|467794006|FG005|Phase 2|Other|7|||
129954289|NCT01136733|467794007|FG006|Phase 2|Other|6|||
129954290|NCT03360071|467794009|FG000|Overall Study|Lost to Follow-up|1|||
129954291|NCT03360071|467794010|FG001|Overall Study|Lost to Follow-up|0|||
129954292|NCT01193283|467794014|FG000|Overall Study|Death|1|||
129954293|NCT03314233|467794020|FG000|Overall Study|No longer eligible at time of delivery|1|||
129954294|NCT00168805|467794022|FG000|Overall Study|Adverse Event|7|||
129954295|NCT00168805|467794023|FG001|Overall Study|Adverse Event|11|||
130081027|NCT03954704|468249573|FG004|Overall Study|Lost to Follow-up|0|||
130081028|NCT03954704|468249574|FG005|Overall Study|Lost to Follow-up|0|||
130081029|NCT03954704|468249575|FG006|Overall Study|Lost to Follow-up|1|||
130081030|NCT03954704|468249569|FG000|Overall Study|Study Terminated by Sponsor|0|||
130081031|NCT03954704|468249570|FG001|Overall Study|Study Terminated by Sponsor|0|||
130081032|NCT03954704|468249571|FG002|Overall Study|Study Terminated by Sponsor|1|||
130081033|NCT03954704|468249572|FG003|Overall Study|Study Terminated by Sponsor|0|||
130081034|NCT03954704|468249573|FG004|Overall Study|Study Terminated by Sponsor|1|||
130081035|NCT03954704|468249574|FG005|Overall Study|Study Terminated by Sponsor|4|||
129954296|NCT00168805|467794024|FG002|Overall Study|Adverse Event|16|||
129954297|NCT00168805|467794022|FG000|Overall Study|Protocol Violation|12|||
130081036|NCT03954704|468249575|FG006|Overall Study|Study Terminated by Sponsor|2|||
130081037|NCT03954704|468249569|FG000|Overall Study|Enrolled but not Treated|0|||
130081038|NCT03954704|468249570|FG001|Overall Study|Enrolled but not Treated|0|||
130081039|NCT03954704|468249571|FG002|Overall Study|Enrolled but not Treated|0|||
130081040|NCT03954704|468249572|FG003|Overall Study|Enrolled but not Treated|0|||
130081041|NCT03954704|468249573|FG004|Overall Study|Enrolled but not Treated|0|||
130081042|NCT03954704|468249574|FG005|Overall Study|Enrolled but not Treated|1|||
130081043|NCT03954704|468249575|FG006|Overall Study|Enrolled but not Treated|0|||
130081044|NCT04412668|468249576|FG000|Overall Study|Death - multiple comorbidities|2|||
130081045|NCT04412668|468249577|FG001|Overall Study|Death - multiple comorbidities|0|||
129954298|NCT00168805|467794023|FG001|Overall Study|Protocol Violation|11|||
129954299|NCT00168805|467794024|FG002|Overall Study|Protocol Violation|8|||
129954300|NCT00168805|467794022|FG000|Overall Study|Lost to Follow-up|12|||
129954301|NCT00168805|467794023|FG001|Overall Study|Lost to Follow-up|17|||
129954302|NCT00168805|467794024|FG002|Overall Study|Lost to Follow-up|11|||
129954303|NCT00168805|467794022|FG000|Overall Study|Withdrawal by Subject|16|||
129954304|NCT00168805|467794023|FG001|Overall Study|Withdrawal by Subject|18|||
129954305|NCT00168805|467794024|FG002|Overall Study|Withdrawal by Subject|21|||
129954306|NCT00168805|467794022|FG000|Overall Study|Other|24|||
129954307|NCT00168805|467794023|FG001|Overall Study|Other|21|||
129954308|NCT00168805|467794024|FG002|Overall Study|Other|22|||
129954309|NCT00168805|467794022|FG000|Treatment|Adverse Event|25|||
129954310|NCT00168805|467794023|FG001|Treatment|Adverse Event|26|||
129954311|NCT00168805|467794024|FG002|Treatment|Adverse Event|32|||
129954312|NCT00168805|467794022|FG000|Treatment|Protocol Violation|3|||
129954313|NCT00168805|467794023|FG001|Treatment|Protocol Violation|5|||
129954314|NCT00168805|467794024|FG002|Treatment|Protocol Violation|5|||
129954315|NCT00168805|467794022|FG000|Treatment|Withdrawal by Subject|3|||
129954316|NCT00168805|467794023|FG001|Treatment|Withdrawal by Subject|7|||
129954317|NCT00168805|467794024|FG002|Treatment|Withdrawal by Subject|8|||
129954318|NCT00168805|467794022|FG000|Treatment|Other|18|||
129954319|NCT00168805|467794023|FG001|Treatment|Other|18|||
129954320|NCT00168805|467794024|FG002|Treatment|Other|17|||
129954321|NCT01114217|467794025|FG000|Overall Study|Adverse Event|5|||
129954322|NCT01114217|467794026|FG001|Overall Study|Adverse Event|3|||
129954323|NCT01114217|467794025|FG000|Overall Study|Lost to Follow-up|17|||
129954324|NCT01114217|467794026|FG001|Overall Study|Lost to Follow-up|33|||
129954325|NCT01114217|467794025|FG000|Overall Study|Withdrawal by Subject|21|||
129954326|NCT01114217|467794026|FG001|Overall Study|Withdrawal by Subject|28|||
129954327|NCT01114217|467794025|FG000|Overall Study|Other-Clerical Error|3|||
129954328|NCT01114217|467794026|FG001|Overall Study|Other-Clerical Error|0|||
129954329|NCT01114217|467794025|FG000|Overall Study|Other-Early termination|6|||
130081046|NCT04412668|468249578|FG002|Overall Study|Death - multiple comorbidities|0|||
130081047|NCT04412668|468249576|FG000|Overall Study|Withdrawal by Subject|3|||
130081048|NCT04412668|468249577|FG001|Overall Study|Withdrawal by Subject|0|||
130081049|NCT04412668|468249578|FG002|Overall Study|Withdrawal by Subject|0|||
130081050|NCT04412668|468249576|FG000|Overall Study|Other than Specified|2|||
130081051|NCT04412668|468249577|FG001|Overall Study|Other than Specified|0|||
130081052|NCT04412668|468249578|FG002|Overall Study|Other than Specified|0|||
130081053|NCT03695471|468251694|FG000|Overall Study|Cancellation|1|||
130081054|NCT02859558|468251695|FG000|Step 1|Not Eligible|0|||
130081055|NCT02859558|468251696|FG001|Step 1|Not Eligible|0|||
129954330|NCT01114217|467794026|FG001|Overall Study|Other-Early termination|10|||
129954331|NCT01114217|467794025|FG000|Overall Study|Other-Procedure|1|||
129954332|NCT01114217|467794026|FG001|Overall Study|Other-Procedure|1|||
129954333|NCT01114217|467794025|FG000|Overall Study|Other-Pregnancy|2|||
129954334|NCT01114217|467794026|FG001|Overall Study|Other-Pregnancy|4|||
129954335|NCT01114217|467794025|FG000|Overall Study|Other-Protocol Violation|1|||
129954336|NCT01114217|467794026|FG001|Overall Study|Other-Protocol Violation|3|||
129954337|NCT01114217|467794025|FG000|Overall Study|Other-Lack of Efficacy|1|||
129954338|NCT01114217|467794026|FG001|Overall Study|Other-Lack of Efficacy|0|||
129954339|NCT01114217|467794025|FG000|Overall Study|Other-Non Compliance|2|||
129954340|NCT01114217|467794026|FG001|Overall Study|Other-Non Compliance|0|||
129954341|NCT01114217|467794025|FG000|Overall Study|Other-Physician Decision|1|||
129954342|NCT01114217|467794026|FG001|Overall Study|Other-Physician Decision|1|||
129954343|NCT01114217|467794025|FG000|Overall Study|Other-Sponsor Decision|10|||
129954344|NCT01114217|467794026|FG001|Overall Study|Other-Sponsor Decision|12|||
129954345|NCT01114217|467794025|FG000|Overall Study|Other-Study Termination|0|||
130081056|NCT02859558|468251697|FG002|Step 1|Not Eligible|0|||
130081057|NCT02859558|468251698|FG003|Step 1|Not Eligible|0|||
130081058|NCT02859558|468251699|FG004|Step 1|Not Eligible|3|||
130081059|NCT02859558|468251695|FG000|Step 1|Lost to Follow-up|1|||
130081060|NCT02859558|468251696|FG001|Step 1|Lost to Follow-up|3|||
130081061|NCT02859558|468251697|FG002|Step 1|Lost to Follow-up|3|||
130081062|NCT02859558|468251698|FG003|Step 1|Lost to Follow-up|0|||
130081063|NCT02859558|468251699|FG004|Step 1|Lost to Follow-up|0|||
130081064|NCT02859558|468251695|FG000|Step 1|Did Not Return to Clinic|2|||
130081065|NCT02859558|468251696|FG001|Step 1|Did Not Return to Clinic|3|||
130081066|NCT02859558|468251697|FG002|Step 1|Did Not Return to Clinic|4|||
130081067|NCT02859558|468251698|FG003|Step 1|Did Not Return to Clinic|0|||
130081068|NCT02859558|468251699|FG004|Step 1|Did Not Return to Clinic|0|||
130081069|NCT02859558|468251695|FG000|Step 1|Moved|0|||
130081070|NCT02859558|468251696|FG001|Step 1|Moved|1|||
130081071|NCT02859558|468251697|FG002|Step 1|Moved|1|||
130081072|NCT02859558|468251698|FG003|Step 1|Moved|0|||
130081073|NCT02859558|468251699|FG004|Step 1|Moved|0|||
130081074|NCT02859558|468251695|FG000|Step 1|Withdrawal By Participant|1|||
130081075|NCT02859558|468251696|FG001|Step 1|Withdrawal By Participant|2|||
130081076|NCT02859558|468251697|FG002|Step 1|Withdrawal By Participant|1|||
130081077|NCT02859558|468251698|FG003|Step 1|Withdrawal By Participant|0|||
130081078|NCT02859558|468251699|FG004|Step 1|Withdrawal By Participant|0|||
130081079|NCT02859558|468251695|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
130081080|NCT02859558|468251696|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130081081|NCT02859558|468251697|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130081082|NCT02859558|468251698|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130081083|NCT02859558|468251699|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
130081084|NCT02859558|468251695|FG000|Step 1|Incarceration|0|||
130081085|NCT02859558|468251696|FG001|Step 1|Incarceration|1|||
130081086|NCT02859558|468251697|FG002|Step 1|Incarceration|0|||
130081087|NCT02859558|468251698|FG003|Step 1|Incarceration|0|||
130081088|NCT02859558|468251699|FG004|Step 1|Incarceration|0|||
130081089|NCT02859558|468251695|FG000|Step 1|Non-Adherence to Study Drug|2|||
130081090|NCT02859558|468251696|FG001|Step 1|Non-Adherence to Study Drug|0|||
130081091|NCT02859558|468251697|FG002|Step 1|Non-Adherence to Study Drug|1|||
130081092|NCT02859558|468251698|FG003|Step 1|Non-Adherence to Study Drug|0|||
130081093|NCT02859558|468251699|FG004|Step 1|Non-Adherence to Study Drug|0|||
130081094|NCT02859558|468251695|FG000|Step 1|Non-Adherence to Study Requirements|3|||
130081095|NCT02859558|468251696|FG001|Step 1|Non-Adherence to Study Requirements|1|||
130081096|NCT02859558|468251697|FG002|Step 1|Non-Adherence to Study Requirements|0|||
130081097|NCT02859558|468251698|FG003|Step 1|Non-Adherence to Study Requirements|0|||
130081098|NCT02859558|468251699|FG004|Step 1|Non-Adherence to Study Requirements|0|||
130081099|NCT02859558|468251695|FG000|Step 1|Virologic Failure|2|||
130081100|NCT02859558|468251696|FG001|Step 1|Virologic Failure|1|||
130081101|NCT02859558|468251697|FG002|Step 1|Virologic Failure|1|||
130081102|NCT02859558|468251698|FG003|Step 1|Virologic Failure|0|||
130081103|NCT02859558|468251699|FG004|Step 1|Virologic Failure|0|||
130081104|NCT02859558|468251695|FG000|Step 2|Lost to Follow-up|3|||
130081105|NCT02859558|468251696|FG001|Step 2|Lost to Follow-up|3|||
130081106|NCT02859558|468251697|FG002|Step 2|Lost to Follow-up|1|||
130081107|NCT02859558|468251698|FG003|Step 2|Lost to Follow-up|0|||
130081108|NCT02859558|468251699|FG004|Step 2|Lost to Follow-up|0|||
130081109|NCT02859558|468251695|FG000|Step 2|Withdrawal by Subject|0|||
130081110|NCT02859558|468251696|FG001|Step 2|Withdrawal by Subject|1|||
130081111|NCT02859558|468251697|FG002|Step 2|Withdrawal by Subject|1|||
130081112|NCT02859558|468251698|FG003|Step 2|Withdrawal by Subject|0|||
130081113|NCT02859558|468251699|FG004|Step 2|Withdrawal by Subject|0|||
130081114|NCT02859558|468251695|FG000|Step 2|Unexpected Closure of Site|0|||
130081115|NCT02859558|468251696|FG001|Step 2|Unexpected Closure of Site|1|||
130081116|NCT02859558|468251697|FG002|Step 2|Unexpected Closure of Site|1|||
130081117|NCT02859558|468251698|FG003|Step 2|Unexpected Closure of Site|0|||
130081118|NCT02859558|468251699|FG004|Step 2|Unexpected Closure of Site|0|||
130081119|NCT02859558|468251695|FG000|Step 2|Death|1|||
130081120|NCT02859558|468251696|FG001|Step 2|Death|0|||
130081121|NCT02859558|468251697|FG002|Step 2|Death|0|||
129954346|NCT01114217|467794026|FG001|Overall Study|Other-Study Termination|1|||
130081122|NCT02859558|468251698|FG003|Step 2|Death|0|||
130081123|NCT02859558|468251699|FG004|Step 2|Death|0|||
130081124|NCT02859558|468251695|FG000|Step 2|Incarceration|0|||
130081125|NCT02859558|468251696|FG001|Step 2|Incarceration|0|||
130081126|NCT02859558|468251697|FG002|Step 2|Incarceration|1|||
130081127|NCT02859558|468251698|FG003|Step 2|Incarceration|0|||
130081128|NCT02859558|468251699|FG004|Step 2|Incarceration|0|||
130081129|NCT05665595|468251700|FG000|Overall Study|Ongoing|692|||
130081130|NCT05665595|468251701|FG001|Overall Study|Ongoing|698|||
130081131|NCT05665595|468251700|FG000|Overall Study|Withdrawal by Subject|2|||
130081132|NCT05665595|468251701|FG001|Overall Study|Withdrawal by Subject|2|||
130081133|NCT05665595|468251700|FG000|Overall Study|Lost to Follow-up|1|||
130081134|NCT05665595|468251701|FG001|Overall Study|Lost to Follow-up|0|||
130081135|NCT05665595|468251700|FG000|Overall Study|Death|6|||
130081136|NCT05665595|468251701|FG001|Overall Study|Death|1|||
130081137|NCT00766142|468251702|FG000|Overall Study|Protocol Violation|4|||
130081138|NCT02358863|468251712|FG000|Overall Study|Physician Decision|3|||
130081139|NCT02531633|468251723|FG000|Part A (52 Weeks)|Sponsor request|24|||
130081140|NCT02531633|468251724|FG001|Part A (52 Weeks)|Sponsor request|24|||
130081141|NCT02531633|468251725|FG002|Part A (52 Weeks)|Sponsor request|18|||
130081142|NCT02531633|468251726|FG003|Part A (52 Weeks)|Sponsor request|18|||
130081143|NCT02531633|468251727|FG004|Part A (52 Weeks)|Sponsor request|19|||
130081144|NCT02531633|468251728|FG005|Part A (52 Weeks)|Sponsor request|0|||
130081145|NCT02531633|468251729|FG006|Part A (52 Weeks)|Sponsor request|0|||
130081146|NCT02531633|468251730|FG007|Part A (52 Weeks)|Sponsor request|0|||
130081147|NCT02531633|468251731|FG008|Part A (52 Weeks)|Sponsor request|0|||
130081148|NCT02531633|468251732|FG009|Part A (52 Weeks)|Sponsor request|0|||
130081149|NCT02531633|468251723|FG000|Part A (52 Weeks)|Protocol Violation|1|||
130081150|NCT02531633|468251724|FG001|Part A (52 Weeks)|Protocol Violation|0|||
130081151|NCT02531633|468251725|FG002|Part A (52 Weeks)|Protocol Violation|0|||
130081152|NCT02531633|468251726|FG003|Part A (52 Weeks)|Protocol Violation|0|||
130081153|NCT02531633|468251727|FG004|Part A (52 Weeks)|Protocol Violation|0|||
130081154|NCT02531633|468251728|FG005|Part A (52 Weeks)|Protocol Violation|0|||
130081155|NCT02531633|468251729|FG006|Part A (52 Weeks)|Protocol Violation|0|||
130081156|NCT02531633|468251730|FG007|Part A (52 Weeks)|Protocol Violation|0|||
130081157|NCT02531633|468251731|FG008|Part A (52 Weeks)|Protocol Violation|0|||
130081158|NCT02531633|468251732|FG009|Part A (52 Weeks)|Protocol Violation|0|||
130081159|NCT02531633|468251723|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
130081160|NCT02531633|468251724|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
130081161|NCT02531633|468251725|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
130081162|NCT02531633|468251726|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
130081163|NCT02531633|468251727|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
130081164|NCT02531633|468251728|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
130081165|NCT02531633|468251729|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
130081166|NCT02531633|468251730|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
130081167|NCT02531633|468251731|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
130081168|NCT02531633|468251732|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
130081169|NCT02531633|468251723|FG000|Part A (52 Weeks)|Physician Decision|1|||
130081170|NCT02531633|468251724|FG001|Part A (52 Weeks)|Physician Decision|4|||
130081171|NCT02531633|468251725|FG002|Part A (52 Weeks)|Physician Decision|3|||
130081172|NCT02531633|468251726|FG003|Part A (52 Weeks)|Physician Decision|1|||
130081173|NCT02531633|468251727|FG004|Part A (52 Weeks)|Physician Decision|0|||
130081174|NCT02531633|468251728|FG005|Part A (52 Weeks)|Physician Decision|0|||
130081175|NCT02531633|468251729|FG006|Part A (52 Weeks)|Physician Decision|0|||
130081176|NCT02531633|468251730|FG007|Part A (52 Weeks)|Physician Decision|0|||
130081177|NCT02531633|468251731|FG008|Part A (52 Weeks)|Physician Decision|0|||
130081178|NCT02531633|468251732|FG009|Part A (52 Weeks)|Physician Decision|0|||
130081179|NCT02531633|468251723|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
130081180|NCT02531633|468251724|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
130081181|NCT02531633|468251725|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
130081182|NCT02531633|468251726|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
130081183|NCT02531633|468251727|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
130081184|NCT02531633|468251728|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
130081185|NCT02531633|468251729|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
130081186|NCT02531633|468251730|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
130081187|NCT02531633|468251731|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
130081188|NCT02531633|468251732|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
130081189|NCT02531633|468251723|FG000|Part A (52 Weeks)|Other|2|||
130081190|NCT02531633|468251724|FG001|Part A (52 Weeks)|Other|0|||
130081191|NCT02531633|468251725|FG002|Part A (52 Weeks)|Other|0|||
130081192|NCT02531633|468251726|FG003|Part A (52 Weeks)|Other|0|||
130081193|NCT02531633|468251727|FG004|Part A (52 Weeks)|Other|0|||
130081194|NCT02531633|468251728|FG005|Part A (52 Weeks)|Other|0|||
130081195|NCT02531633|468251729|FG006|Part A (52 Weeks)|Other|0|||
130081196|NCT02531633|468251730|FG007|Part A (52 Weeks)|Other|0|||
130081197|NCT02531633|468251731|FG008|Part A (52 Weeks)|Other|0|||
130081198|NCT02531633|468251732|FG009|Part A (52 Weeks)|Other|0|||
130081199|NCT02531633|468251723|FG000|Part B (104 Weeks)|Sponsor request|0|||
130081200|NCT02531633|468251724|FG001|Part B (104 Weeks)|Sponsor request|0|||
130081201|NCT02531633|468251725|FG002|Part B (104 Weeks)|Sponsor request|0|||
130081202|NCT02531633|468251726|FG003|Part B (104 Weeks)|Sponsor request|0|||
130081203|NCT02531633|468251727|FG004|Part B (104 Weeks)|Sponsor request|0|||
130081204|NCT02531633|468251728|FG005|Part B (104 Weeks)|Sponsor request|8|||
130081205|NCT02531633|468251729|FG006|Part B (104 Weeks)|Sponsor request|5|||
130081206|NCT02531633|468251730|FG007|Part B (104 Weeks)|Sponsor request|3|||
130081207|NCT02531633|468251731|FG008|Part B (104 Weeks)|Sponsor request|5|||
130081208|NCT02531633|468251732|FG009|Part B (104 Weeks)|Sponsor request|4|||
130081209|NCT02531633|468251723|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
130081210|NCT02531633|468251724|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
130081211|NCT02531633|468251725|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
130081212|NCT02531633|468251726|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
130081213|NCT02531633|468251727|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
130081214|NCT02531633|468251728|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
130081215|NCT02531633|468251729|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
130081216|NCT02531633|468251730|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
130081217|NCT02531633|468251731|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
130081218|NCT02531633|468251732|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
130081219|NCT02155712|468251733|FG000|Overall Study|Death|12|||
130081220|NCT02155712|468251734|FG001|Overall Study|Death|0|||
130081221|NCT02155712|468251733|FG000|Overall Study|Lost to Follow-up|37|||
130081222|NCT02155712|468251734|FG001|Overall Study|Lost to Follow-up|22|||
130081223|NCT02155712|468251733|FG000|Overall Study|Revision of device|4|||
130081224|NCT02155712|468251734|FG001|Overall Study|Revision of device|3|||
130081225|NCT02155712|468251733|FG000|Overall Study|Withdrawal by Subject|39|||
130081226|NCT02155712|468251734|FG001|Overall Study|Withdrawal by Subject|21|||
130081227|NCT02155712|468251733|FG000|Overall Study|Site termination|77|||
130081228|NCT02155712|468251734|FG001|Overall Study|Site termination|19|||
130081229|NCT02155712|468251733|FG000|Overall Study|Sponsor terminated study early|150|||
130081230|NCT02155712|468251734|FG001|Overall Study|Sponsor terminated study early|0|||
130081231|NCT02155712|468251733|FG000|Overall Study|Missed final 5-year protocol visit|0|||
130081232|NCT02155712|468251734|FG001|Overall Study|Missed final 5-year protocol visit|32|||
130081233|NCT02155712|468251733|FG000|Overall Study|Censored because surgery cancelled|6|||
130081234|NCT02155712|468251734|FG001|Overall Study|Censored because surgery cancelled|10|||
130081235|NCT02155712|468251733|FG000|Overall Study|Censored because study device was not implanted|61|||
130081236|NCT02155712|468251734|FG001|Overall Study|Censored because study device was not implanted|66|||
130081237|NCT02155712|468251733|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
130081238|NCT02155712|468251734|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
130081239|NCT05016037|468251735|FG000|Overall Study|Lost to Follow-up|2|||
130081240|NCT04247828|468251751|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
130081241|NCT03797144|468251752|FG000|Enrollment|Protocol Violation|4|||
130081242|NCT03797144|468251753|FG001|Enrollment|Protocol Violation|1|||
130081243|NCT03797144|468251752|FG000|Surgery|Protocol Violation|1|||
130081244|NCT03797144|468251753|FG001|Surgery|Protocol Violation|0|||
130081245|NCT03797144|468251752|FG000|3 Month|Early termination cut-off date|2|||
130081246|NCT03797144|468251753|FG001|3 Month|Early termination cut-off date|0|||
130081247|NCT03797144|468251752|FG000|12 Month|Early termination cut-off date|8|||
130081248|NCT03797144|468251753|FG001|12 Month|Early termination cut-off date|9|||
130081249|NCT03797144|468251752|FG000|24 Month|Early termination cut-off date|1|||
130081250|NCT03797144|468251753|FG001|24 Month|Early termination cut-off date|1|||
130081251|NCT03083470|468251754|FG000|Overall Study|Lost to Follow-up|0|||
130081252|NCT03083470|468251755|FG001|Overall Study|Lost to Follow-up|0|||
130081253|NCT03083470|468251756|FG002|Overall Study|Lost to Follow-up|0|||
130081254|NCT03083470|468251757|FG003|Overall Study|Lost to Follow-up|0|||
130081255|NCT03083470|468251758|FG004|Overall Study|Lost to Follow-up|1|||
130081256|NCT03083470|468251754|FG000|Overall Study|Withdrawal by Subject|0|||
130081257|NCT03083470|468251755|FG001|Overall Study|Withdrawal by Subject|0|||
130081258|NCT03083470|468251756|FG002|Overall Study|Withdrawal by Subject|0|||
130081259|NCT03083470|468251757|FG003|Overall Study|Withdrawal by Subject|0|||
130081260|NCT03083470|468251758|FG004|Overall Study|Withdrawal by Subject|1|||
130081261|NCT00606229|468251759|FG000|Overall Study|Adverse Event|11|||
130081262|NCT00606229|468251759|FG000|Overall Study|Lack of Efficacy|1|||
130081263|NCT00606229|468251759|FG000|Overall Study|Withdrawal by Subject|4|||
130081264|NCT00606229|468251759|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
130081265|NCT00606229|468251759|FG000|Overall Study|change of residence or other commitments|2|||
130081266|NCT03077711|468251760|FG000|Overall Study|Lost to Follow-up|2|||
130081267|NCT03077711|468251761|FG001|Overall Study|Lost to Follow-up|2|||
130120939|NCT01265784|468404866|FG002|Overall Study|Adverse Event|0|||
130081268|NCT03077711|468251760|FG000|Overall Study|noncompliant taking medication|2|||
130081269|NCT03077711|468251761|FG001|Overall Study|noncompliant taking medication|0|||
130081270|NCT01526928|468251762|FG000|Overall Study|Progressive Disease|35|||
130081271|NCT01526928|468251763|FG001|Overall Study|Progressive Disease|17|||
130081272|NCT01526928|468251764|FG002|Overall Study|Progressive Disease|150|||
130081273|NCT01526928|468251765|FG003|Overall Study|Progressive Disease|182|||
130081274|NCT01526928|468251766|FG004|Overall Study|Progressive Disease|76|||
130120940|NCT01265784|468404864|FG000|Overall Study|Death|3|||
130081275|NCT01526928|468251767|FG005|Overall Study|Progressive Disease|4|||
130081276|NCT01526928|468251762|FG000|Overall Study|Adverse Event|2|||
130081277|NCT01526928|468251763|FG001|Overall Study|Adverse Event|1|||
130081278|NCT01526928|468251764|FG002|Overall Study|Adverse Event|29|||
130081279|NCT01526928|468251765|FG003|Overall Study|Adverse Event|40|||
130081280|NCT01526928|468251766|FG004|Overall Study|Adverse Event|13|||
130081281|NCT01526928|468251767|FG005|Overall Study|Adverse Event|2|||
130081282|NCT01526928|468251762|FG000|Overall Study|Death|0|||
130081283|NCT01526928|468251763|FG001|Overall Study|Death|0|||
130081284|NCT01526928|468251764|FG002|Overall Study|Death|3|||
130081285|NCT01526928|468251765|FG003|Overall Study|Death|0|||
130081286|NCT01526928|468251766|FG004|Overall Study|Death|0|||
130081287|NCT01526928|468251767|FG005|Overall Study|Death|0|||
130081288|NCT01526928|468251762|FG000|Overall Study|Withdrawal by Subject|1|||
130081289|NCT01526928|468251763|FG001|Overall Study|Withdrawal by Subject|0|||
130081290|NCT01526928|468251764|FG002|Overall Study|Withdrawal by Subject|13|||
130081291|NCT01526928|468251765|FG003|Overall Study|Withdrawal by Subject|11|||
130081292|NCT01526928|468251766|FG004|Overall Study|Withdrawal by Subject|3|||
130081293|NCT01526928|468251767|FG005|Overall Study|Withdrawal by Subject|0|||
130081294|NCT01526928|468251762|FG000|Overall Study|Physician Decision|0|||
130081295|NCT01526928|468251763|FG001|Overall Study|Physician Decision|0|||
130081296|NCT01526928|468251764|FG002|Overall Study|Physician Decision|2|||
130081297|NCT01526928|468251765|FG003|Overall Study|Physician Decision|5|||
130081298|NCT01526928|468251766|FG004|Overall Study|Physician Decision|0|||
130081299|NCT01526928|468251767|FG005|Overall Study|Physician Decision|0|||
130081300|NCT01526928|468251762|FG000|Overall Study|Other Reason|0|||
130081301|NCT01526928|468251763|FG001|Overall Study|Other Reason|1|||
130081302|NCT01526928|468251764|FG002|Overall Study|Other Reason|11|||
130081303|NCT01526928|468251765|FG003|Overall Study|Other Reason|4|||
130081304|NCT01526928|468251766|FG004|Overall Study|Other Reason|1|||
130081305|NCT01526928|468251767|FG005|Overall Study|Other Reason|0|||
130081306|NCT01526928|468251762|FG000|Overall Study|Lost to Follow-up|0|||
130081307|NCT01526928|468251763|FG001|Overall Study|Lost to Follow-up|0|||
130081308|NCT01526928|468251764|FG002|Overall Study|Lost to Follow-up|0|||
130081309|NCT01526928|468251765|FG003|Overall Study|Lost to Follow-up|1|||
130081310|NCT01526928|468251766|FG004|Overall Study|Lost to Follow-up|0|||
130081311|NCT01526928|468251767|FG005|Overall Study|Lost to Follow-up|0|||
130081312|NCT01526928|468251762|FG000|Overall Study|Protocol Deviation|0|||
130081313|NCT01526928|468251763|FG001|Overall Study|Protocol Deviation|0|||
130081314|NCT01526928|468251764|FG002|Overall Study|Protocol Deviation|0|||
130081315|NCT01526928|468251765|FG003|Overall Study|Protocol Deviation|2|||
130081316|NCT01526928|468251766|FG004|Overall Study|Protocol Deviation|0|||
130081317|NCT01526928|468251767|FG005|Overall Study|Protocol Deviation|0|||
130081318|NCT01526928|468251762|FG000|Overall Study|Missing|0|||
130081319|NCT01526928|468251763|FG001|Overall Study|Missing|0|||
130081320|NCT01526928|468251764|FG002|Overall Study|Missing|1|||
130081321|NCT01526928|468251765|FG003|Overall Study|Missing|0|||
130081322|NCT01526928|468251766|FG004|Overall Study|Missing|2|||
130081323|NCT01526928|468251767|FG005|Overall Study|Missing|0|||
130081324|NCT01108068|468251768|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
130081325|NCT01108068|468251769|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
130081326|NCT00836953|468251770|FG000|Overall Study|Withdrawal by Subject|1|||
130081327|NCT00836953|468251770|FG000|Overall Study|Lost to Follow-up|1|||
130081328|NCT00376675|468251771|FG000|Overall Study|Withdrawal by Subject|9|||
130081329|NCT00376675|468251772|FG001|Overall Study|Withdrawal by Subject|2|||
130081330|NCT00376675|468251771|FG000|Overall Study|Adverse Event|10|||
130081331|NCT00376675|468251772|FG001|Overall Study|Adverse Event|5|||
130081332|NCT00376675|468251771|FG000|Overall Study|Other Reason|1|||
130081333|NCT00376675|468251772|FG001|Overall Study|Other Reason|7|||
130081334|NCT02943668|468251776|FG000|Overall Study|Disease Progression|1|||
130081335|NCT02829775|468251777|FG000|Overall Study|Death|1|||
130081336|NCT02829775|468251777|FG000|Overall Study|Withdrawal by Subject|3|||
130081337|NCT02829775|468251777|FG000|Overall Study|Disease remission|1|||
130081338|NCT01249157|468251778|FG000|Overall Study|Withdrawal by Subject|1|||
130081339|NCT00062647|468251779|FG000|Overall Study|Death|2|||
130081340|NCT00062647|468251780|FG001|Overall Study|Death|2|||
130081341|NCT00062647|468251779|FG000|Overall Study|Adverse Event|1|||
130081342|NCT00062647|468251780|FG001|Overall Study|Adverse Event|1|||
130081343|NCT00062647|468251779|FG000|Overall Study|Withdrawal by Subject|2|||
130081344|NCT00062647|468251780|FG001|Overall Study|Withdrawal by Subject|1|||
130081345|NCT00062647|468251779|FG000|Overall Study|Protocol Violation|1|||
130081346|NCT00062647|468251780|FG001|Overall Study|Protocol Violation|0|||
130081347|NCT00062647|468251779|FG000|Overall Study|Lost to Follow-up|1|||
130081348|NCT00062647|468251780|FG001|Overall Study|Lost to Follow-up|2|||
130081349|NCT00062647|468251779|FG000|Overall Study|Failed continuation criteria|4|||
129954347|NCT01114217|467794025|FG000|Overall Study|Other-Study Withdrawn|1|||
129954348|NCT01114217|467794026|FG001|Overall Study|Other-Study Withdrawn|1|||
130081350|NCT00062647|468251780|FG001|Overall Study|Failed continuation criteria|2|||
130081351|NCT00062647|468251779|FG000|Overall Study|Other|4|||
129954349|NCT01114217|467794025|FG000|Overall Study|Other-Site Stopped Communicating|2|||
130081352|NCT00062647|468251780|FG001|Overall Study|Other|4|||
130081353|NCT00062647|468251779|FG000|Overall Study|Never received study treatment|1|||
130081354|NCT00062647|468251780|FG001|Overall Study|Never received study treatment|1|||
130081355|NCT02392468|468251788|FG000|Overall Study|Adverse Event|0|||
130081356|NCT02392468|468251789|FG001|Overall Study|Adverse Event|1|||
130081357|NCT02392468|468251790|FG002|Overall Study|Adverse Event|0|||
130081358|NCT02392468|468251791|FG003|Overall Study|Adverse Event|0|||
130081359|NCT02392468|468251792|FG004|Overall Study|Adverse Event|0|||
130081360|NCT02392468|468251793|FG005|Overall Study|Adverse Event|1|||
130081361|NCT01313039|468251794|FG000|Overall Study|Physician Decision|1|||
130081362|NCT01313039|468251794|FG000|Overall Study|Adverse Event|1|||
130081363|NCT05083949|468251800|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
130081364|NCT05083949|468251801|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
130081365|NCT05083949|468251800|FG000|Period 1|Adverse Event|1|||
130081366|NCT05083949|468251801|FG001|Period 1|Adverse Event|1|||
130081367|NCT05083949|468251800|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
130081368|NCT05083949|468251801|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
130081369|NCT05083949|468251800|FG000|Period 2|Adverse Event|0|||
130081370|NCT05083949|468251801|FG001|Period 2|Adverse Event|2|||
130081371|NCT02996500|468251802|FG000|Overall Study|Adverse Event|1|||
130081372|NCT02996500|468251803|FG001|Overall Study|Adverse Event|1|||
130081373|NCT02996500|468251804|FG002|Overall Study|Adverse Event|4|||
130081374|NCT02996500|468251805|FG003|Overall Study|Adverse Event|3|||
130081375|NCT02996500|468251806|FG004|Overall Study|Adverse Event|1|||
130081376|NCT02996500|468251807|FG005|Overall Study|Adverse Event|2|||
130081377|NCT02996500|468251802|FG000|Overall Study|Lack of Efficacy|0|||
130081378|NCT02996500|468251803|FG001|Overall Study|Lack of Efficacy|0|||
130081379|NCT02996500|468251804|FG002|Overall Study|Lack of Efficacy|0|||
130081380|NCT02996500|468251805|FG003|Overall Study|Lack of Efficacy|0|||
130081381|NCT02996500|468251806|FG004|Overall Study|Lack of Efficacy|2|||
130081382|NCT02996500|468251807|FG005|Overall Study|Lack of Efficacy|0|||
130081383|NCT02996500|468251802|FG000|Overall Study|Lost to Follow-up|1|||
130081384|NCT02996500|468251803|FG001|Overall Study|Lost to Follow-up|0|||
130081385|NCT02996500|468251804|FG002|Overall Study|Lost to Follow-up|0|||
130081386|NCT02996500|468251805|FG003|Overall Study|Lost to Follow-up|0|||
130081387|NCT02996500|468251806|FG004|Overall Study|Lost to Follow-up|0|||
130081388|NCT02996500|468251807|FG005|Overall Study|Lost to Follow-up|1|||
130081389|NCT02996500|468251802|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130120941|NCT01265784|468404865|FG001|Overall Study|Death|0|||
129954350|NCT01114217|467794026|FG001|Overall Study|Other-Site Stopped Communicating|0|||
129954351|NCT01114217|467794025|FG000|Overall Study|Other-Lost to Follow-up|1|||
129954352|NCT01114217|467794026|FG001|Overall Study|Other-Lost to Follow-up|0|||
129954353|NCT01114217|467794025|FG000|Overall Study|Other-Withdrawal by Subject|1|||
129954354|NCT01114217|467794026|FG001|Overall Study|Other-Withdrawal by Subject|1|||
129954355|NCT01183013|467794029|FG000|Overall Study|Adverse Event|6|||
129954356|NCT01183013|467794030|FG001|Overall Study|Adverse Event|8|||
129954357|NCT01183013|467794031|FG002|Overall Study|Adverse Event|5|||
129954358|NCT01183013|467794032|FG003|Overall Study|Adverse Event|5|||
129954359|NCT01183013|467794033|FG004|Overall Study|Adverse Event|10|||
129954360|NCT01183013|467794034|FG005|Overall Study|Adverse Event|10|||
129954361|NCT01183013|467794035|FG006|Overall Study|Adverse Event|6|||
129954362|NCT01183013|467794029|FG000|Overall Study|Lack of Efficacy|3|||
129954363|NCT01183013|467794030|FG001|Overall Study|Lack of Efficacy|2|||
129954364|NCT01183013|467794031|FG002|Overall Study|Lack of Efficacy|1|||
129954365|NCT01183013|467794032|FG003|Overall Study|Lack of Efficacy|2|||
129954366|NCT01183013|467794033|FG004|Overall Study|Lack of Efficacy|1|||
129954367|NCT01183013|467794034|FG005|Overall Study|Lack of Efficacy|2|||
129954368|NCT01183013|467794035|FG006|Overall Study|Lack of Efficacy|0|||
129954369|NCT01183013|467794029|FG000|Overall Study|Protocol Violation|5|||
129954370|NCT01183013|467794030|FG001|Overall Study|Protocol Violation|2|||
129954371|NCT01183013|467794031|FG002|Overall Study|Protocol Violation|4|||
129954372|NCT01183013|467794032|FG003|Overall Study|Protocol Violation|0|||
129954373|NCT01183013|467794033|FG004|Overall Study|Protocol Violation|4|||
129954374|NCT01183013|467794034|FG005|Overall Study|Protocol Violation|3|||
129954375|NCT01183013|467794035|FG006|Overall Study|Protocol Violation|3|||
129954376|NCT01183013|467794029|FG000|Overall Study|Lost to Follow-up|7|||
129954377|NCT01183013|467794030|FG001|Overall Study|Lost to Follow-up|3|||
129954378|NCT01183013|467794031|FG002|Overall Study|Lost to Follow-up|4|||
129954379|NCT01183013|467794032|FG003|Overall Study|Lost to Follow-up|3|||
129954380|NCT01183013|467794033|FG004|Overall Study|Lost to Follow-up|2|||
129954381|NCT01183013|467794034|FG005|Overall Study|Lost to Follow-up|6|||
129954382|NCT01183013|467794035|FG006|Overall Study|Lost to Follow-up|5|||
129954383|NCT01183013|467794029|FG000|Overall Study|Withdrawal by Subject|9|||
129954384|NCT01183013|467794030|FG001|Overall Study|Withdrawal by Subject|13|||
129954385|NCT01183013|467794031|FG002|Overall Study|Withdrawal by Subject|10|||
129954386|NCT01183013|467794032|FG003|Overall Study|Withdrawal by Subject|8|||
129954387|NCT01183013|467794033|FG004|Overall Study|Withdrawal by Subject|7|||
129954388|NCT01183013|467794034|FG005|Overall Study|Withdrawal by Subject|9|||
129954389|NCT01183013|467794035|FG006|Overall Study|Withdrawal by Subject|10|||
129954390|NCT01183013|467794029|FG000|Overall Study|Reasons other than stated above|15|||
129954391|NCT01183013|467794030|FG001|Overall Study|Reasons other than stated above|11|||
129954392|NCT01183013|467794031|FG002|Overall Study|Reasons other than stated above|17|||
129954393|NCT01183013|467794032|FG003|Overall Study|Reasons other than stated above|12|||
130081390|NCT02996500|468251803|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
130081391|NCT02996500|468251804|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
130081392|NCT02996500|468251805|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
130081393|NCT02996500|468251806|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
130081394|NCT02996500|468251807|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
130081395|NCT02996500|468251802|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129954394|NCT01183013|467794033|FG004|Overall Study|Reasons other than stated above|12|||
129954395|NCT01183013|467794034|FG005|Overall Study|Reasons other than stated above|15|||
130081396|NCT02996500|468251803|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130081397|NCT02996500|468251804|FG002|Overall Study|Non-Compliance With Study Drug|0|||
130081398|NCT02996500|468251805|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130081399|NCT02996500|468251806|FG004|Overall Study|Non-Compliance With Study Drug|0|||
130081400|NCT02996500|468251807|FG005|Overall Study|Non-Compliance With Study Drug|1|||
130081401|NCT02996500|468251802|FG000|Overall Study|Progressive Disease|1|||
130081402|NCT02996500|468251803|FG001|Overall Study|Progressive Disease|0|||
130081403|NCT02996500|468251804|FG002|Overall Study|Progressive Disease|0|||
130081404|NCT02996500|468251805|FG003|Overall Study|Progressive Disease|0|||
130081405|NCT02996500|468251806|FG004|Overall Study|Progressive Disease|0|||
130081406|NCT02996500|468251807|FG005|Overall Study|Progressive Disease|0|||
130081407|NCT02996500|468251802|FG000|Overall Study|Other|2|||
130081408|NCT02996500|468251803|FG001|Overall Study|Other|0|||
130081409|NCT02996500|468251804|FG002|Overall Study|Other|2|||
130081410|NCT02996500|468251805|FG003|Overall Study|Other|0|||
130081411|NCT02996500|468251806|FG004|Overall Study|Other|0|||
130081412|NCT02996500|468251807|FG005|Overall Study|Other|0|||
130081413|NCT02996500|468251802|FG000|Overall Study|Protocol Violation|0|||
130081414|NCT02996500|468251803|FG001|Overall Study|Protocol Violation|0|||
130081415|NCT02996500|468251804|FG002|Overall Study|Protocol Violation|0|||
130081416|NCT02996500|468251805|FG003|Overall Study|Protocol Violation|1|||
130081417|NCT02996500|468251806|FG004|Overall Study|Protocol Violation|0|||
130081418|NCT02996500|468251807|FG005|Overall Study|Protocol Violation|0|||
130081419|NCT02996500|468251802|FG000|Overall Study|Withdrawal by Subject|3|||
130081420|NCT02996500|468251803|FG001|Overall Study|Withdrawal by Subject|0|||
130081421|NCT02996500|468251804|FG002|Overall Study|Withdrawal by Subject|3|||
130081422|NCT02996500|468251805|FG003|Overall Study|Withdrawal by Subject|0|||
130081423|NCT02996500|468251806|FG004|Overall Study|Withdrawal by Subject|2|||
130081424|NCT02996500|468251807|FG005|Overall Study|Withdrawal by Subject|0|||
130081425|NCT01678560|468251808|FG000|Overall Study|Physician Decision|4|||
130081426|NCT01678560|468251809|FG001|Overall Study|Physician Decision|4|||
130081427|NCT01678560|468251808|FG000|Overall Study|Death|0|||
130081428|NCT01678560|468251809|FG001|Overall Study|Death|1|||
130081429|NCT01678560|468251808|FG000|Overall Study|Withdrawal by Subject|0|||
130081430|NCT01678560|468251809|FG001|Overall Study|Withdrawal by Subject|1|||
130081431|NCT00322387|468251813|FG000|Treatment Period|Adverse Event|0|||
130081432|NCT00322387|468251814|FG001|Treatment Period|Adverse Event|1|||
130081433|NCT00322387|468251813|FG000|Follow-up Period|Final assessment not done|1|||
130081434|NCT00322387|468251814|FG001|Follow-up Period|Final assessment not done|3|||
130081435|NCT00322387|468251813|FG000|Follow-up Period|Death|1|||
130081436|NCT00322387|468251814|FG001|Follow-up Period|Death|0|||
130081437|NCT00090766|468251819|FG000|Overall Study|Nephrectomy Planned|0|||
130081438|NCT00090766|468251820|FG001|Overall Study|Nephrectomy Planned|0|||
130081439|NCT00090766|468251821|FG002|Overall Study|Nephrectomy Planned|1|||
130081440|NCT00090766|468251819|FG000|Overall Study|Death|1|||
130081441|NCT00090766|468251820|FG001|Overall Study|Death|0|||
130081442|NCT00090766|468251821|FG002|Overall Study|Death|0|||
130081443|NCT00090766|468251819|FG000|Overall Study|Admin|0|||
130081444|NCT00090766|468251820|FG001|Overall Study|Admin|2|||
130081445|NCT00090766|468251821|FG002|Overall Study|Admin|0|||
130081446|NCT00090766|468251819|FG000|Overall Study|Lost to Follow-up|2|||
130081447|NCT00090766|468251820|FG001|Overall Study|Lost to Follow-up|0|||
130081448|NCT00090766|468251821|FG002|Overall Study|Lost to Follow-up|2|||
130081449|NCT00654368|468251822|FG000|Overall Study|Ineligibility determined|6|||
130081450|NCT00654368|468251823|FG001|Overall Study|Ineligibility determined|0|||
130081451|NCT00654368|468251824|FG002|Overall Study|Ineligibility determined|0|||
130081452|NCT00654368|468251822|FG000|Overall Study|Protocol deviation|3|||
130081453|NCT00654368|468251823|FG001|Overall Study|Protocol deviation|2|||
130081454|NCT00654368|468251824|FG002|Overall Study|Protocol deviation|1|||
130081455|NCT00654368|468251822|FG000|Overall Study|Non-compliance|2|||
130081456|NCT00654368|468251823|FG001|Overall Study|Non-compliance|1|||
130081457|NCT00654368|468251824|FG002|Overall Study|Non-compliance|2|||
130081458|NCT00654368|468251822|FG000|Overall Study|Withdrawal by Subject|5|||
130081459|NCT00654368|468251823|FG001|Overall Study|Withdrawal by Subject|2|||
130081460|NCT00654368|468251824|FG002|Overall Study|Withdrawal by Subject|2|||
130081461|NCT00654368|468251822|FG000|Overall Study|Disease progression|21|||
130081462|NCT00654368|468251823|FG001|Overall Study|Disease progression|31|||
130081463|NCT00654368|468251824|FG002|Overall Study|Disease progression|13|||
130081464|NCT00654368|468251822|FG000|Overall Study|Requirement for alternative therapy|1|||
130081465|NCT00654368|468251823|FG001|Overall Study|Requirement for alternative therapy|1|||
130081466|NCT00654368|468251824|FG002|Overall Study|Requirement for alternative therapy|1|||
130081467|NCT00654368|468251822|FG000|Overall Study|Physician Decision|0|||
130081468|NCT00654368|468251823|FG001|Overall Study|Physician Decision|0|||
130081469|NCT00654368|468251824|FG002|Overall Study|Physician Decision|2|||
130081470|NCT00654368|468251822|FG000|Overall Study|Death|1|||
130081471|NCT00654368|468251823|FG001|Overall Study|Death|0|||
130081472|NCT00654368|468251824|FG002|Overall Study|Death|0|||
130081473|NCT00654368|468251822|FG000|Overall Study|Pregnancy|0|||
130081474|NCT00654368|468251823|FG001|Overall Study|Pregnancy|0|||
130081475|NCT00654368|468251824|FG002|Overall Study|Pregnancy|2|||
130081476|NCT00654368|468251822|FG000|Overall Study|Other|0|||
130081477|NCT00654368|468251823|FG001|Overall Study|Other|2|||
130081478|NCT00654368|468251824|FG002|Overall Study|Other|3|||
130081479|NCT00654368|468251822|FG000|Overall Study|Adverse Event|14|||
130081480|NCT00654368|468251823|FG001|Overall Study|Adverse Event|9|||
130081481|NCT00654368|468251824|FG002|Overall Study|Adverse Event|6|||
130081482|NCT00804986|468251831|FG000|Overall Study|Adverse Event|0|||
130081483|NCT00804986|468251832|FG001|Overall Study|Adverse Event|1|||
130081484|NCT00804986|468251833|FG002|Overall Study|Adverse Event|2|||
130081485|NCT00804986|468251834|FG003|Overall Study|Adverse Event|1|||
130081486|NCT00804986|468251835|FG004|Overall Study|Adverse Event|3|||
130081487|NCT00804986|468251836|FG005|Overall Study|Adverse Event|0|||
130081488|NCT00804986|468251831|FG000|Overall Study|Lack of Efficacy|0|||
130081489|NCT00804986|468251832|FG001|Overall Study|Lack of Efficacy|0|||
130081490|NCT00804986|468251833|FG002|Overall Study|Lack of Efficacy|0|||
130081491|NCT00804986|468251834|FG003|Overall Study|Lack of Efficacy|1|||
130081492|NCT00804986|468251835|FG004|Overall Study|Lack of Efficacy|0|||
130081493|NCT00804986|468251836|FG005|Overall Study|Lack of Efficacy|3|||
130081494|NCT00804986|468251831|FG000|Overall Study|Lost to Follow-up|0|||
129954396|NCT01183013|467794035|FG006|Overall Study|Reasons other than stated above|13|||
129954397|NCT03785210|467794036|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
129979778|NCT01204710|467889468|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
129979779|NCT01204710|467889469|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
129979780|NCT01204710|467889468|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
129979781|NCT01204710|467889469|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
129979782|NCT01204710|467889468|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
129979783|NCT01204710|467889469|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
129979784|NCT01204710|467889468|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
129979785|NCT01204710|467889469|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
129979786|NCT01276379|467889470|FG000|Overall Study|Screening failure|40|||
129979787|NCT00864253|467889471|FG000|Overall Study|Adverse Event|56|||
129979788|NCT00864253|467889472|FG001|Overall Study|Adverse Event|11|||
129979789|NCT00864253|467889471|FG000|Overall Study|Unrelated Adverse Event|3|||
129979790|NCT00864253|467889472|FG001|Overall Study|Unrelated Adverse Event|1|||
129979791|NCT00864253|467889471|FG000|Overall Study|Physician Decision|11|||
129979792|NCT00864253|467889472|FG001|Overall Study|Physician Decision|15|||
129979793|NCT00864253|467889471|FG000|Overall Study|Protocol Violation|0|||
129979794|NCT00864253|467889472|FG001|Overall Study|Protocol Violation|2|||
129979795|NCT00864253|467889471|FG000|Overall Study|Lost to Follow-up|1|||
129979796|NCT00864253|467889472|FG001|Overall Study|Lost to Follow-up|1|||
129979797|NCT00864253|467889471|FG000|Overall Study|Withdrawal by Subject|18|||
129979798|NCT00864253|467889472|FG001|Overall Study|Withdrawal by Subject|18|||
129979799|NCT00864253|467889471|FG000|Overall Study|Death|1|||
129979800|NCT00864253|467889472|FG001|Overall Study|Death|0|||
129979801|NCT00864253|467889471|FG000|Overall Study|Ongoing|2|||
129979802|NCT00864253|467889472|FG001|Overall Study|Ongoing|3|||
129979803|NCT00864253|467889471|FG000|Overall Study|Untreated|7|||
129979804|NCT00864253|467889472|FG001|Overall Study|Untreated|7|||
129979805|NCT01896726|467889473|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
129979806|NCT01896726|467889473|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
129979807|NCT01128114|467889474|FG000|Overall Study|Treatment Withdrawn|6|||
129979808|NCT01128114|467889474|FG000|Overall Study|Screening Failed|2|||
129979809|NCT00208325|467889475|FG000|Overall Study|Death|18|||
129979810|NCT00208325|467889476|FG001|Overall Study|Death|19|||
129979811|NCT00208325|467889477|FG002|Overall Study|Death|7|||
129979812|NCT00208325|467889478|FG003|Overall Study|Death|5|||
129979813|NCT00208325|467889475|FG000|Overall Study|Withdrawal by Subject|0|||
129979814|NCT00208325|467889476|FG001|Overall Study|Withdrawal by Subject|1|||
129979815|NCT00208325|467889477|FG002|Overall Study|Withdrawal by Subject|0|||
129979816|NCT00208325|467889478|FG003|Overall Study|Withdrawal by Subject|0|||
129979817|NCT00208325|467889475|FG000|Overall Study|Revision|4|||
129979818|NCT00208325|467889476|FG001|Overall Study|Revision|1|||
129979819|NCT00208325|467889477|FG002|Overall Study|Revision|0|||
129979820|NCT00208325|467889478|FG003|Overall Study|Revision|4|||
129979821|NCT00208325|467889475|FG000|Overall Study|Lost to Follow-up|1|||
129979822|NCT00208325|467889476|FG001|Overall Study|Lost to Follow-up|0|||
129979823|NCT00208325|467889477|FG002|Overall Study|Lost to Follow-up|2|||
129979824|NCT00208325|467889478|FG003|Overall Study|Lost to Follow-up|0|||
129979825|NCT00208325|467889475|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
129979826|NCT00208325|467889476|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
129979827|NCT00208325|467889477|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
129979828|NCT00208325|467889478|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
129979829|NCT00208325|467889475|FG000|Overall Study|Does not wish to Continue in Study|5|||
129979830|NCT00208325|467889476|FG001|Overall Study|Does not wish to Continue in Study|8|||
129979831|NCT00208325|467889477|FG002|Overall Study|Does not wish to Continue in Study|3|||
129979832|NCT00208325|467889478|FG003|Overall Study|Does not wish to Continue in Study|2|||
129954398|NCT03785210|467794037|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
129954399|NCT00472199|467794063|FG000|Overall Study|Adverse Event|19|||
129954400|NCT00472199|467794064|FG001|Overall Study|Adverse Event|23|||
129954401|NCT00472199|467794063|FG000|Overall Study|Lack of Efficacy|4|||
129954402|NCT00472199|467794064|FG001|Overall Study|Lack of Efficacy|25|||
129954403|NCT00472199|467794063|FG000|Overall Study|Lost to Follow-up|2|||
129954404|NCT00472199|467794064|FG001|Overall Study|Lost to Follow-up|4|||
129954405|NCT00472199|467794063|FG000|Overall Study|Protocol Violation|3|||
129954406|NCT00472199|467794064|FG001|Overall Study|Protocol Violation|2|||
129954407|NCT00472199|467794063|FG000|Overall Study|Withdrawal by Subject|6|||
129954408|NCT00472199|467794064|FG001|Overall Study|Withdrawal by Subject|5|||
129954409|NCT00472199|467794063|FG000|Overall Study|personal reason|0|||
129954410|NCT00472199|467794064|FG001|Overall Study|personal reason|1|||
129954411|NCT00472199|467794063|FG000|Overall Study|patient was asymptomatic|1|||
129954412|NCT00472199|467794064|FG001|Overall Study|patient was asymptomatic|0|||
129954413|NCT01268488|467794066|FG000|Overall Study|Adverse Event|3|||
129954414|NCT01268488|467794066|FG000|Overall Study|Physician Decision|2|||
129954415|NCT01757171|467794067|FG000|Overall Study|Adverse Event|5|||
129954416|NCT01757171|467794068|FG001|Overall Study|Adverse Event|1|||
129954417|NCT01757171|467794067|FG000|Overall Study|Disease Progression|1|||
129954418|NCT01757171|467794068|FG001|Overall Study|Disease Progression|0|||
129954419|NCT01757171|467794067|FG000|Overall Study|Hospitalization|1|||
129954420|NCT01757171|467794068|FG001|Overall Study|Hospitalization|0|||
129954421|NCT01757171|467794067|FG000|Overall Study|ECOG decline|1|||
129954422|NCT01757171|467794068|FG001|Overall Study|ECOG decline|0|||
129954423|NCT01014013|467794072|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
129954424|NCT01014013|467794073|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
129954425|NCT01014013|467794072|FG000|Overall Study|Clinical adverse experience|4|||
129954426|NCT01014013|467794073|FG001|Overall Study|Clinical adverse experience|2|||
129954427|NCT01014013|467794072|FG000|Overall Study|Laboratory adverse experience|1|||
129954428|NCT01014013|467794073|FG001|Overall Study|Laboratory adverse experience|1|||
129954429|NCT01014013|467794072|FG000|Overall Study|Protocol Violation|1|||
129954430|NCT01014013|467794073|FG001|Overall Study|Protocol Violation|3|||
129954431|NCT01014013|467794072|FG000|Overall Study|Withdrawal by Subject|7|||
129954432|NCT01014013|467794073|FG001|Overall Study|Withdrawal by Subject|4|||
129954433|NCT01014013|467794072|FG000|Overall Study|Clinical/microbiologic failure|1|||
129954434|NCT01014013|467794073|FG001|Overall Study|Clinical/microbiologic failure|2|||
129954435|NCT01014013|467794072|FG000|Overall Study|Pathogen culture = no growth|26|||
129954436|NCT01014013|467794073|FG001|Overall Study|Pathogen culture = no growth|34|||
129954437|NCT01014013|467794072|FG000|Overall Study|Negative urine culture|2|||
129954438|NCT01014013|467794073|FG001|Overall Study|Negative urine culture|0|||
129954439|NCT01014013|467794072|FG000|Overall Study|Pathogen resistant|7|||
129954440|NCT01014013|467794073|FG001|Overall Study|Pathogen resistant|4|||
129954441|NCT01014013|467794072|FG000|Overall Study|Physician Decision|0|||
129954442|NCT01014013|467794073|FG001|Overall Study|Physician Decision|1|||
129954443|NCT01014013|467794072|FG000|Overall Study|Another antibiotic therapy required|0|||
129954444|NCT01014013|467794073|FG001|Overall Study|Another antibiotic therapy required|1|||
129954445|NCT01014013|467794072|FG000|Overall Study|Appendectomy|1|||
129954446|NCT01014013|467794073|FG001|Overall Study|Appendectomy|0|||
129954447|NCT01014013|467794072|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
129954448|NCT01014013|467794073|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
129954449|NCT00316121|467794074|FG000|Overall Study|Death|1|||
129954450|NCT00316121|467794075|FG001|Overall Study|Death|0|||
129954451|NCT00316121|467794074|FG000|Overall Study|Lost to Follow-up|14|||
129954452|NCT00316121|467794075|FG001|Overall Study|Lost to Follow-up|8|||
129954453|NCT00316121|467794074|FG000|Overall Study|Withdrawal by Subject|2|||
129954454|NCT00316121|467794075|FG001|Overall Study|Withdrawal by Subject|0|||
129954455|NCT00316121|467794074|FG000|Overall Study|Reason is missing|1|||
129954456|NCT00316121|467794075|FG001|Overall Study|Reason is missing|0|||
129954457|NCT00316121|467794074|FG000|Overall Study|Subject relocated|1|||
129954458|NCT00316121|467794075|FG001|Overall Study|Subject relocated|1|||
129954459|NCT00316121|467794074|FG000|Overall Study|Subject refused to return|1|||
129954460|NCT00316121|467794075|FG001|Overall Study|Subject refused to return|0|||
129954461|NCT00316121|467794074|FG000|Overall Study|Subject no show for visit x 3|1|||
129954462|NCT00316121|467794075|FG001|Overall Study|Subject no show for visit x 3|0|||
129954463|NCT00316121|467794074|FG000|Overall Study|Subject did not have 24 month visit|1|||
129954464|NCT00316121|467794075|FG001|Overall Study|Subject did not have 24 month visit|0|||
129954465|NCT05274906|467794076|FG000|Overall Study|Withdrawal by Subject|2|||
129954466|NCT05274906|467794077|FG001|Overall Study|Withdrawal by Subject|1|||
129954467|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
129954468|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
129954469|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
129954470|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
129954471|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
129954472|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
130081495|NCT00804986|468251832|FG001|Overall Study|Lost to Follow-up|0|||
130081496|NCT00804986|468251833|FG002|Overall Study|Lost to Follow-up|0|||
130081497|NCT00804986|468251834|FG003|Overall Study|Lost to Follow-up|1|||
130081498|NCT00804986|468251835|FG004|Overall Study|Lost to Follow-up|1|||
130081499|NCT00804986|468251836|FG005|Overall Study|Lost to Follow-up|3|||
130081500|NCT00804986|468251831|FG000|Overall Study|Protocol Violation|0|||
130081501|NCT00804986|468251832|FG001|Overall Study|Protocol Violation|1|||
130081502|NCT00804986|468251833|FG002|Overall Study|Protocol Violation|0|||
130081503|NCT00804986|468251834|FG003|Overall Study|Protocol Violation|1|||
130081504|NCT00804986|468251835|FG004|Overall Study|Protocol Violation|0|||
130081505|NCT00804986|468251836|FG005|Overall Study|Protocol Violation|0|||
130081506|NCT00804986|468251831|FG000|Overall Study|Withdrawal by Subject|0|||
130081507|NCT00804986|468251832|FG001|Overall Study|Withdrawal by Subject|3|||
130081508|NCT00804986|468251833|FG002|Overall Study|Withdrawal by Subject|0|||
130081509|NCT00804986|468251834|FG003|Overall Study|Withdrawal by Subject|3|||
130081510|NCT00804986|468251835|FG004|Overall Study|Withdrawal by Subject|5|||
130081511|NCT00804986|468251836|FG005|Overall Study|Withdrawal by Subject|3|||
130081512|NCT00804986|468251831|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
130081513|NCT00804986|468251832|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
130081514|NCT00804986|468251833|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
130081515|NCT00804986|468251834|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
130081516|NCT00804986|468251835|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
130081517|NCT00804986|468251836|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
130081518|NCT00804986|468251831|FG000|Overall Study|Sponsor Decision|0|||
130081519|NCT00804986|468251832|FG001|Overall Study|Sponsor Decision|1|||
130081520|NCT00804986|468251833|FG002|Overall Study|Sponsor Decision|0|||
130081521|NCT00804986|468251834|FG003|Overall Study|Sponsor Decision|0|||
130081522|NCT00804986|468251835|FG004|Overall Study|Sponsor Decision|0|||
130081523|NCT00804986|468251836|FG005|Overall Study|Sponsor Decision|0|||
130081524|NCT00804986|468251831|FG000|Overall Study|Physician Decision|1|||
130081525|NCT00804986|468251832|FG001|Overall Study|Physician Decision|0|||
130081526|NCT00804986|468251833|FG002|Overall Study|Physician Decision|0|||
130081527|NCT00804986|468251834|FG003|Overall Study|Physician Decision|0|||
130081528|NCT00804986|468251835|FG004|Overall Study|Physician Decision|0|||
130081529|NCT00804986|468251836|FG005|Overall Study|Physician Decision|0|||
130081530|NCT00959699|468251841|FG000|Treatment Period|Adverse Event|3|||
130081531|NCT00959699|468251842|FG001|Treatment Period|Adverse Event|13|||
130081532|NCT00959699|468251841|FG000|Treatment Period|Lack of Efficacy|15|||
130081533|NCT00959699|468251842|FG001|Treatment Period|Lack of Efficacy|6|||
130081534|NCT00959699|468251841|FG000|Treatment Period|Lost to Follow-up|0|||
130081535|NCT00959699|468251842|FG001|Treatment Period|Lost to Follow-up|1|||
130081536|NCT00959699|468251841|FG000|Treatment Period|Withdrawal by Subject|1|||
130081537|NCT00959699|468251842|FG001|Treatment Period|Withdrawal by Subject|3|||
130081538|NCT00959699|468251841|FG000|Treatment Period|Non-Compliance with Protocol|0|||
130081539|NCT00959699|468251842|FG001|Treatment Period|Non-Compliance with Protocol|1|||
130081540|NCT00959699|468251841|FG000|Treatment Period|Did not receive treatment|0|||
130081541|NCT00959699|468251842|FG001|Treatment Period|Did not receive treatment|1|||
130081542|NCT00959699|468251841|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
130081543|NCT00959699|468251842|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
130081544|NCT00959699|468251841|FG000|Follow-up Period|Lost to Follow-up|3|||
130081545|NCT00959699|468251842|FG001|Follow-up Period|Lost to Follow-up|2|||
130081546|NCT00959699|468251841|FG000|Follow-up Period|Withdrawal by Subject|3|||
130081547|NCT00959699|468251842|FG001|Follow-up Period|Withdrawal by Subject|4|||
130081548|NCT04228445|468251843|FG000|Overall Study|Lost to Follow-up|1|||
130081549|NCT04228445|468251844|FG001|Overall Study|Lost to Follow-up|1|||
130081550|NCT04228445|468251843|FG000|Overall Study|Physician Decision|1|||
130081551|NCT04228445|468251844|FG001|Overall Study|Physician Decision|2|||
130081552|NCT04228445|468251843|FG000|Overall Study|Withdrawal by Subject|0|||
130081553|NCT04228445|468251844|FG001|Overall Study|Withdrawal by Subject|1|||
130081554|NCT04228445|468251843|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
130081555|NCT04228445|468251844|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
130081556|NCT00606294|468251851|FG000|Overall Study|Withdrawal by Subject|36|||
130081557|NCT00606294|468251852|FG001|Overall Study|Withdrawal by Subject|0|||
129954473|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
130081558|NCT01316380|468251853|FG000|Overall Study|Adverse Event|0|||
130081559|NCT01316380|468251854|FG001|Overall Study|Adverse Event|2|||
130081560|NCT01316380|468251855|FG002|Overall Study|Adverse Event|1|||
130081561|NCT01316380|468251853|FG000|Overall Study|Protocol Violation|0|||
130081562|NCT01316380|468251854|FG001|Overall Study|Protocol Violation|0|||
130081563|NCT01316380|468251855|FG002|Overall Study|Protocol Violation|1|||
130081564|NCT01316380|468251853|FG000|Overall Study|Withdrawal by Subject|1|||
129954474|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
130081565|NCT01316380|468251854|FG001|Overall Study|Withdrawal by Subject|2|||
130081566|NCT01316380|468251855|FG002|Overall Study|Withdrawal by Subject|0|||
130081567|NCT01316380|468251853|FG000|Overall Study|Other|0|||
130081568|NCT01316380|468251854|FG001|Overall Study|Other|1|||
130081569|NCT01316380|468251855|FG002|Overall Study|Other|1|||
130081570|NCT01316380|468251853|FG000|Overall Study|Not treated|1|||
130081571|NCT01316380|468251854|FG001|Overall Study|Not treated|0|||
130081572|NCT01316380|468251855|FG002|Overall Study|Not treated|0|||
130081573|NCT02332876|468251856|FG000|Overall Study|Lost to Follow-up|1|||
130081574|NCT02332876|468251857|FG001|Overall Study|Lost to Follow-up|1|||
130081575|NCT02415595|468251858|FG000|Overall Study|Administrative reason by sponsor|39|||
130081576|NCT02415595|468251859|FG001|Overall Study|Administrative reason by sponsor|40|||
130081577|NCT02415595|468251860|FG002|Overall Study|Administrative reason by sponsor|41|||
130081578|NCT02415595|468251861|FG003|Overall Study|Administrative reason by sponsor|39|||
130081579|NCT02415595|468251858|FG000|Overall Study|Adverse Event|1|||
130081580|NCT02415595|468251859|FG001|Overall Study|Adverse Event|3|||
130081581|NCT02415595|468251860|FG002|Overall Study|Adverse Event|5|||
130081582|NCT02415595|468251861|FG003|Overall Study|Adverse Event|10|||
130081583|NCT02415595|468251858|FG000|Overall Study|Lack of Efficacy|4|||
130081584|NCT02415595|468251859|FG001|Overall Study|Lack of Efficacy|4|||
130081585|NCT02415595|468251860|FG002|Overall Study|Lack of Efficacy|0|||
130081586|NCT02415595|468251861|FG003|Overall Study|Lack of Efficacy|0|||
130081587|NCT02415595|468251858|FG000|Overall Study|Lost to Follow-up|1|||
130081588|NCT02415595|468251859|FG001|Overall Study|Lost to Follow-up|3|||
130081589|NCT02415595|468251860|FG002|Overall Study|Lost to Follow-up|1|||
130081590|NCT02415595|468251861|FG003|Overall Study|Lost to Follow-up|1|||
130081591|NCT02415595|468251858|FG000|Overall Study|Poor/Non-compliance|1|||
130081592|NCT02415595|468251859|FG001|Overall Study|Poor/Non-compliance|0|||
130081593|NCT02415595|468251860|FG002|Overall Study|Poor/Non-compliance|1|||
130081594|NCT02415595|468251861|FG003|Overall Study|Poor/Non-compliance|0|||
130081595|NCT02415595|468251858|FG000|Overall Study|Reached stopping criteria|0|||
130081596|NCT02415595|468251859|FG001|Overall Study|Reached stopping criteria|1|||
130081597|NCT02415595|468251860|FG002|Overall Study|Reached stopping criteria|1|||
130081598|NCT02415595|468251861|FG003|Overall Study|Reached stopping criteria|0|||
130081599|NCT02415595|468251858|FG000|Overall Study|Withdrawal by Subject|4|||
130081600|NCT02415595|468251859|FG001|Overall Study|Withdrawal by Subject|0|||
130081601|NCT02415595|468251860|FG002|Overall Study|Withdrawal by Subject|1|||
130081602|NCT02415595|468251861|FG003|Overall Study|Withdrawal by Subject|3|||
130081603|NCT02415595|468251858|FG000|Overall Study|Other|0|||
130081604|NCT02415595|468251859|FG001|Overall Study|Other|1|||
130081605|NCT02415595|468251860|FG002|Overall Study|Other|1|||
130081606|NCT02415595|468251861|FG003|Overall Study|Other|0|||
130081607|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
130081608|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130081609|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
130081610|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130081611|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
130081612|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130081613|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130081614|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130081615|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
130081616|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130081617|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
130081618|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130081619|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
130081620|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
130081621|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
130081622|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
130081623|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
130081624|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
130081625|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
130081626|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
130081627|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
130081628|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130081629|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130081630|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130081631|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Screen failure|0|||
130081632|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Screen failure|1|||
130081633|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Screen failure|2|||
130081634|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Screen failure|0|||
130081635|NCT02614261|468251862|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
130081636|NCT02614261|468251863|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130081637|NCT02614261|468251864|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
130081638|NCT02614261|468251865|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130081639|NCT02614261|468251862|FG000|Open-Label Extension Phase|Adverse Event|23|||
130081640|NCT02614261|468251863|FG001|Open-Label Extension Phase|Adverse Event|12|||
130081641|NCT02614261|468251864|FG002|Open-Label Extension Phase|Adverse Event|11|||
130081642|NCT02614261|468251865|FG003|Open-Label Extension Phase|Adverse Event|0|||
130081643|NCT02614261|468251862|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
130081644|NCT02614261|468251863|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
130081645|NCT02614261|468251864|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
130081646|NCT02614261|468251865|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
130081647|NCT02614261|468251862|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
130081648|NCT02614261|468251863|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
130081649|NCT02614261|468251864|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
130081650|NCT02614261|468251865|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
130081651|NCT02614261|468251862|FG000|Open-Label Extension Phase|Physician Decision|2|||
130081652|NCT02614261|468251863|FG001|Open-Label Extension Phase|Physician Decision|0|||
130081653|NCT02614261|468251864|FG002|Open-Label Extension Phase|Physician Decision|0|||
130081654|NCT02614261|468251865|FG003|Open-Label Extension Phase|Physician Decision|0|||
130081655|NCT02614261|468251862|FG000|Open-Label Extension Phase|Pregnancy|1|||
130081656|NCT02614261|468251863|FG001|Open-Label Extension Phase|Pregnancy|2|||
130081657|NCT02614261|468251864|FG002|Open-Label Extension Phase|Pregnancy|1|||
130081658|NCT02614261|468251865|FG003|Open-Label Extension Phase|Pregnancy|0|||
130081659|NCT02614261|468251862|FG000|Open-Label Extension Phase|Protocol Violation|3|||
130081660|NCT02614261|468251863|FG001|Open-Label Extension Phase|Protocol Violation|4|||
130081661|NCT02614261|468251864|FG002|Open-Label Extension Phase|Protocol Violation|1|||
130081662|NCT02614261|468251865|FG003|Open-Label Extension Phase|Protocol Violation|0|||
130081663|NCT02614261|468251862|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
130081664|NCT02614261|468251863|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
130081665|NCT02614261|468251864|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
130081666|NCT02614261|468251865|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
130081667|NCT02614261|468251862|FG000|Follow-up Phase|Adverse Event|2|||
130081668|NCT02614261|468251863|FG001|Follow-up Phase|Adverse Event|0|||
130081669|NCT02614261|468251864|FG002|Follow-up Phase|Adverse Event|1|||
130081670|NCT02614261|468251865|FG003|Follow-up Phase|Adverse Event|0|||
130081671|NCT02614261|468251862|FG000|Follow-up Phase|Lost to Follow-up|12|||
130081672|NCT02614261|468251863|FG001|Follow-up Phase|Lost to Follow-up|5|||
130081673|NCT02614261|468251864|FG002|Follow-up Phase|Lost to Follow-up|2|||
130081674|NCT02614261|468251865|FG003|Follow-up Phase|Lost to Follow-up|0|||
130081675|NCT02614261|468251862|FG000|Follow-up Phase|Physician Decision|5|||
130081676|NCT02614261|468251863|FG001|Follow-up Phase|Physician Decision|1|||
130081677|NCT02614261|468251864|FG002|Follow-up Phase|Physician Decision|0|||
130081678|NCT02614261|468251865|FG003|Follow-up Phase|Physician Decision|0|||
130081679|NCT02614261|468251862|FG000|Follow-up Phase|Pregnancy|0|||
130081680|NCT02614261|468251863|FG001|Follow-up Phase|Pregnancy|1|||
130081681|NCT02614261|468251864|FG002|Follow-up Phase|Pregnancy|0|||
130081682|NCT02614261|468251865|FG003|Follow-up Phase|Pregnancy|0|||
130081683|NCT02614261|468251862|FG000|Follow-up Phase|Protocol Violation|1|||
130081684|NCT02614261|468251863|FG001|Follow-up Phase|Protocol Violation|0|||
130081685|NCT02614261|468251864|FG002|Follow-up Phase|Protocol Violation|0|||
130081686|NCT02614261|468251865|FG003|Follow-up Phase|Protocol Violation|0|||
130081687|NCT02614261|468251862|FG000|Follow-up Phase|Withdrawal by Subject|12|||
130081688|NCT02614261|468251863|FG001|Follow-up Phase|Withdrawal by Subject|4|||
130081689|NCT02614261|468251864|FG002|Follow-up Phase|Withdrawal by Subject|11|||
130081690|NCT02614261|468251865|FG003|Follow-up Phase|Withdrawal by Subject|0|||
130081691|NCT02614261|468251862|FG000|Israel Addendum|Withdrawal by Subject|0|||
130081692|NCT02614261|468251863|FG001|Israel Addendum|Withdrawal by Subject|0|||
130081693|NCT02614261|468251864|FG002|Israel Addendum|Withdrawal by Subject|0|||
130081694|NCT02614261|468251865|FG003|Israel Addendum|Withdrawal by Subject|4|||
130081695|NCT03512275|468251870|FG000|Overall Study|Withdrawal by Subject|1|||
130081696|NCT03512275|468251871|FG001|Overall Study|Withdrawal by Subject|3|||
130081697|NCT03512275|468251870|FG000|Overall Study|Physician Decision|0|||
130081698|NCT03512275|468251871|FG001|Overall Study|Physician Decision|1|||
130081699|NCT03512275|468251870|FG000|Overall Study|Lost to Follow-up|0|||
130081700|NCT03512275|468251871|FG001|Overall Study|Lost to Follow-up|3|||
130081701|NCT03512275|468251870|FG000|Overall Study|Other|1|||
130081702|NCT03512275|468251871|FG001|Overall Study|Other|0|||
130081703|NCT00609167|468251872|FG000|Overall Study|Withdrawal by Subject|1|||
130081704|NCT00609167|468251873|FG001|Overall Study|Withdrawal by Subject|0|||
129954475|NCT02213458|467794080|FG000|Overall Study|Refused re-consent|6|||
130081705|NCT00609167|468251872|FG000|Overall Study|Lack of Efficacy|1|||
130081706|NCT00609167|468251873|FG001|Overall Study|Lack of Efficacy|0|||
130081707|NCT00609167|468251872|FG000|Overall Study|Adverse Event|5|||
130081708|NCT00609167|468251873|FG001|Overall Study|Adverse Event|1|||
130081709|NCT00609167|468251872|FG000|Overall Study|Disease Progression|1|||
130081710|NCT00609167|468251873|FG001|Overall Study|Disease Progression|0|||
130081711|NCT00609167|468251872|FG000|Overall Study|Stem Cell Transplant|0|||
130081712|NCT00609167|468251873|FG001|Overall Study|Stem Cell Transplant|6|||
129954476|NCT02213458|467794081|FG001|Overall Study|Refused re-consent|0|||
129954477|NCT02213458|467794080|FG000|Overall Study|Lost to Follow-up|2|||
130081713|NCT02574520|468251874|FG000|Overall Study|Not dosed|2|||
130081714|NCT02574520|468251875|FG001|Overall Study|Not dosed|0|||
130081715|NCT02574520|468251876|FG002|Overall Study|Not dosed|5|||
130081716|NCT02574520|468251877|FG003|Overall Study|Not dosed|4|||
130081717|NCT02574520|468251874|FG000|Overall Study|Adverse Event|0|||
130081718|NCT02574520|468251875|FG001|Overall Study|Adverse Event|0|||
130081719|NCT02574520|468251876|FG002|Overall Study|Adverse Event|0|||
130081720|NCT02574520|468251877|FG003|Overall Study|Adverse Event|1|||
130081721|NCT02574520|468251874|FG000|Overall Study|Withdrawal by Subject|0|||
130081722|NCT02574520|468251875|FG001|Overall Study|Withdrawal by Subject|0|||
130081723|NCT02574520|468251876|FG002|Overall Study|Withdrawal by Subject|0|||
130081724|NCT02574520|468251877|FG003|Overall Study|Withdrawal by Subject|1|||
130081725|NCT02574520|468251874|FG000|Overall Study|Other|0|||
130081726|NCT02574520|468251875|FG001|Overall Study|Other|0|||
130081727|NCT02574520|468251876|FG002|Overall Study|Other|0|||
130081728|NCT02574520|468251877|FG003|Overall Study|Other|2|||
130081729|NCT00397891|468251880|FG000|Overall Study|Withdrawal by Subject|1|||
130081730|NCT00397891|468251881|FG001|Overall Study|Withdrawal by Subject|0|||
130081731|NCT00397891|468251882|FG002|Overall Study|Withdrawal by Subject|0|||
130081732|NCT00397891|468251883|FG003|Overall Study|Withdrawal by Subject|0|||
130081733|NCT00397891|468251884|FG004|Overall Study|Withdrawal by Subject|1|||
130081734|NCT02632344|468253109|FG000|Overall Study|Adverse Event|3|||
130081735|NCT02632344|468253109|FG000|Overall Study|Lack of Efficacy|3|||
130081736|NCT02632344|468253109|FG000|Overall Study|Withdrawal by Subject|2|||
130081737|NCT04076579|468253111|FG000|Overall Study|Adverse Event|2|||
130081738|NCT04076579|468253112|FG001|Overall Study|Adverse Event|0|||
130081739|NCT04076579|468253111|FG000|Overall Study|discontinued due to toxicity|1|||
130081740|NCT04076579|468253112|FG001|Overall Study|discontinued due to toxicity|0|||
130081741|NCT04076579|468253111|FG000|Overall Study|Physician Decision|1|||
130081742|NCT04076579|468253112|FG001|Overall Study|Physician Decision|0|||
130081743|NCT04076579|468253111|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
130081744|NCT04076579|468253112|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
130081745|NCT04076579|468253111|FG000|Overall Study|Noncompliance|0|||
130081746|NCT04076579|468253112|FG001|Overall Study|Noncompliance|1|||
130081747|NCT04076579|468253111|FG000|Overall Study|Withdrawal by Subject|0|||
130081748|NCT04076579|468253112|FG001|Overall Study|Withdrawal by Subject|2|||
130081749|NCT03793010|468253113|FG000|Overall Study|Withdrawal by Subject|5|||
130081750|NCT03793010|468253114|FG001|Overall Study|Withdrawal by Subject|7|||
130081751|NCT03793010|468253113|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
130081752|NCT03793010|468253114|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
130081753|NCT03793010|468253113|FG000|Overall Study|Lost to Follow-up|1|||
130081754|NCT03793010|468253114|FG001|Overall Study|Lost to Follow-up|2|||
130081755|NCT03793010|468253113|FG000|Overall Study|Patient couldn't sit still for injection|1|||
130081756|NCT03793010|468253114|FG001|Overall Study|Patient couldn't sit still for injection|0|||
130081757|NCT03793010|468253113|FG000|Overall Study|Withdrew to pursue other treatment|1|||
130081758|NCT03793010|468253114|FG001|Overall Study|Withdrew to pursue other treatment|0|||
130081759|NCT03793010|468253113|FG000|Overall Study|Did not meet eligibility criteria|1|||
130081760|NCT03793010|468253114|FG001|Overall Study|Did not meet eligibility criteria|0|||
130081761|NCT02903966|468253115|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
130081762|NCT02903966|468253116|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
130081763|NCT02903966|468253115|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
130081764|NCT02903966|468253116|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
130081765|NCT02903966|468253115|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
130081766|NCT02903966|468253116|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
130081767|NCT04924114|468253117|FG000|Overall Study|Withdrawal by Subject|0|||
130081768|NCT04924114|468253118|FG001|Overall Study|Withdrawal by Subject|2|||
130081769|NCT04924114|468253119|FG002|Overall Study|Withdrawal by Subject|2|||
130081770|NCT04924114|468253120|FG003|Overall Study|Withdrawal by Subject|0|||
130081771|NCT04924114|468253121|FG004|Overall Study|Withdrawal by Subject|2|||
130081772|NCT04423718|468253122|FG000|Main Study|Adverse Event|9|||
130081773|NCT04423718|468253123|FG001|Main Study|Adverse Event|5|||
130081774|NCT04423718|468253124|FG002|Main Study|Adverse Event|8|||
130081775|NCT04423718|468253122|FG000|Main Study|Physician Decision|3|||
130081776|NCT04423718|468253123|FG001|Main Study|Physician Decision|3|||
130081777|NCT04423718|468253124|FG002|Main Study|Physician Decision|2|||
130081778|NCT04423718|468253122|FG000|Main Study|Protocol Violation|0|||
130081779|NCT04423718|468253123|FG001|Main Study|Protocol Violation|0|||
130081780|NCT04423718|468253124|FG002|Main Study|Protocol Violation|1|||
130081781|NCT04423718|468253122|FG000|Main Study|Lost to Follow-up|3|||
130081782|NCT04423718|468253123|FG001|Main Study|Lost to Follow-up|3|||
130081783|NCT04423718|468253124|FG002|Main Study|Lost to Follow-up|4|||
130081784|NCT04423718|468253122|FG000|Main Study|Lack of Efficacy|2|||
130081785|NCT04423718|468253123|FG001|Main Study|Lack of Efficacy|1|||
130081786|NCT04423718|468253124|FG002|Main Study|Lack of Efficacy|0|||
130081787|NCT04423718|468253122|FG000|Main Study|Withdrawal by Subject|14|||
130081788|NCT04423718|468253123|FG001|Main Study|Withdrawal by Subject|20|||
130081789|NCT04423718|468253124|FG002|Main Study|Withdrawal by Subject|20|||
130081790|NCT04423718|468253122|FG000|Main Study|Death|10|||
130081791|NCT04423718|468253123|FG001|Main Study|Death|7|||
130081792|NCT04423718|468253124|FG002|Main Study|Death|7|||
129954478|NCT02213458|467794081|FG001|Overall Study|Lost to Follow-up|2|||
129954479|NCT02213458|467794080|FG000|Overall Study|Withdrawal by Subject|26|||
129954480|NCT02213458|467794081|FG001|Overall Study|Withdrawal by Subject|8|||
130081793|NCT04423718|468253122|FG000|Main Study|COVID-19 pandemic|2|||
130081794|NCT04423718|468253123|FG001|Main Study|COVID-19 pandemic|2|||
130081795|NCT04423718|468253124|FG002|Main Study|COVID-19 pandemic|2|||
130081796|NCT04423718|468253122|FG000|Main Study|Other|7|||
130081797|NCT04423718|468253123|FG001|Main Study|Other|3|||
130081798|NCT04423718|468253124|FG002|Main Study|Other|2|||
130081799|NCT04423718|468253122|FG000|Extension Phase|Other|1|||
130081800|NCT04423718|468253123|FG001|Extension Phase|Other|0|||
130081801|NCT04423718|468253124|FG002|Extension Phase|Other|0|||
130081802|NCT04423718|468253122|FG000|Extension Phase|Logistical problems|0|||
130081803|NCT04423718|468253123|FG001|Extension Phase|Logistical problems|1|||
130081804|NCT04423718|468253124|FG002|Extension Phase|Logistical problems|1|||
130081805|NCT04423718|468253122|FG000|Extension Phase|Physician Decision|1|||
130081806|NCT04423718|468253123|FG001|Extension Phase|Physician Decision|0|||
130081807|NCT04423718|468253124|FG002|Extension Phase|Physician Decision|1|||
130081808|NCT04423718|468253122|FG000|Extension Phase|Lack of Efficacy|2|||
130081809|NCT04423718|468253123|FG001|Extension Phase|Lack of Efficacy|0|||
130081810|NCT04423718|468253124|FG002|Extension Phase|Lack of Efficacy|1|||
130081811|NCT04423718|468253122|FG000|Extension Phase|Lost to Follow-up|0|||
130081812|NCT04423718|468253123|FG001|Extension Phase|Lost to Follow-up|2|||
130081813|NCT04423718|468253124|FG002|Extension Phase|Lost to Follow-up|3|||
130081814|NCT04423718|468253122|FG000|Extension Phase|Adverse Event|2|||
130081815|NCT04423718|468253123|FG001|Extension Phase|Adverse Event|3|||
130081816|NCT04423718|468253124|FG002|Extension Phase|Adverse Event|1|||
130081817|NCT04423718|468253122|FG000|Extension Phase|Death|4|||
130081818|NCT04423718|468253123|FG001|Extension Phase|Death|7|||
130081819|NCT04423718|468253124|FG002|Extension Phase|Death|2|||
130081820|NCT04423718|468253122|FG000|Extension Phase|Withdrawal by Subject|11|||
130081821|NCT04423718|468253123|FG001|Extension Phase|Withdrawal by Subject|11|||
130081822|NCT04423718|468253124|FG002|Extension Phase|Withdrawal by Subject|7|||
130081823|NCT00425945|468253125|FG000|Overall Study|Concern about Supplement|2|||
130081824|NCT00425945|468253126|FG001|Overall Study|Concern about Supplement|0|||
130081825|NCT00425945|468253125|FG000|Overall Study|Inconvenience|0|||
130081826|NCT00425945|468253126|FG001|Overall Study|Inconvenience|2|||
130081827|NCT00425945|468253125|FG000|Overall Study|Lost to Follow-up|0|||
130081828|NCT00425945|468253126|FG001|Overall Study|Lost to Follow-up|2|||
130081829|NCT00425945|468253125|FG000|Overall Study|Began hypertension medication|1|||
130081830|NCT00425945|468253126|FG001|Overall Study|Began hypertension medication|0|||
130081831|NCT00425945|468253125|FG000|Overall Study|Began cancer treatments|1|||
130081832|NCT00425945|468253126|FG001|Overall Study|Began cancer treatments|0|||
129954481|NCT00910871|467794082|FG000|Overall Study|Adverse Event|5|||
129954482|NCT00910871|467794082|FG000|Overall Study|Death|12|||
129954483|NCT00910871|467794082|FG000|Overall Study|Lost to Follow-up|8|||
129954484|NCT00910871|467794082|FG000|Overall Study|Protocol Violation|11|||
129954485|NCT00910871|467794082|FG000|Overall Study|Withdrawal by Subject|12|||
129954486|NCT00910871|467794082|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
129954487|NCT00910871|467794082|FG000|Overall Study|Undefined|1|||
129954488|NCT01047306|467794083|FG000|Overall Study|Withdrawal by Subject|2|||
129954489|NCT01047306|467794084|FG001|Overall Study|Withdrawal by Subject|0|||
129954490|NCT01047306|467794083|FG000|Overall Study|Lost to Follow-up|1|||
130081833|NCT00425945|468253125|FG000|Overall Study|Moved from area|0|||
130081834|NCT00425945|468253126|FG001|Overall Study|Moved from area|1|||
130081835|NCT02881151|468253127|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
130081836|NCT04284787|468253128|FG000|Overall Study|Disease Progression|9|||
130081837|NCT04284787|468253129|FG001|Overall Study|Disease Progression|12|||
129954491|NCT01047306|467794084|FG001|Overall Study|Lost to Follow-up|0|||
129954492|NCT04043806|467794085|FG000|Overall Study|Commercial drug is available for participants|13|||
129954493|NCT04043806|467794085|FG000|Overall Study|Physician Decision|2|||
130081838|NCT04284787|468253128|FG000|Overall Study|Physician Decision|12|||
130081839|NCT04284787|468253129|FG001|Overall Study|Physician Decision|7|||
130120942|NCT01265784|468404866|FG002|Overall Study|Death|0|||
129954494|NCT04043806|467794085|FG000|Overall Study|Other|12|||
129954495|NCT04043806|467794085|FG000|Overall Study|Adverse Event|2|||
129954496|NCT04043806|467794085|FG000|Overall Study|Lost to Follow-up|6|||
129954497|NCT04043806|467794085|FG000|Overall Study|Other non-compliance|2|||
129954498|NCT04043806|467794085|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
129954499|NCT04043806|467794085|FG000|Overall Study|Never Dosed|1|||
129954500|NCT04799587|467794087|FG000|Overall Study|Withdrawal by Subject|0|||
130081840|NCT04284787|468253128|FG000|Overall Study|Transplant|5|||
130081841|NCT04284787|468253129|FG001|Overall Study|Transplant|4|||
130081842|NCT04284787|468253128|FG000|Overall Study|Death|1|||
130081843|NCT04284787|468253129|FG001|Overall Study|Death|2|||
130081844|NCT04284787|468253128|FG000|Overall Study|Adverse Event|0|||
130081845|NCT04284787|468253129|FG001|Overall Study|Adverse Event|4|||
130081846|NCT04284787|468253128|FG000|Overall Study|Non-adherence|2|||
130081847|NCT04284787|468253129|FG001|Overall Study|Non-adherence|0|||
130081848|NCT04284787|468253128|FG000|Overall Study|Lack of Efficacy|2|||
130081849|NCT04284787|468253129|FG001|Overall Study|Lack of Efficacy|0|||
130081850|NCT04992507|468253132|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
130081851|NCT04992507|468253133|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
130081852|NCT04992507|468253132|FG000|Overall Study|Death|0|||
130081853|NCT04992507|468253133|FG001|Overall Study|Death|1|||
130081854|NCT03287830|468253134|FG000|Overall Study|Withdrawal by Subject|1|||
130081855|NCT03287830|468253135|FG001|Overall Study|Withdrawal by Subject|1|||
130081856|NCT03287830|468253134|FG000|Overall Study|not meeting inclusion criteria|5|||
130081857|NCT03287830|468253135|FG001|Overall Study|not meeting inclusion criteria|12|||
130081858|NCT02974621|468253136|FG000|Overall Study|Didn't receive study treatment|1|||
130081859|NCT02974621|468253137|FG001|Overall Study|Didn't receive study treatment|10|||
130081860|NCT00557323|468253138|FG000|Overall Study|Death|3|||
130081861|NCT00557323|468253138|FG000|Overall Study|Withdrawal by Subject|2|||
130081862|NCT00557323|468253138|FG000|Overall Study|Administrative change|2|||
130081863|NCT01196091|468253143|FG000|Overall Study|Adverse Event|22|||
130081864|NCT01196091|468253144|FG001|Overall Study|Adverse Event|27|||
130081865|NCT01196091|468253145|FG002|Overall Study|Adverse Event|26|||
130081866|NCT01196091|468253143|FG000|Overall Study|Death|3|||
130081867|NCT01196091|468253144|FG001|Overall Study|Death|2|||
130081868|NCT01196091|468253145|FG002|Overall Study|Death|2|||
130081869|NCT01196091|468253143|FG000|Overall Study|Entry Criteria Not Met|11|||
130081870|NCT01196091|468253144|FG001|Overall Study|Entry Criteria Not Met|11|||
130081871|NCT01196091|468253145|FG002|Overall Study|Entry Criteria Not Met|10|||
130081872|NCT01196091|468253143|FG000|Overall Study|Lack of Efficacy|15|||
130081873|NCT01196091|468253144|FG001|Overall Study|Lack of Efficacy|12|||
130081874|NCT01196091|468253145|FG002|Overall Study|Lack of Efficacy|17|||
130081875|NCT01196091|468253143|FG000|Overall Study|Lost to Follow-up|5|||
130081876|NCT01196091|468253144|FG001|Overall Study|Lost to Follow-up|5|||
130081877|NCT01196091|468253145|FG002|Overall Study|Lost to Follow-up|6|||
130081878|NCT01196091|468253143|FG000|Overall Study|Parent/Caregiver Decision|0|||
130081879|NCT01196091|468253144|FG001|Overall Study|Parent/Caregiver Decision|0|||
130081880|NCT01196091|468253145|FG002|Overall Study|Parent/Caregiver Decision|1|||
130081881|NCT01196091|468253143|FG000|Overall Study|Withdrawal by Subject|16|||
130081882|NCT01196091|468253144|FG001|Overall Study|Withdrawal by Subject|19|||
130081883|NCT01196091|468253145|FG002|Overall Study|Withdrawal by Subject|22|||
130081884|NCT01196091|468253143|FG000|Overall Study|Physician Decision|3|||
130081885|NCT01196091|468253144|FG001|Overall Study|Physician Decision|3|||
130081886|NCT01196091|468253145|FG002|Overall Study|Physician Decision|4|||
130081887|NCT01196091|468253143|FG000|Overall Study|Protocol Violation|1|||
130081888|NCT01196091|468253144|FG001|Overall Study|Protocol Violation|3|||
130081889|NCT01196091|468253145|FG002|Overall Study|Protocol Violation|3|||
130081890|NCT01196091|468253143|FG000|Overall Study|Sponsor Decision|6|||
130081891|NCT01196091|468253144|FG001|Overall Study|Sponsor Decision|5|||
130081892|NCT01196091|468253145|FG002|Overall Study|Sponsor Decision|4|||
130081893|NCT01196091|468253143|FG000|Overall Study|Excluded Site|5|||
130081894|NCT01196091|468253144|FG001|Overall Study|Excluded Site|11|||
130081895|NCT01196091|468253145|FG002|Overall Study|Excluded Site|8|||
130081896|NCT01196091|468253143|FG000|Overall Study|Randomized, No Study Drug Received|1|||
130081897|NCT01196091|468253144|FG001|Overall Study|Randomized, No Study Drug Received|0|||
130081898|NCT01196091|468253145|FG002|Overall Study|Randomized, No Study Drug Received|1|||
130081899|NCT03733249|468253146|FG000|Overall Study|Death|7|||
130081900|NCT03733249|468253146|FG000|Overall Study|Disease relapse|16|||
130081901|NCT03733249|468253146|FG000|Overall Study|Lost to Follow-up|4|||
130081902|NCT03733249|468253146|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
130081903|NCT03733249|468253146|FG000|Overall Study|Withdrawal by Subject|1|||
130081904|NCT02253992|468253147|FG000|Overall Study|Study drug toxicity|1|||
130081905|NCT02253992|468253148|FG001|Overall Study|Study drug toxicity|0|||
130081906|NCT02253992|468253149|FG002|Overall Study|Study drug toxicity|10|||
130081907|NCT02253992|468253147|FG000|Overall Study|Disease progression|4|||
130081908|NCT02253992|468253148|FG001|Overall Study|Disease progression|3|||
130081909|NCT02253992|468253149|FG002|Overall Study|Disease progression|98|||
130081910|NCT02253992|468253147|FG000|Overall Study|Withdrawal by Subject|0|||
130081911|NCT02253992|468253148|FG001|Overall Study|Withdrawal by Subject|0|||
130081912|NCT02253992|468253149|FG002|Overall Study|Withdrawal by Subject|3|||
130081913|NCT02253992|468253147|FG000|Overall Study|Adverse Event|0|||
130081914|NCT02253992|468253148|FG001|Overall Study|Adverse Event|0|||
130081915|NCT02253992|468253149|FG002|Overall Study|Adverse Event|8|||
130081916|NCT02253992|468253147|FG000|Overall Study|Death|0|||
130081917|NCT02253992|468253148|FG001|Overall Study|Death|0|||
130081918|NCT02253992|468253149|FG002|Overall Study|Death|1|||
130081919|NCT02253992|468253147|FG000|Overall Study|Subject discontinued study drug|1|||
130081920|NCT02253992|468253148|FG001|Overall Study|Subject discontinued study drug|0|||
130081921|NCT02253992|468253149|FG002|Overall Study|Subject discontinued study drug|1|||
130081922|NCT02253992|468253147|FG000|Overall Study|Completed treatment as per protocol|0|||
130081923|NCT02253992|468253148|FG001|Overall Study|Completed treatment as per protocol|1|||
130081924|NCT02253992|468253149|FG002|Overall Study|Completed treatment as per protocol|22|||
130081925|NCT02253992|468253147|FG000|Overall Study|Other|0|||
130081926|NCT02253992|468253148|FG001|Overall Study|Other|0|||
130081927|NCT02253992|468253149|FG002|Overall Study|Other|1|||
130081928|NCT00772889|468253150|FG000|Overall Study|Adverse Event|7|||
130081929|NCT00772889|468253151|FG001|Overall Study|Adverse Event|4|||
130081930|NCT00772889|468253152|FG002|Overall Study|Adverse Event|0|||
130081931|NCT00772889|468253150|FG000|Overall Study|Withdrawal by Subject|9|||
130081932|NCT00772889|468253151|FG001|Overall Study|Withdrawal by Subject|8|||
130081933|NCT00772889|468253152|FG002|Overall Study|Withdrawal by Subject|9|||
130081934|NCT00772889|468253150|FG000|Overall Study|Lost to Follow-up|6|||
130081935|NCT00772889|468253151|FG001|Overall Study|Lost to Follow-up|6|||
130081936|NCT00772889|468253152|FG002|Overall Study|Lost to Follow-up|7|||
130081937|NCT03323086|468253153|FG000|Overall Study|Lost to Follow-up|3|||
130081938|NCT03323086|468253154|FG001|Overall Study|Lost to Follow-up|2|||
130081939|NCT02159365|468253155|FG000|Overall Study|Disease Progression|23|||
130081940|NCT02159365|468253155|FG000|Overall Study|Other reasons|11|||
130081941|NCT02159365|468253155|FG000|Overall Study|Administrative reason by Sponsor|9|||
130081942|NCT02159365|468253155|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
130081943|NCT02159365|468253155|FG000|Overall Study|Study drug toxicity|7|||
130081944|NCT02159365|468253155|FG000|Overall Study|Maximum clinical benefit|3|||
130081945|NCT02159365|468253155|FG000|Overall Study|Subject request to discontinue treatment|3|||
130081946|NCT02159365|468253155|FG000|Overall Study|Subject withdrew consent|3|||
130081947|NCT02159365|468253155|FG000|Overall Study|Death|1|||
130081948|NCT02159365|468253155|FG000|Overall Study|Lost to Follow-up|1|||
130081949|NCT00255008|468253156|FG000|Overall Study|Adverse Event|1|||
130081950|NCT00255008|468253157|FG001|Overall Study|Adverse Event|1|||
130081951|NCT00255008|468253158|FG002|Overall Study|Adverse Event|2|||
130081952|NCT00255008|468253159|FG003|Overall Study|Adverse Event|0|||
130081953|NCT00255008|468253156|FG000|Overall Study|Lost to Follow-up|1|||
130081954|NCT00255008|468253157|FG001|Overall Study|Lost to Follow-up|0|||
130081955|NCT00255008|468253158|FG002|Overall Study|Lost to Follow-up|1|||
130081956|NCT00255008|468253159|FG003|Overall Study|Lost to Follow-up|2|||
130081957|NCT00255008|468253156|FG000|Overall Study|Did not meet viral reduction criteria|4|||
130081958|NCT00255008|468253157|FG001|Overall Study|Did not meet viral reduction criteria|5|||
130081959|NCT00255008|468253158|FG002|Overall Study|Did not meet viral reduction criteria|0|||
130081960|NCT00255008|468253159|FG003|Overall Study|Did not meet viral reduction criteria|1|||
130081961|NCT00255008|468253156|FG000|Overall Study|Withdrew consent|0|||
130081962|NCT00255008|468253157|FG001|Overall Study|Withdrew consent|0|||
130081963|NCT00255008|468253158|FG002|Overall Study|Withdrew consent|2|||
130081964|NCT00255008|468253159|FG003|Overall Study|Withdrew consent|0|||
130081965|NCT00255008|468253156|FG000|Overall Study|Sponsor request|18|||
130081966|NCT00255008|468253157|FG001|Overall Study|Sponsor request|3|||
130081967|NCT00255008|468253158|FG002|Overall Study|Sponsor request|8|||
130081968|NCT00255008|468253159|FG003|Overall Study|Sponsor request|17|||
129954501|NCT04799587|467794088|FG001|Overall Study|Withdrawal by Subject|1|||
129954502|NCT01613599|467794091|FG000|Overall Study|Death|9|||
129954503|NCT01613599|467794091|FG000|Overall Study|Lost to Follow-up|5|||
130081969|NCT00255008|468253156|FG000|Overall Study|Adverse lab experience|1|||
130081970|NCT00255008|468253157|FG001|Overall Study|Adverse lab experience|0|||
130081971|NCT00255008|468253158|FG002|Overall Study|Adverse lab experience|0|||
130081972|NCT00255008|468253159|FG003|Overall Study|Adverse lab experience|0|||
130081973|NCT00255008|468253156|FG000|Overall Study|Other|7|||
130081974|NCT00255008|468253157|FG001|Overall Study|Other|0|||
130081975|NCT00255008|468253158|FG002|Overall Study|Other|3|||
130081976|NCT00255008|468253159|FG003|Overall Study|Other|2|||
130081977|NCT00707486|468253160|FG000|Overall Study|Withdrawal by Subject|1|||
130081978|NCT00126425|468253166|FG000|Overall Study|Withdrawal by Subject|17|||
130081979|NCT00126425|468253167|FG001|Overall Study|Withdrawal by Subject|1|||
130081980|NCT00126425|468253166|FG000|Overall Study|Lost to Follow-up|8|||
130081981|NCT00126425|468253167|FG001|Overall Study|Lost to Follow-up|4|||
130081982|NCT00126425|468253166|FG000|Overall Study|Protocol Violation|9|||
130081983|NCT00126425|468253167|FG001|Overall Study|Protocol Violation|6|||
130081984|NCT00126425|468253166|FG000|Overall Study|Adverse Event|1|||
130081985|NCT00126425|468253167|FG001|Overall Study|Adverse Event|0|||
130081986|NCT00126425|468253166|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
130120943|NCT01265784|468404864|FG000|Overall Study|Protocol Violation|2|||
130120944|NCT01265784|468404865|FG001|Overall Study|Protocol Violation|0|||
130081987|NCT00126425|468253167|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
130081988|NCT00126425|468253166|FG000|Overall Study|Other|5|||
130081989|NCT00126425|468253167|FG001|Overall Study|Other|0|||
130081990|NCT02774291|468253168|FG000|Overall Study|Lost to Follow-up|1|||
130120945|NCT01265784|468404866|FG002|Overall Study|Protocol Violation|0|||
130120946|NCT01265784|468404864|FG000|Overall Study|Incorrectly Randomized|0|||
129954504|NCT01613599|467794091|FG000|Overall Study|Withdrawal by Subject|8|||
130081991|NCT00471315|468253169|FG000|Overall Study|Adverse Event|7|||
130081992|NCT00471315|468253169|FG000|Overall Study|Withdrawal by Subject|1|||
130081993|NCT04474366|468253170|FG000|Overall Study|Lost to Follow-up|2|||
130081994|NCT04474366|468253171|FG001|Overall Study|Lost to Follow-up|5|||
130081995|NCT04063865|468253172|FG000|Overall Study|Physician Decision|1|||
130081996|NCT04063865|468253173|FG001|Overall Study|Physician Decision|3|||
130120947|NCT01265784|468404865|FG001|Overall Study|Incorrectly Randomized|0|||
130081997|NCT04063865|468253172|FG000|Overall Study|Study Closed Prior to Completion|4|||
130081998|NCT04063865|468253173|FG001|Overall Study|Study Closed Prior to Completion|4|||
130081999|NCT04063865|468253172|FG000|Overall Study|Withdrawal by Subject|1|||
130082000|NCT04063865|468253173|FG001|Overall Study|Withdrawal by Subject|1|||
130082001|NCT03898323|468253174|FG000|Overall Study|Physician Decision|1|||
130082002|NCT00320190|468253175|FG000|First 12 Months|Completed but did not enter extension|5|||
130082003|NCT00320190|468253176|FG001|First 12 Months|Completed but did not enter extension|3|||
130082004|NCT00320190|468253175|FG000|First 12 Months|Sponsor terminated study|2|||
130082005|NCT00320190|468253176|FG001|First 12 Months|Sponsor terminated study|2|||
130082006|NCT00320190|468253175|FG000|First 12 Months|Lost to Follow-up|0|||
130082007|NCT00320190|468253176|FG001|First 12 Months|Lost to Follow-up|1|||
130082008|NCT00320190|468253175|FG000|First 12 Months|Enrollment failure|0|||
130082009|NCT00320190|468253176|FG001|First 12 Months|Enrollment failure|1|||
130082010|NCT00320190|468253175|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
130082011|NCT00320190|468253176|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
130082012|NCT00320190|468253175|FG000|First 12 Months|Investigator request|0|||
130082013|NCT00320190|468253176|FG001|First 12 Months|Investigator request|1|||
130082014|NCT00320190|468253175|FG000|First 12 Months|Study drug toxicity|0|||
130082015|NCT00320190|468253176|FG001|First 12 Months|Study drug toxicity|1|||
130082016|NCT00320190|468253175|FG000|First 12 Months|Withdrawal by Subject|0|||
130082017|NCT00320190|468253176|FG001|First 12 Months|Withdrawal by Subject|1|||
130082018|NCT00320190|468253175|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
130082019|NCT00320190|468253176|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
130082020|NCT00320190|468253175|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
130082021|NCT00320190|468253176|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
130082022|NCT00320190|468253175|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
130082023|NCT00320190|468253176|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
130082024|NCT00712270|468253178|FG000|Overall Study|Withdrawal by Subject|11|||
130082025|NCT00712270|468253178|FG000|Overall Study|Screen Failure|3|||
130082026|NCT00102804|468253191|FG000|Overall Study|Progressive Disease (PD)|307|||
130082027|NCT00102804|468253192|FG001|Overall Study|Progressive Disease (PD)|196|||
130082028|NCT00102804|468253191|FG000|Overall Study|Withdrawal by Subject|46|||
130082029|NCT00102804|468253192|FG001|Overall Study|Withdrawal by Subject|7|||
130082030|NCT00102804|468253191|FG000|Overall Study|Adverse Event|37|||
129954505|NCT01613599|467794091|FG000|Overall Study|Reason not specified|3|||
129954506|NCT00617708|467794095|FG000|Overall Study|Adverse Event|0|||
130120948|NCT01265784|468404866|FG002|Overall Study|Incorrectly Randomized|1|||
130120949|NCT00984295|468404869|FG000|Overall Study|Lost to Follow-up|31|||
130120950|NCT00984295|468404870|FG001|Overall Study|Lost to Follow-up|12|||
130120951|NCT00984295|468404871|FG002|Overall Study|Lost to Follow-up|13|||
130120952|NCT00984295|468404869|FG000|Overall Study|Protocol Violation|2|||
130120953|NCT00984295|468404870|FG001|Overall Study|Protocol Violation|1|||
130120954|NCT00984295|468404871|FG002|Overall Study|Protocol Violation|4|||
130120955|NCT00984295|468404869|FG000|Overall Study|Withdrawal by Subject|18|||
130120956|NCT00984295|468404870|FG001|Overall Study|Withdrawal by Subject|9|||
130120957|NCT00984295|468404871|FG002|Overall Study|Withdrawal by Subject|12|||
130120958|NCT00984295|468404869|FG000|Overall Study|CAE - discontinued test vaccine|0|||
130120959|NCT00984295|468404870|FG001|Overall Study|CAE - discontinued test vaccine|1|||
129954507|NCT00617708|467794096|FG001|Overall Study|Adverse Event|6|||
129954508|NCT00617708|467794097|FG002|Overall Study|Adverse Event|9|||
129954509|NCT00617708|467794095|FG000|Overall Study|Withdrawal by Subject|1|||
129954510|NCT00617708|467794096|FG001|Overall Study|Withdrawal by Subject|1|||
129954511|NCT00617708|467794097|FG002|Overall Study|Withdrawal by Subject|7|||
129954512|NCT00617708|467794095|FG000|Overall Study|Death|0|||
129954513|NCT00617708|467794096|FG001|Overall Study|Death|6|||
129954514|NCT00617708|467794097|FG002|Overall Study|Death|5|||
129954515|NCT00617708|467794095|FG000|Overall Study|Progression/Relapse|7|||
129954516|NCT00617708|467794096|FG001|Overall Study|Progression/Relapse|40|||
129954517|NCT00617708|467794097|FG002|Overall Study|Progression/Relapse|36|||
129954518|NCT00617708|467794095|FG000|Overall Study|Not protocol specified|1|||
129954519|NCT00617708|467794096|FG001|Overall Study|Not protocol specified|4|||
129954520|NCT00617708|467794097|FG002|Overall Study|Not protocol specified|2|||
129954521|NCT00617708|467794095|FG000|Overall Study|Not eligible|1|||
129954522|NCT00617708|467794096|FG001|Overall Study|Not eligible|3|||
130082031|NCT00102804|468253192|FG001|Overall Study|Adverse Event|3|||
130120960|NCT00984295|468404871|FG002|Overall Study|CAE - discontinued test vaccine|3|||
130120961|NCT00984295|468404869|FG000|Overall Study|Missed one or more blood samplings|3|||
130082032|NCT00102804|468253191|FG000|Overall Study|Physician Decision|24|||
130082033|NCT00102804|468253192|FG001|Overall Study|Physician Decision|6|||
130120962|NCT00984295|468404870|FG001|Overall Study|Missed one or more blood samplings|7|||
129954523|NCT00617708|467794097|FG002|Overall Study|Not eligible|5|||
129954524|NCT02058992|467794098|FG000|Overall Study|Lost to Follow-up|4|||
129954525|NCT02058992|467794098|FG000|Overall Study|Protocol Violation|92|||
129954526|NCT02058992|467794098|FG000|Overall Study|CRF Uncollected|20|||
129954527|NCT02130401|467794099|FG000|Overall Study|Poor enrollment|6|||
130082034|NCT00102804|468253191|FG000|Overall Study|Death|5|||
130082035|NCT00102804|468253192|FG001|Overall Study|Death|6|||
130082036|NCT00102804|468253191|FG000|Overall Study|Enrollment Criteria Not Met|6|||
130082037|NCT00102804|468253192|FG001|Overall Study|Enrollment Criteria Not Met|0|||
130082038|NCT00102804|468253191|FG000|Overall Study|Lost to Follow-up|4|||
130082039|NCT00102804|468253192|FG001|Overall Study|Lost to Follow-up|1|||
130082040|NCT00102804|468253191|FG000|Overall Study|Protocol Violation|2|||
130082041|NCT00102804|468253192|FG001|Overall Study|Protocol Violation|1|||
130082042|NCT00102804|468253191|FG000|Overall Study|Satisfactory Response|2|||
130082043|NCT00102804|468253192|FG001|Overall Study|Satisfactory Response|0|||
130082044|NCT00102804|468253191|FG000|Overall Study|Sponsor Decision|1|||
130082045|NCT00102804|468253192|FG001|Overall Study|Sponsor Decision|0|||
130082046|NCT00102804|468253191|FG000|Overall Study|Alive, Receiving Treatment|7|||
130082047|NCT00102804|468253192|FG001|Overall Study|Alive, Receiving Treatment|2|||
130082048|NCT00112840|468253198|FG000|Overall Study|Physician Decision|1|||
130082049|NCT00112840|468253199|FG001|Overall Study|Physician Decision|0|||
130082050|NCT00112840|468253200|FG002|Overall Study|Physician Decision|0|||
130082051|NCT00112840|468253198|FG000|Overall Study|Withdrawal by Subject|1|||
130082052|NCT00112840|468253199|FG001|Overall Study|Withdrawal by Subject|0|||
130082053|NCT00112840|468253200|FG002|Overall Study|Withdrawal by Subject|1|||
130082054|NCT00112840|468253198|FG000|Overall Study|Protocol Violation|0|||
130082055|NCT00112840|468253199|FG001|Overall Study|Protocol Violation|0|||
130082056|NCT00112840|468253200|FG002|Overall Study|Protocol Violation|5|||
130082057|NCT00683774|468253201|FG000|Overall Study|Withdrawal by Subject|0|||
130082058|NCT00683774|468253202|FG001|Overall Study|Withdrawal by Subject|1|||
130082059|NCT00683774|468253201|FG000|Overall Study|Physician Decision|3|||
130082060|NCT00683774|468253202|FG001|Overall Study|Physician Decision|0|||
130082061|NCT00691054|468253203|FG000|Overall Study|Withdrawal by Subject|1|||
130082062|NCT03595176|468253204|FG000|Overall Study|Death|0|||
130082063|NCT03595176|468253205|FG001|Overall Study|Death|2|||
130082064|NCT03595176|468253204|FG000|Overall Study|Lost to Follow-up|0|||
130082065|NCT03595176|468253205|FG001|Overall Study|Lost to Follow-up|1|||
130082066|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
130082067|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130082068|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130082069|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129954528|NCT03005106|467794100|FG000|Overall Study|Lost to Follow-up|16|||
129954529|NCT03005106|467794100|FG000|Overall Study|Adverse Event|1|||
129954530|NCT03005106|467794100|FG000|Overall Study|Physician Decision|1|||
129954531|NCT03005106|467794100|FG000|Overall Study|Death|2|||
129954532|NCT00321672|467794101|FG000|Overall Study|Withdrawal by Subject|5|||
129954533|NCT00321672|467794102|FG001|Overall Study|Withdrawal by Subject|1|||
129954534|NCT00321672|467794103|FG002|Overall Study|Withdrawal by Subject|2|||
129954535|NCT00321672|467794104|FG003|Overall Study|Withdrawal by Subject|0|||
130082070|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130082071|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
130082072|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
130082073|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130082074|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130082075|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130082076|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130082077|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
130082078|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
130082079|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130082080|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130082081|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130082082|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130082083|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
130082084|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Other|14|||
130082085|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Other|0|||
130082086|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Other|0|||
130082087|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Other|0|||
130082088|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Other|0|||
129954536|NCT00321672|467794101|FG000|Overall Study|Noncompliance|1|||
130082089|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Other|0|||
130082090|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
129954537|NCT00321672|467794102|FG001|Overall Study|Noncompliance|2|||
130082091|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
130082092|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
130082093|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
130082094|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
130082095|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
129954538|NCT00321672|467794103|FG002|Overall Study|Noncompliance|1|||
129954539|NCT00321672|467794104|FG003|Overall Study|Noncompliance|0|||
129954540|NCT00321672|467794101|FG000|Overall Study|Adverse Event|1|||
130082096|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
130082097|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130082098|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130082099|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130082100|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130082101|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
130082102|NCT02141854|468253206|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
130082103|NCT02141854|468253207|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130082104|NCT02141854|468253208|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130082105|NCT02141854|468253209|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130082106|NCT02141854|468253210|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130082107|NCT02141854|468253211|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
130082108|NCT02141854|468253206|FG000|Treatment Period|Protocol Violation|0|||
130082109|NCT02141854|468253207|FG001|Treatment Period|Protocol Violation|1|||
130082110|NCT02141854|468253208|FG002|Treatment Period|Protocol Violation|0|||
130082111|NCT02141854|468253209|FG003|Treatment Period|Protocol Violation|2|||
130082112|NCT02141854|468253210|FG004|Treatment Period|Protocol Violation|2|||
130082113|NCT02141854|468253211|FG005|Treatment Period|Protocol Violation|1|||
130082114|NCT02141854|468253206|FG000|Treatment Period|Noncompliance|0|||
130082115|NCT02141854|468253207|FG001|Treatment Period|Noncompliance|0|||
130082116|NCT02141854|468253208|FG002|Treatment Period|Noncompliance|0|||
130082117|NCT02141854|468253209|FG003|Treatment Period|Noncompliance|1|||
130082118|NCT02141854|468253210|FG004|Treatment Period|Noncompliance|0|||
130082119|NCT02141854|468253211|FG005|Treatment Period|Noncompliance|0|||
130082120|NCT02141854|468253206|FG000|Treatment Period|Lack of Efficacy|0|||
130082121|NCT02141854|468253207|FG001|Treatment Period|Lack of Efficacy|0|||
130082122|NCT02141854|468253208|FG002|Treatment Period|Lack of Efficacy|0|||
130082123|NCT02141854|468253209|FG003|Treatment Period|Lack of Efficacy|1|||
130082124|NCT02141854|468253210|FG004|Treatment Period|Lack of Efficacy|1|||
130082125|NCT02141854|468253211|FG005|Treatment Period|Lack of Efficacy|7|||
130082126|NCT02141854|468253206|FG000|Treatment Period|Pregnancy|0|||
130082127|NCT02141854|468253207|FG001|Treatment Period|Pregnancy|1|||
130082128|NCT02141854|468253208|FG002|Treatment Period|Pregnancy|0|||
130082129|NCT02141854|468253209|FG003|Treatment Period|Pregnancy|0|||
130082130|NCT02141854|468253210|FG004|Treatment Period|Pregnancy|0|||
130082131|NCT02141854|468253211|FG005|Treatment Period|Pregnancy|0|||
130082132|NCT02141854|468253206|FG000|Treatment Period|Other|0|||
130082133|NCT02141854|468253207|FG001|Treatment Period|Other|1|||
130082134|NCT02141854|468253208|FG002|Treatment Period|Other|2|||
130082135|NCT02141854|468253209|FG003|Treatment Period|Other|0|||
130082136|NCT02141854|468253210|FG004|Treatment Period|Other|1|||
130082137|NCT02141854|468253211|FG005|Treatment Period|Other|2|||
130082138|NCT02141854|468253206|FG000|Treatment Period|Adverse Event|0|||
130082139|NCT02141854|468253207|FG001|Treatment Period|Adverse Event|2|||
130082140|NCT02141854|468253208|FG002|Treatment Period|Adverse Event|2|||
130082141|NCT02141854|468253209|FG003|Treatment Period|Adverse Event|0|||
130082142|NCT02141854|468253210|FG004|Treatment Period|Adverse Event|2|||
130082143|NCT02141854|468253211|FG005|Treatment Period|Adverse Event|2|||
130082144|NCT02141854|468253206|FG000|Treatment Period|Withdrawal by Subject|0|||
130082145|NCT02141854|468253207|FG001|Treatment Period|Withdrawal by Subject|2|||
130082146|NCT02141854|468253208|FG002|Treatment Period|Withdrawal by Subject|3|||
130082147|NCT02141854|468253209|FG003|Treatment Period|Withdrawal by Subject|3|||
130082148|NCT02141854|468253210|FG004|Treatment Period|Withdrawal by Subject|4|||
130082149|NCT02141854|468253211|FG005|Treatment Period|Withdrawal by Subject|7|||
130082150|NCT02141854|468253206|FG000|Treatment Period|Disease progression|0|||
130082151|NCT02141854|468253207|FG001|Treatment Period|Disease progression|2|||
130082152|NCT02141854|468253208|FG002|Treatment Period|Disease progression|1|||
130082153|NCT02141854|468253209|FG003|Treatment Period|Disease progression|3|||
130082154|NCT02141854|468253210|FG004|Treatment Period|Disease progression|0|||
130082155|NCT02141854|468253211|FG005|Treatment Period|Disease progression|18|||
130082156|NCT02141854|468253206|FG000|Treatment Period|Lost to Follow-up|0|||
130082157|NCT02141854|468253207|FG001|Treatment Period|Lost to Follow-up|1|||
130082158|NCT02141854|468253208|FG002|Treatment Period|Lost to Follow-up|1|||
130082159|NCT02141854|468253209|FG003|Treatment Period|Lost to Follow-up|1|||
130082160|NCT02141854|468253210|FG004|Treatment Period|Lost to Follow-up|0|||
130082161|NCT02141854|468253211|FG005|Treatment Period|Lost to Follow-up|1|||
130082162|NCT01868594|468253212|FG000|Overall Study|Do not meet inclusion criteria|4|||
130082163|NCT01868594|468253213|FG001|Overall Study|Do not meet inclusion criteria|3|||
130082164|NCT04964557|468253216|FG000|Overall Study|Withdrawal by Subject|3|||
130082165|NCT04964557|468253217|FG001|Overall Study|Withdrawal by Subject|2|||
129954541|NCT00321672|467794102|FG001|Overall Study|Adverse Event|1|||
130082166|NCT04964557|468253216|FG000|Overall Study|Lost to Follow-up|1|||
130082167|NCT04964557|468253217|FG001|Overall Study|Lost to Follow-up|2|||
130082168|NCT04964557|468253216|FG000|Overall Study|Physician Decision|2|||
130082169|NCT04964557|468253217|FG001|Overall Study|Physician Decision|0|||
130082170|NCT04964557|468253216|FG000|Overall Study|Death|3|||
130082171|NCT04964557|468253217|FG001|Overall Study|Death|0|||
129954542|NCT00321672|467794103|FG002|Overall Study|Adverse Event|0|||
130082172|NCT04964557|468253216|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
130082173|NCT04964557|468253217|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
130082174|NCT02659098|468253218|FG000|Overall Study|Withdrawal by Subject|7|||
130082175|NCT04363944|468253219|FG000|Overall Study|Withdrawal by Subject|2|||
130082176|NCT04363944|468253220|FG001|Overall Study|Withdrawal by Subject|0|||
130082177|NCT03991936|468255317|FG000|Overall Study|Lost to Follow-up|1|||
130082178|NCT03991936|468255318|FG001|Overall Study|Lost to Follow-up|1|||
130082179|NCT03991936|468255319|FG002|Overall Study|Lost to Follow-up|1|||
130082180|NCT03991936|468255320|FG003|Overall Study|Lost to Follow-up|1|||
130082181|NCT03991936|468255321|FG004|Overall Study|Lost to Follow-up|1|||
130082182|NCT00939055|468255322|FG000|Overall Study|Discontinuation prior to procedure|4|||
130082183|NCT00939055|468255323|FG001|Overall Study|Discontinuation prior to procedure|0|||
130082184|NCT00584987|468255326|FG000|Overall Study|Protocol Violation|1|||
130082185|NCT00584987|468255327|FG001|Overall Study|Protocol Violation|1|||
130082186|NCT00584987|468255328|FG002|Overall Study|Protocol Violation|1|||
130082187|NCT00584987|468255329|FG003|Overall Study|Protocol Violation|0|||
130082188|NCT00584987|468255326|FG000|Overall Study|Adverse Event|0|||
130082189|NCT00584987|468255327|FG001|Overall Study|Adverse Event|0|||
130082190|NCT00584987|468255328|FG002|Overall Study|Adverse Event|0|||
130082191|NCT00584987|468255329|FG003|Overall Study|Adverse Event|1|||
130082192|NCT03225833|468255330|FG000|Overall Study|Adverse Event|0|||
130082193|NCT03225833|468255331|FG001|Overall Study|Adverse Event|1|||
130082194|NCT03225833|468255332|FG002|Overall Study|Adverse Event|2|||
130082195|NCT03225833|468255333|FG003|Overall Study|Adverse Event|0|||
130082196|NCT03225833|468255334|FG004|Overall Study|Adverse Event|0|||
130082197|NCT03225833|468255335|FG005|Overall Study|Adverse Event|2|||
130082198|NCT03225833|468255330|FG000|Overall Study|Withdrawal by Subject|1|||
130082199|NCT03225833|468255331|FG001|Overall Study|Withdrawal by Subject|0|||
130082200|NCT03225833|468255332|FG002|Overall Study|Withdrawal by Subject|0|||
130082201|NCT03225833|468255333|FG003|Overall Study|Withdrawal by Subject|0|||
130082202|NCT03225833|468255334|FG004|Overall Study|Withdrawal by Subject|1|||
130082203|NCT03225833|468255335|FG005|Overall Study|Withdrawal by Subject|0|||
130082204|NCT03225833|468255330|FG000|Overall Study|Termination of Study by Sponsor|4|||
130082205|NCT03225833|468255331|FG001|Overall Study|Termination of Study by Sponsor|0|||
130082206|NCT03225833|468255332|FG002|Overall Study|Termination of Study by Sponsor|0|||
130082207|NCT03225833|468255333|FG003|Overall Study|Termination of Study by Sponsor|0|||
130082208|NCT03225833|468255334|FG004|Overall Study|Termination of Study by Sponsor|0|||
130082209|NCT03225833|468255335|FG005|Overall Study|Termination of Study by Sponsor|7|||
130082210|NCT03225833|468255330|FG000|Overall Study|Sponsor Decision|0|||
130082211|NCT03225833|468255331|FG001|Overall Study|Sponsor Decision|0|||
130082212|NCT03225833|468255332|FG002|Overall Study|Sponsor Decision|0|||
130082213|NCT03225833|468255333|FG003|Overall Study|Sponsor Decision|0|||
130082214|NCT03225833|468255334|FG004|Overall Study|Sponsor Decision|0|||
130082215|NCT03225833|468255335|FG005|Overall Study|Sponsor Decision|1|||
130082216|NCT03258593|468255337|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
130082217|NCT03258593|468255338|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
130082218|NCT03258593|468255339|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
130082219|NCT03258593|468255340|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
130082220|NCT03258593|468255337|FG000|Run-In Maintenance Phase|Disease progression|3|||
130082221|NCT03258593|468255338|FG001|Run-In Maintenance Phase|Disease progression|0|||
130082222|NCT03258593|468255339|FG002|Run-In Maintenance Phase|Disease progression|0|||
130082223|NCT03258593|468255340|FG003|Run-In Maintenance Phase|Disease progression|0|||
130082224|NCT03258593|468255337|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
130082225|NCT03258593|468255338|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
130082226|NCT03258593|468255339|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
130082227|NCT03258593|468255340|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
130082228|NCT03258593|468255337|FG000|Expansion Maintenance Phase|Physician Decision|0|||
130082229|NCT03258593|468255338|FG001|Expansion Maintenance Phase|Physician Decision|1|||
130082230|NCT03258593|468255339|FG002|Expansion Maintenance Phase|Physician Decision|0|||
130082231|NCT03258593|468255340|FG003|Expansion Maintenance Phase|Physician Decision|0|||
130082232|NCT05318183|468255344|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
130082233|NCT05318183|468255345|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
130082234|NCT05318183|468255344|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
129954543|NCT00321672|467794104|FG003|Overall Study|Adverse Event|0|||
129954544|NCT00321672|467794101|FG000|Overall Study|Lack of Efficacy|1|||
130082235|NCT05318183|468255345|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130082236|NCT03657576|468255346|FG000|Overall Study|Death|0|||
130082237|NCT03657576|468255347|FG001|Overall Study|Death|1|||
130082238|NCT03657576|468255348|FG002|Overall Study|Death|1|||
130082239|NCT03657576|468255349|FG003|Overall Study|Death|0|||
130082240|NCT03657576|468255350|FG004|Overall Study|Death|0|||
130082241|NCT03657576|468255351|FG005|Overall Study|Death|0|||
130082242|NCT03657576|468255346|FG000|Overall Study|Withdrawal by Subject|0|||
130082243|NCT03657576|468255347|FG001|Overall Study|Withdrawal by Subject|0|||
129954545|NCT00321672|467794102|FG001|Overall Study|Lack of Efficacy|1|||
129954546|NCT00321672|467794103|FG002|Overall Study|Lack of Efficacy|0|||
129954547|NCT00321672|467794104|FG003|Overall Study|Lack of Efficacy|0|||
129954548|NCT00321672|467794101|FG000|Overall Study|Lost to Follow-up|2|||
129954549|NCT00321672|467794102|FG001|Overall Study|Lost to Follow-up|0|||
129954550|NCT00321672|467794103|FG002|Overall Study|Lost to Follow-up|4|||
129954551|NCT00321672|467794104|FG003|Overall Study|Lost to Follow-up|2|||
129954552|NCT00321672|467794101|FG000|Overall Study|Death|1|||
129954553|NCT00321672|467794102|FG001|Overall Study|Death|0|||
129954554|NCT00321672|467794103|FG002|Overall Study|Death|0|||
129954555|NCT00321672|467794104|FG003|Overall Study|Death|0|||
129954556|NCT00321672|467794101|FG000|Overall Study|Too far to travel for visits|1|||
129954557|NCT00321672|467794102|FG001|Overall Study|Too far to travel for visits|0|||
129954558|NCT00321672|467794103|FG002|Overall Study|Too far to travel for visits|0|||
129954559|NCT00321672|467794104|FG003|Overall Study|Too far to travel for visits|0|||
129954560|NCT00321672|467794101|FG000|Overall Study|Incarcerated|0|||
129954561|NCT00321672|467794102|FG001|Overall Study|Incarcerated|0|||
129954562|NCT00321672|467794103|FG002|Overall Study|Incarcerated|2|||
129954563|NCT00321672|467794104|FG003|Overall Study|Incarcerated|0|||
129954564|NCT00321672|467794101|FG000|Overall Study|Moved out of state|0|||
129954565|NCT00321672|467794102|FG001|Overall Study|Moved out of state|1|||
129954566|NCT00321672|467794103|FG002|Overall Study|Moved out of state|1|||
129954567|NCT00321672|467794104|FG003|Overall Study|Moved out of state|0|||
129954568|NCT00321672|467794101|FG000|Overall Study|Protocol Violation|0|||
129954569|NCT00321672|467794102|FG001|Overall Study|Protocol Violation|0|||
129954570|NCT00321672|467794103|FG002|Overall Study|Protocol Violation|1|||
129954571|NCT00321672|467794104|FG003|Overall Study|Protocol Violation|0|||
129954572|NCT00321672|467794101|FG000|Overall Study|Diagnosis of testicular cancer|0|||
129954573|NCT00321672|467794102|FG001|Overall Study|Diagnosis of testicular cancer|1|||
129954574|NCT00321672|467794103|FG002|Overall Study|Diagnosis of testicular cancer|0|||
129954575|NCT00321672|467794104|FG003|Overall Study|Diagnosis of testicular cancer|0|||
129954576|NCT00321672|467794101|FG000|Overall Study|Extensive travel required for new job|0|||
129954577|NCT00321672|467794102|FG001|Overall Study|Extensive travel required for new job|1|||
129954578|NCT00321672|467794103|FG002|Overall Study|Extensive travel required for new job|0|||
129954579|NCT00321672|467794104|FG003|Overall Study|Extensive travel required for new job|0|||
129954580|NCT00512902|467794105|FG000|Overall Study|Adverse Event|7|||
129954581|NCT00512902|467794105|FG000|Overall Study|Lost to Follow-up|1|||
129954582|NCT00936065|467794106|FG000|Overall Study|Adverse Event|1|||
129954583|NCT00936065|467794107|FG001|Overall Study|Adverse Event|0|||
129954584|NCT00936065|467794108|FG002|Overall Study|Adverse Event|1|||
129954585|NCT00936065|467794106|FG000|Overall Study|Lack of Efficacy|1|||
129954586|NCT00936065|467794107|FG001|Overall Study|Lack of Efficacy|0|||
129954587|NCT00936065|467794108|FG002|Overall Study|Lack of Efficacy|1|||
129954588|NCT00936065|467794106|FG000|Overall Study|Lost to Follow-up|1|||
129954589|NCT00936065|467794107|FG001|Overall Study|Lost to Follow-up|0|||
129954590|NCT00936065|467794108|FG002|Overall Study|Lost to Follow-up|0|||
129954591|NCT00936065|467794106|FG000|Overall Study|Protocol Violation|1|||
129954592|NCT00936065|467794107|FG001|Overall Study|Protocol Violation|2|||
129954593|NCT00936065|467794108|FG002|Overall Study|Protocol Violation|1|||
129954594|NCT00936065|467794106|FG000|Overall Study|Withdrawal by Subject|0|||
129954595|NCT00936065|467794107|FG001|Overall Study|Withdrawal by Subject|2|||
129954596|NCT00936065|467794108|FG002|Overall Study|Withdrawal by Subject|4|||
129954597|NCT00145496|467794109|FG000|Overall Study|Adverse Event|42|||
129954598|NCT00145496|467794110|FG001|Overall Study|Adverse Event|30|||
129954599|NCT00145496|467794109|FG000|Overall Study|Lack of Efficacy|12|||
129954600|NCT00145496|467794110|FG001|Overall Study|Lack of Efficacy|7|||
129954601|NCT00145496|467794109|FG000|Overall Study|Withdrawal by Subject|32|||
129954602|NCT00145496|467794110|FG001|Overall Study|Withdrawal by Subject|26|||
129954603|NCT00145496|467794109|FG000|Overall Study|Lost to Follow-up|12|||
129954604|NCT00145496|467794110|FG001|Overall Study|Lost to Follow-up|5|||
129954605|NCT00145496|467794109|FG000|Overall Study|Other|25|||
129954606|NCT00145496|467794110|FG001|Overall Study|Other|13|||
129954607|NCT01429285|467794111|FG000|Overall Study|Protocol Violation|9|||
129954608|NCT01429285|467794112|FG001|Overall Study|Protocol Violation|4|||
129954609|NCT01429285|467794111|FG000|Overall Study|Missing Data|5|||
129954610|NCT01429285|467794112|FG001|Overall Study|Missing Data|3|||
129954611|NCT01429285|467794111|FG000|Overall Study|Erroneously Enrolled Twice|8|||
129954612|NCT01429285|467794112|FG001|Overall Study|Erroneously Enrolled Twice|2|||
129954613|NCT03394508|467794115|FG000|Overall Study|Protocol Violation|0|||
129954614|NCT03394508|467794116|FG001|Overall Study|Protocol Violation|3|||
129954615|NCT03394508|467794115|FG000|Overall Study|Lost to Follow-up|1|||
129954616|NCT03394508|467794116|FG001|Overall Study|Lost to Follow-up|0|||
129954617|NCT01288729|467794117|FG000|Overall Study|Withdrawal by Subject|1|||
129954618|NCT01288729|467794118|FG001|Overall Study|Withdrawal by Subject|0|||
129954619|NCT02135445|467794119|FG000|Overall Study|Lost to Follow-up|1|||
129954620|NCT02135445|467794120|FG001|Overall Study|Lost to Follow-up|0|||
129954621|NCT02135445|467794119|FG000|Overall Study|Withdrawal by Subject|1|||
129954622|NCT02135445|467794120|FG001|Overall Study|Withdrawal by Subject|0|||
130082244|NCT03657576|468255348|FG002|Overall Study|Withdrawal by Subject|0|||
130082245|NCT03657576|468255349|FG003|Overall Study|Withdrawal by Subject|1|||
130082246|NCT03657576|468255350|FG004|Overall Study|Withdrawal by Subject|0|||
130082247|NCT03657576|468255351|FG005|Overall Study|Withdrawal by Subject|0|||
130082248|NCT03657576|468255346|FG000|Overall Study|Screen Fail|0|||
130082249|NCT03657576|468255347|FG001|Overall Study|Screen Fail|0|||
130082250|NCT03657576|468255348|FG002|Overall Study|Screen Fail|0|||
130082251|NCT03657576|468255349|FG003|Overall Study|Screen Fail|0|||
130082252|NCT03657576|468255350|FG004|Overall Study|Screen Fail|0|||
130082253|NCT03657576|468255351|FG005|Overall Study|Screen Fail|5|||
130082254|NCT03657576|468255346|FG000|Overall Study|Disease Progression|1|||
130082255|NCT03657576|468255347|FG001|Overall Study|Disease Progression|1|||
129954623|NCT02136797|467795504|FG000|Overall Study|Not Treated|8|||
129954624|NCT03694210|467795505|FG000|Overall Study|Death|1|||
129954625|NCT03694210|467795505|FG000|Overall Study|Screen Failure|7|||
129954626|NCT03050372|467795506|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
129954627|NCT03050372|467795507|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
129954628|NCT03050372|467795506|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
129954629|NCT03050372|467795507|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
129954630|NCT02706834|467795508|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129954631|NCT02706834|467795509|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129954632|NCT02706834|467795510|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129954633|NCT02706834|467795511|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
129954634|NCT02706834|467795512|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
129954635|NCT02706834|467795513|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
129954636|NCT02706834|467795514|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
129954637|NCT02706834|467795515|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
129954638|NCT02706834|467795516|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
129954639|NCT02706834|467795517|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
129954640|NCT02706834|467795518|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
129954641|NCT02706834|467795508|FG000|Overall Study|Lost to Follow-up|0|||
129954642|NCT02706834|467795509|FG001|Overall Study|Lost to Follow-up|0|||
129954643|NCT02706834|467795510|FG002|Overall Study|Lost to Follow-up|1|||
129954644|NCT02706834|467795511|FG003|Overall Study|Lost to Follow-up|0|||
129954645|NCT02706834|467795512|FG004|Overall Study|Lost to Follow-up|0|||
129954646|NCT02706834|467795513|FG005|Overall Study|Lost to Follow-up|0|||
129954647|NCT02706834|467795514|FG006|Overall Study|Lost to Follow-up|0|||
129954648|NCT02706834|467795515|FG007|Overall Study|Lost to Follow-up|0|||
129954649|NCT02706834|467795516|FG008|Overall Study|Lost to Follow-up|0|||
129954650|NCT02706834|467795517|FG009|Overall Study|Lost to Follow-up|0|||
129954651|NCT02706834|467795518|FG010|Overall Study|Lost to Follow-up|0|||
130082256|NCT03657576|468255348|FG002|Overall Study|Disease Progression|0|||
130082257|NCT03657576|468255349|FG003|Overall Study|Disease Progression|5|||
130082258|NCT03657576|468255350|FG004|Overall Study|Disease Progression|0|||
130082259|NCT03657576|468255351|FG005|Overall Study|Disease Progression|0|||
130082260|NCT03657576|468255346|FG000|Overall Study|Insurance Coverage|0|||
130082261|NCT03657576|468255347|FG001|Overall Study|Insurance Coverage|0|||
130082262|NCT03657576|468255348|FG002|Overall Study|Insurance Coverage|0|||
130082263|NCT03657576|468255349|FG003|Overall Study|Insurance Coverage|1|||
130082264|NCT03657576|468255350|FG004|Overall Study|Insurance Coverage|0|||
130082265|NCT03657576|468255351|FG005|Overall Study|Insurance Coverage|0|||
130082266|NCT03381274|468255354|FG000|Overall Study|Death|2|||
130082267|NCT03381274|468255355|FG001|Overall Study|Death|9|||
130082268|NCT03381274|468255356|FG002|Overall Study|Death|3|||
129954652|NCT02706834|467795508|FG000|Overall Study|Voluntary Withdrawal|1|||
129979833|NCT00208325|467889475|FG000|Overall Study|Other|2|||
129979834|NCT00208325|467889476|FG001|Overall Study|Other|1|||
129979835|NCT00208325|467889477|FG002|Overall Study|Other|1|||
129979836|NCT00208325|467889478|FG003|Overall Study|Other|0|||
129979837|NCT00208325|467889475|FG000|Overall Study|Mis-Randomized|17|||
129979838|NCT00208325|467889476|FG001|Overall Study|Mis-Randomized|20|||
129979839|NCT00208325|467889477|FG002|Overall Study|Mis-Randomized|0|||
129979840|NCT00208325|467889478|FG003|Overall Study|Mis-Randomized|0|||
129979841|NCT04445987|467889479|FG000|Overall Study|Adverse Event|0|||
129979842|NCT04445987|467889480|FG001|Overall Study|Adverse Event|0|||
129979843|NCT04445987|467889481|FG002|Overall Study|Adverse Event|1|||
129979844|NCT04445987|467889482|FG003|Overall Study|Adverse Event|0|||
129979845|NCT04445987|467889483|FG004|Overall Study|Adverse Event|4|||
129979846|NCT04445987|467889484|FG005|Overall Study|Adverse Event|0|||
129979847|NCT04445987|467889479|FG000|Overall Study|Lost to Follow-up|4|||
129979848|NCT04445987|467889480|FG001|Overall Study|Lost to Follow-up|3|||
129979849|NCT04445987|467889481|FG002|Overall Study|Lost to Follow-up|1|||
129979850|NCT04445987|467889482|FG003|Overall Study|Lost to Follow-up|1|||
129979851|NCT04445987|467889483|FG004|Overall Study|Lost to Follow-up|29|||
129979852|NCT04445987|467889484|FG005|Overall Study|Lost to Follow-up|0|||
129979853|NCT04445987|467889479|FG000|Overall Study|Physician Decision|0|||
129979854|NCT04445987|467889480|FG001|Overall Study|Physician Decision|0|||
129979855|NCT04445987|467889481|FG002|Overall Study|Physician Decision|0|||
129979856|NCT04445987|467889482|FG003|Overall Study|Physician Decision|0|||
130082269|NCT03381274|468255357|FG003|Overall Study|Death|2|||
130082270|NCT03381274|468255358|FG004|Overall Study|Death|3|||
130082271|NCT03381274|468255354|FG000|Overall Study|Lost to Follow-up|0|||
130082272|NCT03381274|468255355|FG001|Overall Study|Lost to Follow-up|0|||
130082273|NCT03381274|468255356|FG002|Overall Study|Lost to Follow-up|0|||
130082274|NCT03381274|468255357|FG003|Overall Study|Lost to Follow-up|1|||
130082275|NCT03381274|468255358|FG004|Overall Study|Lost to Follow-up|0|||
130082276|NCT03381274|468255354|FG000|Overall Study|Withdrawal by Subject|2|||
130082277|NCT03381274|468255355|FG001|Overall Study|Withdrawal by Subject|1|||
130082278|NCT03381274|468255356|FG002|Overall Study|Withdrawal by Subject|3|||
130082279|NCT03381274|468255357|FG003|Overall Study|Withdrawal by Subject|1|||
130082280|NCT03381274|468255358|FG004|Overall Study|Withdrawal by Subject|0|||
130082281|NCT03381274|468255354|FG000|Overall Study|Other|1|||
130082282|NCT03381274|468255355|FG001|Overall Study|Other|11|||
130082283|NCT03381274|468255356|FG002|Overall Study|Other|0|||
130082284|NCT03381274|468255357|FG003|Overall Study|Other|2|||
130082285|NCT03381274|468255358|FG004|Overall Study|Other|2|||
130082286|NCT01874353|468255359|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
130082287|NCT01874353|468255360|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
130082288|NCT01874353|468255361|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
130082289|NCT01874353|468255362|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
130082290|NCT01874353|468255359|FG000|Overall Study|Lost to Follow-up|2|||
130082291|NCT01874353|468255360|FG001|Overall Study|Lost to Follow-up|2|||
130082292|NCT01874353|468255361|FG002|Overall Study|Lost to Follow-up|2|||
130082293|NCT01874353|468255362|FG003|Overall Study|Lost to Follow-up|0|||
130082294|NCT01874353|468255359|FG000|Overall Study|Death|110|||
130082295|NCT01874353|468255360|FG001|Overall Study|Death|60|||
130082296|NCT01874353|468255361|FG002|Overall Study|Death|13|||
130082297|NCT01874353|468255362|FG003|Overall Study|Death|7|||
130082298|NCT01874353|468255359|FG000|Overall Study|Withdrawal by Subject|13|||
130082299|NCT01874353|468255360|FG001|Overall Study|Withdrawal by Subject|11|||
130082300|NCT01874353|468255361|FG002|Overall Study|Withdrawal by Subject|0|||
130082301|NCT01874353|468255362|FG003|Overall Study|Withdrawal by Subject|0|||
130082302|NCT04392154|468255363|FG000|Overall Study|Adverse Event|3|||
130082303|NCT04392154|468255364|FG001|Overall Study|Adverse Event|46|||
130082304|NCT04392154|468255363|FG000|Overall Study|Due to epidemic/pandemic|0|||
130082305|NCT04392154|468255364|FG001|Overall Study|Due to epidemic/pandemic|1|||
130082306|NCT04392154|468255363|FG000|Overall Study|Lack of Efficacy|1|||
130082307|NCT04392154|468255364|FG001|Overall Study|Lack of Efficacy|47|||
130082308|NCT04392154|468255363|FG000|Overall Study|Lost to Follow-up|11|||
130082309|NCT04392154|468255364|FG001|Overall Study|Lost to Follow-up|61|||
130082310|NCT04392154|468255363|FG000|Overall Study|Geopolitical conflict|1|||
130082311|NCT04392154|468255364|FG001|Overall Study|Geopolitical conflict|1|||
130082312|NCT04392154|468255363|FG000|Overall Study|Physician Decision|1|||
130082313|NCT04392154|468255364|FG001|Overall Study|Physician Decision|5|||
130082314|NCT04392154|468255363|FG000|Overall Study|Pregnancy|1|||
130082315|NCT04392154|468255364|FG001|Overall Study|Pregnancy|8|||
130082316|NCT04392154|468255363|FG000|Overall Study|Protocol deviation|1|||
130082317|NCT04392154|468255364|FG001|Overall Study|Protocol deviation|12|||
130082318|NCT04392154|468255363|FG000|Overall Study|Withdrawal by Subject|18|||
130082319|NCT04392154|468255364|FG001|Overall Study|Withdrawal by Subject|138|||
130082320|NCT04392154|468255363|FG000|Overall Study|Sponsor Decision|1|||
130082321|NCT04392154|468255364|FG001|Overall Study|Sponsor Decision|14|||
130082322|NCT04392154|468255363|FG000|Overall Study|Site Closure|0|||
130082323|NCT04392154|468255364|FG001|Overall Study|Site Closure|4|||
130082324|NCT01327573|468255365|FG000|Overall Study|Physician Decision|3|||
130082325|NCT01327573|468255366|FG001|Overall Study|Physician Decision|1|||
130082326|NCT02136134|468255367|FG000|Overall Study|Death|170|||
130082327|NCT02136134|468255368|FG001|Overall Study|Death|148|||
130082328|NCT02136134|468255367|FG000|Overall Study|Withdrawal by Subject|19|||
130082329|NCT02136134|468255368|FG001|Overall Study|Withdrawal by Subject|10|||
130082330|NCT02136134|468255367|FG000|Overall Study|Lost to Follow-up|3|||
130082331|NCT02136134|468255368|FG001|Overall Study|Lost to Follow-up|3|||
130082332|NCT02136134|468255367|FG000|Overall Study|Uspecified|55|||
130082333|NCT02136134|468255368|FG001|Overall Study|Uspecified|90|||
130082334|NCT03070119|468255371|FG000|Overall Study|Adverse Event|0|||
130082335|NCT03070119|468255372|FG001|Overall Study|Adverse Event|0|||
130082336|NCT03070119|468255373|FG002|Overall Study|Adverse Event|1|||
130082337|NCT03070119|468255371|FG000|Overall Study|Lost to Follow-up|0|||
130082338|NCT03070119|468255372|FG001|Overall Study|Lost to Follow-up|1|||
130082339|NCT03070119|468255373|FG002|Overall Study|Lost to Follow-up|0|||
130082340|NCT03070119|468255371|FG000|Overall Study|Consent Withdrawn|6|||
130120963|NCT00984295|468404871|FG002|Overall Study|Missed one or more blood samplings|2|||
130082341|NCT03070119|468255372|FG001|Overall Study|Consent Withdrawn|5|||
130082342|NCT03070119|468255373|FG002|Overall Study|Consent Withdrawn|3|||
130082343|NCT03070119|468255371|FG000|Overall Study|Investigator Decision|0|||
130082344|NCT03070119|468255372|FG001|Overall Study|Investigator Decision|0|||
130082345|NCT03070119|468255373|FG002|Overall Study|Investigator Decision|1|||
130082346|NCT03070119|468255371|FG000|Overall Study|Death|7|||
130082347|NCT03070119|468255372|FG001|Overall Study|Death|14|||
130082348|NCT03070119|468255373|FG002|Overall Study|Death|5|||
130082349|NCT03070119|468255371|FG000|Overall Study|Disease Progression|5|||
130082350|NCT03070119|468255372|FG001|Overall Study|Disease Progression|7|||
130082351|NCT03070119|468255373|FG002|Overall Study|Disease Progression|7|||
130082352|NCT03070119|468255371|FG000|Overall Study|Reason not Specified|2|||
130082353|NCT03070119|468255372|FG001|Overall Study|Reason not Specified|2|||
130082354|NCT03070119|468255373|FG002|Overall Study|Reason not Specified|1|||
130082355|NCT00732472|468255374|FG000|Overall Study|Adverse Event|0|||
130082356|NCT00732472|468255375|FG001|Overall Study|Adverse Event|1|||
130082357|NCT00732472|468255376|FG002|Overall Study|Adverse Event|1|||
130082358|NCT00732472|468255377|FG003|Overall Study|Adverse Event|1|||
130082359|NCT00732472|468255374|FG000|Overall Study|Protocol Violation|0|||
130082360|NCT00732472|468255375|FG001|Overall Study|Protocol Violation|0|||
130082361|NCT00732472|468255376|FG002|Overall Study|Protocol Violation|0|||
130082362|NCT00732472|468255377|FG003|Overall Study|Protocol Violation|1|||
130082363|NCT00732472|468255374|FG000|Overall Study|Withdrawal by Subject|0|||
130082364|NCT00732472|468255375|FG001|Overall Study|Withdrawal by Subject|2|||
130082365|NCT00732472|468255376|FG002|Overall Study|Withdrawal by Subject|0|||
130082366|NCT00732472|468255377|FG003|Overall Study|Withdrawal by Subject|1|||
130082367|NCT01058395|468255379|FG000|Overall Study|Death|2|||
130082368|NCT01058395|468255380|FG001|Overall Study|Death|1|||
130082369|NCT01058395|468255379|FG000|Overall Study|Lost to Follow-up|1|||
130082370|NCT01058395|468255380|FG001|Overall Study|Lost to Follow-up|0|||
130082371|NCT01266876|468255381|FG000|Overall Study|Adverse Event|0|||
130082372|NCT01266876|468255382|FG001|Overall Study|Adverse Event|0|||
130082373|NCT01266876|468255383|FG002|Overall Study|Adverse Event|0|||
130082374|NCT01266876|468255384|FG003|Overall Study|Adverse Event|1|||
130082375|NCT01266876|468255385|FG004|Overall Study|Adverse Event|0|||
130082376|NCT05180721|468255386|FG000|Overall Study|Lost to Follow-up|4|||
130082377|NCT01996865|468255388|FG000|Induction Period|Protocol Violation|1|||
130082378|NCT01996865|468255389|FG001|Induction Period|Protocol Violation|0|||
130082379|NCT01996865|468255390|FG002|Induction Period|Protocol Violation|0|||
130082380|NCT01996865|468255388|FG000|Induction Period|Progressive Disease|4|||
130082381|NCT01996865|468255389|FG001|Induction Period|Progressive Disease|0|||
130082382|NCT01996865|468255390|FG002|Induction Period|Progressive Disease|0|||
130082383|NCT01996865|468255388|FG000|Induction Period|Lost to Follow-up|10|||
130082384|NCT01996865|468255389|FG001|Induction Period|Lost to Follow-up|0|||
130082385|NCT01996865|468255390|FG002|Induction Period|Lost to Follow-up|0|||
130082386|NCT01996865|468255388|FG000|Induction Period|Other Reasons|13|||
130082387|NCT01996865|468255389|FG001|Induction Period|Other Reasons|0|||
130082388|NCT01996865|468255390|FG002|Induction Period|Other Reasons|0|||
130082389|NCT01996865|468255388|FG000|Induction Period|Adverse Event|20|||
130082390|NCT01996865|468255389|FG001|Induction Period|Adverse Event|0|||
130082391|NCT01996865|468255390|FG002|Induction Period|Adverse Event|0|||
130082392|NCT01996865|468255388|FG000|Induction Period|Withdrawal by Subject|60|||
130082393|NCT01996865|468255389|FG001|Induction Period|Withdrawal by Subject|0|||
130082394|NCT01996865|468255390|FG002|Induction Period|Withdrawal by Subject|0|||
130082395|NCT01996865|468255388|FG000|Induction Period|Death|111|||
130082396|NCT01996865|468255389|FG001|Induction Period|Death|0|||
130082397|NCT01996865|468255390|FG002|Induction Period|Death|0|||
130082398|NCT01996865|468255388|FG000|Maintenance Period|Protocol Violation|0|||
130082399|NCT01996865|468255389|FG001|Maintenance Period|Protocol Violation|1|||
130082400|NCT01996865|468255390|FG002|Maintenance Period|Protocol Violation|1|||
130082401|NCT01996865|468255388|FG000|Maintenance Period|Other reasons|0|||
130082402|NCT01996865|468255389|FG001|Maintenance Period|Other reasons|8|||
130082403|NCT01996865|468255390|FG002|Maintenance Period|Other reasons|5|||
130082404|NCT01996865|468255388|FG000|Maintenance Period|Progressive Disease|0|||
130082405|NCT01996865|468255389|FG001|Maintenance Period|Progressive Disease|6|||
130082406|NCT01996865|468255390|FG002|Maintenance Period|Progressive Disease|23|||
130082407|NCT01996865|468255388|FG000|Maintenance Period|Withdrawal by Subject|0|||
130082408|NCT01996865|468255389|FG001|Maintenance Period|Withdrawal by Subject|18|||
130082409|NCT01996865|468255390|FG002|Maintenance Period|Withdrawal by Subject|4|||
130082410|NCT01996865|468255388|FG000|Maintenance Period|Adverse Event|0|||
130082411|NCT01996865|468255389|FG001|Maintenance Period|Adverse Event|7|||
130082412|NCT01996865|468255390|FG002|Maintenance Period|Adverse Event|7|||
130082413|NCT01996865|468255388|FG000|Maintenance Period|Death|0|||
130082414|NCT01996865|468255389|FG001|Maintenance Period|Death|15|||
130082415|NCT01996865|468255390|FG002|Maintenance Period|Death|3|||
130082416|NCT01996865|468255388|FG000|Maintenance Period|Lost to Follow-up|0|||
130082417|NCT01996865|468255389|FG001|Maintenance Period|Lost to Follow-up|2|||
130082418|NCT01996865|468255390|FG002|Maintenance Period|Lost to Follow-up|0|||
130082419|NCT04083781|468255391|FG000|Main Part|Physician Decision|0|||
130082420|NCT04083781|468255392|FG001|Main Part|Physician Decision|1|||
130082421|NCT04083781|468255393|FG002|Main Part|Physician Decision|2|||
130082422|NCT04083781|468255394|FG003|Main Part|Physician Decision|0|||
130082423|NCT04083781|468255391|FG000|Main Part|Death|1|||
130082424|NCT04083781|468255392|FG001|Main Part|Death|3|||
130082425|NCT04083781|468255393|FG002|Main Part|Death|1|||
130082426|NCT04083781|468255394|FG003|Main Part|Death|0|||
129954653|NCT02706834|467795509|FG001|Overall Study|Voluntary Withdrawal|0|||
129954654|NCT02706834|467795510|FG002|Overall Study|Voluntary Withdrawal|0|||
129954655|NCT02706834|467795511|FG003|Overall Study|Voluntary Withdrawal|0|||
129954656|NCT02706834|467795512|FG004|Overall Study|Voluntary Withdrawal|0|||
129954657|NCT02706834|467795513|FG005|Overall Study|Voluntary Withdrawal|0|||
129954658|NCT02706834|467795514|FG006|Overall Study|Voluntary Withdrawal|0|||
129954659|NCT02706834|467795515|FG007|Overall Study|Voluntary Withdrawal|0|||
129954660|NCT02706834|467795516|FG008|Overall Study|Voluntary Withdrawal|0|||
129954661|NCT02706834|467795517|FG009|Overall Study|Voluntary Withdrawal|1|||
129954662|NCT02706834|467795518|FG010|Overall Study|Voluntary Withdrawal|0|||
129954663|NCT02706834|467795508|FG000|Overall Study|Other Reason Not Specified|1|||
129954664|NCT02706834|467795509|FG001|Overall Study|Other Reason Not Specified|0|||
129954665|NCT02706834|467795510|FG002|Overall Study|Other Reason Not Specified|0|||
129954666|NCT02706834|467795511|FG003|Overall Study|Other Reason Not Specified|0|||
129954667|NCT02706834|467795512|FG004|Overall Study|Other Reason Not Specified|1|||
129954668|NCT02706834|467795513|FG005|Overall Study|Other Reason Not Specified|0|||
129954669|NCT02706834|467795514|FG006|Overall Study|Other Reason Not Specified|0|||
129954670|NCT02706834|467795515|FG007|Overall Study|Other Reason Not Specified|0|||
129954671|NCT02706834|467795516|FG008|Overall Study|Other Reason Not Specified|0|||
129954672|NCT02706834|467795517|FG009|Overall Study|Other Reason Not Specified|0|||
129954673|NCT02706834|467795518|FG010|Overall Study|Other Reason Not Specified|0|||
129954674|NCT00627523|467795519|FG000|Overall Study|Lack of Efficacy|1|||
129954675|NCT00627523|467795520|FG001|Overall Study|Lack of Efficacy|0|||
129954676|NCT00627523|467795519|FG000|Overall Study|Withdrawal by Subject|0|||
129954677|NCT00627523|467795520|FG001|Overall Study|Withdrawal by Subject|2|||
129954678|NCT00627523|467795519|FG000|Overall Study|Other|1|||
129954679|NCT00627523|467795520|FG001|Overall Study|Other|0|||
129954680|NCT02543294|467795523|FG000|Overall Study|Lost to Follow-up|3|||
129954681|NCT02543294|467795523|FG000|Overall Study|Physician Decision|2|||
129954682|NCT02543294|467795523|FG000|Overall Study|Withdrawal by Subject|7|||
129954683|NCT01038128|467795525|FG000|Overall Study|Lack of Efficacy|1|||
129954684|NCT01038128|467795525|FG000|Overall Study|Lost to Follow-up|1|||
129954685|NCT01038128|467795525|FG000|Overall Study|Withdrawal by Subject|2|||
129954686|NCT03672188|467795532|FG000|Overall Study|Withdrawal by Subject|0|||
129954687|NCT03672188|467795533|FG001|Overall Study|Withdrawal by Subject|0|||
129954688|NCT03672188|467795534|FG002|Overall Study|Withdrawal by Subject|0|||
129954689|NCT03672188|467795535|FG003|Overall Study|Withdrawal by Subject|3|||
129954690|NCT03672188|467795536|FG004|Overall Study|Withdrawal by Subject|0|||
129954691|NCT03672188|467795537|FG005|Overall Study|Withdrawal by Subject|0|||
129954692|NCT03672188|467795538|FG006|Overall Study|Withdrawal by Subject|0|||
129954693|NCT03672188|467795539|FG007|Overall Study|Withdrawal by Subject|0|||
129954694|NCT03672188|467795540|FG008|Overall Study|Withdrawal by Subject|0|||
129954695|NCT03672188|467795541|FG009|Overall Study|Withdrawal by Subject|0|||
129954696|NCT03672188|467795542|FG010|Overall Study|Withdrawal by Subject|0|||
129954697|NCT03672188|467795543|FG011|Overall Study|Withdrawal by Subject|0|||
129954698|NCT03672188|467795544|FG012|Overall Study|Withdrawal by Subject|0|||
129954699|NCT03672188|467795545|FG013|Overall Study|Withdrawal by Subject|0|||
129954700|NCT03672188|467795546|FG014|Overall Study|Withdrawal by Subject|0|||
129954701|NCT03672188|467795532|FG000|Overall Study|Death|0|||
129954702|NCT03672188|467795533|FG001|Overall Study|Death|0|||
129954703|NCT03672188|467795534|FG002|Overall Study|Death|0|||
129954704|NCT03672188|467795535|FG003|Overall Study|Death|0|||
129954705|NCT03672188|467795536|FG004|Overall Study|Death|0|||
129954706|NCT03672188|467795537|FG005|Overall Study|Death|0|||
129954707|NCT03672188|467795538|FG006|Overall Study|Death|0|||
129954708|NCT03672188|467795539|FG007|Overall Study|Death|0|||
129954709|NCT03672188|467795540|FG008|Overall Study|Death|0|||
129954710|NCT03672188|467795541|FG009|Overall Study|Death|0|||
129954711|NCT03672188|467795542|FG010|Overall Study|Death|0|||
129954712|NCT03672188|467795543|FG011|Overall Study|Death|0|||
129954713|NCT03672188|467795544|FG012|Overall Study|Death|1|||
129954714|NCT03672188|467795545|FG013|Overall Study|Death|0|||
129954715|NCT03672188|467795546|FG014|Overall Study|Death|0|||
129954716|NCT03672188|467795532|FG000|Overall Study|Lost to Follow-up|0|||
129954717|NCT03672188|467795533|FG001|Overall Study|Lost to Follow-up|0|||
129954718|NCT03672188|467795534|FG002|Overall Study|Lost to Follow-up|1|||
129954719|NCT03672188|467795535|FG003|Overall Study|Lost to Follow-up|0|||
129954720|NCT03672188|467795536|FG004|Overall Study|Lost to Follow-up|0|||
129954721|NCT03672188|467795537|FG005|Overall Study|Lost to Follow-up|0|||
129954722|NCT03672188|467795538|FG006|Overall Study|Lost to Follow-up|0|||
129954723|NCT03672188|467795539|FG007|Overall Study|Lost to Follow-up|0|||
129954724|NCT03672188|467795540|FG008|Overall Study|Lost to Follow-up|0|||
129954725|NCT03672188|467795541|FG009|Overall Study|Lost to Follow-up|0|||
129954726|NCT03672188|467795542|FG010|Overall Study|Lost to Follow-up|0|||
129954727|NCT03672188|467795543|FG011|Overall Study|Lost to Follow-up|0|||
129954728|NCT03672188|467795544|FG012|Overall Study|Lost to Follow-up|0|||
129954729|NCT03672188|467795545|FG013|Overall Study|Lost to Follow-up|0|||
129954730|NCT03672188|467795546|FG014|Overall Study|Lost to Follow-up|0|||
129954731|NCT03320941|467795556|FG000|Overall Study|subject/guardian decision|0|||
129954732|NCT03320941|467795557|FG001|Overall Study|subject/guardian decision|0|||
129954733|NCT03320941|467795558|FG002|Overall Study|subject/guardian decision|0|||
129954734|NCT03320941|467795559|FG003|Overall Study|subject/guardian decision|1|||
130082427|NCT04083781|468255391|FG000|Main Part|Withdrawal by Subject|5|||
130082428|NCT04083781|468255392|FG001|Main Part|Withdrawal by Subject|2|||
130082429|NCT04083781|468255393|FG002|Main Part|Withdrawal by Subject|3|||
130082430|NCT04083781|468255394|FG003|Main Part|Withdrawal by Subject|7|||
130082431|NCT04083781|468255391|FG000|Extension Part|Physician Decision|0|||
130082432|NCT04083781|468255392|FG001|Extension Part|Physician Decision|0|||
130082433|NCT04083781|468255393|FG002|Extension Part|Physician Decision|0|||
130082434|NCT04083781|468255394|FG003|Extension Part|Physician Decision|1|||
130082435|NCT04083781|468255391|FG000|Extension Part|Death|0|||
130082436|NCT04083781|468255392|FG001|Extension Part|Death|1|||
130082437|NCT04083781|468255393|FG002|Extension Part|Death|0|||
130082438|NCT04083781|468255394|FG003|Extension Part|Death|1|||
130082439|NCT04083781|468255391|FG000|Extension Part|Withdrawal by Subject|0|||
130082440|NCT04083781|468255392|FG001|Extension Part|Withdrawal by Subject|1|||
130082441|NCT04083781|468255393|FG002|Extension Part|Withdrawal by Subject|0|||
130082442|NCT04083781|468255394|FG003|Extension Part|Withdrawal by Subject|0|||
130082443|NCT04083781|468255391|FG000|Extension Part|Ongoing|13|||
130082444|NCT04083781|468255392|FG001|Extension Part|Ongoing|25|||
130082445|NCT04083781|468255393|FG002|Extension Part|Ongoing|15|||
130082446|NCT04083781|468255394|FG003|Extension Part|Ongoing|51|||
130082447|NCT03575351|468255397|FG000|Overall Study|Adverse Event|1|||
130082448|NCT03575351|468255398|FG001|Overall Study|Adverse Event|0|||
130082449|NCT03575351|468255397|FG000|Overall Study|Death|2|||
130082450|NCT03575351|468255398|FG001|Overall Study|Death|2|||
130082451|NCT03575351|468255397|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
130082452|NCT03575351|468255398|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
130082453|NCT03575351|468255397|FG000|Overall Study|Lack of Efficacy|28|||
130082454|NCT03575351|468255398|FG001|Overall Study|Lack of Efficacy|0|||
130082455|NCT03575351|468255397|FG000|Overall Study|Withdrawal by Subject|1|||
130082456|NCT03575351|468255398|FG001|Overall Study|Withdrawal by Subject|1|||
130082457|NCT03575351|468255397|FG000|Overall Study|Physician Decision|3|||
130082458|NCT03575351|468255398|FG001|Overall Study|Physician Decision|0|||
130082459|NCT03575351|468255397|FG000|Overall Study|Disease relapse|15|||
130082460|NCT03575351|468255398|FG001|Overall Study|Disease relapse|6|||
130082461|NCT03575351|468255397|FG000|Overall Study|Study drug manufacturing failure|0|||
130082462|NCT03575351|468255398|FG001|Overall Study|Study drug manufacturing failure|1|||
130082463|NCT03575351|468255397|FG000|Overall Study|other reasons|5|||
130082464|NCT03575351|468255398|FG001|Overall Study|other reasons|0|||
130082465|NCT04288089|468255404|FG000|Overall Study|Ongoing Treatment|2|||
130082466|NCT04288089|468255405|FG001|Overall Study|Ongoing Treatment|1|||
130082467|NCT04288089|468255406|FG002|Overall Study|Ongoing Treatment|1|||
130082468|NCT04288089|468255407|FG003|Overall Study|Ongoing Treatment|4|||
130082469|NCT03715205|468255408|FG000|Overall Study|Death|13|||
130082470|NCT03715205|468255408|FG000|Overall Study|Lost to Follow-up|2|||
130082471|NCT03715205|468255408|FG000|Overall Study|Physician Decision|93|||
130082472|NCT03715205|468255408|FG000|Overall Study|Withdrawal by Subject|26|||
130082473|NCT05245071|468255409|FG000|Overall Study|Progressive disease|18|||
130082474|NCT05245071|468255409|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
130082475|NCT05245071|468255409|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
130082476|NCT05304611|468255410|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082477|NCT05304611|468255411|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082478|NCT05304611|468255412|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082479|NCT05304611|468255413|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082480|NCT05304611|468255414|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082481|NCT05304611|468255415|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082482|NCT05304611|468255416|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
129954735|NCT03320941|467795560|FG004|Overall Study|subject/guardian decision|0|||
130120964|NCT00984295|468404869|FG000|Overall Study|Incomplete safety follow-up|11|||
130120965|NCT00984295|468404870|FG001|Overall Study|Incomplete safety follow-up|2|||
130120966|NCT00984295|468404871|FG002|Overall Study|Incomplete safety follow-up|3|||
130082483|NCT05304611|468255417|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082484|NCT05304611|468255418|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
130082485|NCT05304611|468255419|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082486|NCT05304611|468255420|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
130120967|NCT00788957|468404872|FG000|Part 1|Death|8|||
130120968|NCT00788957|468404873|FG001|Part 1|Death|0|||
129954736|NCT03614923|467795561|FG000|Overall Study|Withdrawal by Subject|2|||
130082487|NCT05304611|468255421|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
130082488|NCT05304611|468255410|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
130082489|NCT05304611|468255411|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
130082490|NCT05304611|468255412|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
130082491|NCT05304611|468255413|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
130082492|NCT05304611|468255414|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
130082493|NCT05304611|468255415|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
130120969|NCT00788957|468404874|FG002|Part 1|Death|0|||
130082494|NCT05304611|468255416|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
130082495|NCT05304611|468255417|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
130082496|NCT05304611|468255418|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
130082497|NCT05304611|468255419|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
130082498|NCT05304611|468255420|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
130082499|NCT05304611|468255421|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
130082500|NCT05304611|468255410|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
130082501|NCT05304611|468255411|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
130082502|NCT05304611|468255412|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
130082503|NCT05304611|468255413|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
130082504|NCT05304611|468255414|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
130082505|NCT05304611|468255415|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
130082506|NCT05304611|468255416|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
130082507|NCT05304611|468255417|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
130082508|NCT05304611|468255418|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
130082509|NCT05304611|468255419|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
130082510|NCT05304611|468255420|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
130082511|NCT05304611|468255421|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
130082512|NCT02354690|468255422|FG000|Overall Study|Physician Decision|1|||
130082513|NCT00963820|468255423|FG000|Dose Escalation Phase|Progressive Disease|3|||
130082514|NCT00963820|468255424|FG001|Dose Escalation Phase|Progressive Disease|3|||
130082515|NCT00963820|468255425|FG002|Dose Escalation Phase|Progressive Disease|3|||
130082516|NCT00963820|468255426|FG003|Dose Escalation Phase|Progressive Disease|3|||
130082517|NCT00963820|468255427|FG004|Dose Escalation Phase|Progressive Disease|4|||
130082518|NCT00963820|468255428|FG005|Dose Escalation Phase|Progressive Disease|3|||
130082519|NCT00963820|468255429|FG006|Dose Escalation Phase|Progressive Disease|3|||
130082520|NCT00963820|468255430|FG007|Dose Escalation Phase|Progressive Disease|2|||
130082521|NCT00963820|468255431|FG008|Dose Escalation Phase|Progressive Disease|0|||
130082522|NCT00963820|468255432|FG009|Dose Escalation Phase|Progressive Disease|0|||
130082523|NCT00963820|468255433|FG010|Dose Escalation Phase|Progressive Disease|0|||
130082524|NCT00963820|468255434|FG011|Dose Escalation Phase|Progressive Disease|0|||
130082525|NCT00963820|468255423|FG000|Dose Escalation Phase|Adverse Event|0|||
130082526|NCT00963820|468255424|FG001|Dose Escalation Phase|Adverse Event|0|||
130082527|NCT00963820|468255425|FG002|Dose Escalation Phase|Adverse Event|0|||
130082528|NCT00963820|468255426|FG003|Dose Escalation Phase|Adverse Event|0|||
130082529|NCT00963820|468255427|FG004|Dose Escalation Phase|Adverse Event|0|||
130082530|NCT00963820|468255428|FG005|Dose Escalation Phase|Adverse Event|0|||
130082531|NCT00963820|468255429|FG006|Dose Escalation Phase|Adverse Event|3|||
130082532|NCT00963820|468255430|FG007|Dose Escalation Phase|Adverse Event|1|||
130082533|NCT00963820|468255431|FG008|Dose Escalation Phase|Adverse Event|0|||
130082534|NCT00963820|468255432|FG009|Dose Escalation Phase|Adverse Event|0|||
130082535|NCT00963820|468255433|FG010|Dose Escalation Phase|Adverse Event|0|||
130082536|NCT00963820|468255434|FG011|Dose Escalation Phase|Adverse Event|0|||
130082537|NCT00963820|468255423|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
130082538|NCT00963820|468255424|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
130082539|NCT00963820|468255425|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
130082540|NCT00963820|468255426|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
130082541|NCT00963820|468255427|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
130082542|NCT00963820|468255428|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
130082543|NCT00963820|468255429|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
130082544|NCT00963820|468255430|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
130082545|NCT00963820|468255431|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
130082546|NCT00963820|468255432|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
130082547|NCT00963820|468255433|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
130082548|NCT00963820|468255434|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
130082549|NCT00963820|468255423|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082550|NCT00963820|468255424|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082551|NCT00963820|468255425|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129954737|NCT03614923|467795562|FG001|Overall Study|Withdrawal by Subject|1|||
130082552|NCT00963820|468255426|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082553|NCT00963820|468255427|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129954738|NCT03614923|467795563|FG002|Overall Study|Withdrawal by Subject|1|||
129954739|NCT03614923|467795561|FG000|Overall Study|Adverse Event|0|||
129954740|NCT03614923|467795562|FG001|Overall Study|Adverse Event|2|||
130082554|NCT00963820|468255428|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082555|NCT00963820|468255429|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
130082556|NCT00963820|468255430|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082557|NCT00963820|468255431|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129954741|NCT03614923|467795563|FG002|Overall Study|Adverse Event|1|||
130082558|NCT00963820|468255432|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082559|NCT00963820|468255433|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
130082560|NCT00963820|468255434|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129954742|NCT03614923|467795561|FG000|Overall Study|Lost to Follow-up|1|||
129954743|NCT03614923|467795562|FG001|Overall Study|Lost to Follow-up|0|||
129954744|NCT03614923|467795563|FG002|Overall Study|Lost to Follow-up|1|||
129954745|NCT03614923|467795561|FG000|Overall Study|Lack of Efficacy|2|||
129954746|NCT03614923|467795562|FG001|Overall Study|Lack of Efficacy|0|||
129954747|NCT03614923|467795563|FG002|Overall Study|Lack of Efficacy|1|||
129954748|NCT03614923|467795561|FG000|Overall Study|Non-compliance|0|||
129954749|NCT03614923|467795562|FG001|Overall Study|Non-compliance|1|||
129954750|NCT03614923|467795563|FG002|Overall Study|Non-compliance|0|||
129954751|NCT03614923|467795561|FG000|Overall Study|Other|0|||
129954752|NCT03614923|467795562|FG001|Overall Study|Other|1|||
129954753|NCT03614923|467795563|FG002|Overall Study|Other|1|||
129954754|NCT01107353|467795564|FG000|Overall Study|Positive Drug Screen|1|||
129954755|NCT01107353|467795565|FG001|Overall Study|Positive Drug Screen|0|||
129954756|NCT01745380|467795566|FG000|Overall Study|Lost to Follow-up|1|||
129954757|NCT01745380|467795567|FG001|Overall Study|Lost to Follow-up|0|||
129954758|NCT01745380|467795566|FG000|Overall Study|Lack of Efficacy|0|||
129954759|NCT01745380|467795567|FG001|Overall Study|Lack of Efficacy|1|||
129954760|NCT01882088|467795568|FG000|Overall Study|Intolerance of esophageal manometry|1|||
129954761|NCT01882088|467795568|FG000|Overall Study|no possibility to place the catheter|1|||
129954762|NCT01882088|467795568|FG000|Overall Study|Protocol Violation|1|||
129954763|NCT01882088|467795568|FG000|Overall Study|inadequate pH-impedance tracings|2|||
129954764|NCT02368691|467795569|FG000|Overall Study|Death|13|||
129954765|NCT02368691|467795569|FG000|Overall Study|Lack of Efficacy|15|||
129954766|NCT02368691|467795569|FG000|Overall Study|Physician Decision|4|||
129954767|NCT02720198|467795570|FG000|Overall Study|Withdrawal by Subject|0|||
129954768|NCT02720198|467795571|FG001|Overall Study|Withdrawal by Subject|1|||
129954769|NCT04879823|467795572|FG000|Overall Study|Physician Decision|3|||
129954770|NCT04879823|467795573|FG001|Overall Study|Physician Decision|1|||
129954771|NCT04879823|467795572|FG000|Overall Study|Protocol Violation|2|||
129954772|NCT04879823|467795573|FG001|Overall Study|Protocol Violation|3|||
129954773|NCT04879823|467795572|FG000|Overall Study|Lost to Follow-up|43|||
129954774|NCT04879823|467795573|FG001|Overall Study|Lost to Follow-up|35|||
129954775|NCT02722278|467795578|FG000|Overall Study|Withdrawal by Subject|5|||
129954776|NCT02722278|467795579|FG001|Overall Study|Withdrawal by Subject|3|||
129954777|NCT02722278|467795578|FG000|Overall Study|Adverse Event|4|||
129954778|NCT02722278|467795579|FG001|Overall Study|Adverse Event|1|||
129954779|NCT02722278|467795578|FG000|Overall Study|Lost to Follow-up|2|||
129954780|NCT02722278|467795579|FG001|Overall Study|Lost to Follow-up|0|||
129954781|NCT02722278|467795578|FG000|Overall Study|Protocol Violation|1|||
129954782|NCT02722278|467795579|FG001|Overall Study|Protocol Violation|0|||
129954783|NCT02722278|467795578|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
129954784|NCT02722278|467795579|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
129954785|NCT02722278|467795578|FG000|Overall Study|Subject declined after tx assignment|0|||
129954786|NCT02722278|467795579|FG001|Overall Study|Subject declined after tx assignment|1|||
129954787|NCT02722278|467795578|FG000|Overall Study|Site closure not study related|0|||
129954788|NCT02722278|467795579|FG001|Overall Study|Site closure not study related|1|||
129954789|NCT00203502|467795580|FG000|Overall Study|Death|1|||
129954790|NCT02446912|467795581|FG000|Overall Study|Adverse Event|3|||
129954791|NCT02446912|467795582|FG001|Overall Study|Adverse Event|13|||
129954792|NCT02446912|467795583|FG002|Overall Study|Adverse Event|5|||
129954793|NCT02446912|467795581|FG000|Overall Study|Condition under investigation worsened|0|||
129954794|NCT02446912|467795582|FG001|Overall Study|Condition under investigation worsened|1|||
129954795|NCT02446912|467795583|FG002|Overall Study|Condition under investigation worsened|1|||
129954796|NCT02446912|467795581|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129954797|NCT02446912|467795582|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129954798|NCT02446912|467795583|FG002|Overall Study|Study-specific withdrawal criteria|0|||
129954799|NCT02446912|467795581|FG000|Overall Study|Lack of Efficacy|1|||
129954800|NCT02446912|467795582|FG001|Overall Study|Lack of Efficacy|4|||
129954801|NCT02446912|467795583|FG002|Overall Study|Lack of Efficacy|7|||
129954802|NCT02446912|467795581|FG000|Overall Study|Lost to Follow-up|0|||
129954803|NCT02446912|467795582|FG001|Overall Study|Lost to Follow-up|0|||
129954804|NCT02446912|467795583|FG002|Overall Study|Lost to Follow-up|2|||
129954805|NCT02446912|467795581|FG000|Overall Study|Severe non-compliance to protocol|1|||
129954806|NCT02446912|467795582|FG001|Overall Study|Severe non-compliance to protocol|0|||
129954807|NCT02446912|467795583|FG002|Overall Study|Severe non-compliance to protocol|1|||
129954808|NCT02446912|467795581|FG000|Overall Study|Withdrawal by Subject|10|||
129954809|NCT02446912|467795582|FG001|Overall Study|Withdrawal by Subject|15|||
129954810|NCT02446912|467795583|FG002|Overall Study|Withdrawal by Subject|15|||
129954811|NCT02446912|467795581|FG000|Overall Study|Miscellaneous|2|||
129954812|NCT02446912|467795582|FG001|Overall Study|Miscellaneous|2|||
129954813|NCT02446912|467795583|FG002|Overall Study|Miscellaneous|4|||
129954814|NCT00147745|467795584|FG000|Overall Study|Withdrawal by Subject|1|||
129954815|NCT00147745|467795585|FG001|Overall Study|Withdrawal by Subject|0|||
129954816|NCT00147745|467795586|FG002|Overall Study|Withdrawal by Subject|0|||
129954817|NCT00510783|467795595|FG000|Overall Study|Lost to Follow-up|29|||
129954818|NCT00510783|467795596|FG001|Overall Study|Lost to Follow-up|25|||
130082561|NCT00963820|468255423|FG000|Expansion Phase|Progressive Disease|0|||
130082562|NCT00963820|468255424|FG001|Expansion Phase|Progressive Disease|0|||
130082563|NCT00963820|468255425|FG002|Expansion Phase|Progressive Disease|0|||
130082564|NCT00963820|468255426|FG003|Expansion Phase|Progressive Disease|0|||
130082565|NCT00963820|468255427|FG004|Expansion Phase|Progressive Disease|0|||
130082566|NCT00963820|468255428|FG005|Expansion Phase|Progressive Disease|0|||
130082567|NCT00963820|468255429|FG006|Expansion Phase|Progressive Disease|0|||
130082568|NCT00963820|468255430|FG007|Expansion Phase|Progressive Disease|0|||
130082569|NCT00963820|468255431|FG008|Expansion Phase|Progressive Disease|8|||
130082570|NCT00963820|468255432|FG009|Expansion Phase|Progressive Disease|6|||
130082571|NCT00963820|468255433|FG010|Expansion Phase|Progressive Disease|4|||
130082572|NCT00963820|468255434|FG011|Expansion Phase|Progressive Disease|2|||
130082573|NCT00963820|468255423|FG000|Expansion Phase|Adverse Event|0|||
130082574|NCT00963820|468255424|FG001|Expansion Phase|Adverse Event|0|||
130082575|NCT00963820|468255425|FG002|Expansion Phase|Adverse Event|0|||
130082576|NCT00963820|468255426|FG003|Expansion Phase|Adverse Event|0|||
130082577|NCT00963820|468255427|FG004|Expansion Phase|Adverse Event|0|||
130082578|NCT00963820|468255428|FG005|Expansion Phase|Adverse Event|0|||
130082579|NCT00963820|468255429|FG006|Expansion Phase|Adverse Event|0|||
130082580|NCT00963820|468255430|FG007|Expansion Phase|Adverse Event|0|||
130082581|NCT00963820|468255431|FG008|Expansion Phase|Adverse Event|1|||
130082582|NCT00963820|468255432|FG009|Expansion Phase|Adverse Event|3|||
130082583|NCT00963820|468255433|FG010|Expansion Phase|Adverse Event|0|||
130082584|NCT00963820|468255434|FG011|Expansion Phase|Adverse Event|0|||
130082585|NCT00963820|468255423|FG000|Expansion Phase|Withdrawal by Subject|0|||
130082586|NCT00963820|468255424|FG001|Expansion Phase|Withdrawal by Subject|0|||
130082587|NCT00963820|468255425|FG002|Expansion Phase|Withdrawal by Subject|0|||
130082588|NCT00963820|468255426|FG003|Expansion Phase|Withdrawal by Subject|0|||
130082589|NCT00963820|468255427|FG004|Expansion Phase|Withdrawal by Subject|0|||
130082590|NCT00963820|468255428|FG005|Expansion Phase|Withdrawal by Subject|0|||
130082591|NCT00963820|468255429|FG006|Expansion Phase|Withdrawal by Subject|0|||
130082592|NCT00963820|468255430|FG007|Expansion Phase|Withdrawal by Subject|0|||
130082593|NCT00963820|468255431|FG008|Expansion Phase|Withdrawal by Subject|1|||
130082594|NCT00963820|468255432|FG009|Expansion Phase|Withdrawal by Subject|0|||
130082595|NCT00963820|468255433|FG010|Expansion Phase|Withdrawal by Subject|1|||
130082596|NCT00963820|468255434|FG011|Expansion Phase|Withdrawal by Subject|1|||
130082597|NCT00963820|468255423|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082598|NCT00963820|468255424|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082599|NCT00963820|468255425|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082600|NCT00963820|468255426|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082601|NCT00963820|468255427|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082602|NCT00963820|468255428|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082603|NCT00963820|468255429|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082604|NCT00963820|468255430|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082605|NCT00963820|468255431|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082606|NCT00963820|468255432|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082607|NCT00963820|468255433|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
130082608|NCT00963820|468255434|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
130082609|NCT00355615|468255440|FG000|Randomized Double Blind Period|Adverse Event|1|||
130082610|NCT00355615|468255441|FG001|Randomized Double Blind Period|Adverse Event|0|||
130082611|NCT00355615|468255442|FG002|Randomized Double Blind Period|Adverse Event|0|||
130082612|NCT00355615|468255443|FG003|Randomized Double Blind Period|Adverse Event|0|||
130082613|NCT00355615|468255444|FG004|Randomized Double Blind Period|Adverse Event|0|||
130082614|NCT00355615|468255440|FG000|Randomized Double Blind Period|Protocol Violation|0|||
130082615|NCT00355615|468255441|FG001|Randomized Double Blind Period|Protocol Violation|0|||
130082616|NCT00355615|468255442|FG002|Randomized Double Blind Period|Protocol Violation|1|||
130082617|NCT00355615|468255443|FG003|Randomized Double Blind Period|Protocol Violation|1|||
130082618|NCT00355615|468255444|FG004|Randomized Double Blind Period|Protocol Violation|0|||
130082619|NCT00355615|468255440|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130082620|NCT00355615|468255441|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130082621|NCT00355615|468255442|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130082622|NCT00355615|468255443|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
130082623|NCT00355615|468255444|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
130082624|NCT00355615|468255440|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130082625|NCT00355615|468255441|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130082626|NCT00355615|468255442|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130082627|NCT00355615|468255443|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
130082628|NCT00355615|468255444|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
130082629|NCT00355615|468255440|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130082630|NCT00355615|468255441|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130082631|NCT00355615|468255442|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130082632|NCT00355615|468255443|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
130082633|NCT00355615|468255444|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
130082634|NCT00355615|468255440|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130082635|NCT00355615|468255441|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130082636|NCT00355615|468255442|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130082637|NCT00355615|468255443|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
130082638|NCT00355615|468255444|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
130082639|NCT00796549|468255445|FG000|Overall Study|Adverse Event|11|||
130082640|NCT00796549|468255445|FG000|Overall Study|not entered|149|||
130082641|NCT00796549|468255445|FG000|Overall Study|Other|2|||
130082642|NCT00796549|468255445|FG000|Overall Study|Progressive disease|56|||
130082643|NCT01878175|468255447|FG000|Overall Study|Developed contraindicated health problem|2|||
130082644|NCT03523715|468255448|FG000|Overall Study|Lost to Follow-up|11|||
130082645|NCT03523715|468255449|FG001|Overall Study|Lost to Follow-up|14|||
130082646|NCT03523715|468255448|FG000|Overall Study|Did not meet inclusion criteria|1|||
130082647|NCT03523715|468255449|FG001|Overall Study|Did not meet inclusion criteria|0|||
130082648|NCT03523715|468255448|FG000|Overall Study|Internally inconsistent reporting|0|||
130082649|NCT03523715|468255449|FG001|Overall Study|Internally inconsistent reporting|2|||
130082650|NCT04430036|468255450|FG000|Safety Run in Phase|Progression of disease|2|||
130082651|NCT01842334|468255451|FG000|Overall Study|Withdrawal by Subject|3|||
130082652|NCT01842334|468255452|FG001|Overall Study|Withdrawal by Subject|3|||
130082653|NCT01842334|468255451|FG000|Overall Study|Moved away mid-study|0|||
130082654|NCT01842334|468255452|FG001|Overall Study|Moved away mid-study|1|||
130082655|NCT02201251|468255454|FG000|Overall Study|Adverse Event|1|||
130082656|NCT02201251|468255455|FG001|Overall Study|Adverse Event|1|||
130082657|NCT02201251|468255454|FG000|Overall Study|Protocol Violation|1|||
130082658|NCT02201251|468255455|FG001|Overall Study|Protocol Violation|0|||
130082659|NCT02201251|468255454|FG000|Overall Study|Noncompliance with Study Drug|0|||
130082660|NCT02201251|468255455|FG001|Overall Study|Noncompliance with Study Drug|1|||
130082661|NCT02201251|468255454|FG000|Overall Study|Withdrawal by Subject|2|||
130082662|NCT02201251|468255455|FG001|Overall Study|Withdrawal by Subject|1|||
130082663|NCT02877134|468255459|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082664|NCT02877134|468255460|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
130082665|NCT02877134|468255461|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082666|NCT02877134|468255462|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082667|NCT02877134|468255463|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082668|NCT02877134|468255464|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
130082669|NCT02877134|468255465|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082670|NCT02877134|468255466|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082671|NCT02877134|468255467|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082672|NCT02877134|468255468|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082673|NCT02877134|468255469|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082674|NCT02877134|468255470|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
130082675|NCT02877134|468255459|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082676|NCT02877134|468255460|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
130082677|NCT02877134|468255461|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082678|NCT02877134|468255462|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
130082679|NCT02877134|468255463|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082680|NCT02877134|468255464|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082681|NCT02877134|468255465|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
130082682|NCT02877134|468255466|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082683|NCT02877134|468255467|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082684|NCT02877134|468255468|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082685|NCT02877134|468255469|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082686|NCT02877134|468255470|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
130082687|NCT02877134|468255459|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
130082688|NCT02877134|468255460|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
130082689|NCT02877134|468255461|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
130082690|NCT02877134|468255462|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
130082691|NCT02877134|468255463|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
130082692|NCT02877134|468255464|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
130082693|NCT02877134|468255465|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
130082694|NCT02877134|468255466|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130082695|NCT02877134|468255467|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130082696|NCT02877134|468255468|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
129954819|NCT00510783|467795595|FG000|Overall Study|Withdrawal by Subject|2|||
129954820|NCT00510783|467795596|FG001|Overall Study|Withdrawal by Subject|3|||
130082697|NCT02877134|468255469|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130082698|NCT02877134|468255470|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
130082699|NCT02877134|468255459|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
130082700|NCT02877134|468255460|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
130082701|NCT02877134|468255461|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
130082702|NCT02877134|468255462|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
130082703|NCT02877134|468255463|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
130082704|NCT02877134|468255464|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
130082705|NCT02877134|468255465|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
130082706|NCT02877134|468255466|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
130082707|NCT02877134|468255467|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
130082708|NCT02877134|468255468|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
130082709|NCT02877134|468255469|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
130082710|NCT02877134|468255470|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
130082711|NCT02877134|468255459|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082712|NCT02877134|468255460|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082713|NCT02877134|468255461|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082714|NCT02877134|468255462|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082715|NCT02877134|468255463|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082716|NCT02877134|468255464|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082717|NCT02877134|468255465|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082718|NCT02877134|468255466|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082719|NCT02877134|468255467|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
130082720|NCT02877134|468255468|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082721|NCT02877134|468255469|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082722|NCT02877134|468255470|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
130082723|NCT02877134|468255459|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082724|NCT02877134|468255460|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082725|NCT02877134|468255461|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082726|NCT02877134|468255462|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082727|NCT02877134|468255463|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082728|NCT02877134|468255464|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082729|NCT02877134|468255465|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
130082730|NCT02877134|468255466|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
130082731|NCT02877134|468255467|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
130082732|NCT02877134|468255468|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
130082733|NCT02877134|468255469|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
130082734|NCT02877134|468255470|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
130082735|NCT02877134|468255459|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082736|NCT02877134|468255460|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082737|NCT02877134|468255461|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082738|NCT02877134|468255462|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082739|NCT02877134|468255463|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082740|NCT02877134|468255464|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082741|NCT02877134|468255465|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082742|NCT02877134|468255466|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
130082743|NCT02877134|468255467|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
130082744|NCT02877134|468255468|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
130082745|NCT02877134|468255469|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082746|NCT02877134|468255470|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
130082747|NCT02877134|468255459|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
130082748|NCT02877134|468255460|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
130082749|NCT02877134|468255461|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
130082750|NCT02877134|468255462|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
130082751|NCT02877134|468255463|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
129954821|NCT00510783|467795595|FG000|Overall Study|Protocol Violation|0|||
129954822|NCT00510783|467795596|FG001|Overall Study|Protocol Violation|1|||
129954823|NCT02305797|467795597|FG000|Overall Study|Adverse Event|11|||
129954824|NCT02305797|467795598|FG001|Overall Study|Adverse Event|2|||
129954825|NCT02305797|467795597|FG000|Overall Study|Withdrawal by Subject|9|||
129954826|NCT02305797|467795598|FG001|Overall Study|Withdrawal by Subject|10|||
129954827|NCT02305797|467795597|FG000|Overall Study|Lack of Efficacy|6|||
129954828|NCT02305797|467795598|FG001|Overall Study|Lack of Efficacy|0|||
129954829|NCT02305797|467795597|FG000|Overall Study|Lost to Follow-up|5|||
129954830|NCT02305797|467795598|FG001|Overall Study|Lost to Follow-up|11|||
129954831|NCT02305797|467795597|FG000|Overall Study|Pregnancy|0|||
129954832|NCT02305797|467795598|FG001|Overall Study|Pregnancy|2|||
129954833|NCT02305797|467795597|FG000|Overall Study|Noncompliance|14|||
129954834|NCT02305797|467795598|FG001|Overall Study|Noncompliance|12|||
130082752|NCT02877134|468255464|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
130082753|NCT02877134|468255465|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
130082754|NCT02877134|468255466|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
130082755|NCT02877134|468255467|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
130082756|NCT02877134|468255468|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
130082757|NCT02877134|468255469|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
130082758|NCT02877134|468255470|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
130082759|NCT01332851|468255471|FG000|Overall Study|Withdrawal by Subject|4|||
130082760|NCT01332851|468255472|FG001|Overall Study|Withdrawal by Subject|2|||
130082761|NCT01332851|468255471|FG000|Overall Study|Lost to Follow-up|7|||
130082762|NCT01332851|468255472|FG001|Overall Study|Lost to Follow-up|11|||
130082763|NCT03299166|468255479|FG000|Overall Study|Adverse Event|9|||
130082764|NCT03299166|468255480|FG001|Overall Study|Adverse Event|4|||
130082765|NCT03299166|468255479|FG000|Overall Study|Withdrawal by Subject|6|||
130082766|NCT03299166|468255480|FG001|Overall Study|Withdrawal by Subject|5|||
130082767|NCT03299166|468255479|FG000|Overall Study|Physician Decision|1|||
130082768|NCT03299166|468255480|FG001|Overall Study|Physician Decision|1|||
130082769|NCT03299166|468255479|FG000|Overall Study|Sponsor Decision|3|||
130082770|NCT03299166|468255480|FG001|Overall Study|Sponsor Decision|0|||
130082771|NCT03299166|468255479|FG000|Overall Study|Lost to Follow-up|2|||
130082772|NCT03299166|468255480|FG001|Overall Study|Lost to Follow-up|4|||
130082773|NCT03299166|468255479|FG000|Overall Study|Randomization Error|0|||
130082774|NCT03299166|468255480|FG001|Overall Study|Randomization Error|1|||
130082775|NCT03299166|468255479|FG000|Overall Study|Subject unable to return due to COVID|1|||
130082776|NCT03299166|468255480|FG001|Overall Study|Subject unable to return due to COVID|0|||
130082777|NCT03299166|468255479|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
130082778|NCT03299166|468255480|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
130082779|NCT01197794|468255483|FG000|Overall Study|Adverse Event|3|||
130082780|NCT01197794|468255484|FG001|Overall Study|Adverse Event|2|||
130082781|NCT01197794|468255485|FG002|Overall Study|Adverse Event|4|||
130082782|NCT01197794|468255486|FG003|Overall Study|Adverse Event|4|||
130082783|NCT01197794|468255487|FG004|Overall Study|Adverse Event|4|||
130082784|NCT01197794|468255488|FG005|Overall Study|Adverse Event|2|||
130082785|NCT01197794|468255489|FG006|Overall Study|Adverse Event|3|||
130082786|NCT01197794|468255483|FG000|Overall Study|Protocol Violation|0|||
130082787|NCT01197794|468255484|FG001|Overall Study|Protocol Violation|0|||
130082788|NCT01197794|468255485|FG002|Overall Study|Protocol Violation|0|||
130082789|NCT01197794|468255486|FG003|Overall Study|Protocol Violation|0|||
130082790|NCT01197794|468255487|FG004|Overall Study|Protocol Violation|2|||
130082791|NCT01197794|468255488|FG005|Overall Study|Protocol Violation|0|||
130082792|NCT01197794|468255489|FG006|Overall Study|Protocol Violation|1|||
130082793|NCT01197794|468255483|FG000|Overall Study|Development of study withdrawal criteria|3|||
130082794|NCT01197794|468255484|FG001|Overall Study|Development of study withdrawal criteria|0|||
130082795|NCT01197794|468255485|FG002|Overall Study|Development of study withdrawal criteria|0|||
130082796|NCT01197794|468255486|FG003|Overall Study|Development of study withdrawal criteria|1|||
130082797|NCT01197794|468255487|FG004|Overall Study|Development of study withdrawal criteria|0|||
130082798|NCT01197794|468255488|FG005|Overall Study|Development of study withdrawal criteria|0|||
130082799|NCT01197794|468255489|FG006|Overall Study|Development of study withdrawal criteria|1|||
130082800|NCT01197794|468255483|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
130082801|NCT01197794|468255484|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
130082802|NCT01197794|468255485|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
130082803|NCT01197794|468255486|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
130082804|NCT01197794|468255487|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
130082805|NCT01197794|468255488|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
130082806|NCT01197794|468255489|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
130082807|NCT01197794|468255483|FG000|Overall Study|Withdrawal by Subject|3|||
130082808|NCT01197794|468255484|FG001|Overall Study|Withdrawal by Subject|3|||
130082809|NCT01197794|468255485|FG002|Overall Study|Withdrawal by Subject|4|||
130082810|NCT01197794|468255486|FG003|Overall Study|Withdrawal by Subject|1|||
129954835|NCT02305797|467795597|FG000|Overall Study|Reason not collected|0|||
129954836|NCT02305797|467795598|FG001|Overall Study|Reason not collected|1|||
129954837|NCT00422162|467795599|FG000|Overall Study|Adverse Event|11|||
129954838|NCT00422162|467795600|FG001|Overall Study|Adverse Event|9|||
129954839|NCT00422162|467795599|FG000|Overall Study|Lack of Efficacy|4|||
129954840|NCT00422162|467795600|FG001|Overall Study|Lack of Efficacy|10|||
130082811|NCT01197794|468255487|FG004|Overall Study|Withdrawal by Subject|1|||
130082812|NCT01197794|468255488|FG005|Overall Study|Withdrawal by Subject|5|||
130082813|NCT01197794|468255489|FG006|Overall Study|Withdrawal by Subject|6|||
130082814|NCT01197794|468255483|FG000|Overall Study|Lost to Follow-up|1|||
130082815|NCT01197794|468255484|FG001|Overall Study|Lost to Follow-up|1|||
130082816|NCT01197794|468255485|FG002|Overall Study|Lost to Follow-up|0|||
130082817|NCT01197794|468255486|FG003|Overall Study|Lost to Follow-up|1|||
130082818|NCT01197794|468255487|FG004|Overall Study|Lost to Follow-up|0|||
130082819|NCT01197794|468255488|FG005|Overall Study|Lost to Follow-up|1|||
130082820|NCT01197794|468255489|FG006|Overall Study|Lost to Follow-up|0|||
130082821|NCT01197794|468255483|FG000|Overall Study|Other|1|||
130082822|NCT01197794|468255484|FG001|Overall Study|Other|1|||
129979857|NCT04445987|467889483|FG004|Overall Study|Physician Decision|1|||
129979858|NCT04445987|467889484|FG005|Overall Study|Physician Decision|0|||
129979859|NCT04445987|467889479|FG000|Overall Study|Protocol Violation|1|||
129979860|NCT04445987|467889480|FG001|Overall Study|Protocol Violation|0|||
129979861|NCT04445987|467889481|FG002|Overall Study|Protocol Violation|0|||
129979862|NCT04445987|467889482|FG003|Overall Study|Protocol Violation|0|||
129979863|NCT04445987|467889483|FG004|Overall Study|Protocol Violation|2|||
129979864|NCT04445987|467889484|FG005|Overall Study|Protocol Violation|0|||
129979865|NCT04445987|467889479|FG000|Overall Study|Withdrawal by Subject|4|||
129979866|NCT04445987|467889480|FG001|Overall Study|Withdrawal by Subject|0|||
129979867|NCT04445987|467889481|FG002|Overall Study|Withdrawal by Subject|1|||
129979868|NCT04445987|467889482|FG003|Overall Study|Withdrawal by Subject|0|||
129979869|NCT04445987|467889483|FG004|Overall Study|Withdrawal by Subject|18|||
129979870|NCT04445987|467889484|FG005|Overall Study|Withdrawal by Subject|1|||
129979871|NCT04445987|467889479|FG000|Overall Study|Other reason|0|||
129979872|NCT04445987|467889480|FG001|Overall Study|Other reason|0|||
129979873|NCT04445987|467889481|FG002|Overall Study|Other reason|1|||
129979874|NCT04445987|467889482|FG003|Overall Study|Other reason|0|||
129979875|NCT04445987|467889483|FG004|Overall Study|Other reason|2|||
129979876|NCT04445987|467889484|FG005|Overall Study|Other reason|0|||
129979877|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
129979878|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
129979879|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
129979880|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
129979881|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
129979882|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
129979883|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
129979884|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
129979885|NCT01114880|467889485|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
129979886|NCT01114880|467889486|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
129979887|NCT01114880|467889485|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
129979888|NCT01114880|467889486|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
129979889|NCT02001064|467889492|FG000|Overall Study|Withdrawal by Subject|2|||
129979890|NCT02001064|467889493|FG001|Overall Study|Withdrawal by Subject|1|||
129979891|NCT02108964|467889498|FG000|Overall Study|Progressive disease|15|||
129979892|NCT02108964|467889499|FG001|Overall Study|Progressive disease|31|||
129979893|NCT02108964|467889500|FG002|Overall Study|Progressive disease|54|||
129979894|NCT02108964|467889501|FG003|Overall Study|Progressive disease|7|||
129979895|NCT02108964|467889502|FG004|Overall Study|Progressive disease|20|||
129979896|NCT02108964|467889503|FG005|Overall Study|Progressive disease|4|||
129979897|NCT02108964|467889504|FG006|Overall Study|Progressive disease|6|||
129979898|NCT02108964|467889505|FG007|Overall Study|Progressive disease|33|||
129979899|NCT02108964|467889498|FG000|Overall Study|Physician Decision|1|||
129979900|NCT02108964|467889499|FG001|Overall Study|Physician Decision|5|||
129979901|NCT02108964|467889500|FG002|Overall Study|Physician Decision|7|||
129979902|NCT02108964|467889501|FG003|Overall Study|Physician Decision|1|||
129979903|NCT02108964|467889502|FG004|Overall Study|Physician Decision|2|||
129979904|NCT02108964|467889503|FG005|Overall Study|Physician Decision|1|||
129979905|NCT02108964|467889504|FG006|Overall Study|Physician Decision|1|||
129979906|NCT02108964|467889505|FG007|Overall Study|Physician Decision|3|||
129979907|NCT02108964|467889498|FG000|Overall Study|Adverse Event|0|||
129979908|NCT02108964|467889499|FG001|Overall Study|Adverse Event|0|||
129979909|NCT02108964|467889500|FG002|Overall Study|Adverse Event|4|||
129979910|NCT02108964|467889501|FG003|Overall Study|Adverse Event|0|||
129979911|NCT02108964|467889502|FG004|Overall Study|Adverse Event|1|||
129979912|NCT02108964|467889503|FG005|Overall Study|Adverse Event|0|||
129979913|NCT02108964|467889504|FG006|Overall Study|Adverse Event|3|||
129979914|NCT02108964|467889505|FG007|Overall Study|Adverse Event|2|||
129979915|NCT02108964|467889498|FG000|Overall Study|Death|1|||
129979916|NCT02108964|467889499|FG001|Overall Study|Death|1|||
129979917|NCT02108964|467889500|FG002|Overall Study|Death|4|||
129979918|NCT02108964|467889501|FG003|Overall Study|Death|0|||
129979919|NCT02108964|467889502|FG004|Overall Study|Death|3|||
129979920|NCT02108964|467889503|FG005|Overall Study|Death|0|||
129979921|NCT02108964|467889504|FG006|Overall Study|Death|0|||
129979922|NCT02108964|467889505|FG007|Overall Study|Death|2|||
129979923|NCT02108964|467889498|FG000|Overall Study|Subject/Guardian decision|0|||
129979924|NCT02108964|467889499|FG001|Overall Study|Subject/Guardian decision|1|||
129979925|NCT02108964|467889500|FG002|Overall Study|Subject/Guardian decision|4|||
129979926|NCT02108964|467889501|FG003|Overall Study|Subject/Guardian decision|0|||
129979927|NCT02108964|467889502|FG004|Overall Study|Subject/Guardian decision|2|||
129979928|NCT02108964|467889503|FG005|Overall Study|Subject/Guardian decision|0|||
129979929|NCT02108964|467889504|FG006|Overall Study|Subject/Guardian decision|1|||
129979930|NCT02108964|467889505|FG007|Overall Study|Subject/Guardian decision|2|||
129979931|NCT02108964|467889498|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
130082823|NCT01197794|468255485|FG002|Overall Study|Other|3|||
130082824|NCT01197794|468255486|FG003|Overall Study|Other|0|||
130082825|NCT01197794|468255487|FG004|Overall Study|Other|2|||
130082826|NCT01197794|468255488|FG005|Overall Study|Other|2|||
130082827|NCT01197794|468255489|FG006|Overall Study|Other|4|||
130082828|NCT01055457|468255490|FG000|Overall Study|Lost to Follow-up|0|||
130082829|NCT01055457|468255491|FG001|Overall Study|Lost to Follow-up|1|||
130082830|NCT01055457|468255492|FG002|Overall Study|Lost to Follow-up|0|||
130082831|NCT01055457|468255493|FG003|Overall Study|Lost to Follow-up|0|||
130082832|NCT01055457|468255494|FG004|Overall Study|Lost to Follow-up|0|||
130082833|NCT01055457|468255495|FG005|Overall Study|Lost to Follow-up|1|||
130082834|NCT01055457|468255496|FG006|Overall Study|Lost to Follow-up|0|||
130082835|NCT01055457|468255497|FG007|Overall Study|Lost to Follow-up|0|||
130082836|NCT01055457|468255498|FG008|Overall Study|Lost to Follow-up|0|||
130082837|NCT01055457|468255499|FG009|Overall Study|Lost to Follow-up|0|||
130082838|NCT01055457|468255490|FG000|Overall Study|Protocol Violation|0|||
130082839|NCT01055457|468255491|FG001|Overall Study|Protocol Violation|0|||
130082840|NCT01055457|468255492|FG002|Overall Study|Protocol Violation|1|||
130082841|NCT01055457|468255493|FG003|Overall Study|Protocol Violation|1|||
130082842|NCT01055457|468255494|FG004|Overall Study|Protocol Violation|1|||
130082843|NCT01055457|468255495|FG005|Overall Study|Protocol Violation|2|||
130082844|NCT01055457|468255496|FG006|Overall Study|Protocol Violation|1|||
130082845|NCT01055457|468255497|FG007|Overall Study|Protocol Violation|0|||
130082846|NCT01055457|468255498|FG008|Overall Study|Protocol Violation|0|||
130082847|NCT01055457|468255499|FG009|Overall Study|Protocol Violation|1|||
130082848|NCT01055457|468255490|FG000|Overall Study|Subject Disinterest|0|||
130082849|NCT01055457|468255491|FG001|Overall Study|Subject Disinterest|0|||
130082850|NCT01055457|468255492|FG002|Overall Study|Subject Disinterest|0|||
130082851|NCT01055457|468255493|FG003|Overall Study|Subject Disinterest|0|||
130082852|NCT01055457|468255494|FG004|Overall Study|Subject Disinterest|0|||
130082853|NCT01055457|468255495|FG005|Overall Study|Subject Disinterest|0|||
130082854|NCT01055457|468255496|FG006|Overall Study|Subject Disinterest|0|||
130082855|NCT01055457|468255497|FG007|Overall Study|Subject Disinterest|1|||
130082856|NCT01055457|468255498|FG008|Overall Study|Subject Disinterest|0|||
130082857|NCT01055457|468255499|FG009|Overall Study|Subject Disinterest|0|||
130082858|NCT01055457|468255490|FG000|Overall Study|Subject Ineligible|1|||
130082859|NCT01055457|468255491|FG001|Overall Study|Subject Ineligible|0|||
130082860|NCT01055457|468255492|FG002|Overall Study|Subject Ineligible|1|||
130082861|NCT01055457|468255493|FG003|Overall Study|Subject Ineligible|0|||
130082862|NCT01055457|468255494|FG004|Overall Study|Subject Ineligible|1|||
130082863|NCT01055457|468255495|FG005|Overall Study|Subject Ineligible|0|||
130082864|NCT01055457|468255496|FG006|Overall Study|Subject Ineligible|0|||
130082865|NCT01055457|468255497|FG007|Overall Study|Subject Ineligible|0|||
130082866|NCT01055457|468255498|FG008|Overall Study|Subject Ineligible|0|||
130082867|NCT01055457|468255499|FG009|Overall Study|Subject Ineligible|0|||
130082868|NCT01055457|468255490|FG000|Overall Study|Discomfort|0|||
130082869|NCT01055457|468255491|FG001|Overall Study|Discomfort|0|||
130082870|NCT01055457|468255492|FG002|Overall Study|Discomfort|0|||
130082871|NCT01055457|468255493|FG003|Overall Study|Discomfort|0|||
130082872|NCT01055457|468255494|FG004|Overall Study|Discomfort|1|||
130082873|NCT01055457|468255495|FG005|Overall Study|Discomfort|0|||
130082874|NCT01055457|468255496|FG006|Overall Study|Discomfort|0|||
130082875|NCT01055457|468255497|FG007|Overall Study|Discomfort|0|||
130082876|NCT01055457|468255498|FG008|Overall Study|Discomfort|0|||
129954841|NCT00422162|467795599|FG000|Overall Study|Withdrawal by Subject|7|||
129954842|NCT00422162|467795600|FG001|Overall Study|Withdrawal by Subject|6|||
129954843|NCT00422162|467795599|FG000|Overall Study|Lost to Follow-up|1|||
129954844|NCT00422162|467795600|FG001|Overall Study|Lost to Follow-up|2|||
129954845|NCT00422162|467795599|FG000|Overall Study|Non-Compliant with Protocol|1|||
130082877|NCT01055457|468255499|FG009|Overall Study|Discomfort|0|||
130082878|NCT01055457|468255490|FG000|Overall Study|Pregnancy|0|||
130082879|NCT01055457|468255491|FG001|Overall Study|Pregnancy|0|||
130082880|NCT01055457|468255492|FG002|Overall Study|Pregnancy|0|||
130082881|NCT01055457|468255493|FG003|Overall Study|Pregnancy|1|||
130082882|NCT01055457|468255494|FG004|Overall Study|Pregnancy|0|||
130082883|NCT01055457|468255495|FG005|Overall Study|Pregnancy|0|||
130082884|NCT01055457|468255496|FG006|Overall Study|Pregnancy|0|||
129954846|NCT00422162|467795600|FG001|Overall Study|Non-Compliant with Protocol|1|||
129954847|NCT00422162|467795599|FG000|Overall Study|Other|0|||
130082885|NCT01055457|468255497|FG007|Overall Study|Pregnancy|0|||
130082886|NCT01055457|468255498|FG008|Overall Study|Pregnancy|0|||
130082887|NCT01055457|468255499|FG009|Overall Study|Pregnancy|0|||
130082888|NCT01055457|468255490|FG000|Overall Study|Adverse Event|0|||
130082889|NCT01055457|468255491|FG001|Overall Study|Adverse Event|0|||
130082890|NCT01055457|468255492|FG002|Overall Study|Adverse Event|0|||
130082891|NCT01055457|468255493|FG003|Overall Study|Adverse Event|1|||
130082892|NCT01055457|468255494|FG004|Overall Study|Adverse Event|0|||
130082893|NCT01055457|468255495|FG005|Overall Study|Adverse Event|0|||
130082894|NCT01055457|468255496|FG006|Overall Study|Adverse Event|0|||
130082895|NCT01055457|468255497|FG007|Overall Study|Adverse Event|0|||
130082896|NCT01055457|468255498|FG008|Overall Study|Adverse Event|0|||
130082897|NCT01055457|468255499|FG009|Overall Study|Adverse Event|0|||
130082898|NCT04055844|468255500|FG000|Overall Study|Adverse Event|12|||
129954848|NCT00422162|467795600|FG001|Overall Study|Other|1|||
129954849|NCT00422162|467795599|FG000|Overall Study|Didn't Receive Treatment|0|||
129954850|NCT00422162|467795600|FG001|Overall Study|Didn't Receive Treatment|1|||
129954851|NCT02522299|467795601|FG000|Overall Study|Adverse Event|2|||
129954852|NCT02522299|467795602|FG001|Overall Study|Adverse Event|0|||
129954853|NCT02522299|467795601|FG000|Overall Study|Physician Decision|0|||
129954854|NCT02522299|467795602|FG001|Overall Study|Physician Decision|1|||
129954855|NCT02522299|467795601|FG000|Overall Study|Withdrawal by Subject|2|||
129954856|NCT02522299|467795602|FG001|Overall Study|Withdrawal by Subject|0|||
129954857|NCT00460577|467795605|FG000|Overall Study|Protocol Violation|2|||
129954858|NCT00460577|467795606|FG001|Overall Study|Protocol Violation|6|||
129954859|NCT01878253|467795607|FG000|Overall Study|Death|1|||
129954860|NCT01878253|467795607|FG000|Overall Study|SIdus System Removal|3|||
129954861|NCT01878253|467795607|FG000|Overall Study|Withdrawal by Subject|1|||
130082899|NCT04055844|468255500|FG000|Overall Study|Poor Performance|1|||
130082900|NCT04055844|468255500|FG000|Overall Study|Death|1|||
130082901|NCT00572728|468255505|FG000|Overall Study|Withdrawal by Subject|10|||
130082902|NCT00572728|468255505|FG000|Overall Study|Ineligible|3|||
130082903|NCT00572728|468255505|FG000|Overall Study|Enrolled under Amendment 4|5|||
130082904|NCT00572728|468255505|FG000|Overall Study|Offstudy due to complicating disease|1|||
130082905|NCT00572728|468255505|FG000|Overall Study|FLT1 not completed|4|||
130082906|NCT00572728|468255505|FG000|Overall Study|First Chemotherapy not initiated|2|||
130082907|NCT00572728|468255505|FG000|Overall Study|FLT2 not completed|5|||
130082908|NCT00572728|468255505|FG000|Overall Study|Second chemotherapy not initiated|1|||
130082909|NCT00572728|468255505|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
130082910|NCT00572728|468255505|FG000|Overall Study|Pathology missing|1|||
130082911|NCT03630016|468255510|FG000|Overall Study|Poor Sensor Placement|1|||
130082912|NCT00002981|468255511|FG000|Overall Study|Inevaluable|6|||
130082913|NCT01833806|468255512|FG000|Overall Study|Alternative treatment|2|||
130082914|NCT01833806|468255512|FG000|Overall Study|Death|5|||
130082915|NCT01833806|468255512|FG000|Overall Study|Physician Decision|1|||
130082916|NCT01833806|468255512|FG000|Overall Study|Lost to Follow-up|1|||
130082917|NCT03457636|468255513|FG000|Overall Study|Lost to Follow-up|2|||
130082918|NCT02724111|468255514|FG000|Overall Study|Protocol Violation|2|||
130082919|NCT02724111|468255515|FG001|Overall Study|Protocol Violation|5|||
130082920|NCT01828567|468255516|FG000|Overall Study|Lost to Follow-up|27|||
130082921|NCT01828567|468255517|FG001|Overall Study|Lost to Follow-up|9|||
130082922|NCT01828567|468255516|FG000|Overall Study|Excluded - did not meet criteria|4|||
130082923|NCT01828567|468255517|FG001|Overall Study|Excluded - did not meet criteria|1|||
130082924|NCT01885104|468255518|FG000|Overall Study|Withdrawal of Consent|1|||
130082925|NCT01885104|468255519|FG001|Overall Study|Withdrawal of Consent|0|||
130082926|NCT01885104|468255518|FG000|Overall Study|Lost to Follow-up|0|||
130082927|NCT01885104|468255519|FG001|Overall Study|Lost to Follow-up|1|||
130082928|NCT01885104|468255518|FG000|Overall Study|Physician Decision|1|||
130082929|NCT01885104|468255519|FG001|Overall Study|Physician Decision|0|||
130082930|NCT00374127|468255520|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
130082931|NCT00374127|468255520|FG000|Overall Study|Blood could not be drawn.|2|||
130082932|NCT00374127|468255520|FG000|Overall Study|Protocol Violation|5|||
130082933|NCT00374127|468255520|FG000|Overall Study|Pregnancy|1|||
130082934|NCT04035473|468255521|FG000|Screening/Baseline|Death|0|||
130082935|NCT04035473|468255522|FG001|Screening/Baseline|Death|1|||
130082936|NCT04035473|468255521|FG000|Screening/Baseline|Adverse Event|0|||
129954862|NCT01878253|467795607|FG000|Overall Study|Lost to Follow-up|2|||
129954863|NCT01878253|467795607|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
129954864|NCT00448344|467795612|FG000|Overall Study|Lost to Follow-up|20|||
129954865|NCT00448344|467795613|FG001|Overall Study|Lost to Follow-up|22|||
129954866|NCT00448344|467795612|FG000|Overall Study|Withdrawal by Subject|6|||
130082937|NCT04035473|468255522|FG001|Screening/Baseline|Adverse Event|1|||
130082938|NCT04035473|468255521|FG000|Follow-up Period|Adverse Event|2|||
130082939|NCT04035473|468255522|FG001|Follow-up Period|Adverse Event|0|||
130082940|NCT02875366|468255523|FG000|Overall Study|Adverse Event|0|||
130082941|NCT02875366|468255524|FG001|Overall Study|Adverse Event|2|||
130082942|NCT02875366|468255523|FG000|Overall Study|Noncompliance|0|||
130082943|NCT02875366|468255524|FG001|Overall Study|Noncompliance|1|||
130082944|NCT02735044|468255526|FG000|Overall Study|Adverse Event|3|||
130082945|NCT02735044|468255527|FG001|Overall Study|Adverse Event|3|||
130082946|NCT02735044|468255526|FG000|Overall Study|Lack of Efficacy|1|||
129954867|NCT00448344|467795613|FG001|Overall Study|Withdrawal by Subject|8|||
129954868|NCT00448344|467795612|FG000|Overall Study|Death|3|||
129954869|NCT00448344|467795613|FG001|Overall Study|Death|4|||
130082947|NCT02735044|468255527|FG001|Overall Study|Lack of Efficacy|0|||
130082948|NCT02735044|468255526|FG000|Overall Study|Poor compliance to protocol|7|||
130082949|NCT02735044|468255527|FG001|Overall Study|Poor compliance to protocol|7|||
130082950|NCT02735044|468255526|FG000|Overall Study|Randomized and not treated|0|||
130082951|NCT02735044|468255527|FG001|Overall Study|Randomized and not treated|2|||
129954870|NCT00448344|467795612|FG000|Overall Study|Physician Decision|1|||
129954871|NCT00448344|467795613|FG001|Overall Study|Physician Decision|2|||
129954872|NCT00267865|467795620|FG000|Induction Treatment|Died before completing.|2|||
130082952|NCT02735044|468255526|FG000|Overall Study|Other, not specified above|5|||
129954873|NCT00267865|467795620|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
129954874|NCT03686176|467795621|FG000|Overall Study|Procedure cancelled|1|||
129954875|NCT03686176|467795622|FG001|Overall Study|Procedure cancelled|0|||
129954876|NCT03686176|467795623|FG002|Overall Study|Procedure cancelled|0|||
129954877|NCT03686176|467795621|FG000|Overall Study|VR Malfunction|1|||
129954878|NCT03686176|467795622|FG001|Overall Study|VR Malfunction|0|||
129954879|NCT03686176|467795623|FG002|Overall Study|VR Malfunction|0|||
129954880|NCT03530345|467795633|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
129954881|NCT03530345|467795634|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
129954882|NCT03530345|467795633|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
129954883|NCT03530345|467795634|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
129954884|NCT03530345|467795633|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
129954885|NCT03530345|467795634|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
129954886|NCT03530345|467795633|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
129954887|NCT03530345|467795634|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
130120970|NCT00788957|468404875|FG003|Part 1|Death|0|||
130120971|NCT00788957|468404876|FG004|Part 1|Death|0|||
130120972|NCT00788957|468404877|FG005|Part 1|Death|0|||
130120973|NCT00788957|468404872|FG000|Part 1|Lost to Follow-up|1|||
130120974|NCT00788957|468404873|FG001|Part 1|Lost to Follow-up|0|||
129954888|NCT00644332|467797260|FG000|Overall Study|Adverse Event|11|||
129954889|NCT00644332|467797260|FG000|Overall Study|Withdrawal by Subject|6|||
129954890|NCT00644332|467797260|FG000|Overall Study|Completion Status Unknown|2|||
129954891|NCT00644332|467797260|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
129954892|NCT00644332|467797260|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
129954893|NCT00355784|467797262|FG000|Overall Study|Withdrawal by Subject|0|||
129954894|NCT00355784|467797263|FG001|Overall Study|Withdrawal by Subject|0|||
129954895|NCT00355784|467797264|FG002|Overall Study|Withdrawal by Subject|2|||
129954896|NCT03602053|467797267|FG000|Overall Study|Withdrawal by Subject|7|||
129954897|NCT03602053|467797268|FG001|Overall Study|Withdrawal by Subject|9|||
129954898|NCT03602053|467797269|FG002|Overall Study|Withdrawal by Subject|7|||
129954899|NCT03602053|467797267|FG000|Overall Study|Lost to Follow-up|5|||
129954900|NCT03602053|467797268|FG001|Overall Study|Lost to Follow-up|6|||
129954901|NCT03602053|467797269|FG002|Overall Study|Lost to Follow-up|0|||
129954902|NCT03602053|467797267|FG000|Overall Study|Protocol Violation|3|||
129954903|NCT03602053|467797268|FG001|Overall Study|Protocol Violation|0|||
129954904|NCT03602053|467797269|FG002|Overall Study|Protocol Violation|4|||
129954905|NCT03602053|467797267|FG000|Overall Study|Physician Decision|1|||
129954906|NCT03602053|467797268|FG001|Overall Study|Physician Decision|0|||
129954907|NCT03602053|467797269|FG002|Overall Study|Physician Decision|0|||
129954908|NCT03602053|467797267|FG000|Overall Study|migration|2|||
129954909|NCT03602053|467797268|FG001|Overall Study|migration|3|||
129954910|NCT03602053|467797269|FG002|Overall Study|migration|0|||
129954911|NCT03602053|467797267|FG000|Overall Study|Other|1|||
129954912|NCT03602053|467797268|FG001|Overall Study|Other|0|||
129954913|NCT03602053|467797269|FG002|Overall Study|Other|0|||
129954914|NCT00396409|467797270|FG000|Period 1 - 2007|Adverse Event|0|||
129954915|NCT00396409|467797271|FG001|Period 1 - 2007|Adverse Event|1|||
129954916|NCT00396409|467797270|FG000|Period 1 - 2007|Lack of Efficacy|0|||
129954917|NCT00396409|467797271|FG001|Period 1 - 2007|Lack of Efficacy|1|||
129954918|NCT00396409|467797270|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
129954919|NCT00396409|467797271|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
129954920|NCT00396409|467797270|FG000|Period 1 - 2007|Lost to Follow-up|2|||
129954921|NCT00396409|467797271|FG001|Period 1 - 2007|Lost to Follow-up|3|||
129954922|NCT00396409|467797270|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
129954923|NCT00396409|467797271|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
129954924|NCT00396409|467797270|FG000|Period 2 - 2008|Protocol Violation|1|||
129954925|NCT00396409|467797271|FG001|Period 2 - 2008|Protocol Violation|0|||
129954926|NCT00396409|467797270|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
129954927|NCT00396409|467797271|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
129954928|NCT00396409|467797270|FG000|Period 2 - 2008|Lost to Follow-up|3|||
129954929|NCT00396409|467797271|FG001|Period 2 - 2008|Lost to Follow-up|1|||
129954930|NCT00331799|467797272|FG000|Overall Study|Withdrawal by Subject|2|||
129954931|NCT00331799|467797272|FG000|Overall Study|Sedation|1|||
129954932|NCT04203199|467797275|FG000|First Intervention Period|Lost to Follow-up|0|||
129954933|NCT04203199|467797276|FG001|First Intervention Period|Lost to Follow-up|1|||
129954934|NCT04203199|467797275|FG000|Second Intervention Period|Medication change|1|||
129954935|NCT04203199|467797276|FG001|Second Intervention Period|Medication change|0|||
129954936|NCT01870999|467797280|FG000|Overall Study|Adverse Event|0|||
129954937|NCT01870999|467797281|FG001|Overall Study|Adverse Event|4|||
129954938|NCT01870999|467797282|FG002|Overall Study|Adverse Event|1|||
129954939|NCT01870999|467797280|FG000|Overall Study|Subject met withdrawal criteria|3|||
129954940|NCT01870999|467797281|FG001|Overall Study|Subject met withdrawal criteria|2|||
129954941|NCT01870999|467797282|FG002|Overall Study|Subject met withdrawal criteria|0|||
129954942|NCT01870999|467797280|FG000|Overall Study|Subject withdrawn by Investigator|1|||
130120975|NCT00788957|468404874|FG002|Part 1|Lost to Follow-up|0|||
129954943|NCT01870999|467797281|FG001|Overall Study|Subject withdrawn by Investigator|0|||
129954944|NCT01870999|467797282|FG002|Overall Study|Subject withdrawn by Investigator|0|||
129954945|NCT01870999|467797280|FG000|Overall Study|Withdrawal by Subject|0|||
129954946|NCT01870999|467797281|FG001|Overall Study|Withdrawal by Subject|2|||
129954947|NCT01870999|467797282|FG002|Overall Study|Withdrawal by Subject|5|||
129954948|NCT01870999|467797280|FG000|Overall Study|Protocol Violation|0|||
129954949|NCT01870999|467797281|FG001|Overall Study|Protocol Violation|0|||
129954950|NCT01870999|467797282|FG002|Overall Study|Protocol Violation|1|||
129954951|NCT03034772|467797283|FG000|Overall Study|Adverse Event|0|||
129954952|NCT03034772|467797284|FG001|Overall Study|Adverse Event|1|||
129954953|NCT03034772|467797283|FG000|Overall Study|Withdrawal by Subject|0|||
129954954|NCT03034772|467797284|FG001|Overall Study|Withdrawal by Subject|1|||
129954955|NCT02660034|467797285|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
129954956|NCT02660034|467797286|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
129954957|NCT02660034|467797287|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
129954958|NCT02660034|467797288|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
129954959|NCT02660034|467797289|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
129954960|NCT02660034|467797290|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
129954961|NCT02660034|467797291|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
129954962|NCT02660034|467797292|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
129954963|NCT02660034|467797293|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
129954964|NCT02660034|467797294|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
129954965|NCT02660034|467797295|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
129954966|NCT02660034|467797296|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
129954967|NCT02660034|467797297|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
129954968|NCT02660034|467797298|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
129954969|NCT02660034|467797285|FG000|Overall Study|Progressive Disease (Clinical)|7|||
129954970|NCT02660034|467797286|FG001|Overall Study|Progressive Disease (Clinical)|8|||
129954971|NCT02660034|467797287|FG002|Overall Study|Progressive Disease (Clinical)|3|||
129954972|NCT02660034|467797288|FG003|Overall Study|Progressive Disease (Clinical)|9|||
129954973|NCT02660034|467797289|FG004|Overall Study|Progressive Disease (Clinical)|3|||
129954974|NCT02660034|467797290|FG005|Overall Study|Progressive Disease (Clinical)|0|||
129954975|NCT02660034|467797291|FG006|Overall Study|Progressive Disease (Clinical)|0|||
129954976|NCT02660034|467797292|FG007|Overall Study|Progressive Disease (Clinical)|0|||
129954977|NCT02660034|467797293|FG008|Overall Study|Progressive Disease (Clinical)|0|||
129954978|NCT02660034|467797294|FG009|Overall Study|Progressive Disease (Clinical)|0|||
129954979|NCT02660034|467797295|FG010|Overall Study|Progressive Disease (Clinical)|0|||
129954980|NCT02660034|467797296|FG011|Overall Study|Progressive Disease (Clinical)|0|||
129954981|NCT02660034|467797297|FG012|Overall Study|Progressive Disease (Clinical)|0|||
129954982|NCT02660034|467797298|FG013|Overall Study|Progressive Disease (Clinical)|0|||
129954983|NCT02660034|467797285|FG000|Overall Study|Lost to Follow-up|0|||
129954984|NCT02660034|467797286|FG001|Overall Study|Lost to Follow-up|0|||
129954985|NCT02660034|467797287|FG002|Overall Study|Lost to Follow-up|1|||
129954986|NCT02660034|467797288|FG003|Overall Study|Lost to Follow-up|1|||
129954987|NCT02660034|467797289|FG004|Overall Study|Lost to Follow-up|0|||
129954988|NCT02660034|467797290|FG005|Overall Study|Lost to Follow-up|0|||
129954989|NCT02660034|467797291|FG006|Overall Study|Lost to Follow-up|0|||
129954990|NCT02660034|467797292|FG007|Overall Study|Lost to Follow-up|0|||
129954991|NCT02660034|467797293|FG008|Overall Study|Lost to Follow-up|0|||
129954992|NCT02660034|467797294|FG009|Overall Study|Lost to Follow-up|1|||
129954993|NCT02660034|467797295|FG010|Overall Study|Lost to Follow-up|1|||
129954994|NCT02660034|467797296|FG011|Overall Study|Lost to Follow-up|1|||
129954995|NCT02660034|467797297|FG012|Overall Study|Lost to Follow-up|0|||
129954996|NCT02660034|467797298|FG013|Overall Study|Lost to Follow-up|0|||
129954997|NCT02660034|467797285|FG000|Overall Study|Participant moved into special access scheme|1|||
129954998|NCT02660034|467797286|FG001|Overall Study|Participant moved into special access scheme|2|||
129954999|NCT02660034|467797287|FG002|Overall Study|Participant moved into special access scheme|0|||
129955000|NCT02660034|467797288|FG003|Overall Study|Participant moved into special access scheme|0|||
129955001|NCT02660034|467797289|FG004|Overall Study|Participant moved into special access scheme|0|||
129955002|NCT02660034|467797290|FG005|Overall Study|Participant moved into special access scheme|0|||
129955003|NCT02660034|467797291|FG006|Overall Study|Participant moved into special access scheme|0|||
129955004|NCT02660034|467797292|FG007|Overall Study|Participant moved into special access scheme|0|||
129955005|NCT02660034|467797293|FG008|Overall Study|Participant moved into special access scheme|0|||
129955006|NCT02660034|467797294|FG009|Overall Study|Participant moved into special access scheme|0|||
129955007|NCT02660034|467797295|FG010|Overall Study|Participant moved into special access scheme|0|||
129955008|NCT02660034|467797296|FG011|Overall Study|Participant moved into special access scheme|0|||
129955009|NCT02660034|467797297|FG012|Overall Study|Participant moved into special access scheme|0|||
129955010|NCT02660034|467797298|FG013|Overall Study|Participant moved into special access scheme|0|||
129955011|NCT02660034|467797285|FG000|Overall Study|Adverse Event|1|||
129955012|NCT02660034|467797286|FG001|Overall Study|Adverse Event|0|||
129955013|NCT02660034|467797287|FG002|Overall Study|Adverse Event|0|||
129955014|NCT02660034|467797288|FG003|Overall Study|Adverse Event|0|||
130082953|NCT02735044|468255527|FG001|Overall Study|Other, not specified above|11|||
130082954|NCT01201967|468255529|FG000|Overall Study|Lost to Follow-up|6|||
129955015|NCT02660034|467797289|FG004|Overall Study|Adverse Event|0|||
129955016|NCT02660034|467797290|FG005|Overall Study|Adverse Event|0|||
129955017|NCT02660034|467797291|FG006|Overall Study|Adverse Event|0|||
129955018|NCT02660034|467797292|FG007|Overall Study|Adverse Event|0|||
129955019|NCT02660034|467797293|FG008|Overall Study|Adverse Event|0|||
129955020|NCT02660034|467797294|FG009|Overall Study|Adverse Event|0|||
130082955|NCT01201967|468255530|FG001|Overall Study|Lost to Follow-up|5|||
130082956|NCT01888965|468257156|FG000|Overall Study|Adverse Event|5|||
130082957|NCT01888965|468257156|FG000|Overall Study|Lack of Efficacy|4|||
130082958|NCT01693562|468257157|FG000|Escalation Phase|Withdrawal by Subject|0|||
130082959|NCT01693562|468257158|FG001|Escalation Phase|Withdrawal by Subject|1|||
130082960|NCT01693562|468257159|FG002|Escalation Phase|Withdrawal by Subject|0|||
130082961|NCT01693562|468257160|FG003|Escalation Phase|Withdrawal by Subject|0|||
130082962|NCT01693562|468257161|FG004|Escalation Phase|Withdrawal by Subject|0|||
130082963|NCT01693562|468257162|FG005|Escalation Phase|Withdrawal by Subject|2|||
130082964|NCT01693562|468257163|FG006|Escalation Phase|Withdrawal by Subject|0|||
130082965|NCT01693562|468257164|FG007|Escalation Phase|Withdrawal by Subject|0|||
130082966|NCT01693562|468257165|FG008|Escalation Phase|Withdrawal by Subject|0|||
130082967|NCT01693562|468257166|FG009|Escalation Phase|Withdrawal by Subject|0|||
130082968|NCT01693562|468257167|FG010|Escalation Phase|Withdrawal by Subject|0|||
130082969|NCT01693562|468257168|FG011|Escalation Phase|Withdrawal by Subject|0|||
130082970|NCT01693562|468257169|FG012|Escalation Phase|Withdrawal by Subject|0|||
130082971|NCT01693562|468257170|FG013|Escalation Phase|Withdrawal by Subject|0|||
130082972|NCT01693562|468257171|FG014|Escalation Phase|Withdrawal by Subject|0|||
130082973|NCT01693562|468257172|FG015|Escalation Phase|Withdrawal by Subject|0|||
130082974|NCT01693562|468257173|FG016|Escalation Phase|Withdrawal by Subject|0|||
130082975|NCT01693562|468257174|FG017|Escalation Phase|Withdrawal by Subject|0|||
130082976|NCT01693562|468257175|FG018|Escalation Phase|Withdrawal by Subject|0|||
130082977|NCT01693562|468257176|FG019|Escalation Phase|Withdrawal by Subject|0|||
130082978|NCT01693562|468257177|FG020|Escalation Phase|Withdrawal by Subject|0|||
130082979|NCT01693562|468257178|FG021|Escalation Phase|Withdrawal by Subject|0|||
130082980|NCT01693562|468257179|FG022|Escalation Phase|Withdrawal by Subject|0|||
130082981|NCT01693562|468257157|FG000|Escalation Phase|Death|4|||
130082982|NCT01693562|468257158|FG001|Escalation Phase|Death|2|||
130082983|NCT01693562|468257159|FG002|Escalation Phase|Death|0|||
130082984|NCT01693562|468257160|FG003|Escalation Phase|Death|3|||
130082985|NCT01693562|468257161|FG004|Escalation Phase|Death|6|||
130082986|NCT01693562|468257162|FG005|Escalation Phase|Death|4|||
130082987|NCT01693562|468257163|FG006|Escalation Phase|Death|0|||
130082988|NCT01693562|468257164|FG007|Escalation Phase|Death|0|||
130082989|NCT01693562|468257165|FG008|Escalation Phase|Death|0|||
130082990|NCT01693562|468257166|FG009|Escalation Phase|Death|0|||
130082991|NCT01693562|468257167|FG010|Escalation Phase|Death|0|||
130082992|NCT01693562|468257168|FG011|Escalation Phase|Death|0|||
130082993|NCT01693562|468257169|FG012|Escalation Phase|Death|0|||
130082994|NCT01693562|468257170|FG013|Escalation Phase|Death|0|||
130082995|NCT01693562|468257171|FG014|Escalation Phase|Death|0|||
130082996|NCT01693562|468257172|FG015|Escalation Phase|Death|0|||
130082997|NCT01693562|468257173|FG016|Escalation Phase|Death|0|||
130082998|NCT01693562|468257174|FG017|Escalation Phase|Death|0|||
130082999|NCT01693562|468257175|FG018|Escalation Phase|Death|0|||
130083000|NCT01693562|468257176|FG019|Escalation Phase|Death|0|||
130083001|NCT01693562|468257177|FG020|Escalation Phase|Death|0|||
130083002|NCT01693562|468257178|FG021|Escalation Phase|Death|0|||
130083003|NCT01693562|468257179|FG022|Escalation Phase|Death|0|||
130083004|NCT01693562|468257157|FG000|Escalation Phase|Lost to Follow-up|0|||
130083005|NCT01693562|468257158|FG001|Escalation Phase|Lost to Follow-up|1|||
130083006|NCT01693562|468257159|FG002|Escalation Phase|Lost to Follow-up|1|||
130083007|NCT01693562|468257160|FG003|Escalation Phase|Lost to Follow-up|0|||
130083008|NCT01693562|468257161|FG004|Escalation Phase|Lost to Follow-up|0|||
130083009|NCT01693562|468257162|FG005|Escalation Phase|Lost to Follow-up|0|||
130083010|NCT01693562|468257163|FG006|Escalation Phase|Lost to Follow-up|0|||
129955021|NCT02660034|467797295|FG010|Overall Study|Adverse Event|0|||
129955022|NCT02660034|467797296|FG011|Overall Study|Adverse Event|0|||
130083011|NCT01693562|468257164|FG007|Escalation Phase|Lost to Follow-up|0|||
130083012|NCT01693562|468257165|FG008|Escalation Phase|Lost to Follow-up|0|||
130083013|NCT01693562|468257166|FG009|Escalation Phase|Lost to Follow-up|0|||
130083014|NCT01693562|468257167|FG010|Escalation Phase|Lost to Follow-up|0|||
130083015|NCT01693562|468257168|FG011|Escalation Phase|Lost to Follow-up|0|||
130083016|NCT01693562|468257169|FG012|Escalation Phase|Lost to Follow-up|0|||
129955023|NCT02660034|467797297|FG012|Overall Study|Adverse Event|0|||
129955024|NCT02660034|467797298|FG013|Overall Study|Adverse Event|0|||
130083017|NCT01693562|468257170|FG013|Escalation Phase|Lost to Follow-up|0|||
130083018|NCT01693562|468257171|FG014|Escalation Phase|Lost to Follow-up|0|||
130083019|NCT01693562|468257172|FG015|Escalation Phase|Lost to Follow-up|0|||
130083020|NCT01693562|468257173|FG016|Escalation Phase|Lost to Follow-up|0|||
130083021|NCT01693562|468257174|FG017|Escalation Phase|Lost to Follow-up|0|||
130083022|NCT01693562|468257175|FG018|Escalation Phase|Lost to Follow-up|0|||
130120976|NCT00788957|468404875|FG003|Part 1|Lost to Follow-up|0|||
130120977|NCT00788957|468404876|FG004|Part 1|Lost to Follow-up|0|||
130120978|NCT00788957|468404877|FG005|Part 1|Lost to Follow-up|0|||
130120979|NCT00788957|468404872|FG000|Part 2|Withdrawal by Subject|0|||
129955025|NCT02660034|467797285|FG000|Overall Study|Sponsor Decision|0|||
129955026|NCT02660034|467797286|FG001|Overall Study|Sponsor Decision|1|||
129955027|NCT02660034|467797287|FG002|Overall Study|Sponsor Decision|2|||
129955028|NCT02660034|467797288|FG003|Overall Study|Sponsor Decision|2|||
129955029|NCT02660034|467797289|FG004|Overall Study|Sponsor Decision|3|||
129955030|NCT02660034|467797290|FG005|Overall Study|Sponsor Decision|0|||
129955031|NCT02660034|467797291|FG006|Overall Study|Sponsor Decision|0|||
129955032|NCT02660034|467797292|FG007|Overall Study|Sponsor Decision|0|||
129955033|NCT02660034|467797293|FG008|Overall Study|Sponsor Decision|0|||
129955034|NCT02660034|467797294|FG009|Overall Study|Sponsor Decision|0|||
129955035|NCT02660034|467797295|FG010|Overall Study|Sponsor Decision|0|||
129955036|NCT02660034|467797296|FG011|Overall Study|Sponsor Decision|0|||
129955037|NCT02660034|467797297|FG012|Overall Study|Sponsor Decision|0|||
129955038|NCT02660034|467797298|FG013|Overall Study|Sponsor Decision|1|||
129955039|NCT02660034|467797285|FG000|Overall Study|Withdrawal by Subject|0|||
129955040|NCT02660034|467797286|FG001|Overall Study|Withdrawal by Subject|0|||
129955041|NCT02660034|467797287|FG002|Overall Study|Withdrawal by Subject|0|||
129955042|NCT02660034|467797288|FG003|Overall Study|Withdrawal by Subject|0|||
129955043|NCT02660034|467797289|FG004|Overall Study|Withdrawal by Subject|0|||
129955044|NCT02660034|467797290|FG005|Overall Study|Withdrawal by Subject|0|||
129955045|NCT02660034|467797291|FG006|Overall Study|Withdrawal by Subject|1|||
129955046|NCT02660034|467797292|FG007|Overall Study|Withdrawal by Subject|1|||
129955047|NCT02660034|467797293|FG008|Overall Study|Withdrawal by Subject|1|||
129955048|NCT02660034|467797294|FG009|Overall Study|Withdrawal by Subject|0|||
129955049|NCT02660034|467797295|FG010|Overall Study|Withdrawal by Subject|0|||
129955050|NCT02660034|467797296|FG011|Overall Study|Withdrawal by Subject|1|||
129955051|NCT02660034|467797297|FG012|Overall Study|Withdrawal by Subject|2|||
129955052|NCT02660034|467797298|FG013|Overall Study|Withdrawal by Subject|0|||
129955053|NCT02660034|467797285|FG000|Overall Study|Death|0|||
129955054|NCT02660034|467797286|FG001|Overall Study|Death|0|||
129955055|NCT02660034|467797287|FG002|Overall Study|Death|0|||
129955056|NCT02660034|467797288|FG003|Overall Study|Death|0|||
129955057|NCT02660034|467797289|FG004|Overall Study|Death|0|||
129955058|NCT02660034|467797290|FG005|Overall Study|Death|13|||
129955059|NCT02660034|467797291|FG006|Overall Study|Death|14|||
129955060|NCT02660034|467797292|FG007|Overall Study|Death|10|||
129955061|NCT02660034|467797293|FG008|Overall Study|Death|9|||
129955062|NCT02660034|467797294|FG009|Overall Study|Death|21|||
129955063|NCT02660034|467797295|FG010|Overall Study|Death|17|||
129955064|NCT02660034|467797296|FG011|Overall Study|Death|15|||
129955065|NCT02660034|467797297|FG012|Overall Study|Death|18|||
129955066|NCT02660034|467797298|FG013|Overall Study|Death|7|||
129955067|NCT02660034|467797285|FG000|Overall Study|Physician Decision|0|||
129955068|NCT02660034|467797286|FG001|Overall Study|Physician Decision|0|||
129955069|NCT02660034|467797287|FG002|Overall Study|Physician Decision|0|||
129955070|NCT02660034|467797288|FG003|Overall Study|Physician Decision|0|||
129955071|NCT02660034|467797289|FG004|Overall Study|Physician Decision|0|||
129955072|NCT02660034|467797290|FG005|Overall Study|Physician Decision|0|||
129955073|NCT02660034|467797291|FG006|Overall Study|Physician Decision|0|||
129955074|NCT02660034|467797292|FG007|Overall Study|Physician Decision|0|||
129955075|NCT02660034|467797293|FG008|Overall Study|Physician Decision|0|||
129955076|NCT02660034|467797294|FG009|Overall Study|Physician Decision|0|||
129955077|NCT02660034|467797295|FG010|Overall Study|Physician Decision|0|||
129955078|NCT02660034|467797296|FG011|Overall Study|Physician Decision|0|||
129955079|NCT02660034|467797297|FG012|Overall Study|Physician Decision|0|||
129955080|NCT02660034|467797298|FG013|Overall Study|Physician Decision|1|||
129955081|NCT02660034|467797285|FG000|Overall Study|Participants transferred to LTE|0|||
129955082|NCT02660034|467797286|FG001|Overall Study|Participants transferred to LTE|0|||
130120980|NCT00788957|468404873|FG001|Part 2|Withdrawal by Subject|9|||
130120981|NCT00788957|468404874|FG002|Part 2|Withdrawal by Subject|5|||
130120982|NCT00788957|468404875|FG003|Part 2|Withdrawal by Subject|3|||
129955083|NCT02660034|467797287|FG002|Overall Study|Participants transferred to LTE|0|||
129955084|NCT02660034|467797288|FG003|Overall Study|Participants transferred to LTE|0|||
129955085|NCT02660034|467797289|FG004|Overall Study|Participants transferred to LTE|0|||
129955086|NCT02660034|467797290|FG005|Overall Study|Participants transferred to LTE|10|||
129955087|NCT02660034|467797291|FG006|Overall Study|Participants transferred to LTE|8|||
129955088|NCT02660034|467797292|FG007|Overall Study|Participants transferred to LTE|8|||
129955089|NCT02660034|467797293|FG008|Overall Study|Participants transferred to LTE|10|||
129955090|NCT02660034|467797294|FG009|Overall Study|Participants transferred to LTE|1|||
129955091|NCT02660034|467797295|FG010|Overall Study|Participants transferred to LTE|2|||
129955092|NCT02660034|467797296|FG011|Overall Study|Participants transferred to LTE|4|||
129955093|NCT02660034|467797297|FG012|Overall Study|Participants transferred to LTE|1|||
129955094|NCT02660034|467797298|FG013|Overall Study|Participants transferred to LTE|1|||
129955095|NCT01533181|467797301|FG000|Overall Study|Disease progression pre-active treatment|0|||
130120983|NCT00788957|468404876|FG004|Part 2|Withdrawal by Subject|0|||
130083023|NCT01693562|468257176|FG019|Escalation Phase|Lost to Follow-up|0|||
130083024|NCT01693562|468257177|FG020|Escalation Phase|Lost to Follow-up|0|||
130083025|NCT01693562|468257178|FG021|Escalation Phase|Lost to Follow-up|0|||
130083026|NCT01693562|468257179|FG022|Escalation Phase|Lost to Follow-up|0|||
130083027|NCT01693562|468257157|FG000|Escalation Phase|Other|0|||
130083028|NCT01693562|468257158|FG001|Escalation Phase|Other|0|||
130083029|NCT01693562|468257159|FG002|Escalation Phase|Other|2|||
130083030|NCT01693562|468257160|FG003|Escalation Phase|Other|0|||
130083031|NCT01693562|468257161|FG004|Escalation Phase|Other|0|||
130083032|NCT01693562|468257162|FG005|Escalation Phase|Other|1|||
130083033|NCT01693562|468257163|FG006|Escalation Phase|Other|0|||
130083034|NCT01693562|468257164|FG007|Escalation Phase|Other|0|||
130083035|NCT01693562|468257165|FG008|Escalation Phase|Other|0|||
130083036|NCT01693562|468257166|FG009|Escalation Phase|Other|0|||
130083037|NCT01693562|468257167|FG010|Escalation Phase|Other|0|||
130083038|NCT01693562|468257168|FG011|Escalation Phase|Other|0|||
130083039|NCT01693562|468257169|FG012|Escalation Phase|Other|0|||
130083040|NCT01693562|468257170|FG013|Escalation Phase|Other|0|||
130083041|NCT01693562|468257171|FG014|Escalation Phase|Other|0|||
130083042|NCT01693562|468257172|FG015|Escalation Phase|Other|0|||
130083043|NCT01693562|468257173|FG016|Escalation Phase|Other|0|||
130083044|NCT01693562|468257174|FG017|Escalation Phase|Other|0|||
130083045|NCT01693562|468257175|FG018|Escalation Phase|Other|0|||
130083046|NCT01693562|468257176|FG019|Escalation Phase|Other|0|||
130083047|NCT01693562|468257177|FG020|Escalation Phase|Other|0|||
130083048|NCT01693562|468257178|FG021|Escalation Phase|Other|0|||
130083049|NCT01693562|468257179|FG022|Escalation Phase|Other|0|||
130083050|NCT01693562|468257157|FG000|Exploration Phase|Withdrawal by Subject|0|||
130083051|NCT01693562|468257158|FG001|Exploration Phase|Withdrawal by Subject|0|||
130083052|NCT01693562|468257159|FG002|Exploration Phase|Withdrawal by Subject|0|||
130083053|NCT01693562|468257160|FG003|Exploration Phase|Withdrawal by Subject|0|||
130083054|NCT01693562|468257161|FG004|Exploration Phase|Withdrawal by Subject|0|||
130083055|NCT01693562|468257162|FG005|Exploration Phase|Withdrawal by Subject|0|||
130083056|NCT01693562|468257163|FG006|Exploration Phase|Withdrawal by Subject|2|||
130083057|NCT01693562|468257164|FG007|Exploration Phase|Withdrawal by Subject|0|||
130083058|NCT01693562|468257165|FG008|Exploration Phase|Withdrawal by Subject|0|||
130083059|NCT01693562|468257166|FG009|Exploration Phase|Withdrawal by Subject|0|||
130083060|NCT01693562|468257167|FG010|Exploration Phase|Withdrawal by Subject|0|||
130083061|NCT01693562|468257168|FG011|Exploration Phase|Withdrawal by Subject|0|||
130083062|NCT01693562|468257169|FG012|Exploration Phase|Withdrawal by Subject|0|||
130083063|NCT01693562|468257170|FG013|Exploration Phase|Withdrawal by Subject|0|||
130083064|NCT01693562|468257171|FG014|Exploration Phase|Withdrawal by Subject|0|||
130083065|NCT01693562|468257172|FG015|Exploration Phase|Withdrawal by Subject|0|||
130083066|NCT01693562|468257173|FG016|Exploration Phase|Withdrawal by Subject|0|||
130083067|NCT01693562|468257174|FG017|Exploration Phase|Withdrawal by Subject|0|||
130083068|NCT01693562|468257175|FG018|Exploration Phase|Withdrawal by Subject|0|||
130083069|NCT01693562|468257176|FG019|Exploration Phase|Withdrawal by Subject|0|||
130083070|NCT01693562|468257177|FG020|Exploration Phase|Withdrawal by Subject|0|||
130083071|NCT01693562|468257178|FG021|Exploration Phase|Withdrawal by Subject|0|||
130083072|NCT01693562|468257179|FG022|Exploration Phase|Withdrawal by Subject|0|||
130083073|NCT01693562|468257157|FG000|Exploration Phase|Death|0|||
130083074|NCT01693562|468257158|FG001|Exploration Phase|Death|0|||
130083075|NCT01693562|468257159|FG002|Exploration Phase|Death|0|||
130083076|NCT01693562|468257160|FG003|Exploration Phase|Death|0|||
130083077|NCT01693562|468257161|FG004|Exploration Phase|Death|0|||
130083078|NCT01693562|468257162|FG005|Exploration Phase|Death|0|||
130083079|NCT01693562|468257163|FG006|Exploration Phase|Death|17|||
130083080|NCT01693562|468257164|FG007|Exploration Phase|Death|0|||
130083081|NCT01693562|468257165|FG008|Exploration Phase|Death|0|||
130083082|NCT01693562|468257166|FG009|Exploration Phase|Death|0|||
130083083|NCT01693562|468257167|FG010|Exploration Phase|Death|0|||
130083084|NCT01693562|468257168|FG011|Exploration Phase|Death|0|||
130083085|NCT01693562|468257169|FG012|Exploration Phase|Death|0|||
130083086|NCT01693562|468257170|FG013|Exploration Phase|Death|0|||
130083087|NCT01693562|468257171|FG014|Exploration Phase|Death|0|||
130083088|NCT01693562|468257172|FG015|Exploration Phase|Death|0|||
130083089|NCT01693562|468257173|FG016|Exploration Phase|Death|0|||
130083090|NCT01693562|468257174|FG017|Exploration Phase|Death|0|||
130083091|NCT01693562|468257175|FG018|Exploration Phase|Death|0|||
130083092|NCT01693562|468257176|FG019|Exploration Phase|Death|0|||
130083093|NCT01693562|468257177|FG020|Exploration Phase|Death|0|||
129955096|NCT01533181|467797302|FG001|Overall Study|Disease progression pre-active treatment|1|||
130083094|NCT01693562|468257178|FG021|Exploration Phase|Death|0|||
130083095|NCT01693562|468257179|FG022|Exploration Phase|Death|0|||
130083096|NCT01693562|468257157|FG000|Exploration Phase|Other|0|||
130083097|NCT01693562|468257158|FG001|Exploration Phase|Other|0|||
130083098|NCT01693562|468257159|FG002|Exploration Phase|Other|0|||
130083099|NCT01693562|468257160|FG003|Exploration Phase|Other|0|||
130083100|NCT01693562|468257161|FG004|Exploration Phase|Other|0|||
130083101|NCT01693562|468257162|FG005|Exploration Phase|Other|0|||
130083102|NCT01693562|468257163|FG006|Exploration Phase|Other|2|||
130083103|NCT01693562|468257164|FG007|Exploration Phase|Other|0|||
130083104|NCT01693562|468257165|FG008|Exploration Phase|Other|0|||
130083105|NCT01693562|468257166|FG009|Exploration Phase|Other|0|||
130083106|NCT01693562|468257167|FG010|Exploration Phase|Other|0|||
130083107|NCT01693562|468257168|FG011|Exploration Phase|Other|0|||
130083108|NCT01693562|468257169|FG012|Exploration Phase|Other|0|||
130083109|NCT01693562|468257170|FG013|Exploration Phase|Other|0|||
130083110|NCT01693562|468257171|FG014|Exploration Phase|Other|0|||
130083111|NCT01693562|468257172|FG015|Exploration Phase|Other|0|||
130083112|NCT01693562|468257173|FG016|Exploration Phase|Other|0|||
130083113|NCT01693562|468257174|FG017|Exploration Phase|Other|0|||
130083114|NCT01693562|468257175|FG018|Exploration Phase|Other|0|||
130083115|NCT01693562|468257176|FG019|Exploration Phase|Other|0|||
130083116|NCT01693562|468257177|FG020|Exploration Phase|Other|0|||
130083117|NCT01693562|468257178|FG021|Exploration Phase|Other|0|||
130083118|NCT01693562|468257179|FG022|Exploration Phase|Other|0|||
130083119|NCT01693562|468257157|FG000|Expansion Phase|Withdrawal by Subject|0|||
130083120|NCT01693562|468257158|FG001|Expansion Phase|Withdrawal by Subject|0|||
130083121|NCT01693562|468257159|FG002|Expansion Phase|Withdrawal by Subject|0|||
130083122|NCT01693562|468257160|FG003|Expansion Phase|Withdrawal by Subject|0|||
130083123|NCT01693562|468257161|FG004|Expansion Phase|Withdrawal by Subject|0|||
130083124|NCT01693562|468257162|FG005|Expansion Phase|Withdrawal by Subject|0|||
130083125|NCT01693562|468257163|FG006|Expansion Phase|Withdrawal by Subject|0|||
130083126|NCT01693562|468257164|FG007|Expansion Phase|Withdrawal by Subject|16|||
130083127|NCT01693562|468257165|FG008|Expansion Phase|Withdrawal by Subject|2|||
130083128|NCT01693562|468257166|FG009|Expansion Phase|Withdrawal by Subject|54|||
130083129|NCT01693562|468257167|FG010|Expansion Phase|Withdrawal by Subject|2|||
130083130|NCT01693562|468257168|FG011|Expansion Phase|Withdrawal by Subject|2|||
130083131|NCT01693562|468257169|FG012|Expansion Phase|Withdrawal by Subject|3|||
130083132|NCT01693562|468257170|FG013|Expansion Phase|Withdrawal by Subject|5|||
130083133|NCT01693562|468257171|FG014|Expansion Phase|Withdrawal by Subject|16|||
130083134|NCT01693562|468257172|FG015|Expansion Phase|Withdrawal by Subject|7|||
130083135|NCT01693562|468257173|FG016|Expansion Phase|Withdrawal by Subject|40|||
130083136|NCT01693562|468257174|FG017|Expansion Phase|Withdrawal by Subject|4|||
130083137|NCT01693562|468257175|FG018|Expansion Phase|Withdrawal by Subject|8|||
130083138|NCT01693562|468257176|FG019|Expansion Phase|Withdrawal by Subject|3|||
130083139|NCT01693562|468257177|FG020|Expansion Phase|Withdrawal by Subject|1|||
130083140|NCT01693562|468257178|FG021|Expansion Phase|Withdrawal by Subject|8|||
130083141|NCT01693562|468257179|FG022|Expansion Phase|Withdrawal by Subject|1|||
130083142|NCT01693562|468257157|FG000|Expansion Phase|Death|0|||
130083143|NCT01693562|468257158|FG001|Expansion Phase|Death|0|||
130083144|NCT01693562|468257159|FG002|Expansion Phase|Death|0|||
130083145|NCT01693562|468257160|FG003|Expansion Phase|Death|0|||
130083146|NCT01693562|468257161|FG004|Expansion Phase|Death|0|||
130083147|NCT01693562|468257162|FG005|Expansion Phase|Death|0|||
130083148|NCT01693562|468257163|FG006|Expansion Phase|Death|0|||
130083149|NCT01693562|468257164|FG007|Expansion Phase|Death|42|||
130083150|NCT01693562|468257165|FG008|Expansion Phase|Death|17|||
130083151|NCT01693562|468257166|FG009|Expansion Phase|Death|208|||
130083152|NCT01693562|468257167|FG010|Expansion Phase|Death|30|||
130083153|NCT01693562|468257168|FG011|Expansion Phase|Death|8|||
130083154|NCT01693562|468257169|FG012|Expansion Phase|Death|19|||
130083155|NCT01693562|468257170|FG013|Expansion Phase|Death|42|||
130083156|NCT01693562|468257171|FG014|Expansion Phase|Death|23|||
130083157|NCT01693562|468257172|FG015|Expansion Phase|Death|23|||
130083158|NCT01693562|468257173|FG016|Expansion Phase|Death|128|||
130083159|NCT01693562|468257174|FG017|Expansion Phase|Death|16|||
130083160|NCT01693562|468257175|FG018|Expansion Phase|Death|36|||
130083161|NCT01693562|468257176|FG019|Expansion Phase|Death|16|||
130083162|NCT01693562|468257177|FG020|Expansion Phase|Death|17|||
130083163|NCT01693562|468257178|FG021|Expansion Phase|Death|35|||
130083164|NCT01693562|468257179|FG022|Expansion Phase|Death|7|||
130083165|NCT01693562|468257157|FG000|Expansion Phase|Lost to Follow-up|0|||
130083166|NCT01693562|468257158|FG001|Expansion Phase|Lost to Follow-up|0|||
130083167|NCT01693562|468257159|FG002|Expansion Phase|Lost to Follow-up|0|||
130083168|NCT01693562|468257160|FG003|Expansion Phase|Lost to Follow-up|0|||
130083169|NCT01693562|468257161|FG004|Expansion Phase|Lost to Follow-up|0|||
130083170|NCT01693562|468257162|FG005|Expansion Phase|Lost to Follow-up|0|||
130083171|NCT01693562|468257163|FG006|Expansion Phase|Lost to Follow-up|0|||
130083172|NCT01693562|468257164|FG007|Expansion Phase|Lost to Follow-up|1|||
130083173|NCT01693562|468257165|FG008|Expansion Phase|Lost to Follow-up|2|||
130083174|NCT01693562|468257166|FG009|Expansion Phase|Lost to Follow-up|10|||
130083175|NCT01693562|468257167|FG010|Expansion Phase|Lost to Follow-up|4|||
130083176|NCT01693562|468257168|FG011|Expansion Phase|Lost to Follow-up|4|||
130120984|NCT00788957|468404877|FG005|Part 2|Withdrawal by Subject|0|||
130083177|NCT01693562|468257169|FG012|Expansion Phase|Lost to Follow-up|1|||
130083178|NCT01693562|468257170|FG013|Expansion Phase|Lost to Follow-up|3|||
130083179|NCT01693562|468257171|FG014|Expansion Phase|Lost to Follow-up|0|||
130083180|NCT01693562|468257172|FG015|Expansion Phase|Lost to Follow-up|1|||
130083181|NCT01693562|468257173|FG016|Expansion Phase|Lost to Follow-up|1|||
130083182|NCT01693562|468257174|FG017|Expansion Phase|Lost to Follow-up|0|||
130083183|NCT01693562|468257175|FG018|Expansion Phase|Lost to Follow-up|2|||
130083184|NCT01693562|468257176|FG019|Expansion Phase|Lost to Follow-up|1|||
130083185|NCT01693562|468257177|FG020|Expansion Phase|Lost to Follow-up|2|||
130083186|NCT01693562|468257178|FG021|Expansion Phase|Lost to Follow-up|2|||
130083187|NCT01693562|468257179|FG022|Expansion Phase|Lost to Follow-up|1|||
130083188|NCT01693562|468257157|FG000|Expansion Phase|Other|0|||
130083189|NCT01693562|468257158|FG001|Expansion Phase|Other|0|||
130083190|NCT01693562|468257159|FG002|Expansion Phase|Other|0|||
130083191|NCT01693562|468257160|FG003|Expansion Phase|Other|0|||
130083192|NCT01693562|468257161|FG004|Expansion Phase|Other|0|||
130083193|NCT01693562|468257162|FG005|Expansion Phase|Other|0|||
130083194|NCT01693562|468257163|FG006|Expansion Phase|Other|0|||
130083195|NCT01693562|468257164|FG007|Expansion Phase|Other|3|||
130083196|NCT01693562|468257165|FG008|Expansion Phase|Other|1|||
130083197|NCT01693562|468257166|FG009|Expansion Phase|Other|28|||
130083198|NCT01693562|468257167|FG010|Expansion Phase|Other|4|||
130083199|NCT01693562|468257168|FG011|Expansion Phase|Other|7|||
130083200|NCT01693562|468257169|FG012|Expansion Phase|Other|0|||
130083201|NCT01693562|468257170|FG013|Expansion Phase|Other|1|||
130083202|NCT01693562|468257171|FG014|Expansion Phase|Other|1|||
130083203|NCT01693562|468257172|FG015|Expansion Phase|Other|0|||
130083204|NCT01693562|468257173|FG016|Expansion Phase|Other|28|||
130083205|NCT01693562|468257174|FG017|Expansion Phase|Other|0|||
130083206|NCT01693562|468257175|FG018|Expansion Phase|Other|1|||
130083207|NCT01693562|468257176|FG019|Expansion Phase|Other|0|||
130083208|NCT01693562|468257177|FG020|Expansion Phase|Other|1|||
130083209|NCT01693562|468257178|FG021|Expansion Phase|Other|17|||
130083210|NCT01693562|468257179|FG022|Expansion Phase|Other|1|||
130083211|NCT00887822|468257185|FG000|Overall Study|Insufficient therapeutic response|53|||
130083212|NCT00887822|468257186|FG001|Overall Study|Insufficient therapeutic response|55|||
130083213|NCT00887822|468257185|FG000|Overall Study|Adverse Event|14|||
130083214|NCT00887822|468257186|FG001|Overall Study|Adverse Event|17|||
130083215|NCT00887822|468257185|FG000|Overall Study|Failure to return|11|||
130083216|NCT00887822|468257186|FG001|Overall Study|Failure to return|11|||
130083217|NCT00887822|468257185|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
130083218|NCT00887822|468257186|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
130083219|NCT00887822|468257185|FG000|Overall Study|Administrative/Other than specified|5|||
130083220|NCT00887822|468257186|FG001|Overall Study|Administrative/Other than specified|4|||
130083221|NCT00887822|468257185|FG000|Overall Study|Death|2|||
130083222|NCT00887822|468257186|FG001|Overall Study|Death|3|||
130083223|NCT00887822|468257185|FG000|Overall Study|Protocol Violation|0|||
130083224|NCT00887822|468257186|FG001|Overall Study|Protocol Violation|1|||
130083225|NCT00887822|468257185|FG000|Overall Study|Randomized but not treated|0|||
130083226|NCT00887822|468257186|FG001|Overall Study|Randomized but not treated|1|||
130083227|NCT02987205|468257187|FG000|Overall Study|Adverse Event|1|||
130083228|NCT02987205|468257187|FG000|Overall Study|Withdrawal by Subject|3|||
130083229|NCT04167514|468257188|FG000|Overall Study|Adverse event, not serious|0|||
130083230|NCT04167514|468257189|FG001|Overall Study|Adverse event, not serious|1|||
130083231|NCT04167514|468257188|FG000|Overall Study|Lost to Follow-up|1|||
130083232|NCT04167514|468257189|FG001|Overall Study|Lost to Follow-up|0|||
130083233|NCT04167514|468257188|FG000|Overall Study|Participant Decision|2|||
130083234|NCT04167514|468257189|FG001|Overall Study|Participant Decision|4|||
130083235|NCT04167514|468257188|FG000|Overall Study|Physician Decision|3|||
130083236|NCT04167514|468257189|FG001|Overall Study|Physician Decision|2|||
130083237|NCT04167514|468257188|FG000|Overall Study|Death|14|||
130083238|NCT04167514|468257189|FG001|Overall Study|Death|18|||
130083239|NCT04167514|468257188|FG000|Overall Study|Enrolled but treatment not administered|2|||
130083240|NCT04167514|468257189|FG001|Overall Study|Enrolled but treatment not administered|0|||
130083241|NCT04167514|468257188|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
130083242|NCT04167514|468257189|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
130083243|NCT04167514|468257188|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
130083244|NCT04167514|468257189|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
130083245|NCT03345849|468257190|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
130083246|NCT03345849|468257191|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
130083247|NCT03345849|468257192|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
130083248|NCT03345849|468257193|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
130083249|NCT03345849|468257190|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
130083250|NCT03345849|468257191|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
130083251|NCT03345849|468257192|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
130083252|NCT03345849|468257193|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
130083253|NCT03345849|468257190|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
130083254|NCT03345849|468257191|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
130083255|NCT03345849|468257192|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
130083256|NCT03345849|468257193|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
130083257|NCT03345849|468257190|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
130083258|NCT03345849|468257191|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
130083259|NCT03345849|468257192|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
130083260|NCT03345849|468257193|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
130083261|NCT03345849|468257190|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
130083262|NCT03345849|468257191|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
130083263|NCT03345849|468257192|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
130083264|NCT03345849|468257193|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
130083265|NCT03345849|468257190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
130083266|NCT03345849|468257191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
130083267|NCT03345849|468257192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
130083268|NCT03345849|468257193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
130083269|NCT03345849|468257190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
130083270|NCT03345849|468257191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
130083271|NCT03345849|468257192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
130083272|NCT03345849|468257193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
130083273|NCT03345849|468257190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
130083274|NCT03345849|468257191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
130083275|NCT03345849|468257192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
130083276|NCT03345849|468257193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
130083277|NCT03345849|468257190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130083278|NCT03345849|468257191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130083279|NCT03345849|468257192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
130083280|NCT03345849|468257193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
130083281|NCT03345849|468257190|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
130083282|NCT03345849|468257191|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
130083283|NCT03345849|468257192|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
130083284|NCT03345849|468257193|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
130083285|NCT03345849|468257190|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
130083286|NCT03345849|468257191|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
130083287|NCT03345849|468257192|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
130083288|NCT03345849|468257193|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
130083289|NCT05618808|468257196|FG000|Overall Study|Withdrawal by Subject|3|||
130083290|NCT05618808|468257197|FG001|Overall Study|Withdrawal by Subject|1|||
130083291|NCT05618808|468257198|FG002|Overall Study|Withdrawal by Subject|3|||
130083292|NCT05298774|468257205|FG000|Overall Study|Physician Decision|3|||
130083293|NCT05298774|468257205|FG000|Overall Study|Withdrawal by Subject|2|||
130083294|NCT05298774|468257205|FG000|Overall Study|Lost to Follow-up|3|||
130083295|NCT05298774|468257205|FG000|Overall Study|Screen failure|1|||
130083296|NCT00081263|468257209|FG000|Overall Study|clerical error|1|||
130083297|NCT00081263|468257210|FG001|Overall Study|clerical error|0|||
130083298|NCT00081263|468257209|FG000|Overall Study|wrong cell type|7|||
130083299|NCT00081263|468257210|FG001|Overall Study|wrong cell type|5|||
130083300|NCT00081263|468257209|FG000|Overall Study|improper pre-protocol therapy|0|||
130083301|NCT00081263|468257210|FG001|Overall Study|improper pre-protocol therapy|1|||
130083302|NCT00081263|468257209|FG000|Overall Study|Inadequate pathology|0|||
130083303|NCT00081263|468257210|FG001|Overall Study|Inadequate pathology|1|||
130083304|NCT00081263|468257209|FG000|Overall Study|Never treated|4|||
130083305|NCT00081263|468257210|FG001|Overall Study|Never treated|5|||
130083306|NCT00081263|468257209|FG000|Overall Study|Inadequate data|5|||
130083307|NCT00081263|468257210|FG001|Overall Study|Inadequate data|10|||
130083308|NCT04564027|468257225|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
130083309|NCT04564027|468257226|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
130083310|NCT04564027|468257227|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
130083311|NCT04564027|468257228|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
130083312|NCT01267955|468257231|FG000|Stage 1 (6 Months)|Death|3|||
130083313|NCT01267955|468257231|FG000|Stage 2 (6 Months)|Death|5|||
130083314|NCT01267955|468257231|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
130083315|NCT04517253|468257234|FG000|Primary Treatment Period|Adverse Event|1|||
130083316|NCT04517253|468257235|FG001|Primary Treatment Period|Adverse Event|0|||
130083317|NCT04517253|468257236|FG002|Primary Treatment Period|Adverse Event|0|||
130083318|NCT04517253|468257234|FG000|Primary Treatment Period|Death|0|||
130083319|NCT04517253|468257235|FG001|Primary Treatment Period|Death|1|||
130083320|NCT04517253|468257236|FG002|Primary Treatment Period|Death|0|||
130083321|NCT04517253|468257234|FG000|Maintenance Period|Withdrawal by Subject|1|||
130083322|NCT04517253|468257235|FG001|Maintenance Period|Withdrawal by Subject|0|||
130083323|NCT04517253|468257236|FG002|Maintenance Period|Withdrawal by Subject|0|||
130083324|NCT04517253|468257234|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
130083325|NCT04517253|468257235|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
130083326|NCT04517253|468257236|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
130083327|NCT06048367|468257241|FG000|Overall Study|Withdrawal by Subject|0|||
130083328|NCT06048367|468257242|FG001|Overall Study|Withdrawal by Subject|1|||
130083329|NCT06048367|468257243|FG002|Overall Study|Withdrawal by Subject|0|||
130120985|NCT00788957|468404872|FG000|Part 2|Death|0|||
129955097|NCT01533181|467797301|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
129955098|NCT01533181|467797302|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
129955099|NCT01837719|467797305|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
129955100|NCT01837719|467797305|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
129955101|NCT01703988|467797306|FG000|Overall Study|Investigator Judgment|0|||
129955102|NCT01703988|467797307|FG001|Overall Study|Investigator Judgment|0|||
129955103|NCT01703988|467797308|FG002|Overall Study|Investigator Judgment|0|||
129955104|NCT01703988|467797309|FG003|Overall Study|Investigator Judgment|1|||
129955105|NCT06247488|467797310|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
129955106|NCT06247488|467797311|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955107|NCT06247488|467797312|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955108|NCT06247488|467797313|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955109|NCT06247488|467797314|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955110|NCT06247488|467797315|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955111|NCT06247488|467797310|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955112|NCT06247488|467797311|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955113|NCT06247488|467797312|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955114|NCT06247488|467797313|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
129955115|NCT06247488|467797314|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955116|NCT06247488|467797315|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955117|NCT06247488|467797310|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
129955118|NCT06247488|467797311|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955119|NCT06247488|467797312|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955120|NCT06247488|467797313|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955121|NCT06247488|467797314|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955122|NCT06247488|467797315|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955123|NCT06247488|467797310|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955124|NCT06247488|467797311|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955125|NCT06247488|467797312|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955126|NCT06247488|467797313|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
129955127|NCT06247488|467797314|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955128|NCT06247488|467797315|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955129|NCT06247488|467797310|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955130|NCT06247488|467797311|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955131|NCT06247488|467797312|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955132|NCT06247488|467797313|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955133|NCT06247488|467797314|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955134|NCT06247488|467797315|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
129955135|NCT06247488|467797310|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
129955136|NCT06247488|467797311|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
129955137|NCT06247488|467797312|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
129955138|NCT06247488|467797313|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
129955139|NCT06247488|467797314|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
129955140|NCT06247488|467797315|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
129955141|NCT06247488|467797310|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955142|NCT06247488|467797311|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955143|NCT06247488|467797312|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955144|NCT06247488|467797313|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955145|NCT06247488|467797314|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955146|NCT06247488|467797315|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
129955147|NCT02995733|467797316|FG000|Overall Study|Study site closed|9|||
129955148|NCT02995733|467797317|FG001|Overall Study|Study site closed|10|||
129955149|NCT02995733|467797316|FG000|Overall Study|Death|3|||
129955150|NCT02995733|467797317|FG001|Overall Study|Death|4|||
129955151|NCT02995733|467797316|FG000|Overall Study|Withdrawal by Subject|6|||
129955152|NCT02995733|467797317|FG001|Overall Study|Withdrawal by Subject|2|||
129955153|NCT02995733|467797316|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
129955154|NCT02995733|467797317|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
129955155|NCT02995733|467797316|FG000|Overall Study|Lost to Follow-up|48|||
129955156|NCT02995733|467797317|FG001|Overall Study|Lost to Follow-up|37|||
129955157|NCT02995733|467797316|FG000|Overall Study|Other|0|||
129955158|NCT02995733|467797317|FG001|Overall Study|Other|1|||
129955159|NCT04468633|467797318|FG000|Overall Study|Withdrawal by Subject|4|||
129955160|NCT04468633|467797319|FG001|Overall Study|Withdrawal by Subject|0|||
129955161|NCT00460434|467797322|FG000|Overall Study|Lost to Follow-up|3|||
129955162|NCT00460434|467797323|FG001|Overall Study|Lost to Follow-up|7|||
129955163|NCT02465866|467797324|FG000|Period 3|Withdrawal by Subject|0|||
129955164|NCT02465866|467797325|FG001|Period 3|Withdrawal by Subject|1|||
129955165|NCT02465866|467797326|FG002|Period 3|Withdrawal by Subject|0|||
129955166|NCT02465866|467797327|FG003|Period 3|Withdrawal by Subject|0|||
130083330|NCT06048367|468257244|FG003|Overall Study|Withdrawal by Subject|0|||
130083331|NCT06048367|468257245|FG004|Overall Study|Withdrawal by Subject|0|||
130083332|NCT06048367|468257241|FG000|Overall Study|Withdrawal by Subject|0|||
130083333|NCT06048367|468257242|FG001|Overall Study|Withdrawal by Subject|0|||
130083334|NCT06048367|468257243|FG002|Overall Study|Withdrawal by Subject|1|||
130083335|NCT06048367|468257244|FG003|Overall Study|Withdrawal by Subject|0|||
130083336|NCT06048367|468257245|FG004|Overall Study|Withdrawal by Subject|0|||
130083337|NCT06048367|468257241|FG000|Overall Study|Withdrawal by Subject|0|||
130083338|NCT06048367|468257242|FG001|Overall Study|Withdrawal by Subject|0|||
130083339|NCT06048367|468257243|FG002|Overall Study|Withdrawal by Subject|0|||
130083340|NCT06048367|468257244|FG003|Overall Study|Withdrawal by Subject|1|||
130083341|NCT06048367|468257245|FG004|Overall Study|Withdrawal by Subject|0|||
130083342|NCT06048367|468257241|FG000|Overall Study|Withdrawal by Subject|0|||
130083343|NCT06048367|468257242|FG001|Overall Study|Withdrawal by Subject|0|||
130083344|NCT06048367|468257243|FG002|Overall Study|Withdrawal by Subject|0|||
130083345|NCT06048367|468257244|FG003|Overall Study|Withdrawal by Subject|1|||
130083346|NCT06048367|468257245|FG004|Overall Study|Withdrawal by Subject|0|||
130083347|NCT05549505|468257249|FG000|Overall Study|Lost to Follow-up|2|||
130083348|NCT05549505|468257250|FG001|Overall Study|Lost to Follow-up|0|||
130083349|NCT05549505|468257249|FG000|Overall Study|Withdrawal by Subject|3|||
130083350|NCT05549505|468257250|FG001|Overall Study|Withdrawal by Subject|3|||
130083351|NCT05549505|468257249|FG000|Overall Study|Other: Miscellaneous|3|||
130083352|NCT05549505|468257250|FG001|Overall Study|Other: Miscellaneous|6|||
130083353|NCT01602822|468257253|FG000|Overall Study|Adverse Event|11|||
130083354|NCT05492877|468257257|FG000|Overall Study|Adverse Event|11|||
130083355|NCT05492877|468257258|FG001|Overall Study|Adverse Event|7|||
130083356|NCT05492877|468257257|FG000|Overall Study|Death|1|||
130083357|NCT05492877|468257258|FG001|Overall Study|Death|0|||
130083358|NCT05492877|468257257|FG000|Overall Study|Lost to Follow-up|1|||
130083359|NCT05492877|468257258|FG001|Overall Study|Lost to Follow-up|1|||
130083360|NCT05492877|468257257|FG000|Overall Study|Physician Decision|1|||
130083361|NCT05492877|468257258|FG001|Overall Study|Physician Decision|2|||
130083362|NCT05492877|468257257|FG000|Overall Study|Protocol Violation|1|||
130083363|NCT05492877|468257258|FG001|Overall Study|Protocol Violation|1|||
130083364|NCT05492877|468257257|FG000|Overall Study|Withdrawal by Subject|3|||
130083365|NCT05492877|468257258|FG001|Overall Study|Withdrawal by Subject|7|||
130083366|NCT05492877|468257257|FG000|Overall Study|Reason not specified|6|||
130083367|NCT05492877|468257258|FG001|Overall Study|Reason not specified|4|||
130083368|NCT02286089|468257259|FG000|Overall Study|Ongoing in Study|1|||
130083369|NCT02286089|468257260|FG001|Overall Study|Ongoing in Study|1|||
130083370|NCT02286089|468257261|FG002|Overall Study|Ongoing in Study|4|||
130083371|NCT02286089|468257262|FG003|Overall Study|Ongoing in Study|10|||
130083372|NCT02286089|468257259|FG000|Overall Study|Withdrawal by Subject|0|||
130083373|NCT02286089|468257260|FG001|Overall Study|Withdrawal by Subject|0|||
130083374|NCT02286089|468257261|FG002|Overall Study|Withdrawal by Subject|2|||
130083375|NCT02286089|468257262|FG003|Overall Study|Withdrawal by Subject|2|||
130083376|NCT00129376|468257263|FG000|Overall Study|Adverse Event|1|||
130083377|NCT00129376|468257263|FG000|Overall Study|Lack of Efficacy|1|||
130083378|NCT03218826|468257264|FG000|Overall Study|Non-compliance with protocol|1|||
130083379|NCT03218826|468257265|FG001|Overall Study|Non-compliance with protocol|0|||
130083380|NCT03218826|468257266|FG002|Overall Study|Non-compliance with protocol|2|||
130083381|NCT03218826|468257267|FG003|Overall Study|Non-compliance with protocol|1|||
130083382|NCT03218826|468257268|FG004|Overall Study|Non-compliance with protocol|1|||
130083383|NCT01426009|468257269|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
130083384|NCT01426009|468257269|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
130083385|NCT01426009|468257269|FG000|Washout 1|Withdrawal by Subject|1|||
130083386|NCT01426009|468257269|FG000|Washout 1|Personal Reasons|1|||
130083387|NCT01426009|468257269|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
130083388|NCT01426009|468257269|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
130083389|NCT01426009|468257269|FG000|Washout 2|electrive surgery|1|||
130083390|NCT01426009|468257269|FG000|Washout 3|personal reasons|1|||
130083391|NCT01426009|468257269|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
130083392|NCT01426009|468257269|FG000|Washout 4|Lost to Follow-up|1|||
130083393|NCT00515099|468257276|FG000|Overall Study|Lost to Follow-up|0|||
129955167|NCT02023099|467797328|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
129955168|NCT02023099|467797329|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
129955169|NCT02023099|467797330|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
129955170|NCT02023099|467797328|FG000|Overall Study|Withdrawn Consent|3|||
129955171|NCT02023099|467797329|FG001|Overall Study|Withdrawn Consent|0|||
129955172|NCT02023099|467797330|FG002|Overall Study|Withdrawn Consent|1|||
130083394|NCT00515099|468257277|FG001|Overall Study|Lost to Follow-up|4|||
130083395|NCT00515099|468257276|FG000|Overall Study|Withdrawal by Subject|2|||
130083396|NCT00515099|468257277|FG001|Overall Study|Withdrawal by Subject|0|||
130083397|NCT00515099|468257276|FG000|Overall Study|IRB Recommendation|1|||
130083398|NCT00515099|468257277|FG001|Overall Study|IRB Recommendation|0|||
130083399|NCT04476108|468257278|FG000|Overall Study|Adverse Event|4|||
130083400|NCT04476108|468257279|FG001|Overall Study|Adverse Event|1|||
130083401|NCT04476108|468257278|FG000|Overall Study|Lost to Follow-up|1|||
130083402|NCT04476108|468257279|FG001|Overall Study|Lost to Follow-up|0|||
130083403|NCT04476108|468257278|FG000|Overall Study|Inadvertent Enrollment|1|||
130083404|NCT04476108|468257279|FG001|Overall Study|Inadvertent Enrollment|0|||
130083405|NCT04476108|468257278|FG000|Overall Study|Protocol Violation|1|||
130083406|NCT04476108|468257279|FG001|Overall Study|Protocol Violation|1|||
130083407|NCT04476108|468257278|FG000|Overall Study|Withdrawal by Subject|1|||
130083408|NCT04476108|468257279|FG001|Overall Study|Withdrawal by Subject|1|||
130083409|NCT03685643|468257282|FG000|Overall Study|Lost to Follow-up|14|||
130083410|NCT03685643|468257283|FG001|Overall Study|Lost to Follow-up|22|||
130083411|NCT01347840|468257291|FG000|Overall Study|Withdrawal by Subject|1|||
130083412|NCT00113555|468257292|FG000|Overall Study|Baseline Failure|59|||
130083413|NCT00113555|468257292|FG000|Overall Study|Permanently Explanted|7|||
130083414|NCT00113555|468257292|FG000|Overall Study|Death|1|||
130083415|NCT00113555|468257292|FG000|Overall Study|Missed Followup|4|||
130083416|NCT00113555|468257292|FG000|Overall Study|Lost to Follow-up|8|||
130083417|NCT05307523|468257293|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
130083418|NCT05307523|468257294|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
130083419|NCT05307523|468257293|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
130083420|NCT05307523|468257294|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
130083421|NCT04191096|468257301|FG000|Overall Study|Death|102|||
130083422|NCT04191096|468257302|FG001|Overall Study|Death|89|||
130083423|NCT04191096|468257301|FG000|Overall Study|Lost to Follow-up|1|||
130083424|NCT04191096|468257302|FG001|Overall Study|Lost to Follow-up|1|||
130083425|NCT04191096|468257301|FG000|Overall Study|Withdrawal by Subject|5|||
130083426|NCT04191096|468257302|FG001|Overall Study|Withdrawal by Subject|5|||
130083427|NCT04191096|468257301|FG000|Overall Study|Participants Ongoing|518|||
130083428|NCT04191096|468257302|FG001|Overall Study|Participants Ongoing|530|||
130083429|NCT03128307|468257303|FG000|Overall Study|Lost to Follow-up|29|||
130083430|NCT03128307|468257303|FG000|Overall Study|Withdrawal by Subject|5|||
130083431|NCT02045979|468259117|FG000|Overall Study|Informed Consent Withdrawn|2|||
130083432|NCT02045979|468259118|FG001|Overall Study|Informed Consent Withdrawn|0|||
130083433|NCT02045979|468259119|FG002|Overall Study|Informed Consent Withdrawn|1|||
130083434|NCT02045979|468259117|FG000|Overall Study|not specified above|0|||
130083435|NCT02045979|468259118|FG001|Overall Study|not specified above|1|||
130083436|NCT02045979|468259119|FG002|Overall Study|not specified above|0|||
130083437|NCT02425891|468259120|FG000|Overall Study|Death|333|||
130083438|NCT02425891|468259121|FG001|Overall Study|Death|314|||
130083439|NCT02425891|468259120|FG000|Overall Study|Lost to Follow-up|4|||
130083440|NCT02425891|468259121|FG001|Overall Study|Lost to Follow-up|6|||
130083441|NCT02425891|468259120|FG000|Overall Study|Non-Compliance|1|||
130083442|NCT02425891|468259121|FG001|Overall Study|Non-Compliance|1|||
130083443|NCT02425891|468259120|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
130083444|NCT02425891|468259121|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
130083445|NCT02425891|468259120|FG000|Overall Study|Physician Decision|0|||
130083446|NCT02425891|468259121|FG001|Overall Study|Physician Decision|1|||
130083447|NCT02425891|468259120|FG000|Overall Study|Protocol Violation|1|||
130083448|NCT02425891|468259121|FG001|Overall Study|Protocol Violation|1|||
130083449|NCT02425891|468259120|FG000|Overall Study|Study Terminated By Sponsor|85|||
130083450|NCT02425891|468259121|FG001|Overall Study|Study Terminated By Sponsor|95|||
130083451|NCT02425891|468259120|FG000|Overall Study|Withdrawal by Subject|27|||
130083452|NCT02425891|468259121|FG001|Overall Study|Withdrawal by Subject|32|||
130083453|NCT04124952|468259122|FG000|Overall Study|Lost to Follow-up|1|||
130083454|NCT03558503|468259124|FG000|Overall Study|Adverse Event|1|||
130083455|NCT03558503|468259124|FG000|Overall Study|Death|1|||
130083456|NCT03558503|468259124|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
130083457|NCT02145429|468259125|FG000|Overall Study|Death|4|||
130083458|NCT02145429|468259126|FG001|Overall Study|Death|5|||
130083459|NCT02145429|468259125|FG000|Overall Study|Lost to Follow-up|4|||
130083460|NCT02145429|468259126|FG001|Overall Study|Lost to Follow-up|3|||
130083461|NCT02145429|468259125|FG000|Overall Study|Withdrawal by Subject|8|||
130083462|NCT02145429|468259126|FG001|Overall Study|Withdrawal by Subject|3|||
130083463|NCT02094612|468259127|FG000|Overall Study|Lost to Follow-up|47|||
130083464|NCT02094612|468259128|FG001|Overall Study|Lost to Follow-up|47|||
130083465|NCT02094612|468259127|FG000|Overall Study|Never started ADHD medication|32|||
130083466|NCT02094612|468259128|FG001|Overall Study|Never started ADHD medication|23|||
130083467|NCT03261037|468259131|FG000|Overall Study|Withdrawal by Subject|2|||
130083468|NCT03261037|468259132|FG001|Overall Study|Withdrawal by Subject|13|||
130083469|NCT03261037|468259133|FG002|Overall Study|Withdrawal by Subject|0|||
130083470|NCT03261037|468259134|FG003|Overall Study|Withdrawal by Subject|18|||
130083471|NCT03261037|468259131|FG000|Overall Study|Non-compliance with study procedures|0|||
130083472|NCT03261037|468259132|FG001|Overall Study|Non-compliance with study procedures|2|||
130083473|NCT03261037|468259133|FG002|Overall Study|Non-compliance with study procedures|0|||
130083474|NCT03261037|468259134|FG003|Overall Study|Non-compliance with study procedures|6|||
130083475|NCT03261037|468259131|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
129955173|NCT02023099|467797328|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
129955174|NCT02023099|467797329|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
129955175|NCT02023099|467797330|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
129955176|NCT01469819|467797331|FG000|Overall Study|Withdrawal by Subject|1|||
129955177|NCT01469819|467797331|FG000|Overall Study|Did not meet inclusionary criteria|2|||
129955178|NCT01469819|467797331|FG000|Overall Study|Could not swallow SmartPill|2|||
129955179|NCT01469819|467797331|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
130083476|NCT03261037|468259132|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
130083477|NCT03261037|468259133|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
130083478|NCT03261037|468259134|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
130083479|NCT03261037|468259131|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
130083480|NCT03261037|468259132|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
130083481|NCT03261037|468259133|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
130083482|NCT03261037|468259134|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
130083483|NCT03261037|468259131|FG000|Overall Study|Diagnosed but protocol deviation|1|||
130083484|NCT03261037|468259132|FG001|Overall Study|Diagnosed but protocol deviation|0|||
130083485|NCT03261037|468259133|FG002|Overall Study|Diagnosed but protocol deviation|0|||
130083486|NCT03261037|468259134|FG003|Overall Study|Diagnosed but protocol deviation|0|||
130083487|NCT03261037|468259131|FG000|Overall Study|Participant did not want to continue the study|0|||
130083488|NCT03261037|468259132|FG001|Overall Study|Participant did not want to continue the study|1|||
130083489|NCT03261037|468259133|FG002|Overall Study|Participant did not want to continue the study|0|||
130083490|NCT03261037|468259134|FG003|Overall Study|Participant did not want to continue the study|0|||
130083491|NCT03261037|468259131|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
130083492|NCT03261037|468259132|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
130083493|NCT03261037|468259133|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
130083494|NCT03261037|468259134|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
130083495|NCT03261037|468259131|FG000|Overall Study|Participant presented clinical improvement|0|||
130083496|NCT03261037|468259132|FG001|Overall Study|Participant presented clinical improvement|2|||
130083497|NCT03261037|468259133|FG002|Overall Study|Participant presented clinical improvement|0|||
130083498|NCT03261037|468259134|FG003|Overall Study|Participant presented clinical improvement|0|||
130083499|NCT03261037|468259131|FG000|Overall Study|Technical difficulties|0|||
130083500|NCT03261037|468259132|FG001|Overall Study|Technical difficulties|0|||
130083501|NCT03261037|468259133|FG002|Overall Study|Technical difficulties|0|||
130083502|NCT03261037|468259134|FG003|Overall Study|Technical difficulties|1|||
130083503|NCT03261037|468259131|FG000|Overall Study|Equipment failed to work|0|||
130083504|NCT03261037|468259132|FG001|Overall Study|Equipment failed to work|0|||
130083505|NCT03261037|468259133|FG002|Overall Study|Equipment failed to work|0|||
130083506|NCT03261037|468259134|FG003|Overall Study|Equipment failed to work|1|||
130083507|NCT03261037|468259131|FG000|Overall Study|End of study for participant and no follow up|0|||
130083508|NCT03261037|468259132|FG001|Overall Study|End of study for participant and no follow up|0|||
129955180|NCT04057937|467797332|FG000|Placebo-controlled Phase|Adverse Event|3|||
129955181|NCT04057937|467797333|FG001|Placebo-controlled Phase|Adverse Event|0|||
129955182|NCT04057937|467797332|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
129955183|NCT04057937|467797333|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
129955184|NCT04057937|467797332|FG000|Active-treatment Phase|Pregnancy|0|||
129955185|NCT04057937|467797333|FG001|Active-treatment Phase|Pregnancy|1|||
129955186|NCT04057937|467797332|FG000|Active-treatment Phase|Physician Decision|0|||
129955187|NCT04057937|467797333|FG001|Active-treatment Phase|Physician Decision|1|||
129955188|NCT02504502|467797336|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
129955189|NCT02504502|467797337|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
129955190|NCT02504502|467797336|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
129955191|NCT02504502|467797337|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
129955192|NCT03508830|467797339|FG000|Overall Study|Withdrawal by Subject|3|||
129955193|NCT03508830|467797340|FG001|Overall Study|Withdrawal by Subject|4|||
129955194|NCT03508830|467797339|FG000|Overall Study|Physician Decision|2|||
129955195|NCT03508830|467797340|FG001|Overall Study|Physician Decision|2|||
129955196|NCT04908800|467797341|FG000|Overall Study|Adverse Event|0|||
129955197|NCT04908800|467797342|FG001|Overall Study|Adverse Event|0|||
129955198|NCT04908800|467797343|FG002|Overall Study|Adverse Event|0|||
129955199|NCT04908800|467797344|FG003|Overall Study|Adverse Event|0|||
129955200|NCT04908800|467797345|FG004|Overall Study|Adverse Event|0|||
129955201|NCT04908800|467797346|FG005|Overall Study|Adverse Event|0|||
129955202|NCT04908800|467797347|FG006|Overall Study|Adverse Event|0|||
129955203|NCT04908800|467797348|FG007|Overall Study|Adverse Event|0|||
129955204|NCT04908800|467797349|FG008|Overall Study|Adverse Event|0|||
129955205|NCT04908800|467797350|FG009|Overall Study|Adverse Event|0|||
129955206|NCT04908800|467797351|FG010|Overall Study|Adverse Event|1|||
129955207|NCT04908800|467797352|FG011|Overall Study|Adverse Event|0|||
129955208|NCT04908800|467797353|FG012|Overall Study|Adverse Event|0|||
130083509|NCT03261037|468259133|FG002|Overall Study|End of study for participant and no follow up|0|||
130083510|NCT03261037|468259134|FG003|Overall Study|End of study for participant and no follow up|1|||
130083511|NCT03261037|468259131|FG000|Overall Study|Participant was too weak to continue in study|1|||
130083512|NCT03261037|468259132|FG001|Overall Study|Participant was too weak to continue in study|0|||
130083513|NCT03261037|468259133|FG002|Overall Study|Participant was too weak to continue in study|0|||
130083514|NCT03261037|468259134|FG003|Overall Study|Participant was too weak to continue in study|0|||
130083515|NCT02943577|468259135|FG000|Overall Study|Protocol Violation|0|||
130083516|NCT02943577|468259136|FG001|Overall Study|Protocol Violation|1|||
130083517|NCT02943577|468259135|FG000|Overall Study|Adverse Event|3|||
130083518|NCT02943577|468259136|FG001|Overall Study|Adverse Event|2|||
130083519|NCT02943577|468259135|FG000|Overall Study|Lost to Follow-up|0|||
130083520|NCT02943577|468259136|FG001|Overall Study|Lost to Follow-up|1|||
130083521|NCT02943577|468259135|FG000|Overall Study|Withdrawal by Subject|1|||
130083522|NCT02943577|468259136|FG001|Overall Study|Withdrawal by Subject|1|||
130083523|NCT02943577|468259135|FG000|Overall Study|Pregnancy|1|||
130083524|NCT02943577|468259136|FG001|Overall Study|Pregnancy|0|||
130083525|NCT01944462|468259141|FG000|PPPP Educational Program|Lost to Follow-up|60|||
130083526|NCT04437511|468259142|FG000|Overall Study|Adverse Event|50|||
130083527|NCT04437511|468259143|FG001|Overall Study|Adverse Event|21|||
130083528|NCT04437511|468259142|FG000|Overall Study|Death|15|||
130083529|NCT04437511|468259143|FG001|Overall Study|Death|10|||
130083530|NCT04437511|468259142|FG000|Overall Study|Lost to Follow-up|11|||
130083531|NCT04437511|468259143|FG001|Overall Study|Lost to Follow-up|11|||
130083532|NCT04437511|468259142|FG000|Overall Study|Physician Decision|19|||
130083533|NCT04437511|468259143|FG001|Overall Study|Physician Decision|10|||
130083534|NCT04437511|468259142|FG000|Overall Study|Progressive Disease|4|||
130083535|NCT04437511|468259143|FG001|Overall Study|Progressive Disease|7|||
130083536|NCT04437511|468259142|FG000|Overall Study|Withdrawal by Subject|111|||
130083537|NCT04437511|468259143|FG001|Overall Study|Withdrawal by Subject|94|||
130083538|NCT04437511|468259142|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
130083539|NCT04437511|468259143|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
130083540|NCT04437511|468259142|FG000|Overall Study|Continuing Study|7|||
130083541|NCT04437511|468259143|FG001|Overall Study|Continuing Study|5|||
130083542|NCT04654468|468259146|FG000|Overall Study|Death|1|||
130083543|NCT04654468|468259146|FG000|Overall Study|Ongoing in the Study|50|||
130083544|NCT03093350|468259151|FG000|Overall Study|Death|1|||
130083545|NCT03093350|468259151|FG000|Overall Study|Signed consent, never began treartment|1|||
130083546|NCT00777036|468259156|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
130083547|NCT00777036|468259157|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
130083548|NCT00777036|468259158|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
130083549|NCT00777036|468259159|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
130083550|NCT00777036|468259156|FG000|On Treatment|Administrative Reason By Sponsor|1|||
130083551|NCT00777036|468259157|FG001|On Treatment|Administrative Reason By Sponsor|0|||
130083552|NCT00777036|468259158|FG002|On Treatment|Administrative Reason By Sponsor|9|||
130083553|NCT00777036|468259159|FG003|On Treatment|Administrative Reason By Sponsor|0|||
130083554|NCT00777036|468259156|FG000|On Treatment|Failure to Meet Study Criteria|0|||
130083555|NCT00777036|468259157|FG001|On Treatment|Failure to Meet Study Criteria|1|||
130083556|NCT00777036|468259158|FG002|On Treatment|Failure to Meet Study Criteria|4|||
130083557|NCT00777036|468259159|FG003|On Treatment|Failure to Meet Study Criteria|0|||
130083558|NCT00777036|468259156|FG000|On Treatment|Pregnancy|1|||
130083559|NCT00777036|468259157|FG001|On Treatment|Pregnancy|0|||
130083560|NCT00777036|468259158|FG002|On Treatment|Pregnancy|1|||
130083561|NCT00777036|468259159|FG003|On Treatment|Pregnancy|0|||
130083562|NCT00777036|468259156|FG000|On Treatment|Non-compliance with Study Drug|1|||
130083563|NCT00777036|468259157|FG001|On Treatment|Non-compliance with Study Drug|0|||
130083564|NCT00777036|468259158|FG002|On Treatment|Non-compliance with Study Drug|1|||
130083565|NCT00777036|468259159|FG003|On Treatment|Non-compliance with Study Drug|0|||
130083566|NCT00777036|468259156|FG000|On Treatment|Maximum Clinical Benefit|2|||
130083567|NCT00777036|468259157|FG001|On Treatment|Maximum Clinical Benefit|0|||
130083568|NCT00777036|468259158|FG002|On Treatment|Maximum Clinical Benefit|5|||
130083569|NCT00777036|468259159|FG003|On Treatment|Maximum Clinical Benefit|0|||
130083570|NCT00777036|468259156|FG000|On Treatment|Withdrawal by Subject|0|||
130083571|NCT00777036|468259157|FG001|On Treatment|Withdrawal by Subject|2|||
130083572|NCT00777036|468259158|FG002|On Treatment|Withdrawal by Subject|2|||
130083573|NCT00777036|468259159|FG003|On Treatment|Withdrawal by Subject|0|||
130083574|NCT00777036|468259156|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
130083575|NCT00777036|468259157|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
130083576|NCT00777036|468259158|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
130083577|NCT00777036|468259159|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
130083578|NCT00777036|468259156|FG000|On Treatment|Death|0|||
130083579|NCT00777036|468259157|FG001|On Treatment|Death|2|||
130083580|NCT00777036|468259158|FG002|On Treatment|Death|0|||
129955209|NCT01622088|467797357|FG000|Overall Study|Adverse Event|20|||
130083581|NCT00777036|468259159|FG003|On Treatment|Death|0|||
130083582|NCT00777036|468259156|FG000|On Treatment|Study Drug Toxicity|1|||
130083583|NCT00777036|468259157|FG001|On Treatment|Study Drug Toxicity|0|||
130083584|NCT00777036|468259158|FG002|On Treatment|Study Drug Toxicity|4|||
130083585|NCT00777036|468259159|FG003|On Treatment|Study Drug Toxicity|0|||
130083586|NCT00777036|468259156|FG000|On Treatment|Progressive Disease|6|||
130083587|NCT00777036|468259157|FG001|On Treatment|Progressive Disease|4|||
130083588|NCT00777036|468259158|FG002|On Treatment|Progressive Disease|7|||
130083589|NCT00777036|468259159|FG003|On Treatment|Progressive Disease|0|||
130083590|NCT00777036|468259156|FG000|On Treatment|Not Reported|0|||
130083591|NCT00777036|468259157|FG001|On Treatment|Not Reported|0|||
130083592|NCT00777036|468259158|FG002|On Treatment|Not Reported|2|||
130083593|NCT00777036|468259159|FG003|On Treatment|Not Reported|0|||
130083594|NCT00777036|468259156|FG000|On Treatment|Site Closed|0|||
130083595|NCT00777036|468259157|FG001|On Treatment|Site Closed|1|||
130083596|NCT00777036|468259158|FG002|On Treatment|Site Closed|1|||
130083597|NCT00777036|468259159|FG003|On Treatment|Site Closed|0|||
130083598|NCT00777036|468259156|FG000|Follow-Up|Withdrawal by Subject|0|||
130083599|NCT00777036|468259157|FG001|Follow-Up|Withdrawal by Subject|0|||
130083600|NCT00777036|468259158|FG002|Follow-Up|Withdrawal by Subject|5|||
130083601|NCT00777036|468259159|FG003|Follow-Up|Withdrawal by Subject|0|||
130083602|NCT00777036|468259156|FG000|Follow-Up|Death|1|||
130083603|NCT00777036|468259157|FG001|Follow-Up|Death|9|||
130083604|NCT00777036|468259158|FG002|Follow-Up|Death|0|||
130083605|NCT00777036|468259159|FG003|Follow-Up|Death|0|||
130083606|NCT00777036|468259156|FG000|Follow-Up|Lost to Follow-up|3|||
130083607|NCT00777036|468259157|FG001|Follow-Up|Lost to Follow-up|0|||
130083608|NCT00777036|468259158|FG002|Follow-Up|Lost to Follow-up|0|||
130083609|NCT00777036|468259159|FG003|Follow-Up|Lost to Follow-up|0|||
130083610|NCT00777036|468259156|FG000|Follow-Up|Reason Not Specified|4|||
130083611|NCT00777036|468259157|FG001|Follow-Up|Reason Not Specified|0|||
130083612|NCT00777036|468259158|FG002|Follow-Up|Reason Not Specified|13|||
130083613|NCT00777036|468259159|FG003|Follow-Up|Reason Not Specified|0|||
130083614|NCT00777036|468259156|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
130083615|NCT00777036|468259157|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
130083616|NCT00777036|468259158|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
130083617|NCT00777036|468259159|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
130083618|NCT05827978|468259160|FG000|Overall Study|Adverse Event|1|||
130083619|NCT05827978|468259161|FG001|Overall Study|Adverse Event|0|||
130083620|NCT05827978|468259162|FG002|Overall Study|Adverse Event|0|||
130083621|NCT05827978|468259163|FG003|Overall Study|Adverse Event|1|||
130083622|NCT05827978|468259164|FG004|Overall Study|Adverse Event|0|||
130083623|NCT05827978|468259165|FG005|Overall Study|Adverse Event|0|||
130083624|NCT05827978|468259160|FG000|Overall Study|Death|1|||
130083625|NCT05827978|468259161|FG001|Overall Study|Death|5|||
130083626|NCT05827978|468259162|FG002|Overall Study|Death|2|||
130083627|NCT05827978|468259163|FG003|Overall Study|Death|3|||
130083628|NCT05827978|468259164|FG004|Overall Study|Death|1|||
130083629|NCT05827978|468259165|FG005|Overall Study|Death|3|||
130083630|NCT05827978|468259160|FG000|Overall Study|Lost to Follow-up|57|||
130083631|NCT05827978|468259161|FG001|Overall Study|Lost to Follow-up|88|||
130083632|NCT05827978|468259162|FG002|Overall Study|Lost to Follow-up|54|||
130083633|NCT05827978|468259163|FG003|Overall Study|Lost to Follow-up|47|||
130083634|NCT05827978|468259164|FG004|Overall Study|Lost to Follow-up|25|||
130083635|NCT05827978|468259165|FG005|Overall Study|Lost to Follow-up|10|||
130083636|NCT05827978|468259160|FG000|Overall Study|Noncompliance with Study Procedures|0|||
130083637|NCT05827978|468259161|FG001|Overall Study|Noncompliance with Study Procedures|1|||
130083638|NCT05827978|468259162|FG002|Overall Study|Noncompliance with Study Procedures|1|||
130083639|NCT05827978|468259163|FG003|Overall Study|Noncompliance with Study Procedures|1|||
130083640|NCT05827978|468259164|FG004|Overall Study|Noncompliance with Study Procedures|1|||
130083641|NCT05827978|468259165|FG005|Overall Study|Noncompliance with Study Procedures|0|||
130083642|NCT05827978|468259160|FG000|Overall Study|Physician Decision|2|||
130083643|NCT05827978|468259161|FG001|Overall Study|Physician Decision|0|||
130083644|NCT05827978|468259162|FG002|Overall Study|Physician Decision|1|||
130083645|NCT05827978|468259163|FG003|Overall Study|Physician Decision|2|||
130083646|NCT05827978|468259164|FG004|Overall Study|Physician Decision|1|||
130083647|NCT05827978|468259165|FG005|Overall Study|Physician Decision|1|||
130083648|NCT05827978|468259160|FG000|Overall Study|Protocol Violation|5|||
130083649|NCT05827978|468259161|FG001|Overall Study|Protocol Violation|2|||
130083650|NCT05827978|468259162|FG002|Overall Study|Protocol Violation|0|||
130083651|NCT05827978|468259163|FG003|Overall Study|Protocol Violation|0|||
130083652|NCT05827978|468259164|FG004|Overall Study|Protocol Violation|0|||
130083653|NCT05827978|468259165|FG005|Overall Study|Protocol Violation|0|||
130083654|NCT05827978|468259160|FG000|Overall Study|Withdrawal by Subject|17|||
130083655|NCT05827978|468259161|FG001|Overall Study|Withdrawal by Subject|16|||
130083656|NCT05827978|468259162|FG002|Overall Study|Withdrawal by Subject|10|||
130083657|NCT05827978|468259163|FG003|Overall Study|Withdrawal by Subject|12|||
130083658|NCT05827978|468259164|FG004|Overall Study|Withdrawal by Subject|10|||
130083659|NCT05827978|468259165|FG005|Overall Study|Withdrawal by Subject|9|||
130083660|NCT05827978|468259160|FG000|Overall Study|Other Than Specified|0|||
130120986|NCT00788957|468404873|FG001|Part 2|Death|32|||
130083661|NCT05827978|468259161|FG001|Overall Study|Other Than Specified|0|||
130083662|NCT05827978|468259162|FG002|Overall Study|Other Than Specified|1|||
130083663|NCT05827978|468259163|FG003|Overall Study|Other Than Specified|0|||
130083664|NCT05827978|468259164|FG004|Overall Study|Other Than Specified|2|||
130083665|NCT05827978|468259165|FG005|Overall Study|Other Than Specified|0|||
130083666|NCT05564039|468259166|FG000|Overall Study|Adverse Event|1|||
130083667|NCT05564039|468259167|FG001|Overall Study|Adverse Event|0|||
130083668|NCT05564039|468259166|FG000|Overall Study|Death|1|||
130083669|NCT05564039|468259167|FG001|Overall Study|Death|1|||
130083670|NCT05564039|468259166|FG000|Overall Study|Lost to Follow-up|3|||
130083671|NCT05564039|468259167|FG001|Overall Study|Lost to Follow-up|2|||
130083672|NCT05564039|468259166|FG000|Overall Study|Withdrawal by Subject|2|||
130083673|NCT05564039|468259167|FG001|Overall Study|Withdrawal by Subject|0|||
130083674|NCT05564039|468259166|FG000|Overall Study|Inadvertent enrollment|3|||
130083675|NCT05564039|468259167|FG001|Overall Study|Inadvertent enrollment|6|||
130083676|NCT04651777|468259168|FG000|Overall Study|Adverse Event|1|||
130083677|NCT04651777|468259168|FG000|Overall Study|Withdrawal by Subject|2|||
130083678|NCT04566445|468259169|FG000|Overall Study|Death|4|||
130083679|NCT04566445|468259170|FG001|Overall Study|Death|1|||
130083680|NCT04566445|468259171|FG002|Overall Study|Death|1|||
130083681|NCT04566445|468259169|FG000|Overall Study|Lost to Follow-up|3|||
130083682|NCT04566445|468259170|FG001|Overall Study|Lost to Follow-up|1|||
130083683|NCT04566445|468259171|FG002|Overall Study|Lost to Follow-up|1|||
130083684|NCT04566445|468259169|FG000|Overall Study|Study terminated by sponsor|11|||
130083685|NCT04566445|468259170|FG001|Overall Study|Study terminated by sponsor|17|||
130083686|NCT04566445|468259171|FG002|Overall Study|Study terminated by sponsor|32|||
130083687|NCT04566445|468259169|FG000|Overall Study|Withdrawal by Subject|12|||
130083688|NCT04566445|468259170|FG001|Overall Study|Withdrawal by Subject|14|||
130083689|NCT04566445|468259171|FG002|Overall Study|Withdrawal by Subject|13|||
130083690|NCT04566445|468259169|FG000|Overall Study|Randomized but not treated due to AE|2|||
130083691|NCT04566445|468259170|FG001|Overall Study|Randomized but not treated due to AE|1|||
130083692|NCT04566445|468259171|FG002|Overall Study|Randomized but not treated due to AE|0|||
130083693|NCT04566445|468259169|FG000|Overall Study|Adverse Event|1|||
130083694|NCT04566445|468259170|FG001|Overall Study|Adverse Event|1|||
130083695|NCT04566445|468259171|FG002|Overall Study|Adverse Event|0|||
130083696|NCT04785144|468259172|FG000|Overall Study|Withdrawal by Subject|4|||
130083697|NCT04785144|468259173|FG001|Overall Study|Withdrawal by Subject|1|||
130083698|NCT04785144|468259174|FG002|Overall Study|Withdrawal by Subject|0|||
130083699|NCT04785144|468259175|FG003|Overall Study|Withdrawal by Subject|0|||
130083700|NCT04785144|468259176|FG004|Overall Study|Withdrawal by Subject|0|||
130083701|NCT04785144|468259177|FG005|Overall Study|Withdrawal by Subject|2|||
130083702|NCT04785144|468259178|FG006|Overall Study|Withdrawal by Subject|2|||
130083703|NCT04785144|468259179|FG007|Overall Study|Withdrawal by Subject|0|||
130083704|NCT04785144|468259180|FG008|Overall Study|Withdrawal by Subject|1|||
130083705|NCT04785144|468259181|FG009|Overall Study|Withdrawal by Subject|0|||
130083706|NCT04785144|468259172|FG000|Overall Study|Lost to Follow-up|1|||
130083707|NCT04785144|468259173|FG001|Overall Study|Lost to Follow-up|0|||
130083708|NCT04785144|468259174|FG002|Overall Study|Lost to Follow-up|0|||
130083709|NCT04785144|468259175|FG003|Overall Study|Lost to Follow-up|0|||
130083710|NCT04785144|468259176|FG004|Overall Study|Lost to Follow-up|1|||
130083711|NCT04785144|468259177|FG005|Overall Study|Lost to Follow-up|2|||
130083712|NCT04785144|468259178|FG006|Overall Study|Lost to Follow-up|1|||
130083713|NCT04785144|468259179|FG007|Overall Study|Lost to Follow-up|2|||
130083714|NCT04785144|468259180|FG008|Overall Study|Lost to Follow-up|4|||
130083715|NCT04785144|468259181|FG009|Overall Study|Lost to Follow-up|1|||
129955210|NCT01622088|467797357|FG000|Overall Study|Lost to Follow-up|1|||
129955211|NCT01622088|467797357|FG000|Overall Study|Withdrawal by Subject|20|||
130120987|NCT00788957|468404874|FG002|Part 2|Death|35|||
130120988|NCT00788957|468404875|FG003|Part 2|Death|37|||
130083716|NCT04785144|468259172|FG000|Overall Study|Protocol Violation|0|||
130083717|NCT04785144|468259173|FG001|Overall Study|Protocol Violation|0|||
130083718|NCT04785144|468259174|FG002|Overall Study|Protocol Violation|0|||
129955212|NCT01622088|467797357|FG000|Overall Study|Investigator Decision|1|||
130083719|NCT04785144|468259175|FG003|Overall Study|Protocol Violation|0|||
130083720|NCT04785144|468259176|FG004|Overall Study|Protocol Violation|0|||
130083721|NCT04785144|468259177|FG005|Overall Study|Protocol Violation|0|||
130083722|NCT04785144|468259178|FG006|Overall Study|Protocol Violation|1|||
130083723|NCT04785144|468259179|FG007|Overall Study|Protocol Violation|0|||
130083724|NCT04785144|468259180|FG008|Overall Study|Protocol Violation|0|||
130083725|NCT04785144|468259181|FG009|Overall Study|Protocol Violation|0|||
130083726|NCT04785144|468259172|FG000|Overall Study|Physician Decision|0|||
130083727|NCT04785144|468259173|FG001|Overall Study|Physician Decision|0|||
130120989|NCT00788957|468404876|FG004|Part 2|Death|0|||
130083728|NCT04785144|468259174|FG002|Overall Study|Physician Decision|0|||
130083729|NCT04785144|468259175|FG003|Overall Study|Physician Decision|0|||
130083730|NCT04785144|468259176|FG004|Overall Study|Physician Decision|0|||
130083731|NCT04785144|468259177|FG005|Overall Study|Physician Decision|0|||
130083732|NCT04785144|468259178|FG006|Overall Study|Physician Decision|0|||
130120990|NCT00788957|468404877|FG005|Part 2|Death|0|||
130083733|NCT04785144|468259179|FG007|Overall Study|Physician Decision|0|||
130083734|NCT04785144|468259180|FG008|Overall Study|Physician Decision|0|||
130083735|NCT04785144|468259181|FG009|Overall Study|Physician Decision|1|||
130083736|NCT04785144|468259172|FG000|Overall Study|Unable to continue due to work schedule|0|||
130083737|NCT04785144|468259173|FG001|Overall Study|Unable to continue due to work schedule|0|||
130083738|NCT04785144|468259174|FG002|Overall Study|Unable to continue due to work schedule|0|||
130083739|NCT04785144|468259175|FG003|Overall Study|Unable to continue due to work schedule|0|||
130083740|NCT04785144|468259176|FG004|Overall Study|Unable to continue due to work schedule|0|||
130083741|NCT04785144|468259177|FG005|Overall Study|Unable to continue due to work schedule|0|||
130083742|NCT04785144|468259178|FG006|Overall Study|Unable to continue due to work schedule|0|||
130083743|NCT04785144|468259179|FG007|Overall Study|Unable to continue due to work schedule|0|||
130083744|NCT04785144|468259180|FG008|Overall Study|Unable to continue due to work schedule|0|||
130083745|NCT04785144|468259181|FG009|Overall Study|Unable to continue due to work schedule|1|||
130083746|NCT01263470|468259184|FG000|Overall Study|Adverse Event|2|||
130083747|NCT01263470|468259185|FG001|Overall Study|Adverse Event|2|||
130083748|NCT01263470|468259186|FG002|Overall Study|Adverse Event|1|||
130083749|NCT01263470|468259187|FG003|Overall Study|Adverse Event|1|||
130083750|NCT01263470|468259188|FG004|Overall Study|Adverse Event|2|||
130083751|NCT01263470|468259189|FG005|Overall Study|Adverse Event|2|||
130083752|NCT01263470|468259184|FG000|Overall Study|Protocol Violation|0|||
130083753|NCT01263470|468259185|FG001|Overall Study|Protocol Violation|1|||
130083754|NCT01263470|468259186|FG002|Overall Study|Protocol Violation|0|||
130083755|NCT01263470|468259187|FG003|Overall Study|Protocol Violation|0|||
130083756|NCT01263470|468259188|FG004|Overall Study|Protocol Violation|0|||
130083757|NCT01263470|468259189|FG005|Overall Study|Protocol Violation|1|||
130083758|NCT01263470|468259184|FG000|Overall Study|Withdrawal by Subject|0|||
130083759|NCT01263470|468259185|FG001|Overall Study|Withdrawal by Subject|1|||
130083760|NCT01263470|468259186|FG002|Overall Study|Withdrawal by Subject|1|||
130083761|NCT01263470|468259187|FG003|Overall Study|Withdrawal by Subject|2|||
130083762|NCT01263470|468259188|FG004|Overall Study|Withdrawal by Subject|0|||
130083763|NCT01263470|468259189|FG005|Overall Study|Withdrawal by Subject|2|||
130083764|NCT01263470|468259184|FG000|Overall Study|Lack of Efficacy|0|||
130083765|NCT01263470|468259185|FG001|Overall Study|Lack of Efficacy|0|||
130083766|NCT01263470|468259186|FG002|Overall Study|Lack of Efficacy|2|||
130083767|NCT01263470|468259187|FG003|Overall Study|Lack of Efficacy|0|||
130083768|NCT01263470|468259188|FG004|Overall Study|Lack of Efficacy|0|||
130083769|NCT01263470|468259189|FG005|Overall Study|Lack of Efficacy|0|||
130083770|NCT01263470|468259184|FG000|Overall Study|Participant Unavailability|0|||
130083771|NCT01263470|468259185|FG001|Overall Study|Participant Unavailability|1|||
130083772|NCT01263470|468259186|FG002|Overall Study|Participant Unavailability|0|||
130083773|NCT01263470|468259187|FG003|Overall Study|Participant Unavailability|0|||
130083774|NCT01263470|468259188|FG004|Overall Study|Participant Unavailability|0|||
130083775|NCT01263470|468259189|FG005|Overall Study|Participant Unavailability|0|||
130083776|NCT01263470|468259184|FG000|Overall Study|Study Drug Non-compliance|0|||
130083777|NCT01263470|468259185|FG001|Overall Study|Study Drug Non-compliance|0|||
130083778|NCT01263470|468259186|FG002|Overall Study|Study Drug Non-compliance|0|||
130083779|NCT01263470|468259187|FG003|Overall Study|Study Drug Non-compliance|0|||
130083780|NCT01263470|468259188|FG004|Overall Study|Study Drug Non-compliance|1|||
130083781|NCT01263470|468259189|FG005|Overall Study|Study Drug Non-compliance|0|||
130083782|NCT00610714|468259190|FG000|Overall Study|Adverse Event|3|||
130083783|NCT00610714|468259191|FG001|Overall Study|Adverse Event|1|||
130083784|NCT00610714|468259190|FG000|Overall Study|Death|12|||
130083785|NCT00610714|468259191|FG001|Overall Study|Death|18|||
130083786|NCT00610714|468259190|FG000|Overall Study|Withdrawal by Subject|9|||
130083787|NCT00610714|468259191|FG001|Overall Study|Withdrawal by Subject|3|||
130083788|NCT00610714|468259190|FG000|Overall Study|Study completion at 120 PFS events|2|||
130083789|NCT00610714|468259191|FG001|Overall Study|Study completion at 120 PFS events|2|||
130083790|NCT00712712|468259192|FG000|Overall Study|Protocol Violation|11|||
130083791|NCT00712712|468259192|FG000|Overall Study|Radiofrequency not done|3|||
130083792|NCT00712712|468259192|FG000|Overall Study|Death|8|||
130083793|NCT00712712|468259192|FG000|Overall Study|Withdrawal by Subject|1|||
130083794|NCT00103207|468259193|FG000|Overall Study|Adverse Event|3|||
130083795|NCT00103207|468259193|FG000|Overall Study|Death|1|||
130083796|NCT00103207|468259193|FG000|Overall Study|Withdrawal by Subject|2|||
130083797|NCT00103207|468259193|FG000|Overall Study|Other complicating disease|1|||
130083798|NCT00103207|468259193|FG000|Overall Study|Ineligible|4|||
130083799|NCT00103207|468259193|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
130083800|NCT03598140|468259194|FG000|Overall Study|enrolled but didn't start|1|||
130083801|NCT03598140|468259195|FG001|Overall Study|enrolled but didn't start|0|||
130083802|NCT01029691|468259196|FG000|Continued APAP to Delivery|Death|0|||
130083803|NCT01029691|468259197|FG001|Continued APAP to Delivery|Death|0|||
130083804|NCT01029691|468259198|FG002|Continued APAP to Delivery|Death|1|||
130083805|NCT01023516|468259200|FG000|Overall Study|Voluntary discontinuation|7|||
130083806|NCT01023516|468259201|FG001|Overall Study|Voluntary discontinuation|5|||
130083807|NCT01023516|468259200|FG000|Overall Study|Adverse Event|9|||
130083808|NCT01023516|468259201|FG001|Overall Study|Adverse Event|6|||
130083809|NCT01023516|468259200|FG000|Overall Study|Safety reason|0|||
130083810|NCT01023516|468259201|FG001|Overall Study|Safety reason|3|||
130083811|NCT01023516|468259200|FG000|Overall Study|Study-specific criteria|4|||
130083812|NCT01023516|468259201|FG001|Overall Study|Study-specific criteria|2|||
130083813|NCT01023516|468259200|FG000|Overall Study|Incorrect enrolment|4|||
130083814|NCT01023516|468259201|FG001|Overall Study|Incorrect enrolment|2|||
130083815|NCT04556175|468259204|FG000|Overall Study|Study terminated due to COVID-19|8|||
130083816|NCT04556175|468259205|FG001|Overall Study|Study terminated due to COVID-19|8|||
130083817|NCT02723019|468259213|FG000|Overall Study|Death|17|||
130083818|NCT02723019|468259214|FG001|Overall Study|Death|13|||
130083819|NCT02723019|468259213|FG000|Overall Study|Withdrawal by Subject|11|||
129955213|NCT01622088|467797357|FG000|Overall Study|Death|53|||
129955214|NCT01622088|467797357|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
129955215|NCT00274846|467797360|FG000|Overall Study|Did not receive adequate NK cells|1|||
129955216|NCT03045302|467797361|FG000|Overall Study|Pre-treatment adverse event|1|||
129955217|NCT05287178|467797364|FG000|Overall Study|Lost to Follow-up|2|||
129955218|NCT01648699|467797365|FG000|Overall Study|Death|1|||
129955219|NCT01648699|467797365|FG000|Overall Study|Lost to Follow-up|2|||
129955220|NCT01648699|467797365|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
129955221|NCT02267746|467797366|FG000|Overall Study|Adverse Event|0|||
129955222|NCT02267746|467797367|FG001|Overall Study|Adverse Event|2|||
129955223|NCT02267746|467797368|FG002|Overall Study|Adverse Event|1|||
129955224|NCT02267746|467797366|FG000|Overall Study|Protocol Violation|8|||
129955225|NCT02267746|467797367|FG001|Overall Study|Protocol Violation|7|||
129955226|NCT02267746|467797368|FG002|Overall Study|Protocol Violation|3|||
129955227|NCT02267746|467797366|FG000|Overall Study|Lack of Efficacy|11|||
129955228|NCT02267746|467797367|FG001|Overall Study|Lack of Efficacy|11|||
129955229|NCT02267746|467797368|FG002|Overall Study|Lack of Efficacy|15|||
129955230|NCT02267746|467797366|FG000|Overall Study|Protocol Violation|1|||
129955231|NCT02267746|467797367|FG001|Overall Study|Protocol Violation|2|||
129955232|NCT02267746|467797368|FG002|Overall Study|Protocol Violation|1|||
129955233|NCT02267746|467797366|FG000|Overall Study|Miscellaneous|1|||
129955234|NCT02267746|467797367|FG001|Overall Study|Miscellaneous|0|||
129955235|NCT02267746|467797368|FG002|Overall Study|Miscellaneous|1|||
129955236|NCT04598776|467797373|FG000|Overall Study|Protocol Violation|5|||
129955237|NCT04598776|467797373|FG000|Overall Study|Physician Decision|4|||
129955238|NCT00728884|467797374|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
129955239|NCT00728884|467797374|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
129955240|NCT00348283|467797375|FG000|Induction|Adverse Event|0|||
129955241|NCT00348283|467797376|FG001|Induction|Adverse Event|2|||
129955242|NCT00348283|467797375|FG000|Induction|Protocol Violation|0|||
129955243|NCT00348283|467797376|FG001|Induction|Protocol Violation|4|||
129955244|NCT00348283|467797375|FG000|Double Blind|Adverse Event|2|||
129955245|NCT00348283|467797376|FG001|Double Blind|Adverse Event|5|||
129955246|NCT00348283|467797375|FG000|Double Blind|Withdrawal by Subject|1|||
129955247|NCT00348283|467797376|FG001|Double Blind|Withdrawal by Subject|1|||
129955248|NCT00348283|467797375|FG000|Double Blind|Protocol Violation|0|||
129955249|NCT00348283|467797376|FG001|Double Blind|Protocol Violation|1|||
129955250|NCT00348283|467797375|FG000|Double Blind|Lack of Efficacy|2|||
129955251|NCT00348283|467797376|FG001|Double Blind|Lack of Efficacy|2|||
129955252|NCT00348283|467797375|FG000|Double Blind|Pregnancy|0|||
129955253|NCT00348283|467797376|FG001|Double Blind|Pregnancy|1|||
129955254|NCT00348283|467797375|FG000|Open Label|Adverse Event|0|||
129955255|NCT00348283|467797376|FG001|Open Label|Adverse Event|8|||
129955256|NCT00348283|467797375|FG000|Open Label|Withdrawal by Subject|0|||
129955257|NCT00348283|467797376|FG001|Open Label|Withdrawal by Subject|4|||
129955258|NCT00348283|467797375|FG000|Open Label|Lost to Follow-up|0|||
129955259|NCT00348283|467797376|FG001|Open Label|Lost to Follow-up|1|||
129955260|NCT00348283|467797375|FG000|Open Label|Lack of Efficacy|0|||
129955261|NCT00348283|467797376|FG001|Open Label|Lack of Efficacy|13|||
129955262|NCT00348283|467797375|FG000|Open Label|Administrative reasons|0|||
129955263|NCT00348283|467797376|FG001|Open Label|Administrative reasons|5|||
129955264|NCT00348283|467797375|FG000|Open Label|Subject moved to the United States|0|||
129955265|NCT00348283|467797376|FG001|Open Label|Subject moved to the United States|1|||
129955266|NCT00348283|467797375|FG000|Open Label|Pregnancy|0|||
129955267|NCT00348283|467797376|FG001|Open Label|Pregnancy|1|||
129955268|NCT00348283|467797375|FG000|Open Label|Sponsor decision|0|||
129955269|NCT00348283|467797376|FG001|Open Label|Sponsor decision|1|||
129955270|NCT06312566|467797384|FG000|Overall Study|Protocol Violation|0|||
130083820|NCT02723019|468259214|FG001|Overall Study|Withdrawal by Subject|7|||
129955271|NCT06312566|467797385|FG001|Overall Study|Protocol Violation|1|||
129955272|NCT04736472|467797386|FG000|Overall Study|Lost to Follow-up|1|||
129955273|NCT04736472|467797387|FG001|Overall Study|Lost to Follow-up|0|||
130083821|NCT02723019|468259213|FG000|Overall Study|Lost to Follow-up|57|||
129955274|NCT04736472|467797388|FG002|Overall Study|Lost to Follow-up|0|||
129955275|NCT04736472|467797386|FG000|Overall Study|Withdrawal by Subject|2|||
130083822|NCT02723019|468259214|FG001|Overall Study|Lost to Follow-up|70|||
130083823|NCT00592072|468259217|FG000|Wash Out Period|Lost to Follow-up|1|||
130083824|NCT00592072|468259218|FG001|Wash Out Period|Lost to Follow-up|1|||
130083825|NCT05333289|468259220|FG000|Overall Study|Other|1|||
130083826|NCT05333289|468259221|FG001|Overall Study|Other|0|||
130083827|NCT05333289|468259222|FG002|Overall Study|Other|0|||
130083828|NCT05333289|468259223|FG003|Overall Study|Other|1|||
130083829|NCT05333289|468259224|FG004|Overall Study|Other|1|||
130083830|NCT05333289|468259225|FG005|Overall Study|Other|2|||
130083831|NCT05333289|468259226|FG006|Overall Study|Other|2|||
130083832|NCT05333289|468259227|FG007|Overall Study|Other|0|||
130083833|NCT05333289|468259220|FG000|Overall Study|Withdrawal by Subject|1|||
130083834|NCT05333289|468259221|FG001|Overall Study|Withdrawal by Subject|2|||
130083835|NCT05333289|468259222|FG002|Overall Study|Withdrawal by Subject|2|||
130083836|NCT05333289|468259223|FG003|Overall Study|Withdrawal by Subject|1|||
130083837|NCT05333289|468259224|FG004|Overall Study|Withdrawal by Subject|1|||
130083838|NCT05333289|468259225|FG005|Overall Study|Withdrawal by Subject|2|||
130083839|NCT05333289|468259226|FG006|Overall Study|Withdrawal by Subject|1|||
130083840|NCT05333289|468259227|FG007|Overall Study|Withdrawal by Subject|3|||
130083841|NCT05333289|468259220|FG000|Overall Study|Protocol Violation|1|||
130083842|NCT05333289|468259221|FG001|Overall Study|Protocol Violation|0|||
130083843|NCT05333289|468259222|FG002|Overall Study|Protocol Violation|0|||
129955276|NCT04736472|467797387|FG001|Overall Study|Withdrawal by Subject|0|||
129955277|NCT04736472|467797388|FG002|Overall Study|Withdrawal by Subject|0|||
129955278|NCT04736472|467797386|FG000|Overall Study|Protocol Violation|48|||
129955279|NCT04736472|467797387|FG001|Overall Study|Protocol Violation|0|||
129955280|NCT04736472|467797388|FG002|Overall Study|Protocol Violation|6|||
129955281|NCT03861078|467797389|FG000|Overall Study|COVID-19 shut down|4|||
129955282|NCT03861078|467797389|FG000|Overall Study|Lost to Follow-up|1|||
129955283|NCT03861078|467797389|FG000|Overall Study|Protocol Violation|2|||
129955284|NCT03861078|467797389|FG000|Overall Study|lack of venous access|1|||
129955285|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
129955286|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
129955287|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
129955288|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
129955289|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
129955290|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
129955291|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
129955292|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
129955293|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
129955294|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
129955295|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
129955296|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
129955297|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
129955298|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
129955299|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
129955300|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
129955301|NCT02971683|467797390|FG000|Open-Label|Lost to Follow-up|1|||
129955302|NCT02971683|467797391|FG001|Open-Label|Lost to Follow-up|0|||
129955303|NCT02971683|467797390|FG000|Open-Label|Participants withdrew consent|0|||
129955304|NCT02971683|467797391|FG001|Open-Label|Participants withdrew consent|2|||
129955305|NCT02971683|467797390|FG000|Open-Label|Participant request to discontinue study treatment|1|||
129955306|NCT02971683|467797391|FG001|Open-Label|Participant request to discontinue study treatment|0|||
129955307|NCT02971683|467797390|FG000|Open-Label|Lack of Efficacy|2|||
129955308|NCT02971683|467797391|FG001|Open-Label|Lack of Efficacy|0|||
129955309|NCT02971683|467797390|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
129955310|NCT02971683|467797391|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
129955311|NCT02971683|467797390|FG000|Long-Term Open Label|Participant withdrew consent|1|||
129955312|NCT02971683|467797391|FG001|Long-Term Open Label|Participant withdrew consent|0|||
129955313|NCT02971683|467797390|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
129955314|NCT02971683|467797391|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
129955315|NCT02971683|467797390|FG000|Long-Term Open Label|Adverse Event|1|||
129955316|NCT02971683|467797391|FG001|Long-Term Open Label|Adverse Event|2|||
129955317|NCT02971683|467797390|FG000|Long-Term Open Label|Lack of Efficacy|1|||
129955318|NCT02971683|467797391|FG001|Long-Term Open Label|Lack of Efficacy|1|||
129955319|NCT02268526|467797394|FG000|Overall Study|Adverse Event|0|||
130083844|NCT05333289|468259223|FG003|Overall Study|Protocol Violation|0|||
129955320|NCT02268526|467797395|FG001|Overall Study|Adverse Event|2|||
129955321|NCT02268526|467797396|FG002|Overall Study|Adverse Event|1|||
129955322|NCT02268526|467797394|FG000|Overall Study|Death|1|||
129955323|NCT02268526|467797395|FG001|Overall Study|Death|11|||
129955324|NCT02268526|467797396|FG002|Overall Study|Death|0|||
129955325|NCT02268526|467797394|FG000|Overall Study|protocol deviation|0|||
129955326|NCT02268526|467797395|FG001|Overall Study|protocol deviation|1|||
129955327|NCT02268526|467797396|FG002|Overall Study|protocol deviation|0|||
130083845|NCT05333289|468259224|FG004|Overall Study|Protocol Violation|0|||
130083846|NCT05333289|468259225|FG005|Overall Study|Protocol Violation|0|||
130083847|NCT05333289|468259226|FG006|Overall Study|Protocol Violation|0|||
130083848|NCT05333289|468259227|FG007|Overall Study|Protocol Violation|0|||
130083849|NCT05333289|468259220|FG000|Overall Study|Physician Decision|0|||
130083850|NCT05333289|468259221|FG001|Overall Study|Physician Decision|0|||
130083851|NCT05333289|468259222|FG002|Overall Study|Physician Decision|1|||
130083852|NCT05333289|468259223|FG003|Overall Study|Physician Decision|0|||
130083853|NCT05333289|468259224|FG004|Overall Study|Physician Decision|0|||
130083854|NCT05333289|468259225|FG005|Overall Study|Physician Decision|2|||
130083855|NCT05333289|468259226|FG006|Overall Study|Physician Decision|0|||
130083856|NCT05333289|468259227|FG007|Overall Study|Physician Decision|0|||
130083857|NCT05333289|468259220|FG000|Overall Study|Lost to Follow-up|6|||
130083858|NCT05333289|468259221|FG001|Overall Study|Lost to Follow-up|0|||
130083859|NCT05333289|468259222|FG002|Overall Study|Lost to Follow-up|1|||
130083860|NCT05333289|468259223|FG003|Overall Study|Lost to Follow-up|6|||
130083861|NCT05333289|468259224|FG004|Overall Study|Lost to Follow-up|3|||
130083862|NCT05333289|468259225|FG005|Overall Study|Lost to Follow-up|3|||
130083863|NCT05333289|468259226|FG006|Overall Study|Lost to Follow-up|2|||
130083864|NCT05333289|468259227|FG007|Overall Study|Lost to Follow-up|1|||
130083865|NCT05333289|468259220|FG000|Overall Study|Death|1|||
130083866|NCT05333289|468259221|FG001|Overall Study|Death|0|||
130083867|NCT05333289|468259222|FG002|Overall Study|Death|0|||
130083868|NCT05333289|468259223|FG003|Overall Study|Death|0|||
130083869|NCT05333289|468259224|FG004|Overall Study|Death|0|||
130083870|NCT05333289|468259225|FG005|Overall Study|Death|0|||
130083871|NCT05333289|468259226|FG006|Overall Study|Death|0|||
130083872|NCT05333289|468259227|FG007|Overall Study|Death|0|||
130083873|NCT01060124|468259231|FG000|Overall Study|Other|16|||
130083874|NCT01060124|468259231|FG000|Overall Study|Adverse Event|14|||
130083875|NCT01060124|468259231|FG000|Overall Study|Withdrawal by Subject|7|||
130083876|NCT03858686|468259234|FG000|Period 1|Adverse Event|1|||
130083877|NCT03858686|468259235|FG001|Period 1|Adverse Event|1|||
130083878|NCT03858686|468259234|FG000|Period 1|Lack of compliance|0|||
130083879|NCT03858686|468259235|FG001|Period 1|Lack of compliance|1|||
130083880|NCT03858686|468259234|FG000|Period 1|Adverse Event|0|||
130083881|NCT03858686|468259235|FG001|Period 1|Adverse Event|1|||
130083882|NCT03858686|468259234|FG000|Period 2|Adverse Event|0|||
130083883|NCT03858686|468259235|FG001|Period 2|Adverse Event|1|||
130083884|NCT03231228|468259237|FG000|Overall Study|Lost to Follow-up|2|||
130083885|NCT03231228|468259238|FG001|Overall Study|Lost to Follow-up|0|||
130083886|NCT03231228|468259237|FG000|Overall Study|Physician Decision|1|||
130083887|NCT03231228|468259238|FG001|Overall Study|Physician Decision|0|||
130083888|NCT02299206|468259239|FG000|Overall Study|Lost to Follow-up|1|||
130083889|NCT02299206|468259239|FG000|Overall Study|Withdrawal by Subject|1|||
130083890|NCT01682759|468259241|FG000|Overall Study|Death|2|||
130083891|NCT01682759|468259242|FG001|Overall Study|Death|1|||
130083892|NCT01682759|468259241|FG000|Overall Study|Lost to Follow-up|10|||
130083893|NCT01682759|468259242|FG001|Overall Study|Lost to Follow-up|13|||
130083894|NCT01682759|468259241|FG000|Overall Study|Physician Decision|1|||
130083895|NCT01682759|468259242|FG001|Overall Study|Physician Decision|1|||
130083896|NCT01682759|468259241|FG000|Overall Study|Withdrawal by Subject|56|||
130083897|NCT01682759|468259242|FG001|Overall Study|Withdrawal by Subject|55|||
130083898|NCT02683668|468259246|FG000|Period 2|Withdrawal by Subject|0|||
130083899|NCT02683668|468259247|FG001|Period 2|Withdrawal by Subject|1|||
130083900|NCT02683668|468259248|FG002|Period 2|Withdrawal by Subject|0|||
130083901|NCT03893630|468259249|FG000|Overall Study|Lost to Follow-up|5|||
130083902|NCT03893630|468259250|FG001|Overall Study|Lost to Follow-up|4|||
130083903|NCT03893630|468259251|FG002|Overall Study|Lost to Follow-up|2|||
130083904|NCT03893630|468259249|FG000|Overall Study|Withdrawal by Subject|3|||
130083905|NCT03893630|468259250|FG001|Overall Study|Withdrawal by Subject|6|||
130083906|NCT03893630|468259251|FG002|Overall Study|Withdrawal by Subject|3|||
130083907|NCT03893630|468259249|FG000|Overall Study|Discontinued Intervention|0|||
130083908|NCT03893630|468259250|FG001|Overall Study|Discontinued Intervention|4|||
130083909|NCT03893630|468259251|FG002|Overall Study|Discontinued Intervention|2|||
130083910|NCT03650387|468260838|FG000|Overall Study|Withdrawal by Subject|13|||
130083911|NCT03650387|468260838|FG000|Overall Study|Lost to Follow-up|12|||
130083912|NCT03650387|468260838|FG000|Overall Study|Adverse Event (Not related)|1|||
130083913|NCT03650387|468260838|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
130083914|NCT05815758|468260839|FG000|Overall Study|Adverse Event|6|||
130083915|NCT05815758|468260840|FG001|Overall Study|Adverse Event|2|||
130083916|NCT05815758|468260839|FG000|Overall Study|Lost to Follow-up|14|||
130083917|NCT05815758|468260840|FG001|Overall Study|Lost to Follow-up|1|||
130083918|NCT05815758|468260839|FG000|Overall Study|Withdrawal by Subject|6|||
130083919|NCT05815758|468260840|FG001|Overall Study|Withdrawal by Subject|6|||
130083920|NCT05815758|468260839|FG000|Overall Study|Protocol Violation|1|||
130083921|NCT05815758|468260840|FG001|Overall Study|Protocol Violation|1|||
130083922|NCT05815758|468260839|FG000|Overall Study|Discontinued|4|||
130083923|NCT05815758|468260840|FG001|Overall Study|Discontinued|4|||
130083924|NCT03661983|468260841|FG000|Open Label Stabilization Phase|Adverse Event|5|||
130083925|NCT03661983|468260842|FG001|Open Label Stabilization Phase|Adverse Event|0|||
130083926|NCT03661983|468260843|FG002|Open Label Stabilization Phase|Adverse Event|0|||
130083927|NCT03661983|468260844|FG003|Open Label Stabilization Phase|Adverse Event|0|||
130083928|NCT03661983|468260841|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
130120991|NCT00788957|468404872|FG000|Part 2|Lost to Follow-up|0|||
130083929|NCT03661983|468260842|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
130083930|NCT03661983|468260843|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
130083931|NCT03661983|468260844|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
130083932|NCT03661983|468260841|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
130120992|NCT00788957|468404873|FG001|Part 2|Lost to Follow-up|0|||
129955328|NCT02268526|467797394|FG000|Overall Study|Physician Decision|0|||
129955329|NCT02268526|467797395|FG001|Overall Study|Physician Decision|0|||
129955330|NCT02268526|467797396|FG002|Overall Study|Physician Decision|1|||
129955331|NCT02268526|467797394|FG000|Overall Study|Subject/guardian decision|0|||
129955332|NCT02268526|467797395|FG001|Overall Study|Subject/guardian decision|7|||
129955333|NCT02268526|467797396|FG002|Overall Study|Subject/guardian decision|3|||
129955334|NCT00596960|467797397|FG000|Overall Study|Death|1|||
129955335|NCT00596960|467797398|FG001|Overall Study|Death|2|||
129955336|NCT00596960|467797397|FG000|Overall Study|Lost to Follow-up|6|||
129955337|NCT00596960|467797398|FG001|Overall Study|Lost to Follow-up|5|||
129955338|NCT00596960|467797397|FG000|Overall Study|Withdrawal by Subject|1|||
129955339|NCT00596960|467797398|FG001|Overall Study|Withdrawal by Subject|0|||
129955340|NCT00596960|467797397|FG000|Overall Study|Incarcerated|2|||
129955341|NCT00596960|467797398|FG001|Overall Study|Incarcerated|0|||
129955342|NCT00596960|467797397|FG000|Overall Study|Physician Decision|1|||
129955343|NCT00596960|467797398|FG001|Overall Study|Physician Decision|0|||
129955344|NCT00596960|467797397|FG000|Overall Study|Protocol Violation|0|||
129955345|NCT00596960|467797398|FG001|Overall Study|Protocol Violation|1|||
129955346|NCT00596960|467797397|FG000|Overall Study|No alcohol use data|0|||
129955347|NCT00596960|467797398|FG001|Overall Study|No alcohol use data|1|||
129955348|NCT02374476|467797401|FG000|VT Induced Ablation|Screening Failures|36|||
129955349|NCT02374476|467797402|FG001|VT Induced Ablation|Screening Failures|0|||
129955350|NCT02374476|467797403|FG002|VT Induced Ablation|Screening Failures|0|||
129955351|NCT02374476|467797401|FG000|Arm Assignment|Withdrawal by Subject|0|||
129955352|NCT02374476|467797402|FG001|Arm Assignment|Withdrawal by Subject|0|||
129955353|NCT02374476|467797403|FG002|Arm Assignment|Withdrawal by Subject|1|||
129955354|NCT03305458|467797404|FG000|Overall Study|Withdrawal by Subject|50|||
129955355|NCT03305458|467797405|FG001|Overall Study|Withdrawal by Subject|46|||
129955356|NCT03305458|467797406|FG002|Overall Study|Withdrawal by Subject|93|||
129955357|NCT03305458|467797404|FG000|Overall Study|Lost to Follow-up|85|||
129955358|NCT03305458|467797405|FG001|Overall Study|Lost to Follow-up|85|||
129955359|NCT03305458|467797406|FG002|Overall Study|Lost to Follow-up|35|||
129955360|NCT05431543|467797409|FG000|Overall Study|Medical History|1|||
129955361|NCT05431543|467797410|FG001|Overall Study|Medical History|0|||
129955362|NCT05431543|467797411|FG002|Overall Study|Medical History|0|||
129955363|NCT00440037|467797412|FG000|Overall Study|Withdrawal by Subject|6|||
129955364|NCT00440037|467797412|FG000|Overall Study|Administrative decision|3|||
129955365|NCT00990314|467797413|FG000|Overall Study|Death|2|||
129955366|NCT00990314|467797413|FG000|Overall Study|Adverse Event|2|||
129955367|NCT00990314|467797413|FG000|Overall Study|Withdrawal by Subject|3|||
129955368|NCT00990314|467797413|FG000|Overall Study|Non-Compliance|1|||
129955369|NCT00990314|467797413|FG000|Overall Study|Physician Decision|3|||
129955370|NCT00990314|467797413|FG000|Overall Study|Lack of Efficacy|1|||
129955371|NCT01636778|467797421|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
129955372|NCT01636778|467797422|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
129955373|NCT01636778|467797423|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
129955374|NCT01636778|467797421|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
129955375|NCT01636778|467797422|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
129955376|NCT01636778|467797423|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
129955377|NCT01636778|467797421|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
129955378|NCT01636778|467797422|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
129955379|NCT01636778|467797423|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
129955380|NCT01636778|467797421|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
129955381|NCT01636778|467797422|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
129955382|NCT01636778|467797423|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
129955383|NCT01636778|467797421|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
129955384|NCT01636778|467797422|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
129955385|NCT01636778|467797423|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
129955386|NCT01636778|467797421|FG000|Follow-up Period After Part 2|Other|0|||
129955387|NCT01636778|467797422|FG001|Follow-up Period After Part 2|Other|0|||
129955388|NCT01636778|467797423|FG002|Follow-up Period After Part 2|Other|1|||
129955389|NCT01636778|467797421|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
129955390|NCT01636778|467797422|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
129955391|NCT01636778|467797423|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
129955392|NCT01636778|467797421|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
129955393|NCT01636778|467797422|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
129955394|NCT01636778|467797423|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
129955395|NCT04853394|467797425|FG000|Follow-up Interviews|Lost to Follow-up|22|||
129955396|NCT04853394|467797426|FG001|Follow-up Interviews|Lost to Follow-up|15|||
129955397|NCT04212299|467797427|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
129955398|NCT04413149|467799225|FG000|Overall Study|Death|10|||
129955399|NCT04413149|467799226|FG001|Overall Study|Death|5|||
129955400|NCT04413149|467799225|FG000|Overall Study|Lung transplantation|1|||
129955401|NCT04413149|467799226|FG001|Overall Study|Lung transplantation|0|||
129955402|NCT00705614|467799227|FG000|Initial Intervention|Adverse Event|40|||
129955403|NCT00705614|467799228|FG001|Initial Intervention|Adverse Event|21|||
129955404|NCT00705614|467799227|FG000|Initial Intervention|Lost to Follow-up|310|||
129955405|NCT00705614|467799228|FG001|Initial Intervention|Lost to Follow-up|191|||
129955406|NCT00705614|467799227|FG000|Initial Intervention|Withdrawal by Subject|114|||
129955407|NCT00705614|467799228|FG001|Initial Intervention|Withdrawal by Subject|71|||
129955408|NCT00705614|467799227|FG000|Initial Intervention|Administrative Reason|51|||
129955409|NCT00705614|467799228|FG001|Initial Intervention|Administrative Reason|38|||
129955410|NCT00705614|467799227|FG000|Initial Intervention|Status completion unknown|3|||
129955411|NCT00705614|467799228|FG001|Initial Intervention|Status completion unknown|0|||
129955412|NCT00705614|467799227|FG000|Switch to Remicade|Adverse Event|0|||
129955413|NCT00705614|467799228|FG001|Switch to Remicade|Adverse Event|5|||
129955414|NCT00705614|467799227|FG000|Switch to Remicade|Lost to Follow-up|0|||
129955415|NCT00705614|467799228|FG001|Switch to Remicade|Lost to Follow-up|23|||
129955416|NCT00705614|467799227|FG000|Switch to Remicade|Withdrawal by Subject|0|||
129955417|NCT00705614|467799228|FG001|Switch to Remicade|Withdrawal by Subject|12|||
129955418|NCT00705614|467799227|FG000|Switch to Remicade|Administrative Reason|0|||
129955419|NCT00705614|467799228|FG001|Switch to Remicade|Administrative Reason|9|||
129955420|NCT00676195|467799231|FG000|Overall Study|Lost to Follow-up|1|||
129955421|NCT00676195|467799231|FG000|Overall Study|Adverse Event|1|||
130083933|NCT03661983|468260842|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
130083934|NCT03661983|468260843|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
130083935|NCT03661983|468260844|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
130083936|NCT03661983|468260841|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
130083937|NCT03661983|468260842|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130083938|NCT03661983|468260843|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130083939|NCT03661983|468260844|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
130083940|NCT03661983|468260841|FG000|Double-blind Randomized Phase|Adverse Event|0|||
130083941|NCT03661983|468260842|FG001|Double-blind Randomized Phase|Adverse Event|1|||
130083942|NCT03661983|468260843|FG002|Double-blind Randomized Phase|Adverse Event|0|||
130083943|NCT03661983|468260844|FG003|Double-blind Randomized Phase|Adverse Event|0|||
130083944|NCT03661983|468260841|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
130083945|NCT03661983|468260842|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
130083946|NCT03661983|468260843|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
130083947|NCT03661983|468260844|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
130083948|NCT03661983|468260841|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
130083949|NCT03661983|468260842|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
130083950|NCT03661983|468260843|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
130083951|NCT03661983|468260844|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
130083952|NCT03661983|468260841|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
130083953|NCT03661983|468260842|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
130083954|NCT03661983|468260843|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
130083955|NCT03661983|468260844|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
130083956|NCT01222767|468260845|FG000|Overall Study|Progressive disease|13|||
130083957|NCT01222767|468260845|FG000|Overall Study|Adverse Event|2|||
130083958|NCT01222767|468260845|FG000|Overall Study|Surgical resection|1|||
130083959|NCT01222767|468260845|FG000|Overall Study|Never treated|1|||
130083960|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
130083961|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
130083962|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
130083963|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
130083964|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Death|38|||
130083965|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Death|10|||
130083966|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
130083967|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
129955422|NCT00676195|467799231|FG000|Overall Study|Physician Decision|1|||
129955423|NCT02661490|467799232|FG000|Overall Study|Lost to Follow-up|0|||
130083968|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
130083969|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
130083970|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
130120993|NCT00788957|468404874|FG002|Part 2|Lost to Follow-up|3|||
129955424|NCT02661490|467799233|FG001|Overall Study|Lost to Follow-up|1|||
129955425|NCT02661490|467799234|FG002|Overall Study|Lost to Follow-up|0|||
129955426|NCT02661490|467799235|FG003|Overall Study|Lost to Follow-up|0|||
129955427|NCT02661490|467799236|FG004|Overall Study|Lost to Follow-up|2|||
129955428|NCT02661490|467799232|FG000|Overall Study|Withdrawal by Subject|2|||
129955429|NCT02661490|467799233|FG001|Overall Study|Withdrawal by Subject|0|||
129955430|NCT02661490|467799234|FG002|Overall Study|Withdrawal by Subject|2|||
129955431|NCT02661490|467799235|FG003|Overall Study|Withdrawal by Subject|0|||
129955432|NCT02661490|467799236|FG004|Overall Study|Withdrawal by Subject|0|||
129955433|NCT02661490|467799232|FG000|Overall Study|Death|1|||
129955434|NCT02661490|467799233|FG001|Overall Study|Death|1|||
129955435|NCT02661490|467799234|FG002|Overall Study|Death|0|||
129955436|NCT02661490|467799235|FG003|Overall Study|Death|1|||
129955437|NCT02661490|467799236|FG004|Overall Study|Death|0|||
129955438|NCT02661490|467799232|FG000|Overall Study|Reason not Specified|0|||
129955439|NCT02661490|467799233|FG001|Overall Study|Reason not Specified|0|||
129955440|NCT02661490|467799234|FG002|Overall Study|Reason not Specified|0|||
129955441|NCT02661490|467799235|FG003|Overall Study|Reason not Specified|0|||
129955442|NCT02661490|467799236|FG004|Overall Study|Reason not Specified|1|||
129955443|NCT00814632|467799237|FG000|Overall Study|Lack of Efficacy|2|||
129955444|NCT05335005|467799238|FG000|Overall Study|Lost to Follow-up|1|||
129955445|NCT04050722|467799239|FG000|Overall Study|Withdrawal by Subject|1|||
129955446|NCT04050722|467799240|FG001|Overall Study|Withdrawal by Subject|0|||
129955447|NCT03087851|467799244|FG000|Overall Study|Withdraw on medical grounds|0|||
129955448|NCT03087851|467799245|FG001|Overall Study|Withdraw on medical grounds|1|||
129955449|NCT03087851|467799246|FG002|Overall Study|Withdraw on medical grounds|2|||
129955450|NCT00678899|467799252|FG000|Overall Study|Adverse Event|1|||
129955451|NCT03451292|467799253|FG000|Overall Study|Death|44|||
129955452|NCT03451292|467799254|FG001|Overall Study|Death|59|||
129955453|NCT03451292|467799253|FG000|Overall Study|Withdrawal by Subject|18|||
129955454|NCT03451292|467799254|FG001|Overall Study|Withdrawal by Subject|13|||
129955455|NCT03451292|467799253|FG000|Overall Study|Transplantation|18|||
129955456|NCT03451292|467799254|FG001|Overall Study|Transplantation|12|||
129955457|NCT03451292|467799253|FG000|Overall Study|Lost to Follow-up|4|||
129955458|NCT03451292|467799254|FG001|Overall Study|Lost to Follow-up|12|||
129955459|NCT03451292|467799253|FG000|Overall Study|Physician Decision|4|||
129955460|NCT03451292|467799254|FG001|Overall Study|Physician Decision|3|||
129955461|NCT03451292|467799253|FG000|Overall Study|Adverse Event|3|||
129955462|NCT03451292|467799254|FG001|Overall Study|Adverse Event|3|||
129955463|NCT03451292|467799253|FG000|Overall Study|Non-compliance with Study Drug|2|||
129955464|NCT03451292|467799254|FG001|Overall Study|Non-compliance with Study Drug|0|||
129955465|NCT01572493|467799262|FG000|Overall Study|Physician Decision|1|||
129955466|NCT01572493|467799263|FG001|Overall Study|Physician Decision|0|||
129955467|NCT01572493|467799264|FG002|Overall Study|Physician Decision|0|||
129955468|NCT01572493|467799265|FG003|Overall Study|Physician Decision|0|||
129955469|NCT01572493|467799266|FG004|Overall Study|Physician Decision|0|||
129955470|NCT01572493|467799267|FG005|Overall Study|Physician Decision|0|||
129955471|NCT01572493|467799268|FG006|Overall Study|Physician Decision|0|||
129955472|NCT01572493|467799269|FG007|Overall Study|Physician Decision|0|||
129955473|NCT01572493|467799270|FG008|Overall Study|Physician Decision|0|||
129955474|NCT01572493|467799262|FG000|Overall Study|Switched to alternative treatment|0|||
129955475|NCT01572493|467799263|FG001|Overall Study|Switched to alternative treatment|1|||
129955476|NCT01572493|467799264|FG002|Overall Study|Switched to alternative treatment|2|||
129955477|NCT01572493|467799265|FG003|Overall Study|Switched to alternative treatment|1|||
129955478|NCT01572493|467799266|FG004|Overall Study|Switched to alternative treatment|2|||
129955479|NCT01572493|467799267|FG005|Overall Study|Switched to alternative treatment|0|||
129955480|NCT01572493|467799268|FG006|Overall Study|Switched to alternative treatment|2|||
129955481|NCT01572493|467799269|FG007|Overall Study|Switched to alternative treatment|0|||
129955482|NCT01572493|467799270|FG008|Overall Study|Switched to alternative treatment|2|||
129955483|NCT01572493|467799262|FG000|Overall Study|Death|0|||
129955484|NCT01572493|467799263|FG001|Overall Study|Death|0|||
129955485|NCT01572493|467799264|FG002|Overall Study|Death|0|||
129955486|NCT01572493|467799265|FG003|Overall Study|Death|1|||
129955487|NCT01572493|467799266|FG004|Overall Study|Death|0|||
129955488|NCT01572493|467799267|FG005|Overall Study|Death|1|||
129955489|NCT01572493|467799268|FG006|Overall Study|Death|0|||
129955490|NCT01572493|467799269|FG007|Overall Study|Death|0|||
129955491|NCT01572493|467799270|FG008|Overall Study|Death|0|||
129955492|NCT01572493|467799262|FG000|Overall Study|Adverse Event|0|||
129955493|NCT01572493|467799263|FG001|Overall Study|Adverse Event|0|||
129955494|NCT01572493|467799264|FG002|Overall Study|Adverse Event|0|||
129955495|NCT01572493|467799265|FG003|Overall Study|Adverse Event|0|||
129955496|NCT01572493|467799266|FG004|Overall Study|Adverse Event|0|||
130083971|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
130083972|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
130083973|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
129955497|NCT01572493|467799267|FG005|Overall Study|Adverse Event|0|||
129955498|NCT01572493|467799268|FG006|Overall Study|Adverse Event|1|||
129955499|NCT01572493|467799269|FG007|Overall Study|Adverse Event|0|||
129955500|NCT01572493|467799270|FG008|Overall Study|Adverse Event|0|||
129955501|NCT01234675|467799271|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
129955502|NCT01234675|467799272|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129955503|NCT01234675|467799271|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129955504|NCT01234675|467799272|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
129955505|NCT00609245|467799273|FG000|Overall Study|Adverse Event|1|||
129955506|NCT02889809|467799274|FG000|Overall Study|Withdrawal by Subject|30|||
129955507|NCT02889809|467799275|FG001|Overall Study|Withdrawal by Subject|21|||
129955508|NCT02889809|467799274|FG000|Overall Study|Lost to Follow-up|1|||
129955509|NCT02889809|467799275|FG001|Overall Study|Lost to Follow-up|1|||
129955510|NCT02889809|467799274|FG000|Overall Study|Site Closed|12|||
129955511|NCT02889809|467799275|FG001|Overall Study|Site Closed|11|||
129955512|NCT01090076|467799276|FG000|Overall Study|Death|1|||
129955513|NCT01090076|467799277|FG001|Overall Study|Death|1|||
129955514|NCT01090076|467799276|FG000|Overall Study|Withdrawal by Subject|0|||
129955515|NCT01090076|467799277|FG001|Overall Study|Withdrawal by Subject|1|||
129955516|NCT02798861|467799286|FG000|Overall Study|Lost to Follow-up|22|||
129955517|NCT02798861|467799286|FG000|Overall Study|Withdrawal by Subject|1|||
129955518|NCT02186015|467799287|FG000|Overall Study|Physician Decision|1|||
129955519|NCT02186015|467799288|FG001|Overall Study|Physician Decision|0|||
129955520|NCT00907517|467799289|FG000|Overall Study|Progressive Disease|3|||
129955521|NCT00907517|467799290|FG001|Overall Study|Progressive Disease|3|||
129955522|NCT00907517|467799291|FG002|Overall Study|Progressive Disease|4|||
129955523|NCT00907517|467799292|FG003|Overall Study|Progressive Disease|4|||
129955524|NCT00907517|467799293|FG004|Overall Study|Progressive Disease|4|||
129955525|NCT00907517|467799289|FG000|Overall Study|Symptomatic Deterioration|0|||
129955526|NCT00907517|467799290|FG001|Overall Study|Symptomatic Deterioration|0|||
129955527|NCT00907517|467799291|FG002|Overall Study|Symptomatic Deterioration|0|||
129955528|NCT00907517|467799292|FG003|Overall Study|Symptomatic Deterioration|0|||
129955529|NCT00907517|467799293|FG004|Overall Study|Symptomatic Deterioration|1|||
129955530|NCT01797705|467799295|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
129955531|NCT01797705|467799295|FG000|Overall Study|Withdrawal by Subject|1|||
129955532|NCT01838447|467799296|FG000|Overall Study|Change in surgical plan|1|||
129955533|NCT01838447|467799297|FG001|Overall Study|Change in surgical plan|2|||
129955534|NCT01838447|467799296|FG000|Overall Study|Withdrawal by Subject|1|||
129955535|NCT01838447|467799297|FG001|Overall Study|Withdrawal by Subject|1|||
129955536|NCT02030847|467799298|FG000|Overall Study|Death|10|||
129955537|NCT02030847|467799298|FG000|Overall Study|Disease Progression|15|||
129955538|NCT02030847|467799298|FG000|Overall Study|New Cancer Therapy|8|||
129955539|NCT02030847|467799298|FG000|Overall Study|Physician Decision|3|||
129955540|NCT02030847|467799298|FG000|Overall Study|Withdrawal by Subject|1|||
129955541|NCT01403805|467799301|FG000|Overall Study|Withdrawal by Subject|0|||
129955542|NCT01403805|467799302|FG001|Overall Study|Withdrawal by Subject|4|||
129955543|NCT01403805|467799301|FG000|Overall Study|Lost to Follow-up|0|||
129955544|NCT01403805|467799302|FG001|Overall Study|Lost to Follow-up|2|||
129955545|NCT01403805|467799301|FG000|Overall Study|Death|0|||
129955546|NCT01403805|467799302|FG001|Overall Study|Death|1|||
129955547|NCT01103141|467799303|FG000|Overall Study|Death|0|||
129955548|NCT01103141|467799304|FG001|Overall Study|Death|1|||
129955549|NCT01103141|467799303|FG000|Overall Study|Lost to Follow-up|2|||
129955550|NCT01103141|467799304|FG001|Overall Study|Lost to Follow-up|1|||
129955551|NCT01695993|467799305|FG000|Overall Study|Lost to Follow-up|2|||
129955552|NCT01695993|467799306|FG001|Overall Study|Lost to Follow-up|1|||
129955553|NCT01695993|467799307|FG002|Overall Study|Lost to Follow-up|3|||
129955554|NCT01695993|467799305|FG000|Overall Study|Withdrawal by Subject|2|||
129955555|NCT01695993|467799306|FG001|Overall Study|Withdrawal by Subject|2|||
129955556|NCT01695993|467799307|FG002|Overall Study|Withdrawal by Subject|2|||
129955557|NCT01695993|467799305|FG000|Overall Study|To ill to continue|1|||
129955558|NCT01695993|467799306|FG001|Overall Study|To ill to continue|2|||
129955559|NCT01695993|467799307|FG002|Overall Study|To ill to continue|0|||
129955560|NCT01695993|467799305|FG000|Overall Study|Changed Medical Facility|0|||
129955561|NCT01695993|467799306|FG001|Overall Study|Changed Medical Facility|0|||
129955562|NCT01695993|467799307|FG002|Overall Study|Changed Medical Facility|1|||
129955563|NCT02029521|467799309|FG000|Overall Study|Protocol Violation|1|||
129955564|NCT02029521|467799310|FG001|Overall Study|Protocol Violation|0|||
129955565|NCT02029521|467799309|FG000|Overall Study|Withdrawal by Subject|1|||
129955566|NCT02029521|467799310|FG001|Overall Study|Withdrawal by Subject|1|||
129955567|NCT01072396|467799311|FG000|Period One|Adverse Event|1|||
130083974|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
130083975|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
130083976|NCT02421939|468260846|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
130083977|NCT02421939|468260847|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
130083978|NCT02421939|468260846|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
129955568|NCT01072396|467799312|FG001|Period One|Adverse Event|1|||
129955569|NCT01072396|467799311|FG000|Period One|Protocol Violation|2|||
129955570|NCT01072396|467799312|FG001|Period One|Protocol Violation|1|||
129955571|NCT01072396|467799311|FG000|Period One|Withdrawal by Subject|2|||
129955572|NCT01072396|467799312|FG001|Period One|Withdrawal by Subject|0|||
129955573|NCT01072396|467799311|FG000|Washout Period|Missing termination information|0|||
129955574|NCT01072396|467799312|FG001|Washout Period|Missing termination information|1|||
129955575|NCT01072396|467799311|FG000|Period Two|Adverse Event|0|||
129955576|NCT01072396|467799312|FG001|Period Two|Adverse Event|3|||
129955577|NCT01072396|467799311|FG000|Period Two|Lost to Follow-up|1|||
129955578|NCT01072396|467799312|FG001|Period Two|Lost to Follow-up|0|||
129955579|NCT00105521|467799313|FG000|Overall Study|Other|1|||
129955580|NCT00105521|467799314|FG001|Overall Study|Other|1|||
129955581|NCT00105521|467799315|FG002|Overall Study|Other|2|||
129955582|NCT00105521|467799316|FG003|Overall Study|Other|0|||
129955583|NCT00105521|467799313|FG000|Overall Study|Adverse Event|10|||
129955584|NCT00105521|467799314|FG001|Overall Study|Adverse Event|4|||
129955585|NCT00105521|467799315|FG002|Overall Study|Adverse Event|10|||
129955586|NCT00105521|467799316|FG003|Overall Study|Adverse Event|8|||
129955587|NCT00105521|467799313|FG000|Overall Study|Withdrawal by Subject|1|||
129955588|NCT00105521|467799314|FG001|Overall Study|Withdrawal by Subject|0|||
129955589|NCT00105521|467799315|FG002|Overall Study|Withdrawal by Subject|1|||
129955590|NCT00105521|467799316|FG003|Overall Study|Withdrawal by Subject|4|||
129955591|NCT00105521|467799313|FG000|Overall Study|Lack of Efficacy|0|||
129955592|NCT00105521|467799314|FG001|Overall Study|Lack of Efficacy|0|||
129955593|NCT00105521|467799315|FG002|Overall Study|Lack of Efficacy|0|||
129955594|NCT00105521|467799316|FG003|Overall Study|Lack of Efficacy|1|||
129955595|NCT00105521|467799313|FG000|Overall Study|Protocol Violation|3|||
129955596|NCT00105521|467799314|FG001|Overall Study|Protocol Violation|5|||
129955597|NCT00105521|467799315|FG002|Overall Study|Protocol Violation|4|||
129955598|NCT00105521|467799316|FG003|Overall Study|Protocol Violation|4|||
129955599|NCT00105521|467799313|FG000|Overall Study|Lost to Follow-up|0|||
129955600|NCT00105521|467799314|FG001|Overall Study|Lost to Follow-up|1|||
129955601|NCT00105521|467799315|FG002|Overall Study|Lost to Follow-up|0|||
129955602|NCT00105521|467799316|FG003|Overall Study|Lost to Follow-up|0|||
129955603|NCT02744898|467799317|FG000|Overall Study|Progressive Disease|2|||
129955604|NCT02744898|467799317|FG000|Overall Study|Physician Decision|1|||
129955605|NCT02744898|467799317|FG000|Overall Study|Toxicity|1|||
129955606|NCT03751280|467799328|FG000|Overall Study|Adverse Event|0|||
129955607|NCT03751280|467799329|FG001|Overall Study|Adverse Event|1|||
129955608|NCT03751280|467799328|FG000|Overall Study|Lost to Follow-up|3|||
129955609|NCT03751280|467799329|FG001|Overall Study|Lost to Follow-up|5|||
129955610|NCT03751280|467799328|FG000|Overall Study|Physician Decision|0|||
129955611|NCT03751280|467799329|FG001|Overall Study|Physician Decision|2|||
129955612|NCT03751280|467799328|FG000|Overall Study|Protocol Violation|0|||
129955613|NCT03751280|467799329|FG001|Overall Study|Protocol Violation|2|||
129955614|NCT03751280|467799328|FG000|Overall Study|Withdrawal by Subject|5|||
129955615|NCT03751280|467799329|FG001|Overall Study|Withdrawal by Subject|2|||
129955616|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
129955617|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
129955618|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Adverse Event|4|||
129955619|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Adverse Event|1|||
129955620|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
129955621|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
129955622|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Physician Decision|0|||
129955623|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Physician Decision|2|||
129955624|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Death|1|||
129955625|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Death|0|||
129955626|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
129955627|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
129955628|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
129955629|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
129955630|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Death|2|||
129955631|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Death|1|||
129955632|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
129955633|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
129955634|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
129955635|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
129955636|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
129955637|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
129955638|NCT01348763|467799338|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
129955639|NCT01348763|467799338|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
129955640|NCT01078571|467799339|FG000|Overall Study|Adverse Event|36|||
129955641|NCT01078571|467799339|FG000|Overall Study|Lack of effectiveness|36|||
129955642|NCT01078571|467799339|FG000|Overall Study|Reason not reported|21|||
129955643|NCT01078571|467799339|FG000|Overall Study|Withdrawal by Subject|12|||
129955644|NCT01078571|467799339|FG000|Overall Study|Lost to Follow-up|8|||
129955645|NCT01078571|467799339|FG000|Overall Study|Protocol Violation|2|||
130120994|NCT00788957|468404875|FG003|Part 2|Lost to Follow-up|0|||
129955646|NCT03647709|467799343|FG000|Overall Study|Lost to Follow-up|5|||
129955647|NCT03647709|467799343|FG000|Overall Study|Physician Decision|6|||
129955648|NCT03647709|467799343|FG000|Overall Study|Withdrawal by Subject|3|||
129955649|NCT01257698|467799346|FG000|Overall Study|Protocol Violation|4|||
129955650|NCT01257698|467799347|FG001|Overall Study|Protocol Violation|0|||
129955651|NCT02038803|467799353|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
130120995|NCT00788957|468404876|FG004|Part 2|Lost to Follow-up|0|||
129955652|NCT02038803|467799353|FG000|Overall Study|Lost to Follow-up|1|||
129955653|NCT04372186|467799354|FG000|Overall Study|Death|24|||
129955654|NCT04372186|467799355|FG001|Overall Study|Death|11|||
129955655|NCT04372186|467799354|FG000|Overall Study|Transferred to a different facility for care|0|||
129955656|NCT04372186|467799355|FG001|Overall Study|Transferred to a different facility for care|2|||
129955657|NCT02116582|467799356|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
129955658|NCT02116582|467799356|FG000|Overall Study|Adverse Event|22|||
129955659|NCT02116582|467799356|FG000|Overall Study|Death|9|||
129955660|NCT02116582|467799356|FG000|Overall Study|Progressive Disease|148|||
129955661|NCT02116582|467799356|FG000|Overall Study|Protocol Violation|3|||
129955662|NCT02116582|467799356|FG000|Overall Study|Withdrawal by Subject|8|||
129955663|NCT02116582|467799356|FG000|Overall Study|Other: Miscellaneous|11|||
129955664|NCT02116582|467799356|FG000|Overall Study|Lost to Follow-up|1|||
129955665|NCT02116582|467799356|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
129955666|NCT03219216|467799357|FG000|Overall Study|Lost to Follow-up|0|||
129955667|NCT03219216|467799358|FG001|Overall Study|Lost to Follow-up|1|||
129955668|NCT02332824|467799359|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
129955669|NCT02332824|467799360|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129955670|NCT02332824|467799361|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129955671|NCT02332824|467799362|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129955672|NCT02332824|467799363|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
129955673|NCT02332824|467799364|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
129955674|NCT02332824|467799359|FG000|Overall Study|Voluntary Withdrawal|1|||
129955675|NCT02332824|467799360|FG001|Overall Study|Voluntary Withdrawal|0|||
129955676|NCT02332824|467799361|FG002|Overall Study|Voluntary Withdrawal|0|||
129955677|NCT02332824|467799362|FG003|Overall Study|Voluntary Withdrawal|0|||
129955678|NCT02332824|467799363|FG004|Overall Study|Voluntary Withdrawal|0|||
129955679|NCT02332824|467799364|FG005|Overall Study|Voluntary Withdrawal|0|||
129955680|NCT02332824|467799359|FG000|Overall Study|Inconvenient schedule|1|||
129955681|NCT02332824|467799360|FG001|Overall Study|Inconvenient schedule|1|||
129955682|NCT02332824|467799361|FG002|Overall Study|Inconvenient schedule|0|||
129955683|NCT02332824|467799362|FG003|Overall Study|Inconvenient schedule|0|||
129955684|NCT02332824|467799363|FG004|Overall Study|Inconvenient schedule|0|||
129955685|NCT02332824|467799364|FG005|Overall Study|Inconvenient schedule|0|||
129955686|NCT02332824|467799359|FG000|Overall Study|Transfer|0|||
129955687|NCT02332824|467799360|FG001|Overall Study|Transfer|0|||
129955688|NCT02332824|467799361|FG002|Overall Study|Transfer|1|||
129955689|NCT02332824|467799362|FG003|Overall Study|Transfer|1|||
129955690|NCT02332824|467799363|FG004|Overall Study|Transfer|0|||
129955691|NCT02332824|467799364|FG005|Overall Study|Transfer|0|||
129955692|NCT00498797|467799365|FG000|Overall Study|Withdrawal by Subject|4|||
129955693|NCT00498797|467799366|FG001|Overall Study|Withdrawal by Subject|2|||
129955694|NCT00498797|467799365|FG000|Overall Study|Adverse Event|12|||
129955695|NCT00498797|467799366|FG001|Overall Study|Adverse Event|5|||
129955696|NCT00498797|467799365|FG000|Overall Study|Condition under investigation worsened|19|||
129955697|NCT00498797|467799366|FG001|Overall Study|Condition under investigation worsened|21|||
129955698|NCT00498797|467799365|FG000|Overall Study|Other|3|||
129955699|NCT00498797|467799366|FG001|Overall Study|Other|1|||
129955700|NCT00914732|467799367|FG000|Overall Study|Lost to Follow-up|6|||
129955701|NCT00914732|467799368|FG001|Overall Study|Lost to Follow-up|7|||
129955702|NCT00914732|467799369|FG002|Overall Study|Lost to Follow-up|9|||
129955703|NCT00914732|467799367|FG000|Overall Study|Withdrawal by Subject|3|||
129955704|NCT00914732|467799368|FG001|Overall Study|Withdrawal by Subject|0|||
129955705|NCT00914732|467799369|FG002|Overall Study|Withdrawal by Subject|2|||
129955706|NCT00914732|467799367|FG000|Overall Study|Adverse Event|1|||
129955707|NCT00914732|467799368|FG001|Overall Study|Adverse Event|0|||
129955708|NCT00914732|467799369|FG002|Overall Study|Adverse Event|0|||
129955709|NCT01855399|467799370|FG000|6 Month|Lost to Follow-up|12|||
129955710|NCT01855399|467799371|FG001|6 Month|Lost to Follow-up|9|||
129955711|NCT01855399|467799370|FG000|6 Month|Withdrawal by Subject|8|||
129955712|NCT01855399|467799371|FG001|6 Month|Withdrawal by Subject|6|||
130120996|NCT00788957|468404877|FG005|Part 2|Lost to Follow-up|0|||
130120997|NCT00788957|468404872|FG000|Part 2|On-study at time of data cut-off|0|||
129955713|NCT01855399|467799370|FG000|12 Month|Lost to Follow-up|7|||
129955714|NCT01855399|467799371|FG001|12 Month|Lost to Follow-up|11|||
130120998|NCT00788957|468404873|FG001|Part 2|On-study at time of data cut-off|1|||
130120999|NCT00788957|468404874|FG002|Part 2|On-study at time of data cut-off|1|||
129955715|NCT03953079|467799372|FG000|Core Study|Withdrawal by Subject|1|||
129955716|NCT03953079|467799373|FG001|Core Study|Withdrawal by Subject|2|||
130121000|NCT00788957|468404875|FG003|Part 2|On-study at time of data cut-off|1|||
129955717|NCT03953079|467799374|FG002|Core Study|Withdrawal by Subject|1|||
129955718|NCT03953079|467799372|FG000|Core Study|COVID-19|0|||
129955719|NCT03953079|467799373|FG001|Core Study|COVID-19|1|||
130121001|NCT00788957|468404876|FG004|Part 2|On-study at time of data cut-off|0|||
129955720|NCT03953079|467799374|FG002|Core Study|COVID-19|0|||
129955721|NCT03953079|467799372|FG000|Core Study|Difficulties leaving the house|0|||
129955722|NCT03953079|467799373|FG001|Core Study|Difficulties leaving the house|1|||
129955723|NCT03953079|467799374|FG002|Core Study|Difficulties leaving the house|0|||
129955724|NCT03953079|467799372|FG000|Extension Study|Withdrawal by Subject|1|||
129955725|NCT03953079|467799373|FG001|Extension Study|Withdrawal by Subject|0|||
129955726|NCT03953079|467799374|FG002|Extension Study|Withdrawal by Subject|0|||
129955727|NCT03953079|467799372|FG000|Extension Study|Received Rescue Treatment|5|||
129955728|NCT03953079|467799373|FG001|Extension Study|Received Rescue Treatment|6|||
129955729|NCT03953079|467799374|FG002|Extension Study|Received Rescue Treatment|5|||
129955730|NCT04394624|467799375|FG000|Overall Study|Adverse Event|6|||
129955731|NCT04394624|467799376|FG001|Overall Study|Adverse Event|0|||
129955732|NCT04394624|467799375|FG000|Overall Study|Progressive disease|24|||
129955733|NCT04394624|467799376|FG001|Overall Study|Progressive disease|0|||
129955734|NCT04394624|467799375|FG000|Overall Study|Not related to COVID-19|1|||
129955735|NCT04394624|467799376|FG001|Overall Study|Not related to COVID-19|0|||
129955736|NCT00141271|467799382|FG000|Overall Study|Adverse Event|31|||
129955737|NCT00141271|467799383|FG001|Overall Study|Adverse Event|19|||
129955738|NCT00141271|467799384|FG002|Overall Study|Adverse Event|17|||
129955739|NCT00141271|467799382|FG000|Overall Study|Laboratory Abnormality|2|||
129955740|NCT00141271|467799383|FG001|Overall Study|Laboratory Abnormality|1|||
129955741|NCT00141271|467799384|FG002|Overall Study|Laboratory Abnormality|1|||
129955742|NCT00141271|467799382|FG000|Overall Study|Lack of Efficacy|7|||
129955743|NCT00141271|467799383|FG001|Overall Study|Lack of Efficacy|7|||
129955744|NCT00141271|467799384|FG002|Overall Study|Lack of Efficacy|3|||
129955745|NCT00141271|467799382|FG000|Overall Study|Lost to Follow-up|15|||
129955746|NCT00141271|467799383|FG001|Overall Study|Lost to Follow-up|15|||
129955747|NCT00141271|467799384|FG002|Overall Study|Lost to Follow-up|21|||
129955748|NCT00141271|467799382|FG000|Overall Study|Withdrawal by Subject|14|||
129955749|NCT00141271|467799383|FG001|Overall Study|Withdrawal by Subject|9|||
129955750|NCT00141271|467799384|FG002|Overall Study|Withdrawal by Subject|10|||
129955751|NCT00141271|467799382|FG000|Overall Study|Other|11|||
129955752|NCT00141271|467799383|FG001|Overall Study|Other|12|||
129955753|NCT00141271|467799384|FG002|Overall Study|Other|5|||
129955754|NCT02442622|467799387|FG000|Overall Study|Withdrawal by Subject|3|||
129955755|NCT02442622|467799388|FG001|Overall Study|Withdrawal by Subject|1|||
129955756|NCT02878590|467801245|FG000|Overall Study|Withdrawal by Subject|2|||
129955757|NCT03322514|467801246|FG000|Overall Study|Withdrawal by Subject|1|||
129955758|NCT03322514|467801247|FG001|Overall Study|Withdrawal by Subject|1|||
129955759|NCT01904019|467801251|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
130083979|NCT02421939|468260847|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
130083980|NCT02421939|468260846|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
130083981|NCT02421939|468260847|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
130083982|NCT02421939|468260846|FG000|Long Term Follow up: up to 3 Years|Death|118|||
130083983|NCT02421939|468260847|FG001|Long Term Follow up: up to 3 Years|Death|65|||
130083984|NCT02421939|468260846|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
130083985|NCT02421939|468260847|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
130083986|NCT00729560|468260848|FG000|Overall Study|Withdrawal by Subject|3|||
130083987|NCT03662789|468260849|FG000|Overall Study|Lost to Follow-up|1|||
130083988|NCT03662789|468260850|FG001|Overall Study|Lost to Follow-up|2|||
130083989|NCT03662789|468260849|FG000|Overall Study|Could not perform treadmill test|4|||
130083990|NCT03662789|468260850|FG001|Overall Study|Could not perform treadmill test|4|||
130083991|NCT03662789|468260849|FG000|Overall Study|Death|0|||
130083992|NCT03662789|468260850|FG001|Overall Study|Death|1|||
130083993|NCT02559115|468260851|FG000|Overall Study|Withdrawal by Subject|3|||
130083994|NCT02060903|468260854|FG000|Overall Study|Lost to Follow-up|4|||
130083995|NCT02060903|468260855|FG001|Overall Study|Lost to Follow-up|0|||
130083996|NCT02060903|468260854|FG000|Overall Study|Withdrawal by Subject|0|||
130083997|NCT02060903|468260855|FG001|Overall Study|Withdrawal by Subject|7|||
130083998|NCT00137267|468260856|FG000|Overall Study|Lost to Follow-up|15|||
130083999|NCT00137267|468260857|FG001|Overall Study|Lost to Follow-up|21|||
130084000|NCT00638989|468260858|FG000|Overall Study|Lost to Follow-up|0|||
130084001|NCT00638989|468260859|FG001|Overall Study|Lost to Follow-up|0|||
130084002|NCT00638989|468260860|FG002|Overall Study|Lost to Follow-up|1|||
130084003|NCT01553591|468260866|FG000|Overall Study|Voluntarily withdrew|94|||
130084004|NCT01553591|468260867|FG001|Overall Study|Voluntarily withdrew|79|||
130084005|NCT01553591|468260868|FG002|Overall Study|Voluntarily withdrew|96|||
130084006|NCT01553591|468260866|FG000|Overall Study|Adverse Event|36|||
130084007|NCT01553591|468260867|FG001|Overall Study|Adverse Event|45|||
130121002|NCT00788957|468404877|FG005|Part 2|On-study at time of data cut-off|0|||
130121003|NCT00788957|468404872|FG000|Part 3|Withdrawal by Subject|0|||
129955760|NCT01904019|467801251|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
129955761|NCT01904019|467801251|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
129955762|NCT01904019|467801251|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
129955763|NCT01904019|467801251|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
130084008|NCT01553591|468260868|FG002|Overall Study|Adverse Event|16|||
130121004|NCT00788957|468404873|FG001|Part 3|Withdrawal by Subject|0|||
129955764|NCT01904019|467801251|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
129955765|NCT02388932|467801256|FG000|Overall Study|Death|1|||
129955766|NCT01503515|467801257|FG000|Overall Study|Adverse Event|4|||
129955767|NCT01503515|467801258|FG001|Overall Study|Adverse Event|5|||
129955768|NCT01503515|467801257|FG000|Overall Study|Death|0|||
129955769|NCT01503515|467801258|FG001|Overall Study|Death|1|||
129955770|NCT01503515|467801257|FG000|Overall Study|Physician Decision|14|||
129955771|NCT01503515|467801258|FG001|Overall Study|Physician Decision|23|||
129955772|NCT01503515|467801257|FG000|Overall Study|Withdrawal by Subject|0|||
129955773|NCT01503515|467801258|FG001|Overall Study|Withdrawal by Subject|1|||
130121005|NCT00788957|468404874|FG002|Part 3|Withdrawal by Subject|0|||
129955774|NCT01503515|467801257|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
129955775|NCT01503515|467801258|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
129955776|NCT01503515|467801257|FG000|Overall Study|Ineligible|1|||
129955777|NCT01503515|467801258|FG001|Overall Study|Ineligible|1|||
129955778|NCT02123797|467801262|FG000|Baseline Intervention|Death|9|||
129955779|NCT02123797|467801263|FG001|Baseline Intervention|Death|16|||
129955780|NCT02123797|467801264|FG002|Baseline Intervention|Death|0|||
129955781|NCT02123797|467801265|FG003|Baseline Intervention|Death|0|||
129955782|NCT02123797|467801266|FG004|Baseline Intervention|Death|0|||
129955783|NCT02123797|467801262|FG000|Baseline Intervention|Withdrawal by Subject|2|||
129955784|NCT02123797|467801263|FG001|Baseline Intervention|Withdrawal by Subject|8|||
129955785|NCT02123797|467801264|FG002|Baseline Intervention|Withdrawal by Subject|0|||
129955786|NCT02123797|467801265|FG003|Baseline Intervention|Withdrawal by Subject|0|||
129955787|NCT02123797|467801266|FG004|Baseline Intervention|Withdrawal by Subject|0|||
129955788|NCT02123797|467801262|FG000|Baseline Intervention|Relocation|2|||
129955789|NCT02123797|467801263|FG001|Baseline Intervention|Relocation|0|||
129955790|NCT02123797|467801264|FG002|Baseline Intervention|Relocation|0|||
129955791|NCT02123797|467801265|FG003|Baseline Intervention|Relocation|0|||
129955792|NCT02123797|467801266|FG004|Baseline Intervention|Relocation|0|||
129955793|NCT02123797|467801262|FG000|Baseline Intervention|Out of window for initial survey|6|||
129955794|NCT02123797|467801263|FG001|Baseline Intervention|Out of window for initial survey|13|||
129955795|NCT02123797|467801264|FG002|Baseline Intervention|Out of window for initial survey|0|||
129955796|NCT02123797|467801265|FG003|Baseline Intervention|Out of window for initial survey|0|||
129955797|NCT02123797|467801266|FG004|Baseline Intervention|Out of window for initial survey|0|||
129955798|NCT02123797|467801262|FG000|Baseline Intervention|Lost to Follow-up|0|||
129955799|NCT02123797|467801263|FG001|Baseline Intervention|Lost to Follow-up|5|||
129955800|NCT02123797|467801264|FG002|Baseline Intervention|Lost to Follow-up|0|||
130121006|NCT00788957|468404875|FG003|Part 3|Withdrawal by Subject|0|||
130121007|NCT00788957|468404876|FG004|Part 3|Withdrawal by Subject|0|||
130121008|NCT00788957|468404877|FG005|Part 3|Withdrawal by Subject|2|||
130121009|NCT00788957|468404872|FG000|Part 3|Death|0|||
130121010|NCT00788957|468404873|FG001|Part 3|Death|0|||
130121011|NCT00788957|468404874|FG002|Part 3|Death|0|||
130121012|NCT00788957|468404875|FG003|Part 3|Death|0|||
130121013|NCT00788957|468404876|FG004|Part 3|Death|8|||
130121014|NCT00788957|468404877|FG005|Part 3|Death|8|||
129955801|NCT02123797|467801265|FG003|Baseline Intervention|Lost to Follow-up|0|||
129955802|NCT02123797|467801266|FG004|Baseline Intervention|Lost to Follow-up|0|||
129955803|NCT02123797|467801262|FG000|Baseline Intervention|Other Disease|3|||
129955804|NCT02123797|467801263|FG001|Baseline Intervention|Other Disease|0|||
129955805|NCT02123797|467801264|FG002|Baseline Intervention|Other Disease|0|||
129955806|NCT02123797|467801265|FG003|Baseline Intervention|Other Disease|0|||
129955807|NCT02123797|467801266|FG004|Baseline Intervention|Other Disease|0|||
129955808|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
129955809|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
129955810|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
129955811|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
129955812|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
130084009|NCT01553591|468260866|FG000|Overall Study|Lost to Follow-up|25|||
130084010|NCT01553591|468260867|FG001|Overall Study|Lost to Follow-up|23|||
130084011|NCT01553591|468260868|FG002|Overall Study|Lost to Follow-up|16|||
130084012|NCT01553591|468260866|FG000|Overall Study|Physician decision: other|11|||
130084013|NCT01553591|468260867|FG001|Overall Study|Physician decision: other|14|||
130084014|NCT01553591|468260868|FG002|Overall Study|Physician decision: other|16|||
130084015|NCT01553591|468260866|FG000|Overall Study|Physician decision: lack of efficacy|2|||
130121015|NCT00788957|468404872|FG000|Part 3|On-study at time of data cut-off|0|||
130084016|NCT01553591|468260867|FG001|Overall Study|Physician decision: lack of efficacy|3|||
130121016|NCT00788957|468404873|FG001|Part 3|On-study at time of data cut-off|0|||
130121017|NCT00788957|468404874|FG002|Part 3|On-study at time of data cut-off|0|||
129955813|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
129955814|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
129955815|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
129955816|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
129955817|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
129955818|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
130121018|NCT00788957|468404875|FG003|Part 3|On-study at time of data cut-off|0|||
130121019|NCT00788957|468404876|FG004|Part 3|On-study at time of data cut-off|1|||
130121020|NCT00788957|468404877|FG005|Part 3|On-study at time of data cut-off|0|||
129955819|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
129955820|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955821|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955822|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955823|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955824|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
129955825|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955826|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955827|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955828|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
129955829|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
129955830|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
129955831|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
129955832|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
129955833|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
129955834|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
129955835|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
129955836|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
129955837|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
129955838|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
129955839|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
129955840|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
129955841|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
129955842|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
129955843|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
129955844|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
129955845|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955846|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955847|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955848|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955849|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
129955850|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955851|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955852|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955853|NCT00443755|467801267|FG000|Overall Study|Withdrawal by Subject|2|||
129955854|NCT00443755|467801268|FG001|Overall Study|Withdrawal by Subject|1|||
129955855|NCT02339506|467801278|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
129955856|NCT02339506|467801279|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
129955857|NCT02339506|467801278|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
129955858|NCT02339506|467801279|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
129955859|NCT03997409|467801280|FG000|Overall Study|Protocol Violation|1|||
129955860|NCT03997409|467801281|FG001|Overall Study|Protocol Violation|1|||
129955861|NCT03997409|467801282|FG002|Overall Study|Protocol Violation|0|||
129955862|NCT03997409|467801280|FG000|Overall Study|Withdrawal by Subject|3|||
129955863|NCT03997409|467801281|FG001|Overall Study|Withdrawal by Subject|0|||
129955864|NCT03997409|467801282|FG002|Overall Study|Withdrawal by Subject|0|||
129955865|NCT03997409|467801280|FG000|Overall Study|Lost to Follow-up|0|||
129955866|NCT03997409|467801281|FG001|Overall Study|Lost to Follow-up|0|||
129955867|NCT03997409|467801282|FG002|Overall Study|Lost to Follow-up|1|||
129955868|NCT01753323|467801283|FG000|Overall Study|Lack of Efficacy|0|||
129955869|NCT01753323|467801284|FG001|Overall Study|Lack of Efficacy|0|||
129955870|NCT01753323|467801285|FG002|Overall Study|Lack of Efficacy|8|||
129955871|NCT01753323|467801283|FG000|Overall Study|Protocol deviation|1|||
129955872|NCT01753323|467801284|FG001|Overall Study|Protocol deviation|0|||
129955873|NCT01753323|467801285|FG002|Overall Study|Protocol deviation|0|||
129955874|NCT01753323|467801283|FG000|Overall Study|Adverse Event|0|||
129955875|NCT01753323|467801284|FG001|Overall Study|Adverse Event|0|||
129955876|NCT01753323|467801285|FG002|Overall Study|Adverse Event|1|||
129955877|NCT01116440|467801287|FG000|Treatment|Withdrawal by Subject|2|||
129955878|NCT01116440|467801288|FG001|Treatment|Withdrawal by Subject|2|||
129955879|NCT01116440|467801287|FG000|Treatment|Lost to Follow-up|1|||
129955880|NCT01116440|467801288|FG001|Treatment|Lost to Follow-up|1|||
129955881|NCT01116440|467801287|FG000|Treatment|Protocol Violation|0|||
129955882|NCT01116440|467801288|FG001|Treatment|Protocol Violation|2|||
129955883|NCT01116440|467801287|FG000|Treatment|Lack of Efficacy|0|||
129955884|NCT01116440|467801288|FG001|Treatment|Lack of Efficacy|1|||
129955885|NCT01116440|467801287|FG000|Treatment|Adverse Event|0|||
129955886|NCT01116440|467801288|FG001|Treatment|Adverse Event|1|||
129955887|NCT01116440|467801287|FG000|Withdrawal|Withdrawal by Subject|0|||
129955888|NCT01116440|467801288|FG001|Withdrawal|Withdrawal by Subject|1|||
129955889|NCT01116440|467801287|FG000|Withdrawal|Lost to Follow-up|0|||
129955890|NCT01116440|467801288|FG001|Withdrawal|Lost to Follow-up|1|||
129955891|NCT01116440|467801287|FG000|Follow-up|Lost to Follow-up|0|||
129955892|NCT01116440|467801288|FG001|Follow-up|Lost to Follow-up|1|||
129955893|NCT01116440|467801287|FG000|Follow-up|Withdrawal by Subject|0|||
129955894|NCT01116440|467801288|FG001|Follow-up|Withdrawal by Subject|1|||
129955895|NCT01636258|467801291|FG000|Overall Study|Lost to Follow-up|1|||
129955896|NCT01636258|467801292|FG001|Overall Study|Lost to Follow-up|0|||
129955897|NCT00116584|467801305|FG000|Overall Study|Withdrawal by Subject|1|||
129955898|NCT00116584|467801306|FG001|Overall Study|Withdrawal by Subject|0|||
129955899|NCT00116584|467801305|FG000|Overall Study|Protocol Violation|1|||
129955900|NCT00116584|467801306|FG001|Overall Study|Protocol Violation|1|||
129955901|NCT01498445|467801309|FG000|Overall Study|Lack of Efficacy|0|||
129955902|NCT01498445|467801310|FG001|Overall Study|Lack of Efficacy|0|||
129955903|NCT01498445|467801311|FG002|Overall Study|Lack of Efficacy|1|||
129955904|NCT01498445|467801312|FG003|Overall Study|Lack of Efficacy|2|||
129955905|NCT01498445|467801313|FG004|Overall Study|Lack of Efficacy|0|||
129955906|NCT01498445|467801314|FG005|Overall Study|Lack of Efficacy|0|||
129955907|NCT01498445|467801309|FG000|Overall Study|Screen Failure|0|||
129955908|NCT01498445|467801310|FG001|Overall Study|Screen Failure|0|||
129955909|NCT01498445|467801311|FG002|Overall Study|Screen Failure|0|||
129955910|NCT01498445|467801312|FG003|Overall Study|Screen Failure|0|||
129955911|NCT01498445|467801313|FG004|Overall Study|Screen Failure|1|||
129955912|NCT01498445|467801314|FG005|Overall Study|Screen Failure|1|||
129955913|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
129955914|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
129955915|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
129955916|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
129955917|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
129955918|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
129955919|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Other|3|||
129955920|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Other|0|||
129955921|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Other|0|||
129955922|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
129955923|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
129955924|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
129955925|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
129955926|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
129955927|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
129955928|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
129955929|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
129955930|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
129955931|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Other|0|||
129955932|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Other|1|||
129955933|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Other|0|||
129955934|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
129955935|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
129955936|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
129955937|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
129955938|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
129955939|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
129955940|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
129955941|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
129955942|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
129955943|NCT00561678|467801318|FG000|Overall Study|Withdrawal by Subject|4|||
129955944|NCT00561678|467801319|FG001|Overall Study|Withdrawal by Subject|3|||
129955945|NCT00561678|467801318|FG000|Overall Study|surgery cancelled|1|||
129955946|NCT00561678|467801319|FG001|Overall Study|surgery cancelled|1|||
129955947|NCT00561678|467801318|FG000|Overall Study|surgery rescheduled to different site|2|||
129955948|NCT00561678|467801319|FG001|Overall Study|surgery rescheduled to different site|2|||
129955949|NCT00561678|467801318|FG000|Overall Study|anesthesia provider refusal|1|||
129955950|NCT00561678|467801319|FG001|Overall Study|anesthesia provider refusal|0|||
129955951|NCT04748445|467801320|FG000|Overall Study|No longer met eligibility criteria|12|||
129955952|NCT04748445|467801320|FG000|Overall Study|Other|36|||
129955953|NCT04748445|467801320|FG000|Overall Study|Withdrawal by Subject|553|||
129955954|NCT04748445|467801320|FG000|Overall Study|Lost to Follow-up|30|||
129955955|NCT01106586|467801321|FG000|Overall Study|Adverse Event|9|||
129955956|NCT01106586|467801322|FG001|Overall Study|Adverse Event|15|||
129955957|NCT01106586|467801321|FG000|Overall Study|Death|1|||
129955958|NCT01106586|467801322|FG001|Overall Study|Death|3|||
129955959|NCT01106586|467801321|FG000|Overall Study|Pregnancy|2|||
129955960|NCT01106586|467801322|FG001|Overall Study|Pregnancy|2|||
129955961|NCT01106586|467801321|FG000|Overall Study|Lack of Efficacy|1|||
129955962|NCT01106586|467801322|FG001|Overall Study|Lack of Efficacy|0|||
129955963|NCT01106586|467801321|FG000|Overall Study|Investigator's Discretion|5|||
129955964|NCT01106586|467801322|FG001|Overall Study|Investigator's Discretion|8|||
129955965|NCT01106586|467801321|FG000|Overall Study|Withdrew Consent|18|||
129955966|NCT01106586|467801322|FG001|Overall Study|Withdrew Consent|30|||
129955967|NCT01106586|467801321|FG000|Overall Study|Lost to Follow-up|24|||
129955968|NCT01106586|467801322|FG001|Overall Study|Lost to Follow-up|20|||
129955969|NCT01106586|467801321|FG000|Overall Study|Participant Noncompliance|12|||
129955970|NCT01106586|467801322|FG001|Overall Study|Participant Noncompliance|10|||
129955971|NCT01106586|467801321|FG000|Overall Study|Protocol Violation|1|||
129955972|NCT01106586|467801322|FG001|Overall Study|Protocol Violation|0|||
129955973|NCT01106586|467801321|FG000|Overall Study|Participant Transferred to Another Study|212|||
129955974|NCT01106586|467801322|FG001|Overall Study|Participant Transferred to Another Study|197|||
129955975|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Adverse Event|3|||
129955976|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Adverse Event|0|||
129955977|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
129955978|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
129955979|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Disease Progression|23|||
129955980|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Disease Progression|22|||
129955981|NCT01379521|467801323|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
129955982|NCT01379521|467801324|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
129955983|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
129955984|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
129955985|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
129955986|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
129955987|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
129955988|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
129955989|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Death|2|||
129955990|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Death|1|||
129955991|NCT01379521|467801323|FG000|Post-Treatment Evaluations|Disease Progression|22|||
129955992|NCT01379521|467801324|FG001|Post-Treatment Evaluations|Disease Progression|20|||
129955993|NCT01379521|467801323|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
129955994|NCT01379521|467801324|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
129955995|NCT01379521|467801323|FG000|Post-Treatment Evaluations|Death|1|||
129955996|NCT01379521|467801324|FG001|Post-Treatment Evaluations|Death|0|||
129955997|NCT00938041|467801325|FG000|Overall Study|Lost to Follow-up|6|||
129955998|NCT00938041|467801325|FG000|Overall Study|Received Alternative Therapy|1|||
129955999|NCT00938041|467801325|FG000|Overall Study|Progressive Disease|5|||
129956000|NCT00938041|467801325|FG000|Overall Study|Death|12|||
129956001|NCT00938041|467801325|FG000|Overall Study|Adrenal Insufficiency|3|||
129956002|NCT01026103|467801326|FG000|Overall Study|Physician Decision|1|||
129956003|NCT01026103|467801326|FG000|Overall Study|did not receive study device bc of error|1|||
129956004|NCT00428441|467801327|FG000|Overall Study|Lost to Follow-up|1|||
129956005|NCT02475733|467801328|FG000|Overall Study|Withdrawal by Subject|1|||
129956006|NCT02475733|467801329|FG001|Overall Study|Withdrawal by Subject|0|||
129956007|NCT02475733|467801328|FG000|Overall Study|Physician Decision|1|||
129956008|NCT02475733|467801329|FG001|Overall Study|Physician Decision|0|||
129956009|NCT00404547|467801332|FG000|Overall Study|Adverse Event|39|||
129956010|NCT00404547|467801333|FG001|Overall Study|Adverse Event|6|||
129956011|NCT00404547|467801332|FG000|Overall Study|Withdrawal by Subject|19|||
129956012|NCT00404547|467801333|FG001|Overall Study|Withdrawal by Subject|2|||
129956013|NCT00404547|467801332|FG000|Overall Study|Protocol Violation|0|||
129956014|NCT00404547|467801333|FG001|Overall Study|Protocol Violation|1|||
129956015|NCT00404547|467801332|FG000|Overall Study|Lost to Follow-up|20|||
129956016|NCT00404547|467801333|FG001|Overall Study|Lost to Follow-up|9|||
129956017|NCT00404547|467801332|FG000|Overall Study|Lack of compliance|5|||
129956018|NCT00404547|467801333|FG001|Overall Study|Lack of compliance|1|||
129956019|NCT00404547|467801332|FG000|Overall Study|Other|4|||
129956020|NCT00404547|467801333|FG001|Overall Study|Other|0|||
129956021|NCT00404547|467801332|FG000|Overall Study|Reason not stated|3|||
129956022|NCT00404547|467801333|FG001|Overall Study|Reason not stated|6|||
129956023|NCT03906240|467801334|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
129956024|NCT03906240|467801335|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
129956025|NCT03906240|467801334|FG000|Overall Study|Lost to Follow-up|1|||
129956026|NCT03906240|467801335|FG001|Overall Study|Lost to Follow-up|0|||
129956027|NCT03906240|467801334|FG000|Overall Study|Withdrawal by Subject|0|||
129956028|NCT03906240|467801335|FG001|Overall Study|Withdrawal by Subject|1|||
129956029|NCT00296504|467801340|FG000|Interim Analysis|Withdrawal by Subject|8|||
129956030|NCT00296504|467801341|FG001|Interim Analysis|Withdrawal by Subject|0|||
129956031|NCT00296504|467801342|FG002|Interim Analysis|Withdrawal by Subject|12|||
129956032|NCT00296504|467801343|FG003|Interim Analysis|Withdrawal by Subject|0|||
129956033|NCT00296504|467801344|FG004|Interim Analysis|Withdrawal by Subject|5|||
129956034|NCT00296504|467801345|FG005|Interim Analysis|Withdrawal by Subject|5|||
129956035|NCT00296504|467801346|FG006|Interim Analysis|Withdrawal by Subject|9|||
129956036|NCT00296504|467801347|FG007|Interim Analysis|Withdrawal by Subject|3|||
129956037|NCT00296504|467801348|FG008|Interim Analysis|Withdrawal by Subject|0|||
129956038|NCT00296504|467801340|FG000|Interim Analysis|Lost to Follow-up|13|||
129956039|NCT00296504|467801341|FG001|Interim Analysis|Lost to Follow-up|3|||
129956040|NCT00296504|467801342|FG002|Interim Analysis|Lost to Follow-up|26|||
129956041|NCT00296504|467801343|FG003|Interim Analysis|Lost to Follow-up|8|||
129956042|NCT00296504|467801344|FG004|Interim Analysis|Lost to Follow-up|14|||
129956043|NCT00296504|467801345|FG005|Interim Analysis|Lost to Follow-up|4|||
129956044|NCT00296504|467801346|FG006|Interim Analysis|Lost to Follow-up|11|||
129956045|NCT00296504|467801347|FG007|Interim Analysis|Lost to Follow-up|4|||
130084017|NCT01553591|468260868|FG002|Overall Study|Physician decision: lack of efficacy|7|||
130084018|NCT01553591|468260866|FG000|Overall Study|Protocol Violation|3|||
130084019|NCT01553591|468260867|FG001|Overall Study|Protocol Violation|4|||
130084020|NCT01553591|468260868|FG002|Overall Study|Protocol Violation|4|||
130084021|NCT01553591|468260866|FG000|Overall Study|Sponsor decision|1|||
130084022|NCT01553591|468260867|FG001|Overall Study|Sponsor decision|0|||
130084023|NCT01553591|468260868|FG002|Overall Study|Sponsor decision|3|||
130084024|NCT01553591|468260866|FG000|Overall Study|Randomized and never dispensed drug|0|||
130084025|NCT01553591|468260867|FG001|Overall Study|Randomized and never dispensed drug|1|||
130084026|NCT01553591|468260868|FG002|Overall Study|Randomized and never dispensed drug|0|||
130084027|NCT02871791|468260869|FG000|Phase 1b|Death|0|||
130084028|NCT02871791|468260870|FG001|Phase 1b|Death|1|||
130084029|NCT02871791|468260869|FG000|Phase 1b|progressive disease|6|||
130084030|NCT02871791|468260870|FG001|Phase 1b|progressive disease|2|||
130084031|NCT02871791|468260869|FG000|Phase 2|Death|1|||
130084032|NCT02871791|468260870|FG001|Phase 2|Death|0|||
130084033|NCT02871791|468260869|FG000|Phase 2|Lost to Follow-up|2|||
130084034|NCT02871791|468260870|FG001|Phase 2|Lost to Follow-up|0|||
130084035|NCT04005755|468260871|FG000|Overall Study|Adverse Event|6|||
130121021|NCT03276975|468404878|FG000|Overall Study|Withdrawal by Subject|1|||
130121022|NCT03276975|468404879|FG001|Overall Study|Withdrawal by Subject|0|||
129956046|NCT00296504|467801348|FG008|Interim Analysis|Lost to Follow-up|0|||
129956047|NCT00296504|467801340|FG000|Interim Analysis|Clinical Progression|1|||
129956048|NCT00296504|467801341|FG001|Interim Analysis|Clinical Progression|0|||
129956049|NCT00296504|467801342|FG002|Interim Analysis|Clinical Progression|1|||
129956050|NCT00296504|467801343|FG003|Interim Analysis|Clinical Progression|1|||
129956051|NCT00296504|467801344|FG004|Interim Analysis|Clinical Progression|0|||
129956052|NCT00296504|467801345|FG005|Interim Analysis|Clinical Progression|2|||
129956053|NCT00296504|467801346|FG006|Interim Analysis|Clinical Progression|1|||
129956054|NCT00296504|467801347|FG007|Interim Analysis|Clinical Progression|2|||
129956055|NCT00296504|467801348|FG008|Interim Analysis|Clinical Progression|0|||
129956056|NCT00296504|467801340|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
129956057|NCT00296504|467801341|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
129956058|NCT00296504|467801342|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
129956059|NCT00296504|467801343|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
129956060|NCT00296504|467801344|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
129956061|NCT00296504|467801345|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
129956062|NCT00296504|467801346|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
129956063|NCT00296504|467801347|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
129956064|NCT00296504|467801348|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
129956065|NCT00296504|467801340|FG000|Interim Analysis|Adverse Event|0|||
129956066|NCT00296504|467801341|FG001|Interim Analysis|Adverse Event|0|||
129956067|NCT00296504|467801342|FG002|Interim Analysis|Adverse Event|13|||
129956068|NCT00296504|467801343|FG003|Interim Analysis|Adverse Event|4|||
129956069|NCT00296504|467801344|FG004|Interim Analysis|Adverse Event|6|||
129956070|NCT00296504|467801345|FG005|Interim Analysis|Adverse Event|3|||
129956071|NCT00296504|467801346|FG006|Interim Analysis|Adverse Event|4|||
129956072|NCT00296504|467801347|FG007|Interim Analysis|Adverse Event|5|||
129956073|NCT00296504|467801348|FG008|Interim Analysis|Adverse Event|0|||
129956074|NCT00296504|467801340|FG000|Interim Analysis|Protocol Violation|0|||
129956075|NCT00296504|467801341|FG001|Interim Analysis|Protocol Violation|0|||
130084036|NCT04005755|468260871|FG000|Overall Study|Physician Decision|3|||
130084037|NCT04005755|468260871|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
130084038|NCT04005755|468260871|FG000|Overall Study|Withdrawal by Subject|3|||
130084039|NCT04005755|468260871|FG000|Overall Study|Lost to Follow-up|1|||
130084040|NCT00611767|468260872|FG000|Overall Study|Withdrawal by Subject|4|||
130084041|NCT00611767|468260873|FG001|Overall Study|Withdrawal by Subject|1|||
130084042|NCT00611767|468260872|FG000|Overall Study|Thiopental not available|3|||
130084043|NCT00611767|468260873|FG001|Overall Study|Thiopental not available|0|||
129956076|NCT00296504|467801342|FG002|Interim Analysis|Protocol Violation|2|||
129956077|NCT00296504|467801343|FG003|Interim Analysis|Protocol Violation|0|||
129956078|NCT00296504|467801344|FG004|Interim Analysis|Protocol Violation|1|||
129956079|NCT00296504|467801345|FG005|Interim Analysis|Protocol Violation|0|||
129956080|NCT00296504|467801346|FG006|Interim Analysis|Protocol Violation|0|||
129956081|NCT00296504|467801347|FG007|Interim Analysis|Protocol Violation|1|||
129956082|NCT00296504|467801348|FG008|Interim Analysis|Protocol Violation|0|||
129956083|NCT00296504|467801340|FG000|Interim Analysis|Insufficient CD4 Response|0|||
130084044|NCT00611767|468260872|FG000|Overall Study|didn't like the medication|1|||
129956084|NCT00296504|467801341|FG001|Interim Analysis|Insufficient CD4 Response|0|||
129956085|NCT00296504|467801342|FG002|Interim Analysis|Insufficient CD4 Response|0|||
129956086|NCT00296504|467801343|FG003|Interim Analysis|Insufficient CD4 Response|0|||
129956087|NCT00296504|467801344|FG004|Interim Analysis|Insufficient CD4 Response|1|||
129956088|NCT00296504|467801345|FG005|Interim Analysis|Insufficient CD4 Response|1|||
129956089|NCT00296504|467801346|FG006|Interim Analysis|Insufficient CD4 Response|0|||
129956090|NCT00296504|467801347|FG007|Interim Analysis|Insufficient CD4 Response|0|||
129956091|NCT00296504|467801348|FG008|Interim Analysis|Insufficient CD4 Response|0|||
129956092|NCT00296504|467801340|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
129956093|NCT00296504|467801341|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
129956094|NCT00296504|467801342|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
129956095|NCT00296504|467801343|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
129956096|NCT00296504|467801344|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
129956097|NCT00296504|467801345|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
129956098|NCT00296504|467801346|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
129956099|NCT00296504|467801347|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
129956100|NCT00296504|467801348|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
129956101|NCT00296504|467801340|FG000|Interim Analysis|Pregnancy|4|||
129956102|NCT00296504|467801341|FG001|Interim Analysis|Pregnancy|1|||
129956103|NCT00296504|467801342|FG002|Interim Analysis|Pregnancy|4|||
129956104|NCT00296504|467801343|FG003|Interim Analysis|Pregnancy|2|||
129956105|NCT00296504|467801344|FG004|Interim Analysis|Pregnancy|0|||
129956106|NCT00296504|467801345|FG005|Interim Analysis|Pregnancy|1|||
129956107|NCT00296504|467801346|FG006|Interim Analysis|Pregnancy|1|||
129956108|NCT00296504|467801347|FG007|Interim Analysis|Pregnancy|1|||
129956109|NCT00296504|467801348|FG008|Interim Analysis|Pregnancy|0|||
129956110|NCT00296504|467801340|FG000|Interim Analysis|Death|1|||
129956111|NCT00296504|467801341|FG001|Interim Analysis|Death|0|||
129956112|NCT00296504|467801342|FG002|Interim Analysis|Death|3|||
129956113|NCT00296504|467801343|FG003|Interim Analysis|Death|0|||
129956114|NCT00296504|467801344|FG004|Interim Analysis|Death|0|||
129956115|NCT00296504|467801345|FG005|Interim Analysis|Death|0|||
129956116|NCT00296504|467801346|FG006|Interim Analysis|Death|0|||
129956117|NCT00296504|467801347|FG007|Interim Analysis|Death|0|||
129956118|NCT00296504|467801348|FG008|Interim Analysis|Death|0|||
129956119|NCT00296504|467801340|FG000|Interim Analysis|Participant Non-compliant|0|||
129956120|NCT00296504|467801341|FG001|Interim Analysis|Participant Non-compliant|1|||
129956121|NCT00296504|467801342|FG002|Interim Analysis|Participant Non-compliant|2|||
129956122|NCT00296504|467801343|FG003|Interim Analysis|Participant Non-compliant|1|||
129956123|NCT00296504|467801344|FG004|Interim Analysis|Participant Non-compliant|1|||
129956124|NCT00296504|467801345|FG005|Interim Analysis|Participant Non-compliant|3|||
129956125|NCT00296504|467801346|FG006|Interim Analysis|Participant Non-compliant|6|||
129956126|NCT00296504|467801347|FG007|Interim Analysis|Participant Non-compliant|2|||
129956127|NCT00296504|467801348|FG008|Interim Analysis|Participant Non-compliant|0|||
129956128|NCT00296504|467801340|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956129|NCT00296504|467801341|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956130|NCT00296504|467801342|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
129956131|NCT00296504|467801343|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956132|NCT00296504|467801344|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956133|NCT00296504|467801345|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
129956134|NCT00296504|467801346|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956135|NCT00296504|467801347|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956136|NCT00296504|467801348|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956137|NCT00296504|467801340|FG000|Interim Analysis|To Simplify Treatment|0|||
129956138|NCT00296504|467801341|FG001|Interim Analysis|To Simplify Treatment|0|||
129956139|NCT00296504|467801342|FG002|Interim Analysis|To Simplify Treatment|1|||
129956140|NCT00296504|467801343|FG003|Interim Analysis|To Simplify Treatment|0|||
129956141|NCT00296504|467801344|FG004|Interim Analysis|To Simplify Treatment|0|||
129956142|NCT00296504|467801345|FG005|Interim Analysis|To Simplify Treatment|0|||
129956143|NCT00296504|467801346|FG006|Interim Analysis|To Simplify Treatment|2|||
129956144|NCT00296504|467801347|FG007|Interim Analysis|To Simplify Treatment|0|||
129956145|NCT00296504|467801348|FG008|Interim Analysis|To Simplify Treatment|0|||
129956146|NCT00296504|467801340|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956147|NCT00296504|467801341|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956148|NCT00296504|467801342|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
129956149|NCT00296504|467801343|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956150|NCT00296504|467801344|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956151|NCT00296504|467801345|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956152|NCT00296504|467801346|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956153|NCT00296504|467801347|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956154|NCT00296504|467801348|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956155|NCT00296504|467801340|FG000|Interim Analysis|Participant Moved|1|||
129956156|NCT00296504|467801341|FG001|Interim Analysis|Participant Moved|0|||
129956157|NCT00296504|467801342|FG002|Interim Analysis|Participant Moved|1|||
129956158|NCT00296504|467801343|FG003|Interim Analysis|Participant Moved|0|||
129956159|NCT00296504|467801344|FG004|Interim Analysis|Participant Moved|0|||
129956160|NCT00296504|467801345|FG005|Interim Analysis|Participant Moved|1|||
129956161|NCT00296504|467801346|FG006|Interim Analysis|Participant Moved|1|||
129956162|NCT00296504|467801347|FG007|Interim Analysis|Participant Moved|0|||
129956163|NCT00296504|467801348|FG008|Interim Analysis|Participant Moved|0|||
129956164|NCT00296504|467801340|FG000|Interim Analysis|Participant Was Incarcerated|2|||
129956165|NCT00296504|467801341|FG001|Interim Analysis|Participant Was Incarcerated|0|||
129956166|NCT00296504|467801342|FG002|Interim Analysis|Participant Was Incarcerated|1|||
129956167|NCT00296504|467801343|FG003|Interim Analysis|Participant Was Incarcerated|0|||
129956168|NCT00296504|467801344|FG004|Interim Analysis|Participant Was Incarcerated|0|||
129956169|NCT00296504|467801345|FG005|Interim Analysis|Participant Was Incarcerated|0|||
129956170|NCT00296504|467801346|FG006|Interim Analysis|Participant Was Incarcerated|0|||
129956171|NCT00296504|467801347|FG007|Interim Analysis|Participant Was Incarcerated|0|||
129956172|NCT00296504|467801348|FG008|Interim Analysis|Participant Was Incarcerated|0|||
129956173|NCT00296504|467801340|FG000|Interim Analysis|Resistance to FPV|0|||
129956174|NCT00296504|467801341|FG001|Interim Analysis|Resistance to FPV|0|||
129956175|NCT00296504|467801342|FG002|Interim Analysis|Resistance to FPV|1|||
129956176|NCT00296504|467801343|FG003|Interim Analysis|Resistance to FPV|0|||
129956177|NCT00296504|467801344|FG004|Interim Analysis|Resistance to FPV|0|||
129956178|NCT00296504|467801345|FG005|Interim Analysis|Resistance to FPV|0|||
129956179|NCT00296504|467801346|FG006|Interim Analysis|Resistance to FPV|0|||
129956180|NCT00296504|467801347|FG007|Interim Analysis|Resistance to FPV|0|||
129956181|NCT00296504|467801348|FG008|Interim Analysis|Resistance to FPV|0|||
129956182|NCT00296504|467801340|FG000|Interim Analysis|Physician Decision|0|||
129956183|NCT00296504|467801341|FG001|Interim Analysis|Physician Decision|0|||
129956184|NCT00296504|467801342|FG002|Interim Analysis|Physician Decision|1|||
129956185|NCT00296504|467801343|FG003|Interim Analysis|Physician Decision|0|||
129956186|NCT00296504|467801344|FG004|Interim Analysis|Physician Decision|0|||
129956187|NCT00296504|467801345|FG005|Interim Analysis|Physician Decision|0|||
129956188|NCT00296504|467801346|FG006|Interim Analysis|Physician Decision|0|||
129956189|NCT00296504|467801347|FG007|Interim Analysis|Physician Decision|0|||
129956190|NCT00296504|467801348|FG008|Interim Analysis|Physician Decision|0|||
129956191|NCT00296504|467801340|FG000|Interim Analysis|Principle Investigator Discretion|2|||
129956192|NCT00296504|467801341|FG001|Interim Analysis|Principle Investigator Discretion|0|||
129956193|NCT00296504|467801342|FG002|Interim Analysis|Principle Investigator Discretion|1|||
129956194|NCT00296504|467801343|FG003|Interim Analysis|Principle Investigator Discretion|1|||
129956195|NCT00296504|467801344|FG004|Interim Analysis|Principle Investigator Discretion|0|||
129956196|NCT00296504|467801345|FG005|Interim Analysis|Principle Investigator Discretion|0|||
129956197|NCT00296504|467801346|FG006|Interim Analysis|Principle Investigator Discretion|0|||
129956198|NCT00296504|467801347|FG007|Interim Analysis|Principle Investigator Discretion|0|||
129956199|NCT00296504|467801348|FG008|Interim Analysis|Principle Investigator Discretion|0|||
129956200|NCT00296504|467801340|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
129956201|NCT00296504|467801341|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
129956202|NCT00296504|467801342|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
129956203|NCT00296504|467801343|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
129956204|NCT00296504|467801344|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
129956205|NCT00296504|467801345|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
129956206|NCT00296504|467801346|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
129956207|NCT00296504|467801347|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
129956208|NCT00296504|467801348|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
129956209|NCT00296504|467801340|FG000|Interim Analysis|Non-adherence|2|||
129956210|NCT00296504|467801341|FG001|Interim Analysis|Non-adherence|0|||
129956211|NCT00296504|467801342|FG002|Interim Analysis|Non-adherence|0|||
129956212|NCT00296504|467801343|FG003|Interim Analysis|Non-adherence|0|||
129956213|NCT00296504|467801344|FG004|Interim Analysis|Non-adherence|1|||
129956214|NCT00296504|467801345|FG005|Interim Analysis|Non-adherence|0|||
129956215|NCT00296504|467801346|FG006|Interim Analysis|Non-adherence|0|||
129956216|NCT00296504|467801347|FG007|Interim Analysis|Non-adherence|1|||
129956217|NCT00296504|467801348|FG008|Interim Analysis|Non-adherence|0|||
129956218|NCT00296504|467801340|FG000|Interim Analysis|Site Closing|1|||
129956219|NCT00296504|467801341|FG001|Interim Analysis|Site Closing|0|||
129956220|NCT00296504|467801342|FG002|Interim Analysis|Site Closing|0|||
129956221|NCT00296504|467801343|FG003|Interim Analysis|Site Closing|0|||
129956222|NCT00296504|467801344|FG004|Interim Analysis|Site Closing|0|||
129956223|NCT00296504|467801345|FG005|Interim Analysis|Site Closing|1|||
129956224|NCT00296504|467801346|FG006|Interim Analysis|Site Closing|2|||
129956225|NCT00296504|467801347|FG007|Interim Analysis|Site Closing|0|||
129956226|NCT00296504|467801348|FG008|Interim Analysis|Site Closing|0|||
129956227|NCT00296504|467801340|FG000|Interim Analysis|Lack of Personnel at Site|1|||
129956228|NCT00296504|467801341|FG001|Interim Analysis|Lack of Personnel at Site|0|||
129956229|NCT00296504|467801342|FG002|Interim Analysis|Lack of Personnel at Site|0|||
129956230|NCT00296504|467801343|FG003|Interim Analysis|Lack of Personnel at Site|0|||
129956231|NCT00296504|467801344|FG004|Interim Analysis|Lack of Personnel at Site|0|||
129956232|NCT00296504|467801345|FG005|Interim Analysis|Lack of Personnel at Site|0|||
129956233|NCT00296504|467801346|FG006|Interim Analysis|Lack of Personnel at Site|0|||
129956234|NCT00296504|467801347|FG007|Interim Analysis|Lack of Personnel at Site|0|||
129956235|NCT00296504|467801348|FG008|Interim Analysis|Lack of Personnel at Site|0|||
129956236|NCT00296504|467801340|FG000|Interim Analysis|Missed Schedule Date|1|||
129956237|NCT00296504|467801341|FG001|Interim Analysis|Missed Schedule Date|0|||
129956238|NCT00296504|467801342|FG002|Interim Analysis|Missed Schedule Date|0|||
129956239|NCT00296504|467801343|FG003|Interim Analysis|Missed Schedule Date|0|||
129956240|NCT00296504|467801344|FG004|Interim Analysis|Missed Schedule Date|0|||
129956241|NCT00296504|467801345|FG005|Interim Analysis|Missed Schedule Date|0|||
129956242|NCT00296504|467801346|FG006|Interim Analysis|Missed Schedule Date|0|||
129956243|NCT00296504|467801347|FG007|Interim Analysis|Missed Schedule Date|0|||
129956244|NCT00296504|467801348|FG008|Interim Analysis|Missed Schedule Date|0|||
129956245|NCT00296504|467801340|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
129956246|NCT00296504|467801341|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
129956247|NCT00296504|467801342|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
129956248|NCT00296504|467801343|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
129956249|NCT00296504|467801344|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
129956250|NCT00296504|467801345|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
129956251|NCT00296504|467801346|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
129956252|NCT00296504|467801347|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
129956253|NCT00296504|467801348|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
129956254|NCT00296504|467801340|FG000|Interim Analysis|Participant Stopped|0|||
129956255|NCT00296504|467801341|FG001|Interim Analysis|Participant Stopped|0|||
129956256|NCT00296504|467801342|FG002|Interim Analysis|Participant Stopped|0|||
129956257|NCT00296504|467801343|FG003|Interim Analysis|Participant Stopped|0|||
129956258|NCT00296504|467801344|FG004|Interim Analysis|Participant Stopped|1|||
129956259|NCT00296504|467801345|FG005|Interim Analysis|Participant Stopped|0|||
129956260|NCT00296504|467801346|FG006|Interim Analysis|Participant Stopped|0|||
129956261|NCT00296504|467801347|FG007|Interim Analysis|Participant Stopped|0|||
129956262|NCT00296504|467801348|FG008|Interim Analysis|Participant Stopped|0|||
129956263|NCT00296504|467801340|FG000|Interim Analysis|Physician and Participant Decision|0|||
129956264|NCT00296504|467801341|FG001|Interim Analysis|Physician and Participant Decision|0|||
129956265|NCT00296504|467801342|FG002|Interim Analysis|Physician and Participant Decision|0|||
129956266|NCT00296504|467801343|FG003|Interim Analysis|Physician and Participant Decision|0|||
129956267|NCT00296504|467801344|FG004|Interim Analysis|Physician and Participant Decision|0|||
129956268|NCT00296504|467801345|FG005|Interim Analysis|Physician and Participant Decision|1|||
129956269|NCT00296504|467801346|FG006|Interim Analysis|Physician and Participant Decision|0|||
129956270|NCT00296504|467801347|FG007|Interim Analysis|Physician and Participant Decision|0|||
129956271|NCT00296504|467801348|FG008|Interim Analysis|Physician and Participant Decision|0|||
129956272|NCT00296504|467801340|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
129956273|NCT00296504|467801341|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
129956274|NCT00296504|467801342|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
129956275|NCT00296504|467801343|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
129956276|NCT00296504|467801344|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
129956277|NCT00296504|467801345|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
129956278|NCT00296504|467801346|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
129956279|NCT00296504|467801347|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
129956280|NCT00296504|467801348|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
130084045|NCT00611767|468260873|FG001|Overall Study|didn't like the medication|1|||
130084046|NCT00611767|468260872|FG000|Overall Study|Physician Decision|1|||
129956281|NCT00296504|467801340|FG000|Interim Analysis|Study Ended|0|||
129956282|NCT00296504|467801341|FG001|Interim Analysis|Study Ended|0|||
129956283|NCT00296504|467801342|FG002|Interim Analysis|Study Ended|0|||
129956284|NCT00296504|467801343|FG003|Interim Analysis|Study Ended|0|||
129956285|NCT00296504|467801344|FG004|Interim Analysis|Study Ended|0|||
129956286|NCT00296504|467801345|FG005|Interim Analysis|Study Ended|0|||
129956287|NCT00296504|467801346|FG006|Interim Analysis|Study Ended|1|||
129956288|NCT00296504|467801347|FG007|Interim Analysis|Study Ended|0|||
129956289|NCT00296504|467801348|FG008|Interim Analysis|Study Ended|0|||
129956290|NCT00296504|467801340|FG000|Interim Analysis|Participant Needed Interferon|0|||
129956291|NCT00296504|467801341|FG001|Interim Analysis|Participant Needed Interferon|0|||
129956292|NCT00296504|467801342|FG002|Interim Analysis|Participant Needed Interferon|0|||
129956293|NCT00296504|467801343|FG003|Interim Analysis|Participant Needed Interferon|0|||
129956294|NCT00296504|467801344|FG004|Interim Analysis|Participant Needed Interferon|0|||
129956295|NCT00296504|467801345|FG005|Interim Analysis|Participant Needed Interferon|0|||
129956296|NCT00296504|467801346|FG006|Interim Analysis|Participant Needed Interferon|0|||
129956297|NCT00296504|467801347|FG007|Interim Analysis|Participant Needed Interferon|1|||
130084047|NCT00611767|468260873|FG001|Overall Study|Physician Decision|0|||
129956298|NCT00296504|467801348|FG008|Interim Analysis|Participant Needed Interferon|0|||
129956299|NCT00296504|467801340|FG000|Interim Analysis|Ongoing|32|||
129956300|NCT00296504|467801341|FG001|Interim Analysis|Ongoing|12|||
129956301|NCT00296504|467801342|FG002|Interim Analysis|Ongoing|16|||
129956302|NCT00296504|467801343|FG003|Interim Analysis|Ongoing|22|||
129956303|NCT00296504|467801344|FG004|Interim Analysis|Ongoing|0|||
129956304|NCT00296504|467801345|FG005|Interim Analysis|Ongoing|0|||
129956305|NCT00296504|467801346|FG006|Interim Analysis|Ongoing|30|||
129956306|NCT00296504|467801347|FG007|Interim Analysis|Ongoing|1|||
129956307|NCT00296504|467801348|FG008|Interim Analysis|Ongoing|0|||
129956308|NCT00296504|467801340|FG000|Final Analysis|Withdrawal by Subject|0|||
129956309|NCT00296504|467801341|FG001|Final Analysis|Withdrawal by Subject|0|||
129956310|NCT00296504|467801342|FG002|Final Analysis|Withdrawal by Subject|0|||
129956311|NCT00296504|467801343|FG003|Final Analysis|Withdrawal by Subject|0|||
129956312|NCT00296504|467801344|FG004|Final Analysis|Withdrawal by Subject|0|||
129956313|NCT00296504|467801345|FG005|Final Analysis|Withdrawal by Subject|0|||
129956314|NCT00296504|467801346|FG006|Final Analysis|Withdrawal by Subject|0|||
129956315|NCT00296504|467801347|FG007|Final Analysis|Withdrawal by Subject|0|||
129956316|NCT00296504|467801348|FG008|Final Analysis|Withdrawal by Subject|1|||
129956317|NCT00296504|467801340|FG000|Final Analysis|Lost to Follow-up|0|||
129956318|NCT00296504|467801341|FG001|Final Analysis|Lost to Follow-up|0|||
129956319|NCT00296504|467801342|FG002|Final Analysis|Lost to Follow-up|0|||
129956320|NCT00296504|467801343|FG003|Final Analysis|Lost to Follow-up|0|||
129956321|NCT00296504|467801344|FG004|Final Analysis|Lost to Follow-up|0|||
129956322|NCT00296504|467801345|FG005|Final Analysis|Lost to Follow-up|0|||
129956323|NCT00296504|467801346|FG006|Final Analysis|Lost to Follow-up|0|||
129956324|NCT00296504|467801347|FG007|Final Analysis|Lost to Follow-up|0|||
129956325|NCT00296504|467801348|FG008|Final Analysis|Lost to Follow-up|5|||
129956326|NCT00296504|467801340|FG000|Final Analysis|Insufficient Viral Load Response|0|||
129956327|NCT00296504|467801341|FG001|Final Analysis|Insufficient Viral Load Response|0|||
129956328|NCT00296504|467801342|FG002|Final Analysis|Insufficient Viral Load Response|0|||
129956329|NCT00296504|467801343|FG003|Final Analysis|Insufficient Viral Load Response|0|||
129956330|NCT00296504|467801344|FG004|Final Analysis|Insufficient Viral Load Response|0|||
129956331|NCT00296504|467801345|FG005|Final Analysis|Insufficient Viral Load Response|0|||
129956332|NCT00296504|467801346|FG006|Final Analysis|Insufficient Viral Load Response|0|||
129956333|NCT00296504|467801347|FG007|Final Analysis|Insufficient Viral Load Response|0|||
129956334|NCT00296504|467801348|FG008|Final Analysis|Insufficient Viral Load Response|6|||
129956335|NCT00296504|467801340|FG000|Final Analysis|Adverse Event|0|||
129956336|NCT00296504|467801341|FG001|Final Analysis|Adverse Event|0|||
129956337|NCT00296504|467801342|FG002|Final Analysis|Adverse Event|0|||
129956338|NCT00296504|467801343|FG003|Final Analysis|Adverse Event|0|||
129956339|NCT00296504|467801344|FG004|Final Analysis|Adverse Event|0|||
129956340|NCT00296504|467801345|FG005|Final Analysis|Adverse Event|0|||
129956341|NCT00296504|467801346|FG006|Final Analysis|Adverse Event|0|||
129956342|NCT00296504|467801347|FG007|Final Analysis|Adverse Event|0|||
129956343|NCT00296504|467801348|FG008|Final Analysis|Adverse Event|2|||
129956344|NCT00296504|467801340|FG000|Final Analysis|Pregnancy|0|||
129956345|NCT00296504|467801341|FG001|Final Analysis|Pregnancy|0|||
129956346|NCT00296504|467801342|FG002|Final Analysis|Pregnancy|0|||
129956347|NCT00296504|467801343|FG003|Final Analysis|Pregnancy|0|||
129956348|NCT00296504|467801344|FG004|Final Analysis|Pregnancy|0|||
129956349|NCT00296504|467801345|FG005|Final Analysis|Pregnancy|0|||
129956350|NCT00296504|467801346|FG006|Final Analysis|Pregnancy|0|||
129956351|NCT00296504|467801347|FG007|Final Analysis|Pregnancy|0|||
129956352|NCT00296504|467801348|FG008|Final Analysis|Pregnancy|4|||
129956353|NCT00296504|467801340|FG000|Final Analysis|Tuberculosis|0|||
129956354|NCT00296504|467801341|FG001|Final Analysis|Tuberculosis|0|||
129956355|NCT00296504|467801342|FG002|Final Analysis|Tuberculosis|0|||
129956356|NCT00296504|467801343|FG003|Final Analysis|Tuberculosis|0|||
129956357|NCT00296504|467801344|FG004|Final Analysis|Tuberculosis|0|||
129956358|NCT00296504|467801345|FG005|Final Analysis|Tuberculosis|0|||
129956359|NCT00296504|467801346|FG006|Final Analysis|Tuberculosis|0|||
129956360|NCT00296504|467801347|FG007|Final Analysis|Tuberculosis|0|||
129956361|NCT00296504|467801348|FG008|Final Analysis|Tuberculosis|1|||
129956362|NCT00296504|467801340|FG000|Final Analysis|Participant Moved to Another Country|0|||
129956363|NCT00296504|467801341|FG001|Final Analysis|Participant Moved to Another Country|0|||
130084048|NCT00397631|468260875|FG000|Overall Study|Adverse Event|5|||
129956364|NCT00296504|467801342|FG002|Final Analysis|Participant Moved to Another Country|0|||
129956365|NCT00296504|467801343|FG003|Final Analysis|Participant Moved to Another Country|0|||
129956366|NCT00296504|467801344|FG004|Final Analysis|Participant Moved to Another Country|0|||
129956367|NCT00296504|467801345|FG005|Final Analysis|Participant Moved to Another Country|0|||
129956368|NCT00296504|467801346|FG006|Final Analysis|Participant Moved to Another Country|0|||
129956369|NCT00296504|467801347|FG007|Final Analysis|Participant Moved to Another Country|0|||
129956370|NCT00296504|467801348|FG008|Final Analysis|Participant Moved to Another Country|1|||
129956371|NCT00296504|467801340|FG000|Final Analysis|Poor Adherence|0|||
129956372|NCT00296504|467801341|FG001|Final Analysis|Poor Adherence|0|||
129956373|NCT00296504|467801342|FG002|Final Analysis|Poor Adherence|0|||
129956374|NCT00296504|467801343|FG003|Final Analysis|Poor Adherence|0|||
129956375|NCT00296504|467801344|FG004|Final Analysis|Poor Adherence|0|||
129956376|NCT00296504|467801345|FG005|Final Analysis|Poor Adherence|0|||
129956377|NCT00296504|467801346|FG006|Final Analysis|Poor Adherence|0|||
129956378|NCT00296504|467801347|FG007|Final Analysis|Poor Adherence|0|||
129956379|NCT00296504|467801348|FG008|Final Analysis|Poor Adherence|1|||
129956380|NCT00449033|467801353|FG000|Treatment Period|Adverse Event|117|||
129956381|NCT00449033|467801354|FG001|Treatment Period|Adverse Event|83|||
129956382|NCT00449033|467801353|FG000|Treatment Period|Death|21|||
129956383|NCT00449033|467801354|FG001|Treatment Period|Death|12|||
129956384|NCT00449033|467801353|FG000|Treatment Period|Lost to Follow-up|0|||
129956385|NCT00449033|467801354|FG001|Treatment Period|Lost to Follow-up|2|||
129956386|NCT00449033|467801353|FG000|Treatment Period|Physician Decision|4|||
129956387|NCT00449033|467801354|FG001|Treatment Period|Physician Decision|5|||
129956388|NCT00449033|467801353|FG000|Treatment Period|Protocol Violation|8|||
129956389|NCT00449033|467801354|FG001|Treatment Period|Protocol Violation|7|||
129956390|NCT00449033|467801353|FG000|Treatment Period|Disease Progression|231|||
129956391|NCT00449033|467801354|FG001|Treatment Period|Disease Progression|288|||
129956392|NCT00449033|467801353|FG000|Treatment Period|Consent Withdrawn|36|||
129956393|NCT00449033|467801354|FG001|Treatment Period|Consent Withdrawn|20|||
129956394|NCT00449033|467801353|FG000|Treatment Period|Amended Protocol Criteria|22|||
129956395|NCT00449033|467801354|FG001|Treatment Period|Amended Protocol Criteria|18|||
129956396|NCT00449033|467801353|FG000|Treatment Period|Non-compliance|7|||
129956397|NCT00449033|467801354|FG001|Treatment Period|Non-compliance|8|||
129956398|NCT00449033|467801353|FG000|Treatment Period|Second Malignancy|0|||
129956399|NCT00449033|467801354|FG001|Treatment Period|Second Malignancy|1|||
129956400|NCT00449033|467801353|FG000|Treatment Period|Reason Missing|0|||
129956401|NCT00449033|467801354|FG001|Treatment Period|Reason Missing|4|||
129956402|NCT00449033|467801353|FG000|Treatment Period|Treatment Ongoing|6|||
129956403|NCT00449033|467801354|FG001|Treatment Period|Treatment Ongoing|4|||
129956404|NCT00449033|467801353|FG000|Follow-up Period|Death|299|||
129956405|NCT00449033|467801354|FG001|Follow-up Period|Death|311|||
129956406|NCT00449033|467801353|FG000|Follow-up Period|Lost to Follow-up|6|||
129956407|NCT00449033|467801354|FG001|Follow-up Period|Lost to Follow-up|10|||
129956408|NCT00449033|467801353|FG000|Follow-up Period|Reason Missing|120|||
129956409|NCT00449033|467801354|FG001|Follow-up Period|Reason Missing|113|||
129956410|NCT04393779|467801355|FG000|Overall Study|Death|1|||
129956411|NCT04393779|467801355|FG000|Overall Study|Device reintervention or explant|4|||
129956412|NCT01190228|467801356|FG000|Overall Study|Protocol Violation|4|||
129956413|NCT01190228|467801357|FG001|Overall Study|Protocol Violation|0|||
129956414|NCT01190228|467801358|FG002|Overall Study|Protocol Violation|0|||
130084049|NCT00397631|468260876|FG001|Overall Study|Adverse Event|6|||
130084050|NCT00397631|468260875|FG000|Overall Study|Lack of Efficacy|7|||
130084051|NCT00397631|468260876|FG001|Overall Study|Lack of Efficacy|10|||
130084052|NCT00397631|468260875|FG000|Overall Study|Lost to Follow-up|8|||
130084053|NCT00397631|468260876|FG001|Overall Study|Lost to Follow-up|9|||
130084054|NCT00397631|468260875|FG000|Overall Study|Physician Decision|2|||
130084055|NCT00397631|468260876|FG001|Overall Study|Physician Decision|0|||
130084056|NCT00397631|468260875|FG000|Overall Study|Protocol Violation|0|||
130084057|NCT00397631|468260876|FG001|Overall Study|Protocol Violation|1|||
130084058|NCT00397631|468260875|FG000|Overall Study|Withdrawal by Subject|7|||
130084059|NCT00397631|468260876|FG001|Overall Study|Withdrawal by Subject|14|||
130084060|NCT00397631|468260875|FG000|Overall Study|protocol discontinuation criteria|1|||
130084061|NCT00397631|468260876|FG001|Overall Study|protocol discontinuation criteria|4|||
130084062|NCT02202161|468260877|FG000|Overall Study|Adverse Event|1|||
130084063|NCT02202161|468260878|FG001|Overall Study|Adverse Event|1|||
130084064|NCT02202161|468260879|FG002|Overall Study|Adverse Event|0|||
130084065|NCT02202161|468260880|FG003|Overall Study|Adverse Event|0|||
130084066|NCT02202161|468260881|FG004|Overall Study|Adverse Event|0|||
130084067|NCT02202161|468260882|FG005|Overall Study|Adverse Event|1|||
130084068|NCT02202161|468260883|FG006|Overall Study|Adverse Event|0|||
130084069|NCT02202161|468260884|FG007|Overall Study|Adverse Event|0|||
130084070|NCT02202161|468260877|FG000|Overall Study|Did not meet continuation criteria|0|||
130084071|NCT02202161|468260878|FG001|Overall Study|Did not meet continuation criteria|0|||
130084072|NCT02202161|468260879|FG002|Overall Study|Did not meet continuation criteria|0|||
130084073|NCT02202161|468260880|FG003|Overall Study|Did not meet continuation criteria|0|||
130084074|NCT02202161|468260881|FG004|Overall Study|Did not meet continuation criteria|0|||
130084075|NCT02202161|468260882|FG005|Overall Study|Did not meet continuation criteria|0|||
130084076|NCT02202161|468260883|FG006|Overall Study|Did not meet continuation criteria|0|||
130084077|NCT02202161|468260884|FG007|Overall Study|Did not meet continuation criteria|3|||
130084078|NCT02202161|468260877|FG000|Overall Study|Physician Decision|0|||
130084079|NCT02202161|468260878|FG001|Overall Study|Physician Decision|0|||
130084080|NCT02202161|468260879|FG002|Overall Study|Physician Decision|0|||
130084081|NCT02202161|468260880|FG003|Overall Study|Physician Decision|0|||
130084082|NCT02202161|468260881|FG004|Overall Study|Physician Decision|0|||
130084083|NCT02202161|468260882|FG005|Overall Study|Physician Decision|0|||
130084084|NCT02202161|468260883|FG006|Overall Study|Physician Decision|0|||
130084085|NCT02202161|468260884|FG007|Overall Study|Physician Decision|3|||
130121023|NCT00918567|468404882|FG000|Overall Study|Lack of Efficacy|3|||
130121024|NCT00918567|468404883|FG001|Overall Study|Lack of Efficacy|1|||
130121025|NCT00918567|468404882|FG000|Overall Study|Withdrawal by Subject|1|||
130121026|NCT00918567|468404883|FG001|Overall Study|Withdrawal by Subject|1|||
130121027|NCT00918567|468404882|FG000|Overall Study|Adverse Event|1|||
130121028|NCT00918567|468404883|FG001|Overall Study|Adverse Event|0|||
130121029|NCT02568384|468404888|FG000|Overall Study|Mobile devices incompatible with App|2|||
130121030|NCT00796510|468404889|FG000|Overall Study|Death|1|||
129956415|NCT01190228|467801356|FG000|Overall Study|Withdrawal by Subject|1|||
129956416|NCT01190228|467801357|FG001|Overall Study|Withdrawal by Subject|0|||
129956417|NCT01190228|467801358|FG002|Overall Study|Withdrawal by Subject|0|||
129956418|NCT02588027|467801359|FG000|Overall Study|Withdrawal by Subject|1|||
129956419|NCT02588027|467801360|FG001|Overall Study|Withdrawal by Subject|3|||
129956420|NCT02588027|467801359|FG000|Overall Study|Protocol Violation|4|||
129956421|NCT02588027|467801360|FG001|Overall Study|Protocol Violation|1|||
129956422|NCT03840148|467801363|FG000|Study Drug Disposition|Adverse Event|13|||
129956423|NCT03840148|467801364|FG001|Study Drug Disposition|Adverse Event|2|||
129956424|NCT03840148|467801363|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
129956425|NCT03840148|467801364|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
129956426|NCT03840148|467801363|FG000|Study Drug Disposition|Lack of Efficacy|3|||
129956427|NCT03840148|467801364|FG001|Study Drug Disposition|Lack of Efficacy|0|||
129956428|NCT03840148|467801363|FG000|Study Drug Disposition|Physician Decision|2|||
129956429|NCT03840148|467801364|FG001|Study Drug Disposition|Physician Decision|0|||
129956430|NCT03840148|467801363|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
129956431|NCT03840148|467801364|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
129956432|NCT03840148|467801363|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
129956433|NCT03840148|467801364|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
129956434|NCT03840148|467801363|FG000|Study Completion Disposition|Physician Decision|2|||
129956435|NCT03840148|467801364|FG001|Study Completion Disposition|Physician Decision|0|||
129956436|NCT03840148|467801363|FG000|Study Completion Disposition|Covid-19 related|2|||
129956437|NCT03840148|467801364|FG001|Study Completion Disposition|Covid-19 related|0|||
129956438|NCT03840148|467801363|FG000|Study Completion Disposition|Lost to Follow-up|1|||
129956439|NCT03840148|467801364|FG001|Study Completion Disposition|Lost to Follow-up|1|||
129956440|NCT03840148|467801363|FG000|Study Completion Disposition|Death|1|||
129956441|NCT03840148|467801364|FG001|Study Completion Disposition|Death|0|||
129956442|NCT03840148|467801363|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
129956443|NCT03840148|467801364|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
129956444|NCT03615404|467801365|FG000|Overall Study|Death|1|||
129956445|NCT03615404|467801365|FG000|Overall Study|vaccine did not pass quality assurance|1|||
129956446|NCT01774929|467801366|FG000|Overall Study|Adverse Event|3|||
129956447|NCT00603278|467801368|FG000|Overall Study|Lack of Efficacy|35|||
129956448|NCT00603278|467801369|FG001|Overall Study|Lack of Efficacy|10|||
129956449|NCT00603278|467801370|FG002|Overall Study|Lack of Efficacy|11|||
129956450|NCT00603278|467801371|FG003|Overall Study|Lack of Efficacy|8|||
129956451|NCT00603278|467801372|FG004|Overall Study|Lack of Efficacy|7|||
129956452|NCT00603278|467801373|FG005|Overall Study|Lack of Efficacy|14|||
129956453|NCT00603278|467801368|FG000|Overall Study|Adverse Event|0|||
129956454|NCT00603278|467801369|FG001|Overall Study|Adverse Event|3|||
129956455|NCT00603278|467801370|FG002|Overall Study|Adverse Event|1|||
129956456|NCT00603278|467801371|FG003|Overall Study|Adverse Event|0|||
129956457|NCT00603278|467801372|FG004|Overall Study|Adverse Event|2|||
130121031|NCT00796510|468404890|FG001|Overall Study|Death|0|||
130121032|NCT00796510|468404889|FG000|Overall Study|Study Terminated|2|||
130121033|NCT00796510|468404890|FG001|Overall Study|Study Terminated|0|||
130121034|NCT03008460|468404891|FG000|Overall Study|Protocol deviation|0|||
130121035|NCT03008460|468404892|FG001|Overall Study|Protocol deviation|2|||
129956458|NCT00603278|467801373|FG005|Overall Study|Adverse Event|1|||
129956459|NCT00603278|467801368|FG000|Overall Study|Withdrawal by Subject|2|||
129956460|NCT00603278|467801369|FG001|Overall Study|Withdrawal by Subject|3|||
129956461|NCT00603278|467801370|FG002|Overall Study|Withdrawal by Subject|1|||
129956462|NCT00603278|467801371|FG003|Overall Study|Withdrawal by Subject|2|||
129956463|NCT00603278|467801372|FG004|Overall Study|Withdrawal by Subject|1|||
129956464|NCT00603278|467801373|FG005|Overall Study|Withdrawal by Subject|2|||
129956465|NCT00603278|467801368|FG000|Overall Study|Protocol Violation|3|||
129956466|NCT00603278|467801369|FG001|Overall Study|Protocol Violation|0|||
129956467|NCT00603278|467801370|FG002|Overall Study|Protocol Violation|1|||
129956468|NCT00603278|467801371|FG003|Overall Study|Protocol Violation|1|||
129956469|NCT00603278|467801372|FG004|Overall Study|Protocol Violation|0|||
129956470|NCT00603278|467801373|FG005|Overall Study|Protocol Violation|1|||
129956471|NCT00603278|467801368|FG000|Overall Study|Physician Decision|0|||
129956472|NCT00603278|467801369|FG001|Overall Study|Physician Decision|1|||
129956473|NCT00603278|467801370|FG002|Overall Study|Physician Decision|0|||
129956474|NCT00603278|467801371|FG003|Overall Study|Physician Decision|0|||
130121036|NCT03008460|468404891|FG000|Overall Study|Study drug not dispensed|0|||
129956475|NCT00603278|467801372|FG004|Overall Study|Physician Decision|2|||
129956476|NCT00603278|467801373|FG005|Overall Study|Physician Decision|1|||
129956477|NCT00603278|467801368|FG000|Overall Study|Lost to Follow-up|1|||
129956478|NCT00603278|467801369|FG001|Overall Study|Lost to Follow-up|0|||
129956479|NCT00603278|467801370|FG002|Overall Study|Lost to Follow-up|0|||
129956480|NCT00603278|467801371|FG003|Overall Study|Lost to Follow-up|0|||
129956481|NCT00603278|467801372|FG004|Overall Study|Lost to Follow-up|1|||
129956482|NCT00603278|467801373|FG005|Overall Study|Lost to Follow-up|0|||
129956483|NCT00990821|467801380|FG000|Overall Study|Withdrawal by Subject|0|||
129956484|NCT00990821|467801381|FG001|Overall Study|Withdrawal by Subject|2|||
129956485|NCT00990821|467801382|FG002|Overall Study|Withdrawal by Subject|0|||
129956486|NCT00990821|467801383|FG003|Overall Study|Withdrawal by Subject|0|||
129956487|NCT00990821|467801384|FG004|Overall Study|Withdrawal by Subject|3|||
129956488|NCT00990821|467801385|FG005|Overall Study|Withdrawal by Subject|3|||
129956489|NCT00990821|467801386|FG006|Overall Study|Withdrawal by Subject|1|||
129956490|NCT00990821|467801387|FG007|Overall Study|Withdrawal by Subject|0|||
129956491|NCT00990821|467801388|FG008|Overall Study|Withdrawal by Subject|0|||
129956492|NCT00990821|467801389|FG009|Overall Study|Withdrawal by Subject|1|||
129956493|NCT00990821|467801390|FG010|Overall Study|Withdrawal by Subject|3|||
129956494|NCT00990821|467801391|FG011|Overall Study|Withdrawal by Subject|5|||
129956495|NCT00990821|467801392|FG012|Overall Study|Withdrawal by Subject|2|||
129956496|NCT00990821|467801393|FG013|Overall Study|Withdrawal by Subject|1|||
129956497|NCT04150250|467801394|FG000|Overall Study|Lost to Follow-up|0|||
129956498|NCT04150250|467801395|FG001|Overall Study|Lost to Follow-up|2|||
129956499|NCT01786551|467801396|FG000|Overall Study|Participant withdrew consent|2|||
129956500|NCT00308113|467801398|FG000|Overall Study|Protocol closure|0|||
129956501|NCT00308113|467801399|FG001|Overall Study|Protocol closure|0|||
129956502|NCT00308113|467801400|FG002|Overall Study|Protocol closure|0|||
129956503|NCT00308113|467801401|FG003|Overall Study|Protocol closure|1|||
129956504|NCT01123642|467801404|FG000|Overall Study|Lost to Follow-up|23|||
129956505|NCT01123642|467801404|FG000|Overall Study|Withdrawal by Subject|9|||
129956506|NCT01123642|467801404|FG000|Overall Study|ineligible at baseline assessment|36|||
129956507|NCT01184859|467802943|FG000|Period 1: Single Dose|Insufficient urine production|0|||
129956508|NCT01184859|467802944|FG001|Period 1: Single Dose|Insufficient urine production|1|||
129956509|NCT01184859|467802945|FG002|Period 1: Single Dose|Insufficient urine production|0|||
129956510|NCT01184859|467802946|FG003|Period 1: Single Dose|Insufficient urine production|0|||
129956511|NCT01184859|467802947|FG004|Period 1: Single Dose|Insufficient urine production|0|||
129956512|NCT01184859|467802943|FG000|Period 1: Single Dose|Protocol Violation|0|||
129956513|NCT01184859|467802944|FG001|Period 1: Single Dose|Protocol Violation|1|||
129956514|NCT01184859|467802945|FG002|Period 1: Single Dose|Protocol Violation|0|||
129956515|NCT01184859|467802946|FG003|Period 1: Single Dose|Protocol Violation|0|||
129956516|NCT01184859|467802947|FG004|Period 1: Single Dose|Protocol Violation|0|||
129956517|NCT01184859|467802943|FG000|Period 1: Single Dose|Adverse Event|0|||
129956518|NCT01184859|467802944|FG001|Period 1: Single Dose|Adverse Event|0|||
129956519|NCT01184859|467802945|FG002|Period 1: Single Dose|Adverse Event|0|||
129956520|NCT01184859|467802946|FG003|Period 1: Single Dose|Adverse Event|0|||
129956521|NCT01184859|467802947|FG004|Period 1: Single Dose|Adverse Event|1|||
129956522|NCT01184859|467802943|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956523|NCT01184859|467802944|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956524|NCT01184859|467802945|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956525|NCT01184859|467802946|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956526|NCT01184859|467802947|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
129956527|NCT01184859|467802943|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
129956528|NCT01184859|467802944|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956529|NCT01184859|467802945|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956530|NCT01184859|467802946|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956531|NCT01184859|467802947|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956532|NCT00961298|467802948|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
129956533|NCT00961298|467802948|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
129956534|NCT00961298|467802948|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
129956535|NCT01232569|467802949|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
129956536|NCT01232569|467802950|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129956537|NCT01232569|467802951|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129956538|NCT01232569|467802952|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
129956539|NCT01232569|467802949|FG000|Double-blind Treatment Period|Escape|2|||
129956540|NCT01232569|467802950|FG001|Double-blind Treatment Period|Escape|2|||
129956541|NCT01232569|467802951|FG002|Double-blind Treatment Period|Escape|0|||
129956542|NCT01232569|467802952|FG003|Double-blind Treatment Period|Escape|0|||
129956543|NCT01232569|467802949|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
129956544|NCT01232569|467802950|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129956545|NCT01232569|467802951|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129956546|NCT01232569|467802952|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129956547|NCT01232569|467802949|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
129956548|NCT01232569|467802950|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
129956549|NCT01232569|467802951|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129956550|NCT01232569|467802952|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
129956551|NCT01232569|467802949|FG000|Double-blind Treatment Period|Physician Decision|1|||
129956552|NCT01232569|467802950|FG001|Double-blind Treatment Period|Physician Decision|0|||
129956553|NCT01232569|467802951|FG002|Double-blind Treatment Period|Physician Decision|0|||
129956554|NCT01232569|467802952|FG003|Double-blind Treatment Period|Physician Decision|0|||
129956555|NCT01232569|467802949|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
129956556|NCT01232569|467802950|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
129956557|NCT01232569|467802951|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
129956558|NCT01232569|467802952|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
129956559|NCT01232569|467802949|FG000|Double-blind Treatment Period|Death|2|||
129956560|NCT01232569|467802950|FG001|Double-blind Treatment Period|Death|0|||
129956561|NCT01232569|467802951|FG002|Double-blind Treatment Period|Death|0|||
129956562|NCT01232569|467802952|FG003|Double-blind Treatment Period|Death|0|||
129956563|NCT04044352|467802953|FG000|Overall Study|Lost to Follow-up|9|||
129956564|NCT04044352|467802953|FG000|Overall Study|Withdrawal by Subject|2|||
129956565|NCT00651937|467802954|FG000|Overall Study|Withdrawal by Subject|4|||
129956566|NCT00651937|467802955|FG001|Overall Study|Withdrawal by Subject|1|||
129956567|NCT01537120|467802965|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
129956568|NCT01537120|467802965|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
129956569|NCT02514577|467802966|FG000|Overall Study|Lost to Follow-up|6|||
129956570|NCT02514577|467802967|FG001|Overall Study|Lost to Follow-up|6|||
129956571|NCT02514577|467802966|FG000|Overall Study|Protocol Violation|1|||
129956572|NCT02514577|467802967|FG001|Overall Study|Protocol Violation|0|||
129956573|NCT02514577|467802966|FG000|Overall Study|Withdrawal by Subject|6|||
129956574|NCT02514577|467802967|FG001|Overall Study|Withdrawal by Subject|6|||
129956575|NCT02514577|467802966|FG000|Overall Study|Adverse Event|1|||
129956576|NCT02514577|467802967|FG001|Overall Study|Adverse Event|1|||
129956577|NCT04816708|467802970|FG000|Overall Study|Lost to Follow-up|10|||
129956578|NCT04816708|467802971|FG001|Overall Study|Lost to Follow-up|4|||
129956579|NCT03568708|467802972|FG000|Overall Study|Withdrawal by Subject|1|||
129956580|NCT03568708|467802973|FG001|Overall Study|Withdrawal by Subject|1|||
129956581|NCT03568708|467802972|FG000|Overall Study|Lost to Follow-up|0|||
129956582|NCT03568708|467802973|FG001|Overall Study|Lost to Follow-up|1|||
129956583|NCT00511147|467802974|FG000|Overall Study|Withdrawal by Subject|1|||
129956584|NCT00511147|467802974|FG000|Overall Study|Disease progression|5|||
129956585|NCT00511147|467802974|FG000|Overall Study|Required platelet transfusion|1|||
129956586|NCT00809783|467802975|FG000|Overall Study|Death|1|||
129956587|NCT00809783|467802976|FG001|Overall Study|Death|0|||
129956588|NCT00809783|467802977|FG002|Overall Study|Death|0|||
129956589|NCT00809783|467802975|FG000|Overall Study|Adverse Event|34|||
129956590|NCT00809783|467802976|FG001|Overall Study|Adverse Event|52|||
129956591|NCT00809783|467802977|FG002|Overall Study|Adverse Event|71|||
129956592|NCT00809783|467802975|FG000|Overall Study|Lack of Efficacy|39|||
129956593|NCT00809783|467802976|FG001|Overall Study|Lack of Efficacy|52|||
129956594|NCT00809783|467802977|FG002|Overall Study|Lack of Efficacy|63|||
129956595|NCT00809783|467802975|FG000|Overall Study|Lost to Follow-up|0|||
129956596|NCT00809783|467802976|FG001|Overall Study|Lost to Follow-up|3|||
129956597|NCT00809783|467802977|FG002|Overall Study|Lost to Follow-up|4|||
129956598|NCT00809783|467802975|FG000|Overall Study|Withdrawal by Subject|47|||
129956599|NCT00809783|467802976|FG001|Overall Study|Withdrawal by Subject|72|||
129956600|NCT00809783|467802977|FG002|Overall Study|Withdrawal by Subject|64|||
129956601|NCT00809783|467802975|FG000|Overall Study|Protocol Violation|2|||
129956602|NCT00809783|467802976|FG001|Overall Study|Protocol Violation|6|||
129956603|NCT00809783|467802977|FG002|Overall Study|Protocol Violation|5|||
129956604|NCT00809783|467802975|FG000|Overall Study|Randomized, but not treated|3|||
129956605|NCT00809783|467802976|FG001|Overall Study|Randomized, but not treated|0|||
129956606|NCT00809783|467802977|FG002|Overall Study|Randomized, but not treated|2|||
129956607|NCT00809783|467802975|FG000|Overall Study|Study Terminated by Sponsor|378|||
129956608|NCT00809783|467802976|FG001|Overall Study|Study Terminated by Sponsor|626|||
129956609|NCT00809783|467802977|FG002|Overall Study|Study Terminated by Sponsor|565|||
129956610|NCT00809783|467802975|FG000|Overall Study|Other|21|||
129956611|NCT00809783|467802976|FG001|Overall Study|Other|21|||
129956612|NCT00809783|467802977|FG002|Overall Study|Other|16|||
129956613|NCT00126555|467802978|FG000|Overall Study|Withdrawal by Subject|1|||
129956614|NCT00126555|467802978|FG000|Overall Study|Adverse Event|2|||
129956615|NCT00126555|467802978|FG000|Overall Study|Progressive Disease|3|||
129956616|NCT03132753|467802981|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
129956617|NCT03132753|467802982|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
129956618|NCT03132753|467802981|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
129956619|NCT03132753|467802982|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
129956620|NCT00125853|467802983|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
129956621|NCT00125853|467802984|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
129956622|NCT02350127|467802985|FG000|4-Month Assessment|Withdrawal by Subject|10|||
129956623|NCT02350127|467802986|FG001|4-Month Assessment|Withdrawal by Subject|9|||
129956624|NCT02350127|467802985|FG000|4-Month Assessment|Death|1|||
129956625|NCT02350127|467802986|FG001|4-Month Assessment|Death|0|||
129956626|NCT02350127|467802985|FG000|8-Month Assessment|Death|1|||
129956627|NCT02350127|467802986|FG001|8-Month Assessment|Death|1|||
129956628|NCT02350127|467802985|FG000|8-Month Assessment|Withdrawal by Subject|5|||
129956629|NCT02350127|467802986|FG001|8-Month Assessment|Withdrawal by Subject|8|||
129956630|NCT01446042|467802989|FG000|Overall Study|Withdrawal by Subject|12|||
129956631|NCT01446042|467802990|FG001|Overall Study|Withdrawal by Subject|2|||
129956632|NCT01446042|467802991|FG002|Overall Study|Withdrawal by Subject|4|||
129956633|NCT01446042|467802989|FG000|Overall Study|Adverse Event|1|||
129956634|NCT01446042|467802990|FG001|Overall Study|Adverse Event|0|||
129956635|NCT01446042|467802991|FG002|Overall Study|Adverse Event|4|||
129956636|NCT01446042|467802989|FG000|Overall Study|Lost to Follow-up|5|||
129956637|NCT01446042|467802990|FG001|Overall Study|Lost to Follow-up|0|||
129956638|NCT01446042|467802991|FG002|Overall Study|Lost to Follow-up|0|||
129956639|NCT01446042|467802989|FG000|Overall Study|Other reasons|2|||
129956640|NCT01446042|467802990|FG001|Overall Study|Other reasons|1|||
129956641|NCT01446042|467802991|FG002|Overall Study|Other reasons|1|||
129956642|NCT03575572|467802993|FG000|Overall Study|Withdrawal by Subject|2|||
129956643|NCT03575572|467802993|FG000|Overall Study|Physician Decision|2|||
129956644|NCT00157209|467802994|FG000|Overall Study|Ongoing at data cut-off|10|||
129956645|NCT00157209|467802995|FG001|Overall Study|Ongoing at data cut-off|0|||
129956646|NCT03802513|467803006|FG000|Overall Study|Lost to Follow-up|1|||
129956647|NCT01770509|467803010|FG000|Overall Study|Injury|0|||
129956648|NCT01770509|467803011|FG001|Overall Study|Injury|1|||
129956649|NCT01770509|467803010|FG000|Overall Study|Lost to Follow-up|1|||
129956650|NCT01770509|467803011|FG001|Overall Study|Lost to Follow-up|2|||
129956651|NCT03928821|467803012|FG000|Overall Study|Death|0|||
129956652|NCT03928821|467803013|FG001|Overall Study|Death|1|||
129956653|NCT03928821|467803014|FG002|Overall Study|Death|0|||
129956654|NCT03928821|467803015|FG003|Overall Study|Death|0|||
129956655|NCT03928821|467803012|FG000|Overall Study|Lost to Follow-up|0|||
129956656|NCT03928821|467803013|FG001|Overall Study|Lost to Follow-up|2|||
129956657|NCT03928821|467803014|FG002|Overall Study|Lost to Follow-up|3|||
129956658|NCT03928821|467803015|FG003|Overall Study|Lost to Follow-up|0|||
129956659|NCT03928821|467803012|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129956660|NCT03928821|467803013|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129956661|NCT03928821|467803014|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129956662|NCT03928821|467803015|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
129956663|NCT00985621|467803020|FG000|Overall Study|Adverse Event|2|||
129956664|NCT00985621|467803021|FG001|Overall Study|Adverse Event|3|||
129956665|NCT00985621|467803022|FG002|Overall Study|Adverse Event|4|||
129956666|NCT00985621|467803023|FG003|Overall Study|Adverse Event|16|||
129956667|NCT00985621|467803020|FG000|Overall Study|Lack of Efficacy|10|||
129956668|NCT00985621|467803021|FG001|Overall Study|Lack of Efficacy|6|||
129956669|NCT00985621|467803022|FG002|Overall Study|Lack of Efficacy|5|||
129956670|NCT00985621|467803023|FG003|Overall Study|Lack of Efficacy|12|||
129956671|NCT00985621|467803020|FG000|Overall Study|Lost to Follow-up|2|||
129956672|NCT00985621|467803021|FG001|Overall Study|Lost to Follow-up|3|||
129956673|NCT00985621|467803022|FG002|Overall Study|Lost to Follow-up|4|||
129956674|NCT00985621|467803023|FG003|Overall Study|Lost to Follow-up|4|||
129956675|NCT00985621|467803020|FG000|Overall Study|Study Terminated by Sponsor|89|||
129956676|NCT00985621|467803021|FG001|Overall Study|Study Terminated by Sponsor|108|||
129956677|NCT00985621|467803022|FG002|Overall Study|Study Terminated by Sponsor|99|||
129956678|NCT00985621|467803023|FG003|Overall Study|Study Terminated by Sponsor|92|||
129956679|NCT00985621|467803020|FG000|Overall Study|Protocol Violation|1|||
129956680|NCT00985621|467803021|FG001|Overall Study|Protocol Violation|1|||
129956681|NCT00985621|467803022|FG002|Overall Study|Protocol Violation|1|||
129956682|NCT00985621|467803023|FG003|Overall Study|Protocol Violation|0|||
129956683|NCT00985621|467803020|FG000|Overall Study|Withdrawal by Subject|8|||
129956684|NCT00985621|467803021|FG001|Overall Study|Withdrawal by Subject|10|||
129956685|NCT00985621|467803022|FG002|Overall Study|Withdrawal by Subject|8|||
129956686|NCT00985621|467803023|FG003|Overall Study|Withdrawal by Subject|12|||
129956687|NCT00985621|467803020|FG000|Overall Study|Other|1|||
129956688|NCT00985621|467803021|FG001|Overall Study|Other|0|||
129956689|NCT00985621|467803022|FG002|Overall Study|Other|0|||
129956690|NCT00985621|467803023|FG003|Overall Study|Other|0|||
129956691|NCT00985621|467803020|FG000|Overall Study|Randomized but not Treated|1|||
129956692|NCT00985621|467803021|FG001|Overall Study|Randomized but not Treated|0|||
129956693|NCT00985621|467803022|FG002|Overall Study|Randomized but not Treated|2|||
129956694|NCT00985621|467803023|FG003|Overall Study|Randomized but not Treated|1|||
129956695|NCT01911819|467803024|FG000|Overall Study|Adverse Event|0|||
129956696|NCT01911819|467803025|FG001|Overall Study|Adverse Event|1|||
129956697|NCT01911819|467803026|FG002|Overall Study|Adverse Event|0|||
129956698|NCT01911819|467803024|FG000|Overall Study|Withdrawal by Subject|1|||
129956699|NCT01911819|467803025|FG001|Overall Study|Withdrawal by Subject|1|||
129956700|NCT01911819|467803026|FG002|Overall Study|Withdrawal by Subject|0|||
129956701|NCT04374253|467803027|FG000|Overall Study|Adverse Event|0|||
129956702|NCT04374253|467803028|FG001|Overall Study|Adverse Event|26|||
129956703|NCT04374253|467803029|FG002|Overall Study|Adverse Event|2|||
129956704|NCT04374253|467803030|FG003|Overall Study|Adverse Event|12|||
129956705|NCT04374253|467803027|FG000|Overall Study|Study terminated by sponsor|13|||
129956706|NCT04374253|467803028|FG001|Overall Study|Study terminated by sponsor|593|||
129956707|NCT04374253|467803029|FG002|Overall Study|Study terminated by sponsor|21|||
129956708|NCT04374253|467803030|FG003|Overall Study|Study terminated by sponsor|567|||
129956709|NCT04374253|467803027|FG000|Overall Study|Withdrawal by Subject|0|||
129956710|NCT04374253|467803028|FG001|Overall Study|Withdrawal by Subject|55|||
129956711|NCT04374253|467803029|FG002|Overall Study|Withdrawal by Subject|3|||
129956712|NCT04374253|467803030|FG003|Overall Study|Withdrawal by Subject|40|||
129956713|NCT04374253|467803027|FG000|Overall Study|Physician Decision|1|||
129956714|NCT04374253|467803028|FG001|Overall Study|Physician Decision|10|||
129956715|NCT04374253|467803029|FG002|Overall Study|Physician Decision|1|||
129956716|NCT04374253|467803030|FG003|Overall Study|Physician Decision|10|||
129956717|NCT04374253|467803027|FG000|Overall Study|Protocol Violation|0|||
129956718|NCT04374253|467803028|FG001|Overall Study|Protocol Violation|0|||
129956719|NCT04374253|467803029|FG002|Overall Study|Protocol Violation|0|||
129956720|NCT04374253|467803030|FG003|Overall Study|Protocol Violation|2|||
129956721|NCT04374253|467803027|FG000|Overall Study|Death|0|||
129956722|NCT04374253|467803028|FG001|Overall Study|Death|3|||
129956723|NCT04374253|467803029|FG002|Overall Study|Death|1|||
129956724|NCT04374253|467803030|FG003|Overall Study|Death|1|||
129956725|NCT04374253|467803027|FG000|Overall Study|Lack of Efficacy|0|||
129956726|NCT04374253|467803028|FG001|Overall Study|Lack of Efficacy|0|||
129956727|NCT04374253|467803029|FG002|Overall Study|Lack of Efficacy|0|||
129956728|NCT04374253|467803030|FG003|Overall Study|Lack of Efficacy|1|||
129956729|NCT04374253|467803027|FG000|Overall Study|Lost to Follow-up|1|||
129956730|NCT04374253|467803028|FG001|Overall Study|Lost to Follow-up|1|||
129956731|NCT04374253|467803029|FG002|Overall Study|Lost to Follow-up|0|||
129956732|NCT04374253|467803030|FG003|Overall Study|Lost to Follow-up|2|||
129956733|NCT04374253|467803027|FG000|Overall Study|Reason Not Specified|0|||
129956734|NCT04374253|467803028|FG001|Overall Study|Reason Not Specified|8|||
129956735|NCT04374253|467803029|FG002|Overall Study|Reason Not Specified|0|||
129956736|NCT04374253|467803030|FG003|Overall Study|Reason Not Specified|8|||
129956737|NCT01207453|467803031|FG000|First Intervention|Adverse Event|2|||
129956738|NCT01207453|467803032|FG001|First Intervention|Adverse Event|1|||
129956739|NCT01207453|467803031|FG000|Washout|Adverse Event|1|||
129956740|NCT01207453|467803032|FG001|Washout|Adverse Event|0|||
129956741|NCT01207453|467803031|FG000|Washout|Lost to Follow-up|1|||
129956742|NCT01207453|467803032|FG001|Washout|Lost to Follow-up|0|||
129956743|NCT01207453|467803031|FG000|2nd Intervention|Adverse Event|1|||
129956744|NCT01207453|467803032|FG001|2nd Intervention|Adverse Event|2|||
129956745|NCT01207453|467803031|FG000|2nd Intervention|Lost to Follow-up|1|||
129956746|NCT01207453|467803032|FG001|2nd Intervention|Lost to Follow-up|0|||
129956747|NCT00676663|467803033|FG000|Overall Study|Death|43|||
129956748|NCT00676663|467803034|FG001|Overall Study|Death|27|||
129956749|NCT00676663|467803033|FG000|Overall Study|Withdrew Consent|1|||
129956750|NCT00676663|467803034|FG001|Overall Study|Withdrew Consent|8|||
129956751|NCT00676663|467803033|FG000|Overall Study|Lost to Follow-up|1|||
129956752|NCT00676663|467803034|FG001|Overall Study|Lost to Follow-up|3|||
129956753|NCT00580047|467803035|FG000|Overall Study|Lost to Follow-up|1|||
129956754|NCT00580047|467803036|FG001|Overall Study|Lost to Follow-up|1|||
129956755|NCT00580047|467803037|FG002|Overall Study|Lost to Follow-up|0|||
129956756|NCT00580047|467803035|FG000|Overall Study|Withdrawal by Subject|1|||
129956757|NCT00580047|467803036|FG001|Overall Study|Withdrawal by Subject|1|||
129956758|NCT00580047|467803037|FG002|Overall Study|Withdrawal by Subject|2|||
129956759|NCT00580047|467803035|FG000|Overall Study|Withdrawal by Subject|1|||
129956760|NCT00580047|467803036|FG001|Overall Study|Withdrawal by Subject|0|||
129956761|NCT00580047|467803037|FG002|Overall Study|Withdrawal by Subject|0|||
129956762|NCT04382053|467803043|FG000|Overall Study|Death|6|||
129956763|NCT04382053|467803044|FG001|Overall Study|Death|8|||
129956764|NCT04382053|467803043|FG000|Overall Study|Lost to Follow-up|0|||
129956765|NCT04382053|467803044|FG001|Overall Study|Lost to Follow-up|2|||
129956766|NCT04382053|467803043|FG000|Overall Study|Protocol Deviation|1|||
129956767|NCT04382053|467803044|FG001|Overall Study|Protocol Deviation|2|||
129956768|NCT04382053|467803043|FG000|Overall Study|Withdrawal by Subject|2|||
129956769|NCT04382053|467803044|FG001|Overall Study|Withdrawal by Subject|1|||
129956770|NCT01399905|467803048|FG000|Overall Study|Withdrawal by Subject|1|||
129956771|NCT01399905|467803049|FG001|Overall Study|Withdrawal by Subject|1|||
129956772|NCT02577315|467803052|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129956773|NCT02577315|467803053|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
129956774|NCT00417989|467803054|FG000|Overall Study|Withdrawal by Subject|13|||
129956775|NCT00417989|467803055|FG001|Overall Study|Withdrawal by Subject|13|||
129956776|NCT00417989|467803054|FG000|Overall Study|Lost to Follow-up|1|||
129956777|NCT00417989|467803055|FG001|Overall Study|Lost to Follow-up|6|||
129956778|NCT00417989|467803054|FG000|Overall Study|Protocol Violation|1|||
129956779|NCT00417989|467803055|FG001|Overall Study|Protocol Violation|0|||
129956780|NCT00417989|467803054|FG000|Overall Study|Death|0|||
129956781|NCT00417989|467803055|FG001|Overall Study|Death|1|||
129956782|NCT00417989|467803054|FG000|Overall Study|Physician Decision|5|||
129956783|NCT00417989|467803055|FG001|Overall Study|Physician Decision|2|||
129956784|NCT01945086|467803067|FG000|Overall Study|Withdrawal by Subject|1|||
129956785|NCT01945086|467803068|FG001|Overall Study|Withdrawal by Subject|0|||
129956786|NCT01945086|467803069|FG002|Overall Study|Withdrawal by Subject|1|||
129956787|NCT01945086|467803067|FG000|Overall Study|Adverse Event|0|||
129956788|NCT01945086|467803068|FG001|Overall Study|Adverse Event|0|||
129956789|NCT01945086|467803069|FG002|Overall Study|Adverse Event|1|||
129956790|NCT00170950|467803070|FG000|Overall Study|Death|236|||
129956791|NCT00170950|467803071|FG001|Overall Study|Death|274|||
129956792|NCT00170950|467803070|FG000|Overall Study|Withdrawal by Subject|496|||
129956793|NCT00170950|467803071|FG001|Overall Study|Withdrawal by Subject|498|||
129956794|NCT00170950|467803070|FG000|Overall Study|Lost to Follow-up|134|||
129956795|NCT00170950|467803071|FG001|Overall Study|Lost to Follow-up|115|||
129956796|NCT00170950|467803070|FG000|Overall Study|Missing|2|||
129956797|NCT00170950|467803071|FG001|Overall Study|Missing|1|||
129956798|NCT00170950|467803070|FG000|Overall Study|Termination Data Not Recorded|17|||
129956799|NCT00170950|467803071|FG001|Overall Study|Termination Data Not Recorded|22|||
129956800|NCT00748098|467803072|FG000|First Treatment Intervention Period|Adverse Event|1|||
129956801|NCT00748098|467803073|FG001|First Treatment Intervention Period|Adverse Event|1|||
129956802|NCT00748098|467803072|FG000|First Treatment Intervention Period|Protocol Violation|1|||
129956803|NCT00748098|467803073|FG001|First Treatment Intervention Period|Protocol Violation|0|||
129956804|NCT00748098|467803072|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
129956805|NCT00748098|467803073|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
129956806|NCT00748098|467803072|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
129956807|NCT00748098|467803073|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
129956808|NCT00748098|467803072|FG000|First Taper Period|Protocol Violation|1|||
129956809|NCT00748098|467803073|FG001|First Taper Period|Protocol Violation|0|||
129956810|NCT00748098|467803072|FG000|First Taper Period|Withdrawal by Subject|2|||
129956811|NCT00748098|467803073|FG001|First Taper Period|Withdrawal by Subject|0|||
129956812|NCT00748098|467803072|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
129956813|NCT00748098|467803073|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
129956814|NCT00748098|467803072|FG000|1-Week Washout Period|Adverse Event|0|||
129956815|NCT00748098|467803073|FG001|1-Week Washout Period|Adverse Event|1|||
129956816|NCT00748098|467803072|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
129956817|NCT00748098|467803073|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
129956818|NCT00748098|467803072|FG000|Second Treatment Intervention Period|Adverse Event|4|||
129956819|NCT00748098|467803073|FG001|Second Treatment Intervention Period|Adverse Event|1|||
129956820|NCT00748098|467803072|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
129956821|NCT00748098|467803073|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
129956822|NCT00748098|467803072|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
129956823|NCT00748098|467803073|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
129979932|NCT02108964|467889499|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979933|NCT02108964|467889500|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979934|NCT02108964|467889501|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979935|NCT02108964|467889502|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979936|NCT02108964|467889503|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979937|NCT02108964|467889504|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979938|NCT02108964|467889505|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
129979939|NCT03006848|467889506|FG000|Overall Study|Adverse Event|1|||
129979940|NCT03006848|467889506|FG000|Overall Study|Physician Decision|1|||
129979941|NCT03006848|467889506|FG000|Overall Study|Lack of Efficacy|16|||
129979942|NCT00384397|467889507|FG000|Overall Study|Adverse Event|0|||
129979943|NCT00384397|467889508|FG001|Overall Study|Adverse Event|1|||
129979944|NCT00384397|467889509|FG002|Overall Study|Adverse Event|2|||
129979945|NCT00384397|467889507|FG000|Overall Study|Protocol Violation|7|||
129979946|NCT00384397|467889508|FG001|Overall Study|Protocol Violation|15|||
129979947|NCT00384397|467889509|FG002|Overall Study|Protocol Violation|13|||
129979948|NCT00384397|467889507|FG000|Overall Study|Lost to Follow-up|11|||
129979949|NCT00384397|467889508|FG001|Overall Study|Lost to Follow-up|13|||
129979950|NCT00384397|467889509|FG002|Overall Study|Lost to Follow-up|3|||
129979951|NCT00384397|467889507|FG000|Overall Study|Withdrawal by Subject|14|||
129979952|NCT00384397|467889508|FG001|Overall Study|Withdrawal by Subject|17|||
129979953|NCT00384397|467889509|FG002|Overall Study|Withdrawal by Subject|15|||
129979954|NCT04372121|467889510|FG000|Overall Study|Lost to Follow-up|0|||
129979955|NCT04372121|467889511|FG001|Overall Study|Lost to Follow-up|0|||
129979956|NCT04372121|467889512|FG002|Overall Study|Lost to Follow-up|0|||
129979957|NCT04372121|467889513|FG003|Overall Study|Lost to Follow-up|1|||
129979958|NCT04372121|467889510|FG000|Overall Study|Protocol Violation|0|||
129979959|NCT04372121|467889511|FG001|Overall Study|Protocol Violation|0|||
129979960|NCT04372121|467889512|FG002|Overall Study|Protocol Violation|1|||
129956824|NCT00396097|467804510|FG000|Overall Study|Withdrawal by Subject|17|||
129956825|NCT00396097|467804511|FG001|Overall Study|Withdrawal by Subject|17|||
129956826|NCT00396097|467804510|FG000|Overall Study|Lost to Follow-up|4|||
129956827|NCT00396097|467804511|FG001|Overall Study|Lost to Follow-up|9|||
129956828|NCT00396097|467804510|FG000|Overall Study|Other|3|||
129956829|NCT00396097|467804511|FG001|Overall Study|Other|5|||
129956830|NCT00396097|467804510|FG000|Overall Study|Protocol Violation|0|||
129956831|NCT00396097|467804511|FG001|Overall Study|Protocol Violation|6|||
129956832|NCT00396097|467804510|FG000|Overall Study|Adverse Event|1|||
129956833|NCT00396097|467804511|FG001|Overall Study|Adverse Event|5|||
129956834|NCT00396097|467804510|FG000|Overall Study|Insufficient Clinical Response|1|||
129956835|NCT00396097|467804511|FG001|Overall Study|Insufficient Clinical Response|4|||
129956836|NCT03461211|467804512|FG000|Overall Study|Adverse Event|1|||
129956837|NCT03461211|467804513|FG001|Overall Study|Adverse Event|1|||
129956838|NCT03461211|467804512|FG000|Overall Study|Lack of Efficacy|0|||
129956839|NCT03461211|467804513|FG001|Overall Study|Lack of Efficacy|1|||
129956840|NCT01284634|467804514|FG000|Overall Study|Adverse Event|1|||
129956841|NCT01284634|467804515|FG001|Overall Study|Adverse Event|0|||
129956842|NCT01284634|467804516|FG002|Overall Study|Adverse Event|2|||
129956843|NCT01284634|467804517|FG003|Overall Study|Adverse Event|1|||
129956844|NCT01732588|467804518|FG000|First Intervention (7 Days)|Adverse Event|0|||
129956845|NCT01732588|467804519|FG001|First Intervention (7 Days)|Adverse Event|1|||
129956846|NCT01732588|467804520|FG002|First Intervention (7 Days)|Adverse Event|0|||
129956847|NCT00730925|467804531|FG000|Overall Study|Progressive Disease|21|||
129956848|NCT00730925|467804531|FG000|Overall Study|Dose reducing Event|2|||
129956849|NCT00730925|467804531|FG000|Overall Study|Other Averse Event|7|||
129956850|NCT00730925|467804531|FG000|Overall Study|Protocol Violation|1|||
129956851|NCT00730925|467804531|FG000|Overall Study|Withdrawal by Subject|1|||
129956852|NCT00730925|467804531|FG000|Overall Study|Switch to combination therapy|8|||
129956853|NCT00730925|467804531|FG000|Overall Study|Other|1|||
129956854|NCT00191984|467804538|FG000|Overall Study|Disease Progression|21|||
129956855|NCT00191984|467804538|FG000|Overall Study|Adverse Event|4|||
129956856|NCT00191984|467804538|FG000|Overall Study|Death|2|||
129956857|NCT00191984|467804538|FG000|Overall Study|Entry Criteria Exclusion|1|||
129956858|NCT00191984|467804538|FG000|Overall Study|Withdrawal by Subject|7|||
129956859|NCT00191984|467804538|FG000|Overall Study|Physician Decision|4|||
129956860|NCT01732627|467804539|FG000|Overall Study|Withdrawal by Subject|1|||
129956861|NCT01732627|467804540|FG001|Overall Study|Withdrawal by Subject|0|||
129956862|NCT00005908|467804543|FG000|Overall Study|Withdrawal by Subject|1|||
129956863|NCT00005908|467804544|FG001|Overall Study|Withdrawal by Subject|0|||
129956864|NCT04736602|467804547|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
129956865|NCT04736602|467804547|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
129956866|NCT02131155|467804553|FG000|Overall Study|Adverse Event|1|||
129956867|NCT02131155|467804554|FG001|Overall Study|Adverse Event|0|||
129956868|NCT02131155|467804553|FG000|Overall Study|Treatment completed|1|||
129956869|NCT02131155|467804554|FG001|Overall Study|Treatment completed|0|||
129956870|NCT02131155|467804553|FG000|Overall Study|Primary tumour recurrence|2|||
129956871|NCT02131155|467804554|FG001|Overall Study|Primary tumour recurrence|1|||
129956872|NCT02131155|467804553|FG000|Overall Study|Refused to continue study medication|1|||
129956873|NCT02131155|467804554|FG001|Overall Study|Refused to continue study medication|0|||
129956874|NCT02131155|467804553|FG000|Overall Study|Study early termination|20|||
129956875|NCT02131155|467804554|FG001|Overall Study|Study early termination|10|||
129956876|NCT01887418|467804555|FG000|Overall Study|Travelling difficulties|0|||
129956877|NCT01887418|467804556|FG001|Overall Study|Travelling difficulties|0|||
129956878|NCT01887418|467804557|FG002|Overall Study|Travelling difficulties|1|||
129956879|NCT00475735|467804558|FG000|Treatment Period 1|Adverse Event|2|||
129956880|NCT00475735|467804559|FG001|Treatment Period 1|Adverse Event|0|||
129956881|NCT00475735|467804560|FG002|Treatment Period 1|Adverse Event|0|||
129956882|NCT00475735|467804561|FG003|Treatment Period 1|Adverse Event|0|||
129956883|NCT00475735|467804562|FG004|Treatment Period 1|Adverse Event|0|||
129956884|NCT00475735|467804563|FG005|Treatment Period 1|Adverse Event|0|||
129956885|NCT00475735|467804558|FG000|Treatment Period 1|Lack of Efficacy|1|||
129956886|NCT00475735|467804559|FG001|Treatment Period 1|Lack of Efficacy|0|||
129956887|NCT00475735|467804560|FG002|Treatment Period 1|Lack of Efficacy|0|||
129956888|NCT00475735|467804561|FG003|Treatment Period 1|Lack of Efficacy|0|||
129956889|NCT00475735|467804562|FG004|Treatment Period 1|Lack of Efficacy|0|||
129956890|NCT00475735|467804563|FG005|Treatment Period 1|Lack of Efficacy|0|||
129956891|NCT00475735|467804558|FG000|Treatment Period 1|Lost to Follow-up|0|||
129956892|NCT00475735|467804559|FG001|Treatment Period 1|Lost to Follow-up|0|||
129956893|NCT00475735|467804560|FG002|Treatment Period 1|Lost to Follow-up|0|||
129956894|NCT00475735|467804561|FG003|Treatment Period 1|Lost to Follow-up|0|||
129956895|NCT00475735|467804562|FG004|Treatment Period 1|Lost to Follow-up|0|||
129956896|NCT00475735|467804563|FG005|Treatment Period 1|Lost to Follow-up|1|||
129956897|NCT00475735|467804558|FG000|Treatment Period 1|Protocol Violation|0|||
129956898|NCT00475735|467804559|FG001|Treatment Period 1|Protocol Violation|0|||
129956899|NCT00475735|467804560|FG002|Treatment Period 1|Protocol Violation|0|||
129956900|NCT00475735|467804561|FG003|Treatment Period 1|Protocol Violation|1|||
129956901|NCT00475735|467804562|FG004|Treatment Period 1|Protocol Violation|0|||
129956902|NCT00475735|467804563|FG005|Treatment Period 1|Protocol Violation|0|||
129956903|NCT00475735|467804558|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129956904|NCT00475735|467804559|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129956905|NCT00475735|467804560|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129956906|NCT00475735|467804561|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129956907|NCT00475735|467804562|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129956908|NCT00475735|467804563|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129956909|NCT00475735|467804558|FG000|Treatment Period 1|DC due to AE but continuing|0|||
129956910|NCT00475735|467804559|FG001|Treatment Period 1|DC due to AE but continuing|0|||
129956911|NCT00475735|467804560|FG002|Treatment Period 1|DC due to AE but continuing|0|||
129956912|NCT00475735|467804561|FG003|Treatment Period 1|DC due to AE but continuing|1|||
129956913|NCT00475735|467804562|FG004|Treatment Period 1|DC due to AE but continuing|2|||
129956914|NCT00475735|467804563|FG005|Treatment Period 1|DC due to AE but continuing|2|||
129956915|NCT00475735|467804558|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956916|NCT00475735|467804559|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
129956917|NCT00475735|467804560|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956918|NCT00475735|467804561|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956919|NCT00475735|467804562|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956920|NCT00475735|467804563|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956921|NCT00475735|467804558|FG000|Treatment Washout|Lost to Follow-up|0|||
129956922|NCT00475735|467804559|FG001|Treatment Washout|Lost to Follow-up|1|||
129956923|NCT00475735|467804560|FG002|Treatment Washout|Lost to Follow-up|0|||
129956924|NCT00475735|467804561|FG003|Treatment Washout|Lost to Follow-up|0|||
129956925|NCT00475735|467804562|FG004|Treatment Washout|Lost to Follow-up|0|||
129956926|NCT00475735|467804563|FG005|Treatment Washout|Lost to Follow-up|0|||
129956927|NCT00475735|467804558|FG000|Treatment Washout|Protocol Violation|0|||
129956928|NCT00475735|467804559|FG001|Treatment Washout|Protocol Violation|1|||
129956929|NCT00475735|467804560|FG002|Treatment Washout|Protocol Violation|0|||
129956930|NCT00475735|467804561|FG003|Treatment Washout|Protocol Violation|0|||
129956931|NCT00475735|467804562|FG004|Treatment Washout|Protocol Violation|0|||
129956932|NCT00475735|467804563|FG005|Treatment Washout|Protocol Violation|0|||
129956933|NCT00475735|467804558|FG000|Treatment Period 2|Adverse Event|0|||
129956934|NCT00475735|467804559|FG001|Treatment Period 2|Adverse Event|1|||
129956935|NCT00475735|467804560|FG002|Treatment Period 2|Adverse Event|0|||
129956936|NCT00475735|467804561|FG003|Treatment Period 2|Adverse Event|2|||
129956937|NCT00475735|467804562|FG004|Treatment Period 2|Adverse Event|0|||
129956938|NCT00475735|467804563|FG005|Treatment Period 2|Adverse Event|0|||
129956939|NCT00475735|467804558|FG000|Treatment Period 2|Lack of Efficacy|0|||
129956940|NCT00475735|467804559|FG001|Treatment Period 2|Lack of Efficacy|0|||
129956941|NCT00475735|467804560|FG002|Treatment Period 2|Lack of Efficacy|0|||
129956942|NCT00475735|467804561|FG003|Treatment Period 2|Lack of Efficacy|0|||
129956943|NCT00475735|467804562|FG004|Treatment Period 2|Lack of Efficacy|0|||
129956944|NCT00475735|467804563|FG005|Treatment Period 2|Lack of Efficacy|1|||
129956945|NCT00475735|467804558|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129956946|NCT00475735|467804559|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129956947|NCT00475735|467804560|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129956948|NCT00475735|467804561|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129956949|NCT00475735|467804562|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129956950|NCT00475735|467804563|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129956951|NCT02097056|467804567|FG000|Overall Study|Protocol Violation|2|||
129956952|NCT02097056|467804567|FG000|Overall Study|Withdrawal by Subject|15|||
129956953|NCT02097056|467804567|FG000|Overall Study|Lost to Follow-up|2|||
129956954|NCT02097056|467804567|FG000|Overall Study|Adverse Event|37|||
129956955|NCT02097056|467804567|FG000|Overall Study|Other|2|||
129956956|NCT01323309|467804568|FG000|Overall Study|Death|9|||
129956957|NCT01323309|467804569|FG001|Overall Study|Death|15|||
129956958|NCT01323309|467804570|FG002|Overall Study|Death|5|||
129956959|NCT01323309|467804568|FG000|Overall Study|Lost to Follow-up|11|||
129956960|NCT01323309|467804569|FG001|Overall Study|Lost to Follow-up|14|||
129956961|NCT01323309|467804570|FG002|Overall Study|Lost to Follow-up|24|||
129956962|NCT01323309|467804568|FG000|Overall Study|Withdrawal by Subject|14|||
129956963|NCT01323309|467804569|FG001|Overall Study|Withdrawal by Subject|14|||
129956964|NCT01323309|467804570|FG002|Overall Study|Withdrawal by Subject|18|||
129956965|NCT01323309|467804568|FG000|Overall Study|Disease progression|5|||
129956966|NCT01323309|467804569|FG001|Overall Study|Disease progression|11|||
129956967|NCT01323309|467804570|FG002|Overall Study|Disease progression|4|||
129956968|NCT03048058|467804576|FG000|Overall Study|Lost to Follow-up|4|||
129956969|NCT03048058|467804577|FG001|Overall Study|Lost to Follow-up|0|||
129956970|NCT03048058|467804576|FG000|Overall Study|Withdrawal by Subject|0|||
129956971|NCT03048058|467804577|FG001|Overall Study|Withdrawal by Subject|4|||
129956972|NCT02359552|467804592|FG000|Overall Study|Lost to Follow-up|3|||
129956973|NCT02359552|467804593|FG001|Overall Study|Lost to Follow-up|4|||
129956974|NCT01395914|467804601|FG000|Overall Study|Unrelated to study drug AE|6|||
129956975|NCT01395914|467804602|FG001|Overall Study|Unrelated to study drug AE|1|||
129956976|NCT01395914|467804601|FG000|Overall Study|Death|23|||
130121037|NCT03008460|468404892|FG001|Overall Study|Study drug not dispensed|1|||
130121038|NCT03008460|468404891|FG000|Overall Study|Adverse Event|0|||
130121039|NCT03008460|468404892|FG001|Overall Study|Adverse Event|1|||
130121040|NCT03008460|468404891|FG000|Overall Study|Withdrawal by Subject|5|||
130121041|NCT03008460|468404892|FG001|Overall Study|Withdrawal by Subject|6|||
130121042|NCT03008460|468404891|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
130121043|NCT03008460|468404892|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
130121044|NCT03008460|468404891|FG000|Overall Study|End of study visit outside permitted time window|0|||
130121045|NCT03008460|468404892|FG001|Overall Study|End of study visit outside permitted time window|1|||
130121046|NCT03008460|468404891|FG000|Overall Study|Lost to Follow-up|1|||
130121047|NCT03008460|468404892|FG001|Overall Study|Lost to Follow-up|3|||
130121048|NCT04947579|468404895|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129956977|NCT01395914|467804602|FG001|Overall Study|Death|17|||
129956978|NCT01395914|467804601|FG000|Overall Study|Other|9|||
129956979|NCT01395914|467804602|FG001|Overall Study|Other|3|||
129956980|NCT01395914|467804601|FG000|Overall Study|Withdrawal by patient|27|||
129956981|NCT01395914|467804602|FG001|Overall Study|Withdrawal by patient|14|||
129956982|NCT01395914|467804601|FG000|Overall Study|Study drug-related AE|1|||
130121049|NCT04947579|468404896|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130121050|NCT04947579|468404897|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129956983|NCT01395914|467804602|FG001|Overall Study|Study drug-related AE|0|||
129956984|NCT01395914|467804601|FG000|Overall Study|Lost to Follow-up|6|||
129956985|NCT01395914|467804602|FG001|Overall Study|Lost to Follow-up|2|||
129956986|NCT03023878|467804607|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
129956987|NCT03023878|467804607|FG000|Pre-Study Run-In Period|Death|1|||
129956988|NCT03023878|467804607|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
129956989|NCT03023878|467804607|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
129956990|NCT03023878|467804607|FG000|Treatment Period|Disease Progression|1|||
129956991|NCT03023878|467804607|FG000|Treatment Period|Withdrawal by Subject|1|||
129956992|NCT03023878|467804607|FG000|Treatment Period|Adverse Event|1|||
129956993|NCT03023878|467804607|FG000|Long Term Follow-Up Period|Death|2|||
129956994|NCT01247922|467804611|FG000|Overall Study|Disease progression|4|||
129956995|NCT01876823|467804614|FG000|Overall Study|Withdrawal by Subject|5|||
129956996|NCT01876823|467804614|FG000|Overall Study|Physician Decision|2|||
129956997|NCT01876823|467804614|FG000|Overall Study|Patients moved|2|||
129956998|NCT02849509|467804615|FG000|Overall Study|Worsening of disease under study|1|||
129956999|NCT02849509|467804616|FG001|Overall Study|Worsening of disease under study|1|||
129957000|NCT02849509|467804617|FG002|Overall Study|Worsening of disease under study|1|||
129957001|NCT02849509|467804615|FG000|Overall Study|Worsening of other pre-existing disease|0|||
129957002|NCT02849509|467804616|FG001|Overall Study|Worsening of other pre-existing disease|1|||
129957003|NCT02849509|467804617|FG002|Overall Study|Worsening of other pre-existing disease|2|||
130084086|NCT02202161|468260877|FG000|Overall Study|Withdrawal by Subject|0|||
130084087|NCT02202161|468260878|FG001|Overall Study|Withdrawal by Subject|0|||
130084088|NCT02202161|468260879|FG002|Overall Study|Withdrawal by Subject|0|||
130084089|NCT02202161|468260880|FG003|Overall Study|Withdrawal by Subject|0|||
130084090|NCT02202161|468260881|FG004|Overall Study|Withdrawal by Subject|1|||
130084091|NCT02202161|468260882|FG005|Overall Study|Withdrawal by Subject|0|||
130084092|NCT02202161|468260883|FG006|Overall Study|Withdrawal by Subject|0|||
130084093|NCT02202161|468260884|FG007|Overall Study|Withdrawal by Subject|0|||
130084094|NCT00832091|468260885|FG000|Overall Study|Adverse Event|1|||
130084095|NCT00832091|468260886|FG001|Overall Study|Adverse Event|1|||
130084096|NCT00832091|468260885|FG000|Overall Study|Protocol Violation|1|||
130084097|NCT00832091|468260886|FG001|Overall Study|Protocol Violation|0|||
130084098|NCT00832091|468260885|FG000|Overall Study|Withdrawal by Subject|2|||
130084099|NCT00832091|468260886|FG001|Overall Study|Withdrawal by Subject|1|||
130084100|NCT00832091|468260885|FG000|Overall Study|Prohibited Medication|1|||
130084101|NCT00832091|468260886|FG001|Overall Study|Prohibited Medication|0|||
130084102|NCT02750501|468260887|FG000|Overall Study|Adverse Event|4|||
130084103|NCT02750501|468260887|FG000|Overall Study|Physician Decision|1|||
130084104|NCT02750501|468260887|FG000|Overall Study|Protocol Violation|1|||
130084105|NCT02750501|468260887|FG000|Overall Study|G-tube came out|1|||
130084106|NCT02750501|468260887|FG000|Overall Study|Non-compliant use of PERT|1|||
130084107|NCT01738594|468260888|FG000|Registration and Treatment Start|Adverse Event|0|||
130084108|NCT01738594|468260889|FG001|Registration and Treatment Start|Adverse Event|1|||
129957004|NCT02849509|467804615|FG000|Overall Study|Other adverse event|36|||
130084109|NCT01738594|468260890|FG002|Registration and Treatment Start|Adverse Event|0|||
130084110|NCT01738594|468260891|FG003|Registration and Treatment Start|Adverse Event|0|||
130084111|NCT01738594|468260892|FG004|Registration and Treatment Start|Adverse Event|0|||
130084112|NCT01738594|468260893|FG005|Registration and Treatment Start|Adverse Event|0|||
130084113|NCT01738594|468260894|FG006|Registration and Treatment Start|Adverse Event|0|||
130084114|NCT01738594|468260895|FG007|Registration and Treatment Start|Adverse Event|0|||
129957005|NCT02849509|467804616|FG001|Overall Study|Other adverse event|41|||
130084115|NCT01738594|468260888|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130084116|NCT01738594|468260889|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129957006|NCT02849509|467804617|FG002|Overall Study|Other adverse event|8|||
129957007|NCT02849509|467804615|FG000|Overall Study|Withdrawal by Subject|6|||
129957008|NCT02849509|467804616|FG001|Overall Study|Withdrawal by Subject|17|||
129957009|NCT02849509|467804617|FG002|Overall Study|Withdrawal by Subject|12|||
129957010|NCT02849509|467804615|FG000|Overall Study|Lost to Follow-up|27|||
129957011|NCT02849509|467804616|FG001|Overall Study|Lost to Follow-up|67|||
129957012|NCT02849509|467804617|FG002|Overall Study|Lost to Follow-up|36|||
129957013|NCT02849509|467804615|FG000|Overall Study|Other, reason not specified|14|||
129957014|NCT02849509|467804616|FG001|Overall Study|Other, reason not specified|29|||
129957015|NCT02849509|467804617|FG002|Overall Study|Other, reason not specified|25|||
129957016|NCT02849509|467804615|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
129957017|NCT02849509|467804616|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
129957018|NCT02849509|467804617|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
129957019|NCT00577096|467804620|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
129957020|NCT00577096|467804621|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
129957021|NCT00577096|467804620|FG000|Short Term Participation|Withdrawal by Subject|3|||
129957022|NCT00577096|467804621|FG001|Short Term Participation|Withdrawal by Subject|5|||
129957023|NCT00577096|467804620|FG000|Short Term Participation|Death|1|||
129957024|NCT00577096|467804621|FG001|Short Term Participation|Death|1|||
129957025|NCT00832650|467804622|FG000|Overall Study|Randomized but not treated|0|||
129957026|NCT00832650|467804623|FG001|Overall Study|Randomized but not treated|0|||
129957027|NCT00832650|467804624|FG002|Overall Study|Randomized but not treated|1|||
129957028|NCT00794573|467804630|FG000|Overall Study|Death|3|||
129957029|NCT00794573|467804631|FG001|Overall Study|Death|0|||
129957030|NCT00794573|467804630|FG000|Overall Study|Withdrawal by Subject|9|||
129957031|NCT00794573|467804631|FG001|Overall Study|Withdrawal by Subject|12|||
129957032|NCT00794573|467804630|FG000|Overall Study|Lost to Follow-up|26|||
129957033|NCT00794573|467804631|FG001|Overall Study|Lost to Follow-up|33|||
129957034|NCT00257556|467804634|FG000|Overall Study|Adverse Event|1|||
129957035|NCT00257556|467804635|FG001|Overall Study|Adverse Event|4|||
129957036|NCT00257556|467804634|FG000|Overall Study|Physician Decision|6|||
129957037|NCT00257556|467804635|FG001|Overall Study|Physician Decision|0|||
129957038|NCT00257556|467804634|FG000|Overall Study|Did not meet hCG criterion|3|||
129957039|NCT00257556|467804635|FG001|Overall Study|Did not meet hCG criterion|0|||
129957040|NCT00257556|467804634|FG000|Overall Study|other reason|4|||
129957041|NCT00257556|467804635|FG001|Overall Study|other reason|6|||
129957042|NCT03849300|467804639|FG000|Overall Study|move out to different area|1|||
129957043|NCT03849300|467804640|FG001|Overall Study|move out to different area|3|||
129957044|NCT03849300|467804641|FG002|Overall Study|move out to different area|1|||
129957045|NCT03849300|467804642|FG003|Overall Study|move out to different area|4|||
129957046|NCT03849300|467804639|FG000|Overall Study|scheduling/transportation conflict|4|||
129957047|NCT03849300|467804640|FG001|Overall Study|scheduling/transportation conflict|4|||
129957048|NCT03849300|467804641|FG002|Overall Study|scheduling/transportation conflict|3|||
129957049|NCT03849300|467804642|FG003|Overall Study|scheduling/transportation conflict|2|||
129957050|NCT04839289|467804643|FG000|Overall Study|Withdrawal by Subject|1|||
129957051|NCT04839289|467804644|FG001|Overall Study|Withdrawal by Subject|0|||
129957052|NCT02418819|467804646|FG000|Overall Study|Adverse Event|0|||
129957053|NCT02418819|467804647|FG001|Overall Study|Adverse Event|0|||
129957054|NCT02418819|467804648|FG002|Overall Study|Adverse Event|1|||
129957055|NCT02418819|467804649|FG003|Overall Study|Adverse Event|0|||
129957056|NCT02418819|467804646|FG000|Overall Study|Lost to Follow-up|1|||
129957057|NCT02418819|467804647|FG001|Overall Study|Lost to Follow-up|0|||
129957058|NCT02418819|467804648|FG002|Overall Study|Lost to Follow-up|0|||
129957059|NCT02418819|467804649|FG003|Overall Study|Lost to Follow-up|0|||
129957060|NCT02418819|467804646|FG000|Overall Study|No longer meets eligibility criteria|0|||
129957061|NCT02418819|467804647|FG001|Overall Study|No longer meets eligibility criteria|0|||
129957062|NCT02418819|467804648|FG002|Overall Study|No longer meets eligibility criteria|1|||
129957063|NCT02418819|467804649|FG003|Overall Study|No longer meets eligibility criteria|0|||
129957064|NCT02418819|467804646|FG000|Overall Study|No longer willing to participate|0|||
129957065|NCT02418819|467804647|FG001|Overall Study|No longer willing to participate|0|||
129957066|NCT02418819|467804648|FG002|Overall Study|No longer willing to participate|2|||
129957067|NCT02418819|467804649|FG003|Overall Study|No longer willing to participate|1|||
129957068|NCT04743999|467804650|FG000|3-month Questionnaire|Death|1|||
129957069|NCT04743999|467804650|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
129957070|NCT04743999|467804650|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
129957071|NCT04743999|467804650|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
129957072|NCT01721759|467804651|FG000|Treatment Period|Disease Progression|85|||
129957073|NCT01721759|467804651|FG000|Treatment Period|Study drug toxicity|14|||
129957074|NCT01721759|467804651|FG000|Treatment Period|Death|1|||
129957075|NCT01721759|467804651|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
129957076|NCT01721759|467804651|FG000|Treatment Period|Participant request to withdraw|3|||
129957077|NCT01721759|467804651|FG000|Treatment Period|Other Reasons|3|||
129957078|NCT01721759|467804651|FG000|End of Study Period|Participant Withdrew Consent|5|||
129957079|NCT01721759|467804651|FG000|End of Study Period|Death|101|||
129957080|NCT01721759|467804651|FG000|End of Study Period|Lost to Follow-up|1|||
129957081|NCT01721759|467804651|FG000|End of Study Period|Other Reasons|10|||
129957082|NCT00464737|467804652|FG000|Overall Study|Adverse Event|12|||
129957083|NCT00464737|467804653|FG001|Overall Study|Adverse Event|17|||
129957084|NCT00464737|467804654|FG002|Overall Study|Adverse Event|33|||
129957085|NCT00464737|467804652|FG000|Overall Study|Lack of Efficacy|7|||
129957086|NCT00464737|467804653|FG001|Overall Study|Lack of Efficacy|7|||
129957087|NCT00464737|467804654|FG002|Overall Study|Lack of Efficacy|4|||
129957088|NCT00464737|467804652|FG000|Overall Study|Withdrawal by Subject|5|||
129957089|NCT00464737|467804653|FG001|Overall Study|Withdrawal by Subject|3|||
129957090|NCT00464737|467804654|FG002|Overall Study|Withdrawal by Subject|5|||
129957091|NCT00464737|467804652|FG000|Overall Study|Protocol Violation|1|||
129957092|NCT00464737|467804653|FG001|Overall Study|Protocol Violation|1|||
129957093|NCT00464737|467804654|FG002|Overall Study|Protocol Violation|5|||
129957094|NCT00464737|467804652|FG000|Overall Study|Non-compliance|0|||
129957095|NCT00464737|467804653|FG001|Overall Study|Non-compliance|1|||
129957096|NCT00464737|467804654|FG002|Overall Study|Non-compliance|1|||
129957097|NCT00464737|467804652|FG000|Overall Study|Lost to Follow-up|5|||
129957098|NCT00464737|467804653|FG001|Overall Study|Lost to Follow-up|2|||
129957099|NCT00464737|467804654|FG002|Overall Study|Lost to Follow-up|5|||
129957100|NCT00464737|467804652|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
129957101|NCT00464737|467804653|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
129957102|NCT00464737|467804654|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
129957103|NCT00464737|467804652|FG000|Overall Study|Other: Subject left town; family illness|1|||
129957104|NCT00464737|467804653|FG001|Overall Study|Other: Subject left town; family illness|0|||
129957105|NCT00464737|467804654|FG002|Overall Study|Other: Subject left town; family illness|0|||
129957106|NCT00464737|467804652|FG000|Overall Study|Other: Study demands too great|0|||
129957107|NCT00464737|467804653|FG001|Overall Study|Other: Study demands too great|1|||
129957108|NCT00464737|467804654|FG002|Overall Study|Other: Study demands too great|0|||
129957109|NCT00464737|467804652|FG000|Overall Study|Other: Personal family reasons|0|||
129957110|NCT00464737|467804653|FG001|Overall Study|Other: Personal family reasons|0|||
129957111|NCT00464737|467804654|FG002|Overall Study|Other: Personal family reasons|1|||
129957112|NCT00464737|467804652|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
129957113|NCT00464737|467804653|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
129957114|NCT00464737|467804654|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
129957115|NCT00925288|467806353|FG000|Overall Study|Lost to Follow-up|9|||
129957116|NCT00925288|467806354|FG001|Overall Study|Lost to Follow-up|7|||
129957117|NCT00635570|467806356|FG000|Overall Study|Lost to Follow-up|8|||
129957118|NCT00635570|467806357|FG001|Overall Study|Lost to Follow-up|8|||
129957119|NCT00635570|467806356|FG000|Overall Study|Withdrawal by Subject|1|||
129957120|NCT00635570|467806357|FG001|Overall Study|Withdrawal by Subject|1|||
129957121|NCT00635570|467806356|FG000|Overall Study|Adverse Event|2|||
129957122|NCT00635570|467806357|FG001|Overall Study|Adverse Event|0|||
129957123|NCT00635570|467806356|FG000|Overall Study|Physician Decision|1|||
129957124|NCT00635570|467806357|FG001|Overall Study|Physician Decision|0|||
129957125|NCT00635570|467806356|FG000|Overall Study|Did not complete survey|2|||
129957126|NCT00635570|467806357|FG001|Overall Study|Did not complete survey|1|||
129957127|NCT00635570|467806356|FG000|Overall Study|Early termination(No sexual activity)|1|||
129957128|NCT00635570|467806357|FG001|Overall Study|Early termination(No sexual activity)|1|||
129957129|NCT00377312|467806368|FG000|Overall Study|Adverse Event|1|||
129957130|NCT00377312|467806369|FG001|Overall Study|Adverse Event|1|||
129957131|NCT02775214|467806370|FG000|Overall Study|Withdrawal by Subject|2|||
129957132|NCT02775214|467806371|FG001|Overall Study|Withdrawal by Subject|0|||
129957133|NCT00762723|467806372|FG000|Overall Study|Study Terminated slow enrollement|5|||
129957134|NCT00762723|467806373|FG001|Overall Study|Study Terminated slow enrollement|5|||
129957135|NCT00762723|467806374|FG002|Overall Study|Study Terminated slow enrollement|3|||
129957136|NCT01145417|467806375|FG000|Overall Study|Death|1|||
129957137|NCT01145417|467806376|FG001|Overall Study|Death|0|||
129957138|NCT01145417|467806375|FG000|Overall Study|Lost to Follow-up|2|||
129957139|NCT01145417|467806376|FG001|Overall Study|Lost to Follow-up|1|||
129957140|NCT01145417|467806375|FG000|Overall Study|Withdrawal by Subject|1|||
130121051|NCT04947579|468404898|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
129957141|NCT01145417|467806376|FG001|Overall Study|Withdrawal by Subject|2|||
129957142|NCT01145417|467806375|FG000|Overall Study|Pregnancy|1|||
129957143|NCT01145417|467806376|FG001|Overall Study|Pregnancy|0|||
129957144|NCT01145417|467806375|FG000|Overall Study|Adverse Event|0|||
129957145|NCT01145417|467806376|FG001|Overall Study|Adverse Event|1|||
129957146|NCT01145417|467806375|FG000|Overall Study|Study terminated by sponsor|35|||
130121052|NCT04947579|468404899|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
130121053|NCT04947579|468404900|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129957147|NCT01145417|467806376|FG001|Overall Study|Study terminated by sponsor|43|||
129957148|NCT01145417|467806375|FG000|Overall Study|Other|1|||
129957149|NCT01145417|467806376|FG001|Overall Study|Other|0|||
129957150|NCT01191697|467806377|FG000|Overall Study|Death|1|||
129957151|NCT01191697|467806377|FG000|Overall Study|Physician Decision|2|||
129957152|NCT01191697|467806377|FG000|Overall Study|Pursue chemoradiation|2|||
129957153|NCT01191697|467806377|FG000|Overall Study|Break from chemotherapy|2|||
129957154|NCT01191697|467806377|FG000|Overall Study|Withdrawal by Subject|1|||
129957155|NCT01191697|467806377|FG000|Overall Study|Surveillance|1|||
129957156|NCT01191697|467806377|FG000|Overall Study|Adverse Event|2|||
129957157|NCT01191697|467806377|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
129957158|NCT01191697|467806377|FG000|Overall Study|Not completed but analyzed|25|||
129957159|NCT05372913|467806393|FG000|Overall Study|Withdrawal by Subject|0|||
129957160|NCT05372913|467806394|FG001|Overall Study|Withdrawal by Subject|2|||
129957161|NCT05372913|467806393|FG000|Overall Study|Protocol Violation|2|||
129957162|NCT05372913|467806394|FG001|Overall Study|Protocol Violation|2|||
129957163|NCT05372913|467806393|FG000|Overall Study|Adverse Event|0|||
129957164|NCT05372913|467806394|FG001|Overall Study|Adverse Event|1|||
129957165|NCT05135156|467806395|FG000|Overall Study|Lost to Follow-up|0|||
129957166|NCT05135156|467806396|FG001|Overall Study|Lost to Follow-up|0|||
129957167|NCT05135156|467806397|FG002|Overall Study|Lost to Follow-up|2|||
129957168|NCT02986659|467806398|FG000|First Intervention Period|Adverse Event|3|||
129957169|NCT02986659|467806399|FG001|First Intervention Period|Adverse Event|1|||
129957170|NCT02986659|467806398|FG000|First Intervention Period|Lost to Follow-up|1|||
129957171|NCT02986659|467806399|FG001|First Intervention Period|Lost to Follow-up|0|||
129957172|NCT02986659|467806398|FG000|First Intervention Period|Withdrawal by Subject|0|||
129957173|NCT02986659|467806399|FG001|First Intervention Period|Withdrawal by Subject|1|||
129957174|NCT02986659|467806398|FG000|Second Intervention Period|Adverse Event|0|||
129957175|NCT02986659|467806399|FG001|Second Intervention Period|Adverse Event|6|||
129957176|NCT01059526|467806402|FG000|Overall Study|Patient enrolled but not treated|20|||
130084117|NCT01738594|468260890|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130084118|NCT01738594|468260891|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130084119|NCT01738594|468260892|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130084120|NCT01738594|468260893|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
130084121|NCT01738594|468260894|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130084122|NCT01738594|468260895|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
130084123|NCT01738594|468260888|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084124|NCT01738594|468260889|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
130084125|NCT01738594|468260890|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084126|NCT01738594|468260891|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084127|NCT01738594|468260892|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084128|NCT01738594|468260893|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084129|NCT01738594|468260894|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084130|NCT01738594|468260895|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
130084131|NCT01738594|468260888|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084132|NCT01738594|468260889|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084133|NCT01738594|468260890|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084134|NCT01738594|468260891|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084135|NCT01738594|468260892|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084136|NCT01738594|468260893|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
130084137|NCT01738594|468260894|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084138|NCT01738594|468260895|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
130084139|NCT01738594|468260888|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084140|NCT01738594|468260889|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084141|NCT01738594|468260890|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084142|NCT01738594|468260891|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084143|NCT01738594|468260892|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084144|NCT01738594|468260893|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
130084145|NCT01738594|468260894|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084146|NCT01738594|468260895|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
130084147|NCT01738594|468260888|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084148|NCT01738594|468260889|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084149|NCT01738594|468260890|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084150|NCT01738594|468260891|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084151|NCT01738594|468260892|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
130084152|NCT01738594|468260893|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084153|NCT01738594|468260894|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084154|NCT01738594|468260895|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
130084155|NCT01738594|468260888|FG000|Follow up for 1 Year|Death|0|||
130084156|NCT01738594|468260889|FG001|Follow up for 1 Year|Death|0|||
129957177|NCT01059526|467806403|FG001|Overall Study|Patient enrolled but not treated|17|||
129957178|NCT01059526|467806402|FG000|Overall Study|Adverse Event|2|||
129957179|NCT01059526|467806403|FG001|Overall Study|Adverse Event|2|||
129957180|NCT01059526|467806402|FG000|Overall Study|Protocol Violation|0|||
130121054|NCT04947579|468404895|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130121055|NCT04947579|468404896|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130121056|NCT04947579|468404897|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
130121057|NCT04947579|468404898|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129957181|NCT01059526|467806403|FG001|Overall Study|Protocol Violation|1|||
129957182|NCT01059526|467806402|FG000|Overall Study|Withdrawal by Subject|3|||
129957183|NCT01059526|467806403|FG001|Overall Study|Withdrawal by Subject|1|||
129957184|NCT01059526|467806402|FG000|Overall Study|Lost to Follow-up|4|||
129957185|NCT01059526|467806403|FG001|Overall Study|Lost to Follow-up|1|||
129957186|NCT01059526|467806402|FG000|Overall Study|Patient found to be dermatographic|1|||
129957187|NCT01059526|467806403|FG001|Overall Study|Patient found to be dermatographic|0|||
129957188|NCT02720081|467806404|FG000|Overall Study|Adverse Event|0|||
129957189|NCT02720081|467806405|FG001|Overall Study|Adverse Event|3|||
129957190|NCT02720081|467806404|FG000|Overall Study|Protocol Violation|4|||
129957191|NCT02720081|467806405|FG001|Overall Study|Protocol Violation|1|||
129957192|NCT01370018|467806406|FG000|Overall Study|Did not meet criteria for analysis|1|||
129957193|NCT01525641|467806407|FG000|Overall Study|Case report form not collected|25|||
129957194|NCT01525641|467806407|FG000|Overall Study|No visit since the first visit|16|||
129957195|NCT01525641|467806407|FG000|Overall Study|Adverse Event|73|||
129957196|NCT01525641|467806407|FG000|Overall Study|Lack of Efficacy|24|||
129957197|NCT01525641|467806407|FG000|Overall Study|Improvement|5|||
129957198|NCT01525641|467806407|FG000|Overall Study|Lost to follow-up (relocation)|1|||
129957199|NCT01525641|467806407|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
129957200|NCT01525641|467806407|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
129957201|NCT01525641|467806407|FG000|Overall Study|Other than stated above|7|||
129957202|NCT03772041|467806408|FG000|Overall Study|Adverse Event|8|||
129957203|NCT03772041|467806409|FG001|Overall Study|Adverse Event|3|||
129957204|NCT03772041|467806408|FG000|Overall Study|Withdrawal by Subject|0|||
129957205|NCT03772041|467806409|FG001|Overall Study|Withdrawal by Subject|2|||
129957206|NCT03772041|467806408|FG000|Overall Study|Protocol Violation|4|||
129957207|NCT03772041|467806409|FG001|Overall Study|Protocol Violation|2|||
129957208|NCT03772041|467806408|FG000|Overall Study|Physician Decision|2|||
129957209|NCT03772041|467806409|FG001|Overall Study|Physician Decision|3|||
129957210|NCT05012397|467806414|FG000|Overall Study|Death|10|||
129957211|NCT05012397|467806414|FG000|Overall Study|Physician Decision|9|||
129957212|NCT05012397|467806414|FG000|Overall Study|Withdrawal by Subject|5|||
129957213|NCT05012397|467806414|FG000|Overall Study|Lost to Follow-up|2|||
129957214|NCT03334747|467806415|FG000|Treatment Phase|Technical problems|0|||
129957215|NCT03334747|467806416|FG001|Treatment Phase|Technical problems|0|||
129957216|NCT03334747|467806417|FG002|Treatment Phase|Technical problems|0|||
129957217|NCT03334747|467806418|FG003|Treatment Phase|Technical problems|0|||
129957218|NCT03334747|467806419|FG004|Treatment Phase|Technical problems|1|||
129957219|NCT03334747|467806420|FG005|Treatment Phase|Technical problems|0|||
129957220|NCT03334747|467806421|FG006|Treatment Phase|Technical problems|0|||
129957221|NCT03334747|467806422|FG007|Treatment Phase|Technical problems|0|||
129957222|NCT03334747|467806423|FG008|Treatment Phase|Technical problems|0|||
129957223|NCT03334747|467806415|FG000|Treatment Phase|Subject/guardian decision|1|||
129957224|NCT03334747|467806416|FG001|Treatment Phase|Subject/guardian decision|0|||
129957225|NCT03334747|467806417|FG002|Treatment Phase|Subject/guardian decision|0|||
129957226|NCT03334747|467806418|FG003|Treatment Phase|Subject/guardian decision|0|||
129957227|NCT03334747|467806419|FG004|Treatment Phase|Subject/guardian decision|0|||
129957228|NCT03334747|467806420|FG005|Treatment Phase|Subject/guardian decision|1|||
129957229|NCT03334747|467806421|FG006|Treatment Phase|Subject/guardian decision|0|||
129957230|NCT03334747|467806422|FG007|Treatment Phase|Subject/guardian decision|0|||
129957231|NCT03334747|467806423|FG008|Treatment Phase|Subject/guardian decision|0|||
129957232|NCT03334747|467806415|FG000|Follow-Up Phase|Subject/guardian decision|0|||
129957233|NCT03334747|467806416|FG001|Follow-Up Phase|Subject/guardian decision|0|||
129957234|NCT03334747|467806417|FG002|Follow-Up Phase|Subject/guardian decision|0|||
129957235|NCT03334747|467806418|FG003|Follow-Up Phase|Subject/guardian decision|0|||
129957236|NCT03334747|467806419|FG004|Follow-Up Phase|Subject/guardian decision|0|||
129957237|NCT03334747|467806420|FG005|Follow-Up Phase|Subject/guardian decision|0|||
130121058|NCT04947579|468404899|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
130121059|NCT04947579|468404900|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129957238|NCT03334747|467806421|FG006|Follow-Up Phase|Subject/guardian decision|1|||
129957239|NCT03334747|467806422|FG007|Follow-Up Phase|Subject/guardian decision|0|||
129957240|NCT03334747|467806423|FG008|Follow-Up Phase|Subject/guardian decision|1|||
129957241|NCT02567227|467806424|FG000|9 Weeks|Adverse Event|5|||
129957242|NCT02567227|467806425|FG001|9 Weeks|Adverse Event|5|||
129957243|NCT02567227|467806424|FG000|9 Weeks|Withdrawal by Subject|18|||
129957244|NCT02567227|467806425|FG001|9 Weeks|Withdrawal by Subject|8|||
129957245|NCT02567227|467806424|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
129957246|NCT02567227|467806425|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
129957247|NCT02567227|467806424|FG000|6 Month|Death|2|||
129957248|NCT02567227|467806425|FG001|6 Month|Death|0|||
129957249|NCT02567227|467806424|FG000|6 Month|Lost to Follow-up|43|||
129957250|NCT02567227|467806425|FG001|6 Month|Lost to Follow-up|40|||
129957251|NCT02567227|467806424|FG000|12 Months|Lost to Follow-up|31|||
129957252|NCT02567227|467806425|FG001|12 Months|Lost to Follow-up|32|||
129957253|NCT02567227|467806424|FG000|12 Months|Death|0|||
129957254|NCT02567227|467806425|FG001|12 Months|Death|2|||
129957255|NCT02137239|467806426|FG000|Overall Study|Discontinued Study Treatment|0|||
129957256|NCT02137239|467806427|FG001|Overall Study|Discontinued Study Treatment|3|||
129957257|NCT02137239|467806426|FG000|Overall Study|Withdrew Consent|1|||
129957258|NCT02137239|467806427|FG001|Overall Study|Withdrew Consent|1|||
129957259|NCT02137239|467806426|FG000|Overall Study|Adverse Event|2|||
129957260|NCT02137239|467806427|FG001|Overall Study|Adverse Event|2|||
129957261|NCT02498418|467806431|FG000|Overall Study|Lack of Efficacy|0|||
129957262|NCT02498418|467806432|FG001|Overall Study|Lack of Efficacy|0|||
129957263|NCT02498418|467806433|FG002|Overall Study|Lack of Efficacy|1|||
129957264|NCT02498418|467806431|FG000|Overall Study|Withdrawal by Subject|2|||
129957265|NCT02498418|467806432|FG001|Overall Study|Withdrawal by Subject|0|||
129957266|NCT02498418|467806433|FG002|Overall Study|Withdrawal by Subject|3|||
129957267|NCT02498418|467806431|FG000|Overall Study|Lost to Follow-up|0|||
129957268|NCT02498418|467806432|FG001|Overall Study|Lost to Follow-up|1|||
129957269|NCT02498418|467806433|FG002|Overall Study|Lost to Follow-up|1|||
129957270|NCT02498418|467806431|FG000|Overall Study|Participant taken prohibited medication|0|||
129957271|NCT02498418|467806432|FG001|Overall Study|Participant taken prohibited medication|1|||
129957272|NCT02498418|467806433|FG002|Overall Study|Participant taken prohibited medication|1|||
129957273|NCT00762502|467806434|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
129957274|NCT00762502|467806435|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
129957275|NCT00762502|467806436|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
129957276|NCT00762502|467806434|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
129957277|NCT00762502|467806435|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
129957278|NCT00762502|467806436|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
129957279|NCT00762502|467806434|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
129957280|NCT00762502|467806435|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
129957281|NCT00762502|467806436|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
129957282|NCT03042559|467806437|FG000|Overall Study|drop out|1|||
129957283|NCT03042559|467806438|FG001|Overall Study|drop out|1|||
129957284|NCT01536535|467806442|FG000|Overall Study|Withdrawal by Subject|10|||
129957285|NCT01536535|467806443|FG001|Overall Study|Withdrawal by Subject|5|||
129957286|NCT01536535|467806442|FG000|Overall Study|Lost to Follow-up|4|||
129957287|NCT01536535|467806443|FG001|Overall Study|Lost to Follow-up|6|||
129957288|NCT01536535|467806442|FG000|Overall Study|Physician Decision|1|||
129957289|NCT01536535|467806443|FG001|Overall Study|Physician Decision|1|||
129957290|NCT01536535|467806442|FG000|Overall Study|Participant moved|0|||
129957291|NCT01536535|467806443|FG001|Overall Study|Participant moved|1|||
129957292|NCT00385697|467806446|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
129957293|NCT00385697|467806447|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
129957294|NCT00385697|467806448|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
129957295|NCT00385697|467806449|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
129957296|NCT00385697|467806450|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
129957297|NCT00385697|467806446|FG000|Open-label Segment 1|Lost to Follow-up|1|||
129957298|NCT00385697|467806447|FG001|Open-label Segment 1|Lost to Follow-up|0|||
129957299|NCT00385697|467806448|FG002|Open-label Segment 1|Lost to Follow-up|0|||
129957300|NCT00385697|467806449|FG003|Open-label Segment 1|Lost to Follow-up|0|||
129957301|NCT00385697|467806450|FG004|Open-label Segment 1|Lost to Follow-up|0|||
129957302|NCT00385697|467806446|FG000|Double-blind Segment 2|Adverse Event|0|||
129957303|NCT00385697|467806447|FG001|Double-blind Segment 2|Adverse Event|3|||
129957304|NCT00385697|467806448|FG002|Double-blind Segment 2|Adverse Event|1|||
129957305|NCT00385697|467806449|FG003|Double-blind Segment 2|Adverse Event|0|||
130084157|NCT01738594|468260890|FG002|Follow up for 1 Year|Death|0|||
130084158|NCT01738594|468260891|FG003|Follow up for 1 Year|Death|0|||
130084159|NCT01738594|468260892|FG004|Follow up for 1 Year|Death|0|||
130084160|NCT01738594|468260893|FG005|Follow up for 1 Year|Death|1|||
130084161|NCT01738594|468260894|FG006|Follow up for 1 Year|Death|0|||
130084162|NCT01738594|468260895|FG007|Follow up for 1 Year|Death|0|||
130084163|NCT01738594|468260888|FG000|Follow up for 1 Year|Other|0|||
129957306|NCT00385697|467806450|FG004|Double-blind Segment 2|Adverse Event|0|||
129957307|NCT00385697|467806446|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
130084164|NCT01738594|468260889|FG001|Follow up for 1 Year|Other|0|||
129957308|NCT00385697|467806447|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
129957309|NCT00385697|467806448|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
129957310|NCT00385697|467806449|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
129957311|NCT00385697|467806450|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
129957312|NCT00385697|467806446|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
129957313|NCT00385697|467806447|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
129957314|NCT00385697|467806448|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
129957315|NCT00385697|467806449|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
129957316|NCT00385697|467806450|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
129957317|NCT00385697|467806446|FG000|Double-blind Segment 2|Other|0|||
129957318|NCT00385697|467806447|FG001|Double-blind Segment 2|Other|2|||
129957319|NCT00385697|467806448|FG002|Double-blind Segment 2|Other|0|||
129957320|NCT00385697|467806449|FG003|Double-blind Segment 2|Other|0|||
129957321|NCT00385697|467806450|FG004|Double-blind Segment 2|Other|0|||
129957322|NCT01485991|467806451|FG000|Overall Study|Adverse Event|0|||
130121060|NCT04947579|468404895|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
130121061|NCT04947579|468404896|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
130121062|NCT04947579|468404897|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
130121063|NCT04947579|468404898|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
130121064|NCT04947579|468404899|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
130121065|NCT04947579|468404900|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
130121066|NCT04947579|468404895|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
130121067|NCT04947579|468404896|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
130121068|NCT04947579|468404897|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
130121069|NCT04947579|468404898|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
130121070|NCT04947579|468404899|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
130121071|NCT04947579|468404900|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
130121072|NCT04947579|468404895|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
130121073|NCT04947579|468404896|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130121074|NCT04947579|468404897|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130121075|NCT04947579|468404898|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130121076|NCT04947579|468404899|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130121077|NCT04947579|468404900|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
130121078|NCT04947579|468404895|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130121079|NCT04947579|468404896|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130121080|NCT04947579|468404897|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
130121081|NCT04947579|468404898|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129957323|NCT01485991|467806452|FG001|Overall Study|Adverse Event|4|||
129957324|NCT01485991|467806451|FG000|Overall Study|Lost to Follow-up|13|||
129957325|NCT01485991|467806452|FG001|Overall Study|Lost to Follow-up|10|||
129957326|NCT01485991|467806451|FG000|Overall Study|Withdrawal by Subject|13|||
129957327|NCT01485991|467806452|FG001|Overall Study|Withdrawal by Subject|20|||
129957328|NCT01485991|467806451|FG000|Overall Study|randomized but not treated|6|||
129957329|NCT01485991|467806452|FG001|Overall Study|randomized but not treated|2|||
129957330|NCT02538471|467806454|FG000|Overall Study|Progression of disease|2|||
129957331|NCT01475370|467806455|FG000|Overall Study|Exacerbation of primary disease|2|||
129957332|NCT01475370|467806456|FG001|Overall Study|Exacerbation of primary disease|2|||
129957333|NCT01475370|467806457|FG002|Overall Study|Exacerbation of primary disease|2|||
129957334|NCT01475370|467806455|FG000|Overall Study|Study drug administration difficult|0|||
129957335|NCT01475370|467806456|FG001|Overall Study|Study drug administration difficult|1|||
129957336|NCT01475370|467806457|FG002|Overall Study|Study drug administration difficult|1|||
129957337|NCT01475370|467806455|FG000|Overall Study|Other than specified|1|||
129957338|NCT01475370|467806456|FG001|Overall Study|Other than specified|0|||
129957339|NCT01475370|467806457|FG002|Overall Study|Other than specified|0|||
129957340|NCT00084747|467806460|FG000|Overall Study|Relapsed|8|||
129957341|NCT00084747|467806460|FG000|Overall Study|Death|3|||
129957342|NCT00084747|467806460|FG000|Overall Study|Withdrawal by Subject|2|||
129957343|NCT02382406|467806465|FG000|Study Treatment|Disease Progression|8|||
129957344|NCT02382406|467806466|FG001|Study Treatment|Disease Progression|0|||
129957345|NCT02382406|467806467|FG002|Study Treatment|Disease Progression|20|||
129957346|NCT02382406|467806465|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
129957347|NCT02382406|467806466|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
129957348|NCT02382406|467806467|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
129957349|NCT02382406|467806465|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
129957350|NCT02382406|467806466|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
129957351|NCT02382406|467806467|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
129957352|NCT02382406|467806465|FG000|Study Treatment|symptomatic deterioration|1|||
129957353|NCT02382406|467806466|FG001|Study Treatment|symptomatic deterioration|0|||
129957354|NCT02382406|467806467|FG002|Study Treatment|symptomatic deterioration|1|||
129957355|NCT02382406|467806465|FG000|Study Treatment|Death|0|||
129957356|NCT02382406|467806466|FG001|Study Treatment|Death|0|||
130121082|NCT04947579|468404899|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130121083|NCT04947579|468404900|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
130121084|NCT04947579|468404895|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129957357|NCT02382406|467806467|FG002|Study Treatment|Death|2|||
129957358|NCT02382406|467806465|FG000|Follow up|Death|11|||
129957359|NCT02382406|467806466|FG001|Follow up|Death|0|||
129957360|NCT02382406|467806467|FG002|Follow up|Death|19|||
129957361|NCT02382406|467806465|FG000|Follow up|Symptomatic deterioration|1|||
129957362|NCT02382406|467806466|FG001|Follow up|Symptomatic deterioration|0|||
129957363|NCT02382406|467806467|FG002|Follow up|Symptomatic deterioration|1|||
129957364|NCT02382406|467806465|FG000|Follow up|Patient Refused Follow-up|1|||
129979961|NCT04372121|467889513|FG003|Overall Study|Protocol Violation|0|||
129957365|NCT02382406|467806466|FG001|Follow up|Patient Refused Follow-up|0|||
129957366|NCT02382406|467806467|FG002|Follow up|Patient Refused Follow-up|0|||
129957367|NCT02382406|467806465|FG000|Follow up|Study Terminated|1|||
129957368|NCT02382406|467806466|FG001|Follow up|Study Terminated|0|||
129957369|NCT02382406|467806467|FG002|Follow up|Study Terminated|8|||
129957370|NCT02382406|467806465|FG000|Follow up|Withdrawal by Subject|0|||
129957371|NCT02382406|467806466|FG001|Follow up|Withdrawal by Subject|0|||
129957372|NCT02382406|467806467|FG002|Follow up|Withdrawal by Subject|2|||
129957373|NCT03794609|467806470|FG000|Overall Study|Other|10|||
129957374|NCT03794609|467806470|FG000|Overall Study|Withdrawal by Subject|66|||
129957375|NCT03794609|467806470|FG000|Overall Study|The child is enrolled in an interventional study|70|||
129957376|NCT03794609|467806470|FG000|Overall Study|Inclusion/exclusion criteria|8|||
129957377|NCT03794609|467806470|FG000|Overall Study|At sponsor's request|151|||
129957378|NCT03794609|467806470|FG000|Overall Study|Physician Decision|1|||
129957379|NCT03794609|467806470|FG000|Overall Study|Lost to Follow-up|5|||
129957380|NCT04543942|467806471|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
129957381|NCT04543942|467806472|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
129957382|NCT04543942|467806471|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
129957383|NCT04543942|467806472|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
129957384|NCT04474691|467806479|FG000|Overall Study|Withdrawal by Subject|9|||
129957385|NCT00139659|467806480|FG000|Overall Study|Adverse Event|12|||
129957386|NCT00139659|467806481|FG001|Overall Study|Adverse Event|1|||
129957387|NCT00139659|467806480|FG000|Overall Study|Lack of Efficacy|1|||
129957388|NCT00139659|467806481|FG001|Overall Study|Lack of Efficacy|1|||
129957389|NCT00139659|467806480|FG000|Overall Study|Lost to Follow-up|7|||
129957390|NCT00139659|467806481|FG001|Overall Study|Lost to Follow-up|3|||
129957391|NCT00139659|467806480|FG000|Overall Study|Reason not Specified|6|||
129957392|NCT00139659|467806481|FG001|Overall Study|Reason not Specified|3|||
129957393|NCT00139659|467806480|FG000|Overall Study|Withdrawal by Subject|14|||
129957394|NCT00139659|467806481|FG001|Overall Study|Withdrawal by Subject|10|||
129957395|NCT02391116|467806483|FG000|Treatment|Withdrawal by Subject|1|||
129957396|NCT02391116|467806483|FG000|Treatment|Protocol Violation|1|||
129957397|NCT02391116|467806483|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
129957398|NCT02391116|467806483|FG000|Treatment|AE with Clinical PD|3|||
129957399|NCT02391116|467806483|FG000|Safety Follow-up|Adverse Event|1|||
129957400|NCT02391116|467806483|FG000|Safety Follow-up|Withdrawal by Subject|4|||
129957401|NCT02391116|467806483|FG000|Safety Follow-up|Switching to Other Therapy|4|||
129957402|NCT02391116|467806483|FG000|Safety Follow-up|No Follow Up|1|||
129957403|NCT02391116|467806483|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
129957404|NCT02391116|467806483|FG000|Active Follow-up|Withdrawal by Subject|1|||
129957405|NCT02391116|467806483|FG000|Active Follow-up|Switching to Other Therapy|2|||
129957406|NCT02391116|467806483|FG000|Survival Follow-up|Withdrawal by Subject|3|||
129957407|NCT02391116|467806483|FG000|Survival Follow-up|Switching to Other Therapy|1|||
129957408|NCT01261793|467806487|FG000|Overall Study|Lack of Efficacy|44|||
129957409|NCT01261793|467806488|FG001|Overall Study|Lack of Efficacy|37|||
129957410|NCT01261793|467806489|FG002|Overall Study|Lack of Efficacy|32|||
129957411|NCT01261793|467806487|FG000|Overall Study|Protocol Violation|3|||
129957412|NCT01261793|467806488|FG001|Overall Study|Protocol Violation|5|||
129957413|NCT01261793|467806489|FG002|Overall Study|Protocol Violation|6|||
129957414|NCT01261793|467806487|FG000|Overall Study|Lost to Follow-up|10|||
129957415|NCT01261793|467806488|FG001|Overall Study|Lost to Follow-up|3|||
129957416|NCT01261793|467806489|FG002|Overall Study|Lost to Follow-up|7|||
129957417|NCT01261793|467806487|FG000|Overall Study|Withdrawal by Subject|12|||
129957418|NCT01261793|467806488|FG001|Overall Study|Withdrawal by Subject|14|||
129957419|NCT01261793|467806489|FG002|Overall Study|Withdrawal by Subject|14|||
129957420|NCT01261793|467806487|FG000|Overall Study|Death|3|||
129957421|NCT01261793|467806488|FG001|Overall Study|Death|1|||
129957422|NCT01261793|467806489|FG002|Overall Study|Death|0|||
129957423|NCT01261793|467806487|FG000|Overall Study|Adverse Event|9|||
129957424|NCT01261793|467806488|FG001|Overall Study|Adverse Event|24|||
129957425|NCT01261793|467806489|FG002|Overall Study|Adverse Event|19|||
129957426|NCT01261793|467806487|FG000|Overall Study|Patient non-availability|1|||
129957427|NCT01261793|467806488|FG001|Overall Study|Patient non-availability|1|||
129957428|NCT01261793|467806489|FG002|Overall Study|Patient non-availability|1|||
129957429|NCT01261793|467806487|FG000|Overall Study|Suspected pregnancy|1|||
129957430|NCT01261793|467806488|FG001|Overall Study|Suspected pregnancy|1|||
129957431|NCT01261793|467806489|FG002|Overall Study|Suspected pregnancy|0|||
129957432|NCT01261793|467806487|FG000|Overall Study|Patient non-compliance|1|||
129957433|NCT01261793|467806488|FG001|Overall Study|Patient non-compliance|0|||
129957434|NCT01261793|467806489|FG002|Overall Study|Patient non-compliance|1|||
129957435|NCT01261793|467806487|FG000|Overall Study|Patient pregnant|1|||
129957436|NCT01261793|467806488|FG001|Overall Study|Patient pregnant|0|||
129957437|NCT01261793|467806489|FG002|Overall Study|Patient pregnant|0|||
129957438|NCT01261793|467806487|FG000|Overall Study|Outside the study area|0|||
129957439|NCT01261793|467806488|FG001|Overall Study|Outside the study area|2|||
129957440|NCT01261793|467806489|FG002|Overall Study|Outside the study area|1|||
129957441|NCT01261793|467806487|FG000|Overall Study|Lack of efficacy & patient not available|0|||
129957442|NCT01261793|467806488|FG001|Overall Study|Lack of efficacy & patient not available|1|||
129957443|NCT01261793|467806489|FG002|Overall Study|Lack of efficacy & patient not available|0|||
129957444|NCT01261793|467806487|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
129957445|NCT01261793|467806488|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
129957446|NCT01261793|467806489|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
129957447|NCT01261793|467806487|FG000|Overall Study|Randomization error|0|||
129957448|NCT01261793|467806488|FG001|Overall Study|Randomization error|1|||
129957449|NCT01261793|467806489|FG002|Overall Study|Randomization error|0|||
129957450|NCT01261793|467806487|FG000|Overall Study|Patient unable to start IV line|0|||
129957451|NCT01261793|467806488|FG001|Overall Study|Patient unable to start IV line|0|||
129957452|NCT01261793|467806489|FG002|Overall Study|Patient unable to start IV line|1|||
129957453|NCT02784535|467806490|FG000|Overall Study|Adverse Event|1|||
129957454|NCT02784535|467806491|FG001|Overall Study|Adverse Event|0|||
129957455|NCT02784535|467806490|FG000|Overall Study|Withdrawal by Subject|0|||
129957456|NCT02784535|467806491|FG001|Overall Study|Withdrawal by Subject|1|||
129957457|NCT02784535|467806490|FG000|Overall Study|Physician Decision|0|||
129957458|NCT02784535|467806491|FG001|Overall Study|Physician Decision|1|||
129957459|NCT02335242|467806495|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
129957460|NCT02335242|467806496|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
129957461|NCT02335242|467806495|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
129957462|NCT02335242|467806496|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129957463|NCT02335242|467806495|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
129957464|NCT02335242|467806496|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
129957465|NCT00905255|467806497|FG000|Overall Study|Adverse Event|7|||
129957466|NCT00905255|467806498|FG001|Overall Study|Adverse Event|5|||
129957467|NCT00905255|467806497|FG000|Overall Study|Withdrawal by Subject|5|||
129957468|NCT00905255|467806498|FG001|Overall Study|Withdrawal by Subject|4|||
129957469|NCT00905255|467806497|FG000|Overall Study|Familial and Personal Reasons|1|||
129957470|NCT00905255|467806498|FG001|Overall Study|Familial and Personal Reasons|0|||
129957471|NCT00390806|467806501|FG000|Overall Study|Lost to Follow-up|7|||
129957472|NCT00390806|467806502|FG001|Overall Study|Lost to Follow-up|6|||
129957473|NCT00390806|467806501|FG000|Overall Study|Protocol Violation|2|||
129957474|NCT00390806|467806502|FG001|Overall Study|Protocol Violation|2|||
129957475|NCT00390806|467806501|FG000|Overall Study|Withdrawal by Subject|12|||
129957476|NCT00390806|467806502|FG001|Overall Study|Withdrawal by Subject|15|||
129957477|NCT00390806|467806501|FG000|Overall Study|Investigator Decision|4|||
129957478|NCT00390806|467806502|FG001|Overall Study|Investigator Decision|6|||
129957479|NCT00390806|467806501|FG000|Overall Study|Death|1|||
129957480|NCT00390806|467806502|FG001|Overall Study|Death|0|||
129957481|NCT00390806|467806501|FG000|Overall Study|Physician Decision|0|||
129957482|NCT00390806|467806502|FG001|Overall Study|Physician Decision|1|||
129957483|NCT00390806|467806501|FG000|Overall Study|Ongoing|4|||
129957484|NCT00390806|467806502|FG001|Overall Study|Ongoing|2|||
129957485|NCT00714688|467806503|FG000|Overall Study|Lack of Efficacy|14|||
129957486|NCT00714688|467806504|FG001|Overall Study|Lack of Efficacy|1|||
129957487|NCT00714688|467806505|FG002|Overall Study|Lack of Efficacy|4|||
129957488|NCT00714688|467806503|FG000|Overall Study|Withdrawal by Subject|4|||
129957489|NCT00714688|467806504|FG001|Overall Study|Withdrawal by Subject|3|||
129957490|NCT00714688|467806505|FG002|Overall Study|Withdrawal by Subject|3|||
129957491|NCT00714688|467806503|FG000|Overall Study|Lost to Follow-up|5|||
129957492|NCT00714688|467806504|FG001|Overall Study|Lost to Follow-up|2|||
129957493|NCT00714688|467806505|FG002|Overall Study|Lost to Follow-up|0|||
129957494|NCT00714688|467806503|FG000|Overall Study|Adverse Event|2|||
129957495|NCT00714688|467806504|FG001|Overall Study|Adverse Event|15|||
129957496|NCT00714688|467806505|FG002|Overall Study|Adverse Event|19|||
129957497|NCT00714688|467806503|FG000|Overall Study|Subject Non-compliant|3|||
129957498|NCT00714688|467806504|FG001|Overall Study|Subject Non-compliant|5|||
129957499|NCT00714688|467806505|FG002|Overall Study|Subject Non-compliant|5|||
129957500|NCT00714688|467806503|FG000|Overall Study|Ineligible to Continue the Study|0|||
129957501|NCT00714688|467806504|FG001|Overall Study|Ineligible to Continue the Study|1|||
130121085|NCT04947579|468404896|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
130121086|NCT04947579|468404897|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129957502|NCT00714688|467806505|FG002|Overall Study|Ineligible to Continue the Study|1|||
129957503|NCT00714688|467806503|FG000|Overall Study|Sponsor's Decision|0|||
129957504|NCT00714688|467806504|FG001|Overall Study|Sponsor's Decision|2|||
129957505|NCT00714688|467806505|FG002|Overall Study|Sponsor's Decision|0|||
129957506|NCT00714688|467806503|FG000|Overall Study|Other|1|||
129957507|NCT00714688|467806504|FG001|Overall Study|Other|6|||
129957508|NCT00714688|467806505|FG002|Overall Study|Other|5|||
129957509|NCT01808144|467806507|FG000|Overall Study|Death|1|||
129957510|NCT01808144|467806508|FG001|Overall Study|Death|0|||
129957511|NCT01808144|467806507|FG000|Overall Study|Withdrawal by Subject|16|||
129957512|NCT01808144|467806508|FG001|Overall Study|Withdrawal by Subject|23|||
129957513|NCT01808144|467806507|FG000|Overall Study|Lost to Follow-up|6|||
129957514|NCT01808144|467806508|FG001|Overall Study|Lost to Follow-up|3|||
129957515|NCT01808144|467806507|FG000|Overall Study|Protocol Violation|6|||
129957516|NCT01808144|467806508|FG001|Overall Study|Protocol Violation|6|||
129957517|NCT01808144|467806507|FG000|Overall Study|Gout flare|0|||
129957518|NCT01808144|467806508|FG001|Overall Study|Gout flare|1|||
129957519|NCT01808144|467806507|FG000|Overall Study|Adverse Event|11|||
129957520|NCT01808144|467806508|FG001|Overall Study|Adverse Event|15|||
129957521|NCT00383500|467806509|FG000|Overall Study|Withdrawal by Subject|8|||
129957522|NCT00383500|467806510|FG001|Overall Study|Withdrawal by Subject|3|||
129957523|NCT00383500|467806511|FG002|Overall Study|Withdrawal by Subject|0|||
129957524|NCT00383500|467806509|FG000|Overall Study|Lost to Follow-up|0|||
129957525|NCT00383500|467806510|FG001|Overall Study|Lost to Follow-up|0|||
129957526|NCT00383500|467806511|FG002|Overall Study|Lost to Follow-up|2|||
129957527|NCT02176356|467808143|FG000|Overall Study|Screen Failure|14|||
129957528|NCT02176356|467808143|FG000|Overall Study|Lost to Follow-up|4|||
129957529|NCT02176356|467808143|FG000|Overall Study|Personal Reasons|3|||
129957530|NCT02176356|467808143|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129957531|NCT00792259|467808144|FG000|Overall Study|Poor Quality Scans|1|||
129957532|NCT00792259|467808145|FG001|Overall Study|Poor Quality Scans|0|||
129957533|NCT00792259|467808146|FG002|Overall Study|Poor Quality Scans|0|||
129957534|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
129957535|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
129957536|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
129957537|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
129957538|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
129957539|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
129957540|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
129957541|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
129957542|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
129957543|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
129957544|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
129957545|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
129957546|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
129957547|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
129957548|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
129957549|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
129957550|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
129957551|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
129957552|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
129957553|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
129957554|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
129957555|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
129957556|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
129957557|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
129957558|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
129957559|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
129957560|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
129957561|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
129957562|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
129957563|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
129957564|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
129957565|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
129957566|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
129957567|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
129957568|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
129957569|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
129957570|NCT00371462|467808150|FG000|Overall Study|Withdrawal by Subject|1|||
129957571|NCT00371462|467808151|FG001|Overall Study|Withdrawal by Subject|0|||
129957572|NCT00371462|467808150|FG000|Overall Study|Other|7|||
129957573|NCT00371462|467808151|FG001|Overall Study|Other|8|||
129957574|NCT03721978|467808153|FG000|Overall Study|Withdrawal by Subject|6|||
129957575|NCT03721978|467808154|FG001|Overall Study|Withdrawal by Subject|1|||
129957576|NCT03721978|467808153|FG000|Overall Study|Adverse Event|1|||
129957577|NCT03721978|467808154|FG001|Overall Study|Adverse Event|1|||
129957578|NCT03721978|467808153|FG000|Overall Study|Progressive Disease|1|||
129957579|NCT03721978|467808154|FG001|Overall Study|Progressive Disease|0|||
129957580|NCT03721978|467808153|FG000|Overall Study|Lost to Follow-up|5|||
129957581|NCT03721978|467808154|FG001|Overall Study|Lost to Follow-up|1|||
129957582|NCT03721978|467808153|FG000|Overall Study|Reason not Specified|0|||
129957583|NCT03721978|467808154|FG001|Overall Study|Reason not Specified|2|||
129957584|NCT05244226|467808155|FG000|Overall Study|Adverse Event|1|||
129957585|NCT05244226|467808156|FG001|Overall Study|Adverse Event|0|||
129957586|NCT05244226|467808157|FG002|Overall Study|Adverse Event|0|||
129957587|NCT05244226|467808155|FG000|Overall Study|Lost to Follow-up|0|||
129957588|NCT05244226|467808156|FG001|Overall Study|Lost to Follow-up|0|||
129957589|NCT05244226|467808157|FG002|Overall Study|Lost to Follow-up|1|||
129957590|NCT05244226|467808155|FG000|Overall Study|Protocol Violation|0|||
129957591|NCT05244226|467808156|FG001|Overall Study|Protocol Violation|2|||
129957592|NCT05244226|467808157|FG002|Overall Study|Protocol Violation|2|||
129957593|NCT02507687|467808158|FG000|Overall Study|Adverse Event|3|||
129957594|NCT02507687|467808159|FG001|Overall Study|Adverse Event|2|||
129957595|NCT02507687|467808160|FG002|Overall Study|Adverse Event|2|||
129957596|NCT02507687|467808161|FG003|Overall Study|Adverse Event|2|||
129957597|NCT02507687|467808158|FG000|Overall Study|Withdrawal by Subject|1|||
129957598|NCT02507687|467808159|FG001|Overall Study|Withdrawal by Subject|4|||
129957599|NCT02507687|467808160|FG002|Overall Study|Withdrawal by Subject|6|||
130121087|NCT04947579|468404898|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
130121088|NCT04947579|468404899|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
130121089|NCT04947579|468404900|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
130121090|NCT04947579|468404895|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130121091|NCT04947579|468404896|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129957600|NCT02507687|467808161|FG003|Overall Study|Withdrawal by Subject|6|||
129957601|NCT02507687|467808158|FG000|Overall Study|Protocol Violation|1|||
129957602|NCT02507687|467808159|FG001|Overall Study|Protocol Violation|0|||
129957603|NCT02507687|467808160|FG002|Overall Study|Protocol Violation|2|||
129957604|NCT02507687|467808161|FG003|Overall Study|Protocol Violation|0|||
129957605|NCT02507687|467808158|FG000|Overall Study|Lost to Follow-up|0|||
129957606|NCT02507687|467808159|FG001|Overall Study|Lost to Follow-up|0|||
129957607|NCT02507687|467808160|FG002|Overall Study|Lost to Follow-up|2|||
129957608|NCT02507687|467808161|FG003|Overall Study|Lost to Follow-up|1|||
129957609|NCT02507687|467808158|FG000|Overall Study|Screen Failure|0|||
129957610|NCT02507687|467808159|FG001|Overall Study|Screen Failure|0|||
129957611|NCT02507687|467808160|FG002|Overall Study|Screen Failure|1|||
129957612|NCT02507687|467808161|FG003|Overall Study|Screen Failure|0|||
129957613|NCT02507687|467808158|FG000|Overall Study|Other, Not Specified|0|||
129957614|NCT02507687|467808159|FG001|Overall Study|Other, Not Specified|0|||
129957615|NCT02507687|467808160|FG002|Overall Study|Other, Not Specified|2|||
129957616|NCT02507687|467808161|FG003|Overall Study|Other, Not Specified|4|||
129957617|NCT00733226|467808162|FG000|Overall Study|Withdrawal by Subject|1|||
129957618|NCT00733226|467808163|FG001|Overall Study|Withdrawal by Subject|0|||
129957619|NCT00733226|467808162|FG000|Overall Study|Lost to Follow-up|2|||
129957620|NCT00733226|467808163|FG001|Overall Study|Lost to Follow-up|0|||
129957621|NCT00733226|467808162|FG000|Overall Study|moved to another place|2|||
129957622|NCT00733226|467808163|FG001|Overall Study|moved to another place|0|||
129957623|NCT03722485|467808166|FG000|Overall Study|Withdrawal by Subject|1|||
129957624|NCT03722485|467808167|FG001|Overall Study|Withdrawal by Subject|0|||
129957625|NCT03722485|467808166|FG000|Overall Study|Adverse Event|0|||
129957626|NCT03722485|467808167|FG001|Overall Study|Adverse Event|2|||
129957627|NCT03722485|467808166|FG000|Overall Study|subject discharged prior to study completion|1|||
129957628|NCT03722485|467808167|FG001|Overall Study|subject discharged prior to study completion|5|||
129957629|NCT03722485|467808166|FG000|Overall Study|eligibility criteria not met|2|||
129957630|NCT03722485|467808167|FG001|Overall Study|eligibility criteria not met|0|||
129957631|NCT00349622|467808168|FG000|Overall Study|Death|168|||
129957632|NCT00349622|467808169|FG001|Overall Study|Death|86|||
129957633|NCT00349622|467808168|FG000|Overall Study|Lost to Follow-up|5|||
129957634|NCT00349622|467808169|FG001|Overall Study|Lost to Follow-up|1|||
129957635|NCT00349622|467808168|FG000|Overall Study|Withdrawal by Subject|5|||
129957636|NCT00349622|467808169|FG001|Overall Study|Withdrawal by Subject|9|||
129957637|NCT01902381|467808170|FG000|Overall Study|Withdrawal by Subject|1|||
129957638|NCT00755716|467808175|FG000|Overall Study|Adverse Event|1|||
129957639|NCT00755716|467808176|FG001|Overall Study|Adverse Event|4|||
130121092|NCT04947579|468404897|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
130121093|NCT04947579|468404898|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129957640|NCT00755716|467808177|FG002|Overall Study|Adverse Event|1|||
129957641|NCT00755716|467808175|FG000|Overall Study|Lack of Efficacy|2|||
129957642|NCT00755716|467808176|FG001|Overall Study|Lack of Efficacy|0|||
129957643|NCT00755716|467808177|FG002|Overall Study|Lack of Efficacy|0|||
129957644|NCT00755716|467808175|FG000|Overall Study|Lost to Follow-up|5|||
129957645|NCT00755716|467808176|FG001|Overall Study|Lost to Follow-up|3|||
129957646|NCT00755716|467808177|FG002|Overall Study|Lost to Follow-up|1|||
129957647|NCT00755716|467808175|FG000|Overall Study|work schedule issues|0|||
129957648|NCT00755716|467808176|FG001|Overall Study|work schedule issues|1|||
129957649|NCT00755716|467808177|FG002|Overall Study|work schedule issues|1|||
129957650|NCT02762500|467808178|FG000|Overall Study|Lack of Efficacy|1|||
129957651|NCT02762500|467808179|FG001|Overall Study|Lack of Efficacy|0|||
129957652|NCT02762500|467808178|FG000|Overall Study|Withdrawal by Subject|1|||
129957653|NCT02762500|467808179|FG001|Overall Study|Withdrawal by Subject|1|||
129957654|NCT02762500|467808178|FG000|Overall Study|Adverse Event|0|||
129957655|NCT02762500|467808179|FG001|Overall Study|Adverse Event|2|||
129957656|NCT02229396|467808180|FG000|Overall Study|Adverse Event|6|||
129957657|NCT02229396|467808181|FG001|Overall Study|Adverse Event|12|||
129957658|NCT02229396|467808182|FG002|Overall Study|Adverse Event|12|||
129957659|NCT02229396|467808180|FG000|Overall Study|Death|2|||
129957660|NCT02229396|467808181|FG001|Overall Study|Death|3|||
129957661|NCT02229396|467808182|FG002|Overall Study|Death|1|||
129957662|NCT02229396|467808180|FG000|Overall Study|Lost to Follow-up|14|||
129957663|NCT02229396|467808181|FG001|Overall Study|Lost to Follow-up|14|||
129957664|NCT02229396|467808182|FG002|Overall Study|Lost to Follow-up|21|||
129957665|NCT02229396|467808180|FG000|Overall Study|Protocol Violation|2|||
129957666|NCT02229396|467808181|FG001|Overall Study|Protocol Violation|1|||
129957667|NCT02229396|467808182|FG002|Overall Study|Protocol Violation|0|||
129957668|NCT02229396|467808180|FG000|Overall Study|Patient Incorrectly Randomized|0|||
129957669|NCT02229396|467808181|FG001|Overall Study|Patient Incorrectly Randomized|0|||
129957670|NCT02229396|467808182|FG002|Overall Study|Patient Incorrectly Randomized|1|||
129957671|NCT02229396|467808180|FG000|Overall Study|Other|10|||
129957672|NCT02229396|467808181|FG001|Overall Study|Other|18|||
129957673|NCT02229396|467808182|FG002|Overall Study|Other|15|||
129957674|NCT02229396|467808180|FG000|Overall Study|Withdrawal by Subject|42|||
129957675|NCT02229396|467808181|FG001|Overall Study|Withdrawal by Subject|28|||
129957676|NCT02229396|467808182|FG002|Overall Study|Withdrawal by Subject|41|||
129957677|NCT02229396|467808180|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
129957678|NCT02229396|467808181|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129957679|NCT02229396|467808182|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
129957680|NCT02229396|467808180|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
129957681|NCT02229396|467808181|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
129957682|NCT02229396|467808182|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
129957683|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
129957684|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
129957685|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
129957686|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
129957687|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
129957688|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
129957689|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
129957690|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
129957691|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
129957692|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
129957693|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
129957694|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
129957695|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
129957696|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
129957697|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
129957698|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
129957699|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
129957700|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
129957701|NCT00352053|467808190|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
129957702|NCT00352053|467808191|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
129957703|NCT00352053|467808190|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
129957704|NCT00352053|467808191|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
129957705|NCT00352053|467808190|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
129957706|NCT00352053|467808191|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
129957707|NCT00352053|467808190|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
129957708|NCT00352053|467808191|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
129957709|NCT01066897|467808192|FG000|Overall Study|Withdrawal by Subject|1|||
129957710|NCT01066897|467808193|FG001|Overall Study|Withdrawal by Subject|0|||
129957711|NCT01066897|467808192|FG000|Overall Study|stopped study after developing the flu.|1|||
129957712|NCT01066897|467808193|FG001|Overall Study|stopped study after developing the flu.|0|||
129957713|NCT03275402|467808194|FG000|Overall Study|Death|17|||
129957714|NCT03275402|467808194|FG000|Overall Study|Study terminated by sponsor|21|||
129957715|NCT03275402|467808194|FG000|Overall Study|Withdrawal by Subject|1|||
129957716|NCT02402465|467808196|FG000|Overall Study|Withdrawal by Subject|0|||
129957717|NCT02402465|467808197|FG001|Overall Study|Withdrawal by Subject|0|||
129957718|NCT02402465|467808198|FG002|Overall Study|Withdrawal by Subject|0|||
129957719|NCT02402465|467808199|FG003|Overall Study|Withdrawal by Subject|0|||
129957720|NCT02402465|467808200|FG004|Overall Study|Withdrawal by Subject|0|||
129957721|NCT02402465|467808201|FG005|Overall Study|Withdrawal by Subject|1|||
129957722|NCT02402465|467808196|FG000|Overall Study|Lost to Follow-up|0|||
129957723|NCT02402465|467808197|FG001|Overall Study|Lost to Follow-up|1|||
129957724|NCT02402465|467808198|FG002|Overall Study|Lost to Follow-up|0|||
129957725|NCT02402465|467808199|FG003|Overall Study|Lost to Follow-up|0|||
129957726|NCT02402465|467808200|FG004|Overall Study|Lost to Follow-up|1|||
129957727|NCT02402465|467808201|FG005|Overall Study|Lost to Follow-up|0|||
129957728|NCT03807700|467808202|FG000|Overall Study|Withdrawal by Subject|2|||
129957729|NCT03807700|467808203|FG001|Overall Study|Withdrawal by Subject|1|||
129957730|NCT02005029|467808205|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
129957731|NCT02005029|467808206|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
129957732|NCT01675050|467808207|FG000|Period One Treatment|Withdrawal by Subject|1|||
129957733|NCT01675050|467808208|FG001|Period One Treatment|Withdrawal by Subject|0|||
129957734|NCT02625922|467808209|FG000|Overall Study|Non-availability of IMP|1|||
129957735|NCT02625922|467808210|FG001|Overall Study|Non-availability of IMP|1|||
129957736|NCT02625922|467808209|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
129957737|NCT02625922|467808210|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
129957738|NCT02282917|467808212|FG000|Overall Study|Withdrawal by Subject|1|||
129957739|NCT02282917|467808212|FG000|Overall Study|Screen Failure/Not Eligible|1|||
129957740|NCT01747629|467808213|FG000|Overall Study|Adverse Event|1|||
129957741|NCT01747629|467808214|FG001|Overall Study|Adverse Event|2|||
130121094|NCT04947579|468404899|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
130121095|NCT04947579|468404900|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129957742|NCT01747629|467808213|FG000|Overall Study|Withdrawal by Subject|2|||
129957743|NCT01747629|467808214|FG001|Overall Study|Withdrawal by Subject|2|||
129957744|NCT01747629|467808213|FG000|Overall Study|Noncompliance|1|||
129957745|NCT01747629|467808214|FG001|Overall Study|Noncompliance|1|||
129957746|NCT01747629|467808213|FG000|Overall Study|Inclusion criteria not met|1|||
129957747|NCT01747629|467808214|FG001|Overall Study|Inclusion criteria not met|0|||
129957748|NCT01747629|467808213|FG000|Overall Study|Not treated|1|||
129957749|NCT01747629|467808214|FG001|Overall Study|Not treated|0|||
129957750|NCT01747629|467808213|FG000|Overall Study|Other|2|||
129957751|NCT01747629|467808214|FG001|Overall Study|Other|1|||
129957752|NCT04414397|467808215|FG000|Control Period|Withdrawal by Subject|2|||
129957753|NCT04414397|467808216|FG001|Control Period|Withdrawal by Subject|2|||
129957754|NCT04414397|467808215|FG000|Control Period|Lost to Follow-up|0|||
129957755|NCT04414397|467808216|FG001|Control Period|Lost to Follow-up|4|||
129957756|NCT04414397|467808215|FG000|Control Period|Protocol deviation|0|||
129957757|NCT04414397|467808216|FG001|Control Period|Protocol deviation|1|||
129957758|NCT04414397|467808215|FG000|Post-Control Period|Withdrawal by Subject|3|||
129957759|NCT04414397|467808216|FG001|Post-Control Period|Withdrawal by Subject|6|||
129957760|NCT04414397|467808215|FG000|Post-Control Period|Lost to Follow-up|4|||
129957761|NCT04414397|467808216|FG001|Post-Control Period|Lost to Follow-up|9|||
129957762|NCT04414397|467808215|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
129957763|NCT04414397|467808216|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
129957764|NCT04414397|467808215|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
129957765|NCT04414397|467808216|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
129957766|NCT01920178|467808218|FG000|Overall Study|Lost to Follow-up|2|||
129957767|NCT01920178|467808219|FG001|Overall Study|Lost to Follow-up|1|||
129957768|NCT03562117|467808223|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
129957769|NCT03562117|467808224|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
129957770|NCT03562117|467808225|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
129957771|NCT01294358|467808226|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957772|NCT01294358|467808227|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
129957773|NCT01294358|467808228|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957774|NCT01294358|467808229|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957775|NCT01294358|467808230|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957776|NCT01294358|467808226|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957777|NCT01294358|467808227|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957778|NCT01294358|467808228|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
129957779|NCT01294358|467808229|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957780|NCT01294358|467808230|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957781|NCT01294358|467808226|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957782|NCT01294358|467808227|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957783|NCT01294358|467808228|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957784|NCT01294358|467808229|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
129957785|NCT01294358|467808230|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957786|NCT01294358|467808226|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957787|NCT01294358|467808227|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957788|NCT01294358|467808228|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957789|NCT01294358|467808229|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957790|NCT01294358|467808230|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
129957791|NCT00655668|467808240|FG000|Overall Study|Adverse Event|6|||
129957792|NCT00655668|467808240|FG000|Overall Study|Death|5|||
129957793|NCT00655668|467808240|FG000|Overall Study|Disease Progression|27|||
129957794|NCT00655668|467808240|FG000|Overall Study|Study Terminated|9|||
129957795|NCT00655668|467808240|FG000|Overall Study|Other|1|||
129957796|NCT00655668|467808240|FG000|Overall Study|New Lymphoma Treatment Started|4|||
129957797|NCT00655668|467808240|FG000|Overall Study|Withdrawal by Subject|2|||
129957798|NCT03740919|467808241|FG000|Lead-in Period|Lost to Follow-up|1|||
129957799|NCT03740919|467808242|FG001|Lead-in Period|Lost to Follow-up|0|||
129957800|NCT03740919|467808243|FG002|Lead-in Period|Lost to Follow-up|0|||
129957801|NCT03740919|467808244|FG003|Lead-in Period|Lost to Follow-up|0|||
129957802|NCT03740919|467808241|FG000|Lead-in Period|Physician Decision|2|||
129957803|NCT03740919|467808242|FG001|Lead-in Period|Physician Decision|0|||
129957804|NCT03740919|467808243|FG002|Lead-in Period|Physician Decision|0|||
129957805|NCT03740919|467808244|FG003|Lead-in Period|Physician Decision|0|||
129957806|NCT03740919|467808241|FG000|Lead-in Period|Protocol Violation|1|||
129957807|NCT03740919|467808242|FG001|Lead-in Period|Protocol Violation|0|||
129957808|NCT03740919|467808243|FG002|Lead-in Period|Protocol Violation|0|||
129957809|NCT03740919|467808244|FG003|Lead-in Period|Protocol Violation|0|||
129957810|NCT03740919|467808241|FG000|Lead-in Period|Withdrawal by Subject|10|||
129957811|NCT03740919|467808242|FG001|Lead-in Period|Withdrawal by Subject|0|||
129957812|NCT03740919|467808243|FG002|Lead-in Period|Withdrawal by Subject|0|||
129957813|NCT03740919|467808244|FG003|Lead-in Period|Withdrawal by Subject|0|||
129957814|NCT03740919|467808241|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
129957815|NCT03740919|467808242|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
129957816|NCT03740919|467808243|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
129957817|NCT03740919|467808244|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
129957818|NCT03740919|467808241|FG000|Lead-in Period|Study Task Too Burdensome|1|||
129957819|NCT03740919|467808242|FG001|Lead-in Period|Study Task Too Burdensome|0|||
129957820|NCT03740919|467808243|FG002|Lead-in Period|Study Task Too Burdensome|0|||
129957821|NCT03740919|467808244|FG003|Lead-in Period|Study Task Too Burdensome|0|||
129957822|NCT03740919|467808241|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
129957823|NCT03740919|467808242|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
129957824|NCT03740919|467808243|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
129957825|NCT03740919|467808244|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
129957826|NCT03740919|467808241|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
129957827|NCT03740919|467808242|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
129957828|NCT03740919|467808243|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
129957829|NCT03740919|467808244|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
129957830|NCT03740919|467808241|FG000|Treatment Period|Adverse Event|0|||
129957831|NCT03740919|467808242|FG001|Treatment Period|Adverse Event|0|||
129957832|NCT03740919|467808243|FG002|Treatment Period|Adverse Event|2|||
129957833|NCT03740919|467808244|FG003|Treatment Period|Adverse Event|0|||
129957834|NCT03740919|467808241|FG000|Treatment Period|Protocol Violation|0|||
129957835|NCT03740919|467808242|FG001|Treatment Period|Protocol Violation|1|||
129957836|NCT03740919|467808243|FG002|Treatment Period|Protocol Violation|0|||
129957837|NCT03740919|467808244|FG003|Treatment Period|Protocol Violation|0|||
129957838|NCT03740919|467808241|FG000|Treatment Period|Withdrawal by Subject|0|||
129957839|NCT03740919|467808242|FG001|Treatment Period|Withdrawal by Subject|7|||
129957840|NCT03740919|467808243|FG002|Treatment Period|Withdrawal by Subject|6|||
129957841|NCT03740919|467808244|FG003|Treatment Period|Withdrawal by Subject|2|||
129957842|NCT03740919|467808241|FG000|Treatment Period|Terminated by Sponsor|0|||
129957843|NCT03740919|467808242|FG001|Treatment Period|Terminated by Sponsor|1|||
129957844|NCT03740919|467808243|FG002|Treatment Period|Terminated by Sponsor|0|||
129957845|NCT03740919|467808244|FG003|Treatment Period|Terminated by Sponsor|0|||
129957846|NCT03740919|467808241|FG000|Treatment Period|Issue with Insulin Pump|0|||
129957847|NCT03740919|467808242|FG001|Treatment Period|Issue with Insulin Pump|1|||
129957848|NCT03740919|467808243|FG002|Treatment Period|Issue with Insulin Pump|0|||
129957849|NCT03740919|467808244|FG003|Treatment Period|Issue with Insulin Pump|0|||
129957850|NCT03740919|467808241|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
129957851|NCT03740919|467808242|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
129957852|NCT03740919|467808243|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
129957853|NCT03740919|467808244|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
129957854|NCT03740919|467808241|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
129957855|NCT03740919|467808242|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
129957856|NCT03740919|467808243|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
130121096|NCT04947579|468404895|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
130121097|NCT04947579|468404896|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
130121098|NCT04947579|468404897|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
130121099|NCT04947579|468404898|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
129957857|NCT03740919|467808244|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
129957858|NCT03740919|467808241|FG000|Treatment Period|Not Completing Diary|0|||
129957859|NCT03740919|467808242|FG001|Treatment Period|Not Completing Diary|0|||
129957860|NCT03740919|467808243|FG002|Treatment Period|Not Completing Diary|1|||
129957861|NCT03740919|467808244|FG003|Treatment Period|Not Completing Diary|0|||
129957862|NCT03740919|467808241|FG000|Treatment Period|Insulin Painful to Participant|0|||
129957863|NCT03740919|467808242|FG001|Treatment Period|Insulin Painful to Participant|0|||
129957864|NCT03740919|467808243|FG002|Treatment Period|Insulin Painful to Participant|1|||
129957865|NCT03740919|467808244|FG003|Treatment Period|Insulin Painful to Participant|0|||
129957866|NCT03873038|467808247|FG000|Part 2|Withdrawal by Subject|0|||
130121100|NCT04947579|468404899|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
130121101|NCT04947579|468404900|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
129957867|NCT03873038|467808248|FG001|Part 2|Withdrawal by Subject|0|||
129957868|NCT03873038|467808249|FG002|Part 2|Withdrawal by Subject|0|||
129957869|NCT03873038|467808250|FG003|Part 2|Withdrawal by Subject|0|||
130121102|NCT04947579|468404895|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
130121103|NCT04947579|468404896|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
130121104|NCT04947579|468404897|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
130121105|NCT04947579|468404898|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
130121106|NCT04947579|468404899|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
130121107|NCT04947579|468404900|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
130121108|NCT04947579|468404895|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
129957870|NCT03873038|467808251|FG004|Part 2|Withdrawal by Subject|0|||
129957871|NCT03873038|467808252|FG005|Part 2|Withdrawal by Subject|1|||
129957872|NCT03873038|467808247|FG000|Part 2|Unknon|0|||
129957873|NCT03873038|467808248|FG001|Part 2|Unknon|0|||
129957874|NCT03873038|467808249|FG002|Part 2|Unknon|0|||
129957875|NCT03873038|467808250|FG003|Part 2|Unknon|0|||
129957876|NCT03873038|467808251|FG004|Part 2|Unknon|1|||
129957877|NCT03873038|467808252|FG005|Part 2|Unknon|0|||
129957878|NCT04222088|467808253|FG000|Overall Study|Lost to Follow-up|5|||
129957879|NCT04222088|467808254|FG001|Overall Study|Lost to Follow-up|1|||
129957880|NCT04222088|467808253|FG000|Overall Study|Withdrawal by Subject|4|||
129957881|NCT04222088|467808254|FG001|Overall Study|Withdrawal by Subject|0|||
129957882|NCT00595764|467808255|FG000|Overall Study|Protocol Violation|24|||
129957883|NCT00595764|467808256|FG001|Overall Study|Protocol Violation|19|||
129957884|NCT00595764|467808255|FG000|Overall Study|Missed Medication >1 week|10|||
129957885|NCT00595764|467808256|FG001|Overall Study|Missed Medication >1 week|17|||
129957886|NCT00595764|467808255|FG000|Overall Study|Missed 3 PM visits|1|||
129957887|NCT00595764|467808256|FG001|Overall Study|Missed 3 PM visits|7|||
129957888|NCT00595764|467808255|FG000|Overall Study|Withdrawal by Subject|4|||
129957889|NCT00595764|467808256|FG001|Overall Study|Withdrawal by Subject|0|||
129957890|NCT01894256|467808259|FG000|Part A|Adverse Event|0|||
129957891|NCT01894256|467808260|FG001|Part A|Adverse Event|1|||
129957892|NCT01894256|467808261|FG002|Part A|Adverse Event|0|||
129957893|NCT01894256|467808259|FG000|Part B|Death|0|||
129957894|NCT01894256|467808260|FG001|Part B|Death|1|||
129957895|NCT01894256|467808261|FG002|Part B|Death|1|||
129957896|NCT01894256|467808259|FG000|Part B|Withdrawal by Subject|0|||
129957897|NCT01894256|467808260|FG001|Part B|Withdrawal by Subject|1|||
129957898|NCT01894256|467808261|FG002|Part B|Withdrawal by Subject|0|||
129957899|NCT01894256|467808259|FG000|Part B|Lack of Efficacy|15|||
129957900|NCT01894256|467808260|FG001|Part B|Lack of Efficacy|12|||
129957901|NCT01894256|467808261|FG002|Part B|Lack of Efficacy|13|||
129957902|NCT02133131|467808262|FG000|Overall Study|Adverse Event|0|||
129957903|NCT02133131|467808263|FG001|Overall Study|Adverse Event|0|||
129957904|NCT02133131|467808264|FG002|Overall Study|Adverse Event|0|||
129957905|NCT02133131|467808265|FG003|Overall Study|Adverse Event|1|||
129957906|NCT02133131|467808266|FG004|Overall Study|Adverse Event|0|||
130084165|NCT01738594|468260890|FG002|Follow up for 1 Year|Other|0|||
130084166|NCT01738594|468260891|FG003|Follow up for 1 Year|Other|0|||
130084167|NCT01738594|468260892|FG004|Follow up for 1 Year|Other|0|||
130084168|NCT01738594|468260893|FG005|Follow up for 1 Year|Other|2|||
130084169|NCT01738594|468260894|FG006|Follow up for 1 Year|Other|0|||
130084170|NCT01738594|468260895|FG007|Follow up for 1 Year|Other|0|||
130084171|NCT00403390|468260896|FG000|Overall Study|Withdrawal by Subject|1|||
130084172|NCT00403390|468260897|FG001|Overall Study|Withdrawal by Subject|0|||
130084173|NCT00403390|468260896|FG000|Overall Study|samples lost|1|||
130084174|NCT00403390|468260897|FG001|Overall Study|samples lost|0|||
130084175|NCT00403390|468260896|FG000|Overall Study|non-compliant|1|||
130084176|NCT00403390|468260897|FG001|Overall Study|non-compliant|0|||
130084177|NCT00942422|468260898|FG000|Overall Study|Withdrawal by Subject|1|||
130084178|NCT00942422|468260898|FG000|Overall Study|Death|1|||
130084179|NCT00942422|468260898|FG000|Overall Study|Progressive diease|1|||
129957907|NCT02133131|467808267|FG005|Overall Study|Adverse Event|0|||
129957908|NCT02133131|467808268|FG006|Overall Study|Adverse Event|0|||
129957909|NCT02133131|467808262|FG000|Overall Study|Lost to Follow-up|1|||
129957910|NCT02133131|467808263|FG001|Overall Study|Lost to Follow-up|0|||
129957911|NCT02133131|467808264|FG002|Overall Study|Lost to Follow-up|0|||
129957912|NCT02133131|467808265|FG003|Overall Study|Lost to Follow-up|1|||
129957913|NCT02133131|467808266|FG004|Overall Study|Lost to Follow-up|0|||
129957914|NCT02133131|467808267|FG005|Overall Study|Lost to Follow-up|0|||
129957915|NCT02133131|467808268|FG006|Overall Study|Lost to Follow-up|0|||
129957916|NCT02133131|467808262|FG000|Overall Study|Status not recorded|4|||
129957917|NCT02133131|467808263|FG001|Overall Study|Status not recorded|5|||
129957918|NCT02133131|467808264|FG002|Overall Study|Status not recorded|1|||
129957919|NCT02133131|467808265|FG003|Overall Study|Status not recorded|4|||
129957920|NCT02133131|467808266|FG004|Overall Study|Status not recorded|0|||
129957921|NCT02133131|467808267|FG005|Overall Study|Status not recorded|0|||
129957922|NCT02133131|467808268|FG006|Overall Study|Status not recorded|0|||
129957923|NCT02133131|467808262|FG000|Overall Study|Ongoing in study|0|||
129957924|NCT02133131|467808263|FG001|Overall Study|Ongoing in study|0|||
129957925|NCT02133131|467808264|FG002|Overall Study|Ongoing in study|0|||
129957926|NCT02133131|467808265|FG003|Overall Study|Ongoing in study|0|||
129957927|NCT02133131|467808266|FG004|Overall Study|Ongoing in study|15|||
129957928|NCT02133131|467808267|FG005|Overall Study|Ongoing in study|14|||
129957929|NCT02133131|467808268|FG006|Overall Study|Ongoing in study|11|||
129957930|NCT02133131|467808262|FG000|Overall Study|Protocol Violation|0|||
129957931|NCT02133131|467808263|FG001|Overall Study|Protocol Violation|0|||
129957932|NCT02133131|467808264|FG002|Overall Study|Protocol Violation|0|||
129957933|NCT02133131|467808265|FG003|Overall Study|Protocol Violation|0|||
129957934|NCT02133131|467808266|FG004|Overall Study|Protocol Violation|0|||
129957935|NCT02133131|467808267|FG005|Overall Study|Protocol Violation|0|||
129957936|NCT02133131|467808268|FG006|Overall Study|Protocol Violation|1|||
129957937|NCT01544153|467808269|FG000|Overall Study|Under 18|0|||
129957938|NCT01544153|467808270|FG001|Overall Study|Under 18|1|||
129957939|NCT01544153|467808271|FG002|Overall Study|Under 18|0|||
129957940|NCT01544153|467808272|FG003|Overall Study|Under 18|0|||
129957941|NCT01544153|467808269|FG000|Overall Study|Non-smoker|0|||
129957942|NCT01544153|467808270|FG001|Overall Study|Non-smoker|0|||
129957943|NCT01544153|467808271|FG002|Overall Study|Non-smoker|1|||
129957944|NCT01544153|467808272|FG003|Overall Study|Non-smoker|0|||
129957945|NCT04783519|467808277|FG000|Overall Study|Withdrawal by Subject|2|||
129957946|NCT04783519|467808278|FG001|Overall Study|Withdrawal by Subject|7|||
129957947|NCT04783519|467808279|FG002|Overall Study|Withdrawal by Subject|3|||
129957948|NCT04783519|467808277|FG000|Overall Study|Lost to Follow-up|9|||
129957949|NCT04783519|467808278|FG001|Overall Study|Lost to Follow-up|7|||
129957950|NCT04783519|467808279|FG002|Overall Study|Lost to Follow-up|6|||
129957951|NCT00884793|467808280|FG000|Overall Study|Withdrawal by Subject|1|||
129957952|NCT01032200|467808281|FG000|Overall Study|Death|1|||
129957953|NCT01032200|467808282|FG001|Overall Study|Death|1|||
129957954|NCT01032200|467808281|FG000|Overall Study|Withdrawal by Subject|1|||
129957955|NCT01032200|467808282|FG001|Overall Study|Withdrawal by Subject|3|||
129957956|NCT01032200|467808281|FG000|Overall Study|Toxicity|0|||
129957957|NCT01032200|467808282|FG001|Overall Study|Toxicity|2|||
129957958|NCT01032200|467808281|FG000|Overall Study|Progression|1|||
129957959|NCT01032200|467808282|FG001|Overall Study|Progression|0|||
129957960|NCT01032200|467808281|FG000|Overall Study|Multiple|1|||
129957961|NCT01032200|467808282|FG001|Overall Study|Multiple|1|||
129957962|NCT02316171|467808288|FG000|Overall Study|difficulties with urinary catheter|1|||
129957963|NCT02316171|467808289|FG001|Overall Study|difficulties with urinary catheter|0|||
129957964|NCT02316171|467808290|FG002|Overall Study|difficulties with urinary catheter|0|||
129957965|NCT02316171|467808291|FG003|Overall Study|difficulties with urinary catheter|0|||
129957966|NCT01804140|467808293|FG000|Overall Study|No sampling or biopsy procedures done|114|||
129957967|NCT01524887|467808294|FG000|Overall Study|Withdrawal by Subject|6|||
129957968|NCT01524887|467808295|FG001|Overall Study|Withdrawal by Subject|2|||
129957969|NCT01524887|467808296|FG002|Overall Study|Withdrawal by Subject|3|||
129957970|NCT01524887|467808294|FG000|Overall Study|Adverse Event|5|||
129957971|NCT01524887|467808295|FG001|Overall Study|Adverse Event|1|||
129957972|NCT01524887|467808296|FG002|Overall Study|Adverse Event|1|||
129957973|NCT01524887|467808294|FG000|Overall Study|Protocol Violation|0|||
129957974|NCT01524887|467808295|FG001|Overall Study|Protocol Violation|0|||
129957975|NCT01524887|467808296|FG002|Overall Study|Protocol Violation|1|||
129957976|NCT01524887|467808294|FG000|Overall Study|Study termination|73|||
129957977|NCT01524887|467808295|FG001|Overall Study|Study termination|87|||
129957978|NCT01524887|467808296|FG002|Overall Study|Study termination|79|||
129957979|NCT01524887|467808294|FG000|Overall Study|Withdrawal by Caregiver|0|||
129957980|NCT01524887|467808295|FG001|Overall Study|Withdrawal by Caregiver|0|||
129957981|NCT01524887|467808296|FG002|Overall Study|Withdrawal by Caregiver|2|||
129957982|NCT01524887|467808294|FG000|Overall Study|Use of prohibited medication|1|||
129957983|NCT01524887|467808295|FG001|Overall Study|Use of prohibited medication|0|||
129957984|NCT01524887|467808296|FG002|Overall Study|Use of prohibited medication|0|||
129957985|NCT02785900|467808297|FG000|Overall Study|Study Termination by Sponsor|64|||
129957986|NCT02785900|467808298|FG001|Overall Study|Study Termination by Sponsor|81|||
129957987|NCT02785900|467808297|FG000|Overall Study|Death|46|||
129957988|NCT02785900|467808298|FG001|Overall Study|Death|32|||
129957989|NCT02785900|467808297|FG000|Overall Study|Withdrawal by Subject|4|||
129957990|NCT02785900|467808298|FG001|Overall Study|Withdrawal by Subject|8|||
129957991|NCT02785900|467808297|FG000|Overall Study|Physician Decision|3|||
129957992|NCT02785900|467808298|FG001|Overall Study|Physician Decision|2|||
129957993|NCT03993054|467808299|FG000|Overall Study|PI Decision|1|||
129957994|NCT04341584|467808303|FG000|Overall Study|Withdrew consent|0|||
129957995|NCT04341584|467808304|FG001|Overall Study|Withdrew consent|2|||
129957996|NCT04341584|467808305|FG002|Overall Study|Withdrew consent|2|||
129957997|NCT04341584|467808306|FG003|Overall Study|Withdrew consent|1|||
129957998|NCT00497198|467808308|FG000|Overall Study|Adverse Event|4|||
129957999|NCT00497198|467808309|FG001|Overall Study|Adverse Event|2|||
129958000|NCT00497198|467808308|FG000|Overall Study|Physician Decision|1|||
129958001|NCT00497198|467808309|FG001|Overall Study|Physician Decision|2|||
129958002|NCT00497198|467808308|FG000|Overall Study|Withdrawal by Subject|0|||
129958003|NCT00497198|467808309|FG001|Overall Study|Withdrawal by Subject|1|||
129958004|NCT04267393|467808310|FG000|Randomization|Adverse Event|1|||
129958005|NCT04267393|467808311|FG001|Randomization|Adverse Event|0|||
129958006|NCT04267393|467808312|FG002|Randomization|Adverse Event|0|||
129958007|NCT04267393|467808310|FG000|Randomization|Administrative Reasons by Sponsor|0|||
129958008|NCT04267393|467808311|FG001|Randomization|Administrative Reasons by Sponsor|1|||
129958009|NCT04267393|467808312|FG002|Randomization|Administrative Reasons by Sponsor|0|||
129958010|NCT04267393|467808310|FG000|Treatment Period|Adverse Event|0|||
129958011|NCT04267393|467808311|FG001|Treatment Period|Adverse Event|2|||
129958012|NCT04267393|467808312|FG002|Treatment Period|Adverse Event|3|||
129958013|NCT04267393|467808310|FG000|Treatment Period|Participant Withdrew Consent|0|||
129958014|NCT04267393|467808311|FG001|Treatment Period|Participant Withdrew Consent|0|||
129958015|NCT04267393|467808312|FG002|Treatment Period|Participant Withdrew Consent|1|||
129958016|NCT04267393|467808310|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
129958017|NCT04267393|467808311|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
129958018|NCT04267393|467808312|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
129958019|NCT02799745|467808313|FG000|Overall Study|Participant moved out of state|1|||
129958020|NCT02799745|467808314|FG001|Overall Study|Participant moved out of state|0|||
129958021|NCT02799745|467808313|FG000|Overall Study|Discontinued due to planned surgery|1|||
129958022|NCT02799745|467808314|FG001|Overall Study|Discontinued due to planned surgery|0|||
129958023|NCT02799745|467808313|FG000|Overall Study|Withdrawal by Subject|16|||
129958024|NCT02799745|467808314|FG001|Overall Study|Withdrawal by Subject|25|||
129958025|NCT02799745|467808313|FG000|Overall Study|Protocol Deviation|4|||
129958026|NCT02799745|467808314|FG001|Overall Study|Protocol Deviation|5|||
129958027|NCT02799745|467808313|FG000|Overall Study|Progressive Disease|28|||
129958028|NCT02799745|467808314|FG001|Overall Study|Progressive Disease|38|||
129958029|NCT02799745|467808313|FG000|Overall Study|Lost to Follow-up|3|||
129958030|NCT02799745|467808314|FG001|Overall Study|Lost to Follow-up|2|||
129958031|NCT02799745|467808313|FG000|Overall Study|Death|3|||
129958032|NCT02799745|467808314|FG001|Overall Study|Death|0|||
129958033|NCT02799745|467808313|FG000|Overall Study|Adverse Event|0|||
129958034|NCT02799745|467808314|FG001|Overall Study|Adverse Event|1|||
129958035|NCT04853238|467808315|FG000|Overall Study|Death|4|||
129958036|NCT04853238|467808316|FG001|Overall Study|Death|0|||
129958037|NCT04853238|467808317|FG002|Overall Study|Death|2|||
129958038|NCT04853238|467808315|FG000|Overall Study|Lost to Follow-up|16|||
129958039|NCT04853238|467808316|FG001|Overall Study|Lost to Follow-up|2|||
129958040|NCT04853238|467808317|FG002|Overall Study|Lost to Follow-up|37|||
129958041|NCT04853238|467808315|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
129958042|NCT04853238|467808316|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
129958043|NCT04853238|467808317|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
129958044|NCT04853238|467808315|FG000|Overall Study|Withdrawal by Subject|6|||
129958045|NCT04853238|467808316|FG001|Overall Study|Withdrawal by Subject|0|||
129958046|NCT04853238|467808317|FG002|Overall Study|Withdrawal by Subject|21|||
129958047|NCT04853238|467808315|FG000|Overall Study|Physician Decision|0|||
129958048|NCT04853238|467808316|FG001|Overall Study|Physician Decision|0|||
129958049|NCT04853238|467808317|FG002|Overall Study|Physician Decision|2|||
129958050|NCT04853238|467808315|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
129958051|NCT04853238|467808316|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
129958052|NCT04853238|467808317|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
129958053|NCT01002547|467810293|FG000|Overall Study|Withdrawal by Subject|4|||
129958054|NCT01002547|467810294|FG001|Overall Study|Withdrawal by Subject|0|||
129958055|NCT01002547|467810295|FG002|Overall Study|Withdrawal by Subject|5|||
129958056|NCT01002547|467810293|FG000|Overall Study|Lost to Follow-up|2|||
129958057|NCT01002547|467810294|FG001|Overall Study|Lost to Follow-up|1|||
129958058|NCT01002547|467810295|FG002|Overall Study|Lost to Follow-up|1|||
129958059|NCT01002547|467810293|FG000|Overall Study|Physician Decision|1|||
129958060|NCT01002547|467810294|FG001|Overall Study|Physician Decision|0|||
129958061|NCT01002547|467810295|FG002|Overall Study|Physician Decision|0|||
129958062|NCT01002547|467810293|FG000|Overall Study|Death|0|||
129958063|NCT01002547|467810294|FG001|Overall Study|Death|2|||
129958064|NCT01002547|467810295|FG002|Overall Study|Death|2|||
129958065|NCT01002547|467810293|FG000|Overall Study|Adverse Event|1|||
129958066|NCT01002547|467810294|FG001|Overall Study|Adverse Event|0|||
129958067|NCT01002547|467810295|FG002|Overall Study|Adverse Event|0|||
129958068|NCT02093897|467810302|FG000|Overall Study|Physician Decision|1|||
129958069|NCT02093897|467810302|FG000|Overall Study|Planned age group closure - no's reached|17|||
129958070|NCT02093897|467810302|FG000|Overall Study|Adverse event, non-fatal|1|||
129958071|NCT00088452|467810303|FG000|Overall Study|Did not receive intervention|1|||
129958072|NCT00088452|467810304|FG001|Overall Study|Did not receive intervention|0|||
129958073|NCT00088452|467810305|FG002|Overall Study|Did not receive intervention|1|||
129958074|NCT02081196|467810307|FG000|Overall Study|Lost to Follow-up|1|||
129958075|NCT03098797|467810310|FG000|Part 2 Open Label Extension|Adverse Event|2|||
129958076|NCT03098797|467810311|FG001|Part 2 Open Label Extension|Adverse Event|0|||
129958077|NCT00434577|467810312|FG000|Months 0-3|Serious Adverse Event|0|||
129958078|NCT00434577|467810313|FG001|Months 0-3|Serious Adverse Event|0|||
129958079|NCT00434577|467810314|FG002|Months 0-3|Serious Adverse Event|1|||
129958080|NCT00434577|467810315|FG003|Months 0-3|Serious Adverse Event|0|||
129958081|NCT00434577|467810316|FG004|Months 0-3|Serious Adverse Event|0|||
129958082|NCT00434577|467810312|FG000|Months 0-3|Adverse Event|0|||
129958083|NCT00434577|467810313|FG001|Months 0-3|Adverse Event|1|||
129958084|NCT00434577|467810314|FG002|Months 0-3|Adverse Event|1|||
129958085|NCT00434577|467810315|FG003|Months 0-3|Adverse Event|0|||
129958086|NCT00434577|467810316|FG004|Months 0-3|Adverse Event|0|||
129958087|NCT00434577|467810312|FG000|Months 0-3|Lost to Follow-up|0|||
129958088|NCT00434577|467810313|FG001|Months 0-3|Lost to Follow-up|0|||
129958089|NCT00434577|467810314|FG002|Months 0-3|Lost to Follow-up|0|||
129958090|NCT00434577|467810315|FG003|Months 0-3|Lost to Follow-up|0|||
129958091|NCT00434577|467810316|FG004|Months 0-3|Lost to Follow-up|2|||
129958092|NCT00434577|467810312|FG000|Months 0-3|Protocol Violation|1|||
129958093|NCT00434577|467810313|FG001|Months 0-3|Protocol Violation|0|||
129958094|NCT00434577|467810314|FG002|Months 0-3|Protocol Violation|1|||
129958095|NCT00434577|467810315|FG003|Months 0-3|Protocol Violation|0|||
129958096|NCT00434577|467810316|FG004|Months 0-3|Protocol Violation|0|||
129958097|NCT00434577|467810312|FG000|Months 0-3|Withdrawal by Subject|2|||
129958098|NCT00434577|467810313|FG001|Months 0-3|Withdrawal by Subject|1|||
129958099|NCT00434577|467810314|FG002|Months 0-3|Withdrawal by Subject|1|||
129958100|NCT00434577|467810315|FG003|Months 0-3|Withdrawal by Subject|1|||
129958101|NCT00434577|467810316|FG004|Months 0-3|Withdrawal by Subject|1|||
129958102|NCT01589523|467810329|FG000|Overall Study|Withdrawal by Subject|1|||
129958103|NCT00961896|467810330|FG000|Overall Study|Abnormal laboratory value|0|||
129958104|NCT00961896|467810331|FG001|Overall Study|Abnormal laboratory value|0|||
129958105|NCT00961896|467810332|FG002|Overall Study|Abnormal laboratory value|1|||
129958106|NCT00506922|467810333|FG000|Overall Study|Physician Decision|0|||
129958107|NCT00506922|467810334|FG001|Overall Study|Physician Decision|0|||
129958108|NCT00506922|467810335|FG002|Overall Study|Physician Decision|0|||
129958109|NCT00506922|467810336|FG003|Overall Study|Physician Decision|2|||
129958110|NCT00506922|467810337|FG004|Overall Study|Physician Decision|0|||
129958111|NCT00506922|467810333|FG000|Overall Study|Withdrawal by Subject|0|||
129958112|NCT00506922|467810334|FG001|Overall Study|Withdrawal by Subject|0|||
129958113|NCT00506922|467810335|FG002|Overall Study|Withdrawal by Subject|0|||
129958114|NCT00506922|467810336|FG003|Overall Study|Withdrawal by Subject|0|||
129958115|NCT00506922|467810337|FG004|Overall Study|Withdrawal by Subject|1|||
129958116|NCT02675998|467810346|FG000|8-Week Treatment Period|Adverse Event|6|||
129958117|NCT02675998|467810347|FG001|8-Week Treatment Period|Adverse Event|5|||
129958118|NCT02675998|467810348|FG002|8-Week Treatment Period|Adverse Event|6|||
129958119|NCT02675998|467810349|FG003|8-Week Treatment Period|Adverse Event|0|||
129958120|NCT02675998|467810346|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
129958121|NCT02675998|467810347|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
129958122|NCT02675998|467810348|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
129958123|NCT02675998|467810349|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
129958124|NCT02675998|467810346|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
129958125|NCT02675998|467810347|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
129958126|NCT02675998|467810348|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
129958127|NCT02675998|467810349|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
129958128|NCT02675998|467810346|FG000|8-Week Treatment Period|Physician Decision|1|||
129958129|NCT02675998|467810347|FG001|8-Week Treatment Period|Physician Decision|0|||
129958130|NCT02675998|467810348|FG002|8-Week Treatment Period|Physician Decision|2|||
129958131|NCT02675998|467810349|FG003|8-Week Treatment Period|Physician Decision|0|||
129958132|NCT02675998|467810346|FG000|8-Week Treatment Period|GI side Effects|1|||
129958133|NCT02675998|467810347|FG001|8-Week Treatment Period|GI side Effects|4|||
129958134|NCT02675998|467810348|FG002|8-Week Treatment Period|GI side Effects|2|||
129958135|NCT02675998|467810349|FG003|8-Week Treatment Period|GI side Effects|0|||
129958136|NCT02675998|467810346|FG000|8-Week Treatment Period|Protocol Violation|1|||
130121109|NCT04947579|468404896|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
129958137|NCT02675998|467810347|FG001|8-Week Treatment Period|Protocol Violation|1|||
129958138|NCT02675998|467810348|FG002|8-Week Treatment Period|Protocol Violation|1|||
129958139|NCT02675998|467810349|FG003|8-Week Treatment Period|Protocol Violation|0|||
129958140|NCT02675998|467810346|FG000|8-Week Treatment Period|Other|3|||
129958141|NCT02675998|467810347|FG001|8-Week Treatment Period|Other|1|||
129958142|NCT02675998|467810348|FG002|8-Week Treatment Period|Other|2|||
129958143|NCT02675998|467810349|FG003|8-Week Treatment Period|Other|0|||
129958144|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
129958145|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
129958146|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
129958147|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
129958148|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
129958149|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
129958150|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
129958151|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
130121110|NCT04947579|468404897|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
130121111|NCT04947579|468404898|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
130121112|NCT04947579|468404899|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
130121113|NCT04947579|468404900|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
130121114|NCT03481309|468404901|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
130121115|NCT03481309|468404902|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130121116|NCT03481309|468404903|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130121117|NCT03481309|468404904|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130121118|NCT03481309|468404905|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130121119|NCT03481309|468404906|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
130121120|NCT01575054|468404907|FG000|Overall Study|Other Reasons|5|||
130121121|NCT01575054|468404908|FG001|Overall Study|Other Reasons|3|||
130121122|NCT01575054|468404907|FG000|Overall Study|Protocol Violation|2|||
130121123|NCT01575054|468404908|FG001|Overall Study|Protocol Violation|1|||
130121124|NCT01575054|468404907|FG000|Overall Study|Personal Reasons|10|||
130121125|NCT01575054|468404908|FG001|Overall Study|Personal Reasons|11|||
130121126|NCT01575054|468404907|FG000|Overall Study|Lost to Follow-up|3|||
130121127|NCT01575054|468404908|FG001|Overall Study|Lost to Follow-up|3|||
130121128|NCT01575054|468404907|FG000|Overall Study|Adverse Event|9|||
130121129|NCT01575054|468404908|FG001|Overall Study|Adverse Event|8|||
130121130|NCT03495869|468404911|FG000|Overall Study|Lost to Follow-up|4|||
130121131|NCT03495869|468404912|FG001|Overall Study|Lost to Follow-up|17|||
130121132|NCT03495869|468404913|FG002|Overall Study|Lost to Follow-up|8|||
130121133|NCT03495869|468404914|FG003|Overall Study|Lost to Follow-up|14|||
130121134|NCT03495869|468404911|FG000|Overall Study|Withdrawal by Subject|0|||
130121135|NCT03495869|468404912|FG001|Overall Study|Withdrawal by Subject|3|||
130121136|NCT03495869|468404913|FG002|Overall Study|Withdrawal by Subject|0|||
130121137|NCT03495869|468404914|FG003|Overall Study|Withdrawal by Subject|3|||
130121138|NCT03495869|468404911|FG000|Overall Study|Dropped from study|0|||
130121139|NCT03495869|468404912|FG001|Overall Study|Dropped from study|7|||
130121140|NCT03495869|468404913|FG002|Overall Study|Dropped from study|2|||
130121141|NCT03495869|468404914|FG003|Overall Study|Dropped from study|4|||
130121142|NCT04634409|468404915|FG000|Overall Study|Death|0|||
130121143|NCT04634409|468404916|FG001|Overall Study|Death|0|||
130121144|NCT04634409|468404917|FG002|Overall Study|Death|0|||
130121145|NCT04634409|468404918|FG003|Overall Study|Death|0|||
130121146|NCT04634409|468404919|FG004|Overall Study|Death|0|||
130121147|NCT04634409|468404920|FG005|Overall Study|Death|0|||
130121148|NCT04634409|468404921|FG006|Overall Study|Death|0|||
130121149|NCT04634409|468404922|FG007|Overall Study|Death|0|||
130121150|NCT04634409|468404923|FG008|Overall Study|Death|0|||
130121151|NCT04634409|468404924|FG009|Overall Study|Death|0|||
130121152|NCT04634409|468404925|FG010|Overall Study|Death|1|||
130121153|NCT04634409|468404926|FG011|Overall Study|Death|0|||
130121154|NCT04634409|468404927|FG012|Overall Study|Death|1|||
130121155|NCT04634409|468404928|FG013|Overall Study|Death|0|||
130121156|NCT04634409|468404929|FG014|Overall Study|Death|0|||
130121157|NCT04634409|468404930|FG015|Overall Study|Death|0|||
130121158|NCT04634409|468404931|FG016|Overall Study|Death|0|||
130121159|NCT04634409|468404932|FG017|Overall Study|Death|0|||
130121160|NCT04634409|468404933|FG018|Overall Study|Death|0|||
130121161|NCT04634409|468404934|FG019|Overall Study|Death|0|||
130121162|NCT04634409|468404935|FG020|Overall Study|Death|0|||
130121163|NCT04634409|468404936|FG021|Overall Study|Death|0|||
130121164|NCT04634409|468404937|FG022|Overall Study|Death|0|||
130121165|NCT04634409|468404938|FG023|Overall Study|Death|0|||
130121166|NCT04634409|468404939|FG024|Overall Study|Death|0|||
130121167|NCT04634409|468404940|FG025|Overall Study|Death|0|||
130121168|NCT04634409|468404941|FG026|Overall Study|Death|0|||
130121169|NCT04634409|468404915|FG000|Overall Study|Adverse Event|0|||
130121170|NCT04634409|468404916|FG001|Overall Study|Adverse Event|0|||
130121171|NCT04634409|468404917|FG002|Overall Study|Adverse Event|1|||
130121172|NCT04634409|468404918|FG003|Overall Study|Adverse Event|0|||
130121173|NCT04634409|468404919|FG004|Overall Study|Adverse Event|0|||
130121174|NCT04634409|468404920|FG005|Overall Study|Adverse Event|1|||
130121175|NCT04634409|468404921|FG006|Overall Study|Adverse Event|0|||
130121176|NCT04634409|468404922|FG007|Overall Study|Adverse Event|0|||
130121177|NCT04634409|468404923|FG008|Overall Study|Adverse Event|0|||
129958152|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
130121178|NCT04634409|468404924|FG009|Overall Study|Adverse Event|0|||
130121179|NCT04634409|468404925|FG010|Overall Study|Adverse Event|0|||
130121180|NCT04634409|468404926|FG011|Overall Study|Adverse Event|0|||
130121181|NCT04634409|468404927|FG012|Overall Study|Adverse Event|0|||
130121182|NCT04634409|468404928|FG013|Overall Study|Adverse Event|0|||
130121183|NCT04634409|468404929|FG014|Overall Study|Adverse Event|0|||
130121184|NCT04634409|468404930|FG015|Overall Study|Adverse Event|0|||
130121185|NCT04634409|468404931|FG016|Overall Study|Adverse Event|0|||
130121186|NCT04634409|468404932|FG017|Overall Study|Adverse Event|0|||
130121187|NCT04634409|468404933|FG018|Overall Study|Adverse Event|0|||
130121188|NCT04634409|468404934|FG019|Overall Study|Adverse Event|0|||
130121189|NCT04634409|468404935|FG020|Overall Study|Adverse Event|0|||
129958153|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
129958154|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
129958155|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
129958156|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
129958157|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
129958158|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
129958159|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
129958160|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
129958161|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
129958162|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
129958163|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
129958164|NCT00275301|467810350|FG000|Overall Study|Adverse Event|5|||
129958165|NCT04357964|467810351|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
129958166|NCT04357964|467810352|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
129958167|NCT04357964|467810351|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
129958168|NCT04357964|467810352|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
129958169|NCT04357964|467810351|FG000|Overall Study|Adipose sample was insufficient quality|0|||
129958170|NCT04357964|467810352|FG001|Overall Study|Adipose sample was insufficient quality|1|||
129958171|NCT00848393|467810361|FG000|Overall Study|Protocol Violation|0|||
129958172|NCT00848393|467810362|FG001|Overall Study|Protocol Violation|0|||
129958173|NCT00848393|467810363|FG002|Overall Study|Protocol Violation|1|||
129958174|NCT00848393|467810361|FG000|Overall Study|surgical complications unrelated to stud|0|||
129958175|NCT00848393|467810362|FG001|Overall Study|surgical complications unrelated to stud|0|||
129958176|NCT00848393|467810363|FG002|Overall Study|surgical complications unrelated to stud|2|||
129958177|NCT02561078|467810364|FG000|Overall Study|Adverse Event|5|||
129958178|NCT02561078|467810365|FG001|Overall Study|Adverse Event|2|||
129958179|NCT02561078|467810364|FG000|Overall Study|Death|2|||
129958180|NCT02561078|467810365|FG001|Overall Study|Death|1|||
129958181|NCT02561078|467810364|FG000|Overall Study|Lost to Follow-up|2|||
129958182|NCT02561078|467810365|FG001|Overall Study|Lost to Follow-up|6|||
129958183|NCT02561078|467810364|FG000|Overall Study|Non-Compliance with Study Drug|6|||
130084180|NCT02711553|468260901|FG000|Overall Study|Withdrawal by Subject|2|||
130084181|NCT02711553|468260902|FG001|Overall Study|Withdrawal by Subject|1|||
130084182|NCT02711553|468260903|FG002|Overall Study|Withdrawal by Subject|1|||
130084183|NCT02711553|468260904|FG003|Overall Study|Withdrawal by Subject|0|||
130084184|NCT02711553|468260901|FG000|Overall Study|Lost to Follow-up|3|||
130084185|NCT02711553|468260902|FG001|Overall Study|Lost to Follow-up|3|||
130084186|NCT02711553|468260903|FG002|Overall Study|Lost to Follow-up|6|||
130084187|NCT02711553|468260904|FG003|Overall Study|Lost to Follow-up|3|||
130084188|NCT02711553|468260901|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
130084189|NCT02711553|468260902|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
130084190|NCT02711553|468260903|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
130084191|NCT02711553|468260904|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
130084192|NCT05559203|468260905|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
130084193|NCT03117309|468260906|FG000|Overall Study|Not meeting inclusion criteria|0|||
130084194|NCT03117309|468260907|FG001|Overall Study|Not meeting inclusion criteria|1|||
130084195|NCT04048876|468260908|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
130084196|NCT04048876|468260909|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
130084197|NCT04048876|468260910|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
130084198|NCT04048876|468260911|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
130084199|NCT04048876|468260908|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
130084200|NCT04048876|468260909|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
130084201|NCT04048876|468260910|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
130084202|NCT04048876|468260911|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
130084203|NCT04048876|468260908|FG000|Placebo Controlled Phase|Adverse Event|0|||
130084204|NCT04048876|468260909|FG001|Placebo Controlled Phase|Adverse Event|1|||
130084205|NCT04048876|468260910|FG002|Placebo Controlled Phase|Adverse Event|0|||
130084206|NCT04048876|468260911|FG003|Placebo Controlled Phase|Adverse Event|0|||
130084207|NCT04048876|468260908|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
130084208|NCT04048876|468260909|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
130084209|NCT04048876|468260910|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
130084210|NCT04048876|468260911|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
130084211|NCT02187224|468260912|FG000|Overall Study|Did not show up for test day|1|||
129958184|NCT02561078|467810365|FG001|Overall Study|Non-Compliance with Study Drug|3|||
129958185|NCT02561078|467810364|FG000|Overall Study|Physician Decision|2|||
130084212|NCT02187224|468260913|FG001|Overall Study|Did not show up for test day|0|||
130084213|NCT01010776|468260919|FG000|Main Phase|Withdrawal by Subject|14|||
130084214|NCT01010776|468260919|FG000|Main Phase|Lack of Efficacy|8|||
130084215|NCT01010776|468260919|FG000|Main Phase|Adverse Event|7|||
130121190|NCT04634409|468404936|FG021|Overall Study|Adverse Event|0|||
130121191|NCT04634409|468404937|FG022|Overall Study|Adverse Event|0|||
130121192|NCT04634409|468404938|FG023|Overall Study|Adverse Event|0|||
130121193|NCT04634409|468404939|FG024|Overall Study|Adverse Event|0|||
130121194|NCT04634409|468404940|FG025|Overall Study|Adverse Event|0|||
130121195|NCT04634409|468404941|FG026|Overall Study|Adverse Event|0|||
130121196|NCT04634409|468404915|FG000|Overall Study|Lost to Follow-up|3|||
130121197|NCT04634409|468404916|FG001|Overall Study|Lost to Follow-up|1|||
130121198|NCT04634409|468404917|FG002|Overall Study|Lost to Follow-up|1|||
130121199|NCT04634409|468404918|FG003|Overall Study|Lost to Follow-up|3|||
130121200|NCT04634409|468404919|FG004|Overall Study|Lost to Follow-up|1|||
130121201|NCT04634409|468404920|FG005|Overall Study|Lost to Follow-up|1|||
130121202|NCT04634409|468404921|FG006|Overall Study|Lost to Follow-up|1|||
129958186|NCT02561078|467810365|FG001|Overall Study|Physician Decision|3|||
129958187|NCT02561078|467810364|FG000|Overall Study|Withdrawal by Subject|13|||
129958188|NCT02561078|467810365|FG001|Overall Study|Withdrawal by Subject|10|||
129958189|NCT00043186|467810370|FG000|Overall Study|Physician Decision|0|||
129958190|NCT00043186|467810371|FG001|Overall Study|Physician Decision|0|||
129958191|NCT00043186|467810372|FG002|Overall Study|Physician Decision|3|||
129958192|NCT00043186|467810373|FG003|Overall Study|Physician Decision|0|||
129958193|NCT00043186|467810374|FG004|Overall Study|Physician Decision|1|||
129958194|NCT00043186|467810375|FG005|Overall Study|Physician Decision|0|||
129958195|NCT00043186|467810376|FG006|Overall Study|Physician Decision|0|||
129958196|NCT00043186|467810377|FG007|Overall Study|Physician Decision|1|||
129958197|NCT00043186|467810378|FG008|Overall Study|Physician Decision|1|||
129958198|NCT00043186|467810370|FG000|Overall Study|Adverse Event|2|||
129958199|NCT00043186|467810371|FG001|Overall Study|Adverse Event|2|||
129958200|NCT00043186|467810372|FG002|Overall Study|Adverse Event|2|||
129958201|NCT00043186|467810373|FG003|Overall Study|Adverse Event|3|||
129958202|NCT00043186|467810374|FG004|Overall Study|Adverse Event|2|||
129958203|NCT00043186|467810375|FG005|Overall Study|Adverse Event|1|||
129958204|NCT00043186|467810376|FG006|Overall Study|Adverse Event|2|||
129958205|NCT00043186|467810377|FG007|Overall Study|Adverse Event|1|||
129958206|NCT00043186|467810378|FG008|Overall Study|Adverse Event|3|||
129958207|NCT00043186|467810370|FG000|Overall Study|Withdrawal by Subject|11|||
129958208|NCT00043186|467810371|FG001|Overall Study|Withdrawal by Subject|8|||
129958209|NCT00043186|467810372|FG002|Overall Study|Withdrawal by Subject|11|||
129958210|NCT00043186|467810373|FG003|Overall Study|Withdrawal by Subject|13|||
129958211|NCT00043186|467810374|FG004|Overall Study|Withdrawal by Subject|14|||
129958212|NCT00043186|467810375|FG005|Overall Study|Withdrawal by Subject|6|||
129958213|NCT00043186|467810376|FG006|Overall Study|Withdrawal by Subject|12|||
129958214|NCT00043186|467810377|FG007|Overall Study|Withdrawal by Subject|9|||
129958215|NCT00043186|467810378|FG008|Overall Study|Withdrawal by Subject|10|||
129958216|NCT00043186|467810370|FG000|Overall Study|Death|0|||
129958217|NCT00043186|467810371|FG001|Overall Study|Death|0|||
129958218|NCT00043186|467810372|FG002|Overall Study|Death|1|||
129958219|NCT00043186|467810373|FG003|Overall Study|Death|0|||
129958220|NCT00043186|467810374|FG004|Overall Study|Death|0|||
129958221|NCT00043186|467810375|FG005|Overall Study|Death|0|||
129958222|NCT00043186|467810376|FG006|Overall Study|Death|2|||
129958223|NCT00043186|467810377|FG007|Overall Study|Death|0|||
129958224|NCT00043186|467810378|FG008|Overall Study|Death|0|||
129958225|NCT00043186|467810370|FG000|Overall Study|Disease progression|1|||
129958226|NCT00043186|467810371|FG001|Overall Study|Disease progression|0|||
129958227|NCT00043186|467810372|FG002|Overall Study|Disease progression|0|||
129958228|NCT00043186|467810373|FG003|Overall Study|Disease progression|3|||
129958229|NCT00043186|467810374|FG004|Overall Study|Disease progression|0|||
129958230|NCT00043186|467810375|FG005|Overall Study|Disease progression|0|||
129958231|NCT00043186|467810376|FG006|Overall Study|Disease progression|0|||
129958232|NCT00043186|467810377|FG007|Overall Study|Disease progression|4|||
129958233|NCT00043186|467810378|FG008|Overall Study|Disease progression|0|||
130121203|NCT04634409|468404922|FG007|Overall Study|Lost to Follow-up|3|||
130121204|NCT04634409|468404923|FG008|Overall Study|Lost to Follow-up|3|||
129958234|NCT00043186|467810370|FG000|Overall Study|Ineligibility determined|0|||
130121205|NCT04634409|468404924|FG009|Overall Study|Lost to Follow-up|11|||
130121206|NCT04634409|468404925|FG010|Overall Study|Lost to Follow-up|8|||
129958235|NCT00043186|467810371|FG001|Overall Study|Ineligibility determined|0|||
129958236|NCT00043186|467810372|FG002|Overall Study|Ineligibility determined|0|||
129958237|NCT00043186|467810373|FG003|Overall Study|Ineligibility determined|0|||
129958238|NCT00043186|467810374|FG004|Overall Study|Ineligibility determined|0|||
129958239|NCT00043186|467810375|FG005|Overall Study|Ineligibility determined|0|||
129958240|NCT00043186|467810376|FG006|Overall Study|Ineligibility determined|0|||
130121207|NCT04634409|468404926|FG011|Overall Study|Lost to Follow-up|15|||
130121208|NCT04634409|468404927|FG012|Overall Study|Lost to Follow-up|3|||
129958241|NCT00043186|467810377|FG007|Overall Study|Ineligibility determined|0|||
129958242|NCT00043186|467810378|FG008|Overall Study|Ineligibility determined|1|||
129958243|NCT00043186|467810370|FG000|Overall Study|Lost to Follow-up|3|||
130121209|NCT04634409|468404928|FG013|Overall Study|Lost to Follow-up|2|||
129958244|NCT00043186|467810371|FG001|Overall Study|Lost to Follow-up|5|||
130121210|NCT04634409|468404929|FG014|Overall Study|Lost to Follow-up|7|||
129958245|NCT00043186|467810372|FG002|Overall Study|Lost to Follow-up|1|||
129958246|NCT00043186|467810373|FG003|Overall Study|Lost to Follow-up|1|||
129958247|NCT00043186|467810374|FG004|Overall Study|Lost to Follow-up|1|||
129958248|NCT00043186|467810375|FG005|Overall Study|Lost to Follow-up|1|||
129958249|NCT00043186|467810376|FG006|Overall Study|Lost to Follow-up|1|||
129958250|NCT00043186|467810377|FG007|Overall Study|Lost to Follow-up|1|||
129958251|NCT00043186|467810378|FG008|Overall Study|Lost to Follow-up|2|||
129958252|NCT00043186|467810370|FG000|Overall Study|Noncompliance|0|||
129958253|NCT00043186|467810371|FG001|Overall Study|Noncompliance|0|||
129958254|NCT00043186|467810372|FG002|Overall Study|Noncompliance|1|||
129958255|NCT00043186|467810373|FG003|Overall Study|Noncompliance|1|||
129958256|NCT00043186|467810374|FG004|Overall Study|Noncompliance|0|||
129958257|NCT00043186|467810375|FG005|Overall Study|Noncompliance|0|||
129958258|NCT00043186|467810376|FG006|Overall Study|Noncompliance|0|||
129958259|NCT00043186|467810377|FG007|Overall Study|Noncompliance|0|||
129958260|NCT00043186|467810378|FG008|Overall Study|Noncompliance|0|||
129958261|NCT00043186|467810370|FG000|Overall Study|Other|0|||
129958262|NCT00043186|467810371|FG001|Overall Study|Other|0|||
129958263|NCT00043186|467810372|FG002|Overall Study|Other|1|||
129958264|NCT00043186|467810373|FG003|Overall Study|Other|1|||
129958265|NCT00043186|467810374|FG004|Overall Study|Other|0|||
129958266|NCT00043186|467810375|FG005|Overall Study|Other|0|||
130084216|NCT01010776|468260919|FG000|Main Phase|Lost to Follow-up|6|||
130084217|NCT01010776|468260919|FG000|Main Phase|Non-compliance to study medication|5|||
130084218|NCT01010776|468260919|FG000|Main Phase|Selection failure|2|||
130084219|NCT01010776|468260919|FG000|Main Phase|Inform consent withdrawal|1|||
130084220|NCT01010776|468260919|FG000|Main Phase|Other|1|||
130084221|NCT01010776|468260919|FG000|Main Phase|Did not received study medication|5|||
130084222|NCT01010776|468260919|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
130084223|NCT01010776|468260919|FG000|Extension Phase|Other|3|||
130084224|NCT02583711|468260925|FG000|Overall Study|Withdrawal by Subject|0|||
130084225|NCT02583711|468260926|FG001|Overall Study|Withdrawal by Subject|10|||
130084226|NCT02583711|468260927|FG002|Overall Study|Withdrawal by Subject|0|||
130084227|NCT01012037|468260928|FG000|Overall Study|Adverse Event|0|||
130084228|NCT01012037|468260929|FG001|Overall Study|Adverse Event|8|||
130084229|NCT01012037|468260930|FG002|Overall Study|Adverse Event|3|||
130084230|NCT01012037|468260928|FG000|Overall Study|Protocol Violation|0|||
130084231|NCT01012037|468260929|FG001|Overall Study|Protocol Violation|3|||
130084232|NCT01012037|468260930|FG002|Overall Study|Protocol Violation|5|||
130084233|NCT01012037|468260928|FG000|Overall Study|Withdrawal by Subject|0|||
130084234|NCT01012037|468260929|FG001|Overall Study|Withdrawal by Subject|4|||
130084235|NCT01012037|468260930|FG002|Overall Study|Withdrawal by Subject|1|||
130084236|NCT01012037|468260928|FG000|Overall Study|Other reason (not specified)|1|||
130084237|NCT01012037|468260929|FG001|Overall Study|Other reason (not specified)|1|||
130084238|NCT01012037|468260930|FG002|Overall Study|Other reason (not specified)|1|||
130084239|NCT01708915|468260938|FG000|Overall Study|Adverse Event|1|||
130084240|NCT01708915|468260939|FG001|Overall Study|Adverse Event|0|||
130084241|NCT01708915|468260940|FG002|Overall Study|Adverse Event|9|||
130084242|NCT01708915|468260941|FG003|Overall Study|Adverse Event|13|||
130084243|NCT01708915|468260938|FG000|Overall Study|Lack of Efficacy|84|||
130084244|NCT01708915|468260939|FG001|Overall Study|Lack of Efficacy|60|||
130084245|NCT01708915|468260940|FG002|Overall Study|Lack of Efficacy|35|||
130084246|NCT01708915|468260941|FG003|Overall Study|Lack of Efficacy|15|||
130084247|NCT01708915|468260938|FG000|Overall Study|Protocol Violation|0|||
130084248|NCT01708915|468260939|FG001|Overall Study|Protocol Violation|0|||
130084249|NCT01708915|468260940|FG002|Overall Study|Protocol Violation|0|||
130084250|NCT01708915|468260941|FG003|Overall Study|Protocol Violation|1|||
130084251|NCT01708915|468260938|FG000|Overall Study|Withdrawal by Subject|0|||
130084252|NCT01708915|468260939|FG001|Overall Study|Withdrawal by Subject|1|||
130084253|NCT01708915|468260940|FG002|Overall Study|Withdrawal by Subject|2|||
130084254|NCT01708915|468260941|FG003|Overall Study|Withdrawal by Subject|2|||
130084255|NCT01708915|468260938|FG000|Overall Study|Other reasons than stated above|1|||
130084256|NCT01708915|468260939|FG001|Overall Study|Other reasons than stated above|1|||
130084257|NCT01708915|468260940|FG002|Overall Study|Other reasons than stated above|0|||
130084258|NCT01708915|468260941|FG003|Overall Study|Other reasons than stated above|2|||
129958267|NCT00043186|467810376|FG006|Overall Study|Other|0|||
130084259|NCT01432938|468260942|FG000|First Intervention|Protocol Violation|1|||
130084260|NCT01432938|468260943|FG001|First Intervention|Protocol Violation|0|||
130084261|NCT01432938|468260942|FG000|First Intervention|Physician Decision|1|||
130084262|NCT01432938|468260943|FG001|First Intervention|Physician Decision|0|||
130084263|NCT01432938|468260942|FG000|Second Intervention|Adverse Event|1|||
130084264|NCT01432938|468260943|FG001|Second Intervention|Adverse Event|0|||
130084265|NCT04223778|468260944|FG000|Overall Study|Death|1|||
129958268|NCT00043186|467810377|FG007|Overall Study|Other|0|||
129958269|NCT00043186|467810378|FG008|Overall Study|Other|0|||
129958270|NCT00730847|467810380|FG000|Overall Study|Adverse Event|1|||
129958271|NCT00730847|467810380|FG000|Overall Study|Protocol Violation|2|||
130084266|NCT04223778|468260945|FG001|Overall Study|Death|1|||
130084267|NCT04223778|468260944|FG000|Overall Study|Lost to Follow-up|4|||
129958272|NCT00730847|467810380|FG000|Overall Study|Withdrawal by Subject|16|||
129958273|NCT00730847|467810380|FG000|Overall Study|Lost to Follow-up|67|||
129958274|NCT00730847|467810380|FG000|Overall Study|Unknown completion status|21|||
130084268|NCT04223778|468260945|FG001|Overall Study|Lost to Follow-up|5|||
130084269|NCT04223778|468260944|FG000|Overall Study|Physician Decision|10|||
130084270|NCT04223778|468260945|FG001|Overall Study|Physician Decision|6|||
130084271|NCT04223778|468260944|FG000|Overall Study|Withdrawal by Subject|35|||
129958275|NCT00730847|467810380|FG000|Overall Study|Other|24|||
129958276|NCT03022578|467810381|FG000|Overall Study|Adverse Event|1|||
129958277|NCT03022578|467810381|FG000|Overall Study|Lack of Efficacy|2|||
129958278|NCT03022578|467810381|FG000|Overall Study|Withdrawal by Subject|1|||
129958279|NCT03681353|467810382|FG000|Overall Study|Lost to Follow-up|2|||
129958280|NCT03681353|467810382|FG000|Overall Study|Withdrawal by Subject|3|||
129958281|NCT03681353|467810382|FG000|Overall Study|withdrawn by PI|2|||
129958282|NCT00726388|467810385|FG000|Overall Study|Withdrawal by Subject|5|||
129958283|NCT00726388|467810385|FG000|Overall Study|Adverse Event|3|||
129958284|NCT00726388|467810385|FG000|Overall Study|Lost to Follow-up|10|||
129958285|NCT00726388|467810385|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
129958286|NCT00726388|467810385|FG000|Overall Study|Other|5|||
129958287|NCT00726388|467810385|FG000|Overall Study|Enrolled, Not Treated|79|||
129958288|NCT00111839|467810386|FG000|Overall Study|Disease Progression|30|||
129958289|NCT00111839|467810387|FG001|Overall Study|Disease Progression|33|||
129958290|NCT00111839|467810388|FG002|Overall Study|Disease Progression|33|||
129958291|NCT00111839|467810386|FG000|Overall Study|Adverse Event|5|||
129958292|NCT00111839|467810387|FG001|Overall Study|Adverse Event|3|||
129958293|NCT00111839|467810388|FG002|Overall Study|Adverse Event|1|||
129958294|NCT00111839|467810386|FG000|Overall Study|Protocol Violation|2|||
129958295|NCT00111839|467810387|FG001|Overall Study|Protocol Violation|4|||
129958296|NCT00111839|467810388|FG002|Overall Study|Protocol Violation|2|||
129958297|NCT00111839|467810386|FG000|Overall Study|Death|1|||
129958298|NCT00111839|467810387|FG001|Overall Study|Death|1|||
129958299|NCT00111839|467810388|FG002|Overall Study|Death|6|||
129958300|NCT00111839|467810386|FG000|Overall Study|Withdrawal by Subject|2|||
129958301|NCT00111839|467810387|FG001|Overall Study|Withdrawal by Subject|2|||
129958302|NCT00111839|467810388|FG002|Overall Study|Withdrawal by Subject|2|||
129958303|NCT00111839|467810386|FG000|Overall Study|Lost to Follow-up|1|||
129958304|NCT00111839|467810387|FG001|Overall Study|Lost to Follow-up|0|||
129958305|NCT00111839|467810388|FG002|Overall Study|Lost to Follow-up|0|||
129958306|NCT00111839|467810386|FG000|Overall Study|Logistical Constraint|1|||
129958307|NCT00111839|467810387|FG001|Overall Study|Logistical Constraint|0|||
129958308|NCT00111839|467810388|FG002|Overall Study|Logistical Constraint|0|||
129958309|NCT00111839|467810386|FG000|Overall Study|Other|6|||
129958310|NCT00111839|467810387|FG001|Overall Study|Other|3|||
129958311|NCT00111839|467810388|FG002|Overall Study|Other|3|||
129958312|NCT00111839|467810386|FG000|Overall Study|Randomized but Not Treated|0|||
129958313|NCT00111839|467810387|FG001|Overall Study|Randomized but Not Treated|0|||
129958314|NCT00111839|467810388|FG002|Overall Study|Randomized but Not Treated|2|||
129958315|NCT01011049|467810389|FG000|Overall Study|Protocol Violation|0|||
129958316|NCT01011049|467810390|FG001|Overall Study|Protocol Violation|0|||
129958317|NCT01011049|467810391|FG002|Overall Study|Protocol Violation|2|||
129958318|NCT01011049|467810392|FG003|Overall Study|Protocol Violation|0|||
129958319|NCT01011049|467810389|FG000|Overall Study|Lost to Follow-up|1|||
129958320|NCT01011049|467810390|FG001|Overall Study|Lost to Follow-up|2|||
129958321|NCT01011049|467810391|FG002|Overall Study|Lost to Follow-up|1|||
129958322|NCT01011049|467810392|FG003|Overall Study|Lost to Follow-up|0|||
129958323|NCT01011049|467810389|FG000|Overall Study|Withdrawal by Subject|0|||
129958324|NCT01011049|467810390|FG001|Overall Study|Withdrawal by Subject|0|||
129958325|NCT01011049|467810391|FG002|Overall Study|Withdrawal by Subject|1|||
129958326|NCT01011049|467810392|FG003|Overall Study|Withdrawal by Subject|0|||
129958327|NCT00382408|467810393|FG000|Overall Study|Did not meet protocol requirement|3|||
129958328|NCT00382408|467810394|FG001|Overall Study|Did not meet protocol requirement|3|||
130084272|NCT04223778|468260945|FG001|Overall Study|Withdrawal by Subject|17|||
130084273|NCT04223778|468260944|FG000|Overall Study|Not Reported|7|||
129958329|NCT00382408|467810393|FG000|Overall Study|Protocol Violation|2|||
129958330|NCT00382408|467810394|FG001|Overall Study|Protocol Violation|2|||
129958331|NCT00382408|467810393|FG000|Overall Study|Physician Decision|1|||
129958332|NCT00382408|467810394|FG001|Overall Study|Physician Decision|0|||
129958333|NCT00382408|467810393|FG000|Overall Study|Withdrawal by Subject|17|||
129958334|NCT00382408|467810394|FG001|Overall Study|Withdrawal by Subject|6|||
130084274|NCT04223778|468260945|FG001|Overall Study|Not Reported|8|||
129958335|NCT00382408|467810393|FG000|Overall Study|Pregnancy|2|||
129958336|NCT00382408|467810394|FG001|Overall Study|Pregnancy|0|||
129958337|NCT00382408|467810393|FG000|Overall Study|Lost to Follow-up|19|||
129958338|NCT00382408|467810394|FG001|Overall Study|Lost to Follow-up|8|||
129958339|NCT00382408|467810393|FG000|Overall Study|Other|100|||
129958340|NCT00382408|467810394|FG001|Overall Study|Other|35|||
129958341|NCT02391545|467810398|FG000|Overall Study|Death|0|||
129958342|NCT02391545|467810399|FG001|Overall Study|Death|2|||
129958343|NCT02391545|467810398|FG000|Overall Study|Lost to Follow-up|0|||
130084275|NCT01855919|468262227|FG000|Overall Study|Adverse Event|16|||
129958344|NCT02391545|467810399|FG001|Overall Study|Lost to Follow-up|1|||
129958345|NCT02391545|467810398|FG000|Overall Study|Termination of study by sponsor|20|||
129958346|NCT02391545|467810399|FG001|Overall Study|Termination of study by sponsor|20|||
129958347|NCT02391545|467810398|FG000|Overall Study|Withdrawal by Subject|0|||
129958348|NCT02391545|467810399|FG001|Overall Study|Withdrawal by Subject|1|||
129958349|NCT02391545|467810398|FG000|Overall Study|Other Reasons|6|||
129958350|NCT02391545|467810399|FG001|Overall Study|Other Reasons|4|||
129958351|NCT04754594|467810400|FG000|Blinded Period|Withdrawal by Subject|4|||
129958352|NCT04754594|467810401|FG001|Blinded Period|Withdrawal by Subject|9|||
129958353|NCT04754594|467810402|FG002|Blinded Period|Withdrawal by Subject|0|||
129958354|NCT04754594|467810403|FG003|Blinded Period|Withdrawal by Subject|0|||
129958355|NCT04754594|467810400|FG000|Blinded Period|Protocol Violation|2|||
129958356|NCT04754594|467810401|FG001|Blinded Period|Protocol Violation|2|||
129958357|NCT04754594|467810402|FG002|Blinded Period|Protocol Violation|0|||
129958358|NCT04754594|467810403|FG003|Blinded Period|Protocol Violation|0|||
129958359|NCT04754594|467810400|FG000|Blinded Period|Lost to Follow-up|1|||
129958360|NCT04754594|467810401|FG001|Blinded Period|Lost to Follow-up|1|||
129958361|NCT04754594|467810402|FG002|Blinded Period|Lost to Follow-up|0|||
129958362|NCT04754594|467810403|FG003|Blinded Period|Lost to Follow-up|0|||
129958363|NCT04754594|467810400|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
129958364|NCT04754594|467810401|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
129958365|NCT04754594|467810402|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
129958366|NCT04754594|467810403|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
129958367|NCT04754594|467810400|FG000|Unblinded Period|Withdrawal by Subject|6|||
129958368|NCT04754594|467810401|FG001|Unblinded Period|Withdrawal by Subject|8|||
129958369|NCT04754594|467810402|FG002|Unblinded Period|Withdrawal by Subject|0|||
129958370|NCT04754594|467810403|FG003|Unblinded Period|Withdrawal by Subject|0|||
129958371|NCT04754594|467810400|FG000|Unblinded Period|Lost to Follow-up|5|||
129958372|NCT04754594|467810401|FG001|Unblinded Period|Lost to Follow-up|3|||
129958373|NCT04754594|467810402|FG002|Unblinded Period|Lost to Follow-up|0|||
129958374|NCT04754594|467810403|FG003|Unblinded Period|Lost to Follow-up|0|||
129958375|NCT04754594|467810400|FG000|Unblinded Period|Protocol Violation|2|||
129958376|NCT04754594|467810401|FG001|Unblinded Period|Protocol Violation|4|||
129958377|NCT04754594|467810402|FG002|Unblinded Period|Protocol Violation|0|||
129958378|NCT04754594|467810403|FG003|Unblinded Period|Protocol Violation|0|||
129958379|NCT04754594|467810400|FG000|Unblinded Period|Other|3|||
129958380|NCT04754594|467810401|FG001|Unblinded Period|Other|0|||
129958381|NCT04754594|467810402|FG002|Unblinded Period|Other|0|||
129958382|NCT04754594|467810403|FG003|Unblinded Period|Other|0|||
129958383|NCT04754594|467810400|FG000|Infant Participants|Withdrawal by Subject|0|||
129958384|NCT04754594|467810401|FG001|Infant Participants|Withdrawal by Subject|0|||
129958385|NCT04754594|467810402|FG002|Infant Participants|Withdrawal by Subject|9|||
129958386|NCT04754594|467810403|FG003|Infant Participants|Withdrawal by Subject|17|||
129958387|NCT04754594|467810400|FG000|Infant Participants|Lost to Follow-up|0|||
129958388|NCT04754594|467810401|FG001|Infant Participants|Lost to Follow-up|0|||
129958389|NCT04754594|467810402|FG002|Infant Participants|Lost to Follow-up|4|||
129958390|NCT04754594|467810403|FG003|Infant Participants|Lost to Follow-up|10|||
129958391|NCT04754594|467810400|FG000|Infant Participants|Death|0|||
129958392|NCT04754594|467810401|FG001|Infant Participants|Death|0|||
129958393|NCT04754594|467810402|FG002|Infant Participants|Death|1|||
129958394|NCT04754594|467810403|FG003|Infant Participants|Death|1|||
129958395|NCT04754594|467810400|FG000|Infant Participants|Other|0|||
129958396|NCT04754594|467810401|FG001|Infant Participants|Other|0|||
129958397|NCT04754594|467810402|FG002|Infant Participants|Other|1|||
129958398|NCT04754594|467810403|FG003|Infant Participants|Other|1|||
129958399|NCT03340766|467810406|FG000|Overall Study|Withdrawal by Subject|2|||
129958400|NCT03340766|467810407|FG001|Overall Study|Withdrawal by Subject|1|||
129958401|NCT03340766|467810408|FG002|Overall Study|Withdrawal by Subject|3|||
129958402|NCT03340766|467810406|FG000|Overall Study|Lost to Follow-up|0|||
129958403|NCT03340766|467810407|FG001|Overall Study|Lost to Follow-up|0|||
129958404|NCT03340766|467810408|FG002|Overall Study|Lost to Follow-up|1|||
129958405|NCT03340766|467810406|FG000|Overall Study|Death|6|||
129958406|NCT03340766|467810407|FG001|Overall Study|Death|7|||
129958407|NCT03340766|467810408|FG002|Overall Study|Death|4|||
129958408|NCT00975130|467810414|FG000|Study Part 1|Adverse Event|150|||
129958409|NCT00975130|467810415|FG001|Study Part 1|Adverse Event|0|||
129958410|NCT00975130|467810416|FG002|Study Part 1|Adverse Event|0|||
129958411|NCT00975130|467810414|FG000|Study Part 1|Lost to Follow-up|19|||
129958412|NCT00975130|467810415|FG001|Study Part 1|Lost to Follow-up|0|||
129958413|NCT00975130|467810416|FG002|Study Part 1|Lost to Follow-up|0|||
129958414|NCT00975130|467810414|FG000|Study Part 1|Withdrawal by Subject|61|||
129958415|NCT00975130|467810415|FG001|Study Part 1|Withdrawal by Subject|0|||
129958416|NCT00975130|467810416|FG002|Study Part 1|Withdrawal by Subject|0|||
129958417|NCT00975130|467810414|FG000|Study Part 1|Protocol Violation|13|||
129958418|NCT00975130|467810415|FG001|Study Part 1|Protocol Violation|0|||
129958419|NCT00975130|467810416|FG002|Study Part 1|Protocol Violation|0|||
129958420|NCT00975130|467810414|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
129958421|NCT00975130|467810415|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
129958422|NCT00975130|467810416|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
129958423|NCT00975130|467810414|FG000|Study Part 1|Administrative|4|||
129958424|NCT00975130|467810415|FG001|Study Part 1|Administrative|0|||
129958425|NCT00975130|467810416|FG002|Study Part 1|Administrative|0|||
129958426|NCT00975130|467810414|FG000|Study Part 1|Withdrew Consent|24|||
129958427|NCT00975130|467810415|FG001|Study Part 1|Withdrew Consent|0|||
129958428|NCT00975130|467810416|FG002|Study Part 1|Withdrew Consent|0|||
129958429|NCT00975130|467810414|FG000|Study Part 2|Adverse Event|0|||
129958430|NCT00975130|467810415|FG001|Study Part 2|Adverse Event|14|||
129958431|NCT00975130|467810416|FG002|Study Part 2|Adverse Event|7|||
129958432|NCT00975130|467810414|FG000|Study Part 2|Lost to Follow-up|0|||
129958433|NCT00975130|467810415|FG001|Study Part 2|Lost to Follow-up|0|||
129958434|NCT00975130|467810416|FG002|Study Part 2|Lost to Follow-up|1|||
129958435|NCT00975130|467810414|FG000|Study Part 2|Withdrawal by Subject|0|||
129958436|NCT00975130|467810415|FG001|Study Part 2|Withdrawal by Subject|13|||
129958437|NCT00975130|467810416|FG002|Study Part 2|Withdrawal by Subject|5|||
129958438|NCT00975130|467810414|FG000|Study Part 2|Withdrew Consent|0|||
129958439|NCT00975130|467810415|FG001|Study Part 2|Withdrew Consent|6|||
129958440|NCT00975130|467810416|FG002|Study Part 2|Withdrew Consent|2|||
129958441|NCT00975130|467810414|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
129958442|NCT00975130|467810415|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
129958443|NCT00975130|467810416|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
129958444|NCT00975130|467810414|FG000|Study Part 2|Administrative|0|||
129958445|NCT00975130|467810415|FG001|Study Part 2|Administrative|1|||
129958446|NCT00975130|467810416|FG002|Study Part 2|Administrative|0|||
129958447|NCT00975130|467810414|FG000|Study Part 2|Protocol Violation|0|||
129958448|NCT00975130|467810415|FG001|Study Part 2|Protocol Violation|0|||
129958449|NCT00975130|467810416|FG002|Study Part 2|Protocol Violation|1|||
129958450|NCT00734851|467810417|FG000|Overall Study|Withdrawal by Subject|2|||
129958451|NCT00734851|467810417|FG000|Overall Study|Lost to Follow-up|1|||
129958452|NCT00734851|467810417|FG000|Overall Study|Physician Decision|18|||
129958453|NCT01332318|467810423|FG000|Overall Study|Adverse Event|0|||
129958454|NCT01332318|467810424|FG001|Overall Study|Adverse Event|3|||
129958455|NCT01332318|467810425|FG002|Overall Study|Adverse Event|0|||
129958456|NCT01332318|467810426|FG003|Overall Study|Adverse Event|0|||
129958457|NCT01332318|467810423|FG000|Overall Study|Withdrawal by Subject|1|||
129958458|NCT01332318|467810424|FG001|Overall Study|Withdrawal by Subject|1|||
129958459|NCT01332318|467810425|FG002|Overall Study|Withdrawal by Subject|0|||
129958460|NCT01332318|467810426|FG003|Overall Study|Withdrawal by Subject|1|||
129958461|NCT01332318|467810423|FG000|Overall Study|Protocol Violation|1|||
129958462|NCT01332318|467810424|FG001|Overall Study|Protocol Violation|0|||
129958463|NCT01332318|467810425|FG002|Overall Study|Protocol Violation|1|||
129958464|NCT01332318|467810426|FG003|Overall Study|Protocol Violation|1|||
129958465|NCT02820298|467810427|FG000|Overall Study|Withdrawal by Subject|0|||
129958466|NCT02820298|467810428|FG001|Overall Study|Withdrawal by Subject|1|||
129958467|NCT02820298|467810427|FG000|Overall Study|Physician Decision|1|||
129958468|NCT02820298|467810428|FG001|Overall Study|Physician Decision|0|||
129958469|NCT02820298|467810427|FG000|Overall Study|Protocol Violation|0|||
129958470|NCT02820298|467810428|FG001|Overall Study|Protocol Violation|1|||
129958471|NCT01780584|467810429|FG000|Overall Study|Death|1|||
129958472|NCT01780584|467810430|FG001|Overall Study|Death|0|||
129958473|NCT01780584|467810431|FG002|Overall Study|Death|1|||
129958474|NCT01780584|467810429|FG000|Overall Study|Adverse Event|0|||
129958475|NCT01780584|467810430|FG001|Overall Study|Adverse Event|1|||
129958476|NCT01780584|467810431|FG002|Overall Study|Adverse Event|0|||
129958477|NCT01780584|467810429|FG000|Overall Study|Protocol Violation|0|||
129958478|NCT01780584|467810430|FG001|Overall Study|Protocol Violation|0|||
129958479|NCT01780584|467810431|FG002|Overall Study|Protocol Violation|1|||
129958480|NCT00727259|467810432|FG000|Overall Study|Not all questionnaires completed|1055|||
129958481|NCT01021683|467810433|FG000|Overall Study|Lack of Efficacy|12|||
129958482|NCT01021683|467810433|FG000|Overall Study|Recovery of neutrophil count|51|||
129958483|NCT01021683|467810433|FG000|Overall Study|Other|8|||
129958484|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
129958485|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
129958486|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
129958487|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
129958488|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
130084276|NCT01855919|468262228|FG001|Overall Study|Adverse Event|8|||
129958489|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
129958490|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
129958491|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
129958492|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
129958493|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
129958494|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Death|1|||
129958495|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
129958496|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Missing|3|||
129958497|NCT00645099|467810435|FG000|Overall Study|Lack of Efficacy|15|||
129958498|NCT00645099|467810436|FG001|Overall Study|Lack of Efficacy|6|||
129958499|NCT00645099|467810435|FG000|Overall Study|Withdrawal by Subject|30|||
129958500|NCT00645099|467810436|FG001|Overall Study|Withdrawal by Subject|22|||
129958501|NCT00645099|467810435|FG000|Overall Study|Lost to Follow-up|6|||
129958502|NCT00645099|467810436|FG001|Overall Study|Lost to Follow-up|4|||
129958503|NCT00645099|467810435|FG000|Overall Study|Adverse Event|11|||
129958504|NCT00645099|467810436|FG001|Overall Study|Adverse Event|5|||
129958505|NCT00645099|467810435|FG000|Overall Study|Other|9|||
129958506|NCT00645099|467810436|FG001|Overall Study|Other|5|||
129958507|NCT01201915|467810437|FG000|Overall Study|Adverse Event|2|||
129958508|NCT01201915|467810438|FG001|Overall Study|Adverse Event|1|||
129958509|NCT01201915|467810439|FG002|Overall Study|Adverse Event|1|||
129958510|NCT01201915|467810437|FG000|Overall Study|Lost to Follow-up|0|||
129958511|NCT01201915|467810438|FG001|Overall Study|Lost to Follow-up|4|||
129958512|NCT01201915|467810439|FG002|Overall Study|Lost to Follow-up|0|||
129958513|NCT01201915|467810437|FG000|Overall Study|Physician Decision|3|||
129958514|NCT01201915|467810438|FG001|Overall Study|Physician Decision|0|||
129958515|NCT01201915|467810439|FG002|Overall Study|Physician Decision|0|||
129958516|NCT01201915|467810437|FG000|Overall Study|Subject Decision|3|||
129958517|NCT01201915|467810438|FG001|Overall Study|Subject Decision|3|||
129958518|NCT01201915|467810439|FG002|Overall Study|Subject Decision|5|||
129958519|NCT01201915|467810437|FG000|Overall Study|Target Lesion Progression|0|||
129958520|NCT01201915|467810438|FG001|Overall Study|Target Lesion Progression|3|||
129958521|NCT01201915|467810439|FG002|Overall Study|Target Lesion Progression|0|||
129958522|NCT03406507|467810440|FG000|Extension Period|Lack of Efficacy|0|||
129958523|NCT03406507|467810441|FG001|Extension Period|Lack of Efficacy|1|||
129958524|NCT00663923|467810442|FG000|Overall Study|Lost to Follow-up|2|||
129958525|NCT00547300|467810445|FG000|Overall Study|Study was Administratively Terminated|25|||
129958526|NCT00547300|467810446|FG001|Overall Study|Study was Administratively Terminated|24|||
129958527|NCT00547300|467810445|FG000|Overall Study|Did not Meet Entry Criteria|0|||
129958528|NCT00547300|467810446|FG001|Overall Study|Did not Meet Entry Criteria|2|||
129958529|NCT04380688|467810447|FG000|Overall Study|Death|2|||
129958530|NCT04380688|467810448|FG001|Overall Study|Death|2|||
129958531|NCT04380688|467810447|FG000|Overall Study|Lost to Follow-up|2|||
129958532|NCT04380688|467810448|FG001|Overall Study|Lost to Follow-up|4|||
129958533|NCT04380688|467810447|FG000|Overall Study|Withdrawal by Subject|3|||
129958534|NCT04380688|467810448|FG001|Overall Study|Withdrawal by Subject|3|||
129958535|NCT02329223|467812307|FG000|Overall Study|Withdrawal by Subject|1|||
129958536|NCT02329223|467812308|FG001|Overall Study|Withdrawal by Subject|2|||
129958537|NCT02329223|467812309|FG002|Overall Study|Withdrawal by Subject|5|||
129958538|NCT02329223|467812307|FG000|Overall Study|Physician Decision|0|||
129958539|NCT02329223|467812308|FG001|Overall Study|Physician Decision|0|||
129958540|NCT02329223|467812309|FG002|Overall Study|Physician Decision|1|||
129958541|NCT02329223|467812307|FG000|Overall Study|Adverse Event|0|||
129958542|NCT02329223|467812308|FG001|Overall Study|Adverse Event|1|||
129958543|NCT02329223|467812309|FG002|Overall Study|Adverse Event|0|||
129958544|NCT00381888|467812310|FG000|Overall Study|Death|1|||
129958545|NCT00381888|467812310|FG000|Overall Study|Withdrawal by Subject|1|||
129958546|NCT00381888|467812310|FG000|Overall Study|Physician Decision|1|||
129958547|NCT00381888|467812310|FG000|Overall Study|Protocol Violation|9|||
129958548|NCT00381888|467812310|FG000|Overall Study|Had laparoscopic surgery|2|||
129958549|NCT00381888|467812310|FG000|Overall Study|Surgery was cancelled|2|||
129958550|NCT00381888|467812310|FG000|Overall Study|Adverse Event|1|||
129958551|NCT03449134|467812311|FG000|52-Week Treatment Period|Death|2|||
129958552|NCT03449134|467812312|FG001|52-Week Treatment Period|Death|1|||
129958553|NCT03449134|467812313|FG002|52-Week Treatment Period|Death|0|||
129958554|NCT03449134|467812311|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
129958555|NCT03449134|467812312|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
129958556|NCT03449134|467812313|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
129958557|NCT03449134|467812311|FG000|52-Week Treatment Period|Physician Decision|2|||
129958558|NCT03449134|467812312|FG001|52-Week Treatment Period|Physician Decision|3|||
129958559|NCT03449134|467812313|FG002|52-Week Treatment Period|Physician Decision|3|||
129958560|NCT03449134|467812311|FG000|52-Week Treatment Period|Screen Failure|1|||
129958561|NCT03449134|467812312|FG001|52-Week Treatment Period|Screen Failure|0|||
129958562|NCT03449134|467812313|FG002|52-Week Treatment Period|Screen Failure|1|||
129958563|NCT03449134|467812311|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
129958564|NCT03449134|467812312|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
129958565|NCT03449134|467812313|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
129958566|NCT03449134|467812311|FG000|52-Week Treatment Period|Site Closure|1|||
129958567|NCT03449134|467812312|FG001|52-Week Treatment Period|Site Closure|0|||
129958568|NCT03449134|467812313|FG002|52-Week Treatment Period|Site Closure|0|||
129958569|NCT00957996|467812314|FG000|Overall Study|Death|4|||
129958570|NCT00957996|467812315|FG001|Overall Study|Death|10|||
129958571|NCT00957996|467812314|FG000|Overall Study|Lost to Follow-up|4|||
129958572|NCT00957996|467812315|FG001|Overall Study|Lost to Follow-up|7|||
129958573|NCT00957996|467812314|FG000|Overall Study|Withdrawal by Subject|9|||
129958574|NCT00957996|467812315|FG001|Overall Study|Withdrawal by Subject|2|||
129958575|NCT00957996|467812314|FG000|Overall Study|Adverse Event|2|||
129958576|NCT00957996|467812315|FG001|Overall Study|Adverse Event|1|||
129958577|NCT00957996|467812314|FG000|Overall Study|Physician Decision|1|||
129958578|NCT00957996|467812315|FG001|Overall Study|Physician Decision|1|||
129958579|NCT00957996|467812314|FG000|Overall Study|Influenza-related complication|0|||
129958580|NCT00957996|467812315|FG001|Overall Study|Influenza-related complication|1|||
129958581|NCT00957996|467812314|FG000|Overall Study|Missing|1|||
129958582|NCT00957996|467812315|FG001|Overall Study|Missing|0|||
129958583|NCT00957996|467812314|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
129958584|NCT00957996|467812315|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
129958585|NCT01580995|467812320|FG000|Overall Study|Lost to Follow-up|2|||
129958586|NCT01580995|467812321|FG001|Overall Study|Lost to Follow-up|2|||
129958587|NCT02916706|467812322|FG000|Overall Study|Adverse Event|0|||
129958588|NCT02916706|467812323|FG001|Overall Study|Adverse Event|1|||
129958589|NCT02916706|467812322|FG000|Overall Study|Lost to Follow-up|0|||
129958590|NCT02916706|467812323|FG001|Overall Study|Lost to Follow-up|1|||
129958591|NCT02916706|467812322|FG000|Overall Study|Physician Decision|1|||
129958592|NCT02916706|467812323|FG001|Overall Study|Physician Decision|0|||
129958593|NCT02916706|467812322|FG000|Overall Study|Protocol Violation|3|||
129958594|NCT02916706|467812323|FG001|Overall Study|Protocol Violation|1|||
129958595|NCT02916706|467812322|FG000|Overall Study|Withdrawal by Subject|6|||
129958596|NCT02916706|467812323|FG001|Overall Study|Withdrawal by Subject|9|||
129958597|NCT02916706|467812322|FG000|Overall Study|Other|5|||
129958598|NCT02916706|467812323|FG001|Overall Study|Other|19|||
129958599|NCT00598871|467812324|FG000|Overall Study|Adverse Event|0|||
129958600|NCT00598871|467812325|FG001|Overall Study|Adverse Event|1|||
129958601|NCT01194271|467812326|FG000|Overall Study|Withdrawal by Subject|1|||
129958602|NCT01194271|467812326|FG000|Overall Study|Ineligible, Screen Failure|1|||
129958603|NCT01194271|467812326|FG000|Overall Study|Death|1|||
129958604|NCT01983462|467812327|FG000|Overall Study|Adverse Event|1|||
129958605|NCT01983462|467812328|FG001|Overall Study|Adverse Event|0|||
129958606|NCT01983462|467812329|FG002|Overall Study|Adverse Event|0|||
129958607|NCT00381797|467812330|FG000|Overall Study|Withdrawal by Subject|1|||
129958608|NCT00381797|467812331|FG001|Overall Study|Withdrawal by Subject|1|||
129958609|NCT00381797|467812332|FG002|Overall Study|Withdrawal by Subject|0|||
129958610|NCT00381797|467812333|FG003|Overall Study|Withdrawal by Subject|0|||
129958611|NCT00381797|467812334|FG004|Overall Study|Withdrawal by Subject|2|||
129958612|NCT00381797|467812330|FG000|Overall Study|Ineligible|0|||
129958613|NCT00381797|467812331|FG001|Overall Study|Ineligible|0|||
129958614|NCT00381797|467812332|FG002|Overall Study|Ineligible|0|||
129958615|NCT00381797|467812333|FG003|Overall Study|Ineligible|1|||
129958616|NCT00381797|467812334|FG004|Overall Study|Ineligible|0|||
129958617|NCT00443898|467812335|FG000|Overall Study|Adverse Event|0|||
129958618|NCT00443898|467812336|FG001|Overall Study|Adverse Event|0|||
129958619|NCT00443898|467812337|FG002|Overall Study|Adverse Event|1|||
129958620|NCT00443898|467812338|FG003|Overall Study|Adverse Event|1|||
129958621|NCT00443898|467812335|FG000|Overall Study|Lack of Efficacy|2|||
129958622|NCT00443898|467812336|FG001|Overall Study|Lack of Efficacy|3|||
129958623|NCT00443898|467812337|FG002|Overall Study|Lack of Efficacy|3|||
129958624|NCT00443898|467812338|FG003|Overall Study|Lack of Efficacy|1|||
129958625|NCT00443898|467812335|FG000|Overall Study|Protocol Violation|1|||
129958626|NCT00443898|467812336|FG001|Overall Study|Protocol Violation|1|||
129958627|NCT00443898|467812337|FG002|Overall Study|Protocol Violation|1|||
129958628|NCT00443898|467812338|FG003|Overall Study|Protocol Violation|0|||
129958629|NCT00443898|467812335|FG000|Overall Study|Withdrawal by Subject|11|||
129958630|NCT00443898|467812336|FG001|Overall Study|Withdrawal by Subject|10|||
129958631|NCT00443898|467812337|FG002|Overall Study|Withdrawal by Subject|10|||
129958632|NCT00443898|467812338|FG003|Overall Study|Withdrawal by Subject|6|||
129958633|NCT00443898|467812335|FG000|Overall Study|Lost to Follow-up|10|||
129958634|NCT00443898|467812336|FG001|Overall Study|Lost to Follow-up|10|||
129958635|NCT00443898|467812337|FG002|Overall Study|Lost to Follow-up|14|||
129958636|NCT00443898|467812338|FG003|Overall Study|Lost to Follow-up|10|||
129958637|NCT00443898|467812335|FG000|Overall Study|Death|0|||
129958638|NCT00443898|467812336|FG001|Overall Study|Death|1|||
129958639|NCT00443898|467812337|FG002|Overall Study|Death|0|||
129958640|NCT00443898|467812338|FG003|Overall Study|Death|0|||
129958641|NCT00958711|467812339|FG000|Overall Study|Withdrawal by Subject|0|||
129958642|NCT00958711|467812340|FG001|Overall Study|Withdrawal by Subject|4|||
129958643|NCT00958711|467812339|FG000|Overall Study|Physician Decision|5|||
129958644|NCT00958711|467812340|FG001|Overall Study|Physician Decision|7|||
129958645|NCT00958711|467812339|FG000|Overall Study|Lost to Follow-up|4|||
129958646|NCT00958711|467812340|FG001|Overall Study|Lost to Follow-up|1|||
129958647|NCT00958711|467812339|FG000|Overall Study|Other|2|||
129958648|NCT00958711|467812340|FG001|Overall Study|Other|5|||
129958649|NCT00958711|467812339|FG000|Overall Study|Death|1|||
130121211|NCT04634409|468404930|FG015|Overall Study|Lost to Follow-up|0|||
129958650|NCT00958711|467812340|FG001|Overall Study|Death|2|||
129958651|NCT00958711|467812339|FG000|Overall Study|Adverse Event|1|||
129958652|NCT00958711|467812340|FG001|Overall Study|Adverse Event|2|||
129958653|NCT00550771|467812343|FG000|Overall Study|Adverse Event|11|||
129958654|NCT00550771|467812344|FG001|Overall Study|Adverse Event|3|||
129958655|NCT00550771|467812343|FG000|Overall Study|Discontinued for study-related reasons|0|||
130121212|NCT04634409|468404931|FG016|Overall Study|Lost to Follow-up|0|||
129958656|NCT00550771|467812344|FG001|Overall Study|Discontinued for study-related reasons|1|||
129958657|NCT00550771|467812343|FG000|Overall Study|Physician Decision|2|||
129958658|NCT00550771|467812344|FG001|Overall Study|Physician Decision|0|||
129958659|NCT00550771|467812343|FG000|Overall Study|Withdrawal by Subject|0|||
129958660|NCT00550771|467812344|FG001|Overall Study|Withdrawal by Subject|1|||
129958661|NCT00550771|467812343|FG000|Overall Study|Protocol Violation|4|||
129958662|NCT00550771|467812344|FG001|Overall Study|Protocol Violation|5|||
129958663|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
129958664|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
129958665|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
129958666|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
129958667|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
129958668|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
129958669|NCT00520403|467812346|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
129958670|NCT00520403|467812346|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
129958671|NCT02435381|467812347|FG000|Overall Study|Lost to Follow-up|2|||
129958672|NCT02435381|467812348|FG001|Overall Study|Lost to Follow-up|1|||
129958673|NCT00405912|467812351|FG000|Overall Study|Withdrawal by Subject|12|||
129958674|NCT00405912|467812352|FG001|Overall Study|Withdrawal by Subject|11|||
129958675|NCT00405912|467812353|FG002|Overall Study|Withdrawal by Subject|12|||
129958676|NCT00405912|467812351|FG000|Overall Study|Lost to Follow-up|4|||
129958677|NCT00405912|467812352|FG001|Overall Study|Lost to Follow-up|8|||
129958678|NCT00405912|467812353|FG002|Overall Study|Lost to Follow-up|4|||
129958679|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
129958680|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
129958681|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
129958682|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
129958683|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
129958684|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
129958685|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
129958686|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
129958687|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Death|6|||
129958688|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Death|2|||
129958689|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Death|2|||
129958690|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Death|9|||
129958691|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
129958692|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129958693|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129958694|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
129958695|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
129958696|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
129958697|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
129958698|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
129958699|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
129958700|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
129958701|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
129958702|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
129958703|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
129958704|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
129958705|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
129958706|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
129958707|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
129958708|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
129958709|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
129958710|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
129958711|NCT03730662|467812354|FG000|Variable Treatment Period|Adverse Event|1|||
129958712|NCT03730662|467812355|FG001|Variable Treatment Period|Adverse Event|2|||
129958713|NCT03730662|467812356|FG002|Variable Treatment Period|Adverse Event|0|||
129958714|NCT03730662|467812357|FG003|Variable Treatment Period|Adverse Event|7|||
129958715|NCT03730662|467812354|FG000|Variable Treatment Period|Death|9|||
129958716|NCT03730662|467812355|FG001|Variable Treatment Period|Death|0|||
129958717|NCT03730662|467812356|FG002|Variable Treatment Period|Death|6|||
129958718|NCT03730662|467812357|FG003|Variable Treatment Period|Death|26|||
129958719|NCT03730662|467812354|FG000|Variable Treatment Period|Lost to Follow-up|2|||
129958720|NCT03730662|467812355|FG001|Variable Treatment Period|Lost to Follow-up|1|||
129958721|NCT03730662|467812356|FG002|Variable Treatment Period|Lost to Follow-up|4|||
129958722|NCT03730662|467812357|FG003|Variable Treatment Period|Lost to Follow-up|11|||
129958723|NCT03730662|467812354|FG000|Variable Treatment Period|Personal Reason|0|||
129958724|NCT03730662|467812355|FG001|Variable Treatment Period|Personal Reason|2|||
129958725|NCT03730662|467812356|FG002|Variable Treatment Period|Personal Reason|1|||
129958726|NCT03730662|467812357|FG003|Variable Treatment Period|Personal Reason|6|||
129958727|NCT03730662|467812354|FG000|Variable Treatment Period|Physician Decision|0|||
129958728|NCT03730662|467812355|FG001|Variable Treatment Period|Physician Decision|0|||
129958729|NCT03730662|467812356|FG002|Variable Treatment Period|Physician Decision|0|||
129958730|NCT03730662|467812357|FG003|Variable Treatment Period|Physician Decision|3|||
129958731|NCT03730662|467812354|FG000|Variable Treatment Period|Protocol Violation|0|||
129958732|NCT03730662|467812355|FG001|Variable Treatment Period|Protocol Violation|1|||
129958733|NCT03730662|467812356|FG002|Variable Treatment Period|Protocol Violation|1|||
129958734|NCT03730662|467812357|FG003|Variable Treatment Period|Protocol Violation|1|||
129958735|NCT03730662|467812354|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
129958736|NCT03730662|467812355|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
129958737|NCT03730662|467812356|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
129958738|NCT03730662|467812357|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
129958739|NCT01797562|467812358|FG000|Overall Study|Protocol Violation|5|||
129958740|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
129958741|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
129958742|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
129958743|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
129958744|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Death|0|||
129958745|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Death|1|||
129958746|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
129958747|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
129958748|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
129958749|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
129958750|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
129958751|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
129958752|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
129958753|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
129958754|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
129958755|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
129958756|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
129958757|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
129958758|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
129958759|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
129958760|NCT01309243|467812359|FG000|Extension Phase|Lost to Follow-up|6|||
129958761|NCT01309243|467812360|FG001|Extension Phase|Lost to Follow-up|0|||
129958762|NCT00632931|467812363|FG000|Part 1, Period 1|Protocol Violation|1|||
129958763|NCT00632931|467812364|FG001|Part 1, Period 1|Protocol Violation|0|||
129958764|NCT00632931|467812365|FG002|Part 1, Period 1|Protocol Violation|0|||
129958765|NCT00632931|467812363|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
129958766|NCT00632931|467812364|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
129958767|NCT00632931|467812365|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
129958768|NCT00632931|467812363|FG000|Part 2|Adverse Event|0|||
129958769|NCT00632931|467812364|FG001|Part 2|Adverse Event|0|||
129958770|NCT00632931|467812365|FG002|Part 2|Adverse Event|3|||
129958771|NCT00632931|467812363|FG000|Part 2|Death|0|||
129958772|NCT00632931|467812364|FG001|Part 2|Death|0|||
129958773|NCT00632931|467812365|FG002|Part 2|Death|1|||
129958774|NCT00632931|467812363|FG000|Part 2|Lack of Efficacy|0|||
129958775|NCT00632931|467812364|FG001|Part 2|Lack of Efficacy|0|||
129958776|NCT00632931|467812365|FG002|Part 2|Lack of Efficacy|17|||
129958777|NCT00632931|467812363|FG000|Part 2|Withdrawal by Subject|0|||
129958778|NCT00632931|467812364|FG001|Part 2|Withdrawal by Subject|0|||
129958779|NCT00632931|467812365|FG002|Part 2|Withdrawal by Subject|3|||
129958780|NCT01441583|467812368|FG000|Overall Study|Withdrawal by Subject|1|||
129958781|NCT01441583|467812369|FG001|Overall Study|Withdrawal by Subject|1|||
129958782|NCT01441583|467812370|FG002|Overall Study|Withdrawal by Subject|1|||
129958783|NCT01441583|467812368|FG000|Overall Study|Death|1|||
129958784|NCT01441583|467812369|FG001|Overall Study|Death|0|||
129958785|NCT01441583|467812370|FG002|Overall Study|Death|4|||
129958786|NCT01441583|467812368|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
129958787|NCT01441583|467812369|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
129958788|NCT01441583|467812370|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
129958789|NCT03341312|467812371|FG000|Period 1|Withdrawal by Subject|0|||
129958790|NCT03341312|467812372|FG001|Period 1|Withdrawal by Subject|1|||
129958791|NCT03341312|467812373|FG002|Period 1|Withdrawal by Subject|0|||
129958792|NCT03341312|467812374|FG003|Period 1|Withdrawal by Subject|0|||
129958793|NCT00839306|467812375|FG000|Overall Study|Adverse Event|3|||
129958794|NCT00839306|467812376|FG001|Overall Study|Adverse Event|5|||
129958795|NCT00839306|467812375|FG000|Overall Study|Lost to Follow-up|6|||
129958796|NCT00839306|467812376|FG001|Overall Study|Lost to Follow-up|9|||
129958797|NCT00839306|467812375|FG000|Overall Study|Withdrawal by Subject|5|||
129958798|NCT00839306|467812376|FG001|Overall Study|Withdrawal by Subject|7|||
129958799|NCT00839306|467812375|FG000|Overall Study|Lack of Efficacy|5|||
129958800|NCT00839306|467812376|FG001|Overall Study|Lack of Efficacy|4|||
129958801|NCT00839306|467812375|FG000|Overall Study|Other|6|||
129958802|NCT00839306|467812376|FG001|Overall Study|Other|18|||
129958803|NCT01812707|467812377|FG000|Overall Study|Adverse Event|0|||
129958804|NCT01812707|467812378|FG001|Overall Study|Adverse Event|0|||
129958805|NCT01812707|467812379|FG002|Overall Study|Adverse Event|0|||
129958806|NCT01812707|467812380|FG003|Overall Study|Adverse Event|2|||
129958807|NCT01812707|467812377|FG000|Overall Study|Poor compliance to protocol|1|||
129958808|NCT01812707|467812378|FG001|Overall Study|Poor compliance to protocol|0|||
129958809|NCT01812707|467812379|FG002|Overall Study|Poor compliance to protocol|0|||
129958810|NCT01812707|467812380|FG003|Overall Study|Poor compliance to protocol|0|||
129958811|NCT01812707|467812377|FG000|Overall Study|Consent withdrawn by participant|1|||
129958812|NCT01812707|467812378|FG001|Overall Study|Consent withdrawn by participant|0|||
129958813|NCT01812707|467812379|FG002|Overall Study|Consent withdrawn by participant|0|||
129958814|NCT01812707|467812380|FG003|Overall Study|Consent withdrawn by participant|0|||
129958815|NCT05060237|467812381|FG000|Overall Study|Withdrawal by Subject|4|||
129958816|NCT05060237|467812381|FG000|Overall Study|Screening failure|8|||
129958817|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
129958818|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958819|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958820|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958821|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958822|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958823|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958824|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958825|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958826|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958827|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958828|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958829|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958830|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958831|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958832|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
129958833|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958834|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958835|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958836|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958837|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
129958838|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958839|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958840|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958841|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958842|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958843|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958844|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958845|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958846|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958847|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958848|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958849|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958850|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958851|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958852|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958853|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958854|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958855|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958856|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958857|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958858|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
129958859|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
129958860|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
129958861|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958862|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958863|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
129958864|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958865|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958866|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
130121213|NCT04634409|468404932|FG017|Overall Study|Lost to Follow-up|0|||
129958867|NCT01697592|467812382|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
129958868|NCT01697592|467812383|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958869|NCT01697592|467812384|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958870|NCT01697592|467812385|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
129958871|NCT01697592|467812386|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958872|NCT01697592|467812387|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958873|NCT01697592|467812388|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
130121214|NCT04634409|468404933|FG018|Overall Study|Lost to Follow-up|0|||
129958874|NCT01697592|467812389|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958875|NCT01697592|467812390|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958876|NCT01697592|467812391|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958877|NCT01697592|467812382|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
129958878|NCT01697592|467812383|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958879|NCT01697592|467812384|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958880|NCT01697592|467812385|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958881|NCT01697592|467812386|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958882|NCT01697592|467812387|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
129958883|NCT01697592|467812388|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958884|NCT01697592|467812389|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
129958885|NCT01697592|467812390|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958886|NCT01697592|467812391|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958887|NCT01697592|467812382|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
129958888|NCT01697592|467812383|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958889|NCT01697592|467812384|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958890|NCT01697592|467812385|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
129958891|NCT01697592|467812386|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
129958892|NCT01697592|467812387|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958893|NCT01697592|467812388|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958894|NCT01697592|467812389|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
129958895|NCT01697592|467812390|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
129958896|NCT01697592|467812391|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
129958897|NCT02396758|467812392|FG000|Overall Study|Withdrawal by Subject|2|||
129958898|NCT02396758|467812393|FG001|Overall Study|Withdrawal by Subject|0|||
129958899|NCT02396758|467812394|FG002|Overall Study|Withdrawal by Subject|0|||
129958900|NCT02396758|467812395|FG003|Overall Study|Withdrawal by Subject|1|||
129958901|NCT02396758|467812392|FG000|Overall Study|Lost to Follow-up|8|||
129958902|NCT02396758|467812393|FG001|Overall Study|Lost to Follow-up|5|||
129958903|NCT02396758|467812394|FG002|Overall Study|Lost to Follow-up|3|||
129958904|NCT02396758|467812395|FG003|Overall Study|Lost to Follow-up|3|||
129958905|NCT02396758|467812392|FG000|Overall Study|Death|1|||
129958906|NCT02396758|467812393|FG001|Overall Study|Death|1|||
129958907|NCT02396758|467812394|FG002|Overall Study|Death|0|||
129958908|NCT02396758|467812395|FG003|Overall Study|Death|1|||
129958909|NCT02396758|467812392|FG000|Overall Study|Randomized but not treated|1|||
129958910|NCT02396758|467812393|FG001|Overall Study|Randomized but not treated|0|||
129958911|NCT02396758|467812394|FG002|Overall Study|Randomized but not treated|1|||
129958912|NCT02396758|467812395|FG003|Overall Study|Randomized but not treated|0|||
129958913|NCT00265096|467812396|FG000|Overall Study|Adverse Event|14|||
129958914|NCT00265096|467812397|FG001|Overall Study|Adverse Event|18|||
129958915|NCT00265096|467812398|FG002|Overall Study|Adverse Event|18|||
129958916|NCT00265096|467812396|FG000|Overall Study|Lost to Follow-up|2|||
129958917|NCT00265096|467812397|FG001|Overall Study|Lost to Follow-up|5|||
129958918|NCT00265096|467812398|FG002|Overall Study|Lost to Follow-up|3|||
129958919|NCT00265096|467812396|FG000|Overall Study|Death|0|||
129958920|NCT00265096|467812397|FG001|Overall Study|Death|1|||
129958921|NCT00265096|467812398|FG002|Overall Study|Death|2|||
129958922|NCT00265096|467812396|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
129958923|NCT00265096|467812397|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129958924|NCT00265096|467812398|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
129958925|NCT00265096|467812396|FG000|Overall Study|Other|11|||
129958926|NCT00265096|467812397|FG001|Overall Study|Other|19|||
129958927|NCT00265096|467812398|FG002|Overall Study|Other|10|||
129958928|NCT00774306|467812399|FG000|Overall Study|Adverse Event|3|||
129958929|NCT00774306|467812400|FG001|Overall Study|Adverse Event|0|||
129958930|NCT00774306|467812401|FG002|Overall Study|Adverse Event|0|||
130084277|NCT01855919|468262227|FG000|Overall Study|Lack of Efficacy|1|||
130084278|NCT01855919|468262228|FG001|Overall Study|Lack of Efficacy|3|||
130084279|NCT01855919|468262227|FG000|Overall Study|Withdrawal by Subject|4|||
130084280|NCT01855919|468262228|FG001|Overall Study|Withdrawal by Subject|10|||
130084281|NCT01855919|468262227|FG000|Overall Study|Entry Criteria Not Met|1|||
130084282|NCT01855919|468262228|FG001|Overall Study|Entry Criteria Not Met|1|||
129958931|NCT00774306|467812402|FG003|Overall Study|Adverse Event|0|||
129958932|NCT00774306|467812399|FG000|Overall Study|Protocol Violation|2|||
129958933|NCT00774306|467812400|FG001|Overall Study|Protocol Violation|0|||
129958934|NCT00774306|467812401|FG002|Overall Study|Protocol Violation|3|||
129958935|NCT00774306|467812402|FG003|Overall Study|Protocol Violation|0|||
130084283|NCT01855919|468262227|FG000|Overall Study|Protocol Violation|1|||
129958936|NCT00774306|467812399|FG000|Overall Study|Withdrawal by Subject|6|||
130084284|NCT01855919|468262228|FG001|Overall Study|Protocol Violation|4|||
130084285|NCT04459416|468262229|FG000|Overall Study|Lost to Follow-up|2|||
130084286|NCT04459416|468262230|FG001|Overall Study|Lost to Follow-up|0|||
129958937|NCT00774306|467812400|FG001|Overall Study|Withdrawal by Subject|1|||
129958938|NCT00774306|467812401|FG002|Overall Study|Withdrawal by Subject|1|||
129958939|NCT00774306|467812402|FG003|Overall Study|Withdrawal by Subject|0|||
129958940|NCT00774306|467812399|FG000|Overall Study|Lost to Follow-up|6|||
129958941|NCT00774306|467812400|FG001|Overall Study|Lost to Follow-up|0|||
129958942|NCT00774306|467812401|FG002|Overall Study|Lost to Follow-up|4|||
129958943|NCT00774306|467812402|FG003|Overall Study|Lost to Follow-up|5|||
129958944|NCT00774306|467812399|FG000|Overall Study|Death|1|||
129958945|NCT00774306|467812400|FG001|Overall Study|Death|1|||
129958946|NCT00774306|467812401|FG002|Overall Study|Death|0|||
129958947|NCT00774306|467812402|FG003|Overall Study|Death|0|||
129958948|NCT00666835|467812405|FG000|Overall Study|Withdrawal by Subject|5|||
129958949|NCT00666835|467812406|FG001|Overall Study|Withdrawal by Subject|2|||
129958950|NCT00666835|467812405|FG000|Overall Study|Lack of Efficacy|0|||
129958951|NCT00666835|467812406|FG001|Overall Study|Lack of Efficacy|1|||
129958952|NCT00666835|467812405|FG000|Overall Study|Incl./excl. not fulfilled|7|||
129958953|NCT00666835|467812406|FG001|Overall Study|Incl./excl. not fulfilled|2|||
129958954|NCT00666835|467812405|FG000|Overall Study|Adverse Event|7|||
129958955|NCT00666835|467812406|FG001|Overall Study|Adverse Event|6|||
129958956|NCT00666835|467812405|FG000|Overall Study|Protocol Violation|2|||
129958957|NCT00666835|467812406|FG001|Overall Study|Protocol Violation|0|||
129958958|NCT00666835|467812405|FG000|Overall Study|Death|15|||
129958959|NCT00666835|467812406|FG001|Overall Study|Death|4|||
129958960|NCT00666835|467812405|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
129958961|NCT00666835|467812406|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
129958962|NCT00666835|467812405|FG000|Overall Study|Hemoglobulin concentration|4|||
129958963|NCT00666835|467812406|FG001|Overall Study|Hemoglobulin concentration|3|||
129958964|NCT00666835|467812405|FG000|Overall Study|Planned operation|2|||
129958965|NCT00666835|467812406|FG001|Overall Study|Planned operation|0|||
129958966|NCT00666835|467812405|FG000|Overall Study|Physician Decision|1|||
129958967|NCT00666835|467812406|FG001|Overall Study|Physician Decision|2|||
129958968|NCT01126879|467812407|FG000|Overall Study|Progressive Disease|3|||
129958969|NCT01126879|467812408|FG001|Overall Study|Progressive Disease|1|||
129958970|NCT01126879|467812407|FG000|Overall Study|Withdrawal by Subject|1|||
129958971|NCT01126879|467812408|FG001|Overall Study|Withdrawal by Subject|0|||
129958972|NCT01126879|467812407|FG000|Overall Study|Adverse Event|0|||
129958973|NCT01126879|467812408|FG001|Overall Study|Adverse Event|1|||
129958974|NCT01126879|467812407|FG000|Overall Study|Physician Decision|1|||
129958975|NCT01126879|467812408|FG001|Overall Study|Physician Decision|0|||
129958976|NCT03319719|467812409|FG000|Overall Study|Lost to Follow-up|1|||
129958977|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
129958978|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
129958979|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
129958980|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
129958981|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
129958982|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
129958983|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
129958984|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
129958985|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
129958986|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
129958987|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
129958988|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
129958989|NCT00744796|467812413|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
129958990|NCT03193216|467812417|FG000|Overall Study|Lost to Follow-up|1|||
129958991|NCT03193216|467812418|FG001|Overall Study|Lost to Follow-up|0|||
129958992|NCT03193216|467812417|FG000|Overall Study|Withdrawal by Subject|5|||
129958993|NCT03193216|467812418|FG001|Overall Study|Withdrawal by Subject|0|||
129958994|NCT03193216|467812417|FG000|Overall Study|Physician Decision|4|||
129958995|NCT03193216|467812418|FG001|Overall Study|Physician Decision|0|||
129958996|NCT01514864|467812419|FG000|Overall Study|Disease progression|7|||
129958997|NCT01514864|467812420|FG001|Overall Study|Disease progression|5|||
129958998|NCT01514864|467812419|FG000|Overall Study|Study drug toxicity|2|||
129958999|NCT01514864|467812420|FG001|Overall Study|Study drug toxicity|0|||
129959000|NCT02253147|467812422|FG000|Overall Study|Protocol Violation|30|||
129959001|NCT02253147|467812422|FG000|Overall Study|Did not consent to study extension|9|||
129959002|NCT02253147|467812422|FG000|Overall Study|Conditional re-treatment at W52|5|||
129959003|NCT02253147|467812422|FG000|Overall Study|Lost to Follow-up|2|||
130084287|NCT04459416|468262229|FG000|Overall Study|Withdrawal by Subject|8|||
130084288|NCT04459416|468262230|FG001|Overall Study|Withdrawal by Subject|10|||
130084289|NCT04459416|468262229|FG000|Overall Study|Disease progression|0|||
129959004|NCT02253147|467812422|FG000|Overall Study|Withdrawal by Subject|1|||
129959005|NCT02254681|467812423|FG000|Overall Study|Lack of Efficacy|6|||
129959006|NCT02316847|467812424|FG000|Overall Study|Adverse Event|0|||
129959007|NCT02316847|467812425|FG001|Overall Study|Adverse Event|3|||
129959008|NCT02316847|467812424|FG000|Overall Study|Lost to Follow-up|0|||
129959009|NCT02316847|467812425|FG001|Overall Study|Lost to Follow-up|2|||
129959010|NCT02316847|467812424|FG000|Overall Study|Physician Decision|0|||
130084290|NCT04459416|468262230|FG001|Overall Study|Disease progression|3|||
129959011|NCT02316847|467812425|FG001|Overall Study|Physician Decision|1|||
129959012|NCT02316847|467812424|FG000|Overall Study|Pregnancy|0|||
129959013|NCT02316847|467812425|FG001|Overall Study|Pregnancy|1|||
129959014|NCT02316847|467812424|FG000|Overall Study|Withdrawal by Subject|2|||
129959015|NCT02316847|467812425|FG001|Overall Study|Withdrawal by Subject|9|||
129959016|NCT02316847|467812424|FG000|Overall Study|Noncompliance with study drug|0|||
129959017|NCT02316847|467812425|FG001|Overall Study|Noncompliance with study drug|3|||
129959018|NCT02316847|467812424|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
129959019|NCT02316847|467812425|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
129959020|NCT02621047|467812426|FG000|Overall Study|Adverse Event|0|||
129959021|NCT02621047|467812427|FG001|Overall Study|Adverse Event|0|||
129959022|NCT02621047|467812428|FG002|Overall Study|Adverse Event|1|||
129959023|NCT02236598|467812434|FG000|Overall Study|Adverse Event|0|||
129959024|NCT02236598|467812435|FG001|Overall Study|Adverse Event|1|||
129959025|NCT02236598|467812434|FG000|Overall Study|Withdrawal by Subject|0|||
129959026|NCT02236598|467812435|FG001|Overall Study|Withdrawal by Subject|1|||
129959027|NCT01264887|467812437|FG000|Overall Study|Adverse Event|5|||
129959028|NCT01264887|467812437|FG000|Overall Study|Death|7|||
129959029|NCT01264887|467812437|FG000|Overall Study|Lack of Efficacy|5|||
129959030|NCT01264887|467812437|FG000|Overall Study|Physician Decision|4|||
129959031|NCT01264887|467812437|FG000|Overall Study|Withdrawal by Subject|6|||
129959032|NCT01264887|467812437|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
129959033|NCT01264887|467812437|FG000|Overall Study|Other|2|||
129959034|NCT02171130|467812438|FG000|Overall Study|Death|1|||
129959035|NCT02171130|467812438|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
129959036|NCT02171130|467812438|FG000|Overall Study|Discontinued; Site Termination|5|||
129959037|NCT02171130|467812438|FG000|Overall Study|Withdrawal by Subject|3|||
129959038|NCT02171130|467812438|FG000|Overall Study|Physician Decision|1|||
129959039|NCT02171130|467812438|FG000|Overall Study|Lost to Follow-up|1|||
129959040|NCT02171130|467812438|FG000|Overall Study|Met Exclusion Criteria|1|||
129959041|NCT03544229|467812439|FG000|Overall Study|Adverse Event|1|||
129959042|NCT03544229|467812440|FG001|Overall Study|Adverse Event|0|||
129959043|NCT03544229|467812441|FG002|Overall Study|Adverse Event|1|||
129959044|NCT03544229|467812442|FG003|Overall Study|Adverse Event|0|||
129959045|NCT03544229|467812439|FG000|Overall Study|Protocol Deviation|0|||
129959046|NCT03544229|467812440|FG001|Overall Study|Protocol Deviation|0|||
129959047|NCT03544229|467812441|FG002|Overall Study|Protocol Deviation|1|||
129959048|NCT03544229|467812442|FG003|Overall Study|Protocol Deviation|0|||
129959049|NCT03544229|467812439|FG000|Overall Study|Lost to Follow-up|3|||
129959050|NCT03544229|467812440|FG001|Overall Study|Lost to Follow-up|0|||
129959051|NCT03544229|467812441|FG002|Overall Study|Lost to Follow-up|0|||
129959052|NCT03544229|467812442|FG003|Overall Study|Lost to Follow-up|2|||
129959053|NCT03544229|467812439|FG000|Overall Study|Voluntary Withdrawal|2|||
129959054|NCT03544229|467812440|FG001|Overall Study|Voluntary Withdrawal|1|||
129959055|NCT03544229|467812441|FG002|Overall Study|Voluntary Withdrawal|3|||
129959056|NCT03544229|467812442|FG003|Overall Study|Voluntary Withdrawal|0|||
129959057|NCT03544229|467812439|FG000|Overall Study|Lack of Efficacy|0|||
129959058|NCT03544229|467812440|FG001|Overall Study|Lack of Efficacy|1|||
129959059|NCT03544229|467812441|FG002|Overall Study|Lack of Efficacy|0|||
129959060|NCT03544229|467812442|FG003|Overall Study|Lack of Efficacy|0|||
129959061|NCT03187353|467812444|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
129959062|NCT03187353|467812445|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
129959063|NCT03187353|467812444|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
129959064|NCT03187353|467812445|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129959065|NCT03187353|467812444|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
129959066|NCT03187353|467812445|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
129959067|NCT03187353|467812444|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129959068|NCT03187353|467812445|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
129959069|NCT03187353|467812444|FG000|Washout (2 Weeks)|Adverse Event|2|||
129959070|NCT03187353|467812445|FG001|Washout (2 Weeks)|Adverse Event|0|||
129959071|NCT03187353|467812444|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
129959072|NCT03187353|467812445|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
129959073|NCT01061775|467812446|FG000|Overall Study|Physician Decision|2|||
129959074|NCT01061775|467812446|FG000|Overall Study|Lost to Follow-up|1|||
129959075|NCT03303521|467812447|FG000|Overall Study|Withdrawal by Subject|2|||
129959076|NCT03303521|467812448|FG001|Overall Study|Withdrawal by Subject|0|||
129959077|NCT03303521|467812447|FG000|Overall Study|Death|1|||
129959078|NCT03303521|467812448|FG001|Overall Study|Death|0|||
129959079|NCT03303521|467812447|FG000|Overall Study|Kidney transplantation|0|||
129959080|NCT03303521|467812448|FG001|Overall Study|Kidney transplantation|1|||
129959081|NCT03303521|467812447|FG000|Overall Study|Investigational product discontinuation|0|||
129959082|NCT03303521|467812448|FG001|Overall Study|Investigational product discontinuation|1|||
129959083|NCT03303521|467812447|FG000|Overall Study|Transferred to non-study dialysis center|1|||
129959084|NCT03303521|467812448|FG001|Overall Study|Transferred to non-study dialysis center|0|||
129959085|NCT03303521|467812447|FG000|Overall Study|Non-comliance to study protocol|0|||
129959086|NCT03303521|467812448|FG001|Overall Study|Non-comliance to study protocol|1|||
129959087|NCT03303521|467812447|FG000|Overall Study|Adverse Event|1|||
129959088|NCT03303521|467812448|FG001|Overall Study|Adverse Event|0|||
129959089|NCT02642159|467812449|FG000|Overall Study|Randomized but not treated|1|||
129959090|NCT02642159|467812450|FG001|Overall Study|Randomized but not treated|0|||
129959091|NCT02642159|467812449|FG000|Overall Study|Adverse Event|10|||
129959092|NCT02642159|467812450|FG001|Overall Study|Adverse Event|4|||
129959093|NCT02642159|467812449|FG000|Overall Study|Withdrawal by Subject|9|||
129959094|NCT02642159|467812450|FG001|Overall Study|Withdrawal by Subject|1|||
129959095|NCT02642159|467812449|FG000|Overall Study|Poor compliance to study protocol|1|||
129959096|NCT02642159|467812450|FG001|Overall Study|Poor compliance to study protocol|0|||
129959097|NCT02642159|467812449|FG000|Overall Study|Other than specified above|10|||
129959098|NCT02642159|467812450|FG001|Overall Study|Other than specified above|3|||
129959099|NCT03746483|467812451|FG000|Overall Study|Adverse Event|0|||
129959100|NCT03746483|467812452|FG001|Overall Study|Adverse Event|1|||
129959101|NCT03746483|467812451|FG000|Overall Study|Lack of Efficacy|3|||
129959102|NCT03746483|467812452|FG001|Overall Study|Lack of Efficacy|2|||
129959103|NCT03746483|467812451|FG000|Overall Study|Lost to Follow-up|1|||
129959104|NCT03746483|467812452|FG001|Overall Study|Lost to Follow-up|0|||
129959105|NCT03746483|467812451|FG000|Overall Study|Protocol Violation|2|||
129959106|NCT03746483|467812452|FG001|Overall Study|Protocol Violation|0|||
129959107|NCT01951261|467812455|FG000|Overall Study|Death|1|||
129959108|NCT01951261|467812456|FG001|Overall Study|Death|0|||
129959109|NCT01951261|467812455|FG000|Overall Study|Lost to Follow-up|4|||
129959110|NCT01951261|467812456|FG001|Overall Study|Lost to Follow-up|3|||
129959111|NCT01951261|467812455|FG000|Overall Study|Protocol Violation|4|||
129959112|NCT01951261|467812456|FG001|Overall Study|Protocol Violation|3|||
129959113|NCT01924806|467812457|FG000|Overall Study|Physician Decision|2|||
129959114|NCT01924806|467812458|FG001|Overall Study|Physician Decision|1|||
129959115|NCT02205476|467812459|FG000|Overall Study|Study termination by Sponsor|7|||
129959116|NCT02205476|467812460|FG001|Overall Study|Study termination by Sponsor|3|||
129959117|NCT01313299|467812461|FG000|Overall Study|Adverse Event|3|||
129959118|NCT01313299|467812462|FG001|Overall Study|Adverse Event|1|||
129959119|NCT01313299|467812463|FG002|Overall Study|Adverse Event|1|||
129959120|NCT01313299|467812461|FG000|Overall Study|Lost to Follow-up|1|||
129959121|NCT01313299|467812462|FG001|Overall Study|Lost to Follow-up|0|||
129959122|NCT01313299|467812463|FG002|Overall Study|Lost to Follow-up|0|||
129959123|NCT01313299|467812461|FG000|Overall Study|Protocol Violation|2|||
129959124|NCT01313299|467812462|FG001|Overall Study|Protocol Violation|0|||
129959125|NCT01313299|467812463|FG002|Overall Study|Protocol Violation|0|||
129959126|NCT01313299|467812461|FG000|Overall Study|Withdrawal by Subject|1|||
129959127|NCT01313299|467812462|FG001|Overall Study|Withdrawal by Subject|0|||
129959128|NCT01313299|467812463|FG002|Overall Study|Withdrawal by Subject|2|||
129959129|NCT01313299|467812461|FG000|Overall Study|Family reason and moved out of state|0|||
129959130|NCT01313299|467812462|FG001|Overall Study|Family reason and moved out of state|2|||
129959131|NCT01313299|467812463|FG002|Overall Study|Family reason and moved out of state|0|||
129959132|NCT01313299|467812461|FG000|Overall Study|Lack of subject compliance|0|||
129959133|NCT01313299|467812462|FG001|Overall Study|Lack of subject compliance|0|||
129959134|NCT01313299|467812463|FG002|Overall Study|Lack of subject compliance|1|||
129959135|NCT04089332|467812467|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
129959136|NCT04089332|467812467|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
129959137|NCT04089332|467812467|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
129959138|NCT02256488|467812468|FG000|Overall Study|Lost to Follow-up|6|||
129959139|NCT02256488|467812469|FG001|Overall Study|Lost to Follow-up|6|||
129959140|NCT02256488|467812470|FG002|Overall Study|Lost to Follow-up|9|||
129959141|NCT02256488|467812471|FG003|Overall Study|Lost to Follow-up|3|||
129959142|NCT02256488|467812468|FG000|Overall Study|OTHER|1|||
129959143|NCT02256488|467812469|FG001|Overall Study|OTHER|0|||
129959144|NCT02256488|467812470|FG002|Overall Study|OTHER|1|||
129959145|NCT02256488|467812471|FG003|Overall Study|OTHER|1|||
129959146|NCT02256488|467812468|FG000|Overall Study|Withdrawal by Subject|1|||
129959147|NCT02256488|467812469|FG001|Overall Study|Withdrawal by Subject|0|||
129959148|NCT02256488|467812470|FG002|Overall Study|Withdrawal by Subject|0|||
129959149|NCT02256488|467812471|FG003|Overall Study|Withdrawal by Subject|2|||
129959150|NCT00240097|467812472|FG000|Part I|Adverse Event|1|||
129959151|NCT00240097|467812472|FG000|Part I|Death|1|||
129959152|NCT00240097|467812472|FG000|Part I|histology|1|||
129959153|NCT00240097|467812472|FG000|Part I|unevaluable|1|||
129959154|NCT00240097|467812472|FG000|Part II|did not continue from Part I|23|||
129959155|NCT00818519|467812473|FG000|Overall Study|Adverse Event|2|||
129959156|NCT00818519|467812474|FG001|Overall Study|Adverse Event|2|||
129959157|NCT00818519|467812473|FG000|Overall Study|Lost to Follow-up|4|||
129959158|NCT00818519|467812474|FG001|Overall Study|Lost to Follow-up|6|||
129959159|NCT00818519|467812473|FG000|Overall Study|Protocol Violation|2|||
129959160|NCT00818519|467812474|FG001|Overall Study|Protocol Violation|1|||
129959161|NCT00818519|467812473|FG000|Overall Study|Pregnancy|0|||
129959162|NCT00818519|467812474|FG001|Overall Study|Pregnancy|1|||
129959163|NCT00818519|467812473|FG000|Overall Study|Withdrawal by Subject|4|||
129959164|NCT00818519|467812474|FG001|Overall Study|Withdrawal by Subject|9|||
129959165|NCT00818519|467812473|FG000|Overall Study|participant recovered completely|1|||
129959166|NCT00818519|467812474|FG001|Overall Study|participant recovered completely|0|||
129959167|NCT00818519|467812473|FG000|Overall Study|participant will leave for long tme|1|||
129959168|NCT00818519|467812474|FG001|Overall Study|participant will leave for long tme|0|||
129959169|NCT03356145|467812477|FG000|Overall Study|Withdrawal by Subject|2|||
129959170|NCT03356145|467812478|FG001|Overall Study|Withdrawal by Subject|1|||
129959171|NCT03356145|467812477|FG000|Overall Study|Did not meet inclusion criteria|1|||
129959172|NCT03356145|467812478|FG001|Overall Study|Did not meet inclusion criteria|0|||
129959173|NCT03613454|467812479|FG000|Overall Study|Protocol Violation|1|||
129959174|NCT03613454|467812480|FG001|Overall Study|Protocol Violation|0|||
129959175|NCT03613454|467812479|FG000|Overall Study|Protocol Violation|0|||
129959176|NCT03613454|467812480|FG001|Overall Study|Protocol Violation|1|||
129959177|NCT02963922|467812481|FG000|Overall Study|Adverse Event|15|||
129959178|NCT02963922|467812482|FG001|Overall Study|Adverse Event|6|||
129959179|NCT02963922|467812481|FG000|Overall Study|Protocol deviation|6|||
129959180|NCT02963922|467812482|FG001|Overall Study|Protocol deviation|6|||
129959181|NCT02963922|467812481|FG000|Overall Study|Lack of Efficacy|1|||
129959182|NCT02963922|467812482|FG001|Overall Study|Lack of Efficacy|1|||
129959183|NCT02963922|467812481|FG000|Overall Study|Lost to Follow-up|2|||
129959184|NCT02963922|467812482|FG001|Overall Study|Lost to Follow-up|3|||
129959185|NCT02963922|467812481|FG000|Overall Study|Other|8|||
129959186|NCT02963922|467812482|FG001|Overall Study|Other|14|||
129959187|NCT01967719|467813911|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959188|NCT01967719|467813912|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
129959189|NCT01967719|467813913|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959190|NCT01967719|467813914|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
129959191|NCT01967719|467813911|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
129959192|NCT01967719|467813912|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
129959193|NCT01967719|467813913|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
129959194|NCT01967719|467813914|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
129959195|NCT00796614|467813915|FG000|Overall Study|Adverse Event|1|||
129959196|NCT00796614|467813916|FG001|Overall Study|Adverse Event|2|||
129959197|NCT00796614|467813917|FG002|Overall Study|Adverse Event|0|||
129959198|NCT00796614|467813918|FG003|Overall Study|Adverse Event|0|||
129959199|NCT00796614|467813915|FG000|Overall Study|Protocol Violation|0|||
129959200|NCT00796614|467813916|FG001|Overall Study|Protocol Violation|0|||
129959201|NCT00796614|467813917|FG002|Overall Study|Protocol Violation|2|||
129959202|NCT00796614|467813918|FG003|Overall Study|Protocol Violation|0|||
129959203|NCT00796614|467813915|FG000|Overall Study|Lost to Follow-up|2|||
129959204|NCT00796614|467813916|FG001|Overall Study|Lost to Follow-up|2|||
129959205|NCT00796614|467813917|FG002|Overall Study|Lost to Follow-up|1|||
129959206|NCT00796614|467813918|FG003|Overall Study|Lost to Follow-up|0|||
129959207|NCT00796614|467813915|FG000|Overall Study|Withdrawal by Subject|1|||
129959208|NCT00796614|467813916|FG001|Overall Study|Withdrawal by Subject|0|||
129959209|NCT00796614|467813917|FG002|Overall Study|Withdrawal by Subject|0|||
129959210|NCT00796614|467813918|FG003|Overall Study|Withdrawal by Subject|1|||
129959211|NCT00796614|467813915|FG000|Overall Study|Other than stated|1|||
129959212|NCT00796614|467813916|FG001|Overall Study|Other than stated|0|||
129959213|NCT00796614|467813917|FG002|Overall Study|Other than stated|0|||
129959214|NCT00796614|467813918|FG003|Overall Study|Other than stated|0|||
129959215|NCT01231464|467813919|FG000|Overall Study|Adverse Event|0|||
129959216|NCT01231464|467813920|FG001|Overall Study|Adverse Event|1|||
129959217|NCT01231464|467813919|FG000|Overall Study|Protocol Violation|1|||
129959218|NCT01231464|467813920|FG001|Overall Study|Protocol Violation|2|||
129959219|NCT01231464|467813919|FG000|Overall Study|Lost to Follow-up|1|||
129959220|NCT01231464|467813920|FG001|Overall Study|Lost to Follow-up|2|||
129959221|NCT01231464|467813919|FG000|Overall Study|Withdrawal by Subject|3|||
129959222|NCT01231464|467813920|FG001|Overall Study|Withdrawal by Subject|2|||
129959223|NCT01960348|467813927|FG000|Overall Study|Adverse event, not serious|2|||
129959224|NCT01960348|467813928|FG001|Overall Study|Adverse event, not serious|2|||
129959225|NCT01960348|467813927|FG000|Overall Study|Adverse event, serious fatal|6|||
129959226|NCT01960348|467813928|FG001|Overall Study|Adverse event, serious fatal|5|||
129959227|NCT01960348|467813927|FG000|Overall Study|Adverse event, serious non-fatal|0|||
129959228|NCT01960348|467813928|FG001|Overall Study|Adverse event, serious non-fatal|3|||
129959229|NCT01960348|467813927|FG000|Overall Study|Withdrawal by Subject|1|||
129959230|NCT01960348|467813928|FG001|Overall Study|Withdrawal by Subject|11|||
129959231|NCT01960348|467813927|FG000|Overall Study|Physician Decision|0|||
129959232|NCT01960348|467813928|FG001|Overall Study|Physician Decision|1|||
129959233|NCT01960348|467813927|FG000|Overall Study|Protocol Violation|1|||
129959234|NCT01960348|467813928|FG001|Overall Study|Protocol Violation|0|||
129959235|NCT02151643|467813931|FG000|Overall Study|Adverse Event|2|||
129959236|NCT02151643|467813932|FG001|Overall Study|Adverse Event|0|||
129959237|NCT02151643|467813933|FG002|Overall Study|Adverse Event|1|||
129959238|NCT02151643|467813934|FG003|Overall Study|Adverse Event|4|||
129959239|NCT02151643|467813935|FG004|Overall Study|Adverse Event|0|||
129959240|NCT02151643|467813931|FG000|Overall Study|Withdrawal by Subject|0|||
129959241|NCT02151643|467813932|FG001|Overall Study|Withdrawal by Subject|1|||
129959242|NCT02151643|467813933|FG002|Overall Study|Withdrawal by Subject|1|||
129959243|NCT02151643|467813934|FG003|Overall Study|Withdrawal by Subject|1|||
130121215|NCT04634409|468404934|FG019|Overall Study|Lost to Follow-up|0|||
130121216|NCT04634409|468404935|FG020|Overall Study|Lost to Follow-up|0|||
130121217|NCT04634409|468404936|FG021|Overall Study|Lost to Follow-up|0|||
130121218|NCT04634409|468404937|FG022|Overall Study|Lost to Follow-up|0|||
130121219|NCT04634409|468404938|FG023|Overall Study|Lost to Follow-up|0|||
130121220|NCT04634409|468404939|FG024|Overall Study|Lost to Follow-up|0|||
130121221|NCT04634409|468404940|FG025|Overall Study|Lost to Follow-up|0|||
130121222|NCT04634409|468404941|FG026|Overall Study|Lost to Follow-up|0|||
130121223|NCT04634409|468404915|FG000|Overall Study|Withdrawal by Subject|3|||
130121224|NCT04634409|468404916|FG001|Overall Study|Withdrawal by Subject|1|||
130121225|NCT04634409|468404917|FG002|Overall Study|Withdrawal by Subject|6|||
130121226|NCT04634409|468404918|FG003|Overall Study|Withdrawal by Subject|4|||
130121227|NCT04634409|468404919|FG004|Overall Study|Withdrawal by Subject|2|||
130121228|NCT04634409|468404920|FG005|Overall Study|Withdrawal by Subject|0|||
130121229|NCT04634409|468404921|FG006|Overall Study|Withdrawal by Subject|0|||
130121230|NCT04634409|468404922|FG007|Overall Study|Withdrawal by Subject|2|||
130121231|NCT04634409|468404923|FG008|Overall Study|Withdrawal by Subject|3|||
130121232|NCT04634409|468404924|FG009|Overall Study|Withdrawal by Subject|2|||
130121233|NCT04634409|468404925|FG010|Overall Study|Withdrawal by Subject|3|||
130121234|NCT04634409|468404926|FG011|Overall Study|Withdrawal by Subject|2|||
130121235|NCT04634409|468404927|FG012|Overall Study|Withdrawal by Subject|2|||
130121236|NCT04634409|468404928|FG013|Overall Study|Withdrawal by Subject|1|||
130121237|NCT04634409|468404929|FG014|Overall Study|Withdrawal by Subject|5|||
130121238|NCT04634409|468404930|FG015|Overall Study|Withdrawal by Subject|0|||
130121239|NCT04634409|468404931|FG016|Overall Study|Withdrawal by Subject|0|||
130121240|NCT04634409|468404932|FG017|Overall Study|Withdrawal by Subject|1|||
130121241|NCT04634409|468404933|FG018|Overall Study|Withdrawal by Subject|0|||
129959244|NCT02151643|467813935|FG004|Overall Study|Withdrawal by Subject|1|||
129959245|NCT02151643|467813931|FG000|Overall Study|Hyperphosphataemia|1|||
129959246|NCT02151643|467813932|FG001|Overall Study|Hyperphosphataemia|0|||
130084291|NCT03455530|468262231|FG000|Overall Study|Withdrawal by Subject|9|||
130084292|NCT03455530|468262232|FG001|Overall Study|Withdrawal by Subject|1|||
130084293|NCT03455530|468262233|FG002|Overall Study|Withdrawal by Subject|3|||
130084294|NCT03455530|468262234|FG003|Overall Study|Withdrawal by Subject|3|||
130084295|NCT01592773|468262239|FG000|Overall Study|Study Terminated by Sponsor|582|||
130084296|NCT01592773|468262239|FG000|Overall Study|Withdrawal by Subject|35|||
130084297|NCT01592773|468262239|FG000|Overall Study|Lost to Follow-up|19|||
130084298|NCT01592773|468262239|FG000|Overall Study|Adverse Event|17|||
130084299|NCT01592773|468262239|FG000|Overall Study|Lack of Efficacy|9|||
130084300|NCT01592773|468262239|FG000|Overall Study|Protocol Violation|2|||
130084301|NCT01592773|468262239|FG000|Overall Study|Inclusion/exclusion not meet|1|||
130084302|NCT01592773|468262239|FG000|Overall Study|Other Reason|1|||
130084303|NCT00740116|468262244|FG000|Overall Study|Withdrawal by Subject|1|||
130084304|NCT00740116|468262245|FG001|Overall Study|Withdrawal by Subject|1|||
130084305|NCT00740116|468262244|FG000|Overall Study|Protocol Violation|1|||
130084306|NCT00740116|468262245|FG001|Overall Study|Protocol Violation|4|||
130084307|NCT04418427|468262246|FG000|Overall Study|Death|0|||
130084308|NCT04418427|468262247|FG001|Overall Study|Death|1|||
130084309|NCT04418427|468262248|FG002|Overall Study|Death|0|||
130084310|NCT04418427|468262246|FG000|Overall Study|Lost to Follow-up|0|||
130084311|NCT04418427|468262247|FG001|Overall Study|Lost to Follow-up|2|||
130084312|NCT04418427|468262248|FG002|Overall Study|Lost to Follow-up|2|||
130084313|NCT04418427|468262246|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
130084314|NCT04418427|468262247|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
130084315|NCT04418427|468262248|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
130084316|NCT04418427|468262246|FG000|Overall Study|Pre-existing medical condition|0|||
130084317|NCT04418427|468262247|FG001|Overall Study|Pre-existing medical condition|1|||
130084318|NCT04418427|468262248|FG002|Overall Study|Pre-existing medical condition|0|||
130084319|NCT02499172|468262249|FG000|Overall Study|Financial reason|0|||
130084320|NCT02499172|468262250|FG001|Overall Study|Financial reason|0|||
130084321|NCT02499172|468262251|FG002|Overall Study|Financial reason|523|||
130084322|NCT02499172|468262252|FG003|Overall Study|Financial reason|436|||
130084323|NCT02499172|468262249|FG000|Overall Study|Lost to Follow-up|65|||
130121242|NCT04634409|468404934|FG019|Overall Study|Withdrawal by Subject|0|||
130121243|NCT04634409|468404935|FG020|Overall Study|Withdrawal by Subject|0|||
130121244|NCT04634409|468404936|FG021|Overall Study|Withdrawal by Subject|0|||
130121245|NCT04634409|468404937|FG022|Overall Study|Withdrawal by Subject|0|||
129959247|NCT02151643|467813933|FG002|Overall Study|Hyperphosphataemia|0|||
129959248|NCT02151643|467813934|FG003|Overall Study|Hyperphosphataemia|0|||
130084324|NCT02499172|468262250|FG001|Overall Study|Lost to Follow-up|64|||
130084325|NCT02499172|468262251|FG002|Overall Study|Lost to Follow-up|0|||
130084326|NCT02499172|468262252|FG003|Overall Study|Lost to Follow-up|0|||
130084327|NCT00121485|468262253|FG000|Overall Study|Not implanted|1|||
130084328|NCT00121485|468262254|FG001|Overall Study|Not implanted|5|||
130084329|NCT00121485|468262253|FG000|Overall Study|Crossover|0|||
130084330|NCT00121485|468262254|FG001|Overall Study|Crossover|2|||
130121246|NCT04634409|468404938|FG023|Overall Study|Withdrawal by Subject|1|||
130121247|NCT04634409|468404939|FG024|Overall Study|Withdrawal by Subject|0|||
130121248|NCT04634409|468404940|FG025|Overall Study|Withdrawal by Subject|0|||
130084331|NCT00724243|468262257|FG000|Overall Study|Lack of Efficacy|10|||
130084332|NCT00724243|468262257|FG000|Overall Study|Adverse Event|5|||
130084333|NCT01004861|468262258|FG000|Overall Study|Disease progression|3|||
130084334|NCT01004861|468262259|FG001|Overall Study|Disease progression|4|||
130084335|NCT01004861|468262260|FG002|Overall Study|Disease progression|5|||
130084336|NCT01004861|468262261|FG003|Overall Study|Disease progression|4|||
130084337|NCT01004861|468262262|FG004|Overall Study|Disease progression|4|||
130084338|NCT01004861|468262263|FG005|Overall Study|Disease progression|4|||
130084339|NCT01004861|468262264|FG006|Overall Study|Disease progression|5|||
130084340|NCT01004861|468262265|FG007|Overall Study|Disease progression|1|||
130084341|NCT01004861|468262266|FG008|Overall Study|Disease progression|4|||
130084342|NCT01004861|468262267|FG009|Overall Study|Disease progression|7|||
130121249|NCT04634409|468404941|FG026|Overall Study|Withdrawal by Subject|0|||
130121250|NCT04634409|468404915|FG000|Overall Study|Other - As reported by Investigator|1|||
130121251|NCT04634409|468404916|FG001|Overall Study|Other - As reported by Investigator|0|||
129959249|NCT02151643|467813935|FG004|Overall Study|Hyperphosphataemia|1|||
129959250|NCT02151643|467813931|FG000|Overall Study|High Ferritin levels|3|||
129959251|NCT02151643|467813932|FG001|Overall Study|High Ferritin levels|3|||
129959252|NCT02151643|467813933|FG002|Overall Study|High Ferritin levels|2|||
129959253|NCT02151643|467813934|FG003|Overall Study|High Ferritin levels|2|||
129959254|NCT02151643|467813935|FG004|Overall Study|High Ferritin levels|1|||
129959255|NCT00508274|467813938|FG000|Overall Study|Adverse Event|5|||
129959256|NCT00508274|467813938|FG000|Overall Study|Death|7|||
129959257|NCT00508274|467813938|FG000|Overall Study|Disease progression|32|||
129959258|NCT00508274|467813938|FG000|Overall Study|Withdrawal by Subject|1|||
129959259|NCT00508274|467813938|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
129959260|NCT00508274|467813938|FG000|Overall Study|Missing|3|||
129959261|NCT03296566|467813939|FG000|Overall Study|Lost to Follow-up|19|||
129959262|NCT03296566|467813940|FG001|Overall Study|Lost to Follow-up|46|||
129959263|NCT03296566|467813939|FG000|Overall Study|Withdrawal by Subject|0|||
129959264|NCT03296566|467813940|FG001|Overall Study|Withdrawal by Subject|3|||
129959265|NCT00197106|467813941|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
129959266|NCT00197106|467813942|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
129959267|NCT00197106|467813943|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
129959268|NCT00197106|467813941|FG000|Overall Treatment Period|Lack of Efficacy|0|||
129959269|NCT00197106|467813942|FG001|Overall Treatment Period|Lack of Efficacy|1|||
129959270|NCT00197106|467813943|FG002|Overall Treatment Period|Lack of Efficacy|0|||
129959271|NCT00197106|467813941|FG000|Overall Treatment Period|Lost to Follow-up|0|||
129959272|NCT00197106|467813942|FG001|Overall Treatment Period|Lost to Follow-up|0|||
129959273|NCT00197106|467813943|FG002|Overall Treatment Period|Lost to Follow-up|2|||
129959274|NCT00197106|467813941|FG000|Overall Treatment Period|Protocol Violation|0|||
129959275|NCT00197106|467813942|FG001|Overall Treatment Period|Protocol Violation|0|||
129959276|NCT00197106|467813943|FG002|Overall Treatment Period|Protocol Violation|2|||
129959277|NCT00197106|467813941|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
129959278|NCT00197106|467813942|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
129959279|NCT00197106|467813943|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
129959280|NCT01084239|467813948|FG000|28-Day Follow-up|Lost to Follow-up|4|||
129959281|NCT01084239|467813949|FG001|28-Day Follow-up|Lost to Follow-up|9|||
129959282|NCT02679079|467813950|FG000|Overall Study|Adverse Event|2|||
129959283|NCT02679079|467813951|FG001|Overall Study|Adverse Event|0|||
129959284|NCT02679079|467813952|FG002|Overall Study|Adverse Event|2|||
129959285|NCT02679079|467813950|FG000|Overall Study|Protocol Violation|0|||
129959286|NCT02679079|467813951|FG001|Overall Study|Protocol Violation|1|||
129959287|NCT02679079|467813952|FG002|Overall Study|Protocol Violation|0|||
129959288|NCT02679079|467813950|FG000|Overall Study|Withdrawal by Subject|2|||
129959289|NCT02679079|467813951|FG001|Overall Study|Withdrawal by Subject|1|||
129959290|NCT02679079|467813952|FG002|Overall Study|Withdrawal by Subject|0|||
129959291|NCT03924947|467813953|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959292|NCT03924947|467813954|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959293|NCT03924947|467813955|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
129959294|NCT03924947|467813956|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959295|NCT03924947|467813957|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959296|NCT03924947|467813958|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959297|NCT04150341|467813959|FG000|Overall Study|Physician Decision|0|||
129959298|NCT04150341|467813960|FG001|Overall Study|Physician Decision|0|||
130121252|NCT04634409|468404917|FG002|Overall Study|Other - As reported by Investigator|0|||
129959299|NCT04150341|467813961|FG002|Overall Study|Physician Decision|1|||
129959300|NCT04150341|467813962|FG003|Overall Study|Physician Decision|0|||
129959301|NCT04150341|467813963|FG004|Overall Study|Physician Decision|0|||
129959302|NCT04150341|467813964|FG005|Overall Study|Physician Decision|0|||
130084343|NCT01004861|468262268|FG010|Overall Study|Disease progression|6|||
130084344|NCT01004861|468262269|FG011|Overall Study|Disease progression|3|||
130084345|NCT01004861|468262270|FG012|Overall Study|Disease progression|8|||
130084346|NCT01004861|468262258|FG000|Overall Study|Physician Decision|0|||
130084347|NCT01004861|468262259|FG001|Overall Study|Physician Decision|2|||
130084348|NCT01004861|468262260|FG002|Overall Study|Physician Decision|1|||
130084349|NCT01004861|468262261|FG003|Overall Study|Physician Decision|1|||
130084350|NCT01004861|468262262|FG004|Overall Study|Physician Decision|1|||
130084351|NCT01004861|468262263|FG005|Overall Study|Physician Decision|0|||
130084352|NCT01004861|468262264|FG006|Overall Study|Physician Decision|0|||
130084353|NCT01004861|468262265|FG007|Overall Study|Physician Decision|1|||
130084354|NCT01004861|468262266|FG008|Overall Study|Physician Decision|0|||
130084355|NCT01004861|468262267|FG009|Overall Study|Physician Decision|0|||
130084356|NCT01004861|468262268|FG010|Overall Study|Physician Decision|0|||
130084357|NCT01004861|468262269|FG011|Overall Study|Physician Decision|0|||
130084358|NCT01004861|468262270|FG012|Overall Study|Physician Decision|3|||
130084359|NCT01004861|468262258|FG000|Overall Study|Adverse Event|0|||
130084360|NCT01004861|468262259|FG001|Overall Study|Adverse Event|0|||
130084361|NCT01004861|468262260|FG002|Overall Study|Adverse Event|0|||
130084362|NCT01004861|468262261|FG003|Overall Study|Adverse Event|1|||
130084363|NCT01004861|468262262|FG004|Overall Study|Adverse Event|0|||
130084364|NCT01004861|468262263|FG005|Overall Study|Adverse Event|2|||
129959303|NCT04150341|467813959|FG000|Overall Study|Adverse Event|0|||
129959304|NCT04150341|467813960|FG001|Overall Study|Adverse Event|0|||
129959305|NCT04150341|467813961|FG002|Overall Study|Adverse Event|0|||
129959306|NCT04150341|467813962|FG003|Overall Study|Adverse Event|0|||
129959307|NCT04150341|467813963|FG004|Overall Study|Adverse Event|1|||
129959308|NCT04150341|467813964|FG005|Overall Study|Adverse Event|0|||
129959309|NCT00805285|467813965|FG000|Overall Study|Lack of Efficacy|1|||
129959310|NCT00917462|467813966|FG000|Overall Study|Clinical Deterioration|1|||
129959311|NCT01631825|467813967|FG000|Overall Study|Adverse Event|42|||
129959312|NCT01631825|467813967|FG000|Overall Study|Lack of Efficacy|7|||
129959313|NCT01631825|467813967|FG000|Overall Study|Withdrawal by Subject|9|||
129959314|NCT01631825|467813967|FG000|Overall Study|Protocol Violation|4|||
129959315|NCT01631825|467813967|FG000|Overall Study|Discontinuation criteria|1|||
129959316|NCT01631825|467813967|FG000|Overall Study|Physician Decision|2|||
129959317|NCT05109117|467813968|FG000|Overall Study|Lost to Follow-up|1|||
129959318|NCT05109117|467813968|FG000|Overall Study|Discontinued for non-compliance|1|||
129959319|NCT03226353|467813969|FG000|Overall Study|Withdrawal by Subject|1|||
129959320|NCT03226353|467813969|FG000|Overall Study|Screen Failure|5|||
129959321|NCT00797511|467813971|FG000|Overall Study|Withdrawal by Subject|1|||
129959322|NCT02853305|467813972|FG000|Overall Study|Death|287|||
129959323|NCT02853305|467813973|FG001|Overall Study|Death|249|||
129959324|NCT02853305|467813974|FG002|Overall Study|Death|300|||
129959325|NCT02853305|467813972|FG000|Overall Study|Withdrawal by Subject|2|||
129959326|NCT02853305|467813973|FG001|Overall Study|Withdrawal by Subject|8|||
129959327|NCT02853305|467813974|FG002|Overall Study|Withdrawal by Subject|3|||
129959328|NCT02853305|467813972|FG000|Overall Study|Transferred to Extension Study|46|||
129959329|NCT02853305|467813973|FG001|Overall Study|Transferred to Extension Study|30|||
129959330|NCT02853305|467813974|FG002|Overall Study|Transferred to Extension Study|25|||
129959331|NCT02853305|467813972|FG000|Overall Study|Did Not Continue on Extension Study|16|||
129959332|NCT02853305|467813973|FG001|Overall Study|Did Not Continue on Extension Study|20|||
129959333|NCT02853305|467813974|FG002|Overall Study|Did Not Continue on Extension Study|24|||
129959334|NCT04772313|467813977|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
129959335|NCT04772313|467813977|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
129959336|NCT01836198|467813978|FG000|Part A, Period 2|Protocol Violation|0|||
129959337|NCT01836198|467813979|FG001|Part A, Period 2|Protocol Violation|1|||
129959338|NCT01836198|467813980|FG002|Part A, Period 2|Protocol Violation|0|||
129959339|NCT02215954|467813981|FG000|Overall Study|Adverse Event|0|||
129959340|NCT02215954|467813982|FG001|Overall Study|Adverse Event|0|||
129959341|NCT02215954|467813983|FG002|Overall Study|Adverse Event|1|||
129959342|NCT02215954|467813981|FG000|Overall Study|Withdrawal by Subject|0|||
129959343|NCT02215954|467813982|FG001|Overall Study|Withdrawal by Subject|0|||
129959344|NCT02215954|467813983|FG002|Overall Study|Withdrawal by Subject|2|||
129959345|NCT02215954|467813981|FG000|Overall Study|Not exposed|1|||
129959346|NCT02215954|467813982|FG001|Overall Study|Not exposed|1|||
129959347|NCT02215954|467813983|FG002|Overall Study|Not exposed|3|||
129959348|NCT02460562|467813984|FG000|Overall Study|Lost to Follow-up|15|||
129959349|NCT02460562|467813985|FG001|Overall Study|Lost to Follow-up|16|||
129959350|NCT01654289|467813986|FG000|Overall Study|Withdrawal by Subject|10|||
129959351|NCT01654289|467813987|FG001|Overall Study|Withdrawal by Subject|8|||
129959352|NCT01654289|467813988|FG002|Overall Study|Withdrawal by Subject|5|||
129959353|NCT01654289|467813986|FG000|Overall Study|Withdrew from intervention only|17|||
129959354|NCT01654289|467813987|FG001|Overall Study|Withdrew from intervention only|20|||
129959355|NCT01654289|467813988|FG002|Overall Study|Withdrew from intervention only|0|||
129959356|NCT04194541|467813989|FG000|Day 1 Through 13|Lost to Follow-up|3|||
129959357|NCT04194541|467813989|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
129959358|NCT04194541|467813989|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
130084365|NCT01004861|468262264|FG006|Overall Study|Adverse Event|1|||
130084366|NCT01004861|468262265|FG007|Overall Study|Adverse Event|1|||
130084367|NCT01004861|468262266|FG008|Overall Study|Adverse Event|13|||
130084368|NCT01004861|468262267|FG009|Overall Study|Adverse Event|1|||
130084369|NCT01004861|468262268|FG010|Overall Study|Adverse Event|1|||
130084370|NCT01004861|468262269|FG011|Overall Study|Adverse Event|0|||
129959359|NCT00187135|467813990|FG000|Visit One|Withdrawal by Subject|1|||
129959360|NCT00187135|467813991|FG001|Visit One|Withdrawal by Subject|0|||
129959361|NCT00187135|467813992|FG002|Visit One|Withdrawal by Subject|0|||
129959362|NCT00187135|467813993|FG003|Visit One|Withdrawal by Subject|0|||
129959363|NCT00187135|467813994|FG004|Visit One|Withdrawal by Subject|0|||
129959364|NCT00187135|467813995|FG005|Visit One|Withdrawal by Subject|1|||
129959365|NCT00187135|467813990|FG000|Visit One|Physician Decision|3|||
129959366|NCT00187135|467813991|FG001|Visit One|Physician Decision|1|||
129959367|NCT00187135|467813992|FG002|Visit One|Physician Decision|0|||
129959368|NCT00187135|467813993|FG003|Visit One|Physician Decision|0|||
129959369|NCT00187135|467813994|FG004|Visit One|Physician Decision|0|||
129959370|NCT00187135|467813995|FG005|Visit One|Physician Decision|1|||
129959371|NCT00187135|467813990|FG000|Visit Two|Death|0|||
129959372|NCT00187135|467813991|FG001|Visit Two|Death|0|||
129959373|NCT00187135|467813992|FG002|Visit Two|Death|0|||
129959374|NCT00187135|467813993|FG003|Visit Two|Death|1|||
129959375|NCT00187135|467813994|FG004|Visit Two|Death|0|||
129959376|NCT00187135|467813995|FG005|Visit Two|Death|1|||
129959377|NCT00187135|467813990|FG000|Visit Two|Physician Decision|1|||
129959378|NCT00187135|467813991|FG001|Visit Two|Physician Decision|0|||
129959379|NCT00187135|467813992|FG002|Visit Two|Physician Decision|0|||
129959380|NCT00187135|467813993|FG003|Visit Two|Physician Decision|0|||
129959381|NCT00187135|467813994|FG004|Visit Two|Physician Decision|0|||
129959382|NCT00187135|467813995|FG005|Visit Two|Physician Decision|0|||
129959383|NCT00187135|467813990|FG000|Visit Two|Withdrawal by Subject|1|||
129959384|NCT00187135|467813991|FG001|Visit Two|Withdrawal by Subject|1|||
129959385|NCT00187135|467813992|FG002|Visit Two|Withdrawal by Subject|1|||
129959386|NCT00187135|467813993|FG003|Visit Two|Withdrawal by Subject|0|||
129959387|NCT00187135|467813994|FG004|Visit Two|Withdrawal by Subject|1|||
129959388|NCT00187135|467813995|FG005|Visit Two|Withdrawal by Subject|1|||
129959389|NCT00187135|467813990|FG000|Visit Two|Study Discontinued|3|||
129959390|NCT00187135|467813991|FG001|Visit Two|Study Discontinued|2|||
129959391|NCT00187135|467813992|FG002|Visit Two|Study Discontinued|1|||
129959392|NCT00187135|467813993|FG003|Visit Two|Study Discontinued|7|||
129959393|NCT00187135|467813994|FG004|Visit Two|Study Discontinued|5|||
129959394|NCT00187135|467813995|FG005|Visit Two|Study Discontinued|6|||
129959395|NCT00187135|467813990|FG000|Visit Three|Death|0|||
129959396|NCT00187135|467813991|FG001|Visit Three|Death|0|||
129959397|NCT00187135|467813992|FG002|Visit Three|Death|1|||
129959398|NCT00187135|467813993|FG003|Visit Three|Death|0|||
129959399|NCT00187135|467813994|FG004|Visit Three|Death|1|||
129959400|NCT00187135|467813995|FG005|Visit Three|Death|0|||
129959401|NCT00187135|467813990|FG000|Visit Three|Withdrawal by Subject|0|||
129959402|NCT00187135|467813991|FG001|Visit Three|Withdrawal by Subject|1|||
129959403|NCT00187135|467813992|FG002|Visit Three|Withdrawal by Subject|1|||
129959404|NCT00187135|467813993|FG003|Visit Three|Withdrawal by Subject|2|||
129959405|NCT00187135|467813994|FG004|Visit Three|Withdrawal by Subject|0|||
129959406|NCT00187135|467813995|FG005|Visit Three|Withdrawal by Subject|0|||
129959407|NCT00187135|467813990|FG000|Visit Three|Study Discontinued|7|||
129959408|NCT00187135|467813991|FG001|Visit Three|Study Discontinued|6|||
129959409|NCT00187135|467813992|FG002|Visit Three|Study Discontinued|7|||
129959410|NCT00187135|467813993|FG003|Visit Three|Study Discontinued|7|||
129959411|NCT00187135|467813994|FG004|Visit Three|Study Discontinued|7|||
129959412|NCT00187135|467813995|FG005|Visit Three|Study Discontinued|6|||
129959413|NCT00297778|467813999|FG000|Overall Study|Adverse Event|16|||
129959414|NCT00297778|467814000|FG001|Overall Study|Adverse Event|10|||
129959415|NCT00297778|467813999|FG000|Overall Study|Withdrawal by Subject|1|||
129959416|NCT00297778|467814000|FG001|Overall Study|Withdrawal by Subject|5|||
129959417|NCT00297778|467813999|FG000|Overall Study|Lack of Efficacy|2|||
129959418|NCT00297778|467814000|FG001|Overall Study|Lack of Efficacy|1|||
129959419|NCT00297778|467813999|FG000|Overall Study|Non-compliant with trial protocol|0|||
129959420|NCT00297778|467814000|FG001|Overall Study|Non-compliant with trial protocol|3|||
129959421|NCT00297778|467813999|FG000|Overall Study|Other|0|||
129959422|NCT00297778|467814000|FG001|Overall Study|Other|1|||
129959423|NCT00679549|467814001|FG000|Overall Study|dropout|2|||
129959424|NCT00679549|467814002|FG001|Overall Study|dropout|4|||
129959425|NCT00679549|467814001|FG000|Overall Study|missing outcome echocardiograms|4|||
129959426|NCT00679549|467814002|FG001|Overall Study|missing outcome echocardiograms|5|||
129959427|NCT03280108|467814003|FG000|Overall Study|Lost to Follow-up|2|||
129959428|NCT03280108|467814004|FG001|Overall Study|Lost to Follow-up|0|||
129959429|NCT02201771|467814005|FG000|Overall Study|Death|3|||
129959430|NCT02201771|467814006|FG001|Overall Study|Death|2|||
129959431|NCT02201771|467814007|FG002|Overall Study|Death|0|||
129959432|NCT02201771|467814005|FG000|Overall Study|Protocol Violation|10|||
129959433|NCT02201771|467814006|FG001|Overall Study|Protocol Violation|8|||
129959434|NCT02201771|467814007|FG002|Overall Study|Protocol Violation|10|||
129959435|NCT01820637|467814008|FG000|Overall Study|Death|2|||
129959436|NCT01820637|467814008|FG000|Overall Study|Withdrawal by Subject|1|||
129959437|NCT00264498|467814009|FG000|Randomized Treatment|Death|0|||
129959438|NCT00264498|467814010|FG001|Randomized Treatment|Death|3|||
129959439|NCT00264498|467814009|FG000|Randomized Treatment|Withdrawal by Subject|0|||
129959440|NCT00264498|467814010|FG001|Randomized Treatment|Withdrawal by Subject|1|||
130084371|NCT01004861|468262270|FG012|Overall Study|Adverse Event|2|||
130084372|NCT01004861|468262258|FG000|Overall Study|Protocol Violation|0|||
130084373|NCT01004861|468262259|FG001|Overall Study|Protocol Violation|0|||
130084374|NCT01004861|468262260|FG002|Overall Study|Protocol Violation|0|||
130084375|NCT01004861|468262261|FG003|Overall Study|Protocol Violation|0|||
130084376|NCT01004861|468262262|FG004|Overall Study|Protocol Violation|1|||
130084377|NCT01004861|468262263|FG005|Overall Study|Protocol Violation|0|||
130084378|NCT01004861|468262264|FG006|Overall Study|Protocol Violation|0|||
130084379|NCT01004861|468262265|FG007|Overall Study|Protocol Violation|0|||
130084380|NCT01004861|468262266|FG008|Overall Study|Protocol Violation|0|||
130084381|NCT01004861|468262267|FG009|Overall Study|Protocol Violation|0|||
130084382|NCT01004861|468262268|FG010|Overall Study|Protocol Violation|0|||
130084383|NCT01004861|468262269|FG011|Overall Study|Protocol Violation|0|||
130084384|NCT01004861|468262270|FG012|Overall Study|Protocol Violation|0|||
130084385|NCT01004861|468262258|FG000|Overall Study|Lost to Follow-up|0|||
130084386|NCT01004861|468262259|FG001|Overall Study|Lost to Follow-up|0|||
130084387|NCT01004861|468262260|FG002|Overall Study|Lost to Follow-up|0|||
130084388|NCT01004861|468262261|FG003|Overall Study|Lost to Follow-up|0|||
130084389|NCT01004861|468262262|FG004|Overall Study|Lost to Follow-up|0|||
130084390|NCT01004861|468262263|FG005|Overall Study|Lost to Follow-up|0|||
130084391|NCT01004861|468262264|FG006|Overall Study|Lost to Follow-up|0|||
130084392|NCT01004861|468262265|FG007|Overall Study|Lost to Follow-up|1|||
130084393|NCT01004861|468262266|FG008|Overall Study|Lost to Follow-up|3|||
130084394|NCT01004861|468262267|FG009|Overall Study|Lost to Follow-up|0|||
130084395|NCT01004861|468262268|FG010|Overall Study|Lost to Follow-up|0|||
130084396|NCT01004861|468262269|FG011|Overall Study|Lost to Follow-up|1|||
130084397|NCT01004861|468262270|FG012|Overall Study|Lost to Follow-up|0|||
130084398|NCT01004861|468262258|FG000|Overall Study|Non-compliance|0|||
130084399|NCT01004861|468262259|FG001|Overall Study|Non-compliance|0|||
130084400|NCT01004861|468262260|FG002|Overall Study|Non-compliance|0|||
130084401|NCT01004861|468262261|FG003|Overall Study|Non-compliance|0|||
130084402|NCT01004861|468262262|FG004|Overall Study|Non-compliance|0|||
130084403|NCT01004861|468262263|FG005|Overall Study|Non-compliance|0|||
130084404|NCT01004861|468262264|FG006|Overall Study|Non-compliance|0|||
130084405|NCT01004861|468262265|FG007|Overall Study|Non-compliance|0|||
130084406|NCT01004861|468262266|FG008|Overall Study|Non-compliance|5|||
130084407|NCT01004861|468262267|FG009|Overall Study|Non-compliance|0|||
130084408|NCT01004861|468262268|FG010|Overall Study|Non-compliance|0|||
130084409|NCT01004861|468262269|FG011|Overall Study|Non-compliance|0|||
130084410|NCT01004861|468262270|FG012|Overall Study|Non-compliance|1|||
130084411|NCT01004861|468262258|FG000|Overall Study|Other|0|||
130084412|NCT01004861|468262259|FG001|Overall Study|Other|0|||
130084413|NCT01004861|468262260|FG002|Overall Study|Other|0|||
130084414|NCT01004861|468262261|FG003|Overall Study|Other|0|||
130084415|NCT01004861|468262262|FG004|Overall Study|Other|0|||
130084416|NCT01004861|468262263|FG005|Overall Study|Other|0|||
130084417|NCT01004861|468262264|FG006|Overall Study|Other|0|||
130084418|NCT01004861|468262265|FG007|Overall Study|Other|0|||
130084419|NCT01004861|468262266|FG008|Overall Study|Other|0|||
130084420|NCT01004861|468262267|FG009|Overall Study|Other|2|||
130084421|NCT01004861|468262268|FG010|Overall Study|Other|1|||
130084422|NCT01004861|468262269|FG011|Overall Study|Other|2|||
130084423|NCT01004861|468262270|FG012|Overall Study|Other|3|||
130084424|NCT01004861|468262258|FG000|Overall Study|Patient decision|0|||
130084425|NCT01004861|468262259|FG001|Overall Study|Patient decision|0|||
130084426|NCT01004861|468262260|FG002|Overall Study|Patient decision|0|||
130084427|NCT01004861|468262261|FG003|Overall Study|Patient decision|0|||
130121253|NCT04634409|468404918|FG003|Overall Study|Other - As reported by Investigator|0|||
130121254|NCT04634409|468404919|FG004|Overall Study|Other - As reported by Investigator|0|||
130121255|NCT04634409|468404920|FG005|Overall Study|Other - As reported by Investigator|0|||
130121256|NCT04634409|468404921|FG006|Overall Study|Other - As reported by Investigator|0|||
130121257|NCT04634409|468404922|FG007|Overall Study|Other - As reported by Investigator|6|||
130084428|NCT01004861|468262262|FG004|Overall Study|Patient decision|1|||
130084429|NCT01004861|468262263|FG005|Overall Study|Patient decision|0|||
130084430|NCT01004861|468262264|FG006|Overall Study|Patient decision|1|||
130084431|NCT01004861|468262265|FG007|Overall Study|Patient decision|0|||
130084432|NCT01004861|468262266|FG008|Overall Study|Patient decision|7|||
130084433|NCT01004861|468262267|FG009|Overall Study|Patient decision|1|||
130084434|NCT01004861|468262268|FG010|Overall Study|Patient decision|1|||
130084435|NCT01004861|468262269|FG011|Overall Study|Patient decision|2|||
130084436|NCT01004861|468262270|FG012|Overall Study|Patient decision|3|||
130084437|NCT01004861|468262258|FG000|Overall Study|Transitioned to Phase 4 study|0|||
130084438|NCT01004861|468262259|FG001|Overall Study|Transitioned to Phase 4 study|0|||
130084439|NCT01004861|468262260|FG002|Overall Study|Transitioned to Phase 4 study|0|||
130084440|NCT01004861|468262261|FG003|Overall Study|Transitioned to Phase 4 study|0|||
130084441|NCT01004861|468262262|FG004|Overall Study|Transitioned to Phase 4 study|0|||
130084442|NCT01004861|468262263|FG005|Overall Study|Transitioned to Phase 4 study|0|||
130084443|NCT01004861|468262264|FG006|Overall Study|Transitioned to Phase 4 study|0|||
130084444|NCT01004861|468262265|FG007|Overall Study|Transitioned to Phase 4 study|0|||
130084445|NCT01004861|468262266|FG008|Overall Study|Transitioned to Phase 4 study|2|||
130084446|NCT01004861|468262267|FG009|Overall Study|Transitioned to Phase 4 study|0|||
130084447|NCT01004861|468262268|FG010|Overall Study|Transitioned to Phase 4 study|0|||
130084448|NCT01004861|468262269|FG011|Overall Study|Transitioned to Phase 4 study|0|||
130084449|NCT01004861|468262270|FG012|Overall Study|Transitioned to Phase 4 study|0|||
130084450|NCT01004861|468262258|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084451|NCT01004861|468262259|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084452|NCT01004861|468262260|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084453|NCT01004861|468262261|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084454|NCT01004861|468262262|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084455|NCT01004861|468262263|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084456|NCT01004861|468262264|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084457|NCT01004861|468262265|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084458|NCT01004861|468262266|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
130084459|NCT01004861|468262267|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084460|NCT01004861|468262268|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084461|NCT01004861|468262269|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084462|NCT01004861|468262270|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
130084463|NCT01004861|468262258|FG000|Overall Study|Patient withdrew|0|||
130084464|NCT01004861|468262259|FG001|Overall Study|Patient withdrew|0|||
130084465|NCT01004861|468262260|FG002|Overall Study|Patient withdrew|0|||
130084466|NCT01004861|468262261|FG003|Overall Study|Patient withdrew|0|||
130084467|NCT01004861|468262262|FG004|Overall Study|Patient withdrew|0|||
130084468|NCT01004861|468262263|FG005|Overall Study|Patient withdrew|0|||
130084469|NCT01004861|468262264|FG006|Overall Study|Patient withdrew|0|||
130084470|NCT01004861|468262265|FG007|Overall Study|Patient withdrew|0|||
130084471|NCT01004861|468262266|FG008|Overall Study|Patient withdrew|1|||
130084472|NCT01004861|468262267|FG009|Overall Study|Patient withdrew|0|||
130084473|NCT01004861|468262268|FG010|Overall Study|Patient withdrew|0|||
130084474|NCT01004861|468262269|FG011|Overall Study|Patient withdrew|0|||
130084475|NCT01004861|468262270|FG012|Overall Study|Patient withdrew|0|||
130084476|NCT01004861|468262258|FG000|Overall Study|Surgical resection|0|||
130084477|NCT01004861|468262259|FG001|Overall Study|Surgical resection|0|||
130084478|NCT01004861|468262260|FG002|Overall Study|Surgical resection|0|||
130084479|NCT01004861|468262261|FG003|Overall Study|Surgical resection|0|||
130084480|NCT01004861|468262262|FG004|Overall Study|Surgical resection|0|||
130084481|NCT01004861|468262263|FG005|Overall Study|Surgical resection|0|||
130084482|NCT01004861|468262264|FG006|Overall Study|Surgical resection|0|||
130084483|NCT01004861|468262265|FG007|Overall Study|Surgical resection|0|||
130084484|NCT01004861|468262266|FG008|Overall Study|Surgical resection|1|||
130084485|NCT01004861|468262267|FG009|Overall Study|Surgical resection|0|||
130084486|NCT01004861|468262268|FG010|Overall Study|Surgical resection|0|||
130084487|NCT01004861|468262269|FG011|Overall Study|Surgical resection|0|||
130084488|NCT01004861|468262270|FG012|Overall Study|Surgical resection|0|||
130084489|NCT01004861|468262258|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084490|NCT01004861|468262259|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084491|NCT01004861|468262260|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084492|NCT01004861|468262261|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084493|NCT01004861|468262262|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084494|NCT01004861|468262263|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084495|NCT01004861|468262264|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084496|NCT01004861|468262265|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084497|NCT01004861|468262266|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
130084498|NCT01004861|468262267|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084499|NCT01004861|468262268|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084500|NCT01004861|468262269|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084501|NCT01004861|468262270|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
130084502|NCT01004861|468262258|FG000|Overall Study|Study termination by Sponsor|0|||
130084503|NCT01004861|468262259|FG001|Overall Study|Study termination by Sponsor|0|||
130084504|NCT01004861|468262260|FG002|Overall Study|Study termination by Sponsor|0|||
130084505|NCT01004861|468262261|FG003|Overall Study|Study termination by Sponsor|0|||
130084506|NCT01004861|468262262|FG004|Overall Study|Study termination by Sponsor|0|||
130084507|NCT01004861|468262263|FG005|Overall Study|Study termination by Sponsor|0|||
130084508|NCT01004861|468262264|FG006|Overall Study|Study termination by Sponsor|0|||
130084509|NCT01004861|468262265|FG007|Overall Study|Study termination by Sponsor|0|||
129959441|NCT00264498|467814009|FG000|Randomized Treatment|Objective disease Progression|13|||
129959442|NCT00264498|467814010|FG001|Randomized Treatment|Objective disease Progression|14|||
129959443|NCT00264498|467814009|FG000|Randomized Treatment|Physician Decision|1|||
129959444|NCT00264498|467814010|FG001|Randomized Treatment|Physician Decision|0|||
129959445|NCT00264498|467814009|FG000|Randomized Treatment|Incorrectly randomized|1|||
129959446|NCT00264498|467814010|FG001|Randomized Treatment|Incorrectly randomized|0|||
129959447|NCT00264498|467814009|FG000|Randomized Treatment|Study Closure|1|||
129959448|NCT00264498|467814010|FG001|Randomized Treatment|Study Closure|0|||
129959449|NCT00264498|467814009|FG000|Randomized Treatment|Protocol Violation|1|||
129959450|NCT00264498|467814010|FG001|Randomized Treatment|Protocol Violation|0|||
129959451|NCT00264498|467814009|FG000|Crossover Treatment|Death|1|||
129959452|NCT00264498|467814010|FG001|Crossover Treatment|Death|3|||
129959453|NCT00264498|467814009|FG000|Crossover Treatment|Objective disease progression|4|||
129959454|NCT00264498|467814010|FG001|Crossover Treatment|Objective disease progression|5|||
129959455|NCT00264498|467814009|FG000|Crossover Treatment|Study closure|0|||
129959456|NCT00264498|467814010|FG001|Crossover Treatment|Study closure|1|||
129959457|NCT00264498|467814009|FG000|Crossover Treatment|Withdrawal by Subject|1|||
129959458|NCT00264498|467814010|FG001|Crossover Treatment|Withdrawal by Subject|0|||
129959459|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
129959460|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
129959461|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
129959462|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
129959463|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
129959464|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
129959465|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
129959466|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
129959467|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
129959468|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
129959469|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
129959470|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
129959471|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
129959472|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
129959473|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
129959474|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
129959475|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
129959476|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
129959477|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
129959478|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
129959479|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
129959480|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
129959481|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
129959482|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
129959483|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
129959484|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
129959485|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
129959486|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129959487|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129959488|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
129959489|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129959490|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129959491|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
129959492|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129959493|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129959494|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
129959495|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129959496|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129959497|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
129959498|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
129959499|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
129959500|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
129959501|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129959502|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129959503|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
129959504|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129959505|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129959506|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
129959507|NCT02383927|467814014|FG000|Overall Study|Disease Progression|8|||
129959508|NCT02383927|467814015|FG001|Overall Study|Disease Progression|8|||
129959509|NCT02383927|467814016|FG002|Overall Study|Disease Progression|15|||
129959510|NCT02383927|467814017|FG003|Overall Study|Disease Progression|4|||
129959511|NCT02383927|467814014|FG000|Overall Study|Physician Decision|0|||
129959512|NCT02383927|467814015|FG001|Overall Study|Physician Decision|0|||
129959513|NCT02383927|467814016|FG002|Overall Study|Physician Decision|2|||
129959514|NCT02383927|467814017|FG003|Overall Study|Physician Decision|0|||
129959515|NCT02383927|467814014|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
129959516|NCT02383927|467814015|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
129959517|NCT02383927|467814016|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
129959518|NCT02383927|467814017|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
129959519|NCT02383927|467814014|FG000|Overall Study|Adverse Event|4|||
129959520|NCT02383927|467814015|FG001|Overall Study|Adverse Event|1|||
129959521|NCT02383927|467814016|FG002|Overall Study|Adverse Event|3|||
129959522|NCT02383927|467814017|FG003|Overall Study|Adverse Event|5|||
129959523|NCT02383927|467814014|FG000|Overall Study|Miscellaneous|1|||
129959524|NCT02383927|467814015|FG001|Overall Study|Miscellaneous|0|||
129959525|NCT02383927|467814016|FG002|Overall Study|Miscellaneous|0|||
129959526|NCT02383927|467814017|FG003|Overall Study|Miscellaneous|1|||
129959527|NCT02383927|467814014|FG000|Overall Study|Withdrawal by Subject|0|||
129959528|NCT02383927|467814015|FG001|Overall Study|Withdrawal by Subject|1|||
129959529|NCT02383927|467814016|FG002|Overall Study|Withdrawal by Subject|4|||
129959530|NCT02383927|467814017|FG003|Overall Study|Withdrawal by Subject|0|||
129959531|NCT02865135|467814018|FG000|Overall Study|Death|0|||
129959532|NCT02865135|467814019|FG001|Overall Study|Death|1|||
129959533|NCT02865135|467814020|FG002|Overall Study|Death|0|||
129959534|NCT02865135|467814018|FG000|Overall Study|Progression|6|||
129959535|NCT02865135|467814019|FG001|Overall Study|Progression|2|||
129959536|NCT02865135|467814020|FG002|Overall Study|Progression|2|||
129959537|NCT01071317|467814021|FG000|Overall Study|Lost to Follow-up|2|||
129959538|NCT01071317|467814022|FG001|Overall Study|Lost to Follow-up|2|||
129959539|NCT02040532|467814024|FG000|Overall Study|Lost to Follow-up|1|||
129959540|NCT02040532|467814024|FG000|Overall Study|Physician Decision|4|||
129959541|NCT02040532|467814024|FG000|Overall Study|Adverse Event|4|||
129959542|NCT02040532|467814024|FG000|Overall Study|Withdrawal by Subject|3|||
129959543|NCT03640754|467814029|FG000|Overall Study|Withdrawal by Subject|1|||
129959544|NCT03640754|467814030|FG001|Overall Study|Withdrawal by Subject|0|||
129959545|NCT03640754|467814029|FG000|Overall Study|Lost to Follow-up|0|||
129959546|NCT03640754|467814030|FG001|Overall Study|Lost to Follow-up|1|||
129959547|NCT01679613|467814036|FG000|Overall Study|other than stated above|0|||
129959548|NCT01679613|467814037|FG001|Overall Study|other than stated above|1|||
129959549|NCT01679613|467814038|FG002|Overall Study|other than stated above|2|||
129959550|NCT01679613|467814039|FG003|Overall Study|other than stated above|2|||
129959551|NCT03169530|467814040|FG000|Overall Study|Study ended by NIH|15|||
129959552|NCT03169530|467814041|FG001|Overall Study|Study ended by NIH|17|||
129959553|NCT02154516|467814042|FG000|Overall Study|Withdrawal by Subject|0|||
129959554|NCT02154516|467814043|FG001|Overall Study|Withdrawal by Subject|1|||
129959555|NCT02154516|467814042|FG000|Overall Study|Lost to Follow-up|1|||
129959556|NCT02154516|467814043|FG001|Overall Study|Lost to Follow-up|0|||
129959557|NCT02154516|467814042|FG000|Overall Study|Removal/revision of device|1|||
129959558|NCT02154516|467814043|FG001|Overall Study|Removal/revision of device|0|||
129959559|NCT02154516|467814042|FG000|Overall Study|Death|2|||
129959560|NCT02154516|467814043|FG001|Overall Study|Death|1|||
129959561|NCT02965599|467814044|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
129959562|NCT02965599|467814045|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
129959563|NCT00230971|467814046|FG000|Randomization|No study drug administered|3|||
129959564|NCT00230971|467814047|FG001|Randomization|No study drug administered|3|||
129959565|NCT00230971|467814046|FG000|Baseline Participants|Lost to Follow-up|5|||
129959566|NCT00230971|467814047|FG001|Baseline Participants|Lost to Follow-up|12|||
129959567|NCT00230971|467814046|FG000|Baseline Participants|Death|6|||
129959568|NCT00230971|467814047|FG001|Baseline Participants|Death|5|||
129959569|NCT00230971|467814046|FG000|Baseline Participants|Withdrawal by Subject|7|||
129959570|NCT00230971|467814047|FG001|Baseline Participants|Withdrawal by Subject|1|||
129959571|NCT00230971|467814046|FG000|Baseline Participants|Adverse Event|1|||
129959572|NCT00230971|467814047|FG001|Baseline Participants|Adverse Event|0|||
130084510|NCT01004861|468262266|FG008|Overall Study|Study termination by Sponsor|1|||
129959573|NCT00230971|467814046|FG000|Baseline Participants|No bacteria observed|1|||
129959574|NCT00230971|467814047|FG001|Baseline Participants|No bacteria observed|0|||
129959575|NCT00230971|467814046|FG000|Baseline Participants|Failure to return|1|||
129959576|NCT00230971|467814047|FG001|Baseline Participants|Failure to return|1|||
129959577|NCT00230971|467814046|FG000|Baseline Participants|Reintervention|1|||
129959578|NCT00230971|467814047|FG001|Baseline Participants|Reintervention|0|||
129959579|NCT02956278|467815986|FG000|Overall Study|Withdrawal by Subject|6|||
129959580|NCT02956278|467815987|FG001|Overall Study|Withdrawal by Subject|2|||
129959581|NCT02956278|467815988|FG002|Overall Study|Withdrawal by Subject|0|||
129959582|NCT00509821|467815998|FG000|Study Period 1 (Induction)|Death|0|||
129959583|NCT00509821|467815999|FG001|Study Period 1 (Induction)|Death|1|||
129959584|NCT00509821|467815998|FG000|Study Period 1 (Induction)|Adverse Event|0|||
129959585|NCT00509821|467815999|FG001|Study Period 1 (Induction)|Adverse Event|2|||
129959586|NCT00509821|467815998|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
130084511|NCT01004861|468262267|FG009|Overall Study|Study termination by Sponsor|0|||
130084512|NCT01004861|468262268|FG010|Overall Study|Study termination by Sponsor|0|||
130084513|NCT01004861|468262269|FG011|Overall Study|Study termination by Sponsor|0|||
130084514|NCT01004861|468262270|FG012|Overall Study|Study termination by Sponsor|0|||
130084515|NCT02554721|468262272|FG000|Overall Study|Adverse Event|1|||
130084516|NCT02554721|468262273|FG001|Overall Study|Adverse Event|0|||
130084517|NCT02554721|468262274|FG002|Overall Study|Adverse Event|0|||
130084518|NCT02554721|468262275|FG003|Overall Study|Adverse Event|0|||
130084519|NCT02554721|468262276|FG004|Overall Study|Adverse Event|1|||
130084520|NCT02554721|468262272|FG000|Overall Study|Noncompliance|0|||
130084521|NCT02554721|468262273|FG001|Overall Study|Noncompliance|0|||
130084522|NCT02554721|468262274|FG002|Overall Study|Noncompliance|0|||
130084523|NCT02554721|468262275|FG003|Overall Study|Noncompliance|0|||
130084524|NCT02554721|468262276|FG004|Overall Study|Noncompliance|1|||
130084525|NCT00686699|468262277|FG000|Treatment Period 1|Adverse Event|0|||
130084526|NCT00686699|468262278|FG001|Treatment Period 1|Adverse Event|2|||
130084527|NCT04610827|468262279|FG000|Overall Study|Withdrawal by Subject|1|||
130084528|NCT04610827|468262280|FG001|Overall Study|Withdrawal by Subject|1|||
130084529|NCT04610827|468262281|FG002|Overall Study|Withdrawal by Subject|0|||
130084530|NCT00908895|468262282|FG000|Overall Study|Lost to Follow-up|1|||
130084531|NCT00908895|468262283|FG001|Overall Study|Lost to Follow-up|3|||
130084532|NCT00908895|468262282|FG000|Overall Study|algodystrophy|2|||
130084533|NCT00908895|468262283|FG001|Overall Study|algodystrophy|2|||
130084534|NCT00908895|468262282|FG000|Overall Study|Adverse Event|1|||
130084535|NCT00908895|468262283|FG001|Overall Study|Adverse Event|1|||
130084536|NCT02059174|468262285|FG000|Period 1|Withdrawal by Subject|0|||
130084537|NCT02059174|468262286|FG001|Period 1|Withdrawal by Subject|2|||
130084538|NCT02059174|468262285|FG000|Period 2|Withdrawal by Subject|0|||
130084539|NCT02059174|468262286|FG001|Period 2|Withdrawal by Subject|2|||
130084540|NCT02059174|468262285|FG000|Period 2|Protocol Violation|1|||
130084541|NCT02059174|468262286|FG001|Period 2|Protocol Violation|0|||
130084542|NCT02059174|468262285|FG000|Period 3|Physician Decision|1|||
130084543|NCT02059174|468262286|FG001|Period 3|Physician Decision|0|||
130084544|NCT02306148|468262287|FG000|Overall Study|Adverse Event|12|||
130084545|NCT02306148|468262288|FG001|Overall Study|Adverse Event|6|||
130084546|NCT02306148|468262287|FG000|Overall Study|Lost to Follow-up|1|||
130084547|NCT02306148|468262288|FG001|Overall Study|Lost to Follow-up|4|||
130084548|NCT00087594|468262289|FG000|Overall Study|Adverse Event|2|||
130084549|NCT00087594|468262290|FG001|Overall Study|Adverse Event|3|||
130084550|NCT00087594|468262289|FG000|Overall Study|Lost to Follow-up|0|||
130084551|NCT00087594|468262290|FG001|Overall Study|Lost to Follow-up|2|||
130084552|NCT00087594|468262289|FG000|Overall Study|Withdrawal by Subject|4|||
130084553|NCT00087594|468262290|FG001|Overall Study|Withdrawal by Subject|2|||
130084554|NCT00087594|468262289|FG000|Overall Study|Lack of Efficacy|2|||
130084555|NCT00087594|468262290|FG001|Overall Study|Lack of Efficacy|5|||
130084556|NCT01952041|468262295|FG000|Overall Study|Lost to Follow-up|9|||
130084557|NCT01952041|468262296|FG001|Overall Study|Lost to Follow-up|16|||
130084558|NCT01952041|468262295|FG000|Overall Study|Withdrawal by Subject|7|||
130084559|NCT01952041|468262296|FG001|Overall Study|Withdrawal by Subject|5|||
130084560|NCT01952041|468262295|FG000|Overall Study|Death|1|||
130084561|NCT01952041|468262296|FG001|Overall Study|Death|0|||
130084562|NCT00186121|468262297|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
130084563|NCT00186121|468262297|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
130084564|NCT00186121|468262297|FG000|Overall Study|Not eligible (no treatment)|1|||
130084565|NCT01569568|468262298|FG000|Overall Study|Physician Decision|0|||
130084566|NCT01569568|468262299|FG001|Overall Study|Physician Decision|2|||
130084567|NCT01370499|468262300|FG000|Overall Study|Adverse Event|38|||
130084568|NCT01370499|468262301|FG001|Overall Study|Adverse Event|12|||
130084569|NCT01370499|468262300|FG000|Overall Study|Lack of Efficacy|4|||
130084570|NCT01370499|468262301|FG001|Overall Study|Lack of Efficacy|2|||
130084571|NCT01370499|468262300|FG000|Overall Study|Lost to Follow-up|2|||
130084572|NCT01370499|468262301|FG001|Overall Study|Lost to Follow-up|1|||
130084573|NCT01370499|468262300|FG000|Overall Study|Physician Decision|3|||
130084574|NCT01370499|468262301|FG001|Overall Study|Physician Decision|3|||
130084575|NCT01370499|468262300|FG000|Overall Study|Protocol Violation|5|||
130084576|NCT01370499|468262301|FG001|Overall Study|Protocol Violation|4|||
130121258|NCT04634409|468404923|FG008|Overall Study|Other - As reported by Investigator|4|||
130121259|NCT04634409|468404924|FG009|Overall Study|Other - As reported by Investigator|0|||
130084577|NCT01370499|468262300|FG000|Overall Study|Withdrawal by Subject|18|||
130084578|NCT01370499|468262301|FG001|Overall Study|Withdrawal by Subject|7|||
130084579|NCT01370499|468262300|FG000|Overall Study|Sponsor Decision|41|||
130084580|NCT01370499|468262301|FG001|Overall Study|Sponsor Decision|15|||
130084581|NCT01654224|468262306|FG000|Overall Study|Lost to Follow-up|2|||
130084582|NCT01654224|468262307|FG001|Overall Study|Lost to Follow-up|2|||
130084583|NCT01654224|468262306|FG000|Overall Study|Did not receive allocation|1|||
130084584|NCT01654224|468262307|FG001|Overall Study|Did not receive allocation|8|||
130084585|NCT01654224|468262306|FG000|Overall Study|Insufficient blood sample|3|||
130084586|NCT01654224|468262307|FG001|Overall Study|Insufficient blood sample|2|||
130084587|NCT00166504|468262308|FG000|Overall Study|Adverse Event|3|||
130084588|NCT00166504|468262309|FG001|Overall Study|Adverse Event|3|||
130084589|NCT00166504|468262308|FG000|Overall Study|Lost to Follow-up|1|||
130084590|NCT00166504|468262309|FG001|Overall Study|Lost to Follow-up|1|||
130084591|NCT00166504|468262308|FG000|Overall Study|Withdrawal by Subject|1|||
130084592|NCT00166504|468262309|FG001|Overall Study|Withdrawal by Subject|0|||
130084593|NCT02646891|468262310|FG000|Overall Study|Adverse Event|0|||
130084594|NCT02646891|468262311|FG001|Overall Study|Adverse Event|1|||
130084595|NCT02646891|468262312|FG002|Overall Study|Adverse Event|0|||
130084596|NCT02646891|468262313|FG003|Overall Study|Adverse Event|0|||
130084597|NCT02646891|468262314|FG004|Overall Study|Adverse Event|0|||
130084598|NCT02646891|468262315|FG005|Overall Study|Adverse Event|0|||
130084599|NCT02646891|468262316|FG006|Overall Study|Adverse Event|0|||
130084600|NCT02646891|468262317|FG007|Overall Study|Adverse Event|0|||
130084601|NCT02646891|468262318|FG008|Overall Study|Adverse Event|0|||
130121260|NCT04634409|468404925|FG010|Overall Study|Other - As reported by Investigator|1|||
130121261|NCT04634409|468404926|FG011|Overall Study|Other - As reported by Investigator|2|||
129959587|NCT00509821|467815999|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
129959588|NCT01816685|467816003|FG000|Overall Study|Lost to Follow-up|7|||
129959589|NCT01816685|467816004|FG001|Overall Study|Lost to Follow-up|9|||
129959590|NCT01816685|467816003|FG000|Overall Study|Surgery Cancelled|3|||
129959591|NCT01816685|467816004|FG001|Overall Study|Surgery Cancelled|2|||
129959592|NCT02720185|467816005|FG000|Overall Study|Lost to Follow-up|1|||
129959593|NCT00684203|467816006|FG000|Overall Study|Adverse Event|6|||
129959594|NCT00684203|467816007|FG001|Overall Study|Adverse Event|4|||
129959595|NCT00684203|467816008|FG002|Overall Study|Adverse Event|8|||
129959596|NCT00684203|467816009|FG003|Overall Study|Adverse Event|0|||
129959597|NCT00684203|467816010|FG004|Overall Study|Adverse Event|0|||
129959598|NCT00684203|467816011|FG005|Overall Study|Adverse Event|0|||
129959599|NCT00684203|467816006|FG000|Overall Study|Protocol-defined clinical event|3|||
129959600|NCT00684203|467816007|FG001|Overall Study|Protocol-defined clinical event|1|||
129959601|NCT00684203|467816008|FG002|Overall Study|Protocol-defined clinical event|0|||
129959602|NCT00684203|467816009|FG003|Overall Study|Protocol-defined clinical event|0|||
129959603|NCT00684203|467816010|FG004|Overall Study|Protocol-defined clinical event|0|||
129959604|NCT00684203|467816011|FG005|Overall Study|Protocol-defined clinical event|0|||
129959605|NCT00684203|467816006|FG000|Overall Study|Withdrawal by Subject|0|||
129959606|NCT00684203|467816007|FG001|Overall Study|Withdrawal by Subject|2|||
129959607|NCT00684203|467816008|FG002|Overall Study|Withdrawal by Subject|1|||
129959608|NCT00684203|467816009|FG003|Overall Study|Withdrawal by Subject|0|||
129959609|NCT00684203|467816010|FG004|Overall Study|Withdrawal by Subject|0|||
129959610|NCT00684203|467816011|FG005|Overall Study|Withdrawal by Subject|0|||
129959611|NCT00684203|467816006|FG000|Overall Study|Did not meet protocol eligibility|0|||
129959612|NCT00684203|467816007|FG001|Overall Study|Did not meet protocol eligibility|1|||
129959613|NCT00684203|467816008|FG002|Overall Study|Did not meet protocol eligibility|0|||
129959614|NCT00684203|467816009|FG003|Overall Study|Did not meet protocol eligibility|0|||
129959615|NCT00684203|467816010|FG004|Overall Study|Did not meet protocol eligibility|0|||
129959616|NCT00684203|467816011|FG005|Overall Study|Did not meet protocol eligibility|0|||
129959617|NCT03418493|467816014|FG000|Overall Study|Adverse Event|1|||
129959618|NCT03418493|467816015|FG001|Overall Study|Adverse Event|0|||
129959619|NCT03418493|467816016|FG002|Overall Study|Adverse Event|0|||
129959620|NCT03418493|467816017|FG003|Overall Study|Adverse Event|0|||
129959621|NCT03418493|467816018|FG004|Overall Study|Adverse Event|0|||
129959622|NCT03418493|467816019|FG005|Overall Study|Adverse Event|0|||
129959623|NCT03418493|467816020|FG006|Overall Study|Adverse Event|0|||
129959624|NCT03418493|467816021|FG007|Overall Study|Adverse Event|0|||
129959625|NCT03418493|467816022|FG008|Overall Study|Adverse Event|0|||
129959626|NCT03418493|467816023|FG009|Overall Study|Adverse Event|0|||
129959627|NCT03418493|467816024|FG010|Overall Study|Adverse Event|0|||
129959628|NCT03418493|467816014|FG000|Overall Study|Protocol Violation|0|||
129959629|NCT03418493|467816015|FG001|Overall Study|Protocol Violation|0|||
129959630|NCT03418493|467816016|FG002|Overall Study|Protocol Violation|0|||
129959631|NCT03418493|467816017|FG003|Overall Study|Protocol Violation|0|||
129959632|NCT03418493|467816018|FG004|Overall Study|Protocol Violation|0|||
129959633|NCT03418493|467816019|FG005|Overall Study|Protocol Violation|0|||
129959634|NCT03418493|467816020|FG006|Overall Study|Protocol Violation|0|||
129959635|NCT03418493|467816021|FG007|Overall Study|Protocol Violation|0|||
129959636|NCT03418493|467816022|FG008|Overall Study|Protocol Violation|0|||
130084602|NCT02646891|468262319|FG009|Overall Study|Adverse Event|0|||
130084603|NCT02646891|468262310|FG000|Overall Study|Lost to Follow-up|0|||
129959637|NCT03418493|467816023|FG009|Overall Study|Protocol Violation|1|||
129959638|NCT03418493|467816024|FG010|Overall Study|Protocol Violation|0|||
129959639|NCT00719212|467816025|FG000|Overall Study|Death|41|||
129959640|NCT00719212|467816025|FG000|Overall Study|Lost to Follow-up|2|||
129959641|NCT00719212|467816025|FG000|Overall Study|Withdrawal by Subject|1|||
129959642|NCT05446714|467816026|FG000|Overall Study|Lost to Follow-up|1|||
130084604|NCT02646891|468262311|FG001|Overall Study|Lost to Follow-up|0|||
130084605|NCT02646891|468262312|FG002|Overall Study|Lost to Follow-up|0|||
130084606|NCT02646891|468262313|FG003|Overall Study|Lost to Follow-up|0|||
130084607|NCT02646891|468262314|FG004|Overall Study|Lost to Follow-up|0|||
130084608|NCT02646891|468262315|FG005|Overall Study|Lost to Follow-up|0|||
130084609|NCT02646891|468262316|FG006|Overall Study|Lost to Follow-up|2|||
130084610|NCT02646891|468262317|FG007|Overall Study|Lost to Follow-up|2|||
130084611|NCT02646891|468262318|FG008|Overall Study|Lost to Follow-up|2|||
130084612|NCT02646891|468262319|FG009|Overall Study|Lost to Follow-up|2|||
130084613|NCT02646891|468262310|FG000|Overall Study|Protocol Violation|0|||
130084614|NCT02646891|468262311|FG001|Overall Study|Protocol Violation|0|||
130084615|NCT02646891|468262312|FG002|Overall Study|Protocol Violation|0|||
130084616|NCT02646891|468262313|FG003|Overall Study|Protocol Violation|0|||
130084617|NCT02646891|468262314|FG004|Overall Study|Protocol Violation|0|||
130121262|NCT04634409|468404927|FG012|Overall Study|Other - As reported by Investigator|2|||
130121263|NCT04634409|468404928|FG013|Overall Study|Other - As reported by Investigator|1|||
130121264|NCT04634409|468404929|FG014|Overall Study|Other - As reported by Investigator|0|||
130121265|NCT04634409|468404930|FG015|Overall Study|Other - As reported by Investigator|0|||
130121266|NCT04634409|468404931|FG016|Overall Study|Other - As reported by Investigator|0|||
130121267|NCT04634409|468404932|FG017|Overall Study|Other - As reported by Investigator|0|||
130121268|NCT04634409|468404933|FG018|Overall Study|Other - As reported by Investigator|0|||
130121269|NCT04634409|468404934|FG019|Overall Study|Other - As reported by Investigator|0|||
130121270|NCT04634409|468404935|FG020|Overall Study|Other - As reported by Investigator|0|||
130121271|NCT04634409|468404936|FG021|Overall Study|Other - As reported by Investigator|0|||
130121272|NCT04634409|468404937|FG022|Overall Study|Other - As reported by Investigator|0|||
130121273|NCT04634409|468404938|FG023|Overall Study|Other - As reported by Investigator|0|||
130121274|NCT04634409|468404939|FG024|Overall Study|Other - As reported by Investigator|0|||
130121275|NCT04634409|468404940|FG025|Overall Study|Other - As reported by Investigator|0|||
130121276|NCT04634409|468404941|FG026|Overall Study|Other - As reported by Investigator|0|||
130121277|NCT03708211|468404943|FG000|Overall Study|Progressive Disease|10|||
130121278|NCT03708211|468404944|FG001|Overall Study|Progressive Disease|7|||
130121279|NCT03708211|468404943|FG000|Overall Study|Withdrawal by Subject|0|||
130121280|NCT03708211|468404944|FG001|Overall Study|Withdrawal by Subject|1|||
130121281|NCT03708211|468404943|FG000|Overall Study|Other|2|||
130121282|NCT03708211|468404944|FG001|Overall Study|Other|0|||
130121283|NCT01508936|468404946|FG000|Overall Study|Adverse Event|11|||
130121284|NCT01508936|468404947|FG001|Overall Study|Adverse Event|32|||
130121285|NCT01508936|468404946|FG000|Overall Study|Lack of Efficacy|0|||
130121286|NCT01508936|468404947|FG001|Overall Study|Lack of Efficacy|1|||
130121287|NCT01508936|468404946|FG000|Overall Study|Withdrawal by Subject|4|||
130121288|NCT01508936|468404947|FG001|Overall Study|Withdrawal by Subject|18|||
130121289|NCT01508936|468404946|FG000|Overall Study|Protocol Violation|2|||
130121290|NCT01508936|468404947|FG001|Overall Study|Protocol Violation|3|||
130121291|NCT01508936|468404946|FG000|Overall Study|Lost to Follow-up|2|||
130121292|NCT01508936|468404947|FG001|Overall Study|Lost to Follow-up|9|||
130121293|NCT01508936|468404946|FG000|Overall Study|Other|0|||
130121294|NCT01508936|468404947|FG001|Overall Study|Other|5|||
130121295|NCT01508936|468404946|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
130121296|NCT01508936|468404947|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
130121297|NCT00462982|468404948|FG000|Overall Study|Adverse Event|1|||
130121298|NCT00462982|468404948|FG000|Overall Study|Patient Not Treated|2|||
130121299|NCT01611090|468404949|FG000|Randomized Period|Lost to Follow-up|8|||
130121300|NCT01611090|468404950|FG001|Randomized Period|Lost to Follow-up|3|||
130121301|NCT01611090|468404951|FG002|Randomized Period|Lost to Follow-up|0|||
130121302|NCT01611090|468404949|FG000|Randomized Period|Withdrawal by Subject|22|||
130121303|NCT01611090|468404950|FG001|Randomized Period|Withdrawal by Subject|26|||
130121304|NCT01611090|468404951|FG002|Randomized Period|Withdrawal by Subject|0|||
130121305|NCT01611090|468404949|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
130121306|NCT01611090|468404950|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
130121307|NCT01611090|468404951|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
130121308|NCT01611090|468404949|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
130121309|NCT01611090|468404950|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
130121310|NCT01611090|468404951|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
130121311|NCT01922349|468404952|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
130121312|NCT01922349|468404953|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
130121313|NCT01922349|468404954|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
130121314|NCT01922349|468404955|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
130084618|NCT02646891|468262315|FG005|Overall Study|Protocol Violation|0|||
130084619|NCT02646891|468262316|FG006|Overall Study|Protocol Violation|1|||
130121315|NCT02448771|468404956|FG000|Overall Study|Disease Progression|30|||
130121316|NCT02448771|468404956|FG000|Overall Study|Unacceptable Toxicity|1|||
130121317|NCT02448771|468404956|FG000|Overall Study|Physician Decision|3|||
130121318|NCT02448771|468404956|FG000|Overall Study|Started new therapy|2|||
130121319|NCT00770315|468404957|FG000|Overall Study|Adverse Event|11|||
130121320|NCT00770315|468404958|FG001|Overall Study|Adverse Event|17|||
130121321|NCT00770315|468404959|FG002|Overall Study|Adverse Event|16|||
130121322|NCT00770315|468404960|FG003|Overall Study|Adverse Event|6|||
130121323|NCT00770315|468404957|FG000|Overall Study|Lost to Follow-up|9|||
129959643|NCT05446714|467816027|FG001|Overall Study|Lost to Follow-up|3|||
130084620|NCT02646891|468262317|FG007|Overall Study|Protocol Violation|1|||
130084621|NCT02646891|468262318|FG008|Overall Study|Protocol Violation|0|||
130084622|NCT02646891|468262319|FG009|Overall Study|Protocol Violation|0|||
130084623|NCT02646891|468262310|FG000|Overall Study|Withdrawal by Subject|2|||
130084624|NCT02646891|468262311|FG001|Overall Study|Withdrawal by Subject|0|||
130084625|NCT02646891|468262312|FG002|Overall Study|Withdrawal by Subject|1|||
130084626|NCT02646891|468262313|FG003|Overall Study|Withdrawal by Subject|0|||
130084627|NCT02646891|468262314|FG004|Overall Study|Withdrawal by Subject|0|||
130084628|NCT02646891|468262315|FG005|Overall Study|Withdrawal by Subject|0|||
130084629|NCT02646891|468262316|FG006|Overall Study|Withdrawal by Subject|5|||
130084630|NCT02646891|468262317|FG007|Overall Study|Withdrawal by Subject|9|||
130084631|NCT02646891|468262318|FG008|Overall Study|Withdrawal by Subject|7|||
130084632|NCT02646891|468262319|FG009|Overall Study|Withdrawal by Subject|3|||
130084633|NCT02646891|468262310|FG000|Overall Study|Death|0|||
130084634|NCT02646891|468262311|FG001|Overall Study|Death|0|||
130084635|NCT02646891|468262312|FG002|Overall Study|Death|0|||
130084636|NCT02646891|468262313|FG003|Overall Study|Death|0|||
130084637|NCT02646891|468262314|FG004|Overall Study|Death|0|||
130084638|NCT02646891|468262315|FG005|Overall Study|Death|0|||
130084639|NCT02646891|468262316|FG006|Overall Study|Death|1|||
130084640|NCT02646891|468262317|FG007|Overall Study|Death|1|||
130084641|NCT02646891|468262318|FG008|Overall Study|Death|1|||
130084642|NCT02646891|468262319|FG009|Overall Study|Death|0|||
130084643|NCT00723489|468262320|FG000|Overall Study|Physician Decision|0|||
130084644|NCT00723489|468262321|FG001|Overall Study|Physician Decision|1|||
130084645|NCT00723489|468262322|FG002|Overall Study|Physician Decision|0|||
130084646|NCT00723489|468262323|FG003|Overall Study|Physician Decision|0|||
130084647|NCT00723489|468262320|FG000|Overall Study|Pregnancy|0|||
130084648|NCT00723489|468262321|FG001|Overall Study|Pregnancy|0|||
130084649|NCT00723489|468262322|FG002|Overall Study|Pregnancy|0|||
130084650|NCT00723489|468262323|FG003|Overall Study|Pregnancy|1|||
130084651|NCT00723489|468262320|FG000|Overall Study|Withdrawal by Subject|0|||
130084652|NCT00723489|468262321|FG001|Overall Study|Withdrawal by Subject|0|||
130084653|NCT00723489|468262322|FG002|Overall Study|Withdrawal by Subject|0|||
130084654|NCT00723489|468262323|FG003|Overall Study|Withdrawal by Subject|1|||
130084655|NCT00723489|468262320|FG000|Overall Study|Seropositive at baseline|1|||
130084656|NCT00723489|468262321|FG001|Overall Study|Seropositive at baseline|0|||
130084657|NCT00723489|468262322|FG002|Overall Study|Seropositive at baseline|0|||
130084658|NCT00723489|468262323|FG003|Overall Study|Seropositive at baseline|0|||
130084659|NCT00723489|468262320|FG000|Overall Study|Prohibited Medication|0|||
130084660|NCT00723489|468262321|FG001|Overall Study|Prohibited Medication|0|||
130084661|NCT00723489|468262322|FG002|Overall Study|Prohibited Medication|0|||
130084662|NCT00723489|468262323|FG003|Overall Study|Prohibited Medication|1|||
130084663|NCT00723489|468262320|FG000|Overall Study|Samples Collected Out of Window|0|||
130084664|NCT00723489|468262321|FG001|Overall Study|Samples Collected Out of Window|3|||
130084665|NCT00723489|468262322|FG002|Overall Study|Samples Collected Out of Window|0|||
130084666|NCT00723489|468262323|FG003|Overall Study|Samples Collected Out of Window|0|||
130084667|NCT02274311|468262324|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
130084668|NCT01599585|468262325|FG000|Overall Study|Withdrawal by Subject|16|||
130084669|NCT01599585|468262326|FG001|Overall Study|Withdrawal by Subject|9|||
130084670|NCT01599585|468262325|FG000|Overall Study|Lost to Follow-up|3|||
130084671|NCT01599585|468262326|FG001|Overall Study|Lost to Follow-up|5|||
130084672|NCT01599585|468262325|FG000|Overall Study|randomized did not start treatment|3|||
130084673|NCT01599585|468262326|FG001|Overall Study|randomized did not start treatment|3|||
130084674|NCT00853112|468262328|FG000|Overall Study|Randomized but not treated|0|||
130084675|NCT00853112|468262329|FG001|Overall Study|Randomized but not treated|1|||
130084676|NCT00853112|468262330|FG002|Overall Study|Randomized but not treated|0|||
130084677|NCT00853112|468262331|FG003|Overall Study|Randomized but not treated|2|||
130084678|NCT00853112|468262332|FG004|Overall Study|Randomized but not treated|0|||
130084679|NCT00853112|468262333|FG005|Overall Study|Randomized but not treated|0|||
130084680|NCT00853112|468262334|FG006|Overall Study|Randomized but not treated|1|||
130084681|NCT02477800|468262337|FG000|Placebo-Controlled Period|Adverse Event|16|||
130084682|NCT02477800|468262338|FG001|Placebo-Controlled Period|Adverse Event|25|||
130084683|NCT02477800|468262339|FG002|Placebo-Controlled Period|Adverse Event|28|||
130084684|NCT02477800|468262340|FG003|Placebo-Controlled Period|Adverse Event|0|||
130084685|NCT02477800|468262341|FG004|Placebo-Controlled Period|Adverse Event|0|||
130084686|NCT02477800|468262342|FG005|Placebo-Controlled Period|Adverse Event|0|||
130084687|NCT02477800|468262343|FG006|Placebo-Controlled Period|Adverse Event|0|||
130084688|NCT02477800|468262337|FG000|Placebo-Controlled Period|Change of Treatment|1|||
130084689|NCT02477800|468262338|FG001|Placebo-Controlled Period|Change of Treatment|2|||
129959644|NCT05446714|467816028|FG002|Overall Study|Lost to Follow-up|2|||
130084690|NCT02477800|468262339|FG002|Placebo-Controlled Period|Change of Treatment|1|||
130084691|NCT02477800|468262340|FG003|Placebo-Controlled Period|Change of Treatment|0|||
130084692|NCT02477800|468262341|FG004|Placebo-Controlled Period|Change of Treatment|0|||
130084693|NCT02477800|468262342|FG005|Placebo-Controlled Period|Change of Treatment|0|||
130084694|NCT02477800|468262343|FG006|Placebo-Controlled Period|Change of Treatment|0|||
130084695|NCT02477800|468262337|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
130084696|NCT02477800|468262338|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
130084697|NCT02477800|468262339|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
130084698|NCT02477800|468262340|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
130084699|NCT02477800|468262341|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
130084700|NCT02477800|468262342|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
130084701|NCT02477800|468262343|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
130084702|NCT02477800|468262337|FG000|Placebo-Controlled Period|Death|0|||
130084703|NCT02477800|468262338|FG001|Placebo-Controlled Period|Death|3|||
130084704|NCT02477800|468262339|FG002|Placebo-Controlled Period|Death|2|||
130084705|NCT02477800|468262340|FG003|Placebo-Controlled Period|Death|0|||
130084706|NCT02477800|468262341|FG004|Placebo-Controlled Period|Death|0|||
130084707|NCT02477800|468262342|FG005|Placebo-Controlled Period|Death|0|||
130084708|NCT02477800|468262343|FG006|Placebo-Controlled Period|Death|0|||
130084709|NCT02477800|468262337|FG000|Placebo-Controlled Period|Disease Progression|1|||
130084710|NCT02477800|468262338|FG001|Placebo-Controlled Period|Disease Progression|0|||
130084711|NCT02477800|468262339|FG002|Placebo-Controlled Period|Disease Progression|1|||
130084712|NCT02477800|468262340|FG003|Placebo-Controlled Period|Disease Progression|0|||
130084713|NCT02477800|468262341|FG004|Placebo-Controlled Period|Disease Progression|0|||
130084714|NCT02477800|468262342|FG005|Placebo-Controlled Period|Disease Progression|0|||
130084715|NCT02477800|468262343|FG006|Placebo-Controlled Period|Disease Progression|0|||
130084716|NCT02477800|468262337|FG000|Placebo-Controlled Period|Investigator Decision|3|||
130084717|NCT02477800|468262338|FG001|Placebo-Controlled Period|Investigator Decision|2|||
130084718|NCT02477800|468262339|FG002|Placebo-Controlled Period|Investigator Decision|1|||
130084719|NCT02477800|468262340|FG003|Placebo-Controlled Period|Investigator Decision|0|||
130084720|NCT02477800|468262341|FG004|Placebo-Controlled Period|Investigator Decision|0|||
130084721|NCT02477800|468262342|FG005|Placebo-Controlled Period|Investigator Decision|0|||
130084722|NCT02477800|468262343|FG006|Placebo-Controlled Period|Investigator Decision|0|||
130084723|NCT02477800|468262337|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
130084724|NCT02477800|468262338|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
130084725|NCT02477800|468262339|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
130084726|NCT02477800|468262340|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
130084727|NCT02477800|468262341|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
130084728|NCT02477800|468262342|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
130084729|NCT02477800|468262343|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
130084730|NCT02477800|468262337|FG000|Placebo-Controlled Period|Relocation|2|||
130084731|NCT02477800|468262338|FG001|Placebo-Controlled Period|Relocation|0|||
130084732|NCT02477800|468262339|FG002|Placebo-Controlled Period|Relocation|0|||
130084733|NCT02477800|468262340|FG003|Placebo-Controlled Period|Relocation|0|||
130084734|NCT02477800|468262341|FG004|Placebo-Controlled Period|Relocation|0|||
130084735|NCT02477800|468262342|FG005|Placebo-Controlled Period|Relocation|0|||
130084736|NCT02477800|468262343|FG006|Placebo-Controlled Period|Relocation|0|||
130084737|NCT02477800|468262337|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
130084738|NCT02477800|468262338|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
130084739|NCT02477800|468262339|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
130084740|NCT02477800|468262340|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130084741|NCT02477800|468262341|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130084742|NCT02477800|468262342|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130084743|NCT02477800|468262343|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
130084744|NCT02477800|468262337|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
130084745|NCT02477800|468262338|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
130084746|NCT02477800|468262339|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130084747|NCT02477800|468262340|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130084748|NCT02477800|468262341|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130084749|NCT02477800|468262342|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130084750|NCT02477800|468262343|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
130084751|NCT02477800|468262337|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
129959645|NCT05446714|467816026|FG000|Overall Study|Protocol Violation|2|||
129959646|NCT05446714|467816027|FG001|Overall Study|Protocol Violation|0|||
129959647|NCT05446714|467816028|FG002|Overall Study|Protocol Violation|0|||
129959648|NCT01990313|467816029|FG000|Overall Study|Lost to Follow-up|1|||
129959649|NCT02396953|467816030|FG000|Overall Study|Withdrawal by Subject|0|||
129959650|NCT02396953|467816031|FG001|Overall Study|Withdrawal by Subject|0|||
129959651|NCT02396953|467816032|FG002|Overall Study|Withdrawal by Subject|1|||
129959652|NCT02396953|467816030|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
129959653|NCT02396953|467816031|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
129959654|NCT02396953|467816032|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
129959655|NCT02396953|467816030|FG000|Overall Study|Personal Reasons|1|||
130084752|NCT02477800|468262338|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
130084753|NCT02477800|468262339|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
130084754|NCT02477800|468262340|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
130084755|NCT02477800|468262341|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
130084756|NCT02477800|468262342|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
130084757|NCT02477800|468262343|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
130084758|NCT02477800|468262337|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
130084759|NCT02477800|468262338|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
130084760|NCT02477800|468262339|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
130084761|NCT02477800|468262340|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130084762|NCT02477800|468262341|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130084763|NCT02477800|468262342|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130084764|NCT02477800|468262343|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
130084765|NCT02477800|468262337|FG000|Placebo-Controlled Period|Reason not Specified|161|||
130084766|NCT02477800|468262338|FG001|Placebo-Controlled Period|Reason not Specified|161|||
130084767|NCT02477800|468262339|FG002|Placebo-Controlled Period|Reason not Specified|189|||
130084768|NCT02477800|468262340|FG003|Placebo-Controlled Period|Reason not Specified|0|||
130084769|NCT02477800|468262341|FG004|Placebo-Controlled Period|Reason not Specified|0|||
130084770|NCT02477800|468262342|FG005|Placebo-Controlled Period|Reason not Specified|0|||
130084771|NCT02477800|468262343|FG006|Placebo-Controlled Period|Reason not Specified|0|||
130084772|NCT02477800|468262337|FG000|Long Term Extension Period|Adverse Event|0|||
130084773|NCT02477800|468262338|FG001|Long Term Extension Period|Adverse Event|0|||
130084774|NCT02477800|468262339|FG002|Long Term Extension Period|Adverse Event|0|||
130084775|NCT02477800|468262340|FG003|Long Term Extension Period|Adverse Event|6|||
130084776|NCT02477800|468262341|FG004|Long Term Extension Period|Adverse Event|2|||
130084777|NCT02477800|468262342|FG005|Long Term Extension Period|Adverse Event|4|||
130084778|NCT02477800|468262343|FG006|Long Term Extension Period|Adverse Event|3|||
130084779|NCT02477800|468262337|FG000|Long Term Extension Period|Death|0|||
130084780|NCT02477800|468262338|FG001|Long Term Extension Period|Death|0|||
130084781|NCT02477800|468262339|FG002|Long Term Extension Period|Death|0|||
130084782|NCT02477800|468262340|FG003|Long Term Extension Period|Death|1|||
130084783|NCT02477800|468262341|FG004|Long Term Extension Period|Death|1|||
130084784|NCT02477800|468262342|FG005|Long Term Extension Period|Death|1|||
130084785|NCT02477800|468262343|FG006|Long Term Extension Period|Death|2|||
130084786|NCT02477800|468262337|FG000|Long Term Extension Period|Consent Withdrawn|0|||
130084787|NCT02477800|468262338|FG001|Long Term Extension Period|Consent Withdrawn|0|||
130084788|NCT02477800|468262339|FG002|Long Term Extension Period|Consent Withdrawn|0|||
130084789|NCT02477800|468262340|FG003|Long Term Extension Period|Consent Withdrawn|10|||
130084790|NCT02477800|468262341|FG004|Long Term Extension Period|Consent Withdrawn|4|||
130084791|NCT02477800|468262342|FG005|Long Term Extension Period|Consent Withdrawn|13|||
130084792|NCT02477800|468262343|FG006|Long Term Extension Period|Consent Withdrawn|16|||
130084793|NCT02477800|468262337|FG000|Long Term Extension Period|Disease Progression|0|||
130084794|NCT02477800|468262338|FG001|Long Term Extension Period|Disease Progression|0|||
130084795|NCT02477800|468262339|FG002|Long Term Extension Period|Disease Progression|0|||
130084796|NCT02477800|468262340|FG003|Long Term Extension Period|Disease Progression|3|||
130084797|NCT02477800|468262341|FG004|Long Term Extension Period|Disease Progression|1|||
130084798|NCT02477800|468262342|FG005|Long Term Extension Period|Disease Progression|1|||
130084799|NCT02477800|468262343|FG006|Long Term Extension Period|Disease Progression|0|||
130084800|NCT02477800|468262337|FG000|Long Term Extension Period|Investigator Decision|0|||
130084801|NCT02477800|468262338|FG001|Long Term Extension Period|Investigator Decision|0|||
130084802|NCT02477800|468262339|FG002|Long Term Extension Period|Investigator Decision|0|||
130084803|NCT02477800|468262340|FG003|Long Term Extension Period|Investigator Decision|0|||
130084804|NCT02477800|468262341|FG004|Long Term Extension Period|Investigator Decision|0|||
130084805|NCT02477800|468262342|FG005|Long Term Extension Period|Investigator Decision|0|||
130084806|NCT02477800|468262343|FG006|Long Term Extension Period|Investigator Decision|2|||
130084807|NCT02477800|468262337|FG000|Long Term Extension Period|Lost to Follow-up|0|||
130084808|NCT02477800|468262338|FG001|Long Term Extension Period|Lost to Follow-up|0|||
130084809|NCT02477800|468262339|FG002|Long Term Extension Period|Lost to Follow-up|0|||
130084810|NCT02477800|468262340|FG003|Long Term Extension Period|Lost to Follow-up|0|||
130084811|NCT02477800|468262341|FG004|Long Term Extension Period|Lost to Follow-up|1|||
130084812|NCT02477800|468262342|FG005|Long Term Extension Period|Lost to Follow-up|3|||
130084813|NCT02477800|468262343|FG006|Long Term Extension Period|Lost to Follow-up|0|||
130084814|NCT02477800|468262337|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
130084815|NCT02477800|468262338|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
130084816|NCT02477800|468262339|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
130084817|NCT02477800|468262340|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
130084818|NCT02477800|468262341|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
130084819|NCT02477800|468262342|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
130084820|NCT02477800|468262343|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
130084821|NCT02477800|468262337|FG000|Long Term Extension Period|Study Visit Burden|0|||
130084822|NCT02477800|468262338|FG001|Long Term Extension Period|Study Visit Burden|0|||
130084823|NCT02477800|468262339|FG002|Long Term Extension Period|Study Visit Burden|0|||
130084824|NCT02477800|468262340|FG003|Long Term Extension Period|Study Visit Burden|3|||
130084825|NCT02477800|468262341|FG004|Long Term Extension Period|Study Visit Burden|0|||
130084826|NCT02477800|468262342|FG005|Long Term Extension Period|Study Visit Burden|2|||
130121324|NCT00770315|468404958|FG001|Overall Study|Lost to Follow-up|5|||
130084827|NCT02477800|468262343|FG006|Long Term Extension Period|Study Visit Burden|2|||
130084828|NCT02477800|468262337|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
130084829|NCT02477800|468262338|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
130084830|NCT02477800|468262339|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
130084831|NCT02477800|468262340|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
130084832|NCT02477800|468262341|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
130084833|NCT02477800|468262342|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
130084834|NCT02477800|468262343|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
130084835|NCT02477800|468262337|FG000|Long Term Extension Period|Reason not Specified|0|||
130084836|NCT02477800|468262338|FG001|Long Term Extension Period|Reason not Specified|0|||
130084837|NCT02477800|468262339|FG002|Long Term Extension Period|Reason not Specified|0|||
130084838|NCT02477800|468262340|FG003|Long Term Extension Period|Reason not Specified|126|||
130084839|NCT02477800|468262341|FG004|Long Term Extension Period|Reason not Specified|140|||
130084840|NCT02477800|468262342|FG005|Long Term Extension Period|Reason not Specified|270|||
130084841|NCT02477800|468262343|FG006|Long Term Extension Period|Reason not Specified|224|||
130084842|NCT00958191|468262348|FG000|Overall Study|Death|4|||
130084843|NCT00958191|468262348|FG000|Overall Study|Lost to Follow-up|5|||
130084844|NCT00958191|468262348|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
130084845|NCT00958191|468262348|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
130084846|NCT00958191|468262348|FG000|Overall Study|Revision of study device|4|||
130084847|NCT00958191|468262348|FG000|Overall Study|Site termination|11|||
130084848|NCT00958191|468262348|FG000|Overall Study|No 5 yr x-rays|56|||
130084849|NCT01818765|468262349|FG000|Overall Study|Death|2|||
130084850|NCT02010567|468262350|FG000|Overall Study|Adverse Event|0|||
130084851|NCT02010567|468262351|FG001|Overall Study|Adverse Event|0|||
130084852|NCT02010567|468262352|FG002|Overall Study|Adverse Event|1|||
130084853|NCT02010567|468262353|FG003|Overall Study|Adverse Event|0|||
130084854|NCT02010567|468262354|FG004|Overall Study|Adverse Event|1|||
130084855|NCT02005211|468262355|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130084856|NCT02005211|468262356|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130084857|NCT02005211|468262357|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130084858|NCT02005211|468262358|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130084859|NCT02005211|468262359|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
130084860|NCT02005211|468262360|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130084861|NCT02005211|468262361|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
130084862|NCT00415623|468262363|FG000|Overall Study|Adverse Event|3|||
130084863|NCT00415623|468262364|FG001|Overall Study|Adverse Event|4|||
130084864|NCT00415623|468262363|FG000|Overall Study|Death|1|||
130084865|NCT00415623|468262364|FG001|Overall Study|Death|0|||
130084866|NCT00415623|468262363|FG000|Overall Study|Withdrawal by Subject|1|||
130084867|NCT00415623|468262364|FG001|Overall Study|Withdrawal by Subject|1|||
130084868|NCT00542425|468262365|FG000|Initial 24 Weeks|Administrative reasons|0|||
130084869|NCT00542425|468262366|FG001|Initial 24 Weeks|Administrative reasons|0|||
130084870|NCT00542425|468262367|FG002|Initial 24 Weeks|Administrative reasons|1|||
130084871|NCT00542425|468262368|FG003|Initial 24 Weeks|Administrative reasons|1|||
130084872|NCT00542425|468262369|FG004|Initial 24 Weeks|Administrative reasons|0|||
130084873|NCT00542425|468262365|FG000|Initial 24 Weeks|Adverse Event|0|||
130084874|NCT00542425|468262366|FG001|Initial 24 Weeks|Adverse Event|1|||
130084875|NCT00542425|468262367|FG002|Initial 24 Weeks|Adverse Event|1|||
130084876|NCT00542425|468262368|FG003|Initial 24 Weeks|Adverse Event|3|||
130084877|NCT00542425|468262369|FG004|Initial 24 Weeks|Adverse Event|2|||
130084878|NCT00542425|468262365|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
130084879|NCT00542425|468262366|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
130084880|NCT00542425|468262367|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
130084881|NCT00542425|468262368|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
130084882|NCT00542425|468262369|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
130084883|NCT00542425|468262365|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
130084884|NCT00542425|468262366|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
130084885|NCT00542425|468262367|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
130084886|NCT00542425|468262368|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
130084887|NCT00542425|468262369|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
130084888|NCT00542425|468262365|FG000|Initial 24 Weeks|Non-compliance|0|||
130084889|NCT00542425|468262366|FG001|Initial 24 Weeks|Non-compliance|0|||
130084890|NCT00542425|468262367|FG002|Initial 24 Weeks|Non-compliance|0|||
130084891|NCT00542425|468262368|FG003|Initial 24 Weeks|Non-compliance|1|||
130084892|NCT00542425|468262369|FG004|Initial 24 Weeks|Non-compliance|1|||
129959656|NCT02396953|467816031|FG001|Overall Study|Personal Reasons|1|||
130084893|NCT00542425|468262365|FG000|Initial 24 Weeks|Protocol Violation|0|||
130084894|NCT00542425|468262366|FG001|Initial 24 Weeks|Protocol Violation|0|||
130084895|NCT00542425|468262367|FG002|Initial 24 Weeks|Protocol Violation|0|||
130084896|NCT00542425|468262368|FG003|Initial 24 Weeks|Protocol Violation|1|||
130084897|NCT00542425|468262369|FG004|Initial 24 Weeks|Protocol Violation|0|||
130084898|NCT00542425|468262365|FG000|Initial 24 Weeks|Refusal of treatment|2|||
130084899|NCT00542425|468262366|FG001|Initial 24 Weeks|Refusal of treatment|2|||
130084900|NCT00542425|468262367|FG002|Initial 24 Weeks|Refusal of treatment|1|||
130084901|NCT00542425|468262368|FG003|Initial 24 Weeks|Refusal of treatment|4|||
130084902|NCT00542425|468262369|FG004|Initial 24 Weeks|Refusal of treatment|1|||
130084903|NCT00542425|468262365|FG000|Initial 24 Weeks|Other|0|||
130084904|NCT00542425|468262366|FG001|Initial 24 Weeks|Other|2|||
130084905|NCT00542425|468262367|FG002|Initial 24 Weeks|Other|1|||
130084906|NCT00542425|468262368|FG003|Initial 24 Weeks|Other|0|||
130084907|NCT00542425|468262369|FG004|Initial 24 Weeks|Other|0|||
130084908|NCT00542425|468262365|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
130084909|NCT00542425|468262366|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
130084910|NCT00542425|468262367|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
130084911|NCT00542425|468262368|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
130084912|NCT00542425|468262369|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
130084913|NCT00542425|468262365|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130084914|NCT00542425|468262366|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130084915|NCT00542425|468262367|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
130084916|NCT00542425|468262368|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130084917|NCT00542425|468262369|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
130084918|NCT00542425|468262365|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130084919|NCT00542425|468262366|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
130084920|NCT00542425|468262367|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130084921|NCT00542425|468262368|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130084922|NCT00542425|468262369|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
130084923|NCT00542425|468262365|FG000|Extended 24 Weeks of Treatment|Other|1|||
130084924|NCT00542425|468262366|FG001|Extended 24 Weeks of Treatment|Other|1|||
130084925|NCT00542425|468262367|FG002|Extended 24 Weeks of Treatment|Other|0|||
130084926|NCT00542425|468262368|FG003|Extended 24 Weeks of Treatment|Other|0|||
130084927|NCT00542425|468262369|FG004|Extended 24 Weeks of Treatment|Other|1|||
130084928|NCT01601873|468262370|FG000|Overall Study|Lost to Follow-up|2|||
130084929|NCT01601873|468262371|FG001|Overall Study|Lost to Follow-up|3|||
130084930|NCT02096471|468262372|FG000|Overall Study|Adverse Event|1|||
130084931|NCT02096471|468262372|FG000|Overall Study|Lack of Efficacy|7|||
130084932|NCT02096471|468262372|FG000|Overall Study|Withdrawal by Subject|3|||
130084933|NCT02096471|468262372|FG000|Overall Study|Non-Compliant|2|||
130084934|NCT02449915|468262373|FG000|Overall Study|Exclusion criteria - drug use|1|||
130084935|NCT02449915|468262374|FG001|Overall Study|Exclusion criteria - drug use|0|||
130084936|NCT02449915|468262373|FG000|Overall Study|Withdrawal by Subject|0|||
130084937|NCT02449915|468262374|FG001|Overall Study|Withdrawal by Subject|2|||
130084938|NCT02449915|468262373|FG000|Overall Study|Intraoperative surgical findings|1|||
130084939|NCT02449915|468262374|FG001|Overall Study|Intraoperative surgical findings|1|||
130084940|NCT02449915|468262373|FG000|Overall Study|Abnormal preop lab|0|||
130084941|NCT02449915|468262374|FG001|Overall Study|Abnormal preop lab|1|||
130084942|NCT03037489|468264380|FG000|Overall Study|Adverse Event|4|||
130084943|NCT03037489|468264381|FG001|Overall Study|Adverse Event|0|||
130084944|NCT03037489|468264380|FG000|Overall Study|Withdrawal by Subject|3|||
130084945|NCT03037489|468264381|FG001|Overall Study|Withdrawal by Subject|0|||
130084946|NCT00621764|468264382|FG000|Overall Study|Protocol Violation|0|||
130084947|NCT00621764|468264383|FG001|Overall Study|Protocol Violation|0|||
130084948|NCT00621764|468264384|FG002|Overall Study|Protocol Violation|0|||
130084949|NCT00621764|468264385|FG003|Overall Study|Protocol Violation|1|||
130084950|NCT01293123|468264386|FG000|Overall Study|Lost to Follow-up|0|||
130084951|NCT01293123|468264387|FG001|Overall Study|Lost to Follow-up|1|||
130084952|NCT03031327|468264392|FG000|Overall Study|Withdrawal by Subject|0|||
130084953|NCT03031327|468264393|FG001|Overall Study|Withdrawal by Subject|1|||
130084954|NCT03031327|468264394|FG002|Overall Study|Withdrawal by Subject|1|||
130084955|NCT00211536|468264395|FG000|Overall Study|Withdrawal by Subject|2|||
130084956|NCT00211536|468264396|FG001|Overall Study|Withdrawal by Subject|2|||
130084957|NCT00211536|468264395|FG000|Overall Study|Physician Decision|0|||
130084958|NCT00211536|468264396|FG001|Overall Study|Physician Decision|5|||
130084959|NCT00211536|468264395|FG000|Overall Study|Adverse Event|2|||
130084960|NCT00211536|468264396|FG001|Overall Study|Adverse Event|0|||
129959657|NCT02396953|467816032|FG002|Overall Study|Personal Reasons|0|||
129959658|NCT00329550|467816036|FG000|Overall Study|Adverse Event|3|||
130084961|NCT00003389|468264397|FG000|Overall Study|Disease progression|6|||
130084962|NCT00003389|468264398|FG001|Overall Study|Disease progression|1|||
130084963|NCT00003389|468264397|FG000|Overall Study|Adverse Event|13|||
130084964|NCT00003389|468264398|FG001|Overall Study|Adverse Event|2|||
130084965|NCT00003389|468264397|FG000|Overall Study|Death|0|||
130084966|NCT00003389|468264398|FG001|Overall Study|Death|3|||
130084967|NCT00003389|468264397|FG000|Overall Study|Withdrawal by Subject|12|||
130084968|NCT00003389|468264398|FG001|Overall Study|Withdrawal by Subject|5|||
130084969|NCT00003389|468264397|FG000|Overall Study|Alternative therapy|2|||
130084970|NCT00003389|468264398|FG001|Overall Study|Alternative therapy|1|||
130084971|NCT00003389|468264397|FG000|Overall Study|Complicating disease|1|||
130084972|NCT00003389|468264398|FG001|Overall Study|Complicating disease|0|||
130084973|NCT00003389|468264397|FG000|Overall Study|Off-treatment reason missing|31|||
130084974|NCT00003389|468264398|FG001|Overall Study|Off-treatment reason missing|21|||
130084975|NCT00003389|468264397|FG000|Overall Study|Ineligible|33|||
130084976|NCT00003389|468264398|FG001|Overall Study|Ineligible|27|||
130084977|NCT01997892|468264401|FG000|Overall Study|Physician Decision|2|||
130084978|NCT01997892|468264401|FG000|Overall Study|Lost to Follow-up|6|||
130084979|NCT01997892|468264401|FG000|Overall Study|Death|14|||
130084980|NCT01997892|468264401|FG000|Overall Study|Renal transplant|8|||
130084981|NCT01997892|468264401|FG000|Overall Study|Other|3|||
130084982|NCT01997892|468264401|FG000|Overall Study|Study completion data not recorded|35|||
130084983|NCT02710422|468264402|FG000|Overall Study|Termination of study|9|||
130084984|NCT02710422|468264403|FG001|Overall Study|Termination of study|9|||
130084985|NCT02608099|468264423|FG000|Overall Study|Ablation procedure not initiated|3|||
130084986|NCT02608099|468264424|FG001|Overall Study|Ablation procedure not initiated|2|||
130084987|NCT04657003|468264430|FG000|Overall Study|Adverse Event|5|||
130084988|NCT04657003|468264431|FG001|Overall Study|Adverse Event|1|||
130084989|NCT04657003|468264432|FG002|Overall Study|Adverse Event|5|||
130084990|NCT04657003|468264430|FG000|Overall Study|Death|0|||
130084991|NCT04657003|468264431|FG001|Overall Study|Death|2|||
130084992|NCT04657003|468264432|FG002|Overall Study|Death|0|||
130084993|NCT04657003|468264430|FG000|Overall Study|Lost to Follow-up|8|||
130084994|NCT04657003|468264431|FG001|Overall Study|Lost to Follow-up|4|||
130084995|NCT04657003|468264432|FG002|Overall Study|Lost to Follow-up|10|||
130084996|NCT04657003|468264430|FG000|Overall Study|Other - As Reported by Investigator|3|||
130084997|NCT04657003|468264431|FG001|Overall Study|Other - As Reported by Investigator|2|||
130084998|NCT04657003|468264432|FG002|Overall Study|Other - As Reported by Investigator|2|||
130084999|NCT04657003|468264430|FG000|Overall Study|Pregnancy|2|||
130085000|NCT04657003|468264431|FG001|Overall Study|Pregnancy|0|||
130085001|NCT04657003|468264432|FG002|Overall Study|Pregnancy|2|||
130085002|NCT04657003|468264430|FG000|Overall Study|Withdrawal by Subject|16|||
130085003|NCT04657003|468264431|FG001|Overall Study|Withdrawal by Subject|7|||
130085004|NCT04657003|468264432|FG002|Overall Study|Withdrawal by Subject|10|||
130085005|NCT01736176|468264433|FG000|Overall Study|Adverse Event|3|||
130085006|NCT01736176|468264433|FG000|Overall Study|Withdrawal by Subject|4|||
130085007|NCT01736176|468264433|FG000|Overall Study|Lack of Efficacy|3|||
130085008|NCT01736176|468264433|FG000|Overall Study|Unable to Complete PEG Placement|1|||
130085009|NCT00417248|468264434|FG000|Overall Study|Study Terminated|6|||
130085010|NCT00417248|468264434|FG000|Overall Study|Death|1|||
130085011|NCT00417248|468264434|FG000|Overall Study|Lack of Efficacy|1|||
130085012|NCT00934791|468264435|FG000|Overall Study|Withdrawal by Subject|1|||
130085013|NCT00934791|468264436|FG001|Overall Study|Withdrawal by Subject|0|||
130085014|NCT03763942|468264437|FG000|Overall Study|Lost to Follow-up|114|||
130085015|NCT03763942|468264438|FG001|Overall Study|Lost to Follow-up|54|||
130085016|NCT03763942|468264437|FG000|Overall Study|Protocol Violation|1|||
130085017|NCT03763942|468264438|FG001|Overall Study|Protocol Violation|0|||
130085018|NCT03763942|468264437|FG000|Overall Study|Withdrawal by Subject|2|||
130085019|NCT03763942|468264438|FG001|Overall Study|Withdrawal by Subject|0|||
130085020|NCT03763942|468264437|FG000|Overall Study|Other|2|||
130085021|NCT03763942|468264438|FG001|Overall Study|Other|3|||
130085022|NCT00811395|468264441|FG000|Extension Treatment|Adverse Event|1|||
130085023|NCT00811395|468264442|FG001|Extension Treatment|Adverse Event|2|||
130085024|NCT00811395|468264443|FG002|Extension Treatment|Adverse Event|2|||
130085025|NCT00811395|468264444|FG003|Extension Treatment|Adverse Event|2|||
130085026|NCT00811395|468264445|FG004|Extension Treatment|Adverse Event|0|||
130085027|NCT00811395|468264446|FG005|Extension Treatment|Adverse Event|1|||
130085028|NCT00811395|468264441|FG000|Extension Treatment|Progressive disease|1|||
130085029|NCT00811395|468264442|FG001|Extension Treatment|Progressive disease|1|||
130085030|NCT00811395|468264443|FG002|Extension Treatment|Progressive disease|0|||
130085031|NCT00811395|468264444|FG003|Extension Treatment|Progressive disease|0|||
130085032|NCT00811395|468264445|FG004|Extension Treatment|Progressive disease|0|||
130085033|NCT00811395|468264446|FG005|Extension Treatment|Progressive disease|0|||
130085034|NCT00811395|468264441|FG000|Extension Treatment|Participant did not wish to continue|0|||
129959659|NCT00329550|467816037|FG001|Overall Study|Adverse Event|4|||
129959660|NCT00329550|467816038|FG002|Overall Study|Adverse Event|2|||
130085035|NCT00811395|468264442|FG001|Extension Treatment|Participant did not wish to continue|3|||
130085036|NCT00811395|468264443|FG002|Extension Treatment|Participant did not wish to continue|0|||
130085037|NCT00811395|468264444|FG003|Extension Treatment|Participant did not wish to continue|1|||
130085038|NCT00811395|468264445|FG004|Extension Treatment|Participant did not wish to continue|0|||
130085039|NCT00811395|468264446|FG005|Extension Treatment|Participant did not wish to continue|1|||
130085040|NCT00811395|468264441|FG000|Extension Treatment|Other than above|0|||
130085041|NCT00811395|468264442|FG001|Extension Treatment|Other than above|0|||
130085042|NCT00811395|468264443|FG002|Extension Treatment|Other than above|1|||
130085043|NCT00811395|468264444|FG003|Extension Treatment|Other than above|0|||
130085044|NCT00811395|468264445|FG004|Extension Treatment|Other than above|0|||
129959661|NCT00329550|467816036|FG000|Overall Study|Withdrawal of Consent|1|||
130085045|NCT00811395|468264446|FG005|Extension Treatment|Other than above|0|||
130085046|NCT00170846|468264453|FG000|Overall Study|Subject withdrew Informed Consent|5|||
130085047|NCT00170846|468264454|FG001|Overall Study|Subject withdrew Informed Consent|12|||
129959662|NCT00329550|467816037|FG001|Overall Study|Withdrawal of Consent|0|||
129959663|NCT00329550|467816038|FG002|Overall Study|Withdrawal of Consent|1|||
129959664|NCT00329550|467816036|FG000|Overall Study|Due to Relocation|0|||
129959665|NCT00329550|467816037|FG001|Overall Study|Due to Relocation|0|||
129959666|NCT00329550|467816038|FG002|Overall Study|Due to Relocation|1|||
129959667|NCT00833898|467816048|FG000|Overall Study|Withdrawal by Subject|33|||
129959668|NCT00833898|467816049|FG001|Overall Study|Withdrawal by Subject|27|||
129959669|NCT00833898|467816048|FG000|Overall Study|Lost to Follow-up|7|||
129959670|NCT00833898|467816049|FG001|Overall Study|Lost to Follow-up|7|||
129959671|NCT00833898|467816048|FG000|Overall Study|Patient did not receive transplant|0|||
129959672|NCT00833898|467816049|FG001|Overall Study|Patient did not receive transplant|2|||
129959673|NCT01402063|467816050|FG000|Overall Study|Withdrawal by Subject|3|||
129959674|NCT01402063|467816051|FG001|Overall Study|Withdrawal by Subject|3|||
129959675|NCT02110225|467816055|FG000|Overall Study|Lost to Follow-up|0|||
129959676|NCT02110225|467816056|FG001|Overall Study|Lost to Follow-up|1|||
129959677|NCT02110225|467816057|FG002|Overall Study|Lost to Follow-up|0|||
129959678|NCT02176018|467816058|FG000|Overall Study|Adverse Event|0|||
129959679|NCT02176018|467816059|FG001|Overall Study|Adverse Event|2|||
129959680|NCT02176018|467816058|FG000|Overall Study|Lost to Follow-up|3|||
129959681|NCT02176018|467816059|FG001|Overall Study|Lost to Follow-up|1|||
129959682|NCT02176018|467816058|FG000|Overall Study|Protocol Violation|1|||
129959683|NCT02176018|467816059|FG001|Overall Study|Protocol Violation|1|||
129959684|NCT02176018|467816058|FG000|Overall Study|Withdrawal by Subject|1|||
129959685|NCT02176018|467816059|FG001|Overall Study|Withdrawal by Subject|2|||
129959686|NCT03022045|467816060|FG000|Overall Study|Adverse Event|0|||
129959687|NCT03022045|467816061|FG001|Overall Study|Adverse Event|1|||
129959688|NCT03022045|467816060|FG000|Overall Study|Withdrawal by Subject|1|||
129959689|NCT03022045|467816061|FG001|Overall Study|Withdrawal by Subject|1|||
129959690|NCT02499835|467816065|FG000|Overall Study|Withdrawal by Subject|1|||
129959691|NCT02499835|467816066|FG001|Overall Study|Withdrawal by Subject|0|||
129959692|NCT02499835|467816067|FG002|Overall Study|Withdrawal by Subject|0|||
129959693|NCT02499835|467816068|FG003|Overall Study|Withdrawal by Subject|1|||
129959694|NCT02499835|467816065|FG000|Overall Study|Physician Decision|0|||
129959695|NCT02499835|467816066|FG001|Overall Study|Physician Decision|3|||
129959696|NCT02499835|467816067|FG002|Overall Study|Physician Decision|18|||
129959697|NCT02499835|467816068|FG003|Overall Study|Physician Decision|7|||
129959698|NCT02499835|467816065|FG000|Overall Study|Adverse Event|0|||
129959699|NCT02499835|467816066|FG001|Overall Study|Adverse Event|0|||
129959700|NCT02499835|467816067|FG002|Overall Study|Adverse Event|0|||
129959701|NCT02499835|467816068|FG003|Overall Study|Adverse Event|1|||
129959702|NCT02499835|467816065|FG000|Overall Study|Disease progression|2|||
129959703|NCT02499835|467816066|FG001|Overall Study|Disease progression|1|||
129959704|NCT02499835|467816067|FG002|Overall Study|Disease progression|0|||
129959705|NCT02499835|467816068|FG003|Overall Study|Disease progression|7|||
129959706|NCT03972137|467816069|FG000|Overall Study|Lost to Follow-up|2|||
129959707|NCT03972137|467816069|FG000|Overall Study|Withdrawal by Subject|4|||
129959708|NCT00899379|467816073|FG000|Overall Study|Adverse Event|2|||
129959709|NCT00899379|467816074|FG001|Overall Study|Adverse Event|2|||
129959710|NCT00899379|467816075|FG002|Overall Study|Adverse Event|1|||
129959711|NCT00899379|467816076|FG003|Overall Study|Adverse Event|1|||
129959712|NCT00899379|467816077|FG004|Overall Study|Adverse Event|2|||
129959713|NCT00899379|467816073|FG000|Overall Study|Lack of Efficacy|0|||
129959714|NCT00899379|467816074|FG001|Overall Study|Lack of Efficacy|4|||
129959715|NCT00899379|467816075|FG002|Overall Study|Lack of Efficacy|3|||
129959716|NCT00899379|467816076|FG003|Overall Study|Lack of Efficacy|0|||
129959717|NCT00899379|467816077|FG004|Overall Study|Lack of Efficacy|1|||
129959718|NCT00899379|467816073|FG000|Overall Study|Lost to Follow-up|9|||
129959719|NCT00899379|467816074|FG001|Overall Study|Lost to Follow-up|3|||
129959720|NCT00899379|467816075|FG002|Overall Study|Lost to Follow-up|0|||
129959721|NCT00899379|467816076|FG003|Overall Study|Lost to Follow-up|6|||
129959722|NCT00899379|467816077|FG004|Overall Study|Lost to Follow-up|2|||
129959723|NCT00899379|467816073|FG000|Overall Study|Protocol Violation|0|||
129959724|NCT00899379|467816074|FG001|Overall Study|Protocol Violation|0|||
129959725|NCT00899379|467816075|FG002|Overall Study|Protocol Violation|1|||
130085048|NCT00170846|468264455|FG002|Overall Study|Subject withdrew Informed Consent|8|||
130085049|NCT00170846|468264453|FG000|Overall Study|Lost to Follow-up|6|||
129959726|NCT00899379|467816076|FG003|Overall Study|Protocol Violation|1|||
129959727|NCT00899379|467816077|FG004|Overall Study|Protocol Violation|0|||
129959728|NCT00899379|467816073|FG000|Overall Study|Withdrawal by Subject|2|||
129959729|NCT00899379|467816074|FG001|Overall Study|Withdrawal by Subject|4|||
129959730|NCT00899379|467816075|FG002|Overall Study|Withdrawal by Subject|2|||
129959731|NCT00899379|467816076|FG003|Overall Study|Withdrawal by Subject|3|||
129959732|NCT00899379|467816077|FG004|Overall Study|Withdrawal by Subject|6|||
129959733|NCT00899379|467816073|FG000|Overall Study|Pregnancy|0|||
129959734|NCT00899379|467816074|FG001|Overall Study|Pregnancy|0|||
129959735|NCT00899379|467816075|FG002|Overall Study|Pregnancy|1|||
129959736|NCT00899379|467816076|FG003|Overall Study|Pregnancy|0|||
129959737|NCT00899379|467816077|FG004|Overall Study|Pregnancy|1|||
129959738|NCT00899379|467816073|FG000|Overall Study|Patient Uncooperative|0|||
129959739|NCT00899379|467816074|FG001|Overall Study|Patient Uncooperative|1|||
129959740|NCT00899379|467816075|FG002|Overall Study|Patient Uncooperative|0|||
129959741|NCT00899379|467816076|FG003|Overall Study|Patient Uncooperative|1|||
129959742|NCT00899379|467816077|FG004|Overall Study|Patient Uncooperative|2|||
129959743|NCT00899379|467816073|FG000|Overall Study|Abnormal Baseline ECG|0|||
129959744|NCT00899379|467816074|FG001|Overall Study|Abnormal Baseline ECG|0|||
129959745|NCT00899379|467816075|FG002|Overall Study|Abnormal Baseline ECG|0|||
129959746|NCT00899379|467816076|FG003|Overall Study|Abnormal Baseline ECG|1|||
129959747|NCT00899379|467816077|FG004|Overall Study|Abnormal Baseline ECG|0|||
129959748|NCT00899379|467816073|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959749|NCT00899379|467816074|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959750|NCT00899379|467816075|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959751|NCT00899379|467816076|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959752|NCT00899379|467816077|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959753|NCT00899379|467816073|FG000|Overall Study|Not Completed/Entered Extn|5|||
129959754|NCT00899379|467816074|FG001|Overall Study|Not Completed/Entered Extn|1|||
129959755|NCT00899379|467816075|FG002|Overall Study|Not Completed/Entered Extn|6|||
129959756|NCT00899379|467816076|FG003|Overall Study|Not Completed/Entered Extn|4|||
129959757|NCT00899379|467816077|FG004|Overall Study|Not Completed/Entered Extn|3|||
129959758|NCT00899379|467816073|FG000|Overall Study|Study Terminated|3|||
129959759|NCT00899379|467816074|FG001|Overall Study|Study Terminated|0|||
129959760|NCT00899379|467816075|FG002|Overall Study|Study Terminated|3|||
129959761|NCT00899379|467816076|FG003|Overall Study|Study Terminated|3|||
129959762|NCT00899379|467816077|FG004|Overall Study|Study Terminated|1|||
129959763|NCT00899379|467816073|FG000|Overall Study|Lost to Follow-up|3|||
129959764|NCT00899379|467816074|FG001|Overall Study|Lost to Follow-up|1|||
129959765|NCT00899379|467816075|FG002|Overall Study|Lost to Follow-up|0|||
129959766|NCT00899379|467816076|FG003|Overall Study|Lost to Follow-up|2|||
129959767|NCT00899379|467816077|FG004|Overall Study|Lost to Follow-up|5|||
129959768|NCT00899379|467816073|FG000|Overall Study|Withdrawal by Subject|4|||
129959769|NCT00899379|467816074|FG001|Overall Study|Withdrawal by Subject|7|||
129959770|NCT00899379|467816075|FG002|Overall Study|Withdrawal by Subject|4|||
129959771|NCT00899379|467816076|FG003|Overall Study|Withdrawal by Subject|7|||
129959772|NCT00899379|467816077|FG004|Overall Study|Withdrawal by Subject|2|||
129959773|NCT00899379|467816073|FG000|Overall Study|Pregnancy|1|||
129959774|NCT00899379|467816074|FG001|Overall Study|Pregnancy|0|||
129959775|NCT00899379|467816075|FG002|Overall Study|Pregnancy|0|||
129959776|NCT00899379|467816076|FG003|Overall Study|Pregnancy|0|||
129959777|NCT00899379|467816077|FG004|Overall Study|Pregnancy|0|||
129959778|NCT00899379|467816073|FG000|Overall Study|Patient Uncooperative|0|||
129959779|NCT00899379|467816074|FG001|Overall Study|Patient Uncooperative|0|||
129959780|NCT00899379|467816075|FG002|Overall Study|Patient Uncooperative|0|||
129959781|NCT00899379|467816076|FG003|Overall Study|Patient Uncooperative|1|||
129959782|NCT00899379|467816077|FG004|Overall Study|Patient Uncooperative|0|||
129959783|NCT00899379|467816073|FG000|Overall Study|Abnormal Prestudy Labs|0|||
129959784|NCT00899379|467816074|FG001|Overall Study|Abnormal Prestudy Labs|0|||
129959785|NCT00899379|467816075|FG002|Overall Study|Abnormal Prestudy Labs|0|||
129959786|NCT00899379|467816076|FG003|Overall Study|Abnormal Prestudy Labs|0|||
129959787|NCT00899379|467816077|FG004|Overall Study|Abnormal Prestudy Labs|2|||
129959788|NCT00899379|467816073|FG000|Overall Study|Abnormal Baseline ECG|0|||
129959789|NCT00899379|467816074|FG001|Overall Study|Abnormal Baseline ECG|0|||
129959790|NCT00899379|467816075|FG002|Overall Study|Abnormal Baseline ECG|1|||
129959791|NCT00899379|467816076|FG003|Overall Study|Abnormal Baseline ECG|1|||
129959792|NCT00899379|467816077|FG004|Overall Study|Abnormal Baseline ECG|0|||
129959793|NCT00899379|467816073|FG000|Overall Study|No Attack Pretreatment|3|||
129959794|NCT00899379|467816074|FG001|Overall Study|No Attack Pretreatment|5|||
129959795|NCT00899379|467816075|FG002|Overall Study|No Attack Pretreatment|5|||
129959796|NCT00899379|467816076|FG003|Overall Study|No Attack Pretreatment|6|||
129959797|NCT00899379|467816077|FG004|Overall Study|No Attack Pretreatment|4|||
129959798|NCT00899379|467816073|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959799|NCT00899379|467816074|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959800|NCT00899379|467816075|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959801|NCT00899379|467816076|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959802|NCT00899379|467816077|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959803|NCT00899379|467816073|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
129959804|NCT00899379|467816074|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
129959805|NCT00899379|467816075|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
129959806|NCT00899379|467816076|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
129959807|NCT00899379|467816077|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
129959808|NCT03220776|467816082|FG000|Overall Study|Claustrophobia|0|||
129959809|NCT03220776|467816083|FG001|Overall Study|Claustrophobia|1|||
129959810|NCT03220776|467816084|FG002|Overall Study|Claustrophobia|1|||
129959811|NCT03220776|467816085|FG003|Overall Study|Claustrophobia|0|||
129959812|NCT03220776|467816086|FG004|Overall Study|Claustrophobia|1|||
129959813|NCT03220776|467816087|FG005|Overall Study|Claustrophobia|0|||
129959814|NCT03220776|467816082|FG000|Overall Study|MRI Equipment Failure|1|||
130085050|NCT00170846|468264454|FG001|Overall Study|Lost to Follow-up|3|||
130085051|NCT00170846|468264455|FG002|Overall Study|Lost to Follow-up|2|||
130085052|NCT00170846|468264453|FG000|Overall Study|Death|0|||
130085053|NCT00170846|468264454|FG001|Overall Study|Death|3|||
130085054|NCT00170846|468264455|FG002|Overall Study|Death|3|||
130085055|NCT00170846|468264453|FG000|Overall Study|Reason Missing|0|||
130085056|NCT00170846|468264454|FG001|Overall Study|Reason Missing|1|||
130085057|NCT00170846|468264455|FG002|Overall Study|Reason Missing|0|||
130085058|NCT00118040|468264456|FG000|Overall Study|Adverse Event|0|||
130085059|NCT00118040|468264457|FG001|Overall Study|Adverse Event|1|||
130085060|NCT00118040|468264458|FG002|Overall Study|Adverse Event|0|||
130085061|NCT00118040|468264456|FG000|Overall Study|Withdrawal by Subject|0|||
130085062|NCT00118040|468264457|FG001|Overall Study|Withdrawal by Subject|0|||
130085063|NCT00118040|468264458|FG002|Overall Study|Withdrawal by Subject|2|||
130085064|NCT00118040|468264456|FG000|Overall Study|Medical Contraindication|0|||
130085065|NCT00118040|468264457|FG001|Overall Study|Medical Contraindication|0|||
130085066|NCT00118040|468264458|FG002|Overall Study|Medical Contraindication|1|||
130085067|NCT00118040|468264456|FG000|Overall Study|Non-Compliant Participant|1|||
130085068|NCT00118040|468264457|FG001|Overall Study|Non-Compliant Participant|1|||
130085069|NCT00118040|468264458|FG002|Overall Study|Non-Compliant Participant|2|||
130085070|NCT00118040|468264456|FG000|Overall Study|Other|0|||
130085071|NCT00118040|468264457|FG001|Overall Study|Other|0|||
130085072|NCT00118040|468264458|FG002|Overall Study|Other|1|||
130085073|NCT02607865|468264461|FG000|Overall Study|Lost to Follow-up|9|||
130085074|NCT02607865|468264462|FG001|Overall Study|Lost to Follow-up|7|||
130085075|NCT02607865|468264463|FG002|Overall Study|Lost to Follow-up|7|||
130085076|NCT02607865|468264464|FG003|Overall Study|Lost to Follow-up|5|||
130085077|NCT02607865|468264461|FG000|Overall Study|Withdrawal by Subject|18|||
130085078|NCT02607865|468264462|FG001|Overall Study|Withdrawal by Subject|18|||
130085079|NCT02607865|468264463|FG002|Overall Study|Withdrawal by Subject|17|||
130085080|NCT02607865|468264464|FG003|Overall Study|Withdrawal by Subject|8|||
130085081|NCT02607865|468264461|FG000|Overall Study|Death|5|||
130085082|NCT02607865|468264462|FG001|Overall Study|Death|4|||
130085083|NCT02607865|468264463|FG002|Overall Study|Death|1|||
130085084|NCT02607865|468264464|FG003|Overall Study|Death|3|||
130085085|NCT02607865|468264461|FG000|Overall Study|Unclassified|1|||
130085086|NCT02607865|468264462|FG001|Overall Study|Unclassified|1|||
130085087|NCT02607865|468264463|FG002|Overall Study|Unclassified|2|||
130085088|NCT02607865|468264464|FG003|Overall Study|Unclassified|0|||
130085089|NCT00528840|468264465|FG000|Overall Study|Lost to Follow-up|10|||
130085090|NCT00528840|468264465|FG000|Overall Study|Adverse Event|1|||
130085091|NCT00528840|468264465|FG000|Overall Study|Withdrawal by Subject|17|||
130085092|NCT00528840|468264465|FG000|Overall Study|Death|2|||
130085093|NCT00528840|468264465|FG000|Overall Study|Administrative Reasons|1|||
130085094|NCT00528840|468264465|FG000|Overall Study|Other|2|||
130085095|NCT01970540|468264466|FG000|Overall Study|Non-treatment-related AE|0|||
130085096|NCT01970540|468264467|FG001|Overall Study|Non-treatment-related AE|0|||
130085097|NCT01970540|468264468|FG002|Overall Study|Non-treatment-related AE|1|||
130085098|NCT01970540|468264466|FG000|Overall Study|Progressive disease|55|||
130085099|NCT01970540|468264467|FG001|Overall Study|Progressive disease|23|||
130085100|NCT01970540|468264468|FG002|Overall Study|Progressive disease|10|||
130085101|NCT01970540|468264466|FG000|Overall Study|Treatment delay over protocol|0|||
130085102|NCT01970540|468264467|FG001|Overall Study|Treatment delay over protocol|0|||
130085103|NCT01970540|468264468|FG002|Overall Study|Treatment delay over protocol|1|||
130085104|NCT01970540|468264466|FG000|Overall Study|Physician Decision|7|||
130085105|NCT01970540|468264467|FG001|Overall Study|Physician Decision|2|||
130085106|NCT01970540|468264468|FG002|Overall Study|Physician Decision|0|||
130085107|NCT01970540|468264466|FG000|Overall Study|Clinical progression|0|||
130085108|NCT01970540|468264467|FG001|Overall Study|Clinical progression|1|||
130085109|NCT01970540|468264468|FG002|Overall Study|Clinical progression|1|||
130085110|NCT01970540|468264466|FG000|Overall Study|End of study|2|||
130085111|NCT01970540|468264467|FG001|Overall Study|End of study|0|||
130085112|NCT01970540|468264468|FG002|Overall Study|End of study|2|||
130085113|NCT01970540|468264466|FG000|Overall Study|Adverse Event|0|||
130085114|NCT01970540|468264467|FG001|Overall Study|Adverse Event|2|||
130085115|NCT01970540|468264468|FG002|Overall Study|Adverse Event|1|||
130085116|NCT01970540|468264466|FG000|Overall Study|Treatment-related AE|4|||
130085117|NCT01970540|468264467|FG001|Overall Study|Treatment-related AE|0|||
130085118|NCT01970540|468264468|FG002|Overall Study|Treatment-related AE|2|||
130085119|NCT01970540|468264466|FG000|Overall Study|Withdrawal by Subject|4|||
130085120|NCT01970540|468264467|FG001|Overall Study|Withdrawal by Subject|0|||
130085121|NCT01970540|468264468|FG002|Overall Study|Withdrawal by Subject|1|||
130085122|NCT01970540|468264466|FG000|Overall Study|Clinical deterioration|1|||
130085123|NCT01970540|468264467|FG001|Overall Study|Clinical deterioration|0|||
130085124|NCT01970540|468264468|FG002|Overall Study|Clinical deterioration|0|||
130085125|NCT01756833|468264477|FG000|Overall Study|Withdrawal by Subject|4|||
130085126|NCT01756833|468264478|FG001|Overall Study|Withdrawal by Subject|3|||
130085127|NCT00952588|468264479|FG000|Overall Study|Death|28|||
130085128|NCT00952588|468264480|FG001|Overall Study|Death|13|||
130085129|NCT00952588|468264479|FG000|Overall Study|Withdrawal by Subject|2|||
130085130|NCT00952588|468264480|FG001|Overall Study|Withdrawal by Subject|5|||
130085131|NCT00952588|468264479|FG000|Overall Study|Adverse Event|2|||
130085132|NCT00952588|468264480|FG001|Overall Study|Adverse Event|3|||
130085133|NCT00952588|468264479|FG000|Overall Study|Lost to Follow-up|2|||
130085134|NCT00952588|468264480|FG001|Overall Study|Lost to Follow-up|0|||
130085135|NCT00952588|468264479|FG000|Overall Study|Physician Decision|0|||
130085136|NCT00952588|468264480|FG001|Overall Study|Physician Decision|1|||
130085137|NCT00952588|468264479|FG000|Overall Study|Lack of Efficacy|2|||
130085138|NCT00952588|468264480|FG001|Overall Study|Lack of Efficacy|2|||
130085139|NCT01796106|468264481|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
130085140|NCT01796106|468264482|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
130085141|NCT01766401|468264483|FG000|Overall Study|Adverse Event|7|||
130085142|NCT01766401|468264484|FG001|Overall Study|Adverse Event|22|||
130085143|NCT01766401|468264483|FG000|Overall Study|Lack of Efficacy|1|||
130085144|NCT01766401|468264484|FG001|Overall Study|Lack of Efficacy|2|||
130085145|NCT01766401|468264483|FG000|Overall Study|Protocol Violation|3|||
130085146|NCT01766401|468264484|FG001|Overall Study|Protocol Violation|8|||
130085147|NCT01766401|468264483|FG000|Overall Study|Withdrawal by Subject|15|||
130085148|NCT01766401|468264484|FG001|Overall Study|Withdrawal by Subject|12|||
130085149|NCT01766401|468264483|FG000|Overall Study|Lost to Follow-up|10|||
130085150|NCT01766401|468264484|FG001|Overall Study|Lost to Follow-up|11|||
130085151|NCT01766401|468264483|FG000|Overall Study|Pregnancy|1|||
130085152|NCT01766401|468264484|FG001|Overall Study|Pregnancy|1|||
130085153|NCT02795182|468264488|FG000|Overall Study|Death|5|||
130085154|NCT02795182|468264489|FG001|Overall Study|Death|4|||
130085155|NCT02795182|468264490|FG002|Overall Study|Death|4|||
130085156|NCT02795182|468264491|FG003|Overall Study|Death|18|||
130085157|NCT02795182|468264488|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
130085158|NCT02795182|468264489|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
130085159|NCT02795182|468264490|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
130085160|NCT02795182|468264491|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
130085161|NCT02795182|468264488|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
130085162|NCT02795182|468264489|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
130085163|NCT02795182|468264490|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
130085164|NCT02795182|468264491|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
130085165|NCT02795182|468264488|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
130085166|NCT02795182|468264489|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
130085167|NCT02795182|468264490|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
130085168|NCT02795182|468264491|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
130085169|NCT02795182|468264488|FG000|Overall Study|Withdrawal by Subject|4|||
130085170|NCT02795182|468264489|FG001|Overall Study|Withdrawal by Subject|0|||
130085171|NCT02795182|468264490|FG002|Overall Study|Withdrawal by Subject|0|||
130085172|NCT02795182|468264491|FG003|Overall Study|Withdrawal by Subject|3|||
130085173|NCT02795182|468264488|FG000|Overall Study|Lost to Follow-up|0|||
130085174|NCT02795182|468264489|FG001|Overall Study|Lost to Follow-up|0|||
130085175|NCT02795182|468264490|FG002|Overall Study|Lost to Follow-up|1|||
130085176|NCT02795182|468264491|FG003|Overall Study|Lost to Follow-up|1|||
130085177|NCT02795182|468264488|FG000|Overall Study|Roll Over to Long Term Extension|3|||
130085178|NCT02795182|468264489|FG001|Overall Study|Roll Over to Long Term Extension|3|||
130085179|NCT02795182|468264490|FG002|Overall Study|Roll Over to Long Term Extension|2|||
130085180|NCT02795182|468264491|FG003|Overall Study|Roll Over to Long Term Extension|5|||
130085181|NCT02795182|468264488|FG000|Overall Study|Progressive Disease|0|||
130085182|NCT02795182|468264489|FG001|Overall Study|Progressive Disease|1|||
130085183|NCT02795182|468264490|FG002|Overall Study|Progressive Disease|0|||
130085184|NCT02795182|468264491|FG003|Overall Study|Progressive Disease|4|||
130085185|NCT02795182|468264488|FG000|Overall Study|Physician Decision|0|||
130085186|NCT02795182|468264489|FG001|Overall Study|Physician Decision|0|||
130085187|NCT02795182|468264490|FG002|Overall Study|Physician Decision|0|||
130085188|NCT02795182|468264491|FG003|Overall Study|Physician Decision|1|||
130085189|NCT00398086|468264493|FG000|Overall Study|Unacceptable Toxicity|2|||
130085190|NCT00398086|468264494|FG001|Overall Study|Unacceptable Toxicity|8|||
130085191|NCT00398086|468264495|FG002|Overall Study|Unacceptable Toxicity|2|||
129959815|NCT03220776|467816083|FG001|Overall Study|MRI Equipment Failure|0|||
130085192|NCT00398086|468264493|FG000|Overall Study|Adverse Event|1|||
130085193|NCT00398086|468264494|FG001|Overall Study|Adverse Event|4|||
130085194|NCT00398086|468264495|FG002|Overall Study|Adverse Event|0|||
130085195|NCT00398086|468264493|FG000|Overall Study|Physician Decision|1|||
130085196|NCT00398086|468264494|FG001|Overall Study|Physician Decision|4|||
130085197|NCT00398086|468264495|FG002|Overall Study|Physician Decision|0|||
130085198|NCT00398086|468264493|FG000|Overall Study|Withdrawal by Subject|5|||
130085199|NCT00398086|468264494|FG001|Overall Study|Withdrawal by Subject|7|||
130085200|NCT00398086|468264495|FG002|Overall Study|Withdrawal by Subject|0|||
130085201|NCT01021553|468264496|FG000|Overall Study|Adverse Event|1|||
130085202|NCT01021553|468264497|FG001|Overall Study|Adverse Event|0|||
130085203|NCT01021553|468264498|FG002|Overall Study|Adverse Event|0|||
130085204|NCT01021553|468264496|FG000|Overall Study|Lack of Efficacy|2|||
130085205|NCT01021553|468264497|FG001|Overall Study|Lack of Efficacy|2|||
130085206|NCT01021553|468264498|FG002|Overall Study|Lack of Efficacy|0|||
130085207|NCT01021553|468264496|FG000|Overall Study|Protocol Violation|0|||
130085208|NCT01021553|468264497|FG001|Overall Study|Protocol Violation|2|||
130085209|NCT01021553|468264498|FG002|Overall Study|Protocol Violation|2|||
130085210|NCT01021553|468264496|FG000|Overall Study|Lost to Follow-up|0|||
130085211|NCT01021553|468264497|FG001|Overall Study|Lost to Follow-up|0|||
130085212|NCT01021553|468264498|FG002|Overall Study|Lost to Follow-up|1|||
130085213|NCT01021553|468264496|FG000|Overall Study|Withdrawal by Subject|1|||
130085214|NCT01021553|468264497|FG001|Overall Study|Withdrawal by Subject|1|||
130085215|NCT01021553|468264498|FG002|Overall Study|Withdrawal by Subject|0|||
130085216|NCT01950364|468264499|FG000|Overall Study|Adverse Event|3|||
130085217|NCT01950364|468264500|FG001|Overall Study|Adverse Event|0|||
130085218|NCT01950364|468264499|FG000|Overall Study|Stem Cell Transplant|2|||
130085219|NCT01950364|468264500|FG001|Overall Study|Stem Cell Transplant|6|||
130085220|NCT01950364|468264499|FG000|Overall Study|Disease Progression|5|||
130085221|NCT01950364|468264500|FG001|Overall Study|Disease Progression|2|||
130085222|NCT01950364|468264499|FG000|Overall Study|Withdrawal by Subject|0|||
130085223|NCT01950364|468264500|FG001|Overall Study|Withdrawal by Subject|1|||
130085224|NCT01950364|468264499|FG000|Overall Study|Protocol Violation|0|||
130085225|NCT01950364|468264500|FG001|Overall Study|Protocol Violation|1|||
130085226|NCT00033293|468264501|FG000|Overall Study|Death|0|||
130085227|NCT00033293|468264502|FG001|Overall Study|Death|1|||
130085228|NCT00033293|468264501|FG000|Overall Study|Lack of Efficacy|5|||
130085229|NCT00033293|468264502|FG001|Overall Study|Lack of Efficacy|8|||
130085230|NCT00033293|468264501|FG000|Overall Study|Lost to Follow-up|0|||
130085231|NCT00033293|468264502|FG001|Overall Study|Lost to Follow-up|1|||
130085232|NCT00033293|468264501|FG000|Overall Study|Physician Decision|3|||
130085233|NCT00033293|468264502|FG001|Overall Study|Physician Decision|1|||
130085234|NCT00033293|468264501|FG000|Overall Study|Withdrawal by Subject|1|||
130085235|NCT00033293|468264502|FG001|Overall Study|Withdrawal by Subject|0|||
130085236|NCT00033293|468264501|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
130085237|NCT00033293|468264502|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
130085238|NCT00033293|468264501|FG000|Overall Study|Treatment refused|0|||
130085239|NCT00033293|468264502|FG001|Overall Study|Treatment refused|6|||
130085240|NCT00935701|468264503|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
130085241|NCT00998985|468264504|FG000|Overall Study|Withdrawal by Subject|0|||
130085242|NCT00998985|468264505|FG001|Overall Study|Withdrawal by Subject|0|||
130085243|NCT00998985|468264506|FG002|Overall Study|Withdrawal by Subject|0|||
130085244|NCT00998985|468264507|FG003|Overall Study|Withdrawal by Subject|0|||
130085245|NCT00998985|468264508|FG004|Overall Study|Withdrawal by Subject|0|||
130085246|NCT00998985|468264509|FG005|Overall Study|Withdrawal by Subject|0|||
130085247|NCT00998985|468264510|FG006|Overall Study|Withdrawal by Subject|0|||
130085248|NCT00998985|468264511|FG007|Overall Study|Withdrawal by Subject|0|||
130085249|NCT00998985|468264512|FG008|Overall Study|Withdrawal by Subject|1|||
130085250|NCT00998985|468264513|FG009|Overall Study|Withdrawal by Subject|0|||
130085251|NCT00998985|468264514|FG010|Overall Study|Withdrawal by Subject|0|||
130085252|NCT00998985|468264515|FG011|Overall Study|Withdrawal by Subject|0|||
130085253|NCT00998985|468264516|FG012|Overall Study|Withdrawal by Subject|0|||
130085254|NCT00998985|468264517|FG013|Overall Study|Withdrawal by Subject|0|||
130085255|NCT00998985|468264504|FG000|Overall Study|Protocol Violation|0|||
130085256|NCT00998985|468264505|FG001|Overall Study|Protocol Violation|0|||
130085257|NCT00998985|468264506|FG002|Overall Study|Protocol Violation|0|||
130085258|NCT00998985|468264507|FG003|Overall Study|Protocol Violation|0|||
130085259|NCT00998985|468264508|FG004|Overall Study|Protocol Violation|0|||
130085260|NCT00998985|468264509|FG005|Overall Study|Protocol Violation|1|||
130085261|NCT00998985|468264510|FG006|Overall Study|Protocol Violation|0|||
130085262|NCT00998985|468264511|FG007|Overall Study|Protocol Violation|0|||
130085263|NCT00998985|468264512|FG008|Overall Study|Protocol Violation|0|||
130085264|NCT00998985|468264513|FG009|Overall Study|Protocol Violation|0|||
129959816|NCT03220776|467816084|FG002|Overall Study|MRI Equipment Failure|0|||
129959817|NCT03220776|467816085|FG003|Overall Study|MRI Equipment Failure|0|||
129959818|NCT03220776|467816086|FG004|Overall Study|MRI Equipment Failure|0|||
130085265|NCT00998985|468264514|FG010|Overall Study|Protocol Violation|0|||
130085266|NCT00998985|468264515|FG011|Overall Study|Protocol Violation|0|||
130085267|NCT00998985|468264516|FG012|Overall Study|Protocol Violation|0|||
130085268|NCT00998985|468264517|FG013|Overall Study|Protocol Violation|0|||
130085269|NCT01700140|468264518|FG000|Overall Study|Use of rescue drugs|3|||
130085270|NCT01700140|468264519|FG001|Overall Study|Use of rescue drugs|3|||
130085271|NCT01700140|468264520|FG002|Overall Study|Use of rescue drugs|1|||
130085272|NCT01700140|468264518|FG000|Overall Study|Discontinuation of radiotherapy|1|||
130085273|NCT01700140|468264519|FG001|Overall Study|Discontinuation of radiotherapy|0|||
129959819|NCT03220776|467816087|FG005|Overall Study|MRI Equipment Failure|0|||
130085274|NCT01700140|468264520|FG002|Overall Study|Discontinuation of radiotherapy|0|||
130085275|NCT01700140|468264518|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
130085276|NCT01700140|468264519|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
130085277|NCT01700140|468264520|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
130085278|NCT01700140|468264518|FG000|Overall Study|Aggravation of symptoms|1|||
130085279|NCT01700140|468264519|FG001|Overall Study|Aggravation of symptoms|0|||
130085280|NCT01700140|468264520|FG002|Overall Study|Aggravation of symptoms|0|||
130085281|NCT01700140|468264518|FG000|Overall Study|Adverse Event|0|||
130085282|NCT01700140|468264519|FG001|Overall Study|Adverse Event|1|||
130085283|NCT01700140|468264520|FG002|Overall Study|Adverse Event|0|||
130085284|NCT01700140|468264518|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
130085285|NCT01700140|468264519|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
130085286|NCT01700140|468264520|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
130085287|NCT02573012|468264521|FG000|Overall Study|Adverse Event|5|||
130085288|NCT02573012|468264522|FG001|Overall Study|Adverse Event|5|||
130085289|NCT02573012|468264521|FG000|Overall Study|Lack of Efficacy|5|||
130085290|NCT02573012|468264522|FG001|Overall Study|Lack of Efficacy|4|||
130085291|NCT02573012|468264521|FG000|Overall Study|Non-compliance|1|||
130085292|NCT02573012|468264522|FG001|Overall Study|Non-compliance|2|||
130085293|NCT02573012|468264521|FG000|Overall Study|Withdrawal by Subject|2|||
130085294|NCT02573012|468264522|FG001|Overall Study|Withdrawal by Subject|2|||
130085295|NCT02573012|468264521|FG000|Overall Study|Study Ended per Protocol|1|||
129959820|NCT03220776|467816082|FG000|Overall Study|Inclimate Weather|0|||
129959821|NCT03220776|467816083|FG001|Overall Study|Inclimate Weather|0|||
129959822|NCT03220776|467816084|FG002|Overall Study|Inclimate Weather|0|||
129959823|NCT03220776|467816085|FG003|Overall Study|Inclimate Weather|0|||
129959824|NCT03220776|467816086|FG004|Overall Study|Inclimate Weather|0|||
129959825|NCT03220776|467816087|FG005|Overall Study|Inclimate Weather|1|||
129959826|NCT03220776|467816082|FG000|Overall Study|Physician Decision|0|||
129959827|NCT03220776|467816083|FG001|Overall Study|Physician Decision|0|||
129959828|NCT03220776|467816084|FG002|Overall Study|Physician Decision|0|||
129959829|NCT03220776|467816085|FG003|Overall Study|Physician Decision|1|||
129959830|NCT03220776|467816086|FG004|Overall Study|Physician Decision|0|||
129959831|NCT03220776|467816087|FG005|Overall Study|Physician Decision|0|||
129959832|NCT03220776|467816082|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959833|NCT03220776|467816083|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959834|NCT03220776|467816084|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959835|NCT03220776|467816085|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
129959836|NCT03220776|467816086|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959837|NCT03220776|467816087|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959838|NCT03220776|467816082|FG000|Overall Study|Protocol Violation|0|||
129959839|NCT03220776|467816083|FG001|Overall Study|Protocol Violation|0|||
129959840|NCT03220776|467816084|FG002|Overall Study|Protocol Violation|0|||
129959841|NCT03220776|467816085|FG003|Overall Study|Protocol Violation|2|||
129959842|NCT03220776|467816086|FG004|Overall Study|Protocol Violation|0|||
129959843|NCT03220776|467816087|FG005|Overall Study|Protocol Violation|1|||
129959844|NCT03220776|467816082|FG000|Overall Study|Withdrawal by Subject|1|||
129959845|NCT03220776|467816083|FG001|Overall Study|Withdrawal by Subject|0|||
129959846|NCT03220776|467816084|FG002|Overall Study|Withdrawal by Subject|0|||
129959847|NCT03220776|467816085|FG003|Overall Study|Withdrawal by Subject|0|||
129959848|NCT03220776|467816086|FG004|Overall Study|Withdrawal by Subject|0|||
129959849|NCT03220776|467816087|FG005|Overall Study|Withdrawal by Subject|0|||
129959850|NCT01780545|467816089|FG000|Overall Study|Withdrawal by Subject|3|||
129959851|NCT01780545|467816090|FG001|Overall Study|Withdrawal by Subject|1|||
129959852|NCT01780545|467816089|FG000|Overall Study|Lost to Follow-up|1|||
129959853|NCT01780545|467816090|FG001|Overall Study|Lost to Follow-up|1|||
129959854|NCT03441789|467816091|FG000|Overall Study|Withdrawal by Subject|1|||
129959855|NCT03441789|467816092|FG001|Overall Study|Withdrawal by Subject|1|||
129959856|NCT03441789|467816091|FG000|Overall Study|Adverse Event|0|||
129959857|NCT03441789|467816092|FG001|Overall Study|Adverse Event|1|||
129959858|NCT03441789|467816091|FG000|Overall Study|Protocol Violation|0|||
129959859|NCT03441789|467816092|FG001|Overall Study|Protocol Violation|1|||
129959860|NCT03441789|467816091|FG000|Overall Study|Lost to Follow-up|0|||
129959861|NCT03441789|467816092|FG001|Overall Study|Lost to Follow-up|1|||
129959862|NCT02581189|467816097|FG000|Overall Study|Failure to return|36|||
129959863|NCT02581189|467816097|FG000|Overall Study|Withdrew consent|5|||
129959864|NCT02581189|467816097|FG000|Overall Study|Death|3|||
129959865|NCT02581189|467816097|FG000|Overall Study|Insufficient virological response|2|||
129959866|NCT02581189|467816097|FG000|Overall Study|Other, not specified|7|||
129959867|NCT00843115|467816098|FG000|Overall Study|Death|4|||
129959868|NCT00843115|467816098|FG000|Overall Study|Adverse Event|30|||
129959869|NCT00843115|467816098|FG000|Overall Study|Lost to Follow-up|4|||
129959870|NCT00843115|467816098|FG000|Overall Study|Withdrawal by Subject|17|||
129959871|NCT00843115|467816098|FG000|Overall Study|Family wanted meds stopped|1|||
129959872|NCT00843115|467816098|FG000|Overall Study|Family does not want continuation|1|||
129959873|NCT00843115|467816098|FG000|Overall Study|Patient forgot to take meds|1|||
129959874|NCT00843115|467816098|FG000|Overall Study|Does not meet entrance criteria|1|||
129959875|NCT00843115|467816098|FG000|Overall Study|Physician Decision|1|||
129959876|NCT00843115|467816098|FG000|Overall Study|Family discontinued meds|1|||
129959877|NCT00843115|467816098|FG000|Overall Study|patient took for 2 days then stopped|1|||
129959878|NCT00843115|467816098|FG000|Overall Study|patient never took the medication|1|||
129959879|NCT00843115|467816098|FG000|Overall Study|hospitalized due to deterioration|1|||
129959880|NCT00843115|467816098|FG000|Overall Study|week 12 not done|1|||
129959881|NCT00843115|467816098|FG000|Overall Study|Syndrome De Glissement|1|||
129959882|NCT01037413|467816099|FG000|Part A: Skin Testing|Adverse Event|1|||
129959883|NCT01037413|467816100|FG001|Part A: Skin Testing|Adverse Event|0|||
129959884|NCT01037413|467816099|FG000|Part A: Skin Testing|Protocol Violation|1|||
129959885|NCT01037413|467816100|FG001|Part A: Skin Testing|Protocol Violation|0|||
129959886|NCT01037413|467816099|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
129959887|NCT01037413|467816100|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
129959888|NCT01037413|467816099|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
129959889|NCT01037413|467816100|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
129959890|NCT00619983|467816104|FG000|Test Drug Alone|Withdrawal by Subject|1|||
129959891|NCT00619983|467816105|FG001|Test Drug Alone|Withdrawal by Subject|0|||
129959892|NCT00619983|467816106|FG002|Test Drug Alone|Withdrawal by Subject|0|||
129959893|NCT00619983|467816107|FG003|Test Drug Alone|Withdrawal by Subject|1|||
129959894|NCT00619983|467816104|FG000|Test Drug Alone|Failure of daily diary device|1|||
129959895|NCT00619983|467816105|FG001|Test Drug Alone|Failure of daily diary device|1|||
129959896|NCT00619983|467816106|FG002|Test Drug Alone|Failure of daily diary device|2|||
129959897|NCT00619983|467816107|FG003|Test Drug Alone|Failure of daily diary device|2|||
129959898|NCT03371485|467816111|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
129959899|NCT03371485|467816111|FG000|2-year Follow-up|Death|5|||
129959900|NCT02204319|467816112|FG000|Overall Study|Pregnancy|1|||
129959901|NCT02204319|467816112|FG000|Overall Study|Withdrawal by Subject|2|||
129959902|NCT01177137|467816117|FG000|Overall Study|Withdrawal by Subject|10|||
129959903|NCT01177137|467816118|FG001|Overall Study|Withdrawal by Subject|10|||
129959904|NCT01177137|467816119|FG002|Overall Study|Withdrawal by Subject|2|||
129959905|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
129959906|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
129959907|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129959908|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
129959909|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
129959910|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
129959911|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
129959912|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129959913|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129959914|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129959915|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129959916|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129959917|NCT02959177|467816120|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
129959918|NCT02959177|467816121|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
129959919|NCT02959177|467816122|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
129959920|NCT02959177|467816120|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
129959921|NCT02959177|467816121|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
129959922|NCT02959177|467816122|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
129959923|NCT02959177|467816120|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
129959924|NCT02959177|467816121|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
129959925|NCT02959177|467816122|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
129959926|NCT04531813|467816127|FG000|Overall Study|Protocol Violation|1|||
129959927|NCT04531813|467816127|FG000|Overall Study|Withdrawal by Subject|1|||
129959928|NCT02381652|467816132|FG000|Overall Study|Withdrawal by Subject|0|||
129959929|NCT02381652|467816133|FG001|Overall Study|Withdrawal by Subject|0|||
129959930|NCT02381652|467816134|FG002|Overall Study|Withdrawal by Subject|1|||
129959931|NCT01340300|467816135|FG000|Overall Study|Lost to Follow-up|3|||
129959932|NCT01340300|467816136|FG001|Overall Study|Lost to Follow-up|0|||
129959933|NCT01340300|467816137|FG002|Overall Study|Lost to Follow-up|5|||
129959934|NCT01340300|467816138|FG003|Overall Study|Lost to Follow-up|10|||
129959935|NCT01340300|467816135|FG000|Overall Study|Withdrawal by Subject|5|||
129959936|NCT01340300|467816136|FG001|Overall Study|Withdrawal by Subject|6|||
129959937|NCT01340300|467816137|FG002|Overall Study|Withdrawal by Subject|6|||
129959938|NCT01340300|467816138|FG003|Overall Study|Withdrawal by Subject|3|||
129959939|NCT01340300|467816135|FG000|Overall Study|Adverse Event|1|||
129959940|NCT01340300|467816136|FG001|Overall Study|Adverse Event|0|||
129959941|NCT01340300|467816137|FG002|Overall Study|Adverse Event|4|||
129959942|NCT01340300|467816138|FG003|Overall Study|Adverse Event|0|||
129959943|NCT01340300|467816135|FG000|Overall Study|Physician Decision|0|||
129959944|NCT01340300|467816136|FG001|Overall Study|Physician Decision|1|||
129959945|NCT01340300|467816137|FG002|Overall Study|Physician Decision|0|||
129959946|NCT01340300|467816138|FG003|Overall Study|Physician Decision|0|||
130085296|NCT02573012|468264522|FG001|Overall Study|Study Ended per Protocol|0|||
130085297|NCT02573012|468264521|FG000|Overall Study|Physician Decision|1|||
130085298|NCT02573012|468264522|FG001|Overall Study|Physician Decision|2|||
130085299|NCT01610414|468264523|FG000|Study Start - Month 13|Serious Adverse Event|65|||
130085300|NCT01610414|468264524|FG001|Study Start - Month 13|Serious Adverse Event|67|||
130085301|NCT01610414|468264523|FG000|Study Start - Month 13|Adverse Event|14|||
130085302|NCT01610414|468264524|FG001|Study Start - Month 13|Adverse Event|14|||
130085303|NCT01610414|468264523|FG000|Study Start - Month 13|Protocol Violation|3|||
130085304|NCT01610414|468264524|FG001|Study Start - Month 13|Protocol Violation|1|||
130085305|NCT01610414|468264523|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
130085306|NCT01610414|468264524|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
130085307|NCT01610414|468264523|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
130085308|NCT01610414|468264524|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
130085309|NCT01610414|468264523|FG000|Study Start - Month 13|Lost to Follow-up|4|||
130085310|NCT01610414|468264524|FG001|Study Start - Month 13|Lost to Follow-up|6|||
130085311|NCT01610414|468264523|FG000|Study Start - Month 13|Suspected HZ episode|1|||
130085312|NCT01610414|468264524|FG001|Study Start - Month 13|Suspected HZ episode|3|||
130085313|NCT01610414|468264523|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
130085314|NCT01610414|468264524|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
130085315|NCT01610414|468264523|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
130085316|NCT01610414|468264524|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
130085317|NCT01610414|468264523|FG000|Month 13 - Month 25|Adverse Event|8|||
130085318|NCT01610414|468264524|FG001|Month 13 - Month 25|Adverse Event|4|||
130085319|NCT01610414|468264523|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
130085320|NCT01610414|468264524|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
130085321|NCT01610414|468264523|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
130085322|NCT01610414|468264524|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
130085323|NCT01610414|468264523|FG000|Month 13 - Month 25|Protocol Violation|0|||
130085324|NCT01610414|468264524|FG001|Month 13 - Month 25|Protocol Violation|2|||
130085325|NCT01610414|468264523|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
130085326|NCT01610414|468264524|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
130085327|NCT01610414|468264523|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
130085328|NCT01610414|468264524|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
130085329|NCT01610414|468264523|FG000|After Month 25|Study end not reached|48|||
129959947|NCT01340300|467816135|FG000|Overall Study|Unrelated sickness|0|||
129959948|NCT01340300|467816136|FG001|Overall Study|Unrelated sickness|2|||
129959949|NCT01340300|467816137|FG002|Overall Study|Unrelated sickness|0|||
129959950|NCT01340300|467816138|FG003|Overall Study|Unrelated sickness|1|||
129959951|NCT01954771|467816142|FG000|Overall Study|Missing HbA1c of end-point|1|||
129959952|NCT01954771|467816143|FG001|Overall Study|Missing HbA1c of end-point|1|||
129959953|NCT01954771|467816144|FG002|Overall Study|Missing HbA1c of end-point|0|||
129959954|NCT01954771|467816142|FG000|Overall Study|Missing CGMS of end-point|1|||
129959955|NCT01954771|467816143|FG001|Overall Study|Missing CGMS of end-point|1|||
129959956|NCT01954771|467816144|FG002|Overall Study|Missing CGMS of end-point|0|||
129959957|NCT01954771|467816142|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
129959958|NCT01954771|467816143|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
129959959|NCT01954771|467816144|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
129959960|NCT03635775|467816145|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
129959961|NCT03635775|467816146|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
129959962|NCT03635775|467816147|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
129959963|NCT03635775|467816148|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
129959964|NCT02996097|467816150|FG000|Overall Study|Lost to Follow-up|11|||
129959965|NCT02996097|467816151|FG001|Overall Study|Lost to Follow-up|11|||
129959966|NCT00583115|467816152|FG000|Overall Study|Death|1|||
129959967|NCT01287416|467816155|FG000|Pre-post Training|Withdrawal by Subject|17|||
129959968|NCT01287416|467816156|FG001|Pre-post Training|Withdrawal by Subject|24|||
129959969|NCT01287416|467816155|FG000|Pre-post Training|Lost to Follow-up|5|||
129959970|NCT01287416|467816156|FG001|Pre-post Training|Lost to Follow-up|1|||
129959971|NCT01287416|467816155|FG000|6 Month Follow-up|Lost to Follow-up|3|||
129959972|NCT01287416|467816156|FG001|6 Month Follow-up|Lost to Follow-up|2|||
129959973|NCT02109107|467816157|FG000|Overall Study|Lost to Follow-up|2|||
129959974|NCT02506881|467816163|FG000|First Intervention (Day 1)|Protocol Violation|0|||
129959975|NCT02506881|467816164|FG001|First Intervention (Day 1)|Protocol Violation|0|||
129959976|NCT02506881|467816165|FG002|First Intervention (Day 1)|Protocol Violation|1|||
130085330|NCT01610414|468264524|FG001|After Month 25|Study end not reached|53|||
130085331|NCT02736474|468264531|FG000|Overall Study|Lost to Follow-up|0|||
130085332|NCT02736474|468264532|FG001|Overall Study|Lost to Follow-up|1|||
130085333|NCT02483611|468264533|FG000|Overall Study|Protocol Violation|0|||
130085334|NCT02483611|468264534|FG001|Overall Study|Protocol Violation|0|||
130085335|NCT02483611|468264535|FG002|Overall Study|Protocol Violation|1|||
129959977|NCT02506881|467816166|FG003|First Intervention (Day 1)|Protocol Violation|0|||
129959978|NCT02506881|467816163|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
130085336|NCT02382276|468264536|FG000|Overall Study|Withdrawal by Subject|4|||
130085337|NCT02382276|468264537|FG001|Overall Study|Withdrawal by Subject|8|||
130085338|NCT02382276|468264538|FG002|Overall Study|Withdrawal by Subject|5|||
130085339|NCT02382276|468264536|FG000|Overall Study|Adverse Event|7|||
130085340|NCT02382276|468264537|FG001|Overall Study|Adverse Event|2|||
130085341|NCT02382276|468264538|FG002|Overall Study|Adverse Event|32|||
130085342|NCT02382276|468264536|FG000|Overall Study|Physician Decision|0|||
130085343|NCT02382276|468264537|FG001|Overall Study|Physician Decision|0|||
130085344|NCT02382276|468264538|FG002|Overall Study|Physician Decision|2|||
130085345|NCT02178592|468264539|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
130085346|NCT02178592|468264540|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
130085347|NCT02178592|468264539|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
130085348|NCT02178592|468264540|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
130085349|NCT02178592|468264539|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
130085350|NCT02178592|468264540|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
130085351|NCT02178592|468264539|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
130085352|NCT02178592|468264540|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
130085353|NCT02178592|468264539|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
130085354|NCT02178592|468264540|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
130085355|NCT02178592|468264539|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
130085356|NCT02178592|468264540|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130085357|NCT02178592|468264539|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
130085358|NCT02178592|468264540|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
130085359|NCT02178592|468264539|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
130085360|NCT02178592|468264540|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
130085361|NCT02178592|468264539|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
130085362|NCT02178592|468264540|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
130085363|NCT02178592|468264539|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
130085364|NCT02178592|468264540|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
130085365|NCT02178592|468264539|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
130085366|NCT02178592|468264540|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
130085367|NCT02178592|468264539|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
130085368|NCT02178592|468264540|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
130085369|NCT00518336|468264541|FG000|Year 7|Lost to Follow-up|2|||
130085370|NCT00518336|468264542|FG001|Year 7|Lost to Follow-up|0|||
130085371|NCT00518336|468264541|FG000|Year 7|Could not attend in time|0|||
130085372|NCT00518336|468264542|FG001|Year 7|Could not attend in time|3|||
130085373|NCT00518336|468264541|FG000|Year 8|Lost to Follow-up|1|||
130085374|NCT00518336|468264542|FG001|Year 8|Lost to Follow-up|1|||
130085375|NCT00518336|468264541|FG000|Year 8|Could not attend in time|0|||
130085376|NCT00518336|468264542|FG001|Year 8|Could not attend in time|1|||
130085377|NCT00518336|468264541|FG000|Year 9|Migrated/moved from study area|1|||
130085378|NCT00518336|468264542|FG001|Year 9|Migrated/moved from study area|1|||
130085379|NCT00518336|468264541|FG000|Year 9|Lost to Follow-up|3|||
130085380|NCT00518336|468264542|FG001|Year 9|Lost to Follow-up|0|||
130085381|NCT00518336|468264541|FG000|Year 9|Personal reasons|1|||
130085382|NCT00518336|468264542|FG001|Year 9|Personal reasons|0|||
130085383|NCT00125268|468264543|FG000|Overall Study|Withdrawal by Subject|1|||
130085384|NCT00125268|468264544|FG001|Overall Study|Withdrawal by Subject|1|||
130085385|NCT00286156|468264545|FG000|Overall Study|Missed 12 month visit|0|||
130085386|NCT00286156|468264546|FG001|Overall Study|Missed 12 month visit|0|||
130085387|NCT00286156|468264547|FG002|Overall Study|Missed 12 month visit|1|||
130085388|NCT00286156|468264545|FG000|Overall Study|AE: pulmonary embolus|0|||
130085389|NCT00286156|468264546|FG001|Overall Study|AE: pulmonary embolus|1|||
130085390|NCT00286156|468264547|FG002|Overall Study|AE: pulmonary embolus|0|||
130085391|NCT00286156|468264545|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
130085392|NCT00286156|468264546|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
130085393|NCT00286156|468264547|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
130085394|NCT00286156|468264545|FG000|Overall Study|AE: pneumonia|1|||
130085395|NCT00286156|468264546|FG001|Overall Study|AE: pneumonia|0|||
130121325|NCT00770315|468404959|FG002|Overall Study|Lost to Follow-up|10|||
130121326|NCT00770315|468404960|FG003|Overall Study|Lost to Follow-up|3|||
130121327|NCT00770315|468404957|FG000|Overall Study|Withdrawal by Subject|13|||
130121328|NCT00770315|468404958|FG001|Overall Study|Withdrawal by Subject|17|||
129959979|NCT02506881|467816164|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959980|NCT02506881|467816165|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959981|NCT02506881|467816166|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959982|NCT02506881|467816163|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
129959983|NCT02506881|467816164|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
129959984|NCT02506881|467816165|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
129959985|NCT02506881|467816166|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
130085396|NCT00286156|468264547|FG002|Overall Study|AE: pneumonia|0|||
130085397|NCT06334055|468264551|FG000|Overall Study|Adverse Event|4|||
130121329|NCT00770315|468404959|FG002|Overall Study|Withdrawal by Subject|24|||
130085398|NCT06334055|468264551|FG000|Overall Study|Disqualified|72|||
130085399|NCT02200510|468265749|FG000|Overall Study|Death|1|||
130085400|NCT02200510|468265750|FG001|Overall Study|Death|1|||
130085401|NCT02200510|468265749|FG000|Overall Study|Protocol Violation|0|||
130085402|NCT02200510|468265750|FG001|Overall Study|Protocol Violation|1|||
130085403|NCT02200510|468265749|FG000|Overall Study|Lost to Follow-up|7|||
130085404|NCT02200510|468265750|FG001|Overall Study|Lost to Follow-up|1|||
130085405|NCT02200510|468265749|FG000|Overall Study|potential COI - joined study team|1|||
130085406|NCT02200510|468265750|FG001|Overall Study|potential COI - joined study team|0|||
130085407|NCT00290355|468265751|FG000|Overall Study|Serious adverse event|7|||
130085408|NCT00290355|468265752|FG001|Overall Study|Serious adverse event|4|||
130085409|NCT00290355|468265751|FG000|Overall Study|Study product reactogenicity|1|||
130085410|NCT00290355|468265752|FG001|Overall Study|Study product reactogenicity|0|||
130085411|NCT00290355|468265751|FG000|Overall Study|Protocol Violation|1|||
130085412|NCT00290355|468265752|FG001|Overall Study|Protocol Violation|0|||
130085413|NCT00290355|468265751|FG000|Overall Study|Withdrawal by Subject|2|||
130085414|NCT00290355|468265752|FG001|Overall Study|Withdrawal by Subject|0|||
130085415|NCT00290355|468265751|FG000|Overall Study|Migrated / moved from the study area|1|||
130085416|NCT00290355|468265752|FG001|Overall Study|Migrated / moved from the study area|0|||
130085417|NCT00290355|468265751|FG000|Overall Study|Lost to Follow-up|3|||
130085418|NCT00290355|468265752|FG001|Overall Study|Lost to Follow-up|1|||
130085419|NCT00290355|468265751|FG000|Overall Study|Other|2|||
130085420|NCT00290355|468265752|FG001|Overall Study|Other|0|||
130085421|NCT01542632|468265753|FG000|Overall Study|Withdrawal of Consent|0|||
130085422|NCT01542632|468265754|FG001|Overall Study|Withdrawal of Consent|0|||
130085423|NCT01542632|468265755|FG002|Overall Study|Withdrawal of Consent|0|||
130085424|NCT01542632|468265756|FG003|Overall Study|Withdrawal of Consent|2|||
130085425|NCT01542632|468265757|FG004|Overall Study|Withdrawal of Consent|3|||
130085426|NCT01542632|468265758|FG005|Overall Study|Withdrawal of Consent|0|||
130085427|NCT01542632|468265753|FG000|Overall Study|Adverse Event|0|||
130085428|NCT01542632|468265754|FG001|Overall Study|Adverse Event|0|||
130085429|NCT01542632|468265755|FG002|Overall Study|Adverse Event|1|||
130085430|NCT01542632|468265756|FG003|Overall Study|Adverse Event|0|||
130085431|NCT01542632|468265757|FG004|Overall Study|Adverse Event|0|||
130085432|NCT01542632|468265758|FG005|Overall Study|Adverse Event|0|||
130085433|NCT01542632|468265753|FG000|Overall Study|Lost to Follow-up|0|||
130085434|NCT01542632|468265754|FG001|Overall Study|Lost to Follow-up|1|||
130085435|NCT01542632|468265755|FG002|Overall Study|Lost to Follow-up|0|||
130085436|NCT01542632|468265756|FG003|Overall Study|Lost to Follow-up|0|||
130085437|NCT01542632|468265757|FG004|Overall Study|Lost to Follow-up|0|||
130085438|NCT01542632|468265758|FG005|Overall Study|Lost to Follow-up|0|||
130085439|NCT01542632|468265753|FG000|Overall Study|Sponsor/Investigator Decision|0|||
130085440|NCT01542632|468265754|FG001|Overall Study|Sponsor/Investigator Decision|0|||
130085441|NCT01542632|468265755|FG002|Overall Study|Sponsor/Investigator Decision|0|||
130085442|NCT01542632|468265756|FG003|Overall Study|Sponsor/Investigator Decision|0|||
130085443|NCT01542632|468265757|FG004|Overall Study|Sponsor/Investigator Decision|1|||
130085444|NCT01542632|468265758|FG005|Overall Study|Sponsor/Investigator Decision|0|||
130085445|NCT00033514|468265759|FG000|Overall Study|Lost to Follow-up|1|||
130085446|NCT00033514|468265760|FG001|Overall Study|Lost to Follow-up|1|||
130085447|NCT00033514|468265759|FG000|Overall Study|Withdrawal by Subject|0|||
130085448|NCT00033514|468265760|FG001|Overall Study|Withdrawal by Subject|3|||
130085449|NCT01108263|468265772|FG000|Overall Study|Adverse Event|0|||
130085450|NCT01108263|468265773|FG001|Overall Study|Adverse Event|1|||
130085451|NCT01685372|468265774|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
130085452|NCT01685372|468265775|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
130085453|NCT01488994|468265776|FG000|Overall Study|Withdrawal by Subject|0|||
130085454|NCT01488994|468265777|FG001|Overall Study|Withdrawal by Subject|1|||
130085455|NCT00829010|468265780|FG000|Overall Study|Adverse Event|1|||
130085456|NCT00829010|468265781|FG001|Overall Study|Adverse Event|0|||
130085457|NCT00829010|468265782|FG002|Overall Study|Adverse Event|0|||
130085458|NCT00829010|468265783|FG003|Overall Study|Adverse Event|0|||
130085459|NCT00829010|468265784|FG004|Overall Study|Adverse Event|0|||
130085460|NCT00829010|468265780|FG000|Overall Study|Withdrawal by Subject|0|||
130085461|NCT00829010|468265781|FG001|Overall Study|Withdrawal by Subject|1|||
130085462|NCT00829010|468265782|FG002|Overall Study|Withdrawal by Subject|1|||
130085463|NCT00829010|468265783|FG003|Overall Study|Withdrawal by Subject|0|||
130085464|NCT00829010|468265784|FG004|Overall Study|Withdrawal by Subject|2|||
130085465|NCT00829010|468265780|FG000|Overall Study|Lost to Follow-up|1|||
130085466|NCT00829010|468265781|FG001|Overall Study|Lost to Follow-up|0|||
130085467|NCT00829010|468265782|FG002|Overall Study|Lost to Follow-up|2|||
130085468|NCT00829010|468265783|FG003|Overall Study|Lost to Follow-up|0|||
130085469|NCT00829010|468265784|FG004|Overall Study|Lost to Follow-up|0|||
130085470|NCT00829010|468265780|FG000|Overall Study|Fatality|5|||
130085471|NCT00829010|468265781|FG001|Overall Study|Fatality|4|||
130085472|NCT00829010|468265782|FG002|Overall Study|Fatality|0|||
130085473|NCT00829010|468265783|FG003|Overall Study|Fatality|3|||
130085474|NCT00829010|468265784|FG004|Overall Study|Fatality|0|||
130085475|NCT00829010|468265780|FG000|Overall Study|Migrated/Moved from study area|3|||
129959986|NCT01919398|467816167|FG000|Overall Study|Progressive Disease|0|||
129959987|NCT01919398|467816168|FG001|Overall Study|Progressive Disease|0|||
129959988|NCT01919398|467816169|FG002|Overall Study|Progressive Disease|4|||
129959989|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
129959990|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Duplication|2|||
129959991|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
129959992|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
129959993|NCT02016690|467816172|FG000|Overall Study|Did not meet inclusion criteria|13|||
129959994|NCT02016690|467816172|FG000|Overall Study|Hospitalized for RSV at study start|3|||
129959995|NCT00050167|467816173|FG000|Overall Study|not eligible not invasive|1|||
129959996|NCT00050167|467816174|FG001|Overall Study|not eligible not invasive|1|||
129959997|NCT00495612|467816177|FG000|Overall Study|Lost to Follow-up|1|||
129959998|NCT00495612|467816178|FG001|Overall Study|Lost to Follow-up|0|||
129959999|NCT00495612|467816177|FG000|Overall Study|Subject's Decision to Withdraw|3|||
129960000|NCT00495612|467816178|FG001|Overall Study|Subject's Decision to Withdraw|0|||
129960001|NCT06016127|467816181|FG000|Overall Study|Withdrawal by Subject|4|||
129960002|NCT06016127|467816182|FG001|Overall Study|Withdrawal by Subject|3|||
129960003|NCT02864147|467816188|FG000|Overall Study|Withdrawal by Subject|3|||
129960004|NCT02864147|467816189|FG001|Overall Study|Withdrawal by Subject|2|||
129960005|NCT02864147|467816190|FG002|Overall Study|Withdrawal by Subject|1|||
129960006|NCT02864147|467816188|FG000|Overall Study|Lost to Follow-up|0|||
129960007|NCT02864147|467816189|FG001|Overall Study|Lost to Follow-up|4|||
129960008|NCT02864147|467816190|FG002|Overall Study|Lost to Follow-up|0|||
129960009|NCT02864147|467816188|FG000|Overall Study|Adverse Event|0|||
129960010|NCT02864147|467816189|FG001|Overall Study|Adverse Event|1|||
129960011|NCT02864147|467816190|FG002|Overall Study|Adverse Event|0|||
129960012|NCT02864147|467816188|FG000|Overall Study|Pregnancy|4|||
129960013|NCT02864147|467816189|FG001|Overall Study|Pregnancy|0|||
129960014|NCT02864147|467816190|FG002|Overall Study|Pregnancy|0|||
129960015|NCT02864147|467816188|FG000|Overall Study|Physician Decision|0|||
129960016|NCT02864147|467816189|FG001|Overall Study|Physician Decision|0|||
129960017|NCT02864147|467816190|FG002|Overall Study|Physician Decision|1|||
129960018|NCT02864147|467816188|FG000|Overall Study|Opted for excisional procedures|0|||
129960019|NCT02864147|467816189|FG001|Overall Study|Opted for excisional procedures|0|||
129960020|NCT02864147|467816190|FG002|Overall Study|Opted for excisional procedures|3|||
129960021|NCT01772147|467817778|FG000|Overall Study|Adverse Event|13|||
129960022|NCT01772147|467817779|FG001|Overall Study|Adverse Event|10|||
129960023|NCT01772147|467817780|FG002|Overall Study|Adverse Event|6|||
129960024|NCT01772147|467817778|FG000|Overall Study|Withdrew Consent|7|||
129960025|NCT01772147|467817779|FG001|Overall Study|Withdrew Consent|8|||
129960026|NCT01772147|467817780|FG002|Overall Study|Withdrew Consent|4|||
129960027|NCT01772147|467817778|FG000|Overall Study|Lost to Follow-up|1|||
129960028|NCT01772147|467817779|FG001|Overall Study|Lost to Follow-up|0|||
129960029|NCT01772147|467817780|FG002|Overall Study|Lost to Follow-up|1|||
129960030|NCT01772147|467817778|FG000|Overall Study|Protocol Deviation|2|||
129960031|NCT01772147|467817779|FG001|Overall Study|Protocol Deviation|1|||
129960032|NCT01772147|467817780|FG002|Overall Study|Protocol Deviation|1|||
129960033|NCT01772147|467817778|FG000|Overall Study|Lack of Efficacy|8|||
129960034|NCT01772147|467817779|FG001|Overall Study|Lack of Efficacy|6|||
129960035|NCT01772147|467817780|FG002|Overall Study|Lack of Efficacy|6|||
129960036|NCT02972242|467817781|FG000|Overall Study|Withdrawal by Subject|1|||
129960037|NCT02972242|467817782|FG001|Overall Study|Withdrawal by Subject|0|||
129960038|NCT04572997|467817783|FG000|Overall Study|Adverse Event|1|||
129960039|NCT00740597|467817784|FG000|Overall Study|insurance would not cover treatment|1|||
129960040|NCT00552513|467817785|FG000|Overall Study|Lost to Follow-up|5|||
129960041|NCT00552513|467817786|FG001|Overall Study|Lost to Follow-up|1|||
129960042|NCT01157351|467817787|FG000|Overall Study|Adverse Event|5|||
129960043|NCT01157351|467817788|FG001|Overall Study|Adverse Event|4|||
129960044|NCT01157351|467817787|FG000|Overall Study|Death|1|||
129960045|NCT01157351|467817788|FG001|Overall Study|Death|0|||
129960046|NCT01157351|467817787|FG000|Overall Study|Lost to Follow-up|53|||
129960047|NCT01157351|467817788|FG001|Overall Study|Lost to Follow-up|55|||
129960048|NCT01157351|467817787|FG000|Overall Study|Withdrawal by Subject|37|||
129960049|NCT01157351|467817788|FG001|Overall Study|Withdrawal by Subject|27|||
129960050|NCT01157351|467817787|FG000|Overall Study|Physician Decision|5|||
129960051|NCT01157351|467817788|FG001|Overall Study|Physician Decision|4|||
129960052|NCT01157351|467817787|FG000|Overall Study|Protocol Violation|0|||
129960053|NCT01157351|467817788|FG001|Overall Study|Protocol Violation|1|||
129960054|NCT01157351|467817787|FG000|Overall Study|Other|32|||
129960055|NCT01157351|467817788|FG001|Overall Study|Other|36|||
129960056|NCT01157351|467817787|FG000|Overall Study|Noncompliance with Study Drug|0|||
129960057|NCT01157351|467817788|FG001|Overall Study|Noncompliance with Study Drug|3|||
129960058|NCT01157351|467817787|FG000|Overall Study|Randomized but not Treated|4|||
129960059|NCT01157351|467817788|FG001|Overall Study|Randomized but not Treated|2|||
129960060|NCT00746785|467817789|FG000|Overall Study|Lost to Follow-up|29|||
129960061|NCT00746785|467817790|FG001|Overall Study|Lost to Follow-up|25|||
129960062|NCT00746785|467817791|FG002|Overall Study|Lost to Follow-up|27|||
129960063|NCT02517528|467817793|FG000|Overall Study|Withdrawal by Subject|1|||
130085476|NCT00829010|468265781|FG001|Overall Study|Migrated/Moved from study area|4|||
130085477|NCT00829010|468265782|FG002|Overall Study|Migrated/Moved from study area|0|||
130085478|NCT00829010|468265783|FG003|Overall Study|Migrated/Moved from study area|5|||
130085479|NCT00829010|468265784|FG004|Overall Study|Migrated/Moved from study area|0|||
130085480|NCT00474539|468265787|FG000|Infant Series|Withdrawal by Subject|3|||
130085481|NCT00474539|468265788|FG001|Infant Series|Withdrawal by Subject|4|||
130085482|NCT00474539|468265787|FG000|Infant Series|Randomization error|5|||
130085483|NCT00474539|468265788|FG001|Infant Series|Randomization error|0|||
130085484|NCT00474539|468265787|FG000|Infant Series|Lost to Follow-up|2|||
130085485|NCT00474539|468265788|FG001|Infant Series|Lost to Follow-up|1|||
130085486|NCT00474539|468265787|FG000|Infant Series|Protocol Violation|0|||
130085487|NCT00474539|468265788|FG001|Infant Series|Protocol Violation|1|||
130085488|NCT00474539|468265787|FG000|After Infant Series|Lost to Follow-up|3|||
130085489|NCT00474539|468265788|FG001|After Infant Series|Lost to Follow-up|0|||
130085490|NCT00474539|468265787|FG000|After Infant Series|Withdrawal by Subject|1|||
130085491|NCT00474539|468265788|FG001|After Infant Series|Withdrawal by Subject|0|||
130085492|NCT00474539|468265787|FG000|Toddler Dose|Protocol Violation|1|||
130085493|NCT00474539|468265788|FG001|Toddler Dose|Protocol Violation|0|||
130085494|NCT02061540|468265789|FG000|Overall Study|Adverse Event|2|||
130085495|NCT02061540|468265789|FG000|Overall Study|Withdrawal by Subject|2|||
130085496|NCT02289833|468265791|FG000|Overall Study|Study discontinuation|0|||
130085497|NCT02289833|468265792|FG001|Overall Study|Study discontinuation|1|||
130085498|NCT02289833|468265791|FG000|Overall Study|Lost to Follow-up|4|||
130085499|NCT02289833|468265792|FG001|Overall Study|Lost to Follow-up|0|||
130085500|NCT02289833|468265791|FG000|Overall Study|Death|23|||
130085501|NCT02289833|468265792|FG001|Overall Study|Death|16|||
130085502|NCT01227252|468265793|FG000|Overall Study|Sponsor Decision|0|||
130085503|NCT01227252|468265794|FG001|Overall Study|Sponsor Decision|1|||
130085504|NCT01227252|468265795|FG002|Overall Study|Sponsor Decision|0|||
130085505|NCT01227252|468265796|FG003|Overall Study|Sponsor Decision|0|||
130085506|NCT01227252|468265793|FG000|Overall Study|Lost to Follow-up|0|||
130085507|NCT01227252|468265794|FG001|Overall Study|Lost to Follow-up|1|||
130085508|NCT01227252|468265795|FG002|Overall Study|Lost to Follow-up|0|||
130085509|NCT01227252|468265796|FG003|Overall Study|Lost to Follow-up|0|||
130085510|NCT01227252|468265793|FG000|Overall Study|Withdrawal by Subject|0|||
130085511|NCT01227252|468265794|FG001|Overall Study|Withdrawal by Subject|1|||
130085512|NCT01227252|468265795|FG002|Overall Study|Withdrawal by Subject|0|||
130085513|NCT01227252|468265796|FG003|Overall Study|Withdrawal by Subject|0|||
130085514|NCT02561273|468265803|FG000|Overall Study|Protocol Violation|1|||
130085515|NCT02561273|468265804|FG001|Overall Study|Protocol Violation|0|||
130085516|NCT03442595|468265805|FG000|Overall Study|Lost to Follow-up|94|||
130085517|NCT03442595|468265806|FG001|Overall Study|Lost to Follow-up|0|||
130085518|NCT01657253|468265807|FG000|Overall Study|Lost to Follow-up|6|||
130085519|NCT01657253|468265808|FG001|Overall Study|Lost to Follow-up|5|||
130085520|NCT01657253|468265807|FG000|Overall Study|Withdrawal by Subject|11|||
130085521|NCT01657253|468265808|FG001|Overall Study|Withdrawal by Subject|12|||
130085522|NCT01657253|468265807|FG000|Overall Study|Adverse Event|0|||
130085523|NCT01657253|468265808|FG001|Overall Study|Adverse Event|1|||
130085524|NCT01603628|468265811|FG000|Overall Study|Personal Reasons|1|||
130085525|NCT01603628|468265812|FG001|Overall Study|Personal Reasons|1|||
130085526|NCT01603628|468265813|FG002|Overall Study|Personal Reasons|2|||
130085527|NCT01603628|468265811|FG000|Overall Study|Protocol Violation|1|||
130085528|NCT01603628|468265812|FG001|Overall Study|Protocol Violation|1|||
129960064|NCT03511378|467817796|FG000|Overall Study|Withdrawal by Subject|2|||
129960065|NCT03511378|467817797|FG001|Overall Study|Withdrawal by Subject|2|||
129960066|NCT03511378|467817796|FG000|Overall Study|Patient not coming or schedule visit|1|||
129960067|NCT03511378|467817797|FG001|Overall Study|Patient not coming or schedule visit|0|||
129960068|NCT00837096|467817798|FG000|Overall Study|Physician Decision|1|||
129960069|NCT00837096|467817799|FG001|Overall Study|Physician Decision|1|||
129960070|NCT00837096|467817798|FG000|Overall Study|Not reported|9|||
129960071|NCT00837096|467817799|FG001|Overall Study|Not reported|8|||
129960072|NCT00280683|467817800|FG000|Overall Study|Withdrawal by Subject|1|||
129960073|NCT00280683|467817801|FG001|Overall Study|Withdrawal by Subject|2|||
129960074|NCT00280683|467817800|FG000|Overall Study|Adverse Event|1|||
129960075|NCT00280683|467817801|FG001|Overall Study|Adverse Event|1|||
129960076|NCT01243411|467817802|FG000|Overall Study|Withdrawal by Subject|18|||
129960077|NCT01243411|467817802|FG000|Overall Study|Lost to Follow-up|10|||
129960078|NCT01243411|467817802|FG000|Overall Study|Adverse Event|5|||
129960079|NCT01243411|467817802|FG000|Overall Study|Other|8|||
129960080|NCT00510198|467817803|FG000|Overall Study|Withdrawal by Subject|5|||
129960081|NCT00510198|467817804|FG001|Overall Study|Withdrawal by Subject|4|||
129960082|NCT03168425|467817810|FG000|Overall Study|Lost to Follow-up|5|||
129960083|NCT03168425|467817811|FG001|Overall Study|Lost to Follow-up|8|||
129960084|NCT03168425|467817810|FG000|Overall Study|unable to confirm post op opioids|2|||
129960085|NCT03168425|467817811|FG001|Overall Study|unable to confirm post op opioids|3|||
129960086|NCT04491006|467817812|FG000|Overall Study|Adverse Event|0|||
129960087|NCT04491006|467817813|FG001|Overall Study|Adverse Event|3|||
129960088|NCT04491006|467817814|FG002|Overall Study|Adverse Event|5|||
130085529|NCT01603628|468265813|FG002|Overall Study|Protocol Violation|0|||
130085530|NCT01603628|468265811|FG000|Overall Study|Lost to Follow-up|0|||
130085531|NCT01603628|468265812|FG001|Overall Study|Lost to Follow-up|1|||
130085532|NCT01603628|468265813|FG002|Overall Study|Lost to Follow-up|0|||
130085533|NCT01603628|468265811|FG000|Overall Study|Other Miscellaneous Reason|1|||
130085534|NCT01603628|468265812|FG001|Overall Study|Other Miscellaneous Reason|0|||
130085535|NCT01603628|468265813|FG002|Overall Study|Other Miscellaneous Reason|0|||
130085536|NCT00886587|468265815|FG000|Overall Study|Adverse Event|2|||
130085537|NCT00886587|468265816|FG001|Overall Study|Adverse Event|1|||
130085538|NCT00886587|468265815|FG000|Overall Study|Protocol Violation|2|||
130085539|NCT00886587|468265816|FG001|Overall Study|Protocol Violation|0|||
130085540|NCT00886587|468265815|FG000|Overall Study|Withdrawal by Subject|0|||
130085541|NCT00886587|468265816|FG001|Overall Study|Withdrawal by Subject|1|||
130085542|NCT04107935|468265817|FG000|Overall Study|Death|1|||
130085543|NCT04107935|468265818|FG001|Overall Study|Death|0|||
130085544|NCT00890201|468265819|FG000|Overall Study|Protocol Violation|5|||
130085545|NCT00890201|468265820|FG001|Overall Study|Protocol Violation|56|||
130085546|NCT02087241|468265821|FG000|Overall Study|Death|2|||
130085547|NCT02087241|468265822|FG001|Overall Study|Death|1|||
130085548|NCT02087241|468265823|FG002|Overall Study|Death|1|||
130085549|NCT02087241|468265824|FG003|Overall Study|Death|1|||
130085550|NCT02087241|468265821|FG000|Overall Study|Withdrawal by Subject|1|||
130085551|NCT02087241|468265822|FG001|Overall Study|Withdrawal by Subject|0|||
130085552|NCT02087241|468265823|FG002|Overall Study|Withdrawal by Subject|0|||
130085553|NCT02087241|468265824|FG003|Overall Study|Withdrawal by Subject|1|||
130085554|NCT02087241|468265821|FG000|Overall Study|Progressive Disease|0|||
130085555|NCT02087241|468265822|FG001|Overall Study|Progressive Disease|0|||
130085556|NCT02087241|468265823|FG002|Overall Study|Progressive Disease|0|||
130085557|NCT02087241|468265824|FG003|Overall Study|Progressive Disease|1|||
130085558|NCT02087241|468265821|FG000|Overall Study|Study Terminated by Sponsor|0|||
130085559|NCT02087241|468265822|FG001|Overall Study|Study Terminated by Sponsor|2|||
130085560|NCT02087241|468265823|FG002|Overall Study|Study Terminated by Sponsor|0|||
130085561|NCT02087241|468265824|FG003|Overall Study|Study Terminated by Sponsor|4|||
130085562|NCT02181504|468265825|FG000|Overall Study|Adverse Event|1|||
130085563|NCT02181504|468265826|FG001|Overall Study|Adverse Event|1|||
130085564|NCT02181504|468265827|FG002|Overall Study|Adverse Event|1|||
130085565|NCT00374452|468265830|FG000|Overall Study|Left clinic before intervention started|4|||
130085566|NCT00374452|468265831|FG001|Overall Study|Left clinic before intervention started|1|||
130085567|NCT00374452|468265830|FG000|Overall Study|Change in job role before intervention|0|||
130085568|NCT00374452|468265831|FG001|Overall Study|Change in job role before intervention|1|||
130085569|NCT00374452|468265830|FG000|Overall Study|Left clinic after intervention started|1|||
130085570|NCT00374452|468265831|FG001|Overall Study|Left clinic after intervention started|1|||
130085571|NCT00374452|468265830|FG000|Overall Study|Withdrawal by Subject|0|||
130085572|NCT00374452|468265831|FG001|Overall Study|Withdrawal by Subject|2|||
129960089|NCT04491006|467817812|FG000|Overall Study|Withdrawal by Subject|1|||
129960090|NCT04491006|467817813|FG001|Overall Study|Withdrawal by Subject|0|||
129960091|NCT04491006|467817814|FG002|Overall Study|Withdrawal by Subject|2|||
129960092|NCT01960114|467817818|FG000|Overall Study|Adverse Event|1|||
129960093|NCT01960114|467817819|FG001|Overall Study|Adverse Event|0|||
129960094|NCT01960114|467817818|FG000|Overall Study|Could not swallow study medication|0|||
129960095|NCT01960114|467817819|FG001|Overall Study|Could not swallow study medication|1|||
129960096|NCT02469077|467817820|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
129960097|NCT02469077|467817821|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
129960098|NCT02469077|467817820|FG000|Post Randomization/Intervention Period|Relocated|1|||
129960099|NCT02469077|467817821|FG001|Post Randomization/Intervention Period|Relocated|1|||
129960100|NCT02469077|467817820|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
129960101|NCT02469077|467817821|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
129960102|NCT02469077|467817820|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
130085573|NCT01040728|468265836|FG000|Overall Study|Adverse Event|4|||
130085574|NCT01040728|468265837|FG001|Overall Study|Adverse Event|8|||
130085575|NCT01040728|468265838|FG002|Overall Study|Adverse Event|0|||
130085576|NCT01040728|468265839|FG003|Overall Study|Adverse Event|4|||
130085577|NCT01040728|468265836|FG000|Overall Study|Withdrawal by Subject|0|||
130085578|NCT01040728|468265837|FG001|Overall Study|Withdrawal by Subject|1|||
130085579|NCT01040728|468265838|FG002|Overall Study|Withdrawal by Subject|1|||
130085580|NCT01040728|468265839|FG003|Overall Study|Withdrawal by Subject|0|||
130085581|NCT01040728|468265836|FG000|Overall Study|Protocol Violation|0|||
130085582|NCT01040728|468265837|FG001|Overall Study|Protocol Violation|0|||
130085583|NCT01040728|468265838|FG002|Overall Study|Protocol Violation|0|||
130085584|NCT01040728|468265839|FG003|Overall Study|Protocol Violation|1|||
130085585|NCT01040728|468265836|FG000|Overall Study|Lack of Efficacy|0|||
130085586|NCT01040728|468265837|FG001|Overall Study|Lack of Efficacy|1|||
130085587|NCT01040728|468265838|FG002|Overall Study|Lack of Efficacy|0|||
130085588|NCT01040728|468265839|FG003|Overall Study|Lack of Efficacy|1|||
130085589|NCT01040728|468265836|FG000|Overall Study|Other reasons not listed above|0|||
130085590|NCT01040728|468265837|FG001|Overall Study|Other reasons not listed above|1|||
130085591|NCT01040728|468265838|FG002|Overall Study|Other reasons not listed above|0|||
130085592|NCT01040728|468265839|FG003|Overall Study|Other reasons not listed above|0|||
130085593|NCT01875874|468265842|FG000|Overall Study|Death|3|||
130085594|NCT00590031|468265843|FG000|Overall Study|Adverse Event|3|||
130085595|NCT00590031|468265843|FG000|Overall Study|Withdrawal by Subject|1|||
130085596|NCT00590031|468265843|FG000|Overall Study|Metastatic Disease|1|||
130085597|NCT00590031|468265843|FG000|Overall Study|Admin Hold|1|||
130085598|NCT02463331|468265844|FG000|Overall Study|Adverse Event|4|||
130085599|NCT02463331|468265845|FG001|Overall Study|Adverse Event|2|||
130085600|NCT02463331|468265844|FG000|Overall Study|Lost to Follow-up|1|||
130085601|NCT02463331|468265845|FG001|Overall Study|Lost to Follow-up|1|||
130085602|NCT02463331|468265844|FG000|Overall Study|Pregnancy|2|||
130085603|NCT02463331|468265845|FG001|Overall Study|Pregnancy|3|||
130085604|NCT02463331|468265844|FG000|Overall Study|Lack of Efficacy|6|||
130085605|NCT02463331|468265845|FG001|Overall Study|Lack of Efficacy|0|||
130085606|NCT02463331|468265844|FG000|Overall Study|Physician Decision|3|||
130085607|NCT02463331|468265845|FG001|Overall Study|Physician Decision|0|||
130085608|NCT00826540|468265846|FG000|Overall Study|ineligible|3|||
130085609|NCT00826540|468265846|FG000|Overall Study|Withdrawal by Subject|1|||
130085610|NCT01166386|468265847|FG000|Overall Study|Withdrawal by Subject|3|||
130085611|NCT01166386|468265848|FG001|Overall Study|Withdrawal by Subject|5|||
130085612|NCT01222416|468265849|FG000|Overall Study|ineligible;metastasis|3|||
130085613|NCT01222416|468265850|FG001|Overall Study|ineligible;metastasis|0|||
130085614|NCT01222416|468265849|FG000|Overall Study|Adverse Event|4|||
130085615|NCT01222416|468265850|FG001|Overall Study|Adverse Event|0|||
130085616|NCT01222416|468265849|FG000|Overall Study|Withdrawal by Subject|5|||
130085617|NCT01222416|468265850|FG001|Overall Study|Withdrawal by Subject|0|||
130085618|NCT01222416|468265849|FG000|Overall Study|scheduling|6|||
130085619|NCT01222416|468265850|FG001|Overall Study|scheduling|0|||
130085620|NCT01222416|468265849|FG000|Overall Study|missed view/scan|1|||
130085621|NCT01222416|468265850|FG001|Overall Study|missed view/scan|0|||
130085622|NCT01222416|468265849|FG000|Overall Study|Death|1|||
130085623|NCT01222416|468265850|FG001|Overall Study|Death|0|||
130085624|NCT02520141|468265855|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
130085625|NCT00703781|468265856|FG000|Overall Study|Withdrawal by Subject|1|||
130085626|NCT00703781|468265857|FG001|Overall Study|Withdrawal by Subject|2|||
130085627|NCT00703781|468265856|FG000|Overall Study|Cancelled surgery|1|||
130085628|NCT00703781|468265857|FG001|Overall Study|Cancelled surgery|0|||
130085629|NCT03452397|468265860|FG000|Overall Study|Adverse Event|1|||
130085630|NCT03452397|468265861|FG001|Overall Study|Adverse Event|0|||
130085631|NCT03452397|468265862|FG002|Overall Study|Adverse Event|0|||
130085632|NCT03452397|468265863|FG003|Overall Study|Adverse Event|0|||
130085633|NCT03452397|468265860|FG000|Overall Study|Administrative reason|0|||
130085634|NCT03452397|468265861|FG001|Overall Study|Administrative reason|0|||
130085635|NCT03452397|468265862|FG002|Overall Study|Administrative reason|1|||
130085636|NCT03452397|468265863|FG003|Overall Study|Administrative reason|1|||
130085637|NCT03452397|468265860|FG000|Overall Study|Withdrawal by Subject|0|||
130085638|NCT03452397|468265861|FG001|Overall Study|Withdrawal by Subject|0|||
130085639|NCT03452397|468265862|FG002|Overall Study|Withdrawal by Subject|1|||
130085640|NCT03452397|468265863|FG003|Overall Study|Withdrawal by Subject|0|||
130085641|NCT02691468|468265865|FG000|Overall Study|Bronchial blocker use|2|||
130085642|NCT02691468|468265866|FG001|Overall Study|Bronchial blocker use|1|||
130085643|NCT02691468|468265865|FG000|Overall Study|Lost to Follow-up|2|||
130085644|NCT02691468|468265866|FG001|Overall Study|Lost to Follow-up|1|||
130085645|NCT02691468|468265865|FG000|Overall Study|Failure to advance FOB|2|||
130085646|NCT02691468|468265866|FG001|Overall Study|Failure to advance FOB|0|||
130085647|NCT02545049|468265867|FG000|Overall Study|Withdrawal by Subject|1|||
130085648|NCT02545049|468265868|FG001|Overall Study|Withdrawal by Subject|7|||
130085649|NCT02545049|468265867|FG000|Overall Study|Lost to Follow-up|4|||
130085650|NCT02545049|468265868|FG001|Overall Study|Lost to Follow-up|6|||
130085651|NCT02545049|468265867|FG000|Overall Study|GCP violations|37|||
130085652|NCT02545049|468265868|FG001|Overall Study|GCP violations|48|||
130085653|NCT02972658|468267372|FG000|Overall Study|Adverse Event|0|||
130085654|NCT02972658|468267373|FG001|Overall Study|Adverse Event|3|||
130085655|NCT02972658|468267374|FG002|Overall Study|Adverse Event|0|||
130085656|NCT02972658|468267375|FG003|Overall Study|Adverse Event|2|||
130085657|NCT02972658|468267372|FG000|Overall Study|Other-determined by Investigator|1|||
130085658|NCT02972658|468267373|FG001|Overall Study|Other-determined by Investigator|1|||
130085659|NCT02972658|468267374|FG002|Overall Study|Other-determined by Investigator|0|||
130085660|NCT02972658|468267375|FG003|Overall Study|Other-determined by Investigator|0|||
130085661|NCT02972658|468267372|FG000|Overall Study|Death|0|||
130085662|NCT02972658|468267373|FG001|Overall Study|Death|0|||
129960103|NCT02469077|467817821|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
130085663|NCT02972658|468267374|FG002|Overall Study|Death|0|||
130085664|NCT02972658|468267375|FG003|Overall Study|Death|1|||
130085665|NCT02972658|468267372|FG000|Overall Study|Lost to Follow-up|0|||
130085666|NCT02972658|468267373|FG001|Overall Study|Lost to Follow-up|1|||
130085667|NCT02972658|468267374|FG002|Overall Study|Lost to Follow-up|1|||
130085668|NCT02972658|468267375|FG003|Overall Study|Lost to Follow-up|2|||
130085669|NCT02972658|468267372|FG000|Overall Study|Progressive Disease|0|||
130085670|NCT02972658|468267373|FG001|Overall Study|Progressive Disease|1|||
130085671|NCT02972658|468267374|FG002|Overall Study|Progressive Disease|0|||
130085672|NCT02972658|468267375|FG003|Overall Study|Progressive Disease|1|||
130085673|NCT02972658|468267372|FG000|Overall Study|Withdrawal by Subject|4|||
130085674|NCT02972658|468267373|FG001|Overall Study|Withdrawal by Subject|4|||
130085675|NCT02972658|468267374|FG002|Overall Study|Withdrawal by Subject|1|||
130085676|NCT02972658|468267375|FG003|Overall Study|Withdrawal by Subject|6|||
130085677|NCT02972658|468267372|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
130085678|NCT02972658|468267373|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
130085679|NCT02972658|468267374|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
130085680|NCT02972658|468267375|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
130085681|NCT02972658|468267372|FG000|Overall Study|Sponsor Decision|70|||
130085682|NCT02972658|468267373|FG001|Overall Study|Sponsor Decision|127|||
130085683|NCT02972658|468267374|FG002|Overall Study|Sponsor Decision|72|||
130085684|NCT02972658|468267375|FG003|Overall Study|Sponsor Decision|119|||
130085685|NCT03958149|468267376|FG000|Overall Study|Withdrawal by Subject|0|||
130085686|NCT03958149|468267377|FG001|Overall Study|Withdrawal by Subject|1|||
130085687|NCT02785588|468267378|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
130085688|NCT02785588|468267378|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
130085689|NCT00768040|468267382|FG000|Overall Study|Adverse Event|3|||
130085690|NCT00768040|468267383|FG001|Overall Study|Adverse Event|2|||
130085691|NCT00768040|468267382|FG000|Overall Study|Abnormal laboratory value|1|||
130085692|NCT00768040|468267383|FG001|Overall Study|Abnormal laboratory value|1|||
130085693|NCT02185040|468267385|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
130085694|NCT02185040|468267386|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
130085695|NCT02185040|468267387|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
130085696|NCT02185040|468267388|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
130085697|NCT02185040|468267389|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
130085698|NCT02185040|468267390|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
130085699|NCT02185040|468267391|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
130085700|NCT02185040|468267385|FG000|Part 1 Treatment Phase|Adverse Event|1|||
130085701|NCT02185040|468267386|FG001|Part 1 Treatment Phase|Adverse Event|0|||
130085702|NCT02185040|468267387|FG002|Part 1 Treatment Phase|Adverse Event|0|||
130085703|NCT02185040|468267388|FG003|Part 1 Treatment Phase|Adverse Event|2|||
130085704|NCT02185040|468267389|FG004|Part 1 Treatment Phase|Adverse Event|3|||
130085705|NCT02185040|468267390|FG005|Part 1 Treatment Phase|Adverse Event|0|||
130085706|NCT02185040|468267391|FG006|Part 1 Treatment Phase|Adverse Event|0|||
130085707|NCT02185040|468267385|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130085708|NCT02185040|468267386|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
130085709|NCT02185040|468267387|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130085710|NCT02185040|468267388|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130085711|NCT02185040|468267389|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130085712|NCT02185040|468267390|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130085713|NCT02185040|468267391|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
130085714|NCT02185040|468267385|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
130085715|NCT02185040|468267386|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
130085716|NCT02185040|468267387|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
130085717|NCT02185040|468267388|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
130085718|NCT02185040|468267389|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
130085719|NCT02185040|468267390|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
130085720|NCT02185040|468267391|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
130085721|NCT02185040|468267385|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
130085722|NCT02185040|468267386|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
130085723|NCT02185040|468267387|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
130085724|NCT02185040|468267388|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
130085725|NCT02185040|468267389|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
130085726|NCT02185040|468267390|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
130085727|NCT02185040|468267391|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
130085728|NCT02185040|468267385|FG000|Active Treatment Extension Phase|Adverse Event|0|||
130085729|NCT02185040|468267386|FG001|Active Treatment Extension Phase|Adverse Event|0|||
130085730|NCT02185040|468267387|FG002|Active Treatment Extension Phase|Adverse Event|0|||
130085731|NCT02185040|468267388|FG003|Active Treatment Extension Phase|Adverse Event|0|||
130085732|NCT02185040|468267389|FG004|Active Treatment Extension Phase|Adverse Event|0|||
130085733|NCT02185040|468267390|FG005|Active Treatment Extension Phase|Adverse Event|1|||
130085734|NCT02185040|468267391|FG006|Active Treatment Extension Phase|Adverse Event|4|||
130085735|NCT02185040|468267385|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130085736|NCT02185040|468267386|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130085737|NCT02185040|468267387|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130085738|NCT02185040|468267388|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130085739|NCT02185040|468267389|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
130085740|NCT02185040|468267390|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
130085741|NCT02185040|468267391|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
130085742|NCT02185040|468267385|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
130085743|NCT02185040|468267386|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
130085744|NCT02185040|468267387|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
130085745|NCT02185040|468267388|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
130085746|NCT02185040|468267389|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
130085747|NCT02185040|468267390|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
130085748|NCT02185040|468267391|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
130085749|NCT03347279|468267392|FG000|Overall Study|Withdrawal by Subject|8|||
130085750|NCT03347279|468267393|FG001|Overall Study|Withdrawal by Subject|15|||
130085751|NCT03347279|468267392|FG000|Overall Study|Death|0|||
130085752|NCT03347279|468267393|FG001|Overall Study|Death|2|||
130085753|NCT03347279|468267392|FG000|Overall Study|Lost to Follow-up|5|||
130085754|NCT03347279|468267393|FG001|Overall Study|Lost to Follow-up|2|||
130085755|NCT03347279|468267392|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
130085756|NCT03347279|468267393|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
130085757|NCT03818399|468267396|FG000|Overall Study|Lost to Follow-up|11|||
130085758|NCT03818399|468267396|FG000|Overall Study|Withdrawal by Subject|1|||
130085759|NCT03818399|468267396|FG000|Overall Study|Protocol Violation|2|||
130085760|NCT03557801|468267399|FG000|Overall Study|Protocol Violation|1|||
130085761|NCT03557801|468267400|FG001|Overall Study|Protocol Violation|0|||
130085762|NCT03557801|468267401|FG002|Overall Study|Protocol Violation|0|||
130085763|NCT03557801|468267399|FG000|Overall Study|Withdrawal by Subject|1|||
130085764|NCT03557801|468267400|FG001|Overall Study|Withdrawal by Subject|0|||
130085765|NCT03557801|468267401|FG002|Overall Study|Withdrawal by Subject|3|||
130085766|NCT03557801|468267399|FG000|Overall Study|Lost to Follow-up|0|||
130085767|NCT03557801|468267400|FG001|Overall Study|Lost to Follow-up|1|||
130085768|NCT03557801|468267401|FG002|Overall Study|Lost to Follow-up|0|||
130085769|NCT00141297|468267402|FG000|Overall Study|Adverse Event|0|||
130085770|NCT00141297|468267403|FG001|Overall Study|Adverse Event|0|||
130085771|NCT00141297|468267404|FG002|Overall Study|Adverse Event|1|||
130085772|NCT00141297|468267405|FG003|Overall Study|Adverse Event|0|||
130085773|NCT00141297|468267406|FG004|Overall Study|Adverse Event|1|||
130085774|NCT00141297|468267407|FG005|Overall Study|Adverse Event|1|||
130085775|NCT00141297|468267408|FG006|Overall Study|Adverse Event|0|||
130085776|NCT00141297|468267409|FG007|Overall Study|Adverse Event|1|||
130085777|NCT00141297|468267410|FG008|Overall Study|Adverse Event|1|||
130085778|NCT00141297|468267411|FG009|Overall Study|Adverse Event|0|||
130085779|NCT00141297|468267402|FG000|Overall Study|Death|1|||
130085780|NCT00141297|468267403|FG001|Overall Study|Death|0|||
130085781|NCT00141297|468267404|FG002|Overall Study|Death|0|||
130085782|NCT00141297|468267405|FG003|Overall Study|Death|0|||
130085783|NCT00141297|468267406|FG004|Overall Study|Death|0|||
130085784|NCT00141297|468267407|FG005|Overall Study|Death|0|||
130085785|NCT00141297|468267408|FG006|Overall Study|Death|0|||
130085786|NCT00141297|468267409|FG007|Overall Study|Death|0|||
130085787|NCT00141297|468267410|FG008|Overall Study|Death|1|||
130085788|NCT00141297|468267411|FG009|Overall Study|Death|0|||
130085789|NCT00141297|468267402|FG000|Overall Study|Withdrawal by Subject|0|||
130085790|NCT00141297|468267403|FG001|Overall Study|Withdrawal by Subject|0|||
130085791|NCT00141297|468267404|FG002|Overall Study|Withdrawal by Subject|0|||
130085792|NCT00141297|468267405|FG003|Overall Study|Withdrawal by Subject|0|||
130085793|NCT00141297|468267406|FG004|Overall Study|Withdrawal by Subject|0|||
130085794|NCT00141297|468267407|FG005|Overall Study|Withdrawal by Subject|0|||
130085795|NCT00141297|468267408|FG006|Overall Study|Withdrawal by Subject|0|||
130085796|NCT00141297|468267409|FG007|Overall Study|Withdrawal by Subject|0|||
130085797|NCT00141297|468267410|FG008|Overall Study|Withdrawal by Subject|1|||
130085798|NCT00141297|468267411|FG009|Overall Study|Withdrawal by Subject|0|||
130085799|NCT00141297|468267402|FG000|Overall Study|Other|0|||
130085800|NCT00141297|468267403|FG001|Overall Study|Other|0|||
130085801|NCT00141297|468267404|FG002|Overall Study|Other|0|||
130085802|NCT00141297|468267405|FG003|Overall Study|Other|1|||
130085803|NCT00141297|468267406|FG004|Overall Study|Other|5|||
130085804|NCT00141297|468267407|FG005|Overall Study|Other|0|||
130085805|NCT00141297|468267408|FG006|Overall Study|Other|0|||
130085806|NCT00141297|468267409|FG007|Overall Study|Other|0|||
130085807|NCT00141297|468267410|FG008|Overall Study|Other|2|||
130085808|NCT00141297|468267411|FG009|Overall Study|Other|0|||
130085809|NCT00141297|468267402|FG000|Overall Study|Progressive Disease|2|||
130085810|NCT00141297|468267403|FG001|Overall Study|Progressive Disease|3|||
130085811|NCT00141297|468267404|FG002|Overall Study|Progressive Disease|6|||
130085812|NCT00141297|468267405|FG003|Overall Study|Progressive Disease|2|||
130085813|NCT00141297|468267406|FG004|Overall Study|Progressive Disease|15|||
130085814|NCT00141297|468267407|FG005|Overall Study|Progressive Disease|2|||
130085815|NCT00141297|468267408|FG006|Overall Study|Progressive Disease|3|||
130085816|NCT00141297|468267409|FG007|Overall Study|Progressive Disease|3|||
130085817|NCT00141297|468267410|FG008|Overall Study|Progressive Disease|15|||
130085818|NCT00141297|468267411|FG009|Overall Study|Progressive Disease|6|||
129960104|NCT01040403|467817822|FG000|Overall Study|Adverse Event|10|||
129960105|NCT01040403|467817822|FG000|Overall Study|Protocol Violation|2|||
129960106|NCT01040403|467817822|FG000|Overall Study|Lost to Follow-up|1|||
129960107|NCT01040403|467817822|FG000|Overall Study|Not treated|1|||
129960108|NCT01040403|467817822|FG000|Overall Study|Other reason not defined above|6|||
129960109|NCT01885936|467817823|FG000|Overall Study|Withdrawal by Subject|1|||
129960110|NCT01885936|467817824|FG001|Overall Study|Withdrawal by Subject|0|||
129960111|NCT03036150|467817825|FG000|Overall Study|Withdrawal by Subject|8|||
129960112|NCT03036150|467817826|FG001|Overall Study|Withdrawal by Subject|3|||
129960113|NCT03036150|467817825|FG000|Overall Study|Lost to Follow-up|2|||
129960114|NCT03036150|467817826|FG001|Overall Study|Lost to Follow-up|2|||
129960115|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|no longer interested|1|||
129960116|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|no longer interested|0|||
129960117|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
129960118|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
129960119|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
129960120|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
129960121|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
129960122|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
129960123|NCT00439647|467817829|FG000|Overall Study|Withdrawal by Subject|25|||
129960124|NCT00439647|467817830|FG001|Overall Study|Withdrawal by Subject|22|||
129960125|NCT00439647|467817829|FG000|Overall Study|Death|15|||
129960126|NCT00439647|467817830|FG001|Overall Study|Death|18|||
129960127|NCT00439647|467817829|FG000|Overall Study|Adverse Event|11|||
129960128|NCT00439647|467817830|FG001|Overall Study|Adverse Event|11|||
129960129|NCT00439647|467817829|FG000|Overall Study|Lost to Follow-up|4|||
129960130|NCT00439647|467817830|FG001|Overall Study|Lost to Follow-up|12|||
129960131|NCT00439647|467817829|FG000|Overall Study|Protocol Violation|3|||
129960132|NCT00439647|467817830|FG001|Overall Study|Protocol Violation|4|||
129960133|NCT00439647|467817829|FG000|Overall Study|Lack of Efficacy|0|||
129960134|NCT00439647|467817830|FG001|Overall Study|Lack of Efficacy|4|||
129960135|NCT02845375|467817831|FG000|Overall Study|upper airway obstruction|1|||
129960136|NCT02845375|467817832|FG001|Overall Study|upper airway obstruction|2|||
129960137|NCT02845375|467817833|FG002|Overall Study|upper airway obstruction|1|||
129960138|NCT03041701|467817838|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
129960139|NCT03041701|467817839|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
129960140|NCT03041701|467817840|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
129960141|NCT03041701|467817838|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
129960142|NCT03041701|467817839|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
129960143|NCT03041701|467817840|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
129960144|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
129960145|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
129960146|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
129960147|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
129960148|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
129960149|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
129960150|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
129960151|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
129960152|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
129960153|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
129960154|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
129960155|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
129960156|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
129960157|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
129960158|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
129960159|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
129960160|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
129960161|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
129960162|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
129960163|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
129960164|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
129960165|NCT03569475|467817841|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
129960166|NCT03569475|467817842|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
129960167|NCT03569475|467817843|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
129960168|NCT03569475|467817841|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
129960169|NCT03569475|467817842|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
129960170|NCT03569475|467817843|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
129960171|NCT03638258|467817845|FG000|Overall Study|Adverse Event|1|||
130085819|NCT00141297|468267402|FG000|Overall Study|Transitioned|0|||
130085820|NCT00141297|468267403|FG001|Overall Study|Transitioned|0|||
130085821|NCT00141297|468267404|FG002|Overall Study|Transitioned|0|||
130085822|NCT00141297|468267405|FG003|Overall Study|Transitioned|0|||
130085823|NCT00141297|468267406|FG004|Overall Study|Transitioned|1|||
130085824|NCT00141297|468267407|FG005|Overall Study|Transitioned|0|||
130085825|NCT00141297|468267408|FG006|Overall Study|Transitioned|0|||
130085826|NCT00141297|468267409|FG007|Overall Study|Transitioned|0|||
130085827|NCT00141297|468267410|FG008|Overall Study|Transitioned|0|||
130085828|NCT00141297|468267411|FG009|Overall Study|Transitioned|0|||
130085829|NCT01072500|468267412|FG000|Overall Study|Death|2|||
130085830|NCT01072500|468267413|FG001|Overall Study|Death|2|||
130085831|NCT01072500|468267412|FG000|Overall Study|Lost to Follow-up|5|||
130085832|NCT01072500|468267413|FG001|Overall Study|Lost to Follow-up|2|||
130085833|NCT01072500|468267412|FG000|Overall Study|Withdrawal by Subject|17|||
130085834|NCT01072500|468267413|FG001|Overall Study|Withdrawal by Subject|10|||
130085835|NCT03798366|468267423|FG000|Overall Study|Lost to Follow-up|0|||
130085836|NCT03798366|468267424|FG001|Overall Study|Lost to Follow-up|1|||
130085837|NCT01642004|468267425|FG000|Randomization|Adverse Event unrelated to study drug|1|||
130085838|NCT01642004|468267426|FG001|Randomization|Adverse Event unrelated to study drug|0|||
130085839|NCT01642004|468267425|FG000|Randomization|Participant withdrew consent|1|||
130085840|NCT01642004|468267426|FG001|Randomization|Participant withdrew consent|6|||
130085841|NCT01642004|468267425|FG000|Randomization|No longer meets study criteria|2|||
130085842|NCT01642004|468267426|FG001|Randomization|No longer meets study criteria|2|||
130085843|NCT01642004|468267425|FG000|Treatment|Disease progression|95|||
130085844|NCT01642004|468267426|FG001|Treatment|Disease progression|79|||
130085845|NCT01642004|468267425|FG000|Treatment|Study drug toxicity|10|||
130085846|NCT01642004|468267426|FG001|Treatment|Study drug toxicity|13|||
130085847|NCT01642004|468267425|FG000|Treatment|Death|1|||
130085848|NCT01642004|468267426|FG001|Treatment|Death|1|||
130085849|NCT01642004|468267425|FG000|Treatment|Adverse event unrelated to study drug|9|||
130085850|NCT01642004|468267426|FG001|Treatment|Adverse event unrelated to study drug|13|||
130085851|NCT01642004|468267425|FG000|Treatment|Maximum clinical benefit|1|||
130085852|NCT01642004|468267426|FG001|Treatment|Maximum clinical benefit|9|||
130085853|NCT01642004|468267425|FG000|Treatment|Poor/non-compliance|1|||
130085854|NCT01642004|468267426|FG001|Treatment|Poor/non-compliance|0|||
130085855|NCT01642004|468267425|FG000|Treatment|No longer meets study criteria|1|||
130085856|NCT01642004|468267426|FG001|Treatment|No longer meets study criteria|2|||
130085857|NCT01642004|468267425|FG000|Treatment|Other reasons|2|||
130085858|NCT01642004|468267426|FG001|Treatment|Other reasons|0|||
130085859|NCT01642004|468267425|FG000|Treatment|Not reported|0|||
130085860|NCT01642004|468267426|FG001|Treatment|Not reported|3|||
130085861|NCT01642004|468267425|FG000|Treatment|Participant request to discontinue study treatment|6|||
130085862|NCT01642004|468267426|FG001|Treatment|Participant request to discontinue study treatment|4|||
130085863|NCT01642004|468267425|FG000|Treatment|Participant withdrew consent|5|||
130085864|NCT01642004|468267426|FG001|Treatment|Participant withdrew consent|5|||
130085865|NCT02192190|468267431|FG000|Overall Study|Adverse Event|1|||
130085866|NCT02192190|468267432|FG001|Overall Study|Adverse Event|1|||
130085867|NCT02192190|468267433|FG002|Overall Study|Adverse Event|0|||
130085868|NCT02192190|468267434|FG003|Overall Study|Adverse Event|0|||
130085869|NCT02192190|468267435|FG004|Overall Study|Adverse Event|0|||
130085870|NCT02192190|468267436|FG005|Overall Study|Adverse Event|0|||
130085871|NCT02192190|468267431|FG000|Overall Study|Lost to Follow-up|3|||
130085872|NCT02192190|468267432|FG001|Overall Study|Lost to Follow-up|3|||
130085873|NCT02192190|468267433|FG002|Overall Study|Lost to Follow-up|2|||
130085874|NCT02192190|468267434|FG003|Overall Study|Lost to Follow-up|1|||
130085875|NCT02192190|468267435|FG004|Overall Study|Lost to Follow-up|4|||
130085876|NCT02192190|468267436|FG005|Overall Study|Lost to Follow-up|3|||
130085877|NCT02192190|468267431|FG000|Overall Study|Physician Decision|2|||
130085878|NCT02192190|468267432|FG001|Overall Study|Physician Decision|0|||
130121330|NCT00770315|468404960|FG003|Overall Study|Withdrawal by Subject|20|||
130085879|NCT02192190|468267433|FG002|Overall Study|Physician Decision|0|||
130085880|NCT02192190|468267434|FG003|Overall Study|Physician Decision|0|||
130085881|NCT02192190|468267435|FG004|Overall Study|Physician Decision|0|||
130085882|NCT02192190|468267436|FG005|Overall Study|Physician Decision|0|||
130085883|NCT02192190|468267431|FG000|Overall Study|Terminated by Sponsor|43|||
130085884|NCT02192190|468267432|FG001|Overall Study|Terminated by Sponsor|23|||
130121331|NCT00770315|468404957|FG000|Overall Study|Noncompliance with Protocol|7|||
129960172|NCT03638258|467817846|FG001|Overall Study|Adverse Event|0|||
130085885|NCT02192190|468267433|FG002|Overall Study|Terminated by Sponsor|20|||
130085886|NCT02192190|468267434|FG003|Overall Study|Terminated by Sponsor|23|||
130085887|NCT02192190|468267435|FG004|Overall Study|Terminated by Sponsor|21|||
130085888|NCT02192190|468267436|FG005|Overall Study|Terminated by Sponsor|23|||
130085889|NCT02192190|468267431|FG000|Overall Study|Withdrawal by Subject|4|||
130085890|NCT02192190|468267432|FG001|Overall Study|Withdrawal by Subject|1|||
130085891|NCT02192190|468267433|FG002|Overall Study|Withdrawal by Subject|2|||
130085892|NCT02192190|468267434|FG003|Overall Study|Withdrawal by Subject|1|||
130085893|NCT02192190|468267435|FG004|Overall Study|Withdrawal by Subject|5|||
130085894|NCT02192190|468267436|FG005|Overall Study|Withdrawal by Subject|3|||
130085895|NCT02192190|468267431|FG000|Overall Study|Could not Keep Visit Schedule|1|||
130085896|NCT02192190|468267432|FG001|Overall Study|Could not Keep Visit Schedule|0|||
130085897|NCT02192190|468267433|FG002|Overall Study|Could not Keep Visit Schedule|0|||
130085898|NCT02192190|468267434|FG003|Overall Study|Could not Keep Visit Schedule|0|||
130085899|NCT02192190|468267435|FG004|Overall Study|Could not Keep Visit Schedule|0|||
130085900|NCT02192190|468267436|FG005|Overall Study|Could not Keep Visit Schedule|0|||
130085901|NCT02192190|468267431|FG000|Overall Study|Positive Drug Screen|0|||
130085902|NCT02192190|468267432|FG001|Overall Study|Positive Drug Screen|0|||
130085903|NCT02192190|468267433|FG002|Overall Study|Positive Drug Screen|0|||
130085904|NCT02192190|468267434|FG003|Overall Study|Positive Drug Screen|1|||
130085905|NCT02192190|468267435|FG004|Overall Study|Positive Drug Screen|0|||
130085906|NCT02192190|468267436|FG005|Overall Study|Positive Drug Screen|0|||
130085907|NCT02192190|468267431|FG000|Overall Study|Inadequate Pain Relief|0|||
130085908|NCT02192190|468267432|FG001|Overall Study|Inadequate Pain Relief|1|||
130085909|NCT02192190|468267433|FG002|Overall Study|Inadequate Pain Relief|1|||
130085910|NCT02192190|468267434|FG003|Overall Study|Inadequate Pain Relief|0|||
130085911|NCT02192190|468267435|FG004|Overall Study|Inadequate Pain Relief|0|||
130085912|NCT02192190|468267436|FG005|Overall Study|Inadequate Pain Relief|0|||
130085913|NCT03227692|468267437|FG000|Overall Study|Protocol Violation|1|||
130085914|NCT03227692|468267438|FG001|Overall Study|Protocol Violation|1|||
130085915|NCT03227692|468267437|FG000|Overall Study|Lost to Follow-up|4|||
130085916|NCT03227692|468267438|FG001|Overall Study|Lost to Follow-up|2|||
130085917|NCT03227692|468267437|FG000|Overall Study|Adverse Event|0|||
130085918|NCT03227692|468267438|FG001|Overall Study|Adverse Event|2|||
130085919|NCT01289028|468267442|FG000|Overall Study|Progressive Disease|49|||
130085920|NCT01289028|468267442|FG000|Overall Study|Adverse Event|14|||
130085921|NCT01289028|468267442|FG000|Overall Study|Withdrawal by Subject|6|||
130085922|NCT01289028|468267442|FG000|Overall Study|Death|4|||
130085923|NCT01289028|468267442|FG000|Overall Study|Lack of Efficacy|2|||
130085924|NCT01289028|468267442|FG000|Overall Study|No longer required|2|||
130085925|NCT01289028|468267442|FG000|Overall Study|Lost to Follow-up|2|||
130085926|NCT01289028|468267442|FG000|Overall Study|New Cancer Therapy|2|||
130085927|NCT01289028|468267442|FG000|Overall Study|Abnormal Lab Value|1|||
130085928|NCT01289028|468267442|FG000|Overall Study|Missing reason for discon|1|||
130085929|NCT02120469|468267443|FG000|Overall Study|HER-2/neu-amplified|1|||
130085930|NCT02120469|468267444|FG001|Overall Study|HER-2/neu-amplified|0|||
130085931|NCT02120469|468267445|FG002|Overall Study|HER-2/neu-amplified|1|||
130085932|NCT03267576|468267449|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
130085933|NCT03267576|468267450|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
130085934|NCT03267576|468267449|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
130085935|NCT03267576|468267450|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
130085936|NCT01369069|468267451|FG000|Overall Study|Lost to Follow-up|8|||
130085937|NCT01369069|468267452|FG001|Overall Study|Lost to Follow-up|9|||
130085938|NCT01369069|468267451|FG000|Overall Study|Withdrawal by Subject|9|||
130085939|NCT01369069|468267452|FG001|Overall Study|Withdrawal by Subject|7|||
130085940|NCT00882362|468267453|FG000|Overall Study|Adverse Event|13|||
130085941|NCT00882362|468267454|FG001|Overall Study|Adverse Event|10|||
130085942|NCT00882362|468267453|FG000|Overall Study|Withdrawal by Subject|13|||
130085943|NCT00882362|468267454|FG001|Overall Study|Withdrawal by Subject|10|||
130085944|NCT00882362|468267453|FG000|Overall Study|Lack of Efficacy|3|||
130085945|NCT00882362|468267454|FG001|Overall Study|Lack of Efficacy|0|||
130085946|NCT00882362|468267453|FG000|Overall Study|Protocol Violation|7|||
129960173|NCT03638258|467817847|FG002|Overall Study|Adverse Event|2|||
129960174|NCT03638258|467817845|FG000|Overall Study|Lost to Follow-up|2|||
129960175|NCT03638258|467817846|FG001|Overall Study|Lost to Follow-up|4|||
129960176|NCT03638258|467817847|FG002|Overall Study|Lost to Follow-up|5|||
129960177|NCT03638258|467817845|FG000|Overall Study|Pregnancy|0|||
129960178|NCT03638258|467817846|FG001|Overall Study|Pregnancy|0|||
129960179|NCT03638258|467817847|FG002|Overall Study|Pregnancy|1|||
129960180|NCT03638258|467817845|FG000|Overall Study|Protocol Violation|0|||
129960181|NCT03638258|467817846|FG001|Overall Study|Protocol Violation|0|||
129960182|NCT03638258|467817847|FG002|Overall Study|Protocol Violation|1|||
129960183|NCT03638258|467817845|FG000|Overall Study|Withdrawal by Subject|4|||
129960184|NCT03638258|467817846|FG001|Overall Study|Withdrawal by Subject|5|||
130085947|NCT00882362|468267454|FG001|Overall Study|Protocol Violation|2|||
129960185|NCT03638258|467817847|FG002|Overall Study|Withdrawal by Subject|12|||
129960186|NCT03638258|467817845|FG000|Overall Study|Lack of Efficacy|0|||
129960187|NCT03638258|467817846|FG001|Overall Study|Lack of Efficacy|0|||
129960188|NCT03638258|467817847|FG002|Overall Study|Lack of Efficacy|2|||
130085948|NCT00882362|468267453|FG000|Overall Study|Pregnancy|1|||
130085949|NCT00882362|468267454|FG001|Overall Study|Pregnancy|0|||
130085950|NCT00882362|468267453|FG000|Overall Study|Physician Decision|5|||
130085951|NCT00882362|468267454|FG001|Overall Study|Physician Decision|1|||
130085952|NCT00882362|468267453|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
130085953|NCT00882362|468267454|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
130085954|NCT00882362|468267453|FG000|Overall Study|change of residence or other commitments|5|||
130085955|NCT00882362|468267454|FG001|Overall Study|change of residence or other commitments|0|||
129960189|NCT02630706|467817848|FG000|Overall Study|Adverse Event|2|||
129960190|NCT02630706|467817849|FG001|Overall Study|Adverse Event|1|||
129960191|NCT02630706|467817850|FG002|Overall Study|Adverse Event|1|||
130085956|NCT01846208|468267455|FG000|Overall Study|Withdrew prior to treatment|1|||
130085957|NCT01846208|468267456|FG001|Overall Study|Withdrew prior to treatment|1|||
130085958|NCT01846208|468267457|FG002|Overall Study|Withdrew prior to treatment|1|||
130085959|NCT01846208|468267455|FG000|Overall Study|Dosing Symptoms|1|||
130085960|NCT01846208|468267456|FG001|Overall Study|Dosing Symptoms|2|||
130085961|NCT01846208|468267457|FG002|Overall Study|Dosing Symptoms|6|||
130085962|NCT01846208|468267455|FG000|Overall Study|Withdrawal by Subject|5|||
130085963|NCT01846208|468267456|FG001|Overall Study|Withdrawal by Subject|0|||
130085964|NCT01846208|468267457|FG002|Overall Study|Withdrawal by Subject|0|||
130085965|NCT01846208|468267455|FG000|Overall Study|Non-compliance|1|||
130085966|NCT01846208|468267456|FG001|Overall Study|Non-compliance|1|||
130085967|NCT01846208|468267457|FG002|Overall Study|Non-compliance|0|||
130085968|NCT01846208|468267455|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
130085969|NCT01846208|468267456|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
130085970|NCT01846208|468267457|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
130085971|NCT01846208|468267455|FG000|Overall Study|Refused SU OFC|0|||
130085972|NCT01846208|468267456|FG001|Overall Study|Refused SU OFC|0|||
130085973|NCT01846208|468267457|FG002|Overall Study|Refused SU OFC|1|||
130085974|NCT01268514|468267458|FG000|Overall Study|Adverse Event|20|||
130085975|NCT01268514|468267458|FG000|Overall Study|Death|8|||
130085976|NCT01268514|468267458|FG000|Overall Study|Lost to Follow-up|5|||
130085977|NCT01268514|468267458|FG000|Overall Study|Withdrawal by Subject|3|||
130085978|NCT01268514|468267458|FG000|Overall Study|Withdrawal by Surgeon|5|||
130085979|NCT01424306|468267459|FG000|Overall Study|Protocol Violation|0|||
130085980|NCT01424306|468267460|FG001|Overall Study|Protocol Violation|0|||
130085981|NCT01424306|468267461|FG002|Overall Study|Protocol Violation|0|||
130085982|NCT01424306|468267462|FG003|Overall Study|Protocol Violation|0|||
130085983|NCT01424306|468267463|FG004|Overall Study|Protocol Violation|1|||
130085984|NCT01424306|468267464|FG005|Overall Study|Protocol Violation|0|||
130085985|NCT03196973|468267472|FG000|Overall Study|Adverse Event|1|||
130085986|NCT03196973|468267473|FG001|Overall Study|Adverse Event|1|||
130085987|NCT03196973|468267474|FG002|Overall Study|Adverse Event|2|||
130085988|NCT03196973|468267472|FG000|Overall Study|Lack of Efficacy|2|||
130085989|NCT03196973|468267473|FG001|Overall Study|Lack of Efficacy|6|||
130085990|NCT03196973|468267474|FG002|Overall Study|Lack of Efficacy|1|||
130085991|NCT03196973|468267472|FG000|Overall Study|Lost to Follow-up|4|||
130085992|NCT03196973|468267473|FG001|Overall Study|Lost to Follow-up|3|||
130085993|NCT03196973|468267474|FG002|Overall Study|Lost to Follow-up|2|||
130085994|NCT03196973|468267472|FG000|Overall Study|Consent withdrawn|2|||
130085995|NCT03196973|468267473|FG001|Overall Study|Consent withdrawn|1|||
130085996|NCT03196973|468267474|FG002|Overall Study|Consent withdrawn|0|||
130085997|NCT03196973|468267472|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
130085998|NCT03196973|468267473|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
130085999|NCT03196973|468267474|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
130086000|NCT01809327|468267475|FG000|Overall Study|Lost to Follow-up|5|||
130086001|NCT01809327|468267476|FG001|Overall Study|Lost to Follow-up|2|||
130086002|NCT01809327|468267477|FG002|Overall Study|Lost to Follow-up|4|||
130086003|NCT01809327|468267478|FG003|Overall Study|Lost to Follow-up|2|||
130086004|NCT01809327|468267479|FG004|Overall Study|Lost to Follow-up|3|||
130086005|NCT01809327|468267475|FG000|Overall Study|Withdrawal by Subject|6|||
130086006|NCT01809327|468267476|FG001|Overall Study|Withdrawal by Subject|4|||
130086007|NCT01809327|468267477|FG002|Overall Study|Withdrawal by Subject|4|||
130086008|NCT01809327|468267478|FG003|Overall Study|Withdrawal by Subject|2|||
130086009|NCT01809327|468267479|FG004|Overall Study|Withdrawal by Subject|5|||
130086010|NCT01809327|468267475|FG000|Overall Study|Adverse Event|4|||
130086011|NCT01809327|468267476|FG001|Overall Study|Adverse Event|3|||
130086012|NCT01809327|468267477|FG002|Overall Study|Adverse Event|7|||
130086013|NCT01809327|468267478|FG003|Overall Study|Adverse Event|4|||
130086014|NCT01809327|468267479|FG004|Overall Study|Adverse Event|8|||
129960192|NCT02630706|467817848|FG000|Overall Study|Lost to Follow-up|0|||
129960193|NCT02630706|467817849|FG001|Overall Study|Lost to Follow-up|1|||
130086015|NCT01809327|468267475|FG000|Overall Study|Death|1|||
130086016|NCT01809327|468267476|FG001|Overall Study|Death|0|||
130086017|NCT01809327|468267477|FG002|Overall Study|Death|0|||
130086018|NCT01809327|468267478|FG003|Overall Study|Death|0|||
130086019|NCT01809327|468267479|FG004|Overall Study|Death|0|||
130086020|NCT01809327|468267475|FG000|Overall Study|Protocol Violation|0|||
130086021|NCT01809327|468267476|FG001|Overall Study|Protocol Violation|1|||
130086022|NCT01809327|468267477|FG002|Overall Study|Protocol Violation|0|||
129960194|NCT02630706|467817850|FG002|Overall Study|Lost to Follow-up|2|||
130086023|NCT01809327|468267478|FG003|Overall Study|Protocol Violation|0|||
129960195|NCT02630706|467817848|FG000|Overall Study|Physician Decision|1|||
129960196|NCT02630706|467817849|FG001|Overall Study|Physician Decision|1|||
130086024|NCT01809327|468267479|FG004|Overall Study|Protocol Violation|0|||
130086025|NCT01809327|468267475|FG000|Overall Study|Physician Decision|1|||
130086026|NCT01809327|468267476|FG001|Overall Study|Physician Decision|1|||
130086027|NCT01809327|468267477|FG002|Overall Study|Physician Decision|0|||
129960197|NCT02630706|467817850|FG002|Overall Study|Physician Decision|0|||
129960198|NCT02630706|467817848|FG000|Overall Study|Pregnancy|0|||
129960199|NCT02630706|467817849|FG001|Overall Study|Pregnancy|1|||
129960200|NCT02630706|467817850|FG002|Overall Study|Pregnancy|0|||
129960201|NCT02630706|467817848|FG000|Overall Study|Withdrawal by Subject|4|||
129960202|NCT02630706|467817849|FG001|Overall Study|Withdrawal by Subject|5|||
129960203|NCT02630706|467817850|FG002|Overall Study|Withdrawal by Subject|7|||
129960204|NCT01527500|467817853|FG000|Part A|Administrative|11|||
129960205|NCT01527500|467817854|FG001|Part A|Administrative|7|||
129960206|NCT01527500|467817853|FG000|Part A|Adverse Event|4|||
129960207|NCT01527500|467817854|FG001|Part A|Adverse Event|2|||
129960208|NCT01527500|467817853|FG000|Part A|Death|4|||
129960209|NCT01527500|467817854|FG001|Part A|Death|1|||
129960210|NCT01527500|467817853|FG000|Part A|Lost to Follow-up|0|||
129960211|NCT01527500|467817854|FG001|Part A|Lost to Follow-up|1|||
129960212|NCT01527500|467817853|FG000|Part A|Protocol Deviation|9|||
129960213|NCT01527500|467817854|FG001|Part A|Protocol Deviation|2|||
129960214|NCT01527500|467817853|FG000|Part A|Withdrawal by Subject|2|||
129960215|NCT01527500|467817854|FG001|Part A|Withdrawal by Subject|0|||
129960216|NCT01527500|467817853|FG000|Part B|Adverse Event|1|||
129960217|NCT01527500|467817854|FG001|Part B|Adverse Event|0|||
129960218|NCT03078751|467817862|FG000|Overall Study|Adverse Event|4|||
129960219|NCT03078751|467817863|FG001|Overall Study|Adverse Event|0|||
129960220|NCT03078751|467817862|FG000|Overall Study|Physician Decision|1|||
129960221|NCT03078751|467817863|FG001|Overall Study|Physician Decision|0|||
129960222|NCT03078751|467817862|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
129960223|NCT03078751|467817863|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
129960224|NCT03078751|467817862|FG000|Overall Study|Subject/guardian decision|8|||
129960225|NCT03078751|467817863|FG001|Overall Study|Subject/guardian decision|1|||
129960226|NCT03078751|467817862|FG000|Overall Study|Untreated|0|||
129960227|NCT03078751|467817863|FG001|Overall Study|Untreated|4|||
129960228|NCT00607789|467817864|FG000|Overall Study|Adverse Event|3|||
129960229|NCT00607789|467817865|FG001|Overall Study|Adverse Event|0|||
129960230|NCT00607789|467817864|FG000|Overall Study|Lack of Efficacy|0|||
129960231|NCT00607789|467817865|FG001|Overall Study|Lack of Efficacy|1|||
129960232|NCT00607789|467817864|FG000|Overall Study|Inadequate adherence|3|||
129960233|NCT00607789|467817865|FG001|Overall Study|Inadequate adherence|0|||
129960234|NCT00607789|467817864|FG000|Overall Study|Lost to Follow-up|0|||
129960235|NCT00607789|467817865|FG001|Overall Study|Lost to Follow-up|5|||
129960236|NCT00607789|467817864|FG000|Overall Study|Withdrawal by Subject|1|||
129960237|NCT00607789|467817865|FG001|Overall Study|Withdrawal by Subject|0|||
129960238|NCT01209286|467817866|FG000|Overall Study|Adverse Event|4|||
129960239|NCT01209286|467817867|FG001|Overall Study|Adverse Event|3|||
129960240|NCT01209286|467817868|FG002|Overall Study|Adverse Event|1|||
129960241|NCT01209286|467817866|FG000|Overall Study|Hematological Relapse After Remission|0|||
129960242|NCT01209286|467817867|FG001|Overall Study|Hematological Relapse After Remission|1|||
129960243|NCT01209286|467817868|FG002|Overall Study|Hematological Relapse After Remission|1|||
129960244|NCT01209286|467817866|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
129960245|NCT01209286|467817867|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
129960246|NCT01209286|467817868|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
129960247|NCT01209286|467817866|FG000|Overall Study|Physician Decision|0|||
129960248|NCT01209286|467817867|FG001|Overall Study|Physician Decision|2|||
129960249|NCT01209286|467817868|FG002|Overall Study|Physician Decision|0|||
129960250|NCT01209286|467817866|FG000|Overall Study|Other|0|||
129960251|NCT01209286|467817867|FG001|Overall Study|Other|1|||
129960252|NCT01209286|467817868|FG002|Overall Study|Other|0|||
129960253|NCT03915951|467817869|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
129960254|NCT03915951|467817870|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
129960255|NCT03915951|467817869|FG000|Overall Study|Adverse Event|12|||
129960256|NCT03915951|467817870|FG001|Overall Study|Adverse Event|6|||
129960257|NCT03915951|467817869|FG000|Overall Study|Disease progression (radiological)|17|||
129960258|NCT03915951|467817870|FG001|Overall Study|Disease progression (radiological)|15|||
129960259|NCT03915951|467817869|FG000|Overall Study|Disease progression (clinical)|4|||
129960260|NCT03915951|467817870|FG001|Overall Study|Disease progression (clinical)|1|||
129960261|NCT03915951|467817869|FG000|Overall Study|Patient decision|0|||
129960262|NCT03915951|467817870|FG001|Overall Study|Patient decision|4|||
129960263|NCT03915951|467817869|FG000|Overall Study|Investigator decision|0|||
129960264|NCT03915951|467817870|FG001|Overall Study|Investigator decision|1|||
129960265|NCT03915951|467817869|FG000|Overall Study|Consent withdrawn|1|||
129960266|NCT03915951|467817870|FG001|Overall Study|Consent withdrawn|1|||
129960267|NCT03915951|467817869|FG000|Overall Study|Death|0|||
129960268|NCT03915951|467817870|FG001|Overall Study|Death|3|||
129960269|NCT01121185|467817874|FG000|Overall Study|Not infused|0|||
129960270|NCT01121185|467817875|FG001|Overall Study|Not infused|1|||
129960271|NCT01121185|467817874|FG000|Overall Study|Not transplanted|1|||
129960272|NCT01121185|467817875|FG001|Overall Study|Not transplanted|0|||
129960273|NCT01196741|467817876|FG000|Overall Study|Disease progression|34|||
129960274|NCT01196741|467817877|FG001|Overall Study|Disease progression|14|||
130086028|NCT01809327|468267478|FG003|Overall Study|Physician Decision|0|||
130086029|NCT01809327|468267479|FG004|Overall Study|Physician Decision|0|||
130086030|NCT01809327|468267475|FG000|Overall Study|Pregnancy|1|||
130086031|NCT01809327|468267476|FG001|Overall Study|Pregnancy|0|||
130086032|NCT01809327|468267477|FG002|Overall Study|Pregnancy|0|||
130086033|NCT01809327|468267478|FG003|Overall Study|Pregnancy|0|||
130086034|NCT01809327|468267479|FG004|Overall Study|Pregnancy|0|||
130086035|NCT01809327|468267475|FG000|Overall Study|Other|14|||
130086036|NCT01809327|468267476|FG001|Overall Study|Other|15|||
130086037|NCT01809327|468267477|FG002|Overall Study|Other|7|||
130086038|NCT01809327|468267478|FG003|Overall Study|Other|4|||
130086039|NCT01809327|468267479|FG004|Overall Study|Other|9|||
130086040|NCT03344562|468267480|FG000|Overall Study|Withdrawal by Subject|2|||
130086041|NCT03344562|468267481|FG001|Overall Study|Withdrawal by Subject|0|||
130086042|NCT02390362|468267495|FG000|Overall Study|Withdrawal by Subject|0|||
130086043|NCT02390362|468267496|FG001|Overall Study|Withdrawal by Subject|1|||
130086044|NCT04009824|468267497|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
130086045|NCT04009824|468267498|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
130086046|NCT04009824|468267499|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
130086047|NCT04009824|468267500|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
130086048|NCT04009824|468267501|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
130086049|NCT01024946|468267502|FG000|Overall Study|Screen Failure|3|||
130086050|NCT01024946|468267502|FG000|Overall Study|Withdrawal by Subject|1|||
130086051|NCT01024946|468267502|FG000|Overall Study|Adverse Event|1|||
130086052|NCT02274766|468267503|FG000|Overall Study|Withdrawal by Subject|3|||
130086053|NCT02274766|468267504|FG001|Overall Study|Withdrawal by Subject|6|||
130086054|NCT02274766|468267503|FG000|Overall Study|Did Not Receive Study Drug|1|||
130086055|NCT02274766|468267504|FG001|Overall Study|Did Not Receive Study Drug|1|||
130086056|NCT02274766|468267503|FG000|Overall Study|Subject Unwilling to Proceed|0|||
130086057|NCT02274766|468267504|FG001|Overall Study|Subject Unwilling to Proceed|1|||
130086058|NCT02274766|468267503|FG000|Overall Study|Adverse Event|0|||
130086059|NCT02274766|468267504|FG001|Overall Study|Adverse Event|1|||
130086060|NCT03032523|468267505|FG000|Overall Study|Withdrawal by Subject|2|||
130086061|NCT03032523|468267506|FG001|Overall Study|Withdrawal by Subject|2|||
130086062|NCT03032523|468267505|FG000|Overall Study|Physician Decision|1|||
130086063|NCT03032523|468267506|FG001|Overall Study|Physician Decision|0|||
130086064|NCT00984009|468267509|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
130086065|NCT00281528|468267510|FG000|Overall Study|Progressive Disease|28|||
130086066|NCT00281528|468267511|FG001|Overall Study|Progressive Disease|18|||
130086067|NCT00281528|468267512|FG002|Overall Study|Progressive Disease|27|||
130086068|NCT00281528|468267510|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
130086069|NCT00281528|468267511|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
130086070|NCT00281528|468267512|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
130086071|NCT00281528|468267510|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
130086072|NCT00281528|468267511|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
130086073|NCT00281528|468267512|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
130086074|NCT00281528|468267510|FG000|Overall Study|Physician Decision|11|||
130086075|NCT00281528|468267511|FG001|Overall Study|Physician Decision|4|||
130086076|NCT00281528|468267512|FG002|Overall Study|Physician Decision|5|||
130086077|NCT00281528|468267510|FG000|Overall Study|Protocol Violation|1|||
130086078|NCT00281528|468267511|FG001|Overall Study|Protocol Violation|0|||
130086079|NCT00281528|468267512|FG002|Overall Study|Protocol Violation|1|||
130086080|NCT00281528|468267510|FG000|Overall Study|Withdrawal by Subject|5|||
130086081|NCT00281528|468267511|FG001|Overall Study|Withdrawal by Subject|5|||
130121332|NCT00770315|468404958|FG001|Overall Study|Noncompliance with Protocol|4|||
130086082|NCT00281528|468267512|FG002|Overall Study|Withdrawal by Subject|7|||
130086083|NCT00281528|468267510|FG000|Overall Study|Other|6|||
130086084|NCT00281528|468267511|FG001|Overall Study|Other|3|||
130086085|NCT00281528|468267512|FG002|Overall Study|Other|5|||
130086086|NCT02036476|468267524|FG000|Overall Study|Withdrawal by Subject|2|||
130086087|NCT02036476|468267524|FG000|Overall Study|Progressive Disease|4|||
130086088|NCT02036476|468267524|FG000|Overall Study|Unacceptable Toxicity|2|||
130086089|NCT02168816|468267525|FG000|Overall Study|Lost to Follow-up|2|||
130086090|NCT02168816|468267526|FG001|Overall Study|Lost to Follow-up|2|||
130086091|NCT00424463|468267527|FG000|Overall Study|Adverse Event|2|||
130086092|NCT00424463|468267528|FG001|Overall Study|Adverse Event|3|||
130086093|NCT00424463|468267529|FG002|Overall Study|Adverse Event|2|||
130121333|NCT00770315|468404959|FG002|Overall Study|Noncompliance with Protocol|7|||
130086094|NCT00424463|468267527|FG000|Overall Study|Physician Decision|0|||
130086095|NCT00424463|468267528|FG001|Overall Study|Physician Decision|2|||
130086096|NCT00424463|468267529|FG002|Overall Study|Physician Decision|2|||
130086097|NCT00424463|468267527|FG000|Overall Study|Withdrawal by Subject|4|||
130086098|NCT00424463|468267528|FG001|Overall Study|Withdrawal by Subject|2|||
130086099|NCT00424463|468267529|FG002|Overall Study|Withdrawal by Subject|5|||
130086100|NCT00424463|468267527|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
130086101|NCT00424463|468267528|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
130086102|NCT00424463|468267529|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
130086103|NCT00424463|468267527|FG000|Overall Study|Patient's convenience|0|||
130086104|NCT00424463|468267528|FG001|Overall Study|Patient's convenience|0|||
130086105|NCT00424463|468267529|FG002|Overall Study|Patient's convenience|1|||
130086106|NCT01436357|468267530|FG000|Overall Study|Death|5|||
130086107|NCT01436357|468267531|FG001|Overall Study|Death|1|||
130086108|NCT01436357|468267530|FG000|Overall Study|Enrolled but not vaccinated|1|||
130086109|NCT01436357|468267531|FG001|Overall Study|Enrolled but not vaccinated|1|||
130086110|NCT01436357|468267530|FG000|Overall Study|Incarceration|18|||
130086111|NCT01436357|468267531|FG001|Overall Study|Incarceration|20|||
130086112|NCT01436357|468267530|FG000|Overall Study|Lost to Follow-up|67|||
130086113|NCT01436357|468267531|FG001|Overall Study|Lost to Follow-up|61|||
130086114|NCT01436357|468267530|FG000|Overall Study|Protocol Violation|1|||
130086115|NCT01436357|468267531|FG001|Overall Study|Protocol Violation|0|||
130086116|NCT01436357|468267530|FG000|Overall Study|Withdrawal by Subject|26|||
130086117|NCT01436357|468267531|FG001|Overall Study|Withdrawal by Subject|38|||
130086118|NCT01436357|468267530|FG000|Overall Study|Physician Decision|3|||
130086119|NCT01436357|468267531|FG001|Overall Study|Physician Decision|4|||
130086120|NCT01436357|468267530|FG000|Overall Study|Moved out of area|1|||
130086121|NCT01436357|468267531|FG001|Overall Study|Moved out of area|2|||
130086122|NCT01436357|468267530|FG000|Overall Study|Subject in rehab|0|||
130086123|NCT01436357|468267531|FG001|Overall Study|Subject in rehab|1|||
130086124|NCT00656799|468267532|FG000|Overall Study|Death|2|||
130086125|NCT05281094|468267533|FG000|Overall Study|Adverse Event|1|||
130086126|NCT05281094|468267534|FG001|Overall Study|Adverse Event|0|||
130086127|NCT05281094|468267533|FG000|Overall Study|Lost to Follow-up|29|||
130086128|NCT05281094|468267534|FG001|Overall Study|Lost to Follow-up|22|||
130086129|NCT05281094|468267533|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
130086130|NCT05281094|468267534|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
130086131|NCT05281094|468267533|FG000|Overall Study|Death|1|||
130086132|NCT05281094|468267534|FG001|Overall Study|Death|2|||
130086133|NCT05281094|468267533|FG000|Overall Study|Not pre-specified reason|8|||
130086134|NCT05281094|468267534|FG001|Overall Study|Not pre-specified reason|5|||
130086135|NCT03053180|468269606|FG000|Overall Study|Failure to Return|1|||
130086136|NCT02583399|468269607|FG000|Overall Study|Able to be discharged|3|||
130086137|NCT02583399|468269607|FG000|Overall Study|Wanted to use a restricted medication|3|||
130086138|NCT00364611|468269608|FG000|Overall Study|Did not receive study medication|0|||
130086139|NCT00364611|468269609|FG001|Overall Study|Did not receive study medication|1|||
130086140|NCT00364611|468269608|FG000|Overall Study|Adverse Event|7|||
130086141|NCT00364611|468269609|FG001|Overall Study|Adverse Event|4|||
130086142|NCT00364611|468269608|FG000|Overall Study|Participant's Request|3|||
130086143|NCT00364611|468269609|FG001|Overall Study|Participant's Request|4|||
130086144|NCT00364611|468269608|FG000|Overall Study|Disease Progression|38|||
130086145|NCT00364611|468269609|FG001|Overall Study|Disease Progression|8|||
130086146|NCT00364611|468269608|FG000|Overall Study|Investigator decision|2|||
130086147|NCT00364611|468269609|FG001|Overall Study|Investigator decision|2|||
130086148|NCT00364611|468269608|FG000|Overall Study|Found Ineligible|1|||
130086149|NCT00364611|468269609|FG001|Overall Study|Found Ineligible|0|||
130086150|NCT00364611|468269608|FG000|Overall Study|Presumed CR on Study|0|||
130086151|NCT00364611|468269609|FG001|Overall Study|Presumed CR on Study|1|||
130086152|NCT00364611|468269608|FG000|Overall Study|Receiving Liver Ablation|0|||
130086153|NCT00364611|468269609|FG001|Overall Study|Receiving Liver Ablation|1|||
130086154|NCT02759939|468269614|FG000|Overall Study|Missing data on first outcome assessed|11|||
130086155|NCT02759939|468269615|FG001|Overall Study|Missing data on first outcome assessed|2|||
130086156|NCT02759939|468269616|FG002|Overall Study|Missing data on first outcome assessed|5|||
130086157|NCT02759939|468269617|FG003|Overall Study|Missing data on first outcome assessed|2|||
130086158|NCT02759939|468269614|FG000|Overall Study|Ineligible for T2 and T3|310|||
130086159|NCT02759939|468269615|FG001|Overall Study|Ineligible for T2 and T3|179|||
130086160|NCT02759939|468269616|FG002|Overall Study|Ineligible for T2 and T3|366|||
130086161|NCT02759939|468269617|FG003|Overall Study|Ineligible for T2 and T3|391|||
130086162|NCT02759939|468269614|FG000|Overall Study|Lost to Follow-up|735|||
130086163|NCT02759939|468269615|FG001|Overall Study|Lost to Follow-up|791|||
130086164|NCT02759939|468269616|FG002|Overall Study|Lost to Follow-up|783|||
130086165|NCT02759939|468269617|FG003|Overall Study|Lost to Follow-up|650|||
130086166|NCT04397757|468269619|FG000|Overall Study|Death|3|||
130086167|NCT04397757|468269620|FG001|Overall Study|Death|11|||
130086168|NCT04397757|468269619|FG000|Overall Study|Withdrawal by Subject|2|||
130086169|NCT04397757|468269620|FG001|Overall Study|Withdrawal by Subject|0|||
130086170|NCT04397757|468269619|FG000|Overall Study|Lost to Follow-up|4|||
130086171|NCT04397757|468269620|FG001|Overall Study|Lost to Follow-up|3|||
130086172|NCT00535236|468269625|FG000|Overall Study|Adverse Event|1|||
130086173|NCT00535236|468269626|FG001|Overall Study|Adverse Event|0|||
130086174|NCT00535236|468269627|FG002|Overall Study|Adverse Event|9|||
130086175|NCT00535236|468269628|FG003|Overall Study|Adverse Event|3|||
130086176|NCT00535236|468269629|FG004|Overall Study|Adverse Event|3|||
130086177|NCT00535236|468269630|FG005|Overall Study|Adverse Event|0|||
130086178|NCT00535236|468269631|FG006|Overall Study|Adverse Event|5|||
130086179|NCT00535236|468269632|FG007|Overall Study|Adverse Event|1|||
130086180|NCT00535236|468269633|FG008|Overall Study|Adverse Event|2|||
130086181|NCT00535236|468269634|FG009|Overall Study|Adverse Event|1|||
130086182|NCT00535236|468269625|FG000|Overall Study|Lost to Follow-up|1|||
130086183|NCT00535236|468269626|FG001|Overall Study|Lost to Follow-up|2|||
130086184|NCT00535236|468269627|FG002|Overall Study|Lost to Follow-up|0|||
130086185|NCT00535236|468269628|FG003|Overall Study|Lost to Follow-up|0|||
130086186|NCT00535236|468269629|FG004|Overall Study|Lost to Follow-up|2|||
130086187|NCT00535236|468269630|FG005|Overall Study|Lost to Follow-up|0|||
130086188|NCT00535236|468269631|FG006|Overall Study|Lost to Follow-up|0|||
130086189|NCT00535236|468269632|FG007|Overall Study|Lost to Follow-up|0|||
130086190|NCT00535236|468269633|FG008|Overall Study|Lost to Follow-up|6|||
130086191|NCT00535236|468269634|FG009|Overall Study|Lost to Follow-up|1|||
130086192|NCT00535236|468269625|FG000|Overall Study|Physician Decision|0|||
130086193|NCT00535236|468269626|FG001|Overall Study|Physician Decision|0|||
130086194|NCT00535236|468269627|FG002|Overall Study|Physician Decision|0|||
130086195|NCT00535236|468269628|FG003|Overall Study|Physician Decision|0|||
130086196|NCT00535236|468269629|FG004|Overall Study|Physician Decision|1|||
130086197|NCT00535236|468269630|FG005|Overall Study|Physician Decision|0|||
130086198|NCT00535236|468269631|FG006|Overall Study|Physician Decision|1|||
130086199|NCT00535236|468269632|FG007|Overall Study|Physician Decision|0|||
130086200|NCT00535236|468269633|FG008|Overall Study|Physician Decision|0|||
130086201|NCT00535236|468269634|FG009|Overall Study|Physician Decision|0|||
130086202|NCT00535236|468269625|FG000|Overall Study|Protocol Violation|2|||
130086203|NCT00535236|468269626|FG001|Overall Study|Protocol Violation|0|||
130086204|NCT00535236|468269627|FG002|Overall Study|Protocol Violation|1|||
130086205|NCT00535236|468269628|FG003|Overall Study|Protocol Violation|0|||
130086206|NCT00535236|468269629|FG004|Overall Study|Protocol Violation|0|||
130086207|NCT00535236|468269630|FG005|Overall Study|Protocol Violation|0|||
130086208|NCT00535236|468269631|FG006|Overall Study|Protocol Violation|0|||
130086209|NCT00535236|468269632|FG007|Overall Study|Protocol Violation|0|||
130086210|NCT00535236|468269633|FG008|Overall Study|Protocol Violation|1|||
130086211|NCT00535236|468269634|FG009|Overall Study|Protocol Violation|0|||
130086212|NCT00535236|468269625|FG000|Overall Study|Withdrawal by Subject|3|||
130086213|NCT00535236|468269626|FG001|Overall Study|Withdrawal by Subject|0|||
130086214|NCT00535236|468269627|FG002|Overall Study|Withdrawal by Subject|2|||
130086215|NCT00535236|468269628|FG003|Overall Study|Withdrawal by Subject|1|||
130086216|NCT00535236|468269629|FG004|Overall Study|Withdrawal by Subject|6|||
130086217|NCT00535236|468269630|FG005|Overall Study|Withdrawal by Subject|1|||
130086218|NCT00535236|468269631|FG006|Overall Study|Withdrawal by Subject|5|||
130086219|NCT00535236|468269632|FG007|Overall Study|Withdrawal by Subject|0|||
130086220|NCT00535236|468269633|FG008|Overall Study|Withdrawal by Subject|4|||
130086221|NCT00535236|468269634|FG009|Overall Study|Withdrawal by Subject|2|||
130086222|NCT03288987|468269636|FG000|Overall Study|Protocol Violation|10|||
130086223|NCT03288987|468269637|FG001|Overall Study|Protocol Violation|4|||
130086224|NCT04905563|468269640|FG000|Overall Study|Withdrawal by Subject|1|||
130086225|NCT04905563|468269641|FG001|Overall Study|Withdrawal by Subject|0|||
130086226|NCT04905563|468269640|FG000|Overall Study|Standard of care orders entered by resident|1|||
130086227|NCT04905563|468269641|FG001|Overall Study|Standard of care orders entered by resident|0|||
130086228|NCT04905563|468269640|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
130086229|NCT04905563|468269641|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
130086230|NCT04905563|468269640|FG000|Overall Study|Withdrawal by Subject|0|||
130086231|NCT04905563|468269641|FG001|Overall Study|Withdrawal by Subject|1|||
130086232|NCT02447952|468269645|FG000|Overall Study|Adverse Event|2|||
130086233|NCT02447952|468269645|FG000|Overall Study|Physician Decision|1|||
130086234|NCT02447952|468269645|FG000|Overall Study|Withdrawal by Subject|4|||
130086235|NCT04554394|468269646|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
129960275|NCT01196741|467817876|FG000|Overall Study|Adverse Event|10|||
129960276|NCT01196741|467817877|FG001|Overall Study|Adverse Event|6|||
130086236|NCT04554394|468269647|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
130086237|NCT04554394|468269646|FG000|Overall Study|Withdrawal by Subject|2|||
130086238|NCT04554394|468269647|FG001|Overall Study|Withdrawal by Subject|2|||
130086239|NCT04554394|468269646|FG000|Overall Study|Lost to Follow-up|2|||
130086240|NCT04554394|468269647|FG001|Overall Study|Lost to Follow-up|2|||
130086241|NCT04554394|468269646|FG000|Overall Study|Physician Decision|1|||
130086242|NCT04554394|468269647|FG001|Overall Study|Physician Decision|1|||
130086243|NCT02584660|468269651|FG000|Overall Study|Adverse Event|4|||
130086244|NCT02584660|468269652|FG001|Overall Study|Adverse Event|0|||
130086245|NCT02584660|468269651|FG000|Overall Study|Lost to Follow-up|3|||
130086246|NCT02584660|468269652|FG001|Overall Study|Lost to Follow-up|4|||
130086247|NCT02584660|468269651|FG000|Overall Study|Protocol Violation|0|||
130086248|NCT02584660|468269652|FG001|Overall Study|Protocol Violation|1|||
130086249|NCT02584660|468269651|FG000|Overall Study|Withdrawal by Subject|0|||
130086250|NCT02584660|468269652|FG001|Overall Study|Withdrawal by Subject|2|||
130086251|NCT02584660|468269651|FG000|Overall Study|Other|0|||
130086252|NCT02584660|468269652|FG001|Overall Study|Other|1|||
130086253|NCT03099304|468269655|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
130086254|NCT03099304|468269656|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
130086255|NCT03099304|468269657|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
130086256|NCT03099304|468269658|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
130086257|NCT03099304|468269659|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
130086258|NCT03099304|468269660|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
130086259|NCT03099304|468269655|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
130086260|NCT03099304|468269656|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
130086261|NCT03099304|468269657|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130086262|NCT03099304|468269658|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130086263|NCT03099304|468269659|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130086264|NCT03099304|468269660|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
130086265|NCT03099304|468269655|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
130086266|NCT03099304|468269656|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
130086267|NCT03099304|468269657|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
130086268|NCT03099304|468269658|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
130086269|NCT03099304|468269659|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
130086270|NCT03099304|468269660|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
130086271|NCT03099304|468269655|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
130086272|NCT03099304|468269656|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
130086273|NCT03099304|468269657|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
130086274|NCT03099304|468269658|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
130086275|NCT03099304|468269659|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
130086276|NCT03099304|468269660|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
130086277|NCT03099304|468269655|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130086278|NCT03099304|468269656|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130086279|NCT03099304|468269657|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
130086280|NCT03099304|468269658|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
130086281|NCT03099304|468269659|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130086282|NCT03099304|468269660|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
130086283|NCT03099304|468269655|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130086284|NCT03099304|468269656|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130086285|NCT03099304|468269657|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
130086286|NCT03099304|468269658|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130086287|NCT03099304|468269659|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130086288|NCT03099304|468269660|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
130086289|NCT03099304|468269655|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
130086290|NCT03099304|468269656|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
130086291|NCT03099304|468269657|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
130086292|NCT03099304|468269658|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
130086293|NCT03099304|468269659|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
130086294|NCT03099304|468269660|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
130086295|NCT03099304|468269655|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
130086296|NCT03099304|468269656|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
130086297|NCT03099304|468269657|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
130086298|NCT03099304|468269658|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
130086299|NCT03099304|468269659|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
130086300|NCT03099304|468269660|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
130086301|NCT03099304|468269655|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130086302|NCT03099304|468269656|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130086303|NCT03099304|468269657|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130086304|NCT03099304|468269658|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
130086305|NCT03099304|468269659|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
130086306|NCT03099304|468269660|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
130086307|NCT03099304|468269655|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
130086308|NCT03099304|468269656|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
130086309|NCT03099304|468269657|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
130086310|NCT03099304|468269658|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
130086311|NCT03099304|468269659|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
130086312|NCT03099304|468269660|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
130086313|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
130086314|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
130086315|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
130086316|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
130121334|NCT00770315|468404960|FG003|Overall Study|Noncompliance with Protocol|9|||
130121335|NCT02683187|468404961|FG000|Overall Study|Failed IV access|3|||
130086317|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
130086318|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
130086319|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
130086320|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
130086321|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
130086322|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
130086323|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
130086324|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
129960277|NCT01196741|467817876|FG000|Overall Study|Serious Adverse Event|3|||
129960278|NCT01196741|467817877|FG001|Overall Study|Serious Adverse Event|1|||
129960279|NCT01196741|467817876|FG000|Overall Study|Dose limiting Adverse Event|2|||
129960280|NCT01196741|467817877|FG001|Overall Study|Dose limiting Adverse Event|1|||
129960281|NCT01196741|467817876|FG000|Overall Study|Withdrawal by Subject|3|||
129960282|NCT01196741|467817877|FG001|Overall Study|Withdrawal by Subject|0|||
129960283|NCT01196741|467817876|FG000|Overall Study|Other reason|3|||
129960284|NCT01196741|467817877|FG001|Overall Study|Other reason|3|||
129960285|NCT01196741|467817876|FG000|Overall Study|Other|3|||
129960286|NCT01196741|467817877|FG001|Overall Study|Other|2|||
129960287|NCT01196741|467817876|FG000|Overall Study|Protocol Violation|2|||
129960288|NCT01196741|467817877|FG001|Overall Study|Protocol Violation|1|||
129960289|NCT01064856|467817879|FG000|Double-blind (DB) Period|Adverse Event|1|||
129960290|NCT01064856|467817880|FG001|Double-blind (DB) Period|Adverse Event|0|||
129960291|NCT01064856|467817881|FG002|Double-blind (DB) Period|Adverse Event|0|||
129960292|NCT01064856|467817882|FG003|Double-blind (DB) Period|Adverse Event|0|||
129960293|NCT01064856|467817879|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
129960294|NCT01064856|467817880|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
129960295|NCT01064856|467817881|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
129960296|NCT01064856|467817882|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
129960297|NCT01064856|467817879|FG000|Open-label (OL) Period|Adverse Event|0|||
129960298|NCT01064856|467817880|FG001|Open-label (OL) Period|Adverse Event|0|||
129960299|NCT01064856|467817881|FG002|Open-label (OL) Period|Adverse Event|12|||
129960300|NCT01064856|467817882|FG003|Open-label (OL) Period|Adverse Event|6|||
129960301|NCT01064856|467817879|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
129960302|NCT01064856|467817880|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
129960303|NCT01064856|467817881|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
129960304|NCT01064856|467817882|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
129960305|NCT01064856|467817879|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
129960306|NCT01064856|467817880|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
129960307|NCT01064856|467817881|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
129960308|NCT01064856|467817882|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
129960309|NCT01064856|467817879|FG000|Open-label (OL) Period|Other|0|||
129960310|NCT01064856|467817880|FG001|Open-label (OL) Period|Other|0|||
129960311|NCT01064856|467817881|FG002|Open-label (OL) Period|Other|7|||
129960312|NCT01064856|467817882|FG003|Open-label (OL) Period|Other|7|||
129960313|NCT01204775|467817885|FG000|Overall Study|Poor/non-compliance|0|||
129960314|NCT01204775|467817886|FG001|Overall Study|Poor/non-compliance|1|||
129960315|NCT01204775|467817885|FG000|Overall Study|Withdrawal by Subject|1|||
129960316|NCT01204775|467817886|FG001|Overall Study|Withdrawal by Subject|0|||
129960317|NCT02273180|467817887|FG000|Overall Study|Adverse Event|2|||
129960318|NCT02273180|467817888|FG001|Overall Study|Adverse Event|2|||
129960319|NCT02273180|467817887|FG000|Overall Study|Lack of Efficacy|1|||
129960320|NCT02273180|467817888|FG001|Overall Study|Lack of Efficacy|0|||
129960321|NCT02273180|467817887|FG000|Overall Study|Protocol Violation|1|||
129960322|NCT02273180|467817888|FG001|Overall Study|Protocol Violation|7|||
129960323|NCT02273180|467817887|FG000|Overall Study|Randomized but not treated|1|||
129960324|NCT02273180|467817888|FG001|Overall Study|Randomized but not treated|0|||
129960325|NCT02273180|467817887|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
129960326|NCT02273180|467817888|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
129960327|NCT02273180|467817887|FG000|Overall Study|Other than specified above|21|||
129960328|NCT02273180|467817888|FG001|Overall Study|Other than specified above|10|||
129960329|NCT00509925|467817889|FG000|Overall Study|Personal reasons|0|||
129960330|NCT00509925|467817890|FG001|Overall Study|Personal reasons|1|||
129960331|NCT03749616|467817893|FG000|Overall Study|Lost to Follow-up|4|||
129960332|NCT03749616|467817894|FG001|Overall Study|Lost to Follow-up|7|||
129960333|NCT03749616|467817893|FG000|Overall Study|Screen Failure|1|||
129960334|NCT03749616|467817894|FG001|Overall Study|Screen Failure|1|||
129960335|NCT03749616|467817893|FG000|Overall Study|Withdrawal by Subject|2|||
129960336|NCT03749616|467817894|FG001|Overall Study|Withdrawal by Subject|0|||
129960337|NCT04435522|467817897|FG000|Overall Study|Withdrawal by Subject|2|||
129960338|NCT03302559|467817898|FG000|Overall Study|Adverse Event|2|||
129960339|NCT03302559|467817898|FG000|Overall Study|Lost to Follow-up|1|||
129960340|NCT03302559|467817898|FG000|Overall Study|Withdrew Consent|3|||
129960341|NCT00951171|467817899|FG000|Overall Study|Adverse Event|2|||
129960342|NCT00951171|467817900|FG001|Overall Study|Adverse Event|0|||
129960343|NCT00919061|467817901|FG000|Overall Study|Adverse Event|1|||
129960344|NCT00919061|467817901|FG000|Overall Study|Withdrawal by Subject|1|||
129960345|NCT04130061|467817904|FG000|Overall Study|OR team forgot to request membrane|1|||
129960346|NCT04130061|467817905|FG001|Overall Study|OR team forgot to request membrane|0|||
129960347|NCT05294328|467817912|FG000|Overall Study|Adverse Event|1|||
129960348|NCT05294328|467817913|FG001|Overall Study|Adverse Event|0|||
129960349|NCT05294328|467817914|FG002|Overall Study|Adverse Event|0|||
130086325|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
129960350|NCT05294328|467817912|FG000|Overall Study|Physician Decision|1|||
129960351|NCT05294328|467817913|FG001|Overall Study|Physician Decision|1|||
130086326|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
130086327|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
130086328|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
130086329|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
130086330|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
130086331|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
130086332|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
130086333|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
130086334|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
130086335|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
130086336|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
130086337|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
130086338|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
130086339|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
130086340|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
130086341|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
130086342|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
130086343|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
130086344|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
130086345|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
130086346|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
130086347|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
130086348|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
130086349|NCT03099304|468269655|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
130086350|NCT03099304|468269656|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
130086351|NCT03099304|468269657|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
130086352|NCT03099304|468269658|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
130086353|NCT03099304|468269659|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
130086354|NCT03099304|468269660|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
130086355|NCT00715949|468269664|FG000|Overall Study|could not finish first test|4|||
130086356|NCT01142791|468269676|FG000|Overall Study|Alternative Treatment|1|||
130086357|NCT01142791|468269677|FG001|Overall Study|Alternative Treatment|0|||
130086358|NCT01142791|468269676|FG000|Overall Study|Lost to Follow-up|1|||
130086359|NCT01142791|468269677|FG001|Overall Study|Lost to Follow-up|0|||
130086360|NCT01142791|468269676|FG000|Overall Study|Withdrawal by Subject|5|||
130086361|NCT01142791|468269677|FG001|Overall Study|Withdrawal by Subject|0|||
130086362|NCT01142791|468269676|FG000|Overall Study|Received only 1 sonication|0|||
130086363|NCT01142791|468269677|FG001|Overall Study|Received only 1 sonication|6|||
130086364|NCT02608892|468269678|FG000|Overall Study|Lost to Follow-up|1|||
130086365|NCT02608892|468269679|FG001|Overall Study|Lost to Follow-up|0|||
130086366|NCT02590406|468269680|FG000|Overall Study|Adverse Event|1|||
130086367|NCT02590406|468269681|FG001|Overall Study|Adverse Event|0|||
130086368|NCT02590406|468269680|FG000|Overall Study|Saturometer malfunction|0|||
130086369|NCT02590406|468269681|FG001|Overall Study|Saturometer malfunction|1|||
130086370|NCT00957723|468269682|FG000|Overall Study|Death|3|||
130086371|NCT00957723|468269682|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
130086372|NCT00957723|468269682|FG000|Overall Study|Lost to Follow-up|8|||
130086373|NCT00957723|468269682|FG000|Overall Study|Withdrawal by Subject|24|||
130086374|NCT00957723|468269682|FG000|Overall Study|Investigative Site Terminated|61|||
130086375|NCT00957723|468269682|FG000|Overall Study|Intercurrent Illness|2|||
130086376|NCT00957723|468269682|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
130086377|NCT05375838|468269683|FG000|Overall Study|Other|0|||
130086378|NCT05375838|468269684|FG001|Overall Study|Other|0|||
130086379|NCT05375838|468269685|FG002|Overall Study|Other|0|||
130086380|NCT05375838|468269686|FG003|Overall Study|Other|1|||
130086381|NCT05375838|468269687|FG004|Overall Study|Other|1|||
130086382|NCT05375838|468269688|FG005|Overall Study|Other|0|||
130086383|NCT05375838|468269683|FG000|Overall Study|Withdrawal by Subject|2|||
130086384|NCT05375838|468269684|FG001|Overall Study|Withdrawal by Subject|1|||
130086385|NCT05375838|468269685|FG002|Overall Study|Withdrawal by Subject|3|||
130086386|NCT05375838|468269686|FG003|Overall Study|Withdrawal by Subject|2|||
130086387|NCT05375838|468269687|FG004|Overall Study|Withdrawal by Subject|2|||
130086388|NCT05375838|468269688|FG005|Overall Study|Withdrawal by Subject|0|||
130086389|NCT05375838|468269683|FG000|Overall Study|Protocol Violation|0|||
130086390|NCT05375838|468269684|FG001|Overall Study|Protocol Violation|0|||
130086391|NCT05375838|468269685|FG002|Overall Study|Protocol Violation|0|||
130086392|NCT05375838|468269686|FG003|Overall Study|Protocol Violation|0|||
130086393|NCT05375838|468269687|FG004|Overall Study|Protocol Violation|1|||
130086394|NCT05375838|468269688|FG005|Overall Study|Protocol Violation|0|||
130086395|NCT05375838|468269683|FG000|Overall Study|Physician Decision|0|||
130086396|NCT05375838|468269684|FG001|Overall Study|Physician Decision|1|||
130086397|NCT05375838|468269685|FG002|Overall Study|Physician Decision|0|||
130086398|NCT05375838|468269686|FG003|Overall Study|Physician Decision|0|||
130086399|NCT05375838|468269687|FG004|Overall Study|Physician Decision|0|||
130086400|NCT05375838|468269688|FG005|Overall Study|Physician Decision|1|||
130086401|NCT05375838|468269683|FG000|Overall Study|Lost to Follow-up|2|||
130086402|NCT05375838|468269684|FG001|Overall Study|Lost to Follow-up|7|||
130086403|NCT05375838|468269685|FG002|Overall Study|Lost to Follow-up|0|||
130086404|NCT05375838|468269686|FG003|Overall Study|Lost to Follow-up|4|||
130086405|NCT05375838|468269687|FG004|Overall Study|Lost to Follow-up|2|||
130086406|NCT05375838|468269688|FG005|Overall Study|Lost to Follow-up|3|||
130086407|NCT01984294|468269691|FG000|Overall Study|Randomized but Never Treated|0|||
130086408|NCT01984294|468269692|FG001|Overall Study|Randomized but Never Treated|0|||
130086409|NCT01984294|468269693|FG002|Overall Study|Randomized but Never Treated|1|||
130086410|NCT01984294|468269691|FG000|Overall Study|Lack of Efficacy|4|||
130086411|NCT01984294|468269692|FG001|Overall Study|Lack of Efficacy|2|||
130086412|NCT01984294|468269693|FG002|Overall Study|Lack of Efficacy|6|||
130086413|NCT01984294|468269691|FG000|Overall Study|Adverse Event|0|||
130086414|NCT01984294|468269692|FG001|Overall Study|Adverse Event|1|||
130086415|NCT01984294|468269693|FG002|Overall Study|Adverse Event|0|||
130086416|NCT02993783|468269696|FG000|Overall Study|Reason not Specified|6|||
130086417|NCT02993783|468269697|FG001|Overall Study|Reason not Specified|9|||
130086418|NCT01987609|468269701|FG000|Overall Study|Adverse Event|1|||
130086419|NCT02610231|468269702|FG000|Overall Study|Withdrawal by Subject|27|||
130086420|NCT02610231|468269702|FG000|Overall Study|Adverse Event|20|||
130086421|NCT02610231|468269702|FG000|Overall Study|Death|5|||
130086422|NCT02610231|468269702|FG000|Overall Study|Surgery|2|||
130086423|NCT02610231|468269702|FG000|Overall Study|Physician Decision|1|||
130086424|NCT02610231|468269702|FG000|Overall Study|Non Compliance|2|||
130086425|NCT02610231|468269702|FG000|Overall Study|Other|3|||
130086426|NCT00806494|468269703|FG000|Overall Study|Adverse Event|29|||
130086427|NCT00806494|468269703|FG000|Overall Study|Lack of Efficacy|6|||
130086428|NCT00806494|468269703|FG000|Overall Study|Lost to Follow-up|10|||
130086429|NCT00806494|468269703|FG000|Overall Study|Other|30|||
130086430|NCT00806494|468269703|FG000|Overall Study|Withdrawal by Subject|5|||
130086431|NCT01279954|468269704|FG000|Overall Study|Lack of Efficacy|3|||
130086432|NCT01279954|468269705|FG001|Overall Study|Lack of Efficacy|4|||
130086433|NCT02709889|468269706|FG000|Overall Study|Withdrawal by Subject|11|||
130086434|NCT02709889|468269707|FG001|Overall Study|Withdrawal by Subject|10|||
130086435|NCT02709889|468269708|FG002|Overall Study|Withdrawal by Subject|2|||
130086436|NCT02709889|468269709|FG003|Overall Study|Withdrawal by Subject|12|||
130086437|NCT02709889|468269706|FG000|Overall Study|Death|25|||
130086438|NCT02709889|468269707|FG001|Overall Study|Death|38|||
130086439|NCT02709889|468269708|FG002|Overall Study|Death|4|||
130086440|NCT02709889|468269709|FG003|Overall Study|Death|44|||
130086441|NCT02709889|468269706|FG000|Overall Study|Physician Decision|1|||
130086442|NCT02709889|468269707|FG001|Overall Study|Physician Decision|2|||
130086443|NCT02709889|468269708|FG002|Overall Study|Physician Decision|3|||
130086444|NCT02709889|468269709|FG003|Overall Study|Physician Decision|5|||
130086445|NCT02709889|468269706|FG000|Overall Study|Lost to Follow-up|2|||
130086446|NCT02709889|468269707|FG001|Overall Study|Lost to Follow-up|0|||
130086447|NCT02709889|468269708|FG002|Overall Study|Lost to Follow-up|0|||
130086448|NCT02709889|468269709|FG003|Overall Study|Lost to Follow-up|4|||
130086449|NCT02709889|468269706|FG000|Overall Study|Study Terminated by Sponsor|4|||
130086450|NCT02709889|468269707|FG001|Overall Study|Study Terminated by Sponsor|6|||
130086451|NCT02709889|468269708|FG002|Overall Study|Study Terminated by Sponsor|2|||
130086452|NCT02709889|468269709|FG003|Overall Study|Study Terminated by Sponsor|17|||
130086453|NCT02709889|468269706|FG000|Overall Study|Other, Not Specified|0|||
130086454|NCT02709889|468269707|FG001|Overall Study|Other, Not Specified|1|||
130086455|NCT02709889|468269708|FG002|Overall Study|Other, Not Specified|1|||
130086456|NCT02709889|468269709|FG003|Overall Study|Other, Not Specified|6|||
130086457|NCT00537810|468269710|FG000|Overall Study|Withdrawal by Subject|4|||
130086458|NCT00537810|468269711|FG001|Overall Study|Withdrawal by Subject|11|||
130086459|NCT00537810|468269712|FG002|Overall Study|Withdrawal by Subject|4|||
130086460|NCT00537810|468269713|FG003|Overall Study|Withdrawal by Subject|3|||
130086461|NCT00537810|468269710|FG000|Overall Study|Medically withdrawn|2|||
130086462|NCT00537810|468269711|FG001|Overall Study|Medically withdrawn|2|||
130086463|NCT00537810|468269712|FG002|Overall Study|Medically withdrawn|0|||
130086464|NCT00537810|468269713|FG003|Overall Study|Medically withdrawn|1|||
130086465|NCT01066546|468269714|FG000|Overall Study|Study terminated by sponsor|5|||
130086466|NCT03258762|468269723|FG000|Overall Study|Lost to Follow-up|0|||
130086467|NCT03258762|468269724|FG001|Overall Study|Lost to Follow-up|1|||
130086468|NCT01711359|468269725|FG000|Treatment Period|Withdrawal by Subject|18|||
130086469|NCT01711359|468269726|FG001|Treatment Period|Withdrawal by Subject|7|||
130086470|NCT01711359|468269727|FG002|Treatment Period|Withdrawal by Subject|13|||
130086471|NCT01711359|468269725|FG000|Treatment Period|Lack of Efficacy|13|||
130086472|NCT01711359|468269726|FG001|Treatment Period|Lack of Efficacy|2|||
130086473|NCT01711359|468269727|FG002|Treatment Period|Lack of Efficacy|2|||
130086474|NCT01711359|468269725|FG000|Treatment Period|Adverse Event|8|||
130086475|NCT01711359|468269726|FG001|Treatment Period|Adverse Event|10|||
130086476|NCT01711359|468269727|FG002|Treatment Period|Adverse Event|24|||
130086477|NCT01711359|468269725|FG000|Treatment Period|Physician Decision|4|||
130086478|NCT01711359|468269726|FG001|Treatment Period|Physician Decision|3|||
130086479|NCT01711359|468269727|FG002|Treatment Period|Physician Decision|2|||
130086480|NCT01711359|468269725|FG000|Treatment Period|Death|3|||
130086481|NCT01711359|468269726|FG001|Treatment Period|Death|0|||
130086482|NCT01711359|468269727|FG002|Treatment Period|Death|0|||
130086483|NCT01711359|468269725|FG000|Treatment Period|Entry Criteria Not Met|1|||
130086484|NCT01711359|468269726|FG001|Treatment Period|Entry Criteria Not Met|0|||
130086485|NCT01711359|468269727|FG002|Treatment Period|Entry Criteria Not Met|0|||
130086486|NCT01711359|468269725|FG000|Treatment Period|Sponsor Decision|1|||
130086487|NCT01711359|468269726|FG001|Treatment Period|Sponsor Decision|0|||
130086488|NCT01711359|468269727|FG002|Treatment Period|Sponsor Decision|0|||
130086489|NCT01711359|468269725|FG000|Treatment Period|Lost to Follow-up|1|||
130086490|NCT01711359|468269726|FG001|Treatment Period|Lost to Follow-up|1|||
130086491|NCT01711359|468269727|FG002|Treatment Period|Lost to Follow-up|1|||
130086492|NCT01711359|468269725|FG000|Treatment Period|Randomized, Not Treated|3|||
130086493|NCT01711359|468269726|FG001|Treatment Period|Randomized, Not Treated|1|||
130086494|NCT01711359|468269727|FG002|Treatment Period|Randomized, Not Treated|0|||
130086495|NCT00554840|468269728|FG000|Overall Study|Physician Decision|0|||
130086496|NCT00554840|468269729|FG001|Overall Study|Physician Decision|1|||
130086497|NCT01385098|468269730|FG000|Overall Study|Adverse Event|10|||
130086498|NCT01385098|468269730|FG000|Overall Study|Lost to Follow-up|4|||
130086499|NCT02698176|468269731|FG000|Overall Study|Progressive disease|4|||
130086500|NCT02698176|468269732|FG001|Overall Study|Progressive disease|3|||
130086501|NCT02698176|468269733|FG002|Overall Study|Progressive disease|1|||
130086502|NCT02698176|468269734|FG003|Overall Study|Progressive disease|0|||
130086503|NCT02698176|468269731|FG000|Overall Study|Adverse Event|2|||
130086504|NCT02698176|468269732|FG001|Overall Study|Adverse Event|0|||
130086505|NCT02698176|468269733|FG002|Overall Study|Adverse Event|0|||
130086506|NCT02698176|468269734|FG003|Overall Study|Adverse Event|0|||
130086507|NCT02698176|468269731|FG000|Overall Study|Clinical progression|3|||
130086508|NCT02698176|468269732|FG001|Overall Study|Clinical progression|0|||
130086509|NCT02698176|468269733|FG002|Overall Study|Clinical progression|0|||
130086510|NCT02698176|468269734|FG003|Overall Study|Clinical progression|0|||
130086511|NCT00925522|468269735|FG000|Overall Study|study closed -- business decision|20|||
130086512|NCT02561572|468269742|FG000|Overall Study|Inadequate time before surgery|2|||
130086513|NCT02561572|468269743|FG001|Overall Study|Inadequate time before surgery|1|||
130086514|NCT02561572|468269742|FG000|Overall Study|Protocol Violation|0|||
130086515|NCT02561572|468269743|FG001|Overall Study|Protocol Violation|1|||
130086516|NCT00795717|468269744|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
130086517|NCT00795717|468269745|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
130086518|NCT00795717|468269744|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
130086519|NCT00795717|468269745|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
130086520|NCT00795717|468269744|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
130086521|NCT00795717|468269745|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
130086522|NCT00795717|468269744|FG000|Phase II|too busy|0|||
130086523|NCT00795717|468269745|FG001|Phase II|too busy|1|||
130086524|NCT00410514|468269748|FG000|Overall Study|Adverse Event|2|||
130086525|NCT00410514|468269749|FG001|Overall Study|Adverse Event|2|||
130086526|NCT00410514|468269750|FG002|Overall Study|Adverse Event|2|||
130086527|NCT00410514|468269748|FG000|Overall Study|Protocol Violation|0|||
130086528|NCT00410514|468269749|FG001|Overall Study|Protocol Violation|1|||
130086529|NCT00410514|468269750|FG002|Overall Study|Protocol Violation|1|||
130086530|NCT00410514|468269748|FG000|Overall Study|Lost to Follow-up|0|||
130086531|NCT00410514|468269749|FG001|Overall Study|Lost to Follow-up|0|||
130086532|NCT00410514|468269750|FG002|Overall Study|Lost to Follow-up|2|||
130086533|NCT00410514|468269748|FG000|Overall Study|Non-compliant with study procedures|0|||
130086534|NCT00410514|468269749|FG001|Overall Study|Non-compliant with study procedures|0|||
130086535|NCT00410514|468269750|FG002|Overall Study|Non-compliant with study procedures|2|||
130086536|NCT02985684|468269754|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
130086537|NCT02985684|468269754|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
130086538|NCT02985684|468269754|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
130086539|NCT00631969|468269760|FG000|Overall Study|Adverse Event|3|||
130086540|NCT00631969|468269761|FG001|Overall Study|Adverse Event|1|||
130086541|NCT00631969|468269760|FG000|Overall Study|Lack of Efficacy|2|||
130086542|NCT00631969|468269761|FG001|Overall Study|Lack of Efficacy|8|||
130086543|NCT00631969|468269760|FG000|Overall Study|Lost to Follow-up|2|||
130086544|NCT00631969|468269761|FG001|Overall Study|Lost to Follow-up|1|||
130086545|NCT00631969|468269760|FG000|Overall Study|Protocol Violation|1|||
130086546|NCT00631969|468269761|FG001|Overall Study|Protocol Violation|1|||
130086547|NCT00631969|468269760|FG000|Overall Study|Consent Withdrawn|5|||
130086548|NCT00631969|468269761|FG001|Overall Study|Consent Withdrawn|7|||
130086549|NCT00631969|468269760|FG000|Overall Study|Noncompliant With Study Medication|0|||
130086550|NCT00631969|468269761|FG001|Overall Study|Noncompliant With Study Medication|1|||
130086551|NCT00631969|468269760|FG000|Overall Study|No Drug Exposure|2|||
130086552|NCT00631969|468269761|FG001|Overall Study|No Drug Exposure|2|||
130086553|NCT05315297|468269762|FG000|Overall Study|Lost to Follow-up|6|||
130086554|NCT05315297|468269763|FG001|Overall Study|Lost to Follow-up|4|||
130086555|NCT05315297|468269762|FG000|Overall Study|Withdrawal by Subject|0|||
130086556|NCT05315297|468269763|FG001|Overall Study|Withdrawal by Subject|1|||
130086557|NCT04144140|468271504|FG000|Overall Study|Other|0|||
130086558|NCT04144140|468271505|FG001|Overall Study|Other|0|||
130086559|NCT04144140|468271506|FG002|Overall Study|Other|0|||
130086560|NCT04144140|468271507|FG003|Overall Study|Other|0|||
129960352|NCT05294328|467817914|FG002|Overall Study|Physician Decision|0|||
129960353|NCT05294328|467817912|FG000|Overall Study|Withdrawal by Subject|0|||
129960354|NCT05294328|467817913|FG001|Overall Study|Withdrawal by Subject|2|||
129960355|NCT05294328|467817914|FG002|Overall Study|Withdrawal by Subject|1|||
129960356|NCT05294328|467817912|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
129960357|NCT05294328|467817913|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
129960358|NCT05294328|467817914|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
129960359|NCT02056873|467817915|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
129960360|NCT00113269|467819483|FG000|Overall Study|Not transplanted, donor issues|4|||
129960361|NCT00113269|467819484|FG001|Overall Study|Not transplanted, donor issues|0|||
129960362|NCT00113269|467819485|FG002|Overall Study|Not transplanted, donor issues|2|||
129960363|NCT00113269|467819486|FG003|Overall Study|Not transplanted, donor issues|2|||
129960364|NCT00113269|467819483|FG000|Overall Study|Not transplanted, recipient issues|2|||
129960365|NCT00113269|467819484|FG001|Overall Study|Not transplanted, recipient issues|1|||
129960366|NCT00113269|467819485|FG002|Overall Study|Not transplanted, recipient issues|7|||
129960367|NCT00113269|467819486|FG003|Overall Study|Not transplanted, recipient issues|4|||
129960368|NCT00113269|467819483|FG000|Overall Study|Early graft loss, technical|0|||
129960369|NCT00113269|467819484|FG001|Overall Study|Early graft loss, technical|0|||
129960370|NCT00113269|467819485|FG002|Overall Study|Early graft loss, technical|2|||
129960371|NCT00113269|467819486|FG003|Overall Study|Early graft loss, technical|0|||
129960372|NCT00113269|467819483|FG000|Overall Study|Death in operating room|0|||
129960373|NCT00113269|467819484|FG001|Overall Study|Death in operating room|0|||
129960374|NCT00113269|467819485|FG002|Overall Study|Death in operating room|0|||
129960375|NCT00113269|467819486|FG003|Overall Study|Death in operating room|1|||
129960376|NCT00113269|467819483|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
129960377|NCT00113269|467819484|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
129960378|NCT00113269|467819485|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
129960379|NCT00113269|467819486|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
129960380|NCT00113269|467819483|FG000|Overall Study|Adverse Event|2|||
129960381|NCT00113269|467819484|FG001|Overall Study|Adverse Event|7|||
129960382|NCT00113269|467819485|FG002|Overall Study|Adverse Event|11|||
129960383|NCT00113269|467819486|FG003|Overall Study|Adverse Event|7|||
129960384|NCT00113269|467819483|FG000|Overall Study|Withdrawal by Subject|4|||
129960385|NCT00113269|467819484|FG001|Overall Study|Withdrawal by Subject|3|||
129960386|NCT00113269|467819485|FG002|Overall Study|Withdrawal by Subject|4|||
129960387|NCT00113269|467819486|FG003|Overall Study|Withdrawal by Subject|2|||
129960388|NCT00113269|467819483|FG000|Overall Study|Graft loss|6|||
129960389|NCT00113269|467819484|FG001|Overall Study|Graft loss|6|||
129960390|NCT00113269|467819485|FG002|Overall Study|Graft loss|4|||
129960391|NCT00113269|467819486|FG003|Overall Study|Graft loss|9|||
129960392|NCT00113269|467819483|FG000|Overall Study|Protocol Violation|1|||
129960393|NCT00113269|467819484|FG001|Overall Study|Protocol Violation|0|||
129960394|NCT00113269|467819485|FG002|Overall Study|Protocol Violation|4|||
129960395|NCT00113269|467819486|FG003|Overall Study|Protocol Violation|2|||
129960396|NCT00113269|467819483|FG000|Overall Study|Lost to Follow-up|2|||
129960397|NCT00113269|467819484|FG001|Overall Study|Lost to Follow-up|3|||
129960398|NCT00113269|467819485|FG002|Overall Study|Lost to Follow-up|6|||
129960399|NCT00113269|467819486|FG003|Overall Study|Lost to Follow-up|3|||
129960400|NCT00113269|467819483|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
129960401|NCT00113269|467819484|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
129960402|NCT00113269|467819485|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
129960403|NCT00113269|467819486|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
129960404|NCT00113269|467819483|FG000|Overall Study|Discontinued due to rejection|0|||
129960405|NCT00113269|467819484|FG001|Overall Study|Discontinued due to rejection|0|||
129960406|NCT00113269|467819485|FG002|Overall Study|Discontinued due to rejection|1|||
129960407|NCT00113269|467819486|FG003|Overall Study|Discontinued due to rejection|0|||
129960408|NCT00113269|467819483|FG000|Overall Study|Moved|0|||
129960409|NCT00113269|467819484|FG001|Overall Study|Moved|1|||
129960410|NCT00113269|467819485|FG002|Overall Study|Moved|0|||
129960411|NCT00113269|467819486|FG003|Overall Study|Moved|3|||
129960412|NCT00113269|467819483|FG000|Overall Study|Received pancreas transplant|0|||
130086561|NCT04144140|468271508|FG004|Overall Study|Other|0|||
130086562|NCT04144140|468271509|FG005|Overall Study|Other|1|||
130086563|NCT04144140|468271510|FG006|Overall Study|Other|0|||
129960413|NCT00113269|467819484|FG001|Overall Study|Received pancreas transplant|0|||
129960414|NCT00113269|467819485|FG002|Overall Study|Received pancreas transplant|0|||
130086564|NCT01465958|468271511|FG000|Run-in Phase|Protocol Violation|1|||
130086565|NCT01465958|468271512|FG001|Run-in Phase|Protocol Violation|0|||
130086566|NCT01465958|468271511|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
130086567|NCT01465958|468271512|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
130086568|NCT00669240|468271521|FG000|Overall Study|Lack of Efficacy|33|||
130086569|NCT00669240|468271521|FG000|Overall Study|Withdrawal by Subject|42|||
130086570|NCT00669240|468271521|FG000|Overall Study|Lost to Follow-up|34|||
130086571|NCT00669240|468271521|FG000|Overall Study|Adverse Event|21|||
130086572|NCT00669240|468271521|FG000|Overall Study|Other|19|||
130086573|NCT00669240|468271521|FG000|Overall Study|Enrolled but not treated|15|||
130086574|NCT00669240|468271521|FG000|Overall Study|Enrolled but no dosing record|1|||
130086575|NCT00959192|468271526|FG000|Overall Study|Adverse Event|1|||
130086576|NCT00959192|468271527|FG001|Overall Study|Adverse Event|1|||
130086577|NCT00959192|468271528|FG002|Overall Study|Adverse Event|1|||
130086578|NCT00959192|468271529|FG003|Overall Study|Adverse Event|0|||
130086579|NCT00959192|468271526|FG000|Overall Study|Investigator Request|1|||
130086580|NCT00959192|468271527|FG001|Overall Study|Investigator Request|0|||
130086581|NCT00959192|468271528|FG002|Overall Study|Investigator Request|0|||
130086582|NCT00959192|468271529|FG003|Overall Study|Investigator Request|0|||
130086583|NCT00959192|468271526|FG000|Overall Study|Caregiver Request|0|||
130086584|NCT00959192|468271527|FG001|Overall Study|Caregiver Request|0|||
130086585|NCT00959192|468271528|FG002|Overall Study|Caregiver Request|2|||
130086586|NCT00959192|468271529|FG003|Overall Study|Caregiver Request|1|||
130086587|NCT00532441|468271530|FG000|Overall Study|Death|1|||
130086588|NCT00532441|468271531|FG001|Overall Study|Death|0|||
130086589|NCT01967134|468271532|FG000|Overall Study|Lost to Follow-up|0|||
130086590|NCT01967134|468271533|FG001|Overall Study|Lost to Follow-up|1|||
130086591|NCT01967134|468271534|FG002|Overall Study|Lost to Follow-up|0|||
130086592|NCT00443534|468271535|FG000|Overall Study|Lack of Efficacy|67|||
130086593|NCT00443534|468271535|FG000|Overall Study|Adverse Event|16|||
130086594|NCT00443534|468271535|FG000|Overall Study|Death|9|||
130086595|NCT00443534|468271535|FG000|Overall Study|Withdrawal by Subject|8|||
130086596|NCT00443534|468271535|FG000|Overall Study|Study Terminated by Sponsor|12|||
130086597|NCT00443534|468271535|FG000|Overall Study|Other|10|||
130086598|NCT00443534|468271535|FG000|Overall Study|Enrolled, Not Treated|1|||
130086599|NCT05466240|468271537|FG000|Overall Study|Adverse Event|1|||
130086600|NCT05466240|468271538|FG001|Overall Study|Adverse Event|0|||
130086601|NCT05466240|468271537|FG000|Overall Study|Withdrawal by Subject|1|||
130086602|NCT05466240|468271538|FG001|Overall Study|Withdrawal by Subject|0|||
130086603|NCT00305773|468271539|FG000|Overall Study|Death|3|||
130086604|NCT00305773|468271540|FG001|Overall Study|Death|2|||
130086605|NCT00305773|468271539|FG000|Overall Study|Adverse Event|1|||
130086606|NCT00305773|468271540|FG001|Overall Study|Adverse Event|2|||
130086607|NCT00305773|468271539|FG000|Overall Study|Alternative Treatment|4|||
130086608|NCT00305773|468271540|FG001|Overall Study|Alternative Treatment|4|||
130086609|NCT00305773|468271539|FG000|Overall Study|Physician Decision|1|||
130086610|NCT00305773|468271540|FG001|Overall Study|Physician Decision|1|||
130086611|NCT00305773|468271539|FG000|Overall Study|Withdrawal by Subject|1|||
130086612|NCT00305773|468271540|FG001|Overall Study|Withdrawal by Subject|4|||
130086613|NCT00305773|468271539|FG000|Overall Study|Disease Progression|1|||
130086614|NCT00305773|468271540|FG001|Overall Study|Disease Progression|3|||
130086615|NCT00305773|468271539|FG000|Overall Study|All other reasons|3|||
130086616|NCT00305773|468271540|FG001|Overall Study|All other reasons|2|||
130086617|NCT02679222|468271541|FG000|Overall Study|No time for project|1|||
130086618|NCT04097925|468271542|FG000|Overall Study|Withdrawal by Subject|1|||
130086619|NCT04735432|468271546|FG000|Overall Study|Other - due to personal reason|1|||
130086620|NCT04735432|468271547|FG001|Overall Study|Other - due to personal reason|0|||
130086621|NCT04735432|468271546|FG000|Overall Study|Adverse Event|2|||
130086622|NCT04735432|468271547|FG001|Overall Study|Adverse Event|0|||
130086623|NCT00626327|468271552|FG000|Overall Study|Withdrawal by Subject|21|||
130086624|NCT00626327|468271553|FG001|Overall Study|Withdrawal by Subject|29|||
130086625|NCT00626327|468271554|FG002|Overall Study|Withdrawal by Subject|30|||
130086626|NCT00626327|468271552|FG000|Overall Study|Adverse Event|1|||
129960415|NCT00113269|467819486|FG003|Overall Study|Received pancreas transplant|2|||
129960416|NCT00113269|467819483|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
130086627|NCT00626327|468271553|FG001|Overall Study|Adverse Event|0|||
130086628|NCT00626327|468271554|FG002|Overall Study|Adverse Event|0|||
130086629|NCT00626327|468271552|FG000|Overall Study|Lost to Follow-up|24|||
130086630|NCT00626327|468271553|FG001|Overall Study|Lost to Follow-up|21|||
130086631|NCT00626327|468271554|FG002|Overall Study|Lost to Follow-up|23|||
130086632|NCT00626327|468271552|FG000|Overall Study|Inappropriate enrollment|4|||
130086633|NCT00626327|468271553|FG001|Overall Study|Inappropriate enrollment|5|||
129960417|NCT00113269|467819484|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
130086634|NCT00626327|468271554|FG002|Overall Study|Inappropriate enrollment|3|||
130086635|NCT00626327|468271552|FG000|Overall Study|Administrative Reason|2|||
130086636|NCT00626327|468271553|FG001|Overall Study|Administrative Reason|0|||
130086637|NCT00626327|468271554|FG002|Overall Study|Administrative Reason|6|||
130086638|NCT00626327|468271552|FG000|Overall Study|Protocol Violation|26|||
130086639|NCT00626327|468271553|FG001|Overall Study|Protocol Violation|4|||
130086640|NCT00626327|468271554|FG002|Overall Study|Protocol Violation|26|||
130086641|NCT01823991|468271555|FG000|Overall Study|Withdrawal by Subject|8|||
129960418|NCT00113269|467819485|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
129960419|NCT00113269|467819486|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
129960420|NCT00113269|467819483|FG000|Overall Study|Did not meet eligibility criteria|1|||
129960421|NCT00113269|467819484|FG001|Overall Study|Did not meet eligibility criteria|0|||
129960422|NCT00113269|467819485|FG002|Overall Study|Did not meet eligibility criteria|0|||
129960423|NCT00113269|467819486|FG003|Overall Study|Did not meet eligibility criteria|1|||
129960424|NCT00113269|467819483|FG000|Overall Study|Unable to return for follow up|2|||
129960425|NCT00113269|467819484|FG001|Overall Study|Unable to return for follow up|1|||
129960426|NCT00113269|467819485|FG002|Overall Study|Unable to return for follow up|0|||
129960427|NCT00113269|467819486|FG003|Overall Study|Unable to return for follow up|0|||
129960428|NCT01821729|467819487|FG000|Overall Study|Withdrawal by Subject|1|||
129960429|NCT01093599|467819490|FG000|Overall Study|Lost to Follow-up|32|||
129960430|NCT01093599|467819491|FG001|Overall Study|Lost to Follow-up|46|||
129960431|NCT01703845|467819492|FG000|Overall Study|Adverse Event|1|||
129960432|NCT01703845|467819493|FG001|Overall Study|Adverse Event|0|||
129960433|NCT01703845|467819492|FG000|Overall Study|Protocol Violation|1|||
129960434|NCT01703845|467819493|FG001|Overall Study|Protocol Violation|0|||
129960435|NCT01703845|467819492|FG000|Overall Study|other than stated above|1|||
129960436|NCT01703845|467819493|FG001|Overall Study|other than stated above|0|||
129960437|NCT01644188|467819494|FG000|Overall Study|Adverse Event|44|||
129960438|NCT01644188|467819495|FG001|Overall Study|Adverse Event|20|||
129960439|NCT01644188|467819494|FG000|Overall Study|Poor compliance to protocol|26|||
129960440|NCT01644188|467819495|FG001|Overall Study|Poor compliance to protocol|14|||
129960441|NCT01644188|467819494|FG000|Overall Study|Physician Decision|1|||
129960442|NCT01644188|467819495|FG001|Overall Study|Physician Decision|3|||
129960443|NCT01644188|467819494|FG000|Overall Study|Participant moved|7|||
129960444|NCT01644188|467819495|FG001|Overall Study|Participant moved|2|||
129960445|NCT01644188|467819494|FG000|Overall Study|Related to auto-injector administration|2|||
129960446|NCT01644188|467819495|FG001|Overall Study|Related to auto-injector administration|2|||
129960447|NCT01644188|467819494|FG000|Overall Study|Consent withdrawn by participant|14|||
129960448|NCT01644188|467819495|FG001|Overall Study|Consent withdrawn by participant|7|||
129960449|NCT01644188|467819494|FG000|Overall Study|Selection criteria finally not met|2|||
129960450|NCT01644188|467819495|FG001|Overall Study|Selection criteria finally not met|0|||
129960451|NCT01644188|467819494|FG000|Overall Study|Lost to Follow-up|1|||
129960452|NCT01644188|467819495|FG001|Overall Study|Lost to Follow-up|0|||
129960453|NCT01644188|467819494|FG000|Overall Study|Death|4|||
129960454|NCT01644188|467819495|FG001|Overall Study|Death|3|||
129960455|NCT01644188|467819494|FG000|Overall Study|Last visit outside protocol visit window|14|||
129960456|NCT01644188|467819495|FG001|Overall Study|Last visit outside protocol visit window|16|||
129960457|NCT01644188|467819494|FG000|Overall Study|Site closure|1|||
129960458|NCT01644188|467819495|FG001|Overall Study|Site closure|1|||
129960459|NCT01644188|467819494|FG000|Overall Study|Other than specified above|6|||
129960460|NCT01644188|467819495|FG001|Overall Study|Other than specified above|7|||
129960461|NCT00966979|467819499|FG000|Overall Study|Death|1|||
129960462|NCT00966979|467819499|FG000|Overall Study|Lost to Follow-up|6|||
129960463|NCT00966979|467819499|FG000|Overall Study|Withdrawal by Subject|14|||
129960464|NCT00966979|467819499|FG000|Overall Study|Adverse Event|5|||
129960465|NCT00966979|467819499|FG000|Overall Study|Sponsor terminated early|49|||
129960466|NCT00966979|467819499|FG000|Overall Study|Censored because surgery not done|2|||
129960467|NCT00966979|467819499|FG000|Overall Study|Censored because study device was not implanted|14|||
129960468|NCT00966979|467819499|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
129960469|NCT04140266|467819500|FG000|Overall Study|Physician Decision|2|||
129960470|NCT04140266|467819501|FG001|Overall Study|Physician Decision|0|||
129960471|NCT04140266|467819500|FG000|Overall Study|Withdrawal by Subject|4|||
129960472|NCT04140266|467819501|FG001|Overall Study|Withdrawal by Subject|2|||
129960473|NCT03119688|467819505|FG000|Overall Study|Adverse Event|4|||
129960474|NCT03226106|467819506|FG000|Overall Study|Withdrawal by Subject|2|||
129960475|NCT03226106|467819507|FG001|Overall Study|Withdrawal by Subject|0|||
129960476|NCT03226106|467819506|FG000|Overall Study|Adverse Event|1|||
129960477|NCT03226106|467819507|FG001|Overall Study|Adverse Event|0|||
129960478|NCT03226106|467819506|FG000|Overall Study|Lost to Follow-up|2|||
129960479|NCT03226106|467819507|FG001|Overall Study|Lost to Follow-up|0|||
129960480|NCT00721214|467819508|FG000|Overall Study|Chose another center for transplant|1|||
129960481|NCT00721214|467819508|FG000|Overall Study|Death|3|||
129960482|NCT00488319|467819509|FG000|Overall Study|Adverse Event|1|||
129960483|NCT00488319|467819510|FG001|Overall Study|Adverse Event|2|||
129960484|NCT00488319|467819511|FG002|Overall Study|Adverse Event|23|||
129960485|NCT00488319|467819509|FG000|Overall Study|Lack of Efficacy|6|||
129960486|NCT00488319|467819510|FG001|Overall Study|Lack of Efficacy|12|||
129960487|NCT00488319|467819511|FG002|Overall Study|Lack of Efficacy|27|||
129960488|NCT00488319|467819509|FG000|Overall Study|Lost to Follow-up|3|||
129960489|NCT00488319|467819510|FG001|Overall Study|Lost to Follow-up|5|||
129960490|NCT00488319|467819511|FG002|Overall Study|Lost to Follow-up|16|||
129960491|NCT00488319|467819509|FG000|Overall Study|Withdrawal by Subject|5|||
129960492|NCT00488319|467819510|FG001|Overall Study|Withdrawal by Subject|20|||
129960493|NCT00488319|467819511|FG002|Overall Study|Withdrawal by Subject|44|||
130086642|NCT01823991|468271556|FG001|Overall Study|Withdrawal by Subject|5|||
130086643|NCT05158244|468271557|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
130086644|NCT05158244|468271558|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130086645|NCT05158244|468271559|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130086646|NCT05158244|468271560|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130086647|NCT05158244|468271561|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
130086648|NCT05158244|468271557|FG000|Overall Study|Withdrawal by Subject|0|||
130086649|NCT05158244|468271558|FG001|Overall Study|Withdrawal by Subject|0|||
130086650|NCT05158244|468271559|FG002|Overall Study|Withdrawal by Subject|1|||
130086651|NCT05158244|468271560|FG003|Overall Study|Withdrawal by Subject|0|||
130086652|NCT05158244|468271561|FG004|Overall Study|Withdrawal by Subject|0|||
130086653|NCT01066819|468271563|FG000|Overall Study|Adverse Event|18|||
130086654|NCT01066819|468271564|FG001|Overall Study|Adverse Event|1|||
130086655|NCT01066819|468271565|FG002|Overall Study|Adverse Event|6|||
130086656|NCT01066819|468271566|FG003|Overall Study|Adverse Event|0|||
130086657|NCT01066819|468271567|FG004|Overall Study|Adverse Event|0|||
130086658|NCT01066819|468271568|FG005|Overall Study|Adverse Event|0|||
130086659|NCT01066819|468271563|FG000|Overall Study|Death|5|||
130086660|NCT01066819|468271564|FG001|Overall Study|Death|0|||
130086661|NCT01066819|468271565|FG002|Overall Study|Death|1|||
130086662|NCT01066819|468271566|FG003|Overall Study|Death|0|||
130086663|NCT01066819|468271567|FG004|Overall Study|Death|0|||
130086664|NCT01066819|468271568|FG005|Overall Study|Death|0|||
130086665|NCT01066819|468271563|FG000|Overall Study|Lack of Efficacy|22|||
130086666|NCT01066819|468271564|FG001|Overall Study|Lack of Efficacy|1|||
130086667|NCT01066819|468271565|FG002|Overall Study|Lack of Efficacy|2|||
130086668|NCT01066819|468271566|FG003|Overall Study|Lack of Efficacy|1|||
130086669|NCT01066819|468271567|FG004|Overall Study|Lack of Efficacy|0|||
130086670|NCT01066819|468271568|FG005|Overall Study|Lack of Efficacy|0|||
130086671|NCT01066819|468271563|FG000|Overall Study|Physician Decision|6|||
130086672|NCT01066819|468271564|FG001|Overall Study|Physician Decision|2|||
130086673|NCT01066819|468271565|FG002|Overall Study|Physician Decision|3|||
130086674|NCT01066819|468271566|FG003|Overall Study|Physician Decision|0|||
130086675|NCT01066819|468271567|FG004|Overall Study|Physician Decision|0|||
130086676|NCT01066819|468271568|FG005|Overall Study|Physician Decision|0|||
130086677|NCT01066819|468271563|FG000|Overall Study|Protocol Violation|12|||
130086678|NCT01066819|468271564|FG001|Overall Study|Protocol Violation|6|||
130086679|NCT01066819|468271565|FG002|Overall Study|Protocol Violation|0|||
130086680|NCT01066819|468271566|FG003|Overall Study|Protocol Violation|0|||
130086681|NCT01066819|468271567|FG004|Overall Study|Protocol Violation|0|||
130086682|NCT01066819|468271568|FG005|Overall Study|Protocol Violation|0|||
130086683|NCT01066819|468271563|FG000|Overall Study|Withdrawal by Subject|29|||
130086684|NCT01066819|468271564|FG001|Overall Study|Withdrawal by Subject|11|||
130086685|NCT01066819|468271565|FG002|Overall Study|Withdrawal by Subject|6|||
130086686|NCT01066819|468271566|FG003|Overall Study|Withdrawal by Subject|0|||
130086687|NCT01066819|468271567|FG004|Overall Study|Withdrawal by Subject|0|||
130086688|NCT01066819|468271568|FG005|Overall Study|Withdrawal by Subject|0|||
130086689|NCT01066819|468271563|FG000|Overall Study|Administrative|6|||
130086690|NCT01066819|468271564|FG001|Overall Study|Administrative|4|||
130086691|NCT01066819|468271565|FG002|Overall Study|Administrative|2|||
130086692|NCT01066819|468271566|FG003|Overall Study|Administrative|0|||
130086693|NCT01066819|468271567|FG004|Overall Study|Administrative|0|||
130086694|NCT01066819|468271568|FG005|Overall Study|Administrative|0|||
130086695|NCT01066819|468271563|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
130086696|NCT01066819|468271564|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
130086697|NCT01066819|468271565|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
130086698|NCT01066819|468271566|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
130086699|NCT01066819|468271567|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
130086700|NCT01066819|468271568|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
130086701|NCT01066819|468271563|FG000|Overall Study|Early termination|2|||
130086702|NCT01066819|468271564|FG001|Overall Study|Early termination|0|||
130086703|NCT01066819|468271565|FG002|Overall Study|Early termination|0|||
130086704|NCT01066819|468271566|FG003|Overall Study|Early termination|0|||
130086705|NCT01066819|468271567|FG004|Overall Study|Early termination|0|||
130086706|NCT01066819|468271568|FG005|Overall Study|Early termination|0|||
130086707|NCT01066819|468271563|FG000|Overall Study|Failed to return|298|||
130086708|NCT01066819|468271564|FG001|Overall Study|Failed to return|107|||
130086709|NCT01066819|468271565|FG002|Overall Study|Failed to return|68|||
130086710|NCT01066819|468271566|FG003|Overall Study|Failed to return|7|||
130086711|NCT01066819|468271567|FG004|Overall Study|Failed to return|2|||
130086712|NCT01066819|468271568|FG005|Overall Study|Failed to return|3|||
130086713|NCT01066819|468271563|FG000|Overall Study|Lab test not done|9|||
130086714|NCT01066819|468271564|FG001|Overall Study|Lab test not done|0|||
130086715|NCT01066819|468271565|FG002|Overall Study|Lab test not done|2|||
129960494|NCT00488319|467819509|FG000|Overall Study|Other reasons for withdrawal|0|||
130086716|NCT01066819|468271566|FG003|Overall Study|Lab test not done|1|||
130086717|NCT01066819|468271567|FG004|Overall Study|Lab test not done|0|||
130086718|NCT01066819|468271568|FG005|Overall Study|Lab test not done|0|||
130086719|NCT01066819|468271563|FG000|Overall Study|Miscellaneous|28|||
130086720|NCT01066819|468271564|FG001|Overall Study|Miscellaneous|10|||
130086721|NCT01066819|468271565|FG002|Overall Study|Miscellaneous|18|||
130086722|NCT01066819|468271566|FG003|Overall Study|Miscellaneous|1|||
130086723|NCT01066819|468271567|FG004|Overall Study|Miscellaneous|0|||
130086724|NCT01066819|468271568|FG005|Overall Study|Miscellaneous|0|||
130086725|NCT01066819|468271563|FG000|Overall Study|Non responders|123|||
130086726|NCT01066819|468271564|FG001|Overall Study|Non responders|2|||
130086727|NCT01066819|468271565|FG002|Overall Study|Non responders|7|||
130086728|NCT01066819|468271566|FG003|Overall Study|Non responders|2|||
130086729|NCT01066819|468271567|FG004|Overall Study|Non responders|0|||
130086730|NCT01066819|468271568|FG005|Overall Study|Non responders|1|||
130086731|NCT01066819|468271563|FG000|Overall Study|Not categorised|9|||
130086732|NCT01066819|468271564|FG001|Overall Study|Not categorised|2|||
130086733|NCT01066819|468271565|FG002|Overall Study|Not categorised|6|||
130086734|NCT01066819|468271566|FG003|Overall Study|Not categorised|1|||
130086735|NCT01066819|468271567|FG004|Overall Study|Not categorised|0|||
130086736|NCT01066819|468271568|FG005|Overall Study|Not categorised|0|||
130086737|NCT01066819|468271563|FG000|Overall Study|Relapse|16|||
130086738|NCT01066819|468271564|FG001|Overall Study|Relapse|4|||
130086739|NCT01066819|468271565|FG002|Overall Study|Relapse|3|||
130086740|NCT01066819|468271566|FG003|Overall Study|Relapse|0|||
130086741|NCT01066819|468271567|FG004|Overall Study|Relapse|0|||
130086742|NCT01066819|468271568|FG005|Overall Study|Relapse|0|||
130086743|NCT01066819|468271563|FG000|Overall Study|Results not available|1|||
130086744|NCT01066819|468271564|FG001|Overall Study|Results not available|0|||
130086745|NCT01066819|468271565|FG002|Overall Study|Results not available|0|||
130086746|NCT01066819|468271566|FG003|Overall Study|Results not available|0|||
130086747|NCT01066819|468271567|FG004|Overall Study|Results not available|0|||
130086748|NCT01066819|468271568|FG005|Overall Study|Results not available|0|||
130086749|NCT01066819|468271563|FG000|Overall Study|Screen failure|1|||
130086750|NCT01066819|468271564|FG001|Overall Study|Screen failure|0|||
130086751|NCT01066819|468271565|FG002|Overall Study|Screen failure|0|||
130086752|NCT01066819|468271566|FG003|Overall Study|Screen failure|0|||
130086753|NCT01066819|468271567|FG004|Overall Study|Screen failure|0|||
130086754|NCT01066819|468271568|FG005|Overall Study|Screen failure|0|||
130086755|NCT01066819|468271563|FG000|Overall Study|Spontaneous cure|1|||
130086756|NCT01066819|468271564|FG001|Overall Study|Spontaneous cure|0|||
130086757|NCT01066819|468271565|FG002|Overall Study|Spontaneous cure|0|||
130086758|NCT01066819|468271566|FG003|Overall Study|Spontaneous cure|0|||
130086759|NCT01066819|468271567|FG004|Overall Study|Spontaneous cure|0|||
130086760|NCT01066819|468271568|FG005|Overall Study|Spontaneous cure|0|||
130086761|NCT01066819|468271563|FG000|Overall Study|Treatment never started|85|||
130086762|NCT01066819|468271564|FG001|Overall Study|Treatment never started|19|||
130086763|NCT01066819|468271565|FG002|Overall Study|Treatment never started|19|||
130086764|NCT01066819|468271566|FG003|Overall Study|Treatment never started|3|||
130086765|NCT01066819|468271567|FG004|Overall Study|Treatment never started|2|||
130086766|NCT01066819|468271568|FG005|Overall Study|Treatment never started|2|||
130086767|NCT01066819|468271563|FG000|Overall Study|Treatment stopped|12|||
130086768|NCT01066819|468271564|FG001|Overall Study|Treatment stopped|1|||
130086769|NCT01066819|468271565|FG002|Overall Study|Treatment stopped|2|||
130086770|NCT01066819|468271566|FG003|Overall Study|Treatment stopped|1|||
130086771|NCT01066819|468271567|FG004|Overall Study|Treatment stopped|0|||
130086772|NCT01066819|468271568|FG005|Overall Study|Treatment stopped|0|||
130086773|NCT01066819|468271563|FG000|Overall Study|Other|5|||
130086774|NCT01066819|468271564|FG001|Overall Study|Other|1|||
130086775|NCT01066819|468271565|FG002|Overall Study|Other|1|||
130086776|NCT01066819|468271566|FG003|Overall Study|Other|0|||
129960495|NCT00488319|467819510|FG001|Overall Study|Other reasons for withdrawal|4|||
129960496|NCT00488319|467819511|FG002|Overall Study|Other reasons for withdrawal|12|||
129960497|NCT01649557|467819512|FG000|Overall Study|Lost to Follow-up|5|||
130086777|NCT01066819|468271567|FG004|Overall Study|Other|0|||
130086778|NCT01066819|468271568|FG005|Overall Study|Other|0|||
130086779|NCT00805194|468271569|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
130086780|NCT00805194|468271570|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
130086781|NCT00805194|468271569|FG000|Overall Study|Worsening or AE of underlying disease|64|||
130086782|NCT00805194|468271570|FG001|Overall Study|Worsening or AE of underlying disease|70|||
130086783|NCT00805194|468271569|FG000|Overall Study|Other AE|84|||
130086784|NCT00805194|468271570|FG001|Overall Study|Other AE|73|||
130086785|NCT00805194|468271569|FG000|Overall Study|Protocol Violation|9|||
130086786|NCT00805194|468271570|FG001|Overall Study|Protocol Violation|9|||
130086787|NCT00805194|468271569|FG000|Overall Study|Lost to Follow-up|5|||
130086788|NCT00805194|468271570|FG001|Overall Study|Lost to Follow-up|5|||
130086789|NCT00805194|468271569|FG000|Overall Study|Withdrawal by Subject|60|||
130086790|NCT00805194|468271570|FG001|Overall Study|Withdrawal by Subject|42|||
130086791|NCT00805194|468271569|FG000|Overall Study|Not treated|3|||
130086792|NCT00805194|468271570|FG001|Overall Study|Not treated|4|||
130086793|NCT00805194|468271569|FG000|Overall Study|Reasons other than stated above|20|||
130086794|NCT00805194|468271570|FG001|Overall Study|Reasons other than stated above|16|||
130086795|NCT01051856|468271580|FG000|Overall Study|Withdrawal by Subject|1|||
130086796|NCT01051856|468271581|FG001|Overall Study|Withdrawal by Subject|0|||
130086797|NCT02381795|468271582|FG000|Overall Study|Withdrawal by Subject|1|||
130086798|NCT02381795|468271582|FG000|Overall Study|Study Terminated|2|||
130086799|NCT02176226|468271585|FG000|Overall Study|Lost to Follow-up|3|||
130086800|NCT02176226|468271585|FG000|Overall Study|Withdrew prior to treatment|6|||
130086801|NCT02908841|468271590|FG000|Overall Study|Physician Decision|4|||
130086802|NCT02908841|468271591|FG001|Overall Study|Physician Decision|0|||
130086803|NCT01611558|468271592|FG000|Induction Phase|Study drug toxicity|15|||
130086804|NCT01611558|468271592|FG000|Induction Phase|Disease progression|18|||
130086805|NCT01611558|468271592|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
130086806|NCT01611558|468271592|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
130086807|NCT01611558|468271592|FG000|Induction Phase|Death|1|||
130086808|NCT01611558|468271592|FG000|Maintenance Phase|Withdrawal by Subject|1|||
130086809|NCT01611558|468271592|FG000|Maintenance Phase|Elevated Uric acid|1|||
130086810|NCT01412333|468271599|FG000|Overall Study|Adverse Event|40|||
130086811|NCT01412333|468271600|FG001|Overall Study|Adverse Event|42|||
130086812|NCT01412333|468271599|FG000|Overall Study|Death|5|||
130086813|NCT01412333|468271600|FG001|Overall Study|Death|6|||
130086814|NCT01412333|468271599|FG000|Overall Study|Lack of Efficacy|22|||
130086815|NCT01412333|468271600|FG001|Overall Study|Lack of Efficacy|10|||
130086816|NCT01412333|468271599|FG000|Overall Study|Lost to Follow-up|15|||
130086817|NCT01412333|468271600|FG001|Overall Study|Lost to Follow-up|12|||
130086818|NCT01412333|468271599|FG000|Overall Study|Non-Compliance|3|||
130086819|NCT01412333|468271600|FG001|Overall Study|Non-Compliance|7|||
130086820|NCT01412333|468271599|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130086821|NCT01412333|468271600|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130086822|NCT01412333|468271599|FG000|Overall Study|Other|30|||
130086823|NCT01412333|468271600|FG001|Overall Study|Other|33|||
130086824|NCT01412333|468271599|FG000|Overall Study|Physician Decision|11|||
130086825|NCT01412333|468271600|FG001|Overall Study|Physician Decision|16|||
130086826|NCT01412333|468271599|FG000|Overall Study|Pregnancy|6|||
130086827|NCT01412333|468271600|FG001|Overall Study|Pregnancy|4|||
130086828|NCT01412333|468271599|FG000|Overall Study|Protocol Violation|1|||
130086829|NCT01412333|468271600|FG001|Overall Study|Protocol Violation|2|||
130086830|NCT01412333|468271599|FG000|Overall Study|Study Terminated By Sponsor|3|||
130086831|NCT01412333|468271600|FG001|Overall Study|Study Terminated By Sponsor|2|||
130086832|NCT01412333|468271599|FG000|Overall Study|Withdrawal by Subject|51|||
130086833|NCT01412333|468271600|FG001|Overall Study|Withdrawal by Subject|54|||
130086834|NCT01412333|468271599|FG000|Overall Study|Missing|1|||
130086835|NCT01412333|468271600|FG001|Overall Study|Missing|3|||
130086836|NCT04005885|468271601|FG000|First Intervention|Withdrawal by Subject|1|||
130086837|NCT04005885|468271602|FG001|First Intervention|Withdrawal by Subject|1|||
130086838|NCT04005885|468271601|FG000|Second Intervention|Withdrawal by Subject|0|||
130086839|NCT04005885|468271602|FG001|Second Intervention|Withdrawal by Subject|2|||
130086840|NCT00750867|468271603|FG000|Overall Study|Adverse Event|2|||
130086841|NCT02718625|468271605|FG000|Overall Study|Adverse Event|0|||
130086842|NCT02718625|468271606|FG001|Overall Study|Adverse Event|1|||
130086843|NCT02718625|468271605|FG000|Overall Study|Termination of Study by Sponsor|0|||
130086844|NCT02718625|468271606|FG001|Overall Study|Termination of Study by Sponsor|1|||
130086845|NCT01947127|468271611|FG000|Overall Study|Protocol Violation|18|||
130086846|NCT01947127|468271612|FG001|Overall Study|Protocol Violation|38|||
130086847|NCT01947127|468271611|FG000|Overall Study|Withdrawal by Subject|1|||
130086848|NCT01947127|468271612|FG001|Overall Study|Withdrawal by Subject|1|||
130086849|NCT01947127|468271611|FG000|Overall Study|Data loss|4|||
130086850|NCT01947127|468271612|FG001|Overall Study|Data loss|4|||
130086851|NCT01836549|468271613|FG000|Overall Study|Did not receive study drug|0|||
130086852|NCT01836549|468271614|FG001|Overall Study|Did not receive study drug|0|||
130086853|NCT01836549|468271615|FG002|Overall Study|Did not receive study drug|1|||
130121336|NCT02683187|468404961|FG000|Overall Study|Withdrawal by Subject|5|||
130121337|NCT02585258|468404962|FG000|Overall Study|Adverse Event|28|||
130121338|NCT02585258|468404963|FG001|Overall Study|Adverse Event|29|||
130121339|NCT02585258|468404962|FG000|Overall Study|Death|3|||
130121340|NCT02585258|468404963|FG001|Overall Study|Death|2|||
130121341|NCT02585258|468404962|FG000|Overall Study|Lack of Efficacy|7|||
130121342|NCT02585258|468404963|FG001|Overall Study|Lack of Efficacy|9|||
130086854|NCT01836549|468271616|FG003|Overall Study|Did not receive study drug|0|||
130086855|NCT01836549|468271617|FG004|Overall Study|Did not receive study drug|0|||
130086856|NCT01836549|468271618|FG005|Overall Study|Did not receive study drug|0|||
130086857|NCT01836549|468271619|FG006|Overall Study|Did not receive study drug|0|||
130086858|NCT01836549|468271613|FG000|Overall Study|Patient declared ineligible|0|||
130086859|NCT01836549|468271614|FG001|Overall Study|Patient declared ineligible|0|||
130086860|NCT01836549|468271615|FG002|Overall Study|Patient declared ineligible|0|||
130121343|NCT02585258|468404962|FG000|Overall Study|includes covid-related access problems|42|||
130086861|NCT01836549|468271616|FG003|Overall Study|Patient declared ineligible|1|||
130086862|NCT01836549|468271617|FG004|Overall Study|Patient declared ineligible|0|||
130086863|NCT01836549|468271618|FG005|Overall Study|Patient declared ineligible|0|||
130086864|NCT01836549|468271619|FG006|Overall Study|Patient declared ineligible|0|||
130086865|NCT01836549|468271613|FG000|Overall Study|Patient inevaluable to start therapy|0|||
130086866|NCT01836549|468271614|FG001|Overall Study|Patient inevaluable to start therapy|0|||
130086867|NCT01836549|468271615|FG002|Overall Study|Patient inevaluable to start therapy|0|||
130086868|NCT01836549|468271616|FG003|Overall Study|Patient inevaluable to start therapy|0|||
130086869|NCT01836549|468271617|FG004|Overall Study|Patient inevaluable to start therapy|0|||
130086870|NCT01836549|468271618|FG005|Overall Study|Patient inevaluable to start therapy|0|||
130086871|NCT01836549|468271619|FG006|Overall Study|Patient inevaluable to start therapy|1|||
130086872|NCT04652102|468271620|FG000|Overall Study|Adverse Event|14|||
130086873|NCT04652102|468271621|FG001|Overall Study|Adverse Event|13|||
130086874|NCT04652102|468271620|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
130086875|NCT04652102|468271621|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
130086876|NCT04652102|468271620|FG000|Overall Study|Physician Decision|78|||
130086877|NCT04652102|468271621|FG001|Overall Study|Physician Decision|40|||
130086878|NCT04652102|468271620|FG000|Overall Study|Study Ended by Sponsor|64|||
130086879|NCT04652102|468271621|FG001|Overall Study|Study Ended by Sponsor|17|||
130086880|NCT04652102|468271620|FG000|Overall Study|Withdrawal by Subject|4625|||
130086881|NCT04652102|468271621|FG001|Overall Study|Withdrawal by Subject|5594|||
130086882|NCT04652102|468271620|FG000|Overall Study|Lost to Follow-up|2019|||
130086883|NCT04652102|468271621|FG001|Overall Study|Lost to Follow-up|1082|||
130086884|NCT04652102|468271620|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
130086885|NCT04652102|468271621|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
130086886|NCT04652102|468271620|FG000|Overall Study|Miscellaneous|80|||
130086887|NCT04652102|468271621|FG001|Overall Study|Miscellaneous|64|||
130086888|NCT02516306|468271622|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
130086889|NCT02516306|468271623|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
130086890|NCT01969565|468271626|FG000|Overall Study|Withdrawal by Subject|1|||
130086891|NCT00696774|468271627|FG000|Period II|Adverse Event|0|||
130086892|NCT00696774|468271628|FG001|Period II|Adverse Event|0|||
130086893|NCT00696774|468271629|FG002|Period II|Adverse Event|15|||
130086894|NCT00696774|468271627|FG000|Period II|Lost to Follow-up|0|||
130086895|NCT00696774|468271628|FG001|Period II|Lost to Follow-up|0|||
130086896|NCT00696774|468271629|FG002|Period II|Lost to Follow-up|4|||
130086897|NCT00696774|468271627|FG000|Period II|Protocol Violation|0|||
130086898|NCT00696774|468271628|FG001|Period II|Protocol Violation|0|||
130086899|NCT00696774|468271629|FG002|Period II|Protocol Violation|11|||
130086900|NCT00696774|468271627|FG000|Period II|Withdrawal by Subject|0|||
130086901|NCT00696774|468271628|FG001|Period II|Withdrawal by Subject|0|||
130086902|NCT00696774|468271629|FG002|Period II|Withdrawal by Subject|4|||
130086903|NCT00696774|468271627|FG000|Period II|Sponsor Decision|0|||
130086904|NCT00696774|468271628|FG001|Period II|Sponsor Decision|0|||
130086905|NCT00696774|468271629|FG002|Period II|Sponsor Decision|0|||
130086906|NCT00696774|468271627|FG000|Period II|Lack of Efficacy|0|||
130086907|NCT00696774|468271628|FG001|Period II|Lack of Efficacy|0|||
130086908|NCT00696774|468271629|FG002|Period II|Lack of Efficacy|2|||
130086909|NCT00696774|468271627|FG000|Period III|Adverse Event|1|||
130086910|NCT00696774|468271628|FG001|Period III|Adverse Event|1|||
130086911|NCT00696774|468271629|FG002|Period III|Adverse Event|0|||
130086912|NCT00696774|468271627|FG000|Period III|Lost to Follow-up|2|||
130086913|NCT00696774|468271628|FG001|Period III|Lost to Follow-up|1|||
130086914|NCT00696774|468271629|FG002|Period III|Lost to Follow-up|0|||
130086915|NCT00696774|468271627|FG000|Period III|Protocol Violation|1|||
130086916|NCT00696774|468271628|FG001|Period III|Protocol Violation|1|||
130086917|NCT00696774|468271629|FG002|Period III|Protocol Violation|0|||
130086918|NCT00696774|468271627|FG000|Period III|Withdrawal by Subject|1|||
130086919|NCT00696774|468271628|FG001|Period III|Withdrawal by Subject|2|||
130086920|NCT00696774|468271629|FG002|Period III|Withdrawal by Subject|0|||
130086921|NCT00696774|468271627|FG000|Period III|Sponsor Decision|2|||
130086922|NCT00696774|468271628|FG001|Period III|Sponsor Decision|0|||
130086923|NCT00696774|468271629|FG002|Period III|Sponsor Decision|0|||
130086924|NCT00696774|468271627|FG000|Period III|Lack of Efficacy|0|||
130086925|NCT00696774|468271628|FG001|Period III|Lack of Efficacy|2|||
130086926|NCT00696774|468271629|FG002|Period III|Lack of Efficacy|0|||
130086927|NCT03490734|468271630|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
130086928|NCT03490734|468271631|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
130086929|NCT03490734|468271632|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
130086930|NCT03490734|468271633|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
130086931|NCT03490734|468271630|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130086932|NCT03490734|468271631|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130086933|NCT03490734|468271632|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
130086934|NCT03490734|468271633|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
130086935|NCT03490734|468271630|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
130086936|NCT03490734|468271631|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
130086937|NCT03490734|468271632|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
130086938|NCT03490734|468271633|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
130086939|NCT03490734|468271630|FG000|Post-intervention Scan Visit|Adverse Event|2|||
130121344|NCT02585258|468404963|FG001|Overall Study|includes covid-related access problems|46|||
130086940|NCT03490734|468271631|FG001|Post-intervention Scan Visit|Adverse Event|0|||
130086941|NCT03490734|468271632|FG002|Post-intervention Scan Visit|Adverse Event|0|||
130086942|NCT03490734|468271633|FG003|Post-intervention Scan Visit|Adverse Event|0|||
130086943|NCT03490734|468271630|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
130086944|NCT03490734|468271631|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
130086945|NCT03490734|468271632|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
130086946|NCT03490734|468271633|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
130086947|NCT03490734|468271630|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
130086948|NCT03490734|468271631|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
130086949|NCT03490734|468271632|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
130086950|NCT03490734|468271633|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
130086951|NCT00887913|468271634|FG000|Overall Study|Withdrawal by Subject|6|||
130086952|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
130086953|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
130086954|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
130086955|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
130086956|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
130086957|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
130086958|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
130086959|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
130086960|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Death|0|||
130086961|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Death|0|||
130086962|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Death|0|||
130086963|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Death|1|||
130086964|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Death|1|||
130086965|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Death|0|||
130086966|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Death|2|||
130086967|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Death|0|||
130086968|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086969|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086970|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086971|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
130086972|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086973|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086974|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086975|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
130086976|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086977|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086978|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086979|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
130086980|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086981|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086982|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086983|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
130086984|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130086985|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130086986|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130086987|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
130086988|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130086989|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
130086990|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
130086991|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
130086992|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130086993|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130086994|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130086995|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
130086996|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
130086997|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
130086998|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
130086999|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
129960498|NCT01649557|467819513|FG001|Overall Study|Lost to Follow-up|0|||
130087000|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130087001|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130087002|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130087003|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130087004|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
129960499|NCT01649557|467819514|FG002|Overall Study|Lost to Follow-up|3|||
129960500|NCT01649557|467819512|FG000|Overall Study|Adverse Event|7|||
130087005|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
130087006|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
130087007|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
130087008|NCT02442765|468271635|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130087009|NCT02442765|468271636|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130087010|NCT02442765|468271637|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130087011|NCT02442765|468271638|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130087012|NCT02442765|468271639|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
130087013|NCT02442765|468271640|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130087014|NCT02442765|468271641|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
130087015|NCT02442765|468271642|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
130087016|NCT01200758|468271645|FG000|Stage I|Death|0|||
130087017|NCT01200758|468271646|FG001|Stage I|Death|1|||
130087018|NCT01200758|468271647|FG002|Stage I|Death|0|||
130087019|NCT01200758|468271648|FG003|Stage I|Death|0|||
130087020|NCT01200758|468271645|FG000|Stage I|Physician Decision|1|||
130087021|NCT01200758|468271646|FG001|Stage I|Physician Decision|1|||
130087022|NCT01200758|468271647|FG002|Stage I|Physician Decision|0|||
130087023|NCT01200758|468271648|FG003|Stage I|Physician Decision|0|||
130087024|NCT01200758|468271645|FG000|Stage I|Lack of Efficacy|2|||
130087025|NCT01200758|468271646|FG001|Stage I|Lack of Efficacy|1|||
130087026|NCT01200758|468271647|FG002|Stage I|Lack of Efficacy|0|||
130087027|NCT01200758|468271648|FG003|Stage I|Lack of Efficacy|0|||
130087028|NCT01200758|468271645|FG000|Stage I|Adverse Event|5|||
130087029|NCT01200758|468271646|FG001|Stage I|Adverse Event|5|||
130087030|NCT01200758|468271647|FG002|Stage I|Adverse Event|0|||
130087031|NCT01200758|468271648|FG003|Stage I|Adverse Event|0|||
130087032|NCT01200758|468271645|FG000|Stage I|Withdrawal by Subject|1|||
130087033|NCT01200758|468271646|FG001|Stage I|Withdrawal by Subject|2|||
130087034|NCT01200758|468271647|FG002|Stage I|Withdrawal by Subject|0|||
130087035|NCT01200758|468271648|FG003|Stage I|Withdrawal by Subject|0|||
130087036|NCT01200758|468271645|FG000|Stage I|Disease Progression|9|||
130087037|NCT01200758|468271646|FG001|Stage I|Disease Progression|7|||
130087038|NCT01200758|468271647|FG002|Stage I|Disease Progression|0|||
130087039|NCT01200758|468271648|FG003|Stage I|Disease Progression|0|||
130087040|NCT01200758|468271645|FG000|Stage 2|Disease Progression|0|||
130087041|NCT01200758|468271646|FG001|Stage 2|Disease Progression|0|||
130087042|NCT01200758|468271647|FG002|Stage 2|Disease Progression|16|||
130087043|NCT01200758|468271648|FG003|Stage 2|Disease Progression|21|||
130087044|NCT01200758|468271645|FG000|Stage 2|Lack of Efficacy|0|||
130087045|NCT01200758|468271646|FG001|Stage 2|Lack of Efficacy|0|||
130087046|NCT01200758|468271647|FG002|Stage 2|Lack of Efficacy|4|||
130087047|NCT01200758|468271648|FG003|Stage 2|Lack of Efficacy|2|||
130087048|NCT01200758|468271645|FG000|Stage 2|Physician Decision|0|||
130087049|NCT01200758|468271646|FG001|Stage 2|Physician Decision|0|||
130087050|NCT01200758|468271647|FG002|Stage 2|Physician Decision|5|||
130087051|NCT01200758|468271648|FG003|Stage 2|Physician Decision|7|||
130087052|NCT01200758|468271645|FG000|Stage 2|Adverse Event|0|||
130087053|NCT01200758|468271646|FG001|Stage 2|Adverse Event|0|||
130087054|NCT01200758|468271647|FG002|Stage 2|Adverse Event|5|||
130087055|NCT01200758|468271648|FG003|Stage 2|Adverse Event|9|||
130087056|NCT01200758|468271645|FG000|Stage 2|Withdrawal by Subject|0|||
130087057|NCT01200758|468271646|FG001|Stage 2|Withdrawal by Subject|0|||
130087058|NCT01200758|468271647|FG002|Stage 2|Withdrawal by Subject|4|||
130087059|NCT01200758|468271648|FG003|Stage 2|Withdrawal by Subject|1|||
130087060|NCT01200758|468271645|FG000|Stage 2|Lost to Follow-up|0|||
130087061|NCT01200758|468271646|FG001|Stage 2|Lost to Follow-up|0|||
130087062|NCT01200758|468271647|FG002|Stage 2|Lost to Follow-up|3|||
130087063|NCT01200758|468271648|FG003|Stage 2|Lost to Follow-up|1|||
130121345|NCT02585258|468404962|FG000|Overall Study|Lost to Follow-up|5|||
130087064|NCT01200758|468271645|FG000|Stage 2|Protocol Violation|0|||
130087065|NCT01200758|468271646|FG001|Stage 2|Protocol Violation|0|||
130087066|NCT01200758|468271647|FG002|Stage 2|Protocol Violation|1|||
130087067|NCT01200758|468271648|FG003|Stage 2|Protocol Violation|4|||
130087068|NCT01200758|468271645|FG000|Stage 2|Death|0|||
130087069|NCT01200758|468271646|FG001|Stage 2|Death|0|||
130121346|NCT02585258|468404963|FG001|Overall Study|Lost to Follow-up|2|||
130087070|NCT01200758|468271647|FG002|Stage 2|Death|3|||
130087071|NCT01200758|468271648|FG003|Stage 2|Death|5|||
130087072|NCT01371721|468271649|FG000|Overall Study|Adverse Event|5|||
130087073|NCT01371721|468271650|FG001|Overall Study|Adverse Event|4|||
130087074|NCT01371721|468271651|FG002|Overall Study|Adverse Event|5|||
130087075|NCT01371721|468271649|FG000|Overall Study|Protocol Violation|6|||
130121347|NCT01919190|468406761|FG000|Overall Study|Intra-op findings, etc.|3|||
130121348|NCT01919190|468406762|FG001|Overall Study|Intra-op findings, etc.|0|||
130087076|NCT01371721|468271650|FG001|Overall Study|Protocol Violation|4|||
130087077|NCT01371721|468271651|FG002|Overall Study|Protocol Violation|5|||
130087078|NCT01371721|468271649|FG000|Overall Study|Lost to Follow-up|8|||
130087079|NCT01371721|468271650|FG001|Overall Study|Lost to Follow-up|2|||
130087080|NCT01371721|468271651|FG002|Overall Study|Lost to Follow-up|6|||
130087081|NCT01371721|468271649|FG000|Overall Study|Withdrawal by Subject|5|||
130087082|NCT01371721|468271650|FG001|Overall Study|Withdrawal by Subject|7|||
130087083|NCT01371721|468271651|FG002|Overall Study|Withdrawal by Subject|11|||
130087084|NCT01371721|468271649|FG000|Overall Study|Other|2|||
130087085|NCT01371721|468271650|FG001|Overall Study|Other|3|||
130087086|NCT01371721|468271651|FG002|Overall Study|Other|0|||
130087087|NCT01371721|468271649|FG000|Overall Study|Lack of Efficacy|2|||
130087088|NCT01371721|468271650|FG001|Overall Study|Lack of Efficacy|4|||
130087089|NCT01371721|468271651|FG002|Overall Study|Lack of Efficacy|3|||
130087090|NCT01371721|468271649|FG000|Overall Study|Randomized but not treated|1|||
130087091|NCT01371721|468271650|FG001|Overall Study|Randomized but not treated|0|||
130087092|NCT01371721|468271651|FG002|Overall Study|Randomized but not treated|0|||
130087093|NCT00545584|468271652|FG000|Overall Study|Only one reason for discontinuation|62|||
130087094|NCT00545584|468271653|FG001|Overall Study|Only one reason for discontinuation|61|||
130087095|NCT00545584|468271654|FG002|Overall Study|Only one reason for discontinuation|48|||
130087096|NCT00545584|468271652|FG000|Overall Study|Two or more reasons for discontinuation|17|||
130087097|NCT00545584|468271653|FG001|Overall Study|Two or more reasons for discontinuation|19|||
130087098|NCT00545584|468271654|FG002|Overall Study|Two or more reasons for discontinuation|8|||
130087099|NCT03525613|468271657|FG000|Overall Study|Adverse Event|11|||
130087100|NCT03525613|468271658|FG001|Overall Study|Adverse Event|8|||
130087101|NCT03525613|468271659|FG002|Overall Study|Adverse Event|3|||
130087102|NCT03525613|468271660|FG003|Overall Study|Adverse Event|3|||
130087103|NCT03525613|468271657|FG000|Overall Study|Lost to Follow-up|4|||
130087104|NCT03525613|468271658|FG001|Overall Study|Lost to Follow-up|5|||
130087105|NCT03525613|468271659|FG002|Overall Study|Lost to Follow-up|3|||
130087106|NCT03525613|468271660|FG003|Overall Study|Lost to Follow-up|2|||
130087107|NCT03525613|468271657|FG000|Overall Study|Physician Decision|0|||
130087108|NCT03525613|468271658|FG001|Overall Study|Physician Decision|1|||
130087109|NCT03525613|468271659|FG002|Overall Study|Physician Decision|0|||
130087110|NCT03525613|468271660|FG003|Overall Study|Physician Decision|1|||
130087111|NCT03525613|468271657|FG000|Overall Study|Consent Withdrawal|25|||
130087112|NCT03525613|468271658|FG001|Overall Study|Consent Withdrawal|16|||
130087113|NCT03525613|468271659|FG002|Overall Study|Consent Withdrawal|12|||
130087114|NCT03525613|468271660|FG003|Overall Study|Consent Withdrawal|9|||
130087115|NCT03525613|468271657|FG000|Overall Study|Death|20|||
130087116|NCT03525613|468271658|FG001|Overall Study|Death|9|||
130087117|NCT03525613|468271659|FG002|Overall Study|Death|7|||
130087118|NCT03525613|468271660|FG003|Overall Study|Death|1|||
130087119|NCT03525613|468271657|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
130087120|NCT03525613|468271658|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
130087121|NCT03525613|468271659|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
130087122|NCT03525613|468271660|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
130087123|NCT00461552|468271661|FG000|Overall Study|Drug Dispensing error|0|||
130087124|NCT00461552|468271662|FG001|Overall Study|Drug Dispensing error|2|||
130087125|NCT00523744|468271663|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
130087126|NCT00523744|468271663|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
130087127|NCT00523744|468271663|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
130087128|NCT00523744|468271663|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
130087129|NCT00523744|468271663|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
130087130|NCT00523744|468271663|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
130087131|NCT03049852|468271664|FG000|Overall Study|Lost to Follow-up|0|||
130087132|NCT03049852|468271665|FG001|Overall Study|Lost to Follow-up|1|||
130087133|NCT03049852|468271666|FG002|Overall Study|Lost to Follow-up|0|||
130087134|NCT01021423|468271667|FG000|Overall Study|Study terminated|4|||
130087135|NCT01021423|468271668|FG001|Overall Study|Study terminated|5|||
129960501|NCT01649557|467819513|FG001|Overall Study|Adverse Event|5|||
130087136|NCT04728815|468271669|FG000|Overall Study|Lost to Follow-up|3|||
130121349|NCT02322047|468406768|FG000|Overall Study|Physician Decision|1|||
129960502|NCT01649557|467819514|FG002|Overall Study|Adverse Event|1|||
130087137|NCT04728815|468271670|FG001|Overall Study|Lost to Follow-up|0|||
130087138|NCT04728815|468271671|FG002|Overall Study|Lost to Follow-up|0|||
130087139|NCT04728815|468271672|FG003|Overall Study|Lost to Follow-up|1|||
130087140|NCT04728815|468271673|FG004|Overall Study|Lost to Follow-up|1|||
130121350|NCT02322047|468406769|FG001|Overall Study|Physician Decision|0|||
130121351|NCT02322047|468406770|FG002|Overall Study|Physician Decision|0|||
129960503|NCT01649557|467819512|FG000|Overall Study|Met withdrawal criteria|4|||
129960504|NCT01649557|467819513|FG001|Overall Study|Met withdrawal criteria|0|||
129960505|NCT01649557|467819514|FG002|Overall Study|Met withdrawal criteria|0|||
130087141|NCT04728815|468271674|FG005|Overall Study|Lost to Follow-up|0|||
130087142|NCT04728815|468271675|FG006|Overall Study|Lost to Follow-up|2|||
130087143|NCT04728815|468271676|FG007|Overall Study|Lost to Follow-up|0|||
130087144|NCT04728815|468271669|FG000|Overall Study|Physician Decision|0|||
130087145|NCT04728815|468271670|FG001|Overall Study|Physician Decision|0|||
130087146|NCT04728815|468271671|FG002|Overall Study|Physician Decision|1|||
130087147|NCT04728815|468271672|FG003|Overall Study|Physician Decision|0|||
130087148|NCT04728815|468271673|FG004|Overall Study|Physician Decision|0|||
130087149|NCT04728815|468271674|FG005|Overall Study|Physician Decision|0|||
130087150|NCT04728815|468271675|FG006|Overall Study|Physician Decision|0|||
130087151|NCT04728815|468271676|FG007|Overall Study|Physician Decision|0|||
130087152|NCT04728815|468271669|FG000|Overall Study|Treatment drop|0|||
130087153|NCT04728815|468271670|FG001|Overall Study|Treatment drop|2|||
130087154|NCT04728815|468271671|FG002|Overall Study|Treatment drop|1|||
130087155|NCT04728815|468271672|FG003|Overall Study|Treatment drop|0|||
130087156|NCT04728815|468271673|FG004|Overall Study|Treatment drop|3|||
130087157|NCT04728815|468271674|FG005|Overall Study|Treatment drop|1|||
130087158|NCT04728815|468271675|FG006|Overall Study|Treatment drop|3|||
130087159|NCT04728815|468271676|FG007|Overall Study|Treatment drop|0|||
130087160|NCT04728815|468271669|FG000|Overall Study|Study drop|0|||
130087161|NCT04728815|468271670|FG001|Overall Study|Study drop|3|||
130087162|NCT04728815|468271671|FG002|Overall Study|Study drop|3|||
130087163|NCT04728815|468271672|FG003|Overall Study|Study drop|0|||
130087164|NCT04728815|468271673|FG004|Overall Study|Study drop|0|||
130087165|NCT04728815|468271674|FG005|Overall Study|Study drop|0|||
130087166|NCT04728815|468271675|FG006|Overall Study|Study drop|7|||
130087167|NCT04728815|468271676|FG007|Overall Study|Study drop|0|||
130087168|NCT00957034|468271677|FG000|Overall Study|Adverse Event|0|||
130087169|NCT00957034|468271678|FG001|Overall Study|Adverse Event|1|||
130087170|NCT00957034|468271679|FG002|Overall Study|Adverse Event|1|||
130087171|NCT00957034|468271677|FG000|Overall Study|Sponsor Terminated Study|6|||
130087172|NCT00957034|468271678|FG001|Overall Study|Sponsor Terminated Study|1|||
130087173|NCT00957034|468271679|FG002|Overall Study|Sponsor Terminated Study|5|||
130087174|NCT00957034|468271677|FG000|Overall Study|Withdrawal by Subject|0|||
130087175|NCT00957034|468271678|FG001|Overall Study|Withdrawal by Subject|2|||
130087176|NCT00957034|468271679|FG002|Overall Study|Withdrawal by Subject|0|||
130087177|NCT02390167|468274230|FG000|Overall Study|Lost to Follow-up|1|||
130087178|NCT02033369|468274231|FG000|Overall Study|Physician Decision|1|||
130087179|NCT02033369|468274232|FG001|Overall Study|Physician Decision|2|||
129960506|NCT01649557|467819512|FG000|Overall Study|Physician Decision|8|||
129960507|NCT01649557|467819513|FG001|Overall Study|Physician Decision|2|||
129960508|NCT01649557|467819514|FG002|Overall Study|Physician Decision|1|||
129960509|NCT01649557|467819512|FG000|Overall Study|Withdrawal by Subject|15|||
129960510|NCT01649557|467819513|FG001|Overall Study|Withdrawal by Subject|5|||
130087180|NCT02033369|468274231|FG000|Overall Study|Not a good demographic match|0|||
130087181|NCT02033369|468274232|FG001|Overall Study|Not a good demographic match|2|||
130087182|NCT02033369|468274231|FG000|Overall Study|Withdrawal by Subject|1|||
130087183|NCT02033369|468274232|FG001|Overall Study|Withdrawal by Subject|1|||
130087184|NCT02033369|468274231|FG000|Overall Study|Lost to Follow-up|1|||
130087185|NCT02033369|468274232|FG001|Overall Study|Lost to Follow-up|0|||
130087186|NCT02033369|468274231|FG000|Overall Study|Protocol Violation|2|||
130087187|NCT02033369|468274232|FG001|Overall Study|Protocol Violation|0|||
130087188|NCT01265719|468274238|FG000|Overall Study|Does not meet entrance criteria|0|||
130087189|NCT01265719|468274239|FG001|Overall Study|Does not meet entrance criteria|3|||
130087190|NCT01265719|468274238|FG000|Overall Study|Other reasons|2|||
130087191|NCT01265719|468274239|FG001|Overall Study|Other reasons|0|||
129960511|NCT01649557|467819514|FG002|Overall Study|Withdrawal by Subject|4|||
129960512|NCT01649557|467819512|FG000|Overall Study|Protocol deviation|0|||
129960513|NCT01649557|467819513|FG001|Overall Study|Protocol deviation|2|||
129960514|NCT01649557|467819514|FG002|Overall Study|Protocol deviation|0|||
129960515|NCT01649557|467819512|FG000|Overall Study|Lack of Efficacy|5|||
129960516|NCT01649557|467819513|FG001|Overall Study|Lack of Efficacy|0|||
129960517|NCT01649557|467819514|FG002|Overall Study|Lack of Efficacy|0|||
129960518|NCT03712449|467819518|FG000|Overall Study|Withdraw Consent|0|||
129960519|NCT03712449|467819519|FG001|Overall Study|Withdraw Consent|1|||
129960520|NCT00666198|467819525|FG000|Overall Study|Protocol Violation|10|||
130087192|NCT01265719|468274238|FG000|Overall Study|Withdrawal by Subject|8|||
130087193|NCT01265719|468274239|FG001|Overall Study|Withdrawal by Subject|3|||
130087194|NCT01265719|468274238|FG000|Overall Study|Lost to Follow-up|2|||
130087195|NCT01265719|468274239|FG001|Overall Study|Lost to Follow-up|7|||
130087196|NCT01265719|468274238|FG000|Overall Study|Adverse Event|2|||
130087197|NCT01265719|468274239|FG001|Overall Study|Adverse Event|0|||
130087198|NCT04335929|468274240|FG000|Overall Study|Lost to Follow-up|10|||
130087199|NCT00413231|468274241|FG000|0 to 30-day Post Treatment|Death|5|||
130087200|NCT00413231|468274241|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
130087201|NCT00413231|468274241|FG000|30-day to 365-day Post Treatment|Death|13|||
130087202|NCT00413231|468274241|FG000|365-day to 60-month Post Treatment|Death|36|||
130087203|NCT00413231|468274241|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
130087204|NCT00413231|468274241|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
130087205|NCT00413231|468274241|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
130121352|NCT02322047|468406771|FG003|Overall Study|Physician Decision|0|||
129960521|NCT00666198|467819525|FG000|Overall Study|No Visit After First Day of Treatment|13|||
129960522|NCT00666198|467819525|FG000|Overall Study|Safety Not Assessable|6|||
129960523|NCT00666198|467819525|FG000|Overall Study|No Drug Administration|4|||
130087206|NCT00945945|468274242|FG000|Overall Study|Adverse Event|15|||
130087207|NCT00945945|468274243|FG001|Overall Study|Adverse Event|35|||
130087208|NCT00945945|468274242|FG000|Overall Study|Withdrawal by Subject|7|||
130087209|NCT00945945|468274243|FG001|Overall Study|Withdrawal by Subject|10|||
130087210|NCT00945945|468274242|FG000|Overall Study|Lost to Follow-up|4|||
130087211|NCT00945945|468274243|FG001|Overall Study|Lost to Follow-up|5|||
130087212|NCT00945945|468274242|FG000|Overall Study|Lack of Efficacy|6|||
130087213|NCT00945945|468274243|FG001|Overall Study|Lack of Efficacy|2|||
130087214|NCT00945945|468274242|FG000|Overall Study|Protocol Violation|4|||
130087215|NCT00945945|468274243|FG001|Overall Study|Protocol Violation|2|||
130087216|NCT00945945|468274242|FG000|Overall Study|Entry Criteria Not Met|0|||
130087217|NCT00945945|468274243|FG001|Overall Study|Entry Criteria Not Met|1|||
130087218|NCT02408016|468274244|FG000|Overall Study|Death|6|||
130087219|NCT02408016|468274245|FG001|Overall Study|Death|1|||
130087220|NCT02408016|468274246|FG002|Overall Study|Death|0|||
130087221|NCT02408016|468274244|FG000|Overall Study|Physician Decision|0|||
130087222|NCT02408016|468274245|FG001|Overall Study|Physician Decision|2|||
130087223|NCT02408016|468274246|FG002|Overall Study|Physician Decision|0|||
130087224|NCT02275052|468274247|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130087225|NCT02275052|468274248|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
130087226|NCT02275052|468274249|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130087227|NCT02275052|468274250|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
130087228|NCT02275052|468274247|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
130087229|NCT02275052|468274248|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
130087230|NCT02275052|468274249|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
129960524|NCT05153499|467819526|FG000|Overall Study|Withdrawal by Subject|1|||
129960525|NCT05153499|467819527|FG001|Overall Study|Withdrawal by Subject|0|||
130087231|NCT02275052|468274250|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
130087232|NCT02275052|468274247|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
130087233|NCT02275052|468274248|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
130087234|NCT02275052|468274249|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130087235|NCT02275052|468274250|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130087236|NCT02275052|468274247|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
130087237|NCT02275052|468274248|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
130087238|NCT02275052|468274249|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
130087239|NCT02275052|468274250|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
130087240|NCT02275052|468274247|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
130087241|NCT02275052|468274248|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130087242|NCT02275052|468274249|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130087243|NCT02275052|468274250|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
130087244|NCT02275052|468274247|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
130087245|NCT02275052|468274248|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
130087246|NCT02275052|468274249|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
130087247|NCT02275052|468274250|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
130087248|NCT02275052|468274247|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
130087249|NCT02275052|468274248|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
130087250|NCT02275052|468274249|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
130087251|NCT02275052|468274250|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
130087252|NCT02275052|468274247|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130087253|NCT02275052|468274248|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
130087254|NCT02275052|468274249|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
130087255|NCT02275052|468274250|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
130087256|NCT02275052|468274247|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130087257|NCT02275052|468274248|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130087258|NCT02275052|468274249|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130087259|NCT02275052|468274250|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
130087260|NCT02275052|468274247|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130087261|NCT02275052|468274248|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
130087262|NCT02275052|468274249|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
130087263|NCT02275052|468274250|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
130087264|NCT02275052|468274247|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130087265|NCT02275052|468274248|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130087266|NCT02275052|468274249|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
130087267|NCT02275052|468274250|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
130087268|NCT02807376|468274253|FG000|Overall Study|Intra-operative exclusion criteria|3|||
130087269|NCT02807376|468274254|FG001|Overall Study|Intra-operative exclusion criteria|0|||
130087270|NCT02807376|468274253|FG000|Overall Study|Lost to Follow-up|0|||
130087271|NCT02807376|468274254|FG001|Overall Study|Lost to Follow-up|1|||
130087272|NCT00846027|468274255|FG000|Overall Study|Death|3|||
130087273|NCT00846027|468274255|FG000|Overall Study|Disease Progression|30|||
130087274|NCT00846027|468274255|FG000|Overall Study|Toxicity|12|||
130087275|NCT00846027|468274255|FG000|Overall Study|Patient Decision|7|||
130087276|NCT00846027|468274255|FG000|Overall Study|Investigator Discretion|29|||
130087277|NCT00846027|468274255|FG000|Overall Study|Protocol Violation|2|||
130087278|NCT00846027|468274255|FG000|Overall Study|Subject Not Treated|7|||
130087279|NCT00808028|468274256|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
130087280|NCT00808028|468274257|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
130087281|NCT00808028|468274258|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
130087282|NCT00808028|468274259|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
130087283|NCT00808028|468274256|FG000|Stage 1 (6 Months)|Other|1|||
130087284|NCT00808028|468274257|FG001|Stage 1 (6 Months)|Other|0|||
130087285|NCT00808028|468274258|FG002|Stage 1 (6 Months)|Other|2|||
130087286|NCT00808028|468274259|FG003|Stage 1 (6 Months)|Other|4|||
129960526|NCT05153499|467819526|FG000|Overall Study|Clinical Hold|1|||
129960527|NCT05153499|467819527|FG001|Overall Study|Clinical Hold|0|||
130087287|NCT00808028|468274256|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
130087288|NCT00808028|468274257|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
130087289|NCT00808028|468274258|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
130087290|NCT00808028|468274259|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
130087291|NCT00808028|468274256|FG000|Stage 1 (6 Months)|Adverse Event|0|||
130087292|NCT00808028|468274257|FG001|Stage 1 (6 Months)|Adverse Event|0|||
130087293|NCT00808028|468274258|FG002|Stage 1 (6 Months)|Adverse Event|1|||
130087294|NCT00808028|468274259|FG003|Stage 1 (6 Months)|Adverse Event|2|||
130087295|NCT00808028|468274256|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
130087296|NCT00808028|468274257|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
130087297|NCT00808028|468274258|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
130087298|NCT00808028|468274259|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
130087299|NCT00808028|468274256|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
130087300|NCT00808028|468274257|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
130087301|NCT00808028|468274258|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
130087302|NCT00808028|468274259|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
130087303|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
130087304|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
130087305|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
130087306|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
130087307|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
130087308|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
130087309|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
130087310|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
130087311|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
130087312|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
130087313|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
130087314|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
130087315|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
130087316|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
130087317|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
130087318|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
130087319|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
130087320|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
130087321|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
130087322|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
130087323|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
130087324|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
130087325|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
130087326|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
130087327|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
130087328|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
130087329|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
130087330|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
130087331|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
130087332|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
130087333|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
130087334|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
130087335|NCT00808028|468274256|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
130087336|NCT00808028|468274257|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
130087337|NCT00808028|468274258|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
130087338|NCT00808028|468274259|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
130087339|NCT01797302|468274260|FG000|Overall Study|Lost to Follow-up|16|||
130087340|NCT01797302|468274261|FG001|Overall Study|Lost to Follow-up|23|||
130087341|NCT01797302|468274262|FG002|Overall Study|Lost to Follow-up|22|||
130087342|NCT01797302|468274260|FG000|Overall Study|Withdrawal by Subject|1|||
130087343|NCT01797302|468274261|FG001|Overall Study|Withdrawal by Subject|3|||
130087344|NCT01797302|468274262|FG002|Overall Study|Withdrawal by Subject|4|||
130087345|NCT03228836|468274263|FG000|Overall Study|Adverse Event|3|||
130087346|NCT03228836|468274263|FG000|Overall Study|Withdrawal by Subject|1|||
130087347|NCT03228836|468274263|FG000|Overall Study|Death|1|||
130087348|NCT03228836|468274263|FG000|Overall Study|Physician Decision|1|||
130087349|NCT03228836|468274263|FG000|Overall Study|Disease Progression|7|||
130087350|NCT03228836|468274263|FG000|Overall Study|Other|4|||
130087351|NCT02773849|468274265|FG000|Overall Study|Lost to Follow-up|11|||
130087352|NCT02773849|468274265|FG000|Overall Study|Death|26|||
130087353|NCT02773849|468274265|FG000|Overall Study|Withdrawal by Subject|5|||
130087354|NCT02773849|468274265|FG000|Overall Study|Withdrawal of Consent|9|||
130087355|NCT02773849|468274265|FG000|Overall Study|Other: not due to lack of tolerability|11|||
130087356|NCT00948389|468274266|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
130087357|NCT00948389|468274267|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
130087358|NCT00948389|468274268|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
130087359|NCT00948389|468274269|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
130087360|NCT00948389|468274270|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
130087361|NCT00948389|468274266|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
130087362|NCT00948389|468274267|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
130087363|NCT00948389|468274268|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
130087364|NCT00948389|468274269|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
130087365|NCT00948389|468274270|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
130087366|NCT00948389|468274266|FG000|Overall Study|Both Progression and Toxicity|1|||
130087367|NCT00948389|468274267|FG001|Overall Study|Both Progression and Toxicity|0|||
130087368|NCT00948389|468274268|FG002|Overall Study|Both Progression and Toxicity|0|||
130087369|NCT00948389|468274269|FG003|Overall Study|Both Progression and Toxicity|0|||
130087370|NCT00948389|468274270|FG004|Overall Study|Both Progression and Toxicity|0|||
130087371|NCT02418000|468274275|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
130087372|NCT02418000|468274276|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087373|NCT02418000|468274277|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087374|NCT02418000|468274278|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087375|NCT02418000|468274279|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087376|NCT02418000|468274275|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
130087377|NCT02418000|468274276|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130087378|NCT02418000|468274277|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130087379|NCT02418000|468274278|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130087380|NCT02418000|468274279|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
130087381|NCT02418000|468274275|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
130087382|NCT02418000|468274276|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130087383|NCT02418000|468274277|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130087384|NCT02418000|468274278|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130087385|NCT02418000|468274279|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
130087386|NCT02418000|468274275|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087387|NCT02418000|468274276|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
130087388|NCT02418000|468274277|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087389|NCT02418000|468274278|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087390|NCT02418000|468274279|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
130087391|NCT02418000|468274275|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130087392|NCT02418000|468274276|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
130087393|NCT02418000|468274277|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130087394|NCT02418000|468274278|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130087395|NCT02418000|468274279|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
130087396|NCT02418000|468274275|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087397|NCT02418000|468274276|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087398|NCT02418000|468274277|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
130087399|NCT02418000|468274278|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087400|NCT02418000|468274279|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087401|NCT02418000|468274275|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087402|NCT02418000|468274276|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087403|NCT02418000|468274277|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087404|NCT02418000|468274278|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
130087405|NCT02418000|468274279|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087406|NCT02418000|468274275|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130087407|NCT02418000|468274276|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130087408|NCT02418000|468274277|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130087409|NCT02418000|468274278|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
130087410|NCT02418000|468274279|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
130087411|NCT02418000|468274275|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087412|NCT02418000|468274276|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087413|NCT02418000|468274277|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087414|NCT02418000|468274278|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
130087415|NCT02418000|468274279|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
130087416|NCT00508001|468274281|FG000|Overall Study|Adverse Event|2|||
130087417|NCT00508001|468274282|FG001|Overall Study|Adverse Event|0|||
130087418|NCT00508001|468274283|FG002|Overall Study|Adverse Event|4|||
130087419|NCT00508001|468274281|FG000|Overall Study|condition under investigation worsened|13|||
130087420|NCT00508001|468274282|FG001|Overall Study|condition under investigation worsened|7|||
130087421|NCT00508001|468274283|FG002|Overall Study|condition under investigation worsened|1|||
130087422|NCT00508001|468274281|FG000|Overall Study|Death|0|||
130087423|NCT00508001|468274282|FG001|Overall Study|Death|1|||
130087424|NCT00508001|468274283|FG002|Overall Study|Death|1|||
130087425|NCT00508001|468274281|FG000|Overall Study|Withdrawal by Subject|4|||
130087426|NCT00508001|468274282|FG001|Overall Study|Withdrawal by Subject|4|||
130087427|NCT00508001|468274283|FG002|Overall Study|Withdrawal by Subject|1|||
130087428|NCT00732199|468274290|FG000|Overall Study|Withdrawal by Subject|25|||
130087429|NCT00732199|468274291|FG001|Overall Study|Withdrawal by Subject|18|||
130087430|NCT00732199|468274290|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
130087431|NCT00732199|468274291|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
130087432|NCT02870348|468274302|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
130087433|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Adverse Event|30|||
130087434|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Adverse Event|25|||
130087435|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Adverse Event|23|||
130087436|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Adverse Event|14|||
130087437|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Death|0|||
130087438|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Death|0|||
130087439|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Death|1|||
130087440|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Death|0|||
130087441|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Physician Decision|0|||
130087442|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Physician Decision|1|||
130087443|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Physician Decision|0|||
130087444|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Physician Decision|1|||
130087445|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
130087446|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
130087447|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
130087448|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
130087449|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Other|6|||
130087450|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Other|1|||
130087451|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Other|0|||
130087452|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Other|2|||
130087453|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
130087454|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
130087455|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
130087456|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
130087457|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
130087458|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
130087459|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
130087460|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
130087461|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
130087462|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
130087463|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
130087464|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
130087465|NCT00242710|468274304|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
130087466|NCT00242710|468274305|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
130087467|NCT00242710|468274306|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
130087468|NCT00242710|468274307|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
130087469|NCT00242710|468274304|FG000|Period Between Core Study and Extension|Adverse Event|2|||
130087470|NCT00242710|468274305|FG001|Period Between Core Study and Extension|Adverse Event|3|||
130087471|NCT00242710|468274306|FG002|Period Between Core Study and Extension|Adverse Event|5|||
130087472|NCT00242710|468274307|FG003|Period Between Core Study and Extension|Adverse Event|2|||
130087473|NCT00242710|468274304|FG000|Period Between Core Study and Extension|Physician Decision|1|||
130087474|NCT00242710|468274305|FG001|Period Between Core Study and Extension|Physician Decision|1|||
130087475|NCT00242710|468274306|FG002|Period Between Core Study and Extension|Physician Decision|0|||
130087476|NCT00242710|468274307|FG003|Period Between Core Study and Extension|Physician Decision|0|||
130087477|NCT00242710|468274304|FG000|Period Between Core Study and Extension|Other|24|||
130087478|NCT00242710|468274305|FG001|Period Between Core Study and Extension|Other|24|||
130087479|NCT00242710|468274306|FG002|Period Between Core Study and Extension|Other|9|||
130087480|NCT00242710|468274307|FG003|Period Between Core Study and Extension|Other|11|||
130087481|NCT00242710|468274304|FG000|Period Between Core Study and Extension|Extension not Available|17|||
130087482|NCT00242710|468274305|FG001|Period Between Core Study and Extension|Extension not Available|21|||
130087483|NCT00242710|468274306|FG002|Period Between Core Study and Extension|Extension not Available|8|||
130087484|NCT00242710|468274307|FG003|Period Between Core Study and Extension|Extension not Available|7|||
130087485|NCT00242710|468274304|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
130087486|NCT00242710|468274305|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
130121353|NCT02322047|468406768|FG000|Overall Study|Withdrawal by Subject|1|||
130121354|NCT02322047|468406769|FG001|Overall Study|Withdrawal by Subject|0|||
130121355|NCT02322047|468406770|FG002|Overall Study|Withdrawal by Subject|0|||
130121356|NCT02322047|468406771|FG003|Overall Study|Withdrawal by Subject|1|||
130121357|NCT02322047|468406768|FG000|Overall Study|Adverse Event|0|||
130121358|NCT02322047|468406769|FG001|Overall Study|Adverse Event|1|||
130121359|NCT02322047|468406770|FG002|Overall Study|Adverse Event|0|||
130121360|NCT02322047|468406771|FG003|Overall Study|Adverse Event|0|||
130121361|NCT02322047|468406768|FG000|Overall Study|Lost to Follow-up|0|||
130121362|NCT02322047|468406769|FG001|Overall Study|Lost to Follow-up|0|||
130121363|NCT02322047|468406770|FG002|Overall Study|Lost to Follow-up|1|||
130121364|NCT02322047|468406771|FG003|Overall Study|Lost to Follow-up|1|||
130121365|NCT02207231|468406772|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
130121366|NCT02207231|468406773|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
130121367|NCT02207231|468406774|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
130121368|NCT02207231|468406775|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
130121369|NCT02207231|468406772|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
130121370|NCT02207231|468406773|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
130121371|NCT02207231|468406774|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
130121372|NCT02207231|468406775|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
130121373|NCT02207231|468406772|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
130121374|NCT02207231|468406773|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
130121375|NCT02207231|468406774|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
130121376|NCT02207231|468406775|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
130121377|NCT02207231|468406772|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
130121378|NCT02207231|468406773|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
130121379|NCT02207231|468406774|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
130121380|NCT02207231|468406775|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
130121381|NCT02207231|468406772|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
130121382|NCT02207231|468406773|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
130121383|NCT02207231|468406774|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
130121384|NCT02207231|468406775|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
130121385|NCT02207231|468406772|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
130121386|NCT02207231|468406773|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
130121387|NCT02207231|468406774|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
130121388|NCT02207231|468406775|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
130121389|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
130121390|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
130121391|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
130121392|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
130121393|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
130121394|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
130121395|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
130121396|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
130121397|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
130121398|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
130121399|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
130121400|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
130121401|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
130121402|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
130121403|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
130087487|NCT00242710|468274306|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
130087488|NCT00242710|468274307|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
130087489|NCT00242710|468274304|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
130087490|NCT00242710|468274305|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
130087491|NCT00242710|468274306|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
130087492|NCT00242710|468274307|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
130087493|NCT00242710|468274304|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
130087494|NCT00242710|468274305|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
130087495|NCT00242710|468274306|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
130087496|NCT00242710|468274307|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
130087497|NCT00242710|468274304|FG000|Study Extension (up to Year 2)|Death|0|||
130121404|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
130121405|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
130087498|NCT00242710|468274305|FG001|Study Extension (up to Year 2)|Death|0|||
130121406|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
130121407|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
130087499|NCT00242710|468274306|FG002|Study Extension (up to Year 2)|Death|0|||
130087500|NCT00242710|468274307|FG003|Study Extension (up to Year 2)|Death|1|||
130087501|NCT00242710|468274304|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
130087502|NCT00242710|468274305|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
130087503|NCT00242710|468274306|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
130087504|NCT00242710|468274307|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
130087505|NCT00242710|468274304|FG000|Study Extension (up to Year 2)|Other|3|||
130087506|NCT00242710|468274305|FG001|Study Extension (up to Year 2)|Other|5|||
130087507|NCT00242710|468274306|FG002|Study Extension (up to Year 2)|Other|4|||
130087508|NCT00242710|468274307|FG003|Study Extension (up to Year 2)|Other|3|||
130087509|NCT00242710|468274304|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
130087510|NCT00242710|468274305|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
130087511|NCT00242710|468274306|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
130087512|NCT00242710|468274307|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
130087513|NCT00242710|468274304|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
130087514|NCT00242710|468274305|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
130087515|NCT00242710|468274306|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
130087516|NCT00242710|468274307|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
130087517|NCT00579527|468274308|FG000|Overall Study|Death|4|||
130087518|NCT03961529|468274309|FG000|Overall Study|Adverse Event|13|||
130087519|NCT03961529|468274310|FG001|Overall Study|Adverse Event|5|||
130087520|NCT03961529|468274311|FG002|Overall Study|Adverse Event|2|||
130087521|NCT03961529|468274309|FG000|Overall Study|Withdrawal by Subject|17|||
130087522|NCT03961529|468274310|FG001|Overall Study|Withdrawal by Subject|2|||
130087523|NCT03961529|468274311|FG002|Overall Study|Withdrawal by Subject|1|||
130087524|NCT03961529|468274309|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130087525|NCT03961529|468274310|FG001|Overall Study|Withdrawal by parent/guardian|7|||
130087526|NCT03961529|468274311|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130087527|NCT03961529|468274309|FG000|Overall Study|Physician Decision|2|||
130087528|NCT03961529|468274310|FG001|Overall Study|Physician Decision|1|||
130087529|NCT03961529|468274311|FG002|Overall Study|Physician Decision|1|||
130087530|NCT03961529|468274309|FG000|Overall Study|Lost to Follow-up|2|||
130087531|NCT03961529|468274310|FG001|Overall Study|Lost to Follow-up|1|||
130087532|NCT03961529|468274311|FG002|Overall Study|Lost to Follow-up|0|||
130087533|NCT03961529|468274309|FG000|Overall Study|Lack of Efficacy|2|||
130087534|NCT03961529|468274310|FG001|Overall Study|Lack of Efficacy|0|||
130087535|NCT03961529|468274311|FG002|Overall Study|Lack of Efficacy|1|||
130087536|NCT03961529|468274309|FG000|Overall Study|Other|6|||
130087537|NCT03961529|468274310|FG001|Overall Study|Other|1|||
130087538|NCT03961529|468274311|FG002|Overall Study|Other|0|||
130087539|NCT03644173|468274314|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
130087540|NCT03644173|468274314|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
130087541|NCT03644173|468274314|FG000|Participants at the 1-month Follow up|Death|2|||
130087542|NCT03644173|468274314|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
130087543|NCT00381706|468274315|FG000|Overall Study|Never treated|7|||
130087544|NCT00381706|468274316|FG001|Overall Study|Never treated|2|||
130087545|NCT00381706|468274317|FG002|Overall Study|Never treated|1|||
130087546|NCT00256204|468274322|FG000|Overall Study|Adverse Event|10|||
130087547|NCT00256204|468274323|FG001|Overall Study|Adverse Event|14|||
130087548|NCT00256204|468274324|FG002|Overall Study|Adverse Event|16|||
130087549|NCT00256204|468274325|FG003|Overall Study|Adverse Event|14|||
130087550|NCT00256204|468274322|FG000|Overall Study|Death|0|||
130087551|NCT00256204|468274323|FG001|Overall Study|Death|1|||
130087552|NCT00256204|468274324|FG002|Overall Study|Death|0|||
130087553|NCT00256204|468274325|FG003|Overall Study|Death|0|||
130087554|NCT00256204|468274322|FG000|Overall Study|Lost to Follow-up|1|||
130087555|NCT00256204|468274323|FG001|Overall Study|Lost to Follow-up|1|||
130087556|NCT00256204|468274324|FG002|Overall Study|Lost to Follow-up|1|||
130087557|NCT00256204|468274325|FG003|Overall Study|Lost to Follow-up|2|||
130087558|NCT00256204|468274322|FG000|Overall Study|Protocol Violation|1|||
130087559|NCT00256204|468274323|FG001|Overall Study|Protocol Violation|0|||
130087560|NCT00256204|468274324|FG002|Overall Study|Protocol Violation|2|||
130087561|NCT00256204|468274325|FG003|Overall Study|Protocol Violation|1|||
130087562|NCT00256204|468274322|FG000|Overall Study|Physician Decision|0|||
130087563|NCT00256204|468274323|FG001|Overall Study|Physician Decision|0|||
130087564|NCT00256204|468274324|FG002|Overall Study|Physician Decision|1|||
130087565|NCT00256204|468274325|FG003|Overall Study|Physician Decision|2|||
130121408|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
130121409|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
130121410|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
130087566|NCT00256204|468274322|FG000|Overall Study|Withdrawal by Subject|17|||
130087567|NCT00256204|468274323|FG001|Overall Study|Withdrawal by Subject|6|||
130087568|NCT00256204|468274324|FG002|Overall Study|Withdrawal by Subject|7|||
130087569|NCT00256204|468274325|FG003|Overall Study|Withdrawal by Subject|5|||
130087570|NCT00256204|468274322|FG000|Overall Study|Need for additional prohibited treatment|38|||
130087571|NCT00256204|468274323|FG001|Overall Study|Need for additional prohibited treatment|28|||
130087572|NCT00256204|468274324|FG002|Overall Study|Need for additional prohibited treatment|27|||
130087573|NCT00256204|468274325|FG003|Overall Study|Need for additional prohibited treatment|25|||
130087574|NCT00808132|468274326|FG000|Overall Study|Adverse Event|34|||
130087575|NCT00808132|468274327|FG001|Overall Study|Adverse Event|33|||
130087576|NCT00808132|468274328|FG002|Overall Study|Adverse Event|16|||
130087577|NCT00808132|468274329|FG003|Overall Study|Adverse Event|31|||
130087578|NCT00808132|468274330|FG004|Overall Study|Adverse Event|33|||
130087579|NCT00808132|468274326|FG000|Overall Study|Death|0|||
130087580|NCT00808132|468274327|FG001|Overall Study|Death|0|||
130087581|NCT00808132|468274328|FG002|Overall Study|Death|0|||
130087582|NCT00808132|468274329|FG003|Overall Study|Death|0|||
130087583|NCT00808132|468274330|FG004|Overall Study|Death|1|||
130087584|NCT00808132|468274326|FG000|Overall Study|Physician Decision|0|||
130087585|NCT00808132|468274327|FG001|Overall Study|Physician Decision|1|||
130087586|NCT00808132|468274328|FG002|Overall Study|Physician Decision|0|||
130087587|NCT00808132|468274329|FG003|Overall Study|Physician Decision|0|||
130087588|NCT00808132|468274330|FG004|Overall Study|Physician Decision|0|||
130087589|NCT00808132|468274326|FG000|Overall Study|Lost to Follow-up|8|||
130087590|NCT00808132|468274327|FG001|Overall Study|Lost to Follow-up|10|||
130087591|NCT00808132|468274328|FG002|Overall Study|Lost to Follow-up|11|||
130087592|NCT00808132|468274329|FG003|Overall Study|Lost to Follow-up|8|||
130087593|NCT00808132|468274330|FG004|Overall Study|Lost to Follow-up|9|||
130087594|NCT00808132|468274326|FG000|Overall Study|Protocol Violation|8|||
130087595|NCT00808132|468274327|FG001|Overall Study|Protocol Violation|9|||
130087596|NCT00808132|468274328|FG002|Overall Study|Protocol Violation|4|||
130087597|NCT00808132|468274329|FG003|Overall Study|Protocol Violation|9|||
130087598|NCT00808132|468274330|FG004|Overall Study|Protocol Violation|5|||
130087599|NCT00808132|468274326|FG000|Overall Study|Withdrawal by Subject|27|||
130087600|NCT00808132|468274327|FG001|Overall Study|Withdrawal by Subject|18|||
130087601|NCT00808132|468274328|FG002|Overall Study|Withdrawal by Subject|2|||
130087602|NCT00808132|468274329|FG003|Overall Study|Withdrawal by Subject|7|||
130087603|NCT00808132|468274330|FG004|Overall Study|Withdrawal by Subject|16|||
130087604|NCT00808132|468274326|FG000|Overall Study|Other|6|||
130087605|NCT00808132|468274327|FG001|Overall Study|Other|4|||
130087606|NCT00808132|468274328|FG002|Overall Study|Other|6|||
130087607|NCT00808132|468274329|FG003|Overall Study|Other|2|||
130087608|NCT00808132|468274330|FG004|Overall Study|Other|15|||
130087609|NCT00808132|468274326|FG000|Overall Study|Randomized, but not treated|10|||
130087610|NCT00808132|468274327|FG001|Overall Study|Randomized, but not treated|7|||
130087611|NCT00808132|468274328|FG002|Overall Study|Randomized, but not treated|9|||
130087612|NCT00808132|468274329|FG003|Overall Study|Randomized, but not treated|8|||
130087613|NCT00808132|468274330|FG004|Overall Study|Randomized, but not treated|9|||
130087614|NCT00808132|468274326|FG000|Overall Study|Unsatisfactory response|5|||
130087615|NCT00808132|468274327|FG001|Overall Study|Unsatisfactory response|6|||
130087616|NCT00808132|468274328|FG002|Overall Study|Unsatisfactory response|6|||
130087617|NCT00808132|468274329|FG003|Overall Study|Unsatisfactory response|4|||
130087618|NCT00808132|468274330|FG004|Overall Study|Unsatisfactory response|12|||
130087619|NCT01948791|468274333|FG000|Overall Study|Adverse Event|12|||
130087620|NCT01948791|468274333|FG000|Overall Study|Lack of Efficacy|3|||
130087621|NCT01948791|468274333|FG000|Overall Study|Protocol Violation|2|||
129960528|NCT05153499|467819526|FG000|Overall Study|Study Termination|6|||
129960529|NCT05153499|467819527|FG001|Overall Study|Study Termination|5|||
129960530|NCT03029234|467819531|FG000|Overall Study|Sponsor Decision|1|||
129960531|NCT03029234|467819531|FG000|Overall Study|Withdrawal by Subject|5|||
129960532|NCT03029234|467819531|FG000|Overall Study|Death|91|||
129960533|NCT03029234|467819531|FG000|Overall Study|Lost to Follow-up|2|||
129960534|NCT02166047|467819532|FG000|Overall Study|Withdrawal by Participant|0|||
129960535|NCT02166047|467819533|FG001|Overall Study|Withdrawal by Participant|1|||
129960536|NCT02166047|467819534|FG002|Overall Study|Withdrawal by Participant|2|||
129960537|NCT02166047|467819535|FG003|Overall Study|Withdrawal by Participant|0|||
129960538|NCT02166047|467819536|FG004|Overall Study|Withdrawal by Participant|0|||
129960539|NCT02166047|467819537|FG005|Overall Study|Withdrawal by Participant|0|||
130087622|NCT01948791|468274333|FG000|Overall Study|Withdrawal by Subject|5|||
130087623|NCT01948791|468274333|FG000|Overall Study|Lost to Follow-up|6|||
130087624|NCT01948791|468274333|FG000|Overall Study|Management issues|1|||
130087625|NCT01948791|468274333|FG000|Overall Study|Others|7|||
130087626|NCT01948791|468274333|FG000|Overall Study|Screening failure|35|||
130087627|NCT02555722|468274348|FG000|Week 2|Adverse Event|0|||
130087628|NCT02555722|468274349|FG001|Week 2|Adverse Event|1|||
130087629|NCT02555722|468274348|FG000|Week 2|Withdrawal by Subject|1|||
130087630|NCT02555722|468274349|FG001|Week 2|Withdrawal by Subject|0|||
130087631|NCT02555722|468274348|FG000|Month 1|Lens Discomfort|1|||
130087632|NCT02555722|468274349|FG001|Month 1|Lens Discomfort|0|||
130087633|NCT02555722|468274348|FG000|Month 2|Withdrawal by Subject|3|||
129960540|NCT02166047|467819538|FG006|Overall Study|Withdrawal by Participant|1|||
129960541|NCT02166047|467819539|FG007|Overall Study|Withdrawal by Participant|0|||
130087634|NCT02555722|468274349|FG001|Month 2|Withdrawal by Subject|0|||
130087635|NCT02555722|468274348|FG000|Month 2|Lost to Follow-up|1|||
130087636|NCT02555722|468274349|FG001|Month 2|Lost to Follow-up|0|||
130087637|NCT00702949|468274350|FG000|Overall Study|Refusal|3|||
129960542|NCT02166047|467819540|FG008|Overall Study|Withdrawal by Participant|0|||
129960543|NCT02166047|467819541|FG009|Overall Study|Withdrawal by Participant|0|||
129960544|NCT02166047|467819542|FG010|Overall Study|Withdrawal by Participant|0|||
129960545|NCT02166047|467819543|FG011|Overall Study|Withdrawal by Participant|0|||
129960546|NCT02166047|467819532|FG000|Overall Study|Adverse Event|0|||
129960547|NCT02166047|467819533|FG001|Overall Study|Adverse Event|0|||
129960548|NCT02166047|467819534|FG002|Overall Study|Adverse Event|0|||
129960549|NCT02166047|467819535|FG003|Overall Study|Adverse Event|0|||
129960550|NCT02166047|467819536|FG004|Overall Study|Adverse Event|1|||
129960551|NCT02166047|467819537|FG005|Overall Study|Adverse Event|0|||
129960552|NCT02166047|467819538|FG006|Overall Study|Adverse Event|1|||
129960553|NCT02166047|467819539|FG007|Overall Study|Adverse Event|0|||
129960554|NCT02166047|467819540|FG008|Overall Study|Adverse Event|0|||
129960555|NCT02166047|467819541|FG009|Overall Study|Adverse Event|0|||
129960556|NCT02166047|467819542|FG010|Overall Study|Adverse Event|2|||
129960557|NCT02166047|467819543|FG011|Overall Study|Adverse Event|0|||
129960558|NCT01649297|467819544|FG000|Overall Study|Adverse Event|5|||
129960559|NCT01649297|467819545|FG001|Overall Study|Adverse Event|5|||
129960560|NCT01649297|467819546|FG002|Overall Study|Adverse Event|4|||
130087638|NCT00702949|468274351|FG001|Overall Study|Refusal|2|||
130087639|NCT00702949|468274352|FG002|Overall Study|Refusal|2|||
130087640|NCT00702949|468274350|FG000|Overall Study|Adverse Event|1|||
130087641|NCT00702949|468274351|FG001|Overall Study|Adverse Event|6|||
130087642|NCT00702949|468274352|FG002|Overall Study|Adverse Event|3|||
130087643|NCT00702949|468274350|FG000|Overall Study|Other Medical Reason/unknown|1|||
130087644|NCT00702949|468274351|FG001|Overall Study|Other Medical Reason/unknown|1|||
130087645|NCT00702949|468274352|FG002|Overall Study|Other Medical Reason/unknown|3|||
130087646|NCT04491591|468274354|FG000|Overall Study|Accidently randomized|3|||
130087647|NCT04491591|468274355|FG001|Overall Study|Accidently randomized|1|||
130087648|NCT04491591|468274356|FG002|Overall Study|Accidently randomized|0|||
130087649|NCT04491591|468274354|FG000|Overall Study|Did not complete survey|28|||
130087650|NCT04491591|468274355|FG001|Overall Study|Did not complete survey|20|||
130087651|NCT04491591|468274356|FG002|Overall Study|Did not complete survey|3|||
130087652|NCT00135694|468274357|FG000|Overall Study|Adverse Event|17|||
130087653|NCT00135694|468274358|FG001|Overall Study|Adverse Event|4|||
130087654|NCT00135694|468274359|FG002|Overall Study|Adverse Event|0|||
130087655|NCT00135694|468274357|FG000|Overall Study|Death|14|||
130087656|NCT00135694|468274358|FG001|Overall Study|Death|1|||
130087657|NCT00135694|468274359|FG002|Overall Study|Death|2|||
130087658|NCT00135694|468274357|FG000|Overall Study|Lost to Follow-up|8|||
130087659|NCT00135694|468274358|FG001|Overall Study|Lost to Follow-up|7|||
130087660|NCT00135694|468274359|FG002|Overall Study|Lost to Follow-up|1|||
130087661|NCT00135694|468274357|FG000|Overall Study|Withdrawal by Subject|41|||
130087662|NCT00135694|468274358|FG001|Overall Study|Withdrawal by Subject|7|||
130087663|NCT00135694|468274359|FG002|Overall Study|Withdrawal by Subject|4|||
130087664|NCT00135694|468274357|FG000|Overall Study|Protocol Violation|19|||
130087665|NCT00135694|468274358|FG001|Overall Study|Protocol Violation|1|||
130087666|NCT00135694|468274359|FG002|Overall Study|Protocol Violation|0|||
130087667|NCT00135694|468274357|FG000|Overall Study|Hepatitis C related reasons|39|||
130087668|NCT00135694|468274358|FG001|Overall Study|Hepatitis C related reasons|1|||
130087669|NCT00135694|468274359|FG002|Overall Study|Hepatitis C related reasons|0|||
130087670|NCT00135694|468274357|FG000|Overall Study|Ineligible for Random assignment|42|||
130087671|NCT00135694|468274358|FG001|Overall Study|Ineligible for Random assignment|0|||
130087672|NCT00135694|468274359|FG002|Overall Study|Ineligible for Random assignment|0|||
130087673|NCT00472043|468274361|FG000|Overall Study|Withdrawal by Subject|1|||
130087674|NCT00472043|468274362|FG001|Overall Study|Withdrawal by Subject|0|||
130087675|NCT00472043|468274361|FG000|Overall Study|Death|1|||
130087676|NCT00472043|468274362|FG001|Overall Study|Death|0|||
130087677|NCT02802735|468274363|FG000|Overall Study|Withdrawal by Subject|0|||
130087678|NCT02802735|468274364|FG001|Overall Study|Withdrawal by Subject|1|||
130087679|NCT02802735|468274365|FG002|Overall Study|Withdrawal by Subject|0|||
130087680|NCT02802735|468274366|FG003|Overall Study|Withdrawal by Subject|0|||
130087681|NCT02802735|468274367|FG004|Overall Study|Withdrawal by Subject|0|||
130087682|NCT03922711|468274368|FG000|Overall Study|Adverse Event|3|||
130087683|NCT03922711|468274369|FG001|Overall Study|Adverse Event|2|||
130087684|NCT03922711|468274370|FG002|Overall Study|Adverse Event|2|||
129960561|NCT01649297|467819547|FG003|Overall Study|Adverse Event|13|||
129960562|NCT01649297|467819548|FG004|Overall Study|Adverse Event|1|||
129960563|NCT01649297|467819544|FG000|Overall Study|Lack of Efficacy|0|||
130087685|NCT03922711|468274368|FG000|Overall Study|Protocol Violation|1|||
130087686|NCT03922711|468274369|FG001|Overall Study|Protocol Violation|0|||
130087687|NCT03922711|468274370|FG002|Overall Study|Protocol Violation|0|||
130087688|NCT03922711|468274368|FG000|Overall Study|Withdrawal by Subject|0|||
130087689|NCT03922711|468274369|FG001|Overall Study|Withdrawal by Subject|3|||
130087690|NCT03922711|468274370|FG002|Overall Study|Withdrawal by Subject|1|||
130087691|NCT03922711|468274368|FG000|Overall Study|Not further specified|0|||
130087692|NCT03922711|468274369|FG001|Overall Study|Not further specified|0|||
130087693|NCT03922711|468274370|FG002|Overall Study|Not further specified|1|||
129960564|NCT01649297|467819545|FG001|Overall Study|Lack of Efficacy|0|||
129960565|NCT01649297|467819546|FG002|Overall Study|Lack of Efficacy|0|||
129960566|NCT01649297|467819547|FG003|Overall Study|Lack of Efficacy|0|||
129960567|NCT01649297|467819548|FG004|Overall Study|Lack of Efficacy|1|||
129960568|NCT01649297|467819544|FG000|Overall Study|Non compliant with Protocol|1|||
129960569|NCT01649297|467819545|FG001|Overall Study|Non compliant with Protocol|0|||
129960570|NCT01649297|467819546|FG002|Overall Study|Non compliant with Protocol|3|||
129960571|NCT01649297|467819547|FG003|Overall Study|Non compliant with Protocol|2|||
129960572|NCT01649297|467819548|FG004|Overall Study|Non compliant with Protocol|1|||
129960573|NCT01649297|467819544|FG000|Overall Study|Lost to Follow-up|1|||
129960574|NCT01649297|467819545|FG001|Overall Study|Lost to Follow-up|1|||
129960575|NCT01649297|467819546|FG002|Overall Study|Lost to Follow-up|4|||
129960576|NCT01649297|467819547|FG003|Overall Study|Lost to Follow-up|3|||
129960577|NCT01649297|467819548|FG004|Overall Study|Lost to Follow-up|0|||
129960578|NCT01649297|467819544|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
129960579|NCT01649297|467819545|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
129960580|NCT01649297|467819546|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
129960581|NCT01649297|467819547|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
129960582|NCT01649297|467819548|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
129960583|NCT01649297|467819544|FG000|Overall Study|For other reason|4|||
129960584|NCT01649297|467819545|FG001|Overall Study|For other reason|1|||
129960585|NCT01649297|467819546|FG002|Overall Study|For other reason|2|||
129960586|NCT01649297|467819547|FG003|Overall Study|For other reason|0|||
129960587|NCT01649297|467819548|FG004|Overall Study|For other reason|0|||
129960588|NCT01685047|467819549|FG000|Overall Study|Withdrawal by Subject|20|||
129960589|NCT01685047|467819549|FG000|Overall Study|Death|26|||
129960590|NCT01685047|467819549|FG000|Overall Study|Lost to Follow-up|8|||
129960591|NCT01685047|467819549|FG000|Overall Study|Physician Decision|25|||
129960592|NCT01685047|467819549|FG000|Overall Study|Adverse Event|5|||
129960593|NCT01685047|467819549|FG000|Overall Study|patient withdrawn by sponsor|1|||
129960594|NCT02490878|467819556|FG000|Overall Study|deemed ineligible|0|||
129960595|NCT02490878|467819557|FG001|Overall Study|deemed ineligible|1|||
129960596|NCT02490878|467819556|FG000|Overall Study|progression prior to treatment|0|||
129960597|NCT02490878|467819557|FG001|Overall Study|progression prior to treatment|1|||
129960598|NCT02490878|467819556|FG000|Overall Study|only submitted baseline QOL|0|||
129960599|NCT02490878|467819557|FG001|Overall Study|only submitted baseline QOL|1|||
129960600|NCT00451555|467819558|FG000|Overall Study|Protocol Violation|2|||
129960601|NCT00451555|467819559|FG001|Overall Study|Protocol Violation|2|||
129960602|NCT00451555|467819558|FG000|Overall Study|Adverse Event|3|||
129960603|NCT00451555|467819559|FG001|Overall Study|Adverse Event|1|||
129960604|NCT00451555|467819558|FG000|Overall Study|Withdrawal by Subject|6|||
129960605|NCT00451555|467819559|FG001|Overall Study|Withdrawal by Subject|0|||
129960606|NCT00451555|467819558|FG000|Overall Study|Physician Decision|2|||
130121411|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
130121412|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
130121413|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
130121414|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
130121415|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
130121416|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
130121417|NCT02207231|468406772|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
130121418|NCT02207231|468406773|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
130121419|NCT02207231|468406774|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
130121420|NCT02207231|468406775|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
130121421|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
130121422|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
130121423|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
130121424|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
130121425|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
130121426|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
130121427|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
130121428|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
130121429|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
130121430|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
130121431|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
130121432|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
129960607|NCT00451555|467819559|FG001|Overall Study|Physician Decision|1|||
129960608|NCT00922441|467819562|FG000|Overall Study|Protocol Violation|0|||
129960609|NCT00922441|467819563|FG001|Overall Study|Protocol Violation|0|||
129960610|NCT00922441|467819564|FG002|Overall Study|Protocol Violation|2|||
129960611|NCT00922441|467819562|FG000|Overall Study|Withdrawal by Subject|0|||
129960612|NCT00922441|467819563|FG001|Overall Study|Withdrawal by Subject|0|||
129960613|NCT00922441|467819564|FG002|Overall Study|Withdrawal by Subject|1|||
129960614|NCT02973477|467819567|FG000|First Intervention|Lost to Follow-up|0|||
129960615|NCT02973477|467819568|FG001|First Intervention|Lost to Follow-up|2|||
129960616|NCT02973477|467819567|FG000|Washout|Withdrawal by Subject|1|||
129960617|NCT02973477|467819568|FG001|Washout|Withdrawal by Subject|0|||
129960618|NCT02973477|467819567|FG000|Second Intervention|Lost to Follow-up|1|||
129960619|NCT02973477|467819568|FG001|Second Intervention|Lost to Follow-up|0|||
129960620|NCT00317603|467819572|FG000|Overall Study|Progressive Disease|3|||
129960621|NCT00523549|467819575|FG000|Overall Study|Adverse Event|6|||
129960622|NCT00523549|467819576|FG001|Overall Study|Adverse Event|3|||
129960623|NCT00523549|467819575|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129960624|NCT00523549|467819576|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129960625|NCT00523549|467819575|FG000|Overall Study|Protocol Deviation|3|||
129960626|NCT00523549|467819576|FG001|Overall Study|Protocol Deviation|1|||
129960627|NCT00523549|467819575|FG000|Overall Study|Patient withdrew consent|7|||
129960628|NCT00523549|467819576|FG001|Overall Study|Patient withdrew consent|6|||
129960629|NCT00523549|467819575|FG000|Overall Study|Lost to Follow-up|3|||
129960630|NCT00523549|467819576|FG001|Overall Study|Lost to Follow-up|5|||
129960631|NCT00053352|467819581|FG000|Overall Study|Lost to Follow-up|0|||
129960632|NCT00053352|467819582|FG001|Overall Study|Lost to Follow-up|1|||
129960633|NCT00053352|467819581|FG000|Overall Study|Physician Decision|11|||
129960634|NCT00053352|467819582|FG001|Overall Study|Physician Decision|1|||
129960635|NCT00053352|467819581|FG000|Overall Study|Withdrawal by Subject|1|||
129960636|NCT00053352|467819582|FG001|Overall Study|Withdrawal by Subject|0|||
129960637|NCT00053352|467819581|FG000|Overall Study|Ineligible|8|||
129960638|NCT00053352|467819582|FG001|Overall Study|Ineligible|8|||
129960639|NCT00053352|467819581|FG000|Overall Study|Disease at new site|1|||
129960640|NCT00053352|467819582|FG001|Overall Study|Disease at new site|0|||
129960641|NCT00931918|467819583|FG000|Overall Study|Adverse Event|4|||
129960642|NCT00931918|467819584|FG001|Overall Study|Adverse Event|6|||
129960643|NCT00931918|467819583|FG000|Overall Study|Progressive Disease|2|||
129960644|NCT00931918|467819584|FG001|Overall Study|Progressive Disease|1|||
129960645|NCT00931918|467819583|FG000|Overall Study|Symptomatic Deterioration|1|||
129960646|NCT00931918|467819584|FG001|Overall Study|Symptomatic Deterioration|0|||
129960647|NCT00931918|467819583|FG000|Overall Study|Withdrawal by Patient|3|||
129960648|NCT00931918|467819584|FG001|Overall Study|Withdrawal by Patient|4|||
129960649|NCT00931918|467819583|FG000|Overall Study|Other Reason not Specified|4|||
129960650|NCT00931918|467819584|FG001|Overall Study|Other Reason not Specified|4|||
129960651|NCT00931918|467819583|FG000|Overall Study|Did not receive study drug|3|||
129960652|NCT00931918|467819584|FG001|Overall Study|Did not receive study drug|2|||
129960653|NCT00570921|467819585|FG000|Overall Study|Protocol Violation|1|||
129960654|NCT00570921|467819585|FG000|Overall Study|Physician Decision|1|||
129960655|NCT00784277|467819587|FG000|IR Treatment|Adverse Event|4|||
129960656|NCT00784277|467819588|FG001|IR Treatment|Adverse Event|8|||
129960657|NCT00784277|467819589|FG002|IR Treatment|Adverse Event|19|||
129960658|NCT00784277|467819590|FG003|IR Treatment|Adverse Event|35|||
129960659|NCT00784277|467819591|FG004|IR Treatment|Adverse Event|0|||
129960660|NCT00784277|467819592|FG005|IR Treatment|Adverse Event|0|||
129960661|NCT00784277|467819593|FG006|IR Treatment|Adverse Event|0|||
129960662|NCT00784277|467819587|FG000|IR Treatment|Lack of Efficacy|4|||
129960663|NCT00784277|467819588|FG001|IR Treatment|Lack of Efficacy|4|||
129960664|NCT00784277|467819589|FG002|IR Treatment|Lack of Efficacy|1|||
129960665|NCT00784277|467819590|FG003|IR Treatment|Lack of Efficacy|0|||
129960666|NCT00784277|467819591|FG004|IR Treatment|Lack of Efficacy|0|||
129960667|NCT00784277|467819592|FG005|IR Treatment|Lack of Efficacy|0|||
129960668|NCT00784277|467819593|FG006|IR Treatment|Lack of Efficacy|0|||
129960669|NCT00784277|467819587|FG000|IR Treatment|Lost to Follow-up|1|||
129960670|NCT00784277|467819588|FG001|IR Treatment|Lost to Follow-up|0|||
129960671|NCT00784277|467819589|FG002|IR Treatment|Lost to Follow-up|1|||
129960672|NCT00784277|467819590|FG003|IR Treatment|Lost to Follow-up|0|||
129960673|NCT00784277|467819591|FG004|IR Treatment|Lost to Follow-up|0|||
129960674|NCT00784277|467819592|FG005|IR Treatment|Lost to Follow-up|0|||
129960675|NCT00784277|467819593|FG006|IR Treatment|Lost to Follow-up|0|||
130087694|NCT00420212|468274373|FG000|Overall Study|Adverse Event|22|||
130087695|NCT00420212|468274374|FG001|Overall Study|Adverse Event|40|||
130087696|NCT00420212|468274375|FG002|Overall Study|Adverse Event|36|||
130087697|NCT00420212|468274373|FG000|Overall Study|Lost to Follow-up|9|||
130087698|NCT00420212|468274374|FG001|Overall Study|Lost to Follow-up|11|||
130087699|NCT00420212|468274375|FG002|Overall Study|Lost to Follow-up|11|||
130087700|NCT00420212|468274373|FG000|Overall Study|Withdrawal by Subject|31|||
129960676|NCT00784277|467819587|FG000|IR Treatment|Withdrawal by Subject|5|||
129960677|NCT00784277|467819588|FG001|IR Treatment|Withdrawal by Subject|1|||
129960678|NCT00784277|467819589|FG002|IR Treatment|Withdrawal by Subject|4|||
129960679|NCT00784277|467819590|FG003|IR Treatment|Withdrawal by Subject|6|||
129960680|NCT00784277|467819591|FG004|IR Treatment|Withdrawal by Subject|0|||
129960681|NCT00784277|467819592|FG005|IR Treatment|Withdrawal by Subject|0|||
129960682|NCT00784277|467819593|FG006|IR Treatment|Withdrawal by Subject|0|||
129960683|NCT00784277|467819587|FG000|IR Treatment|Resolution Of Pain|0|||
129960684|NCT00784277|467819588|FG001|IR Treatment|Resolution Of Pain|1|||
129960685|NCT00784277|467819589|FG002|IR Treatment|Resolution Of Pain|0|||
129960686|NCT00784277|467819590|FG003|IR Treatment|Resolution Of Pain|0|||
130087701|NCT00420212|468274374|FG001|Overall Study|Withdrawal by Subject|22|||
130087702|NCT00420212|468274375|FG002|Overall Study|Withdrawal by Subject|19|||
129960687|NCT00784277|467819591|FG004|IR Treatment|Resolution Of Pain|0|||
129960688|NCT00784277|467819592|FG005|IR Treatment|Resolution Of Pain|0|||
130087703|NCT00420212|468274373|FG000|Overall Study|Physician Decision|4|||
130087704|NCT00420212|468274374|FG001|Overall Study|Physician Decision|4|||
130087705|NCT00420212|468274375|FG002|Overall Study|Physician Decision|3|||
130087706|NCT00420212|468274373|FG000|Overall Study|Protocol Violation|4|||
130087707|NCT00420212|468274374|FG001|Overall Study|Protocol Violation|4|||
130087708|NCT00420212|468274375|FG002|Overall Study|Protocol Violation|8|||
130087709|NCT00420212|468274373|FG000|Overall Study|Death|0|||
130087710|NCT00420212|468274374|FG001|Overall Study|Death|0|||
130087711|NCT00420212|468274375|FG002|Overall Study|Death|1|||
130087712|NCT00420212|468274373|FG000|Overall Study|Other-Unspecified|21|||
130087713|NCT00420212|468274374|FG001|Overall Study|Other-Unspecified|14|||
130087714|NCT00420212|468274375|FG002|Overall Study|Other-Unspecified|18|||
130087715|NCT00877890|468274378|FG000|Overall Study|Adverse Event|6|||
130087716|NCT00877890|468274379|FG001|Overall Study|Adverse Event|6|||
130087717|NCT00877890|468274378|FG000|Overall Study|Lost to Follow-up|5|||
130087718|NCT00877890|468274379|FG001|Overall Study|Lost to Follow-up|5|||
130087719|NCT00877890|468274378|FG000|Overall Study|Protocol Violation|0|||
130087720|NCT00877890|468274379|FG001|Overall Study|Protocol Violation|1|||
130087721|NCT00877890|468274378|FG000|Overall Study|Withdrawal of Consent|6|||
130087722|NCT00877890|468274379|FG001|Overall Study|Withdrawal of Consent|12|||
130087723|NCT00877890|468274378|FG000|Overall Study|Investigator Decision|0|||
130087724|NCT00877890|468274379|FG001|Overall Study|Investigator Decision|2|||
130087725|NCT00877890|468274378|FG000|Overall Study|Loss of Glucose Control|3|||
130087726|NCT00877890|468274379|FG001|Overall Study|Loss of Glucose Control|4|||
130087727|NCT01058356|468274385|FG000|Overall Study|Adverse Event|5|||
130087728|NCT01058356|468274385|FG000|Overall Study|Administration of contraindicated drugs|12|||
130087729|NCT01058356|468274385|FG000|Overall Study|Withdrawal by Subject|21|||
130087730|NCT01058356|468274385|FG000|Overall Study|Lost to Follow-up|4|||
130087731|NCT00606021|468274392|FG000|Induction Phase|Death|73|||
130087732|NCT00606021|468274393|FG001|Induction Phase|Death|0|||
130087733|NCT00606021|468274394|FG002|Induction Phase|Death|0|||
130087734|NCT00606021|468274392|FG000|Induction Phase|Physician Decision|2|||
130087735|NCT00606021|468274393|FG001|Induction Phase|Physician Decision|0|||
130087736|NCT00606021|468274394|FG002|Induction Phase|Physician Decision|0|||
130087737|NCT00606021|468274392|FG000|Induction Phase|Withdrawal by Subject|2|||
130087738|NCT00606021|468274393|FG001|Induction Phase|Withdrawal by Subject|0|||
130087739|NCT00606021|468274394|FG002|Induction Phase|Withdrawal by Subject|0|||
130087740|NCT00606021|468274392|FG000|Induction Phase|Lost to Follow-up|10|||
130087741|NCT00606021|468274393|FG001|Induction Phase|Lost to Follow-up|0|||
130087742|NCT00606021|468274394|FG002|Induction Phase|Lost to Follow-up|0|||
130087743|NCT00606021|468274392|FG000|Maintenance Phase|Death|0|||
130087744|NCT00606021|468274393|FG001|Maintenance Phase|Death|17|||
130087745|NCT00606021|468274394|FG002|Maintenance Phase|Death|15|||
130087746|NCT00606021|468274392|FG000|Maintenance Phase|Physician Decision|0|||
130087747|NCT00606021|468274393|FG001|Maintenance Phase|Physician Decision|1|||
130087748|NCT00606021|468274394|FG002|Maintenance Phase|Physician Decision|0|||
130087749|NCT00606021|468274392|FG000|Maintenance Phase|Lost to Follow-up|0|||
130087750|NCT00606021|468274393|FG001|Maintenance Phase|Lost to Follow-up|5|||
130087751|NCT00606021|468274394|FG002|Maintenance Phase|Lost to Follow-up|2|||
130087752|NCT02067104|468274395|FG000|Overall Study|Study termination due to low accrual|4|||
130087753|NCT02067104|468274396|FG001|Overall Study|Study termination due to low accrual|5|||
130087754|NCT04815291|468274408|FG000|Overall Study|Lost to Follow-up|1|||
130087755|NCT04815291|468274408|FG000|Overall Study|Physician Decision|4|||
130087756|NCT04815291|468274408|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
130087757|NCT02140762|468274409|FG000|Overall Study|Adverse Event|1|||
130087758|NCT02140762|468274410|FG001|Overall Study|Adverse Event|1|||
130087759|NCT02140762|468274409|FG000|Overall Study|Lost to Follow-up|9|||
130087760|NCT02140762|468274410|FG001|Overall Study|Lost to Follow-up|5|||
130087761|NCT02140762|468274409|FG000|Overall Study|Protocol Violation|1|||
130121433|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
129960689|NCT00784277|467819593|FG006|IR Treatment|Resolution Of Pain|0|||
129960690|NCT00784277|467819587|FG000|IR Treatment|Other|2|||
130087762|NCT02140762|468274410|FG001|Overall Study|Protocol Violation|1|||
130087763|NCT02140762|468274409|FG000|Overall Study|Withdrawal by Subject|6|||
130087764|NCT02140762|468274410|FG001|Overall Study|Withdrawal by Subject|4|||
130087765|NCT02140762|468274409|FG000|Overall Study|Other|0|||
130087766|NCT02140762|468274410|FG001|Overall Study|Other|1|||
130087767|NCT00095836|468274412|FG000|Overall Study|Lost to Follow-up|1|||
130087768|NCT00095836|468274412|FG000|Overall Study|Adverse Event|1|||
130087769|NCT00095836|468274412|FG000|Overall Study|Death|2|||
130087770|NCT00962780|468274416|FG000|Overall Study|Death|0|||
130087771|NCT00962780|468274417|FG001|Overall Study|Death|1|||
130087772|NCT00962780|468274416|FG000|Overall Study|Protocol Violation|9|||
130087773|NCT00962780|468274417|FG001|Overall Study|Protocol Violation|4|||
130087774|NCT00962780|468274416|FG000|Overall Study|Withdrawal by Subject|1|||
130087775|NCT00962780|468274417|FG001|Overall Study|Withdrawal by Subject|8|||
129960691|NCT00784277|467819588|FG001|IR Treatment|Other|3|||
129960692|NCT00784277|467819589|FG002|IR Treatment|Other|3|||
129960693|NCT00784277|467819590|FG003|IR Treatment|Other|2|||
129960694|NCT00784277|467819591|FG004|IR Treatment|Other|0|||
129960695|NCT00784277|467819592|FG005|IR Treatment|Other|0|||
129960696|NCT00784277|467819593|FG006|IR Treatment|Other|0|||
129960697|NCT00784277|467819587|FG000|ER Treatment|Adverse Event|0|||
129960698|NCT00784277|467819588|FG001|ER Treatment|Adverse Event|0|||
129960699|NCT00784277|467819589|FG002|ER Treatment|Adverse Event|0|||
129960700|NCT00784277|467819590|FG003|ER Treatment|Adverse Event|0|||
129960701|NCT00784277|467819591|FG004|ER Treatment|Adverse Event|1|||
129960702|NCT00784277|467819592|FG005|ER Treatment|Adverse Event|7|||
129960703|NCT00784277|467819593|FG006|ER Treatment|Adverse Event|7|||
129960704|NCT00784277|467819587|FG000|ER Treatment|Lack of Efficacy|0|||
129960705|NCT00784277|467819588|FG001|ER Treatment|Lack of Efficacy|0|||
129960706|NCT00784277|467819589|FG002|ER Treatment|Lack of Efficacy|0|||
129960707|NCT00784277|467819590|FG003|ER Treatment|Lack of Efficacy|0|||
129960708|NCT00784277|467819591|FG004|ER Treatment|Lack of Efficacy|3|||
129960709|NCT00784277|467819592|FG005|ER Treatment|Lack of Efficacy|4|||
129960710|NCT00784277|467819593|FG006|ER Treatment|Lack of Efficacy|0|||
129960711|NCT00784277|467819587|FG000|ER Treatment|Lost to Follow-up|0|||
129960712|NCT00784277|467819588|FG001|ER Treatment|Lost to Follow-up|0|||
129960713|NCT00784277|467819589|FG002|ER Treatment|Lost to Follow-up|0|||
129960714|NCT00784277|467819590|FG003|ER Treatment|Lost to Follow-up|0|||
129960715|NCT00784277|467819591|FG004|ER Treatment|Lost to Follow-up|0|||
129960716|NCT00784277|467819592|FG005|ER Treatment|Lost to Follow-up|2|||
129960717|NCT00784277|467819593|FG006|ER Treatment|Lost to Follow-up|0|||
129960718|NCT00784277|467819587|FG000|ER Treatment|Withdrawal by Subject|0|||
129960719|NCT00784277|467819588|FG001|ER Treatment|Withdrawal by Subject|0|||
129960720|NCT00784277|467819589|FG002|ER Treatment|Withdrawal by Subject|0|||
129960721|NCT00784277|467819590|FG003|ER Treatment|Withdrawal by Subject|0|||
129960722|NCT00784277|467819591|FG004|ER Treatment|Withdrawal by Subject|2|||
129960723|NCT00784277|467819592|FG005|ER Treatment|Withdrawal by Subject|5|||
129960724|NCT00784277|467819593|FG006|ER Treatment|Withdrawal by Subject|3|||
129960725|NCT00784277|467819587|FG000|ER Treatment|Study Medication Non-Compliant|0|||
129960726|NCT00784277|467819588|FG001|ER Treatment|Study Medication Non-Compliant|0|||
129960727|NCT00784277|467819589|FG002|ER Treatment|Study Medication Non-Compliant|0|||
129960728|NCT00784277|467819590|FG003|ER Treatment|Study Medication Non-Compliant|0|||
129960729|NCT00784277|467819591|FG004|ER Treatment|Study Medication Non-Compliant|2|||
129960730|NCT00784277|467819592|FG005|ER Treatment|Study Medication Non-Compliant|3|||
129960731|NCT00784277|467819593|FG006|ER Treatment|Study Medication Non-Compliant|3|||
129960732|NCT00784277|467819587|FG000|ER Treatment|Other|0|||
129960733|NCT00784277|467819588|FG001|ER Treatment|Other|0|||
129960734|NCT00784277|467819589|FG002|ER Treatment|Other|0|||
129960735|NCT00784277|467819590|FG003|ER Treatment|Other|0|||
129960736|NCT00784277|467819591|FG004|ER Treatment|Other|1|||
129960737|NCT00784277|467819592|FG005|ER Treatment|Other|3|||
129960738|NCT00784277|467819593|FG006|ER Treatment|Other|2|||
129960739|NCT00588341|467819594|FG000|Overall Study|Withdrawal by Subject|3|||
129960740|NCT00588341|467819594|FG000|Overall Study|Not treated due to metastatic disease|1|||
129960741|NCT00588341|467819594|FG000|Overall Study|Patient ineligible|1|||
129960742|NCT00745121|467819598|FG000|Overall Study|Death|3|||
129960743|NCT00745121|467819599|FG001|Overall Study|Death|0|||
129960744|NCT00745121|467819598|FG000|Overall Study|Adverse Event|1|||
129960745|NCT00745121|467819599|FG001|Overall Study|Adverse Event|0|||
129960746|NCT00745121|467819598|FG000|Overall Study|Lost to Follow-up|1|||
129960747|NCT00745121|467819599|FG001|Overall Study|Lost to Follow-up|0|||
129960748|NCT00745121|467819598|FG000|Overall Study|Withdrawal by Subject|4|||
129960749|NCT00745121|467819599|FG001|Overall Study|Withdrawal by Subject|2|||
129960750|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
129960751|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960752|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960753|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960754|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960755|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
129960756|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960757|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960758|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960759|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960760|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
129960761|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960762|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960763|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960764|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960765|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
129960766|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129960767|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130087776|NCT00962780|468274416|FG000|Overall Study|Other|0|||
130087777|NCT00962780|468274417|FG001|Overall Study|Other|1|||
130087778|NCT02363322|468274418|FG000|Overall Study|Lost to Follow-up|1|||
130087779|NCT02363322|468274419|FG001|Overall Study|Lost to Follow-up|0|||
130087780|NCT02055976|468274420|FG000|Overall Study|Other|0|||
130087781|NCT02055976|468274421|FG001|Overall Study|Other|0|||
130087782|NCT02055976|468274422|FG002|Overall Study|Other|1|||
130087783|NCT02055976|468274423|FG003|Overall Study|Other|0|||
130087784|NCT02055976|468274424|FG004|Overall Study|Other|0|||
130087785|NCT02055976|468274425|FG005|Overall Study|Other|0|||
130087786|NCT02055976|468274426|FG006|Overall Study|Other|0|||
130087787|NCT02055976|468274427|FG007|Overall Study|Other|0|||
130087788|NCT02055976|468274428|FG008|Overall Study|Other|0|||
130087789|NCT02055976|468274420|FG000|Overall Study|Adverse Event|0|||
130087790|NCT02055976|468274421|FG001|Overall Study|Adverse Event|0|||
130087791|NCT02055976|468274422|FG002|Overall Study|Adverse Event|0|||
130087792|NCT02055976|468274423|FG003|Overall Study|Adverse Event|0|||
130087793|NCT02055976|468274424|FG004|Overall Study|Adverse Event|0|||
130087794|NCT02055976|468274425|FG005|Overall Study|Adverse Event|1|||
130087795|NCT02055976|468274426|FG006|Overall Study|Adverse Event|1|||
130087796|NCT02055976|468274427|FG007|Overall Study|Adverse Event|0|||
130087797|NCT02055976|468274428|FG008|Overall Study|Adverse Event|0|||
130087798|NCT02055976|468274420|FG000|Overall Study|Does not meet entrance criteria|0|||
130087799|NCT02055976|468274421|FG001|Overall Study|Does not meet entrance criteria|0|||
130087800|NCT02055976|468274422|FG002|Overall Study|Does not meet entrance criteria|0|||
130087801|NCT02055976|468274423|FG003|Overall Study|Does not meet entrance criteria|0|||
130087802|NCT02055976|468274424|FG004|Overall Study|Does not meet entrance criteria|0|||
130087803|NCT02055976|468274425|FG005|Overall Study|Does not meet entrance criteria|0|||
130087804|NCT02055976|468274426|FG006|Overall Study|Does not meet entrance criteria|1|||
130087805|NCT02055976|468274427|FG007|Overall Study|Does not meet entrance criteria|0|||
130087806|NCT02055976|468274428|FG008|Overall Study|Does not meet entrance criteria|0|||
130087807|NCT02055976|468274420|FG000|Overall Study|Lost to Follow-up|0|||
130087808|NCT02055976|468274421|FG001|Overall Study|Lost to Follow-up|0|||
130087809|NCT02055976|468274422|FG002|Overall Study|Lost to Follow-up|0|||
130087810|NCT02055976|468274423|FG003|Overall Study|Lost to Follow-up|1|||
130087811|NCT02055976|468274424|FG004|Overall Study|Lost to Follow-up|0|||
130087812|NCT02055976|468274425|FG005|Overall Study|Lost to Follow-up|0|||
130087813|NCT02055976|468274426|FG006|Overall Study|Lost to Follow-up|0|||
130087814|NCT02055976|468274427|FG007|Overall Study|Lost to Follow-up|0|||
130087815|NCT02055976|468274428|FG008|Overall Study|Lost to Follow-up|0|||
130087816|NCT00027846|468276232|FG000|Overall Study|Lost to Follow-up|0|||
130087817|NCT00027846|468276233|FG001|Overall Study|Lost to Follow-up|41|||
130087818|NCT00027846|468276234|FG002|Overall Study|Lost to Follow-up|9|||
130087819|NCT00027846|468276232|FG000|Overall Study|Withdrawal by Subject|0|||
130087820|NCT00027846|468276233|FG001|Overall Study|Withdrawal by Subject|14|||
130087821|NCT00027846|468276234|FG002|Overall Study|Withdrawal by Subject|7|||
130087822|NCT00027846|468276232|FG000|Overall Study|Ineligible for study|2|||
130087823|NCT00027846|468276233|FG001|Overall Study|Ineligible for study|6|||
130087824|NCT00027846|468276234|FG002|Overall Study|Ineligible for study|14|||
130087825|NCT00027846|468276232|FG000|Overall Study|Entry into another COG therapeutic study|0|||
130087826|NCT00027846|468276233|FG001|Overall Study|Entry into another COG therapeutic study|5|||
130087827|NCT00027846|468276234|FG002|Overall Study|Entry into another COG therapeutic study|2|||
130087828|NCT00027846|468276232|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
130087829|NCT00027846|468276233|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
130087830|NCT00027846|468276234|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
130087831|NCT05604781|468276240|FG000|Overall Study|Lost to Follow-up|3|||
130087832|NCT05604781|468276240|FG000|Overall Study|Adverse Event|1|||
130087833|NCT02889861|468276251|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
130087834|NCT01864746|468276252|FG000|Overall Study|Disease recurrence|25|||
130087835|NCT01864746|468276253|FG001|Overall Study|Disease recurrence|40|||
130087836|NCT01864746|468276252|FG000|Overall Study|Second primary invasive nonbreast|2|||
130087837|NCT01864746|468276253|FG001|Overall Study|Second primary invasive nonbreast|3|||
130087838|NCT01864746|468276252|FG000|Overall Study|Death|2|||
129960768|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129960769|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
130087839|NCT01864746|468276253|FG001|Overall Study|Death|1|||
130087840|NCT01864746|468276252|FG000|Overall Study|Adverse Event|33|||
130087841|NCT01864746|468276253|FG001|Overall Study|Adverse Event|5|||
130087842|NCT01864746|468276252|FG000|Overall Study|Withdrawal by Subject|56|||
130087843|NCT01864746|468276253|FG001|Overall Study|Withdrawal by Subject|41|||
130087844|NCT01864746|468276252|FG000|Overall Study|Physician Decision|5|||
130087845|NCT01864746|468276253|FG001|Overall Study|Physician Decision|6|||
130087846|NCT01005966|468276254|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130087847|NCT01005966|468276255|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130087848|NCT01005966|468276256|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
130087849|NCT01005966|468276257|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
130087850|NCT01005966|468276258|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
130121434|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
130121435|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
130121436|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
130121437|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
130121438|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
130121439|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
130121440|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
130121441|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
130121442|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
130121443|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
130121444|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
130121445|NCT02207231|468406772|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
130121446|NCT02207231|468406773|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
130121447|NCT02207231|468406774|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
130121448|NCT02207231|468406775|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
130121449|NCT00502775|468406778|FG000|Overall Study|Adverse Event|1|||
130121450|NCT00502775|468406779|FG001|Overall Study|Adverse Event|2|||
130121451|NCT00502775|468406780|FG002|Overall Study|Adverse Event|1|||
130121452|NCT00502775|468406778|FG000|Overall Study|Protocol Violation|1|||
130121453|NCT00502775|468406779|FG001|Overall Study|Protocol Violation|5|||
130121454|NCT00502775|468406780|FG002|Overall Study|Protocol Violation|2|||
130121455|NCT00502775|468406778|FG000|Overall Study|Withdrawal by Subject|1|||
130121456|NCT00502775|468406779|FG001|Overall Study|Withdrawal by Subject|1|||
130121457|NCT00502775|468406780|FG002|Overall Study|Withdrawal by Subject|2|||
130121458|NCT00502775|468406778|FG000|Overall Study|Sponsor Terminated Study|1|||
130121459|NCT00502775|468406779|FG001|Overall Study|Sponsor Terminated Study|0|||
130121460|NCT00502775|468406780|FG002|Overall Study|Sponsor Terminated Study|1|||
130121461|NCT00502775|468406778|FG000|Overall Study|Non-compliance with eDiary|4|||
130121462|NCT00502775|468406779|FG001|Overall Study|Non-compliance with eDiary|1|||
130121463|NCT00502775|468406780|FG002|Overall Study|Non-compliance with eDiary|1|||
130121464|NCT00502775|468406778|FG000|Overall Study|Subject unable to swallow capsule|1|||
130121465|NCT00502775|468406779|FG001|Overall Study|Subject unable to swallow capsule|0|||
130121466|NCT00502775|468406780|FG002|Overall Study|Subject unable to swallow capsule|1|||
130121467|NCT00502775|468406778|FG000|Overall Study|Logpad compliance <80%|1|||
130121468|NCT00502775|468406779|FG001|Overall Study|Logpad compliance <80%|0|||
130121469|NCT00502775|468406780|FG002|Overall Study|Logpad compliance <80%|0|||
130121470|NCT00502775|468406778|FG000|Overall Study|Randomized in error|0|||
130121471|NCT00502775|468406779|FG001|Overall Study|Randomized in error|1|||
130121472|NCT00502775|468406780|FG002|Overall Study|Randomized in error|1|||
130121473|NCT00502775|468406778|FG000|Overall Study|Non-compliance|0|||
130121474|NCT00502775|468406779|FG001|Overall Study|Non-compliance|2|||
130121475|NCT00502775|468406780|FG002|Overall Study|Non-compliance|2|||
130121476|NCT00502775|468406778|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
130121477|NCT00502775|468406779|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
130121478|NCT00502775|468406780|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
130121479|NCT00502775|468406778|FG000|Overall Study|Declining pollen counts|0|||
130121480|NCT00502775|468406779|FG001|Overall Study|Declining pollen counts|1|||
130121481|NCT00502775|468406780|FG002|Overall Study|Declining pollen counts|1|||
129960770|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
129960771|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960772|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960773|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960774|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960775|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
129960776|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960777|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960778|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960779|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960780|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
129960781|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960782|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960783|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960784|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960785|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
129960786|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
129960787|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
130121482|NCT00502775|468406778|FG000|Overall Study|Subject in jail|0|||
130121483|NCT00502775|468406779|FG001|Overall Study|Subject in jail|1|||
130121484|NCT00502775|468406780|FG002|Overall Study|Subject in jail|0|||
130121485|NCT00502775|468406778|FG000|Overall Study|Subject took disallowed drug|0|||
130121486|NCT00502775|468406779|FG001|Overall Study|Subject took disallowed drug|0|||
129960788|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
129960789|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
129960790|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
129960791|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
129960792|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
129960793|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
129960794|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
129960795|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129960796|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
129960797|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
129960798|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
129960799|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
129960800|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129960801|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129960802|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129960803|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129960804|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129960805|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
129960806|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
129960807|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129960808|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
129960809|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
129960810|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
129960811|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
129960812|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
129960813|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
129960814|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
129960815|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129960816|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129960817|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129960818|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129960819|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
129960820|NCT00640042|467819611|FG000|Enrollment|Did not receive study drug|83|||
129960821|NCT01363297|467819622|FG000|Overall Study|Other|0|||
129960822|NCT01363297|467819623|FG001|Overall Study|Other|0|||
129960823|NCT01363297|467819624|FG002|Overall Study|Other|0|||
129960824|NCT01363297|467819625|FG003|Overall Study|Other|0|||
129960825|NCT01363297|467819626|FG004|Overall Study|Other|1|||
129960826|NCT01363297|467819622|FG000|Overall Study|Death|3|||
129960827|NCT01363297|467819623|FG001|Overall Study|Death|6|||
129960828|NCT01363297|467819624|FG002|Overall Study|Death|6|||
129960829|NCT01363297|467819625|FG003|Overall Study|Death|10|||
129960830|NCT01363297|467819626|FG004|Overall Study|Death|30|||
129960831|NCT02515097|467819627|FG000|Overall Study|Lost to Follow-up|4|||
129960832|NCT02515097|467819628|FG001|Overall Study|Lost to Follow-up|2|||
129960833|NCT02515097|467819627|FG000|Overall Study|Withdrawal by Subject|1|||
129960834|NCT02515097|467819628|FG001|Overall Study|Withdrawal by Subject|3|||
129960835|NCT02515097|467819627|FG000|Overall Study|Adverse Event|2|||
129960836|NCT02515097|467819628|FG001|Overall Study|Adverse Event|1|||
129960837|NCT01180790|467819634|FG000|Overall Study|Adverse Event|1|||
129960838|NCT01180790|467819635|FG001|Overall Study|Adverse Event|1|||
129960839|NCT01180790|467819636|FG002|Overall Study|Adverse Event|2|||
129960840|NCT01180790|467819637|FG003|Overall Study|Adverse Event|0|||
129960841|NCT01180790|467819638|FG004|Overall Study|Adverse Event|1|||
129960842|NCT01180790|467819639|FG005|Overall Study|Adverse Event|3|||
129960843|NCT01180790|467819640|FG006|Overall Study|Adverse Event|0|||
129960844|NCT01180790|467819634|FG000|Overall Study|Withdrawal by Subject|3|||
129960845|NCT01180790|467819635|FG001|Overall Study|Withdrawal by Subject|0|||
129960846|NCT01180790|467819636|FG002|Overall Study|Withdrawal by Subject|5|||
129960847|NCT01180790|467819637|FG003|Overall Study|Withdrawal by Subject|0|||
129960848|NCT01180790|467819638|FG004|Overall Study|Withdrawal by Subject|2|||
129960849|NCT01180790|467819639|FG005|Overall Study|Withdrawal by Subject|1|||
129960850|NCT01180790|467819640|FG006|Overall Study|Withdrawal by Subject|0|||
129960851|NCT01180790|467819634|FG000|Overall Study|Lost to Follow-up|3|||
129960852|NCT01180790|467819635|FG001|Overall Study|Lost to Follow-up|1|||
129960853|NCT01180790|467819636|FG002|Overall Study|Lost to Follow-up|0|||
129960854|NCT01180790|467819637|FG003|Overall Study|Lost to Follow-up|2|||
129960855|NCT01180790|467819638|FG004|Overall Study|Lost to Follow-up|1|||
129960856|NCT01180790|467819639|FG005|Overall Study|Lost to Follow-up|0|||
129960857|NCT01180790|467819640|FG006|Overall Study|Lost to Follow-up|1|||
129960858|NCT01180790|467819634|FG000|Overall Study|Physician Decision|1|||
129960859|NCT01180790|467819635|FG001|Overall Study|Physician Decision|0|||
130087851|NCT01005966|468276254|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130087852|NCT01005966|468276255|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
130087853|NCT01005966|468276256|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130087854|NCT01005966|468276257|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
130087855|NCT01005966|468276258|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
130087856|NCT01005966|468276254|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130087857|NCT01005966|468276255|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130087858|NCT01005966|468276256|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130087859|NCT01005966|468276257|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
130087860|NCT01005966|468276258|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
130087861|NCT01005966|468276254|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
130087862|NCT01005966|468276255|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
130087863|NCT01005966|468276256|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
130087864|NCT01005966|468276257|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
130087865|NCT01005966|468276258|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
130087866|NCT01005966|468276254|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130087867|NCT01005966|468276255|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130087868|NCT01005966|468276256|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130087869|NCT01005966|468276257|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
130087870|NCT01005966|468276258|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
130087871|NCT01005966|468276254|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130087872|NCT01005966|468276255|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130087873|NCT01005966|468276256|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
130087874|NCT01005966|468276257|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130087875|NCT01005966|468276258|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
130087876|NCT01005966|468276254|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
130087877|NCT01005966|468276255|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
130087878|NCT01005966|468276256|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
130087879|NCT01005966|468276257|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
130087880|NCT01005966|468276258|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
130087881|NCT01005966|468276254|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130087882|NCT01005966|468276255|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
130087883|NCT01005966|468276256|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130087884|NCT01005966|468276257|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130087885|NCT01005966|468276258|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
130087886|NCT01005966|468276254|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
130087887|NCT01005966|468276255|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
130087888|NCT01005966|468276256|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
130087889|NCT01005966|468276257|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
130087890|NCT01005966|468276258|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
130087891|NCT01451203|468276259|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
130087892|NCT01451203|468276260|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
130087893|NCT01451203|468276259|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
130087894|NCT01451203|468276260|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
130087895|NCT01451203|468276259|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
130087896|NCT01451203|468276260|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
130087897|NCT01451203|468276259|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
130087898|NCT01451203|468276260|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
130087899|NCT01451203|468276259|FG000|Double-blind Treatment Period|Adverse Event|6|||
130087900|NCT01451203|468276260|FG001|Double-blind Treatment Period|Adverse Event|9|||
130087901|NCT01451203|468276259|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
130087902|NCT01451203|468276260|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
130087903|NCT01451203|468276259|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
130087904|NCT01451203|468276260|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
130087905|NCT01451203|468276259|FG000|Double-blind Treatment Period|Investigator decision|2|||
130087906|NCT01451203|468276260|FG001|Double-blind Treatment Period|Investigator decision|0|||
130087907|NCT01451203|468276259|FG000|Post-treatment Period|Consent withdrawn|2|||
130087908|NCT01451203|468276260|FG001|Post-treatment Period|Consent withdrawn|4|||
130087909|NCT01451203|468276259|FG000|Post-treatment Period|Lack of Efficacy|12|||
130087910|NCT01451203|468276260|FG001|Post-treatment Period|Lack of Efficacy|28|||
130087911|NCT01451203|468276259|FG000|Post-treatment Period|Adverse Event|0|||
130087912|NCT01451203|468276260|FG001|Post-treatment Period|Adverse Event|1|||
130087913|NCT01451203|468276259|FG000|Post-treatment Period|Investigator decision|0|||
130087914|NCT01451203|468276260|FG001|Post-treatment Period|Investigator decision|1|||
130087915|NCT03890731|468276261|FG000|Overall Study|Progressive disease|1|||
130087916|NCT03890731|468276261|FG000|Overall Study|Patient's decision|1|||
130087917|NCT03890731|468276261|FG000|Overall Study|Adverse Event|4|||
130087918|NCT00027027|468276265|FG000|Overall Study|Adverse Event|0|||
130087919|NCT00027027|468276266|FG001|Overall Study|Adverse Event|0|||
130087920|NCT00027027|468276267|FG002|Overall Study|Adverse Event|1|||
130087921|NCT00027027|468276268|FG003|Overall Study|Adverse Event|0|||
130087922|NCT00027027|468276269|FG004|Overall Study|Adverse Event|1|||
130087923|NCT00027027|468276265|FG000|Overall Study|Admitted for Signs of PD|0|||
130087924|NCT00027027|468276266|FG001|Overall Study|Admitted for Signs of PD|0|||
130087925|NCT00027027|468276267|FG002|Overall Study|Admitted for Signs of PD|0|||
130087926|NCT00027027|468276268|FG003|Overall Study|Admitted for Signs of PD|0|||
130087927|NCT00027027|468276269|FG004|Overall Study|Admitted for Signs of PD|1|||
130087928|NCT00027027|468276265|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
130087929|NCT00027027|468276266|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
130087930|NCT00027027|468276267|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
130087931|NCT00027027|468276268|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
130087932|NCT00027027|468276269|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
130087933|NCT00027027|468276265|FG000|Overall Study|PD Requiring Surgery|0|||
130087934|NCT00027027|468276266|FG001|Overall Study|PD Requiring Surgery|0|||
130087935|NCT00027027|468276267|FG002|Overall Study|PD Requiring Surgery|1|||
130087936|NCT00027027|468276268|FG003|Overall Study|PD Requiring Surgery|0|||
130087937|NCT00027027|468276269|FG004|Overall Study|PD Requiring Surgery|0|||
130087938|NCT00027027|468276265|FG000|Overall Study|Physician Decision Due To PD|2|||
130087939|NCT00027027|468276266|FG001|Overall Study|Physician Decision Due To PD|3|||
130087940|NCT00027027|468276267|FG002|Overall Study|Physician Decision Due To PD|2|||
130087941|NCT00027027|468276268|FG003|Overall Study|Physician Decision Due To PD|3|||
130087942|NCT00027027|468276269|FG004|Overall Study|Physician Decision Due To PD|5|||
130087943|NCT00027027|468276265|FG000|Overall Study|Withdrawal by Subject|0|||
130087944|NCT00027027|468276266|FG001|Overall Study|Withdrawal by Subject|0|||
130087945|NCT00027027|468276267|FG002|Overall Study|Withdrawal by Subject|0|||
130087946|NCT00027027|468276268|FG003|Overall Study|Withdrawal by Subject|0|||
130087947|NCT00027027|468276269|FG004|Overall Study|Withdrawal by Subject|1|||
130087948|NCT02039687|468276275|FG000|Overall Study|Adverse Event|0|||
130087949|NCT02039687|468276276|FG001|Overall Study|Adverse Event|0|||
130087950|NCT02039687|468276277|FG002|Overall Study|Adverse Event|1|||
130087951|NCT02039687|468276278|FG003|Overall Study|Adverse Event|0|||
130087952|NCT02039687|468276275|FG000|Overall Study|Withdrawal by Subject|0|||
130087953|NCT02039687|468276276|FG001|Overall Study|Withdrawal by Subject|1|||
130087954|NCT02039687|468276277|FG002|Overall Study|Withdrawal by Subject|0|||
130087955|NCT02039687|468276278|FG003|Overall Study|Withdrawal by Subject|0|||
130087956|NCT02039687|468276275|FG000|Overall Study|treatment assignment could not be confir|0|||
130087957|NCT02039687|468276276|FG001|Overall Study|treatment assignment could not be confir|0|||
130087958|NCT02039687|468276277|FG002|Overall Study|treatment assignment could not be confir|2|||
130087959|NCT02039687|468276278|FG003|Overall Study|treatment assignment could not be confir|0|||
130087960|NCT00303329|468276290|FG000|Overall Study|Adverse Event|7|||
130087961|NCT00303329|468276291|FG001|Overall Study|Adverse Event|14|||
130087962|NCT00303329|468276290|FG000|Overall Study|Abnormal Laboratory Values|0|||
130087963|NCT00303329|468276291|FG001|Overall Study|Abnormal Laboratory Values|1|||
130087964|NCT00303329|468276290|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
130087965|NCT00303329|468276291|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130087966|NCT00303329|468276290|FG000|Overall Study|Condition no longer requires study drug|0|||
130087967|NCT00303329|468276291|FG001|Overall Study|Condition no longer requires study drug|8|||
130087968|NCT00303329|468276290|FG000|Overall Study|Protocol Violation|3|||
130087969|NCT00303329|468276291|FG001|Overall Study|Protocol Violation|0|||
130087970|NCT00303329|468276290|FG000|Overall Study|Withdrawal by Subject|9|||
130087971|NCT00303329|468276291|FG001|Overall Study|Withdrawal by Subject|15|||
130087972|NCT00303329|468276290|FG000|Overall Study|Lost to Follow-up|0|||
130087973|NCT00303329|468276291|FG001|Overall Study|Lost to Follow-up|1|||
130087974|NCT00303329|468276290|FG000|Overall Study|Administrative problems|1|||
130087975|NCT00303329|468276291|FG001|Overall Study|Administrative problems|0|||
130087976|NCT00303329|468276290|FG000|Overall Study|Death|2|||
130087977|NCT00303329|468276291|FG001|Overall Study|Death|12|||
130087978|NCT00303329|468276290|FG000|Overall Study|Stopped at end of core|3|||
130087979|NCT00303329|468276291|FG001|Overall Study|Stopped at end of core|9|||
130087980|NCT00303329|468276290|FG000|Overall Study|Stopped at end of extension 1|1|||
130087981|NCT00303329|468276291|FG001|Overall Study|Stopped at end of extension 1|0|||
130087982|NCT02967562|468276292|FG000|Overall Study|Consent not obtained|1|||
130087983|NCT02967562|468276293|FG001|Overall Study|Consent not obtained|0|||
130087984|NCT02967562|468276292|FG000|Overall Study|High leak precluding analysis|1|||
130087985|NCT02967562|468276293|FG001|Overall Study|High leak precluding analysis|1|||
130087986|NCT00106626|468276294|FG000|Overall Study|Adverse Event|5|||
130087987|NCT00106626|468276295|FG001|Overall Study|Adverse Event|4|||
130087988|NCT00106626|468276296|FG002|Overall Study|Adverse Event|3|||
130087989|NCT00106626|468276297|FG003|Overall Study|Adverse Event|3|||
130087990|NCT00106626|468276294|FG000|Overall Study|Progressive Disease|4|||
130087991|NCT00106626|468276295|FG001|Overall Study|Progressive Disease|1|||
130087992|NCT00106626|468276296|FG002|Overall Study|Progressive Disease|9|||
130087993|NCT00106626|468276297|FG003|Overall Study|Progressive Disease|10|||
130087994|NCT00106626|468276294|FG000|Overall Study|Received radiation on new therapy|1|||
130087995|NCT00106626|468276295|FG001|Overall Study|Received radiation on new therapy|0|||
130087996|NCT00106626|468276296|FG002|Overall Study|Received radiation on new therapy|0|||
130087997|NCT00106626|468276297|FG003|Overall Study|Received radiation on new therapy|0|||
130087998|NCT00106626|468276294|FG000|Overall Study|> 14 day delay in therapy start|0|||
130087999|NCT00106626|468276295|FG001|Overall Study|> 14 day delay in therapy start|1|||
130088000|NCT00106626|468276296|FG002|Overall Study|> 14 day delay in therapy start|0|||
130088001|NCT00106626|468276297|FG003|Overall Study|> 14 day delay in therapy start|0|||
130088002|NCT00672139|468276302|FG000|Overall Study|Death|14|||
130088003|NCT00672139|468276303|FG001|Overall Study|Death|23|||
130088004|NCT00672139|468276302|FG000|Overall Study|Withdrawal by Subject|2|||
130088005|NCT00672139|468276303|FG001|Overall Study|Withdrawal by Subject|11|||
130088006|NCT00672139|468276302|FG000|Overall Study|Adverse Event|4|||
130088007|NCT00672139|468276303|FG001|Overall Study|Adverse Event|7|||
130088008|NCT00672139|468276302|FG000|Overall Study|Physician Decision|2|||
130088009|NCT00672139|468276303|FG001|Overall Study|Physician Decision|0|||
130088010|NCT00672139|468276302|FG000|Overall Study|Lack of Efficacy|4|||
130088011|NCT00672139|468276303|FG001|Overall Study|Lack of Efficacy|1|||
130088012|NCT00672139|468276302|FG000|Overall Study|Protocol Violation|1|||
130088013|NCT00672139|468276303|FG001|Overall Study|Protocol Violation|1|||
130088014|NCT00672139|468276302|FG000|Overall Study|hospice discharge, caregiver requests|3|||
130088015|NCT00672139|468276303|FG001|Overall Study|hospice discharge, caregiver requests|2|||
130088016|NCT01038635|468276310|FG000|Overall Study|Disease Progression|2|||
130088017|NCT01038635|468276311|FG001|Overall Study|Disease Progression|0|||
130088018|NCT01038635|468276312|FG002|Overall Study|Disease Progression|0|||
130088019|NCT01038635|468276313|FG003|Overall Study|Disease Progression|0|||
130088020|NCT01038635|468276314|FG004|Overall Study|Disease Progression|0|||
130088021|NCT01038635|468276315|FG005|Overall Study|Disease Progression|0|||
130088022|NCT01038635|468276316|FG006|Overall Study|Disease Progression|1|||
130088023|NCT01038635|468276317|FG007|Overall Study|Disease Progression|4|||
129960860|NCT01180790|467819636|FG002|Overall Study|Physician Decision|0|||
129960861|NCT01180790|467819637|FG003|Overall Study|Physician Decision|1|||
129960862|NCT01180790|467819638|FG004|Overall Study|Physician Decision|0|||
129960863|NCT01180790|467819639|FG005|Overall Study|Physician Decision|0|||
129960864|NCT01180790|467819640|FG006|Overall Study|Physician Decision|0|||
129960865|NCT01180790|467819634|FG000|Overall Study|Lack of Efficacy|1|||
129960866|NCT01180790|467819635|FG001|Overall Study|Lack of Efficacy|2|||
129960867|NCT01180790|467819636|FG002|Overall Study|Lack of Efficacy|5|||
129960868|NCT01180790|467819637|FG003|Overall Study|Lack of Efficacy|6|||
129960869|NCT01180790|467819638|FG004|Overall Study|Lack of Efficacy|1|||
129960870|NCT01180790|467819639|FG005|Overall Study|Lack of Efficacy|3|||
129960871|NCT01180790|467819640|FG006|Overall Study|Lack of Efficacy|0|||
129960872|NCT01180790|467819634|FG000|Overall Study|compliance|0|||
129960873|NCT01180790|467819635|FG001|Overall Study|compliance|1|||
129960874|NCT01180790|467819636|FG002|Overall Study|compliance|0|||
129960875|NCT01180790|467819637|FG003|Overall Study|compliance|0|||
129960876|NCT01180790|467819638|FG004|Overall Study|compliance|0|||
129960877|NCT01180790|467819639|FG005|Overall Study|compliance|0|||
129960878|NCT01180790|467819640|FG006|Overall Study|compliance|0|||
129960879|NCT01180790|467819634|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960880|NCT01180790|467819635|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960881|NCT01180790|467819636|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
129960882|NCT01180790|467819637|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960883|NCT01180790|467819638|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960884|NCT01180790|467819639|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960885|NCT01180790|467819640|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960886|NCT01568112|467819643|FG000|Overall Study|Randomized But Not Treated|0|||
129960887|NCT01568112|467819644|FG001|Overall Study|Randomized But Not Treated|1|||
129960888|NCT01568112|467819645|FG002|Overall Study|Randomized But Not Treated|0|||
129960889|NCT01568112|467819646|FG003|Overall Study|Randomized But Not Treated|0|||
129960890|NCT01568112|467819643|FG000|Overall Study|Withdrew due to Adverse Event|2|||
129960891|NCT01568112|467819644|FG001|Overall Study|Withdrew due to Adverse Event|4|||
129960892|NCT01568112|467819645|FG002|Overall Study|Withdrew due to Adverse Event|6|||
129960893|NCT01568112|467819646|FG003|Overall Study|Withdrew due to Adverse Event|3|||
129960894|NCT01568112|467819643|FG000|Overall Study|Lost to Follow-up|0|||
130088024|NCT01038635|468276318|FG008|Overall Study|Disease Progression|0|||
130088025|NCT01038635|468276310|FG000|Overall Study|Death|0|||
130088026|NCT01038635|468276311|FG001|Overall Study|Death|0|||
129960895|NCT01568112|467819644|FG001|Overall Study|Lost to Follow-up|0|||
129960896|NCT01568112|467819645|FG002|Overall Study|Lost to Follow-up|0|||
129960897|NCT01568112|467819646|FG003|Overall Study|Lost to Follow-up|1|||
129960898|NCT01568112|467819643|FG000|Overall Study|Withdrawal by Subject|2|||
129960899|NCT01568112|467819644|FG001|Overall Study|Withdrawal by Subject|3|||
130088027|NCT01038635|468276312|FG002|Overall Study|Death|0|||
129960900|NCT01568112|467819645|FG002|Overall Study|Withdrawal by Subject|0|||
130088028|NCT01038635|468276313|FG003|Overall Study|Death|0|||
130088029|NCT01038635|468276314|FG004|Overall Study|Death|1|||
130088030|NCT01038635|468276315|FG005|Overall Study|Death|0|||
130088031|NCT01038635|468276316|FG006|Overall Study|Death|1|||
130088032|NCT01038635|468276317|FG007|Overall Study|Death|1|||
130088033|NCT01038635|468276318|FG008|Overall Study|Death|2|||
130088034|NCT01562327|468276319|FG000|Overall Study|Adverse Event|2|||
130088035|NCT01562327|468276319|FG000|Overall Study|Lack of Efficacy|1|||
130088036|NCT01562327|468276319|FG000|Overall Study|Participant drop-out|1|||
130088037|NCT01562327|468276319|FG000|Overall Study|Infusion not received at 6 month window|4|||
130088038|NCT01060150|468276320|FG000|Overall Study|Adverse Event|6|||
130088039|NCT01060150|468276320|FG000|Overall Study|Lost to Follow-up|1|||
130088040|NCT01060150|468276320|FG000|Overall Study|Protocol Violation|6|||
130088041|NCT01060150|468276320|FG000|Overall Study|Withdrawal by Subject|8|||
130088042|NCT01060150|468276320|FG000|Overall Study|Enrolled, but not treated|2|||
130088043|NCT03018340|468276321|FG000|Overall Study|Adverse Event|1|||
130088044|NCT03018340|468276322|FG001|Overall Study|Adverse Event|2|||
130088045|NCT03018340|468276321|FG000|Overall Study|Withdrawal by Subject|0|||
130088046|NCT03018340|468276322|FG001|Overall Study|Withdrawal by Subject|8|||
130088047|NCT03018340|468276321|FG000|Overall Study|Lack of Efficacy|0|||
130088048|NCT03018340|468276322|FG001|Overall Study|Lack of Efficacy|1|||
130088049|NCT03018340|468276321|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
130088050|NCT03018340|468276322|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
130088051|NCT03018340|468276321|FG000|Overall Study|Lost to Follow-up|1|||
130088052|NCT03018340|468276322|FG001|Overall Study|Lost to Follow-up|7|||
129960901|NCT01568112|467819646|FG003|Overall Study|Withdrawal by Subject|7|||
129960902|NCT01568112|467819643|FG000|Overall Study|Withdrawal by Physician|1|||
129960903|NCT01568112|467819644|FG001|Overall Study|Withdrawal by Physician|0|||
129960904|NCT01568112|467819645|FG002|Overall Study|Withdrawal by Physician|1|||
129960905|NCT01568112|467819646|FG003|Overall Study|Withdrawal by Physician|1|||
129960906|NCT02544113|467821480|FG000|Overall Study|Death|3|||
129960907|NCT02544113|467821481|FG001|Overall Study|Death|4|||
129960908|NCT02847637|467821483|FG000|Overall Study|Withdrawal by Subject|0|||
129960909|NCT02847637|467821484|FG001|Overall Study|Withdrawal by Subject|1|||
129960910|NCT02847637|467821485|FG002|Overall Study|Withdrawal by Subject|1|||
129960911|NCT02847637|467821486|FG003|Overall Study|Withdrawal by Subject|0|||
129960912|NCT02847637|467821483|FG000|Overall Study|Lost to Follow-up|1|||
129960913|NCT02847637|467821484|FG001|Overall Study|Lost to Follow-up|1|||
129960914|NCT02847637|467821485|FG002|Overall Study|Lost to Follow-up|0|||
129960915|NCT02847637|467821486|FG003|Overall Study|Lost to Follow-up|0|||
129960916|NCT01746108|467821489|FG000|Overall Study|Migrated /moved from study area|0|||
129960917|NCT01746108|467821490|FG001|Overall Study|Migrated /moved from study area|1|||
129960918|NCT01746108|467821491|FG002|Overall Study|Migrated /moved from study area|0|||
129960919|NCT01746108|467821489|FG000|Overall Study|Adverse event, non-fatal|0|||
129960920|NCT01746108|467821490|FG001|Overall Study|Adverse event, non-fatal|1|||
129960921|NCT01746108|467821491|FG002|Overall Study|Adverse event, non-fatal|0|||
129960922|NCT01746108|467821489|FG000|Overall Study|Withdrawal by Subject|0|||
129960923|NCT01746108|467821490|FG001|Overall Study|Withdrawal by Subject|1|||
129960924|NCT01746108|467821491|FG002|Overall Study|Withdrawal by Subject|0|||
129960925|NCT01746108|467821489|FG000|Overall Study|Lost to Follow-up|0|||
129960926|NCT01746108|467821490|FG001|Overall Study|Lost to Follow-up|1|||
129960927|NCT01746108|467821491|FG002|Overall Study|Lost to Follow-up|0|||
129960928|NCT01388478|467821497|FG000|Overall Study|Adverse Event|4|||
129960929|NCT01388478|467821497|FG000|Overall Study|Withdrawal by Subject|1|||
130088053|NCT03018340|468276321|FG000|Overall Study|Protocol Violation|3|||
130088054|NCT03018340|468276322|FG001|Overall Study|Protocol Violation|7|||
130088055|NCT03018340|468276321|FG000|Overall Study|Not further specified|0|||
130088056|NCT03018340|468276322|FG001|Overall Study|Not further specified|1|||
130088057|NCT00550615|468276325|FG000|Overall Study|Withdrawal by Subject|0|||
130088058|NCT00550615|468276326|FG001|Overall Study|Withdrawal by Subject|0|||
130088059|NCT00550615|468276327|FG002|Overall Study|Withdrawal by Subject|2|||
130088060|NCT00550615|468276328|FG003|Overall Study|Withdrawal by Subject|3|||
130088061|NCT00550615|468276325|FG000|Overall Study|Not evaluable|0|||
130088062|NCT00550615|468276326|FG001|Overall Study|Not evaluable|0|||
130088063|NCT00550615|468276327|FG002|Overall Study|Not evaluable|2|||
130088064|NCT00550615|468276328|FG003|Overall Study|Not evaluable|7|||
130088065|NCT02405091|468276329|FG000|Overall Study|Adverse Event|16|||
130088066|NCT02405091|468276330|FG001|Overall Study|Adverse Event|10|||
130088067|NCT02405091|468276331|FG002|Overall Study|Adverse Event|0|||
129960930|NCT01990664|467821498|FG000|Overall Study|Lost to Follow-up|2|||
130088068|NCT02405091|468276329|FG000|Overall Study|Protocol Violation|1|||
130088069|NCT02405091|468276330|FG001|Overall Study|Protocol Violation|0|||
130088070|NCT02405091|468276331|FG002|Overall Study|Protocol Violation|0|||
130088071|NCT02405091|468276329|FG000|Overall Study|Noncompliance|1|||
130088072|NCT02405091|468276330|FG001|Overall Study|Noncompliance|6|||
130088073|NCT02405091|468276331|FG002|Overall Study|Noncompliance|2|||
130088074|NCT02405091|468276329|FG000|Overall Study|Withdrawal by Subject|4|||
129960931|NCT01990664|467821499|FG001|Overall Study|Lost to Follow-up|6|||
129960932|NCT01990664|467821498|FG000|Overall Study|Withdrawal by Subject|2|||
129960933|NCT01990664|467821499|FG001|Overall Study|Withdrawal by Subject|3|||
130088075|NCT02405091|468276330|FG001|Overall Study|Withdrawal by Subject|8|||
130088076|NCT02405091|468276331|FG002|Overall Study|Withdrawal by Subject|0|||
130121487|NCT00502775|468406780|FG002|Overall Study|Subject took disallowed drug|1|||
130121488|NCT00287118|468406787|FG000|Overall Study|Adverse Event|30|||
130121489|NCT00287118|468406787|FG000|Overall Study|Death|1|||
130121490|NCT00287118|468406787|FG000|Overall Study|Lack of Efficacy|11|||
130121491|NCT00287118|468406787|FG000|Overall Study|Lost to Follow-up|1|||
130121492|NCT00287118|468406787|FG000|Overall Study|Protocol Violation|2|||
130121493|NCT00287118|468406787|FG000|Overall Study|Other|7|||
130121494|NCT00262600|468406788|FG000|Overall Study|Lost to Follow-up|17|||
130121495|NCT00262600|468406789|FG001|Overall Study|Lost to Follow-up|31|||
130121496|NCT00262600|468406790|FG002|Overall Study|Lost to Follow-up|41|||
130121497|NCT00262600|468406788|FG000|Overall Study|Withdrawal by Subject|128|||
130121498|NCT00262600|468406789|FG001|Overall Study|Withdrawal by Subject|145|||
130121499|NCT00262600|468406790|FG002|Overall Study|Withdrawal by Subject|139|||
130121500|NCT00262600|468406788|FG000|Overall Study|Not Treated|32|||
130121501|NCT00262600|468406789|FG001|Overall Study|Not Treated|17|||
130121502|NCT00262600|468406790|FG002|Overall Study|Not Treated|24|||
130121503|NCT00262600|468406788|FG000|Overall Study|Other|58|||
130121504|NCT00262600|468406789|FG001|Overall Study|Other|59|||
130121505|NCT00262600|468406790|FG002|Overall Study|Other|62|||
130121506|NCT02906709|468406791|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
130121507|NCT02906709|468406792|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
130121508|NCT02906709|468406791|FG000|Phase A (Week 0 to Week 16)|Death|0|||
130121509|NCT02906709|468406792|FG001|Phase A (Week 0 to Week 16)|Death|1|||
130121510|NCT02906709|468406791|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
130121511|NCT02906709|468406792|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
130121512|NCT02906709|468406791|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
130121513|NCT02906709|468406792|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
130121514|NCT02153398|468406793|FG000|Overall Study|Withdrawal by Subject|1|||
130121515|NCT02153398|468406794|FG001|Overall Study|Withdrawal by Subject|0|||
130121516|NCT02153398|468406795|FG002|Overall Study|Withdrawal by Subject|0|||
130121517|NCT02153398|468406796|FG003|Overall Study|Withdrawal by Subject|0|||
130121518|NCT02153398|468406797|FG004|Overall Study|Withdrawal by Subject|0|||
130121519|NCT02153398|468406793|FG000|Overall Study|Adverse Event|0|||
130121520|NCT02153398|468406794|FG001|Overall Study|Adverse Event|0|||
130121521|NCT02153398|468406795|FG002|Overall Study|Adverse Event|1|||
130121522|NCT02153398|468406796|FG003|Overall Study|Adverse Event|1|||
130121523|NCT02153398|468406797|FG004|Overall Study|Adverse Event|0|||
130121524|NCT00721409|468406798|FG000|Overall Study|Global deterioration of health status|2|||
130121525|NCT00721409|468406799|FG001|Overall Study|Global deterioration of health status|6|||
130121526|NCT00721409|468406800|FG002|Overall Study|Global deterioration of health status|3|||
130121527|NCT00721409|468406798|FG000|Overall Study|Death|0|||
130121528|NCT00721409|468406799|FG001|Overall Study|Death|1|||
130121529|NCT00721409|468406800|FG002|Overall Study|Death|0|||
130121530|NCT00721409|468406798|FG000|Overall Study|Randomized not Treated|0|||
130121531|NCT00721409|468406799|FG001|Overall Study|Randomized not Treated|1|||
130121532|NCT00721409|468406800|FG002|Overall Study|Randomized not Treated|4|||
130121533|NCT00721409|468406798|FG000|Overall Study|Reason not specified|1|||
130121534|NCT00721409|468406799|FG001|Overall Study|Reason not specified|0|||
130121535|NCT00721409|468406800|FG002|Overall Study|Reason not specified|2|||
130121536|NCT00721409|468406798|FG000|Overall Study|Adverse Event|0|||
130121537|NCT00721409|468406799|FG001|Overall Study|Adverse Event|13|||
130121538|NCT00721409|468406800|FG002|Overall Study|Adverse Event|2|||
130121539|NCT00721409|468406798|FG000|Overall Study|Lost to Follow-up|0|||
130121540|NCT00721409|468406799|FG001|Overall Study|Lost to Follow-up|0|||
129960934|NCT01990664|467821498|FG000|Overall Study|Protocol Violation|1|||
129960935|NCT01990664|467821499|FG001|Overall Study|Protocol Violation|0|||
129960936|NCT01990664|467821498|FG000|Overall Study|Lens Discomfort|1|||
129960937|NCT01990664|467821499|FG001|Overall Study|Lens Discomfort|1|||
129960938|NCT01990664|467821498|FG000|Overall Study|Lens Handling Difficulties|1|||
130121541|NCT00721409|468406800|FG002|Overall Study|Lost to Follow-up|1|||
130121542|NCT00721409|468406798|FG000|Overall Study|Withdrawal by Subject|1|||
130121543|NCT00721409|468406799|FG001|Overall Study|Withdrawal by Subject|6|||
130121544|NCT00721409|468406800|FG002|Overall Study|Withdrawal by Subject|5|||
130121545|NCT00721409|468406798|FG000|Overall Study|Objective progression or relapse|8|||
130121546|NCT00721409|468406799|FG001|Overall Study|Objective progression or relapse|55|||
130121547|NCT00721409|468406800|FG002|Overall Study|Objective progression or relapse|62|||
130121548|NCT02402166|468406801|FG000|Overall Study|Adverse Event|2|||
130121549|NCT02402166|468406801|FG000|Overall Study|Withdrawal by Subject|2|||
130121550|NCT02402166|468406801|FG000|Overall Study|Lost to Follow-up|1|||
129960939|NCT01990664|467821499|FG001|Overall Study|Lens Handling Difficulties|0|||
129960940|NCT01990664|467821498|FG000|Overall Study|Unsatisfactory Visual Response|0|||
129960941|NCT01990664|467821499|FG001|Overall Study|Unsatisfactory Visual Response|1|||
129960942|NCT02246218|467821500|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129960943|NCT02246218|467821501|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130121551|NCT03331042|468406802|FG000|Overall Study|Protocol Violation|1|||
130121552|NCT03331042|468406803|FG001|Overall Study|Protocol Violation|0|||
130121553|NCT03331042|468406804|FG002|Overall Study|Protocol Violation|0|||
130088077|NCT02405091|468276329|FG000|Overall Study|Death|0|||
130088078|NCT02405091|468276330|FG001|Overall Study|Death|1|||
130088079|NCT02405091|468276331|FG002|Overall Study|Death|0|||
130088080|NCT02405091|468276329|FG000|Overall Study|Lost to Follow-up|5|||
130088081|NCT02405091|468276330|FG001|Overall Study|Lost to Follow-up|6|||
130088082|NCT02405091|468276331|FG002|Overall Study|Lost to Follow-up|0|||
130088083|NCT02405091|468276329|FG000|Overall Study|Physician Decision|2|||
130088084|NCT02405091|468276330|FG001|Overall Study|Physician Decision|2|||
130088085|NCT02405091|468276331|FG002|Overall Study|Physician Decision|0|||
130088086|NCT01955005|468276349|FG000|Overall Study|Withdrawal by Subject|3|||
130088087|NCT01955005|468276350|FG001|Overall Study|Withdrawal by Subject|5|||
130088088|NCT00352027|468276351|FG000|Overall Study|Progressive disease|3|||
130088089|NCT03147495|468276357|FG000|Overall Study|Physician Decision|0|||
130088090|NCT03147495|468276358|FG001|Overall Study|Physician Decision|6|||
130088091|NCT00742391|468276361|FG000|Overall Study|Adverse Event|2|||
130088092|NCT00742391|468276362|FG001|Overall Study|Adverse Event|1|||
130088093|NCT00742391|468276361|FG000|Overall Study|Lost to Follow-up|1|||
130088094|NCT00742391|468276362|FG001|Overall Study|Lost to Follow-up|0|||
130088095|NCT00742391|468276361|FG000|Overall Study|Protocol Violation|1|||
130088096|NCT00742391|468276362|FG001|Overall Study|Protocol Violation|0|||
130088097|NCT02975206|468276369|FG000|Overall Study|Withdrawal by Subject|14|||
130088098|NCT02975206|468276370|FG001|Overall Study|Withdrawal by Subject|11|||
130088099|NCT02975206|468276371|FG002|Overall Study|Withdrawal by Subject|11|||
130088100|NCT02975206|468276369|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
130088101|NCT02975206|468276370|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
130088102|NCT02975206|468276371|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
130088103|NCT01981096|468276372|FG000|Overall Study|Parent illness|1|||
130088104|NCT01981096|468276373|FG001|Overall Study|Parent illness|0|||
130088105|NCT01981096|468276372|FG000|Overall Study|Withdrawal by Subject|0|||
130088106|NCT01981096|468276373|FG001|Overall Study|Withdrawal by Subject|1|||
130088107|NCT01981096|468276372|FG000|Overall Study|Lost to Follow-up|2|||
130088108|NCT01981096|468276373|FG001|Overall Study|Lost to Follow-up|0|||
130088109|NCT00866606|468276374|FG000|Overall Study|Lost to Follow-up|3|||
130088110|NCT00866606|468276374|FG000|Overall Study|Adverse Event|1|||
130088111|NCT01225211|468276375|FG000|Overall Study|Adverse Event|0|||
130088112|NCT01225211|468276376|FG001|Overall Study|Adverse Event|0|||
130088113|NCT01225211|468276377|FG002|Overall Study|Adverse Event|1|||
130088114|NCT01225211|468276378|FG003|Overall Study|Adverse Event|0|||
130088115|NCT01225211|468276379|FG004|Overall Study|Adverse Event|0|||
130088116|NCT01225211|468276380|FG005|Overall Study|Adverse Event|0|||
130088117|NCT01225211|468276381|FG006|Overall Study|Adverse Event|0|||
130088118|NCT01225211|468276382|FG007|Overall Study|Adverse Event|0|||
130088119|NCT01225211|468276383|FG008|Overall Study|Adverse Event|0|||
130088120|NCT01225211|468276384|FG009|Overall Study|Adverse Event|1|||
130088121|NCT01225211|468276375|FG000|Overall Study|Withdrawal by Subject|0|||
130088122|NCT01225211|468276376|FG001|Overall Study|Withdrawal by Subject|0|||
130088123|NCT01225211|468276377|FG002|Overall Study|Withdrawal by Subject|0|||
130088124|NCT01225211|468276378|FG003|Overall Study|Withdrawal by Subject|0|||
130088125|NCT01225211|468276379|FG004|Overall Study|Withdrawal by Subject|0|||
130088126|NCT01225211|468276380|FG005|Overall Study|Withdrawal by Subject|0|||
130088127|NCT01225211|468276381|FG006|Overall Study|Withdrawal by Subject|1|||
130088128|NCT01225211|468276382|FG007|Overall Study|Withdrawal by Subject|0|||
130088129|NCT01225211|468276383|FG008|Overall Study|Withdrawal by Subject|1|||
130088130|NCT01225211|468276384|FG009|Overall Study|Withdrawal by Subject|3|||
130088131|NCT01225211|468276375|FG000|Overall Study|Other|0|||
130088132|NCT01225211|468276376|FG001|Overall Study|Other|0|||
130088133|NCT01225211|468276377|FG002|Overall Study|Other|0|||
130088134|NCT01225211|468276378|FG003|Overall Study|Other|0|||
130088135|NCT01225211|468276379|FG004|Overall Study|Other|0|||
130088136|NCT01225211|468276380|FG005|Overall Study|Other|0|||
130088137|NCT01225211|468276381|FG006|Overall Study|Other|0|||
130088138|NCT01225211|468276382|FG007|Overall Study|Other|0|||
130088139|NCT01225211|468276383|FG008|Overall Study|Other|0|||
130088140|NCT01225211|468276384|FG009|Overall Study|Other|1|||
130088141|NCT00392210|468276403|FG000|First Voiding Trial|Physician Decision|2|||
130088142|NCT00392210|468276404|FG001|First Voiding Trial|Physician Decision|2|||
130088143|NCT00989664|468276405|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
130088144|NCT00989664|468276405|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
130088145|NCT00989664|468276405|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
130088146|NCT00989664|468276405|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
130088147|NCT00989664|468276405|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
130088148|NCT00989664|468276405|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
130088149|NCT00989664|468276405|FG000|Long-Term Follow-Up|Death|3|||
130088150|NCT01230827|468276406|FG000|Overall Study|Lost to Follow-up|0|||
130088151|NCT01230827|468276407|FG001|Overall Study|Lost to Follow-up|0|||
130088152|NCT01230827|468276408|FG002|Overall Study|Lost to Follow-up|1|||
130088153|NCT01230827|468276409|FG003|Overall Study|Lost to Follow-up|3|||
130088154|NCT01230827|468276406|FG000|Overall Study|Withdrawal by Subject|1|||
130088155|NCT01230827|468276407|FG001|Overall Study|Withdrawal by Subject|0|||
130088156|NCT01230827|468276408|FG002|Overall Study|Withdrawal by Subject|3|||
130088157|NCT01230827|468276409|FG003|Overall Study|Withdrawal by Subject|2|||
130088158|NCT01230827|468276406|FG000|Overall Study|Lack of Efficacy|14|||
130088159|NCT01230827|468276407|FG001|Overall Study|Lack of Efficacy|1|||
130088160|NCT01230827|468276408|FG002|Overall Study|Lack of Efficacy|2|||
130088161|NCT01230827|468276409|FG003|Overall Study|Lack of Efficacy|3|||
130088162|NCT01230827|468276406|FG000|Overall Study|Adverse Event|4|||
130088163|NCT01230827|468276407|FG001|Overall Study|Adverse Event|2|||
130088164|NCT01230827|468276408|FG002|Overall Study|Adverse Event|3|||
130088165|NCT01230827|468276409|FG003|Overall Study|Adverse Event|7|||
130088166|NCT01230827|468276406|FG000|Overall Study|Recovery|0|||
130088167|NCT01230827|468276407|FG001|Overall Study|Recovery|6|||
130088168|NCT01230827|468276408|FG002|Overall Study|Recovery|0|||
130088169|NCT01230827|468276409|FG003|Overall Study|Recovery|0|||
130088170|NCT01230827|468276406|FG000|Overall Study|Study terminated by Sponsor|0|||
130088171|NCT01230827|468276407|FG001|Overall Study|Study terminated by Sponsor|2|||
130088172|NCT01230827|468276408|FG002|Overall Study|Study terminated by Sponsor|56|||
130088173|NCT01230827|468276409|FG003|Overall Study|Study terminated by Sponsor|63|||
130088174|NCT00805142|468276410|FG000|Titration Period|Adverse Event|3|||
130088175|NCT00805142|468276411|FG001|Titration Period|Adverse Event|3|||
130088176|NCT00805142|468276410|FG000|Titration Period|Lack of Efficacy|1|||
130088177|NCT00805142|468276411|FG001|Titration Period|Lack of Efficacy|1|||
130088178|NCT00805142|468276410|FG000|Titration Period|Lost to Follow-up|0|||
130088179|NCT00805142|468276411|FG001|Titration Period|Lost to Follow-up|1|||
130088180|NCT00805142|468276410|FG000|Titration Period|Disease Progression|2|||
130088181|NCT00805142|468276411|FG001|Titration Period|Disease Progression|1|||
130088182|NCT00805142|468276410|FG000|Titration Period|Withdrawal of consent|0|||
130088183|NCT00805142|468276411|FG001|Titration Period|Withdrawal of consent|1|||
130088184|NCT00805142|468276410|FG000|Titration Period|Other|0|||
130088185|NCT00805142|468276411|FG001|Titration Period|Other|3|||
130088186|NCT00805142|468276410|FG000|Maintenance Period|Adverse Event|0|||
130088187|NCT00805142|468276411|FG001|Maintenance Period|Adverse Event|1|||
130088188|NCT00805142|468276410|FG000|Maintenance Period|Other|0|||
130088189|NCT00805142|468276411|FG001|Maintenance Period|Other|1|||
130088190|NCT02886338|468276412|FG000|Overall Study|Withdrawal by Subject|1|||
130088191|NCT00122317|468276413|FG000|Overall Study|Death|3|||
130088192|NCT00122317|468276413|FG000|Overall Study|Adverse Event|4|||
130088193|NCT00122317|468276413|FG000|Overall Study|Physician Decision|2|||
130088194|NCT00122317|468276413|FG000|Overall Study|patient non-compliance|1|||
130088195|NCT00122317|468276413|FG000|Overall Study|Withdrawal by Subject|1|||
130088196|NCT00394654|468276414|FG000|Overall Study|Lost to Follow-up|1|||
130088197|NCT00394654|468276415|FG001|Overall Study|Lost to Follow-up|0|||
130088198|NCT00394654|468276414|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
130088199|NCT00394654|468276415|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
130088200|NCT03756285|468276416|FG000|Overall Study|Lost to Follow-up|0|||
130088201|NCT03756285|468276417|FG001|Overall Study|Lost to Follow-up|1|||
130088202|NCT03756285|468276416|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
130088203|NCT03756285|468276417|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
130088204|NCT03756285|468276416|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
130088205|NCT03756285|468276417|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
130088206|NCT03458234|468276420|FG000|Overall Study|Withdrawal by Subject|1|||
130088207|NCT01021293|468276422|FG000|Overall Study|Serious Adverse Event|2|||
130088208|NCT01021293|468276423|FG001|Overall Study|Serious Adverse Event|1|||
130088209|NCT01021293|468276422|FG000|Overall Study|Adverse Event|2|||
130088210|NCT01021293|468276423|FG001|Overall Study|Adverse Event|1|||
130088211|NCT01021293|468276422|FG000|Overall Study|Withdrawal by Subject|1|||
130088212|NCT01021293|468276423|FG001|Overall Study|Withdrawal by Subject|3|||
130088213|NCT01021293|468276422|FG000|Overall Study|Migrated/moved from study area|6|||
130088214|NCT01021293|468276423|FG001|Overall Study|Migrated/moved from study area|18|||
130088215|NCT01021293|468276422|FG000|Overall Study|Lost to Follow-up|1|||
130121554|NCT03331042|468406805|FG003|Overall Study|Protocol Violation|0|||
130121555|NCT03331042|468406802|FG000|Overall Study|Physician Decision|0|||
130121556|NCT03331042|468406803|FG001|Overall Study|Physician Decision|0|||
130088216|NCT01021293|468276423|FG001|Overall Study|Lost to Follow-up|1|||
130088217|NCT03812224|468279245|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
130088218|NCT03812224|468279246|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130088219|NCT03812224|468279245|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
130088220|NCT03812224|468279246|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
130088221|NCT03812224|468279245|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
130088222|NCT03812224|468279246|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
130088223|NCT03812224|468279245|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
130088224|NCT03812224|468279246|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
130088225|NCT02500901|468279247|FG000|Overall Study|Disease ProgressionDD|2|||
130088226|NCT00542321|468279250|FG000|Overall Study|Death|0|||
130121557|NCT03331042|468406804|FG002|Overall Study|Physician Decision|1|||
129960944|NCT02246218|467821500|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
129960945|NCT02246218|467821501|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
129960946|NCT02246218|467821500|FG000|Overall Study|Adverse Event|1|||
129960947|NCT02246218|467821501|FG001|Overall Study|Adverse Event|1|||
129960948|NCT02246218|467821500|FG000|Overall Study|Lost to Follow-up|1|||
129960949|NCT02246218|467821501|FG001|Overall Study|Lost to Follow-up|0|||
129960950|NCT03891641|467821502|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
129960951|NCT03891641|467821503|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
129960952|NCT01093222|467821504|FG000|Overall Study|Ineligible|6|||
129960953|NCT01093222|467821504|FG000|Overall Study|Adverse Event|7|||
129960954|NCT01093222|467821504|FG000|Overall Study|Progression/relapse|24|||
129960955|NCT01093222|467821504|FG000|Overall Study|Death|2|||
129960956|NCT01093222|467821504|FG000|Overall Study|Not protocol specified|1|||
129960957|NCT02025985|467821507|FG000|Overall Study|Consent withdrawn|0|||
129960958|NCT02025985|467821508|FG001|Overall Study|Consent withdrawn|0|||
129960959|NCT02025985|467821509|FG002|Overall Study|Consent withdrawn|1|||
129960960|NCT02025985|467821510|FG003|Overall Study|Consent withdrawn|0|||
129960961|NCT02025985|467821511|FG004|Overall Study|Consent withdrawn|0|||
129960962|NCT02025985|467821507|FG000|Overall Study|Termination of study by Sponsor|4|||
129960963|NCT02025985|467821508|FG001|Overall Study|Termination of study by Sponsor|3|||
129960964|NCT02025985|467821509|FG002|Overall Study|Termination of study by Sponsor|1|||
129960965|NCT02025985|467821510|FG003|Overall Study|Termination of study by Sponsor|1|||
129960966|NCT02025985|467821511|FG004|Overall Study|Termination of study by Sponsor|3|||
129960967|NCT02025985|467821507|FG000|Overall Study|Death|21|||
129960968|NCT02025985|467821508|FG001|Overall Study|Death|20|||
129960969|NCT02025985|467821509|FG002|Overall Study|Death|23|||
129960970|NCT02025985|467821510|FG003|Overall Study|Death|20|||
129960971|NCT02025985|467821511|FG004|Overall Study|Death|17|||
129960972|NCT03723915|467821523|FG000|Screening|Failed to meet screening requirements.|2|||
129960973|NCT03723915|467821523|FG000|On Treatment|Failed to meet treatment requirements|2|||
129960974|NCT01713998|467821525|FG000|Overall Study|Lost to Follow-up|2|||
129960975|NCT01713998|467821526|FG001|Overall Study|Lost to Follow-up|0|||
129960976|NCT01713998|467821527|FG002|Overall Study|Lost to Follow-up|2|||
129960977|NCT01713998|467821525|FG000|Overall Study|Withdrawal by Subject|1|||
129960978|NCT01713998|467821526|FG001|Overall Study|Withdrawal by Subject|0|||
129960979|NCT01713998|467821527|FG002|Overall Study|Withdrawal by Subject|0|||
129960980|NCT02101268|467821528|FG000|Randomized Treatment Phase|Subject Decision|8|||
129960981|NCT02101268|467821529|FG001|Randomized Treatment Phase|Subject Decision|4|||
129960982|NCT02101268|467821530|FG002|Randomized Treatment Phase|Subject Decision|0|||
129960983|NCT02101268|467821531|FG003|Randomized Treatment Phase|Subject Decision|0|||
129960984|NCT02101268|467821528|FG000|Randomized Treatment Phase|Physician Decision|4|||
129960985|NCT02101268|467821529|FG001|Randomized Treatment Phase|Physician Decision|1|||
129960986|NCT02101268|467821530|FG002|Randomized Treatment Phase|Physician Decision|0|||
129960987|NCT02101268|467821531|FG003|Randomized Treatment Phase|Physician Decision|0|||
129960988|NCT02101268|467821528|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
129960989|NCT02101268|467821529|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
129960990|NCT02101268|467821530|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
129960991|NCT02101268|467821531|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
129960992|NCT02101268|467821528|FG000|Randomized Treatment Phase|Adverse Event|6|||
129960993|NCT02101268|467821529|FG001|Randomized Treatment Phase|Adverse Event|0|||
129960994|NCT02101268|467821530|FG002|Randomized Treatment Phase|Adverse Event|0|||
129960995|NCT02101268|467821531|FG003|Randomized Treatment Phase|Adverse Event|0|||
129960996|NCT02101268|467821528|FG000|Randomized Treatment Phase|Death|5|||
129960997|NCT02101268|467821529|FG001|Randomized Treatment Phase|Death|4|||
129960998|NCT02101268|467821530|FG002|Randomized Treatment Phase|Death|0|||
129960999|NCT02101268|467821531|FG003|Randomized Treatment Phase|Death|0|||
129961000|NCT02101268|467821528|FG000|Randomized Treatment Phase|Disease Progression|4|||
129961001|NCT02101268|467821529|FG001|Randomized Treatment Phase|Disease Progression|1|||
129961002|NCT02101268|467821530|FG002|Randomized Treatment Phase|Disease Progression|0|||
129961003|NCT02101268|467821531|FG003|Randomized Treatment Phase|Disease Progression|0|||
129961004|NCT02101268|467821528|FG000|Extended Treatment Phase|Subject Decision|0|||
129961005|NCT02101268|467821529|FG001|Extended Treatment Phase|Subject Decision|0|||
129961006|NCT02101268|467821530|FG002|Extended Treatment Phase|Subject Decision|3|||
129961007|NCT02101268|467821531|FG003|Extended Treatment Phase|Subject Decision|2|||
129961008|NCT02101268|467821528|FG000|Extended Treatment Phase|Physician Decision|0|||
129961009|NCT02101268|467821529|FG001|Extended Treatment Phase|Physician Decision|0|||
129961010|NCT02101268|467821530|FG002|Extended Treatment Phase|Physician Decision|5|||
129961011|NCT02101268|467821531|FG003|Extended Treatment Phase|Physician Decision|2|||
129961012|NCT02101268|467821528|FG000|Extended Treatment Phase|Adverse Event|0|||
129961013|NCT02101268|467821529|FG001|Extended Treatment Phase|Adverse Event|0|||
129961014|NCT02101268|467821530|FG002|Extended Treatment Phase|Adverse Event|14|||
129961015|NCT02101268|467821531|FG003|Extended Treatment Phase|Adverse Event|18|||
129961016|NCT02101268|467821528|FG000|Extended Treatment Phase|Death|0|||
129961017|NCT02101268|467821529|FG001|Extended Treatment Phase|Death|0|||
129961018|NCT02101268|467821530|FG002|Extended Treatment Phase|Death|5|||
130088227|NCT00542321|468279251|FG001|Overall Study|Death|1|||
130088228|NCT00253747|468279257|FG000|Overall Study|Lost to Follow-up|13|||
130088229|NCT00253747|468279258|FG001|Overall Study|Lost to Follow-up|14|||
130088230|NCT00253747|468279257|FG000|Overall Study|Withdrawal by Subject|10|||
130088231|NCT00253747|468279258|FG001|Overall Study|Withdrawal by Subject|11|||
130088232|NCT00253747|468279257|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
130088233|NCT00253747|468279258|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
130088234|NCT00718887|468279260|FG000|Overall Study|Withdrawal by Subject|3|||
130088235|NCT00718887|468279261|FG001|Overall Study|Withdrawal by Subject|2|||
130088236|NCT00718887|468279260|FG000|Overall Study|Not identified|2|||
130088237|NCT00718887|468279261|FG001|Overall Study|Not identified|7|||
130088238|NCT05102734|468279263|FG000|Overall Study|Did not require vasopressors|1|||
130088239|NCT05102734|468279264|FG001|Overall Study|Did not require vasopressors|0|||
130088240|NCT05102734|468279263|FG000|Overall Study|Did not have functioning PA catheter|1|||
130088241|NCT05102734|468279264|FG001|Overall Study|Did not have functioning PA catheter|0|||
130088242|NCT05102734|468279263|FG000|Overall Study|Inadequate video quality|2|||
130088243|NCT05102734|468279264|FG001|Overall Study|Inadequate video quality|0|||
130088244|NCT04235959|468279265|FG000|Overall Study|Protocol Violation|0|||
130088245|NCT04235959|468279266|FG001|Overall Study|Protocol Violation|1|||
130088246|NCT04235959|468279267|FG002|Overall Study|Protocol Violation|0|||
130088247|NCT04235959|468279265|FG000|Overall Study|Adverse Event|1|||
130088248|NCT04235959|468279266|FG001|Overall Study|Adverse Event|0|||
130088249|NCT04235959|468279267|FG002|Overall Study|Adverse Event|0|||
130088250|NCT00608426|468279268|FG000|Overall Study|Death|32|||
130088251|NCT00608426|468279269|FG001|Overall Study|Death|36|||
130088252|NCT00608426|468279268|FG000|Overall Study|Lost to Follow-up|485|||
130088253|NCT00608426|468279269|FG001|Overall Study|Lost to Follow-up|521|||
130088254|NCT00608426|468279268|FG000|Overall Study|refused, health issues, wrong address|319|||
130088255|NCT00608426|468279269|FG001|Overall Study|refused, health issues, wrong address|348|||
130088256|NCT03055806|468279273|FG000|Overall Study|Adverse Event|0|||
130088257|NCT03055806|468279274|FG001|Overall Study|Adverse Event|0|||
130088258|NCT03055806|468279275|FG002|Overall Study|Adverse Event|1|||
130088259|NCT03055806|468279276|FG003|Overall Study|Adverse Event|1|||
130088260|NCT03055806|468279273|FG000|Overall Study|Lost to Follow-up|0|||
130088261|NCT03055806|468279274|FG001|Overall Study|Lost to Follow-up|3|||
130088262|NCT03055806|468279275|FG002|Overall Study|Lost to Follow-up|6|||
130088263|NCT03055806|468279276|FG003|Overall Study|Lost to Follow-up|7|||
130088264|NCT03055806|468279273|FG000|Overall Study|Physician Decision|1|||
130088265|NCT03055806|468279274|FG001|Overall Study|Physician Decision|0|||
130088266|NCT03055806|468279275|FG002|Overall Study|Physician Decision|0|||
130088267|NCT03055806|468279276|FG003|Overall Study|Physician Decision|1|||
130088268|NCT03055806|468279273|FG000|Overall Study|Protocol Violation|1|||
130088269|NCT03055806|468279274|FG001|Overall Study|Protocol Violation|0|||
130088270|NCT03055806|468279275|FG002|Overall Study|Protocol Violation|0|||
130088271|NCT03055806|468279276|FG003|Overall Study|Protocol Violation|0|||
130088272|NCT03055806|468279273|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
130088273|NCT03055806|468279274|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
130088274|NCT03055806|468279275|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
130088275|NCT03055806|468279276|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
130088276|NCT03055806|468279273|FG000|Overall Study|Withdrawal of consent to continue study|2|||
130088277|NCT03055806|468279274|FG001|Overall Study|Withdrawal of consent to continue study|3|||
130088278|NCT03055806|468279275|FG002|Overall Study|Withdrawal of consent to continue study|4|||
130088279|NCT03055806|468279276|FG003|Overall Study|Withdrawal of consent to continue study|6|||
130088280|NCT03055806|468279273|FG000|Overall Study|Partner not willing to try intercourse|1|||
130088281|NCT03055806|468279274|FG001|Overall Study|Partner not willing to try intercourse|0|||
130088282|NCT03055806|468279275|FG002|Overall Study|Partner not willing to try intercourse|0|||
130088283|NCT03055806|468279276|FG003|Overall Study|Partner not willing to try intercourse|0|||
130088284|NCT04601194|468279277|FG000|Overall Study|Lost to Follow-up|7|||
130088285|NCT02630459|468279278|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130121558|NCT03331042|468406805|FG003|Overall Study|Physician Decision|0|||
130121559|NCT03331042|468406802|FG000|Overall Study|Lost to Follow-up|0|||
130121560|NCT03331042|468406803|FG001|Overall Study|Lost to Follow-up|0|||
130121561|NCT03331042|468406804|FG002|Overall Study|Lost to Follow-up|0|||
130121562|NCT03331042|468406805|FG003|Overall Study|Lost to Follow-up|1|||
130121563|NCT00001849|468406809|FG000|Overall Study|Death|4|||
130088286|NCT02630459|468279279|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
130088287|NCT02630459|468279280|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130088288|NCT02630459|468279281|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
130088289|NCT02630459|468279282|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130088290|NCT02630459|468279283|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130088291|NCT02630459|468279284|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130088292|NCT02630459|468279285|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
130121564|NCT00001849|468406809|FG000|Overall Study|Lost to Follow-up|2|||
130121565|NCT00001849|468406809|FG000|Overall Study|Withdrawal by Subject|2|||
130088293|NCT02630459|468279278|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088294|NCT02630459|468279279|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088295|NCT02630459|468279280|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
130088296|NCT02630459|468279281|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088297|NCT02630459|468279282|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088298|NCT02630459|468279283|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088299|NCT02630459|468279284|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088300|NCT02630459|468279285|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
130088301|NCT02630459|468279278|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
130088302|NCT02630459|468279279|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
130088303|NCT02630459|468279280|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
130088304|NCT02630459|468279281|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
130088305|NCT02630459|468279282|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130088306|NCT02630459|468279283|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130088307|NCT02630459|468279284|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130088308|NCT02630459|468279285|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
130088309|NCT02630459|468279278|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
130088310|NCT02630459|468279279|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088311|NCT02630459|468279280|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088312|NCT02630459|468279281|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088313|NCT02630459|468279282|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088314|NCT02630459|468279283|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088315|NCT02630459|468279284|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088316|NCT02630459|468279285|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
130088317|NCT02630459|468279278|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130088318|NCT02630459|468279279|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130088319|NCT02630459|468279280|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129961019|NCT02101268|467821531|FG003|Extended Treatment Phase|Death|1|||
129961020|NCT02101268|467821528|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
129961021|NCT02101268|467821529|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
129961022|NCT02101268|467821530|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
129961023|NCT02101268|467821531|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
129961024|NCT02101268|467821528|FG000|Extended Treatment Phase|Disease Progression|0|||
129961025|NCT02101268|467821529|FG001|Extended Treatment Phase|Disease Progression|0|||
129961026|NCT02101268|467821530|FG002|Extended Treatment Phase|Disease Progression|13|||
129961027|NCT02101268|467821531|FG003|Extended Treatment Phase|Disease Progression|6|||
129961028|NCT02101268|467821528|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
129961029|NCT02101268|467821529|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
129961030|NCT02101268|467821530|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
130088320|NCT02630459|468279281|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130088321|NCT02630459|468279282|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
130088322|NCT02630459|468279283|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
130088323|NCT02630459|468279284|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130088324|NCT02630459|468279285|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
130088325|NCT02630459|468279278|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130088326|NCT02630459|468279279|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130088327|NCT02630459|468279280|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130088328|NCT02630459|468279281|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130088329|NCT02630459|468279282|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
130088330|NCT02630459|468279283|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
130088331|NCT02630459|468279284|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130088332|NCT02630459|468279285|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
130088333|NCT02630459|468279278|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130088334|NCT02630459|468279279|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130088335|NCT02630459|468279280|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130088336|NCT02630459|468279281|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130088337|NCT02630459|468279282|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
130088338|NCT02630459|468279283|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130088339|NCT02630459|468279284|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
130088340|NCT02630459|468279285|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129961031|NCT02101268|467821531|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
130088341|NCT00125138|468279286|FG000|Overall Study|Adverse Event|1|||
130088342|NCT00125138|468279287|FG001|Overall Study|Adverse Event|0|||
130088343|NCT00125138|468279288|FG002|Overall Study|Adverse Event|3|||
129961032|NCT00740870|467821532|FG000|Overall Study|Not Catheterized|4|||
129961033|NCT00740870|467821532|FG000|Overall Study|Further testing contraindicated implant|17|||
130088344|NCT00125138|468279289|FG003|Overall Study|Adverse Event|2|||
130088345|NCT00125138|468279286|FG000|Overall Study|Withdrawal by Subject|2|||
130088346|NCT00125138|468279287|FG001|Overall Study|Withdrawal by Subject|3|||
130088347|NCT00125138|468279288|FG002|Overall Study|Withdrawal by Subject|1|||
130088348|NCT00125138|468279289|FG003|Overall Study|Withdrawal by Subject|1|||
130088349|NCT00125138|468279286|FG000|Overall Study|Lack of Efficacy|0|||
130088350|NCT00125138|468279287|FG001|Overall Study|Lack of Efficacy|0|||
130088351|NCT00125138|468279288|FG002|Overall Study|Lack of Efficacy|0|||
130088352|NCT00125138|468279289|FG003|Overall Study|Lack of Efficacy|1|||
130088353|NCT00125138|468279286|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
130088354|NCT00125138|468279287|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
130088355|NCT00125138|468279288|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
130088356|NCT00125138|468279289|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
130088357|NCT00348686|468279296|FG000|Overall Study|Withdrawal by Subject|45|||
130088358|NCT00348686|468279296|FG000|Overall Study|Adverse Event|5|||
130088359|NCT00348686|468279296|FG000|Overall Study|Protocol Violation|6|||
130088360|NCT00348686|468279296|FG000|Overall Study|Lost to Follow-up|2|||
130088361|NCT00348686|468279296|FG000|Overall Study|Multiple Reasons|8|||
130088362|NCT01258738|468279297|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
130088363|NCT01258738|468279298|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
130088364|NCT01258738|468279297|FG000|Double-blind Period|Withdrawal by Subject|2|||
130088365|NCT01258738|468279298|FG001|Double-blind Period|Withdrawal by Subject|2|||
130088366|NCT01258738|468279297|FG000|Double-blind Period|Protocol Violation|1|||
130088367|NCT01258738|468279298|FG001|Double-blind Period|Protocol Violation|1|||
130088368|NCT01258738|468279297|FG000|Double-blind Period|Adverse Event|3|||
130088369|NCT01258738|468279298|FG001|Double-blind Period|Adverse Event|1|||
130088370|NCT01258738|468279297|FG000|Open-label Period|Did not meet inclusion criteria|0|||
130088371|NCT01258738|468279298|FG001|Open-label Period|Did not meet inclusion criteria|1|||
130088372|NCT01258738|468279297|FG000|Open-label Period|Insufficient clinical response|5|||
130088373|NCT01258738|468279298|FG001|Open-label Period|Insufficient clinical response|3|||
130088374|NCT01258738|468279297|FG000|Open-label Period|Lost to Follow-up|0|||
130088375|NCT01258738|468279298|FG001|Open-label Period|Lost to Follow-up|2|||
130088376|NCT01258738|468279297|FG000|Open-label Period|Withdrawal by Subject|5|||
130088377|NCT01258738|468279298|FG001|Open-label Period|Withdrawal by Subject|6|||
130088378|NCT01258738|468279297|FG000|Open-label Period|Protocol Violation|2|||
130088379|NCT01258738|468279298|FG001|Open-label Period|Protocol Violation|2|||
130088380|NCT01258738|468279297|FG000|Open-label Period|Adverse Event|4|||
130088381|NCT01258738|468279298|FG001|Open-label Period|Adverse Event|5|||
130088382|NCT01258738|468279297|FG000|Open-label Period|Other Reasons|0|||
130088383|NCT01258738|468279298|FG001|Open-label Period|Other Reasons|1|||
130088384|NCT01258738|468279297|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
130088385|NCT01258738|468279298|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
130088386|NCT00689611|468279299|FG000|Overall Study|Death|6|||
130088387|NCT00689611|468279300|FG001|Overall Study|Death|9|||
130088388|NCT00689611|468279299|FG000|Overall Study|Withdrawal by Subject|8|||
130088389|NCT00689611|468279300|FG001|Overall Study|Withdrawal by Subject|9|||
130088390|NCT00689611|468279299|FG000|Overall Study|Lost to Follow-up|27|||
130088391|NCT00689611|468279300|FG001|Overall Study|Lost to Follow-up|28|||
130088392|NCT00568399|468279301|FG000|Overall Study|Death|2|||
130088393|NCT00568399|468279301|FG000|Overall Study|Adverse Event|5|||
130088394|NCT00568399|468279301|FG000|Overall Study|Withdrawal by Subject|8|||
130088395|NCT01904760|468279308|FG000|Overall Study|Protocol Violation|1|||
130088396|NCT01904760|468279309|FG001|Overall Study|Protocol Violation|0|||
130088397|NCT04249076|468279319|FG000|Overall Study|Adverse Event|1|||
130088398|NCT04249076|468279320|FG001|Overall Study|Adverse Event|1|||
130088399|NCT04249076|468279319|FG000|Overall Study|Protocol Violation|1|||
130088400|NCT04249076|468279320|FG001|Overall Study|Protocol Violation|2|||
130088401|NCT04249076|468279319|FG000|Overall Study|Lack of Efficacy|0|||
130088402|NCT04249076|468279320|FG001|Overall Study|Lack of Efficacy|1|||
130088403|NCT04249076|468279319|FG000|Overall Study|Withdrawal by Subject|0|||
130088404|NCT04249076|468279320|FG001|Overall Study|Withdrawal by Subject|1|||
130088405|NCT00783263|468279321|FG000|Overall Study|Adverse Event|3|||
130088406|NCT00783263|468279322|FG001|Overall Study|Adverse Event|0|||
130088407|NCT00783263|468279323|FG002|Overall Study|Adverse Event|2|||
130088408|NCT00783263|468279324|FG003|Overall Study|Adverse Event|1|||
130088409|NCT00783263|468279321|FG000|Overall Study|Lost to Follow-up|1|||
130088410|NCT00783263|468279322|FG001|Overall Study|Lost to Follow-up|1|||
130088411|NCT00783263|468279323|FG002|Overall Study|Lost to Follow-up|0|||
130121566|NCT00001849|468406809|FG000|Overall Study|tumor remained occult|6|||
130088412|NCT00783263|468279324|FG003|Overall Study|Lost to Follow-up|0|||
130088413|NCT00783263|468279321|FG000|Overall Study|Withdrawal by Subject|0|||
130088414|NCT00783263|468279322|FG001|Overall Study|Withdrawal by Subject|1|||
130088415|NCT00783263|468279323|FG002|Overall Study|Withdrawal by Subject|1|||
130088416|NCT00783263|468279324|FG003|Overall Study|Withdrawal by Subject|2|||
130088417|NCT00405756|468279325|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
130088418|NCT00405756|468279326|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
130121567|NCT02428699|468406811|FG000|Washout Period 1|Screen Failure|1|||
130088419|NCT00405756|468279327|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
130088420|NCT00405756|468279325|FG000|Double-blind Treatment|Adverse Event|31|||
130088421|NCT00405756|468279326|FG001|Double-blind Treatment|Adverse Event|27|||
130088422|NCT00405756|468279327|FG002|Double-blind Treatment|Adverse Event|12|||
130088423|NCT00405756|468279325|FG000|Double-blind Treatment|Disease Progression|47|||
130088424|NCT00405756|468279326|FG001|Double-blind Treatment|Disease Progression|81|||
130088425|NCT00405756|468279327|FG002|Double-blind Treatment|Disease Progression|102|||
130088426|NCT00405756|468279325|FG000|Double-blind Treatment|Lack of Efficacy|1|||
130088427|NCT00405756|468279326|FG001|Double-blind Treatment|Lack of Efficacy|4|||
130088428|NCT00405756|468279327|FG002|Double-blind Treatment|Lack of Efficacy|2|||
130088429|NCT00405756|468279325|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
130088430|NCT00405756|468279326|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
130088431|NCT00405756|468279327|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
130088432|NCT00405756|468279325|FG000|Double-blind Treatment|Lost to Follow-up|1|||
130088433|NCT00405756|468279326|FG001|Double-blind Treatment|Lost to Follow-up|0|||
130088434|NCT00405756|468279327|FG002|Double-blind Treatment|Lost to Follow-up|0|||
130088435|NCT00405756|468279325|FG000|Double-blind Treatment|Death|4|||
130088436|NCT00405756|468279326|FG001|Double-blind Treatment|Death|4|||
130088437|NCT00405756|468279327|FG002|Double-blind Treatment|Death|4|||
130088438|NCT00405756|468279325|FG000|Double-blind Treatment|Protocol Violation|1|||
130088439|NCT00405756|468279326|FG001|Double-blind Treatment|Protocol Violation|0|||
130088440|NCT00405756|468279327|FG002|Double-blind Treatment|Protocol Violation|2|||
130088441|NCT00405756|468279325|FG000|Double-blind Treatment|Other|7|||
130088442|NCT00405756|468279326|FG001|Double-blind Treatment|Other|4|||
130088443|NCT00405756|468279327|FG002|Double-blind Treatment|Other|4|||
130088444|NCT00405756|468279325|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
130088445|NCT00405756|468279326|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
130088446|NCT00405756|468279327|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
130088447|NCT00405756|468279325|FG000|Open-label Extension|Adverse Event|1|||
130088448|NCT00405756|468279326|FG001|Open-label Extension|Adverse Event|3|||
130088449|NCT00405756|468279327|FG002|Open-label Extension|Adverse Event|7|||
130088450|NCT00405756|468279325|FG000|Open-label Extension|Disease Progression|8|||
130088451|NCT00405756|468279326|FG001|Open-label Extension|Disease Progression|23|||
130088452|NCT00405756|468279327|FG002|Open-label Extension|Disease Progression|26|||
130088453|NCT00405756|468279325|FG000|Open-label Extension|Withdrawal by Subject|2|||
130088454|NCT00405756|468279326|FG001|Open-label Extension|Withdrawal by Subject|3|||
130088455|NCT00405756|468279327|FG002|Open-label Extension|Withdrawal by Subject|3|||
130088456|NCT00405756|468279325|FG000|Open-label Extension|Death|1|||
130088457|NCT00405756|468279326|FG001|Open-label Extension|Death|2|||
130088458|NCT00405756|468279327|FG002|Open-label Extension|Death|4|||
130088459|NCT00405756|468279325|FG000|Open-label Extension|Other|0|||
130088460|NCT00405756|468279326|FG001|Open-label Extension|Other|1|||
130088461|NCT00405756|468279327|FG002|Open-label Extension|Other|7|||
130088462|NCT00405756|468279325|FG000|Follow-up|Ongoing in Follow-up Period|52|||
130088463|NCT00405756|468279326|FG001|Follow-up|Ongoing in Follow-up Period|51|||
130088464|NCT00405756|468279327|FG002|Follow-up|Ongoing in Follow-up Period|60|||
130088465|NCT00405756|468279325|FG000|Follow-up|Death|21|||
130088466|NCT00405756|468279326|FG001|Follow-up|Death|31|||
130088467|NCT00405756|468279327|FG002|Follow-up|Death|24|||
130088468|NCT00405756|468279325|FG000|Follow-up|Lost to Follow-up|2|||
130088469|NCT00405756|468279326|FG001|Follow-up|Lost to Follow-up|8|||
130088470|NCT00405756|468279327|FG002|Follow-up|Lost to Follow-up|4|||
130088471|NCT01117428|468279328|FG000|Overall Study|Lack of Efficacy|1|||
130088472|NCT01117428|468279329|FG001|Overall Study|Lack of Efficacy|0|||
130088473|NCT01117428|468279330|FG002|Overall Study|Lack of Efficacy|0|||
130088474|NCT01117428|468279331|FG003|Overall Study|Lack of Efficacy|0|||
130088475|NCT01117428|468279332|FG004|Overall Study|Lack of Efficacy|0|||
130088476|NCT01117428|468279333|FG005|Overall Study|Lack of Efficacy|0|||
130121568|NCT02428699|468406812|FG001|Washout Period 1|Screen Failure|2|||
130121569|NCT01574248|468406813|FG000|Overall Study|Withdrawal by Subject|2|||
130121570|NCT01574248|468406814|FG001|Overall Study|Withdrawal by Subject|0|||
130121571|NCT01574248|468406813|FG000|Overall Study|Missing primary endpoint data|1|||
130121572|NCT01574248|468406814|FG001|Overall Study|Missing primary endpoint data|0|||
130088477|NCT01117428|468279328|FG000|Overall Study|Adverse Event|4|||
130088478|NCT01117428|468279329|FG001|Overall Study|Adverse Event|0|||
130088479|NCT01117428|468279330|FG002|Overall Study|Adverse Event|0|||
130088480|NCT01117428|468279331|FG003|Overall Study|Adverse Event|0|||
130088481|NCT01117428|468279332|FG004|Overall Study|Adverse Event|1|||
130088482|NCT01117428|468279333|FG005|Overall Study|Adverse Event|2|||
130088483|NCT01117428|468279328|FG000|Overall Study|Death|0|||
130088484|NCT01117428|468279329|FG001|Overall Study|Death|1|||
130088485|NCT01117428|468279330|FG002|Overall Study|Death|2|||
130088486|NCT01117428|468279331|FG003|Overall Study|Death|0|||
130088487|NCT01117428|468279332|FG004|Overall Study|Death|0|||
130121573|NCT01424722|468406815|FG000|Overall Study|Sponsor terminated investigation|2258|||
130121574|NCT01781286|468406818|FG000|Overall Study|Lost to Follow-up|0|||
130121575|NCT01781286|468406819|FG001|Overall Study|Lost to Follow-up|0|||
130088488|NCT01117428|468279333|FG005|Overall Study|Death|1|||
130121576|NCT01781286|468406820|FG002|Overall Study|Lost to Follow-up|0|||
130121577|NCT01781286|468406821|FG003|Overall Study|Lost to Follow-up|0|||
130121578|NCT01781286|468406822|FG004|Overall Study|Lost to Follow-up|0|||
130121579|NCT01781286|468406823|FG005|Overall Study|Lost to Follow-up|1|||
130121580|NCT01781286|468406818|FG000|Overall Study|Time Constraints|2|||
130121581|NCT01781286|468406819|FG001|Overall Study|Time Constraints|0|||
130121582|NCT01781286|468406820|FG002|Overall Study|Time Constraints|2|||
130121583|NCT01781286|468406821|FG003|Overall Study|Time Constraints|0|||
130121584|NCT01781286|468406822|FG004|Overall Study|Time Constraints|0|||
130121585|NCT01781286|468406823|FG005|Overall Study|Time Constraints|0|||
130121586|NCT01781286|468406818|FG000|Overall Study|Noncompliance|0|||
130121587|NCT01781286|468406819|FG001|Overall Study|Noncompliance|0|||
130121588|NCT01781286|468406820|FG002|Overall Study|Noncompliance|0|||
130121589|NCT01781286|468406821|FG003|Overall Study|Noncompliance|1|||
130121590|NCT01781286|468406822|FG004|Overall Study|Noncompliance|0|||
130121591|NCT01781286|468406823|FG005|Overall Study|Noncompliance|0|||
130121592|NCT00995410|468406824|FG000|Overall Study|Adverse Event|51|||
130121593|NCT00995410|468406824|FG000|Overall Study|Withdrawal by Subject|7|||
130121594|NCT00995410|468406824|FG000|Overall Study|Lost to Follow-up|2|||
130121595|NCT00995410|468406824|FG000|Overall Study|Misc|28|||
130121596|NCT03594123|468406825|FG000|Overall Study|Lost to Follow-up|0|||
130121597|NCT03594123|468406826|FG001|Overall Study|Lost to Follow-up|1|||
130121598|NCT03594123|468406825|FG000|Overall Study|Adverse Event|8|||
130121599|NCT03594123|468406826|FG001|Overall Study|Adverse Event|5|||
130121600|NCT03594123|468406825|FG000|Overall Study|Site Terminated by Sponsor|4|||
130121601|NCT03594123|468406826|FG001|Overall Study|Site Terminated by Sponsor|1|||
130121602|NCT03594123|468406825|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
130121603|NCT03594123|468406826|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
130121604|NCT03594123|468406825|FG000|Overall Study|Lack of Efficacy|1|||
130121605|NCT03594123|468406826|FG001|Overall Study|Lack of Efficacy|0|||
130121606|NCT03594123|468406825|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
130121607|NCT03594123|468406826|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
130121608|NCT02483975|468406827|FG000|Overall Study|Adverse Event|0|||
130121609|NCT02483975|468406828|FG001|Overall Study|Adverse Event|1|||
130121610|NCT02483975|468406827|FG000|Overall Study|Lost to Follow-up|0|||
130121611|NCT02483975|468406828|FG001|Overall Study|Lost to Follow-up|1|||
130121612|NCT02483975|468406827|FG000|Overall Study|Physician Decision|2|||
130121613|NCT02483975|468406828|FG001|Overall Study|Physician Decision|0|||
130121614|NCT01505530|468406831|FG000|Overall Study|Progressive Disease|19|||
130121615|NCT01505530|468406832|FG001|Overall Study|Progressive Disease|17|||
130121616|NCT01505530|468406833|FG002|Overall Study|Progressive Disease|18|||
130121617|NCT01505530|468406831|FG000|Overall Study|Adverse Event|1|||
130121618|NCT01505530|468406832|FG001|Overall Study|Adverse Event|1|||
130121619|NCT01505530|468406833|FG002|Overall Study|Adverse Event|0|||
130121620|NCT01505530|468406831|FG000|Overall Study|Withdrawal by Subject|7|||
130121621|NCT01505530|468406832|FG001|Overall Study|Withdrawal by Subject|8|||
130121622|NCT01505530|468406833|FG002|Overall Study|Withdrawal by Subject|6|||
130121623|NCT01505530|468406831|FG000|Overall Study|Physician Decision|6|||
130121624|NCT01505530|468406832|FG001|Overall Study|Physician Decision|2|||
130121625|NCT01505530|468406833|FG002|Overall Study|Physician Decision|5|||
130121626|NCT01505530|468406831|FG000|Overall Study|Sponsor Decision|1|||
130121627|NCT01505530|468406832|FG001|Overall Study|Sponsor Decision|8|||
130121628|NCT01505530|468406833|FG002|Overall Study|Sponsor Decision|7|||
130121629|NCT01505530|468406831|FG000|Overall Study|Death|7|||
130121630|NCT01505530|468406832|FG001|Overall Study|Death|6|||
130121631|NCT01505530|468406833|FG002|Overall Study|Death|5|||
130121632|NCT01505530|468406831|FG000|Overall Study|entry criteria not met|0|||
130121633|NCT01505530|468406832|FG001|Overall Study|entry criteria not met|1|||
130121634|NCT01505530|468406833|FG002|Overall Study|entry criteria not met|0|||
130121635|NCT02492958|468406834|FG000|Overall Study|Withdrawal by Subject|0|||
130121636|NCT02492958|468406835|FG001|Overall Study|Withdrawal by Subject|0|||
130121637|NCT02492958|468406836|FG002|Overall Study|Withdrawal by Subject|1|||
130121638|NCT02492958|468406837|FG003|Overall Study|Withdrawal by Subject|0|||
130121639|NCT02492958|468406834|FG000|Overall Study|Adverse Event|1|||
130121640|NCT02492958|468406835|FG001|Overall Study|Adverse Event|0|||
130121641|NCT02492958|468406836|FG002|Overall Study|Adverse Event|1|||
130121642|NCT02492958|468406837|FG003|Overall Study|Adverse Event|0|||
130121643|NCT01901055|468406838|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
130121644|NCT01901055|468406839|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
130121645|NCT01901055|468406838|FG000|Randomization But Not Titrated|Physician Decision|0|||
130121646|NCT01901055|468406839|FG001|Randomization But Not Titrated|Physician Decision|1|||
130121647|NCT01901055|468406838|FG000|Started Protocol to Week 6|Physician Decision|2|||
130121648|NCT01901055|468406839|FG001|Started Protocol to Week 6|Physician Decision|1|||
130121649|NCT01901055|468406838|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
130121650|NCT01901055|468406839|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
130121651|NCT01901055|468406838|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
130154866|NCT00958126|468526621|FG000|Overall Study|Sponsor/Investigator decision|0|||
130088489|NCT01117428|468279328|FG000|Overall Study|Physician Decision|0|||
130088490|NCT01117428|468279329|FG001|Overall Study|Physician Decision|1|||
130088491|NCT01117428|468279330|FG002|Overall Study|Physician Decision|0|||
130088492|NCT01117428|468279331|FG003|Overall Study|Physician Decision|0|||
130088493|NCT01117428|468279332|FG004|Overall Study|Physician Decision|0|||
130088494|NCT01117428|468279333|FG005|Overall Study|Physician Decision|0|||
130088495|NCT01117428|468279328|FG000|Overall Study|Withdrawal by Subject|0|||
130088496|NCT01117428|468279329|FG001|Overall Study|Withdrawal by Subject|0|||
130088497|NCT01117428|468279330|FG002|Overall Study|Withdrawal by Subject|1|||
130088498|NCT01117428|468279331|FG003|Overall Study|Withdrawal by Subject|0|||
130088499|NCT01117428|468279332|FG004|Overall Study|Withdrawal by Subject|0|||
130088500|NCT01117428|468279333|FG005|Overall Study|Withdrawal by Subject|0|||
130088501|NCT01117428|468279328|FG000|Overall Study|Progressive disease|15|||
130088502|NCT01117428|468279329|FG001|Overall Study|Progressive disease|27|||
130088503|NCT01117428|468279330|FG002|Overall Study|Progressive disease|10|||
130088504|NCT01117428|468279331|FG003|Overall Study|Progressive disease|12|||
130088505|NCT01117428|468279332|FG004|Overall Study|Progressive disease|16|||
130088506|NCT01117428|468279333|FG005|Overall Study|Progressive disease|17|||
130088507|NCT03018028|468279334|FG000|Overall Study|Withdrawal by Subject|3|||
130088508|NCT03018028|468279335|FG001|Overall Study|Withdrawal by Subject|0|||
130088509|NCT03018028|468279336|FG002|Overall Study|Withdrawal by Subject|1|||
130088510|NCT03018028|468279337|FG003|Overall Study|Withdrawal by Subject|2|||
130088511|NCT03018028|468279338|FG004|Overall Study|Withdrawal by Subject|0|||
130088512|NCT02519777|468279340|FG000|Overall Study|Death|1|||
130088513|NCT02519777|468279341|FG001|Overall Study|Death|0|||
130088514|NCT02519777|468279342|FG002|Overall Study|Death|0|||
130088515|NCT02519777|468279340|FG000|Overall Study|Lost to Follow-up|0|||
130088516|NCT02519777|468279341|FG001|Overall Study|Lost to Follow-up|4|||
130088517|NCT02519777|468279342|FG002|Overall Study|Lost to Follow-up|2|||
130088518|NCT02519777|468279340|FG000|Overall Study|Withdrawal by Subject|3|||
130088519|NCT02519777|468279341|FG001|Overall Study|Withdrawal by Subject|1|||
130088520|NCT02519777|468279342|FG002|Overall Study|Withdrawal by Subject|0|||
130088521|NCT02519777|468279340|FG000|Overall Study|Severe Debilitation|1|||
130088522|NCT02519777|468279341|FG001|Overall Study|Severe Debilitation|1|||
130088523|NCT02519777|468279342|FG002|Overall Study|Severe Debilitation|1|||
130088524|NCT02519777|468279340|FG000|Overall Study|Not able to get to clinic|1|||
130088525|NCT02519777|468279341|FG001|Overall Study|Not able to get to clinic|2|||
130088526|NCT02519777|468279342|FG002|Overall Study|Not able to get to clinic|1|||
130088527|NCT01683058|468279344|FG000|Overall Study|Lost to Follow-up|9|||
130088528|NCT01683058|468279344|FG000|Overall Study|Adverse Event|6|||
130088529|NCT01683058|468279344|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
130088530|NCT01683058|468279344|FG000|Overall Study|Withdrawal by Subject|7|||
130088531|NCT01683058|468279344|FG000|Overall Study|Lack of Efficacy|2|||
130088532|NCT04062240|468279348|FG000|Overall Study|equipment malfunction|1|||
130088533|NCT01957111|468279349|FG000|Overall Study|Withdrawal by Subject|1|||
130088534|NCT01957111|468279350|FG001|Overall Study|Withdrawal by Subject|1|||
130088535|NCT01057394|468279351|FG000|Overall Study|Not eligible|0|||
130088536|NCT01057394|468279352|FG001|Overall Study|Not eligible|2|||
130088537|NCT01195636|468279353|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
130088538|NCT01195636|468279354|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
130088539|NCT01195636|468279353|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
130088540|NCT01195636|468279354|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
130088541|NCT01195636|468279353|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130088542|NCT01195636|468279354|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
130088543|NCT01195636|468279353|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
130088544|NCT01195636|468279354|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
130088545|NCT01195636|468279353|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
130088546|NCT01195636|468279354|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
130088547|NCT01195636|468279353|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
130088548|NCT01195636|468279354|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
130088549|NCT01195636|468279353|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
130088550|NCT01195636|468279354|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
130088551|NCT01195636|468279353|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
130121652|NCT01901055|468406839|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
130088552|NCT01195636|468279354|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
130088553|NCT03500419|468279355|FG000|Overall Study|Withdrawal by Subject|2|||
130088554|NCT03500419|468279356|FG001|Overall Study|Withdrawal by Subject|25|||
130088555|NCT00203294|468279357|FG000|Overall Study|Withdrawal by Subject|8|||
129961034|NCT00607997|467821533|FG000|Overall Study|Lack of Efficacy|6|||
130088556|NCT00203294|468279358|FG001|Overall Study|Withdrawal by Subject|13|||
130088557|NCT00082628|468279359|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130088558|NCT00082628|468279360|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
130088559|NCT00082628|468279361|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130088560|NCT00082628|468279362|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130088561|NCT00082628|468279363|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
130088562|NCT00082628|468279359|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
130088563|NCT00082628|468279360|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
130088564|NCT00082628|468279361|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
130088565|NCT00082628|468279362|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
130088566|NCT00082628|468279363|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
130088567|NCT00082628|468279359|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
130088568|NCT00082628|468279360|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
130088569|NCT00082628|468279361|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
130088570|NCT00082628|468279362|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
130088571|NCT00082628|468279363|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
130088572|NCT00082628|468279359|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
130088573|NCT00082628|468279360|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
130088574|NCT00082628|468279361|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130088575|NCT00082628|468279362|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130088576|NCT00082628|468279363|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
130088577|NCT00082628|468279359|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130088578|NCT00082628|468279360|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130088579|NCT00082628|468279361|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130088580|NCT00082628|468279362|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
130088581|NCT00082628|468279363|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
130088582|NCT00082628|468279359|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130088583|NCT00082628|468279360|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130088584|NCT00082628|468279361|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130088585|NCT00082628|468279362|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
130088586|NCT00082628|468279363|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
130088587|NCT00082628|468279359|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
130088588|NCT00082628|468279360|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
130088589|NCT00082628|468279361|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
130088590|NCT00082628|468279362|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
130088591|NCT00082628|468279363|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
130088592|NCT01566981|468279364|FG000|Overall Study|Lost to Follow-up|5|||
130088593|NCT01566981|468279365|FG001|Overall Study|Lost to Follow-up|8|||
130088594|NCT01234337|468279369|FG000|Overall Study|Adverse Event|58|||
130088595|NCT01234337|468279370|FG001|Overall Study|Adverse Event|21|||
130088596|NCT01234337|468279369|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
130088597|NCT01234337|468279370|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
130088598|NCT01234337|468279369|FG000|Overall Study|Investi. decision not protocol driven|5|||
130088599|NCT01234337|468279370|FG001|Overall Study|Investi. decision not protocol driven|6|||
130088600|NCT01234337|468279369|FG000|Overall Study|Non-compliant with study medication|3|||
130088601|NCT01234337|468279370|FG001|Overall Study|Non-compliant with study medication|2|||
130088602|NCT01234337|468279369|FG000|Overall Study|Randomized but not treated|6|||
130088603|NCT01234337|468279370|FG001|Overall Study|Randomized but not treated|4|||
130088604|NCT01234337|468279369|FG000|Overall Study|Lost to Follow-up|0|||
130088605|NCT01234337|468279370|FG001|Overall Study|Lost to Follow-up|1|||
130088606|NCT01234337|468279369|FG000|Overall Study|Protocol Violation|2|||
130088607|NCT01234337|468279370|FG001|Overall Study|Protocol Violation|3|||
130088608|NCT01234337|468279369|FG000|Overall Study|Withdrawal by Subject|11|||
130088609|NCT01234337|468279370|FG001|Overall Study|Withdrawal by Subject|9|||
130088610|NCT01234337|468279369|FG000|Overall Study|Death|0|||
130088611|NCT01234337|468279370|FG001|Overall Study|Death|1|||
130088612|NCT01234337|468279369|FG000|Overall Study|Switch to commercial drug|0|||
130088613|NCT01234337|468279370|FG001|Overall Study|Switch to commercial drug|1|||
130088614|NCT03481634|468279371|FG000|Overall Study|Withdrawal by Subject|16|||
130088615|NCT03481634|468279372|FG001|Overall Study|Withdrawal by Subject|19|||
130088616|NCT03481634|468279373|FG002|Overall Study|Withdrawal by Subject|14|||
130088617|NCT03481634|468279371|FG000|Overall Study|Protocol Violation|1|||
130088618|NCT03481634|468279372|FG001|Overall Study|Protocol Violation|0|||
130088619|NCT03481634|468279373|FG002|Overall Study|Protocol Violation|1|||
130088620|NCT03481634|468279371|FG000|Overall Study|Progressive disease|0|||
130088621|NCT03481634|468279372|FG001|Overall Study|Progressive disease|1|||
130088622|NCT03481634|468279373|FG002|Overall Study|Progressive disease|0|||
130088623|NCT03481634|468279371|FG000|Overall Study|Physician Decision|3|||
130088624|NCT03481634|468279372|FG001|Overall Study|Physician Decision|0|||
130088625|NCT03481634|468279373|FG002|Overall Study|Physician Decision|1|||
130088626|NCT03481634|468279371|FG000|Overall Study|Lost to Follow-up|3|||
130088627|NCT03481634|468279372|FG001|Overall Study|Lost to Follow-up|4|||
130088628|NCT03481634|468279373|FG002|Overall Study|Lost to Follow-up|4|||
130088629|NCT03481634|468279371|FG000|Overall Study|Death|4|||
130088630|NCT03481634|468279372|FG001|Overall Study|Death|8|||
130088631|NCT03481634|468279373|FG002|Overall Study|Death|7|||
130088632|NCT03481634|468279371|FG000|Overall Study|Adverse Event|6|||
130088633|NCT03481634|468279372|FG001|Overall Study|Adverse Event|3|||
130088634|NCT03481634|468279373|FG002|Overall Study|Adverse Event|7|||
130088635|NCT00994890|468279376|FG000|Overall Study|Adverse Event|13|||
130088636|NCT00994890|468279377|FG001|Overall Study|Adverse Event|9|||
130088637|NCT00994890|468279378|FG002|Overall Study|Adverse Event|11|||
130088638|NCT00994890|468279376|FG000|Overall Study|Lack of Efficacy|0|||
130088639|NCT00994890|468279377|FG001|Overall Study|Lack of Efficacy|0|||
130088640|NCT00994890|468279378|FG002|Overall Study|Lack of Efficacy|1|||
130088641|NCT00994890|468279376|FG000|Overall Study|Lost to Follow-up|6|||
130088642|NCT00994890|468279377|FG001|Overall Study|Lost to Follow-up|1|||
130088643|NCT00994890|468279378|FG002|Overall Study|Lost to Follow-up|3|||
130088644|NCT00994890|468279376|FG000|Overall Study|No longer willing to participate|8|||
130088645|NCT00994890|468279377|FG001|Overall Study|No longer willing to participate|5|||
130088646|NCT00994890|468279378|FG002|Overall Study|No longer willing to participate|13|||
130088647|NCT00994890|468279376|FG000|Overall Study|Protocol Violation|2|||
130088648|NCT00994890|468279377|FG001|Overall Study|Protocol Violation|4|||
130088649|NCT00994890|468279378|FG002|Overall Study|Protocol Violation|0|||
130088650|NCT00994890|468279376|FG000|Overall Study|Study terminated by sponsor|199|||
130088651|NCT00994890|468279377|FG001|Overall Study|Study terminated by sponsor|201|||
130088652|NCT00994890|468279378|FG002|Overall Study|Study terminated by sponsor|197|||
130088653|NCT00994890|468279376|FG000|Overall Study|Randomized, but not treated|1|||
130088654|NCT00994890|468279377|FG001|Overall Study|Randomized, but not treated|0|||
130088655|NCT00994890|468279378|FG002|Overall Study|Randomized, but not treated|0|||
130088656|NCT00994890|468279376|FG000|Overall Study|Other|2|||
130088657|NCT00994890|468279377|FG001|Overall Study|Other|2|||
130088658|NCT00994890|468279378|FG002|Overall Study|Other|1|||
130088659|NCT03323385|468279383|FG000|Overall Study|Withdrawal by Subject|1|||
130088660|NCT03323385|468279384|FG001|Overall Study|Withdrawal by Subject|2|||
130088661|NCT03323385|468279383|FG000|Overall Study|Noncompliance|0|||
130088662|NCT03323385|468279384|FG001|Overall Study|Noncompliance|1|||
130088663|NCT00247962|468279385|FG000|Overall Study|Adverse Event|15|||
130088664|NCT00247962|468279386|FG001|Overall Study|Adverse Event|12|||
130088665|NCT00247962|468279385|FG000|Overall Study|Lost to Follow-up|3|||
130088666|NCT00247962|468279386|FG001|Overall Study|Lost to Follow-up|1|||
130088667|NCT00247962|468279385|FG000|Overall Study|Physician Decision|0|||
130088668|NCT00247962|468279386|FG001|Overall Study|Physician Decision|1|||
130088669|NCT00247962|468279385|FG000|Overall Study|Protocol Violation|1|||
130088670|NCT00247962|468279386|FG001|Overall Study|Protocol Violation|1|||
130088671|NCT00247962|468279385|FG000|Overall Study|Withdrawal by Subject|3|||
130088672|NCT00247962|468279386|FG001|Overall Study|Withdrawal by Subject|2|||
130088673|NCT00247962|468279385|FG000|Overall Study|Lack of Efficacy|4|||
130088674|NCT00247962|468279386|FG001|Overall Study|Lack of Efficacy|2|||
130088675|NCT01849289|468279387|FG000|Overall Study|Adverse Event|3|||
130088676|NCT01849289|468279388|FG001|Overall Study|Adverse Event|3|||
130088677|NCT01849289|468279387|FG000|Overall Study|Protocol Violation|3|||
130088678|NCT01849289|468279388|FG001|Overall Study|Protocol Violation|3|||
130088679|NCT01849289|468279387|FG000|Overall Study|Withdrawal criteria|1|||
130088680|NCT01849289|468279388|FG001|Overall Study|Withdrawal criteria|0|||
130088681|NCT01849289|468279387|FG000|Overall Study|Unclassified|25|||
130088682|NCT01849289|468279388|FG001|Overall Study|Unclassified|18|||
130088683|NCT01469637|468279389|FG000|First Intervention|Unacceptable behavior|0|||
130088684|NCT01469637|468279390|FG001|First Intervention|Unacceptable behavior|1|||
130088685|NCT01469637|468279389|FG000|Second Intervention|Incarcerated|1|||
130088686|NCT01469637|468279390|FG001|Second Intervention|Incarcerated|0|||
130088687|NCT00598585|468279391|FG000|Overall Study|Lost to Follow-up|1|||
130088688|NCT00598585|468279392|FG001|Overall Study|Lost to Follow-up|0|||
130088689|NCT03480360|468279393|FG000|Overall Study|Death|2|||
130088690|NCT02607735|468279396|FG000|Primary Study|Randomized but Never Treated|1|||
130088691|NCT02607735|468279397|FG001|Primary Study|Randomized but Never Treated|0|||
130088692|NCT02607735|468279398|FG002|Primary Study|Randomized but Never Treated|0|||
130088693|NCT02607735|468279396|FG000|Primary Study|Lost to Follow-up|4|||
130088694|NCT02607735|468279397|FG001|Primary Study|Lost to Follow-up|0|||
130088695|NCT02607735|468279398|FG002|Primary Study|Lost to Follow-up|0|||
130088696|NCT02607735|468279396|FG000|Primary Study|Withdrew Consent|2|||
130088697|NCT02607735|468279397|FG001|Primary Study|Withdrew Consent|0|||
130088698|NCT02607735|468279398|FG002|Primary Study|Withdrew Consent|0|||
130088699|NCT02607735|468279396|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
130088700|NCT02607735|468279397|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
130088701|NCT02607735|468279398|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
130088702|NCT02607735|468279396|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
130088703|NCT02607735|468279397|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
130088704|NCT02607735|468279398|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
130088705|NCT02394028|468279399|FG000|Induction Phase|Adverse Event|2|||
130088706|NCT02394028|468279400|FG001|Induction Phase|Adverse Event|4|||
130088707|NCT02394028|468279401|FG002|Induction Phase|Adverse Event|1|||
129961035|NCT00607997|467821534|FG001|Overall Study|Lack of Efficacy|20|||
129961036|NCT00607997|467821535|FG002|Overall Study|Lack of Efficacy|14|||
129961037|NCT00607997|467821536|FG003|Overall Study|Lack of Efficacy|10|||
129961038|NCT00607997|467821533|FG000|Overall Study|Death|8|||
129961039|NCT00607997|467821534|FG001|Overall Study|Death|5|||
129961040|NCT00607997|467821535|FG002|Overall Study|Death|2|||
129961041|NCT00607997|467821536|FG003|Overall Study|Death|5|||
129961042|NCT00607997|467821533|FG000|Overall Study|Adverse Event|3|||
129961043|NCT00607997|467821534|FG001|Overall Study|Adverse Event|1|||
129961044|NCT00607997|467821535|FG002|Overall Study|Adverse Event|2|||
129961045|NCT00607997|467821536|FG003|Overall Study|Adverse Event|0|||
129961046|NCT00607997|467821533|FG000|Overall Study|Physician Decision|4|||
129961047|NCT00607997|467821534|FG001|Overall Study|Physician Decision|1|||
129961048|NCT00607997|467821535|FG002|Overall Study|Physician Decision|0|||
129961049|NCT00607997|467821536|FG003|Overall Study|Physician Decision|0|||
129961050|NCT00607997|467821533|FG000|Overall Study|Relapse, recurrent illness|4|||
129961051|NCT00607997|467821534|FG001|Overall Study|Relapse, recurrent illness|0|||
129961052|NCT00607997|467821535|FG002|Overall Study|Relapse, recurrent illness|2|||
129961053|NCT00607997|467821536|FG003|Overall Study|Relapse, recurrent illness|0|||
129961054|NCT00607997|467821533|FG000|Overall Study|Other without explanation|2|||
129961055|NCT00607997|467821534|FG001|Overall Study|Other without explanation|0|||
129961056|NCT00607997|467821535|FG002|Overall Study|Other without explanation|4|||
129961057|NCT00607997|467821536|FG003|Overall Study|Other without explanation|1|||
129961058|NCT00839332|467821537|FG000|Phase 1|Disease Progression|38|||
129961059|NCT00839332|467821538|FG001|Phase 1|Disease Progression|0|||
129961060|NCT00839332|467821539|FG002|Phase 1|Disease Progression|0|||
129961061|NCT00839332|467821537|FG000|Phase 1|Adverse Event|6|||
129961062|NCT00839332|467821538|FG001|Phase 1|Adverse Event|0|||
129961063|NCT00839332|467821539|FG002|Phase 1|Adverse Event|0|||
129961064|NCT00839332|467821537|FG000|Phase 1|Withdrawal by Subject|4|||
129961065|NCT00839332|467821538|FG001|Phase 1|Withdrawal by Subject|0|||
129961066|NCT00839332|467821539|FG002|Phase 1|Withdrawal by Subject|0|||
129961067|NCT00839332|467821537|FG000|Phase 1|Physician Decision|2|||
129961068|NCT00839332|467821538|FG001|Phase 1|Physician Decision|0|||
129961069|NCT00839332|467821539|FG002|Phase 1|Physician Decision|0|||
129961070|NCT00839332|467821537|FG000|Phase 2|Protocol Violation|0|||
129961071|NCT00839332|467821538|FG001|Phase 2|Protocol Violation|1|||
129961072|NCT00839332|467821539|FG002|Phase 2|Protocol Violation|0|||
129961073|NCT00839332|467821537|FG000|Phase 2|Disease Progression|0|||
129961074|NCT00839332|467821538|FG001|Phase 2|Disease Progression|46|||
129961075|NCT00839332|467821539|FG002|Phase 2|Disease Progression|21|||
129961076|NCT00839332|467821537|FG000|Phase 2|Adverse Event|0|||
129961077|NCT00839332|467821538|FG001|Phase 2|Adverse Event|8|||
129961078|NCT00839332|467821539|FG002|Phase 2|Adverse Event|6|||
129961079|NCT00839332|467821537|FG000|Phase 2|Death|0|||
129961080|NCT00839332|467821538|FG001|Phase 2|Death|4|||
129961081|NCT00839332|467821539|FG002|Phase 2|Death|2|||
129961082|NCT00839332|467821537|FG000|Phase 2|Withdrawal by Subject|0|||
129961083|NCT00839332|467821538|FG001|Phase 2|Withdrawal by Subject|5|||
129961084|NCT00839332|467821539|FG002|Phase 2|Withdrawal by Subject|8|||
129961085|NCT00839332|467821537|FG000|Phase 2|Physician Decision|0|||
129961086|NCT00839332|467821538|FG001|Phase 2|Physician Decision|4|||
129961087|NCT00839332|467821539|FG002|Phase 2|Physician Decision|1|||
129961088|NCT00839332|467821537|FG000|Phase 2|Lost to Follow-up|0|||
129961089|NCT00839332|467821538|FG001|Phase 2|Lost to Follow-up|0|||
129961090|NCT00839332|467821539|FG002|Phase 2|Lost to Follow-up|1|||
129961091|NCT01200485|467821540|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
129961092|NCT01200485|467821541|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
129961093|NCT01200485|467821542|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
129961094|NCT01200485|467821540|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
129961095|NCT01200485|467821541|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
129961096|NCT01200485|467821542|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
129961097|NCT06080438|467821543|FG000|Overall Study|Lost to Follow-up|2|||
129961098|NCT03589300|467821544|FG000|Overall Study|Adverse Event|2|||
129961099|NCT03589300|467821544|FG000|Overall Study|Death|4|||
129961100|NCT03589300|467821544|FG000|Overall Study|Lost to Follow-up|12|||
129961101|NCT03589300|467821544|FG000|Overall Study|Withdrawal by Subject|5|||
129961102|NCT01678898|467821547|FG000|PB-102-F01|Adverse Event|0|||
129961103|NCT01678898|467821548|FG001|PB-102-F01|Adverse Event|1|||
129961104|NCT01678898|467821549|FG002|PB-102-F01|Adverse Event|0|||
129961105|NCT01678898|467821547|FG000|PB-102-F01|Physician Decision|0|||
129961106|NCT01678898|467821548|FG001|PB-102-F01|Physician Decision|1|||
129961107|NCT01678898|467821549|FG002|PB-102-F01|Physician Decision|0|||
129961108|NCT02864342|467821551|FG000|Overall Study|Eligibility Criteria Deviation|2|||
129961109|NCT02864342|467821552|FG001|Overall Study|Eligibility Criteria Deviation|3|||
129961110|NCT02864342|467821551|FG000|Overall Study|Withdrawal by Subject|4|||
129961111|NCT02864342|467821552|FG001|Overall Study|Withdrawal by Subject|2|||
129961112|NCT02864342|467821551|FG000|Overall Study|Device Technology Issue|6|||
129961113|NCT02864342|467821552|FG001|Overall Study|Device Technology Issue|7|||
129961114|NCT02864342|467821551|FG000|Overall Study|Death|0|||
130121653|NCT01901055|468406838|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
130121654|NCT01901055|468406839|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
130121655|NCT01901055|468406838|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
130121656|NCT01901055|468406839|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
130088708|NCT02394028|468279402|FG003|Induction Phase|Adverse Event|2|||
130088709|NCT02394028|468279403|FG004|Induction Phase|Adverse Event|5|||
130088710|NCT02394028|468279404|FG005|Induction Phase|Adverse Event|2|||
130088711|NCT02394028|468279405|FG006|Induction Phase|Adverse Event|0|||
130088712|NCT02394028|468279406|FG007|Induction Phase|Adverse Event|0|||
130088713|NCT02394028|468279407|FG008|Induction Phase|Adverse Event|0|||
130088714|NCT02394028|468279408|FG009|Induction Phase|Adverse Event|0|||
130088715|NCT02394028|468279409|FG010|Induction Phase|Adverse Event|0|||
130088716|NCT02394028|468279399|FG000|Induction Phase|Lack of Efficacy|3|||
130088717|NCT02394028|468279400|FG001|Induction Phase|Lack of Efficacy|6|||
130088718|NCT02394028|468279401|FG002|Induction Phase|Lack of Efficacy|2|||
130088719|NCT02394028|468279402|FG003|Induction Phase|Lack of Efficacy|17|||
130088720|NCT02394028|468279403|FG004|Induction Phase|Lack of Efficacy|14|||
130088721|NCT02394028|468279404|FG005|Induction Phase|Lack of Efficacy|8|||
130088722|NCT02394028|468279405|FG006|Induction Phase|Lack of Efficacy|17|||
130088723|NCT02394028|468279406|FG007|Induction Phase|Lack of Efficacy|23|||
130088724|NCT02394028|468279407|FG008|Induction Phase|Lack of Efficacy|0|||
130088725|NCT02394028|468279408|FG009|Induction Phase|Lack of Efficacy|0|||
130088726|NCT02394028|468279409|FG010|Induction Phase|Lack of Efficacy|0|||
130088727|NCT02394028|468279399|FG000|Induction Phase|Lost to Follow-up|1|||
130088728|NCT02394028|468279400|FG001|Induction Phase|Lost to Follow-up|0|||
130088729|NCT02394028|468279401|FG002|Induction Phase|Lost to Follow-up|0|||
130088730|NCT02394028|468279402|FG003|Induction Phase|Lost to Follow-up|1|||
130088731|NCT02394028|468279403|FG004|Induction Phase|Lost to Follow-up|0|||
130088732|NCT02394028|468279404|FG005|Induction Phase|Lost to Follow-up|0|||
130088733|NCT02394028|468279405|FG006|Induction Phase|Lost to Follow-up|1|||
130088734|NCT02394028|468279406|FG007|Induction Phase|Lost to Follow-up|0|||
130088735|NCT02394028|468279407|FG008|Induction Phase|Lost to Follow-up|0|||
130088736|NCT02394028|468279408|FG009|Induction Phase|Lost to Follow-up|0|||
130088737|NCT02394028|468279409|FG010|Induction Phase|Lost to Follow-up|0|||
130088738|NCT02394028|468279399|FG000|Induction Phase|Non-compliance|0|||
130088739|NCT02394028|468279400|FG001|Induction Phase|Non-compliance|1|||
130088740|NCT02394028|468279401|FG002|Induction Phase|Non-compliance|3|||
130088741|NCT02394028|468279402|FG003|Induction Phase|Non-compliance|1|||
130088742|NCT02394028|468279403|FG004|Induction Phase|Non-compliance|3|||
130088743|NCT02394028|468279404|FG005|Induction Phase|Non-compliance|0|||
130088744|NCT02394028|468279405|FG006|Induction Phase|Non-compliance|1|||
130088745|NCT02394028|468279406|FG007|Induction Phase|Non-compliance|1|||
130088746|NCT02394028|468279407|FG008|Induction Phase|Non-compliance|0|||
130088747|NCT02394028|468279408|FG009|Induction Phase|Non-compliance|0|||
130088748|NCT02394028|468279409|FG010|Induction Phase|Non-compliance|0|||
130088749|NCT02394028|468279399|FG000|Induction Phase|Physician Decision|0|||
130088750|NCT02394028|468279400|FG001|Induction Phase|Physician Decision|0|||
130088751|NCT02394028|468279401|FG002|Induction Phase|Physician Decision|1|||
130088752|NCT02394028|468279402|FG003|Induction Phase|Physician Decision|4|||
130088753|NCT02394028|468279403|FG004|Induction Phase|Physician Decision|0|||
130088754|NCT02394028|468279404|FG005|Induction Phase|Physician Decision|2|||
130088755|NCT02394028|468279405|FG006|Induction Phase|Physician Decision|1|||
130088756|NCT02394028|468279406|FG007|Induction Phase|Physician Decision|0|||
130088757|NCT02394028|468279407|FG008|Induction Phase|Physician Decision|0|||
130088758|NCT02394028|468279408|FG009|Induction Phase|Physician Decision|0|||
130088759|NCT02394028|468279409|FG010|Induction Phase|Physician Decision|0|||
130088760|NCT02394028|468279399|FG000|Induction Phase|Protocol Violation|0|||
130088761|NCT02394028|468279400|FG001|Induction Phase|Protocol Violation|2|||
130088762|NCT02394028|468279401|FG002|Induction Phase|Protocol Violation|0|||
130121657|NCT01901055|468406838|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
130121658|NCT01901055|468406839|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
129961115|NCT02864342|467821552|FG001|Overall Study|Death|1|||
129961116|NCT02864342|467821551|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
129961117|NCT02864342|467821552|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
129961118|NCT02864342|467821551|FG000|Overall Study|Lost to Follow-up|1|||
130088763|NCT02394028|468279402|FG003|Induction Phase|Protocol Violation|3|||
130088764|NCT02394028|468279403|FG004|Induction Phase|Protocol Violation|0|||
130088765|NCT02394028|468279404|FG005|Induction Phase|Protocol Violation|1|||
130088766|NCT02394028|468279405|FG006|Induction Phase|Protocol Violation|1|||
130088767|NCT02394028|468279406|FG007|Induction Phase|Protocol Violation|0|||
130088768|NCT02394028|468279407|FG008|Induction Phase|Protocol Violation|0|||
130088769|NCT02394028|468279408|FG009|Induction Phase|Protocol Violation|0|||
130088770|NCT02394028|468279409|FG010|Induction Phase|Protocol Violation|0|||
130088771|NCT02394028|468279399|FG000|Induction Phase|Withdrawal by Subject|1|||
130088772|NCT02394028|468279400|FG001|Induction Phase|Withdrawal by Subject|2|||
130088773|NCT02394028|468279401|FG002|Induction Phase|Withdrawal by Subject|4|||
130088774|NCT02394028|468279402|FG003|Induction Phase|Withdrawal by Subject|6|||
130088775|NCT02394028|468279403|FG004|Induction Phase|Withdrawal by Subject|7|||
130088776|NCT02394028|468279404|FG005|Induction Phase|Withdrawal by Subject|4|||
130088777|NCT02394028|468279405|FG006|Induction Phase|Withdrawal by Subject|3|||
130088778|NCT02394028|468279406|FG007|Induction Phase|Withdrawal by Subject|6|||
130088779|NCT02394028|468279407|FG008|Induction Phase|Withdrawal by Subject|0|||
130088780|NCT02394028|468279408|FG009|Induction Phase|Withdrawal by Subject|0|||
130088781|NCT02394028|468279409|FG010|Induction Phase|Withdrawal by Subject|0|||
130088782|NCT02394028|468279399|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088783|NCT02394028|468279400|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088784|NCT02394028|468279401|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088785|NCT02394028|468279402|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088786|NCT02394028|468279403|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088787|NCT02394028|468279404|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088788|NCT02394028|468279405|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
130088789|NCT02394028|468279406|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088790|NCT02394028|468279407|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088791|NCT02394028|468279408|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088792|NCT02394028|468279409|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
130088793|NCT02394028|468279399|FG000|Induction Phase|Sponsor decision|0|||
130088794|NCT02394028|468279400|FG001|Induction Phase|Sponsor decision|1|||
130088795|NCT02394028|468279401|FG002|Induction Phase|Sponsor decision|2|||
130088796|NCT02394028|468279402|FG003|Induction Phase|Sponsor decision|0|||
130088797|NCT02394028|468279403|FG004|Induction Phase|Sponsor decision|0|||
130088798|NCT02394028|468279404|FG005|Induction Phase|Sponsor decision|0|||
130088799|NCT02394028|468279405|FG006|Induction Phase|Sponsor decision|0|||
130088800|NCT02394028|468279406|FG007|Induction Phase|Sponsor decision|0|||
130088801|NCT02394028|468279407|FG008|Induction Phase|Sponsor decision|0|||
130088802|NCT02394028|468279408|FG009|Induction Phase|Sponsor decision|0|||
130088803|NCT02394028|468279409|FG010|Induction Phase|Sponsor decision|0|||
130088804|NCT02394028|468279399|FG000|Induction Phase|Technical reason|0|||
130088805|NCT02394028|468279400|FG001|Induction Phase|Technical reason|0|||
130088806|NCT02394028|468279401|FG002|Induction Phase|Technical reason|0|||
130088807|NCT02394028|468279402|FG003|Induction Phase|Technical reason|1|||
130088808|NCT02394028|468279403|FG004|Induction Phase|Technical reason|0|||
130088809|NCT02394028|468279404|FG005|Induction Phase|Technical reason|0|||
130088810|NCT02394028|468279405|FG006|Induction Phase|Technical reason|0|||
130088811|NCT02394028|468279406|FG007|Induction Phase|Technical reason|0|||
130088812|NCT02394028|468279407|FG008|Induction Phase|Technical reason|0|||
130088813|NCT02394028|468279408|FG009|Induction Phase|Technical reason|0|||
130088814|NCT02394028|468279409|FG010|Induction Phase|Technical reason|0|||
130088815|NCT02394028|468279399|FG000|Induction Phase|:ack of calculation|0|||
130088816|NCT02394028|468279400|FG001|Induction Phase|:ack of calculation|0|||
130088817|NCT02394028|468279401|FG002|Induction Phase|:ack of calculation|0|||
130088818|NCT02394028|468279402|FG003|Induction Phase|:ack of calculation|0|||
130088819|NCT02394028|468279403|FG004|Induction Phase|:ack of calculation|0|||
130088820|NCT02394028|468279404|FG005|Induction Phase|:ack of calculation|0|||
130088821|NCT02394028|468279405|FG006|Induction Phase|:ack of calculation|0|||
130088822|NCT02394028|468279406|FG007|Induction Phase|:ack of calculation|1|||
130088823|NCT02394028|468279407|FG008|Induction Phase|:ack of calculation|0|||
130088824|NCT02394028|468279408|FG009|Induction Phase|:ack of calculation|0|||
130088825|NCT02394028|468279409|FG010|Induction Phase|:ack of calculation|0|||
130088826|NCT02394028|468279399|FG000|Maintenance Phase|Protocol Violation|0|||
130088827|NCT02394028|468279400|FG001|Maintenance Phase|Protocol Violation|0|||
130088828|NCT02394028|468279401|FG002|Maintenance Phase|Protocol Violation|0|||
130088829|NCT02394028|468279402|FG003|Maintenance Phase|Protocol Violation|0|||
130088830|NCT02394028|468279403|FG004|Maintenance Phase|Protocol Violation|0|||
130088831|NCT02394028|468279404|FG005|Maintenance Phase|Protocol Violation|0|||
130088832|NCT02394028|468279405|FG006|Maintenance Phase|Protocol Violation|0|||
130088833|NCT02394028|468279406|FG007|Maintenance Phase|Protocol Violation|0|||
130088834|NCT02394028|468279407|FG008|Maintenance Phase|Protocol Violation|0|||
130088835|NCT02394028|468279408|FG009|Maintenance Phase|Protocol Violation|0|||
130088836|NCT02394028|468279409|FG010|Maintenance Phase|Protocol Violation|1|||
130088837|NCT02394028|468279399|FG000|Maintenance Phase|Physician Decision|0|||
130088838|NCT02394028|468279400|FG001|Maintenance Phase|Physician Decision|0|||
130088839|NCT02394028|468279401|FG002|Maintenance Phase|Physician Decision|0|||
130088840|NCT02394028|468279402|FG003|Maintenance Phase|Physician Decision|0|||
130088841|NCT02394028|468279403|FG004|Maintenance Phase|Physician Decision|0|||
130088842|NCT02394028|468279404|FG005|Maintenance Phase|Physician Decision|0|||
130088843|NCT02394028|468279405|FG006|Maintenance Phase|Physician Decision|0|||
130088844|NCT02394028|468279406|FG007|Maintenance Phase|Physician Decision|0|||
130088845|NCT02394028|468279407|FG008|Maintenance Phase|Physician Decision|1|||
130088846|NCT02394028|468279408|FG009|Maintenance Phase|Physician Decision|3|||
130088847|NCT02394028|468279409|FG010|Maintenance Phase|Physician Decision|2|||
130088848|NCT02394028|468279399|FG000|Maintenance Phase|Lack of Efficacy|0|||
130088849|NCT02394028|468279400|FG001|Maintenance Phase|Lack of Efficacy|0|||
130088850|NCT02394028|468279401|FG002|Maintenance Phase|Lack of Efficacy|0|||
130088851|NCT02394028|468279402|FG003|Maintenance Phase|Lack of Efficacy|0|||
130088852|NCT02394028|468279403|FG004|Maintenance Phase|Lack of Efficacy|0|||
130088853|NCT02394028|468279404|FG005|Maintenance Phase|Lack of Efficacy|0|||
130088854|NCT02394028|468279405|FG006|Maintenance Phase|Lack of Efficacy|0|||
130088855|NCT02394028|468279406|FG007|Maintenance Phase|Lack of Efficacy|0|||
130088856|NCT02394028|468279407|FG008|Maintenance Phase|Lack of Efficacy|7|||
130088857|NCT02394028|468279408|FG009|Maintenance Phase|Lack of Efficacy|25|||
130088858|NCT02394028|468279409|FG010|Maintenance Phase|Lack of Efficacy|33|||
130088859|NCT02394028|468279399|FG000|Maintenance Phase|Death|0|||
130088860|NCT02394028|468279400|FG001|Maintenance Phase|Death|0|||
130088861|NCT02394028|468279401|FG002|Maintenance Phase|Death|0|||
130088862|NCT02394028|468279402|FG003|Maintenance Phase|Death|0|||
130088863|NCT02394028|468279403|FG004|Maintenance Phase|Death|0|||
130088864|NCT02394028|468279404|FG005|Maintenance Phase|Death|0|||
130088865|NCT02394028|468279405|FG006|Maintenance Phase|Death|0|||
130088866|NCT02394028|468279406|FG007|Maintenance Phase|Death|0|||
130088867|NCT02394028|468279407|FG008|Maintenance Phase|Death|0|||
130088868|NCT02394028|468279408|FG009|Maintenance Phase|Death|0|||
130088869|NCT02394028|468279409|FG010|Maintenance Phase|Death|1|||
130088870|NCT02394028|468279399|FG000|Maintenance Phase|Adverse Event|0|||
130088871|NCT02394028|468279400|FG001|Maintenance Phase|Adverse Event|0|||
130088872|NCT02394028|468279401|FG002|Maintenance Phase|Adverse Event|0|||
130088873|NCT02394028|468279402|FG003|Maintenance Phase|Adverse Event|0|||
130088874|NCT02394028|468279403|FG004|Maintenance Phase|Adverse Event|0|||
130088875|NCT02394028|468279404|FG005|Maintenance Phase|Adverse Event|0|||
130088876|NCT02394028|468279405|FG006|Maintenance Phase|Adverse Event|0|||
130088877|NCT02394028|468279406|FG007|Maintenance Phase|Adverse Event|0|||
130088878|NCT02394028|468279407|FG008|Maintenance Phase|Adverse Event|1|||
130088879|NCT02394028|468279408|FG009|Maintenance Phase|Adverse Event|1|||
130088880|NCT02394028|468279409|FG010|Maintenance Phase|Adverse Event|3|||
130088881|NCT02394028|468279399|FG000|Maintenance Phase|Site closure|0|||
130088882|NCT02394028|468279400|FG001|Maintenance Phase|Site closure|0|||
130088883|NCT02394028|468279401|FG002|Maintenance Phase|Site closure|0|||
130088884|NCT02394028|468279402|FG003|Maintenance Phase|Site closure|0|||
130088885|NCT02394028|468279403|FG004|Maintenance Phase|Site closure|0|||
130088886|NCT02394028|468279404|FG005|Maintenance Phase|Site closure|0|||
130088887|NCT02394028|468279405|FG006|Maintenance Phase|Site closure|0|||
130088888|NCT02394028|468279406|FG007|Maintenance Phase|Site closure|0|||
130088889|NCT02394028|468279407|FG008|Maintenance Phase|Site closure|0|||
130088890|NCT02394028|468279408|FG009|Maintenance Phase|Site closure|1|||
130088891|NCT02394028|468279409|FG010|Maintenance Phase|Site closure|0|||
130088892|NCT02394028|468279399|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130088893|NCT02394028|468279400|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130088894|NCT02394028|468279401|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130088895|NCT02394028|468279402|FG003|Maintenance Phase|Withdrawal by Subject|0|||
130088896|NCT02394028|468279403|FG004|Maintenance Phase|Withdrawal by Subject|0|||
130088897|NCT02394028|468279404|FG005|Maintenance Phase|Withdrawal by Subject|0|||
130088898|NCT02394028|468279405|FG006|Maintenance Phase|Withdrawal by Subject|0|||
130088899|NCT02394028|468279406|FG007|Maintenance Phase|Withdrawal by Subject|0|||
130088900|NCT02394028|468279407|FG008|Maintenance Phase|Withdrawal by Subject|3|||
130088901|NCT02394028|468279408|FG009|Maintenance Phase|Withdrawal by Subject|12|||
130088902|NCT02394028|468279409|FG010|Maintenance Phase|Withdrawal by Subject|12|||
130088903|NCT02355665|468279412|FG000|Overall Study|Adverse Event|16|||
130088904|NCT02355665|468279413|FG001|Overall Study|Adverse Event|24|||
130088905|NCT02355665|468279412|FG000|Overall Study|Protocol Violation|2|||
130088906|NCT02355665|468279413|FG001|Overall Study|Protocol Violation|0|||
130088907|NCT02355665|468279412|FG000|Overall Study|Withdrawal by Subject|90|||
130088908|NCT02355665|468279413|FG001|Overall Study|Withdrawal by Subject|100|||
130088909|NCT02355665|468279412|FG000|Overall Study|Lost to Follow-up|131|||
130088910|NCT02355665|468279413|FG001|Overall Study|Lost to Follow-up|103|||
130088911|NCT02355665|468279412|FG000|Overall Study|Death|4|||
130088912|NCT02355665|468279413|FG001|Overall Study|Death|2|||
130088913|NCT02355665|468279412|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
130088914|NCT02355665|468279413|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
130088915|NCT04129242|468279414|FG000|Overall Study|Physician Decision|1|||
130088916|NCT04129242|468279415|FG001|Overall Study|Physician Decision|1|||
130088917|NCT04129242|468279414|FG000|Overall Study|Protocol Violation|0|||
130088918|NCT04129242|468279415|FG001|Overall Study|Protocol Violation|1|||
130088919|NCT01775995|468279416|FG000|Overall Study|Lost to Follow-up|1|||
130088920|NCT01775995|468279417|FG001|Overall Study|Lost to Follow-up|1|||
130088921|NCT02918006|468279419|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
129961119|NCT02864342|467821552|FG001|Overall Study|Lost to Follow-up|5|||
130088922|NCT02918006|468279420|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
130088923|NCT02918006|468279421|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
130088924|NCT02918006|468279419|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
130088925|NCT02918006|468279420|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
130088926|NCT02918006|468279421|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
129961120|NCT02864342|467821551|FG000|Overall Study|Lost Device|1|||
129961121|NCT02864342|467821552|FG001|Overall Study|Lost Device|0|||
129961122|NCT02864342|467821551|FG000|Overall Study|Adverse Event|1|||
129961123|NCT02864342|467821552|FG001|Overall Study|Adverse Event|0|||
129961124|NCT00776984|467821553|FG000|Overall Study|Adverse Event|8|||
129961125|NCT00776984|467821554|FG001|Overall Study|Adverse Event|2|||
129961126|NCT00776984|467821553|FG000|Overall Study|Protocol Violation|4|||
129961127|NCT00776984|467821554|FG001|Overall Study|Protocol Violation|2|||
129961128|NCT00776984|467821553|FG000|Overall Study|Lost to Follow-up|2|||
129961129|NCT00776984|467821554|FG001|Overall Study|Lost to Follow-up|0|||
129961130|NCT00776984|467821553|FG000|Overall Study|Withdrawal by Subject|12|||
129961131|NCT00776984|467821554|FG001|Overall Study|Withdrawal by Subject|7|||
129961132|NCT00776984|467821553|FG000|Overall Study|Lack of Efficacy|0|||
129961133|NCT00776984|467821554|FG001|Overall Study|Lack of Efficacy|1|||
129961134|NCT00776984|467821553|FG000|Overall Study|Other|5|||
129961135|NCT00776984|467821554|FG001|Overall Study|Other|9|||
129961136|NCT02573883|467821557|FG000|Six Month Follow Up|Lost to Follow-up|1|||
129961137|NCT02573883|467821558|FG001|Six Month Follow Up|Lost to Follow-up|0|||
129961138|NCT02573883|467821559|FG002|Six Month Follow Up|Lost to Follow-up|0|||
129961139|NCT02573883|467821560|FG003|Six Month Follow Up|Lost to Follow-up|0|||
129961140|NCT02573883|467821557|FG000|One Year Follow Up|Lost to Follow-up|2|||
129961141|NCT02573883|467821558|FG001|One Year Follow Up|Lost to Follow-up|1|||
129961142|NCT02573883|467821559|FG002|One Year Follow Up|Lost to Follow-up|0|||
129961143|NCT02573883|467821560|FG003|One Year Follow Up|Lost to Follow-up|0|||
129961144|NCT01544309|467821561|FG000|Overall Study|Withdrawal by Subject|12|||
129961145|NCT01544309|467821562|FG001|Overall Study|Withdrawal by Subject|7|||
129961146|NCT01544309|467821561|FG000|Overall Study|Protocol Violation|2|||
129961147|NCT01544309|467821562|FG001|Overall Study|Protocol Violation|1|||
129961148|NCT01544309|467821561|FG000|Overall Study|Physician Decision|4|||
129961149|NCT01544309|467821562|FG001|Overall Study|Physician Decision|1|||
129961150|NCT01544309|467821561|FG000|Overall Study|Not performed pre-dose examination|1|||
129961151|NCT01544309|467821562|FG001|Overall Study|Not performed pre-dose examination|2|||
129961152|NCT01544309|467821561|FG000|Overall Study|Administered prohibit prior medication|1|||
129961153|NCT01544309|467821562|FG001|Overall Study|Administered prohibit prior medication|0|||
129961154|NCT00118703|467821563|FG000|Overall Study|Protocol Violation|1|||
129961155|NCT00118703|467821564|FG001|Overall Study|Protocol Violation|0|||
129961156|NCT00118703|467821563|FG000|Overall Study|Adverse Event|1|||
129961157|NCT00118703|467821564|FG001|Overall Study|Adverse Event|1|||
129961158|NCT00118703|467821563|FG000|Overall Study|Participant took two different treatment|0|||
129961159|NCT00118703|467821564|FG001|Overall Study|Participant took two different treatment|1|||
129961160|NCT00118703|467821563|FG000|Overall Study|Withdrawal by Subject|2|||
129961161|NCT00118703|467821564|FG001|Overall Study|Withdrawal by Subject|5|||
129961162|NCT00118703|467821563|FG000|Overall Study|Lost to Follow-up|1|||
129961163|NCT00118703|467821564|FG001|Overall Study|Lost to Follow-up|2|||
129961164|NCT03796208|467821570|FG000|Overall Study|Withdrawal by Subject|3|||
129961165|NCT03796208|467821571|FG001|Overall Study|Withdrawal by Subject|0|||
129961166|NCT03796208|467821570|FG000|Overall Study|Loss of pregnancy|1|||
129961167|NCT03796208|467821571|FG001|Overall Study|Loss of pregnancy|1|||
129961168|NCT03796208|467821570|FG000|Overall Study|Changed prenatal clinics|0|||
129961169|NCT03796208|467821571|FG001|Overall Study|Changed prenatal clinics|5|||
129961170|NCT03796208|467821570|FG000|Overall Study|Lost to Follow-up|20|||
129961171|NCT03796208|467821571|FG001|Overall Study|Lost to Follow-up|16|||
129961172|NCT02725008|467821572|FG000|Overall Study|Lost to Follow-up|7|||
129961173|NCT02725008|467821573|FG001|Overall Study|Lost to Follow-up|9|||
129961174|NCT02725008|467821572|FG000|Overall Study|Withdrawal by Subject|2|||
129961175|NCT02725008|467821573|FG001|Overall Study|Withdrawal by Subject|2|||
129961176|NCT02725008|467821572|FG000|Overall Study|Admitted to hospital|0|||
129961177|NCT02725008|467821573|FG001|Overall Study|Admitted to hospital|1|||
129961178|NCT01560585|467821574|FG000|Overall Study|Physician Decision|3|||
129961179|NCT00519285|467821575|FG000|Overall Study|Adverse Event|127|||
130088927|NCT02918006|468279419|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
129961180|NCT00519285|467821576|FG001|Overall Study|Adverse Event|266|||
129961181|NCT00519285|467821575|FG000|Overall Study|Disease progression|334|||
129961182|NCT00519285|467821576|FG001|Overall Study|Disease progression|186|||
130088928|NCT02918006|468279420|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
129961183|NCT00519285|467821575|FG000|Overall Study|Physician Decision|75|||
129961184|NCT00519285|467821576|FG001|Overall Study|Physician Decision|47|||
129961185|NCT00519285|467821575|FG000|Overall Study|Participant's request|53|||
129961186|NCT00519285|467821576|FG001|Overall Study|Participant's request|84|||
129961187|NCT00519285|467821575|FG000|Overall Study|Consent withdrawn|4|||
129961188|NCT00519285|467821576|FG001|Overall Study|Consent withdrawn|5|||
129961189|NCT00519285|467821575|FG000|Overall Study|Poor compliance to protocol|5|||
129961190|NCT00519285|467821576|FG001|Overall Study|Poor compliance to protocol|7|||
129961191|NCT00519285|467821575|FG000|Overall Study|Reason unspecified|5|||
129961192|NCT00519285|467821576|FG001|Overall Study|Reason unspecified|8|||
129961193|NCT00519285|467821575|FG000|Overall Study|Not treated|8|||
129961194|NCT00519285|467821576|FG001|Overall Study|Not treated|7|||
129961195|NCT00519285|467821575|FG000|Overall Study|Treatment ongoing|1|||
130088929|NCT02918006|468279421|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
130088930|NCT02918006|468279419|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
130088931|NCT02918006|468279420|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
130088932|NCT02918006|468279421|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
130088933|NCT02918006|468279419|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
130088934|NCT02918006|468279420|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
130088935|NCT02918006|468279421|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
130088936|NCT02918006|468279419|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
130088937|NCT02918006|468279420|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
130088938|NCT02918006|468279421|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
130088939|NCT02918006|468279419|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
130088940|NCT02918006|468279420|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
130088941|NCT02918006|468279421|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
130088942|NCT02918006|468279419|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
130088943|NCT02918006|468279420|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
130088944|NCT02918006|468279421|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
130088945|NCT02918006|468279419|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
130088946|NCT02918006|468279420|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
130088947|NCT02918006|468279421|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
130088948|NCT01156012|468279423|FG000|Overall Study|Adverse Event|3|||
130088949|NCT01156012|468279424|FG001|Overall Study|Adverse Event|1|||
130088950|NCT01156012|468279423|FG000|Overall Study|Lost to Follow-up|1|||
130088951|NCT01156012|468279424|FG001|Overall Study|Lost to Follow-up|0|||
130088952|NCT01156012|468279423|FG000|Overall Study|Withdrawal by Subject|1|||
130088953|NCT01156012|468279424|FG001|Overall Study|Withdrawal by Subject|0|||
130088954|NCT01156012|468279423|FG000|Overall Study|use of commercial drug instead of study|0|||
130088955|NCT01156012|468279424|FG001|Overall Study|use of commercial drug instead of study|1|||
130088956|NCT01156012|468279423|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
130088957|NCT01156012|468279424|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
130088958|NCT02475564|468279425|FG000|Overall Study|Withdrawal by Subject|1|||
130088959|NCT02475564|468279426|FG001|Overall Study|Withdrawal by Subject|0|||
130088960|NCT02475564|468279425|FG000|Overall Study|Lost to Follow-up|2|||
130088961|NCT02475564|468279426|FG001|Overall Study|Lost to Follow-up|1|||
130088962|NCT02475564|468279425|FG000|Overall Study|Intense Menstrual bleeding|1|||
130088963|NCT02475564|468279426|FG001|Overall Study|Intense Menstrual bleeding|0|||
130088964|NCT02705755|468279428|FG000|Part A (6 Days)|Adverse Event|1|||
130088965|NCT02705755|468279429|FG001|Part A (6 Days)|Adverse Event|0|||
130088966|NCT02705755|468279430|FG002|Part A (6 Days)|Adverse Event|0|||
130088967|NCT02705755|468279431|FG003|Part A (6 Days)|Adverse Event|0|||
130088968|NCT02705755|468279428|FG000|Part A (6 Days)|Physician Decision|3|||
130088969|NCT02705755|468279429|FG001|Part A (6 Days)|Physician Decision|0|||
130088970|NCT02705755|468279430|FG002|Part A (6 Days)|Physician Decision|0|||
130088971|NCT02705755|468279431|FG003|Part A (6 Days)|Physician Decision|0|||
130088972|NCT02705755|468279428|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
130088973|NCT02705755|468279429|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
130088974|NCT02705755|468279430|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
130088975|NCT02705755|468279431|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
130088976|NCT02705755|468279428|FG000|Part C (20 Weeks)|Physician Decision|0|||
130088977|NCT02705755|468279429|FG001|Part C (20 Weeks)|Physician Decision|0|||
130088978|NCT02705755|468279430|FG002|Part C (20 Weeks)|Physician Decision|0|||
130088979|NCT02705755|468279431|FG003|Part C (20 Weeks)|Physician Decision|2|||
130088980|NCT02705755|468279428|FG000|Part C (20 Weeks)|Adverse Event|0|||
130088981|NCT02705755|468279429|FG001|Part C (20 Weeks)|Adverse Event|0|||
130088982|NCT02705755|468279430|FG002|Part C (20 Weeks)|Adverse Event|0|||
130088983|NCT02705755|468279431|FG003|Part C (20 Weeks)|Adverse Event|6|||
130088984|NCT02705755|468279428|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
130088985|NCT02705755|468279429|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
130088986|NCT02705755|468279430|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
130088987|NCT02705755|468279431|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
130088988|NCT01084096|468280675|FG000|Overall Study|Lost to Follow-up|1501|||
130088989|NCT01084096|468280676|FG001|Overall Study|Lost to Follow-up|1833|||
130088990|NCT01084096|468280675|FG000|Overall Study|Withdrawal by Subject|3|||
130088991|NCT01084096|468280676|FG001|Overall Study|Withdrawal by Subject|0|||
130088992|NCT01084096|468280675|FG000|Overall Study|Woman had a miscarriage|21|||
130088993|NCT01084096|468280676|FG001|Overall Study|Woman had a miscarriage|17|||
130088994|NCT01354964|468280677|FG000|Overall Study|Lost to Follow-up|2|||
130088995|NCT01354964|468280678|FG001|Overall Study|Lost to Follow-up|0|||
130088996|NCT01354964|468280677|FG000|Overall Study|IV access issues|1|||
130088997|NCT01354964|468280678|FG001|Overall Study|IV access issues|1|||
130088998|NCT01354964|468280677|FG000|Overall Study|Physician Decision|1|||
130088999|NCT01354964|468280678|FG001|Overall Study|Physician Decision|0|||
130089000|NCT04450394|468280687|FG000|Overall Study|Adverse Event|2|||
130089001|NCT04450394|468280688|FG001|Overall Study|Adverse Event|0|||
130089002|NCT04450394|468280689|FG002|Overall Study|Adverse Event|0|||
130121659|NCT01901055|468406838|FG000|Week 24|Withdrawal by Subject|13|||
130121660|NCT01901055|468406839|FG001|Week 24|Withdrawal by Subject|19|||
130121661|NCT01901055|468406838|FG000|Week 24|Physician Decision|1|||
130121662|NCT01901055|468406839|FG001|Week 24|Physician Decision|0|||
130121663|NCT01901055|468406838|FG000|Week 36|Withdrawal by Subject|0|||
130121664|NCT01901055|468406839|FG001|Week 36|Withdrawal by Subject|5|||
130121665|NCT02660242|468406852|FG000|Glucose Tabs|Lost to Follow-up|1|||
130121666|NCT02660242|468406852|FG000|Glucagon Injection|Lost to Follow-up|1|||
130121667|NCT00770510|468406854|FG000|Overall Study|Lost to Follow-up|2|||
130121668|NCT00770510|468406854|FG000|Overall Study|Pregnancy|1|||
130121669|NCT00770510|468406854|FG000|Overall Study|Withdrawal by Subject|2|||
130121670|NCT02192099|468406860|FG000|Overall Study|Adverse Event|1|||
130121671|NCT02192099|468406860|FG000|Overall Study|Lost to Follow-up|2|||
130121672|NCT02192099|468406860|FG000|Overall Study|Physician Decision|1|||
130121673|NCT02192099|468406860|FG000|Overall Study|Pregnancy|1|||
130121674|NCT02192099|468406860|FG000|Overall Study|Protocol Violation|8|||
130121675|NCT02192099|468406860|FG000|Overall Study|Study Terminated by Sponsor|32|||
130121676|NCT02192099|468406860|FG000|Overall Study|Withdrawal by Subject|11|||
130121677|NCT02192099|468406860|FG000|Overall Study|Miscellaneous Reasons|5|||
130121678|NCT00995553|468406864|FG000|Overall Study|Withdrawal by Subject|2|||
130121679|NCT00995553|468406865|FG001|Overall Study|Withdrawal by Subject|6|||
130121680|NCT01089647|468406866|FG000|Overall Study|Lost to Follow-up|2|||
130121681|NCT01089647|468406867|FG001|Overall Study|Lost to Follow-up|2|||
130121682|NCT01089647|468406866|FG000|Overall Study|Withdrawal by Subject|2|||
130121683|NCT01089647|468406867|FG001|Overall Study|Withdrawal by Subject|1|||
130121684|NCT01089647|468406866|FG000|Overall Study|Adverse Event|0|||
130121685|NCT01089647|468406867|FG001|Overall Study|Adverse Event|1|||
130121686|NCT02001558|468406870|FG000|Overall Study|Lost to Follow-up|8|||
130121687|NCT02001558|468406871|FG001|Overall Study|Lost to Follow-up|14|||
130121688|NCT02780687|468406880|FG000|Overall Study|Adverse Event|1|||
130121689|NCT02780687|468406881|FG001|Overall Study|Adverse Event|1|||
130121690|NCT02780687|468406880|FG000|Overall Study|Withdrawal by Subject|2|||
130121691|NCT02780687|468406881|FG001|Overall Study|Withdrawal by Subject|1|||
130121692|NCT02780687|468406880|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
129961196|NCT00519285|467821576|FG001|Overall Study|Treatment ongoing|2|||
130089003|NCT04450394|468280687|FG000|Overall Study|Death|0|||
130089004|NCT04450394|468280688|FG001|Overall Study|Death|1|||
130089005|NCT04450394|468280689|FG002|Overall Study|Death|0|||
130089006|NCT04450394|468280687|FG000|Overall Study|Lost to Follow-up|0|||
130089007|NCT04450394|468280688|FG001|Overall Study|Lost to Follow-up|3|||
130089008|NCT04450394|468280689|FG002|Overall Study|Lost to Follow-up|0|||
130089009|NCT04450394|468280687|FG000|Overall Study|Physician Decision|0|||
130089010|NCT04450394|468280688|FG001|Overall Study|Physician Decision|1|||
130089011|NCT04450394|468280689|FG002|Overall Study|Physician Decision|0|||
130089012|NCT04450394|468280687|FG000|Overall Study|Protocol Violation|2|||
130089013|NCT04450394|468280688|FG001|Overall Study|Protocol Violation|0|||
130089014|NCT04450394|468280689|FG002|Overall Study|Protocol Violation|0|||
130089015|NCT04450394|468280687|FG000|Overall Study|Withdrawal by Subject|6|||
130089016|NCT04450394|468280688|FG001|Overall Study|Withdrawal by Subject|9|||
130089017|NCT04450394|468280689|FG002|Overall Study|Withdrawal by Subject|0|||
130089018|NCT02155660|468280694|FG000|Overall Study|Other Reason|8|||
130089019|NCT02155660|468280695|FG001|Overall Study|Other Reason|6|||
130089020|NCT02155660|468280696|FG002|Overall Study|Other Reason|10|||
130089021|NCT02155660|468280697|FG003|Overall Study|Other Reason|10|||
130089022|NCT02155660|468280694|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130089023|NCT02155660|468280695|FG001|Overall Study|Study-specific withdrawal criteria|1|||
130089024|NCT02155660|468280696|FG002|Overall Study|Study-specific withdrawal criteria|1|||
130089025|NCT02155660|468280697|FG003|Overall Study|Study-specific withdrawal criteria|1|||
130089026|NCT02155660|468280694|FG000|Overall Study|Severe non-compliance|0|||
130089027|NCT02155660|468280695|FG001|Overall Study|Severe non-compliance|4|||
130089028|NCT02155660|468280696|FG002|Overall Study|Severe non-compliance|0|||
130089029|NCT02155660|468280697|FG003|Overall Study|Severe non-compliance|1|||
130089030|NCT02155660|468280694|FG000|Overall Study|Adverse Event|2|||
130089031|NCT02155660|468280695|FG001|Overall Study|Adverse Event|6|||
130089032|NCT02155660|468280696|FG002|Overall Study|Adverse Event|3|||
130089033|NCT02155660|468280697|FG003|Overall Study|Adverse Event|1|||
130089034|NCT02155660|468280694|FG000|Overall Study|Lost to Follow-up|3|||
130089035|NCT02155660|468280695|FG001|Overall Study|Lost to Follow-up|6|||
130089036|NCT02155660|468280696|FG002|Overall Study|Lost to Follow-up|5|||
130089037|NCT02155660|468280697|FG003|Overall Study|Lost to Follow-up|8|||
130089038|NCT02155660|468280694|FG000|Overall Study|Death|17|||
130089039|NCT02155660|468280695|FG001|Overall Study|Death|19|||
130121693|NCT02780687|468406881|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
130121694|NCT02780687|468406880|FG000|Overall Study|progressive disease|29|||
130121695|NCT02780687|468406881|FG001|Overall Study|progressive disease|6|||
130089040|NCT02155660|468280696|FG002|Overall Study|Death|17|||
130089041|NCT02155660|468280697|FG003|Overall Study|Death|19|||
130121696|NCT00368277|468406882|FG000|Overall Study|Adverse Event|33|||
130121697|NCT00368277|468406883|FG001|Overall Study|Adverse Event|49|||
130089042|NCT02155660|468280694|FG000|Overall Study|Withdrawal by Subject|28|||
130089043|NCT02155660|468280695|FG001|Overall Study|Withdrawal by Subject|31|||
130089044|NCT02155660|468280696|FG002|Overall Study|Withdrawal by Subject|24|||
130089045|NCT02155660|468280697|FG003|Overall Study|Withdrawal by Subject|21|||
130089046|NCT00303719|468280698|FG000|Overall Study|Not evaluable, prior therapies|0|||
130089047|NCT00303719|468280699|FG001|Overall Study|Not evaluable, prior therapies|30|||
130089048|NCT00303719|468280698|FG000|Overall Study|Lost to Follow-up|0|||
130089049|NCT00303719|468280699|FG001|Overall Study|Lost to Follow-up|7|||
130089050|NCT01641952|468280700|FG000|Overall Study|Lost to Follow-up|28|||
130089051|NCT01641952|468280700|FG000|Overall Study|Adverse Event|6|||
130089052|NCT00561912|468280710|FG000|Overall Study|ineligible|1|||
130089053|NCT02643420|468280711|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
130089054|NCT02643420|468280712|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
130089055|NCT02643420|468280711|FG000|Overall Study|Withdrawal by Subject|25|||
130089056|NCT02643420|468280712|FG001|Overall Study|Withdrawal by Subject|19|||
130089057|NCT02643420|468280711|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
130089058|NCT02643420|468280712|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
130089059|NCT02643420|468280711|FG000|Overall Study|Lost to Follow-up|6|||
130089060|NCT02643420|468280712|FG001|Overall Study|Lost to Follow-up|10|||
130089061|NCT02643420|468280711|FG000|Overall Study|Investigator Decision|2|||
130089062|NCT02643420|468280712|FG001|Overall Study|Investigator Decision|4|||
130089063|NCT02643420|468280711|FG000|Overall Study|Sponsor decision|1|||
130089064|NCT02643420|468280712|FG001|Overall Study|Sponsor decision|1|||
130089065|NCT02643420|468280711|FG000|Overall Study|Death|0|||
130089066|NCT02643420|468280712|FG001|Overall Study|Death|2|||
130089067|NCT02643420|468280711|FG000|Overall Study|Reason not Specified|8|||
130089068|NCT02643420|468280712|FG001|Overall Study|Reason not Specified|7|||
130089069|NCT02127970|468280713|FG000|Overall Study|Adverse Event|2|||
130089070|NCT02127970|468280714|FG001|Overall Study|Adverse Event|1|||
130089071|NCT02127970|468280713|FG000|Overall Study|Death|1|||
130089072|NCT02127970|468280714|FG001|Overall Study|Death|1|||
130089073|NCT02127970|468280713|FG000|Overall Study|Lost to Follow-up|14|||
130089074|NCT02127970|468280714|FG001|Overall Study|Lost to Follow-up|14|||
130089075|NCT02127970|468280713|FG000|Overall Study|Reason not Specified|4|||
130089076|NCT02127970|468280714|FG001|Overall Study|Reason not Specified|7|||
130089077|NCT02127970|468280713|FG000|Overall Study|Pregnancy|0|||
130089078|NCT02127970|468280714|FG001|Overall Study|Pregnancy|1|||
130089079|NCT02127970|468280713|FG000|Overall Study|Subject Withdrew Consent|5|||
130089080|NCT02127970|468280714|FG001|Overall Study|Subject Withdrew Consent|3|||
130089081|NCT01398176|468280715|FG000|Overall Study|Lost to Follow-up|1|||
130089082|NCT01398176|468280716|FG001|Overall Study|Lost to Follow-up|3|||
130089083|NCT01398176|468280715|FG000|Overall Study|Physician Decision|2|||
130089084|NCT01398176|468280716|FG001|Overall Study|Physician Decision|3|||
130089085|NCT02988115|468280718|FG000|Overall Study|Adverse Event|6|||
130089086|NCT02988115|468280719|FG001|Overall Study|Adverse Event|1|||
130089087|NCT02988115|468280718|FG000|Overall Study|Sponsor Decision|5|||
130089088|NCT02988115|468280719|FG001|Overall Study|Sponsor Decision|2|||
130089089|NCT02988115|468280718|FG000|Overall Study|Withdrawal by Subject|1|||
130089090|NCT02988115|468280719|FG001|Overall Study|Withdrawal by Subject|1|||
130089091|NCT02988115|468280718|FG000|Overall Study|Withdrawn by Mistake|1|||
130089092|NCT02988115|468280719|FG001|Overall Study|Withdrawn by Mistake|0|||
130089093|NCT02988115|468280718|FG000|Overall Study|Lost to Follow-up|1|||
130089094|NCT02988115|468280719|FG001|Overall Study|Lost to Follow-up|0|||
130089095|NCT01731951|468280720|FG000|Overall Study|Documented Disease Progression|1|||
130089096|NCT01731951|468280721|FG001|Overall Study|Documented Disease Progression|0|||
130089097|NCT01731951|468280722|FG002|Overall Study|Documented Disease Progression|0|||
130089098|NCT01731951|468280723|FG003|Overall Study|Documented Disease Progression|0|||
130089099|NCT01731951|468280724|FG004|Overall Study|Documented Disease Progression|0|||
130089100|NCT01731951|468280725|FG005|Overall Study|Documented Disease Progression|0|||
130089101|NCT01731951|468280720|FG000|Overall Study|Lost to Follow-up|2|||
130089102|NCT01731951|468280721|FG001|Overall Study|Lost to Follow-up|0|||
129961197|NCT01020747|467821581|FG000|Overall Study|Withdrawal by Subject|1|||
130089103|NCT01731951|468280722|FG002|Overall Study|Lost to Follow-up|0|||
130089104|NCT01731951|468280723|FG003|Overall Study|Lost to Follow-up|1|||
130089105|NCT01731951|468280724|FG004|Overall Study|Lost to Follow-up|3|||
130089106|NCT01731951|468280725|FG005|Overall Study|Lost to Follow-up|1|||
130089107|NCT01731951|468280720|FG000|Overall Study|Withdrawal of Consent|1|||
130089108|NCT01731951|468280721|FG001|Overall Study|Withdrawal of Consent|0|||
130089109|NCT01731951|468280722|FG002|Overall Study|Withdrawal of Consent|0|||
130089110|NCT01731951|468280723|FG003|Overall Study|Withdrawal of Consent|0|||
130089111|NCT01731951|468280724|FG004|Overall Study|Withdrawal of Consent|0|||
130089112|NCT01731951|468280725|FG005|Overall Study|Withdrawal of Consent|2|||
130089113|NCT01731951|468280720|FG000|Overall Study|Death|13|||
130089114|NCT01731951|468280721|FG001|Overall Study|Death|15|||
130089115|NCT01731951|468280722|FG002|Overall Study|Death|9|||
130089116|NCT01731951|468280723|FG003|Overall Study|Death|8|||
130089117|NCT01731951|468280724|FG004|Overall Study|Death|9|||
130121698|NCT00368277|468406882|FG000|Overall Study|Death|2|||
130121699|NCT00368277|468406883|FG001|Overall Study|Death|1|||
130121700|NCT00368277|468406882|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
130121701|NCT00368277|468406883|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
130121702|NCT00368277|468406882|FG000|Overall Study|Protocol deviation|7|||
130121703|NCT00368277|468406883|FG001|Overall Study|Protocol deviation|0|||
130121704|NCT00368277|468406882|FG000|Overall Study|Patient withdrew consent|32|||
130121705|NCT00368277|468406883|FG001|Overall Study|Patient withdrew consent|28|||
130121706|NCT00368277|468406882|FG000|Overall Study|Lost to Follow-up|8|||
130121707|NCT00368277|468406883|FG001|Overall Study|Lost to Follow-up|6|||
130121708|NCT03283709|468406895|FG000|Overall Study|trial terminated|0|||
130121709|NCT03283709|468406896|FG001|Overall Study|trial terminated|1|||
130121710|NCT01734772|468406897|FG000|Overall Study|Adverse Event|1|||
130121711|NCT01734772|468406898|FG001|Overall Study|Adverse Event|2|||
130121712|NCT01734772|468406897|FG000|Overall Study|Withdrawal by Subject|0|||
130121713|NCT01734772|468406898|FG001|Overall Study|Withdrawal by Subject|1|||
130121714|NCT01867242|468406899|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
130121715|NCT01867242|468406900|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
130121716|NCT01867242|468406901|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
130121717|NCT01790568|468406907|FG000|Overall Study|Progression prior to transplant|0|||
130121718|NCT01790568|468406908|FG001|Overall Study|Progression prior to transplant|1|||
130121719|NCT00264810|468406909|FG000|Baseline|Withdrawal by Subject|10|||
130121720|NCT00264810|468406910|FG001|Baseline|Withdrawal by Subject|10|||
130121721|NCT00264810|468406909|FG000|Baseline|Physician Decision|7|||
130121722|NCT00264810|468406910|FG001|Baseline|Physician Decision|8|||
130121723|NCT00264810|468406909|FG000|Baseline|Subject Compliance Failure|3|||
130121724|NCT00264810|468406910|FG001|Baseline|Subject Compliance Failure|3|||
130121725|NCT00264810|468406909|FG000|Baseline|Insufficient Seizure Frequency|2|||
130121726|NCT00264810|468406910|FG001|Baseline|Insufficient Seizure Frequency|2|||
130121727|NCT00264810|468406909|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
130121728|NCT00264810|468406910|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
130121729|NCT00264810|468406909|FG000|Baseline|Other|0|||
130121730|NCT00264810|468406910|FG001|Baseline|Other|1|||
130121731|NCT00264810|468406909|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
130121732|NCT00264810|468406910|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
130121733|NCT00264810|468406909|FG000|Stimulation Optimization Period|Death|0|||
130121734|NCT00264810|468406910|FG001|Stimulation Optimization Period|Death|1|||
130121735|NCT00264810|468406909|FG000|Blinded Evaluation Period|Explant due to infection|1|||
130121736|NCT00264810|468406910|FG001|Blinded Evaluation Period|Explant due to infection|1|||
130121737|NCT00264810|468406909|FG000|Open Label Evaluation Period|Explant due to infection|1|||
130121738|NCT00264810|468406910|FG001|Open Label Evaluation Period|Explant due to infection|1|||
130121739|NCT00264810|468406909|FG000|Open Label Evaluation Period|Death|3|||
130121740|NCT00264810|468406910|FG001|Open Label Evaluation Period|Death|2|||
130121741|NCT00264810|468406909|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
130121742|NCT00264810|468406910|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
130121743|NCT02994056|468406911|FG000|Overall Study|Death|8|||
130089118|NCT01731951|468280725|FG005|Overall Study|Death|6|||
130089119|NCT03287089|468280726|FG000|Overall Study|Lost to Follow-up|0|||
130089120|NCT03287089|468280727|FG001|Overall Study|Lost to Follow-up|2|||
130089121|NCT03287089|468280726|FG000|Overall Study|Physician Decision|0|||
130089122|NCT03287089|468280727|FG001|Overall Study|Physician Decision|2|||
130089123|NCT03287089|468280726|FG000|Overall Study|Withdrawal by Subject|0|||
130089124|NCT03287089|468280727|FG001|Overall Study|Withdrawal by Subject|2|||
130089125|NCT00775138|468280728|FG000|Overall Study|Withdrawal by Subject|0|||
130089126|NCT00775138|468280729|FG001|Overall Study|Withdrawal by Subject|0|||
130089127|NCT00775138|468280730|FG002|Overall Study|Withdrawal by Subject|2|||
130089128|NCT00775138|468280731|FG003|Overall Study|Withdrawal by Subject|2|||
130089129|NCT00775138|468280728|FG000|Overall Study|Adverse Event|0|||
130089130|NCT00775138|468280729|FG001|Overall Study|Adverse Event|0|||
130089131|NCT00775138|468280730|FG002|Overall Study|Adverse Event|1|||
130121744|NCT02994056|468406911|FG000|Overall Study|Withdrew Consent|1|||
130121745|NCT02199509|468406914|FG000|Overall Study|Suicidal Ideation|0|||
130121746|NCT02199509|468406915|FG001|Overall Study|Suicidal Ideation|1|||
130121747|NCT02199509|468406914|FG000|Overall Study|Misunderstood titration schedule|1|||
130089132|NCT00775138|468280731|FG003|Overall Study|Adverse Event|0|||
130089133|NCT04880642|468280732|FG000|Randomization|Withdrawal by Subject|2|||
130089134|NCT04880642|468280733|FG001|Randomization|Withdrawal by Subject|3|||
130089135|NCT04880642|468280732|FG000|Treatment Period|Adverse Event|0|||
130089136|NCT04880642|468280733|FG001|Treatment Period|Adverse Event|1|||
130121748|NCT02199509|468406915|FG001|Overall Study|Misunderstood titration schedule|0|||
130121749|NCT02093689|468406916|FG000|Overall Study|Physician Decision|4|||
130121750|NCT02093689|468406917|FG001|Overall Study|Physician Decision|0|||
130121751|NCT02093689|468406918|FG002|Overall Study|Physician Decision|0|||
130121752|NCT03309956|468406922|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
130121753|NCT02768298|468406923|FG000|Overall Study|Adverse Event|1|||
130089137|NCT04880642|468280732|FG000|Treatment Period|Death|6|||
129961198|NCT02175745|467821582|FG000|Overall Study|Not Eligible|1|||
129961199|NCT01078584|467821585|FG000|Overall Study|Final Status Unknown|1073|||
129961200|NCT01078584|467821585|FG000|Overall Study|Lost to Follow-up|670|||
129961201|NCT01078584|467821585|FG000|Overall Study|Non-serious Adverse Event|577|||
129961202|NCT01078584|467821585|FG000|Overall Study|Withdrawal of Consent|244|||
129961203|NCT01078584|467821585|FG000|Overall Study|Physician Withdrew from Study|90|||
129961204|NCT01078584|467821585|FG000|Overall Study|Non-compliance|67|||
129961205|NCT01078584|467821585|FG000|Overall Study|Blood Pressure Controlled|49|||
129961206|NCT01078584|467821585|FG000|Overall Study|Physician Switched Medication|26|||
129961207|NCT01078584|467821585|FG000|Overall Study|Physician Discontinued Patient|12|||
129961208|NCT01078584|467821585|FG000|Overall Study|Lack of Efficacy|98|||
129961209|NCT01078584|467821585|FG000|Overall Study|Protocol Violation|75|||
129961210|NCT01078584|467821585|FG000|Overall Study|Serious Adverse Event|27|||
129961211|NCT01078584|467821585|FG000|Overall Study|Multiple Reasons|2|||
129961212|NCT03015181|467821586|FG000|Overall Study|Enrolled, but product never administered|1|||
129961213|NCT03015181|467821587|FG001|Overall Study|Enrolled, but product never administered|0|||
129961214|NCT03015181|467821588|FG002|Overall Study|Enrolled, but product never administered|0|||
129961215|NCT03015181|467821589|FG003|Overall Study|Enrolled, but product never administered|0|||
129961216|NCT03015181|467821590|FG004|Overall Study|Enrolled, but product never administered|0|||
129961217|NCT03015181|467821591|FG005|Overall Study|Enrolled, but product never administered|0|||
129961218|NCT03015181|467821592|FG006|Overall Study|Enrolled, but product never administered|0|||
129961219|NCT03015181|467821586|FG000|Overall Study|Withdrawal by Subject|0|||
129961220|NCT03015181|467821587|FG001|Overall Study|Withdrawal by Subject|0|||
129961221|NCT03015181|467821588|FG002|Overall Study|Withdrawal by Subject|0|||
129961222|NCT03015181|467821589|FG003|Overall Study|Withdrawal by Subject|0|||
129961223|NCT03015181|467821590|FG004|Overall Study|Withdrawal by Subject|0|||
129961224|NCT03015181|467821591|FG005|Overall Study|Withdrawal by Subject|1|||
129961225|NCT03015181|467821592|FG006|Overall Study|Withdrawal by Subject|0|||
129961226|NCT03015181|467821586|FG000|Overall Study|Physician Decision|0|||
129961227|NCT03015181|467821587|FG001|Overall Study|Physician Decision|0|||
129961228|NCT03015181|467821588|FG002|Overall Study|Physician Decision|0|||
129961229|NCT03015181|467821589|FG003|Overall Study|Physician Decision|0|||
129961230|NCT03015181|467821590|FG004|Overall Study|Physician Decision|0|||
129961231|NCT03015181|467821591|FG005|Overall Study|Physician Decision|0|||
129961232|NCT03015181|467821592|FG006|Overall Study|Physician Decision|1|||
129961233|NCT02551692|467821594|FG000|Overall Study|Lost to Follow-up|0|||
129961234|NCT02551692|467821595|FG001|Overall Study|Lost to Follow-up|1|||
129961235|NCT02551692|467821596|FG002|Overall Study|Lost to Follow-up|4|||
129961236|NCT02551692|467821594|FG000|Overall Study|Withdrawal by Subject|1|||
129961237|NCT02551692|467821595|FG001|Overall Study|Withdrawal by Subject|0|||
129961238|NCT02551692|467821596|FG002|Overall Study|Withdrawal by Subject|1|||
129961239|NCT01091519|467821597|FG000|Overall Study|Adverse Event|12|||
129961240|NCT01091519|467821598|FG001|Overall Study|Adverse Event|16|||
129961241|NCT01091519|467821597|FG000|Overall Study|Death|1|||
129961242|NCT01091519|467821598|FG001|Overall Study|Death|0|||
129961243|NCT01091519|467821597|FG000|Overall Study|Lack of Efficacy|16|||
129961244|NCT01091519|467821598|FG001|Overall Study|Lack of Efficacy|19|||
129961245|NCT01091519|467821597|FG000|Overall Study|Lost to Follow-up|14|||
129961246|NCT01091519|467821598|FG001|Overall Study|Lost to Follow-up|24|||
129961247|NCT01091519|467821597|FG000|Overall Study|Withdrawal by Subject|2|||
129961248|NCT01091519|467821598|FG001|Overall Study|Withdrawal by Subject|2|||
129961249|NCT01091519|467821597|FG000|Overall Study|Other|6|||
129961250|NCT01091519|467821598|FG001|Overall Study|Other|8|||
129961251|NCT01091519|467821597|FG000|Overall Study|Randomized not treated|4|||
129961252|NCT01091519|467821598|FG001|Overall Study|Randomized not treated|4|||
129961253|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
129961254|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
129961255|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
129961256|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Other|1|||
129961257|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Other|0|||
129961258|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Other|0|||
129961259|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Physician Decision|3|||
129961260|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Physician Decision|0|||
129961261|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Physician Decision|0|||
129961262|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
130089138|NCT04880642|468280733|FG001|Treatment Period|Death|6|||
130089139|NCT04880642|468280732|FG000|Treatment Period|Lost to Follow-up|1|||
129961263|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
129961264|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
130089140|NCT04880642|468280733|FG001|Treatment Period|Lost to Follow-up|0|||
130089141|NCT04880642|468280732|FG000|Treatment Period|Protocol Violation|0|||
129961265|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
129961266|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
129961267|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
129961268|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Adverse Event|18|||
129961269|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Adverse Event|0|||
129961270|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Adverse Event|0|||
129961271|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
129961272|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
129961273|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
129961274|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
129961275|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
129961276|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
129961277|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
129961278|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
129961279|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
129961280|NCT03030599|467821601|FG000|Stable Dose|Protocol deviation|3|||
129961281|NCT03030599|467821602|FG001|Stable Dose|Protocol deviation|0|||
129961282|NCT03030599|467821603|FG002|Stable Dose|Protocol deviation|0|||
129961283|NCT03030599|467821601|FG000|Stable Dose|Adverse Event|1|||
129961284|NCT03030599|467821602|FG001|Stable Dose|Adverse Event|0|||
129961285|NCT03030599|467821603|FG002|Stable Dose|Adverse Event|0|||
129961286|NCT03030599|467821601|FG000|Stable Dose|Lost to Follow-up|1|||
129961287|NCT03030599|467821602|FG001|Stable Dose|Lost to Follow-up|0|||
129961288|NCT03030599|467821603|FG002|Stable Dose|Lost to Follow-up|0|||
129961289|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
129961290|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
129961291|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
129961292|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
129961293|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
129961294|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
129961295|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
129961296|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
129961297|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
129961298|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
129961299|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
129961300|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
129961301|NCT03030599|467821601|FG000|Open-label Extension|Adverse Event|3|||
129961302|NCT03030599|467821602|FG001|Open-label Extension|Adverse Event|0|||
129961303|NCT03030599|467821603|FG002|Open-label Extension|Adverse Event|0|||
129961304|NCT03030599|467821601|FG000|Open-label Extension|Lost to Follow-up|2|||
129961305|NCT03030599|467821602|FG001|Open-label Extension|Lost to Follow-up|0|||
129961306|NCT03030599|467821603|FG002|Open-label Extension|Lost to Follow-up|0|||
129961307|NCT03030599|467821601|FG000|Open-label Extension|Lack of Efficacy|1|||
129961308|NCT03030599|467821602|FG001|Open-label Extension|Lack of Efficacy|0|||
129961309|NCT03030599|467821603|FG002|Open-label Extension|Lack of Efficacy|0|||
129961310|NCT03030599|467821601|FG000|Open-label Extension|Other Reason|1|||
129961311|NCT03030599|467821602|FG001|Open-label Extension|Other Reason|0|||
129961312|NCT03030599|467821603|FG002|Open-label Extension|Other Reason|0|||
129961313|NCT01592383|467821604|FG000|Overall Study|Adverse Event|1|||
129961314|NCT04582864|467821605|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
129961315|NCT04582864|467821605|FG000|Overall Study|Death|1|||
129961316|NCT04167085|467821606|FG000|Baseline|Withdrawal by Subject|2|||
129961317|NCT04167085|467821607|FG001|Baseline|Withdrawal by Subject|1|||
129961318|NCT04167085|467821606|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
129961319|NCT04167085|467821607|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
129961320|NCT02481934|467821611|FG000|Overall Study|Death|2|||
129961321|NCT00942188|467821612|FG000|Overall Study|Adverse Event|0|||
129961322|NCT00942188|467821613|FG001|Overall Study|Adverse Event|3|||
129961323|NCT00942188|467821614|FG002|Overall Study|Adverse Event|2|||
129961324|NCT00942188|467821615|FG003|Overall Study|Adverse Event|0|||
129961325|NCT00942188|467821612|FG000|Overall Study|Lack of Efficacy|0|||
129961326|NCT00942188|467821613|FG001|Overall Study|Lack of Efficacy|0|||
129961327|NCT00942188|467821614|FG002|Overall Study|Lack of Efficacy|0|||
129961328|NCT00942188|467821615|FG003|Overall Study|Lack of Efficacy|1|||
129961329|NCT00942188|467821612|FG000|Overall Study|Protocol Violation|1|||
129961330|NCT00942188|467821613|FG001|Overall Study|Protocol Violation|1|||
130089142|NCT04880642|468280733|FG001|Treatment Period|Protocol Violation|1|||
130089143|NCT04880642|468280732|FG000|Treatment Period|Withdrawal by Subject|5|||
130089144|NCT04880642|468280733|FG001|Treatment Period|Withdrawal by Subject|3|||
129961331|NCT00942188|467821614|FG002|Overall Study|Protocol Violation|0|||
129961332|NCT00942188|467821615|FG003|Overall Study|Protocol Violation|0|||
129961333|NCT00942188|467821612|FG000|Overall Study|Lost to Follow-up|2|||
129961334|NCT00942188|467821613|FG001|Overall Study|Lost to Follow-up|1|||
129961335|NCT00942188|467821614|FG002|Overall Study|Lost to Follow-up|2|||
130089145|NCT04880642|468280732|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
129961336|NCT00942188|467821615|FG003|Overall Study|Lost to Follow-up|0|||
129961337|NCT00942188|467821612|FG000|Overall Study|Withdrawal by Subject|1|||
129961338|NCT00942188|467821613|FG001|Overall Study|Withdrawal by Subject|3|||
130089146|NCT04880642|468280733|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
130089147|NCT04880642|468280732|FG000|Follow-up|Death|4|||
130089148|NCT04880642|468280733|FG001|Follow-up|Death|3|||
130089149|NCT04880642|468280732|FG000|Follow-up|Withdrawal by Subject|1|||
130089150|NCT04880642|468280733|FG001|Follow-up|Withdrawal by Subject|0|||
130089151|NCT00104299|468280734|FG000|Overall Study|Adverse Event|3|||
130089152|NCT00104299|468280735|FG001|Overall Study|Adverse Event|1|||
130089153|NCT00104299|468280734|FG000|Overall Study|Death|2|||
130089154|NCT00104299|468280735|FG001|Overall Study|Death|2|||
130089155|NCT00104299|468280734|FG000|Overall Study|Withdrawal by Subject|2|||
130089156|NCT00104299|468280735|FG001|Overall Study|Withdrawal by Subject|6|||
130089157|NCT00104299|468280734|FG000|Overall Study|Physician Decision|1|||
130089158|NCT00104299|468280735|FG001|Overall Study|Physician Decision|1|||
130089159|NCT00104299|468280734|FG000|Overall Study|To have renal transplant|1|||
130089160|NCT00104299|468280735|FG001|Overall Study|To have renal transplant|0|||
130089161|NCT02452034|468280736|FG000|Overall Study|Adverse Event|0|||
130089162|NCT02452034|468280737|FG001|Overall Study|Adverse Event|0|||
130089163|NCT02452034|468280738|FG002|Overall Study|Adverse Event|0|||
130089164|NCT02452034|468280739|FG003|Overall Study|Adverse Event|0|||
130089165|NCT02452034|468280740|FG004|Overall Study|Adverse Event|0|||
130089166|NCT02452034|468280741|FG005|Overall Study|Adverse Event|1|||
130089167|NCT02452034|468280736|FG000|Overall Study|Death|0|||
130089168|NCT02452034|468280737|FG001|Overall Study|Death|0|||
130089169|NCT02452034|468280738|FG002|Overall Study|Death|0|||
130089170|NCT02452034|468280739|FG003|Overall Study|Death|0|||
130089171|NCT02452034|468280740|FG004|Overall Study|Death|1|||
130089172|NCT02452034|468280741|FG005|Overall Study|Death|1|||
130089173|NCT02452034|468280736|FG000|Overall Study|Physician Decision|0|||
130089174|NCT02452034|468280737|FG001|Overall Study|Physician Decision|1|||
130089175|NCT02452034|468280738|FG002|Overall Study|Physician Decision|1|||
130089176|NCT02452034|468280739|FG003|Overall Study|Physician Decision|0|||
130089177|NCT02452034|468280740|FG004|Overall Study|Physician Decision|0|||
130089178|NCT02452034|468280741|FG005|Overall Study|Physician Decision|0|||
130089179|NCT02452034|468280736|FG000|Overall Study|Protocol Violation|0|||
130089180|NCT02452034|468280737|FG001|Overall Study|Protocol Violation|0|||
130089181|NCT02452034|468280738|FG002|Overall Study|Protocol Violation|0|||
130089182|NCT02452034|468280739|FG003|Overall Study|Protocol Violation|0|||
130089183|NCT02452034|468280740|FG004|Overall Study|Protocol Violation|0|||
130089184|NCT02452034|468280741|FG005|Overall Study|Protocol Violation|1|||
130089185|NCT02452034|468280736|FG000|Overall Study|Screen Failure|1|||
130089186|NCT02452034|468280737|FG001|Overall Study|Screen Failure|0|||
130089187|NCT02452034|468280738|FG002|Overall Study|Screen Failure|0|||
130089188|NCT02452034|468280739|FG003|Overall Study|Screen Failure|1|||
130089189|NCT02452034|468280740|FG004|Overall Study|Screen Failure|0|||
130089190|NCT02452034|468280741|FG005|Overall Study|Screen Failure|0|||
130089191|NCT02452034|468280736|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130089192|NCT02452034|468280737|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
130089193|NCT02452034|468280738|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130089194|NCT02452034|468280739|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
130089195|NCT02452034|468280740|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
130089196|NCT02452034|468280741|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
130089197|NCT00561795|468280742|FG000|Overall Study|Adverse Event|3|||
130089198|NCT00561795|468280743|FG001|Overall Study|Adverse Event|3|||
130089199|NCT00561795|468280744|FG002|Overall Study|Adverse Event|0|||
130089200|NCT00561795|468280745|FG003|Overall Study|Adverse Event|0|||
130089201|NCT00561795|468280742|FG000|Overall Study|Study Closed/Terminated|0|||
130089202|NCT00561795|468280743|FG001|Overall Study|Study Closed/Terminated|3|||
130089203|NCT00561795|468280744|FG002|Overall Study|Study Closed/Terminated|0|||
130089204|NCT00561795|468280745|FG003|Overall Study|Study Closed/Terminated|0|||
130089205|NCT00561795|468280742|FG000|Overall Study|Physician Decision|1|||
130089206|NCT00561795|468280743|FG001|Overall Study|Physician Decision|0|||
130089207|NCT00561795|468280744|FG002|Overall Study|Physician Decision|0|||
130089208|NCT00561795|468280745|FG003|Overall Study|Physician Decision|0|||
130089209|NCT02195531|468280747|FG000|Overall Study|Withdrawal by Subject|1|||
130121754|NCT02768298|468406924|FG001|Overall Study|Adverse Event|4|||
130121755|NCT02768298|468406923|FG000|Overall Study|Death|2|||
130089210|NCT02195531|468280748|FG001|Overall Study|Withdrawal by Subject|1|||
130089211|NCT02195531|468280749|FG002|Overall Study|Withdrawal by Subject|1|||
130089212|NCT02543801|468280751|FG000|Overall Study|Protocol Violation|1|||
130089213|NCT02543801|468280752|FG001|Overall Study|Protocol Violation|2|||
130089214|NCT02543801|468280753|FG002|Overall Study|Protocol Violation|0|||
130089215|NCT02543801|468280754|FG003|Overall Study|Protocol Violation|0|||
130089216|NCT01034709|468280757|FG000|Overall Study|Protocol Violation|9|||
130089217|NCT01034709|468280758|FG001|Overall Study|Protocol Violation|16|||
130089218|NCT02364999|468280774|FG000|Overall Study|Death|136|||
130089219|NCT02364999|468280775|FG001|Overall Study|Death|138|||
130089220|NCT02364999|468280774|FG000|Overall Study|Lost to Follow-up|10|||
130089221|NCT02364999|468280775|FG001|Overall Study|Lost to Follow-up|15|||
130089222|NCT02364999|468280774|FG000|Overall Study|Protocol Violation|3|||
130089223|NCT02364999|468280775|FG001|Overall Study|Protocol Violation|2|||
130089224|NCT02364999|468280774|FG000|Overall Study|Withdrawal by Subject|14|||
130089225|NCT02364999|468280775|FG001|Overall Study|Withdrawal by Subject|14|||
130089226|NCT02364999|468280774|FG000|Overall Study|Other|0|||
130089227|NCT02364999|468280775|FG001|Overall Study|Other|1|||
130089228|NCT02364999|468280774|FG000|Overall Study|Randomized but did not receive treatment|2|||
130089229|NCT02364999|468280775|FG001|Overall Study|Randomized but did not receive treatment|3|||
130089230|NCT02177942|468280776|FG000|Overall Study|Adverse Event|1|||
130089231|NCT02177942|468280777|FG001|Overall Study|Adverse Event|0|||
130089232|NCT02177942|468280776|FG000|Overall Study|Lost to Follow-up|1|||
130089233|NCT02177942|468280777|FG001|Overall Study|Lost to Follow-up|1|||
130089234|NCT02177942|468280776|FG000|Overall Study|Protocol Violation|4|||
130089235|NCT02177942|468280777|FG001|Overall Study|Protocol Violation|6|||
130089236|NCT02177942|468280776|FG000|Overall Study|Withdrawal by Subject|71|||
130089237|NCT02177942|468280777|FG001|Overall Study|Withdrawal by Subject|81|||
130089238|NCT01351415|468280778|FG000|Overall Study|Withdrawal by Subject|15|||
130089239|NCT01351415|468280779|FG001|Overall Study|Withdrawal by Subject|17|||
130089240|NCT01351415|468280778|FG000|Overall Study|Trial termination by the Sponsor|28|||
130089241|NCT01351415|468280779|FG001|Overall Study|Trial termination by the Sponsor|19|||
130089242|NCT01351415|468280778|FG000|Overall Study|Lost to Follow-up|5|||
130089243|NCT01351415|468280779|FG001|Overall Study|Lost to Follow-up|7|||
130089244|NCT01351415|468280778|FG000|Overall Study|Death|190|||
130089245|NCT01351415|468280779|FG001|Overall Study|Death|187|||
130089246|NCT01351415|468280778|FG000|Overall Study|Physician Decision|2|||
130089247|NCT01351415|468280779|FG001|Overall Study|Physician Decision|3|||
130089248|NCT01351415|468280778|FG000|Overall Study|Reason unknown|0|||
130089249|NCT01351415|468280779|FG001|Overall Study|Reason unknown|2|||
130089250|NCT01351415|468280778|FG000|Overall Study|Never Started|5|||
130089251|NCT01351415|468280779|FG001|Overall Study|Never Started|5|||
130089252|NCT00699582|468280784|FG000|Overall Study|Adverse Event|4|||
130089253|NCT00699582|468280785|FG001|Overall Study|Adverse Event|11|||
130089254|NCT00699582|468280786|FG002|Overall Study|Adverse Event|23|||
130089255|NCT00699582|468280784|FG000|Overall Study|Withdrawal by Subject|6|||
130089256|NCT00699582|468280785|FG001|Overall Study|Withdrawal by Subject|7|||
130089257|NCT00699582|468280786|FG002|Overall Study|Withdrawal by Subject|4|||
130089258|NCT00699582|468280784|FG000|Overall Study|Lack of Efficacy|1|||
130089259|NCT00699582|468280785|FG001|Overall Study|Lack of Efficacy|0|||
130089260|NCT00699582|468280786|FG002|Overall Study|Lack of Efficacy|1|||
130089261|NCT00699582|468280784|FG000|Overall Study|Progressive Disease|1|||
130089262|NCT00699582|468280785|FG001|Overall Study|Progressive Disease|0|||
130089263|NCT00699582|468280786|FG002|Overall Study|Progressive Disease|0|||
130089264|NCT00699582|468280784|FG000|Overall Study|Administrative/Other|4|||
130089265|NCT00699582|468280785|FG001|Overall Study|Administrative/Other|3|||
130089266|NCT00699582|468280786|FG002|Overall Study|Administrative/Other|0|||
130089267|NCT00699582|468280784|FG000|Overall Study|Randomized, Not Treated|2|||
130089268|NCT00699582|468280785|FG001|Overall Study|Randomized, Not Treated|1|||
130089269|NCT00699582|468280786|FG002|Overall Study|Randomized, Not Treated|0|||
130089270|NCT04118127|468280787|FG000|Overall Study|Trial terminated by sponsor|0|||
130089271|NCT04118127|468280788|FG001|Overall Study|Trial terminated by sponsor|12|||
130089272|NCT04118127|468280787|FG000|Overall Study|Adverse Event|1|||
130089273|NCT04118127|468280788|FG001|Overall Study|Adverse Event|2|||
130089274|NCT04118127|468280787|FG000|Overall Study|Physician Decision|0|||
130089275|NCT04118127|468280788|FG001|Overall Study|Physician Decision|1|||
130089276|NCT04118127|468280787|FG000|Overall Study|Withdrawal by Subject|2|||
130089277|NCT04118127|468280788|FG001|Overall Study|Withdrawal by Subject|1|||
130089278|NCT00660816|468280791|FG000|Overall Study|Adverse Event|1|||
130089279|NCT00660816|468280792|FG001|Overall Study|Adverse Event|2|||
130089280|NCT00660816|468280791|FG000|Overall Study|Withdrawal by Subject|1|||
130089281|NCT00660816|468280792|FG001|Overall Study|Withdrawal by Subject|0|||
130089282|NCT00660816|468280791|FG000|Overall Study|Death|0|||
130089283|NCT00660816|468280792|FG001|Overall Study|Death|2|||
130089284|NCT00660816|468280791|FG000|Overall Study|Lack of Efficacy|1|||
130089285|NCT00660816|468280792|FG001|Overall Study|Lack of Efficacy|0|||
130089286|NCT00660816|468280791|FG000|Overall Study|Physician Decision|0|||
130089287|NCT00660816|468280792|FG001|Overall Study|Physician Decision|2|||
130089288|NCT00660816|468280791|FG000|Overall Study|Protocol Violation|1|||
130089289|NCT00660816|468280792|FG001|Overall Study|Protocol Violation|0|||
130089290|NCT00660816|468280791|FG000|Overall Study|Disease Progression|16|||
130089291|NCT00660816|468280792|FG001|Overall Study|Disease Progression|12|||
130089292|NCT00660816|468280791|FG000|Overall Study|Complicating Disease|0|||
130089293|NCT00660816|468280792|FG001|Overall Study|Complicating Disease|1|||
130089294|NCT02692560|468280793|FG000|Overall Study|Withdrawal by Subject|0|||
130089295|NCT02692560|468280794|FG001|Overall Study|Withdrawal by Subject|6|||
130089296|NCT01326910|468280795|FG000|Overall Study|Withdrawal by Subject|3|||
130089297|NCT01326910|468280796|FG001|Overall Study|Withdrawal by Subject|2|||
130089298|NCT01326910|468280795|FG000|Overall Study|Protocol Violation|1|||
130089299|NCT01326910|468280796|FG001|Overall Study|Protocol Violation|1|||
130089300|NCT01681836|468280799|FG000|Second Intervention|Withdrawal by Subject|0|||
130089301|NCT01681836|468280800|FG001|Second Intervention|Withdrawal by Subject|1|||
130121756|NCT02768298|468406924|FG001|Overall Study|Death|1|||
129961339|NCT00942188|467821614|FG002|Overall Study|Withdrawal by Subject|4|||
129961340|NCT00942188|467821615|FG003|Overall Study|Withdrawal by Subject|2|||
129961341|NCT00942188|467821612|FG000|Overall Study|Physician Decision|0|||
129961342|NCT00942188|467821613|FG001|Overall Study|Physician Decision|0|||
129961343|NCT00942188|467821614|FG002|Overall Study|Physician Decision|1|||
129961344|NCT00942188|467821615|FG003|Overall Study|Physician Decision|0|||
129961345|NCT00942188|467821612|FG000|Overall Study|Sponsor Decision|0|||
129961346|NCT00942188|467821613|FG001|Overall Study|Sponsor Decision|2|||
129961347|NCT00942188|467821614|FG002|Overall Study|Sponsor Decision|0|||
129961348|NCT00942188|467821615|FG003|Overall Study|Sponsor Decision|1|||
129961349|NCT01374971|467821616|FG000|Overall Study|Withdrawal by Subject|1|||
129961350|NCT00560313|467823975|FG000|Overall Study|Adverse Events or Death|2|||
129961351|NCT00560313|467823975|FG000|Overall Study|Withdrawal by Subject|2|||
129961352|NCT00560313|467823975|FG000|Overall Study|Lost to Follow-up|1|||
129961353|NCT00560313|467823975|FG000|Overall Study|Protocol Violation|1|||
129961354|NCT00526097|467823979|FG000|Overall Study|Adverse Event|6|||
129961355|NCT00526097|467823980|FG001|Overall Study|Adverse Event|44|||
129961356|NCT00526097|467823979|FG000|Overall Study|Protocol Violation|4|||
129961357|NCT00526097|467823980|FG001|Overall Study|Protocol Violation|10|||
129961358|NCT00526097|467823979|FG000|Overall Study|Withdrawal by Subject|3|||
129961359|NCT00526097|467823980|FG001|Overall Study|Withdrawal by Subject|1|||
129961360|NCT00526097|467823979|FG000|Overall Study|Other|2|||
129961361|NCT00526097|467823980|FG001|Overall Study|Other|1|||
129961362|NCT00943618|467823981|FG000|Overall Study|Lost to Follow-up|38|||
129961363|NCT00943618|467823982|FG001|Overall Study|Lost to Follow-up|48|||
129961364|NCT00943618|467823983|FG002|Overall Study|Lost to Follow-up|20|||
129961365|NCT00943618|467823981|FG000|Overall Study|Discontinued Medication|17|||
129961366|NCT00943618|467823982|FG001|Overall Study|Discontinued Medication|29|||
129961367|NCT00943618|467823983|FG002|Overall Study|Discontinued Medication|11|||
129961368|NCT03713281|467823993|FG000|Overall Study|Lens handling difficuluties|2|||
129961369|NCT03713281|467823993|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
129961370|NCT05006417|467823996|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
129961371|NCT02158247|467823997|FG000|Overall Study|Invisible vocal cords|5|||
129961372|NCT00875615|467824006|FG000|Overall Study|Withdrawal by Subject|1|||
129961373|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
129961374|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
129961375|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
129961376|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
129961377|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
129961378|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
129961379|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
129961380|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
129961381|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
129961382|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
129961383|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
129961384|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
129961385|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
129961386|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
129961387|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
129961388|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
129961389|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
129961390|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
129961391|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
129961392|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
129961393|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
129961394|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
129961395|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
129961396|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
129961397|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
129961398|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
129961399|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
129961400|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
130089302|NCT01241318|468280803|FG000|Overall Study|Woman: false pregnancies|27|||
130089303|NCT01241318|468280804|FG001|Overall Study|Woman: false pregnancies|15|||
130089304|NCT01241318|468280803|FG000|Overall Study|Woman: miscarriage/abortion|46|||
130089305|NCT01241318|468280804|FG001|Overall Study|Woman: miscarriage/abortion|38|||
129961401|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
129961402|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
130089306|NCT01241318|468280803|FG000|Overall Study|Withdrawal by Subject|175|||
130089307|NCT01241318|468280804|FG001|Overall Study|Withdrawal by Subject|46|||
129961403|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
129961404|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
129961405|NCT00468858|467824013|FG000|Overall Study|Adverse Event|0|||
129961406|NCT00468858|467824014|FG001|Overall Study|Adverse Event|1|||
129961407|NCT00468858|467824015|FG002|Overall Study|Adverse Event|0|||
129961408|NCT00468858|467824013|FG000|Overall Study|Withdrawal by Subject|7|||
129961409|NCT00468858|467824014|FG001|Overall Study|Withdrawal by Subject|4|||
129961410|NCT00468858|467824015|FG002|Overall Study|Withdrawal by Subject|5|||
129961411|NCT00468858|467824013|FG000|Overall Study|Relocation|1|||
129961412|NCT00468858|467824014|FG001|Overall Study|Relocation|3|||
129961413|NCT00468858|467824015|FG002|Overall Study|Relocation|3|||
129961414|NCT00468858|467824013|FG000|Overall Study|Lost to Follow-up|1|||
129961415|NCT00468858|467824014|FG001|Overall Study|Lost to Follow-up|2|||
129961416|NCT00468858|467824015|FG002|Overall Study|Lost to Follow-up|5|||
129961417|NCT00468858|467824013|FG000|Overall Study|Other|0|||
129961418|NCT00468858|467824014|FG001|Overall Study|Other|0|||
129961419|NCT00468858|467824015|FG002|Overall Study|Other|1|||
129961420|NCT02741713|467824019|FG000|Overall Study|Surgery type changed intra-operatively|2|||
129961421|NCT02741713|467824020|FG001|Overall Study|Surgery type changed intra-operatively|1|||
129961422|NCT00809341|467824023|FG000|Overall Study|Physician Decision|0|||
129961423|NCT00809341|467824024|FG001|Overall Study|Physician Decision|1|||
129961424|NCT00550446|467824025|FG000|Up To Week 12|Adverse Event|2|||
129961425|NCT00550446|467824026|FG001|Up To Week 12|Adverse Event|2|||
129961426|NCT00550446|467824027|FG002|Up To Week 12|Adverse Event|0|||
129961427|NCT00550446|467824028|FG003|Up To Week 12|Adverse Event|0|||
129961428|NCT00550446|467824029|FG004|Up To Week 12|Adverse Event|2|||
129961429|NCT00550446|467824030|FG005|Up To Week 12|Adverse Event|2|||
129961430|NCT00550446|467824031|FG006|Up To Week 12|Adverse Event|1|||
129961431|NCT00550446|467824032|FG007|Up To Week 12|Adverse Event|0|||
129961432|NCT00550446|467824033|FG008|Up To Week 12|Adverse Event|0|||
129961433|NCT00550446|467824034|FG009|Up To Week 12|Adverse Event|0|||
129961434|NCT00550446|467824035|FG010|Up To Week 12|Adverse Event|0|||
129961435|NCT00550446|467824025|FG000|Up To Week 12|Lack of Efficacy|3|||
129961436|NCT00550446|467824026|FG001|Up To Week 12|Lack of Efficacy|1|||
129961437|NCT00550446|467824027|FG002|Up To Week 12|Lack of Efficacy|0|||
129961438|NCT00550446|467824028|FG003|Up To Week 12|Lack of Efficacy|1|||
129961439|NCT00550446|467824029|FG004|Up To Week 12|Lack of Efficacy|0|||
129961440|NCT00550446|467824030|FG005|Up To Week 12|Lack of Efficacy|3|||
129961441|NCT00550446|467824031|FG006|Up To Week 12|Lack of Efficacy|3|||
129961442|NCT00550446|467824032|FG007|Up To Week 12|Lack of Efficacy|0|||
129961443|NCT00550446|467824033|FG008|Up To Week 12|Lack of Efficacy|0|||
129961444|NCT00550446|467824034|FG009|Up To Week 12|Lack of Efficacy|0|||
129961445|NCT00550446|467824035|FG010|Up To Week 12|Lack of Efficacy|0|||
129961446|NCT00550446|467824025|FG000|Up To Week 12|Lost to Follow-up|0|||
129961447|NCT00550446|467824026|FG001|Up To Week 12|Lost to Follow-up|1|||
129961448|NCT00550446|467824027|FG002|Up To Week 12|Lost to Follow-up|0|||
129961449|NCT00550446|467824028|FG003|Up To Week 12|Lost to Follow-up|0|||
129961450|NCT00550446|467824029|FG004|Up To Week 12|Lost to Follow-up|1|||
129961451|NCT00550446|467824030|FG005|Up To Week 12|Lost to Follow-up|1|||
129961452|NCT00550446|467824031|FG006|Up To Week 12|Lost to Follow-up|2|||
129961453|NCT00550446|467824032|FG007|Up To Week 12|Lost to Follow-up|0|||
129961454|NCT00550446|467824033|FG008|Up To Week 12|Lost to Follow-up|0|||
129961455|NCT00550446|467824034|FG009|Up To Week 12|Lost to Follow-up|0|||
129961456|NCT00550446|467824035|FG010|Up To Week 12|Lost to Follow-up|0|||
129961457|NCT00550446|467824025|FG000|Up To Week 12|Withdrawal by Subject|2|||
129961458|NCT00550446|467824026|FG001|Up To Week 12|Withdrawal by Subject|0|||
129961459|NCT00550446|467824027|FG002|Up To Week 12|Withdrawal by Subject|3|||
129961460|NCT00550446|467824028|FG003|Up To Week 12|Withdrawal by Subject|2|||
129961461|NCT00550446|467824029|FG004|Up To Week 12|Withdrawal by Subject|0|||
129961462|NCT00550446|467824030|FG005|Up To Week 12|Withdrawal by Subject|1|||
129961463|NCT00550446|467824031|FG006|Up To Week 12|Withdrawal by Subject|3|||
129961464|NCT00550446|467824032|FG007|Up To Week 12|Withdrawal by Subject|0|||
129961465|NCT00550446|467824033|FG008|Up To Week 12|Withdrawal by Subject|0|||
129961466|NCT00550446|467824034|FG009|Up To Week 12|Withdrawal by Subject|0|||
129961467|NCT00550446|467824035|FG010|Up To Week 12|Withdrawal by Subject|0|||
129961468|NCT00550446|467824025|FG000|Up To Week 12|Other|3|||
129961469|NCT00550446|467824026|FG001|Up To Week 12|Other|0|||
129961470|NCT00550446|467824027|FG002|Up To Week 12|Other|0|||
129961471|NCT00550446|467824028|FG003|Up To Week 12|Other|0|||
129961472|NCT00550446|467824029|FG004|Up To Week 12|Other|0|||
129961473|NCT00550446|467824030|FG005|Up To Week 12|Other|1|||
129961474|NCT00550446|467824031|FG006|Up To Week 12|Other|4|||
129961475|NCT00550446|467824032|FG007|Up To Week 12|Other|0|||
129961476|NCT00550446|467824033|FG008|Up To Week 12|Other|0|||
129961477|NCT00550446|467824034|FG009|Up To Week 12|Other|0|||
129961478|NCT00550446|467824035|FG010|Up To Week 12|Other|0|||
129961479|NCT00550446|467824025|FG000|Up To Week 12|Randomized not treated|0|||
129961480|NCT00550446|467824026|FG001|Up To Week 12|Randomized not treated|1|||
129961481|NCT00550446|467824027|FG002|Up To Week 12|Randomized not treated|1|||
129961482|NCT00550446|467824028|FG003|Up To Week 12|Randomized not treated|0|||
130089308|NCT01241318|468280803|FG000|Overall Study|Lost to Follow-up|740|||
130089309|NCT01241318|468280804|FG001|Overall Study|Lost to Follow-up|455|||
129961483|NCT00550446|467824029|FG004|Up To Week 12|Randomized not treated|0|||
129961484|NCT00550446|467824030|FG005|Up To Week 12|Randomized not treated|0|||
129961485|NCT00550446|467824031|FG006|Up To Week 12|Randomized not treated|0|||
129961486|NCT00550446|467824032|FG007|Up To Week 12|Randomized not treated|0|||
129961487|NCT00550446|467824033|FG008|Up To Week 12|Randomized not treated|0|||
129961488|NCT00550446|467824034|FG009|Up To Week 12|Randomized not treated|0|||
129961489|NCT00550446|467824035|FG010|Up To Week 12|Randomized not treated|0|||
129961490|NCT00550446|467824025|FG000|Post Week 12|Adverse Event|2|||
129961491|NCT00550446|467824026|FG001|Post Week 12|Adverse Event|1|||
129961492|NCT00550446|467824027|FG002|Post Week 12|Adverse Event|1|||
129961493|NCT00550446|467824028|FG003|Post Week 12|Adverse Event|1|||
129961494|NCT00550446|467824029|FG004|Post Week 12|Adverse Event|1|||
129961495|NCT00550446|467824030|FG005|Post Week 12|Adverse Event|1|||
129961496|NCT00550446|467824031|FG006|Post Week 12|Adverse Event|0|||
129961497|NCT00550446|467824032|FG007|Post Week 12|Adverse Event|0|||
129961498|NCT00550446|467824033|FG008|Post Week 12|Adverse Event|0|||
129961499|NCT00550446|467824034|FG009|Post Week 12|Adverse Event|4|||
129961500|NCT00550446|467824035|FG010|Post Week 12|Adverse Event|0|||
129961501|NCT00550446|467824025|FG000|Post Week 12|Lack of Efficacy|0|||
129961502|NCT00550446|467824026|FG001|Post Week 12|Lack of Efficacy|0|||
129961503|NCT00550446|467824027|FG002|Post Week 12|Lack of Efficacy|1|||
129961504|NCT00550446|467824028|FG003|Post Week 12|Lack of Efficacy|0|||
129961505|NCT00550446|467824029|FG004|Post Week 12|Lack of Efficacy|0|||
129961506|NCT00550446|467824030|FG005|Post Week 12|Lack of Efficacy|0|||
129961507|NCT00550446|467824031|FG006|Post Week 12|Lack of Efficacy|0|||
129961508|NCT00550446|467824032|FG007|Post Week 12|Lack of Efficacy|1|||
129961509|NCT00550446|467824033|FG008|Post Week 12|Lack of Efficacy|1|||
129961510|NCT00550446|467824034|FG009|Post Week 12|Lack of Efficacy|2|||
129961511|NCT00550446|467824035|FG010|Post Week 12|Lack of Efficacy|1|||
129961512|NCT00550446|467824025|FG000|Post Week 12|Lost to Follow-up|0|||
129961513|NCT00550446|467824026|FG001|Post Week 12|Lost to Follow-up|0|||
129961514|NCT00550446|467824027|FG002|Post Week 12|Lost to Follow-up|1|||
129961515|NCT00550446|467824028|FG003|Post Week 12|Lost to Follow-up|1|||
129961516|NCT00550446|467824029|FG004|Post Week 12|Lost to Follow-up|0|||
129961517|NCT00550446|467824030|FG005|Post Week 12|Lost to Follow-up|0|||
129961518|NCT00550446|467824031|FG006|Post Week 12|Lost to Follow-up|1|||
129961519|NCT00550446|467824032|FG007|Post Week 12|Lost to Follow-up|0|||
129961520|NCT00550446|467824033|FG008|Post Week 12|Lost to Follow-up|0|||
129961521|NCT00550446|467824034|FG009|Post Week 12|Lost to Follow-up|0|||
129961522|NCT00550446|467824035|FG010|Post Week 12|Lost to Follow-up|0|||
129961523|NCT00550446|467824025|FG000|Post Week 12|Withdrawal by Subject|0|||
129961524|NCT00550446|467824026|FG001|Post Week 12|Withdrawal by Subject|0|||
129961525|NCT00550446|467824027|FG002|Post Week 12|Withdrawal by Subject|0|||
129961526|NCT00550446|467824028|FG003|Post Week 12|Withdrawal by Subject|0|||
129961527|NCT00550446|467824029|FG004|Post Week 12|Withdrawal by Subject|1|||
129961528|NCT00550446|467824030|FG005|Post Week 12|Withdrawal by Subject|0|||
129961529|NCT00550446|467824031|FG006|Post Week 12|Withdrawal by Subject|0|||
129961530|NCT00550446|467824032|FG007|Post Week 12|Withdrawal by Subject|0|||
129961531|NCT00550446|467824033|FG008|Post Week 12|Withdrawal by Subject|0|||
129961532|NCT00550446|467824034|FG009|Post Week 12|Withdrawal by Subject|0|||
129961533|NCT00550446|467824035|FG010|Post Week 12|Withdrawal by Subject|0|||
129961534|NCT00550446|467824025|FG000|Post Week 12|Other|1|||
129961535|NCT00550446|467824026|FG001|Post Week 12|Other|1|||
129961536|NCT00550446|467824027|FG002|Post Week 12|Other|0|||
129961537|NCT00550446|467824028|FG003|Post Week 12|Other|1|||
129961538|NCT00550446|467824029|FG004|Post Week 12|Other|0|||
129961539|NCT00550446|467824030|FG005|Post Week 12|Other|0|||
129961540|NCT00550446|467824031|FG006|Post Week 12|Other|1|||
130089310|NCT01241318|468280803|FG000|Overall Study|Death|2|||
130089311|NCT01241318|468280804|FG001|Overall Study|Death|4|||
130089312|NCT01241318|468280803|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
130089313|NCT01241318|468280804|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
129961541|NCT00550446|467824032|FG007|Post Week 12|Other|0|||
129961542|NCT00550446|467824033|FG008|Post Week 12|Other|1|||
129961543|NCT00550446|467824034|FG009|Post Week 12|Other|1|||
129961544|NCT00550446|467824035|FG010|Post Week 12|Other|0|||
129961545|NCT02716298|467824036|FG000|First Intervention (1 Month)|Lens discomfort|1|||
129961546|NCT02716298|467824037|FG001|First Intervention (1 Month)|Lens discomfort|1|||
129961547|NCT03503162|467824038|FG000|Overall Study|did not meet eligibility|1|||
129961548|NCT04952701|467824039|FG000|Control Lens|Physician Decision|4|||
129961549|NCT04952701|467824039|FG000|Test Lens|Physician Decision|1|||
129961550|NCT01670188|467824042|FG000|Overall Study|Death|0|||
129961551|NCT01670188|467824043|FG001|Overall Study|Death|1|||
129961552|NCT02212301|467824044|FG000|Period 1|Lost to Follow-up|0|||
129961553|NCT02212301|467824045|FG001|Period 1|Lost to Follow-up|1|||
129961554|NCT03927222|467824046|FG000|Overall Study|Progression|3|||
129961555|NCT03927222|467824046|FG000|Overall Study|CMV testing results inconclusive|1|||
130089314|NCT01241318|468280803|FG000|Overall Study|Woman: Stillborn infant|129|||
129961556|NCT03927222|467824046|FG000|Overall Study|Unable to generate enough vaccines|1|||
129961557|NCT03927222|467824046|FG000|Overall Study|Early study termination|1|||
129961558|NCT00578318|467824051|FG000|Overall Study|Lost to Follow-up|2|||
129961559|NCT00578318|467824052|FG001|Overall Study|Lost to Follow-up|0|||
129961560|NCT00578318|467824051|FG000|Overall Study|Physician Decision|1|||
129961561|NCT00578318|467824052|FG001|Overall Study|Physician Decision|0|||
129961562|NCT00866918|467824053|FG000|Overall Study|Death|1|||
129961563|NCT00866918|467824054|FG001|Overall Study|Death|5|||
129961564|NCT00866918|467824053|FG000|Overall Study|Lack of Efficacy|1|||
129961565|NCT00866918|467824054|FG001|Overall Study|Lack of Efficacy|1|||
129961566|NCT00866918|467824053|FG000|Overall Study|Physician Decision|10|||
129961567|NCT00866918|467824054|FG001|Overall Study|Physician Decision|2|||
129961568|NCT00866918|467824053|FG000|Overall Study|Ineligible|2|||
129961569|NCT00866918|467824054|FG001|Overall Study|Ineligible|4|||
129961570|NCT00866918|467824053|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
129961571|NCT00866918|467824054|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
129961572|NCT00866918|467824053|FG000|Overall Study|Secondary malignancy|1|||
129961573|NCT00866918|467824054|FG001|Overall Study|Secondary malignancy|0|||
129961574|NCT00527514|467824056|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
129961575|NCT00527514|467824056|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
129961576|NCT00527514|467824056|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
129961577|NCT00527514|467824056|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
129961578|NCT00527514|467824056|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
129961579|NCT00527514|467824056|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
129961580|NCT00527514|467824056|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
129961581|NCT00001941|467824063|FG000|Overall Study|not treated- rapidly progressing disease|0|||
129961582|NCT00001941|467824064|FG001|Overall Study|not treated- rapidly progressing disease|0|||
129961583|NCT00001941|467824065|FG002|Overall Study|not treated- rapidly progressing disease|0|||
129961584|NCT00001941|467824066|FG003|Overall Study|not treated- rapidly progressing disease|0|||
129961585|NCT00001941|467824067|FG004|Overall Study|not treated- rapidly progressing disease|1|||
129961586|NCT01281917|467824074|FG000|Overall Study|Withdrawal by Subject|1|||
129961587|NCT01978236|467824076|FG000|Overall Study|Discontinued due to study close|2|||
130089315|NCT01241318|468280804|FG001|Overall Study|Woman: Stillborn infant|146|||
130089316|NCT01454531|468280807|FG000|Overall Study|Adverse Event|14|||
130089317|NCT01454531|468280807|FG000|Overall Study|Withdrawal by Subject|5|||
130089318|NCT01454531|468280807|FG000|Overall Study|Lost to Follow-up|1|||
130089319|NCT01454531|468280807|FG000|Overall Study|Physician Decision|1|||
130089320|NCT01454531|468280807|FG000|Overall Study|Delay in IMP administration|1|||
130089321|NCT01454531|468280807|FG000|Overall Study|Other|1|||
130089322|NCT02504424|468280814|FG000|Overall Study|Withdrawal by Subject|2|||
130089323|NCT00440232|468280815|FG000|Overall Study|Lost to Follow-up|1|||
130089324|NCT00440232|468280816|FG001|Overall Study|Lost to Follow-up|1|||
130089325|NCT00440232|468280815|FG000|Overall Study|Unable to treat within allowed time|0|||
130089326|NCT00440232|468280816|FG001|Overall Study|Unable to treat within allowed time|1|||
130089327|NCT00440232|468280815|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
130089328|NCT00440232|468280816|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
130089329|NCT00426842|468280817|FG000|Overall Study|Lost to Follow-up|1|||
130089330|NCT01277666|468280820|FG000|Overall Study|Adverse Event|26|||
130089331|NCT01277666|468280821|FG001|Overall Study|Adverse Event|25|||
130089332|NCT01277666|468280822|FG002|Overall Study|Adverse Event|20|||
130089333|NCT01277666|468280820|FG000|Overall Study|Lack of Efficacy|8|||
130089334|NCT01277666|468280821|FG001|Overall Study|Lack of Efficacy|20|||
130089335|NCT01277666|468280822|FG002|Overall Study|Lack of Efficacy|12|||
130089336|NCT01277666|468280820|FG000|Overall Study|Protocol Violation|2|||
130089337|NCT01277666|468280821|FG001|Overall Study|Protocol Violation|3|||
130089338|NCT01277666|468280822|FG002|Overall Study|Protocol Violation|2|||
130089339|NCT01277666|468280820|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
130089340|NCT01277666|468280821|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
130089341|NCT01277666|468280822|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
130089342|NCT01277666|468280820|FG000|Overall Study|Lost to Follow-up|1|||
130089343|NCT01277666|468280821|FG001|Overall Study|Lost to Follow-up|1|||
130089344|NCT01277666|468280822|FG002|Overall Study|Lost to Follow-up|2|||
130089345|NCT01277666|468280820|FG000|Overall Study|Withdrawal by Subject|7|||
130089346|NCT01277666|468280821|FG001|Overall Study|Withdrawal by Subject|8|||
130089347|NCT01277666|468280822|FG002|Overall Study|Withdrawal by Subject|6|||
130089348|NCT01277666|468280820|FG000|Overall Study|Death|0|||
130089349|NCT01277666|468280821|FG001|Overall Study|Death|0|||
130089350|NCT01277666|468280822|FG002|Overall Study|Death|1|||
130089351|NCT02728804|468280830|FG000|Overall Study|Ineligible|3|||
130089352|NCT02728804|468280830|FG000|Overall Study|Did not complete baseline questionnaire|9|||
129961588|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
129961589|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
129961590|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
129961591|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
129961592|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
130089353|NCT02728804|468280830|FG000|Overall Study|Death|99|||
130089354|NCT02551874|468282825|FG000|Overall Study|Lost to Follow-up|0|||
130089355|NCT02551874|468282826|FG001|Overall Study|Lost to Follow-up|2|||
130089356|NCT02551874|468282825|FG000|Overall Study|Pregnancy|0|||
130089357|NCT02551874|468282826|FG001|Overall Study|Pregnancy|1|||
130089358|NCT02551874|468282825|FG000|Overall Study|Reason not reported|10|||
130089359|NCT02551874|468282826|FG001|Overall Study|Reason not reported|4|||
130089360|NCT02551874|468282825|FG000|Overall Study|Did not receive randomized treatment|0|||
130089361|NCT02551874|468282826|FG001|Overall Study|Did not receive randomized treatment|7|||
130089362|NCT02551874|468282825|FG000|Overall Study|Did not enter long-term study|18|||
130089363|NCT02551874|468282826|FG001|Overall Study|Did not enter long-term study|25|||
130089364|NCT01640353|468282829|FG000|Overall Study|Withdrew prior to treatment|10|||
130089365|NCT01640353|468282829|FG000|Overall Study|Withdrawn from analysis at term site|12|||
130089366|NCT01640353|468282829|FG000|Overall Study|Withdrawal by Subject|5|||
130089367|NCT01640353|468282829|FG000|Overall Study|Death|2|||
130089368|NCT01640353|468282829|FG000|Overall Study|Early site termination|3|||
130089369|NCT01640353|468282829|FG000|Overall Study|Lost to Follow-up|12|||
130089370|NCT01640353|468282829|FG000|Overall Study|Physician Decision|1|||
130089371|NCT01524900|468282834|FG000|Overall Study|Lost to Follow-up|3|||
130089372|NCT01524900|468282835|FG001|Overall Study|Lost to Follow-up|12|||
130089373|NCT01524900|468282836|FG002|Overall Study|Lost to Follow-up|1|||
130089374|NCT01524900|468282837|FG003|Overall Study|Lost to Follow-up|0|||
130089375|NCT01524900|468282838|FG004|Overall Study|Lost to Follow-up|0|||
130089376|NCT01524900|468282834|FG000|Overall Study|Other reason than stated above|1|||
130089377|NCT01524900|468282835|FG001|Overall Study|Other reason than stated above|1|||
130089378|NCT01524900|468282836|FG002|Overall Study|Other reason than stated above|0|||
130089379|NCT01524900|468282837|FG003|Overall Study|Other reason than stated above|0|||
130089380|NCT01524900|468282838|FG004|Overall Study|Other reason than stated above|0|||
130089381|NCT01524900|468282834|FG000|Overall Study|No reason documented|2|||
130089382|NCT01524900|468282835|FG001|Overall Study|No reason documented|1|||
130089383|NCT01524900|468282836|FG002|Overall Study|No reason documented|0|||
130089384|NCT01524900|468282837|FG003|Overall Study|No reason documented|1|||
130089385|NCT01524900|468282838|FG004|Overall Study|No reason documented|0|||
130089386|NCT03758612|468282839|FG000|Washout Period|Withdrawal by Subject|0|||
130089387|NCT03758612|468282840|FG001|Washout Period|Withdrawal by Subject|0|||
130089388|NCT03758612|468282841|FG002|Washout Period|Withdrawal by Subject|2|||
130089389|NCT03758612|468282842|FG003|Washout Period|Withdrawal by Subject|0|||
130089390|NCT03758612|468282843|FG004|Washout Period|Withdrawal by Subject|0|||
130089391|NCT03758612|468282844|FG005|Washout Period|Withdrawal by Subject|0|||
130089392|NCT03758612|468282845|FG006|Washout Period|Withdrawal by Subject|0|||
130089393|NCT03758612|468282846|FG007|Washout Period|Withdrawal by Subject|0|||
130089394|NCT03758612|468282847|FG008|Washout Period|Withdrawal by Subject|0|||
130089395|NCT03758612|468282848|FG009|Washout Period|Withdrawal by Subject|0|||
130089396|NCT03758612|468282849|FG010|Washout Period|Withdrawal by Subject|0|||
130089397|NCT03758612|468282850|FG011|Washout Period|Withdrawal by Subject|0|||
130089398|NCT03758612|468282839|FG000|Period 2|Protocol Violation|0|||
130089399|NCT03758612|468282840|FG001|Period 2|Protocol Violation|0|||
130089400|NCT03758612|468282841|FG002|Period 2|Protocol Violation|0|||
130089401|NCT03758612|468282842|FG003|Period 2|Protocol Violation|0|||
130089402|NCT03758612|468282843|FG004|Period 2|Protocol Violation|1|||
130089403|NCT03758612|468282844|FG005|Period 2|Protocol Violation|0|||
130089404|NCT03758612|468282845|FG006|Period 2|Protocol Violation|0|||
130089405|NCT03758612|468282846|FG007|Period 2|Protocol Violation|0|||
130089406|NCT03758612|468282847|FG008|Period 2|Protocol Violation|0|||
130089407|NCT03758612|468282848|FG009|Period 2|Protocol Violation|0|||
130089408|NCT03758612|468282849|FG010|Period 2|Protocol Violation|0|||
130089409|NCT03758612|468282850|FG011|Period 2|Protocol Violation|0|||
130089410|NCT01603615|468282852|FG000|Overall Study|Did not Receive Treatment|7|||
130089411|NCT01603615|468282852|FG000|Overall Study|Lost to Follow-up|9|||
130089412|NCT01603615|468282852|FG000|Overall Study|Personal Reasons|17|||
130089413|NCT01603615|468282852|FG000|Overall Study|Other Miscellaneous|1|||
130089414|NCT03419741|468282853|FG000|Overall Study|Adverse Event|1|||
130089415|NCT03419741|468282854|FG001|Overall Study|Adverse Event|0|||
130089416|NCT03419741|468282853|FG000|Overall Study|Withdrawal by Subject|1|||
130089417|NCT03419741|468282854|FG001|Overall Study|Withdrawal by Subject|2|||
130089418|NCT04354870|468282855|FG000|Overall Study|Lost to Follow-up|32|||
130089419|NCT04354870|468282856|FG001|Overall Study|Lost to Follow-up|12|||
130089420|NCT04354870|468282855|FG000|Overall Study|Withdrawal by Subject|10|||
130089421|NCT04354870|468282856|FG001|Overall Study|Withdrawal by Subject|16|||
130089422|NCT04354870|468282855|FG000|Overall Study|Did not complete all study visits|6|||
130089423|NCT04354870|468282856|FG001|Overall Study|Did not complete all study visits|5|||
130089424|NCT03384316|468282857|FG000|Overall Study|Screen failure|0|||
130089425|NCT03384316|468282858|FG001|Overall Study|Screen failure|1|||
130089426|NCT02194699|468282869|FG000|Randomised|Did not receive treatment|1|||
130089427|NCT02194699|468282870|FG001|Randomised|Did not receive treatment|5|||
130089428|NCT02194699|468282869|FG000|Randomised|Without potential for 52 weeks of IP|5|||
130089429|NCT02194699|468282870|FG001|Randomised|Without potential for 52 weeks of IP|5|||
130089430|NCT02194699|468282869|FG000|Randomised|Duplicate patient|2|||
130089431|NCT02194699|468282870|FG001|Randomised|Duplicate patient|1|||
130089432|NCT02194699|468282869|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
130089433|NCT02194699|468282870|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
130089434|NCT02194699|468282869|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
130089435|NCT02194699|468282870|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
130089436|NCT02194699|468282869|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
130089437|NCT02194699|468282870|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
130089438|NCT02194699|468282869|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
130089439|NCT02194699|468282870|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
130089440|NCT02194699|468282869|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
130089441|NCT02194699|468282870|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
130089442|NCT02194699|468282869|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
130089443|NCT02194699|468282870|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
130089444|NCT00298766|468282871|FG000|Overall Study|Adverse Event|18|||
130089445|NCT00298766|468282871|FG000|Overall Study|Death|2|||
130089446|NCT00298766|468282871|FG000|Overall Study|Withdrawal by Subject|9|||
130089447|NCT00298766|468282871|FG000|Overall Study|Treatment ongoing|4|||
130089448|NCT00298766|468282871|FG000|Overall Study|Progression of amyloid markers|4|||
130089449|NCT00298766|468282871|FG000|Overall Study|Deterioration in KPS and organ function|1|||
130089450|NCT00298766|468282871|FG000|Overall Study|Subjects overall condition deterioration|4|||
130089451|NCT00298766|468282871|FG000|Overall Study|Other|4|||
130089452|NCT00386152|468282872|FG000|Overall Study|Adverse Event|6|||
130089453|NCT00386152|468282873|FG001|Overall Study|Adverse Event|5|||
130089454|NCT00386152|468282874|FG002|Overall Study|Adverse Event|4|||
130089455|NCT00386152|468282872|FG000|Overall Study|Chang from original chemo stratification|4|||
130089456|NCT00386152|468282873|FG001|Overall Study|Chang from original chemo stratification|5|||
130089457|NCT00386152|468282874|FG002|Overall Study|Chang from original chemo stratification|6|||
130089458|NCT00386152|468282872|FG000|Overall Study|Death|3|||
130089459|NCT00386152|468282873|FG001|Overall Study|Death|0|||
130089460|NCT00386152|468282874|FG002|Overall Study|Death|1|||
130089461|NCT00386152|468282872|FG000|Overall Study|Disease progression|7|||
130089462|NCT00386152|468282873|FG001|Overall Study|Disease progression|4|||
130089463|NCT00386152|468282874|FG002|Overall Study|Disease progression|5|||
130089464|NCT00386152|468282872|FG000|Overall Study|Physician Decision|13|||
130089465|NCT00386152|468282873|FG001|Overall Study|Physician Decision|10|||
130089466|NCT00386152|468282874|FG002|Overall Study|Physician Decision|4|||
130089467|NCT00386152|468282872|FG000|Overall Study|Lost to Follow-up|1|||
130089468|NCT00386152|468282873|FG001|Overall Study|Lost to Follow-up|0|||
130089469|NCT00386152|468282874|FG002|Overall Study|Lost to Follow-up|0|||
130089470|NCT00386152|468282872|FG000|Overall Study|Completed chemotherapy|4|||
130089471|NCT00386152|468282873|FG001|Overall Study|Completed chemotherapy|5|||
130089472|NCT00386152|468282874|FG002|Overall Study|Completed chemotherapy|1|||
130089473|NCT00386152|468282872|FG000|Overall Study|Protocol Violation|3|||
130089474|NCT00386152|468282873|FG001|Overall Study|Protocol Violation|5|||
130089475|NCT00386152|468282874|FG002|Overall Study|Protocol Violation|2|||
130089476|NCT00386152|468282872|FG000|Overall Study|Withdrawal by Subject|3|||
130089477|NCT00386152|468282873|FG001|Overall Study|Withdrawal by Subject|6|||
130089478|NCT00386152|468282874|FG002|Overall Study|Withdrawal by Subject|10|||
130089479|NCT03633461|468282889|FG000|Overall Study|Lost to Follow-up|0|||
130089480|NCT03633461|468282890|FG001|Overall Study|Lost to Follow-up|1|||
130089481|NCT03938857|468282893|FG000|Overall Study|Physician Decision|1|||
130089482|NCT03938857|468282894|FG001|Overall Study|Physician Decision|0|||
130089483|NCT03938857|468282895|FG002|Overall Study|Physician Decision|0|||
130089484|NCT03938857|468282896|FG003|Overall Study|Physician Decision|0|||
130089485|NCT02516605|468282897|FG000|Overall Study|Protocol Violation|0|||
130089486|NCT02516605|468282898|FG001|Overall Study|Protocol Violation|0|||
130089487|NCT02516605|468282899|FG002|Overall Study|Protocol Violation|0|||
130089488|NCT02516605|468282900|FG003|Overall Study|Protocol Violation|0|||
130089489|NCT02516605|468282901|FG004|Overall Study|Protocol Violation|1|||
130089490|NCT02516605|468282897|FG000|Overall Study|Withdrawal by Subject|0|||
130089491|NCT02516605|468282898|FG001|Overall Study|Withdrawal by Subject|0|||
130089492|NCT02516605|468282899|FG002|Overall Study|Withdrawal by Subject|0|||
130121757|NCT02768298|468406923|FG000|Overall Study|Non-compliance with study treatment|0|||
130121758|NCT02768298|468406924|FG001|Overall Study|Non-compliance with study treatment|1|||
130089493|NCT02516605|468282900|FG003|Overall Study|Withdrawal by Subject|1|||
130089494|NCT02516605|468282901|FG004|Overall Study|Withdrawal by Subject|0|||
130089495|NCT02577107|468282902|FG000|Overall Study|Protocol deviation|0|||
130089496|NCT02577107|468282903|FG001|Overall Study|Protocol deviation|1|||
130089497|NCT00577382|468282904|FG000|Overall Study|Adverse Event|0|||
130089498|NCT00577382|468282905|FG001|Overall Study|Adverse Event|6|||
130089499|NCT00577382|468282904|FG000|Overall Study|Withdrawal by Subject|0|||
130089500|NCT00577382|468282905|FG001|Overall Study|Withdrawal by Subject|1|||
130089501|NCT00577382|468282904|FG000|Overall Study|Progressive Disease|17|||
130121759|NCT02768298|468406923|FG000|Overall Study|Subject/guardian decision|1|||
130121760|NCT02768298|468406924|FG001|Overall Study|Subject/guardian decision|0|||
130089502|NCT00577382|468282905|FG001|Overall Study|Progressive Disease|19|||
130089503|NCT00577382|468282904|FG000|Overall Study|Intercurrent Illness|1|||
130089504|NCT00577382|468282905|FG001|Overall Study|Intercurrent Illness|2|||
130089505|NCT00577382|468282904|FG000|Overall Study|Death|1|||
130089506|NCT00577382|468282905|FG001|Overall Study|Death|1|||
130089507|NCT00577382|468282904|FG000|Overall Study|Lost to Follow-up|2|||
130089508|NCT00577382|468282905|FG001|Overall Study|Lost to Follow-up|2|||
130089509|NCT01710709|468282906|FG000|Overall Study|Lost to Follow-up|29|||
130089510|NCT01710709|468282906|FG000|Overall Study|Adverse Event|48|||
130089511|NCT01710709|468282906|FG000|Overall Study|Participant met withdrawal criteria|33|||
130089512|NCT01710709|468282906|FG000|Overall Study|Participant withdrawn by investigator|2|||
130089513|NCT01710709|468282906|FG000|Overall Study|Withdrawal by Subject|53|||
130089514|NCT01710709|468282906|FG000|Overall Study|Protocol Violation|5|||
130089515|NCT01710709|468282906|FG000|Overall Study|Lack of Efficacy|3|||
130089516|NCT00508872|468282908|FG000|Overall Study|Lost to Follow-up|1|||
130089517|NCT00508872|468282908|FG000|Overall Study|Physician Decision|1|||
130089518|NCT03007472|468282909|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
130089519|NCT03007472|468282909|FG000|Overall Study|Death|2|||
130089520|NCT03007472|468282909|FG000|Overall Study|Loss to Follow Up|1|||
130089521|NCT01977651|468282918|FG000|4 Month Treatment Period|Adverse Event|34|||
130089522|NCT01977651|468282918|FG000|4 Month Treatment Period|Death|3|||
130089523|NCT01977651|468282918|FG000|4 Month Treatment Period|Progressive Disease|43|||
130089524|NCT01977651|468282918|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
130089525|NCT01977651|468282918|FG000|4 Month Treatment Period|Physician Decision|4|||
130089526|NCT01977651|468282918|FG000|1 Year Extension Period|Adverse Event|14|||
130089527|NCT01977651|468282918|FG000|1 Year Extension Period|Death|10|||
130089528|NCT01977651|468282918|FG000|1 Year Extension Period|Lost to Follow-up|2|||
130089529|NCT01977651|468282918|FG000|1 Year Extension Period|Progressive Disease|86|||
130089530|NCT01977651|468282918|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
130089531|NCT01977651|468282918|FG000|1 Year Extension Period|Physician Decision|6|||
130089532|NCT01977651|468282918|FG000|1 Year Extension Period|Miscellaneous|1|||
130089533|NCT01977651|468282918|FG000|Post 1 Year Extension Period|Adverse Event|5|||
130089534|NCT01977651|468282918|FG000|Post 1 Year Extension Period|Death|13|||
130089535|NCT01977651|468282918|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
130089536|NCT01977651|468282918|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
130089537|NCT01977651|468282918|FG000|Post 1 Year Extension Period|Physician Decision|4|||
130089538|NCT01977651|468282918|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
130089539|NCT00661362|468282919|FG000|Overall Study|Adverse Event|5|||
130089540|NCT00661362|468282920|FG001|Overall Study|Adverse Event|4|||
130089541|NCT00661362|468282919|FG000|Overall Study|Incorrect enrollment|2|||
130089542|NCT00661362|468282920|FG001|Overall Study|Incorrect enrollment|0|||
130089543|NCT00661362|468282919|FG000|Overall Study|Study specific discontinuation criteria|4|||
130089544|NCT00661362|468282920|FG001|Overall Study|Study specific discontinuation criteria|11|||
130089545|NCT00661362|468282919|FG000|Overall Study|Withdrawal by Subject|13|||
130089546|NCT00661362|468282920|FG001|Overall Study|Withdrawal by Subject|23|||
130089547|NCT00661362|468282919|FG000|Overall Study|Lost to Follow-up|3|||
130089548|NCT00661362|468282920|FG001|Overall Study|Lost to Follow-up|1|||
130089549|NCT00661362|468282919|FG000|Overall Study|Severe non-compliance to protocol|0|||
130089550|NCT00661362|468282920|FG001|Overall Study|Severe non-compliance to protocol|1|||
130089551|NCT00661362|468282919|FG000|Overall Study|Safety reasons|1|||
130089552|NCT00661362|468282920|FG001|Overall Study|Safety reasons|0|||
130089553|NCT00661362|468282919|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
130089554|NCT00661362|468282920|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
130121761|NCT02768298|468406923|FG000|Overall Study|Withdrawal of informed consent|0|||
130121762|NCT02768298|468406924|FG001|Overall Study|Withdrawal of informed consent|1|||
130121763|NCT02346201|468406926|FG000|Overall Study|Adverse Event|3|||
130121764|NCT02346201|468406927|FG001|Overall Study|Adverse Event|2|||
130121765|NCT02346201|468406926|FG000|Overall Study|Lost to Follow-up|1|||
130121766|NCT02346201|468406927|FG001|Overall Study|Lost to Follow-up|0|||
130089555|NCT02906644|468282921|FG000|First 2 Weeks|Withdrawal by Subject|0|||
130089556|NCT02906644|468282922|FG001|First 2 Weeks|Withdrawal by Subject|2|||
130089557|NCT02906644|468282921|FG000|First 2 Weeks|Physician Decision|1|||
130121767|NCT02346201|468406926|FG000|Overall Study|Withdrawal by Subject|6|||
130121768|NCT02346201|468406927|FG001|Overall Study|Withdrawal by Subject|3|||
130121769|NCT02346201|468406926|FG000|Overall Study|Unavailable for future follow-up|0|||
130121770|NCT02346201|468406927|FG001|Overall Study|Unavailable for future follow-up|1|||
130089558|NCT02906644|468282922|FG001|First 2 Weeks|Physician Decision|1|||
130089559|NCT02906644|468282921|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
130089560|NCT02906644|468282922|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
130089561|NCT02906644|468282921|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
130089562|NCT02906644|468282922|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
130089563|NCT03672006|468282923|FG000|Overall Study|exclusion criteria met|0|||
130089564|NCT03672006|468282924|FG001|Overall Study|exclusion criteria met|1|||
130089565|NCT01453439|468282925|FG000|Treatment Phase|Withdrawal by Subject|13|||
130121771|NCT02346201|468406926|FG000|Overall Study|Physician Decision|0|||
129961593|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
129961594|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Rejections|0|||
129961595|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Rejections|0|||
129961596|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Rejections|55|||
129961597|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
129961598|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
129961599|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
129961600|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
129961601|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
129961602|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
130089566|NCT01453439|468282926|FG001|Treatment Phase|Withdrawal by Subject|10|||
130089567|NCT01453439|468282925|FG000|Treatment Phase|Suicidal Ideation|2|||
130089568|NCT01453439|468282926|FG001|Treatment Phase|Suicidal Ideation|0|||
130089569|NCT01453439|468282925|FG000|Treatment Phase|Need for higher level of care|1|||
129961603|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Other issues|0|||
129961604|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Other issues|0|||
129961605|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Other issues|6|||
129961606|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
129961607|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
129961608|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
129961609|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Rejection|11|||
129961610|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Rejection|5|||
129961611|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Rejection|0|||
129961612|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Death|2|||
129961613|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Death|5|||
129961614|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Death|0|||
129961615|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
129961616|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
129961617|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
129961618|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
129961619|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
129961620|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
129961621|NCT00819013|467824081|FG000|Overall Study|Not meeting continuing study eligibility|2|||
129961622|NCT00819013|467824082|FG001|Overall Study|Not meeting continuing study eligibility|1|||
129961623|NCT00819013|467824083|FG002|Overall Study|Not meeting continuing study eligibility|2|||
129961624|NCT00819013|467824084|FG003|Overall Study|Not meeting continuing study eligibility|1|||
129961625|NCT00819013|467824081|FG000|Overall Study|Adverse Event|0|||
129961626|NCT00819013|467824082|FG001|Overall Study|Adverse Event|0|||
129961627|NCT00819013|467824083|FG002|Overall Study|Adverse Event|1|||
129961628|NCT00819013|467824084|FG003|Overall Study|Adverse Event|0|||
129961629|NCT00819013|467824081|FG000|Overall Study|Withdrawal by Subject|1|||
129961630|NCT00819013|467824082|FG001|Overall Study|Withdrawal by Subject|0|||
129961631|NCT00819013|467824083|FG002|Overall Study|Withdrawal by Subject|1|||
129961632|NCT00819013|467824084|FG003|Overall Study|Withdrawal by Subject|0|||
129961633|NCT00819013|467824081|FG000|Overall Study|Lost to Follow-up|0|||
129961634|NCT00819013|467824082|FG001|Overall Study|Lost to Follow-up|0|||
129961635|NCT00819013|467824083|FG002|Overall Study|Lost to Follow-up|1|||
129961636|NCT00819013|467824084|FG003|Overall Study|Lost to Follow-up|2|||
129961637|NCT00819013|467824081|FG000|Overall Study|Death|0|||
129961638|NCT00819013|467824082|FG001|Overall Study|Death|0|||
129961639|NCT00819013|467824083|FG002|Overall Study|Death|0|||
129961640|NCT00819013|467824084|FG003|Overall Study|Death|1|||
129961641|NCT00576823|467824087|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
129961642|NCT00576823|467824088|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
129961643|NCT00576823|467824089|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
129961644|NCT00576823|467824087|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
129961645|NCT00576823|467824088|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
129961646|NCT00576823|467824089|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
129961647|NCT00510146|467824090|FG000|Double-Blind Treatment|Adverse Event|30|||
129961648|NCT00510146|467824091|FG001|Double-Blind Treatment|Adverse Event|13|||
129961649|NCT00510146|467824090|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
129961650|NCT00510146|467824091|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
129961651|NCT00510146|467824090|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
129961652|NCT00510146|467824091|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
129961653|NCT00510146|467824090|FG000|Double-Blind Treatment|Physician Decision|6|||
129961654|NCT00510146|467824091|FG001|Double-Blind Treatment|Physician Decision|0|||
129961655|NCT00510146|467824090|FG000|Double-Blind Treatment|Protocol Violation|1|||
129961656|NCT00510146|467824091|FG001|Double-Blind Treatment|Protocol Violation|2|||
129961657|NCT00510146|467824090|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
129961658|NCT00510146|467824091|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
129961659|NCT00510146|467824090|FG000|Double-Blind Treatment|Clinical Relapse|0|||
129961660|NCT00510146|467824091|FG001|Double-Blind Treatment|Clinical Relapse|1|||
129961661|NCT00510146|467824090|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
130089570|NCT01453439|468282926|FG001|Treatment Phase|Need for higher level of care|1|||
130089571|NCT01453439|468282925|FG000|Treatment Phase|Therapist conflict of interest|1|||
130089572|NCT01453439|468282926|FG001|Treatment Phase|Therapist conflict of interest|0|||
130089573|NCT01453439|468282925|FG000|Follow-up|Withdrawal by Subject|0|||
130089574|NCT01453439|468282926|FG001|Follow-up|Withdrawal by Subject|1|||
130089575|NCT01453439|468282925|FG000|Follow-up|Lost to Follow-up|5|||
130089576|NCT01453439|468282926|FG001|Follow-up|Lost to Follow-up|10|||
130089577|NCT01014442|468282927|FG000|Overall Study|Adverse Event|0|||
130089578|NCT01014442|468282928|FG001|Overall Study|Adverse Event|8|||
130089579|NCT01014442|468282927|FG000|Overall Study|Withdrawal by Subject|4|||
130089580|NCT01014442|468282928|FG001|Overall Study|Withdrawal by Subject|4|||
130089581|NCT01014442|468282927|FG000|Overall Study|Protocol Violation|2|||
130089582|NCT01014442|468282928|FG001|Overall Study|Protocol Violation|5|||
130089583|NCT01014442|468282927|FG000|Overall Study|Lack of Compliance|0|||
130089584|NCT01014442|468282928|FG001|Overall Study|Lack of Compliance|1|||
130089585|NCT01014442|468282927|FG000|Overall Study|Unspecified Reason|1|||
130089586|NCT01014442|468282928|FG001|Overall Study|Unspecified Reason|1|||
130089587|NCT00490815|468282938|FG000|Overall Study|Adverse Event|2|||
130089588|NCT00490815|468282939|FG001|Overall Study|Adverse Event|3|||
130089589|NCT00490815|468282938|FG000|Overall Study|Withdrawal by Subject|4|||
130089590|NCT00490815|468282939|FG001|Overall Study|Withdrawal by Subject|0|||
130089591|NCT00490815|468282938|FG000|Overall Study|Lost to Follow-up|1|||
130089592|NCT00490815|468282939|FG001|Overall Study|Lost to Follow-up|3|||
130089593|NCT00490815|468282938|FG000|Overall Study|Death|1|||
130089594|NCT00490815|468282939|FG001|Overall Study|Death|3|||
130089595|NCT02135848|468282943|FG000|Overall Study|Adverse Event|2|||
130089596|NCT02135848|468282944|FG001|Overall Study|Adverse Event|0|||
130089597|NCT02135848|468282943|FG000|Overall Study|Withdrawal by Subject|1|||
130089598|NCT02135848|468282944|FG001|Overall Study|Withdrawal by Subject|1|||
130089599|NCT00089505|468282945|FG000|Overall Study|Death|4|||
130089600|NCT00089505|468282946|FG001|Overall Study|Death|1|||
130089601|NCT00089505|468282947|FG002|Overall Study|Death|5|||
130089602|NCT00089505|468282948|FG003|Overall Study|Death|8|||
130089603|NCT00089505|468282945|FG000|Overall Study|Withdrawal by Subject|3|||
130089604|NCT00089505|468282946|FG001|Overall Study|Withdrawal by Subject|0|||
130089605|NCT00089505|468282947|FG002|Overall Study|Withdrawal by Subject|6|||
130089606|NCT00089505|468282948|FG003|Overall Study|Withdrawal by Subject|6|||
130089607|NCT00089505|468282945|FG000|Overall Study|Lost to Follow-up|1|||
130089608|NCT00089505|468282946|FG001|Overall Study|Lost to Follow-up|1|||
130089609|NCT00089505|468282947|FG002|Overall Study|Lost to Follow-up|9|||
130089610|NCT00089505|468282948|FG003|Overall Study|Lost to Follow-up|7|||
130089611|NCT00089505|468282945|FG000|Overall Study|Physician Decision|1|||
130089612|NCT00089505|468282946|FG001|Overall Study|Physician Decision|0|||
130089613|NCT00089505|468282947|FG002|Overall Study|Physician Decision|0|||
130089614|NCT00089505|468282948|FG003|Overall Study|Physician Decision|0|||
130089615|NCT00089505|468282945|FG000|Overall Study|Protocol Violation|0|||
130089616|NCT00089505|468282946|FG001|Overall Study|Protocol Violation|0|||
130089617|NCT00089505|468282947|FG002|Overall Study|Protocol Violation|1|||
130089618|NCT00089505|468282948|FG003|Overall Study|Protocol Violation|0|||
130089619|NCT01646255|468282953|FG000|Overall Study|Adverse Event|7|||
130089620|NCT01646255|468282954|FG001|Overall Study|Adverse Event|8|||
130089621|NCT01646255|468282953|FG000|Overall Study|Lack of Efficacy|2|||
130089622|NCT01646255|468282954|FG001|Overall Study|Lack of Efficacy|0|||
130089623|NCT01646255|468282953|FG000|Overall Study|Withdrawal by Subject|10|||
130089624|NCT01646255|468282954|FG001|Overall Study|Withdrawal by Subject|6|||
130089625|NCT01646255|468282953|FG000|Overall Study|Compliance is not well|1|||
130089626|NCT01646255|468282954|FG001|Overall Study|Compliance is not well|0|||
130089627|NCT01646255|468282953|FG000|Overall Study|Inclusion Criteria Deviation|1|||
130089628|NCT01646255|468282954|FG001|Overall Study|Inclusion Criteria Deviation|0|||
130089629|NCT03480841|468282957|FG000|Overall Study|Lost to Follow-up|2|||
130089630|NCT00266695|468282958|FG000|Overall Study|Adverse Event|1|||
130089631|NCT00266695|468282958|FG000|Overall Study|Death|9|||
130089632|NCT00266695|468282958|FG000|Overall Study|Physician Decision|1|||
130089633|NCT00266695|468282958|FG000|Overall Study|Lost to Follow-up|3|||
130089634|NCT00266695|468282958|FG000|Overall Study|Withdrawal by Subject|15|||
130089635|NCT02380703|468282959|FG000|Overall Study|Withdrawal by Subject|12|||
130089636|NCT02380703|468282960|FG001|Overall Study|Withdrawal by Subject|9|||
130089637|NCT02380703|468282959|FG000|Overall Study|Lost to Follow-up|12|||
130089638|NCT02380703|468282960|FG001|Overall Study|Lost to Follow-up|12|||
130089639|NCT02380703|468282959|FG000|Overall Study|Caregiver death|1|||
130089640|NCT02380703|468282960|FG001|Overall Study|Caregiver death|0|||
130089641|NCT02380703|468282959|FG000|Overall Study|Person with dementia (PWD) death|7|||
130121772|NCT02346201|468406927|FG001|Overall Study|Physician Decision|1|||
130089642|NCT02380703|468282960|FG001|Overall Study|Person with dementia (PWD) death|8|||
130089643|NCT02380703|468282959|FG000|Overall Study|Entered Long-term Care|4|||
130089644|NCT02380703|468282960|FG001|Overall Study|Entered Long-term Care|7|||
130089645|NCT01362049|468282961|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
130089646|NCT01362049|468282962|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
130121773|NCT02346201|468406926|FG000|Overall Study|Missed final visit|0|||
130089647|NCT01362049|468282963|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
130089648|NCT01362049|468282964|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
130089649|NCT01362049|468282961|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
130089650|NCT01362049|468282962|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
130089651|NCT01362049|468282963|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
130089652|NCT01362049|468282964|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
130089653|NCT03607994|468282965|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
130089654|NCT03607994|468282966|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
130089655|NCT02417935|468282967|FG000|Treatment Period|Adverse Event|12|||
130089656|NCT02417935|468282968|FG001|Treatment Period|Adverse Event|10|||
130089657|NCT02417935|468282967|FG000|Treatment Period|Lost to Follow-up|1|||
130089658|NCT02417935|468282968|FG001|Treatment Period|Lost to Follow-up|0|||
130089659|NCT02417935|468282967|FG000|Treatment Period|Entry Criteria not met|0|||
130089660|NCT02417935|468282968|FG001|Treatment Period|Entry Criteria not met|1|||
130089661|NCT02417935|468282967|FG000|Treatment Period|Protocol Violation|2|||
130089662|NCT02417935|468282968|FG001|Treatment Period|Protocol Violation|1|||
130089663|NCT02417935|468282967|FG000|Treatment Period|Withdrawal by Subject|3|||
130089664|NCT02417935|468282968|FG001|Treatment Period|Withdrawal by Subject|3|||
130089665|NCT02417935|468282967|FG000|Treatment Period|Physician Decision|3|||
130089666|NCT02417935|468282968|FG001|Treatment Period|Physician Decision|1|||
130089667|NCT02850276|468282973|FG000|Overall Study|screen failure|43|||
130089668|NCT02850276|468282973|FG000|Overall Study|Withdrawal by Subject|14|||
130089669|NCT02850276|468282973|FG000|Overall Study|Physician Decision|2|||
130089670|NCT02850276|468282973|FG000|Overall Study|Lost to Follow-up|2|||
130089671|NCT00819052|468282974|FG000|Overall Study|Adverse Event|0|||
130089672|NCT00819052|468282975|FG001|Overall Study|Adverse Event|5|||
130089673|NCT00819052|468282974|FG000|Overall Study|Protocol Violation|1|||
130089674|NCT00819052|468282975|FG001|Overall Study|Protocol Violation|2|||
130089675|NCT00819052|468282974|FG000|Overall Study|Lost to Follow-up|1|||
130089676|NCT00819052|468282975|FG001|Overall Study|Lost to Follow-up|2|||
130089677|NCT00819052|468282974|FG000|Overall Study|Withdrawal by Subject|1|||
130089678|NCT00819052|468282975|FG001|Overall Study|Withdrawal by Subject|2|||
130089679|NCT00819052|468282974|FG000|Overall Study|Lack of Efficacy|1|||
130089680|NCT00819052|468282975|FG001|Overall Study|Lack of Efficacy|1|||
130089681|NCT00819052|468282974|FG000|Overall Study|Pregnancy|1|||
130089682|NCT00819052|468282975|FG001|Overall Study|Pregnancy|2|||
130089683|NCT00819052|468282974|FG000|Overall Study|Death or events leading to death|1|||
130089684|NCT00819052|468282975|FG001|Overall Study|Death or events leading to death|0|||
130089685|NCT00362297|468282976|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
130089686|NCT00362297|468282977|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
130089687|NCT01747655|468282980|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
130089688|NCT01747655|468282981|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
130089689|NCT01747655|468282980|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
130089690|NCT01747655|468282981|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
130089691|NCT01747655|468282980|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
130089692|NCT01747655|468282981|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
130089693|NCT00982111|468282982|FG000|Overall Study|Adverse Event|1|||
130089694|NCT00982111|468282983|FG001|Overall Study|Adverse Event|1|||
130089695|NCT00982111|468282982|FG000|Overall Study|Progressive Disease|46|||
130089696|NCT00982111|468282983|FG001|Overall Study|Progressive Disease|39|||
130089697|NCT00982111|468282982|FG000|Overall Study|Lost to Follow-up|9|||
130089698|NCT00982111|468282983|FG001|Overall Study|Lost to Follow-up|6|||
130089699|NCT00982111|468282982|FG000|Overall Study|New Anti-Cancer Therapy|5|||
130089700|NCT00982111|468282983|FG001|Overall Study|New Anti-Cancer Therapy|5|||
130089701|NCT00982111|468282982|FG000|Overall Study|Medical Decision|1|||
130089702|NCT00982111|468282983|FG001|Overall Study|Medical Decision|0|||
130089703|NCT00982111|468282982|FG000|Overall Study|Withdrawal by Subject|17|||
130089704|NCT00982111|468282983|FG001|Overall Study|Withdrawal by Subject|19|||
130089705|NCT00982111|468282982|FG000|Overall Study|Global Study End|0|||
130089706|NCT00982111|468282983|FG001|Overall Study|Global Study End|1|||
130089707|NCT00982111|468282982|FG000|Overall Study|Sponsor's Decision|0|||
130089708|NCT00982111|468282983|FG001|Overall Study|Sponsor's Decision|1|||
130089709|NCT01070381|468282984|FG000|Period 2, 1 Week of Wear|Handling|0|||
130089710|NCT01070381|468282985|FG001|Period 2, 1 Week of Wear|Handling|1|||
130089711|NCT01070381|468282984|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
130089712|NCT01070381|468282985|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
130089713|NCT03512028|468282987|FG000|Overall Study|Withdrawal by Subject|2|||
130089714|NCT03512028|468282988|FG001|Overall Study|Withdrawal by Subject|0|||
130089715|NCT03512028|468282987|FG000|Overall Study|Protocol Violation|2|||
130089716|NCT03512028|468282988|FG001|Overall Study|Protocol Violation|0|||
130089717|NCT01259388|468282989|FG000|Overall Study|Adverse Event|3|||
130089718|NCT01259388|468282990|FG001|Overall Study|Adverse Event|0|||
130089719|NCT01259388|468282989|FG000|Overall Study|Withdrawal by Subject|1|||
130089720|NCT01259388|468282990|FG001|Overall Study|Withdrawal by Subject|1|||
130089721|NCT01259388|468282989|FG000|Overall Study|Physician Decision|1|||
130089722|NCT01259388|468282990|FG001|Overall Study|Physician Decision|0|||
130089723|NCT02743494|468282993|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
130089724|NCT02743494|468282994|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
130089725|NCT02743494|468282993|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
130089726|NCT02743494|468282994|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
130089727|NCT02743494|468282993|FG000|Treatment Period|Completed treatment|229|||
130089728|NCT02743494|468282994|FG001|Treatment Period|Completed treatment|99|||
130089729|NCT02743494|468282993|FG000|Treatment Period|Disease recurrence|149|||
130089730|NCT02743494|468282994|FG001|Treatment Period|Disease recurrence|113|||
130089731|NCT02743494|468282993|FG000|Treatment Period|Study drug toxicity|57|||
130089732|NCT02743494|468282994|FG001|Treatment Period|Study drug toxicity|8|||
130089733|NCT02743494|468282993|FG000|Treatment Period|Death|1|||
130089734|NCT02743494|468282994|FG001|Treatment Period|Death|0|||
130089735|NCT02743494|468282993|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
130089736|NCT02743494|468282994|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
130089737|NCT02743494|468282993|FG000|Treatment Period|Participant request to discontinue treatment|30|||
130089738|NCT02743494|468282994|FG001|Treatment Period|Participant request to discontinue treatment|5|||
130089739|NCT02743494|468282993|FG000|Treatment Period|Participant withdrew consent|12|||
130089740|NCT02743494|468282994|FG001|Treatment Period|Participant withdrew consent|4|||
130089741|NCT02743494|468282993|FG000|Treatment Period|Lost to Follow-up|0|||
130089742|NCT02743494|468282994|FG001|Treatment Period|Lost to Follow-up|1|||
130089743|NCT02743494|468282993|FG000|Treatment Period|Poor/Non-compliance|1|||
130089744|NCT02743494|468282994|FG001|Treatment Period|Poor/Non-compliance|0|||
130089745|NCT02743494|468282993|FG000|Treatment Period|Other reasons|7|||
130089746|NCT02743494|468282994|FG001|Treatment Period|Other reasons|2|||
130089747|NCT03529162|468282995|FG000|Overall Study|Lost to Follow-up|2|||
130089748|NCT03529162|468282996|FG001|Overall Study|Lost to Follow-up|2|||
130089749|NCT00983827|468282997|FG000|Overall Study|Withdrawal by Subject|1|||
130089750|NCT01521494|468282998|FG000|Overall Study|Adverse Event|1|||
130089751|NCT01521494|468282999|FG001|Overall Study|Adverse Event|2|||
130089752|NCT01521494|468283000|FG002|Overall Study|Adverse Event|9|||
130089753|NCT01521494|468283001|FG003|Overall Study|Adverse Event|6|||
130089754|NCT01521494|468283002|FG004|Overall Study|Adverse Event|2|||
130089755|NCT01521494|468282998|FG000|Overall Study|Lack of Efficacy|0|||
130089756|NCT01521494|468282999|FG001|Overall Study|Lack of Efficacy|0|||
130089757|NCT01521494|468283000|FG002|Overall Study|Lack of Efficacy|0|||
130089758|NCT01521494|468283001|FG003|Overall Study|Lack of Efficacy|0|||
130089759|NCT01521494|468283002|FG004|Overall Study|Lack of Efficacy|2|||
130089760|NCT01521494|468282998|FG000|Overall Study|Withdrawal by Subject|1|||
130089761|NCT01521494|468282999|FG001|Overall Study|Withdrawal by Subject|1|||
130089762|NCT01521494|468283000|FG002|Overall Study|Withdrawal by Subject|0|||
130089763|NCT01521494|468283001|FG003|Overall Study|Withdrawal by Subject|2|||
130089764|NCT01521494|468283002|FG004|Overall Study|Withdrawal by Subject|0|||
130089765|NCT01521494|468282998|FG000|Overall Study|Decrease in serum phosphate|0|||
130089766|NCT01521494|468282999|FG001|Overall Study|Decrease in serum phosphate|2|||
130089767|NCT01521494|468283000|FG002|Overall Study|Decrease in serum phosphate|3|||
130089768|NCT01521494|468283001|FG003|Overall Study|Decrease in serum phosphate|12|||
130089769|NCT01521494|468283002|FG004|Overall Study|Decrease in serum phosphate|0|||
130089770|NCT01521494|468282998|FG000|Overall Study|Decrease in serum calcium|0|||
130089771|NCT01521494|468282999|FG001|Overall Study|Decrease in serum calcium|0|||
130089772|NCT01521494|468283000|FG002|Overall Study|Decrease in serum calcium|0|||
130089773|NCT01521494|468283001|FG003|Overall Study|Decrease in serum calcium|1|||
130089774|NCT01521494|468283002|FG004|Overall Study|Decrease in serum calcium|1|||
130089775|NCT01521494|468282998|FG000|Overall Study|Physician Decision|0|||
130089776|NCT01521494|468282999|FG001|Overall Study|Physician Decision|0|||
130089777|NCT01521494|468283000|FG002|Overall Study|Physician Decision|0|||
130089778|NCT01521494|468283001|FG003|Overall Study|Physician Decision|0|||
130089779|NCT01521494|468283002|FG004|Overall Study|Physician Decision|2|||
130089780|NCT01854918|468283005|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
130089781|NCT01854918|468283006|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
130089782|NCT01854918|468283005|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
130089783|NCT01854918|468283006|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
130089784|NCT01854918|468283005|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
130089785|NCT01854918|468283006|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
130089786|NCT01854918|468283005|FG000|SOC-controlled Period (Year 1)|Death|5|||
130089787|NCT01854918|468283006|FG001|SOC-controlled Period (Year 1)|Death|5|||
130089788|NCT01854918|468283005|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
130089789|NCT01854918|468283006|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
130089790|NCT01854918|468283005|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
130089791|NCT01854918|468283006|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
130089792|NCT01854918|468283005|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
130089793|NCT01854918|468283006|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
130089794|NCT01854918|468283005|FG000|All-IP Period (Years 2 and 3)|Death|5|||
129961662|NCT00510146|467824091|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
129961663|NCT00510146|467824090|FG000|Open-Label Treatment|Adverse Event|22|||
129961664|NCT00510146|467824091|FG001|Open-Label Treatment|Adverse Event|8|||
129961665|NCT00510146|467824090|FG000|Open-Label Treatment|Death|1|||
129961666|NCT00510146|467824091|FG001|Open-Label Treatment|Death|1|||
129961667|NCT00510146|467824090|FG000|Open-Label Treatment|Lack of Efficacy|4|||
129961668|NCT00510146|467824091|FG001|Open-Label Treatment|Lack of Efficacy|0|||
129961669|NCT00510146|467824090|FG000|Open-Label Treatment|Lost to Follow-up|10|||
129961670|NCT00510146|467824091|FG001|Open-Label Treatment|Lost to Follow-up|1|||
129961671|NCT00510146|467824090|FG000|Open-Label Treatment|Physician Decision|3|||
129961672|NCT00510146|467824091|FG001|Open-Label Treatment|Physician Decision|1|||
129961673|NCT00510146|467824090|FG000|Open-Label Treatment|Protocol Violation|4|||
129961674|NCT00510146|467824091|FG001|Open-Label Treatment|Protocol Violation|2|||
129961675|NCT00510146|467824090|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
129961676|NCT00510146|467824091|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
129961677|NCT00510146|467824090|FG000|Open-Label Treatment|Clinical Relapse|1|||
129961678|NCT00510146|467824091|FG001|Open-Label Treatment|Clinical Relapse|1|||
129961679|NCT00510146|467824090|FG000|Open-Label Treatment|Sponsor Decision|2|||
129961680|NCT00510146|467824091|FG001|Open-Label Treatment|Sponsor Decision|0|||
129961681|NCT03188536|467824094|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
129961682|NCT03188536|467824094|FG000|Overall Study|Not participated/met inclusion criteria|1|||
129961683|NCT01930214|467824096|FG000|Overall Study|Death|4|||
129961684|NCT01930214|467824097|FG001|Overall Study|Death|4|||
129961685|NCT01930214|467824098|FG002|Overall Study|Death|11|||
129961686|NCT01930214|467824096|FG000|Overall Study|Lost to Follow-up|12|||
129961687|NCT01930214|467824097|FG001|Overall Study|Lost to Follow-up|13|||
129961688|NCT01930214|467824098|FG002|Overall Study|Lost to Follow-up|12|||
129961689|NCT01930214|467824096|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
129961690|NCT01930214|467824097|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
129961691|NCT01930214|467824098|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
129961692|NCT01930214|467824096|FG000|Overall Study|Physician Decision|2|||
129961693|NCT01930214|467824097|FG001|Overall Study|Physician Decision|0|||
129961694|NCT01930214|467824098|FG002|Overall Study|Physician Decision|0|||
129961695|NCT02132117|467824099|FG000|Overall Study|Adverse Event|6|||
129961696|NCT02132117|467824100|FG001|Overall Study|Adverse Event|1|||
129961697|NCT02132117|467824099|FG000|Overall Study|Lost to Follow-up|2|||
129961698|NCT02132117|467824100|FG001|Overall Study|Lost to Follow-up|2|||
129961699|NCT02132117|467824099|FG000|Overall Study|Personal Reasons|1|||
129961700|NCT02132117|467824100|FG001|Overall Study|Personal Reasons|2|||
129961701|NCT02132117|467824099|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129961702|NCT02132117|467824100|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129961703|NCT01222078|467824106|FG000|Overall Study|Early termination of the study|1|||
129961704|NCT00808899|467824108|FG000|Overall Study|Death|1|||
129961705|NCT00808899|467824108|FG000|Overall Study|Physician Decision|3|||
129961706|NCT04688086|467824113|FG000|Overall Study|Lost to Follow-up|164|||
129961707|NCT04688086|467824113|FG000|Overall Study|Imaging error;|64|||
129961708|NCT03120949|467824114|FG000|Overall Study|randomized in error|1|||
129961709|NCT03120949|467824115|FG001|Overall Study|randomized in error|0|||
129961710|NCT03120949|467824114|FG000|Overall Study|Death|13|||
129961711|NCT03120949|467824115|FG001|Overall Study|Death|13|||
129961712|NCT03120949|467824114|FG000|Overall Study|Lost to Follow-up|23|||
129961713|NCT03120949|467824115|FG001|Overall Study|Lost to Follow-up|13|||
129961714|NCT03120949|467824114|FG000|Overall Study|Withdrawal by Subject|139|||
129961715|NCT03120949|467824115|FG001|Overall Study|Withdrawal by Subject|124|||
129961716|NCT03120949|467824114|FG000|Overall Study|Covid-19|43|||
129961717|NCT03120949|467824115|FG001|Overall Study|Covid-19|34|||
129961718|NCT03120949|467824114|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
129961719|NCT03120949|467824115|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
129961720|NCT03120949|467824114|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
129961721|NCT03120949|467824115|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
129961722|NCT03120949|467824114|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
129961723|NCT03120949|467824115|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
129961724|NCT03120949|467824114|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
129961725|NCT03120949|467824115|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
129961726|NCT03120949|467824114|FG000|Overall Study|Site was closed|2|||
129961727|NCT03120949|467824115|FG001|Overall Study|Site was closed|3|||
129961728|NCT03120949|467824114|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
129961729|NCT03120949|467824115|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
129961730|NCT03120949|467824114|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
129961731|NCT03120949|467824115|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
130089795|NCT01854918|468283006|FG001|All-IP Period (Years 2 and 3)|Death|16|||
130089796|NCT02146352|468283007|FG000|Overall Study|Death|1|||
130089797|NCT02146352|468283007|FG000|Overall Study|Patient entered hospice care|1|||
130089798|NCT00939094|468283008|FG000|Overall Study|Adverse Event|9|||
130089799|NCT00939094|468283009|FG001|Overall Study|Adverse Event|0|||
130089800|NCT00939094|468283008|FG000|Overall Study|Withdrawal by Subject|1|||
130089801|NCT00939094|468283009|FG001|Overall Study|Withdrawal by Subject|6|||
130089802|NCT00939094|468283008|FG000|Overall Study|Lost to Follow-up|1|||
130089803|NCT00939094|468283009|FG001|Overall Study|Lost to Follow-up|1|||
130089804|NCT00939094|468283008|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130089805|NCT00939094|468283009|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130089806|NCT00939094|468283008|FG000|Overall Study|Severe non-compliance to protocol|0|||
130089807|NCT00939094|468283009|FG001|Overall Study|Severe non-compliance to protocol|1|||
130089808|NCT00939094|468283008|FG000|Overall Study|Study stopped by sponsor|0|||
130089809|NCT00939094|468283009|FG001|Overall Study|Study stopped by sponsor|2|||
130089810|NCT00939094|468283008|FG000|Overall Study|Abnormal ECG findings|1|||
130089811|NCT00939094|468283009|FG001|Overall Study|Abnormal ECG findings|0|||
130089812|NCT01906489|468283010|FG000|Overall Study|Adverse Event|10|||
130089813|NCT01906489|468283011|FG001|Overall Study|Adverse Event|3|||
130089814|NCT01906489|468283010|FG000|Overall Study|Worsening of CKD|6|||
130089815|NCT01906489|468283011|FG001|Overall Study|Worsening of CKD|4|||
130089816|NCT01906489|468283010|FG000|Overall Study|Withdrawal by Subject|5|||
130089817|NCT01906489|468283011|FG001|Overall Study|Withdrawal by Subject|0|||
130089818|NCT01906489|468283010|FG000|Overall Study|Worsening of Anemia|1|||
130089819|NCT01906489|468283011|FG001|Overall Study|Worsening of Anemia|0|||
130089820|NCT01906489|468283010|FG000|Overall Study|Protocol Violation|0|||
130089821|NCT01906489|468283011|FG001|Overall Study|Protocol Violation|1|||
130089822|NCT01906489|468283010|FG000|Overall Study|Non- Compliance|1|||
130089823|NCT01906489|468283011|FG001|Overall Study|Non- Compliance|0|||
130089824|NCT01906489|468283010|FG000|Overall Study|Sponsor Decision|1|||
130089825|NCT01906489|468283011|FG001|Overall Study|Sponsor Decision|0|||
130089826|NCT01906489|468283010|FG000|Overall Study|Lost to Follow-up|1|||
130089827|NCT01906489|468283011|FG001|Overall Study|Lost to Follow-up|1|||
130089828|NCT01906489|468283010|FG000|Overall Study|Other|1|||
130089829|NCT01906489|468283011|FG001|Overall Study|Other|0|||
130089830|NCT00303602|468284533|FG000|Overall Study|Adverse Event|2|||
130089831|NCT00303602|468284534|FG001|Overall Study|Adverse Event|2|||
130121774|NCT02346201|468406927|FG001|Overall Study|Missed final visit|2|||
130121775|NCT00679367|468406928|FG000|Overall Study|Adverse Event|7|||
130121776|NCT00679367|468406928|FG000|Overall Study|inability to swallow oral drugs|1|||
130121777|NCT00679367|468406928|FG000|Overall Study|Lack of Efficacy|3|||
130121778|NCT00679367|468406928|FG000|Overall Study|Withdrawal by Subject|1|||
130121779|NCT04603937|468406931|FG000|Overall Study|Adverse Event|9|||
130121780|NCT04603937|468406932|FG001|Overall Study|Adverse Event|10|||
130089832|NCT00303602|468284533|FG000|Overall Study|Withdrawal by Subject|5|||
130089833|NCT00303602|468284534|FG001|Overall Study|Withdrawal by Subject|6|||
130089834|NCT00303602|468284533|FG000|Overall Study|Lost to Follow-up|5|||
130089835|NCT00303602|468284534|FG001|Overall Study|Lost to Follow-up|2|||
130089836|NCT00303602|468284533|FG000|Overall Study|Protocol entry criteria not met|2|||
130089837|NCT00303602|468284534|FG001|Overall Study|Protocol entry criteria not met|2|||
130089838|NCT00303602|468284533|FG000|Overall Study|Physician Decision|2|||
130089839|NCT00303602|468284534|FG001|Overall Study|Physician Decision|1|||
130089840|NCT00303602|468284533|FG000|Overall Study|Noncompliance|2|||
130121781|NCT04603937|468406931|FG000|Overall Study|Withdrawal by Subject|7|||
130121782|NCT04603937|468406932|FG001|Overall Study|Withdrawal by Subject|6|||
130121783|NCT04603937|468406931|FG000|Overall Study|Lost to Follow-up|5|||
130089841|NCT00303602|468284534|FG001|Overall Study|Noncompliance|2|||
130089842|NCT00303602|468284533|FG000|Overall Study|Protocol Violation|1|||
130089843|NCT00303602|468284534|FG001|Overall Study|Protocol Violation|0|||
130089844|NCT00313716|468284537|FG000|Overall Study|Death|3|||
130089845|NCT00313716|468284538|FG001|Overall Study|Death|2|||
130089846|NCT00313716|468284539|FG002|Overall Study|Death|9|||
130089847|NCT00313716|468284540|FG003|Overall Study|Death|3|||
130121784|NCT04603937|468406932|FG001|Overall Study|Lost to Follow-up|6|||
129961732|NCT03120949|467824114|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
130089848|NCT00313716|468284541|FG004|Overall Study|Death|5|||
130089849|NCT00313716|468284542|FG005|Overall Study|Death|9|||
130089850|NCT00313716|468284537|FG000|Overall Study|Lost to Follow-up|2|||
130089851|NCT00313716|468284538|FG001|Overall Study|Lost to Follow-up|5|||
130089852|NCT00313716|468284539|FG002|Overall Study|Lost to Follow-up|2|||
130089853|NCT00313716|468284540|FG003|Overall Study|Lost to Follow-up|1|||
130089854|NCT00313716|468284541|FG004|Overall Study|Lost to Follow-up|0|||
130089855|NCT00313716|468284542|FG005|Overall Study|Lost to Follow-up|4|||
130089856|NCT00313716|468284537|FG000|Overall Study|Withdrawal by Subject|0|||
130089857|NCT00313716|468284538|FG001|Overall Study|Withdrawal by Subject|1|||
130089858|NCT00313716|468284539|FG002|Overall Study|Withdrawal by Subject|1|||
130121785|NCT04603937|468406931|FG000|Overall Study|Physician Decision|0|||
130121786|NCT04603937|468406932|FG001|Overall Study|Physician Decision|1|||
130089859|NCT00313716|468284540|FG003|Overall Study|Withdrawal by Subject|0|||
130089860|NCT00313716|468284541|FG004|Overall Study|Withdrawal by Subject|1|||
130089861|NCT00313716|468284542|FG005|Overall Study|Withdrawal by Subject|0|||
130089862|NCT00663208|468284543|FG000|Treatment Period|Lost to Follow-up|0|||
130089863|NCT00663208|468284544|FG001|Treatment Period|Lost to Follow-up|1|||
130089864|NCT00663208|468284545|FG002|Treatment Period|Lost to Follow-up|0|||
130089865|NCT00663208|468284546|FG003|Treatment Period|Lost to Follow-up|0|||
130089866|NCT00663208|468284547|FG004|Treatment Period|Lost to Follow-up|0|||
130089867|NCT00663208|468284548|FG005|Treatment Period|Lost to Follow-up|0|||
130089868|NCT00663208|468284549|FG006|Treatment Period|Lost to Follow-up|0|||
130089869|NCT00663208|468284543|FG000|Follow-up Period|Lost to Follow-up|2|||
130089870|NCT00663208|468284544|FG001|Follow-up Period|Lost to Follow-up|0|||
130089871|NCT00663208|468284545|FG002|Follow-up Period|Lost to Follow-up|3|||
130089872|NCT00663208|468284546|FG003|Follow-up Period|Lost to Follow-up|2|||
130089873|NCT00663208|468284547|FG004|Follow-up Period|Lost to Follow-up|0|||
130089874|NCT00663208|468284548|FG005|Follow-up Period|Lost to Follow-up|0|||
130089875|NCT00663208|468284549|FG006|Follow-up Period|Lost to Follow-up|0|||
130089876|NCT00663208|468284543|FG000|Follow-up Period|Other reason|1|||
130089877|NCT00663208|468284544|FG001|Follow-up Period|Other reason|0|||
130089878|NCT00663208|468284545|FG002|Follow-up Period|Other reason|0|||
130089879|NCT00663208|468284546|FG003|Follow-up Period|Other reason|0|||
130089880|NCT00663208|468284547|FG004|Follow-up Period|Other reason|0|||
130089881|NCT00663208|468284548|FG005|Follow-up Period|Other reason|0|||
130089882|NCT00663208|468284549|FG006|Follow-up Period|Other reason|1|||
130089883|NCT02719028|468284550|FG000|Overall Study|Adverse Event|2|||
130089884|NCT02719028|468284551|FG001|Overall Study|Adverse Event|1|||
130089885|NCT02719028|468284552|FG002|Overall Study|Adverse Event|4|||
130089886|NCT02719028|468284553|FG003|Overall Study|Adverse Event|8|||
130089887|NCT02719028|468284550|FG000|Overall Study|Physician Decision|0|||
130089888|NCT02719028|468284551|FG001|Overall Study|Physician Decision|1|||
130089889|NCT02719028|468284552|FG002|Overall Study|Physician Decision|1|||
130089890|NCT02719028|468284553|FG003|Overall Study|Physician Decision|1|||
130089891|NCT02719028|468284550|FG000|Overall Study|Use of prohibited medication|0|||
130089892|NCT02719028|468284551|FG001|Overall Study|Use of prohibited medication|0|||
130089893|NCT02719028|468284552|FG002|Overall Study|Use of prohibited medication|1|||
130089894|NCT02719028|468284553|FG003|Overall Study|Use of prohibited medication|0|||
130089895|NCT02719028|468284550|FG000|Overall Study|Protocol Violation|0|||
130089896|NCT02719028|468284551|FG001|Overall Study|Protocol Violation|0|||
130089897|NCT02719028|468284552|FG002|Overall Study|Protocol Violation|0|||
130089898|NCT02719028|468284553|FG003|Overall Study|Protocol Violation|1|||
130089899|NCT01539720|468284554|FG000|Overall Study|Screen Fail|15|||
130089900|NCT01539720|468284555|FG001|Overall Study|Screen Fail|3|||
130089901|NCT01539720|468284554|FG000|Overall Study|Lost to Follow-up|14|||
130089902|NCT01539720|468284555|FG001|Overall Study|Lost to Follow-up|7|||
130089903|NCT03287960|468284556|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
130089904|NCT03287960|468284556|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
130089905|NCT03730987|468284559|FG000|Overall Study|Lost to Follow-up|2|||
130089906|NCT03730987|468284560|FG001|Overall Study|Lost to Follow-up|0|||
130089907|NCT03730987|468284561|FG002|Overall Study|Lost to Follow-up|2|||
130089908|NCT03730987|468284562|FG003|Overall Study|Lost to Follow-up|0|||
130089909|NCT01345162|468284567|FG000|Overall Study|Protocol Violation|2|||
130089910|NCT01345162|468284568|FG001|Overall Study|Protocol Violation|4|||
130089911|NCT01220024|468284570|FG000|Overall Study|Lost to Follow-up|1|||
130089912|NCT01220024|468284571|FG001|Overall Study|Lost to Follow-up|1|||
130089913|NCT01756846|468284572|FG000|Overall Study|Lost to Follow-up|5|||
130089914|NCT01756846|468284573|FG001|Overall Study|Lost to Follow-up|10|||
130089915|NCT01756846|468284572|FG000|Overall Study|Withdrawal by Subject|1|||
130089916|NCT01756846|468284573|FG001|Overall Study|Withdrawal by Subject|2|||
130089917|NCT01284127|468284576|FG000|Overall Study|Adverse Event|2|||
130089918|NCT01284127|468284576|FG000|Overall Study|Withdrawal by Subject|4|||
130089919|NCT01284127|468284576|FG000|Overall Study|Physician Decision|1|||
130121787|NCT04603937|468406931|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
130089920|NCT00545740|468284577|FG000|Overall Study|Lack of Efficacy|34|||
130089921|NCT00545740|468284578|FG001|Overall Study|Lack of Efficacy|35|||
130089922|NCT00545740|468284579|FG002|Overall Study|Lack of Efficacy|47|||
130089923|NCT00545740|468284580|FG003|Overall Study|Lack of Efficacy|36|||
130089924|NCT00545740|468284577|FG000|Overall Study|Withdrawal by Subject|17|||
130089925|NCT00545740|468284578|FG001|Overall Study|Withdrawal by Subject|15|||
130089926|NCT00545740|468284579|FG002|Overall Study|Withdrawal by Subject|16|||
130089927|NCT00545740|468284580|FG003|Overall Study|Withdrawal by Subject|18|||
130089928|NCT00545740|468284577|FG000|Overall Study|Adverse Event|10|||
130089929|NCT00545740|468284578|FG001|Overall Study|Adverse Event|18|||
130089930|NCT00545740|468284579|FG002|Overall Study|Adverse Event|19|||
130089931|NCT00545740|468284580|FG003|Overall Study|Adverse Event|9|||
130089932|NCT00545740|468284577|FG000|Overall Study|Lost to Follow-up|7|||
130089933|NCT00545740|468284578|FG001|Overall Study|Lost to Follow-up|5|||
130089934|NCT00545740|468284579|FG002|Overall Study|Lost to Follow-up|5|||
130089935|NCT00545740|468284580|FG003|Overall Study|Lost to Follow-up|6|||
130089936|NCT00545740|468284577|FG000|Overall Study|Protocol Violation|1|||
130089937|NCT00545740|468284578|FG001|Overall Study|Protocol Violation|3|||
130089938|NCT00545740|468284579|FG002|Overall Study|Protocol Violation|1|||
130089939|NCT00545740|468284580|FG003|Overall Study|Protocol Violation|0|||
130089940|NCT00545740|468284577|FG000|Overall Study|Non-compliance|0|||
130089941|NCT00545740|468284578|FG001|Overall Study|Non-compliance|2|||
130089942|NCT00545740|468284579|FG002|Overall Study|Non-compliance|1|||
130089943|NCT00545740|468284580|FG003|Overall Study|Non-compliance|0|||
130089944|NCT00545740|468284577|FG000|Overall Study|Moved|2|||
130089945|NCT00545740|468284578|FG001|Overall Study|Moved|0|||
130089946|NCT00545740|468284579|FG002|Overall Study|Moved|1|||
130089947|NCT00545740|468284580|FG003|Overall Study|Moved|0|||
130089948|NCT00545740|468284577|FG000|Overall Study|Diverticulitis attack|0|||
130089949|NCT00545740|468284578|FG001|Overall Study|Diverticulitis attack|0|||
130089950|NCT00545740|468284579|FG002|Overall Study|Diverticulitis attack|1|||
130089951|NCT00545740|468284580|FG003|Overall Study|Diverticulitis attack|1|||
130089952|NCT00545740|468284577|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
130089953|NCT00545740|468284578|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
130089954|NCT00545740|468284579|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
130089955|NCT00545740|468284580|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
130089956|NCT00545740|468284577|FG000|Overall Study|Site closure|1|||
130089957|NCT00545740|468284578|FG001|Overall Study|Site closure|0|||
130089958|NCT00545740|468284579|FG002|Overall Study|Site closure|0|||
130089959|NCT00545740|468284580|FG003|Overall Study|Site closure|0|||
130089960|NCT00545740|468284577|FG000|Overall Study|Missed visit|1|||
130089961|NCT00545740|468284578|FG001|Overall Study|Missed visit|0|||
130089962|NCT00545740|468284579|FG002|Overall Study|Missed visit|0|||
130089963|NCT00545740|468284580|FG003|Overall Study|Missed visit|0|||
130089964|NCT00545740|468284577|FG000|Overall Study|Physician Decision|0|||
130089965|NCT00545740|468284578|FG001|Overall Study|Physician Decision|0|||
130089966|NCT00545740|468284579|FG002|Overall Study|Physician Decision|3|||
130089967|NCT00545740|468284580|FG003|Overall Study|Physician Decision|0|||
130089968|NCT00545740|468284577|FG000|Overall Study|Accepted only monthly telephone calls|1|||
130089969|NCT00545740|468284578|FG001|Overall Study|Accepted only monthly telephone calls|0|||
130089970|NCT00545740|468284579|FG002|Overall Study|Accepted only monthly telephone calls|0|||
130089971|NCT00545740|468284580|FG003|Overall Study|Accepted only monthly telephone calls|0|||
130089972|NCT00545740|468284577|FG000|Overall Study|Sponsor decision|0|||
130089973|NCT00545740|468284578|FG001|Overall Study|Sponsor decision|1|||
130089974|NCT00545740|468284579|FG002|Overall Study|Sponsor decision|0|||
130089975|NCT00545740|468284580|FG003|Overall Study|Sponsor decision|0|||
130089976|NCT00545740|468284577|FG000|Overall Study|Lack of time|0|||
130089977|NCT00545740|468284578|FG001|Overall Study|Lack of time|1|||
130089978|NCT00545740|468284579|FG002|Overall Study|Lack of time|0|||
130089979|NCT00545740|468284580|FG003|Overall Study|Lack of time|0|||
130089980|NCT00545740|468284577|FG000|Overall Study|Non-adherence to visits|0|||
130089981|NCT00545740|468284578|FG001|Overall Study|Non-adherence to visits|1|||
130089982|NCT00545740|468284579|FG002|Overall Study|Non-adherence to visits|0|||
130089983|NCT00545740|468284580|FG003|Overall Study|Non-adherence to visits|0|||
130089984|NCT00545740|468284577|FG000|Overall Study|Patient difficulties|0|||
130089985|NCT00545740|468284578|FG001|Overall Study|Patient difficulties|1|||
130089986|NCT00545740|468284579|FG002|Overall Study|Patient difficulties|0|||
130089987|NCT00545740|468284580|FG003|Overall Study|Patient difficulties|0|||
130089988|NCT00545740|468284577|FG000|Overall Study|Husband against study|0|||
130089989|NCT00545740|468284578|FG001|Overall Study|Husband against study|0|||
130089990|NCT00545740|468284579|FG002|Overall Study|Husband against study|1|||
130089991|NCT00545740|468284580|FG003|Overall Study|Husband against study|0|||
130089992|NCT04212221|468284586|FG000|Overall Study|Remained on Treatment|0|||
130089993|NCT04212221|468284587|FG001|Overall Study|Remained on Treatment|0|||
130089994|NCT04212221|468284588|FG002|Overall Study|Remained on Treatment|0|||
130089995|NCT04212221|468284589|FG003|Overall Study|Remained on Treatment|1|||
130089996|NCT04212221|468284590|FG004|Overall Study|Remained on Treatment|0|||
130089997|NCT04212221|468284591|FG005|Overall Study|Remained on Treatment|0|||
130089998|NCT04212221|468284592|FG006|Overall Study|Remained on Treatment|3|||
130089999|NCT04212221|468284593|FG007|Overall Study|Remained on Treatment|9|||
129961733|NCT03120949|467824115|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
130090000|NCT04212221|468284586|FG000|Overall Study|Adverse Event|0|||
130090001|NCT04212221|468284587|FG001|Overall Study|Adverse Event|0|||
130090002|NCT04212221|468284588|FG002|Overall Study|Adverse Event|0|||
130090003|NCT04212221|468284589|FG003|Overall Study|Adverse Event|0|||
130090004|NCT04212221|468284590|FG004|Overall Study|Adverse Event|0|||
130090005|NCT04212221|468284591|FG005|Overall Study|Adverse Event|0|||
130090006|NCT04212221|468284592|FG006|Overall Study|Adverse Event|2|||
130090007|NCT04212221|468284593|FG007|Overall Study|Adverse Event|3|||
130090008|NCT04212221|468284586|FG000|Overall Study|Death|0|||
130090009|NCT04212221|468284587|FG001|Overall Study|Death|0|||
130090010|NCT04212221|468284588|FG002|Overall Study|Death|0|||
130090011|NCT04212221|468284589|FG003|Overall Study|Death|0|||
130090012|NCT04212221|468284590|FG004|Overall Study|Death|0|||
130090013|NCT04212221|468284591|FG005|Overall Study|Death|0|||
130090014|NCT04212221|468284592|FG006|Overall Study|Death|0|||
130090015|NCT04212221|468284593|FG007|Overall Study|Death|2|||
130090016|NCT04212221|468284586|FG000|Overall Study|Disease progression according to irRECIST|1|||
130090017|NCT04212221|468284587|FG001|Overall Study|Disease progression according to irRECIST|2|||
130090018|NCT04212221|468284588|FG002|Overall Study|Disease progression according to irRECIST|3|||
130090019|NCT04212221|468284589|FG003|Overall Study|Disease progression according to irRECIST|3|||
130090020|NCT04212221|468284590|FG004|Overall Study|Disease progression according to irRECIST|2|||
130090021|NCT04212221|468284591|FG005|Overall Study|Disease progression according to irRECIST|2|||
130090022|NCT04212221|468284592|FG006|Overall Study|Disease progression according to irRECIST|21|||
130090023|NCT04212221|468284593|FG007|Overall Study|Disease progression according to irRECIST|17|||
130090024|NCT04212221|468284586|FG000|Overall Study|Global Deterioration of Health Status|0|||
130090025|NCT04212221|468284587|FG001|Overall Study|Global Deterioration of Health Status|0|||
130090026|NCT04212221|468284588|FG002|Overall Study|Global Deterioration of Health Status|0|||
130090027|NCT04212221|468284589|FG003|Overall Study|Global Deterioration of Health Status|0|||
130090028|NCT04212221|468284590|FG004|Overall Study|Global Deterioration of Health Status|0|||
130090029|NCT04212221|468284591|FG005|Overall Study|Global Deterioration of Health Status|0|||
130090030|NCT04212221|468284592|FG006|Overall Study|Global Deterioration of Health Status|0|||
130090031|NCT04212221|468284593|FG007|Overall Study|Global Deterioration of Health Status|2|||
130090032|NCT04212221|468284586|FG000|Overall Study|Investigator's Decision|0|||
130090033|NCT04212221|468284587|FG001|Overall Study|Investigator's Decision|0|||
130090034|NCT04212221|468284588|FG002|Overall Study|Investigator's Decision|0|||
130090035|NCT04212221|468284589|FG003|Overall Study|Investigator's Decision|1|||
130090036|NCT04212221|468284590|FG004|Overall Study|Investigator's Decision|0|||
130090037|NCT04212221|468284591|FG005|Overall Study|Investigator's Decision|0|||
130090038|NCT04212221|468284592|FG006|Overall Study|Investigator's Decision|3|||
130090039|NCT04212221|468284593|FG007|Overall Study|Investigator's Decision|0|||
130090040|NCT04212221|468284586|FG000|Overall Study|Participant refused to continue treatment|0|||
130090041|NCT04212221|468284587|FG001|Overall Study|Participant refused to continue treatment|1|||
130090042|NCT04212221|468284588|FG002|Overall Study|Participant refused to continue treatment|0|||
130090043|NCT04212221|468284589|FG003|Overall Study|Participant refused to continue treatment|1|||
130090044|NCT04212221|468284590|FG004|Overall Study|Participant refused to continue treatment|1|||
130090045|NCT04212221|468284591|FG005|Overall Study|Participant refused to continue treatment|2|||
130090046|NCT04212221|468284592|FG006|Overall Study|Participant refused to continue treatment|4|||
130090047|NCT04212221|468284593|FG007|Overall Study|Participant refused to continue treatment|2|||
130090048|NCT04212221|468284586|FG000|Overall Study|Protocol Violation|0|||
130090049|NCT04212221|468284587|FG001|Overall Study|Protocol Violation|0|||
130090050|NCT04212221|468284588|FG002|Overall Study|Protocol Violation|0|||
130090051|NCT04212221|468284589|FG003|Overall Study|Protocol Violation|0|||
130090052|NCT04212221|468284590|FG004|Overall Study|Protocol Violation|0|||
130090053|NCT04212221|468284591|FG005|Overall Study|Protocol Violation|0|||
130090054|NCT04212221|468284592|FG006|Overall Study|Protocol Violation|0|||
130090055|NCT04212221|468284593|FG007|Overall Study|Protocol Violation|1|||
130090056|NCT03742271|468284598|FG000|Overall Study|Unsatisfactory Visual Response|1|||
130090057|NCT03742271|468284598|FG000|Overall Study|Withdrawal by Subject|3|||
130090058|NCT03742271|468284598|FG000|Overall Study|Lost to Follow-up|4|||
130090059|NCT03742271|468284598|FG000|Overall Study|Failed Insertion & removal|3|||
130090060|NCT03742271|468284598|FG000|Overall Study|Protocol Violation|1|||
130090061|NCT01624974|468284601|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
130090062|NCT01624974|468284602|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
130090063|NCT01624974|468284601|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
130090064|NCT01624974|468284602|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
130090065|NCT01624974|468284601|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
130090066|NCT01624974|468284602|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
130090067|NCT01624974|468284601|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
130090068|NCT01624974|468284602|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
130090069|NCT01624974|468284601|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
130090070|NCT01624974|468284602|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
130090071|NCT01624974|468284601|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
130090072|NCT01624974|468284602|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
130090073|NCT01624974|468284601|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
130090074|NCT01624974|468284602|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
130090075|NCT01624974|468284601|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
130090076|NCT01624974|468284602|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
130090077|NCT01624974|468284601|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
130090078|NCT01624974|468284602|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
130090079|NCT01624974|468284601|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
130090080|NCT01624974|468284602|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
130090081|NCT01624974|468284601|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
130090082|NCT01624974|468284602|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
130090083|NCT01624974|468284601|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
130090084|NCT01624974|468284602|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
130090085|NCT01376908|468284603|FG000|Overall Study|Protocol Violation|1|||
130090086|NCT01376908|468284604|FG001|Overall Study|Protocol Violation|1|||
130090087|NCT01376908|468284603|FG000|Overall Study|Withdrawal by Subject|1|||
130090088|NCT01376908|468284604|FG001|Overall Study|Withdrawal by Subject|2|||
130090089|NCT01468844|468284605|FG000|Overall Study|Adverse Event|1|||
130090090|NCT01468844|468284606|FG001|Overall Study|Adverse Event|0|||
130090091|NCT01468844|468284605|FG000|Overall Study|Withdrawal by Subject|1|||
130090092|NCT01468844|468284606|FG001|Overall Study|Withdrawal by Subject|0|||
130090093|NCT02142712|468284607|FG000|Overall Study|Lost to Follow-up|1|||
130090094|NCT02142712|468284608|FG001|Overall Study|Lost to Follow-up|1|||
130090095|NCT02142712|468284609|FG002|Overall Study|Lost to Follow-up|1|||
130090096|NCT02142712|468284610|FG003|Overall Study|Lost to Follow-up|0|||
130090097|NCT01899729|468284611|FG000|Overall Study|Adverse Event|1|||
130090098|NCT01899729|468284612|FG001|Overall Study|Adverse Event|0|||
130090099|NCT01899729|468284613|FG002|Overall Study|Adverse Event|0|||
130090100|NCT01899729|468284614|FG003|Overall Study|Adverse Event|0|||
130090101|NCT01899729|468284615|FG004|Overall Study|Adverse Event|1|||
130090102|NCT01899729|468284611|FG000|Overall Study|Withdrawal by Subject|1|||
130090103|NCT01899729|468284612|FG001|Overall Study|Withdrawal by Subject|2|||
130090104|NCT01899729|468284613|FG002|Overall Study|Withdrawal by Subject|0|||
130090105|NCT01899729|468284614|FG003|Overall Study|Withdrawal by Subject|0|||
130090106|NCT01899729|468284615|FG004|Overall Study|Withdrawal by Subject|0|||
130090107|NCT01899729|468284611|FG000|Overall Study|Lack of Efficacy|0|||
130090108|NCT01899729|468284612|FG001|Overall Study|Lack of Efficacy|0|||
130090109|NCT01899729|468284613|FG002|Overall Study|Lack of Efficacy|2|||
130090110|NCT01899729|468284614|FG003|Overall Study|Lack of Efficacy|0|||
130090111|NCT01899729|468284615|FG004|Overall Study|Lack of Efficacy|1|||
130090112|NCT02853318|468284618|FG000|Overall Study|Withdrawal by Subject|1|||
130090113|NCT00252499|468284621|FG000|Overall Study|Lost to Follow-up|1|||
130090114|NCT00252499|468284622|FG001|Overall Study|Lost to Follow-up|0|||
130090115|NCT00252499|468284623|FG002|Overall Study|Lost to Follow-up|0|||
130090116|NCT02646332|468284629|FG000|Overall Study|Lost to Follow-up|0|||
130090117|NCT02646332|468284630|FG001|Overall Study|Lost to Follow-up|3|||
130090118|NCT04490499|468284631|FG000|Overall Study|Withdrawal by Subject|2|||
130090119|NCT01882439|468284632|FG000|Overall Study|Adverse event related to study drug|3|||
130090120|NCT01882439|468284633|FG001|Overall Study|Adverse event related to study drug|8|||
130090121|NCT01882439|468284634|FG002|Overall Study|Adverse event related to study drug|1|||
130090122|NCT01882439|468284635|FG003|Overall Study|Adverse event related to study drug|2|||
130090123|NCT01882439|468284632|FG000|Overall Study|Pregnancy|0|||
130090124|NCT01882439|468284633|FG001|Overall Study|Pregnancy|1|||
130090125|NCT01882439|468284634|FG002|Overall Study|Pregnancy|0|||
130090126|NCT01882439|468284635|FG003|Overall Study|Pregnancy|0|||
130090127|NCT01882439|468284632|FG000|Overall Study|Protocol Violation|2|||
130090128|NCT01882439|468284633|FG001|Overall Study|Protocol Violation|2|||
130090129|NCT01882439|468284634|FG002|Overall Study|Protocol Violation|0|||
130090130|NCT01882439|468284635|FG003|Overall Study|Protocol Violation|1|||
130090131|NCT01882439|468284632|FG000|Overall Study|No longer willing to participate|1|||
130090132|NCT01882439|468284633|FG001|Overall Study|No longer willing to participate|4|||
130090133|NCT01882439|468284634|FG002|Overall Study|No longer willing to participate|2|||
130090134|NCT01882439|468284635|FG003|Overall Study|No longer willing to participate|3|||
130090135|NCT01882439|468284632|FG000|Overall Study|Medication error with no associated AE|0|||
130090136|NCT01882439|468284633|FG001|Overall Study|Medication error with no associated AE|0|||
130090137|NCT01882439|468284634|FG002|Overall Study|Medication error with no associated AE|2|||
130090138|NCT01882439|468284635|FG003|Overall Study|Medication error with no associated AE|0|||
130090139|NCT01882439|468284632|FG000|Overall Study|Insufficient clinical response|1|||
130090140|NCT01882439|468284633|FG001|Overall Study|Insufficient clinical response|4|||
130090141|NCT01882439|468284634|FG002|Overall Study|Insufficient clinical response|4|||
130090142|NCT01882439|468284635|FG003|Overall Study|Insufficient clinical response|2|||
130090143|NCT01882439|468284632|FG000|Overall Study|Adverse event unrelated to study drug|2|||
130090144|NCT01882439|468284633|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130090145|NCT01882439|468284634|FG002|Overall Study|Adverse event unrelated to study drug|1|||
130090146|NCT01882439|468284635|FG003|Overall Study|Adverse event unrelated to study drug|1|||
130090147|NCT01997333|468284640|FG000|Randomization and Treatment|Disease Progression|70|||
130090148|NCT01997333|468284641|FG001|Randomization and Treatment|Disease Progression|159|||
130090149|NCT01997333|468284640|FG000|Randomization and Treatment|Adverse Event|10|||
130090150|NCT01997333|468284641|FG001|Randomization and Treatment|Adverse Event|32|||
130090151|NCT01997333|468284640|FG000|Randomization and Treatment|Physician Decision|0|||
130090152|NCT01997333|468284641|FG001|Randomization and Treatment|Physician Decision|4|||
130090153|NCT01997333|468284640|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
130090154|NCT01997333|468284641|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
130090155|NCT01997333|468284640|FG000|Randomization and Treatment|Did not receive treatment|17|||
130090156|NCT01997333|468284641|FG001|Randomization and Treatment|Did not receive treatment|5|||
130090157|NCT01997333|468284640|FG000|Survival Follow up|Withdrawal by Subject|15|||
129961734|NCT03120949|467824114|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
129961735|NCT03120949|467824115|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
129961736|NCT03120949|467824114|FG000|Overall Study|Other: Adverse Event|0|||
129961737|NCT03120949|467824115|FG001|Overall Study|Other: Adverse Event|1|||
129961738|NCT03120949|467824114|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
129961739|NCT03120949|467824115|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
129961740|NCT03120949|467824114|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
129961741|NCT03120949|467824115|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
129961742|NCT03120949|467824114|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
129961743|NCT03120949|467824115|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
129961744|NCT03120949|467824114|FG000|Overall Study|Personal Reasons|0|||
129961745|NCT03120949|467824115|FG001|Overall Study|Personal Reasons|1|||
129961746|NCT03120949|467824114|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
129961747|NCT03120949|467824115|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
129961748|NCT03120949|467824114|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
129961749|NCT03120949|467824115|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
129961750|NCT03120949|467824114|FG000|Overall Study|Compliance With Medication|0|||
129961751|NCT03120949|467824115|FG001|Overall Study|Compliance With Medication|1|||
129961752|NCT03120949|467824114|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
129961753|NCT03120949|467824115|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
129961754|NCT03120949|467824114|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
129961755|NCT03120949|467824115|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
129961756|NCT03120949|467824114|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
129961757|NCT03120949|467824115|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
129961758|NCT00988117|467824116|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
129961759|NCT00988117|467824116|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
129961760|NCT00853021|467824119|FG000|Overall Study|Adverse Event|2|||
129961761|NCT00853021|467824119|FG000|Overall Study|Withdrawal by Subject|2|||
129961762|NCT00853021|467824119|FG000|Overall Study|Death|1|||
129961763|NCT01329419|467824120|FG000|Overall Study|Protocol Violation|235|||
129961764|NCT04522778|467824123|FG000|Overall Study|Patient did not want to wear the device|1|||
129961765|NCT04522778|467824124|FG001|Overall Study|Patient did not want to wear the device|0|||
129961766|NCT04522778|467824123|FG000|Overall Study|Lost to Follow-up|0|||
129961767|NCT04522778|467824124|FG001|Overall Study|Lost to Follow-up|1|||
129961768|NCT01225159|467824125|FG000|Overall Study|Change operation|1|||
129961769|NCT01225159|467824126|FG001|Overall Study|Change operation|0|||
129961770|NCT01220856|467824130|FG000|Overall Study|graft loss|3|||
129961771|NCT01220856|467824131|FG001|Overall Study|graft loss|3|||
129961772|NCT01220856|467824130|FG000|Overall Study|Lost to Follow-up|1|||
129961773|NCT01220856|467824131|FG001|Overall Study|Lost to Follow-up|0|||
129961774|NCT04088500|467824132|FG000|Overall Study|Reason unknown|1|||
129961775|NCT04088500|467824132|FG000|Overall Study|Participant withdrew consent|1|||
129961776|NCT04088500|467824132|FG000|Overall Study|Disease progression|3|||
129961777|NCT00981578|467824133|FG000|Overall Study|Death|1|||
129961778|NCT00981578|467824133|FG000|Overall Study|Withdrawal by Subject|2|||
129961779|NCT04206384|467824134|FG000|Overall Study|Withdrawal by Subject|8|||
129961780|NCT04206384|467824134|FG000|Overall Study|Adverse Event|2|||
129961781|NCT02212197|467824135|FG000|Overall Study|Need for radiotherapy|1|||
129961782|NCT02212197|467824136|FG001|Overall Study|Need for radiotherapy|0|||
129961783|NCT02212197|467824137|FG002|Overall Study|Need for radiotherapy|0|||
129961784|NCT01177228|467824140|FG000|Overall Study|Positive tuberculosis test|0|||
129961785|NCT01177228|467824141|FG001|Overall Study|Positive tuberculosis test|1|||
129961786|NCT01177228|467824142|FG002|Overall Study|Positive tuberculosis test|0|||
129961787|NCT01177228|467824143|FG003|Overall Study|Positive tuberculosis test|0|||
129961788|NCT01177228|467824140|FG000|Overall Study|Worsening disease activity|1|||
129961789|NCT01177228|467824141|FG001|Overall Study|Worsening disease activity|0|||
129961790|NCT01177228|467824142|FG002|Overall Study|Worsening disease activity|0|||
129961791|NCT01177228|467824143|FG003|Overall Study|Worsening disease activity|0|||
129961792|NCT01177228|467824140|FG000|Overall Study|Withdrawal by Subject|0|||
129961793|NCT01177228|467824141|FG001|Overall Study|Withdrawal by Subject|1|||
129961794|NCT01177228|467824142|FG002|Overall Study|Withdrawal by Subject|0|||
129961795|NCT01177228|467824143|FG003|Overall Study|Withdrawal by Subject|0|||
129961796|NCT01494298|467824144|FG000|Overall Study|Protocol Violation|2|||
129961797|NCT01494298|467824145|FG001|Overall Study|Protocol Violation|8|||
129961798|NCT00006436|467824147|FG000|Overall Study|Refused further treatment|2|||
129961799|NCT00006436|467824147|FG000|Overall Study|Declined to participate (before treatment started)|1|||
129961800|NCT00316589|467824148|FG000|Overall Study|Withdrawal by Subject|0|||
129961801|NCT00316589|467824149|FG001|Overall Study|Withdrawal by Subject|5|||
129961802|NCT00316589|467824150|FG002|Overall Study|Withdrawal by Subject|0|||
129961803|NCT00316589|467824151|FG003|Overall Study|Withdrawal by Subject|1|||
130090158|NCT01997333|468284641|FG001|Survival Follow up|Withdrawal by Subject|6|||
130090159|NCT01997333|468284640|FG000|Survival Follow up|Lost to Follow-up|0|||
130090160|NCT01997333|468284641|FG001|Survival Follow up|Lost to Follow-up|6|||
130090161|NCT01997333|468284640|FG000|Survival Follow up|Various|1|||
130090162|NCT01997333|468284641|FG001|Survival Follow up|Various|2|||
130090163|NCT02269709|468284642|FG000|Time of Enrollment|Withdrawal by Subject|3|||
130090164|NCT02269709|468284642|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
130090165|NCT02269709|468284642|FG000|Six Month Follow-up|Lost to Follow-up|12|||
130090166|NCT02909504|468284643|FG000|Overall Study|Adverse Event|2|||
130090167|NCT02909504|468284643|FG000|Overall Study|Lack of Efficacy|3|||
130090168|NCT02909504|468284643|FG000|Overall Study|Withdrawal by Subject|4|||
130090169|NCT02909504|468284643|FG000|Overall Study|Pregnancy|1|||
130090170|NCT02909504|468284643|FG000|Overall Study|Subject moved|1|||
130090171|NCT02909504|468284643|FG000|Overall Study|Lost to Follow-up|1|||
130090172|NCT04411472|468284644|FG000|Overall Study|Adverse Event|5|||
130090173|NCT04411472|468284645|FG001|Overall Study|Adverse Event|10|||
130090174|NCT04411472|468284646|FG002|Overall Study|Adverse Event|1|||
130090175|NCT04411472|468284647|FG003|Overall Study|Adverse Event|0|||
130090176|NCT04411472|468284648|FG004|Overall Study|Adverse Event|0|||
130090177|NCT04411472|468284649|FG005|Overall Study|Adverse Event|0|||
130090178|NCT04411472|468284644|FG000|Overall Study|Protocol Violation|1|||
130090179|NCT04411472|468284645|FG001|Overall Study|Protocol Violation|0|||
130090180|NCT04411472|468284646|FG002|Overall Study|Protocol Violation|0|||
130090181|NCT04411472|468284647|FG003|Overall Study|Protocol Violation|0|||
130090182|NCT04411472|468284648|FG004|Overall Study|Protocol Violation|0|||
130090183|NCT04411472|468284649|FG005|Overall Study|Protocol Violation|0|||
130090184|NCT04411472|468284644|FG000|Overall Study|Withdrawal by Subject|0|||
130090185|NCT04411472|468284645|FG001|Overall Study|Withdrawal by Subject|1|||
130090186|NCT04411472|468284646|FG002|Overall Study|Withdrawal by Subject|0|||
130090187|NCT04411472|468284647|FG003|Overall Study|Withdrawal by Subject|1|||
130090188|NCT04411472|468284648|FG004|Overall Study|Withdrawal by Subject|0|||
130090189|NCT04411472|468284649|FG005|Overall Study|Withdrawal by Subject|0|||
130090190|NCT04411472|468284644|FG000|Overall Study|Physician Decision|1|||
130090191|NCT04411472|468284645|FG001|Overall Study|Physician Decision|0|||
130090192|NCT04411472|468284646|FG002|Overall Study|Physician Decision|0|||
130090193|NCT04411472|468284647|FG003|Overall Study|Physician Decision|0|||
130090194|NCT04411472|468284648|FG004|Overall Study|Physician Decision|0|||
130090195|NCT04411472|468284649|FG005|Overall Study|Physician Decision|0|||
130090196|NCT04411472|468284644|FG000|Overall Study|Study terminated by sponsor|17|||
130090197|NCT04411472|468284645|FG001|Overall Study|Study terminated by sponsor|20|||
130090198|NCT04411472|468284646|FG002|Overall Study|Study terminated by sponsor|3|||
130090199|NCT04411472|468284647|FG003|Overall Study|Study terminated by sponsor|0|||
130090200|NCT04411472|468284648|FG004|Overall Study|Study terminated by sponsor|0|||
130090201|NCT04411472|468284649|FG005|Overall Study|Study terminated by sponsor|0|||
130090202|NCT05060003|468284651|FG000|Overall Study|ctDNA negative|7|||
130090203|NCT03769753|468284652|FG000|Overall Study|Not Treated|6|||
130090204|NCT03769753|468284652|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
130090205|NCT03702166|468284653|FG000|Overall Study|Lost to Follow-up|1|||
130090206|NCT03702166|468284653|FG000|Overall Study|Withdrawal by Subject|1|||
130090207|NCT00684073|468284654|FG000|Selection|Selection/non-selection criteria|3|||
130090208|NCT00684073|468284654|FG000|Selection|Death|1|||
130090209|NCT00684073|468284654|FG000|Selection|noncompliance|1|||
130090210|NCT00684073|468284654|FG000|Selection|Lost to Follow-up|1|||
130090211|NCT00684073|468284654|FG000|Selection|request of the sponsor|1|||
130090212|NCT00684073|468284654|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
130090213|NCT01657903|468284655|FG000|Overall Study|Lost to Follow-up|1|||
130090214|NCT01657903|468284655|FG000|Overall Study|Withdrawal by Subject|1|||
130090215|NCT01888367|468284659|FG000|Overall Study|Physician Decision|3|||
130090216|NCT01888367|468284660|FG001|Overall Study|Physician Decision|4|||
130090217|NCT01888367|468284661|FG002|Overall Study|Physician Decision|2|||
130090218|NCT01888367|468284659|FG000|Overall Study|Death|2|||
130090219|NCT01888367|468284660|FG001|Overall Study|Death|0|||
130090220|NCT01888367|468284661|FG002|Overall Study|Death|1|||
130090221|NCT01888367|468284659|FG000|Overall Study|Withdrawal by Subject|1|||
130090222|NCT01888367|468284660|FG001|Overall Study|Withdrawal by Subject|0|||
130090223|NCT01888367|468284661|FG002|Overall Study|Withdrawal by Subject|1|||
130090224|NCT01888367|468284659|FG000|Overall Study|Lost to Follow-up|1|||
130090225|NCT01888367|468284660|FG001|Overall Study|Lost to Follow-up|1|||
130090226|NCT01888367|468284661|FG002|Overall Study|Lost to Follow-up|0|||
130090227|NCT01888367|468284659|FG000|Overall Study|Protocol Violation|0|||
130090228|NCT01888367|468284660|FG001|Overall Study|Protocol Violation|0|||
130090229|NCT01888367|468284661|FG002|Overall Study|Protocol Violation|1|||
130090230|NCT01888367|468284659|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
130121788|NCT04603937|468406932|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
130090231|NCT01888367|468284660|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
130090232|NCT01888367|468284661|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
130090233|NCT03969589|468284664|FG000|Overall Study|Lost to Follow-up|3|||
130090234|NCT03969589|468284665|FG001|Overall Study|Lost to Follow-up|2|||
130090235|NCT03969589|468284664|FG000|Overall Study|Declined Follow-Up|0|||
130090236|NCT03969589|468284665|FG001|Overall Study|Declined Follow-Up|1|||
130090237|NCT00517634|468284666|FG000|Second Treatment Period|Withdrawal by Subject|0|||
130090238|NCT00517634|468284667|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130090239|NCT00517634|468284668|FG002|Second Treatment Period|Withdrawal by Subject|0|||
130090240|NCT00517634|468284669|FG003|Second Treatment Period|Withdrawal by Subject|0|||
130090241|NCT00517634|468284670|FG004|Second Treatment Period|Withdrawal by Subject|1|||
130090242|NCT00517634|468284671|FG005|Second Treatment Period|Withdrawal by Subject|0|||
130090243|NCT03091920|468284674|FG000|Overall Study|Adverse Event|0|||
130090244|NCT03091920|468284675|FG001|Overall Study|Adverse Event|1|||
130090245|NCT03091920|468284676|FG002|Overall Study|Adverse Event|0|||
130090246|NCT03143855|468284677|FG000|Overall Study|Withdrawal by Subject|4|||
130090247|NCT03143855|468284678|FG001|Overall Study|Withdrawal by Subject|3|||
130090248|NCT03143855|468284677|FG000|Overall Study|Protocol Violation|1|||
130090249|NCT03143855|468284678|FG001|Overall Study|Protocol Violation|0|||
130090250|NCT03143855|468284677|FG000|Overall Study|Participant experienced withdrawal|0|||
130090251|NCT03143855|468284678|FG001|Overall Study|Participant experienced withdrawal|1|||
130090252|NCT00453349|468284679|FG000|Randomized|Adverse Event|12|||
130090253|NCT00453349|468284680|FG001|Randomized|Adverse Event|11|||
130090254|NCT00453349|468284679|FG000|Randomized|Lack of Efficacy|2|||
130090255|NCT00453349|468284680|FG001|Randomized|Lack of Efficacy|1|||
130090256|NCT00453349|468284679|FG000|Randomized|Lost to Follow-up|7|||
130090257|NCT00453349|468284680|FG001|Randomized|Lost to Follow-up|5|||
130090258|NCT00453349|468284679|FG000|Randomized|Protocol Violation|1|||
130090259|NCT00453349|468284680|FG001|Randomized|Protocol Violation|1|||
130090260|NCT00453349|468284679|FG000|Randomized|Withdrawal by Subject|3|||
130090261|NCT00453349|468284680|FG001|Randomized|Withdrawal by Subject|5|||
130090262|NCT00453349|468284679|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
130090263|NCT00453349|468284680|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
130090264|NCT00453349|468284679|FG000|Completed Study|Adverse Event|12|||
130090265|NCT00453349|468284680|FG001|Completed Study|Adverse Event|11|||
130090266|NCT00453349|468284679|FG000|Completed Study|Lack of Efficacy|2|||
130090267|NCT00453349|468284680|FG001|Completed Study|Lack of Efficacy|1|||
130090268|NCT00453349|468284679|FG000|Completed Study|Lost to Follow-up|7|||
130090269|NCT00453349|468284680|FG001|Completed Study|Lost to Follow-up|5|||
130090270|NCT00453349|468284679|FG000|Completed Study|Protocol Violation|1|||
130090271|NCT00453349|468284680|FG001|Completed Study|Protocol Violation|1|||
130090272|NCT00453349|468284679|FG000|Completed Study|Withdrawal by Subject|3|||
130090273|NCT00453349|468284680|FG001|Completed Study|Withdrawal by Subject|5|||
130090274|NCT00453349|468284679|FG000|Completed Study|Lost to follow up after study treatment|2|||
130090275|NCT00453349|468284680|FG001|Completed Study|Lost to follow up after study treatment|11|||
130090276|NCT01513460|468284683|FG000|Overall Study|Death|0|||
130090277|NCT01513460|468284684|FG001|Overall Study|Death|0|||
130090278|NCT01513460|468284685|FG002|Overall Study|Death|1|||
130090279|NCT01513460|468284683|FG000|Overall Study|Lost to Follow-up|0|||
130090280|NCT01513460|468284684|FG001|Overall Study|Lost to Follow-up|0|||
130090281|NCT01513460|468284685|FG002|Overall Study|Lost to Follow-up|2|||
130090282|NCT01513460|468284683|FG000|Overall Study|Abnormal laboratory value|1|||
130090283|NCT01513460|468284684|FG001|Overall Study|Abnormal laboratory value|0|||
130090284|NCT01513460|468284685|FG002|Overall Study|Abnormal laboratory value|1|||
130090285|NCT01513460|468284683|FG000|Overall Study|Lack of Efficacy|1|||
130090286|NCT01513460|468284684|FG001|Overall Study|Lack of Efficacy|2|||
130090287|NCT01513460|468284685|FG002|Overall Study|Lack of Efficacy|5|||
130090288|NCT01513460|468284683|FG000|Overall Study|Protocol deviations|3|||
129961804|NCT00316589|467824148|FG000|Overall Study|Subject unwilling/unable to comply|0|||
130090289|NCT01513460|468284684|FG001|Overall Study|Protocol deviations|4|||
130090290|NCT01513460|468284685|FG002|Overall Study|Protocol deviations|3|||
130090291|NCT01513460|468284683|FG000|Overall Study|Withdrawal by Subject|7|||
130090292|NCT01513460|468284684|FG001|Overall Study|Withdrawal by Subject|8|||
130090293|NCT01513460|468284685|FG002|Overall Study|Withdrawal by Subject|21|||
130090294|NCT01513460|468284683|FG000|Overall Study|Adverse Event|16|||
130090295|NCT01513460|468284684|FG001|Overall Study|Adverse Event|18|||
130090296|NCT01513460|468284685|FG002|Overall Study|Adverse Event|23|||
129961805|NCT00316589|467824149|FG001|Overall Study|Subject unwilling/unable to comply|6|||
129961806|NCT00316589|467824150|FG002|Overall Study|Subject unwilling/unable to comply|0|||
130090297|NCT01513460|468284683|FG000|Overall Study|Abnormal test procedure|1|||
130090298|NCT01513460|468284684|FG001|Overall Study|Abnormal test procedure|0|||
130090299|NCT01513460|468284685|FG002|Overall Study|Abnormal test procedure|0|||
130090300|NCT00489216|468284689|FG000|Overall Study|Adverse Event|1|||
130090301|NCT01503229|468286780|FG000|Overall Study|Withdrew consent|1|||
130090302|NCT01078389|468286781|FG000|Overall Study|Adverse Event|10|||
129961807|NCT00316589|467824151|FG003|Overall Study|Subject unwilling/unable to comply|2|||
129961808|NCT00316589|467824148|FG000|Overall Study|Adverse Event|1|||
130090303|NCT01078389|468286782|FG001|Overall Study|Adverse Event|6|||
130090304|NCT01078389|468286781|FG000|Overall Study|Major Protocol Deviation|2|||
130090305|NCT01078389|468286782|FG001|Overall Study|Major Protocol Deviation|0|||
130090306|NCT01078389|468286781|FG000|Overall Study|Lost to Follow-up|23|||
130090307|NCT01078389|468286782|FG001|Overall Study|Lost to Follow-up|23|||
130090308|NCT01078389|468286781|FG000|Overall Study|Voluntary Withdrawal|20|||
130090309|NCT01078389|468286782|FG001|Overall Study|Voluntary Withdrawal|36|||
130090310|NCT01078389|468286781|FG000|Overall Study|Other|9|||
130090311|NCT01078389|468286782|FG001|Overall Study|Other|2|||
130090312|NCT01002573|468286783|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
130090313|NCT01002573|468286784|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
130090314|NCT02028182|468286785|FG000|Overall Study|Protocol Violation|2|||
130090315|NCT01684930|468286788|FG000|Overall Study|Withdrawal by Subject|3|||
130090316|NCT01684930|468286789|FG001|Overall Study|Withdrawal by Subject|1|||
130090317|NCT02198040|468286790|FG000|Overall Study|Work reasons|0|||
129961809|NCT00316589|467824149|FG001|Overall Study|Adverse Event|0|||
129961810|NCT00316589|467824150|FG002|Overall Study|Adverse Event|0|||
129961811|NCT00316589|467824151|FG003|Overall Study|Adverse Event|1|||
129961812|NCT00316589|467824148|FG000|Overall Study|Physician Decision|0|||
129961813|NCT00316589|467824149|FG001|Overall Study|Physician Decision|1|||
129961814|NCT00316589|467824150|FG002|Overall Study|Physician Decision|0|||
129961815|NCT00316589|467824151|FG003|Overall Study|Physician Decision|0|||
129961816|NCT00316589|467824148|FG000|Overall Study|Other reason|0|||
129961817|NCT00316589|467824149|FG001|Overall Study|Other reason|12|||
129961818|NCT00316589|467824150|FG002|Overall Study|Other reason|1|||
129961819|NCT00316589|467824151|FG003|Overall Study|Other reason|1|||
129961820|NCT01482819|467824152|FG000|Overall Study|Lost to Follow-up|2|||
129961821|NCT00562484|467824153|FG000|Overall Study|Adverse Event|6|||
129961822|NCT00562484|467824154|FG001|Overall Study|Adverse Event|1|||
129961823|NCT00562484|467824153|FG000|Overall Study|Protocol Violation|11|||
129961824|NCT00562484|467824154|FG001|Overall Study|Protocol Violation|2|||
129961825|NCT00562484|467824153|FG000|Overall Study|Withdrawal by Subject|12|||
129961826|NCT00562484|467824154|FG001|Overall Study|Withdrawal by Subject|9|||
129961827|NCT00562484|467824153|FG000|Overall Study|Moved away from the study area|20|||
129961828|NCT00562484|467824154|FG001|Overall Study|Moved away from the study area|9|||
129961829|NCT00562484|467824153|FG000|Overall Study|Lost to Follow-up|132|||
129961830|NCT00562484|467824154|FG001|Overall Study|Lost to Follow-up|71|||
129961831|NCT00562484|467824153|FG000|Overall Study|Reason not provided or not specified|25|||
129961832|NCT00562484|467824154|FG001|Overall Study|Reason not provided or not specified|12|||
129961833|NCT00702520|467824155|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
129961834|NCT00702520|467824156|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
129961835|NCT00702520|467824157|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
129961836|NCT00702520|467824158|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
129961837|NCT00702520|467824155|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
129961838|NCT00702520|467824156|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
129961839|NCT00702520|467824157|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
129961840|NCT00702520|467824158|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
129961841|NCT00702520|467824155|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
129961842|NCT00702520|467824156|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
129961843|NCT00702520|467824157|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
129961844|NCT00702520|467824158|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
129961845|NCT00276016|467824159|FG000|Intervention 1|Withdrawal by Subject|0|||
129961846|NCT00276016|467824160|FG001|Intervention 1|Withdrawal by Subject|1|||
129961847|NCT00276016|467824161|FG002|Intervention 1|Withdrawal by Subject|0|||
129961848|NCT00276016|467824162|FG003|Intervention 1|Withdrawal by Subject|0|||
129961849|NCT00276016|467824163|FG004|Intervention 1|Withdrawal by Subject|0|||
129961850|NCT00276016|467824164|FG005|Intervention 1|Withdrawal by Subject|0|||
129961851|NCT05041439|467824165|FG000|Overall Study|Withdrawal by Subject|1|||
129961852|NCT05041439|467824166|FG001|Overall Study|Withdrawal by Subject|1|||
129961853|NCT05041439|467824165|FG000|Overall Study|Death|1|||
129961854|NCT05041439|467824166|FG001|Overall Study|Death|0|||
129961855|NCT01904136|467825592|FG000|Overall Study|Physician Decision|0|||
129961856|NCT01904136|467825593|FG001|Overall Study|Physician Decision|0|||
129961857|NCT01904136|467825594|FG002|Overall Study|Physician Decision|0|||
129961858|NCT01904136|467825595|FG003|Overall Study|Physician Decision|0|||
129961859|NCT01904136|467825596|FG004|Overall Study|Physician Decision|0|||
129961860|NCT01904136|467825597|FG005|Overall Study|Physician Decision|1|||
129961861|NCT01904136|467825598|FG006|Overall Study|Physician Decision|0|||
130090318|NCT02198040|468286791|FG001|Overall Study|Work reasons|1|||
130090319|NCT02198040|468286792|FG002|Overall Study|Work reasons|0|||
129961862|NCT01904136|467825599|FG007|Overall Study|Physician Decision|0|||
129961863|NCT01904136|467825600|FG008|Overall Study|Physician Decision|0|||
129961864|NCT01222533|467825609|FG000|Overall Study|Adverse Event|5|||
129961865|NCT01222533|467825609|FG000|Overall Study|Withdrawal by Subject|5|||
129961866|NCT01222533|467825609|FG000|Overall Study|Other|4|||
129961867|NCT01947517|467825610|FG000|Overall Study|Withdrawal by Subject|1|||
129961868|NCT01947517|467825611|FG001|Overall Study|Withdrawal by Subject|1|||
130090320|NCT02198040|468286790|FG000|Overall Study|Withdrawal by Subject|0|||
130090321|NCT02198040|468286791|FG001|Overall Study|Withdrawal by Subject|0|||
130090322|NCT02198040|468286792|FG002|Overall Study|Withdrawal by Subject|1|||
130090323|NCT04524663|468286793|FG000|Overall Study|Withdrawal by Subject|0|||
130090324|NCT04524663|468286794|FG001|Overall Study|Withdrawal by Subject|2|||
130090325|NCT00337935|468286795|FG000|Overall Study|Adverse Event|2|||
130090326|NCT00337935|468286796|FG001|Overall Study|Adverse Event|5|||
130090327|NCT00337935|468286795|FG000|Overall Study|Death|2|||
130090328|NCT00337935|468286796|FG001|Overall Study|Death|8|||
130090329|NCT00337935|468286795|FG000|Overall Study|Physician Decision|1|||
130090330|NCT00337935|468286796|FG001|Overall Study|Physician Decision|1|||
130090331|NCT00337935|468286795|FG000|Overall Study|Lost to Follow-up|0|||
130090332|NCT00337935|468286796|FG001|Overall Study|Lost to Follow-up|1|||
130090333|NCT00337935|468286795|FG000|Overall Study|Protocol Violation|4|||
130090334|NCT00337935|468286796|FG001|Overall Study|Protocol Violation|3|||
130090335|NCT00337935|468286795|FG000|Overall Study|Withdrawal by Subject|1|||
130090336|NCT00337935|468286796|FG001|Overall Study|Withdrawal by Subject|7|||
130090337|NCT00337935|468286795|FG000|Overall Study|Other|0|||
130090338|NCT00337935|468286796|FG001|Overall Study|Other|1|||
130090339|NCT00337935|468286795|FG000|Overall Study|Lack of Efficacy|0|||
130090340|NCT00337935|468286796|FG001|Overall Study|Lack of Efficacy|1|||
130090341|NCT01884675|468286797|FG000|Overall Study|Study closed/terminated|3|||
130090342|NCT01884675|468286798|FG001|Overall Study|Study closed/terminated|2|||
130090343|NCT02361307|468286799|FG000|Overall Study|Unstable medical condition.|0|||
130090344|NCT02361307|468286800|FG001|Overall Study|Unstable medical condition.|1|||
130090345|NCT00711009|468286801|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
130090346|NCT00711009|468286802|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
130090347|NCT00711009|468286801|FG000|Overall Study|Withdrawal by Subject|4|||
130090348|NCT00711009|468286802|FG001|Overall Study|Withdrawal by Subject|2|||
130090349|NCT00711009|468286801|FG000|Overall Study|Lost to Follow-up|3|||
130090350|NCT00711009|468286802|FG001|Overall Study|Lost to Follow-up|9|||
130090351|NCT00711009|468286801|FG000|Overall Study|Participant Noncompliant|0|||
130090352|NCT00711009|468286802|FG001|Overall Study|Participant Noncompliant|1|||
130090353|NCT00711009|468286801|FG000|Overall Study|Virologic Failure|2|||
130090354|NCT00711009|468286802|FG001|Overall Study|Virologic Failure|1|||
130090355|NCT00711009|468286801|FG000|Overall Study|Pregnancy|1|||
130090356|NCT00711009|468286802|FG001|Overall Study|Pregnancy|0|||
130090357|NCT00711009|468286801|FG000|Overall Study|Site closing|0|||
130090358|NCT00711009|468286802|FG001|Overall Study|Site closing|1|||
130090359|NCT00711009|468286801|FG000|Overall Study|Dose adjustment|1|||
130090360|NCT00711009|468286802|FG001|Overall Study|Dose adjustment|0|||
130090361|NCT03359811|468286803|FG000|Overall Study|Protocol Violation|2|||
130090362|NCT03359811|468286804|FG001|Overall Study|Protocol Violation|0|||
130090363|NCT01682876|468286806|FG000|Overall Study|Administrative reason|4|||
130090364|NCT01682876|468286807|FG001|Overall Study|Administrative reason|4|||
130090365|NCT01682876|468286808|FG002|Overall Study|Administrative reason|0|||
130090366|NCT01682876|468286809|FG003|Overall Study|Administrative reason|3|||
130090367|NCT01682876|468286806|FG000|Overall Study|Adverse Event|0|||
130090368|NCT01682876|468286807|FG001|Overall Study|Adverse Event|0|||
130090369|NCT01682876|468286808|FG002|Overall Study|Adverse Event|0|||
130090370|NCT01682876|468286809|FG003|Overall Study|Adverse Event|1|||
130090371|NCT01682876|468286806|FG000|Overall Study|Lost to Follow-up|11|||
130090372|NCT01682876|468286807|FG001|Overall Study|Lost to Follow-up|15|||
130090373|NCT01682876|468286808|FG002|Overall Study|Lost to Follow-up|9|||
130090374|NCT01682876|468286809|FG003|Overall Study|Lost to Follow-up|11|||
130090375|NCT01682876|468286806|FG000|Overall Study|Protocol Violation|1|||
130090376|NCT01682876|468286807|FG001|Overall Study|Protocol Violation|1|||
130090377|NCT01682876|468286808|FG002|Overall Study|Protocol Violation|1|||
130090378|NCT01682876|468286809|FG003|Overall Study|Protocol Violation|1|||
130090379|NCT01682876|468286806|FG000|Overall Study|Withdrawal by Subject|4|||
130090380|NCT01682876|468286807|FG001|Overall Study|Withdrawal by Subject|0|||
130090381|NCT01682876|468286808|FG002|Overall Study|Withdrawal by Subject|0|||
130090382|NCT01682876|468286809|FG003|Overall Study|Withdrawal by Subject|2|||
130090383|NCT01682876|468286806|FG000|Overall Study|Other|1|||
130090384|NCT01682876|468286807|FG001|Overall Study|Other|0|||
130090385|NCT01682876|468286808|FG002|Overall Study|Other|1|||
130121789|NCT02518685|468406933|FG000|Overall Study|Adverse Event|29|||
130121790|NCT02518685|468406934|FG001|Overall Study|Adverse Event|1|||
130090386|NCT01682876|468286809|FG003|Overall Study|Other|1|||
130090387|NCT02534324|468286813|FG000|Overall Study|Protocol Violation|4|||
130090388|NCT02534324|468286814|FG001|Overall Study|Protocol Violation|1|||
130090389|NCT02534324|468286813|FG000|Overall Study|Lost to Follow-up|20|||
130090390|NCT02534324|468286814|FG001|Overall Study|Lost to Follow-up|7|||
130090391|NCT02534324|468286813|FG000|Overall Study|Adverse Event|1|||
130090392|NCT02534324|468286814|FG001|Overall Study|Adverse Event|0|||
130090393|NCT01459016|468286817|FG000|Overall Study|Withdrawal by Subject|11|||
130090394|NCT01459016|468286817|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
130090395|NCT00240331|468286818|FG000|Overall Study|Withdrawal by Subject|125|||
130090396|NCT00240331|468286819|FG001|Overall Study|Withdrawal by Subject|132|||
130090397|NCT00240331|468286818|FG000|Overall Study|Option selected by investigator|1|||
130121791|NCT02518685|468406933|FG000|Overall Study|Withdrawal by Subject|10|||
130121792|NCT02518685|468406934|FG001|Overall Study|Withdrawal by Subject|3|||
130121793|NCT02518685|468406933|FG000|Overall Study|relocation, study fatigue|7|||
130121794|NCT02518685|468406934|FG001|Overall Study|relocation, study fatigue|2|||
130121795|NCT02518685|468406933|FG000|Overall Study|Pregnancy|1|||
130121796|NCT02518685|468406934|FG001|Overall Study|Pregnancy|0|||
130121797|NCT02518685|468406933|FG000|Overall Study|Physician Decision|1|||
130121798|NCT02518685|468406934|FG001|Overall Study|Physician Decision|0|||
130121799|NCT02518685|468406933|FG000|Overall Study|Lost to Follow-up|1|||
130121800|NCT02518685|468406934|FG001|Overall Study|Lost to Follow-up|4|||
130121801|NCT00922779|468406935|FG000|Overall Study|Adverse Event|67|||
130121802|NCT00922779|468406935|FG000|Overall Study|Pregnancy|7|||
130121803|NCT00922779|468406935|FG000|Overall Study|Withdrawal by Subject|308|||
130121804|NCT00922779|468406935|FG000|Overall Study|Lost to Follow-up|44|||
130121805|NCT00922779|468406935|FG000|Overall Study|Other|27|||
130121806|NCT00922779|468406935|FG000|Overall Study|Missing|1874|||
130121807|NCT01298570|468408682|FG000|Overall Study|Disease progression, relapse during acti|64|||
130121808|NCT01298570|468408683|FG001|Overall Study|Disease progression, relapse during acti|40|||
130121809|NCT01298570|468408682|FG000|Overall Study|Adverse Event|20|||
130121810|NCT01298570|468408683|FG001|Overall Study|Adverse Event|2|||
130121811|NCT01298570|468408682|FG000|Overall Study|Withdrawal by Subject|21|||
130121812|NCT01298570|468408683|FG001|Overall Study|Withdrawal by Subject|6|||
130121813|NCT01298570|468408682|FG000|Overall Study|Treatment delay > 4 weeks|4|||
130121814|NCT01298570|468408683|FG001|Overall Study|Treatment delay > 4 weeks|5|||
130121815|NCT01298570|468408682|FG000|Overall Study|Physician Decision|4|||
130121816|NCT01298570|468408683|FG001|Overall Study|Physician Decision|2|||
130121817|NCT01298570|468408682|FG000|Overall Study|Other complicating disease|2|||
130121818|NCT01298570|468408683|FG001|Overall Study|Other complicating disease|1|||
130121819|NCT01298570|468408682|FG000|Overall Study|Surgery|2|||
130121820|NCT01298570|468408683|FG001|Overall Study|Surgery|1|||
130121821|NCT01298570|468408682|FG000|Overall Study|Symptomatic progression/deterioration|3|||
130121822|NCT01298570|468408683|FG001|Overall Study|Symptomatic progression/deterioration|2|||
130121823|NCT01298570|468408682|FG000|Overall Study|Death|0|||
130121824|NCT01298570|468408683|FG001|Overall Study|Death|1|||
130121825|NCT01298570|468408682|FG000|Overall Study|Ineligibility|0|||
130121826|NCT01298570|468408683|FG001|Overall Study|Ineligibility|1|||
130121827|NCT01210001|468408684|FG000|Overall Study|Not treated|1|||
130121828|NCT01210001|468408685|FG001|Overall Study|Not treated|0|||
129961869|NCT00460564|467825615|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
129961870|NCT00460564|467825616|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
129961871|NCT00460564|467825617|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961872|NCT00460564|467825618|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961873|NCT00460564|467825619|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961874|NCT00460564|467825620|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961875|NCT00460564|467825621|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961876|NCT00460564|467825622|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961877|NCT00460564|467825615|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
129961878|NCT00460564|467825616|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961879|NCT00460564|467825617|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961880|NCT00460564|467825618|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961881|NCT00460564|467825619|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961882|NCT00460564|467825620|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961883|NCT00460564|467825621|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961884|NCT00460564|467825622|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961885|NCT00460564|467825615|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961886|NCT00460564|467825616|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961887|NCT00460564|467825617|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961888|NCT00460564|467825618|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961889|NCT00460564|467825619|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
129961890|NCT00460564|467825620|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
129961891|NCT00460564|467825621|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
129961892|NCT00460564|467825622|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961893|NCT00460564|467825615|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961894|NCT00460564|467825616|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961895|NCT00460564|467825617|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961896|NCT00460564|467825618|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961897|NCT00460564|467825619|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
129961898|NCT00460564|467825620|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
129961899|NCT00460564|467825621|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130121829|NCT01210001|468408686|FG002|Overall Study|Not treated|0|||
130121830|NCT01210001|468408684|FG000|Overall Study|Adverse Event|4|||
130121831|NCT01210001|468408685|FG001|Overall Study|Adverse Event|2|||
130121832|NCT01210001|468408686|FG002|Overall Study|Adverse Event|5|||
130121833|NCT01210001|468408684|FG000|Overall Study|Non compliant with protocol|2|||
130121834|NCT01210001|468408685|FG001|Overall Study|Non compliant with protocol|2|||
130121835|NCT01210001|468408686|FG002|Overall Study|Non compliant with protocol|3|||
130090398|NCT00240331|468286819|FG001|Overall Study|Option selected by investigator|2|||
130090399|NCT02491463|468286826|FG000|Overall Study|Withdrawal by Subject|1|||
130090400|NCT02491463|468286827|FG001|Overall Study|Withdrawal by Subject|2|||
130090401|NCT02491463|468286828|FG002|Overall Study|Withdrawal by Subject|0|||
130090402|NCT02491463|468286829|FG003|Overall Study|Withdrawal by Subject|0|||
130090403|NCT02491463|468286826|FG000|Overall Study|Migrated/moved from study area|1|||
130090404|NCT02491463|468286827|FG001|Overall Study|Migrated/moved from study area|5|||
130090405|NCT02491463|468286828|FG002|Overall Study|Migrated/moved from study area|1|||
130090406|NCT02491463|468286829|FG003|Overall Study|Migrated/moved from study area|1|||
130090407|NCT02491463|468286826|FG000|Overall Study|Lost to Follow-up|0|||
130090408|NCT02491463|468286827|FG001|Overall Study|Lost to Follow-up|3|||
130090409|NCT02491463|468286828|FG002|Overall Study|Lost to Follow-up|3|||
130090410|NCT02491463|468286829|FG003|Overall Study|Lost to Follow-up|0|||
130090411|NCT01491802|468286830|FG000|Overall Study|Adverse Event|1|||
130090412|NCT01491802|468286831|FG001|Overall Study|Adverse Event|1|||
130090413|NCT01491802|468286830|FG000|Overall Study|Withdrawal by Subject|0|||
130090414|NCT01491802|468286831|FG001|Overall Study|Withdrawal by Subject|1|||
130090415|NCT01041027|468286835|FG000|Overall Study|Withdrawal by Subject|2|||
130090416|NCT01041027|468286835|FG000|Overall Study|Protocol Violation|1|||
130090417|NCT01041027|468286835|FG000|Overall Study|Delayed Radiation Therapy|1|||
130090418|NCT01041027|468286835|FG000|Overall Study|Adverse Event|4|||
130090419|NCT01249404|468286836|FG000|Overall Study|Study treatment not received|0|||
130090420|NCT01249404|468286837|FG001|Overall Study|Study treatment not received|1|||
130090421|NCT01249404|468286838|FG002|Overall Study|Study treatment not received|2|||
130090422|NCT01249404|468286836|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
130090423|NCT01249404|468286837|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
130090424|NCT01249404|468286838|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
130090425|NCT01249404|468286836|FG000|Overall Study|Adverse Event|2|||
130090426|NCT01249404|468286837|FG001|Overall Study|Adverse Event|2|||
130090427|NCT01249404|468286838|FG002|Overall Study|Adverse Event|2|||
130090428|NCT01249404|468286836|FG000|Overall Study|Withdrawal by Subject|2|||
130090429|NCT01249404|468286837|FG001|Overall Study|Withdrawal by Subject|2|||
130090430|NCT01249404|468286838|FG002|Overall Study|Withdrawal by Subject|0|||
130090431|NCT01249404|468286836|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
130090432|NCT01249404|468286837|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
130090433|NCT01249404|468286838|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
130090434|NCT01249404|468286836|FG000|Overall Study|Non compliance to visit schedule|0|||
130090435|NCT01249404|468286837|FG001|Overall Study|Non compliance to visit schedule|1|||
130090436|NCT01249404|468286838|FG002|Overall Study|Non compliance to visit schedule|0|||
130090437|NCT04563845|468286839|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090438|NCT04563845|468286840|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090439|NCT04563845|468286841|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090440|NCT04563845|468286842|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090441|NCT04563845|468286843|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090442|NCT04563845|468286844|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090443|NCT04563845|468286845|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090444|NCT04563845|468286846|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
130090445|NCT04563845|468286847|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090446|NCT04563845|468286848|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090447|NCT04563845|468286849|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090448|NCT04563845|468286850|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090449|NCT04563845|468286851|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090450|NCT04563845|468286852|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
130090451|NCT04563845|468286839|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090452|NCT04563845|468286840|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090453|NCT04563845|468286841|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090454|NCT04563845|468286842|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090455|NCT04563845|468286843|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
130090456|NCT04563845|468286844|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090457|NCT04563845|468286845|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090458|NCT04563845|468286846|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090459|NCT04563845|468286847|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090460|NCT04563845|468286848|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090461|NCT04563845|468286849|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090462|NCT04563845|468286850|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129961900|NCT00460564|467825622|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
130090463|NCT04563845|468286851|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090464|NCT04563845|468286852|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
130090465|NCT01020812|468286853|FG000|Overall Study|Physician Decision|1|||
130090466|NCT01020812|468286853|FG000|Overall Study|Withdrawal by Subject|1|||
130090467|NCT01020812|468286853|FG000|Overall Study|Protocol Violation|1|||
130090468|NCT02528643|468286854|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
130090469|NCT02528643|468286855|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
130090470|NCT02528643|468286854|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
130090471|NCT02528643|468286855|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
130090472|NCT02528643|468286854|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
130090473|NCT02528643|468286855|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
130090474|NCT02528643|468286854|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
130090475|NCT02528643|468286855|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
130090476|NCT02528643|468286854|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
130090477|NCT02528643|468286855|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
130090478|NCT02528643|468286854|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
130090479|NCT02528643|468286855|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
130090480|NCT02528643|468286854|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
130090481|NCT02528643|468286855|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
130090482|NCT02927990|468286856|FG000|Overall Study|Protocol Violation|4|||
130090483|NCT02927990|468286856|FG000|Overall Study|Physician Decision|9|||
130090484|NCT02927990|468286856|FG000|Overall Study|Room switched and therefore no study device available|15|||
130090485|NCT02927990|468286856|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
130090486|NCT00960323|468286857|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
130090487|NCT02146274|468286858|FG000|Overall Study|Protocol Violation|73|||
130090488|NCT03824704|468286864|FG000|Overall Study|Study Terminated by Sponsor|1|||
130090489|NCT01191190|468286868|FG000|Overall Study|Withdrawal by Subject|1|||
130090490|NCT01667731|468286870|FG000|Overall Study|Enrolled but not treated|0|||
130090491|NCT01667731|468286871|FG001|Overall Study|Enrolled but not treated|0|||
130090492|NCT01667731|468286872|FG002|Overall Study|Enrolled but not treated|0|||
130090493|NCT01667731|468286873|FG003|Overall Study|Enrolled but not treated|0|||
130090494|NCT01667731|468286874|FG004|Overall Study|Enrolled but not treated|1|||
130090495|NCT01667731|468286870|FG000|Overall Study|Efficacy Failure|1|||
130090496|NCT01667731|468286871|FG001|Overall Study|Efficacy Failure|12|||
130090497|NCT01667731|468286872|FG002|Overall Study|Efficacy Failure|0|||
130090498|NCT01667731|468286873|FG003|Overall Study|Efficacy Failure|1|||
130090499|NCT01667731|468286874|FG004|Overall Study|Efficacy Failure|24|||
130090500|NCT01667731|468286870|FG000|Overall Study|Lost to Follow-up|2|||
130090501|NCT01667731|468286871|FG001|Overall Study|Lost to Follow-up|3|||
130090502|NCT01667731|468286872|FG002|Overall Study|Lost to Follow-up|1|||
130090503|NCT01667731|468286873|FG003|Overall Study|Lost to Follow-up|1|||
130090504|NCT01667731|468286874|FG004|Overall Study|Lost to Follow-up|2|||
130090505|NCT01667731|468286870|FG000|Overall Study|Subject Withdrew Consent|2|||
130090506|NCT01667731|468286871|FG001|Overall Study|Subject Withdrew Consent|0|||
130090507|NCT01667731|468286872|FG002|Overall Study|Subject Withdrew Consent|1|||
130090508|NCT01667731|468286873|FG003|Overall Study|Subject Withdrew Consent|0|||
130090509|NCT01667731|468286874|FG004|Overall Study|Subject Withdrew Consent|1|||
130090510|NCT01667731|468286870|FG000|Overall Study|Death|0|||
130090511|NCT01667731|468286871|FG001|Overall Study|Death|1|||
130090512|NCT01667731|468286872|FG002|Overall Study|Death|0|||
130090513|NCT01667731|468286873|FG003|Overall Study|Death|0|||
130090514|NCT01667731|468286874|FG004|Overall Study|Death|0|||
130090515|NCT01425268|468286875|FG000|Overall Study|Withdrawal by Subject|2|||
130090516|NCT01425268|468286876|FG001|Overall Study|Withdrawal by Subject|0|||
130090517|NCT01425268|468286875|FG000|Overall Study|Sponsor Decision|5|||
130090518|NCT01425268|468286876|FG001|Overall Study|Sponsor Decision|0|||
130090519|NCT01425268|468286875|FG000|Overall Study|Physician Decision|1|||
130090520|NCT01425268|468286876|FG001|Overall Study|Physician Decision|0|||
130090521|NCT02839330|468286877|FG000|Overall Study|Adverse Event|0|||
130090522|NCT02839330|468286878|FG001|Overall Study|Adverse Event|1|||
130090523|NCT02839330|468286879|FG002|Overall Study|Adverse Event|2|||
130090524|NCT02839330|468286880|FG003|Overall Study|Adverse Event|2|||
130090525|NCT02839330|468286877|FG000|Overall Study|Death|4|||
130090526|NCT02839330|468286878|FG001|Overall Study|Death|6|||
130090527|NCT02839330|468286879|FG002|Overall Study|Death|1|||
130090528|NCT02839330|468286880|FG003|Overall Study|Death|1|||
130090529|NCT02839330|468286877|FG000|Overall Study|Withdrawal by Subject|27|||
130090530|NCT02839330|468286878|FG001|Overall Study|Withdrawal by Subject|19|||
130090531|NCT02839330|468286879|FG002|Overall Study|Withdrawal by Subject|11|||
130090532|NCT02839330|468286880|FG003|Overall Study|Withdrawal by Subject|13|||
129961901|NCT00460564|467825615|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130090533|NCT02839330|468286877|FG000|Overall Study|Lost to Follow-up|22|||
130090534|NCT02839330|468286878|FG001|Overall Study|Lost to Follow-up|27|||
130090535|NCT02839330|468286879|FG002|Overall Study|Lost to Follow-up|29|||
130090536|NCT02839330|468286880|FG003|Overall Study|Lost to Follow-up|25|||
130090537|NCT02839330|468286877|FG000|Overall Study|Administrative Reason|0|||
130090538|NCT02839330|468286878|FG001|Overall Study|Administrative Reason|0|||
130090539|NCT02839330|468286879|FG002|Overall Study|Administrative Reason|0|||
130121836|NCT01210001|468408684|FG000|Overall Study|Lost to Follow-up|4|||
130121837|NCT01210001|468408685|FG001|Overall Study|Lost to Follow-up|3|||
130121838|NCT01210001|468408686|FG002|Overall Study|Lost to Follow-up|2|||
130121839|NCT01210001|468408684|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
130121840|NCT01210001|468408685|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
130121841|NCT01210001|468408686|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
130121842|NCT01210001|468408684|FG000|Overall Study|Other reason not defined above|2|||
130121843|NCT01210001|468408685|FG001|Overall Study|Other reason not defined above|2|||
130121844|NCT01210001|468408686|FG002|Overall Study|Other reason not defined above|1|||
130121845|NCT01739790|468408687|FG000|Overall Study|Early Trial Termination|2|||
130121846|NCT01739790|468408688|FG001|Overall Study|Early Trial Termination|4|||
130121847|NCT01451762|468408692|FG000|Overall Study|Lost to Follow-up|3|||
130121848|NCT01451762|468408693|FG001|Overall Study|Lost to Follow-up|6|||
130121849|NCT01451762|468408694|FG002|Overall Study|Lost to Follow-up|6|||
130121850|NCT04471207|468408695|FG000|Overall Study|Lost to Follow-up|4|||
130121851|NCT04471207|468408696|FG001|Overall Study|Lost to Follow-up|1|||
130121852|NCT04471207|468408695|FG000|Overall Study|Medication Contraindication|0|||
130121853|NCT04471207|468408696|FG001|Overall Study|Medication Contraindication|1|||
130121854|NCT04471207|468408695|FG000|Overall Study|Loss of Interest|2|||
130121855|NCT04471207|468408696|FG001|Overall Study|Loss of Interest|1|||
130121856|NCT04471207|468408695|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
130121857|NCT04471207|468408696|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
130121858|NCT04471207|468408695|FG000|Overall Study|Scheduling Conflicts|3|||
130121859|NCT04471207|468408696|FG001|Overall Study|Scheduling Conflicts|1|||
130121860|NCT04471207|468408695|FG000|Overall Study|Physician Decision|1|||
130121861|NCT04471207|468408696|FG001|Overall Study|Physician Decision|0|||
130121862|NCT04471207|468408695|FG000|Overall Study|Unwilling to Use System|0|||
130121863|NCT04471207|468408696|FG001|Overall Study|Unwilling to Use System|1|||
130121864|NCT00561730|468408697|FG000|Overall Study|Adverse Event|2|||
130121865|NCT00561730|468408697|FG000|Overall Study|Handling of the drug|1|||
130121866|NCT00561730|468408697|FG000|Overall Study|Lost to Follow-up|5|||
130121867|NCT00561730|468408697|FG000|Overall Study|Not specified reasons|1|||
130121868|NCT00376220|468408698|FG000|Overall Study|Lost to Follow-up|7|||
130121869|NCT00376220|468408699|FG001|Overall Study|Lost to Follow-up|10|||
130121870|NCT00376220|468408698|FG000|Overall Study|Withdrawal by Subject|3|||
130121871|NCT00376220|468408699|FG001|Overall Study|Withdrawal by Subject|2|||
130121872|NCT00531206|468408704|FG000|Overall Study|Adverse Event related|5|||
130121873|NCT00531206|468408704|FG000|Overall Study|Lack of Efficacy|2|||
130121874|NCT00531206|468408704|FG000|Overall Study|Lost to Follow-up|5|||
130121875|NCT00531206|468408704|FG000|Overall Study|including non-related adverse events|8|||
130121876|NCT00322491|468408714|FG000|Overall Study|Adverse Event|1|||
130121877|NCT00322491|468408715|FG001|Overall Study|Adverse Event|0|||
130121878|NCT00322491|468408714|FG000|Overall Study|Death|1|||
130121879|NCT00322491|468408715|FG001|Overall Study|Death|2|||
130121880|NCT00688064|468408717|FG000|Overall Study|Protocol Violation|0|||
130121881|NCT00688064|468408718|FG001|Overall Study|Protocol Violation|1|||
130121882|NCT00688064|468408717|FG000|Overall Study|Adverse Event|2|||
130121883|NCT00688064|468408718|FG001|Overall Study|Adverse Event|4|||
130121884|NCT00688064|468408717|FG000|Overall Study|Withdrawal by Subject|7|||
130121885|NCT00688064|468408718|FG001|Overall Study|Withdrawal by Subject|7|||
130121886|NCT00688064|468408717|FG000|Overall Study|Lost to Follow-up|10|||
130121887|NCT00688064|468408718|FG001|Overall Study|Lost to Follow-up|10|||
130121888|NCT00688064|468408717|FG000|Overall Study|Lack of Efficacy|0|||
130121889|NCT00688064|468408718|FG001|Overall Study|Lack of Efficacy|1|||
130121890|NCT00688064|468408717|FG000|Overall Study|Pregnancy|1|||
130121891|NCT00688064|468408718|FG001|Overall Study|Pregnancy|0|||
130121892|NCT00688064|468408717|FG000|Overall Study|Any other reasons|1|||
130121893|NCT00688064|468408718|FG001|Overall Study|Any other reasons|3|||
130121894|NCT00720096|468408719|FG000|Overall Study|Withdrawal by Subject|0|||
130121895|NCT00720096|468408720|FG001|Overall Study|Withdrawal by Subject|2|||
130121896|NCT00442936|468408721|FG000|Overall Study|Protocol Violation|1|||
130121897|NCT00442936|468408722|FG001|Overall Study|Protocol Violation|0|||
130121898|NCT00442936|468408723|FG002|Overall Study|Protocol Violation|1|||
129961902|NCT00460564|467825616|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
130121899|NCT00442936|468408724|FG003|Overall Study|Protocol Violation|1|||
130121900|NCT00524459|468408725|FG000|Overall Study|Withdrawal by Subject|1|||
130121901|NCT00524459|468408725|FG000|Overall Study|Other|1|||
130121902|NCT00818883|468408726|FG000|Overall Study|Adverse Event|28|||
130121903|NCT00818883|468408727|FG001|Overall Study|Adverse Event|19|||
130121904|NCT00818883|468408726|FG000|Overall Study|Protocol Violation|2|||
130121905|NCT00818883|468408727|FG001|Overall Study|Protocol Violation|2|||
130121906|NCT00818883|468408726|FG000|Overall Study|Lost to Follow-up|3|||
130121907|NCT00818883|468408727|FG001|Overall Study|Lost to Follow-up|2|||
130121908|NCT00818883|468408726|FG000|Overall Study|Withdrawal by Subject|16|||
130121909|NCT00818883|468408727|FG001|Overall Study|Withdrawal by Subject|14|||
130121910|NCT00818883|468408726|FG000|Overall Study|Lack of Efficacy|0|||
130121911|NCT00818883|468408727|FG001|Overall Study|Lack of Efficacy|2|||
130121912|NCT00818883|468408726|FG000|Overall Study|Other|2|||
130090540|NCT02839330|468286880|FG003|Overall Study|Administrative Reason|1|||
130090541|NCT02839330|468286877|FG000|Overall Study|Protocol Violation|1|||
130090542|NCT02839330|468286878|FG001|Overall Study|Protocol Violation|2|||
130090543|NCT02839330|468286879|FG002|Overall Study|Protocol Violation|2|||
130090544|NCT02839330|468286880|FG003|Overall Study|Protocol Violation|3|||
130090545|NCT02839330|468286877|FG000|Overall Study|Other reason, not specified|4|||
130090546|NCT02839330|468286878|FG001|Overall Study|Other reason, not specified|3|||
130090547|NCT02839330|468286879|FG002|Overall Study|Other reason, not specified|3|||
130090548|NCT02839330|468286880|FG003|Overall Study|Other reason, not specified|6|||
130090549|NCT01871870|468286884|FG000|Overall Study|Hardware issues|7|||
130090550|NCT01871870|468286884|FG000|Overall Study|hyperglycemia|2|||
130090551|NCT00883896|468286885|FG000|Overall Study|Lost to Follow-up|0|||
130090552|NCT00883896|468286886|FG001|Overall Study|Lost to Follow-up|0|||
130090553|NCT00883896|468286887|FG002|Overall Study|Lost to Follow-up|0|||
130090554|NCT00883896|468286888|FG003|Overall Study|Lost to Follow-up|2|||
130090555|NCT00883896|468286885|FG000|Overall Study|Withdrawal by Subject|5|||
130090556|NCT00883896|468286886|FG001|Overall Study|Withdrawal by Subject|0|||
130090557|NCT00883896|468286887|FG002|Overall Study|Withdrawal by Subject|1|||
130090558|NCT00883896|468286888|FG003|Overall Study|Withdrawal by Subject|3|||
130090559|NCT00883896|468286885|FG000|Overall Study|Lack of Efficacy|0|||
130090560|NCT00883896|468286886|FG001|Overall Study|Lack of Efficacy|0|||
130090561|NCT00883896|468286887|FG002|Overall Study|Lack of Efficacy|0|||
130090562|NCT00883896|468286888|FG003|Overall Study|Lack of Efficacy|2|||
130090563|NCT00883896|468286885|FG000|Overall Study|Other|1|||
130090564|NCT00883896|468286886|FG001|Overall Study|Other|0|||
130090565|NCT00883896|468286887|FG002|Overall Study|Other|0|||
130090566|NCT00883896|468286888|FG003|Overall Study|Other|0|||
130090567|NCT01856920|468286898|FG000|Overall Study|Disease Progression On Study|3|||
130090568|NCT01856920|468286899|FG001|Overall Study|Disease Progression On Study|4|||
130090569|NCT01856920|468286898|FG000|Overall Study|Disease Progression before Treatment|1|||
130090570|NCT01856920|468286899|FG001|Overall Study|Disease Progression before Treatment|0|||
130090571|NCT01856920|468286898|FG000|Overall Study|Ineligible|0|||
130090572|NCT01856920|468286899|FG001|Overall Study|Ineligible|1|||
130090573|NCT01856920|468286898|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
130090574|NCT01856920|468286899|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
130090575|NCT01856920|468286898|FG000|Overall Study|Refused further Treatment|5|||
130090576|NCT01856920|468286899|FG001|Overall Study|Refused further Treatment|1|||
130090577|NCT01856920|468286898|FG000|Overall Study|Other Reasons|0|||
130090578|NCT01856920|468286899|FG001|Overall Study|Other Reasons|1|||
130090579|NCT01856920|468286898|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
130090580|NCT01856920|468286899|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
130090581|NCT02545270|468286900|FG000|Overall Study|technical difficulties|0|||
130090582|NCT02545270|468286901|FG001|Overall Study|technical difficulties|1|||
130090583|NCT02545270|468286902|FG002|Overall Study|technical difficulties|0|||
130090584|NCT02545270|468286900|FG000|Overall Study|Videos being too similar to other|0|||
130090585|NCT02545270|468286901|FG001|Overall Study|Videos being too similar to other|0|||
130090586|NCT02545270|468286902|FG002|Overall Study|Videos being too similar to other|2|||
130090587|NCT01716585|468286909|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
130090588|NCT01716585|468286910|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
130090589|NCT01716585|468286909|FG000|Double-blind Treatment|Adverse Event|2|||
130090590|NCT01716585|468286910|FG001|Double-blind Treatment|Adverse Event|1|||
130090591|NCT01716585|468286909|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
130090592|NCT01716585|468286910|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
130090593|NCT01716585|468286909|FG000|Double-blind Treatment|Lost to Follow-up|2|||
130121913|NCT00818883|468408727|FG001|Overall Study|Other|7|||
130121914|NCT03992196|468408728|FG000|Enrollment|lost to follow-up prior dosing|1|||
130121915|NCT03992196|468408729|FG001|Enrollment|lost to follow-up prior dosing|0|||
130121916|NCT03992196|468408730|FG002|Enrollment|lost to follow-up prior dosing|0|||
130090594|NCT01716585|468286910|FG001|Double-blind Treatment|Lost to Follow-up|0|||
130090595|NCT01716585|468286909|FG000|Double-blind Treatment|Subject Noncompliant|1|||
130090596|NCT01716585|468286910|FG001|Double-blind Treatment|Subject Noncompliant|0|||
130090597|NCT01716585|468286909|FG000|Double-blind Treatment|Other|1|||
130090598|NCT01716585|468286910|FG001|Double-blind Treatment|Other|0|||
130090599|NCT01716585|468286909|FG000|Open-label Treatment|Adverse Event|0|||
130090600|NCT01716585|468286910|FG001|Open-label Treatment|Adverse Event|2|||
130090601|NCT01716585|468286909|FG000|Open-label Treatment|Virologic Failure|0|||
130090602|NCT01716585|468286910|FG001|Open-label Treatment|Virologic Failure|2|||
130121917|NCT03992196|468408728|FG000|Treatment|Protocol Violation|0|||
130090603|NCT01716585|468286909|FG000|Open-label Treatment|Withdrawal by Subject|0|||
130090604|NCT01716585|468286910|FG001|Open-label Treatment|Withdrawal by Subject|3|||
130090605|NCT00174460|468286915|FG000|Overall Study|Withdrawal by Subject|0|||
130090606|NCT00174460|468286916|FG001|Overall Study|Withdrawal by Subject|1|||
130090607|NCT00579059|468286917|FG000|Overall Study|Study Canceled at 1 Year|21|||
130090608|NCT00579059|468286918|FG001|Overall Study|Study Canceled at 1 Year|10|||
130090609|NCT00779506|468286920|FG000|Overall Study|Screening Failed|2|||
129961903|NCT00460564|467825617|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961904|NCT00460564|467825618|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961905|NCT00460564|467825619|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
129961906|NCT00460564|467825620|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961907|NCT00460564|467825621|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961908|NCT00460564|467825622|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961909|NCT00320398|467825627|FG000|Overall Study|Adverse Event|1|||
129961910|NCT00320398|467825628|FG001|Overall Study|Adverse Event|4|||
129961911|NCT00320398|467825627|FG000|Overall Study|Other|1|||
129961912|NCT00320398|467825628|FG001|Overall Study|Other|0|||
129961913|NCT00630552|467825629|FG000|Overall Study|Adverse Event|0|||
129961914|NCT00630552|467825630|FG001|Overall Study|Adverse Event|1|||
129961915|NCT00630552|467825631|FG002|Overall Study|Adverse Event|5|||
129961916|NCT00630552|467825632|FG003|Overall Study|Adverse Event|4|||
129961917|NCT00630552|467825633|FG004|Overall Study|Adverse Event|2|||
129961918|NCT00630552|467825629|FG000|Overall Study|Disease progression|5|||
129961919|NCT00630552|467825630|FG001|Overall Study|Disease progression|6|||
129961920|NCT00630552|467825631|FG002|Overall Study|Disease progression|27|||
129961921|NCT00630552|467825632|FG003|Overall Study|Disease progression|22|||
129961922|NCT00630552|467825633|FG004|Overall Study|Disease progression|31|||
129961923|NCT00630552|467825629|FG000|Overall Study|Never received IP|0|||
129961924|NCT00630552|467825630|FG001|Overall Study|Never received IP|0|||
129961925|NCT00630552|467825631|FG002|Overall Study|Never received IP|0|||
129961926|NCT00630552|467825632|FG003|Overall Study|Never received IP|2|||
129961927|NCT00630552|467825633|FG004|Overall Study|Never received IP|2|||
129961928|NCT00630552|467825629|FG000|Overall Study|Ineligibility determined|0|||
129961929|NCT00630552|467825630|FG001|Overall Study|Ineligibility determined|0|||
129961930|NCT00630552|467825631|FG002|Overall Study|Ineligibility determined|0|||
129961931|NCT00630552|467825632|FG003|Overall Study|Ineligibility determined|0|||
129961932|NCT00630552|467825633|FG004|Overall Study|Ineligibility determined|1|||
129961933|NCT00630552|467825629|FG000|Overall Study|Protocol Violation|0|||
129961934|NCT00630552|467825630|FG001|Overall Study|Protocol Violation|0|||
129961935|NCT00630552|467825631|FG002|Overall Study|Protocol Violation|0|||
129961936|NCT00630552|467825632|FG003|Overall Study|Protocol Violation|1|||
129961937|NCT00630552|467825633|FG004|Overall Study|Protocol Violation|0|||
129961938|NCT00630552|467825629|FG000|Overall Study|Physician Decision|0|||
129961939|NCT00630552|467825630|FG001|Overall Study|Physician Decision|0|||
129961940|NCT00630552|467825631|FG002|Overall Study|Physician Decision|0|||
129961941|NCT00630552|467825632|FG003|Overall Study|Physician Decision|0|||
129961942|NCT00630552|467825633|FG004|Overall Study|Physician Decision|1|||
129961943|NCT00630552|467825629|FG000|Overall Study|Death|0|||
129961944|NCT00630552|467825630|FG001|Overall Study|Death|0|||
129961945|NCT00630552|467825631|FG002|Overall Study|Death|1|||
129961946|NCT00630552|467825632|FG003|Overall Study|Death|2|||
129961947|NCT00630552|467825633|FG004|Overall Study|Death|2|||
129961948|NCT00630552|467825629|FG000|Overall Study|Withdrawal by Subject|0|||
129961949|NCT00630552|467825630|FG001|Overall Study|Withdrawal by Subject|0|||
129961950|NCT00630552|467825631|FG002|Overall Study|Withdrawal by Subject|0|||
129961951|NCT00630552|467825632|FG003|Overall Study|Withdrawal by Subject|1|||
129961952|NCT00630552|467825633|FG004|Overall Study|Withdrawal by Subject|0|||
129961953|NCT00630552|467825629|FG000|Overall Study|Other|0|||
129961954|NCT00630552|467825630|FG001|Overall Study|Other|0|||
129961955|NCT00630552|467825631|FG002|Overall Study|Other|4|||
129961956|NCT00630552|467825632|FG003|Overall Study|Other|2|||
129961957|NCT00630552|467825633|FG004|Overall Study|Other|0|||
129961958|NCT04349644|467825634|FG000|Allocation/Pretest|Lost to pretest|0|||
129961959|NCT04349644|467825635|FG001|Allocation/Pretest|Lost to pretest|3|||
129961960|NCT04349644|467825634|FG000|Posttest|Lost to posttest|0|||
129961961|NCT04349644|467825635|FG001|Posttest|Lost to posttest|8|||
129961962|NCT04349644|467825634|FG000|Posttest|Discontinued intervention|6|||
129961963|NCT04349644|467825635|FG001|Posttest|Discontinued intervention|0|||
129961964|NCT04349644|467825634|FG000|Follow-up|Lost to Follow-up|0|||
129961965|NCT04349644|467825635|FG001|Follow-up|Lost to Follow-up|2|||
129961966|NCT00983905|467825637|FG000|Theophylline Alone|Adverse Event|1|||
129961967|NCT00983905|467825637|FG000|Colchicine Alone|Adverse Event|2|||
129961968|NCT01169636|467825638|FG000|Overall Study|Adverse Event|0|||
129961969|NCT01169636|467825639|FG001|Overall Study|Adverse Event|0|||
129961970|NCT01169636|467825640|FG002|Overall Study|Adverse Event|1|||
129961971|NCT01169636|467825641|FG003|Overall Study|Adverse Event|1|||
129961972|NCT01169636|467825642|FG004|Overall Study|Adverse Event|0|||
129961973|NCT01169636|467825638|FG000|Overall Study|Screen failure|0|||
129961974|NCT01169636|467825639|FG001|Overall Study|Screen failure|0|||
129961975|NCT01169636|467825640|FG002|Overall Study|Screen failure|2|||
129961976|NCT01169636|467825641|FG003|Overall Study|Screen failure|0|||
129961977|NCT01169636|467825642|FG004|Overall Study|Screen failure|0|||
129961978|NCT01169636|467825638|FG000|Overall Study|Withdrawal by Subject|0|||
129961979|NCT01169636|467825639|FG001|Overall Study|Withdrawal by Subject|0|||
129961980|NCT01169636|467825640|FG002|Overall Study|Withdrawal by Subject|0|||
130121918|NCT03992196|468408729|FG001|Treatment|Protocol Violation|0|||
130090610|NCT00779506|468286920|FG000|Overall Study|Adverse Event|4|||
130090611|NCT00779506|468286920|FG000|Overall Study|Lack of Efficacy|11|||
130090612|NCT00779506|468286920|FG000|Overall Study|Protocol Violation|5|||
130090613|NCT00779506|468286920|FG000|Overall Study|Withdrawal by Subject|6|||
130090614|NCT00779506|468286920|FG000|Overall Study|Lost to Follow-up|1|||
130090615|NCT04047472|468286921|FG000|Overall Study|Adverse Event|3|||
130090616|NCT04047472|468286922|FG001|Overall Study|Adverse Event|3|||
130090617|NCT04047472|468286921|FG000|Overall Study|Death|0|||
130090618|NCT04047472|468286922|FG001|Overall Study|Death|1|||
130090619|NCT04047472|468286921|FG000|Overall Study|Lost to Follow-up|1|||
130090620|NCT04047472|468286922|FG001|Overall Study|Lost to Follow-up|0|||
130090621|NCT04047472|468286921|FG000|Overall Study|Physician Decision|1|||
130090622|NCT04047472|468286922|FG001|Overall Study|Physician Decision|2|||
130090623|NCT04047472|468286921|FG000|Overall Study|Protocol Violation|1|||
130090624|NCT04047472|468286922|FG001|Overall Study|Protocol Violation|0|||
130090625|NCT04047472|468286921|FG000|Overall Study|Withdrawal by Subject|10|||
130090626|NCT04047472|468286922|FG001|Overall Study|Withdrawal by Subject|10|||
130090627|NCT02030067|468286923|FG000|Overall Study|Disease Progression|1|||
130090628|NCT02030067|468286924|FG001|Overall Study|Disease Progression|1|||
130090629|NCT02030067|468286925|FG002|Overall Study|Disease Progression|2|||
130090630|NCT02030067|468286926|FG003|Overall Study|Disease Progression|2|||
130090631|NCT02030067|468286927|FG004|Overall Study|Disease Progression|3|||
130090632|NCT02030067|468286928|FG005|Overall Study|Disease Progression|2|||
130090633|NCT02030067|468286929|FG006|Overall Study|Disease Progression|3|||
130090634|NCT02030067|468286930|FG007|Overall Study|Disease Progression|3|||
130090635|NCT02030067|468286931|FG008|Overall Study|Disease Progression|4|||
130090636|NCT02030067|468286932|FG009|Overall Study|Disease Progression|3|||
130090637|NCT02030067|468286933|FG010|Overall Study|Disease Progression|7|||
130090638|NCT02030067|468286934|FG011|Overall Study|Disease Progression|2|||
130090639|NCT02030067|468286935|FG012|Overall Study|Disease Progression|59|||
130090640|NCT02030067|468286923|FG000|Overall Study|Withdrawal by Subject|0|||
130090641|NCT02030067|468286924|FG001|Overall Study|Withdrawal by Subject|0|||
130090642|NCT02030067|468286925|FG002|Overall Study|Withdrawal by Subject|0|||
130090643|NCT02030067|468286926|FG003|Overall Study|Withdrawal by Subject|1|||
130090644|NCT02030067|468286927|FG004|Overall Study|Withdrawal by Subject|0|||
130090645|NCT02030067|468286928|FG005|Overall Study|Withdrawal by Subject|0|||
130090646|NCT02030067|468286929|FG006|Overall Study|Withdrawal by Subject|0|||
130090647|NCT02030067|468286930|FG007|Overall Study|Withdrawal by Subject|1|||
130090648|NCT02030067|468286931|FG008|Overall Study|Withdrawal by Subject|0|||
130090649|NCT02030067|468286932|FG009|Overall Study|Withdrawal by Subject|0|||
130090650|NCT02030067|468286933|FG010|Overall Study|Withdrawal by Subject|3|||
130090651|NCT02030067|468286934|FG011|Overall Study|Withdrawal by Subject|0|||
130090652|NCT02030067|468286935|FG012|Overall Study|Withdrawal by Subject|6|||
130090653|NCT02030067|468286923|FG000|Overall Study|Physician Decision|0|||
130090654|NCT02030067|468286924|FG001|Overall Study|Physician Decision|0|||
130090655|NCT02030067|468286925|FG002|Overall Study|Physician Decision|0|||
130090656|NCT02030067|468286926|FG003|Overall Study|Physician Decision|0|||
130090657|NCT02030067|468286927|FG004|Overall Study|Physician Decision|0|||
130090658|NCT02030067|468286928|FG005|Overall Study|Physician Decision|0|||
130090659|NCT02030067|468286929|FG006|Overall Study|Physician Decision|0|||
130090660|NCT02030067|468286930|FG007|Overall Study|Physician Decision|0|||
130090661|NCT02030067|468286931|FG008|Overall Study|Physician Decision|0|||
130090662|NCT02030067|468286932|FG009|Overall Study|Physician Decision|0|||
130090663|NCT02030067|468286933|FG010|Overall Study|Physician Decision|1|||
130090664|NCT02030067|468286934|FG011|Overall Study|Physician Decision|0|||
130090665|NCT02030067|468286935|FG012|Overall Study|Physician Decision|3|||
130090666|NCT02030067|468286923|FG000|Overall Study|other reasons|0|||
130090667|NCT02030067|468286924|FG001|Overall Study|other reasons|0|||
130090668|NCT02030067|468286925|FG002|Overall Study|other reasons|0|||
130090669|NCT02030067|468286926|FG003|Overall Study|other reasons|0|||
130090670|NCT02030067|468286927|FG004|Overall Study|other reasons|0|||
130090671|NCT02030067|468286928|FG005|Overall Study|other reasons|1|||
130090672|NCT02030067|468286929|FG006|Overall Study|other reasons|0|||
130090673|NCT02030067|468286930|FG007|Overall Study|other reasons|0|||
130090674|NCT02030067|468286931|FG008|Overall Study|other reasons|2|||
130090675|NCT02030067|468286932|FG009|Overall Study|other reasons|0|||
130090676|NCT02030067|468286933|FG010|Overall Study|other reasons|0|||
130090677|NCT02030067|468286934|FG011|Overall Study|other reasons|0|||
130090678|NCT02030067|468286935|FG012|Overall Study|other reasons|4|||
130090679|NCT02030067|468286923|FG000|Overall Study|Adverse Event|0|||
130090680|NCT02030067|468286924|FG001|Overall Study|Adverse Event|0|||
130090681|NCT02030067|468286925|FG002|Overall Study|Adverse Event|0|||
130090682|NCT02030067|468286926|FG003|Overall Study|Adverse Event|0|||
130090683|NCT02030067|468286927|FG004|Overall Study|Adverse Event|0|||
130090684|NCT02030067|468286928|FG005|Overall Study|Adverse Event|0|||
130090685|NCT02030067|468286929|FG006|Overall Study|Adverse Event|0|||
130090686|NCT02030067|468286930|FG007|Overall Study|Adverse Event|0|||
130090687|NCT02030067|468286931|FG008|Overall Study|Adverse Event|0|||
130090688|NCT02030067|468286932|FG009|Overall Study|Adverse Event|0|||
130090689|NCT02030067|468286933|FG010|Overall Study|Adverse Event|0|||
130090690|NCT02030067|468286934|FG011|Overall Study|Adverse Event|1|||
130090691|NCT02030067|468286935|FG012|Overall Study|Adverse Event|8|||
130090692|NCT01632345|468286936|FG000|Treatment: Part I|Adverse Event|1|||
130090693|NCT01632345|468286937|FG001|Treatment: Part I|Adverse Event|4|||
130090694|NCT01632345|468286938|FG002|Treatment: Part I|Adverse Event|2|||
130090695|NCT01632345|468286939|FG003|Treatment: Part I|Adverse Event|1|||
130090696|NCT01632345|468286940|FG004|Treatment: Part I|Adverse Event|3|||
130090697|NCT01632345|468286941|FG005|Treatment: Part I|Adverse Event|0|||
130090698|NCT01632345|468286942|FG006|Treatment: Part I|Adverse Event|0|||
130090699|NCT01632345|468286936|FG000|Treatment: Part I|Lack of Efficacy|0|||
130090700|NCT01632345|468286937|FG001|Treatment: Part I|Lack of Efficacy|1|||
130090701|NCT01632345|468286938|FG002|Treatment: Part I|Lack of Efficacy|0|||
130090702|NCT01632345|468286939|FG003|Treatment: Part I|Lack of Efficacy|1|||
130090703|NCT01632345|468286940|FG004|Treatment: Part I|Lack of Efficacy|1|||
130090704|NCT01632345|468286941|FG005|Treatment: Part I|Lack of Efficacy|0|||
130090705|NCT01632345|468286942|FG006|Treatment: Part I|Lack of Efficacy|0|||
130090706|NCT01632345|468286936|FG000|Treatment: Part I|Lost to Follow-up|3|||
130090707|NCT01632345|468286937|FG001|Treatment: Part I|Lost to Follow-up|2|||
130090708|NCT01632345|468286938|FG002|Treatment: Part I|Lost to Follow-up|1|||
130090709|NCT01632345|468286939|FG003|Treatment: Part I|Lost to Follow-up|3|||
130090710|NCT01632345|468286940|FG004|Treatment: Part I|Lost to Follow-up|4|||
130090711|NCT01632345|468286941|FG005|Treatment: Part I|Lost to Follow-up|0|||
130090712|NCT01632345|468286942|FG006|Treatment: Part I|Lost to Follow-up|0|||
130090713|NCT01632345|468286936|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
130090714|NCT01632345|468286937|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
130090715|NCT01632345|468286938|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
130090716|NCT01632345|468286939|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
130090717|NCT01632345|468286940|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
130090718|NCT01632345|468286941|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
130090719|NCT01632345|468286942|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
130090720|NCT01632345|468286936|FG000|Treatment: Part I|Physician Decision|2|||
130090721|NCT01632345|468286937|FG001|Treatment: Part I|Physician Decision|1|||
130090722|NCT01632345|468286938|FG002|Treatment: Part I|Physician Decision|0|||
130090723|NCT01632345|468286939|FG003|Treatment: Part I|Physician Decision|0|||
130090724|NCT01632345|468286940|FG004|Treatment: Part I|Physician Decision|1|||
130090725|NCT01632345|468286941|FG005|Treatment: Part I|Physician Decision|0|||
130090726|NCT01632345|468286942|FG006|Treatment: Part I|Physician Decision|0|||
130090727|NCT01632345|468286936|FG000|Treatment: Part I|Pregnancy|0|||
130090728|NCT01632345|468286937|FG001|Treatment: Part I|Pregnancy|1|||
130090729|NCT01632345|468286938|FG002|Treatment: Part I|Pregnancy|0|||
130090730|NCT01632345|468286939|FG003|Treatment: Part I|Pregnancy|0|||
130090731|NCT01632345|468286940|FG004|Treatment: Part I|Pregnancy|0|||
130090732|NCT01632345|468286941|FG005|Treatment: Part I|Pregnancy|0|||
130090733|NCT01632345|468286942|FG006|Treatment: Part I|Pregnancy|0|||
130090734|NCT01632345|468286936|FG000|Treatment: Part I|Protocol Deviation|0|||
130090735|NCT01632345|468286937|FG001|Treatment: Part I|Protocol Deviation|0|||
130090736|NCT01632345|468286938|FG002|Treatment: Part I|Protocol Deviation|1|||
130090737|NCT01632345|468286939|FG003|Treatment: Part I|Protocol Deviation|1|||
130090738|NCT01632345|468286940|FG004|Treatment: Part I|Protocol Deviation|0|||
130090739|NCT01632345|468286941|FG005|Treatment: Part I|Protocol Deviation|0|||
130090740|NCT01632345|468286942|FG006|Treatment: Part I|Protocol Deviation|0|||
130090741|NCT01632345|468286936|FG000|Treatment: Part I|Withdrawal by Subject|3|||
130090742|NCT01632345|468286937|FG001|Treatment: Part I|Withdrawal by Subject|4|||
130090743|NCT01632345|468286938|FG002|Treatment: Part I|Withdrawal by Subject|4|||
130090744|NCT01632345|468286939|FG003|Treatment: Part I|Withdrawal by Subject|1|||
130090745|NCT01632345|468286940|FG004|Treatment: Part I|Withdrawal by Subject|4|||
130090746|NCT01632345|468286941|FG005|Treatment: Part I|Withdrawal by Subject|0|||
130090747|NCT01632345|468286942|FG006|Treatment: Part I|Withdrawal by Subject|0|||
130090748|NCT01632345|468286936|FG000|Treatment: Part II|Adverse Event|0|||
130090749|NCT01632345|468286937|FG001|Treatment: Part II|Adverse Event|0|||
130090750|NCT01632345|468286938|FG002|Treatment: Part II|Adverse Event|0|||
130090751|NCT01632345|468286939|FG003|Treatment: Part II|Adverse Event|0|||
130090752|NCT01632345|468286940|FG004|Treatment: Part II|Adverse Event|0|||
130090753|NCT01632345|468286941|FG005|Treatment: Part II|Adverse Event|3|||
130090754|NCT01632345|468286942|FG006|Treatment: Part II|Adverse Event|8|||
130090755|NCT01632345|468286936|FG000|Treatment: Part II|Lost to Follow-up|0|||
130090756|NCT01632345|468286937|FG001|Treatment: Part II|Lost to Follow-up|0|||
130090757|NCT01632345|468286938|FG002|Treatment: Part II|Lost to Follow-up|0|||
129961981|NCT01169636|467825641|FG003|Overall Study|Withdrawal by Subject|0|||
130090758|NCT01632345|468286939|FG003|Treatment: Part II|Lost to Follow-up|0|||
130090759|NCT01632345|468286940|FG004|Treatment: Part II|Lost to Follow-up|0|||
130090760|NCT01632345|468286941|FG005|Treatment: Part II|Lost to Follow-up|3|||
130090761|NCT01632345|468286942|FG006|Treatment: Part II|Lost to Follow-up|1|||
130090762|NCT01632345|468286936|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
130090763|NCT01632345|468286937|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
129961982|NCT01169636|467825642|FG004|Overall Study|Withdrawal by Subject|3|||
130090764|NCT01632345|468286938|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
130090765|NCT01632345|468286939|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
130090766|NCT01632345|468286940|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
130090767|NCT01632345|468286941|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
130090768|NCT01632345|468286942|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
130090769|NCT01632345|468286936|FG000|Treatment: Part II|Withdrawal by Subject|0|||
130090770|NCT01632345|468286937|FG001|Treatment: Part II|Withdrawal by Subject|0|||
130090771|NCT01632345|468286938|FG002|Treatment: Part II|Withdrawal by Subject|0|||
130090772|NCT01632345|468286939|FG003|Treatment: Part II|Withdrawal by Subject|0|||
130090773|NCT01632345|468286940|FG004|Treatment: Part II|Withdrawal by Subject|0|||
130090774|NCT01632345|468286941|FG005|Treatment: Part II|Withdrawal by Subject|2|||
130090775|NCT01632345|468286942|FG006|Treatment: Part II|Withdrawal by Subject|2|||
130090776|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
130090777|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
130090778|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
130090779|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
130090780|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
130090781|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
130090782|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Death|1|||
130090783|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Death|1|||
130090784|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Death|1|||
130090785|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Death|0|||
130090786|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Death|0|||
130090787|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Death|0|||
130090788|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
130090789|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
130090790|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130090791|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130090792|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130090793|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
130090794|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130090795|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130090796|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
130090797|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130090798|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130090799|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
130090800|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130090801|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
130090802|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130090803|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130090804|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130090805|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
130090806|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
130090807|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
130090808|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
130090809|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
130090810|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
130090811|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
130090812|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
130090813|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
130090814|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
130090815|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
130090816|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
130090817|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
130090818|NCT03370133|468286950|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
130090819|NCT03370133|468286951|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
130090820|NCT03370133|468286952|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
130090821|NCT03370133|468286953|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
130090822|NCT03370133|468286954|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
130090823|NCT03370133|468286955|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
130090824|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
130090825|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
130090826|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
130090827|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
130090828|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
130090829|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
130090830|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130090831|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130090832|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130090833|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
130090834|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
130090835|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
130090836|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130090837|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130090838|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130090839|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
130090840|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
130090841|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
130090842|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130090843|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130090844|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130090845|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
130090846|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
130090847|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
130090848|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
130090849|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
130090850|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
130090851|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
130090852|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
130090853|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
130090854|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130090855|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130090856|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130090857|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130090858|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
130090859|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
130090860|NCT03370133|468286950|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130090861|NCT03370133|468286951|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130090862|NCT03370133|468286952|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130090863|NCT03370133|468286953|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130090864|NCT03370133|468286954|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
130090865|NCT03370133|468286955|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
130090866|NCT00636506|468286956|FG000|Overall Study|Lost to Follow-up|8|||
130090867|NCT00636506|468286956|FG000|Overall Study|Explanted|1|||
130090868|NCT00636506|468286956|FG000|Overall Study|Withdrawal by Subject|6|||
130090869|NCT00636506|468286956|FG000|Overall Study|Procedure aborted|1|||
130090870|NCT03125902|468286957|FG000|Overall Study|Adverse Event|0|||
130090871|NCT03125902|468286958|FG001|Overall Study|Adverse Event|1|||
130090872|NCT03125902|468286957|FG000|Overall Study|Death|119|||
130090873|NCT03125902|468286958|FG001|Overall Study|Death|229|||
130090874|NCT03125902|468286957|FG000|Overall Study|Lost to Follow-up|4|||
130090875|NCT03125902|468286958|FG001|Overall Study|Lost to Follow-up|13|||
130090876|NCT03125902|468286957|FG000|Overall Study|Other|0|||
130090877|NCT03125902|468286958|FG001|Overall Study|Other|4|||
130090878|NCT03125902|468286957|FG000|Overall Study|Physician Decision|2|||
130090879|NCT03125902|468286958|FG001|Overall Study|Physician Decision|1|||
130090880|NCT03125902|468286957|FG000|Overall Study|Progressive Disease|0|||
130090881|NCT03125902|468286958|FG001|Overall Study|Progressive Disease|3|||
130090882|NCT03125902|468286957|FG000|Overall Study|Study Terminated By Sponsor|74|||
130090883|NCT03125902|468286958|FG001|Overall Study|Study Terminated By Sponsor|143|||
130090884|NCT03125902|468286957|FG000|Overall Study|Withdrawal by Subject|21|||
130090885|NCT03125902|468286958|FG001|Overall Study|Withdrawal by Subject|37|||
130090886|NCT01843933|468286959|FG000|Overall Study|Data lost|6|||
130090887|NCT01843933|468286960|FG001|Overall Study|Data lost|4|||
130090888|NCT01535638|468286961|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
130090889|NCT01535638|468286962|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
130090890|NCT01535638|468286963|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
130090891|NCT01535638|468286964|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
130090892|NCT01535638|468286965|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
130090893|NCT01535638|468286966|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
130090894|NCT01535638|468286961|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
130090895|NCT01535638|468286962|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
130090896|NCT01535638|468286963|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
130090897|NCT01535638|468286964|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
130090898|NCT01535638|468286965|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
130090899|NCT01535638|468286966|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
130090900|NCT01482598|468286967|FG000|Overall Study|Death|7|||
130090901|NCT01482598|468286968|FG001|Overall Study|Death|10|||
130090902|NCT01482598|468286967|FG000|Overall Study|Physician Decision|0|||
130090903|NCT01482598|468286968|FG001|Overall Study|Physician Decision|3|||
130090904|NCT01482598|468286967|FG000|Overall Study|Withdrawal by Subject|4|||
130090905|NCT01482598|468286968|FG001|Overall Study|Withdrawal by Subject|5|||
130090906|NCT01482598|468286967|FG000|Overall Study|Lost to Follow-up|5|||
130090907|NCT01482598|468286968|FG001|Overall Study|Lost to Follow-up|4|||
130090908|NCT02694562|468286969|FG000|Overall Study|Death|8|||
130090909|NCT02694562|468286969|FG000|Overall Study|Protocol Violation|4|||
130090910|NCT02694562|468286969|FG000|Overall Study|Lost to Follow-up|3|||
130090911|NCT02694562|468286969|FG000|Overall Study|Screen Failure|2|||
130090912|NCT02694562|468286969|FG000|Overall Study|Physician Decision|1|||
130090913|NCT01373294|468286970|FG000|Overall Study|Adverse Event|1|||
130090914|NCT01373294|468286971|FG001|Overall Study|Adverse Event|0|||
130090915|NCT01333865|468286972|FG000|Overall Study|Adverse Event|2|||
130090916|NCT04823494|468289078|FG000|Overall Study|Programming software malfunction.|1|||
130090917|NCT04823494|468289079|FG001|Overall Study|Programming software malfunction.|0|||
130090918|NCT04823494|468289078|FG000|Overall Study|Withdrawal by Subject|1|||
130090919|NCT04823494|468289079|FG001|Overall Study|Withdrawal by Subject|0|||
130090920|NCT04823494|468289078|FG000|Overall Study|Devices lost|0|||
130090921|NCT04823494|468289079|FG001|Overall Study|Devices lost|1|||
130090922|NCT03726320|468289080|FG000|Overall Study|Lost to Follow-up|2|||
130090923|NCT03726320|468289081|FG001|Overall Study|Lost to Follow-up|4|||
130090924|NCT03726320|468289082|FG002|Overall Study|Lost to Follow-up|0|||
130090925|NCT03726320|468289080|FG000|Overall Study|Time Constraints|4|||
130090926|NCT03726320|468289081|FG001|Overall Study|Time Constraints|1|||
130090927|NCT03726320|468289082|FG002|Overall Study|Time Constraints|0|||
130090928|NCT03726320|468289080|FG000|Overall Study|Ineligible after enrollment|3|||
130090929|NCT03726320|468289081|FG001|Overall Study|Ineligible after enrollment|3|||
130090930|NCT03726320|468289082|FG002|Overall Study|Ineligible after enrollment|0|||
130090931|NCT03726320|468289080|FG000|Overall Study|Clinic / insurance issue|2|||
130090932|NCT03726320|468289081|FG001|Overall Study|Clinic / insurance issue|0|||
130090933|NCT03726320|468289082|FG002|Overall Study|Clinic / insurance issue|0|||
130090934|NCT03726320|468289080|FG000|Overall Study|Language barrier|1|||
130090935|NCT03726320|468289081|FG001|Overall Study|Language barrier|0|||
130090936|NCT03726320|468289082|FG002|Overall Study|Language barrier|0|||
130090937|NCT03726320|468289080|FG000|Overall Study|Provider left the clinic|0|||
130090938|NCT03726320|468289081|FG001|Overall Study|Provider left the clinic|0|||
130090939|NCT03726320|468289082|FG002|Overall Study|Provider left the clinic|1|||
130090940|NCT03691831|468289085|FG000|Overall Study|Lost to Follow-up|16|||
130090941|NCT03691831|468289086|FG001|Overall Study|Lost to Follow-up|12|||
130090942|NCT03691831|468289085|FG000|Overall Study|Withdrawal by Subject|9|||
130090943|NCT03691831|468289086|FG001|Overall Study|Withdrawal by Subject|17|||
130090944|NCT03691831|468289085|FG000|Overall Study|Investigator Decision|2|||
130090945|NCT03691831|468289086|FG001|Overall Study|Investigator Decision|2|||
130090946|NCT03922945|468289087|FG000|Overall Study|Adverse Event|1|||
130090947|NCT03922945|468289088|FG001|Overall Study|Adverse Event|1|||
130090948|NCT03922945|468289089|FG002|Overall Study|Adverse Event|2|||
130090949|NCT03922945|468289087|FG000|Overall Study|Lost to Follow-up|13|||
130090950|NCT03922945|468289088|FG001|Overall Study|Lost to Follow-up|9|||
130090951|NCT03922945|468289089|FG002|Overall Study|Lost to Follow-up|20|||
130090952|NCT03922945|468289087|FG000|Overall Study|Lack of Efficacy|2|||
130090953|NCT03922945|468289088|FG001|Overall Study|Lack of Efficacy|0|||
130090954|NCT03922945|468289089|FG002|Overall Study|Lack of Efficacy|1|||
130090955|NCT03922945|468289087|FG000|Overall Study|Protocol Non-Compliance|0|||
130090956|NCT03922945|468289088|FG001|Overall Study|Protocol Non-Compliance|0|||
130090957|NCT03922945|468289089|FG002|Overall Study|Protocol Non-Compliance|1|||
130090958|NCT03922945|468289087|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
130090959|NCT03922945|468289088|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
130090960|NCT03922945|468289089|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
130090961|NCT03922945|468289087|FG000|Overall Study|All Other Personal Reasons|1|||
130090962|NCT03922945|468289088|FG001|Overall Study|All Other Personal Reasons|1|||
130090963|NCT03922945|468289089|FG002|Overall Study|All Other Personal Reasons|2|||
130090964|NCT00039377|468289091|FG000|Initial Registration|Adverse Event|2|||
130090965|NCT00039377|468289092|FG001|Initial Registration|Adverse Event|0|||
130090966|NCT00039377|468289093|FG002|Initial Registration|Adverse Event|0|||
130090967|NCT00039377|468289094|FG003|Initial Registration|Adverse Event|0|||
130090968|NCT00039377|468289091|FG000|Initial Registration|Relapsed|6|||
130090969|NCT00039377|468289092|FG001|Initial Registration|Relapsed|0|||
130090970|NCT00039377|468289093|FG002|Initial Registration|Relapsed|0|||
130090971|NCT00039377|468289094|FG003|Initial Registration|Relapsed|0|||
130090972|NCT00039377|468289091|FG000|Initial Registration|Received non-protocol therapy|11|||
130090973|NCT00039377|468289092|FG001|Initial Registration|Received non-protocol therapy|0|||
130090974|NCT00039377|468289093|FG002|Initial Registration|Received non-protocol therapy|0|||
130090975|NCT00039377|468289094|FG003|Initial Registration|Received non-protocol therapy|0|||
130090976|NCT00039377|468289091|FG000|Initial Registration|Withdrawal by Subject|3|||
130090977|NCT00039377|468289092|FG001|Initial Registration|Withdrawal by Subject|0|||
130090978|NCT00039377|468289093|FG002|Initial Registration|Withdrawal by Subject|0|||
130090979|NCT00039377|468289094|FG003|Initial Registration|Withdrawal by Subject|0|||
130090980|NCT04067310|468289098|FG000|Overall Study|Physician Decision|2|||
130090981|NCT04067310|468289099|FG001|Overall Study|Physician Decision|6|||
130090982|NCT04067310|468289098|FG000|Overall Study|Lost to Follow-up|0|||
130090983|NCT04067310|468289099|FG001|Overall Study|Lost to Follow-up|1|||
130090984|NCT04067310|468289098|FG000|Overall Study|Withdrawal by Subject|3|||
130090985|NCT04067310|468289099|FG001|Overall Study|Withdrawal by Subject|0|||
130090986|NCT01347931|468289100|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
130090987|NCT00761891|468289101|FG000|Overall Study|Withdrawal by Subject|10|||
130090988|NCT01707667|468289102|FG000|Period 1|expulsion of colonic sensor catheter|1|||
130090989|NCT01707667|468289103|FG001|Period 1|expulsion of colonic sensor catheter|0|||
130090990|NCT02074059|468289109|FG000|Overall Study|Death|0|||
130090991|NCT02074059|468289110|FG001|Overall Study|Death|0|||
130090992|NCT02074059|468289111|FG002|Overall Study|Death|0|||
130090993|NCT02074059|468289112|FG003|Overall Study|Death|0|||
130090994|NCT02074059|468289113|FG004|Overall Study|Death|1|||
130090995|NCT02074059|468289114|FG005|Overall Study|Death|1|||
130090996|NCT02764229|468289120|FG000|Overall Study|Withdrawal by Subject|15|||
130090997|NCT02764229|468289120|FG000|Overall Study|Adverse Event|9|||
130090998|NCT02764229|468289120|FG000|Overall Study|Physician Decision|5|||
130090999|NCT02764229|468289120|FG000|Overall Study|Lost to Follow-up|3|||
130091000|NCT02764229|468289120|FG000|Overall Study|Lack of Efficacy|1|||
130091001|NCT02764229|468289120|FG000|Overall Study|Study Stopped by Sponsor|69|||
130091002|NCT00779142|468289121|FG000|Overall Study|Screen Failures|3|||
130091003|NCT00265382|468289124|FG000|Overall Study|Adverse Event|21|||
130091004|NCT00265382|468289124|FG000|Overall Study|Laboratory Abnormality|1|||
130091005|NCT00265382|468289124|FG000|Overall Study|Lost to Follow-up|3|||
130091006|NCT00265382|468289124|FG000|Overall Study|Lack of Efficacy|6|||
130091007|NCT00265382|468289124|FG000|Overall Study|Miscellaneous|6|||
130091008|NCT00265382|468289124|FG000|Overall Study|Withdrawal by Subject|13|||
130091009|NCT00265382|468289124|FG000|Overall Study|Study terminated by sponsor|94|||
130091010|NCT00265382|468289124|FG000|Overall Study|Death|1|||
130091011|NCT02242305|468289126|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
130091012|NCT02242305|468289127|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
130091013|NCT02242305|468289126|FG000|Overall Study|Adverse Event|1|||
130091014|NCT02242305|468289127|FG001|Overall Study|Adverse Event|0|||
130091015|NCT02242305|468289126|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
130091016|NCT02242305|468289127|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
130091017|NCT02242305|468289126|FG000|Overall Study|Subject withdraws inform consent|0|||
130091018|NCT02242305|468289127|FG001|Overall Study|Subject withdraws inform consent|4|||
130091019|NCT02242305|468289126|FG000|Overall Study|Lost to Follow-up|2|||
130091020|NCT02242305|468289127|FG001|Overall Study|Lost to Follow-up|0|||
130091021|NCT01724021|468289130|FG000|Overall Study|Adverse Event|11|||
130091022|NCT01724021|468289131|FG001|Overall Study|Adverse Event|6|||
130091023|NCT01724021|468289130|FG000|Overall Study|Death|46|||
130091024|NCT01724021|468289131|FG001|Overall Study|Death|58|||
130091025|NCT01724021|468289130|FG000|Overall Study|Participant request/ Withdrew consent|18|||
130091026|NCT01724021|468289131|FG001|Overall Study|Participant request/ Withdrew consent|14|||
130091027|NCT01724021|468289130|FG000|Overall Study|Lost to Follow-up|15|||
130091028|NCT01724021|468289131|FG001|Overall Study|Lost to Follow-up|15|||
130091029|NCT01724021|468289130|FG000|Overall Study|Reason Not Specified|36|||
130091030|NCT01724021|468289131|FG001|Overall Study|Reason Not Specified|39|||
130091031|NCT01724021|468289130|FG000|Overall Study|Missing|1|||
130091032|NCT01724021|468289131|FG001|Overall Study|Missing|1|||
130091033|NCT00529152|468289132|FG000|Overall Study|Adverse Event|2|||
130091034|NCT00529152|468289132|FG000|Overall Study|Withdrawal by Subject|2|||
130091035|NCT00529152|468289132|FG000|Overall Study|Lost to Follow-up|1|||
129961983|NCT02705625|467825643|FG000|Overall Study|Protocol Violation|1|||
129961984|NCT02705625|467825644|FG001|Overall Study|Protocol Violation|0|||
129961985|NCT02705625|467825645|FG002|Overall Study|Protocol Violation|0|||
129961986|NCT02705625|467825643|FG000|Overall Study|Adverse Event|6|||
129961987|NCT02705625|467825644|FG001|Overall Study|Adverse Event|5|||
130091036|NCT03524664|468289138|FG000|Overall Study|Withdrawal by Subject|1|||
130091037|NCT03524664|468289139|FG001|Overall Study|Withdrawal by Subject|2|||
130091038|NCT03524664|468289138|FG000|Overall Study|Lost to Follow-up|4|||
130091039|NCT03524664|468289139|FG001|Overall Study|Lost to Follow-up|13|||
130091040|NCT00620815|468289142|FG000|Overall Study|Adverse Event|1|||
130091041|NCT00620815|468289143|FG001|Overall Study|Adverse Event|1|||
130091042|NCT00620815|468289144|FG002|Overall Study|Adverse Event|2|||
130091043|NCT00620815|468289142|FG000|Overall Study|Withdrawal by Subject|1|||
130091044|NCT00620815|468289143|FG001|Overall Study|Withdrawal by Subject|2|||
130091045|NCT00620815|468289144|FG002|Overall Study|Withdrawal by Subject|0|||
130091046|NCT00620815|468289142|FG000|Overall Study|Lost to Follow-up|1|||
130091047|NCT00620815|468289143|FG001|Overall Study|Lost to Follow-up|6|||
130091048|NCT00620815|468289144|FG002|Overall Study|Lost to Follow-up|3|||
130091049|NCT00620815|468289142|FG000|Overall Study|Inappropriate enrolment|0|||
130091050|NCT00620815|468289143|FG001|Overall Study|Inappropriate enrolment|0|||
129961988|NCT02705625|467825645|FG002|Overall Study|Adverse Event|2|||
130091051|NCT00620815|468289144|FG002|Overall Study|Inappropriate enrolment|1|||
130091052|NCT00620815|468289142|FG000|Overall Study|Protocol Violation|1|||
130091053|NCT00620815|468289143|FG001|Overall Study|Protocol Violation|2|||
130091054|NCT00620815|468289144|FG002|Overall Study|Protocol Violation|1|||
130091055|NCT01920061|468289146|FG000|Overall Study|Death|1|||
130091056|NCT01920061|468289147|FG001|Overall Study|Death|1|||
130091057|NCT01920061|468289148|FG002|Overall Study|Death|0|||
130091058|NCT01920061|468289149|FG003|Overall Study|Death|1|||
130091059|NCT01920061|468289150|FG004|Overall Study|Death|1|||
130091060|NCT01920061|468289151|FG005|Overall Study|Death|0|||
130091061|NCT01920061|468289152|FG006|Overall Study|Death|0|||
130091062|NCT01920061|468289153|FG007|Overall Study|Death|1|||
130091063|NCT01920061|468289154|FG008|Overall Study|Death|0|||
130091064|NCT01920061|468289155|FG009|Overall Study|Death|1|||
130091065|NCT01920061|468289156|FG010|Overall Study|Death|0|||
130091066|NCT01920061|468289157|FG011|Overall Study|Death|1|||
130091067|NCT01920061|468289158|FG012|Overall Study|Death|0|||
130091068|NCT01920061|468289159|FG013|Overall Study|Death|2|||
130091069|NCT01920061|468289160|FG014|Overall Study|Death|0|||
130091070|NCT01920061|468289161|FG015|Overall Study|Death|0|||
130091071|NCT01920061|468289162|FG016|Overall Study|Death|0|||
130091072|NCT01920061|468289163|FG017|Overall Study|Death|0|||
130091073|NCT01920061|468289164|FG018|Overall Study|Death|1|||
130091074|NCT01920061|468289165|FG019|Overall Study|Death|0|||
130091075|NCT01920061|468289146|FG000|Overall Study|Lost to Follow-up|0|||
130091076|NCT01920061|468289147|FG001|Overall Study|Lost to Follow-up|2|||
130091077|NCT01920061|468289148|FG002|Overall Study|Lost to Follow-up|0|||
130091078|NCT01920061|468289149|FG003|Overall Study|Lost to Follow-up|0|||
130091079|NCT01920061|468289150|FG004|Overall Study|Lost to Follow-up|0|||
130091080|NCT01920061|468289151|FG005|Overall Study|Lost to Follow-up|0|||
130091081|NCT01920061|468289152|FG006|Overall Study|Lost to Follow-up|1|||
130091082|NCT01920061|468289153|FG007|Overall Study|Lost to Follow-up|0|||
130091083|NCT01920061|468289154|FG008|Overall Study|Lost to Follow-up|0|||
130091084|NCT01920061|468289155|FG009|Overall Study|Lost to Follow-up|0|||
130091085|NCT01920061|468289156|FG010|Overall Study|Lost to Follow-up|3|||
130091086|NCT01920061|468289157|FG011|Overall Study|Lost to Follow-up|0|||
130091087|NCT01920061|468289158|FG012|Overall Study|Lost to Follow-up|0|||
130091088|NCT01920061|468289159|FG013|Overall Study|Lost to Follow-up|0|||
130091089|NCT01920061|468289160|FG014|Overall Study|Lost to Follow-up|0|||
130091090|NCT01920061|468289161|FG015|Overall Study|Lost to Follow-up|0|||
130091091|NCT01920061|468289162|FG016|Overall Study|Lost to Follow-up|0|||
130091092|NCT01920061|468289163|FG017|Overall Study|Lost to Follow-up|1|||
130091093|NCT01920061|468289164|FG018|Overall Study|Lost to Follow-up|4|||
130091094|NCT01920061|468289165|FG019|Overall Study|Lost to Follow-up|3|||
130091095|NCT01920061|468289146|FG000|Overall Study|Other|1|||
130091096|NCT01920061|468289147|FG001|Overall Study|Other|1|||
130091097|NCT01920061|468289148|FG002|Overall Study|Other|2|||
130091098|NCT01920061|468289149|FG003|Overall Study|Other|1|||
130091099|NCT01920061|468289150|FG004|Overall Study|Other|0|||
130091100|NCT01920061|468289151|FG005|Overall Study|Other|1|||
130091101|NCT01920061|468289152|FG006|Overall Study|Other|0|||
130091102|NCT01920061|468289153|FG007|Overall Study|Other|0|||
130091103|NCT01920061|468289154|FG008|Overall Study|Other|0|||
130091104|NCT01920061|468289155|FG009|Overall Study|Other|1|||
130091105|NCT01920061|468289156|FG010|Overall Study|Other|1|||
130091106|NCT01920061|468289157|FG011|Overall Study|Other|2|||
130091107|NCT01920061|468289158|FG012|Overall Study|Other|1|||
130091108|NCT01920061|468289159|FG013|Overall Study|Other|4|||
130091109|NCT01920061|468289160|FG014|Overall Study|Other|0|||
130091110|NCT01920061|468289161|FG015|Overall Study|Other|1|||
130091111|NCT01920061|468289162|FG016|Overall Study|Other|1|||
130091112|NCT01920061|468289163|FG017|Overall Study|Other|0|||
130091113|NCT01920061|468289164|FG018|Overall Study|Other|1|||
130091114|NCT01920061|468289165|FG019|Overall Study|Other|1|||
130091115|NCT01920061|468289146|FG000|Overall Study|Participant refused further follow-up|0|||
130091116|NCT01920061|468289147|FG001|Overall Study|Participant refused further follow-up|0|||
130091117|NCT01920061|468289148|FG002|Overall Study|Participant refused further follow-up|0|||
130091118|NCT01920061|468289149|FG003|Overall Study|Participant refused further follow-up|0|||
130091119|NCT01920061|468289150|FG004|Overall Study|Participant refused further follow-up|1|||
130091120|NCT01920061|468289151|FG005|Overall Study|Participant refused further follow-up|1|||
130091121|NCT01920061|468289152|FG006|Overall Study|Participant refused further follow-up|0|||
130091122|NCT01920061|468289153|FG007|Overall Study|Participant refused further follow-up|0|||
130091123|NCT01920061|468289154|FG008|Overall Study|Participant refused further follow-up|1|||
130091124|NCT01920061|468289155|FG009|Overall Study|Participant refused further follow-up|0|||
130091125|NCT01920061|468289156|FG010|Overall Study|Participant refused further follow-up|1|||
130091126|NCT01920061|468289157|FG011|Overall Study|Participant refused further follow-up|0|||
130091127|NCT01920061|468289158|FG012|Overall Study|Participant refused further follow-up|1|||
130091128|NCT01920061|468289159|FG013|Overall Study|Participant refused further follow-up|0|||
130091129|NCT01920061|468289160|FG014|Overall Study|Participant refused further follow-up|1|||
130091130|NCT01920061|468289161|FG015|Overall Study|Participant refused further follow-up|2|||
130091131|NCT01920061|468289162|FG016|Overall Study|Participant refused further follow-up|1|||
130091132|NCT01920061|468289163|FG017|Overall Study|Participant refused further follow-up|1|||
130091133|NCT01920061|468289164|FG018|Overall Study|Participant refused further follow-up|0|||
130091134|NCT01920061|468289165|FG019|Overall Study|Participant refused further follow-up|0|||
130091135|NCT00877929|468289166|FG000|Overall Study|Adverse Event|11|||
130091136|NCT00877929|468289167|FG001|Overall Study|Adverse Event|20|||
130091137|NCT00877929|468289166|FG000|Overall Study|Protocol Violation|3|||
130091138|NCT00877929|468289167|FG001|Overall Study|Protocol Violation|3|||
130091139|NCT00877929|468289166|FG000|Overall Study|Lost to Follow-up|0|||
130091140|NCT00877929|468289167|FG001|Overall Study|Lost to Follow-up|1|||
130091141|NCT00877929|468289166|FG000|Overall Study|Withdrawal by Subject|4|||
130091142|NCT00877929|468289167|FG001|Overall Study|Withdrawal by Subject|4|||
130091143|NCT00877929|468289166|FG000|Overall Study|Lack of Efficacy|0|||
130091144|NCT00877929|468289167|FG001|Overall Study|Lack of Efficacy|1|||
130091145|NCT00877929|468289166|FG000|Overall Study|Other reason (not specified)|2|||
130091146|NCT00877929|468289167|FG001|Overall Study|Other reason (not specified)|6|||
130091147|NCT00689728|468289169|FG000|Double-Blind Treatment|Adverse Event|1|||
130091148|NCT00689728|468289170|FG001|Double-Blind Treatment|Adverse Event|0|||
130091149|NCT00689728|468289171|FG002|Double-Blind Treatment|Adverse Event|0|||
130091150|NCT00689728|468289169|FG000|Double-Blind Treatment|Protocol Violation|0|||
130091151|NCT00689728|468289170|FG001|Double-Blind Treatment|Protocol Violation|0|||
130091152|NCT00689728|468289171|FG002|Double-Blind Treatment|Protocol Violation|1|||
130091153|NCT00689728|468289169|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
130091154|NCT00689728|468289170|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
130091155|NCT00689728|468289171|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
130091156|NCT00689728|468289169|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
130091157|NCT00689728|468289170|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
130091158|NCT00689728|468289171|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
130091159|NCT00689728|468289169|FG000|Rescue|Adverse Event|0|||
130091160|NCT00689728|468289170|FG001|Rescue|Adverse Event|1|||
130091161|NCT00689728|468289171|FG002|Rescue|Adverse Event|0|||
130091162|NCT00689728|468289169|FG000|Rescue|Withdrawal by Subject|1|||
130091163|NCT00689728|468289170|FG001|Rescue|Withdrawal by Subject|1|||
130091164|NCT00689728|468289171|FG002|Rescue|Withdrawal by Subject|1|||
130091165|NCT00689728|468289169|FG000|Optional Follow-Up|Adverse Event|1|||
130091166|NCT00689728|468289170|FG001|Optional Follow-Up|Adverse Event|0|||
130091167|NCT00689728|468289171|FG002|Optional Follow-Up|Adverse Event|0|||
130091168|NCT00689728|468289169|FG000|Optional Follow-Up|Lack of Efficacy|0|||
130091169|NCT00689728|468289170|FG001|Optional Follow-Up|Lack of Efficacy|1|||
130091170|NCT00689728|468289171|FG002|Optional Follow-Up|Lack of Efficacy|1|||
130091171|NCT00689728|468289169|FG000|Optional Follow-Up|Lost to Follow-up|0|||
130091172|NCT00689728|468289170|FG001|Optional Follow-Up|Lost to Follow-up|1|||
130091173|NCT00689728|468289171|FG002|Optional Follow-Up|Lost to Follow-up|1|||
130091174|NCT00689728|468289169|FG000|Optional Follow-Up|Protocol Violation|0|||
130091175|NCT00689728|468289170|FG001|Optional Follow-Up|Protocol Violation|0|||
130091176|NCT00689728|468289171|FG002|Optional Follow-Up|Protocol Violation|1|||
130091177|NCT00689728|468289169|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
130091178|NCT00689728|468289170|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
130091179|NCT00689728|468289171|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
130091180|NCT00842829|468289172|FG000|Dose Titration Period|Adverse Event|11|||
130091181|NCT00842829|468289173|FG001|Dose Titration Period|Adverse Event|10|||
130091182|NCT00842829|468289174|FG002|Dose Titration Period|Adverse Event|0|||
130091183|NCT00842829|468289172|FG000|Dose Titration Period|Lack of Efficacy|4|||
130091184|NCT00842829|468289173|FG001|Dose Titration Period|Lack of Efficacy|1|||
130091185|NCT00842829|468289174|FG002|Dose Titration Period|Lack of Efficacy|0|||
130091186|NCT00842829|468289172|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
130091187|NCT00842829|468289173|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
130091188|NCT00842829|468289174|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
130091189|NCT00842829|468289172|FG000|Dose Titration Period|Withdrawal by Subject|2|||
130091190|NCT00842829|468289173|FG001|Dose Titration Period|Withdrawal by Subject|6|||
130121919|NCT03992196|468408730|FG002|Treatment|Protocol Violation|1|||
130121920|NCT03992196|468408728|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
130121921|NCT03992196|468408729|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
130091191|NCT00842829|468289174|FG002|Dose Titration Period|Withdrawal by Subject|0|||
130091192|NCT00842829|468289172|FG000|Dose Titration Period|Other|5|||
130091193|NCT00842829|468289173|FG001|Dose Titration Period|Other|4|||
130091194|NCT00842829|468289174|FG002|Dose Titration Period|Other|0|||
130091195|NCT00842829|468289172|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
130091196|NCT00842829|468289173|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
130091197|NCT00842829|468289174|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
130091198|NCT00842829|468289172|FG000|Dose Titration Period|Non-compliance to study drug|2|||
130091199|NCT00842829|468289173|FG001|Dose Titration Period|Non-compliance to study drug|1|||
130121922|NCT03992196|468408730|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
130121923|NCT03992196|468408728|FG000|Treatment|Withdrawal due to non-compliance|0|||
130091200|NCT00842829|468289174|FG002|Dose Titration Period|Non-compliance to study drug|0|||
130091201|NCT00842829|468289172|FG000|Treatment Period|Adverse Event|0|||
130091202|NCT00842829|468289173|FG001|Treatment Period|Adverse Event|0|||
130091203|NCT00842829|468289174|FG002|Treatment Period|Adverse Event|15|||
130091204|NCT00842829|468289172|FG000|Treatment Period|Lack of Efficacy|0|||
130091205|NCT00842829|468289173|FG001|Treatment Period|Lack of Efficacy|0|||
130091206|NCT00842829|468289174|FG002|Treatment Period|Lack of Efficacy|6|||
130091207|NCT00842829|468289172|FG000|Treatment Period|Unstable persistent cancer pain|0|||
130091208|NCT00842829|468289173|FG001|Treatment Period|Unstable persistent cancer pain|0|||
130091209|NCT00842829|468289174|FG002|Treatment Period|Unstable persistent cancer pain|5|||
130091210|NCT00842829|468289172|FG000|Treatment Period|Withdrawal by Subject|0|||
130091211|NCT00842829|468289173|FG001|Treatment Period|Withdrawal by Subject|0|||
130091212|NCT00842829|468289174|FG002|Treatment Period|Withdrawal by Subject|11|||
130091213|NCT00842829|468289172|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
130091214|NCT00842829|468289173|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
130091215|NCT00842829|468289174|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
130091216|NCT00842829|468289172|FG000|Treatment Period|Protocol Violation|0|||
130091217|NCT00842829|468289173|FG001|Treatment Period|Protocol Violation|0|||
130091218|NCT00842829|468289174|FG002|Treatment Period|Protocol Violation|2|||
130091219|NCT00842829|468289172|FG000|Treatment Period|Other|0|||
130091220|NCT00842829|468289173|FG001|Treatment Period|Other|0|||
130091221|NCT00842829|468289174|FG002|Treatment Period|Other|18|||
130091222|NCT00842829|468289172|FG000|Treatment Period|Non-compliance to study procedures|0|||
130091223|NCT00842829|468289173|FG001|Treatment Period|Non-compliance to study procedures|0|||
130091224|NCT00842829|468289174|FG002|Treatment Period|Non-compliance to study procedures|4|||
130091225|NCT00842829|468289172|FG000|Treatment Period|Unclear completion status|0|||
130091226|NCT00842829|468289173|FG001|Treatment Period|Unclear completion status|0|||
130091227|NCT00842829|468289174|FG002|Treatment Period|Unclear completion status|1|||
130091228|NCT00842829|468289172|FG000|Continuation Period|Adverse Event|0|||
130091229|NCT00842829|468289173|FG001|Continuation Period|Adverse Event|0|||
130091230|NCT00842829|468289174|FG002|Continuation Period|Adverse Event|32|||
130091231|NCT00842829|468289172|FG000|Continuation Period|Lack of Efficacy|0|||
130091232|NCT00842829|468289173|FG001|Continuation Period|Lack of Efficacy|0|||
130091233|NCT00842829|468289174|FG002|Continuation Period|Lack of Efficacy|6|||
130091234|NCT00842829|468289172|FG000|Continuation Period|Unstable persistent cancer pain|0|||
130091235|NCT00842829|468289173|FG001|Continuation Period|Unstable persistent cancer pain|0|||
130091236|NCT00842829|468289174|FG002|Continuation Period|Unstable persistent cancer pain|3|||
130091237|NCT00842829|468289172|FG000|Continuation Period|Withdrawal by Subject|0|||
130091238|NCT00842829|468289173|FG001|Continuation Period|Withdrawal by Subject|0|||
130091239|NCT00842829|468289174|FG002|Continuation Period|Withdrawal by Subject|10|||
130091240|NCT00842829|468289172|FG000|Continuation Period|Other|0|||
130091241|NCT00842829|468289173|FG001|Continuation Period|Other|0|||
130091242|NCT00842829|468289174|FG002|Continuation Period|Other|7|||
130091243|NCT00842829|468289172|FG000|Continuation Period|Non-compliance to study procedures|0|||
130091244|NCT00842829|468289173|FG001|Continuation Period|Non-compliance to study procedures|0|||
130091245|NCT00842829|468289174|FG002|Continuation Period|Non-compliance to study procedures|2|||
130091246|NCT00842829|468289172|FG000|Continuation Period|Non-compliance to study drug|0|||
130091247|NCT00842829|468289173|FG001|Continuation Period|Non-compliance to study drug|0|||
130091248|NCT00842829|468289174|FG002|Continuation Period|Non-compliance to study drug|1|||
130091249|NCT03590613|468289178|FG000|Period 2, 4 Days|Physician Decision|0|||
130091250|NCT03590613|468289179|FG001|Period 2, 4 Days|Physician Decision|0|||
129961989|NCT02705625|467825643|FG000|Overall Study|Death|0|||
129961990|NCT02705625|467825644|FG001|Overall Study|Death|0|||
130091251|NCT03590613|468289180|FG002|Period 2, 4 Days|Physician Decision|0|||
130091252|NCT03590613|468289181|FG003|Period 2, 4 Days|Physician Decision|1|||
130091253|NCT04369742|468289182|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
130091254|NCT04369742|468289183|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
130091255|NCT04369742|468289182|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
130091256|NCT04369742|468289183|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
130091257|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Death|2|||
130091258|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Death|0|||
130091259|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Adverse Event|33|||
130091260|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Adverse Event|31|||
130091261|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
130091262|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
130091263|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
130091264|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
130091265|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
130091266|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
129961991|NCT02705625|467825645|FG002|Overall Study|Death|1|||
130091267|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Other|7|||
130091268|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Other|8|||
130091269|NCT00280059|468289184|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
130091270|NCT00280059|468289185|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
130091271|NCT01130831|468289190|FG000|Overall Study|Withdrawal by Subject|7|||
130091272|NCT01130831|468289190|FG000|Overall Study|Death|4|||
130091273|NCT01130831|468289190|FG000|Overall Study|Information was missing|3|||
130091274|NCT00951912|468289191|FG000|Overall Study|Lack of Efficacy|1|||
130091275|NCT00951912|468289192|FG001|Overall Study|Lack of Efficacy|0|||
130091276|NCT00951912|468289193|FG002|Overall Study|Lack of Efficacy|0|||
130091277|NCT00951912|468289191|FG000|Overall Study|Adverse Event|0|||
130091278|NCT00951912|468289192|FG001|Overall Study|Adverse Event|1|||
130091279|NCT00951912|468289193|FG002|Overall Study|Adverse Event|1|||
130091280|NCT00951912|468289191|FG000|Overall Study|Lost to Follow-up|2|||
130091281|NCT00951912|468289192|FG001|Overall Study|Lost to Follow-up|2|||
130091282|NCT00951912|468289193|FG002|Overall Study|Lost to Follow-up|0|||
130091283|NCT00951912|468289191|FG000|Overall Study|Physician Decision|1|||
130091284|NCT00951912|468289192|FG001|Overall Study|Physician Decision|0|||
130091285|NCT00951912|468289193|FG002|Overall Study|Physician Decision|1|||
130091286|NCT00951912|468289191|FG000|Overall Study|Withdrawal by Subject|1|||
130091287|NCT00951912|468289192|FG001|Overall Study|Withdrawal by Subject|1|||
130091288|NCT00951912|468289193|FG002|Overall Study|Withdrawal by Subject|0|||
130091289|NCT00951912|468289191|FG000|Overall Study|Other:Depression|1|||
130091290|NCT00951912|468289192|FG001|Overall Study|Other:Depression|0|||
130091291|NCT00951912|468289193|FG002|Overall Study|Other:Depression|0|||
130091292|NCT00951912|468289191|FG000|Overall Study|Other: Colon cancer|1|||
130091293|NCT00951912|468289192|FG001|Overall Study|Other: Colon cancer|0|||
130091294|NCT00951912|468289193|FG002|Overall Study|Other: Colon cancer|0|||
130091295|NCT00951912|468289191|FG000|Overall Study|Other: Stroke|0|||
130091296|NCT00951912|468289192|FG001|Overall Study|Other: Stroke|1|||
130091297|NCT00951912|468289193|FG002|Overall Study|Other: Stroke|0|||
130091298|NCT03417999|468289194|FG000|Overall Study|Withdrawal by Subject|1|||
130091299|NCT03417999|468289195|FG001|Overall Study|Withdrawal by Subject|0|||
130091300|NCT03417999|468289196|FG002|Overall Study|Withdrawal by Subject|0|||
130091301|NCT03417999|468289194|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
130121924|NCT03992196|468408729|FG001|Treatment|Withdrawal due to non-compliance|0|||
130121925|NCT03992196|468408730|FG002|Treatment|Withdrawal due to non-compliance|1|||
130121926|NCT03992196|468408728|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
130121927|NCT03992196|468408729|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
130121928|NCT03992196|468408730|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
130121929|NCT03992196|468408728|FG000|Treatment|Withdrawal by parent/guardian|0|||
130121930|NCT03992196|468408729|FG001|Treatment|Withdrawal by parent/guardian|0|||
130121931|NCT03992196|468408730|FG002|Treatment|Withdrawal by parent/guardian|2|||
130121932|NCT00048048|468408731|FG000|Core Treatment|Withdrawal by Subject|0|||
130121933|NCT00048048|468408732|FG001|Core Treatment|Withdrawal by Subject|0|||
130121934|NCT00048048|468408733|FG002|Core Treatment|Withdrawal by Subject|1|||
130121935|NCT00048048|468408734|FG003|Core Treatment|Withdrawal by Subject|0|||
130121936|NCT00048048|468408735|FG004|Core Treatment|Withdrawal by Subject|0|||
130121937|NCT00048048|468408736|FG005|Core Treatment|Withdrawal by Subject|0|||
130121938|NCT00048048|468408737|FG006|Core Treatment|Withdrawal by Subject|0|||
130121939|NCT00048048|468408738|FG007|Core Treatment|Withdrawal by Subject|0|||
130121940|NCT00048048|468408739|FG008|Core Treatment|Withdrawal by Subject|0|||
130121941|NCT00048048|468408740|FG009|Core Treatment|Withdrawal by Subject|0|||
130121942|NCT00048048|468408741|FG010|Core Treatment|Withdrawal by Subject|0|||
130121943|NCT00048048|468408742|FG011|Core Treatment|Withdrawal by Subject|0|||
130121944|NCT00048048|468408731|FG000|Core Treatment|Adverse Event|0|||
130121945|NCT00048048|468408732|FG001|Core Treatment|Adverse Event|0|||
129961992|NCT02705625|467825643|FG000|Overall Study|Withdrawal by Subject|1|||
129961993|NCT02705625|467825644|FG001|Overall Study|Withdrawal by Subject|4|||
129961994|NCT02705625|467825645|FG002|Overall Study|Withdrawal by Subject|5|||
129961995|NCT02705625|467825643|FG000|Overall Study|Lost to Follow-up|0|||
130091302|NCT03417999|468289195|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
130091303|NCT03417999|468289196|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
130091304|NCT03417999|468289194|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
130091305|NCT03417999|468289195|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
130091306|NCT03417999|468289196|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
130091307|NCT03417999|468289194|FG000|Overall Study|Inadequate study staff available to process samples|0|||
130091308|NCT03417999|468289195|FG001|Overall Study|Inadequate study staff available to process samples|0|||
130091309|NCT03417999|468289196|FG002|Overall Study|Inadequate study staff available to process samples|1|||
130091310|NCT00422942|468289202|FG000|Overall Study|Study terminated by Sponsor|3|||
130091311|NCT02612194|468289203|FG000|Overall Study|Death|5|||
130121946|NCT00048048|468408733|FG002|Core Treatment|Adverse Event|0|||
130121947|NCT00048048|468408734|FG003|Core Treatment|Adverse Event|0|||
129961996|NCT02705625|467825644|FG001|Overall Study|Lost to Follow-up|0|||
130091312|NCT02612194|468289204|FG001|Overall Study|Death|0|||
130091313|NCT02612194|468289205|FG002|Overall Study|Death|2|||
130091314|NCT02612194|468289203|FG000|Overall Study|Early Study Termination|1|||
130091315|NCT02612194|468289204|FG001|Overall Study|Early Study Termination|0|||
130091316|NCT02612194|468289205|FG002|Overall Study|Early Study Termination|0|||
130091317|NCT02539160|468289206|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
130091318|NCT02539160|468289207|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
130091319|NCT02539160|468289208|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
130091320|NCT02539160|468289209|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
130091321|NCT02539160|468289206|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
130091322|NCT02539160|468289207|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
130091323|NCT02539160|468289208|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
130091324|NCT02539160|468289209|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
130091325|NCT02539160|468289206|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
130091326|NCT02539160|468289207|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
130091327|NCT02539160|468289208|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
130091328|NCT02539160|468289209|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
130091329|NCT01681004|468289212|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
130091330|NCT01681004|468289213|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
130091331|NCT01681004|468289212|FG000|Study Completion|Lost to Follow-up|8|||
130091332|NCT01681004|468289213|FG001|Study Completion|Lost to Follow-up|3|||
130091333|NCT01681004|468289212|FG000|Study Completion|Physician Decision|1|||
130091334|NCT01681004|468289213|FG001|Study Completion|Physician Decision|3|||
130091335|NCT01681004|468289212|FG000|Study Completion|Site Termination|2|||
130091336|NCT01681004|468289213|FG001|Study Completion|Site Termination|1|||
130091337|NCT01681004|468289212|FG000|Study Completion|Death|1|||
130091338|NCT01681004|468289213|FG001|Study Completion|Death|1|||
130091339|NCT02828982|468289214|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130091340|NCT02828982|468289215|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
130091341|NCT00372905|468289216|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
130091342|NCT00372905|468289217|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
130091343|NCT00372905|468289218|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
130091344|NCT00372905|468289219|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
130091345|NCT00372905|468289216|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
130091346|NCT00372905|468289217|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
130091347|NCT00372905|468289218|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
130091348|NCT00372905|468289219|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
130091349|NCT00372905|468289216|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
130091350|NCT00372905|468289217|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
130091351|NCT00372905|468289218|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
130091352|NCT00372905|468289219|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
130091353|NCT00372905|468289216|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
130091354|NCT00372905|468289217|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
130091355|NCT00372905|468289218|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
130091356|NCT00372905|468289219|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
130091357|NCT00372905|468289216|FG000|Follow up Until Relapse or Progression|Study closed|0|||
130091358|NCT00372905|468289217|FG001|Follow up Until Relapse or Progression|Study closed|0|||
130091359|NCT00372905|468289218|FG002|Follow up Until Relapse or Progression|Study closed|0|||
130091360|NCT00372905|468289219|FG003|Follow up Until Relapse or Progression|Study closed|3|||
130091361|NCT00372905|468289216|FG000|Follow up Until Relapse or Progression|Other|0|||
130091362|NCT00372905|468289217|FG001|Follow up Until Relapse or Progression|Other|1|||
130091363|NCT00372905|468289218|FG002|Follow up Until Relapse or Progression|Other|0|||
130091364|NCT00372905|468289219|FG003|Follow up Until Relapse or Progression|Other|0|||
130091365|NCT02312934|468289220|FG000|Overall Study|Lost to Follow-up|1|||
130091366|NCT02312934|468289221|FG001|Overall Study|Lost to Follow-up|0|||
130091367|NCT02312934|468289220|FG000|Overall Study|Physician Decision|1|||
130091368|NCT02312934|468289221|FG001|Overall Study|Physician Decision|0|||
130091369|NCT00701064|468289223|FG000|Overall Study|Protocol Violation|1|||
130091370|NCT00701064|468289224|FG001|Overall Study|Protocol Violation|1|||
130091371|NCT00701064|468289223|FG000|Overall Study|Withdrawal by Subject|1|||
130091372|NCT00701064|468289224|FG001|Overall Study|Withdrawal by Subject|1|||
130091373|NCT00701064|468289223|FG000|Overall Study|initiated other PTSD treatment|2|||
130091374|NCT00701064|468289224|FG001|Overall Study|initiated other PTSD treatment|2|||
130121948|NCT00048048|468408735|FG004|Core Treatment|Adverse Event|0|||
130091375|NCT00689299|468289225|FG000|Overall Study|Adverse Event|2|||
130091376|NCT00689299|468289226|FG001|Overall Study|Adverse Event|1|||
130091377|NCT00689299|468289227|FG002|Overall Study|Adverse Event|1|||
130091378|NCT00689299|468289225|FG000|Overall Study|Lost to Follow-up|0|||
130091379|NCT00689299|468289226|FG001|Overall Study|Lost to Follow-up|1|||
130091380|NCT00689299|468289227|FG002|Overall Study|Lost to Follow-up|1|||
130091381|NCT00689299|468289225|FG000|Overall Study|Withdrawal by Subject|4|||
130091382|NCT00689299|468289226|FG001|Overall Study|Withdrawal by Subject|1|||
130091383|NCT00689299|468289227|FG002|Overall Study|Withdrawal by Subject|3|||
130091384|NCT00689299|468289225|FG000|Overall Study|Protocol Violation|1|||
130091385|NCT00689299|468289226|FG001|Overall Study|Protocol Violation|0|||
130091386|NCT00689299|468289227|FG002|Overall Study|Protocol Violation|0|||
130091387|NCT02613910|468289230|FG000|Overall Study|Termination of study|1|||
130091388|NCT02098733|468289231|FG000|Overall Study|Data Not Available|5|||
130091389|NCT02098733|468289231|FG000|Overall Study|Lost to Follow-up|5|||
130091390|NCT00695318|468289232|FG000|Overall Study|Lost to Follow-up|1|||
130091391|NCT00695318|468289233|FG001|Overall Study|Lost to Follow-up|0|||
130091392|NCT00695318|468289232|FG000|Overall Study|Withdrawal by Subject|2|||
130091393|NCT00695318|468289233|FG001|Overall Study|Withdrawal by Subject|0|||
130091394|NCT00695318|468289232|FG000|Overall Study|Death|1|||
130091395|NCT00695318|468289233|FG001|Overall Study|Death|1|||
130091396|NCT00695318|468289232|FG000|Overall Study|Study Terminated|1|||
130091397|NCT00695318|468289233|FG001|Overall Study|Study Terminated|0|||
130091398|NCT03395704|468289234|FG000|Overall Study|Adverse Event|2|||
130091399|NCT03395704|468289235|FG001|Overall Study|Adverse Event|1|||
130091400|NCT03395704|468289234|FG000|Overall Study|Withdrawal by Subject|2|||
130091401|NCT03395704|468289235|FG001|Overall Study|Withdrawal by Subject|1|||
130091402|NCT03395704|468289234|FG000|Overall Study|Physician Decision|0|||
130091403|NCT03395704|468289235|FG001|Overall Study|Physician Decision|1|||
130091404|NCT00434876|468289238|FG000|Overall Study|Lost to Follow-up|1|||
130091405|NCT00434876|468289239|FG001|Overall Study|Lost to Follow-up|1|||
130091406|NCT00758394|468289240|FG000|2nd Intervention Order|Lost to Follow-up|0|||
130091407|NCT00758394|468289241|FG001|2nd Intervention Order|Lost to Follow-up|1|||
130091408|NCT00758394|468289242|FG002|2nd Intervention Order|Lost to Follow-up|0|||
130091409|NCT00758394|468289243|FG003|2nd Intervention Order|Lost to Follow-up|0|||
130091410|NCT00758394|468289240|FG000|3rd Intervention|Lost to Follow-up|1|||
130091411|NCT00758394|468289241|FG001|3rd Intervention|Lost to Follow-up|0|||
130091412|NCT00758394|468289242|FG002|3rd Intervention|Lost to Follow-up|0|||
130091413|NCT00758394|468289243|FG003|3rd Intervention|Lost to Follow-up|1|||
130091414|NCT03044730|468289254|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
130091415|NCT03044730|468289254|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
130091416|NCT03044730|468289254|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
130091417|NCT03044730|468289254|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
130091418|NCT03044730|468289254|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
130091419|NCT03044730|468289254|FG000|Cycles 4 and Beyond|Adverse Event|1|||
130091420|NCT03044730|468289254|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
130091421|NCT03044730|468289254|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
130091422|NCT03044730|468289254|FG000|On Follow-up for 2 Years|Death|17|||
130091423|NCT02493712|468290696|FG000|Overall Study|Withdrawal by Subject|1|||
130091424|NCT02493712|468290697|FG001|Overall Study|Withdrawal by Subject|0|||
130091425|NCT02493712|468290698|FG002|Overall Study|Withdrawal by Subject|2|||
130091426|NCT02493712|468290696|FG000|Overall Study|Protocol Violation|0|||
130091427|NCT02493712|468290697|FG001|Overall Study|Protocol Violation|0|||
130091428|NCT02493712|468290698|FG002|Overall Study|Protocol Violation|1|||
130091429|NCT02493712|468290696|FG000|Overall Study|Lost to Follow-up|1|||
130091430|NCT02493712|468290697|FG001|Overall Study|Lost to Follow-up|0|||
130091431|NCT02493712|468290698|FG002|Overall Study|Lost to Follow-up|0|||
130091432|NCT02493712|468290696|FG000|Overall Study|Physician Decision|0|||
130091433|NCT02493712|468290697|FG001|Overall Study|Physician Decision|1|||
130091434|NCT02493712|468290698|FG002|Overall Study|Physician Decision|0|||
130091435|NCT02493712|468290696|FG000|Overall Study|Lack of Efficacy|0|||
130091436|NCT02493712|468290697|FG001|Overall Study|Lack of Efficacy|5|||
130091437|NCT02493712|468290698|FG002|Overall Study|Lack of Efficacy|3|||
130091438|NCT04120116|468290699|FG000|Overall Study|Lost to Follow-up|0|||
130091439|NCT04120116|468290700|FG001|Overall Study|Lost to Follow-up|1|||
130091440|NCT04120116|468290701|FG002|Overall Study|Lost to Follow-up|0|||
130091441|NCT04120116|468290702|FG003|Overall Study|Lost to Follow-up|2|||
130091442|NCT04120116|468290699|FG000|Overall Study|Withdrawal by Subject|1|||
130091443|NCT04120116|468290700|FG001|Overall Study|Withdrawal by Subject|0|||
130091444|NCT04120116|468290701|FG002|Overall Study|Withdrawal by Subject|1|||
130091445|NCT04120116|468290702|FG003|Overall Study|Withdrawal by Subject|1|||
130091446|NCT04120116|468290699|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
130091447|NCT04120116|468290700|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
130091448|NCT04120116|468290701|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
130091449|NCT04120116|468290702|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
130091450|NCT02087085|468290703|FG000|Overall Study|Adverse Event|10|||
130091451|NCT02087085|468290704|FG001|Overall Study|Adverse Event|14|||
130091452|NCT02087085|468290703|FG000|Overall Study|Lack of Efficacy|4|||
130091453|NCT02087085|468290704|FG001|Overall Study|Lack of Efficacy|3|||
130091454|NCT02087085|468290703|FG000|Overall Study|Lost to Follow-up|6|||
130091455|NCT02087085|468290704|FG001|Overall Study|Lost to Follow-up|4|||
130091456|NCT02087085|468290703|FG000|Overall Study|Withdrawal by Subject|9|||
130091457|NCT02087085|468290704|FG001|Overall Study|Withdrawal by Subject|11|||
130091458|NCT02087085|468290703|FG000|Overall Study|Protocol Violation|1|||
130091459|NCT02087085|468290704|FG001|Overall Study|Protocol Violation|0|||
130091460|NCT02087085|468290703|FG000|Overall Study|Study Terminated by Sponsor|87|||
130091461|NCT02087085|468290704|FG001|Overall Study|Study Terminated by Sponsor|80|||
130091462|NCT02087085|468290703|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130091463|NCT02087085|468290704|FG001|Overall Study|Other Miscellaneous Reasons|4|||
129961997|NCT02705625|467825645|FG002|Overall Study|Lost to Follow-up|1|||
129961998|NCT02705625|467825643|FG000|Overall Study|Non-compliance|0|||
129961999|NCT02705625|467825644|FG001|Overall Study|Non-compliance|1|||
129962000|NCT02705625|467825645|FG002|Overall Study|Non-compliance|1|||
129962001|NCT02705625|467825643|FG000|Overall Study|Overdosing|0|||
129962002|NCT02705625|467825644|FG001|Overall Study|Overdosing|0|||
129962003|NCT02705625|467825645|FG002|Overall Study|Overdosing|1|||
129962004|NCT00494026|467825646|FG000|Overall Study|Sponsor Decision|4|||
129962005|NCT04544865|467825647|FG000|Overall Study|Death|0|||
129962006|NCT04544865|467825648|FG001|Overall Study|Death|2|||
129962007|NCT04544865|467825647|FG000|Overall Study|Lost to Follow-up|11|||
129962008|NCT04544865|467825648|FG001|Overall Study|Lost to Follow-up|7|||
129962009|NCT04544865|467825647|FG000|Overall Study|Withdrawal by Subject|0|||
129962010|NCT04544865|467825648|FG001|Overall Study|Withdrawal by Subject|1|||
129962011|NCT04544865|467825647|FG000|Overall Study|Other|0|||
129962012|NCT04544865|467825648|FG001|Overall Study|Other|1|||
129962013|NCT02815735|467825649|FG000|First Intervention (4 Weeks)|Discomfort|1|||
129962014|NCT02815735|467825650|FG001|First Intervention (4 Weeks)|Discomfort|0|||
129962015|NCT02815735|467825649|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
129962016|NCT02815735|467825650|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129962017|NCT02815735|467825649|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
129962018|NCT02815735|467825650|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
129962019|NCT02815735|467825649|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
129962020|NCT02815735|467825650|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
129962021|NCT00225277|467825656|FG000|Overall Study|Adverse Event|30|||
129962022|NCT00225277|467825657|FG001|Overall Study|Adverse Event|34|||
129962023|NCT00225277|467825656|FG000|Overall Study|Lack of Efficacy|4|||
129962024|NCT00225277|467825657|FG001|Overall Study|Lack of Efficacy|1|||
129962025|NCT00225277|467825656|FG000|Overall Study|Lost to Follow-up|4|||
129962026|NCT00225277|467825657|FG001|Overall Study|Lost to Follow-up|6|||
129962027|NCT00225277|467825656|FG000|Overall Study|Physician Decision|6|||
129962028|NCT00225277|467825657|FG001|Overall Study|Physician Decision|8|||
129962029|NCT00225277|467825656|FG000|Overall Study|Protocol Violation|6|||
129962030|NCT00225277|467825657|FG001|Overall Study|Protocol Violation|3|||
129962031|NCT00225277|467825656|FG000|Overall Study|Withdrawal by Subject|40|||
129962032|NCT00225277|467825657|FG001|Overall Study|Withdrawal by Subject|34|||
129962033|NCT00225277|467825656|FG000|Overall Study|Other|7|||
129962034|NCT00225277|467825657|FG001|Overall Study|Other|9|||
129962035|NCT04582669|467825664|FG000|Overall Study|Subject missed appointment(s).|1|||
129962036|NCT04582669|467825665|FG001|Overall Study|Subject missed appointment(s).|0|||
129962037|NCT04582669|467825666|FG002|Overall Study|Subject missed appointment(s).|1|||
129962038|NCT04582669|467825667|FG003|Overall Study|Subject missed appointment(s).|2|||
129962039|NCT04582669|467825664|FG000|Overall Study|Protocol Violation|0|||
129962040|NCT04582669|467825665|FG001|Overall Study|Protocol Violation|1|||
129962041|NCT04582669|467825666|FG002|Overall Study|Protocol Violation|1|||
129962042|NCT04582669|467825667|FG003|Overall Study|Protocol Violation|0|||
129962043|NCT00591409|467825668|FG000|Overall Study|Not Treated|0|||
129962044|NCT00591409|467825669|FG001|Overall Study|Not Treated|0|||
129962045|NCT00591409|467825670|FG002|Overall Study|Not Treated|0|||
129962046|NCT00591409|467825671|FG003|Overall Study|Not Treated|0|||
129962047|NCT00591409|467825672|FG004|Overall Study|Not Treated|1|||
129962048|NCT00591409|467825673|FG005|Overall Study|Not Treated|0|||
129962049|NCT00591409|467825674|FG006|Overall Study|Not Treated|0|||
129962050|NCT00591409|467825675|FG007|Overall Study|Not Treated|0|||
129962051|NCT00591409|467825676|FG008|Overall Study|Not Treated|0|||
129962052|NCT00591409|467825677|FG009|Overall Study|Not Treated|1|||
129962053|NCT00677092|467825678|FG000|Overall Study|Adverse Event|1|||
129962054|NCT00677092|467825678|FG000|Overall Study|Lost to Follow-up|1|||
129962055|NCT00677092|467825678|FG000|Overall Study|Withdrawal by Subject|3|||
129962056|NCT00677092|467825678|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
129962057|NCT00920699|467825679|FG000|Overall Study|Withdrawal by Subject|2|||
129962058|NCT00920699|467825680|FG001|Overall Study|Withdrawal by Subject|0|||
129962059|NCT00920699|467825681|FG002|Overall Study|Withdrawal by Subject|2|||
129962060|NCT00920699|467825679|FG000|Overall Study|no longer met eligibility|0|||
129962061|NCT00920699|467825680|FG001|Overall Study|no longer met eligibility|1|||
129962062|NCT00920699|467825681|FG002|Overall Study|no longer met eligibility|0|||
129962063|NCT00920699|467825679|FG000|Overall Study|Lost to Follow-up|0|||
129962064|NCT00920699|467825680|FG001|Overall Study|Lost to Follow-up|0|||
129962065|NCT00920699|467825681|FG002|Overall Study|Lost to Follow-up|2|||
129962066|NCT00363649|467825684|FG000|Overall Study|Withdrawal by Subject|1|||
129962067|NCT00363649|467825685|FG001|Overall Study|Withdrawal by Subject|1|||
129962068|NCT00363649|467825684|FG000|Overall Study|Adverse Event|6|||
129962069|NCT00363649|467825685|FG001|Overall Study|Adverse Event|0|||
129962070|NCT04947436|467825688|FG000|Overall Study|Lost to Follow-up|3|||
129962071|NCT04947436|467825689|FG001|Overall Study|Lost to Follow-up|7|||
129962072|NCT04947436|467825690|FG002|Overall Study|Lost to Follow-up|5|||
129962073|NCT04947436|467825688|FG000|Overall Study|Death|1|||
129962074|NCT04947436|467825689|FG001|Overall Study|Death|1|||
129962075|NCT04947436|467825690|FG002|Overall Study|Death|1|||
129962076|NCT02161185|467825692|FG000|Treatment Phase|Administrative/Other|7|||
129962077|NCT00372255|467825693|FG000|Overall Study|Withdrawn for other reasons|2|||
129962078|NCT00372255|467825694|FG001|Overall Study|Withdrawn for other reasons|1|||
129962079|NCT02970305|467825700|FG000|Overall Study|Adverse Event|10|||
129962080|NCT02970305|467825701|FG001|Overall Study|Adverse Event|6|||
129962081|NCT02970305|467825700|FG000|Overall Study|Lack of Efficacy|1|||
129962082|NCT02970305|467825701|FG001|Overall Study|Lack of Efficacy|1|||
129962083|NCT02970305|467825700|FG000|Overall Study|Noncompliance with study drug|2|||
129962084|NCT02970305|467825701|FG001|Overall Study|Noncompliance with study drug|4|||
129962085|NCT02970305|467825700|FG000|Overall Study|Protocol Violation|2|||
130091464|NCT00682539|468290712|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
130091465|NCT00682539|468290713|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
130091466|NCT00682539|468290714|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
130091467|NCT00682539|468290712|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
130091468|NCT00682539|468290713|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
130091469|NCT00682539|468290714|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
130091470|NCT03339999|468290715|FG000|Overall Study|Adverse Event|1|||
130091471|NCT03339999|468290716|FG001|Overall Study|Adverse Event|2|||
130091472|NCT03339999|468290717|FG002|Overall Study|Adverse Event|2|||
130091473|NCT03339999|468290718|FG003|Overall Study|Adverse Event|1|||
130091474|NCT03339999|468290715|FG000|Overall Study|Lack of Efficacy|0|||
130091475|NCT03339999|468290716|FG001|Overall Study|Lack of Efficacy|1|||
130091476|NCT03339999|468290717|FG002|Overall Study|Lack of Efficacy|0|||
130091477|NCT03339999|468290718|FG003|Overall Study|Lack of Efficacy|0|||
130091478|NCT03339999|468290715|FG000|Overall Study|Lost to Follow-up|0|||
130091479|NCT03339999|468290716|FG001|Overall Study|Lost to Follow-up|0|||
130091480|NCT03339999|468290717|FG002|Overall Study|Lost to Follow-up|0|||
130091481|NCT03339999|468290718|FG003|Overall Study|Lost to Follow-up|1|||
130091482|NCT03339999|468290715|FG000|Overall Study|Study Terminated by Sponsor|6|||
130091483|NCT03339999|468290716|FG001|Overall Study|Study Terminated by Sponsor|3|||
130091484|NCT03339999|468290717|FG002|Overall Study|Study Terminated by Sponsor|4|||
130091485|NCT03339999|468290718|FG003|Overall Study|Study Terminated by Sponsor|3|||
130091486|NCT01729559|468290729|FG000|Overall Study|Protocol Violation|31|||
130091487|NCT01729559|468290730|FG001|Overall Study|Protocol Violation|28|||
130091488|NCT03764813|468290731|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
130091489|NCT03764813|468290732|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
130091490|NCT03764813|468290733|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
130091491|NCT03764813|468290734|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
130091492|NCT03432819|468290736|FG000|Overall Study|Lost to Follow-up|2|||
130091493|NCT03432819|468290737|FG001|Overall Study|Lost to Follow-up|2|||
130091494|NCT03432819|468290736|FG000|Overall Study|Withdrawal by Subject|5|||
130091495|NCT03432819|468290737|FG001|Overall Study|Withdrawal by Subject|3|||
130091496|NCT04382066|468290739|FG000|Overall Study|Adverse Event|1|||
130091497|NCT04382066|468290740|FG001|Overall Study|Adverse Event|0|||
130091498|NCT04382066|468290741|FG002|Overall Study|Adverse Event|0|||
130091499|NCT04382066|468290739|FG000|Overall Study|Death|1|||
130091500|NCT04382066|468290740|FG001|Overall Study|Death|0|||
130091501|NCT04382066|468290741|FG002|Overall Study|Death|1|||
130091502|NCT00504595|468290742|FG000|Overall Study|Lack of Efficacy|1|||
130091503|NCT00504595|468290743|FG001|Overall Study|Lack of Efficacy|0|||
130091504|NCT00504595|468290744|FG002|Overall Study|Lack of Efficacy|0|||
130091505|NCT00504595|468290745|FG003|Overall Study|Lack of Efficacy|0|||
130091506|NCT00504595|468290742|FG000|Overall Study|Other|0|||
130091507|NCT00504595|468290743|FG001|Overall Study|Other|0|||
130091508|NCT00504595|468290744|FG002|Overall Study|Other|2|||
130091509|NCT00504595|468290745|FG003|Overall Study|Other|0|||
130091510|NCT03326323|468290746|FG000|Overall Study|Unable to receive ANH protocol|3|||
130121949|NCT00048048|468408736|FG005|Core Treatment|Adverse Event|0|||
130121950|NCT00048048|468408737|FG006|Core Treatment|Adverse Event|0|||
130121951|NCT00048048|468408738|FG007|Core Treatment|Adverse Event|1|||
129962086|NCT02970305|467825701|FG001|Overall Study|Protocol Violation|2|||
129962087|NCT02970305|467825700|FG000|Overall Study|Withdrawal by Subject|12|||
129962088|NCT02970305|467825701|FG001|Overall Study|Withdrawal by Subject|11|||
129962089|NCT02970305|467825700|FG000|Overall Study|Not further specified|1|||
129962090|NCT02970305|467825701|FG001|Overall Study|Not further specified|2|||
129962091|NCT02970305|467825700|FG000|Overall Study|Lost to Follow-up|1|||
130091511|NCT04225026|468290748|FG000|Overall Study|Withdrawal by Subject|4|||
130091512|NCT04225026|468290748|FG000|Overall Study|Adverse Event|1|||
130091513|NCT04225026|468290748|FG000|Overall Study|Other|1|||
130091514|NCT04225026|468290748|FG000|Overall Study|Death|11|||
130091515|NCT04225026|468290748|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
130091516|NCT04738123|468290752|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
130091517|NCT04738123|468290753|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
130121952|NCT00048048|468408739|FG008|Core Treatment|Adverse Event|0|||
129962092|NCT02970305|467825701|FG001|Overall Study|Lost to Follow-up|2|||
129962093|NCT00983892|467825702|FG000|Overall Study|Withdrawal by Subject|10|||
130091518|NCT04738123|468290752|FG000|Overall Study|Progressive Disease|0|||
130121953|NCT00048048|468408740|FG009|Core Treatment|Adverse Event|0|||
130121954|NCT00048048|468408741|FG010|Core Treatment|Adverse Event|0|||
130121955|NCT00048048|468408742|FG011|Core Treatment|Adverse Event|0|||
130121956|NCT00048048|468408731|FG000|Extension Year 1|Early withdrawals|0|||
130121957|NCT00048048|468408732|FG001|Extension Year 1|Early withdrawals|0|||
130121958|NCT00048048|468408733|FG002|Extension Year 1|Early withdrawals|0|||
130121959|NCT00048048|468408734|FG003|Extension Year 1|Early withdrawals|0|||
130121960|NCT00048048|468408735|FG004|Extension Year 1|Early withdrawals|0|||
130121961|NCT00048048|468408736|FG005|Extension Year 1|Early withdrawals|0|||
130121962|NCT00048048|468408737|FG006|Extension Year 1|Early withdrawals|0|||
130121963|NCT00048048|468408738|FG007|Extension Year 1|Early withdrawals|0|||
130121964|NCT00048048|468408739|FG008|Extension Year 1|Early withdrawals|0|||
130121965|NCT00048048|468408740|FG009|Extension Year 1|Early withdrawals|2|||
130121966|NCT00048048|468408741|FG010|Extension Year 1|Early withdrawals|2|||
130121967|NCT00048048|468408742|FG011|Extension Year 1|Early withdrawals|4|||
130121968|NCT00048048|468408731|FG000|Extension Year 2|Early withdrawals|0|||
130121969|NCT00048048|468408732|FG001|Extension Year 2|Early withdrawals|0|||
130121970|NCT00048048|468408733|FG002|Extension Year 2|Early withdrawals|0|||
130121971|NCT00048048|468408734|FG003|Extension Year 2|Early withdrawals|0|||
130121972|NCT00048048|468408735|FG004|Extension Year 2|Early withdrawals|0|||
130121973|NCT00048048|468408736|FG005|Extension Year 2|Early withdrawals|0|||
130121974|NCT00048048|468408737|FG006|Extension Year 2|Early withdrawals|0|||
130121975|NCT00048048|468408738|FG007|Extension Year 2|Early withdrawals|0|||
130121976|NCT00048048|468408739|FG008|Extension Year 2|Early withdrawals|0|||
130121977|NCT00048048|468408740|FG009|Extension Year 2|Early withdrawals|0|||
130121978|NCT00048048|468408741|FG010|Extension Year 2|Early withdrawals|4|||
130121979|NCT00048048|468408742|FG011|Extension Year 2|Early withdrawals|2|||
130121980|NCT02684578|468408743|FG000|Overall Study|Withdrawal by Subject|10|||
130121981|NCT02684578|468408744|FG001|Overall Study|Withdrawal by Subject|7|||
130121982|NCT02684578|468408743|FG000|Overall Study|Lost to Follow-up|0|||
130121983|NCT02684578|468408744|FG001|Overall Study|Lost to Follow-up|3|||
130121984|NCT02684578|468408743|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
130121985|NCT02684578|468408744|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
130121986|NCT02684578|468408743|FG000|Overall Study|Missing follow-up data|0|||
130121987|NCT02684578|468408744|FG001|Overall Study|Missing follow-up data|1|||
130121988|NCT00973700|468408745|FG000|Overall Study|Withdrawal by Subject|2|||
130121989|NCT00973700|468408746|FG001|Overall Study|Withdrawal by Subject|2|||
130121990|NCT00973700|468408747|FG002|Overall Study|Withdrawal by Subject|8|||
130121991|NCT00973700|468408748|FG003|Overall Study|Withdrawal by Subject|4|||
130121992|NCT00973700|468408749|FG004|Overall Study|Withdrawal by Subject|4|||
130121993|NCT00973700|468408745|FG000|Overall Study|Lost to Follow-up|5|||
130121994|NCT00973700|468408746|FG001|Overall Study|Lost to Follow-up|0|||
130121995|NCT00973700|468408747|FG002|Overall Study|Lost to Follow-up|1|||
130121996|NCT00973700|468408748|FG003|Overall Study|Lost to Follow-up|8|||
130121997|NCT00973700|468408749|FG004|Overall Study|Lost to Follow-up|5|||
130121998|NCT00973700|468408745|FG000|Overall Study|Inappropriate enrolment|0|||
130121999|NCT00973700|468408746|FG001|Overall Study|Inappropriate enrolment|0|||
130122000|NCT00973700|468408747|FG002|Overall Study|Inappropriate enrolment|0|||
130122001|NCT00973700|468408748|FG003|Overall Study|Inappropriate enrolment|4|||
130122002|NCT00973700|468408749|FG004|Overall Study|Inappropriate enrolment|0|||
130122003|NCT00973700|468408745|FG000|Overall Study|Unable to Classify|0|||
130122004|NCT00973700|468408746|FG001|Overall Study|Unable to Classify|0|||
130122005|NCT00973700|468408747|FG002|Overall Study|Unable to Classify|1|||
130122006|NCT00973700|468408748|FG003|Overall Study|Unable to Classify|2|||
130122007|NCT00973700|468408749|FG004|Overall Study|Unable to Classify|1|||
130122008|NCT05518487|468408750|FG000|Overall Study|Withdrawal by Subject|3|||
130122009|NCT02497781|468408752|FG000|Overall Study|Withdrawal by Subject|2|||
130122010|NCT02497781|468408753|FG001|Overall Study|Withdrawal by Subject|0|||
130122011|NCT02497781|468408752|FG000|Overall Study|Lack of Efficacy|0|||
130122012|NCT02497781|468408753|FG001|Overall Study|Lack of Efficacy|1|||
130122013|NCT02497781|468408752|FG000|Overall Study|Randomised but not treated|1|||
130122014|NCT02497781|468408753|FG001|Overall Study|Randomised but not treated|1|||
130122015|NCT02497781|468408752|FG000|Overall Study|Lost to Follow-up|1|||
130122016|NCT02497781|468408753|FG001|Overall Study|Lost to Follow-up|1|||
130122017|NCT02752776|468408754|FG000|Overall Study|Adverse Event|15|||
130122018|NCT02752776|468408755|FG001|Overall Study|Adverse Event|23|||
130122019|NCT02752776|468408756|FG002|Overall Study|Adverse Event|11|||
130122020|NCT02752776|468408754|FG000|Overall Study|Lack of Efficacy|2|||
130122021|NCT02752776|468408755|FG001|Overall Study|Lack of Efficacy|6|||
130122022|NCT02752776|468408756|FG002|Overall Study|Lack of Efficacy|14|||
130122023|NCT02752776|468408754|FG000|Overall Study|Lost to Follow-up|11|||
130122024|NCT02752776|468408755|FG001|Overall Study|Lost to Follow-up|12|||
130122025|NCT02752776|468408756|FG002|Overall Study|Lost to Follow-up|4|||
130122026|NCT02752776|468408754|FG000|Overall Study|Non-compliance with study treatment|0|||
130122027|NCT02752776|468408755|FG001|Overall Study|Non-compliance with study treatment|0|||
130122028|NCT02752776|468408756|FG002|Overall Study|Non-compliance with study treatment|1|||
130122029|NCT02752776|468408754|FG000|Overall Study|Physician Decision|2|||
130122030|NCT02752776|468408755|FG001|Overall Study|Physician Decision|6|||
130122031|NCT02752776|468408756|FG002|Overall Study|Physician Decision|2|||
130122032|NCT02752776|468408754|FG000|Overall Study|Pregnancy|1|||
130122033|NCT02752776|468408755|FG001|Overall Study|Pregnancy|6|||
130122034|NCT02752776|468408756|FG002|Overall Study|Pregnancy|3|||
130122035|NCT02752776|468408754|FG000|Overall Study|Protocol Violation|10|||
130122036|NCT02752776|468408755|FG001|Overall Study|Protocol Violation|13|||
130122037|NCT02752776|468408756|FG002|Overall Study|Protocol Violation|6|||
130122038|NCT02752776|468408754|FG000|Overall Study|Subject/guardian decision|8|||
130122039|NCT02752776|468408755|FG001|Overall Study|Subject/guardian decision|6|||
130122040|NCT02752776|468408756|FG002|Overall Study|Subject/guardian decision|4|||
130122041|NCT02752776|468408754|FG000|Overall Study|Death|0|||
130122042|NCT02752776|468408755|FG001|Overall Study|Death|0|||
130122043|NCT02752776|468408756|FG002|Overall Study|Death|1|||
130122044|NCT02752776|468408754|FG000|Overall Study|Withdrawal by Subject|3|||
130122045|NCT02752776|468408755|FG001|Overall Study|Withdrawal by Subject|4|||
130122046|NCT02752776|468408756|FG002|Overall Study|Withdrawal by Subject|2|||
130122047|NCT01193608|468408757|FG000|Overall Study|Other|0|||
130122048|NCT01193608|468408758|FG001|Overall Study|Other|1|||
130122049|NCT01193608|468408759|FG002|Overall Study|Other|0|||
130122050|NCT01193608|468408760|FG003|Overall Study|Other|0|||
130122051|NCT01193608|468408761|FG004|Overall Study|Other|0|||
130091519|NCT04738123|468290753|FG001|Overall Study|Progressive Disease|4|||
130091520|NCT04738123|468290752|FG000|Overall Study|Adverse Event|8|||
130091521|NCT04738123|468290753|FG001|Overall Study|Adverse Event|7|||
130091522|NCT04738123|468290752|FG000|Overall Study|Other Reasons|0|||
130091523|NCT04738123|468290753|FG001|Overall Study|Other Reasons|1|||
130091524|NCT04738123|468290752|FG000|Overall Study|Suicidal or assaultive behavior|0|||
130091525|NCT04738123|468290753|FG001|Overall Study|Suicidal or assaultive behavior|2|||
130091526|NCT04738123|468290752|FG000|Overall Study|Protocol Violation|2|||
130091527|NCT04738123|468290753|FG001|Overall Study|Protocol Violation|2|||
130091528|NCT04738123|468290752|FG000|Overall Study|Consent Withdrawn|35|||
130091529|NCT04738123|468290753|FG001|Overall Study|Consent Withdrawn|22|||
130091530|NCT00851721|468290754|FG000|Overall Study|planned surgery|1|||
130091531|NCT00851721|468290755|FG001|Overall Study|planned surgery|0|||
130091532|NCT00851721|468290754|FG000|Overall Study|Death|1|||
130091533|NCT00851721|468290755|FG001|Overall Study|Death|0|||
130091534|NCT00851721|468290754|FG000|Overall Study|Adverse Event|0|||
130091535|NCT00851721|468290755|FG001|Overall Study|Adverse Event|1|||
130091536|NCT03137433|468290757|FG000|Overall Study|Withdrawal by Subject|11|||
130091537|NCT03137433|468290758|FG001|Overall Study|Withdrawal by Subject|11|||
130091538|NCT03137433|468290757|FG000|Overall Study|Lost to Follow-up|5|||
130091539|NCT03137433|468290758|FG001|Overall Study|Lost to Follow-up|6|||
130091540|NCT03137433|468290757|FG000|Overall Study|Physician Decision|2|||
130091541|NCT03137433|468290758|FG001|Overall Study|Physician Decision|0|||
130091542|NCT03137433|468290757|FG000|Overall Study|Moved out of study area|1|||
130091543|NCT03137433|468290758|FG001|Overall Study|Moved out of study area|0|||
130091544|NCT03137433|468290757|FG000|Overall Study|Too far out of window due to COVID|0|||
130091545|NCT03137433|468290758|FG001|Overall Study|Too far out of window due to COVID|1|||
130091546|NCT00083616|468290759|FG000|Overall Study|Disease Progression|16|||
130091547|NCT00083616|468290759|FG000|Overall Study|Lost to Follow-up|1|||
130091548|NCT00083616|468290759|FG000|Overall Study|Physician Decision|2|||
130091549|NCT00083616|468290759|FG000|Overall Study|Withdrawal by Subject|3|||
130091550|NCT00083616|468290759|FG000|Overall Study|Ineligibility determined|2|||
130091551|NCT00083616|468290759|FG000|Overall Study|Non-compliance|1|||
130091552|NCT00083616|468290759|FG000|Overall Study|Other|6|||
130122052|NCT01193608|468408762|FG005|Overall Study|Other|0|||
130122053|NCT01193608|468408757|FG000|Overall Study|Withdrawal by Subject|0|||
130122054|NCT01193608|468408758|FG001|Overall Study|Withdrawal by Subject|1|||
130122055|NCT01193608|468408759|FG002|Overall Study|Withdrawal by Subject|2|||
130122056|NCT01193608|468408760|FG003|Overall Study|Withdrawal by Subject|3|||
130122057|NCT01193608|468408761|FG004|Overall Study|Withdrawal by Subject|3|||
130122058|NCT01193608|468408762|FG005|Overall Study|Withdrawal by Subject|0|||
130122059|NCT01193608|468408757|FG000|Overall Study|Lost to Follow-up|0|||
130122060|NCT01193608|468408758|FG001|Overall Study|Lost to Follow-up|0|||
130122061|NCT01193608|468408759|FG002|Overall Study|Lost to Follow-up|0|||
130091553|NCT00760994|468290762|FG000|Overall Study|Lost to Follow-up|4|||
130091554|NCT00760994|468290763|FG001|Overall Study|Lost to Follow-up|4|||
130091555|NCT00760994|468290764|FG002|Overall Study|Lost to Follow-up|3|||
130122062|NCT01193608|468408760|FG003|Overall Study|Lost to Follow-up|0|||
130091556|NCT02132312|468290765|FG000|Overall Study|Adverse Event|2|||
130091557|NCT02132312|468290766|FG001|Overall Study|Adverse Event|0|||
130091558|NCT02132312|468290765|FG000|Overall Study|Physician Decision|1|||
130091559|NCT02132312|468290766|FG001|Overall Study|Physician Decision|1|||
130091560|NCT02132312|468290765|FG000|Overall Study|Protocol Violation|0|||
130091561|NCT02132312|468290766|FG001|Overall Study|Protocol Violation|1|||
130122063|NCT01193608|468408761|FG004|Overall Study|Lost to Follow-up|1|||
130122064|NCT01193608|468408762|FG005|Overall Study|Lost to Follow-up|2|||
130122065|NCT01193608|468408757|FG000|Overall Study|Adverse Event|0|||
130122066|NCT01193608|468408758|FG001|Overall Study|Adverse Event|0|||
130091562|NCT02132312|468290765|FG000|Overall Study|Withdrawal by Subject|1|||
130091563|NCT02132312|468290766|FG001|Overall Study|Withdrawal by Subject|0|||
130091564|NCT02132312|468290765|FG000|Overall Study|Lost to Follow-up|2|||
130091565|NCT02132312|468290766|FG001|Overall Study|Lost to Follow-up|1|||
130091566|NCT03258710|468290767|FG000|Overall Study|Adverse Event|1|||
130091567|NCT03258710|468290767|FG000|Overall Study|Protocol-defined stopping criteria|1|||
130091568|NCT03258710|468290767|FG000|Overall Study|Physician Decision|1|||
130091569|NCT03451630|468290768|FG000|Overall Study|Death|15|||
130091570|NCT03451630|468290769|FG001|Overall Study|Death|16|||
130091571|NCT03451630|468290770|FG002|Overall Study|Death|11|||
130091572|NCT03451630|468290768|FG000|Overall Study|Lost to Follow-up|9|||
130091573|NCT03451630|468290769|FG001|Overall Study|Lost to Follow-up|0|||
130091574|NCT03451630|468290770|FG002|Overall Study|Lost to Follow-up|4|||
130091575|NCT03451630|468290768|FG000|Overall Study|Withdrawal by Subject|0|||
130091576|NCT03451630|468290769|FG001|Overall Study|Withdrawal by Subject|3|||
130091577|NCT03451630|468290770|FG002|Overall Study|Withdrawal by Subject|0|||
130091578|NCT03451630|468290768|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
130091579|NCT03451630|468290769|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
130091580|NCT03451630|468290770|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
130091581|NCT02041533|468290774|FG000|Pre-Treatment Period|Disease Progression|1|||
130091582|NCT02041533|468290775|FG001|Pre-Treatment Period|Disease Progression|1|||
130091583|NCT02041533|468290774|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
130091584|NCT02041533|468290775|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
130091585|NCT02041533|468290774|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
130091586|NCT02041533|468290775|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
130091587|NCT02041533|468290774|FG000|Treatment Period|Disease progression|189|||
130091588|NCT02041533|468290775|FG001|Treatment Period|Disease progression|146|||
130091589|NCT02041533|468290774|FG000|Treatment Period|Study drug toxicity|30|||
130091590|NCT02041533|468290775|FG001|Treatment Period|Study drug toxicity|34|||
130091591|NCT02041533|468290774|FG000|Treatment Period|Death|1|||
130091592|NCT02041533|468290775|FG001|Treatment Period|Death|0|||
130091593|NCT02041533|468290774|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
130091594|NCT02041533|468290775|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
130091595|NCT02041533|468290774|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
130091596|NCT02041533|468290775|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
130091597|NCT02041533|468290774|FG000|Treatment Period|Participant withdrew consent|2|||
130091598|NCT02041533|468290775|FG001|Treatment Period|Participant withdrew consent|2|||
130091599|NCT02041533|468290774|FG000|Treatment Period|Maximum clinical benefit|0|||
130091600|NCT02041533|468290775|FG001|Treatment Period|Maximum clinical benefit|18|||
130091601|NCT02041533|468290774|FG000|Treatment Period|Poor/Non-compliance|1|||
130091602|NCT02041533|468290775|FG001|Treatment Period|Poor/Non-compliance|0|||
130091603|NCT02041533|468290774|FG000|Treatment Period|Administrative reason by sponsor|1|||
130091604|NCT02041533|468290775|FG001|Treatment Period|Administrative reason by sponsor|0|||
130091605|NCT02041533|468290774|FG000|Treatment Period|Other reasons|9|||
130091606|NCT02041533|468290775|FG001|Treatment Period|Other reasons|2|||
130091607|NCT02041533|468290774|FG000|Treatment Period|Not Reported|0|||
130091608|NCT02041533|468290775|FG001|Treatment Period|Not Reported|1|||
130091609|NCT00565721|468290776|FG000|Overall Study|Screen Failure|2|||
130091610|NCT00565721|468290776|FG000|Overall Study|Lost to Follow-up|6|||
130091611|NCT00565721|468290776|FG000|Overall Study|Technical Problems|1|||
130091612|NCT00565721|468290776|FG000|Overall Study|Physician Decision|2|||
130091613|NCT00565721|468290776|FG000|Overall Study|Other reasons|6|||
130091614|NCT02500706|468290777|FG000|Overall Study|Adverse Event|0|||
130091615|NCT02500706|468290778|FG001|Overall Study|Adverse Event|0|||
130091616|NCT02500706|468290779|FG002|Overall Study|Adverse Event|1|||
130091617|NCT02500706|468290777|FG000|Overall Study|Lost to Follow-up|0|||
130091618|NCT02500706|468290778|FG001|Overall Study|Lost to Follow-up|1|||
130091619|NCT02500706|468290779|FG002|Overall Study|Lost to Follow-up|1|||
130091620|NCT02500706|468290777|FG000|Overall Study|Withdrawal by Subject|4|||
130091621|NCT02500706|468290778|FG001|Overall Study|Withdrawal by Subject|6|||
129962094|NCT00983892|467825703|FG001|Overall Study|Withdrawal by Subject|12|||
130091622|NCT02500706|468290779|FG002|Overall Study|Withdrawal by Subject|4|||
130091623|NCT02500706|468290777|FG000|Overall Study|Unclassified|0|||
130091624|NCT02500706|468290778|FG001|Overall Study|Unclassified|0|||
130091625|NCT02500706|468290779|FG002|Overall Study|Unclassified|1|||
130091626|NCT01497899|468290780|FG000|Double-Blind Phase|Randomized but not Treated|1|||
130091627|NCT01497899|468290781|FG001|Double-Blind Phase|Randomized but not Treated|0|||
130091628|NCT01497899|468290782|FG002|Double-Blind Phase|Randomized but not Treated|0|||
130091629|NCT01497899|468290783|FG003|Double-Blind Phase|Randomized but not Treated|0|||
130091630|NCT01497899|468290780|FG000|Double-Blind Phase|Adverse Event|1|||
130091631|NCT01497899|468290781|FG001|Double-Blind Phase|Adverse Event|0|||
129962095|NCT00312845|467825704|FG000|Overall Study|Adverse Event|19|||
129962096|NCT00312845|467825705|FG001|Overall Study|Adverse Event|5|||
129962097|NCT00312845|467825704|FG000|Overall Study|Death|2|||
129962098|NCT00312845|467825705|FG001|Overall Study|Death|2|||
129962099|NCT00312845|467825704|FG000|Overall Study|Withdrawal by Subject|14|||
129962100|NCT00312845|467825705|FG001|Overall Study|Withdrawal by Subject|6|||
130091632|NCT01497899|468290782|FG002|Double-Blind Phase|Adverse Event|0|||
130091633|NCT01497899|468290783|FG003|Double-Blind Phase|Adverse Event|0|||
130091634|NCT01497899|468290780|FG000|Double-Blind Phase|Lack of Efficacy|0|||
130091635|NCT01497899|468290781|FG001|Double-Blind Phase|Lack of Efficacy|1|||
130091636|NCT01497899|468290782|FG002|Double-Blind Phase|Lack of Efficacy|0|||
130091637|NCT01497899|468290783|FG003|Double-Blind Phase|Lack of Efficacy|0|||
130091638|NCT01497899|468290780|FG000|Double-Blind Phase|Investigator's Discretion|1|||
130091639|NCT01497899|468290781|FG001|Double-Blind Phase|Investigator's Discretion|0|||
130091640|NCT01497899|468290782|FG002|Double-Blind Phase|Investigator's Discretion|0|||
130091641|NCT01497899|468290783|FG003|Double-Blind Phase|Investigator's Discretion|0|||
130091642|NCT01497899|468290780|FG000|Double-Blind Phase|Withdrew Consent|0|||
130091643|NCT01497899|468290781|FG001|Double-Blind Phase|Withdrew Consent|1|||
130091644|NCT01497899|468290782|FG002|Double-Blind Phase|Withdrew Consent|0|||
130091645|NCT01497899|468290783|FG003|Double-Blind Phase|Withdrew Consent|0|||
130091646|NCT01497899|468290780|FG000|Double-Blind Phase|Lost to Follow-up|3|||
130091647|NCT01497899|468290781|FG001|Double-Blind Phase|Lost to Follow-up|2|||
130091648|NCT01497899|468290782|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130091649|NCT01497899|468290783|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130091650|NCT01497899|468290780|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
130091651|NCT01497899|468290781|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
130091652|NCT01497899|468290782|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
130091653|NCT01497899|468290783|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
130091654|NCT01497899|468290780|FG000|Open-Label Extension Phase|Adverse Event|1|||
130091655|NCT01497899|468290781|FG001|Open-Label Extension Phase|Adverse Event|0|||
130091656|NCT01497899|468290782|FG002|Open-Label Extension Phase|Adverse Event|0|||
130091657|NCT01497899|468290783|FG003|Open-Label Extension Phase|Adverse Event|0|||
130091658|NCT01497899|468290780|FG000|Open-Label Extension Phase|Death|1|||
130091659|NCT01497899|468290781|FG001|Open-Label Extension Phase|Death|0|||
130091660|NCT01497899|468290782|FG002|Open-Label Extension Phase|Death|0|||
130091661|NCT01497899|468290783|FG003|Open-Label Extension Phase|Death|0|||
130091662|NCT01497899|468290780|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
130091663|NCT01497899|468290781|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
130091664|NCT01497899|468290782|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
130091665|NCT01497899|468290783|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
130091666|NCT01497899|468290780|FG000|Open-Label Extension Phase|Pregnancy|0|||
130091667|NCT01497899|468290781|FG001|Open-Label Extension Phase|Pregnancy|1|||
130091668|NCT01497899|468290782|FG002|Open-Label Extension Phase|Pregnancy|1|||
130091669|NCT01497899|468290783|FG003|Open-Label Extension Phase|Pregnancy|0|||
130091670|NCT01497899|468290780|FG000|Open-Label Extension Phase|Protocol Violation|0|||
130091671|NCT01497899|468290781|FG001|Open-Label Extension Phase|Protocol Violation|0|||
130091672|NCT01497899|468290782|FG002|Open-Label Extension Phase|Protocol Violation|1|||
130091673|NCT01497899|468290783|FG003|Open-Label Extension Phase|Protocol Violation|0|||
130091674|NCT01497899|468290780|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
130091675|NCT01497899|468290781|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
130091676|NCT01497899|468290782|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
130091677|NCT01497899|468290783|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
130091678|NCT00286234|468290785|FG000|Overall Study|Protocol Violation|1|||
130091679|NCT00286234|468290786|FG001|Overall Study|Protocol Violation|2|||
130091680|NCT00286234|468290787|FG002|Overall Study|Protocol Violation|0|||
130091681|NCT00286234|468290788|FG003|Overall Study|Protocol Violation|1|||
130091682|NCT00286234|468290785|FG000|Overall Study|Physician Decision|1|||
129962101|NCT00312845|467825704|FG000|Overall Study|Disease Progression|56|||
129962102|NCT00312845|467825705|FG001|Overall Study|Disease Progression|77|||
129962103|NCT00312845|467825704|FG000|Overall Study|Lost to Follow-up|2|||
129962104|NCT00312845|467825705|FG001|Overall Study|Lost to Follow-up|0|||
129962105|NCT00312845|467825704|FG000|Overall Study|Other|6|||
129962106|NCT00312845|467825705|FG001|Overall Study|Other|5|||
129962107|NCT03512288|467825708|FG000|Overall Study|Adverse Event|1|||
129962108|NCT03512288|467825709|FG001|Overall Study|Adverse Event|0|||
129962109|NCT03512288|467825708|FG000|Overall Study|Lost to Follow-up|12|||
129962110|NCT03512288|467825709|FG001|Overall Study|Lost to Follow-up|15|||
129962111|NCT03512288|467825708|FG000|Overall Study|Physician Decision|0|||
129962112|NCT03512288|467825709|FG001|Overall Study|Physician Decision|2|||
129962113|NCT03512288|467825708|FG000|Overall Study|Protocol Violation|6|||
130091683|NCT00286234|468290786|FG001|Overall Study|Physician Decision|0|||
130091684|NCT00286234|468290787|FG002|Overall Study|Physician Decision|0|||
130091685|NCT00286234|468290788|FG003|Overall Study|Physician Decision|1|||
130091686|NCT00286234|468290785|FG000|Overall Study|Adverse Event|0|||
130091687|NCT00286234|468290786|FG001|Overall Study|Adverse Event|0|||
130091688|NCT00286234|468290787|FG002|Overall Study|Adverse Event|0|||
130091689|NCT00286234|468290788|FG003|Overall Study|Adverse Event|1|||
129962114|NCT03512288|467825709|FG001|Overall Study|Protocol Violation|4|||
129962115|NCT03512288|467825708|FG000|Overall Study|Medication error without associated adverse event|1|||
130091690|NCT00286234|468290785|FG000|Overall Study|Adverse Event|0|||
130091691|NCT00286234|468290786|FG001|Overall Study|Adverse Event|0|||
130091692|NCT00286234|468290787|FG002|Overall Study|Adverse Event|0|||
130091693|NCT00286234|468290788|FG003|Overall Study|Adverse Event|1|||
130091694|NCT01874288|468290791|FG000|Overall Study|Withdrawal by Subject|1|||
130091695|NCT01874288|468290792|FG001|Overall Study|Withdrawal by Subject|0|||
130091696|NCT01874288|468290793|FG002|Overall Study|Withdrawal by Subject|2|||
130091697|NCT01874288|468290794|FG003|Overall Study|Withdrawal by Subject|1|||
130091698|NCT01874288|468290795|FG004|Overall Study|Withdrawal by Subject|1|||
130091699|NCT01874288|468290791|FG000|Overall Study|Physician Decision|0|||
130091700|NCT01874288|468290792|FG001|Overall Study|Physician Decision|0|||
130091701|NCT01874288|468290793|FG002|Overall Study|Physician Decision|0|||
130091702|NCT01874288|468290794|FG003|Overall Study|Physician Decision|1|||
130091703|NCT01874288|468290795|FG004|Overall Study|Physician Decision|0|||
130091704|NCT01874288|468290791|FG000|Overall Study|Progressive disease|2|||
130091705|NCT01874288|468290792|FG001|Overall Study|Progressive disease|0|||
130091706|NCT01874288|468290793|FG002|Overall Study|Progressive disease|3|||
130091707|NCT01874288|468290794|FG003|Overall Study|Progressive disease|5|||
130091708|NCT01874288|468290795|FG004|Overall Study|Progressive disease|1|||
130091709|NCT00591786|468290800|FG000|Overall Study|Withdrawal of Informed Consent|0|||
130091710|NCT00591786|468290801|FG001|Overall Study|Withdrawal of Informed Consent|0|||
130091711|NCT00591786|468290802|FG002|Overall Study|Withdrawal of Informed Consent|1|||
130091712|NCT00591786|468290803|FG003|Overall Study|Withdrawal of Informed Consent|0|||
130091713|NCT00591786|468290804|FG004|Overall Study|Withdrawal of Informed Consent|0|||
130091714|NCT00591786|468290805|FG005|Overall Study|Withdrawal of Informed Consent|0|||
130091715|NCT00591786|468290806|FG006|Overall Study|Withdrawal of Informed Consent|0|||
130091716|NCT00591786|468290807|FG007|Overall Study|Withdrawal of Informed Consent|0|||
130091717|NCT00591786|468290808|FG008|Overall Study|Withdrawal of Informed Consent|0|||
130091718|NCT00591786|468290809|FG009|Overall Study|Withdrawal of Informed Consent|0|||
130091719|NCT00554229|468290810|FG000|Overall Study|Lost to Follow-up|3|||
130091720|NCT00554229|468290811|FG001|Overall Study|Lost to Follow-up|6|||
130091721|NCT00554229|468290810|FG000|Overall Study|Withdrawal by Subject|29|||
130091722|NCT00554229|468290811|FG001|Overall Study|Withdrawal by Subject|37|||
130091723|NCT00554229|468290810|FG000|Overall Study|Adverse Event|71|||
130091724|NCT00554229|468290811|FG001|Overall Study|Adverse Event|39|||
130091725|NCT00554229|468290810|FG000|Overall Study|Protocol Violation|3|||
130091726|NCT00554229|468290811|FG001|Overall Study|Protocol Violation|3|||
130091727|NCT00554229|468290810|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
130091728|NCT00554229|468290811|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
130091729|NCT00554229|468290810|FG000|Overall Study|Randomised but no treatment received|1|||
130091730|NCT00554229|468290811|FG001|Overall Study|Randomised but no treatment received|0|||
130091731|NCT01140646|468290812|FG000|Overall Study|Adverse Event|4|||
130091732|NCT01140646|468290812|FG000|Overall Study|Refused Further Treatment|5|||
130091733|NCT00784836|468290817|FG000|Overall Study|Early Study Termination|3|||
130091734|NCT00660829|468290818|FG000|Overall Study|Adverse Event|3|||
130091735|NCT00660829|468290819|FG001|Overall Study|Adverse Event|4|||
130091736|NCT00660829|468290818|FG000|Overall Study|Lack of Efficacy|2|||
130091737|NCT00660829|468290819|FG001|Overall Study|Lack of Efficacy|3|||
130091738|NCT00660829|468290818|FG000|Overall Study|Non-Compliance|0|||
130091739|NCT00660829|468290819|FG001|Overall Study|Non-Compliance|4|||
130091740|NCT00660829|468290818|FG000|Overall Study|Withdrawal by Subject|1|||
130091741|NCT00660829|468290819|FG001|Overall Study|Withdrawal by Subject|2|||
130091742|NCT00660829|468290818|FG000|Overall Study|Lost to Follow-up|3|||
130091743|NCT00660829|468290819|FG001|Overall Study|Lost to Follow-up|2|||
130122067|NCT01193608|468408759|FG002|Overall Study|Adverse Event|0|||
130122068|NCT01193608|468408760|FG003|Overall Study|Adverse Event|0|||
130122069|NCT01193608|468408761|FG004|Overall Study|Adverse Event|1|||
130122070|NCT01193608|468408762|FG005|Overall Study|Adverse Event|0|||
130091744|NCT00660829|468290818|FG000|Overall Study|Other|9|||
130091745|NCT00660829|468290819|FG001|Overall Study|Other|4|||
130091746|NCT02127931|468290820|FG000|Overall Study|Glitch in Game|1|||
130091747|NCT00690612|468292459|FG000|Overall Study|Adverse Event|1|||
130091748|NCT00690612|468292459|FG000|Overall Study|Withdrawal by Subject|2|||
130091749|NCT01233076|468292460|FG000|Period 2, One Week|Lost to Follow-up|1|||
130091750|NCT01233076|468292461|FG001|Period 2, One Week|Lost to Follow-up|0|||
130091751|NCT01786707|468292463|FG000|Overall Study|Lost to Follow-up|1|||
130091752|NCT01786707|468292464|FG001|Overall Study|Lost to Follow-up|1|||
130091753|NCT02058940|468292465|FG000|Overall Study|Discharged from Critical Care Unit|1|||
130122071|NCT00712010|468408763|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
130091754|NCT01519700|468292466|FG000|Overall Study|Death|1|||
130091755|NCT01519700|468292467|FG001|Overall Study|Death|0|||
130091756|NCT01519700|468292468|FG002|Overall Study|Death|0|||
130091757|NCT01519700|468292469|FG003|Overall Study|Death|0|||
130091758|NCT01519700|468292466|FG000|Overall Study|Lost to Follow-up|0|||
130091759|NCT01519700|468292467|FG001|Overall Study|Lost to Follow-up|0|||
130091760|NCT01519700|468292468|FG002|Overall Study|Lost to Follow-up|1|||
130091761|NCT01519700|468292469|FG003|Overall Study|Lost to Follow-up|1|||
130122072|NCT01946165|468408764|FG000|Overall Study|Physician Decision|2|||
129962116|NCT03512288|467825709|FG001|Overall Study|Medication error without associated adverse event|0|||
129962117|NCT03512288|467825708|FG000|Overall Study|No longer met eligibility criteria|5|||
129962118|NCT03512288|467825709|FG001|Overall Study|No longer met eligibility criteria|2|||
129962119|NCT03512288|467825708|FG000|Overall Study|Withdrawal by parent/guardian|14|||
129962120|NCT03512288|467825709|FG001|Overall Study|Withdrawal by parent/guardian|18|||
129962121|NCT03512288|467825708|FG000|Overall Study|Other|1|||
129962122|NCT03512288|467825709|FG001|Overall Study|Other|1|||
129962123|NCT03512288|467825708|FG000|Overall Study|Randomized but not treated|1|||
129962124|NCT03512288|467825709|FG001|Overall Study|Randomized but not treated|1|||
129962125|NCT01208870|467825710|FG000|Overall Study|Lost to Follow-up|2|||
129962126|NCT01208870|467825711|FG001|Overall Study|Lost to Follow-up|8|||
129962127|NCT02930837|467825714|FG000|Overall Study|Adverse Event|6|||
129962128|NCT02930837|467825714|FG000|Overall Study|Lost to Follow-up|5|||
129962129|NCT02930837|467825714|FG000|Overall Study|Withdrawal by Subject|1|||
129962130|NCT01393613|467825715|FG000|Overall Study|Adverse Event|11|||
129962131|NCT01393613|467825716|FG001|Overall Study|Adverse Event|11|||
129962132|NCT01393613|467825717|FG002|Overall Study|Adverse Event|13|||
129962133|NCT01393613|467825718|FG003|Overall Study|Adverse Event|22|||
129962134|NCT01393613|467825715|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
129962135|NCT01393613|467825716|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
129962136|NCT01393613|467825717|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
129962137|NCT01393613|467825718|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
129962138|NCT01393613|467825715|FG000|Overall Study|Physician Decision|2|||
129962139|NCT01393613|467825716|FG001|Overall Study|Physician Decision|0|||
129962140|NCT01393613|467825717|FG002|Overall Study|Physician Decision|0|||
129962141|NCT01393613|467825718|FG003|Overall Study|Physician Decision|1|||
129962142|NCT01393613|467825715|FG000|Overall Study|Withdrawal by Subject|15|||
129962143|NCT01393613|467825716|FG001|Overall Study|Withdrawal by Subject|25|||
129962144|NCT01393613|467825717|FG002|Overall Study|Withdrawal by Subject|23|||
129962145|NCT01393613|467825718|FG003|Overall Study|Withdrawal by Subject|21|||
129962146|NCT01393613|467825715|FG000|Overall Study|Protocol Deviation|2|||
129962147|NCT01393613|467825716|FG001|Overall Study|Protocol Deviation|1|||
129962148|NCT01393613|467825717|FG002|Overall Study|Protocol Deviation|0|||
129962149|NCT01393613|467825718|FG003|Overall Study|Protocol Deviation|0|||
129962150|NCT01393613|467825715|FG000|Overall Study|Lack of Efficacy|9|||
129962151|NCT01393613|467825716|FG001|Overall Study|Lack of Efficacy|20|||
129962152|NCT01393613|467825717|FG002|Overall Study|Lack of Efficacy|16|||
129962153|NCT01393613|467825718|FG003|Overall Study|Lack of Efficacy|21|||
129962154|NCT03821064|467825721|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
129962155|NCT01283971|467825724|FG000|Overall Study|Adverse Event|3|||
129962156|NCT01283971|467825725|FG001|Overall Study|Adverse Event|5|||
129962157|NCT01283971|467825724|FG000|Overall Study|Insufficient therapeutic responses|3|||
129962158|NCT01283971|467825725|FG001|Overall Study|Insufficient therapeutic responses|3|||
129962159|NCT01283971|467825724|FG000|Overall Study|Protocol Violation|5|||
129962160|NCT01283971|467825725|FG001|Overall Study|Protocol Violation|1|||
129962161|NCT01283971|467825724|FG000|Overall Study|Refused treatment|3|||
129962162|NCT01283971|467825725|FG001|Overall Study|Refused treatment|1|||
129962163|NCT01283971|467825724|FG000|Overall Study|Failure to return|0|||
129962164|NCT01283971|467825725|FG001|Overall Study|Failure to return|1|||
129962165|NCT01283971|467825724|FG000|Overall Study|Administrative reasons|1|||
129962166|NCT01283971|467825725|FG001|Overall Study|Administrative reasons|1|||
129962167|NCT02598934|467825734|FG000|Overall Study|Adverse Event|11|||
129962168|NCT02598934|467825735|FG001|Overall Study|Adverse Event|13|||
129962169|NCT02598934|467825734|FG000|Overall Study|Failure to Return|3|||
129962170|NCT02598934|467825735|FG001|Overall Study|Failure to Return|3|||
129962171|NCT02598934|467825734|FG000|Overall Study|Withdrawal by Subject|2|||
130091762|NCT01519700|468292466|FG000|Overall Study|Physician Decision|1|||
130091763|NCT01519700|468292467|FG001|Overall Study|Physician Decision|1|||
130091764|NCT01519700|468292468|FG002|Overall Study|Physician Decision|3|||
130091765|NCT01519700|468292469|FG003|Overall Study|Physician Decision|0|||
130091766|NCT01519700|468292466|FG000|Overall Study|Withdrawal by Subject|5|||
129962172|NCT02598934|467825735|FG001|Overall Study|Withdrawal by Subject|3|||
129962173|NCT02598934|467825734|FG000|Overall Study|Administrative|2|||
129962174|NCT02598934|467825735|FG001|Overall Study|Administrative|1|||
129962175|NCT02598934|467825734|FG000|Overall Study|Protocol Violation|1|||
129962176|NCT02598934|467825735|FG001|Overall Study|Protocol Violation|2|||
129962177|NCT03325608|467825738|FG000|Overall Study|Lost to Follow-up|23|||
129962178|NCT03325608|467825739|FG001|Overall Study|Lost to Follow-up|23|||
129962179|NCT03325608|467825740|FG002|Overall Study|Lost to Follow-up|30|||
129962180|NCT03325608|467825741|FG003|Overall Study|Lost to Follow-up|30|||
129962181|NCT03325608|467825738|FG000|Overall Study|Death of Caregiver|0|||
129962182|NCT03325608|467825739|FG001|Overall Study|Death of Caregiver|0|||
129962183|NCT03325608|467825740|FG002|Overall Study|Death of Caregiver|2|||
129962184|NCT03325608|467825741|FG003|Overall Study|Death of Caregiver|2|||
129962185|NCT03325608|467825738|FG000|Overall Study|Death of Care Recipient|34|||
129962186|NCT03325608|467825739|FG001|Overall Study|Death of Care Recipient|34|||
130091767|NCT01519700|468292467|FG001|Overall Study|Withdrawal by Subject|3|||
129962187|NCT03325608|467825740|FG002|Overall Study|Death of Care Recipient|28|||
129962188|NCT03325608|467825741|FG003|Overall Study|Death of Care Recipient|28|||
129962189|NCT03325608|467825738|FG000|Overall Study|Withdrawal by Subject|49|||
129962190|NCT03325608|467825739|FG001|Overall Study|Withdrawal by Subject|49|||
129962191|NCT03325608|467825740|FG002|Overall Study|Withdrawal by Subject|35|||
129962192|NCT03325608|467825741|FG003|Overall Study|Withdrawal by Subject|35|||
129962193|NCT03325608|467825738|FG000|Overall Study|Ineligible|7|||
129962194|NCT03325608|467825739|FG001|Overall Study|Ineligible|7|||
129962195|NCT03325608|467825740|FG002|Overall Study|Ineligible|5|||
129962196|NCT03325608|467825741|FG003|Overall Study|Ineligible|5|||
129962197|NCT02188784|467825742|FG000|Overall Study|Death|3|||
129962198|NCT02188784|467825743|FG001|Overall Study|Death|1|||
129962199|NCT02188784|467825742|FG000|Overall Study|Lost to Follow-up|1|||
129962200|NCT02188784|467825743|FG001|Overall Study|Lost to Follow-up|0|||
129962201|NCT02188784|467825742|FG000|Overall Study|Withdrawal by Subject|3|||
129962202|NCT02188784|467825743|FG001|Overall Study|Withdrawal by Subject|9|||
129962203|NCT02188784|467825742|FG000|Overall Study|Physician Decision|2|||
129962204|NCT02188784|467825743|FG001|Overall Study|Physician Decision|3|||
129962205|NCT04944784|467825744|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
129962206|NCT04944784|467825745|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
129962207|NCT04944784|467825746|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
129962208|NCT04944784|467825747|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
129962209|NCT04944784|467825744|FG000|Double-blind Period|Adverse Event|20|||
129962210|NCT04944784|467825745|FG001|Double-blind Period|Adverse Event|4|||
129962211|NCT04944784|467825746|FG002|Double-blind Period|Adverse Event|0|||
129962212|NCT04944784|467825747|FG003|Double-blind Period|Adverse Event|0|||
129962213|NCT04944784|467825744|FG000|Double-blind Period|Withdrawal by Subject|15|||
129962214|NCT04944784|467825745|FG001|Double-blind Period|Withdrawal by Subject|4|||
129962215|NCT04944784|467825746|FG002|Double-blind Period|Withdrawal by Subject|0|||
129962216|NCT04944784|467825747|FG003|Double-blind Period|Withdrawal by Subject|0|||
129962217|NCT04944784|467825744|FG000|Double-blind Period|Death|7|||
129962218|NCT04944784|467825745|FG001|Double-blind Period|Death|2|||
129962219|NCT04944784|467825746|FG002|Double-blind Period|Death|0|||
129962220|NCT04944784|467825747|FG003|Double-blind Period|Death|0|||
129962221|NCT04944784|467825744|FG000|Double-blind Period|Physician Decision|2|||
129962222|NCT04944784|467825745|FG001|Double-blind Period|Physician Decision|1|||
129962223|NCT04944784|467825746|FG002|Double-blind Period|Physician Decision|0|||
129962224|NCT04944784|467825747|FG003|Double-blind Period|Physician Decision|0|||
129962225|NCT04944784|467825744|FG000|Double-blind Period|Lack of Efficacy|0|||
129962226|NCT04944784|467825745|FG001|Double-blind Period|Lack of Efficacy|1|||
129962227|NCT04944784|467825746|FG002|Double-blind Period|Lack of Efficacy|0|||
129962228|NCT04944784|467825747|FG003|Double-blind Period|Lack of Efficacy|0|||
129962229|NCT04944784|467825744|FG000|Double-blind Period|Sponsor Request|2|||
129962230|NCT04944784|467825745|FG001|Double-blind Period|Sponsor Request|1|||
129962231|NCT04944784|467825746|FG002|Double-blind Period|Sponsor Request|0|||
129962232|NCT04944784|467825747|FG003|Double-blind Period|Sponsor Request|0|||
129962233|NCT04944784|467825744|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
129962234|NCT04944784|467825745|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
129962235|NCT04944784|467825746|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
129962236|NCT04944784|467825747|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
129962237|NCT04944784|467825744|FG000|Double-blind Period|Participant Choice|1|||
129962238|NCT04944784|467825745|FG001|Double-blind Period|Participant Choice|1|||
129962239|NCT04944784|467825746|FG002|Double-blind Period|Participant Choice|0|||
129962240|NCT04944784|467825747|FG003|Double-blind Period|Participant Choice|0|||
129962241|NCT04944784|467825744|FG000|Double-blind Period|Progressive Disease|2|||
129962242|NCT04944784|467825745|FG001|Double-blind Period|Progressive Disease|2|||
129962243|NCT04944784|467825746|FG002|Double-blind Period|Progressive Disease|0|||
129962244|NCT04944784|467825747|FG003|Double-blind Period|Progressive Disease|0|||
129962245|NCT04944784|467825744|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
129962246|NCT04944784|467825745|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
129962247|NCT04944784|467825746|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
129962248|NCT04944784|467825747|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
129962249|NCT04944784|467825744|FG000|Active Drug Period|Adverse Event|0|||
129962250|NCT04944784|467825745|FG001|Active Drug Period|Adverse Event|0|||
129962251|NCT04944784|467825746|FG002|Active Drug Period|Adverse Event|3|||
129962252|NCT04944784|467825747|FG003|Active Drug Period|Adverse Event|6|||
129962253|NCT04944784|467825744|FG000|Active Drug Period|Withdrawal by Subject|0|||
129962254|NCT04944784|467825745|FG001|Active Drug Period|Withdrawal by Subject|0|||
129962255|NCT04944784|467825746|FG002|Active Drug Period|Withdrawal by Subject|4|||
129962256|NCT04944784|467825747|FG003|Active Drug Period|Withdrawal by Subject|7|||
129962257|NCT04944784|467825744|FG000|Active Drug Period|Death|0|||
129962258|NCT04944784|467825745|FG001|Active Drug Period|Death|0|||
129962259|NCT04944784|467825746|FG002|Active Drug Period|Death|3|||
129962260|NCT04944784|467825747|FG003|Active Drug Period|Death|4|||
129962261|NCT04944784|467825744|FG000|Active Drug Period|Lack of Efficacy|0|||
129962262|NCT04944784|467825745|FG001|Active Drug Period|Lack of Efficacy|0|||
129962263|NCT04944784|467825746|FG002|Active Drug Period|Lack of Efficacy|2|||
129962264|NCT04944784|467825747|FG003|Active Drug Period|Lack of Efficacy|2|||
129962265|NCT04944784|467825744|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
129962266|NCT04944784|467825745|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
129962267|NCT04944784|467825746|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
129962268|NCT04944784|467825747|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
129962269|NCT04944784|467825744|FG000|Active Drug Period|Participant Choice|0|||
129962270|NCT04944784|467825745|FG001|Active Drug Period|Participant Choice|0|||
129962271|NCT04944784|467825746|FG002|Active Drug Period|Participant Choice|0|||
129962272|NCT04944784|467825747|FG003|Active Drug Period|Participant Choice|1|||
129962273|NCT04944784|467825744|FG000|Active Drug Period|Progressive Disease|0|||
129962274|NCT04944784|467825745|FG001|Active Drug Period|Progressive Disease|0|||
129962275|NCT04944784|467825746|FG002|Active Drug Period|Progressive Disease|4|||
129962276|NCT04944784|467825747|FG003|Active Drug Period|Progressive Disease|4|||
129962277|NCT04944784|467825744|FG000|Active Drug Period|Lost to Follow-up|0|||
129962278|NCT04944784|467825745|FG001|Active Drug Period|Lost to Follow-up|0|||
129962279|NCT04944784|467825746|FG002|Active Drug Period|Lost to Follow-up|0|||
129962280|NCT04944784|467825747|FG003|Active Drug Period|Lost to Follow-up|1|||
129962281|NCT00853372|467827065|FG000|Overall Study|Death|30|||
129962282|NCT00853372|467827066|FG001|Overall Study|Death|26|||
129962283|NCT00853372|467827065|FG000|Overall Study|Lost to Follow-up|1|||
129962284|NCT00853372|467827066|FG001|Overall Study|Lost to Follow-up|2|||
129962285|NCT00853372|467827065|FG000|Overall Study|Full Consent Withdrawn|1|||
129962286|NCT00853372|467827066|FG001|Overall Study|Full Consent Withdrawn|1|||
129962287|NCT01268098|467827069|FG000|Overall Study|Adverse Event|1|||
129962288|NCT01268098|467827070|FG001|Overall Study|Adverse Event|0|||
129962289|NCT01929876|467827072|FG000|Period 2|Non-Compliance|1|||
129962290|NCT01845649|467827073|FG000|Overall Study|Adverse Event|7|||
129962291|NCT01845649|467827074|FG001|Overall Study|Adverse Event|10|||
130091768|NCT01519700|468292468|FG002|Overall Study|Withdrawal by Subject|3|||
130091769|NCT01519700|468292469|FG003|Overall Study|Withdrawal by Subject|2|||
130091770|NCT01519700|468292466|FG000|Overall Study|Other Reason|2|||
130091771|NCT01519700|468292467|FG001|Overall Study|Other Reason|2|||
130091772|NCT01519700|468292468|FG002|Overall Study|Other Reason|0|||
130091773|NCT01519700|468292469|FG003|Overall Study|Other Reason|4|||
130091774|NCT05637515|468292470|FG000|Overall Study|Withdrawal by Subject|17|||
130091775|NCT05637515|468292471|FG001|Overall Study|Withdrawal by Subject|17|||
130091776|NCT02079077|468292473|FG000|Overall Study|Lost to Follow-up|5|||
130091777|NCT02079077|468292474|FG001|Overall Study|Lost to Follow-up|7|||
130091778|NCT02079077|468292473|FG000|Overall Study|Became STIs Positive|1|||
130091779|NCT02079077|468292474|FG001|Overall Study|Became STIs Positive|2|||
130091780|NCT00772031|468292475|FG000|Overall Study|Early termination of trial|12|||
130091781|NCT00772031|468292476|FG001|Overall Study|Early termination of trial|10|||
130091782|NCT00772031|468292475|FG000|Overall Study|Lost to Follow-up|20|||
130091783|NCT00772031|468292476|FG001|Overall Study|Lost to Follow-up|33|||
130091784|NCT00656136|468292477|FG000|Overall Study|Progressive disease|177|||
130091785|NCT00656136|468292478|FG001|Overall Study|Progressive disease|322|||
130091786|NCT00656136|468292477|FG000|Overall Study|Other Adverse Event|5|||
130091787|NCT00656136|468292478|FG001|Overall Study|Other Adverse Event|51|||
130091788|NCT00656136|468292477|FG000|Overall Study|Protocol Violation|2|||
130091789|NCT00656136|468292478|FG001|Overall Study|Protocol Violation|3|||
130091790|NCT00656136|468292477|FG000|Overall Study|Patient refused to take study medication|7|||
130091791|NCT00656136|468292478|FG001|Overall Study|Patient refused to take study medication|10|||
130091792|NCT00656136|468292477|FG000|Overall Study|Unknown and others|4|||
130091793|NCT00656136|468292478|FG001|Overall Study|Unknown and others|4|||
130091794|NCT00635804|468292479|FG000|Overall Study|Adverse Event|0|||
130091795|NCT00635804|468292480|FG001|Overall Study|Adverse Event|0|||
130091796|NCT00635804|468292481|FG002|Overall Study|Adverse Event|0|||
130091797|NCT00635804|468292482|FG003|Overall Study|Adverse Event|0|||
130091798|NCT00635804|468292483|FG004|Overall Study|Adverse Event|0|||
130091799|NCT00635804|468292484|FG005|Overall Study|Adverse Event|1|||
130091800|NCT00635804|468292485|FG006|Overall Study|Adverse Event|0|||
130091801|NCT00635804|468292486|FG007|Overall Study|Adverse Event|0|||
130091802|NCT00635804|468292479|FG000|Overall Study|Withdrawal by Subject|1|||
130091803|NCT00635804|468292480|FG001|Overall Study|Withdrawal by Subject|0|||
130091804|NCT00635804|468292481|FG002|Overall Study|Withdrawal by Subject|0|||
129962292|NCT01845649|467827073|FG000|Overall Study|Lack of Efficacy|1|||
129962293|NCT01845649|467827074|FG001|Overall Study|Lack of Efficacy|1|||
129962294|NCT01845649|467827073|FG000|Overall Study|Lost to Follow-up|2|||
130091805|NCT00635804|468292482|FG003|Overall Study|Withdrawal by Subject|0|||
130091806|NCT00635804|468292483|FG004|Overall Study|Withdrawal by Subject|0|||
130091807|NCT00635804|468292484|FG005|Overall Study|Withdrawal by Subject|0|||
130091808|NCT00635804|468292485|FG006|Overall Study|Withdrawal by Subject|0|||
130091809|NCT00635804|468292486|FG007|Overall Study|Withdrawal by Subject|0|||
130091810|NCT02718131|468292487|FG000|Overall Study|Withdrawal by Subject|1|||
129962295|NCT01845649|467827074|FG001|Overall Study|Lost to Follow-up|2|||
129962296|NCT01845649|467827073|FG000|Overall Study|Withdrew Consent|12|||
130091811|NCT02718131|468292488|FG001|Overall Study|Withdrawal by Subject|0|||
129962297|NCT01845649|467827074|FG001|Overall Study|Withdrew Consent|4|||
129962298|NCT01845649|467827073|FG000|Overall Study|Protocol Deviation|7|||
129962299|NCT01845649|467827074|FG001|Overall Study|Protocol Deviation|4|||
129962300|NCT01845649|467827073|FG000|Overall Study|Reason not Specified|2|||
129962301|NCT01845649|467827074|FG001|Overall Study|Reason not Specified|1|||
129962302|NCT03991988|467827075|FG000|Overall Study|Withdrawal by Subject|2|||
129962303|NCT03991988|467827076|FG001|Overall Study|Withdrawal by Subject|2|||
129962304|NCT02418845|467827078|FG000|Overall Study|Lost to Follow-up|7|||
129962305|NCT02418845|467827079|FG001|Overall Study|Lost to Follow-up|2|||
129962306|NCT02418845|467827078|FG000|Overall Study|Lack of Efficacy|0|||
129962307|NCT02418845|467827079|FG001|Overall Study|Lack of Efficacy|3|||
129962308|NCT02418845|467827078|FG000|Overall Study|Physician Decision|5|||
129962309|NCT02418845|467827079|FG001|Overall Study|Physician Decision|5|||
129962310|NCT02418845|467827078|FG000|Overall Study|Protocol Violation|1|||
129962311|NCT02418845|467827079|FG001|Overall Study|Protocol Violation|0|||
129962312|NCT02418845|467827078|FG000|Overall Study|Withdrawal by Subject|3|||
129962313|NCT02418845|467827079|FG001|Overall Study|Withdrawal by Subject|2|||
129962314|NCT00487552|467827080|FG000|Overall Study|Unsuccessful magnet placements|3|||
129962315|NCT00487552|467827080|FG000|Overall Study|Death due to progressive malignancy|2|||
129962316|NCT00487552|467827080|FG000|Overall Study|Stent not placed|1|||
129962317|NCT02412111|467827081|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
129962318|NCT02412111|467827082|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
129962319|NCT02412111|467827083|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
129962320|NCT02412111|467827081|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
129962321|NCT02412111|467827082|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
129962322|NCT02412111|467827083|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
129962323|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
129962324|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
129962325|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
129962326|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
129962327|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
129962328|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
129962329|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
129962330|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
129962331|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
129962332|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
129962333|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
129962334|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
129962335|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Other|0|||
129962336|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Other|0|||
129962337|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Other|2|||
129962338|NCT01057251|467827085|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
129962339|NCT01057251|467827086|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
129962340|NCT01057251|467827085|FG000|Overall Study|Adverse Event|4|||
129962341|NCT01057251|467827086|FG001|Overall Study|Adverse Event|2|||
129962342|NCT01057251|467827085|FG000|Overall Study|Lack of Efficacy|2|||
129962343|NCT01057251|467827086|FG001|Overall Study|Lack of Efficacy|11|||
129962344|NCT01057251|467827085|FG000|Overall Study|Protocol Violation|6|||
129962345|NCT01057251|467827086|FG001|Overall Study|Protocol Violation|2|||
129962346|NCT01057251|467827085|FG000|Overall Study|Withdrawal by Subject|4|||
129962347|NCT01057251|467827086|FG001|Overall Study|Withdrawal by Subject|5|||
129962348|NCT01057251|467827085|FG000|Overall Study|Lost to Follow-up|7|||
129962349|NCT01057251|467827086|FG001|Overall Study|Lost to Follow-up|6|||
129962350|NCT01057251|467827085|FG000|Overall Study|Other Reason|1|||
129962351|NCT01057251|467827086|FG001|Overall Study|Other Reason|1|||
129962352|NCT00784147|467827087|FG000|Overall Study|Lost to Follow-up|2|||
129962353|NCT00784147|467827088|FG001|Overall Study|Lost to Follow-up|4|||
129962354|NCT00784147|467827087|FG000|Overall Study|Withdrawal by Subject|1|||
129962355|NCT00784147|467827088|FG001|Overall Study|Withdrawal by Subject|3|||
129962356|NCT00784147|467827087|FG000|Overall Study|Physician Decision|2|||
129962357|NCT00784147|467827088|FG001|Overall Study|Physician Decision|1|||
129962358|NCT00784147|467827087|FG000|Overall Study|Protocol Violation|1|||
129962359|NCT00784147|467827088|FG001|Overall Study|Protocol Violation|1|||
129962360|NCT00784147|467827087|FG000|Overall Study|Death|2|||
129962361|NCT00784147|467827088|FG001|Overall Study|Death|0|||
129962362|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
129962363|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
129962364|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
129962365|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
129962366|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
130091812|NCT02718131|468292487|FG000|Overall Study|Adverse Event|1|||
130091813|NCT02718131|468292488|FG001|Overall Study|Adverse Event|0|||
130091814|NCT02718131|468292487|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
129962367|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
129962368|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
130122073|NCT01946165|468408765|FG001|Overall Study|Physician Decision|0|||
130122074|NCT01946165|468408764|FG000|Overall Study|Withdrawal by Subject|0|||
130122075|NCT01946165|468408765|FG001|Overall Study|Withdrawal by Subject|2|||
130122076|NCT00454636|468408766|FG000|Overall Study|Adverse Event|10|||
130122077|NCT00454636|468408767|FG001|Overall Study|Adverse Event|6|||
130122078|NCT00454636|468408768|FG002|Overall Study|Adverse Event|9|||
130122079|NCT00454636|468408769|FG003|Overall Study|Adverse Event|15|||
130122080|NCT00454636|468408766|FG000|Overall Study|Disease Progression|11|||
130122081|NCT00454636|468408767|FG001|Overall Study|Disease Progression|12|||
130122082|NCT00454636|468408768|FG002|Overall Study|Disease Progression|4|||
130122083|NCT00454636|468408769|FG003|Overall Study|Disease Progression|11|||
130122084|NCT00454636|468408766|FG000|Overall Study|Protocol Violation|3|||
130122085|NCT00454636|468408767|FG001|Overall Study|Protocol Violation|2|||
130122086|NCT00454636|468408768|FG002|Overall Study|Protocol Violation|3|||
130122087|NCT00454636|468408769|FG003|Overall Study|Protocol Violation|3|||
130122088|NCT00454636|468408766|FG000|Overall Study|Death|6|||
130122089|NCT00454636|468408767|FG001|Overall Study|Death|1|||
130122090|NCT00454636|468408768|FG002|Overall Study|Death|1|||
130122091|NCT00454636|468408769|FG003|Overall Study|Death|1|||
129962369|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
129962370|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
129962371|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
129962372|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
129962373|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
129962374|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
129962375|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
129962376|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
129962377|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
129962378|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
129962379|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
129962380|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
129962381|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
129962382|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
129962383|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
129962384|NCT02637856|467827089|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
129962385|NCT02637856|467827090|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
129962386|NCT02637856|467827089|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
129962387|NCT02637856|467827090|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
129962388|NCT02973802|467827097|FG000|Overall Study|Lost to Follow-up|1|||
129962389|NCT02973802|467827097|FG000|Overall Study|Withdrawal by Subject|1|||
129962390|NCT03357471|467827098|FG000|Overall Study|Adverse Event|1|||
129962391|NCT03357471|467827099|FG001|Overall Study|Adverse Event|0|||
129962392|NCT03357471|467827098|FG000|Overall Study|Lost to Follow-up|1|||
129962393|NCT03357471|467827099|FG001|Overall Study|Lost to Follow-up|0|||
129962394|NCT00706914|467827100|FG000|Overall Study|Lack of Efficacy|0|||
129962395|NCT00706914|467827101|FG001|Overall Study|Lack of Efficacy|1|||
129962396|NCT00706914|467827102|FG002|Overall Study|Lack of Efficacy|0|||
129962397|NCT00706914|467827100|FG000|Overall Study|Lost to Follow-up|1|||
129962398|NCT00706914|467827101|FG001|Overall Study|Lost to Follow-up|0|||
129962399|NCT00706914|467827102|FG002|Overall Study|Lost to Follow-up|0|||
129962400|NCT00706914|467827100|FG000|Overall Study|Adverse Event|2|||
129962401|NCT00706914|467827101|FG001|Overall Study|Adverse Event|2|||
129962402|NCT00706914|467827102|FG002|Overall Study|Adverse Event|0|||
130091815|NCT02718131|468292488|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
130091816|NCT01101321|468292489|FG000|Period 1|Withdrawal by Subject|1|||
130091817|NCT01101321|468292490|FG001|Period 1|Withdrawal by Subject|1|||
130091818|NCT01101321|468292489|FG000|Period 1|Adverse Event|3|||
130091819|NCT01101321|468292490|FG001|Period 1|Adverse Event|3|||
130091820|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
130091821|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
130091822|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
130091823|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
130091824|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
130091825|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
129962403|NCT00706914|467827100|FG000|Overall Study|Protocol Violation|3|||
129962404|NCT00706914|467827101|FG001|Overall Study|Protocol Violation|1|||
130091826|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
130122092|NCT00454636|468408766|FG000|Overall Study|Patient refusal|1|||
130122093|NCT00454636|468408767|FG001|Overall Study|Patient refusal|1|||
130122094|NCT00454636|468408768|FG002|Overall Study|Patient refusal|3|||
130122095|NCT00454636|468408769|FG003|Overall Study|Patient refusal|2|||
130122096|NCT00454636|468408766|FG000|Overall Study|Lost to Follow-up|0|||
129962405|NCT00706914|467827102|FG002|Overall Study|Protocol Violation|1|||
129962406|NCT00702650|467827103|FG000|Overall Study|Withdrawal by Subject|9|||
129962407|NCT00702650|467827103|FG000|Overall Study|Non-Compliance of Study Drug|3|||
129962408|NCT00702650|467827103|FG000|Overall Study|Lost to Follow-up|2|||
129962409|NCT00702650|467827103|FG000|Overall Study|Non-Compliance with Site Directives|1|||
129962410|NCT00702650|467827103|FG000|Overall Study|Sponsor Request|1|||
129962411|NCT00702650|467827103|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
129962412|NCT00702650|467827103|FG000|Overall Study|Adverse Event|3|||
129962413|NCT01850823|467827104|FG000|Overall Study|Early Visit Window|0|||
129962414|NCT01850823|467827105|FG001|Overall Study|Early Visit Window|1|||
129962415|NCT01850823|467827106|FG002|Overall Study|Early Visit Window|4|||
129962416|NCT01850823|467827104|FG000|Overall Study|Enrolled in Error|0|||
129962417|NCT01850823|467827105|FG001|Overall Study|Enrolled in Error|1|||
129962418|NCT01850823|467827106|FG002|Overall Study|Enrolled in Error|2|||
129962419|NCT01850823|467827104|FG000|Overall Study|Lack of Efficacy|1|||
129962420|NCT01850823|467827105|FG001|Overall Study|Lack of Efficacy|0|||
129962421|NCT01850823|467827106|FG002|Overall Study|Lack of Efficacy|0|||
129962422|NCT01850823|467827104|FG000|Overall Study|Lost to Follow-up|0|||
129962423|NCT01850823|467827105|FG001|Overall Study|Lost to Follow-up|0|||
129962424|NCT01850823|467827106|FG002|Overall Study|Lost to Follow-up|1|||
129962425|NCT01850823|467827104|FG000|Overall Study|Restricted Medication|0|||
129962426|NCT01850823|467827105|FG001|Overall Study|Restricted Medication|0|||
129962427|NCT01850823|467827106|FG002|Overall Study|Restricted Medication|2|||
129962428|NCT01850823|467827104|FG000|Overall Study|Significant worstening of SAR|0|||
129962429|NCT01850823|467827105|FG001|Overall Study|Significant worstening of SAR|1|||
129962430|NCT01850823|467827106|FG002|Overall Study|Significant worstening of SAR|0|||
129962431|NCT01850823|467827104|FG000|Overall Study|Withdrawal by Subject|2|||
129962432|NCT01850823|467827105|FG001|Overall Study|Withdrawal by Subject|0|||
129962433|NCT01850823|467827106|FG002|Overall Study|Withdrawal by Subject|1|||
129962434|NCT01751165|467827107|FG000|Overall Study|Adverse event, serious fatal|1|||
129962435|NCT01751165|467827108|FG001|Overall Study|Adverse event, serious fatal|0|||
129962436|NCT01751165|467827109|FG002|Overall Study|Adverse event, serious fatal|1|||
129962437|NCT01751165|467827107|FG000|Overall Study|Withdrawal by Subject|0|||
129962438|NCT01751165|467827108|FG001|Overall Study|Withdrawal by Subject|0|||
129962439|NCT01751165|467827109|FG002|Overall Study|Withdrawal by Subject|1|||
129962440|NCT01751165|467827107|FG000|Overall Study|Serious adverse event|0|||
129962441|NCT01751165|467827108|FG001|Overall Study|Serious adverse event|2|||
129962442|NCT01751165|467827109|FG002|Overall Study|Serious adverse event|0|||
129962443|NCT01751165|467827107|FG000|Overall Study|Lost to Follow-up|1|||
129962444|NCT01751165|467827108|FG001|Overall Study|Lost to Follow-up|1|||
129962445|NCT01751165|467827109|FG002|Overall Study|Lost to Follow-up|1|||
129962446|NCT00988533|467827114|FG000|Overall Study|Lost to Follow-up|3|||
129962447|NCT00943722|467827117|FG000|Base Study|Adverse Event|0|||
129962448|NCT00943722|467827118|FG001|Base Study|Adverse Event|0|||
129962449|NCT00943722|467827119|FG002|Base Study|Adverse Event|0|||
129962450|NCT00943722|467827120|FG003|Base Study|Adverse Event|1|||
129962451|NCT00943722|467827121|FG004|Base Study|Adverse Event|0|||
129962452|NCT00943722|467827122|FG005|Base Study|Adverse Event|0|||
129962453|NCT00943722|467827123|FG006|Base Study|Adverse Event|0|||
129962454|NCT00943722|467827117|FG000|Base Study|Lost to Follow-up|12|||
129962455|NCT00943722|467827118|FG001|Base Study|Lost to Follow-up|8|||
129962456|NCT00943722|467827119|FG002|Base Study|Lost to Follow-up|10|||
129962457|NCT00943722|467827120|FG003|Base Study|Lost to Follow-up|8|||
129962458|NCT00943722|467827121|FG004|Base Study|Lost to Follow-up|11|||
129962459|NCT00943722|467827122|FG005|Base Study|Lost to Follow-up|0|||
129962460|NCT00943722|467827123|FG006|Base Study|Lost to Follow-up|0|||
129962461|NCT00943722|467827117|FG000|Base Study|Physician Decision|1|||
129962462|NCT00943722|467827118|FG001|Base Study|Physician Decision|0|||
129962463|NCT00943722|467827119|FG002|Base Study|Physician Decision|0|||
129962464|NCT00943722|467827120|FG003|Base Study|Physician Decision|0|||
129962465|NCT00943722|467827121|FG004|Base Study|Physician Decision|1|||
129962466|NCT00943722|467827122|FG005|Base Study|Physician Decision|0|||
129962467|NCT00943722|467827123|FG006|Base Study|Physician Decision|0|||
129962468|NCT00943722|467827117|FG000|Base Study|Pregnancy|0|||
129962469|NCT00943722|467827118|FG001|Base Study|Pregnancy|0|||
129962470|NCT00943722|467827119|FG002|Base Study|Pregnancy|1|||
129962471|NCT00943722|467827120|FG003|Base Study|Pregnancy|0|||
129962472|NCT00943722|467827121|FG004|Base Study|Pregnancy|2|||
129962473|NCT00943722|467827122|FG005|Base Study|Pregnancy|0|||
129962474|NCT00943722|467827123|FG006|Base Study|Pregnancy|0|||
129962475|NCT00943722|467827117|FG000|Base Study|Protocol Violation|0|||
129962476|NCT00943722|467827118|FG001|Base Study|Protocol Violation|1|||
129962477|NCT00943722|467827119|FG002|Base Study|Protocol Violation|0|||
129962478|NCT00943722|467827120|FG003|Base Study|Protocol Violation|0|||
129962479|NCT00943722|467827121|FG004|Base Study|Protocol Violation|2|||
129962480|NCT00943722|467827122|FG005|Base Study|Protocol Violation|0|||
129962481|NCT00943722|467827123|FG006|Base Study|Protocol Violation|0|||
129962482|NCT00943722|467827117|FG000|Base Study|Withdrawal by Subject|12|||
129962483|NCT00943722|467827118|FG001|Base Study|Withdrawal by Subject|13|||
129962484|NCT00943722|467827119|FG002|Base Study|Withdrawal by Subject|2|||
129962485|NCT00943722|467827120|FG003|Base Study|Withdrawal by Subject|13|||
129962486|NCT00943722|467827121|FG004|Base Study|Withdrawal by Subject|8|||
129962487|NCT00943722|467827122|FG005|Base Study|Withdrawal by Subject|0|||
129962488|NCT00943722|467827123|FG006|Base Study|Withdrawal by Subject|0|||
129962489|NCT00943722|467827117|FG000|Base Study|Month 12 visit not completed|0|||
129962490|NCT00943722|467827118|FG001|Base Study|Month 12 visit not completed|0|||
129962491|NCT00943722|467827119|FG002|Base Study|Month 12 visit not completed|0|||
129962492|NCT00943722|467827120|FG003|Base Study|Month 12 visit not completed|0|||
129962493|NCT00943722|467827121|FG004|Base Study|Month 12 visit not completed|2|||
129962494|NCT00943722|467827122|FG005|Base Study|Month 12 visit not completed|0|||
129962495|NCT00943722|467827123|FG006|Base Study|Month 12 visit not completed|0|||
129962496|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Adverse Event|0|||
129962497|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Adverse Event|0|||
129962498|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Adverse Event|0|||
129962499|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Adverse Event|0|||
129962500|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Adverse Event|0|||
129962501|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Adverse Event|1|||
129962502|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Adverse Event|0|||
129962503|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962504|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962505|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962506|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962507|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962508|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
129962509|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
129962510|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962511|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962512|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962513|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962514|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962515|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
129962516|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
129962517|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
129962518|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
129962519|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
129962520|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
129962521|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
129962522|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
129962523|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
129962524|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
129962525|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
129962526|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
129962527|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
129962528|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
129962529|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
129962530|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
129962531|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962532|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962533|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962534|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962535|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962536|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
129962537|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
129962538|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
129962539|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
129962540|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
129962541|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
130091827|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
129962542|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
129962543|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
129962544|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
129962545|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
129962546|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
129962547|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
129962548|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
129962549|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
130091828|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
130091829|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
129962550|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
130091830|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
129962551|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
129962552|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962553|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962554|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962555|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
130091831|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
129962556|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962557|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
129962558|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
129962559|NCT02895360|467827128|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
129962560|NCT02895360|467827129|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962561|NCT02895360|467827130|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962562|NCT02895360|467827131|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962563|NCT02895360|467827132|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962564|NCT02895360|467827133|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962565|NCT02895360|467827128|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962566|NCT02895360|467827129|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
129962567|NCT02895360|467827130|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962568|NCT02895360|467827131|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962569|NCT02895360|467827132|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962570|NCT02895360|467827133|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962571|NCT02895360|467827128|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962572|NCT02895360|467827129|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962573|NCT02895360|467827130|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
129962574|NCT02895360|467827131|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962575|NCT02895360|467827132|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962576|NCT02895360|467827133|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962577|NCT02895360|467827128|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962578|NCT02895360|467827129|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962579|NCT02895360|467827130|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
129962580|NCT02895360|467827131|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962581|NCT02895360|467827132|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962582|NCT02895360|467827133|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962583|NCT02895360|467827128|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962584|NCT02895360|467827129|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962585|NCT02895360|467827130|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962586|NCT02895360|467827131|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
129962587|NCT02895360|467827132|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962588|NCT02895360|467827133|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962589|NCT02895360|467827128|FG000|Phase 2a|Adverse Event|0|||
129962590|NCT02895360|467827129|FG001|Phase 2a|Adverse Event|0|||
129962591|NCT02895360|467827130|FG002|Phase 2a|Adverse Event|0|||
129962592|NCT02895360|467827131|FG003|Phase 2a|Adverse Event|0|||
129962593|NCT02895360|467827132|FG004|Phase 2a|Adverse Event|0|||
129962594|NCT02895360|467827133|FG005|Phase 2a|Adverse Event|1|||
129962595|NCT02895360|467827128|FG000|Phase 2a|Progressive disease|0|||
129962596|NCT02895360|467827129|FG001|Phase 2a|Progressive disease|0|||
129962597|NCT02895360|467827130|FG002|Phase 2a|Progressive disease|0|||
129962598|NCT02895360|467827131|FG003|Phase 2a|Progressive disease|0|||
129962599|NCT02895360|467827132|FG004|Phase 2a|Progressive disease|11|||
129962600|NCT02895360|467827133|FG005|Phase 2a|Progressive disease|11|||
129962601|NCT00307164|467827136|FG000|Overall Study|Death|1|||
129962602|NCT00307164|467827137|FG001|Overall Study|Death|0|||
129962603|NCT00307164|467827136|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129962604|NCT00307164|467827137|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129962605|NCT00307164|467827136|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
129962606|NCT00307164|467827137|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
129962607|NCT00307164|467827136|FG000|Overall Study|Withdrawal by Subject|1|||
129962608|NCT00307164|467827137|FG001|Overall Study|Withdrawal by Subject|8|||
129962609|NCT00307164|467827136|FG000|Overall Study|Not compliant with requirements|4|||
129962610|NCT00307164|467827137|FG001|Overall Study|Not compliant with requirements|4|||
129962611|NCT00307164|467827136|FG000|Overall Study|Lost to Follow-up|6|||
129962612|NCT00307164|467827137|FG001|Overall Study|Lost to Follow-up|1|||
129962613|NCT01732926|467827139|FG000|Overall Study|Study Terminated by Sponsor|168|||
129962614|NCT01732926|467827140|FG001|Overall Study|Study Terminated by Sponsor|80|||
129962615|NCT01732926|467827139|FG000|Overall Study|Withdrawal by Subject|46|||
129962616|NCT01732926|467827140|FG001|Overall Study|Withdrawal by Subject|8|||
129962617|NCT01732926|467827139|FG000|Overall Study|Physician Decision|24|||
129962618|NCT01732926|467827140|FG001|Overall Study|Physician Decision|11|||
129962619|NCT01732926|467827139|FG000|Overall Study|Other Reason|21|||
129962620|NCT01732926|467827140|FG001|Overall Study|Other Reason|4|||
129962621|NCT01732926|467827139|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
130091832|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
129962622|NCT01732926|467827140|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
129962623|NCT01732926|467827139|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
129962624|NCT01732926|467827140|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
129962625|NCT02262364|467827142|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
129962626|NCT01049984|467827143|FG000|Overall Study|Withdrawal by Subject|1|||
129962627|NCT01049984|467827144|FG001|Overall Study|Withdrawal by Subject|5|||
129962628|NCT01049984|467827143|FG000|Overall Study|Protocol Violation|3|||
129962629|NCT01049984|467827144|FG001|Overall Study|Protocol Violation|4|||
129962630|NCT01049984|467827143|FG000|Overall Study|Lost to Follow-up|2|||
129962631|NCT01049984|467827144|FG001|Overall Study|Lost to Follow-up|1|||
129962632|NCT01049984|467827143|FG000|Overall Study|Adverse Event|13|||
129962633|NCT01049984|467827144|FG001|Overall Study|Adverse Event|7|||
129962634|NCT01049984|467827143|FG000|Overall Study|Treatment failure|0|||
129962635|NCT01049984|467827144|FG001|Overall Study|Treatment failure|2|||
129962636|NCT04191148|467827150|FG000|Overall Study|Withdrawal by Subject|1|||
129962637|NCT04191148|467827151|FG001|Overall Study|Withdrawal by Subject|0|||
129962638|NCT04191148|467827150|FG000|Overall Study|Adverse Event|1|||
129962639|NCT04191148|467827151|FG001|Overall Study|Adverse Event|0|||
129962640|NCT01274559|467827154|FG000|Overall Study|Adverse Event|57|||
129962641|NCT01274559|467827155|FG001|Overall Study|Adverse Event|13|||
129962642|NCT01274559|467827154|FG000|Overall Study|Death|1|||
129962643|NCT01274559|467827155|FG001|Overall Study|Death|1|||
129962644|NCT01274559|467827154|FG000|Overall Study|Lost to Follow-up|3|||
129962645|NCT01274559|467827155|FG001|Overall Study|Lost to Follow-up|3|||
129962646|NCT01274559|467827154|FG000|Overall Study|Non-compliance with Study Drug|2|||
129962647|NCT01274559|467827155|FG001|Overall Study|Non-compliance with Study Drug|4|||
129962648|NCT01274559|467827154|FG000|Overall Study|Physician Decision|2|||
129962649|NCT01274559|467827155|FG001|Overall Study|Physician Decision|1|||
129962650|NCT01274559|467827154|FG000|Overall Study|Protocol Violation|28|||
129962651|NCT01274559|467827155|FG001|Overall Study|Protocol Violation|23|||
129962652|NCT01274559|467827154|FG000|Overall Study|Study Terminated by Sponsor|79|||
129962653|NCT01274559|467827155|FG001|Overall Study|Study Terminated by Sponsor|87|||
129962654|NCT01274559|467827154|FG000|Overall Study|Withdrawal by Subject|25|||
129962655|NCT01274559|467827155|FG001|Overall Study|Withdrawal by Subject|13|||
129962656|NCT02560389|467827166|FG000|Overall Study|Lost to Follow-up|1|||
129962657|NCT02560389|467827167|FG001|Overall Study|Lost to Follow-up|2|||
129962658|NCT02560389|467827168|FG002|Overall Study|Lost to Follow-up|2|||
129962659|NCT02560389|467827166|FG000|Overall Study|Tested positive for illicit substance|0|||
129962660|NCT02560389|467827167|FG001|Overall Study|Tested positive for illicit substance|1|||
129962661|NCT02560389|467827168|FG002|Overall Study|Tested positive for illicit substance|0|||
129962662|NCT03409731|467827173|FG000|Overall Study|Withdrawal by Subject|17|||
129962663|NCT03409731|467827173|FG000|Overall Study|Death|4|||
129962664|NCT00827775|467827179|FG000|Overall Study|Withdrawal by Subject|0|||
129962665|NCT00827775|467827180|FG001|Overall Study|Withdrawal by Subject|5|||
129962666|NCT02287883|467827184|FG000|Overall Study|Death|8|||
129962667|NCT02287883|467827185|FG001|Overall Study|Death|7|||
129962668|NCT02287883|467827184|FG000|Overall Study|No longer eligible|222|||
129962669|NCT02287883|467827185|FG001|Overall Study|No longer eligible|182|||
129962670|NCT02287883|467827184|FG000|Overall Study|Non-response to survey|229|||
129962671|NCT02287883|467827185|FG001|Overall Study|Non-response to survey|237|||
129962672|NCT00802438|467827186|FG000|Overall Study|Screen Failure|20|||
129962673|NCT00802438|467827186|FG000|Overall Study|Withdrawal by Subject|7|||
129962674|NCT00802438|467827186|FG000|Overall Study|Physician Decision|1|||
129962675|NCT03175198|467827187|FG000|Overall Study|Adverse Event|480|||
129962676|NCT03175198|467827187|FG000|Overall Study|No actual visit|120|||
129962677|NCT03175198|467827187|FG000|Overall Study|Registration rule not followed|4|||
129962678|NCT03175198|467827187|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
129962679|NCT03175198|467827187|FG000|Overall Study|Other personal reason|509|||
129962680|NCT03175198|467827187|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
129962681|NCT03175198|467827187|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
129962682|NCT03175198|467827187|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
129962683|NCT03175198|467827187|FG000|Overall Study|To conduct invasive treatment of operation|53|||
129962684|NCT03175198|467827187|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
129962685|NCT01260142|467827189|FG000|Treatment Period 1|Study on hold|1|||
130122097|NCT00454636|468408767|FG001|Overall Study|Lost to Follow-up|1|||
129962686|NCT01260142|467827190|FG001|Treatment Period 1|Study on hold|1|||
129962687|NCT01260142|467827191|FG002|Treatment Period 1|Study on hold|0|||
129962688|NCT01260142|467827192|FG003|Treatment Period 1|Study on hold|0|||
129962689|NCT01260142|467827193|FG004|Treatment Period 1|Study on hold|1|||
130122098|NCT00454636|468408768|FG002|Overall Study|Lost to Follow-up|0|||
130122099|NCT00454636|468408769|FG003|Overall Study|Lost to Follow-up|0|||
129962690|NCT01260142|467827194|FG005|Treatment Period 1|Study on hold|2|||
129962691|NCT01260142|467827189|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962692|NCT01260142|467827190|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962693|NCT01260142|467827191|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
130122100|NCT01400113|468408770|FG000|Overall Study|Withdrawal by Subject|1|||
129962694|NCT01260142|467827192|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962695|NCT01260142|467827193|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
129962696|NCT01260142|467827194|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962697|NCT01260142|467827189|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129962698|NCT01260142|467827190|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129962699|NCT01260142|467827191|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129962700|NCT01260142|467827192|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129962701|NCT01260142|467827193|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129962702|NCT01260142|467827194|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129962703|NCT00496834|467827198|FG000|Overall Study|Withdrawal by Subject|4|||
129962704|NCT00496834|467827199|FG001|Overall Study|Withdrawal by Subject|6|||
129962705|NCT00496834|467827198|FG000|Overall Study|Contraindicated medication administered|0|||
129962706|NCT00496834|467827199|FG001|Overall Study|Contraindicated medication administered|1|||
129962707|NCT00496834|467827198|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
129962708|NCT00496834|467827199|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
129962709|NCT00496834|467827198|FG000|Overall Study|Adverse Event|5|||
129962710|NCT00496834|467827199|FG001|Overall Study|Adverse Event|3|||
129962711|NCT00496834|467827198|FG000|Overall Study|IP administration violation|2|||
129962712|NCT00496834|467827199|FG001|Overall Study|IP administration violation|0|||
129962713|NCT00496834|467827198|FG000|Overall Study|Lost to Follow-up|2|||
129962714|NCT00496834|467827199|FG001|Overall Study|Lost to Follow-up|0|||
129962715|NCT00496834|467827198|FG000|Overall Study|Blood Pressure control failure|2|||
130091833|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
130091834|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
130091835|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|Other|6|||
130091836|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|Other|6|||
130091837|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|Other|7|||
130091838|NCT02681094|468292491|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
130091839|NCT02681094|468292492|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
130091840|NCT02681094|468292493|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
130091841|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|Participant decision|7|||
130091842|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|Participant decision|10|||
130091843|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|Participant decision|9|||
130091844|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
130091845|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
130091846|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
130091847|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
130091848|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
130091849|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
130091850|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
130091851|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
130091852|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
130091853|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
130091854|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
130091855|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
130091856|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|Other|6|||
130091857|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|Other|6|||
130091858|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|Other|7|||
130091859|NCT02681094|468292491|FG000|2 - Enrolled Participants Set|No treatment given|0|||
130091860|NCT02681094|468292492|FG001|2 - Enrolled Participants Set|No treatment given|1|||
130091861|NCT02681094|468292493|FG002|2 - Enrolled Participants Set|No treatment given|1|||
130091862|NCT00134563|468292496|FG000|Overall Study|Not treated due to protocol violation|0|||
130091863|NCT00134563|468292497|FG001|Overall Study|Not treated due to protocol violation|1|||
130091864|NCT00134563|468292498|FG002|Overall Study|Not treated due to protocol violation|1|||
130091865|NCT00134563|468292496|FG000|Overall Study|Adverse Event|29|||
130091866|NCT00134563|468292497|FG001|Overall Study|Adverse Event|37|||
130091867|NCT00134563|468292498|FG002|Overall Study|Adverse Event|38|||
130091868|NCT00134563|468292496|FG000|Overall Study|Lack of Efficacy|24|||
130091869|NCT00134563|468292497|FG001|Overall Study|Lack of Efficacy|14|||
130091870|NCT00134563|468292498|FG002|Overall Study|Lack of Efficacy|17|||
130091871|NCT00134563|468292496|FG000|Overall Study|Protocol Violation|3|||
130091872|NCT00134563|468292497|FG001|Overall Study|Protocol Violation|2|||
130091873|NCT00134563|468292498|FG002|Overall Study|Protocol Violation|5|||
130091874|NCT00134563|468292496|FG000|Overall Study|Lost to Follow-up|4|||
130091875|NCT00134563|468292497|FG001|Overall Study|Lost to Follow-up|0|||
130091876|NCT00134563|468292498|FG002|Overall Study|Lost to Follow-up|2|||
130091877|NCT00134563|468292496|FG000|Overall Study|progressive disease|11|||
129962716|NCT00496834|467827199|FG001|Overall Study|Blood Pressure control failure|1|||
129962717|NCT01227928|467827200|FG000|Overall Study|Lost to Follow-up|4|||
130091878|NCT00134563|468292497|FG001|Overall Study|progressive disease|4|||
130091879|NCT00134563|468292498|FG002|Overall Study|progressive disease|2|||
129962718|NCT01227928|467827201|FG001|Overall Study|Lost to Follow-up|2|||
129962719|NCT01227928|467827200|FG000|Overall Study|Withdrawal by Subject|4|||
129962720|NCT01227928|467827201|FG001|Overall Study|Withdrawal by Subject|3|||
129962721|NCT01227928|467827200|FG000|Overall Study|Death|14|||
129962722|NCT01227928|467827201|FG001|Overall Study|Death|12|||
129962723|NCT04159805|467827204|FG000|Overall Study|Withdrawal by Subject|0|||
129962724|NCT04159805|467827205|FG001|Overall Study|Withdrawal by Subject|2|||
129962725|NCT04159805|467827206|FG002|Overall Study|Withdrawal by Subject|2|||
129962726|NCT02154347|467827207|FG000|Double-blind Period|Adverse Event|1|||
129962727|NCT02154347|467827208|FG001|Double-blind Period|Adverse Event|2|||
129962728|NCT02154347|467827207|FG000|Double-blind Period|Lack of Efficacy|1|||
129962729|NCT02154347|467827208|FG001|Double-blind Period|Lack of Efficacy|0|||
129962730|NCT02154347|467827207|FG000|Double-blind Period|Physician Decision|0|||
129962731|NCT02154347|467827208|FG001|Double-blind Period|Physician Decision|1|||
129962732|NCT02154347|467827207|FG000|Double-blind Period|Withdrawal by Subject|1|||
129962733|NCT02154347|467827208|FG001|Double-blind Period|Withdrawal by Subject|1|||
129962734|NCT02154347|467827207|FG000|Open-label Period|Adverse Event|3|||
129962735|NCT02154347|467827208|FG001|Open-label Period|Adverse Event|4|||
129962736|NCT02154347|467827207|FG000|Open-label Period|Lack of Efficacy|4|||
129962737|NCT02154347|467827208|FG001|Open-label Period|Lack of Efficacy|19|||
129962738|NCT02154347|467827207|FG000|Open-label Period|Protocol Violation|0|||
129962739|NCT02154347|467827208|FG001|Open-label Period|Protocol Violation|1|||
129962740|NCT02154347|467827207|FG000|Open-label Period|Withdrawal by Subject|0|||
129962741|NCT02154347|467827208|FG001|Open-label Period|Withdrawal by Subject|1|||
129962742|NCT02473913|467827210|FG000|Overall Study|Lost to Follow-up|3|||
129962743|NCT02473913|467827211|FG001|Overall Study|Lost to Follow-up|3|||
129962744|NCT01190449|467827214|FG000|Overall Study|Ineligible|0|||
129962745|NCT01190449|467827215|FG001|Overall Study|Ineligible|4|||
129962746|NCT02210208|467829090|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
129962747|NCT02210208|467829090|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
129962748|NCT02210208|467829090|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
129962749|NCT01171183|467829091|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
129962750|NCT01171183|467829092|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
129962751|NCT01171183|467829091|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
129962752|NCT01171183|467829092|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
129962753|NCT01171183|467829091|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
129962754|NCT01171183|467829092|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
129962755|NCT01171183|467829091|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
129962756|NCT01171183|467829092|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
129962757|NCT01171183|467829091|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
129962758|NCT01171183|467829092|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
129962759|NCT01171183|467829091|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
129962760|NCT01171183|467829092|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
129962761|NCT01066936|467829093|FG000|Overall Study|Death|2|||
129962762|NCT01066936|467829093|FG000|Overall Study|Device revised/removed|1|||
129962763|NCT01066936|467829093|FG000|Overall Study|Lost to Follow-up|3|||
129962764|NCT01066936|467829093|FG000|Overall Study|Withdrawal by Subject|4|||
129962765|NCT00362375|467829099|FG000|Overall Study|Lost to Follow-up|40|||
129962766|NCT00362375|467829100|FG001|Overall Study|Lost to Follow-up|35|||
129962767|NCT04984239|467829101|FG000|Overall Study|Lost to Follow-up|1|||
129962768|NCT04190225|467829102|FG000|Overall Study|Lost to Follow-up|2|||
129962769|NCT04190225|467829103|FG001|Overall Study|Lost to Follow-up|3|||
129962770|NCT04190225|467829102|FG000|Overall Study|Withdrawal by Subject|3|||
129962771|NCT04190225|467829103|FG001|Overall Study|Withdrawal by Subject|2|||
129962772|NCT04190225|467829102|FG000|Overall Study|Unrelated health condition|2|||
129962773|NCT04190225|467829103|FG001|Overall Study|Unrelated health condition|0|||
129962774|NCT01114139|467829105|FG000|Overall Study|Adverse Event|3|||
129962775|NCT01114139|467829106|FG001|Overall Study|Adverse Event|2|||
129962776|NCT01114139|467829105|FG000|Overall Study|Lost to Follow-up|15|||
129962777|NCT01114139|467829106|FG001|Overall Study|Lost to Follow-up|3|||
129962778|NCT01114139|467829105|FG000|Overall Study|Withdrawal by Subject|17|||
129962779|NCT01114139|467829106|FG001|Overall Study|Withdrawal by Subject|6|||
129962780|NCT01114139|467829105|FG000|Overall Study|Other-Missed 1 visit|1|||
129962781|NCT01114139|467829106|FG001|Overall Study|Other-Missed 1 visit|0|||
129962782|NCT01114139|467829105|FG000|Overall Study|Other-Protocol Violation|1|||
129962783|NCT01114139|467829106|FG001|Overall Study|Other-Protocol Violation|0|||
129962784|NCT01114139|467829105|FG000|Overall Study|Other-Out of window for study drug dose|1|||
129962785|NCT01114139|467829106|FG001|Overall Study|Other-Out of window for study drug dose|0|||
129962786|NCT01114139|467829105|FG000|Overall Study|Other-Participant falsified records|0|||
129962787|NCT01114139|467829106|FG001|Overall Study|Other-Participant falsified records|1|||
129962788|NCT01114139|467829105|FG000|Overall Study|Other-Participant went on hospice|0|||
129962789|NCT01114139|467829106|FG001|Overall Study|Other-Participant went on hospice|1|||
129962790|NCT01114139|467829105|FG000|Overall Study|Other-Physician changed treatment|1|||
129962791|NCT01114139|467829106|FG001|Overall Study|Other-Physician changed treatment|0|||
129962792|NCT01114139|467829105|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
129962793|NCT01114139|467829106|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
129962794|NCT02994784|467829107|FG000|6 Months Follow-up|Lost to Follow-up|3|||
129962795|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
129962796|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
129962797|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
129962798|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
129962799|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
129962800|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
129962801|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Missing|2|||
129962802|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Missing|2|||
129962803|NCT00477464|467829111|FG000|Overall Study|Lost to Follow-up|1|||
129962804|NCT00477464|467829111|FG000|Overall Study|Death|36|||
129962805|NCT00477464|467829111|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
129962806|NCT00639769|467829112|FG000|Overall Study|Death|2|||
129962807|NCT00639769|467829112|FG000|Overall Study|Adverse Event|7|||
129962808|NCT00639769|467829112|FG000|Overall Study|Lack of Efficacy|1|||
129962809|NCT00639769|467829112|FG000|Overall Study|Disease progression|26|||
129962810|NCT00639769|467829112|FG000|Overall Study|Withdrawal by Subject|4|||
129962811|NCT00863798|467829113|FG000|Overall Study|Adverse Event|5|||
129962812|NCT00863798|467829114|FG001|Overall Study|Adverse Event|2|||
129962813|NCT00863798|467829115|FG002|Overall Study|Adverse Event|4|||
129962814|NCT00863798|467829113|FG000|Overall Study|Participant failed to return|2|||
129962815|NCT00863798|467829114|FG001|Overall Study|Participant failed to return|1|||
129962816|NCT00863798|467829115|FG002|Overall Study|Participant failed to return|0|||
129962817|NCT00863798|467829113|FG000|Overall Study|Investigator request|1|||
129962818|NCT00863798|467829114|FG001|Overall Study|Investigator request|2|||
130091880|NCT00134563|468292496|FG000|Overall Study|did not wish to continue|33|||
130091881|NCT00134563|468292497|FG001|Overall Study|did not wish to continue|32|||
130091882|NCT00134563|468292498|FG002|Overall Study|did not wish to continue|26|||
130091883|NCT00134563|468292496|FG000|Overall Study|Reason other than above|0|||
130091884|NCT00134563|468292497|FG001|Overall Study|Reason other than above|2|||
130091885|NCT00134563|468292498|FG002|Overall Study|Reason other than above|5|||
130091886|NCT03382639|468292499|FG000|Overall Study|Adverse Event|2|||
130091887|NCT03382639|468292500|FG001|Overall Study|Adverse Event|0|||
130091888|NCT03382639|468292501|FG002|Overall Study|Adverse Event|1|||
130091889|NCT03382639|468292502|FG003|Overall Study|Adverse Event|1|||
130091890|NCT03382639|468292499|FG000|Overall Study|Lost to Follow-up|1|||
130091891|NCT03382639|468292500|FG001|Overall Study|Lost to Follow-up|0|||
130091892|NCT03382639|468292501|FG002|Overall Study|Lost to Follow-up|0|||
130091893|NCT03382639|468292502|FG003|Overall Study|Lost to Follow-up|0|||
130091894|NCT03382639|468292499|FG000|Overall Study|Withdrawal by Subject|4|||
130091895|NCT03382639|468292500|FG001|Overall Study|Withdrawal by Subject|3|||
130091896|NCT03382639|468292501|FG002|Overall Study|Withdrawal by Subject|2|||
130091897|NCT03382639|468292502|FG003|Overall Study|Withdrawal by Subject|3|||
130091898|NCT03382639|468292499|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
130091899|NCT03382639|468292500|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
130091900|NCT03382639|468292501|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
130091901|NCT03382639|468292502|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
130091902|NCT03382639|468292499|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
130091903|NCT03382639|468292500|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
130091904|NCT03382639|468292501|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
130091905|NCT03382639|468292502|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
130091906|NCT03382639|468292499|FG000|Overall Study|Other|2|||
130091907|NCT03382639|468292500|FG001|Overall Study|Other|0|||
130091908|NCT03382639|468292501|FG002|Overall Study|Other|0|||
130091909|NCT03382639|468292502|FG003|Overall Study|Other|3|||
130091910|NCT02406586|468292503|FG000|Overall Study|Lost to Follow-up|0|||
130091911|NCT02406586|468292504|FG001|Overall Study|Lost to Follow-up|4|||
130091912|NCT02406586|468292505|FG002|Overall Study|Lost to Follow-up|2|||
130091913|NCT02406586|468292503|FG000|Overall Study|Withdrawal by Subject|1|||
130091914|NCT02406586|468292504|FG001|Overall Study|Withdrawal by Subject|0|||
130091915|NCT02406586|468292505|FG002|Overall Study|Withdrawal by Subject|0|||
129962819|NCT00863798|467829115|FG002|Overall Study|Investigator request|1|||
129962820|NCT00863798|467829113|FG000|Overall Study|Lack of Efficacy|4|||
129962821|NCT00863798|467829114|FG001|Overall Study|Lack of Efficacy|3|||
129962822|NCT00863798|467829115|FG002|Overall Study|Lack of Efficacy|6|||
130091916|NCT02477215|468292510|FG000|Dose Escalation Phase|Physician Decision|1|||
130091917|NCT02477215|468292511|FG001|Dose Escalation Phase|Physician Decision|2|||
130091918|NCT02477215|468292512|FG002|Dose Escalation Phase|Physician Decision|0|||
130091919|NCT02477215|468292510|FG000|Fixed Dose Phase|Physician Decision|0|||
130091920|NCT02477215|468292511|FG001|Fixed Dose Phase|Physician Decision|7|||
130091921|NCT02477215|468292512|FG002|Fixed Dose Phase|Physician Decision|0|||
130091922|NCT01911546|468292515|FG000|Overall Study|Lost to Follow-up|1|||
129962823|NCT00863798|467829113|FG000|Overall Study|Lost to Follow-up|6|||
129962824|NCT00863798|467829114|FG001|Overall Study|Lost to Follow-up|9|||
129962825|NCT00863798|467829115|FG002|Overall Study|Lost to Follow-up|5|||
129962826|NCT00863798|467829113|FG000|Overall Study|Other|2|||
129962827|NCT00863798|467829114|FG001|Overall Study|Other|3|||
129962828|NCT00863798|467829115|FG002|Overall Study|Other|1|||
129962829|NCT00863798|467829113|FG000|Overall Study|Protocol Violation|0|||
129962830|NCT00863798|467829114|FG001|Overall Study|Protocol Violation|1|||
129962831|NCT00863798|467829115|FG002|Overall Study|Protocol Violation|1|||
129962832|NCT00863798|467829113|FG000|Overall Study|Withdrawal by Subject|8|||
129962833|NCT00863798|467829114|FG001|Overall Study|Withdrawal by Subject|7|||
129962834|NCT00863798|467829115|FG002|Overall Study|Withdrawal by Subject|4|||
129962835|NCT00863798|467829113|FG000|Overall Study|Randomized not treated|4|||
129962836|NCT00863798|467829114|FG001|Overall Study|Randomized not treated|2|||
129962837|NCT00863798|467829115|FG002|Overall Study|Randomized not treated|3|||
129962838|NCT04238520|467829116|FG000|Overall Study|Withdrawal by Subject|1|||
129962839|NCT04238520|467829117|FG001|Overall Study|Withdrawal by Subject|1|||
129962840|NCT04238520|467829116|FG000|Overall Study|Lost to Follow-up|1|||
129962841|NCT04238520|467829117|FG001|Overall Study|Lost to Follow-up|2|||
129962842|NCT04238520|467829116|FG000|Overall Study|Death|0|||
129962843|NCT04238520|467829117|FG001|Overall Study|Death|2|||
129962844|NCT04238520|467829116|FG000|Overall Study|Unsafe home environment for research staff|0|||
129962845|NCT04238520|467829117|FG001|Overall Study|Unsafe home environment for research staff|1|||
129962846|NCT01470599|467829118|FG000|Overall Study|Did not meet entrance criteria|1|||
129962847|NCT01470599|467829119|FG001|Overall Study|Did not meet entrance criteria|0|||
129962848|NCT01470599|467829118|FG000|Overall Study|Lost to Follow-up|2|||
129962849|NCT01470599|467829119|FG001|Overall Study|Lost to Follow-up|1|||
129962850|NCT01470599|467829118|FG000|Overall Study|Withdrawal by Subject|3|||
129962851|NCT01470599|467829119|FG001|Overall Study|Withdrawal by Subject|4|||
129962852|NCT01470599|467829118|FG000|Overall Study|Other|1|||
129962853|NCT01470599|467829119|FG001|Overall Study|Other|0|||
129962854|NCT01470599|467829118|FG000|Overall Study|Protocol Violation|3|||
129962855|NCT01470599|467829119|FG001|Overall Study|Protocol Violation|1|||
129962856|NCT01470599|467829118|FG000|Overall Study|Adverse event related to study drug|2|||
129962857|NCT01470599|467829119|FG001|Overall Study|Adverse event related to study drug|5|||
129962858|NCT01470599|467829118|FG000|Overall Study|Insufficient clinical response|6|||
129962859|NCT01470599|467829119|FG001|Overall Study|Insufficient clinical response|27|||
129962860|NCT01470599|467829118|FG000|Overall Study|Adverse event not related to study drug|1|||
129962861|NCT01470599|467829119|FG001|Overall Study|Adverse event not related to study drug|5|||
129962862|NCT00195442|467829120|FG000|Overall Study|Less than expected therapeutic effect|38|||
129962863|NCT00195442|467829120|FG000|Overall Study|Lost to Follow-up|27|||
129962864|NCT00195442|467829120|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
129962865|NCT00195442|467829120|FG000|Overall Study|Intermittent product shortage|21|||
129962866|NCT00195442|467829120|FG000|Overall Study|Death|7|||
129962867|NCT00195442|467829120|FG000|Overall Study|No reason specified|4|||
129962868|NCT00195442|467829120|FG000|Overall Study|Poor cooperation|2|||
129962869|NCT00195442|467829120|FG000|Overall Study|Other|14|||
129962870|NCT01917006|467829121|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
129962871|NCT01917006|467829122|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
129962872|NCT01917006|467829123|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
129962873|NCT01917006|467829124|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
129962874|NCT01917006|467829125|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
129962875|NCT01917006|467829126|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
129962876|NCT01917006|467829127|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
129962877|NCT01917006|467829128|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
129962878|NCT01917006|467829121|FG000|Randomized-treatment Period|Personal Reasons|0|||
129962879|NCT01917006|467829122|FG001|Randomized-treatment Period|Personal Reasons|0|||
129962880|NCT01917006|467829123|FG002|Randomized-treatment Period|Personal Reasons|0|||
129962881|NCT01917006|467829124|FG003|Randomized-treatment Period|Personal Reasons|0|||
129962882|NCT01917006|467829125|FG004|Randomized-treatment Period|Personal Reasons|0|||
129962883|NCT01917006|467829126|FG005|Randomized-treatment Period|Personal Reasons|1|||
129962884|NCT01917006|467829127|FG006|Randomized-treatment Period|Personal Reasons|0|||
129962885|NCT01917006|467829128|FG007|Randomized-treatment Period|Personal Reasons|0|||
129962886|NCT01917006|467829121|FG000|Randomized-treatment Period|Protocol Violation|1|||
129962887|NCT01917006|467829122|FG001|Randomized-treatment Period|Protocol Violation|0|||
129962888|NCT01917006|467829123|FG002|Randomized-treatment Period|Protocol Violation|0|||
129962889|NCT01917006|467829124|FG003|Randomized-treatment Period|Protocol Violation|0|||
129962890|NCT01917006|467829125|FG004|Randomized-treatment Period|Protocol Violation|0|||
129962891|NCT01917006|467829126|FG005|Randomized-treatment Period|Protocol Violation|0|||
129962892|NCT01917006|467829127|FG006|Randomized-treatment Period|Protocol Violation|0|||
129962893|NCT01917006|467829128|FG007|Randomized-treatment Period|Protocol Violation|0|||
129962894|NCT01917006|467829121|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962895|NCT01917006|467829122|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962896|NCT01917006|467829123|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962897|NCT01917006|467829124|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962898|NCT01917006|467829125|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962899|NCT01917006|467829126|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962900|NCT01917006|467829127|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
129962901|NCT01917006|467829128|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962902|NCT01917006|467829121|FG000|Open-label Period|Adverse Event|0|||
129962903|NCT01917006|467829122|FG001|Open-label Period|Adverse Event|0|||
129962904|NCT01917006|467829123|FG002|Open-label Period|Adverse Event|0|||
129962905|NCT01917006|467829124|FG003|Open-label Period|Adverse Event|0|||
129962906|NCT01917006|467829125|FG004|Open-label Period|Adverse Event|0|||
129962907|NCT01917006|467829126|FG005|Open-label Period|Adverse Event|0|||
129962908|NCT01917006|467829127|FG006|Open-label Period|Adverse Event|0|||
130122101|NCT01400113|468408771|FG001|Overall Study|Withdrawal by Subject|1|||
130122102|NCT01179919|468408772|FG000|Overall Study|Protocol Violation|1|||
130122103|NCT01179919|468408772|FG000|Overall Study|Adverse Event|1|||
130122104|NCT00806156|468408773|FG000|Overall Study|Death|35|||
130122105|NCT00806156|468408774|FG001|Overall Study|Death|95|||
130122106|NCT00806156|468408773|FG000|Overall Study|Did not meet eligibility criteria|1|||
130122107|NCT00806156|468408774|FG001|Overall Study|Did not meet eligibility criteria|0|||
130122108|NCT00806156|468408773|FG000|Overall Study|Study terminated by Sponsor|2|||
130122109|NCT00806156|468408774|FG001|Overall Study|Study terminated by Sponsor|40|||
130122110|NCT00806156|468408773|FG000|Overall Study|Consent withdrawn by subject|1|||
130122111|NCT00806156|468408774|FG001|Overall Study|Consent withdrawn by subject|3|||
130122112|NCT00806156|468408773|FG000|Overall Study|Lost to Follow-up|0|||
130122113|NCT00806156|468408774|FG001|Overall Study|Lost to Follow-up|1|||
130122114|NCT00525590|468408775|FG000|Overall Study|Adverse Event|3|||
130122115|NCT00525590|468408775|FG000|Overall Study|Physician Decision|3|||
130122116|NCT00525590|468408775|FG000|Overall Study|Withdrawal by Subject|16|||
130122117|NCT00525590|468408775|FG000|Overall Study|Lost to Follow-up|1|||
130122118|NCT00525590|468408775|FG000|Overall Study|Death|9|||
130122119|NCT00525590|468408775|FG000|Overall Study|Other|13|||
130122120|NCT01025037|468408776|FG000|Overall Study|Adverse Event|3|||
130122121|NCT01025037|468408776|FG000|Overall Study|Lost to Follow-up|7|||
130122122|NCT01025037|468408776|FG000|Overall Study|Withdrawal by Subject|1|||
130122123|NCT00337571|468408777|FG000|Overall Study|Lack of Efficacy|3|||
130122124|NCT00337571|468408778|FG001|Overall Study|Lack of Efficacy|0|||
130122125|NCT00337571|468408779|FG002|Overall Study|Lack of Efficacy|0|||
130122126|NCT00337571|468408780|FG003|Overall Study|Lack of Efficacy|0|||
130122127|NCT00337571|468408777|FG000|Overall Study|Adverse Event|4|||
130122128|NCT00337571|468408778|FG001|Overall Study|Adverse Event|5|||
130122129|NCT00337571|468408779|FG002|Overall Study|Adverse Event|8|||
130122130|NCT00337571|468408780|FG003|Overall Study|Adverse Event|4|||
130122131|NCT00337571|468408777|FG000|Overall Study|Withdrawal by Subject|2|||
130122132|NCT00337571|468408778|FG001|Overall Study|Withdrawal by Subject|2|||
130122133|NCT00337571|468408779|FG002|Overall Study|Withdrawal by Subject|1|||
130122134|NCT00337571|468408780|FG003|Overall Study|Withdrawal by Subject|0|||
130122135|NCT00337571|468408777|FG000|Overall Study|Lost to Follow-up|3|||
130122136|NCT00337571|468408778|FG001|Overall Study|Lost to Follow-up|1|||
130122137|NCT00337571|468408779|FG002|Overall Study|Lost to Follow-up|0|||
130122138|NCT00337571|468408780|FG003|Overall Study|Lost to Follow-up|1|||
130122139|NCT00337571|468408777|FG000|Overall Study|Poor/noncompliance|1|||
130122140|NCT00337571|468408778|FG001|Overall Study|Poor/noncompliance|1|||
130122141|NCT00337571|468408779|FG002|Overall Study|Poor/noncompliance|1|||
130122142|NCT00337571|468408780|FG003|Overall Study|Poor/noncompliance|1|||
130122143|NCT00337571|468408777|FG000|Overall Study|No longer met study criteria|1|||
130122144|NCT00337571|468408778|FG001|Overall Study|No longer met study criteria|0|||
130122145|NCT00337571|468408779|FG002|Overall Study|No longer met study criteria|0|||
130122146|NCT00337571|468408780|FG003|Overall Study|No longer met study criteria|0|||
130122147|NCT00337571|468408777|FG000|Overall Study|High Potassium level|0|||
130122148|NCT00337571|468408778|FG001|Overall Study|High Potassium level|0|||
130122149|NCT00337571|468408779|FG002|Overall Study|High Potassium level|0|||
130122150|NCT00337571|468408780|FG003|Overall Study|High Potassium level|1|||
130122151|NCT02114697|468408781|FG000|Overall Study|Study terminated|5|||
130122152|NCT02114697|468408782|FG001|Overall Study|Study terminated|4|||
130122153|NCT03552757|468408789|FG000|Overall Study|Withdrawal by Subject|10|||
129962909|NCT01917006|467829128|FG007|Open-label Period|Adverse Event|1|||
129962910|NCT01917006|467829121|FG000|Open-label Period|Lost to Follow-up|0|||
129962911|NCT01917006|467829122|FG001|Open-label Period|Lost to Follow-up|0|||
129962912|NCT01917006|467829123|FG002|Open-label Period|Lost to Follow-up|0|||
129962913|NCT01917006|467829124|FG003|Open-label Period|Lost to Follow-up|0|||
130122154|NCT03552757|468408790|FG001|Overall Study|Withdrawal by Subject|5|||
130122155|NCT03552757|468408791|FG002|Overall Study|Withdrawal by Subject|12|||
130122156|NCT03552757|468408789|FG000|Overall Study|Lost to Follow-up|2|||
130122157|NCT03552757|468408790|FG001|Overall Study|Lost to Follow-up|7|||
130122158|NCT03552757|468408791|FG002|Overall Study|Lost to Follow-up|7|||
130122159|NCT03552757|468408789|FG000|Overall Study|Death|1|||
130122160|NCT03552757|468408790|FG001|Overall Study|Death|1|||
130122161|NCT03552757|468408791|FG002|Overall Study|Death|1|||
129962914|NCT01917006|467829125|FG004|Open-label Period|Lost to Follow-up|0|||
130122162|NCT00449150|468408792|FG000|Overall Study|Adverse Event|11|||
130122163|NCT00449150|468408793|FG001|Overall Study|Adverse Event|18|||
129962915|NCT01917006|467829126|FG005|Open-label Period|Lost to Follow-up|0|||
129962916|NCT01917006|467829127|FG006|Open-label Period|Lost to Follow-up|0|||
129962917|NCT01917006|467829128|FG007|Open-label Period|Lost to Follow-up|1|||
129962918|NCT00847132|467829131|FG000|Overall Study|Death|1|||
129962919|NCT00847132|467829132|FG001|Overall Study|Death|1|||
129962920|NCT03596242|467829133|FG000|Overall Study|Lost to Follow-up|2|||
129962921|NCT03596242|467829134|FG001|Overall Study|Lost to Follow-up|2|||
129962922|NCT02509312|467829135|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
129962923|NCT02509312|467829136|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
129962924|NCT02509312|467829135|FG000|Overall Study|Obstetrician refusal|0|||
129962925|NCT02509312|467829136|FG001|Overall Study|Obstetrician refusal|1|||
129962926|NCT02509312|467829135|FG000|Overall Study|Patient elected for TOLAC|1|||
129962927|NCT02509312|467829136|FG001|Overall Study|Patient elected for TOLAC|0|||
129962928|NCT02509312|467829135|FG000|Overall Study|Cesarean deemed stat|1|||
129962929|NCT02509312|467829136|FG001|Overall Study|Cesarean deemed stat|0|||
129962930|NCT02509312|467829135|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
129962931|NCT02509312|467829136|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
129962932|NCT01036165|467829141|FG000|Overall Study|Adverse Event|6|||
129962933|NCT01036165|467829141|FG000|Overall Study|Lost to Follow-up|2|||
129962934|NCT01036165|467829141|FG000|Overall Study|Withdrawal by Subject|3|||
129962935|NCT01036165|467829141|FG000|Overall Study|Device Related Issues|3|||
129962936|NCT01036165|467829141|FG000|Overall Study|Problems finding proper area to inject|1|||
129962937|NCT00913523|467829148|FG000|Overall Study|Withdrawal by Subject|3|||
129962938|NCT00913523|467829149|FG001|Overall Study|Withdrawal by Subject|2|||
129962939|NCT00913523|467829150|FG002|Overall Study|Withdrawal by Subject|2|||
129962940|NCT00913523|467829148|FG000|Overall Study|Lost to Follow-up|1|||
129962941|NCT00913523|467829149|FG001|Overall Study|Lost to Follow-up|1|||
129962942|NCT00913523|467829150|FG002|Overall Study|Lost to Follow-up|1|||
129962943|NCT00913523|467829148|FG000|Overall Study|Adverse Event|1|||
129962944|NCT00913523|467829149|FG001|Overall Study|Adverse Event|0|||
129962945|NCT00913523|467829150|FG002|Overall Study|Adverse Event|0|||
129962946|NCT00913523|467829148|FG000|Overall Study|Protocol Violation|5|||
129962947|NCT00913523|467829149|FG001|Overall Study|Protocol Violation|8|||
129962948|NCT00913523|467829150|FG002|Overall Study|Protocol Violation|8|||
129962949|NCT00913523|467829148|FG000|Overall Study|Pregnancy|1|||
129962950|NCT00913523|467829149|FG001|Overall Study|Pregnancy|3|||
129962951|NCT00913523|467829150|FG002|Overall Study|Pregnancy|0|||
129962952|NCT00913523|467829148|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
129962953|NCT00913523|467829149|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
129962954|NCT00913523|467829150|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
129962955|NCT00916305|467829151|FG000|Overall Study|Lost to Follow-up|21|||
129962956|NCT00916305|467829152|FG001|Overall Study|Lost to Follow-up|27|||
130122164|NCT00449150|468408794|FG002|Overall Study|Adverse Event|9|||
130122165|NCT00449150|468408792|FG000|Overall Study|Lack of Efficacy|1|||
130122166|NCT00449150|468408793|FG001|Overall Study|Lack of Efficacy|2|||
130122167|NCT00449150|468408794|FG002|Overall Study|Lack of Efficacy|2|||
130122168|NCT00449150|468408792|FG000|Overall Study|Other|16|||
130122169|NCT00449150|468408793|FG001|Overall Study|Other|13|||
130122170|NCT00449150|468408794|FG002|Overall Study|Other|14|||
130122171|NCT00449150|468408792|FG000|Overall Study|Withdrawal by Subject|17|||
130122172|NCT00449150|468408793|FG001|Overall Study|Withdrawal by Subject|18|||
130122173|NCT00449150|468408794|FG002|Overall Study|Withdrawal by Subject|21|||
130122174|NCT00449150|468408792|FG000|Overall Study|Protocol Violation|1|||
129962957|NCT00916305|467829151|FG000|Overall Study|Withdrawal by Subject|0|||
129962958|NCT00916305|467829152|FG001|Overall Study|Withdrawal by Subject|1|||
129962959|NCT01844726|467829153|FG000|Overall Study|Withdrawal by Subject|0|||
129962960|NCT01844726|467829154|FG001|Overall Study|Withdrawal by Subject|1|||
129962961|NCT01844726|467829153|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
130122175|NCT00449150|468408793|FG001|Overall Study|Protocol Violation|2|||
130122176|NCT00449150|468408794|FG002|Overall Study|Protocol Violation|1|||
130122177|NCT02674334|468408795|FG000|Overall Study|Lost to Follow-up|5|||
130122178|NCT02674334|468408796|FG001|Overall Study|Lost to Follow-up|3|||
130122179|NCT02674334|468408795|FG000|Overall Study|participant difficulty breathing|1|||
129962962|NCT01844726|467829154|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
129962963|NCT01475461|467829157|FG000|Run-in Period|Not meet eligibility criteria|16|||
129962964|NCT01475461|467829158|FG001|Run-in Period|Not meet eligibility criteria|0|||
129962965|NCT01475461|467829159|FG002|Run-in Period|Not meet eligibility criteria|0|||
129962966|NCT01475461|467829160|FG003|Run-in Period|Not meet eligibility criteria|0|||
129962967|NCT01475461|467829161|FG004|Run-in Period|Not meet eligibility criteria|0|||
129962968|NCT01475461|467829162|FG005|Run-in Period|Not meet eligibility criteria|0|||
130122180|NCT02674334|468408796|FG001|Overall Study|participant difficulty breathing|0|||
130122181|NCT02674334|468408795|FG000|Overall Study|NIRS not recording|1|||
130122182|NCT02674334|468408796|FG001|Overall Study|NIRS not recording|0|||
129962969|NCT01475461|467829163|FG006|Run-in Period|Not meet eligibility criteria|0|||
129962970|NCT01475461|467829157|FG000|Run-in Period|Lost to Follow-up|7|||
129962971|NCT01475461|467829158|FG001|Run-in Period|Lost to Follow-up|0|||
129962972|NCT01475461|467829159|FG002|Run-in Period|Lost to Follow-up|0|||
129962973|NCT01475461|467829160|FG003|Run-in Period|Lost to Follow-up|0|||
129962974|NCT01475461|467829161|FG004|Run-in Period|Lost to Follow-up|0|||
129962975|NCT01475461|467829162|FG005|Run-in Period|Lost to Follow-up|0|||
129962976|NCT01475461|467829163|FG006|Run-in Period|Lost to Follow-up|0|||
129962977|NCT01475461|467829157|FG000|Run-in Period|Withdrawal by Subject|11|||
129962978|NCT01475461|467829158|FG001|Run-in Period|Withdrawal by Subject|0|||
129962979|NCT01475461|467829159|FG002|Run-in Period|Withdrawal by Subject|0|||
129962980|NCT01475461|467829160|FG003|Run-in Period|Withdrawal by Subject|0|||
129962981|NCT01475461|467829161|FG004|Run-in Period|Withdrawal by Subject|0|||
129962982|NCT01475461|467829162|FG005|Run-in Period|Withdrawal by Subject|0|||
129962983|NCT01475461|467829163|FG006|Run-in Period|Withdrawal by Subject|0|||
129962984|NCT01475461|467829157|FG000|Run-in Period|Other|3|||
129962985|NCT01475461|467829158|FG001|Run-in Period|Other|0|||
129962986|NCT01475461|467829159|FG002|Run-in Period|Other|0|||
129962987|NCT01475461|467829160|FG003|Run-in Period|Other|0|||
129962988|NCT01475461|467829161|FG004|Run-in Period|Other|0|||
129962989|NCT01475461|467829162|FG005|Run-in Period|Other|0|||
129962990|NCT01475461|467829163|FG006|Run-in Period|Other|0|||
129962991|NCT01475461|467829157|FG000|Run-in Period|Protocol Violation|4|||
129962992|NCT01475461|467829158|FG001|Run-in Period|Protocol Violation|0|||
129962993|NCT01475461|467829159|FG002|Run-in Period|Protocol Violation|0|||
129962994|NCT01475461|467829160|FG003|Run-in Period|Protocol Violation|0|||
129962995|NCT01475461|467829161|FG004|Run-in Period|Protocol Violation|0|||
129962996|NCT01475461|467829162|FG005|Run-in Period|Protocol Violation|0|||
129962997|NCT01475461|467829163|FG006|Run-in Period|Protocol Violation|0|||
129962998|NCT01475461|467829157|FG000|Treatment Period|Death|0|||
129962999|NCT01475461|467829158|FG001|Treatment Period|Death|0|||
129963000|NCT01475461|467829159|FG002|Treatment Period|Death|0|||
129963001|NCT01475461|467829160|FG003|Treatment Period|Death|1|||
129963002|NCT01475461|467829161|FG004|Treatment Period|Death|0|||
129963003|NCT01475461|467829162|FG005|Treatment Period|Death|0|||
129963004|NCT01475461|467829163|FG006|Treatment Period|Death|0|||
129963005|NCT01475461|467829157|FG000|Treatment Period|Lost to Follow-up|0|||
129963006|NCT01475461|467829158|FG001|Treatment Period|Lost to Follow-up|3|||
129963007|NCT01475461|467829159|FG002|Treatment Period|Lost to Follow-up|2|||
129963008|NCT01475461|467829160|FG003|Treatment Period|Lost to Follow-up|3|||
129963009|NCT01475461|467829161|FG004|Treatment Period|Lost to Follow-up|1|||
129963010|NCT01475461|467829162|FG005|Treatment Period|Lost to Follow-up|2|||
129963011|NCT01475461|467829163|FG006|Treatment Period|Lost to Follow-up|1|||
129963012|NCT01475461|467829157|FG000|Treatment Period|Withdrawal by Subject|0|||
129963013|NCT01475461|467829158|FG001|Treatment Period|Withdrawal by Subject|2|||
129963014|NCT01475461|467829159|FG002|Treatment Period|Withdrawal by Subject|2|||
129963015|NCT01475461|467829160|FG003|Treatment Period|Withdrawal by Subject|0|||
129963016|NCT01475461|467829161|FG004|Treatment Period|Withdrawal by Subject|2|||
129963017|NCT01475461|467829162|FG005|Treatment Period|Withdrawal by Subject|2|||
129963018|NCT01475461|467829163|FG006|Treatment Period|Withdrawal by Subject|0|||
129963019|NCT01475461|467829157|FG000|Treatment Period|Other|0|||
129963020|NCT01475461|467829158|FG001|Treatment Period|Other|1|||
129963021|NCT01475461|467829159|FG002|Treatment Period|Other|0|||
129963022|NCT01475461|467829160|FG003|Treatment Period|Other|0|||
129963023|NCT01475461|467829161|FG004|Treatment Period|Other|0|||
129963024|NCT01475461|467829162|FG005|Treatment Period|Other|0|||
129963025|NCT01475461|467829163|FG006|Treatment Period|Other|0|||
129963026|NCT01475461|467829157|FG000|Treatment Period|Protocol Violation|0|||
129963027|NCT01475461|467829158|FG001|Treatment Period|Protocol Violation|1|||
129963028|NCT01475461|467829159|FG002|Treatment Period|Protocol Violation|0|||
129963029|NCT01475461|467829160|FG003|Treatment Period|Protocol Violation|0|||
129963030|NCT01475461|467829161|FG004|Treatment Period|Protocol Violation|0|||
129963031|NCT01475461|467829162|FG005|Treatment Period|Protocol Violation|0|||
129963032|NCT01475461|467829163|FG006|Treatment Period|Protocol Violation|1|||
129963033|NCT01475461|467829157|FG000|Treatment Period|Lack of Efficacy|0|||
129963034|NCT01475461|467829158|FG001|Treatment Period|Lack of Efficacy|2|||
130122183|NCT01345019|468408803|FG000|Blinded Treatment Phase|Death|147|||
130122184|NCT01345019|468408804|FG001|Blinded Treatment Phase|Death|137|||
129963035|NCT01475461|467829159|FG002|Treatment Period|Lack of Efficacy|0|||
129963036|NCT01475461|467829160|FG003|Treatment Period|Lack of Efficacy|2|||
129963037|NCT01475461|467829161|FG004|Treatment Period|Lack of Efficacy|1|||
129963038|NCT01475461|467829162|FG005|Treatment Period|Lack of Efficacy|1|||
130122185|NCT01345019|468408803|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
129963039|NCT01475461|467829163|FG006|Treatment Period|Lack of Efficacy|0|||
129963040|NCT01475461|467829157|FG000|Treatment Period|Medication Error|0|||
129963041|NCT01475461|467829158|FG001|Treatment Period|Medication Error|0|||
129963042|NCT01475461|467829159|FG002|Treatment Period|Medication Error|0|||
129963043|NCT01475461|467829160|FG003|Treatment Period|Medication Error|1|||
129963044|NCT01475461|467829161|FG004|Treatment Period|Medication Error|0|||
129963045|NCT01475461|467829162|FG005|Treatment Period|Medication Error|0|||
129963046|NCT01475461|467829163|FG006|Treatment Period|Medication Error|0|||
129963047|NCT01475461|467829157|FG000|Treatment Period|Adverse Event|0|||
129963048|NCT01475461|467829158|FG001|Treatment Period|Adverse Event|0|||
129963049|NCT01475461|467829159|FG002|Treatment Period|Adverse Event|0|||
129963050|NCT01475461|467829160|FG003|Treatment Period|Adverse Event|1|||
129963051|NCT01475461|467829161|FG004|Treatment Period|Adverse Event|0|||
129963052|NCT01475461|467829162|FG005|Treatment Period|Adverse Event|0|||
129963053|NCT01475461|467829163|FG006|Treatment Period|Adverse Event|0|||
129963054|NCT02512861|467829169|FG000|Overall Study|Protocol Violation|3|||
129963055|NCT02512861|467829170|FG001|Overall Study|Protocol Violation|7|||
129963056|NCT02512861|467829169|FG000|Overall Study|Physician Decision|3|||
129963057|NCT02512861|467829170|FG001|Overall Study|Physician Decision|1|||
129963058|NCT02512861|467829169|FG000|Overall Study|Withdrawal by Subject|0|||
129963059|NCT02512861|467829170|FG001|Overall Study|Withdrawal by Subject|1|||
129963060|NCT03214250|467829173|FG000|Overall Study|Death|5|||
129963061|NCT03214250|467829174|FG001|Overall Study|Death|5|||
129963062|NCT03214250|467829175|FG002|Overall Study|Death|7|||
129963063|NCT03214250|467829176|FG003|Overall Study|Death|4|||
129963064|NCT03214250|467829177|FG004|Overall Study|Death|23|||
129963065|NCT03214250|467829178|FG005|Overall Study|Death|23|||
129963066|NCT03214250|467829179|FG006|Overall Study|Death|24|||
129963067|NCT03214250|467829173|FG000|Overall Study|Lost to Follow-up|0|||
129963068|NCT03214250|467829174|FG001|Overall Study|Lost to Follow-up|0|||
129963069|NCT03214250|467829175|FG002|Overall Study|Lost to Follow-up|0|||
129963070|NCT03214250|467829176|FG003|Overall Study|Lost to Follow-up|1|||
129963071|NCT03214250|467829177|FG004|Overall Study|Lost to Follow-up|1|||
129963072|NCT03214250|467829178|FG005|Overall Study|Lost to Follow-up|2|||
129963073|NCT03214250|467829179|FG006|Overall Study|Lost to Follow-up|0|||
129963074|NCT03214250|467829173|FG000|Overall Study|Other|0|||
129963075|NCT03214250|467829174|FG001|Overall Study|Other|0|||
129963076|NCT03214250|467829175|FG002|Overall Study|Other|0|||
129963077|NCT03214250|467829176|FG003|Overall Study|Other|0|||
129963078|NCT03214250|467829177|FG004|Overall Study|Other|1|||
129963079|NCT03214250|467829178|FG005|Overall Study|Other|1|||
129963080|NCT03214250|467829179|FG006|Overall Study|Other|2|||
129963081|NCT03214250|467829173|FG000|Overall Study|Remains on Study|2|||
129963082|NCT03214250|467829174|FG001|Overall Study|Remains on Study|2|||
129963083|NCT03214250|467829175|FG002|Overall Study|Remains on Study|0|||
129963084|NCT03214250|467829176|FG003|Overall Study|Remains on Study|1|||
129963085|NCT03214250|467829177|FG004|Overall Study|Remains on Study|7|||
129963086|NCT03214250|467829178|FG005|Overall Study|Remains on Study|5|||
129963087|NCT03214250|467829179|FG006|Overall Study|Remains on Study|3|||
129963088|NCT03214250|467829173|FG000|Overall Study|Withdrawal by Subject|0|||
129963089|NCT03214250|467829174|FG001|Overall Study|Withdrawal by Subject|0|||
129963090|NCT03214250|467829175|FG002|Overall Study|Withdrawal by Subject|1|||
129963091|NCT03214250|467829176|FG003|Overall Study|Withdrawal by Subject|2|||
129963092|NCT03214250|467829177|FG004|Overall Study|Withdrawal by Subject|5|||
129963093|NCT03214250|467829178|FG005|Overall Study|Withdrawal by Subject|0|||
129963094|NCT03214250|467829179|FG006|Overall Study|Withdrawal by Subject|2|||
129963095|NCT00292981|467829183|FG000|Overall Study|Adverse Event|1|||
129963096|NCT00292981|467829183|FG000|Overall Study|Lost to Follow-up|13|||
129963097|NCT00292981|467829183|FG000|Overall Study|Withdrawal by Subject|22|||
129963098|NCT00292981|467829183|FG000|Overall Study|Other|3|||
129963099|NCT00594178|467829184|FG000|Overall Study|Physician Decision|5|||
129963100|NCT02971228|467829187|FG000|Overall Study|Withdrawal by Subject|1|||
129963101|NCT02971228|467829188|FG001|Overall Study|Withdrawal by Subject|1|||
129963102|NCT02971228|467829189|FG002|Overall Study|Withdrawal by Subject|0|||
129963103|NCT02971228|467829190|FG003|Overall Study|Withdrawal by Subject|0|||
129963104|NCT02971228|467829191|FG004|Overall Study|Withdrawal by Subject|0|||
129963105|NCT02971228|467829187|FG000|Overall Study|Logistical challenges|0|||
129963106|NCT02971228|467829188|FG001|Overall Study|Logistical challenges|1|||
129963107|NCT02971228|467829189|FG002|Overall Study|Logistical challenges|0|||
129963108|NCT02971228|467829190|FG003|Overall Study|Logistical challenges|0|||
130091923|NCT01911546|468292515|FG000|Overall Study|Everolimus was discontinued|5|||
130091924|NCT01474291|468292516|FG000|Overall Study|Not Evaluable for Efficacy|26|||
129963109|NCT02971228|467829191|FG004|Overall Study|Logistical challenges|0|||
129963110|NCT00905034|467829193|FG000|Overall Study|Withdrawal by Subject|1|||
129963111|NCT00394589|467829194|FG000|Overall Study|Adverse Event|2|||
129963112|NCT00394589|467829195|FG001|Overall Study|Adverse Event|1|||
129963113|NCT00394589|467829196|FG002|Overall Study|Adverse Event|2|||
129963114|NCT00394589|467829194|FG000|Overall Study|Lack of Efficacy|2|||
130091925|NCT01474291|468292516|FG000|Overall Study|Lack of Treatment Efficacy|88|||
129963115|NCT00394589|467829195|FG001|Overall Study|Lack of Efficacy|2|||
129963116|NCT00394589|467829196|FG002|Overall Study|Lack of Efficacy|3|||
129963117|NCT00394589|467829194|FG000|Overall Study|Protocol Violation|4|||
129963118|NCT00394589|467829195|FG001|Overall Study|Protocol Violation|0|||
129963119|NCT00394589|467829196|FG002|Overall Study|Protocol Violation|2|||
129963120|NCT04081389|467829197|FG000|Overall Study|Withdrawal by Subject|0|||
129963121|NCT04081389|467829198|FG001|Overall Study|Withdrawal by Subject|0|||
129963122|NCT04081389|467829199|FG002|Overall Study|Withdrawal by Subject|1|||
129963123|NCT04081389|467829200|FG003|Overall Study|Withdrawal by Subject|0|||
129963124|NCT04016805|467829201|FG000|Overall Study|Sponsor's Discretion|30|||
129963125|NCT04016805|467829202|FG001|Overall Study|Sponsor's Discretion|6|||
129963126|NCT04016805|467829203|FG002|Overall Study|Sponsor's Discretion|5|||
129963127|NCT00545571|467829204|FG000|Overall Study|Administrative Reasons|1|||
129963128|NCT00545571|467829204|FG000|Overall Study|Adverse Event|2|||
129963129|NCT00545571|467829204|FG000|Overall Study|Death|5|||
129963130|NCT00545571|467829204|FG000|Overall Study|Lack of Efficacy|1|||
129963131|NCT00545571|467829204|FG000|Overall Study|Protocol Violation|2|||
129963132|NCT00545571|467829204|FG000|Overall Study|Refused Treatment|1|||
129963133|NCT00545571|467829204|FG000|Overall Study|Screen Failure|16|||
129963134|NCT00545571|467829204|FG000|Overall Study|Transfusion|12|||
129963135|NCT00545571|467829204|FG000|Overall Study|Early Termination of Study|24|||
129963136|NCT00545571|467829204|FG000|Overall Study|Kidney Transplantation|3|||
129963137|NCT01193218|467829205|FG000|0-12 Weeks|Adverse Event|6|||
129963138|NCT01193218|467829206|FG001|0-12 Weeks|Adverse Event|0|||
129963139|NCT01193218|467829207|FG002|0-12 Weeks|Adverse Event|1|||
129963140|NCT01193218|467829208|FG003|0-12 Weeks|Adverse Event|0|||
129963141|NCT01193218|467829209|FG004|0-12 Weeks|Adverse Event|0|||
129963142|NCT01193218|467829210|FG005|0-12 Weeks|Adverse Event|2|||
129963143|NCT01193218|467829211|FG006|0-12 Weeks|Adverse Event|2|||
129963144|NCT01193218|467829212|FG007|0-12 Weeks|Adverse Event|0|||
129963145|NCT01193218|467829205|FG000|0-12 Weeks|Protocol Violation|0|||
129963146|NCT01193218|467829206|FG001|0-12 Weeks|Protocol Violation|0|||
129963147|NCT01193218|467829207|FG002|0-12 Weeks|Protocol Violation|0|||
129963148|NCT01193218|467829208|FG003|0-12 Weeks|Protocol Violation|0|||
129963149|NCT01193218|467829209|FG004|0-12 Weeks|Protocol Violation|1|||
129963150|NCT01193218|467829210|FG005|0-12 Weeks|Protocol Violation|1|||
129963151|NCT01193218|467829211|FG006|0-12 Weeks|Protocol Violation|0|||
129963152|NCT01193218|467829212|FG007|0-12 Weeks|Protocol Violation|0|||
129963153|NCT01193218|467829205|FG000|0-12 Weeks|Withdrawal by Subject|3|||
129963154|NCT01193218|467829206|FG001|0-12 Weeks|Withdrawal by Subject|0|||
129963155|NCT01193218|467829207|FG002|0-12 Weeks|Withdrawal by Subject|2|||
129963156|NCT01193218|467829208|FG003|0-12 Weeks|Withdrawal by Subject|0|||
129963157|NCT01193218|467829209|FG004|0-12 Weeks|Withdrawal by Subject|0|||
129963158|NCT01193218|467829210|FG005|0-12 Weeks|Withdrawal by Subject|0|||
129963159|NCT01193218|467829211|FG006|0-12 Weeks|Withdrawal by Subject|1|||
129963160|NCT01193218|467829212|FG007|0-12 Weeks|Withdrawal by Subject|0|||
129963161|NCT01193218|467829205|FG000|12-52 Weeks|Adverse Event|1|||
129963162|NCT01193218|467829206|FG001|12-52 Weeks|Adverse Event|0|||
129963163|NCT01193218|467829207|FG002|12-52 Weeks|Adverse Event|1|||
129963164|NCT01193218|467829208|FG003|12-52 Weeks|Adverse Event|2|||
129963165|NCT01193218|467829209|FG004|12-52 Weeks|Adverse Event|3|||
129963166|NCT01193218|467829210|FG005|12-52 Weeks|Adverse Event|3|||
129963167|NCT01193218|467829211|FG006|12-52 Weeks|Adverse Event|1|||
129963168|NCT01193218|467829212|FG007|12-52 Weeks|Adverse Event|2|||
130091926|NCT01474291|468292516|FG000|Overall Study|Adverse Event|53|||
130091927|NCT01474291|468292516|FG000|Overall Study|Lost to Follow-up|29|||
130091928|NCT01474291|468292516|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
130091929|NCT01474291|468292516|FG000|Overall Study|No Reason Reported|10|||
130091930|NCT01474291|468292516|FG000|Overall Study|Death|2|||
130091931|NCT00310440|468292517|FG000|Overall Study|Lost to Follow-up|17|||
130091932|NCT00310440|468292518|FG001|Overall Study|Lost to Follow-up|8|||
130091933|NCT00310440|468292517|FG000|Overall Study|Withdrawal by Subject|2|||
130091934|NCT00310440|468292518|FG001|Overall Study|Withdrawal by Subject|1|||
130091935|NCT00310440|468292517|FG000|Overall Study|Missed 12 Month Visit|7|||
130091936|NCT00310440|468292518|FG001|Overall Study|Missed 12 Month Visit|4|||
130091937|NCT03380091|468292521|FG000|Overall Study|Withdrawal by Subject|2|||
130091938|NCT03380091|468292522|FG001|Overall Study|Withdrawal by Subject|1|||
130091939|NCT05602818|468292523|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
130091940|NCT05602818|468292524|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
130091941|NCT05602818|468292525|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
130091942|NCT05602818|468292526|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
130091943|NCT05602818|468292527|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
130091944|NCT05602818|468292528|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
130091945|NCT05602818|468292529|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
130091946|NCT05602818|468292530|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
129963169|NCT01193218|467829205|FG000|12-52 Weeks|Lack of Efficacy|0|||
129963170|NCT01193218|467829206|FG001|12-52 Weeks|Lack of Efficacy|0|||
129963171|NCT01193218|467829207|FG002|12-52 Weeks|Lack of Efficacy|0|||
130091947|NCT05602818|468292531|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
130091948|NCT05602818|468292532|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
129963172|NCT01193218|467829208|FG003|12-52 Weeks|Lack of Efficacy|0|||
129963173|NCT01193218|467829209|FG004|12-52 Weeks|Lack of Efficacy|0|||
129963174|NCT01193218|467829210|FG005|12-52 Weeks|Lack of Efficacy|0|||
129963175|NCT01193218|467829211|FG006|12-52 Weeks|Lack of Efficacy|1|||
129963176|NCT01193218|467829212|FG007|12-52 Weeks|Lack of Efficacy|0|||
129963177|NCT01193218|467829205|FG000|12-52 Weeks|Withdrawal by Subject|3|||
129963178|NCT01193218|467829206|FG001|12-52 Weeks|Withdrawal by Subject|0|||
129963179|NCT01193218|467829207|FG002|12-52 Weeks|Withdrawal by Subject|3|||
129963180|NCT01193218|467829208|FG003|12-52 Weeks|Withdrawal by Subject|0|||
129963181|NCT01193218|467829209|FG004|12-52 Weeks|Withdrawal by Subject|0|||
129963182|NCT01193218|467829210|FG005|12-52 Weeks|Withdrawal by Subject|2|||
129963183|NCT01193218|467829211|FG006|12-52 Weeks|Withdrawal by Subject|1|||
129963184|NCT01193218|467829212|FG007|12-52 Weeks|Withdrawal by Subject|2|||
129963185|NCT01193218|467829205|FG000|12-52 Weeks|Other reason than above|1|||
129963186|NCT01193218|467829206|FG001|12-52 Weeks|Other reason than above|0|||
129963187|NCT01193218|467829207|FG002|12-52 Weeks|Other reason than above|0|||
129963188|NCT01193218|467829208|FG003|12-52 Weeks|Other reason than above|1|||
129963189|NCT01193218|467829209|FG004|12-52 Weeks|Other reason than above|1|||
129963190|NCT01193218|467829210|FG005|12-52 Weeks|Other reason than above|0|||
129963191|NCT01193218|467829211|FG006|12-52 Weeks|Other reason than above|0|||
129963192|NCT01193218|467829212|FG007|12-52 Weeks|Other reason than above|0|||
129963193|NCT01013740|467829213|FG000|Overall Study|Lost to Follow-up|3|||
129963194|NCT01013740|467829214|FG001|Overall Study|Lost to Follow-up|5|||
129963195|NCT01013740|467829213|FG000|Overall Study|Physician Decision|2|||
129963196|NCT01013740|467829214|FG001|Overall Study|Physician Decision|0|||
129963197|NCT01013740|467829213|FG000|Overall Study|Withdrawal by Subject|2|||
129963198|NCT01013740|467829214|FG001|Overall Study|Withdrawal by Subject|10|||
129963199|NCT01013740|467829213|FG000|Overall Study|study close / terminated : done in error|2|||
129963200|NCT01013740|467829214|FG001|Overall Study|study close / terminated : done in error|1|||
129963201|NCT01013740|467829213|FG000|Overall Study|Missing|2|||
129963202|NCT01013740|467829214|FG001|Overall Study|Missing|1|||
129963203|NCT01013740|467829213|FG000|Overall Study|Ongoing: Study records not completed|0|||
129963204|NCT01013740|467829214|FG001|Overall Study|Ongoing: Study records not completed|2|||
129963205|NCT00338949|467829215|FG000|Subject Screening|Screen failures|11|||
129963206|NCT00338949|467829216|FG001|Subject Screening|Screen failures|11|||
129963207|NCT00338949|467829215|FG000|Randomization|Withdrawal by Subject|1|||
129963208|NCT00338949|467829216|FG001|Randomization|Withdrawal by Subject|0|||
129963209|NCT00338949|467829215|FG000|Randomization|Adverse Event|0|||
129963210|NCT00338949|467829216|FG001|Randomization|Adverse Event|5|||
129963211|NCT03811834|467829217|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
129963212|NCT01242371|467829218|FG000|Overall Study|Withdrawal by Subject|2|||
129963213|NCT01242371|467829219|FG001|Overall Study|Withdrawal by Subject|2|||
129963214|NCT01242371|467829218|FG000|Overall Study|Protocol Violation|0|||
129963215|NCT01242371|467829219|FG001|Overall Study|Protocol Violation|3|||
129963216|NCT00025662|467829220|FG000|Overall Study|Withdrawal by Subject|2|||
129963217|NCT00025662|467829220|FG000|Overall Study|Technical failure of manipulation|1|||
129963218|NCT01349036|467829221|FG000|Overall Study|Disease progression|13|||
129963219|NCT01349036|467829222|FG001|Overall Study|Disease progression|22|||
129963220|NCT01349036|467829221|FG000|Overall Study|Other|1|||
129963221|NCT01349036|467829222|FG001|Overall Study|Other|0|||
129963222|NCT01349036|467829221|FG000|Overall Study|Withdrawal by Subject|0|||
129963223|NCT01349036|467829222|FG001|Overall Study|Withdrawal by Subject|2|||
129963224|NCT01215032|467829225|FG000|Overall Study|Adverse Event|3|||
129963225|NCT01215032|467829225|FG000|Overall Study|Lack of Efficacy|17|||
129963226|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
129963227|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
129963228|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
129963229|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
129963230|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
129963231|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
129963232|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
129963233|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
129963234|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
129963235|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
129963236|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
129963237|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
129963238|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
129963239|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
129963240|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
129963241|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
129963242|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
129963243|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
129963244|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
129963245|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
129963246|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
129963247|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
129963248|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
129963249|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
129979962|NCT04372121|467889510|FG000|Overall Study|Withdrawal by Subject|3|||
129963250|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
129963251|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
129963252|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
129963253|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
129963254|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
129963255|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
129963256|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
129963257|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
129963258|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
129963259|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
129963260|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
129963261|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
129963262|NCT03028012|467829229|FG000|Overall Study|Lost to Follow-up|2|||
129963263|NCT03028012|467829230|FG001|Overall Study|Lost to Follow-up|3|||
129963264|NCT03028012|467829231|FG002|Overall Study|Lost to Follow-up|3|||
129963265|NCT02484547|467829238|FG000|Placebo-Controlled Period|Adverse Event|10|||
129963266|NCT02484547|467829239|FG001|Placebo-Controlled Period|Adverse Event|13|||
129963267|NCT02484547|467829240|FG002|Placebo-Controlled Period|Adverse Event|20|||
129963268|NCT02484547|467829241|FG003|Placebo-Controlled Period|Adverse Event|0|||
129963269|NCT02484547|467829242|FG004|Placebo-Controlled Period|Adverse Event|0|||
129963270|NCT02484547|467829243|FG005|Placebo-Controlled Period|Adverse Event|0|||
129963271|NCT02484547|467829244|FG006|Placebo-Controlled Period|Adverse Event|0|||
129963272|NCT02484547|467829238|FG000|Placebo-Controlled Period|Change of Treatment|0|||
129963273|NCT02484547|467829239|FG001|Placebo-Controlled Period|Change of Treatment|0|||
129963274|NCT02484547|467829240|FG002|Placebo-Controlled Period|Change of Treatment|1|||
129963275|NCT02484547|467829241|FG003|Placebo-Controlled Period|Change of Treatment|0|||
129963276|NCT02484547|467829242|FG004|Placebo-Controlled Period|Change of Treatment|0|||
129963277|NCT02484547|467829243|FG005|Placebo-Controlled Period|Change of Treatment|0|||
129963278|NCT02484547|467829244|FG006|Placebo-Controlled Period|Change of Treatment|0|||
129963279|NCT02484547|467829238|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
129963280|NCT02484547|467829239|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
129963281|NCT02484547|467829240|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
129963282|NCT02484547|467829241|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
129963283|NCT02484547|467829242|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
129963284|NCT02484547|467829243|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
129963285|NCT02484547|467829244|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
129963286|NCT02484547|467829238|FG000|Placebo-Controlled Period|Death|5|||
129963287|NCT02484547|467829239|FG001|Placebo-Controlled Period|Death|0|||
129963288|NCT02484547|467829240|FG002|Placebo-Controlled Period|Death|6|||
129963289|NCT02484547|467829241|FG003|Placebo-Controlled Period|Death|0|||
129963290|NCT02484547|467829242|FG004|Placebo-Controlled Period|Death|0|||
129963291|NCT02484547|467829243|FG005|Placebo-Controlled Period|Death|0|||
129963292|NCT02484547|467829244|FG006|Placebo-Controlled Period|Death|0|||
129963293|NCT02484547|467829238|FG000|Placebo-Controlled Period|Disease Progression|2|||
129963294|NCT02484547|467829239|FG001|Placebo-Controlled Period|Disease Progression|0|||
129963295|NCT02484547|467829240|FG002|Placebo-Controlled Period|Disease Progression|1|||
129963296|NCT02484547|467829241|FG003|Placebo-Controlled Period|Disease Progression|0|||
129963297|NCT02484547|467829242|FG004|Placebo-Controlled Period|Disease Progression|0|||
129963298|NCT02484547|467829243|FG005|Placebo-Controlled Period|Disease Progression|0|||
129963299|NCT02484547|467829244|FG006|Placebo-Controlled Period|Disease Progression|0|||
129963300|NCT02484547|467829238|FG000|Placebo-Controlled Period|Investigator Decision|2|||
129963301|NCT02484547|467829239|FG001|Placebo-Controlled Period|Investigator Decision|2|||
129963302|NCT02484547|467829240|FG002|Placebo-Controlled Period|Investigator Decision|5|||
129963303|NCT02484547|467829241|FG003|Placebo-Controlled Period|Investigator Decision|0|||
129963304|NCT02484547|467829242|FG004|Placebo-Controlled Period|Investigator Decision|0|||
129963305|NCT02484547|467829243|FG005|Placebo-Controlled Period|Investigator Decision|0|||
129963306|NCT02484547|467829244|FG006|Placebo-Controlled Period|Investigator Decision|0|||
129963307|NCT02484547|467829238|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
129963308|NCT02484547|467829239|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
129963309|NCT02484547|467829240|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
129963310|NCT02484547|467829241|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
129963311|NCT02484547|467829242|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
129963312|NCT02484547|467829243|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
129963313|NCT02484547|467829244|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
129963314|NCT02484547|467829238|FG000|Placebo-Controlled Period|Relocation|1|||
129963315|NCT02484547|467829239|FG001|Placebo-Controlled Period|Relocation|1|||
129963316|NCT02484547|467829240|FG002|Placebo-Controlled Period|Relocation|1|||
129963317|NCT02484547|467829241|FG003|Placebo-Controlled Period|Relocation|0|||
129963318|NCT02484547|467829242|FG004|Placebo-Controlled Period|Relocation|0|||
129963319|NCT02484547|467829243|FG005|Placebo-Controlled Period|Relocation|0|||
129963320|NCT02484547|467829244|FG006|Placebo-Controlled Period|Relocation|0|||
129963321|NCT02484547|467829238|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
129963322|NCT02484547|467829239|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
129963323|NCT02484547|467829240|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
129963324|NCT02484547|467829241|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
129963325|NCT02484547|467829242|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
129963326|NCT02484547|467829243|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
129963327|NCT02484547|467829244|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
129963328|NCT02484547|467829238|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
129963329|NCT02484547|467829239|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129963330|NCT02484547|467829240|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129963331|NCT02484547|467829241|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963332|NCT02484547|467829242|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963333|NCT02484547|467829243|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963334|NCT02484547|467829244|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963335|NCT02484547|467829238|FG000|Placebo-Controlled Period|Reason not Specified|216|||
129963336|NCT02484547|467829239|FG001|Placebo-Controlled Period|Reason not Specified|194|||
129963337|NCT02484547|467829240|FG002|Placebo-Controlled Period|Reason not Specified|183|||
129963338|NCT02484547|467829241|FG003|Placebo-Controlled Period|Reason not Specified|0|||
129963339|NCT02484547|467829242|FG004|Placebo-Controlled Period|Reason not Specified|0|||
129963340|NCT02484547|467829243|FG005|Placebo-Controlled Period|Reason not Specified|0|||
129963341|NCT02484547|467829244|FG006|Placebo-Controlled Period|Reason not Specified|0|||
129963342|NCT02484547|467829238|FG000|Long-Term Extension Period|Adverse Event|0|||
129963343|NCT02484547|467829239|FG001|Long-Term Extension Period|Adverse Event|0|||
129963344|NCT02484547|467829240|FG002|Long-Term Extension Period|Adverse Event|0|||
129963345|NCT02484547|467829241|FG003|Long-Term Extension Period|Adverse Event|0|||
129963346|NCT02484547|467829242|FG004|Long-Term Extension Period|Adverse Event|1|||
129963347|NCT02484547|467829243|FG005|Long-Term Extension Period|Adverse Event|3|||
129963348|NCT02484547|467829244|FG006|Long-Term Extension Period|Adverse Event|2|||
129963349|NCT02484547|467829238|FG000|Long-Term Extension Period|Death|0|||
129963350|NCT02484547|467829239|FG001|Long-Term Extension Period|Death|0|||
129963351|NCT02484547|467829240|FG002|Long-Term Extension Period|Death|0|||
129963352|NCT02484547|467829241|FG003|Long-Term Extension Period|Death|0|||
129963353|NCT02484547|467829242|FG004|Long-Term Extension Period|Death|0|||
129963354|NCT02484547|467829243|FG005|Long-Term Extension Period|Death|3|||
129963355|NCT02484547|467829244|FG006|Long-Term Extension Period|Death|0|||
129963356|NCT02484547|467829238|FG000|Long-Term Extension Period|Disease Progression|0|||
129963357|NCT02484547|467829239|FG001|Long-Term Extension Period|Disease Progression|0|||
129963358|NCT02484547|467829240|FG002|Long-Term Extension Period|Disease Progression|0|||
129963359|NCT02484547|467829241|FG003|Long-Term Extension Period|Disease Progression|0|||
129963360|NCT02484547|467829242|FG004|Long-Term Extension Period|Disease Progression|2|||
129963361|NCT02484547|467829243|FG005|Long-Term Extension Period|Disease Progression|4|||
129963362|NCT02484547|467829244|FG006|Long-Term Extension Period|Disease Progression|0|||
129963363|NCT02484547|467829238|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
129963364|NCT02484547|467829239|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
129963365|NCT02484547|467829240|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
129963366|NCT02484547|467829241|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
129963367|NCT02484547|467829242|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
129963368|NCT02484547|467829243|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
129963369|NCT02484547|467829244|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
129963370|NCT02484547|467829238|FG000|Long-Term Extension Period|Loss of Capacity|0|||
129963371|NCT02484547|467829239|FG001|Long-Term Extension Period|Loss of Capacity|0|||
129963372|NCT02484547|467829240|FG002|Long-Term Extension Period|Loss of Capacity|0|||
129963373|NCT02484547|467829241|FG003|Long-Term Extension Period|Loss of Capacity|0|||
129963374|NCT02484547|467829242|FG004|Long-Term Extension Period|Loss of Capacity|1|||
129963375|NCT02484547|467829243|FG005|Long-Term Extension Period|Loss of Capacity|0|||
129963376|NCT02484547|467829244|FG006|Long-Term Extension Period|Loss of Capacity|0|||
129963377|NCT02484547|467829238|FG000|Long-Term Extension Period|Change of Treatment|0|||
129963378|NCT02484547|467829239|FG001|Long-Term Extension Period|Change of Treatment|0|||
129963379|NCT02484547|467829240|FG002|Long-Term Extension Period|Change of Treatment|0|||
129963380|NCT02484547|467829241|FG003|Long-Term Extension Period|Change of Treatment|0|||
129963381|NCT02484547|467829242|FG004|Long-Term Extension Period|Change of Treatment|0|||
129963382|NCT02484547|467829243|FG005|Long-Term Extension Period|Change of Treatment|0|||
129963383|NCT02484547|467829244|FG006|Long-Term Extension Period|Change of Treatment|1|||
129963384|NCT02484547|467829238|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
129963385|NCT02484547|467829239|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
129963386|NCT02484547|467829240|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
129963387|NCT02484547|467829241|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
129963388|NCT02484547|467829242|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
129963389|NCT02484547|467829243|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
129963390|NCT02484547|467829244|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
129963391|NCT02484547|467829238|FG000|Long-Term Extension Period|Investigator Decision|0|||
129963392|NCT02484547|467829239|FG001|Long-Term Extension Period|Investigator Decision|0|||
129963393|NCT02484547|467829240|FG002|Long-Term Extension Period|Investigator Decision|0|||
129963394|NCT02484547|467829241|FG003|Long-Term Extension Period|Investigator Decision|2|||
129963395|NCT02484547|467829242|FG004|Long-Term Extension Period|Investigator Decision|1|||
129963396|NCT02484547|467829243|FG005|Long-Term Extension Period|Investigator Decision|0|||
129963397|NCT02484547|467829244|FG006|Long-Term Extension Period|Investigator Decision|1|||
129963398|NCT02484547|467829238|FG000|Long-Term Extension Period|Relocation|0|||
129963399|NCT02484547|467829239|FG001|Long-Term Extension Period|Relocation|0|||
129963400|NCT02484547|467829240|FG002|Long-Term Extension Period|Relocation|0|||
129963401|NCT02484547|467829241|FG003|Long-Term Extension Period|Relocation|1|||
129963402|NCT02484547|467829242|FG004|Long-Term Extension Period|Relocation|1|||
129963403|NCT02484547|467829243|FG005|Long-Term Extension Period|Relocation|0|||
129963404|NCT02484547|467829244|FG006|Long-Term Extension Period|Relocation|0|||
129963405|NCT02484547|467829238|FG000|Long-Term Extension Period|Study Visit Burden|0|||
129963406|NCT02484547|467829239|FG001|Long-Term Extension Period|Study Visit Burden|0|||
129963407|NCT02484547|467829240|FG002|Long-Term Extension Period|Study Visit Burden|0|||
129963408|NCT02484547|467829241|FG003|Long-Term Extension Period|Study Visit Burden|2|||
129963409|NCT02484547|467829242|FG004|Long-Term Extension Period|Study Visit Burden|0|||
129963410|NCT02484547|467829243|FG005|Long-Term Extension Period|Study Visit Burden|0|||
129963411|NCT02484547|467829244|FG006|Long-Term Extension Period|Study Visit Burden|3|||
129963412|NCT02484547|467829238|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963413|NCT02484547|467829239|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963414|NCT02484547|467829240|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963415|NCT02484547|467829241|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963416|NCT02484547|467829242|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
129963417|NCT02484547|467829243|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
129963418|NCT02484547|467829244|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
129963419|NCT02484547|467829238|FG000|Long-Term Extension Period|Reason not Specified|0|||
129963420|NCT02484547|467829239|FG001|Long-Term Extension Period|Reason not Specified|0|||
129963421|NCT02484547|467829240|FG002|Long-Term Extension Period|Reason not Specified|0|||
129963422|NCT02484547|467829241|FG003|Long-Term Extension Period|Reason not Specified|119|||
129963423|NCT02484547|467829242|FG004|Long-Term Extension Period|Reason not Specified|117|||
129963424|NCT02484547|467829243|FG005|Long-Term Extension Period|Reason not Specified|223|||
129963425|NCT02484547|467829244|FG006|Long-Term Extension Period|Reason not Specified|231|||
129963426|NCT01813305|467829245|FG000|Overall Study|Withdrawal by Subject|12|||
129963427|NCT01813305|467829246|FG001|Overall Study|Withdrawal by Subject|5|||
129963428|NCT01813305|467829245|FG000|Overall Study|Safety Concern|4|||
129963429|NCT01813305|467829246|FG001|Overall Study|Safety Concern|0|||
129963430|NCT01813305|467829245|FG000|Overall Study|Ulcer became worse|4|||
129963431|NCT01813305|467829246|FG001|Overall Study|Ulcer became worse|0|||
129963432|NCT01813305|467829245|FG000|Overall Study|Physician Decision|4|||
129963433|NCT01813305|467829246|FG001|Overall Study|Physician Decision|0|||
129963434|NCT01813305|467829245|FG000|Overall Study|Lost to Follow-up|3|||
129963435|NCT01813305|467829246|FG001|Overall Study|Lost to Follow-up|1|||
129963436|NCT01813305|467829245|FG000|Overall Study|Protocol Violation|1|||
129963437|NCT01813305|467829246|FG001|Overall Study|Protocol Violation|0|||
129963438|NCT01813305|467829245|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
129963439|NCT01813305|467829246|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
129963440|NCT01665599|467829250|FG000|Overall Study|Adverse Event|1|||
129963441|NCT01665599|467829250|FG000|Overall Study|Consent Withdrawn|1|||
129963442|NCT01665599|467829250|FG000|Overall Study|Investigator/Sponsor decision|1|||
129963443|NCT01665599|467829250|FG000|Overall Study|Death|1|||
129963444|NCT01665599|467829250|FG000|Overall Study|Lost to Follow-up|2|||
129963445|NCT01665599|467829250|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
129963446|NCT01665599|467829250|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
129963447|NCT01424189|467829251|FG000|Overall Study|Adverse Event|1|||
129963448|NCT01424189|467829252|FG001|Overall Study|Adverse Event|0|||
129963449|NCT01424189|467829251|FG000|Overall Study|Lost to Follow-up|4|||
129963450|NCT01424189|467829252|FG001|Overall Study|Lost to Follow-up|1|||
129963451|NCT01424189|467829251|FG000|Overall Study|Withdrawal by Subject|4|||
129963452|NCT01424189|467829252|FG001|Overall Study|Withdrawal by Subject|4|||
129963453|NCT01424189|467829251|FG000|Overall Study|Subject moved|1|||
129963454|NCT01424189|467829252|FG001|Overall Study|Subject moved|0|||
129963455|NCT01424189|467829251|FG000|Overall Study|Death|3|||
129963456|NCT01424189|467829252|FG001|Overall Study|Death|1|||
129963457|NCT01705145|467829253|FG000|Part B|Adverse Event|1|||
129963458|NCT01203956|467829257|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
129963459|NCT01203956|467829258|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
130122186|NCT01345019|468408804|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
129963460|NCT00069277|467829259|FG000|Overall Study|Adverse Event|3|||
129963461|NCT00069277|467829259|FG000|Overall Study|Withdrawal by Subject|1|||
130122187|NCT01345019|468408803|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
129963462|NCT00069277|467829259|FG000|Overall Study|Progressive Disease|15|||
129963463|NCT00069277|467829259|FG000|Overall Study|Physician Decision|2|||
129963464|NCT02230306|467829260|FG000|Overall Study|Did not receive study treatment|1|||
129963465|NCT00361842|467829261|FG000|Overall Study|Withdrawal by Subject|2|||
129963466|NCT00361842|467829262|FG001|Overall Study|Withdrawal by Subject|3|||
129963467|NCT00361842|467829261|FG000|Overall Study|Death|2|||
129963468|NCT00361842|467829262|FG001|Overall Study|Death|1|||
129963469|NCT00361842|467829261|FG000|Overall Study|Disease progression|19|||
129963470|NCT00361842|467829262|FG001|Overall Study|Disease progression|20|||
129963471|NCT00361842|467829261|FG000|Overall Study|Adverse Event|2|||
129963472|NCT00361842|467829262|FG001|Overall Study|Adverse Event|3|||
129963473|NCT00361842|467829261|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
129963474|NCT00361842|467829262|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
129963475|NCT00361842|467829261|FG000|Overall Study|Other|1|||
129963476|NCT00361842|467829262|FG001|Overall Study|Other|0|||
129963477|NCT00361842|467829261|FG000|Overall Study|Other|0|||
129963478|NCT00361842|467829262|FG001|Overall Study|Other|2|||
129963479|NCT01077622|467829263|FG000|Overall Study|Physician Decision|2|||
129963480|NCT01077622|467829263|FG000|Overall Study|Withdrawal by Subject|1|||
129963481|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
129963482|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
129963483|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
129963484|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
129963485|NCT00424177|467829264|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
129963486|NCT00424177|467829264|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
129963487|NCT00424177|467829264|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
129963488|NCT00424177|467829264|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
129963489|NCT00424177|467829264|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
129963490|NCT00424177|467829264|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
129963491|NCT01502371|467829267|FG000|Overall Study|Withdrawal by Subject|1|||
129963492|NCT01502371|467829268|FG001|Overall Study|Withdrawal by Subject|2|||
129963493|NCT01502371|467829269|FG002|Overall Study|Withdrawal by Subject|1|||
129963494|NCT01502371|467829270|FG003|Overall Study|Withdrawal by Subject|1|||
129963495|NCT01502371|467829271|FG004|Overall Study|Withdrawal by Subject|1|||
129963496|NCT01502371|467829267|FG000|Overall Study|Adverse Event|2|||
129963497|NCT01502371|467829268|FG001|Overall Study|Adverse Event|1|||
129963498|NCT01502371|467829269|FG002|Overall Study|Adverse Event|0|||
129963499|NCT01502371|467829270|FG003|Overall Study|Adverse Event|4|||
129963500|NCT01502371|467829271|FG004|Overall Study|Adverse Event|3|||
129963501|NCT01502371|467829267|FG000|Overall Study|Treatment Failure|22|||
129963502|NCT01502371|467829268|FG001|Overall Study|Treatment Failure|20|||
129963503|NCT01502371|467829269|FG002|Overall Study|Treatment Failure|12|||
129963504|NCT01502371|467829270|FG003|Overall Study|Treatment Failure|19|||
129963505|NCT01502371|467829271|FG004|Overall Study|Treatment Failure|30|||
129963506|NCT01502371|467829267|FG000|Overall Study|Lack of Efficacy|3|||
129963507|NCT01502371|467829268|FG001|Overall Study|Lack of Efficacy|3|||
129963508|NCT01502371|467829269|FG002|Overall Study|Lack of Efficacy|2|||
129963509|NCT01502371|467829270|FG003|Overall Study|Lack of Efficacy|2|||
129963510|NCT01502371|467829271|FG004|Overall Study|Lack of Efficacy|4|||
129963511|NCT01502371|467829267|FG000|Overall Study|Physician Decision|3|||
129963512|NCT01502371|467829268|FG001|Overall Study|Physician Decision|0|||
129963513|NCT01502371|467829269|FG002|Overall Study|Physician Decision|0|||
129963514|NCT01502371|467829270|FG003|Overall Study|Physician Decision|0|||
129963515|NCT01502371|467829271|FG004|Overall Study|Physician Decision|1|||
129963516|NCT01502371|467829267|FG000|Overall Study|Noncompliance with Study Drug|0|||
129963517|NCT01502371|467829268|FG001|Overall Study|Noncompliance with Study Drug|0|||
129963518|NCT01502371|467829269|FG002|Overall Study|Noncompliance with Study Drug|1|||
129963519|NCT01502371|467829270|FG003|Overall Study|Noncompliance with Study Drug|2|||
129963520|NCT01502371|467829271|FG004|Overall Study|Noncompliance with Study Drug|1|||
129963521|NCT01502371|467829267|FG000|Overall Study|Technical Problems|1|||
129963522|NCT01502371|467829268|FG001|Overall Study|Technical Problems|0|||
129963523|NCT01502371|467829269|FG002|Overall Study|Technical Problems|2|||
129963524|NCT01502371|467829270|FG003|Overall Study|Technical Problems|4|||
129963525|NCT01502371|467829271|FG004|Overall Study|Technical Problems|1|||
129963526|NCT01502371|467829267|FG000|Overall Study|Protocol Violation|9|||
129963527|NCT01502371|467829268|FG001|Overall Study|Protocol Violation|5|||
129963528|NCT01502371|467829269|FG002|Overall Study|Protocol Violation|6|||
129963529|NCT01502371|467829270|FG003|Overall Study|Protocol Violation|5|||
129963530|NCT01502371|467829271|FG004|Overall Study|Protocol Violation|10|||
129963531|NCT01502371|467829267|FG000|Overall Study|Excluded Medication|0|||
129963532|NCT01502371|467829268|FG001|Overall Study|Excluded Medication|1|||
129963533|NCT01502371|467829269|FG002|Overall Study|Excluded Medication|1|||
129963534|NCT01502371|467829270|FG003|Overall Study|Excluded Medication|0|||
129963535|NCT01502371|467829271|FG004|Overall Study|Excluded Medication|1|||
129963536|NCT03282799|467829272|FG000|Overall Study|Pregnancy|1|||
129963537|NCT03282799|467829273|FG001|Overall Study|Pregnancy|0|||
129963538|NCT03282799|467829272|FG000|Overall Study|Physician Decision|1|||
129963539|NCT03282799|467829273|FG001|Overall Study|Physician Decision|0|||
129963540|NCT01726049|467830553|FG000|Overall Study|Death|1|||
129963541|NCT01726049|467830554|FG001|Overall Study|Death|1|||
129963542|NCT01726049|467830553|FG000|Overall Study|Adverse Event|4|||
129963543|NCT01726049|467830554|FG001|Overall Study|Adverse Event|1|||
129963544|NCT01726049|467830553|FG000|Overall Study|refused second HC|0|||
129963545|NCT01726049|467830554|FG001|Overall Study|refused second HC|2|||
129963546|NCT04156399|467830562|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
129963547|NCT04156399|467830562|FG000|Overall Study|study suspension due to COVID pandemic|3|||
129963548|NCT03440047|467830563|FG000|Overall Study|Withdrawal by Subject|2|||
129963549|NCT01181609|467830564|FG000|Overall Study|Adverse Event|1|||
129963550|NCT01181609|467830564|FG000|Overall Study|Withdrawal by Subject|1|||
129963551|NCT01181609|467830564|FG000|Overall Study|Lost to Follow-up|1|||
129963552|NCT01181609|467830564|FG000|Overall Study|Death|50|||
129963553|NCT01722045|467830565|FG000|Overall Study|Adverse Event|8|||
129963554|NCT01722045|467830565|FG000|Overall Study|Death|3|||
129963555|NCT01722045|467830565|FG000|Overall Study|Withdrawal by Subject|8|||
129963556|NCT01722045|467830565|FG000|Overall Study|Lost to Follow-up|4|||
129963557|NCT01722045|467830565|FG000|Overall Study|Protocol Deviation|1|||
129963558|NCT01722045|467830565|FG000|Overall Study|Physician Decision|3|||
129963559|NCT01722045|467830565|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
129963560|NCT03834623|467830575|FG000|Overall Study|Progression|0|||
129963561|NCT03834623|467830576|FG001|Overall Study|Progression|1|||
129963562|NCT00478647|467830577|FG000|Overall Study|Adverse Event|1|||
129963563|NCT00478647|467830577|FG000|Overall Study|Withdrawal by Subject|1|||
129963564|NCT00511836|467830580|FG000|Double-blind Period|Lost to Follow-up|1|||
129963565|NCT00511836|467830581|FG001|Double-blind Period|Lost to Follow-up|0|||
129963566|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
129963567|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
129963568|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
129963569|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
129963570|NCT01755546|467830582|FG000|Titration Phase|Adverse Event|11|||
129963571|NCT01755546|467830582|FG000|Titration Phase|Lack of Efficacy|18|||
129963572|NCT01755546|467830582|FG000|Titration Phase|Protocol Violation|9|||
129963573|NCT01755546|467830582|FG000|Titration Phase|Lost to Follow-up|2|||
129963574|NCT01755546|467830582|FG000|Titration Phase|Other and Continuing|22|||
129963575|NCT01755546|467830582|FG000|Titration Phase|Withdrawal by Subject|8|||
129963576|NCT01755546|467830582|FG000|Long Term Treatment|Adverse Event|12|||
129963577|NCT01755546|467830582|FG000|Long Term Treatment|Lack of Efficacy|6|||
129963578|NCT01755546|467830582|FG000|Long Term Treatment|Protocol Violation|10|||
129963579|NCT01755546|467830582|FG000|Long Term Treatment|Withdrawal by Subject|35|||
129963580|NCT01755546|467830582|FG000|Long Term Treatment|Lost to Follow-up|17|||
129963581|NCT01755546|467830582|FG000|Long Term Treatment|other and ongoing|41|||
129963582|NCT04606199|467830583|FG000|Overall Study|Withdrawal by Subject|2|||
129963583|NCT02624869|467830584|FG000|Overall Study|Lost to Follow-up|0|||
129963584|NCT02624869|467830585|FG001|Overall Study|Lost to Follow-up|0|||
129963585|NCT02624869|467830586|FG002|Overall Study|Lost to Follow-up|1|||
129963586|NCT02624869|467830584|FG000|Overall Study|Withdrawal by Subject|1|||
129963587|NCT02624869|467830585|FG001|Overall Study|Withdrawal by Subject|3|||
129963588|NCT02624869|467830586|FG002|Overall Study|Withdrawal by Subject|1|||
129963589|NCT04051242|467830591|FG000|Overall Study|Withdrawal by Subject|1|||
130091949|NCT05602818|468292533|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
130091950|NCT05602818|468292534|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
130091951|NCT05602818|468292523|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
130091952|NCT05602818|468292524|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
130091953|NCT05602818|468292525|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091954|NCT05602818|468292526|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091955|NCT05602818|468292527|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091956|NCT05602818|468292528|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091957|NCT05602818|468292529|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091958|NCT05602818|468292530|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091959|NCT05602818|468292531|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091960|NCT05602818|468292532|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091961|NCT05602818|468292533|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091962|NCT05602818|468292534|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
130091963|NCT05602818|468292523|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
130091964|NCT05602818|468292524|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130122188|NCT01345019|468408804|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
129963590|NCT04051242|467830591|FG000|Overall Study|Physician Decision|1|||
129963591|NCT00496626|467830592|FG000|Overall Study|Lost to Follow-up|0|||
129963592|NCT00496626|467830593|FG001|Overall Study|Lost to Follow-up|1|||
129963593|NCT00496626|467830592|FG000|Overall Study|Protocol Violation|1|||
129963594|NCT00496626|467830593|FG001|Overall Study|Protocol Violation|0|||
129963595|NCT00496626|467830592|FG000|Overall Study|Withdrawal by Subject|5|||
129963596|NCT00496626|467830593|FG001|Overall Study|Withdrawal by Subject|4|||
129963597|NCT00496626|467830592|FG000|Overall Study|Relocated|0|||
129963598|NCT00496626|467830593|FG001|Overall Study|Relocated|1|||
129963599|NCT00727415|467830594|FG000|Phase I|Dose Limiting Toxicity|2|||
129963600|NCT00853229|467830596|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
129963601|NCT00853229|467830597|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
129963602|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
129963603|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
129963604|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
129963605|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
129963606|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
129963607|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
129963608|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
129963609|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
129963610|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
129963611|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
129963612|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
129963613|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
129963614|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
129963615|NCT00776659|467830605|FG000|Overall Study|Lost to Follow-up|15|||
129963616|NCT00776659|467830605|FG000|Overall Study|Withdrawal by Subject|10|||
129963617|NCT00776659|467830605|FG000|Overall Study|Study Terminated by Sponsor|1|||
129963618|NCT01233999|467830608|FG000|Overall Study|Withdrawal by Subject|1|||
129963619|NCT01233999|467830608|FG000|Overall Study|Lost to Follow-up|1|||
129963620|NCT01167192|467830609|FG000|Overall Study|Adverse Event|1|||
129963621|NCT01167192|467830609|FG000|Overall Study|Death|1|||
129963622|NCT01167192|467830609|FG000|Overall Study|Withdrawal by Subject|1|||
129963623|NCT01167192|467830609|FG000|Overall Study|Insurance denial|1|||
129963624|NCT00129649|467830615|FG000|Overall Study|Withdrawal by Subject|76|||
129963625|NCT00129649|467830616|FG001|Overall Study|Withdrawal by Subject|65|||
129963626|NCT00025506|467830617|FG000|Overall Study|Ineligible: clerical error|1|||
129963627|NCT00025506|467830617|FG000|Overall Study|Ineligible: wrong cell type|5|||
129963628|NCT00025506|467830617|FG000|Overall Study|Ineligible: inadequate pathology|2|||
129963629|NCT00025506|467830617|FG000|Overall Study|Never Treated|2|||
129963630|NCT01321723|467830618|FG000|Overall Study|Adverse Event|3|||
129963631|NCT01321723|467830619|FG001|Overall Study|Adverse Event|5|||
129963632|NCT01321723|467830620|FG002|Overall Study|Adverse Event|2|||
129963633|NCT01321723|467830618|FG000|Overall Study|Withdrawal by Subject|2|||
129963634|NCT01321723|467830619|FG001|Overall Study|Withdrawal by Subject|0|||
129963635|NCT01321723|467830620|FG002|Overall Study|Withdrawal by Subject|2|||
129963636|NCT00713206|467830621|FG000|Overall Study|Lost to Follow-up|4|||
129963637|NCT00713206|467830622|FG001|Overall Study|Lost to Follow-up|4|||
129963638|NCT00713206|467830621|FG000|Overall Study|Death|1|||
129963639|NCT00713206|467830622|FG001|Overall Study|Death|0|||
129963640|NCT02561806|467830623|FG000|Induction Period|Adverse Event|0|||
129963641|NCT02561806|467830624|FG001|Induction Period|Adverse Event|2|||
129963642|NCT02561806|467830623|FG000|Induction Period|Lack of Efficacy|1|||
129963643|NCT02561806|467830624|FG001|Induction Period|Lack of Efficacy|0|||
129963644|NCT02561806|467830623|FG000|Induction Period|Withdrawal by Subject|0|||
129963645|NCT02561806|467830624|FG001|Induction Period|Withdrawal by Subject|2|||
129963646|NCT02561806|467830623|FG000|Induction Period|Site staff became unblinded|1|||
129963647|NCT02561806|467830624|FG001|Induction Period|Site staff became unblinded|0|||
129963648|NCT02561806|467830623|FG000|Induction Period|Randomized but not treated|0|||
129963649|NCT02561806|467830624|FG001|Induction Period|Randomized but not treated|1|||
129963650|NCT02561806|467830623|FG000|Maintenance Period|Adverse Event|2|||
129963651|NCT02561806|467830624|FG001|Maintenance Period|Adverse Event|1|||
129963652|NCT02561806|467830623|FG000|Maintenance Period|Lack of Efficacy|3|||
129963653|NCT02561806|467830624|FG001|Maintenance Period|Lack of Efficacy|1|||
129963654|NCT02561806|467830623|FG000|Maintenance Period|Lost to Follow-up|2|||
129963655|NCT02561806|467830624|FG001|Maintenance Period|Lost to Follow-up|2|||
129963656|NCT02561806|467830623|FG000|Maintenance Period|Protocol Violation|1|||
129963657|NCT02561806|467830624|FG001|Maintenance Period|Protocol Violation|0|||
129963658|NCT02561806|467830623|FG000|Maintenance Period|Withdrawal by Subject|5|||
129963659|NCT02561806|467830624|FG001|Maintenance Period|Withdrawal by Subject|3|||
129963660|NCT02561806|467830623|FG000|Maintenance Period|Site staff became unblinded|0|||
129963661|NCT02561806|467830624|FG001|Maintenance Period|Site staff became unblinded|1|||
129963662|NCT02561806|467830623|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
129963663|NCT02561806|467830624|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
129963664|NCT02561806|467830623|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
129963665|NCT02561806|467830624|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
129963666|NCT02547441|467830625|FG000|Double-Blind Study Period|Adverse Event|4|||
129963667|NCT02547441|467830626|FG001|Double-Blind Study Period|Adverse Event|9|||
129963668|NCT02547441|467830625|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
129963669|NCT02547441|467830626|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
129963670|NCT02547441|467830625|FG000|Double-Blind Study Period|Physician Decision|1|||
129963671|NCT02547441|467830626|FG001|Double-Blind Study Period|Physician Decision|0|||
129963672|NCT02547441|467830625|FG000|Double-Blind Study Period|Protocol Violation|1|||
129963673|NCT02547441|467830626|FG001|Double-Blind Study Period|Protocol Violation|2|||
129963674|NCT02547441|467830625|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
129963675|NCT02547441|467830626|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
129963676|NCT02547441|467830625|FG000|Double-Blind Study Period|Sponsor Decision|1|||
129963677|NCT02547441|467830626|FG001|Double-Blind Study Period|Sponsor Decision|0|||
129963678|NCT02547441|467830625|FG000|Open-Label Study Period|Adverse Event|10|||
129963679|NCT02547441|467830626|FG001|Open-Label Study Period|Adverse Event|11|||
129963680|NCT02547441|467830625|FG000|Open-Label Study Period|Lack of Efficacy|3|||
129963681|NCT02547441|467830626|FG001|Open-Label Study Period|Lack of Efficacy|2|||
129963682|NCT02547441|467830625|FG000|Open-Label Study Period|Lost to Follow-up|7|||
129963683|NCT02547441|467830626|FG001|Open-Label Study Period|Lost to Follow-up|8|||
129963684|NCT02547441|467830625|FG000|Open-Label Study Period|Physician Decision|1|||
129963685|NCT02547441|467830626|FG001|Open-Label Study Period|Physician Decision|0|||
129963686|NCT02547441|467830625|FG000|Open-Label Study Period|Protocol Violation|2|||
129963687|NCT02547441|467830626|FG001|Open-Label Study Period|Protocol Violation|0|||
129963688|NCT02547441|467830625|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
129963689|NCT02547441|467830626|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
129963690|NCT02547441|467830625|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
129963691|NCT02547441|467830626|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
129963692|NCT01322009|467830627|FG000|Overall Study|Death|0|||
129963693|NCT01322009|467830628|FG001|Overall Study|Death|1|||
129963694|NCT01322009|467830627|FG000|Overall Study|Adverse Event|0|||
129963695|NCT01322009|467830628|FG001|Overall Study|Adverse Event|1|||
129963696|NCT01322009|467830627|FG000|Overall Study|ng tube discontinued|0|||
129963697|NCT01322009|467830628|FG001|Overall Study|ng tube discontinued|1|||
129963698|NCT02427958|467830634|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
129963699|NCT02427958|467830634|FG000|Overall Study|Lost to Follow-up|6|||
129963700|NCT02427958|467830634|FG000|Overall Study|Withdrawal by Subject|14|||
129963701|NCT02427958|467830634|FG000|Overall Study|Lack of Efficacy|1|||
129963702|NCT00582114|467830637|FG000|Overall Study|Death|4|||
129963703|NCT00582114|467830638|FG001|Overall Study|Death|4|||
129963704|NCT00582114|467830637|FG000|Overall Study|Kidney Transplant|3|||
129963705|NCT00582114|467830638|FG001|Overall Study|Kidney Transplant|1|||
129963706|NCT00582114|467830637|FG000|Overall Study|Lost to Follow-up|7|||
129963707|NCT00582114|467830638|FG001|Overall Study|Lost to Follow-up|6|||
129963708|NCT00582114|467830637|FG000|Overall Study|Withdrawal by Subject|8|||
129963709|NCT00582114|467830638|FG001|Overall Study|Withdrawal by Subject|16|||
129963710|NCT00582114|467830637|FG000|Overall Study|Adverse Event|1|||
129963711|NCT00582114|467830638|FG001|Overall Study|Adverse Event|1|||
129963712|NCT00582114|467830637|FG000|Overall Study|Physician Decision|0|||
129963713|NCT00582114|467830638|FG001|Overall Study|Physician Decision|6|||
129963714|NCT00582114|467830637|FG000|Overall Study|Stopped by data safety monitoring board|19|||
129963715|NCT00582114|467830638|FG001|Overall Study|Stopped by data safety monitoring board|20|||
129963716|NCT02604342|467830639|FG000|Overall Study|Death|32|||
129963717|NCT02604342|467830640|FG001|Overall Study|Death|16|||
129963718|NCT02604342|467830639|FG000|Overall Study|Progression of disease|1|||
129963719|NCT02604342|467830640|FG001|Overall Study|Progression of disease|0|||
129963720|NCT02604342|467830639|FG000|Overall Study|Withdrawal by Subject|5|||
129963721|NCT02604342|467830640|FG001|Overall Study|Withdrawal by Subject|6|||
129963722|NCT02604342|467830639|FG000|Overall Study|Other|1|||
129963723|NCT02604342|467830640|FG001|Overall Study|Other|0|||
129963724|NCT02604342|467830639|FG000|Overall Study|Study Termination by Sponsor|1|||
129963725|NCT02604342|467830640|FG001|Overall Study|Study Termination by Sponsor|0|||
129963726|NCT02604342|467830639|FG000|Overall Study|Lost to Follow-up|1|||
129963727|NCT02604342|467830640|FG001|Overall Study|Lost to Follow-up|1|||
129963728|NCT02604342|467830639|FG000|Overall Study|Physician Decision|2|||
129963729|NCT02604342|467830640|FG001|Overall Study|Physician Decision|0|||
129963730|NCT00130728|467830641|FG000|Overall Study|Death|258|||
129963731|NCT00130728|467830642|FG001|Overall Study|Death|258|||
129963732|NCT00130728|467830641|FG000|Overall Study|Lost to Follow-up|4|||
129963733|NCT00130728|467830642|FG001|Overall Study|Lost to Follow-up|0|||
129963734|NCT00130728|467830641|FG000|Overall Study|Withdrawal by Subject|0|||
129963735|NCT00130728|467830642|FG001|Overall Study|Withdrawal by Subject|2|||
130122189|NCT01345019|468408803|FG000|Blinded Treatment Phase|Disease Progression|12|||
130122190|NCT01345019|468408804|FG001|Blinded Treatment Phase|Disease Progression|10|||
130122191|NCT01345019|468408803|FG000|Blinded Treatment Phase|Adverse Event|6|||
129963736|NCT00746356|467830643|FG000|Overall Study|Withdrawal by Subject|2|||
129963737|NCT00746356|467830644|FG001|Overall Study|Withdrawal by Subject|3|||
129963738|NCT00746356|467830643|FG000|Overall Study|Death|7|||
129963739|NCT00746356|467830644|FG001|Overall Study|Death|3|||
129963740|NCT00746356|467830643|FG000|Overall Study|Lost to Follow-up|1|||
129963741|NCT00746356|467830644|FG001|Overall Study|Lost to Follow-up|0|||
129963742|NCT00746356|467830643|FG000|Overall Study|Removal of Device|0|||
129963743|NCT00746356|467830644|FG001|Overall Study|Removal of Device|1|||
129963744|NCT00746356|467830643|FG000|Overall Study|Patient relocated|1|||
129963745|NCT00746356|467830644|FG001|Overall Study|Patient relocated|0|||
129963746|NCT02881047|467830647|FG000|Overall Study|Adverse Event|1|||
129963747|NCT02881047|467830647|FG000|Overall Study|Withdrawal by Subject|1|||
129963748|NCT04814992|467830654|FG000|Overall Study|Withdrawal by Subject|6|||
129963749|NCT04814992|467830655|FG001|Overall Study|Withdrawal by Subject|3|||
129963750|NCT04814992|467830654|FG000|Overall Study|Lost to Follow-up|1|||
129963751|NCT04814992|467830655|FG001|Overall Study|Lost to Follow-up|4|||
129963752|NCT00691678|467830656|FG000|Overall Study|Adverse Event|5|||
129963753|NCT00691678|467830656|FG000|Overall Study|life events, pain|11|||
129963754|NCT01503164|467830660|FG000|Overall Study|Withdrawal by Subject|2|||
129963755|NCT01503164|467830661|FG001|Overall Study|Withdrawal by Subject|1|||
129963756|NCT01831726|467830662|FG000|Overall Study|Adverse Event|16|||
129963757|NCT01831726|467830662|FG000|Overall Study|Death|7|||
129963758|NCT01831726|467830662|FG000|Overall Study|Disease Progression|49|||
129963759|NCT01831726|467830662|FG000|Overall Study|Physician Decision|1|||
129963760|NCT01831726|467830662|FG000|Overall Study|Subject/guardian decision|7|||
129963761|NCT03049306|467830663|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
129963762|NCT03049306|467830664|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
129963763|NCT03151551|467830665|FG000|Open-Label Treatment Period|Adverse Event|0|||
129963764|NCT03151551|467830666|FG001|Open-Label Treatment Period|Adverse Event|2|||
129963765|NCT03151551|467830665|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
129963766|NCT03151551|467830666|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
129963767|NCT03151551|467830665|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
129963768|NCT03151551|467830666|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
129963769|NCT03151551|467830665|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
129963770|NCT03151551|467830666|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
129963771|NCT03151551|467830665|FG000|Open-Label Treatment Period|Physician Decision|3|||
129963772|NCT03151551|467830666|FG001|Open-Label Treatment Period|Physician Decision|0|||
129963773|NCT03151551|467830665|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
129963774|NCT03151551|467830666|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
129963775|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
129963776|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
129963777|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
129963778|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129963779|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
129963780|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
129963781|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
129963782|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
129963783|NCT00514813|467830671|FG000|Overall Study|Study terminated|14|||
129963784|NCT00514813|467830672|FG001|Overall Study|Study terminated|74|||
129963785|NCT00514813|467830673|FG002|Overall Study|Study terminated|40|||
129963786|NCT00514813|467830674|FG003|Overall Study|Study terminated|2|||
129963787|NCT00514813|467830671|FG000|Overall Study|Adverse Event|0|||
129963788|NCT00514813|467830672|FG001|Overall Study|Adverse Event|2|||
129963789|NCT00514813|467830673|FG002|Overall Study|Adverse Event|2|||
129963790|NCT00514813|467830674|FG003|Overall Study|Adverse Event|0|||
130122192|NCT01345019|468408804|FG001|Blinded Treatment Phase|Adverse Event|13|||
130122193|NCT01345019|468408803|FG000|Blinded Treatment Phase|Administrative Decision|10|||
130122194|NCT01345019|468408804|FG001|Blinded Treatment Phase|Administrative Decision|8|||
130122195|NCT01345019|468408803|FG000|Blinded Treatment Phase|Noncompliance|5|||
130122196|NCT01345019|468408804|FG001|Blinded Treatment Phase|Noncompliance|3|||
130122197|NCT01345019|468408803|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
130122198|NCT01345019|468408804|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
130122199|NCT01345019|468408803|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
130122200|NCT01345019|468408804|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
130122201|NCT01345019|468408803|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
130122202|NCT01345019|468408804|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
130122203|NCT01345019|468408803|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
130122204|NCT01345019|468408804|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
130122205|NCT01345019|468408803|FG000|Open Label Treatment Phase|Death|49|||
130122206|NCT01345019|468408804|FG001|Open Label Treatment Phase|Death|48|||
130122207|NCT01345019|468408803|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
130122208|NCT01345019|468408804|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
130122209|NCT01345019|468408803|FG000|Open Label Treatment Phase|Adverse Event|30|||
130122210|NCT01345019|468408804|FG001|Open Label Treatment Phase|Adverse Event|51|||
130122211|NCT01345019|468408803|FG000|Open Label Treatment Phase|Administrative Decision|30|||
130122212|NCT01345019|468408804|FG001|Open Label Treatment Phase|Administrative Decision|15|||
129963791|NCT00514813|467830671|FG000|Overall Study|Protocol Violation|1|||
129963792|NCT00514813|467830672|FG001|Overall Study|Protocol Violation|0|||
129963793|NCT00514813|467830673|FG002|Overall Study|Protocol Violation|0|||
130122213|NCT01345019|468408803|FG000|Open Label Treatment Phase|Disease Progression|17|||
130122214|NCT01345019|468408804|FG001|Open Label Treatment Phase|Disease Progression|18|||
129963794|NCT00514813|467830674|FG003|Overall Study|Protocol Violation|0|||
129963795|NCT00514813|467830671|FG000|Overall Study|Withdrawal by Subject|0|||
129963796|NCT00514813|467830672|FG001|Overall Study|Withdrawal by Subject|1|||
129963797|NCT00514813|467830673|FG002|Overall Study|Withdrawal by Subject|0|||
129963798|NCT00514813|467830674|FG003|Overall Study|Withdrawal by Subject|0|||
129963799|NCT00514813|467830671|FG000|Overall Study|Lack of Efficacy|0|||
129963800|NCT00514813|467830672|FG001|Overall Study|Lack of Efficacy|1|||
129963801|NCT00514813|467830673|FG002|Overall Study|Lack of Efficacy|0|||
129963802|NCT00514813|467830674|FG003|Overall Study|Lack of Efficacy|0|||
129963803|NCT00514813|467830671|FG000|Overall Study|Kidney transplant|0|||
129963804|NCT00514813|467830672|FG001|Overall Study|Kidney transplant|6|||
129963805|NCT00514813|467830673|FG002|Overall Study|Kidney transplant|2|||
129963806|NCT00514813|467830674|FG003|Overall Study|Kidney transplant|0|||
129963807|NCT00514813|467830671|FG000|Overall Study|Death|0|||
129963808|NCT00514813|467830672|FG001|Overall Study|Death|2|||
129963809|NCT00514813|467830673|FG002|Overall Study|Death|3|||
129963810|NCT00514813|467830674|FG003|Overall Study|Death|2|||
129963811|NCT02979613|467830675|FG000|Double-Blind Phase|Withdrew Consent|2|||
129963812|NCT02979613|467830676|FG001|Double-Blind Phase|Withdrew Consent|4|||
129963813|NCT02979613|467830675|FG000|Double-Blind Phase|Pregnancy|2|||
129963814|NCT02979613|467830676|FG001|Double-Blind Phase|Pregnancy|2|||
129963815|NCT02979613|467830675|FG000|Double-Blind Phase|Adverse Event|2|||
129963816|NCT02979613|467830676|FG001|Double-Blind Phase|Adverse Event|0|||
129963817|NCT02979613|467830675|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129963818|NCT02979613|467830676|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129963819|NCT02979613|467830675|FG000|Double-Blind Phase|Protocol Violation|1|||
129963820|NCT02979613|467830676|FG001|Double-Blind Phase|Protocol Violation|1|||
129963821|NCT02979613|467830675|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
129963822|NCT02979613|467830676|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
129963823|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
129963824|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
129963825|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
129963826|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
129963827|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Death|0|||
129963828|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Death|1|||
129963829|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
129963830|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
129963831|NCT00143598|467830679|FG000|Overall Study|Lost to Follow-up|23|||
129963832|NCT00143598|467830680|FG001|Overall Study|Lost to Follow-up|21|||
129963833|NCT00143598|467830679|FG000|Overall Study|Withdrawal by Subject|33|||
129963834|NCT00143598|467830680|FG001|Overall Study|Withdrawal by Subject|37|||
129963835|NCT00143598|467830679|FG000|Overall Study|Death|36|||
129963836|NCT00143598|467830680|FG001|Overall Study|Death|36|||
129963837|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
129963838|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
129963839|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
129963840|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
129963841|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
129963842|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
129963843|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
129963844|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
129963845|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
129963846|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
129963847|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
129963848|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
129963849|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
129963850|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
129963851|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
129963852|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
129963853|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
129963854|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
129963855|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
129963856|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
129963857|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
129963858|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
129963859|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
129963860|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
130091965|NCT05602818|468292525|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129963861|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
129963862|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
129963863|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
129963864|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
129963865|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
129963866|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
129963867|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
129963868|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
129963869|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
129963870|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
129963871|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
129963872|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
129963873|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
129963874|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
129963875|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
129963876|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
129963877|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
129963878|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
129963879|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
129963880|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
129963881|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
129963882|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
129963883|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
129963884|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
129963885|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Death|2|||
129963886|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Death|0|||
129963887|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Death|1|||
129963888|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Death|0|||
129963889|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
129963890|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
129963891|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
129963892|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
129963893|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
129963894|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
129963895|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
129963896|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
129963897|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
129963898|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
129963899|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
129963900|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
129963901|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Moved|32|||
129963902|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Moved|2|||
129963903|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Moved|28|||
129963904|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Moved|0|||
129963905|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
129963906|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
129963907|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
129963908|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
129963909|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Travel|2|||
129963910|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Travel|0|||
129963911|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Travel|0|||
129963912|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Travel|0|||
129963913|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
129963914|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
129963915|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
129963916|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
129963917|NCT00092521|467832325|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
129963918|NCT00092521|467832326|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
129963919|NCT00092521|467832327|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
129963920|NCT00092521|467832328|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
129963921|NCT00092521|467832325|FG000|Extension Study (Group 4)|Adverse Event|0|||
129963922|NCT00092521|467832326|FG001|Extension Study (Group 4)|Adverse Event|0|||
129963923|NCT00092521|467832327|FG002|Extension Study (Group 4)|Adverse Event|0|||
129963924|NCT00092521|467832328|FG003|Extension Study (Group 4)|Adverse Event|2|||
129963925|NCT00092521|467832325|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
129963926|NCT00092521|467832326|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
129963927|NCT00092521|467832327|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
129963928|NCT00092521|467832328|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
129963929|NCT00092521|467832325|FG000|Extension Study (Group 4)|Pregnancy|0|||
129963930|NCT00092521|467832326|FG001|Extension Study (Group 4)|Pregnancy|0|||
129963931|NCT00092521|467832327|FG002|Extension Study (Group 4)|Pregnancy|0|||
129963932|NCT00092521|467832328|FG003|Extension Study (Group 4)|Pregnancy|4|||
129963933|NCT00092521|467832325|FG000|Extension Study (Group 4)|Protocol Violation|0|||
129963934|NCT00092521|467832326|FG001|Extension Study (Group 4)|Protocol Violation|0|||
129963935|NCT00092521|467832327|FG002|Extension Study (Group 4)|Protocol Violation|0|||
129963936|NCT00092521|467832328|FG003|Extension Study (Group 4)|Protocol Violation|2|||
129963937|NCT00092521|467832325|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
129963938|NCT00092521|467832326|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
129963939|NCT00092521|467832327|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
129963940|NCT00092521|467832328|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
129963941|NCT00092521|467832325|FG000|Extension Study (Group 4)|Moved|0|||
129963942|NCT00092521|467832326|FG001|Extension Study (Group 4)|Moved|0|||
129963943|NCT00092521|467832327|FG002|Extension Study (Group 4)|Moved|0|||
129963944|NCT00092521|467832328|FG003|Extension Study (Group 4)|Moved|16|||
129963945|NCT00092521|467832325|FG000|Extension Study (Group 4)|Site Terminated|0|||
129963946|NCT00092521|467832326|FG001|Extension Study (Group 4)|Site Terminated|0|||
129963947|NCT00092521|467832327|FG002|Extension Study (Group 4)|Site Terminated|0|||
129963948|NCT00092521|467832328|FG003|Extension Study (Group 4)|Site Terminated|4|||
129963949|NCT00092521|467832325|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
129963950|NCT00092521|467832326|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
129963951|NCT00092521|467832327|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
129963952|NCT00092521|467832328|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
129963953|NCT03464383|467832329|FG000|Overall Study|Lost to Follow-up|1|||
129963954|NCT03464383|467832330|FG001|Overall Study|Lost to Follow-up|0|||
129963955|NCT03464383|467832331|FG002|Overall Study|Lost to Follow-up|0|||
129963956|NCT03464383|467832329|FG000|Overall Study|Withdrawal by Subject|0|||
129963957|NCT03464383|467832330|FG001|Overall Study|Withdrawal by Subject|1|||
129963958|NCT03464383|467832331|FG002|Overall Study|Withdrawal by Subject|0|||
129963959|NCT00605566|467832332|FG000|Overall Study|Adverse Event|1|||
129963960|NCT00605566|467832332|FG000|Overall Study|Clinical deterioration|1|||
129963961|NCT00605566|467832332|FG000|Overall Study|Poor compliance in run-in period|1|||
129963962|NCT00695136|467832340|FG000|Overall Study|Withdrawal by Subject|1|||
129963963|NCT00695136|467832340|FG000|Overall Study|unrelated adverse event|1|||
129963964|NCT02826798|467832342|FG000|Overall Study|Withdrawal by Subject|0|||
129963965|NCT02826798|467832343|FG001|Overall Study|Withdrawal by Subject|1|||
129963966|NCT02826798|467832344|FG002|Overall Study|Withdrawal by Subject|0|||
129963967|NCT02826798|467832345|FG003|Overall Study|Withdrawal by Subject|1|||
129963968|NCT02826798|467832346|FG004|Overall Study|Withdrawal by Subject|0|||
129963969|NCT02806505|467832347|FG000|Overall Study|Adverse event/intercurrent illness|1|||
129963970|NCT02806505|467832348|FG001|Overall Study|Adverse event/intercurrent illness|3|||
129963971|NCT02806505|467832347|FG000|Overall Study|Death|4|||
129963972|NCT02806505|467832348|FG001|Overall Study|Death|0|||
129963973|NCT02806505|467832347|FG000|Overall Study|Did not cooperate/refused treatment|3|||
129963974|NCT02806505|467832348|FG001|Overall Study|Did not cooperate/refused treatment|3|||
129963975|NCT02806505|467832347|FG000|Overall Study|Failure to return|0|||
129963976|NCT02806505|467832348|FG001|Overall Study|Failure to return|1|||
129963977|NCT02806505|467832347|FG000|Overall Study|Insufficient therapeutic response|2|||
129963978|NCT02806505|467832348|FG001|Overall Study|Insufficient therapeutic response|4|||
129963979|NCT01333111|467832351|FG000|Overall Study|patient undergoing major surgery|0|||
129963980|NCT01333111|467832352|FG001|Overall Study|patient undergoing major surgery|2|||
129963981|NCT01333111|467832353|FG002|Overall Study|patient undergoing major surgery|0|||
129963982|NCT01333111|467832351|FG000|Overall Study|personal reasons|0|||
129963983|NCT01333111|467832352|FG001|Overall Study|personal reasons|0|||
129963984|NCT01333111|467832353|FG002|Overall Study|personal reasons|1|||
129963985|NCT01333111|467832351|FG000|Overall Study|unclassified|1|||
129963986|NCT01333111|467832352|FG001|Overall Study|unclassified|0|||
129963987|NCT01333111|467832353|FG002|Overall Study|unclassified|0|||
129963988|NCT01333111|467832351|FG000|Overall Study|withdrawal criteria|0|||
129963989|NCT01333111|467832352|FG001|Overall Study|withdrawal criteria|1|||
129963990|NCT01333111|467832353|FG002|Overall Study|withdrawal criteria|0|||
129963991|NCT01333111|467832351|FG000|Overall Study|Non-compliance|1|||
129963992|NCT01333111|467832352|FG001|Overall Study|Non-compliance|0|||
129963993|NCT01333111|467832353|FG002|Overall Study|Non-compliance|0|||
129963994|NCT01333111|467832351|FG000|Overall Study|Ineffective therapy|0|||
129963995|NCT01333111|467832352|FG001|Overall Study|Ineffective therapy|0|||
129963996|NCT01333111|467832353|FG002|Overall Study|Ineffective therapy|1|||
129963997|NCT02161406|467832354|FG000|Overall Study|Death|2|||
129963998|NCT02161406|467832355|FG001|Overall Study|Death|1|||
129963999|NCT02161406|467832354|FG000|Overall Study|Lost to Follow-up|2|||
129964000|NCT02161406|467832355|FG001|Overall Study|Lost to Follow-up|1|||
129964001|NCT02161406|467832354|FG000|Overall Study|Withdrawal by Subject|2|||
129964002|NCT02161406|467832355|FG001|Overall Study|Withdrawal by Subject|4|||
129964003|NCT02161406|467832354|FG000|Overall Study|investigator withdrew subject|3|||
129964004|NCT02161406|467832355|FG001|Overall Study|investigator withdrew subject|1|||
129964005|NCT02161406|467832354|FG000|Overall Study|Lack of Efficacy|1|||
129964006|NCT02161406|467832355|FG001|Overall Study|Lack of Efficacy|1|||
129964007|NCT02161406|467832354|FG000|Overall Study|relocation|0|||
129964008|NCT02161406|467832355|FG001|Overall Study|relocation|1|||
129964009|NCT00664105|467832356|FG000|Overall Study|Death|3|||
129964010|NCT00664105|467832356|FG000|Overall Study|Withdrawal by Subject|5|||
129964011|NCT00664105|467832356|FG000|Overall Study|Adverse Event|9|||
129964012|NCT00664105|467832356|FG000|Overall Study|Disease progression|7|||
129964013|NCT04732871|467832357|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
130091966|NCT05602818|468292526|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129964014|NCT04732871|467832358|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
129964015|NCT04732871|467832359|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
129964016|NCT04732871|467832357|FG000|Overall Study|Lost to Follow-up|7|||
129964017|NCT04732871|467832358|FG001|Overall Study|Lost to Follow-up|4|||
129964018|NCT04732871|467832359|FG002|Overall Study|Lost to Follow-up|3|||
129964019|NCT04732871|467832357|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
129964020|NCT04732871|467832358|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
129964021|NCT04732871|467832359|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
129964022|NCT04732871|467832357|FG000|Overall Study|Migrated / moved from the study area|5|||
129964023|NCT04732871|467832358|FG001|Overall Study|Migrated / moved from the study area|0|||
129964024|NCT04732871|467832359|FG002|Overall Study|Migrated / moved from the study area|0|||
129964025|NCT04732871|467832357|FG000|Overall Study|Other|1|||
129964026|NCT04732871|467832358|FG001|Overall Study|Other|0|||
129964027|NCT04732871|467832359|FG002|Overall Study|Other|1|||
129964028|NCT04732871|467832357|FG000|Overall Study|Ongoing|6|||
129964029|NCT04732871|467832358|FG001|Overall Study|Ongoing|0|||
129964030|NCT04732871|467832359|FG002|Overall Study|Ongoing|1|||
129964031|NCT04732871|467832357|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
129964032|NCT04732871|467832358|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
129964033|NCT04732871|467832359|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
129964034|NCT02034162|467832362|FG000|Double-blind|Lost to Follow-up|3|||
129964035|NCT02034162|467832363|FG001|Double-blind|Lost to Follow-up|0|||
129964036|NCT02034162|467832364|FG002|Double-blind|Lost to Follow-up|0|||
129964037|NCT02034162|467832362|FG000|Double-blind|Physician Decision|1|||
129964038|NCT02034162|467832363|FG001|Double-blind|Physician Decision|0|||
129964039|NCT02034162|467832364|FG002|Double-blind|Physician Decision|0|||
129964040|NCT02034162|467832362|FG000|Double-blind|Protocol Violation|0|||
129964041|NCT02034162|467832363|FG001|Double-blind|Protocol Violation|1|||
129964042|NCT02034162|467832364|FG002|Double-blind|Protocol Violation|0|||
129964043|NCT02034162|467832362|FG000|Double-blind|Withdrawal by Subject|5|||
129964044|NCT02034162|467832363|FG001|Double-blind|Withdrawal by Subject|7|||
129964045|NCT02034162|467832364|FG002|Double-blind|Withdrawal by Subject|0|||
129964046|NCT03458728|467832366|FG000|Overall Study|Adverse Event|1|||
129964047|NCT03458728|467832367|FG001|Overall Study|Adverse Event|0|||
129964048|NCT03458728|467832366|FG000|Overall Study|Physician Decision|1|||
129964049|NCT03458728|467832367|FG001|Overall Study|Physician Decision|0|||
129964050|NCT03458728|467832366|FG000|Overall Study|Progressive disease - clinical assessment|1|||
129964051|NCT03458728|467832367|FG001|Overall Study|Progressive disease - clinical assessment|0|||
129964052|NCT03458728|467832366|FG000|Overall Study|Progressive disease - radiological progression|21|||
129964053|NCT03458728|467832367|FG001|Overall Study|Progressive disease - radiological progression|6|||
129964054|NCT03458728|467832366|FG000|Overall Study|Withdrawal by Subject|0|||
129964055|NCT03458728|467832367|FG001|Overall Study|Withdrawal by Subject|1|||
129964056|NCT00908349|467832371|FG000|Overall Study|Adverse Event|10|||
129964057|NCT00908349|467832371|FG000|Overall Study|Withdrawal by Subject|9|||
129964058|NCT00908349|467832371|FG000|Overall Study|Physician Decision|5|||
129964059|NCT00908349|467832371|FG000|Overall Study|Lost to Follow-up|5|||
129964060|NCT00908349|467832371|FG000|Overall Study|Various|6|||
129964061|NCT03294941|467832377|FG000|Overall Study|Withdrawal by Subject|0|||
129964062|NCT03294941|467832378|FG001|Overall Study|Withdrawal by Subject|2|||
129964063|NCT03927690|467832379|FG000|Overall Study|Withdrawal by Subject|3|||
129964064|NCT03927690|467832380|FG001|Overall Study|Withdrawal by Subject|1|||
129964065|NCT03927690|467832381|FG002|Overall Study|Withdrawal by Subject|1|||
129964066|NCT03927690|467832379|FG000|Overall Study|Adverse Event|1|||
130091967|NCT05602818|468292527|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130091968|NCT05602818|468292528|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130091969|NCT05602818|468292529|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130091970|NCT05602818|468292530|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129964067|NCT03927690|467832380|FG001|Overall Study|Adverse Event|0|||
129964068|NCT03927690|467832381|FG002|Overall Study|Adverse Event|0|||
129964069|NCT03927690|467832379|FG000|Overall Study|Death|1|||
129964070|NCT03927690|467832380|FG001|Overall Study|Death|0|||
129964071|NCT03927690|467832381|FG002|Overall Study|Death|0|||
129964072|NCT03927690|467832379|FG000|Overall Study|Lost to Follow-up|2|||
129964073|NCT03927690|467832380|FG001|Overall Study|Lost to Follow-up|2|||
129964074|NCT03927690|467832381|FG002|Overall Study|Lost to Follow-up|1|||
129964075|NCT01202409|467832385|FG000|Overall Study|Adverse Event|1|||
129964076|NCT01202409|467832385|FG000|Overall Study|Ineligible - KRAS mutants|7|||
129964077|NCT00337285|467832386|FG000|Overall Study|Withdrawal by Subject|42|||
129964078|NCT00337285|467832386|FG000|Overall Study|Lost to Follow-up|41|||
129964079|NCT00337285|467832386|FG000|Overall Study|Adverse Event|28|||
129964080|NCT00337285|467832386|FG000|Overall Study|Protocol Violation|27|||
129964081|NCT00337285|467832386|FG000|Overall Study|Lack of Efficacy|11|||
129964082|NCT00337285|467832386|FG000|Overall Study|Death|1|||
129964083|NCT00337285|467832386|FG000|Overall Study|Physician Decision|1|||
129964084|NCT00337285|467832386|FG000|Overall Study|Lack of protocol compliance|7|||
129964085|NCT01774019|467832387|FG000|Overall Study|No longer meets protocol criteria|2|||
129964086|NCT01774019|467832388|FG001|Overall Study|No longer meets protocol criteria|0|||
129964087|NCT01774019|467832387|FG000|Overall Study|Withdrawal by Subject|1|||
129964088|NCT01774019|467832388|FG001|Overall Study|Withdrawal by Subject|0|||
129964089|NCT01774019|467832387|FG000|Overall Study|Surgery delayed > 120 days|1|||
129964090|NCT01774019|467832388|FG001|Overall Study|Surgery delayed > 120 days|0|||
129964091|NCT01774019|467832387|FG000|Overall Study|Patient refused surgery|1|||
129964092|NCT01774019|467832388|FG001|Overall Study|Patient refused surgery|1|||
129964093|NCT01774019|467832387|FG000|Overall Study|Unable to implant study device|1|||
129964094|NCT01774019|467832388|FG001|Overall Study|Unable to implant study device|0|||
129964095|NCT01774019|467832387|FG000|Overall Study|Lost to Follow-up|0|||
129964096|NCT01774019|467832388|FG001|Overall Study|Lost to Follow-up|3|||
129964097|NCT00553605|467832389|FG000|Overall Study|Did not meet entrance criteria|1|||
129964098|NCT00553605|467832390|FG001|Overall Study|Did not meet entrance criteria|3|||
129964099|NCT00553605|467832389|FG000|Overall Study|Did not receive full dose|1|||
129964100|NCT00553605|467832390|FG001|Overall Study|Did not receive full dose|0|||
129964101|NCT00553605|467832389|FG000|Overall Study|Randomized but not treated|2|||
129964102|NCT00553605|467832390|FG001|Overall Study|Randomized but not treated|0|||
129964103|NCT01004185|467832391|FG000|Overall Study|Adverse Event|1|||
129964104|NCT01004185|467832392|FG001|Overall Study|Adverse Event|1|||
129964105|NCT01004185|467832391|FG000|Overall Study|Lost to Follow-up|0|||
129964106|NCT01004185|467832392|FG001|Overall Study|Lost to Follow-up|1|||
129964107|NCT01004185|467832391|FG000|Overall Study|Lack of Efficacy|2|||
129964108|NCT01004185|467832392|FG001|Overall Study|Lack of Efficacy|1|||
129964109|NCT01004185|467832391|FG000|Overall Study|Sponsor Terminated Study|4|||
129964110|NCT01004185|467832392|FG001|Overall Study|Sponsor Terminated Study|5|||
129964111|NCT01004185|467832391|FG000|Overall Study|Withdrawal by Subject|2|||
129964112|NCT01004185|467832392|FG001|Overall Study|Withdrawal by Subject|1|||
129964113|NCT03481556|467832397|FG000|Overall Study|Adverse Event|1|||
129964114|NCT03481556|467832398|FG001|Overall Study|Adverse Event|0|||
129964115|NCT03481556|467832399|FG002|Overall Study|Adverse Event|0|||
129964116|NCT03481556|467832400|FG003|Overall Study|Adverse Event|0|||
129964117|NCT03481556|467832397|FG000|Overall Study|Death|4|||
129964118|NCT03481556|467832398|FG001|Overall Study|Death|2|||
129964119|NCT03481556|467832399|FG002|Overall Study|Death|3|||
129964120|NCT03481556|467832400|FG003|Overall Study|Death|16|||
129964121|NCT03481556|467832397|FG000|Overall Study|Study Terminated by Sponsor|10|||
129964122|NCT03481556|467832398|FG001|Overall Study|Study Terminated by Sponsor|5|||
129964123|NCT03481556|467832399|FG002|Overall Study|Study Terminated by Sponsor|2|||
129964124|NCT03481556|467832400|FG003|Overall Study|Study Terminated by Sponsor|9|||
129964125|NCT03463577|467832401|FG000|Overall Study|Lost to Follow-up|238|||
129964126|NCT03463577|467832402|FG001|Overall Study|Lost to Follow-up|435|||
129964127|NCT03463577|467832403|FG002|Overall Study|Lost to Follow-up|0|||
129964128|NCT03463577|467832404|FG003|Overall Study|Lost to Follow-up|0|||
129964129|NCT03463577|467832405|FG004|Overall Study|Lost to Follow-up|0|||
129964130|NCT03463577|467832406|FG005|Overall Study|Lost to Follow-up|0|||
129964131|NCT03463577|467832401|FG000|Overall Study|With unknown pregnancy outcome|0|||
129964132|NCT03463577|467832402|FG001|Overall Study|With unknown pregnancy outcome|5|||
129964133|NCT03463577|467832403|FG002|Overall Study|With unknown pregnancy outcome|0|||
129964134|NCT03463577|467832404|FG003|Overall Study|With unknown pregnancy outcome|0|||
129964135|NCT03463577|467832405|FG004|Overall Study|With unknown pregnancy outcome|0|||
129964136|NCT03463577|467832406|FG005|Overall Study|With unknown pregnancy outcome|0|||
129964137|NCT03463577|467832401|FG000|Overall Study|Maternal death|2|||
129964138|NCT03463577|467832402|FG001|Overall Study|Maternal death|0|||
129964139|NCT03463577|467832403|FG002|Overall Study|Maternal death|0|||
129964140|NCT03463577|467832404|FG003|Overall Study|Maternal death|0|||
129964141|NCT03463577|467832405|FG004|Overall Study|Maternal death|0|||
129964142|NCT03463577|467832406|FG005|Overall Study|Maternal death|0|||
129964143|NCT03463577|467832401|FG000|Overall Study|Neonatal death|0|||
129964144|NCT03463577|467832402|FG001|Overall Study|Neonatal death|0|||
129964145|NCT03463577|467832403|FG002|Overall Study|Neonatal death|0|||
129964146|NCT03463577|467832404|FG003|Overall Study|Neonatal death|15|||
129964147|NCT03463577|467832405|FG004|Overall Study|Neonatal death|17|||
129964148|NCT03463577|467832406|FG005|Overall Study|Neonatal death|0|||
129964149|NCT01085812|467832408|FG000|Open-Label Period|Adverse Event|0|||
129964150|NCT01085812|467832409|FG001|Open-Label Period|Adverse Event|80|||
129964151|NCT01085812|467832408|FG000|Open-Label Period|Lack of Efficacy|0|||
129964152|NCT01085812|467832409|FG001|Open-Label Period|Lack of Efficacy|26|||
129964153|NCT01085812|467832408|FG000|Open-Label Period|Protocol Violation|0|||
129964154|NCT01085812|467832409|FG001|Open-Label Period|Protocol Violation|39|||
129964155|NCT01085812|467832408|FG000|Open-Label Period|Withdrawal by Subject|0|||
129964156|NCT01085812|467832409|FG001|Open-Label Period|Withdrawal by Subject|53|||
129964157|NCT01085812|467832408|FG000|Open-Label Period|Lost to Follow-up|0|||
129964158|NCT01085812|467832409|FG001|Open-Label Period|Lost to Follow-up|42|||
129964159|NCT01085812|467832408|FG000|Double-Blind Period|Adverse Event|3|||
129964160|NCT01085812|467832409|FG001|Double-Blind Period|Adverse Event|8|||
129964161|NCT01085812|467832408|FG000|Double-Blind Period|Protocol Violation|2|||
129964162|NCT01085812|467832409|FG001|Double-Blind Period|Protocol Violation|7|||
129964163|NCT01085812|467832408|FG000|Double-Blind Period|Withdrawal by Subject|11|||
129964164|NCT01085812|467832409|FG001|Double-Blind Period|Withdrawal by Subject|24|||
129964165|NCT01085812|467832408|FG000|Double-Blind Period|Lost to Follow-up|5|||
129964166|NCT01085812|467832409|FG001|Double-Blind Period|Lost to Follow-up|17|||
129964167|NCT01085812|467832408|FG000|Double-Blind Period|Other Reasons|0|||
129964168|NCT01085812|467832409|FG001|Double-Blind Period|Other Reasons|2|||
129964169|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
129964170|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
129964171|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
129964172|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
129964173|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
129964174|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
129964175|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
129964176|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
129964177|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
129964178|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
129964179|NCT01101997|467832410|FG000|Overall Study|Withdrawal by Subject|2|||
129964180|NCT01172639|467832413|FG000|Overall Study|Death|1|||
129964181|NCT01172639|467832414|FG001|Overall Study|Death|1|||
129964182|NCT01172639|467832415|FG002|Overall Study|Death|0|||
129964183|NCT01172639|467832416|FG003|Overall Study|Death|0|||
129964184|NCT01172639|467832417|FG004|Overall Study|Death|0|||
129964185|NCT01172639|467832413|FG000|Overall Study|Lost to Follow-up|9|||
129964186|NCT01172639|467832414|FG001|Overall Study|Lost to Follow-up|7|||
129964187|NCT01172639|467832415|FG002|Overall Study|Lost to Follow-up|11|||
129964188|NCT01172639|467832416|FG003|Overall Study|Lost to Follow-up|6|||
129964189|NCT01172639|467832417|FG004|Overall Study|Lost to Follow-up|6|||
129964190|NCT01172639|467832413|FG000|Overall Study|Withdrawal by Subject|3|||
129964191|NCT01172639|467832414|FG001|Overall Study|Withdrawal by Subject|3|||
129964192|NCT01172639|467832415|FG002|Overall Study|Withdrawal by Subject|5|||
129964193|NCT01172639|467832416|FG003|Overall Study|Withdrawal by Subject|5|||
129964194|NCT01172639|467832417|FG004|Overall Study|Withdrawal by Subject|0|||
129964195|NCT02172950|467832418|FG000|Overall Study|Physician Decision|3|||
129964196|NCT02172950|467832419|FG001|Overall Study|Physician Decision|3|||
129964197|NCT02172950|467832418|FG000|Overall Study|Lack of Efficacy|1|||
129964198|NCT02172950|467832419|FG001|Overall Study|Lack of Efficacy|0|||
129964199|NCT02172950|467832418|FG000|Overall Study|Adverse Event|4|||
129964200|NCT02172950|467832419|FG001|Overall Study|Adverse Event|1|||
129964201|NCT02172950|467832418|FG000|Overall Study|Withdrawal by Subject|10|||
129964202|NCT02172950|467832419|FG001|Overall Study|Withdrawal by Subject|0|||
129964203|NCT02172950|467832418|FG000|Overall Study|Protocol Violation|1|||
129964204|NCT02172950|467832419|FG001|Overall Study|Protocol Violation|0|||
129964205|NCT02172950|467832418|FG000|Overall Study|Lost to Follow-up|1|||
129964206|NCT02172950|467832419|FG001|Overall Study|Lost to Follow-up|0|||
129964207|NCT02172950|467832418|FG000|Overall Study|Death|1|||
129964208|NCT02172950|467832419|FG001|Overall Study|Death|0|||
129964209|NCT02172950|467832418|FG000|Overall Study|Patient traveling|1|||
129964210|NCT02172950|467832419|FG001|Overall Study|Patient traveling|0|||
129964211|NCT02172950|467832418|FG000|Overall Study|Patient went to other country|1|||
129964212|NCT02172950|467832419|FG001|Overall Study|Patient went to other country|0|||
129964213|NCT02172950|467832418|FG000|Overall Study|Patient relocated overseas|1|||
129964214|NCT02172950|467832419|FG001|Overall Study|Patient relocated overseas|1|||
129964215|NCT02172950|467832418|FG000|Overall Study|Patient moving|1|||
129964216|NCT02172950|467832419|FG001|Overall Study|Patient moving|0|||
129964217|NCT00469456|467832420|FG000|Overall Study|Adverse Event|4|||
129964218|NCT00469456|467832421|FG001|Overall Study|Adverse Event|3|||
129964219|NCT00469456|467832420|FG000|Overall Study|Protocol Violation|1|||
129964220|NCT00469456|467832421|FG001|Overall Study|Protocol Violation|0|||
129964221|NCT00469456|467832420|FG000|Overall Study|Withdrawal by Subject|4|||
129964222|NCT00469456|467832421|FG001|Overall Study|Withdrawal by Subject|1|||
130091971|NCT05602818|468292531|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130091972|NCT05602818|468292532|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129964223|NCT00611715|467832422|FG000|Overall Study|Disease Progression|24|||
129964224|NCT00611715|467832423|FG001|Overall Study|Disease Progression|4|||
129964225|NCT00611715|467832422|FG000|Overall Study|Withdrawal by Subject|5|||
129964226|NCT00611715|467832423|FG001|Overall Study|Withdrawal by Subject|1|||
129964227|NCT00611715|467832422|FG000|Overall Study|Adverse Event|9|||
129964228|NCT00611715|467832423|FG001|Overall Study|Adverse Event|1|||
129964229|NCT00611715|467832422|FG000|Overall Study|Death|1|||
129964230|NCT00611715|467832423|FG001|Overall Study|Death|0|||
129964231|NCT00611715|467832422|FG000|Overall Study|two patients are still on treatment|2|||
129964232|NCT00611715|467832423|FG001|Overall Study|two patients are still on treatment|0|||
129964233|NCT00107978|467832426|FG000|Overall Study|Adverse Event|1|||
129964234|NCT00107978|467832427|FG001|Overall Study|Adverse Event|5|||
129964235|NCT00107978|467832426|FG000|Overall Study|Death|3|||
130122215|NCT01345019|468408803|FG000|Open Label Treatment Phase|Noncompliance|5|||
130122216|NCT01345019|468408804|FG001|Open Label Treatment Phase|Noncompliance|4|||
130122217|NCT01345019|468408803|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
130122218|NCT01345019|468408804|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
130122219|NCT01345019|468408803|FG000|Open Label Treatment Phase|Pregnancy|1|||
130122220|NCT01345019|468408804|FG001|Open Label Treatment Phase|Pregnancy|0|||
130122221|NCT01345019|468408803|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
130122222|NCT01345019|468408804|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
130122223|NCT01345019|468408803|FG000|Open Label Treatment Phase|Protocol Violation|0|||
130122224|NCT01345019|468408804|FG001|Open Label Treatment Phase|Protocol Violation|1|||
130122225|NCT03830164|468408805|FG000|Overall Study|Adverse Event|0|||
130122226|NCT03830164|468408806|FG001|Overall Study|Adverse Event|2|||
130122227|NCT03830164|468408807|FG002|Overall Study|Adverse Event|0|||
130122228|NCT03830164|468408805|FG000|Overall Study|Lack of Efficacy|1|||
130122229|NCT03830164|468408806|FG001|Overall Study|Lack of Efficacy|5|||
130122230|NCT03830164|468408807|FG002|Overall Study|Lack of Efficacy|0|||
130122231|NCT03830164|468408805|FG000|Overall Study|Lost to Follow-up|0|||
130122232|NCT03830164|468408806|FG001|Overall Study|Lost to Follow-up|1|||
130122233|NCT03830164|468408807|FG002|Overall Study|Lost to Follow-up|0|||
130122234|NCT03830164|468408805|FG000|Overall Study|Withdrawal by Subject|1|||
130122235|NCT03830164|468408806|FG001|Overall Study|Withdrawal by Subject|0|||
130122236|NCT03830164|468408807|FG002|Overall Study|Withdrawal by Subject|0|||
130122237|NCT02796664|468408808|FG000|Overall Study|Withdrawal by Subject|0|||
130122238|NCT02796664|468408809|FG001|Overall Study|Withdrawal by Subject|3|||
130122239|NCT02796664|468408808|FG000|Overall Study|Noncompliance|1|||
130122240|NCT02796664|468408809|FG001|Overall Study|Noncompliance|1|||
130122241|NCT02796664|468408808|FG000|Overall Study|Death|0|||
130122242|NCT02796664|468408809|FG001|Overall Study|Death|1|||
130122243|NCT02246478|468408810|FG000|Multiple-dose Phase|Protocol Violation|1|||
130122244|NCT02246478|468408811|FG001|Multiple-dose Phase|Protocol Violation|0|||
130122245|NCT02246478|468408812|FG002|Multiple-dose Phase|Protocol Violation|0|||
130122246|NCT02246478|468408813|FG003|Multiple-dose Phase|Protocol Violation|1|||
130122247|NCT01531205|468408815|FG000|Overall Study|Did not proceed to surgery|1|||
130122248|NCT00950807|468408820|FG000|Treatment Period 1|Lack of Efficacy|1|||
130122249|NCT00950807|468408821|FG001|Treatment Period 1|Lack of Efficacy|0|||
130122250|NCT00950807|468408822|FG002|Treatment Period 1|Lack of Efficacy|0|||
130122251|NCT00950807|468408823|FG003|Treatment Period 1|Lack of Efficacy|0|||
130122252|NCT00950807|468408824|FG004|Treatment Period 1|Lack of Efficacy|0|||
130122253|NCT00950807|468408825|FG005|Treatment Period 1|Lack of Efficacy|1|||
130122254|NCT00950807|468408826|FG006|Treatment Period 1|Lack of Efficacy|0|||
130122255|NCT00950807|468408827|FG007|Treatment Period 1|Lack of Efficacy|0|||
130122256|NCT00950807|468408828|FG008|Treatment Period 1|Lack of Efficacy|0|||
130122257|NCT00950807|468408829|FG009|Treatment Period 1|Lack of Efficacy|0|||
130122258|NCT00950807|468408820|FG000|Treatment Period 1|Protocol Violation|1|||
130122259|NCT00950807|468408821|FG001|Treatment Period 1|Protocol Violation|0|||
130122260|NCT00950807|468408822|FG002|Treatment Period 1|Protocol Violation|0|||
130122261|NCT00950807|468408823|FG003|Treatment Period 1|Protocol Violation|0|||
130122262|NCT00950807|468408824|FG004|Treatment Period 1|Protocol Violation|0|||
130122263|NCT00950807|468408825|FG005|Treatment Period 1|Protocol Violation|0|||
130122264|NCT00950807|468408826|FG006|Treatment Period 1|Protocol Violation|0|||
130122265|NCT00950807|468408827|FG007|Treatment Period 1|Protocol Violation|0|||
130122266|NCT00950807|468408828|FG008|Treatment Period 1|Protocol Violation|0|||
130122267|NCT00950807|468408829|FG009|Treatment Period 1|Protocol Violation|0|||
130122268|NCT00950807|468408820|FG000|Treatment Period 1|Lost to Follow-up|0|||
130122269|NCT00950807|468408821|FG001|Treatment Period 1|Lost to Follow-up|0|||
130122270|NCT00950807|468408822|FG002|Treatment Period 1|Lost to Follow-up|1|||
130122271|NCT00950807|468408823|FG003|Treatment Period 1|Lost to Follow-up|0|||
130122272|NCT00950807|468408824|FG004|Treatment Period 1|Lost to Follow-up|0|||
130122273|NCT00950807|468408825|FG005|Treatment Period 1|Lost to Follow-up|0|||
130122274|NCT00950807|468408826|FG006|Treatment Period 1|Lost to Follow-up|0|||
130122275|NCT00950807|468408827|FG007|Treatment Period 1|Lost to Follow-up|0|||
130122276|NCT00950807|468408828|FG008|Treatment Period 1|Lost to Follow-up|0|||
130122277|NCT00950807|468408829|FG009|Treatment Period 1|Lost to Follow-up|0|||
130122278|NCT00950807|468408820|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130122279|NCT00950807|468408821|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130122280|NCT00950807|468408822|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130122281|NCT00950807|468408823|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130122282|NCT00950807|468408824|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130122283|NCT00950807|468408825|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130122284|NCT00950807|468408826|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130122285|NCT00950807|468408827|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130122286|NCT00950807|468408828|FG008|Treatment Period 1|Withdrawal by Subject|1|||
130122287|NCT00950807|468408829|FG009|Treatment Period 1|Withdrawal by Subject|0|||
130122288|NCT00950807|468408820|FG000|Treatment Period 1|Adverse Event|0|||
130122289|NCT00950807|468408821|FG001|Treatment Period 1|Adverse Event|0|||
130122290|NCT00950807|468408822|FG002|Treatment Period 1|Adverse Event|0|||
129964236|NCT00107978|467832427|FG001|Overall Study|Death|3|||
129964237|NCT00107978|467832426|FG000|Overall Study|Lost to Follow-up|20|||
129964238|NCT00107978|467832427|FG001|Overall Study|Lost to Follow-up|28|||
129964239|NCT00107978|467832426|FG000|Overall Study|Withdrawal by Subject|4|||
129964240|NCT00107978|467832427|FG001|Overall Study|Withdrawal by Subject|9|||
129964241|NCT00107978|467832426|FG000|Overall Study|Protocol Violation|0|||
129964242|NCT00107978|467832427|FG001|Overall Study|Protocol Violation|1|||
129964243|NCT00107978|467832426|FG000|Overall Study|Other|5|||
129964244|NCT00107978|467832427|FG001|Overall Study|Other|4|||
129964245|NCT02669407|467832428|FG000|Overall Study|Physician Decision|3|||
129964246|NCT00704171|467832434|FG000|Overall Study|Withdrawal by Subject|1|||
129964247|NCT00704171|467832435|FG001|Overall Study|Withdrawal by Subject|0|||
129964248|NCT01874665|467832436|FG000|Overall Study|Adverse Event|6|||
129964249|NCT01874665|467832437|FG001|Overall Study|Adverse Event|2|||
129964250|NCT01874665|467832436|FG000|Overall Study|Withdrawal by Subject|4|||
129964251|NCT01874665|467832437|FG001|Overall Study|Withdrawal by Subject|1|||
129964252|NCT01874665|467832436|FG000|Overall Study|Physician Decision|3|||
129964253|NCT01874665|467832437|FG001|Overall Study|Physician Decision|0|||
129964254|NCT01874665|467832436|FG000|Overall Study|Clinical Progressive Disease|4|||
129964255|NCT01874665|467832437|FG001|Overall Study|Clinical Progressive Disease|3|||
129964256|NCT01874665|467832436|FG000|Overall Study|Study Terminated by Sponsor|0|||
129964257|NCT01874665|467832437|FG001|Overall Study|Study Terminated by Sponsor|2|||
129964258|NCT01874665|467832436|FG000|Overall Study|Documented Progressive Disease|11|||
129964259|NCT01874665|467832437|FG001|Overall Study|Documented Progressive Disease|7|||
129964260|NCT01874665|467832436|FG000|Overall Study|Other|2|||
129964261|NCT01874665|467832437|FG001|Overall Study|Other|0|||
129964262|NCT00350298|467832438|FG000|Overall Study|Death|7|||
129964263|NCT00350298|467832439|FG001|Overall Study|Death|8|||
129964264|NCT00350298|467832438|FG000|Overall Study|Lost to Follow-up|1|||
129964265|NCT00350298|467832439|FG001|Overall Study|Lost to Follow-up|2|||
129964266|NCT00350298|467832438|FG000|Overall Study|Withdrawal by Subject|1|||
129964267|NCT00350298|467832439|FG001|Overall Study|Withdrawal by Subject|3|||
129964268|NCT03634839|467832442|FG000|First Intervention (2 Hours)|Adverse Event|0|||
129964269|NCT03634839|467832443|FG001|First Intervention (2 Hours)|Adverse Event|2|||
129964270|NCT02447432|467832446|FG000|Epoch 001|Adverse Event|1|||
129964271|NCT02447432|467832447|FG001|Epoch 001|Adverse Event|1|||
129964272|NCT02447432|467832446|FG000|Epoch 001|Withdrawal by Subject|0|||
129964273|NCT02447432|467832447|FG001|Epoch 001|Withdrawal by Subject|4|||
129964274|NCT02447432|467832446|FG000|Epoch 001|Migrated/moved from study area|3|||
129964275|NCT02447432|467832447|FG001|Epoch 001|Migrated/moved from study area|5|||
129964276|NCT02447432|467832446|FG000|Epoch 001|Lost to Follow-up|1|||
129964277|NCT02447432|467832447|FG001|Epoch 001|Lost to Follow-up|3|||
129964278|NCT00233389|467832448|FG000|Overall Study|Adverse Event|5|||
129964279|NCT00233389|467832449|FG001|Overall Study|Adverse Event|5|||
129964280|NCT00233389|467832448|FG000|Overall Study|Lack of Efficacy|11|||
129964281|NCT00233389|467832449|FG001|Overall Study|Lack of Efficacy|8|||
129964282|NCT00233389|467832448|FG000|Overall Study|Lost to Follow-up|1|||
129964283|NCT00233389|467832449|FG001|Overall Study|Lost to Follow-up|1|||
129964284|NCT00233389|467832448|FG000|Overall Study|Physician Decision|1|||
129964285|NCT00233389|467832449|FG001|Overall Study|Physician Decision|0|||
129964286|NCT00233389|467832448|FG000|Overall Study|Protocol Violation|0|||
129964287|NCT00233389|467832449|FG001|Overall Study|Protocol Violation|1|||
129964288|NCT00233389|467832448|FG000|Overall Study|Withdrawal by Subject|0|||
129964289|NCT00233389|467832449|FG001|Overall Study|Withdrawal by Subject|1|||
129964290|NCT04962698|467832454|FG000|Motor Imagery|Technical difficulty|1|||
129964291|NCT04962698|467832455|FG001|Motor Imagery|Technical difficulty|0|||
129964292|NCT04962698|467832454|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
129964293|NCT04962698|467832455|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
129964294|NCT04962698|467832454|FG000|Kinesthetic MI|Technical difficulty|1|||
129964295|NCT04962698|467832455|FG001|Kinesthetic MI|Technical difficulty|0|||
129964296|NCT04962698|467832454|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
130091973|NCT05602818|468292533|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129964297|NCT04962698|467832455|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
129964298|NCT04962698|467832454|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
129964299|NCT04962698|467832455|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
129964300|NCT04962698|467832454|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
129964301|NCT04962698|467832455|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
129964302|NCT04962698|467832454|FG000|Virtual-hand Interaction|Technical difficulty|1|||
129964303|NCT04962698|467832455|FG001|Virtual-hand Interaction|Technical difficulty|0|||
129964304|NCT04962698|467832454|FG000|Robotic Action Observation|Technical difficulty|1|||
129964305|NCT04962698|467832455|FG001|Robotic Action Observation|Technical difficulty|0|||
129964306|NCT04962698|467832454|FG000|Rest|Technical difficulty|1|||
129964307|NCT04962698|467832455|FG001|Rest|Technical difficulty|0|||
129964308|NCT04962698|467832454|FG000|Rest|Exclusion criteria met after enrollment|0|||
129964309|NCT04962698|467832455|FG001|Rest|Exclusion criteria met after enrollment|2|||
129964310|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
130122291|NCT00950807|468408823|FG003|Treatment Period 1|Adverse Event|0|||
130122292|NCT00950807|468408824|FG004|Treatment Period 1|Adverse Event|0|||
130122293|NCT00950807|468408825|FG005|Treatment Period 1|Adverse Event|1|||
130122294|NCT00950807|468408826|FG006|Treatment Period 1|Adverse Event|0|||
130122295|NCT00950807|468408827|FG007|Treatment Period 1|Adverse Event|0|||
130122296|NCT00950807|468408828|FG008|Treatment Period 1|Adverse Event|0|||
130122297|NCT00950807|468408829|FG009|Treatment Period 1|Adverse Event|0|||
130122298|NCT00950807|468408820|FG000|Washout Period 1|Lack of Efficacy|0|||
130122299|NCT00950807|468408821|FG001|Washout Period 1|Lack of Efficacy|0|||
130122300|NCT00950807|468408822|FG002|Washout Period 1|Lack of Efficacy|0|||
130122301|NCT00950807|468408823|FG003|Washout Period 1|Lack of Efficacy|0|||
130122302|NCT00950807|468408824|FG004|Washout Period 1|Lack of Efficacy|0|||
130122303|NCT00950807|468408825|FG005|Washout Period 1|Lack of Efficacy|0|||
130122304|NCT00950807|468408826|FG006|Washout Period 1|Lack of Efficacy|1|||
130122305|NCT00950807|468408827|FG007|Washout Period 1|Lack of Efficacy|0|||
130122306|NCT00950807|468408828|FG008|Washout Period 1|Lack of Efficacy|0|||
130122307|NCT00950807|468408829|FG009|Washout Period 1|Lack of Efficacy|0|||
130122308|NCT00950807|468408820|FG000|Washout Period 1|Withdrawal by Subject|0|||
130122309|NCT00950807|468408821|FG001|Washout Period 1|Withdrawal by Subject|0|||
130122310|NCT00950807|468408822|FG002|Washout Period 1|Withdrawal by Subject|0|||
130122311|NCT00950807|468408823|FG003|Washout Period 1|Withdrawal by Subject|0|||
130122312|NCT00950807|468408824|FG004|Washout Period 1|Withdrawal by Subject|0|||
130122313|NCT00950807|468408825|FG005|Washout Period 1|Withdrawal by Subject|0|||
130122314|NCT00950807|468408826|FG006|Washout Period 1|Withdrawal by Subject|0|||
130122315|NCT00950807|468408827|FG007|Washout Period 1|Withdrawal by Subject|0|||
130122316|NCT00950807|468408828|FG008|Washout Period 1|Withdrawal by Subject|1|||
130122317|NCT00950807|468408829|FG009|Washout Period 1|Withdrawal by Subject|0|||
130122318|NCT00950807|468408820|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
130122319|NCT00950807|468408821|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130122320|NCT00950807|468408822|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130122321|NCT00950807|468408823|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130122322|NCT00950807|468408824|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130122323|NCT00950807|468408825|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130122324|NCT00950807|468408826|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
130122325|NCT00950807|468408827|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
130122326|NCT00950807|468408828|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
130122327|NCT00950807|468408829|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129964311|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
129964312|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
129964313|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
129964314|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
129964315|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
129964316|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
129964317|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
129964318|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
129964319|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
129964320|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
129964321|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
129964322|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
129964323|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
129964324|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
129964325|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
129964326|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
129964327|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
129964328|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
129964329|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
129964330|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
129964331|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
129964332|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
129964333|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
129964334|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
129964335|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
129964336|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
129964337|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
129964338|NCT01710800|467832473|FG000|Overall Study|Withdrawal by Subject|21|||
130122328|NCT00950807|468408820|FG000|Washout Period 1|Adverse Event|2|||
130122329|NCT00950807|468408821|FG001|Washout Period 1|Adverse Event|0|||
130122330|NCT00950807|468408822|FG002|Washout Period 1|Adverse Event|0|||
130122331|NCT00950807|468408823|FG003|Washout Period 1|Adverse Event|1|||
130122332|NCT00950807|468408824|FG004|Washout Period 1|Adverse Event|1|||
130122333|NCT00950807|468408825|FG005|Washout Period 1|Adverse Event|0|||
130122334|NCT00950807|468408826|FG006|Washout Period 1|Adverse Event|0|||
129964339|NCT01710800|467832473|FG000|Overall Study|Protocol Violation|1|||
129964340|NCT00511797|467832474|FG000|Overall Study|Adverse Event|1|||
129964341|NCT00511797|467832475|FG001|Overall Study|Adverse Event|2|||
129964342|NCT00511797|467832476|FG002|Overall Study|Adverse Event|2|||
129964343|NCT00511797|467832477|FG003|Overall Study|Adverse Event|2|||
129964344|NCT00511797|467832474|FG000|Overall Study|Lost to Follow-up|1|||
129964345|NCT00511797|467832475|FG001|Overall Study|Lost to Follow-up|0|||
129964346|NCT00511797|467832476|FG002|Overall Study|Lost to Follow-up|0|||
129964347|NCT00511797|467832477|FG003|Overall Study|Lost to Follow-up|1|||
129964348|NCT00511797|467832474|FG000|Overall Study|Pregnancy|0|||
129964349|NCT00511797|467832475|FG001|Overall Study|Pregnancy|0|||
129964350|NCT00511797|467832476|FG002|Overall Study|Pregnancy|0|||
129964351|NCT00511797|467832477|FG003|Overall Study|Pregnancy|1|||
129964352|NCT00511797|467832474|FG000|Overall Study|Protocol Violation|0|||
129964353|NCT00511797|467832475|FG001|Overall Study|Protocol Violation|2|||
129964354|NCT00511797|467832476|FG002|Overall Study|Protocol Violation|2|||
129964355|NCT00511797|467832477|FG003|Overall Study|Protocol Violation|3|||
129964356|NCT00511797|467832474|FG000|Overall Study|Withdrawal by Subject|3|||
129964357|NCT00511797|467832475|FG001|Overall Study|Withdrawal by Subject|3|||
129964358|NCT00511797|467832476|FG002|Overall Study|Withdrawal by Subject|4|||
129964359|NCT00511797|467832477|FG003|Overall Study|Withdrawal by Subject|2|||
129964360|NCT00511797|467832474|FG000|Overall Study|Never dispensed|1|||
129964361|NCT00511797|467832475|FG001|Overall Study|Never dispensed|0|||
129964362|NCT00511797|467832476|FG002|Overall Study|Never dispensed|1|||
129964363|NCT00511797|467832477|FG003|Overall Study|Never dispensed|3|||
129964364|NCT00511797|467832474|FG000|Overall Study|Study drug not taken|0|||
129964365|NCT00511797|467832475|FG001|Overall Study|Study drug not taken|1|||
129964366|NCT00511797|467832476|FG002|Overall Study|Study drug not taken|0|||
129964367|NCT00511797|467832477|FG003|Overall Study|Study drug not taken|1|||
129964368|NCT00511797|467832474|FG000|Overall Study|Partially missing diary|0|||
129964369|NCT00511797|467832475|FG001|Overall Study|Partially missing diary|0|||
129964370|NCT00511797|467832476|FG002|Overall Study|Partially missing diary|1|||
129964371|NCT00511797|467832477|FG003|Overall Study|Partially missing diary|0|||
129964372|NCT00511797|467832474|FG000|Overall Study|Other (moving etc)|1|||
129964373|NCT00511797|467832475|FG001|Overall Study|Other (moving etc)|0|||
129964374|NCT00511797|467832476|FG002|Overall Study|Other (moving etc)|1|||
129964375|NCT00511797|467832477|FG003|Overall Study|Other (moving etc)|2|||
129964376|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
129964377|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
129964378|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
129964379|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
129964380|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
129964381|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Death|1|||
129964382|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Death|0|||
129964383|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Death|0|||
129964384|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Death|0|||
129964385|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Death|0|||
129964386|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964387|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
129964388|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964389|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964390|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964391|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964392|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
130122335|NCT00950807|468408827|FG007|Washout Period 1|Adverse Event|0|||
130122336|NCT00950807|468408828|FG008|Washout Period 1|Adverse Event|0|||
130122337|NCT00950807|468408829|FG009|Washout Period 1|Adverse Event|0|||
130122338|NCT00950807|468408820|FG000|Treatment Period 2|Lack of Efficacy|1|||
130122339|NCT00950807|468408821|FG001|Treatment Period 2|Lack of Efficacy|0|||
129964393|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964394|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964395|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964396|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
129964397|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
129964398|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
129964399|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
129964400|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
129964401|NCT03974100|467832478|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129964402|NCT03974100|467832479|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129964403|NCT03974100|467832480|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
130122340|NCT00950807|468408822|FG002|Treatment Period 2|Lack of Efficacy|0|||
129964404|NCT03974100|467832481|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
129964405|NCT03974100|467832482|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129964406|NCT03974100|467832478|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
129964407|NCT03974100|467832479|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
129964408|NCT03974100|467832480|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
130122341|NCT00950807|468408823|FG003|Treatment Period 2|Lack of Efficacy|0|||
129964409|NCT03974100|467832481|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
129964410|NCT03974100|467832482|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
129964411|NCT01560871|467832485|FG000|Overall Study|transportation issues|2|||
129964412|NCT01560871|467832486|FG001|Overall Study|transportation issues|1|||
129964413|NCT01560871|467832485|FG000|Overall Study|relocation|1|||
129964414|NCT01560871|467832486|FG001|Overall Study|relocation|0|||
129964415|NCT01560871|467832485|FG000|Overall Study|readmission to a hospital|2|||
129964416|NCT01560871|467832486|FG001|Overall Study|readmission to a hospital|1|||
129964417|NCT01560871|467832485|FG000|Overall Study|Lost to Follow-up|1|||
129964418|NCT01560871|467832486|FG001|Overall Study|Lost to Follow-up|0|||
129964419|NCT02024750|467832487|FG000|Overall Study|Withdrawal by Subject|2|||
129964420|NCT02024750|467832488|FG001|Overall Study|Withdrawal by Subject|1|||
129964421|NCT04088136|467832495|FG000|Overall Study|Withdrawal by Subject|5|||
129964422|NCT04088136|467832496|FG001|Overall Study|Withdrawal by Subject|0|||
129964423|NCT04088136|467832495|FG000|Overall Study|Lack of Efficacy|0|||
129964424|NCT04088136|467832496|FG001|Overall Study|Lack of Efficacy|1|||
129964425|NCT00934700|467832497|FG000|Overall Study|missing scan|5|||
129964426|NCT00934700|467832498|FG001|Overall Study|missing scan|9|||
129964427|NCT00934700|467832497|FG000|Overall Study|Death|8|||
129964428|NCT00934700|467832498|FG001|Overall Study|Death|3|||
129964429|NCT01075100|467832501|FG000|Overall Study|Adverse Event|15|||
129964430|NCT01075100|467832502|FG001|Overall Study|Adverse Event|18|||
129964431|NCT01075100|467832501|FG000|Overall Study|Patient Request|4|||
129964432|NCT01075100|467832502|FG001|Overall Study|Patient Request|4|||
129964433|NCT01075100|467832501|FG000|Overall Study|Investigator Request|2|||
129964434|NCT01075100|467832502|FG001|Overall Study|Investigator Request|1|||
129964435|NCT01075100|467832501|FG000|Overall Study|Disease Progression|25|||
129964436|NCT01075100|467832502|FG001|Overall Study|Disease Progression|29|||
129964437|NCT01075100|467832501|FG000|Overall Study|Other|3|||
129964438|NCT01075100|467832502|FG001|Overall Study|Other|1|||
129964439|NCT02250183|467832503|FG000|Overall Study|Withdrawal by Subject|2|||
129964440|NCT02250183|467832503|FG000|Overall Study|Adverse Event|5|||
129964441|NCT02250183|467832503|FG000|Overall Study|Lost to Follow-up|1|||
129964442|NCT05896696|467832504|FG000|Overall Study|Screening Failure|7|||
129964443|NCT05896696|467832504|FG000|Overall Study|Withdrawal by Subject|2|||
129964444|NCT03900715|467832505|FG000|Overall Study|Protocol Deviation|1|||
129964445|NCT03900715|467832505|FG000|Overall Study|Lack of Efficacy|1|||
129964446|NCT03900715|467832505|FG000|Overall Study|Progressive Disease|6|||
129964447|NCT03900715|467832505|FG000|Overall Study|Adverse Event|2|||
129964448|NCT03900715|467832505|FG000|Overall Study|Other reasons|11|||
129964449|NCT01878383|467834384|FG000|Overall Study|Lost to Follow-up|0|||
129964450|NCT01878383|467834385|FG001|Overall Study|Lost to Follow-up|1499|||
129964451|NCT03475056|467834386|FG000|Overall Study|Lost to Follow-up|0|||
129964452|NCT03475056|467834387|FG001|Overall Study|Lost to Follow-up|1|||
129964453|NCT03475056|467834386|FG000|Overall Study|Moved from Area|0|||
129964454|NCT03475056|467834387|FG001|Overall Study|Moved from Area|2|||
129964455|NCT01932762|467834390|FG000|Overall Study|Withdrawal by Subject|1|||
129964456|NCT01932762|467834391|FG001|Overall Study|Withdrawal by Subject|2|||
129964457|NCT01932762|467834392|FG002|Overall Study|Withdrawal by Subject|0|||
129964458|NCT01932762|467834393|FG003|Overall Study|Withdrawal by Subject|0|||
129964459|NCT01932762|467834390|FG000|Overall Study|Lost to Follow-up|4|||
129964460|NCT01932762|467834391|FG001|Overall Study|Lost to Follow-up|0|||
129964461|NCT01932762|467834392|FG002|Overall Study|Lost to Follow-up|0|||
129964462|NCT01932762|467834393|FG003|Overall Study|Lost to Follow-up|1|||
129964463|NCT01932762|467834390|FG000|Overall Study|Physician Decision|1|||
129964464|NCT01932762|467834391|FG001|Overall Study|Physician Decision|0|||
129964465|NCT01932762|467834392|FG002|Overall Study|Physician Decision|0|||
129964466|NCT01932762|467834393|FG003|Overall Study|Physician Decision|0|||
129964467|NCT02080403|467834396|FG000|Overall Study|Adverse Event|5|||
129964468|NCT02080403|467834397|FG001|Overall Study|Adverse Event|1|||
129964469|NCT02080403|467834396|FG000|Overall Study|Death|0|||
129964470|NCT02080403|467834397|FG001|Overall Study|Death|2|||
129964471|NCT02080403|467834396|FG000|Overall Study|Lost to Follow-up|2|||
129964472|NCT02080403|467834397|FG001|Overall Study|Lost to Follow-up|0|||
129964473|NCT02080403|467834396|FG000|Overall Study|Pregnancy|0|||
129964474|NCT02080403|467834397|FG001|Overall Study|Pregnancy|1|||
129964475|NCT02080403|467834396|FG000|Overall Study|Protocol Violation|3|||
129964476|NCT02080403|467834397|FG001|Overall Study|Protocol Violation|7|||
130122342|NCT00950807|468408824|FG004|Treatment Period 2|Lack of Efficacy|0|||
129964477|NCT02080403|467834396|FG000|Overall Study|Withdrawal by Subject|5|||
129964478|NCT02080403|467834397|FG001|Overall Study|Withdrawal by Subject|1|||
129964479|NCT01101334|467834398|FG000|Overall Study|Adverse Event|9|||
129964480|NCT01101334|467834399|FG001|Overall Study|Adverse Event|4|||
129964481|NCT01101334|467834398|FG000|Overall Study|Death|7|||
129964482|NCT01101334|467834399|FG001|Overall Study|Death|1|||
129964483|NCT01101334|467834398|FG000|Overall Study|Withdrawal by Subject|4|||
129964484|NCT01101334|467834399|FG001|Overall Study|Withdrawal by Subject|3|||
129964485|NCT01101334|467834398|FG000|Overall Study|Withdrawal by Sponsor|1|||
129964486|NCT01101334|467834399|FG001|Overall Study|Withdrawal by Sponsor|1|||
129964487|NCT01101334|467834398|FG000|Overall Study|Progressive Disease|22|||
129964488|NCT01101334|467834399|FG001|Overall Study|Progressive Disease|35|||
129964489|NCT01101334|467834398|FG000|Overall Study|Other|2|||
129964490|NCT01101334|467834399|FG001|Overall Study|Other|1|||
129964491|NCT03864341|467834402|FG000|Overall Study|Withdrawal by Subject|1|||
129964492|NCT00263211|467834404|FG000|Overall Study|Death|1|||
129964493|NCT00263211|467834405|FG001|Overall Study|Death|0|||
129964494|NCT00263211|467834404|FG000|Overall Study|Withdrawal by Subject|3|||
129964495|NCT00263211|467834405|FG001|Overall Study|Withdrawal by Subject|0|||
129964496|NCT00263211|467834404|FG000|Overall Study|Protocol Violation|1|||
129964497|NCT00263211|467834405|FG001|Overall Study|Protocol Violation|0|||
129964498|NCT00263211|467834404|FG000|Overall Study|Disease Progression|0|||
129964499|NCT00263211|467834405|FG001|Overall Study|Disease Progression|1|||
129964500|NCT00760513|467834406|FG000|Overall Study|Withdrawal by Subject|5|||
129964501|NCT00760513|467834407|FG001|Overall Study|Withdrawal by Subject|7|||
129964502|NCT01468077|467834408|FG000|Overall Study|Adverse Event|2|||
129964503|NCT01468077|467834409|FG001|Overall Study|Adverse Event|2|||
129964504|NCT01468077|467834408|FG000|Overall Study|Lack of Efficacy|1|||
129964505|NCT01468077|467834409|FG001|Overall Study|Lack of Efficacy|1|||
129964506|NCT01468077|467834408|FG000|Overall Study|Physician Decision|1|||
129964507|NCT01468077|467834409|FG001|Overall Study|Physician Decision|0|||
129964508|NCT02647788|467834415|FG000|Overall Study|Lost to Follow-up|13|||
129964509|NCT02647788|467834416|FG001|Overall Study|Lost to Follow-up|11|||
129964510|NCT02647788|467834415|FG000|Overall Study|Did not want opiate|0|||
129964511|NCT02647788|467834416|FG001|Overall Study|Did not want opiate|1|||
129964512|NCT02647788|467834415|FG000|Overall Study|Withdrawal by Subject|1|||
129964513|NCT02647788|467834416|FG001|Overall Study|Withdrawal by Subject|0|||
129964514|NCT02647788|467834415|FG000|Overall Study|Felt itchy with assigned medication|1|||
129964515|NCT02647788|467834416|FG001|Overall Study|Felt itchy with assigned medication|0|||
129964516|NCT02647788|467834415|FG000|Overall Study|Felt nauseous with assigned medication|1|||
129964517|NCT02647788|467834416|FG001|Overall Study|Felt nauseous with assigned medication|1|||
129964518|NCT01588366|467834422|FG000|Overall Study|Adverse Event|0|||
129964519|NCT01588366|467834423|FG001|Overall Study|Adverse Event|1|||
129964520|NCT01588366|467834424|FG002|Overall Study|Adverse Event|0|||
129964521|NCT01588366|467834425|FG003|Overall Study|Adverse Event|1|||
129964522|NCT01588366|467834426|FG004|Overall Study|Adverse Event|0|||
129964523|NCT01588366|467834427|FG005|Overall Study|Adverse Event|2|||
129964524|NCT00719043|467834428|FG000|Overall Study|Adverse Event|5|||
129964525|NCT00719043|467834429|FG001|Overall Study|Adverse Event|1|||
129964526|NCT00719043|467834430|FG002|Overall Study|Adverse Event|2|||
129964527|NCT00719043|467834431|FG003|Overall Study|Adverse Event|2|||
129964528|NCT00719043|467834432|FG004|Overall Study|Adverse Event|1|||
129964529|NCT00719043|467834433|FG005|Overall Study|Adverse Event|4|||
129964530|NCT00719043|467834434|FG006|Overall Study|Adverse Event|4|||
129964531|NCT00719043|467834428|FG000|Overall Study|Lost to Follow-up|14|||
129964532|NCT00719043|467834429|FG001|Overall Study|Lost to Follow-up|10|||
129964533|NCT00719043|467834430|FG002|Overall Study|Lost to Follow-up|8|||
129964534|NCT00719043|467834431|FG003|Overall Study|Lost to Follow-up|9|||
129964535|NCT00719043|467834432|FG004|Overall Study|Lost to Follow-up|10|||
129964536|NCT00719043|467834433|FG005|Overall Study|Lost to Follow-up|9|||
129964537|NCT00719043|467834434|FG006|Overall Study|Lost to Follow-up|9|||
129964538|NCT00719043|467834428|FG000|Overall Study|Protocol Violation|0|||
129964539|NCT00719043|467834429|FG001|Overall Study|Protocol Violation|0|||
129964540|NCT00719043|467834430|FG002|Overall Study|Protocol Violation|0|||
129964541|NCT00719043|467834431|FG003|Overall Study|Protocol Violation|0|||
129964542|NCT00719043|467834432|FG004|Overall Study|Protocol Violation|0|||
129964543|NCT00719043|467834433|FG005|Overall Study|Protocol Violation|1|||
129964544|NCT00719043|467834434|FG006|Overall Study|Protocol Violation|0|||
129964545|NCT00719043|467834428|FG000|Overall Study|Other|1|||
129964546|NCT00719043|467834429|FG001|Overall Study|Other|0|||
129964547|NCT00719043|467834430|FG002|Overall Study|Other|1|||
129964548|NCT00719043|467834431|FG003|Overall Study|Other|2|||
129964549|NCT00719043|467834432|FG004|Overall Study|Other|0|||
129964550|NCT00719043|467834433|FG005|Overall Study|Other|2|||
129964551|NCT00719043|467834434|FG006|Overall Study|Other|1|||
129964552|NCT00719043|467834428|FG000|Overall Study|Withdrawal by Subject|12|||
130091974|NCT05602818|468292534|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
130091975|NCT05602818|468292523|FG000|Qualification Phase (3 Days)|Other|1|||
129964553|NCT00719043|467834429|FG001|Overall Study|Withdrawal by Subject|14|||
129964554|NCT00719043|467834430|FG002|Overall Study|Withdrawal by Subject|9|||
129964555|NCT00719043|467834431|FG003|Overall Study|Withdrawal by Subject|10|||
129964556|NCT00719043|467834432|FG004|Overall Study|Withdrawal by Subject|16|||
129964557|NCT00719043|467834433|FG005|Overall Study|Withdrawal by Subject|18|||
129964558|NCT00719043|467834434|FG006|Overall Study|Withdrawal by Subject|14|||
129964559|NCT00302159|467834435|FG000|Overall Study|pt declined before treatment started|1|||
129964560|NCT00302159|467834435|FG000|Overall Study|pt started Avastin|1|||
129964561|NCT03245619|467834436|FG000|Part A (Up to Day 22)|Physician Decision|4|||
129964562|NCT03245619|467834437|FG001|Part A (Up to Day 22)|Physician Decision|6|||
129964563|NCT03245619|467834438|FG002|Part A (Up to Day 22)|Physician Decision|6|||
129964564|NCT03245619|467834439|FG003|Part A (Up to Day 22)|Physician Decision|0|||
130091976|NCT05602818|468292524|FG001|Qualification Phase (3 Days)|Other|0|||
129964565|NCT03245619|467834440|FG004|Part A (Up to Day 22)|Physician Decision|0|||
129964566|NCT03245619|467834441|FG005|Part A (Up to Day 22)|Physician Decision|0|||
129964567|NCT03245619|467834442|FG006|Part A (Up to Day 22)|Physician Decision|0|||
129964568|NCT03245619|467834443|FG007|Part A (Up to Day 22)|Physician Decision|0|||
129964569|NCT03245619|467834444|FG008|Part A (Up to Day 22)|Physician Decision|0|||
129964570|NCT03245619|467834445|FG009|Part A (Up to Day 22)|Physician Decision|0|||
129964571|NCT03245619|467834446|FG010|Part A (Up to Day 22)|Physician Decision|0|||
129964572|NCT03245619|467834447|FG011|Part A (Up to Day 22)|Physician Decision|0|||
129964573|NCT03245619|467834448|FG012|Part A (Up to Day 22)|Physician Decision|0|||
129964574|NCT03245619|467834449|FG013|Part A (Up to Day 22)|Physician Decision|0|||
129964575|NCT03245619|467834450|FG014|Part A (Up to Day 22)|Physician Decision|0|||
129964576|NCT03245619|467834451|FG015|Part A (Up to Day 22)|Physician Decision|0|||
129964577|NCT03245619|467834452|FG016|Part A (Up to Day 22)|Physician Decision|0|||
129964578|NCT02835092|467834455|FG000|Overall Study|Withdrawal by Subject|3|||
129964579|NCT02835092|467834456|FG001|Overall Study|Withdrawal by Subject|6|||
129964580|NCT02835092|467834457|FG002|Overall Study|Withdrawal by Subject|3|||
129964581|NCT02835092|467834455|FG000|Overall Study|Lost to Follow-up|0|||
129964582|NCT02835092|467834456|FG001|Overall Study|Lost to Follow-up|2|||
129964583|NCT02835092|467834457|FG002|Overall Study|Lost to Follow-up|0|||
129964584|NCT01657877|467834459|FG000|Overall Study|Withdrawal by Subject|4|||
129964585|NCT01657877|467834459|FG000|Overall Study|Protocol Violation|6|||
129964586|NCT01657877|467834459|FG000|Overall Study|Adverse Event|2|||
129964587|NCT01657877|467834459|FG000|Overall Study|Other Reason|2|||
129964588|NCT01114672|467834461|FG000|Overall Study|Death|0|||
129964589|NCT01114672|467834462|FG001|Overall Study|Death|1|||
129964590|NCT01114672|467834461|FG000|Overall Study|Withdrawal by Subject|2|||
129964591|NCT01114672|467834462|FG001|Overall Study|Withdrawal by Subject|1|||
129964592|NCT01114672|467834461|FG000|Overall Study|Lost to Follow-up|1|||
129964593|NCT01114672|467834462|FG001|Overall Study|Lost to Follow-up|0|||
129964594|NCT01114672|467834461|FG000|Overall Study|transplanted|1|||
129964595|NCT01114672|467834462|FG001|Overall Study|transplanted|0|||
129964596|NCT02586415|467834467|FG000|Overall Study|Death|13|||
129964597|NCT02586415|467834468|FG001|Overall Study|Death|23|||
129964598|NCT02586415|467834467|FG000|Overall Study|Lost to Follow-up|1|||
129964599|NCT02586415|467834468|FG001|Overall Study|Lost to Follow-up|2|||
129964600|NCT02872311|467834469|FG000|Overall Study|Death|2|||
129964601|NCT02872311|467834470|FG001|Overall Study|Death|0|||
129964602|NCT02872311|467834471|FG002|Overall Study|Death|0|||
129964603|NCT02872311|467834472|FG003|Overall Study|Death|0|||
129964604|NCT02872311|467834473|FG004|Overall Study|Death|0|||
129964605|NCT02872311|467834469|FG000|Overall Study|Lost to Follow-up|2|||
129964606|NCT02872311|467834470|FG001|Overall Study|Lost to Follow-up|0|||
129964607|NCT02872311|467834471|FG002|Overall Study|Lost to Follow-up|0|||
129964608|NCT02872311|467834472|FG003|Overall Study|Lost to Follow-up|0|||
129964609|NCT02872311|467834473|FG004|Overall Study|Lost to Follow-up|0|||
129964610|NCT02872311|467834469|FG000|Overall Study|Protocol Violation|0|||
129964611|NCT02872311|467834470|FG001|Overall Study|Protocol Violation|2|||
129964612|NCT02872311|467834471|FG002|Overall Study|Protocol Violation|1|||
129964613|NCT02872311|467834472|FG003|Overall Study|Protocol Violation|0|||
129964614|NCT02872311|467834473|FG004|Overall Study|Protocol Violation|0|||
129964615|NCT04545476|467834474|FG000|Overall Study|Lost to Follow-up|1|||
129964616|NCT04545476|467834475|FG001|Overall Study|Lost to Follow-up|1|||
129964617|NCT04545476|467834476|FG002|Overall Study|Lost to Follow-up|0|||
129964618|NCT04545476|467834477|FG003|Overall Study|Lost to Follow-up|0|||
129964619|NCT00690378|467834478|FG000|Overall Study|Adverse Event|1|||
129964620|NCT00690378|467834479|FG001|Overall Study|Adverse Event|0|||
129964621|NCT00690378|467834478|FG000|Overall Study|Withdrawal by Subject|2|||
129964622|NCT00690378|467834479|FG001|Overall Study|Withdrawal by Subject|0|||
129964623|NCT00690378|467834478|FG000|Overall Study|Protocol Violation|1|||
129964624|NCT00690378|467834479|FG001|Overall Study|Protocol Violation|0|||
129964625|NCT00690378|467834478|FG000|Overall Study|Lost to Follow-up|2|||
129964626|NCT00690378|467834479|FG001|Overall Study|Lost to Follow-up|3|||
129964627|NCT00690378|467834478|FG000|Overall Study|Did not meet inc/exc criteria|13|||
129964628|NCT00690378|467834479|FG001|Overall Study|Did not meet inc/exc criteria|11|||
129964629|NCT00690378|467834478|FG000|Overall Study|Social problem|1|||
129964630|NCT00690378|467834479|FG001|Overall Study|Social problem|0|||
129964631|NCT02019641|467834480|FG000|10-Week Follow up|Withdrawal by investigator|2|||
129964632|NCT02019641|467834481|FG001|10-Week Follow up|Withdrawal by investigator|0|||
129964633|NCT02019641|467834482|FG002|10-Week Follow up|Withdrawal by investigator|0|||
129964634|NCT02019641|467834480|FG000|10-Week Follow up|Withdrawal by Subject|1|||
129964635|NCT02019641|467834481|FG001|10-Week Follow up|Withdrawal by Subject|1|||
129964636|NCT02019641|467834482|FG002|10-Week Follow up|Withdrawal by Subject|0|||
129964637|NCT02019641|467834480|FG000|20-Week Follow up|Withdrawal by investigator|0|||
129964638|NCT02019641|467834481|FG001|20-Week Follow up|Withdrawal by investigator|0|||
129964639|NCT02019641|467834482|FG002|20-Week Follow up|Withdrawal by investigator|1|||
129964640|NCT03318783|467834483|FG000|Overall Study|Withdrawal by Subject|0|||
129964641|NCT03318783|467834484|FG001|Overall Study|Withdrawal by Subject|1|||
129964642|NCT03318783|467834483|FG000|Overall Study|Death|0|||
129964643|NCT03318783|467834484|FG001|Overall Study|Death|1|||
129964644|NCT03410108|467834487|FG000|Overall Study|Ongoing|41|||
129964645|NCT03410108|467834487|FG000|Overall Study|Adverse Event|4|||
129964646|NCT03410108|467834487|FG000|Overall Study|Progressive Disease|58|||
129964647|NCT03410108|467834487|FG000|Overall Study|Withdrawal by Subject|1|||
129964648|NCT04035577|467834491|FG000|Overall Study|Lost to Follow-up|1|||
129964649|NCT04035577|467834491|FG000|Overall Study|Withdrawal by Subject|1|||
129964650|NCT03269695|467834492|FG000|Overall Study|Adverse Event|2|||
129964651|NCT03269695|467834493|FG001|Overall Study|Adverse Event|1|||
129964652|NCT03269695|467834492|FG000|Overall Study|Lack of Efficacy|0|||
129964653|NCT03269695|467834493|FG001|Overall Study|Lack of Efficacy|1|||
129964654|NCT03269695|467834492|FG000|Overall Study|Withdrawal by Subject|0|||
129964655|NCT03269695|467834493|FG001|Overall Study|Withdrawal by Subject|1|||
129964656|NCT00104637|467834495|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
129964657|NCT00104637|467834496|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
129964658|NCT01313624|467834497|FG000|Double-Blind Phase|Adverse Event|27|||
129964659|NCT01313624|467834498|FG001|Double-Blind Phase|Adverse Event|4|||
129964660|NCT01313624|467834497|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
129964661|NCT01313624|467834498|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
129964662|NCT01313624|467834497|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129964663|NCT01313624|467834498|FG001|Double-Blind Phase|Lost to Follow-up|2|||
129964664|NCT01313624|467834497|FG000|Double-Blind Phase|Physician Decision|1|||
129964665|NCT01313624|467834498|FG001|Double-Blind Phase|Physician Decision|0|||
129964666|NCT01313624|467834497|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129964667|NCT01313624|467834498|FG001|Double-Blind Phase|Lack of Efficacy|0|||
129964668|NCT01313624|467834497|FG000|Open-Label Phase|Adverse Event|1|||
129964669|NCT01313624|467834498|FG001|Open-Label Phase|Adverse Event|10|||
129964670|NCT01313624|467834497|FG000|Open-Label Phase|Withdrawal by Subject|2|||
129964671|NCT01313624|467834498|FG001|Open-Label Phase|Withdrawal by Subject|2|||
129964672|NCT01313624|467834497|FG000|Open-Label Phase|Lost to Follow-up|1|||
129964673|NCT01313624|467834498|FG001|Open-Label Phase|Lost to Follow-up|1|||
129964674|NCT00505414|467834499|FG000|Titration Phase|Adverse Event|0|||
129964675|NCT00505414|467834500|FG001|Titration Phase|Adverse Event|0|||
129964676|NCT00505414|467834501|FG002|Titration Phase|Adverse Event|0|||
129964677|NCT00505414|467834502|FG003|Titration Phase|Adverse Event|8|||
129964678|NCT00505414|467834503|FG004|Titration Phase|Adverse Event|3|||
129964679|NCT00505414|467834499|FG000|Titration Phase|Death|0|||
129964680|NCT00505414|467834500|FG001|Titration Phase|Death|0|||
129964681|NCT00505414|467834501|FG002|Titration Phase|Death|0|||
129964682|NCT00505414|467834502|FG003|Titration Phase|Death|2|||
129964683|NCT00505414|467834503|FG004|Titration Phase|Death|0|||
129964684|NCT00505414|467834499|FG000|Titration Phase|Lack of Efficacy|0|||
129964685|NCT00505414|467834500|FG001|Titration Phase|Lack of Efficacy|0|||
129964686|NCT00505414|467834501|FG002|Titration Phase|Lack of Efficacy|0|||
129964687|NCT00505414|467834502|FG003|Titration Phase|Lack of Efficacy|10|||
129964688|NCT00505414|467834503|FG004|Titration Phase|Lack of Efficacy|1|||
129964689|NCT00505414|467834499|FG000|Titration Phase|Protocol Violation|0|||
129964690|NCT00505414|467834500|FG001|Titration Phase|Protocol Violation|0|||
129964691|NCT00505414|467834501|FG002|Titration Phase|Protocol Violation|0|||
129964692|NCT00505414|467834502|FG003|Titration Phase|Protocol Violation|0|||
129964693|NCT00505414|467834503|FG004|Titration Phase|Protocol Violation|1|||
129964694|NCT00505414|467834499|FG000|Titration Phase|Withdrawal by Subject|0|||
129964695|NCT00505414|467834500|FG001|Titration Phase|Withdrawal by Subject|0|||
129964696|NCT00505414|467834501|FG002|Titration Phase|Withdrawal by Subject|0|||
129964697|NCT00505414|467834502|FG003|Titration Phase|Withdrawal by Subject|3|||
129964698|NCT00505414|467834503|FG004|Titration Phase|Withdrawal by Subject|4|||
129964699|NCT00505414|467834499|FG000|Titration Phase|Underlying disease and therapy required|0|||
129964700|NCT00505414|467834500|FG001|Titration Phase|Underlying disease and therapy required|0|||
129964701|NCT00505414|467834501|FG002|Titration Phase|Underlying disease and therapy required|0|||
129964702|NCT00505414|467834502|FG003|Titration Phase|Underlying disease and therapy required|7|||
129964703|NCT00505414|467834503|FG004|Titration Phase|Underlying disease and therapy required|3|||
129964704|NCT00505414|467834499|FG000|Maintenance Phase|Adverse Event|2|||
130122343|NCT00950807|468408825|FG005|Treatment Period 2|Lack of Efficacy|0|||
130122344|NCT00950807|468408826|FG006|Treatment Period 2|Lack of Efficacy|0|||
130122345|NCT00950807|468408827|FG007|Treatment Period 2|Lack of Efficacy|0|||
129964705|NCT00505414|467834500|FG001|Maintenance Phase|Adverse Event|2|||
129964706|NCT00505414|467834501|FG002|Maintenance Phase|Adverse Event|3|||
129964707|NCT00505414|467834502|FG003|Maintenance Phase|Adverse Event|0|||
129964708|NCT00505414|467834503|FG004|Maintenance Phase|Adverse Event|0|||
129964709|NCT00505414|467834499|FG000|Maintenance Phase|Death|2|||
129964710|NCT00505414|467834500|FG001|Maintenance Phase|Death|0|||
129964711|NCT00505414|467834501|FG002|Maintenance Phase|Death|1|||
129964712|NCT00505414|467834502|FG003|Maintenance Phase|Death|0|||
129964713|NCT00505414|467834503|FG004|Maintenance Phase|Death|0|||
129964714|NCT00505414|467834499|FG000|Maintenance Phase|Lack of Efficacy|2|||
129964715|NCT00505414|467834500|FG001|Maintenance Phase|Lack of Efficacy|1|||
129964716|NCT00505414|467834501|FG002|Maintenance Phase|Lack of Efficacy|1|||
129964717|NCT00505414|467834502|FG003|Maintenance Phase|Lack of Efficacy|0|||
129964718|NCT00505414|467834503|FG004|Maintenance Phase|Lack of Efficacy|0|||
129964719|NCT00505414|467834499|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129964720|NCT00505414|467834500|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129964721|NCT00505414|467834501|FG002|Maintenance Phase|Withdrawal by Subject|1|||
129964722|NCT00505414|467834502|FG003|Maintenance Phase|Withdrawal by Subject|0|||
129964723|NCT00505414|467834503|FG004|Maintenance Phase|Withdrawal by Subject|0|||
129964724|NCT00505414|467834499|FG000|Maintenance Phase|underlying disease and therapy required|0|||
129964725|NCT00505414|467834500|FG001|Maintenance Phase|underlying disease and therapy required|2|||
129964726|NCT00505414|467834501|FG002|Maintenance Phase|underlying disease and therapy required|2|||
129964727|NCT00505414|467834502|FG003|Maintenance Phase|underlying disease and therapy required|0|||
129964728|NCT00505414|467834503|FG004|Maintenance Phase|underlying disease and therapy required|0|||
129964729|NCT00846768|467834504|FG000|Overall Study|Adverse Event|0|||
129964730|NCT00846768|467834505|FG001|Overall Study|Adverse Event|1|||
129964731|NCT00846768|467834506|FG002|Overall Study|Adverse Event|0|||
129964732|NCT00846768|467834507|FG003|Overall Study|Adverse Event|0|||
129964733|NCT00644878|467834508|FG000|Overall Study|Adverse Event|2|||
129964734|NCT00644878|467834508|FG000|Overall Study|Abnormal laboratory value|3|||
129964735|NCT00644878|467834508|FG000|Overall Study|Protocol deviation|2|||
129964736|NCT00644878|467834508|FG000|Overall Study|Treatment duration completed as per protocol|11|||
129964737|NCT00591591|467834513|FG000|Overall Study|Withdrawal by Subject|1|||
129964738|NCT00591591|467834514|FG001|Overall Study|Withdrawal by Subject|37|||
129964739|NCT00591591|467834513|FG000|Overall Study|Lack of Efficacy|10|||
129964740|NCT00591591|467834514|FG001|Overall Study|Lack of Efficacy|2|||
129964741|NCT01841112|467834518|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
129964742|NCT01841112|467834519|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
129964743|NCT01841112|467834520|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
129964744|NCT01841112|467834521|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
129964745|NCT01841112|467834522|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
129964746|NCT00878553|467834523|FG000|Sleep Study|Withdrawal by Subject|2|||
129964747|NCT00878553|467834524|FG001|Sleep Study|Withdrawal by Subject|0|||
129964748|NCT00878553|467834525|FG002|Sleep Study|Withdrawal by Subject|0|||
129964749|NCT00878553|467834526|FG003|Sleep Study|Withdrawal by Subject|0|||
129964750|NCT00878553|467834527|FG004|Sleep Study|Withdrawal by Subject|0|||
129964751|NCT00878553|467834523|FG000|Sleep Study|Lost to Follow-up|1|||
129964752|NCT00878553|467834524|FG001|Sleep Study|Lost to Follow-up|0|||
129964753|NCT00878553|467834525|FG002|Sleep Study|Lost to Follow-up|0|||
129964754|NCT00878553|467834526|FG003|Sleep Study|Lost to Follow-up|0|||
129964755|NCT00878553|467834527|FG004|Sleep Study|Lost to Follow-up|0|||
129964756|NCT00878553|467834523|FG000|Sleep Study|car accident|1|||
129964757|NCT00878553|467834524|FG001|Sleep Study|car accident|0|||
129964758|NCT00878553|467834525|FG002|Sleep Study|car accident|0|||
129964759|NCT00878553|467834526|FG003|Sleep Study|car accident|0|||
129964760|NCT00878553|467834527|FG004|Sleep Study|car accident|0|||
129964761|NCT00878553|467834523|FG000|Sleep Study|family emergency|1|||
129964762|NCT00878553|467834524|FG001|Sleep Study|family emergency|0|||
129964763|NCT00878553|467834525|FG002|Sleep Study|family emergency|0|||
129964764|NCT00878553|467834526|FG003|Sleep Study|family emergency|0|||
129964765|NCT00878553|467834527|FG004|Sleep Study|family emergency|0|||
129964766|NCT00878553|467834523|FG000|PK Study|Withdrawal by Subject|0|||
129964767|NCT00878553|467834524|FG001|PK Study|Withdrawal by Subject|0|||
129964768|NCT00878553|467834525|FG002|PK Study|Withdrawal by Subject|0|||
129964769|NCT00878553|467834526|FG003|PK Study|Withdrawal by Subject|1|||
129964770|NCT00878553|467834527|FG004|PK Study|Withdrawal by Subject|0|||
129964771|NCT00912223|467834528|FG000|Overall Study|Withdrawal by Subject|1|||
129964772|NCT00912223|467834528|FG000|Overall Study|Not transplanted|1|||
129964773|NCT00912223|467834528|FG000|Overall Study|Transformed disease|1|||
129964774|NCT00461123|467834529|FG000|Overall Study|Adverse Event|1|||
129964775|NCT00461123|467834530|FG001|Overall Study|Adverse Event|0|||
129964776|NCT00461123|467834529|FG000|Overall Study|Lost to Follow-up|1|||
129964777|NCT00461123|467834530|FG001|Overall Study|Lost to Follow-up|1|||
129964778|NCT00461123|467834529|FG000|Overall Study|Protocol Violation|3|||
130091977|NCT05602818|468292525|FG002|Qualification Phase (3 Days)|Other|0|||
130091978|NCT05602818|468292526|FG003|Qualification Phase (3 Days)|Other|0|||
130091979|NCT05602818|468292527|FG004|Qualification Phase (3 Days)|Other|0|||
130091980|NCT05602818|468292528|FG005|Qualification Phase (3 Days)|Other|0|||
130091981|NCT05602818|468292529|FG006|Qualification Phase (3 Days)|Other|0|||
129964779|NCT00461123|467834530|FG001|Overall Study|Protocol Violation|2|||
129964780|NCT00461123|467834529|FG000|Overall Study|Withdrawal by Subject|1|||
129964781|NCT00461123|467834530|FG001|Overall Study|Withdrawal by Subject|3|||
129964782|NCT00927901|467834531|FG000|Treatment Period 1|Subject withdrew consent|0|||
129964783|NCT00927901|467834532|FG001|Treatment Period 1|Subject withdrew consent|0|||
129964784|NCT00927901|467834533|FG002|Treatment Period 1|Subject withdrew consent|1|||
129964785|NCT00927901|467834534|FG003|Treatment Period 1|Subject withdrew consent|0|||
129964786|NCT00927901|467834531|FG000|Treatment Period 4|Adverse Event|0|||
129964787|NCT00927901|467834532|FG001|Treatment Period 4|Adverse Event|0|||
129964788|NCT00927901|467834533|FG002|Treatment Period 4|Adverse Event|0|||
129964789|NCT00927901|467834534|FG003|Treatment Period 4|Adverse Event|1|||
130091982|NCT05602818|468292530|FG007|Qualification Phase (3 Days)|Other|0|||
129964790|NCT00927901|467834531|FG000|Treatment Period 4|Subject withdrew consent|0|||
129964791|NCT00927901|467834532|FG001|Treatment Period 4|Subject withdrew consent|0|||
129964792|NCT00927901|467834533|FG002|Treatment Period 4|Subject withdrew consent|1|||
129964793|NCT00927901|467834534|FG003|Treatment Period 4|Subject withdrew consent|0|||
129964794|NCT03029819|467834535|FG000|Overall Study|Lost to Follow-up|3|||
129964795|NCT03029819|467834536|FG001|Overall Study|Lost to Follow-up|5|||
129964796|NCT03029819|467834535|FG000|Overall Study|Removed due to disruptive behavior|0|||
129964797|NCT03029819|467834536|FG001|Overall Study|Removed due to disruptive behavior|1|||
129964798|NCT03605368|467834539|FG000|Overall Study|Lost to Follow-up|2|||
129964799|NCT03605368|467834540|FG001|Overall Study|Lost to Follow-up|1|||
129964800|NCT03605368|467834541|FG002|Overall Study|Lost to Follow-up|3|||
129964801|NCT03605368|467834542|FG003|Overall Study|Lost to Follow-up|2|||
129964802|NCT03605368|467834539|FG000|Overall Study|Withdrawal by Subject|0|||
129964803|NCT03605368|467834540|FG001|Overall Study|Withdrawal by Subject|0|||
129964804|NCT03605368|467834541|FG002|Overall Study|Withdrawal by Subject|4|||
129964805|NCT03605368|467834542|FG003|Overall Study|Withdrawal by Subject|3|||
129964806|NCT02650466|467834544|FG000|Overall Study|Physician Decision|1|||
129964807|NCT02650466|467834544|FG000|Overall Study|Withdrawal by Subject|5|||
129964808|NCT02650466|467834544|FG000|Overall Study|Lost to Follow-up|1|||
129964809|NCT01837797|467834545|FG000|Period 1|Adverse Event|9|||
129964810|NCT01837797|467834546|FG001|Period 1|Adverse Event|0|||
129964811|NCT01837797|467834547|FG002|Period 1|Adverse Event|0|||
129964812|NCT01837797|467834548|FG003|Period 1|Adverse Event|0|||
129964813|NCT01837797|467834549|FG004|Period 1|Adverse Event|0|||
129964814|NCT01837797|467834545|FG000|Period 1|Withdrawal by Subject|6|||
129964815|NCT01837797|467834546|FG001|Period 1|Withdrawal by Subject|0|||
129964816|NCT01837797|467834547|FG002|Period 1|Withdrawal by Subject|0|||
129964817|NCT01837797|467834548|FG003|Period 1|Withdrawal by Subject|0|||
129964818|NCT01837797|467834549|FG004|Period 1|Withdrawal by Subject|0|||
129964819|NCT01837797|467834545|FG000|Period 1|Administrative reasons|76|||
129964820|NCT01837797|467834546|FG001|Period 1|Administrative reasons|0|||
129964821|NCT01837797|467834547|FG002|Period 1|Administrative reasons|0|||
129964822|NCT01837797|467834548|FG003|Period 1|Administrative reasons|0|||
129964823|NCT01837797|467834549|FG004|Period 1|Administrative reasons|0|||
129964824|NCT01837797|467834545|FG000|Period 1|Withdrawal of consent before treatment|1|||
129964825|NCT01837797|467834546|FG001|Period 1|Withdrawal of consent before treatment|0|||
129964826|NCT01837797|467834547|FG002|Period 1|Withdrawal of consent before treatment|0|||
129964827|NCT01837797|467834548|FG003|Period 1|Withdrawal of consent before treatment|0|||
129964828|NCT01837797|467834549|FG004|Period 1|Withdrawal of consent before treatment|0|||
129964829|NCT01837797|467834545|FG000|Period 1|Other|10|||
129964830|NCT01837797|467834546|FG001|Period 1|Other|0|||
129964831|NCT01837797|467834547|FG002|Period 1|Other|0|||
129964832|NCT01837797|467834548|FG003|Period 1|Other|0|||
129964833|NCT01837797|467834549|FG004|Period 1|Other|0|||
129964834|NCT01837797|467834545|FG000|Period 2|Administrative or other reasons|0|||
129964835|NCT01837797|467834546|FG001|Period 2|Administrative or other reasons|5|||
129964836|NCT01837797|467834547|FG002|Period 2|Administrative or other reasons|2|||
129964837|NCT01837797|467834548|FG003|Period 2|Administrative or other reasons|4|||
129964838|NCT01837797|467834549|FG004|Period 2|Administrative or other reasons|0|||
129964839|NCT01837797|467834545|FG000|Period 2|Adverse Event|0|||
129964840|NCT01837797|467834546|FG001|Period 2|Adverse Event|0|||
129964841|NCT01837797|467834547|FG002|Period 2|Adverse Event|0|||
129964842|NCT01837797|467834548|FG003|Period 2|Adverse Event|1|||
129964843|NCT01837797|467834549|FG004|Period 2|Adverse Event|0|||
129964844|NCT01837797|467834545|FG000|Period 3|Adverse Event|0|||
129964845|NCT01837797|467834546|FG001|Period 3|Adverse Event|0|||
129964846|NCT01837797|467834547|FG002|Period 3|Adverse Event|0|||
129964847|NCT01837797|467834548|FG003|Period 3|Adverse Event|0|||
129964848|NCT01837797|467834549|FG004|Period 3|Adverse Event|1|||
129964849|NCT01837797|467834545|FG000|Period 3|Administrative reasons|0|||
129964850|NCT01837797|467834546|FG001|Period 3|Administrative reasons|0|||
129964851|NCT01837797|467834547|FG002|Period 3|Administrative reasons|0|||
129964852|NCT01837797|467834548|FG003|Period 3|Administrative reasons|0|||
129964853|NCT01837797|467834549|FG004|Period 3|Administrative reasons|20|||
129964854|NCT01837797|467834545|FG000|Period 3|Other|0|||
129964855|NCT01837797|467834546|FG001|Period 3|Other|0|||
129964856|NCT01837797|467834547|FG002|Period 3|Other|0|||
129964857|NCT01837797|467834548|FG003|Period 3|Other|0|||
129964858|NCT01837797|467834549|FG004|Period 3|Other|2|||
129964859|NCT03797989|467834550|FG000|VAC069A|Withdrawal by Subject|0|||
129964860|NCT03797989|467834551|FG001|VAC069A|Withdrawal by Subject|0|||
129964861|NCT03797989|467834552|FG002|VAC069A|Withdrawal by Subject|1|||
129964862|NCT03797989|467834553|FG003|VAC069A|Withdrawal by Subject|0|||
129964863|NCT03797989|467834554|FG004|VAC069A|Withdrawal by Subject|0|||
129964864|NCT03797989|467834555|FG005|VAC069A|Withdrawal by Subject|0|||
129964865|NCT03797989|467834556|FG006|VAC069A|Withdrawal by Subject|0|||
129964866|NCT03797989|467834557|FG007|VAC069A|Withdrawal by Subject|0|||
129964867|NCT03797989|467834558|FG008|VAC069A|Withdrawal by Subject|0|||
129964868|NCT03797989|467834559|FG009|VAC069A|Withdrawal by Subject|0|||
129964869|NCT03797989|467834560|FG010|VAC069A|Withdrawal by Subject|0|||
129964870|NCT03797989|467834561|FG011|VAC069A|Withdrawal by Subject|0|||
130122346|NCT00950807|468408828|FG008|Treatment Period 2|Lack of Efficacy|0|||
130122347|NCT00950807|468408829|FG009|Treatment Period 2|Lack of Efficacy|0|||
130122348|NCT00950807|468408820|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129964871|NCT00604188|467834563|FG000|Overall Study|Adverse Event|1|||
129964872|NCT00604188|467834564|FG001|Overall Study|Adverse Event|4|||
129964873|NCT00604188|467834563|FG000|Overall Study|Lost to Follow-up|17|||
129964874|NCT00604188|467834564|FG001|Overall Study|Lost to Follow-up|15|||
129964875|NCT00604188|467834563|FG000|Overall Study|Withdrawal by Subject|5|||
129964876|NCT00604188|467834564|FG001|Overall Study|Withdrawal by Subject|1|||
129964877|NCT00604188|467834563|FG000|Overall Study|Non-compliance with protocol|4|||
129964878|NCT00604188|467834564|FG001|Overall Study|Non-compliance with protocol|4|||
129964879|NCT00604188|467834563|FG000|Overall Study|Did not receive study drug|0|||
129964880|NCT00604188|467834564|FG001|Overall Study|Did not receive study drug|1|||
129964881|NCT00356759|467834565|FG000|Overall Study|Death|5|||
129964882|NCT00356759|467834566|FG001|Overall Study|Death|2|||
129964883|NCT00356759|467834565|FG000|Overall Study|Withdrawal by Subject|2|||
129964884|NCT00356759|467834566|FG001|Overall Study|Withdrawal by Subject|2|||
129964885|NCT00356759|467834565|FG000|Overall Study|Adverse Event|1|||
129964886|NCT00356759|467834566|FG001|Overall Study|Adverse Event|3|||
129964887|NCT00356759|467834565|FG000|Overall Study|Lost to Follow-up|1|||
129964888|NCT00356759|467834566|FG001|Overall Study|Lost to Follow-up|1|||
129964889|NCT00356759|467834565|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
129964890|NCT00356759|467834566|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
129964891|NCT01999972|467836819|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
129964892|NCT01999972|467836820|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
129964893|NCT01999972|467836821|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
129964894|NCT01999972|467836822|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
129964895|NCT01999972|467836823|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
129964896|NCT01999972|467836824|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
129964897|NCT01999972|467836819|FG000|Dose Escalation Part|Death|0|||
129964898|NCT01999972|467836820|FG001|Dose Escalation Part|Death|1|||
129964899|NCT01999972|467836821|FG002|Dose Escalation Part|Death|0|||
129964900|NCT01999972|467836822|FG003|Dose Escalation Part|Death|0|||
129964901|NCT01999972|467836823|FG004|Dose Escalation Part|Death|0|||
129964902|NCT01999972|467836824|FG005|Dose Escalation Part|Death|0|||
129964903|NCT01999972|467836819|FG000|Dose Escalation Part|Enrolled but not treated|0|||
129964904|NCT01999972|467836820|FG001|Dose Escalation Part|Enrolled but not treated|0|||
129964905|NCT01999972|467836821|FG002|Dose Escalation Part|Enrolled but not treated|1|||
129964906|NCT01999972|467836822|FG003|Dose Escalation Part|Enrolled but not treated|1|||
129964907|NCT01999972|467836823|FG004|Dose Escalation Part|Enrolled but not treated|0|||
129964908|NCT01999972|467836824|FG005|Dose Escalation Part|Enrolled but not treated|0|||
129964909|NCT01999972|467836819|FG000|Dose Escalation Part|Disease progression|3|||
129964910|NCT01999972|467836820|FG001|Dose Escalation Part|Disease progression|2|||
129964911|NCT01999972|467836821|FG002|Dose Escalation Part|Disease progression|3|||
129964912|NCT01999972|467836822|FG003|Dose Escalation Part|Disease progression|6|||
129964913|NCT01999972|467836823|FG004|Dose Escalation Part|Disease progression|0|||
129964914|NCT01999972|467836824|FG005|Dose Escalation Part|Disease progression|0|||
129964915|NCT01999972|467836819|FG000|Dose Escalation Part|Adverse Event|0|||
129964916|NCT01999972|467836820|FG001|Dose Escalation Part|Adverse Event|0|||
129964917|NCT01999972|467836821|FG002|Dose Escalation Part|Adverse Event|0|||
129964918|NCT01999972|467836822|FG003|Dose Escalation Part|Adverse Event|2|||
129964919|NCT01999972|467836823|FG004|Dose Escalation Part|Adverse Event|0|||
129964920|NCT01999972|467836824|FG005|Dose Escalation Part|Adverse Event|0|||
129964921|NCT01999972|467836819|FG000|Dose Escalation Part|Global deterioration of health status|1|||
129964922|NCT01999972|467836820|FG001|Dose Escalation Part|Global deterioration of health status|0|||
129964923|NCT01999972|467836821|FG002|Dose Escalation Part|Global deterioration of health status|0|||
129964924|NCT01999972|467836822|FG003|Dose Escalation Part|Global deterioration of health status|1|||
129964925|NCT01999972|467836823|FG004|Dose Escalation Part|Global deterioration of health status|0|||
129964926|NCT01999972|467836824|FG005|Dose Escalation Part|Global deterioration of health status|0|||
129964927|NCT01999972|467836819|FG000|Dose Expansion Part|Death|0|||
129964928|NCT01999972|467836820|FG001|Dose Expansion Part|Death|0|||
129964929|NCT01999972|467836821|FG002|Dose Expansion Part|Death|0|||
129964930|NCT01999972|467836822|FG003|Dose Expansion Part|Death|0|||
129964931|NCT01999972|467836823|FG004|Dose Expansion Part|Death|2|||
129964932|NCT01999972|467836824|FG005|Dose Expansion Part|Death|1|||
129964933|NCT01999972|467836819|FG000|Dose Expansion Part|Disease progression|0|||
129964934|NCT01999972|467836820|FG001|Dose Expansion Part|Disease progression|0|||
129964935|NCT01999972|467836821|FG002|Dose Expansion Part|Disease progression|0|||
129964936|NCT01999972|467836822|FG003|Dose Expansion Part|Disease progression|0|||
129964937|NCT01999972|467836823|FG004|Dose Expansion Part|Disease progression|9|||
129964938|NCT01999972|467836824|FG005|Dose Expansion Part|Disease progression|3|||
129964939|NCT01999972|467836819|FG000|Dose Expansion Part|Sponsor decision|0|||
129964940|NCT01999972|467836820|FG001|Dose Expansion Part|Sponsor decision|0|||
129964941|NCT01999972|467836821|FG002|Dose Expansion Part|Sponsor decision|0|||
129964942|NCT01999972|467836822|FG003|Dose Expansion Part|Sponsor decision|0|||
129964943|NCT01999972|467836823|FG004|Dose Expansion Part|Sponsor decision|1|||
129964944|NCT01999972|467836824|FG005|Dose Expansion Part|Sponsor decision|0|||
129964945|NCT01999972|467836819|FG000|Dose Expansion Part|Adverse Event|0|||
129964946|NCT01999972|467836820|FG001|Dose Expansion Part|Adverse Event|0|||
129964947|NCT01999972|467836821|FG002|Dose Expansion Part|Adverse Event|0|||
129964948|NCT01999972|467836822|FG003|Dose Expansion Part|Adverse Event|0|||
129964949|NCT01999972|467836823|FG004|Dose Expansion Part|Adverse Event|4|||
129964950|NCT01999972|467836824|FG005|Dose Expansion Part|Adverse Event|2|||
129964951|NCT01999972|467836819|FG000|Dose Expansion Part|Participant's non-compliance|0|||
129964952|NCT01999972|467836820|FG001|Dose Expansion Part|Participant's non-compliance|0|||
129964953|NCT01999972|467836821|FG002|Dose Expansion Part|Participant's non-compliance|0|||
129964954|NCT01999972|467836822|FG003|Dose Expansion Part|Participant's non-compliance|0|||
129964955|NCT01999972|467836823|FG004|Dose Expansion Part|Participant's non-compliance|0|||
129964956|NCT01999972|467836824|FG005|Dose Expansion Part|Participant's non-compliance|1|||
129964957|NCT01999972|467836819|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
129964958|NCT01999972|467836820|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
129964959|NCT01999972|467836821|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
129964960|NCT01999972|467836822|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
129964961|NCT01999972|467836823|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
129964962|NCT01999972|467836824|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
129964963|NCT01999972|467836819|FG000|Dose Expansion Part|Changed to standard of care|0|||
129964964|NCT01999972|467836820|FG001|Dose Expansion Part|Changed to standard of care|0|||
129964965|NCT01999972|467836821|FG002|Dose Expansion Part|Changed to standard of care|0|||
129964966|NCT01999972|467836822|FG003|Dose Expansion Part|Changed to standard of care|0|||
129964967|NCT01999972|467836823|FG004|Dose Expansion Part|Changed to standard of care|1|||
129964968|NCT01999972|467836824|FG005|Dose Expansion Part|Changed to standard of care|0|||
129964969|NCT02202109|467836825|FG000|Overall Study|Lost to Follow-up|88|||
129964970|NCT02202109|467836826|FG001|Overall Study|Lost to Follow-up|87|||
129964971|NCT02202109|467836825|FG000|Overall Study|Withdrawal by Subject|2|||
129964972|NCT02202109|467836826|FG001|Overall Study|Withdrawal by Subject|0|||
129964973|NCT00612352|467836828|FG000|Overall Study|Adverse Event|1|||
129964974|NCT00612352|467836829|FG001|Overall Study|Adverse Event|0|||
129964975|NCT00612352|467836828|FG000|Overall Study|Withdrawal by Subject|3|||
129964976|NCT00612352|467836829|FG001|Overall Study|Withdrawal by Subject|5|||
129964977|NCT00612352|467836828|FG000|Overall Study|moved out of state|1|||
129964978|NCT00612352|467836829|FG001|Overall Study|moved out of state|0|||
129964979|NCT00612352|467836828|FG000|Overall Study|didn't return calls/show up on test date|4|||
129964980|NCT00612352|467836829|FG001|Overall Study|didn't return calls/show up on test date|1|||
129964981|NCT04843579|467836836|FG000|Overall Study|Adverse Event|1|||
129964982|NCT04843579|467836836|FG000|Overall Study|Disease Progression|1|||
129964983|NCT00761956|467836837|FG000|Overall Study|Lost to Follow-up|6|||
129964984|NCT00761956|467836838|FG001|Overall Study|Lost to Follow-up|11|||
129964985|NCT00761956|467836837|FG000|Overall Study|Withdrawal by Subject|3|||
129964986|NCT00761956|467836838|FG001|Overall Study|Withdrawal by Subject|8|||
129964987|NCT00761956|467836837|FG000|Overall Study|Death|0|||
129964988|NCT00761956|467836838|FG001|Overall Study|Death|1|||
129964989|NCT00761956|467836837|FG000|Overall Study|Adverse Event|26|||
129964990|NCT00761956|467836838|FG001|Overall Study|Adverse Event|34|||
129964991|NCT03024996|467836840|FG000|Overall Study|Death|57|||
129964992|NCT03024996|467836841|FG001|Overall Study|Death|55|||
129964993|NCT03024996|467836840|FG000|Overall Study|Disease relapse|1|||
129964994|NCT03024996|467836841|FG001|Overall Study|Disease relapse|0|||
129964995|NCT03024996|467836840|FG000|Overall Study|Lost to Follow-up|5|||
129964996|NCT03024996|467836841|FG001|Overall Study|Lost to Follow-up|10|||
129964997|NCT03024996|467836840|FG000|Overall Study|Other|3|||
129964998|NCT03024996|467836841|FG001|Overall Study|Other|3|||
129964999|NCT03024996|467836840|FG000|Overall Study|Physician Decision|0|||
129965000|NCT03024996|467836841|FG001|Overall Study|Physician Decision|1|||
129965001|NCT03024996|467836840|FG000|Overall Study|Study terminated by sponsor|303|||
129965002|NCT03024996|467836841|FG001|Overall Study|Study terminated by sponsor|283|||
129965003|NCT03024996|467836840|FG000|Overall Study|Withdrawal by Subject|21|||
129965004|NCT03024996|467836841|FG001|Overall Study|Withdrawal by Subject|36|||
129965005|NCT01951378|467836845|FG000|Overall Study|Study Terminated-Not completed|23|||
129965006|NCT01951378|467836846|FG001|Overall Study|Study Terminated-Not completed|17|||
130122349|NCT00950807|468408821|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129965007|NCT00464945|467836847|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
129965008|NCT00464945|467836848|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
129965009|NCT00464945|467836847|FG000|Infant Series|Protocol Violation|1|||
130122350|NCT00950807|468408822|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129965010|NCT00464945|467836848|FG001|Infant Series|Protocol Violation|0|||
129965011|NCT00464945|467836847|FG000|Infant Series|Lost to Follow-up|1|||
130122351|NCT00950807|468408823|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129965012|NCT00464945|467836848|FG001|Infant Series|Lost to Follow-up|0|||
129965013|NCT00464945|467836847|FG000|After Infant Series|Withdrawal by Subject|0|||
129965014|NCT00464945|467836848|FG001|After Infant Series|Withdrawal by Subject|2|||
129965015|NCT00464945|467836847|FG000|Toddler Dose|Lost to Follow-up|0|||
129965016|NCT00464945|467836848|FG001|Toddler Dose|Lost to Follow-up|1|||
129965017|NCT03065933|467836851|FG000|Overall Study|study terminated|5|||
129965018|NCT02536742|467836852|FG000|Overall Study|Did not start protocol therapy|1|||
129965019|NCT02536742|467836852|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
129965020|NCT04629443|467836853|FG000|Overall Study|Adverse Event|2|||
129965021|NCT04629443|467836854|FG001|Overall Study|Adverse Event|1|||
129965022|NCT04629443|467836855|FG002|Overall Study|Adverse Event|2|||
129965023|NCT04629443|467836853|FG000|Overall Study|Progressive Disease|2|||
129965024|NCT04629443|467836854|FG001|Overall Study|Progressive Disease|3|||
129965025|NCT04629443|467836855|FG002|Overall Study|Progressive Disease|3|||
129965026|NCT04629443|467836853|FG000|Overall Study|Physician Decision|1|||
129965027|NCT04629443|467836854|FG001|Overall Study|Physician Decision|3|||
129965028|NCT04629443|467836855|FG002|Overall Study|Physician Decision|0|||
129965029|NCT01547117|467836857|FG000|Overall Study|Physician Decision|0|||
129965030|NCT01547117|467836858|FG001|Overall Study|Physician Decision|1|||
129965031|NCT01547117|467836859|FG002|Overall Study|Physician Decision|1|||
129965032|NCT01547117|467836860|FG003|Overall Study|Physician Decision|3|||
129965033|NCT01547117|467836857|FG000|Overall Study|Withdrawal by Subject|1|||
129965034|NCT01547117|467836858|FG001|Overall Study|Withdrawal by Subject|2|||
129965035|NCT01547117|467836859|FG002|Overall Study|Withdrawal by Subject|1|||
129965036|NCT01547117|467836860|FG003|Overall Study|Withdrawal by Subject|2|||
129965037|NCT03491215|467836862|FG000|Overall Study|Death|6|||
129965038|NCT03491215|467836863|FG001|Overall Study|Death|2|||
129965039|NCT03491215|467836864|FG002|Overall Study|Death|1|||
129965040|NCT03491215|467836865|FG003|Overall Study|Death|0|||
129965041|NCT03491215|467836862|FG000|Overall Study|Physician Decision|1|||
129965042|NCT03491215|467836863|FG001|Overall Study|Physician Decision|0|||
129965043|NCT03491215|467836864|FG002|Overall Study|Physician Decision|0|||
129965044|NCT03491215|467836865|FG003|Overall Study|Physician Decision|0|||
129965045|NCT01336205|467836868|FG000|Overall Study|Other|22|||
129965046|NCT01336205|467836869|FG001|Overall Study|Other|9|||
129965047|NCT01336205|467836868|FG000|Overall Study|Lost to Follow-up|40|||
129965048|NCT01336205|467836869|FG001|Overall Study|Lost to Follow-up|20|||
129965049|NCT01336205|467836868|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
129965050|NCT01336205|467836869|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
129965051|NCT01336205|467836868|FG000|Overall Study|Lack of Efficacy|4|||
129965052|NCT01336205|467836869|FG001|Overall Study|Lack of Efficacy|0|||
129965053|NCT01336205|467836868|FG000|Overall Study|Severe noncompliance with protocol|9|||
129965054|NCT01336205|467836869|FG001|Overall Study|Severe noncompliance with protocol|2|||
129965055|NCT01336205|467836868|FG000|Overall Study|Adverse Event|56|||
129965056|NCT01336205|467836869|FG001|Overall Study|Adverse Event|6|||
129965057|NCT01336205|467836868|FG000|Overall Study|Death|1|||
129965058|NCT01336205|467836869|FG001|Overall Study|Death|1|||
129965059|NCT01336205|467836868|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
129965060|NCT01336205|467836869|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
129965061|NCT01336205|467836868|FG000|Overall Study|Withdrawal by Subject|72|||
129965062|NCT01336205|467836869|FG001|Overall Study|Withdrawal by Subject|38|||
129965063|NCT01336205|467836868|FG000|Overall Study|Did not receive treatment|4|||
129965064|NCT01336205|467836869|FG001|Overall Study|Did not receive treatment|0|||
129965065|NCT01006616|467836870|FG000|Period 1 (6 Months)|Adverse Event|10|||
129965066|NCT01006616|467836871|FG001|Period 1 (6 Months)|Adverse Event|31|||
129965067|NCT01006616|467836872|FG002|Period 1 (6 Months)|Adverse Event|37|||
129965068|NCT01006616|467836873|FG003|Period 1 (6 Months)|Adverse Event|9|||
129965069|NCT01006616|467836870|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
130122352|NCT00950807|468408824|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130122353|NCT00950807|468408825|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130122354|NCT00950807|468408826|FG006|Treatment Period 2|Withdrawal by Subject|1|||
130122355|NCT00950807|468408827|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130122356|NCT00950807|468408828|FG008|Treatment Period 2|Withdrawal by Subject|0|||
129965070|NCT01006616|467836871|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
129965071|NCT01006616|467836872|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
129965072|NCT01006616|467836873|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
129965073|NCT01006616|467836870|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
129965074|NCT01006616|467836871|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
129965075|NCT01006616|467836872|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
129965076|NCT01006616|467836873|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
129965077|NCT01006616|467836870|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
129965078|NCT01006616|467836871|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
129965079|NCT01006616|467836872|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
129965080|NCT01006616|467836873|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
129965081|NCT01006616|467836870|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
130122357|NCT00950807|468408829|FG009|Treatment Period 2|Withdrawal by Subject|0|||
130122358|NCT00950807|468408820|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
129965082|NCT01006616|467836871|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
129965083|NCT01006616|467836872|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
129965084|NCT01006616|467836873|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
129965085|NCT01006616|467836870|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
129965086|NCT01006616|467836871|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
129965087|NCT01006616|467836872|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
129965088|NCT01006616|467836873|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
129965089|NCT01006616|467836870|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
129965090|NCT01006616|467836871|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
129965091|NCT01006616|467836872|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
129965092|NCT01006616|467836873|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
129965093|NCT01006616|467836870|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
129965094|NCT01006616|467836871|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
129965095|NCT01006616|467836872|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
129965096|NCT01006616|467836873|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
129965097|NCT01006616|467836870|FG000|Period 1 (6 Months)|Not Treated|0|||
129965098|NCT01006616|467836871|FG001|Period 1 (6 Months)|Not Treated|0|||
129965099|NCT01006616|467836872|FG002|Period 1 (6 Months)|Not Treated|1|||
129965100|NCT01006616|467836873|FG003|Period 1 (6 Months)|Not Treated|1|||
129965101|NCT01006616|467836870|FG000|Period 2 (18 Months)|Adverse Event|6|||
129965102|NCT01006616|467836871|FG001|Period 2 (18 Months)|Adverse Event|6|||
129965103|NCT01006616|467836872|FG002|Period 2 (18 Months)|Adverse Event|6|||
129965104|NCT01006616|467836873|FG003|Period 2 (18 Months)|Adverse Event|4|||
129965105|NCT01006616|467836870|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
129965106|NCT01006616|467836871|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
129965107|NCT01006616|467836872|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
129965108|NCT01006616|467836873|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
129965109|NCT01006616|467836870|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
129965110|NCT01006616|467836871|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
129965111|NCT01006616|467836872|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
129965112|NCT01006616|467836873|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
129965113|NCT01006616|467836870|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
129965114|NCT01006616|467836871|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
129965115|NCT01006616|467836872|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
129965116|NCT01006616|467836873|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
129965117|NCT01006616|467836870|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
129965118|NCT01006616|467836871|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
129965119|NCT01006616|467836872|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
129965120|NCT01006616|467836873|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
129965121|NCT01006616|467836870|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
129965122|NCT01006616|467836871|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
129965123|NCT01006616|467836872|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
129965124|NCT01006616|467836873|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
129965125|NCT01006616|467836870|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
129965126|NCT01006616|467836871|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
129965127|NCT01006616|467836872|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
129965128|NCT01006616|467836873|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
129965129|NCT01006616|467836870|FG000|Period 2 (18 Months)|Study Terminated|63|||
129965130|NCT01006616|467836871|FG001|Period 2 (18 Months)|Study Terminated|46|||
129965131|NCT01006616|467836872|FG002|Period 2 (18 Months)|Study Terminated|44|||
129965132|NCT01006616|467836873|FG003|Period 2 (18 Months)|Study Terminated|70|||
129965133|NCT03672175|467836874|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
129965134|NCT03672175|467836875|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
129965135|NCT03672175|467836876|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
129965136|NCT03672175|467836874|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
129965137|NCT03672175|467836875|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
129965138|NCT03672175|467836876|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
129965139|NCT03672175|467836874|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
129965140|NCT03672175|467836875|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
129965141|NCT03672175|467836876|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
129965142|NCT03672175|467836874|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
129965143|NCT03672175|467836875|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
129965144|NCT03672175|467836876|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
130122359|NCT00950807|468408821|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122360|NCT00950807|468408822|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122361|NCT00950807|468408823|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129965145|NCT03672175|467836874|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
129965146|NCT03672175|467836875|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
129965147|NCT03672175|467836876|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
129965148|NCT03672175|467836874|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
129965149|NCT03672175|467836875|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
129965150|NCT03672175|467836876|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
129965151|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
129965152|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
129965153|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
129965154|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
129965155|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
129965156|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
129965157|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
129965158|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
129965159|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
129965160|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
129965161|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
129965162|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
129965163|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
129965164|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
129965165|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
129965166|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
129965167|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
129965168|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
129965169|NCT02482935|467836877|FG000|Period 1|Withdrawal by Subject|1|||
129965170|NCT02482935|467836878|FG001|Period 1|Withdrawal by Subject|0|||
129965171|NCT03414047|467836879|FG000|Overall Study|Adverse Event|0|||
129965172|NCT03414047|467836880|FG001|Overall Study|Adverse Event|0|||
129965173|NCT03414047|467836881|FG002|Overall Study|Adverse Event|1|||
129965174|NCT03414047|467836882|FG003|Overall Study|Adverse Event|1|||
129965175|NCT03414047|467836879|FG000|Overall Study|Physician Decision|1|||
129965176|NCT03414047|467836880|FG001|Overall Study|Physician Decision|0|||
129965177|NCT03414047|467836881|FG002|Overall Study|Physician Decision|0|||
129965178|NCT03414047|467836882|FG003|Overall Study|Physician Decision|1|||
129965179|NCT03414047|467836879|FG000|Overall Study|Withdrawal by Subject|1|||
129965180|NCT03414047|467836880|FG001|Overall Study|Withdrawal by Subject|0|||
129965181|NCT03414047|467836881|FG002|Overall Study|Withdrawal by Subject|2|||
129965182|NCT03414047|467836882|FG003|Overall Study|Withdrawal by Subject|0|||
129965183|NCT01585298|467836885|FG000|Overall Study|Study completion was not documented.|1|||
129965184|NCT01585298|467836885|FG000|Overall Study|Protocol deviation|1|||
129965185|NCT01585298|467836885|FG000|Overall Study|Administrative problems|4|||
129965186|NCT01585298|467836885|FG000|Overall Study|Lost to Follow-up|2|||
129965187|NCT01585298|467836885|FG000|Overall Study|Withdrawal by Subject|4|||
129965188|NCT01585298|467836885|FG000|Overall Study|Abnormal test procedure results|1|||
129965189|NCT01585298|467836885|FG000|Overall Study|Adverse Event|24|||
129965190|NCT02777242|467836889|FG000|Overall Study|Other|2|||
129965191|NCT02777242|467836889|FG000|Overall Study|Lost to Follow-up|1|||
129965192|NCT02777242|467836889|FG000|Overall Study|Multiple|1|||
129965193|NCT02777242|467836889|FG000|Overall Study|Sponsor's request|1|||
129965194|NCT02777242|467836889|FG000|Overall Study|Withdrawal by Subject|1|||
129965195|NCT01898442|467836890|FG000|Overall Study|Hemolysis/technical problems|1|||
129965196|NCT01898442|467836891|FG001|Overall Study|Hemolysis/technical problems|2|||
129965197|NCT01898442|467836892|FG002|Overall Study|Hemolysis/technical problems|2|||
130122362|NCT00950807|468408824|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122363|NCT00950807|468408825|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122364|NCT00950807|468408826|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122365|NCT00950807|468408827|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122366|NCT00950807|468408828|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122367|NCT00950807|468408829|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
130122368|NCT00950807|468408820|FG000|Treatment Period 2|Adverse Event|0|||
130122369|NCT00950807|468408821|FG001|Treatment Period 2|Adverse Event|1|||
130122370|NCT00950807|468408822|FG002|Treatment Period 2|Adverse Event|0|||
130122371|NCT00950807|468408823|FG003|Treatment Period 2|Adverse Event|1|||
130122372|NCT00950807|468408824|FG004|Treatment Period 2|Adverse Event|0|||
130122373|NCT00950807|468408825|FG005|Treatment Period 2|Adverse Event|1|||
130122374|NCT00950807|468408826|FG006|Treatment Period 2|Adverse Event|0|||
130122375|NCT00950807|468408827|FG007|Treatment Period 2|Adverse Event|1|||
130122376|NCT00950807|468408828|FG008|Treatment Period 2|Adverse Event|0|||
130122377|NCT00950807|468408829|FG009|Treatment Period 2|Adverse Event|0|||
130122378|NCT00950807|468408820|FG000|Washout Period 2|Lack of Efficacy|1|||
130122379|NCT00950807|468408821|FG001|Washout Period 2|Lack of Efficacy|0|||
130122380|NCT00950807|468408822|FG002|Washout Period 2|Lack of Efficacy|0|||
129965198|NCT01898442|467836890|FG000|Overall Study|Patient vomited pills|0|||
129965199|NCT01898442|467836891|FG001|Overall Study|Patient vomited pills|0|||
129965200|NCT01898442|467836892|FG002|Overall Study|Patient vomited pills|1|||
129965201|NCT05178979|467836893|FG000|Overall Study|Death|0|||
129965202|NCT05178979|467836894|FG001|Overall Study|Death|5|||
129965203|NCT05178979|467836895|FG002|Overall Study|Death|0|||
129965204|NCT05178979|467836896|FG003|Overall Study|Death|3|||
129965205|NCT05178979|467836893|FG000|Overall Study|Adverse Event|0|||
129965206|NCT05178979|467836894|FG001|Overall Study|Adverse Event|1|||
129965207|NCT05178979|467836895|FG002|Overall Study|Adverse Event|0|||
129965208|NCT05178979|467836896|FG003|Overall Study|Adverse Event|0|||
129965209|NCT05178979|467836893|FG000|Overall Study|Lost to Follow-up|1|||
129965210|NCT05178979|467836894|FG001|Overall Study|Lost to Follow-up|8|||
129965211|NCT05178979|467836895|FG002|Overall Study|Lost to Follow-up|3|||
129965212|NCT05178979|467836896|FG003|Overall Study|Lost to Follow-up|8|||
129965213|NCT01704547|467836903|FG000|Overall Study|Physician Decision|4|||
129965214|NCT01704547|467836903|FG000|Overall Study|Withdrawal by Subject|1|||
129965215|NCT00468130|467836913|FG000|Overall Study|Adverse Event|2|||
129965216|NCT00468130|467836914|FG001|Overall Study|Adverse Event|1|||
129965217|NCT00468130|467836913|FG000|Overall Study|Withdrawal by Subject|0|||
129965218|NCT00468130|467836914|FG001|Overall Study|Withdrawal by Subject|1|||
129965219|NCT00436956|467836915|FG000|Overall Study|Not evaluable|1|||
129965220|NCT00436956|467836916|FG001|Overall Study|Not evaluable|0|||
129965221|NCT02143063|467836919|FG000|Overall Study|Lost to Follow-up|16|||
129965222|NCT02143063|467836920|FG001|Overall Study|Lost to Follow-up|28|||
129965223|NCT02143063|467836921|FG002|Overall Study|Lost to Follow-up|29|||
129965224|NCT02143063|467836919|FG000|Overall Study|Withdrawal by Subject|0|||
129965225|NCT02143063|467836920|FG001|Overall Study|Withdrawal by Subject|1|||
129965226|NCT02143063|467836921|FG002|Overall Study|Withdrawal by Subject|0|||
129965227|NCT02143063|467836919|FG000|Overall Study|Death|0|||
129965228|NCT02143063|467836920|FG001|Overall Study|Death|1|||
129965229|NCT02143063|467836921|FG002|Overall Study|Death|1|||
129965230|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
129965231|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
129965232|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
129965233|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
129965234|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
129965235|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
129965236|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
129965237|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
129965238|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
129965239|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
129965240|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
129965241|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
129965242|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
129965243|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
129965244|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
129965245|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
129965246|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
129965247|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
129965248|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
129965249|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
129965250|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
129965251|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
129965252|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
129965253|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
129965254|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
129965255|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
129965256|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
129965257|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
129965258|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
129965259|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
129965260|NCT00909532|467836927|FG000|Overall Study|Adverse Event|4|||
129965261|NCT00909532|467836928|FG001|Overall Study|Adverse Event|1|||
129965262|NCT00909532|467836927|FG000|Overall Study|Pregnancy|0|||
129965263|NCT00909532|467836928|FG001|Overall Study|Pregnancy|1|||
129965264|NCT00909532|467836927|FG000|Overall Study|Prohibited Medication|2|||
129965265|NCT00909532|467836928|FG001|Overall Study|Prohibited Medication|1|||
129965266|NCT00909532|467836927|FG000|Overall Study|Withdrawal of Consent|1|||
129965267|NCT00909532|467836928|FG001|Overall Study|Withdrawal of Consent|1|||
129965268|NCT00909532|467836927|FG000|Overall Study|Noncompliance with Study Requirements|0|||
130091983|NCT05602818|468292531|FG008|Qualification Phase (3 Days)|Other|0|||
129965269|NCT00909532|467836928|FG001|Overall Study|Noncompliance with Study Requirements|2|||
129965270|NCT00909532|467836927|FG000|Overall Study|Physician Decision|1|||
129965271|NCT00909532|467836928|FG001|Overall Study|Physician Decision|0|||
129965272|NCT00909532|467836927|FG000|Overall Study|Wrong Genotype|1|||
129965273|NCT00909532|467836928|FG001|Overall Study|Wrong Genotype|0|||
129965274|NCT00909532|467836927|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
129965275|NCT00909532|467836928|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
129965276|NCT01130168|467836929|FG000|Period 1|Withdrawal by Subject|0|||
129965277|NCT01130168|467836930|FG001|Period 1|Withdrawal by Subject|1|||
129965278|NCT01130168|467836931|FG002|Period 1|Withdrawal by Subject|0|||
130091984|NCT05602818|468292532|FG009|Qualification Phase (3 Days)|Other|0|||
129965279|NCT01130168|467836932|FG003|Period 1|Withdrawal by Subject|1|||
129965280|NCT01130168|467836933|FG004|Period 1|Withdrawal by Subject|0|||
129965281|NCT01130168|467836934|FG005|Period 1|Withdrawal by Subject|0|||
129965282|NCT01130168|467836929|FG000|Period 1|Discontinued For Other Reason|0|||
129965283|NCT01130168|467836930|FG001|Period 1|Discontinued For Other Reason|0|||
129965284|NCT01130168|467836931|FG002|Period 1|Discontinued For Other Reason|1|||
129965285|NCT01130168|467836932|FG003|Period 1|Discontinued For Other Reason|1|||
129965286|NCT01130168|467836933|FG004|Period 1|Discontinued For Other Reason|0|||
129965287|NCT01130168|467836934|FG005|Period 1|Discontinued For Other Reason|0|||
129965288|NCT01130168|467836929|FG000|Period 1|Adverse Event|0|||
129965289|NCT01130168|467836930|FG001|Period 1|Adverse Event|0|||
129965290|NCT01130168|467836931|FG002|Period 1|Adverse Event|0|||
129965291|NCT01130168|467836932|FG003|Period 1|Adverse Event|1|||
129965292|NCT01130168|467836933|FG004|Period 1|Adverse Event|0|||
129965293|NCT01130168|467836934|FG005|Period 1|Adverse Event|0|||
129965294|NCT01263925|467836941|FG000|Overall Study|Protocol Violation|1|||
129965295|NCT01263925|467836942|FG001|Overall Study|Protocol Violation|0|||
129965296|NCT01263925|467836941|FG000|Overall Study|Lack of Efficacy|0|||
129965297|NCT01263925|467836942|FG001|Overall Study|Lack of Efficacy|1|||
129965298|NCT01263925|467836941|FG000|Overall Study|Adverse Event|23|||
129965299|NCT01263925|467836942|FG001|Overall Study|Adverse Event|22|||
129965300|NCT01263925|467836941|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
129965301|NCT01263925|467836942|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
129965302|NCT01263925|467836941|FG000|Overall Study|Withdrawal by Subject|6|||
129965303|NCT01263925|467836942|FG001|Overall Study|Withdrawal by Subject|8|||
129965304|NCT01263925|467836941|FG000|Overall Study|Other|4|||
129965305|NCT01263925|467836942|FG001|Overall Study|Other|4|||
129965306|NCT01263925|467836941|FG000|Overall Study|Lost to Follow-up|3|||
129965307|NCT01263925|467836942|FG001|Overall Study|Lost to Follow-up|1|||
129965308|NCT01263925|467836941|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
129965309|NCT01263925|467836942|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
129965310|NCT01263925|467836941|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
129965311|NCT01263925|467836942|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
129965312|NCT01263925|467836941|FG000|Overall Study|AE/ Withdrawal|1|||
129965313|NCT01263925|467836942|FG001|Overall Study|AE/ Withdrawal|4|||
129965314|NCT01263925|467836941|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
129965315|NCT01263925|467836942|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
129965316|NCT01263925|467836941|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
129965317|NCT01263925|467836942|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
129965318|NCT01263925|467836941|FG000|Overall Study|Withdrawal/ Not specified|0|||
129965319|NCT01263925|467836942|FG001|Overall Study|Withdrawal/ Not specified|1|||
129965320|NCT01726517|467836952|FG000|Overall Study|Withdrawal by Subject|0|||
129965321|NCT01726517|467836953|FG001|Overall Study|Withdrawal by Subject|0|||
129965322|NCT01726517|467836954|FG002|Overall Study|Withdrawal by Subject|1|||
129965323|NCT01726517|467836955|FG003|Overall Study|Withdrawal by Subject|0|||
129965324|NCT01726517|467836956|FG004|Overall Study|Withdrawal by Subject|0|||
129965325|NCT00573651|467836957|FG000|Overall Study|Lost to Follow-up|3|||
129965326|NCT00573651|467836957|FG000|Overall Study|Withdrawal by Subject|1|||
129965327|NCT03765164|467836958|FG000|Pre-intervention|Withdrawal by Subject|5|||
129965328|NCT03765164|467836959|FG001|Pre-intervention|Withdrawal by Subject|6|||
129965329|NCT03448536|467836961|FG000|Overall Study|Protocol Violation|2|||
129965330|NCT03448536|467836962|FG001|Overall Study|Protocol Violation|0|||
129965331|NCT03448536|467836961|FG000|Overall Study|Pregnancy|1|||
129965332|NCT03448536|467836962|FG001|Overall Study|Pregnancy|0|||
129965333|NCT03448536|467836961|FG000|Overall Study|Withdrawal by Subject|1|||
129965334|NCT03448536|467836962|FG001|Overall Study|Withdrawal by Subject|2|||
129965335|NCT03448536|467836961|FG000|Overall Study|Lost to Follow-up|3|||
129965336|NCT03448536|467836962|FG001|Overall Study|Lost to Follow-up|2|||
129965337|NCT03448536|467836961|FG000|Overall Study|Inadequate pain reporter|1|||
129965338|NCT03448536|467836962|FG001|Overall Study|Inadequate pain reporter|0|||
129965339|NCT03448536|467836961|FG000|Overall Study|Other|3|||
129965340|NCT03448536|467836962|FG001|Overall Study|Other|0|||
129965341|NCT03448536|467836961|FG000|Overall Study|Physician Decision|1|||
129965342|NCT03448536|467836962|FG001|Overall Study|Physician Decision|0|||
129965343|NCT04052997|467836985|FG000|Overall Study|Withdrawal by Subject|17|||
129965344|NCT04052997|467836985|FG000|Overall Study|Physician Decision|50|||
129965345|NCT04052997|467836985|FG000|Overall Study|Death|43|||
129965346|NCT04052997|467836985|FG000|Overall Study|Lost to Follow-up|5|||
129965347|NCT04052997|467836985|FG000|Overall Study|Progression of Disease|1|||
129965348|NCT01024036|467836986|FG000|Blinded Treatment|Adverse Event|1|||
129965349|NCT01024036|467836987|FG001|Blinded Treatment|Adverse Event|1|||
129965350|NCT01024036|467836986|FG000|Blinded Treatment|Lack of Efficacy|16|||
129965351|NCT01024036|467836987|FG001|Blinded Treatment|Lack of Efficacy|14|||
129965352|NCT01024036|467836986|FG000|Blinded Treatment|Physician Decision|1|||
129965353|NCT01024036|467836987|FG001|Blinded Treatment|Physician Decision|0|||
129965354|NCT01024036|467836986|FG000|Blinded Treatment|Death|0|||
129965355|NCT01024036|467836987|FG001|Blinded Treatment|Death|2|||
129965356|NCT01024036|467836986|FG000|Blinded Treatment|Withdrawal by Subject|4|||
129965357|NCT01024036|467836987|FG001|Blinded Treatment|Withdrawal by Subject|3|||
129965358|NCT01024036|467836986|FG000|Unblinded Treatment|Adverse Event|0|||
129965359|NCT01024036|467836987|FG001|Unblinded Treatment|Adverse Event|1|||
129965360|NCT01024036|467836986|FG000|Unblinded Treatment|Lack of Efficacy|0|||
129965361|NCT01024036|467836987|FG001|Unblinded Treatment|Lack of Efficacy|2|||
129965362|NCT01024036|467836986|FG000|Follow-Up Period|Lost to Follow-up|1|||
129965363|NCT01024036|467836987|FG001|Follow-Up Period|Lost to Follow-up|1|||
129965364|NCT01024036|467836986|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129965365|NCT01024036|467836987|FG001|Follow-Up Period|Withdrawal by Subject|1|||
129965366|NCT01024036|467836986|FG000|Follow-Up Period|Adverse Event|4|||
129965367|NCT01024036|467836987|FG001|Follow-Up Period|Adverse Event|1|||
129965368|NCT00474383|467836997|FG000|Main Study|Adverse Event|11|||
129965369|NCT00474383|467836998|FG001|Main Study|Adverse Event|0|||
129965370|NCT00474383|467836997|FG000|Main Study|Symptomatic Deterioration|1|||
129965371|NCT00474383|467836998|FG001|Main Study|Symptomatic Deterioration|0|||
129965372|NCT00474383|467836997|FG000|Main Study|Progressive Disease|23|||
129965373|NCT00474383|467836998|FG001|Main Study|Progressive Disease|0|||
129965374|NCT00474383|467836997|FG000|Main Study|Other|1|||
129965375|NCT00474383|467836998|FG001|Main Study|Other|0|||
129965376|NCT00474383|467836997|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
129965377|NCT00474383|467836998|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
129965378|NCT00474383|467836997|FG000|Extension|Progressive Disease|0|||
129965379|NCT00474383|467836998|FG001|Extension|Progressive Disease|5|||
129965380|NCT02998918|467836999|FG000|Overall Study|Withdrawal by Subject|1|||
129965381|NCT02998918|467837000|FG001|Overall Study|Withdrawal by Subject|0|||
129965382|NCT00443599|467837008|FG000|Overall Study|Physician Decision|2|||
129965383|NCT00443599|467837009|FG001|Overall Study|Physician Decision|1|||
129965384|NCT00443599|467837008|FG000|Overall Study|Death|1|||
129965385|NCT00443599|467837009|FG001|Overall Study|Death|1|||
129965386|NCT00443599|467837008|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
129965387|NCT00443599|467837009|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
129965388|NCT04811339|467837010|FG000|Overall Study|lack of transportation not wanting to return|4|||
129965389|NCT04811339|467837011|FG001|Overall Study|lack of transportation not wanting to return|8|||
129965390|NCT04811339|467837012|FG002|Overall Study|lack of transportation not wanting to return|0|||
129965391|NCT04811339|467837010|FG000|Overall Study|Adverse Event|3|||
129965392|NCT04811339|467837011|FG001|Overall Study|Adverse Event|0|||
129965393|NCT04811339|467837012|FG002|Overall Study|Adverse Event|0|||
129965394|NCT04811339|467837010|FG000|Overall Study|Lost to Follow-up|1|||
129965395|NCT04811339|467837011|FG001|Overall Study|Lost to Follow-up|0|||
129965396|NCT04811339|467837012|FG002|Overall Study|Lost to Follow-up|0|||
129965397|NCT04811339|467837010|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
129965398|NCT04811339|467837011|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
129965399|NCT04811339|467837012|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
129965400|NCT04811339|467837010|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
129965401|NCT04811339|467837011|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
129965402|NCT04811339|467837012|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
129965403|NCT04811339|467837010|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
129965404|NCT04811339|467837011|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
129965405|NCT04811339|467837012|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
129965406|NCT04811339|467837010|FG000|Overall Study|Withdrawal by Subject|0|||
129965407|NCT04811339|467837011|FG001|Overall Study|Withdrawal by Subject|3|||
129965408|NCT04811339|467837012|FG002|Overall Study|Withdrawal by Subject|0|||
129965409|NCT04811339|467837010|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
129965410|NCT04811339|467837011|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
129965411|NCT04811339|467837012|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
129965412|NCT04811339|467837010|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
129965413|NCT04811339|467837011|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
129965414|NCT04811339|467837012|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
129965415|NCT01986114|467839001|FG000|Overall Study|Adverse Event|59|||
129965416|NCT01986114|467839001|FG000|Overall Study|Lack of Efficacy|23|||
129965417|NCT01986114|467839001|FG000|Overall Study|Withdrawal by Subject|58|||
129965418|NCT01986114|467839001|FG000|Overall Study|Noncompliance|3|||
130091985|NCT05602818|468292533|FG010|Qualification Phase (3 Days)|Other|0|||
130091986|NCT05602818|468292534|FG011|Qualification Phase (3 Days)|Other|0|||
129965419|NCT01986114|467839001|FG000|Overall Study|Protocol Violation|1|||
129965420|NCT01986114|467839001|FG000|Overall Study|Lost to Follow-up|5|||
129965421|NCT01986114|467839001|FG000|Overall Study|Other reason|7|||
129965422|NCT02808975|467839002|FG000|Overall Study|Adverse Event|3|||
129965423|NCT02808975|467839003|FG001|Overall Study|Adverse Event|4|||
129965424|NCT02808975|467839002|FG000|Overall Study|Withdrew consent|9|||
129965425|NCT02808975|467839003|FG001|Overall Study|Withdrew consent|8|||
129965426|NCT02808975|467839002|FG000|Overall Study|Lost to Follow-up|4|||
129965427|NCT02808975|467839003|FG001|Overall Study|Lost to Follow-up|6|||
129965428|NCT02808975|467839002|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
129965429|NCT02808975|467839003|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
129965430|NCT02808975|467839002|FG000|Overall Study|Other, not specified|5|||
129965431|NCT02808975|467839003|FG001|Overall Study|Other, not specified|1|||
129965432|NCT00030823|467839004|FG000|Overall Study|Withdrawal by Subject|1|||
129965433|NCT04333147|467839006|FG000|Overall Study|Adverse Event|43|||
129965434|NCT04333147|467839007|FG001|Overall Study|Adverse Event|40|||
129965435|NCT04333147|467839006|FG000|Overall Study|Lack of Efficacy|49|||
129965436|NCT04333147|467839007|FG001|Overall Study|Lack of Efficacy|48|||
129965437|NCT04333147|467839006|FG000|Overall Study|Lost to Follow-up|19|||
129965438|NCT04333147|467839007|FG001|Overall Study|Lost to Follow-up|16|||
129965439|NCT04333147|467839006|FG000|Overall Study|Physician Decision|17|||
129965440|NCT04333147|467839007|FG001|Overall Study|Physician Decision|20|||
129965441|NCT04333147|467839006|FG000|Overall Study|Withdrawal by Subject|65|||
129965442|NCT04333147|467839007|FG001|Overall Study|Withdrawal by Subject|68|||
129965443|NCT04333147|467839006|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
129965444|NCT04333147|467839007|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
129965445|NCT04333147|467839006|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
129965446|NCT04333147|467839007|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
129965447|NCT04333147|467839006|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
129965448|NCT04333147|467839007|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
129965449|NCT02106195|467839008|FG000|Overall Study|Adverse Event|2|||
129965450|NCT02106195|467839008|FG000|Overall Study|Protocol Violation|1|||
129965451|NCT03062449|467839009|FG000|Overall Study|Withdrawal by Subject|7|||
129965452|NCT03062449|467839010|FG001|Overall Study|Withdrawal by Subject|1|||
129965453|NCT04702893|467839012|FG000|Overall Study|Other reasons than listed|11|||
129965454|NCT04702893|467839012|FG000|Overall Study|Withdrawal by Subject|3|||
129965455|NCT04702893|467839012|FG000|Overall Study|Lost to Follow-up|7|||
130122381|NCT00950807|468408823|FG003|Washout Period 2|Lack of Efficacy|0|||
130122382|NCT00950807|468408824|FG004|Washout Period 2|Lack of Efficacy|0|||
130122383|NCT00950807|468408825|FG005|Washout Period 2|Lack of Efficacy|0|||
130122384|NCT00950807|468408826|FG006|Washout Period 2|Lack of Efficacy|0|||
130122385|NCT00950807|468408827|FG007|Washout Period 2|Lack of Efficacy|0|||
130122386|NCT00950807|468408828|FG008|Washout Period 2|Lack of Efficacy|0|||
130122387|NCT00950807|468408829|FG009|Washout Period 2|Lack of Efficacy|0|||
130122388|NCT00950807|468408820|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130122389|NCT00950807|468408821|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130122390|NCT00950807|468408822|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130122391|NCT00950807|468408823|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130122392|NCT00950807|468408824|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130122393|NCT00950807|468408825|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130122394|NCT00950807|468408826|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130122395|NCT00950807|468408827|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
130122396|NCT00950807|468408828|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130122397|NCT00950807|468408829|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
130122398|NCT00950807|468408820|FG000|Washout Period 2|Adverse Event|3|||
130122399|NCT00950807|468408821|FG001|Washout Period 2|Adverse Event|0|||
130122400|NCT00950807|468408822|FG002|Washout Period 2|Adverse Event|0|||
130122401|NCT00950807|468408823|FG003|Washout Period 2|Adverse Event|1|||
130122402|NCT00950807|468408824|FG004|Washout Period 2|Adverse Event|0|||
130122403|NCT00950807|468408825|FG005|Washout Period 2|Adverse Event|0|||
130122404|NCT00950807|468408826|FG006|Washout Period 2|Adverse Event|0|||
130122405|NCT00950807|468408827|FG007|Washout Period 2|Adverse Event|0|||
130122406|NCT00950807|468408828|FG008|Washout Period 2|Adverse Event|0|||
130122407|NCT00950807|468408829|FG009|Washout Period 2|Adverse Event|0|||
130122408|NCT00950807|468408820|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130122409|NCT00950807|468408821|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130122410|NCT00950807|468408822|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130122411|NCT00950807|468408823|FG003|Treatment Period 3|Withdrawal by Subject|0|||
130122412|NCT00950807|468408824|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130122413|NCT00950807|468408825|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130122414|NCT00950807|468408826|FG006|Treatment Period 3|Withdrawal by Subject|0|||
130122415|NCT00950807|468408827|FG007|Treatment Period 3|Withdrawal by Subject|0|||
130122416|NCT00950807|468408828|FG008|Treatment Period 3|Withdrawal by Subject|0|||
130122417|NCT00950807|468408829|FG009|Treatment Period 3|Withdrawal by Subject|1|||
130122418|NCT00950807|468408820|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
130122419|NCT00950807|468408821|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122420|NCT00950807|468408822|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129965456|NCT04702893|467839012|FG000|Overall Study|Death|10|||
129965457|NCT04702893|467839012|FG000|Overall Study|Not treated|6|||
129965458|NCT00408928|467839013|FG000|Overall Study|Withdrawal by Subject|1|||
129965459|NCT00408928|467839013|FG000|Overall Study|Death|1|||
129965460|NCT00408928|467839013|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
129965461|NCT04469465|467839014|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
129965462|NCT04469465|467839015|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
129965463|NCT04469465|467839014|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
129965464|NCT04469465|467839015|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
129965465|NCT04469465|467839014|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
129965466|NCT04469465|467839015|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
129965467|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
129965468|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
129965469|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
129965470|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
129965471|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
129965472|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
129965473|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Death|0|||
129965474|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Death|1|||
129965475|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
129965476|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
129965477|NCT03194867|467839016|FG000|Overall Study|Incorrect completion of end of study form|0|||
129965478|NCT03194867|467839017|FG001|Overall Study|Incorrect completion of end of study form|0|||
129965479|NCT03194867|467839018|FG002|Overall Study|Incorrect completion of end of study form|1|||
129965480|NCT03194867|467839019|FG003|Overall Study|Incorrect completion of end of study form|0|||
129965481|NCT03305809|467839020|FG000|Overall Study|Adverse Event|2|||
129965482|NCT03305809|467839021|FG001|Overall Study|Adverse Event|2|||
129965483|NCT03305809|467839022|FG002|Overall Study|Adverse Event|6|||
129965484|NCT03305809|467839023|FG003|Overall Study|Adverse Event|6|||
129965485|NCT03305809|467839020|FG000|Overall Study|Death|0|||
129965486|NCT03305809|467839021|FG001|Overall Study|Death|0|||
129965487|NCT03305809|467839022|FG002|Overall Study|Death|1|||
129965488|NCT03305809|467839023|FG003|Overall Study|Death|1|||
129965489|NCT03305809|467839020|FG000|Overall Study|Lost to Follow-up|1|||
129965490|NCT03305809|467839021|FG001|Overall Study|Lost to Follow-up|2|||
129965491|NCT03305809|467839022|FG002|Overall Study|Lost to Follow-up|0|||
129965492|NCT03305809|467839023|FG003|Overall Study|Lost to Follow-up|0|||
129965493|NCT03305809|467839020|FG000|Overall Study|Sponsor Decision|1|||
129965494|NCT03305809|467839021|FG001|Overall Study|Sponsor Decision|0|||
129965495|NCT03305809|467839022|FG002|Overall Study|Sponsor Decision|1|||
129965496|NCT03305809|467839023|FG003|Overall Study|Sponsor Decision|8|||
129965497|NCT03305809|467839020|FG000|Overall Study|Physician Decision|0|||
129965498|NCT03305809|467839021|FG001|Overall Study|Physician Decision|0|||
129965499|NCT03305809|467839022|FG002|Overall Study|Physician Decision|2|||
129965500|NCT03305809|467839023|FG003|Overall Study|Physician Decision|4|||
129965501|NCT03305809|467839020|FG000|Overall Study|Progressive Disease|0|||
129965502|NCT03305809|467839021|FG001|Overall Study|Progressive Disease|0|||
129965503|NCT03305809|467839022|FG002|Overall Study|Progressive Disease|1|||
129965504|NCT03305809|467839023|FG003|Overall Study|Progressive Disease|0|||
129965505|NCT03305809|467839020|FG000|Overall Study|Protocol Violation|1|||
129965506|NCT03305809|467839021|FG001|Overall Study|Protocol Violation|0|||
129965507|NCT03305809|467839022|FG002|Overall Study|Protocol Violation|2|||
129965508|NCT03305809|467839023|FG003|Overall Study|Protocol Violation|3|||
129965509|NCT03305809|467839020|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
129965510|NCT03305809|467839021|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
129965511|NCT03305809|467839022|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
129965512|NCT03305809|467839023|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
129965513|NCT03305809|467839020|FG000|Overall Study|Withdrawal by Subject|2|||
130122421|NCT00950807|468408823|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122422|NCT00950807|468408824|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122423|NCT00950807|468408825|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122424|NCT00950807|468408826|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122425|NCT00950807|468408827|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
130122426|NCT00950807|468408828|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122427|NCT00950807|468408829|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
130122428|NCT00950807|468408820|FG000|Treatment Period 3|Adverse Event|0|||
130122429|NCT00950807|468408821|FG001|Treatment Period 3|Adverse Event|0|||
130122430|NCT00950807|468408822|FG002|Treatment Period 3|Adverse Event|0|||
130122431|NCT00950807|468408823|FG003|Treatment Period 3|Adverse Event|0|||
129965514|NCT03305809|467839021|FG001|Overall Study|Withdrawal by Subject|4|||
129965515|NCT03305809|467839022|FG002|Overall Study|Withdrawal by Subject|5|||
129965516|NCT03305809|467839023|FG003|Overall Study|Withdrawal by Subject|2|||
129965517|NCT03305809|467839020|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
129965518|NCT03305809|467839021|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
129965519|NCT03305809|467839022|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
129965520|NCT03305809|467839023|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
129965521|NCT00816556|467839024|FG000|Overall Study|Adverse Event|1|||
129965522|NCT00816556|467839025|FG001|Overall Study|Adverse Event|1|||
129965523|NCT00816556|467839026|FG002|Overall Study|Adverse Event|1|||
129965524|NCT00816556|467839024|FG000|Overall Study|Withdrawal by Subject|1|||
129965525|NCT00816556|467839025|FG001|Overall Study|Withdrawal by Subject|1|||
129965526|NCT00816556|467839026|FG002|Overall Study|Withdrawal by Subject|1|||
129965527|NCT00816556|467839024|FG000|Overall Study|Lost to Follow-up|0|||
129965528|NCT00816556|467839025|FG001|Overall Study|Lost to Follow-up|0|||
129965529|NCT00816556|467839026|FG002|Overall Study|Lost to Follow-up|1|||
129965530|NCT03546816|467839027|FG000|Overall Study|Adverse Event|5|||
129965531|NCT03546816|467839028|FG001|Overall Study|Adverse Event|3|||
129965532|NCT03546816|467839027|FG000|Overall Study|Lack of Efficacy|2|||
129965533|NCT03546816|467839028|FG001|Overall Study|Lack of Efficacy|4|||
129965534|NCT03546816|467839027|FG000|Overall Study|Pregnancy|1|||
129965535|NCT03546816|467839028|FG001|Overall Study|Pregnancy|0|||
129965536|NCT03546816|467839027|FG000|Overall Study|Physician Decision|2|||
129965537|NCT03546816|467839028|FG001|Overall Study|Physician Decision|0|||
129965538|NCT03546816|467839027|FG000|Overall Study|Withdrawal by Subject|8|||
129965539|NCT03546816|467839028|FG001|Overall Study|Withdrawal by Subject|10|||
129965540|NCT03546816|467839027|FG000|Overall Study|Lost to Follow-up|3|||
129965541|NCT03546816|467839028|FG001|Overall Study|Lost to Follow-up|2|||
129965542|NCT02438371|467839029|FG000|Overall Study|Lost to Follow-up|3|||
129965543|NCT02438371|467839030|FG001|Overall Study|Lost to Follow-up|2|||
129965544|NCT02438371|467839029|FG000|Overall Study|Withdrawal by Subject|1|||
129965545|NCT02438371|467839030|FG001|Overall Study|Withdrawal by Subject|1|||
129965546|NCT01161446|467839031|FG000|Overall Study|Lost to Follow-up|18|||
129965547|NCT01161446|467839032|FG001|Overall Study|Lost to Follow-up|14|||
129965548|NCT01161446|467839031|FG000|Overall Study|Withdrawal by Subject|0|||
129965549|NCT01161446|467839032|FG001|Overall Study|Withdrawal by Subject|1|||
129965550|NCT01660256|467839035|FG000|Overall Study|Adverse Event|4|||
129965551|NCT01660256|467839036|FG001|Overall Study|Adverse Event|0|||
129965552|NCT01660256|467839037|FG002|Overall Study|Adverse Event|2|||
129965553|NCT01660256|467839035|FG000|Overall Study|Withdrawal by Subject|1|||
129965554|NCT01660256|467839036|FG001|Overall Study|Withdrawal by Subject|0|||
129965555|NCT01660256|467839037|FG002|Overall Study|Withdrawal by Subject|2|||
129965556|NCT01162135|467839039|FG000|Overall Study|Withdrawal by Subject|1|||
129965557|NCT01162135|467839039|FG000|Overall Study|Severe back pain|1|||
129965558|NCT01162135|467839039|FG000|Overall Study|Ineligible|1|||
129965559|NCT02088554|467839040|FG000|Overall Study|Exited before procedure|130|||
129965560|NCT02088554|467839040|FG000|Overall Study|Attempted but not implanted|31|||
129965561|NCT02088554|467839040|FG000|Overall Study|Implant not attempted|19|||
129965562|NCT02088554|467839040|FG000|Overall Study|Pending next visit|532|||
129965563|NCT02088554|467839040|FG000|Overall Study|Death|170|||
129965564|NCT02088554|467839040|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
129965565|NCT02088554|467839040|FG000|Overall Study|Lost to Follow-up|23|||
129965566|NCT02088554|467839040|FG000|Overall Study|Explanted|32|||
129965567|NCT02088554|467839040|FG000|Overall Study|Any other reason not covered by previous categories|11|||
129965568|NCT00551135|467839041|FG000|Overall Study|Adverse Event|1|||
129965569|NCT00551135|467839042|FG001|Overall Study|Adverse Event|0|||
129965570|NCT00551135|467839043|FG002|Overall Study|Adverse Event|1|||
129965571|NCT00551135|467839044|FG003|Overall Study|Adverse Event|1|||
129965572|NCT00551135|467839041|FG000|Overall Study|Lost to Follow-up|0|||
129965573|NCT00551135|467839042|FG001|Overall Study|Lost to Follow-up|0|||
129965574|NCT00551135|467839043|FG002|Overall Study|Lost to Follow-up|0|||
129965575|NCT00551135|467839044|FG003|Overall Study|Lost to Follow-up|1|||
129965576|NCT00551135|467839041|FG000|Overall Study|Other|3|||
129965577|NCT00551135|467839042|FG001|Overall Study|Other|2|||
129965578|NCT00551135|467839043|FG002|Overall Study|Other|1|||
129965579|NCT00551135|467839044|FG003|Overall Study|Other|2|||
129965580|NCT00551135|467839041|FG000|Overall Study|Withdrawal by Subject|1|||
129965581|NCT00551135|467839042|FG001|Overall Study|Withdrawal by Subject|0|||
129965582|NCT00551135|467839043|FG002|Overall Study|Withdrawal by Subject|3|||
129965583|NCT00551135|467839044|FG003|Overall Study|Withdrawal by Subject|1|||
129965584|NCT00858247|467839045|FG000|Baseline Assessment|Withdrawal by Subject|1|||
129965585|NCT00858247|467839046|FG001|Baseline Assessment|Withdrawal by Subject|1|||
129965586|NCT00858247|467839045|FG000|Baseline Assessment|Poor IV access|1|||
129965587|NCT00858247|467839046|FG001|Baseline Assessment|Poor IV access|0|||
129965588|NCT00858247|467839045|FG000|Baseline Assessment|Protocol Violation|0|||
129965589|NCT00858247|467839046|FG001|Baseline Assessment|Protocol Violation|1|||
129965590|NCT00858247|467839045|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
129965591|NCT00858247|467839046|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
129965592|NCT03898960|467839049|FG000|Overall Study|Death|10|||
129965593|NCT00548847|467839050|FG000|Overall Study|Disease progression|7|||
129965594|NCT01379703|467839051|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
129965595|NCT01379703|467839052|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
129965596|NCT01379703|467839053|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
129965597|NCT01379703|467839051|FG000|Study Start Through 9 Months|Adverse Event|0|||
129965598|NCT01379703|467839052|FG001|Study Start Through 9 Months|Adverse Event|14|||
129965599|NCT01379703|467839053|FG002|Study Start Through 9 Months|Adverse Event|10|||
129965600|NCT01379703|467839051|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
129965601|NCT01379703|467839052|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
130122432|NCT00950807|468408824|FG004|Treatment Period 3|Adverse Event|0|||
130122433|NCT00950807|468408825|FG005|Treatment Period 3|Adverse Event|0|||
130122434|NCT00950807|468408826|FG006|Treatment Period 3|Adverse Event|1|||
130122435|NCT00950807|468408827|FG007|Treatment Period 3|Adverse Event|0|||
130122436|NCT00950807|468408828|FG008|Treatment Period 3|Adverse Event|0|||
130122437|NCT00950807|468408829|FG009|Treatment Period 3|Adverse Event|0|||
130122438|NCT00337077|468408830|FG000|Overall Study|Progressive disease|25|||
130122439|NCT00337077|468408831|FG001|Overall Study|Progressive disease|37|||
130122440|NCT00337077|468408832|FG002|Overall Study|Progressive disease|19|||
130122441|NCT00337077|468408830|FG000|Overall Study|Adverse Event|7|||
130122442|NCT00337077|468408831|FG001|Overall Study|Adverse Event|7|||
130122443|NCT00337077|468408832|FG002|Overall Study|Adverse Event|1|||
130122444|NCT00337077|468408830|FG000|Overall Study|Death|0|||
130122445|NCT00337077|468408831|FG001|Overall Study|Death|1|||
130122446|NCT00337077|468408832|FG002|Overall Study|Death|0|||
130122447|NCT00337077|468408830|FG000|Overall Study|Withdrawal by Subject|7|||
130122448|NCT00337077|468408831|FG001|Overall Study|Withdrawal by Subject|2|||
130122449|NCT00337077|468408832|FG002|Overall Study|Withdrawal by Subject|2|||
130122450|NCT00337077|468408830|FG000|Overall Study|Alternative therapy|1|||
130122451|NCT00337077|468408831|FG001|Overall Study|Alternative therapy|0|||
130122452|NCT00337077|468408832|FG002|Overall Study|Alternative therapy|0|||
129965602|NCT01379703|467839053|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
129965603|NCT01379703|467839051|FG000|Study Start Through 9 Months|Treatment Failure|0|||
129965604|NCT01379703|467839052|FG001|Study Start Through 9 Months|Treatment Failure|2|||
129965605|NCT01379703|467839053|FG002|Study Start Through 9 Months|Treatment Failure|2|||
129965606|NCT01379703|467839051|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
129965607|NCT01379703|467839052|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
129965608|NCT01379703|467839053|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
129965609|NCT01379703|467839051|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
129965610|NCT01379703|467839052|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
129965611|NCT01379703|467839053|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
129965612|NCT01379703|467839051|FG000|Study Start Through 9 Months|Medication not available|0|||
129965613|NCT01379703|467839052|FG001|Study Start Through 9 Months|Medication not available|2|||
129965614|NCT01379703|467839053|FG002|Study Start Through 9 Months|Medication not available|1|||
129965615|NCT01379703|467839051|FG000|Study Start Through 9 Months|Poor general condition|0|||
129965616|NCT01379703|467839052|FG001|Study Start Through 9 Months|Poor general condition|1|||
129965617|NCT01379703|467839053|FG002|Study Start Through 9 Months|Poor general condition|0|||
129965618|NCT01379703|467839051|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
129965619|NCT01379703|467839052|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
129965620|NCT01379703|467839053|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
129965621|NCT01379703|467839051|FG000|Study Start Through 9 Months|Reason unknown|2|||
129965622|NCT01379703|467839052|FG001|Study Start Through 9 Months|Reason unknown|31|||
129965623|NCT01379703|467839053|FG002|Study Start Through 9 Months|Reason unknown|24|||
129965624|NCT01379703|467839051|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
129965625|NCT01379703|467839052|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
129965626|NCT01379703|467839053|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
129965627|NCT01379703|467839051|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
129965628|NCT01379703|467839052|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
129965629|NCT01379703|467839053|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
129965630|NCT01379703|467839051|FG000|9 Months Through 18 Months|Adverse Event|0|||
129965631|NCT01379703|467839052|FG001|9 Months Through 18 Months|Adverse Event|6|||
129965632|NCT01379703|467839053|FG002|9 Months Through 18 Months|Adverse Event|0|||
129965633|NCT01379703|467839051|FG000|9 Months Through 18 Months|Treatment failure|0|||
129965634|NCT01379703|467839052|FG001|9 Months Through 18 Months|Treatment failure|5|||
129965635|NCT01379703|467839053|FG002|9 Months Through 18 Months|Treatment failure|0|||
129965636|NCT01379703|467839051|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
129965637|NCT01379703|467839052|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
129965638|NCT01379703|467839053|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
129965639|NCT01379703|467839051|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
130122453|NCT00337077|468408830|FG000|Overall Study|Physician Decision|1|||
130122454|NCT00337077|468408831|FG001|Overall Study|Physician Decision|4|||
130122455|NCT00337077|468408832|FG002|Overall Study|Physician Decision|2|||
130122456|NCT00337077|468408830|FG000|Overall Study|Never started treatment|1|||
130122457|NCT00337077|468408831|FG001|Overall Study|Never started treatment|1|||
130122458|NCT00337077|468408832|FG002|Overall Study|Never started treatment|0|||
130122459|NCT00337077|468408830|FG000|Overall Study|Ineligible|1|||
129965640|NCT01379703|467839052|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
129965641|NCT01379703|467839053|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
129965642|NCT01379703|467839051|FG000|9 Months Through 18 Months|Fatigue|0|||
129965643|NCT01379703|467839052|FG001|9 Months Through 18 Months|Fatigue|1|||
129965644|NCT01379703|467839053|FG002|9 Months Through 18 Months|Fatigue|0|||
129965645|NCT01379703|467839051|FG000|9 Months Through 18 Months|Reason Unknown|0|||
130122460|NCT00337077|468408831|FG001|Overall Study|Ineligible|1|||
129965646|NCT01379703|467839052|FG001|9 Months Through 18 Months|Reason Unknown|23|||
129965647|NCT01379703|467839053|FG002|9 Months Through 18 Months|Reason Unknown|0|||
129965648|NCT01316887|467839054|FG000|Overall Study|Adverse Event|13|||
130091987|NCT05602818|468292523|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091988|NCT05602818|468292524|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
130091989|NCT05602818|468292525|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091990|NCT05602818|468292526|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091991|NCT05602818|468292527|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091992|NCT05602818|468292528|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091993|NCT05602818|468292529|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091994|NCT05602818|468292530|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091995|NCT05602818|468292531|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091996|NCT05602818|468292532|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091997|NCT05602818|468292533|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091998|NCT05602818|468292534|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
130091999|NCT05602818|468292523|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
130092000|NCT05602818|468292524|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
130092001|NCT05602818|468292525|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
130092002|NCT05602818|468292526|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
130092003|NCT05602818|468292527|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
130092004|NCT05602818|468292528|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
130092005|NCT05602818|468292529|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
130092006|NCT05602818|468292530|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
130092007|NCT05602818|468292531|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
130092008|NCT05602818|468292532|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
130092009|NCT05602818|468292533|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
130092010|NCT05602818|468292534|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
130092011|NCT05602818|468292523|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092012|NCT05602818|468292524|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092013|NCT05602818|468292525|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092014|NCT05602818|468292526|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092015|NCT05602818|468292527|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092016|NCT05602818|468292528|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092017|NCT05602818|468292529|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092018|NCT05602818|468292530|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092019|NCT05602818|468292531|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092020|NCT05602818|468292532|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
130092021|NCT05602818|468292533|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
130092022|NCT05602818|468292534|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
130092023|NCT05602818|468292523|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
130092024|NCT05602818|468292524|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
130092025|NCT05602818|468292525|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
130092026|NCT05602818|468292526|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
130092027|NCT05602818|468292527|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
130092028|NCT05602818|468292528|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
130092029|NCT05602818|468292529|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
130092030|NCT05602818|468292530|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
130092031|NCT05602818|468292531|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
130092032|NCT05602818|468292532|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
130092033|NCT05602818|468292533|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
130092034|NCT05602818|468292534|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
130092035|NCT04594213|468292539|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
130092036|NCT04594213|468292540|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
130092037|NCT04594213|468292541|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
130092038|NCT04594213|468292542|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130092039|NCT04594213|468292543|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130092040|NCT04594213|468292544|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
130092041|NCT04594213|468292539|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130092042|NCT04594213|468292540|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
130092043|NCT04594213|468292541|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130092044|NCT04594213|468292542|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130092045|NCT04594213|468292543|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130092046|NCT04594213|468292544|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
130092047|NCT04594213|468292539|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
130092048|NCT04594213|468292540|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130092049|NCT04594213|468292541|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
130092050|NCT04594213|468292542|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130122461|NCT00337077|468408832|FG002|Overall Study|Ineligible|1|||
130122462|NCT04646109|468408841|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
130122463|NCT04646109|468408842|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
130122464|NCT03815942|468410506|FG000|Overall Study|Withdrawal by Subject|0|||
130122465|NCT03815942|468410507|FG001|Overall Study|Withdrawal by Subject|17|||
130122466|NCT02785913|468410508|FG000|Overall Study|Adverse Event|5|||
130122467|NCT02785913|468410508|FG000|Overall Study|Death|2|||
130122468|NCT02785913|468410508|FG000|Overall Study|Progression|18|||
130122469|NCT02785913|468410508|FG000|Overall Study|Not protocol specified|1|||
130122470|NCT03717064|468410509|FG000|Period 2|Adverse Event|1|||
130122471|NCT02841709|468410510|FG000|5th Intervention|Adverse Event|2|||
130122472|NCT02841709|468410511|FG001|5th Intervention|Adverse Event|0|||
130122473|NCT02841709|468410512|FG002|5th Intervention|Adverse Event|0|||
130122474|NCT02841709|468410513|FG003|5th Intervention|Adverse Event|0|||
130122475|NCT02841709|468410514|FG004|5th Intervention|Adverse Event|2|||
130122476|NCT01929109|468410515|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
130122477|NCT01929109|468410516|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
130122478|NCT01929109|468410517|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
130122479|NCT01929109|468410518|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
130122480|NCT01929109|468410519|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
130122481|NCT00076102|468410520|FG000|Overall Study|Clinical progression|1|||
130122482|NCT00076102|468410520|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
130122483|NCT00076102|468410520|FG000|Overall Study|plexiform neurofibroma surgery|1|||
130122484|NCT00076102|468410520|FG000|Overall Study|refusal of further therapy|2|||
130122485|NCT01402908|468410523|FG000|Overall Study|Withdrawal by Subject|30|||
130122486|NCT01402908|468410524|FG001|Overall Study|Withdrawal by Subject|17|||
130122487|NCT01402908|468410523|FG000|Overall Study|Lost to Follow-up|3|||
130122488|NCT01402908|468410524|FG001|Overall Study|Lost to Follow-up|1|||
130122489|NCT01402908|468410523|FG000|Overall Study|Physician Decision|1|||
130122490|NCT01402908|468410524|FG001|Overall Study|Physician Decision|0|||
130122491|NCT02581345|468410525|FG000|Part 1: up to Week 16|Adverse Event|3|||
130122492|NCT02581345|468410526|FG001|Part 1: up to Week 16|Adverse Event|8|||
130122493|NCT02581345|468410527|FG002|Part 1: up to Week 16|Adverse Event|0|||
130122494|NCT02581345|468410528|FG003|Part 1: up to Week 16|Adverse Event|0|||
130122495|NCT02581345|468410525|FG000|Part 1: up to Week 16|Physician Decision|2|||
130122496|NCT02581345|468410526|FG001|Part 1: up to Week 16|Physician Decision|4|||
130122497|NCT02581345|468410527|FG002|Part 1: up to Week 16|Physician Decision|0|||
130122498|NCT02581345|468410528|FG003|Part 1: up to Week 16|Physician Decision|0|||
130122499|NCT02581345|468410525|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
130122500|NCT02581345|468410526|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
130122501|NCT02581345|468410527|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
130122502|NCT02581345|468410528|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
130122503|NCT02581345|468410525|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
130122504|NCT02581345|468410526|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
130122505|NCT02581345|468410527|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
130122506|NCT02581345|468410528|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
130122507|NCT02581345|468410525|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
130122508|NCT02581345|468410526|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
130122509|NCT02581345|468410527|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
129965649|NCT01316887|467839055|FG001|Overall Study|Adverse Event|21|||
129965650|NCT01316887|467839056|FG002|Overall Study|Adverse Event|17|||
129965651|NCT01316887|467839054|FG000|Overall Study|Lack of Efficacy|9|||
129965652|NCT01316887|467839055|FG001|Overall Study|Lack of Efficacy|3|||
129965653|NCT01316887|467839056|FG002|Overall Study|Lack of Efficacy|1|||
129965654|NCT01316887|467839054|FG000|Overall Study|Protocol Violation|2|||
129965655|NCT01316887|467839055|FG001|Overall Study|Protocol Violation|6|||
129965656|NCT01316887|467839056|FG002|Overall Study|Protocol Violation|6|||
129965657|NCT01316887|467839054|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
129965658|NCT01316887|467839055|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
129965659|NCT01316887|467839056|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
129965660|NCT01316887|467839054|FG000|Overall Study|Study Closed/Terminated|2|||
130122510|NCT02581345|468410528|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
130122511|NCT02581345|468410525|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
130122512|NCT02581345|468410526|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
130122513|NCT02581345|468410527|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
130122514|NCT02581345|468410528|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
130122515|NCT02581345|468410525|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
130122516|NCT02581345|468410526|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
130122517|NCT02581345|468410527|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
130122518|NCT02581345|468410528|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
129965661|NCT01316887|467839055|FG001|Overall Study|Study Closed/Terminated|4|||
129965662|NCT01316887|467839056|FG002|Overall Study|Study Closed/Terminated|3|||
129965663|NCT01316887|467839054|FG000|Overall Study|Lost to Follow-up|1|||
129965664|NCT01316887|467839055|FG001|Overall Study|Lost to Follow-up|7|||
129965665|NCT01316887|467839056|FG002|Overall Study|Lost to Follow-up|5|||
129965666|NCT01316887|467839054|FG000|Overall Study|Withdrawal by Subject|8|||
129965667|NCT01316887|467839055|FG001|Overall Study|Withdrawal by Subject|16|||
129965668|NCT01316887|467839056|FG002|Overall Study|Withdrawal by Subject|15|||
129965669|NCT00813098|467839059|FG000|Overall Study|Adverse Event|2|||
129965670|NCT00813098|467839060|FG001|Overall Study|Adverse Event|4|||
129965671|NCT00813098|467839061|FG002|Overall Study|Adverse Event|1|||
129965672|NCT00813098|467839059|FG000|Overall Study|Withdrawal by Subject|0|||
129965673|NCT00813098|467839060|FG001|Overall Study|Withdrawal by Subject|1|||
129965674|NCT00813098|467839061|FG002|Overall Study|Withdrawal by Subject|0|||
129965675|NCT00813098|467839059|FG000|Overall Study|Inability to complete study procedures|1|||
129965676|NCT00813098|467839060|FG001|Overall Study|Inability to complete study procedures|0|||
129965677|NCT00813098|467839061|FG002|Overall Study|Inability to complete study procedures|0|||
129965678|NCT00813098|467839059|FG000|Overall Study|Lost to Follow-up|0|||
129965679|NCT00813098|467839060|FG001|Overall Study|Lost to Follow-up|1|||
129965680|NCT00813098|467839061|FG002|Overall Study|Lost to Follow-up|0|||
129965681|NCT00813098|467839059|FG000|Overall Study|Protocol Violation|0|||
129965682|NCT00813098|467839060|FG001|Overall Study|Protocol Violation|0|||
129965683|NCT00813098|467839061|FG002|Overall Study|Protocol Violation|1|||
129965684|NCT00813098|467839059|FG000|Overall Study|Principal Investigator decision|0|||
129965685|NCT00813098|467839060|FG001|Overall Study|Principal Investigator decision|1|||
129965686|NCT00813098|467839061|FG002|Overall Study|Principal Investigator decision|0|||
129965687|NCT00813098|467839059|FG000|Overall Study|Withdrew Consent|0|||
129965688|NCT00813098|467839060|FG001|Overall Study|Withdrew Consent|1|||
129965689|NCT00813098|467839061|FG002|Overall Study|Withdrew Consent|0|||
129965690|NCT03470545|467839064|FG000|Overall Study|Death|0|||
129965691|NCT03470545|467839065|FG001|Overall Study|Death|1|||
129965692|NCT03470545|467839064|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
129965693|NCT03470545|467839065|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
129965694|NCT03470545|467839064|FG000|Overall Study|Adverse Event|2|||
129965695|NCT03470545|467839065|FG001|Overall Study|Adverse Event|0|||
129965696|NCT03470545|467839064|FG000|Overall Study|Withdrawal by Subject|1|||
129965697|NCT03470545|467839065|FG001|Overall Study|Withdrawal by Subject|1|||
129965698|NCT03470545|467839064|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
129965699|NCT03470545|467839065|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
129965700|NCT00585975|467839066|FG000|Overall Study|Withdrawal by Subject|3|||
129965701|NCT00585975|467839067|FG001|Overall Study|Withdrawal by Subject|3|||
129965702|NCT00585975|467839066|FG000|Overall Study|Lost to Follow-up|2|||
129965703|NCT00585975|467839067|FG001|Overall Study|Lost to Follow-up|1|||
129965704|NCT00585975|467839066|FG000|Overall Study|Enrollment met/over-enrolled|10|||
129965705|NCT00585975|467839067|FG001|Overall Study|Enrollment met/over-enrolled|9|||
129965706|NCT01772563|467839068|FG000|Cycle 1|Dose limiting toxicity|2|||
129965707|NCT01772563|467839068|FG000|Cycle 1|Progressive disease|2|||
129965708|NCT01772563|467839068|FG000|Cycle 2 and Beyond|Progressive disease|17|||
129965709|NCT01772563|467839068|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
129965710|NCT01772563|467839068|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
129965711|NCT01192776|467839069|FG000|Overall Study|Death|8|||
129965712|NCT01192776|467839070|FG001|Overall Study|Death|15|||
129965713|NCT01192776|467839071|FG002|Overall Study|Death|18|||
129965714|NCT01192776|467839072|FG003|Overall Study|Death|15|||
129965715|NCT01192776|467839069|FG000|Overall Study|Lost to Follow-up|3|||
129965716|NCT01192776|467839070|FG001|Overall Study|Lost to Follow-up|6|||
129965717|NCT01192776|467839071|FG002|Overall Study|Lost to Follow-up|3|||
130122519|NCT02581345|468410525|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
130122520|NCT02581345|468410526|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
130122521|NCT02581345|468410527|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
130122522|NCT02581345|468410528|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
130122523|NCT02581345|468410525|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
130122524|NCT02581345|468410526|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
129965718|NCT01192776|467839072|FG003|Overall Study|Lost to Follow-up|5|||
129965719|NCT01086384|467839075|FG000|2-week Run-in Period|Adverse Event|1|||
129965720|NCT01086384|467839076|FG001|2-week Run-in Period|Adverse Event|0|||
129965721|NCT01086384|467839077|FG002|2-week Run-in Period|Adverse Event|0|||
129965722|NCT01086384|467839075|FG000|2-week Run-in Period|Protocol Violation|1|||
129965723|NCT01086384|467839076|FG001|2-week Run-in Period|Protocol Violation|0|||
129965724|NCT01086384|467839077|FG002|2-week Run-in Period|Protocol Violation|0|||
129965725|NCT01086384|467839075|FG000|2-week Run-in Period|Lost to Follow-up|1|||
129965726|NCT01086384|467839076|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129965727|NCT01086384|467839077|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129965728|NCT01086384|467839075|FG000|2-week Run-in Period|Physician Decision|6|||
129965729|NCT01086384|467839076|FG001|2-week Run-in Period|Physician Decision|0|||
129965730|NCT01086384|467839077|FG002|2-week Run-in Period|Physician Decision|0|||
129965731|NCT01086384|467839075|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
129965732|NCT01086384|467839076|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129965733|NCT01086384|467839077|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129965734|NCT01086384|467839075|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
129965735|NCT01086384|467839076|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
129965736|NCT01086384|467839077|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
129965737|NCT01086384|467839075|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
129965738|NCT01086384|467839076|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
129965739|NCT01086384|467839077|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
129965740|NCT01086384|467839075|FG000|2-week Run-in Period|Randomized in Error|1|||
129965741|NCT01086384|467839076|FG001|2-week Run-in Period|Randomized in Error|0|||
129965742|NCT01086384|467839077|FG002|2-week Run-in Period|Randomized in Error|0|||
129965743|NCT01086384|467839075|FG000|Treatment Period|Withdrawal by Subject|0|||
129965744|NCT01086384|467839076|FG001|Treatment Period|Withdrawal by Subject|53|||
129965745|NCT01086384|467839077|FG002|Treatment Period|Withdrawal by Subject|55|||
129965746|NCT01086384|467839075|FG000|Treatment Period|Protocol Violation|0|||
129965747|NCT01086384|467839076|FG001|Treatment Period|Protocol Violation|26|||
129965748|NCT01086384|467839077|FG002|Treatment Period|Protocol Violation|17|||
129965749|NCT01086384|467839075|FG000|Treatment Period|Lack of Efficacy|0|||
129965750|NCT01086384|467839076|FG001|Treatment Period|Lack of Efficacy|22|||
129965751|NCT01086384|467839077|FG002|Treatment Period|Lack of Efficacy|13|||
129965752|NCT01086384|467839075|FG000|Treatment Period|Adverse Event|0|||
129965753|NCT01086384|467839076|FG001|Treatment Period|Adverse Event|19|||
129965754|NCT01086384|467839077|FG002|Treatment Period|Adverse Event|15|||
129965755|NCT01086384|467839075|FG000|Treatment Period|Lost to Follow-up|0|||
129965756|NCT01086384|467839076|FG001|Treatment Period|Lost to Follow-up|11|||
129965757|NCT01086384|467839077|FG002|Treatment Period|Lost to Follow-up|9|||
129965758|NCT01086384|467839075|FG000|Treatment Period|Physician Decision|0|||
129965759|NCT01086384|467839076|FG001|Treatment Period|Physician Decision|9|||
129965760|NCT01086384|467839077|FG002|Treatment Period|Physician Decision|6|||
129965761|NCT01086384|467839075|FG000|Treatment Period|Study Closed/Terminated|0|||
129965762|NCT01086384|467839076|FG001|Treatment Period|Study Closed/Terminated|7|||
129965763|NCT01086384|467839077|FG002|Treatment Period|Study Closed/Terminated|8|||
129965764|NCT01086384|467839075|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
129965765|NCT01086384|467839076|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
129965766|NCT01086384|467839077|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
129965767|NCT01086384|467839075|FG000|Treatment Period|Received Treatment in Error|0|||
129965768|NCT01086384|467839076|FG001|Treatment Period|Received Treatment in Error|1|||
129965769|NCT01086384|467839077|FG002|Treatment Period|Received Treatment in Error|0|||
129965770|NCT01747837|467839078|FG000|Overall Study|Lost to Follow-up|5|||
129965771|NCT01747837|467839079|FG001|Overall Study|Lost to Follow-up|2|||
129965772|NCT01747837|467839078|FG000|Overall Study|Death|4|||
129965773|NCT01747837|467839079|FG001|Overall Study|Death|4|||
129965774|NCT01253447|467839081|FG000|Overall Study|Adverse Event|2|||
129965775|NCT00817336|467839082|FG000|Overall Study|Withdrawal by Subject|1|||
129965776|NCT00817336|467839083|FG001|Overall Study|Withdrawal by Subject|1|||
129965777|NCT01435798|467839084|FG000|Overall Study|Withdrawal by Subject|1|||
129965778|NCT01121913|467839087|FG000|First Intervention Period|Adverse Event|0|||
129965779|NCT01121913|467839088|FG001|First Intervention Period|Adverse Event|0|||
129965780|NCT01121913|467839089|FG002|First Intervention Period|Adverse Event|1|||
129965781|NCT01121913|467839090|FG003|First Intervention Period|Adverse Event|0|||
129965782|NCT01121913|467839087|FG000|First Washout Period|Withdrawal by Subject|1|||
129965783|NCT01121913|467839088|FG001|First Washout Period|Withdrawal by Subject|0|||
129965784|NCT01121913|467839089|FG002|First Washout Period|Withdrawal by Subject|0|||
129965785|NCT01121913|467839090|FG003|First Washout Period|Withdrawal by Subject|0|||
129965786|NCT01121913|467839087|FG000|Second Intervention Period|Adverse Event|0|||
129965787|NCT01121913|467839088|FG001|Second Intervention Period|Adverse Event|0|||
129965788|NCT01121913|467839089|FG002|Second Intervention Period|Adverse Event|1|||
129965789|NCT01121913|467839090|FG003|Second Intervention Period|Adverse Event|0|||
129965790|NCT01121913|467839087|FG000|Second Washout Period|Withdrawal by Subject|0|||
129965791|NCT01121913|467839088|FG001|Second Washout Period|Withdrawal by Subject|0|||
129965792|NCT01121913|467839089|FG002|Second Washout Period|Withdrawal by Subject|1|||
129965793|NCT01121913|467839090|FG003|Second Washout Period|Withdrawal by Subject|0|||
129965794|NCT01121913|467839087|FG000|Third Washout Period|Adverse Event|1|||
129965795|NCT01121913|467839088|FG001|Third Washout Period|Adverse Event|0|||
129965796|NCT01121913|467839089|FG002|Third Washout Period|Adverse Event|0|||
129965797|NCT01121913|467839090|FG003|Third Washout Period|Adverse Event|0|||
129965798|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965799|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965800|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
129965801|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965802|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965803|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965804|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
129965805|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965806|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
130122525|NCT02581345|468410527|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
130122526|NCT02581345|468410528|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
130122527|NCT02581345|468410525|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
130122528|NCT02581345|468410526|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
130122529|NCT02581345|468410527|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
130122530|NCT02581345|468410528|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
130122531|NCT02581345|468410525|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
130122532|NCT02581345|468410526|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
130122533|NCT02581345|468410527|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
130122534|NCT02581345|468410528|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
130122535|NCT02581345|468410525|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
130122536|NCT02581345|468410526|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
130122537|NCT02581345|468410527|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
130122538|NCT02581345|468410528|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
130122539|NCT00920140|468410530|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
130122540|NCT00920140|468410531|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
130122541|NCT00920140|468410532|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
130122542|NCT00920140|468410533|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
130122543|NCT00920140|468410534|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
130122544|NCT00920140|468410530|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
130122545|NCT00920140|468410531|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
130122546|NCT00920140|468410532|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130122547|NCT00920140|468410533|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130122548|NCT00920140|468410534|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
130122549|NCT00920140|468410530|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130122550|NCT00920140|468410531|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
130122551|NCT00920140|468410532|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130122552|NCT00920140|468410533|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130122553|NCT00920140|468410534|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
130122554|NCT00920140|468410530|FG000|Phase 2|Adverse Event|0|||
130122555|NCT00920140|468410531|FG001|Phase 2|Adverse Event|0|||
130122556|NCT00920140|468410532|FG002|Phase 2|Adverse Event|14|||
130122557|NCT00920140|468410533|FG003|Phase 2|Adverse Event|2|||
130122558|NCT00920140|468410534|FG004|Phase 2|Adverse Event|3|||
130122559|NCT00920140|468410530|FG000|Phase 2|Lack of Efficacy|0|||
130122560|NCT00920140|468410531|FG001|Phase 2|Lack of Efficacy|0|||
130122561|NCT00920140|468410532|FG002|Phase 2|Lack of Efficacy|29|||
130122562|NCT00920140|468410533|FG003|Phase 2|Lack of Efficacy|14|||
130122563|NCT00920140|468410534|FG004|Phase 2|Lack of Efficacy|5|||
130122564|NCT00920140|468410530|FG000|Phase 2|Lost to Follow-up|0|||
130122565|NCT00920140|468410531|FG001|Phase 2|Lost to Follow-up|0|||
130122566|NCT00920140|468410532|FG002|Phase 2|Lost to Follow-up|0|||
130122567|NCT00920140|468410533|FG003|Phase 2|Lost to Follow-up|1|||
130122568|NCT00920140|468410534|FG004|Phase 2|Lost to Follow-up|0|||
130122569|NCT00920140|468410530|FG000|Phase 2|Physician Decision|0|||
130122570|NCT00920140|468410531|FG001|Phase 2|Physician Decision|0|||
130122571|NCT00920140|468410532|FG002|Phase 2|Physician Decision|3|||
130122572|NCT00920140|468410533|FG003|Phase 2|Physician Decision|3|||
130122573|NCT00920140|468410534|FG004|Phase 2|Physician Decision|2|||
130122574|NCT00920140|468410530|FG000|Phase 2|Withdrawal by Subject|0|||
130122575|NCT00920140|468410531|FG001|Phase 2|Withdrawal by Subject|0|||
130122576|NCT00920140|468410532|FG002|Phase 2|Withdrawal by Subject|4|||
130122577|NCT00920140|468410533|FG003|Phase 2|Withdrawal by Subject|2|||
130122578|NCT00920140|468410534|FG004|Phase 2|Withdrawal by Subject|1|||
129965807|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
129965808|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
129965809|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
129965810|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
129965811|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
129965812|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
129965813|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
129965814|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965815|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965816|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
129965817|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
129965818|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965819|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965820|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965821|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965822|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
130122579|NCT01124149|468410535|FG000|Acute Phase|Withdrawal by Subject|22|||
130122580|NCT01124149|468410535|FG000|Acute Phase|Adverse Event|21|||
130122581|NCT01124149|468410535|FG000|Acute Phase|Lack of Efficacy|17|||
130122582|NCT01124149|468410535|FG000|Acute Phase|Protocol Violation|14|||
130122583|NCT01124149|468410535|FG000|Acute Phase|Lost to Follow-up|2|||
130122584|NCT01124149|468410535|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
130122585|NCT01124149|468410535|FG000|Acute Phase|Sponsor request|1|||
130122586|NCT01124149|468410535|FG000|Acute Phase|UC symptoms not ameliorated|1|||
130122587|NCT01124149|468410535|FG000|Acute Phase|Non-compliance|1|||
130122588|NCT01124149|468410535|FG000|Acute Phase|Low hemoglobin|1|||
130122589|NCT01124149|468410535|FG000|Acute Phase|Travelling to another country|1|||
130122590|NCT01124149|468410535|FG000|Acute Phase|Sponsor decision|1|||
130122591|NCT01124149|468410535|FG000|Maintenance Phase|Lack of Efficacy|40|||
130122592|NCT01124149|468410535|FG000|Maintenance Phase|Adverse Event|24|||
130122593|NCT01124149|468410535|FG000|Maintenance Phase|Lost to Follow-up|15|||
130122594|NCT01124149|468410535|FG000|Maintenance Phase|Withdrawal by Subject|10|||
130122595|NCT01124149|468410535|FG000|Maintenance Phase|Protocol Violation|5|||
130122596|NCT01124149|468410535|FG000|Maintenance Phase|Coordinator error|1|||
130122597|NCT01124149|468410535|FG000|Maintenance Phase|Non-compliance|1|||
130122598|NCT00977106|468410536|FG000|Overall Study|Adverse Event|5|||
130122599|NCT00977106|468410537|FG001|Overall Study|Adverse Event|6|||
130122600|NCT00977106|468410536|FG000|Overall Study|Withdrawal by Subject|2|||
130122601|NCT00977106|468410537|FG001|Overall Study|Withdrawal by Subject|2|||
130122602|NCT00977106|468410536|FG000|Overall Study|Lack of Efficacy|2|||
130122603|NCT00977106|468410537|FG001|Overall Study|Lack of Efficacy|2|||
130122604|NCT00977106|468410536|FG000|Overall Study|Protocol Violation|0|||
130122605|NCT00977106|468410537|FG001|Overall Study|Protocol Violation|1|||
130122606|NCT00977106|468410536|FG000|Overall Study|Other|1|||
130122607|NCT00977106|468410537|FG001|Overall Study|Other|0|||
130122608|NCT01644500|468410538|FG000|Overall Study|Adverse Event|6|||
129965823|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
129965824|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129965825|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129965826|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
129965827|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
129965828|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
129965829|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129965830|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
129965831|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965832|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965833|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965834|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965835|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965836|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
129965837|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965838|NCT00937521|467839092|FG000|Booster Phase|Adverse Event|0|||
129965839|NCT00937521|467839093|FG001|Booster Phase|Adverse Event|0|||
129965840|NCT00937521|467839094|FG002|Booster Phase|Adverse Event|0|||
129965841|NCT00937521|467839095|FG003|Booster Phase|Adverse Event|0|||
129965842|NCT00937521|467839096|FG004|Booster Phase|Adverse Event|0|||
129965843|NCT00937521|467839097|FG005|Booster Phase|Adverse Event|0|||
129965844|NCT00937521|467839098|FG006|Booster Phase|Adverse Event|1|||
129965845|NCT00937521|467839099|FG007|Booster Phase|Adverse Event|0|||
129965846|NCT00937521|467839092|FG000|Booster Phase|Withdrawal by Subject|1|||
129965847|NCT00937521|467839093|FG001|Booster Phase|Withdrawal by Subject|0|||
129965848|NCT00937521|467839094|FG002|Booster Phase|Withdrawal by Subject|0|||
129965849|NCT00937521|467839095|FG003|Booster Phase|Withdrawal by Subject|1|||
129965850|NCT00937521|467839096|FG004|Booster Phase|Withdrawal by Subject|0|||
129965851|NCT00937521|467839097|FG005|Booster Phase|Withdrawal by Subject|0|||
129965852|NCT00937521|467839098|FG006|Booster Phase|Withdrawal by Subject|0|||
129965853|NCT00937521|467839099|FG007|Booster Phase|Withdrawal by Subject|2|||
129965854|NCT00937521|467839092|FG000|Booster Phase|Lost to Follow-up|2|||
130122609|NCT01644500|468410539|FG001|Overall Study|Adverse Event|1|||
129965855|NCT00937521|467839093|FG001|Booster Phase|Lost to Follow-up|2|||
129965856|NCT00937521|467839094|FG002|Booster Phase|Lost to Follow-up|4|||
129965857|NCT00937521|467839095|FG003|Booster Phase|Lost to Follow-up|2|||
129965858|NCT00937521|467839096|FG004|Booster Phase|Lost to Follow-up|4|||
129965859|NCT00937521|467839097|FG005|Booster Phase|Lost to Follow-up|4|||
129965860|NCT00937521|467839098|FG006|Booster Phase|Lost to Follow-up|3|||
130122610|NCT01644500|468410540|FG002|Overall Study|Adverse Event|2|||
130122611|NCT01644500|468410538|FG000|Overall Study|Death|0|||
130122612|NCT01644500|468410539|FG001|Overall Study|Death|1|||
130122613|NCT01644500|468410540|FG002|Overall Study|Death|0|||
130122614|NCT01644500|468410538|FG000|Overall Study|Lost to Follow-up|3|||
130122615|NCT01644500|468410539|FG001|Overall Study|Lost to Follow-up|8|||
130122616|NCT01644500|468410540|FG002|Overall Study|Lost to Follow-up|0|||
130122617|NCT01644500|468410538|FG000|Overall Study|Protocol Violation|1|||
129965861|NCT00937521|467839099|FG007|Booster Phase|Lost to Follow-up|0|||
130122618|NCT01644500|468410539|FG001|Overall Study|Protocol Violation|1|||
129965862|NCT00937521|467839092|FG000|Booster Phase|Administrative Reason|0|||
129965863|NCT00937521|467839093|FG001|Booster Phase|Administrative Reason|0|||
129965864|NCT00937521|467839094|FG002|Booster Phase|Administrative Reason|1|||
129965865|NCT00937521|467839095|FG003|Booster Phase|Administrative Reason|0|||
129965866|NCT00937521|467839096|FG004|Booster Phase|Administrative Reason|1|||
129965867|NCT00937521|467839097|FG005|Booster Phase|Administrative Reason|1|||
129965868|NCT00937521|467839098|FG006|Booster Phase|Administrative Reason|0|||
129965869|NCT00937521|467839099|FG007|Booster Phase|Administrative Reason|0|||
129965870|NCT00937521|467839092|FG000|Booster Phase|Protocol Deviation|0|||
129965871|NCT00937521|467839093|FG001|Booster Phase|Protocol Deviation|0|||
129965872|NCT00937521|467839094|FG002|Booster Phase|Protocol Deviation|0|||
129965873|NCT00937521|467839095|FG003|Booster Phase|Protocol Deviation|0|||
129965874|NCT00937521|467839096|FG004|Booster Phase|Protocol Deviation|0|||
129965875|NCT00937521|467839097|FG005|Booster Phase|Protocol Deviation|0|||
129965876|NCT00937521|467839098|FG006|Booster Phase|Protocol Deviation|1|||
129965877|NCT00937521|467839099|FG007|Booster Phase|Protocol Deviation|0|||
129965878|NCT01721746|467839100|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
129965879|NCT01721746|467839101|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
129965880|NCT01721746|467839100|FG000|Pre-Treatment|Withdrawal by Subject|1|||
129965881|NCT01721746|467839101|FG001|Pre-Treatment|Withdrawal by Subject|16|||
129965882|NCT01721746|467839100|FG000|Pre-Treatment|Poor/Non-compliance|1|||
129965883|NCT01721746|467839101|FG001|Pre-Treatment|Poor/Non-compliance|0|||
129965884|NCT01721746|467839100|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
129965885|NCT01721746|467839101|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
129965886|NCT01721746|467839100|FG000|Treatment|Disease Progression|192|||
129965887|NCT01721746|467839101|FG001|Treatment|Disease Progression|74|||
129965888|NCT01721746|467839100|FG000|Treatment|Study Drug Toxicity|19|||
129965889|NCT01721746|467839101|FG001|Treatment|Study Drug Toxicity|11|||
129965890|NCT01721746|467839100|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
129965891|NCT01721746|467839101|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
129965892|NCT01721746|467839100|FG000|Treatment|Participant request to discontinue Study treatment|26|||
129965893|NCT01721746|467839101|FG001|Treatment|Participant request to discontinue Study treatment|7|||
129965894|NCT01721746|467839100|FG000|Treatment|Participant withdrew consent|4|||
129965895|NCT01721746|467839101|FG001|Treatment|Participant withdrew consent|2|||
129965896|NCT01721746|467839100|FG000|Treatment|Maximum Clinical Benefit|9|||
129965897|NCT01721746|467839101|FG001|Treatment|Maximum Clinical Benefit|3|||
129965898|NCT01721746|467839100|FG000|Treatment|Poor/Non-compliance|2|||
129965899|NCT01721746|467839101|FG001|Treatment|Poor/Non-compliance|0|||
129965900|NCT01721746|467839100|FG000|Treatment|Participant no longer met Study criteria|4|||
129965901|NCT01721746|467839101|FG001|Treatment|Participant no longer met Study criteria|0|||
129965902|NCT01721746|467839100|FG000|Treatment|Other reasons|6|||
129965903|NCT01721746|467839101|FG001|Treatment|Other reasons|2|||
129965904|NCT04358068|467839102|FG000|Overall Study|Did not initiate study treatment|2|||
129965905|NCT04358068|467839103|FG001|Overall Study|Did not initiate study treatment|2|||
129965906|NCT02447718|467839104|FG000|Overall Study|Lost to Follow-up|8|||
129965907|NCT02447718|467839105|FG001|Overall Study|Lost to Follow-up|0|||
129965908|NCT02447718|467839104|FG000|Overall Study|Withdrawal by Subject|3|||
129965909|NCT02447718|467839105|FG001|Overall Study|Withdrawal by Subject|0|||
129965910|NCT02447718|467839104|FG000|Overall Study|Screen Failure|1|||
129965911|NCT02447718|467839105|FG001|Overall Study|Screen Failure|0|||
129965912|NCT00239681|467839106|FG000|Overall Study|Adverse Event|100|||
129965913|NCT00239681|467839107|FG001|Overall Study|Adverse Event|99|||
129965914|NCT00239681|467839106|FG000|Overall Study|Withdrawal by Subject|458|||
129965915|NCT00239681|467839107|FG001|Overall Study|Withdrawal by Subject|489|||
129965916|NCT00239681|467839106|FG000|Overall Study|Lost to Follow-up|28|||
129965917|NCT00239681|467839107|FG001|Overall Study|Lost to Follow-up|22|||
129965918|NCT00239681|467839106|FG000|Overall Study|Protocol Violation|4|||
129965919|NCT00239681|467839107|FG001|Overall Study|Protocol Violation|4|||
129965920|NCT00239681|467839106|FG000|Overall Study|Physician Decision|13|||
129965921|NCT00239681|467839107|FG001|Overall Study|Physician Decision|17|||
129965922|NCT00239681|467839106|FG000|Overall Study|No information chacked on CaseReportForm|90|||
129965923|NCT00239681|467839107|FG001|Overall Study|No information chacked on CaseReportForm|84|||
129965924|NCT03599622|467839108|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
129965925|NCT03599622|467839109|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
129965926|NCT03599622|467839110|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
129965927|NCT03599622|467839111|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
129965928|NCT03599622|467839108|FG000|Pre-Treatment Period|Other reasons|1|||
129965929|NCT03599622|467839109|FG001|Pre-Treatment Period|Other reasons|1|||
129965930|NCT03599622|467839110|FG002|Pre-Treatment Period|Other reasons|1|||
129965931|NCT03599622|467839111|FG003|Pre-Treatment Period|Other reasons|0|||
129965932|NCT03599622|467839108|FG000|Treatment Period|Adverse Event|11|||
129965933|NCT03599622|467839109|FG001|Treatment Period|Adverse Event|20|||
129965934|NCT03599622|467839110|FG002|Treatment Period|Adverse Event|18|||
129965935|NCT03599622|467839111|FG003|Treatment Period|Adverse Event|2|||
129965936|NCT03599622|467839108|FG000|Treatment Period|Lack of Efficacy|18|||
129965937|NCT03599622|467839109|FG001|Treatment Period|Lack of Efficacy|12|||
129965938|NCT03599622|467839110|FG002|Treatment Period|Lack of Efficacy|13|||
129965939|NCT03599622|467839111|FG003|Treatment Period|Lack of Efficacy|2|||
129965940|NCT03599622|467839108|FG000|Treatment Period|Withdrawal by Subject|5|||
129965941|NCT03599622|467839109|FG001|Treatment Period|Withdrawal by Subject|11|||
129965942|NCT03599622|467839110|FG002|Treatment Period|Withdrawal by Subject|16|||
129965943|NCT03599622|467839111|FG003|Treatment Period|Withdrawal by Subject|1|||
129965944|NCT03599622|467839108|FG000|Treatment Period|Other reasons|4|||
129965945|NCT03599622|467839109|FG001|Treatment Period|Other reasons|6|||
129965946|NCT03599622|467839110|FG002|Treatment Period|Other reasons|7|||
129965947|NCT03599622|467839111|FG003|Treatment Period|Other reasons|0|||
129965948|NCT03599622|467839108|FG000|Treatment Period|Lost to Follow-up|1|||
129965949|NCT03599622|467839109|FG001|Treatment Period|Lost to Follow-up|0|||
129965950|NCT03599622|467839110|FG002|Treatment Period|Lost to Follow-up|0|||
129965951|NCT03599622|467839111|FG003|Treatment Period|Lost to Follow-up|0|||
129965952|NCT03599622|467839108|FG000|Treatment Period|Study terminated by sponsor|7|||
129965953|NCT03599622|467839109|FG001|Treatment Period|Study terminated by sponsor|20|||
129965954|NCT03599622|467839110|FG002|Treatment Period|Study terminated by sponsor|15|||
129965955|NCT03599622|467839111|FG003|Treatment Period|Study terminated by sponsor|0|||
129965956|NCT03599622|467839108|FG000|Treatment Period|Site terminated by sponsor|0|||
129965957|NCT03599622|467839109|FG001|Treatment Period|Site terminated by sponsor|1|||
129965958|NCT03599622|467839110|FG002|Treatment Period|Site terminated by sponsor|0|||
129965959|NCT03599622|467839111|FG003|Treatment Period|Site terminated by sponsor|0|||
129965960|NCT00770588|467839112|FG000|Overall Study|Adverse Event|9|||
129965961|NCT00770588|467839113|FG001|Overall Study|Adverse Event|2|||
129965962|NCT00770588|467839112|FG000|Overall Study|Death caused by progression of disease|70|||
129965963|NCT00770588|467839113|FG001|Overall Study|Death caused by progression of disease|91|||
129965964|NCT00770588|467839112|FG000|Overall Study|Lost to Follow-up|1|||
129965965|NCT00770588|467839113|FG001|Overall Study|Lost to Follow-up|1|||
129965966|NCT00770588|467839112|FG000|Overall Study|Withdrawal by Subject|1|||
129965967|NCT00770588|467839113|FG001|Overall Study|Withdrawal by Subject|1|||
129965968|NCT01006889|467839114|FG000|Overall Study|Withdrawal by Subject|3|||
129965969|NCT00623363|467839115|FG000|Overall Study|Adverse Event|2|||
129965970|NCT00623363|467839116|FG001|Overall Study|Adverse Event|2|||
129965971|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
129965972|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
129965973|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
129965974|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
129965975|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
129965976|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
129965977|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
129965978|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
129965979|NCT00823836|467839118|FG000|Long-term Phase|Adverse Event|3|||
129965980|NCT00823836|467839119|FG001|Long-term Phase|Adverse Event|2|||
129965981|NCT00823836|467839118|FG000|Long-term Phase|Physician Decision|1|||
129965982|NCT00823836|467839119|FG001|Long-term Phase|Physician Decision|2|||
129965983|NCT00823836|467839118|FG000|Long-term Phase|Withdrawal by Subject|1|||
129965984|NCT00823836|467839119|FG001|Long-term Phase|Withdrawal by Subject|1|||
129965985|NCT01438840|467839121|FG000|Core Study|Adverse Event|0|||
129965986|NCT01438840|467839122|FG001|Core Study|Adverse Event|3|||
129965987|NCT01438840|467839123|FG002|Core Study|Adverse Event|0|||
129965988|NCT01438840|467839121|FG000|Core Study|Lack of Efficacy|15|||
129965989|NCT01438840|467839122|FG001|Core Study|Lack of Efficacy|7|||
129965990|NCT01438840|467839123|FG002|Core Study|Lack of Efficacy|0|||
129965991|NCT01438840|467839121|FG000|Core Study|Withdrawal of consent|1|||
129965992|NCT01438840|467839122|FG001|Core Study|Withdrawal of consent|0|||
129965993|NCT01438840|467839123|FG002|Core Study|Withdrawal of consent|0|||
129965994|NCT01438840|467839121|FG000|Extension Phase|Adverse Event|0|||
129965995|NCT01438840|467839122|FG001|Extension Phase|Adverse Event|0|||
130122619|NCT01644500|468410540|FG002|Overall Study|Protocol Violation|0|||
129965996|NCT01438840|467839123|FG002|Extension Phase|Adverse Event|3|||
129965997|NCT01438840|467839121|FG000|Extension Phase|Lost to Follow-up|0|||
129965998|NCT01438840|467839122|FG001|Extension Phase|Lost to Follow-up|0|||
129965999|NCT01438840|467839123|FG002|Extension Phase|Lost to Follow-up|1|||
129966000|NCT01438840|467839121|FG000|Extension Phase|Withdrawal by Subject|0|||
129966001|NCT01438840|467839122|FG001|Extension Phase|Withdrawal by Subject|0|||
129966002|NCT01438840|467839123|FG002|Extension Phase|Withdrawal by Subject|3|||
129966003|NCT01438840|467839121|FG000|Extension Phase|Lack of Efficacy|0|||
129966004|NCT01438840|467839122|FG001|Extension Phase|Lack of Efficacy|0|||
129966005|NCT01438840|467839123|FG002|Extension Phase|Lack of Efficacy|2|||
129966006|NCT01438840|467839121|FG000|Extension Phase|Other|0|||
129966007|NCT01438840|467839122|FG001|Extension Phase|Other|0|||
129966008|NCT01438840|467839123|FG002|Extension Phase|Other|1|||
129966009|NCT02062645|467839126|FG000|Overall Study|Adverse Event|2|||
129966010|NCT02062645|467839126|FG000|Overall Study|Protocol Violation|8|||
129966011|NCT02062645|467839126|FG000|Overall Study|Lost to Follow-up|5|||
129966012|NCT00798304|467839127|FG000|Overall Study|Adverse Event|0|||
129966013|NCT00798304|467839128|FG001|Overall Study|Adverse Event|1|||
129966014|NCT00798304|467839129|FG002|Overall Study|Adverse Event|1|||
129966015|NCT00798304|467839127|FG000|Overall Study|Discontinuation by Sponsor|14|||
129966016|NCT00798304|467839128|FG001|Overall Study|Discontinuation by Sponsor|21|||
129966017|NCT00798304|467839129|FG002|Overall Study|Discontinuation by Sponsor|9|||
129966018|NCT01774305|467839130|FG000|Overall Study|Physician Decision|1|||
129966019|NCT01774305|467839131|FG001|Overall Study|Physician Decision|0|||
129966020|NCT01157377|467839135|FG000|Overall Study|Lost to Follow-up|0|||
129966021|NCT01157377|467839136|FG001|Overall Study|Lost to Follow-up|0|||
129966022|NCT01157377|467839137|FG002|Overall Study|Lost to Follow-up|1|||
129966023|NCT01157377|467839138|FG003|Overall Study|Lost to Follow-up|0|||
129966024|NCT01157377|467839139|FG004|Overall Study|Lost to Follow-up|1|||
129966025|NCT01157377|467839140|FG005|Overall Study|Lost to Follow-up|1|||
129966026|NCT01157377|467839141|FG006|Overall Study|Lost to Follow-up|0|||
129966027|NCT01157377|467839135|FG000|Overall Study|Personal Reasons|2|||
129966028|NCT01157377|467839136|FG001|Overall Study|Personal Reasons|1|||
129966029|NCT01157377|467839137|FG002|Overall Study|Personal Reasons|0|||
129966030|NCT01157377|467839138|FG003|Overall Study|Personal Reasons|1|||
129966031|NCT01157377|467839139|FG004|Overall Study|Personal Reasons|0|||
129966032|NCT01157377|467839140|FG005|Overall Study|Personal Reasons|0|||
129966033|NCT01157377|467839141|FG006|Overall Study|Personal Reasons|0|||
129966034|NCT01157377|467839135|FG000|Overall Study|Protocol Violation|0|||
129966035|NCT01157377|467839136|FG001|Overall Study|Protocol Violation|0|||
129966036|NCT01157377|467839137|FG002|Overall Study|Protocol Violation|0|||
129966037|NCT01157377|467839138|FG003|Overall Study|Protocol Violation|0|||
129966038|NCT01157377|467839139|FG004|Overall Study|Protocol Violation|0|||
129966039|NCT01157377|467839140|FG005|Overall Study|Protocol Violation|1|||
129966040|NCT01157377|467839141|FG006|Overall Study|Protocol Violation|0|||
129966041|NCT01157377|467839135|FG000|Overall Study|Lack of Efficacy|0|||
129966042|NCT01157377|467839136|FG001|Overall Study|Lack of Efficacy|0|||
129966043|NCT01157377|467839137|FG002|Overall Study|Lack of Efficacy|0|||
129966044|NCT01157377|467839138|FG003|Overall Study|Lack of Efficacy|0|||
129966045|NCT01157377|467839139|FG004|Overall Study|Lack of Efficacy|0|||
129966046|NCT01157377|467839140|FG005|Overall Study|Lack of Efficacy|0|||
129966047|NCT01157377|467839141|FG006|Overall Study|Lack of Efficacy|1|||
129966048|NCT01157377|467839135|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129966049|NCT01157377|467839136|FG001|Overall Study|Other Miscellaneous Reasons|2|||
129966050|NCT01157377|467839137|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129966051|NCT01157377|467839138|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129966052|NCT01157377|467839139|FG004|Overall Study|Other Miscellaneous Reasons|1|||
129966053|NCT01157377|467839140|FG005|Overall Study|Other Miscellaneous Reasons|1|||
129966054|NCT01157377|467839141|FG006|Overall Study|Other Miscellaneous Reasons|1|||
129966055|NCT02760485|467839144|FG000|Phase 1|Death|3|||
129966056|NCT02760485|467839145|FG001|Phase 1|Death|6|||
129966057|NCT02760485|467839146|FG002|Phase 1|Death|0|||
129966058|NCT02760485|467839144|FG000|Phase 1|Withdrawal by Subject|2|||
129966059|NCT02760485|467839145|FG001|Phase 1|Withdrawal by Subject|0|||
129966060|NCT02760485|467839146|FG002|Phase 1|Withdrawal by Subject|0|||
129966061|NCT02760485|467839144|FG000|Phase 1|Progressive Disease|1|||
129966062|NCT02760485|467839145|FG001|Phase 1|Progressive Disease|0|||
129966063|NCT02760485|467839146|FG002|Phase 1|Progressive Disease|0|||
129966064|NCT02760485|467839144|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
129966065|NCT02760485|467839145|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
129966066|NCT02760485|467839146|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
129966067|NCT02760485|467839144|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
129966068|NCT02760485|467839145|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
129966069|NCT02760485|467839146|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
129966070|NCT02760485|467839144|FG000|Phase 2|Death|0|||
129966071|NCT02760485|467839145|FG001|Phase 2|Death|0|||
129966072|NCT02760485|467839146|FG002|Phase 2|Death|12|||
129966073|NCT02760485|467839144|FG000|Phase 2|Withdrawal by Subject|0|||
129966074|NCT02760485|467839145|FG001|Phase 2|Withdrawal by Subject|0|||
129966075|NCT02760485|467839146|FG002|Phase 2|Withdrawal by Subject|3|||
129966076|NCT02760485|467839144|FG000|Phase 2|Progressive Disease|0|||
129966077|NCT02760485|467839145|FG001|Phase 2|Progressive Disease|0|||
129966078|NCT02760485|467839146|FG002|Phase 2|Progressive Disease|1|||
129966079|NCT02760485|467839144|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
129966080|NCT02760485|467839145|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
129966081|NCT02760485|467839146|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
129966082|NCT02261285|467839147|FG000|Overall Study|Disease progression|0|||
129966083|NCT02261285|467839148|FG001|Overall Study|Disease progression|0|||
129966084|NCT02261285|467839149|FG002|Overall Study|Disease progression|1|||
129966085|NCT01702519|467839150|FG000|Washout Period|Lost to Follow-up|1|||
129966086|NCT01702519|467839151|FG001|Washout Period|Lost to Follow-up|0|||
129966087|NCT01702519|467839150|FG000|Washout Period|Withdrawal by Subject|0|||
129966088|NCT01702519|467839151|FG001|Washout Period|Withdrawal by Subject|2|||
129966089|NCT03738397|467839152|FG000|Overall Study|Adverse Event|3|||
130122620|NCT01644500|468410538|FG000|Overall Study|Withdrawal by Subject|11|||
129966090|NCT03738397|467839153|FG001|Overall Study|Adverse Event|7|||
129966091|NCT03738397|467839152|FG000|Overall Study|Withdrawal by Subject|8|||
129966092|NCT03738397|467839153|FG001|Overall Study|Withdrawal by Subject|11|||
129966093|NCT03738397|467839152|FG000|Overall Study|Lost to Follow-up|7|||
129966094|NCT03738397|467839153|FG001|Overall Study|Lost to Follow-up|5|||
129966095|NCT03738397|467839152|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129966096|NCT03738397|467839153|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
129966097|NCT03738397|467839152|FG000|Overall Study|Other|4|||
129966098|NCT03738397|467839153|FG001|Overall Study|Other|6|||
129966099|NCT00904722|467839156|FG000|Overall Study|Physician Decision|1|||
129966100|NCT01087814|467839157|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
129966101|NCT01087814|467839158|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
129966102|NCT01087814|467839157|FG000|Second Intervention (5 Days)|Physician Decision|1|||
129966103|NCT01087814|467839158|FG001|Second Intervention (5 Days)|Physician Decision|0|||
129966104|NCT01891890|467839159|FG000|Overall Study|Lost to Follow-up|0|||
129966105|NCT01891890|467839160|FG001|Overall Study|Lost to Follow-up|0|||
129966106|NCT01891890|467839161|FG002|Overall Study|Lost to Follow-up|1|||
129966107|NCT01891890|467839159|FG000|Overall Study|Study ended before endpoint reached|7|||
129966108|NCT01891890|467839160|FG001|Overall Study|Study ended before endpoint reached|3|||
129966109|NCT01891890|467839161|FG002|Overall Study|Study ended before endpoint reached|6|||
129966110|NCT04680637|467839162|FG000|Overall Study|Lost to Follow-up|0|||
129966111|NCT04680637|467839163|FG001|Overall Study|Lost to Follow-up|1|||
129966112|NCT04680637|467839164|FG002|Overall Study|Lost to Follow-up|0|||
129966113|NCT04680637|467839165|FG003|Overall Study|Lost to Follow-up|1|||
129966114|NCT04680637|467839162|FG000|Overall Study|Death|1|||
129966115|NCT04680637|467839163|FG001|Overall Study|Death|0|||
129966116|NCT04680637|467839164|FG002|Overall Study|Death|0|||
129966117|NCT04680637|467839165|FG003|Overall Study|Death|0|||
129966118|NCT04680637|467839162|FG000|Overall Study|Withdrawal by Subject|7|||
129966119|NCT04680637|467839163|FG001|Overall Study|Withdrawal by Subject|10|||
129966120|NCT04680637|467839164|FG002|Overall Study|Withdrawal by Subject|17|||
129966121|NCT04680637|467839165|FG003|Overall Study|Withdrawal by Subject|15|||
129966122|NCT04680637|467839162|FG000|Overall Study|Decision by Sponsor|21|||
129966123|NCT04680637|467839163|FG001|Overall Study|Decision by Sponsor|15|||
129966124|NCT04680637|467839164|FG002|Overall Study|Decision by Sponsor|7|||
129966125|NCT04680637|467839165|FG003|Overall Study|Decision by Sponsor|32|||
129966126|NCT00497874|467841029|FG000|Overall Study|Withdrawal by Subject|48|||
129966127|NCT00497874|467841030|FG001|Overall Study|Withdrawal by Subject|17|||
129966128|NCT00497874|467841029|FG000|Overall Study|Illness|8|||
129966129|NCT00497874|467841030|FG001|Overall Study|Illness|4|||
129966130|NCT00497874|467841029|FG000|Overall Study|Death|2|||
129966131|NCT00497874|467841030|FG001|Overall Study|Death|4|||
129966132|NCT00497874|467841029|FG000|Overall Study|Unable to contact|52|||
129966133|NCT00497874|467841030|FG001|Overall Study|Unable to contact|67|||
129966134|NCT00497874|467841029|FG000|Overall Study|Unable to schedule|37|||
129966135|NCT00497874|467841030|FG001|Overall Study|Unable to schedule|24|||
129966136|NCT01256671|467841034|FG000|Overall Study|Adverse Event|29|||
129966137|NCT01256671|467841034|FG000|Overall Study|Lost to Follow-up|16|||
129966138|NCT01256671|467841034|FG000|Overall Study|Withdrawal by Subject|31|||
129966139|NCT01256671|467841034|FG000|Overall Study|Physician Decision|3|||
129966140|NCT01256671|467841034|FG000|Overall Study|Lack of Efficacy|4|||
129966141|NCT01256671|467841034|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
129966142|NCT04009629|467841035|FG000|Overall Study|Withdrawal by Subject|2|||
129966143|NCT04009629|467841036|FG001|Overall Study|Withdrawal by Subject|0|||
129966144|NCT03602586|467841037|FG000|Overall Study|Withdrawal by Subject|3|||
129966145|NCT00891046|467841040|FG000|Overall Study|Protocol Violation|1|||
129966146|NCT00891046|467841041|FG001|Overall Study|Protocol Violation|1|||
129966147|NCT00891046|467841042|FG002|Overall Study|Protocol Violation|0|||
129966148|NCT00891046|467841043|FG003|Overall Study|Protocol Violation|0|||
129966149|NCT00891046|467841044|FG004|Overall Study|Protocol Violation|1|||
129966150|NCT00891046|467841040|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129966151|NCT00891046|467841041|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129966152|NCT00891046|467841042|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
129966153|NCT00891046|467841043|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129966154|NCT00891046|467841044|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
129966155|NCT00891046|467841040|FG000|Overall Study|Administrative problems|0|||
129966156|NCT00891046|467841041|FG001|Overall Study|Administrative problems|0|||
129966157|NCT00891046|467841042|FG002|Overall Study|Administrative problems|0|||
129966158|NCT00891046|467841043|FG003|Overall Study|Administrative problems|0|||
129966159|NCT00891046|467841044|FG004|Overall Study|Administrative problems|1|||
129966160|NCT00891046|467841040|FG000|Overall Study|Participant no longer required drug|0|||
129966161|NCT00891046|467841041|FG001|Overall Study|Participant no longer required drug|2|||
129966162|NCT00891046|467841042|FG002|Overall Study|Participant no longer required drug|0|||
129966163|NCT00891046|467841043|FG003|Overall Study|Participant no longer required drug|0|||
129966164|NCT00891046|467841044|FG004|Overall Study|Participant no longer required drug|1|||
129966165|NCT00891046|467841040|FG000|Overall Study|Adverse Event|4|||
129966166|NCT00891046|467841041|FG001|Overall Study|Adverse Event|3|||
129966167|NCT00891046|467841042|FG002|Overall Study|Adverse Event|2|||
130092051|NCT04594213|468292543|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129966168|NCT00891046|467841043|FG003|Overall Study|Adverse Event|0|||
129966169|NCT00891046|467841044|FG004|Overall Study|Adverse Event|14|||
129966170|NCT00891046|467841040|FG000|Overall Study|Withdrawal by Subject|2|||
129966171|NCT00891046|467841041|FG001|Overall Study|Withdrawal by Subject|1|||
129966172|NCT00891046|467841042|FG002|Overall Study|Withdrawal by Subject|2|||
129966173|NCT00891046|467841043|FG003|Overall Study|Withdrawal by Subject|1|||
129966174|NCT00891046|467841044|FG004|Overall Study|Withdrawal by Subject|1|||
129966175|NCT00891046|467841040|FG000|Overall Study|Lost to Follow-up|0|||
129966176|NCT00891046|467841041|FG001|Overall Study|Lost to Follow-up|0|||
129966177|NCT00891046|467841042|FG002|Overall Study|Lost to Follow-up|0|||
129966178|NCT00891046|467841043|FG003|Overall Study|Lost to Follow-up|0|||
129966179|NCT00891046|467841044|FG004|Overall Study|Lost to Follow-up|1|||
129966180|NCT04523207|467841047|FG000|Overall Study|Adverse Event|5|||
129966181|NCT04523207|467841048|FG001|Overall Study|Adverse Event|1|||
129966182|NCT04523207|467841047|FG000|Overall Study|Lost to Follow-up|2|||
129966183|NCT04523207|467841048|FG001|Overall Study|Lost to Follow-up|0|||
129966184|NCT04523207|467841047|FG000|Overall Study|Withdrawal by Subject|2|||
129966185|NCT04523207|467841048|FG001|Overall Study|Withdrawal by Subject|0|||
129966186|NCT04523207|467841047|FG000|Overall Study|Progressive Disease|2|||
129966187|NCT04523207|467841048|FG001|Overall Study|Progressive Disease|1|||
129966188|NCT04523207|467841047|FG000|Overall Study|Other|7|||
129966189|NCT04523207|467841048|FG001|Overall Study|Other|1|||
129966190|NCT03113383|467841049|FG000|Overall Study|Death|4|||
129966191|NCT03113383|467841050|FG001|Overall Study|Death|0|||
129966192|NCT03568812|467841052|FG000|Overall Study|Physician Decision|0|||
129966193|NCT03568812|467841053|FG001|Overall Study|Physician Decision|1|||
129966194|NCT04014790|467841054|FG000|Overall Study|Death|4|||
129966195|NCT04014790|467841054|FG000|Overall Study|Adverse Event|1|||
129966196|NCT04014790|467841054|FG000|Overall Study|Withdrawal by Subject|1|||
129966197|NCT01010204|467841057|FG000|Overall Study|Lost to Follow-up|2|||
129966198|NCT01010204|467841058|FG001|Overall Study|Lost to Follow-up|2|||
129966199|NCT01010204|467841057|FG000|Overall Study|Adverse Event|1|||
129966200|NCT01010204|467841058|FG001|Overall Study|Adverse Event|3|||
129966201|NCT01010204|467841057|FG000|Overall Study|Withdrawal by Subject|2|||
129966202|NCT01010204|467841058|FG001|Overall Study|Withdrawal by Subject|3|||
129966203|NCT01010204|467841057|FG000|Overall Study|psychiatric hospitalization|2|||
129966204|NCT01010204|467841058|FG001|Overall Study|psychiatric hospitalization|1|||
129966205|NCT01519778|467841059|FG000|Overall Study|Withdrawal by Subject|3|||
129966206|NCT01519778|467841059|FG000|Overall Study|Lost to Follow-up|10|||
129966207|NCT01519778|467841059|FG000|Overall Study|Physician Decision|1|||
129966208|NCT02330562|467841060|FG000|Overall Study|Adverse Event|0|||
129966209|NCT02330562|467841061|FG001|Overall Study|Adverse Event|0|||
129966210|NCT02330562|467841062|FG002|Overall Study|Adverse Event|3|||
129966211|NCT02330562|467841063|FG003|Overall Study|Adverse Event|0|||
129966212|NCT02330562|467841064|FG004|Overall Study|Adverse Event|3|||
129966213|NCT02330562|467841065|FG005|Overall Study|Adverse Event|1|||
129966214|NCT02330562|467841066|FG006|Overall Study|Adverse Event|0|||
129966215|NCT02330562|467841067|FG007|Overall Study|Adverse Event|0|||
129966216|NCT02330562|467841068|FG008|Overall Study|Adverse Event|0|||
129966217|NCT02330562|467841069|FG009|Overall Study|Adverse Event|1|||
129966218|NCT02330562|467841070|FG010|Overall Study|Adverse Event|1|||
129966219|NCT02330562|467841060|FG000|Overall Study|Participant decision|1|||
129966220|NCT02330562|467841061|FG001|Overall Study|Participant decision|0|||
129966221|NCT02330562|467841062|FG002|Overall Study|Participant decision|4|||
129966222|NCT02330562|467841063|FG003|Overall Study|Participant decision|1|||
129966223|NCT02330562|467841064|FG004|Overall Study|Participant decision|5|||
129966224|NCT02330562|467841065|FG005|Overall Study|Participant decision|2|||
129966225|NCT02330562|467841066|FG006|Overall Study|Participant decision|0|||
129966226|NCT02330562|467841067|FG007|Overall Study|Participant decision|0|||
129966227|NCT02330562|467841068|FG008|Overall Study|Participant decision|0|||
129966228|NCT02330562|467841069|FG009|Overall Study|Participant decision|3|||
129966229|NCT02330562|467841070|FG010|Overall Study|Participant decision|0|||
129966230|NCT02330562|467841060|FG000|Overall Study|Disease progression|5|||
129966231|NCT02330562|467841061|FG001|Overall Study|Disease progression|3|||
129966232|NCT02330562|467841062|FG002|Overall Study|Disease progression|20|||
129966233|NCT02330562|467841063|FG003|Overall Study|Disease progression|28|||
129966234|NCT02330562|467841064|FG004|Overall Study|Disease progression|23|||
129966235|NCT02330562|467841065|FG005|Overall Study|Disease progression|7|||
129966236|NCT02330562|467841066|FG006|Overall Study|Disease progression|1|||
129966237|NCT02330562|467841067|FG007|Overall Study|Disease progression|1|||
129966238|NCT02330562|467841068|FG008|Overall Study|Disease progression|1|||
129966239|NCT02330562|467841069|FG009|Overall Study|Disease progression|0|||
129966240|NCT02330562|467841070|FG010|Overall Study|Disease progression|5|||
129966241|NCT02330562|467841060|FG000|Overall Study|Other reasons|0|||
129966242|NCT02330562|467841061|FG001|Overall Study|Other reasons|0|||
129966243|NCT02330562|467841062|FG002|Overall Study|Other reasons|0|||
129966244|NCT02330562|467841063|FG003|Overall Study|Other reasons|1|||
129966245|NCT02330562|467841064|FG004|Overall Study|Other reasons|0|||
129966246|NCT02330562|467841065|FG005|Overall Study|Other reasons|0|||
129966247|NCT02330562|467841066|FG006|Overall Study|Other reasons|0|||
129966248|NCT02330562|467841067|FG007|Overall Study|Other reasons|0|||
129966249|NCT02330562|467841068|FG008|Overall Study|Other reasons|0|||
129966250|NCT02330562|467841069|FG009|Overall Study|Other reasons|0|||
129966251|NCT02330562|467841070|FG010|Overall Study|Other reasons|0|||
129966252|NCT02330562|467841060|FG000|Overall Study|Withdrawal by Subject|0|||
129966253|NCT02330562|467841061|FG001|Overall Study|Withdrawal by Subject|0|||
129966254|NCT02330562|467841062|FG002|Overall Study|Withdrawal by Subject|0|||
129966255|NCT02330562|467841063|FG003|Overall Study|Withdrawal by Subject|0|||
129966256|NCT02330562|467841064|FG004|Overall Study|Withdrawal by Subject|0|||
129966257|NCT02330562|467841065|FG005|Overall Study|Withdrawal by Subject|0|||
129966258|NCT02330562|467841066|FG006|Overall Study|Withdrawal by Subject|0|||
129966259|NCT02330562|467841067|FG007|Overall Study|Withdrawal by Subject|0|||
129966260|NCT02330562|467841068|FG008|Overall Study|Withdrawal by Subject|0|||
129966261|NCT02330562|467841069|FG009|Overall Study|Withdrawal by Subject|1|||
129966262|NCT02330562|467841070|FG010|Overall Study|Withdrawal by Subject|0|||
129966263|NCT01657799|467841071|FG000|Overall Study|Adverse Event Related to progression|6|||
129966264|NCT01657799|467841072|FG001|Overall Study|Adverse Event Related to progression|8|||
129966265|NCT01657799|467841073|FG002|Overall Study|Adverse Event Related to progression|12|||
129966266|NCT01657799|467841071|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
129966267|NCT01657799|467841072|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
129966268|NCT01657799|467841073|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
129966269|NCT01657799|467841071|FG000|Overall Study|Withdrawal by Subject|13|||
129966270|NCT01657799|467841072|FG001|Overall Study|Withdrawal by Subject|10|||
129966271|NCT01657799|467841073|FG002|Overall Study|Withdrawal by Subject|10|||
129966272|NCT01657799|467841071|FG000|Overall Study|Lost to Follow-up|1|||
129966273|NCT01657799|467841072|FG001|Overall Study|Lost to Follow-up|0|||
129966274|NCT01657799|467841073|FG002|Overall Study|Lost to Follow-up|1|||
129966275|NCT01657799|467841071|FG000|Overall Study|Disease Progression|2|||
129966276|NCT01657799|467841072|FG001|Overall Study|Disease Progression|4|||
129966277|NCT01657799|467841073|FG002|Overall Study|Disease Progression|4|||
129966278|NCT01657799|467841071|FG000|Overall Study|Progressive Disease Clinical|7|||
129966279|NCT01657799|467841072|FG001|Overall Study|Progressive Disease Clinical|4|||
129966280|NCT01657799|467841073|FG002|Overall Study|Progressive Disease Clinical|7|||
129966281|NCT01657799|467841071|FG000|Overall Study|Radiographic & Clinical Progression|16|||
129966282|NCT01657799|467841072|FG001|Overall Study|Radiographic & Clinical Progression|11|||
129966283|NCT01657799|467841073|FG002|Overall Study|Radiographic & Clinical Progression|15|||
129966284|NCT01657799|467841071|FG000|Overall Study|Other|52|||
129966285|NCT01657799|467841072|FG001|Overall Study|Other|62|||
129966286|NCT01657799|467841073|FG002|Overall Study|Other|49|||
129966287|NCT03021551|467841074|FG000|Overall Study|Equipment Issues|2|||
129966288|NCT03021551|467841074|FG000|Overall Study|Protocol Violation|1|||
129966289|NCT01015677|467841076|FG000|Overall Study|Adverse Event|0|||
129966290|NCT01015677|467841077|FG001|Overall Study|Adverse Event|1|||
129966291|NCT01015677|467841078|FG002|Overall Study|Adverse Event|0|||
129966292|NCT01015677|467841076|FG000|Overall Study|Lack of Efficacy|0|||
129966293|NCT01015677|467841077|FG001|Overall Study|Lack of Efficacy|1|||
129966294|NCT01015677|467841078|FG002|Overall Study|Lack of Efficacy|0|||
129966295|NCT01015677|467841076|FG000|Overall Study|Protocol Violation|0|||
129966296|NCT01015677|467841077|FG001|Overall Study|Protocol Violation|1|||
129966297|NCT01015677|467841078|FG002|Overall Study|Protocol Violation|0|||
129966298|NCT01015677|467841076|FG000|Overall Study|Withdrawal by Subject|1|||
129966299|NCT01015677|467841077|FG001|Overall Study|Withdrawal by Subject|1|||
129966300|NCT01015677|467841078|FG002|Overall Study|Withdrawal by Subject|0|||
129966301|NCT01646385|467841082|FG000|Overall Study|Death|202|||
129966302|NCT01646385|467841083|FG001|Overall Study|Death|222|||
129966303|NCT01646385|467841082|FG000|Overall Study|Switched to alternate biologic|636|||
129966304|NCT01646385|467841083|FG001|Overall Study|Switched to alternate biologic|649|||
129966305|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
129966306|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
129966307|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
129966308|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
129966309|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
129966310|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
129966311|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
129966312|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
129966313|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
129966314|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
129966315|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
129966316|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
129966317|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
129966318|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
129966319|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
129966320|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
129966321|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
129966322|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
129966323|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
129966324|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
129966325|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
129966326|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
129966327|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
129966328|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
129966329|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
129966330|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
129966331|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
129966332|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
129966333|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
129966334|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
129966335|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
129966336|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
129966337|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
129966338|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
129966339|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
129966340|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
129966341|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
129966342|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
129966343|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
129966344|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
129966345|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
129966346|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
129966347|NCT04799418|467841087|FG000|Overall Study|Death|1|||
129966348|NCT04799418|467841088|FG001|Overall Study|Death|1|||
129966349|NCT04799418|467841087|FG000|Overall Study|Lack of Efficacy|14|||
129966350|NCT04799418|467841088|FG001|Overall Study|Lack of Efficacy|14|||
129966351|NCT04799418|467841087|FG000|Overall Study|Withdrawal by Subject|10|||
129966352|NCT04799418|467841088|FG001|Overall Study|Withdrawal by Subject|7|||
129966353|NCT04799418|467841087|FG000|Overall Study|Adverse Event|3|||
129966354|NCT04799418|467841088|FG001|Overall Study|Adverse Event|2|||
129966355|NCT03297398|467841089|FG000|Overall Study|Sponsor's decision|6|||
129966356|NCT03297398|467841090|FG001|Overall Study|Sponsor's decision|9|||
129966357|NCT03297398|467841091|FG002|Overall Study|Sponsor's decision|7|||
129966358|NCT03297398|467841089|FG000|Overall Study|Adverse Event|1|||
129966359|NCT03297398|467841090|FG001|Overall Study|Adverse Event|4|||
129966360|NCT03297398|467841091|FG002|Overall Study|Adverse Event|4|||
129966361|NCT03297398|467841089|FG000|Overall Study|Withdrawal by Subject|1|||
129966362|NCT03297398|467841090|FG001|Overall Study|Withdrawal by Subject|2|||
129966363|NCT03297398|467841091|FG002|Overall Study|Withdrawal by Subject|2|||
129966364|NCT03297398|467841089|FG000|Overall Study|Protocol Violation|0|||
129966365|NCT03297398|467841090|FG001|Overall Study|Protocol Violation|2|||
129966366|NCT03297398|467841091|FG002|Overall Study|Protocol Violation|0|||
129966367|NCT03297398|467841089|FG000|Overall Study|Physician Decision|0|||
129966368|NCT03297398|467841090|FG001|Overall Study|Physician Decision|0|||
129966369|NCT03297398|467841091|FG002|Overall Study|Physician Decision|1|||
129966370|NCT03297398|467841089|FG000|Overall Study|Lost to Follow-up|0|||
129966371|NCT03297398|467841090|FG001|Overall Study|Lost to Follow-up|0|||
129966372|NCT03297398|467841091|FG002|Overall Study|Lost to Follow-up|1|||
129966373|NCT00236184|467841096|FG000|Overall Study|Adverse Event|5|||
129966374|NCT00236184|467841097|FG001|Overall Study|Adverse Event|2|||
129966375|NCT00236184|467841096|FG000|Overall Study|Lack of Efficacy|0|||
129966376|NCT00236184|467841097|FG001|Overall Study|Lack of Efficacy|1|||
129966377|NCT00236184|467841096|FG000|Overall Study|Lost to Follow-up|3|||
129966378|NCT00236184|467841097|FG001|Overall Study|Lost to Follow-up|4|||
129966379|NCT00236184|467841096|FG000|Overall Study|Physician Decision|1|||
129966380|NCT00236184|467841097|FG001|Overall Study|Physician Decision|1|||
129966381|NCT00236184|467841096|FG000|Overall Study|Withdrawal by Subject|3|||
129966382|NCT00236184|467841097|FG001|Overall Study|Withdrawal by Subject|0|||
129966383|NCT00236184|467841096|FG000|Overall Study|Protocol Violation|3|||
129966384|NCT00236184|467841097|FG001|Overall Study|Protocol Violation|0|||
129966385|NCT00236184|467841096|FG000|Overall Study|non-compliance with study drug|2|||
130122621|NCT01644500|468410539|FG001|Overall Study|Withdrawal by Subject|12|||
129966386|NCT00236184|467841097|FG001|Overall Study|non-compliance with study drug|1|||
129966387|NCT00236184|467841096|FG000|Overall Study|other|1|||
129966388|NCT00236184|467841097|FG001|Overall Study|other|2|||
129966389|NCT02312206|467841098|FG000|Overall Study|Adverse Event|3|||
129966390|NCT02312206|467841099|FG001|Overall Study|Adverse Event|6|||
129966391|NCT02312206|467841098|FG000|Overall Study|Withdrawal by Subject|6|||
129966392|NCT02312206|467841099|FG001|Overall Study|Withdrawal by Subject|6|||
129966393|NCT02312206|467841098|FG000|Overall Study|Physician Decision|7|||
129966394|NCT02312206|467841099|FG001|Overall Study|Physician Decision|6|||
129966395|NCT02312206|467841098|FG000|Overall Study|Death|31|||
129966396|NCT02312206|467841099|FG001|Overall Study|Death|36|||
129966397|NCT02312206|467841098|FG000|Overall Study|Study Terminated by Sponsor|81|||
129966398|NCT02312206|467841099|FG001|Overall Study|Study Terminated by Sponsor|74|||
129966399|NCT02312206|467841098|FG000|Overall Study|Patient transferred to hospice|0|||
129966400|NCT02312206|467841099|FG001|Overall Study|Patient transferred to hospice|1|||
129966401|NCT02312206|467841098|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
129966402|NCT02312206|467841099|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
129966403|NCT02312206|467841098|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
129966404|NCT02312206|467841099|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
129966405|NCT02312206|467841098|FG000|Overall Study|Disease Progression|1|||
129966406|NCT02312206|467841099|FG001|Overall Study|Disease Progression|0|||
129966407|NCT03082612|467841100|FG000|Overall Study|Lost to Follow-up|2|||
129966408|NCT03082612|467841101|FG001|Overall Study|Lost to Follow-up|0|||
129966409|NCT03732820|467841108|FG000|Overall Study|Death|168|||
129966410|NCT03732820|467841109|FG001|Overall Study|Death|203|||
129966411|NCT03732820|467841108|FG000|Overall Study|Other|2|||
129966412|NCT03732820|467841109|FG001|Overall Study|Other|2|||
129966413|NCT03732820|467841108|FG000|Overall Study|Failure to meet randomisation criteria|1|||
129966414|NCT03732820|467841109|FG001|Overall Study|Failure to meet randomisation criteria|1|||
129966415|NCT03732820|467841108|FG000|Overall Study|Patient decision|14|||
129966416|NCT03732820|467841109|FG001|Overall Study|Patient decision|10|||
129966417|NCT03732820|467841108|FG000|Overall Study|Screen failure|0|||
129966418|NCT03732820|467841109|FG001|Overall Study|Screen failure|1|||
129966419|NCT03732820|467841108|FG000|Overall Study|Patients ongoing study at data cut off|210|||
129966420|NCT03732820|467841109|FG001|Overall Study|Patients ongoing study at data cut off|178|||
129966421|NCT03732820|467841108|FG000|Overall Study|Lost to Follow-up|4|||
129966422|NCT03732820|467841109|FG001|Overall Study|Lost to Follow-up|2|||
129966423|NCT00992992|467841110|FG000|Overall Study|Lost to Follow-up|3|||
129966424|NCT00992992|467841110|FG000|Overall Study|Death|16|||
129966425|NCT00992992|467841110|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
129966426|NCT00992992|467841110|FG000|Overall Study|Sponsor Closed the Study|4|||
129966427|NCT00832000|467841112|FG000|Overall Study|Adverse Event|2|||
129966428|NCT00832000|467841113|FG001|Overall Study|Adverse Event|0|||
129966429|NCT00832000|467841112|FG000|Overall Study|Withdrawal by Subject|1|||
129966430|NCT00832000|467841113|FG001|Overall Study|Withdrawal by Subject|0|||
129966431|NCT00832000|467841112|FG000|Overall Study|No calls to IVR in either period|1|||
129966432|NCT00832000|467841113|FG001|Overall Study|No calls to IVR in either period|1|||
129966433|NCT00832000|467841112|FG000|Overall Study|No calls to IVR in period 2|2|||
129966434|NCT00832000|467841113|FG001|Overall Study|No calls to IVR in period 2|0|||
129966435|NCT02725567|467841115|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
129966436|NCT02725567|467841116|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
129966437|NCT02725567|467841115|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
129966438|NCT02725567|467841116|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
129966439|NCT02725567|467841115|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
129966440|NCT02725567|467841116|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
129966441|NCT00255944|467841117|FG000|Overall Study|Lost to Follow-up|797|||
129966442|NCT00255944|467841118|FG001|Overall Study|Lost to Follow-up|834|||
129966443|NCT01129115|467841119|FG000|Overall Study|Adverse Event|1|||
129966444|NCT01129115|467841120|FG001|Overall Study|Adverse Event|2|||
129966445|NCT01129115|467841121|FG002|Overall Study|Adverse Event|3|||
129966446|NCT01129115|467841122|FG003|Overall Study|Adverse Event|3|||
129966447|NCT01129115|467841119|FG000|Overall Study|Withdrawal by Subject|1|||
129966448|NCT01129115|467841120|FG001|Overall Study|Withdrawal by Subject|3|||
129966449|NCT01129115|467841121|FG002|Overall Study|Withdrawal by Subject|1|||
129966450|NCT01129115|467841122|FG003|Overall Study|Withdrawal by Subject|4|||
129966451|NCT01129115|467841119|FG000|Overall Study|Protocol Violation|0|||
129966452|NCT01129115|467841120|FG001|Overall Study|Protocol Violation|2|||
129966453|NCT01129115|467841121|FG002|Overall Study|Protocol Violation|2|||
129966454|NCT01129115|467841122|FG003|Overall Study|Protocol Violation|2|||
129966455|NCT02299427|467841124|FG000|Overall Study|Withdrawal by Subject|1|||
129966456|NCT02299427|467841125|FG001|Overall Study|Withdrawal by Subject|0|||
129966457|NCT02299427|467841124|FG000|Overall Study|Lost to Follow-up|1|||
129966458|NCT02299427|467841125|FG001|Overall Study|Lost to Follow-up|3|||
130122622|NCT01644500|468410540|FG002|Overall Study|Withdrawal by Subject|12|||
130122623|NCT01644500|468410538|FG000|Overall Study|Physician Decision|1|||
129966459|NCT02299427|467841124|FG000|Overall Study|not adherent to dog website use|21|||
129966460|NCT02299427|467841125|FG001|Overall Study|not adherent to dog website use|0|||
130122624|NCT01644500|468410539|FG001|Overall Study|Physician Decision|1|||
129966461|NCT02108652|467841126|FG000|Overall Study|Death|253|||
129966462|NCT02108652|467841126|FG000|Overall Study|Lost to Follow-up|2|||
129966463|NCT02108652|467841126|FG000|Overall Study|Withdrawal by Subject|16|||
129966464|NCT02108652|467841126|FG000|Overall Study|Study Terminated By Sponsor|31|||
129966465|NCT02108652|467841126|FG000|Overall Study|Non-Compliance|1|||
129966466|NCT02108652|467841126|FG000|Overall Study|Physician Decision|6|||
129966467|NCT02108652|467841126|FG000|Overall Study|Progression Of Disease|1|||
129966468|NCT02564718|467841129|FG000|Overall Study|Withdrew from treatment|0|||
129966469|NCT02564718|467841130|FG001|Overall Study|Withdrew from treatment|1|||
129966470|NCT00935259|467841131|FG000|Period 1|Administrative (scheduling conflict)|1|||
129966471|NCT00935259|467841132|FG001|Period 1|Administrative (scheduling conflict)|1|||
129966472|NCT00874497|467841136|FG000|Overall Study|Lost to Follow-up|2|||
129966473|NCT00874497|467841137|FG001|Overall Study|Lost to Follow-up|4|||
129966474|NCT00874497|467841136|FG000|Overall Study|Adverse Event|9|||
129966475|NCT00874497|467841137|FG001|Overall Study|Adverse Event|4|||
129966476|NCT00874497|467841136|FG000|Overall Study|Sponsor Discontinued Trial|7|||
129966477|NCT00874497|467841137|FG001|Overall Study|Sponsor Discontinued Trial|3|||
129966478|NCT00874497|467841136|FG000|Overall Study|Met Withdrawal Criteria|4|||
129966479|NCT00874497|467841137|FG001|Overall Study|Met Withdrawal Criteria|2|||
129966480|NCT00874497|467841136|FG000|Overall Study|Physician Decision|1|||
129966481|NCT00874497|467841137|FG001|Overall Study|Physician Decision|1|||
129966482|NCT00874497|467841136|FG000|Overall Study|Withdrawal by Subject|5|||
129966483|NCT00874497|467841137|FG001|Overall Study|Withdrawal by Subject|4|||
129966484|NCT01017263|467841138|FG000|Overall Study|not eligible|12|||
129966485|NCT02980705|467841139|FG000|Overall Study|Adverse Event|0|||
129966486|NCT02980705|467841140|FG001|Overall Study|Adverse Event|1|||
129966487|NCT02980705|467841139|FG000|Overall Study|Withdrawal by Subject|6|||
129966488|NCT02980705|467841140|FG001|Overall Study|Withdrawal by Subject|9|||
130122625|NCT01644500|468410540|FG002|Overall Study|Physician Decision|1|||
130122626|NCT01400425|468410548|FG000|Overall Study|Withdrawal by Subject|10|||
130122627|NCT02388763|468410551|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
130122628|NCT02388763|468410552|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
130122629|NCT02388763|468410551|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
130122630|NCT02388763|468410552|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
130122631|NCT02194998|468410561|FG000|On-HCV Treatment|Did not pick up study medication|0|||
130122632|NCT02194998|468410562|FG001|On-HCV Treatment|Did not pick up study medication|1|||
130122633|NCT02194998|468410563|FG002|On-HCV Treatment|Did not pick up study medication|0|||
130122634|NCT02194998|468410564|FG003|On-HCV Treatment|Did not pick up study medication|0|||
130122635|NCT02194998|468410561|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
130122636|NCT02194998|468410562|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
130122637|NCT02194998|468410563|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
130122638|NCT02194998|468410564|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
130122639|NCT01458405|468410567|FG000|Phase 1 (up to 12 Months)|Other|0|||
130122640|NCT01458405|468410568|FG001|Phase 1 (up to 12 Months)|Other|1|||
130122641|NCT01458405|468410569|FG002|Phase 1 (up to 12 Months)|Other|0|||
130122642|NCT01458405|468410570|FG003|Phase 1 (up to 12 Months)|Other|0|||
130122643|NCT01458405|468410567|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
130122644|NCT01458405|468410568|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
130122645|NCT01458405|468410569|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
130122646|NCT01458405|468410570|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
130122647|NCT01458405|468410567|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130122648|NCT01458405|468410568|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130122649|NCT01458405|468410569|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
130122650|NCT01458405|468410570|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
130122651|NCT01458405|468410567|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130122652|NCT01458405|468410568|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130122653|NCT01458405|468410569|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
130122654|NCT01458405|468410570|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
129966489|NCT02980705|467841139|FG000|Overall Study|withdrew participation|0|||
129966490|NCT02980705|467841140|FG001|Overall Study|withdrew participation|1|||
129966491|NCT02980705|467841139|FG000|Overall Study|Lost to Follow-up|2|||
129966492|NCT02980705|467841140|FG001|Overall Study|Lost to Follow-up|0|||
129966493|NCT00263575|467841141|FG000|Titration Period|Adverse Event|14|||
129966494|NCT00263575|467841141|FG000|Titration Period|Withdrawal by Subject|10|||
129966495|NCT00263575|467841141|FG000|Titration Period|Protocol Violation|9|||
129966496|NCT00263575|467841141|FG000|Titration Period|Sponsor Decision|2|||
129966497|NCT00263575|467841141|FG000|Titration Period|Other|2|||
129966498|NCT00263575|467841141|FG000|Titration Period|Lack of Efficacy|6|||
129966499|NCT00263575|467841141|FG000|Maintence Period|Adverse Event|23|||
129966500|NCT00263575|467841141|FG000|Maintence Period|Withdrawal by Subject|8|||
130122655|NCT02236130|468410571|FG000|Overall Study|Lost to Follow-up|7|||
130122656|NCT02236130|468410572|FG001|Overall Study|Lost to Follow-up|12|||
130122657|NCT01890915|468410578|FG000|Overall Study|Adverse Event|1|||
130122658|NCT01890915|468410579|FG001|Overall Study|Adverse Event|0|||
130122659|NCT01890915|468410578|FG000|Overall Study|Protocol Violation|2|||
130122660|NCT01890915|468410579|FG001|Overall Study|Protocol Violation|0|||
129966501|NCT00263575|467841141|FG000|Maintence Period|Protocol Violation|4|||
129966502|NCT00263575|467841141|FG000|Maintence Period|Lack of Efficacy|4|||
129966503|NCT00263575|467841141|FG000|Maintence Period|Physician Decision|6|||
129966504|NCT00263575|467841141|FG000|Maintence Period|Lost to Follow-up|1|||
129966505|NCT00263575|467841141|FG000|Maintence Period|Sponsor Decision|24|||
129966506|NCT00263575|467841141|FG000|Maintence Period|Other|7|||
129966507|NCT04353817|467841142|FG000|Overall Study|Adverse Event|0|||
129966508|NCT04353817|467841143|FG001|Overall Study|Adverse Event|1|||
129966509|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
129966510|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
129966511|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
129966512|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Death|0|||
129966513|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Death|0|||
129966514|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Death|1|||
129966515|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
129966516|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
129966517|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
129966518|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
129966519|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
129966520|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
129966521|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
129966522|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
129966523|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
129966524|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
129966525|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
129966526|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
129966527|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Death|0|||
129966528|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Death|1|||
129966529|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Death|0|||
130092052|NCT04594213|468292544|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
130092053|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130092054|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130122661|NCT01890915|468410578|FG000|Overall Study|Equipment Malfunction|0|||
130122662|NCT01890915|468410579|FG001|Overall Study|Equipment Malfunction|1|||
130122663|NCT00424489|468410580|FG000|Overall Study|Death|3|||
130122664|NCT00386009|468410584|FG000|Overall Study|Adverse Event|0|||
130122665|NCT00386009|468410585|FG001|Overall Study|Adverse Event|2|||
130122666|NCT00386009|468410584|FG000|Overall Study|Death|1|||
130122667|NCT00386009|468410585|FG001|Overall Study|Death|0|||
130122668|NCT00386009|468410584|FG000|Overall Study|Entry Criteria Not Met|0|||
130122669|NCT00386009|468410585|FG001|Overall Study|Entry Criteria Not Met|2|||
130122670|NCT00386009|468410584|FG000|Overall Study|Lost to Follow-up|1|||
130122671|NCT00386009|468410585|FG001|Overall Study|Lost to Follow-up|1|||
130122672|NCT00386009|468410584|FG000|Overall Study|Protocol Violation|1|||
130122673|NCT00386009|468410585|FG001|Overall Study|Protocol Violation|0|||
130122674|NCT00386009|468410584|FG000|Overall Study|Sponsor Decision|1|||
130122675|NCT00386009|468410585|FG001|Overall Study|Sponsor Decision|1|||
130122676|NCT00386009|468410584|FG000|Overall Study|Withdrawal by Subject|5|||
130122677|NCT00386009|468410585|FG001|Overall Study|Withdrawal by Subject|4|||
130122678|NCT02465567|468410586|FG000|Overall Study|Adverse Event|118|||
130122679|NCT02465567|468410587|FG001|Overall Study|Adverse Event|113|||
130122680|NCT02465567|468410588|FG002|Overall Study|Adverse Event|147|||
130122681|NCT02465567|468410589|FG003|Overall Study|Adverse Event|138|||
130122682|NCT02465567|468410586|FG000|Overall Study|Lack of Efficacy|103|||
130122683|NCT02465567|468410587|FG001|Overall Study|Lack of Efficacy|102|||
130122684|NCT02465567|468410588|FG002|Overall Study|Lack of Efficacy|171|||
130122685|NCT02465567|468410589|FG003|Overall Study|Lack of Efficacy|135|||
130122686|NCT02465567|468410586|FG000|Overall Study|Withdrawal by Subject|104|||
130122687|NCT02465567|468410587|FG001|Overall Study|Withdrawal by Subject|94|||
130122688|NCT02465567|468410588|FG002|Overall Study|Withdrawal by Subject|123|||
130122689|NCT02465567|468410589|FG003|Overall Study|Withdrawal by Subject|130|||
130122690|NCT02465567|468410586|FG000|Overall Study|Physician Decision|23|||
130092055|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130092056|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130092057|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
130092058|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
130092059|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130092060|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130122691|NCT02465567|468410587|FG001|Overall Study|Physician Decision|33|||
130122692|NCT02465567|468410588|FG002|Overall Study|Physician Decision|38|||
130122693|NCT02465567|468410589|FG003|Overall Study|Physician Decision|28|||
129966530|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
129966531|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
129966532|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
129966533|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
130122694|NCT02465567|468410586|FG000|Overall Study|Major Protocol Deviation|24|||
130122695|NCT02465567|468410587|FG001|Overall Study|Major Protocol Deviation|26|||
130122696|NCT02465567|468410588|FG002|Overall Study|Major Protocol Deviation|22|||
130122697|NCT02465567|468410589|FG003|Overall Study|Major Protocol Deviation|25|||
130122698|NCT02465567|468410586|FG000|Overall Study|Lost to Follow-up|25|||
130122699|NCT02465567|468410587|FG001|Overall Study|Lost to Follow-up|21|||
130122700|NCT02465567|468410588|FG002|Overall Study|Lost to Follow-up|19|||
130122701|NCT02465567|468410589|FG003|Overall Study|Lost to Follow-up|15|||
130122702|NCT02465567|468410586|FG000|Overall Study|Protocol Specified Criteria|20|||
129966534|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
129966535|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
129966536|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
129966537|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
129966538|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
129966539|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
129966540|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
129966541|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
129966542|NCT00002597|467841151|FG000|Overall Study|Protocol Violation|19|||
129966543|NCT00002597|467841152|FG001|Overall Study|Protocol Violation|17|||
129966544|NCT00002597|467841151|FG000|Overall Study|Withdrawal by Subject|7|||
129966545|NCT00002597|467841152|FG001|Overall Study|Withdrawal by Subject|6|||
129966546|NCT01426113|467841153|FG000|Overall Study|Study Discontinued|1|||
129966547|NCT01426113|467841154|FG001|Overall Study|Study Discontinued|1|||
129966548|NCT01426113|467841153|FG000|Overall Study|Adverse Event|0|||
129966549|NCT01426113|467841154|FG001|Overall Study|Adverse Event|1|||
129966550|NCT02654132|467841155|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
129966551|NCT02654132|467841156|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
129966552|NCT02654132|467841155|FG000|Treatment Period|Disease progression|43|||
129966553|NCT02654132|467841156|FG001|Treatment Period|Disease progression|38|||
129966554|NCT02654132|467841155|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
129966555|NCT02654132|467841156|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
129966556|NCT02654132|467841155|FG000|Treatment Period|Other reasons|4|||
129966557|NCT02654132|467841156|FG001|Treatment Period|Other reasons|2|||
129966558|NCT02654132|467841155|FG000|Treatment Period|Study drug toxicity|2|||
129966559|NCT02654132|467841156|FG001|Treatment Period|Study drug toxicity|2|||
129966560|NCT02654132|467841155|FG000|Treatment Period|Withdrawal by Subject|2|||
129966561|NCT02654132|467841156|FG001|Treatment Period|Withdrawal by Subject|1|||
129966562|NCT02654132|467841155|FG000|Treatment Period|Maximum Clinical Benefit|0|||
129966563|NCT02654132|467841156|FG001|Treatment Period|Maximum Clinical Benefit|2|||
129966564|NCT02654132|467841155|FG000|Treatment Period|Participant request to discontinue|2|||
129966565|NCT02654132|467841156|FG001|Treatment Period|Participant request to discontinue|0|||
129966566|NCT02654132|467841155|FG000|Treatment Period|Administrative reasons by sponsor|0|||
129966567|NCT02654132|467841156|FG001|Treatment Period|Administrative reasons by sponsor|1|||
129966568|NCT02654132|467841155|FG000|Treatment Period|Death|1|||
129966569|NCT02654132|467841156|FG001|Treatment Period|Death|0|||
129966570|NCT02485899|467841158|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
129966571|NCT02485899|467841159|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129966572|NCT02485899|467841158|FG000|Overall Study|Withdrawal by Subject|1|||
129966573|NCT02485899|467841159|FG001|Overall Study|Withdrawal by Subject|0|||
129966574|NCT02485899|467841158|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
129966575|NCT02485899|467841159|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
129966576|NCT01918371|467841160|FG000|Overall Study|Missing Data|1|||
129966577|NCT01918371|467841161|FG001|Overall Study|Missing Data|1|||
129966578|NCT03517111|467841166|FG000|Enrolled|Withdrawal by Subject|0|||
129966579|NCT03517111|467841167|FG001|Enrolled|Withdrawal by Subject|1|||
129966580|NCT03517111|467841168|FG002|Enrolled|Withdrawal by Subject|0|||
129966581|NCT03517111|467841166|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
129966582|NCT03517111|467841167|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
129966583|NCT03517111|467841168|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
129966584|NCT03517111|467841166|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
129966585|NCT03517111|467841167|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
130122703|NCT02465567|468410587|FG001|Overall Study|Protocol Specified Criteria|10|||
130122704|NCT02465567|468410588|FG002|Overall Study|Protocol Specified Criteria|9|||
129966586|NCT03517111|467841168|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
129966587|NCT03517111|467841166|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
129966588|NCT03517111|467841167|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
129966589|NCT03517111|467841168|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
129966590|NCT03517111|467841166|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
129966591|NCT03517111|467841167|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
129966592|NCT03517111|467841168|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
129966593|NCT00621192|467841169|FG000|Overall Study|Withdrawal by Subject|0|||
129966594|NCT00621192|467841170|FG001|Overall Study|Withdrawal by Subject|0|||
129966595|NCT00621192|467841171|FG002|Overall Study|Withdrawal by Subject|2|||
129966596|NCT00621192|467841172|FG003|Overall Study|Withdrawal by Subject|0|||
129966597|NCT00621192|467841169|FG000|Overall Study|Physician Decision|1|||
129966598|NCT00621192|467841170|FG001|Overall Study|Physician Decision|3|||
129966599|NCT00621192|467841171|FG002|Overall Study|Physician Decision|0|||
129966600|NCT00621192|467841172|FG003|Overall Study|Physician Decision|0|||
129966601|NCT00621192|467841169|FG000|Overall Study|Protocol Violation|1|||
129966602|NCT00621192|467841170|FG001|Overall Study|Protocol Violation|0|||
129966603|NCT00621192|467841171|FG002|Overall Study|Protocol Violation|0|||
129966604|NCT00621192|467841172|FG003|Overall Study|Protocol Violation|1|||
129966605|NCT00621192|467841169|FG000|Overall Study|Adverse Event|0|||
129966606|NCT00621192|467841170|FG001|Overall Study|Adverse Event|1|||
129966607|NCT00621192|467841171|FG002|Overall Study|Adverse Event|0|||
129966608|NCT00621192|467841172|FG003|Overall Study|Adverse Event|1|||
129966609|NCT00621192|467841169|FG000|Overall Study|Death|2|||
129966610|NCT00621192|467841170|FG001|Overall Study|Death|5|||
129966611|NCT00621192|467841171|FG002|Overall Study|Death|0|||
129966612|NCT00621192|467841172|FG003|Overall Study|Death|0|||
129966613|NCT00621192|467841169|FG000|Overall Study|Final Assessments not Completed|0|||
129966614|NCT00621192|467841170|FG001|Overall Study|Final Assessments not Completed|0|||
129966615|NCT00621192|467841171|FG002|Overall Study|Final Assessments not Completed|3|||
129966616|NCT00621192|467841172|FG003|Overall Study|Final Assessments not Completed|1|||
129966617|NCT01880437|467841173|FG000|Overall Study|Death|12|||
129966618|NCT01880437|467841174|FG001|Overall Study|Death|4|||
129966619|NCT01880437|467841175|FG002|Overall Study|Death|17|||
129966620|NCT01880437|467841173|FG000|Overall Study|Study terminated by Sponsor|3|||
129966621|NCT01880437|467841174|FG001|Overall Study|Study terminated by Sponsor|0|||
129966622|NCT01880437|467841175|FG002|Overall Study|Study terminated by Sponsor|2|||
129966623|NCT02725528|467841181|FG000|Overall Study|Lost to Follow-up|1|||
129966624|NCT02725528|467841182|FG001|Overall Study|Lost to Follow-up|4|||
129966625|NCT02725528|467841181|FG000|Overall Study|Withdrawal by Subject|0|||
129966626|NCT02725528|467841182|FG001|Overall Study|Withdrawal by Subject|1|||
129966627|NCT02569957|467841183|FG000|Overall Study|Withdrawal by Subject|0|||
129966628|NCT02569957|467841184|FG001|Overall Study|Withdrawal by Subject|1|||
129966629|NCT04354168|467841185|FG000|Overall Study|Lost to Follow-up|22|||
129966630|NCT02804399|467841190|FG000|Period 2|Adverse Event|0|||
129966631|NCT02804399|467841191|FG001|Period 2|Adverse Event|1|||
129966632|NCT04211389|467841192|FG000|Overall Study|Adverse Event|1|||
129966633|NCT04211389|467841193|FG001|Overall Study|Adverse Event|2|||
129966634|NCT04211389|467841192|FG000|Overall Study|Lost to Follow-up|15|||
129966635|NCT04211389|467841193|FG001|Overall Study|Lost to Follow-up|7|||
129966636|NCT04211389|467841192|FG000|Overall Study|Protocol Violation|0|||
129966637|NCT04211389|467841193|FG001|Overall Study|Protocol Violation|1|||
129966638|NCT04211389|467841192|FG000|Overall Study|Withdrawal by Subject|10|||
129966639|NCT04211389|467841193|FG001|Overall Study|Withdrawal by Subject|11|||
129966640|NCT01062971|467841200|FG000|Overall Study|Protocol Violation|1|||
129966641|NCT01062971|467841201|FG001|Overall Study|Protocol Violation|3|||
129966642|NCT01062971|467841200|FG000|Overall Study|Lost to Follow-up|3|||
129966643|NCT01062971|467841201|FG001|Overall Study|Lost to Follow-up|4|||
129966644|NCT01530087|467841202|FG000|Overall Study|Physician Decision|2|||
129966645|NCT05523219|467841203|FG000|Overall Study|Wrong inclusion|1|||
129966646|NCT05523219|467841203|FG000|Overall Study|Lost to Follow-up|7|||
129966647|NCT01182207|467841204|FG000|First Intervention|Positive Hepatitis Results|0|||
129966648|NCT01182207|467841205|FG001|First Intervention|Positive Hepatitis Results|1|||
129966649|NCT01182207|467841204|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
129966650|NCT01182207|467841205|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
129966651|NCT01161628|467841206|FG000|Overall Study|Death|6|||
129966652|NCT01161628|467841206|FG000|Overall Study|Lack of Efficacy|2|||
129966653|NCT02037256|467841209|FG000|Overall Study|Protocol Violation|0|||
129966654|NCT02037256|467841210|FG001|Overall Study|Protocol Violation|1|||
129966655|NCT02037256|467841209|FG000|Overall Study|Withdrawn prior to Velcade|0|||
129966656|NCT02037256|467841210|FG001|Overall Study|Withdrawn prior to Velcade|2|||
129966657|NCT04398368|467843025|FG000|Overall Study|Withdrawal by Subject|2|||
130122705|NCT02465567|468410589|FG003|Overall Study|Protocol Specified Criteria|12|||
130122706|NCT02465567|468410586|FG000|Overall Study|Administrative Reasons|12|||
129966658|NCT00328562|467843032|FG000|Overall Study|Disease progression|1|||
129966659|NCT04486313|467843033|FG000|Overall Study|Lost to Follow-up|7|||
129966660|NCT04486313|467843034|FG001|Overall Study|Lost to Follow-up|9|||
129966661|NCT04486313|467843033|FG000|Overall Study|Withdrawal by Subject|8|||
129966662|NCT04486313|467843034|FG001|Overall Study|Withdrawal by Subject|6|||
129966663|NCT04486313|467843033|FG000|Overall Study|Physician Decision|1|||
129966664|NCT04486313|467843034|FG001|Overall Study|Physician Decision|1|||
129966665|NCT04486313|467843033|FG000|Overall Study|Death|2|||
129966666|NCT04486313|467843034|FG001|Overall Study|Death|0|||
129966667|NCT04486313|467843033|FG000|Overall Study|Protocol Violation|1|||
129966668|NCT04486313|467843034|FG001|Overall Study|Protocol Violation|1|||
129966669|NCT00412880|467843035|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
129966670|NCT00412880|467843035|FG000|Overall Study|Consent withdrawn|1|||
129966671|NCT00412880|467843035|FG000|Overall Study|Adverse Event|1|||
129966672|NCT00412880|467843035|FG000|Overall Study|Progressive disease|20|||
129966673|NCT01288209|467843036|FG000|Overall Study|Withdrawal by Subject|1|||
129966674|NCT01288209|467843037|FG001|Overall Study|Withdrawal by Subject|3|||
129966675|NCT01288209|467843036|FG000|Overall Study|Other|1|||
129966676|NCT01288209|467843037|FG001|Overall Study|Other|0|||
129966677|NCT01496365|467843038|FG000|Overall Study|Adverse Event|2|||
129966678|NCT01496365|467843039|FG001|Overall Study|Adverse Event|3|||
129966679|NCT01496365|467843040|FG002|Overall Study|Adverse Event|3|||
129966680|NCT01496365|467843041|FG003|Overall Study|Adverse Event|2|||
129966681|NCT01496365|467843042|FG004|Overall Study|Adverse Event|5|||
129966682|NCT01496365|467843043|FG005|Overall Study|Adverse Event|6|||
129966683|NCT01496365|467843044|FG006|Overall Study|Adverse Event|4|||
129966684|NCT01496365|467843038|FG000|Overall Study|Withdrawal by Subject|6|||
129966685|NCT01496365|467843039|FG001|Overall Study|Withdrawal by Subject|6|||
129966686|NCT01496365|467843040|FG002|Overall Study|Withdrawal by Subject|0|||
129966687|NCT01496365|467843041|FG003|Overall Study|Withdrawal by Subject|1|||
129966688|NCT01496365|467843042|FG004|Overall Study|Withdrawal by Subject|3|||
129966689|NCT01496365|467843043|FG005|Overall Study|Withdrawal by Subject|2|||
129966690|NCT01496365|467843044|FG006|Overall Study|Withdrawal by Subject|1|||
129966691|NCT01496365|467843038|FG000|Overall Study|Protocol Violation|2|||
129966692|NCT01496365|467843039|FG001|Overall Study|Protocol Violation|1|||
129966693|NCT01496365|467843040|FG002|Overall Study|Protocol Violation|1|||
129966694|NCT01496365|467843041|FG003|Overall Study|Protocol Violation|0|||
129966695|NCT01496365|467843042|FG004|Overall Study|Protocol Violation|0|||
129966696|NCT01496365|467843043|FG005|Overall Study|Protocol Violation|1|||
129966697|NCT01496365|467843044|FG006|Overall Study|Protocol Violation|0|||
129966698|NCT01496365|467843038|FG000|Overall Study|Lack of Efficacy|1|||
129966699|NCT01496365|467843039|FG001|Overall Study|Lack of Efficacy|0|||
129966700|NCT01496365|467843040|FG002|Overall Study|Lack of Efficacy|0|||
129966701|NCT01496365|467843041|FG003|Overall Study|Lack of Efficacy|0|||
129966702|NCT01496365|467843042|FG004|Overall Study|Lack of Efficacy|0|||
129966703|NCT01496365|467843043|FG005|Overall Study|Lack of Efficacy|1|||
129966704|NCT01496365|467843044|FG006|Overall Study|Lack of Efficacy|0|||
129966705|NCT01496365|467843038|FG000|Overall Study|Lost to Follow-up|0|||
129966706|NCT01496365|467843039|FG001|Overall Study|Lost to Follow-up|1|||
129966707|NCT01496365|467843040|FG002|Overall Study|Lost to Follow-up|0|||
129966708|NCT01496365|467843041|FG003|Overall Study|Lost to Follow-up|0|||
129966709|NCT01496365|467843042|FG004|Overall Study|Lost to Follow-up|2|||
129966710|NCT01496365|467843043|FG005|Overall Study|Lost to Follow-up|0|||
129966711|NCT01496365|467843044|FG006|Overall Study|Lost to Follow-up|0|||
129966712|NCT01496365|467843038|FG000|Overall Study|Other|4|||
129966713|NCT01496365|467843039|FG001|Overall Study|Other|4|||
129966714|NCT01496365|467843040|FG002|Overall Study|Other|2|||
129966715|NCT01496365|467843041|FG003|Overall Study|Other|1|||
129966716|NCT01496365|467843042|FG004|Overall Study|Other|3|||
129966717|NCT01496365|467843043|FG005|Overall Study|Other|0|||
129966718|NCT01496365|467843044|FG006|Overall Study|Other|1|||
129966719|NCT01843777|467843045|FG000|Overall Study|Withdrawal by Subject|1|||
129966720|NCT01843777|467843046|FG001|Overall Study|Withdrawal by Subject|0|||
129966721|NCT02165397|467843054|FG000|Overall Study|Death|7|||
129966722|NCT02165397|467843055|FG001|Overall Study|Death|10|||
129966723|NCT02165397|467843056|FG002|Overall Study|Death|8|||
129966724|NCT02165397|467843054|FG000|Overall Study|Lost to Follow-up|1|||
129966725|NCT02165397|467843055|FG001|Overall Study|Lost to Follow-up|3|||
130092061|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
130092062|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
130092063|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
130092064|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
130092065|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130092066|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130092067|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130092068|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130122707|NCT02465567|468410587|FG001|Overall Study|Administrative Reasons|9|||
129966726|NCT02165397|467843056|FG002|Overall Study|Lost to Follow-up|0|||
129966727|NCT02165397|467843054|FG000|Overall Study|Withdrawal by Subject|6|||
129966728|NCT02165397|467843055|FG001|Overall Study|Withdrawal by Subject|6|||
129966729|NCT02165397|467843056|FG002|Overall Study|Withdrawal by Subject|1|||
129966730|NCT02165397|467843054|FG000|Overall Study|Other, Not Specified|0|||
129966731|NCT02165397|467843055|FG001|Overall Study|Other, Not Specified|0|||
129966732|NCT02165397|467843056|FG002|Overall Study|Other, Not Specified|1|||
129966733|NCT02250534|467843065|FG000|Overall Study|Lost to Follow-up|18|||
129966734|NCT02250534|467843066|FG001|Overall Study|Lost to Follow-up|28|||
129966735|NCT02250534|467843067|FG002|Overall Study|Lost to Follow-up|33|||
129966736|NCT02250534|467843065|FG000|Overall Study|Personal reasons|7|||
129966737|NCT02250534|467843066|FG001|Overall Study|Personal reasons|8|||
129966738|NCT02250534|467843067|FG002|Overall Study|Personal reasons|14|||
129966739|NCT02250534|467843065|FG000|Overall Study|Adverse Event|6|||
129966740|NCT02250534|467843066|FG001|Overall Study|Adverse Event|3|||
129966741|NCT02250534|467843067|FG002|Overall Study|Adverse Event|8|||
129966742|NCT02250534|467843065|FG000|Overall Study|incarcerated|2|||
129966743|NCT02250534|467843066|FG001|Overall Study|incarcerated|1|||
129966744|NCT02250534|467843067|FG002|Overall Study|incarcerated|2|||
129966745|NCT02250534|467843065|FG000|Overall Study|Withdrawal by Subject|0|||
129966746|NCT02250534|467843066|FG001|Overall Study|Withdrawal by Subject|1|||
129966747|NCT02250534|467843067|FG002|Overall Study|Withdrawal by Subject|2|||
129966748|NCT02250534|467843065|FG000|Overall Study|Death|0|||
129966749|NCT02250534|467843066|FG001|Overall Study|Death|1|||
129966750|NCT02250534|467843067|FG002|Overall Study|Death|1|||
129966751|NCT02250534|467843065|FG000|Overall Study|Physician Decision|1|||
129966752|NCT02250534|467843066|FG001|Overall Study|Physician Decision|3|||
129966753|NCT02250534|467843067|FG002|Overall Study|Physician Decision|1|||
129966754|NCT02250534|467843065|FG000|Overall Study|Protocol Violation|1|||
129966755|NCT02250534|467843066|FG001|Overall Study|Protocol Violation|0|||
129966756|NCT02250534|467843067|FG002|Overall Study|Protocol Violation|1|||
129966757|NCT02250534|467843065|FG000|Overall Study|Reason unknown|1|||
129966758|NCT02250534|467843066|FG001|Overall Study|Reason unknown|0|||
129966759|NCT02250534|467843067|FG002|Overall Study|Reason unknown|0|||
129966760|NCT00217022|467843068|FG000|Overall Study|Withdrawal by Subject|1|||
129966761|NCT00217022|467843069|FG001|Overall Study|Withdrawal by Subject|1|||
129966762|NCT01182181|467843070|FG000|First Intervention|Adverse Event|1|||
129966763|NCT01182181|467843071|FG001|First Intervention|Adverse Event|0|||
129966764|NCT01182181|467843070|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
129966765|NCT01182181|467843071|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
130092069|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
130092070|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
130092071|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130092072|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130092073|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130092074|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
130092075|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130092076|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
130092077|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130092078|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130092079|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130092080|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
130092081|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130092082|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
130092083|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130092084|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130092085|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
130092086|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
130092087|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
130092088|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
130092089|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130092090|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130092091|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
130092092|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
130092093|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
130092094|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
130092095|NCT04594213|468292539|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
130092096|NCT04594213|468292540|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
130092097|NCT04594213|468292541|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
130092098|NCT04594213|468292542|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
130092099|NCT04594213|468292543|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
130092100|NCT04594213|468292544|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
130092101|NCT02046993|468292546|FG000|Overall Study|Withdrawal by Subject|2|||
130092102|NCT02046993|468292547|FG001|Overall Study|Withdrawal by Subject|10|||
130092103|NCT02046993|468292546|FG000|Overall Study|Lost to Follow-up|1|||
130092104|NCT02046993|468292547|FG001|Overall Study|Lost to Follow-up|1|||
130092105|NCT00679354|468292552|FG000|Overall Study|Death|3|||
130092106|NCT00679354|468292552|FG000|Overall Study|Lack of Efficacy|22|||
130092107|NCT00679354|468292552|FG000|Overall Study|Physician Decision|4|||
130092108|NCT00679354|468292552|FG000|Overall Study|Ineligible|1|||
130092109|NCT01654666|468292557|FG000|Overall Study|Protocol Violation|7|||
130092110|NCT01654666|468292558|FG001|Overall Study|Protocol Violation|4|||
130092111|NCT01654666|468292559|FG002|Overall Study|Protocol Violation|8|||
130092112|NCT01654666|468292557|FG000|Overall Study|Lost to Follow-up|4|||
130092113|NCT01654666|468292558|FG001|Overall Study|Lost to Follow-up|5|||
130092114|NCT01654666|468292559|FG002|Overall Study|Lost to Follow-up|5|||
130092115|NCT01654666|468292557|FG000|Overall Study|Withdrawal by Subject|4|||
130092116|NCT01654666|468292558|FG001|Overall Study|Withdrawal by Subject|4|||
130092117|NCT01654666|468292559|FG002|Overall Study|Withdrawal by Subject|1|||
129966766|NCT03845075|467843072|FG000|Part 1 - DB|Withdrawal by Subject|1|||
129966767|NCT03845075|467843073|FG001|Part 1 - DB|Withdrawal by Subject|1|||
130092118|NCT00535262|468292562|FG000|Overall Study|No funding|3|||
129966768|NCT03845075|467843074|FG002|Part 1 - DB|Withdrawal by Subject|0|||
129966769|NCT03845075|467843075|FG003|Part 1 - DB|Withdrawal by Subject|0|||
129966770|NCT03845075|467843072|FG000|Part 1 - DB|Adverse Event|0|||
129966771|NCT03845075|467843073|FG001|Part 1 - DB|Adverse Event|1|||
129966772|NCT03845075|467843074|FG002|Part 1 - DB|Adverse Event|0|||
129966773|NCT03845075|467843075|FG003|Part 1 - DB|Adverse Event|0|||
129966774|NCT03845075|467843072|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
129966775|NCT03845075|467843073|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
129966776|NCT03845075|467843074|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
129966777|NCT03845075|467843075|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
129966778|NCT03856047|467843076|FG000|Overall Study|Withdrawal by Subject|0|||
129966779|NCT03856047|467843077|FG001|Overall Study|Withdrawal by Subject|1|||
129966780|NCT03856047|467843078|FG002|Overall Study|Withdrawal by Subject|1|||
129966781|NCT03856047|467843079|FG003|Overall Study|Withdrawal by Subject|0|||
129966782|NCT03856047|467843080|FG004|Overall Study|Withdrawal by Subject|3|||
129966783|NCT03856047|467843081|FG005|Overall Study|Withdrawal by Subject|0|||
129966784|NCT03856047|467843082|FG006|Overall Study|Withdrawal by Subject|2|||
129966785|NCT03856047|467843076|FG000|Overall Study|Lost to Follow-up|4|||
129966786|NCT03856047|467843077|FG001|Overall Study|Lost to Follow-up|2|||
129966787|NCT03856047|467843078|FG002|Overall Study|Lost to Follow-up|3|||
129966788|NCT03856047|467843079|FG003|Overall Study|Lost to Follow-up|1|||
129966789|NCT03856047|467843080|FG004|Overall Study|Lost to Follow-up|4|||
129966790|NCT03856047|467843081|FG005|Overall Study|Lost to Follow-up|4|||
129966791|NCT03856047|467843082|FG006|Overall Study|Lost to Follow-up|4|||
129966792|NCT01278615|467843083|FG000|Overall Study|Withdrawal by Subject|2|||
129966793|NCT00905359|467843084|FG000|Overall Study|Lost to Follow-up|17|||
129966794|NCT00905359|467843085|FG001|Overall Study|Lost to Follow-up|10|||
129966795|NCT00905359|467843084|FG000|Overall Study|Death|2|||
129966796|NCT00905359|467843085|FG001|Overall Study|Death|0|||
129966797|NCT00905359|467843084|FG000|Overall Study|Withdrawal consent|5|||
129966798|NCT00905359|467843085|FG001|Overall Study|Withdrawal consent|6|||
129966799|NCT02138253|467843086|FG000|Overall Study|Adverse Event|3|||
129966800|NCT02138253|467843087|FG001|Overall Study|Adverse Event|3|||
129966801|NCT02138253|467843086|FG000|Overall Study|Lost to Follow-up|2|||
129966802|NCT02138253|467843087|FG001|Overall Study|Lost to Follow-up|1|||
129966803|NCT02138253|467843086|FG000|Overall Study|Physician Decision|2|||
129966804|NCT02138253|467843087|FG001|Overall Study|Physician Decision|0|||
129966805|NCT02138253|467843086|FG000|Overall Study|Non compliance|1|||
129966806|NCT02138253|467843087|FG001|Overall Study|Non compliance|0|||
129966807|NCT02138253|467843086|FG000|Overall Study|Withdrawal by Subject|1|||
129966808|NCT02138253|467843087|FG001|Overall Study|Withdrawal by Subject|0|||
129966809|NCT02872012|467843088|FG000|Overall Study|Withdrawal by Subject|1|||
129966810|NCT02872012|467843089|FG001|Overall Study|Withdrawal by Subject|0|||
129966811|NCT02872012|467843090|FG002|Overall Study|Withdrawal by Subject|0|||
129966812|NCT02872012|467843091|FG003|Overall Study|Withdrawal by Subject|0|||
129966813|NCT02872012|467843092|FG004|Overall Study|Withdrawal by Subject|0|||
129966814|NCT01728623|467843093|FG000|Overall Study|Disease progression|26|||
129966815|NCT01728623|467843093|FG000|Overall Study|Adverse Event|1|||
129966816|NCT01728623|467843093|FG000|Overall Study|Withdrawal by Subject|1|||
129966817|NCT00243022|467843094|FG000|Overall Study|Withdrawal by Subject|1|||
129966818|NCT00243022|467843095|FG001|Overall Study|Withdrawal by Subject|0|||
129966819|NCT00243022|467843094|FG000|Overall Study|Death|1|||
129966820|NCT00243022|467843095|FG001|Overall Study|Death|0|||
129966821|NCT00243022|467843094|FG000|Overall Study|Difficult Travel Distance|0|||
129966822|NCT00243022|467843095|FG001|Overall Study|Difficult Travel Distance|1|||
129966823|NCT04706793|467843096|FG000|Treatment|Disease worsening|10|||
129966824|NCT04706793|467843097|FG001|Treatment|Disease worsening|10|||
129966825|NCT04706793|467843096|FG000|Follow-up|Lack of Efficacy|1|||
129966826|NCT04706793|467843097|FG001|Follow-up|Lack of Efficacy|0|||
129966827|NCT04706793|467843096|FG000|Follow-up|Disease worsening|8|||
129966828|NCT04706793|467843097|FG001|Follow-up|Disease worsening|10|||
129966829|NCT04706793|467843096|FG000|Follow-up|Adverse Event|1|||
129966830|NCT04706793|467843097|FG001|Follow-up|Adverse Event|0|||
129966831|NCT03713320|467843100|FG000|Randomized Period|Adverse Event|1|||
129966832|NCT03713320|467843101|FG001|Randomized Period|Adverse Event|5|||
129966833|NCT03713320|467843102|FG002|Randomized Period|Adverse Event|0|||
129966834|NCT03713320|467843100|FG000|Randomized Period|Physician Decision|1|||
130092119|NCT02898662|468292563|FG000|Overall Study|Adverse Event|1|||
130092120|NCT02898662|468292564|FG001|Overall Study|Adverse Event|0|||
129966835|NCT03713320|467843101|FG001|Randomized Period|Physician Decision|1|||
129966836|NCT03713320|467843102|FG002|Randomized Period|Physician Decision|0|||
129966837|NCT03713320|467843100|FG000|Randomized Period|Withdrawal by Subject|4|||
129966838|NCT03713320|467843101|FG001|Randomized Period|Withdrawal by Subject|0|||
129966839|NCT03713320|467843102|FG002|Randomized Period|Withdrawal by Subject|0|||
129966840|NCT03713320|467843100|FG000|Randomized Period|Participant decision|3|||
129966841|NCT03713320|467843101|FG001|Randomized Period|Participant decision|1|||
129966842|NCT03713320|467843102|FG002|Randomized Period|Participant decision|0|||
129966843|NCT03713320|467843100|FG000|Randomized Period|Study terminated by sponsor|6|||
129966844|NCT03713320|467843101|FG001|Randomized Period|Study terminated by sponsor|3|||
129966845|NCT03713320|467843102|FG002|Randomized Period|Study terminated by sponsor|0|||
129966846|NCT03713320|467843100|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
129966847|NCT03713320|467843101|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
129966848|NCT03713320|467843102|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
129966849|NCT03713320|467843100|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
129966850|NCT03713320|467843101|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
129966851|NCT03713320|467843102|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
129966852|NCT01781832|467843103|FG000|Overall Study|Withdrawal by Subject|1|||
129966853|NCT02719743|467843104|FG000|Overall Study|Consent withdrawal|0|||
129966854|NCT02719743|467843105|FG001|Overall Study|Consent withdrawal|2|||
129966855|NCT02719743|467843106|FG002|Overall Study|Consent withdrawal|0|||
129966856|NCT02719743|467843107|FG003|Overall Study|Consent withdrawal|1|||
129966857|NCT02719743|467843108|FG004|Overall Study|Consent withdrawal|0|||
129966858|NCT02719743|467843104|FG000|Overall Study|Migrated/moved from study area|0|||
129966859|NCT02719743|467843105|FG001|Overall Study|Migrated/moved from study area|0|||
129966860|NCT02719743|467843106|FG002|Overall Study|Migrated/moved from study area|0|||
129966861|NCT02719743|467843107|FG003|Overall Study|Migrated/moved from study area|0|||
129966862|NCT02719743|467843108|FG004|Overall Study|Migrated/moved from study area|2|||
129966863|NCT02719743|467843104|FG000|Overall Study|Lost to Follow-up|1|||
129966864|NCT02719743|467843105|FG001|Overall Study|Lost to Follow-up|1|||
129966865|NCT02719743|467843106|FG002|Overall Study|Lost to Follow-up|0|||
129966866|NCT02719743|467843107|FG003|Overall Study|Lost to Follow-up|0|||
129966867|NCT02719743|467843108|FG004|Overall Study|Lost to Follow-up|0|||
129966868|NCT01209598|467843109|FG000|Overall Study|Withdrawal by Subject|1|||
129966869|NCT01209598|467843110|FG001|Overall Study|Withdrawal by Subject|0|||
129966870|NCT02601209|467843111|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
129966871|NCT02601209|467843112|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
129966872|NCT02601209|467843113|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
129966873|NCT02601209|467843114|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966874|NCT02601209|467843115|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966875|NCT02601209|467843116|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966876|NCT02601209|467843117|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966877|NCT02601209|467843118|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966878|NCT02601209|467843119|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966879|NCT02601209|467843111|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966880|NCT02601209|467843112|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966881|NCT02601209|467843113|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966882|NCT02601209|467843114|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966883|NCT02601209|467843115|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
129966884|NCT02601209|467843116|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
129966885|NCT02601209|467843117|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
129966886|NCT02601209|467843118|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966887|NCT02601209|467843119|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966888|NCT03636373|467843120|FG000|Overall Study|Study closure due to Covid-19|1|||
129966889|NCT03636373|467843121|FG001|Overall Study|Study closure due to Covid-19|0|||
129966890|NCT00572533|467843122|FG000|Overall Study|Death|4|||
129966891|NCT00572533|467843123|FG001|Overall Study|Death|1|||
129966892|NCT00572533|467843122|FG000|Overall Study|Received Kidney Transplant|2|||
129966893|NCT00572533|467843123|FG001|Overall Study|Received Kidney Transplant|1|||
129966894|NCT00572533|467843122|FG000|Overall Study|Social Issues|1|||
129966895|NCT00572533|467843123|FG001|Overall Study|Social Issues|0|||
129966896|NCT00572533|467843122|FG000|Overall Study|Transfer out of Facility|0|||
129966897|NCT00572533|467843123|FG001|Overall Study|Transfer out of Facility|1|||
129966898|NCT03772613|467843124|FG000|Overall Study|Lost to Follow-up|0|||
129966899|NCT03772613|467843125|FG001|Overall Study|Lost to Follow-up|1|||
129966900|NCT03772613|467843126|FG002|Overall Study|Lost to Follow-up|1|||
129966901|NCT01427738|467843127|FG000|Overall Study|Death|12|||
129966902|NCT01427738|467843128|FG001|Overall Study|Death|9|||
129966903|NCT01427738|467843127|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129966904|NCT01427738|467843128|FG001|Overall Study|Severe debilitation, unable to continue|1|||
129966905|NCT01427738|467843127|FG000|Overall Study|Subject unable to get to clinic|5|||
129966906|NCT01427738|467843128|FG001|Overall Study|Subject unable to get to clinic|2|||
129966907|NCT01427738|467843127|FG000|Overall Study|Withdrawal by Subject|0|||
129966908|NCT01427738|467843128|FG001|Overall Study|Withdrawal by Subject|2|||
129966909|NCT01427738|467843127|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
129966910|NCT01427738|467843128|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
129966911|NCT01427738|467843127|FG000|Overall Study|Lost to Follow-up|1|||
129966912|NCT01427738|467843128|FG001|Overall Study|Lost to Follow-up|5|||
129966913|NCT00661713|467843129|FG000|Overall Study|Death|1|||
129966914|NCT00661713|467843130|FG001|Overall Study|Death|0|||
129966915|NCT00661713|467843131|FG002|Overall Study|Death|0|||
130092121|NCT02898662|468292563|FG000|Overall Study|Loss of asthma control|23|||
130092122|NCT02898662|468292564|FG001|Overall Study|Loss of asthma control|24|||
130092123|NCT02898662|468292563|FG000|Overall Study|Withdrawal by Subject|4|||
130092124|NCT02898662|468292564|FG001|Overall Study|Withdrawal by Subject|1|||
130092125|NCT02898662|468292563|FG000|Overall Study|Technical issue|0|||
130092126|NCT02898662|468292564|FG001|Overall Study|Technical issue|1|||
130092127|NCT02898662|468292563|FG000|Overall Study|Randomized in error|0|||
130092128|NCT02898662|468292564|FG001|Overall Study|Randomized in error|1|||
130092129|NCT02898662|468292563|FG000|Overall Study|Subject decision|1|||
130092130|NCT02898662|468292564|FG001|Overall Study|Subject decision|0|||
130092131|NCT02898662|468292563|FG000|Overall Study|Other|0|||
130092132|NCT02898662|468292564|FG001|Overall Study|Other|1|||
130092133|NCT03802331|468292565|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
130092134|NCT03802331|468292566|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
130092135|NCT00917553|468292567|FG000|Overall Study|Lost to Follow-up|2|||
130092136|NCT00917553|468292568|FG001|Overall Study|Lost to Follow-up|1|||
130092137|NCT01616173|468292569|FG000|Overall Study|Lost to Follow-up|0|||
130092138|NCT01616173|468292570|FG001|Overall Study|Lost to Follow-up|2|||
130092139|NCT01616173|468292571|FG002|Overall Study|Lost to Follow-up|0|||
130092140|NCT00672490|468292573|FG000|Overall Study|Withdrawal by Subject|8|||
130092141|NCT00672490|468292574|FG001|Overall Study|Withdrawal by Subject|8|||
130092142|NCT00672490|468292573|FG000|Overall Study|Lack of Compliance|2|||
130092143|NCT00672490|468292574|FG001|Overall Study|Lack of Compliance|7|||
130092144|NCT00672490|468292573|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
130092145|NCT00672490|468292574|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
130092146|NCT00672490|468292573|FG000|Overall Study|Adverse Event|5|||
130092147|NCT00672490|468292574|FG001|Overall Study|Adverse Event|8|||
130092148|NCT00672490|468292573|FG000|Overall Study|Violation of Concomitant Medicine|1|||
130092149|NCT00672490|468292574|FG001|Overall Study|Violation of Concomitant Medicine|0|||
130092150|NCT00672490|468292573|FG000|Overall Study|Intolerance|0|||
130092151|NCT00672490|468292574|FG001|Overall Study|Intolerance|2|||
130092152|NCT00672490|468292573|FG000|Overall Study|Lost to Follow-up|1|||
130092153|NCT00672490|468292574|FG001|Overall Study|Lost to Follow-up|5|||
130092154|NCT00672490|468292573|FG000|Overall Study|No reason was provided|6|||
130092155|NCT00672490|468292574|FG001|Overall Study|No reason was provided|2|||
130092156|NCT03604159|468292579|FG000|Overall Study|Lost to Follow-up|6|||
130092157|NCT03604159|468292580|FG001|Overall Study|Lost to Follow-up|7|||
130092158|NCT04533204|468292583|FG000|Overall Study|Unable to understand training instructions|1|||
130092159|NCT04533204|468292584|FG001|Overall Study|Unable to understand training instructions|1|||
130092160|NCT03982069|468292585|FG000|Overall Study|Lost to Follow-up|5|||
130092161|NCT03982069|468292586|FG001|Overall Study|Lost to Follow-up|5|||
130092162|NCT03982069|468292587|FG002|Overall Study|Lost to Follow-up|3|||
130092163|NCT03982069|468292588|FG003|Overall Study|Lost to Follow-up|5|||
130092164|NCT03982069|468292585|FG000|Overall Study|Physician Decision|0|||
130092165|NCT03982069|468292586|FG001|Overall Study|Physician Decision|1|||
130092166|NCT03982069|468292587|FG002|Overall Study|Physician Decision|0|||
130092167|NCT03982069|468292588|FG003|Overall Study|Physician Decision|0|||
130092168|NCT03982069|468292585|FG000|Overall Study|Withdrawal by Subject|2|||
130092169|NCT03982069|468292586|FG001|Overall Study|Withdrawal by Subject|1|||
130092170|NCT03982069|468292587|FG002|Overall Study|Withdrawal by Subject|5|||
130092171|NCT03982069|468292588|FG003|Overall Study|Withdrawal by Subject|2|||
130092172|NCT03982069|468292585|FG000|Overall Study|Specimen loss|3|||
130092173|NCT03982069|468292586|FG001|Overall Study|Specimen loss|3|||
130092174|NCT03982069|468292587|FG002|Overall Study|Specimen loss|1|||
130092175|NCT03982069|468292588|FG003|Overall Study|Specimen loss|1|||
130092176|NCT01218477|468292589|FG000|Overall Study|Disease progression|2|||
130092177|NCT01218477|468292590|FG001|Overall Study|Disease progression|3|||
130092178|NCT01218477|468292591|FG002|Overall Study|Disease progression|6|||
130092179|NCT01218477|468292592|FG003|Overall Study|Disease progression|2|||
130092180|NCT01218477|468292589|FG000|Overall Study|Study drug toxicity|0|||
130092181|NCT01218477|468292590|FG001|Overall Study|Study drug toxicity|2|||
130092182|NCT01218477|468292591|FG002|Overall Study|Study drug toxicity|5|||
130092183|NCT01218477|468292592|FG003|Overall Study|Study drug toxicity|0|||
130092184|NCT01218477|468292589|FG000|Overall Study|No longer meets study criteria|1|||
130092185|NCT01218477|468292590|FG001|Overall Study|No longer meets study criteria|0|||
130092186|NCT01218477|468292591|FG002|Overall Study|No longer meets study criteria|0|||
130092187|NCT01218477|468292592|FG003|Overall Study|No longer meets study criteria|0|||
130092188|NCT01218477|468292589|FG000|Overall Study|Withdrawal by Subject|0|||
130092189|NCT01218477|468292590|FG001|Overall Study|Withdrawal by Subject|0|||
130092190|NCT01218477|468292591|FG002|Overall Study|Withdrawal by Subject|1|||
130092191|NCT01218477|468292592|FG003|Overall Study|Withdrawal by Subject|0|||
130092192|NCT01218477|468292589|FG000|Overall Study|Prepared for cell transplantation|0|||
130092193|NCT01218477|468292590|FG001|Overall Study|Prepared for cell transplantation|1|||
130092194|NCT01218477|468292591|FG002|Overall Study|Prepared for cell transplantation|1|||
130092195|NCT01218477|468292592|FG003|Overall Study|Prepared for cell transplantation|0|||
130092196|NCT01218477|468292589|FG000|Overall Study|Administrative reason by sponsor|0|||
130092197|NCT01218477|468292590|FG001|Overall Study|Administrative reason by sponsor|0|||
129966916|NCT00661713|467843132|FG003|Overall Study|Death|0|||
129966917|NCT00661713|467843133|FG004|Overall Study|Death|1|||
129966918|NCT00661713|467843134|FG005|Overall Study|Death|0|||
129966919|NCT00661713|467843135|FG006|Overall Study|Death|0|||
129966920|NCT00661713|467843136|FG007|Overall Study|Death|0|||
129966921|NCT00661713|467843129|FG000|Overall Study|Unable to Classify|1|||
129966922|NCT00661713|467843130|FG001|Overall Study|Unable to Classify|0|||
129966923|NCT00661713|467843131|FG002|Overall Study|Unable to Classify|0|||
129966924|NCT00661713|467843132|FG003|Overall Study|Unable to Classify|0|||
129966925|NCT00661713|467843133|FG004|Overall Study|Unable to Classify|0|||
129966926|NCT00661713|467843134|FG005|Overall Study|Unable to Classify|0|||
129966927|NCT00661713|467843135|FG006|Overall Study|Unable to Classify|0|||
129966928|NCT00661713|467843136|FG007|Overall Study|Unable to Classify|0|||
129966929|NCT00661713|467843129|FG000|Overall Study|Protocol Violation|1|||
129966930|NCT00661713|467843130|FG001|Overall Study|Protocol Violation|6|||
129966931|NCT00661713|467843131|FG002|Overall Study|Protocol Violation|3|||
129966932|NCT00661713|467843132|FG003|Overall Study|Protocol Violation|3|||
129966933|NCT00661713|467843133|FG004|Overall Study|Protocol Violation|0|||
129966934|NCT00661713|467843134|FG005|Overall Study|Protocol Violation|2|||
129966935|NCT00661713|467843135|FG006|Overall Study|Protocol Violation|2|||
129966936|NCT00661713|467843136|FG007|Overall Study|Protocol Violation|1|||
129966937|NCT00661713|467843129|FG000|Overall Study|Withdrawal by Subject|11|||
129966938|NCT00661713|467843130|FG001|Overall Study|Withdrawal by Subject|25|||
129966939|NCT00661713|467843131|FG002|Overall Study|Withdrawal by Subject|12|||
129966940|NCT00661713|467843132|FG003|Overall Study|Withdrawal by Subject|21|||
129966941|NCT00661713|467843133|FG004|Overall Study|Withdrawal by Subject|12|||
129966942|NCT00661713|467843134|FG005|Overall Study|Withdrawal by Subject|26|||
129966943|NCT00661713|467843135|FG006|Overall Study|Withdrawal by Subject|45|||
129966944|NCT00661713|467843136|FG007|Overall Study|Withdrawal by Subject|9|||
129966945|NCT00661713|467843129|FG000|Overall Study|Lost to Follow-up|2|||
129966946|NCT00661713|467843130|FG001|Overall Study|Lost to Follow-up|7|||
129966947|NCT00661713|467843131|FG002|Overall Study|Lost to Follow-up|2|||
129966948|NCT00661713|467843132|FG003|Overall Study|Lost to Follow-up|2|||
129966949|NCT00661713|467843133|FG004|Overall Study|Lost to Follow-up|5|||
129966950|NCT00661713|467843134|FG005|Overall Study|Lost to Follow-up|7|||
129966951|NCT00661713|467843135|FG006|Overall Study|Lost to Follow-up|14|||
129966952|NCT00661713|467843136|FG007|Overall Study|Lost to Follow-up|1|||
129966953|NCT00661713|467843129|FG000|Overall Study|Administrative Reason|0|||
129966954|NCT00661713|467843130|FG001|Overall Study|Administrative Reason|1|||
129966955|NCT00661713|467843131|FG002|Overall Study|Administrative Reason|0|||
129966956|NCT00661713|467843132|FG003|Overall Study|Administrative Reason|2|||
129966957|NCT00661713|467843133|FG004|Overall Study|Administrative Reason|2|||
129966958|NCT00661713|467843134|FG005|Overall Study|Administrative Reason|2|||
129966959|NCT00661713|467843135|FG006|Overall Study|Administrative Reason|1|||
129966960|NCT00661713|467843136|FG007|Overall Study|Administrative Reason|0|||
129966961|NCT00661713|467843129|FG000|Overall Study|Adverse Event|0|||
129966962|NCT00661713|467843130|FG001|Overall Study|Adverse Event|0|||
129966963|NCT00661713|467843131|FG002|Overall Study|Adverse Event|0|||
129966964|NCT00661713|467843132|FG003|Overall Study|Adverse Event|0|||
129966965|NCT00661713|467843133|FG004|Overall Study|Adverse Event|0|||
129966966|NCT00661713|467843134|FG005|Overall Study|Adverse Event|0|||
129966967|NCT00661713|467843135|FG006|Overall Study|Adverse Event|1|||
129966968|NCT00661713|467843136|FG007|Overall Study|Adverse Event|0|||
129966969|NCT00661713|467843129|FG000|Overall Study|Inappropriate Enrollment|0|||
129966970|NCT00661713|467843130|FG001|Overall Study|Inappropriate Enrollment|0|||
129966971|NCT00661713|467843131|FG002|Overall Study|Inappropriate Enrollment|0|||
129966972|NCT00661713|467843132|FG003|Overall Study|Inappropriate Enrollment|0|||
129966973|NCT00661713|467843133|FG004|Overall Study|Inappropriate Enrollment|0|||
129966974|NCT00661713|467843134|FG005|Overall Study|Inappropriate Enrollment|0|||
129966975|NCT00661713|467843135|FG006|Overall Study|Inappropriate Enrollment|1|||
129966976|NCT00661713|467843136|FG007|Overall Study|Inappropriate Enrollment|0|||
129966977|NCT02658175|467843137|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
129966978|NCT02658175|467843138|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
129966979|NCT02658175|467843139|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
129966980|NCT02658175|467843137|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
129966981|NCT02658175|467843138|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
129966982|NCT02658175|467843139|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
129966983|NCT02658175|467843137|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
129966984|NCT02658175|467843138|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
129966985|NCT02658175|467843139|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
129966986|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
129966987|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
129966988|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
129966989|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
129966990|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
129966991|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
129966992|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
129966993|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
129966994|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
129966995|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
129966996|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
129966997|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
129966998|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
129966999|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
129967000|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
130092198|NCT01218477|468292591|FG002|Overall Study|Administrative reason by sponsor|1|||
130092199|NCT01218477|468292592|FG003|Overall Study|Administrative reason by sponsor|0|||
130092200|NCT01218477|468292589|FG000|Overall Study|Maximum clinical benefit|0|||
130092201|NCT01218477|468292590|FG001|Overall Study|Maximum clinical benefit|2|||
130092202|NCT01218477|468292591|FG002|Overall Study|Maximum clinical benefit|0|||
130092203|NCT01218477|468292592|FG003|Overall Study|Maximum clinical benefit|0|||
130092204|NCT00787527|468292595|FG000|Overall Study|Toxicity|3|||
130092205|NCT01474993|468292596|FG000|Overall Study|Lost to Follow-up|1|||
130092206|NCT01474993|468292597|FG001|Overall Study|Lost to Follow-up|2|||
130092207|NCT01474993|468292596|FG000|Overall Study|Adverse Event|0|||
130092208|NCT01474993|468292597|FG001|Overall Study|Adverse Event|1|||
130092209|NCT01853397|468292598|FG000|Overall Study|Withdrawal by Subject|0|||
130092210|NCT01853397|468292599|FG001|Overall Study|Withdrawal by Subject|0|||
130092211|NCT01853397|468292600|FG002|Overall Study|Withdrawal by Subject|0|||
130092212|NCT01853397|468292601|FG003|Overall Study|Withdrawal by Subject|1|||
130092213|NCT01853397|468292598|FG000|Overall Study|Subject Noncompliance|0|||
130092214|NCT01853397|468292599|FG001|Overall Study|Subject Noncompliance|0|||
130092215|NCT01853397|468292600|FG002|Overall Study|Subject Noncompliance|0|||
130092216|NCT01853397|468292601|FG003|Overall Study|Subject Noncompliance|1|||
130092217|NCT00486720|468292602|FG000|Overall Study|Adverse Event|1|||
130092218|NCT00486720|468292603|FG001|Overall Study|Adverse Event|2|||
130092219|NCT00486720|468292602|FG000|Overall Study|Lack of Efficacy|4|||
130092220|NCT00486720|468292603|FG001|Overall Study|Lack of Efficacy|6|||
130092221|NCT00486720|468292602|FG000|Overall Study|Physician Decision|1|||
130092222|NCT00486720|468292603|FG001|Overall Study|Physician Decision|2|||
130092223|NCT00486720|468292602|FG000|Overall Study|Protocol Violation|1|||
130092224|NCT00486720|468292603|FG001|Overall Study|Protocol Violation|0|||
130092225|NCT00486720|468292602|FG000|Overall Study|Withdrawal by Subject|3|||
130092226|NCT00486720|468292603|FG001|Overall Study|Withdrawal by Subject|1|||
130092227|NCT00486720|468292602|FG000|Overall Study|Progressive Disease|0|||
130092228|NCT00486720|468292603|FG001|Overall Study|Progressive Disease|1|||
130092229|NCT02452892|468292604|FG000|Week 1 Initial Randommization|Adverse Event|1|||
130092230|NCT02452892|468292605|FG001|Week 1 Initial Randommization|Adverse Event|0|||
130092231|NCT02452892|468292606|FG002|Week 1 Initial Randommization|Adverse Event|0|||
130092232|NCT02452892|468292607|FG003|Week 1 Initial Randommization|Adverse Event|0|||
130092233|NCT02452892|468292604|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
130092234|NCT02452892|468292605|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
130092235|NCT02452892|468292606|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
130092236|NCT02452892|468292607|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
130092237|NCT02452892|468292604|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
130092238|NCT02452892|468292605|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
130092239|NCT02452892|468292606|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
130092240|NCT02452892|468292607|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
130092241|NCT02452892|468292604|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
130092242|NCT02452892|468292605|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
130092243|NCT02452892|468292606|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
130092244|NCT02452892|468292607|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
130092245|NCT02452892|468292604|FG000|Follow-up|Withdrawal by Subject|0|||
130092246|NCT02452892|468292605|FG001|Follow-up|Withdrawal by Subject|0|||
130092247|NCT02452892|468292606|FG002|Follow-up|Withdrawal by Subject|0|||
130092248|NCT02452892|468292607|FG003|Follow-up|Withdrawal by Subject|1|||
130092249|NCT02452892|468292604|FG000|Follow-up|Subject left town on Day 42|1|||
130092250|NCT02452892|468292605|FG001|Follow-up|Subject left town on Day 42|0|||
130092251|NCT02452892|468292606|FG002|Follow-up|Subject left town on Day 42|0|||
130092252|NCT02452892|468292607|FG003|Follow-up|Subject left town on Day 42|0|||
130092253|NCT00955682|468292608|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
130092254|NCT00955682|468292609|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
130092255|NCT02117024|468292610|FG000|Overall Study|Progressive Disease|26|||
130092256|NCT02117024|468292611|FG001|Overall Study|Progressive Disease|9|||
130092257|NCT02117024|468292610|FG000|Overall Study|Significant Clinical Progression|7|||
130092258|NCT02117024|468292611|FG001|Overall Study|Significant Clinical Progression|4|||
130092259|NCT02117024|468292610|FG000|Overall Study|Death|5|||
129967001|NCT02658175|467843137|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
129967002|NCT02658175|467843138|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
129967003|NCT02658175|467843139|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
129967004|NCT02658175|467843137|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
129967005|NCT02658175|467843138|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
129967006|NCT02658175|467843139|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
129967007|NCT01801982|467843143|FG000|Overall Study|Lost to Follow-up|1|||
129967008|NCT02918292|467843144|FG000|Study Enrollment Prior to Transplant|Death|1|||
129967009|NCT02918292|467843144|FG000|Study Follow up After Transplant|Death|6|||
129967010|NCT00727506|467843145|FG000|Overall Study|Adverse Event|0|||
129967011|NCT00727506|467843146|FG001|Overall Study|Adverse Event|0|||
129967012|NCT00727506|467843147|FG002|Overall Study|Adverse Event|4|||
129967013|NCT00727506|467843148|FG003|Overall Study|Adverse Event|4|||
129967014|NCT00727506|467843149|FG004|Overall Study|Adverse Event|1|||
129967015|NCT00727506|467843150|FG005|Overall Study|Adverse Event|8|||
129967016|NCT00727506|467843145|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129967017|NCT00727506|467843146|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967018|NCT00727506|467843147|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129967019|NCT00727506|467843148|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967020|NCT00727506|467843149|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967021|NCT00727506|467843150|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967022|NCT00727506|467843145|FG000|Overall Study|Progressive disease|4|||
129967023|NCT00727506|467843146|FG001|Overall Study|Progressive disease|7|||
129967024|NCT00727506|467843147|FG002|Overall Study|Progressive disease|9|||
129967025|NCT00727506|467843148|FG003|Overall Study|Progressive disease|28|||
129967026|NCT00727506|467843149|FG004|Overall Study|Progressive disease|38|||
129967027|NCT00727506|467843150|FG005|Overall Study|Progressive disease|28|||
129967028|NCT00727506|467843145|FG000|Overall Study|Refused to continue medication|0|||
129967029|NCT00727506|467843146|FG001|Overall Study|Refused to continue medication|1|||
129967030|NCT00727506|467843147|FG002|Overall Study|Refused to continue medication|2|||
129967031|NCT00727506|467843148|FG003|Overall Study|Refused to continue medication|3|||
129967032|NCT00727506|467843149|FG004|Overall Study|Refused to continue medication|1|||
129967033|NCT00727506|467843150|FG005|Overall Study|Refused to continue medication|2|||
129967034|NCT00727506|467843145|FG000|Overall Study|Other reason not described above|0|||
129967035|NCT00727506|467843146|FG001|Overall Study|Other reason not described above|0|||
129967036|NCT00727506|467843147|FG002|Overall Study|Other reason not described above|1|||
129967037|NCT00727506|467843148|FG003|Overall Study|Other reason not described above|4|||
129967038|NCT00727506|467843149|FG004|Overall Study|Other reason not described above|1|||
129967039|NCT00727506|467843150|FG005|Overall Study|Other reason not described above|1|||
129967040|NCT00715117|467843151|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
129967041|NCT00715117|467843152|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
129967042|NCT01482429|467843153|FG000|Care Usual|Protocol Violation|0|||
129967043|NCT01482429|467843154|FG001|Care Usual|Protocol Violation|172|||
129967044|NCT01482429|467843153|FG000|Care Usual|Lost to Follow-up|0|||
129967045|NCT01482429|467843154|FG001|Care Usual|Lost to Follow-up|1|||
129967046|NCT01482429|467843153|FG000|Protocol|Protocol Violation|275|||
129967047|NCT01482429|467843154|FG001|Protocol|Protocol Violation|0|||
129967048|NCT01214421|467843155|FG000|Overall Study|Lost to Follow-up|7|||
129967049|NCT01214421|467843156|FG001|Overall Study|Lost to Follow-up|3|||
129967050|NCT01214421|467843157|FG002|Overall Study|Lost to Follow-up|7|||
129967051|NCT01214421|467843158|FG003|Overall Study|Lost to Follow-up|3|||
129967052|NCT01214421|467843155|FG000|Overall Study|Adverse Event|16|||
129967053|NCT01214421|467843156|FG001|Overall Study|Adverse Event|35|||
129967054|NCT01214421|467843157|FG002|Overall Study|Adverse Event|14|||
129967055|NCT01214421|467843158|FG003|Overall Study|Adverse Event|3|||
129967056|NCT01214421|467843155|FG000|Overall Study|Sponsor Discontinued Site|1|||
129967057|NCT01214421|467843156|FG001|Overall Study|Sponsor Discontinued Site|2|||
129967058|NCT01214421|467843157|FG002|Overall Study|Sponsor Discontinued Site|0|||
129967059|NCT01214421|467843158|FG003|Overall Study|Sponsor Discontinued Site|0|||
129967060|NCT01214421|467843155|FG000|Overall Study|Withdrawal Criteria Met|3|||
129967061|NCT01214421|467843156|FG001|Overall Study|Withdrawal Criteria Met|0|||
129967062|NCT01214421|467843157|FG002|Overall Study|Withdrawal Criteria Met|2|||
129967063|NCT01214421|467843158|FG003|Overall Study|Withdrawal Criteria Met|1|||
129967064|NCT01214421|467843155|FG000|Overall Study|Physician Decision|2|||
129967065|NCT01214421|467843156|FG001|Overall Study|Physician Decision|0|||
129967066|NCT01214421|467843157|FG002|Overall Study|Physician Decision|4|||
129967067|NCT01214421|467843158|FG003|Overall Study|Physician Decision|0|||
129967068|NCT01214421|467843155|FG000|Overall Study|Withdrawal by Subject|21|||
129967069|NCT01214421|467843156|FG001|Overall Study|Withdrawal by Subject|18|||
129967070|NCT01214421|467843157|FG002|Overall Study|Withdrawal by Subject|11|||
129967071|NCT01214421|467843158|FG003|Overall Study|Withdrawal by Subject|2|||
129967072|NCT03561597|467843159|FG000|Overall Study|Lost to Follow-up|20|||
129967073|NCT03783689|467843161|FG000|Overall Study|Adverse Event|2|||
129967074|NCT03783689|467843162|FG001|Overall Study|Adverse Event|0|||
130122708|NCT02465567|468410588|FG002|Overall Study|Administrative Reasons|11|||
130122709|NCT02465567|468410589|FG003|Overall Study|Administrative Reasons|5|||
130122710|NCT02465567|468410586|FG000|Overall Study|Randomized but not treated|1|||
130122711|NCT02465567|468410587|FG001|Overall Study|Randomized but not treated|5|||
130122712|NCT02465567|468410588|FG002|Overall Study|Randomized but not treated|4|||
130122713|NCT02465567|468410589|FG003|Overall Study|Randomized but not treated|5|||
130122714|NCT02465567|468410586|FG000|Overall Study|enrolled in >1 studies|18|||
130122715|NCT02465567|468410587|FG001|Overall Study|enrolled in >1 studies|11|||
130122716|NCT02465567|468410588|FG002|Overall Study|enrolled in >1 studies|19|||
130122717|NCT02465567|468410589|FG003|Overall Study|enrolled in >1 studies|15|||
130122718|NCT02465567|468410586|FG000|Overall Study|missing PI Signature|1|||
130122719|NCT02465567|468410587|FG001|Overall Study|missing PI Signature|0|||
130122720|NCT02465567|468410588|FG002|Overall Study|missing PI Signature|0|||
130122721|NCT02465567|468410589|FG003|Overall Study|missing PI Signature|0|||
130122722|NCT00497796|468410590|FG000|Overall Study|Adverse event (not related)|9|||
130122723|NCT00497796|468410591|FG001|Overall Study|Adverse event (not related)|9|||
130122724|NCT00497796|468410590|FG000|Overall Study|Adverse event (related)|5|||
130122725|NCT00497796|468410591|FG001|Overall Study|Adverse event (related)|4|||
130122726|NCT00497796|468410590|FG000|Overall Study|CMV infection or disease treatment|30|||
130122727|NCT00497796|468410591|FG001|Overall Study|CMV infection or disease treatment|4|||
130122728|NCT00497796|468410590|FG000|Overall Study|Consent withdrawn|10|||
130122729|NCT00497796|468410591|FG001|Overall Study|Consent withdrawn|3|||
130122730|NCT00497796|468410590|FG000|Overall Study|Investigator/sponsor discretion|31|||
130122731|NCT00497796|468410591|FG001|Overall Study|Investigator/sponsor discretion|34|||
130122732|NCT00497796|468410590|FG000|Overall Study|Lost to Follow-up|0|||
130122733|NCT00497796|468410591|FG001|Overall Study|Lost to Follow-up|1|||
129967075|NCT03783689|467843161|FG000|Overall Study|Lost to Follow-up|2|||
129967076|NCT03783689|467843162|FG001|Overall Study|Lost to Follow-up|1|||
129967077|NCT03783689|467843161|FG000|Overall Study|Physician Decision|2|||
129967078|NCT03783689|467843162|FG001|Overall Study|Physician Decision|1|||
129967079|NCT03783689|467843161|FG000|Overall Study|Withdrawal by Subject|3|||
129967080|NCT03783689|467843162|FG001|Overall Study|Withdrawal by Subject|3|||
129967081|NCT02392104|467843165|FG000|Overall Study|discontinuation of warfarin|3|||
129967082|NCT02392104|467843165|FG000|Overall Study|bleeding event|1|||
129967083|NCT02392104|467843165|FG000|Overall Study|transferred care to another doctor|2|||
129967084|NCT02392104|467843165|FG000|Overall Study|INR goal range changed|1|||
129967085|NCT02392104|467843165|FG000|Overall Study|admitted to skilled nursing facility|3|||
129967086|NCT02392104|467843165|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
129967087|NCT04887506|467843166|FG000|Overall Study|Death|1|||
129967088|NCT04887506|467843167|FG001|Overall Study|Death|1|||
129967089|NCT04887506|467843166|FG000|Overall Study|Withdrawal by Subject|0|||
129967090|NCT04887506|467843167|FG001|Overall Study|Withdrawal by Subject|3|||
129967091|NCT04887506|467843166|FG000|Overall Study|Adverse Event|4|||
129967092|NCT04887506|467843167|FG001|Overall Study|Adverse Event|3|||
129967093|NCT04887506|467843166|FG000|Overall Study|Other - Not Reported|1|||
129967094|NCT04887506|467843167|FG001|Overall Study|Other - Not Reported|1|||
129967095|NCT01255761|467843168|FG000|Overall Study|Adverse Event|29|||
129967096|NCT01255761|467843169|FG001|Overall Study|Adverse Event|43|||
129967097|NCT01255761|467843168|FG000|Overall Study|Lack of Efficacy|86|||
129967098|NCT01255761|467843169|FG001|Overall Study|Lack of Efficacy|74|||
129967099|NCT01255761|467843168|FG000|Overall Study|Protocol Violation|9|||
129967100|NCT01255761|467843169|FG001|Overall Study|Protocol Violation|5|||
129967101|NCT01255761|467843168|FG000|Overall Study|Lost to Follow-up|10|||
129967102|NCT01255761|467843169|FG001|Overall Study|Lost to Follow-up|8|||
129967103|NCT01255761|467843168|FG000|Overall Study|Withdrawal by Subject|11|||
129967104|NCT01255761|467843169|FG001|Overall Study|Withdrawal by Subject|27|||
129967105|NCT01255761|467843168|FG000|Overall Study|Other Reasons|37|||
129967106|NCT01255761|467843169|FG001|Overall Study|Other Reasons|18|||
129967107|NCT05613088|467843172|FG000|Treatment|Ongoing Study Treatment|9|||
129967108|NCT05613088|467843173|FG001|Treatment|Ongoing Study Treatment|2|||
129967109|NCT05613088|467843172|FG000|Treatment|Adverse Event|3|||
130122734|NCT00497796|468410590|FG000|Overall Study|Not applicable (randomized not treated)|0|||
130122735|NCT00497796|468410591|FG001|Overall Study|Not applicable (randomized not treated)|4|||
130122736|NCT01492400|468410592|FG000|Overall Study|Miscellaneous Reasons|2|||
129967110|NCT05613088|467843173|FG001|Treatment|Adverse Event|1|||
129967111|NCT05613088|467843172|FG000|Treatment|Other Reasons|0|||
129967112|NCT05613088|467843173|FG001|Treatment|Other Reasons|1|||
129967113|NCT05613088|467843172|FG000|Treatment|Progressive Disease|58|||
129967114|NCT05613088|467843173|FG001|Treatment|Progressive Disease|26|||
129967115|NCT05613088|467843172|FG000|Treatment|Withdrawal by Subject|0|||
129967116|NCT05613088|467843173|FG001|Treatment|Withdrawal by Subject|4|||
129967117|NCT03569891|467843176|FG000|Lead-in|Ineligible during lead-in|8|||
129967118|NCT03569891|467843176|FG000|Lead-in|Withdrawal by Subject|3|||
129967119|NCT03569891|467843176|FG000|Lead-in|Risks related to COVID-19|2|||
129967120|NCT03569891|467843176|FG000|AMT-061|Adverse Event|1|||
129967121|NCT02647645|467843179|FG000|Overall Study|Lost to Follow-up|2|||
129967122|NCT02647645|467843180|FG001|Overall Study|Lost to Follow-up|1|||
129967123|NCT00356811|467843181|FG000|Overall Study|Death|35|||
129967124|NCT00356811|467843181|FG000|Overall Study|Lost to Follow-up|2|||
129967125|NCT00356811|467843181|FG000|Overall Study|Withdrawal by Subject|6|||
129967126|NCT00356811|467843181|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
129967127|NCT00356811|467843181|FG000|Overall Study|Study Is Terminating|3|||
129967128|NCT00356811|467843181|FG000|Overall Study|Site Closed during Follow-up|2|||
129967129|NCT02101983|467843182|FG000|Overall Study|Physician Decision|1|||
129967130|NCT02101983|467843183|FG001|Overall Study|Physician Decision|0|||
129967131|NCT03614676|467844883|FG000|Overall Study|Delivery before planned visit|2|||
129967132|NCT03614676|467844884|FG001|Overall Study|Delivery before planned visit|0|||
129967133|NCT03614676|467844883|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
129967134|NCT03614676|467844884|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
129967135|NCT03614676|467844883|FG000|Overall Study|Migrated / moved from the study area|30|||
129967136|NCT03614676|467844884|FG001|Overall Study|Migrated / moved from the study area|22|||
129967137|NCT03614676|467844883|FG000|Overall Study|Lost to Follow-up|17|||
129967138|NCT03614676|467844884|FG001|Overall Study|Lost to Follow-up|42|||
129967139|NCT03614676|467844883|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
129967140|NCT03614676|467844884|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
129967141|NCT03614676|467844883|FG000|Overall Study|Other|16|||
129967142|NCT03614676|467844884|FG001|Overall Study|Other|47|||
129967143|NCT03614676|467844883|FG000|Overall Study|Protocol Violation|0|||
129967144|NCT03614676|467844884|FG001|Overall Study|Protocol Violation|2|||
129967145|NCT03614676|467844883|FG000|Overall Study|Neonatal event of interest|0|||
129967146|NCT03614676|467844884|FG001|Overall Study|Neonatal event of interest|6|||
129967147|NCT03614676|467844883|FG000|Overall Study|Death in infant greater than 28 days old|0|||
129967148|NCT03614676|467844884|FG001|Overall Study|Death in infant greater than 28 days old|12|||
129967149|NCT03614676|467844883|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
129967150|NCT03614676|467844884|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
129967151|NCT00903760|467844885|FG000|Overall Study|Disease Progression/Death|8|||
129967152|NCT00903760|467844886|FG001|Overall Study|Disease Progression/Death|6|||
129967153|NCT00903760|467844885|FG000|Overall Study|Stem Cell Transplant|8|||
129967154|NCT00903760|467844886|FG001|Overall Study|Stem Cell Transplant|4|||
129967155|NCT00903760|467844885|FG000|Overall Study|Physician Decision|1|||
129967156|NCT00903760|467844886|FG001|Overall Study|Physician Decision|2|||
129967157|NCT00903760|467844885|FG000|Overall Study|Death|0|||
129967158|NCT00903760|467844886|FG001|Overall Study|Death|1|||
129967159|NCT00903760|467844885|FG000|Overall Study|Lost to Follow-up|1|||
129967160|NCT00903760|467844886|FG001|Overall Study|Lost to Follow-up|0|||
129967161|NCT00903760|467844885|FG000|Overall Study|Withdrawal by Subject|1|||
129967162|NCT00903760|467844886|FG001|Overall Study|Withdrawal by Subject|2|||
129967163|NCT00903760|467844885|FG000|Overall Study|Off treatment for long period|0|||
129967164|NCT00903760|467844886|FG001|Overall Study|Off treatment for long period|1|||
129967165|NCT02388347|467844887|FG000|Overall Study|Withdrawal by Subject|0|||
129967166|NCT02388347|467844888|FG001|Overall Study|Withdrawal by Subject|0|||
129967167|NCT02388347|467844889|FG002|Overall Study|Withdrawal by Subject|1|||
129967168|NCT02388347|467844890|FG003|Overall Study|Withdrawal by Subject|0|||
129967169|NCT02388347|467844891|FG004|Overall Study|Withdrawal by Subject|0|||
129967170|NCT02825251|467844893|FG000|Overall Study|Adverse Event|0|||
129967171|NCT02825251|467844894|FG001|Overall Study|Adverse Event|1|||
129967172|NCT02825251|467844893|FG000|Overall Study|Lost to Follow-up|0|||
129967173|NCT02825251|467844894|FG001|Overall Study|Lost to Follow-up|1|||
129967174|NCT02825251|467844893|FG000|Overall Study|Withdrawal by Subject|1|||
129967175|NCT02825251|467844894|FG001|Overall Study|Withdrawal by Subject|4|||
129967176|NCT02825251|467844893|FG000|Overall Study|Unclassified|2|||
129967177|NCT02825251|467844894|FG001|Overall Study|Unclassified|0|||
129967178|NCT01845805|467844895|FG000|Overall Study|Withdrawal by Subject|1|||
129967179|NCT01845805|467844896|FG001|Overall Study|Withdrawal by Subject|2|||
129967180|NCT01845805|467844895|FG000|Overall Study|Disease Progression|13|||
129967181|NCT01845805|467844896|FG001|Overall Study|Disease Progression|14|||
129967182|NCT01845805|467844895|FG000|Overall Study|Drug-related Toxicity|4|||
129967183|NCT01845805|467844896|FG001|Overall Study|Drug-related Toxicity|0|||
129967184|NCT04795336|467844898|FG000|Overall Study|Withdrawal by Subject|3|||
129967185|NCT04795336|467844899|FG001|Overall Study|Withdrawal by Subject|4|||
129967186|NCT04795336|467844900|FG002|Overall Study|Withdrawal by Subject|3|||
129967187|NCT04795336|467844901|FG003|Overall Study|Withdrawal by Subject|12|||
129967188|NCT04795336|467844898|FG000|Overall Study|Lost study logs|0|||
129967189|NCT04795336|467844899|FG001|Overall Study|Lost study logs|1|||
129967190|NCT04795336|467844900|FG002|Overall Study|Lost study logs|0|||
129967191|NCT04795336|467844901|FG003|Overall Study|Lost study logs|2|||
129967192|NCT04795336|467844898|FG000|Overall Study|Did not take study medication|2|||
129967193|NCT04795336|467844899|FG001|Overall Study|Did not take study medication|0|||
129967194|NCT04795336|467844900|FG002|Overall Study|Did not take study medication|0|||
129967195|NCT04795336|467844901|FG003|Overall Study|Did not take study medication|0|||
129967196|NCT03898700|467844902|FG000|Overall Study|Withdrawal by Subject|2|||
129967197|NCT00971997|467844903|FG000|Overall Study|Adverse Event|2|||
129967198|NCT00971997|467844903|FG000|Overall Study|Death|1|||
129967199|NCT00971997|467844903|FG000|Overall Study|Protocol Violation|4|||
129967200|NCT00971997|467844903|FG000|Overall Study|Withdrawal by Subject|5|||
129967201|NCT00971997|467844903|FG000|Overall Study|Physician Decision|7|||
129967202|NCT01266018|467844907|FG000|Overall Study|Physician Decision|1|||
129967203|NCT01266018|467844908|FG001|Overall Study|Physician Decision|0|||
129967204|NCT01266018|467844907|FG000|Overall Study|Progressive disease|0|||
129967205|NCT01266018|467844908|FG001|Overall Study|Progressive disease|1|||
129967206|NCT02684123|467844909|FG000|Phase 1|Lack of Efficacy|5|||
129967207|NCT02684123|467844910|FG001|Phase 1|Lack of Efficacy|0|||
129967208|NCT02684123|467844909|FG000|Phase 1|Adverse Event|3|||
129967209|NCT02684123|467844910|FG001|Phase 1|Adverse Event|0|||
129967210|NCT02684123|467844909|FG000|Phase 1|Lost to Follow-up|0|||
129967211|NCT02684123|467844910|FG001|Phase 1|Lost to Follow-up|1|||
129967212|NCT02684123|467844909|FG000|Phase 2|Lack of Efficacy|1|||
129967213|NCT02684123|467844910|FG001|Phase 2|Lack of Efficacy|8|||
129967214|NCT00516139|467844911|FG000|Overall Study|Adverse Event|27|||
129967215|NCT00516139|467844911|FG000|Overall Study|Lost to Follow-up|1|||
129967216|NCT00516139|467844911|FG000|Overall Study|Protocol Violation|1|||
129967217|NCT00516139|467844911|FG000|Overall Study|Withdrawal by Subject|8|||
129967218|NCT00516139|467844911|FG000|Overall Study|Lack of Efficacy|1|||
129967219|NCT00416598|467844912|FG000|Induction & Intensification|Adverse Event|38|||
129967220|NCT00416598|467844912|FG000|Induction & Intensification|Death|32|||
129967221|NCT00416598|467844912|FG000|Induction & Intensification|Withdrawal by Subject|46|||
129967222|NCT00416598|467844912|FG000|Induction & Intensification|Alternative Treatment|135|||
129967223|NCT00416598|467844912|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
129967224|NCT00416598|467844912|FG000|Induction & Intensification|Relapse/progression|29|||
129967225|NCT00416598|467844912|FG000|Induction & Intensification|Failed induction|87|||
129967226|NCT00416598|467844912|FG000|Decitabine Maintenance|Adverse Event|5|||
129967227|NCT00416598|467844912|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
129967228|NCT00416598|467844912|FG000|Decitabine Maintenance|Progression/relapse|38|||
129967229|NCT00416598|467844912|FG000|Decitabine Maintenance|Alternative treatment|2|||
129967230|NCT00416598|467844912|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
129967231|NCT02166476|467844919|FG000|Overall Study|Withdrawal by Subject|5|||
129967232|NCT02166476|467844920|FG001|Overall Study|Withdrawal by Subject|7|||
129967233|NCT02166476|467844919|FG000|Overall Study|Adverse Event|3|||
129967234|NCT02166476|467844920|FG001|Overall Study|Adverse Event|3|||
129967235|NCT02166476|467844919|FG000|Overall Study|Lost to Follow-up|5|||
129967236|NCT02166476|467844920|FG001|Overall Study|Lost to Follow-up|10|||
129967237|NCT02166476|467844919|FG000|Overall Study|Physician Decision|1|||
129967238|NCT02166476|467844920|FG001|Overall Study|Physician Decision|0|||
129967239|NCT02166476|467844919|FG000|Overall Study|Unable to Come for Visit|0|||
129967240|NCT02166476|467844920|FG001|Overall Study|Unable to Come for Visit|3|||
129967241|NCT02053610|467844925|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
129967242|NCT02053610|467844926|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
129967243|NCT02053610|467844925|FG000|Overall Study|Withdrew Consent|2|||
129967244|NCT02053610|467844926|FG001|Overall Study|Withdrew Consent|9|||
129967245|NCT02053610|467844925|FG000|Overall Study|Death|5|||
129967246|NCT02053610|467844926|FG001|Overall Study|Death|5|||
129967247|NCT02053610|467844925|FG000|Overall Study|Administrative/Other|1|||
129967248|NCT02053610|467844926|FG001|Overall Study|Administrative/Other|1|||
129967249|NCT02053610|467844925|FG000|Overall Study|Disease Progression|2|||
129967250|NCT02053610|467844926|FG001|Overall Study|Disease Progression|3|||
129967251|NCT02053610|467844925|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
129967252|NCT02053610|467844926|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
129967253|NCT02053610|467844925|FG000|Overall Study|Did not Receive Treatment|4|||
129967254|NCT02053610|467844926|FG001|Overall Study|Did not Receive Treatment|2|||
129967255|NCT02053610|467844925|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129967256|NCT02053610|467844926|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129967257|NCT02053610|467844925|FG000|Overall Study|Violation of Selection Criteria|1|||
129967258|NCT02053610|467844926|FG001|Overall Study|Violation of Selection Criteria|0|||
129967259|NCT00543062|467844932|FG000|Overall Study|Withdrawal by Subject|1|||
129967260|NCT00543062|467844933|FG001|Overall Study|Withdrawal by Subject|0|||
130092260|NCT02117024|468292611|FG001|Overall Study|Death|0|||
129967261|NCT00543062|467844934|FG002|Overall Study|Withdrawal by Subject|2|||
129967262|NCT00543062|467844935|FG003|Overall Study|Withdrawal by Subject|0|||
129967263|NCT00543062|467844932|FG000|Overall Study|Adverse Event|0|||
129967264|NCT00543062|467844933|FG001|Overall Study|Adverse Event|1|||
129967265|NCT00543062|467844934|FG002|Overall Study|Adverse Event|1|||
129967266|NCT00543062|467844935|FG003|Overall Study|Adverse Event|1|||
129967267|NCT00543062|467844932|FG000|Overall Study|Protocol Violation|1|||
129967268|NCT00543062|467844933|FG001|Overall Study|Protocol Violation|0|||
129967269|NCT00543062|467844934|FG002|Overall Study|Protocol Violation|0|||
129967270|NCT00543062|467844935|FG003|Overall Study|Protocol Violation|0|||
129967271|NCT01513330|467844936|FG000|SenSura Mio First,|Adverse Event|2|||
130092261|NCT02117024|468292610|FG000|Overall Study|Withdrawal by Subject|3|||
129967272|NCT01513330|467844937|FG001|SenSura Mio First,|Adverse Event|0|||
129967273|NCT01513330|467844936|FG000|SenSura Mio First,|Lack of Efficacy|0|||
129967274|NCT01513330|467844937|FG001|SenSura Mio First,|Lack of Efficacy|1|||
129967275|NCT01513330|467844936|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
129967276|NCT01513330|467844937|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
129967277|NCT01513330|467844936|FG000|SenSura Mio First,|Other|1|||
129967278|NCT01513330|467844937|FG001|SenSura Mio First,|Other|0|||
129967279|NCT01513330|467844936|FG000|Standard Care First,|Lack of Efficacy|2|||
129967280|NCT01513330|467844937|FG001|Standard Care First,|Lack of Efficacy|2|||
129967281|NCT01513330|467844936|FG000|Standard Care First,|Withdrawal by Subject|1|||
129967282|NCT01513330|467844937|FG001|Standard Care First,|Withdrawal by Subject|2|||
129967283|NCT01513330|467844936|FG000|Standard Care First,|Other|1|||
129967284|NCT01513330|467844937|FG001|Standard Care First,|Other|0|||
129967285|NCT02232399|467844942|FG000|Overall Study|Adverse Event|1|||
129967286|NCT02232399|467844943|FG001|Overall Study|Adverse Event|0|||
129967287|NCT02232399|467844942|FG000|Overall Study|Withdrawal by Subject|0|||
129967288|NCT02232399|467844943|FG001|Overall Study|Withdrawal by Subject|1|||
129967289|NCT01777334|467844944|FG000|Overall Study|Adverse Event|18|||
129967290|NCT01777334|467844945|FG001|Overall Study|Adverse Event|14|||
129967291|NCT01777334|467844944|FG000|Overall Study|Lack of Efficacy|15|||
129967292|NCT01777334|467844945|FG001|Overall Study|Lack of Efficacy|29|||
129967293|NCT01777334|467844944|FG000|Overall Study|Protocol Violation|3|||
129967294|NCT01777334|467844945|FG001|Overall Study|Protocol Violation|7|||
129967295|NCT01777334|467844944|FG000|Overall Study|Lost to Follow-up|3|||
129967296|NCT01777334|467844945|FG001|Overall Study|Lost to Follow-up|2|||
129967297|NCT01777334|467844944|FG000|Overall Study|Withdrawal by Subject|14|||
129967298|NCT01777334|467844945|FG001|Overall Study|Withdrawal by Subject|11|||
129967299|NCT00632021|467844957|FG000|Overall Study|Withdrawal/death|4|||
129967300|NCT00632021|467844958|FG001|Overall Study|Withdrawal/death|7|||
129967301|NCT00952848|467844961|FG000|Overall Study|Withdrawal by Subject|4|||
129967302|NCT00458393|467844962|FG000|Overall Study|Withdrawal by Subject|67|||
129967303|NCT00458393|467844963|FG001|Overall Study|Withdrawal by Subject|80|||
129967304|NCT00458393|467844962|FG000|Overall Study|Physician Decision|31|||
129967305|NCT00458393|467844963|FG001|Overall Study|Physician Decision|22|||
129967306|NCT00458393|467844962|FG000|Overall Study|Relocated|77|||
129967307|NCT00458393|467844963|FG001|Overall Study|Relocated|81|||
129967308|NCT00458393|467844962|FG000|Overall Study|Lost to Follow-up|115|||
129967309|NCT00458393|467844963|FG001|Overall Study|Lost to Follow-up|92|||
129967310|NCT00458393|467844962|FG000|Overall Study|Sites marked other on the form.|19|||
129967311|NCT00458393|467844963|FG001|Overall Study|Sites marked other on the form.|20|||
129967312|NCT00857233|467844966|FG000|Overall Study|Adverse Event|24|||
129967313|NCT00857233|467844966|FG000|Overall Study|Lack of Efficacy|1|||
129967314|NCT00857233|467844966|FG000|Overall Study|Non-compliance|1|||
129967315|NCT00857233|467844966|FG000|Overall Study|Withdrawal of Consent|9|||
129967316|NCT00857233|467844966|FG000|Overall Study|Lost to Follow-up|4|||
129967317|NCT00857233|467844966|FG000|Overall Study|Nursing Home Placement|14|||
129967318|NCT00857233|467844966|FG000|Overall Study|Other Reasons|2|||
129967319|NCT01587118|467844967|FG000|Overall Study|Adverse Event|3|||
129967320|NCT01587118|467844967|FG000|Overall Study|Lost to Follow-up|2|||
129967321|NCT01587118|467844967|FG000|Overall Study|Relocation|1|||
129967322|NCT01587118|467844967|FG000|Overall Study|nonresponse|1|||
129967323|NCT00537329|467844968|FG000|Overall Study|Death|10|||
129967324|NCT00537329|467844968|FG000|Overall Study|Adverse Event|3|||
129967325|NCT00537329|467844968|FG000|Overall Study|Lack of Efficacy|2|||
129967326|NCT00537329|467844968|FG000|Overall Study|Lost to Follow-up|6|||
129967327|NCT00537329|467844968|FG000|Overall Study|Withdrawal by Subject|4|||
129967328|NCT00537329|467844968|FG000|Overall Study|Other|1|||
129967329|NCT02287233|467844970|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
129967330|NCT02287233|467844971|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
129967331|NCT02287233|467844972|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
130122737|NCT01492400|468410593|FG001|Overall Study|Miscellaneous Reasons|3|||
129967332|NCT02287233|467844970|FG000|Overall Study|Adverse Event Related to Progression|0|||
129967333|NCT02287233|467844971|FG001|Overall Study|Adverse Event Related to Progression|2|||
129967334|NCT02287233|467844972|FG002|Overall Study|Adverse Event Related to Progression|8|||
129967335|NCT02287233|467844970|FG000|Overall Study|Physician Decision|1|||
129967336|NCT02287233|467844971|FG001|Overall Study|Physician Decision|2|||
129967337|NCT02287233|467844972|FG002|Overall Study|Physician Decision|4|||
129967338|NCT02287233|467844970|FG000|Overall Study|Progressive Disease with Death|0|||
129967339|NCT02287233|467844971|FG001|Overall Study|Progressive Disease with Death|0|||
129967340|NCT02287233|467844972|FG002|Overall Study|Progressive Disease with Death|10|||
129967341|NCT02287233|467844970|FG000|Overall Study|Progressive Disease Without Death|2|||
129967342|NCT02287233|467844971|FG001|Overall Study|Progressive Disease Without Death|3|||
129967343|NCT02287233|467844972|FG002|Overall Study|Progressive Disease Without Death|20|||
129967344|NCT02287233|467844970|FG000|Overall Study|Withdrawal by Subject|1|||
129967345|NCT02287233|467844971|FG001|Overall Study|Withdrawal by Subject|1|||
129967346|NCT02287233|467844972|FG002|Overall Study|Withdrawal by Subject|7|||
129967347|NCT02287233|467844970|FG000|Overall Study|Other|3|||
129967348|NCT02287233|467844971|FG001|Overall Study|Other|0|||
129967349|NCT02287233|467844972|FG002|Overall Study|Other|15|||
129967350|NCT02287233|467844970|FG000|Overall Study|Did Not Receive Treatment|0|||
129967351|NCT02287233|467844971|FG001|Overall Study|Did Not Receive Treatment|0|||
129967352|NCT02287233|467844972|FG002|Overall Study|Did Not Receive Treatment|2|||
129967353|NCT00085566|467844973|FG000|Overall Study|Adverse Event|0|||
129967354|NCT00085566|467844974|FG001|Overall Study|Adverse Event|0|||
129967355|NCT00085566|467844975|FG002|Overall Study|Adverse Event|10|||
129967356|NCT00085566|467844973|FG000|Overall Study|Patient Not treated|0|||
129967357|NCT00085566|467844974|FG001|Overall Study|Patient Not treated|0|||
129967358|NCT00085566|467844975|FG002|Overall Study|Patient Not treated|3|||
129967359|NCT00085566|467844973|FG000|Overall Study|Clinical progression|0|||
129967360|NCT00085566|467844974|FG001|Overall Study|Clinical progression|0|||
129967361|NCT00085566|467844975|FG002|Overall Study|Clinical progression|1|||
129967362|NCT03174782|467844976|FG000|Overall Study|Protocol Violation|1|||
129967363|NCT03174782|467844977|FG001|Overall Study|Protocol Violation|0|||
129967364|NCT03174782|467844976|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
129967365|NCT03174782|467844977|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
129967366|NCT03178045|467844978|FG000|Overall Study|Withdrawal by Subject|5|||
129967367|NCT03178045|467844979|FG001|Overall Study|Withdrawal by Subject|7|||
129967368|NCT03178045|467844978|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
129967369|NCT03178045|467844979|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
129967370|NCT03178045|467844978|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
129967371|NCT03178045|467844979|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
129967372|NCT03432390|467844982|FG000|Apnea Period|Protocol Violation|2|||
129967373|NCT03432390|467844983|FG001|Apnea Period|Protocol Violation|2|||
129967374|NCT00547534|467844987|FG000|Overall Study|Adverse Event|7|||
129967375|NCT00547534|467844987|FG000|Overall Study|Disease Progression|4|||
129967376|NCT00763451|467844989|FG000|Overall Study|Adverse Event|4|||
129967377|NCT00763451|467844990|FG001|Overall Study|Adverse Event|6|||
129967378|NCT00763451|467844991|FG002|Overall Study|Adverse Event|19|||
129967379|NCT00763451|467844992|FG003|Overall Study|Adverse Event|14|||
129967380|NCT00763451|467844989|FG000|Overall Study|Lack of Efficacy|1|||
129967381|NCT00763451|467844990|FG001|Overall Study|Lack of Efficacy|4|||
129967382|NCT00763451|467844991|FG002|Overall Study|Lack of Efficacy|3|||
129967383|NCT00763451|467844992|FG003|Overall Study|Lack of Efficacy|2|||
129967384|NCT00763451|467844989|FG000|Overall Study|Withdrawal by Subject|1|||
129967385|NCT00763451|467844990|FG001|Overall Study|Withdrawal by Subject|6|||
129967386|NCT00763451|467844991|FG002|Overall Study|Withdrawal by Subject|9|||
129967387|NCT00763451|467844992|FG003|Overall Study|Withdrawal by Subject|7|||
129967388|NCT00763451|467844989|FG000|Overall Study|Protocol Violation|0|||
129967389|NCT00763451|467844990|FG001|Overall Study|Protocol Violation|0|||
129967390|NCT00763451|467844991|FG002|Overall Study|Protocol Violation|1|||
129967391|NCT00763451|467844992|FG003|Overall Study|Protocol Violation|0|||
129967392|NCT00763451|467844989|FG000|Overall Study|Poor Compliance to Protocol|1|||
129967393|NCT00763451|467844990|FG001|Overall Study|Poor Compliance to Protocol|1|||
129967394|NCT00763451|467844991|FG002|Overall Study|Poor Compliance to Protocol|2|||
129967395|NCT00763451|467844992|FG003|Overall Study|Poor Compliance to Protocol|2|||
129967396|NCT00763451|467844989|FG000|Overall Study|Familial and Personal Reasons|5|||
129967397|NCT00763451|467844990|FG001|Overall Study|Familial and Personal Reasons|3|||
129967398|NCT00763451|467844991|FG002|Overall Study|Familial and Personal Reasons|5|||
129967399|NCT00763451|467844992|FG003|Overall Study|Familial and Personal Reasons|4|||
129967400|NCT00763451|467844989|FG000|Overall Study|Randomized but not Treated|1|||
129967401|NCT00763451|467844990|FG001|Overall Study|Randomized but not Treated|1|||
129967402|NCT00763451|467844991|FG002|Overall Study|Randomized but not Treated|0|||
130122738|NCT01492400|468410592|FG000|Overall Study|Personal Reasons|0|||
130122739|NCT01492400|468410593|FG001|Overall Study|Personal Reasons|5|||
130122740|NCT01492400|468410592|FG000|Overall Study|Lost to Follow-up|3|||
129967403|NCT00763451|467844992|FG003|Overall Study|Randomized but not Treated|0|||
130122741|NCT01492400|468410593|FG001|Overall Study|Lost to Follow-up|1|||
130122742|NCT01492400|468410592|FG000|Overall Study|Pregnancy|0|||
130122743|NCT01492400|468410593|FG001|Overall Study|Pregnancy|1|||
129967404|NCT00763451|467844989|FG000|Overall Study|Study Site Reason|0|||
129967405|NCT00763451|467844990|FG001|Overall Study|Study Site Reason|1|||
129967406|NCT00763451|467844991|FG002|Overall Study|Study Site Reason|1|||
129967407|NCT00763451|467844992|FG003|Overall Study|Study Site Reason|1|||
129967408|NCT00725543|467844996|FG000|Overall Study|Adverse Event|10|||
129967409|NCT00725543|467844996|FG000|Overall Study|Lack of Efficacy|3|||
129967410|NCT00725543|467844996|FG000|Overall Study|Withdrawal by Subject|10|||
130122744|NCT01492400|468410592|FG000|Overall Study|Lack of Efficacy|1|||
129967411|NCT00725543|467844996|FG000|Overall Study|Physician Decision|5|||
129967412|NCT00725543|467844996|FG000|Overall Study|Lost to Follow-up|4|||
129967413|NCT00725543|467844996|FG000|Overall Study|Non-compliance|2|||
129967414|NCT00725543|467844996|FG000|Overall Study|Other|119|||
129967415|NCT05594589|467844997|FG000|Overall Study|Other|0|||
130122745|NCT01492400|468410593|FG001|Overall Study|Lack of Efficacy|1|||
129967416|NCT05594589|467844998|FG001|Overall Study|Other|1|||
129967417|NCT05594589|467844999|FG002|Overall Study|Other|0|||
129967418|NCT02168478|467845006|FG000|Overall Study|Withdrawal by Subject|1|||
129967419|NCT02168478|467845006|FG000|Overall Study|Did Not Consent to Participation|2|||
129967420|NCT02168478|467845006|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
129967421|NCT00087555|467845007|FG000|Overall Study|Adverse Event|3|||
129967422|NCT00087555|467845008|FG001|Overall Study|Adverse Event|6|||
129967423|NCT00087555|467845009|FG002|Overall Study|Adverse Event|14|||
129967424|NCT00087555|467845007|FG000|Overall Study|Lost to Follow-up|0|||
129967425|NCT00087555|467845008|FG001|Overall Study|Lost to Follow-up|1|||
129967426|NCT00087555|467845009|FG002|Overall Study|Lost to Follow-up|1|||
129967427|NCT00087555|467845007|FG000|Overall Study|Non - Compliance|1|||
129967428|NCT00087555|467845008|FG001|Overall Study|Non - Compliance|0|||
129967429|NCT00087555|467845009|FG002|Overall Study|Non - Compliance|0|||
129967430|NCT00087555|467845007|FG000|Overall Study|Protocol Violation|0|||
129967431|NCT00087555|467845008|FG001|Overall Study|Protocol Violation|0|||
129967432|NCT00087555|467845009|FG002|Overall Study|Protocol Violation|2|||
129967433|NCT00087555|467845007|FG000|Overall Study|Screen Failure|1|||
129967434|NCT00087555|467845008|FG001|Overall Study|Screen Failure|1|||
129967435|NCT00087555|467845009|FG002|Overall Study|Screen Failure|0|||
129967436|NCT00087555|467845007|FG000|Overall Study|Pregnancy|0|||
129967437|NCT00087555|467845008|FG001|Overall Study|Pregnancy|1|||
129967438|NCT00087555|467845009|FG002|Overall Study|Pregnancy|1|||
129967439|NCT00087555|467845007|FG000|Overall Study|Withdrawal by Subject|3|||
129967440|NCT00087555|467845008|FG001|Overall Study|Withdrawal by Subject|2|||
129967441|NCT00087555|467845009|FG002|Overall Study|Withdrawal by Subject|1|||
129967442|NCT00087555|467845007|FG000|Overall Study|Lack of Efficacy|2|||
129967443|NCT00087555|467845008|FG001|Overall Study|Lack of Efficacy|0|||
129967444|NCT00087555|467845009|FG002|Overall Study|Lack of Efficacy|1|||
129967445|NCT00087555|467845007|FG000|Overall Study|Non Compliance|0|||
129967446|NCT00087555|467845008|FG001|Overall Study|Non Compliance|0|||
130092262|NCT02117024|468292611|FG001|Overall Study|Withdrawal by Subject|1|||
130092263|NCT02117024|468292610|FG000|Overall Study|Protocol Violation|1|||
130092264|NCT02117024|468292611|FG001|Overall Study|Protocol Violation|0|||
130092265|NCT02117024|468292610|FG000|Overall Study|Adverse Event|1|||
130092266|NCT02117024|468292611|FG001|Overall Study|Adverse Event|2|||
130092267|NCT02117024|468292610|FG000|Overall Study|Randomized in Error|1|||
130092268|NCT02117024|468292611|FG001|Overall Study|Randomized in Error|0|||
130092269|NCT02117024|468292610|FG000|Overall Study|Patient returned to primary oncologist|0|||
130092270|NCT02117024|468292611|FG001|Overall Study|Patient returned to primary oncologist|1|||
130092271|NCT02117024|468292610|FG000|Overall Study|Patient took treatment break|0|||
130092272|NCT02117024|468292611|FG001|Overall Study|Patient took treatment break|1|||
130092273|NCT02117024|468292610|FG000|Overall Study|Physician Decision|0|||
130092274|NCT02117024|468292611|FG001|Overall Study|Physician Decision|2|||
130092275|NCT02813681|468292614|FG000|Overall Study|Physician Decision|5|||
130092276|NCT02813681|468292615|FG001|Overall Study|Physician Decision|5|||
130092277|NCT02813681|468292616|FG002|Overall Study|Physician Decision|0|||
130092278|NCT02813681|468292614|FG000|Overall Study|Lost to Follow-up|0|||
130092279|NCT02813681|468292615|FG001|Overall Study|Lost to Follow-up|1|||
130092280|NCT02813681|468292616|FG002|Overall Study|Lost to Follow-up|0|||
130092281|NCT05047601|468292621|FG000|Overall Study|Lost to Follow-up|9|||
130092282|NCT05047601|468292622|FG001|Overall Study|Lost to Follow-up|11|||
130092283|NCT05047601|468292623|FG002|Overall Study|Lost to Follow-up|7|||
130092284|NCT05047601|468292621|FG000|Overall Study|Withdrawal by Subject|25|||
130092285|NCT05047601|468292622|FG001|Overall Study|Withdrawal by Subject|36|||
130092286|NCT05047601|468292623|FG002|Overall Study|Withdrawal by Subject|23|||
130092287|NCT05047601|468292621|FG000|Overall Study|Other|10|||
130092288|NCT05047601|468292622|FG001|Overall Study|Other|6|||
130092289|NCT05047601|468292623|FG002|Overall Study|Other|5|||
130092290|NCT00283062|468292628|FG000|Overall Study|Did not receive any study medication|5|||
130092291|NCT00283062|468292629|FG001|Overall Study|Did not receive any study medication|4|||
130092292|NCT00283062|468292630|FG002|Overall Study|Did not receive any study medication|36|||
130092293|NCT00283062|468292631|FG003|Overall Study|Did not receive any study medication|45|||
130092294|NCT00283062|468292628|FG000|Overall Study|Adverse Event|2|||
130092295|NCT00283062|468292629|FG001|Overall Study|Adverse Event|0|||
130092296|NCT00283062|468292630|FG002|Overall Study|Adverse Event|1|||
130092297|NCT00283062|468292631|FG003|Overall Study|Adverse Event|0|||
130092298|NCT00283062|468292628|FG000|Overall Study|Lost to Follow-up|1|||
129967447|NCT00087555|467845009|FG002|Overall Study|Non Compliance|1|||
130092299|NCT00283062|468292629|FG001|Overall Study|Lost to Follow-up|0|||
130122746|NCT01492400|468410592|FG000|Overall Study|Adverse Event|10|||
129967448|NCT00087555|467845007|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
129967449|NCT00087555|467845008|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
129967450|NCT00087555|467845009|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
129967451|NCT00087555|467845007|FG000|Overall Study|Patient wanted to go back on Med|1|||
129967452|NCT00087555|467845008|FG001|Overall Study|Patient wanted to go back on Med|0|||
129967453|NCT00087555|467845009|FG002|Overall Study|Patient wanted to go back on Med|0|||
130092300|NCT00283062|468292630|FG002|Overall Study|Lost to Follow-up|1|||
130092301|NCT00283062|468292631|FG003|Overall Study|Lost to Follow-up|0|||
130092302|NCT00283062|468292628|FG000|Overall Study|Progressive disease|0|||
129967454|NCT02344173|467845018|FG000|Procedure|Ablation Procedure Not Performed|7|||
129967455|NCT02344173|467845018|FG000|12-month Visit|Death|8|||
129967456|NCT02344173|467845018|FG000|12-month Visit|Withdrawal by Subject|30|||
129967457|NCT02344173|467845018|FG000|12-month Visit|Lost to Follow-up|58|||
129967458|NCT03845023|467845019|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
129967459|NCT03845023|467845020|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
129967460|NCT03845023|467845021|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
129967461|NCT03845023|467845022|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
129967462|NCT03845023|467845019|FG000|Follow-Up (14 Days)|Adverse Event|0|||
129967463|NCT03845023|467845020|FG001|Follow-Up (14 Days)|Adverse Event|0|||
129967464|NCT03845023|467845021|FG002|Follow-Up (14 Days)|Adverse Event|1|||
129967465|NCT03845023|467845022|FG003|Follow-Up (14 Days)|Adverse Event|1|||
129967466|NCT05314374|467845023|FG000|Overall Study|Adverse Event|2|||
129967467|NCT05314374|467845024|FG001|Overall Study|Adverse Event|2|||
129967468|NCT02554383|467845025|FG000|Overall Study|Ineligible|3|||
129967469|NCT02554383|467845026|FG001|Overall Study|Ineligible|2|||
129967470|NCT02554383|467845025|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
129967471|NCT02554383|467845026|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
129967472|NCT02554383|467845025|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
129967473|NCT02554383|467845026|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
129967474|NCT02554383|467845025|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
129967475|NCT02554383|467845026|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
129967476|NCT01185171|467845029|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
129967477|NCT01185171|467845029|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
129967478|NCT01185171|467845029|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
129967479|NCT01185171|467845029|FG000|Maintenance|Elevated liver transaminases|3|||
129967480|NCT01185171|467845029|FG000|Maintenance|Rush|2|||
129967481|NCT01185171|467845029|FG000|Maintenance|Diarrhea|1|||
129967482|NCT01185171|467845029|FG000|Maintenance|Xerostomia|1|||
129967483|NCT01185171|467845029|FG000|Maintenance|Nausea|1|||
129967484|NCT01185171|467845029|FG000|Maintenance|Comorbid Illness|2|||
129967485|NCT01185171|467845029|FG000|Maintenance|Withdrawal by Subject|1|||
129967486|NCT01185171|467845029|FG000|Maintenance|Disease Recurrence|1|||
129967487|NCT02581059|467845030|FG000|Study Treatment|Disease Progression|1|||
129967488|NCT02581059|467845031|FG001|Study Treatment|Disease Progression|1|||
129967489|NCT02581059|467845030|FG000|Study Treatment|Adverse Event|2|||
129967490|NCT02581059|467845031|FG001|Study Treatment|Adverse Event|1|||
129967491|NCT02581059|467845030|FG000|Study Treatment|Death|1|||
129967492|NCT02581059|467845031|FG001|Study Treatment|Death|1|||
129967493|NCT02581059|467845030|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129967494|NCT02581059|467845031|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
129967495|NCT02581059|467845030|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
129967496|NCT02581059|467845031|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
129967497|NCT02581059|467845030|FG000|Follow up|Death|1|||
129967498|NCT02581059|467845031|FG001|Follow up|Death|3|||
129967499|NCT02581059|467845030|FG000|Follow up|study terminated|1|||
129967500|NCT02581059|467845031|FG001|Follow up|study terminated|1|||
129967501|NCT02581059|467845030|FG000|Follow up|screen failure|0|||
129967502|NCT02581059|467845031|FG001|Follow up|screen failure|1|||
129967503|NCT02581059|467845030|FG000|Follow up|Patient started new clinical trial|1|||
129967504|NCT02581059|467845031|FG001|Follow up|Patient started new clinical trial|0|||
129967505|NCT02394665|467845036|FG000|Overall Study|Physician Decision|1|||
129967506|NCT02394665|467845037|FG001|Overall Study|Physician Decision|0|||
129967507|NCT02394665|467845038|FG002|Overall Study|Physician Decision|0|||
129967508|NCT02636608|467845039|FG000|Overall Study|Failure to Return|4|||
129967509|NCT02636608|467845039|FG000|Overall Study|Insufficient Virological Response|1|||
129967510|NCT02636608|467845039|FG000|Overall Study|Death|3|||
129967511|NCT02636608|467845039|FG000|Overall Study|Other|2|||
129967512|NCT02636608|467845039|FG000|Overall Study|Did Not Receive Treatment|1|||
129967513|NCT03912532|467845040|FG000|Overall Study|Adverse Event|3|||
129967514|NCT03912532|467845041|FG001|Overall Study|Adverse Event|3|||
129967515|NCT03912532|467845042|FG002|Overall Study|Adverse Event|2|||
130092303|NCT00283062|468292629|FG001|Overall Study|Progressive disease|0|||
130092304|NCT00283062|468292630|FG002|Overall Study|Progressive disease|1|||
130092305|NCT00283062|468292631|FG003|Overall Study|Progressive disease|0|||
130092306|NCT00283062|468292628|FG000|Overall Study|Participant did not wish to continue|3|||
130092307|NCT00283062|468292629|FG001|Overall Study|Participant did not wish to continue|2|||
130092308|NCT00283062|468292630|FG002|Overall Study|Participant did not wish to continue|1|||
130092309|NCT00283062|468292631|FG003|Overall Study|Participant did not wish to continue|0|||
130092310|NCT00283062|468292628|FG000|Overall Study|Undefined|0|||
129967516|NCT03912532|467845043|FG003|Overall Study|Adverse Event|2|||
129967517|NCT03912532|467845040|FG000|Overall Study|Lost to Follow-up|3|||
129967518|NCT03912532|467845041|FG001|Overall Study|Lost to Follow-up|2|||
129967519|NCT03912532|467845042|FG002|Overall Study|Lost to Follow-up|1|||
129967520|NCT03912532|467845043|FG003|Overall Study|Lost to Follow-up|2|||
130092311|NCT00283062|468292629|FG001|Overall Study|Undefined|1|||
130092312|NCT00283062|468292630|FG002|Overall Study|Undefined|1|||
130092313|NCT00283062|468292631|FG003|Overall Study|Undefined|4|||
130092314|NCT00283062|468292628|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
130092315|NCT00283062|468292629|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
130092316|NCT00283062|468292630|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
130092317|NCT00283062|468292631|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
130092318|NCT03137173|468292632|FG000|Overall Study|Withdrawal by Subject|8|||
130092319|NCT03137173|468292633|FG001|Overall Study|Withdrawal by Subject|13|||
130092320|NCT03137173|468292632|FG000|Overall Study|Death|1|||
130092321|NCT03137173|468292633|FG001|Overall Study|Death|3|||
130092322|NCT03137173|468292632|FG000|Overall Study|Physician Decision|1|||
130092323|NCT03137173|468292633|FG001|Overall Study|Physician Decision|0|||
130092324|NCT03137173|468292632|FG000|Overall Study|Lost to Follow-up|13|||
130092325|NCT03137173|468292633|FG001|Overall Study|Lost to Follow-up|18|||
130092326|NCT03137173|468292632|FG000|Overall Study|Other reasons|3|||
130092327|NCT03137173|468292633|FG001|Overall Study|Other reasons|2|||
130092328|NCT01365468|468292634|FG000|Overall Study|Physician Decision|1|||
130092329|NCT01365468|468292635|FG001|Overall Study|Physician Decision|0|||
130092330|NCT01365468|468292634|FG000|Overall Study|Disease progression|1|||
130092331|NCT01365468|468292635|FG001|Overall Study|Disease progression|0|||
130092332|NCT01365468|468292634|FG000|Overall Study|Lost to Follow-up|2|||
130092333|NCT01365468|468292635|FG001|Overall Study|Lost to Follow-up|0|||
130122747|NCT01492400|468410593|FG001|Overall Study|Adverse Event|5|||
130122748|NCT00604500|468410594|FG000|Overall Study|Adverse Event|2|||
130122749|NCT00604500|468410594|FG000|Overall Study|Protocol Violation|2|||
130122750|NCT00604500|468410594|FG000|Overall Study|Treatment Failure|1|||
130122751|NCT00604500|468410594|FG000|Overall Study|Withdrawal by Subject|4|||
130122752|NCT00604500|468410594|FG000|Overall Study|Administrative|1|||
130122753|NCT00604500|468410594|FG000|Overall Study|Did not meet protocol eligibility|1|||
130122754|NCT00320112|468410596|FG000|Overall Study|Lost to Follow-up|3|||
130122755|NCT00320112|468410597|FG001|Overall Study|Lost to Follow-up|4|||
130122756|NCT00320112|468410596|FG000|Overall Study|Withdrawal by Subject|3|||
130122757|NCT00320112|468410597|FG001|Overall Study|Withdrawal by Subject|0|||
130122758|NCT00320112|468410596|FG000|Overall Study|Death|2|||
130122759|NCT00320112|468410597|FG001|Overall Study|Death|1|||
130122760|NCT02899338|468410598|FG000|Overall Study|Adverse Event|1|||
130122761|NCT02899338|468410599|FG001|Overall Study|Adverse Event|2|||
130122762|NCT02899338|468410598|FG000|Overall Study|Withdrawal by Subject|2|||
130122763|NCT02899338|468410599|FG001|Overall Study|Withdrawal by Subject|0|||
130122764|NCT02353169|468410602|FG000|Overall Study|QTc > 450 msec|1|||
130122765|NCT02353169|468410603|FG001|Overall Study|QTc > 450 msec|1|||
130122766|NCT02353169|468410604|FG002|Overall Study|QTc > 450 msec|1|||
130122767|NCT02353169|468410605|FG003|Overall Study|QTc > 450 msec|1|||
130122768|NCT02353169|468410602|FG000|Overall Study|OR team declined|2|||
130122769|NCT02353169|468410603|FG001|Overall Study|OR team declined|0|||
130122770|NCT02353169|468410604|FG002|Overall Study|OR team declined|0|||
130122771|NCT02353169|468410605|FG003|Overall Study|OR team declined|0|||
130122772|NCT02353169|468410602|FG000|Overall Study|Inhalational induction|0|||
130122773|NCT02353169|468410603|FG001|Overall Study|Inhalational induction|2|||
130122774|NCT02353169|468410604|FG002|Overall Study|Inhalational induction|0|||
130122775|NCT02353169|468410605|FG003|Overall Study|Inhalational induction|0|||
130122776|NCT02353169|468410602|FG000|Overall Study|ECG data error|0|||
130122777|NCT02353169|468410603|FG001|Overall Study|ECG data error|3|||
130122778|NCT02353169|468410604|FG002|Overall Study|ECG data error|2|||
130122779|NCT02353169|468410605|FG003|Overall Study|ECG data error|2|||
130122780|NCT02353169|468410602|FG000|Overall Study|Pre-op medication|0|||
130122781|NCT02353169|468410603|FG001|Overall Study|Pre-op medication|0|||
130122782|NCT02353169|468410604|FG002|Overall Study|Pre-op medication|1|||
130122783|NCT02353169|468410605|FG003|Overall Study|Pre-op medication|0|||
130122784|NCT00117949|468410606|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
130122785|NCT00117949|468410607|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
130122786|NCT00117949|468410608|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
130122787|NCT00117949|468410609|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
130122788|NCT00117949|468410606|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
130092334|NCT00423267|468292638|FG000|Period A|Withdrawal by Subject|0|||
130122789|NCT00117949|468410607|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
130122790|NCT00117949|468410608|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
130122791|NCT00117949|468410609|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
130122792|NCT00117949|468410606|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
130122793|NCT00117949|468410607|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
130122794|NCT00117949|468410608|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
129967521|NCT03912532|467845040|FG000|Overall Study|Withdrawal by Subject|1|||
130092335|NCT00423267|468292639|FG001|Period A|Withdrawal by Subject|1|||
130092336|NCT00423267|468292638|FG000|Period A|Non-compliance with protocol|1|||
130122795|NCT00117949|468410609|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
130092337|NCT00423267|468292639|FG001|Period A|Non-compliance with protocol|0|||
130092338|NCT00423267|468292638|FG000|Period A|Administrative|1|||
130122796|NCT00117949|468410606|FG000|Overall Study|PSA increase >=10ng/mL|0|||
129967522|NCT03912532|467845041|FG001|Overall Study|Withdrawal by Subject|1|||
129967523|NCT03912532|467845042|FG002|Overall Study|Withdrawal by Subject|2|||
129967524|NCT03912532|467845043|FG003|Overall Study|Withdrawal by Subject|0|||
129967525|NCT03912532|467845040|FG000|Overall Study|Physician Decision|1|||
129967526|NCT03912532|467845041|FG001|Overall Study|Physician Decision|0|||
129967527|NCT03912532|467845042|FG002|Overall Study|Physician Decision|0|||
129967528|NCT03912532|467845043|FG003|Overall Study|Physician Decision|3|||
129967529|NCT03912532|467845040|FG000|Overall Study|Other|0|||
129967530|NCT03912532|467845041|FG001|Overall Study|Other|1|||
129967531|NCT03912532|467845042|FG002|Overall Study|Other|1|||
129967532|NCT03912532|467845043|FG003|Overall Study|Other|0|||
129967533|NCT03783871|467845048|FG000|Overall Study|Withdrawal by Subject|15|||
129967534|NCT03783871|467845048|FG000|Overall Study|Death|13|||
129967535|NCT03783871|467845048|FG000|Overall Study|Lost to Follow-up|2|||
129967536|NCT04594733|467845049|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129967537|NCT04594733|467845050|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129967538|NCT04594733|467845049|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
129967539|NCT04594733|467845050|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
129967540|NCT04594733|467845049|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
129967541|NCT04594733|467845050|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129967542|NCT02386839|467845051|FG000|Overall Study|Death|1|||
129967543|NCT02386839|467845052|FG001|Overall Study|Death|0|||
129967544|NCT02386839|467845051|FG000|Overall Study|Withdrawal by Subject|9|||
129967545|NCT02386839|467845052|FG001|Overall Study|Withdrawal by Subject|10|||
129967546|NCT02386839|467845051|FG000|Overall Study|Lost to Follow-up|4|||
129967547|NCT02386839|467845052|FG001|Overall Study|Lost to Follow-up|4|||
129967548|NCT02386839|467845051|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
129967549|NCT02386839|467845052|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
129967550|NCT02386839|467845051|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
129967551|NCT02386839|467845052|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
129967552|NCT02386839|467845051|FG000|Overall Study|Other (unspecified)|1|||
130092339|NCT00423267|468292639|FG001|Period A|Administrative|0|||
130092340|NCT00827112|468292640|FG000|Overall Study|Adverse Event|2|||
130092341|NCT00827112|468292641|FG001|Overall Study|Adverse Event|0|||
130092342|NCT00827112|468292640|FG000|Overall Study|Lack of Efficacy|2|||
130092343|NCT00827112|468292641|FG001|Overall Study|Lack of Efficacy|0|||
130092344|NCT00827112|468292640|FG000|Overall Study|Lost to Follow-up|3|||
130092345|NCT00827112|468292641|FG001|Overall Study|Lost to Follow-up|2|||
130092346|NCT00827112|468292640|FG000|Overall Study|Pregnancy|0|||
130092347|NCT00827112|468292641|FG001|Overall Study|Pregnancy|1|||
130092348|NCT00827112|468292640|FG000|Overall Study|Protocol Violation|0|||
130092349|NCT00827112|468292641|FG001|Overall Study|Protocol Violation|2|||
130092350|NCT00827112|468292640|FG000|Overall Study|Withdrawal by Subject|2|||
130092351|NCT00827112|468292641|FG001|Overall Study|Withdrawal by Subject|1|||
130092352|NCT00827112|468292640|FG000|Overall Study|Randomized but not treated|5|||
130092353|NCT00827112|468292641|FG001|Overall Study|Randomized but not treated|3|||
130092354|NCT00827112|468292640|FG000|Overall Study|Other|1|||
130092355|NCT00827112|468292641|FG001|Overall Study|Other|3|||
130092356|NCT01475214|468292642|FG000|Overall Study|Lost to Follow-up|1|||
130092357|NCT01475214|468292643|FG001|Overall Study|Lost to Follow-up|0|||
130092358|NCT01475214|468292644|FG002|Overall Study|Lost to Follow-up|1|||
130092359|NCT01475214|468292642|FG000|Overall Study|Physician Decision|2|||
130092360|NCT01475214|468292643|FG001|Overall Study|Physician Decision|0|||
130092361|NCT01475214|468292644|FG002|Overall Study|Physician Decision|0|||
130092362|NCT01475214|468292642|FG000|Overall Study|Withdrawal by Subject|2|||
130092363|NCT01475214|468292643|FG001|Overall Study|Withdrawal by Subject|4|||
130092364|NCT01475214|468292644|FG002|Overall Study|Withdrawal by Subject|1|||
130092365|NCT00911508|468294476|FG000|Overall Study|Lost to Follow-up|27|||
130092366|NCT00911508|468294477|FG001|Overall Study|Lost to Follow-up|18|||
130092367|NCT00911508|468294476|FG000|Overall Study|Withdrawal by Subject|79|||
130092368|NCT00911508|468294477|FG001|Overall Study|Withdrawal by Subject|112|||
130092369|NCT01409382|468294478|FG000|Overall Study|Lost to Follow-up|1|||
130092370|NCT01409382|468294479|FG001|Overall Study|Lost to Follow-up|1|||
130092371|NCT01409382|468294478|FG000|Overall Study|Protocol Violation|0|||
130092372|NCT01409382|468294479|FG001|Overall Study|Protocol Violation|3|||
130092373|NCT01409382|468294478|FG000|Overall Study|Multiple pregnancy|2|||
130092374|NCT01409382|468294479|FG001|Overall Study|Multiple pregnancy|4|||
130092375|NCT01409382|468294478|FG000|Overall Study|Still pregnant when study ended|13|||
130092376|NCT01409382|468294479|FG001|Overall Study|Still pregnant when study ended|2|||
130092377|NCT01409382|468294478|FG000|Overall Study|Did not manage to get pregnant|64|||
130092378|NCT01409382|468294479|FG001|Overall Study|Did not manage to get pregnant|70|||
130092379|NCT01409382|468294478|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
130092380|NCT01409382|468294479|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
130092381|NCT01004822|468294480|FG000|Overall Study|Objective progression or relapse|3|||
130092382|NCT01004822|468294481|FG001|Overall Study|Objective progression or relapse|3|||
129967553|NCT02386839|467845052|FG001|Overall Study|Other (unspecified)|0|||
130092383|NCT01004822|468294482|FG002|Overall Study|Objective progression or relapse|0|||
130092384|NCT01004822|468294483|FG003|Overall Study|Objective progression or relapse|1|||
130092385|NCT01004822|468294484|FG004|Overall Study|Objective progression or relapse|2|||
130092386|NCT01004822|468294485|FG005|Overall Study|Objective progression or relapse|2|||
130092387|NCT01004822|468294486|FG006|Overall Study|Objective progression or relapse|1|||
130092388|NCT01004822|468294487|FG007|Overall Study|Objective progression or relapse|4|||
130092389|NCT01004822|468294480|FG000|Overall Study|Global deterioration of health status|0|||
130092390|NCT01004822|468294481|FG001|Overall Study|Global deterioration of health status|0|||
130092391|NCT01004822|468294482|FG002|Overall Study|Global deterioration of health status|0|||
130092392|NCT01004822|468294483|FG003|Overall Study|Global deterioration of health status|1|||
130092393|NCT01004822|468294484|FG004|Overall Study|Global deterioration of health status|0|||
130092394|NCT01004822|468294485|FG005|Overall Study|Global deterioration of health status|0|||
130092395|NCT01004822|468294486|FG006|Overall Study|Global deterioration of health status|1|||
130092396|NCT01004822|468294487|FG007|Overall Study|Global deterioration of health status|0|||
130092397|NCT01004822|468294480|FG000|Overall Study|No longer willing to continue|0|||
130092398|NCT01004822|468294481|FG001|Overall Study|No longer willing to continue|0|||
130092399|NCT01004822|468294482|FG002|Overall Study|No longer willing to continue|0|||
130092400|NCT01004822|468294483|FG003|Overall Study|No longer willing to continue|1|||
130092401|NCT01004822|468294484|FG004|Overall Study|No longer willing to continue|2|||
130092402|NCT01004822|468294485|FG005|Overall Study|No longer willing to continue|1|||
130092403|NCT01004822|468294486|FG006|Overall Study|No longer willing to continue|1|||
130092404|NCT01004822|468294487|FG007|Overall Study|No longer willing to continue|0|||
130092405|NCT01004822|468294480|FG000|Overall Study|Adverse Event|0|||
130092406|NCT01004822|468294481|FG001|Overall Study|Adverse Event|0|||
130092407|NCT01004822|468294482|FG002|Overall Study|Adverse Event|0|||
130092408|NCT01004822|468294483|FG003|Overall Study|Adverse Event|0|||
130092409|NCT01004822|468294484|FG004|Overall Study|Adverse Event|0|||
130092410|NCT01004822|468294485|FG005|Overall Study|Adverse Event|0|||
130092411|NCT01004822|468294486|FG006|Overall Study|Adverse Event|1|||
130092412|NCT01004822|468294487|FG007|Overall Study|Adverse Event|1|||
130092413|NCT01004822|468294480|FG000|Overall Study|Other|0|||
130092414|NCT01004822|468294481|FG001|Overall Study|Other|0|||
130092415|NCT01004822|468294482|FG002|Overall Study|Other|4|||
130092416|NCT01004822|468294483|FG003|Overall Study|Other|1|||
130092417|NCT01004822|468294484|FG004|Overall Study|Other|0|||
130092418|NCT01004822|468294485|FG005|Overall Study|Other|1|||
130092419|NCT01004822|468294486|FG006|Overall Study|Other|0|||
130092420|NCT01004822|468294487|FG007|Overall Study|Other|0|||
130092421|NCT01858701|468294488|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
130092422|NCT01858701|468294489|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
130092423|NCT01858701|468294488|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
130092424|NCT01858701|468294489|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
130092425|NCT01858701|468294488|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
130092426|NCT01858701|468294489|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
130092427|NCT01858701|468294488|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
130092428|NCT01858701|468294489|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
130092429|NCT01789476|468294497|FG000|Overall Study|Lack of Efficacy|6|||
130092430|NCT01789476|468294498|FG001|Overall Study|Lack of Efficacy|2|||
130092431|NCT01789476|468294497|FG000|Overall Study|Adverse Event|1|||
130092432|NCT01789476|468294498|FG001|Overall Study|Adverse Event|0|||
130092433|NCT01789476|468294497|FG000|Overall Study|Unable to get IV access|1|||
130092434|NCT01789476|468294498|FG001|Overall Study|Unable to get IV access|0|||
130092435|NCT00501969|468294499|FG000|Overall Study|Major Protocol Violation|4|||
130092436|NCT00501969|468294499|FG000|Overall Study|Lack of Efficacy|29|||
130092437|NCT00501969|468294499|FG000|Overall Study|Adverse Event|76|||
130092438|NCT00501969|468294499|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
130092439|NCT00501969|468294499|FG000|Overall Study|Subject withdrew consent|51|||
130092440|NCT00501969|468294499|FG000|Overall Study|Lost to Follow-up|4|||
130092441|NCT00501969|468294499|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
130092442|NCT00501969|468294499|FG000|Overall Study|Other: Sponsors Request|10|||
130092443|NCT00501969|468294499|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
130092444|NCT00501969|468294499|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
130092445|NCT00501969|468294499|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
130092446|NCT00501969|468294499|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
130092447|NCT00501969|468294499|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
130092448|NCT00501969|468294499|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
130092449|NCT00501969|468294499|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
130092450|NCT00501969|468294499|FG000|Overall Study|Other: As Required by Local EC|2|||
130092451|NCT00501969|468294499|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
130092452|NCT00501969|468294499|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
130092453|NCT00965458|468294500|FG000|Overall Study|Adverse Event|1|||
130092454|NCT00965458|468294501|FG001|Overall Study|Adverse Event|0|||
130092455|NCT00965458|468294500|FG000|Overall Study|Lost to Follow-up|1|||
130092456|NCT00965458|468294501|FG001|Overall Study|Lost to Follow-up|3|||
130092457|NCT00965458|468294500|FG000|Overall Study|Withdrawal by Subject|0|||
130122797|NCT00117949|468410607|FG001|Overall Study|PSA increase >=10ng/mL|1|||
130122798|NCT00117949|468410608|FG002|Overall Study|PSA increase >=10ng/mL|1|||
130122799|NCT00117949|468410609|FG003|Overall Study|PSA increase >=10ng/mL|0|||
130122800|NCT00117949|468410606|FG000|Overall Study|PSA reduction <=50%|0|||
130122801|NCT00117949|468410607|FG001|Overall Study|PSA reduction <=50%|2|||
130122802|NCT00117949|468410608|FG002|Overall Study|PSA reduction <=50%|2|||
130122803|NCT00117949|468410609|FG003|Overall Study|PSA reduction <=50%|4|||
130122804|NCT00117949|468410606|FG000|Overall Study|Hepatic abnormalities|0|||
130122805|NCT00117949|468410607|FG001|Overall Study|Hepatic abnormalities|1|||
130122806|NCT00117949|468410608|FG002|Overall Study|Hepatic abnormalities|0|||
130122807|NCT00117949|468410609|FG003|Overall Study|Hepatic abnormalities|1|||
130092458|NCT00965458|468294501|FG001|Overall Study|Withdrawal by Subject|1|||
130122808|NCT03184441|468410615|FG000|Overall Study|Withdrawal by Subject|1|||
130122809|NCT01868009|468410618|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
130122810|NCT01868009|468410619|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
130122811|NCT01868009|468410618|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
130122812|NCT01868009|468410619|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
130122813|NCT01868009|468410618|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
130122814|NCT01868009|468410619|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
130122815|NCT04803357|468410622|FG000|Overall Study|Withdrawal by Subject|31|||
130122816|NCT04803357|468410623|FG001|Overall Study|Withdrawal by Subject|5|||
130122817|NCT00182091|468410624|FG000|Overall Study|Withdrawal by Subject|1|||
130122818|NCT00182091|468410625|FG001|Overall Study|Withdrawal by Subject|0|||
130122819|NCT00182091|468410626|FG002|Overall Study|Withdrawal by Subject|0|||
130122820|NCT00182091|468410627|FG003|Overall Study|Withdrawal by Subject|0|||
130122821|NCT01046253|468410628|FG000|Second Intervention|Adverse Event|0|||
130122822|NCT01046253|468410629|FG001|Second Intervention|Adverse Event|1|||
130122823|NCT01046253|468410628|FG000|Second Intervention|Protocol Violation|0|||
130122824|NCT01046253|468410629|FG001|Second Intervention|Protocol Violation|1|||
130122825|NCT02339909|468410632|FG000|Overall Study|Became ineligible after randomisation|89|||
130122826|NCT02339909|468410633|FG001|Overall Study|Became ineligible after randomisation|63|||
130122827|NCT02339909|468410634|FG002|Overall Study|Became ineligible after randomisation|71|||
130122828|NCT00860028|468410642|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
130122829|NCT00860028|468410643|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
130122830|NCT01658943|468410645|FG000|Overall Study|Adverse Event|6|||
130122831|NCT01658943|468410646|FG001|Overall Study|Adverse Event|13|||
130122832|NCT01658943|468410645|FG000|Overall Study|Withdrawal by Subject|9|||
130122833|NCT01658943|468410646|FG001|Overall Study|Withdrawal by Subject|2|||
130122834|NCT01658943|468410645|FG000|Overall Study|Progression/Relapse|39|||
130122835|NCT01658943|468410646|FG001|Overall Study|Progression/Relapse|40|||
130122836|NCT01658943|468410645|FG000|Overall Study|Death|4|||
130122837|NCT01658943|468410646|FG001|Overall Study|Death|2|||
130122838|NCT01658943|468410645|FG000|Overall Study|not protocol specified|4|||
130122839|NCT01658943|468410646|FG001|Overall Study|not protocol specified|1|||
130122840|NCT01658943|468410645|FG000|Overall Study|Not eligible|7|||
130122841|NCT01658943|468410646|FG001|Overall Study|Not eligible|9|||
130122842|NCT01658943|468410645|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
130122843|NCT01658943|468410646|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
130122844|NCT00475020|468410648|FG000|Overall Study|Physician Decision|3|||
130122845|NCT00475020|468410648|FG000|Overall Study|Insurance Denial|1|||
130122846|NCT00475020|468410648|FG000|Overall Study|Donor not able to donate the last minute|1|||
130122847|NCT02514174|468410652|FG000|Overall Study|Patient refused to continue medication|1|||
130122848|NCT02514174|468410652|FG000|Overall Study|Adverse Event|2|||
130122849|NCT02514174|468410652|FG000|Overall Study|Study closed by sponsor|9|||
130122850|NCT02514174|468410652|FG000|Overall Study|Progressive disease|11|||
130122851|NCT02514174|468410652|FG000|Overall Study|Treatment change|1|||
130122852|NCT02514174|468410652|FG000|Overall Study|Treated off study with Afatinib.|1|||
130092459|NCT05111548|468294508|FG000|Overall Study|Withdrawal by Subject|2|||
130092460|NCT05111548|468294509|FG001|Overall Study|Withdrawal by Subject|1|||
130092461|NCT05111548|468294508|FG000|Overall Study|Adverse Event|1|||
130092462|NCT05111548|468294509|FG001|Overall Study|Adverse Event|0|||
130092463|NCT00379639|468294510|FG000|Overall Study|Disease Progression|3|||
130092464|NCT00379639|468294511|FG001|Overall Study|Disease Progression|3|||
130092465|NCT00379639|468294512|FG002|Overall Study|Disease Progression|3|||
130092466|NCT00379639|468294513|FG003|Overall Study|Disease Progression|4|||
130092467|NCT00379639|468294514|FG004|Overall Study|Disease Progression|4|||
130092468|NCT00379639|468294510|FG000|Overall Study|Physician Decision|0|||
130092469|NCT00379639|468294511|FG001|Overall Study|Physician Decision|2|||
130092470|NCT00379639|468294512|FG002|Overall Study|Physician Decision|1|||
130092471|NCT00379639|468294513|FG003|Overall Study|Physician Decision|1|||
130092472|NCT00379639|468294514|FG004|Overall Study|Physician Decision|0|||
130092473|NCT00379639|468294510|FG000|Overall Study|Symptomatic Deterioration|0|||
130092474|NCT00379639|468294511|FG001|Overall Study|Symptomatic Deterioration|0|||
130122853|NCT02130466|468410653|FG000|Overall Study|Death|4|||
130122854|NCT02130466|468410654|FG001|Overall Study|Death|1|||
130092475|NCT00379639|468294512|FG002|Overall Study|Symptomatic Deterioration|1|||
129967554|NCT00826228|467847021|FG000|Overall Study|Withdrawal by Subject|1|||
129967555|NCT02820597|467847022|FG000|Overall Study|Lost to Follow-up|12|||
129967556|NCT00575042|467847023|FG000|Overall Study|Adverse Event|2|||
129967557|NCT00575042|467847023|FG000|Overall Study|Lost to Follow-up|1|||
129967558|NCT02666664|467847024|FG000|Overall Study|Physician Decision|0|||
129967559|NCT02666664|467847025|FG001|Overall Study|Physician Decision|1|||
129967560|NCT02666664|467847024|FG000|Overall Study|Protocol Violation|0|||
129967561|NCT02666664|467847025|FG001|Overall Study|Protocol Violation|2|||
129967562|NCT02666664|467847024|FG000|Overall Study|Other|0|||
129967563|NCT02666664|467847025|FG001|Overall Study|Other|1|||
129967564|NCT02666664|467847024|FG000|Overall Study|Adverse Event|12|||
129967565|NCT02666664|467847025|FG001|Overall Study|Adverse Event|37|||
129967566|NCT02666664|467847024|FG000|Overall Study|Withdrawal by participant|23|||
129967567|NCT02666664|467847025|FG001|Overall Study|Withdrawal by participant|40|||
129967568|NCT02666664|467847024|FG000|Overall Study|Sponsor decision|0|||
129967569|NCT02666664|467847025|FG001|Overall Study|Sponsor decision|1|||
129967570|NCT02666664|467847024|FG000|Overall Study|Lost to Follow-up|1|||
129967571|NCT02666664|467847025|FG001|Overall Study|Lost to Follow-up|2|||
129967572|NCT03616964|467847026|FG000|Overall Study|Adverse Event|15|||
129967573|NCT03616964|467847027|FG001|Overall Study|Adverse Event|10|||
129967574|NCT03616964|467847028|FG002|Overall Study|Adverse Event|16|||
129967575|NCT03616964|467847026|FG000|Overall Study|Death|3|||
129967576|NCT03616964|467847027|FG001|Overall Study|Death|0|||
130092476|NCT00379639|468294513|FG003|Overall Study|Symptomatic Deterioration|0|||
130092477|NCT00379639|468294514|FG004|Overall Study|Symptomatic Deterioration|1|||
130092478|NCT00379639|468294510|FG000|Overall Study|Adverse Event|0|||
130092479|NCT00379639|468294511|FG001|Overall Study|Adverse Event|0|||
130092480|NCT00379639|468294512|FG002|Overall Study|Adverse Event|1|||
130092481|NCT00379639|468294513|FG003|Overall Study|Adverse Event|0|||
130092482|NCT00379639|468294514|FG004|Overall Study|Adverse Event|1|||
130092483|NCT00379639|468294510|FG000|Overall Study|Lost to Follow-up|0|||
130092484|NCT00379639|468294511|FG001|Overall Study|Lost to Follow-up|0|||
130092485|NCT00379639|468294512|FG002|Overall Study|Lost to Follow-up|0|||
130092486|NCT00379639|468294513|FG003|Overall Study|Lost to Follow-up|1|||
130092487|NCT00379639|468294514|FG004|Overall Study|Lost to Follow-up|0|||
130092488|NCT00379639|468294510|FG000|Overall Study|Other|0|||
130092489|NCT00379639|468294511|FG001|Overall Study|Other|0|||
130092490|NCT00379639|468294512|FG002|Overall Study|Other|3|||
130092491|NCT00379639|468294513|FG003|Overall Study|Other|0|||
130092492|NCT00379639|468294514|FG004|Overall Study|Other|0|||
130092493|NCT00594958|468294515|FG000|Overall Study|Withdrawal by Subject|1|||
130092494|NCT00594958|468294516|FG001|Overall Study|Withdrawal by Subject|0|||
130092495|NCT00594958|468294517|FG002|Overall Study|Withdrawal by Subject|1|||
130092496|NCT00594958|468294515|FG000|Overall Study|Adverse Event|4|||
130092497|NCT00594958|468294516|FG001|Overall Study|Adverse Event|1|||
130092498|NCT00594958|468294517|FG002|Overall Study|Adverse Event|2|||
130092499|NCT00594958|468294515|FG000|Overall Study|Pregnancy|0|||
130092500|NCT00594958|468294516|FG001|Overall Study|Pregnancy|2|||
130092501|NCT00594958|468294517|FG002|Overall Study|Pregnancy|0|||
130092502|NCT00594958|468294515|FG000|Overall Study|Protocol Violation|1|||
130092503|NCT00594958|468294516|FG001|Overall Study|Protocol Violation|0|||
130092504|NCT00594958|468294517|FG002|Overall Study|Protocol Violation|2|||
130092505|NCT00594958|468294515|FG000|Overall Study|Lost to Follow-up|5|||
130092506|NCT00594958|468294516|FG001|Overall Study|Lost to Follow-up|0|||
130092507|NCT00594958|468294517|FG002|Overall Study|Lost to Follow-up|3|||
130092508|NCT00594958|468294515|FG000|Overall Study|administrative|3|||
130092509|NCT00594958|468294516|FG001|Overall Study|administrative|0|||
130092510|NCT00594958|468294517|FG002|Overall Study|administrative|2|||
130092511|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
130092512|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
130092513|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092514|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092515|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092516|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092517|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092518|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092519|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092520|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092521|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129967577|NCT03616964|467847028|FG002|Overall Study|Death|4|||
129967578|NCT03616964|467847026|FG000|Overall Study|Lack of Efficacy|4|||
129967579|NCT03616964|467847027|FG001|Overall Study|Lack of Efficacy|8|||
130092522|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
130092523|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
129967580|NCT03616964|467847028|FG002|Overall Study|Lack of Efficacy|8|||
129967581|NCT03616964|467847026|FG000|Overall Study|Lost to Follow-up|2|||
129967582|NCT03616964|467847027|FG001|Overall Study|Lost to Follow-up|1|||
129967583|NCT03616964|467847028|FG002|Overall Study|Lost to Follow-up|3|||
130122855|NCT02130466|468410655|FG002|Overall Study|Death|1|||
130122856|NCT02130466|468410656|FG003|Overall Study|Death|3|||
130122857|NCT02130466|468410657|FG004|Overall Study|Death|2|||
130122858|NCT02130466|468410658|FG005|Overall Study|Death|30|||
130122859|NCT02130466|468410659|FG006|Overall Study|Death|45|||
130122860|NCT02130466|468410660|FG007|Overall Study|Death|2|||
130122861|NCT02130466|468410661|FG008|Overall Study|Death|3|||
130122862|NCT02130466|468410662|FG009|Overall Study|Death|4|||
130122863|NCT02130466|468410663|FG010|Overall Study|Death|5|||
130122864|NCT02130466|468410664|FG011|Overall Study|Death|3|||
130122865|NCT02130466|468410665|FG012|Overall Study|Death|11|||
130122866|NCT02130466|468410666|FG013|Overall Study|Death|7|||
130122867|NCT02130466|468410653|FG000|Overall Study|Lost to Follow-up|1|||
130122868|NCT02130466|468410654|FG001|Overall Study|Lost to Follow-up|0|||
130122869|NCT02130466|468410655|FG002|Overall Study|Lost to Follow-up|0|||
130122870|NCT02130466|468410656|FG003|Overall Study|Lost to Follow-up|0|||
130122871|NCT02130466|468410657|FG004|Overall Study|Lost to Follow-up|0|||
130122872|NCT02130466|468410658|FG005|Overall Study|Lost to Follow-up|1|||
130122873|NCT02130466|468410659|FG006|Overall Study|Lost to Follow-up|0|||
130122874|NCT02130466|468410660|FG007|Overall Study|Lost to Follow-up|0|||
130122875|NCT02130466|468410661|FG008|Overall Study|Lost to Follow-up|0|||
130122876|NCT02130466|468410662|FG009|Overall Study|Lost to Follow-up|0|||
130122877|NCT02130466|468410663|FG010|Overall Study|Lost to Follow-up|0|||
130122878|NCT02130466|468410664|FG011|Overall Study|Lost to Follow-up|0|||
130122879|NCT02130466|468410665|FG012|Overall Study|Lost to Follow-up|1|||
130122880|NCT02130466|468410666|FG013|Overall Study|Lost to Follow-up|0|||
130122881|NCT02130466|468410653|FG000|Overall Study|Physician Decision|0|||
130122882|NCT02130466|468410654|FG001|Overall Study|Physician Decision|0|||
130122883|NCT02130466|468410655|FG002|Overall Study|Physician Decision|0|||
130122884|NCT02130466|468410656|FG003|Overall Study|Physician Decision|0|||
130122885|NCT02130466|468410657|FG004|Overall Study|Physician Decision|0|||
130122886|NCT02130466|468410658|FG005|Overall Study|Physician Decision|1|||
130122887|NCT02130466|468410659|FG006|Overall Study|Physician Decision|1|||
130122888|NCT02130466|468410660|FG007|Overall Study|Physician Decision|0|||
130122889|NCT02130466|468410661|FG008|Overall Study|Physician Decision|0|||
130122890|NCT02130466|468410662|FG009|Overall Study|Physician Decision|0|||
130122891|NCT02130466|468410663|FG010|Overall Study|Physician Decision|0|||
130122892|NCT02130466|468410664|FG011|Overall Study|Physician Decision|0|||
130122893|NCT02130466|468410665|FG012|Overall Study|Physician Decision|0|||
130122894|NCT02130466|468410666|FG013|Overall Study|Physician Decision|0|||
130122895|NCT02130466|468410653|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130122896|NCT02130466|468410654|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
130122897|NCT02130466|468410655|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130122898|NCT02130466|468410656|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
130122899|NCT02130466|468410657|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130122900|NCT02130466|468410658|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
130122901|NCT02130466|468410659|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
130122902|NCT02130466|468410660|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130122903|NCT02130466|468410661|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130122904|NCT02130466|468410662|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130122905|NCT02130466|468410663|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
130122906|NCT02130466|468410664|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130122907|NCT02130466|468410665|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
130122908|NCT02130466|468410666|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
130122909|NCT02130466|468410653|FG000|Overall Study|Withdrawal by Subject|1|||
130122910|NCT02130466|468410654|FG001|Overall Study|Withdrawal by Subject|0|||
130122911|NCT02130466|468410655|FG002|Overall Study|Withdrawal by Subject|0|||
130122912|NCT02130466|468410656|FG003|Overall Study|Withdrawal by Subject|0|||
130122913|NCT02130466|468410657|FG004|Overall Study|Withdrawal by Subject|0|||
130122914|NCT02130466|468410658|FG005|Overall Study|Withdrawal by Subject|1|||
130122915|NCT02130466|468410659|FG006|Overall Study|Withdrawal by Subject|0|||
130122916|NCT02130466|468410660|FG007|Overall Study|Withdrawal by Subject|0|||
130122917|NCT02130466|468410661|FG008|Overall Study|Withdrawal by Subject|1|||
130122918|NCT02130466|468410662|FG009|Overall Study|Withdrawal by Subject|0|||
130122919|NCT02130466|468410663|FG010|Overall Study|Withdrawal by Subject|0|||
130122920|NCT02130466|468410664|FG011|Overall Study|Withdrawal by Subject|0|||
130122921|NCT02130466|468410665|FG012|Overall Study|Withdrawal by Subject|0|||
130122922|NCT02130466|468410666|FG013|Overall Study|Withdrawal by Subject|0|||
130122923|NCT04529109|468410667|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
130122924|NCT04529109|468410668|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
130122925|NCT00993616|468410669|FG000|Overall Study|No tumor at entry|1|||
130122926|NCT00993616|468410669|FG000|Overall Study|Never treated|1|||
130122927|NCT01244126|468412143|FG000|Overall Study|Protocol Violation|3|||
130122928|NCT01244126|468412144|FG001|Overall Study|Protocol Violation|3|||
130122929|NCT01244126|468412145|FG002|Overall Study|Protocol Violation|9|||
130122930|NCT00863746|468412150|FG000|Treatment|Not treated|4|||
130122931|NCT00863746|468412151|FG001|Treatment|Not treated|2|||
130122932|NCT00863746|468412150|FG000|Treatment|Adverse Event|41|||
130122933|NCT00863746|468412151|FG001|Treatment|Adverse Event|16|||
130122934|NCT00863746|468412150|FG000|Treatment|non-compliant with study medication|4|||
130122935|NCT00863746|468412151|FG001|Treatment|non-compliant with study medication|0|||
130122936|NCT00863746|468412150|FG000|Treatment|Consent withdrawn|15|||
130122937|NCT00863746|468412151|FG001|Treatment|Consent withdrawn|14|||
130122938|NCT00863746|468412150|FG000|Treatment|Lost to Follow-up|1|||
130122939|NCT00863746|468412151|FG001|Treatment|Lost to Follow-up|0|||
130122940|NCT00863746|468412150|FG000|Treatment|Protocol Violation|5|||
130122941|NCT00863746|468412151|FG001|Treatment|Protocol Violation|3|||
130122942|NCT00863746|468412150|FG000|Treatment|Other|1|||
130122943|NCT00863746|468412151|FG001|Treatment|Other|0|||
130122944|NCT00863746|468412150|FG000|Survival Follow up|Death|244|||
130122945|NCT00863746|468412151|FG001|Survival Follow up|Death|271|||
130122946|NCT00863746|468412150|FG000|Survival Follow up|Lost to Follow-up|2|||
130122947|NCT00863746|468412151|FG001|Survival Follow up|Lost to Follow-up|1|||
130122948|NCT00863746|468412150|FG000|Survival Follow up|Consent Withdrawn|7|||
130122949|NCT00863746|468412151|FG001|Survival Follow up|Consent Withdrawn|8|||
130122950|NCT00453362|468412152|FG000|Overall Study|Adverse Event|5|||
130122951|NCT00453362|468412152|FG000|Overall Study|Death|7|||
130122952|NCT00453362|468412152|FG000|Overall Study|Physician Decision|2|||
130122953|NCT00453362|468412152|FG000|Overall Study|Withdrawal by Subject|3|||
130122954|NCT00453362|468412152|FG000|Overall Study|Progression of disease|56|||
130122955|NCT00453362|468412152|FG000|Overall Study|Screening Failure|14|||
130122956|NCT04885296|468412153|FG000|Period 1|Covid-19 Related|1|||
130122957|NCT04885296|468412154|FG001|Period 1|Covid-19 Related|0|||
130122958|NCT04885296|468412153|FG000|Period 1|Adverse Event|0|||
130122959|NCT04885296|468412154|FG001|Period 1|Adverse Event|1|||
130122960|NCT04885296|468412153|FG000|Period 1|Withdrawal by Subject|1|||
130122961|NCT04885296|468412154|FG001|Period 1|Withdrawal by Subject|1|||
130122962|NCT04885296|468412153|FG000|Period 1|Test Article No Longer Available|1|||
130122963|NCT04885296|468412154|FG001|Period 1|Test Article No Longer Available|0|||
130122964|NCT04885296|468412153|FG000|Period 1|Dispensed Study lens in Error|1|||
130122965|NCT04885296|468412154|FG001|Period 1|Dispensed Study lens in Error|0|||
130122966|NCT04885296|468412153|FG000|Period 1|Lost to Follow-up|1|||
130122967|NCT04885296|468412154|FG001|Period 1|Lost to Follow-up|0|||
130122968|NCT04885296|468412153|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
130122969|NCT04885296|468412154|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
130122970|NCT00862979|468412155|FG000|Overall Study|Adverse Event|6|||
130122971|NCT00862979|468412156|FG001|Overall Study|Adverse Event|3|||
130122972|NCT00862979|468412155|FG000|Overall Study|Protocol Violation|0|||
130122973|NCT00862979|468412156|FG001|Overall Study|Protocol Violation|1|||
130122974|NCT00862979|468412155|FG000|Overall Study|Patient withdrew consent|2|||
130122975|NCT00862979|468412156|FG001|Overall Study|Patient withdrew consent|1|||
130122976|NCT00862979|468412155|FG000|Overall Study|Administrative problems|0|||
130122977|NCT00862979|468412156|FG001|Overall Study|Administrative problems|1|||
130122978|NCT00862979|468412155|FG000|Overall Study|Death|0|||
130122979|NCT00862979|468412156|FG001|Overall Study|Death|1|||
130122980|NCT01367275|468412160|FG000|Overall Study|Ineligible|1|||
130122981|NCT01367275|468412160|FG000|Overall Study|Disease Progression|2|||
130122982|NCT05346055|468412161|FG000|Overall Study|Withdrawal by Subject|1|||
130122983|NCT05346055|468412161|FG000|Overall Study|Protocol Violation|1|||
130122984|NCT05346055|468412161|FG000|Overall Study|Therapist decision|1|||
130122985|NCT01545076|468412164|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
130122986|NCT01545076|468412165|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
130122987|NCT01545076|468412166|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
130122988|NCT01545076|468412167|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
129967584|NCT03616964|467847026|FG000|Overall Study|Withdrawal by Subject|18|||
129967585|NCT03616964|467847027|FG001|Overall Study|Withdrawal by Subject|14|||
130122989|NCT01545076|468412168|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
130122990|NCT01545076|468412164|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
130122991|NCT01545076|468412165|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
130122992|NCT01545076|468412166|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
130122993|NCT01545076|468412167|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
130122994|NCT01545076|468412168|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
130122995|NCT01545076|468412164|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
130122996|NCT01545076|468412165|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
130122997|NCT01545076|468412166|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
129967586|NCT03616964|467847028|FG002|Overall Study|Withdrawal by Subject|21|||
129967587|NCT03616964|467847026|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
130122998|NCT01545076|468412167|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
130122999|NCT01545076|468412168|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
130123000|NCT01545076|468412164|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
130123001|NCT01545076|468412165|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130123002|NCT01545076|468412166|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129967588|NCT03616964|467847027|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
129967589|NCT03616964|467847028|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
129967590|NCT03616964|467847026|FG000|Overall Study|Sponsor's Decision|1|||
129967591|NCT03616964|467847027|FG001|Overall Study|Sponsor's Decision|0|||
129967592|NCT03616964|467847028|FG002|Overall Study|Sponsor's Decision|0|||
129967593|NCT03616964|467847026|FG000|Overall Study|Physician Decision|0|||
129967594|NCT03616964|467847027|FG001|Overall Study|Physician Decision|2|||
129967595|NCT03616964|467847028|FG002|Overall Study|Physician Decision|0|||
129967596|NCT03616964|467847026|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
129967597|NCT03616964|467847027|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
129967598|NCT03616964|467847028|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
129967599|NCT03616964|467847026|FG000|Overall Study|Protocol Violation|0|||
129967600|NCT03616964|467847027|FG001|Overall Study|Protocol Violation|1|||
129967601|NCT03616964|467847028|FG002|Overall Study|Protocol Violation|0|||
129967602|NCT03616964|467847026|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
129967603|NCT03616964|467847027|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
129967604|NCT03616964|467847028|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
129967605|NCT03616964|467847026|FG000|Overall Study|Randomized but Never Treated|1|||
129967606|NCT03616964|467847027|FG001|Overall Study|Randomized but Never Treated|1|||
129967607|NCT03616964|467847028|FG002|Overall Study|Randomized but Never Treated|1|||
129967608|NCT03167151|467847031|FG000|Overall Study|Withdrawal by Subject|1|||
129967609|NCT03167151|467847032|FG001|Overall Study|Withdrawal by Subject|0|||
129967610|NCT03167151|467847033|FG002|Overall Study|Withdrawal by Subject|0|||
129967611|NCT03167151|467847031|FG000|Overall Study|No evidence of tumour at surgery|0|||
129967612|NCT03167151|467847032|FG001|Overall Study|No evidence of tumour at surgery|1|||
129967613|NCT03167151|467847033|FG002|Overall Study|No evidence of tumour at surgery|1|||
129967614|NCT01458522|467847034|FG000|Overall Study|Withdrawal by Subject|2|||
129967615|NCT01458522|467847035|FG001|Overall Study|Withdrawal by Subject|2|||
129967616|NCT01458522|467847034|FG000|Overall Study|Physician Decision|1|||
129967617|NCT01458522|467847035|FG001|Overall Study|Physician Decision|9|||
129967618|NCT04367480|467847038|FG000|Overall Study|Adverse Event|1|||
129967619|NCT04367480|467847039|FG001|Overall Study|Adverse Event|1|||
129967620|NCT04367480|467847038|FG000|Overall Study|Death|1|||
129967621|NCT04367480|467847039|FG001|Overall Study|Death|0|||
129967622|NCT04367480|467847038|FG000|Overall Study|Lost to Follow-up|1|||
129967623|NCT04367480|467847039|FG001|Overall Study|Lost to Follow-up|1|||
129967624|NCT04367480|467847038|FG000|Overall Study|Withdrawal by Subject|0|||
129967625|NCT04367480|467847039|FG001|Overall Study|Withdrawal by Subject|3|||
129967626|NCT04367480|467847038|FG000|Overall Study|App glitch during the study|1|||
129967627|NCT04367480|467847039|FG001|Overall Study|App glitch during the study|0|||
129967628|NCT04367480|467847038|FG000|Overall Study|Device Distribution Error|0|||
129967629|NCT04367480|467847039|FG001|Overall Study|Device Distribution Error|2|||
129967630|NCT04367480|467847038|FG000|Overall Study|Ineligible after Randomization|0|||
129967631|NCT04367480|467847039|FG001|Overall Study|Ineligible after Randomization|1|||
129967632|NCT04367480|467847038|FG000|Overall Study|Other Medical Reasons|0|||
129967633|NCT04367480|467847039|FG001|Overall Study|Other Medical Reasons|2|||
129967634|NCT04120376|467847040|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
129967635|NCT04120376|467847041|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
129967636|NCT02641587|467847042|FG000|Confinement Period|Adverse Event|1|||
129967637|NCT02641587|467847043|FG001|Confinement Period|Adverse Event|0|||
129967638|NCT02641587|467847042|FG000|Confinement Period|Withdrawal by Subject|2|||
129967639|NCT02641587|467847043|FG001|Confinement Period|Withdrawal by Subject|1|||
129967640|NCT02641587|467847042|FG000|Ambulatory Period|Withdrawal by Subject|1|||
129967641|NCT02641587|467847043|FG001|Ambulatory Period|Withdrawal by Subject|0|||
129967642|NCT01165177|467847044|FG000|Overall Study|Serious Adverse Event|227|||
129967643|NCT01165177|467847045|FG001|Overall Study|Serious Adverse Event|235|||
129967644|NCT01165177|467847044|FG000|Overall Study|Withdrawal by Subject|368|||
129967645|NCT01165177|467847045|FG001|Overall Study|Withdrawal by Subject|354|||
129967646|NCT01165177|467847044|FG000|Overall Study|Protocol Violation|19|||
129967647|NCT01165177|467847045|FG001|Overall Study|Protocol Violation|21|||
129967648|NCT01165177|467847044|FG000|Overall Study|Non-serious adverse event|30|||
129967649|NCT01165177|467847045|FG001|Overall Study|Non-serious adverse event|18|||
129967650|NCT01165177|467847044|FG000|Overall Study|Other unspecified reasons|47|||
129967651|NCT01165177|467847045|FG001|Overall Study|Other unspecified reasons|35|||
129967652|NCT01165177|467847044|FG000|Overall Study|Suspected HZ episode|0|||
129967653|NCT01165177|467847045|FG001|Overall Study|Suspected HZ episode|2|||
129967654|NCT01165177|467847044|FG000|Overall Study|Lost to Follow-up|183|||
129967655|NCT01165177|467847045|FG001|Overall Study|Lost to Follow-up|194|||
129967656|NCT01165177|467847044|FG000|Overall Study|Migrated/ moved from study area|48|||
129967657|NCT01165177|467847045|FG001|Overall Study|Migrated/ moved from study area|43|||
129967658|NCT00634842|467847046|FG000|Overall Study|Adverse Event|2|||
129967659|NCT00634842|467847047|FG001|Overall Study|Adverse Event|3|||
129967660|NCT00634842|467847046|FG000|Overall Study|Protocol Violation|8|||
129967661|NCT00634842|467847047|FG001|Overall Study|Protocol Violation|4|||
130123003|NCT01545076|468412167|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130123004|NCT01545076|468412168|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
130123005|NCT01545076|468412164|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
130123006|NCT01545076|468412165|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130123007|NCT01545076|468412166|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130123008|NCT01545076|468412167|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130123009|NCT01545076|468412168|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
130123010|NCT01545076|468412164|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130123011|NCT01545076|468412165|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130123012|NCT01545076|468412166|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130123013|NCT01545076|468412167|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
130123014|NCT01545076|468412168|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
130123015|NCT01545076|468412164|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
130123016|NCT01545076|468412165|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
130123017|NCT01545076|468412166|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
130123018|NCT01545076|468412167|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
130123019|NCT01545076|468412168|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
130123020|NCT01545076|468412164|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130123021|NCT01545076|468412165|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
130123022|NCT01545076|468412166|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
130123023|NCT01545076|468412167|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130123024|NCT01545076|468412168|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
130123025|NCT01545076|468412164|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
130123026|NCT01545076|468412165|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
130123027|NCT01545076|468412166|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
130123028|NCT01545076|468412167|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
130123029|NCT01545076|468412168|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
130123030|NCT03444038|468412169|FG000|Overall Study|Adverse Event|12|||
130123031|NCT03444038|468412169|FG000|Overall Study|Withdrawal by Subject|7|||
130123032|NCT03444038|468412169|FG000|Overall Study|Lost to Follow-up|1|||
130123033|NCT03444038|468412169|FG000|Overall Study|Physician Decision|2|||
130123034|NCT03444038|468412169|FG000|Overall Study|Lack of Efficacy|7|||
130123035|NCT00264797|468412177|FG000|Overall Study|Withdrawal by Subject|11|||
130123036|NCT00264797|468412178|FG001|Overall Study|Withdrawal by Subject|11|||
130123037|NCT00264797|468412177|FG000|Overall Study|Lost to Follow-up|9|||
130123038|NCT00264797|468412178|FG001|Overall Study|Lost to Follow-up|17|||
130123039|NCT00264797|468412177|FG000|Overall Study|Moved from area|3|||
130123040|NCT00264797|468412178|FG001|Overall Study|Moved from area|1|||
130123041|NCT00264797|468412177|FG000|Overall Study|Practical Problems|2|||
130123042|NCT00264797|468412178|FG001|Overall Study|Practical Problems|3|||
130123043|NCT00264797|468412177|FG000|Overall Study|Incarceration|4|||
130123044|NCT00264797|468412178|FG001|Overall Study|Incarceration|5|||
130123045|NCT00264797|468412177|FG000|Overall Study|Pressure/advice from Outsiders|1|||
130123046|NCT00264797|468412178|FG001|Overall Study|Pressure/advice from Outsiders|1|||
130123047|NCT00264797|468412177|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
130123048|NCT00264797|468412178|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
130123049|NCT00264797|468412177|FG000|Overall Study|Other|3|||
130123050|NCT00264797|468412178|FG001|Overall Study|Other|4|||
130123051|NCT01153984|468412179|FG000|Overall Study|Withdrawal by Subject|1|||
130123052|NCT01153984|468412179|FG000|Overall Study|Adverse Event|1|||
130123053|NCT02460159|468412180|FG000|Overall Study|Adverse Event|4|||
130123054|NCT02460159|468412181|FG001|Overall Study|Adverse Event|1|||
130123055|NCT02460159|468412180|FG000|Overall Study|Withdrawal by Subject|2|||
130123056|NCT02460159|468412181|FG001|Overall Study|Withdrawal by Subject|0|||
130123057|NCT01249664|468412182|FG000|Overall Study|Withdrawal by Subject|5|||
130123058|NCT01249664|468412183|FG001|Overall Study|Withdrawal by Subject|0|||
130123059|NCT01249664|468412182|FG000|Overall Study|Adverse Event|1|||
130123060|NCT01249664|468412183|FG001|Overall Study|Adverse Event|0|||
130123061|NCT02636907|468412186|FG000|Autoinjector Assessment Period|Adverse Event|2|||
130123062|NCT02636907|468412186|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
130123063|NCT02636907|468412186|FG000|Extension Phase|Adverse Event|2|||
130123064|NCT02636907|468412186|FG000|Extension Phase|Withdrawal by Subject|4|||
130123065|NCT02636907|468412186|FG000|Extension Phase|Physician Decision|1|||
130123066|NCT02636907|468412186|FG000|Extension Phase|Lost to Follow-up|2|||
130123067|NCT02636907|468412186|FG000|Extension Phase|Lack of Efficacy|1|||
130123068|NCT00762086|468412187|FG000|Overall Study|Adverse Event|2|||
130123069|NCT00762086|468412188|FG001|Overall Study|Adverse Event|0|||
130123070|NCT00762086|468412187|FG000|Overall Study|Lost to Follow-up|0|||
130123071|NCT00762086|468412188|FG001|Overall Study|Lost to Follow-up|2|||
130123072|NCT00762086|468412187|FG000|Overall Study|Non compliance|1|||
129967662|NCT00634842|467847046|FG000|Overall Study|Move to another state|1|||
129967663|NCT00634842|467847047|FG001|Overall Study|Move to another state|0|||
130123073|NCT00762086|468412188|FG001|Overall Study|Non compliance|0|||
130123074|NCT00762086|468412187|FG000|Overall Study|Withdrawal by Subject|2|||
130123075|NCT00762086|468412188|FG001|Overall Study|Withdrawal by Subject|2|||
130123076|NCT00762086|468412187|FG000|Overall Study|Ineligible to participate in the study|1|||
130123077|NCT00762086|468412188|FG001|Overall Study|Ineligible to participate in the study|0|||
130123078|NCT00860405|468412197|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
130123079|NCT00860405|468412198|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
130123080|NCT01876706|468412201|FG000|Overall Study|BPH Intervention|9|||
130123081|NCT01876706|468412201|FG000|Overall Study|Lost to Follow-up|7|||
130123082|NCT01876706|468412201|FG000|Overall Study|Withdrawals|6|||
130123083|NCT01876706|468412201|FG000|Overall Study|Death|3|||
130123084|NCT00659607|468412202|FG000|Overall Study|No blood pressure recorded|147|||
130123085|NCT00659607|468412202|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
130123086|NCT00659607|468412202|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
130123087|NCT00659607|468412202|FG000|Overall Study|No recorded efficacy data|15|||
130123088|NCT00659607|468412202|FG000|Overall Study|Inconsistent BP measuring date|2|||
130123089|NCT01370408|468412205|FG000|Overall Study|treatment failure|9|||
130123090|NCT01062256|468412206|FG000|Overall Study|Adverse Event|1|||
130123091|NCT01062256|468412207|FG001|Overall Study|Adverse Event|0|||
130123092|NCT01062256|468412208|FG002|Overall Study|Adverse Event|0|||
130123093|NCT01062256|468412206|FG000|Overall Study|Withdrawal by Subject|1|||
130123094|NCT01062256|468412207|FG001|Overall Study|Withdrawal by Subject|1|||
130123095|NCT01062256|468412208|FG002|Overall Study|Withdrawal by Subject|1|||
130123096|NCT01062256|468412206|FG000|Overall Study|Ineligible|1|||
130123097|NCT01062256|468412207|FG001|Overall Study|Ineligible|4|||
130123098|NCT01062256|468412208|FG002|Overall Study|Ineligible|3|||
130123099|NCT01062256|468412206|FG000|Overall Study|Administrative|0|||
130123100|NCT01062256|468412207|FG001|Overall Study|Administrative|2|||
130123101|NCT01062256|468412208|FG002|Overall Study|Administrative|0|||
130123102|NCT03049488|468412209|FG000|Overall Study|Lost to Follow-up|1|||
130123103|NCT03049488|468412210|FG001|Overall Study|Lost to Follow-up|1|||
130123104|NCT03049488|468412211|FG002|Overall Study|Lost to Follow-up|0|||
130123105|NCT03049488|468412212|FG003|Overall Study|Lost to Follow-up|0|||
130123106|NCT03049488|468412213|FG004|Overall Study|Lost to Follow-up|0|||
130123107|NCT03049488|468412214|FG005|Overall Study|Lost to Follow-up|0|||
130123108|NCT03049488|468412209|FG000|Overall Study|Moved from Area|1|||
130123109|NCT03049488|468412210|FG001|Overall Study|Moved from Area|0|||
130123110|NCT03049488|468412211|FG002|Overall Study|Moved from Area|0|||
130123111|NCT03049488|468412212|FG003|Overall Study|Moved from Area|1|||
130123112|NCT03049488|468412213|FG004|Overall Study|Moved from Area|1|||
130123113|NCT03049488|468412214|FG005|Overall Study|Moved from Area|0|||
130123114|NCT03049488|468412209|FG000|Overall Study|Physician Decision|0|||
130123115|NCT03049488|468412210|FG001|Overall Study|Physician Decision|1|||
130123116|NCT03049488|468412211|FG002|Overall Study|Physician Decision|0|||
130123117|NCT03049488|468412212|FG003|Overall Study|Physician Decision|0|||
130123118|NCT03049488|468412213|FG004|Overall Study|Physician Decision|0|||
130123119|NCT03049488|468412214|FG005|Overall Study|Physician Decision|0|||
130123120|NCT03049488|468412209|FG000|Overall Study|Withdrawal by Subject|0|||
130123121|NCT03049488|468412210|FG001|Overall Study|Withdrawal by Subject|0|||
130123122|NCT03049488|468412211|FG002|Overall Study|Withdrawal by Subject|0|||
130123123|NCT03049488|468412212|FG003|Overall Study|Withdrawal by Subject|1|||
130123124|NCT03049488|468412213|FG004|Overall Study|Withdrawal by Subject|1|||
130123125|NCT03049488|468412214|FG005|Overall Study|Withdrawal by Subject|0|||
130123126|NCT00891293|468412215|FG000|Overall Study|Adverse Event|2|||
130123127|NCT00891293|468412215|FG000|Overall Study|Protocol Violation|2|||
130123128|NCT00891293|468412215|FG000|Overall Study|Laboratory abnormality|4|||
130123129|NCT00891293|468412215|FG000|Overall Study|Lost to Follow-up|7|||
130123130|NCT00891293|468412215|FG000|Overall Study|Subject withdrew consent|7|||
129967664|NCT00634842|467847046|FG000|Overall Study|Inclusion criteria were not met|1|||
129967665|NCT00634842|467847047|FG001|Overall Study|Inclusion criteria were not met|0|||
129967666|NCT00634842|467847046|FG000|Overall Study|Lost to Follow-up|1|||
129967667|NCT00634842|467847047|FG001|Overall Study|Lost to Follow-up|2|||
129967668|NCT00634842|467847046|FG000|Overall Study|Physician Decision|1|||
129967669|NCT00634842|467847047|FG001|Overall Study|Physician Decision|0|||
129967670|NCT00634842|467847046|FG000|Overall Study|Withdrawal by Subject|1|||
129967671|NCT00634842|467847047|FG001|Overall Study|Withdrawal by Subject|3|||
129967672|NCT00634842|467847046|FG000|Overall Study|Lack of time and intolerance to drug|0|||
130123131|NCT00891293|468412215|FG000|Overall Study|Sponsor termination|62|||
130123132|NCT01448057|468412216|FG000|Overall Study|Protocol Violation|3|||
130123133|NCT01448057|468412217|FG001|Overall Study|Protocol Violation|2|||
130123134|NCT01448057|468412216|FG000|Overall Study|Lost to Follow-up|3|||
130123135|NCT01448057|468412217|FG001|Overall Study|Lost to Follow-up|0|||
129967673|NCT00634842|467847047|FG001|Overall Study|Lack of time and intolerance to drug|1|||
130123136|NCT01448057|468412216|FG000|Overall Study|Adverse Event|0|||
130123137|NCT01448057|468412217|FG001|Overall Study|Adverse Event|2|||
130123138|NCT01448057|468412216|FG000|Overall Study|Withdrawal by Subject|2|||
130123139|NCT01448057|468412217|FG001|Overall Study|Withdrawal by Subject|0|||
130123140|NCT03883906|468412221|FG000|Overall Study|Withdrawal by Subject|2|||
129967674|NCT00634842|467847046|FG000|Overall Study|Discontinued due to injection|0|||
129967675|NCT00634842|467847047|FG001|Overall Study|Discontinued due to injection|2|||
129967676|NCT00634842|467847046|FG000|Overall Study|No need of study drug to treat diabetes|0|||
129967677|NCT00634842|467847047|FG001|Overall Study|No need of study drug to treat diabetes|1|||
129967678|NCT00634842|467847046|FG000|Overall Study|No wish to keep taking Avandia|0|||
129967679|NCT00634842|467847047|FG001|Overall Study|No wish to keep taking Avandia|1|||
129967680|NCT00634842|467847046|FG000|Overall Study|Subject off study drug for too long|0|||
129967681|NCT00634842|467847047|FG001|Overall Study|Subject off study drug for too long|1|||
129967682|NCT00810342|467847050|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
129967683|NCT00810342|467847051|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
130123141|NCT03883906|468412221|FG000|Overall Study|Physician Decision|5|||
130123142|NCT00486837|468412222|FG000|Overall Study|Withdrawal by Subject|1|||
130123143|NCT00486837|468412223|FG001|Overall Study|Withdrawal by Subject|0|||
130123144|NCT00486837|468412222|FG000|Overall Study|Adverse Event|1|||
130123145|NCT00486837|468412223|FG001|Overall Study|Adverse Event|1|||
130123146|NCT00486837|468412222|FG000|Overall Study|Protocol Violation|4|||
130123147|NCT00486837|468412223|FG001|Overall Study|Protocol Violation|2|||
130123148|NCT00486837|468412222|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
130123149|NCT00486837|468412223|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
130123150|NCT00796822|468412233|FG000|Overall Study|Lost to Follow-up|2|||
130123151|NCT00796822|468412234|FG001|Overall Study|Lost to Follow-up|0|||
130123152|NCT00796822|468412233|FG000|Overall Study|Adverse Event|1|||
130123153|NCT00796822|468412234|FG001|Overall Study|Adverse Event|0|||
130123154|NCT00906347|468412235|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
130123155|NCT00906347|468412236|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
130123156|NCT00906347|468412235|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
130123157|NCT00906347|468412236|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
130123158|NCT00906347|468412235|FG000|Received Study Drug|Refused study drug|1|||
130123159|NCT00906347|468412236|FG001|Received Study Drug|Refused study drug|0|||
130123160|NCT00906347|468412235|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
130123161|NCT00906347|468412236|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
130123162|NCT00680121|468412238|FG000|Overall Study|Lost to Follow-up|27|||
130123163|NCT00680121|468412239|FG001|Overall Study|Lost to Follow-up|23|||
130123164|NCT02603952|468412242|FG000|Overall Study|Withdrawal by Subject|1|||
130123165|NCT02603952|468412243|FG001|Overall Study|Withdrawal by Subject|0|||
130123166|NCT02603952|468412244|FG002|Overall Study|Withdrawal by Subject|0|||
130123167|NCT02603952|468412245|FG003|Overall Study|Withdrawal by Subject|0|||
130123168|NCT02603952|468412242|FG000|Overall Study|Received oseltamivir by error|0|||
130123169|NCT02603952|468412243|FG001|Overall Study|Received oseltamivir by error|0|||
130123170|NCT02603952|468412244|FG002|Overall Study|Received oseltamivir by error|0|||
130123171|NCT02603952|468412245|FG003|Overall Study|Received oseltamivir by error|1|||
130123172|NCT00577460|468412248|FG000|Overall Study|Adverse Event|11|||
130123173|NCT00577460|468412249|FG001|Overall Study|Adverse Event|7|||
130123174|NCT00577460|468412250|FG002|Overall Study|Adverse Event|14|||
130123175|NCT00577460|468412248|FG000|Overall Study|Protocol Violation|0|||
130123176|NCT00577460|468412249|FG001|Overall Study|Protocol Violation|1|||
130123177|NCT00577460|468412250|FG002|Overall Study|Protocol Violation|1|||
130123178|NCT00577460|468412248|FG000|Overall Study|Lost to Follow-up|0|||
130123179|NCT00577460|468412249|FG001|Overall Study|Lost to Follow-up|3|||
130123180|NCT00577460|468412250|FG002|Overall Study|Lost to Follow-up|4|||
130123181|NCT00577460|468412248|FG000|Overall Study|Withdrawal by Subject|5|||
130123182|NCT00577460|468412249|FG001|Overall Study|Withdrawal by Subject|5|||
130123183|NCT00577460|468412250|FG002|Overall Study|Withdrawal by Subject|6|||
130123184|NCT00577460|468412248|FG000|Overall Study|Other|0|||
130123185|NCT00577460|468412249|FG001|Overall Study|Other|3|||
130123186|NCT00577460|468412250|FG002|Overall Study|Other|2|||
130123187|NCT01318499|468412251|FG000|Overall Study|Adverse Event|16|||
130123188|NCT01318499|468412252|FG001|Overall Study|Adverse Event|11|||
130123189|NCT01318499|468412253|FG002|Overall Study|Adverse Event|6|||
130123190|NCT01318499|468412251|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
130123191|NCT01318499|468412252|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
130123192|NCT01318499|468412253|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
130123193|NCT01318499|468412251|FG000|Overall Study|Noncompliance|2|||
130123194|NCT01318499|468412252|FG001|Overall Study|Noncompliance|3|||
129967684|NCT00810342|467847050|FG000|Month 1 Follow-up|Pregnancy|1|||
129967685|NCT00810342|467847051|FG001|Month 1 Follow-up|Pregnancy|0|||
129967686|NCT00810342|467847050|FG000|6-month Follow-up|Lost to Follow-up|18|||
129967687|NCT00810342|467847051|FG001|6-month Follow-up|Lost to Follow-up|6|||
129967688|NCT00810342|467847050|FG000|6-month Follow-up|Pregnancy|6|||
129967689|NCT00810342|467847051|FG001|6-month Follow-up|Pregnancy|2|||
130123195|NCT01318499|468412253|FG002|Overall Study|Noncompliance|0|||
129967690|NCT00810342|467847050|FG000|12-month Followup|Pregnancy|9|||
130123196|NCT01318499|468412251|FG000|Overall Study|Treatment Failure|19|||
130123197|NCT01318499|468412252|FG001|Overall Study|Treatment Failure|19|||
130123198|NCT01318499|468412253|FG002|Overall Study|Treatment Failure|101|||
130123199|NCT01318499|468412251|FG000|Overall Study|Protocol Violation|2|||
130123200|NCT01318499|468412252|FG001|Overall Study|Protocol Violation|4|||
130123201|NCT01318499|468412253|FG002|Overall Study|Protocol Violation|2|||
130123202|NCT01318499|468412251|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
130123203|NCT01318499|468412252|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
130123204|NCT01318499|468412253|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
130123205|NCT01318499|468412251|FG000|Overall Study|Other|7|||
130123206|NCT01318499|468412252|FG001|Overall Study|Other|10|||
130123207|NCT01318499|468412253|FG002|Overall Study|Other|22|||
130123208|NCT01347710|468412257|FG000|Overall Study|Withdrawal by Subject|2|||
130123209|NCT01347710|468412257|FG000|Overall Study|Adverse Event|4|||
130123210|NCT01347710|468412257|FG000|Overall Study|Angio or SPECT not completed|18|||
130123211|NCT01347710|468412257|FG000|Overall Study|issue with vitals prior to dosing|1|||
130123212|NCT01347710|468412257|FG000|Overall Study|Lost to Follow-up|1|||
130123213|NCT01347710|468412257|FG000|Overall Study|Physician Decision|2|||
130123214|NCT01347710|468412257|FG000|Overall Study|Other|3|||
130123215|NCT04591626|468412258|FG000|Overall Study|Adverse Event|4|||
130123216|NCT04591626|468412259|FG001|Overall Study|Adverse Event|0|||
130123217|NCT04591626|468412258|FG000|Overall Study|Withdrawal by Subject|5|||
130123218|NCT04591626|468412259|FG001|Overall Study|Withdrawal by Subject|3|||
130123219|NCT04591626|468412258|FG000|Overall Study|Physician Decision|0|||
130123220|NCT04591626|468412259|FG001|Overall Study|Physician Decision|1|||
130123221|NCT04591626|468412258|FG000|Overall Study|Death|0|||
130123222|NCT04591626|468412259|FG001|Overall Study|Death|1|||
130123223|NCT04591626|468412258|FG000|Overall Study|Non-Compliance with Study Drug|1|||
130123224|NCT04591626|468412259|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130123225|NCT02672553|468412261|FG000|Overall Study|Death|3|||
130123226|NCT02672553|468412262|FG001|Overall Study|Death|5|||
130123227|NCT02672553|468412261|FG000|Overall Study|Valve Explant|1|||
130123228|NCT02672553|468412262|FG001|Overall Study|Valve Explant|0|||
130123229|NCT02672553|468412261|FG000|Overall Study|Conversion to Commercial Valve|3|||
130123230|NCT02672553|468412262|FG001|Overall Study|Conversion to Commercial Valve|0|||
130123231|NCT02672553|468412261|FG000|Overall Study|Withdrawal by Subject|3|||
130123232|NCT02672553|468412262|FG001|Overall Study|Withdrawal by Subject|3|||
130123233|NCT02672553|468412261|FG000|Overall Study|Intraoperative screen failure|2|||
130123234|NCT02672553|468412262|FG001|Overall Study|Intraoperative screen failure|0|||
130123235|NCT01606306|468412263|FG000|Overall Study|Lack of Efficacy|2|||
130123236|NCT01606306|468412264|FG001|Overall Study|Lack of Efficacy|1|||
130123237|NCT01606306|468412265|FG002|Overall Study|Lack of Efficacy|4|||
130123238|NCT01606306|468412266|FG003|Overall Study|Lack of Efficacy|4|||
130123239|NCT01606306|468412267|FG004|Overall Study|Lack of Efficacy|1|||
130123240|NCT01606306|468412268|FG005|Overall Study|Lack of Efficacy|2|||
130123241|NCT01606306|468412263|FG000|Overall Study|Adverse Event|1|||
130123242|NCT01606306|468412264|FG001|Overall Study|Adverse Event|0|||
130123243|NCT01606306|468412265|FG002|Overall Study|Adverse Event|1|||
130123244|NCT01606306|468412266|FG003|Overall Study|Adverse Event|1|||
130123245|NCT01606306|468412267|FG004|Overall Study|Adverse Event|2|||
130123246|NCT01606306|468412268|FG005|Overall Study|Adverse Event|0|||
130123247|NCT01606306|468412263|FG000|Overall Study|Lost to Follow-up|7|||
130123248|NCT01606306|468412264|FG001|Overall Study|Lost to Follow-up|4|||
130123249|NCT01606306|468412265|FG002|Overall Study|Lost to Follow-up|5|||
130123250|NCT01606306|468412266|FG003|Overall Study|Lost to Follow-up|4|||
130123251|NCT01606306|468412267|FG004|Overall Study|Lost to Follow-up|3|||
130123252|NCT01606306|468412268|FG005|Overall Study|Lost to Follow-up|5|||
130123253|NCT01606306|468412263|FG000|Overall Study|Withdrawal by Subject|4|||
130123254|NCT01606306|468412264|FG001|Overall Study|Withdrawal by Subject|3|||
130123255|NCT01606306|468412265|FG002|Overall Study|Withdrawal by Subject|4|||
130123256|NCT01606306|468412266|FG003|Overall Study|Withdrawal by Subject|4|||
130123257|NCT01606306|468412267|FG004|Overall Study|Withdrawal by Subject|5|||
130123258|NCT01606306|468412268|FG005|Overall Study|Withdrawal by Subject|4|||
130123259|NCT01606306|468412263|FG000|Overall Study|Physician Decision|1|||
130123260|NCT01606306|468412264|FG001|Overall Study|Physician Decision|2|||
130123261|NCT01606306|468412265|FG002|Overall Study|Physician Decision|0|||
130123262|NCT01606306|468412266|FG003|Overall Study|Physician Decision|0|||
130123263|NCT01606306|468412267|FG004|Overall Study|Physician Decision|0|||
130123264|NCT01606306|468412268|FG005|Overall Study|Physician Decision|0|||
130123265|NCT00408902|468412271|FG000|Overall Study|Lack of Efficacy|7|||
130123266|NCT00408902|468412271|FG000|Overall Study|Adverse Event|3|||
130123267|NCT00970281|468412272|FG000|Overall Study|Lack of Efficacy|1|||
130123268|NCT00970281|468412273|FG001|Overall Study|Lack of Efficacy|14|||
130123269|NCT00970281|468412272|FG000|Overall Study|Withdrawal by Subject|0|||
130123270|NCT00970281|468412273|FG001|Overall Study|Withdrawal by Subject|1|||
130123271|NCT00970281|468412272|FG000|Overall Study|Physician Decision|1|||
130123272|NCT00970281|468412273|FG001|Overall Study|Physician Decision|1|||
130123273|NCT00878995|468412276|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
130123274|NCT00878995|468412277|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
130123275|NCT00841100|468412278|FG000|Phase 1 (28 Days)|Adverse Event|1|||
130123276|NCT00841100|468412278|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
130123277|NCT03338972|468412279|FG000|Overall Study|Death|1|||
130123278|NCT03338972|468412280|FG001|Overall Study|Death|1|||
130123279|NCT03338972|468412281|FG002|Overall Study|Death|0|||
130123280|NCT03338972|468412282|FG003|Overall Study|Death|0|||
130123281|NCT03338972|468412279|FG000|Overall Study|Withdrawal by Subject|1|||
130123282|NCT03338972|468412280|FG001|Overall Study|Withdrawal by Subject|0|||
130123283|NCT03338972|468412281|FG002|Overall Study|Withdrawal by Subject|0|||
130123284|NCT03338972|468412282|FG003|Overall Study|Withdrawal by Subject|0|||
130123285|NCT02480764|468412283|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
130123286|NCT02480764|468412284|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
130123287|NCT02480764|468412285|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
130123288|NCT02480764|468412283|FG000|Overall Study|Major Protocol Deviation|1|||
130123289|NCT02480764|468412284|FG001|Overall Study|Major Protocol Deviation|4|||
130123290|NCT02480764|468412285|FG002|Overall Study|Major Protocol Deviation|3|||
130123291|NCT02480764|468412283|FG000|Overall Study|Lost to Follow-up|0|||
130123292|NCT02480764|468412284|FG001|Overall Study|Lost to Follow-up|1|||
130123293|NCT02480764|468412285|FG002|Overall Study|Lost to Follow-up|2|||
130123294|NCT02480764|468412283|FG000|Overall Study|Voluntary Withdrawal|6|||
130123295|NCT02480764|468412284|FG001|Overall Study|Voluntary Withdrawal|5|||
130123296|NCT02480764|468412285|FG002|Overall Study|Voluntary Withdrawal|10|||
130123297|NCT02480764|468412283|FG000|Overall Study|Lack of Efficacy|0|||
130123298|NCT02480764|468412284|FG001|Overall Study|Lack of Efficacy|3|||
130123299|NCT02480764|468412285|FG002|Overall Study|Lack of Efficacy|3|||
130123300|NCT02480764|468412283|FG000|Overall Study|Reason not Specified|0|||
130123301|NCT02480764|468412284|FG001|Overall Study|Reason not Specified|1|||
130123302|NCT02480764|468412285|FG002|Overall Study|Reason not Specified|0|||
130123303|NCT01355081|468412286|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
130123304|NCT01355081|468412287|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130123305|NCT01355081|468412288|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130123306|NCT01355081|468412286|FG000|Overall Study|Major Protocol Deviation|0|||
130123307|NCT01355081|468412287|FG001|Overall Study|Major Protocol Deviation|1|||
130123308|NCT01355081|468412288|FG002|Overall Study|Major Protocol Deviation|0|||
130123309|NCT01355081|468412286|FG000|Overall Study|Lost to Follow-up|0|||
130123310|NCT01355081|468412287|FG001|Overall Study|Lost to Follow-up|0|||
130123311|NCT01355081|468412288|FG002|Overall Study|Lost to Follow-up|1|||
130123312|NCT01355081|468412286|FG000|Overall Study|Withdrawal of Consent|2|||
130123313|NCT01355081|468412287|FG001|Overall Study|Withdrawal of Consent|3|||
130123314|NCT01355081|468412288|FG002|Overall Study|Withdrawal of Consent|3|||
130123315|NCT01355081|468412286|FG000|Overall Study|Lack of Efficacy|2|||
130123316|NCT01355081|468412287|FG001|Overall Study|Lack of Efficacy|1|||
130123317|NCT01355081|468412288|FG002|Overall Study|Lack of Efficacy|1|||
130123318|NCT01355081|468412286|FG000|Overall Study|Non Compliance with Study Medication|0|||
130123319|NCT01355081|468412287|FG001|Overall Study|Non Compliance with Study Medication|1|||
130123320|NCT01355081|468412288|FG002|Overall Study|Non Compliance with Study Medication|0|||
130123321|NCT01475474|468412289|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
130123322|NCT01475474|468412289|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
130123323|NCT00788125|468413577|FG000|Overall Study|Death|6|||
130123324|NCT03100903|468413584|FG000|Overall Study|Withdrawal by Subject|0|||
130123325|NCT03100903|468413585|FG001|Overall Study|Withdrawal by Subject|0|||
130123326|NCT03100903|468413586|FG002|Overall Study|Withdrawal by Subject|1|||
130123327|NCT00433147|468413587|FG000|Overall Study|Adverse Event|0|||
130123328|NCT00433147|468413588|FG001|Overall Study|Adverse Event|1|||
130123329|NCT00433147|468413589|FG002|Overall Study|Adverse Event|0|||
130123330|NCT00433147|468413590|FG003|Overall Study|Adverse Event|0|||
130123331|NCT01882647|468413591|FG000|Overall Study|Lost to Follow-up|2|||
130123332|NCT01882647|468413592|FG001|Overall Study|Lost to Follow-up|2|||
130123333|NCT01882647|468413591|FG000|Overall Study|Withdrawal by Subject|0|||
130123334|NCT01882647|468413592|FG001|Overall Study|Withdrawal by Subject|4|||
130123335|NCT01027143|468413595|FG000|Overall Study|Lost to Follow-up|9|||
130123336|NCT01027143|468413596|FG001|Overall Study|Lost to Follow-up|4|||
130123337|NCT03292653|468413598|FG000|Overall Study|Adverse Event|0|||
130123338|NCT03292653|468413599|FG001|Overall Study|Adverse Event|0|||
130123339|NCT03292653|468413600|FG002|Overall Study|Adverse Event|1|||
129967691|NCT00810342|467847051|FG001|12-month Followup|Pregnancy|10|||
130123340|NCT03292653|468413598|FG000|Overall Study|Did not Receive Treatment|1|||
130123341|NCT03292653|468413599|FG001|Overall Study|Did not Receive Treatment|0|||
130123342|NCT03292653|468413600|FG002|Overall Study|Did not Receive Treatment|0|||
130123343|NCT02564263|468413601|FG000|Overall Study|Adverse Event|31|||
130123344|NCT02564263|468413602|FG001|Overall Study|Adverse Event|29|||
130123345|NCT02564263|468413601|FG000|Overall Study|Death|270|||
130123346|NCT02564263|468413602|FG001|Overall Study|Death|262|||
130123347|NCT02564263|468413601|FG000|Overall Study|Withdrawal by Subject|4|||
130123348|NCT02564263|468413602|FG001|Overall Study|Withdrawal by Subject|19|||
130123349|NCT02564263|468413601|FG000|Overall Study|Sponsor's decision|9|||
130123350|NCT02564263|468413602|FG001|Overall Study|Sponsor's decision|4|||
130123351|NCT03311646|468413603|FG000|Overall Study|Physician Decision|1|||
130123352|NCT03311646|468413603|FG000|Overall Study|Withdrawal by Subject|5|||
130092524|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092525|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092526|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092527|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092528|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092529|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
130092530|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092531|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092532|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092533|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
130092534|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
130092535|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092536|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
130092537|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092538|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092539|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092540|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092541|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092542|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092543|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092544|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092545|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092546|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
130092547|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
130092548|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
130092549|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
130092550|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
130092551|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
130092552|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
130092553|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
130092554|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
130092555|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
130092556|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
130092557|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
130092558|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
130092559|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092560|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092561|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092562|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092563|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092564|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
130092565|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092566|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092567|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092568|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092569|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092570|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
130092571|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092572|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092573|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092574|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092575|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092576|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
130092577|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092578|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092579|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092580|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092581|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092582|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
130092583|NCT00151775|468294518|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092584|NCT00151775|468294519|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092585|NCT00151775|468294520|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092586|NCT00151775|468294521|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092587|NCT00151775|468294522|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092588|NCT00151775|468294523|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130123353|NCT03311646|468413603|FG000|Overall Study|Lost to Follow-up|5|||
130123354|NCT03311646|468413603|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
130123355|NCT00728949|468413609|FG000|Overall Study|Adverse Event|8|||
130123356|NCT00728949|468413610|FG001|Overall Study|Adverse Event|0|||
130123357|NCT00728949|468413609|FG000|Overall Study|Withdrawal by Subject|2|||
130123358|NCT00728949|468413610|FG001|Overall Study|Withdrawal by Subject|2|||
130123359|NCT00728949|468413609|FG000|Overall Study|Abnormal Lab Results|0|||
130123360|NCT00728949|468413610|FG001|Overall Study|Abnormal Lab Results|2|||
130123361|NCT00728949|468413609|FG000|Overall Study|On treatment at cutoff date|1|||
130123362|NCT00728949|468413610|FG001|Overall Study|On treatment at cutoff date|0|||
130123363|NCT03127137|468413612|FG000|Overall Study|Requested sedation after consent|1|||
130123364|NCT03127137|468413613|FG001|Overall Study|Requested sedation after consent|0|||
130123365|NCT03127137|468413612|FG000|Overall Study|Malfunction in electronic data collection|1|||
130123366|NCT03127137|468413613|FG001|Overall Study|Malfunction in electronic data collection|0|||
130123367|NCT03127137|468413612|FG000|Overall Study|Post procedure testing could not be obtained|0|||
130123368|NCT03127137|468413613|FG001|Overall Study|Post procedure testing could not be obtained|1|||
130123369|NCT02319148|468413614|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
130123370|NCT02319148|468413615|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
130123371|NCT02319148|468413616|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
130123372|NCT02319148|468413617|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
130123373|NCT02319148|468413614|FG000|Second Intervention Period|No longer willing to participate|0|||
130123374|NCT02319148|468413615|FG001|Second Intervention Period|No longer willing to participate|1|||
130123375|NCT02319148|468413616|FG002|Second Intervention Period|No longer willing to participate|0|||
130123376|NCT02319148|468413617|FG003|Second Intervention Period|No longer willing to participate|0|||
130123377|NCT02319148|468413614|FG000|Second Intervention Period|Other|0|||
130123378|NCT02319148|468413615|FG001|Second Intervention Period|Other|0|||
130123379|NCT02319148|468413616|FG002|Second Intervention Period|Other|0|||
130123380|NCT02319148|468413617|FG003|Second Intervention Period|Other|1|||
130123381|NCT01087970|468413619|FG000|Overall Study|Protocol Violation|2|||
130123382|NCT00543309|468413620|FG000|Overall Study|Physician Decision|0|||
130123383|NCT00543309|468413621|FG001|Overall Study|Physician Decision|1|||
130123384|NCT00543309|468413622|FG002|Overall Study|Physician Decision|0|||
130123385|NCT01682083|468413625|FG000|Overall Study|Lost to Follow-up|11|||
130123386|NCT01682083|468413626|FG001|Overall Study|Lost to Follow-up|18|||
130123387|NCT01682083|468413625|FG000|Overall Study|Withdrawal by Subject|31|||
130123388|NCT01682083|468413626|FG001|Overall Study|Withdrawal by Subject|40|||
130123389|NCT01682083|468413625|FG000|Overall Study|Death|60|||
130123390|NCT01682083|468413626|FG001|Overall Study|Death|93|||
130123391|NCT01682083|468413625|FG000|Overall Study|Physician Decision|5|||
130123392|NCT01682083|468413626|FG001|Overall Study|Physician Decision|4|||
130123393|NCT01074554|468413628|FG000|Overall Study|Adverse Event|3|||
130123394|NCT01074554|468413629|FG001|Overall Study|Adverse Event|3|||
130123395|NCT01074554|468413628|FG000|Overall Study|Lost to Follow-up|0|||
130123396|NCT01074554|468413629|FG001|Overall Study|Lost to Follow-up|1|||
130123397|NCT01239121|468413630|FG000|Overall Study|Withdrawal by Subject|2|||
130123398|NCT01239121|468413631|FG001|Overall Study|Withdrawal by Subject|4|||
130123399|NCT01239121|468413632|FG002|Overall Study|Withdrawal by Subject|0|||
130123400|NCT04276883|468413633|FG000|Overall Study|Withdrawal by Subject|2|||
130123401|NCT04276883|468413634|FG001|Overall Study|Withdrawal by Subject|3|||
130123402|NCT04276883|468413635|FG002|Overall Study|Withdrawal by Subject|6|||
130123403|NCT04276883|468413633|FG000|Overall Study|Lost to Follow-up|1|||
130123404|NCT04276883|468413634|FG001|Overall Study|Lost to Follow-up|3|||
130123405|NCT04276883|468413635|FG002|Overall Study|Lost to Follow-up|0|||
130123406|NCT04276883|468413633|FG000|Overall Study|Adverse Event|0|||
130123407|NCT04276883|468413634|FG001|Overall Study|Adverse Event|1|||
130123408|NCT04276883|468413635|FG002|Overall Study|Adverse Event|0|||
130123409|NCT04276883|468413633|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
130123410|NCT04276883|468413634|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
130123411|NCT04276883|468413635|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
130123412|NCT02073643|468413638|FG000|Overall Study|Lost to Follow-up|24|||
130123413|NCT02468778|468413644|FG000|Overall Study|Death|2|||
130123414|NCT02468778|468413645|FG001|Overall Study|Death|1|||
130123415|NCT02468778|468413646|FG002|Overall Study|Death|0|||
130123416|NCT02468778|468413644|FG000|Overall Study|Lost to Follow-up|1|||
130123417|NCT02468778|468413645|FG001|Overall Study|Lost to Follow-up|2|||
130123418|NCT02468778|468413646|FG002|Overall Study|Lost to Follow-up|2|||
130123419|NCT02468778|468413644|FG000|Overall Study|Withdrawal by Subject|0|||
130123420|NCT02468778|468413645|FG001|Overall Study|Withdrawal by Subject|1|||
130123421|NCT02468778|468413646|FG002|Overall Study|Withdrawal by Subject|1|||
130123422|NCT00414765|468413649|FG000|Overall Study|Adverse Event|5|||
129967692|NCT00810342|467847050|FG000|12-month Followup|Lost to Follow-up|3|||
129967693|NCT00810342|467847051|FG001|12-month Followup|Lost to Follow-up|1|||
130123423|NCT00414765|468413650|FG001|Overall Study|Adverse Event|9|||
130123424|NCT00414765|468413649|FG000|Overall Study|Withdrawal by Subject|1|||
130123425|NCT00414765|468413650|FG001|Overall Study|Withdrawal by Subject|1|||
130123426|NCT00414765|468413649|FG000|Overall Study|Disease Progression|0|||
130123427|NCT00414765|468413650|FG001|Overall Study|Disease Progression|1|||
130123428|NCT03130699|468413651|FG000|Overall Study|Lost to Follow-up|34|||
130123429|NCT03130699|468413652|FG001|Overall Study|Lost to Follow-up|37|||
130123430|NCT03130699|468413653|FG002|Overall Study|Lost to Follow-up|26|||
130123431|NCT03130699|468413651|FG000|Overall Study|Withdrawal by Subject|5|||
130123432|NCT03130699|468413652|FG001|Overall Study|Withdrawal by Subject|1|||
130123433|NCT03130699|468413653|FG002|Overall Study|Withdrawal by Subject|0|||
130123434|NCT03130699|468413651|FG000|Overall Study|Withdrawal by PI|1|||
130123435|NCT03130699|468413652|FG001|Overall Study|Withdrawal by PI|2|||
130123436|NCT03130699|468413653|FG002|Overall Study|Withdrawal by PI|5|||
130123437|NCT03130699|468413651|FG000|Overall Study|Death|0|||
130123438|NCT03130699|468413652|FG001|Overall Study|Death|0|||
130123439|NCT03130699|468413653|FG002|Overall Study|Death|1|||
130123440|NCT01199861|468413654|FG000|Overall Study|Administrative problems|1|||
130123441|NCT01199861|468413655|FG001|Overall Study|Administrative problems|0|||
130123442|NCT01199861|468413654|FG000|Overall Study|Adverse Event|1|||
130123443|NCT01199861|468413655|FG001|Overall Study|Adverse Event|0|||
130123444|NCT04534283|468413656|FG000|Overall Study|Physician Decision|2|||
130123445|NCT04534283|468413656|FG000|Overall Study|Withdrawal by Subject|1|||
130123446|NCT04534283|468413656|FG000|Overall Study|Disease Progression|12|||
130123447|NCT04534283|468413656|FG000|Overall Study|Adverse Event|1|||
130123448|NCT00661505|468413657|FG000|Overall Study|Adverse Event|3|||
130123449|NCT00661505|468413657|FG000|Overall Study|Protocol Violation|14|||
130123450|NCT00661505|468413657|FG000|Overall Study|Withdrawal by Subject|8|||
130123451|NCT00661505|468413657|FG000|Overall Study|Lost to Follow-up|3|||
130123452|NCT00661505|468413657|FG000|Overall Study|Other|2|||
130123453|NCT00669864|468413658|FG000|Overall Study|Lost to Follow-up|2|||
130123454|NCT00669864|468413658|FG000|Overall Study|Protocol Violation|2|||
130123455|NCT00669864|468413658|FG000|Overall Study|Withdrawal by Subject|3|||
130123456|NCT00669864|468413658|FG000|Overall Study|Other|2|||
130123457|NCT02545998|468413669|FG000|Overall Study|Lost to Follow-up|12|||
130123458|NCT02545998|468413670|FG001|Overall Study|Lost to Follow-up|3|||
130123459|NCT02545998|468413669|FG000|Overall Study|Withdrawal by Subject|3|||
130123460|NCT02545998|468413670|FG001|Overall Study|Withdrawal by Subject|2|||
130123461|NCT01226797|468413683|FG000|Overall Study|Adverse Event|1|||
130123462|NCT01226797|468413684|FG001|Overall Study|Adverse Event|0|||
130123463|NCT01226797|468413683|FG000|Overall Study|No longer willing to participate|1|||
130123464|NCT01226797|468413684|FG001|Overall Study|No longer willing to participate|0|||
130123465|NCT01226797|468413683|FG000|Overall Study|Protocol Violation|0|||
130123466|NCT01226797|468413684|FG001|Overall Study|Protocol Violation|1|||
130123467|NCT04977336|468413685|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
130123468|NCT04977336|468413686|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130123469|NCT04977336|468413687|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
130123470|NCT04977336|468413688|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
130123471|NCT04977336|468413689|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130123472|NCT04977336|468413685|FG000|Overall Study|Lost to Follow-up|0|||
130123473|NCT04977336|468413686|FG001|Overall Study|Lost to Follow-up|0|||
130123474|NCT04977336|468413687|FG002|Overall Study|Lost to Follow-up|1|||
130123475|NCT04977336|468413688|FG003|Overall Study|Lost to Follow-up|0|||
130123476|NCT04977336|468413689|FG004|Overall Study|Lost to Follow-up|0|||
130123477|NCT01030965|468413691|FG000|Overall Study|Lack of Efficacy|3|||
130123478|NCT01030965|468413692|FG001|Overall Study|Lack of Efficacy|2|||
130123479|NCT01030965|468413693|FG002|Overall Study|Lack of Efficacy|0|||
130123480|NCT01030965|468413694|FG003|Overall Study|Lack of Efficacy|3|||
130123481|NCT01030965|468413691|FG000|Overall Study|Protocol Violation|1|||
130123482|NCT01030965|468413692|FG001|Overall Study|Protocol Violation|1|||
130123483|NCT01030965|468413693|FG002|Overall Study|Protocol Violation|1|||
130123484|NCT01030965|468413694|FG003|Overall Study|Protocol Violation|1|||
130123485|NCT01030965|468413691|FG000|Overall Study|Adverse Event|0|||
130123486|NCT01030965|468413692|FG001|Overall Study|Adverse Event|1|||
130123487|NCT01030965|468413693|FG002|Overall Study|Adverse Event|2|||
130123488|NCT01030965|468413694|FG003|Overall Study|Adverse Event|1|||
130123489|NCT01030965|468413691|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
130123490|NCT01030965|468413692|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
130123491|NCT01030965|468413693|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
130123492|NCT01030965|468413694|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
130123493|NCT01030965|468413691|FG000|Overall Study|Withdrawal by Subject|0|||
130123494|NCT01030965|468413692|FG001|Overall Study|Withdrawal by Subject|1|||
130123495|NCT01030965|468413693|FG002|Overall Study|Withdrawal by Subject|0|||
130123496|NCT01030965|468413694|FG003|Overall Study|Withdrawal by Subject|2|||
130123497|NCT03144687|468413697|FG000|Overall Study|Death|0|||
130123498|NCT03144687|468413698|FG001|Overall Study|Death|2|||
130123499|NCT03144687|468413697|FG000|Overall Study|Lost to Follow-up|0|||
130123500|NCT03144687|468413698|FG001|Overall Study|Lost to Follow-up|1|||
130123501|NCT03144687|468413697|FG000|Overall Study|Physician Decision|0|||
130123502|NCT03144687|468413698|FG001|Overall Study|Physician Decision|1|||
130123503|NCT03144687|468413697|FG000|Overall Study|Withdrawal by Subject|1|||
130123504|NCT03144687|468413698|FG001|Overall Study|Withdrawal by Subject|3|||
130123505|NCT03144687|468413697|FG000|Overall Study|Not Reported|2|||
130123506|NCT03144687|468413698|FG001|Overall Study|Not Reported|0|||
130123507|NCT01054599|468413699|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
130123508|NCT01054599|468413700|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
130123509|NCT01054599|468413699|FG000|Overall Study|Protocol Violation|1|||
130123510|NCT01054599|468413700|FG001|Overall Study|Protocol Violation|0|||
130123511|NCT01054599|468413699|FG000|Overall Study|Spells/seizure-like episodes|1|||
130123512|NCT01054599|468413700|FG001|Overall Study|Spells/seizure-like episodes|1|||
130123513|NCT01054599|468413699|FG000|Overall Study|Timing/scheduling difficulties|1|||
130123514|NCT01054599|468413700|FG001|Overall Study|Timing/scheduling difficulties|1|||
130123515|NCT01054599|468413699|FG000|Overall Study|Visual impairment, WTAR <80|0|||
130123516|NCT01054599|468413700|FG001|Overall Study|Visual impairment, WTAR <80|1|||
130123517|NCT01054599|468413699|FG000|Overall Study|Lost to Follow-up|0|||
130123518|NCT01054599|468413700|FG001|Overall Study|Lost to Follow-up|2|||
130123519|NCT01054599|468413699|FG000|Overall Study|Adverse Event|0|||
130123520|NCT01054599|468413700|FG001|Overall Study|Adverse Event|1|||
130123521|NCT01054599|468413699|FG000|Overall Study|Withdrawal by Subject|0|||
130123522|NCT01054599|468413700|FG001|Overall Study|Withdrawal by Subject|1|||
130123523|NCT00743197|468413701|FG000|Overall Study|Study terminated due to departure of PI.|1|||
130123524|NCT00743197|468413702|FG001|Overall Study|Study terminated due to departure of PI.|2|||
130123525|NCT04025879|468413705|FG000|Randomization|Participant withdrew consent|0|||
130123526|NCT04025879|468413706|FG001|Randomization|Participant withdrew consent|1|||
130123527|NCT04025879|468413705|FG000|Randomization|Participant no longer met study criteria|1|||
130123528|NCT04025879|468413706|FG001|Randomization|Participant no longer met study criteria|1|||
130123529|NCT04025879|468413705|FG000|Treatment|Ongoing treatment|10|||
130123530|NCT04025879|468413706|FG001|Treatment|Ongoing treatment|8|||
130123531|NCT04025879|468413705|FG000|Treatment|Disease progression/recurrence|36|||
130123532|NCT04025879|468413706|FG001|Treatment|Disease progression/recurrence|72|||
130123533|NCT04025879|468413705|FG000|Treatment|Study drug toxicity|36|||
130123534|NCT04025879|468413706|FG001|Treatment|Study drug toxicity|13|||
130123535|NCT04025879|468413705|FG000|Treatment|Death|2|||
130123536|NCT04025879|468413706|FG001|Treatment|Death|0|||
130123537|NCT04025879|468413705|FG000|Treatment|Adverse event unrelated to study drug|21|||
130123538|NCT04025879|468413706|FG001|Treatment|Adverse event unrelated to study drug|14|||
130123539|NCT04025879|468413705|FG000|Treatment|Participant request to discontinue study treatment|16|||
130123540|NCT04025879|468413706|FG001|Treatment|Participant request to discontinue study treatment|8|||
130123541|NCT04025879|468413705|FG000|Treatment|Participant withdrew consent|1|||
130123542|NCT04025879|468413706|FG001|Treatment|Participant withdrew consent|3|||
130123543|NCT04025879|468413705|FG000|Treatment|Participant no longer meets study criteria|3|||
130123544|NCT04025879|468413706|FG001|Treatment|Participant no longer meets study criteria|2|||
130123545|NCT04025879|468413705|FG000|Treatment|Lost to Follow-up|1|||
130123546|NCT04025879|468413706|FG001|Treatment|Lost to Follow-up|0|||
130123547|NCT04025879|468413705|FG000|Treatment|Other reasons|15|||
130123548|NCT04025879|468413706|FG001|Treatment|Other reasons|17|||
130123549|NCT04025879|468413705|FG000|Treatment|Administrative reason by sponsor|0|||
130123550|NCT04025879|468413706|FG001|Treatment|Administrative reason by sponsor|1|||
130123551|NCT04025879|468413705|FG000|Treatment|Not reported|2|||
130123552|NCT04025879|468413706|FG001|Treatment|Not reported|0|||
130123553|NCT02170688|468413707|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
130123554|NCT02170688|468413708|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
130123555|NCT02170688|468413709|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
130123556|NCT02170688|468413710|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
130123557|NCT02170688|468413711|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
130123558|NCT02170688|468413707|FG000|Overall Study|Full dose not received|0|||
130123559|NCT02170688|468413708|FG001|Overall Study|Full dose not received|1|||
130123560|NCT02170688|468413709|FG002|Overall Study|Full dose not received|0|||
130123561|NCT02170688|468413710|FG003|Overall Study|Full dose not received|0|||
130123562|NCT02170688|468413711|FG004|Overall Study|Full dose not received|0|||
130123563|NCT02170688|468413707|FG000|Overall Study|Physician Decision|0|||
130123564|NCT02170688|468413708|FG001|Overall Study|Physician Decision|0|||
130123565|NCT02170688|468413709|FG002|Overall Study|Physician Decision|1|||
130123566|NCT02170688|468413710|FG003|Overall Study|Physician Decision|0|||
130123567|NCT02170688|468413711|FG004|Overall Study|Physician Decision|0|||
130123568|NCT01471522|468413714|FG000|Overall Study|Withdrawal by Subject|28|||
129967694|NCT04504630|467847053|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
129967695|NCT04504630|467847054|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
130123569|NCT01471522|468413715|FG001|Overall Study|Withdrawal by Subject|22|||
130123570|NCT01471522|468413714|FG000|Overall Study|Lost to Follow-up|36|||
130123571|NCT01471522|468413715|FG001|Overall Study|Lost to Follow-up|26|||
130123572|NCT02507375|468413717|FG000|Overall Study|Progressive Disease|4|||
130123573|NCT02507375|468413718|FG001|Overall Study|Progressive Disease|5|||
130123574|NCT02507375|468413717|FG000|Overall Study|Death|0|||
130123575|NCT02507375|468413718|FG001|Overall Study|Death|1|||
129967696|NCT04504630|467847053|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
130123576|NCT02507375|468413717|FG000|Overall Study|Refused treatment|0|||
130123577|NCT02507375|468413718|FG001|Overall Study|Refused treatment|1|||
130123578|NCT02507375|468413717|FG000|Overall Study|Adverse Event|0|||
130123579|NCT02507375|468413718|FG001|Overall Study|Adverse Event|1|||
130123580|NCT00522457|468413719|FG000|Overall Study|Due to disease progression|16|||
130123581|NCT00522457|468413719|FG000|Overall Study|Adverse Event|2|||
130123582|NCT01691248|468413720|FG000|Overall Study|Protocol Violation|43|||
130123583|NCT01691248|468413721|FG001|Overall Study|Protocol Violation|27|||
130123584|NCT01691248|468413720|FG000|Overall Study|Adverse Event|24|||
130123585|NCT01691248|468413721|FG001|Overall Study|Adverse Event|22|||
130123586|NCT01691248|468413720|FG000|Overall Study|Withdrawal by Subject|20|||
130123587|NCT01691248|468413721|FG001|Overall Study|Withdrawal by Subject|18|||
130123588|NCT01691248|468413720|FG000|Overall Study|Confirmed CDAD|14|||
130123589|NCT01691248|468413721|FG001|Overall Study|Confirmed CDAD|31|||
130123590|NCT01691248|468413720|FG000|Overall Study|Lost to Follow-up|2|||
130123591|NCT01691248|468413721|FG001|Overall Study|Lost to Follow-up|5|||
130123592|NCT01691248|468413720|FG000|Overall Study|Reason not provided|4|||
130123593|NCT01691248|468413721|FG001|Overall Study|Reason not provided|4|||
130123594|NCT01691248|468413720|FG000|Overall Study|Not Treated|4|||
130123595|NCT01691248|468413721|FG001|Overall Study|Not Treated|7|||
130123596|NCT02863575|468413722|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
130123597|NCT02863575|468413723|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
130123598|NCT02863575|468413724|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
130123599|NCT02863575|468413722|FG000|Overall Study|Withdrawal by Subject|0|||
130123600|NCT02863575|468413723|FG001|Overall Study|Withdrawal by Subject|1|||
130123601|NCT02863575|468413724|FG002|Overall Study|Withdrawal by Subject|1|||
130123602|NCT02863575|468413722|FG000|Overall Study|Adverse Event|0|||
130123603|NCT02863575|468413723|FG001|Overall Study|Adverse Event|1|||
130123604|NCT02863575|468413724|FG002|Overall Study|Adverse Event|0|||
130123605|NCT00444145|468415649|FG000|Overall Study|Withdrawal by Subject|2|||
130123606|NCT00444145|468415649|FG000|Overall Study|Lost to Follow-up|1|||
130123607|NCT00444145|468415649|FG000|Overall Study|non-compliant|11|||
130123608|NCT00444145|468415649|FG000|Overall Study|Screen Failures|5|||
130123609|NCT01374919|468415650|FG000|Overall Study|Withdrawal by Subject|2|||
130123610|NCT00630305|468415651|FG000|Overall Study|Withdrawal by Subject|1|||
130123611|NCT00630305|468415651|FG000|Overall Study|Inability to insert contact lens|1|||
130123612|NCT01494506|468415652|FG000|Overall Study|Lack of Efficacy|77|||
130123613|NCT01494506|468415653|FG001|Overall Study|Lack of Efficacy|83|||
130123614|NCT01494506|468415654|FG002|Overall Study|Lack of Efficacy|57|||
130123615|NCT01494506|468415652|FG000|Overall Study|Adverse Event|17|||
130123616|NCT01494506|468415653|FG001|Overall Study|Adverse Event|10|||
130123617|NCT01494506|468415654|FG002|Overall Study|Adverse Event|11|||
130123618|NCT01494506|468415652|FG000|Overall Study|Death|9|||
130123619|NCT01494506|468415653|FG001|Overall Study|Death|5|||
130123620|NCT01494506|468415654|FG002|Overall Study|Death|2|||
130123621|NCT01494506|468415652|FG000|Overall Study|Physician Decision|7|||
130123622|NCT01494506|468415653|FG001|Overall Study|Physician Decision|5|||
130123623|NCT01494506|468415654|FG002|Overall Study|Physician Decision|4|||
130123624|NCT01494506|468415652|FG000|Overall Study|Withdrawal by Subject|17|||
130123625|NCT01494506|468415653|FG001|Overall Study|Withdrawal by Subject|20|||
130123626|NCT01494506|468415654|FG002|Overall Study|Withdrawal by Subject|14|||
130123627|NCT01494506|468415652|FG000|Overall Study|Clinical Deterioration|21|||
130123628|NCT01494506|468415653|FG001|Overall Study|Clinical Deterioration|17|||
130123629|NCT01494506|468415654|FG002|Overall Study|Clinical Deterioration|13|||
130123630|NCT01494506|468415652|FG000|Overall Study|Sponsor Decision|0|||
130123631|NCT01494506|468415653|FG001|Overall Study|Sponsor Decision|0|||
130123632|NCT01494506|468415654|FG002|Overall Study|Sponsor Decision|1|||
130123633|NCT01494506|468415652|FG000|Overall Study|Other|0|||
130123634|NCT01494506|468415653|FG001|Overall Study|Other|3|||
130123635|NCT01494506|468415654|FG002|Overall Study|Other|1|||
130123636|NCT03471078|468415668|FG000|Overall Study|Withdrawal by Subject|9|||
130123637|NCT03471078|468415669|FG001|Overall Study|Withdrawal by Subject|1|||
130123638|NCT03471078|468415668|FG000|Overall Study|Adverse Event|4|||
130123639|NCT03471078|468415669|FG001|Overall Study|Adverse Event|1|||
130123640|NCT03471078|468415668|FG000|Overall Study|Physician Decision|3|||
130123641|NCT03471078|468415669|FG001|Overall Study|Physician Decision|2|||
130123642|NCT03471078|468415668|FG000|Overall Study|Death|2|||
130123643|NCT03471078|468415669|FG001|Overall Study|Death|0|||
130123644|NCT03471078|468415668|FG000|Overall Study|Other|3|||
130123645|NCT03471078|468415669|FG001|Overall Study|Other|2|||
130123646|NCT02473640|468415673|FG000|Treatment Period 1|Adverse Event|1|||
130123647|NCT02395822|468415674|FG000|Overall Study|Withdrawal by Subject|1|||
130123648|NCT02395822|468415674|FG000|Overall Study|Death|1|||
130123649|NCT02777528|468415677|FG000|Overall Study|Still in study|24|||
130123650|NCT02777528|468415678|FG001|Overall Study|Still in study|10|||
130123651|NCT02777528|468415679|FG002|Overall Study|Still in study|1|||
130123652|NCT02777528|468415677|FG000|Overall Study|Study Device Explanted|1|||
130123653|NCT02777528|468415678|FG001|Overall Study|Study Device Explanted|0|||
130123654|NCT02777528|468415679|FG002|Overall Study|Study Device Explanted|0|||
130123655|NCT02777528|468415677|FG000|Overall Study|Death|14|||
130123656|NCT02777528|468415678|FG001|Overall Study|Death|7|||
130123657|NCT02777528|468415679|FG002|Overall Study|Death|1|||
130123658|NCT02777528|468415677|FG000|Overall Study|Withdrawal by Subject|2|||
130123659|NCT02777528|468415678|FG001|Overall Study|Withdrawal by Subject|2|||
130123660|NCT02777528|468415679|FG002|Overall Study|Withdrawal by Subject|1|||
130123661|NCT02777528|468415677|FG000|Overall Study|Physician Decision|2|||
130123662|NCT02777528|468415678|FG001|Overall Study|Physician Decision|1|||
130123663|NCT02777528|468415679|FG002|Overall Study|Physician Decision|0|||
130123664|NCT02777528|468415677|FG000|Overall Study|Lost to Follow-up|2|||
130123665|NCT02777528|468415678|FG001|Overall Study|Lost to Follow-up|0|||
130123666|NCT02777528|468415679|FG002|Overall Study|Lost to Follow-up|0|||
130123667|NCT02777528|468415677|FG000|Overall Study|Discontinued due to Other|1|||
130123668|NCT02777528|468415678|FG001|Overall Study|Discontinued due to Other|0|||
130123669|NCT02777528|468415679|FG002|Overall Study|Discontinued due to Other|0|||
130123670|NCT02127281|468415680|FG000|Overall Study|Lost to Follow-up|1|||
130123671|NCT02127281|468415681|FG001|Overall Study|Lost to Follow-up|0|||
130123672|NCT02937701|468415682|FG000|Day 1 to Week 22|Adverse Event|11|||
130123673|NCT02937701|468415683|FG001|Day 1 to Week 22|Adverse Event|14|||
130123674|NCT02937701|468415684|FG002|Day 1 to Week 22|Adverse Event|0|||
130123675|NCT02937701|468415685|FG003|Day 1 to Week 22|Adverse Event|0|||
130123676|NCT02937701|468415686|FG004|Day 1 to Week 22|Adverse Event|0|||
130123677|NCT02937701|468415682|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
130123678|NCT02937701|468415683|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
130123679|NCT02937701|468415684|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
130123680|NCT02937701|468415685|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
130123681|NCT02937701|468415686|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
130123682|NCT02937701|468415682|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
130123683|NCT02937701|468415683|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
130123684|NCT02937701|468415684|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130123685|NCT02937701|468415685|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130123686|NCT02937701|468415686|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
130123687|NCT02937701|468415682|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
130123688|NCT02937701|468415683|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
130123689|NCT02937701|468415684|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
130123690|NCT02937701|468415685|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
130123691|NCT02937701|468415686|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
130123692|NCT02937701|468415682|FG000|Day 1 to Week 22|Death|1|||
130123693|NCT02937701|468415683|FG001|Day 1 to Week 22|Death|1|||
130123694|NCT02937701|468415684|FG002|Day 1 to Week 22|Death|0|||
130123695|NCT02937701|468415685|FG003|Day 1 to Week 22|Death|0|||
130123696|NCT02937701|468415686|FG004|Day 1 to Week 22|Death|0|||
130123697|NCT02937701|468415682|FG000|Day 1 to Week 22|Protocol Violation|1|||
130123698|NCT02937701|468415683|FG001|Day 1 to Week 22|Protocol Violation|1|||
130123699|NCT02937701|468415684|FG002|Day 1 to Week 22|Protocol Violation|0|||
130123700|NCT02937701|468415685|FG003|Day 1 to Week 22|Protocol Violation|0|||
130123701|NCT02937701|468415686|FG004|Day 1 to Week 22|Protocol Violation|0|||
130123702|NCT02937701|468415682|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
130123703|NCT02937701|468415683|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
130123704|NCT02937701|468415684|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
130123705|NCT02937701|468415685|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
130123706|NCT02937701|468415686|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
130123707|NCT02937701|468415682|FG000|Day 1 to Week 22|Physician Decision|2|||
130123708|NCT02937701|468415683|FG001|Day 1 to Week 22|Physician Decision|0|||
130123709|NCT02937701|468415684|FG002|Day 1 to Week 22|Physician Decision|0|||
130123710|NCT02937701|468415685|FG003|Day 1 to Week 22|Physician Decision|0|||
130123711|NCT02937701|468415686|FG004|Day 1 to Week 22|Physician Decision|0|||
130123712|NCT02937701|468415682|FG000|Day 1 to Week 22|Other|1|||
130123713|NCT02937701|468415683|FG001|Day 1 to Week 22|Other|0|||
130123714|NCT02937701|468415684|FG002|Day 1 to Week 22|Other|0|||
130123715|NCT02937701|468415685|FG003|Day 1 to Week 22|Other|0|||
130123716|NCT02937701|468415686|FG004|Day 1 to Week 22|Other|0|||
130123717|NCT02937701|468415682|FG000|Week 22 to Week 50|Adverse Event|0|||
130123718|NCT02937701|468415683|FG001|Week 22 to Week 50|Adverse Event|0|||
130123719|NCT02937701|468415684|FG002|Week 22 to Week 50|Adverse Event|10|||
130123720|NCT02937701|468415685|FG003|Week 22 to Week 50|Adverse Event|3|||
130123721|NCT02937701|468415686|FG004|Week 22 to Week 50|Adverse Event|3|||
130123722|NCT02937701|468415682|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
130123723|NCT02937701|468415683|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
130123724|NCT02937701|468415684|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
130123725|NCT02937701|468415685|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
130123726|NCT02937701|468415686|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
130123727|NCT02937701|468415682|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
130123728|NCT02937701|468415683|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
130123729|NCT02937701|468415684|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
130123730|NCT02937701|468415685|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
130123731|NCT02937701|468415686|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
130123732|NCT02937701|468415682|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
130123733|NCT02937701|468415683|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
130123734|NCT02937701|468415684|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
130123735|NCT02937701|468415685|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
130123736|NCT02937701|468415686|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
130123737|NCT02937701|468415682|FG000|Week 22 to Week 50|Physician Decision|0|||
130123738|NCT02937701|468415683|FG001|Week 22 to Week 50|Physician Decision|0|||
130123739|NCT02937701|468415684|FG002|Week 22 to Week 50|Physician Decision|2|||
130123740|NCT02937701|468415685|FG003|Week 22 to Week 50|Physician Decision|0|||
130123741|NCT02937701|468415686|FG004|Week 22 to Week 50|Physician Decision|1|||
130123742|NCT02937701|468415682|FG000|Week 22 to Week 50|Other|0|||
130123743|NCT02937701|468415683|FG001|Week 22 to Week 50|Other|0|||
130123744|NCT02937701|468415684|FG002|Week 22 to Week 50|Other|0|||
130123745|NCT02937701|468415685|FG003|Week 22 to Week 50|Other|0|||
130123746|NCT02937701|468415686|FG004|Week 22 to Week 50|Other|1|||
130123747|NCT04720664|468415687|FG000|Overall Study|Adverse Event|2|||
130123748|NCT04720664|468415687|FG000|Overall Study|Lack of Efficacy|9|||
130123749|NCT01492361|468415688|FG000|Overall Study|Withdrawal by Subject|281|||
130123750|NCT01492361|468415689|FG001|Overall Study|Withdrawal by Subject|297|||
130123751|NCT01492361|468415688|FG000|Overall Study|Physician Decision|12|||
130123752|NCT01492361|468415689|FG001|Overall Study|Physician Decision|12|||
130123753|NCT01492361|468415688|FG000|Overall Study|Lost to Follow-up|6|||
130123754|NCT01492361|468415689|FG001|Overall Study|Lost to Follow-up|13|||
130123755|NCT01492361|468415688|FG000|Overall Study|Other than specified above|106|||
130123756|NCT01492361|468415689|FG001|Overall Study|Other than specified above|138|||
130123757|NCT01996033|468415695|FG000|Overall Study|Death|1|||
130123758|NCT01996033|468415695|FG000|Overall Study|Physician Decision|1|||
130123759|NCT01996033|468415695|FG000|Overall Study|Withdrawal by Subject|4|||
130123760|NCT01996033|468415695|FG000|Overall Study|Lost to Follow-up|3|||
130123761|NCT03227445|468415700|FG000|Period 1 (28 Days)|Adverse Event|1|||
130123762|NCT03227445|468415701|FG001|Period 1 (28 Days)|Adverse Event|2|||
130123763|NCT03227445|468415702|FG002|Period 1 (28 Days)|Adverse Event|0|||
130123764|NCT03227445|468415703|FG003|Period 1 (28 Days)|Adverse Event|1|||
130123765|NCT03227445|468415700|FG000|Period 1 (28 Days)|Protocol Violation|1|||
130123766|NCT03227445|468415701|FG001|Period 1 (28 Days)|Protocol Violation|0|||
130123767|NCT03227445|468415702|FG002|Period 1 (28 Days)|Protocol Violation|0|||
130123768|NCT03227445|468415703|FG003|Period 1 (28 Days)|Protocol Violation|0|||
130123769|NCT03227445|468415700|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
130123770|NCT03227445|468415701|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
130123771|NCT03227445|468415702|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
130123772|NCT03227445|468415703|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
130123773|NCT03227445|468415700|FG000|Period 2 (28 Days)|Adverse Event|1|||
130123774|NCT03227445|468415701|FG001|Period 2 (28 Days)|Adverse Event|0|||
130123775|NCT03227445|468415702|FG002|Period 2 (28 Days)|Adverse Event|2|||
130123776|NCT03227445|468415703|FG003|Period 2 (28 Days)|Adverse Event|1|||
130123777|NCT03227445|468415700|FG000|Period 2 (28 Days)|Protocol Violation|0|||
130123778|NCT03227445|468415701|FG001|Period 2 (28 Days)|Protocol Violation|0|||
130123779|NCT03227445|468415702|FG002|Period 2 (28 Days)|Protocol Violation|0|||
130123780|NCT03227445|468415703|FG003|Period 2 (28 Days)|Protocol Violation|1|||
130123781|NCT03227445|468415700|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
130123782|NCT03227445|468415701|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
130123783|NCT03227445|468415702|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
130123784|NCT03227445|468415703|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
130123785|NCT00755196|468415705|FG000|Overall Study|Lost to Follow-up|1|||
130123786|NCT00755196|468415705|FG000|Overall Study|Lack of Efficiency|1|||
130092589|NCT00151775|468294524|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
130092590|NCT00151775|468294525|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092591|NCT00151775|468294526|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092592|NCT00151775|468294527|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092593|NCT00151775|468294528|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092594|NCT00151775|468294529|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
130092595|NCT00151775|468294518|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092596|NCT00151775|468294519|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092597|NCT00151775|468294520|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092598|NCT00151775|468294521|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092599|NCT00151775|468294522|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092600|NCT00151775|468294523|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
130092601|NCT00151775|468294524|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092602|NCT00151775|468294525|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130123787|NCT03247556|468415708|FG000|Overall Study|Adverse Event|1|||
130123788|NCT03247556|468415709|FG001|Overall Study|Adverse Event|4|||
130123789|NCT03247556|468415710|FG002|Overall Study|Adverse Event|5|||
130123790|NCT03247556|468415708|FG000|Overall Study|Lost to Follow-up|5|||
130123791|NCT03247556|468415709|FG001|Overall Study|Lost to Follow-up|5|||
130123792|NCT03247556|468415710|FG002|Overall Study|Lost to Follow-up|4|||
130123793|NCT03247556|468415708|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
130123794|NCT03247556|468415709|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
130123795|NCT03247556|468415710|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
130123796|NCT03247556|468415708|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
130123797|NCT03247556|468415709|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
130123798|NCT03247556|468415710|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
130123799|NCT03247556|468415708|FG000|Overall Study|Protocol Violation|2|||
130123800|NCT03247556|468415709|FG001|Overall Study|Protocol Violation|0|||
130123801|NCT03247556|468415710|FG002|Overall Study|Protocol Violation|1|||
130123802|NCT03247556|468415708|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
130123803|NCT03247556|468415709|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
130123804|NCT03247556|468415710|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
130123805|NCT03952143|468415711|FG000|Lead-In Period|Adverse Event|2|||
130123806|NCT03952143|468415712|FG001|Lead-In Period|Adverse Event|0|||
130123807|NCT03952143|468415713|FG002|Lead-In Period|Adverse Event|0|||
130123808|NCT03952143|468415711|FG000|Lead-In Period|Lack of Efficacy|2|||
130123809|NCT03952143|468415712|FG001|Lead-In Period|Lack of Efficacy|0|||
130123810|NCT03952143|468415713|FG002|Lead-In Period|Lack of Efficacy|0|||
130123811|NCT03952143|468415711|FG000|Lead-In Period|Physician Decision|5|||
130123812|NCT03952143|468415712|FG001|Lead-In Period|Physician Decision|0|||
130123813|NCT03952143|468415713|FG002|Lead-In Period|Physician Decision|0|||
130123814|NCT03952143|468415711|FG000|Lead-In Period|Protocol Violation|5|||
130123815|NCT03952143|468415712|FG001|Lead-In Period|Protocol Violation|0|||
130123816|NCT03952143|468415713|FG002|Lead-In Period|Protocol Violation|0|||
130123817|NCT03952143|468415711|FG000|Lead-In Period|Withdrawal by Subject|19|||
130123818|NCT03952143|468415712|FG001|Lead-In Period|Withdrawal by Subject|0|||
130123819|NCT03952143|468415713|FG002|Lead-In Period|Withdrawal by Subject|0|||
130123820|NCT03952143|468415711|FG000|Treatment Period|Adverse Event|0|||
130123821|NCT03952143|468415712|FG001|Treatment Period|Adverse Event|0|||
130123822|NCT03952143|468415713|FG002|Treatment Period|Adverse Event|1|||
130123823|NCT03952143|468415711|FG000|Treatment Period|Lost to Follow-up|0|||
130123824|NCT03952143|468415712|FG001|Treatment Period|Lost to Follow-up|2|||
130123825|NCT03952143|468415713|FG002|Treatment Period|Lost to Follow-up|0|||
130123826|NCT03952143|468415711|FG000|Treatment Period|Physician Decision|0|||
130123827|NCT03952143|468415712|FG001|Treatment Period|Physician Decision|0|||
130123828|NCT03952143|468415713|FG002|Treatment Period|Physician Decision|2|||
130123829|NCT03952143|468415711|FG000|Treatment Period|Protocol Violation|0|||
130123830|NCT03952143|468415712|FG001|Treatment Period|Protocol Violation|0|||
130123831|NCT03952143|468415713|FG002|Treatment Period|Protocol Violation|1|||
130123832|NCT03952143|468415711|FG000|Treatment Period|Withdrawal by Subject|0|||
130123833|NCT03952143|468415712|FG001|Treatment Period|Withdrawal by Subject|5|||
130123834|NCT03952143|468415713|FG002|Treatment Period|Withdrawal by Subject|26|||
130123835|NCT03952143|468415711|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
130123836|NCT03952143|468415712|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
130123837|NCT03952143|468415713|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
130123838|NCT03952143|468415711|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
130123839|NCT03952143|468415712|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
130123840|NCT03952143|468415713|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
130123841|NCT01866319|468415714|FG000|Overall Study|Adverse Event|12|||
130123842|NCT01866319|468415715|FG001|Overall Study|Adverse Event|5|||
130123843|NCT01866319|468415716|FG002|Overall Study|Adverse Event|9|||
130123844|NCT01866319|468415714|FG000|Overall Study|Clinical progression|3|||
130123845|NCT01866319|468415715|FG001|Overall Study|Clinical progression|2|||
130123846|NCT01866319|468415716|FG002|Overall Study|Clinical progression|2|||
130123847|NCT01866319|468415714|FG000|Overall Study|Death|153|||
130123848|NCT01866319|468415715|FG001|Overall Study|Death|154|||
130123849|NCT01866319|468415716|FG002|Overall Study|Death|147|||
130123850|NCT01866319|468415714|FG000|Overall Study|Lost to Follow-up|6|||
130123851|NCT01866319|468415715|FG001|Overall Study|Lost to Follow-up|3|||
130123852|NCT01866319|468415716|FG002|Overall Study|Lost to Follow-up|8|||
130123853|NCT01866319|468415714|FG000|Overall Study|Physician Decision|1|||
129967697|NCT04504630|467847054|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
129967698|NCT02229578|467847078|FG000|Overall Study|Withdrawal by Subject|1|||
129967699|NCT02229578|467847079|FG001|Overall Study|Withdrawal by Subject|3|||
130123854|NCT01866319|468415715|FG001|Overall Study|Physician Decision|0|||
130123855|NCT01866319|468415716|FG002|Overall Study|Physician Decision|1|||
130123856|NCT01866319|468415714|FG000|Overall Study|Protocol Violation|0|||
129967700|NCT02229578|467847078|FG000|Overall Study|Protocol Violation|2|||
129967701|NCT02229578|467847079|FG001|Overall Study|Protocol Violation|0|||
130123857|NCT01866319|468415715|FG001|Overall Study|Protocol Violation|0|||
130123858|NCT01866319|468415716|FG002|Overall Study|Protocol Violation|1|||
130123859|NCT01866319|468415714|FG000|Overall Study|Withdrawal by Subject|32|||
130123860|NCT01866319|468415715|FG001|Overall Study|Withdrawal by Subject|14|||
130123861|NCT01866319|468415716|FG002|Overall Study|Withdrawal by Subject|12|||
130123862|NCT03980483|468415720|FG000|Overall Study|Adverse Event|13|||
130123863|NCT03980483|468415721|FG001|Overall Study|Adverse Event|29|||
130123864|NCT03980483|468415722|FG002|Overall Study|Adverse Event|11|||
130123865|NCT03980483|468415723|FG003|Overall Study|Adverse Event|2|||
130123866|NCT03980483|468415724|FG004|Overall Study|Adverse Event|2|||
130123867|NCT03980483|468415725|FG005|Overall Study|Adverse Event|2|||
130123868|NCT03980483|468415720|FG000|Overall Study|Lack of Efficacy|7|||
130123869|NCT03980483|468415721|FG001|Overall Study|Lack of Efficacy|6|||
130123870|NCT03980483|468415722|FG002|Overall Study|Lack of Efficacy|0|||
130123871|NCT03980483|468415723|FG003|Overall Study|Lack of Efficacy|3|||
130123872|NCT03980483|468415724|FG004|Overall Study|Lack of Efficacy|1|||
130123873|NCT03980483|468415725|FG005|Overall Study|Lack of Efficacy|1|||
130123874|NCT03980483|468415720|FG000|Overall Study|Lost to Follow-up|2|||
130123875|NCT03980483|468415721|FG001|Overall Study|Lost to Follow-up|4|||
130123876|NCT03980483|468415722|FG002|Overall Study|Lost to Follow-up|2|||
130123877|NCT03980483|468415723|FG003|Overall Study|Lost to Follow-up|1|||
130123878|NCT03980483|468415724|FG004|Overall Study|Lost to Follow-up|2|||
130123879|NCT03980483|468415725|FG005|Overall Study|Lost to Follow-up|0|||
130123880|NCT03980483|468415720|FG000|Overall Study|Protocol Violation|4|||
130123881|NCT03980483|468415721|FG001|Overall Study|Protocol Violation|2|||
130123882|NCT03980483|468415722|FG002|Overall Study|Protocol Violation|1|||
130123883|NCT03980483|468415723|FG003|Overall Study|Protocol Violation|1|||
130123884|NCT03980483|468415724|FG004|Overall Study|Protocol Violation|0|||
130123885|NCT03980483|468415725|FG005|Overall Study|Protocol Violation|0|||
130123886|NCT03980483|468415720|FG000|Overall Study|Physician Decision|14|||
130123887|NCT03980483|468415721|FG001|Overall Study|Physician Decision|10|||
130123888|NCT03980483|468415722|FG002|Overall Study|Physician Decision|7|||
130123889|NCT03980483|468415723|FG003|Overall Study|Physician Decision|4|||
130123890|NCT03980483|468415724|FG004|Overall Study|Physician Decision|4|||
130123891|NCT03980483|468415725|FG005|Overall Study|Physician Decision|2|||
130123892|NCT03980483|468415720|FG000|Overall Study|Withdrawal by Subject|38|||
130123893|NCT03980483|468415721|FG001|Overall Study|Withdrawal by Subject|21|||
130123894|NCT03980483|468415722|FG002|Overall Study|Withdrawal by Subject|15|||
130123895|NCT03980483|468415723|FG003|Overall Study|Withdrawal by Subject|5|||
130123896|NCT03980483|468415724|FG004|Overall Study|Withdrawal by Subject|3|||
130123897|NCT03980483|468415725|FG005|Overall Study|Withdrawal by Subject|4|||
130123898|NCT03980483|468415720|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
130123899|NCT03980483|468415721|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130123900|NCT03980483|468415722|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130123901|NCT03980483|468415723|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130123902|NCT03980483|468415724|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130123903|NCT03980483|468415725|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130123904|NCT03980483|468415720|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130123905|NCT03980483|468415721|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
130123906|NCT03980483|468415722|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130123907|NCT03980483|468415723|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130123908|NCT03980483|468415724|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130123909|NCT03980483|468415725|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
130123910|NCT03980483|468415720|FG000|Overall Study|Other|0|||
130123911|NCT03980483|468415721|FG001|Overall Study|Other|1|||
130123912|NCT03980483|468415722|FG002|Overall Study|Other|0|||
130123913|NCT03980483|468415723|FG003|Overall Study|Other|0|||
130123914|NCT03980483|468415724|FG004|Overall Study|Other|0|||
130123915|NCT03980483|468415725|FG005|Overall Study|Other|0|||
130123916|NCT00760266|468415728|FG000|Overall Study|Adverse Event|13|||
130123917|NCT00760266|468415729|FG001|Overall Study|Adverse Event|7|||
130123918|NCT00760266|468415728|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130123919|NCT00760266|468415729|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130123920|NCT00760266|468415728|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130123921|NCT00760266|468415729|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130123922|NCT00760266|468415728|FG000|Overall Study|Lack of Efficacy|2|||
130123923|NCT00760266|468415729|FG001|Overall Study|Lack of Efficacy|2|||
130123924|NCT00760266|468415728|FG000|Overall Study|Protocol deviation|2|||
130123925|NCT00760266|468415729|FG001|Overall Study|Protocol deviation|4|||
130123926|NCT00760266|468415728|FG000|Overall Study|Patient withdrew consent|3|||
130123927|NCT00760266|468415729|FG001|Overall Study|Patient withdrew consent|3|||
130123928|NCT00760266|468415728|FG000|Overall Study|Lost to Follow-up|2|||
130123929|NCT00760266|468415729|FG001|Overall Study|Lost to Follow-up|1|||
130123930|NCT00760266|468415728|FG000|Overall Study|Administrative Problems|0|||
130123931|NCT00760266|468415729|FG001|Overall Study|Administrative Problems|1|||
130123932|NCT01225146|468415730|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
130123933|NCT01225146|468415731|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
130123934|NCT00623779|468415733|FG000|Overall Study|Adverse Event|1|||
130123935|NCT00623779|468415734|FG001|Overall Study|Adverse Event|3|||
130123936|NCT00623779|468415735|FG002|Overall Study|Adverse Event|0|||
130123937|NCT00623779|468415733|FG000|Overall Study|Criteria from CSR|2|||
130123938|NCT00623779|468415734|FG001|Overall Study|Criteria from CSR|0|||
130123939|NCT00623779|468415735|FG002|Overall Study|Criteria from CSR|1|||
130123940|NCT00220337|468415738|FG000|Overall Study|Adverse Event|70|||
130123941|NCT00220337|468415738|FG000|Overall Study|Lack of Efficacy|17|||
130123942|NCT00220337|468415738|FG000|Overall Study|Withdrawal by Subject|68|||
130123943|NCT00220337|468415738|FG000|Overall Study|Protocol Violation|2|||
130123944|NCT00220337|468415738|FG000|Overall Study|Lost to Follow-up|5|||
130123945|NCT00220337|468415738|FG000|Overall Study|Other|12|||
130123946|NCT00220337|468415738|FG000|Overall Study|Unsatisfactory compliance|5|||
130123947|NCT00944697|468415741|FG000|Overall Study|Withdrawal by Subject|1|||
130123948|NCT00944697|468415742|FG001|Overall Study|Withdrawal by Subject|1|||
130123949|NCT00944697|468415741|FG000|Overall Study|Adverse Event|0|||
130123950|NCT00944697|468415742|FG001|Overall Study|Adverse Event|3|||
130123951|NCT00944697|468415741|FG000|Overall Study|Administrative|1|||
130123952|NCT00944697|468415742|FG001|Overall Study|Administrative|1|||
130123953|NCT02732210|468415743|FG000|Overall Study|Site Closed|0|||
130123954|NCT02732210|468415744|FG001|Overall Study|Site Closed|11|||
130123955|NCT02732210|468415743|FG000|Overall Study|Study Ended|13|||
130123956|NCT02732210|468415744|FG001|Overall Study|Study Ended|13|||
130123957|NCT02732210|468415743|FG000|Overall Study|Withdrawal by Subject|28|||
130123958|NCT02732210|468415744|FG001|Overall Study|Withdrawal by Subject|87|||
130123959|NCT02732210|468415743|FG000|Overall Study|Lost to Follow-up|5|||
130123960|NCT02732210|468415744|FG001|Overall Study|Lost to Follow-up|57|||
130123961|NCT02732210|468415743|FG000|Overall Study|Death|4|||
130123962|NCT02732210|468415744|FG001|Overall Study|Death|15|||
130123963|NCT02732210|468415743|FG000|Overall Study|Other|35|||
130123964|NCT02732210|468415744|FG001|Overall Study|Other|103|||
130123965|NCT02732210|468415743|FG000|Overall Study|Missing|0|||
130123966|NCT02732210|468415744|FG001|Overall Study|Missing|8|||
130123967|NCT02191891|468415747|FG000|Overall Study|Withdrawal by Subject|0|||
130123968|NCT02191891|468415748|FG001|Overall Study|Withdrawal by Subject|1|||
130123969|NCT02191891|468415749|FG002|Overall Study|Withdrawal by Subject|0|||
130123970|NCT02191891|468415750|FG003|Overall Study|Withdrawal by Subject|0|||
130123971|NCT02191891|468415751|FG004|Overall Study|Withdrawal by Subject|1|||
130123972|NCT02191891|468415747|FG000|Overall Study|Adverse Event|0|||
130123973|NCT02191891|468415748|FG001|Overall Study|Adverse Event|1|||
130123974|NCT02191891|468415749|FG002|Overall Study|Adverse Event|0|||
130123975|NCT02191891|468415750|FG003|Overall Study|Adverse Event|0|||
130123976|NCT02191891|468415751|FG004|Overall Study|Adverse Event|2|||
130123977|NCT02191891|468415747|FG000|Overall Study|Disease Progression|4|||
130123978|NCT02191891|468415748|FG001|Overall Study|Disease Progression|10|||
130123979|NCT02191891|468415749|FG002|Overall Study|Disease Progression|4|||
130123980|NCT02191891|468415750|FG003|Overall Study|Disease Progression|2|||
130123981|NCT02191891|468415751|FG004|Overall Study|Disease Progression|7|||
130123982|NCT01974141|468415764|FG000|Overall Study|Other Reasons|28|||
130123983|NCT01974141|468415765|FG001|Overall Study|Other Reasons|18|||
130123984|NCT01974141|468415764|FG000|Overall Study|Protocol Violation|2|||
130123985|NCT01974141|468415765|FG001|Overall Study|Protocol Violation|6|||
130123986|NCT01974141|468415764|FG000|Overall Study|Personal Reasons|21|||
130123987|NCT01974141|468415765|FG001|Overall Study|Personal Reasons|20|||
130123988|NCT01974141|468415764|FG000|Overall Study|Lost to Follow-up|38|||
130123989|NCT01974141|468415765|FG001|Overall Study|Lost to Follow-up|29|||
130123990|NCT01974141|468415764|FG000|Overall Study|Pregnancy|3|||
130123991|NCT01974141|468415765|FG001|Overall Study|Pregnancy|3|||
130123992|NCT01974141|468415764|FG000|Overall Study|Lack of Efficacy|0|||
130123993|NCT01974141|468415765|FG001|Overall Study|Lack of Efficacy|1|||
130123994|NCT01974141|468415764|FG000|Overall Study|Adverse Event|4|||
130123995|NCT01974141|468415765|FG001|Overall Study|Adverse Event|5|||
130123996|NCT01004172|468415769|FG000|Overall Study|Progressive Disease in CNS Only|16|||
130123997|NCT01004172|468415769|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
130123998|NCT01004172|468415769|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
130123999|NCT01004172|468415769|FG000|Overall Study|Adverse Event|1|||
130124000|NCT01004172|468415769|FG000|Overall Study|Physician Decision|1|||
130124001|NCT01004172|468415769|FG000|Overall Study|Symptomatic Deterioration|2|||
130124002|NCT00950872|468415770|FG000|Overall Study|Withdrawal by Subject|1|||
130124003|NCT00950872|468415770|FG000|Overall Study|Did not have surgery|2|||
130124004|NCT02003183|468415771|FG000|Overall Study|Lost to Follow-up|0|||
130124005|NCT02003183|468415772|FG001|Overall Study|Lost to Follow-up|2|||
130124006|NCT01139164|468415773|FG000|Overall Study|Withdrawn prior to study start|0|||
130124007|NCT01139164|468415774|FG001|Overall Study|Withdrawn prior to study start|2|||
130124008|NCT01139164|468415775|FG002|Overall Study|Withdrawn prior to study start|0|||
130124009|NCT01759290|468415776|FG000|Overall Study|Subjects withdrawn consent|5|||
130124010|NCT01759290|468415776|FG000|Overall Study|Physician Decision|2|||
130124011|NCT01759290|468415776|FG000|Overall Study|Death|17|||
130124012|NCT01759290|468415776|FG000|Overall Study|Lost to Follow-up|53|||
130124013|NCT01759290|468415776|FG000|Overall Study|Unknown reason|4|||
130124014|NCT00406848|468415777|FG000|Overall Study|Withdrawal by Subject|27|||
130124015|NCT00406848|468415778|FG001|Overall Study|Withdrawal by Subject|22|||
130124016|NCT00406848|468415777|FG000|Overall Study|Adverse Event|38|||
130124017|NCT00406848|468415778|FG001|Overall Study|Adverse Event|7|||
130124018|NCT00406848|468415777|FG000|Overall Study|Lack of Efficacy|9|||
130124019|NCT00406848|468415778|FG001|Overall Study|Lack of Efficacy|14|||
130124020|NCT00406848|468415777|FG000|Overall Study|Protocol Violation|10|||
130124021|NCT00406848|468415778|FG001|Overall Study|Protocol Violation|6|||
130124022|NCT00406848|468415777|FG000|Overall Study|Lost to Follow-up|6|||
130124023|NCT00406848|468415778|FG001|Overall Study|Lost to Follow-up|2|||
130124024|NCT00406848|468415777|FG000|Overall Study|Physician Decision|2|||
130124025|NCT00406848|468415778|FG001|Overall Study|Physician Decision|2|||
130124026|NCT00406848|468415777|FG000|Overall Study|Sponsor Decision|1|||
130124027|NCT00406848|468415778|FG001|Overall Study|Sponsor Decision|1|||
130124028|NCT03629249|468415779|FG000|Overall Study|Study terminated by sponsor|197|||
130124029|NCT03629249|468415780|FG001|Overall Study|Study terminated by sponsor|197|||
130124030|NCT03629249|468415781|FG002|Overall Study|Study terminated by sponsor|194|||
130124031|NCT03629249|468415779|FG000|Overall Study|Protocol deviation|0|||
130124032|NCT03629249|468415780|FG001|Overall Study|Protocol deviation|2|||
130124033|NCT03629249|468415781|FG002|Overall Study|Protocol deviation|5|||
130124034|NCT03629249|468415779|FG000|Overall Study|Subject decision|1|||
130124035|NCT03629249|468415780|FG001|Overall Study|Subject decision|1|||
130124036|NCT03629249|468415781|FG002|Overall Study|Subject decision|3|||
130124037|NCT03629249|468415779|FG000|Overall Study|Adverse Event|1|||
130124038|NCT03629249|468415780|FG001|Overall Study|Adverse Event|1|||
130124039|NCT03629249|468415781|FG002|Overall Study|Adverse Event|0|||
130124040|NCT03629249|468415779|FG000|Overall Study|Death|1|||
130124041|NCT03629249|468415780|FG001|Overall Study|Death|0|||
130124042|NCT03629249|468415781|FG002|Overall Study|Death|0|||
130124043|NCT03629249|468415779|FG000|Overall Study|Physician Decision|1|||
130124044|NCT03629249|468415780|FG001|Overall Study|Physician Decision|0|||
130124045|NCT03629249|468415781|FG002|Overall Study|Physician Decision|0|||
130124046|NCT00352690|468415782|FG000|Overall Study|Determined to be ineligible|2|||
130124047|NCT00352690|468415783|FG001|Overall Study|Determined to be ineligible|0|||
130124048|NCT02719522|468415786|FG000|Overall Study|Implant Failure|4|||
130124049|NCT02719522|468415786|FG000|Overall Study|Death|2|||
130124050|NCT02719522|468415786|FG000|Overall Study|Lost to Follow-up|5|||
130124051|NCT02097290|468415789|FG000|Overall Study|Death|6|||
130124052|NCT02097290|468415789|FG000|Overall Study|Total Withdrawals|3|||
130124053|NCT02097290|468415789|FG000|Overall Study|Attempt|8|||
130124054|NCT05277389|468415790|FG000|Overall Study|Lost to Follow-up|1|||
130124055|NCT05277389|468415791|FG001|Overall Study|Lost to Follow-up|4|||
130124056|NCT06096168|468415792|FG000|Overall Study|Death|30|||
130124057|NCT06096168|468415792|FG000|Overall Study|Revision|2|||
130124058|NCT01478620|468415793|FG000|Overall Study|Lost to Follow-up|6|||
130124059|NCT02888171|468415796|FG000|Overall Study|Lost to Follow-up|2|||
130124060|NCT02888171|468415797|FG001|Overall Study|Lost to Follow-up|1|||
130124061|NCT02888171|468415796|FG000|Overall Study|Withdrawal by Subject|3|||
130124062|NCT02888171|468415797|FG001|Overall Study|Withdrawal by Subject|2|||
130124063|NCT02888171|468415796|FG000|Overall Study|Adverse Event|0|||
130124064|NCT02888171|468415797|FG001|Overall Study|Adverse Event|1|||
130124065|NCT01411332|468415798|FG000|Enrollment|Protocol Violation|0|||
130124066|NCT01411332|468415799|FG001|Enrollment|Protocol Violation|1|||
130124067|NCT01411332|468415798|FG000|Enrollment|Withdrawal by Subject|0|||
130124068|NCT01411332|468415799|FG001|Enrollment|Withdrawal by Subject|1|||
130124069|NCT01411332|468415798|FG000|Treatment|Lost to Follow-up|1|||
130124070|NCT01411332|468415799|FG001|Treatment|Lost to Follow-up|0|||
130124071|NCT03805438|468417111|FG000|Overall Study|Lack of Efficacy|1|||
130124072|NCT03805438|468417111|FG000|Overall Study|Protocol Violation|1|||
130124073|NCT00366899|468417112|FG000|Infant Series|Withdrawal by Subject|4|||
130124074|NCT00366899|468417113|FG001|Infant Series|Withdrawal by Subject|7|||
130124075|NCT00366899|468417112|FG000|Infant Series|Protocol Violation|2|||
130124076|NCT00366899|468417113|FG001|Infant Series|Protocol Violation|1|||
130124077|NCT00366899|468417112|FG000|Infant Series|Failed to return|1|||
130124078|NCT00366899|468417113|FG001|Infant Series|Failed to return|1|||
130124079|NCT00366899|468417112|FG000|Infant Series|Lost to Follow-up|0|||
130124080|NCT00366899|468417113|FG001|Infant Series|Lost to Follow-up|2|||
130124081|NCT00366899|468417112|FG000|Infant Series|Adverse Event|0|||
130124082|NCT00366899|468417113|FG001|Infant Series|Adverse Event|1|||
130124083|NCT00366899|468417112|FG000|Infant Series|Physician Decision|1|||
130124084|NCT00366899|468417113|FG001|Infant Series|Physician Decision|0|||
130124085|NCT00366899|468417112|FG000|Infant Series|Randomized but not consented|1|||
130124086|NCT00366899|468417113|FG001|Infant Series|Randomized but not consented|0|||
130124087|NCT00366899|468417112|FG000|After Infant Series|Lost to Follow-up|4|||
130124088|NCT00366899|468417113|FG001|After Infant Series|Lost to Follow-up|3|||
130124089|NCT00366899|468417112|FG000|After Infant Series|Withdrawal by Subject|1|||
130124090|NCT00366899|468417113|FG001|After Infant Series|Withdrawal by Subject|4|||
130124091|NCT00366899|468417112|FG000|After Infant Series|Adverse Event|1|||
130124092|NCT00366899|468417113|FG001|After Infant Series|Adverse Event|2|||
130124093|NCT00366899|468417112|FG000|After Infant Series|Protocol Violation|1|||
130124094|NCT00366899|468417113|FG001|After Infant Series|Protocol Violation|0|||
130124095|NCT00366899|468417112|FG000|Toddler Dose|Withdrawal by Subject|1|||
130124096|NCT00366899|468417113|FG001|Toddler Dose|Withdrawal by Subject|1|||
129967702|NCT00943787|467847080|FG000|Overall Study|Physician Decision|4|||
130124097|NCT00366899|468417112|FG000|Toddler Dose|Protocol Violation|1|||
130124098|NCT00366899|468417113|FG001|Toddler Dose|Protocol Violation|0|||
130124099|NCT01619800|468417114|FG000|Overall Study|study terminated|2|||
130124100|NCT01619800|468417115|FG001|Overall Study|study terminated|0|||
130124101|NCT00419770|468417117|FG000|Overall Study|Withdrawal by Subject|5|||
130124102|NCT00419770|468417118|FG001|Overall Study|Withdrawal by Subject|1|||
130124103|NCT02848326|468417119|FG000|Treatment Period|Adverse Event|5|||
130124104|NCT02848326|468417120|FG001|Treatment Period|Adverse Event|4|||
130124105|NCT02848326|468417121|FG002|Treatment Period|Adverse Event|11|||
130124106|NCT02848326|468417122|FG003|Treatment Period|Adverse Event|6|||
130124107|NCT02848326|468417123|FG004|Treatment Period|Adverse Event|5|||
130124108|NCT02848326|468417124|FG005|Treatment Period|Adverse Event|7|||
130124109|NCT02848326|468417119|FG000|Treatment Period|Withdrawal of Consent|20|||
130124110|NCT02848326|468417120|FG001|Treatment Period|Withdrawal of Consent|6|||
130124111|NCT02848326|468417121|FG002|Treatment Period|Withdrawal of Consent|9|||
130124112|NCT02848326|468417122|FG003|Treatment Period|Withdrawal of Consent|6|||
130124113|NCT02848326|468417123|FG004|Treatment Period|Withdrawal of Consent|9|||
130124114|NCT02848326|468417124|FG005|Treatment Period|Withdrawal of Consent|6|||
130124115|NCT02848326|468417119|FG000|Treatment Period|Lost to Follow-up|5|||
130124116|NCT02848326|468417120|FG001|Treatment Period|Lost to Follow-up|1|||
130124117|NCT02848326|468417121|FG002|Treatment Period|Lost to Follow-up|11|||
130124118|NCT02848326|468417122|FG003|Treatment Period|Lost to Follow-up|7|||
130124119|NCT02848326|468417123|FG004|Treatment Period|Lost to Follow-up|2|||
130124120|NCT02848326|468417124|FG005|Treatment Period|Lost to Follow-up|3|||
130124121|NCT02848326|468417119|FG000|Treatment Period|Pregnancy|0|||
130124122|NCT02848326|468417120|FG001|Treatment Period|Pregnancy|0|||
130124123|NCT02848326|468417121|FG002|Treatment Period|Pregnancy|1|||
130124124|NCT02848326|468417122|FG003|Treatment Period|Pregnancy|1|||
130124125|NCT02848326|468417123|FG004|Treatment Period|Pregnancy|0|||
130124126|NCT02848326|468417124|FG005|Treatment Period|Pregnancy|1|||
130124127|NCT02848326|468417119|FG000|Treatment Period|Protocol Violation|4|||
130124128|NCT02848326|468417120|FG001|Treatment Period|Protocol Violation|3|||
130124129|NCT02848326|468417121|FG002|Treatment Period|Protocol Violation|4|||
130124130|NCT02848326|468417122|FG003|Treatment Period|Protocol Violation|2|||
130124131|NCT02848326|468417123|FG004|Treatment Period|Protocol Violation|3|||
130124132|NCT02848326|468417124|FG005|Treatment Period|Protocol Violation|3|||
130124133|NCT02848326|468417119|FG000|Treatment Period|Non-compliance with Study Drug|4|||
130124134|NCT02848326|468417120|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130124135|NCT02848326|468417121|FG002|Treatment Period|Non-compliance with Study Drug|0|||
130124136|NCT02848326|468417122|FG003|Treatment Period|Non-compliance with Study Drug|1|||
130124137|NCT02848326|468417123|FG004|Treatment Period|Non-compliance with Study Drug|0|||
130124138|NCT02848326|468417124|FG005|Treatment Period|Non-compliance with Study Drug|0|||
130124139|NCT02848326|468417119|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
130124140|NCT02848326|468417120|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
130124141|NCT02848326|468417121|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
130124142|NCT02848326|468417122|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
130124143|NCT02848326|468417123|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
130124144|NCT02848326|468417124|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
130124145|NCT02848326|468417119|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
130124146|NCT02848326|468417120|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
130124147|NCT02848326|468417121|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
130124148|NCT02848326|468417122|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
130124149|NCT02848326|468417123|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
130124150|NCT02848326|468417124|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
130124151|NCT00414466|468417131|FG000|Overall Study|Adverse Event|0|||
130124152|NCT00414466|468417132|FG001|Overall Study|Adverse Event|0|||
130124153|NCT00414466|468417133|FG002|Overall Study|Adverse Event|1|||
130124154|NCT00414466|468417134|FG003|Overall Study|Adverse Event|1|||
130124155|NCT00414466|468417131|FG000|Overall Study|Lack of Efficacy|1|||
130124156|NCT00414466|468417132|FG001|Overall Study|Lack of Efficacy|0|||
130124157|NCT00414466|468417133|FG002|Overall Study|Lack of Efficacy|0|||
130124158|NCT00414466|468417134|FG003|Overall Study|Lack of Efficacy|0|||
130124159|NCT00414466|468417131|FG000|Overall Study|Withdrawn by Sponsor|1|||
130124160|NCT00414466|468417132|FG001|Overall Study|Withdrawn by Sponsor|0|||
130124161|NCT00414466|468417133|FG002|Overall Study|Withdrawn by Sponsor|0|||
130124162|NCT00414466|468417134|FG003|Overall Study|Withdrawn by Sponsor|0|||
130124163|NCT04526210|468417135|FG000|Overall Study|Sponsor decision|7|||
130124164|NCT04526210|468417136|FG001|Overall Study|Sponsor decision|5|||
130124165|NCT04526210|468417135|FG000|Overall Study|Withdrawal by Subject|3|||
130124166|NCT04526210|468417136|FG001|Overall Study|Withdrawal by Subject|2|||
130124167|NCT02637232|468417137|FG000|Overall Study|Lost to Follow-up|42|||
130124168|NCT02637232|468417137|FG000|Overall Study|Adverse Event|11|||
130124169|NCT02637232|468417137|FG000|Overall Study|patient 's decision|2|||
130124170|NCT01781637|468417138|FG000|Overall Study|Adverse Event|1|||
130124171|NCT01781637|468417139|FG001|Overall Study|Adverse Event|0|||
130124172|NCT01781637|468417138|FG000|Overall Study|Lack of Efficacy|2|||
130124173|NCT01781637|468417139|FG001|Overall Study|Lack of Efficacy|6|||
130124174|NCT01781637|468417138|FG000|Overall Study|Withdrawal by Subject|1|||
130124175|NCT01781637|468417139|FG001|Overall Study|Withdrawal by Subject|0|||
130124176|NCT02999178|468417140|FG000|Overall Study|Adverse Event|85|||
130124177|NCT02999178|468417141|FG001|Overall Study|Adverse Event|62|||
130124178|NCT02999178|468417140|FG000|Overall Study|Protocol Violation|1|||
130124179|NCT02999178|468417141|FG001|Overall Study|Protocol Violation|2|||
130124180|NCT02999178|468417140|FG000|Overall Study|Lost to Follow-up|0|||
130124181|NCT02999178|468417141|FG001|Overall Study|Lost to Follow-up|2|||
130124182|NCT02999178|468417140|FG000|Overall Study|Withdrawal by Subject|21|||
130124183|NCT02999178|468417141|FG001|Overall Study|Withdrawal by Subject|21|||
130124184|NCT02999178|468417140|FG000|Overall Study|Other reason not defined above|7|||
130124185|NCT02999178|468417141|FG001|Overall Study|Other reason not defined above|13|||
130124186|NCT00090857|468417142|FG000|Overall Study|Lost to Follow-up|0|||
130124187|NCT00090857|468417143|FG001|Overall Study|Lost to Follow-up|1|||
130124188|NCT00090857|468417142|FG000|Overall Study|Withdrawal by Subject|2|||
130124189|NCT00090857|468417143|FG001|Overall Study|Withdrawal by Subject|0|||
130124190|NCT00090857|468417142|FG000|Overall Study|Adverse Event|2|||
130124191|NCT00090857|468417143|FG001|Overall Study|Adverse Event|2|||
130124192|NCT05097326|468417145|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
130124193|NCT05097326|468417146|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
130124194|NCT02684344|468417148|FG000|Overall Study|Withdrawal by Subject|0|||
130124195|NCT02684344|468417149|FG001|Overall Study|Withdrawal by Subject|1|||
130124196|NCT03480425|468417150|FG000|Overall Study|Force transducer technical failure|1|||
130124197|NCT02424188|468417152|FG000|Overall Study|Death|2|||
130124198|NCT02424188|468417153|FG001|Overall Study|Death|2|||
130124199|NCT02424188|468417152|FG000|Overall Study|Lost to Follow-up|1|||
130124200|NCT02424188|468417153|FG001|Overall Study|Lost to Follow-up|3|||
130124201|NCT02424188|468417152|FG000|Overall Study|Incarceration|1|||
130124202|NCT02424188|468417153|FG001|Overall Study|Incarceration|0|||
130124203|NCT01085045|468417154|FG000|Part A|Withdrawal by Subject|4|||
130124204|NCT01085045|468417154|FG000|Part A|Adverse Event|6|||
130124205|NCT01085045|468417154|FG000|Part A|Protocol Violation|1|||
130124206|NCT01085045|468417154|FG000|Part A|Protocol Specified Criteria|7|||
130124207|NCT01085045|468417154|FG000|Part B|Withdrawal by Subject|2|||
130124208|NCT01085045|468417154|FG000|Part B|Protocol Specified Criteria|6|||
130124209|NCT01085045|468417154|FG000|Part B|Lost to Follow-up|1|||
130124210|NCT01085045|468417154|FG000|Part B|Adverse Event|6|||
130124211|NCT00416520|468417160|FG000|Open-label Period|Adverse Event|28|||
130124212|NCT00416520|468417161|FG001|Open-label Period|Adverse Event|10|||
130124213|NCT00416520|468417162|FG002|Open-label Period|Adverse Event|0|||
130124214|NCT00416520|468417163|FG003|Open-label Period|Adverse Event|0|||
130124215|NCT00416520|468417160|FG000|Open-label Period|Death|2|||
130124216|NCT00416520|468417161|FG001|Open-label Period|Death|1|||
130124217|NCT00416520|468417162|FG002|Open-label Period|Death|0|||
130124218|NCT00416520|468417163|FG003|Open-label Period|Death|0|||
130124219|NCT00416520|468417160|FG000|Open-label Period|Lack of Efficacy|8|||
130124220|NCT00416520|468417161|FG001|Open-label Period|Lack of Efficacy|1|||
130124221|NCT00416520|468417162|FG002|Open-label Period|Lack of Efficacy|0|||
130124222|NCT00416520|468417163|FG003|Open-label Period|Lack of Efficacy|0|||
130124223|NCT00416520|468417160|FG000|Open-label Period|Protocol Violation|3|||
130124224|NCT00416520|468417161|FG001|Open-label Period|Protocol Violation|3|||
130124225|NCT00416520|468417162|FG002|Open-label Period|Protocol Violation|0|||
130124226|NCT00416520|468417163|FG003|Open-label Period|Protocol Violation|0|||
130124227|NCT00416520|468417160|FG000|Open-label Period|Withdrawal by Subject|16|||
130124228|NCT00416520|468417161|FG001|Open-label Period|Withdrawal by Subject|5|||
130124229|NCT00416520|468417162|FG002|Open-label Period|Withdrawal by Subject|0|||
130124230|NCT00416520|468417163|FG003|Open-label Period|Withdrawal by Subject|0|||
130124231|NCT00416520|468417160|FG000|Open-label Period|Other Reasons|3|||
130124232|NCT00416520|468417161|FG001|Open-label Period|Other Reasons|12|||
130124233|NCT00416520|468417162|FG002|Open-label Period|Other Reasons|0|||
130124234|NCT00416520|468417163|FG003|Open-label Period|Other Reasons|0|||
130124235|NCT00416520|468417160|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130124236|NCT00416520|468417161|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130124237|NCT00416520|468417162|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
130124238|NCT00416520|468417163|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
130124239|NCT00416520|468417160|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130124240|NCT00416520|468417161|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130124241|NCT00416520|468417162|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
130124242|NCT00416520|468417163|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
130124243|NCT00416520|468417160|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
130124244|NCT00416520|468417161|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
130124245|NCT00416520|468417162|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
130124246|NCT00416520|468417163|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
130124247|NCT01703832|468417164|FG000|Overall Study|Withdrawal by Subject|1|||
130124248|NCT01703832|468417165|FG001|Overall Study|Withdrawal by Subject|0|||
130124249|NCT01991470|468417166|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
130124250|NCT01991470|468417166|FG000|Enlite 1 Period|Adverse Event|1|||
130124251|NCT01991470|468417166|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
130124252|NCT01991470|468417166|FG000|Enlite 3 Period|Lost to Follow-up|1|||
130124253|NCT01991470|468417166|FG000|Enlite 3 Period|Physician Decision|2|||
130124254|NCT01991470|468417166|FG000|Enlite 3 Period|Physician Decision|8|||
130124255|NCT01991470|468417166|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
130124256|NCT00243932|468417167|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
130124257|NCT00243932|468417168|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
130124258|NCT00243932|468417169|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
130124259|NCT02143102|468417172|FG000|Overall Study|Lost to Follow-up|11|||
130124260|NCT02143102|468417173|FG001|Overall Study|Lost to Follow-up|0|||
130124261|NCT01203878|468417174|FG000|Overall Study|Withdrawal by Subject|0|||
130124262|NCT01203878|468417175|FG001|Overall Study|Withdrawal by Subject|0|||
130124263|NCT01203878|468417176|FG002|Overall Study|Withdrawal by Subject|1|||
130124264|NCT01203878|468417174|FG000|Overall Study|Adverse Event|0|||
130124265|NCT01203878|468417175|FG001|Overall Study|Adverse Event|0|||
130124266|NCT01203878|468417176|FG002|Overall Study|Adverse Event|2|||
130124267|NCT01273181|468417177|FG000|Phase I, Dose 1|Study termination|1|||
130124268|NCT01273181|468417178|FG001|Phase I, Dose 1|Study termination|0|||
130124269|NCT01273181|468417179|FG002|Phase I, Dose 1|Study termination|0|||
130124270|NCT01273181|468417180|FG003|Phase I, Dose 1|Study termination|0|||
130124271|NCT01273181|468417177|FG000|Phase I, Dose 2|Death during treatment|0|||
130124272|NCT01273181|468417178|FG001|Phase I, Dose 2|Death during treatment|1|||
130124273|NCT01273181|468417179|FG002|Phase I, Dose 2|Death during treatment|0|||
130124274|NCT01273181|468417180|FG003|Phase I, Dose 2|Death during treatment|0|||
130124275|NCT01273181|468417177|FG000|Phase 2, Dose 1|Study termination|0|||
130124276|NCT01273181|468417178|FG001|Phase 2, Dose 1|Study termination|0|||
130124277|NCT01273181|468417179|FG002|Phase 2, Dose 1|Study termination|1|||
130124278|NCT01273181|468417180|FG003|Phase 2, Dose 1|Study termination|0|||
130124279|NCT01273181|468417177|FG000|Phase 2, Dose 2|Death during treatment|0|||
130124280|NCT01273181|468417178|FG001|Phase 2, Dose 2|Death during treatment|0|||
130124281|NCT01273181|468417179|FG002|Phase 2, Dose 2|Death during treatment|0|||
130124282|NCT01273181|468417180|FG003|Phase 2, Dose 2|Death during treatment|1|||
130124283|NCT03657160|468417181|FG000|Overall Study|Adverse Event|5|||
130124284|NCT03657160|468417182|FG001|Overall Study|Adverse Event|6|||
130124285|NCT03657160|468417181|FG000|Overall Study|Protocol Deviation|3|||
130124286|NCT03657160|468417182|FG001|Overall Study|Protocol Deviation|0|||
130124287|NCT03657160|468417181|FG000|Overall Study|Withdrawal by Subject|18|||
130124288|NCT03657160|468417182|FG001|Overall Study|Withdrawal by Subject|16|||
130124289|NCT03657160|468417181|FG000|Overall Study|Site Termination|1|||
130124290|NCT03657160|468417182|FG001|Overall Study|Site Termination|0|||
130124291|NCT03657160|468417181|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
130124292|NCT03657160|468417182|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
130124293|NCT03657160|468417181|FG000|Overall Study|Death|33|||
130124294|NCT03657160|468417182|FG001|Overall Study|Death|26|||
130124295|NCT03657160|468417181|FG000|Overall Study|Death (COVID-19-Related)|1|||
130124296|NCT03657160|468417182|FG001|Overall Study|Death (COVID-19-Related)|0|||
130124297|NCT03657160|468417181|FG000|Overall Study|Reason Not Specified|5|||
130124298|NCT03657160|468417182|FG001|Overall Study|Reason Not Specified|5|||
130124299|NCT03657160|468417181|FG000|Overall Study|Other (COVID-19-Related)|0|||
130124300|NCT03657160|468417182|FG001|Overall Study|Other (COVID-19-Related)|1|||
130124301|NCT04638153|468417183|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130124302|NCT04638153|468417184|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130124303|NCT04638153|468417185|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130124304|NCT04638153|468417183|FG000|Overall Study|Study terminated by sponsor|4|||
130124305|NCT04638153|468417184|FG001|Overall Study|Study terminated by sponsor|2|||
130124306|NCT04638153|468417185|FG002|Overall Study|Study terminated by sponsor|14|||
130124307|NCT04006171|468417188|FG000|Overall Study|Withdrawal by Subject|8|||
130124308|NCT04006171|468417189|FG001|Overall Study|Withdrawal by Subject|7|||
130124309|NCT04006171|468417188|FG000|Overall Study|missing serum samples|2|||
130124310|NCT04006171|468417189|FG001|Overall Study|missing serum samples|2|||
130124311|NCT04006171|468417188|FG000|Overall Study|insufficient sample volume|2|||
130124312|NCT04006171|468417189|FG001|Overall Study|insufficient sample volume|3|||
129967703|NCT00943787|467847080|FG000|Overall Study|Withdrawal by Subject|3|||
130124313|NCT00440557|468417191|FG000|Overall Study|Withdrawal by Subject|10|||
130124314|NCT00440557|468417192|FG001|Overall Study|Withdrawal by Subject|5|||
130124315|NCT00440557|468417193|FG002|Overall Study|Withdrawal by Subject|11|||
130124316|NCT00440557|468417191|FG000|Overall Study|Lost to Follow-up|1|||
129967704|NCT02706951|467847082|FG000|Period 1|Adverse Event|1|||
130124317|NCT00440557|468417192|FG001|Overall Study|Lost to Follow-up|2|||
130124318|NCT00440557|468417193|FG002|Overall Study|Lost to Follow-up|6|||
130124319|NCT00440557|468417191|FG000|Overall Study|Adverse Event|3|||
130124320|NCT00440557|468417192|FG001|Overall Study|Adverse Event|3|||
130124321|NCT00440557|468417193|FG002|Overall Study|Adverse Event|5|||
130124322|NCT00440557|468417191|FG000|Overall Study|Death|2|||
130124323|NCT00440557|468417192|FG001|Overall Study|Death|6|||
130124324|NCT00440557|468417193|FG002|Overall Study|Death|3|||
130124325|NCT00440557|468417191|FG000|Overall Study|Began Dialysis|4|||
129967705|NCT02706951|467847083|FG001|Period 1|Adverse Event|5|||
129967706|NCT02706951|467847084|FG002|Period 1|Adverse Event|3|||
130124326|NCT00440557|468417192|FG001|Overall Study|Began Dialysis|1|||
130124327|NCT00440557|468417193|FG002|Overall Study|Began Dialysis|4|||
130124328|NCT00440557|468417191|FG000|Overall Study|Principal Investigator decision|0|||
130124329|NCT00440557|468417192|FG001|Overall Study|Principal Investigator decision|3|||
130124330|NCT00440557|468417193|FG002|Overall Study|Principal Investigator decision|1|||
130124331|NCT00440557|468417191|FG000|Overall Study|Patient moved|1|||
130124332|NCT00440557|468417192|FG001|Overall Study|Patient moved|2|||
130124333|NCT00440557|468417193|FG002|Overall Study|Patient moved|1|||
130124334|NCT00440557|468417191|FG000|Overall Study|Principal Investigator's office closed|3|||
130124335|NCT00440557|468417192|FG001|Overall Study|Principal Investigator's office closed|6|||
130124336|NCT00440557|468417193|FG002|Overall Study|Principal Investigator's office closed|4|||
130124337|NCT00440557|468417191|FG000|Overall Study|Patient transferred to nursing home|0|||
130124338|NCT00440557|468417192|FG001|Overall Study|Patient transferred to nursing home|1|||
130124339|NCT00440557|468417193|FG002|Overall Study|Patient transferred to nursing home|0|||
130124340|NCT00440557|468417191|FG000|Overall Study|Patient had surgery|1|||
130124341|NCT00440557|468417192|FG001|Overall Study|Patient had surgery|0|||
130124342|NCT00440557|468417193|FG002|Overall Study|Patient had surgery|0|||
130124343|NCT00874237|468417198|FG000|Overall Study|Physician Decision|0|||
130124344|NCT00874237|468417199|FG001|Overall Study|Physician Decision|1|||
130124345|NCT00874237|468417200|FG002|Overall Study|Physician Decision|0|||
130124346|NCT00874237|468417201|FG003|Overall Study|Physician Decision|0|||
130124347|NCT00874237|468417202|FG004|Overall Study|Physician Decision|0|||
130124348|NCT00874237|468417203|FG005|Overall Study|Physician Decision|0|||
130124349|NCT00874237|468417198|FG000|Overall Study|Withdrawal by Subject|0|||
130124350|NCT00874237|468417199|FG001|Overall Study|Withdrawal by Subject|0|||
130124351|NCT00874237|468417200|FG002|Overall Study|Withdrawal by Subject|1|||
130124352|NCT00874237|468417201|FG003|Overall Study|Withdrawal by Subject|0|||
130124353|NCT00874237|468417202|FG004|Overall Study|Withdrawal by Subject|0|||
130124354|NCT00874237|468417203|FG005|Overall Study|Withdrawal by Subject|0|||
130124355|NCT03912337|468417204|FG000|Overall Study|Withdrawal of Consent From Study|1|||
130124356|NCT03912337|468417205|FG001|Overall Study|Withdrawal of Consent From Study|0|||
130124357|NCT03912337|468417204|FG000|Overall Study|Lost to Follow-up|1|||
130124358|NCT03912337|468417205|FG001|Overall Study|Lost to Follow-up|1|||
130124359|NCT03752528|468417206|FG000|Part A|Lost to Follow-up|1|||
130124360|NCT03752528|468417206|FG000|Part A|Protocol Violation|1|||
130124361|NCT03752528|468417206|FG000|Part B|Protocol Violation|1|||
130124362|NCT03752528|468417206|FG000|Part B|Study terminated by sponsor|3|||
130124363|NCT00537030|468417207|FG000|Overall Study|Physician Decision|2|||
130124364|NCT00537030|468417207|FG000|Overall Study|Withdrawal by Subject|2|||
130124365|NCT00537030|468417207|FG000|Overall Study|≥ Grade 2 allergy|7|||
130124366|NCT00537030|468417207|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
130124367|NCT00537030|468417207|FG000|Overall Study|Ineligible|2|||
130124368|NCT00537030|468417207|FG000|Overall Study|Inevaluable|2|||
130124369|NCT02458469|468417208|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130124370|NCT02458469|468417209|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130124371|NCT02458469|468417210|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
130124372|NCT02458469|468417211|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130124373|NCT02458469|468417212|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130124374|NCT02458469|468417213|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
130124375|NCT02458469|468417208|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
130124376|NCT02458469|468417209|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
130124377|NCT02458469|468417210|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
130124378|NCT02458469|468417211|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
130124379|NCT02458469|468417212|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
130124380|NCT02458469|468417213|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
130124381|NCT02458469|468417208|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130124382|NCT02458469|468417209|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130124383|NCT02458469|468417210|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130124384|NCT02458469|468417211|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130124385|NCT02458469|468417212|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
130124386|NCT02458469|468417213|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
130124387|NCT03561883|468417214|FG000|Overall Study|Adverse Event|10|||
130124388|NCT03561883|468417215|FG001|Overall Study|Adverse Event|13|||
130124389|NCT03561883|468417214|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130124390|NCT03561883|468417215|FG001|Overall Study|Non-Compliance With Study Drug|2|||
130124391|NCT03561883|468417214|FG000|Overall Study|Protocol Violation|2|||
130124392|NCT03561883|468417215|FG001|Overall Study|Protocol Violation|3|||
130124393|NCT03561883|468417214|FG000|Overall Study|Withdrawal by Subject|14|||
130124394|NCT03561883|468417215|FG001|Overall Study|Withdrawal by Subject|6|||
130124395|NCT03561883|468417214|FG000|Overall Study|Lost to Follow-up|2|||
130124396|NCT03561883|468417215|FG001|Overall Study|Lost to Follow-up|6|||
130124397|NCT03561883|468417214|FG000|Overall Study|Study Terminated by Sponsor|12|||
130124398|NCT03561883|468417215|FG001|Overall Study|Study Terminated by Sponsor|11|||
130124399|NCT03561883|468417214|FG000|Overall Study|Physician Decision|1|||
130124400|NCT03561883|468417215|FG001|Overall Study|Physician Decision|0|||
130124401|NCT03561883|468417214|FG000|Overall Study|Randomized by Mistake|1|||
130124402|NCT03561883|468417215|FG001|Overall Study|Randomized by Mistake|0|||
130124403|NCT03561883|468417214|FG000|Overall Study|Other, Not Specified|3|||
130124404|NCT03561883|468417215|FG001|Overall Study|Other, Not Specified|2|||
130124405|NCT06354270|468417216|FG000|Overall Study|Withdrawal by Subject|1|||
130124406|NCT06354270|468417217|FG001|Overall Study|Withdrawal by Subject|0|||
130124407|NCT01939197|468417218|FG000|Overall Study|Withdrawal by Subject|1|||
130124408|NCT01939197|468417219|FG001|Overall Study|Withdrawal by Subject|0|||
130124409|NCT01939197|468417220|FG002|Overall Study|Withdrawal by Subject|0|||
130124410|NCT01939197|468417221|FG003|Overall Study|Withdrawal by Subject|0|||
130124411|NCT01939197|468417222|FG004|Overall Study|Withdrawal by Subject|1|||
130124412|NCT01939197|468417223|FG005|Overall Study|Withdrawal by Subject|0|||
130124413|NCT01939197|468417224|FG006|Overall Study|Withdrawal by Subject|0|||
130124414|NCT01939197|468417218|FG000|Overall Study|Lost to Follow-up|0|||
130124415|NCT01939197|468417219|FG001|Overall Study|Lost to Follow-up|1|||
130124416|NCT01939197|468417220|FG002|Overall Study|Lost to Follow-up|0|||
130124417|NCT01939197|468417221|FG003|Overall Study|Lost to Follow-up|1|||
130124418|NCT01939197|468417222|FG004|Overall Study|Lost to Follow-up|3|||
130124419|NCT01939197|468417223|FG005|Overall Study|Lost to Follow-up|1|||
130124420|NCT01939197|468417224|FG006|Overall Study|Lost to Follow-up|2|||
130124421|NCT00745095|468417225|FG000|Overall Study|Declined to participate|1|||
130124422|NCT00745095|468417226|FG001|Overall Study|Declined to participate|0|||
130124423|NCT00745095|468417227|FG002|Overall Study|Declined to participate|0|||
130124424|NCT00745095|468417228|FG003|Overall Study|Declined to participate|0|||
130124425|NCT00745095|468417229|FG004|Overall Study|Declined to participate|92|||
130124426|NCT00745095|468417230|FG005|Overall Study|Declined to participate|95|||
130124427|NCT00745095|468417225|FG000|Overall Study|Ineligible due to GFR criteria|0|||
130124428|NCT00745095|468417226|FG001|Overall Study|Ineligible due to GFR criteria|2|||
130124429|NCT00745095|468417227|FG002|Overall Study|Ineligible due to GFR criteria|3|||
130124430|NCT00745095|468417228|FG003|Overall Study|Ineligible due to GFR criteria|3|||
130124431|NCT00745095|468417229|FG004|Overall Study|Ineligible due to GFR criteria|30|||
130124432|NCT00745095|468417230|FG005|Overall Study|Ineligible due to GFR criteria|28|||
130124433|NCT00958243|468417231|FG000|Overall Study|Withdrawal by Subject|0|||
130124434|NCT00958243|468417232|FG001|Overall Study|Withdrawal by Subject|1|||
130124435|NCT00958243|468417233|FG002|Overall Study|Withdrawal by Subject|3|||
130124436|NCT00958243|468417234|FG003|Overall Study|Withdrawal by Subject|1|||
130124437|NCT00958243|468417235|FG004|Overall Study|Withdrawal by Subject|1|||
130124438|NCT00958243|468417236|FG005|Overall Study|Withdrawal by Subject|5|||
130124439|NCT00958243|468417231|FG000|Overall Study|Lost to Follow-up|2|||
130124440|NCT00958243|468417232|FG001|Overall Study|Lost to Follow-up|5|||
130124441|NCT00958243|468417233|FG002|Overall Study|Lost to Follow-up|11|||
130124442|NCT00958243|468417234|FG003|Overall Study|Lost to Follow-up|2|||
130124443|NCT00958243|468417235|FG004|Overall Study|Lost to Follow-up|8|||
130124444|NCT00958243|468417236|FG005|Overall Study|Lost to Follow-up|5|||
130124445|NCT03544138|468417247|FG000|Overall Study|Lost to Follow-up|29|||
130124446|NCT01766778|468417248|FG000|Overall Study|Adverse Event|4|||
130124447|NCT01766778|468417249|FG001|Overall Study|Adverse Event|4|||
130124448|NCT01766778|468417248|FG000|Overall Study|Withdrawal by Subject|1|||
130124449|NCT01766778|468417249|FG001|Overall Study|Withdrawal by Subject|0|||
130154867|NCT00958126|468526622|FG001|Overall Study|Sponsor/Investigator decision|0|||
130154868|NCT00958126|468526623|FG002|Overall Study|Sponsor/Investigator decision|0|||
130154869|NCT00958126|468526624|FG003|Overall Study|Sponsor/Investigator decision|1|||
130154870|NCT00958126|468526625|FG004|Overall Study|Sponsor/Investigator decision|0|||
130154871|NCT00958126|468526626|FG005|Overall Study|Sponsor/Investigator decision|0|||
130154872|NCT00958126|468526627|FG006|Overall Study|Sponsor/Investigator decision|0|||
130154873|NCT00958126|468526628|FG007|Overall Study|Sponsor/Investigator decision|0|||
130154874|NCT00958126|468526621|FG000|Overall Study|Other Reason|0|||
130154875|NCT00958126|468526622|FG001|Overall Study|Other Reason|0|||
130154876|NCT00958126|468526623|FG002|Overall Study|Other Reason|0|||
130154877|NCT00958126|468526624|FG003|Overall Study|Other Reason|1|||
130154878|NCT00958126|468526625|FG004|Overall Study|Other Reason|0|||
130154879|NCT00958126|468526626|FG005|Overall Study|Other Reason|1|||
130154880|NCT00958126|468526627|FG006|Overall Study|Other Reason|0|||
130154881|NCT00958126|468526628|FG007|Overall Study|Other Reason|0|||
130154882|NCT03401073|468526629|FG000|Overall Study|Lost to Follow-up|1|||
130154883|NCT03401073|468526630|FG001|Overall Study|Lost to Follow-up|2|||
130154884|NCT00733369|468526633|FG000|Overall Study|Lost to Follow-up|2|||
130154885|NCT00733369|468526634|FG001|Overall Study|Lost to Follow-up|1|||
130154886|NCT00733369|468526633|FG000|Overall Study|Adverse Event|4|||
130154887|NCT00733369|468526634|FG001|Overall Study|Adverse Event|4|||
130154888|NCT00733369|468526633|FG000|Overall Study|Protocol Violation|4|||
130154889|NCT00733369|468526634|FG001|Overall Study|Protocol Violation|4|||
130154890|NCT01470612|468526638|FG000|Overall Study|Adverse Event|20|||
130154891|NCT01470612|468526639|FG001|Overall Study|Adverse Event|80|||
130154892|NCT01470612|468526638|FG000|Overall Study|Death|0|||
130154893|NCT01470612|468526639|FG001|Overall Study|Death|1|||
130154894|NCT01470612|468526638|FG000|Overall Study|Lack of Efficacy|20|||
130154895|NCT01470612|468526639|FG001|Overall Study|Lack of Efficacy|326|||
130154896|NCT01470612|468526638|FG000|Overall Study|Lost to Follow-up|2|||
130124450|NCT00883090|468418505|FG000|Overall Study|Sponsor's decision|1|||
130124451|NCT00883090|468418505|FG000|Overall Study|Withdrawal by Subject|1|||
130124452|NCT03831048|468418508|FG000|Overall Study|Protocol Violation|9|||
130124453|NCT03831048|468418509|FG001|Overall Study|Protocol Violation|3|||
130124454|NCT03831048|468418508|FG000|Overall Study|Death|4|||
130124455|NCT03831048|468418509|FG001|Overall Study|Death|9|||
130124456|NCT03831048|468418508|FG000|Overall Study|Re-transplant|0|||
130124457|NCT03831048|468418509|FG001|Overall Study|Re-transplant|2|||
130124458|NCT03831048|468418508|FG000|Overall Study|Protocol violation and death|1|||
130124459|NCT03831048|468418509|FG001|Overall Study|Protocol violation and death|1|||
130124460|NCT00560235|468418510|FG000|Phase 1|Discontinued|8|||
130124461|NCT00560235|468418511|FG001|Phase 1|Discontinued|0|||
130124462|NCT00560235|468418512|FG002|Phase 1|Discontinued|0|||
130124463|NCT00560235|468418510|FG000|Phase 1B|Discontinued|0|||
130124464|NCT00560235|468418511|FG001|Phase 1B|Discontinued|19|||
130124465|NCT00560235|468418512|FG002|Phase 1B|Discontinued|0|||
130124466|NCT00560235|468418510|FG000|Phase 2|Discontinued|0|||
130124467|NCT00560235|468418511|FG001|Phase 2|Discontinued|0|||
130124468|NCT00560235|468418512|FG002|Phase 2|Discontinued|96|||
130124469|NCT00560235|468418510|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
130124470|NCT00560235|468418511|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
130124471|NCT00560235|468418512|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
130124472|NCT00880568|468418514|FG000|Overall Study|Disease progression|3|||
130124473|NCT00880568|468418515|FG001|Overall Study|Disease progression|3|||
130124474|NCT00880568|468418516|FG002|Overall Study|Disease progression|3|||
130124475|NCT00880568|468418517|FG003|Overall Study|Disease progression|1|||
130124476|NCT00880568|468418518|FG004|Overall Study|Disease progression|3|||
130124477|NCT00880568|468418519|FG005|Overall Study|Disease progression|3|||
130124478|NCT00880568|468418520|FG006|Overall Study|Disease progression|5|||
130124479|NCT00880568|468418521|FG007|Overall Study|Disease progression|0|||
130124480|NCT00880568|468418522|FG008|Overall Study|Disease progression|3|||
130124481|NCT00880568|468418514|FG000|Overall Study|Adverse Event|0|||
130124482|NCT00880568|468418515|FG001|Overall Study|Adverse Event|0|||
130124483|NCT00880568|468418516|FG002|Overall Study|Adverse Event|0|||
130124484|NCT00880568|468418517|FG003|Overall Study|Adverse Event|0|||
130124485|NCT00880568|468418518|FG004|Overall Study|Adverse Event|0|||
130124486|NCT00880568|468418519|FG005|Overall Study|Adverse Event|0|||
130124487|NCT00880568|468418520|FG006|Overall Study|Adverse Event|1|||
130124488|NCT00880568|468418521|FG007|Overall Study|Adverse Event|1|||
130124489|NCT00880568|468418522|FG008|Overall Study|Adverse Event|0|||
130124490|NCT00880568|468418514|FG000|Overall Study|Withdrawal by Subject|0|||
130124491|NCT00880568|468418515|FG001|Overall Study|Withdrawal by Subject|0|||
130124492|NCT00880568|468418516|FG002|Overall Study|Withdrawal by Subject|0|||
130124493|NCT00880568|468418517|FG003|Overall Study|Withdrawal by Subject|0|||
130124494|NCT00880568|468418518|FG004|Overall Study|Withdrawal by Subject|0|||
130124495|NCT00880568|468418519|FG005|Overall Study|Withdrawal by Subject|0|||
130124496|NCT00880568|468418520|FG006|Overall Study|Withdrawal by Subject|0|||
130124497|NCT00880568|468418521|FG007|Overall Study|Withdrawal by Subject|1|||
130124498|NCT00880568|468418522|FG008|Overall Study|Withdrawal by Subject|0|||
130124499|NCT00849901|468418523|FG000|Acute Treatment Phase|Adverse Event|9|||
130124500|NCT00849901|468418524|FG001|Acute Treatment Phase|Adverse Event|1|||
130124501|NCT00849901|468418525|FG002|Acute Treatment Phase|Adverse Event|3|||
130124502|NCT00849901|468418523|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
130124503|NCT00849901|468418524|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
130124504|NCT00849901|468418525|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
130124505|NCT00849901|468418523|FG000|Acute Treatment Phase|Protocol Violation|0|||
130124506|NCT00849901|468418524|FG001|Acute Treatment Phase|Protocol Violation|2|||
130124507|NCT00849901|468418525|FG002|Acute Treatment Phase|Protocol Violation|1|||
130124508|NCT00849901|468418523|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
130124509|NCT00849901|468418524|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
130124510|NCT00849901|468418525|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
130124511|NCT00849901|468418523|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
129967707|NCT02706951|467847085|FG003|Period 1|Adverse Event|0|||
130124512|NCT00849901|468418524|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
130124513|NCT00849901|468418525|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
130124514|NCT00849901|468418523|FG000|Acute Treatment Phase|Physician Decision|1|||
130124515|NCT00849901|468418524|FG001|Acute Treatment Phase|Physician Decision|1|||
130124516|NCT00849901|468418525|FG002|Acute Treatment Phase|Physician Decision|1|||
130124517|NCT00849901|468418523|FG000|Acute Treatment Phase|Sponsor Decision|1|||
130124518|NCT00849901|468418524|FG001|Acute Treatment Phase|Sponsor Decision|0|||
130124519|NCT00849901|468418525|FG002|Acute Treatment Phase|Sponsor Decision|0|||
130124520|NCT00849901|468418523|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
130124521|NCT00849901|468418524|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
130124522|NCT00849901|468418525|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
130124523|NCT00849901|468418523|FG000|Extension Phase|Adverse Event|2|||
130124524|NCT00849901|468418524|FG001|Extension Phase|Adverse Event|8|||
130124525|NCT00849901|468418525|FG002|Extension Phase|Adverse Event|4|||
130124526|NCT00849901|468418523|FG000|Extension Phase|Lost to Follow-up|3|||
130124527|NCT00849901|468418524|FG001|Extension Phase|Lost to Follow-up|0|||
130124528|NCT00849901|468418525|FG002|Extension Phase|Lost to Follow-up|1|||
130124529|NCT00849901|468418523|FG000|Extension Phase|Protocol Violation|2|||
130124530|NCT00849901|468418524|FG001|Extension Phase|Protocol Violation|2|||
130124531|NCT00849901|468418525|FG002|Extension Phase|Protocol Violation|4|||
130124532|NCT00849901|468418523|FG000|Extension Phase|Withdrawal by Subject|7|||
130124533|NCT00849901|468418524|FG001|Extension Phase|Withdrawal by Subject|6|||
130124534|NCT00849901|468418525|FG002|Extension Phase|Withdrawal by Subject|3|||
130124535|NCT00849901|468418523|FG000|Extension Phase|Parent or Caregiver Decision|10|||
130124536|NCT00849901|468418524|FG001|Extension Phase|Parent or Caregiver Decision|4|||
130124537|NCT00849901|468418525|FG002|Extension Phase|Parent or Caregiver Decision|4|||
130124538|NCT00849901|468418523|FG000|Extension Phase|Physician Decision|1|||
130124539|NCT00849901|468418524|FG001|Extension Phase|Physician Decision|2|||
130124540|NCT00849901|468418525|FG002|Extension Phase|Physician Decision|0|||
130124541|NCT00849901|468418523|FG000|Extension Phase|Lack of Efficacy|2|||
130124542|NCT00849901|468418524|FG001|Extension Phase|Lack of Efficacy|4|||
130124543|NCT00849901|468418525|FG002|Extension Phase|Lack of Efficacy|1|||
130124544|NCT00437658|468418526|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
130124545|NCT00437658|468418527|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
130124546|NCT00437658|468418528|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
130124547|NCT00437658|468418526|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
130124548|NCT00437658|468418527|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
130124549|NCT00437658|468418528|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
130124550|NCT00437658|468418526|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
130124551|NCT00437658|468418527|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
130124552|NCT00437658|468418528|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
130124553|NCT00437658|468418526|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
130124554|NCT00437658|468418527|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
130124555|NCT00437658|468418528|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
130124556|NCT00437658|468418526|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
130124557|NCT00437658|468418527|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
130124558|NCT00437658|468418528|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
130124559|NCT00437658|468418526|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
130124560|NCT00437658|468418527|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
130124561|NCT00437658|468418528|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
130124562|NCT00437658|468418526|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
130124563|NCT00437658|468418527|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
130124564|NCT00437658|468418528|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
130124565|NCT00437658|468418526|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
130124566|NCT00437658|468418527|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
130124567|NCT00437658|468418528|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
130124568|NCT00437658|468418526|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
130124569|NCT00437658|468418527|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
130124570|NCT00437658|468418528|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
130124571|NCT00437658|468418526|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
130124572|NCT00437658|468418527|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
130124573|NCT00437658|468418528|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
130124574|NCT00437658|468418526|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
130124575|NCT00437658|468418527|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
130124576|NCT00437658|468418528|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
130124577|NCT00437658|468418526|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
130124578|NCT00437658|468418527|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
130124579|NCT00437658|468418528|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
130124580|NCT04407806|468418529|FG000|Overall Study|Withdrawal by Subject|1|||
130124581|NCT04407806|468418530|FG001|Overall Study|Withdrawal by Subject|2|||
130124582|NCT02731157|468418531|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
130124583|NCT05150964|468418534|FG000|Overall Study|Lost to Follow-up|2|||
130124584|NCT01856309|468418535|FG000|Overall Study|Death|4|||
130124585|NCT01856309|468418536|FG001|Overall Study|Death|6|||
130124586|NCT01856309|468418537|FG002|Overall Study|Death|11|||
130124587|NCT01856309|468418538|FG003|Overall Study|Death|6|||
130124588|NCT01856309|468418535|FG000|Overall Study|Lost to Follow-up|6|||
130124589|NCT01856309|468418536|FG001|Overall Study|Lost to Follow-up|2|||
130124590|NCT01856309|468418537|FG002|Overall Study|Lost to Follow-up|4|||
130124591|NCT01856309|468418538|FG003|Overall Study|Lost to Follow-up|8|||
130124592|NCT01856309|468418535|FG000|Overall Study|Withdrawal by Subject|11|||
130124593|NCT01856309|468418536|FG001|Overall Study|Withdrawal by Subject|13|||
130124594|NCT01856309|468418537|FG002|Overall Study|Withdrawal by Subject|28|||
130124595|NCT01856309|468418538|FG003|Overall Study|Withdrawal by Subject|26|||
130124596|NCT01856309|468418535|FG000|Overall Study|Other|227|||
130124597|NCT01856309|468418536|FG001|Overall Study|Other|225|||
130124598|NCT01856309|468418537|FG002|Overall Study|Other|447|||
130124599|NCT01856309|468418538|FG003|Overall Study|Other|469|||
130124600|NCT01856309|468418535|FG000|Overall Study|Lack of Efficacy|14|||
130124601|NCT01856309|468418536|FG001|Overall Study|Lack of Efficacy|9|||
130124602|NCT01856309|468418537|FG002|Overall Study|Lack of Efficacy|40|||
130124603|NCT01856309|468418538|FG003|Overall Study|Lack of Efficacy|25|||
130124604|NCT01856309|468418535|FG000|Overall Study|Adverse Event|31|||
130124605|NCT01856309|468418536|FG001|Overall Study|Adverse Event|31|||
130124606|NCT01856309|468418537|FG002|Overall Study|Adverse Event|55|||
130124607|NCT01856309|468418538|FG003|Overall Study|Adverse Event|65|||
130124608|NCT01856309|468418535|FG000|Overall Study|Pregnancy|0|||
130124609|NCT01856309|468418536|FG001|Overall Study|Pregnancy|0|||
130124610|NCT01856309|468418537|FG002|Overall Study|Pregnancy|0|||
130124611|NCT01856309|468418538|FG003|Overall Study|Pregnancy|1|||
130124612|NCT01856309|468418535|FG000|Overall Study|Physician Decision|6|||
130124613|NCT01856309|468418536|FG001|Overall Study|Physician Decision|1|||
130124614|NCT01856309|468418537|FG002|Overall Study|Physician Decision|6|||
130124615|NCT01856309|468418538|FG003|Overall Study|Physician Decision|8|||
130124616|NCT01856309|468418535|FG000|Overall Study|Noncompliance With Study Drug|0|||
130124617|NCT01856309|468418536|FG001|Overall Study|Noncompliance With Study Drug|1|||
130124618|NCT01856309|468418537|FG002|Overall Study|Noncompliance With Study Drug|4|||
130124619|NCT01856309|468418538|FG003|Overall Study|Noncompliance With Study Drug|1|||
130124620|NCT01434693|468418539|FG000|Overall Study|Adverse Event|1|||
130124621|NCT01434693|468418540|FG001|Overall Study|Adverse Event|0|||
130124622|NCT01434693|468418541|FG002|Overall Study|Adverse Event|0|||
130124623|NCT01434693|468418542|FG003|Overall Study|Adverse Event|0|||
130124624|NCT01434693|468418539|FG000|Overall Study|Withdrawal by Subject|1|||
130124625|NCT01434693|468418540|FG001|Overall Study|Withdrawal by Subject|0|||
130124626|NCT01434693|468418541|FG002|Overall Study|Withdrawal by Subject|1|||
130124627|NCT01434693|468418542|FG003|Overall Study|Withdrawal by Subject|1|||
130124628|NCT01434693|468418539|FG000|Overall Study|Lost to Follow-up|1|||
130124629|NCT01434693|468418540|FG001|Overall Study|Lost to Follow-up|0|||
130124630|NCT01434693|468418541|FG002|Overall Study|Lost to Follow-up|0|||
130124631|NCT01434693|468418542|FG003|Overall Study|Lost to Follow-up|0|||
130124632|NCT01440283|468418543|FG000|Overall Study|Death|3|||
130124633|NCT01440283|468418543|FG000|Overall Study|Withdrawal by Subject|4|||
130124634|NCT01440283|468418543|FG000|Overall Study|Physician Decision|3|||
130124635|NCT00669942|468418545|FG000|Parts 2 and 3|Adverse Event|0|||
130124636|NCT00669942|468418546|FG001|Parts 2 and 3|Adverse Event|0|||
130124637|NCT00669942|468418547|FG002|Parts 2 and 3|Adverse Event|0|||
130124638|NCT00669942|468418548|FG003|Parts 2 and 3|Adverse Event|0|||
130124639|NCT00669942|468418549|FG004|Parts 2 and 3|Adverse Event|0|||
130124640|NCT00669942|468418550|FG005|Parts 2 and 3|Adverse Event|0|||
130124641|NCT00669942|468418551|FG006|Parts 2 and 3|Adverse Event|0|||
130124642|NCT00669942|468418552|FG007|Parts 2 and 3|Adverse Event|2|||
130124643|NCT00669942|468418553|FG008|Parts 2 and 3|Adverse Event|1|||
130124644|NCT00669942|468418554|FG009|Parts 2 and 3|Adverse Event|0|||
130124645|NCT00669942|468418555|FG010|Parts 2 and 3|Adverse Event|0|||
130124646|NCT00669942|468418556|FG011|Parts 2 and 3|Adverse Event|0|||
130124647|NCT00669942|468418545|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
130124648|NCT00669942|468418546|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
130124649|NCT00669942|468418547|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
130124650|NCT00669942|468418548|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
130124651|NCT00669942|468418549|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
130124652|NCT00669942|468418550|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
130124653|NCT00669942|468418551|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
130124654|NCT00669942|468418552|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
130124655|NCT00669942|468418553|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
130124656|NCT00669942|468418554|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
130124657|NCT00669942|468418555|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
130124658|NCT00669942|468418556|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
130124659|NCT00669942|468418545|FG000|Parts 2 and 3|Protocol Violation|0|||
130124660|NCT00669942|468418546|FG001|Parts 2 and 3|Protocol Violation|0|||
130124661|NCT00669942|468418547|FG002|Parts 2 and 3|Protocol Violation|0|||
130124662|NCT00669942|468418548|FG003|Parts 2 and 3|Protocol Violation|0|||
130124663|NCT00669942|468418549|FG004|Parts 2 and 3|Protocol Violation|0|||
130124664|NCT00669942|468418550|FG005|Parts 2 and 3|Protocol Violation|1|||
130124665|NCT00669942|468418551|FG006|Parts 2 and 3|Protocol Violation|0|||
130124666|NCT00669942|468418552|FG007|Parts 2 and 3|Protocol Violation|0|||
130124667|NCT00669942|468418553|FG008|Parts 2 and 3|Protocol Violation|0|||
130124668|NCT00669942|468418554|FG009|Parts 2 and 3|Protocol Violation|0|||
130124669|NCT00669942|468418555|FG010|Parts 2 and 3|Protocol Violation|0|||
130124670|NCT00669942|468418556|FG011|Parts 2 and 3|Protocol Violation|0|||
130124671|NCT01941030|468418570|FG000|Overall Study|Death|3|||
130124672|NCT01941030|468418571|FG001|Overall Study|Death|2|||
130124673|NCT01941030|468418570|FG000|Overall Study|Lost to Follow-up|6|||
130124674|NCT01941030|468418571|FG001|Overall Study|Lost to Follow-up|5|||
130124675|NCT01941030|468418570|FG000|Overall Study|Withdrawal by Subject|4|||
130124676|NCT01941030|468418571|FG001|Overall Study|Withdrawal by Subject|6|||
130124677|NCT00162123|468418574|FG000|Overall Study|Disease progression|27|||
130124678|NCT00162123|468418575|FG001|Overall Study|Disease progression|19|||
130124679|NCT00162123|468418576|FG002|Overall Study|Disease progression|10|||
130124680|NCT00162123|468418577|FG003|Overall Study|Disease progression|4|||
130124681|NCT00162123|468418578|FG004|Overall Study|Disease progression|8|||
130124682|NCT00162123|468418579|FG005|Overall Study|Disease progression|3|||
130124683|NCT00162123|468418580|FG006|Overall Study|Disease progression|1|||
130124684|NCT00162123|468418581|FG007|Overall Study|Disease progression|0|||
130124685|NCT00162123|468418574|FG000|Overall Study|Study drug toxicity|6|||
130124686|NCT00162123|468418575|FG001|Overall Study|Study drug toxicity|1|||
130124687|NCT00162123|468418576|FG002|Overall Study|Study drug toxicity|5|||
130124688|NCT00162123|468418577|FG003|Overall Study|Study drug toxicity|0|||
130124689|NCT00162123|468418578|FG004|Overall Study|Study drug toxicity|4|||
130124690|NCT00162123|468418579|FG005|Overall Study|Study drug toxicity|1|||
130124691|NCT00162123|468418580|FG006|Overall Study|Study drug toxicity|1|||
130124692|NCT00162123|468418581|FG007|Overall Study|Study drug toxicity|0|||
130124693|NCT00162123|468418574|FG000|Overall Study|Death|3|||
130124694|NCT00162123|468418575|FG001|Overall Study|Death|3|||
130124695|NCT00162123|468418576|FG002|Overall Study|Death|1|||
130124696|NCT00162123|468418577|FG003|Overall Study|Death|1|||
130124697|NCT00162123|468418578|FG004|Overall Study|Death|1|||
130124698|NCT00162123|468418579|FG005|Overall Study|Death|1|||
130124699|NCT00162123|468418580|FG006|Overall Study|Death|0|||
130124700|NCT00162123|468418581|FG007|Overall Study|Death|0|||
130124701|NCT00162123|468418574|FG000|Overall Study|Withdrawal by Subject|2|||
130124702|NCT00162123|468418575|FG001|Overall Study|Withdrawal by Subject|0|||
130124703|NCT00162123|468418576|FG002|Overall Study|Withdrawal by Subject|2|||
130124704|NCT00162123|468418577|FG003|Overall Study|Withdrawal by Subject|1|||
130124705|NCT00162123|468418578|FG004|Overall Study|Withdrawal by Subject|1|||
130124706|NCT00162123|468418579|FG005|Overall Study|Withdrawal by Subject|2|||
130124707|NCT00162123|468418580|FG006|Overall Study|Withdrawal by Subject|1|||
130124708|NCT00162123|468418581|FG007|Overall Study|Withdrawal by Subject|0|||
130124709|NCT00162123|468418574|FG000|Overall Study|Deterioration without progression|2|||
130124710|NCT00162123|468418575|FG001|Overall Study|Deterioration without progression|2|||
130124711|NCT00162123|468418576|FG002|Overall Study|Deterioration without progression|3|||
130124712|NCT00162123|468418577|FG003|Overall Study|Deterioration without progression|0|||
130124713|NCT00162123|468418578|FG004|Overall Study|Deterioration without progression|1|||
130124714|NCT00162123|468418579|FG005|Overall Study|Deterioration without progression|0|||
130124715|NCT00162123|468418580|FG006|Overall Study|Deterioration without progression|0|||
130124716|NCT00162123|468418581|FG007|Overall Study|Deterioration without progression|0|||
130124717|NCT00162123|468418574|FG000|Overall Study|Adverse Event|1|||
130124718|NCT00162123|468418575|FG001|Overall Study|Adverse Event|2|||
130124719|NCT00162123|468418576|FG002|Overall Study|Adverse Event|0|||
130124720|NCT00162123|468418577|FG003|Overall Study|Adverse Event|2|||
130124721|NCT00162123|468418578|FG004|Overall Study|Adverse Event|1|||
130124722|NCT00162123|468418579|FG005|Overall Study|Adverse Event|0|||
130124723|NCT00162123|468418580|FG006|Overall Study|Adverse Event|0|||
130124724|NCT00162123|468418581|FG007|Overall Study|Adverse Event|0|||
130124725|NCT00162123|468418574|FG000|Overall Study|Not specified (before treatment)|2|||
130124726|NCT00162123|468418575|FG001|Overall Study|Not specified (before treatment)|0|||
130124727|NCT00162123|468418576|FG002|Overall Study|Not specified (before treatment)|0|||
130124728|NCT00162123|468418577|FG003|Overall Study|Not specified (before treatment)|0|||
130124729|NCT00162123|468418578|FG004|Overall Study|Not specified (before treatment)|12|||
130124730|NCT00162123|468418579|FG005|Overall Study|Not specified (before treatment)|1|||
130124731|NCT00162123|468418580|FG006|Overall Study|Not specified (before treatment)|0|||
130124732|NCT00162123|468418581|FG007|Overall Study|Not specified (before treatment)|0|||
130124733|NCT00162123|468418574|FG000|Overall Study|Not specified (after start of treatment)|0|||
130124734|NCT00162123|468418575|FG001|Overall Study|Not specified (after start of treatment)|0|||
130124735|NCT00162123|468418576|FG002|Overall Study|Not specified (after start of treatment)|0|||
130124736|NCT00162123|468418577|FG003|Overall Study|Not specified (after start of treatment)|0|||
130124737|NCT00162123|468418578|FG004|Overall Study|Not specified (after start of treatment)|3|||
130124738|NCT00162123|468418579|FG005|Overall Study|Not specified (after start of treatment)|0|||
130124739|NCT00162123|468418580|FG006|Overall Study|Not specified (after start of treatment)|0|||
130124740|NCT00162123|468418581|FG007|Overall Study|Not specified (after start of treatment)|0|||
130124741|NCT00162123|468418574|FG000|Overall Study|Physician Decision|1|||
130124742|NCT00162123|468418575|FG001|Overall Study|Physician Decision|2|||
130124743|NCT00162123|468418576|FG002|Overall Study|Physician Decision|0|||
130124744|NCT00162123|468418577|FG003|Overall Study|Physician Decision|0|||
130124745|NCT00162123|468418578|FG004|Overall Study|Physician Decision|0|||
130124746|NCT00162123|468418579|FG005|Overall Study|Physician Decision|1|||
130124747|NCT00162123|468418580|FG006|Overall Study|Physician Decision|1|||
130124748|NCT00162123|468418581|FG007|Overall Study|Physician Decision|0|||
130124749|NCT00162123|468418574|FG000|Overall Study|Tumor assessment only (not treated)|0|||
130124750|NCT00162123|468418575|FG001|Overall Study|Tumor assessment only (not treated)|0|||
130124751|NCT00162123|468418576|FG002|Overall Study|Tumor assessment only (not treated)|0|||
130124752|NCT00162123|468418577|FG003|Overall Study|Tumor assessment only (not treated)|0|||
130124753|NCT00162123|468418578|FG004|Overall Study|Tumor assessment only (not treated)|0|||
130124754|NCT00162123|468418579|FG005|Overall Study|Tumor assessment only (not treated)|0|||
130124755|NCT00162123|468418580|FG006|Overall Study|Tumor assessment only (not treated)|0|||
130124756|NCT00162123|468418581|FG007|Overall Study|Tumor assessment only (not treated)|1|||
130124757|NCT00162123|468418574|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
130124758|NCT00162123|468418575|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
130124759|NCT00162123|468418576|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
130124760|NCT00162123|468418577|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
130124761|NCT00162123|468418578|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
130124762|NCT00162123|468418579|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
130124763|NCT00162123|468418580|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
130124764|NCT00162123|468418581|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
130124765|NCT02016170|468418582|FG000|Overall Study|Adverse Event|1|||
130124766|NCT02016170|468418583|FG001|Overall Study|Adverse Event|1|||
130124767|NCT02016170|468418584|FG002|Overall Study|Adverse Event|0|||
130124768|NCT02016170|468418582|FG000|Overall Study|Protocol Violation|1|||
130124769|NCT02016170|468418583|FG001|Overall Study|Protocol Violation|0|||
130124770|NCT02016170|468418584|FG002|Overall Study|Protocol Violation|0|||
130124771|NCT02327130|468418587|FG000|Overall Study|Discharged in less than 5 days|5|||
130124772|NCT02327130|468418587|FG000|Overall Study|Physician Decision|2|||
130124773|NCT02327130|468418587|FG000|Overall Study|Unable to provide breath sample|1|||
130124774|NCT02327130|468418587|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
130124775|NCT02327130|468418587|FG000|Overall Study|Met exclusion criteria|3|||
130124776|NCT01378975|468418591|FG000|Overall Study|Death|77|||
130124777|NCT01378975|468418592|FG001|Overall Study|Death|46|||
130124778|NCT01378975|468418591|FG000|Overall Study|Investigator Request|1|||
130124779|NCT01378975|468418592|FG001|Overall Study|Investigator Request|0|||
130124780|NCT01378975|468418591|FG000|Overall Study|Lost to Follow-up|4|||
130124781|NCT01378975|468418592|FG001|Overall Study|Lost to Follow-up|1|||
130124782|NCT01378975|468418591|FG000|Overall Study|Withdrew Consent|4|||
130124783|NCT01378975|468418592|FG001|Overall Study|Withdrew Consent|3|||
130124784|NCT02343120|468418596|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
130092603|NCT00151775|468294526|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092604|NCT00151775|468294527|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092605|NCT00151775|468294528|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092606|NCT00151775|468294529|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
130092607|NCT00151775|468294518|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
130092608|NCT00151775|468294519|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
130092609|NCT00151775|468294520|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
130092610|NCT00151775|468294521|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
130092611|NCT00151775|468294522|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
130092612|NCT00151775|468294523|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
130092613|NCT00151775|468294524|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
130092614|NCT00151775|468294525|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
130092615|NCT00151775|468294526|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
130092616|NCT00151775|468294527|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
130092617|NCT00151775|468294528|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
130092618|NCT00151775|468294529|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
130092619|NCT00151775|468294518|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092620|NCT00151775|468294519|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092621|NCT00151775|468294520|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092622|NCT00151775|468294521|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092623|NCT00151775|468294522|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092624|NCT00151775|468294523|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092625|NCT00151775|468294524|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
130092626|NCT00151775|468294525|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092627|NCT00151775|468294526|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092628|NCT00151775|468294527|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092629|NCT00151775|468294528|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092630|NCT00151775|468294529|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
130092631|NCT00151775|468294518|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092632|NCT00151775|468294519|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092633|NCT00151775|468294520|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
130092634|NCT00151775|468294521|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092635|NCT00151775|468294522|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092636|NCT00151775|468294523|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092637|NCT00151775|468294524|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092638|NCT00151775|468294525|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092639|NCT00151775|468294526|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092640|NCT00151775|468294527|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092641|NCT00151775|468294528|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130092642|NCT00151775|468294529|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
130124785|NCT02343120|468418597|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
130124786|NCT02343120|468418598|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
130092643|NCT00151775|468294518|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092644|NCT00151775|468294519|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092645|NCT00151775|468294520|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
130092646|NCT00151775|468294521|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092647|NCT00151775|468294522|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092648|NCT00151775|468294523|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092649|NCT00151775|468294524|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092650|NCT00151775|468294525|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092651|NCT00151775|468294526|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092652|NCT00151775|468294527|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092653|NCT00151775|468294528|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092654|NCT00151775|468294529|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
130092655|NCT00151775|468294518|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092656|NCT00151775|468294519|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092657|NCT00151775|468294520|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092658|NCT00151775|468294521|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092659|NCT00151775|468294522|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092660|NCT00151775|468294523|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092661|NCT00151775|468294524|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092662|NCT00151775|468294525|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092663|NCT00151775|468294526|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092664|NCT00151775|468294527|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092665|NCT00151775|468294528|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
130092666|NCT00151775|468294529|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
130092667|NCT00151775|468294518|FG000|Period 4: Open Label|Increased blood pressure|0|||
130092668|NCT00151775|468294519|FG001|Period 4: Open Label|Increased blood pressure|0|||
130092669|NCT00151775|468294520|FG002|Period 4: Open Label|Increased blood pressure|0|||
130092670|NCT00151775|468294521|FG003|Period 4: Open Label|Increased blood pressure|0|||
130092671|NCT00151775|468294522|FG004|Period 4: Open Label|Increased blood pressure|1|||
130092672|NCT00151775|468294523|FG005|Period 4: Open Label|Increased blood pressure|0|||
130092673|NCT00151775|468294524|FG006|Period 4: Open Label|Increased blood pressure|0|||
130092674|NCT00151775|468294525|FG007|Period 4: Open Label|Increased blood pressure|0|||
130092675|NCT00151775|468294526|FG008|Period 4: Open Label|Increased blood pressure|0|||
130092676|NCT00151775|468294527|FG009|Period 4: Open Label|Increased blood pressure|1|||
130092677|NCT00151775|468294528|FG010|Period 4: Open Label|Increased blood pressure|0|||
130092678|NCT00151775|468294529|FG011|Period 4: Open Label|Increased blood pressure|0|||
130092679|NCT00151775|468294518|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
130092680|NCT00151775|468294519|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
130092681|NCT00151775|468294520|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
130092682|NCT00151775|468294521|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
130092683|NCT00151775|468294522|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
130092684|NCT00151775|468294523|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
130092685|NCT00151775|468294524|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
130092686|NCT00151775|468294525|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
130092687|NCT00151775|468294526|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
130092688|NCT00151775|468294527|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
130092689|NCT00151775|468294528|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
130092690|NCT00151775|468294529|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
130092691|NCT00151775|468294518|FG000|Period 4: Open Label|Adverse Event|0|||
130092692|NCT00151775|468294519|FG001|Period 4: Open Label|Adverse Event|0|||
130092693|NCT00151775|468294520|FG002|Period 4: Open Label|Adverse Event|0|||
130092694|NCT00151775|468294521|FG003|Period 4: Open Label|Adverse Event|0|||
130092695|NCT00151775|468294522|FG004|Period 4: Open Label|Adverse Event|1|||
130092696|NCT00151775|468294523|FG005|Period 4: Open Label|Adverse Event|0|||
130092697|NCT00151775|468294524|FG006|Period 4: Open Label|Adverse Event|0|||
130092698|NCT00151775|468294525|FG007|Period 4: Open Label|Adverse Event|0|||
130092699|NCT00151775|468294526|FG008|Period 4: Open Label|Adverse Event|0|||
130092700|NCT00151775|468294527|FG009|Period 4: Open Label|Adverse Event|2|||
130092701|NCT00151775|468294528|FG010|Period 4: Open Label|Adverse Event|0|||
130092702|NCT00151775|468294529|FG011|Period 4: Open Label|Adverse Event|0|||
130092703|NCT00151775|468294518|FG000|Period 4: Open Label|Lost to Follow-up|0|||
130092704|NCT00151775|468294519|FG001|Period 4: Open Label|Lost to Follow-up|0|||
130092705|NCT00151775|468294520|FG002|Period 4: Open Label|Lost to Follow-up|0|||
130092706|NCT00151775|468294521|FG003|Period 4: Open Label|Lost to Follow-up|0|||
130092707|NCT00151775|468294522|FG004|Period 4: Open Label|Lost to Follow-up|17|||
130092708|NCT00151775|468294523|FG005|Period 4: Open Label|Lost to Follow-up|0|||
130092709|NCT00151775|468294524|FG006|Period 4: Open Label|Lost to Follow-up|0|||
130092710|NCT00151775|468294525|FG007|Period 4: Open Label|Lost to Follow-up|0|||
130092711|NCT00151775|468294526|FG008|Period 4: Open Label|Lost to Follow-up|0|||
130092712|NCT00151775|468294527|FG009|Period 4: Open Label|Lost to Follow-up|7|||
130124787|NCT02343120|468418599|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
130124788|NCT02343120|468418600|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
130124789|NCT02343120|468418596|FG000|Part 1: Dose Escalation|Death|1|||
130124790|NCT02343120|468418597|FG001|Part 1: Dose Escalation|Death|2|||
130124791|NCT02343120|468418598|FG002|Part 1: Dose Escalation|Death|2|||
130124792|NCT02343120|468418599|FG003|Part 1: Dose Escalation|Death|2|||
130124793|NCT02343120|468418600|FG004|Part 1: Dose Escalation|Death|1|||
130124794|NCT02343120|468418596|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
130124795|NCT02343120|468418597|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
130124796|NCT02343120|468418598|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
130124797|NCT02343120|468418599|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
130124798|NCT02343120|468418600|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
130124799|NCT02343120|468418596|FG000|Part 2: Expansion|Sponsor decision|0|||
130124800|NCT02343120|468418597|FG001|Part 2: Expansion|Sponsor decision|0|||
130124801|NCT02343120|468418598|FG002|Part 2: Expansion|Sponsor decision|0|||
130124802|NCT02343120|468418599|FG003|Part 2: Expansion|Sponsor decision|165|||
130124803|NCT02343120|468418600|FG004|Part 2: Expansion|Sponsor decision|67|||
130124804|NCT02343120|468418596|FG000|Part 2: Expansion|Death|0|||
130124805|NCT02343120|468418597|FG001|Part 2: Expansion|Death|0|||
130124806|NCT02343120|468418598|FG002|Part 2: Expansion|Death|0|||
130124807|NCT02343120|468418599|FG003|Part 2: Expansion|Death|74|||
130124808|NCT02343120|468418600|FG004|Part 2: Expansion|Death|17|||
130124809|NCT02343120|468418596|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
130124810|NCT02343120|468418597|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
130124811|NCT02343120|468418598|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
130124812|NCT02343120|468418599|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
130124813|NCT02343120|468418600|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
130124814|NCT02343120|468418596|FG000|Part 2: Expansion|Lost to Follow-up|0|||
130124815|NCT02343120|468418597|FG001|Part 2: Expansion|Lost to Follow-up|0|||
130124816|NCT02343120|468418598|FG002|Part 2: Expansion|Lost to Follow-up|0|||
130124817|NCT02343120|468418599|FG003|Part 2: Expansion|Lost to Follow-up|5|||
130124818|NCT02343120|468418600|FG004|Part 2: Expansion|Lost to Follow-up|2|||
130124819|NCT02343120|468418596|FG000|Part 2: Expansion|Other|0|||
130124820|NCT02343120|468418597|FG001|Part 2: Expansion|Other|0|||
130124821|NCT02343120|468418598|FG002|Part 2: Expansion|Other|0|||
130124822|NCT02343120|468418599|FG003|Part 2: Expansion|Other|1|||
130124823|NCT02343120|468418600|FG004|Part 2: Expansion|Other|5|||
130124824|NCT02343120|468418596|FG000|Part 2: Expansion|Adverse Event|0|||
130124825|NCT02343120|468418597|FG001|Part 2: Expansion|Adverse Event|0|||
130124826|NCT02343120|468418598|FG002|Part 2: Expansion|Adverse Event|0|||
130124827|NCT02343120|468418599|FG003|Part 2: Expansion|Adverse Event|1|||
130124828|NCT02343120|468418600|FG004|Part 2: Expansion|Adverse Event|1|||
130124829|NCT03991494|468418603|FG000|Overall Study|Progressive Disease|4|||
130124830|NCT02534493|468418606|FG000|Overall Study|Lost to Follow-up|1|||
130124831|NCT02534493|468418606|FG000|Overall Study|Withdrawal by Subject|1|||
130124832|NCT01104662|468418609|FG000|Overall Study|Adverse Event|2|||
130124833|NCT01104662|468418610|FG001|Overall Study|Adverse Event|2|||
130124834|NCT01104662|468418611|FG002|Overall Study|Adverse Event|0|||
130124835|NCT01104662|468418612|FG003|Overall Study|Adverse Event|1|||
130124836|NCT01104662|468418613|FG004|Overall Study|Adverse Event|1|||
130124837|NCT01104662|468418614|FG005|Overall Study|Adverse Event|1|||
130124838|NCT01104662|468418615|FG006|Overall Study|Adverse Event|0|||
130124839|NCT01104662|468418616|FG007|Overall Study|Adverse Event|0|||
130124840|NCT01104662|468418609|FG000|Overall Study|Clinical Failure|1|||
130124841|NCT01104662|468418610|FG001|Overall Study|Clinical Failure|0|||
130124842|NCT01104662|468418611|FG002|Overall Study|Clinical Failure|0|||
130124843|NCT01104662|468418612|FG003|Overall Study|Clinical Failure|0|||
130124844|NCT01104662|468418613|FG004|Overall Study|Clinical Failure|0|||
130124845|NCT01104662|468418614|FG005|Overall Study|Clinical Failure|1|||
130124846|NCT01104662|468418615|FG006|Overall Study|Clinical Failure|0|||
130124847|NCT01104662|468418616|FG007|Overall Study|Clinical Failure|0|||
130124848|NCT01104662|468418609|FG000|Overall Study|Participant left investigator's care|1|||
130124849|NCT01104662|468418610|FG001|Overall Study|Participant left investigator's care|1|||
130124850|NCT01104662|468418611|FG002|Overall Study|Participant left investigator's care|0|||
130124851|NCT01104662|468418612|FG003|Overall Study|Participant left investigator's care|0|||
130124852|NCT01104662|468418613|FG004|Overall Study|Participant left investigator's care|0|||
130124853|NCT01104662|468418614|FG005|Overall Study|Participant left investigator's care|0|||
130124854|NCT01104662|468418615|FG006|Overall Study|Participant left investigator's care|0|||
130124855|NCT01104662|468418616|FG007|Overall Study|Participant left investigator's care|0|||
130124856|NCT01104662|468418609|FG000|Overall Study|Reason not specified|3|||
130124857|NCT01104662|468418610|FG001|Overall Study|Reason not specified|3|||
130124858|NCT01104662|468418611|FG002|Overall Study|Reason not specified|0|||
130124859|NCT01104662|468418612|FG003|Overall Study|Reason not specified|0|||
130124860|NCT01104662|468418613|FG004|Overall Study|Reason not specified|0|||
130124861|NCT01104662|468418614|FG005|Overall Study|Reason not specified|1|||
130124862|NCT01104662|468418615|FG006|Overall Study|Reason not specified|0|||
130124863|NCT01104662|468418616|FG007|Overall Study|Reason not specified|0|||
130124864|NCT01104662|468418609|FG000|Overall Study|Randomized but not treated|3|||
130124865|NCT01104662|468418610|FG001|Overall Study|Randomized but not treated|4|||
130124866|NCT01104662|468418611|FG002|Overall Study|Randomized but not treated|1|||
130124867|NCT01104662|468418612|FG003|Overall Study|Randomized but not treated|0|||
130124868|NCT01104662|468418613|FG004|Overall Study|Randomized but not treated|0|||
130124869|NCT01104662|468418614|FG005|Overall Study|Randomized but not treated|1|||
130124870|NCT01104662|468418615|FG006|Overall Study|Randomized but not treated|0|||
130124871|NCT01104662|468418616|FG007|Overall Study|Randomized but not treated|0|||
130124872|NCT02079532|468418617|FG000|Overall Study|Adverse Event|7|||
130124873|NCT02079532|468418617|FG000|Overall Study|Additional or changed therapy|2|||
130124874|NCT02079532|468418617|FG000|Overall Study|Lack of Efficacy|9|||
130124875|NCT02079532|468418617|FG000|Overall Study|Protocol Violation|3|||
130124876|NCT02079532|468418617|FG000|Overall Study|Withdrawal by Subject|1|||
130124877|NCT02079532|468418617|FG000|Overall Study|Administrative problems|1|||
130124878|NCT02079532|468418617|FG000|Overall Study|Inclusion into ReFIRST|3|||
130124879|NCT02079532|468418617|FG000|Overall Study|Other|3|||
130124880|NCT02158936|468418620|FG000|Overall Study|Study closed/ terminated|57|||
130124881|NCT02158936|468418621|FG001|Overall Study|Study closed/ terminated|77|||
130124882|NCT02158936|468418620|FG000|Overall Study|Azacitidine tx discontinued|53|||
130124883|NCT02158936|468418621|FG001|Overall Study|Azacitidine tx discontinued|46|||
130124884|NCT02158936|468418620|FG000|Overall Study|Adverse Event|39|||
130124885|NCT02158936|468418621|FG001|Overall Study|Adverse Event|24|||
130124886|NCT02158936|468418620|FG000|Overall Study|Withdrawal by Subject|15|||
130124887|NCT02158936|468418621|FG001|Overall Study|Withdrawal by Subject|16|||
130124888|NCT02158936|468418620|FG000|Overall Study|Physician Decision|15|||
130124889|NCT02158936|468418621|FG001|Overall Study|Physician Decision|13|||
130124890|NCT02158936|468418620|FG000|Overall Study|Lost to Follow-up|0|||
130124891|NCT02158936|468418621|FG001|Overall Study|Lost to Follow-up|1|||
130124892|NCT01432171|468418622|FG000|Overall Study|Death|1|||
130124893|NCT01432171|468418623|FG001|Overall Study|Death|2|||
130124894|NCT01432171|468418622|FG000|Overall Study|Lost to Follow-up|6|||
130124895|NCT01432171|468418623|FG001|Overall Study|Lost to Follow-up|5|||
130124896|NCT01432171|468418622|FG000|Overall Study|Withdrawal by Subject|3|||
130124897|NCT01432171|468418623|FG001|Overall Study|Withdrawal by Subject|1|||
130124898|NCT01432171|468418622|FG000|Overall Study|Noncompliance|2|||
130124899|NCT01432171|468418623|FG001|Overall Study|Noncompliance|3|||
130124900|NCT01432171|468418622|FG000|Overall Study|Insurance denial trial coverage|1|||
130124901|NCT01432171|468418623|FG001|Overall Study|Insurance denial trial coverage|0|||
130124902|NCT01432171|468418622|FG000|Overall Study|Patient moved to palliative care|1|||
130124903|NCT01432171|468418623|FG001|Overall Study|Patient moved to palliative care|0|||
130124904|NCT01706926|468418624|FG000|Overall Study|Lost to Follow-up|0|||
130124905|NCT01706926|468418625|FG001|Overall Study|Lost to Follow-up|0|||
130124906|NCT01706926|468418626|FG002|Overall Study|Lost to Follow-up|1|||
130124907|NCT01706926|468418627|FG003|Overall Study|Lost to Follow-up|0|||
130124908|NCT01706926|468418624|FG000|Overall Study|Withdrawal by Subject|2|||
130124909|NCT01706926|468418625|FG001|Overall Study|Withdrawal by Subject|0|||
130124910|NCT01706926|468418626|FG002|Overall Study|Withdrawal by Subject|1|||
130124911|NCT01706926|468418627|FG003|Overall Study|Withdrawal by Subject|2|||
130124912|NCT01706926|468418624|FG000|Overall Study|Other|4|||
130124913|NCT01706926|468418625|FG001|Overall Study|Other|4|||
130124914|NCT01706926|468418626|FG002|Overall Study|Other|4|||
130124915|NCT01706926|468418627|FG003|Overall Study|Other|3|||
130124916|NCT05628675|468420190|FG000|Overall Study|Lost to Follow-up|2|||
130124917|NCT05628675|468420190|FG000|Overall Study|Withdrawal by Subject|1|||
130124918|NCT01941095|468420191|FG000|Overall Study|Insufficient therapeutic response|13|||
130124919|NCT01941095|468420191|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
130124920|NCT01941095|468420191|FG000|Overall Study|Adverse Event|11|||
130124921|NCT01941095|468420191|FG000|Overall Study|Physician Decision|3|||
130124922|NCT01941095|468420191|FG000|Overall Study|Withdrawal by Subject|17|||
130124923|NCT01941095|468420191|FG000|Overall Study|Lost to Follow-up|10|||
130124924|NCT02918877|468420194|FG000|Overall Study|Withdrawal by Subject|2|||
130124925|NCT02918877|468420195|FG001|Overall Study|Withdrawal by Subject|2|||
130124926|NCT02918877|468420194|FG000|Overall Study|Surgery cancelled|1|||
130124927|NCT02918877|468420195|FG001|Overall Study|Surgery cancelled|0|||
130124928|NCT02918877|468420194|FG000|Overall Study|Physician Decision|1|||
130124929|NCT02918877|468420195|FG001|Overall Study|Physician Decision|0|||
130124930|NCT02918877|468420194|FG000|Overall Study|Received intraoperative steroids|1|||
130124931|NCT02918877|468420195|FG001|Overall Study|Received intraoperative steroids|0|||
130124932|NCT02918877|468420194|FG000|Overall Study|Unable to obtain lab samples|1|||
130124933|NCT02918877|468420195|FG001|Overall Study|Unable to obtain lab samples|0|||
130124934|NCT02918877|468420194|FG000|Overall Study|Unsafe to perform BAL|0|||
130124935|NCT02918877|468420195|FG001|Overall Study|Unsafe to perform BAL|1|||
130124936|NCT01648166|468420196|FG000|Overall Study|inadequate toenail samples|53|||
130124937|NCT01648166|468420197|FG001|Overall Study|inadequate toenail samples|100|||
130124938|NCT02532764|468420198|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130124939|NCT02532764|468420199|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130124940|NCT02532764|468420200|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130154897|NCT01470612|468526639|FG001|Overall Study|Lost to Follow-up|5|||
130124941|NCT02532764|468420201|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130124942|NCT02532764|468420202|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130124943|NCT02532764|468420203|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130124944|NCT02532764|468420204|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
130124945|NCT02532764|468420205|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130124946|NCT02532764|468420206|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130124947|NCT02532764|468420207|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
130124948|NCT03527745|468420208|FG000|Overall Study|Lost to Follow-up|3|||
130124949|NCT03527745|468420209|FG001|Overall Study|Lost to Follow-up|6|||
130124950|NCT03527745|468420210|FG002|Overall Study|Lost to Follow-up|7|||
130124951|NCT03527745|468420211|FG003|Overall Study|Lost to Follow-up|9|||
130124952|NCT03527745|468420212|FG004|Overall Study|Lost to Follow-up|0|||
130124953|NCT03527745|468420213|FG005|Overall Study|Lost to Follow-up|2|||
130124954|NCT03527745|468420214|FG006|Overall Study|Lost to Follow-up|3|||
130124955|NCT03527745|468420215|FG007|Overall Study|Lost to Follow-up|2|||
130124956|NCT03527745|468420216|FG008|Overall Study|Lost to Follow-up|3|||
130124957|NCT03527745|468420217|FG009|Overall Study|Lost to Follow-up|2|||
130124958|NCT03527745|468420218|FG010|Overall Study|Lost to Follow-up|1|||
130124959|NCT03527745|468420219|FG011|Overall Study|Lost to Follow-up|1|||
130124960|NCT03527745|468420220|FG012|Overall Study|Lost to Follow-up|0|||
130124961|NCT03527745|468420221|FG013|Overall Study|Lost to Follow-up|0|||
130124962|NCT03527745|468420222|FG014|Overall Study|Lost to Follow-up|0|||
130124963|NCT03527745|468420223|FG015|Overall Study|Lost to Follow-up|0|||
130124964|NCT03527745|468420224|FG016|Overall Study|Lost to Follow-up|1|||
130124965|NCT03527745|468420225|FG017|Overall Study|Lost to Follow-up|0|||
130124966|NCT03527745|468420226|FG018|Overall Study|Lost to Follow-up|0|||
130124967|NCT03527745|468420227|FG019|Overall Study|Lost to Follow-up|1|||
130124968|NCT03527745|468420228|FG020|Overall Study|Lost to Follow-up|1|||
130124969|NCT03527745|468420229|FG021|Overall Study|Lost to Follow-up|5|||
130124970|NCT03527745|468420230|FG022|Overall Study|Lost to Follow-up|6|||
130124971|NCT03527745|468420231|FG023|Overall Study|Lost to Follow-up|8|||
130124972|NCT03527745|468420232|FG024|Overall Study|Lost to Follow-up|1|||
130124973|NCT03527745|468420233|FG025|Overall Study|Lost to Follow-up|3|||
130124974|NCT01475838|468420234|FG000|Randomized Phase|Randomized but Not Treated|0|||
130124975|NCT01475838|468420235|FG001|Randomized Phase|Randomized but Not Treated|5|||
130124976|NCT01475838|468420234|FG000|Randomized Phase|Adverse Event|6|||
130124977|NCT01475838|468420235|FG001|Randomized Phase|Adverse Event|1|||
130124978|NCT01475838|468420234|FG000|Randomized Phase|Pregnancy|0|||
130124979|NCT01475838|468420235|FG001|Randomized Phase|Pregnancy|1|||
130124980|NCT01475838|468420234|FG000|Randomized Phase|Investigators Discretion|1|||
130124981|NCT01475838|468420235|FG001|Randomized Phase|Investigators Discretion|2|||
130124982|NCT01475838|468420234|FG000|Randomized Phase|Withdrew Consent|10|||
130124983|NCT01475838|468420235|FG001|Randomized Phase|Withdrew Consent|14|||
130124984|NCT01475838|468420234|FG000|Randomized Phase|Lost to Follow-up|3|||
130124985|NCT01475838|468420235|FG001|Randomized Phase|Lost to Follow-up|4|||
130124986|NCT01475838|468420234|FG000|Randomized Phase|Participant Noncompliance|1|||
130124987|NCT01475838|468420235|FG001|Randomized Phase|Participant Noncompliance|5|||
130124988|NCT01475838|468420234|FG000|Randomized Phase|Protocol Violation|9|||
130124989|NCT01475838|468420235|FG001|Randomized Phase|Protocol Violation|4|||
130124990|NCT01475838|468420234|FG000|Extension Phase|Participant Noncompliance|1|||
130124991|NCT01475838|468420235|FG001|Extension Phase|Participant Noncompliance|0|||
130124992|NCT00048568|468420236|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
130124993|NCT00048568|468420237|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
130124994|NCT00048568|468420238|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
130124995|NCT00048568|468420236|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
130124996|NCT00048568|468420237|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
130124997|NCT00048568|468420238|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
130124998|NCT00048568|468420236|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
130124999|NCT00048568|468420237|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
130125000|NCT00048568|468420238|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
130125001|NCT00048568|468420236|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
130125002|NCT00048568|468420237|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
130125003|NCT00048568|468420238|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
130125004|NCT00048568|468420236|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
130125005|NCT00048568|468420237|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
130125006|NCT00048568|468420238|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
130125007|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|Death|1|||
130125008|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|Death|1|||
130125009|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|Death|0|||
130125010|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
130125011|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
130125012|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
130125013|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
130125014|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
130125015|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
130125016|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
130125017|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
130125018|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
130125019|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
130125020|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
130125021|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
130125022|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
130125023|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
130125024|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
130125025|NCT00048568|468420236|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
130125026|NCT00048568|468420237|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
130125027|NCT00048568|468420238|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
130125028|NCT00048568|468420236|FG000|Open-Label Period|Death|0|||
130125029|NCT00048568|468420237|FG001|Open-Label Period|Death|0|||
130125030|NCT00048568|468420238|FG002|Open-Label Period|Death|13|||
130125031|NCT00048568|468420236|FG000|Open-Label Period|Adverse Event|0|||
130125032|NCT00048568|468420237|FG001|Open-Label Period|Adverse Event|0|||
130125033|NCT00048568|468420238|FG002|Open-Label Period|Adverse Event|49|||
130125034|NCT00048568|468420236|FG000|Open-Label Period|Lack of Efficacy|0|||
130125035|NCT00048568|468420237|FG001|Open-Label Period|Lack of Efficacy|0|||
130125036|NCT00048568|468420238|FG002|Open-Label Period|Lack of Efficacy|32|||
130125037|NCT00048568|468420236|FG000|Open-Label Period|Withdrawal by Subject|0|||
130125038|NCT00048568|468420237|FG001|Open-Label Period|Withdrawal by Subject|0|||
130125039|NCT00048568|468420238|FG002|Open-Label Period|Withdrawal by Subject|26|||
130125040|NCT00048568|468420236|FG000|Open-Label Period|Pregnancy|0|||
130125041|NCT00048568|468420237|FG001|Open-Label Period|Pregnancy|0|||
130125042|NCT00048568|468420238|FG002|Open-Label Period|Pregnancy|5|||
130125043|NCT00048568|468420236|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
130125044|NCT00048568|468420237|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
130125045|NCT00048568|468420238|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
130125046|NCT00048568|468420236|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
130125047|NCT00048568|468420237|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
130125048|NCT00048568|468420238|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
130125049|NCT00048568|468420236|FG000|Open-Label Period|Unknown Reasons|0|||
130125050|NCT00048568|468420237|FG001|Open-Label Period|Unknown Reasons|0|||
130125051|NCT00048568|468420238|FG002|Open-Label Period|Unknown Reasons|25|||
130125052|NCT00048568|468420236|FG000|Open-Label Period|Lost to Follow-up|0|||
130125053|NCT00048568|468420237|FG001|Open-Label Period|Lost to Follow-up|0|||
130125054|NCT00048568|468420238|FG002|Open-Label Period|Lost to Follow-up|7|||
130125055|NCT01717976|468420239|FG000|Overall Study|Protocol Violation|0|||
130125056|NCT01717976|468420240|FG001|Overall Study|Protocol Violation|1|||
130125057|NCT01315249|468420247|FG000|Overall Study|Adverse Event|22|||
130125058|NCT01315249|468420248|FG001|Overall Study|Adverse Event|26|||
130125059|NCT01315249|468420247|FG000|Overall Study|Withdrawal by Subject|11|||
130125060|NCT01315249|468420248|FG001|Overall Study|Withdrawal by Subject|10|||
130125061|NCT01315249|468420247|FG000|Overall Study|Protocol Violation|8|||
130125062|NCT01315249|468420248|FG001|Overall Study|Protocol Violation|5|||
130125063|NCT01315249|468420247|FG000|Overall Study|Abnormal test results|1|||
130125064|NCT01315249|468420248|FG001|Overall Study|Abnormal test results|2|||
130125065|NCT01315249|468420247|FG000|Overall Study|Administrative problems|1|||
130125066|NCT01315249|468420248|FG001|Overall Study|Administrative problems|0|||
130125067|NCT01315249|468420247|FG000|Overall Study|inability to use device|1|||
130125068|NCT01315249|468420248|FG001|Overall Study|inability to use device|0|||
130125069|NCT01315249|468420247|FG000|Overall Study|Lack of Efficacy|0|||
130125070|NCT01315249|468420248|FG001|Overall Study|Lack of Efficacy|1|||
130125071|NCT01315249|468420247|FG000|Overall Study|Lost to Follow-up|0|||
130125072|NCT01315249|468420248|FG001|Overall Study|Lost to Follow-up|2|||
130125073|NCT01315249|468420247|FG000|Overall Study|Death|0|||
130125074|NCT01315249|468420248|FG001|Overall Study|Death|1|||
130125075|NCT04099888|468420269|FG000|Overall Study|Study terminated by sponsor|9|||
130125076|NCT04099888|468420270|FG001|Overall Study|Study terminated by sponsor|11|||
130125077|NCT04099888|468420269|FG000|Overall Study|Lost to Follow-up|1|||
130125078|NCT04099888|468420270|FG001|Overall Study|Lost to Follow-up|1|||
130125079|NCT04099888|468420269|FG000|Overall Study|Withdrawal by Subject|5|||
130125080|NCT04099888|468420270|FG001|Overall Study|Withdrawal by Subject|6|||
130125081|NCT04099888|468420269|FG000|Overall Study|Death|5|||
130125082|NCT04099888|468420270|FG001|Overall Study|Death|2|||
130125083|NCT04099888|468420269|FG000|Overall Study|Other|1|||
130125084|NCT04099888|468420270|FG001|Overall Study|Other|0|||
130125085|NCT04538170|468420271|FG000|Overall Study|Withdrawal by Subject|104|||
130125086|NCT04538170|468420272|FG001|Overall Study|Withdrawal by Subject|210|||
130125087|NCT00274937|468420276|FG000|Overall Study|Physician Decision|10|||
130125088|NCT00274937|468420276|FG000|Overall Study|Withdrawal by Subject|6|||
130125089|NCT00274937|468420276|FG000|Overall Study|Progressive Disease|4|||
130125090|NCT00864097|468420279|FG000|Overall Study|Death|0|||
130125091|NCT00864097|468420280|FG001|Overall Study|Death|1|||
130125092|NCT00864097|468420281|FG002|Overall Study|Death|0|||
130125093|NCT00864097|468420282|FG003|Overall Study|Death|0|||
130125094|NCT00864097|468420279|FG000|Overall Study|Adverse Event|6|||
130125095|NCT00864097|468420280|FG001|Overall Study|Adverse Event|8|||
130125096|NCT00864097|468420281|FG002|Overall Study|Adverse Event|11|||
130125097|NCT00864097|468420282|FG003|Overall Study|Adverse Event|9|||
130125098|NCT00864097|468420279|FG000|Overall Study|Lack of Efficacy|9|||
130125099|NCT00864097|468420280|FG001|Overall Study|Lack of Efficacy|3|||
130125100|NCT00864097|468420281|FG002|Overall Study|Lack of Efficacy|7|||
130125101|NCT00864097|468420282|FG003|Overall Study|Lack of Efficacy|2|||
130125102|NCT00864097|468420279|FG000|Overall Study|Lost to Follow-up|0|||
130125103|NCT00864097|468420280|FG001|Overall Study|Lost to Follow-up|1|||
130125104|NCT00864097|468420281|FG002|Overall Study|Lost to Follow-up|0|||
130125105|NCT00864097|468420282|FG003|Overall Study|Lost to Follow-up|1|||
130125106|NCT00864097|468420279|FG000|Overall Study|Withdrawal by Subject|15|||
130125107|NCT00864097|468420280|FG001|Overall Study|Withdrawal by Subject|11|||
130125108|NCT00864097|468420281|FG002|Overall Study|Withdrawal by Subject|11|||
130125109|NCT00864097|468420282|FG003|Overall Study|Withdrawal by Subject|12|||
130125110|NCT00864097|468420279|FG000|Overall Study|Protocol Violation|2|||
130125111|NCT00864097|468420280|FG001|Overall Study|Protocol Violation|1|||
130125112|NCT00864097|468420281|FG002|Overall Study|Protocol Violation|0|||
130125113|NCT00864097|468420282|FG003|Overall Study|Protocol Violation|1|||
130125114|NCT00864097|468420279|FG000|Overall Study|Terminated by sponsor|105|||
130125115|NCT00864097|468420280|FG001|Overall Study|Terminated by sponsor|112|||
130125116|NCT00864097|468420281|FG002|Overall Study|Terminated by sponsor|102|||
130125117|NCT00864097|468420282|FG003|Overall Study|Terminated by sponsor|99|||
130125118|NCT00864097|468420279|FG000|Overall Study|Randomized but not treated|2|||
130125119|NCT00864097|468420280|FG001|Overall Study|Randomized but not treated|0|||
130125120|NCT00864097|468420281|FG002|Overall Study|Randomized but not treated|1|||
130125121|NCT00864097|468420282|FG003|Overall Study|Randomized but not treated|0|||
130125122|NCT00864097|468420279|FG000|Overall Study|Other|0|||
130125123|NCT00864097|468420280|FG001|Overall Study|Other|0|||
130125124|NCT00864097|468420281|FG002|Overall Study|Other|0|||
130125125|NCT00864097|468420282|FG003|Overall Study|Other|1|||
130125126|NCT00262223|468420288|FG000|Treatment Phase|Withdrawal by Subject|3|||
130125127|NCT00262223|468420289|FG001|Treatment Phase|Withdrawal by Subject|6|||
130125128|NCT00262223|468420288|FG000|Treatment Phase|Adverse Event|1|||
130125129|NCT00262223|468420289|FG001|Treatment Phase|Adverse Event|2|||
130125130|NCT00262223|468420288|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
130125131|NCT00262223|468420289|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
130125132|NCT00262223|468420288|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
130125133|NCT00262223|468420289|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
130125134|NCT00262223|468420288|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
130125135|NCT00262223|468420289|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
130125136|NCT01804270|468420290|FG000|Overall Study|Withdrawal by Subject|1|||
130125137|NCT01804270|468420291|FG001|Overall Study|Withdrawal by Subject|1|||
130125138|NCT02152566|468420293|FG000|Overall Study|Lost to Follow-up|1|||
130125139|NCT02152566|468420293|FG000|Overall Study|Withdrawal by Subject|2|||
130125140|NCT01328093|468420297|FG000|Double-Blind Phase|Adverse Event|78|||
130125141|NCT01328093|468420298|FG001|Double-Blind Phase|Adverse Event|15|||
130125142|NCT01328093|468420297|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
130125143|NCT01328093|468420298|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
130125144|NCT01328093|468420297|FG000|Double-Blind Phase|Lost to Follow-up|39|||
130125145|NCT01328093|468420298|FG001|Double-Blind Phase|Lost to Follow-up|14|||
130125146|NCT01328093|468420297|FG000|Double-Blind Phase|Protocol Violation|30|||
130125147|NCT01328093|468420298|FG001|Double-Blind Phase|Protocol Violation|10|||
130125148|NCT01328093|468420297|FG000|Double-Blind Phase|Lack of Efficacy|55|||
130125149|NCT01328093|468420298|FG001|Double-Blind Phase|Lack of Efficacy|13|||
130125150|NCT01328093|468420297|FG000|Double-Blind Phase|Sponsor Decision|17|||
130125151|NCT01328093|468420298|FG001|Double-Blind Phase|Sponsor Decision|3|||
130125152|NCT01328093|468420297|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
130125153|NCT01328093|468420298|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
130125154|NCT01328093|468420297|FG000|Double-Blind Phase|Scheduling conflict|8|||
130125155|NCT01328093|468420298|FG001|Double-Blind Phase|Scheduling conflict|3|||
130125156|NCT01328093|468420297|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
130125157|NCT01328093|468420298|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
130125158|NCT01328093|468420297|FG000|Double-Blind Phase|Death|1|||
130125159|NCT01328093|468420298|FG001|Double-Blind Phase|Death|0|||
130125160|NCT01328093|468420297|FG000|Open-Label Phase|Sponsor Decision|98|||
130125161|NCT01328093|468420298|FG001|Open-Label Phase|Sponsor Decision|34|||
130125162|NCT01328093|468420297|FG000|Open-Label Phase|Protocol Violation|8|||
130125163|NCT01328093|468420298|FG001|Open-Label Phase|Protocol Violation|3|||
130125164|NCT01328093|468420297|FG000|Open-Label Phase|Lost to Follow-up|10|||
130125165|NCT01328093|468420298|FG001|Open-Label Phase|Lost to Follow-up|1|||
130125166|NCT01328093|468420297|FG000|Open-Label Phase|Adverse Event|10|||
130125167|NCT01328093|468420298|FG001|Open-Label Phase|Adverse Event|4|||
130125168|NCT01328093|468420297|FG000|Open-Label Phase|Lack of Efficacy|5|||
130125169|NCT01328093|468420298|FG001|Open-Label Phase|Lack of Efficacy|6|||
130125170|NCT01328093|468420297|FG000|Open-Label Phase|Withdrawal by Subject|4|||
130125171|NCT01328093|468420298|FG001|Open-Label Phase|Withdrawal by Subject|1|||
130125172|NCT01328093|468420297|FG000|Open-Label Phase|Scheduling conflict|2|||
130125173|NCT01328093|468420298|FG001|Open-Label Phase|Scheduling conflict|1|||
130125174|NCT01328093|468420297|FG000|Open-Label Phase|Subject is moving or has moved|2|||
130125175|NCT01328093|468420298|FG001|Open-Label Phase|Subject is moving or has moved|0|||
130125176|NCT01328093|468420297|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
130125177|NCT01328093|468420298|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
130125178|NCT00832377|468420299|FG000|Overall Study|Protocol Violation|1|||
130125179|NCT03661528|468420300|FG000|Overall Study|Death|1|||
130125180|NCT03661528|468420301|FG001|Overall Study|Death|0|||
130125181|NCT03661528|468420300|FG000|Overall Study|Physician Decision|3|||
130125182|NCT03661528|468420301|FG001|Overall Study|Physician Decision|1|||
130125183|NCT03661528|468420300|FG000|Overall Study|Other than Specified|5|||
130125184|NCT03661528|468420301|FG001|Overall Study|Other than Specified|2|||
130125185|NCT03661528|468420300|FG000|Overall Study|Withdrawal by Subject|5|||
130125186|NCT03661528|468420301|FG001|Overall Study|Withdrawal by Subject|3|||
130125187|NCT03661528|468420300|FG000|Overall Study|Disease Progression|8|||
130125188|NCT03661528|468420301|FG001|Overall Study|Disease Progression|13|||
130125189|NCT03661528|468420300|FG000|Overall Study|Adverse Event|61|||
130125190|NCT03661528|468420301|FG001|Overall Study|Adverse Event|55|||
130125191|NCT02017964|468420303|FG000|Overall Study|Patient deemed ineligible|1|||
130125192|NCT00925769|468420304|FG000|Overall Study|Major toxicity|1|||
130125193|NCT00925769|468420305|FG001|Overall Study|Major toxicity|0|||
130125194|NCT00925769|468420306|FG002|Overall Study|Major toxicity|1|||
130125195|NCT00925769|468420307|FG003|Overall Study|Major toxicity|1|||
130125196|NCT00925769|468420308|FG004|Overall Study|Major toxicity|0|||
130125197|NCT00925769|468420309|FG005|Overall Study|Major toxicity|0|||
130125198|NCT00925769|468420304|FG000|Overall Study|Disease progression|4|||
130125199|NCT00925769|468420305|FG001|Overall Study|Disease progression|5|||
130125200|NCT00925769|468420306|FG002|Overall Study|Disease progression|3|||
130125201|NCT00925769|468420307|FG003|Overall Study|Disease progression|4|||
130125202|NCT00925769|468420308|FG004|Overall Study|Disease progression|2|||
130125203|NCT00925769|468420309|FG005|Overall Study|Disease progression|3|||
130125204|NCT00925769|468420304|FG000|Overall Study|Death|0|||
130125205|NCT00925769|468420305|FG001|Overall Study|Death|0|||
130125206|NCT00925769|468420306|FG002|Overall Study|Death|1|||
130125207|NCT00925769|468420307|FG003|Overall Study|Death|0|||
130125208|NCT00925769|468420308|FG004|Overall Study|Death|0|||
130125209|NCT00925769|468420309|FG005|Overall Study|Death|0|||
130125210|NCT00925769|468420304|FG000|Overall Study|Physician Decision|1|||
130125211|NCT00925769|468420305|FG001|Overall Study|Physician Decision|0|||
130125212|NCT00925769|468420306|FG002|Overall Study|Physician Decision|0|||
130125213|NCT00925769|468420307|FG003|Overall Study|Physician Decision|0|||
130125214|NCT00925769|468420308|FG004|Overall Study|Physician Decision|0|||
130125215|NCT00925769|468420309|FG005|Overall Study|Physician Decision|0|||
130125216|NCT00925769|468420304|FG000|Overall Study|Missing documentation|0|||
130125217|NCT00925769|468420305|FG001|Overall Study|Missing documentation|1|||
130125218|NCT00925769|468420306|FG002|Overall Study|Missing documentation|0|||
130125219|NCT00925769|468420307|FG003|Overall Study|Missing documentation|0|||
130125220|NCT00925769|468420308|FG004|Overall Study|Missing documentation|0|||
130125221|NCT00925769|468420309|FG005|Overall Study|Missing documentation|0|||
130125222|NCT00925769|468420304|FG000|Overall Study|End of study visit not done|0|||
130125223|NCT00925769|468420305|FG001|Overall Study|End of study visit not done|0|||
130125224|NCT00925769|468420306|FG002|Overall Study|End of study visit not done|1|||
130125225|NCT00925769|468420307|FG003|Overall Study|End of study visit not done|0|||
130125226|NCT00925769|468420308|FG004|Overall Study|End of study visit not done|0|||
130125227|NCT00925769|468420309|FG005|Overall Study|End of study visit not done|0|||
130125228|NCT00925769|468420304|FG000|Overall Study|Participant is unable to swallow drug|0|||
130125229|NCT00925769|468420305|FG001|Overall Study|Participant is unable to swallow drug|0|||
130125230|NCT00925769|468420306|FG002|Overall Study|Participant is unable to swallow drug|0|||
130125231|NCT00925769|468420307|FG003|Overall Study|Participant is unable to swallow drug|1|||
130125232|NCT00925769|468420308|FG004|Overall Study|Participant is unable to swallow drug|0|||
130125233|NCT00925769|468420309|FG005|Overall Study|Participant is unable to swallow drug|0|||
130125234|NCT00925769|468420304|FG000|Overall Study|Adverse Event|0|||
130125235|NCT00925769|468420305|FG001|Overall Study|Adverse Event|0|||
130125236|NCT00925769|468420306|FG002|Overall Study|Adverse Event|0|||
130125237|NCT00925769|468420307|FG003|Overall Study|Adverse Event|0|||
130125238|NCT00925769|468420308|FG004|Overall Study|Adverse Event|1|||
130125239|NCT00925769|468420309|FG005|Overall Study|Adverse Event|0|||
130125240|NCT01449630|468420311|FG000|Period 1|Physician Decision|1|||
130125241|NCT01449630|468420312|FG001|Period 1|Physician Decision|0|||
130125242|NCT01449630|468420313|FG002|Period 1|Physician Decision|0|||
130125243|NCT01449630|468420314|FG003|Period 1|Physician Decision|1|||
130125244|NCT01449630|468420315|FG004|Period 1|Physician Decision|0|||
130125245|NCT01449630|468420316|FG005|Period 1|Physician Decision|0|||
130125246|NCT01449630|468420317|FG006|Period 1|Physician Decision|0|||
130125247|NCT01449630|468420318|FG007|Period 1|Physician Decision|0|||
130125248|NCT01449630|468420319|FG008|Period 1|Physician Decision|0|||
130125249|NCT01449630|468420311|FG000|Period 1|Sponsor Decision|0|||
130125250|NCT01449630|468420312|FG001|Period 1|Sponsor Decision|0|||
130125251|NCT01449630|468420313|FG002|Period 1|Sponsor Decision|0|||
130125252|NCT01449630|468420314|FG003|Period 1|Sponsor Decision|0|||
130125253|NCT01449630|468420315|FG004|Period 1|Sponsor Decision|0|||
130125254|NCT01449630|468420316|FG005|Period 1|Sponsor Decision|1|||
130125255|NCT01449630|468420317|FG006|Period 1|Sponsor Decision|0|||
130125256|NCT01449630|468420318|FG007|Period 1|Sponsor Decision|0|||
130125257|NCT01449630|468420319|FG008|Period 1|Sponsor Decision|0|||
130125258|NCT01449630|468420311|FG000|Period 2|Sponsor Decision|0|||
130125259|NCT01449630|468420312|FG001|Period 2|Sponsor Decision|0|||
130125260|NCT01449630|468420313|FG002|Period 2|Sponsor Decision|0|||
130125261|NCT01449630|468420314|FG003|Period 2|Sponsor Decision|0|||
130125262|NCT01449630|468420315|FG004|Period 2|Sponsor Decision|0|||
130125263|NCT01449630|468420316|FG005|Period 2|Sponsor Decision|0|||
130125264|NCT01449630|468420317|FG006|Period 2|Sponsor Decision|1|||
130125265|NCT01449630|468420318|FG007|Period 2|Sponsor Decision|0|||
130125266|NCT01449630|468420319|FG008|Period 2|Sponsor Decision|0|||
130125267|NCT01735630|468420324|FG000|Overall Study|Adverse Event|8|||
130125268|NCT01735630|468420325|FG001|Overall Study|Adverse Event|7|||
130125269|NCT01735630|468420324|FG000|Overall Study|Lost to Follow-up|1|||
130125270|NCT01735630|468420325|FG001|Overall Study|Lost to Follow-up|0|||
130125271|NCT01735630|468420324|FG000|Overall Study|Physician Decision|0|||
130125272|NCT01735630|468420325|FG001|Overall Study|Physician Decision|1|||
130125273|NCT01735630|468420324|FG000|Overall Study|Sponsor Decision|2|||
130125274|NCT01735630|468420325|FG001|Overall Study|Sponsor Decision|1|||
130125275|NCT01735630|468420324|FG000|Overall Study|Withdrawal by Subject|7|||
130125276|NCT01735630|468420325|FG001|Overall Study|Withdrawal by Subject|9|||
130125277|NCT03099538|468420326|FG000|Overall Study|Lack of Efficacy|3|||
130125278|NCT01720264|468420327|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
130125279|NCT01720264|468420327|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
130125280|NCT01720264|468420327|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
130125281|NCT00615069|468420337|FG000|Overall Study|Death|10|||
130125282|NCT00615069|468420337|FG000|Overall Study|Physician Decision|2|||
130125283|NCT00615069|468420337|FG000|Overall Study|Withdrawal by Subject|4|||
130125284|NCT00259012|468420339|FG000|Overall Study|Adverse Event|0|||
130125285|NCT00259012|468420340|FG001|Overall Study|Adverse Event|1|||
130125286|NCT00259012|468420339|FG000|Overall Study|Withdrawal by Subject|1|||
130125287|NCT00259012|468420340|FG001|Overall Study|Withdrawal by Subject|0|||
130125288|NCT00259012|468420339|FG000|Overall Study|Physician Decision|0|||
129967708|NCT02706951|467847086|FG004|Period 1|Adverse Event|0|||
129967709|NCT02706951|467847082|FG000|Period 1|Withdrawal by Subject|10|||
130125289|NCT00259012|468420340|FG001|Overall Study|Physician Decision|1|||
130125290|NCT00259012|468420339|FG000|Overall Study|Lost to Follow-up|0|||
130125291|NCT00259012|468420340|FG001|Overall Study|Lost to Follow-up|1|||
130125292|NCT00259012|468420339|FG000|Overall Study|Protocol Violation|1|||
130125293|NCT00259012|468420340|FG001|Overall Study|Protocol Violation|1|||
130125294|NCT01479439|468420344|FG000|Overall Study|Adverse Event|1|||
130125295|NCT01479439|468420345|FG001|Overall Study|Adverse Event|0|||
130125296|NCT01479439|468420346|FG002|Overall Study|Adverse Event|0|||
130125297|NCT01479439|468420344|FG000|Overall Study|Lost to Follow-up|0|||
130125298|NCT01479439|468420345|FG001|Overall Study|Lost to Follow-up|1|||
130125299|NCT01479439|468420346|FG002|Overall Study|Lost to Follow-up|0|||
130125300|NCT01479439|468420344|FG000|Overall Study|Protocol Violation|0|||
130125301|NCT01479439|468420345|FG001|Overall Study|Protocol Violation|0|||
130125302|NCT01479439|468420346|FG002|Overall Study|Protocol Violation|2|||
130125303|NCT01936948|468420347|FG000|Overall Study|no 30-day follow-up data|0|||
130125304|NCT01936948|468420348|FG001|Overall Study|no 30-day follow-up data|3|||
130125305|NCT01936948|468420349|FG002|Overall Study|no 30-day follow-up data|3|||
130125306|NCT01936948|468420350|FG003|Overall Study|no 30-day follow-up data|3|||
130125307|NCT02365207|468420351|FG000|Overall Study|Withdrawal by Subject|1|||
130125308|NCT02365207|468420351|FG000|Overall Study|Physician Decision|1|||
130125309|NCT02930005|468420352|FG000|Overall Study|Lost to Follow-up|1|||
130125310|NCT02930005|468420353|FG001|Overall Study|Lost to Follow-up|5|||
129967710|NCT02706951|467847083|FG001|Period 1|Withdrawal by Subject|6|||
130125311|NCT02781727|468420354|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
130125312|NCT02781727|468420355|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
130125313|NCT02781727|468420354|FG000|Treatment Period|Withdrawal by Subject|1|||
130125314|NCT02781727|468420355|FG001|Treatment Period|Withdrawal by Subject|0|||
130125315|NCT02781727|468420354|FG000|Treatment Period|Lost to Follow-up|0|||
130125316|NCT02781727|468420355|FG001|Treatment Period|Lost to Follow-up|1|||
130125317|NCT00822926|468420361|FG000|Second Injection Visit|Lost to Follow-up|1|||
129967711|NCT02706951|467847084|FG002|Period 1|Withdrawal by Subject|6|||
130125318|NCT00822926|468420362|FG001|Second Injection Visit|Lost to Follow-up|0|||
130125319|NCT00822926|468420361|FG000|Second Injection Visit|Withdrawal by Subject|0|||
130125320|NCT00822926|468420362|FG001|Second Injection Visit|Withdrawal by Subject|1|||
130125321|NCT02924038|468421886|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
130125322|NCT02924038|468421887|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
130125323|NCT01108094|468421888|FG000|Overall Study|Adverse Event|2|||
130125324|NCT01108094|468421889|FG001|Overall Study|Adverse Event|0|||
130125325|NCT01108094|468421890|FG002|Overall Study|Adverse Event|0|||
130125326|NCT01108094|468421891|FG003|Overall Study|Adverse Event|0|||
130125327|NCT01108094|468421888|FG000|Overall Study|Withdrawal by Subject|1|||
130125328|NCT01108094|468421889|FG001|Overall Study|Withdrawal by Subject|0|||
130125329|NCT01108094|468421890|FG002|Overall Study|Withdrawal by Subject|0|||
130125330|NCT01108094|468421891|FG003|Overall Study|Withdrawal by Subject|0|||
130125331|NCT01101022|468421899|FG000|Overall Study|Adverse Event|6|||
130125332|NCT01101022|468421900|FG001|Overall Study|Adverse Event|2|||
130125333|NCT01101022|468421899|FG000|Overall Study|Protocol Violation|4|||
130125334|NCT01101022|468421900|FG001|Overall Study|Protocol Violation|3|||
130125335|NCT01101022|468421899|FG000|Overall Study|Withdrawal by Subject|3|||
130125336|NCT01101022|468421900|FG001|Overall Study|Withdrawal by Subject|8|||
130125337|NCT01101022|468421899|FG000|Overall Study|Lost to Follow-up|1|||
130125338|NCT01101022|468421900|FG001|Overall Study|Lost to Follow-up|4|||
130125339|NCT01101022|468421899|FG000|Overall Study|Lack of Efficacy|0|||
130125340|NCT01101022|468421900|FG001|Overall Study|Lack of Efficacy|7|||
130125341|NCT01101022|468421899|FG000|Overall Study|Sponsor decision|1|||
130125342|NCT01101022|468421900|FG001|Overall Study|Sponsor decision|1|||
130125343|NCT01101022|468421899|FG000|Overall Study|Non-compliance|1|||
130125344|NCT01101022|468421900|FG001|Overall Study|Non-compliance|0|||
130125345|NCT01101022|468421899|FG000|Overall Study|Work schedule|1|||
130125346|NCT01101022|468421900|FG001|Overall Study|Work schedule|1|||
130125347|NCT01101022|468421899|FG000|Overall Study|Vacation|0|||
130125348|NCT01101022|468421900|FG001|Overall Study|Vacation|1|||
130125349|NCT01519661|468421901|FG000|Overall Study|Protocol deviation|6|||
130125350|NCT01519661|468421901|FG000|Overall Study|Lost to Follow-up|3|||
130125351|NCT01519661|468421901|FG000|Overall Study|Withdrawal by Subject|17|||
130125352|NCT01519661|468421901|FG000|Overall Study|Lack of Efficacy|6|||
130125353|NCT01519661|468421901|FG000|Overall Study|Adverse Event|29|||
130125354|NCT01139047|468421902|FG000|Overall Study|Withdrawal by Subject|1|||
130125355|NCT05818137|468421903|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130125356|NCT05818137|468421903|FG000|Extension Treatment Period|Ongoing participants|44|||
130125357|NCT01604850|468421906|FG000|Overall Study|Enrolled but never treated|0|||
130125358|NCT01604850|468421907|FG001|Overall Study|Enrolled but never treated|1|||
130125359|NCT01604850|468421906|FG000|Overall Study|Efficacy Failure|50|||
130125360|NCT01604850|468421907|FG001|Overall Study|Efficacy Failure|29|||
130125361|NCT01604850|468421906|FG000|Overall Study|Lost to Follow-up|1|||
130125362|NCT01604850|468421907|FG001|Overall Study|Lost to Follow-up|0|||
130125363|NCT01604850|468421906|FG000|Overall Study|Subject withdrew consent|1|||
130125364|NCT01604850|468421907|FG001|Overall Study|Subject withdrew consent|0|||
130125365|NCT00727571|468421908|FG000|Overall Study|Ineligibility determined|1|||
130125366|NCT00727571|468421909|FG001|Overall Study|Ineligibility determined|1|||
130125367|NCT00727571|468421910|FG002|Overall Study|Ineligibility determined|1|||
130125368|NCT00727571|468421911|FG003|Overall Study|Ineligibility determined|0|||
130125369|NCT00727571|468421908|FG000|Overall Study|Death|0|||
130125370|NCT00727571|468421909|FG001|Overall Study|Death|19|||
130125371|NCT00727571|468421910|FG002|Overall Study|Death|5|||
130125372|NCT00727571|468421911|FG003|Overall Study|Death|1|||
130125373|NCT00727571|468421908|FG000|Overall Study|Physician Decision|0|||
130125374|NCT00727571|468421909|FG001|Overall Study|Physician Decision|5|||
130125375|NCT00727571|468421910|FG002|Overall Study|Physician Decision|0|||
130125376|NCT00727571|468421911|FG003|Overall Study|Physician Decision|0|||
130125377|NCT00727571|468421908|FG000|Overall Study|Withdrawal by Subject|0|||
130125378|NCT00727571|468421909|FG001|Overall Study|Withdrawal by Subject|10|||
130125379|NCT00727571|468421910|FG002|Overall Study|Withdrawal by Subject|11|||
130125380|NCT00727571|468421911|FG003|Overall Study|Withdrawal by Subject|0|||
130125381|NCT00727571|468421908|FG000|Overall Study|Subject Non Compliance|0|||
130125382|NCT00727571|468421909|FG001|Overall Study|Subject Non Compliance|6|||
130125383|NCT00727571|468421910|FG002|Overall Study|Subject Non Compliance|0|||
130125384|NCT00727571|468421911|FG003|Overall Study|Subject Non Compliance|4|||
130125385|NCT00727571|468421908|FG000|Overall Study|Dismissed from nursing home|0|||
130125386|NCT00727571|468421909|FG001|Overall Study|Dismissed from nursing home|9|||
130125387|NCT00727571|468421910|FG002|Overall Study|Dismissed from nursing home|5|||
130125388|NCT00727571|468421911|FG003|Overall Study|Dismissed from nursing home|0|||
130125389|NCT00727571|468421908|FG000|Overall Study|Hospitalization|0|||
130125390|NCT00727571|468421909|FG001|Overall Study|Hospitalization|1|||
130125391|NCT00727571|468421910|FG002|Overall Study|Hospitalization|0|||
130125392|NCT00727571|468421911|FG003|Overall Study|Hospitalization|1|||
130125393|NCT00727571|468421908|FG000|Overall Study|AE not leading to hospitalization|0|||
130125394|NCT00727571|468421909|FG001|Overall Study|AE not leading to hospitalization|0|||
130125395|NCT00727571|468421910|FG002|Overall Study|AE not leading to hospitalization|2|||
130125396|NCT00727571|468421911|FG003|Overall Study|AE not leading to hospitalization|0|||
130125397|NCT00727571|468421908|FG000|Overall Study|Other|0|||
130125398|NCT00727571|468421909|FG001|Overall Study|Other|4|||
130125399|NCT00727571|468421910|FG002|Overall Study|Other|6|||
130125400|NCT00727571|468421911|FG003|Overall Study|Other|0|||
130125401|NCT03164772|468421912|FG000|Overall Study|Death|4|||
130125402|NCT03164772|468421913|FG001|Overall Study|Death|2|||
130125403|NCT03164772|468421912|FG000|Overall Study|Adverse Event|1|||
130125404|NCT03164772|468421913|FG001|Overall Study|Adverse Event|4|||
130125405|NCT03164772|468421912|FG000|Overall Study|Progressive Disease|11|||
130125406|NCT03164772|468421913|FG001|Overall Study|Progressive Disease|21|||
130125407|NCT03164772|468421912|FG000|Overall Study|Physician Decision|2|||
130125408|NCT03164772|468421913|FG001|Overall Study|Physician Decision|0|||
130125409|NCT03164772|468421912|FG000|Overall Study|Withdrawal by Subject|0|||
130125410|NCT03164772|468421913|FG001|Overall Study|Withdrawal by Subject|4|||
130125411|NCT00051025|468421915|FG000|Overall Study|Progressive Disease|1|||
130125412|NCT00051025|468421916|FG001|Overall Study|Progressive Disease|1|||
130125413|NCT00051025|468421915|FG000|Overall Study|Adverse Event|1|||
130125414|NCT00051025|468421916|FG001|Overall Study|Adverse Event|1|||
130125415|NCT00051025|468421915|FG000|Overall Study|Withdrawal by Subject|0|||
130125416|NCT00051025|468421916|FG001|Overall Study|Withdrawal by Subject|1|||
130125417|NCT00051025|468421915|FG000|Overall Study|Death|0|||
130125418|NCT00051025|468421916|FG001|Overall Study|Death|1|||
130125419|NCT02189941|468421917|FG000|Overall Study|Non-compliance|0|||
130125420|NCT02189941|468421918|FG001|Overall Study|Non-compliance|0|||
130125421|NCT02189941|468421919|FG002|Overall Study|Non-compliance|1|||
130125422|NCT00445003|468421921|FG000|Overall Study|Death|1|||
130125423|NCT00445003|468421922|FG001|Overall Study|Death|2|||
130125424|NCT00445003|468421923|FG002|Overall Study|Death|1|||
130125425|NCT00445003|468421921|FG000|Overall Study|Missed Visit|3|||
130125426|NCT00445003|468421922|FG001|Overall Study|Missed Visit|5|||
130125427|NCT00445003|468421923|FG002|Overall Study|Missed Visit|1|||
130125428|NCT00445003|468421921|FG000|Overall Study|Dropped|1|||
130125429|NCT00445003|468421922|FG001|Overall Study|Dropped|3|||
130125430|NCT00445003|468421923|FG002|Overall Study|Dropped|2|||
130125431|NCT01471093|468421924|FG000|Overall Study|Adverse Event|1|||
130125432|NCT01471093|468421925|FG001|Overall Study|Adverse Event|0|||
130125433|NCT01471093|468421926|FG002|Overall Study|Adverse Event|0|||
130125434|NCT01471093|468421927|FG003|Overall Study|Adverse Event|0|||
130125435|NCT02475954|468421928|FG000|Overall Study|Withdrawal by Subject|2|||
130125436|NCT02475954|468421929|FG001|Overall Study|Withdrawal by Subject|2|||
130125437|NCT02475954|468421928|FG000|Overall Study|Lost to Follow-up|11|||
130125438|NCT02475954|468421929|FG001|Overall Study|Lost to Follow-up|9|||
130125439|NCT02475954|468421928|FG000|Overall Study|Death|1|||
130125440|NCT02475954|468421929|FG001|Overall Study|Death|1|||
130125441|NCT02932878|468421930|FG000|Overall Study|Due to Lab Results|2|||
130125442|NCT02932878|468421931|FG001|Overall Study|Due to Lab Results|1|||
130125443|NCT01918397|468421932|FG000|Overall Study|Never started treatment|2|||
130125444|NCT01918397|468421933|FG001|Overall Study|Never started treatment|1|||
130125445|NCT01918397|468421934|FG002|Overall Study|Never started treatment|0|||
130125446|NCT01918397|468421935|FG003|Overall Study|Never started treatment|0|||
130125447|NCT01918397|468421932|FG000|Overall Study|Adverse Event|1|||
130125448|NCT01918397|468421933|FG001|Overall Study|Adverse Event|1|||
130125449|NCT01918397|468421934|FG002|Overall Study|Adverse Event|1|||
130125450|NCT01918397|468421935|FG003|Overall Study|Adverse Event|0|||
130125451|NCT01918397|468421932|FG000|Overall Study|Lack of compliance|2|||
130125452|NCT01918397|468421933|FG001|Overall Study|Lack of compliance|2|||
130125453|NCT01918397|468421934|FG002|Overall Study|Lack of compliance|3|||
130125454|NCT01918397|468421935|FG003|Overall Study|Lack of compliance|0|||
130125455|NCT01918397|468421932|FG000|Overall Study|Pregnancy|0|||
130125456|NCT01918397|468421933|FG001|Overall Study|Pregnancy|1|||
130125457|NCT01918397|468421934|FG002|Overall Study|Pregnancy|0|||
130125458|NCT01918397|468421935|FG003|Overall Study|Pregnancy|0|||
130125459|NCT01918397|468421932|FG000|Overall Study|Rifampin susceptible|0|||
130125460|NCT01918397|468421933|FG001|Overall Study|Rifampin susceptible|0|||
130125461|NCT01918397|468421934|FG002|Overall Study|Rifampin susceptible|0|||
130125462|NCT01918397|468421935|FG003|Overall Study|Rifampin susceptible|2|||
130125463|NCT01918397|468421932|FG000|Overall Study|Treatment failure|0|||
130125464|NCT01918397|468421933|FG001|Overall Study|Treatment failure|0|||
130125465|NCT01918397|468421934|FG002|Overall Study|Treatment failure|0|||
130125466|NCT01918397|468421935|FG003|Overall Study|Treatment failure|1|||
130125467|NCT01918397|468421932|FG000|Overall Study|Withdrawal by Subject|3|||
130125468|NCT01918397|468421933|FG001|Overall Study|Withdrawal by Subject|2|||
130125469|NCT01918397|468421934|FG002|Overall Study|Withdrawal by Subject|1|||
130125470|NCT01918397|468421935|FG003|Overall Study|Withdrawal by Subject|1|||
130125471|NCT01918397|468421932|FG000|Overall Study|XDR at baseline|0|||
130125472|NCT01918397|468421933|FG001|Overall Study|XDR at baseline|0|||
130125473|NCT01918397|468421934|FG002|Overall Study|XDR at baseline|1|||
130125474|NCT01918397|468421935|FG003|Overall Study|XDR at baseline|0|||
130125475|NCT01918397|468421932|FG000|Overall Study|Lost to Follow-up|2|||
130125476|NCT01918397|468421933|FG001|Overall Study|Lost to Follow-up|1|||
130125477|NCT01918397|468421934|FG002|Overall Study|Lost to Follow-up|1|||
130125478|NCT01918397|468421935|FG003|Overall Study|Lost to Follow-up|1|||
130125479|NCT01918397|468421932|FG000|Overall Study|Increased QTc|1|||
130125480|NCT01918397|468421933|FG001|Overall Study|Increased QTc|0|||
130125481|NCT01918397|468421934|FG002|Overall Study|Increased QTc|0|||
130125482|NCT01918397|468421935|FG003|Overall Study|Increased QTc|1|||
130125483|NCT01918397|468421932|FG000|Overall Study|Death|0|||
130125484|NCT01918397|468421933|FG001|Overall Study|Death|0|||
130125485|NCT01918397|468421934|FG002|Overall Study|Death|1|||
130125486|NCT01918397|468421935|FG003|Overall Study|Death|0|||
130125487|NCT01918397|468421932|FG000|Overall Study|Involved in another investigative trial|0|||
130125488|NCT01918397|468421933|FG001|Overall Study|Involved in another investigative trial|0|||
130125489|NCT01918397|468421934|FG002|Overall Study|Involved in another investigative trial|0|||
130092713|NCT00151775|468294528|FG010|Period 4: Open Label|Lost to Follow-up|0|||
130092714|NCT00151775|468294529|FG011|Period 4: Open Label|Lost to Follow-up|0|||
130092715|NCT00151775|468294518|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
130092716|NCT00151775|468294519|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
130092717|NCT00151775|468294520|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
130092718|NCT00151775|468294521|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
130092719|NCT00151775|468294522|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
130092720|NCT00151775|468294523|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
130092721|NCT00151775|468294524|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
130092722|NCT00151775|468294525|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
130092723|NCT00151775|468294526|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
130092724|NCT00151775|468294527|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
130092725|NCT00151775|468294528|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
130092726|NCT00151775|468294529|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
130092727|NCT00151775|468294518|FG000|Period 4: Open Label|Other|0|||
130092728|NCT00151775|468294519|FG001|Period 4: Open Label|Other|0|||
130092729|NCT00151775|468294520|FG002|Period 4: Open Label|Other|0|||
130092730|NCT00151775|468294521|FG003|Period 4: Open Label|Other|0|||
130092731|NCT00151775|468294522|FG004|Period 4: Open Label|Other|1|||
130092732|NCT00151775|468294523|FG005|Period 4: Open Label|Other|0|||
130092733|NCT00151775|468294524|FG006|Period 4: Open Label|Other|0|||
130092734|NCT00151775|468294525|FG007|Period 4: Open Label|Other|0|||
130092735|NCT00151775|468294526|FG008|Period 4: Open Label|Other|0|||
130092736|NCT00151775|468294527|FG009|Period 4: Open Label|Other|3|||
130092737|NCT00151775|468294528|FG010|Period 4: Open Label|Other|0|||
130092738|NCT00151775|468294529|FG011|Period 4: Open Label|Other|0|||
130092739|NCT00151775|468294518|FG000|Period 4: Open Label|Physician Decision|0|||
130092740|NCT00151775|468294519|FG001|Period 4: Open Label|Physician Decision|0|||
130092741|NCT00151775|468294520|FG002|Period 4: Open Label|Physician Decision|0|||
130092742|NCT00151775|468294521|FG003|Period 4: Open Label|Physician Decision|0|||
130092743|NCT00151775|468294522|FG004|Period 4: Open Label|Physician Decision|0|||
130092744|NCT00151775|468294523|FG005|Period 4: Open Label|Physician Decision|0|||
130092745|NCT00151775|468294524|FG006|Period 4: Open Label|Physician Decision|0|||
130092746|NCT00151775|468294525|FG007|Period 4: Open Label|Physician Decision|0|||
130092747|NCT00151775|468294526|FG008|Period 4: Open Label|Physician Decision|0|||
130092748|NCT00151775|468294527|FG009|Period 4: Open Label|Physician Decision|2|||
130092749|NCT00151775|468294528|FG010|Period 4: Open Label|Physician Decision|0|||
130092750|NCT00151775|468294529|FG011|Period 4: Open Label|Physician Decision|0|||
130092751|NCT00151775|468294518|FG000|Period 4: Open Label|Protocol Violation|0|||
130092752|NCT00151775|468294519|FG001|Period 4: Open Label|Protocol Violation|0|||
130092753|NCT00151775|468294520|FG002|Period 4: Open Label|Protocol Violation|0|||
130092754|NCT00151775|468294521|FG003|Period 4: Open Label|Protocol Violation|0|||
130092755|NCT00151775|468294522|FG004|Period 4: Open Label|Protocol Violation|1|||
130092756|NCT00151775|468294523|FG005|Period 4: Open Label|Protocol Violation|0|||
130092757|NCT00151775|468294524|FG006|Period 4: Open Label|Protocol Violation|0|||
130092758|NCT00151775|468294525|FG007|Period 4: Open Label|Protocol Violation|0|||
130092759|NCT00151775|468294526|FG008|Period 4: Open Label|Protocol Violation|0|||
130092760|NCT00151775|468294527|FG009|Period 4: Open Label|Protocol Violation|0|||
130092761|NCT00151775|468294528|FG010|Period 4: Open Label|Protocol Violation|0|||
130092762|NCT00151775|468294529|FG011|Period 4: Open Label|Protocol Violation|0|||
130092763|NCT04516291|468294530|FG000|Treatment Period (24 Weeks)|Other|1|||
130092764|NCT04516291|468294531|FG001|Treatment Period (24 Weeks)|Other|0|||
130092765|NCT04516291|468294532|FG002|Treatment Period (24 Weeks)|Other|0|||
130092766|NCT04516291|468294533|FG003|Treatment Period (24 Weeks)|Other|2|||
130125490|NCT01918397|468421935|FG003|Overall Study|Involved in another investigative trial|1|||
130092767|NCT04516291|468294534|FG004|Treatment Period (24 Weeks)|Other|2|||
130092768|NCT04516291|468294535|FG005|Treatment Period (24 Weeks)|Other|4|||
130092769|NCT04516291|468294536|FG006|Treatment Period (24 Weeks)|Other|2|||
130092770|NCT04516291|468294537|FG007|Treatment Period (24 Weeks)|Other|0|||
130092771|NCT04516291|468294530|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130092772|NCT04516291|468294531|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
130092773|NCT04516291|468294532|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130125491|NCT00620022|468421936|FG000|Treatment Period 1|Adverse Event|4|||
130125492|NCT00620022|468421937|FG001|Treatment Period 1|Adverse Event|6|||
130125493|NCT00620022|468421936|FG000|Treatment Period 1|Subject withdrew consent|1|||
130125494|NCT00620022|468421937|FG001|Treatment Period 1|Subject withdrew consent|0|||
130125495|NCT00620022|468421936|FG000|Treatment Period 2|Adverse Event|2|||
130125496|NCT00620022|468421937|FG001|Treatment Period 2|Adverse Event|2|||
130125497|NCT03478397|468421938|FG000|Overall Study|Refused to participate|31|||
130125498|NCT03478397|468421939|FG001|Overall Study|Refused to participate|7|||
130125499|NCT02942264|468421940|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125500|NCT02942264|468421941|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
130125501|NCT02942264|468421942|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125502|NCT02942264|468421943|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125503|NCT02942264|468421944|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125504|NCT02942264|468421945|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125505|NCT02942264|468421946|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
130125506|NCT02942264|468421947|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125507|NCT02942264|468421948|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
130125508|NCT02942264|468421940|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125509|NCT02942264|468421941|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125510|NCT02942264|468421942|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125511|NCT02942264|468421943|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125512|NCT02942264|468421944|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125513|NCT02942264|468421945|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125514|NCT02942264|468421946|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125515|NCT02942264|468421947|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
130125516|NCT02942264|468421948|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
130125517|NCT02334722|468421949|FG000|Overall Study|Lost to Follow-up|4|||
130125518|NCT02334722|468421950|FG001|Overall Study|Lost to Follow-up|0|||
130125519|NCT02334722|468421949|FG000|Overall Study|6 week questionnaire not completed|2|||
130125520|NCT02334722|468421950|FG001|Overall Study|6 week questionnaire not completed|0|||
130125521|NCT02334722|468421949|FG000|Overall Study|Unable to obtain medication|1|||
130125522|NCT02334722|468421950|FG001|Overall Study|Unable to obtain medication|1|||
130125523|NCT02334722|468421949|FG000|Overall Study|Withdrawal by Subject|0|||
130125524|NCT02334722|468421950|FG001|Overall Study|Withdrawal by Subject|3|||
130125525|NCT02334722|468421949|FG000|Overall Study|Adverse Event|0|||
130125526|NCT02334722|468421950|FG001|Overall Study|Adverse Event|2|||
130125527|NCT02334722|468421949|FG000|Overall Study|Physician Decision|0|||
130125528|NCT02334722|468421950|FG001|Overall Study|Physician Decision|1|||
130125529|NCT00856388|468421951|FG000|Overall Study|Other|1|||
130125530|NCT01617668|468421954|FG000|Overall Study|Adverse Event|7|||
130125531|NCT01617668|468421955|FG001|Overall Study|Adverse Event|0|||
130125532|NCT01617668|468421956|FG002|Overall Study|Adverse Event|12|||
130125533|NCT01617668|468421957|FG003|Overall Study|Adverse Event|5|||
130125534|NCT01617668|468421954|FG000|Overall Study|Physician Decision|1|||
130125535|NCT01617668|468421955|FG001|Overall Study|Physician Decision|2|||
130125536|NCT01617668|468421956|FG002|Overall Study|Physician Decision|3|||
130125537|NCT01617668|468421957|FG003|Overall Study|Physician Decision|0|||
130125538|NCT01617668|468421954|FG000|Overall Study|Progressive Disease|4|||
130125539|NCT01617668|468421955|FG001|Overall Study|Progressive Disease|4|||
130125540|NCT01617668|468421956|FG002|Overall Study|Progressive Disease|6|||
130125541|NCT01617668|468421957|FG003|Overall Study|Progressive Disease|9|||
130125542|NCT01617668|468421954|FG000|Overall Study|Subject/guardian decision|1|||
130125543|NCT01617668|468421955|FG001|Overall Study|Subject/guardian decision|3|||
130125544|NCT01617668|468421956|FG002|Overall Study|Subject/guardian decision|2|||
130125545|NCT01617668|468421957|FG003|Overall Study|Subject/guardian decision|1|||
130125546|NCT00686959|468421958|FG000|Overall Study|Participants censored (no death events)|124|||
130125547|NCT00686959|468421959|FG001|Overall Study|Participants censored (no death events)|117|||
130125548|NCT00150462|468421962|FG000|Overall Study|Disease Progression or Relapse|3|||
130125549|NCT00150462|468421963|FG001|Overall Study|Disease Progression or Relapse|1|||
130125550|NCT00150462|468421964|FG002|Overall Study|Disease Progression or Relapse|2|||
130125551|NCT00150462|468421965|FG003|Overall Study|Disease Progression or Relapse|1|||
130125552|NCT00150462|468421966|FG004|Overall Study|Disease Progression or Relapse|2|||
130125553|NCT00150462|468421967|FG005|Overall Study|Disease Progression or Relapse|2|||
130125554|NCT00150462|468421968|FG006|Overall Study|Disease Progression or Relapse|3|||
130125555|NCT00150462|468421969|FG007|Overall Study|Disease Progression or Relapse|5|||
130125556|NCT00150462|468421970|FG008|Overall Study|Disease Progression or Relapse|5|||
130125557|NCT00150462|468421971|FG009|Overall Study|Disease Progression or Relapse|3|||
130125558|NCT00150462|468421972|FG010|Overall Study|Disease Progression or Relapse|2|||
130125559|NCT00150462|468421962|FG000|Overall Study|Withdrawal by Subject|0|||
130125560|NCT00150462|468421963|FG001|Overall Study|Withdrawal by Subject|1|||
130125561|NCT00150462|468421964|FG002|Overall Study|Withdrawal by Subject|1|||
130125562|NCT00150462|468421965|FG003|Overall Study|Withdrawal by Subject|0|||
130125563|NCT00150462|468421966|FG004|Overall Study|Withdrawal by Subject|1|||
130125564|NCT00150462|468421967|FG005|Overall Study|Withdrawal by Subject|2|||
130125565|NCT00150462|468421968|FG006|Overall Study|Withdrawal by Subject|0|||
129967712|NCT02706951|467847085|FG003|Period 1|Withdrawal by Subject|0|||
130125566|NCT00150462|468421969|FG007|Overall Study|Withdrawal by Subject|1|||
130125567|NCT00150462|468421970|FG008|Overall Study|Withdrawal by Subject|0|||
130125568|NCT00150462|468421971|FG009|Overall Study|Withdrawal by Subject|1|||
130125569|NCT00150462|468421972|FG010|Overall Study|Withdrawal by Subject|0|||
130125570|NCT00150462|468421962|FG000|Overall Study|Death|0|||
130125571|NCT00150462|468421963|FG001|Overall Study|Death|1|||
130125572|NCT00150462|468421964|FG002|Overall Study|Death|0|||
130125573|NCT00150462|468421965|FG003|Overall Study|Death|0|||
130125574|NCT00150462|468421966|FG004|Overall Study|Death|0|||
130125575|NCT00150462|468421967|FG005|Overall Study|Death|0|||
130125576|NCT00150462|468421968|FG006|Overall Study|Death|0|||
130125577|NCT00150462|468421969|FG007|Overall Study|Death|0|||
130125578|NCT00150462|468421970|FG008|Overall Study|Death|1|||
130125579|NCT00150462|468421971|FG009|Overall Study|Death|0|||
130125580|NCT00150462|468421972|FG010|Overall Study|Death|0|||
130125581|NCT00150462|468421962|FG000|Overall Study|Adverse Event|0|||
130125582|NCT00150462|468421963|FG001|Overall Study|Adverse Event|0|||
130125583|NCT00150462|468421964|FG002|Overall Study|Adverse Event|0|||
130125584|NCT00150462|468421965|FG003|Overall Study|Adverse Event|1|||
130125585|NCT00150462|468421966|FG004|Overall Study|Adverse Event|0|||
130125586|NCT00150462|468421967|FG005|Overall Study|Adverse Event|0|||
130125587|NCT00150462|468421968|FG006|Overall Study|Adverse Event|0|||
130125588|NCT00150462|468421969|FG007|Overall Study|Adverse Event|2|||
130125589|NCT00150462|468421970|FG008|Overall Study|Adverse Event|0|||
130125590|NCT00150462|468421971|FG009|Overall Study|Adverse Event|1|||
130125591|NCT00150462|468421972|FG010|Overall Study|Adverse Event|0|||
130125592|NCT00150462|468421962|FG000|Overall Study|Physician Decision|0|||
130125593|NCT00150462|468421963|FG001|Overall Study|Physician Decision|0|||
130125594|NCT00150462|468421964|FG002|Overall Study|Physician Decision|1|||
130125595|NCT00150462|468421965|FG003|Overall Study|Physician Decision|1|||
130125596|NCT00150462|468421966|FG004|Overall Study|Physician Decision|0|||
130125597|NCT00150462|468421967|FG005|Overall Study|Physician Decision|0|||
130125598|NCT00150462|468421968|FG006|Overall Study|Physician Decision|0|||
130125599|NCT00150462|468421969|FG007|Overall Study|Physician Decision|0|||
130125600|NCT00150462|468421970|FG008|Overall Study|Physician Decision|0|||
130125601|NCT00150462|468421971|FG009|Overall Study|Physician Decision|0|||
130125602|NCT00150462|468421972|FG010|Overall Study|Physician Decision|0|||
130125603|NCT00150462|468421962|FG000|Overall Study|Other|0|||
130125604|NCT00150462|468421963|FG001|Overall Study|Other|0|||
130125605|NCT00150462|468421964|FG002|Overall Study|Other|0|||
130125606|NCT00150462|468421965|FG003|Overall Study|Other|0|||
130125607|NCT00150462|468421966|FG004|Overall Study|Other|0|||
130125608|NCT00150462|468421967|FG005|Overall Study|Other|0|||
130125609|NCT00150462|468421968|FG006|Overall Study|Other|0|||
130125610|NCT00150462|468421969|FG007|Overall Study|Other|0|||
130125611|NCT00150462|468421970|FG008|Overall Study|Other|0|||
130125612|NCT00150462|468421971|FG009|Overall Study|Other|1|||
130125613|NCT00150462|468421972|FG010|Overall Study|Other|1|||
130125614|NCT00569374|468421973|FG000|Overall Study|Withdrawal by Subject|4|||
130125615|NCT00912288|468421976|FG000|Overall Study|Death|0|||
130125616|NCT00912288|468421977|FG001|Overall Study|Death|1|||
130125617|NCT00912288|468421976|FG000|Overall Study|Adverse Event|1|||
130125618|NCT00912288|468421977|FG001|Overall Study|Adverse Event|1|||
130125619|NCT00912288|468421976|FG000|Overall Study|Lost to Follow-up|1|||
130125620|NCT00912288|468421977|FG001|Overall Study|Lost to Follow-up|0|||
130125621|NCT00912288|468421976|FG000|Overall Study|Protocol Violation|1|||
130125622|NCT00912288|468421977|FG001|Overall Study|Protocol Violation|0|||
130125623|NCT00912288|468421976|FG000|Overall Study|Withdrawal by Subject|3|||
130125624|NCT00912288|468421977|FG001|Overall Study|Withdrawal by Subject|3|||
130125625|NCT00912288|468421976|FG000|Overall Study|Study terminated by sponsor|34|||
130125626|NCT00912288|468421977|FG001|Overall Study|Study terminated by sponsor|35|||
130125627|NCT00912288|468421976|FG000|Overall Study|Other|1|||
130125628|NCT00912288|468421977|FG001|Overall Study|Other|0|||
130125629|NCT01196052|468421980|FG000|Overall Study|Adverse Event|9|||
130125630|NCT01196052|468421980|FG000|Overall Study|Lost to Follow-up|1|||
130125631|NCT01196052|468421980|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
130125632|NCT01196052|468421980|FG000|Overall Study|Reason not Specified|5|||
130125633|NCT01196052|468421980|FG000|Overall Study|Withdrawal by Subject|6|||
130125634|NCT02178722|468421981|FG000|Overall Study|Withdrawal by Subject|0|||
130125635|NCT02178722|468421982|FG001|Overall Study|Withdrawal by Subject|0|||
130125636|NCT02178722|468421983|FG002|Overall Study|Withdrawal by Subject|0|||
130125637|NCT02178722|468421984|FG003|Overall Study|Withdrawal by Subject|2|||
130125638|NCT02178722|468421985|FG004|Overall Study|Withdrawal by Subject|33|||
130125639|NCT02178722|468421981|FG000|Overall Study|Death|2|||
130125640|NCT02178722|468421982|FG001|Overall Study|Death|13|||
130125641|NCT02178722|468421983|FG002|Overall Study|Death|12|||
130125642|NCT02178722|468421984|FG003|Overall Study|Death|12|||
130125643|NCT02178722|468421985|FG004|Overall Study|Death|205|||
130125644|NCT02178722|468421981|FG000|Overall Study|Lost to Follow-up|0|||
130125645|NCT02178722|468421982|FG001|Overall Study|Lost to Follow-up|0|||
130125646|NCT02178722|468421983|FG002|Overall Study|Lost to Follow-up|0|||
130125647|NCT02178722|468421984|FG003|Overall Study|Lost to Follow-up|2|||
130092774|NCT04516291|468294533|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130092775|NCT04516291|468294534|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130092776|NCT04516291|468294535|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130092777|NCT04516291|468294536|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130092778|NCT04516291|468294537|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130092779|NCT04516291|468294530|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092780|NCT04516291|468294531|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092781|NCT04516291|468294532|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092782|NCT04516291|468294533|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
130092783|NCT04516291|468294534|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092784|NCT04516291|468294535|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092785|NCT04516291|468294536|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092786|NCT04516291|468294537|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
130092787|NCT04516291|468294530|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092788|NCT04516291|468294531|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130092789|NCT04516291|468294532|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092790|NCT04516291|468294533|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092791|NCT04516291|468294534|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092792|NCT04516291|468294535|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092793|NCT04516291|468294536|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092794|NCT04516291|468294537|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130092795|NCT04516291|468294530|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
130092796|NCT04516291|468294531|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
130092797|NCT04516291|468294532|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
130092798|NCT04516291|468294533|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
130092799|NCT04516291|468294534|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
130092800|NCT04516291|468294535|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
130092801|NCT04516291|468294536|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
130092802|NCT04516291|468294537|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
130092803|NCT04516291|468294530|FG000|Follow-up Period (12 Weeks)|Other|0|||
130092804|NCT04516291|468294531|FG001|Follow-up Period (12 Weeks)|Other|1|||
130092805|NCT04516291|468294532|FG002|Follow-up Period (12 Weeks)|Other|0|||
130092806|NCT04516291|468294533|FG003|Follow-up Period (12 Weeks)|Other|2|||
130092807|NCT04516291|468294534|FG004|Follow-up Period (12 Weeks)|Other|0|||
130092808|NCT04516291|468294535|FG005|Follow-up Period (12 Weeks)|Other|0|||
130092809|NCT04516291|468294536|FG006|Follow-up Period (12 Weeks)|Other|0|||
130092810|NCT04516291|468294537|FG007|Follow-up Period (12 Weeks)|Other|0|||
130092811|NCT04516291|468294530|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092812|NCT04516291|468294531|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092813|NCT04516291|468294532|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092814|NCT04516291|468294533|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092815|NCT04516291|468294534|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
130092816|NCT04516291|468294535|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092817|NCT04516291|468294536|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092818|NCT04516291|468294537|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
130092819|NCT04516291|468294530|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
130092820|NCT04516291|468294531|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
130092821|NCT04516291|468294532|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
130092822|NCT04516291|468294533|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
130092823|NCT04516291|468294534|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
130092824|NCT04516291|468294535|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
130092825|NCT04516291|468294536|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
130092826|NCT04516291|468294537|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
130092827|NCT03039686|468294538|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
130092828|NCT03039686|468294539|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
130092829|NCT03039686|468294540|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
130092830|NCT03039686|468294538|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
130092831|NCT03039686|468294539|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
130092832|NCT03039686|468294540|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
130092833|NCT03039686|468294538|FG000|Double-blind Period|Withdrawal by Subject|2|||
130092834|NCT03039686|468294539|FG001|Double-blind Period|Withdrawal by Subject|2|||
130092835|NCT03039686|468294540|FG002|Double-blind Period|Withdrawal by Subject|1|||
130092836|NCT03039686|468294538|FG000|Double-blind Period|Death|0|||
130092837|NCT03039686|468294539|FG001|Double-blind Period|Death|0|||
130092838|NCT03039686|468294540|FG002|Double-blind Period|Death|1|||
130092839|NCT03039686|468294538|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
130092840|NCT03039686|468294539|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
130092841|NCT03039686|468294540|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
130092842|NCT03039686|468294538|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
130092843|NCT03039686|468294539|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
130125648|NCT02178722|468421985|FG004|Overall Study|Lost to Follow-up|11|||
129967713|NCT02706951|467847086|FG004|Period 1|Withdrawal by Subject|0|||
130125649|NCT02178722|468421981|FG000|Overall Study|Study terminated by Sponsor|2|||
130125650|NCT02178722|468421982|FG001|Overall Study|Study terminated by Sponsor|7|||
130125651|NCT02178722|468421983|FG002|Overall Study|Study terminated by Sponsor|6|||
130125652|NCT02178722|468421984|FG003|Overall Study|Study terminated by Sponsor|4|||
130125653|NCT02178722|468421985|FG004|Overall Study|Study terminated by Sponsor|128|||
130125654|NCT02178722|468421981|FG000|Overall Study|Physician Decision|0|||
130125655|NCT02178722|468421982|FG001|Overall Study|Physician Decision|0|||
130125656|NCT02178722|468421983|FG002|Overall Study|Physician Decision|0|||
130125657|NCT02178722|468421984|FG003|Overall Study|Physician Decision|0|||
130125658|NCT02178722|468421985|FG004|Overall Study|Physician Decision|3|||
130125659|NCT02178722|468421981|FG000|Overall Study|Other|0|||
130125660|NCT02178722|468421982|FG001|Overall Study|Other|0|||
130125661|NCT02178722|468421983|FG002|Overall Study|Other|0|||
130125662|NCT02178722|468421984|FG003|Overall Study|Other|0|||
130125663|NCT02178722|468421985|FG004|Overall Study|Other|2|||
130125664|NCT01572948|468421986|FG000|Overall Study|Lost to Follow-up|1|||
130125665|NCT01572948|468421987|FG001|Overall Study|Lost to Follow-up|0|||
130125666|NCT01572948|468421986|FG000|Overall Study|unable to contact|0|||
130125667|NCT01572948|468421987|FG001|Overall Study|unable to contact|1|||
130125668|NCT03553823|468421988|FG000|Overall Study|Physician Decision|0|||
130125669|NCT03553823|468421989|FG001|Overall Study|Physician Decision|1|||
130125670|NCT03340727|468421990|FG000|Overall Study|Death|1|||
130125671|NCT03340727|468421991|FG001|Overall Study|Death|0|||
130125672|NCT03340727|468421990|FG000|Overall Study|Lost to Follow-up|31|||
130125673|NCT03340727|468421991|FG001|Overall Study|Lost to Follow-up|35|||
130125674|NCT03340727|468421990|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
130125675|NCT03340727|468421991|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
130125676|NCT03340727|468421990|FG000|Overall Study|Transferred to another facility|10|||
130125677|NCT03340727|468421991|FG001|Overall Study|Transferred to another facility|7|||
130125678|NCT03340727|468421990|FG000|Overall Study|Withdrawal by Subject|28|||
130125679|NCT03340727|468421991|FG001|Overall Study|Withdrawal by Subject|17|||
130125680|NCT03603314|468421992|FG000|Overall Study|Lost to Follow-up|0|||
130125681|NCT03603314|468421993|FG001|Overall Study|Lost to Follow-up|3|||
130125682|NCT03603314|468421994|FG002|Overall Study|Lost to Follow-up|0|||
130125683|NCT03603314|468421992|FG000|Overall Study|Protocol Violation|0|||
130125684|NCT03603314|468421993|FG001|Overall Study|Protocol Violation|1|||
130125685|NCT03603314|468421994|FG002|Overall Study|Protocol Violation|0|||
130125686|NCT03603314|468421992|FG000|Overall Study|Adverse Event|2|||
130125687|NCT03603314|468421993|FG001|Overall Study|Adverse Event|0|||
130125688|NCT03603314|468421994|FG002|Overall Study|Adverse Event|0|||
130125689|NCT03603314|468421992|FG000|Overall Study|Physician Decision|1|||
130125690|NCT03603314|468421993|FG001|Overall Study|Physician Decision|1|||
130125691|NCT03603314|468421994|FG002|Overall Study|Physician Decision|0|||
130125692|NCT03603314|468421992|FG000|Overall Study|Withdrawal by Subject|4|||
130125693|NCT03603314|468421993|FG001|Overall Study|Withdrawal by Subject|5|||
130125694|NCT03603314|468421994|FG002|Overall Study|Withdrawal by Subject|3|||
130125695|NCT03603314|468421992|FG000|Overall Study|Other|0|||
130125696|NCT03603314|468421993|FG001|Overall Study|Other|1|||
130125697|NCT03603314|468421994|FG002|Overall Study|Other|0|||
130125698|NCT03450070|468421995|FG000|Overall Study|Withdrawal by Subject|8|||
130125699|NCT00877032|468421996|FG000|Overall Study|Did not meet entrance criteria|0|||
130125700|NCT00877032|468421997|FG001|Overall Study|Did not meet entrance criteria|0|||
130125701|NCT00877032|468421998|FG002|Overall Study|Did not meet entrance criteria|0|||
130125702|NCT00877032|468421999|FG003|Overall Study|Did not meet entrance criteria|1|||
130125703|NCT00877032|468422000|FG004|Overall Study|Did not meet entrance criteria|0|||
130125704|NCT00877032|468422001|FG005|Overall Study|Did not meet entrance criteria|0|||
130125705|NCT00877032|468422002|FG006|Overall Study|Did not meet entrance criteria|2|||
130125706|NCT05067647|468422011|FG000|Overall Study|Lost to Follow-up|1|||
130125707|NCT00870870|468422013|FG000|Overall Study|Withdrawal by Subject|0|||
130125708|NCT00870870|468422014|FG001|Overall Study|Withdrawal by Subject|1|||
130125709|NCT00870870|468422015|FG002|Overall Study|Withdrawal by Subject|1|||
130125710|NCT00870870|468422016|FG003|Overall Study|Withdrawal by Subject|3|||
130125711|NCT00870870|468422013|FG000|Overall Study|Adverse Event|0|||
130125712|NCT00870870|468422014|FG001|Overall Study|Adverse Event|0|||
130125713|NCT00870870|468422015|FG002|Overall Study|Adverse Event|2|||
130125714|NCT00870870|468422016|FG003|Overall Study|Adverse Event|2|||
130125715|NCT03125200|468422019|FG000|Overall Study|Study Termination|0|||
130125716|NCT03125200|468422020|FG001|Overall Study|Study Termination|0|||
130125717|NCT03125200|468422021|FG002|Overall Study|Study Termination|0|||
130125718|NCT03125200|468422022|FG003|Overall Study|Study Termination|1|||
130125719|NCT03125200|468422023|FG004|Overall Study|Study Termination|1|||
130125720|NCT03125200|468422024|FG005|Overall Study|Study Termination|2|||
130125721|NCT03125200|468422025|FG006|Overall Study|Study Termination|1|||
130125722|NCT03125200|468422019|FG000|Overall Study|Clinical Progression|0|||
130125723|NCT03125200|468422020|FG001|Overall Study|Clinical Progression|0|||
130125724|NCT03125200|468422021|FG002|Overall Study|Clinical Progression|0|||
130125725|NCT03125200|468422022|FG003|Overall Study|Clinical Progression|1|||
130125726|NCT03125200|468422023|FG004|Overall Study|Clinical Progression|0|||
130125727|NCT03125200|468422024|FG005|Overall Study|Clinical Progression|1|||
130125728|NCT03125200|468422025|FG006|Overall Study|Clinical Progression|0|||
130125729|NCT03125200|468422019|FG000|Overall Study|Progressive Disease|2|||
130125730|NCT03125200|468422020|FG001|Overall Study|Progressive Disease|1|||
130125731|NCT03125200|468422021|FG002|Overall Study|Progressive Disease|2|||
130125732|NCT03125200|468422022|FG003|Overall Study|Progressive Disease|1|||
130125733|NCT03125200|468422023|FG004|Overall Study|Progressive Disease|2|||
130125734|NCT03125200|468422024|FG005|Overall Study|Progressive Disease|0|||
130125735|NCT03125200|468422025|FG006|Overall Study|Progressive Disease|1|||
130125736|NCT03125200|468422019|FG000|Overall Study|Lack of Efficacy|0|||
130125737|NCT03125200|468422020|FG001|Overall Study|Lack of Efficacy|0|||
130125738|NCT03125200|468422021|FG002|Overall Study|Lack of Efficacy|0|||
130125739|NCT03125200|468422022|FG003|Overall Study|Lack of Efficacy|1|||
130125740|NCT03125200|468422023|FG004|Overall Study|Lack of Efficacy|0|||
130125741|NCT03125200|468422024|FG005|Overall Study|Lack of Efficacy|0|||
130125742|NCT03125200|468422025|FG006|Overall Study|Lack of Efficacy|0|||
130125743|NCT03125200|468422019|FG000|Overall Study|Toxicity|0|||
130125744|NCT03125200|468422020|FG001|Overall Study|Toxicity|0|||
130125745|NCT03125200|468422021|FG002|Overall Study|Toxicity|0|||
130125746|NCT03125200|468422022|FG003|Overall Study|Toxicity|1|||
130125747|NCT03125200|468422023|FG004|Overall Study|Toxicity|0|||
130125748|NCT03125200|468422024|FG005|Overall Study|Toxicity|0|||
130125749|NCT03125200|468422025|FG006|Overall Study|Toxicity|0|||
130125750|NCT03125200|468422019|FG000|Overall Study|Consent Withdrawn by Subject|0|||
130125751|NCT03125200|468422020|FG001|Overall Study|Consent Withdrawn by Subject|1|||
130125752|NCT03125200|468422021|FG002|Overall Study|Consent Withdrawn by Subject|0|||
130125753|NCT03125200|468422022|FG003|Overall Study|Consent Withdrawn by Subject|0|||
130125754|NCT03125200|468422023|FG004|Overall Study|Consent Withdrawn by Subject|1|||
130125755|NCT03125200|468422024|FG005|Overall Study|Consent Withdrawn by Subject|0|||
130125756|NCT03125200|468422025|FG006|Overall Study|Consent Withdrawn by Subject|1|||
130125757|NCT00119379|468422029|FG000|Overall Study|Adverse Event|4|||
130125758|NCT00119379|468422030|FG001|Overall Study|Adverse Event|1|||
130125759|NCT01937390|468422038|FG000|Overall Study|Death|2|||
130125760|NCT01937390|468422038|FG000|Overall Study|Lost to Follow-up|7|||
130125761|NCT01937390|468422038|FG000|Overall Study|Withdrawal by Subject|5|||
130125762|NCT01937390|468422038|FG000|Overall Study|Fail to return|21|||
130125763|NCT01706536|468422042|FG000|Overall Study|Withdrawal by Subject|1|||
130125764|NCT01706536|468422043|FG001|Overall Study|Withdrawal by Subject|0|||
130125765|NCT01706536|468422044|FG002|Overall Study|Withdrawal by Subject|1|||
130125766|NCT01706536|468422045|FG003|Overall Study|Withdrawal by Subject|0|||
130125767|NCT01706536|468422046|FG004|Overall Study|Withdrawal by Subject|0|||
130125768|NCT01706536|468422042|FG000|Overall Study|Adverse Event|2|||
130125769|NCT01706536|468422043|FG001|Overall Study|Adverse Event|3|||
130125770|NCT01706536|468422044|FG002|Overall Study|Adverse Event|4|||
130125771|NCT01706536|468422045|FG003|Overall Study|Adverse Event|3|||
130125772|NCT01706536|468422046|FG004|Overall Study|Adverse Event|2|||
130125773|NCT01706536|468422042|FG000|Overall Study|Lack of Efficacy|1|||
130125774|NCT01706536|468422043|FG001|Overall Study|Lack of Efficacy|0|||
130125775|NCT01706536|468422044|FG002|Overall Study|Lack of Efficacy|0|||
130125776|NCT01706536|468422045|FG003|Overall Study|Lack of Efficacy|1|||
130125777|NCT01706536|468422046|FG004|Overall Study|Lack of Efficacy|0|||
130125778|NCT01706536|468422042|FG000|Overall Study|non compliance|0|||
130125779|NCT01706536|468422043|FG001|Overall Study|non compliance|1|||
130125780|NCT01706536|468422044|FG002|Overall Study|non compliance|0|||
130125781|NCT01706536|468422045|FG003|Overall Study|non compliance|0|||
130125782|NCT01706536|468422046|FG004|Overall Study|non compliance|0|||
130125783|NCT00683293|468422055|FG000|Overall Study|Withdrawal by Subject|2|||
130125784|NCT00683293|468422056|FG001|Overall Study|Withdrawal by Subject|3|||
130125785|NCT03262012|468422057|FG000|Overall Study|Withdrawal by Subject|15|||
130125786|NCT03262012|468422058|FG001|Overall Study|Withdrawal by Subject|13|||
130125787|NCT03262012|468422059|FG002|Overall Study|Withdrawal by Subject|8|||
130125788|NCT03262012|468422060|FG003|Overall Study|Withdrawal by Subject|7|||
130125789|NCT03262012|468422057|FG000|Overall Study|Adverse Event|10|||
130125790|NCT03262012|468422058|FG001|Overall Study|Adverse Event|12|||
130125791|NCT03262012|468422059|FG002|Overall Study|Adverse Event|4|||
130125792|NCT03262012|468422060|FG003|Overall Study|Adverse Event|6|||
130125793|NCT03262012|468422057|FG000|Overall Study|Physician Decision|2|||
130125794|NCT03262012|468422058|FG001|Overall Study|Physician Decision|5|||
130125795|NCT03262012|468422059|FG002|Overall Study|Physician Decision|1|||
130125796|NCT03262012|468422060|FG003|Overall Study|Physician Decision|0|||
130125797|NCT03262012|468422057|FG000|Overall Study|Lack of Efficacy|0|||
130125798|NCT03262012|468422058|FG001|Overall Study|Lack of Efficacy|5|||
130125799|NCT03262012|468422059|FG002|Overall Study|Lack of Efficacy|1|||
130125800|NCT03262012|468422060|FG003|Overall Study|Lack of Efficacy|2|||
130125801|NCT03262012|468422057|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
130125802|NCT03262012|468422058|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
130125803|NCT03262012|468422059|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
130125804|NCT03262012|468422060|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
130125805|NCT01469546|468422061|FG000|Received 5 mg Dose|Adverse Event|13|||
130125806|NCT01469546|468422061|FG000|Received 5 mg Dose|Death|2|||
130125807|NCT01469546|468422061|FG000|Received 5 mg Dose|Protocol Violation|2|||
130125808|NCT01469546|468422061|FG000|Received 5 mg Dose|Progressive Disease|3|||
130125809|NCT01469546|468422061|FG000|Received 5 mg Dose|Physician Decision|3|||
130125810|NCT03601637|468423461|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
130125811|NCT03601637|468423462|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
130125812|NCT03601637|468423461|FG000|Overall Study|Adverse Event|1|||
130125813|NCT03601637|468423462|FG001|Overall Study|Adverse Event|1|||
130125814|NCT03601637|468423461|FG000|Overall Study|Other|0|||
130125815|NCT03601637|468423462|FG001|Overall Study|Other|1|||
130125816|NCT01248247|468423463|FG000|Overall Study|Adverse Event|2|||
130125817|NCT01248247|468423464|FG001|Overall Study|Adverse Event|4|||
130125818|NCT01248247|468423465|FG002|Overall Study|Adverse Event|4|||
130125819|NCT01248247|468423466|FG003|Overall Study|Adverse Event|2|||
130125820|NCT01248247|468423463|FG000|Overall Study|Death|0|||
130125821|NCT01248247|468423464|FG001|Overall Study|Death|1|||
130125822|NCT01248247|468423465|FG002|Overall Study|Death|4|||
130125823|NCT01248247|468423466|FG003|Overall Study|Death|7|||
130125824|NCT01248247|468423463|FG000|Overall Study|Lost to Follow-up|0|||
130125825|NCT01248247|468423464|FG001|Overall Study|Lost to Follow-up|1|||
130125826|NCT01248247|468423465|FG002|Overall Study|Lost to Follow-up|1|||
130125827|NCT01248247|468423466|FG003|Overall Study|Lost to Follow-up|0|||
130125828|NCT01248247|468423463|FG000|Overall Study|Alternative treatment|0|||
130125829|NCT01248247|468423464|FG001|Overall Study|Alternative treatment|1|||
130125830|NCT01248247|468423465|FG002|Overall Study|Alternative treatment|0|||
130125831|NCT01248247|468423466|FG003|Overall Study|Alternative treatment|0|||
130125832|NCT01248247|468423463|FG000|Overall Study|Other|2|||
130125833|NCT01248247|468423464|FG001|Overall Study|Other|8|||
130125834|NCT01248247|468423465|FG002|Overall Study|Other|8|||
130125835|NCT01248247|468423466|FG003|Overall Study|Other|5|||
130125836|NCT01248247|468423463|FG000|Overall Study|Progression|18|||
130125837|NCT01248247|468423464|FG001|Overall Study|Progression|27|||
130125838|NCT01248247|468423465|FG002|Overall Study|Progression|56|||
130125839|NCT01248247|468423466|FG003|Overall Study|Progression|44|||
130125840|NCT01248247|468423463|FG000|Overall Study|Refuse further treatment|0|||
130125841|NCT01248247|468423464|FG001|Overall Study|Refuse further treatment|0|||
130125842|NCT01248247|468423465|FG002|Overall Study|Refuse further treatment|1|||
130125843|NCT01248247|468423466|FG003|Overall Study|Refuse further treatment|2|||
130125844|NCT01248247|468423463|FG000|Overall Study|Complicating disease|0|||
130125845|NCT01248247|468423464|FG001|Overall Study|Complicating disease|0|||
130125846|NCT01248247|468423465|FG002|Overall Study|Complicating disease|1|||
130125847|NCT01248247|468423466|FG003|Overall Study|Complicating disease|1|||
130125848|NCT01507051|468423472|FG000|Overall Study|Withdrawal by Subject|1|||
130125849|NCT01507051|468423473|FG001|Overall Study|Withdrawal by Subject|3|||
130125850|NCT01507051|468423474|FG002|Overall Study|Withdrawal by Subject|1|||
130125851|NCT01507051|468423475|FG003|Overall Study|Withdrawal by Subject|6|||
130125852|NCT01507051|468423472|FG000|Overall Study|Physician Decision|0|||
130125853|NCT01507051|468423473|FG001|Overall Study|Physician Decision|0|||
130125854|NCT01507051|468423474|FG002|Overall Study|Physician Decision|0|||
130125855|NCT01507051|468423475|FG003|Overall Study|Physician Decision|1|||
130125856|NCT01507051|468423472|FG000|Overall Study|Adverse Event|1|||
130125857|NCT01507051|468423473|FG001|Overall Study|Adverse Event|0|||
130125858|NCT01507051|468423474|FG002|Overall Study|Adverse Event|0|||
130125859|NCT01507051|468423475|FG003|Overall Study|Adverse Event|0|||
130125860|NCT00420303|468423476|FG000|Overall Study|Serious Adverse Event|1|||
130125861|NCT00420303|468423477|FG001|Overall Study|Serious Adverse Event|0|||
130125862|NCT00420303|468423476|FG000|Overall Study|Lack of Efficacy|0|||
130125863|NCT00420303|468423477|FG001|Overall Study|Lack of Efficacy|3|||
130125864|NCT00420303|468423476|FG000|Overall Study|Physician Decision|0|||
130125865|NCT00420303|468423477|FG001|Overall Study|Physician Decision|1|||
130125866|NCT00745420|468423479|FG000|Overall Study|Ineligible|1|||
130125867|NCT00485472|468423480|FG000|Overall Study|Adverse Event|8|||
130125868|NCT00485472|468423481|FG001|Overall Study|Adverse Event|5|||
130125869|NCT00485472|468423480|FG000|Overall Study|Lack of Efficacy|5|||
130125870|NCT00485472|468423481|FG001|Overall Study|Lack of Efficacy|4|||
130125871|NCT00485472|468423480|FG000|Overall Study|Withdrawal by Subject|1|||
130125872|NCT00485472|468423481|FG001|Overall Study|Withdrawal by Subject|0|||
130125873|NCT00485472|468423480|FG000|Overall Study|Protocol Violation|0|||
130125874|NCT00485472|468423481|FG001|Overall Study|Protocol Violation|1|||
130125875|NCT00485472|468423480|FG000|Overall Study|Other|2|||
130125876|NCT00485472|468423481|FG001|Overall Study|Other|1|||
130125877|NCT00485472|468423480|FG000|Overall Study|Lost to Follow-up|0|||
130125878|NCT00485472|468423481|FG001|Overall Study|Lost to Follow-up|1|||
130125879|NCT00088829|468423486|FG000|Overall Study|PI left institution and study was close|22|||
130125880|NCT04455633|468423487|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
130125881|NCT04455633|468423488|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
130125882|NCT04455633|468423489|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
130125883|NCT04455633|468423487|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
130125884|NCT04455633|468423488|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
130125885|NCT04455633|468423489|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
130125886|NCT04455633|468423487|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
130125887|NCT04455633|468423488|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
130125888|NCT04455633|468423489|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
130125889|NCT04455633|468423487|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
130125890|NCT04455633|468423488|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
130125891|NCT04455633|468423489|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
130125892|NCT04015232|468423491|FG000|Overall Study|Withdrawal by Subject|7|||
130125893|NCT04015232|468423492|FG001|Overall Study|Withdrawal by Subject|4|||
130125894|NCT04015232|468423491|FG000|Overall Study|Protocol Violation|1|||
130125895|NCT04015232|468423492|FG001|Overall Study|Protocol Violation|0|||
130125896|NCT04015232|468423491|FG000|Overall Study|Medical Grounds|3|||
130125897|NCT04015232|468423492|FG001|Overall Study|Medical Grounds|3|||
130125898|NCT01029353|468423495|FG000|Overall Study|Lost to Follow-up|4|||
130125899|NCT01029353|468423496|FG001|Overall Study|Lost to Follow-up|5|||
130125900|NCT01029353|468423497|FG002|Overall Study|Lost to Follow-up|5|||
130125901|NCT01029353|468423498|FG003|Overall Study|Lost to Follow-up|4|||
130125902|NCT01029353|468423495|FG000|Overall Study|Consent Withdrawn|2|||
130125903|NCT01029353|468423496|FG001|Overall Study|Consent Withdrawn|0|||
130125904|NCT01029353|468423497|FG002|Overall Study|Consent Withdrawn|0|||
130125905|NCT01029353|468423498|FG003|Overall Study|Consent Withdrawn|0|||
130125906|NCT01029353|468423495|FG000|Overall Study|Primary Outcome Indeterminate|1|||
130125907|NCT01029353|468423496|FG001|Overall Study|Primary Outcome Indeterminate|3|||
130125908|NCT01029353|468423497|FG002|Overall Study|Primary Outcome Indeterminate|2|||
130125909|NCT01029353|468423498|FG003|Overall Study|Primary Outcome Indeterminate|0|||
130125910|NCT01287013|468423499|FG000|Overall Study|Non-evaluable|3|||
130125911|NCT01287013|468423500|FG001|Overall Study|Non-evaluable|5|||
130125912|NCT01287013|468423501|FG002|Overall Study|Non-evaluable|21|||
130125913|NCT01900730|468423502|FG000|Overall Study|Withdrawal by Subject|1|||
130125914|NCT01900730|468423503|FG001|Overall Study|Withdrawal by Subject|0|||
130125915|NCT01900730|468423502|FG000|Overall Study|Screen Failure|1|||
130125916|NCT01900730|468423503|FG001|Overall Study|Screen Failure|0|||
130125917|NCT02109042|468423504|FG000|Overall Study|Sponsor Decision|15|||
130125918|NCT03203447|468423505|FG000|Overall Study|Withdrawal by Subject|2|||
130125919|NCT03203447|468423506|FG001|Overall Study|Withdrawal by Subject|1|||
130125920|NCT03203447|468423505|FG000|Overall Study|Lost to Follow-up|1|||
130125921|NCT03203447|468423506|FG001|Overall Study|Lost to Follow-up|10|||
130125922|NCT03203447|468423505|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
130125923|NCT03203447|468423506|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
130125924|NCT00050778|468423507|FG000|Overall Study|Adverse Event|13|||
130125925|NCT00050778|468423508|FG001|Overall Study|Adverse Event|3|||
130125926|NCT00050778|468423509|FG002|Overall Study|Adverse Event|2|||
130125927|NCT00050778|468423507|FG000|Overall Study|Death|0|||
130125928|NCT00050778|468423508|FG001|Overall Study|Death|1|||
130125929|NCT00050778|468423509|FG002|Overall Study|Death|1|||
130125930|NCT00050778|468423507|FG000|Overall Study|Lack of Efficacy|16|||
130125931|NCT00050778|468423508|FG001|Overall Study|Lack of Efficacy|2|||
130125932|NCT00050778|468423509|FG002|Overall Study|Lack of Efficacy|2|||
130125933|NCT00050778|468423507|FG000|Overall Study|Lost to Follow-up|0|||
130125934|NCT00050778|468423508|FG001|Overall Study|Lost to Follow-up|2|||
130125935|NCT00050778|468423509|FG002|Overall Study|Lost to Follow-up|4|||
130125936|NCT00050778|468423507|FG000|Overall Study|Physician Decision|3|||
130125937|NCT00050778|468423508|FG001|Overall Study|Physician Decision|0|||
130125938|NCT00050778|468423509|FG002|Overall Study|Physician Decision|2|||
130125939|NCT00050778|468423507|FG000|Overall Study|Protocol Violation|2|||
130125940|NCT00050778|468423508|FG001|Overall Study|Protocol Violation|0|||
130125941|NCT00050778|468423509|FG002|Overall Study|Protocol Violation|1|||
130125942|NCT00050778|468423507|FG000|Overall Study|Withdrawal by Subject|6|||
130125943|NCT00050778|468423508|FG001|Overall Study|Withdrawal by Subject|8|||
130125944|NCT00050778|468423509|FG002|Overall Study|Withdrawal by Subject|4|||
130125945|NCT00050778|468423507|FG000|Overall Study|Randomized but not treated|4|||
130125946|NCT00050778|468423508|FG001|Overall Study|Randomized but not treated|5|||
130125947|NCT00050778|468423509|FG002|Overall Study|Randomized but not treated|2|||
130125948|NCT00050778|468423507|FG000|Overall Study|Familial and personal reasons|1|||
130125949|NCT00050778|468423508|FG001|Overall Study|Familial and personal reasons|0|||
130125950|NCT00050778|468423509|FG002|Overall Study|Familial and personal reasons|0|||
130125951|NCT01496183|468423519|FG000|Overall Study|Physician Decision|3|||
129967714|NCT02706951|467847082|FG000|Period 1|Lost to Follow-up|0|||
130125952|NCT01496183|468423520|FG001|Overall Study|Physician Decision|1|||
130125953|NCT01496183|468423519|FG000|Overall Study|Withdrawal by Subject|0|||
130125954|NCT01496183|468423520|FG001|Overall Study|Withdrawal by Subject|1|||
130125955|NCT03002077|468423521|FG000|Overall Study|Non-compliance with Study Drug|4|||
130125956|NCT03002077|468423521|FG000|Overall Study|Non-compliance w/Background ADT|1|||
130125957|NCT03002077|468423521|FG000|Overall Study|Study Terminated by Sponsor|257|||
130125958|NCT03002077|468423521|FG000|Overall Study|Site Terminated by Sponsor|5|||
130125959|NCT03002077|468423521|FG000|Overall Study|Miscellaneous Reasons|10|||
129967715|NCT02706951|467847083|FG001|Period 1|Lost to Follow-up|4|||
129967716|NCT02706951|467847084|FG002|Period 1|Lost to Follow-up|1|||
129967717|NCT02706951|467847085|FG003|Period 1|Lost to Follow-up|0|||
129967718|NCT02706951|467847086|FG004|Period 1|Lost to Follow-up|0|||
129967719|NCT02706951|467847082|FG000|Period 1|Other|2|||
129967720|NCT02706951|467847083|FG001|Period 1|Other|1|||
129967721|NCT02706951|467847084|FG002|Period 1|Other|0|||
129967722|NCT02706951|467847085|FG003|Period 1|Other|0|||
129967723|NCT02706951|467847086|FG004|Period 1|Other|0|||
129967724|NCT02706951|467847082|FG000|Period 2|Adverse Event|0|||
129967725|NCT02706951|467847083|FG001|Period 2|Adverse Event|0|||
129967726|NCT02706951|467847084|FG002|Period 2|Adverse Event|0|||
129967727|NCT02706951|467847085|FG003|Period 2|Adverse Event|25|||
129967728|NCT02706951|467847086|FG004|Period 2|Adverse Event|34|||
129967729|NCT02706951|467847082|FG000|Period 2|Withdrawal by Subject|0|||
129967730|NCT02706951|467847083|FG001|Period 2|Withdrawal by Subject|0|||
129967731|NCT02706951|467847084|FG002|Period 2|Withdrawal by Subject|0|||
129967732|NCT02706951|467847085|FG003|Period 2|Withdrawal by Subject|38|||
129967733|NCT02706951|467847086|FG004|Period 2|Withdrawal by Subject|44|||
129967734|NCT02706951|467847082|FG000|Period 2|Lost to Follow-up|0|||
129967735|NCT02706951|467847083|FG001|Period 2|Lost to Follow-up|0|||
129967736|NCT02706951|467847084|FG002|Period 2|Lost to Follow-up|0|||
129967737|NCT02706951|467847085|FG003|Period 2|Lost to Follow-up|17|||
129967738|NCT02706951|467847086|FG004|Period 2|Lost to Follow-up|9|||
129967739|NCT02706951|467847082|FG000|Period 2|COVID-19 Related|0|||
129967740|NCT02706951|467847083|FG001|Period 2|COVID-19 Related|0|||
129967741|NCT02706951|467847084|FG002|Period 2|COVID-19 Related|0|||
129967742|NCT02706951|467847085|FG003|Period 2|COVID-19 Related|1|||
129967743|NCT02706951|467847086|FG004|Period 2|COVID-19 Related|2|||
130125960|NCT03002077|468423521|FG000|Overall Study|Adverse Event|23|||
130125961|NCT03002077|468423521|FG000|Overall Study|Lack of Efficacy|20|||
130125962|NCT03002077|468423521|FG000|Overall Study|Withdrawal by Subject|72|||
130125963|NCT03002077|468423521|FG000|Overall Study|Lost to Follow-up|21|||
130125964|NCT03002077|468423521|FG000|Overall Study|Pregnancy|4|||
130125965|NCT03002077|468423521|FG000|Overall Study|Protocol Violation|21|||
130125966|NCT04625114|468423522|FG000|Overall Study|Adverse Event|3|||
130125967|NCT04625114|468423523|FG001|Overall Study|Adverse Event|1|||
130125968|NCT04625114|468423522|FG000|Overall Study|Withdrawal by Subject|2|||
130125969|NCT04625114|468423523|FG001|Overall Study|Withdrawal by Subject|0|||
130125970|NCT02849652|468423526|FG000|Overall Study|Lost to Follow-up|104|||
130125971|NCT02849652|468423527|FG001|Overall Study|Lost to Follow-up|35|||
130125972|NCT02849652|468423528|FG002|Overall Study|Lost to Follow-up|116|||
130125973|NCT02849652|468423529|FG003|Overall Study|Lost to Follow-up|22|||
130125974|NCT02849652|468423526|FG000|Overall Study|Withdrawal by Subject|10|||
130125975|NCT02849652|468423527|FG001|Overall Study|Withdrawal by Subject|2|||
130125976|NCT02849652|468423528|FG002|Overall Study|Withdrawal by Subject|8|||
130125977|NCT02849652|468423529|FG003|Overall Study|Withdrawal by Subject|4|||
130125978|NCT01863745|468423530|FG000|Overall Study|Disease Progression|9|||
130125979|NCT01863745|468423530|FG000|Overall Study|Adverse Event|2|||
130125980|NCT01863745|468423530|FG000|Overall Study|Death|1|||
130125981|NCT01863745|468423530|FG000|Overall Study|Withdrawal by Subject|1|||
130125982|NCT00472290|468423531|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
130125983|NCT00472290|468423531|FG000|Overall Study|Protocol Specified Criteria|7|||
130125984|NCT00472290|468423531|FG000|Overall Study|Administrative Decision|37|||
130125985|NCT00472290|468423531|FG000|Overall Study|Death|3|||
130125986|NCT00472290|468423531|FG000|Overall Study|Lost to Follow-up|1|||
130125987|NCT00472290|468423531|FG000|Overall Study|Lack of Efficacy|1|||
130125988|NCT00472290|468423531|FG000|Overall Study|Disease Progression|4|||
129967744|NCT02706951|467847082|FG000|Period 2|Other|0|||
129967745|NCT02706951|467847083|FG001|Period 2|Other|0|||
129967746|NCT02706951|467847084|FG002|Period 2|Other|0|||
129967747|NCT02706951|467847085|FG003|Period 2|Other|37|||
129967748|NCT02706951|467847086|FG004|Period 2|Other|31|||
129967749|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
129967750|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
129967751|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
130125989|NCT00472290|468423531|FG000|Overall Study|Withdrawal by Subject|5|||
130125990|NCT00472290|468423531|FG000|Overall Study|Adverse Event|6|||
130125991|NCT00472290|468423531|FG000|Overall Study|Requirement for alternative therapy|7|||
130125992|NCT00777829|468423532|FG000|Overall Study|Withdrawal by Subject|0|||
130125993|NCT00777829|468423533|FG001|Overall Study|Withdrawal by Subject|2|||
130125994|NCT00336479|468423538|FG000|Overall Study|Adverse Event|8|||
130125995|NCT00336479|468423539|FG001|Overall Study|Adverse Event|11|||
129967752|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
129967753|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
129967754|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
129967755|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
129967756|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
130125996|NCT00336479|468423540|FG002|Overall Study|Adverse Event|18|||
130125997|NCT00336479|468423541|FG003|Overall Study|Adverse Event|4|||
130125998|NCT00336479|468423538|FG000|Overall Study|Noncompliant|1|||
130125999|NCT00336479|468423539|FG001|Overall Study|Noncompliant|7|||
130126000|NCT00336479|468423540|FG002|Overall Study|Noncompliant|3|||
130126001|NCT00336479|468423541|FG003|Overall Study|Noncompliant|0|||
130126002|NCT00336479|468423538|FG000|Overall Study|Physician Decision|2|||
130126003|NCT00336479|468423539|FG001|Overall Study|Physician Decision|3|||
130126004|NCT00336479|468423540|FG002|Overall Study|Physician Decision|1|||
130126005|NCT00336479|468423541|FG003|Overall Study|Physician Decision|0|||
130126006|NCT00336479|468423538|FG000|Overall Study|Lost to Follow-up|3|||
130126007|NCT00336479|468423539|FG001|Overall Study|Lost to Follow-up|2|||
130126008|NCT00336479|468423540|FG002|Overall Study|Lost to Follow-up|0|||
130126009|NCT00336479|468423541|FG003|Overall Study|Lost to Follow-up|0|||
130126010|NCT00336479|468423538|FG000|Overall Study|Withdrawal by Subject|3|||
130126011|NCT00336479|468423539|FG001|Overall Study|Withdrawal by Subject|2|||
130126012|NCT00336479|468423540|FG002|Overall Study|Withdrawal by Subject|3|||
130126013|NCT00336479|468423541|FG003|Overall Study|Withdrawal by Subject|0|||
130126014|NCT00336479|468423538|FG000|Overall Study|Other|0|||
130126015|NCT00336479|468423539|FG001|Overall Study|Other|0|||
130126016|NCT00336479|468423540|FG002|Overall Study|Other|1|||
130126017|NCT00336479|468423541|FG003|Overall Study|Other|0|||
130126018|NCT00336479|468423538|FG000|Overall Study|Virologic Stopping Rule|20|||
130126019|NCT00336479|468423539|FG001|Overall Study|Virologic Stopping Rule|0|||
130126020|NCT00336479|468423540|FG002|Overall Study|Virologic Stopping Rule|0|||
130126021|NCT00336479|468423541|FG003|Overall Study|Virologic Stopping Rule|0|||
130126022|NCT01722877|468423542|FG000|Overall Study|Death|1|||
130126023|NCT01722877|468423542|FG000|Overall Study|Lost to Follow-up|1|||
130126024|NCT01395030|468423545|FG000|Overall Study|Did not complete FCH PET/CT|7|||
130126025|NCT02079766|468423546|FG000|Overall Study|Physician Decision|1|||
130126026|NCT02079766|468423547|FG001|Overall Study|Physician Decision|0|||
130126027|NCT02079766|468423546|FG000|Overall Study|Withdrawal by Subject|1|||
130126028|NCT02079766|468423547|FG001|Overall Study|Withdrawal by Subject|0|||
130126029|NCT02373098|468423548|FG000|Overall Study|Lost to Follow-up|1|||
130126030|NCT02373098|468423549|FG001|Overall Study|Lost to Follow-up|0|||
130126031|NCT02373098|468423548|FG000|Overall Study|Protocol Violation|3|||
130126032|NCT02373098|468423549|FG001|Overall Study|Protocol Violation|0|||
130126033|NCT02373098|468423548|FG000|Overall Study|Withdrawal by Subject|5|||
130126034|NCT02373098|468423549|FG001|Overall Study|Withdrawal by Subject|0|||
130126035|NCT02373098|468423548|FG000|Overall Study|Adverse Event|3|||
130126036|NCT02373098|468423549|FG001|Overall Study|Adverse Event|0|||
130126037|NCT00857623|468423554|FG000|Overall Study|Adverse Event|5|||
130126038|NCT00857623|468423555|FG001|Overall Study|Adverse Event|2|||
130126039|NCT00857623|468423554|FG000|Overall Study|Study-specific discontinuation criteria|5|||
130126040|NCT00857623|468423555|FG001|Overall Study|Study-specific discontinuation criteria|3|||
130126041|NCT00857623|468423554|FG000|Overall Study|Withdrawal by Subject|2|||
130126042|NCT00857623|468423555|FG001|Overall Study|Withdrawal by Subject|1|||
130126043|NCT00857623|468423554|FG000|Overall Study|Lack of Efficacy|1|||
130126044|NCT00857623|468423555|FG001|Overall Study|Lack of Efficacy|1|||
130126045|NCT00857623|468423554|FG000|Overall Study|Severe non-compliance to protocol|1|||
130126046|NCT00857623|468423555|FG001|Overall Study|Severe non-compliance to protocol|1|||
130126047|NCT00857623|468423554|FG000|Overall Study|Intake of prohibited medication|0|||
130126048|NCT00857623|468423555|FG001|Overall Study|Intake of prohibited medication|1|||
130126049|NCT00857623|468423554|FG000|Overall Study|Positive for HEP C|0|||
130126050|NCT00857623|468423555|FG001|Overall Study|Positive for HEP C|1|||
130126051|NCT05214560|468423556|FG000|Overall Study|Screening Failure|1|||
130126052|NCT05214560|468423556|FG000|Overall Study|Physician Decision|4|||
130126053|NCT05214560|468423556|FG000|Overall Study|Withdrawal by Subject|1|||
130126054|NCT05214560|468423556|FG000|Overall Study|Lost to Follow-up|2|||
130126055|NCT05214560|468423556|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
130126056|NCT05214560|468423556|FG000|Overall Study|Study physician not available for the anesthesia|3|||
130126057|NCT05214560|468423556|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
130126058|NCT05214560|468423556|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
130126059|NCT05214560|468423556|FG000|Overall Study|Surgery not performed|3|||
130126060|NCT03639311|468423557|FG000|Maintenance Phase|Lost to Follow-up|1|||
130126061|NCT03639311|468423558|FG001|Maintenance Phase|Lost to Follow-up|0|||
130126062|NCT03639311|468423559|FG002|Maintenance Phase|Lost to Follow-up|0|||
130126063|NCT03639311|468423557|FG000|Maintenance Phase|Adverse Event|1|||
130126064|NCT03639311|468423558|FG001|Maintenance Phase|Adverse Event|0|||
130126065|NCT03639311|468423559|FG002|Maintenance Phase|Adverse Event|0|||
130126066|NCT03639311|468423557|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
130126067|NCT03639311|468423558|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
130126068|NCT03639311|468423559|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
130126069|NCT03639311|468423557|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
130126070|NCT03639311|468423558|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
130126071|NCT03639311|468423559|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
130126072|NCT03639311|468423557|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
130126073|NCT03639311|468423558|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130126074|NCT03639311|468423559|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
130126075|NCT03639311|468423557|FG000|Maintenance Phase|Lack of Efficacy|1|||
130126076|NCT03639311|468423558|FG001|Maintenance Phase|Lack of Efficacy|0|||
130126077|NCT03639311|468423559|FG002|Maintenance Phase|Lack of Efficacy|0|||
130126078|NCT03018249|468423566|FG000|Overall Study|Withdrawal by Subject|2|||
130126079|NCT03018249|468423567|FG001|Overall Study|Withdrawal by Subject|2|||
130126080|NCT00694551|468423568|FG000|Overall Study|Disease Progression|1|||
130126081|NCT00694551|468423569|FG001|Overall Study|Disease Progression|0|||
130126082|NCT00694551|468423570|FG002|Overall Study|Disease Progression|1|||
130126083|NCT02920996|468423575|FG000|Overall Study|Adverse Event|8|||
130126084|NCT02920996|468423576|FG001|Overall Study|Adverse Event|0|||
130126085|NCT02920996|468423575|FG000|Overall Study|Physician Decision|1|||
130126086|NCT02920996|468423576|FG001|Overall Study|Physician Decision|0|||
130126087|NCT02920996|468423575|FG000|Overall Study|Death|1|||
130126088|NCT02920996|468423576|FG001|Overall Study|Death|0|||
130126089|NCT02920996|468423575|FG000|Overall Study|Missing|1|||
130126090|NCT02920996|468423576|FG001|Overall Study|Missing|0|||
130126091|NCT02920996|468423575|FG000|Overall Study|Subject Non-Compliance|1|||
130126092|NCT02920996|468423576|FG001|Overall Study|Subject Non-Compliance|0|||
130126093|NCT01402947|468423579|FG000|First Intervention|Adverse Event|0|||
130126094|NCT01402947|468423580|FG001|First Intervention|Adverse Event|1|||
130126095|NCT00385684|468423581|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
130126096|NCT00385684|468423582|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
130126097|NCT00385684|468423581|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
130126098|NCT00385684|468423582|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
130126099|NCT00385684|468423581|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
130126100|NCT00385684|468423582|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
130126101|NCT02801877|468423583|FG000|Overall Study|Lost to Follow-up|1|||
130126102|NCT02801877|468423584|FG001|Overall Study|Lost to Follow-up|1|||
130126103|NCT02801877|468423585|FG002|Overall Study|Lost to Follow-up|2|||
130126104|NCT02801877|468423586|FG003|Overall Study|Lost to Follow-up|0|||
130126105|NCT02801877|468423583|FG000|Overall Study|Never Started Treatment|2|||
130126106|NCT02801877|468423584|FG001|Overall Study|Never Started Treatment|0|||
130126107|NCT02801877|468423585|FG002|Overall Study|Never Started Treatment|4|||
130126108|NCT02801877|468423586|FG003|Overall Study|Never Started Treatment|0|||
130126109|NCT00154102|468423587|FG000|Overall Study|investigational study phase ongoing|7|||
130126110|NCT00154102|468423588|FG001|Overall Study|investigational study phase ongoing|2|||
130126111|NCT00591630|468423589|FG000|Overall Study|Death|0|||
130126112|NCT00591630|468423590|FG001|Overall Study|Death|0|||
130126113|NCT00591630|468423591|FG002|Overall Study|Death|1|||
130126114|NCT00591630|468423592|FG003|Overall Study|Death|0|||
130126115|NCT00463606|468423593|FG000|Overall Study|Adverse Event|21|||
130126116|NCT00463606|468423594|FG001|Overall Study|Adverse Event|18|||
130126117|NCT00463606|468423595|FG002|Overall Study|Adverse Event|11|||
130126118|NCT00463606|468423593|FG000|Overall Study|Withdrawal by Subject|11|||
130126119|NCT00463606|468423594|FG001|Overall Study|Withdrawal by Subject|11|||
130126120|NCT00463606|468423595|FG002|Overall Study|Withdrawal by Subject|5|||
130126121|NCT00463606|468423593|FG000|Overall Study|Lost to Follow-up|2|||
130126122|NCT00463606|468423594|FG001|Overall Study|Lost to Follow-up|2|||
130126123|NCT00463606|468423595|FG002|Overall Study|Lost to Follow-up|3|||
130126124|NCT00463606|468423593|FG000|Overall Study|Subject noncompliance|1|||
130126125|NCT00463606|468423594|FG001|Overall Study|Subject noncompliance|1|||
130126126|NCT00463606|468423595|FG002|Overall Study|Subject noncompliance|0|||
130126127|NCT00463606|468423593|FG000|Overall Study|Subject moved out of town|1|||
130126128|NCT00463606|468423594|FG001|Overall Study|Subject moved out of town|0|||
130126129|NCT00463606|468423595|FG002|Overall Study|Subject moved out of town|0|||
130126130|NCT00463606|468423593|FG000|Overall Study|Physician Decision|0|||
130126131|NCT00463606|468423594|FG001|Overall Study|Physician Decision|1|||
130126132|NCT00463606|468423595|FG002|Overall Study|Physician Decision|0|||
130126133|NCT00463606|468423593|FG000|Overall Study|Sponsor request|0|||
130126134|NCT00463606|468423594|FG001|Overall Study|Sponsor request|1|||
130126135|NCT00463606|468423595|FG002|Overall Study|Sponsor request|0|||
130126136|NCT00463606|468423593|FG000|Overall Study|Exclusion criteria violation|2|||
130126137|NCT00463606|468423594|FG001|Overall Study|Exclusion criteria violation|0|||
130126138|NCT00463606|468423595|FG002|Overall Study|Exclusion criteria violation|0|||
130126139|NCT00463606|468423593|FG000|Overall Study|Coordinator error|1|||
130126140|NCT00463606|468423594|FG001|Overall Study|Coordinator error|0|||
130126141|NCT00463606|468423595|FG002|Overall Study|Coordinator error|0|||
130126142|NCT00463606|468423593|FG000|Overall Study|Patient randomized in error|1|||
130126143|NCT00463606|468423594|FG001|Overall Study|Patient randomized in error|0|||
130126144|NCT00463606|468423595|FG002|Overall Study|Patient randomized in error|0|||
130126145|NCT00463606|468423593|FG000|Overall Study|Participation in another ABT-335 trial|1|||
130126146|NCT00463606|468423594|FG001|Overall Study|Participation in another ABT-335 trial|0|||
130126147|NCT00463606|468423595|FG002|Overall Study|Participation in another ABT-335 trial|0|||
130126148|NCT00463606|468423593|FG000|Overall Study|Protocol Violation|0|||
130126149|NCT00463606|468423594|FG001|Overall Study|Protocol Violation|0|||
130126150|NCT00463606|468423595|FG002|Overall Study|Protocol Violation|1|||
130126151|NCT02682602|468423597|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
130126152|NCT02682602|468423598|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
130126153|NCT02682602|468423597|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
130126154|NCT02682602|468423598|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
130126155|NCT04349917|468425480|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
130126156|NCT04349917|468425481|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
130126157|NCT04349917|468425480|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
130126158|NCT04349917|468425481|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
130126159|NCT00441467|468425482|FG000|Overall Study|Adverse Event|6|||
130126160|NCT00441467|468425482|FG000|Overall Study|Withdrawal by Subject|3|||
130126161|NCT00441467|468425482|FG000|Overall Study|Progressive disease|9|||
130126162|NCT01042522|468425483|FG000|Overall Study|Adverse Event|1|||
130126163|NCT01042522|468425484|FG001|Overall Study|Adverse Event|2|||
130126164|NCT01042522|468425483|FG000|Overall Study|Disease Progression|5|||
130126165|NCT01042522|468425484|FG001|Overall Study|Disease Progression|0|||
130126166|NCT01042522|468425483|FG000|Overall Study|Death|1|||
130126167|NCT01042522|468425484|FG001|Overall Study|Death|0|||
130126168|NCT01042522|468425483|FG000|Overall Study|Patient Refused|0|||
130126169|NCT01042522|468425484|FG001|Overall Study|Patient Refused|3|||
130126170|NCT01042522|468425483|FG000|Overall Study|Withdrawal by Subject|1|||
130126171|NCT01042522|468425484|FG001|Overall Study|Withdrawal by Subject|1|||
130126172|NCT00528606|468425485|FG000|Overall Study|Withdrew consent|4|||
130126173|NCT00528606|468425486|FG001|Overall Study|Withdrew consent|3|||
130126174|NCT00528606|468425485|FG000|Overall Study|Lost to Follow-up|4|||
130126175|NCT00528606|468425486|FG001|Overall Study|Lost to Follow-up|1|||
130126176|NCT00528606|468425485|FG000|Overall Study|Adverse Event|3|||
130126177|NCT00528606|468425486|FG001|Overall Study|Adverse Event|0|||
130126178|NCT00528606|468425485|FG000|Overall Study|Other|2|||
130126179|NCT00528606|468425486|FG001|Overall Study|Other|0|||
130126180|NCT02188303|468425491|FG000|Overall Study|Adverse Event|0|||
130126181|NCT02188303|468425492|FG001|Overall Study|Adverse Event|0|||
130126182|NCT02188303|468425493|FG002|Overall Study|Adverse Event|0|||
130126183|NCT02188303|468425494|FG003|Overall Study|Adverse Event|0|||
130126184|NCT02188303|468425495|FG004|Overall Study|Adverse Event|0|||
130126185|NCT02188303|468425496|FG005|Overall Study|Adverse Event|2|||
130126186|NCT02188303|468425497|FG006|Overall Study|Adverse Event|0|||
130126187|NCT02188303|468425498|FG007|Overall Study|Adverse Event|2|||
130126188|NCT02188303|468425491|FG000|Overall Study|Dose Termination Criteria Met|0|||
130126189|NCT02188303|468425492|FG001|Overall Study|Dose Termination Criteria Met|0|||
130126190|NCT02188303|468425493|FG002|Overall Study|Dose Termination Criteria Met|0|||
130126191|NCT02188303|468425494|FG003|Overall Study|Dose Termination Criteria Met|0|||
130126192|NCT02188303|468425495|FG004|Overall Study|Dose Termination Criteria Met|0|||
130126193|NCT02188303|468425496|FG005|Overall Study|Dose Termination Criteria Met|0|||
130126194|NCT02188303|468425497|FG006|Overall Study|Dose Termination Criteria Met|2|||
130126195|NCT02188303|468425498|FG007|Overall Study|Dose Termination Criteria Met|4|||
130126196|NCT04206332|468425499|FG000|Part A|Lost to Follow-up|0|||
130126197|NCT04206332|468425500|FG001|Part A|Lost to Follow-up|1|||
130126198|NCT04206332|468425501|FG002|Part A|Lost to Follow-up|0|||
130126199|NCT04206332|468425502|FG003|Part A|Lost to Follow-up|0|||
130126200|NCT04206332|468425503|FG004|Part A|Lost to Follow-up|0|||
130126201|NCT04206332|468425504|FG005|Part A|Lost to Follow-up|0|||
130126202|NCT04206332|468425505|FG006|Part A|Lost to Follow-up|0|||
130126203|NCT04206332|468425506|FG007|Part A|Lost to Follow-up|0|||
130126204|NCT04206332|468425507|FG008|Part A|Lost to Follow-up|0|||
130126205|NCT04206332|468425508|FG009|Part A|Lost to Follow-up|0|||
130126206|NCT04206332|468425509|FG010|Part A|Lost to Follow-up|0|||
130126207|NCT04206332|468425510|FG011|Part A|Lost to Follow-up|0|||
130126208|NCT04206332|468425511|FG012|Part A|Lost to Follow-up|0|||
130126209|NCT04206332|468425512|FG013|Part A|Lost to Follow-up|0|||
130126210|NCT04206332|468425513|FG014|Part A|Lost to Follow-up|0|||
130126211|NCT04206332|468425514|FG015|Part A|Lost to Follow-up|0|||
130126212|NCT04206332|468425515|FG016|Part A|Lost to Follow-up|0|||
130126213|NCT04206332|468425499|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126214|NCT04206332|468425500|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126215|NCT04206332|468425501|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126216|NCT04206332|468425502|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126217|NCT04206332|468425503|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126218|NCT04206332|468425504|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
130126219|NCT04206332|468425505|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126220|NCT04206332|468425506|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126221|NCT04206332|468425507|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130092844|NCT03039686|468294540|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
130092845|NCT03039686|468294538|FG000|Open Label Period|Withdrawal by Subject|0|||
130092846|NCT03039686|468294539|FG001|Open Label Period|Withdrawal by Subject|3|||
130092847|NCT03039686|468294540|FG002|Open Label Period|Withdrawal by Subject|1|||
130092848|NCT02158949|468294541|FG000|Overall Study|Withdrawal by Subject|1|||
130092849|NCT02158949|468294542|FG001|Overall Study|Withdrawal by Subject|0|||
130092850|NCT02158949|468294541|FG000|Overall Study|Lost to Follow-up|5|||
130092851|NCT02158949|468294542|FG001|Overall Study|Lost to Follow-up|11|||
130092852|NCT02181634|468294543|FG000|Overall Study|Lack of Efficacy|33|||
130092853|NCT02181634|468294543|FG000|Overall Study|Adverse Event|17|||
130092854|NCT02181634|468294543|FG000|Overall Study|Physician Decision|8|||
130092855|NCT02181634|468294543|FG000|Overall Study|Withdrawal by Subject|5|||
130092856|NCT02181634|468294543|FG000|Overall Study|Death|2|||
130092857|NCT02181634|468294543|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
130092858|NCT02181634|468294543|FG000|Overall Study|Ineligible|1|||
130092859|NCT02181634|468294543|FG000|Overall Study|Max number of dose reduction|1|||
130092860|NCT02181634|468294543|FG000|Overall Study|Symptomatic progression|1|||
130092861|NCT02181634|468294543|FG000|Overall Study|Patient opted to proceed to surgery|1|||
130092862|NCT02505945|468294548|FG000|Overall Study|Withdrawal by Subject|13|||
130092863|NCT02505945|468294549|FG001|Overall Study|Withdrawal by Subject|2|||
130092864|NCT02505945|468294548|FG000|Overall Study|Adverse Event|1|||
130092865|NCT02505945|468294549|FG001|Overall Study|Adverse Event|0|||
130092866|NCT02505945|468294548|FG000|Overall Study|Physician Decision|2|||
130092867|NCT02505945|468294549|FG001|Overall Study|Physician Decision|1|||
130092868|NCT02505945|468294548|FG000|Overall Study|Lost to Follow-up|6|||
130092869|NCT02505945|468294549|FG001|Overall Study|Lost to Follow-up|1|||
130092870|NCT01097057|468294550|FG000|Overall Study|Physician Decision|3|||
130092871|NCT01270139|468294551|FG000|Overall Study|Adverse Event|8|||
130092872|NCT01270139|468294552|FG001|Overall Study|Adverse Event|17|||
130092873|NCT01270139|468294553|FG002|Overall Study|Adverse Event|18|||
130092874|NCT01270139|468294551|FG000|Overall Study|Lost to Follow-up|10|||
130092875|NCT01270139|468294552|FG001|Overall Study|Lost to Follow-up|9|||
130092876|NCT01270139|468294553|FG002|Overall Study|Lost to Follow-up|2|||
130092877|NCT02210559|468294554|FG000|Overall Study|Progressive Disease|3|||
130092878|NCT02210559|468294555|FG001|Overall Study|Progressive Disease|2|||
130092879|NCT02210559|468294554|FG000|Overall Study|Adverse Event|2|||
130092880|NCT02210559|468294555|FG001|Overall Study|Adverse Event|2|||
130092881|NCT02210559|468294554|FG000|Overall Study|Physician Decision|1|||
130092882|NCT02210559|468294555|FG001|Overall Study|Physician Decision|0|||
130092883|NCT02210559|468294554|FG000|Overall Study|Withdrawal by Subject|0|||
130092884|NCT02210559|468294555|FG001|Overall Study|Withdrawal by Subject|1|||
130092885|NCT02210559|468294554|FG000|Overall Study|Other than specified|0|||
130092886|NCT02210559|468294555|FG001|Overall Study|Other than specified|1|||
130092887|NCT02546193|468294556|FG000|Overall Study|Withdrawal by Subject|2|||
130092888|NCT02546193|468294557|FG001|Overall Study|Withdrawal by Subject|0|||
130092889|NCT02546193|468294558|FG002|Overall Study|Withdrawal by Subject|1|||
130092890|NCT02546193|468294559|FG003|Overall Study|Withdrawal by Subject|0|||
130092891|NCT02546193|468294556|FG000|Overall Study|Not eligible at time of induction|4|||
130092892|NCT02546193|468294557|FG001|Overall Study|Not eligible at time of induction|6|||
130092893|NCT02546193|468294558|FG002|Overall Study|Not eligible at time of induction|1|||
130092894|NCT02546193|468294559|FG003|Overall Study|Not eligible at time of induction|0|||
130092895|NCT01287403|468294560|FG000|1st Intervention (1 Day)|Adverse Event|1|||
130092896|NCT00148109|468294561|FG000|Overall Study|Lack of Efficacy|10|||
130092897|NCT00148109|468294562|FG001|Overall Study|Lack of Efficacy|18|||
130092898|NCT00148109|468294561|FG000|Overall Study|Adverse Event|0|||
130092899|NCT00148109|468294562|FG001|Overall Study|Adverse Event|2|||
130092900|NCT00148109|468294561|FG000|Overall Study|Withdrawal by Subject|2|||
130092901|NCT00148109|468294562|FG001|Overall Study|Withdrawal by Subject|0|||
130092902|NCT01098266|468294563|FG000|Overall Study|Physician Decision|1|||
130092903|NCT01098266|468294564|FG001|Overall Study|Physician Decision|0|||
130092904|NCT01098266|468294563|FG000|Overall Study|Death|3|||
130092905|NCT01098266|468294564|FG001|Overall Study|Death|2|||
130092906|NCT01098266|468294563|FG000|Overall Study|Withdrawal by Subject|3|||
130092907|NCT01098266|468294564|FG001|Overall Study|Withdrawal by Subject|5|||
130092908|NCT00649220|468294568|FG000|Overall Study|Adverse Event|2|||
130092909|NCT00649220|468294568|FG000|Overall Study|Withdrawal by Subject|1|||
130092910|NCT00525499|468294569|FG000|Overall Study|Lost to Follow-up|2|||
130092911|NCT00525499|468294570|FG001|Overall Study|Lost to Follow-up|4|||
130092912|NCT00525499|468294571|FG002|Overall Study|Lost to Follow-up|1|||
130092913|NCT00525499|468294572|FG003|Overall Study|Lost to Follow-up|4|||
130092914|NCT00525499|468294569|FG000|Overall Study|Adverse Event|0|||
130092915|NCT00525499|468294570|FG001|Overall Study|Adverse Event|1|||
130092916|NCT00525499|468294571|FG002|Overall Study|Adverse Event|0|||
130092917|NCT00525499|468294572|FG003|Overall Study|Adverse Event|1|||
130092918|NCT00525499|468294569|FG000|Overall Study|Withdrawal by Subject|5|||
130092919|NCT00525499|468294570|FG001|Overall Study|Withdrawal by Subject|1|||
130092920|NCT00525499|468294571|FG002|Overall Study|Withdrawal by Subject|5|||
130092921|NCT00525499|468294572|FG003|Overall Study|Withdrawal by Subject|2|||
130126222|NCT04206332|468425508|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126223|NCT04206332|468425509|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126224|NCT04206332|468425510|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126225|NCT04206332|468425511|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126226|NCT04206332|468425512|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126227|NCT04206332|468425513|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126228|NCT04206332|468425514|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126229|NCT04206332|468425515|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
130126230|NCT04206332|468425499|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126231|NCT04206332|468425500|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126232|NCT04206332|468425501|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126233|NCT04206332|468425502|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126234|NCT04206332|468425503|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126235|NCT04206332|468425504|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126236|NCT04206332|468425505|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126237|NCT04206332|468425506|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
130126238|NCT04206332|468425507|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126239|NCT04206332|468425508|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126240|NCT04206332|468425509|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
130126241|NCT04206332|468425510|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126242|NCT04206332|468425511|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126243|NCT04206332|468425512|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126244|NCT04206332|468425513|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126245|NCT04206332|468425514|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126246|NCT04206332|468425515|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126247|NCT04206332|468425499|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126248|NCT04206332|468425500|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126249|NCT04206332|468425501|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126250|NCT04206332|468425502|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126251|NCT04206332|468425503|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126252|NCT04206332|468425504|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126253|NCT04206332|468425505|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126254|NCT04206332|468425506|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126255|NCT04206332|468425507|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126256|NCT04206332|468425508|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126257|NCT04206332|468425509|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126258|NCT04206332|468425510|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126259|NCT04206332|468425511|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126260|NCT04206332|468425512|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126261|NCT04206332|468425513|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126262|NCT04206332|468425514|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
130126263|NCT04206332|468425515|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
130126264|NCT04206332|468425499|FG000|Part C|Withdrawal by Subject|0|||
130126265|NCT04206332|468425500|FG001|Part C|Withdrawal by Subject|0|||
130126266|NCT04206332|468425501|FG002|Part C|Withdrawal by Subject|0|||
130126267|NCT04206332|468425502|FG003|Part C|Withdrawal by Subject|0|||
130126268|NCT04206332|468425503|FG004|Part C|Withdrawal by Subject|0|||
130126269|NCT04206332|468425504|FG005|Part C|Withdrawal by Subject|0|||
130126270|NCT04206332|468425505|FG006|Part C|Withdrawal by Subject|0|||
130126271|NCT04206332|468425506|FG007|Part C|Withdrawal by Subject|0|||
130126272|NCT04206332|468425507|FG008|Part C|Withdrawal by Subject|0|||
130126273|NCT04206332|468425508|FG009|Part C|Withdrawal by Subject|0|||
130126274|NCT04206332|468425509|FG010|Part C|Withdrawal by Subject|0|||
130126275|NCT04206332|468425510|FG011|Part C|Withdrawal by Subject|0|||
130126276|NCT04206332|468425511|FG012|Part C|Withdrawal by Subject|0|||
130126277|NCT04206332|468425512|FG013|Part C|Withdrawal by Subject|0|||
130126278|NCT04206332|468425513|FG014|Part C|Withdrawal by Subject|2|||
130126279|NCT04206332|468425514|FG015|Part C|Withdrawal by Subject|0|||
130126280|NCT04206332|468425515|FG016|Part C|Withdrawal by Subject|0|||
130126281|NCT01126736|468425518|FG000|Overall Study|Death|2|||
130126282|NCT01126736|468425519|FG001|Overall Study|Death|2|||
130126283|NCT01126736|468425520|FG002|Overall Study|Death|1|||
130126284|NCT01126736|468425521|FG003|Overall Study|Death|19|||
130126285|NCT01126736|468425522|FG004|Overall Study|Death|19|||
130126286|NCT01126736|468425518|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130126287|NCT01126736|468425519|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130126288|NCT01126736|468425520|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
130126289|NCT01126736|468425521|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
130126290|NCT01126736|468425522|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
130126291|NCT01126736|468425518|FG000|Overall Study|Lost to Follow-up|0|||
130126292|NCT01126736|468425519|FG001|Overall Study|Lost to Follow-up|0|||
130126293|NCT01126736|468425520|FG002|Overall Study|Lost to Follow-up|0|||
130126294|NCT01126736|468425521|FG003|Overall Study|Lost to Follow-up|1|||
130126295|NCT01126736|468425522|FG004|Overall Study|Lost to Follow-up|1|||
130126296|NCT01126736|468425518|FG000|Overall Study|Administrative reasons|0|||
130126297|NCT01126736|468425519|FG001|Overall Study|Administrative reasons|0|||
130126298|NCT01126736|468425520|FG002|Overall Study|Administrative reasons|0|||
130126299|NCT01126736|468425521|FG003|Overall Study|Administrative reasons|0|||
130126300|NCT01126736|468425522|FG004|Overall Study|Administrative reasons|1|||
130126301|NCT01126736|468425518|FG000|Overall Study|Progressive disease|0|||
130126302|NCT01126736|468425519|FG001|Overall Study|Progressive disease|0|||
130126303|NCT01126736|468425520|FG002|Overall Study|Progressive disease|0|||
130126304|NCT01126736|468425521|FG003|Overall Study|Progressive disease|2|||
130126305|NCT01126736|468425522|FG004|Overall Study|Progressive disease|1|||
130126306|NCT01126736|468425518|FG000|Overall Study|Withdrawal by Subject|0|||
130126307|NCT01126736|468425519|FG001|Overall Study|Withdrawal by Subject|0|||
130126308|NCT01126736|468425520|FG002|Overall Study|Withdrawal by Subject|0|||
130126309|NCT01126736|468425521|FG003|Overall Study|Withdrawal by Subject|1|||
130126310|NCT01126736|468425522|FG004|Overall Study|Withdrawal by Subject|1|||
130126311|NCT01126736|468425518|FG000|Overall Study|Other|2|||
130126312|NCT01126736|468425519|FG001|Overall Study|Other|4|||
130126313|NCT01126736|468425520|FG002|Overall Study|Other|4|||
130126314|NCT01126736|468425521|FG003|Overall Study|Other|16|||
130126315|NCT01126736|468425522|FG004|Overall Study|Other|15|||
130126316|NCT00064753|468425523|FG000|Overall Study|Death|251|||
130126317|NCT00064753|468425524|FG001|Overall Study|Death|242|||
130126318|NCT00064753|468425523|FG000|Overall Study|Withdrawal by Subject|198|||
130126319|NCT00064753|468425524|FG001|Overall Study|Withdrawal by Subject|171|||
130126320|NCT00064753|468425523|FG000|Overall Study|Lost to Follow-up|225|||
130126321|NCT00064753|468425524|FG001|Overall Study|Lost to Follow-up|235|||
130126322|NCT04869787|468425531|FG000|Screening|Physician Decision|1|||
130126323|NCT04869787|468425531|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
130126324|NCT00813293|468425533|FG000|Overall Study|Intercurrent illness|1|||
130126325|NCT00813293|468425534|FG001|Overall Study|Intercurrent illness|0|||
130126326|NCT00813293|468425533|FG000|Overall Study|Adverse Event|0|||
130126327|NCT00813293|468425534|FG001|Overall Study|Adverse Event|1|||
130126328|NCT02914600|468425535|FG000|Overall Study|Adverse Event|298|||
130126329|NCT02914600|468425536|FG001|Overall Study|Adverse Event|35|||
130126330|NCT02914600|468425537|FG002|Overall Study|Adverse Event|25|||
130126331|NCT02914600|468425535|FG000|Overall Study|Sponsors decision|287|||
130126332|NCT02914600|468425536|FG001|Overall Study|Sponsors decision|41|||
130126333|NCT02914600|468425537|FG002|Overall Study|Sponsors decision|12|||
130126334|NCT02914600|468425535|FG000|Overall Study|Withdrawal by Subject|158|||
130126335|NCT02914600|468425536|FG001|Overall Study|Withdrawal by Subject|20|||
130126336|NCT02914600|468425537|FG002|Overall Study|Withdrawal by Subject|18|||
130126337|NCT02914600|468425535|FG000|Overall Study|Investigators discretion|169|||
130126338|NCT02914600|468425536|FG001|Overall Study|Investigators discretion|14|||
130126339|NCT02914600|468425537|FG002|Overall Study|Investigators discretion|13|||
130126340|NCT02914600|468425535|FG000|Overall Study|Lost to Follow-up|10|||
130126341|NCT02914600|468425536|FG001|Overall Study|Lost to Follow-up|4|||
130126342|NCT02914600|468425537|FG002|Overall Study|Lost to Follow-up|0|||
130126343|NCT02914600|468425535|FG000|Overall Study|Pregnancy|8|||
130126344|NCT02914600|468425536|FG001|Overall Study|Pregnancy|0|||
130126345|NCT02914600|468425537|FG002|Overall Study|Pregnancy|0|||
130126346|NCT02914600|468425535|FG000|Overall Study|Protocol Violation|5|||
130126347|NCT02914600|468425536|FG001|Overall Study|Protocol Violation|3|||
130126348|NCT02914600|468425537|FG002|Overall Study|Protocol Violation|0|||
130126349|NCT02914600|468425535|FG000|Overall Study|Non-compliance with study drug|6|||
130126350|NCT02914600|468425536|FG001|Overall Study|Non-compliance with study drug|1|||
130126351|NCT02914600|468425537|FG002|Overall Study|Non-compliance with study drug|0|||
130126352|NCT02914600|468425535|FG000|Overall Study|Death|3|||
130126353|NCT02914600|468425536|FG001|Overall Study|Death|1|||
130126354|NCT02914600|468425537|FG002|Overall Study|Death|1|||
130092922|NCT00525499|468294569|FG000|Overall Study|Protocol Violation|0|||
130092923|NCT00525499|468294570|FG001|Overall Study|Protocol Violation|1|||
130092924|NCT00525499|468294571|FG002|Overall Study|Protocol Violation|1|||
130092925|NCT00525499|468294572|FG003|Overall Study|Protocol Violation|0|||
130092926|NCT00438815|468294573|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
130092927|NCT00438815|468294573|FG000|Overall Study|3-month follow-up no longer required|12|||
130092928|NCT00438815|468294573|FG000|Overall Study|Noncompliance with protocol requirements|9|||
130092929|NCT00438815|468294573|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
130092930|NCT00438815|468294573|FG000|Overall Study|Lost to Follow-up|6|||
130092931|NCT00438815|468294573|FG000|Overall Study|Withdrawal by Subject|6|||
130092932|NCT00438815|468294573|FG000|Overall Study|Death|1|||
130092933|NCT01733758|468294576|FG000|Overall Study|Adverse Event|5|||
130092934|NCT01733758|468294577|FG001|Overall Study|Adverse Event|7|||
130092935|NCT01733758|468294578|FG002|Overall Study|Adverse Event|8|||
130092936|NCT01733758|468294579|FG003|Overall Study|Adverse Event|1|||
130092937|NCT01733758|468294576|FG000|Overall Study|Withdrawal by Subject|1|||
130092938|NCT01733758|468294577|FG001|Overall Study|Withdrawal by Subject|1|||
130092939|NCT01733758|468294578|FG002|Overall Study|Withdrawal by Subject|5|||
130092940|NCT01733758|468294579|FG003|Overall Study|Withdrawal by Subject|3|||
130092941|NCT01733758|468294576|FG000|Overall Study|Persistent Hyperglycemia|3|||
130092942|NCT01733758|468294577|FG001|Overall Study|Persistent Hyperglycemia|2|||
130092943|NCT01733758|468294578|FG002|Overall Study|Persistent Hyperglycemia|0|||
130092944|NCT01733758|468294579|FG003|Overall Study|Persistent Hyperglycemia|0|||
130092945|NCT01733758|468294576|FG000|Overall Study|Protocol Violation|0|||
130092946|NCT01733758|468294577|FG001|Overall Study|Protocol Violation|1|||
130092947|NCT01733758|468294578|FG002|Overall Study|Protocol Violation|2|||
130092948|NCT01733758|468294579|FG003|Overall Study|Protocol Violation|2|||
130092949|NCT01733758|468294576|FG000|Overall Study|Non-compliance|1|||
130092950|NCT01733758|468294577|FG001|Overall Study|Non-compliance|0|||
130092951|NCT01733758|468294578|FG002|Overall Study|Non-compliance|0|||
130092952|NCT01733758|468294579|FG003|Overall Study|Non-compliance|0|||
130092953|NCT01733758|468294576|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
130092954|NCT01733758|468294577|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
130092955|NCT01733758|468294578|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
130092956|NCT01733758|468294579|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
130092957|NCT01733758|468294576|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
130092958|NCT01733758|468294577|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
130092959|NCT01733758|468294578|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
130092960|NCT01733758|468294579|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
130092961|NCT03814499|468294580|FG000|Overall Study|Lost to Follow-up|3|||
130092962|NCT01589185|468294581|FG000|Overall Study|Death|1|||
130092963|NCT01589185|468294582|FG001|Overall Study|Death|2|||
130092964|NCT01589185|468294583|FG002|Overall Study|Death|2|||
130092965|NCT01589185|468294584|FG003|Overall Study|Death|0|||
130092966|NCT01589185|468294585|FG004|Overall Study|Death|1|||
130092967|NCT01589185|468294581|FG000|Overall Study|Lost to Follow-up|1|||
130092968|NCT01589185|468294582|FG001|Overall Study|Lost to Follow-up|0|||
130092969|NCT01589185|468294583|FG002|Overall Study|Lost to Follow-up|2|||
130092970|NCT01589185|468294584|FG003|Overall Study|Lost to Follow-up|3|||
130092971|NCT01589185|468294585|FG004|Overall Study|Lost to Follow-up|0|||
130092972|NCT00598442|468294588|FG000|Overall Study|Adverse Event|3|||
130092973|NCT00598442|468294589|FG001|Overall Study|Adverse Event|0|||
130092974|NCT00598442|468294590|FG002|Overall Study|Adverse Event|0|||
130092975|NCT00598442|468294588|FG000|Overall Study|Death|19|||
130092976|NCT00598442|468294589|FG001|Overall Study|Death|11|||
130092977|NCT00598442|468294590|FG002|Overall Study|Death|11|||
130092978|NCT00598442|468294588|FG000|Overall Study|Lost to Follow-up|4|||
130092979|NCT00598442|468294589|FG001|Overall Study|Lost to Follow-up|3|||
130092980|NCT00598442|468294590|FG002|Overall Study|Lost to Follow-up|3|||
130092981|NCT00598442|468294588|FG000|Overall Study|Physician Decision|2|||
130092982|NCT00598442|468294589|FG001|Overall Study|Physician Decision|1|||
130092983|NCT00598442|468294590|FG002|Overall Study|Physician Decision|1|||
130092984|NCT00598442|468294588|FG000|Overall Study|Withdrawal by Subject|8|||
130092985|NCT00598442|468294589|FG001|Overall Study|Withdrawal by Subject|16|||
130092986|NCT00598442|468294590|FG002|Overall Study|Withdrawal by Subject|6|||
130092987|NCT00598442|468294588|FG000|Overall Study|Noncompliance|0|||
130092988|NCT00598442|468294589|FG001|Overall Study|Noncompliance|2|||
130092989|NCT00598442|468294590|FG002|Overall Study|Noncompliance|1|||
130092990|NCT00598442|468294588|FG000|Overall Study|Relocation|1|||
130092991|NCT00598442|468294589|FG001|Overall Study|Relocation|4|||
130092992|NCT00598442|468294590|FG002|Overall Study|Relocation|0|||
130092993|NCT00598442|468294588|FG000|Overall Study|Renal transplant|0|||
130092994|NCT00598442|468294589|FG001|Overall Study|Renal transplant|0|||
130092995|NCT00598442|468294590|FG002|Overall Study|Renal transplant|1|||
130092996|NCT00598442|468294588|FG000|Overall Study|Site closed by sponsor|5|||
130092997|NCT00598442|468294589|FG001|Overall Study|Site closed by sponsor|2|||
130092998|NCT00598442|468294590|FG002|Overall Study|Site closed by sponsor|1|||
130092999|NCT00598442|468294588|FG000|Overall Study|Started dialysis|1|||
130126355|NCT02914600|468425535|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
130126356|NCT02914600|468425536|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
130126357|NCT02914600|468425537|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
130126358|NCT02914600|468425535|FG000|Overall Study|Enrolled but not treated|1|||
130126359|NCT02914600|468425536|FG001|Overall Study|Enrolled but not treated|0|||
130126360|NCT02914600|468425537|FG002|Overall Study|Enrolled but not treated|0|||
130126361|NCT00454909|468425538|FG000|Overall Study|Withdrawal by Subject|1|||
130126362|NCT00454909|468425539|FG001|Overall Study|Withdrawal by Subject|0|||
130126363|NCT00454909|468425540|FG002|Overall Study|Withdrawal by Subject|0|||
130126364|NCT00454909|468425538|FG000|Overall Study|Migrated/moved from study area|0|||
130126365|NCT00454909|468425539|FG001|Overall Study|Migrated/moved from study area|0|||
130126366|NCT00454909|468425540|FG002|Overall Study|Migrated/moved from study area|1|||
130126367|NCT00454909|468425538|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
130126368|NCT00454909|468425539|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
130126369|NCT00454909|468425540|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
130126370|NCT00454909|468425538|FG000|Overall Study|Others|1|||
130126371|NCT00454909|468425539|FG001|Overall Study|Others|0|||
130126372|NCT00454909|468425540|FG002|Overall Study|Others|0|||
130126373|NCT02996682|468425541|FG000|Overall Study|Death|0|||
130126374|NCT02996682|468425542|FG001|Overall Study|Death|3|||
130126375|NCT02457520|468425543|FG000|Active Treatment Phase|Adverse Event|10|||
130126376|NCT02457520|468425543|FG000|Active Treatment Phase|Lost to Follow-up|8|||
130126377|NCT02457520|468425543|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
130126378|NCT02457520|468425543|FG000|Active Treatment Phase|other|4|||
130126379|NCT02457520|468425543|FG000|Active Treatment Phase|Physician Decision|1|||
130126380|NCT02457520|468425543|FG000|Active Treatment Phase|Protocol Violation|1|||
130126381|NCT02457520|468425543|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
130126382|NCT02457520|468425543|FG000|Post-treatment Period|Other: Retreatment Required|7|||
130126383|NCT02457520|468425543|FG000|Post-treatment Period|Lost to Follow-up|23|||
130126384|NCT02457520|468425543|FG000|Post-treatment Period|Other|3|||
130126385|NCT02457520|468425543|FG000|Post-treatment Period|Physician Decision|1|||
130126386|NCT02457520|468425543|FG000|Post-treatment Period|Withdrawal by Subject|14|||
130126387|NCT02107092|468425544|FG000|Overall Study|Miscellaneous|3|||
130126388|NCT02107092|468425544|FG000|Overall Study|Subject compliance|3|||
130126389|NCT02107092|468425544|FG000|Overall Study|Hypo-or hyperkalemia|2|||
130126390|NCT02107092|468425544|FG000|Overall Study|Met ECG withdrawal criteria|3|||
130126391|NCT02107092|468425544|FG000|Overall Study|Physician Decision|3|||
130126392|NCT02107092|468425544|FG000|Overall Study|Lost to Follow-up|2|||
130126393|NCT02107092|468425544|FG000|Overall Study|Withdrawal by Subject|9|||
130126394|NCT02107092|468425544|FG000|Overall Study|Adverse Event|7|||
130126395|NCT02107092|468425544|FG000|Overall Study|Expected progression of CKD|12|||
130126396|NCT00282048|468425545|FG000|Overall Study|Lack of Efficacy|30|||
130126397|NCT00282048|468425545|FG000|Overall Study|Adverse Event|22|||
130126398|NCT00282048|468425545|FG000|Overall Study|Withdrawal by Subject|1|||
130126399|NCT00282048|468425545|FG000|Overall Study|Other|8|||
130126400|NCT00282048|468425545|FG000|Overall Study|Ongoing|1|||
130126401|NCT03522675|468425547|FG000|Overall Study|Screen fail|1|||
130126402|NCT03522675|468425547|FG000|Overall Study|Non-reactive to histamine|1|||
130126403|NCT00707161|468425548|FG000|Overall Study|Physician Decision|6|||
130126404|NCT00696020|468425551|FG000|Overall Study|Adverse Event|3|||
130126405|NCT00696020|468425552|FG001|Overall Study|Adverse Event|1|||
130126406|NCT00696020|468425553|FG002|Overall Study|Adverse Event|2|||
130126407|NCT00696020|468425554|FG003|Overall Study|Adverse Event|1|||
130126408|NCT00696020|468425551|FG000|Overall Study|Lack of Efficacy|1|||
130126409|NCT00696020|468425552|FG001|Overall Study|Lack of Efficacy|0|||
130126410|NCT00696020|468425553|FG002|Overall Study|Lack of Efficacy|0|||
130126411|NCT00696020|468425554|FG003|Overall Study|Lack of Efficacy|0|||
130126412|NCT00696020|468425551|FG000|Overall Study|Protocol Violation|0|||
130126413|NCT00696020|468425552|FG001|Overall Study|Protocol Violation|0|||
130126414|NCT00696020|468425553|FG002|Overall Study|Protocol Violation|0|||
130126415|NCT00696020|468425554|FG003|Overall Study|Protocol Violation|1|||
130126416|NCT00696020|468425551|FG000|Overall Study|Withdrawal by Subject|0|||
130126417|NCT00696020|468425552|FG001|Overall Study|Withdrawal by Subject|1|||
130126418|NCT00696020|468425553|FG002|Overall Study|Withdrawal by Subject|0|||
130126419|NCT00696020|468425554|FG003|Overall Study|Withdrawal by Subject|1|||
130126420|NCT00696020|468425551|FG000|Overall Study|Other not stated above|0|||
130126421|NCT00696020|468425552|FG001|Overall Study|Other not stated above|0|||
129967757|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
130126422|NCT00696020|468425553|FG002|Overall Study|Other not stated above|1|||
130126423|NCT00696020|468425554|FG003|Overall Study|Other not stated above|1|||
130126424|NCT01387022|468425555|FG000|Overall Study|Death|1|||
130126425|NCT01387022|468425556|FG001|Overall Study|Death|1|||
130126426|NCT01387022|468425555|FG000|Overall Study|Lost to Follow-up|0|||
130126427|NCT01387022|468425556|FG001|Overall Study|Lost to Follow-up|3|||
130126428|NCT02076022|468425557|FG000|Overall Study|Withdrawal by Subject|2|||
130126429|NCT02076022|468425558|FG001|Overall Study|Withdrawal by Subject|0|||
130126430|NCT02661295|468425563|FG000|Overall Study|Death|1|||
130126431|NCT02661295|468425563|FG000|Overall Study|Transferred Out|1|||
130126432|NCT02661295|468425563|FG000|Overall Study|Kidney Transplant|1|||
130126433|NCT02661295|468425563|FG000|Overall Study|Withdrawn due to side effects|8|||
130126434|NCT02661295|468425563|FG000|Overall Study|Withdrawn due to access type|1|||
130126435|NCT02661295|468425563|FG000|Overall Study|Withdrawn due to allergies|1|||
130126436|NCT02661295|468425563|FG000|Overall Study|Withdrawn due to non-compliance|1|||
130126437|NCT02661295|468425563|FG000|Overall Study|Withdrawal by Subject|3|||
130093000|NCT00598442|468294589|FG001|Overall Study|Started dialysis|0|||
130093001|NCT00598442|468294590|FG002|Overall Study|Started dialysis|0|||
130093002|NCT00368069|468294591|FG000|Overall Study|Adverse Event|5|||
130093003|NCT00368069|468294592|FG001|Overall Study|Adverse Event|2|||
130093004|NCT00368069|468294591|FG000|Overall Study|Lack of Efficacy|0|||
130093005|NCT00368069|468294592|FG001|Overall Study|Lack of Efficacy|1|||
130093006|NCT00368069|468294591|FG000|Overall Study|Lost to Follow-up|1|||
130093007|NCT00368069|468294592|FG001|Overall Study|Lost to Follow-up|0|||
130093008|NCT00368069|468294591|FG000|Overall Study|Protocol Violation|0|||
130093009|NCT00368069|468294592|FG001|Overall Study|Protocol Violation|2|||
130093010|NCT00368069|468294591|FG000|Overall Study|Withdrawal of Consent|2|||
130093011|NCT00368069|468294592|FG001|Overall Study|Withdrawal of Consent|1|||
130093012|NCT00368069|468294591|FG000|Overall Study|no blood sampling possible|0|||
130093013|NCT00368069|468294592|FG001|Overall Study|no blood sampling possible|1|||
130093014|NCT03907072|468294596|FG000|Overall Study|Study Terminated by Sponsor|2|||
130093015|NCT03907072|468294597|FG001|Overall Study|Study Terminated by Sponsor|2|||
130093016|NCT03907072|468294598|FG002|Overall Study|Study Terminated by Sponsor|2|||
130093017|NCT01430559|468294601|FG000|Overall Study|Adverse Event|7|||
130093018|NCT01430559|468294602|FG001|Overall Study|Adverse Event|3|||
130093019|NCT01430559|468294601|FG000|Overall Study|Entry criteria not met|1|||
130093020|NCT01430559|468294602|FG001|Overall Study|Entry criteria not met|1|||
130093021|NCT01430559|468294601|FG000|Overall Study|Lost to Follow-up|1|||
130093022|NCT01430559|468294602|FG001|Overall Study|Lost to Follow-up|0|||
130093023|NCT01430559|468294601|FG000|Overall Study|Medication error|1|||
130093024|NCT01430559|468294602|FG001|Overall Study|Medication error|0|||
130093025|NCT01430559|468294601|FG000|Overall Study|Withdrawal by Subject|3|||
130093026|NCT01430559|468294602|FG001|Overall Study|Withdrawal by Subject|2|||
130093027|NCT01430559|468294601|FG000|Overall Study|Protocol Violation|1|||
130093028|NCT01430559|468294602|FG001|Overall Study|Protocol Violation|0|||
130093029|NCT01430559|468294601|FG000|Overall Study|Other|3|||
130093030|NCT01430559|468294602|FG001|Overall Study|Other|3|||
130093031|NCT01430559|468294601|FG000|Overall Study|Randomized, Not Treated|3|||
130093032|NCT01430559|468294602|FG001|Overall Study|Randomized, Not Treated|3|||
130093033|NCT01177943|468294604|FG000|First Intervention|Withdrawal by Subject|2|||
130093034|NCT01177943|468294605|FG001|First Intervention|Withdrawal by Subject|0|||
130093035|NCT03319160|468294606|FG000|Overall Study|Data not available.|7|||
130093036|NCT00697255|468294607|FG000|Stage 1a|Insufficient ovarian response|1|||
130093037|NCT00697255|468294608|FG001|Stage 1a|Insufficient ovarian response|0|||
130093038|NCT00697255|468294607|FG000|Stage 1a|Multifollicular growth|1|||
130093039|NCT00697255|468294608|FG001|Stage 1a|Multifollicular growth|0|||
130093040|NCT00697255|468294607|FG000|Stage 1a|Not growing of dominant follicle|1|||
130093041|NCT00697255|468294608|FG001|Stage 1a|Not growing of dominant follicle|0|||
130093042|NCT00697255|468294607|FG000|Stage 1b|Not growing of dominant follicle|0|||
130093043|NCT00697255|468294608|FG001|Stage 1b|Not growing of dominant follicle|1|||
130093044|NCT00697255|468294607|FG000|Stage 1b|Insufficient ovarian response|0|||
130093045|NCT00697255|468294608|FG001|Stage 1b|Insufficient ovarian response|1|||
130093046|NCT01303159|468294612|FG000|Overall Study|Death|16|||
130093047|NCT01303159|468294612|FG000|Overall Study|Study Termination|7|||
130093048|NCT00496782|468294613|FG000|Overall Study|Protocol Violation|1|||
130093049|NCT00496782|468294614|FG001|Overall Study|Protocol Violation|2|||
130093050|NCT02431559|468294619|FG000|Overall Study|Adverse Event|0|||
130093051|NCT02431559|468294620|FG001|Overall Study|Adverse Event|1|||
130093052|NCT02431559|468294621|FG002|Overall Study|Adverse Event|0|||
130093053|NCT02431559|468294622|FG003|Overall Study|Adverse Event|4|||
130093054|NCT02431559|468294619|FG000|Overall Study|Progressive disease|2|||
130093055|NCT02431559|468294620|FG001|Overall Study|Progressive disease|1|||
130093056|NCT02431559|468294621|FG002|Overall Study|Progressive disease|4|||
130093057|NCT02431559|468294622|FG003|Overall Study|Progressive disease|22|||
130093058|NCT02431559|468294619|FG000|Overall Study|Withdrawal by Subject|0|||
130093059|NCT02431559|468294620|FG001|Overall Study|Withdrawal by Subject|1|||
130093060|NCT02431559|468294621|FG002|Overall Study|Withdrawal by Subject|0|||
130093061|NCT02431559|468294622|FG003|Overall Study|Withdrawal by Subject|4|||
130093062|NCT02431559|468294619|FG000|Overall Study|Physician Decision|0|||
130093063|NCT02431559|468294620|FG001|Overall Study|Physician Decision|0|||
130093064|NCT02431559|468294621|FG002|Overall Study|Physician Decision|0|||
130093065|NCT02431559|468294622|FG003|Overall Study|Physician Decision|1|||
130093066|NCT01005875|468294625|FG000|Overall Study|Death|3|||
130093067|NCT00643851|468294628|FG000|Overall Study|Death|0|||
130093068|NCT00643851|468294629|FG001|Overall Study|Death|1|||
130093069|NCT00643851|468294630|FG002|Overall Study|Death|0|||
130093070|NCT00643851|468294628|FG000|Overall Study|Lack of Efficacy|0|||
130126438|NCT02661295|468425563|FG000|Overall Study|Failed screening|2|||
130126439|NCT04213326|468425564|FG000|Overall Study|Consent withdrawn|51|||
130126440|NCT04213326|468425565|FG001|Overall Study|Consent withdrawn|241|||
130126441|NCT04213326|468425564|FG000|Overall Study|Lost to Follow-up|50|||
130126442|NCT04213326|468425565|FG001|Overall Study|Lost to Follow-up|902|||
130126443|NCT04213326|468425564|FG000|Overall Study|Protocol Violation|3|||
130126444|NCT04213326|468425565|FG001|Overall Study|Protocol Violation|25|||
130126445|NCT04213326|468425564|FG000|Overall Study|Participant eligibility changed|106|||
130126446|NCT04213326|468425565|FG001|Overall Study|Participant eligibility changed|19|||
130126447|NCT04213326|468425564|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
130126448|NCT04213326|468425565|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
130126449|NCT04213326|468425564|FG000|Overall Study|Incomplete study visit|0|||
130126450|NCT04213326|468425565|FG001|Overall Study|Incomplete study visit|367|||
130126451|NCT02549092|468425566|FG000|Treatment Period|Adverse Event|2|||
130126452|NCT02549092|468425567|FG001|Treatment Period|Adverse Event|2|||
130126453|NCT02549092|468425566|FG000|Treatment Period|Withdrawal by Subject|1|||
130126454|NCT02549092|468425567|FG001|Treatment Period|Withdrawal by Subject|3|||
130126455|NCT02549092|468425566|FG000|Treatment Period|Lack of Efficacy|0|||
130126456|NCT02549092|468425567|FG001|Treatment Period|Lack of Efficacy|2|||
130126457|NCT02549092|468425566|FG000|Extension/Transition Period|Adverse Event|1|||
130126458|NCT02549092|468425567|FG001|Extension/Transition Period|Adverse Event|1|||
130126459|NCT02549092|468425566|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
130126460|NCT02549092|468425567|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
130126461|NCT02549092|468425566|FG000|Extension/Transition Period|Other, Not Specified|4|||
130126462|NCT02549092|468425567|FG001|Extension/Transition Period|Other, Not Specified|2|||
130126463|NCT03627091|468425568|FG000|Overall Study|Adverse Event|0|||
130126464|NCT03627091|468425569|FG001|Overall Study|Adverse Event|0|||
130126465|NCT03627091|468425570|FG002|Overall Study|Adverse Event|2|||
130126466|NCT03627091|468425568|FG000|Overall Study|Withdrawal by Subject|2|||
130126467|NCT03627091|468425569|FG001|Overall Study|Withdrawal by Subject|0|||
130126468|NCT03627091|468425570|FG002|Overall Study|Withdrawal by Subject|2|||
130126469|NCT03627091|468425568|FG000|Overall Study|Physician Decision|2|||
130126470|NCT03627091|468425569|FG001|Overall Study|Physician Decision|0|||
130126471|NCT03627091|468425570|FG002|Overall Study|Physician Decision|0|||
130126472|NCT03627091|468425568|FG000|Overall Study|Site terminated by sponsor|0|||
130126473|NCT03627091|468425569|FG001|Overall Study|Site terminated by sponsor|1|||
130126474|NCT03627091|468425570|FG002|Overall Study|Site terminated by sponsor|0|||
130126475|NCT03627091|468425568|FG000|Overall Study|Disease relapse|7|||
130126476|NCT03627091|468425569|FG001|Overall Study|Disease relapse|5|||
130126477|NCT03627091|468425570|FG002|Overall Study|Disease relapse|1|||
130126478|NCT03627091|468425568|FG000|Overall Study|Other|1|||
130126479|NCT03627091|468425569|FG001|Overall Study|Other|0|||
130126480|NCT03627091|468425570|FG002|Overall Study|Other|0|||
130126481|NCT00450190|468425571|FG000|Overall Study|Withdrawal by Subject|2|||
130126482|NCT01376167|468425576|FG000|Overall Study|Lost to Follow-up|2|||
130126483|NCT01376167|468425577|FG001|Overall Study|Lost to Follow-up|4|||
130126484|NCT01376167|468425578|FG002|Overall Study|Lost to Follow-up|2|||
130126485|NCT01376167|468425576|FG000|Overall Study|Physician Decision|1|||
130126486|NCT01376167|468425577|FG001|Overall Study|Physician Decision|1|||
130126487|NCT01376167|468425578|FG002|Overall Study|Physician Decision|0|||
130126488|NCT01376167|468425576|FG000|Overall Study|Withdrawal by Subject|1|||
130126489|NCT01376167|468425577|FG001|Overall Study|Withdrawal by Subject|5|||
130126490|NCT01376167|468425578|FG002|Overall Study|Withdrawal by Subject|4|||
130126491|NCT02193165|468425581|FG000|4 Week Product Use|Lost to Follow-up|1|||
130126492|NCT02193165|468425582|FG001|4 Week Product Use|Lost to Follow-up|1|||
130126493|NCT02193165|468425583|FG002|4 Week Product Use|Lost to Follow-up|1|||
130126494|NCT02193165|468425581|FG000|6 Week Product Use|Lost to Follow-up|0|||
130126495|NCT02193165|468425582|FG001|6 Week Product Use|Lost to Follow-up|1|||
130126496|NCT02193165|468425583|FG002|6 Week Product Use|Lost to Follow-up|0|||
130126497|NCT01498120|468425589|FG000|Overall Study|Lost to Follow-up|1|||
130126498|NCT01498120|468425589|FG000|Overall Study|Withdrawal by Subject|5|||
130126499|NCT01498120|468425589|FG000|Overall Study|AE, non-serious non-fatal|3|||
130126500|NCT01498120|468425589|FG000|Overall Study|Other|4|||
130126501|NCT01173692|468425590|FG000|Overall Study|Adverse Event|1|||
130126502|NCT01173692|468425591|FG001|Overall Study|Adverse Event|2|||
130126503|NCT01173692|468425590|FG000|Overall Study|Withdrawal by Subject|1|||
130126504|NCT01173692|468425591|FG001|Overall Study|Withdrawal by Subject|3|||
129967758|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
129967759|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
130126505|NCT00678639|468425592|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
130126506|NCT00678639|468425593|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
130126507|NCT00986245|468425596|FG000|First Intervention|Poor compliance|8|||
130126508|NCT00986245|468425597|FG001|First Intervention|Poor compliance|4|||
130126509|NCT00986245|468425596|FG000|First Intervention|Lack of Efficacy|1|||
130126510|NCT00986245|468425597|FG001|First Intervention|Lack of Efficacy|2|||
130126511|NCT00986245|468425596|FG000|First Intervention|Withdrawal by Subject|0|||
130126512|NCT00986245|468425597|FG001|First Intervention|Withdrawal by Subject|1|||
129967760|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
129967761|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
129967762|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
129967763|NCT01216072|467847087|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
129967764|NCT01216072|467847088|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
129967765|NCT01216072|467847087|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
129967766|NCT01216072|467847088|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
129967767|NCT01216072|467847087|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
129967768|NCT01216072|467847088|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
129967769|NCT04294667|467847089|FG000|Overall Study|Lack of Efficacy|4|||
129967770|NCT04294667|467847090|FG001|Overall Study|Lack of Efficacy|4|||
129967771|NCT04294667|467847089|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
129967772|NCT04294667|467847090|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
129967773|NCT04294667|467847089|FG000|Overall Study|Patient has a Renal Flare|1|||
129967774|NCT04294667|467847090|FG001|Overall Study|Patient has a Renal Flare|0|||
129967775|NCT04294667|467847089|FG000|Overall Study|SLE Worsening|0|||
129967776|NCT04294667|467847090|FG001|Overall Study|SLE Worsening|1|||
129967777|NCT04294667|467847089|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
129967778|NCT04294667|467847090|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
129967779|NCT04294667|467847089|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
129967780|NCT04294667|467847090|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
129967781|NCT04294667|467847089|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
129967782|NCT04294667|467847090|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
129967783|NCT04294667|467847089|FG000|Overall Study|Subject Moved to Another State|0|||
129967784|NCT04294667|467847090|FG001|Overall Study|Subject Moved to Another State|1|||
130093071|NCT00643851|468294629|FG001|Overall Study|Lack of Efficacy|1|||
130093072|NCT00643851|468294630|FG002|Overall Study|Lack of Efficacy|0|||
130093073|NCT00643851|468294628|FG000|Overall Study|Adverse Event|2|||
130093074|NCT00643851|468294629|FG001|Overall Study|Adverse Event|6|||
130093075|NCT00643851|468294630|FG002|Overall Study|Adverse Event|6|||
130093076|NCT00643851|468294628|FG000|Overall Study|Lost to Follow-up|4|||
130093077|NCT00643851|468294629|FG001|Overall Study|Lost to Follow-up|6|||
130093078|NCT00643851|468294630|FG002|Overall Study|Lost to Follow-up|9|||
130093079|NCT00643851|468294628|FG000|Overall Study|Withdrawal by Subject|8|||
130093080|NCT00643851|468294629|FG001|Overall Study|Withdrawal by Subject|15|||
130093081|NCT00643851|468294630|FG002|Overall Study|Withdrawal by Subject|9|||
130093082|NCT00643851|468294628|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
130093083|NCT00643851|468294629|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
130093084|NCT00643851|468294630|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
130093085|NCT04806334|468294633|FG000|Overall Study|Withdrawal by Subject|1|||
130093086|NCT03077646|468294637|FG000|Overall Study|Lost to Follow-up|29|||
130093087|NCT03077646|468294638|FG001|Overall Study|Lost to Follow-up|30|||
130093088|NCT03077646|468294639|FG002|Overall Study|Lost to Follow-up|31|||
130093089|NCT00765726|468294640|FG000|Overall Study|Withdrawal by Subject|1|||
130093090|NCT00765726|468294640|FG000|Overall Study|Discontinuation of study by sponsor|8|||
130093091|NCT02058966|468294641|FG000|Open-Label Methamphetamine|Adverse Event|1|||
130093092|NCT02058966|468294641|FG000|First Intervention|Withdrawal by Subject|1|||
130093093|NCT01265511|468294642|FG000|Overall Study|Lack of Efficacy|2|||
130093094|NCT01265511|468294643|FG001|Overall Study|Lack of Efficacy|1|||
130093095|NCT01265511|468294642|FG000|Overall Study|Met stopping rules|0|||
130093096|NCT01265511|468294643|FG001|Overall Study|Met stopping rules|2|||
130093097|NCT02993731|468294644|FG000|Overall Study|Study Termination|101|||
130093098|NCT02993731|468294645|FG001|Overall Study|Study Termination|105|||
130093099|NCT00323479|468294646|FG000|Overall Study|Adverse Event|2|||
130093100|NCT00323479|468294646|FG000|Overall Study|Withdrawal by Subject|2|||
130093101|NCT00323479|468294646|FG000|Overall Study|Protocol Violation|3|||
130093102|NCT00323479|468294646|FG000|Overall Study|house moving|1|||
130093103|NCT01362062|468294649|FG000|Overall Study|Adverse Event|1|||
130093104|NCT01362062|468294650|FG001|Overall Study|Adverse Event|0|||
130093105|NCT01362062|468294649|FG000|Overall Study|Lost to Follow-up|11|||
130093106|NCT01362062|468294650|FG001|Overall Study|Lost to Follow-up|0|||
130093107|NCT01362062|468294649|FG000|Overall Study|Withdrawal by Subject|2|||
130093108|NCT01362062|468294650|FG001|Overall Study|Withdrawal by Subject|0|||
130093109|NCT01362062|468294649|FG000|Overall Study|Non-compliant participant|2|||
130093110|NCT01362062|468294650|FG001|Overall Study|Non-compliant participant|0|||
130093111|NCT01362062|468294649|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
130093112|NCT01362062|468294650|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
130093113|NCT01362062|468294649|FG000|Overall Study|Had significant improvement|9|||
130093114|NCT01362062|468294650|FG001|Overall Study|Had significant improvement|0|||
130093115|NCT02545504|468294652|FG000|Overall Study|Death|174|||
130093116|NCT02545504|468294653|FG001|Overall Study|Death|168|||
130093117|NCT02545504|468294652|FG000|Overall Study|Unknown reason|30|||
129967785|NCT04294667|467847089|FG000|Overall Study|Adverse event, serious fatal|0|||
129967786|NCT04294667|467847090|FG001|Overall Study|Adverse event, serious fatal|1|||
129967787|NCT04294667|467847089|FG000|Overall Study|Adverse event, non-fatal|3|||
129967788|NCT04294667|467847090|FG001|Overall Study|Adverse event, non-fatal|4|||
129967789|NCT02599688|467847091|FG000|Overall Study|Lack of Efficacy|1|||
129967790|NCT02599688|467847091|FG000|Overall Study|Withdrawal by Subject|1|||
129967791|NCT02599688|467847091|FG000|Overall Study|Termination by Sponsor|2|||
129967792|NCT01841697|467847092|FG000|Overall Study|Death|0|||
129967793|NCT01841697|467847093|FG001|Overall Study|Death|1|||
129967794|NCT01841697|467847092|FG000|Overall Study|Lost to Follow-up|4|||
129967795|NCT01841697|467847093|FG001|Overall Study|Lost to Follow-up|1|||
129967796|NCT01841697|467847092|FG000|Overall Study|Withdrawal by Subject|16|||
129967797|NCT01841697|467847093|FG001|Overall Study|Withdrawal by Subject|16|||
129967798|NCT00756457|467847094|FG000|Overall Study|Lost to Follow-up|1|||
129967799|NCT00756457|467847095|FG001|Overall Study|Lost to Follow-up|2|||
129967800|NCT01777490|467847096|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
129967801|NCT01777490|467847097|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
129967802|NCT01777490|467847098|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
129967803|NCT01777490|467847099|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
129967804|NCT00822770|467847100|FG000|Overall Study|Not treated|1|||
129967805|NCT00822770|467847101|FG001|Overall Study|Not treated|0|||
129967806|NCT00822770|467847100|FG000|Overall Study|Complication/Incomplete treatment|1|||
129967807|NCT00822770|467847101|FG001|Overall Study|Complication/Incomplete treatment|0|||
129967808|NCT00822770|467847100|FG000|Overall Study|Death|1|||
129967809|NCT00822770|467847101|FG001|Overall Study|Death|1|||
129967810|NCT02818998|467847102|FG000|Overall Study|Adverse Event|3|||
129967811|NCT02818998|467847103|FG001|Overall Study|Adverse Event|2|||
129967812|NCT02818998|467847104|FG002|Overall Study|Adverse Event|1|||
129967813|NCT02818998|467847102|FG000|Overall Study|Lost to Follow-up|4|||
129967814|NCT02818998|467847103|FG001|Overall Study|Lost to Follow-up|1|||
129967815|NCT02818998|467847104|FG002|Overall Study|Lost to Follow-up|2|||
129967816|NCT02818998|467847102|FG000|Overall Study|Withdrawal by sponsor|0|||
129967817|NCT02818998|467847103|FG001|Overall Study|Withdrawal by sponsor|1|||
129967818|NCT02818998|467847104|FG002|Overall Study|Withdrawal by sponsor|1|||
129967819|NCT02818998|467847102|FG000|Overall Study|Death|3|||
129967820|NCT02818998|467847103|FG001|Overall Study|Death|6|||
129967821|NCT02818998|467847104|FG002|Overall Study|Death|8|||
129967822|NCT02818998|467847102|FG000|Overall Study|Withdrawal by Subject|7|||
129967823|NCT02818998|467847103|FG001|Overall Study|Withdrawal by Subject|6|||
129967824|NCT02818998|467847104|FG002|Overall Study|Withdrawal by Subject|6|||
129967825|NCT02818998|467847102|FG000|Overall Study|Physician Decision|1|||
129967826|NCT02818998|467847103|FG001|Overall Study|Physician Decision|0|||
129967827|NCT02818998|467847104|FG002|Overall Study|Physician Decision|0|||
129967828|NCT01101061|467847105|FG000|Overall Study|Adverse Event|0|||
129967829|NCT01101061|467847106|FG001|Overall Study|Adverse Event|0|||
129967830|NCT01101061|467847107|FG002|Overall Study|Adverse Event|1|||
129967831|NCT01101061|467847108|FG003|Overall Study|Adverse Event|0|||
129967832|NCT01101061|467847109|FG004|Overall Study|Adverse Event|0|||
129967833|NCT01101061|467847110|FG005|Overall Study|Adverse Event|0|||
129967834|NCT05043883|467847111|FG000|Overall Study|Minimum required measurements could not be taken|4|||
129967835|NCT02049515|467847112|FG000|Overall Study|Adverse Event|46|||
129967836|NCT02049515|467847113|FG001|Overall Study|Adverse Event|2|||
129967837|NCT02049515|467847112|FG000|Overall Study|Protocol-specified Disease Progression|23|||
129967838|NCT02049515|467847113|FG001|Overall Study|Protocol-specified Disease Progression|2|||
129967839|NCT02049515|467847112|FG000|Overall Study|Death|6|||
129967840|NCT02049515|467847113|FG001|Overall Study|Death|0|||
129967841|NCT02049515|467847112|FG000|Overall Study|Physician Decision|5|||
129967842|NCT02049515|467847113|FG001|Overall Study|Physician Decision|1|||
129967843|NCT02049515|467847112|FG000|Overall Study|Withdrawal by Subject|3|||
130093118|NCT02545504|468294653|FG001|Overall Study|Unknown reason|32|||
130093119|NCT02545504|468294652|FG000|Overall Study|Withdrew consent|9|||
130093120|NCT02545504|468294653|FG001|Overall Study|Withdrew consent|11|||
130093121|NCT02545504|468294652|FG000|Overall Study|Investigator's discretion|3|||
130093122|NCT02545504|468294653|FG001|Overall Study|Investigator's discretion|1|||
130093123|NCT02545504|468294652|FG000|Overall Study|Lost to Follow-up|2|||
130093124|NCT02545504|468294653|FG001|Overall Study|Lost to Follow-up|2|||
130093125|NCT00967343|468294654|FG000|Overall Study|Study termination by sponsor|12|||
130093126|NCT00967343|468294654|FG000|Overall Study|Death|24|||
130093127|NCT00967343|468294654|FG000|Overall Study|Relapse|1|||
130093128|NCT00967343|468294654|FG000|Overall Study|Lost to Follow-up|1|||
130093129|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
130093130|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
130093131|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
130093132|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
130093133|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
130093134|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
129967844|NCT02049515|467847113|FG001|Overall Study|Withdrawal by Subject|0|||
129967845|NCT02049515|467847112|FG000|Overall Study|Termination of the Study by Sponsor|2|||
129967846|NCT02049515|467847113|FG001|Overall Study|Termination of the Study by Sponsor|0|||
129967847|NCT02049515|467847112|FG000|Overall Study|Protocol Violation|1|||
129967848|NCT02049515|467847113|FG001|Overall Study|Protocol Violation|1|||
129967849|NCT02049515|467847112|FG000|Overall Study|Clinical Deterioration|1|||
129967850|NCT02049515|467847113|FG001|Overall Study|Clinical Deterioration|0|||
129967851|NCT02049515|467847112|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
129967852|NCT02049515|467847113|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
129967853|NCT02049515|467847112|FG000|Overall Study|Treatment Interruption >42 Days|1|||
129967854|NCT02049515|467847113|FG001|Overall Study|Treatment Interruption >42 Days|0|||
129967855|NCT02049515|467847112|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
129967856|NCT02049515|467847113|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
129967857|NCT00224029|467847114|FG000|Overall Study|Lost to Follow-up|1|||
129967858|NCT00224029|467847114|FG000|Overall Study|Withdrawal by Subject|4|||
129967859|NCT00224029|467847114|FG000|Overall Study|Other|1|||
129967860|NCT01390441|467847115|FG000|Treatment Period|Protocol Violation|0|||
129967861|NCT01390441|467847116|FG001|Treatment Period|Protocol Violation|1|||
129967862|NCT01390441|467847117|FG002|Treatment Period|Protocol Violation|0|||
129967863|NCT01390441|467847118|FG003|Treatment Period|Protocol Violation|0|||
129967864|NCT01390441|467847119|FG004|Treatment Period|Protocol Violation|0|||
129967865|NCT01390441|467847115|FG000|Treatment Period|Physician Decision|0|||
129967866|NCT01390441|467847116|FG001|Treatment Period|Physician Decision|0|||
129967867|NCT01390441|467847117|FG002|Treatment Period|Physician Decision|0|||
129967868|NCT01390441|467847118|FG003|Treatment Period|Physician Decision|1|||
129967869|NCT01390441|467847119|FG004|Treatment Period|Physician Decision|0|||
129967870|NCT01390441|467847115|FG000|Treatment Period|Lack of Efficacy|0|||
129967871|NCT01390441|467847116|FG001|Treatment Period|Lack of Efficacy|0|||
129967872|NCT01390441|467847117|FG002|Treatment Period|Lack of Efficacy|0|||
129967873|NCT01390441|467847118|FG003|Treatment Period|Lack of Efficacy|0|||
129967874|NCT01390441|467847119|FG004|Treatment Period|Lack of Efficacy|1|||
129967875|NCT01390441|467847115|FG000|Treatment Period|Unknown due to early stopping of study|0|||
129967876|NCT01390441|467847116|FG001|Treatment Period|Unknown due to early stopping of study|0|||
129967877|NCT01390441|467847117|FG002|Treatment Period|Unknown due to early stopping of study|8|||
129967878|NCT01390441|467847118|FG003|Treatment Period|Unknown due to early stopping of study|11|||
129967879|NCT01390441|467847119|FG004|Treatment Period|Unknown due to early stopping of study|7|||
129967880|NCT01390441|467847115|FG000|Treatment Period|Adverse Event|0|||
129967881|NCT01390441|467847116|FG001|Treatment Period|Adverse Event|0|||
129967882|NCT01390441|467847117|FG002|Treatment Period|Adverse Event|1|||
129967883|NCT01390441|467847118|FG003|Treatment Period|Adverse Event|1|||
129967884|NCT01390441|467847119|FG004|Treatment Period|Adverse Event|2|||
129967885|NCT01390441|467847115|FG000|Treatment Period|Withdrawal by Subject|0|||
129967886|NCT01390441|467847116|FG001|Treatment Period|Withdrawal by Subject|0|||
129967887|NCT01390441|467847117|FG002|Treatment Period|Withdrawal by Subject|1|||
129967888|NCT01390441|467847118|FG003|Treatment Period|Withdrawal by Subject|0|||
129967889|NCT01390441|467847119|FG004|Treatment Period|Withdrawal by Subject|1|||
129967890|NCT01390441|467847115|FG000|Treatment Period|Lost to Follow-up|1|||
129967891|NCT01390441|467847116|FG001|Treatment Period|Lost to Follow-up|0|||
129967892|NCT01390441|467847117|FG002|Treatment Period|Lost to Follow-up|0|||
129967893|NCT01390441|467847118|FG003|Treatment Period|Lost to Follow-up|0|||
129967894|NCT01390441|467847119|FG004|Treatment Period|Lost to Follow-up|0|||
129967895|NCT01390441|467847115|FG000|Extension Period|Protocol Violation|3|||
129967896|NCT01390441|467847116|FG001|Extension Period|Protocol Violation|1|||
129967897|NCT01390441|467847117|FG002|Extension Period|Protocol Violation|0|||
129967898|NCT01390441|467847118|FG003|Extension Period|Protocol Violation|1|||
129967899|NCT01390441|467847119|FG004|Extension Period|Protocol Violation|0|||
129967900|NCT01407276|467847120|FG000|Overall Study|Withdrawal by Subject|0|||
129967901|NCT01407276|467847121|FG001|Overall Study|Withdrawal by Subject|0|||
129967902|NCT01407276|467847122|FG002|Overall Study|Withdrawal by Subject|0|||
129967903|NCT01407276|467847123|FG003|Overall Study|Withdrawal by Subject|0|||
129967904|NCT01407276|467847124|FG004|Overall Study|Withdrawal by Subject|0|||
130126513|NCT00986245|468425596|FG000|First Intervention|Protocol Violation|0|||
130126514|NCT00986245|468425597|FG001|First Intervention|Protocol Violation|1|||
129967905|NCT01407276|467847125|FG005|Overall Study|Withdrawal by Subject|0|||
129967906|NCT01407276|467847126|FG006|Overall Study|Withdrawal by Subject|0|||
129967907|NCT01407276|467847127|FG007|Overall Study|Withdrawal by Subject|1|||
129967908|NCT02635386|467847128|FG000|Overall Study|Pregnancy|2|||
129967909|NCT02635386|467847129|FG001|Overall Study|Pregnancy|0|||
129967910|NCT02635386|467847130|FG002|Overall Study|Pregnancy|0|||
129967911|NCT02635386|467847131|FG003|Overall Study|Pregnancy|0|||
129967912|NCT02635386|467847132|FG004|Overall Study|Pregnancy|2|||
129967913|NCT02635386|467847128|FG000|Overall Study|Withdrawal by Subject|1|||
129967914|NCT02635386|467847129|FG001|Overall Study|Withdrawal by Subject|1|||
129967915|NCT02635386|467847130|FG002|Overall Study|Withdrawal by Subject|0|||
130126515|NCT00986245|468425596|FG000|First Intervention|Out of indication|1|||
129967916|NCT02635386|467847131|FG003|Overall Study|Withdrawal by Subject|1|||
129967917|NCT02635386|467847132|FG004|Overall Study|Withdrawal by Subject|0|||
129967918|NCT02635386|467847128|FG000|Overall Study|Physician Decision|0|||
129967919|NCT02635386|467847129|FG001|Overall Study|Physician Decision|1|||
129967920|NCT02635386|467847130|FG002|Overall Study|Physician Decision|0|||
129967921|NCT02635386|467847131|FG003|Overall Study|Physician Decision|0|||
129967922|NCT02635386|467847132|FG004|Overall Study|Physician Decision|0|||
129967923|NCT02635386|467847128|FG000|Overall Study|Moved Out of State|0|||
129967924|NCT02635386|467847129|FG001|Overall Study|Moved Out of State|1|||
129967925|NCT02635386|467847130|FG002|Overall Study|Moved Out of State|0|||
129967926|NCT02635386|467847131|FG003|Overall Study|Moved Out of State|0|||
129967927|NCT02635386|467847132|FG004|Overall Study|Moved Out of State|0|||
129967928|NCT02635386|467847128|FG000|Overall Study|Noncompliant|0|||
129967929|NCT02635386|467847129|FG001|Overall Study|Noncompliant|2|||
129967930|NCT02635386|467847130|FG002|Overall Study|Noncompliant|1|||
129967931|NCT02635386|467847131|FG003|Overall Study|Noncompliant|1|||
129967932|NCT02635386|467847132|FG004|Overall Study|Noncompliant|1|||
129967933|NCT02635386|467847128|FG000|Overall Study|side effects|0|||
129967934|NCT02635386|467847129|FG001|Overall Study|side effects|0|||
129967935|NCT02635386|467847130|FG002|Overall Study|side effects|1|||
129967936|NCT02635386|467847131|FG003|Overall Study|side effects|4|||
129967937|NCT02635386|467847132|FG004|Overall Study|side effects|6|||
129967938|NCT02635386|467847128|FG000|Overall Study|needed other major surgery|0|||
129967939|NCT02635386|467847129|FG001|Overall Study|needed other major surgery|1|||
129967940|NCT02635386|467847130|FG002|Overall Study|needed other major surgery|0|||
129967941|NCT02635386|467847131|FG003|Overall Study|needed other major surgery|0|||
129967942|NCT02635386|467847132|FG004|Overall Study|needed other major surgery|0|||
129967943|NCT02635386|467847128|FG000|Overall Study|Other medical problems not drug related|0|||
129967944|NCT02635386|467847129|FG001|Overall Study|Other medical problems not drug related|0|||
129967945|NCT02635386|467847130|FG002|Overall Study|Other medical problems not drug related|0|||
129967946|NCT02635386|467847131|FG003|Overall Study|Other medical problems not drug related|1|||
129967947|NCT02635386|467847132|FG004|Overall Study|Other medical problems not drug related|0|||
129967948|NCT00778921|467847136|FG000|Overall Study|Adverse Event|9|||
129967949|NCT00778921|467847137|FG001|Overall Study|Adverse Event|10|||
129967950|NCT00778921|467847138|FG002|Overall Study|Adverse Event|14|||
129967951|NCT00778921|467847136|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129967952|NCT00778921|467847137|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
129967953|NCT00778921|467847138|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129967954|NCT00778921|467847136|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
129967955|NCT00778921|467847137|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129967956|NCT00778921|467847138|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
129967957|NCT00778921|467847136|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
129967958|NCT00778921|467847137|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
129967959|NCT00778921|467847138|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
129967960|NCT00778921|467847136|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
129967961|NCT00778921|467847137|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
129967962|NCT00778921|467847138|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
129967963|NCT00778921|467847136|FG000|Overall Study|Patient withdrew request|3|||
129967964|NCT00778921|467847137|FG001|Overall Study|Patient withdrew request|1|||
129967965|NCT00778921|467847138|FG002|Overall Study|Patient withdrew request|6|||
129967966|NCT00778921|467847136|FG000|Overall Study|Lost to Follow-up|0|||
129967967|NCT00778921|467847137|FG001|Overall Study|Lost to Follow-up|2|||
129967968|NCT00778921|467847138|FG002|Overall Study|Lost to Follow-up|1|||
129967969|NCT00778921|467847136|FG000|Overall Study|Administrative Problems|1|||
129967970|NCT00778921|467847137|FG001|Overall Study|Administrative Problems|2|||
129967971|NCT00778921|467847138|FG002|Overall Study|Administrative Problems|0|||
129967972|NCT00778921|467847136|FG000|Overall Study|Protocol Violation|3|||
129967973|NCT00778921|467847137|FG001|Overall Study|Protocol Violation|0|||
129967974|NCT00778921|467847138|FG002|Overall Study|Protocol Violation|2|||
129967975|NCT00778921|467847136|FG000|Overall Study|Not treated|0|||
129967976|NCT00778921|467847137|FG001|Overall Study|Not treated|2|||
129967977|NCT00778921|467847138|FG002|Overall Study|Not treated|2|||
129967978|NCT04805073|467847139|FG000|Overall Study|study personnel not available|2|||
129967979|NCT04805073|467847140|FG001|Overall Study|study personnel not available|0|||
129967980|NCT04805073|467847139|FG000|Overall Study|spinal anesthesia failure|0|||
129967981|NCT04805073|467847140|FG001|Overall Study|spinal anesthesia failure|1|||
129967982|NCT04805073|467847139|FG000|Overall Study|Lost to Follow-up|0|||
130093135|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
130093136|NCT00950755|468294656|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
129967983|NCT04805073|467847140|FG001|Overall Study|Lost to Follow-up|2|||
129967984|NCT01163474|467847141|FG000|Overall Study|Withdrawal by Subject|1|||
129967985|NCT01163474|467847141|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
129967986|NCT01163474|467847141|FG000|Overall Study|Lost to Follow-up|3|||
129967987|NCT01078922|467847149|FG000|Overall Study|Adverse Event|1|||
129967988|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
129967989|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
129967990|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
129967991|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
129967992|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
129967993|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
129967994|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
129967995|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
129967996|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
129967997|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
129967998|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
129967999|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
129968000|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Other|4|||
129968001|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Other|4|||
129968002|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Other|2|||
129968003|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Other|2|||
129968004|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
129968005|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
129968006|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
129968007|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
129968008|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
129968009|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
129968010|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
129968011|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
129968012|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
129968013|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
129968014|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
129968015|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
129968016|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
129968017|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
129968018|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
129968019|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
129968020|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Other|1|||
129968021|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Other|0|||
129968022|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Other|1|||
129968023|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Other|4|||
129968024|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
129968025|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
129968026|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
129968027|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
129968028|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
129968029|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
129968030|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
129968031|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
129968032|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
129968033|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
129968034|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
129968035|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
129968036|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
129968037|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
129968038|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
129968039|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
129968040|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Other|8|||
129968041|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Other|5|||
129968042|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Other|15|||
129968043|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Other|15|||
129968044|NCT01174264|467847156|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
129968045|NCT01174264|467847157|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
129968046|NCT01174264|467847158|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
129968047|NCT01174264|467847156|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
129968048|NCT01174264|467847157|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
129968049|NCT01174264|467847158|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
129968050|NCT01174264|467847156|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
129968051|NCT01174264|467847157|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
129968052|NCT01174264|467847158|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
129968053|NCT02058836|467847162|FG000|Overall Study|Withdrawal by Subject|1|||
129968054|NCT02058836|467847163|FG001|Overall Study|Withdrawal by Subject|1|||
129968055|NCT00267098|467847164|FG000|Overall Study|Death|0|||
129968056|NCT00267098|467847165|FG001|Overall Study|Death|0|||
129968057|NCT00267098|467847166|FG002|Overall Study|Death|57|||
129968058|NCT00267098|467847167|FG003|Overall Study|Death|66|||
129968059|NCT00267098|467847168|FG004|Overall Study|Death|14|||
129968060|NCT00267098|467847169|FG005|Overall Study|Death|23|||
129968061|NCT00267098|467847170|FG006|Overall Study|Death|28|||
129968062|NCT00267098|467847171|FG007|Overall Study|Death|9|||
129968063|NCT00267098|467847164|FG000|Overall Study|Lost to Follow-up|0|||
129968064|NCT00267098|467847165|FG001|Overall Study|Lost to Follow-up|0|||
129968065|NCT00267098|467847166|FG002|Overall Study|Lost to Follow-up|6|||
129968066|NCT00267098|467847167|FG003|Overall Study|Lost to Follow-up|5|||
129968067|NCT00267098|467847168|FG004|Overall Study|Lost to Follow-up|2|||
129968068|NCT00267098|467847169|FG005|Overall Study|Lost to Follow-up|3|||
129968069|NCT00267098|467847170|FG006|Overall Study|Lost to Follow-up|1|||
129968070|NCT00267098|467847171|FG007|Overall Study|Lost to Follow-up|1|||
129968071|NCT00267098|467847164|FG000|Overall Study|Withdrawal by Subject|8|||
129968072|NCT00267098|467847165|FG001|Overall Study|Withdrawal by Subject|0|||
129968073|NCT00267098|467847166|FG002|Overall Study|Withdrawal by Subject|24|||
129968074|NCT00267098|467847167|FG003|Overall Study|Withdrawal by Subject|21|||
129968075|NCT00267098|467847168|FG004|Overall Study|Withdrawal by Subject|12|||
129968076|NCT00267098|467847169|FG005|Overall Study|Withdrawal by Subject|9|||
129968077|NCT00267098|467847170|FG006|Overall Study|Withdrawal by Subject|12|||
129968078|NCT00267098|467847171|FG007|Overall Study|Withdrawal by Subject|5|||
129968079|NCT00267098|467847164|FG000|Overall Study|Physician Decision|5|||
129968080|NCT00267098|467847165|FG001|Overall Study|Physician Decision|0|||
129968081|NCT00267098|467847166|FG002|Overall Study|Physician Decision|7|||
129968082|NCT00267098|467847167|FG003|Overall Study|Physician Decision|11|||
129968083|NCT00267098|467847168|FG004|Overall Study|Physician Decision|5|||
129968084|NCT00267098|467847169|FG005|Overall Study|Physician Decision|4|||
129968085|NCT00267098|467847170|FG006|Overall Study|Physician Decision|3|||
129968086|NCT00267098|467847171|FG007|Overall Study|Physician Decision|0|||
129968087|NCT00267098|467847164|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
129968088|NCT00267098|467847165|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968089|NCT00267098|467847166|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968090|NCT00267098|467847167|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968091|NCT00267098|467847168|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
129968092|NCT00267098|467847169|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968093|NCT00267098|467847170|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968094|NCT00267098|467847171|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968095|NCT00267098|467847164|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968096|NCT00267098|467847165|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
129968097|NCT00267098|467847166|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968098|NCT00267098|467847167|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968099|NCT00267098|467847168|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968100|NCT00267098|467847169|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968101|NCT00267098|467847170|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968102|NCT00267098|467847171|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968103|NCT00267098|467847164|FG000|Overall Study|Site closure|0|||
129968104|NCT00267098|467847165|FG001|Overall Study|Site closure|0|||
129968105|NCT00267098|467847166|FG002|Overall Study|Site closure|0|||
129968106|NCT00267098|467847167|FG003|Overall Study|Site closure|1|||
129968107|NCT00267098|467847168|FG004|Overall Study|Site closure|0|||
129968108|NCT00267098|467847169|FG005|Overall Study|Site closure|1|||
129968109|NCT00267098|467847170|FG006|Overall Study|Site closure|1|||
129968110|NCT00267098|467847171|FG007|Overall Study|Site closure|0|||
129968111|NCT00267098|467847164|FG000|Overall Study|Explanted Medtronic device|0|||
129968112|NCT00267098|467847165|FG001|Overall Study|Explanted Medtronic device|0|||
129968113|NCT00267098|467847166|FG002|Overall Study|Explanted Medtronic device|0|||
129968114|NCT00267098|467847167|FG003|Overall Study|Explanted Medtronic device|1|||
129968115|NCT00267098|467847168|FG004|Overall Study|Explanted Medtronic device|0|||
129968116|NCT00267098|467847169|FG005|Overall Study|Explanted Medtronic device|0|||
129968117|NCT00267098|467847170|FG006|Overall Study|Explanted Medtronic device|0|||
130126516|NCT00986245|468425597|FG001|First Intervention|Out of indication|0|||
130126517|NCT00986245|468425596|FG000|Second Intervention|Poor compliance|1|||
130126518|NCT00986245|468425597|FG001|Second Intervention|Poor compliance|0|||
130126519|NCT00986245|468425596|FG000|Second Intervention|Lost to Follow-up|1|||
129968118|NCT00267098|467847171|FG007|Overall Study|Explanted Medtronic device|0|||
129968119|NCT00267098|467847164|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968120|NCT00267098|467847165|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968121|NCT00267098|467847166|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968122|NCT00267098|467847167|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
130126520|NCT00986245|468425597|FG001|Second Intervention|Lost to Follow-up|0|||
129968123|NCT00267098|467847168|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
129968124|NCT00267098|467847169|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968125|NCT00267098|467847170|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968126|NCT00267098|467847171|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968127|NCT00267098|467847164|FG000|Overall Study|Subject listed for heart transplant|0|||
129968128|NCT00267098|467847165|FG001|Overall Study|Subject listed for heart transplant|0|||
129968129|NCT00267098|467847166|FG002|Overall Study|Subject listed for heart transplant|0|||
129968130|NCT00267098|467847167|FG003|Overall Study|Subject listed for heart transplant|0|||
129968131|NCT00267098|467847168|FG004|Overall Study|Subject listed for heart transplant|0|||
129968132|NCT00267098|467847169|FG005|Overall Study|Subject listed for heart transplant|0|||
129968133|NCT00267098|467847170|FG006|Overall Study|Subject listed for heart transplant|1|||
129968134|NCT00267098|467847171|FG007|Overall Study|Subject listed for heart transplant|0|||
129968135|NCT00267098|467847164|FG000|Overall Study|Sponsor withdrew subject|0|||
129968136|NCT00267098|467847165|FG001|Overall Study|Sponsor withdrew subject|0|||
129968137|NCT00267098|467847166|FG002|Overall Study|Sponsor withdrew subject|0|||
129968138|NCT00267098|467847167|FG003|Overall Study|Sponsor withdrew subject|1|||
129968139|NCT00267098|467847168|FG004|Overall Study|Sponsor withdrew subject|0|||
129968140|NCT00267098|467847169|FG005|Overall Study|Sponsor withdrew subject|0|||
129968141|NCT00267098|467847170|FG006|Overall Study|Sponsor withdrew subject|0|||
129968142|NCT00267098|467847171|FG007|Overall Study|Sponsor withdrew subject|0|||
129968143|NCT02689453|467847176|FG000|Overall Study|Progressive disease|0|||
129968144|NCT02689453|467847177|FG001|Overall Study|Progressive disease|1|||
129968145|NCT02689453|467847178|FG002|Overall Study|Progressive disease|1|||
129968146|NCT02688530|467847179|FG000|Overall Study|Withdrawal by Subject|0|||
129968147|NCT02688530|467847180|FG001|Overall Study|Withdrawal by Subject|1|||
129968148|NCT02688530|467847181|FG002|Overall Study|Withdrawal by Subject|0|||
129968149|NCT02688530|467847182|FG003|Overall Study|Withdrawal by Subject|0|||
129968150|NCT02688530|467847179|FG000|Overall Study|Lost to Follow-up|0|||
129968151|NCT02688530|467847180|FG001|Overall Study|Lost to Follow-up|0|||
129968152|NCT02688530|467847181|FG002|Overall Study|Lost to Follow-up|2|||
129968153|NCT02688530|467847182|FG003|Overall Study|Lost to Follow-up|0|||
129968154|NCT01658020|467847183|FG000|Overall Study|Adverse Event|3|||
129968155|NCT01658020|467847184|FG001|Overall Study|Adverse Event|3|||
129968156|NCT01658020|467847183|FG000|Overall Study|Lost to Follow-up|1|||
129968157|NCT01658020|467847184|FG001|Overall Study|Lost to Follow-up|0|||
129968158|NCT01658020|467847183|FG000|Overall Study|Withdrawal by Subject|4|||
129968159|NCT01658020|467847184|FG001|Overall Study|Withdrawal by Subject|5|||
129968160|NCT01658020|467847183|FG000|Overall Study|Protocol Violation|0|||
129968161|NCT01658020|467847184|FG001|Overall Study|Protocol Violation|1|||
129968162|NCT04206085|467847185|FG000|Overall Study|Lost to Follow-up|0|||
129968163|NCT04206085|467847186|FG001|Overall Study|Lost to Follow-up|1|||
129968164|NCT04206085|467847187|FG002|Overall Study|Lost to Follow-up|0|||
129968165|NCT04206085|467847185|FG000|Overall Study|Lost to Follow-up|0|||
129968166|NCT04206085|467847186|FG001|Overall Study|Lost to Follow-up|0|||
129968167|NCT04206085|467847187|FG002|Overall Study|Lost to Follow-up|1|||
129968168|NCT00815919|467847190|FG000|Overall Study|Unrelated Fungal Infection|1|||
129968169|NCT00815919|467847190|FG000|Overall Study|AML Relapse|1|||
129968170|NCT00815919|467847190|FG000|Overall Study|Lack of Efficacy|2|||
129968171|NCT01466790|467847193|FG000|Overall Study|Adverse Event|1|||
129968172|NCT01466790|467847194|FG001|Overall Study|Adverse Event|0|||
129968173|NCT01466790|467847195|FG002|Overall Study|Adverse Event|0|||
129968174|NCT01466790|467847196|FG003|Overall Study|Adverse Event|0|||
129968175|NCT01466790|467847197|FG004|Overall Study|Adverse Event|2|||
129968176|NCT01466790|467847198|FG005|Overall Study|Adverse Event|0|||
129968177|NCT01466790|467847199|FG006|Overall Study|Adverse Event|0|||
129968178|NCT01466790|467847200|FG007|Overall Study|Adverse Event|0|||
129968179|NCT01466790|467847193|FG000|Overall Study|Lost to Follow-up|2|||
129968180|NCT01466790|467847194|FG001|Overall Study|Lost to Follow-up|0|||
129968181|NCT01466790|467847195|FG002|Overall Study|Lost to Follow-up|0|||
129968182|NCT01466790|467847196|FG003|Overall Study|Lost to Follow-up|0|||
129968183|NCT01466790|467847197|FG004|Overall Study|Lost to Follow-up|0|||
129968184|NCT01466790|467847198|FG005|Overall Study|Lost to Follow-up|0|||
129968185|NCT01466790|467847199|FG006|Overall Study|Lost to Follow-up|0|||
129968186|NCT01466790|467847200|FG007|Overall Study|Lost to Follow-up|0|||
129968187|NCT01466790|467847193|FG000|Overall Study|Withdrawal by Subject|1|||
129968188|NCT01466790|467847194|FG001|Overall Study|Withdrawal by Subject|1|||
129968189|NCT01466790|467847195|FG002|Overall Study|Withdrawal by Subject|0|||
129968190|NCT01466790|467847196|FG003|Overall Study|Withdrawal by Subject|0|||
129968191|NCT01466790|467847197|FG004|Overall Study|Withdrawal by Subject|1|||
129968192|NCT01466790|467847198|FG005|Overall Study|Withdrawal by Subject|0|||
130093137|NCT00950755|468294656|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
130093138|NCT00950755|468294656|FG000|Long-Term Follow-Up|Death|8|||
130093139|NCT02926833|468296832|FG000|Overall Study|Death|1|||
130093140|NCT02926833|468296833|FG001|Overall Study|Death|1|||
129968193|NCT01466790|467847199|FG006|Overall Study|Withdrawal by Subject|1|||
129968194|NCT01466790|467847200|FG007|Overall Study|Withdrawal by Subject|1|||
129968195|NCT01251887|467847201|FG000|Overall Study|Scheduling conflict|1|||
129968196|NCT01251887|467847202|FG001|Overall Study|Scheduling conflict|2|||
130093141|NCT02926833|468296834|FG002|Overall Study|Death|2|||
129968197|NCT01251887|467847203|FG002|Overall Study|Scheduling conflict|2|||
129968198|NCT01251887|467847201|FG000|Overall Study|Physician Decision|0|||
129968199|NCT01251887|467847202|FG001|Overall Study|Physician Decision|1|||
129968200|NCT01251887|467847203|FG002|Overall Study|Physician Decision|0|||
129968201|NCT04650698|467848584|FG000|Overall Study|Protocol Violation|2|||
129968202|NCT04650698|467848585|FG001|Overall Study|Protocol Violation|1|||
130093142|NCT02926833|468296835|FG003|Overall Study|Death|13|||
130126521|NCT00986245|468425596|FG000|Second Intervention|Protocol Violation|0|||
130126522|NCT00986245|468425597|FG001|Second Intervention|Protocol Violation|1|||
130126523|NCT01214850|468425600|FG000|Overall Study|Withdrawal by Subject|38|||
130126524|NCT01214850|468425601|FG001|Overall Study|Withdrawal by Subject|31|||
130126525|NCT01214850|468425602|FG002|Overall Study|Withdrawal by Subject|28|||
130126526|NCT01214850|468425600|FG000|Overall Study|Lost to Follow-up|124|||
130126527|NCT01214850|468425601|FG001|Overall Study|Lost to Follow-up|98|||
130126528|NCT01214850|468425602|FG002|Overall Study|Lost to Follow-up|123|||
130126529|NCT01214850|468425600|FG000|Overall Study|Protocol Violation|5|||
130126530|NCT01214850|468425601|FG001|Overall Study|Protocol Violation|5|||
130126531|NCT01214850|468425602|FG002|Overall Study|Protocol Violation|6|||
130126532|NCT01214850|468425600|FG000|Overall Study|Adverse event or death|11|||
130126533|NCT01214850|468425601|FG001|Overall Study|Adverse event or death|8|||
130126534|NCT01214850|468425602|FG002|Overall Study|Adverse event or death|3|||
130126535|NCT01214850|468425600|FG000|Overall Study|Inappropriate enrollment|2|||
130126536|NCT01214850|468425601|FG001|Overall Study|Inappropriate enrollment|1|||
130126537|NCT01214850|468425602|FG002|Overall Study|Inappropriate enrollment|0|||
129968203|NCT04650698|467848584|FG000|Overall Study|Withdrawal by Subject|0|||
129968204|NCT04650698|467848585|FG001|Overall Study|Withdrawal by Subject|1|||
129968205|NCT00307047|467848586|FG000|Overall Study|Lost to Follow-up|35|||
129968206|NCT00307047|467848587|FG001|Overall Study|Lost to Follow-up|24|||
129968207|NCT00307047|467848586|FG000|Overall Study|Withdrawal by Subject|6|||
129968208|NCT00307047|467848587|FG001|Overall Study|Withdrawal by Subject|6|||
129968209|NCT00307047|467848586|FG000|Overall Study|Physician Decision|1|||
129968210|NCT00307047|467848587|FG001|Overall Study|Physician Decision|2|||
129968211|NCT00307047|467848586|FG000|Overall Study|Lost to follow-up for other reasons|0|||
129968212|NCT00307047|467848587|FG001|Overall Study|Lost to follow-up for other reasons|1|||
129968213|NCT00307047|467848586|FG000|Overall Study|All death, all MI, all Revascularization|27|||
129968214|NCT00307047|467848587|FG001|Overall Study|All death, all MI, all Revascularization|16|||
129968215|NCT03778294|467848588|FG000|Overall Study|Death|1|||
129968216|NCT03778294|467848588|FG000|Overall Study|Issues with insurance|1|||
129968217|NCT03778294|467848588|FG000|Overall Study|disease progression before treatment|2|||
129968218|NCT00487825|467848592|FG000|Overall Study|Adverse Event|2|||
129968219|NCT00487825|467848593|FG001|Overall Study|Adverse Event|2|||
129968220|NCT00487825|467848592|FG000|Overall Study|Lack of Efficacy|1|||
129968221|NCT00487825|467848593|FG001|Overall Study|Lack of Efficacy|1|||
129968222|NCT00487825|467848592|FG000|Overall Study|Other|3|||
129968223|NCT00487825|467848593|FG001|Overall Study|Other|2|||
129968224|NCT02104505|467848594|FG000|First Intervention (14 Days)|Adverse Event|2|||
129968225|NCT02104505|467848595|FG001|First Intervention (14 Days)|Adverse Event|0|||
129968226|NCT02104505|467848594|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
129968227|NCT02104505|467848595|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
129968228|NCT02104505|467848594|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
129968229|NCT02104505|467848595|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
129968230|NCT02104505|467848594|FG000|First Intervention (14 Days)|exclusionary condition|0|||
129968231|NCT02104505|467848595|FG001|First Intervention (14 Days)|exclusionary condition|1|||
129968232|NCT02104505|467848594|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129968233|NCT02104505|467848595|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129968234|NCT02104505|467848594|FG000|Second Intervention (14 Days)|Adverse Event|2|||
129968235|NCT02104505|467848595|FG001|Second Intervention (14 Days)|Adverse Event|0|||
129968236|NCT01639742|467848598|FG000|Overall Study|Study Ongoing|17|||
129968237|NCT01639742|467848598|FG000|Overall Study|Lost to Follow-up|1|||
129968238|NCT01190644|467848599|FG000|Overall Study|Death|2|||
129968239|NCT01190644|467848599|FG000|Overall Study|Disease progression|1|||
129968240|NCT02366143|467848600|FG000|Overall Study|Death|307|||
129968241|NCT02366143|467848601|FG001|Overall Study|Death|278|||
129968242|NCT02366143|467848602|FG002|Overall Study|Death|280|||
129968243|NCT02366143|467848600|FG000|Overall Study|Lost to Follow-up|2|||
129968244|NCT02366143|467848601|FG001|Overall Study|Lost to Follow-up|4|||
129968245|NCT02366143|467848602|FG002|Overall Study|Lost to Follow-up|2|||
129968246|NCT02366143|467848600|FG000|Overall Study|Physician Decision|1|||
129968247|NCT02366143|467848601|FG001|Overall Study|Physician Decision|2|||
129968248|NCT02366143|467848602|FG002|Overall Study|Physician Decision|1|||
129968249|NCT02366143|467848600|FG000|Overall Study|Protocol Violation|0|||
129968250|NCT02366143|467848601|FG001|Overall Study|Protocol Violation|0|||
129968251|NCT02366143|467848602|FG002|Overall Study|Protocol Violation|2|||
129968252|NCT02366143|467848600|FG000|Overall Study|Withdrawal by Subject|16|||
129968253|NCT02366143|467848601|FG001|Overall Study|Withdrawal by Subject|17|||
129968254|NCT02366143|467848602|FG002|Overall Study|Withdrawal by Subject|22|||
129968255|NCT02366143|467848600|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
129968256|NCT02366143|467848601|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
129968257|NCT02366143|467848602|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
129968258|NCT02366143|467848600|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
129968259|NCT02366143|467848601|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
129968260|NCT02366143|467848602|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
129968261|NCT02366143|467848600|FG000|Overall Study|Randomization Error|1|||
129968262|NCT02366143|467848601|FG001|Overall Study|Randomization Error|0|||
129968263|NCT02366143|467848602|FG002|Overall Study|Randomization Error|0|||
129968264|NCT02366143|467848600|FG000|Overall Study|PI Move and Site Closure|1|||
129968265|NCT02366143|467848601|FG001|Overall Study|PI Move and Site Closure|0|||
129968266|NCT02366143|467848602|FG002|Overall Study|PI Move and Site Closure|1|||
129968267|NCT02366143|467848600|FG000|Overall Study|Study Terminated By Sponsor|0|||
129968268|NCT02366143|467848601|FG001|Overall Study|Study Terminated By Sponsor|0|||
129968269|NCT02366143|467848602|FG002|Overall Study|Study Terminated By Sponsor|2|||
129968270|NCT02366143|467848600|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
129968271|NCT02366143|467848601|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
129968272|NCT02366143|467848602|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
129968273|NCT02366143|467848600|FG000|Overall Study|Patient moved to roll-over study|1|||
129968274|NCT02366143|467848601|FG001|Overall Study|Patient moved to roll-over study|19|||
129968275|NCT02366143|467848602|FG002|Overall Study|Patient moved to roll-over study|28|||
129968276|NCT02366143|467848600|FG000|Overall Study|Patient moved to commercial stock|0|||
129968277|NCT02366143|467848601|FG001|Overall Study|Patient moved to commercial stock|0|||
129968278|NCT02366143|467848602|FG002|Overall Study|Patient moved to commercial stock|1|||
129968279|NCT02366143|467848600|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
129968280|NCT02366143|467848601|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
129968281|NCT02366143|467848602|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
129968282|NCT02366143|467848600|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
129968283|NCT02366143|467848601|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
129968284|NCT02366143|467848602|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
129968285|NCT02366143|467848600|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
129968286|NCT02366143|467848601|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
129968287|NCT02366143|467848602|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
129968288|NCT02366143|467848600|FG000|Overall Study|Requester's instructions|1|||
129968289|NCT02366143|467848601|FG001|Overall Study|Requester's instructions|1|||
129968290|NCT02366143|467848602|FG002|Overall Study|Requester's instructions|1|||
129968291|NCT02366143|467848600|FG000|Overall Study|Uneligible|0|||
129968292|NCT02366143|467848601|FG001|Overall Study|Uneligible|1|||
129968293|NCT02366143|467848602|FG002|Overall Study|Uneligible|0|||
129968294|NCT02366143|467848600|FG000|Overall Study|Post Trial Migration|0|||
129968295|NCT02366143|467848601|FG001|Overall Study|Post Trial Migration|1|||
129968296|NCT02366143|467848602|FG002|Overall Study|Post Trial Migration|0|||
129968297|NCT02366143|467848600|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
129968298|NCT02366143|467848601|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
129968299|NCT02366143|467848602|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
129968300|NCT02366143|467848600|FG000|Overall Study|Patient switched to PTAP|0|||
129968301|NCT02366143|467848601|FG001|Overall Study|Patient switched to PTAP|1|||
129968302|NCT02366143|467848602|FG002|Overall Study|Patient switched to PTAP|0|||
129968303|NCT02366143|467848600|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
129968304|NCT02366143|467848601|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
129968305|NCT02366143|467848602|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
129968306|NCT04411186|467848603|FG000|Overall Study|Withdrawn due to protocol violation|0|||
129968307|NCT04411186|467848604|FG001|Overall Study|Withdrawn due to protocol violation|1|||
129968308|NCT01053247|467848605|FG000|Overall Study|Withdrawal by Subject|9|||
129968309|NCT01053247|467848606|FG001|Overall Study|Withdrawal by Subject|4|||
129968310|NCT01053247|467848607|FG002|Overall Study|Withdrawal by Subject|15|||
129968311|NCT01053247|467848605|FG000|Overall Study|Lack of Efficacy|1|||
129968312|NCT01053247|467848606|FG001|Overall Study|Lack of Efficacy|0|||
129968313|NCT01053247|467848607|FG002|Overall Study|Lack of Efficacy|1|||
129968314|NCT01053247|467848605|FG000|Overall Study|Protocol Violation|2|||
129968315|NCT01053247|467848606|FG001|Overall Study|Protocol Violation|1|||
129968316|NCT01053247|467848607|FG002|Overall Study|Protocol Violation|2|||
129968317|NCT01053247|467848605|FG000|Overall Study|Lost to Follow-up|8|||
129968318|NCT01053247|467848606|FG001|Overall Study|Lost to Follow-up|5|||
129968319|NCT01053247|467848607|FG002|Overall Study|Lost to Follow-up|7|||
129968320|NCT01053247|467848605|FG000|Overall Study|Adverse Event|0|||
129968321|NCT01053247|467848606|FG001|Overall Study|Adverse Event|9|||
129968322|NCT01053247|467848607|FG002|Overall Study|Adverse Event|3|||
129968323|NCT00701909|467848610|FG000|Overall Study|Withdrawal by Subject|0|||
129968324|NCT00701909|467848611|FG001|Overall Study|Withdrawal by Subject|1|||
129968325|NCT03023722|467848616|FG000|Overall Study|No follow-up assessment|4|||
130093143|NCT02926833|468296832|FG000|Overall Study|Lost to Follow-up|1|||
130093144|NCT02926833|468296833|FG001|Overall Study|Lost to Follow-up|2|||
130093145|NCT02926833|468296834|FG002|Overall Study|Lost to Follow-up|0|||
130093146|NCT02926833|468296835|FG003|Overall Study|Lost to Follow-up|3|||
130093147|NCT02926833|468296832|FG000|Overall Study|Full Consent Withdrawal|0|||
129968326|NCT01385748|467848617|FG000|Overall Study|Withdrawal by Subject|7|||
129968327|NCT01385748|467848618|FG001|Overall Study|Withdrawal by Subject|4|||
129968328|NCT01385748|467848619|FG002|Overall Study|Withdrawal by Subject|5|||
129968329|NCT01385748|467848617|FG000|Overall Study|Noncompliance|3|||
129968330|NCT01385748|467848618|FG001|Overall Study|Noncompliance|1|||
129968331|NCT01385748|467848619|FG002|Overall Study|Noncompliance|6|||
129968332|NCT01385748|467848617|FG000|Overall Study|Other|1|||
129968333|NCT01385748|467848618|FG001|Overall Study|Other|7|||
129968334|NCT01385748|467848619|FG002|Overall Study|Other|1|||
129968335|NCT01385748|467848617|FG000|Overall Study|Adverse Event|4|||
129968336|NCT01385748|467848618|FG001|Overall Study|Adverse Event|2|||
129968337|NCT01385748|467848619|FG002|Overall Study|Adverse Event|1|||
129968338|NCT00589303|467848626|FG000|Overall Study|Withdrawal by Subject|2|||
129968339|NCT00589303|467848627|FG001|Overall Study|Withdrawal by Subject|1|||
129968340|NCT00730015|467848630|FG000|Overall Study|Adverse Event|11|||
129968341|NCT00730015|467848631|FG001|Overall Study|Adverse Event|10|||
129968342|NCT00730015|467848632|FG002|Overall Study|Adverse Event|8|||
129968343|NCT00730015|467848630|FG000|Overall Study|Protocol Violation|2|||
129968344|NCT00730015|467848631|FG001|Overall Study|Protocol Violation|6|||
129968345|NCT00730015|467848632|FG002|Overall Study|Protocol Violation|4|||
129968346|NCT00730015|467848630|FG000|Overall Study|Withdrawal by Subject|12|||
129968347|NCT00730015|467848631|FG001|Overall Study|Withdrawal by Subject|12|||
129968348|NCT00730015|467848632|FG002|Overall Study|Withdrawal by Subject|8|||
129968349|NCT00730015|467848630|FG000|Overall Study|Lost to Follow-up|4|||
129968350|NCT00730015|467848631|FG001|Overall Study|Lost to Follow-up|10|||
129968351|NCT00730015|467848632|FG002|Overall Study|Lost to Follow-up|3|||
129968352|NCT00730015|467848630|FG000|Overall Study|Lack of Efficacy|1|||
129968353|NCT00730015|467848631|FG001|Overall Study|Lack of Efficacy|2|||
129968354|NCT00730015|467848632|FG002|Overall Study|Lack of Efficacy|8|||
129968355|NCT00730015|467848630|FG000|Overall Study|Other Reason|1|||
129968356|NCT00730015|467848631|FG001|Overall Study|Other Reason|0|||
129968357|NCT00730015|467848632|FG002|Overall Study|Other Reason|1|||
129968358|NCT01663506|467848633|FG000|Overall Study|Lack of Efficacy|3|||
129968359|NCT01663506|467848633|FG000|Overall Study|Consent Withdrawal by Subject|1|||
129968360|NCT01663506|467848633|FG000|Overall Study|Lost to Follow-up|1|||
129968361|NCT01663506|467848633|FG000|Overall Study|Adverse Event|1|||
129968362|NCT01663506|467848633|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
129968363|NCT01234883|467848634|FG000|Overall Study|Early treatment release|8|||
129968364|NCT01234883|467848635|FG001|Overall Study|Early treatment release|10|||
129968365|NCT01234883|467848634|FG000|Overall Study|Parent/guardian withdrew consent|1|||
129968366|NCT01234883|467848635|FG001|Overall Study|Parent/guardian withdrew consent|2|||
129968367|NCT01234883|467848634|FG000|Overall Study|Technical difficulties with IV infusion|0|||
129968368|NCT01234883|467848635|FG001|Overall Study|Technical difficulties with IV infusion|1|||
129968369|NCT01234883|467848634|FG000|Overall Study|Inclusion/exclusion failure|1|||
129968370|NCT01234883|467848635|FG001|Overall Study|Inclusion/exclusion failure|0|||
129968371|NCT04351269|467848636|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
129968372|NCT04351269|467848637|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
129968373|NCT04351269|467848638|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
129968374|NCT04351269|467848636|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
129968375|NCT04351269|467848637|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
129968376|NCT04351269|467848638|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
129968377|NCT04351269|467848636|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
129968378|NCT04351269|467848637|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
129968379|NCT04351269|467848638|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
129968380|NCT04351269|467848636|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
129968381|NCT04351269|467848637|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
129968382|NCT04351269|467848638|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
129968383|NCT04351269|467848636|FG000|Overall Study|Lost to Follow-up|1|||
129968384|NCT04351269|467848637|FG001|Overall Study|Lost to Follow-up|3|||
129968385|NCT04351269|467848638|FG002|Overall Study|Lost to Follow-up|0|||
129968386|NCT03210519|467848639|FG000|Overall Study|Adverse Event|2|||
129968387|NCT03210519|467848640|FG001|Overall Study|Adverse Event|0|||
129968388|NCT02270671|467848643|FG000|Overall Study|Withdrawal by Subject|1|||
129968389|NCT02270671|467848644|FG001|Overall Study|Withdrawal by Subject|1|||
129968390|NCT02270671|467848643|FG000|Overall Study|Protocol Violation|0|||
129968391|NCT02270671|467848644|FG001|Overall Study|Protocol Violation|1|||
129968392|NCT02270671|467848643|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
129968393|NCT02270671|467848644|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
129968394|NCT02270671|467848643|FG000|Overall Study|Lost to Follow-up|2|||
130093148|NCT02926833|468296833|FG001|Overall Study|Full Consent Withdrawal|0|||
130093149|NCT02926833|468296834|FG002|Overall Study|Full Consent Withdrawal|0|||
130093150|NCT02926833|468296835|FG003|Overall Study|Full Consent Withdrawal|2|||
130093151|NCT02926833|468296832|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
129968395|NCT02270671|467848644|FG001|Overall Study|Lost to Follow-up|1|||
129968396|NCT00174447|467848654|FG000|Overall Study|Adverse Event|19|||
129968397|NCT00174447|467848654|FG000|Overall Study|Withdrawal by Subject|15|||
129968398|NCT00174447|467848654|FG000|Overall Study|Protocol Violation|1|||
129968399|NCT00174447|467848654|FG000|Overall Study|Lack of Efficacy|1|||
129968400|NCT00174447|467848654|FG000|Overall Study|Administrative reason/Other|2|||
129968401|NCT01437423|467848655|FG000|Overall Study|Lost to Follow-up|12|||
129968402|NCT01437423|467848655|FG000|Overall Study|Off label usage|3|||
129968403|NCT00633945|467848656|FG000|Overall Study|Physician Decision|2|||
129968404|NCT01271504|467848657|FG000|Overall Study|Death|7|||
129968405|NCT01271504|467848658|FG001|Overall Study|Death|6|||
129968406|NCT01271504|467848659|FG002|Overall Study|Death|32|||
129968407|NCT01271504|467848660|FG003|Overall Study|Death|32|||
129968408|NCT01271504|467848657|FG000|Overall Study|Lost to Follow-up|0|||
129968409|NCT01271504|467848658|FG001|Overall Study|Lost to Follow-up|1|||
129968410|NCT01271504|467848659|FG002|Overall Study|Lost to Follow-up|3|||
129968411|NCT01271504|467848660|FG003|Overall Study|Lost to Follow-up|1|||
129968412|NCT01271504|467848657|FG000|Overall Study|Protocol Violation|0|||
129968413|NCT01271504|467848658|FG001|Overall Study|Protocol Violation|0|||
129968414|NCT01271504|467848659|FG002|Overall Study|Protocol Violation|0|||
129968415|NCT01271504|467848660|FG003|Overall Study|Protocol Violation|2|||
129968416|NCT01271504|467848657|FG000|Overall Study|Administrative Reasons|0|||
129968417|NCT01271504|467848658|FG001|Overall Study|Administrative Reasons|0|||
129968418|NCT01271504|467848659|FG002|Overall Study|Administrative Reasons|6|||
129968419|NCT01271504|467848660|FG003|Overall Study|Administrative Reasons|5|||
129968420|NCT01271504|467848657|FG000|Overall Study|Withdrawal by Subject|0|||
129968421|NCT01271504|467848658|FG001|Overall Study|Withdrawal by Subject|0|||
129968422|NCT01271504|467848659|FG002|Overall Study|Withdrawal by Subject|1|||
129968423|NCT01271504|467848660|FG003|Overall Study|Withdrawal by Subject|3|||
129968424|NCT01271504|467848657|FG000|Overall Study|Other|0|||
129968425|NCT01271504|467848658|FG001|Overall Study|Other|1|||
129968426|NCT01271504|467848659|FG002|Overall Study|Other|2|||
129968427|NCT01271504|467848660|FG003|Overall Study|Other|0|||
129968428|NCT03865953|467848661|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
129968429|NCT03865953|467848662|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129968430|NCT03865953|467848661|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
129968431|NCT03865953|467848662|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
129968432|NCT03865953|467848661|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
129968433|NCT03865953|467848662|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
129968434|NCT02353871|467848667|FG000|Overall Study|Protocol deviation|0|||
129968435|NCT02353871|467848668|FG001|Overall Study|Protocol deviation|1|||
129968436|NCT02353871|467848667|FG000|Overall Study|Consent withdrawn|1|||
129968437|NCT02353871|467848668|FG001|Overall Study|Consent withdrawn|8|||
129968438|NCT02353871|467848667|FG000|Overall Study|Lost to Follow-up|2|||
129968439|NCT02353871|467848668|FG001|Overall Study|Lost to Follow-up|0|||
129968440|NCT00115336|467848669|FG000|Overall Study|Hospital discharge before study drug|0|||
129968441|NCT00115336|467848670|FG001|Overall Study|Hospital discharge before study drug|1|||
129968442|NCT01191008|467848684|FG000|Overall Study|Protocol Violation|7|||
129968443|NCT01191008|467848684|FG000|Overall Study|Lost to Follow-up|8|||
129968444|NCT04905849|467848687|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
129968445|NCT04905849|467848688|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
129968446|NCT00838929|467848693|FG000|Overall Study|Protocol Violation|0|||
129968447|NCT00838929|467848694|FG001|Overall Study|Protocol Violation|1|||
129968448|NCT00838929|467848695|FG002|Overall Study|Protocol Violation|0|||
129968449|NCT00838929|467848693|FG000|Overall Study|Disease progression|0|||
129968450|NCT00838929|467848694|FG001|Overall Study|Disease progression|2|||
129968451|NCT00838929|467848695|FG002|Overall Study|Disease progression|1|||
129968452|NCT04913948|467848703|FG000|Overall Study|Withdrawal by Subject|2|||
129968453|NCT04913948|467848703|FG000|Overall Study|Sample processing issues|1|||
129968454|NCT04913948|467848703|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
129968455|NCT01068210|467848706|FG000|Overall Study|Lost to Follow-up|1|||
129968456|NCT01068210|467848707|FG001|Overall Study|Lost to Follow-up|2|||
129968457|NCT01068210|467848708|FG002|Overall Study|Lost to Follow-up|2|||
129968458|NCT01068210|467848709|FG003|Overall Study|Lost to Follow-up|1|||
129968459|NCT01068210|467848706|FG000|Overall Study|Second cancer|0|||
129968460|NCT01068210|467848707|FG001|Overall Study|Second cancer|1|||
129968461|NCT01068210|467848708|FG002|Overall Study|Second cancer|0|||
129968462|NCT01068210|467848709|FG003|Overall Study|Second cancer|0|||
129968463|NCT01068210|467848706|FG000|Overall Study|Disease progression|0|||
129968464|NCT01068210|467848707|FG001|Overall Study|Disease progression|0|||
129968465|NCT01068210|467848708|FG002|Overall Study|Disease progression|0|||
129968466|NCT01068210|467848709|FG003|Overall Study|Disease progression|2|||
129968467|NCT04199052|467848710|FG000|Overall Study|Lost to Follow-up|11|||
129968468|NCT04199052|467848711|FG001|Overall Study|Lost to Follow-up|18|||
129968469|NCT00699842|467848712|FG000|Overall Study|Death|0|||
129968470|NCT00699842|467848713|FG001|Overall Study|Death|1|||
129968471|NCT00699842|467848714|FG002|Overall Study|Death|0|||
129968472|NCT03522389|467848715|FG000|Overall Study|Lost to Follow-up|1|||
129968473|NCT03522389|467848716|FG001|Overall Study|Lost to Follow-up|1|||
129968474|NCT03522389|467848717|FG002|Overall Study|Lost to Follow-up|2|||
129968475|NCT03522389|467848715|FG000|Overall Study|had herniated nucleus pulposus|0|||
129968476|NCT03522389|467848716|FG001|Overall Study|had herniated nucleus pulposus|1|||
129968477|NCT03522389|467848717|FG002|Overall Study|had herniated nucleus pulposus|0|||
129968478|NCT03522389|467848715|FG000|Overall Study|go to work in other province|1|||
129968479|NCT03522389|467848716|FG001|Overall Study|go to work in other province|0|||
129968480|NCT03522389|467848717|FG002|Overall Study|go to work in other province|0|||
129968481|NCT04750577|467848718|FG000|Overall Study|Adverse Event|2|||
129968482|NCT04750577|467848719|FG001|Overall Study|Adverse Event|10|||
129968483|NCT04750577|467848720|FG002|Overall Study|Adverse Event|8|||
129968484|NCT04750577|467848721|FG003|Overall Study|Adverse Event|1|||
129968485|NCT04750577|467848718|FG000|Overall Study|Change of residence|0|||
129968486|NCT04750577|467848719|FG001|Overall Study|Change of residence|0|||
129968487|NCT04750577|467848720|FG002|Overall Study|Change of residence|1|||
129968488|NCT04750577|467848721|FG003|Overall Study|Change of residence|0|||
129968489|NCT04750577|467848718|FG000|Overall Study|Burden of study procedures|0|||
129968490|NCT04750577|467848719|FG001|Overall Study|Burden of study procedures|2|||
129968491|NCT04750577|467848720|FG002|Overall Study|Burden of study procedures|2|||
129968492|NCT04750577|467848721|FG003|Overall Study|Burden of study procedures|0|||
129968493|NCT04750577|467848718|FG000|Overall Study|Prematurely discontinued|0|||
129968494|NCT04750577|467848719|FG001|Overall Study|Prematurely discontinued|0|||
129968495|NCT04750577|467848720|FG002|Overall Study|Prematurely discontinued|0|||
129968496|NCT04750577|467848721|FG003|Overall Study|Prematurely discontinued|2|||
129968497|NCT04750577|467848718|FG000|Overall Study|Protocol deviation|1|||
129968498|NCT04750577|467848719|FG001|Overall Study|Protocol deviation|1|||
129968499|NCT04750577|467848720|FG002|Overall Study|Protocol deviation|1|||
129968500|NCT04750577|467848721|FG003|Overall Study|Protocol deviation|1|||
129968501|NCT04750577|467848718|FG000|Overall Study|Other than listed|3|||
129968502|NCT04750577|467848719|FG001|Overall Study|Other than listed|2|||
129968503|NCT04750577|467848720|FG002|Overall Study|Other than listed|2|||
129968504|NCT04750577|467848721|FG003|Overall Study|Other than listed|1|||
129968505|NCT04750577|467848718|FG000|Overall Study|Not treated|0|||
129968506|NCT04750577|467848719|FG001|Overall Study|Not treated|0|||
129968507|NCT04750577|467848720|FG002|Overall Study|Not treated|0|||
129968508|NCT04750577|467848721|FG003|Overall Study|Not treated|2|||
129968509|NCT04599907|467848726|FG000|Overall Study|Withdrawal by Subject|1|||
129968510|NCT04599907|467848727|FG001|Overall Study|Withdrawal by Subject|7|||
129968511|NCT04599907|467848728|FG002|Overall Study|Withdrawal by Subject|6|||
129968512|NCT04599907|467848726|FG000|Overall Study|Lost to Follow-up|0|||
129968513|NCT04599907|467848727|FG001|Overall Study|Lost to Follow-up|1|||
129968514|NCT04599907|467848728|FG002|Overall Study|Lost to Follow-up|0|||
129968515|NCT03668223|467848730|FG000|Overall Study|Death|10|||
129968516|NCT03668223|467848731|FG001|Overall Study|Death|5|||
129968517|NCT03668223|467848730|FG000|Overall Study|Lost to Follow-up|12|||
129968518|NCT03668223|467848731|FG001|Overall Study|Lost to Follow-up|12|||
129968519|NCT03668223|467848730|FG000|Overall Study|Withdrawal by Subject|8|||
129968520|NCT03668223|467848731|FG001|Overall Study|Withdrawal by Subject|3|||
129968521|NCT01103232|467848732|FG000|Overall Study|Withdrawal by Subject|1|||
129968522|NCT01103232|467848733|FG001|Overall Study|Withdrawal by Subject|1|||
129968523|NCT01103232|467848732|FG000|Overall Study|Protocol Violation|0|||
129968524|NCT01103232|467848733|FG001|Overall Study|Protocol Violation|1|||
129968525|NCT05347485|467848736|FG000|Overall Study|Death|14|||
129968526|NCT05347485|467848736|FG000|Overall Study|Lost to Follow-up|2|||
129968527|NCT05347485|467848736|FG000|Overall Study|Withdrawal by Subject|13|||
129968528|NCT05347485|467848736|FG000|Overall Study|Progressive Disease|1|||
130093152|NCT02926833|468296833|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
130093153|NCT02926833|468296834|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
130093154|NCT02926833|468296835|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
130093155|NCT02926833|468296832|FG000|Overall Study|Investigator Decision|0|||
130093156|NCT02926833|468296833|FG001|Overall Study|Investigator Decision|1|||
130093157|NCT02926833|468296834|FG002|Overall Study|Investigator Decision|0|||
130093158|NCT02926833|468296835|FG003|Overall Study|Investigator Decision|0|||
130093159|NCT02926833|468296832|FG000|Overall Study|Adverse Event|0|||
130093160|NCT02926833|468296833|FG001|Overall Study|Adverse Event|0|||
130093161|NCT02926833|468296834|FG002|Overall Study|Adverse Event|1|||
130093162|NCT02926833|468296835|FG003|Overall Study|Adverse Event|0|||
129968529|NCT05347485|467848736|FG000|Overall Study|Study Terminated by Sponsor|49|||
129968530|NCT05347485|467848736|FG000|Overall Study|Other|1|||
129968531|NCT05347485|467848736|FG000|Overall Study|Enrolled (consented) but not treated|4|||
129968532|NCT05347485|467848736|FG000|Overall Study|Disease Relapse|2|||
129968533|NCT04886518|467848737|FG000|Overall Study|Noncompliance with study drug|1|||
129968534|NCT04886518|467848738|FG001|Overall Study|Noncompliance with study drug|0|||
129968535|NCT04886518|467848739|FG002|Overall Study|Noncompliance with study drug|0|||
129968536|NCT04886518|467848737|FG000|Overall Study|Adverse Event|0|||
129968537|NCT04886518|467848738|FG001|Overall Study|Adverse Event|1|||
129968538|NCT04886518|467848739|FG002|Overall Study|Adverse Event|0|||
130126538|NCT01214850|468425600|FG000|Overall Study|Administrative reason|1|||
130126539|NCT01214850|468425601|FG001|Overall Study|Administrative reason|0|||
130126540|NCT01214850|468425602|FG002|Overall Study|Administrative reason|0|||
130126541|NCT01214850|468425600|FG000|Overall Study|Unable to classify|2|||
130126542|NCT01214850|468425601|FG001|Overall Study|Unable to classify|1|||
130126543|NCT01214850|468425602|FG002|Overall Study|Unable to classify|1|||
130126544|NCT00565448|468425606|FG000|Overall Study|Adverse Event|1|||
130126545|NCT00565448|468425607|FG001|Overall Study|Adverse Event|2|||
130126546|NCT00565448|468425606|FG000|Overall Study|Disease progression|1|||
130126547|NCT00565448|468425607|FG001|Overall Study|Disease progression|0|||
130126548|NCT00565448|468425606|FG000|Overall Study|Withdrawal by Subject|1|||
130126549|NCT00565448|468425607|FG001|Overall Study|Withdrawal by Subject|0|||
130126550|NCT00193609|468425608|FG000|Overall Study|Lack of Efficacy|2|||
130126551|NCT00193609|468425608|FG000|Overall Study|Adverse Event|2|||
130126552|NCT00854308|468425610|FG000|Overall Study|Disease progression|42|||
130126553|NCT00854308|468425611|FG001|Overall Study|Disease progression|50|||
130126554|NCT00854308|468425610|FG000|Overall Study|Adverse Event|8|||
130126555|NCT00854308|468425611|FG001|Overall Study|Adverse Event|3|||
130126556|NCT00854308|468425610|FG000|Overall Study|Death|2|||
130126557|NCT00854308|468425611|FG001|Overall Study|Death|5|||
130126558|NCT00854308|468425610|FG000|Overall Study|Physician Decision|6|||
130126559|NCT00854308|468425611|FG001|Overall Study|Physician Decision|6|||
130126560|NCT00854308|468425610|FG000|Overall Study|Withdrawal by Subject|4|||
130126561|NCT00854308|468425611|FG001|Overall Study|Withdrawal by Subject|2|||
130126562|NCT00854308|468425610|FG000|Overall Study|Sponsor's decision to terminate study|0|||
129968539|NCT04886518|467848737|FG000|Overall Study|Withdrawal by Subject|1|||
129968540|NCT04886518|467848738|FG001|Overall Study|Withdrawal by Subject|0|||
129968541|NCT04886518|467848739|FG002|Overall Study|Withdrawal by Subject|0|||
129968542|NCT03733899|467848740|FG000|Period 1|Protocol Violation|0|||
129968543|NCT03733899|467848741|FG001|Period 1|Protocol Violation|0|||
129968544|NCT03733899|467848742|FG002|Period 1|Protocol Violation|0|||
129968545|NCT03733899|467848743|FG003|Period 1|Protocol Violation|0|||
129968546|NCT03733899|467848744|FG004|Period 1|Protocol Violation|0|||
129968547|NCT03733899|467848745|FG005|Period 1|Protocol Violation|1|||
129968548|NCT03733899|467848740|FG000|Period 2|Unscuccessful Treatment|0|||
129968549|NCT03733899|467848741|FG001|Period 2|Unscuccessful Treatment|1|||
129968550|NCT03733899|467848742|FG002|Period 2|Unscuccessful Treatment|0|||
129968551|NCT03733899|467848743|FG003|Period 2|Unscuccessful Treatment|0|||
130126563|NCT00854308|468425611|FG001|Overall Study|Sponsor's decision to terminate study|1|||
130126564|NCT00610363|468425612|FG000|Overall Study|Non-compliance with protocol|0|||
130126565|NCT00610363|468425613|FG001|Overall Study|Non-compliance with protocol|1|||
130126566|NCT00610363|468425612|FG000|Overall Study|Adverse Event|3|||
130126567|NCT00610363|468425613|FG001|Overall Study|Adverse Event|1|||
130126568|NCT00610363|468425612|FG000|Overall Study|Lack of Efficacy|2|||
130126569|NCT00610363|468425613|FG001|Overall Study|Lack of Efficacy|0|||
130126570|NCT00610363|468425612|FG000|Overall Study|Lost to Follow-up|4|||
130126571|NCT00610363|468425613|FG001|Overall Study|Lost to Follow-up|0|||
130126572|NCT00610363|468425612|FG000|Overall Study|Withdrawal by Subject|1|||
130126573|NCT00610363|468425613|FG001|Overall Study|Withdrawal by Subject|0|||
130126574|NCT00610363|468425612|FG000|Overall Study|Other than specified above|1|||
130126575|NCT00610363|468425613|FG001|Overall Study|Other than specified above|1|||
130126576|NCT03048500|468425614|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
130126577|NCT03048500|468425614|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
130126578|NCT03048500|468425614|FG000|Reached 1st Response/Continued Treatment|Death|1|||
130126579|NCT03048500|468425614|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
130126580|NCT03048500|468425614|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
130126581|NCT03048500|468425614|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
130126582|NCT03048500|468425614|FG000|Follow up for 3 Years|Death|12|||
130126583|NCT00302952|468425615|FG000|Overall Study|Physician Decision|1|||
130126584|NCT00302952|468425616|FG001|Overall Study|Physician Decision|1|||
129968552|NCT03733899|467848744|FG004|Period 2|Unscuccessful Treatment|0|||
129968553|NCT03733899|467848745|FG005|Period 2|Unscuccessful Treatment|0|||
129968554|NCT03733899|467848740|FG000|Period 3|Withdrawal by Subject|1|||
129968555|NCT03733899|467848741|FG001|Period 3|Withdrawal by Subject|0|||
129968556|NCT03733899|467848742|FG002|Period 3|Withdrawal by Subject|0|||
129968557|NCT03733899|467848743|FG003|Period 3|Withdrawal by Subject|0|||
129968558|NCT03733899|467848744|FG004|Period 3|Withdrawal by Subject|0|||
130126585|NCT00302952|468425615|FG000|Overall Study|Withdrawal by Subject|2|||
130126586|NCT00302952|468425616|FG001|Overall Study|Withdrawal by Subject|3|||
130126587|NCT00302952|468425615|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
130126588|NCT00302952|468425616|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
130126589|NCT02008565|468425630|FG000|Overall Study|Protocol Violation|1|||
130126590|NCT02008565|468425631|FG001|Overall Study|Protocol Violation|1|||
130126591|NCT02008565|468425632|FG002|Overall Study|Protocol Violation|2|||
130126592|NCT02008565|468425633|FG003|Overall Study|Protocol Violation|0|||
129968559|NCT03733899|467848745|FG005|Period 3|Withdrawal by Subject|0|||
129968560|NCT02354651|467850484|FG000|Overall Study|Withdrawal by Subject|2|||
130126593|NCT03435081|468425634|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
130126594|NCT03435081|468425635|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
130126595|NCT03435081|468425636|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
130126596|NCT03435081|468425634|FG000|Week 0 to Week 16|Adverse Event|2|||
130126597|NCT03435081|468425635|FG001|Week 0 to Week 16|Adverse Event|2|||
130126598|NCT03435081|468425636|FG002|Week 0 to Week 16|Adverse Event|2|||
130126599|NCT03435081|468425634|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
129968561|NCT02354651|467850484|FG000|Overall Study|Physician Decision|1|||
129968562|NCT01377389|467850485|FG000|Overall Study|Withdrawal by Subject|1|||
129968563|NCT01377389|467850485|FG000|Overall Study|Screen failure|2|||
129968564|NCT03382561|467850486|FG000|Overall Study|Disease progression|47|||
129968565|NCT03382561|467850487|FG001|Overall Study|Disease progression|6|||
129968566|NCT03382561|467850486|FG000|Overall Study|Adverse Event|10|||
129968567|NCT03382561|467850487|FG001|Overall Study|Adverse Event|2|||
129968568|NCT03382561|467850486|FG000|Overall Study|Death|8|||
129968569|NCT03382561|467850487|FG001|Overall Study|Death|3|||
129968570|NCT03382561|467850486|FG000|Overall Study|Withdrawal by Subject|6|||
129968571|NCT03382561|467850487|FG001|Overall Study|Withdrawal by Subject|5|||
129968572|NCT03382561|467850486|FG000|Overall Study|Alternative therapy|2|||
129968573|NCT03382561|467850487|FG001|Overall Study|Alternative therapy|8|||
129968574|NCT03382561|467850486|FG000|Overall Study|Never started treatment|3|||
129968575|NCT03382561|467850487|FG001|Overall Study|Never started treatment|6|||
130093163|NCT02926833|468296832|FG000|Overall Study|Partial Withdrawal of Consent|0|||
130093164|NCT02926833|468296833|FG001|Overall Study|Partial Withdrawal of Consent|0|||
130093165|NCT02926833|468296834|FG002|Overall Study|Partial Withdrawal of Consent|0|||
130093166|NCT02926833|468296835|FG003|Overall Study|Partial Withdrawal of Consent|1|||
130093167|NCT01189201|468296838|FG000|Overall Study|Adverse Event|1|||
130093168|NCT01277757|468296839|FG000|Overall Study|Disease Progression|1|||
130093169|NCT01277757|468296839|FG000|Overall Study|Withdrawal by Subject|1|||
130093170|NCT04308668|468296840|FG000|Overall Study|Lost to Follow-up|32|||
130093171|NCT04308668|468296841|FG001|Overall Study|Lost to Follow-up|38|||
130093172|NCT04308668|468296840|FG000|Overall Study|Withdrawal by Subject|4|||
130093173|NCT04308668|468296841|FG001|Overall Study|Withdrawal by Subject|4|||
130093174|NCT01336647|468296842|FG000|Overall Study|Lost to Follow-up|4|||
130093175|NCT01336647|468296843|FG001|Overall Study|Lost to Follow-up|1|||
130093176|NCT01336647|468296844|FG002|Overall Study|Lost to Follow-up|3|||
130093177|NCT03808298|468296845|FG000|Overall Study|Adverse Event|3|||
130093178|NCT03808298|468296845|FG000|Overall Study|Physician Decision|1|||
130093179|NCT03808298|468296845|FG000|Overall Study|Withdrawal by Subject|1|||
130093180|NCT03808298|468296845|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
130093181|NCT01674010|468296846|FG000|Open Treatment Phase 1|Adverse Event|10|||
130093182|NCT01674010|468296847|FG001|Open Treatment Phase 1|Adverse Event|0|||
130093183|NCT01674010|468296848|FG002|Open Treatment Phase 1|Adverse Event|0|||
130093184|NCT01674010|468296846|FG000|Open Treatment Phase 1|Death|1|||
130093185|NCT01674010|468296847|FG001|Open Treatment Phase 1|Death|0|||
130093186|NCT01674010|468296848|FG002|Open Treatment Phase 1|Death|0|||
130093187|NCT01674010|468296846|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
130093188|NCT01674010|468296847|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
130093189|NCT01674010|468296848|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
130093190|NCT01674010|468296846|FG000|Open Treatment Phase 1|Physician Decision|9|||
130093191|NCT01674010|468296847|FG001|Open Treatment Phase 1|Physician Decision|0|||
130093192|NCT01674010|468296848|FG002|Open Treatment Phase 1|Physician Decision|0|||
130093193|NCT01674010|468296846|FG000|Open Treatment Phase 1|Protocol Violation|7|||
130093194|NCT01674010|468296847|FG001|Open Treatment Phase 1|Protocol Violation|0|||
130093195|NCT01674010|468296848|FG002|Open Treatment Phase 1|Protocol Violation|0|||
130093196|NCT01674010|468296846|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
130093197|NCT01674010|468296847|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
130093198|NCT01674010|468296848|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
130093199|NCT01674010|468296846|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
130093200|NCT01674010|468296847|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
130093201|NCT01674010|468296848|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
130093202|NCT01674010|468296846|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
130093203|NCT01674010|468296847|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
130093204|NCT01674010|468296848|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
130093205|NCT01674010|468296846|FG000|Randomization Phase 2|Adverse Event|0|||
130126600|NCT03435081|468425635|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
130126601|NCT03435081|468425636|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
129968576|NCT03382561|467850486|FG000|Overall Study|Lack of Efficacy|0|||
129968577|NCT03382561|467850487|FG001|Overall Study|Lack of Efficacy|1|||
130093206|NCT01674010|468296847|FG001|Randomization Phase 2|Adverse Event|1|||
130093207|NCT01674010|468296848|FG002|Randomization Phase 2|Adverse Event|1|||
130093208|NCT01674010|468296846|FG000|Randomization Phase 2|Lost to Follow-up|0|||
130093209|NCT01674010|468296847|FG001|Randomization Phase 2|Lost to Follow-up|1|||
130093210|NCT01674010|468296848|FG002|Randomization Phase 2|Lost to Follow-up|2|||
130093211|NCT01674010|468296846|FG000|Randomization Phase 2|Mood episode recurrence|0|||
130126602|NCT03435081|468425634|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
129968578|NCT03382561|467850486|FG000|Overall Study|Physician Decision|0|||
129968579|NCT03382561|467850487|FG001|Overall Study|Physician Decision|1|||
129968580|NCT03382561|467850486|FG000|Overall Study|Other complicating disease|0|||
129968581|NCT03382561|467850487|FG001|Overall Study|Other complicating disease|1|||
129968582|NCT01131104|467850488|FG000|Overall Study|Withdrawal by Subject|3|||
129968583|NCT01131104|467850488|FG000|Overall Study|Physician Decision|4|||
129968584|NCT01131104|467850488|FG000|Overall Study|Information Not Available|5|||
129968585|NCT01131104|467850488|FG000|Overall Study|No Information on Index Date of Onset|1|||
129968586|NCT01245140|467850489|FG000|Overall Study|Adverse Event|1|||
129968587|NCT01245140|467850490|FG001|Overall Study|Adverse Event|3|||
129968588|NCT01245140|467850489|FG000|Overall Study|Lack of Efficacy|2|||
129968589|NCT01245140|467850490|FG001|Overall Study|Lack of Efficacy|4|||
129968590|NCT01245140|467850489|FG000|Overall Study|Protocol Violation|0|||
129968591|NCT01245140|467850490|FG001|Overall Study|Protocol Violation|1|||
129968592|NCT01245140|467850489|FG000|Overall Study|Withdrawal by Subject|0|||
129968593|NCT01245140|467850490|FG001|Overall Study|Withdrawal by Subject|1|||
129968594|NCT01245140|467850489|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
129968595|NCT01245140|467850490|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
129968596|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968597|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
129968598|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
129968599|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
129968600|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968601|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968602|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968603|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968604|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968605|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
129968606|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
129968607|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
129968608|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968609|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968610|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968611|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968612|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
129968613|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968614|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968615|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968616|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968617|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968618|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968619|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968620|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
129968621|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968622|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968623|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968624|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968625|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968626|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968627|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968628|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968629|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968630|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968631|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
129968632|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968633|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968634|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968635|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968636|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968637|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968638|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968639|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968640|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
129968641|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
129968642|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
129968643|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
129968644|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968645|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968646|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968647|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968648|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
129968649|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
129968650|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
129968651|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
129968652|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968653|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968654|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968655|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968656|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
129968657|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
129968658|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968659|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
129968660|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968661|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968662|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968663|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968664|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968665|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968666|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968667|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
129968668|NCT00334542|467850499|FG000|Overall Study|Adverse Event|3|||
129968669|NCT00334542|467850499|FG000|Overall Study|Withdrawal by Subject|1|||
129968670|NCT00334542|467850499|FG000|Overall Study|New cancer diagnosis|1|||
129968671|NCT02370251|467850500|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
129968672|NCT02370251|467850500|FG000|Overall Study|Death|4|||
129968673|NCT00013611|467850501|FG000|Overall Study|Lost to Follow-up|91|||
129968674|NCT00013611|467850502|FG001|Overall Study|Lost to Follow-up|100|||
129968675|NCT01150045|467850503|FG000|Overall Study|Protocol Violation|0|||
129968676|NCT01150045|467850504|FG001|Overall Study|Protocol Violation|1|||
129968677|NCT01150045|467850505|FG002|Overall Study|Protocol Violation|0|||
129968678|NCT01150045|467850506|FG003|Overall Study|Protocol Violation|1|||
129968679|NCT02094898|467850513|FG000|Overall Study|Clinical Worsening|2|||
129968680|NCT02094898|467850513|FG000|Overall Study|Adverse Event|2|||
129968681|NCT02094898|467850513|FG000|Overall Study|Lack of Efficacy|1|||
129968682|NCT05382039|467850514|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
129968683|NCT05382039|467850515|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
129968684|NCT05382039|467850516|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
129968685|NCT05382039|467850514|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
129968686|NCT05382039|467850515|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
129968687|NCT05382039|467850516|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
129968688|NCT05382039|467850514|FG000|Overall Study|waiting for confirmation|0|||
130126603|NCT03435081|468425635|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
129968689|NCT05382039|467850515|FG001|Overall Study|waiting for confirmation|0|||
129968690|NCT05382039|467850516|FG002|Overall Study|waiting for confirmation|1|||
129968691|NCT01432626|467850517|FG000|Overall Study|LV function recovered|2|||
129968692|NCT01432626|467850517|FG000|Overall Study|Withdrawal by Subject|2|||
129968693|NCT01432626|467850517|FG000|Overall Study|Only 1 image competed|2|||
129968694|NCT01432626|467850517|FG000|Overall Study|Imaging agent not available|1|||
129968695|NCT05878873|467850520|FG000|Overall Study|Lost to Follow-up|2|||
129968696|NCT05878873|467850521|FG001|Overall Study|Lost to Follow-up|0|||
130126604|NCT03435081|468425636|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
130126605|NCT03435081|468425634|FG000|Week 0 to Week 16|Pregnancy|1|||
130126606|NCT03435081|468425635|FG001|Week 0 to Week 16|Pregnancy|0|||
129968697|NCT00882115|467850523|FG000|Overall Study|Withdrawal by Subject|3|||
129968698|NCT00882115|467850523|FG000|Overall Study|did not respond to DEP challe|6|||
129968699|NCT02552147|467850524|FG000|First Intervention (7 Days)|Protocol Violation|1|||
129968700|NCT02552147|467850525|FG001|First Intervention (7 Days)|Protocol Violation|0|||
129968701|NCT02552147|467850524|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
129968702|NCT02552147|467850525|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
130126607|NCT03435081|468425636|FG002|Week 0 to Week 16|Pregnancy|0|||
129968703|NCT01547598|467850526|FG000|Overall Study|Withdrew consent|1|||
129968704|NCT01547598|467850527|FG001|Overall Study|Withdrew consent|1|||
130126608|NCT03435081|468425634|FG000|Week 0 to Week 16|Non-compliance|1|||
130126609|NCT03435081|468425635|FG001|Week 0 to Week 16|Non-compliance|0|||
129968705|NCT01547598|467850526|FG000|Overall Study|Lost to Follow-up|1|||
129968706|NCT01547598|467850527|FG001|Overall Study|Lost to Follow-up|1|||
129968707|NCT01547598|467850526|FG000|Overall Study|Adverse Event|1|||
129968708|NCT01547598|467850527|FG001|Overall Study|Adverse Event|1|||
129968709|NCT01547598|467850526|FG000|Overall Study|Protocol Violation|1|||
129968710|NCT01547598|467850527|FG001|Overall Study|Protocol Violation|1|||
129968711|NCT01547598|467850526|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129968712|NCT01547598|467850527|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129968713|NCT02229227|467850528|FG000|Overall Study|Adverse Event|14|||
129968714|NCT02229227|467850529|FG001|Overall Study|Adverse Event|9|||
129968715|NCT02229227|467850528|FG000|Overall Study|Lack of Efficacy|3|||
129968716|NCT02229227|467850529|FG001|Overall Study|Lack of Efficacy|3|||
129968717|NCT02229227|467850528|FG000|Overall Study|Protocol Violation|6|||
129968718|NCT02229227|467850529|FG001|Overall Study|Protocol Violation|8|||
129968719|NCT02229227|467850528|FG000|Overall Study|Protocol defined stopping criteria|1|||
129968720|NCT02229227|467850529|FG001|Overall Study|Protocol defined stopping criteria|3|||
129968721|NCT02229227|467850528|FG000|Overall Study|Lost to Follow-up|3|||
129968722|NCT02229227|467850529|FG001|Overall Study|Lost to Follow-up|3|||
129968723|NCT02229227|467850528|FG000|Overall Study|Study terminated by sponsor|11|||
129968724|NCT02229227|467850529|FG001|Overall Study|Study terminated by sponsor|11|||
129968725|NCT02229227|467850528|FG000|Overall Study|Withdrawal by Subject|8|||
129968726|NCT02229227|467850529|FG001|Overall Study|Withdrawal by Subject|12|||
129968727|NCT02229227|467850528|FG000|Overall Study|Other|0|||
129968728|NCT02229227|467850529|FG001|Overall Study|Other|1|||
129968729|NCT02229227|467850528|FG000|Overall Study|Physician Decision|5|||
129968730|NCT02229227|467850529|FG001|Overall Study|Physician Decision|12|||
129968731|NCT04071301|467850530|FG000|Overall Study|Withdrawal by Subject|6|||
129968732|NCT04071301|467850530|FG000|Overall Study|Death|1|||
129968733|NCT02125279|467850531|FG000|Overall Study|Lack of Efficacy|2|||
129968734|NCT02125279|467850531|FG000|Overall Study|Withdrawal by Subject|6|||
129968735|NCT02125279|467850531|FG000|Overall Study|Protocol Violation|1|||
129968736|NCT02125279|467850531|FG000|Overall Study|Lost to Follow-up|4|||
129968737|NCT01850589|467850537|FG000|Overall Study|Withdrawal by Subject|8|||
129968738|NCT01850589|467850538|FG001|Overall Study|Withdrawal by Subject|0|||
129968739|NCT04468230|467850543|FG000|Overall Study|Adverse Event|2|||
129968740|NCT03721705|467850546|FG000|Overall Study|Adverse Event|2|||
129968741|NCT03721705|467850547|FG001|Overall Study|Adverse Event|0|||
129968742|NCT03721705|467850546|FG000|Overall Study|Withdrawal by Subject|4|||
129968743|NCT03721705|467850547|FG001|Overall Study|Withdrawal by Subject|10|||
129968744|NCT03721705|467850546|FG000|Overall Study|No Suitable Study Partner|1|||
129968745|NCT03721705|467850547|FG001|Overall Study|No Suitable Study Partner|0|||
129968746|NCT03721705|467850546|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
129968747|NCT03721705|467850547|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
129968748|NCT03721705|467850546|FG000|Overall Study|Death|0|||
129968749|NCT03721705|467850547|FG001|Overall Study|Death|1|||
129968750|NCT01790295|467850548|FG000|Overall Study|Adverse Event|1|||
129968751|NCT01790295|467850548|FG000|Overall Study|Death|4|||
129968752|NCT01790295|467850548|FG000|Overall Study|Lack of Efficacy|2|||
129968753|NCT01790295|467850548|FG000|Overall Study|Study closure|4|||
129968754|NCT03721172|467850551|FG000|Placebo-controlled Phase|Adverse Event|7|||
129968755|NCT03721172|467850552|FG001|Placebo-controlled Phase|Adverse Event|7|||
129968756|NCT03721172|467850553|FG002|Placebo-controlled Phase|Adverse Event|0|||
129968757|NCT03721172|467850551|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
129968758|NCT03721172|467850552|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
129968759|NCT03721172|467850553|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
129968760|NCT03721172|467850551|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
129968761|NCT03721172|467850552|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
129968762|NCT03721172|467850553|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
129968763|NCT03721172|467850551|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
129968764|NCT03721172|467850552|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
129968765|NCT03721172|467850553|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
129968766|NCT03721172|467850551|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
130093212|NCT01674010|468296847|FG001|Randomization Phase 2|Mood episode recurrence|8|||
130093213|NCT01674010|468296848|FG002|Randomization Phase 2|Mood episode recurrence|2|||
130093214|NCT01674010|468296846|FG000|Randomization Phase 2|Physician Decision|0|||
130093215|NCT01674010|468296847|FG001|Randomization Phase 2|Physician Decision|0|||
130093216|NCT01674010|468296848|FG002|Randomization Phase 2|Physician Decision|2|||
130093217|NCT01674010|468296846|FG000|Randomization Phase 2|Pregnancy|0|||
129968767|NCT03721172|467850552|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
129968768|NCT03721172|467850553|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
129968769|NCT03721172|467850551|FG000|Placebo-controlled Phase|Other|3|||
129968770|NCT03721172|467850552|FG001|Placebo-controlled Phase|Other|0|||
129968771|NCT03721172|467850553|FG002|Placebo-controlled Phase|Other|0|||
129968772|NCT03721172|467850551|FG000|Apremilast Extension Phase|Adverse Event|0|||
129968773|NCT03721172|467850552|FG001|Apremilast Extension Phase|Adverse Event|0|||
129968774|NCT03721172|467850553|FG002|Apremilast Extension Phase|Adverse Event|10|||
129968775|NCT03721172|467850551|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
129968776|NCT03721172|467850552|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
129968777|NCT03721172|467850553|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
129968778|NCT03721172|467850551|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
129968779|NCT03721172|467850552|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
129968780|NCT03721172|467850553|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
129968781|NCT03721172|467850551|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
129968782|NCT03721172|467850552|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
129968783|NCT03721172|467850553|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
129968784|NCT03721172|467850551|FG000|Apremilast Extension Phase|Protocol Violation|0|||
129968785|NCT03721172|467850552|FG001|Apremilast Extension Phase|Protocol Violation|0|||
129968786|NCT03721172|467850553|FG002|Apremilast Extension Phase|Protocol Violation|1|||
129968787|NCT03721172|467850551|FG000|Apremilast Extension Phase|Physician Decision|0|||
129968788|NCT03721172|467850552|FG001|Apremilast Extension Phase|Physician Decision|0|||
129968789|NCT03721172|467850553|FG002|Apremilast Extension Phase|Physician Decision|1|||
129968790|NCT03721172|467850551|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
129968791|NCT03721172|467850552|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
129968792|NCT03721172|467850553|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
129968793|NCT03721172|467850551|FG000|Apremilast Extension Phase|Other|0|||
129968794|NCT03721172|467850552|FG001|Apremilast Extension Phase|Other|0|||
129968795|NCT03721172|467850553|FG002|Apremilast Extension Phase|Other|3|||
129968796|NCT03721172|467850551|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
129968797|NCT03721172|467850552|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
129968798|NCT03721172|467850553|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
129968799|NCT00420784|467850554|FG000|Overall Study|Adverse Event|11|||
129968800|NCT00420784|467850555|FG001|Overall Study|Adverse Event|29|||
129968801|NCT00420784|467850556|FG002|Overall Study|Adverse Event|10|||
129968802|NCT00420784|467850557|FG003|Overall Study|Adverse Event|5|||
129968803|NCT00420784|467850554|FG000|Overall Study|Withdrawal by Subject|0|||
129968804|NCT00420784|467850555|FG001|Overall Study|Withdrawal by Subject|1|||
129968805|NCT00420784|467850556|FG002|Overall Study|Withdrawal by Subject|0|||
129968806|NCT00420784|467850557|FG003|Overall Study|Withdrawal by Subject|0|||
129968807|NCT00420784|467850554|FG000|Overall Study|Lost to Follow-up|0|||
129968808|NCT00420784|467850555|FG001|Overall Study|Lost to Follow-up|0|||
129968809|NCT00420784|467850556|FG002|Overall Study|Lost to Follow-up|2|||
129968810|NCT00420784|467850557|FG003|Overall Study|Lost to Follow-up|1|||
129968811|NCT00420784|467850554|FG000|Overall Study|Virologic Stopping Rule|17|||
129968812|NCT00420784|467850555|FG001|Overall Study|Virologic Stopping Rule|26|||
129968813|NCT00420784|467850556|FG002|Overall Study|Virologic Stopping Rule|41|||
129968814|NCT00420784|467850557|FG003|Overall Study|Virologic Stopping Rule|67|||
129968815|NCT00420784|467850554|FG000|Overall Study|Other|1|||
129968816|NCT00420784|467850555|FG001|Overall Study|Other|2|||
129968817|NCT00420784|467850556|FG002|Overall Study|Other|0|||
129968818|NCT00420784|467850557|FG003|Overall Study|Other|5|||
129968819|NCT02402322|467850560|FG000|Pretreatment|Withdrawal by Subject|3|||
129968820|NCT02402322|467850561|FG001|Pretreatment|Withdrawal by Subject|1|||
129968821|NCT02402322|467850562|FG002|Pretreatment|Withdrawal by Subject|1|||
129968822|NCT02402322|467850560|FG000|Follow-up|Withdrawal by Subject|6|||
129968823|NCT02402322|467850561|FG001|Follow-up|Withdrawal by Subject|3|||
129968824|NCT02402322|467850562|FG002|Follow-up|Withdrawal by Subject|24|||
129968825|NCT04593823|467850563|FG000|Overall Study|Withdrawal by Subject|1|||
129968826|NCT04593823|467850564|FG001|Overall Study|Withdrawal by Subject|1|||
129968827|NCT04593823|467850563|FG000|Overall Study|Lost to Follow-up|0|||
129968828|NCT04593823|467850564|FG001|Overall Study|Lost to Follow-up|1|||
129968829|NCT02472145|467850565|FG000|Overall Study|Death|10|||
129968830|NCT02472145|467850566|FG001|Overall Study|Death|101|||
129968831|NCT02472145|467850567|FG002|Overall Study|Death|99|||
129968832|NCT02472145|467850565|FG000|Overall Study|Lost to Follow-up|0|||
129968833|NCT02472145|467850566|FG001|Overall Study|Lost to Follow-up|1|||
129968834|NCT02472145|467850567|FG002|Overall Study|Lost to Follow-up|0|||
129968835|NCT02472145|467850565|FG000|Overall Study|Withdrawal by Subject|0|||
129968836|NCT02472145|467850566|FG001|Overall Study|Withdrawal by Subject|9|||
129968837|NCT02472145|467850567|FG002|Overall Study|Withdrawal by Subject|13|||
129968838|NCT02472145|467850565|FG000|Overall Study|Sponsor decision|0|||
129968839|NCT02472145|467850566|FG001|Overall Study|Sponsor decision|3|||
129968840|NCT02472145|467850567|FG002|Overall Study|Sponsor decision|2|||
129968841|NCT02472145|467850565|FG000|Overall Study|Other|0|||
129968842|NCT02472145|467850566|FG001|Overall Study|Other|45|||
129968843|NCT02472145|467850567|FG002|Overall Study|Other|43|||
129968844|NCT01080326|467850568|FG000|Overall Study|Patient deterioration prior to procedure|3|||
129968845|NCT01080326|467850568|FG000|Overall Study|Surgeon decision|1|||
129968846|NCT01318876|467850569|FG000|Day 8 Survey|email address invalid|96|||
129968847|NCT01318876|467850569|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
129968848|NCT01318876|467850569|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
129968849|NCT01296555|467850570|FG000|Overall Study|Adverse Event|0|||
129968850|NCT01296555|467850571|FG001|Overall Study|Adverse Event|0|||
129968851|NCT01296555|467850572|FG002|Overall Study|Adverse Event|1|||
129968852|NCT01296555|467850573|FG003|Overall Study|Adverse Event|1|||
129968853|NCT01296555|467850574|FG004|Overall Study|Adverse Event|2|||
129968854|NCT01296555|467850575|FG005|Overall Study|Adverse Event|4|||
129968855|NCT01296555|467850576|FG006|Overall Study|Adverse Event|1|||
129968856|NCT01296555|467850577|FG007|Overall Study|Adverse Event|4|||
129968857|NCT01296555|467850578|FG008|Overall Study|Adverse Event|3|||
129968858|NCT01296555|467850579|FG009|Overall Study|Adverse Event|1|||
129968859|NCT01296555|467850580|FG010|Overall Study|Adverse Event|0|||
129968860|NCT01296555|467850581|FG011|Overall Study|Adverse Event|4|||
129968861|NCT01296555|467850582|FG012|Overall Study|Adverse Event|1|||
129968862|NCT01296555|467850583|FG013|Overall Study|Adverse Event|4|||
129968863|NCT01296555|467850584|FG014|Overall Study|Adverse Event|0|||
129968864|NCT01296555|467850585|FG015|Overall Study|Adverse Event|0|||
129968865|NCT01296555|467850586|FG016|Overall Study|Adverse Event|0|||
129968866|NCT01296555|467850587|FG017|Overall Study|Adverse Event|0|||
129968867|NCT01296555|467850588|FG018|Overall Study|Adverse Event|0|||
129968868|NCT01296555|467850589|FG019|Overall Study|Adverse Event|1|||
129968869|NCT01296555|467850590|FG020|Overall Study|Adverse Event|0|||
129968870|NCT01296555|467850591|FG021|Overall Study|Adverse Event|0|||
129968871|NCT01296555|467850592|FG022|Overall Study|Adverse Event|0|||
129968872|NCT01296555|467850593|FG023|Overall Study|Adverse Event|0|||
129968873|NCT01296555|467850594|FG024|Overall Study|Adverse Event|0|||
129968874|NCT01296555|467850595|FG025|Overall Study|Adverse Event|0|||
129968875|NCT01296555|467850596|FG026|Overall Study|Adverse Event|0|||
130126610|NCT03435081|468425636|FG002|Week 0 to Week 16|Non-compliance|2|||
130126611|NCT03435081|468425634|FG000|Week 0 to Week 16|Inadequate Response|0|||
130126612|NCT03435081|468425635|FG001|Week 0 to Week 16|Inadequate Response|1|||
130126613|NCT03435081|468425636|FG002|Week 0 to Week 16|Inadequate Response|0|||
129968876|NCT01296555|467850597|FG027|Overall Study|Adverse Event|0|||
129968877|NCT01296555|467850598|FG028|Overall Study|Adverse Event|0|||
129968878|NCT01296555|467850570|FG000|Overall Study|Reason Not Specified|0|||
129968879|NCT01296555|467850571|FG001|Overall Study|Reason Not Specified|0|||
129968880|NCT01296555|467850572|FG002|Overall Study|Reason Not Specified|0|||
129968881|NCT01296555|467850573|FG003|Overall Study|Reason Not Specified|0|||
129968882|NCT01296555|467850574|FG004|Overall Study|Reason Not Specified|0|||
129968883|NCT01296555|467850575|FG005|Overall Study|Reason Not Specified|0|||
129968884|NCT01296555|467850576|FG006|Overall Study|Reason Not Specified|0|||
129968885|NCT01296555|467850577|FG007|Overall Study|Reason Not Specified|0|||
129968886|NCT01296555|467850578|FG008|Overall Study|Reason Not Specified|0|||
129968887|NCT01296555|467850579|FG009|Overall Study|Reason Not Specified|0|||
129968888|NCT01296555|467850580|FG010|Overall Study|Reason Not Specified|0|||
129968889|NCT01296555|467850581|FG011|Overall Study|Reason Not Specified|0|||
129968890|NCT01296555|467850582|FG012|Overall Study|Reason Not Specified|0|||
130126614|NCT03435081|468425634|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
129968891|NCT01296555|467850583|FG013|Overall Study|Reason Not Specified|1|||
129968892|NCT01296555|467850584|FG014|Overall Study|Reason Not Specified|2|||
129968893|NCT01296555|467850585|FG015|Overall Study|Reason Not Specified|3|||
129968894|NCT01296555|467850586|FG016|Overall Study|Reason Not Specified|7|||
129968895|NCT01296555|467850587|FG017|Overall Study|Reason Not Specified|4|||
129968896|NCT01296555|467850588|FG018|Overall Study|Reason Not Specified|3|||
129968897|NCT01296555|467850589|FG019|Overall Study|Reason Not Specified|7|||
129968898|NCT01296555|467850590|FG020|Overall Study|Reason Not Specified|11|||
129968899|NCT01296555|467850591|FG021|Overall Study|Reason Not Specified|5|||
129968900|NCT01296555|467850592|FG022|Overall Study|Reason Not Specified|5|||
129968901|NCT01296555|467850593|FG023|Overall Study|Reason Not Specified|7|||
130126615|NCT03435081|468425635|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
130126616|NCT03435081|468425636|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
130126617|NCT03435081|468425634|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
130126618|NCT03435081|468425635|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
129968902|NCT01296555|467850594|FG024|Overall Study|Reason Not Specified|2|||
129968903|NCT01296555|467850595|FG025|Overall Study|Reason Not Specified|2|||
129968904|NCT01296555|467850596|FG026|Overall Study|Reason Not Specified|19|||
129968905|NCT01296555|467850597|FG027|Overall Study|Reason Not Specified|11|||
129968906|NCT01296555|467850598|FG028|Overall Study|Reason Not Specified|9|||
129968907|NCT01296555|467850570|FG000|Overall Study|Physician Decision|0|||
129968908|NCT01296555|467850571|FG001|Overall Study|Physician Decision|0|||
129968909|NCT01296555|467850572|FG002|Overall Study|Physician Decision|0|||
129968910|NCT01296555|467850573|FG003|Overall Study|Physician Decision|0|||
129968911|NCT01296555|467850574|FG004|Overall Study|Physician Decision|1|||
129968912|NCT01296555|467850575|FG005|Overall Study|Physician Decision|0|||
129968913|NCT01296555|467850576|FG006|Overall Study|Physician Decision|0|||
129968914|NCT01296555|467850577|FG007|Overall Study|Physician Decision|0|||
129968915|NCT01296555|467850578|FG008|Overall Study|Physician Decision|0|||
129968916|NCT01296555|467850579|FG009|Overall Study|Physician Decision|0|||
130126619|NCT03435081|468425636|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
130126620|NCT03435081|468425634|FG000|Week 16 to Week 104|Adverse Event|1|||
129968917|NCT01296555|467850580|FG010|Overall Study|Physician Decision|0|||
129968918|NCT01296555|467850581|FG011|Overall Study|Physician Decision|0|||
129968919|NCT01296555|467850582|FG012|Overall Study|Physician Decision|0|||
129968920|NCT01296555|467850583|FG013|Overall Study|Physician Decision|1|||
129968921|NCT01296555|467850584|FG014|Overall Study|Physician Decision|0|||
129968922|NCT01296555|467850585|FG015|Overall Study|Physician Decision|0|||
129968923|NCT01296555|467850586|FG016|Overall Study|Physician Decision|0|||
129968924|NCT01296555|467850587|FG017|Overall Study|Physician Decision|0|||
129968925|NCT01296555|467850588|FG018|Overall Study|Physician Decision|0|||
129968926|NCT01296555|467850589|FG019|Overall Study|Physician Decision|1|||
129968927|NCT01296555|467850590|FG020|Overall Study|Physician Decision|0|||
129968928|NCT01296555|467850591|FG021|Overall Study|Physician Decision|0|||
129968929|NCT01296555|467850592|FG022|Overall Study|Physician Decision|0|||
129968930|NCT01296555|467850593|FG023|Overall Study|Physician Decision|0|||
129968931|NCT01296555|467850594|FG024|Overall Study|Physician Decision|0|||
129968932|NCT01296555|467850595|FG025|Overall Study|Physician Decision|0|||
129968933|NCT01296555|467850596|FG026|Overall Study|Physician Decision|0|||
129968934|NCT01296555|467850597|FG027|Overall Study|Physician Decision|0|||
129968935|NCT01296555|467850598|FG028|Overall Study|Physician Decision|0|||
129968936|NCT01296555|467850570|FG000|Overall Study|Progressive Disease|6|||
129968937|NCT01296555|467850571|FG001|Overall Study|Progressive Disease|3|||
129968938|NCT01296555|467850572|FG002|Overall Study|Progressive Disease|3|||
129968939|NCT01296555|467850573|FG003|Overall Study|Progressive Disease|7|||
129968940|NCT01296555|467850574|FG004|Overall Study|Progressive Disease|6|||
129968941|NCT01296555|467850575|FG005|Overall Study|Progressive Disease|16|||
129968942|NCT01296555|467850576|FG006|Overall Study|Progressive Disease|16|||
129968943|NCT01296555|467850577|FG007|Overall Study|Progressive Disease|8|||
129968944|NCT01296555|467850578|FG008|Overall Study|Progressive Disease|7|||
129968945|NCT01296555|467850579|FG009|Overall Study|Progressive Disease|18|||
129968946|NCT01296555|467850580|FG010|Overall Study|Progressive Disease|7|||
129968947|NCT01296555|467850581|FG011|Overall Study|Progressive Disease|14|||
129968948|NCT01296555|467850582|FG012|Overall Study|Progressive Disease|5|||
129968949|NCT01296555|467850583|FG013|Overall Study|Progressive Disease|12|||
129968950|NCT01296555|467850584|FG014|Overall Study|Progressive Disease|1|||
129968951|NCT01296555|467850585|FG015|Overall Study|Progressive Disease|1|||
129968952|NCT01296555|467850586|FG016|Overall Study|Progressive Disease|0|||
129968953|NCT01296555|467850587|FG017|Overall Study|Progressive Disease|0|||
129968954|NCT01296555|467850588|FG018|Overall Study|Progressive Disease|0|||
129968955|NCT01296555|467850589|FG019|Overall Study|Progressive Disease|1|||
129968956|NCT01296555|467850590|FG020|Overall Study|Progressive Disease|0|||
129968957|NCT01296555|467850591|FG021|Overall Study|Progressive Disease|0|||
129968958|NCT01296555|467850592|FG022|Overall Study|Progressive Disease|0|||
129968959|NCT01296555|467850593|FG023|Overall Study|Progressive Disease|0|||
129968960|NCT01296555|467850594|FG024|Overall Study|Progressive Disease|1|||
129968961|NCT01296555|467850595|FG025|Overall Study|Progressive Disease|0|||
129968962|NCT01296555|467850596|FG026|Overall Study|Progressive Disease|5|||
129968963|NCT01296555|467850597|FG027|Overall Study|Progressive Disease|1|||
129968964|NCT01296555|467850598|FG028|Overall Study|Progressive Disease|0|||
129968965|NCT01296555|467850570|FG000|Overall Study|Protocol Violation|0|||
129968966|NCT01296555|467850571|FG001|Overall Study|Protocol Violation|0|||
129968967|NCT01296555|467850572|FG002|Overall Study|Protocol Violation|0|||
129968968|NCT01296555|467850573|FG003|Overall Study|Protocol Violation|0|||
129968969|NCT01296555|467850574|FG004|Overall Study|Protocol Violation|0|||
129968970|NCT01296555|467850575|FG005|Overall Study|Protocol Violation|0|||
129968971|NCT01296555|467850576|FG006|Overall Study|Protocol Violation|0|||
129968972|NCT01296555|467850577|FG007|Overall Study|Protocol Violation|0|||
129968973|NCT01296555|467850578|FG008|Overall Study|Protocol Violation|0|||
129968974|NCT01296555|467850579|FG009|Overall Study|Protocol Violation|0|||
129968975|NCT01296555|467850580|FG010|Overall Study|Protocol Violation|0|||
129968976|NCT01296555|467850581|FG011|Overall Study|Protocol Violation|0|||
129968977|NCT01296555|467850582|FG012|Overall Study|Protocol Violation|0|||
129968978|NCT01296555|467850583|FG013|Overall Study|Protocol Violation|1|||
129968979|NCT01296555|467850584|FG014|Overall Study|Protocol Violation|0|||
129968980|NCT01296555|467850585|FG015|Overall Study|Protocol Violation|0|||
129968981|NCT01296555|467850586|FG016|Overall Study|Protocol Violation|0|||
129968982|NCT01296555|467850587|FG017|Overall Study|Protocol Violation|0|||
129968983|NCT01296555|467850588|FG018|Overall Study|Protocol Violation|0|||
129968984|NCT01296555|467850589|FG019|Overall Study|Protocol Violation|0|||
129968985|NCT01296555|467850590|FG020|Overall Study|Protocol Violation|0|||
129968986|NCT01296555|467850591|FG021|Overall Study|Protocol Violation|0|||
129968987|NCT01296555|467850592|FG022|Overall Study|Protocol Violation|0|||
129968988|NCT01296555|467850593|FG023|Overall Study|Protocol Violation|0|||
130093218|NCT01674010|468296847|FG001|Randomization Phase 2|Pregnancy|1|||
130093219|NCT01674010|468296848|FG002|Randomization Phase 2|Pregnancy|1|||
129968989|NCT01296555|467850594|FG024|Overall Study|Protocol Violation|0|||
129968990|NCT01296555|467850595|FG025|Overall Study|Protocol Violation|0|||
129968991|NCT01296555|467850596|FG026|Overall Study|Protocol Violation|0|||
129968992|NCT01296555|467850597|FG027|Overall Study|Protocol Violation|0|||
129968993|NCT01296555|467850598|FG028|Overall Study|Protocol Violation|0|||
129968994|NCT01296555|467850570|FG000|Overall Study|Study Terminated By Sponsor|0|||
129968995|NCT01296555|467850571|FG001|Overall Study|Study Terminated By Sponsor|0|||
129968996|NCT01296555|467850572|FG002|Overall Study|Study Terminated By Sponsor|0|||
129968997|NCT01296555|467850573|FG003|Overall Study|Study Terminated By Sponsor|0|||
129968998|NCT01296555|467850574|FG004|Overall Study|Study Terminated By Sponsor|0|||
129968999|NCT01296555|467850575|FG005|Overall Study|Study Terminated By Sponsor|0|||
129969000|NCT01296555|467850576|FG006|Overall Study|Study Terminated By Sponsor|0|||
129969001|NCT01296555|467850577|FG007|Overall Study|Study Terminated By Sponsor|0|||
129969002|NCT01296555|467850578|FG008|Overall Study|Study Terminated By Sponsor|0|||
129969003|NCT01296555|467850579|FG009|Overall Study|Study Terminated By Sponsor|0|||
129969004|NCT01296555|467850580|FG010|Overall Study|Study Terminated By Sponsor|0|||
129969005|NCT01296555|467850581|FG011|Overall Study|Study Terminated By Sponsor|0|||
129969006|NCT01296555|467850582|FG012|Overall Study|Study Terminated By Sponsor|0|||
129969007|NCT01296555|467850583|FG013|Overall Study|Study Terminated By Sponsor|0|||
129969008|NCT01296555|467850584|FG014|Overall Study|Study Terminated By Sponsor|0|||
129969009|NCT01296555|467850585|FG015|Overall Study|Study Terminated By Sponsor|0|||
129969010|NCT01296555|467850586|FG016|Overall Study|Study Terminated By Sponsor|0|||
129969011|NCT01296555|467850587|FG017|Overall Study|Study Terminated By Sponsor|0|||
129969012|NCT01296555|467850588|FG018|Overall Study|Study Terminated By Sponsor|0|||
129969013|NCT01296555|467850589|FG019|Overall Study|Study Terminated By Sponsor|0|||
129969014|NCT01296555|467850590|FG020|Overall Study|Study Terminated By Sponsor|0|||
129969015|NCT01296555|467850591|FG021|Overall Study|Study Terminated By Sponsor|0|||
129969016|NCT01296555|467850592|FG022|Overall Study|Study Terminated By Sponsor|0|||
130126621|NCT03435081|468425635|FG001|Week 16 to Week 104|Adverse Event|0|||
130126622|NCT03435081|468425636|FG002|Week 16 to Week 104|Adverse Event|2|||
130126623|NCT03435081|468425634|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
130126624|NCT03435081|468425635|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
130126625|NCT03435081|468425636|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
130126626|NCT03435081|468425634|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
130126627|NCT03435081|468425635|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
130126628|NCT03435081|468425636|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
130126629|NCT03435081|468425634|FG000|Week 16 to Week 104|Non--Compliance|0|||
130126630|NCT03435081|468425635|FG001|Week 16 to Week 104|Non--Compliance|0|||
130126631|NCT03435081|468425636|FG002|Week 16 to Week 104|Non--Compliance|1|||
130126632|NCT00420238|468425637|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
130126633|NCT00420238|468425638|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
130126634|NCT00420238|468425637|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
130126635|NCT00420238|468425638|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
130126636|NCT00420238|468425637|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
130126637|NCT00420238|468425638|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
130126638|NCT00420238|468425637|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
130126639|NCT00420238|468425638|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
130126640|NCT00420238|468425637|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
129969017|NCT01296555|467850593|FG023|Overall Study|Study Terminated By Sponsor|0|||
129969018|NCT01296555|467850594|FG024|Overall Study|Study Terminated By Sponsor|0|||
129969019|NCT01296555|467850595|FG025|Overall Study|Study Terminated By Sponsor|1|||
129969020|NCT01296555|467850596|FG026|Overall Study|Study Terminated By Sponsor|0|||
129969021|NCT01296555|467850597|FG027|Overall Study|Study Terminated By Sponsor|0|||
129969022|NCT01296555|467850598|FG028|Overall Study|Study Terminated By Sponsor|0|||
129969023|NCT01296555|467850570|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969024|NCT01296555|467850571|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969025|NCT01296555|467850572|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969026|NCT01296555|467850573|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130126641|NCT00420238|468425638|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
130126642|NCT00420238|468425637|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
129969027|NCT01296555|467850574|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969028|NCT01296555|467850575|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969029|NCT01296555|467850576|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969030|NCT01296555|467850577|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969031|NCT01296555|467850578|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969032|NCT01296555|467850579|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969033|NCT01296555|467850580|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130126643|NCT00420238|468425638|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
130126644|NCT00304083|468425640|FG000|Overall Study|Withdrawal by Subject|4|||
130126645|NCT00304083|468425641|FG001|Overall Study|Withdrawal by Subject|2|||
130126646|NCT00304083|468425640|FG000|Overall Study|Physician Decision|8|||
130126647|NCT00304083|468425641|FG001|Overall Study|Physician Decision|3|||
129969034|NCT01296555|467850581|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969035|NCT01296555|467850582|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130126648|NCT00304083|468425640|FG000|Overall Study|Disease Progression|5|||
129969036|NCT01296555|467850583|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969037|NCT01296555|467850584|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
130126649|NCT00304083|468425641|FG001|Overall Study|Disease Progression|1|||
129969038|NCT01296555|467850585|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969039|NCT01296555|467850586|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969040|NCT01296555|467850587|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969041|NCT01296555|467850588|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969042|NCT01296555|467850589|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
129969043|NCT01296555|467850590|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969044|NCT01296555|467850591|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969045|NCT01296555|467850592|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969046|NCT01296555|467850593|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969047|NCT01296555|467850594|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969048|NCT01296555|467850595|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969049|NCT01296555|467850596|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969050|NCT01296555|467850597|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969051|NCT01296555|467850598|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969052|NCT01296555|467850570|FG000|Overall Study|Death|0|||
129969053|NCT01296555|467850571|FG001|Overall Study|Death|0|||
129969054|NCT01296555|467850572|FG002|Overall Study|Death|0|||
129969055|NCT01296555|467850573|FG003|Overall Study|Death|2|||
129969056|NCT01296555|467850574|FG004|Overall Study|Death|1|||
129969057|NCT01296555|467850575|FG005|Overall Study|Death|0|||
129969058|NCT01296555|467850576|FG006|Overall Study|Death|2|||
129969059|NCT01296555|467850577|FG007|Overall Study|Death|0|||
129969060|NCT01296555|467850578|FG008|Overall Study|Death|0|||
129969061|NCT01296555|467850579|FG009|Overall Study|Death|1|||
129969062|NCT01296555|467850580|FG010|Overall Study|Death|0|||
129969063|NCT01296555|467850581|FG011|Overall Study|Death|1|||
129969064|NCT01296555|467850582|FG012|Overall Study|Death|0|||
129969065|NCT01296555|467850583|FG013|Overall Study|Death|2|||
129969066|NCT01296555|467850584|FG014|Overall Study|Death|27|||
129969067|NCT01296555|467850585|FG015|Overall Study|Death|15|||
129969068|NCT01296555|467850586|FG016|Overall Study|Death|11|||
129969069|NCT01296555|467850587|FG017|Overall Study|Death|11|||
129969070|NCT01296555|467850588|FG018|Overall Study|Death|17|||
129969071|NCT01296555|467850589|FG019|Overall Study|Death|12|||
129969072|NCT01296555|467850590|FG020|Overall Study|Death|13|||
129969073|NCT01296555|467850591|FG021|Overall Study|Death|12|||
129969074|NCT01296555|467850592|FG022|Overall Study|Death|12|||
129969075|NCT01296555|467850593|FG023|Overall Study|Death|13|||
129969076|NCT01296555|467850594|FG024|Overall Study|Death|7|||
129969077|NCT01296555|467850595|FG025|Overall Study|Death|7|||
129969078|NCT01296555|467850596|FG026|Overall Study|Death|35|||
129969079|NCT01296555|467850597|FG027|Overall Study|Death|92|||
129969080|NCT01296555|467850598|FG028|Overall Study|Death|44|||
129969081|NCT01296555|467850570|FG000|Overall Study|Lost to Follow-up|0|||
129969082|NCT01296555|467850571|FG001|Overall Study|Lost to Follow-up|0|||
129969083|NCT01296555|467850572|FG002|Overall Study|Lost to Follow-up|0|||
129969084|NCT01296555|467850573|FG003|Overall Study|Lost to Follow-up|0|||
129969085|NCT01296555|467850574|FG004|Overall Study|Lost to Follow-up|0|||
129969086|NCT01296555|467850575|FG005|Overall Study|Lost to Follow-up|0|||
130126650|NCT00304083|468425640|FG000|Overall Study|Other|5|||
130126651|NCT00304083|468425641|FG001|Overall Study|Other|2|||
130126652|NCT03966365|468425644|FG000|Overall Study|Protocol Violation|1|||
130126653|NCT03966365|468425645|FG001|Overall Study|Protocol Violation|0|||
130126654|NCT01044732|468425646|FG000|Overall Study|Lost to Follow-up|2|||
130126655|NCT01044732|468425647|FG001|Overall Study|Lost to Follow-up|1|||
130126656|NCT01044732|468425646|FG000|Overall Study|Physician Decision|5|||
130126657|NCT01044732|468425647|FG001|Overall Study|Physician Decision|3|||
130126658|NCT01044732|468425646|FG000|Overall Study|Protocol Violation|11|||
130126659|NCT01044732|468425647|FG001|Overall Study|Protocol Violation|12|||
130126660|NCT01044732|468425646|FG000|Overall Study|Withdrawal by Subject|0|||
129969087|NCT01296555|467850576|FG006|Overall Study|Lost to Follow-up|0|||
129969088|NCT01296555|467850577|FG007|Overall Study|Lost to Follow-up|0|||
129969089|NCT01296555|467850578|FG008|Overall Study|Lost to Follow-up|0|||
129969090|NCT01296555|467850579|FG009|Overall Study|Lost to Follow-up|0|||
129969091|NCT01296555|467850580|FG010|Overall Study|Lost to Follow-up|0|||
129969092|NCT01296555|467850581|FG011|Overall Study|Lost to Follow-up|0|||
129969093|NCT01296555|467850582|FG012|Overall Study|Lost to Follow-up|0|||
129969094|NCT01296555|467850583|FG013|Overall Study|Lost to Follow-up|0|||
129969095|NCT01296555|467850584|FG014|Overall Study|Lost to Follow-up|2|||
130126661|NCT01044732|468425647|FG001|Overall Study|Withdrawal by Subject|1|||
129969096|NCT01296555|467850585|FG015|Overall Study|Lost to Follow-up|1|||
129969097|NCT01296555|467850586|FG016|Overall Study|Lost to Follow-up|0|||
129969098|NCT01296555|467850587|FG017|Overall Study|Lost to Follow-up|2|||
129969099|NCT01296555|467850588|FG018|Overall Study|Lost to Follow-up|0|||
129969100|NCT01296555|467850589|FG019|Overall Study|Lost to Follow-up|2|||
129969101|NCT01296555|467850590|FG020|Overall Study|Lost to Follow-up|3|||
129969102|NCT01296555|467850591|FG021|Overall Study|Lost to Follow-up|2|||
129969103|NCT01296555|467850592|FG022|Overall Study|Lost to Follow-up|0|||
129969104|NCT01296555|467850593|FG023|Overall Study|Lost to Follow-up|0|||
129969105|NCT01296555|467850594|FG024|Overall Study|Lost to Follow-up|0|||
129969106|NCT01296555|467850595|FG025|Overall Study|Lost to Follow-up|0|||
130126662|NCT01044732|468425646|FG000|Overall Study|Inadequate bowel preparation|11|||
130126663|NCT01044732|468425647|FG001|Overall Study|Inadequate bowel preparation|17|||
130126664|NCT01044732|468425646|FG000|Overall Study|Inability to reach cecum|5|||
130126665|NCT01044732|468425647|FG001|Overall Study|Inability to reach cecum|2|||
130126666|NCT01044732|468425646|FG000|Overall Study|Technical error or malfunction|15|||
130126667|NCT01044732|468425647|FG001|Overall Study|Technical error or malfunction|14|||
130126668|NCT01569152|468425648|FG000|Phase IIa, Period 1|Early Escape|5|||
130126669|NCT01569152|468425649|FG001|Phase IIa, Period 1|Early Escape|22|||
130126670|NCT01569152|468425650|FG002|Phase IIa, Period 1|Early Escape|0|||
130126671|NCT01569152|468425648|FG000|Phase IIa, Period 1|Adverse Event|4|||
130126672|NCT01569152|468425649|FG001|Phase IIa, Period 1|Adverse Event|0|||
130126673|NCT01569152|468425650|FG002|Phase IIa, Period 1|Adverse Event|0|||
130126674|NCT01569152|468425648|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
130126675|NCT01569152|468425649|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
130126676|NCT01569152|468425650|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
130126677|NCT01569152|468425648|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
130126678|NCT01569152|468425649|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
130126679|NCT01569152|468425650|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
130126680|NCT01569152|468425648|FG000|Phase IIa, Period 1|Protocol Violation|0|||
130126681|NCT01569152|468425649|FG001|Phase IIa, Period 1|Protocol Violation|1|||
130126682|NCT01569152|468425650|FG002|Phase IIa, Period 1|Protocol Violation|0|||
130126683|NCT01569152|468425648|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
130126684|NCT01569152|468425649|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
130126685|NCT01569152|468425650|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
130126686|NCT01569152|468425648|FG000|Safety Extension, Period 3|Adverse Event|0|||
130126687|NCT01569152|468425649|FG001|Safety Extension, Period 3|Adverse Event|0|||
130126688|NCT01569152|468425650|FG002|Safety Extension, Period 3|Adverse Event|4|||
130126689|NCT01569152|468425648|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
130126690|NCT01569152|468425649|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
130126691|NCT01569152|468425650|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
130126692|NCT01569152|468425648|FG000|Safety Extension, Period 3|Physician Decision|0|||
130126693|NCT01569152|468425649|FG001|Safety Extension, Period 3|Physician Decision|0|||
130126694|NCT01569152|468425650|FG002|Safety Extension, Period 3|Physician Decision|2|||
129969107|NCT01296555|467850596|FG026|Overall Study|Lost to Follow-up|3|||
129969108|NCT01296555|467850597|FG027|Overall Study|Lost to Follow-up|13|||
129969109|NCT01296555|467850598|FG028|Overall Study|Lost to Follow-up|5|||
129969110|NCT01296555|467850570|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129969111|NCT01296555|467850571|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129969112|NCT01296555|467850572|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129969113|NCT01296555|467850573|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129969114|NCT01296555|467850574|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129969115|NCT01296555|467850575|FG005|Overall Study|Non-Compliance With Study Drug|0|||
129969116|NCT01296555|467850576|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129969117|NCT01296555|467850577|FG007|Overall Study|Non-Compliance With Study Drug|1|||
129969118|NCT01296555|467850578|FG008|Overall Study|Non-Compliance With Study Drug|0|||
129969119|NCT01296555|467850579|FG009|Overall Study|Non-Compliance With Study Drug|0|||
129969120|NCT01296555|467850580|FG010|Overall Study|Non-Compliance With Study Drug|0|||
129969121|NCT01296555|467850581|FG011|Overall Study|Non-Compliance With Study Drug|0|||
129969122|NCT01296555|467850582|FG012|Overall Study|Non-Compliance With Study Drug|0|||
129969123|NCT01296555|467850583|FG013|Overall Study|Non-Compliance With Study Drug|0|||
129969124|NCT01296555|467850584|FG014|Overall Study|Non-Compliance With Study Drug|0|||
129969125|NCT01296555|467850585|FG015|Overall Study|Non-Compliance With Study Drug|0|||
129969126|NCT01296555|467850586|FG016|Overall Study|Non-Compliance With Study Drug|0|||
129969127|NCT01296555|467850587|FG017|Overall Study|Non-Compliance With Study Drug|0|||
129969128|NCT01296555|467850588|FG018|Overall Study|Non-Compliance With Study Drug|0|||
129969129|NCT01296555|467850589|FG019|Overall Study|Non-Compliance With Study Drug|0|||
129969130|NCT01296555|467850590|FG020|Overall Study|Non-Compliance With Study Drug|0|||
129969131|NCT01296555|467850591|FG021|Overall Study|Non-Compliance With Study Drug|0|||
129969132|NCT01296555|467850592|FG022|Overall Study|Non-Compliance With Study Drug|0|||
129969133|NCT01296555|467850593|FG023|Overall Study|Non-Compliance With Study Drug|0|||
130126695|NCT01569152|468425648|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
129969134|NCT01296555|467850594|FG024|Overall Study|Non-Compliance With Study Drug|0|||
129969135|NCT01296555|467850595|FG025|Overall Study|Non-Compliance With Study Drug|0|||
129969136|NCT01296555|467850596|FG026|Overall Study|Non-Compliance With Study Drug|0|||
129969137|NCT01296555|467850597|FG027|Overall Study|Non-Compliance With Study Drug|0|||
129969138|NCT01296555|467850598|FG028|Overall Study|Non-Compliance With Study Drug|0|||
129969139|NCT01296555|467850570|FG000|Overall Study|Withdrawal by Subject|0|||
129969140|NCT01296555|467850571|FG001|Overall Study|Withdrawal by Subject|0|||
130126696|NCT01569152|468425649|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
130126697|NCT01569152|468425650|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
130126698|NCT00824265|468425655|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
130126699|NCT00824265|468425656|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
130126700|NCT00824265|468425655|FG000|Treatment Phase|Protocol Violation|1|||
129969141|NCT01296555|467850572|FG002|Overall Study|Withdrawal by Subject|0|||
129969142|NCT01296555|467850573|FG003|Overall Study|Withdrawal by Subject|0|||
129969143|NCT01296555|467850574|FG004|Overall Study|Withdrawal by Subject|1|||
129969144|NCT01296555|467850575|FG005|Overall Study|Withdrawal by Subject|0|||
129969145|NCT01296555|467850576|FG006|Overall Study|Withdrawal by Subject|1|||
129969146|NCT01296555|467850577|FG007|Overall Study|Withdrawal by Subject|0|||
129969147|NCT01296555|467850578|FG008|Overall Study|Withdrawal by Subject|0|||
129969148|NCT01296555|467850579|FG009|Overall Study|Withdrawal by Subject|0|||
129969149|NCT01296555|467850580|FG010|Overall Study|Withdrawal by Subject|1|||
129969150|NCT01296555|467850581|FG011|Overall Study|Withdrawal by Subject|1|||
129969151|NCT01296555|467850582|FG012|Overall Study|Withdrawal by Subject|0|||
129969152|NCT01296555|467850583|FG013|Overall Study|Withdrawal by Subject|0|||
129969153|NCT01296555|467850584|FG014|Overall Study|Withdrawal by Subject|3|||
129969154|NCT01296555|467850585|FG015|Overall Study|Withdrawal by Subject|0|||
129969155|NCT01296555|467850586|FG016|Overall Study|Withdrawal by Subject|2|||
129969156|NCT01296555|467850587|FG017|Overall Study|Withdrawal by Subject|1|||
129969157|NCT01296555|467850588|FG018|Overall Study|Withdrawal by Subject|0|||
129969158|NCT01296555|467850589|FG019|Overall Study|Withdrawal by Subject|1|||
129969159|NCT01296555|467850590|FG020|Overall Study|Withdrawal by Subject|1|||
129969160|NCT01296555|467850591|FG021|Overall Study|Withdrawal by Subject|1|||
129969161|NCT01296555|467850592|FG022|Overall Study|Withdrawal by Subject|3|||
129969162|NCT01296555|467850593|FG023|Overall Study|Withdrawal by Subject|0|||
129969163|NCT01296555|467850594|FG024|Overall Study|Withdrawal by Subject|0|||
129969164|NCT01296555|467850595|FG025|Overall Study|Withdrawal by Subject|0|||
129969165|NCT01296555|467850596|FG026|Overall Study|Withdrawal by Subject|8|||
129969166|NCT01296555|467850597|FG027|Overall Study|Withdrawal by Subject|4|||
129969167|NCT01296555|467850598|FG028|Overall Study|Withdrawal by Subject|2|||
130126701|NCT00824265|468425656|FG001|Treatment Phase|Protocol Violation|0|||
130126702|NCT00824265|468425655|FG000|Treatment Phase|Lost to Follow-up|1|||
130126703|NCT00824265|468425656|FG001|Treatment Phase|Lost to Follow-up|1|||
130126704|NCT00824265|468425655|FG000|Treatment Phase|Physician Decision|6|||
130126705|NCT00824265|468425656|FG001|Treatment Phase|Physician Decision|12|||
130126706|NCT00824265|468425655|FG000|Treatment Phase|Withdrawal by Subject|6|||
130126707|NCT00824265|468425656|FG001|Treatment Phase|Withdrawal by Subject|15|||
130126708|NCT00824265|468425655|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
130126709|NCT00824265|468425656|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
130126710|NCT00824265|468425655|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
130126711|NCT00824265|468425656|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
130126712|NCT04188106|468427410|FG000|Overall Study|Lost to Follow-up|5|||
130126713|NCT04188106|468427410|FG000|Overall Study|Non-Compliance|1|||
129969168|NCT03000348|467850603|FG000|Overall Study|Adverse Event|1|||
129969169|NCT03000348|467850604|FG001|Overall Study|Adverse Event|1|||
129969170|NCT03000348|467850605|FG002|Overall Study|Adverse Event|1|||
129969171|NCT03000348|467850606|FG003|Overall Study|Adverse Event|1|||
129969172|NCT03000348|467850607|FG004|Overall Study|Adverse Event|1|||
129969173|NCT03000348|467850608|FG005|Overall Study|Adverse Event|1|||
129969174|NCT03000348|467850603|FG000|Overall Study|Lost to Follow-up|0|||
129969175|NCT03000348|467850604|FG001|Overall Study|Lost to Follow-up|0|||
129969176|NCT03000348|467850605|FG002|Overall Study|Lost to Follow-up|1|||
129969177|NCT03000348|467850606|FG003|Overall Study|Lost to Follow-up|0|||
129969178|NCT03000348|467850607|FG004|Overall Study|Lost to Follow-up|0|||
129969179|NCT03000348|467850608|FG005|Overall Study|Lost to Follow-up|0|||
129969180|NCT03000348|467850603|FG000|Overall Study|Withdrawal by Subject|0|||
129969181|NCT03000348|467850604|FG001|Overall Study|Withdrawal by Subject|1|||
129969182|NCT03000348|467850605|FG002|Overall Study|Withdrawal by Subject|0|||
129969183|NCT03000348|467850606|FG003|Overall Study|Withdrawal by Subject|0|||
129969184|NCT03000348|467850607|FG004|Overall Study|Withdrawal by Subject|0|||
129969185|NCT03000348|467850608|FG005|Overall Study|Withdrawal by Subject|0|||
130126714|NCT00705536|468427411|FG000|Start Period 1|Withdrawal by Subject|0|||
129969186|NCT03000348|467850603|FG000|Overall Study|Consent|0|||
129969187|NCT03000348|467850604|FG001|Overall Study|Consent|0|||
129969188|NCT03000348|467850605|FG002|Overall Study|Consent|0|||
129969189|NCT03000348|467850606|FG003|Overall Study|Consent|0|||
129969190|NCT03000348|467850607|FG004|Overall Study|Consent|1|||
129969191|NCT03000348|467850608|FG005|Overall Study|Consent|0|||
129969192|NCT03000348|467850603|FG000|Overall Study|Failure to expectorate sputum|1|||
129969193|NCT03000348|467850604|FG001|Overall Study|Failure to expectorate sputum|0|||
129969194|NCT03000348|467850605|FG002|Overall Study|Failure to expectorate sputum|1|||
129969195|NCT03000348|467850606|FG003|Overall Study|Failure to expectorate sputum|0|||
129969196|NCT03000348|467850607|FG004|Overall Study|Failure to expectorate sputum|1|||
129969197|NCT03000348|467850608|FG005|Overall Study|Failure to expectorate sputum|0|||
129969198|NCT03000348|467850603|FG000|Overall Study|No gram negative|1|||
129969199|NCT03000348|467850604|FG001|Overall Study|No gram negative|2|||
129969200|NCT03000348|467850605|FG002|Overall Study|No gram negative|1|||
130126715|NCT00705536|468427412|FG001|Start Period 1|Withdrawal by Subject|0|||
130126716|NCT00705536|468427413|FG002|Start Period 1|Withdrawal by Subject|0|||
129969201|NCT03000348|467850606|FG003|Overall Study|No gram negative|1|||
129969202|NCT03000348|467850607|FG004|Overall Study|No gram negative|1|||
129969203|NCT03000348|467850608|FG005|Overall Study|No gram negative|1|||
129969204|NCT03000348|467850603|FG000|Overall Study|Patient had no transport|0|||
129969205|NCT03000348|467850604|FG001|Overall Study|Patient had no transport|0|||
129969206|NCT03000348|467850605|FG002|Overall Study|Patient had no transport|0|||
129969207|NCT03000348|467850606|FG003|Overall Study|Patient had no transport|1|||
129969208|NCT03000348|467850607|FG004|Overall Study|Patient had no transport|0|||
129969209|NCT03000348|467850608|FG005|Overall Study|Patient had no transport|0|||
129969210|NCT03000348|467850603|FG000|Overall Study|Dosing|0|||
129969211|NCT03000348|467850604|FG001|Overall Study|Dosing|0|||
129969212|NCT03000348|467850605|FG002|Overall Study|Dosing|0|||
129969213|NCT03000348|467850606|FG003|Overall Study|Dosing|0|||
129969214|NCT03000348|467850607|FG004|Overall Study|Dosing|1|||
129969215|NCT03000348|467850608|FG005|Overall Study|Dosing|0|||
129969216|NCT04042077|467850609|FG000|Overall Study|Adverse Event|0|||
129969217|NCT04042077|467850610|FG001|Overall Study|Adverse Event|1|||
129969218|NCT04042077|467850609|FG000|Overall Study|Death|2|||
129969219|NCT04042077|467850610|FG001|Overall Study|Death|1|||
129969220|NCT04042077|467850609|FG000|Overall Study|Physician Decision|2|||
129969221|NCT04042077|467850610|FG001|Overall Study|Physician Decision|0|||
129969222|NCT04042077|467850609|FG000|Overall Study|Withdrawal by Subject|3|||
129969223|NCT04042077|467850610|FG001|Overall Study|Withdrawal by Subject|2|||
129969224|NCT04042077|467850609|FG000|Overall Study|Lack of Efficacy|0|||
129969225|NCT04042077|467850610|FG001|Overall Study|Lack of Efficacy|1|||
129969226|NCT00745498|467850612|FG000|Overall Study|Lost to Follow-up|1|||
129969227|NCT00745498|467850613|FG001|Overall Study|Lost to Follow-up|1|||
129969228|NCT00745498|467850614|FG002|Overall Study|Lost to Follow-up|3|||
129969229|NCT00745498|467850612|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
129969230|NCT00745498|467850613|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
129969231|NCT00745498|467850614|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
129969232|NCT00745498|467850612|FG000|Overall Study|Non-PDR related VH|0|||
129969233|NCT00745498|467850613|FG001|Overall Study|Non-PDR related VH|1|||
129969234|NCT00745498|467850614|FG002|Overall Study|Non-PDR related VH|1|||
129969235|NCT00745498|467850612|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
129969236|NCT00745498|467850613|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
129969237|NCT00745498|467850614|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
129969238|NCT02031536|467850618|FG000|Overall Study|ineligible|1|||
129969239|NCT02031536|467850619|FG001|Overall Study|ineligible|0|||
129969240|NCT01827046|467850624|FG000|Overall Study|Lost to Follow-up|1|||
129969241|NCT01827046|467850625|FG001|Overall Study|Lost to Follow-up|5|||
129969242|NCT01827046|467850624|FG000|Overall Study|Withdrawal by Subject|0|||
129969243|NCT01827046|467850625|FG001|Overall Study|Withdrawal by Subject|4|||
129969244|NCT01294436|467850626|FG000|Overall Study|Adverse Event|10|||
129969245|NCT01294436|467850627|FG001|Overall Study|Adverse Event|17|||
129969246|NCT01294436|467850626|FG000|Overall Study|Withdrawal by Subject|11|||
129969247|NCT01294436|467850627|FG001|Overall Study|Withdrawal by Subject|28|||
129969248|NCT01294436|467850626|FG000|Overall Study|subject no longer meets study criteria|5|||
129969249|NCT01294436|467850627|FG001|Overall Study|subject no longer meets study criteria|20|||
129969250|NCT01294436|467850626|FG000|Overall Study|poor/non-compliance|2|||
129969251|NCT01294436|467850627|FG001|Overall Study|poor/non-compliance|5|||
129969252|NCT00585078|467850630|FG000|Overall Study|Withdrawal by Subject|4|||
129969253|NCT00585078|467850630|FG000|Overall Study|Poor performance status|1|||
129969254|NCT00585078|467850630|FG000|Overall Study|Disease Progression|24|||
129969255|NCT00585078|467850630|FG000|Overall Study|Adverse Event|10|||
129969256|NCT00585078|467850630|FG000|Overall Study|Death|1|||
129969257|NCT02781311|467850633|FG000|Overall Study|Adverse Event|2|||
129969258|NCT02781311|467850634|FG001|Overall Study|Adverse Event|6|||
129969259|NCT02781311|467850635|FG002|Overall Study|Adverse Event|1|||
129969260|NCT02781311|467850633|FG000|Overall Study|Withdrawal of Consent|11|||
129969261|NCT02781311|467850634|FG001|Overall Study|Withdrawal of Consent|12|||
129969262|NCT02781311|467850635|FG002|Overall Study|Withdrawal of Consent|2|||
129969263|NCT02781311|467850633|FG000|Overall Study|Lost to Follow-up|11|||
129969264|NCT02781311|467850634|FG001|Overall Study|Lost to Follow-up|8|||
129969265|NCT02781311|467850635|FG002|Overall Study|Lost to Follow-up|1|||
129969266|NCT02781311|467850633|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129969267|NCT02781311|467850634|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129969268|NCT02781311|467850635|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129969269|NCT01056263|467850638|FG000|Overall Study|Adverse Event|12|||
129969270|NCT01056263|467850638|FG000|Overall Study|Death|1|||
129969271|NCT01056263|467850638|FG000|Overall Study|Withdrawal by Subject|1|||
129969272|NCT01056263|467850638|FG000|Overall Study|Lack of Efficacy|29|||
129969273|NCT01056263|467850638|FG000|Overall Study|Progressive disease|2|||
129969274|NCT01056263|467850638|FG000|Overall Study|Neoplasm progression|1|||
129969275|NCT01056263|467850638|FG000|Overall Study|Objective progression or relapse|1|||
129969276|NCT01056263|467850638|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
129969277|NCT02257918|467850639|FG000|Overall Study|Lost to Follow-up|4|||
129969278|NCT02257918|467850640|FG001|Overall Study|Lost to Follow-up|1|||
129969279|NCT02257918|467850641|FG002|Overall Study|Lost to Follow-up|0|||
129969280|NCT02257918|467850639|FG000|Overall Study|Withdrawal by Subject|0|||
129969281|NCT02257918|467850640|FG001|Overall Study|Withdrawal by Subject|0|||
129969282|NCT02257918|467850641|FG002|Overall Study|Withdrawal by Subject|1|||
129969283|NCT02257918|467850639|FG000|Overall Study|Pregnancy|0|||
129969284|NCT02257918|467850640|FG001|Overall Study|Pregnancy|0|||
129969285|NCT02257918|467850641|FG002|Overall Study|Pregnancy|1|||
129969286|NCT03371823|467850645|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
129969287|NCT03371823|467850646|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
129969288|NCT01263054|467850650|FG000|Overall Study|Death|1|||
129969289|NCT01263054|467850651|FG001|Overall Study|Death|0|||
129969290|NCT01263054|467850650|FG000|Overall Study|Lost to Follow-up|2|||
129969291|NCT01263054|467850651|FG001|Overall Study|Lost to Follow-up|2|||
129969292|NCT01263054|467850650|FG000|Overall Study|Withdrawal by Subject|1|||
129969293|NCT01263054|467850651|FG001|Overall Study|Withdrawal by Subject|3|||
129969294|NCT01263054|467850650|FG000|Overall Study|Qualification Violation|1|||
129969295|NCT01263054|467850651|FG001|Overall Study|Qualification Violation|0|||
129969296|NCT01263054|467850650|FG000|Overall Study|Other|0|||
129969297|NCT01263054|467850651|FG001|Overall Study|Other|1|||
129969298|NCT02242643|467850652|FG000|Overall Study|Protocol Violation|1|||
129969299|NCT02242643|467850653|FG001|Overall Study|Protocol Violation|2|||
129969300|NCT02242643|467850652|FG000|Overall Study|Withdrawal by Subject|15|||
129969301|NCT02242643|467850653|FG001|Overall Study|Withdrawal by Subject|10|||
129969302|NCT02242643|467850652|FG000|Overall Study|Migrated/moved from study area|1|||
129969303|NCT02242643|467850653|FG001|Overall Study|Migrated/moved from study area|3|||
129969304|NCT02242643|467850652|FG000|Overall Study|Lost to Follow-up|54|||
129969305|NCT02242643|467850653|FG001|Overall Study|Lost to Follow-up|61|||
129969306|NCT02242643|467850652|FG000|Overall Study|Child placed in foster care by family|0|||
129969307|NCT02242643|467850653|FG001|Overall Study|Child placed in foster care by family|1|||
129969308|NCT02242643|467850652|FG000|Overall Study|Non-compliance|1|||
129969309|NCT02242643|467850653|FG001|Overall Study|Non-compliance|0|||
129969310|NCT02242643|467850652|FG000|Overall Study|Consent withdrawal by parent|1|||
129969311|NCT02242643|467850653|FG001|Overall Study|Consent withdrawal by parent|0|||
129969312|NCT02242643|467850652|FG000|Overall Study|Protocol requirements not followed|1|||
129969313|NCT02242643|467850653|FG001|Overall Study|Protocol requirements not followed|0|||
129969314|NCT02242643|467850652|FG000|Overall Study|Language barrier|1|||
129969315|NCT02242643|467850653|FG001|Overall Study|Language barrier|0|||
129969316|NCT02242643|467850652|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
129969317|NCT02242643|467850653|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
129969318|NCT02282059|467850660|FG000|Overall Study|Other|15|||
129969319|NCT02282059|467850661|FG001|Overall Study|Other|3|||
129969320|NCT02282059|467850660|FG000|Overall Study|Participant refused further follow-up|8|||
129969321|NCT02282059|467850661|FG001|Overall Study|Participant refused further follow-up|4|||
129969322|NCT02282059|467850660|FG000|Overall Study|Lost to Follow-up|19|||
129969323|NCT02282059|467850661|FG001|Overall Study|Lost to Follow-up|3|||
129969324|NCT02282059|467850660|FG000|Overall Study|Death|40|||
129969325|NCT02282059|467850661|FG001|Overall Study|Death|8|||
129969326|NCT05093504|467850662|FG000|Overall Study|Death|0|||
129969327|NCT05093504|467850663|FG001|Overall Study|Death|1|||
129969328|NCT02035696|467852892|FG000|Overall Study|Lost to Follow-up|0|||
129969329|NCT02035696|467852893|FG001|Overall Study|Lost to Follow-up|3|||
129969330|NCT02035696|467852894|FG002|Overall Study|Lost to Follow-up|1|||
129969331|NCT02035696|467852895|FG003|Overall Study|Lost to Follow-up|2|||
129969332|NCT02035696|467852892|FG000|Overall Study|Withdrawal by Subject|3|||
129969333|NCT02035696|467852893|FG001|Overall Study|Withdrawal by Subject|0|||
129969334|NCT02035696|467852894|FG002|Overall Study|Withdrawal by Subject|2|||
129969335|NCT02035696|467852895|FG003|Overall Study|Withdrawal by Subject|1|||
129969336|NCT01090011|467852896|FG000|Overall Study|Progressive disease|128|||
129969337|NCT01090011|467852896|FG000|Overall Study|Adverse Event|32|||
129969338|NCT01090011|467852896|FG000|Overall Study|Protocol Violation|1|||
129969339|NCT01090011|467852896|FG000|Overall Study|Refusal to start/continue medication|5|||
129969340|NCT01090011|467852896|FG000|Overall Study|Other reason not defined above|5|||
130126717|NCT00705536|468427414|FG003|Start Period 1|Withdrawal by Subject|1|||
129969341|NCT00379769|467852897|FG000|Main Study|Death|57|||
129969342|NCT00379769|467852898|FG001|Main Study|Death|67|||
129969343|NCT00379769|467852899|FG002|Main Study|Death|54|||
129969344|NCT00379769|467852900|FG003|Main Study|Death|72|||
129969345|NCT00379769|467852901|FG004|Main Study|Death|0|||
129969346|NCT00379769|467852902|FG005|Main Study|Death|0|||
129969347|NCT00379769|467852897|FG000|Main Study|Adverse Event|5|||
129969348|NCT00379769|467852898|FG001|Main Study|Adverse Event|8|||
129969349|NCT00379769|467852899|FG002|Main Study|Adverse Event|10|||
129969350|NCT00379769|467852900|FG003|Main Study|Adverse Event|11|||
129969351|NCT00379769|467852901|FG004|Main Study|Adverse Event|0|||
129969352|NCT00379769|467852902|FG005|Main Study|Adverse Event|0|||
129969353|NCT00379769|467852897|FG000|Main Study|Lost to Follow-up|29|||
129969354|NCT00379769|467852898|FG001|Main Study|Lost to Follow-up|29|||
129969355|NCT00379769|467852899|FG002|Main Study|Lost to Follow-up|25|||
129969356|NCT00379769|467852900|FG003|Main Study|Lost to Follow-up|26|||
129969357|NCT00379769|467852901|FG004|Main Study|Lost to Follow-up|0|||
129969358|NCT00379769|467852902|FG005|Main Study|Lost to Follow-up|0|||
129969359|NCT00379769|467852897|FG000|Main Study|Withdrawal by Subject|46|||
129969360|NCT00379769|467852898|FG001|Main Study|Withdrawal by Subject|56|||
129969361|NCT00379769|467852899|FG002|Main Study|Withdrawal by Subject|72|||
129969362|NCT00379769|467852900|FG003|Main Study|Withdrawal by Subject|70|||
129969363|NCT00379769|467852901|FG004|Main Study|Withdrawal by Subject|0|||
129969364|NCT00379769|467852902|FG005|Main Study|Withdrawal by Subject|0|||
129969365|NCT00379769|467852897|FG000|Main Study|Moved to survival status follow-up only|27|||
129969366|NCT00379769|467852898|FG001|Main Study|Moved to survival status follow-up only|25|||
129969367|NCT00379769|467852899|FG002|Main Study|Moved to survival status follow-up only|32|||
129969368|NCT00379769|467852900|FG003|Main Study|Moved to survival status follow-up only|36|||
129969369|NCT00379769|467852901|FG004|Main Study|Moved to survival status follow-up only|0|||
129969370|NCT00379769|467852902|FG005|Main Study|Moved to survival status follow-up only|0|||
129969371|NCT00379769|467852897|FG000|Main Study|Participant moved|3|||
129969372|NCT00379769|467852898|FG001|Main Study|Participant moved|2|||
129969373|NCT00379769|467852899|FG002|Main Study|Participant moved|3|||
129969374|NCT00379769|467852900|FG003|Main Study|Participant moved|3|||
129969375|NCT00379769|467852901|FG004|Main Study|Participant moved|0|||
129969376|NCT00379769|467852902|FG005|Main Study|Participant moved|0|||
129969377|NCT00379769|467852897|FG000|Main Study|Poor compliance|3|||
129969378|NCT00379769|467852898|FG001|Main Study|Poor compliance|2|||
129969379|NCT00379769|467852899|FG002|Main Study|Poor compliance|2|||
129969380|NCT00379769|467852900|FG003|Main Study|Poor compliance|1|||
129969381|NCT00379769|467852901|FG004|Main Study|Poor compliance|0|||
129969382|NCT00379769|467852902|FG005|Main Study|Poor compliance|0|||
129969383|NCT00379769|467852897|FG000|Main Study|Prohibited glucose lowering medication|0|||
129969384|NCT00379769|467852898|FG001|Main Study|Prohibited glucose lowering medication|3|||
129969385|NCT00379769|467852899|FG002|Main Study|Prohibited glucose lowering medication|0|||
129969386|NCT00379769|467852900|FG003|Main Study|Prohibited glucose lowering medication|1|||
129969387|NCT00379769|467852901|FG004|Main Study|Prohibited glucose lowering medication|0|||
129969388|NCT00379769|467852902|FG005|Main Study|Prohibited glucose lowering medication|0|||
129969389|NCT00379769|467852897|FG000|Main Study|Site closed|4|||
129969390|NCT00379769|467852898|FG001|Main Study|Site closed|4|||
129969391|NCT00379769|467852899|FG002|Main Study|Site closed|4|||
129969392|NCT00379769|467852900|FG003|Main Study|Site closed|8|||
129969393|NCT00379769|467852901|FG004|Main Study|Site closed|0|||
129969394|NCT00379769|467852902|FG005|Main Study|Site closed|0|||
129969395|NCT00379769|467852897|FG000|Main Study|Entry criteria violation|0|||
129969396|NCT00379769|467852898|FG001|Main Study|Entry criteria violation|0|||
129969397|NCT00379769|467852899|FG002|Main Study|Entry criteria violation|1|||
129969398|NCT00379769|467852900|FG003|Main Study|Entry criteria violation|1|||
129969399|NCT00379769|467852901|FG004|Main Study|Entry criteria violation|0|||
129969400|NCT00379769|467852902|FG005|Main Study|Entry criteria violation|0|||
129969401|NCT00379769|467852897|FG000|Main Study|Participant did not take study drug|0|||
129969402|NCT00379769|467852898|FG001|Main Study|Participant did not take study drug|0|||
129969403|NCT00379769|467852899|FG002|Main Study|Participant did not take study drug|1|||
129969404|NCT00379769|467852900|FG003|Main Study|Participant did not take study drug|0|||
129969405|NCT00379769|467852901|FG004|Main Study|Participant did not take study drug|0|||
129969406|NCT00379769|467852902|FG005|Main Study|Participant did not take study drug|0|||
129969407|NCT00379769|467852897|FG000|Main Study|Physician Decision|2|||
129969408|NCT00379769|467852898|FG001|Main Study|Physician Decision|2|||
129969409|NCT00379769|467852899|FG002|Main Study|Physician Decision|1|||
129969410|NCT00379769|467852900|FG003|Main Study|Physician Decision|1|||
129969411|NCT00379769|467852901|FG004|Main Study|Physician Decision|0|||
129969412|NCT00379769|467852902|FG005|Main Study|Physician Decision|0|||
129969413|NCT00379769|467852897|FG000|Main Study|Participant completed study at visit 27|1|||
129969414|NCT00379769|467852898|FG001|Main Study|Participant completed study at visit 27|0|||
129969415|NCT00379769|467852899|FG002|Main Study|Participant completed study at visit 27|0|||
129969416|NCT00379769|467852900|FG003|Main Study|Participant completed study at visit 27|0|||
129969417|NCT00379769|467852901|FG004|Main Study|Participant completed study at visit 27|0|||
129969418|NCT00379769|467852902|FG005|Main Study|Participant completed study at visit 27|0|||
129969419|NCT00379769|467852897|FG000|Main Study|Personal reasons|1|||
129969420|NCT00379769|467852898|FG001|Main Study|Personal reasons|0|||
129969421|NCT00379769|467852899|FG002|Main Study|Personal reasons|0|||
129969422|NCT00379769|467852900|FG003|Main Study|Personal reasons|0|||
129969423|NCT00379769|467852901|FG004|Main Study|Personal reasons|0|||
129969424|NCT00379769|467852902|FG005|Main Study|Personal reasons|0|||
129969425|NCT00379769|467852897|FG000|Main Study|Risk of heart failure|0|||
129969426|NCT00379769|467852898|FG001|Main Study|Risk of heart failure|1|||
129969427|NCT00379769|467852899|FG002|Main Study|Risk of heart failure|0|||
129969428|NCT00379769|467852900|FG003|Main Study|Risk of heart failure|0|||
129969429|NCT00379769|467852901|FG004|Main Study|Risk of heart failure|0|||
129969430|NCT00379769|467852902|FG005|Main Study|Risk of heart failure|0|||
129969431|NCT00379769|467852897|FG000|Main Study|Investigator refused to log temperature|0|||
129969432|NCT00379769|467852898|FG001|Main Study|Investigator refused to log temperature|0|||
129969433|NCT00379769|467852899|FG002|Main Study|Investigator refused to log temperature|1|||
129969434|NCT00379769|467852900|FG003|Main Study|Investigator refused to log temperature|0|||
129969435|NCT00379769|467852901|FG004|Main Study|Investigator refused to log temperature|0|||
129969436|NCT00379769|467852902|FG005|Main Study|Investigator refused to log temperature|0|||
129969437|NCT00379769|467852897|FG000|Main Study|Reason unspecified|0|||
129969438|NCT00379769|467852898|FG001|Main Study|Reason unspecified|0|||
129969439|NCT00379769|467852899|FG002|Main Study|Reason unspecified|1|||
130126718|NCT02289963|468427415|FG000|Overall Study|Adverse Event|1|||
130126719|NCT02289963|468427416|FG001|Overall Study|Adverse Event|2|||
130126720|NCT02289963|468427415|FG000|Overall Study|Poor compliance to protocol|1|||
130126721|NCT02289963|468427416|FG001|Overall Study|Poor compliance to protocol|0|||
130126722|NCT02289963|468427415|FG000|Overall Study|Withdrawal by Subject|1|||
130126723|NCT02289963|468427416|FG001|Overall Study|Withdrawal by Subject|0|||
130126724|NCT02289963|468427415|FG000|Overall Study|Last injection missed|2|||
130126725|NCT02289963|468427416|FG001|Overall Study|Last injection missed|2|||
130126726|NCT02289963|468427415|FG000|Overall Study|End treatment visit outside visit window|0|||
129969440|NCT00379769|467852900|FG003|Main Study|Reason unspecified|0|||
129969441|NCT00379769|467852901|FG004|Main Study|Reason unspecified|0|||
129969442|NCT00379769|467852902|FG005|Main Study|Reason unspecified|0|||
129969443|NCT00379769|467852897|FG000|Observational Follow-up|Death|0|||
129969444|NCT00379769|467852898|FG001|Observational Follow-up|Death|0|||
129969445|NCT00379769|467852899|FG002|Observational Follow-up|Death|0|||
129969446|NCT00379769|467852900|FG003|Observational Follow-up|Death|0|||
129969447|NCT00379769|467852901|FG004|Observational Follow-up|Death|78|||
129969448|NCT00379769|467852902|FG005|Observational Follow-up|Death|70|||
129969449|NCT00379769|467852897|FG000|Observational Follow-up|Adverse Event|0|||
129969450|NCT00379769|467852898|FG001|Observational Follow-up|Adverse Event|0|||
129969451|NCT00379769|467852899|FG002|Observational Follow-up|Adverse Event|0|||
129969452|NCT00379769|467852900|FG003|Observational Follow-up|Adverse Event|0|||
129969453|NCT00379769|467852901|FG004|Observational Follow-up|Adverse Event|1|||
129969454|NCT00379769|467852902|FG005|Observational Follow-up|Adverse Event|0|||
129969455|NCT00379769|467852897|FG000|Observational Follow-up|Lost to Follow-up|0|||
129969456|NCT00379769|467852898|FG001|Observational Follow-up|Lost to Follow-up|0|||
129969457|NCT00379769|467852899|FG002|Observational Follow-up|Lost to Follow-up|0|||
129969458|NCT00379769|467852900|FG003|Observational Follow-up|Lost to Follow-up|0|||
129969459|NCT00379769|467852901|FG004|Observational Follow-up|Lost to Follow-up|25|||
129969460|NCT00379769|467852902|FG005|Observational Follow-up|Lost to Follow-up|27|||
129969461|NCT00379769|467852897|FG000|Observational Follow-up|Withdrawal by Subject|0|||
129969462|NCT00379769|467852898|FG001|Observational Follow-up|Withdrawal by Subject|0|||
129969463|NCT00379769|467852899|FG002|Observational Follow-up|Withdrawal by Subject|0|||
129969464|NCT00379769|467852900|FG003|Observational Follow-up|Withdrawal by Subject|0|||
129969465|NCT00379769|467852901|FG004|Observational Follow-up|Withdrawal by Subject|12|||
129969466|NCT00379769|467852902|FG005|Observational Follow-up|Withdrawal by Subject|12|||
129969467|NCT00379769|467852897|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969468|NCT00379769|467852898|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969469|NCT00379769|467852899|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969470|NCT00379769|467852900|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969471|NCT00379769|467852901|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
129969472|NCT00379769|467852902|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
129969473|NCT00379769|467852897|FG000|Observational Follow-up|Physician Decision|0|||
129969474|NCT00379769|467852898|FG001|Observational Follow-up|Physician Decision|0|||
129969475|NCT00379769|467852899|FG002|Observational Follow-up|Physician Decision|0|||
129969476|NCT00379769|467852900|FG003|Observational Follow-up|Physician Decision|0|||
129969477|NCT00379769|467852901|FG004|Observational Follow-up|Physician Decision|8|||
129969478|NCT00379769|467852902|FG005|Observational Follow-up|Physician Decision|8|||
129969479|NCT00379769|467852897|FG000|Observational Follow-up|Site Closed Early|0|||
129969480|NCT00379769|467852898|FG001|Observational Follow-up|Site Closed Early|0|||
130126727|NCT02289963|468427416|FG001|Overall Study|End treatment visit outside visit window|4|||
130126728|NCT02289963|468427415|FG000|Overall Study|Other than specified above|0|||
130126729|NCT02289963|468427416|FG001|Overall Study|Other than specified above|2|||
130126730|NCT00549718|468427419|FG000|Overall Study|Insufficient clinical response|20|||
129969481|NCT00379769|467852899|FG002|Observational Follow-up|Site Closed Early|0|||
129969482|NCT00379769|467852900|FG003|Observational Follow-up|Site Closed Early|0|||
129969483|NCT00379769|467852901|FG004|Observational Follow-up|Site Closed Early|6|||
129969484|NCT00379769|467852902|FG005|Observational Follow-up|Site Closed Early|7|||
129969485|NCT00379769|467852897|FG000|Observational Follow-up|Participant Moved|0|||
129969486|NCT00379769|467852898|FG001|Observational Follow-up|Participant Moved|0|||
129969487|NCT00379769|467852899|FG002|Observational Follow-up|Participant Moved|0|||
129969488|NCT00379769|467852900|FG003|Observational Follow-up|Participant Moved|0|||
129969489|NCT00379769|467852901|FG004|Observational Follow-up|Participant Moved|0|||
129969490|NCT00379769|467852902|FG005|Observational Follow-up|Participant Moved|1|||
129969491|NCT00379769|467852897|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
130126731|NCT00549718|468427420|FG001|Overall Study|Insufficient clinical response|7|||
129969492|NCT00379769|467852898|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969493|NCT00379769|467852899|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969494|NCT00379769|467852900|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969495|NCT00379769|467852901|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
129969496|NCT00379769|467852902|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
129969497|NCT01689363|467852907|FG000|Overall Study|Protocol Violation|0|||
129969498|NCT01689363|467852908|FG001|Overall Study|Protocol Violation|1|||
129969499|NCT01689363|467852909|FG002|Overall Study|Protocol Violation|0|||
129969500|NCT01689363|467852910|FG003|Overall Study|Protocol Violation|0|||
129969501|NCT01689363|467852911|FG004|Overall Study|Protocol Violation|0|||
129969502|NCT01689363|467852912|FG005|Overall Study|Protocol Violation|0|||
129969503|NCT01689363|467852913|FG006|Overall Study|Protocol Violation|0|||
129969504|NCT01689363|467852914|FG007|Overall Study|Protocol Violation|0|||
129969505|NCT02859064|467852915|FG000|Overall Study|Progressive Disease|3|||
129969506|NCT02859064|467852915|FG000|Overall Study|Physician Decision|1|||
129969507|NCT02859064|467852915|FG000|Overall Study|Withdrawal by Subject|1|||
129969508|NCT02859064|467852915|FG000|Overall Study|Death|1|||
129969509|NCT00321685|467852916|FG000|Overall Study|Adverse Event|18|||
129969510|NCT00321685|467852916|FG000|Overall Study|Death|2|||
129969511|NCT00321685|467852916|FG000|Overall Study|Withdrawal by Subject|8|||
129969512|NCT00321685|467852916|FG000|Overall Study|Alternative therapy|1|||
129969513|NCT00321685|467852916|FG000|Overall Study|Complicating disese|1|||
129969514|NCT00321685|467852916|FG000|Overall Study|Other|5|||
129969515|NCT00321685|467852916|FG000|Overall Study|Not start protocol therapy|2|||
129969516|NCT00321685|467852916|FG000|Overall Study|Ineligible|2|||
129969517|NCT00127842|467852917|FG000|Overall Study|Adverse Event|15|||
129969518|NCT00127842|467852917|FG000|Overall Study|Withdrawal by Subject|3|||
129969519|NCT00127842|467852917|FG000|Overall Study|Lost to Follow-up|1|||
129969520|NCT00127842|467852917|FG000|Overall Study|Lack of Efficacy|12|||
129969521|NCT00127842|467852917|FG000|Overall Study|Noncompliance|2|||
129969522|NCT00127842|467852917|FG000|Overall Study|Protocol Violation|1|||
129969523|NCT00127842|467852917|FG000|Overall Study|Other|5|||
129969524|NCT01638390|467852920|FG000|Overall Study|screening failures|21|||
129969525|NCT01536587|467852921|FG000|Overall Study|Adverse Event|2|||
129969526|NCT01434680|467852922|FG000|Overall Study|Withdrawal by Subject|1|||
129969527|NCT01434680|467852923|FG001|Overall Study|Withdrawal by Subject|0|||
129969528|NCT01434680|467852924|FG002|Overall Study|Withdrawal by Subject|2|||
129969529|NCT01434680|467852925|FG003|Overall Study|Withdrawal by Subject|0|||
129969530|NCT01434680|467852922|FG000|Overall Study|Lost to Follow-up|1|||
129969531|NCT01434680|467852923|FG001|Overall Study|Lost to Follow-up|1|||
129969532|NCT01434680|467852924|FG002|Overall Study|Lost to Follow-up|0|||
129969533|NCT01434680|467852925|FG003|Overall Study|Lost to Follow-up|0|||
129969534|NCT01434680|467852922|FG000|Overall Study|Protocol Violation|1|||
129969535|NCT01434680|467852923|FG001|Overall Study|Protocol Violation|1|||
129969536|NCT01434680|467852924|FG002|Overall Study|Protocol Violation|0|||
129969537|NCT01434680|467852925|FG003|Overall Study|Protocol Violation|0|||
129969538|NCT05765435|467852928|FG000|Overall Study|Lost to Follow-up|0|||
129969539|NCT05765435|467852929|FG001|Overall Study|Lost to Follow-up|1|||
129969540|NCT05765435|467852930|FG002|Overall Study|Lost to Follow-up|0|||
129969541|NCT05765435|467852928|FG000|Overall Study|Withdrawal by Subject|0|||
129969542|NCT05765435|467852929|FG001|Overall Study|Withdrawal by Subject|0|||
129969543|NCT05765435|467852930|FG002|Overall Study|Withdrawal by Subject|1|||
129969544|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
129969545|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
129969546|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
129969547|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
129969548|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
129969549|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
129969550|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
129969551|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
129969552|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Unclassified|10|||
129969553|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Unclassified|15|||
130126732|NCT00549718|468427421|FG002|Overall Study|Insufficient clinical response|18|||
130126733|NCT00549718|468427422|FG003|Overall Study|Insufficient clinical response|32|||
130126734|NCT00549718|468427419|FG000|Overall Study|Adverse Event|6|||
130126735|NCT00549718|468427420|FG001|Overall Study|Adverse Event|8|||
129969554|NCT00781937|467852939|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
129969555|NCT00781937|467852940|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
129969556|NCT00781937|467852939|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
129969557|NCT00781937|467852940|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
129969558|NCT04698915|467852941|FG000|Overall Study|Adverse Event|2|||
130126736|NCT00549718|468427421|FG002|Overall Study|Adverse Event|7|||
129969559|NCT04698915|467852942|FG001|Overall Study|Adverse Event|0|||
129969560|NCT04698915|467852941|FG000|Overall Study|Death|23|||
129969561|NCT04698915|467852942|FG001|Overall Study|Death|20|||
129969562|NCT04698915|467852941|FG000|Overall Study|Physician Decision|1|||
129969563|NCT04698915|467852942|FG001|Overall Study|Physician Decision|1|||
129969564|NCT04698915|467852941|FG000|Overall Study|Lost to Follow-up|1|||
129969565|NCT04698915|467852942|FG001|Overall Study|Lost to Follow-up|0|||
129969566|NCT04698915|467852941|FG000|Overall Study|Study Terminated by Sponsor|55|||
129969567|NCT04698915|467852942|FG001|Overall Study|Study Terminated by Sponsor|60|||
129969568|NCT04698915|467852941|FG000|Overall Study|Withdrawal by Subject|2|||
129969569|NCT04698915|467852942|FG001|Overall Study|Withdrawal by Subject|3|||
129969570|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Death|2|||
129969571|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Death|2|||
129969572|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Death|3|||
130126737|NCT00549718|468427422|FG003|Overall Study|Adverse Event|3|||
130126738|NCT00549718|468427419|FG000|Overall Study|Lost to Follow-up|4|||
130126739|NCT00549718|468427420|FG001|Overall Study|Lost to Follow-up|2|||
130126740|NCT00549718|468427421|FG002|Overall Study|Lost to Follow-up|0|||
130126741|NCT00549718|468427422|FG003|Overall Study|Lost to Follow-up|6|||
130126742|NCT00549718|468427419|FG000|Overall Study|Withdrawal by Subject|9|||
130126743|NCT00549718|468427420|FG001|Overall Study|Withdrawal by Subject|18|||
130126744|NCT00549718|468427421|FG002|Overall Study|Withdrawal by Subject|12|||
130126745|NCT00549718|468427422|FG003|Overall Study|Withdrawal by Subject|13|||
130126746|NCT00549718|468427419|FG000|Overall Study|Administrative|2|||
130126747|NCT00549718|468427420|FG001|Overall Study|Administrative|2|||
130126748|NCT00549718|468427421|FG002|Overall Study|Administrative|2|||
130126749|NCT00549718|468427422|FG003|Overall Study|Administrative|1|||
130126750|NCT01675622|468427425|FG000|Overall Study|Withdrawal by Subject|2|||
130126751|NCT01675622|468427426|FG001|Overall Study|Withdrawal by Subject|2|||
130126752|NCT01675622|468427425|FG000|Overall Study|Adverse Event|12|||
130126753|NCT01675622|468427426|FG001|Overall Study|Adverse Event|10|||
130126754|NCT01675622|468427425|FG000|Overall Study|Protocol Violation|4|||
130126755|NCT01675622|468427426|FG001|Overall Study|Protocol Violation|1|||
130126756|NCT01675622|468427425|FG000|Overall Study|Lack of Efficacy|2|||
130126757|NCT01675622|468427426|FG001|Overall Study|Lack of Efficacy|4|||
130126758|NCT01675622|468427425|FG000|Overall Study|Lost to Follow-up|1|||
130126759|NCT01675622|468427426|FG001|Overall Study|Lost to Follow-up|3|||
130126760|NCT01675622|468427425|FG000|Overall Study|Other|5|||
130126761|NCT01675622|468427426|FG001|Overall Study|Other|4|||
130126762|NCT02880761|468427428|FG000|Overall Study|Death|6|||
130126763|NCT02880761|468427429|FG001|Overall Study|Death|8|||
130126764|NCT02880761|468427428|FG000|Overall Study|Withdrawal by Subject|3|||
130126765|NCT02880761|468427429|FG001|Overall Study|Withdrawal by Subject|6|||
130126766|NCT02880761|468427428|FG000|Overall Study|Protocol Violation|4|||
130126767|NCT02880761|468427429|FG001|Overall Study|Protocol Violation|3|||
130126768|NCT02880761|468427428|FG000|Overall Study|Lost to Follow-up|3|||
130126769|NCT02880761|468427429|FG001|Overall Study|Lost to Follow-up|4|||
130126770|NCT03075761|468427430|FG000|Overall Study|Lost to Follow-up|1|||
130126771|NCT03075761|468427431|FG001|Overall Study|Lost to Follow-up|6|||
130126772|NCT02106156|468427432|FG000|Overall Study|Patient Died|19|||
130126773|NCT02106156|468427433|FG001|Overall Study|Patient Died|0|||
130126774|NCT02106156|468427434|FG002|Overall Study|Patient Died|0|||
130126775|NCT02106156|468427432|FG000|Overall Study|Lack of Tolerability|305|||
130126776|NCT02106156|468427433|FG001|Overall Study|Lack of Tolerability|3|||
130126777|NCT02106156|468427434|FG002|Overall Study|Lack of Tolerability|0|||
130126778|NCT02106156|468427432|FG000|Overall Study|Lack of Virological Response|1044|||
130126779|NCT02106156|468427433|FG001|Overall Study|Lack of Virological Response|8|||
130126780|NCT02106156|468427434|FG002|Overall Study|Lack of Virological Response|0|||
130126781|NCT02106156|468427432|FG000|Overall Study|Concomitant Disease|74|||
130126782|NCT02106156|468427433|FG001|Overall Study|Concomitant Disease|2|||
130126783|NCT02106156|468427434|FG002|Overall Study|Concomitant Disease|0|||
130126784|NCT02106156|468427432|FG000|Overall Study|Lack of Compliance|211|||
130126785|NCT02106156|468427433|FG001|Overall Study|Lack of Compliance|7|||
130126786|NCT02106156|468427434|FG002|Overall Study|Lack of Compliance|0|||
130126787|NCT02106156|468427432|FG000|Overall Study|Patients Request|307|||
130126788|NCT02106156|468427433|FG001|Overall Study|Patients Request|9|||
130126789|NCT02106156|468427434|FG002|Overall Study|Patients Request|0|||
130126790|NCT02106156|468427432|FG000|Overall Study|Lost to Follow-up|451|||
130126791|NCT02106156|468427433|FG001|Overall Study|Lost to Follow-up|8|||
130126792|NCT02106156|468427434|FG002|Overall Study|Lost to Follow-up|0|||
130126793|NCT02106156|468427432|FG000|Overall Study|Unplanned Event|82|||
130126794|NCT02106156|468427433|FG001|Overall Study|Unplanned Event|2|||
130126795|NCT02106156|468427434|FG002|Overall Study|Unplanned Event|0|||
130126796|NCT02106156|468427432|FG000|Overall Study|Change of Laboratory Parameter|10|||
130126797|NCT02106156|468427433|FG001|Overall Study|Change of Laboratory Parameter|0|||
130126798|NCT02106156|468427434|FG002|Overall Study|Change of Laboratory Parameter|0|||
130126799|NCT02106156|468427432|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
130126800|NCT02106156|468427433|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
130126801|NCT02106156|468427434|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
130126802|NCT02106156|468427432|FG000|Overall Study|Relocation/Change of Physician|40|||
130126803|NCT02106156|468427433|FG001|Overall Study|Relocation/Change of Physician|1|||
129969573|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Death|2|||
129969574|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Death|6|||
130126804|NCT02106156|468427434|FG002|Overall Study|Relocation/Change of Physician|0|||
130126805|NCT05017480|468427441|FG000|Stage 1 Study|Withdrawal by Subject|8|||
130126806|NCT05017480|468427442|FG001|Stage 1 Study|Withdrawal by Subject|6|||
130126807|NCT05017480|468427443|FG002|Stage 1 Study|Withdrawal by Subject|0|||
130126808|NCT05017480|468427444|FG003|Stage 1 Study|Withdrawal by Subject|0|||
130126809|NCT05017480|468427445|FG004|Stage 1 Study|Withdrawal by Subject|0|||
130126810|NCT05017480|468427441|FG000|Stage 1 Study|Adverse Event|1|||
130126811|NCT05017480|468427442|FG001|Stage 1 Study|Adverse Event|1|||
130126812|NCT05017480|468427443|FG002|Stage 1 Study|Adverse Event|0|||
130126813|NCT05017480|468427444|FG003|Stage 1 Study|Adverse Event|0|||
130126814|NCT05017480|468427445|FG004|Stage 1 Study|Adverse Event|0|||
130126815|NCT05017480|468427441|FG000|Stage 1 Study|Poor Compliance|1|||
130126816|NCT05017480|468427442|FG001|Stage 1 Study|Poor Compliance|1|||
130126817|NCT05017480|468427443|FG002|Stage 1 Study|Poor Compliance|0|||
130126818|NCT05017480|468427444|FG003|Stage 1 Study|Poor Compliance|0|||
130126819|NCT05017480|468427445|FG004|Stage 1 Study|Poor Compliance|0|||
130126820|NCT05017480|468427441|FG000|Stage 1 Study|Physician Decision|0|||
130126821|NCT05017480|468427442|FG001|Stage 1 Study|Physician Decision|1|||
130126822|NCT05017480|468427443|FG002|Stage 1 Study|Physician Decision|0|||
130126823|NCT05017480|468427444|FG003|Stage 1 Study|Physician Decision|0|||
130126824|NCT05017480|468427445|FG004|Stage 1 Study|Physician Decision|0|||
130126825|NCT05017480|468427441|FG000|Stage 2 Study|Withdrawal by Subject|0|||
130126826|NCT05017480|468427442|FG001|Stage 2 Study|Withdrawal by Subject|0|||
130126827|NCT05017480|468427443|FG002|Stage 2 Study|Withdrawal by Subject|6|||
130126828|NCT05017480|468427444|FG003|Stage 2 Study|Withdrawal by Subject|9|||
130126829|NCT05017480|468427445|FG004|Stage 2 Study|Withdrawal by Subject|11|||
130126830|NCT05017480|468427441|FG000|Stage 2 Study|Lost to Follow-up|0|||
130126831|NCT05017480|468427442|FG001|Stage 2 Study|Lost to Follow-up|0|||
130126832|NCT05017480|468427443|FG002|Stage 2 Study|Lost to Follow-up|0|||
130126833|NCT05017480|468427444|FG003|Stage 2 Study|Lost to Follow-up|2|||
130126834|NCT05017480|468427445|FG004|Stage 2 Study|Lost to Follow-up|1|||
130126835|NCT05017480|468427441|FG000|Stage 2 Study|Adverse Event|0|||
130126836|NCT05017480|468427442|FG001|Stage 2 Study|Adverse Event|0|||
130126837|NCT05017480|468427443|FG002|Stage 2 Study|Adverse Event|0|||
130126838|NCT05017480|468427444|FG003|Stage 2 Study|Adverse Event|1|||
130126839|NCT05017480|468427445|FG004|Stage 2 Study|Adverse Event|0|||
130126840|NCT05017480|468427441|FG000|Stage 2 Study|COVID-19|0|||
130126841|NCT05017480|468427442|FG001|Stage 2 Study|COVID-19|0|||
130126842|NCT05017480|468427443|FG002|Stage 2 Study|COVID-19|0|||
130126843|NCT05017480|468427444|FG003|Stage 2 Study|COVID-19|1|||
130126844|NCT05017480|468427445|FG004|Stage 2 Study|COVID-19|0|||
130126845|NCT05017480|468427441|FG000|Stage 2 Study|Pregnancy|0|||
130126846|NCT05017480|468427442|FG001|Stage 2 Study|Pregnancy|0|||
130126847|NCT05017480|468427443|FG002|Stage 2 Study|Pregnancy|0|||
130126848|NCT05017480|468427444|FG003|Stage 2 Study|Pregnancy|0|||
130126849|NCT05017480|468427445|FG004|Stage 2 Study|Pregnancy|1|||
130126850|NCT02311361|468427446|FG000|Overall Study|Did not receive treatment|0|||
130126851|NCT02311361|468427447|FG001|Overall Study|Did not receive treatment|1|||
130126852|NCT02311361|468427448|FG002|Overall Study|Did not receive treatment|0|||
130126853|NCT02311361|468427449|FG003|Overall Study|Did not receive treatment|1|||
130126854|NCT02653664|468427450|FG000|Post-Treatment|Withdrawal by Subject|6|||
130126855|NCT02653664|468427451|FG001|Post-Treatment|Withdrawal by Subject|5|||
130126856|NCT02653664|468427452|FG002|Post-Treatment|Withdrawal by Subject|7|||
130126857|NCT02653664|468427450|FG000|Post-Treatment|Lost to Follow-up|8|||
130126858|NCT02653664|468427451|FG001|Post-Treatment|Lost to Follow-up|1|||
130126859|NCT02653664|468427452|FG002|Post-Treatment|Lost to Follow-up|7|||
130126860|NCT02653664|468427450|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
130126861|NCT02653664|468427451|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
130126862|NCT02653664|468427452|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
130126863|NCT02653664|468427450|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
130126864|NCT02653664|468427451|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
130126865|NCT02653664|468427452|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
130126866|NCT02653664|468427450|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130126867|NCT02653664|468427451|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
129969575|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Death|5|||
129969576|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Death|3|||
130126868|NCT02653664|468427452|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130126869|NCT02653664|468427450|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
130126870|NCT02653664|468427451|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
130126871|NCT02653664|468427452|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
130126872|NCT02653664|468427450|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
130126873|NCT02653664|468427451|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
130126874|NCT02653664|468427452|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
130126875|NCT02653664|468427450|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
130126876|NCT02653664|468427451|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
130126877|NCT02653664|468427452|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
130126878|NCT02653664|468427450|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130093220|NCT01674010|468296846|FG000|Randomization Phase 2|Protocol Violation|0|||
130093221|NCT01674010|468296847|FG001|Randomization Phase 2|Protocol Violation|1|||
130093222|NCT01674010|468296848|FG002|Randomization Phase 2|Protocol Violation|1|||
130093223|NCT01674010|468296846|FG000|Randomization Phase 2|Sponsor Decision|0|||
130093224|NCT01674010|468296847|FG001|Randomization Phase 2|Sponsor Decision|42|||
130093225|NCT01674010|468296848|FG002|Randomization Phase 2|Sponsor Decision|45|||
130093226|NCT01674010|468296846|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
130093227|NCT01674010|468296847|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
130093228|NCT01674010|468296848|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
130093229|NCT01801475|468296852|FG000|Overall Study|Withdrawal by Subject|0|||
130093230|NCT01801475|468296853|FG001|Overall Study|Withdrawal by Subject|0|||
130093231|NCT01801475|468296854|FG002|Overall Study|Withdrawal by Subject|0|||
130093232|NCT01801475|468296855|FG003|Overall Study|Withdrawal by Subject|0|||
130093233|NCT01801475|468296856|FG004|Overall Study|Withdrawal by Subject|1|||
130093234|NCT00421928|468296857|FG000|Overall Study|Adverse Event|61|||
130093235|NCT00421928|468296858|FG001|Overall Study|Adverse Event|140|||
130093236|NCT00421928|468296859|FG002|Overall Study|Adverse Event|22|||
130093237|NCT00421928|468296857|FG000|Overall Study|Lost to Follow-up|5|||
130093238|NCT00421928|468296858|FG001|Overall Study|Lost to Follow-up|0|||
130093239|NCT00421928|468296859|FG002|Overall Study|Lost to Follow-up|3|||
130093240|NCT00421928|468296857|FG000|Overall Study|Withdrawal by Subject|50|||
130093241|NCT00421928|468296858|FG001|Overall Study|Withdrawal by Subject|48|||
130093242|NCT00421928|468296859|FG002|Overall Study|Withdrawal by Subject|43|||
130093243|NCT00421928|468296857|FG000|Overall Study|Lack of Efficacy|15|||
130093244|NCT00421928|468296858|FG001|Overall Study|Lack of Efficacy|7|||
130093245|NCT00421928|468296859|FG002|Overall Study|Lack of Efficacy|35|||
130093246|NCT00421928|468296857|FG000|Overall Study|Study drug non-compliant|6|||
130093247|NCT00421928|468296858|FG001|Overall Study|Study drug non-compliant|7|||
130093248|NCT00421928|468296859|FG002|Overall Study|Study drug non-compliant|4|||
130093249|NCT00421928|468296857|FG000|Overall Study|All other|26|||
130093250|NCT00421928|468296858|FG001|Overall Study|All other|21|||
130093251|NCT00421928|468296859|FG002|Overall Study|All other|27|||
130093252|NCT00421928|468296857|FG000|Overall Study|Death|0|||
130093253|NCT00421928|468296858|FG001|Overall Study|Death|1|||
130093254|NCT00421928|468296859|FG002|Overall Study|Death|0|||
130093255|NCT05056311|468296866|FG000|Overall Study|Lost to Follow-up|14|||
130093256|NCT05056311|468296866|FG000|Overall Study|Withdrawal by Subject|1|||
130093257|NCT05056311|468296866|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
130093258|NCT02713490|468296868|FG000|Overall Study|Withdrawal by Subject|2|||
130093259|NCT02713490|468296869|FG001|Overall Study|Withdrawal by Subject|1|||
130093260|NCT02713490|468296868|FG000|Overall Study|Did not receive study drug|1|||
130093261|NCT02713490|468296869|FG001|Overall Study|Did not receive study drug|0|||
130093262|NCT02713490|468296868|FG000|Overall Study|Met exclusion criteria|0|||
130093263|NCT02713490|468296869|FG001|Overall Study|Met exclusion criteria|1|||
130093264|NCT00346775|468296870|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
130093265|NCT00346775|468296871|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
130093266|NCT00346775|468296870|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
130093267|NCT00346775|468296871|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
130093268|NCT00346775|468296870|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
130093269|NCT00346775|468296871|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
130093270|NCT02946515|468296872|FG000|Overall Study|Lost to Follow-up|2|||
130093271|NCT02946515|468296873|FG001|Overall Study|Lost to Follow-up|1|||
130093272|NCT03799198|468296874|FG000|Overall Study|Lost to Follow-up|4|||
130093273|NCT03799198|468296875|FG001|Overall Study|Lost to Follow-up|8|||
130093274|NCT03799198|468296874|FG000|Overall Study|Death|0|||
130093275|NCT03799198|468296875|FG001|Overall Study|Death|1|||
130093276|NCT00960869|468296879|FG000|Overall Study|Adverse Event|17|||
130093277|NCT00960869|468296880|FG001|Overall Study|Adverse Event|26|||
130093278|NCT00960869|468296879|FG000|Overall Study|Withdrawal by Subject|16|||
130093279|NCT00960869|468296880|FG001|Overall Study|Withdrawal by Subject|14|||
130093280|NCT00960869|468296879|FG000|Overall Study|Lost to Follow-up|1|||
130093281|NCT00960869|468296880|FG001|Overall Study|Lost to Follow-up|4|||
130093282|NCT00960869|468296879|FG000|Overall Study|Misc|19|||
130093283|NCT00960869|468296880|FG001|Overall Study|Misc|18|||
130093284|NCT01714726|468296881|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
130093285|NCT01714726|468296882|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
130093286|NCT01714726|468296883|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
130093287|NCT01714726|468296884|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
130093288|NCT01714726|468296881|FG000|Double-Blinded Induction Period|Adverse Event|0|||
130093289|NCT01714726|468296882|FG001|Double-Blinded Induction Period|Adverse Event|1|||
130093290|NCT01714726|468296883|FG002|Double-Blinded Induction Period|Adverse Event|0|||
130093291|NCT01714726|468296884|FG003|Double-Blinded Induction Period|Adverse Event|0|||
130093292|NCT01714726|468296881|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
130093293|NCT01714726|468296882|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
130093294|NCT01714726|468296883|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
130126879|NCT02653664|468427451|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
130126880|NCT02653664|468427452|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
130126881|NCT02653664|468427450|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
130126882|NCT02653664|468427451|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
130126883|NCT02653664|468427452|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
130126884|NCT00633594|468427453|FG000|Overall Study|Adverse Event|0|||
130126885|NCT00633594|468427454|FG001|Overall Study|Adverse Event|4|||
130126886|NCT00633594|468427455|FG002|Overall Study|Adverse Event|7|||
130126887|NCT00633594|468427453|FG000|Overall Study|Death|0|||
130126888|NCT00633594|468427454|FG001|Overall Study|Death|1|||
130126889|NCT00633594|468427455|FG002|Overall Study|Death|2|||
130126890|NCT00633594|468427453|FG000|Overall Study|Disease Progression|0|||
130126891|NCT00633594|468427454|FG001|Overall Study|Disease Progression|0|||
130126892|NCT00633594|468427455|FG002|Overall Study|Disease Progression|1|||
130126893|NCT00365300|468427459|FG000|Open-label Phase|Adverse Event|4|||
130126894|NCT00365300|468427460|FG001|Open-label Phase|Adverse Event|0|||
130126895|NCT00365300|468427459|FG000|Open-label Phase|Failed to Return|1|||
130126896|NCT00365300|468427460|FG001|Open-label Phase|Failed to Return|0|||
130126897|NCT00365300|468427459|FG000|Open-label Phase|Physician Decision|1|||
130126898|NCT00365300|468427460|FG001|Open-label Phase|Physician Decision|0|||
130126899|NCT00365300|468427459|FG000|Open-label Phase|Noncompliance|9|||
130126900|NCT00365300|468427460|FG001|Open-label Phase|Noncompliance|0|||
130126901|NCT00365300|468427459|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
130126902|NCT00365300|468427460|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
130126903|NCT00365300|468427459|FG000|Open-label Phase|Protocol Violation|1|||
130126904|NCT00365300|468427460|FG001|Open-label Phase|Protocol Violation|0|||
130126905|NCT00365300|468427459|FG000|Open-label Phase|Lack of Efficacy|1|||
130126906|NCT00365300|468427460|FG001|Open-label Phase|Lack of Efficacy|0|||
130126907|NCT00365300|468427459|FG000|Open-label Phase|Patient skipped open label phase|1|||
130126908|NCT00365300|468427460|FG001|Open-label Phase|Patient skipped open label phase|0|||
130126909|NCT00365300|468427459|FG000|Double-blind Phase|Failed to return|1|||
130126910|NCT00365300|468427460|FG001|Double-blind Phase|Failed to return|0|||
130126911|NCT00365300|468427459|FG000|Double-blind Phase|Noncompliance|1|||
130126912|NCT00365300|468427460|FG001|Double-blind Phase|Noncompliance|1|||
130126913|NCT00365300|468427459|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130126914|NCT00365300|468427460|FG001|Double-blind Phase|Withdrawal by Subject|1|||
130126915|NCT00365300|468427459|FG000|Double-blind Phase|Protocol Violation|3|||
130126916|NCT00365300|468427460|FG001|Double-blind Phase|Protocol Violation|1|||
130126917|NCT00365300|468427459|FG000|Double-blind Phase|Lack of Efficacy|6|||
130126918|NCT00365300|468427460|FG001|Double-blind Phase|Lack of Efficacy|6|||
130126919|NCT02896361|468427461|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
130126920|NCT02896361|468427462|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
130126921|NCT02896361|468427463|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
130126922|NCT02896361|468427461|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
130126923|NCT02896361|468427462|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
130126924|NCT02896361|468427463|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
130126925|NCT01179048|468427465|FG000|Overall Study|Withdrawn - does not allow contact|4|||
130126926|NCT01179048|468427466|FG001|Overall Study|Withdrawn - does not allow contact|8|||
130126927|NCT01179048|468427465|FG000|Overall Study|Lost to Follow-up|8|||
130126928|NCT01179048|468427466|FG001|Overall Study|Lost to Follow-up|9|||
130126929|NCT01179048|468427465|FG000|Overall Study|Alive|127|||
130126930|NCT01179048|468427466|FG001|Overall Study|Alive|142|||
130126931|NCT01520909|468427478|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
130126932|NCT01520909|468427479|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
130126933|NCT01520909|468427480|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
130126934|NCT01520909|468427478|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
130126935|NCT01520909|468427479|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
130126936|NCT01520909|468427480|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
130126937|NCT01520909|468427478|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
130126938|NCT01520909|468427479|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
130126939|NCT01520909|468427480|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
130126940|NCT01520909|468427478|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
130126941|NCT01520909|468427479|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
130126942|NCT01520909|468427480|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
130126943|NCT01038856|468427487|FG000|Overall Study|Adverse Event|2|||
130126944|NCT02087904|468427488|FG000|Overall Study|Did Not Receive Study Drug|0|||
130126945|NCT02087904|468427489|FG001|Overall Study|Did Not Receive Study Drug|0|||
130126946|NCT02087904|468427490|FG002|Overall Study|Did Not Receive Study Drug|2|||
130126947|NCT02087904|468427491|FG003|Overall Study|Did Not Receive Study Drug|1|||
130126948|NCT02087904|468427488|FG000|Overall Study|Adverse Event|8|||
130126949|NCT02087904|468427489|FG001|Overall Study|Adverse Event|4|||
130126950|NCT02087904|468427490|FG002|Overall Study|Adverse Event|4|||
130126951|NCT02087904|468427491|FG003|Overall Study|Adverse Event|12|||
130126952|NCT02087904|468427488|FG000|Overall Study|Lack of Efficacy|3|||
130126953|NCT02087904|468427489|FG001|Overall Study|Lack of Efficacy|6|||
130126954|NCT02087904|468427490|FG002|Overall Study|Lack of Efficacy|3|||
130126955|NCT02087904|468427491|FG003|Overall Study|Lack of Efficacy|2|||
130126956|NCT02087904|468427488|FG000|Overall Study|Other|6|||
130126957|NCT02087904|468427489|FG001|Overall Study|Other|2|||
130126958|NCT02087904|468427490|FG002|Overall Study|Other|4|||
130126959|NCT02087904|468427491|FG003|Overall Study|Other|4|||
130126960|NCT02087904|468427488|FG000|Overall Study|Withdrawal by Subject|8|||
130126961|NCT02087904|468427489|FG001|Overall Study|Withdrawal by Subject|3|||
130126962|NCT02087904|468427490|FG002|Overall Study|Withdrawal by Subject|7|||
130126963|NCT02087904|468427491|FG003|Overall Study|Withdrawal by Subject|4|||
130126964|NCT02087904|468427488|FG000|Overall Study|Lost to Follow-up|0|||
130126965|NCT02087904|468427489|FG001|Overall Study|Lost to Follow-up|4|||
130126966|NCT02087904|468427490|FG002|Overall Study|Lost to Follow-up|2|||
130126967|NCT02087904|468427491|FG003|Overall Study|Lost to Follow-up|2|||
130126968|NCT02910037|468427492|FG000|Overall Study|Withdrawal by Subject|4|||
130126969|NCT02910037|468427492|FG000|Overall Study|Lost to Follow-up|6|||
130126970|NCT02015390|468427500|FG000|Overall Study|Lost to Follow-up|1|||
130126971|NCT02015390|468427501|FG001|Overall Study|Lost to Follow-up|0|||
130126972|NCT02015390|468427500|FG000|Overall Study|Adverse Event|0|||
130126973|NCT02015390|468427501|FG001|Overall Study|Adverse Event|3|||
130126974|NCT02015390|468427500|FG000|Overall Study|Physician Decision|0|||
130126975|NCT02015390|468427501|FG001|Overall Study|Physician Decision|1|||
130126976|NCT02193880|468427502|FG000|Overall Study|patients did not collect enough HPC|3|||
130126977|NCT03136380|468427503|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130126978|NCT03136380|468427504|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
130126979|NCT03136380|468427505|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130126980|NCT03136380|468427506|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130126981|NCT03136380|468427507|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
130126982|NCT01661686|468427511|FG000|Overall Study|Lost to Follow-up|2|||
130126983|NCT01661686|468427512|FG001|Overall Study|Lost to Follow-up|1|||
130126984|NCT01661686|468427511|FG000|Overall Study|did not receive allocated intervention|0|||
130126985|NCT01661686|468427512|FG001|Overall Study|did not receive allocated intervention|1|||
130126986|NCT02419937|468427515|FG000|Overall Study|Lost to Follow-up|1|||
130126987|NCT02419937|468427516|FG001|Overall Study|Lost to Follow-up|0|||
130126988|NCT00553280|468427518|FG000|Overall Study|Adverse Event|19|||
130126989|NCT00553280|468427518|FG000|Overall Study|Lack of Efficacy|3|||
130126990|NCT00553280|468427518|FG000|Overall Study|Withdrawal by Subject|3|||
130126991|NCT00553280|468427518|FG000|Overall Study|Physician Decision|1|||
130126992|NCT01544127|468427519|FG000|Overall Study|Lost to Follow-up|4|||
130126993|NCT01544127|468427520|FG001|Overall Study|Lost to Follow-up|2|||
130126994|NCT01544127|468427521|FG002|Overall Study|Lost to Follow-up|9|||
130126995|NCT01544127|468427519|FG000|Overall Study|Withdrawal by Subject|2|||
130126996|NCT01544127|468427520|FG001|Overall Study|Withdrawal by Subject|2|||
130126997|NCT01544127|468427521|FG002|Overall Study|Withdrawal by Subject|1|||
130126998|NCT01544127|468427519|FG000|Overall Study|Discharged out of catchment area|1|||
130126999|NCT01544127|468427520|FG001|Overall Study|Discharged out of catchment area|1|||
130127000|NCT01544127|468427521|FG002|Overall Study|Discharged out of catchment area|1|||
130127001|NCT01544127|468427519|FG000|Overall Study|Death|1|||
130127002|NCT01544127|468427520|FG001|Overall Study|Death|0|||
130127003|NCT01544127|468427521|FG002|Overall Study|Death|0|||
130127004|NCT01544127|468427519|FG000|Overall Study|Jail or Prison|1|||
130127005|NCT01544127|468427520|FG001|Overall Study|Jail or Prison|1|||
130127006|NCT01544127|468427521|FG002|Overall Study|Jail or Prison|2|||
130127007|NCT01544127|468427519|FG000|Overall Study|Became Psychotic|1|||
130127008|NCT01544127|468427520|FG001|Overall Study|Became Psychotic|0|||
130127009|NCT01544127|468427521|FG002|Overall Study|Became Psychotic|0|||
130127010|NCT01544127|468427519|FG000|Overall Study|Researcher withdrew|1|||
130127011|NCT01544127|468427520|FG001|Overall Study|Researcher withdrew|0|||
130127012|NCT01544127|468427521|FG002|Overall Study|Researcher withdrew|0|||
130127013|NCT01544127|468427519|FG000|Overall Study|Went active duty|0|||
130127014|NCT01544127|468427520|FG001|Overall Study|Went active duty|0|||
130127015|NCT01544127|468427521|FG002|Overall Study|Went active duty|1|||
130127016|NCT02794974|468427524|FG000|Overall Study|Physician Decision|0|||
130127017|NCT02794974|468427525|FG001|Overall Study|Physician Decision|1|||
130127018|NCT00533273|468427526|FG000|Double-blind|Withdrew consent|0|||
130127019|NCT00533273|468427527|FG001|Double-blind|Withdrew consent|2|||
130127020|NCT00533273|468427526|FG000|Open-label|Withdrawal by Subject|6|||
130127021|NCT00533273|468427527|FG001|Open-label|Withdrawal by Subject|0|||
130127022|NCT02202850|468427529|FG000|Overall Study|Other|2|||
130127023|NCT02202850|468427530|FG001|Overall Study|Other|2|||
130127024|NCT02202850|468427529|FG000|Overall Study|Enbrel treatment discontinued|15|||
130127025|NCT02202850|468427530|FG001|Overall Study|Enbrel treatment discontinued|3|||
130127026|NCT02202850|468427529|FG000|Overall Study|Lost to Follow-up|7|||
130127027|NCT02202850|468427530|FG001|Overall Study|Lost to Follow-up|1|||
130127028|NCT01873586|468427531|FG000|Overall Study|Lost to Follow-up|3|||
130127029|NCT00624065|468427532|FG000|Overall Study|Adverse Event|5|||
130127030|NCT00624065|468427533|FG001|Overall Study|Adverse Event|6|||
130127031|NCT00624065|468427532|FG000|Overall Study|Lost to Follow-up|4|||
130127032|NCT00624065|468427533|FG001|Overall Study|Lost to Follow-up|1|||
130127033|NCT00624065|468427532|FG000|Overall Study|Consent withdrawn|6|||
130127034|NCT00624065|468427533|FG001|Overall Study|Consent withdrawn|5|||
130127035|NCT00624065|468427532|FG000|Overall Study|Lack of Efficacy|0|||
129969577|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Death|2|||
130093295|NCT01714726|468296884|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
130093296|NCT01714726|468296881|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
130093297|NCT01714726|468296882|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
130093298|NCT01714726|468296883|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
130093299|NCT01714726|468296884|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
130093300|NCT01714726|468296881|FG000|Open-Label Period|Other|0|||
130093301|NCT01714726|468296882|FG001|Open-Label Period|Other|0|||
130093302|NCT01714726|468296883|FG002|Open-Label Period|Other|1|||
130093303|NCT01714726|468296884|FG003|Open-Label Period|Other|3|||
130093304|NCT01714726|468296881|FG000|Open-Label Period|Adverse Event|0|||
130093305|NCT01714726|468296882|FG001|Open-Label Period|Adverse Event|0|||
130093306|NCT01714726|468296883|FG002|Open-Label Period|Adverse Event|1|||
130093307|NCT01714726|468296884|FG003|Open-Label Period|Adverse Event|0|||
130093308|NCT01714726|468296881|FG000|Open-Label Period|Withdrawal by Subject|0|||
130093309|NCT01714726|468296882|FG001|Open-Label Period|Withdrawal by Subject|0|||
130093310|NCT01714726|468296883|FG002|Open-Label Period|Withdrawal by Subject|9|||
130093311|NCT01714726|468296884|FG003|Open-Label Period|Withdrawal by Subject|19|||
130093312|NCT01714726|468296881|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
130093313|NCT01714726|468296882|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
130093314|NCT01714726|468296883|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
130093315|NCT01714726|468296884|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
130093316|NCT01714726|468296881|FG000|Open-Label Period|Lost to Follow-up|0|||
130093317|NCT01714726|468296882|FG001|Open-Label Period|Lost to Follow-up|0|||
130093318|NCT01714726|468296883|FG002|Open-Label Period|Lost to Follow-up|3|||
130093319|NCT01714726|468296884|FG003|Open-Label Period|Lost to Follow-up|4|||
130093320|NCT01096017|468296887|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
130093321|NCT01096017|468296888|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
130093322|NCT00665366|468296893|FG000|Overall Study|Lack of Efficacy|11|||
130093323|NCT00665366|468296894|FG001|Overall Study|Lack of Efficacy|10|||
130093324|NCT00665366|468296893|FG000|Overall Study|Adverse Event|25|||
130093325|NCT00665366|468296894|FG001|Overall Study|Adverse Event|23|||
130093326|NCT00665366|468296893|FG000|Overall Study|Withdrawal by Subject|11|||
130093327|NCT00665366|468296894|FG001|Overall Study|Withdrawal by Subject|14|||
130093328|NCT00665366|468296893|FG000|Overall Study|Lost to Follow-up|3|||
130093329|NCT00665366|468296894|FG001|Overall Study|Lost to Follow-up|5|||
130093330|NCT00665366|468296893|FG000|Overall Study|Poor compliance/noncompliance|3|||
130093331|NCT00665366|468296894|FG001|Overall Study|Poor compliance/noncompliance|5|||
130093332|NCT00665366|468296893|FG000|Overall Study|Pregnancy|1|||
130093333|NCT00665366|468296894|FG001|Overall Study|Pregnancy|0|||
130093334|NCT00665366|468296893|FG000|Overall Study|No longer meets study criteria|0|||
130093335|NCT00665366|468296894|FG001|Overall Study|No longer meets study criteria|1|||
130093336|NCT00665366|468296893|FG000|Overall Study|Other reasons|4|||
130093337|NCT00665366|468296894|FG001|Overall Study|Other reasons|1|||
130093338|NCT04177862|468296895|FG000|Overall Study|Protocol Violation|2|||
130093339|NCT04177862|468296896|FG001|Overall Study|Protocol Violation|7|||
130093340|NCT03233009|468296909|FG000|Overall Study|Lost to Follow-up|1|||
130093341|NCT00474994|468296919|FG000|Overall Study|Patient Not treated|1|||
130093342|NCT00474994|468296919|FG000|Overall Study|Patient evaluable for toxicity only|3|||
130093343|NCT00474994|468296919|FG000|Overall Study|Patient found to be ineligible|1|||
130093344|NCT00278473|468296920|FG000|Overall Study|drop out|4|||
130093345|NCT00278473|468296921|FG001|Overall Study|drop out|3|||
130093346|NCT02322866|468296923|FG000|Overall Study|Adverse Event|6|||
130093347|NCT02322866|468296924|FG001|Overall Study|Adverse Event|11|||
130093348|NCT02322866|468296923|FG000|Overall Study|Withdrawal of Consent|16|||
130093349|NCT02322866|468296924|FG001|Overall Study|Withdrawal of Consent|25|||
130093350|NCT02322866|468296923|FG000|Overall Study|Lost to Follow-up|36|||
130093351|NCT02322866|468296924|FG001|Overall Study|Lost to Follow-up|39|||
130093352|NCT02322866|468296923|FG000|Overall Study|Protocol Violation|1|||
130093353|NCT02322866|468296924|FG001|Overall Study|Protocol Violation|0|||
130093354|NCT02322866|468296923|FG000|Overall Study|Noncompliance with Treatment|3|||
130093355|NCT02322866|468296924|FG001|Overall Study|Noncompliance with Treatment|4|||
130093356|NCT02322866|468296923|FG000|Overall Study|Lack of Efficacy|3|||
130093357|NCT02322866|468296924|FG001|Overall Study|Lack of Efficacy|1|||
130093358|NCT02322866|468296923|FG000|Overall Study|Other Miscellaneous Reasons|6|||
130093359|NCT02322866|468296924|FG001|Overall Study|Other Miscellaneous Reasons|6|||
130093360|NCT06045026|468296928|FG000|Overall Study|Lost to Follow-up|60|||
130093361|NCT06045026|468296928|FG000|Overall Study|Adverse Event|12|||
130093362|NCT06045026|468296928|FG000|Overall Study|Withdrawal by Subject|3|||
130093363|NCT06045026|468296928|FG000|Overall Study|Enrollment closed|1|||
130093364|NCT01928758|468296937|FG000|Overall Study|Lost to Follow-up|14|||
130127036|NCT00624065|468427533|FG001|Overall Study|Lack of Efficacy|3|||
130127037|NCT00624065|468427532|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
130127038|NCT00624065|468427533|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
130127039|NCT00312663|468427534|FG000|Immunization Phase|Adverse Event|0|||
130127040|NCT00312663|468427535|FG001|Immunization Phase|Adverse Event|1|||
130127041|NCT00312663|468427536|FG002|Immunization Phase|Adverse Event|0|||
130127042|NCT00301366|468427537|FG000|Overall Study|Adverse Event|1|||
130127043|NCT02511782|468427540|FG000|Overall Study|Withdrawal by Subject|1|||
130127044|NCT02511782|468427541|FG001|Overall Study|Withdrawal by Subject|0|||
130127045|NCT02511782|468427542|FG002|Overall Study|Withdrawal by Subject|0|||
130127046|NCT01536574|468427543|FG000|Overall Study|Adverse Event|4|||
130127047|NCT01536574|468427544|FG001|Overall Study|Adverse Event|5|||
130127048|NCT01536574|468427543|FG000|Overall Study|Withdrawal by Subject|1|||
130127049|NCT01536574|468427544|FG001|Overall Study|Withdrawal by Subject|2|||
130127050|NCT01536574|468427543|FG000|Overall Study|Lack of Efficacy|1|||
130127051|NCT01536574|468427544|FG001|Overall Study|Lack of Efficacy|0|||
130127052|NCT03361228|468427547|FG000|Overall Study|Other|1|||
130127053|NCT03361228|468427548|FG001|Overall Study|Other|1|||
130127054|NCT03361228|468427547|FG000|Overall Study|Death|3|||
130127055|NCT03361228|468427548|FG001|Overall Study|Death|0|||
130127056|NCT02193178|468427549|FG000|Overall Study|Lost to Follow-up|1|||
130127057|NCT02193178|468427549|FG000|Overall Study|Dry eyes|1|||
130127058|NCT04320849|468427552|FG000|Overall Study|Withdrawal by Subject|4|||
130127059|NCT04320849|468427552|FG000|Overall Study|Imaging data unavailable|2|||
130127060|NCT04320849|468427552|FG000|Overall Study|Incomplete imaging|2|||
130127061|NCT00214422|468427553|FG000|Overall Study|Physician Decision|2|||
130127062|NCT00214422|468427554|FG001|Overall Study|Physician Decision|0|||
130127063|NCT00214422|468427555|FG002|Overall Study|Physician Decision|0|||
130127064|NCT00214422|468427553|FG000|Overall Study|Developed esophageal ca|1|||
130127065|NCT00214422|468427554|FG001|Overall Study|Developed esophageal ca|0|||
130127066|NCT00214422|468427555|FG002|Overall Study|Developed esophageal ca|0|||
130127067|NCT00214422|468427553|FG000|Overall Study|Pt taken off study|1|||
130127068|NCT00214422|468427554|FG001|Overall Study|Pt taken off study|1|||
130127069|NCT00214422|468427555|FG002|Overall Study|Pt taken off study|0|||
130127070|NCT00214422|468427553|FG000|Overall Study|Disease progression on study|1|||
130127071|NCT00214422|468427554|FG001|Overall Study|Disease progression on study|0|||
130127072|NCT00214422|468427555|FG002|Overall Study|Disease progression on study|0|||
130127073|NCT00214422|468427553|FG000|Overall Study|Unable to make a radiation treatment|0|||
130127074|NCT00214422|468427554|FG001|Overall Study|Unable to make a radiation treatment|0|||
130127075|NCT00214422|468427555|FG002|Overall Study|Unable to make a radiation treatment|1|||
130127076|NCT03929393|468427556|FG000|Overall Study|Death|1|||
130127077|NCT03929393|468427557|FG001|Overall Study|Death|0|||
130127078|NCT03929393|468427556|FG000|Overall Study|Time Commitment|2|||
130127079|NCT03929393|468427557|FG001|Overall Study|Time Commitment|5|||
130127080|NCT03929393|468427556|FG000|Overall Study|Motor Vehicle Accident|0|||
130127081|NCT03929393|468427557|FG001|Overall Study|Motor Vehicle Accident|1|||
130127082|NCT03929393|468427556|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
130127083|NCT03929393|468427557|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
130127084|NCT03929393|468427556|FG000|Overall Study|Other|1|||
130127085|NCT03929393|468427557|FG001|Overall Study|Other|3|||
130127086|NCT04149964|468427558|FG000|Overall Study|Lost to Follow-up|19|||
130127087|NCT04149964|468427559|FG001|Overall Study|Lost to Follow-up|18|||
130127088|NCT01223365|468427560|FG000|Open-label Titration Period|Enrolled but not treated|1|||
130127089|NCT01223365|468427560|FG000|Open-label Titration Period|Adverse Event|23|||
130127090|NCT01223365|468427560|FG000|Open-label Titration Period|Lack of Efficacy|3|||
130127091|NCT01223365|468427560|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
130127092|NCT01223365|468427560|FG000|Open-label Titration Period|Protocol Violation|1|||
130127093|NCT01223365|468427560|FG000|Open-label Titration Period|Lost to Follow-up|2|||
130127094|NCT01223365|468427560|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
130127095|NCT01223365|468427560|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
130127096|NCT01223365|468427560|FG000|Open-label Titration Period|Starting physical therapy|1|||
130127097|NCT01223365|468427560|FG000|Open-label Treatment Period|Adverse Event|39|||
130127098|NCT01223365|468427560|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
130127099|NCT01223365|468427560|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
130127100|NCT01223365|468427560|FG000|Open-label Treatment Period|Protocol Violation|15|||
130127101|NCT01223365|468427560|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
130127102|NCT01223365|468427560|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
130127103|NCT01223365|468427560|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
130127104|NCT01223365|468427560|FG000|Open-label Treatment Period|Moved out of area|2|||
130127105|NCT01223365|468427560|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
130127106|NCT01223365|468427560|FG000|Open-label Treatment Period|"Out of window"|1|||
130127107|NCT01223365|468427560|FG000|Open-label Treatment Period|Starting physical therapy|1|||
130127108|NCT01223365|468427560|FG000|Open-label Treatment Period|Physician Decision|2|||
130127109|NCT03567174|468427561|FG000|Overall Study|Death|24|||
130127110|NCT03567174|468427562|FG001|Overall Study|Death|31|||
130127111|NCT03567174|468427561|FG000|Overall Study|Lost to Follow-up|165|||
130127112|NCT03567174|468427562|FG001|Overall Study|Lost to Follow-up|174|||
130127113|NCT02817841|468429429|FG000|Overall Study|Lost to Follow-up|287|||
130127114|NCT02817841|468429429|FG000|Overall Study|Withdrawal by Subject|183|||
130127115|NCT02817841|468429429|FG000|Overall Study|Adverse event not related to bleeding|131|||
130127116|NCT02817841|468429429|FG000|Overall Study|Adverse event related to bleeding|51|||
130127117|NCT02817841|468429429|FG000|Overall Study|Pregnancy|32|||
130127118|NCT02817841|468429429|FG000|Overall Study|Pregnancy wish|17|||
130127119|NCT02817841|468429429|FG000|Overall Study|Other reasons|53|||
130127120|NCT02817841|468429429|FG000|Overall Study|Protocol Violation|94|||
130127121|NCT02424097|468429438|FG000|Overall Study|Lost to Follow-up|1|||
130127122|NCT02424097|468429439|FG001|Overall Study|Lost to Follow-up|2|||
130127123|NCT04032977|468429440|FG000|Overall Study|Withdrawal by Subject|6|||
130127124|NCT04032977|468429441|FG001|Overall Study|Withdrawal by Subject|1|||
130127125|NCT04032977|468429440|FG000|Overall Study|Lost to Follow-up|2|||
130127126|NCT04032977|468429441|FG001|Overall Study|Lost to Follow-up|7|||
130127127|NCT04032977|468429440|FG000|Overall Study|Pregnancy|1|||
130127128|NCT04032977|468429441|FG001|Overall Study|Pregnancy|0|||
130127129|NCT03597256|468429442|FG000|Overall Study|Lost to Follow-up|3|||
130127130|NCT03597256|468429443|FG001|Overall Study|Lost to Follow-up|1|||
130127131|NCT03597256|468429442|FG000|Overall Study|Withdrawal by Subject|0|||
130127132|NCT03597256|468429443|FG001|Overall Study|Withdrawal by Subject|1|||
130127133|NCT03597256|468429442|FG000|Overall Study|Could not return for treatment|0|||
130127134|NCT03597256|468429443|FG001|Overall Study|Could not return for treatment|1|||
130127135|NCT03597256|468429442|FG000|Overall Study|Moved from location|0|||
130127136|NCT03597256|468429443|FG001|Overall Study|Moved from location|1|||
130127137|NCT03597256|468429442|FG000|Overall Study|Not accepted the treatment|0|||
130127138|NCT03597256|468429443|FG001|Overall Study|Not accepted the treatment|1|||
130127139|NCT01136382|468429449|FG000|Overall Study|Other|8|||
130127140|NCT01136382|468429450|FG001|Overall Study|Other|3|||
130127141|NCT01136382|468429449|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
130127142|NCT01136382|468429450|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
130127143|NCT01136382|468429449|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130127144|NCT01136382|468429450|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
130127145|NCT01136382|468429449|FG000|Overall Study|Withdrawal by Subject|4|||
130127146|NCT01136382|468429450|FG001|Overall Study|Withdrawal by Subject|1|||
130127147|NCT00746798|468429453|FG000|Overall Study|Protocol Violation|0|||
130127148|NCT00746798|468429454|FG001|Overall Study|Protocol Violation|1|||
130127149|NCT00746798|468429455|FG002|Overall Study|Protocol Violation|0|||
130127150|NCT00746798|468429456|FG003|Overall Study|Protocol Violation|0|||
130127151|NCT00746798|468429453|FG000|Overall Study|Withdrawal by Subject|0|||
130127152|NCT00746798|468429454|FG001|Overall Study|Withdrawal by Subject|1|||
130127153|NCT00746798|468429455|FG002|Overall Study|Withdrawal by Subject|1|||
130127154|NCT00746798|468429456|FG003|Overall Study|Withdrawal by Subject|0|||
130127155|NCT00746798|468429453|FG000|Overall Study|Death|0|||
130127156|NCT00746798|468429454|FG001|Overall Study|Death|0|||
130127157|NCT00746798|468429455|FG002|Overall Study|Death|2|||
130127158|NCT00746798|468429456|FG003|Overall Study|Death|0|||
130127159|NCT00746798|468429453|FG000|Overall Study|Participant unable to return for visit|1|||
130127160|NCT00746798|468429454|FG001|Overall Study|Participant unable to return for visit|0|||
130127161|NCT00746798|468429455|FG002|Overall Study|Participant unable to return for visit|0|||
130127162|NCT00746798|468429456|FG003|Overall Study|Participant unable to return for visit|0|||
130127163|NCT01045096|468429457|FG000|Overall Study|Withdrawal by Subject|2|||
130127164|NCT01045096|468429458|FG001|Overall Study|Withdrawal by Subject|0|||
130127165|NCT01045096|468429459|FG002|Overall Study|Withdrawal by Subject|0|||
130127166|NCT01045096|468429457|FG000|Overall Study|Other|1|||
130127167|NCT01045096|468429458|FG001|Overall Study|Other|0|||
130127168|NCT01045096|468429459|FG002|Overall Study|Other|0|||
130127169|NCT01511939|468429461|FG000|Overall Study|Withdrawal by Subject|2|||
130127170|NCT01511939|468429462|FG001|Overall Study|Withdrawal by Subject|1|||
130127171|NCT01511939|468429463|FG002|Overall Study|Withdrawal by Subject|0|||
130127172|NCT00324168|468429468|FG000|Overall Study|Lost to Follow-up|19|||
130127173|NCT00324168|468429469|FG001|Overall Study|Lost to Follow-up|18|||
130127174|NCT00324168|468429468|FG000|Overall Study|Death|3|||
130127175|NCT00324168|468429469|FG001|Overall Study|Death|3|||
130127176|NCT00324168|468429468|FG000|Overall Study|Patient did not visit in f/u window|6|||
130127177|NCT00324168|468429469|FG001|Overall Study|Patient did not visit in f/u window|9|||
130127178|NCT03497897|468429471|FG000|Overall Study|Adverse Event|1|||
130127179|NCT03497897|468429472|FG001|Overall Study|Adverse Event|1|||
130127180|NCT03497897|468429473|FG002|Overall Study|Adverse Event|1|||
130127181|NCT03497897|468429471|FG000|Overall Study|Lost to Follow-up|2|||
130127182|NCT03497897|468429472|FG001|Overall Study|Lost to Follow-up|0|||
130127183|NCT03497897|468429473|FG002|Overall Study|Lost to Follow-up|2|||
130127184|NCT03497897|468429471|FG000|Overall Study|Physician Decision|1|||
130127185|NCT03497897|468429472|FG001|Overall Study|Physician Decision|0|||
130127186|NCT03497897|468429473|FG002|Overall Study|Physician Decision|0|||
130127187|NCT03497897|468429471|FG000|Overall Study|Subject/Guardian Decision|2|||
130127188|NCT03497897|468429472|FG001|Overall Study|Subject/Guardian Decision|1|||
130127189|NCT03497897|468429473|FG002|Overall Study|Subject/Guardian Decision|3|||
130127190|NCT00358449|468429478|FG000|Overall Study|Adverse Event|1|||
130127191|NCT00358449|468429479|FG001|Overall Study|Adverse Event|0|||
130127192|NCT00358449|468429480|FG002|Overall Study|Adverse Event|1|||
130127193|NCT00358449|468429478|FG000|Overall Study|Lost to Follow-up|1|||
130127194|NCT00358449|468429479|FG001|Overall Study|Lost to Follow-up|0|||
130127195|NCT00358449|468429480|FG002|Overall Study|Lost to Follow-up|0|||
130127196|NCT00358449|468429478|FG000|Overall Study|Withdrawal by Subject|2|||
130127197|NCT00358449|468429479|FG001|Overall Study|Withdrawal by Subject|0|||
130127198|NCT00358449|468429480|FG002|Overall Study|Withdrawal by Subject|0|||
130127199|NCT00358449|468429478|FG000|Overall Study|Lack of Efficacy|0|||
130127200|NCT00358449|468429479|FG001|Overall Study|Lack of Efficacy|1|||
130127201|NCT00358449|468429480|FG002|Overall Study|Lack of Efficacy|0|||
130127202|NCT00358449|468429478|FG000|Overall Study|Steriod Inhaler was Increased|0|||
130127203|NCT00358449|468429479|FG001|Overall Study|Steriod Inhaler was Increased|0|||
130127204|NCT00358449|468429480|FG002|Overall Study|Steriod Inhaler was Increased|1|||
130127205|NCT01367457|468429481|FG000|Overall Study|Death|2|||
130127206|NCT01367457|468429482|FG001|Overall Study|Death|0|||
130127207|NCT01367457|468429483|FG002|Overall Study|Death|0|||
130127208|NCT01367457|468429481|FG000|Overall Study|Investigator's decision|2|||
130127209|NCT01367457|468429482|FG001|Overall Study|Investigator's decision|0|||
130127210|NCT01367457|468429483|FG002|Overall Study|Investigator's decision|0|||
130127211|NCT01367457|468429481|FG000|Overall Study|Clinical decline (CD)|2|||
130127212|NCT01367457|468429482|FG001|Overall Study|Clinical decline (CD)|0|||
130127213|NCT01367457|468429483|FG002|Overall Study|Clinical decline (CD)|0|||
130127214|NCT01367457|468429481|FG000|Overall Study|Progression and death|8|||
130127215|NCT01367457|468429482|FG001|Overall Study|Progression and death|0|||
130127216|NCT01367457|468429483|FG002|Overall Study|Progression and death|0|||
130127217|NCT01367457|468429481|FG000|Overall Study|Toxicity|16|||
130127218|NCT01367457|468429482|FG001|Overall Study|Toxicity|0|||
130127219|NCT01367457|468429483|FG002|Overall Study|Toxicity|0|||
130127220|NCT01367457|468429481|FG000|Overall Study|Progression|137|||
130127221|NCT01367457|468429482|FG001|Overall Study|Progression|0|||
130127222|NCT01367457|468429483|FG002|Overall Study|Progression|0|||
130127223|NCT01367457|468429481|FG000|Overall Study|Patient asks for rest + slow progression|1|||
130127224|NCT01367457|468429482|FG001|Overall Study|Patient asks for rest + slow progression|0|||
130127225|NCT01367457|468429483|FG002|Overall Study|Patient asks for rest + slow progression|0|||
130127226|NCT01367457|468429481|FG000|Overall Study|Investigator's opinion, stable disease|1|||
130127227|NCT01367457|468429482|FG001|Overall Study|Investigator's opinion, stable disease|0|||
130127228|NCT01367457|468429483|FG002|Overall Study|Investigator's opinion, stable disease|0|||
130127229|NCT01367457|468429481|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
130127230|NCT01367457|468429482|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
130127231|NCT01367457|468429483|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
130127232|NCT01367457|468429481|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
130127233|NCT01367457|468429482|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
130127234|NCT01367457|468429483|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
130127235|NCT01367457|468429481|FG000|Overall Study|low grade toxicities + stable disease|1|||
130127236|NCT01367457|468429482|FG001|Overall Study|low grade toxicities + stable disease|0|||
130127237|NCT01367457|468429483|FG002|Overall Study|low grade toxicities + stable disease|0|||
130127238|NCT01367457|468429481|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
130127239|NCT01367457|468429482|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
130127240|NCT01367457|468429483|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
130127241|NCT01367457|468429481|FG000|Overall Study|Withdrawal by Subject|1|||
130127242|NCT01367457|468429482|FG001|Overall Study|Withdrawal by Subject|0|||
130127243|NCT01367457|468429483|FG002|Overall Study|Withdrawal by Subject|0|||
130127244|NCT01367457|468429481|FG000|Overall Study|CD, associated leukaemia|1|||
130127245|NCT01367457|468429482|FG001|Overall Study|CD, associated leukaemia|0|||
130127246|NCT01367457|468429483|FG002|Overall Study|CD, associated leukaemia|0|||
130127247|NCT01367457|468429481|FG000|Overall Study|Uncontrolled pain|1|||
130127248|NCT01367457|468429482|FG001|Overall Study|Uncontrolled pain|0|||
130127249|NCT01367457|468429483|FG002|Overall Study|Uncontrolled pain|0|||
130127250|NCT01367457|468429481|FG000|Overall Study|Overall status worsens to grade 4|1|||
130127251|NCT01367457|468429482|FG001|Overall Study|Overall status worsens to grade 4|0|||
130127252|NCT01367457|468429483|FG002|Overall Study|Overall status worsens to grade 4|0|||
130127253|NCT01367457|468429481|FG000|Overall Study|Stabilisation + frequent infections|1|||
130127254|NCT01367457|468429482|FG001|Overall Study|Stabilisation + frequent infections|0|||
130127255|NCT01367457|468429483|FG002|Overall Study|Stabilisation + frequent infections|0|||
130127256|NCT01367457|468429481|FG000|Overall Study|No clinical benefit|1|||
130127257|NCT01367457|468429482|FG001|Overall Study|No clinical benefit|0|||
130127258|NCT01367457|468429483|FG002|Overall Study|No clinical benefit|0|||
130127259|NCT01367457|468429481|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
130127260|NCT01367457|468429482|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
130127261|NCT01367457|468429483|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
130127262|NCT01367457|468429481|FG000|Overall Study|Overall decline|1|||
130093365|NCT01928758|468296938|FG001|Overall Study|Lost to Follow-up|9|||
130093366|NCT01928758|468296937|FG000|Overall Study|Withdrawal by Subject|5|||
130093367|NCT01928758|468296938|FG001|Overall Study|Withdrawal by Subject|2|||
130093368|NCT01928758|468296937|FG000|Overall Study|Adverse Event|3|||
130093369|NCT01928758|468296938|FG001|Overall Study|Adverse Event|5|||
130093370|NCT01928758|468296937|FG000|Overall Study|Protocol Violation|3|||
130093371|NCT01928758|468296938|FG001|Overall Study|Protocol Violation|4|||
130093372|NCT00719706|468296939|FG000|Overall Study|Adverse Event|5|||
130093373|NCT00719706|468296940|FG001|Overall Study|Adverse Event|4|||
130093374|NCT00719706|468296939|FG000|Overall Study|Withdrawal by Subject|1|||
130093375|NCT00719706|468296940|FG001|Overall Study|Withdrawal by Subject|2|||
130093376|NCT00719706|468296939|FG000|Overall Study|Protocol Violation|3|||
130093377|NCT00719706|468296940|FG001|Overall Study|Protocol Violation|0|||
130093378|NCT02452320|468296944|FG000|Overall Study|Adverse Event|0|||
130093379|NCT02452320|468296945|FG001|Overall Study|Adverse Event|1|||
130093380|NCT03198559|468296946|FG000|Overall Study|Adverse Event|2|||
130093381|NCT01072175|468296947|FG000|Part A (Drug-Drug Interaction)|Death|1|||
130093382|NCT01072175|468296948|FG001|Part A (Drug-Drug Interaction)|Death|0|||
130093383|NCT01072175|468296949|FG002|Part A (Drug-Drug Interaction)|Death|0|||
130093384|NCT01072175|468296950|FG003|Part A (Drug-Drug Interaction)|Death|0|||
130093385|NCT01072175|468296951|FG004|Part A (Drug-Drug Interaction)|Death|0|||
130093386|NCT01072175|468296952|FG005|Part A (Drug-Drug Interaction)|Death|0|||
130093387|NCT01072175|468296953|FG006|Part A (Drug-Drug Interaction)|Death|0|||
130093388|NCT01072175|468296954|FG007|Part A (Drug-Drug Interaction)|Death|0|||
130093389|NCT01072175|468296955|FG008|Part A (Drug-Drug Interaction)|Death|0|||
130093390|NCT01072175|468296956|FG009|Part A (Drug-Drug Interaction)|Death|0|||
130093391|NCT01072175|468296957|FG010|Part A (Drug-Drug Interaction)|Death|0|||
130093392|NCT01072175|468296958|FG011|Part A (Drug-Drug Interaction)|Death|0|||
130093393|NCT01072175|468296959|FG012|Part A (Drug-Drug Interaction)|Death|0|||
130093394|NCT01072175|468296947|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
130093395|NCT01072175|468296948|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093396|NCT01072175|468296949|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093397|NCT01072175|468296950|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093398|NCT01072175|468296951|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093399|NCT01072175|468296952|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093400|NCT01072175|468296953|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093401|NCT01072175|468296954|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093402|NCT01072175|468296955|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093403|NCT01072175|468296956|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093404|NCT01072175|468296957|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093405|NCT01072175|468296958|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093406|NCT01072175|468296959|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
130093407|NCT01072175|468296947|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
130093408|NCT01072175|468296948|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093409|NCT01072175|468296949|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093410|NCT01072175|468296950|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093411|NCT01072175|468296951|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093412|NCT01072175|468296952|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093413|NCT01072175|468296953|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093414|NCT01072175|468296954|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093415|NCT01072175|468296955|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093416|NCT01072175|468296956|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093417|NCT01072175|468296957|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093418|NCT01072175|468296958|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093419|NCT01072175|468296959|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
130093420|NCT01072175|468296947|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
130093421|NCT01072175|468296948|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
130093422|NCT01072175|468296949|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
130093423|NCT01072175|468296950|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
130093424|NCT01072175|468296951|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
130093425|NCT01072175|468296952|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
130093426|NCT01072175|468296953|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
130093427|NCT01072175|468296954|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
130093428|NCT01072175|468296955|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
130093429|NCT01072175|468296956|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
130093430|NCT01072175|468296957|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
130093431|NCT01072175|468296958|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
130093432|NCT01072175|468296959|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
130093433|NCT01072175|468296947|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093434|NCT01072175|468296948|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093435|NCT01072175|468296949|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
130093436|NCT01072175|468296950|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130127263|NCT01367457|468429482|FG001|Overall Study|Overall decline|0|||
130127264|NCT01367457|468429483|FG002|Overall Study|Overall decline|0|||
130127265|NCT01367457|468429481|FG000|Overall Study|Rejection of treatment|1|||
130127266|NCT01367457|468429482|FG001|Overall Study|Rejection of treatment|0|||
130127267|NCT01367457|468429483|FG002|Overall Study|Rejection of treatment|0|||
130127268|NCT01367457|468429481|FG000|Overall Study|Lost to Follow-up|1|||
130127269|NCT01367457|468429482|FG001|Overall Study|Lost to Follow-up|0|||
130127270|NCT01367457|468429483|FG002|Overall Study|Lost to Follow-up|0|||
130127271|NCT01367457|468429481|FG000|Overall Study|Death from septic shock|1|||
130127272|NCT01367457|468429482|FG001|Overall Study|Death from septic shock|0|||
130127273|NCT01367457|468429483|FG002|Overall Study|Death from septic shock|0|||
130127274|NCT01367457|468429481|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
130127275|NCT01367457|468429482|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
130127276|NCT01367457|468429483|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
130127277|NCT01367457|468429481|FG000|Overall Study|Patient's Wish|1|||
130127278|NCT01367457|468429482|FG001|Overall Study|Patient's Wish|0|||
130127279|NCT01367457|468429483|FG002|Overall Study|Patient's Wish|0|||
130127280|NCT01367457|468429481|FG000|Overall Study|Palliative. Overall decline|1|||
130127281|NCT01367457|468429482|FG001|Overall Study|Palliative. Overall decline|0|||
130127282|NCT01367457|468429483|FG002|Overall Study|Palliative. Overall decline|0|||
130127283|NCT01367457|468429481|FG000|Overall Study|Suspected DP/suspected active infection|1|||
130127284|NCT01367457|468429482|FG001|Overall Study|Suspected DP/suspected active infection|0|||
130127285|NCT01367457|468429483|FG002|Overall Study|Suspected DP/suspected active infection|0|||
130127286|NCT02300103|468429487|FG000|Overall Study|Lack of Efficacy|3|||
130127287|NCT02300103|468429487|FG000|Overall Study|Protocol Violation|1|||
130127288|NCT02300103|468429487|FG000|Overall Study|Withdrew Consent|2|||
130127289|NCT04091971|468429488|FG000|Overall Study|Withdrawal by Subject|1|||
130127290|NCT04091971|468429488|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
130127291|NCT04091971|468429488|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
130127292|NCT01391793|468429489|FG000|Overall Study|Ineligible|3|||
130127293|NCT01391793|468429490|FG001|Overall Study|Ineligible|0|||
130127294|NCT01391793|468429489|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
130127295|NCT01391793|468429490|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
130127296|NCT01391793|468429489|FG000|Overall Study|No DMSA|73|||
130127297|NCT01391793|468429490|FG001|Overall Study|No DMSA|57|||
130127298|NCT01666730|468429493|FG000|Overall Study|Adverse Event|16|||
130127299|NCT01666730|468429493|FG000|Overall Study|Death|2|||
130127300|NCT01666730|468429493|FG000|Overall Study|Physician Decision|5|||
130127301|NCT01666730|468429493|FG000|Overall Study|Withdrawal by Subject|9|||
130127302|NCT01666730|468429493|FG000|Overall Study|Disease progression/relapse|18|||
130127303|NCT04466111|468429494|FG000|Prior to Trial Phase|Physician Decision|1|||
130127304|NCT00105196|468429498|FG000|Overall Study|Lack of Efficacy|2|||
130127305|NCT00105196|468429499|FG001|Overall Study|Lack of Efficacy|3|||
130127306|NCT00105196|468429498|FG000|Overall Study|Adverse Event|11|||
130127307|NCT00105196|468429499|FG001|Overall Study|Adverse Event|3|||
130127308|NCT00105196|468429498|FG000|Overall Study|Withdrawal by Subject|6|||
130127309|NCT00105196|468429499|FG001|Overall Study|Withdrawal by Subject|6|||
130127310|NCT00105196|468429498|FG000|Overall Study|Lost to Follow-up|3|||
130127311|NCT00105196|468429499|FG001|Overall Study|Lost to Follow-up|2|||
130127312|NCT00105196|468429498|FG000|Overall Study|Poor/noncompliance|3|||
130127313|NCT00105196|468429499|FG001|Overall Study|Poor/noncompliance|4|||
130127314|NCT00105196|468429498|FG000|Overall Study|Protocol Violation|5|||
130127315|NCT00105196|468429499|FG001|Overall Study|Protocol Violation|2|||
130127316|NCT00105196|468429498|FG000|Overall Study|pending surgery|0|||
130127317|NCT00105196|468429499|FG001|Overall Study|pending surgery|1|||
130127318|NCT00105196|468429498|FG000|Overall Study|marijuana use|0|||
130127319|NCT00105196|468429499|FG001|Overall Study|marijuana use|1|||
130127320|NCT00105196|468429498|FG000|Overall Study|Subject became unblinded|0|||
130127321|NCT00105196|468429499|FG001|Overall Study|Subject became unblinded|1|||
130127322|NCT03025880|468429500|FG000|Overall Study|Adverse Event|1|||
130127323|NCT03025880|468429501|FG001|Overall Study|Adverse Event|0|||
130127324|NCT03025880|468429500|FG000|Overall Study|Death|1|||
130127325|NCT03025880|468429501|FG001|Overall Study|Death|1|||
130127326|NCT03025880|468429500|FG000|Overall Study|Withdrawal by Subject|0|||
130127327|NCT03025880|468429501|FG001|Overall Study|Withdrawal by Subject|1|||
130127328|NCT03025880|468429500|FG000|Overall Study|Physician Decision|0|||
130127329|NCT03025880|468429501|FG001|Overall Study|Physician Decision|1|||
130127330|NCT03025880|468429500|FG000|Overall Study|Progressive Disease|12|||
130127331|NCT03025880|468429501|FG001|Overall Study|Progressive Disease|19|||
130127332|NCT01389102|468429502|FG000|Overall Study|Adverse Event|1|||
130127333|NCT01389102|468429503|FG001|Overall Study|Adverse Event|3|||
130127334|NCT01389102|468429504|FG002|Overall Study|Adverse Event|2|||
130127335|NCT01389102|468429505|FG003|Overall Study|Adverse Event|2|||
130127336|NCT01389102|468429506|FG004|Overall Study|Adverse Event|2|||
130127337|NCT01389102|468429507|FG005|Overall Study|Adverse Event|2|||
130127338|NCT01389102|468429502|FG000|Overall Study|Hurricane Katrina|4|||
130127339|NCT01389102|468429503|FG001|Overall Study|Hurricane Katrina|2|||
130127340|NCT01389102|468429504|FG002|Overall Study|Hurricane Katrina|3|||
130127341|NCT01389102|468429505|FG003|Overall Study|Hurricane Katrina|0|||
130127342|NCT01389102|468429506|FG004|Overall Study|Hurricane Katrina|3|||
130127343|NCT01389102|468429507|FG005|Overall Study|Hurricane Katrina|1|||
130127344|NCT01389102|468429502|FG000|Overall Study|Lost to Follow-up|4|||
130127345|NCT01389102|468429503|FG001|Overall Study|Lost to Follow-up|1|||
130127346|NCT01389102|468429504|FG002|Overall Study|Lost to Follow-up|1|||
130127347|NCT01389102|468429505|FG003|Overall Study|Lost to Follow-up|2|||
130127348|NCT01389102|468429506|FG004|Overall Study|Lost to Follow-up|4|||
130127349|NCT01389102|468429507|FG005|Overall Study|Lost to Follow-up|1|||
130127350|NCT01389102|468429502|FG000|Overall Study|Protocol Violation|0|||
130127351|NCT01389102|468429503|FG001|Overall Study|Protocol Violation|0|||
130127352|NCT01389102|468429504|FG002|Overall Study|Protocol Violation|3|||
130127353|NCT01389102|468429505|FG003|Overall Study|Protocol Violation|0|||
130127354|NCT01389102|468429506|FG004|Overall Study|Protocol Violation|1|||
130127355|NCT01389102|468429507|FG005|Overall Study|Protocol Violation|1|||
130127356|NCT01389102|468429502|FG000|Overall Study|Withdrawal by Subject|7|||
130127357|NCT01389102|468429503|FG001|Overall Study|Withdrawal by Subject|4|||
130127358|NCT01389102|468429504|FG002|Overall Study|Withdrawal by Subject|9|||
130127359|NCT01389102|468429505|FG003|Overall Study|Withdrawal by Subject|2|||
130127360|NCT01389102|468429506|FG004|Overall Study|Withdrawal by Subject|3|||
130127361|NCT01389102|468429507|FG005|Overall Study|Withdrawal by Subject|3|||
130127362|NCT01389102|468429502|FG000|Overall Study|Subject Traveling Out of Country|0|||
130127363|NCT01389102|468429503|FG001|Overall Study|Subject Traveling Out of Country|0|||
130127364|NCT01389102|468429504|FG002|Overall Study|Subject Traveling Out of Country|0|||
130127365|NCT01389102|468429505|FG003|Overall Study|Subject Traveling Out of Country|1|||
130127366|NCT01389102|468429506|FG004|Overall Study|Subject Traveling Out of Country|0|||
130127367|NCT01389102|468429507|FG005|Overall Study|Subject Traveling Out of Country|0|||
130127368|NCT01389102|468429502|FG000|Overall Study|Subject Moved|2|||
130127369|NCT01389102|468429503|FG001|Overall Study|Subject Moved|0|||
130127370|NCT01389102|468429504|FG002|Overall Study|Subject Moved|1|||
130127371|NCT01389102|468429505|FG003|Overall Study|Subject Moved|0|||
130127372|NCT01389102|468429506|FG004|Overall Study|Subject Moved|0|||
130127373|NCT01389102|468429507|FG005|Overall Study|Subject Moved|0|||
130127374|NCT01389102|468429502|FG000|Overall Study|Unavailable due to husband's illness|0|||
130127375|NCT01389102|468429503|FG001|Overall Study|Unavailable due to husband's illness|1|||
130127376|NCT01389102|468429504|FG002|Overall Study|Unavailable due to husband's illness|0|||
130127377|NCT01389102|468429505|FG003|Overall Study|Unavailable due to husband's illness|0|||
130127378|NCT01389102|468429506|FG004|Overall Study|Unavailable due to husband's illness|0|||
130127379|NCT01389102|468429507|FG005|Overall Study|Unavailable due to husband's illness|0|||
130127380|NCT01389102|468429502|FG000|Overall Study|Investigator Judgement|0|||
130127381|NCT01389102|468429503|FG001|Overall Study|Investigator Judgement|1|||
130127382|NCT01389102|468429504|FG002|Overall Study|Investigator Judgement|0|||
130127383|NCT01389102|468429505|FG003|Overall Study|Investigator Judgement|0|||
130127384|NCT01389102|468429506|FG004|Overall Study|Investigator Judgement|0|||
130127385|NCT01389102|468429507|FG005|Overall Study|Investigator Judgement|0|||
130127386|NCT00893464|468429508|FG000|Overall Study|Did not complete therapy/experience PD|0|||
130127387|NCT00893464|468429509|FG001|Overall Study|Did not complete therapy/experience PD|0|||
130127388|NCT00893464|468429510|FG002|Overall Study|Did not complete therapy/experience PD|0|||
130127389|NCT00893464|468429511|FG003|Overall Study|Did not complete therapy/experience PD|0|||
130127390|NCT00893464|468429512|FG004|Overall Study|Did not complete therapy/experience PD|0|||
130127391|NCT00893464|468429513|FG005|Overall Study|Did not complete therapy/experience PD|0|||
130127392|NCT00893464|468429514|FG006|Overall Study|Did not complete therapy/experience PD|2|||
130127393|NCT00893464|468429515|FG007|Overall Study|Did not complete therapy/experience PD|2|||
130127394|NCT00436553|468429516|FG000|Overall Study|Adverse Event|4|||
130127395|NCT00436553|468429517|FG001|Overall Study|Adverse Event|3|||
130127396|NCT00436553|468429518|FG002|Overall Study|Adverse Event|4|||
130127397|NCT00436553|468429516|FG000|Overall Study|Death|3|||
130127398|NCT00436553|468429517|FG001|Overall Study|Death|1|||
130127399|NCT00436553|468429518|FG002|Overall Study|Death|3|||
130127400|NCT00436553|468429516|FG000|Overall Study|Lost to Follow-up|0|||
130127401|NCT00436553|468429517|FG001|Overall Study|Lost to Follow-up|2|||
130127402|NCT00436553|468429518|FG002|Overall Study|Lost to Follow-up|0|||
130127403|NCT00436553|468429516|FG000|Overall Study|Protocol Violation|1|||
130127404|NCT00436553|468429517|FG001|Overall Study|Protocol Violation|0|||
130127405|NCT00436553|468429518|FG002|Overall Study|Protocol Violation|0|||
130127406|NCT00436553|468429516|FG000|Overall Study|Withdrawal by Subject|5|||
130127407|NCT00436553|468429517|FG001|Overall Study|Withdrawal by Subject|6|||
130127408|NCT00436553|468429518|FG002|Overall Study|Withdrawal by Subject|3|||
130127409|NCT01035060|468429523|FG000|Overall Study|Lost to Follow-up|0|||
130127410|NCT01035060|468429524|FG001|Overall Study|Lost to Follow-up|7|||
130127411|NCT01035060|468429523|FG000|Overall Study|Did not quality after 2nd screening|14|||
130127412|NCT01035060|468429524|FG001|Overall Study|Did not quality after 2nd screening|1|||
130127413|NCT01035060|468429523|FG000|Overall Study|Withdrawal by Subject|8|||
130127414|NCT01035060|468429524|FG001|Overall Study|Withdrawal by Subject|6|||
130127415|NCT01035060|468429523|FG000|Overall Study|Physician Decision|2|||
130127416|NCT01035060|468429524|FG001|Overall Study|Physician Decision|0|||
130127417|NCT01981720|468429529|FG000|Overall Study|Adverse Event|1|||
130127418|NCT01981720|468429529|FG000|Overall Study|Withdrawal by Subject|3|||
130127419|NCT01981720|468429529|FG000|Overall Study|Pregnancy|1|||
130127420|NCT02674477|468429530|FG000|Overall Study|Protocol Violation|8|||
130127421|NCT02674477|468429531|FG001|Overall Study|Protocol Violation|2|||
130127422|NCT01536405|468429534|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
130127423|NCT01536405|468429535|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
130127424|NCT01536405|468429534|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
130127425|NCT01536405|468429535|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
130127426|NCT01536405|468429534|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
130127427|NCT01536405|468429535|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
130127428|NCT01536405|468429534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
130127429|NCT01536405|468429535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
130127430|NCT01536405|468429534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
130127431|NCT01536405|468429535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
130127432|NCT01536405|468429534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
130127433|NCT01536405|468429535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
130127434|NCT01536405|468429534|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
130127435|NCT01536405|468429535|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
130127436|NCT01536405|468429534|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
130127437|NCT01536405|468429535|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
130127438|NCT01536405|468429534|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
130127439|NCT01536405|468429535|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
130127440|NCT01536405|468429534|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
130127441|NCT01536405|468429535|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
130127442|NCT01536405|468429534|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
130127443|NCT01536405|468429535|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
130127444|NCT01536405|468429534|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
130127445|NCT01536405|468429535|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
130127446|NCT01536405|468429534|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
130127447|NCT01536405|468429535|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
130127448|NCT02514122|468429536|FG000|Overall Study|Withdrawal by Subject|2|||
130127449|NCT02514122|468429537|FG001|Overall Study|Withdrawal by Subject|0|||
130127450|NCT04239872|468429538|FG000|Overall Study|Lost to Follow-up|0|||
130127451|NCT04239872|468429539|FG001|Overall Study|Lost to Follow-up|1|||
130127452|NCT01472341|468429540|FG000|Overall Study|Started insulin therapy|55|||
130127453|NCT01472341|468429540|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
130127454|NCT01472341|468429540|FG000|Overall Study|Withdrawal by Subject|39|||
130127455|NCT01472341|468429540|FG000|Overall Study|Lost to Follow-up|52|||
130127456|NCT01472341|468429540|FG000|Overall Study|Laboratory parameters unavailable|25|||
129969578|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Death|3|||
129969579|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Death|1|||
129969580|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Death|5|||
129969581|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Death|7|||
129969582|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Death|11|||
129969583|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Death|0|||
129969584|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Death|0|||
129969585|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Death|0|||
129969586|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Death|0|||
129969587|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Death|0|||
129969588|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Death|0|||
129969589|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
129969590|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969591|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969592|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
129969593|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
129969594|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
129969595|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969596|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
129969597|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969598|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
129969599|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130127457|NCT01472341|468429540|FG000|Overall Study|Death|9|||
130127458|NCT00112463|468429543|FG000|Overall Study|Physician Decision|1|||
130127459|NCT00112463|468429543|FG000|Overall Study|Progression|30|||
130127460|NCT00112463|468429543|FG000|Overall Study|Second Primary|1|||
130127461|NCT00112463|468429543|FG000|Overall Study|Toxicity|3|||
130127462|NCT00112463|468429543|FG000|Overall Study|Withdrawal by Subject|2|||
129969600|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
130127463|NCT00112463|468429543|FG000|Overall Study|Never started treatment|2|||
130127464|NCT01118312|468429550|FG000|Overall Study|Lost to Follow-up|33|||
130127465|NCT01118312|468429551|FG001|Overall Study|Lost to Follow-up|32|||
130127466|NCT01118312|468429550|FG000|Overall Study|Withdrawal by Subject|1|||
130127467|NCT01118312|468429551|FG001|Overall Study|Withdrawal by Subject|3|||
130127468|NCT00296647|468429552|FG000|Overall Study|Death|4|||
130127469|NCT00296647|468429553|FG001|Overall Study|Death|1|||
130127470|NCT00296647|468429554|FG002|Overall Study|Death|2|||
130127471|NCT00296647|468429555|FG003|Overall Study|Death|1|||
130127472|NCT00296647|468429556|FG004|Overall Study|Death|1|||
130127473|NCT00296647|468429552|FG000|Overall Study|Withdrawal by Subject|28|||
130127474|NCT00296647|468429553|FG001|Overall Study|Withdrawal by Subject|27|||
130127475|NCT00296647|468429554|FG002|Overall Study|Withdrawal by Subject|32|||
130127476|NCT00296647|468429555|FG003|Overall Study|Withdrawal by Subject|16|||
130127477|NCT00296647|468429556|FG004|Overall Study|Withdrawal by Subject|19|||
130127478|NCT01629381|468429557|FG000|Overall Study|Withdrawal by Subject|2|||
130127479|NCT01629381|468429558|FG001|Overall Study|Withdrawal by Subject|5|||
130127480|NCT00735904|468429559|FG000|Overall Study|Adverse Event|3|||
130127481|NCT00735904|468429559|FG000|Overall Study|Death|20|||
130127482|NCT00735904|468429559|FG000|Overall Study|Protocol Violation|1|||
130127483|NCT00735904|468429559|FG000|Overall Study|Withdrawal by Subject|1|||
130127484|NCT00735904|468429559|FG000|Overall Study|Study Terminated by Sponsor|5|||
130127485|NCT00735904|468429559|FG000|Overall Study|Other|8|||
130127486|NCT01390844|468429560|FG000|Treatment Phase|Adverse Event|12|||
130127487|NCT01390844|468429561|FG001|Treatment Phase|Adverse Event|2|||
130127488|NCT01390844|468429562|FG002|Treatment Phase|Adverse Event|3|||
130127489|NCT01390844|468429563|FG003|Treatment Phase|Adverse Event|2|||
130127490|NCT01390844|468429560|FG000|Treatment Phase|Treatment Failure|23|||
130127491|NCT01390844|468429561|FG001|Treatment Phase|Treatment Failure|25|||
130127492|NCT01390844|468429562|FG002|Treatment Phase|Treatment Failure|10|||
130127493|NCT01390844|468429563|FG003|Treatment Phase|Treatment Failure|13|||
130127494|NCT01390844|468429560|FG000|Treatment Phase|Non-Medical Reasons|5|||
130127495|NCT01390844|468429561|FG001|Treatment Phase|Non-Medical Reasons|1|||
130127496|NCT01390844|468429562|FG002|Treatment Phase|Non-Medical Reasons|8|||
130127497|NCT01390844|468429563|FG003|Treatment Phase|Non-Medical Reasons|1|||
130127498|NCT01390844|468429560|FG000|Treatment Phase|Non-GCP Compliant|0|||
130127499|NCT01390844|468429561|FG001|Treatment Phase|Non-GCP Compliant|0|||
130127500|NCT01390844|468429562|FG002|Treatment Phase|Non-GCP Compliant|10|||
130127501|NCT01390844|468429563|FG003|Treatment Phase|Non-GCP Compliant|3|||
130127502|NCT01390844|468429560|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
130127503|NCT01390844|468429561|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
130127504|NCT01390844|468429562|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
130127505|NCT01390844|468429563|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
130127506|NCT03204539|468429568|FG000|Overall Study|Loss of funding|0|||
130127507|NCT03204539|468429569|FG001|Overall Study|Loss of funding|1|||
130127508|NCT01171963|468429570|FG000|Overall Study|Adverse Event|10|||
130127509|NCT01171963|468429571|FG001|Overall Study|Adverse Event|15|||
130127510|NCT01171963|468429570|FG000|Overall Study|Lost to Follow-up|23|||
130127511|NCT01171963|468429571|FG001|Overall Study|Lost to Follow-up|24|||
130127512|NCT01171963|468429570|FG000|Overall Study|Other - diarrhoea|1|||
130127513|NCT01171963|468429571|FG001|Overall Study|Other - diarrhoea|0|||
130127514|NCT01171963|468429570|FG000|Overall Study|Withdrawal by Subject|114|||
130127515|NCT01171963|468429571|FG001|Overall Study|Withdrawal by Subject|129|||
130127516|NCT05093205|468429572|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
130127517|NCT05093205|468429573|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
130127518|NCT05093205|468429574|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
130127519|NCT05093205|468429575|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
130127520|NCT05093205|468429576|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
130127521|NCT05093205|468429577|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
130127522|NCT05093205|468429578|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
130127523|NCT05093205|468429579|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
130127524|NCT05093205|468429580|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
130127525|NCT05093205|468429581|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
130127526|NCT05093205|468429582|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
130127527|NCT05093205|468429583|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
130127528|NCT05093205|468429584|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
130127529|NCT05093205|468429572|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127530|NCT05093205|468429573|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127531|NCT05093205|468429574|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
130127532|NCT05093205|468429575|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127533|NCT05093205|468429576|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127534|NCT05093205|468429577|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127535|NCT05093205|468429578|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127536|NCT05093205|468429579|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127537|NCT05093205|468429580|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127538|NCT05093205|468429581|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127539|NCT05093205|468429582|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127540|NCT05093205|468429583|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127541|NCT05093205|468429584|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
130127542|NCT05093205|468429572|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
130127543|NCT05093205|468429573|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
130127544|NCT05093205|468429574|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
130127545|NCT05093205|468429575|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
130127546|NCT05093205|468429576|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
130127547|NCT05093205|468429577|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
130127548|NCT05093205|468429578|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
130127549|NCT05093205|468429579|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
130127550|NCT05093205|468429580|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
130127551|NCT05093205|468429581|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
130127552|NCT05093205|468429582|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
130127553|NCT05093205|468429583|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
130127554|NCT05093205|468429584|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
130127555|NCT05093205|468429572|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
130127556|NCT05093205|468429573|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
130127557|NCT05093205|468429574|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
130127558|NCT05093205|468429575|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
130127559|NCT05093205|468429576|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
130127560|NCT05093205|468429577|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
130127561|NCT05093205|468429578|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
130127562|NCT05093205|468429579|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
130127563|NCT05093205|468429580|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
130127564|NCT05093205|468429581|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
130127565|NCT05093205|468429582|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
130127566|NCT05093205|468429583|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
130127567|NCT05093205|468429584|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
130127568|NCT05093205|468429572|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
130127569|NCT05093205|468429573|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
130127570|NCT05093205|468429574|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
130127571|NCT05093205|468429575|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
130127572|NCT05093205|468429576|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
130127573|NCT05093205|468429577|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
130127574|NCT05093205|468429578|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
130127575|NCT05093205|468429579|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
130127576|NCT05093205|468429580|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
130127577|NCT05093205|468429581|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
130127578|NCT05093205|468429582|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
130127579|NCT05093205|468429583|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
130127580|NCT05093205|468429584|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
130127581|NCT05093205|468429572|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
130127582|NCT05093205|468429573|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
130127583|NCT05093205|468429574|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
130127584|NCT05093205|468429575|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
130127585|NCT05093205|468429576|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
130127586|NCT05093205|468429577|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
130127587|NCT05093205|468429578|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
130127588|NCT05093205|468429579|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
130127589|NCT05093205|468429580|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
130127590|NCT05093205|468429581|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
130127591|NCT05093205|468429582|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
130127592|NCT05093205|468429583|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
130127593|NCT05093205|468429584|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
130127594|NCT05093205|468429572|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
130127595|NCT05093205|468429573|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
130127596|NCT05093205|468429574|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
130127597|NCT05093205|468429575|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
130127598|NCT05093205|468429576|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
130127599|NCT05093205|468429577|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
130127600|NCT05093205|468429578|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
130127601|NCT05093205|468429579|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
130127602|NCT05093205|468429580|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
130127603|NCT05093205|468429581|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
130127604|NCT05093205|468429582|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
130127605|NCT05093205|468429583|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
130127606|NCT05093205|468429584|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
130127607|NCT05093205|468429572|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
130127608|NCT05093205|468429573|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
130127609|NCT05093205|468429574|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
130127610|NCT05093205|468429575|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
130127611|NCT05093205|468429576|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
130127612|NCT05093205|468429577|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
130127613|NCT05093205|468429578|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
130127614|NCT05093205|468429579|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
130127615|NCT05093205|468429580|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
130127616|NCT05093205|468429581|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
130127617|NCT05093205|468429582|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
130127618|NCT05093205|468429583|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
130127619|NCT05093205|468429584|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
130127620|NCT05093205|468429572|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127621|NCT05093205|468429573|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127622|NCT05093205|468429574|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127623|NCT05093205|468429575|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127624|NCT05093205|468429576|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127625|NCT05093205|468429577|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127626|NCT05093205|468429578|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127627|NCT05093205|468429579|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127628|NCT05093205|468429580|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127629|NCT05093205|468429581|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
130127630|NCT05093205|468429582|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127631|NCT05093205|468429583|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127632|NCT05093205|468429584|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
130127633|NCT05093205|468429572|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
130127634|NCT05093205|468429573|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
130127635|NCT05093205|468429574|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
130127636|NCT05093205|468429575|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
130127637|NCT05093205|468429576|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
130127638|NCT05093205|468429577|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
130127639|NCT05093205|468429578|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
130127640|NCT05093205|468429579|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
130127641|NCT05093205|468429580|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
130127642|NCT05093205|468429581|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
130127643|NCT05093205|468429582|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
130127644|NCT05093205|468429583|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
130127645|NCT05093205|468429584|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
130127646|NCT05093205|468429572|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127647|NCT05093205|468429573|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127648|NCT05093205|468429574|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127649|NCT05093205|468429575|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127650|NCT05093205|468429576|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127651|NCT05093205|468429577|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127652|NCT05093205|468429578|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129969601|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
129969602|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969603|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969604|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969605|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969606|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969607|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969608|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969609|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969610|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969611|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969612|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969613|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969614|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969615|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969616|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969617|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969618|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969619|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130127653|NCT05093205|468429579|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127654|NCT05093205|468429580|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127655|NCT05093205|468429581|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127656|NCT05093205|468429582|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
130127657|NCT05093205|468429583|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129969620|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969621|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
130127658|NCT05093205|468429584|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
130127659|NCT05093205|468429572|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127660|NCT05093205|468429573|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127661|NCT05093205|468429574|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127662|NCT05093205|468429575|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129969622|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969623|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969624|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969625|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969626|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969627|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969628|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969629|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969630|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969631|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969632|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969633|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969634|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969635|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969636|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
129969637|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969638|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969639|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
129969640|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969641|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969642|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969643|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969644|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969645|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969646|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Death|0|||
129969647|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Death|0|||
129969648|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Death|0|||
129969649|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Death|0|||
129969650|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Death|0|||
129969651|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Death|0|||
129969652|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Death|0|||
129969653|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Death|0|||
129969654|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Death|0|||
129969655|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Death|0|||
129969656|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Death|0|||
129969657|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Death|0|||
129969658|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Death|0|||
129969659|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Death|20|||
129969660|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Death|13|||
129969661|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Death|9|||
129969662|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Death|5|||
129969663|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Death|14|||
129969664|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Death|12|||
129969665|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969666|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969667|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969668|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969669|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969670|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969671|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969672|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969673|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969674|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969675|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969676|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969677|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969678|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969679|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
129969680|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
129969681|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
130127663|NCT05093205|468429576|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129969682|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
129969683|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
129969684|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969685|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969686|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969687|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969688|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969689|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969690|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969691|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969692|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969693|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969694|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969695|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969696|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969697|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969698|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
129969699|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
129969700|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969701|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969702|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
129969703|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969704|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969705|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969706|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969707|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969708|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969709|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969710|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969711|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969712|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969713|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969714|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969715|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969716|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
129969717|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969718|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969719|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
129969720|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
129969721|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969722|NCT00126659|467852962|FG000|Overall Study|Adverse Event|0|||
129969723|NCT00126659|467852963|FG001|Overall Study|Adverse Event|0|||
129969724|NCT00126659|467852964|FG002|Overall Study|Adverse Event|2|||
129969725|NCT02367352|467852965|FG000|Overall Study|Progressive disease|7|||
129969726|NCT02367352|467852966|FG001|Overall Study|Progressive disease|0|||
129969727|NCT02367352|467852967|FG002|Overall Study|Progressive disease|0|||
129969728|NCT02367352|467852965|FG000|Overall Study|Participant Received Alternative Therapy|1|||
129969729|NCT02367352|467852966|FG001|Overall Study|Participant Received Alternative Therapy|0|||
129969730|NCT02367352|467852967|FG002|Overall Study|Participant Received Alternative Therapy|0|||
129969731|NCT02367352|467852965|FG000|Overall Study|Adverse Event|1|||
129969732|NCT02367352|467852966|FG001|Overall Study|Adverse Event|0|||
129969733|NCT02367352|467852967|FG002|Overall Study|Adverse Event|0|||
129969734|NCT01375751|467852972|FG000|Overall Study|Other|0|||
129969735|NCT01375751|467852973|FG001|Overall Study|Other|1|||
129969736|NCT01375751|467852974|FG002|Overall Study|Other|0|||
129969737|NCT02980523|467852975|FG000|Overall Study|Lost to Follow-up|1|||
129969738|NCT02980523|467852976|FG001|Overall Study|Lost to Follow-up|4|||
129969739|NCT02980523|467852977|FG002|Overall Study|Lost to Follow-up|1|||
129969740|NCT02980523|467852978|FG003|Overall Study|Lost to Follow-up|2|||
129969741|NCT02980523|467852979|FG004|Overall Study|Lost to Follow-up|1|||
129969742|NCT02980523|467852975|FG000|Overall Study|Excluded from analysis|1|||
129969743|NCT02980523|467852976|FG001|Overall Study|Excluded from analysis|3|||
129969744|NCT02980523|467852977|FG002|Overall Study|Excluded from analysis|1|||
129969745|NCT02980523|467852978|FG003|Overall Study|Excluded from analysis|1|||
129969746|NCT02980523|467852979|FG004|Overall Study|Excluded from analysis|1|||
129969747|NCT02980523|467852975|FG000|Overall Study|Lack of Efficacy|1|||
129969748|NCT02980523|467852976|FG001|Overall Study|Lack of Efficacy|4|||
129969749|NCT02980523|467852977|FG002|Overall Study|Lack of Efficacy|4|||
129969750|NCT02980523|467852978|FG003|Overall Study|Lack of Efficacy|5|||
129969751|NCT02980523|467852979|FG004|Overall Study|Lack of Efficacy|8|||
129969752|NCT02980523|467852975|FG000|Overall Study|Did not receive intervention|0|||
129969753|NCT02980523|467852976|FG001|Overall Study|Did not receive intervention|0|||
129969754|NCT02980523|467852977|FG002|Overall Study|Did not receive intervention|0|||
129969755|NCT02980523|467852978|FG003|Overall Study|Did not receive intervention|1|||
129969756|NCT02980523|467852979|FG004|Overall Study|Did not receive intervention|0|||
129969757|NCT02375347|467852980|FG000|Overall Study|Protocol Violation|1|||
129969758|NCT05186311|467852984|FG000|Part A: Serum|Withdrawal by Subject|1|||
130093437|NCT01072175|468296951|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
129969759|NCT02417441|467852993|FG000|Overall Study|Inconclusive due to missing data|52|||
129969760|NCT02417441|467852994|FG001|Overall Study|Inconclusive due to missing data|19|||
129969761|NCT00983853|467852995|FG000|Overall Study|Lost to Follow-up|1|||
129969762|NCT00983853|467852996|FG001|Overall Study|Lost to Follow-up|1|||
129969763|NCT00983853|467852997|FG002|Overall Study|Lost to Follow-up|2|||
129969764|NCT00983853|467852998|FG003|Overall Study|Lost to Follow-up|2|||
129969765|NCT00983853|467852999|FG004|Overall Study|Lost to Follow-up|2|||
129969766|NCT00983853|467853000|FG005|Overall Study|Lost to Follow-up|1|||
129969767|NCT00983853|467852995|FG000|Overall Study|Withdrawal by Subject|0|||
129969768|NCT00983853|467852996|FG001|Overall Study|Withdrawal by Subject|0|||
129969769|NCT00983853|467852997|FG002|Overall Study|Withdrawal by Subject|1|||
129969770|NCT00983853|467852998|FG003|Overall Study|Withdrawal by Subject|0|||
129969771|NCT00983853|467852999|FG004|Overall Study|Withdrawal by Subject|1|||
129969772|NCT00983853|467853000|FG005|Overall Study|Withdrawal by Subject|0|||
129969773|NCT00983853|467852995|FG000|Overall Study|Unable to come to study follow-up visits|0|||
129969774|NCT00983853|467852996|FG001|Overall Study|Unable to come to study follow-up visits|1|||
129969775|NCT00983853|467852997|FG002|Overall Study|Unable to come to study follow-up visits|0|||
129969776|NCT00983853|467852998|FG003|Overall Study|Unable to come to study follow-up visits|0|||
129969777|NCT00983853|467852999|FG004|Overall Study|Unable to come to study follow-up visits|0|||
129969778|NCT00983853|467853000|FG005|Overall Study|Unable to come to study follow-up visits|0|||
129969779|NCT03603639|467853001|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969780|NCT03603639|467853002|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969781|NCT03603639|467853003|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969782|NCT03603639|467853004|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
129969783|NCT03603639|467853005|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969784|NCT03603639|467853006|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969785|NCT03603639|467853001|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
129969786|NCT03603639|467853002|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
129969787|NCT03603639|467853003|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
129969788|NCT03603639|467853004|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
129969789|NCT03603639|467853005|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
129969790|NCT03603639|467853006|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
129969791|NCT01628692|467853008|FG000|Overall Study|Lack of Efficacy|4|||
129969792|NCT01628692|467853009|FG001|Overall Study|Lack of Efficacy|4|||
129969793|NCT01628692|467853010|FG002|Overall Study|Lack of Efficacy|5|||
129969794|NCT01628692|467853011|FG003|Overall Study|Lack of Efficacy|1|||
129969795|NCT01628692|467853012|FG004|Overall Study|Lack of Efficacy|4|||
129969796|NCT01628692|467853013|FG005|Overall Study|Lack of Efficacy|7|||
129969797|NCT01628692|467853008|FG000|Overall Study|Adverse Event|2|||
129969798|NCT01628692|467853009|FG001|Overall Study|Adverse Event|0|||
129969799|NCT01628692|467853010|FG002|Overall Study|Adverse Event|2|||
129969800|NCT01628692|467853011|FG003|Overall Study|Adverse Event|0|||
129969801|NCT01628692|467853012|FG004|Overall Study|Adverse Event|0|||
129969802|NCT01628692|467853013|FG005|Overall Study|Adverse Event|0|||
129969803|NCT01628692|467853008|FG000|Overall Study|Withdrawal by Subject|0|||
129969804|NCT01628692|467853009|FG001|Overall Study|Withdrawal by Subject|1|||
129969805|NCT01628692|467853010|FG002|Overall Study|Withdrawal by Subject|1|||
129969806|NCT01628692|467853011|FG003|Overall Study|Withdrawal by Subject|0|||
129969807|NCT01628692|467853012|FG004|Overall Study|Withdrawal by Subject|0|||
129969808|NCT01628692|467853013|FG005|Overall Study|Withdrawal by Subject|0|||
129969809|NCT01628692|467853008|FG000|Overall Study|Death|0|||
129969810|NCT01628692|467853009|FG001|Overall Study|Death|1|||
129969811|NCT01628692|467853010|FG002|Overall Study|Death|0|||
129969812|NCT01628692|467853011|FG003|Overall Study|Death|0|||
129969813|NCT01628692|467853012|FG004|Overall Study|Death|0|||
129969814|NCT01628692|467853013|FG005|Overall Study|Death|0|||
130127664|NCT05093205|468429577|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127665|NCT05093205|468429578|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127666|NCT05093205|468429579|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127667|NCT05093205|468429580|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127668|NCT05093205|468429581|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127669|NCT05093205|468429582|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127670|NCT05093205|468429583|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
130127671|NCT05093205|468429584|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
130127672|NCT05093205|468429572|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
129969815|NCT01628692|467853008|FG000|Overall Study|Poor compliance/noncompliance|1|||
129969816|NCT01628692|467853009|FG001|Overall Study|Poor compliance/noncompliance|0|||
129969817|NCT01628692|467853010|FG002|Overall Study|Poor compliance/noncompliance|0|||
129969818|NCT01628692|467853011|FG003|Overall Study|Poor compliance/noncompliance|0|||
129969819|NCT01628692|467853012|FG004|Overall Study|Poor compliance/noncompliance|0|||
129969820|NCT01628692|467853013|FG005|Overall Study|Poor compliance/noncompliance|0|||
129969821|NCT01628692|467853008|FG000|Overall Study|Administrative reason by sponsor|0|||
129969822|NCT01628692|467853009|FG001|Overall Study|Administrative reason by sponsor|0|||
129969823|NCT01628692|467853010|FG002|Overall Study|Administrative reason by sponsor|0|||
129969824|NCT01628692|467853011|FG003|Overall Study|Administrative reason by sponsor|0|||
129969825|NCT01628692|467853012|FG004|Overall Study|Administrative reason by sponsor|0|||
129969826|NCT01628692|467853013|FG005|Overall Study|Administrative reason by sponsor|1|||
129969827|NCT01628692|467853008|FG000|Overall Study|Completed 12 Week only|0|||
129969828|NCT01628692|467853009|FG001|Overall Study|Completed 12 Week only|0|||
129969829|NCT01628692|467853010|FG002|Overall Study|Completed 12 Week only|0|||
129969830|NCT01628692|467853011|FG003|Overall Study|Completed 12 Week only|0|||
129969831|NCT01628692|467853012|FG004|Overall Study|Completed 12 Week only|0|||
129969832|NCT01628692|467853013|FG005|Overall Study|Completed 12 Week only|1|||
129969833|NCT00723125|467853015|FG000|Overall Study|Met Dx|1|||
129969834|NCT00723125|467853016|FG001|Overall Study|Met Dx|0|||
129969835|NCT00723125|467853015|FG000|Overall Study|Withdrawal by Subject|15|||
129969836|NCT00723125|467853016|FG001|Overall Study|Withdrawal by Subject|6|||
129969837|NCT00723125|467853015|FG000|Overall Study|Adverse Event|2|||
129969838|NCT00723125|467853016|FG001|Overall Study|Adverse Event|0|||
129969839|NCT02196077|467853017|FG000|Overall Study|Adverse Event|4|||
129969840|NCT02196077|467853017|FG000|Overall Study|Lack of Efficacy|1|||
129969841|NCT02196077|467853017|FG000|Overall Study|Withdrawal by Subject|14|||
129969842|NCT02196077|467853017|FG000|Overall Study|Physician Decision|1|||
129969843|NCT02196077|467853017|FG000|Overall Study|Lost to Follow-up|3|||
129969844|NCT02196077|467853017|FG000|Overall Study|Protocol Violation|24|||
129969845|NCT00003477|467853032|FG000|Overall Study|Not evalauable|4|||
129969846|NCT01236352|467853033|FG000|Overall Study|Death|0|||
129969847|NCT01236352|467853034|FG001|Overall Study|Death|0|||
129969848|NCT01236352|467853035|FG002|Overall Study|Death|0|||
129969849|NCT01236352|467853036|FG003|Overall Study|Death|0|||
129969850|NCT01236352|467853037|FG004|Overall Study|Death|0|||
129969851|NCT01236352|467853038|FG005|Overall Study|Death|0|||
129969852|NCT01236352|467853039|FG006|Overall Study|Death|0|||
129969853|NCT01236352|467853040|FG007|Overall Study|Death|1|||
129969854|NCT01236352|467853041|FG008|Overall Study|Death|0|||
129969855|NCT01236352|467853042|FG009|Overall Study|Death|0|||
129969856|NCT01236352|467853043|FG010|Overall Study|Death|0|||
129969857|NCT01236352|467853033|FG000|Overall Study|Withdrawal by Subject|0|||
129969858|NCT01236352|467853034|FG001|Overall Study|Withdrawal by Subject|0|||
129969859|NCT01236352|467853035|FG002|Overall Study|Withdrawal by Subject|0|||
129969860|NCT01236352|467853036|FG003|Overall Study|Withdrawal by Subject|0|||
129969861|NCT01236352|467853037|FG004|Overall Study|Withdrawal by Subject|0|||
129969862|NCT01236352|467853038|FG005|Overall Study|Withdrawal by Subject|0|||
129969863|NCT01236352|467853039|FG006|Overall Study|Withdrawal by Subject|0|||
129969864|NCT01236352|467853040|FG007|Overall Study|Withdrawal by Subject|0|||
129969865|NCT01236352|467853041|FG008|Overall Study|Withdrawal by Subject|0|||
129969866|NCT01236352|467853042|FG009|Overall Study|Withdrawal by Subject|2|||
129969867|NCT01236352|467853043|FG010|Overall Study|Withdrawal by Subject|1|||
129969868|NCT01236352|467853033|FG000|Overall Study|Adverse Event|0|||
129969869|NCT01236352|467853034|FG001|Overall Study|Adverse Event|0|||
129969870|NCT01236352|467853035|FG002|Overall Study|Adverse Event|0|||
129969871|NCT01236352|467853036|FG003|Overall Study|Adverse Event|0|||
129969872|NCT01236352|467853037|FG004|Overall Study|Adverse Event|0|||
129969873|NCT01236352|467853038|FG005|Overall Study|Adverse Event|0|||
129969874|NCT01236352|467853039|FG006|Overall Study|Adverse Event|2|||
129969875|NCT01236352|467853040|FG007|Overall Study|Adverse Event|0|||
129969876|NCT01236352|467853041|FG008|Overall Study|Adverse Event|0|||
129969877|NCT01236352|467853042|FG009|Overall Study|Adverse Event|4|||
129969878|NCT01236352|467853043|FG010|Overall Study|Adverse Event|1|||
129969879|NCT01236352|467853033|FG000|Overall Study|Study drug toxicity|0|||
130127673|NCT05093205|468429573|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
130127674|NCT05093205|468429574|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
130127675|NCT05093205|468429575|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
130127676|NCT05093205|468429576|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
130127677|NCT05093205|468429577|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
130127678|NCT05093205|468429578|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
130127679|NCT05093205|468429579|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
130127680|NCT05093205|468429580|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
130127681|NCT05093205|468429581|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
129969880|NCT01236352|467853034|FG001|Overall Study|Study drug toxicity|0|||
129969881|NCT01236352|467853035|FG002|Overall Study|Study drug toxicity|0|||
129969882|NCT01236352|467853036|FG003|Overall Study|Study drug toxicity|0|||
130127682|NCT05093205|468429582|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
130127683|NCT05093205|468429583|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
129969883|NCT01236352|467853037|FG004|Overall Study|Study drug toxicity|0|||
129969884|NCT01236352|467853038|FG005|Overall Study|Study drug toxicity|1|||
129969885|NCT01236352|467853039|FG006|Overall Study|Study drug toxicity|1|||
129969886|NCT01236352|467853040|FG007|Overall Study|Study drug toxicity|0|||
129969887|NCT01236352|467853041|FG008|Overall Study|Study drug toxicity|0|||
129969888|NCT01236352|467853042|FG009|Overall Study|Study drug toxicity|2|||
129969889|NCT01236352|467853043|FG010|Overall Study|Study drug toxicity|2|||
129969890|NCT01236352|467853033|FG000|Overall Study|Disease progression|1|||
130127684|NCT05093205|468429584|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
129969891|NCT01236352|467853034|FG001|Overall Study|Disease progression|2|||
129969892|NCT01236352|467853035|FG002|Overall Study|Disease progression|1|||
130127685|NCT05093205|468429572|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127686|NCT05093205|468429573|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127687|NCT05093205|468429574|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127688|NCT05093205|468429575|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127689|NCT05093205|468429576|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127690|NCT05093205|468429577|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127691|NCT05093205|468429578|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127692|NCT05093205|468429579|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127693|NCT05093205|468429580|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127694|NCT05093205|468429581|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127695|NCT05093205|468429582|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127696|NCT05093205|468429583|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
130127697|NCT05093205|468429584|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
130127698|NCT04185909|468429586|FG000|Overall Study|Lost to Follow-up|1|||
130127699|NCT01417078|468429587|FG000|Overall Study|Withdrawal by Subject|1|||
130127700|NCT00626548|468429588|FG000|Overall Study|Adverse Event|164|||
130127701|NCT00626548|468429589|FG001|Overall Study|Adverse Event|44|||
130127702|NCT00626548|468429588|FG000|Overall Study|Withdrawal by Subject|42|||
130127703|NCT00626548|468429589|FG001|Overall Study|Withdrawal by Subject|46|||
130127704|NCT00626548|468429588|FG000|Overall Study|Protocol Violation|4|||
130127705|NCT00626548|468429589|FG001|Overall Study|Protocol Violation|11|||
130127706|NCT00626548|468429588|FG000|Overall Study|Lost to Follow-up|2|||
130127707|NCT00626548|468429589|FG001|Overall Study|Lost to Follow-up|2|||
130127708|NCT00626548|468429588|FG000|Overall Study|Other termination reason|493|||
130127709|NCT00626548|468429589|FG001|Overall Study|Other termination reason|613|||
130127710|NCT00048581|468429590|FG000|Double-Blind Period|Adverse Event|9|||
130127711|NCT00048581|468429591|FG001|Double-Blind Period|Adverse Event|5|||
130127712|NCT00048581|468429592|FG002|Double-Blind Period|Adverse Event|0|||
130127713|NCT00048581|468429590|FG000|Double-Blind Period|Lack of Efficacy|14|||
129969893|NCT01236352|467853036|FG003|Overall Study|Disease progression|2|||
130127714|NCT00048581|468429591|FG001|Double-Blind Period|Lack of Efficacy|27|||
130127715|NCT00048581|468429592|FG002|Double-Blind Period|Lack of Efficacy|0|||
129969894|NCT01236352|467853037|FG004|Overall Study|Disease progression|2|||
129969895|NCT01236352|467853038|FG005|Overall Study|Disease progression|2|||
129969896|NCT01236352|467853039|FG006|Overall Study|Disease progression|1|||
129969897|NCT01236352|467853040|FG007|Overall Study|Disease progression|3|||
130127716|NCT00048581|468429590|FG000|Double-Blind Period|Lost to Follow-up|5|||
130127717|NCT00048581|468429591|FG001|Double-Blind Period|Lost to Follow-up|0|||
130127718|NCT00048581|468429592|FG002|Double-Blind Period|Lost to Follow-up|0|||
130127719|NCT00048581|468429590|FG000|Double-Blind Period|Withdrawal by Subject|5|||
130127720|NCT00048581|468429591|FG001|Double-Blind Period|Withdrawal by Subject|2|||
130127721|NCT00048581|468429592|FG002|Double-Blind Period|Withdrawal by Subject|0|||
130127722|NCT00048581|468429590|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
130127723|NCT00048581|468429591|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
130127724|NCT00048581|468429592|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
130127725|NCT00048581|468429590|FG000|Double-Blind Period|Investigator Decision|1|||
130127726|NCT00048581|468429591|FG001|Double-Blind Period|Investigator Decision|0|||
129969898|NCT01236352|467853041|FG008|Overall Study|Disease progression|2|||
129969899|NCT01236352|467853042|FG009|Overall Study|Disease progression|2|||
129969900|NCT01236352|467853043|FG010|Overall Study|Disease progression|2|||
129969901|NCT01236352|467853033|FG000|Overall Study|Poor/Non-compliance|1|||
129969902|NCT01236352|467853034|FG001|Overall Study|Poor/Non-compliance|0|||
129969903|NCT01236352|467853035|FG002|Overall Study|Poor/Non-compliance|0|||
129969904|NCT01236352|467853036|FG003|Overall Study|Poor/Non-compliance|0|||
129969905|NCT01236352|467853037|FG004|Overall Study|Poor/Non-compliance|0|||
129969906|NCT01236352|467853038|FG005|Overall Study|Poor/Non-compliance|0|||
129969907|NCT01236352|467853039|FG006|Overall Study|Poor/Non-compliance|0|||
129969908|NCT01236352|467853040|FG007|Overall Study|Poor/Non-compliance|0|||
129969909|NCT01236352|467853041|FG008|Overall Study|Poor/Non-compliance|0|||
129969910|NCT01236352|467853042|FG009|Overall Study|Poor/Non-compliance|0|||
129969911|NCT01236352|467853043|FG010|Overall Study|Poor/Non-compliance|0|||
130127727|NCT00048581|468429592|FG002|Double-Blind Period|Investigator Decision|0|||
130127728|NCT00048581|468429590|FG000|Open-Label Period|Death|0|||
130127729|NCT00048581|468429591|FG001|Open-Label Period|Death|0|||
129969912|NCT01236352|467853033|FG000|Overall Study|Maximum clinical benefit|1|||
129969913|NCT01236352|467853034|FG001|Overall Study|Maximum clinical benefit|1|||
129969914|NCT01236352|467853035|FG002|Overall Study|Maximum clinical benefit|1|||
130127730|NCT00048581|468429592|FG002|Open-Label Period|Death|4|||
130127731|NCT00048581|468429590|FG000|Open-Label Period|Adverse Event|0|||
130127732|NCT00048581|468429591|FG001|Open-Label Period|Adverse Event|0|||
130127733|NCT00048581|468429592|FG002|Open-Label Period|Adverse Event|37|||
130127734|NCT00048581|468429590|FG000|Open-Label Period|Lack of Efficacy|0|||
130127735|NCT00048581|468429591|FG001|Open-Label Period|Lack of Efficacy|0|||
130127736|NCT00048581|468429592|FG002|Open-Label Period|Lack of Efficacy|69|||
130127737|NCT00048581|468429590|FG000|Open-Label Period|Lost to Follow-up|0|||
129969915|NCT01236352|467853036|FG003|Overall Study|Maximum clinical benefit|0|||
130127738|NCT00048581|468429591|FG001|Open-Label Period|Lost to Follow-up|0|||
130127739|NCT00048581|468429592|FG002|Open-Label Period|Lost to Follow-up|14|||
130127740|NCT00048581|468429590|FG000|Open-Label Period|Withdrawal by Subject|0|||
130127741|NCT00048581|468429591|FG001|Open-Label Period|Withdrawal by Subject|0|||
130127742|NCT00048581|468429592|FG002|Open-Label Period|Withdrawal by Subject|20|||
130127743|NCT00048581|468429590|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
130127744|NCT00048581|468429591|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
130127745|NCT00048581|468429592|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
130127746|NCT00048581|468429590|FG000|Open-Label Period|Poor/Non-compliance|0|||
130127747|NCT00048581|468429591|FG001|Open-Label Period|Poor/Non-compliance|0|||
130127748|NCT00048581|468429592|FG002|Open-Label Period|Poor/Non-compliance|5|||
130127749|NCT00048581|468429590|FG000|Open-Label Period|Pregnancy|0|||
130127750|NCT00048581|468429591|FG001|Open-Label Period|Pregnancy|0|||
130127751|NCT00048581|468429592|FG002|Open-Label Period|Pregnancy|7|||
130127752|NCT00048581|468429590|FG000|Open-Label Period|Study Site Closure|0|||
130127753|NCT00048581|468429591|FG001|Open-Label Period|Study Site Closure|0|||
130127754|NCT00048581|468429592|FG002|Open-Label Period|Study Site Closure|2|||
130127755|NCT00048581|468429590|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
130127756|NCT00048581|468429591|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
130127757|NCT00048581|468429592|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
130127758|NCT00048581|468429590|FG000|Open-Label Period|Problem With Transportation To Site|0|||
130127759|NCT00048581|468429591|FG001|Open-Label Period|Problem With Transportation To Site|0|||
130127760|NCT00048581|468429592|FG002|Open-Label Period|Problem With Transportation To Site|1|||
130127761|NCT00048581|468429590|FG000|Open-Label Period|Primary Investigator Retired|0|||
130127762|NCT00048581|468429591|FG001|Open-Label Period|Primary Investigator Retired|0|||
130127763|NCT00048581|468429592|FG002|Open-Label Period|Primary Investigator Retired|2|||
130127764|NCT00048581|468429590|FG000|Open-Label Period|Study Ended By Sponsor|0|||
130127765|NCT00048581|468429591|FG001|Open-Label Period|Study Ended By Sponsor|0|||
130127766|NCT00048581|468429592|FG002|Open-Label Period|Study Ended By Sponsor|1|||
130127767|NCT01059903|468429594|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
130127768|NCT01059903|468429595|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
130127769|NCT00385593|468429602|FG000|Overall Study|Adverse Event|3|||
130127770|NCT00385593|468429603|FG001|Overall Study|Adverse Event|2|||
130127771|NCT00385593|468429602|FG000|Overall Study|Withdrawal by Subject|17|||
130127772|NCT00385593|468429603|FG001|Overall Study|Withdrawal by Subject|7|||
130127773|NCT00385593|468429602|FG000|Overall Study|Lost to Follow-up|12|||
130127774|NCT00385593|468429603|FG001|Overall Study|Lost to Follow-up|8|||
130127775|NCT00385593|468429602|FG000|Overall Study|Protocol Violation|7|||
130127776|NCT00385593|468429603|FG001|Overall Study|Protocol Violation|4|||
130127777|NCT00385593|468429602|FG000|Overall Study|Several reasons|17|||
130127778|NCT00385593|468429603|FG001|Overall Study|Several reasons|15|||
130127779|NCT00385593|468429602|FG000|Overall Study|Incorrect inclusion|2|||
130127780|NCT00385593|468429603|FG001|Overall Study|Incorrect inclusion|0|||
130127781|NCT00385593|468429602|FG000|Overall Study|Incorrect randomization|0|||
130127782|NCT00385593|468429603|FG001|Overall Study|Incorrect randomization|1|||
130127783|NCT02100228|468429604|FG000|Overall Study|Other|19|||
130127784|NCT02100228|468429605|FG001|Overall Study|Other|19|||
130127785|NCT02100228|468429604|FG000|Overall Study|Administrative reason|0|||
130127786|NCT02100228|468429605|FG001|Overall Study|Administrative reason|1|||
130127787|NCT02100228|468429604|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
130127788|NCT02100228|468429605|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
130127789|NCT02100228|468429604|FG000|Overall Study|Non-compliance|0|||
130127790|NCT02100228|468429605|FG001|Overall Study|Non-compliance|3|||
130127791|NCT02100228|468429604|FG000|Overall Study|Lost to Follow-up|0|||
130127792|NCT02100228|468429605|FG001|Overall Study|Lost to Follow-up|1|||
130127793|NCT02100228|468429604|FG000|Overall Study|Withdrawal by Subject|27|||
130127794|NCT02100228|468429605|FG001|Overall Study|Withdrawal by Subject|37|||
130127795|NCT02100228|468429604|FG000|Overall Study|Adverse Event|16|||
130127796|NCT02100228|468429605|FG001|Overall Study|Adverse Event|12|||
130127797|NCT02100228|468429604|FG000|Overall Study|Death|1|||
130127798|NCT02100228|468429605|FG001|Overall Study|Death|1|||
130127799|NCT00319735|468429606|FG000|Overall Study|Death|2|||
130127800|NCT04753437|468429609|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130127801|NCT04753437|468429610|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
130127802|NCT04753437|468429609|FG000|Overall Study|Liver Function Test Abnormalities|2|||
130127803|NCT04753437|468429610|FG001|Overall Study|Liver Function Test Abnormalities|4|||
130127804|NCT03243630|468429611|FG000|Overall Study|Protocol Violation|1|||
130127805|NCT03243630|468429611|FG000|Overall Study|Physician Decision|1|||
130127806|NCT02140060|468429612|FG000|Overall Study|Adverse Event|0|||
130127807|NCT02140060|468429613|FG001|Overall Study|Adverse Event|0|||
130127808|NCT02140060|468429614|FG002|Overall Study|Adverse Event|0|||
130127809|NCT02140060|468429615|FG003|Overall Study|Adverse Event|1|||
130127810|NCT02140060|468429616|FG004|Overall Study|Adverse Event|1|||
130127811|NCT02140060|468429617|FG005|Overall Study|Adverse Event|1|||
130127812|NCT02140060|468429612|FG000|Overall Study|Lack of Efficacy|0|||
130127813|NCT02140060|468429613|FG001|Overall Study|Lack of Efficacy|0|||
130127814|NCT02140060|468429614|FG002|Overall Study|Lack of Efficacy|0|||
130127815|NCT02140060|468429615|FG003|Overall Study|Lack of Efficacy|1|||
130127816|NCT02140060|468429616|FG004|Overall Study|Lack of Efficacy|0|||
130127817|NCT02140060|468429617|FG005|Overall Study|Lack of Efficacy|0|||
130127818|NCT01746017|468431201|FG000|Period 1|Withdrawal by Subject|0|||
130127819|NCT01746017|468431202|FG001|Period 1|Withdrawal by Subject|0|||
130127820|NCT01746017|468431203|FG002|Period 1|Withdrawal by Subject|0|||
130127821|NCT01746017|468431204|FG003|Period 1|Withdrawal by Subject|0|||
130127822|NCT01746017|468431205|FG004|Period 1|Withdrawal by Subject|0|||
130127823|NCT01746017|468431206|FG005|Period 1|Withdrawal by Subject|0|||
130127824|NCT01746017|468431207|FG006|Period 1|Withdrawal by Subject|1|||
130127825|NCT01746017|468431208|FG007|Period 1|Withdrawal by Subject|0|||
130127826|NCT01746017|468431209|FG008|Period 1|Withdrawal by Subject|0|||
130127827|NCT01746017|468431210|FG009|Period 1|Withdrawal by Subject|0|||
130127828|NCT01746017|468431211|FG010|Period 1|Withdrawal by Subject|0|||
130127829|NCT01746017|468431201|FG000|Period 3|Withdrawal by Subject|0|||
130127830|NCT01746017|468431202|FG001|Period 3|Withdrawal by Subject|0|||
130127831|NCT01746017|468431203|FG002|Period 3|Withdrawal by Subject|0|||
130127832|NCT01746017|468431204|FG003|Period 3|Withdrawal by Subject|0|||
130127833|NCT01746017|468431205|FG004|Period 3|Withdrawal by Subject|0|||
130127834|NCT01746017|468431206|FG005|Period 3|Withdrawal by Subject|1|||
130127835|NCT01746017|468431207|FG006|Period 3|Withdrawal by Subject|0|||
130127836|NCT01746017|468431208|FG007|Period 3|Withdrawal by Subject|0|||
130127837|NCT01746017|468431209|FG008|Period 3|Withdrawal by Subject|0|||
130127838|NCT01746017|468431210|FG009|Period 3|Withdrawal by Subject|0|||
130127839|NCT01746017|468431211|FG010|Period 3|Withdrawal by Subject|0|||
130127840|NCT00397488|468431212|FG000|Overall Study|Withdrawal by Subject|3|||
130127841|NCT00397488|468431212|FG000|Overall Study|Adverse Event|3|||
130127842|NCT00397488|468431212|FG000|Overall Study|Death|1|||
130127843|NCT02943447|468431213|FG000|Blinded Study Phase|Withdrew Consent|1|||
130127844|NCT02943447|468431214|FG001|Blinded Study Phase|Withdrew Consent|2|||
130127845|NCT02943447|468431215|FG002|Blinded Study Phase|Withdrew Consent|1|||
129969916|NCT01236352|467853037|FG004|Overall Study|Maximum clinical benefit|2|||
129969917|NCT01236352|467853038|FG005|Overall Study|Maximum clinical benefit|0|||
129969918|NCT01236352|467853039|FG006|Overall Study|Maximum clinical benefit|3|||
129969919|NCT01236352|467853040|FG007|Overall Study|Maximum clinical benefit|1|||
129969920|NCT01236352|467853041|FG008|Overall Study|Maximum clinical benefit|1|||
129969921|NCT01236352|467853042|FG009|Overall Study|Maximum clinical benefit|4|||
129969922|NCT01236352|467853043|FG010|Overall Study|Maximum clinical benefit|2|||
129969923|NCT01236352|467853033|FG000|Overall Study|Subject request to discontinue treatment|0|||
129969924|NCT01236352|467853034|FG001|Overall Study|Subject request to discontinue treatment|0|||
129969925|NCT01236352|467853035|FG002|Overall Study|Subject request to discontinue treatment|1|||
129969926|NCT01236352|467853036|FG003|Overall Study|Subject request to discontinue treatment|1|||
129969927|NCT01236352|467853037|FG004|Overall Study|Subject request to discontinue treatment|0|||
129969928|NCT01236352|467853038|FG005|Overall Study|Subject request to discontinue treatment|1|||
129969929|NCT01236352|467853039|FG006|Overall Study|Subject request to discontinue treatment|0|||
129969930|NCT01236352|467853040|FG007|Overall Study|Subject request to discontinue treatment|0|||
129969931|NCT01236352|467853041|FG008|Overall Study|Subject request to discontinue treatment|0|||
129969932|NCT01236352|467853042|FG009|Overall Study|Subject request to discontinue treatment|1|||
129969933|NCT01236352|467853043|FG010|Overall Study|Subject request to discontinue treatment|4|||
129969934|NCT01236352|467853033|FG000|Overall Study|Subject to receive drug via EAP|1|||
129969935|NCT01236352|467853034|FG001|Overall Study|Subject to receive drug via EAP|1|||
129969936|NCT01236352|467853035|FG002|Overall Study|Subject to receive drug via EAP|1|||
129969937|NCT01236352|467853036|FG003|Overall Study|Subject to receive drug via EAP|0|||
129969938|NCT01236352|467853037|FG004|Overall Study|Subject to receive drug via EAP|0|||
129969939|NCT01236352|467853038|FG005|Overall Study|Subject to receive drug via EAP|0|||
129969940|NCT01236352|467853039|FG006|Overall Study|Subject to receive drug via EAP|0|||
129969941|NCT01236352|467853040|FG007|Overall Study|Subject to receive drug via EAP|2|||
129969942|NCT01236352|467853041|FG008|Overall Study|Subject to receive drug via EAP|0|||
129969943|NCT01236352|467853042|FG009|Overall Study|Subject to receive drug via EAP|4|||
129969944|NCT01236352|467853043|FG010|Overall Study|Subject to receive drug via EAP|0|||
129969945|NCT01236352|467853033|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
129969946|NCT01236352|467853034|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
129969947|NCT01236352|467853035|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
129969948|NCT01236352|467853036|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
130127846|NCT02943447|468431213|FG000|Blinded Study Phase|Adverse Event|3|||
130127847|NCT02943447|468431214|FG001|Blinded Study Phase|Adverse Event|0|||
130127848|NCT02943447|468431215|FG002|Blinded Study Phase|Adverse Event|0|||
130127849|NCT02943447|468431213|FG000|Blinded Study Phase|Investigator's discretion|1|||
130127850|NCT02943447|468431214|FG001|Blinded Study Phase|Investigator's discretion|0|||
130127851|NCT02943447|468431215|FG002|Blinded Study Phase|Investigator's discretion|0|||
130127852|NCT02943447|468431213|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
130127853|NCT02943447|468431214|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
130127854|NCT02943447|468431215|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
130127855|NCT02943447|468431213|FG000|Open-Label Extension Phase|Adverse Event|4|||
130127856|NCT02943447|468431214|FG001|Open-Label Extension Phase|Adverse Event|7|||
130127857|NCT02943447|468431215|FG002|Open-Label Extension Phase|Adverse Event|3|||
130127858|NCT02943447|468431213|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
130127859|NCT02943447|468431214|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
130127860|NCT02943447|468431215|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
130127861|NCT02943447|468431213|FG000|Open-Label Extension Phase|Withdrew consent|1|||
130127862|NCT02943447|468431214|FG001|Open-Label Extension Phase|Withdrew consent|1|||
130127863|NCT02943447|468431215|FG002|Open-Label Extension Phase|Withdrew consent|1|||
130127864|NCT02943447|468431213|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
130127865|NCT02943447|468431214|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
130127866|NCT02943447|468431215|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130127867|NCT01294787|468431216|FG000|Period 1|Adverse Event|0|||
130127868|NCT01294787|468431217|FG001|Period 1|Adverse Event|0|||
130127869|NCT01294787|468431218|FG002|Period 1|Adverse Event|0|||
130127870|NCT01294787|468431219|FG003|Period 1|Adverse Event|0|||
130127871|NCT01294787|468431220|FG004|Period 1|Adverse Event|1|||
130127872|NCT01294787|468431221|FG005|Period 1|Adverse Event|0|||
130127873|NCT01294787|468431216|FG000|Period 1|Withdrawal by Subject|0|||
130127874|NCT01294787|468431217|FG001|Period 1|Withdrawal by Subject|0|||
130127875|NCT01294787|468431218|FG002|Period 1|Withdrawal by Subject|0|||
129969949|NCT01236352|467853037|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
129969950|NCT01236352|467853038|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
129969951|NCT01236352|467853039|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
129969952|NCT01236352|467853040|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
129969953|NCT01236352|467853041|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
129969954|NCT01236352|467853042|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
129969955|NCT01236352|467853043|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
129969956|NCT01236352|467853033|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969957|NCT01236352|467853034|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130127876|NCT01294787|468431219|FG003|Period 1|Withdrawal by Subject|1|||
130127877|NCT01294787|468431220|FG004|Period 1|Withdrawal by Subject|1|||
130127878|NCT01294787|468431221|FG005|Period 1|Withdrawal by Subject|1|||
130127879|NCT01294787|468431216|FG000|Period 1|Administrative problem|0|||
130127880|NCT01294787|468431217|FG001|Period 1|Administrative problem|0|||
130127881|NCT01294787|468431218|FG002|Period 1|Administrative problem|1|||
130127882|NCT01294787|468431219|FG003|Period 1|Administrative problem|0|||
130127883|NCT01294787|468431220|FG004|Period 1|Administrative problem|0|||
130127884|NCT01294787|468431221|FG005|Period 1|Administrative problem|1|||
130127885|NCT01294787|468431216|FG000|Period 2|Adverse Event|0|||
130127886|NCT01294787|468431217|FG001|Period 2|Adverse Event|3|||
130127887|NCT01294787|468431218|FG002|Period 2|Adverse Event|0|||
130127888|NCT01294787|468431219|FG003|Period 2|Adverse Event|1|||
130127889|NCT01294787|468431220|FG004|Period 2|Adverse Event|0|||
130127890|NCT01294787|468431221|FG005|Period 2|Adverse Event|0|||
130127891|NCT01294787|468431216|FG000|Period 2|No longer needs study drug|0|||
130127892|NCT01294787|468431217|FG001|Period 2|No longer needs study drug|0|||
130127893|NCT01294787|468431218|FG002|Period 2|No longer needs study drug|0|||
130127894|NCT01294787|468431219|FG003|Period 2|No longer needs study drug|1|||
130127895|NCT01294787|468431220|FG004|Period 2|No longer needs study drug|0|||
130127896|NCT01294787|468431221|FG005|Period 2|No longer needs study drug|0|||
130127897|NCT01294787|468431216|FG000|Period 3|Adverse Event|0|||
130127898|NCT01294787|468431217|FG001|Period 3|Adverse Event|0|||
130127899|NCT01294787|468431218|FG002|Period 3|Adverse Event|0|||
130127900|NCT01294787|468431219|FG003|Period 3|Adverse Event|0|||
130127901|NCT01294787|468431220|FG004|Period 3|Adverse Event|1|||
130127902|NCT01294787|468431221|FG005|Period 3|Adverse Event|0|||
130127903|NCT01725529|468431227|FG000|Overall Study|Adverse Event|1|||
130127904|NCT01725529|468431228|FG001|Overall Study|Adverse Event|0|||
130127905|NCT01725529|468431229|FG002|Overall Study|Adverse Event|0|||
130127906|NCT01725529|468431227|FG000|Overall Study|Lost to Follow-up|2|||
130127907|NCT01725529|468431228|FG001|Overall Study|Lost to Follow-up|1|||
130127908|NCT01725529|468431229|FG002|Overall Study|Lost to Follow-up|1|||
130127909|NCT01725529|468431227|FG000|Overall Study|Protocol Violation|0|||
130127910|NCT01725529|468431228|FG001|Overall Study|Protocol Violation|1|||
130127911|NCT01725529|468431229|FG002|Overall Study|Protocol Violation|1|||
130127912|NCT01725529|468431227|FG000|Overall Study|Withdrawal by Subject|12|||
129969958|NCT01236352|467853035|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969959|NCT01236352|467853036|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
130127913|NCT01725529|468431228|FG001|Overall Study|Withdrawal by Subject|14|||
130127914|NCT01725529|468431229|FG002|Overall Study|Withdrawal by Subject|8|||
130127915|NCT01948258|468431235|FG000|Overall Study|Pregnancy|41|||
130127916|NCT01948258|468431235|FG000|Overall Study|Did not complete by cut-off date|35|||
130127917|NCT01948258|468431235|FG000|Overall Study|Lost to Follow-up|27|||
130127918|NCT01948258|468431235|FG000|Overall Study|Withdrawal by SPD|8|||
130127919|NCT01948258|468431235|FG000|Overall Study|Withdrawal by Subject|6|||
130127920|NCT01948258|468431235|FG000|Overall Study|Health Care Professional|43|||
129969960|NCT01236352|467853037|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969961|NCT01236352|467853038|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969962|NCT01236352|467853039|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969963|NCT01236352|467853040|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969964|NCT01236352|467853041|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969965|NCT01236352|467853042|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969966|NCT01236352|467853043|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
129969967|NCT01236352|467853033|FG000|Overall Study|Lack of response to drug|0|||
129969968|NCT01236352|467853034|FG001|Overall Study|Lack of response to drug|0|||
129969969|NCT01236352|467853035|FG002|Overall Study|Lack of response to drug|0|||
129969970|NCT01236352|467853036|FG003|Overall Study|Lack of response to drug|0|||
129969971|NCT01236352|467853037|FG004|Overall Study|Lack of response to drug|0|||
129969972|NCT01236352|467853038|FG005|Overall Study|Lack of response to drug|0|||
129969973|NCT01236352|467853039|FG006|Overall Study|Lack of response to drug|0|||
129969974|NCT01236352|467853040|FG007|Overall Study|Lack of response to drug|0|||
129969975|NCT01236352|467853041|FG008|Overall Study|Lack of response to drug|0|||
129969976|NCT01236352|467853042|FG009|Overall Study|Lack of response to drug|1|||
129969977|NCT01236352|467853043|FG010|Overall Study|Lack of response to drug|1|||
129969978|NCT01236352|467853033|FG000|Overall Study|Patient transferred to IST|0|||
130127921|NCT01948258|468431235|FG000|Overall Study|Removed from statistical analysis|2|||
130127922|NCT04657770|468431236|FG000|Overall Study|Withdrawal by Subject|3|||
130127923|NCT04657770|468431236|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
130127924|NCT03655106|468431237|FG000|Overall Study|Withdrawal by Subject|3|||
130127925|NCT03655106|468431238|FG001|Overall Study|Withdrawal by Subject|2|||
130127926|NCT03655106|468431237|FG000|Overall Study|Lost to Follow-up|2|||
130127927|NCT03655106|468431238|FG001|Overall Study|Lost to Follow-up|1|||
130127928|NCT03655106|468431237|FG000|Overall Study|Duplicate Enrollment|1|||
130127929|NCT03655106|468431238|FG001|Overall Study|Duplicate Enrollment|1|||
130127930|NCT03655106|468431237|FG000|Overall Study|Protocol Violation|3|||
130127931|NCT03655106|468431238|FG001|Overall Study|Protocol Violation|0|||
130127932|NCT03785548|468431239|FG000|Overall Study|age > 80|1|||
130127933|NCT03785548|468431240|FG001|Overall Study|age > 80|0|||
130127934|NCT03785548|468431239|FG000|Overall Study|no Postop queries|1|||
130127935|NCT03785548|468431240|FG001|Overall Study|no Postop queries|0|||
130127936|NCT00667095|468431250|FG000|Overall Study|Withdrawal by Subject|0|||
130127937|NCT00667095|468431251|FG001|Overall Study|Withdrawal by Subject|1|||
130127938|NCT01882257|468431252|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
130127939|NCT01882257|468431253|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
130127940|NCT01882257|468431254|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
130127941|NCT01882257|468431252|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
130127942|NCT01882257|468431253|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
130127943|NCT01882257|468431254|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
130127944|NCT00496964|468431260|FG000|Overall Study|Withdrawal by Subject|0|||
130127945|NCT00496964|468431261|FG001|Overall Study|Withdrawal by Subject|1|||
130127946|NCT02058498|468431262|FG000|Overall Study|Withdrawal by Subject|4|||
130127947|NCT05327491|468431263|FG000|Periods 1 & 2|Miscellaneous|0|||
130127948|NCT05327491|468431264|FG001|Periods 1 & 2|Miscellaneous|1|||
130127949|NCT05327491|468431265|FG002|Periods 1 & 2|Miscellaneous|0|||
130127950|NCT05327491|468431266|FG003|Periods 1 & 2|Miscellaneous|0|||
130127951|NCT05327491|468431263|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
130127952|NCT05327491|468431264|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
130127953|NCT05327491|468431265|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
130127954|NCT05327491|468431266|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
130127955|NCT05038293|468431267|FG000|Overall Study|device was not operating properly for one subject.|1|||
130127956|NCT05038293|468431268|FG001|Overall Study|device was not operating properly for one subject.|0|||
130127957|NCT05038293|468431267|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
130127958|NCT05038293|468431268|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
130127959|NCT01171989|468431269|FG000|Overall Study|Lost to Follow-up|0|||
130127960|NCT01171989|468431270|FG001|Overall Study|Lost to Follow-up|0|||
130127961|NCT01171989|468431271|FG002|Overall Study|Lost to Follow-up|1|||
130127962|NCT01247701|468431274|FG000|Overall Study|Death|2|||
130127963|NCT01247701|468431274|FG000|Overall Study|Relapsed|8|||
130127964|NCT04166630|468431275|FG000|Overall Study|Withdrawal by Subject|0|||
130127965|NCT04166630|468431276|FG001|Overall Study|Withdrawal by Subject|1|||
130127966|NCT00096447|468431277|FG000|Overall Study|Never treated|1|||
130127967|NCT04088760|468431278|FG000|Overall Study|Physician Decision|1|||
130127968|NCT00184600|468431279|FG000|Overall Study|Adverse Event|9|||
130127969|NCT00184600|468431280|FG001|Overall Study|Adverse Event|0|||
129969979|NCT01236352|467853034|FG001|Overall Study|Patient transferred to IST|0|||
129969980|NCT01236352|467853035|FG002|Overall Study|Patient transferred to IST|0|||
130127970|NCT00184600|468431281|FG002|Overall Study|Adverse Event|5|||
130127971|NCT00184600|468431279|FG000|Overall Study|Death|3|||
130127972|NCT00184600|468431280|FG001|Overall Study|Death|9|||
130127973|NCT00184600|468431281|FG002|Overall Study|Death|7|||
130127974|NCT00184600|468431279|FG000|Overall Study|Lack of Efficacy|3|||
130127975|NCT00184600|468431280|FG001|Overall Study|Lack of Efficacy|1|||
130127976|NCT00184600|468431281|FG002|Overall Study|Lack of Efficacy|3|||
130127977|NCT00184600|468431279|FG000|Overall Study|Lost to Follow-up|4|||
130127978|NCT00184600|468431280|FG001|Overall Study|Lost to Follow-up|6|||
130127979|NCT00184600|468431281|FG002|Overall Study|Lost to Follow-up|1|||
130127980|NCT00184600|468431279|FG000|Overall Study|Protocol Violation|2|||
130127981|NCT00184600|468431280|FG001|Overall Study|Protocol Violation|2|||
130127982|NCT00184600|468431281|FG002|Overall Study|Protocol Violation|3|||
129969981|NCT01236352|467853036|FG003|Overall Study|Patient transferred to IST|0|||
129969982|NCT01236352|467853037|FG004|Overall Study|Patient transferred to IST|0|||
129969983|NCT01236352|467853038|FG005|Overall Study|Patient transferred to IST|0|||
129969984|NCT01236352|467853039|FG006|Overall Study|Patient transferred to IST|0|||
129969985|NCT01236352|467853040|FG007|Overall Study|Patient transferred to IST|0|||
129969986|NCT01236352|467853041|FG008|Overall Study|Patient transferred to IST|0|||
129969987|NCT01236352|467853042|FG009|Overall Study|Patient transferred to IST|2|||
129969988|NCT01236352|467853043|FG010|Overall Study|Patient transferred to IST|6|||
129969989|NCT01575873|467853044|FG000|Overall Study|Withdrawal by Subject|15|||
129969990|NCT01575873|467853045|FG001|Overall Study|Withdrawal by Subject|20|||
129969991|NCT01575873|467853046|FG002|Overall Study|Withdrawal by Subject|34|||
129969992|NCT01575873|467853047|FG003|Overall Study|Withdrawal by Subject|34|||
129969993|NCT01575873|467853044|FG000|Overall Study|Adverse Event|7|||
129969994|NCT01575873|467853045|FG001|Overall Study|Adverse Event|7|||
129969995|NCT01575873|467853046|FG002|Overall Study|Adverse Event|9|||
129969996|NCT01575873|467853047|FG003|Overall Study|Adverse Event|12|||
129969997|NCT01575873|467853044|FG000|Overall Study|Lost to Follow-up|1|||
129969998|NCT01575873|467853045|FG001|Overall Study|Lost to Follow-up|3|||
129969999|NCT01575873|467853046|FG002|Overall Study|Lost to Follow-up|13|||
129970000|NCT01575873|467853047|FG003|Overall Study|Lost to Follow-up|5|||
129970001|NCT01575873|467853044|FG000|Overall Study|Death|3|||
129970002|NCT01575873|467853045|FG001|Overall Study|Death|2|||
129970003|NCT01575873|467853046|FG002|Overall Study|Death|8|||
129970004|NCT01575873|467853047|FG003|Overall Study|Death|9|||
129970005|NCT01575873|467853044|FG000|Overall Study|Noncompliance|1|||
129970006|NCT01575873|467853045|FG001|Overall Study|Noncompliance|2|||
129970007|NCT01575873|467853046|FG002|Overall Study|Noncompliance|4|||
129970008|NCT01575873|467853047|FG003|Overall Study|Noncompliance|3|||
129970009|NCT01575873|467853044|FG000|Overall Study|Administrative decision|1|||
129970010|NCT01575873|467853045|FG001|Overall Study|Administrative decision|1|||
129970011|NCT01575873|467853046|FG002|Overall Study|Administrative decision|1|||
129970012|NCT01575873|467853047|FG003|Overall Study|Administrative decision|0|||
129970013|NCT01575873|467853044|FG000|Overall Study|Protocol deviation|0|||
129970014|NCT01575873|467853045|FG001|Overall Study|Protocol deviation|1|||
129970015|NCT01575873|467853046|FG002|Overall Study|Protocol deviation|0|||
129970016|NCT01575873|467853047|FG003|Overall Study|Protocol deviation|1|||
129970017|NCT01575873|467853044|FG000|Overall Study|Requirement for Alternative Therapy|0|||
129970018|NCT01575873|467853045|FG001|Overall Study|Requirement for Alternative Therapy|0|||
129970019|NCT01575873|467853046|FG002|Overall Study|Requirement for Alternative Therapy|1|||
129970020|NCT01575873|467853047|FG003|Overall Study|Requirement for Alternative Therapy|1|||
129970021|NCT01575873|467853044|FG000|Overall Study|Other|0|||
129970022|NCT01575873|467853045|FG001|Overall Study|Other|0|||
129970023|NCT01575873|467853046|FG002|Overall Study|Other|4|||
129970024|NCT01575873|467853047|FG003|Overall Study|Other|2|||
129970025|NCT00965497|467853048|FG000|Overall Study|Physician Decision|1|||
129970026|NCT00246090|467853053|FG000|Overall Study|Adverse Event|25|||
129970027|NCT00246090|467853053|FG000|Overall Study|Withdrawal by Subject|7|||
129970028|NCT00246090|467853053|FG000|Overall Study|Progressive Disease|212|||
129970029|NCT00246090|467853053|FG000|Overall Study|Clinical Progression|30|||
129970030|NCT00246090|467853053|FG000|Overall Study|Physician Decision|11|||
129970031|NCT00246090|467853053|FG000|Overall Study|Not Otherwise Specified|10|||
129970032|NCT02734004|467853054|FG000|Overall Study|Death|36|||
129970033|NCT02734004|467853055|FG001|Overall Study|Death|24|||
129970034|NCT02734004|467853056|FG002|Overall Study|Death|26|||
129970035|NCT02734004|467853057|FG003|Overall Study|Death|35|||
130127983|NCT00184600|468431279|FG000|Overall Study|Withdrawal by Subject|20|||
130127984|NCT00184600|468431280|FG001|Overall Study|Withdrawal by Subject|28|||
130127985|NCT00184600|468431281|FG002|Overall Study|Withdrawal by Subject|12|||
129970036|NCT02734004|467853058|FG004|Overall Study|Death|13|||
129970037|NCT02734004|467853059|FG005|Overall Study|Death|17|||
129970038|NCT02734004|467853060|FG006|Overall Study|Death|20|||
129970039|NCT02734004|467853054|FG000|Overall Study|Lost to Follow-up|1|||
129970040|NCT02734004|467853055|FG001|Overall Study|Lost to Follow-up|1|||
129970041|NCT02734004|467853056|FG002|Overall Study|Lost to Follow-up|0|||
129970042|NCT02734004|467853057|FG003|Overall Study|Lost to Follow-up|0|||
129970043|NCT02734004|467853058|FG004|Overall Study|Lost to Follow-up|1|||
129970044|NCT02734004|467853059|FG005|Overall Study|Lost to Follow-up|0|||
129970045|NCT02734004|467853060|FG006|Overall Study|Lost to Follow-up|0|||
129970046|NCT02734004|467853054|FG000|Overall Study|Withdrawal by Subject|3|||
130127986|NCT00184600|468431279|FG000|Overall Study|Unclassified|4|||
130127987|NCT00184600|468431280|FG001|Overall Study|Unclassified|5|||
129970047|NCT02734004|467853055|FG001|Overall Study|Withdrawal by Subject|1|||
129970048|NCT02734004|467853056|FG002|Overall Study|Withdrawal by Subject|1|||
129970049|NCT02734004|467853057|FG003|Overall Study|Withdrawal by Subject|1|||
129970050|NCT02734004|467853058|FG004|Overall Study|Withdrawal by Subject|3|||
129970051|NCT02734004|467853059|FG005|Overall Study|Withdrawal by Subject|0|||
129970052|NCT02734004|467853060|FG006|Overall Study|Withdrawal by Subject|2|||
129970053|NCT02734004|467853054|FG000|Overall Study|Other|0|||
129970054|NCT02734004|467853055|FG001|Overall Study|Other|8|||
129970055|NCT02734004|467853056|FG002|Overall Study|Other|7|||
129970056|NCT02734004|467853057|FG003|Overall Study|Other|4|||
129970057|NCT02734004|467853058|FG004|Overall Study|Other|34|||
129970058|NCT02734004|467853059|FG005|Overall Study|Other|14|||
129970059|NCT02734004|467853060|FG006|Overall Study|Other|10|||
129970060|NCT01536171|467853061|FG000|Overall Study|Withdrawal by Subject|1|||
129970061|NCT01018732|467853062|FG000|Overall Study|Lost to Follow-up|0|||
129970062|NCT01018732|467853063|FG001|Overall Study|Lost to Follow-up|0|||
129970063|NCT01018732|467853064|FG002|Overall Study|Lost to Follow-up|3|||
129970064|NCT01018732|467853062|FG000|Overall Study|Protocol Violation|1|||
129970065|NCT01018732|467853063|FG001|Overall Study|Protocol Violation|1|||
129970066|NCT01018732|467853064|FG002|Overall Study|Protocol Violation|0|||
129970067|NCT01018732|467853062|FG000|Overall Study|Inappropriate Enrollment|0|||
129970068|NCT01018732|467853063|FG001|Overall Study|Inappropriate Enrollment|1|||
129970069|NCT01018732|467853064|FG002|Overall Study|Inappropriate Enrollment|0|||
129970070|NCT01018732|467853062|FG000|Overall Study|Unable to Classify|0|||
129970071|NCT01018732|467853063|FG001|Overall Study|Unable to Classify|0|||
130127988|NCT00184600|468431281|FG002|Overall Study|Unclassified|3|||
130127989|NCT00286754|468431282|FG000|Overall Study|Adverse Event|2|||
130127990|NCT00286754|468431283|FG001|Overall Study|Adverse Event|2|||
130127991|NCT00286754|468431284|FG002|Overall Study|Adverse Event|3|||
129970072|NCT01018732|467853064|FG002|Overall Study|Unable to Classify|1|||
129970073|NCT05990387|467853065|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
129970074|NCT05990387|467853066|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
129970075|NCT01806389|467853067|FG000|Overall Study|Withdrawal by Subject|4|||
129970076|NCT00936598|467853070|FG000|Overall Study|Withdrawal by Subject|1|||
129970077|NCT00936598|467853071|FG001|Overall Study|Withdrawal by Subject|0|||
129970078|NCT00936598|467853070|FG000|Overall Study|Ineligible after consent|1|||
129970079|NCT00936598|467853071|FG001|Overall Study|Ineligible after consent|0|||
129970080|NCT01310699|467853072|FG000|Overall Study|Patients did not complete tandem.|4|||
129970081|NCT01310699|467853073|FG001|Overall Study|Patients did not complete tandem.|6|||
129970082|NCT00926575|467853074|FG000|Overall Study|Adverse Event|1|||
129970083|NCT00926575|467853075|FG001|Overall Study|Adverse Event|1|||
129970084|NCT00926575|467853074|FG000|Overall Study|Death|4|||
129970085|NCT00926575|467853075|FG001|Overall Study|Death|4|||
129970086|NCT00926575|467853074|FG000|Overall Study|Lost to Follow-up|1|||
129970087|NCT00926575|467853075|FG001|Overall Study|Lost to Follow-up|1|||
129970088|NCT00926575|467853074|FG000|Overall Study|Physician Decision|1|||
129970089|NCT00926575|467853075|FG001|Overall Study|Physician Decision|2|||
129970090|NCT00926575|467853074|FG000|Overall Study|Protocol Violation|1|||
129970091|NCT00926575|467853075|FG001|Overall Study|Protocol Violation|0|||
130127992|NCT00286754|468431282|FG000|Overall Study|Withdrawal by Subject|6|||
130127993|NCT00286754|468431283|FG001|Overall Study|Withdrawal by Subject|2|||
130127994|NCT00286754|468431284|FG002|Overall Study|Withdrawal by Subject|0|||
130127995|NCT00286754|468431282|FG000|Overall Study|Lost to Follow-up|12|||
130127996|NCT00286754|468431283|FG001|Overall Study|Lost to Follow-up|14|||
130127997|NCT00286754|468431284|FG002|Overall Study|Lost to Follow-up|6|||
130127998|NCT00286754|468431282|FG000|Overall Study|Moved out of state|0|||
130127999|NCT00286754|468431283|FG001|Overall Study|Moved out of state|0|||
130128000|NCT00286754|468431284|FG002|Overall Study|Moved out of state|1|||
130128001|NCT02336165|468431285|FG000|Overall Study|Death|3|||
130128002|NCT02336165|468431286|FG001|Overall Study|Death|0|||
130128003|NCT02336165|468431287|FG002|Overall Study|Death|0|||
130128004|NCT02336165|468431288|FG003|Overall Study|Death|0|||
130128005|NCT02336165|468431289|FG004|Overall Study|Death|1|||
130128006|NCT02336165|468431285|FG000|Overall Study|Physician Decision|2|||
130128007|NCT02336165|468431286|FG001|Overall Study|Physician Decision|2|||
130128008|NCT02336165|468431287|FG002|Overall Study|Physician Decision|1|||
129970092|NCT00926575|467853074|FG000|Overall Study|Withdrawal by Subject|8|||
129970093|NCT00926575|467853075|FG001|Overall Study|Withdrawal by Subject|9|||
129970094|NCT02201901|467853078|FG000|Overall Study|Randomized but never treated|0|||
129970095|NCT02201901|467853079|FG001|Overall Study|Randomized but never treated|1|||
129970096|NCT02201901|467853080|FG002|Overall Study|Randomized but never treated|0|||
129970097|NCT02201901|467853078|FG000|Overall Study|Lack of Efficacy|7|||
129970098|NCT02201901|467853079|FG001|Overall Study|Lack of Efficacy|1|||
129970099|NCT02201901|467853080|FG002|Overall Study|Lack of Efficacy|6|||
130128009|NCT02336165|468431288|FG003|Overall Study|Physician Decision|1|||
129970100|NCT02201901|467853078|FG000|Overall Study|Death|3|||
129970101|NCT02201901|467853079|FG001|Overall Study|Death|3|||
129970102|NCT02201901|467853080|FG002|Overall Study|Death|3|||
130128010|NCT02336165|468431289|FG004|Overall Study|Physician Decision|0|||
130128011|NCT02336165|468431285|FG000|Overall Study|Withdrawal by Subject|0|||
129970103|NCT02201901|467853078|FG000|Overall Study|Lost to Follow-up|2|||
129970104|NCT02201901|467853079|FG001|Overall Study|Lost to Follow-up|3|||
129970105|NCT02201901|467853080|FG002|Overall Study|Lost to Follow-up|2|||
130093438|NCT01072175|468296952|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093439|NCT01072175|468296953|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093440|NCT01072175|468296954|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093441|NCT01072175|468296955|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093442|NCT01072175|468296956|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093443|NCT01072175|468296957|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093444|NCT01072175|468296958|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093445|NCT01072175|468296959|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
130093446|NCT01072175|468296947|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093447|NCT01072175|468296948|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
130093448|NCT01072175|468296949|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093449|NCT01072175|468296950|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
130093450|NCT01072175|468296951|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
130093451|NCT01072175|468296952|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093452|NCT01072175|468296953|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093453|NCT01072175|468296954|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093454|NCT01072175|468296955|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093455|NCT01072175|468296956|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093456|NCT01072175|468296957|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093457|NCT01072175|468296958|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093458|NCT01072175|468296959|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
130093459|NCT01072175|468296947|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093460|NCT01072175|468296948|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093461|NCT01072175|468296949|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
130093462|NCT01072175|468296950|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
130093463|NCT01072175|468296951|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
130093464|NCT01072175|468296952|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093465|NCT01072175|468296953|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093466|NCT01072175|468296954|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093467|NCT01072175|468296955|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093468|NCT01072175|468296956|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093469|NCT01072175|468296957|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093470|NCT01072175|468296958|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093471|NCT01072175|468296959|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
130093472|NCT01072175|468296947|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093473|NCT01072175|468296948|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
130093474|NCT01072175|468296949|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093475|NCT01072175|468296950|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
130093476|NCT01072175|468296951|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
130093477|NCT01072175|468296952|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093478|NCT01072175|468296953|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093479|NCT01072175|468296954|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093480|NCT01072175|468296955|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093481|NCT01072175|468296956|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093482|NCT01072175|468296957|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093483|NCT01072175|468296958|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093484|NCT01072175|468296959|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
130093485|NCT01072175|468296947|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
130093486|NCT01072175|468296948|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
130093487|NCT01072175|468296949|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
130093488|NCT01072175|468296950|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
130093489|NCT01072175|468296951|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
130093490|NCT01072175|468296952|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
130093491|NCT01072175|468296953|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
130093492|NCT01072175|468296954|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
130093493|NCT01072175|468296955|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
130093494|NCT01072175|468296956|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
130093495|NCT01072175|468296957|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
130093496|NCT01072175|468296958|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
130093497|NCT01072175|468296959|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
130093498|NCT01072175|468296947|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093499|NCT01072175|468296948|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129970106|NCT02201901|467853078|FG000|Overall Study|Withdrew Consent|2|||
130128012|NCT02336165|468431286|FG001|Overall Study|Withdrawal by Subject|0|||
130128013|NCT02336165|468431287|FG002|Overall Study|Withdrawal by Subject|1|||
129970107|NCT02201901|467853079|FG001|Overall Study|Withdrew Consent|0|||
129970108|NCT02201901|467853080|FG002|Overall Study|Withdrew Consent|2|||
129970109|NCT02201901|467853078|FG000|Overall Study|Adverse Event|1|||
129970110|NCT02201901|467853079|FG001|Overall Study|Adverse Event|1|||
129970111|NCT02201901|467853080|FG002|Overall Study|Adverse Event|0|||
129970112|NCT02633397|467853082|FG000|Overall Study|Adverse Event|8|||
129970113|NCT02633397|467853083|FG001|Overall Study|Adverse Event|8|||
129970114|NCT02633397|467853082|FG000|Overall Study|Study Burden|4|||
129970115|NCT02633397|467853083|FG001|Overall Study|Study Burden|1|||
129970116|NCT02633397|467853082|FG000|Overall Study|Treatment interruption|2|||
129970117|NCT02633397|467853083|FG001|Overall Study|Treatment interruption|5|||
130128014|NCT02336165|468431288|FG003|Overall Study|Withdrawal by Subject|0|||
130128015|NCT02336165|468431289|FG004|Overall Study|Withdrawal by Subject|1|||
130128016|NCT02336165|468431285|FG000|Overall Study|Adverse Event|4|||
130128017|NCT02336165|468431286|FG001|Overall Study|Adverse Event|1|||
130128018|NCT02336165|468431287|FG002|Overall Study|Adverse Event|2|||
130128019|NCT02336165|468431288|FG003|Overall Study|Adverse Event|4|||
130128020|NCT02336165|468431289|FG004|Overall Study|Adverse Event|1|||
130128021|NCT02336165|468431285|FG000|Overall Study|Progressive disease|23|||
130128022|NCT02336165|468431286|FG001|Overall Study|Progressive disease|22|||
130128023|NCT02336165|468431287|FG002|Overall Study|Progressive disease|27|||
130128024|NCT02336165|468431288|FG003|Overall Study|Progressive disease|24|||
129970118|NCT02633397|467853082|FG000|Overall Study|Death|2|||
129970119|NCT02633397|467853083|FG001|Overall Study|Death|2|||
129970120|NCT02633397|467853082|FG000|Overall Study|Physician Decision|0|||
129970121|NCT02633397|467853083|FG001|Overall Study|Physician Decision|1|||
129970122|NCT03595878|467853084|FG000|Overall Study|Death|2|||
129970123|NCT03595878|467853085|FG001|Overall Study|Death|1|||
129970124|NCT03595878|467853086|FG002|Overall Study|Death|0|||
129970125|NCT03595878|467853084|FG000|Overall Study|Disease progression|2|||
129970126|NCT03595878|467853085|FG001|Overall Study|Disease progression|1|||
129970127|NCT03595878|467853086|FG002|Overall Study|Disease progression|2|||
129970128|NCT03494985|467853087|FG000|Overall Study|Adverse Event|3|||
129970129|NCT03494985|467853088|FG001|Overall Study|Adverse Event|2|||
129970130|NCT03494985|467853089|FG002|Overall Study|Adverse Event|3|||
129970131|NCT03494985|467853090|FG003|Overall Study|Adverse Event|0|||
129970132|NCT03494985|467853087|FG000|Overall Study|Other (Withdrawal of consent)|2|||
129970133|NCT03494985|467853088|FG001|Overall Study|Other (Withdrawal of consent)|3|||
129970134|NCT03494985|467853089|FG002|Overall Study|Other (Withdrawal of consent)|2|||
129970135|NCT03494985|467853090|FG003|Overall Study|Other (Withdrawal of consent)|5|||
129970136|NCT03494985|467853087|FG000|Overall Study|Other (Not specified)|0|||
129970137|NCT03494985|467853088|FG001|Overall Study|Other (Not specified)|1|||
129970138|NCT03494985|467853089|FG002|Overall Study|Other (Not specified)|1|||
129970139|NCT03494985|467853090|FG003|Overall Study|Other (Not specified)|0|||
129970140|NCT03036124|467853091|FG000|Overall Study|Lost to Follow-up|0|||
129970141|NCT03036124|467853092|FG001|Overall Study|Lost to Follow-up|2|||
129970142|NCT03036124|467853091|FG000|Overall Study|Withdrawal by Subject|5|||
129970143|NCT03036124|467853092|FG001|Overall Study|Withdrawal by Subject|4|||
129970144|NCT02394925|467853093|FG000|Overall Study|Adverse Event|1|||
129970145|NCT02394925|467853093|FG000|Overall Study|Lens Discomfort|3|||
129970146|NCT02394925|467853093|FG000|Overall Study|Lens handling difficulities|5|||
129970147|NCT02394925|467853093|FG000|Overall Study|Lost to Follow-up|9|||
129970148|NCT02394925|467853093|FG000|Overall Study|Protocol Violation|5|||
129970149|NCT02394925|467853093|FG000|Overall Study|No longer meet eligibility criteria|1|||
129970150|NCT02394925|467853093|FG000|Overall Study|Unsatisfactory Visual Response|5|||
130128025|NCT02336165|468431289|FG004|Overall Study|Progressive disease|19|||
130128026|NCT02336165|468431285|FG000|Overall Study|Non-compliance|1|||
130128027|NCT02336165|468431286|FG001|Overall Study|Non-compliance|0|||
129970151|NCT00966264|467854585|FG000|Overall Study|Lost to Follow-up|4|||
129970152|NCT00966264|467854586|FG001|Overall Study|Lost to Follow-up|3|||
129970153|NCT01246999|467854587|FG000|Overall Study|Lost to Follow-up|0|||
129970154|NCT01246999|467854588|FG001|Overall Study|Lost to Follow-up|1|||
129970155|NCT01246999|467854589|FG002|Overall Study|Lost to Follow-up|0|||
130128028|NCT02336165|468431287|FG002|Overall Study|Non-compliance|0|||
129970156|NCT01246999|467854590|FG003|Overall Study|Lost to Follow-up|0|||
130128029|NCT02336165|468431288|FG003|Overall Study|Non-compliance|1|||
129970157|NCT01246999|467854587|FG000|Overall Study|Withdrawal by Subject|0|||
129970158|NCT01246999|467854588|FG001|Overall Study|Withdrawal by Subject|0|||
130128030|NCT02336165|468431289|FG004|Overall Study|Non-compliance|0|||
129970159|NCT01246999|467854589|FG002|Overall Study|Withdrawal by Subject|0|||
129970160|NCT01246999|467854590|FG003|Overall Study|Withdrawal by Subject|2|||
129970161|NCT01867047|467854591|FG000|Overall Study|Lost to Follow-up|3|||
129970162|NCT01867047|467854592|FG001|Overall Study|Lost to Follow-up|3|||
130128031|NCT02336165|468431285|FG000|Overall Study|Other|1|||
129970163|NCT01867047|467854591|FG000|Overall Study|Withdrawal by Subject|2|||
129970164|NCT01867047|467854592|FG001|Overall Study|Withdrawal by Subject|0|||
130128032|NCT02336165|468431286|FG001|Overall Study|Other|0|||
129970165|NCT01867047|467854591|FG000|Overall Study|Physician Decision|2|||
129970166|NCT01867047|467854592|FG001|Overall Study|Physician Decision|0|||
129970167|NCT01867047|467854591|FG000|Overall Study|surgery not indicated in protocol|1|||
129970168|NCT01867047|467854592|FG001|Overall Study|surgery not indicated in protocol|2|||
129970169|NCT04596995|467854593|FG000|Overall Study|Lack of Efficacy|8|||
129970170|NCT04596995|467854593|FG000|Overall Study|Lost to Follow-up|3|||
129970171|NCT04596995|467854593|FG000|Overall Study|Withdrawal by Subject|12|||
129970172|NCT04596995|467854593|FG000|Overall Study|Sponsor decision|3|||
129970173|NCT04596995|467854593|FG000|Overall Study|Enrolled in managed access program|3|||
129970174|NCT00590564|467854595|FG000|Overall Study|Withdrawal by Subject|4|||
129970175|NCT00590564|467854595|FG000|Overall Study|Lost to Follow-up|6|||
129970176|NCT00590564|467854595|FG000|Overall Study|Protocol Violation|1|||
129970177|NCT00590564|467854595|FG000|Overall Study|Patient Found to be Ineligible|1|||
129970178|NCT00590564|467854595|FG000|Overall Study|Patient Non-compliance|6|||
129970179|NCT03020069|467854599|FG000|Overall Study|Lost to Follow-up|0|||
129970180|NCT03020069|467854600|FG001|Overall Study|Lost to Follow-up|1|||
129970181|NCT01907906|467854604|FG000|Overall Study|Withdrawal by Subject|1|||
129970182|NCT01907906|467854605|FG001|Overall Study|Withdrawal by Subject|0|||
129970183|NCT01907906|467854604|FG000|Overall Study|Physician Decision|3|||
129970184|NCT01907906|467854605|FG001|Overall Study|Physician Decision|1|||
129970185|NCT02786004|467854606|FG000|Overall Study|Withdrawal by Subject|0|||
129970186|NCT02786004|467854607|FG001|Overall Study|Withdrawal by Subject|1|||
129970187|NCT01013961|467854611|FG000|Overall Study|Adverse Event|2|||
129970188|NCT01013961|467854612|FG001|Overall Study|Adverse Event|2|||
129970189|NCT01013961|467854611|FG000|Overall Study|Withdrawal by Subject|1|||
129970190|NCT01013961|467854612|FG001|Overall Study|Withdrawal by Subject|0|||
129970191|NCT01013961|467854611|FG000|Overall Study|Physician Decision|0|||
129970192|NCT01013961|467854612|FG001|Overall Study|Physician Decision|1|||
129970193|NCT00559377|467854613|FG000|Overall Study|Withdrawal by Subject|9|||
130093500|NCT01072175|468296949|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129970194|NCT00940875|467854614|FG000|Treatment Phase|Adverse Event|9|||
129970195|NCT00940875|467854615|FG001|Treatment Phase|Adverse Event|3|||
129970196|NCT00940875|467854614|FG000|Treatment Phase|Death|3|||
129970197|NCT00940875|467854615|FG001|Treatment Phase|Death|5|||
129970198|NCT00940875|467854614|FG000|Treatment Phase|Lack of Efficacy|1|||
129970199|NCT00940875|467854615|FG001|Treatment Phase|Lack of Efficacy|0|||
129970200|NCT00940875|467854614|FG000|Treatment Phase|Withdrawal by Subject|3|||
130093501|NCT01072175|468296950|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093502|NCT01072175|468296951|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093503|NCT01072175|468296952|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
130093504|NCT01072175|468296953|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
130093505|NCT01072175|468296954|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
130093506|NCT01072175|468296955|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093507|NCT01072175|468296956|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093508|NCT01072175|468296957|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093509|NCT01072175|468296958|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093510|NCT01072175|468296959|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
130093511|NCT01072175|468296947|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093512|NCT01072175|468296948|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093513|NCT01072175|468296949|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093514|NCT01072175|468296950|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093515|NCT01072175|468296951|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093516|NCT01072175|468296952|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093517|NCT01072175|468296953|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
130093518|NCT01072175|468296954|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
130093519|NCT01072175|468296955|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093520|NCT01072175|468296956|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093521|NCT01072175|468296957|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093522|NCT01072175|468296958|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093523|NCT01072175|468296959|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
130093524|NCT01072175|468296947|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093525|NCT01072175|468296948|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093526|NCT01072175|468296949|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093527|NCT01072175|468296950|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093528|NCT01072175|468296951|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093529|NCT01072175|468296952|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
130093530|NCT01072175|468296953|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
130093531|NCT01072175|468296954|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
130093532|NCT01072175|468296955|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093533|NCT01072175|468296956|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093534|NCT01072175|468296957|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130128033|NCT02336165|468431287|FG002|Overall Study|Other|0|||
130128034|NCT02336165|468431288|FG003|Overall Study|Other|1|||
130128035|NCT02336165|468431289|FG004|Overall Study|Other|0|||
130128036|NCT02726581|468431292|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130128037|NCT02726581|468431293|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
130128038|NCT02726581|468431294|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130128039|NCT02726581|468431292|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
130128040|NCT02726581|468431293|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
130128041|NCT02726581|468431294|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
130128042|NCT02726581|468431292|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130128043|NCT02726581|468431293|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130128044|NCT02726581|468431294|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130128045|NCT02726581|468431292|FG000|Treatment Period|Disease progression|47|||
130128046|NCT02726581|468431293|FG001|Treatment Period|Disease progression|50|||
130128047|NCT02726581|468431294|FG002|Treatment Period|Disease progression|16|||
130128048|NCT02726581|468431292|FG000|Treatment Period|Other reasons|9|||
130128049|NCT02726581|468431293|FG001|Treatment Period|Other reasons|8|||
130128050|NCT02726581|468431294|FG002|Treatment Period|Other reasons|2|||
130128051|NCT02726581|468431292|FG000|Treatment Period|Study drug toxicity|6|||
130128052|NCT02726581|468431293|FG001|Treatment Period|Study drug toxicity|3|||
130128053|NCT02726581|468431294|FG002|Treatment Period|Study drug toxicity|2|||
130128054|NCT02726581|468431292|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
130128055|NCT02726581|468431293|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
129970201|NCT00940875|467854615|FG001|Treatment Phase|Withdrawal by Subject|0|||
129970202|NCT00940875|467854614|FG000|Treatment Phase|Disease progression|9|||
129970203|NCT00940875|467854615|FG001|Treatment Phase|Disease progression|11|||
129970204|NCT00940875|467854614|FG000|Treatment Phase|Physician Decision|1|||
129970205|NCT00940875|467854615|FG001|Treatment Phase|Physician Decision|0|||
129970206|NCT00940875|467854614|FG000|Post-Study Treatment|Death|0|||
129970207|NCT00940875|467854615|FG001|Post-Study Treatment|Death|1|||
129970208|NCT00940875|467854614|FG000|Post-Study Treatment|Disease Progression|0|||
129970209|NCT00940875|467854615|FG001|Post-Study Treatment|Disease Progression|2|||
129970210|NCT00490945|467854616|FG000|Overall Study|Adverse Event|0|||
129970211|NCT00490945|467854617|FG001|Overall Study|Adverse Event|1|||
129970212|NCT00490945|467854618|FG002|Overall Study|Adverse Event|0|||
129970213|NCT00490945|467854619|FG003|Overall Study|Adverse Event|0|||
129970214|NCT00490945|467854620|FG004|Overall Study|Adverse Event|0|||
129970215|NCT02879383|467854628|FG000|First 24 Weeks|Physician Decision|0|||
129970216|NCT02879383|467854629|FG001|First 24 Weeks|Physician Decision|1|||
129970217|NCT02879383|467854630|FG002|First 24 Weeks|Physician Decision|0|||
129970218|NCT02879383|467854631|FG003|First 24 Weeks|Physician Decision|0|||
129970219|NCT03016598|467854641|FG000|Overall Study|Lost to Follow-up|0|||
129970220|NCT03016598|467854642|FG001|Overall Study|Lost to Follow-up|2|||
129970221|NCT02947100|467854643|FG000|Overall Study|study terminated early|3|||
129970222|NCT02947100|467854643|FG000|Overall Study|did not meet inclusion criteria|1|||
129970223|NCT00742326|467854646|FG000|Overall Study|Physician Decision|0|||
129970224|NCT00742326|467854647|FG001|Overall Study|Physician Decision|1|||
129970225|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
129970226|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
129970227|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
129970228|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
129970229|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
129970230|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
129970231|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
129970232|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
129970233|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
129970234|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
129970235|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
129970236|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
130128056|NCT02726581|468431294|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
130128057|NCT02726581|468431292|FG000|Treatment Period|Participant withdrew consent|3|||
130128058|NCT02726581|468431293|FG001|Treatment Period|Participant withdrew consent|1|||
130128059|NCT02726581|468431294|FG002|Treatment Period|Participant withdrew consent|1|||
130128060|NCT02726581|468431292|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
130128061|NCT02726581|468431293|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
130128062|NCT02726581|468431294|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
130128063|NCT02726581|468431292|FG000|Treatment Period|Maximum clinical benefit|0|||
130128064|NCT02726581|468431293|FG001|Treatment Period|Maximum clinical benefit|2|||
129970237|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
130128065|NCT02726581|468431294|FG002|Treatment Period|Maximum clinical benefit|0|||
129970238|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
129970239|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
129970240|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
129970241|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
129970242|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
129970243|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Missing|2|||
129970244|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Missing|1|||
129970245|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
129970246|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
129970247|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
129970248|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
129970249|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
129970250|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
130128066|NCT02726581|468431292|FG000|Treatment Period|Death|1|||
130128067|NCT02726581|468431293|FG001|Treatment Period|Death|0|||
130128068|NCT02726581|468431294|FG002|Treatment Period|Death|0|||
130128069|NCT02726581|468431292|FG000|Treatment Period|Poor/non-compliance|1|||
130128070|NCT02726581|468431293|FG001|Treatment Period|Poor/non-compliance|0|||
130128071|NCT02726581|468431294|FG002|Treatment Period|Poor/non-compliance|0|||
130128072|NCT02726581|468431292|FG000|Treatment Period|Participant no longer meets study criteria|0|||
130128073|NCT02726581|468431293|FG001|Treatment Period|Participant no longer meets study criteria|1|||
130128074|NCT02726581|468431294|FG002|Treatment Period|Participant no longer meets study criteria|0|||
130128075|NCT00552669|468431298|FG000|Overall Study|Death|3|||
129970251|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
129970252|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
129970253|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
129970254|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
129970255|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
129970256|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
129970257|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
129970258|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
129970259|NCT00409409|467854651|FG000|Overall Study|Adverse Event|7|||
129970260|NCT00409409|467854652|FG001|Overall Study|Adverse Event|2|||
129970261|NCT00409409|467854651|FG000|Overall Study|Withdrawal by Subject|1|||
129970262|NCT00409409|467854652|FG001|Overall Study|Withdrawal by Subject|1|||
129970263|NCT00409409|467854651|FG000|Overall Study|Any other reason not above-mentioned|0|||
129970264|NCT00409409|467854652|FG001|Overall Study|Any other reason not above-mentioned|1|||
129970265|NCT03635086|467854656|FG000|Overall Study|Withdrawal of consent|0|||
129970266|NCT03635086|467854657|FG001|Overall Study|Withdrawal of consent|0|||
129970267|NCT03635086|467854658|FG002|Overall Study|Withdrawal of consent|1|||
129970268|NCT03635086|467854659|FG003|Overall Study|Withdrawal of consent|0|||
129970269|NCT03635086|467854660|FG004|Overall Study|Withdrawal of consent|0|||
129970270|NCT03635086|467854656|FG000|Overall Study|Adverse Event|0|||
129970271|NCT03635086|467854657|FG001|Overall Study|Adverse Event|1|||
129970272|NCT03635086|467854658|FG002|Overall Study|Adverse Event|0|||
129970273|NCT03635086|467854659|FG003|Overall Study|Adverse Event|0|||
129970274|NCT03635086|467854660|FG004|Overall Study|Adverse Event|0|||
129970275|NCT03635086|467854656|FG000|Overall Study|Lost to Follow-up|1|||
129970276|NCT03635086|467854657|FG001|Overall Study|Lost to Follow-up|0|||
129970277|NCT03635086|467854658|FG002|Overall Study|Lost to Follow-up|0|||
129970278|NCT03635086|467854659|FG003|Overall Study|Lost to Follow-up|0|||
129970279|NCT03635086|467854660|FG004|Overall Study|Lost to Follow-up|0|||
129970280|NCT00478205|467854661|FG000|Overall Study|Adverse Event|182|||
129970281|NCT00478205|467854662|FG001|Overall Study|Adverse Event|39|||
129970282|NCT00478205|467854661|FG000|Overall Study|Medication Non-compliance|9|||
129970283|NCT00478205|467854662|FG001|Overall Study|Medication Non-compliance|4|||
129970284|NCT00478205|467854661|FG000|Overall Study|Protocol Violation|15|||
129970285|NCT00478205|467854662|FG001|Overall Study|Protocol Violation|5|||
129970286|NCT00478205|467854661|FG000|Overall Study|Request of Investigator or Sponsor|4|||
129970287|NCT00478205|467854662|FG001|Overall Study|Request of Investigator or Sponsor|5|||
129970288|NCT00478205|467854661|FG000|Overall Study|Withdrawal by Subject|61|||
129970289|NCT00478205|467854662|FG001|Overall Study|Withdrawal by Subject|22|||
129970290|NCT00478205|467854661|FG000|Overall Study|Lack of Efficacy|1|||
129970291|NCT00478205|467854662|FG001|Overall Study|Lack of Efficacy|0|||
130128076|NCT00552669|468431299|FG001|Overall Study|Death|7|||
130128077|NCT01844375|468431300|FG000|Overall Study|Protocol Violation|1|||
129970292|NCT00478205|467854661|FG000|Overall Study|Other|24|||
129970293|NCT00478205|467854662|FG001|Overall Study|Other|12|||
129970294|NCT01012947|467854663|FG000|Overall Study|Lost to Follow-up|131|||
129970295|NCT01012947|467854664|FG001|Overall Study|Lost to Follow-up|135|||
129970296|NCT01012947|467854665|FG002|Overall Study|Lost to Follow-up|130|||
129970297|NCT01012947|467854666|FG003|Overall Study|Lost to Follow-up|118|||
129970298|NCT01012947|467854667|FG004|Overall Study|Lost to Follow-up|142|||
129970299|NCT04016272|467854670|FG000|Overall Study|Withdrawal by Subject|1|||
129970300|NCT04016272|467854671|FG001|Overall Study|Withdrawal by Subject|2|||
129970301|NCT00825305|467854672|FG000|Overall Study|Adverse Event|1|||
129970302|NCT00825305|467854673|FG001|Overall Study|Adverse Event|1|||
129970303|NCT00825305|467854672|FG000|Overall Study|Withdrawal by Subject|6|||
129970304|NCT00825305|467854673|FG001|Overall Study|Withdrawal by Subject|12|||
129970305|NCT00825305|467854672|FG000|Overall Study|Inappropriate inclusion|1|||
129970306|NCT00825305|467854673|FG001|Overall Study|Inappropriate inclusion|0|||
129970307|NCT00825305|467854672|FG000|Overall Study|Protocol Violation|9|||
129970308|NCT00825305|467854673|FG001|Overall Study|Protocol Violation|9|||
129970309|NCT00825305|467854672|FG000|Overall Study|Can not be classified|0|||
129970310|NCT00825305|467854673|FG001|Overall Study|Can not be classified|1|||
130128078|NCT01844375|468431301|FG001|Overall Study|Protocol Violation|1|||
130128079|NCT03020615|468431302|FG000|Overall Study|Physician Decision|3|||
130128080|NCT03020615|468431303|FG001|Overall Study|Physician Decision|1|||
130128081|NCT03020615|468431304|FG002|Overall Study|Physician Decision|2|||
130128082|NCT03020615|468431302|FG000|Overall Study|Parent/guardian/patient choice|3|||
130128083|NCT03020615|468431303|FG001|Overall Study|Parent/guardian/patient choice|0|||
129970311|NCT01850030|467854676|FG000|Overall Study|Adverse Event|64|||
129970312|NCT01850030|467854677|FG001|Overall Study|Adverse Event|82|||
129970313|NCT01850030|467854676|FG000|Overall Study|Lack of Efficacy|3|||
129970314|NCT01850030|467854677|FG001|Overall Study|Lack of Efficacy|1|||
129970315|NCT01850030|467854676|FG000|Overall Study|Lost to Follow-up|5|||
129970316|NCT01850030|467854677|FG001|Overall Study|Lost to Follow-up|5|||
129970317|NCT01850030|467854676|FG000|Overall Study|Withdrawal by Subject|3|||
129970318|NCT01850030|467854677|FG001|Overall Study|Withdrawal by Subject|4|||
129970319|NCT01850030|467854676|FG000|Overall Study|Protocol Violation|24|||
129970320|NCT01850030|467854677|FG001|Overall Study|Protocol Violation|28|||
129970321|NCT01850030|467854676|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
129970322|NCT01850030|467854677|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
129970323|NCT02638103|467854678|FG000|Overall Study|Adverse Event|13|||
129970324|NCT02638103|467854679|FG001|Overall Study|Adverse Event|12|||
129970325|NCT02638103|467854680|FG002|Overall Study|Adverse Event|19|||
129970326|NCT02638103|467854681|FG003|Overall Study|Adverse Event|12|||
129970327|NCT02638103|467854678|FG000|Overall Study|Withdrawal by Subject|43|||
129970328|NCT02638103|467854679|FG001|Overall Study|Withdrawal by Subject|53|||
129970329|NCT02638103|467854680|FG002|Overall Study|Withdrawal by Subject|30|||
129970330|NCT02638103|467854681|FG003|Overall Study|Withdrawal by Subject|61|||
129970331|NCT02638103|467854678|FG000|Overall Study|Protocol Violation|1|||
129970332|NCT02638103|467854679|FG001|Overall Study|Protocol Violation|2|||
129970333|NCT02638103|467854680|FG002|Overall Study|Protocol Violation|1|||
129970334|NCT02638103|467854681|FG003|Overall Study|Protocol Violation|4|||
129970335|NCT02638103|467854678|FG000|Overall Study|Pregnancy|2|||
129970336|NCT02638103|467854679|FG001|Overall Study|Pregnancy|3|||
129970337|NCT02638103|467854680|FG002|Overall Study|Pregnancy|0|||
129970338|NCT02638103|467854681|FG003|Overall Study|Pregnancy|1|||
129970339|NCT02638103|467854678|FG000|Overall Study|Non-compliance to Study Procedures|2|||
129970340|NCT02638103|467854679|FG001|Overall Study|Non-compliance to Study Procedures|1|||
129970341|NCT02638103|467854680|FG002|Overall Study|Non-compliance to Study Procedures|1|||
129970342|NCT02638103|467854681|FG003|Overall Study|Non-compliance to Study Procedures|1|||
129970343|NCT02638103|467854678|FG000|Overall Study|Lost to Follow-up|26|||
129970344|NCT02638103|467854679|FG001|Overall Study|Lost to Follow-up|33|||
129970345|NCT02638103|467854680|FG002|Overall Study|Lost to Follow-up|20|||
129970346|NCT02638103|467854681|FG003|Overall Study|Lost to Follow-up|37|||
129970347|NCT02638103|467854678|FG000|Overall Study|Lack of Efficacy|14|||
129970348|NCT02638103|467854679|FG001|Overall Study|Lack of Efficacy|10|||
129970349|NCT02638103|467854680|FG002|Overall Study|Lack of Efficacy|12|||
129970350|NCT02638103|467854681|FG003|Overall Study|Lack of Efficacy|22|||
129970351|NCT02638103|467854678|FG000|Overall Study|Other than specified|5|||
129970352|NCT02638103|467854679|FG001|Overall Study|Other than specified|4|||
129970353|NCT02638103|467854680|FG002|Overall Study|Other than specified|2|||
129970354|NCT02638103|467854681|FG003|Overall Study|Other than specified|4|||
129970355|NCT02165826|467854690|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
129970356|NCT02165826|467854691|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
129970357|NCT02165826|467854692|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
129970358|NCT02165826|467854690|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
129970359|NCT02165826|467854691|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
130128084|NCT03020615|468431304|FG002|Overall Study|Parent/guardian/patient choice|4|||
130128085|NCT03020615|468431302|FG000|Overall Study|Screen failure|0|||
130128086|NCT03020615|468431303|FG001|Overall Study|Screen failure|0|||
130128087|NCT03020615|468431304|FG002|Overall Study|Screen failure|1|||
130128088|NCT03020615|468431302|FG000|Overall Study|Death|1|||
130128089|NCT03020615|468431303|FG001|Overall Study|Death|0|||
129970360|NCT02165826|467854692|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
129970361|NCT02165826|467854690|FG000|Main Treatment Period|Lost to Follow-up|4|||
129970362|NCT02165826|467854691|FG001|Main Treatment Period|Lost to Follow-up|2|||
129970363|NCT02165826|467854692|FG002|Main Treatment Period|Lost to Follow-up|1|||
129970364|NCT02165826|467854690|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
129970365|NCT02165826|467854691|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
130128090|NCT03020615|468431304|FG002|Overall Study|Death|0|||
130128091|NCT03020615|468431302|FG000|Overall Study|Lost to Follow-up|0|||
130128092|NCT03020615|468431303|FG001|Overall Study|Lost to Follow-up|1|||
129970366|NCT02165826|467854692|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
129970367|NCT02165826|467854690|FG000|Main Treatment Period|Lack of Efficacy|2|||
129970368|NCT02165826|467854691|FG001|Main Treatment Period|Lack of Efficacy|0|||
129970369|NCT02165826|467854692|FG002|Main Treatment Period|Lack of Efficacy|0|||
129970370|NCT02165826|467854690|FG000|Main Treatment Period|Reason Not Specified|8|||
129970371|NCT02165826|467854691|FG001|Main Treatment Period|Reason Not Specified|5|||
129970372|NCT02165826|467854692|FG002|Main Treatment Period|Reason Not Specified|16|||
129970373|NCT02165826|467854690|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
129970374|NCT02165826|467854691|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
129970375|NCT02165826|467854692|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
129970376|NCT02165826|467854690|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
129970377|NCT02165826|467854691|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
129970378|NCT02165826|467854692|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
129970379|NCT02165826|467854690|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
129970380|NCT02165826|467854691|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
129970381|NCT02165826|467854692|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
129970382|NCT02165826|467854690|FG000|Down-Titration Period|Reason Not Specified|1|||
129970383|NCT02165826|467854691|FG001|Down-Titration Period|Reason Not Specified|0|||
129970384|NCT02165826|467854692|FG002|Down-Titration Period|Reason Not Specified|2|||
129970385|NCT04547023|467854695|FG000|Overall Study|Did Not Receive Intervention|3|||
129970386|NCT04547023|467854696|FG001|Overall Study|Did Not Receive Intervention|2|||
129970387|NCT04547023|467854695|FG000|Overall Study|Lost to Follow-up|1|||
130128093|NCT03020615|468431304|FG002|Overall Study|Lost to Follow-up|0|||
130128094|NCT00252720|468431306|FG000|Overall Study|Withdrawal by Subject|95|||
130128095|NCT00252720|468431307|FG001|Overall Study|Withdrawal by Subject|97|||
130128096|NCT00252720|468431306|FG000|Overall Study|Death|7|||
129970388|NCT04547023|467854696|FG001|Overall Study|Lost to Follow-up|1|||
129970389|NCT01262092|467854697|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
129970390|NCT01262092|467854698|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
129970391|NCT01262092|467854697|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
129970392|NCT01262092|467854698|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
129970393|NCT01262092|467854697|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
129970394|NCT01262092|467854698|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
129970395|NCT01262092|467854697|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
130128097|NCT00252720|468431307|FG001|Overall Study|Death|8|||
130128098|NCT00252720|468431306|FG000|Overall Study|Moving|23|||
130128099|NCT00252720|468431307|FG001|Overall Study|Moving|42|||
130128100|NCT00252720|468431306|FG000|Overall Study|Mainly patients lost to follow-up|7|||
130128101|NCT00252720|468431307|FG001|Overall Study|Mainly patients lost to follow-up|18|||
130128102|NCT01546545|468431313|FG000|Overall Study|Withdrawal by Subject|1|||
130128103|NCT04060147|468431314|FG000|Overall Study|Withdrew consent|1|||
130128104|NCT02057458|468431318|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
130128105|NCT02057458|468431319|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
130128106|NCT02057458|468431320|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
130128107|NCT02057458|468431318|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
130128108|NCT02057458|468431319|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
130128109|NCT02057458|468431320|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
130128110|NCT02057458|468431318|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
130128111|NCT02057458|468431319|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
130128112|NCT02057458|468431320|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
129970396|NCT01262092|467854698|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
129970397|NCT03784820|467854699|FG000|Overall Study|Lost to Follow-up|5|||
129970398|NCT03784820|467854700|FG001|Overall Study|Lost to Follow-up|5|||
129970399|NCT03784820|467854701|FG002|Overall Study|Lost to Follow-up|3|||
130128113|NCT03693430|468431321|FG000|Overall Study|Lost to Follow-up|3|||
130128114|NCT03693430|468431322|FG001|Overall Study|Lost to Follow-up|14|||
129970400|NCT03784820|467854702|FG003|Overall Study|Lost to Follow-up|3|||
129970401|NCT04147858|467854703|FG000|Overall Study|Adverse Event|6|||
129970402|NCT04147858|467854704|FG001|Overall Study|Adverse Event|6|||
129970403|NCT04147858|467854705|FG002|Overall Study|Adverse Event|6|||
129970404|NCT04147858|467854703|FG000|Overall Study|Lack of Efficacy|3|||
129970405|NCT04147858|467854704|FG001|Overall Study|Lack of Efficacy|3|||
129970406|NCT04147858|467854705|FG002|Overall Study|Lack of Efficacy|1|||
129970407|NCT04147858|467854703|FG000|Overall Study|Lost to Follow-up|1|||
130128115|NCT03693430|468431321|FG000|Overall Study|Death|1|||
130128116|NCT03693430|468431322|FG001|Overall Study|Death|0|||
130128117|NCT03693430|468431321|FG000|Overall Study|Withdrawal by Subject|0|||
129970408|NCT04147858|467854704|FG001|Overall Study|Lost to Follow-up|6|||
129970409|NCT04147858|467854705|FG002|Overall Study|Lost to Follow-up|2|||
130128118|NCT03693430|468431322|FG001|Overall Study|Withdrawal by Subject|4|||
130128119|NCT00585689|468431323|FG000|Overall Study|Received different ABI-007 schedule|3|||
130128120|NCT00585689|468431323|FG000|Overall Study|Adverse Event|1|||
129970410|NCT04147858|467854703|FG000|Overall Study|Withdrawal by Subject|3|||
129970411|NCT04147858|467854704|FG001|Overall Study|Withdrawal by Subject|4|||
129970412|NCT04147858|467854705|FG002|Overall Study|Withdrawal by Subject|10|||
129970413|NCT04147858|467854703|FG000|Overall Study|Subject Noncompliance, Other|4|||
129970414|NCT04147858|467854704|FG001|Overall Study|Subject Noncompliance, Other|3|||
129970415|NCT04147858|467854705|FG002|Overall Study|Subject Noncompliance, Other|1|||
129970416|NCT00365547|467854712|FG000|Overall Study|Insurance did not cover Avastin|1|||
129970417|NCT00365547|467854712|FG000|Overall Study|Screen failure|1|||
129970418|NCT00365547|467854712|FG000|Overall Study|Withdrawal by Subject|1|||
129970419|NCT03170518|467854713|FG000|Overall Study|Lost to Follow-up|4|||
129970420|NCT03170518|467854714|FG001|Overall Study|Lost to Follow-up|1|||
129970421|NCT03170518|467854715|FG002|Overall Study|Lost to Follow-up|0|||
129970422|NCT03170518|467854713|FG000|Overall Study|Physician Decision|1|||
129970423|NCT03170518|467854714|FG001|Overall Study|Physician Decision|0|||
129970424|NCT03170518|467854715|FG002|Overall Study|Physician Decision|0|||
129970425|NCT03170518|467854713|FG000|Overall Study|Withdrawal by Subject|4|||
129970426|NCT03170518|467854714|FG001|Overall Study|Withdrawal by Subject|5|||
129970427|NCT03170518|467854715|FG002|Overall Study|Withdrawal by Subject|2|||
129970428|NCT03170518|467854713|FG000|Overall Study|Site terminated by sponsor|0|||
129970429|NCT03170518|467854714|FG001|Overall Study|Site terminated by sponsor|1|||
129970430|NCT03170518|467854715|FG002|Overall Study|Site terminated by sponsor|0|||
129970431|NCT03170518|467854713|FG000|Overall Study|Non-compliance with study drug|1|||
129970432|NCT03170518|467854714|FG001|Overall Study|Non-compliance with study drug|0|||
129970433|NCT03170518|467854715|FG002|Overall Study|Non-compliance with study drug|1|||
129970434|NCT03170518|467854713|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129970435|NCT03170518|467854714|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129970436|NCT03170518|467854715|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129970437|NCT04428476|467854716|FG000|Overall Study|Withdrawal by Subject|1|||
129970438|NCT04428476|467854716|FG000|Overall Study|Still on treatment|12|||
129970439|NCT00546078|467854717|FG000|Overall Study|Lost to Follow-up|1|||
129970440|NCT00546078|467854718|FG001|Overall Study|Lost to Follow-up|3|||
129970441|NCT00546078|467854717|FG000|Overall Study|Withdrawal by Subject|2|||
129970442|NCT00546078|467854718|FG001|Overall Study|Withdrawal by Subject|3|||
129970443|NCT00546078|467854717|FG000|Overall Study|Other reason|1|||
129970444|NCT00546078|467854718|FG001|Overall Study|Other reason|1|||
129970445|NCT03023423|467854721|FG000|Overall Study|Death|5|||
129970446|NCT03023423|467854722|FG001|Overall Study|Death|12|||
129970447|NCT03023423|467854723|FG002|Overall Study|Death|20|||
129970448|NCT03023423|467854721|FG000|Overall Study|Other|0|||
129970449|NCT03023423|467854722|FG001|Overall Study|Other|2|||
129970450|NCT03023423|467854723|FG002|Overall Study|Other|2|||
129970451|NCT03023423|467854721|FG000|Overall Study|Ongoing|2|||
129970452|NCT03023423|467854722|FG001|Overall Study|Ongoing|32|||
129970453|NCT03023423|467854723|FG002|Overall Study|Ongoing|24|||
129970454|NCT03512197|467854724|FG000|Overall Study|Guardian decision|1|||
129970455|NCT03512197|467854725|FG001|Overall Study|Guardian decision|1|||
129970456|NCT03512197|467854724|FG000|Overall Study|Lack of Efficacy|19|||
129970457|NCT03512197|467854725|FG001|Overall Study|Lack of Efficacy|11|||
129970458|NCT03512197|467854724|FG000|Overall Study|New Therapy for Study Indication|16|||
129970459|NCT03512197|467854725|FG001|Overall Study|New Therapy for Study Indication|16|||
129970460|NCT03512197|467854724|FG000|Overall Study|Physician Decision|60|||
129970461|NCT03512197|467854725|FG001|Overall Study|Physician Decision|60|||
129970462|NCT03512197|467854724|FG000|Overall Study|Protocol Violation|0|||
129970463|NCT03512197|467854725|FG001|Overall Study|Protocol Violation|2|||
129970464|NCT03512197|467854724|FG000|Overall Study|Terminated by Sponsored|46|||
129970465|NCT03512197|467854725|FG001|Overall Study|Terminated by Sponsored|50|||
129970466|NCT03512197|467854724|FG000|Overall Study|Subject Decision|15|||
129970467|NCT03512197|467854725|FG001|Overall Study|Subject Decision|12|||
129970468|NCT03512197|467854724|FG000|Overall Study|Withdrawal of informed consent|20|||
129970469|NCT03512197|467854725|FG001|Overall Study|Withdrawal of informed consent|14|||
129970470|NCT03512197|467854724|FG000|Overall Study|Adverse Event|30|||
129970471|NCT03512197|467854725|FG001|Overall Study|Adverse Event|34|||
129970472|NCT03512197|467854724|FG000|Overall Study|Death|14|||
129970473|NCT03512197|467854725|FG001|Overall Study|Death|9|||
129970474|NCT03512197|467854724|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
129970475|NCT03512197|467854725|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
129970476|NCT03512197|467854724|FG000|Overall Study|Missing|3|||
129970477|NCT03512197|467854725|FG001|Overall Study|Missing|13|||
129970478|NCT03842436|467854726|FG000|Overall Study|Lost to Follow-up|1|||
129970479|NCT00490698|467854727|FG000|Overall Study|Withdrawal by Subject|1|||
129970480|NCT00490698|467854727|FG000|Overall Study|Disease Progression|7|||
129970481|NCT00490698|467854727|FG000|Overall Study|Physician Decision|2|||
129970482|NCT03358238|467854733|FG000|Overall Study|Withdrawal by Subject|0|||
129970483|NCT03358238|467854734|FG001|Overall Study|Withdrawal by Subject|1|||
129970484|NCT01431950|467854735|FG000|Overall Study|Study Site Closed/Terminated|7|||
129970485|NCT01431950|467854736|FG001|Overall Study|Study Site Closed/Terminated|3|||
129970486|NCT01431950|467854735|FG000|Overall Study|Withdrawal by Subject|4|||
129970487|NCT01431950|467854736|FG001|Overall Study|Withdrawal by Subject|3|||
129970488|NCT01431950|467854735|FG000|Overall Study|Protocol Violation|2|||
129970489|NCT01431950|467854736|FG001|Overall Study|Protocol Violation|3|||
129970490|NCT01431950|467854735|FG000|Overall Study|Adverse Event|2|||
129970491|NCT01431950|467854736|FG001|Overall Study|Adverse Event|2|||
129970492|NCT01431950|467854735|FG000|Overall Study|Physician Decision|2|||
129970493|NCT01431950|467854736|FG001|Overall Study|Physician Decision|1|||
129970494|NCT01431950|467854735|FG000|Overall Study|Lack of Efficacy|2|||
129970495|NCT01431950|467854736|FG001|Overall Study|Lack of Efficacy|1|||
129970496|NCT01431950|467854735|FG000|Overall Study|Lost to Follow-up|0|||
129970497|NCT01431950|467854736|FG001|Overall Study|Lost to Follow-up|1|||
129970498|NCT01431950|467854735|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
130128121|NCT00585689|468431323|FG000|Overall Study|Patient Declined Surgery|1|||
130128122|NCT00585689|468431323|FG000|Overall Study|Patient had unresectable disease|1|||
129970499|NCT01431950|467854736|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129970500|NCT01439867|467856524|FG000|Overall Study|Non-compliance|0|||
129970501|NCT01439867|467856525|FG001|Overall Study|Non-compliance|1|||
129970502|NCT01439867|467856524|FG000|Overall Study|Withdrawal by Subject|1|||
129970503|NCT01439867|467856525|FG001|Overall Study|Withdrawal by Subject|2|||
129970504|NCT01439867|467856524|FG000|Overall Study|Administrative Decision|4|||
129970505|NCT01439867|467856525|FG001|Overall Study|Administrative Decision|5|||
129970506|NCT01439867|467856524|FG000|Overall Study|Protocol-specified Criteria|1|||
129970507|NCT01439867|467856525|FG001|Overall Study|Protocol-specified Criteria|0|||
129970508|NCT00863512|467856526|FG000|Overall Study|Adverse Event|2|||
129970509|NCT00863512|467856527|FG001|Overall Study|Adverse Event|0|||
129970510|NCT00863512|467856526|FG000|Overall Study|Withdrawal by Subject|11|||
129970511|NCT00863512|467856527|FG001|Overall Study|Withdrawal by Subject|0|||
129970512|NCT00863512|467856526|FG000|Overall Study|Physician Decision|1|||
129970513|NCT00863512|467856527|FG001|Overall Study|Physician Decision|0|||
129970514|NCT02037477|467856528|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
129970515|NCT02037477|467856529|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
129970516|NCT02037477|467856530|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
129970517|NCT02037477|467856531|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
129970518|NCT02635360|467856532|FG000|Overall Study|Adverse Event|0|||
129970519|NCT02635360|467856533|FG001|Overall Study|Adverse Event|3|||
129970520|NCT02635360|467856532|FG000|Overall Study|Withdrawal by Subject|2|||
129970521|NCT02635360|467856533|FG001|Overall Study|Withdrawal by Subject|0|||
129970522|NCT02635360|467856532|FG000|Overall Study|Non-Compliance|3|||
129970523|NCT02635360|467856533|FG001|Overall Study|Non-Compliance|1|||
129970524|NCT02635360|467856532|FG000|Overall Study|Disease Progression|0|||
129970525|NCT02635360|467856533|FG001|Overall Study|Disease Progression|2|||
129970526|NCT02635360|467856532|FG000|Overall Study|Lost to Follow-up|1|||
129970527|NCT02635360|467856533|FG001|Overall Study|Lost to Follow-up|1|||
129970528|NCT04978350|467856534|FG000|Overall Study|Lost to Follow-up|6|||
129970529|NCT00983749|467856537|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
129970530|NCT00983749|467856538|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
129970531|NCT01952847|467856539|FG000|Overall Study|Ineligible|1|||
129970532|NCT01952847|467856540|FG001|Overall Study|Ineligible|0|||
129970533|NCT01952847|467856541|FG002|Overall Study|Ineligible|0|||
129970534|NCT01952847|467856542|FG003|Overall Study|Ineligible|0|||
129970535|NCT01952847|467856539|FG000|Overall Study|Lack of Insurance Coverage|0|||
129970536|NCT01952847|467856540|FG001|Overall Study|Lack of Insurance Coverage|1|||
129970537|NCT01952847|467856541|FG002|Overall Study|Lack of Insurance Coverage|0|||
130128123|NCT00585689|468431323|FG000|Overall Study|Death|1|||
129970538|NCT01952847|467856542|FG003|Overall Study|Lack of Insurance Coverage|0|||
130128124|NCT02421952|468431330|FG000|Overall Study|Diary Not Returned|93|||
130128125|NCT02421952|468431330|FG000|Overall Study|Failed seriation task|13|||
130128126|NCT02421952|468431330|FG000|Overall Study|Subject uncooperative for baseline test|2|||
129970539|NCT01952847|467856539|FG000|Overall Study|Withdrawal by Subject|1|||
130128127|NCT02421952|468431330|FG000|Overall Study|Surgery cancelled|1|||
130128128|NCT00854100|468431331|FG000|Overall Study|Inability to complete the study visits|0|||
130128129|NCT00854100|468431332|FG001|Overall Study|Inability to complete the study visits|0|||
130128130|NCT00854100|468431333|FG002|Overall Study|Inability to complete the study visits|1|||
129970540|NCT01952847|467856540|FG001|Overall Study|Withdrawal by Subject|1|||
129970541|NCT01952847|467856541|FG002|Overall Study|Withdrawal by Subject|0|||
129970542|NCT01952847|467856542|FG003|Overall Study|Withdrawal by Subject|1|||
129970543|NCT02577003|467856545|FG000|Overall Study|Adverse Event|2|||
129970544|NCT02577003|467856546|FG001|Overall Study|Adverse Event|4|||
129970545|NCT02577003|467856545|FG000|Overall Study|Withdrawal by Subject|0|||
129970546|NCT02577003|467856546|FG001|Overall Study|Withdrawal by Subject|1|||
129970547|NCT03334253|467856548|FG000|Overall Study|Withdrawal by Subject|1|||
129970548|NCT03334253|467856549|FG001|Overall Study|Withdrawal by Subject|0|||
129970549|NCT03334253|467856548|FG000|Overall Study|Lost to Follow-up|4|||
129970550|NCT03334253|467856549|FG001|Overall Study|Lost to Follow-up|3|||
129970551|NCT03334253|467856548|FG000|Overall Study|Moved residence|2|||
129970552|NCT03334253|467856549|FG001|Overall Study|Moved residence|2|||
130128131|NCT00854100|468431331|FG000|Overall Study|Lost to Follow-up|2|||
129970553|NCT00203047|467856550|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
129970554|NCT00203047|467856551|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
129970555|NCT00203047|467856550|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
129970556|NCT00203047|467856551|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
129970557|NCT00203047|467856550|FG000|Overall Study|Withdrawal by Subject|13|||
129970558|NCT00203047|467856551|FG001|Overall Study|Withdrawal by Subject|47|||
129970559|NCT00203047|467856550|FG000|Overall Study|Teva requested participant withdrawal|1|||
129970560|NCT00203047|467856551|FG001|Overall Study|Teva requested participant withdrawal|1|||
129970561|NCT00203047|467856550|FG000|Overall Study|Physician Decision|8|||
129970562|NCT00203047|467856551|FG001|Overall Study|Physician Decision|7|||
129970563|NCT00203047|467856550|FG000|Overall Study|Non-compliance|4|||
129970564|NCT00203047|467856551|FG001|Overall Study|Non-compliance|8|||
129970565|NCT00203047|467856550|FG000|Overall Study|Protocol Violation|1|||
129970566|NCT00203047|467856551|FG001|Overall Study|Protocol Violation|0|||
129970567|NCT00203047|467856550|FG000|Overall Study|Lost to Follow-up|11|||
129970568|NCT00203047|467856551|FG001|Overall Study|Lost to Follow-up|5|||
129970569|NCT00203047|467856550|FG000|Overall Study|Adverse Event|8|||
129970570|NCT00203047|467856551|FG001|Overall Study|Adverse Event|18|||
129970571|NCT00203047|467856550|FG000|Overall Study|Death|1|||
129970572|NCT00203047|467856551|FG001|Overall Study|Death|2|||
129970573|NCT00203047|467856550|FG000|Overall Study|Pregnancy|3|||
129970574|NCT00203047|467856551|FG001|Overall Study|Pregnancy|0|||
129970575|NCT00203047|467856550|FG000|Overall Study|Other|5|||
129970576|NCT00203047|467856551|FG001|Overall Study|Other|5|||
129970577|NCT00340704|467856552|FG000|PK Study|Adverse Event|0|||
129970578|NCT00340704|467856553|FG001|PK Study|Adverse Event|1|||
129970579|NCT00340704|467856554|FG002|PK Study|Adverse Event|0|||
129970580|NCT00340704|467856555|FG003|PK Study|Adverse Event|0|||
129970581|NCT00340704|467856556|FG004|PK Study|Adverse Event|0|||
129970582|NCT00340704|467856557|FG005|PK Study|Adverse Event|0|||
129970583|NCT00340704|467856558|FG006|PK Study|Adverse Event|0|||
129970584|NCT00340704|467856559|FG007|PK Study|Adverse Event|0|||
129970585|NCT00340704|467856560|FG008|PK Study|Adverse Event|0|||
129970586|NCT00340704|467856552|FG000|PK Study|Not treated|0|||
129970587|NCT00340704|467856553|FG001|PK Study|Not treated|0|||
129970588|NCT00340704|467856554|FG002|PK Study|Not treated|1|||
129970589|NCT00340704|467856555|FG003|PK Study|Not treated|0|||
129970590|NCT00340704|467856556|FG004|PK Study|Not treated|0|||
129970591|NCT00340704|467856557|FG005|PK Study|Not treated|0|||
129970592|NCT00340704|467856558|FG006|PK Study|Not treated|0|||
129970593|NCT00340704|467856559|FG007|PK Study|Not treated|0|||
129970594|NCT00340704|467856560|FG008|PK Study|Not treated|0|||
129970595|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970596|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970597|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970598|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
129970599|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
129970600|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970601|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970602|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
129970603|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
129970604|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970605|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970606|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970607|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970608|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970609|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
129970610|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970611|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970612|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970613|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970614|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970615|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970616|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970617|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
129970618|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
129970619|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970620|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970621|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970622|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970623|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970624|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970625|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970626|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970627|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
129970628|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
129970629|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
129970630|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
129970631|NCT00121667|467856561|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
129970632|NCT00121667|467856562|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
129970633|NCT00121667|467856563|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
129970634|NCT00121667|467856564|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
129970635|NCT00121667|467856561|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
129970636|NCT00121667|467856562|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
129970637|NCT00121667|467856563|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
129970638|NCT00121667|467856564|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
129970639|NCT00121667|467856561|FG000|Short Term (ST) Period|Adverse Event|5|||
129970640|NCT00121667|467856562|FG001|Short Term (ST) Period|Adverse Event|6|||
129970641|NCT00121667|467856563|FG002|Short Term (ST) Period|Adverse Event|5|||
129970642|NCT00121667|467856564|FG003|Short Term (ST) Period|Adverse Event|3|||
129970643|NCT00121667|467856561|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
129970644|NCT00121667|467856562|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
129970645|NCT00121667|467856563|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
129970646|NCT00121667|467856564|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
129970647|NCT00121667|467856561|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
129970648|NCT00121667|467856562|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
129970649|NCT00121667|467856563|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
129970650|NCT00121667|467856564|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
129970651|NCT00121667|467856561|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
129970652|NCT00121667|467856562|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
129970653|NCT00121667|467856563|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
129970654|NCT00121667|467856564|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
129970655|NCT00121667|467856561|FG000|Short Term (ST) Period|Other Reason|3|||
129970656|NCT00121667|467856562|FG001|Short Term (ST) Period|Other Reason|0|||
129970657|NCT00121667|467856563|FG002|Short Term (ST) Period|Other Reason|0|||
129970658|NCT00121667|467856564|FG003|Short Term (ST) Period|Other Reason|0|||
129970659|NCT00121667|467856561|FG000|Short Term (ST) Period|Death|0|||
129970660|NCT00121667|467856562|FG001|Short Term (ST) Period|Death|0|||
129970661|NCT00121667|467856563|FG002|Short Term (ST) Period|Death|0|||
129970662|NCT00121667|467856564|FG003|Short Term (ST) Period|Death|1|||
129970663|NCT00121667|467856561|FG000|Short Term (ST) Period|Pregnancy|0|||
129970664|NCT00121667|467856562|FG001|Short Term (ST) Period|Pregnancy|0|||
129970665|NCT00121667|467856563|FG002|Short Term (ST) Period|Pregnancy|0|||
129970666|NCT00121667|467856564|FG003|Short Term (ST) Period|Pregnancy|1|||
129970667|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
129970668|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
129970669|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
129970670|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
129970671|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
129970672|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
129970673|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
129970674|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
129970675|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
130128132|NCT00854100|468431332|FG001|Overall Study|Lost to Follow-up|0|||
130128133|NCT00854100|468431333|FG002|Overall Study|Lost to Follow-up|3|||
130128134|NCT00854100|468431331|FG000|Overall Study|Withdrawal by Subject|3|||
130128135|NCT00854100|468431332|FG001|Overall Study|Withdrawal by Subject|1|||
130128136|NCT00854100|468431333|FG002|Overall Study|Withdrawal by Subject|2|||
130128137|NCT00854100|468431331|FG000|Overall Study|Protocol Violation|2|||
130128138|NCT00854100|468431332|FG001|Overall Study|Protocol Violation|4|||
130128139|NCT00854100|468431333|FG002|Overall Study|Protocol Violation|3|||
130128140|NCT00854100|468431331|FG000|Overall Study|Adverse Event|2|||
130128141|NCT00854100|468431332|FG001|Overall Study|Adverse Event|1|||
130128142|NCT00854100|468431333|FG002|Overall Study|Adverse Event|2|||
129970676|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
130128143|NCT02216071|468431343|FG000|Overall Study|Withdrawal by Subject|7|||
130128144|NCT02216071|468431344|FG001|Overall Study|Withdrawal by Subject|2|||
130128145|NCT02216071|468431343|FG000|Overall Study|Lost to Follow-up|3|||
130128146|NCT02216071|468431344|FG001|Overall Study|Lost to Follow-up|3|||
130128147|NCT02216071|468431343|FG000|Overall Study|Protocol Violation|3|||
130128148|NCT02216071|468431344|FG001|Overall Study|Protocol Violation|5|||
130128149|NCT02216071|468431343|FG000|Overall Study|Other|2|||
130128150|NCT02216071|468431344|FG001|Overall Study|Other|2|||
130128151|NCT00389064|468431345|FG000|Overall Study|Adverse Event|11|||
130128152|NCT00389064|468431346|FG001|Overall Study|Adverse Event|3|||
130128153|NCT00389064|468431345|FG000|Overall Study|Lack of Efficacy|3|||
130128154|NCT00389064|468431346|FG001|Overall Study|Lack of Efficacy|14|||
130128155|NCT00389064|468431345|FG000|Overall Study|Withdrawal by Subject|17|||
130128156|NCT00389064|468431346|FG001|Overall Study|Withdrawal by Subject|27|||
130128157|NCT00389064|468431345|FG000|Overall Study|Physician Decision|2|||
130128158|NCT00389064|468431346|FG001|Overall Study|Physician Decision|2|||
130128159|NCT00389064|468431345|FG000|Overall Study|Lost to Follow-up|1|||
130128160|NCT00389064|468431346|FG001|Overall Study|Lost to Follow-up|2|||
130128161|NCT00389064|468431345|FG000|Overall Study|Protocol Violation|2|||
130128162|NCT00389064|468431346|FG001|Overall Study|Protocol Violation|0|||
130128163|NCT00389064|468431345|FG000|Overall Study|Multiple Reasons|9|||
130128164|NCT00389064|468431346|FG001|Overall Study|Multiple Reasons|11|||
130128165|NCT01387737|468432562|FG000|Overall Study|Adverse Event|20|||
130128166|NCT01387737|468432563|FG001|Overall Study|Adverse Event|30|||
130128167|NCT01387737|468432562|FG000|Overall Study|Lack of Efficacy|1|||
130128168|NCT01387737|468432563|FG001|Overall Study|Lack of Efficacy|0|||
130128169|NCT01387737|468432562|FG000|Overall Study|Physician Decision|3|||
130128170|NCT01387737|468432563|FG001|Overall Study|Physician Decision|10|||
130128171|NCT01387737|468432562|FG000|Overall Study|Withdrawal by Subject|27|||
130128172|NCT01387737|468432563|FG001|Overall Study|Withdrawal by Subject|31|||
130128173|NCT01387737|468432562|FG000|Overall Study|Clearly not eligible for the study|1|||
130128174|NCT01387737|468432563|FG001|Overall Study|Clearly not eligible for the study|3|||
130128175|NCT01215981|468432566|FG000|Overall Study|Physician Decision|0|||
130128176|NCT01215981|468432567|FG001|Overall Study|Physician Decision|1|||
130128177|NCT01215981|468432566|FG000|Overall Study|Protocol Violation|1|||
130128178|NCT01215981|468432567|FG001|Overall Study|Protocol Violation|0|||
130128179|NCT01215981|468432566|FG000|Overall Study|Withdrawal by Subject|1|||
130128180|NCT01215981|468432567|FG001|Overall Study|Withdrawal by Subject|0|||
130128181|NCT00840632|468432573|FG000|First Intervention|Withdrawal by Subject|0|||
130128182|NCT00840632|468432574|FG001|First Intervention|Withdrawal by Subject|1|||
130128183|NCT00840632|468432573|FG000|Washout|Withdrawal by Subject|1|||
130128184|NCT00840632|468432574|FG001|Washout|Withdrawal by Subject|1|||
130128185|NCT01049334|468432577|FG000|Overall Study|Withdrawal by Subject|5|||
130128186|NCT01049334|468432578|FG001|Overall Study|Withdrawal by Subject|3|||
130128187|NCT01049334|468432577|FG000|Overall Study|Adverse Event|2|||
130128188|NCT01049334|468432578|FG001|Overall Study|Adverse Event|3|||
130128189|NCT01049334|468432577|FG000|Overall Study|Physician Decision|2|||
130128190|NCT01049334|468432578|FG001|Overall Study|Physician Decision|0|||
130128191|NCT01049334|468432577|FG000|Overall Study|Protocol Violation|0|||
130128192|NCT01049334|468432578|FG001|Overall Study|Protocol Violation|1|||
130128193|NCT03447262|468432585|FG000|Overall Study|Adverse Event|7|||
130128194|NCT03447262|468432585|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
130128195|NCT03447262|468432585|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
130128196|NCT03447262|468432585|FG000|Overall Study|Death|2|||
130128197|NCT03447262|468432585|FG000|Overall Study|Study Termination by Sponsor|455|||
130128198|NCT03447262|468432585|FG000|Overall Study|Other|4|||
130128199|NCT03351335|468432587|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
130128200|NCT03351335|468432588|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
130128201|NCT03351335|468432589|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
130128202|NCT00469417|468432590|FG000|Overall Study|Treatment failure all lesions|18|||
130128203|NCT00469417|468432591|FG001|Overall Study|Treatment failure all lesions|11|||
130128204|NCT00469417|468432590|FG000|Overall Study|Consent withdrawn|1|||
130128205|NCT00469417|468432591|FG001|Overall Study|Consent withdrawn|1|||
130128206|NCT00469417|468432590|FG000|Overall Study|Adverse Event|8|||
130128207|NCT00469417|468432591|FG001|Overall Study|Adverse Event|2|||
130128208|NCT00469417|468432590|FG000|Overall Study|Lost to Follow-up|1|||
130128209|NCT00469417|468432591|FG001|Overall Study|Lost to Follow-up|2|||
130128210|NCT00469417|468432590|FG000|Overall Study|Intercurrent disease|0|||
130128211|NCT00469417|468432591|FG001|Overall Study|Intercurrent disease|1|||
130128212|NCT00469417|468432590|FG000|Overall Study|Randomized but not treated|2|||
130128213|NCT00469417|468432591|FG001|Overall Study|Randomized but not treated|0|||
130128214|NCT00834743|468432594|FG000|Second Intervention|Withdrawal by Subject|1|||
130128215|NCT00834743|468432595|FG001|Second Intervention|Withdrawal by Subject|0|||
130128216|NCT00086996|468432597|FG000|Overall Study|Adverse Event|29|||
130128217|NCT00086996|468432597|FG000|Overall Study|Death|4|||
130128218|NCT00086996|468432597|FG000|Overall Study|progression/relapse|7|||
130128219|NCT00086996|468432597|FG000|Overall Study|Withdrawal by Subject|13|||
130128220|NCT00086996|468432597|FG000|Overall Study|Other|6|||
129970677|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
129970678|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
130128221|NCT00086996|468432597|FG000|Overall Study|not eligible|5|||
130128222|NCT00004562|468432598|FG000|Overall Study|Lost to Follow-up|102|||
130128223|NCT00004562|468432599|FG001|Overall Study|Lost to Follow-up|91|||
130128224|NCT04274686|468432601|FG000|Overall Study|Physician Decision|1|||
130128225|NCT04274686|468432602|FG001|Overall Study|Physician Decision|0|||
130128226|NCT00376623|468432603|FG000|Overall Study|Progressive disease|35|||
130128227|NCT00376623|468432604|FG001|Overall Study|Progressive disease|22|||
130128228|NCT00376623|468432605|FG002|Overall Study|Progressive disease|17|||
130128229|NCT00376623|468432603|FG000|Overall Study|Lost to Follow-up|0|||
130128230|NCT00376623|468432604|FG001|Overall Study|Lost to Follow-up|1|||
129970679|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
129970680|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
129970681|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
129970682|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
129970683|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
129970684|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
129970685|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
129970686|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
129970687|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
129970688|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
129970689|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
129970690|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
129970691|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
129970692|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
129970693|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
129970694|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
129970695|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
129970696|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
129970697|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
129970698|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
129970699|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
129970700|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
129970701|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
129970702|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
129970703|NCT01453023|467856565|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
129970704|NCT01453023|467856566|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
129970705|NCT01453023|467856565|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
129970706|NCT01453023|467856566|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
129970707|NCT01453023|467856565|FG000|Treatment Period 2|Protocol Violation|0|||
129970708|NCT01453023|467856566|FG001|Treatment Period 2|Protocol Violation|1|||
129970709|NCT02413593|467856582|FG000|Overall Study|Lost to Follow-up|3|||
129970710|NCT02413593|467856582|FG000|Overall Study|Adverse Event|1|||
129970711|NCT01807182|467856583|FG000|Overall Study|Death|1|||
129970712|NCT01807182|467856583|FG000|Overall Study|New therapy|1|||
129970713|NCT01807182|467856583|FG000|Overall Study|Moved to hospice care|1|||
129970714|NCT03513068|467856585|FG000|Overall Study|Death|1|||
129970715|NCT03513068|467856586|FG001|Overall Study|Death|0|||
129970716|NCT03513068|467856585|FG000|Overall Study|Withdrawal by Subject|4|||
129970717|NCT03513068|467856586|FG001|Overall Study|Withdrawal by Subject|6|||
129970718|NCT01791413|467856587|FG000|Overall Study|Lost to Follow-up|5|||
129970719|NCT01791413|467856588|FG001|Overall Study|Lost to Follow-up|1|||
129970720|NCT00250432|467856590|FG000|Overall Study|Adverse Event|25|||
130128231|NCT00376623|468432605|FG002|Overall Study|Lost to Follow-up|0|||
130128232|NCT00376623|468432603|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
130128233|NCT00376623|468432604|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
130128234|NCT00376623|468432605|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
130128235|NCT00376623|468432603|FG000|Overall Study|Not treated with BI 2536|1|||
130128236|NCT00376623|468432604|FG001|Overall Study|Not treated with BI 2536|0|||
130128237|NCT00376623|468432605|FG002|Overall Study|Not treated with BI 2536|0|||
130128238|NCT00376623|468432603|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
130128239|NCT00376623|468432604|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130128240|NCT00376623|468432605|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130128241|NCT00376623|468432603|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
130128242|NCT00376623|468432604|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
130128243|NCT00376623|468432605|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
130128244|NCT00376623|468432603|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
130128245|NCT00376623|468432604|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
130128246|NCT00376623|468432605|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
130128247|NCT00376623|468432603|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
130128248|NCT00376623|468432604|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
130128249|NCT00376623|468432605|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
130128250|NCT00376623|468432603|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130128251|NCT00376623|468432604|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
130128252|NCT00376623|468432605|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
130128253|NCT00376623|468432603|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
130128254|NCT00376623|468432604|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
130128255|NCT00376623|468432605|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
130128256|NCT00376623|468432603|FG000|Overall Study|Increase of tumour markers|0|||
130128257|NCT00376623|468432604|FG001|Overall Study|Increase of tumour markers|1|||
130128258|NCT00376623|468432605|FG002|Overall Study|Increase of tumour markers|0|||
130128259|NCT00376623|468432603|FG000|Overall Study|Bone metastasis|1|||
130128260|NCT00376623|468432604|FG001|Overall Study|Bone metastasis|0|||
130128261|NCT00376623|468432605|FG002|Overall Study|Bone metastasis|0|||
130128262|NCT00910663|468432610|FG000|Period 1|Withdrawal by Subject|0|||
130128263|NCT00910663|468432611|FG001|Period 1|Withdrawal by Subject|1|||
130128264|NCT02865850|468432612|FG000|Overall Study|Death|15|||
130128265|NCT02865850|468432613|FG001|Overall Study|Death|19|||
130128266|NCT02865850|468432612|FG000|Overall Study|Withdrawal by Subject|3|||
130128267|NCT02865850|468432613|FG001|Overall Study|Withdrawal by Subject|2|||
130128268|NCT02865850|468432612|FG000|Overall Study|Lost to Follow-up|3|||
130128269|NCT02865850|468432613|FG001|Overall Study|Lost to Follow-up|2|||
130128270|NCT01772537|468432615|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
130128271|NCT01772537|468432616|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
130128272|NCT01772537|468432617|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
130128273|NCT03195491|468432618|FG000|Overall Study|Study drug toxicity|25|||
130128274|NCT03195491|468432619|FG001|Overall Study|Study drug toxicity|3|||
130128275|NCT03195491|468432618|FG000|Overall Study|Maximum clinical benefit|5|||
130128276|NCT03195491|468432619|FG001|Overall Study|Maximum clinical benefit|0|||
130128277|NCT03195491|468432618|FG000|Overall Study|Lost to Follow-up|1|||
130128278|NCT03195491|468432619|FG001|Overall Study|Lost to Follow-up|0|||
130128279|NCT03195491|468432618|FG000|Overall Study|Death|3|||
130128280|NCT03195491|468432619|FG001|Overall Study|Death|0|||
130128281|NCT03195491|468432618|FG000|Overall Study|Adverse event unrelated to study drug|19|||
130128282|NCT03195491|468432619|FG001|Overall Study|Adverse event unrelated to study drug|2|||
130128283|NCT03195491|468432618|FG000|Overall Study|Disease progression|266|||
130128284|NCT03195491|468432619|FG001|Overall Study|Disease progression|8|||
130128285|NCT03195491|468432618|FG000|Overall Study|Other reasons|10|||
130128286|NCT03195491|468432619|FG001|Overall Study|Other reasons|0|||
130128287|NCT03195491|468432618|FG000|Overall Study|Participant withdrew consent|8|||
130128288|NCT03195491|468432619|FG001|Overall Study|Participant withdrew consent|1|||
130128289|NCT03195491|468432618|FG000|Overall Study|Participant no longer meets study criteria|0|||
130128290|NCT03195491|468432619|FG001|Overall Study|Participant no longer meets study criteria|1|||
130128291|NCT03195491|468432618|FG000|Overall Study|Participant request to discontinue study treatment|10|||
130128292|NCT03195491|468432619|FG001|Overall Study|Participant request to discontinue study treatment|0|||
130128293|NCT01263704|468432620|FG000|Overall Study|Progressive disease|18|||
130128294|NCT01263704|468432620|FG000|Overall Study|Adverse Event|3|||
130128295|NCT01263704|468432620|FG000|Overall Study|Death|2|||
130128296|NCT01263704|468432620|FG000|Overall Study|Patient withdrew consent|2|||
130128297|NCT01263704|468432620|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130128298|NCT01263704|468432620|FG000|Overall Study|Lost to Follow-up|1|||
130128299|NCT01263704|468432620|FG000|Overall Study|Colon metastases|1|||
130128300|NCT01263704|468432620|FG000|Overall Study|Principal Investigator (PI) decision|1|||
130128301|NCT01185821|468432626|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130128302|NCT01185821|468432627|FG001|Overall Study|Abnormal laboratory value(s)|2|||
130128303|NCT01185821|468432628|FG002|Overall Study|Abnormal laboratory value(s)|1|||
130128304|NCT01185821|468432629|FG003|Overall Study|Abnormal laboratory value(s)|0|||
130128305|NCT01185821|468432630|FG004|Overall Study|Abnormal laboratory value(s)|0|||
130128306|NCT01185821|468432626|FG000|Overall Study|Protocol Violation|0|||
130128307|NCT01185821|468432627|FG001|Overall Study|Protocol Violation|0|||
130128308|NCT01185821|468432628|FG002|Overall Study|Protocol Violation|0|||
130128309|NCT01185821|468432629|FG003|Overall Study|Protocol Violation|1|||
130128310|NCT01185821|468432630|FG004|Overall Study|Protocol Violation|1|||
130128311|NCT01185821|468432626|FG000|Overall Study|Abnormal test procedure result|0|||
130128312|NCT01185821|468432627|FG001|Overall Study|Abnormal test procedure result|0|||
130128313|NCT01185821|468432628|FG002|Overall Study|Abnormal test procedure result|0|||
130128314|NCT01185821|468432629|FG003|Overall Study|Abnormal test procedure result|0|||
130128315|NCT01185821|468432630|FG004|Overall Study|Abnormal test procedure result|1|||
130128316|NCT01185821|468432626|FG000|Overall Study|Death|0|||
130128317|NCT01185821|468432627|FG001|Overall Study|Death|1|||
130128318|NCT01185821|468432628|FG002|Overall Study|Death|0|||
130128319|NCT01185821|468432629|FG003|Overall Study|Death|0|||
130128320|NCT01185821|468432630|FG004|Overall Study|Death|0|||
130128321|NCT01185821|468432626|FG000|Overall Study|Condition no longer required study drug|0|||
130128322|NCT01185821|468432627|FG001|Overall Study|Condition no longer required study drug|0|||
130128323|NCT01185821|468432628|FG002|Overall Study|Condition no longer required study drug|0|||
130128324|NCT01185821|468432629|FG003|Overall Study|Condition no longer required study drug|0|||
130128325|NCT01185821|468432630|FG004|Overall Study|Condition no longer required study drug|1|||
130128326|NCT01185821|468432626|FG000|Overall Study|Adverse Event|2|||
130128327|NCT01185821|468432627|FG001|Overall Study|Adverse Event|3|||
130128328|NCT01185821|468432628|FG002|Overall Study|Adverse Event|1|||
130128329|NCT01185821|468432629|FG003|Overall Study|Adverse Event|2|||
130128330|NCT01185821|468432630|FG004|Overall Study|Adverse Event|5|||
130128331|NCT01185821|468432626|FG000|Overall Study|Lack of Efficacy|0|||
130128332|NCT01185821|468432627|FG001|Overall Study|Lack of Efficacy|0|||
130128333|NCT01185821|468432628|FG002|Overall Study|Lack of Efficacy|3|||
130128334|NCT01185821|468432629|FG003|Overall Study|Lack of Efficacy|0|||
130128335|NCT01185821|468432630|FG004|Overall Study|Lack of Efficacy|9|||
130128336|NCT01185821|468432626|FG000|Overall Study|Withdrawal by Subject|3|||
130128337|NCT01185821|468432627|FG001|Overall Study|Withdrawal by Subject|2|||
130128338|NCT01185821|468432628|FG002|Overall Study|Withdrawal by Subject|2|||
130128339|NCT01185821|468432629|FG003|Overall Study|Withdrawal by Subject|1|||
130128340|NCT01185821|468432630|FG004|Overall Study|Withdrawal by Subject|3|||
130128341|NCT01185821|468432626|FG000|Overall Study|Lost to Follow-up|1|||
130128342|NCT01185821|468432627|FG001|Overall Study|Lost to Follow-up|1|||
130128343|NCT01185821|468432628|FG002|Overall Study|Lost to Follow-up|2|||
130128344|NCT01185821|468432629|FG003|Overall Study|Lost to Follow-up|1|||
130128345|NCT01185821|468432630|FG004|Overall Study|Lost to Follow-up|2|||
130128346|NCT01185821|468432626|FG000|Overall Study|Administrative problems|0|||
130128347|NCT01185821|468432627|FG001|Overall Study|Administrative problems|0|||
130128348|NCT01185821|468432628|FG002|Overall Study|Administrative problems|1|||
130128349|NCT01185821|468432629|FG003|Overall Study|Administrative problems|1|||
130128350|NCT01185821|468432630|FG004|Overall Study|Administrative problems|2|||
130128351|NCT02979353|468432632|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
130128352|NCT02979353|468432633|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
130128353|NCT02979353|468432632|FG000|Overall Study|Withdrawal by Subject|16|||
130128354|NCT02979353|468432633|FG001|Overall Study|Withdrawal by Subject|12|||
130128355|NCT02979353|468432632|FG000|Overall Study|Death|10|||
130128356|NCT02979353|468432633|FG001|Overall Study|Death|11|||
130128357|NCT02979353|468432632|FG000|Overall Study|Transfer to Hospice Care|19|||
130128358|NCT02979353|468432633|FG001|Overall Study|Transfer to Hospice Care|14|||
130128359|NCT02979353|468432632|FG000|Overall Study|Lost to Follow-up|1|||
130128360|NCT02979353|468432633|FG001|Overall Study|Lost to Follow-up|5|||
130128361|NCT00550537|468432634|FG000|Overall Study|Death|18|||
130128362|NCT00550537|468432634|FG000|Overall Study|Adverse Event|20|||
130128363|NCT00550537|468432634|FG000|Overall Study|Disease progression before|46|||
130128364|NCT00550537|468432634|FG000|Overall Study|Withdrawal by Subject|7|||
130128365|NCT00550537|468432634|FG000|Overall Study|Change in treatment plan|4|||
130128366|NCT00550537|468432634|FG000|Overall Study|Other complicating ilness|3|||
130128367|NCT00550537|468432634|FG000|Overall Study|Declining performance status|2|||
130128368|NCT00550537|468432634|FG000|Overall Study|Treated closer to home|4|||
130128369|NCT00268905|468432635|FG000|Overall Study|Adverse Event|3|||
130128370|NCT00268905|468432636|FG001|Overall Study|Adverse Event|0|||
130128371|NCT00268905|468432637|FG002|Overall Study|Adverse Event|4|||
130128372|NCT00268905|468432635|FG000|Overall Study|Lost to Follow-up|0|||
130128373|NCT00268905|468432636|FG001|Overall Study|Lost to Follow-up|1|||
130128374|NCT00268905|468432637|FG002|Overall Study|Lost to Follow-up|0|||
130128375|NCT00268905|468432635|FG000|Overall Study|Withdrawal by Subject|0|||
130128376|NCT00268905|468432636|FG001|Overall Study|Withdrawal by Subject|0|||
130128377|NCT00268905|468432637|FG002|Overall Study|Withdrawal by Subject|3|||
130128378|NCT00268905|468432635|FG000|Overall Study|Progressive Disease|28|||
130128379|NCT00268905|468432636|FG001|Overall Study|Progressive Disease|4|||
130128380|NCT00268905|468432637|FG002|Overall Study|Progressive Disease|3|||
130128381|NCT00268905|468432635|FG000|Overall Study|Physician Decision|3|||
130128382|NCT00268905|468432636|FG001|Overall Study|Physician Decision|0|||
130128383|NCT00268905|468432637|FG002|Overall Study|Physician Decision|1|||
130128384|NCT00268905|468432635|FG000|Overall Study|Clinical Progression|9|||
130128385|NCT00268905|468432636|FG001|Overall Study|Clinical Progression|4|||
130128386|NCT00268905|468432637|FG002|Overall Study|Clinical Progression|1|||
130128387|NCT00617305|468432638|FG000|Overall Study|Adverse Event|4|||
130128388|NCT00617305|468432639|FG001|Overall Study|Adverse Event|0|||
130128389|NCT00617305|468432640|FG002|Overall Study|Adverse Event|0|||
130128390|NCT00617305|468432638|FG000|Overall Study|Death|1|||
130128391|NCT00617305|468432639|FG001|Overall Study|Death|0|||
130128392|NCT00617305|468432640|FG002|Overall Study|Death|0|||
130128393|NCT00617305|468432638|FG000|Overall Study|Physician Decision|1|||
130128394|NCT00617305|468432639|FG001|Overall Study|Physician Decision|0|||
130128395|NCT00617305|468432640|FG002|Overall Study|Physician Decision|0|||
130128396|NCT00617305|468432638|FG000|Overall Study|Protocol Violation|1|||
130128397|NCT00617305|468432639|FG001|Overall Study|Protocol Violation|0|||
130128398|NCT00617305|468432640|FG002|Overall Study|Protocol Violation|1|||
130128399|NCT00617305|468432638|FG000|Overall Study|Withdrawal by Subject|1|||
130128400|NCT00617305|468432639|FG001|Overall Study|Withdrawal by Subject|0|||
130128401|NCT00617305|468432640|FG002|Overall Study|Withdrawal by Subject|0|||
130128402|NCT04510285|468432641|FG000|Overall Study|Death|1|||
130128403|NCT01406795|468432642|FG000|Overall Study|Withdrawal by Subject|1|||
130128404|NCT03897088|468432643|FG000|Overall Study|Withdrawal by Subject|12|||
130128405|NCT03897088|468432644|FG001|Overall Study|Withdrawal by Subject|12|||
130128406|NCT03897088|468432643|FG000|Overall Study|Lost to Follow-up|7|||
130128407|NCT03897088|468432644|FG001|Overall Study|Lost to Follow-up|15|||
130128408|NCT03897088|468432643|FG000|Overall Study|Sponsor Decision|1|||
130128409|NCT03897088|468432644|FG001|Overall Study|Sponsor Decision|2|||
130128410|NCT03897088|468432643|FG000|Overall Study|COVID-19|2|||
130128411|NCT03897088|468432644|FG001|Overall Study|COVID-19|0|||
130128412|NCT03897088|468432643|FG000|Overall Study|Other|3|||
130128413|NCT03897088|468432644|FG001|Overall Study|Other|0|||
130128414|NCT03897088|468432643|FG000|Overall Study|Non-compliance with Study Drug|1|||
130128415|NCT03897088|468432644|FG001|Overall Study|Non-compliance with Study Drug|1|||
130128416|NCT03897088|468432643|FG000|Overall Study|Pregnancy|0|||
130128417|NCT03897088|468432644|FG001|Overall Study|Pregnancy|1|||
130128418|NCT00855738|468432645|FG000|Overall Study|Lost to Follow-up|2|||
130128419|NCT00855738|468432645|FG000|Overall Study|Adverse Event|1|||
130128420|NCT00855738|468432645|FG000|Overall Study|Subject Defaulted|1|||
130128421|NCT00855738|468432645|FG000|Overall Study|Death|1|||
130128422|NCT04384978|468432648|FG000|Overall Study|Withdrawal by Subject|4|||
130128423|NCT04384978|468432649|FG001|Overall Study|Withdrawal by Subject|0|||
130128424|NCT03555305|468432650|FG000|Period 1|Physician Decision|0|||
130128425|NCT03555305|468432651|FG001|Period 1|Physician Decision|1|||
130128426|NCT03555305|468432650|FG000|Period 1|Adverse Event|0|||
130128427|NCT03555305|468432651|FG001|Period 1|Adverse Event|1|||
130128428|NCT03586726|468432659|FG000|Overall Study|Withdrawal by Subject|1|||
130128429|NCT03420300|468432662|FG000|Overall Study|Death|2|||
130128430|NCT03500692|468432677|FG000|Overall Study|Death|163|||
130128431|NCT03500692|468432677|FG000|Overall Study|Lost to Follow-up|75|||
130128432|NCT03500692|468432677|FG000|Overall Study|Termination Reasons|3|||
130128433|NCT01811953|468434066|FG000|Overall Study|Adverse Event|0|||
130128434|NCT01811953|468434067|FG001|Overall Study|Adverse Event|0|||
130128435|NCT01811953|468434068|FG002|Overall Study|Adverse Event|0|||
130128436|NCT01811953|468434069|FG003|Overall Study|Adverse Event|1|||
130128437|NCT01811953|468434070|FG004|Overall Study|Adverse Event|0|||
130128438|NCT01811953|468434071|FG005|Overall Study|Adverse Event|1|||
130128439|NCT01811953|468434066|FG000|Overall Study|Protocol Violation|0|||
130128440|NCT01811953|468434067|FG001|Overall Study|Protocol Violation|0|||
130128441|NCT01811953|468434068|FG002|Overall Study|Protocol Violation|0|||
130128442|NCT01811953|468434069|FG003|Overall Study|Protocol Violation|0|||
130128443|NCT01811953|468434070|FG004|Overall Study|Protocol Violation|1|||
130128444|NCT01811953|468434071|FG005|Overall Study|Protocol Violation|0|||
130128445|NCT02262377|468434073|FG000|Overall Study|Lost to Follow-up|5|||
130128446|NCT02262377|468434074|FG001|Overall Study|Lost to Follow-up|6|||
130128447|NCT02262377|468434073|FG000|Overall Study|Found ineligible after enrollment|3|||
130128448|NCT02262377|468434074|FG001|Overall Study|Found ineligible after enrollment|0|||
130128449|NCT02262377|468434073|FG000|Overall Study|Withdrawal by Subject|4|||
130128450|NCT02262377|468434074|FG001|Overall Study|Withdrawal by Subject|0|||
130128451|NCT00371839|468434076|FG000|Overall Study|Death|4|||
130128452|NCT00371839|468434077|FG001|Overall Study|Death|0|||
130128453|NCT00371839|468434078|FG002|Overall Study|Death|0|||
130128454|NCT00371839|468434076|FG000|Overall Study|Withdrawal by Subject|7|||
130128455|NCT00371839|468434077|FG001|Overall Study|Withdrawal by Subject|4|||
130128456|NCT00371839|468434078|FG002|Overall Study|Withdrawal by Subject|0|||
130128457|NCT00371839|468434076|FG000|Overall Study|Lost to Follow-up|6|||
130128458|NCT00371839|468434077|FG001|Overall Study|Lost to Follow-up|3|||
130128459|NCT00371839|468434078|FG002|Overall Study|Lost to Follow-up|2|||
130128460|NCT00723528|468434079|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
130128461|NCT00723528|468434080|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
130128462|NCT00723528|468434081|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
130128463|NCT00723528|468434082|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
130128464|NCT00723528|468434083|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
130128465|NCT00723528|468434084|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
130128466|NCT00723528|468434085|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
130128467|NCT00723528|468434079|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
130128468|NCT00723528|468434080|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130128469|NCT00723528|468434081|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130128470|NCT00723528|468434082|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130128471|NCT00723528|468434083|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130128472|NCT00723528|468434084|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130128473|NCT00723528|468434085|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
130128474|NCT00723528|468434079|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
130128475|NCT00723528|468434080|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
130128476|NCT00723528|468434081|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
130128477|NCT00723528|468434082|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
130128478|NCT00723528|468434083|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
130128479|NCT00723528|468434084|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
130128480|NCT00723528|468434085|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
130128481|NCT00723528|468434079|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130128482|NCT00723528|468434080|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130128483|NCT00723528|468434081|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
130128484|NCT00723528|468434082|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130128485|NCT00723528|468434083|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130128486|NCT00723528|468434084|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130128487|NCT00723528|468434085|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
130128488|NCT00723528|468434079|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
130128489|NCT00723528|468434080|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130128490|NCT00723528|468434081|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
130128491|NCT00723528|468434082|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130128492|NCT00723528|468434083|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130128493|NCT00723528|468434084|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130128494|NCT00723528|468434085|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
130128495|NCT00723528|468434079|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130128496|NCT00723528|468434080|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130128497|NCT00723528|468434081|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130128498|NCT00723528|468434082|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130128499|NCT00723528|468434083|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
130128500|NCT00723528|468434084|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130128501|NCT00723528|468434085|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
130128502|NCT00723528|468434079|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130128503|NCT00723528|468434080|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130128504|NCT00723528|468434081|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130128505|NCT00723528|468434082|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130128506|NCT00723528|468434083|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130128507|NCT00723528|468434084|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
130128508|NCT00723528|468434085|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
130128509|NCT00723528|468434079|FG000|Period 2: After Controlled Period|Other|0|||
130128510|NCT00723528|468434080|FG001|Period 2: After Controlled Period|Other|0|||
130128511|NCT00723528|468434081|FG002|Period 2: After Controlled Period|Other|0|||
130128512|NCT00723528|468434082|FG003|Period 2: After Controlled Period|Other|0|||
130128513|NCT00723528|468434083|FG004|Period 2: After Controlled Period|Other|1|||
130128514|NCT00723528|468434084|FG005|Period 2: After Controlled Period|Other|4|||
130128515|NCT00723528|468434085|FG006|Period 2: After Controlled Period|Other|0|||
130128516|NCT00723528|468434079|FG000|Period 2: After Controlled Period|Adverse Event|0|||
130128517|NCT00723528|468434080|FG001|Period 2: After Controlled Period|Adverse Event|0|||
130128518|NCT00723528|468434081|FG002|Period 2: After Controlled Period|Adverse Event|0|||
130128519|NCT00723528|468434082|FG003|Period 2: After Controlled Period|Adverse Event|0|||
130128520|NCT00723528|468434083|FG004|Period 2: After Controlled Period|Adverse Event|1|||
130128521|NCT00723528|468434084|FG005|Period 2: After Controlled Period|Adverse Event|0|||
130128522|NCT00723528|468434085|FG006|Period 2: After Controlled Period|Adverse Event|1|||
130128523|NCT00723528|468434079|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130154898|NCT01470612|468526638|FG000|Overall Study|Did not meet entrance criteria|0|||
130093535|NCT01072175|468296958|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093536|NCT01072175|468296959|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
130093537|NCT01072175|468296947|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093538|NCT01072175|468296948|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093539|NCT01072175|468296949|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093540|NCT01072175|468296950|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093541|NCT01072175|468296951|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093542|NCT01072175|468296952|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
130093543|NCT01072175|468296953|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
130093544|NCT01072175|468296954|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093545|NCT01072175|468296955|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093546|NCT01072175|468296956|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093547|NCT01072175|468296957|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093548|NCT01072175|468296958|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093549|NCT01072175|468296959|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
130093550|NCT01072175|468296947|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093551|NCT01072175|468296948|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093552|NCT01072175|468296949|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093553|NCT01072175|468296950|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129970721|NCT00250432|467856591|FG001|Overall Study|Adverse Event|29|||
130128524|NCT00723528|468434080|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130128525|NCT00723528|468434081|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130128526|NCT00723528|468434082|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130128527|NCT00723528|468434083|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130128528|NCT00723528|468434084|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
130128529|NCT00723528|468434085|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
130128530|NCT00723528|468434079|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130128531|NCT00723528|468434080|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130128532|NCT00723528|468434081|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130128533|NCT00723528|468434082|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130128534|NCT00723528|468434083|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130128535|NCT00723528|468434084|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
130128536|NCT00723528|468434085|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
130128537|NCT01993030|468434086|FG000|Overall Study|Adverse Event|0|||
130128538|NCT01993030|468434087|FG001|Overall Study|Adverse Event|4|||
130128539|NCT01710657|468434088|FG000|Overall Study|Lost to Follow-up|2|||
130128540|NCT01710657|468434089|FG001|Overall Study|Lost to Follow-up|0|||
130128541|NCT01710657|468434090|FG002|Overall Study|Lost to Follow-up|1|||
130128542|NCT01710657|468434088|FG000|Overall Study|Protocol Violation|2|||
130128543|NCT01710657|468434089|FG001|Overall Study|Protocol Violation|2|||
130128544|NCT01710657|468434090|FG002|Overall Study|Protocol Violation|0|||
130128545|NCT01710657|468434088|FG000|Overall Study|Adverse Event|14|||
130128546|NCT01710657|468434089|FG001|Overall Study|Adverse Event|8|||
130128547|NCT01710657|468434090|FG002|Overall Study|Adverse Event|28|||
130128548|NCT01710657|468434088|FG000|Overall Study|Withdrawal by Subject|0|||
130128549|NCT01710657|468434089|FG001|Overall Study|Withdrawal by Subject|1|||
130128550|NCT01710657|468434090|FG002|Overall Study|Withdrawal by Subject|2|||
130128551|NCT01710657|468434088|FG000|Overall Study|Lack of Efficacy|0|||
130128552|NCT01710657|468434089|FG001|Overall Study|Lack of Efficacy|1|||
130128553|NCT01710657|468434090|FG002|Overall Study|Lack of Efficacy|1|||
130128554|NCT01591785|468434093|FG000|Overall Study|worsening condition|1|||
129970722|NCT00250432|467856590|FG000|Overall Study|Lack of Efficacy|2|||
129970723|NCT00250432|467856591|FG001|Overall Study|Lack of Efficacy|1|||
129970724|NCT00250432|467856590|FG000|Overall Study|Lost to Follow-up|6|||
129970725|NCT00250432|467856591|FG001|Overall Study|Lost to Follow-up|5|||
129970726|NCT00250432|467856590|FG000|Overall Study|Patient Moved|0|||
129970727|NCT00250432|467856591|FG001|Overall Study|Patient Moved|1|||
129970728|NCT00250432|467856590|FG000|Overall Study|Protocol Violation|0|||
129970729|NCT00250432|467856591|FG001|Overall Study|Protocol Violation|3|||
129970730|NCT00250432|467856590|FG000|Overall Study|Withdrawal by Subject|6|||
129970731|NCT00250432|467856591|FG001|Overall Study|Withdrawal by Subject|2|||
129970732|NCT00250432|467856590|FG000|Overall Study|Pt died out of posttherapy report period|6|||
129970733|NCT00250432|467856591|FG001|Overall Study|Pt died out of posttherapy report period|5|||
129970734|NCT00250432|467856590|FG000|Overall Study|Pt was considered untreatable|0|||
129970735|NCT00250432|467856591|FG001|Overall Study|Pt was considered untreatable|1|||
129970736|NCT00658606|467856592|FG000|Overall Study|Adverse Event|2|||
129970737|NCT00658606|467856593|FG001|Overall Study|Adverse Event|1|||
129970738|NCT00658606|467856592|FG000|Overall Study|Lack of Efficacy|6|||
129970739|NCT00658606|467856593|FG001|Overall Study|Lack of Efficacy|3|||
129970740|NCT00658606|467856592|FG000|Overall Study|Lost to Follow-up|1|||
129970741|NCT00658606|467856593|FG001|Overall Study|Lost to Follow-up|0|||
129970742|NCT00658606|467856592|FG000|Overall Study|Withdrawal by Subject|7|||
129970743|NCT00658606|467856593|FG001|Overall Study|Withdrawal by Subject|16|||
129970744|NCT00658606|467856592|FG000|Overall Study|Lack of Compliance|0|||
129970745|NCT00658606|467856593|FG001|Overall Study|Lack of Compliance|3|||
129970746|NCT00583947|467856594|FG000|Cross-over Period|Adverse Event|2|||
129970747|NCT00583947|467856595|FG001|Cross-over Period|Adverse Event|0|||
129970748|NCT00583947|467856594|FG000|Cross-over Period|Withdrawal by Subject|2|||
129970749|NCT00583947|467856595|FG001|Cross-over Period|Withdrawal by Subject|0|||
129970750|NCT00583947|467856594|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
129970751|NCT00583947|467856595|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
129970752|NCT00583947|467856594|FG000|Cross-over Period|Other|1|||
130128555|NCT01591785|468434094|FG001|Overall Study|worsening condition|2|||
130128556|NCT01591785|468434093|FG000|Overall Study|Protocol Violation|2|||
129970753|NCT00583947|467856595|FG001|Cross-over Period|Other|1|||
129970754|NCT02559310|467856597|FG000|Overall Study|Death|4|||
129970755|NCT02559310|467856598|FG001|Overall Study|Death|3|||
129970756|NCT02559310|467856597|FG000|Overall Study|Lost to Follow-up|5|||
129970757|NCT02559310|467856598|FG001|Overall Study|Lost to Follow-up|3|||
129970758|NCT02559310|467856597|FG000|Overall Study|Physician Decision|2|||
129970759|NCT02559310|467856598|FG001|Overall Study|Physician Decision|1|||
129970760|NCT02559310|467856597|FG000|Overall Study|Withdrawal by Subject|13|||
129970761|NCT02559310|467856598|FG001|Overall Study|Withdrawal by Subject|9|||
130128557|NCT01591785|468434094|FG001|Overall Study|Protocol Violation|0|||
130128558|NCT01591785|468434093|FG000|Overall Study|Lost to Follow-up|1|||
130128559|NCT01591785|468434094|FG001|Overall Study|Lost to Follow-up|0|||
130128560|NCT00667862|468434095|FG000|Overall Study|Adverse Event|9|||
130128561|NCT00667862|468434095|FG000|Overall Study|Death|1|||
130128562|NCT00667862|468434095|FG000|Overall Study|Disease Progression|22|||
130128563|NCT00667862|468434095|FG000|Overall Study|Withdrawal by Subject|3|||
130128564|NCT00905346|468434099|FG000|Period 1|Withdrawal by Subject|1|||
130128565|NCT00905346|468434100|FG001|Period 1|Withdrawal by Subject|0|||
130128566|NCT01435265|468434101|FG000|Overall Study|Lost to Follow-up|0|||
130128567|NCT01435265|468434102|FG001|Overall Study|Lost to Follow-up|1|||
130128568|NCT00909610|468434105|FG000|Period: First Intervention|Adverse Event|0|||
130128569|NCT00909610|468434106|FG001|Period: First Intervention|Adverse Event|1|||
130128570|NCT00909610|468434105|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
130128571|NCT00909610|468434106|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
130128572|NCT00909610|468434105|FG000|Period: Second Intervention|Adverse Event|1|||
130128573|NCT00909610|468434106|FG001|Period: Second Intervention|Adverse Event|0|||
130128574|NCT05612724|468434113|FG000|Overall Study|Lost to Follow-up|4|||
130128575|NCT02128997|468434114|FG000|Overall Study|Lost to Follow-up|6|||
130128576|NCT02128997|468434115|FG001|Overall Study|Lost to Follow-up|11|||
130128577|NCT04000815|468434122|FG000|Overall Study|Lost to Follow-up|9|||
130128578|NCT04000815|468434123|FG001|Overall Study|Lost to Follow-up|2|||
130128579|NCT04000815|468434124|FG002|Overall Study|Lost to Follow-up|3|||
129970762|NCT02559310|467856597|FG000|Overall Study|Sponsor Decision|0|||
129970763|NCT02559310|467856598|FG001|Overall Study|Sponsor Decision|1|||
130128580|NCT04000815|468434122|FG000|Overall Study|Withdrawal by Subject|4|||
130128581|NCT04000815|468434123|FG001|Overall Study|Withdrawal by Subject|3|||
130128582|NCT04000815|468434124|FG002|Overall Study|Withdrawal by Subject|2|||
130128583|NCT04000815|468434122|FG000|Overall Study|Right ovarian cyst occured|1|||
130128584|NCT04000815|468434123|FG001|Overall Study|Right ovarian cyst occured|0|||
130128585|NCT04000815|468434124|FG002|Overall Study|Right ovarian cyst occured|0|||
130128586|NCT04000815|468434122|FG000|Overall Study|Hypertension occured on follow up|0|||
130128587|NCT04000815|468434123|FG001|Overall Study|Hypertension occured on follow up|0|||
130128588|NCT04000815|468434124|FG002|Overall Study|Hypertension occured on follow up|2|||
130128589|NCT00239577|468434125|FG000|Primary Phase|Adverse Event|0|||
130128590|NCT00239577|468434126|FG001|Primary Phase|Adverse Event|0|||
130128591|NCT00239577|468434127|FG002|Primary Phase|Adverse Event|1|||
130128592|NCT00239577|468434128|FG003|Primary Phase|Adverse Event|0|||
130128593|NCT00239577|468434125|FG000|Primary Phase|Other|5|||
130128594|NCT00239577|468434126|FG001|Primary Phase|Other|3|||
130128595|NCT00239577|468434127|FG002|Primary Phase|Other|2|||
130128596|NCT00239577|468434128|FG003|Primary Phase|Other|0|||
130128597|NCT03988803|468434131|FG000|Period 2|Prematurely discontinued from medication|2|||
130128598|NCT03988803|468434131|FG000|Period 2|Adverse Event|1|||
130128599|NCT02736721|468434132|FG000|Overall Study|Adverse Event|8|||
130128600|NCT02736721|468434132|FG000|Overall Study|Lost to Follow-up|3|||
130128601|NCT02736721|468434132|FG000|Overall Study|Other|5|||
130128602|NCT03021018|468434134|FG000|Overall Study|Adverse Event|1|||
130128603|NCT03021018|468434135|FG001|Overall Study|Adverse Event|0|||
130128604|NCT03021018|468434136|FG002|Overall Study|Adverse Event|0|||
130128605|NCT03021018|468434134|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
130128606|NCT03021018|468434135|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
130128607|NCT03021018|468434136|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
130128608|NCT04123548|468434147|FG000|Overall Study|Withdrawal by Subject|1|||
129970764|NCT02559310|467856597|FG000|Overall Study|Randomized but not treated|3|||
129970765|NCT02559310|467856598|FG001|Overall Study|Randomized but not treated|2|||
130128609|NCT04123548|468434147|FG000|Overall Study|Lost to Follow-up|8|||
130128610|NCT04123548|468434147|FG000|Overall Study|Death|4|||
130128611|NCT04123548|468434147|FG000|Overall Study|Reason Not Specified|1|||
130128612|NCT00418184|468434150|FG000|Double-blind Phase|Withdrawal by Subject|22|||
130128613|NCT00418184|468434151|FG001|Double-blind Phase|Withdrawal by Subject|9|||
130128614|NCT00418184|468434150|FG000|Double-blind Phase|Adverse Event|2|||
130128615|NCT00418184|468434151|FG001|Double-blind Phase|Adverse Event|1|||
130128616|NCT00418184|468434150|FG000|Double-blind Phase|Poor compliance|3|||
130128617|NCT00418184|468434151|FG001|Double-blind Phase|Poor compliance|1|||
130128618|NCT00620074|468434152|FG000|Overall Study|Adverse Event|1|||
130128619|NCT01838941|468434153|FG000|Overall Study|Adverse Event|1|||
130128620|NCT01838941|468434153|FG000|Overall Study|Withdrawal by Subject|1|||
130128621|NCT02822235|468434154|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
130128622|NCT02822235|468434155|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
130128623|NCT02822235|468434154|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
130128624|NCT02822235|468434155|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
130128625|NCT02822235|468434154|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
130128626|NCT02822235|468434155|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
130128627|NCT02822235|468434154|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
130128628|NCT02822235|468434155|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
130128629|NCT02822235|468434154|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
130128630|NCT02822235|468434155|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
130128631|NCT02822235|468434154|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
130128632|NCT02822235|468434155|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
130128633|NCT03214952|468434156|FG000|Overall Study|Protocol Deviation|45|||
130128634|NCT03214952|468434156|FG000|Overall Study|Case Report Forms Uncollected|13|||
130128635|NCT03769896|468434159|FG000|Open-label Phase|Lack of Efficacy|5|||
130128636|NCT03769896|468434160|FG001|Open-label Phase|Lack of Efficacy|0|||
130128637|NCT03769896|468434159|FG000|Open-label Phase|Adverse Event|3|||
130128638|NCT03769896|468434160|FG001|Open-label Phase|Adverse Event|0|||
130128639|NCT03769896|468434159|FG000|Open-label Phase|Withdrawal by Subject|1|||
130128640|NCT03769896|468434160|FG001|Open-label Phase|Withdrawal by Subject|0|||
130128641|NCT00829530|468434161|FG000|First Intervention|Adverse Event|0|||
130128642|NCT00829530|468434162|FG001|First Intervention|Adverse Event|1|||
130128643|NCT00829530|468434161|FG000|First Intervention|Intolerance to Venopuncture|0|||
130128644|NCT00829530|468434162|FG001|First Intervention|Intolerance to Venopuncture|1|||
130128645|NCT00829530|468434161|FG000|Second Intervention|Intolerance to Venopuncture|1|||
130128646|NCT00829530|468434162|FG001|Second Intervention|Intolerance to Venopuncture|0|||
130128647|NCT01015625|468434165|FG000|Overall Study|Lost to Follow-up|3|||
130128648|NCT01015625|468434166|FG001|Overall Study|Lost to Follow-up|1|||
130128649|NCT01015625|468434165|FG000|Overall Study|Withdrawal by Subject|2|||
130128650|NCT01015625|468434166|FG001|Overall Study|Withdrawal by Subject|3|||
130128651|NCT01015625|468434165|FG000|Overall Study|Physician Decision|2|||
130128652|NCT01015625|468434166|FG001|Overall Study|Physician Decision|0|||
130128653|NCT01015625|468434165|FG000|Overall Study|Death|30|||
130128654|NCT01015625|468434166|FG001|Overall Study|Death|22|||
130128655|NCT04112823|468434167|FG000|Overall Study|Lost to Follow-up|2|||
130128656|NCT04112823|468434168|FG001|Overall Study|Lost to Follow-up|3|||
130128657|NCT00625443|468434169|FG000|Overall Study|Adverse Event|1|||
130128658|NCT00625443|468434170|FG001|Overall Study|Adverse Event|4|||
130128659|NCT00625443|468434171|FG002|Overall Study|Adverse Event|0|||
130128660|NCT00625443|468434169|FG000|Overall Study|Non-compliance with protocol|0|||
130128661|NCT00625443|468434170|FG001|Overall Study|Non-compliance with protocol|1|||
130128662|NCT00625443|468434171|FG002|Overall Study|Non-compliance with protocol|0|||
130128663|NCT00625443|468434169|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
130128664|NCT00625443|468434170|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
130128665|NCT00625443|468434171|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
130128666|NCT00625443|468434169|FG000|Overall Study|Withdrawal by Subject|0|||
130128667|NCT00625443|468434170|FG001|Overall Study|Withdrawal by Subject|1|||
130128668|NCT00625443|468434171|FG002|Overall Study|Withdrawal by Subject|2|||
130128669|NCT00625443|468434169|FG000|Overall Study|Physician Decision|0|||
130128670|NCT00625443|468434170|FG001|Overall Study|Physician Decision|4|||
130128671|NCT00625443|468434171|FG002|Overall Study|Physician Decision|2|||
130128672|NCT00625443|468434169|FG000|Overall Study|Other|0|||
130128673|NCT00625443|468434170|FG001|Overall Study|Other|1|||
130128674|NCT00625443|468434171|FG002|Overall Study|Other|1|||
130128675|NCT02472366|468434172|FG000|Overall Study|Lost to Follow-up|1|||
130128676|NCT02472366|468434173|FG001|Overall Study|Lost to Follow-up|0|||
130128677|NCT02728102|468434174|FG000|Overall Study|Death|3|||
130128678|NCT02728102|468434175|FG001|Overall Study|Death|0|||
130128679|NCT02728102|468434176|FG002|Overall Study|Death|1|||
130128680|NCT02728102|468434174|FG000|Overall Study|Withdrawal by Subject|0|||
130128681|NCT02728102|468434175|FG001|Overall Study|Withdrawal by Subject|2|||
130128682|NCT02728102|468434176|FG002|Overall Study|Withdrawal by Subject|3|||
130128683|NCT02728102|468434174|FG000|Overall Study|Physician Decision|1|||
130128684|NCT02728102|468434175|FG001|Overall Study|Physician Decision|1|||
130128685|NCT02728102|468434176|FG002|Overall Study|Physician Decision|0|||
130128686|NCT02728102|468434174|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
130128687|NCT02728102|468434175|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
130128688|NCT02728102|468434176|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
130128689|NCT02728102|468434174|FG000|Overall Study|Covid|0|||
130128690|NCT02728102|468434175|FG001|Overall Study|Covid|0|||
130128691|NCT02728102|468434176|FG002|Overall Study|Covid|1|||
130128692|NCT01182415|468434177|FG000|Overall Study|Lost to Follow-up|1|||
130128693|NCT02587962|468434179|FG000|Overall Study|Adverse Event|0|||
130128694|NCT02587962|468434180|FG001|Overall Study|Adverse Event|0|||
130128695|NCT02587962|468434181|FG002|Overall Study|Adverse Event|1|||
130128696|NCT02587962|468434182|FG003|Overall Study|Adverse Event|0|||
130128697|NCT02587962|468434183|FG004|Overall Study|Adverse Event|0|||
130128698|NCT02587962|468434179|FG000|Overall Study|Withdrawal by Subject|0|||
130128699|NCT02587962|468434180|FG001|Overall Study|Withdrawal by Subject|0|||
130128700|NCT02587962|468434181|FG002|Overall Study|Withdrawal by Subject|1|||
130128701|NCT02587962|468434182|FG003|Overall Study|Withdrawal by Subject|1|||
130128702|NCT02587962|468434183|FG004|Overall Study|Withdrawal by Subject|4|||
130128703|NCT02587962|468434179|FG000|Overall Study|Radiological progression|2|||
130128704|NCT02587962|468434180|FG001|Overall Study|Radiological progression|2|||
130128705|NCT02587962|468434181|FG002|Overall Study|Radiological progression|2|||
130093554|NCT01072175|468296951|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093555|NCT01072175|468296952|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093556|NCT01072175|468296953|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093557|NCT01072175|468296954|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093558|NCT01072175|468296955|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
130093559|NCT01072175|468296956|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093560|NCT01072175|468296957|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093561|NCT01072175|468296958|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093562|NCT01072175|468296959|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
130093563|NCT01072175|468296947|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093564|NCT01072175|468296948|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093565|NCT01072175|468296949|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093566|NCT01072175|468296950|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093567|NCT01072175|468296951|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093568|NCT01072175|468296952|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093569|NCT01072175|468296953|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093570|NCT01072175|468296954|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093571|NCT01072175|468296955|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
130093572|NCT01072175|468296956|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093573|NCT01072175|468296957|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093574|NCT01072175|468296958|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093575|NCT01072175|468296959|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
130093576|NCT01072175|468296947|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093577|NCT01072175|468296948|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093578|NCT01072175|468296949|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093579|NCT01072175|468296950|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093580|NCT01072175|468296951|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093581|NCT01072175|468296952|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093582|NCT01072175|468296953|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093583|NCT01072175|468296954|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093584|NCT01072175|468296955|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
130093585|NCT01072175|468296956|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093586|NCT01072175|468296957|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093587|NCT01072175|468296958|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093588|NCT01072175|468296959|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
130093589|NCT01072175|468296947|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093590|NCT01072175|468296948|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093591|NCT01072175|468296949|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093592|NCT01072175|468296950|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093593|NCT01072175|468296951|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093594|NCT01072175|468296952|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093595|NCT01072175|468296953|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093596|NCT01072175|468296954|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093597|NCT01072175|468296955|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
130093598|NCT01072175|468296956|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093599|NCT01072175|468296957|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093600|NCT01072175|468296958|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093601|NCT01072175|468296959|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
130093602|NCT01072175|468296947|FG000|Part D (HPMC Capsules)|Death|0|||
130093603|NCT01072175|468296948|FG001|Part D (HPMC Capsules)|Death|0|||
130093604|NCT01072175|468296949|FG002|Part D (HPMC Capsules)|Death|0|||
130093605|NCT01072175|468296950|FG003|Part D (HPMC Capsules)|Death|0|||
130093606|NCT01072175|468296951|FG004|Part D (HPMC Capsules)|Death|0|||
130093607|NCT01072175|468296952|FG005|Part D (HPMC Capsules)|Death|0|||
130093608|NCT01072175|468296953|FG006|Part D (HPMC Capsules)|Death|0|||
130093609|NCT01072175|468296954|FG007|Part D (HPMC Capsules)|Death|0|||
130093610|NCT01072175|468296955|FG008|Part D (HPMC Capsules)|Death|0|||
130093611|NCT01072175|468296956|FG009|Part D (HPMC Capsules)|Death|10|||
130093612|NCT01072175|468296957|FG010|Part D (HPMC Capsules)|Death|12|||
130093613|NCT01072175|468296958|FG011|Part D (HPMC Capsules)|Death|28|||
130093614|NCT01072175|468296959|FG012|Part D (HPMC Capsules)|Death|26|||
130093615|NCT01072175|468296947|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
130093616|NCT01072175|468296948|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
129970766|NCT01740154|467856599|FG000|Overall Study|Adverse Event|1|||
129970767|NCT00469859|467856600|FG000|Overall Study|Inevaluable|0|||
130093617|NCT01072175|468296949|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
129970768|NCT00469859|467856601|FG001|Overall Study|Inevaluable|2|||
130128706|NCT02587962|468434182|FG003|Overall Study|Radiological progression|5|||
130128707|NCT02587962|468434183|FG004|Overall Study|Radiological progression|10|||
130128708|NCT02587962|468434179|FG000|Overall Study|Clinical progression|0|||
130128709|NCT02587962|468434180|FG001|Overall Study|Clinical progression|1|||
130128710|NCT02587962|468434181|FG002|Overall Study|Clinical progression|2|||
130128711|NCT02587962|468434182|FG003|Overall Study|Clinical progression|0|||
130128712|NCT02587962|468434183|FG004|Overall Study|Clinical progression|1|||
130128713|NCT01422538|468434187|FG000|Overall Study|Lost to Follow-up|0|||
130128714|NCT01422538|468434188|FG001|Overall Study|Lost to Follow-up|1|||
130128715|NCT01422538|468434189|FG002|Overall Study|Lost to Follow-up|1|||
130128716|NCT01422538|468434187|FG000|Overall Study|Missed visit|0|||
130128717|NCT01422538|468434188|FG001|Overall Study|Missed visit|1|||
130128718|NCT01422538|468434189|FG002|Overall Study|Missed visit|1|||
130128719|NCT02770820|468434190|FG000|Overall Study|Death|1|||
130128720|NCT02770820|468434190|FG000|Overall Study|Physician Decision|2|||
130128721|NCT02098876|468434193|FG000|Overall Study|Withdrawal by Subject|5|||
130128722|NCT02098876|468434194|FG001|Overall Study|Withdrawal by Subject|5|||
130128723|NCT01061866|468434195|FG000|Overall Study|Adverse Event|2|||
130128724|NCT00772941|468434196|FG000|Overall Study|CRFs not available|195|||
130128725|NCT00772941|468434196|FG000|Overall Study|Study not completed|16|||
130128726|NCT00772941|468434196|FG000|Overall Study|Missed Visits|374|||
130128727|NCT00772941|468434196|FG000|Overall Study|Poor Compliance|7|||
130128728|NCT00772941|468434196|FG000|Overall Study|GPSP Violation|90|||
130128729|NCT04786184|468434197|FG000|Overall Study|Adverse Event|4|||
130128730|NCT04786184|468434198|FG001|Overall Study|Adverse Event|0|||
130128731|NCT04786184|468434197|FG000|Overall Study|Withdrawal by Subject|3|||
130128732|NCT04786184|468434198|FG001|Overall Study|Withdrawal by Subject|1|||
130128733|NCT04786184|468434197|FG000|Overall Study|Lost to Follow-up|4|||
130128734|NCT04786184|468434198|FG001|Overall Study|Lost to Follow-up|2|||
130128735|NCT00834756|468434199|FG000|First Intervention|Adverse Event|1|||
130128736|NCT00834756|468434200|FG001|First Intervention|Adverse Event|0|||
130128737|NCT00834756|468434199|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130128738|NCT00834756|468434200|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
130128739|NCT02017223|468434213|FG000|Overall Study|Algorithm problems|2|||
130128740|NCT04263649|468434215|FG000|Overall Study|Adverse Event|53|||
130128741|NCT04263649|468434215|FG000|Overall Study|Lost to Follow-up|3|||
130128742|NCT04263649|468434215|FG000|Overall Study|Death|29|||
130128743|NCT04263649|468434215|FG000|Overall Study|Device deficiency|19|||
130128744|NCT04263649|468434215|FG000|Overall Study|other reasons|11|||
130128745|NCT01534520|468434216|FG000|Overall Study|Adverse Event|0|||
130128746|NCT01534520|468434217|FG001|Overall Study|Adverse Event|1|||
130128747|NCT01079988|468434220|FG000|Overall Study|Lost to Follow-up|0|||
130128748|NCT01079988|468434221|FG001|Overall Study|Lost to Follow-up|0|||
130128749|NCT01079988|468434222|FG002|Overall Study|Lost to Follow-up|0|||
130128750|NCT01079988|468434223|FG003|Overall Study|Lost to Follow-up|1|||
130128751|NCT01079988|468434224|FG004|Overall Study|Lost to Follow-up|0|||
130128752|NCT01079988|468434220|FG000|Overall Study|Lack of Efficacy|1|||
130128753|NCT01079988|468434221|FG001|Overall Study|Lack of Efficacy|0|||
130128754|NCT01079988|468434222|FG002|Overall Study|Lack of Efficacy|0|||
130128755|NCT01079988|468434223|FG003|Overall Study|Lack of Efficacy|0|||
130128756|NCT01079988|468434224|FG004|Overall Study|Lack of Efficacy|0|||
130128757|NCT01079988|468434220|FG000|Overall Study|Other|0|||
130128758|NCT01079988|468434221|FG001|Overall Study|Other|0|||
130128759|NCT01079988|468434222|FG002|Overall Study|Other|0|||
130128760|NCT01079988|468434223|FG003|Overall Study|Other|2|||
130128761|NCT01079988|468434224|FG004|Overall Study|Other|1|||
129970769|NCT05226130|467856602|FG000|Overall Study|Lost to Follow-up|0|||
129970770|NCT05226130|467856603|FG001|Overall Study|Lost to Follow-up|1|||
129970771|NCT05226130|467856602|FG000|Overall Study|Not treatment adherent|0|||
130128762|NCT02392000|468434229|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
130128763|NCT02392000|468434229|FG000|Overall Study|Withdrawal by Subject|1|||
130128764|NCT02392000|468434229|FG000|Overall Study|Lost to Follow-up|8|||
130128765|NCT06358820|468435711|FG000|Overall Study|Adverse Event|11|||
130128766|NCT06358820|468435711|FG000|Overall Study|kidney transplantation|3|||
130128767|NCT06358820|468435711|FG000|Overall Study|patient voluntary withdrawal|6|||
130128768|NCT06358820|468435711|FG000|Overall Study|Physician Decision|1|||
130128769|NCT01066143|468435712|FG000|Overall Study|ineligible for the study|8|||
130128770|NCT05376319|468435713|FG000|Overall Study|Funding termination|2|||
130128771|NCT05376319|468435714|FG001|Overall Study|Funding termination|4|||
130128772|NCT01124175|468435715|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130128773|NCT01124175|468435716|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
130128774|NCT00942968|468435719|FG000|Overall Study|Adverse Event|60|||
130128775|NCT00942968|468435719|FG000|Overall Study|Death|76|||
130128776|NCT00942968|468435719|FG000|Overall Study|Protocol Violation|9|||
130128777|NCT00942968|468435719|FG000|Overall Study|Lost to Follow-up|4|||
130128778|NCT00942968|468435719|FG000|Overall Study|Withdrawal by Subject|44|||
130128779|NCT00942968|468435719|FG000|Overall Study|Sponsor request|5|||
130128780|NCT00942968|468435719|FG000|Overall Study|Physician Decision|11|||
130128781|NCT00942968|468435719|FG000|Overall Study|Progression of disease|12|||
130128782|NCT00942968|468435719|FG000|Overall Study|Inferior vena cava filter placement|4|||
130128783|NCT00942968|468435719|FG000|Overall Study|Pulmonary embolism (PE)|1|||
130128784|NCT00942968|468435719|FG000|Overall Study|Participant required pancreatic biopsy|1|||
130128785|NCT00942968|468435719|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
130128786|NCT00218257|468435725|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
130128787|NCT00218257|468435726|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
130128788|NCT01466166|468435727|FG000|Overall Study|Death|1|||
130128789|NCT01466166|468435727|FG000|Overall Study|Lost to Follow-up|7|||
130128790|NCT01466166|468435727|FG000|Overall Study|Infusion Reaction (IR)|27|||
130128791|NCT01466166|468435727|FG000|Overall Study|Adverse Event (Other than IR)|11|||
130128792|NCT01466166|468435727|FG000|Overall Study|Elevated Serum Uric Acid|78|||
130128793|NCT01466166|468435727|FG000|Overall Study|Withdrawal by Subject|13|||
130128794|NCT01466166|468435727|FG000|Overall Study|Sponsor Decision|4|||
130128795|NCT01466166|468435727|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
130128796|NCT01466166|468435727|FG000|Overall Study|Other|20|||
130128797|NCT01340495|468435734|FG000|Overall Study|Withdrawal by Subject|1|||
130128798|NCT00070291|468435735|FG000|Step 1|Withdrawal by Subject|1|||
130128799|NCT00070291|468435735|FG000|Step 1|Adverse Event|1|||
130128800|NCT00070291|468435735|FG000|Step 2|Adverse Event|1|||
130128801|NCT00520130|468435738|FG000|Overall Study|Disease progression on study|4|||
130128802|NCT00520130|468435739|FG001|Overall Study|Disease progression on study|0|||
130128803|NCT00520130|468435738|FG000|Overall Study|Physician Decision|1|||
130128804|NCT00520130|468435739|FG001|Overall Study|Physician Decision|1|||
130128805|NCT02028715|468435742|FG000|Overall Study|Adverse Event|2|||
130128806|NCT02028715|468435743|FG001|Overall Study|Adverse Event|2|||
130128807|NCT02028715|468435742|FG000|Overall Study|Physician Decision|1|||
130128808|NCT02028715|468435743|FG001|Overall Study|Physician Decision|0|||
130128809|NCT02028715|468435742|FG000|Overall Study|Did not complete satisfaction surveys|2|||
130128810|NCT02028715|468435743|FG001|Overall Study|Did not complete satisfaction surveys|2|||
130128811|NCT04915755|468435744|FG000|Overall Study|Physician Decision|3|||
130128812|NCT04915755|468435745|FG001|Overall Study|Physician Decision|2|||
130128813|NCT04915755|468435744|FG000|Overall Study|Withdrawal by Subject|1|||
130128814|NCT04915755|468435745|FG001|Overall Study|Withdrawal by Subject|1|||
130128815|NCT04915755|468435744|FG000|Overall Study|Ongoing for PACT|3|||
130128816|NCT04915755|468435745|FG001|Overall Study|Ongoing for PACT|2|||
130128817|NCT04915755|468435744|FG000|Overall Study|Other|7|||
130128818|NCT04915755|468435745|FG001|Overall Study|Other|11|||
130128819|NCT02533258|468435746|FG000|Overall Study|Adverse Event|1|||
130128820|NCT02533258|468435746|FG000|Overall Study|Death|2|||
130128821|NCT02533258|468435746|FG000|Overall Study|Other|1|||
130128822|NCT02533258|468435746|FG000|Overall Study|Economic factor|1|||
130128823|NCT02533258|468435746|FG000|Overall Study|Progression of pleural effusion|1|||
130128824|NCT02533258|468435746|FG000|Overall Study|Lack of Efficacy|2|||
130128825|NCT02495857|468435748|FG000|Overall Study|Adverse Event|5|||
130128826|NCT02495857|468435749|FG001|Overall Study|Adverse Event|0|||
130128827|NCT02495857|468435750|FG002|Overall Study|Adverse Event|1|||
130128828|NCT02495857|468435748|FG000|Overall Study|Withdrawal by Subject|9|||
130128829|NCT02495857|468435749|FG001|Overall Study|Withdrawal by Subject|6|||
130128830|NCT02495857|468435750|FG002|Overall Study|Withdrawal by Subject|10|||
130128831|NCT02495857|468435748|FG000|Overall Study|Physician Decision|0|||
130128832|NCT02495857|468435749|FG001|Overall Study|Physician Decision|1|||
130128833|NCT02495857|468435750|FG002|Overall Study|Physician Decision|0|||
130128834|NCT02495857|468435748|FG000|Overall Study|Protocol Violation|1|||
130128835|NCT02495857|468435749|FG001|Overall Study|Protocol Violation|1|||
130128836|NCT02495857|468435750|FG002|Overall Study|Protocol Violation|2|||
130128837|NCT02495857|468435748|FG000|Overall Study|Lost to Follow-up|4|||
130128838|NCT02495857|468435749|FG001|Overall Study|Lost to Follow-up|5|||
130128839|NCT02495857|468435750|FG002|Overall Study|Lost to Follow-up|3|||
130128840|NCT02495857|468435748|FG000|Overall Study|Other|3|||
130128841|NCT02495857|468435749|FG001|Overall Study|Other|3|||
130128842|NCT02495857|468435750|FG002|Overall Study|Other|2|||
130128843|NCT00396279|468435751|FG000|Overall Study|Ongoing in study|26|||
130128844|NCT00396279|468435751|FG000|Overall Study|Disease progression|2|||
130128845|NCT00396279|468435751|FG000|Overall Study|Withdrawal by Subject|1|||
130128846|NCT00396279|468435751|FG000|Overall Study|Physician Decision|1|||
130128847|NCT02883452|468435752|FG000|Overall Study|Withdrawal by Subject|1|||
130128848|NCT02883452|468435753|FG001|Overall Study|Withdrawal by Subject|1|||
130128849|NCT02883452|468435754|FG002|Overall Study|Withdrawal by Subject|3|||
130128850|NCT02883452|468435755|FG003|Overall Study|Withdrawal by Subject|0|||
130128851|NCT02883452|468435756|FG004|Overall Study|Withdrawal by Subject|2|||
130128852|NCT02883452|468435757|FG005|Overall Study|Withdrawal by Subject|5|||
130128853|NCT02883452|468435752|FG000|Overall Study|Disease progression|1|||
130128854|NCT02883452|468435753|FG001|Overall Study|Disease progression|0|||
130128855|NCT02883452|468435754|FG002|Overall Study|Disease progression|0|||
130128856|NCT02883452|468435755|FG003|Overall Study|Disease progression|1|||
130128857|NCT02883452|468435756|FG004|Overall Study|Disease progression|4|||
130128858|NCT02883452|468435757|FG005|Overall Study|Disease progression|5|||
130128859|NCT02883452|468435752|FG000|Overall Study|Adverse Event|2|||
130128860|NCT02883452|468435753|FG001|Overall Study|Adverse Event|1|||
130128861|NCT02883452|468435754|FG002|Overall Study|Adverse Event|1|||
130128862|NCT02883452|468435755|FG003|Overall Study|Adverse Event|1|||
130128863|NCT02883452|468435756|FG004|Overall Study|Adverse Event|1|||
130128864|NCT02883452|468435757|FG005|Overall Study|Adverse Event|3|||
130128865|NCT02883452|468435752|FG000|Overall Study|Physician Decision|0|||
130128866|NCT02883452|468435753|FG001|Overall Study|Physician Decision|0|||
130128867|NCT02883452|468435754|FG002|Overall Study|Physician Decision|0|||
130128868|NCT02883452|468435755|FG003|Overall Study|Physician Decision|0|||
130128869|NCT02883452|468435756|FG004|Overall Study|Physician Decision|4|||
130128870|NCT02883452|468435757|FG005|Overall Study|Physician Decision|1|||
130128871|NCT02883452|468435752|FG000|Overall Study|Death|1|||
130128872|NCT02883452|468435753|FG001|Overall Study|Death|0|||
130128873|NCT02883452|468435754|FG002|Overall Study|Death|1|||
130128874|NCT02883452|468435755|FG003|Overall Study|Death|0|||
130128875|NCT02883452|468435756|FG004|Overall Study|Death|0|||
130128876|NCT02883452|468435757|FG005|Overall Study|Death|0|||
130128877|NCT02883452|468435752|FG000|Overall Study|Other|0|||
130128878|NCT02883452|468435753|FG001|Overall Study|Other|0|||
130128879|NCT02883452|468435754|FG002|Overall Study|Other|0|||
130128880|NCT02883452|468435755|FG003|Overall Study|Other|0|||
130128881|NCT02883452|468435756|FG004|Overall Study|Other|0|||
130128882|NCT02883452|468435757|FG005|Overall Study|Other|1|||
130128883|NCT00830206|468435758|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
130128884|NCT00830206|468435759|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
130128885|NCT04605094|468435761|FG000|Overall Study|Adverse Event|2|||
130128886|NCT04605094|468435762|FG001|Overall Study|Adverse Event|2|||
130128887|NCT04605094|468435761|FG000|Overall Study|Lost to Follow-up|1|||
130128888|NCT04605094|468435762|FG001|Overall Study|Lost to Follow-up|4|||
130128889|NCT04605094|468435761|FG000|Overall Study|Physician Decision|2|||
130128890|NCT04605094|468435762|FG001|Overall Study|Physician Decision|2|||
130128891|NCT04605094|468435761|FG000|Overall Study|Study terminated by Sponsor|31|||
130128892|NCT04605094|468435762|FG001|Overall Study|Study terminated by Sponsor|33|||
130128893|NCT04605094|468435761|FG000|Overall Study|Withdrawal by Subject|22|||
130128894|NCT04605094|468435762|FG001|Overall Study|Withdrawal by Subject|19|||
130128895|NCT04605094|468435761|FG000|Overall Study|Other|1|||
130128896|NCT04605094|468435762|FG001|Overall Study|Other|1|||
130128897|NCT02724462|468435763|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
130128898|NCT02724462|468435764|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
130128899|NCT02724462|468435763|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130128900|NCT02724462|468435764|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130128901|NCT02724462|468435763|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
130128902|NCT02724462|468435764|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
130128903|NCT02724462|468435763|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130128904|NCT02724462|468435764|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130128905|NCT02724462|468435763|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
130128906|NCT02724462|468435764|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
130128907|NCT02724462|468435763|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
130128908|NCT02724462|468435764|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
130128909|NCT01900691|468435765|FG000|Overall Study|Death|7|||
130128910|NCT01900691|468435765|FG000|Overall Study|Lost to Follow-up|4|||
130128911|NCT01900691|468435765|FG000|Overall Study|Study Device Not Placed|3|||
130128912|NCT01900691|468435765|FG000|Overall Study|Non study stent placed|2|||
130128913|NCT01900691|468435765|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
130128914|NCT01900691|468435765|FG000|Overall Study|Complete stent migration through digestive tract|1|||
130128915|NCT01954394|468435768|FG000|Overall Study|Enrolled but not treated|1|||
130128916|NCT01954394|468435769|FG001|Overall Study|Enrolled but not treated|0|||
130128917|NCT01954394|468435768|FG000|Overall Study|Adverse Event|10|||
130128918|NCT01954394|468435769|FG001|Overall Study|Adverse Event|23|||
130128919|NCT01954394|468435768|FG000|Overall Study|Poor compliance to protocol|7|||
130128920|NCT01954394|468435769|FG001|Overall Study|Poor compliance to protocol|7|||
130128921|NCT01954394|468435768|FG000|Overall Study|Participant Moved|0|||
130128922|NCT01954394|468435769|FG001|Overall Study|Participant Moved|4|||
130128923|NCT01954394|468435768|FG000|Overall Study|Related to Study Drug administration|2|||
130128924|NCT01954394|468435769|FG001|Overall Study|Related to Study Drug administration|2|||
130128925|NCT01954394|468435768|FG000|Overall Study|Other than specified above|10|||
130128926|NCT01954394|468435769|FG001|Overall Study|Other than specified above|21|||
130128927|NCT02422264|468435779|FG000|Overall Study|Serious Adverse Event|1|||
130128928|NCT02422264|468435780|FG001|Overall Study|Serious Adverse Event|0|||
130128929|NCT02422264|468435779|FG000|Overall Study|Withdrawal by Subject|1|||
130128930|NCT02422264|468435780|FG001|Overall Study|Withdrawal by Subject|2|||
130128931|NCT02422264|468435779|FG000|Overall Study|Migrated/moved from study area|3|||
130128932|NCT02422264|468435780|FG001|Overall Study|Migrated/moved from study area|1|||
130128933|NCT02422264|468435779|FG000|Overall Study|Subject vaccinated outside of the study|0|||
130128934|NCT02422264|468435780|FG001|Overall Study|Subject vaccinated outside of the study|1|||
130128935|NCT00328926|468435781|FG000|Overall Study|Pregnancy|2|||
130128936|NCT00328926|468435782|FG001|Overall Study|Pregnancy|1|||
130128937|NCT00328926|468435783|FG002|Overall Study|Pregnancy|0|||
130128938|NCT00328926|468435781|FG000|Overall Study|Lost to Follow-up|0|||
130128939|NCT00328926|468435782|FG001|Overall Study|Lost to Follow-up|1|||
130128940|NCT00328926|468435783|FG002|Overall Study|Lost to Follow-up|0|||
130128941|NCT00328926|468435781|FG000|Overall Study|Death|0|||
130128942|NCT00328926|468435782|FG001|Overall Study|Death|0|||
130128943|NCT00328926|468435783|FG002|Overall Study|Death|1|||
130128944|NCT00328926|468435781|FG000|Overall Study|In vitro fertilization treatment|0|||
130128945|NCT00328926|468435782|FG001|Overall Study|In vitro fertilization treatment|0|||
130128946|NCT00328926|468435783|FG002|Overall Study|In vitro fertilization treatment|1|||
130128947|NCT00328926|468435781|FG000|Overall Study|Lack of ovarian response|0|||
130128948|NCT00328926|468435782|FG001|Overall Study|Lack of ovarian response|1|||
130128949|NCT00328926|468435783|FG002|Overall Study|Lack of ovarian response|0|||
130128950|NCT02269657|468435784|FG000|Overall Study|Protocol Violation|3|||
130128951|NCT00851877|468435787|FG000|Phase I-1|Death|1|||
130128952|NCT00851877|468435788|FG001|Phase I-1|Death|0|||
130128953|NCT00851877|468435789|FG002|Phase I-1|Death|0|||
130128954|NCT00851877|468435787|FG000|Phase II|Withdrawal by Subject|0|||
130128955|NCT00851877|468435788|FG001|Phase II|Withdrawal by Subject|0|||
130128956|NCT00851877|468435789|FG002|Phase II|Withdrawal by Subject|3|||
130128957|NCT00829673|468435790|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130128958|NCT00829673|468435791|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
130128959|NCT03450057|468435792|FG000|Overall Study|Death|17|||
130128960|NCT03450057|468435792|FG000|Overall Study|ICF withdrawal|4|||
130128961|NCT03450057|468435792|FG000|Overall Study|Lost to Follow-up|2|||
130128962|NCT00573066|468435793|FG000|Overall Study|Exclusion criteria|18|||
130128963|NCT00573066|468435793|FG000|Overall Study|IV malfunction|1|||
130128964|NCT00573066|468435793|FG000|Overall Study|Postoperative bleeding|1|||
130128965|NCT01034358|468435794|FG000|Overall Study|Withdrawal by Subject|1|||
130128966|NCT01034358|468435794|FG000|Overall Study|Protocol Violation|1|||
130128967|NCT00829790|468435797|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
130128968|NCT00829790|468435798|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
130128969|NCT02246166|468435799|FG000|Overall Study|Protocol Violation|1|||
130128970|NCT02246166|468435800|FG001|Overall Study|Protocol Violation|0|||
130128971|NCT01534663|468435801|FG000|Overall Study|Lost to Follow-up|0|||
130128972|NCT01534663|468435802|FG001|Overall Study|Lost to Follow-up|2|||
130128973|NCT01534663|468435801|FG000|Overall Study|Adverse Event|2|||
130128974|NCT01534663|468435802|FG001|Overall Study|Adverse Event|1|||
130128975|NCT00627016|468435803|FG000|Overall Study|Adverse Event|1|||
130128976|NCT00627016|468435804|FG001|Overall Study|Adverse Event|1|||
130128977|NCT00627016|468435803|FG000|Overall Study|Protocol Violation|0|||
130128978|NCT00627016|468435804|FG001|Overall Study|Protocol Violation|2|||
130128979|NCT00627016|468435803|FG000|Overall Study|Lost to Follow-up|0|||
130128980|NCT00627016|468435804|FG001|Overall Study|Lost to Follow-up|1|||
130128981|NCT00627016|468435803|FG000|Overall Study|Withdrawal by Subject|2|||
130128982|NCT00627016|468435804|FG001|Overall Study|Withdrawal by Subject|1|||
130128983|NCT00627016|468435803|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
130128984|NCT00627016|468435804|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
130128985|NCT00627016|468435803|FG000|Overall Study|Lack of Efficacy|1|||
130128986|NCT00627016|468435804|FG001|Overall Study|Lack of Efficacy|0|||
130128987|NCT00627016|468435803|FG000|Overall Study|Placed on Excluded Drugs|1|||
130128988|NCT00627016|468435804|FG001|Overall Study|Placed on Excluded Drugs|0|||
130128989|NCT00627016|468435803|FG000|Overall Study|Pregnancy|1|||
130128990|NCT00627016|468435804|FG001|Overall Study|Pregnancy|0|||
130128991|NCT00377260|468435805|FG000|Overall Study|Lost to Follow-up|0|||
130128992|NCT00377260|468435806|FG001|Overall Study|Lost to Follow-up|1|||
130128993|NCT00377260|468435805|FG000|Overall Study|Withdrawal by Subject|2|||
130128994|NCT00377260|468435806|FG001|Overall Study|Withdrawal by Subject|4|||
130128995|NCT03107091|468435807|FG000|Overall Study|Physician Decision|1|||
130128996|NCT04567186|468435812|FG000|Period 1|COVID-19 related|1|||
130128997|NCT04567186|468435813|FG001|Period 1|COVID-19 related|0|||
130128998|NCT04567186|468435812|FG000|Period 1|Protocol Violation|0|||
130128999|NCT04567186|468435813|FG001|Period 1|Protocol Violation|1|||
130129000|NCT04567186|468435812|FG000|Period 1|Adverse Event|0|||
130129001|NCT04567186|468435813|FG001|Period 1|Adverse Event|2|||
130129002|NCT04567186|468435812|FG000|Period 2|COVID-19 Related|0|||
130129003|NCT04567186|468435813|FG001|Period 2|COVID-19 Related|1|||
130129004|NCT04567186|468435812|FG000|Period 2|Protocol Violation|0|||
130129005|NCT04567186|468435813|FG001|Period 2|Protocol Violation|1|||
130129006|NCT04567186|468435812|FG000|Period 2|Lost to Follow-up|0|||
130129007|NCT04567186|468435813|FG001|Period 2|Lost to Follow-up|1|||
130129008|NCT04567186|468435812|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
130129009|NCT04567186|468435813|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
130129010|NCT02924883|468435814|FG000|Overall Study|Death|39|||
130129011|NCT02924883|468435815|FG001|Overall Study|Death|20|||
130129012|NCT02924883|468435814|FG000|Overall Study|Lost to Follow-up|1|||
130129013|NCT02924883|468435815|FG001|Overall Study|Lost to Follow-up|0|||
130129014|NCT02924883|468435814|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
130129015|NCT02924883|468435815|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
130129016|NCT02924883|468435814|FG000|Overall Study|Protocol Violation|1|||
130129017|NCT02924883|468435815|FG001|Overall Study|Protocol Violation|0|||
130129018|NCT02924883|468435814|FG000|Overall Study|Withdrawal by Subject|22|||
130129019|NCT02924883|468435815|FG001|Overall Study|Withdrawal by Subject|16|||
130129020|NCT02924883|468435814|FG000|Overall Study|Progressive Disease|1|||
130129021|NCT02924883|468435815|FG001|Overall Study|Progressive Disease|0|||
130129022|NCT02924883|468435814|FG000|Overall Study|Study Terminated by Sponsor|69|||
130129023|NCT02924883|468435815|FG001|Overall Study|Study Terminated by Sponsor|32|||
130129024|NCT01256684|468435820|FG000|Overall Study|Adverse Event|1|||
130129025|NCT01256684|468435821|FG001|Overall Study|Adverse Event|4|||
130129026|NCT01256684|468435822|FG002|Overall Study|Adverse Event|2|||
130129027|NCT01256684|468435820|FG000|Overall Study|Withdrawal by Subject|4|||
130129028|NCT01256684|468435821|FG001|Overall Study|Withdrawal by Subject|0|||
130129029|NCT01256684|468435822|FG002|Overall Study|Withdrawal by Subject|2|||
130129030|NCT01256684|468435820|FG000|Overall Study|Physician Decision|0|||
130129031|NCT01256684|468435821|FG001|Overall Study|Physician Decision|1|||
130129032|NCT01256684|468435822|FG002|Overall Study|Physician Decision|0|||
130129033|NCT01256684|468435820|FG000|Overall Study|Lack of Efficacy|0|||
130129034|NCT01256684|468435821|FG001|Overall Study|Lack of Efficacy|1|||
130129035|NCT01256684|468435822|FG002|Overall Study|Lack of Efficacy|1|||
130129036|NCT01256684|468435820|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
130129037|NCT01256684|468435821|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
130129038|NCT01256684|468435822|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
130129039|NCT01185548|468435825|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
130129040|NCT02678286|468435826|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
130129041|NCT02678286|468435827|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
130129042|NCT02678286|468435826|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
130129043|NCT02678286|468435827|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
130129044|NCT02678286|468435826|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
130129045|NCT02678286|468435827|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
130129046|NCT02678286|468435826|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
130129047|NCT02678286|468435827|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
130129048|NCT02678286|468435826|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
130129049|NCT02678286|468435827|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
130129050|NCT01702987|468435829|FG000|Overall Study|Withdrawal by Subject|1|||
130129051|NCT01702987|468435830|FG001|Overall Study|Withdrawal by Subject|0|||
130129052|NCT05169710|468435833|FG000|Overall Study|Adverse Event|1|||
130129053|NCT05169710|468435834|FG001|Overall Study|Adverse Event|2|||
130129054|NCT05169710|468435835|FG002|Overall Study|Adverse Event|2|||
130129055|NCT05169710|468435833|FG000|Overall Study|Lost to Follow-up|0|||
130129056|NCT05169710|468435834|FG001|Overall Study|Lost to Follow-up|0|||
130129057|NCT05169710|468435835|FG002|Overall Study|Lost to Follow-up|1|||
130129058|NCT05169710|468435833|FG000|Overall Study|Withdrawal by Subject|2|||
130129059|NCT05169710|468435834|FG001|Overall Study|Withdrawal by Subject|1|||
130129060|NCT05169710|468435835|FG002|Overall Study|Withdrawal by Subject|0|||
130129061|NCT05169710|468435833|FG000|Overall Study|Other Study Discontinuation Reason|0|||
130129062|NCT05169710|468435834|FG001|Overall Study|Other Study Discontinuation Reason|2|||
130129063|NCT05169710|468435835|FG002|Overall Study|Other Study Discontinuation Reason|0|||
130129064|NCT01686438|468435840|FG000|Overall Study|Lost to Follow-up|8|||
130129065|NCT01686438|468435841|FG001|Overall Study|Lost to Follow-up|9|||
130129066|NCT01686438|468435842|FG002|Overall Study|Lost to Follow-up|10|||
130129067|NCT01686438|468435840|FG000|Overall Study|Adverse Event|0|||
130129068|NCT01686438|468435841|FG001|Overall Study|Adverse Event|0|||
130129069|NCT01686438|468435842|FG002|Overall Study|Adverse Event|1|||
130129070|NCT01686438|468435840|FG000|Overall Study|Protocol Violation|0|||
130129071|NCT01686438|468435841|FG001|Overall Study|Protocol Violation|0|||
130129072|NCT01686438|468435842|FG002|Overall Study|Protocol Violation|1|||
130129073|NCT01686438|468435840|FG000|Overall Study|Withdrawal by Subject|0|||
130129074|NCT01686438|468435841|FG001|Overall Study|Withdrawal by Subject|0|||
130129075|NCT01686438|468435842|FG002|Overall Study|Withdrawal by Subject|1|||
130129076|NCT02601560|468435846|FG000|Overall Study|Other|0|||
130129077|NCT02601560|468435847|FG001|Overall Study|Other|0|||
130129078|NCT02601560|468435848|FG002|Overall Study|Other|0|||
130129079|NCT02601560|468435849|FG003|Overall Study|Other|0|||
130129080|NCT02601560|468435850|FG004|Overall Study|Other|0|||
129970772|NCT05226130|467856603|FG001|Overall Study|Not treatment adherent|2|||
129970773|NCT03358472|467856604|FG000|Overall Study|Death|6|||
129970774|NCT03358472|467856605|FG001|Overall Study|Death|3|||
130129081|NCT02601560|468435851|FG005|Overall Study|Other|0|||
130129082|NCT02601560|468435852|FG006|Overall Study|Other|1|||
130129083|NCT02601560|468435853|FG007|Overall Study|Other|0|||
130129084|NCT03459807|468435854|FG000|Overall Study|Withdrawal due to transplant|0|||
130129085|NCT03459807|468435855|FG001|Overall Study|Withdrawal due to transplant|1|||
130129086|NCT03707912|468435858|FG000|Overall Study|Violation of inclusion criteria|1|||
130129087|NCT03707912|468435859|FG001|Overall Study|Violation of inclusion criteria|0|||
130129088|NCT02039908|468435860|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
129970775|NCT03358472|467856606|FG002|Overall Study|Death|10|||
129970776|NCT03358472|467856604|FG000|Overall Study|Physician Decision|0|||
130129089|NCT02039908|468435861|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
130129090|NCT02039908|468435862|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
130129091|NCT02039908|468435863|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
130129092|NCT02039908|468435860|FG000|Phase 1-Summer|Protocol Violation|6|||
130129093|NCT02039908|468435861|FG001|Phase 1-Summer|Protocol Violation|0|||
130129094|NCT02039908|468435862|FG002|Phase 1-Summer|Protocol Violation|0|||
130129095|NCT02039908|468435863|FG003|Phase 1-Summer|Protocol Violation|0|||
130129096|NCT02039908|468435860|FG000|Phase 2-School Year|Lost to Follow-up|0|||
130129097|NCT02039908|468435861|FG001|Phase 2-School Year|Lost to Follow-up|0|||
130129098|NCT02039908|468435862|FG002|Phase 2-School Year|Lost to Follow-up|1|||
130129099|NCT02039908|468435863|FG003|Phase 2-School Year|Lost to Follow-up|3|||
130129100|NCT02039908|468435860|FG000|Phase 2-School Year|Protocol Violation|0|||
130129101|NCT02039908|468435861|FG001|Phase 2-School Year|Protocol Violation|0|||
130129102|NCT02039908|468435862|FG002|Phase 2-School Year|Protocol Violation|3|||
130129103|NCT02039908|468435863|FG003|Phase 2-School Year|Protocol Violation|0|||
130129104|NCT02039908|468435860|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
130129105|NCT02039908|468435861|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
130129106|NCT02039908|468435862|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
130129107|NCT02039908|468435863|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
130129108|NCT01802320|468435864|FG000|Overall Study|Death|1|||
130129109|NCT01802320|468435864|FG000|Overall Study|Withdrawal by Subject|1|||
130129110|NCT02331394|468437722|FG000|Overall Study|Disease progression|1|||
130129111|NCT01313273|468437723|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
130129112|NCT01313273|468437724|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
130129113|NCT01313273|468437723|FG000|Overall Study|Withdrawal by Subject|1|||
130129114|NCT01313273|468437724|FG001|Overall Study|Withdrawal by Subject|0|||
130129115|NCT01313273|468437723|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
130129116|NCT01313273|468437724|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
130129117|NCT03687736|468437725|FG000|Overall Study|Lost to Follow-up|7|||
130129118|NCT03687736|468437725|FG000|Overall Study|Withdrawal by Subject|3|||
130129119|NCT01270503|468437726|FG000|Overall Study|Lost to Follow-up|1|||
130129120|NCT02459951|468437727|FG000|Overall Study|Unable to meet holding requirement|1|||
130129121|NCT02481830|468437731|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
130129122|NCT02481830|468437732|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
130129123|NCT02481830|468437731|FG000|Pre-treatment|Withdrawal by Subject|0|||
130129124|NCT02481830|468437732|FG001|Pre-treatment|Withdrawal by Subject|10|||
130129125|NCT02481830|468437731|FG000|Pre-treatment|Disease Progression|1|||
130129126|NCT02481830|468437732|FG001|Pre-treatment|Disease Progression|1|||
130129127|NCT02481830|468437731|FG000|Pre-treatment|Other reasons|0|||
130129128|NCT02481830|468437732|FG001|Pre-treatment|Other reasons|1|||
130129129|NCT02481830|468437731|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
130129130|NCT02481830|468437732|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
130129131|NCT02481830|468437731|FG000|Treatment|Disease Progression|233|||
130129132|NCT02481830|468437732|FG001|Treatment|Disease Progression|171|||
130129133|NCT02481830|468437731|FG000|Treatment|Study drug toxicity|18|||
130129134|NCT02481830|468437732|FG001|Treatment|Study drug toxicity|38|||
130129135|NCT02481830|468437731|FG000|Treatment|Death|1|||
130129136|NCT02481830|468437732|FG001|Treatment|Death|1|||
130129137|NCT02481830|468437731|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
130129138|NCT02481830|468437732|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
130129139|NCT02481830|468437731|FG000|Treatment|Participants request to discontinue Study treatment|6|||
130129140|NCT02481830|468437732|FG001|Treatment|Participants request to discontinue Study treatment|34|||
130129141|NCT02481830|468437731|FG000|Treatment|Withdrawal by Subject|2|||
130129142|NCT02481830|468437732|FG001|Treatment|Withdrawal by Subject|3|||
130129143|NCT02481830|468437731|FG000|Treatment|Lost to Follow-up|1|||
130129144|NCT02481830|468437732|FG001|Treatment|Lost to Follow-up|0|||
130129145|NCT02481830|468437731|FG000|Treatment|Maximum Clinical Benefit|0|||
130129146|NCT02481830|468437732|FG001|Treatment|Maximum Clinical Benefit|5|||
130129147|NCT02481830|468437731|FG000|Treatment|Administrative reason by sponsor|1|||
130129148|NCT02481830|468437732|FG001|Treatment|Administrative reason by sponsor|1|||
130129149|NCT02481830|468437731|FG000|Treatment|Other reasons|6|||
130129150|NCT02481830|468437732|FG001|Treatment|Other reasons|1|||
130129151|NCT00102440|468437733|FG000|Overall Study|Lost to Follow-up|25|||
130129152|NCT00102440|468437734|FG001|Overall Study|Lost to Follow-up|18|||
130129153|NCT00102440|468437735|FG002|Overall Study|Lost to Follow-up|21|||
130129154|NCT00102440|468437733|FG000|Overall Study|Adverse Event|16|||
130129155|NCT00102440|468437734|FG001|Overall Study|Adverse Event|23|||
130129156|NCT00102440|468437735|FG002|Overall Study|Adverse Event|8|||
130129157|NCT00102440|468437733|FG000|Overall Study|Gout Flare|10|||
130129158|NCT00102440|468437734|FG001|Overall Study|Gout Flare|28|||
130129159|NCT00102440|468437735|FG002|Overall Study|Gout Flare|9|||
130129160|NCT00102440|468437733|FG000|Overall Study|Personal Reason(s)|19|||
130129161|NCT00102440|468437734|FG001|Overall Study|Personal Reason(s)|13|||
130129162|NCT00102440|468437735|FG002|Overall Study|Personal Reason(s)|13|||
130129163|NCT00102440|468437733|FG000|Overall Study|Other|11|||
130129164|NCT00102440|468437734|FG001|Overall Study|Other|14|||
130129165|NCT00102440|468437735|FG002|Overall Study|Other|14|||
130129166|NCT00102440|468437733|FG000|Overall Study|Protocol Violation|7|||
130129167|NCT00102440|468437734|FG001|Overall Study|Protocol Violation|2|||
130129168|NCT00102440|468437735|FG002|Overall Study|Protocol Violation|1|||
130129169|NCT04627038|468437736|FG000|Overall Study|Adverse Event|36|||
130129170|NCT04627038|468437737|FG001|Overall Study|Adverse Event|8|||
130129171|NCT04627038|468437736|FG000|Overall Study|Lost to Follow-up|1|||
130129172|NCT04627038|468437737|FG001|Overall Study|Lost to Follow-up|0|||
130129173|NCT04627038|468437736|FG000|Overall Study|Physician Decision|0|||
130129174|NCT04627038|468437737|FG001|Overall Study|Physician Decision|1|||
130129175|NCT04627038|468437736|FG000|Overall Study|Protocol Violation|3|||
130129176|NCT04627038|468437737|FG001|Overall Study|Protocol Violation|1|||
130129177|NCT04627038|468437736|FG000|Overall Study|Withdrawal by Subject|13|||
130129178|NCT04627038|468437737|FG001|Overall Study|Withdrawal by Subject|3|||
130129179|NCT04627038|468437736|FG000|Overall Study|Non-compliance with study drug|0|||
130129180|NCT04627038|468437737|FG001|Overall Study|Non-compliance with study drug|1|||
130129181|NCT04627038|468437736|FG000|Overall Study|Prohibited Concomitant Medication|1|||
130129182|NCT04627038|468437737|FG001|Overall Study|Prohibited Concomitant Medication|0|||
130129183|NCT02255097|468437738|FG000|Overall Study|Death|151|||
130129184|NCT02255097|468437738|FG000|Overall Study|Lost to Follow-up|5|||
130129185|NCT02255097|468437738|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
130129186|NCT02255097|468437738|FG000|Overall Study|Withdrawal by Subject|7|||
130129187|NCT02255097|468437738|FG000|Overall Study|Allocated but not treated|1|||
130129188|NCT01010542|468437744|FG000|Overall Study|Adverse Event|0|||
130129189|NCT01010542|468437745|FG001|Overall Study|Adverse Event|1|||
130129190|NCT01010542|468437746|FG002|Overall Study|Adverse Event|0|||
130129191|NCT01010542|468437744|FG000|Overall Study|Lost to Follow-up|0|||
130129192|NCT01010542|468437745|FG001|Overall Study|Lost to Follow-up|1|||
130129193|NCT01010542|468437746|FG002|Overall Study|Lost to Follow-up|0|||
130129194|NCT01010542|468437744|FG000|Overall Study|Withdrawal by Subject|0|||
130129195|NCT01010542|468437745|FG001|Overall Study|Withdrawal by Subject|3|||
130129196|NCT01010542|468437746|FG002|Overall Study|Withdrawal by Subject|2|||
130129197|NCT01745120|468437747|FG000|Overall Study|Investigator decision|1|||
130129198|NCT01745120|468437748|FG001|Overall Study|Investigator decision|0|||
130129199|NCT03956862|468437749|FG000|Overall Study|Lost to Follow-up|1|||
130129200|NCT03956862|468437750|FG001|Overall Study|Lost to Follow-up|1|||
130129201|NCT03956862|468437749|FG000|Overall Study|Withdrawal by Subject|1|||
130129202|NCT03956862|468437750|FG001|Overall Study|Withdrawal by Subject|1|||
130129203|NCT00579670|468437754|FG000|Overall Study|Death|1|||
130129204|NCT00579670|468437755|FG001|Overall Study|Death|0|||
130129205|NCT00579670|468437756|FG002|Overall Study|Death|0|||
130129206|NCT00579670|468437757|FG003|Overall Study|Death|0|||
130129207|NCT00579670|468437758|FG004|Overall Study|Death|0|||
130129208|NCT00579670|468437754|FG000|Overall Study|Adverse Event|1|||
130129209|NCT00579670|468437755|FG001|Overall Study|Adverse Event|0|||
130129210|NCT00579670|468437756|FG002|Overall Study|Adverse Event|1|||
130129211|NCT00579670|468437757|FG003|Overall Study|Adverse Event|2|||
130129212|NCT00579670|468437758|FG004|Overall Study|Adverse Event|0|||
130129213|NCT00579670|468437754|FG000|Overall Study|Lack of Efficacy|0|||
130129214|NCT00579670|468437755|FG001|Overall Study|Lack of Efficacy|0|||
130129215|NCT00579670|468437756|FG002|Overall Study|Lack of Efficacy|1|||
130129216|NCT00579670|468437757|FG003|Overall Study|Lack of Efficacy|14|||
130129217|NCT00579670|468437758|FG004|Overall Study|Lack of Efficacy|0|||
130129218|NCT00579670|468437754|FG000|Overall Study|Lost to Follow-up|0|||
130129219|NCT00579670|468437755|FG001|Overall Study|Lost to Follow-up|1|||
130129220|NCT00579670|468437756|FG002|Overall Study|Lost to Follow-up|0|||
130129221|NCT00579670|468437757|FG003|Overall Study|Lost to Follow-up|4|||
130129222|NCT00579670|468437758|FG004|Overall Study|Lost to Follow-up|0|||
130129223|NCT00579670|468437754|FG000|Overall Study|Other|0|||
130129224|NCT00579670|468437755|FG001|Overall Study|Other|0|||
130129225|NCT00579670|468437756|FG002|Overall Study|Other|1|||
130129226|NCT00579670|468437757|FG003|Overall Study|Other|2|||
130129227|NCT00579670|468437758|FG004|Overall Study|Other|0|||
130129228|NCT00579670|468437754|FG000|Overall Study|Withdrawal by Subject|0|||
130129229|NCT00579670|468437755|FG001|Overall Study|Withdrawal by Subject|0|||
130129230|NCT00579670|468437756|FG002|Overall Study|Withdrawal by Subject|1|||
130129231|NCT00579670|468437757|FG003|Overall Study|Withdrawal by Subject|0|||
130129232|NCT00579670|468437758|FG004|Overall Study|Withdrawal by Subject|0|||
130129233|NCT00850174|468437762|FG000|Washout: One Week|Withdrawal by Subject|0|||
130129234|NCT00850174|468437763|FG001|Washout: One Week|Withdrawal by Subject|2|||
130129235|NCT00850174|468437762|FG000|Second Intervention|Withdrawal by Subject|1|||
130129236|NCT00850174|468437763|FG001|Second Intervention|Withdrawal by Subject|0|||
130129237|NCT01363765|468437766|FG000|Overall Study|non-diagnostic|2621|||
130129238|NCT01363765|468437767|FG001|Overall Study|non-diagnostic|1124|||
130129239|NCT01363765|468437766|FG000|Overall Study|duplicate records|736|||
130129240|NCT01363765|468437767|FG001|Overall Study|duplicate records|3177|||
130129241|NCT01363765|468437766|FG000|Overall Study|non-resident|156|||
130129242|NCT01363765|468437767|FG001|Overall Study|non-resident|76|||
130129243|NCT01363765|468437766|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
130129244|NCT01363765|468437767|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
130129245|NCT01363765|468437766|FG000|Overall Study|smear during intervention|2170|||
130129246|NCT01363765|468437767|FG001|Overall Study|smear during intervention|0|||
130129247|NCT00635492|468437768|FG000|Overall Study|Death|12|||
130129248|NCT00635492|468437769|FG001|Overall Study|Death|40|||
130129249|NCT00635492|468437768|FG000|Overall Study|Lost to Follow-up|151|||
130129250|NCT00635492|468437769|FG001|Overall Study|Lost to Follow-up|172|||
130129251|NCT00635492|468437768|FG000|Overall Study|Physician Decision|32|||
130129252|NCT00635492|468437769|FG001|Overall Study|Physician Decision|22|||
130129253|NCT00635492|468437768|FG000|Overall Study|Sponsor decision|2|||
130129254|NCT00635492|468437769|FG001|Overall Study|Sponsor decision|3|||
130129255|NCT00635492|468437768|FG000|Overall Study|Withdrawal by Subject|82|||
130129256|NCT00635492|468437769|FG001|Overall Study|Withdrawal by Subject|45|||
130129257|NCT01900626|468437770|FG000|Overall Study|study was closed due to low enrollment|1|||
130129258|NCT01900626|468437771|FG001|Overall Study|study was closed due to low enrollment|1|||
130129259|NCT02682784|468437772|FG000|Overall Study|Withdrawal by Subject|0|||
130129260|NCT02682784|468437773|FG001|Overall Study|Withdrawal by Subject|2|||
130129261|NCT02682784|468437774|FG002|Overall Study|Withdrawal by Subject|1|||
130129262|NCT02682784|468437775|FG003|Overall Study|Withdrawal by Subject|2|||
130129263|NCT02682784|468437772|FG000|Overall Study|Physician Decision|1|||
130129264|NCT02682784|468437773|FG001|Overall Study|Physician Decision|0|||
130129265|NCT02682784|468437774|FG002|Overall Study|Physician Decision|1|||
130129266|NCT02682784|468437775|FG003|Overall Study|Physician Decision|1|||
130129267|NCT04533594|468437776|FG000|Overall Study|Death|26|||
130129268|NCT03138967|468437781|FG000|Overall Study|Death|0|||
130129269|NCT03138967|468437782|FG001|Overall Study|Death|1|||
130129270|NCT03138967|468437781|FG000|Overall Study|Physician Decision|1|||
130129271|NCT03138967|468437782|FG001|Overall Study|Physician Decision|3|||
130129272|NCT00836056|468437791|FG000|First Intervention|Adverse Event|1|||
130129273|NCT00836056|468437792|FG001|First Intervention|Adverse Event|0|||
130129274|NCT00846495|468437793|FG000|Overall Study|Lost to Follow-up|1|||
130129275|NCT00846495|468437794|FG001|Overall Study|Lost to Follow-up|0|||
130129276|NCT00846495|468437793|FG000|Overall Study|Adverse Event|5|||
130129277|NCT00846495|468437794|FG001|Overall Study|Adverse Event|1|||
130129278|NCT00846495|468437793|FG000|Overall Study|Lack of Efficacy|1|||
130129279|NCT00846495|468437794|FG001|Overall Study|Lack of Efficacy|2|||
130129280|NCT00846495|468437793|FG000|Overall Study|Physician Decision|1|||
130129281|NCT00846495|468437794|FG001|Overall Study|Physician Decision|0|||
130129282|NCT01029340|468437795|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
130129283|NCT01029340|468437796|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
130129284|NCT01029340|468437797|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
130129285|NCT01029340|468437798|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
130129286|NCT01029340|468437799|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
130129287|NCT01029340|468437800|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
130129288|NCT01029340|468437795|FG000|Part B Treatment Period|Protocol Violation|0|||
130129289|NCT01029340|468437796|FG001|Part B Treatment Period|Protocol Violation|0|||
130129290|NCT01029340|468437797|FG002|Part B Treatment Period|Protocol Violation|1|||
130129291|NCT01029340|468437798|FG003|Part B Treatment Period|Protocol Violation|0|||
130129292|NCT01029340|468437799|FG004|Part B Treatment Period|Protocol Violation|0|||
130129293|NCT01029340|468437800|FG005|Part B Treatment Period|Protocol Violation|0|||
130129294|NCT01029340|468437795|FG000|Extension Period|Adverse Event|0|||
130129295|NCT01029340|468437796|FG001|Extension Period|Adverse Event|0|||
130129296|NCT01029340|468437797|FG002|Extension Period|Adverse Event|0|||
130129297|NCT01029340|468437798|FG003|Extension Period|Adverse Event|0|||
130129298|NCT01029340|468437799|FG004|Extension Period|Adverse Event|0|||
130129299|NCT01029340|468437800|FG005|Extension Period|Adverse Event|1|||
130129300|NCT01029340|468437795|FG000|Extension Period|starting another study|0|||
130129301|NCT01029340|468437796|FG001|Extension Period|starting another study|0|||
130129302|NCT01029340|468437797|FG002|Extension Period|starting another study|0|||
130129303|NCT01029340|468437798|FG003|Extension Period|starting another study|0|||
130129304|NCT01029340|468437799|FG004|Extension Period|starting another study|0|||
130129305|NCT01029340|468437800|FG005|Extension Period|starting another study|8|||
130129306|NCT01029340|468437795|FG000|Extension Period|non-compliance|0|||
130129307|NCT01029340|468437796|FG001|Extension Period|non-compliance|0|||
130129308|NCT01029340|468437797|FG002|Extension Period|non-compliance|0|||
130129309|NCT01029340|468437798|FG003|Extension Period|non-compliance|0|||
130129310|NCT01029340|468437799|FG004|Extension Period|non-compliance|0|||
130129311|NCT01029340|468437800|FG005|Extension Period|non-compliance|1|||
130129312|NCT01029340|468437795|FG000|Extension Period|Withdrawal by Subject|0|||
130129313|NCT01029340|468437796|FG001|Extension Period|Withdrawal by Subject|0|||
130129314|NCT01029340|468437797|FG002|Extension Period|Withdrawal by Subject|0|||
130129315|NCT01029340|468437798|FG003|Extension Period|Withdrawal by Subject|0|||
130129316|NCT01029340|468437799|FG004|Extension Period|Withdrawal by Subject|0|||
130129317|NCT01029340|468437800|FG005|Extension Period|Withdrawal by Subject|1|||
130129318|NCT01029340|468437795|FG000|Extension Period|Physician Decision|0|||
130129319|NCT01029340|468437796|FG001|Extension Period|Physician Decision|0|||
130129320|NCT01029340|468437797|FG002|Extension Period|Physician Decision|0|||
130129321|NCT01029340|468437798|FG003|Extension Period|Physician Decision|0|||
129970777|NCT03358472|467856605|FG001|Overall Study|Physician Decision|1|||
129970778|NCT03358472|467856606|FG002|Overall Study|Physician Decision|0|||
129970779|NCT03358472|467856604|FG000|Overall Study|Withdrawal by Subject|0|||
129970780|NCT03358472|467856605|FG001|Overall Study|Withdrawal by Subject|0|||
129970781|NCT03358472|467856606|FG002|Overall Study|Withdrawal by Subject|1|||
129970782|NCT03358472|467856604|FG000|Overall Study|On-going at clinical cut off date|9|||
130093618|NCT01072175|468296950|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
130093619|NCT01072175|468296951|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
130093620|NCT01072175|468296952|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
130093621|NCT01072175|468296953|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
130093622|NCT01072175|468296954|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
130093623|NCT01072175|468296955|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
130093624|NCT01072175|468296956|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
130093625|NCT01072175|468296957|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
130093626|NCT01072175|468296958|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
130093627|NCT01072175|468296959|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
130093628|NCT01072175|468296947|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093629|NCT01072175|468296948|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093630|NCT01072175|468296949|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093631|NCT01072175|468296950|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093632|NCT01072175|468296951|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093633|NCT01072175|468296952|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093634|NCT01072175|468296953|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093635|NCT01072175|468296954|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093636|NCT01072175|468296955|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093637|NCT01072175|468296956|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
130093638|NCT01072175|468296957|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
130093639|NCT01072175|468296958|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
130093640|NCT01072175|468296959|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
130093641|NCT01072175|468296947|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093642|NCT01072175|468296948|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093643|NCT01072175|468296949|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093644|NCT01072175|468296950|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093645|NCT01072175|468296951|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093646|NCT01072175|468296952|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093647|NCT01072175|468296953|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093648|NCT01072175|468296954|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093649|NCT01072175|468296955|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
130093650|NCT01072175|468296956|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
130093651|NCT01072175|468296957|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
130093652|NCT01072175|468296958|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
130093653|NCT01072175|468296959|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
130093654|NCT01072175|468296947|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093655|NCT01072175|468296948|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093656|NCT01072175|468296949|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093657|NCT01072175|468296950|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093658|NCT01072175|468296951|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093659|NCT01072175|468296952|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093660|NCT01072175|468296953|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093661|NCT01072175|468296954|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093662|NCT01072175|468296955|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093663|NCT01072175|468296956|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093664|NCT01072175|468296957|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
130093665|NCT01072175|468296958|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
130093666|NCT01072175|468296959|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
130093667|NCT02557308|468296960|FG000|Overall Study|Withdrawal by Subject|11|||
130093668|NCT02557308|468296961|FG001|Overall Study|Withdrawal by Subject|3|||
130093669|NCT02557308|468296962|FG002|Overall Study|Withdrawal by Subject|2|||
130093670|NCT02557308|468296963|FG003|Overall Study|Withdrawal by Subject|0|||
130093671|NCT02557308|468296964|FG004|Overall Study|Withdrawal by Subject|1|||
130093672|NCT02557308|468296965|FG005|Overall Study|Withdrawal by Subject|0|||
130093673|NCT02557308|468296966|FG006|Overall Study|Withdrawal by Subject|10|||
130093674|NCT02557308|468296967|FG007|Overall Study|Withdrawal by Subject|1|||
130093675|NCT02557308|468296960|FG000|Overall Study|Disease Progression|0|||
130093676|NCT02557308|468296961|FG001|Overall Study|Disease Progression|1|||
130093677|NCT02557308|468296962|FG002|Overall Study|Disease Progression|0|||
130093678|NCT02557308|468296963|FG003|Overall Study|Disease Progression|0|||
130093679|NCT02557308|468296964|FG004|Overall Study|Disease Progression|0|||
130093680|NCT02557308|468296965|FG005|Overall Study|Disease Progression|0|||
130093681|NCT02557308|468296966|FG006|Overall Study|Disease Progression|0|||
130093682|NCT02557308|468296967|FG007|Overall Study|Disease Progression|0|||
130093683|NCT02557308|468296960|FG000|Overall Study|Lack of Efficacy|3|||
130093684|NCT02557308|468296961|FG001|Overall Study|Lack of Efficacy|0|||
129970783|NCT03358472|467856605|FG001|Overall Study|On-going at clinical cut off date|6|||
130129322|NCT01029340|468437799|FG004|Extension Period|Physician Decision|0|||
130129323|NCT01029340|468437800|FG005|Extension Period|Physician Decision|1|||
130129324|NCT02648347|468437801|FG000|Overall Study|Death|174|||
130129325|NCT02648347|468437802|FG001|Overall Study|Death|167|||
130129326|NCT02648347|468437801|FG000|Overall Study|Withdrawal by Subject|16|||
130129327|NCT02648347|468437802|FG001|Overall Study|Withdrawal by Subject|9|||
130129328|NCT02648347|468437801|FG000|Overall Study|Lost to Follow-up|18|||
130129329|NCT02648347|468437802|FG001|Overall Study|Lost to Follow-up|21|||
130129330|NCT02648347|468437801|FG000|Overall Study|Missing|1|||
130129331|NCT02648347|468437802|FG001|Overall Study|Missing|0|||
130129332|NCT01265056|468437806|FG000|Initial Study Period|Withdrawal by Subject|1|||
130129333|NCT01265056|468437807|FG001|Initial Study Period|Withdrawal by Subject|1|||
130129334|NCT01265056|468437806|FG000|Initial Study Period|Withdrawal by Subject|1|||
130129335|NCT01265056|468437807|FG001|Initial Study Period|Withdrawal by Subject|1|||
130129336|NCT01265056|468437806|FG000|Follow up|Lost to Follow-up|7|||
130129337|NCT01265056|468437807|FG001|Follow up|Lost to Follow-up|3|||
130129338|NCT00833937|468437816|FG000|Washout|Withdrawal by Subject|1|||
130129339|NCT00833937|468437817|FG001|Washout|Withdrawal by Subject|0|||
130129340|NCT03725605|468437818|FG000|Overall Study|Unsuccessful TIL expansion|2|||
130129341|NCT03135834|468437826|FG000|Stage 1|Adverse Event|1|||
130129342|NCT03135834|468437827|FG001|Stage 1|Adverse Event|2|||
130129343|NCT03135834|468437828|FG002|Stage 1|Adverse Event|2|||
130129344|NCT03135834|468437829|FG003|Stage 1|Adverse Event|1|||
130129345|NCT03135834|468437826|FG000|Stage 1|Death|1|||
130129346|NCT03135834|468437827|FG001|Stage 1|Death|0|||
130129347|NCT03135834|468437828|FG002|Stage 1|Death|0|||
130129348|NCT03135834|468437829|FG003|Stage 1|Death|0|||
130129349|NCT03135834|468437826|FG000|Stage 1|Lost to Follow-up|17|||
130129350|NCT03135834|468437827|FG001|Stage 1|Lost to Follow-up|24|||
130129351|NCT03135834|468437828|FG002|Stage 1|Lost to Follow-up|21|||
130129352|NCT03135834|468437829|FG003|Stage 1|Lost to Follow-up|38|||
130129353|NCT03135834|468437826|FG000|Stage 1|No longer met eligibility criteria|1|||
130129354|NCT03135834|468437827|FG001|Stage 1|No longer met eligibility criteria|6|||
130129355|NCT03135834|468437828|FG002|Stage 1|No longer met eligibility criteria|2|||
130129356|NCT03135834|468437829|FG003|Stage 1|No longer met eligibility criteria|5|||
130129357|NCT03135834|468437826|FG000|Stage 1|Other|0|||
130129358|NCT03135834|468437827|FG001|Stage 1|Other|2|||
130129359|NCT03135834|468437828|FG002|Stage 1|Other|1|||
130129360|NCT03135834|468437829|FG003|Stage 1|Other|0|||
130129361|NCT03135834|468437826|FG000|Stage 1|Physician Decision|0|||
130129362|NCT03135834|468437827|FG001|Stage 1|Physician Decision|1|||
130129363|NCT03135834|468437828|FG002|Stage 1|Physician Decision|0|||
130129364|NCT03135834|468437829|FG003|Stage 1|Physician Decision|0|||
130129365|NCT03135834|468437826|FG000|Stage 1|Pregnancy|0|||
130129366|NCT03135834|468437827|FG001|Stage 1|Pregnancy|4|||
130129367|NCT03135834|468437828|FG002|Stage 1|Pregnancy|2|||
130129368|NCT03135834|468437829|FG003|Stage 1|Pregnancy|4|||
130129369|NCT03135834|468437826|FG000|Stage 1|Protocol Violation|1|||
130129370|NCT03135834|468437827|FG001|Stage 1|Protocol Violation|1|||
130129371|NCT03135834|468437828|FG002|Stage 1|Protocol Violation|2|||
130129372|NCT03135834|468437829|FG003|Stage 1|Protocol Violation|1|||
130129373|NCT03135834|468437826|FG000|Stage 1|Withdrawal by parent/guardian|2|||
130129374|NCT03135834|468437827|FG001|Stage 1|Withdrawal by parent/guardian|10|||
130129375|NCT03135834|468437828|FG002|Stage 1|Withdrawal by parent/guardian|2|||
130129376|NCT03135834|468437829|FG003|Stage 1|Withdrawal by parent/guardian|1|||
130129377|NCT03135834|468437826|FG000|Stage 1|Withdrawal by Subject|16|||
130129378|NCT03135834|468437827|FG001|Stage 1|Withdrawal by Subject|22|||
130129379|NCT03135834|468437828|FG002|Stage 1|Withdrawal by Subject|7|||
129970784|NCT03358472|467856606|FG002|Overall Study|On-going at clinical cut off date|5|||
129970785|NCT02520310|467856607|FG000|At 6 Months Clinical Follow-up|Death|1|||
129970786|NCT02520310|467856607|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
130129380|NCT03135834|468437829|FG003|Stage 1|Withdrawal by Subject|10|||
130129381|NCT03135834|468437826|FG000|Stage 1|Randomized but not Vaccinated|0|||
130129382|NCT03135834|468437827|FG001|Stage 1|Randomized but not Vaccinated|3|||
130129383|NCT03135834|468437828|FG002|Stage 1|Randomized but not Vaccinated|1|||
130129384|NCT03135834|468437829|FG003|Stage 1|Randomized but not Vaccinated|6|||
130129385|NCT03135834|468437826|FG000|Stage 2|Lost to Follow-up|0|||
130129386|NCT03135834|468437827|FG001|Stage 2|Lost to Follow-up|1|||
129970787|NCT02520310|467856607|FG000|AT 3 Year Clinical Follow-up|Death|2|||
130129387|NCT03135834|468437828|FG002|Stage 2|Lost to Follow-up|0|||
130129388|NCT03135834|468437829|FG003|Stage 2|Lost to Follow-up|0|||
130129389|NCT03135834|468437826|FG000|Stage 2|Withdrawal by Subject|0|||
129970788|NCT02520310|467856607|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
129970789|NCT02520310|467856607|FG000|AT 4 Year Clinical Follow-up|Death|1|||
130129390|NCT03135834|468437827|FG001|Stage 2|Withdrawal by Subject|1|||
130129391|NCT03135834|468437828|FG002|Stage 2|Withdrawal by Subject|0|||
130129392|NCT03135834|468437829|FG003|Stage 2|Withdrawal by Subject|0|||
130129393|NCT03135834|468437826|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
130129394|NCT03135834|468437827|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
130129395|NCT03135834|468437828|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
130129396|NCT03135834|468437829|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
130129397|NCT03135834|468437826|FG000|Stage 2|Did not receive Booster Vaccination|1|||
130129398|NCT03135834|468437827|FG001|Stage 2|Did not receive Booster Vaccination|1|||
130129399|NCT03135834|468437828|FG002|Stage 2|Did not receive Booster Vaccination|0|||
130129400|NCT03135834|468437829|FG003|Stage 2|Did not receive Booster Vaccination|0|||
130129401|NCT00965185|468437830|FG000|Overall Study|Lost to Follow-up|2|||
130129402|NCT00965185|468437831|FG001|Overall Study|Lost to Follow-up|0|||
130129403|NCT00965185|468437830|FG000|Overall Study|Withdrawal by Subject|0|||
130129404|NCT00965185|468437831|FG001|Overall Study|Withdrawal by Subject|1|||
130129405|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
130129406|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
130129407|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
130129408|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
130129409|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
130129410|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
130129411|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
130129412|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
130129413|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
130129414|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
130129415|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
130129416|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
130129417|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130129418|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130129419|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
130129420|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
130129421|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
130129422|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
130129423|NCT01045161|468437832|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
130129424|NCT01045161|468437833|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
130129425|NCT01045161|468437834|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
130129426|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
130129427|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
130129428|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
130129429|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
130129430|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
130129431|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
130129432|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
130129433|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
130129434|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
130129435|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
130129436|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
130129437|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
130129438|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
130129439|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
130129440|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
130129441|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
130129442|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
130129443|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
130129444|NCT01045161|468437832|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
130129445|NCT01045161|468437833|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
130129446|NCT01045161|468437834|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
130129447|NCT03686033|468437835|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
130129448|NCT03686033|468437836|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
130129449|NCT03686033|468437837|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
130129450|NCT03686033|468437838|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
130129451|NCT03686033|468437839|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
130129452|NCT03686033|468437840|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
130129453|NCT03197883|468437841|FG000|Overall Study|Adverse Event|1|||
130129454|NCT03197883|468437842|FG001|Overall Study|Adverse Event|1|||
130129455|NCT03197883|468437841|FG000|Overall Study|Lost to Follow-up|1|||
130129456|NCT03197883|468437842|FG001|Overall Study|Lost to Follow-up|0|||
130129457|NCT03197883|468437841|FG000|Overall Study|Protocol Violation|1|||
130129458|NCT03197883|468437842|FG001|Overall Study|Protocol Violation|0|||
129970790|NCT02520310|467856607|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
130129459|NCT03197883|468437841|FG000|Overall Study|Other (Not Specified)|0|||
130129460|NCT03197883|468437842|FG001|Overall Study|Other (Not Specified)|5|||
130129461|NCT02272777|468437844|FG000|Overall Study|Adverse Event|0|||
130129462|NCT02272777|468437845|FG001|Overall Study|Adverse Event|1|||
130129463|NCT02272777|468437844|FG000|Overall Study|Withdrawal by Subject|0|||
130129464|NCT02272777|468437845|FG001|Overall Study|Withdrawal by Subject|3|||
130129465|NCT02272777|468437844|FG000|Overall Study|Lost to Follow-up|2|||
130129466|NCT02272777|468437845|FG001|Overall Study|Lost to Follow-up|0|||
130129467|NCT02272777|468437844|FG000|Overall Study|Other|2|||
130129468|NCT02272777|468437845|FG001|Overall Study|Other|0|||
130129469|NCT05275205|468437846|FG000|Overall Study|Adverse Event|1|||
130129470|NCT05275205|468437847|FG001|Overall Study|Adverse Event|2|||
130129471|NCT05275205|468437846|FG000|Overall Study|Physician Decision|1|||
130129472|NCT05275205|468437847|FG001|Overall Study|Physician Decision|1|||
130129473|NCT05275205|468437846|FG000|Overall Study|Withdrawal by Subject|2|||
130129474|NCT05275205|468437847|FG001|Overall Study|Withdrawal by Subject|3|||
130129475|NCT05275205|468437846|FG000|Overall Study|Death|1|||
130129476|NCT05275205|468437847|FG001|Overall Study|Death|0|||
130129477|NCT05275205|468437846|FG000|Overall Study|Patient unable to attend visits|1|||
130129478|NCT05275205|468437847|FG001|Overall Study|Patient unable to attend visits|0|||
130129479|NCT02066922|468437848|FG000|Overall Study|Adverse Event|1|||
130129480|NCT00440297|468437849|FG000|Overall Study|Adverse Event|8|||
130129481|NCT00440297|468437850|FG001|Overall Study|Adverse Event|5|||
130129482|NCT00440297|468437849|FG000|Overall Study|Lost to Follow-up|1|||
130129483|NCT00440297|468437850|FG001|Overall Study|Lost to Follow-up|0|||
130129484|NCT00440297|468437849|FG000|Overall Study|Physician Decision|1|||
130129485|NCT00440297|468437850|FG001|Overall Study|Physician Decision|0|||
130129486|NCT00440297|468437849|FG000|Overall Study|Protocol Violation|11|||
130129487|NCT00440297|468437850|FG001|Overall Study|Protocol Violation|7|||
130129488|NCT00440297|468437849|FG000|Overall Study|Withdrawal by Subject|1|||
130093685|NCT02557308|468296962|FG002|Overall Study|Lack of Efficacy|0|||
130093686|NCT02557308|468296963|FG003|Overall Study|Lack of Efficacy|0|||
130093687|NCT02557308|468296964|FG004|Overall Study|Lack of Efficacy|0|||
130093688|NCT02557308|468296965|FG005|Overall Study|Lack of Efficacy|0|||
130093689|NCT02557308|468296966|FG006|Overall Study|Lack of Efficacy|1|||
130093690|NCT02557308|468296967|FG007|Overall Study|Lack of Efficacy|0|||
130093691|NCT02557308|468296960|FG000|Overall Study|Adverse Event|4|||
130093692|NCT02557308|468296961|FG001|Overall Study|Adverse Event|1|||
130093693|NCT02557308|468296962|FG002|Overall Study|Adverse Event|2|||
130093694|NCT02557308|468296963|FG003|Overall Study|Adverse Event|0|||
130093695|NCT02557308|468296964|FG004|Overall Study|Adverse Event|0|||
130093696|NCT02557308|468296965|FG005|Overall Study|Adverse Event|0|||
130093697|NCT02557308|468296966|FG006|Overall Study|Adverse Event|4|||
130093698|NCT02557308|468296967|FG007|Overall Study|Adverse Event|1|||
130093699|NCT02557308|468296960|FG000|Overall Study|Lost to Follow-up|2|||
130093700|NCT02557308|468296961|FG001|Overall Study|Lost to Follow-up|0|||
130093701|NCT02557308|468296962|FG002|Overall Study|Lost to Follow-up|1|||
130093702|NCT02557308|468296963|FG003|Overall Study|Lost to Follow-up|0|||
130093703|NCT02557308|468296964|FG004|Overall Study|Lost to Follow-up|0|||
130093704|NCT02557308|468296965|FG005|Overall Study|Lost to Follow-up|0|||
130093705|NCT02557308|468296966|FG006|Overall Study|Lost to Follow-up|2|||
130093706|NCT02557308|468296967|FG007|Overall Study|Lost to Follow-up|0|||
130093707|NCT02557308|468296960|FG000|Overall Study|Death|1|||
130093708|NCT02557308|468296961|FG001|Overall Study|Death|0|||
130093709|NCT02557308|468296962|FG002|Overall Study|Death|0|||
130093710|NCT02557308|468296963|FG003|Overall Study|Death|0|||
130093711|NCT02557308|468296964|FG004|Overall Study|Death|0|||
130093712|NCT02557308|468296965|FG005|Overall Study|Death|0|||
130093713|NCT02557308|468296966|FG006|Overall Study|Death|0|||
130093714|NCT02557308|468296967|FG007|Overall Study|Death|0|||
130093715|NCT02557308|468296960|FG000|Overall Study|Study Close|98|||
130093716|NCT02557308|468296961|FG001|Overall Study|Study Close|18|||
130093717|NCT02557308|468296962|FG002|Overall Study|Study Close|5|||
130093718|NCT02557308|468296963|FG003|Overall Study|Study Close|3|||
130093719|NCT02557308|468296964|FG004|Overall Study|Study Close|1|||
130093720|NCT02557308|468296965|FG005|Overall Study|Study Close|0|||
130093721|NCT02557308|468296966|FG006|Overall Study|Study Close|123|||
130093722|NCT02557308|468296967|FG007|Overall Study|Study Close|5|||
130093723|NCT02557308|468296960|FG000|Overall Study|Except for study close|5|||
130093724|NCT02557308|468296961|FG001|Overall Study|Except for study close|0|||
130093725|NCT02557308|468296962|FG002|Overall Study|Except for study close|0|||
130093726|NCT02557308|468296963|FG003|Overall Study|Except for study close|0|||
130093727|NCT02557308|468296964|FG004|Overall Study|Except for study close|3|||
130093728|NCT02557308|468296965|FG005|Overall Study|Except for study close|0|||
130093729|NCT02557308|468296966|FG006|Overall Study|Except for study close|6|||
130093730|NCT02557308|468296967|FG007|Overall Study|Except for study close|10|||
130093731|NCT01980056|468296970|FG000|Overall Study|Death|1|||
130093732|NCT01980056|468296971|FG001|Overall Study|Death|1|||
130093733|NCT01980056|468296972|FG002|Overall Study|Death|0|||
130093734|NCT00351611|468296973|FG000|Overall Study|Adverse Event|11|||
130093735|NCT00351611|468296974|FG001|Overall Study|Adverse Event|3|||
130093736|NCT00351611|468296973|FG000|Overall Study|Death|1|||
130093737|NCT00351611|468296974|FG001|Overall Study|Death|0|||
130093738|NCT00351611|468296973|FG000|Overall Study|Lost to Follow-up|1|||
130093739|NCT00351611|468296974|FG001|Overall Study|Lost to Follow-up|0|||
130129489|NCT00440297|468437850|FG001|Overall Study|Withdrawal by Subject|6|||
130129490|NCT00440297|468437849|FG000|Overall Study|Randomized by mistake|1|||
130129491|NCT00440297|468437850|FG001|Overall Study|Randomized by mistake|0|||
130129492|NCT03020641|468437851|FG000|Overall Study|Lost to Follow-up|0|||
130129493|NCT03020641|468437852|FG001|Overall Study|Lost to Follow-up|1|||
130129494|NCT03020641|468437851|FG000|Overall Study|Converted to open surgery|2|||
130129495|NCT03020641|468437852|FG001|Overall Study|Converted to open surgery|1|||
130129496|NCT03020641|468437851|FG000|Overall Study|for surgery not performed|0|||
130129497|NCT03020641|468437852|FG001|Overall Study|for surgery not performed|1|||
130129498|NCT00837486|468437856|FG000|Blinded-treatment Phase|Physician Decision|1|||
130129499|NCT00837486|468437857|FG001|Blinded-treatment Phase|Physician Decision|0|||
130129500|NCT00837486|468437856|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
130129501|NCT00837486|468437857|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
130129502|NCT00837486|468437856|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
130129503|NCT00837486|468437857|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
130129504|NCT00837486|468437856|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
130129505|NCT00837486|468437857|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
130129506|NCT01577381|468437859|FG000|Overall Study|Discontinued|2|||
130129507|NCT01577381|468437860|FG001|Overall Study|Discontinued|1|||
130129508|NCT01577381|468437861|FG002|Overall Study|Discontinued|2|||
130129509|NCT01577381|468437862|FG003|Overall Study|Discontinued|2|||
130129510|NCT01577381|468437859|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
130129511|NCT01577381|468437860|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
130129512|NCT01577381|468437861|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
130129513|NCT01577381|468437862|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
130129514|NCT00819741|468437863|FG000|Overall Study|Adverse Event|5|||
130129515|NCT00819741|468437864|FG001|Overall Study|Adverse Event|2|||
130129516|NCT00819741|468437863|FG000|Overall Study|Lack of Efficacy|0|||
130129517|NCT00819741|468437864|FG001|Overall Study|Lack of Efficacy|2|||
130129518|NCT00819741|468437863|FG000|Overall Study|Lost to Follow-up|3|||
130129519|NCT00819741|468437864|FG001|Overall Study|Lost to Follow-up|1|||
130129520|NCT00819741|468437863|FG000|Overall Study|Protocol Violation|3|||
130129521|NCT00819741|468437864|FG001|Overall Study|Protocol Violation|4|||
130129522|NCT00819741|468437863|FG000|Overall Study|Withdrawal by Subject|2|||
130129523|NCT00819741|468437864|FG001|Overall Study|Withdrawal by Subject|2|||
130129524|NCT00819741|468437863|FG000|Overall Study|Unclassified|6|||
130129525|NCT00819741|468437864|FG001|Overall Study|Unclassified|0|||
130129526|NCT00819741|468437863|FG000|Overall Study|Reasons unknown|3|||
130129527|NCT00819741|468437864|FG001|Overall Study|Reasons unknown|3|||
130129528|NCT01597245|468437865|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
130129529|NCT01597245|468437866|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
130129530|NCT01597245|468437867|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
130129531|NCT01597245|468437868|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
130129532|NCT01597245|468437869|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129533|NCT01597245|468437870|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129534|NCT01597245|468437871|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129535|NCT01597245|468437872|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129536|NCT01597245|468437873|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129537|NCT01597245|468437874|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129538|NCT01597245|468437875|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129539|NCT01597245|468437876|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129540|NCT01597245|468437877|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129541|NCT01597245|468437878|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129542|NCT01597245|468437879|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129543|NCT01597245|468437880|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129544|NCT01597245|468437881|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129545|NCT01597245|468437882|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129546|NCT01597245|468437883|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129547|NCT01597245|468437884|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129970791|NCT01340014|467856608|FG000|Period 1, First 7 Days|Adverse Event|1|||
130129548|NCT01597245|468437885|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
130129549|NCT01597245|468437865|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
130129550|NCT01597245|468437866|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
130129551|NCT01597245|468437867|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
130129552|NCT01597245|468437868|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
130129553|NCT01597245|468437869|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129554|NCT01597245|468437870|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129555|NCT01597245|468437871|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129556|NCT01597245|468437872|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129557|NCT01597245|468437873|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129558|NCT01597245|468437874|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129970792|NCT01340014|467856609|FG001|Period 1, First 7 Days|Adverse Event|0|||
130129559|NCT01597245|468437875|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129560|NCT01597245|468437876|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129561|NCT01597245|468437877|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129562|NCT01597245|468437878|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129563|NCT01597245|468437879|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129564|NCT01597245|468437880|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129565|NCT01597245|468437881|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129566|NCT01597245|468437882|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129567|NCT01597245|468437883|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129568|NCT01597245|468437884|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129569|NCT01597245|468437885|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
130129570|NCT01597245|468437865|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
130129571|NCT01597245|468437866|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
130129572|NCT01597245|468437867|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
130129573|NCT01597245|468437868|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
130129574|NCT01597245|468437869|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129575|NCT01597245|468437870|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129576|NCT01597245|468437871|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129577|NCT01597245|468437872|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129578|NCT01597245|468437873|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129579|NCT01597245|468437874|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129580|NCT01597245|468437875|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129581|NCT01597245|468437876|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129582|NCT01597245|468437877|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129583|NCT01597245|468437878|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129584|NCT01597245|468437879|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129585|NCT01597245|468437880|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129586|NCT01597245|468437881|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129587|NCT01597245|468437882|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129588|NCT01597245|468437883|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129589|NCT01597245|468437884|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129590|NCT01597245|468437885|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
130129591|NCT01597245|468437865|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
130129592|NCT01597245|468437866|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
130129593|NCT01597245|468437867|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
130129594|NCT01597245|468437868|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129595|NCT01597245|468437869|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129596|NCT01597245|468437870|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129597|NCT01597245|468437871|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129598|NCT01597245|468437872|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129599|NCT01597245|468437873|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129600|NCT01597245|468437874|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129601|NCT01597245|468437875|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129602|NCT01597245|468437876|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129603|NCT01597245|468437877|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129604|NCT01597245|468437878|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129605|NCT01597245|468437879|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129606|NCT01597245|468437880|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129607|NCT01597245|468437881|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129608|NCT01597245|468437882|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129609|NCT01597245|468437883|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129610|NCT01597245|468437884|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129611|NCT01597245|468437885|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
130129612|NCT01597245|468437865|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
130129613|NCT01597245|468437866|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129614|NCT01597245|468437867|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129615|NCT01597245|468437868|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
130129616|NCT01597245|468437869|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129617|NCT01597245|468437870|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129618|NCT01597245|468437871|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129619|NCT01597245|468437872|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129620|NCT01597245|468437873|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129621|NCT01597245|468437874|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129622|NCT01597245|468437875|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129623|NCT01597245|468437876|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129624|NCT01597245|468437877|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129625|NCT01597245|468437878|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129626|NCT01597245|468437879|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129627|NCT01597245|468437880|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129628|NCT01597245|468437881|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129629|NCT01597245|468437882|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129630|NCT01597245|468437883|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129631|NCT01597245|468437884|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129632|NCT01597245|468437885|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
130129633|NCT01597245|468437865|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
130129634|NCT01597245|468437866|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
130129635|NCT01597245|468437867|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
130129636|NCT01597245|468437868|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129637|NCT01597245|468437869|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129638|NCT01597245|468437870|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129639|NCT01597245|468437871|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129640|NCT01597245|468437872|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129641|NCT01597245|468437873|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129642|NCT01597245|468437874|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129643|NCT01597245|468437875|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129644|NCT01597245|468437876|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129645|NCT01597245|468437877|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129646|NCT01597245|468437878|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129647|NCT01597245|468437879|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129648|NCT01597245|468437880|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129649|NCT01597245|468437881|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129650|NCT01597245|468437882|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129651|NCT01597245|468437883|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129652|NCT01597245|468437884|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129653|NCT01597245|468437885|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
130129654|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129655|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129656|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129657|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129658|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129659|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
130129660|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
130129661|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129662|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129663|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129664|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129665|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129666|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129667|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129668|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129669|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129670|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129671|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129672|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129673|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129674|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
130129675|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129676|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129677|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129678|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129679|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
130129680|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
130129681|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
130129682|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
130129683|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129684|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
130129685|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129686|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129687|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129688|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129689|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129690|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129691|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129692|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129693|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129694|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129695|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
130129696|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129697|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129698|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129699|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129700|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129701|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
130129702|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129703|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129704|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
130129705|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129706|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
130129707|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
130129708|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
130129709|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129710|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129711|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129712|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129713|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129714|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129715|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129716|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
130129717|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129718|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129719|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129720|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129721|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
130129722|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
130129723|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
130129724|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
130129725|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
130129726|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
130129727|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
130129728|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
130129729|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
130129730|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129731|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129732|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129733|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129734|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129735|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129736|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129737|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
130129738|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129739|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129740|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129741|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129742|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
130129743|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
130129744|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
130129745|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129746|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
130129747|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
130129748|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
130129749|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
130129750|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
130129751|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129752|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129753|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129754|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129755|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129756|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129757|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129758|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
130129759|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129760|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129761|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129762|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129763|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130129764|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129765|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129766|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129767|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
130129768|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130129769|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
130129770|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129771|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
130129772|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129773|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129774|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129775|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129776|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129777|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129778|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129779|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
130129780|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129781|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129782|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129783|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129784|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
130129785|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
130129786|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130129787|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129788|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130129789|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130129790|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130129791|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
130129792|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
130129793|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129794|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129795|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129796|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129797|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129798|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129799|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129800|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
130129801|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129802|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129803|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129804|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129805|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129806|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130129807|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129808|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129970793|NCT01340014|467856608|FG000|Period 1, First 7 Days|Personal Reasons|1|||
129970794|NCT01340014|467856609|FG001|Period 1, First 7 Days|Personal Reasons|0|||
129970795|NCT01340014|467856608|FG000|Period 2, Second 7 Days|Adverse Event|0|||
129970796|NCT01340014|467856609|FG001|Period 2, Second 7 Days|Adverse Event|1|||
129970797|NCT04535544|467856611|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
129970798|NCT04535544|467856612|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
129970799|NCT04535544|467856613|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
129970800|NCT04535544|467856614|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
129970801|NCT04535544|467856611|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
129970802|NCT04535544|467856612|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
129970803|NCT04535544|467856613|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
129970804|NCT04535544|467856614|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
129970805|NCT04535544|467856611|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
129970806|NCT04535544|467856612|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
129970807|NCT04535544|467856613|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
129970808|NCT04535544|467856614|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
129970809|NCT04535544|467856611|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
129970810|NCT04535544|467856612|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
129970811|NCT04535544|467856613|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
129970812|NCT04535544|467856614|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
129970813|NCT04535544|467856611|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
129970814|NCT04535544|467856612|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
129970815|NCT04535544|467856613|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
129970816|NCT04535544|467856614|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
129970817|NCT04535544|467856611|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
129970818|NCT04535544|467856612|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
130129809|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130129810|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130129811|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130129812|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
130129813|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129814|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129815|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129816|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129817|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129818|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129819|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129820|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129821|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
130129822|NCT01597245|468437865|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129823|NCT01597245|468437866|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129824|NCT01597245|468437867|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129825|NCT01597245|468437868|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129826|NCT01597245|468437869|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129827|NCT01597245|468437870|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129828|NCT01597245|468437871|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129829|NCT01597245|468437872|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129830|NCT01597245|468437873|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129831|NCT01597245|468437874|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129832|NCT01597245|468437875|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
130129833|NCT01597245|468437876|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129834|NCT01597245|468437877|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129835|NCT01597245|468437878|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129836|NCT01597245|468437879|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129837|NCT01597245|468437880|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129838|NCT01597245|468437881|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129839|NCT01597245|468437882|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129840|NCT01597245|468437883|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129841|NCT01597245|468437884|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129842|NCT01597245|468437885|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
130129843|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129844|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129845|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129846|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129847|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129848|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129849|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129850|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129851|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129852|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129853|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129854|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129855|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129856|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
130129857|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
130129858|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
130129859|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129860|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129861|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129862|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129863|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
130129864|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129865|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129866|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129867|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129868|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129869|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129870|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129871|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129872|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129873|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129874|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129875|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129876|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129877|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
130129878|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
130129879|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
130129880|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129881|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129882|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129883|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129884|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
130129885|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129886|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129887|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129888|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129889|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129890|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129891|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129892|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129893|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129894|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129895|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129896|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129897|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129898|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129899|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
130129900|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
130129901|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129902|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129903|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129904|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129905|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
130129906|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129907|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129908|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129909|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129910|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129911|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129912|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129913|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129914|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129915|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129916|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129917|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129918|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129919|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130093740|NCT00351611|468296973|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
130093741|NCT00351611|468296974|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
130093742|NCT00351611|468296973|FG000|Overall Study|Other|1|||
130093743|NCT00351611|468296974|FG001|Overall Study|Other|0|||
130093744|NCT00351611|468296973|FG000|Overall Study|Protocol Violation|0|||
130093745|NCT00351611|468296974|FG001|Overall Study|Protocol Violation|2|||
130093746|NCT00808665|468296975|FG000|Overall Study|Withdrawal by Subject|1|||
130093747|NCT00808665|468296976|FG001|Overall Study|Withdrawal by Subject|0|||
130093748|NCT00808665|468296975|FG000|Overall Study|only required minimally invasive surgery|1|||
130093749|NCT00808665|468296976|FG001|Overall Study|only required minimally invasive surgery|0|||
130093750|NCT00808665|468296975|FG000|Overall Study|surgery cancelled|1|||
130093751|NCT00808665|468296976|FG001|Overall Study|surgery cancelled|0|||
130093752|NCT00808665|468296975|FG000|Overall Study|required an additional procedure|0|||
130093753|NCT00808665|468296976|FG001|Overall Study|required an additional procedure|1|||
130093754|NCT00808665|468296975|FG000|Overall Study|Physician Decision|3|||
130093755|NCT00808665|468296976|FG001|Overall Study|Physician Decision|1|||
130093756|NCT00808665|468296975|FG000|Overall Study|Medication stopped by resident|0|||
130093757|NCT00808665|468296976|FG001|Overall Study|Medication stopped by resident|1|||
130093758|NCT00665002|468296977|FG000|Overall Study|Progression/relapse during treatment|11|||
130093759|NCT00665002|468296977|FG000|Overall Study|Cytogenetic resistance|1|||
130093760|NCT01288911|468296988|FG000|Double-blind Period|Death|11|||
130093761|NCT01288911|468296989|FG001|Double-blind Period|Death|7|||
130093762|NCT01288911|468296988|FG000|Double-blind Period|Lost to Follow-up|0|||
130093763|NCT01288911|468296989|FG001|Double-blind Period|Lost to Follow-up|2|||
130093764|NCT01288911|468296988|FG000|Double-blind Period|Progressive Disease|75|||
130093765|NCT01288911|468296989|FG001|Double-blind Period|Progressive Disease|103|||
130093766|NCT01288911|468296988|FG000|Double-blind Period|Protocol Violation|1|||
130093767|NCT01288911|468296989|FG001|Double-blind Period|Protocol Violation|0|||
130093768|NCT01288911|468296988|FG000|Double-blind Period|Withdrawal by Subject|25|||
130093769|NCT01288911|468296989|FG001|Double-blind Period|Withdrawal by Subject|26|||
130093770|NCT01288911|468296988|FG000|Double-blind Period|Miscellaneous Reason|29|||
130093771|NCT01288911|468296989|FG001|Double-blind Period|Miscellaneous Reason|42|||
130093772|NCT01288911|468296988|FG000|Double-blind Period|Randomized but never received study drug|1|||
130093773|NCT01288911|468296989|FG001|Double-blind Period|Randomized but never received study drug|2|||
130093774|NCT01288911|468296988|FG000|Open-label Period (All Enzalutamide)|Death|0|||
130093775|NCT01288911|468296989|FG001|Open-label Period (All Enzalutamide)|Death|1|||
130093776|NCT01288911|468296988|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
130093777|NCT01288911|468296989|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
130093778|NCT01288911|468296988|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
130093779|NCT01288911|468296989|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
130093780|NCT01288911|468296988|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
130093781|NCT01288911|468296989|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
130093782|NCT01288911|468296988|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
130093783|NCT01288911|468296989|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
130093784|NCT01288911|468296988|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
130093785|NCT01288911|468296989|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
130093786|NCT02543918|468296990|FG000|Overall Study|Never treated|0|||
130093787|NCT02543918|468296991|FG001|Overall Study|Never treated|1|||
130093788|NCT02543918|468296990|FG000|Overall Study|Lost to Follow-up|1|||
130093789|NCT02543918|468296991|FG001|Overall Study|Lost to Follow-up|1|||
130093790|NCT02543918|468296990|FG000|Overall Study|Withdrawal by Subject|1|||
130093791|NCT02543918|468296991|FG001|Overall Study|Withdrawal by Subject|1|||
130093792|NCT02543918|468296990|FG000|Overall Study|Adverse Event|1|||
130093793|NCT02543918|468296991|FG001|Overall Study|Adverse Event|1|||
130093794|NCT01348828|468296994|FG000|Overall Study|Death|20|||
130093795|NCT01348828|468296994|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
130093796|NCT01348828|468296994|FG000|Overall Study|Conversion|2|||
130093797|NCT01348828|468296994|FG000|Overall Study|missed visit|1|||
130093798|NCT00242658|468296997|FG000|Overall Study|Lost to Follow-up|22|||
130093799|NCT00242658|468296998|FG001|Overall Study|Lost to Follow-up|19|||
130093800|NCT01815099|468296999|FG000|Overall Study|Lack of Efficacy|1|||
130093801|NCT01815099|468296999|FG000|Overall Study|unable to attend study visits|1|||
130093802|NCT04557189|468297000|FG000|Overall Study|Adverse Event|0|||
130093803|NCT04557189|468297001|FG001|Overall Study|Adverse Event|1|||
130093804|NCT04557189|468297000|FG000|Overall Study|Lost to Follow-up|1|||
130093805|NCT04557189|468297001|FG001|Overall Study|Lost to Follow-up|1|||
130093806|NCT04557189|468297000|FG000|Overall Study|Withdrawal by Subject|2|||
130093807|NCT04557189|468297001|FG001|Overall Study|Withdrawal by Subject|1|||
130093808|NCT04557189|468297000|FG000|Overall Study|Reason not Specified|3|||
130093809|NCT04557189|468297001|FG001|Overall Study|Reason not Specified|6|||
130093810|NCT01731600|468297004|FG000|Overall Study|Adverse Event|2|||
130093811|NCT01731600|468297005|FG001|Overall Study|Adverse Event|0|||
130093812|NCT01731600|468297004|FG000|Overall Study|Withdrawal criteria|1|||
130093813|NCT01731600|468297005|FG001|Overall Study|Withdrawal criteria|0|||
130129920|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
130129921|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
130129922|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129923|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129924|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129925|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129926|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
130129927|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129928|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129929|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129930|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129931|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129932|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129933|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129934|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129935|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129936|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129937|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129938|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129939|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129940|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
130129941|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
130129942|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
130129943|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129944|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129945|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129946|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129947|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
130129948|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129949|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129950|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129951|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129952|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129953|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129954|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129955|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129956|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129957|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129958|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129959|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129960|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129961|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129962|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
130129963|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
130129964|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129965|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129966|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129967|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129968|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
130129969|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129970|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129971|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129972|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129973|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129974|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129975|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129976|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129977|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129978|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129979|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129980|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129981|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129982|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129983|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
130129984|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
130129985|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129986|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129987|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129988|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129989|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
130129990|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129991|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129992|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129993|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129994|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129995|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129996|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129997|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129998|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130129999|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130000|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130001|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130002|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130003|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130004|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
130130005|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
130130006|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130007|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130008|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130009|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130010|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
130130011|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130012|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130013|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130014|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130015|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130016|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130017|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130018|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130019|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130020|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130021|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130022|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130023|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130024|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130025|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
130130026|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
130130027|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130028|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130029|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130030|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130031|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
130130032|NCT01597245|468437865|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130033|NCT01597245|468437866|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130034|NCT01597245|468437867|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130035|NCT01597245|468437868|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130036|NCT01597245|468437869|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130037|NCT01597245|468437870|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130038|NCT01597245|468437871|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130039|NCT01597245|468437872|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130040|NCT01597245|468437873|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130041|NCT01597245|468437874|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130042|NCT01597245|468437875|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130043|NCT01597245|468437876|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130044|NCT01597245|468437877|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130045|NCT01597245|468437878|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
130130046|NCT01597245|468437879|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130047|NCT01597245|468437880|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129970819|NCT04535544|467856613|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
129970820|NCT04535544|467856614|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
129970821|NCT04535544|467856611|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
129970822|NCT04535544|467856612|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
130093814|NCT01731600|468297004|FG000|Overall Study|Other reasons|3|||
130093815|NCT01731600|468297005|FG001|Overall Study|Other reasons|0|||
130093816|NCT00465894|468297006|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
130093817|NCT00465894|468297007|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
130093818|NCT00465894|468297006|FG000|Treatment For 12 Weeks|Family Issues|1|||
130093819|NCT00465894|468297007|FG001|Treatment For 12 Weeks|Family Issues|1|||
130093820|NCT00465894|468297006|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
130093821|NCT00465894|468297007|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
130093822|NCT01636076|468297008|FG000|Overall Study|Terminated by sponsor|1|||
130093823|NCT01636076|468297009|FG001|Overall Study|Terminated by sponsor|1|||
130093824|NCT01636076|468297008|FG000|Overall Study|Lack of Efficacy|0|||
130093825|NCT01636076|468297009|FG001|Overall Study|Lack of Efficacy|1|||
130093826|NCT01636076|468297008|FG000|Overall Study|Lost to Follow-up|1|||
130093827|NCT01636076|468297009|FG001|Overall Study|Lost to Follow-up|0|||
130093828|NCT01636076|468297008|FG000|Overall Study|Physician Decision|1|||
130093829|NCT01636076|468297009|FG001|Overall Study|Physician Decision|1|||
130093830|NCT01636076|468297008|FG000|Overall Study|Non-compliance with study treatment|1|||
130093831|NCT01636076|468297009|FG001|Overall Study|Non-compliance with study treatment|1|||
130093832|NCT01636076|468297008|FG000|Overall Study|Adverse Event|6|||
130093833|NCT01636076|468297009|FG001|Overall Study|Adverse Event|11|||
130093834|NCT01636076|468297008|FG000|Overall Study|Withdrawal by Subject|7|||
130093835|NCT01636076|468297009|FG001|Overall Study|Withdrawal by Subject|10|||
130093836|NCT02173158|468297011|FG000|Efficacy Phase|Adverse Event|1|||
130093837|NCT01728454|468297023|FG000|Stage 1 and 2|Pregnancy|1|||
130093838|NCT01728454|468297024|FG001|Stage 1 and 2|Pregnancy|0|||
130093839|NCT01728454|468297025|FG002|Stage 1 and 2|Pregnancy|0|||
130093840|NCT01728454|468297023|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
130093841|NCT01728454|468297024|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
130093842|NCT01728454|468297025|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
130093843|NCT01728454|468297023|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
130093844|NCT01728454|468297024|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
130093845|NCT01728454|468297025|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
130093846|NCT01728454|468297023|FG000|Stage 1 and 2|Lost to Follow-up|1|||
130093847|NCT01728454|468297024|FG001|Stage 1 and 2|Lost to Follow-up|1|||
130093848|NCT01728454|468297025|FG002|Stage 1 and 2|Lost to Follow-up|0|||
130093849|NCT01728454|468297023|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
130093850|NCT01728454|468297024|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
130093851|NCT01728454|468297025|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
130093852|NCT01728454|468297023|FG000|Stage 3|Reason Missing|0|||
130093853|NCT01728454|468297024|FG001|Stage 3|Reason Missing|0|||
130093854|NCT01728454|468297025|FG002|Stage 3|Reason Missing|1|||
130093855|NCT01728454|468297023|FG000|Stage 3|Subject Required Other Treatment|0|||
130093856|NCT01728454|468297024|FG001|Stage 3|Subject Required Other Treatment|1|||
130093857|NCT01728454|468297025|FG002|Stage 3|Subject Required Other Treatment|0|||
130093858|NCT01728454|468297023|FG000|Stage 3|Pregnancy|1|||
130093859|NCT01728454|468297024|FG001|Stage 3|Pregnancy|0|||
130093860|NCT01728454|468297025|FG002|Stage 3|Pregnancy|0|||
130093861|NCT01728454|468297023|FG000|Stage 3|Withdrew Consent|1|||
130093862|NCT01728454|468297024|FG001|Stage 3|Withdrew Consent|0|||
130093863|NCT01728454|468297025|FG002|Stage 3|Withdrew Consent|1|||
130093864|NCT01728454|468297023|FG000|Stage 3|Non-compliance with Protocol|0|||
130093865|NCT01728454|468297024|FG001|Stage 3|Non-compliance with Protocol|0|||
130093866|NCT01728454|468297025|FG002|Stage 3|Non-compliance with Protocol|1|||
130093867|NCT01728454|468297023|FG000|Stage 3|Lost to Follow-up|0|||
130093868|NCT01728454|468297024|FG001|Stage 3|Lost to Follow-up|3|||
130093869|NCT01728454|468297025|FG002|Stage 3|Lost to Follow-up|1|||
130093870|NCT01728454|468297023|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
130093871|NCT01728454|468297024|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
130093872|NCT01728454|468297025|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
130093873|NCT01190839|468297026|FG000|Overall Study|Adverse Event|32|||
130093874|NCT01190839|468297027|FG001|Overall Study|Adverse Event|41|||
130093875|NCT01190839|468297026|FG000|Overall Study|Protocol Violation|2|||
130093876|NCT01190839|468297027|FG001|Overall Study|Protocol Violation|2|||
130093877|NCT01190839|468297026|FG000|Overall Study|Lost to Follow-up|7|||
130093878|NCT01190839|468297027|FG001|Overall Study|Lost to Follow-up|1|||
130093879|NCT01190839|468297026|FG000|Overall Study|Death|1|||
130093880|NCT01190839|468297027|FG001|Overall Study|Death|0|||
130093881|NCT01190839|468297026|FG000|Overall Study|Trial stopped by Sponsor|71|||
130093882|NCT01190839|468297027|FG001|Overall Study|Trial stopped by Sponsor|68|||
130093883|NCT01190839|468297026|FG000|Overall Study|Undefined|35|||
130093884|NCT01190839|468297027|FG001|Overall Study|Undefined|31|||
130093885|NCT01190839|468297026|FG000|Overall Study|Randomized but not treated|2|||
130093886|NCT01190839|468297027|FG001|Overall Study|Randomized but not treated|4|||
130093887|NCT00508820|468297029|FG000|Overall Study|Adverse Event|6|||
130130048|NCT01597245|468437881|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130049|NCT01597245|468437882|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130050|NCT01597245|468437883|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130051|NCT01597245|468437884|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130052|NCT01597245|468437885|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
130130053|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130054|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130055|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130056|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130057|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130058|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129970823|NCT04535544|467856613|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
129970824|NCT04535544|467856614|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
129970825|NCT04535544|467856611|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
129970826|NCT04535544|467856612|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
129970827|NCT04535544|467856613|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
129970828|NCT04535544|467856614|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
129970829|NCT05131477|467856621|FG000|PART 1|Withdrawal by Subject|2|||
129970830|NCT05131477|467856622|FG001|PART 1|Withdrawal by Subject|9|||
130130059|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130060|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130061|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130062|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130063|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130064|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130065|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130066|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130067|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130068|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
130130069|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
130130070|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
130130071|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
130130072|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
130130073|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
130130074|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130075|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130076|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130077|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130078|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130079|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130080|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130081|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130082|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130083|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130084|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130085|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130086|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130087|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130088|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130089|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130090|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
130130091|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
130130092|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
130130093|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
130130094|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
130130095|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130096|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130097|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130098|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130099|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129970831|NCT05131477|467856623|FG002|PART 1|Withdrawal by Subject|6|||
129970832|NCT05131477|467856624|FG003|PART 1|Withdrawal by Subject|2|||
129970833|NCT05131477|467856625|FG004|PART 1|Withdrawal by Subject|8|||
129970834|NCT05131477|467856626|FG005|PART 1|Withdrawal by Subject|0|||
129970835|NCT05131477|467856627|FG006|PART 1|Withdrawal by Subject|0|||
129970836|NCT05131477|467856628|FG007|PART 1|Withdrawal by Subject|0|||
130130100|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130101|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130102|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130103|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130104|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130105|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130106|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130107|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130108|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130109|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130110|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130111|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
130130112|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130113|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
130130114|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
130130115|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
130130116|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130117|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130118|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130119|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130120|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130121|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130122|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130123|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130124|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130125|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130126|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130127|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130128|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130129|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130130|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130131|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130132|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130133|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
130130134|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
130130135|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
130130136|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
130130137|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130138|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130139|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130140|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130141|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130142|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130143|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130144|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130145|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130146|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130147|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130148|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130149|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130150|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130151|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130152|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130153|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
130130154|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130155|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
130130156|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
130130157|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
130130158|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130159|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130160|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129970837|NCT05131477|467856629|FG008|PART 1|Withdrawal by Subject|0|||
129970838|NCT05131477|467856630|FG009|PART 1|Withdrawal by Subject|0|||
130130161|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130162|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130163|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130164|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130165|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130166|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130167|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130168|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130169|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130170|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130171|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130172|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130173|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130174|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
130130175|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130176|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
130130177|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
130130178|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
130130179|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130180|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130181|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130182|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130183|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130184|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130185|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130186|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130187|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130188|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130189|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130190|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130191|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130192|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130193|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130194|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130195|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
130130196|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130197|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130198|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
130130199|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
130130200|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130201|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130202|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130203|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130204|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130205|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130206|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130207|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130208|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130209|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130210|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130211|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130212|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130213|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130214|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130215|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129970839|NCT05131477|467856631|FG010|PART 1|Withdrawal by Subject|0|||
129970840|NCT05131477|467856632|FG011|PART 1|Withdrawal by Subject|0|||
129970841|NCT05131477|467856633|FG012|PART 1|Withdrawal by Subject|0|||
129970842|NCT05131477|467856634|FG013|PART 1|Withdrawal by Subject|0|||
129970843|NCT05131477|467856621|FG000|PART 1|Physician Decision|1|||
129970844|NCT05131477|467856622|FG001|PART 1|Physician Decision|0|||
129970845|NCT05131477|467856623|FG002|PART 1|Physician Decision|0|||
129970846|NCT05131477|467856624|FG003|PART 1|Physician Decision|0|||
129970847|NCT05131477|467856625|FG004|PART 1|Physician Decision|0|||
130130216|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
130130217|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130218|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130219|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
130130220|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
130130221|NCT01597245|468437865|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130222|NCT01597245|468437866|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130223|NCT01597245|468437867|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130224|NCT01597245|468437868|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130225|NCT01597245|468437869|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130226|NCT01597245|468437870|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130227|NCT01597245|468437871|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130228|NCT01597245|468437872|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130229|NCT01597245|468437873|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130230|NCT01597245|468437874|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130231|NCT01597245|468437875|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130232|NCT01597245|468437876|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130233|NCT01597245|468437877|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130234|NCT01597245|468437878|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130235|NCT01597245|468437879|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130236|NCT01597245|468437880|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130237|NCT01597245|468437881|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130238|NCT01597245|468437882|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130239|NCT01597245|468437883|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130240|NCT01597245|468437884|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
130130241|NCT01597245|468437885|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
130130242|NCT01313780|468437886|FG000|Overall Study|Lack of Efficacy|4|||
130130243|NCT01313780|468437887|FG001|Overall Study|Lack of Efficacy|2|||
130130244|NCT01313780|468437886|FG000|Overall Study|Adverse Event|6|||
130130245|NCT01313780|468437887|FG001|Overall Study|Adverse Event|11|||
130130246|NCT01313780|468437886|FG000|Overall Study|Withdrawal by Subject|2|||
130130247|NCT01313780|468437887|FG001|Overall Study|Withdrawal by Subject|8|||
130130248|NCT01313780|468437886|FG000|Overall Study|Protocol Violation|10|||
130130249|NCT01313780|468437887|FG001|Overall Study|Protocol Violation|4|||
130130250|NCT01313780|468437886|FG000|Overall Study|missing data|3|||
130130251|NCT01313780|468437887|FG001|Overall Study|missing data|3|||
130130252|NCT00731783|468437888|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
130130253|NCT00731783|468437889|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
130130254|NCT00731783|468437888|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
130130255|NCT00731783|468437889|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
130130256|NCT00731783|468437888|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
130130257|NCT00731783|468437889|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
130130258|NCT00731783|468437888|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
130130259|NCT00731783|468437889|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
130130260|NCT02956460|468439291|FG000|Lens 1|Lost to Follow-up|1|||
130130261|NCT02956460|468439292|FG001|Lens 1|Lost to Follow-up|0|||
130130262|NCT04129346|468439293|FG000|Overall Study|Death|1|||
130130263|NCT04129346|468439294|FG001|Overall Study|Death|0|||
130130264|NCT02077465|468439295|FG000|Overall Study|Withdrew Consent|0|||
130130265|NCT02077465|468439296|FG001|Overall Study|Withdrew Consent|1|||
130130266|NCT02077465|468439295|FG000|Overall Study|Lost to Follow-up|1|||
130130267|NCT02077465|468439296|FG001|Overall Study|Lost to Follow-up|0|||
130130268|NCT01827163|468439297|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
130130269|NCT01827163|468439297|FG000|Overall Study|Adverse Event|9|||
130130270|NCT03375463|468439298|FG000|Period 1|Lost to Follow-up|0|||
130130271|NCT03375463|468439299|FG001|Period 1|Lost to Follow-up|0|||
130130272|NCT03375463|468439300|FG002|Period 1|Lost to Follow-up|1|||
130130273|NCT03375463|468439301|FG003|Period 1|Lost to Follow-up|0|||
130130274|NCT03375463|468439302|FG004|Period 1|Lost to Follow-up|0|||
130130275|NCT03375463|468439303|FG005|Period 1|Lost to Follow-up|0|||
130130276|NCT03375463|468439298|FG000|Period 1|Adverse Event|0|||
130130277|NCT03375463|468439299|FG001|Period 1|Adverse Event|0|||
130130278|NCT03375463|468439300|FG002|Period 1|Adverse Event|0|||
130130279|NCT03375463|468439301|FG003|Period 1|Adverse Event|0|||
130130280|NCT03375463|468439302|FG004|Period 1|Adverse Event|1|||
130130281|NCT03375463|468439303|FG005|Period 1|Adverse Event|0|||
130130282|NCT03375463|468439298|FG000|Period 2|Lost to Follow-up|1|||
130130283|NCT03375463|468439299|FG001|Period 2|Lost to Follow-up|1|||
130130284|NCT03375463|468439300|FG002|Period 2|Lost to Follow-up|0|||
130130285|NCT03375463|468439301|FG003|Period 2|Lost to Follow-up|0|||
130130286|NCT03375463|468439302|FG004|Period 2|Lost to Follow-up|0|||
130130287|NCT03375463|468439303|FG005|Period 2|Lost to Follow-up|0|||
130130288|NCT01602419|468439304|FG000|Overall Study|Not treated with Wilate|9|||
130130289|NCT01602419|468439304|FG000|Overall Study|Adverse Drug Reaction|4|||
130130290|NCT01602419|468439304|FG000|Overall Study|Insurance issues|3|||
129970848|NCT05131477|467856626|FG005|PART 1|Physician Decision|0|||
129970849|NCT05131477|467856627|FG006|PART 1|Physician Decision|0|||
129970850|NCT05131477|467856628|FG007|PART 1|Physician Decision|0|||
130093888|NCT00508820|468297030|FG001|Overall Study|Adverse Event|10|||
130093889|NCT00508820|468297029|FG000|Overall Study|Death|6|||
130093890|NCT00508820|468297030|FG001|Overall Study|Death|8|||
130093891|NCT00508820|468297029|FG000|Overall Study|Lost to Follow-up|1|||
130093892|NCT00508820|468297030|FG001|Overall Study|Lost to Follow-up|1|||
130093893|NCT00508820|468297029|FG000|Overall Study|Physician Decision|8|||
130093894|NCT00508820|468297030|FG001|Overall Study|Physician Decision|2|||
130093895|NCT00508820|468297029|FG000|Overall Study|Pregnancy|0|||
130093896|NCT00508820|468297030|FG001|Overall Study|Pregnancy|2|||
130093897|NCT00508820|468297029|FG000|Overall Study|Protocol Violation|2|||
130093898|NCT00508820|468297030|FG001|Overall Study|Protocol Violation|0|||
130093899|NCT00508820|468297029|FG000|Overall Study|Withdrawal by Subject|10|||
130093900|NCT00508820|468297030|FG001|Overall Study|Withdrawal by Subject|12|||
130093901|NCT00508820|468297029|FG000|Overall Study|Other|11|||
130093902|NCT00508820|468297030|FG001|Overall Study|Other|2|||
130093903|NCT00508820|468297029|FG000|Overall Study|Noncompliance|1|||
130093904|NCT00508820|468297030|FG001|Overall Study|Noncompliance|0|||
130093905|NCT00508820|468297029|FG000|Overall Study|Requirement for alternative therapy|7|||
130093906|NCT00508820|468297030|FG001|Overall Study|Requirement for alternative therapy|15|||
130093907|NCT00508820|468297029|FG000|Overall Study|Protocol-specified Criteria|3|||
130093908|NCT00508820|468297030|FG001|Overall Study|Protocol-specified Criteria|12|||
130093909|NCT01266967|468298701|FG000|Overall Study|Death|69|||
130093910|NCT01266967|468298702|FG001|Overall Study|Death|61|||
130093911|NCT01266967|468298701|FG000|Overall Study|Study Closed/Terminated|15|||
130093912|NCT01266967|468298702|FG001|Overall Study|Study Closed/Terminated|17|||
130093913|NCT01266967|468298701|FG000|Overall Study|Lost to Follow-up|2|||
130093914|NCT01266967|468298702|FG001|Overall Study|Lost to Follow-up|1|||
130093915|NCT01266967|468298701|FG000|Overall Study|Physician Decision|0|||
130093916|NCT01266967|468298702|FG001|Overall Study|Physician Decision|1|||
130093917|NCT01266967|468298701|FG000|Overall Study|Withdrawal by Subject|3|||
130093918|NCT01266967|468298702|FG001|Overall Study|Withdrawal by Subject|3|||
130093919|NCT01945866|468298703|FG000|Overall Study|Eyes did not complete or were dropped|2|||
130093920|NCT01945866|468298704|FG001|Overall Study|Eyes did not complete or were dropped|0|||
130093921|NCT04398030|468298705|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
130093922|NCT04398030|468298706|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
130093923|NCT04398030|468298705|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
130093924|NCT04398030|468298706|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
130093925|NCT03159455|468298709|FG000|Overall Study|Adverse Event|0|||
130093926|NCT03159455|468298710|FG001|Overall Study|Adverse Event|0|||
130093927|NCT03159455|468298711|FG002|Overall Study|Adverse Event|0|||
130093928|NCT03159455|468298712|FG003|Overall Study|Adverse Event|0|||
130093929|NCT03159455|468298713|FG004|Overall Study|Adverse Event|0|||
130093930|NCT03159455|468298714|FG005|Overall Study|Adverse Event|1|||
130093931|NCT02501642|468298721|FG000|Overall Study|Lost to Follow-up|7|||
130093932|NCT02501642|468298722|FG001|Overall Study|Lost to Follow-up|11|||
130093933|NCT00548340|468298723|FG000|Overall Study|Protocol Violation|2|||
130093934|NCT00548340|468298724|FG001|Overall Study|Protocol Violation|3|||
130093935|NCT00548340|468298725|FG002|Overall Study|Protocol Violation|3|||
130093936|NCT00548340|468298723|FG000|Overall Study|Adverse Event|2|||
130093937|NCT00548340|468298724|FG001|Overall Study|Adverse Event|2|||
130093938|NCT00548340|468298725|FG002|Overall Study|Adverse Event|2|||
130093939|NCT00548340|468298723|FG000|Overall Study|Lost to Follow-up|1|||
130093940|NCT00548340|468298724|FG001|Overall Study|Lost to Follow-up|1|||
130093941|NCT00548340|468298725|FG002|Overall Study|Lost to Follow-up|0|||
130093942|NCT00548340|468298723|FG000|Overall Study|Withdrawal by Subject|2|||
130093943|NCT00548340|468298724|FG001|Overall Study|Withdrawal by Subject|4|||
130093944|NCT00548340|468298725|FG002|Overall Study|Withdrawal by Subject|3|||
130093945|NCT00548340|468298723|FG000|Overall Study|Other|1|||
130130291|NCT01602419|468439304|FG000|Overall Study|Changed treatment centre|1|||
130130292|NCT01602419|468439304|FG000|Overall Study|Treatment centre closed|1|||
130130293|NCT01602419|468439304|FG000|Overall Study|Withdrawal by Subject|5|||
130130294|NCT01602419|468439304|FG000|Overall Study|Lost to Follow-up|6|||
130093946|NCT00548340|468298724|FG001|Overall Study|Other|1|||
130093947|NCT00548340|468298725|FG002|Overall Study|Other|1|||
130093948|NCT01846442|468298729|FG000|Overall Study|Adverse Event|2|||
130093949|NCT01846442|468298730|FG001|Overall Study|Adverse Event|4|||
130093950|NCT01846442|468298731|FG002|Overall Study|Adverse Event|2|||
130093951|NCT01846442|468298732|FG003|Overall Study|Adverse Event|1|||
130093952|NCT01846442|468298729|FG000|Overall Study|Lost to Follow-up|0|||
130093953|NCT01846442|468298730|FG001|Overall Study|Lost to Follow-up|0|||
130130295|NCT01792635|468439305|FG000|Part B|Adverse Event|0|||
129970851|NCT05131477|467856629|FG008|PART 1|Physician Decision|0|||
130093954|NCT01846442|468298731|FG002|Overall Study|Lost to Follow-up|1|||
130093955|NCT01846442|468298732|FG003|Overall Study|Lost to Follow-up|0|||
130093956|NCT01846442|468298729|FG000|Overall Study|Withdrawal by Subject|3|||
130093957|NCT01846442|468298730|FG001|Overall Study|Withdrawal by Subject|2|||
130130296|NCT01792635|468439306|FG001|Part B|Adverse Event|0|||
130130297|NCT01792635|468439307|FG002|Part B|Adverse Event|1|||
130130298|NCT01792635|468439305|FG000|Part B|Study terminated|0|||
130130299|NCT01792635|468439306|FG001|Part B|Study terminated|4|||
130130300|NCT01792635|468439307|FG002|Part B|Study terminated|3|||
130130301|NCT01513174|468439310|FG000|Overall Study|Inclusion Error|1|||
130130302|NCT01513174|468439311|FG001|Overall Study|Inclusion Error|7|||
130130303|NCT01513174|468439310|FG000|Overall Study|Not receive study treatment|3|||
130130304|NCT01513174|468439311|FG001|Overall Study|Not receive study treatment|1|||
130130305|NCT00467363|468439312|FG000|Overall Study|Lost to Follow-up|80|||
130130306|NCT00467363|468439313|FG001|Overall Study|Lost to Follow-up|70|||
130130307|NCT00365846|468439314|FG000|Overall Study|Lost to Follow-up|1|||
130130308|NCT04400890|468439315|FG000|Overall Study|Withdrawal by Subject|3|||
130130309|NCT04400890|468439316|FG001|Overall Study|Withdrawal by Subject|2|||
130130310|NCT00723710|468439317|FG000|Overall Study|Disease progression|48|||
130130311|NCT00723710|468439317|FG000|Overall Study|Adverse Event|88|||
130130312|NCT00723710|468439317|FG000|Overall Study|Withdrawal by Subject|36|||
130130313|NCT00723710|468439317|FG000|Overall Study|Physician Decision|2|||
130130314|NCT04405570|468439318|FG000|Overall Study|Adverse Event|0|||
130130315|NCT04405570|468439319|FG001|Overall Study|Adverse Event|1|||
130130316|NCT04405570|468439320|FG002|Overall Study|Adverse Event|1|||
130130317|NCT04405570|468439321|FG003|Overall Study|Adverse Event|1|||
130130318|NCT04405570|468439318|FG000|Overall Study|Lost to Follow-up|0|||
130130319|NCT04405570|468439319|FG001|Overall Study|Lost to Follow-up|1|||
130130320|NCT04405570|468439320|FG002|Overall Study|Lost to Follow-up|0|||
130130321|NCT04405570|468439321|FG003|Overall Study|Lost to Follow-up|0|||
130130322|NCT04405570|468439318|FG000|Overall Study|Physician Decision|0|||
130130323|NCT04405570|468439319|FG001|Overall Study|Physician Decision|0|||
130130324|NCT04405570|468439320|FG002|Overall Study|Physician Decision|1|||
130130325|NCT04405570|468439321|FG003|Overall Study|Physician Decision|0|||
130130326|NCT04405570|468439318|FG000|Overall Study|Withdrawal by Subject|0|||
130130327|NCT04405570|468439319|FG001|Overall Study|Withdrawal by Subject|1|||
130130328|NCT04405570|468439320|FG002|Overall Study|Withdrawal by Subject|1|||
130130329|NCT04405570|468439321|FG003|Overall Study|Withdrawal by Subject|0|||
130130330|NCT04405570|468439318|FG000|Overall Study|Randomized not dosed|0|||
130130331|NCT04405570|468439319|FG001|Overall Study|Randomized not dosed|2|||
130130332|NCT04405570|468439320|FG002|Overall Study|Randomized not dosed|0|||
130130333|NCT04405570|468439321|FG003|Overall Study|Randomized not dosed|0|||
130130334|NCT04499963|468439322|FG000|Overall Study|Adverse Event|3|||
130130335|NCT04499963|468439323|FG001|Overall Study|Adverse Event|0|||
130130336|NCT04499963|468439322|FG000|Overall Study|Death|3|||
130130337|NCT04499963|468439323|FG001|Overall Study|Death|0|||
130130338|NCT04499963|468439322|FG000|Overall Study|Lack of Efficacy|7|||
130130339|NCT04499963|468439323|FG001|Overall Study|Lack of Efficacy|0|||
130130340|NCT04499963|468439322|FG000|Overall Study|Lost to Follow-up|2|||
130130341|NCT04499963|468439323|FG001|Overall Study|Lost to Follow-up|0|||
130130342|NCT03546842|468439329|FG000|Overall Study|Protocol Violation|1|||
130130343|NCT03546842|468439329|FG000|Overall Study|Withdrawal by Subject|2|||
130130344|NCT02711852|468439337|FG000|Overall Study|Death|5|||
130130345|NCT02711852|468439337|FG000|Overall Study|Lost to Follow-up|1|||
130130346|NCT02711852|468439337|FG000|Overall Study|Completed follow-up|3|||
130130347|NCT02711852|468439337|FG000|Overall Study|Withdrawal by Subject|1|||
130130348|NCT02453386|468439342|FG000|Overall Study|Adverse Event|22|||
130130349|NCT02453386|468439343|FG001|Overall Study|Adverse Event|30|||
130130350|NCT02453386|468439344|FG002|Overall Study|Adverse Event|15|||
130130351|NCT02453386|468439342|FG000|Overall Study|Protocol Violation|1|||
130130352|NCT02453386|468439343|FG001|Overall Study|Protocol Violation|0|||
130130353|NCT02453386|468439344|FG002|Overall Study|Protocol Violation|1|||
130130354|NCT02453386|468439342|FG000|Overall Study|Withdrawal by Subject|10|||
130130355|NCT02453386|468439343|FG001|Overall Study|Withdrawal by Subject|9|||
130130356|NCT02453386|468439344|FG002|Overall Study|Withdrawal by Subject|9|||
130130357|NCT02453386|468439342|FG000|Overall Study|Sponsor Terminated Study|14|||
130130358|NCT02453386|468439343|FG001|Overall Study|Sponsor Terminated Study|8|||
130130359|NCT02453386|468439344|FG002|Overall Study|Sponsor Terminated Study|11|||
130130360|NCT02453386|468439342|FG000|Overall Study|Subject Terminated by Sponsor|1|||
130130361|NCT02453386|468439343|FG001|Overall Study|Subject Terminated by Sponsor|1|||
130130362|NCT02453386|468439344|FG002|Overall Study|Subject Terminated by Sponsor|1|||
130130363|NCT02453386|468439342|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
130130364|NCT02453386|468439343|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
130130365|NCT02453386|468439344|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
130130366|NCT02453386|468439342|FG000|Overall Study|Lost to Follow-up|0|||
130130367|NCT02453386|468439343|FG001|Overall Study|Lost to Follow-up|0|||
130130368|NCT02453386|468439344|FG002|Overall Study|Lost to Follow-up|1|||
130130369|NCT02453386|468439342|FG000|Overall Study|Other|1|||
130130370|NCT02453386|468439343|FG001|Overall Study|Other|0|||
130130371|NCT02453386|468439344|FG002|Overall Study|Other|1|||
130130372|NCT03233724|468439345|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130130373|NCT03233724|468439346|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130130374|NCT03233724|468439347|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130130375|NCT03233724|468439348|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
130130376|NCT03233724|468439349|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
130130377|NCT03233724|468439345|FG000|Phase I Dose Escalation|Best interest of participant|1|||
130130378|NCT03233724|468439346|FG001|Phase I Dose Escalation|Best interest of participant|1|||
130130379|NCT03233724|468439347|FG002|Phase I Dose Escalation|Best interest of participant|1|||
130130380|NCT03233724|468439348|FG003|Phase I Dose Escalation|Best interest of participant|0|||
130130381|NCT03233724|468439349|FG004|Phase I Dose Escalation|Best interest of participant|0|||
130130382|NCT03233724|468439345|FG000|Phase I Dose Escalation|Physician Decision|0|||
130130383|NCT03233724|468439346|FG001|Phase I Dose Escalation|Physician Decision|0|||
130130384|NCT03233724|468439347|FG002|Phase I Dose Escalation|Physician Decision|1|||
130130385|NCT03233724|468439348|FG003|Phase I Dose Escalation|Physician Decision|0|||
130130386|NCT03233724|468439349|FG004|Phase I Dose Escalation|Physician Decision|0|||
130130387|NCT03233724|468439345|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130130388|NCT03233724|468439346|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130130389|NCT03233724|468439347|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
130130390|NCT03233724|468439348|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130130391|NCT03233724|468439349|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
130130392|NCT02388191|468439351|FG000|Overall Study|Patient did not receive IUD|1|||
130130393|NCT02388191|468439352|FG001|Overall Study|Patient did not receive IUD|0|||
130130394|NCT03031847|468439353|FG000|Overall Study|Death|1|||
130130395|NCT03031847|468439354|FG001|Overall Study|Death|1|||
130130396|NCT03031847|468439355|FG002|Overall Study|Death|2|||
130130397|NCT03031847|468439356|FG003|Overall Study|Death|3|||
130130398|NCT03031847|468439353|FG000|Overall Study|Lost to Follow-up|1|||
130130399|NCT03031847|468439354|FG001|Overall Study|Lost to Follow-up|1|||
130130400|NCT03031847|468439355|FG002|Overall Study|Lost to Follow-up|2|||
130130401|NCT03031847|468439356|FG003|Overall Study|Lost to Follow-up|3|||
130130402|NCT00858845|468439358|FG000|Overall Study|Patient underwent heart transplant.|0|||
130130403|NCT00858845|468439359|FG001|Overall Study|Patient underwent heart transplant.|1|||
130130404|NCT01353664|468439361|FG000|Overall Study|Other|3|||
130130405|NCT01353664|468439361|FG000|Overall Study|Disease Progression|16|||
130130406|NCT02605928|468439364|FG000|Overall Study|Model tuning phase|28|||
129970852|NCT05131477|467856630|FG009|PART 1|Physician Decision|0|||
129970853|NCT05131477|467856631|FG010|PART 1|Physician Decision|0|||
129970854|NCT05131477|467856632|FG011|PART 1|Physician Decision|0|||
129970855|NCT05131477|467856633|FG012|PART 1|Physician Decision|0|||
129970856|NCT05131477|467856634|FG013|PART 1|Physician Decision|0|||
129970857|NCT05131477|467856621|FG000|PART 1|Adverse Event|3|||
129970858|NCT05131477|467856622|FG001|PART 1|Adverse Event|5|||
129970859|NCT05131477|467856623|FG002|PART 1|Adverse Event|1|||
129970860|NCT05131477|467856624|FG003|PART 1|Adverse Event|6|||
129970861|NCT05131477|467856625|FG004|PART 1|Adverse Event|4|||
129970862|NCT05131477|467856626|FG005|PART 1|Adverse Event|0|||
129970863|NCT05131477|467856627|FG006|PART 1|Adverse Event|0|||
129970864|NCT05131477|467856628|FG007|PART 1|Adverse Event|0|||
129970865|NCT05131477|467856629|FG008|PART 1|Adverse Event|0|||
129970866|NCT05131477|467856630|FG009|PART 1|Adverse Event|0|||
129970867|NCT05131477|467856631|FG010|PART 1|Adverse Event|0|||
129970868|NCT05131477|467856632|FG011|PART 1|Adverse Event|0|||
129970869|NCT05131477|467856633|FG012|PART 1|Adverse Event|0|||
129970870|NCT05131477|467856634|FG013|PART 1|Adverse Event|0|||
129970871|NCT05131477|467856621|FG000|PART 1|unclassified|1|||
129970872|NCT05131477|467856622|FG001|PART 1|unclassified|1|||
129970873|NCT05131477|467856623|FG002|PART 1|unclassified|0|||
129970874|NCT05131477|467856624|FG003|PART 1|unclassified|0|||
129970875|NCT05131477|467856625|FG004|PART 1|unclassified|4|||
129970876|NCT05131477|467856626|FG005|PART 1|unclassified|0|||
129970877|NCT05131477|467856627|FG006|PART 1|unclassified|0|||
129970878|NCT05131477|467856628|FG007|PART 1|unclassified|0|||
129970879|NCT05131477|467856629|FG008|PART 1|unclassified|0|||
129970880|NCT05131477|467856630|FG009|PART 1|unclassified|0|||
129970881|NCT05131477|467856631|FG010|PART 1|unclassified|0|||
129970882|NCT05131477|467856632|FG011|PART 1|unclassified|0|||
129970883|NCT05131477|467856633|FG012|PART 1|unclassified|0|||
129970884|NCT05131477|467856634|FG013|PART 1|unclassified|0|||
129970885|NCT05131477|467856621|FG000|PART 1|Randomized and not treated|0|||
130130407|NCT02605928|468439364|FG000|Overall Study|Lack of Efficacy|5|||
130130408|NCT02612337|468439372|FG000|Overall Study|Lack of Efficacy|1|||
130130409|NCT02612337|468439373|FG001|Overall Study|Lack of Efficacy|0|||
129970886|NCT05131477|467856622|FG001|PART 1|Randomized and not treated|0|||
129970887|NCT05131477|467856623|FG002|PART 1|Randomized and not treated|0|||
129970888|NCT05131477|467856624|FG003|PART 1|Randomized and not treated|1|||
129970889|NCT05131477|467856625|FG004|PART 1|Randomized and not treated|1|||
129970890|NCT05131477|467856626|FG005|PART 1|Randomized and not treated|0|||
129970891|NCT05131477|467856627|FG006|PART 1|Randomized and not treated|0|||
129970892|NCT05131477|467856628|FG007|PART 1|Randomized and not treated|0|||
129970893|NCT05131477|467856629|FG008|PART 1|Randomized and not treated|0|||
129970894|NCT05131477|467856630|FG009|PART 1|Randomized and not treated|0|||
129970895|NCT05131477|467856631|FG010|PART 1|Randomized and not treated|0|||
129970896|NCT05131477|467856632|FG011|PART 1|Randomized and not treated|0|||
129970897|NCT05131477|467856633|FG012|PART 1|Randomized and not treated|0|||
129970898|NCT05131477|467856634|FG013|PART 1|Randomized and not treated|0|||
129970899|NCT05131477|467856621|FG000|PART 1|Protocol Violation|2|||
129970900|NCT05131477|467856622|FG001|PART 1|Protocol Violation|0|||
129970901|NCT05131477|467856623|FG002|PART 1|Protocol Violation|0|||
129970902|NCT05131477|467856624|FG003|PART 1|Protocol Violation|1|||
129970903|NCT05131477|467856625|FG004|PART 1|Protocol Violation|0|||
129970904|NCT05131477|467856626|FG005|PART 1|Protocol Violation|0|||
129970905|NCT05131477|467856627|FG006|PART 1|Protocol Violation|0|||
129970906|NCT05131477|467856628|FG007|PART 1|Protocol Violation|0|||
129970907|NCT05131477|467856629|FG008|PART 1|Protocol Violation|0|||
129970908|NCT05131477|467856630|FG009|PART 1|Protocol Violation|0|||
129970909|NCT05131477|467856631|FG010|PART 1|Protocol Violation|0|||
129970910|NCT05131477|467856632|FG011|PART 1|Protocol Violation|0|||
129970911|NCT05131477|467856633|FG012|PART 1|Protocol Violation|0|||
129970912|NCT05131477|467856634|FG013|PART 1|Protocol Violation|0|||
129970913|NCT05131477|467856621|FG000|PART 1|Lack of Efficacy|0|||
129970914|NCT05131477|467856622|FG001|PART 1|Lack of Efficacy|1|||
129970915|NCT05131477|467856623|FG002|PART 1|Lack of Efficacy|1|||
129970916|NCT05131477|467856624|FG003|PART 1|Lack of Efficacy|2|||
129970917|NCT05131477|467856625|FG004|PART 1|Lack of Efficacy|5|||
129970918|NCT05131477|467856626|FG005|PART 1|Lack of Efficacy|0|||
129970919|NCT05131477|467856627|FG006|PART 1|Lack of Efficacy|0|||
129970920|NCT05131477|467856628|FG007|PART 1|Lack of Efficacy|0|||
129970921|NCT05131477|467856629|FG008|PART 1|Lack of Efficacy|0|||
129970922|NCT05131477|467856630|FG009|PART 1|Lack of Efficacy|0|||
129970923|NCT05131477|467856631|FG010|PART 1|Lack of Efficacy|0|||
129970924|NCT05131477|467856632|FG011|PART 1|Lack of Efficacy|0|||
129970925|NCT05131477|467856633|FG012|PART 1|Lack of Efficacy|0|||
129970926|NCT05131477|467856634|FG013|PART 1|Lack of Efficacy|0|||
129970927|NCT05131477|467856621|FG000|PART 2|Withdrawal by Subject|0|||
129970928|NCT05131477|467856622|FG001|PART 2|Withdrawal by Subject|0|||
129970929|NCT05131477|467856623|FG002|PART 2|Withdrawal by Subject|0|||
129970930|NCT05131477|467856624|FG003|PART 2|Withdrawal by Subject|0|||
129970931|NCT05131477|467856625|FG004|PART 2|Withdrawal by Subject|0|||
129970932|NCT05131477|467856626|FG005|PART 2|Withdrawal by Subject|0|||
129970933|NCT05131477|467856627|FG006|PART 2|Withdrawal by Subject|2|||
129970934|NCT05131477|467856628|FG007|PART 2|Withdrawal by Subject|0|||
129970935|NCT05131477|467856629|FG008|PART 2|Withdrawal by Subject|0|||
129970936|NCT05131477|467856630|FG009|PART 2|Withdrawal by Subject|0|||
129970937|NCT05131477|467856631|FG010|PART 2|Withdrawal by Subject|2|||
129970938|NCT05131477|467856632|FG011|PART 2|Withdrawal by Subject|0|||
129970939|NCT05131477|467856633|FG012|PART 2|Withdrawal by Subject|2|||
129970940|NCT05131477|467856634|FG013|PART 2|Withdrawal by Subject|2|||
129970941|NCT05131477|467856621|FG000|PART 2|Other|0|||
129970942|NCT05131477|467856622|FG001|PART 2|Other|0|||
129970943|NCT05131477|467856623|FG002|PART 2|Other|0|||
129970944|NCT05131477|467856624|FG003|PART 2|Other|0|||
129970945|NCT05131477|467856625|FG004|PART 2|Other|0|||
129970946|NCT05131477|467856626|FG005|PART 2|Other|0|||
129970947|NCT05131477|467856627|FG006|PART 2|Other|0|||
130130410|NCT02612337|468439372|FG000|Overall Study|Withdrawal by Subject|2|||
130130411|NCT02612337|468439373|FG001|Overall Study|Withdrawal by Subject|2|||
130130412|NCT02612337|468439372|FG000|Overall Study|Did not receive study drug|0|||
130130413|NCT02612337|468439373|FG001|Overall Study|Did not receive study drug|1|||
130130414|NCT02242201|468439374|FG000|Overall Study|preoperative identified neuropathy|2|||
130130415|NCT02242201|468439375|FG001|Overall Study|preoperative identified neuropathy|0|||
130130416|NCT02242201|468439376|FG002|Overall Study|preoperative identified neuropathy|0|||
130130417|NCT02242201|468439374|FG000|Overall Study|planned post-op anticoagulation|1|||
130130418|NCT02242201|468439375|FG001|Overall Study|planned post-op anticoagulation|0|||
130130419|NCT02242201|468439376|FG002|Overall Study|planned post-op anticoagulation|0|||
130130420|NCT02242201|468439374|FG000|Overall Study|changed surgical procedure|1|||
129970948|NCT05131477|467856628|FG007|PART 2|Other|0|||
130093958|NCT01846442|468298731|FG002|Overall Study|Withdrawal by Subject|0|||
130093959|NCT01846442|468298732|FG003|Overall Study|Withdrawal by Subject|1|||
130093960|NCT01846442|468298729|FG000|Overall Study|Left the city/Lost medication|1|||
130093961|NCT01846442|468298730|FG001|Overall Study|Left the city/Lost medication|0|||
130093962|NCT01846442|468298731|FG002|Overall Study|Left the city/Lost medication|1|||
130093963|NCT01846442|468298732|FG003|Overall Study|Left the city/Lost medication|1|||
130093964|NCT01399619|468298742|FG000|Overall Study|Adverse Event|10|||
130093965|NCT01399619|468298743|FG001|Overall Study|Adverse Event|0|||
130093966|NCT01399619|468298744|FG002|Overall Study|Adverse Event|4|||
130093967|NCT01399619|468298745|FG003|Overall Study|Adverse Event|10|||
129970949|NCT05131477|467856629|FG008|PART 2|Other|1|||
129970950|NCT05131477|467856630|FG009|PART 2|Other|1|||
129970951|NCT05131477|467856631|FG010|PART 2|Other|0|||
129970952|NCT05131477|467856632|FG011|PART 2|Other|0|||
129970953|NCT05131477|467856633|FG012|PART 2|Other|1|||
129970954|NCT05131477|467856634|FG013|PART 2|Other|0|||
129970955|NCT05131477|467856621|FG000|PART 2|Lack of Efficacy|0|||
129970956|NCT05131477|467856622|FG001|PART 2|Lack of Efficacy|0|||
130130421|NCT02242201|468439375|FG001|Overall Study|changed surgical procedure|0|||
130130422|NCT02242201|468439376|FG002|Overall Study|changed surgical procedure|0|||
130130423|NCT02242201|468439374|FG000|Overall Study|postponed surgery|0|||
130130424|NCT02242201|468439375|FG001|Overall Study|postponed surgery|0|||
130130425|NCT02242201|468439376|FG002|Overall Study|postponed surgery|1|||
130130426|NCT02242201|468439374|FG000|Overall Study|preoperative opioid consumption|0|||
130130427|NCT02242201|468439375|FG001|Overall Study|preoperative opioid consumption|1|||
130130428|NCT02242201|468439376|FG002|Overall Study|preoperative opioid consumption|0|||
130130429|NCT02374853|468439379|FG000|Overall Study|Surgery Cancelled|5|||
130130430|NCT02374853|468439380|FG001|Overall Study|Surgery Cancelled|11|||
130130431|NCT02281084|468439382|FG000|Overall Study|Death|21|||
130130432|NCT02281084|468439383|FG001|Overall Study|Death|18|||
130130433|NCT02281084|468439384|FG002|Overall Study|Death|3|||
130130434|NCT02281084|468439385|FG003|Overall Study|Death|5|||
130130435|NCT02281084|468439382|FG000|Overall Study|Adverse Event|1|||
130130436|NCT02281084|468439383|FG001|Overall Study|Adverse Event|0|||
130130437|NCT02281084|468439384|FG002|Overall Study|Adverse Event|0|||
130130438|NCT02281084|468439385|FG003|Overall Study|Adverse Event|0|||
130130439|NCT02281084|468439382|FG000|Overall Study|Withdrawal by Subject|2|||
130130440|NCT02281084|468439383|FG001|Overall Study|Withdrawal by Subject|2|||
130130441|NCT02281084|468439384|FG002|Overall Study|Withdrawal by Subject|0|||
130130442|NCT02281084|468439385|FG003|Overall Study|Withdrawal by Subject|0|||
130130443|NCT02281084|468439382|FG000|Overall Study|Site Closure by Sponsor|5|||
130130444|NCT02281084|468439383|FG001|Overall Study|Site Closure by Sponsor|1|||
130130445|NCT02281084|468439384|FG002|Overall Study|Site Closure by Sponsor|2|||
130130446|NCT02281084|468439385|FG003|Overall Study|Site Closure by Sponsor|0|||
130130447|NCT01697696|468439386|FG000|Overall Study|Study terminated by sponsor|0|||
130130448|NCT01697696|468439387|FG001|Overall Study|Study terminated by sponsor|3|||
130130449|NCT01697696|468439386|FG000|Overall Study|Protocol deviation|1|||
130130450|NCT01697696|468439387|FG001|Overall Study|Protocol deviation|0|||
130130451|NCT01697696|468439386|FG000|Overall Study|Physician Decision|1|||
130130452|NCT01697696|468439387|FG001|Overall Study|Physician Decision|0|||
130130453|NCT01697696|468439386|FG000|Overall Study|Death|4|||
130130454|NCT01697696|468439387|FG001|Overall Study|Death|2|||
130130455|NCT01697696|468439386|FG000|Overall Study|Lost to Follow-up|10|||
130130456|NCT01697696|468439387|FG001|Overall Study|Lost to Follow-up|7|||
130130457|NCT01697696|468439386|FG000|Overall Study|Subject/guardian decision|31|||
130130458|NCT01697696|468439387|FG001|Overall Study|Subject/guardian decision|35|||
130130459|NCT01424644|468439388|FG000|Overall Study|Adverse Event|2|||
130130460|NCT01424644|468439389|FG001|Overall Study|Adverse Event|0|||
130130461|NCT01424644|468439388|FG000|Overall Study|Withdrawal by Subject|9|||
130130462|NCT01424644|468439389|FG001|Overall Study|Withdrawal by Subject|12|||
130130463|NCT01424644|468439388|FG000|Overall Study|Lost to Follow-up|16|||
130130464|NCT01424644|468439389|FG001|Overall Study|Lost to Follow-up|12|||
130130465|NCT01424644|468439388|FG000|Overall Study|Protocol Violation|4|||
130130466|NCT01424644|468439389|FG001|Overall Study|Protocol Violation|3|||
130130467|NCT01424644|468439388|FG000|Overall Study|Administrative Reason|1|||
130130468|NCT01424644|468439389|FG001|Overall Study|Administrative Reason|0|||
130130469|NCT01424644|468439388|FG000|Overall Study|Unable to Classify|1|||
130130470|NCT01424644|468439389|FG001|Overall Study|Unable to Classify|0|||
130130471|NCT05593965|468439390|FG000|1st Intervention (1 Day)|Technical error|1|||
130130472|NCT05593965|468439391|FG001|1st Intervention (1 Day)|Technical error|0|||
130130473|NCT01880593|468439404|FG000|Overall Study|Adverse Event|1|||
130130474|NCT01880593|468439405|FG001|Overall Study|Adverse Event|0|||
130130475|NCT01880593|468439404|FG000|Overall Study|Lack of Efficacy|1|||
130130476|NCT01880593|468439405|FG001|Overall Study|Lack of Efficacy|5|||
130130477|NCT01880593|468439404|FG000|Overall Study|Withdrawal by Subject|6|||
130130478|NCT01880593|468439405|FG001|Overall Study|Withdrawal by Subject|1|||
130130479|NCT02445339|468439413|FG000|Overall Study|Physician Decision|1|||
130130480|NCT02445339|468439414|FG001|Overall Study|Physician Decision|0|||
130130481|NCT02445339|468439413|FG000|Overall Study|Lost to Follow-up|11|||
130130482|NCT02445339|468439414|FG001|Overall Study|Lost to Follow-up|15|||
130130483|NCT02024932|468439415|FG000|Overall Study|Adverse Event|2|||
130130484|NCT02024932|468439416|FG001|Overall Study|Adverse Event|3|||
129970957|NCT05131477|467856623|FG002|PART 2|Lack of Efficacy|0|||
129970958|NCT05131477|467856624|FG003|PART 2|Lack of Efficacy|0|||
129970959|NCT05131477|467856625|FG004|PART 2|Lack of Efficacy|0|||
129970960|NCT05131477|467856626|FG005|PART 2|Lack of Efficacy|1|||
129970961|NCT05131477|467856627|FG006|PART 2|Lack of Efficacy|1|||
129970962|NCT05131477|467856628|FG007|PART 2|Lack of Efficacy|0|||
130130485|NCT02024932|468439417|FG002|Overall Study|Adverse Event|0|||
130130486|NCT02024932|468439418|FG003|Overall Study|Adverse Event|0|||
130130487|NCT02024932|468439419|FG004|Overall Study|Adverse Event|2|||
129970963|NCT05131477|467856629|FG008|PART 2|Lack of Efficacy|3|||
129970964|NCT05131477|467856630|FG009|PART 2|Lack of Efficacy|0|||
129970965|NCT05131477|467856631|FG010|PART 2|Lack of Efficacy|1|||
129970966|NCT05131477|467856632|FG011|PART 2|Lack of Efficacy|0|||
130130488|NCT02024932|468439420|FG005|Overall Study|Adverse Event|0|||
130130489|NCT02024932|468439415|FG000|Overall Study|Abnormal laboratory value|0|||
130130490|NCT02024932|468439416|FG001|Overall Study|Abnormal laboratory value|0|||
129970967|NCT05131477|467856633|FG012|PART 2|Lack of Efficacy|2|||
129970968|NCT05131477|467856634|FG013|PART 2|Lack of Efficacy|0|||
129970969|NCT05131477|467856621|FG000|PART 2|Unclassified|0|||
129970970|NCT05131477|467856622|FG001|PART 2|Unclassified|0|||
129970971|NCT05131477|467856623|FG002|PART 2|Unclassified|0|||
129970972|NCT05131477|467856624|FG003|PART 2|Unclassified|0|||
130130491|NCT02024932|468439417|FG002|Overall Study|Abnormal laboratory value|0|||
130130492|NCT02024932|468439418|FG003|Overall Study|Abnormal laboratory value|2|||
130130493|NCT02024932|468439419|FG004|Overall Study|Abnormal laboratory value|0|||
130130494|NCT02024932|468439420|FG005|Overall Study|Abnormal laboratory value|0|||
130130495|NCT03041025|468439421|FG000|Overall Study|Adverse Event|0|||
130130496|NCT03041025|468439422|FG001|Overall Study|Adverse Event|0|||
130130497|NCT03041025|468439423|FG002|Overall Study|Adverse Event|1|||
130130498|NCT03041025|468439421|FG000|Overall Study|Lost to Follow-up|1|||
130130499|NCT03041025|468439422|FG001|Overall Study|Lost to Follow-up|0|||
130130500|NCT03041025|468439423|FG002|Overall Study|Lost to Follow-up|0|||
130130501|NCT03041025|468439421|FG000|Overall Study|Withdrawal by Subject|0|||
130130502|NCT03041025|468439422|FG001|Overall Study|Withdrawal by Subject|0|||
130130503|NCT03041025|468439423|FG002|Overall Study|Withdrawal by Subject|1|||
130130504|NCT00939003|468439426|FG000|Double-blind Treatment Period|Adverse Event|1|||
130130505|NCT00939003|468439427|FG001|Double-blind Treatment Period|Adverse Event|1|||
130130506|NCT00939003|468439426|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130130507|NCT00939003|468439427|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
130130508|NCT00939003|468439426|FG000|Double-blind Treatment Period|Pregnancy|0|||
130130509|NCT00939003|468439427|FG001|Double-blind Treatment Period|Pregnancy|1|||
130130510|NCT00939003|468439426|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
130130511|NCT00939003|468439427|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
130130512|NCT00939003|468439426|FG000|Open-label Treatment Period|Adverse Event|4|||
130130513|NCT00939003|468439427|FG001|Open-label Treatment Period|Adverse Event|8|||
130130514|NCT00939003|468439426|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
130130515|NCT00939003|468439427|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
130130516|NCT00939003|468439426|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
130130517|NCT00939003|468439427|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
130130518|NCT00939003|468439426|FG000|Open-label Treatment Period|Pregnancy|1|||
130130519|NCT00939003|468439427|FG001|Open-label Treatment Period|Pregnancy|1|||
130130520|NCT00939003|468439426|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
130130521|NCT00939003|468439427|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
130130522|NCT00939003|468439426|FG000|Open-label Treatment Period|Site Closure|3|||
130130523|NCT00939003|468439427|FG001|Open-label Treatment Period|Site Closure|4|||
130130524|NCT00727961|468439428|FG000|Overall Study|Lost to Follow-up|1|||
130130525|NCT00727961|468439428|FG000|Overall Study|Adverse Event|4|||
130130526|NCT00727961|468439428|FG000|Overall Study|Patient's refusal|2|||
130130527|NCT00727961|468439428|FG000|Overall Study|Progression|30|||
130130528|NCT02131129|468439429|FG000|Overall Study|Withdrawal by Subject|1|||
130130529|NCT02131129|468439430|FG001|Overall Study|Withdrawal by Subject|0|||
130130530|NCT02865122|468439431|FG000|Overall Study|Adverse Event|1|||
130130531|NCT02865122|468439432|FG001|Overall Study|Adverse Event|0|||
130130532|NCT02865122|468439433|FG002|Overall Study|Adverse Event|0|||
130130533|NCT03880266|468439434|FG000|Overall Study|Withdrawal by Subject|0|||
130130534|NCT03880266|468439435|FG001|Overall Study|Withdrawal by Subject|1|||
130130535|NCT03880266|468439436|FG002|Overall Study|Withdrawal by Subject|1|||
130130536|NCT03880266|468439437|FG003|Overall Study|Withdrawal by Subject|0|||
130130537|NCT03880266|468439438|FG004|Overall Study|Withdrawal by Subject|0|||
130130538|NCT03880266|468439439|FG005|Overall Study|Withdrawal by Subject|0|||
130130539|NCT03880266|468439440|FG006|Overall Study|Withdrawal by Subject|0|||
130130540|NCT03880266|468439441|FG007|Overall Study|Withdrawal by Subject|0|||
130130541|NCT03161405|468439442|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
130130542|NCT02186821|468439445|FG000|Overall Study|Adverse Event|9|||
130130543|NCT02186821|468439445|FG000|Overall Study|Death|2|||
130130544|NCT02186821|468439445|FG000|Overall Study|Disease progression|32|||
130130545|NCT02186821|468439445|FG000|Overall Study|Protocol Violation|1|||
130130546|NCT02186821|468439445|FG000|Overall Study|Physician Decision|1|||
130130547|NCT02186821|468439445|FG000|Overall Study|Study terminated by sponsor|2|||
130130548|NCT01421277|468439446|FG000|Overall Study|Lack of qualifying event|0|||
130130549|NCT01421277|468439447|FG001|Overall Study|Lack of qualifying event|61|||
130130550|NCT01421277|468439446|FG000|Overall Study|Incomplete baseline data|0|||
130130551|NCT01421277|468439447|FG001|Overall Study|Incomplete baseline data|31|||
130130552|NCT00119015|468439454|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
130130553|NCT00119015|468439455|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
130130554|NCT00119015|468439456|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
130130555|NCT05369208|468441048|FG000|Core Phase|Prohibited Medication Required|2|||
130130556|NCT05369208|468441048|FG000|Core Phase|Adverse Event|1|||
130130557|NCT05369208|468441048|FG000|Core Phase|Lack of Efficacy|1|||
129970973|NCT05131477|467856625|FG004|PART 2|Unclassified|0|||
129970974|NCT05131477|467856626|FG005|PART 2|Unclassified|0|||
129970975|NCT05131477|467856627|FG006|PART 2|Unclassified|0|||
129970976|NCT05131477|467856628|FG007|PART 2|Unclassified|0|||
130130558|NCT03235739|468441049|FG000|Overall Study|Withdrawal by Subject|2|||
130130559|NCT03235739|468441050|FG001|Overall Study|Withdrawal by Subject|2|||
130130560|NCT03235739|468441049|FG000|Overall Study|Physician Decision|0|||
130130561|NCT03235739|468441050|FG001|Overall Study|Physician Decision|1|||
130130562|NCT00467896|468441051|FG000|Overall Study|Consent Withdrawal|18|||
130130563|NCT00467896|468441051|FG000|Overall Study|Adverse Event|7|||
130130564|NCT00467896|468441051|FG000|Overall Study|Serious Adverse Event|13|||
130130565|NCT00467896|468441051|FG000|Overall Study|Non-compliance|3|||
130130566|NCT00467896|468441051|FG000|Overall Study|Changed therapy|2|||
130130567|NCT00467896|468441051|FG000|Overall Study|Patient received transplant|2|||
130130568|NCT00467896|468441051|FG000|Overall Study|Patient had atrial septostomy|1|||
130130569|NCT00467896|468441051|FG000|Overall Study|Patient weaned off iloprost|1|||
130130570|NCT00467896|468441051|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
130130571|NCT00467896|468441051|FG000|Overall Study|Started intravenous prostacyclin|1|||
130130572|NCT00467896|468441051|FG000|Overall Study|Started inhaled Remodulin|1|||
130130573|NCT00467896|468441051|FG000|Overall Study|Patient had no improvement|1|||
130130574|NCT03772522|468441052|FG000|Pre-intervention|Withdrawal by Subject|3|||
130130575|NCT03772522|468441053|FG001|Pre-intervention|Withdrawal by Subject|4|||
130130576|NCT03772522|468441052|FG000|Intervention|Withdrawal by Subject|1|||
130130577|NCT03772522|468441053|FG001|Intervention|Withdrawal by Subject|0|||
130130578|NCT03772522|468441052|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
130130579|NCT03772522|468441053|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
130130580|NCT03818581|468441054|FG000|Overall Study|Adverse Event|1|||
130130581|NCT03818581|468441055|FG001|Overall Study|Adverse Event|0|||
130130582|NCT03818581|468441056|FG002|Overall Study|Adverse Event|0|||
130130583|NCT03818581|468441057|FG003|Overall Study|Adverse Event|0|||
130130584|NCT03818581|468441058|FG004|Overall Study|Adverse Event|0|||
130130585|NCT03818581|468441054|FG000|Overall Study|Covid-19|2|||
130130586|NCT03818581|468441055|FG001|Overall Study|Covid-19|0|||
130130587|NCT03818581|468441056|FG002|Overall Study|Covid-19|0|||
130130588|NCT03818581|468441057|FG003|Overall Study|Covid-19|0|||
130130589|NCT03818581|468441058|FG004|Overall Study|Covid-19|1|||
130130590|NCT03818581|468441054|FG000|Overall Study|Withdrawal by Subject|0|||
130130591|NCT03818581|468441055|FG001|Overall Study|Withdrawal by Subject|0|||
130130592|NCT03818581|468441056|FG002|Overall Study|Withdrawal by Subject|0|||
130130593|NCT03818581|468441057|FG003|Overall Study|Withdrawal by Subject|0|||
130130594|NCT03818581|468441058|FG004|Overall Study|Withdrawal by Subject|1|||
130130595|NCT03818581|468441054|FG000|Overall Study|No longer met study criteria|0|||
130130596|NCT03818581|468441055|FG001|Overall Study|No longer met study criteria|0|||
130130597|NCT03818581|468441056|FG002|Overall Study|No longer met study criteria|0|||
130130598|NCT03818581|468441057|FG003|Overall Study|No longer met study criteria|0|||
130130599|NCT03818581|468441058|FG004|Overall Study|No longer met study criteria|1|||
130130600|NCT00462345|468441059|FG000|Overall Study|Withdrawal by Subject|2|||
130130601|NCT00462345|468441059|FG000|Overall Study|Did not complete second course|1|||
130130602|NCT01149473|468441060|FG000|First Intervention|Adverse Event|1|||
130130603|NCT01149473|468441061|FG001|First Intervention|Adverse Event|1|||
130130604|NCT01149473|468441060|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130130605|NCT01149473|468441061|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130130606|NCT04089735|468441062|FG000|Overall Study|Adverse Event|1|||
130130607|NCT04089735|468441063|FG001|Overall Study|Adverse Event|0|||
130130608|NCT04089735|468441064|FG002|Overall Study|Adverse Event|1|||
130130609|NCT04089735|468441065|FG003|Overall Study|Adverse Event|1|||
130130610|NCT04089735|468441066|FG004|Overall Study|Adverse Event|0|||
130130611|NCT04089735|468441067|FG005|Overall Study|Adverse Event|0|||
130130612|NCT04089735|468441062|FG000|Overall Study|Physician Decision|0|||
130130613|NCT04089735|468441063|FG001|Overall Study|Physician Decision|3|||
130130614|NCT04089735|468441064|FG002|Overall Study|Physician Decision|0|||
130130615|NCT04089735|468441065|FG003|Overall Study|Physician Decision|0|||
130130616|NCT04089735|468441066|FG004|Overall Study|Physician Decision|0|||
130130617|NCT04089735|468441067|FG005|Overall Study|Physician Decision|0|||
130130618|NCT04089735|468441062|FG000|Overall Study|Withdrawal by Subject|0|||
130130619|NCT04089735|468441063|FG001|Overall Study|Withdrawal by Subject|0|||
130130620|NCT04089735|468441064|FG002|Overall Study|Withdrawal by Subject|1|||
130130621|NCT04089735|468441065|FG003|Overall Study|Withdrawal by Subject|0|||
130130622|NCT04089735|468441066|FG004|Overall Study|Withdrawal by Subject|0|||
130130623|NCT04089735|468441067|FG005|Overall Study|Withdrawal by Subject|0|||
130130624|NCT04089735|468441062|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
130130625|NCT04089735|468441063|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
130130626|NCT04089735|468441064|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
130130627|NCT04089735|468441065|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
130130628|NCT04089735|468441066|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
130130629|NCT04089735|468441067|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
130130630|NCT01439880|468441069|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
130130631|NCT01439880|468441070|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
130130632|NCT01439880|468441069|FG000|SOC-controlled Period (Year 1)|Death|2|||
130130633|NCT01439880|468441070|FG001|SOC-controlled Period (Year 1)|Death|1|||
130130634|NCT01439880|468441069|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
130130635|NCT01439880|468441070|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
130130636|NCT01439880|468441069|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
130130637|NCT01439880|468441070|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
130130638|NCT01439880|468441069|FG000|SOC-controlled Period (Year 1)|Other|8|||
130130639|NCT01439880|468441070|FG001|SOC-controlled Period (Year 1)|Other|13|||
130130640|NCT01439880|468441069|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
130130641|NCT01439880|468441070|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
130130642|NCT01439880|468441069|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
130130643|NCT01439880|468441070|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
130130644|NCT01439880|468441069|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
130130645|NCT01439880|468441070|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
130130646|NCT01439880|468441069|FG000|All-IP Period (Years 2 to 5)|Death|3|||
130130647|NCT01439880|468441070|FG001|All-IP Period (Years 2 to 5)|Death|13|||
130130648|NCT01439880|468441069|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
130130649|NCT01439880|468441070|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
130130650|NCT01439880|468441069|FG000|All-IP Period (Years 2 to 5)|Other|14|||
130130651|NCT01439880|468441070|FG001|All-IP Period (Years 2 to 5)|Other|31|||
130130652|NCT01439880|468441069|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
130130653|NCT01439880|468441070|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
130130654|NCT03874715|468441072|FG000|Overall Study|Adverse Event|2|||
130130655|NCT03874715|468441073|FG001|Overall Study|Adverse Event|0|||
129970977|NCT05131477|467856629|FG008|PART 2|Unclassified|0|||
129970978|NCT05131477|467856630|FG009|PART 2|Unclassified|0|||
129970979|NCT05131477|467856631|FG010|PART 2|Unclassified|1|||
129970980|NCT05131477|467856632|FG011|PART 2|Unclassified|0|||
129970981|NCT05131477|467856633|FG012|PART 2|Unclassified|0|||
129970982|NCT05131477|467856634|FG013|PART 2|Unclassified|0|||
130093968|NCT01399619|468298742|FG000|Overall Study|Lack of Efficacy|9|||
130093969|NCT01399619|468298743|FG001|Overall Study|Lack of Efficacy|0|||
130093970|NCT01399619|468298744|FG002|Overall Study|Lack of Efficacy|5|||
130093971|NCT01399619|468298745|FG003|Overall Study|Lack of Efficacy|0|||
130093972|NCT01399619|468298742|FG000|Overall Study|Withdrawal by Subject|6|||
130093973|NCT01399619|468298743|FG001|Overall Study|Withdrawal by Subject|0|||
130093974|NCT01399619|468298744|FG002|Overall Study|Withdrawal by Subject|3|||
130093975|NCT01399619|468298745|FG003|Overall Study|Withdrawal by Subject|4|||
130093976|NCT01399619|468298742|FG000|Overall Study|Protocol Violation|0|||
130093977|NCT01399619|468298743|FG001|Overall Study|Protocol Violation|0|||
130093978|NCT01399619|468298744|FG002|Overall Study|Protocol Violation|0|||
130093979|NCT01399619|468298745|FG003|Overall Study|Protocol Violation|1|||
130093980|NCT01399619|468298742|FG000|Overall Study|Not treated|0|||
130093981|NCT01399619|468298743|FG001|Overall Study|Not treated|0|||
130093982|NCT01399619|468298744|FG002|Overall Study|Not treated|0|||
130093983|NCT01399619|468298745|FG003|Overall Study|Not treated|2|||
130093984|NCT00998166|468298746|FG000|Overall Study|Early Study Termination|8|||
130093985|NCT00408408|468298747|FG000|Overall Study|No follow up data|2|||
130093986|NCT00408408|468298748|FG001|Overall Study|No follow up data|3|||
130093987|NCT00408408|468298749|FG002|Overall Study|No follow up data|0|||
130093988|NCT00408408|468298750|FG003|Overall Study|No follow up data|7|||
130093989|NCT00408408|468298751|FG004|Overall Study|No follow up data|5|||
130093990|NCT00408408|468298752|FG005|Overall Study|No follow up data|3|||
130093991|NCT00267202|468298755|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
130093992|NCT00267202|468298756|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
130093993|NCT00267202|468298755|FG000|Overall Study|Withdrawal by Subject|12|||
130093994|NCT00267202|468298756|FG001|Overall Study|Withdrawal by Subject|15|||
130093995|NCT00267202|468298755|FG000|Overall Study|Adverse Event|13|||
130093996|NCT00267202|468298756|FG001|Overall Study|Adverse Event|7|||
130093997|NCT00267202|468298755|FG000|Overall Study|Protocol Violation|2|||
130093998|NCT00267202|468298756|FG001|Overall Study|Protocol Violation|3|||
130093999|NCT00267202|468298755|FG000|Overall Study|Administrative problems|2|||
130094000|NCT00267202|468298756|FG001|Overall Study|Administrative problems|1|||
130094001|NCT00267202|468298755|FG000|Overall Study|Lost to Follow-up|3|||
130094002|NCT00267202|468298756|FG001|Overall Study|Lost to Follow-up|0|||
130094003|NCT00612456|468298759|FG000|Overall Study|Adverse Event|1|||
130094004|NCT00612456|468298760|FG001|Overall Study|Adverse Event|0|||
130094005|NCT00612456|468298761|FG002|Overall Study|Adverse Event|0|||
130094006|NCT00612456|468298759|FG000|Overall Study|Lack of Efficacy|1|||
130094007|NCT00612456|468298760|FG001|Overall Study|Lack of Efficacy|1|||
130094008|NCT00612456|468298761|FG002|Overall Study|Lack of Efficacy|0|||
130094009|NCT00612456|468298759|FG000|Overall Study|Withdrawal by Subject|0|||
130094010|NCT00612456|468298760|FG001|Overall Study|Withdrawal by Subject|1|||
130094011|NCT00612456|468298761|FG002|Overall Study|Withdrawal by Subject|0|||
130130656|NCT03874715|468441072|FG000|Overall Study|Poor compliance to protocol|5|||
130130657|NCT03874715|468441073|FG001|Overall Study|Poor compliance to protocol|1|||
130130658|NCT03874715|468441072|FG000|Overall Study|Withdrawal by Subject|1|||
130130659|NCT03874715|468441073|FG001|Overall Study|Withdrawal by Subject|0|||
130130660|NCT03874715|468441072|FG000|Overall Study|Other-unspecified|1|||
130130661|NCT03874715|468441073|FG001|Overall Study|Other-unspecified|0|||
130130662|NCT00834067|468441076|FG000|Washout of 21 Days|Protocol Violation|0|||
130130663|NCT00834067|468441077|FG001|Washout of 21 Days|Protocol Violation|1|||
130130664|NCT01083693|468441078|FG000|Overall Study|Adverse Event|1|||
130130665|NCT01083693|468441079|FG001|Overall Study|Adverse Event|1|||
130130666|NCT01083693|468441080|FG002|Overall Study|Adverse Event|0|||
130130667|NCT01083693|468441078|FG000|Overall Study|Lost to Follow-up|2|||
130130668|NCT01083693|468441079|FG001|Overall Study|Lost to Follow-up|0|||
130130669|NCT01083693|468441080|FG002|Overall Study|Lost to Follow-up|2|||
130130670|NCT01083693|468441078|FG000|Overall Study|Lack of effectiveness|13|||
130130671|NCT01083693|468441079|FG001|Overall Study|Lack of effectiveness|2|||
130130672|NCT01083693|468441080|FG002|Overall Study|Lack of effectiveness|2|||
130130673|NCT01083693|468441078|FG000|Overall Study|Patient Moved|0|||
130130674|NCT01083693|468441079|FG001|Overall Study|Patient Moved|1|||
130130675|NCT01083693|468441080|FG002|Overall Study|Patient Moved|0|||
130130676|NCT01083693|468441078|FG000|Overall Study|Complete remission|0|||
130130677|NCT01083693|468441079|FG001|Overall Study|Complete remission|1|||
130130678|NCT01083693|468441080|FG002|Overall Study|Complete remission|0|||
130130679|NCT01083693|468441078|FG000|Overall Study|Other medical condition/surgery|1|||
130130680|NCT01083693|468441079|FG001|Overall Study|Other medical condition/surgery|1|||
130130681|NCT01083693|468441080|FG002|Overall Study|Other medical condition/surgery|0|||
130130682|NCT01083693|468441078|FG000|Overall Study|Withdrawal by Subject|3|||
130130683|NCT01083693|468441079|FG001|Overall Study|Withdrawal by Subject|0|||
130130684|NCT01083693|468441080|FG002|Overall Study|Withdrawal by Subject|2|||
130130685|NCT01083693|468441078|FG000|Overall Study|Reason unknown|0|||
130130686|NCT01083693|468441079|FG001|Overall Study|Reason unknown|0|||
130130687|NCT01083693|468441080|FG002|Overall Study|Reason unknown|1|||
130130688|NCT01705574|468441081|FG000|Double-Blind Phase|Lost to Follow-up|12|||
130130689|NCT01705574|468441082|FG001|Double-Blind Phase|Lost to Follow-up|16|||
130130690|NCT01705574|468441083|FG002|Double-Blind Phase|Lost to Follow-up|0|||
130130691|NCT01705574|468441084|FG003|Double-Blind Phase|Lost to Follow-up|0|||
130130692|NCT01705574|468441081|FG000|Double-Blind Phase|Adverse Event|3|||
130130693|NCT01705574|468441082|FG001|Double-Blind Phase|Adverse Event|10|||
130130694|NCT01705574|468441083|FG002|Double-Blind Phase|Adverse Event|0|||
130130695|NCT01705574|468441084|FG003|Double-Blind Phase|Adverse Event|0|||
130130696|NCT01705574|468441081|FG000|Double-Blind Phase|Withdrew Consent|8|||
130130697|NCT01705574|468441082|FG001|Double-Blind Phase|Withdrew Consent|5|||
130130698|NCT01705574|468441083|FG002|Double-Blind Phase|Withdrew Consent|0|||
130130699|NCT01705574|468441084|FG003|Double-Blind Phase|Withdrew Consent|0|||
130130700|NCT01705574|468441081|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
130130701|NCT01705574|468441082|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
130130702|NCT01705574|468441083|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
130130703|NCT01705574|468441084|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
130130704|NCT01705574|468441081|FG000|Double-Blind Phase|Pregnancy|1|||
130130705|NCT01705574|468441082|FG001|Double-Blind Phase|Pregnancy|1|||
130130706|NCT01705574|468441083|FG002|Double-Blind Phase|Pregnancy|0|||
130130707|NCT01705574|468441084|FG003|Double-Blind Phase|Pregnancy|0|||
130130708|NCT01705574|468441081|FG000|Double-Blind Phase|Protocol Violation|1|||
130130709|NCT01705574|468441082|FG001|Double-Blind Phase|Protocol Violation|0|||
130130710|NCT01705574|468441083|FG002|Double-Blind Phase|Protocol Violation|0|||
130130711|NCT01705574|468441084|FG003|Double-Blind Phase|Protocol Violation|0|||
130130712|NCT01705574|468441081|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
130130713|NCT01705574|468441082|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
130130714|NCT01705574|468441083|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
130130715|NCT01705574|468441084|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
130130716|NCT01705574|468441081|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
130130717|NCT01705574|468441082|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129970983|NCT05131477|467856621|FG000|PART 2|Re-randomized and not treated|0|||
129970984|NCT05131477|467856622|FG001|PART 2|Re-randomized and not treated|0|||
130130718|NCT01705574|468441083|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
130130719|NCT01705574|468441084|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
130130720|NCT01705574|468441081|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
130130721|NCT01705574|468441082|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
130130722|NCT01705574|468441083|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
130130723|NCT01705574|468441084|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
130130724|NCT01705574|468441081|FG000|Open-Label Extension Phase|Adverse Event|3|||
130130725|NCT01705574|468441082|FG001|Open-Label Extension Phase|Adverse Event|0|||
130130726|NCT01705574|468441083|FG002|Open-Label Extension Phase|Adverse Event|0|||
130130727|NCT01705574|468441084|FG003|Open-Label Extension Phase|Adverse Event|1|||
130130728|NCT01705574|468441081|FG000|Open-Label Extension Phase|Death|2|||
130130729|NCT01705574|468441082|FG001|Open-Label Extension Phase|Death|0|||
130130730|NCT01705574|468441083|FG002|Open-Label Extension Phase|Death|1|||
130130731|NCT01705574|468441084|FG003|Open-Label Extension Phase|Death|0|||
130130732|NCT01705574|468441081|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130130733|NCT01705574|468441082|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130130734|NCT01705574|468441083|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
130130735|NCT01705574|468441084|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
130130736|NCT01705574|468441081|FG000|Open-Label Extension Phase|Physician Decision|0|||
130130737|NCT01705574|468441082|FG001|Open-Label Extension Phase|Physician Decision|0|||
130130738|NCT01705574|468441083|FG002|Open-Label Extension Phase|Physician Decision|2|||
130130739|NCT01705574|468441084|FG003|Open-Label Extension Phase|Physician Decision|0|||
130130740|NCT01705574|468441081|FG000|Open-Label Extension Phase|Pregnancy|0|||
130130741|NCT01705574|468441082|FG001|Open-Label Extension Phase|Pregnancy|0|||
130130742|NCT01705574|468441083|FG002|Open-Label Extension Phase|Pregnancy|1|||
130130743|NCT01705574|468441084|FG003|Open-Label Extension Phase|Pregnancy|1|||
130130744|NCT02543203|468441085|FG000|Overall Study|Unpalatable Fragrance|2|||
130130745|NCT02543203|468441086|FG001|Overall Study|Unpalatable Fragrance|2|||
130130746|NCT02543203|468441085|FG000|Overall Study|Lost to Follow-up|1|||
130130747|NCT02543203|468441086|FG001|Overall Study|Lost to Follow-up|0|||
130130748|NCT02543203|468441085|FG000|Overall Study|Increased Irritability|1|||
130130749|NCT02543203|468441086|FG001|Overall Study|Increased Irritability|0|||
130130750|NCT02543203|468441085|FG000|Overall Study|Family|1|||
130130751|NCT02543203|468441086|FG001|Overall Study|Family|2|||
130130752|NCT02543203|468441085|FG000|Overall Study|Negative Behavior|1|||
130130753|NCT02543203|468441086|FG001|Overall Study|Negative Behavior|0|||
130130754|NCT02543203|468441085|FG000|Overall Study|Withdrawal by Subject|0|||
130130755|NCT02543203|468441086|FG001|Overall Study|Withdrawal by Subject|1|||
130130756|NCT00089661|468441087|FG000|Overall Study|Adverse Event|0|||
130130757|NCT00089661|468441088|FG001|Overall Study|Adverse Event|2|||
130130758|NCT00089661|468441087|FG000|Overall Study|Death|1|||
130130759|NCT00089661|468441088|FG001|Overall Study|Death|0|||
130130760|NCT00089661|468441087|FG000|Overall Study|Lost to Follow-up|0|||
130130761|NCT00089661|468441088|FG001|Overall Study|Lost to Follow-up|3|||
130130762|NCT00089661|468441087|FG000|Overall Study|Withdrawal by Subject|11|||
130130763|NCT00089661|468441088|FG001|Overall Study|Withdrawal by Subject|9|||
130130764|NCT00089661|468441087|FG000|Overall Study|Disease progression|1|||
129970985|NCT05131477|467856623|FG002|PART 2|Re-randomized and not treated|0|||
129970986|NCT05131477|467856624|FG003|PART 2|Re-randomized and not treated|0|||
130130765|NCT00089661|468441088|FG001|Overall Study|Disease progression|3|||
130130766|NCT00089661|468441087|FG000|Overall Study|Ineligibility determined|4|||
130130767|NCT00089661|468441088|FG001|Overall Study|Ineligibility determined|4|||
130130768|NCT00089661|468441087|FG000|Overall Study|Noncompliance|2|||
130130769|NCT00089661|468441088|FG001|Overall Study|Noncompliance|4|||
130130770|NCT00089661|468441087|FG000|Overall Study|Other|2|||
130130771|NCT00089661|468441088|FG001|Overall Study|Other|1|||
130130772|NCT01273805|468441089|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
130130773|NCT01273805|468441090|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
129970987|NCT05131477|467856625|FG004|PART 2|Re-randomized and not treated|0|||
129970988|NCT05131477|467856626|FG005|PART 2|Re-randomized and not treated|0|||
129970989|NCT05131477|467856627|FG006|PART 2|Re-randomized and not treated|0|||
129970990|NCT05131477|467856628|FG007|PART 2|Re-randomized and not treated|1|||
129970991|NCT05131477|467856629|FG008|PART 2|Re-randomized and not treated|0|||
129970992|NCT05131477|467856630|FG009|PART 2|Re-randomized and not treated|0|||
129970993|NCT05131477|467856631|FG010|PART 2|Re-randomized and not treated|1|||
129970994|NCT05131477|467856632|FG011|PART 2|Re-randomized and not treated|0|||
129970995|NCT05131477|467856633|FG012|PART 2|Re-randomized and not treated|1|||
129970996|NCT05131477|467856634|FG013|PART 2|Re-randomized and not treated|1|||
129970997|NCT02194829|467856635|FG000|Overall Study|Adverse Event|2|||
129970998|NCT02194829|467856636|FG001|Overall Study|Adverse Event|2|||
129970999|NCT02194829|467856635|FG000|Overall Study|Death|0|||
129971000|NCT02194829|467856636|FG001|Overall Study|Death|1|||
129971001|NCT02194829|467856635|FG000|Overall Study|Disease progression|0|||
129971002|NCT02194829|467856636|FG001|Overall Study|Disease progression|1|||
129971003|NCT02194829|467856635|FG000|Overall Study|Withdrawal by Subject|0|||
129971004|NCT02194829|467856636|FG001|Overall Study|Withdrawal by Subject|1|||
130130774|NCT02647944|468441091|FG000|Overall Study|Withdrawal by Subject|0|||
130130775|NCT02647944|468441092|FG001|Overall Study|Withdrawal by Subject|3|||
130130776|NCT02647944|468441091|FG000|Overall Study|Adverse Event|2|||
130130777|NCT02647944|468441092|FG001|Overall Study|Adverse Event|0|||
130130778|NCT02760368|468441094|FG000|Overall Study|Withdrawal by Subject|8|||
130130779|NCT02760368|468441095|FG001|Overall Study|Withdrawal by Subject|12|||
130130780|NCT02760368|468441096|FG002|Overall Study|Withdrawal by Subject|9|||
130130781|NCT02760368|468441094|FG000|Overall Study|Screen Failure|0|||
130130782|NCT02760368|468441095|FG001|Overall Study|Screen Failure|0|||
129971005|NCT02194829|467856635|FG000|Overall Study|Never started protocol therapy|0|||
129971006|NCT02194829|467856636|FG001|Overall Study|Never started protocol therapy|1|||
129971007|NCT05101993|467856641|FG000|Overall Study|Withdrawal by Subject|1|||
129971008|NCT01124838|467856642|FG000|Overall Study|Miscellaneous|4|||
129971009|NCT01124838|467856643|FG001|Overall Study|Miscellaneous|2|||
129971010|NCT01124838|467856642|FG000|Overall Study|Adverse Event|7|||
129971011|NCT01124838|467856643|FG001|Overall Study|Adverse Event|11|||
129971012|NCT01124838|467856642|FG000|Overall Study|Lack of Efficacy|2|||
130094012|NCT00265109|468298762|FG000|Overall Study|Withdrawal by Subject|5|||
130094013|NCT00265109|468298762|FG000|Overall Study|Adverse Event|1|||
130094014|NCT00920582|468298763|FG000|Overall Study|Lost to Follow-up|5|||
130094015|NCT00920582|468298764|FG001|Overall Study|Lost to Follow-up|1|||
130094016|NCT00920582|468298765|FG002|Overall Study|Lost to Follow-up|2|||
130094017|NCT00920582|468298766|FG003|Overall Study|Lost to Follow-up|0|||
130094018|NCT00920582|468298763|FG000|Overall Study|Withdrawal by Subject|5|||
130094019|NCT00920582|468298764|FG001|Overall Study|Withdrawal by Subject|4|||
130094020|NCT00920582|468298765|FG002|Overall Study|Withdrawal by Subject|6|||
130094021|NCT00920582|468298766|FG003|Overall Study|Withdrawal by Subject|3|||
130094022|NCT00920582|468298763|FG000|Overall Study|Protocol Violation|1|||
130094023|NCT00920582|468298764|FG001|Overall Study|Protocol Violation|0|||
130130783|NCT02760368|468441096|FG002|Overall Study|Screen Failure|1|||
130130784|NCT02760368|468441094|FG000|Overall Study|Death|0|||
130130785|NCT02760368|468441095|FG001|Overall Study|Death|1|||
130130786|NCT02760368|468441096|FG002|Overall Study|Death|0|||
130130787|NCT02760368|468441094|FG000|Overall Study|Withdrawal by Sponsor|0|||
130130788|NCT02760368|468441095|FG001|Overall Study|Withdrawal by Sponsor|0|||
130130789|NCT02760368|468441096|FG002|Overall Study|Withdrawal by Sponsor|1|||
130130790|NCT02294604|468441097|FG000|Overall Study|Did not provide samples for culture|0|||
130130791|NCT02294604|468441098|FG001|Overall Study|Did not provide samples for culture|1|||
130130792|NCT02294604|468441099|FG002|Overall Study|Did not provide samples for culture|0|||
130130793|NCT02294604|468441097|FG000|Overall Study|Culture contamination|1|||
130130794|NCT02294604|468441098|FG001|Overall Study|Culture contamination|2|||
130130795|NCT02294604|468441099|FG002|Overall Study|Culture contamination|0|||
130130796|NCT02902211|468441102|FG000|First Three Months|Withdrawal by Subject|7|||
130130797|NCT02902211|468441103|FG001|First Three Months|Withdrawal by Subject|3|||
130130798|NCT01401647|468441111|FG000|Overall Study|Withdrawal by Subject|1|||
130130799|NCT01401647|468441112|FG001|Overall Study|Withdrawal by Subject|5|||
130130800|NCT01401647|468441113|FG002|Overall Study|Withdrawal by Subject|2|||
130130801|NCT01401647|468441111|FG000|Overall Study|Lost to Follow-up|3|||
130130802|NCT01401647|468441112|FG001|Overall Study|Lost to Follow-up|3|||
130130803|NCT01401647|468441113|FG002|Overall Study|Lost to Follow-up|1|||
130130804|NCT00473330|468441117|FG000|Core Study|Adverse Event|4|||
130130805|NCT00473330|468441118|FG001|Core Study|Adverse Event|4|||
130130806|NCT00473330|468441119|FG002|Core Study|Adverse Event|1|||
130130807|NCT00473330|468441117|FG000|Core Study|Death|6|||
130130808|NCT00473330|468441118|FG001|Core Study|Death|4|||
130130809|NCT00473330|468441119|FG002|Core Study|Death|4|||
130130810|NCT00473330|468441117|FG000|Core Study|Lost to Follow-up|5|||
130130811|NCT00473330|468441118|FG001|Core Study|Lost to Follow-up|5|||
130130812|NCT00473330|468441119|FG002|Core Study|Lost to Follow-up|10|||
130130813|NCT00473330|468441117|FG000|Core Study|Physician Decision|2|||
130130814|NCT00473330|468441118|FG001|Core Study|Physician Decision|1|||
130130815|NCT00473330|468441119|FG002|Core Study|Physician Decision|3|||
130130816|NCT00473330|468441117|FG000|Core Study|Subject Non-compliance|1|||
130130817|NCT00473330|468441118|FG001|Core Study|Subject Non-compliance|2|||
130130818|NCT00473330|468441119|FG002|Core Study|Subject Non-compliance|1|||
130130819|NCT00473330|468441117|FG000|Core Study|Subject Required Other Therapy|0|||
130130820|NCT00473330|468441118|FG001|Core Study|Subject Required Other Therapy|1|||
130130821|NCT00473330|468441119|FG002|Core Study|Subject Required Other Therapy|3|||
130130822|NCT00473330|468441117|FG000|Core Study|Subject's Decision|9|||
130130823|NCT00473330|468441118|FG001|Core Study|Subject's Decision|8|||
130130824|NCT00473330|468441119|FG002|Core Study|Subject's Decision|19|||
130130825|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
130130826|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
130130827|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
130130828|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Death|2|||
130130829|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Death|0|||
130130830|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Death|0|||
130130831|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
130130832|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
130130833|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
130130834|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
130130835|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
130130836|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
130130837|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
130094024|NCT00920582|468298765|FG002|Overall Study|Protocol Violation|0|||
130094025|NCT00920582|468298766|FG003|Overall Study|Protocol Violation|0|||
130130838|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
130130839|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
130130840|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
129971013|NCT01124838|467856643|FG001|Overall Study|Lack of Efficacy|0|||
129971014|NCT01124838|467856642|FG000|Overall Study|Withdrawal by Subject|3|||
129971015|NCT01124838|467856643|FG001|Overall Study|Withdrawal by Subject|2|||
129971016|NCT01124838|467856642|FG000|Overall Study|Lost to Follow-up|2|||
129971017|NCT01124838|467856643|FG001|Overall Study|Lost to Follow-up|0|||
129971018|NCT04297618|467856644|FG000|Overall Study|Adverse Event|1|||
129971019|NCT04297618|467856644|FG000|Overall Study|Withdrawal by Subject|1|||
129971020|NCT06719986|467856645|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
129971021|NCT06719986|467856646|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
129971022|NCT06719986|467856647|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
129971023|NCT06719986|467856645|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
129971024|NCT06719986|467856646|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
129971025|NCT06719986|467856647|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
129971026|NCT02600897|467856649|FG000|Overall Study|Death|1|||
129971027|NCT02600897|467856650|FG001|Overall Study|Death|2|||
129971028|NCT02600897|467856651|FG002|Overall Study|Death|1|||
129971029|NCT02600897|467856652|FG003|Overall Study|Death|2|||
129971030|NCT02600897|467856653|FG004|Overall Study|Death|3|||
129971031|NCT02600897|467856654|FG005|Overall Study|Death|2|||
129971032|NCT02600897|467856655|FG006|Overall Study|Death|10|||
129971033|NCT02600897|467856656|FG007|Overall Study|Death|7|||
129971034|NCT02600897|467856657|FG008|Overall Study|Death|20|||
129971035|NCT02600897|467856649|FG000|Overall Study|Lost to Follow-up|1|||
129971036|NCT02600897|467856650|FG001|Overall Study|Lost to Follow-up|0|||
129971037|NCT02600897|467856651|FG002|Overall Study|Lost to Follow-up|0|||
129971038|NCT02600897|467856652|FG003|Overall Study|Lost to Follow-up|0|||
129971039|NCT02600897|467856653|FG004|Overall Study|Lost to Follow-up|0|||
129971040|NCT02600897|467856654|FG005|Overall Study|Lost to Follow-up|0|||
129971041|NCT02600897|467856655|FG006|Overall Study|Lost to Follow-up|0|||
129971042|NCT02600897|467856656|FG007|Overall Study|Lost to Follow-up|1|||
129971043|NCT02600897|467856657|FG008|Overall Study|Lost to Follow-up|0|||
129971044|NCT02600897|467856649|FG000|Overall Study|Withdrawal by Subject|0|||
129971045|NCT02600897|467856650|FG001|Overall Study|Withdrawal by Subject|0|||
129971046|NCT02600897|467856651|FG002|Overall Study|Withdrawal by Subject|0|||
129971047|NCT02600897|467856652|FG003|Overall Study|Withdrawal by Subject|0|||
129971048|NCT02600897|467856653|FG004|Overall Study|Withdrawal by Subject|0|||
129971049|NCT02600897|467856654|FG005|Overall Study|Withdrawal by Subject|0|||
129971050|NCT02600897|467856655|FG006|Overall Study|Withdrawal by Subject|0|||
129971051|NCT02600897|467856656|FG007|Overall Study|Withdrawal by Subject|4|||
129971052|NCT02600897|467856657|FG008|Overall Study|Withdrawal by Subject|2|||
129971053|NCT02600897|467856649|FG000|Overall Study|Reason Not Specified|0|||
129971054|NCT02600897|467856650|FG001|Overall Study|Reason Not Specified|0|||
129971055|NCT02600897|467856651|FG002|Overall Study|Reason Not Specified|0|||
129971056|NCT02600897|467856652|FG003|Overall Study|Reason Not Specified|0|||
129971057|NCT02600897|467856653|FG004|Overall Study|Reason Not Specified|0|||
129971058|NCT02600897|467856654|FG005|Overall Study|Reason Not Specified|0|||
129971059|NCT02600897|467856655|FG006|Overall Study|Reason Not Specified|0|||
129971060|NCT02600897|467856656|FG007|Overall Study|Reason Not Specified|0|||
129971061|NCT02600897|467856657|FG008|Overall Study|Reason Not Specified|1|||
130094026|NCT00920582|468298763|FG000|Overall Study|Other|2|||
130094027|NCT00920582|468298764|FG001|Overall Study|Other|1|||
130094028|NCT00920582|468298765|FG002|Overall Study|Other|3|||
130094029|NCT00920582|468298766|FG003|Overall Study|Other|2|||
130094030|NCT03457701|468298769|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
130094031|NCT03457701|468298770|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
130094032|NCT03457701|468298769|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
130094033|NCT03457701|468298770|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
130094034|NCT02243306|468298771|FG000|Overall Study|Adverse Event|0|||
130094035|NCT02243306|468298772|FG001|Overall Study|Adverse Event|1|||
130094036|NCT02243306|468298771|FG000|Overall Study|Other: Reached stopping criteria|0|||
130094037|NCT02243306|468298772|FG001|Overall Study|Other: Reached stopping criteria|1|||
130094038|NCT02243306|468298771|FG000|Overall Study|Physician Decision|0|||
130094039|NCT02243306|468298772|FG001|Overall Study|Physician Decision|1|||
130094040|NCT00606931|468298776|FG000|Overall Study|Withdrawal by Subject|3|||
130094041|NCT02924129|468298790|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
130094042|NCT02924129|468298791|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
130094043|NCT02924129|468298790|FG000|Overall Study|Withdrawal by Subject|2|||
130094044|NCT02924129|468298791|FG001|Overall Study|Withdrawal by Subject|2|||
130094045|NCT02924129|468298790|FG000|Overall Study|Physician Decision|1|||
130094046|NCT02924129|468298791|FG001|Overall Study|Physician Decision|0|||
130094047|NCT02924129|468298790|FG000|Overall Study|Missed Visit|0|||
130094048|NCT02924129|468298791|FG001|Overall Study|Missed Visit|1|||
130094049|NCT00302731|468298796|FG000|Overall Study|Lost to Follow-up|1|||
130094050|NCT00302731|468298797|FG001|Overall Study|Lost to Follow-up|2|||
130094051|NCT00302731|468298798|FG002|Overall Study|Lost to Follow-up|0|||
130130841|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
130130842|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
130130843|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
130130844|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
130130845|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
130130846|NCT00473330|468441117|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
130130847|NCT00473330|468441118|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
130130848|NCT00473330|468441119|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
130130849|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
130130850|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
130130851|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
130130852|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Death|2|||
130130853|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Death|2|||
130130854|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Death|1|||
130130855|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
130130856|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
130130857|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
130130858|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
130130859|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
130130860|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
130130861|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
130130862|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
130130863|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
130130864|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
130130865|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
130130866|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
130130867|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
130130868|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
130130869|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
130130870|NCT00473330|468441117|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
130130871|NCT00473330|468441118|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
130130872|NCT00473330|468441119|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
130130873|NCT01975948|468441120|FG000|Overall Study|Withdrawal by Subject|17|||
130130874|NCT01975948|468441121|FG001|Overall Study|Withdrawal by Subject|21|||
130130875|NCT01975948|468441122|FG002|Overall Study|Withdrawal by Subject|7|||
130130876|NCT01975948|468441123|FG003|Overall Study|Withdrawal by Subject|6|||
130130877|NCT01675765|468441124|FG000|Overall Study|Progressive disease|4|||
130130878|NCT01675765|468441125|FG001|Overall Study|Progressive disease|4|||
130130879|NCT01675765|468441124|FG000|Overall Study|Adverse Event|1|||
130130880|NCT01675765|468441125|FG001|Overall Study|Adverse Event|2|||
130130881|NCT01675765|468441124|FG000|Overall Study|Withdrawal by Subject|2|||
130130882|NCT01675765|468441125|FG001|Overall Study|Withdrawal by Subject|0|||
130130883|NCT01675765|468441124|FG000|Overall Study|Death|1|||
130130884|NCT01675765|468441125|FG001|Overall Study|Death|0|||
130130885|NCT01675765|468441124|FG000|Overall Study|Clinical progression|3|||
130130886|NCT01675765|468441125|FG001|Overall Study|Clinical progression|2|||
130130887|NCT03965091|468441127|FG000|Overall Study|Adverse Event|0|||
130130888|NCT03965091|468441128|FG001|Overall Study|Adverse Event|2|||
130130889|NCT03965091|468441129|FG002|Overall Study|Adverse Event|3|||
130130890|NCT03965091|468441127|FG000|Overall Study|Withdrawal by Subject|11|||
130130891|NCT03965091|468441128|FG001|Overall Study|Withdrawal by Subject|3|||
130130892|NCT03965091|468441129|FG002|Overall Study|Withdrawal by Subject|5|||
130130893|NCT03965091|468441127|FG000|Overall Study|Non-compliance with study drug|0|||
130130894|NCT03965091|468441128|FG001|Overall Study|Non-compliance with study drug|0|||
130130895|NCT03965091|468441129|FG002|Overall Study|Non-compliance with study drug|1|||
130130896|NCT03965091|468441127|FG000|Overall Study|Lost to Follow-up|1|||
130130897|NCT03965091|468441128|FG001|Overall Study|Lost to Follow-up|1|||
130130898|NCT03965091|468441129|FG002|Overall Study|Lost to Follow-up|1|||
130130899|NCT03965091|468441127|FG000|Overall Study|Lack of Efficacy|2|||
130130900|NCT03965091|468441128|FG001|Overall Study|Lack of Efficacy|0|||
130130901|NCT03965091|468441129|FG002|Overall Study|Lack of Efficacy|0|||
130130902|NCT03965091|468441127|FG000|Overall Study|Other than specified|9|||
130130903|NCT03965091|468441128|FG001|Overall Study|Other than specified|11|||
130130904|NCT03965091|468441129|FG002|Overall Study|Other than specified|8|||
130130905|NCT03500341|468441130|FG000|Overall Study|Withdrawn prior to Completion|2|||
130130906|NCT02576938|468441131|FG000|Overall Study|Adverse Event|5|||
130130907|NCT02576938|468441132|FG001|Overall Study|Adverse Event|3|||
130130908|NCT02576938|468441133|FG002|Overall Study|Adverse Event|6|||
130130909|NCT02576938|468441131|FG000|Overall Study|Protocol Violation|1|||
130130910|NCT02576938|468441132|FG001|Overall Study|Protocol Violation|1|||
130130911|NCT02576938|468441133|FG002|Overall Study|Protocol Violation|1|||
130130912|NCT02576938|468441131|FG000|Overall Study|Withdrawal by Subject|3|||
130130913|NCT02576938|468441132|FG001|Overall Study|Withdrawal by Subject|2|||
130130914|NCT02576938|468441133|FG002|Overall Study|Withdrawal by Subject|4|||
130130915|NCT02576938|468441131|FG000|Overall Study|Lack of Efficacy|9|||
130130916|NCT02576938|468441132|FG001|Overall Study|Lack of Efficacy|4|||
130130917|NCT02576938|468441133|FG002|Overall Study|Lack of Efficacy|0|||
130130918|NCT02576938|468441131|FG000|Overall Study|Lost to Follow-up|2|||
130130919|NCT02576938|468441132|FG001|Overall Study|Lost to Follow-up|0|||
130130920|NCT02576938|468441133|FG002|Overall Study|Lost to Follow-up|1|||
130130921|NCT02576938|468441131|FG000|Overall Study|Physician Decision|0|||
130130922|NCT02576938|468441132|FG001|Overall Study|Physician Decision|1|||
130130923|NCT02576938|468441133|FG002|Overall Study|Physician Decision|0|||
130130924|NCT02576938|468441131|FG000|Overall Study|Met Exclusion Criteria|0|||
130130925|NCT02576938|468441132|FG001|Overall Study|Met Exclusion Criteria|1|||
130130926|NCT02576938|468441133|FG002|Overall Study|Met Exclusion Criteria|0|||
130130927|NCT00003659|468441150|FG000|Overall Study|Withdrawal by Subject|3|||
130130928|NCT04022954|468441151|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
130130929|NCT04022954|468441151|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
130130930|NCT04022954|468441151|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
130130931|NCT03017885|468441152|FG000|Overall Study|Adverse Event|2|||
130130932|NCT03017885|468441153|FG001|Overall Study|Adverse Event|0|||
130130933|NCT03017885|468441154|FG002|Overall Study|Adverse Event|0|||
130130934|NCT03017885|468441155|FG003|Overall Study|Adverse Event|0|||
130130935|NCT03017885|468441156|FG004|Overall Study|Adverse Event|0|||
130130936|NCT03017885|468441157|FG005|Overall Study|Adverse Event|0|||
130130937|NCT03017885|468441152|FG000|Overall Study|Progression of disease|4|||
130130938|NCT03017885|468441153|FG001|Overall Study|Progression of disease|3|||
130130939|NCT03017885|468441154|FG002|Overall Study|Progression of disease|4|||
130130940|NCT03017885|468441155|FG003|Overall Study|Progression of disease|0|||
130130941|NCT03017885|468441156|FG004|Overall Study|Progression of disease|0|||
130130942|NCT03017885|468441157|FG005|Overall Study|Progression of disease|0|||
130130943|NCT03017885|468441152|FG000|Overall Study|Other than listed|1|||
130130944|NCT03017885|468441153|FG001|Overall Study|Other than listed|2|||
130130945|NCT03017885|468441154|FG002|Overall Study|Other than listed|1|||
130130946|NCT03017885|468441155|FG003|Overall Study|Other than listed|0|||
130130947|NCT03017885|468441156|FG004|Overall Study|Other than listed|0|||
130130948|NCT03017885|468441157|FG005|Overall Study|Other than listed|0|||
130130949|NCT03017885|468441152|FG000|Overall Study|Lost to Follow-up|2|||
130130950|NCT03017885|468441153|FG001|Overall Study|Lost to Follow-up|0|||
130130951|NCT03017885|468441154|FG002|Overall Study|Lost to Follow-up|3|||
130130952|NCT03017885|468441155|FG003|Overall Study|Lost to Follow-up|0|||
130130953|NCT03017885|468441156|FG004|Overall Study|Lost to Follow-up|0|||
130130954|NCT03017885|468441157|FG005|Overall Study|Lost to Follow-up|0|||
130130955|NCT03017885|468441152|FG000|Overall Study|Change to other anti-cancer therapy|0|||
130130956|NCT03017885|468441153|FG001|Overall Study|Change to other anti-cancer therapy|0|||
130130957|NCT03017885|468441154|FG002|Overall Study|Change to other anti-cancer therapy|1|||
130130958|NCT03017885|468441155|FG003|Overall Study|Change to other anti-cancer therapy|0|||
130130959|NCT03017885|468441156|FG004|Overall Study|Change to other anti-cancer therapy|0|||
130130960|NCT03017885|468441157|FG005|Overall Study|Change to other anti-cancer therapy|0|||
130130961|NCT00984126|468441161|FG000|Overall Study|Protocol Violation|0|||
130130962|NCT00984126|468441162|FG001|Overall Study|Protocol Violation|0|||
130130963|NCT00984126|468441163|FG002|Overall Study|Protocol Violation|1|||
130130964|NCT00984126|468441164|FG003|Overall Study|Protocol Violation|2|||
130130965|NCT00984126|468441161|FG000|Overall Study|Adverse Event|0|||
130130966|NCT00984126|468441162|FG001|Overall Study|Adverse Event|0|||
130130967|NCT00984126|468441163|FG002|Overall Study|Adverse Event|0|||
130130968|NCT00984126|468441164|FG003|Overall Study|Adverse Event|2|||
130130969|NCT00984126|468441161|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
129971062|NCT02726945|467856658|FG000|Overall Study|Withdrawal by Subject|0|||
129971063|NCT02726945|467856659|FG001|Overall Study|Withdrawal by Subject|0|||
130130970|NCT00984126|468441162|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
130130971|NCT00984126|468441163|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
130130972|NCT00984126|468441164|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
130130973|NCT00984126|468441161|FG000|Overall Study|Withdrawal criteria|0|||
130130974|NCT00984126|468441162|FG001|Overall Study|Withdrawal criteria|1|||
130130975|NCT00984126|468441163|FG002|Overall Study|Withdrawal criteria|3|||
130130976|NCT00984126|468441164|FG003|Overall Study|Withdrawal criteria|9|||
130130977|NCT01001208|468441165|FG000|Overall Study|Adverse Event|10|||
130130978|NCT01001208|468441166|FG001|Overall Study|Adverse Event|5|||
129971064|NCT02726945|467856660|FG002|Overall Study|Withdrawal by Subject|1|||
130130979|NCT01001208|468441165|FG000|Overall Study|Lost to Follow-up|5|||
130130980|NCT01001208|468441166|FG001|Overall Study|Lost to Follow-up|9|||
130130981|NCT01001208|468441165|FG000|Overall Study|Physician Decision|1|||
130130982|NCT01001208|468441166|FG001|Overall Study|Physician Decision|0|||
130130983|NCT01001208|468441165|FG000|Overall Study|Withdrawal by Subject|4|||
130130984|NCT01001208|468441166|FG001|Overall Study|Withdrawal by Subject|5|||
130130985|NCT01001208|468441165|FG000|Overall Study|Ineligibility Determined|4|||
130130986|NCT01001208|468441166|FG001|Overall Study|Ineligibility Determined|2|||
130130987|NCT01001208|468441165|FG000|Overall Study|Noncompliance|4|||
130130988|NCT01001208|468441166|FG001|Overall Study|Noncompliance|7|||
130130989|NCT01001208|468441165|FG000|Overall Study|Disease Progression|0|||
130130990|NCT01001208|468441166|FG001|Overall Study|Disease Progression|3|||
130130991|NCT01001208|468441165|FG000|Overall Study|Other|0|||
130130992|NCT01001208|468441166|FG001|Overall Study|Other|2|||
130130993|NCT01864174|468441167|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
130130994|NCT01864174|468441168|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
130130995|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
130130996|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
130130997|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
130130998|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
130130999|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
130131000|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
130131001|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Death|1|||
130131002|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Death|0|||
130131003|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
130131004|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
130131005|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
130131006|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
130131007|NCT01864174|468441167|FG000|Double Blind - Compliant Randomized|Other|6|||
130131008|NCT01864174|468441168|FG001|Double Blind - Compliant Randomized|Other|10|||
130131009|NCT01864174|468441167|FG000|Off Treatment Follow-Up|Other|2|||
130131010|NCT01864174|468441168|FG001|Off Treatment Follow-Up|Other|0|||
130131011|NCT01864174|468441167|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
130131012|NCT01864174|468441168|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
130131013|NCT01723397|468441172|FG000|Study Period 1|Protocol Violation|0|||
130131014|NCT01723397|468441173|FG001|Study Period 1|Protocol Violation|1|||
130131015|NCT01723397|468441172|FG000|Study Period 2|Protocol Violation|0|||
130131016|NCT01723397|468441173|FG001|Study Period 2|Protocol Violation|1|||
130131017|NCT00468286|468441174|FG000|Overall Study|Adverse Event|1|||
130131018|NCT00468286|468441175|FG001|Overall Study|Adverse Event|6|||
130131019|NCT00468286|468441174|FG000|Overall Study|Protocol Violation|2|||
130131020|NCT00468286|468441175|FG001|Overall Study|Protocol Violation|2|||
130131021|NCT00468286|468441174|FG000|Overall Study|Withdrawal by Subject|4|||
130131022|NCT00468286|468441175|FG001|Overall Study|Withdrawal by Subject|3|||
130131023|NCT00468286|468441174|FG000|Overall Study|Physician Decision|0|||
130131024|NCT00468286|468441175|FG001|Overall Study|Physician Decision|1|||
130131025|NCT02196675|468441176|FG000|Overall Study|Withdrawal by Subject|1|||
130131026|NCT02196675|468441177|FG001|Overall Study|Withdrawal by Subject|0|||
130131027|NCT02196675|468441178|FG002|Overall Study|Withdrawal by Subject|0|||
130131028|NCT02196675|468441176|FG000|Overall Study|Intra-operative surgical exclusion|1|||
130131029|NCT02196675|468441177|FG001|Overall Study|Intra-operative surgical exclusion|1|||
130131030|NCT02196675|468441178|FG002|Overall Study|Intra-operative surgical exclusion|0|||
130131031|NCT02196675|468441176|FG000|Overall Study|Protocol Violation|0|||
130131032|NCT02196675|468441177|FG001|Overall Study|Protocol Violation|1|||
130131033|NCT02196675|468441178|FG002|Overall Study|Protocol Violation|0|||
130131034|NCT02196675|468441176|FG000|Overall Study|Death|0|||
130131035|NCT02196675|468441177|FG001|Overall Study|Death|0|||
130131036|NCT02196675|468441178|FG002|Overall Study|Death|1|||
130131037|NCT02158663|468441179|FG000|Overall Study|Withdrawal by Subject|5|||
130131038|NCT02158663|468441180|FG001|Overall Study|Withdrawal by Subject|4|||
130131039|NCT00537979|468441181|FG000|Overall Study|Adverse Event|2|||
130131040|NCT00537979|468441182|FG001|Overall Study|Adverse Event|2|||
130131041|NCT00537979|468441181|FG000|Overall Study|Withdrawal by Subject|1|||
130131042|NCT00537979|468441182|FG001|Overall Study|Withdrawal by Subject|4|||
130131043|NCT00537979|468441181|FG000|Overall Study|Lost to Follow-up|1|||
130131044|NCT00537979|468441182|FG001|Overall Study|Lost to Follow-up|4|||
130131045|NCT00537979|468441181|FG000|Overall Study|Lack of Efficacy|0|||
130131046|NCT00537979|468441182|FG001|Overall Study|Lack of Efficacy|1|||
130131047|NCT00537979|468441181|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
130131048|NCT00537979|468441182|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
130131049|NCT00537979|468441181|FG000|Overall Study|Death|0|||
130131050|NCT00537979|468441182|FG001|Overall Study|Death|3|||
130131051|NCT00537979|468441181|FG000|Overall Study|Kidney transplant|0|||
130131052|NCT00537979|468441182|FG001|Overall Study|Kidney transplant|3|||
130131053|NCT00537979|468441181|FG000|Overall Study|Heart failure|0|||
130131054|NCT00537979|468441182|FG001|Overall Study|Heart failure|1|||
130131055|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
130131056|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
130131057|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
130131058|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
130131059|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
130131060|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
130131061|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
130131062|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
130131063|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
130131064|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
130131065|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
130131066|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
130131067|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
130131068|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
130131069|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
130131070|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
130131071|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
130131072|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
130131073|NCT02009163|468441183|FG000|Open-label Period (Non-randomized)|Other|13|||
130131074|NCT02009163|468441184|FG001|Open-label Period (Non-randomized)|Other|0|||
130131075|NCT02009163|468441185|FG002|Open-label Period (Non-randomized)|Other|0|||
130131076|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
130131077|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
130131078|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
130131079|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
130131080|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
130131081|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
130131082|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Adverse Event|0|||
130131083|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Adverse Event|0|||
130131084|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Adverse Event|6|||
130131085|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
130131086|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
130131087|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
130131088|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
130131089|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
130131090|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
130131091|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Pregnancy|0|||
130131092|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Pregnancy|0|||
130131093|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Pregnancy|2|||
130131094|NCT02009163|468441183|FG000|Randomized-withdrawal Period|Other|0|||
130131095|NCT02009163|468441184|FG001|Randomized-withdrawal Period|Other|9|||
130131096|NCT02009163|468441185|FG002|Randomized-withdrawal Period|Other|5|||
130131097|NCT01218867|468441188|FG000|Overall Study|Death during treatment|0|||
130131098|NCT01218867|468441189|FG001|Overall Study|Death during treatment|0|||
130131099|NCT01218867|468441190|FG002|Overall Study|Death during treatment|0|||
130131100|NCT01218867|468441191|FG003|Overall Study|Death during treatment|0|||
130131101|NCT01218867|468441192|FG004|Overall Study|Death during treatment|0|||
130131102|NCT01218867|468441193|FG005|Overall Study|Death during treatment|0|||
130131103|NCT01218867|468441194|FG006|Overall Study|Death during treatment|1|||
130131104|NCT01218867|468441195|FG007|Overall Study|Death during treatment|0|||
130131105|NCT01218867|468441196|FG008|Overall Study|Death during treatment|0|||
130131106|NCT01218867|468441197|FG009|Overall Study|Death during treatment|0|||
130131107|NCT01218867|468441198|FG010|Overall Study|Death during treatment|0|||
130131108|NCT01474551|468441200|FG000|Overall Study|Death|1|||
130131109|NCT04419311|468441202|FG000|Overall Study|Lost to Follow-up|1|||
130131110|NCT04419311|468441203|FG001|Overall Study|Lost to Follow-up|0|||
130131111|NCT00465270|468441206|FG000|Overall Study|Death|7|||
130131112|NCT00465270|468441207|FG001|Overall Study|Death|11|||
130131113|NCT00465270|468441206|FG000|Overall Study|Withdrawal by Subject|34|||
130131114|NCT00465270|468441207|FG001|Overall Study|Withdrawal by Subject|78|||
130131115|NCT00465270|468441206|FG000|Overall Study|Lost to Follow-up|60|||
130131116|NCT00465270|468441207|FG001|Overall Study|Lost to Follow-up|67|||
130131117|NCT00465270|468441206|FG000|Overall Study|Investigator request|3|||
130131118|NCT00465270|468441207|FG001|Overall Study|Investigator request|4|||
130131119|NCT02089997|468441223|FG000|Overall Study|Case report forms uncollected|99|||
130131120|NCT02089997|468441223|FG000|Overall Study|Protocol Violation|147|||
130131121|NCT02441309|468441224|FG000|Overall Study|Disease progression|2|||
130131122|NCT02441309|468441225|FG001|Overall Study|Disease progression|1|||
130131123|NCT02441309|468441226|FG002|Overall Study|Disease progression|2|||
130131124|NCT02441309|468441224|FG000|Overall Study|Adverse Event|0|||
130131125|NCT02441309|468441225|FG001|Overall Study|Adverse Event|1|||
130131126|NCT02441309|468441226|FG002|Overall Study|Adverse Event|0|||
130131127|NCT02441309|468441224|FG000|Overall Study|Withdrawal by Subject|1|||
130131128|NCT02441309|468441225|FG001|Overall Study|Withdrawal by Subject|0|||
130131129|NCT02441309|468441226|FG002|Overall Study|Withdrawal by Subject|1|||
130131130|NCT02335658|468441231|FG000|Overall Study|Adverse Event|18|||
130131131|NCT02335658|468441232|FG001|Overall Study|Adverse Event|12|||
130131132|NCT02335658|468441231|FG000|Overall Study|Lack of Efficacy|4|||
130131133|NCT02335658|468441232|FG001|Overall Study|Lack of Efficacy|5|||
130131134|NCT02335658|468441231|FG000|Overall Study|Pregnancy|1|||
130131135|NCT02335658|468441232|FG001|Overall Study|Pregnancy|0|||
130131136|NCT02335658|468441231|FG000|Overall Study|Withdrawal by Subject|13|||
130131137|NCT02335658|468441232|FG001|Overall Study|Withdrawal by Subject|21|||
130131138|NCT02335658|468441231|FG000|Overall Study|non-compliance|2|||
130131139|NCT02335658|468441232|FG001|Overall Study|non-compliance|3|||
130131140|NCT02335658|468441231|FG000|Overall Study|other reason|2|||
130131141|NCT02335658|468441232|FG001|Overall Study|other reason|3|||
130131142|NCT02305758|468441233|FG000|Overall Study|Death|27|||
130131143|NCT02305758|468441234|FG001|Overall Study|Death|27|||
130131144|NCT02305758|468441233|FG000|Overall Study|Withdrew consent|9|||
130131145|NCT02305758|468441234|FG001|Overall Study|Withdrew consent|2|||
130131146|NCT02305758|468441233|FG000|Overall Study|Lost to Follow-up|6|||
130131147|NCT02305758|468441234|FG001|Overall Study|Lost to Follow-up|1|||
130131148|NCT02305758|468441233|FG000|Overall Study|Study Terminated by Sponsor|21|||
130131149|NCT02305758|468441234|FG001|Overall Study|Study Terminated by Sponsor|34|||
130131150|NCT02305758|468441233|FG000|Overall Study|Other, not specified|2|||
130131151|NCT02305758|468441234|FG001|Overall Study|Other, not specified|1|||
130131152|NCT02032888|468441237|FG000|Treatment Period|Poor compliance/noncompliance|1|||
130131153|NCT02032888|468441238|FG001|Treatment Period|Poor compliance/noncompliance|1|||
130131154|NCT02032888|468441239|FG002|Treatment Period|Poor compliance/noncompliance|0|||
130131155|NCT02032888|468441237|FG000|Treatment Period|Other|1|||
130131156|NCT02032888|468441238|FG001|Treatment Period|Other|1|||
130131157|NCT02032888|468441239|FG002|Treatment Period|Other|0|||
130131158|NCT02032888|468441237|FG000|Follow-up Period|Lost to Follow-up|1|||
130131159|NCT02032888|468441238|FG001|Follow-up Period|Lost to Follow-up|1|||
130131160|NCT02032888|468441239|FG002|Follow-up Period|Lost to Follow-up|0|||
130131161|NCT02032888|468441237|FG000|Follow-up Period|Death|1|||
130131162|NCT02032888|468441238|FG001|Follow-up Period|Death|1|||
130131163|NCT02032888|468441239|FG002|Follow-up Period|Death|0|||
130131164|NCT02032888|468441237|FG000|Follow-up Period|Other|1|||
130131165|NCT02032888|468441238|FG001|Follow-up Period|Other|0|||
130131166|NCT02032888|468441239|FG002|Follow-up Period|Other|0|||
130131167|NCT03616106|468441242|FG000|Overall Study|Removed by PI|6|||
130131168|NCT03616106|468441243|FG001|Overall Study|Removed by PI|0|||
130131169|NCT03616106|468441242|FG000|Overall Study|Withdrawal by Subject|1|||
130131170|NCT03616106|468441243|FG001|Overall Study|Withdrawal by Subject|1|||
130131171|NCT03616106|468441242|FG000|Overall Study|Lost to Follow-up|7|||
130131172|NCT03616106|468441243|FG001|Overall Study|Lost to Follow-up|0|||
130131173|NCT03206177|468441244|FG000|Overall Study|Withdrawal by Subject|1|||
130131174|NCT02963259|468441245|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
130131175|NCT02963259|468441245|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
130131176|NCT02963259|468441245|FG000|Overall Study|Death|1|||
130131177|NCT02963259|468441245|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
130131178|NCT04611789|468441246|FG000|Overall Study|Lost to Follow-up|1|||
130131179|NCT04611789|468441247|FG001|Overall Study|Lost to Follow-up|0|||
130131180|NCT04611789|468441248|FG002|Overall Study|Lost to Follow-up|0|||
130131181|NCT02655679|468441249|FG000|Overall Study|Adverse Event|0|||
130131182|NCT02655679|468441250|FG001|Overall Study|Adverse Event|1|||
130131183|NCT02655679|468441251|FG002|Overall Study|Adverse Event|0|||
130131184|NCT02655679|468441252|FG003|Overall Study|Adverse Event|0|||
130131185|NCT02655679|468441253|FG004|Overall Study|Adverse Event|0|||
130131186|NCT02655679|468441249|FG000|Overall Study|Withdrawal by Subject|1|||
130131187|NCT02655679|468441250|FG001|Overall Study|Withdrawal by Subject|1|||
130131188|NCT02655679|468441251|FG002|Overall Study|Withdrawal by Subject|0|||
129971065|NCT02726945|467856658|FG000|Overall Study|Elected to have total knee replacement|0|||
129971066|NCT02726945|467856659|FG001|Overall Study|Elected to have total knee replacement|1|||
129971067|NCT02726945|467856660|FG002|Overall Study|Elected to have total knee replacement|0|||
129971068|NCT05992922|467856661|FG000|Overall Study|Adverse Event|6|||
129971069|NCT05992922|467856662|FG001|Overall Study|Adverse Event|0|||
130131189|NCT02655679|468441252|FG003|Overall Study|Withdrawal by Subject|3|||
130131190|NCT02655679|468441253|FG004|Overall Study|Withdrawal by Subject|1|||
130131191|NCT02655679|468441249|FG000|Overall Study|Inability to Comply with the Protocol|1|||
130131192|NCT02655679|468441250|FG001|Overall Study|Inability to Comply with the Protocol|0|||
130131193|NCT02655679|468441251|FG002|Overall Study|Inability to Comply with the Protocol|0|||
129971070|NCT05992922|467856661|FG000|Overall Study|Sponsor Termination of Study|14|||
129971071|NCT05992922|467856662|FG001|Overall Study|Sponsor Termination of Study|20|||
130131194|NCT02655679|468441252|FG003|Overall Study|Inability to Comply with the Protocol|0|||
129971072|NCT02172911|467858387|FG000|Overall Study|Serious Adverse Event|0|||
130131195|NCT02655679|468441253|FG004|Overall Study|Inability to Comply with the Protocol|0|||
130131196|NCT02655679|468441249|FG000|Overall Study|Lost to Follow-up|0|||
130131197|NCT02655679|468441250|FG001|Overall Study|Lost to Follow-up|1|||
130131198|NCT02655679|468441251|FG002|Overall Study|Lost to Follow-up|1|||
130131199|NCT02655679|468441252|FG003|Overall Study|Lost to Follow-up|1|||
130131200|NCT02655679|468441253|FG004|Overall Study|Lost to Follow-up|0|||
130131201|NCT02655679|468441249|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130131202|NCT02655679|468441250|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130131203|NCT02655679|468441251|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130131204|NCT02655679|468441252|FG003|Overall Study|Other Miscellaneous Reasons|0|||
130131205|NCT02655679|468441253|FG004|Overall Study|Other Miscellaneous Reasons|0|||
130131206|NCT05472038|468442636|FG000|Overall Study|Adverse Event|0|||
130131207|NCT05472038|468442637|FG001|Overall Study|Adverse Event|0|||
130131208|NCT05472038|468442638|FG002|Overall Study|Adverse Event|1|||
130131209|NCT05472038|468442639|FG003|Overall Study|Adverse Event|0|||
130131210|NCT05472038|468442640|FG004|Overall Study|Adverse Event|0|||
130131211|NCT05472038|468442641|FG005|Overall Study|Adverse Event|0|||
130131212|NCT05472038|468442642|FG006|Overall Study|Adverse Event|0|||
130131213|NCT05472038|468442643|FG007|Overall Study|Adverse Event|0|||
130131214|NCT05472038|468442644|FG008|Overall Study|Adverse Event|0|||
130131215|NCT05472038|468442645|FG009|Overall Study|Adverse Event|0|||
130131216|NCT05472038|468442646|FG010|Overall Study|Adverse Event|0|||
130131217|NCT05472038|468442647|FG011|Overall Study|Adverse Event|0|||
130131218|NCT05472038|468442636|FG000|Overall Study|Death|0|||
130131219|NCT05472038|468442637|FG001|Overall Study|Death|0|||
130131220|NCT05472038|468442638|FG002|Overall Study|Death|0|||
130131221|NCT05472038|468442639|FG003|Overall Study|Death|0|||
130131222|NCT05472038|468442640|FG004|Overall Study|Death|0|||
130131223|NCT05472038|468442641|FG005|Overall Study|Death|1|||
130131224|NCT05472038|468442642|FG006|Overall Study|Death|0|||
130131225|NCT05472038|468442643|FG007|Overall Study|Death|0|||
130131226|NCT05472038|468442644|FG008|Overall Study|Death|0|||
130131227|NCT05472038|468442645|FG009|Overall Study|Death|0|||
130131228|NCT05472038|468442646|FG010|Overall Study|Death|0|||
130131229|NCT05472038|468442647|FG011|Overall Study|Death|0|||
130131230|NCT05472038|468442636|FG000|Overall Study|Lost to Follow-up|1|||
130131231|NCT05472038|468442637|FG001|Overall Study|Lost to Follow-up|3|||
130131232|NCT05472038|468442638|FG002|Overall Study|Lost to Follow-up|3|||
130131233|NCT05472038|468442639|FG003|Overall Study|Lost to Follow-up|9|||
130131234|NCT05472038|468442640|FG004|Overall Study|Lost to Follow-up|2|||
130131235|NCT05472038|468442641|FG005|Overall Study|Lost to Follow-up|2|||
130131236|NCT05472038|468442642|FG006|Overall Study|Lost to Follow-up|1|||
130131237|NCT05472038|468442643|FG007|Overall Study|Lost to Follow-up|0|||
130131238|NCT05472038|468442644|FG008|Overall Study|Lost to Follow-up|1|||
130131239|NCT05472038|468442645|FG009|Overall Study|Lost to Follow-up|0|||
130131240|NCT05472038|468442646|FG010|Overall Study|Lost to Follow-up|2|||
130131241|NCT05472038|468442647|FG011|Overall Study|Lost to Follow-up|1|||
130131242|NCT05472038|468442636|FG000|Overall Study|Physician Decision|0|||
130131243|NCT05472038|468442637|FG001|Overall Study|Physician Decision|0|||
130131244|NCT05472038|468442638|FG002|Overall Study|Physician Decision|0|||
130131245|NCT05472038|468442639|FG003|Overall Study|Physician Decision|0|||
130131246|NCT05472038|468442640|FG004|Overall Study|Physician Decision|1|||
130131247|NCT05472038|468442641|FG005|Overall Study|Physician Decision|0|||
130131248|NCT05472038|468442642|FG006|Overall Study|Physician Decision|0|||
130131249|NCT05472038|468442643|FG007|Overall Study|Physician Decision|0|||
130131250|NCT05472038|468442644|FG008|Overall Study|Physician Decision|0|||
129971073|NCT02172911|467858388|FG001|Overall Study|Serious Adverse Event|1|||
129971074|NCT02172911|467858387|FG000|Overall Study|Progression of Disease|0|||
129971075|NCT02172911|467858388|FG001|Overall Study|Progression of Disease|1|||
129971076|NCT02172911|467858387|FG000|Overall Study|Loss of insurance coverage|1|||
129971077|NCT02172911|467858388|FG001|Overall Study|Loss of insurance coverage|0|||
130131251|NCT05472038|468442645|FG009|Overall Study|Physician Decision|0|||
130131252|NCT05472038|468442646|FG010|Overall Study|Physician Decision|0|||
130131253|NCT05472038|468442647|FG011|Overall Study|Physician Decision|0|||
130131254|NCT05472038|468442636|FG000|Overall Study|Withdrawal by Subject|1|||
130131255|NCT05472038|468442637|FG001|Overall Study|Withdrawal by Subject|3|||
130131256|NCT05472038|468442638|FG002|Overall Study|Withdrawal by Subject|1|||
130131257|NCT05472038|468442639|FG003|Overall Study|Withdrawal by Subject|6|||
130131258|NCT05472038|468442640|FG004|Overall Study|Withdrawal by Subject|1|||
130131259|NCT05472038|468442641|FG005|Overall Study|Withdrawal by Subject|3|||
130131260|NCT05472038|468442642|FG006|Overall Study|Withdrawal by Subject|0|||
130131261|NCT05472038|468442643|FG007|Overall Study|Withdrawal by Subject|2|||
129971078|NCT02737826|467858389|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
129971079|NCT02737826|467858390|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
129971080|NCT02737826|467858391|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
129971081|NCT00129935|467858392|FG000|Overall Study|Adverse Event|18|||
129971082|NCT00129935|467858393|FG001|Overall Study|Adverse Event|56|||
129971083|NCT00129935|467858392|FG000|Overall Study|Death|1|||
130131262|NCT05472038|468442644|FG008|Overall Study|Withdrawal by Subject|3|||
130131263|NCT05472038|468442645|FG009|Overall Study|Withdrawal by Subject|1|||
130131264|NCT05472038|468442646|FG010|Overall Study|Withdrawal by Subject|2|||
130131265|NCT05472038|468442647|FG011|Overall Study|Withdrawal by Subject|2|||
130131266|NCT05472038|468442636|FG000|Overall Study|Protocol Violation|0|||
130131267|NCT05472038|468442637|FG001|Overall Study|Protocol Violation|0|||
130131268|NCT05472038|468442638|FG002|Overall Study|Protocol Violation|0|||
129971084|NCT00129935|467858393|FG001|Overall Study|Death|1|||
129971085|NCT00129935|467858392|FG000|Overall Study|Withdrawal by Subject|7|||
129971086|NCT00129935|467858393|FG001|Overall Study|Withdrawal by Subject|20|||
129971087|NCT00129935|467858392|FG000|Overall Study|Protocol Violation|0|||
129971088|NCT00129935|467858393|FG001|Overall Study|Protocol Violation|4|||
129971089|NCT00129935|467858392|FG000|Overall Study|Physician Decision|3|||
129971090|NCT00129935|467858393|FG001|Overall Study|Physician Decision|4|||
129971091|NCT00129935|467858392|FG000|Overall Study|Recurrence|1|||
129971092|NCT00129935|467858393|FG001|Overall Study|Recurrence|3|||
129971093|NCT00129935|467858392|FG000|Overall Study|Second primary|0|||
129971094|NCT00129935|467858393|FG001|Overall Study|Second primary|1|||
129971095|NCT00129935|467858392|FG000|Overall Study|Other|3|||
129971096|NCT00129935|467858393|FG001|Overall Study|Other|2|||
129971097|NCT00129935|467858392|FG000|Overall Study|Crossed to the other arm|2|||
129971098|NCT00129935|467858393|FG001|Overall Study|Crossed to the other arm|1|||
129971099|NCT00129935|467858392|FG000|Overall Study|Incorrect study treatment|1|||
129971100|NCT00129935|467858393|FG001|Overall Study|Incorrect study treatment|0|||
129971101|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
129971102|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
129971103|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
129971104|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Death|4|||
129971105|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Death|2|||
129971106|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Death|3|||
129971107|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
129971108|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
129971109|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
129971110|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
129971111|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
129971112|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
129971113|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
130094052|NCT00302731|468298799|FG003|Overall Study|Lost to Follow-up|0|||
130094053|NCT00302731|468298796|FG000|Overall Study|Adverse Event|0|||
130094054|NCT00302731|468298797|FG001|Overall Study|Adverse Event|2|||
130094055|NCT00302731|468298798|FG002|Overall Study|Adverse Event|2|||
130094056|NCT00302731|468298799|FG003|Overall Study|Adverse Event|0|||
130094057|NCT00302731|468298796|FG000|Overall Study|Withdrawal by Subject|1|||
130094058|NCT00302731|468298797|FG001|Overall Study|Withdrawal by Subject|1|||
130094059|NCT00302731|468298798|FG002|Overall Study|Withdrawal by Subject|0|||
130094060|NCT00302731|468298799|FG003|Overall Study|Withdrawal by Subject|0|||
130094061|NCT00302731|468298796|FG000|Overall Study|Protocol Violation|1|||
130094062|NCT00302731|468298797|FG001|Overall Study|Protocol Violation|0|||
130094063|NCT00302731|468298798|FG002|Overall Study|Protocol Violation|0|||
130094064|NCT00302731|468298799|FG003|Overall Study|Protocol Violation|0|||
130094065|NCT00302731|468298796|FG000|Overall Study|cancer unrelated to study discovered|1|||
130094066|NCT00302731|468298797|FG001|Overall Study|cancer unrelated to study discovered|0|||
130094067|NCT00302731|468298798|FG002|Overall Study|cancer unrelated to study discovered|1|||
130094068|NCT00302731|468298799|FG003|Overall Study|cancer unrelated to study discovered|0|||
130094069|NCT01000311|468298800|FG000|Overall Study|Adverse Event|2|||
130094070|NCT01000311|468298801|FG001|Overall Study|Adverse Event|5|||
130094071|NCT01000311|468298800|FG000|Overall Study|Withdrawal by Subject|16|||
130094072|NCT01000311|468298801|FG001|Overall Study|Withdrawal by Subject|24|||
130094073|NCT01000311|468298800|FG000|Overall Study|Lost to Follow-up|15|||
130094074|NCT01000311|468298801|FG001|Overall Study|Lost to Follow-up|24|||
130094075|NCT01000311|468298800|FG000|Overall Study|Protocol Violation|1|||
130094076|NCT01000311|468298801|FG001|Overall Study|Protocol Violation|2|||
130094077|NCT01000311|468298800|FG000|Overall Study|Inappropriate enrollment|2|||
130094078|NCT01000311|468298801|FG001|Overall Study|Inappropriate enrollment|0|||
130094079|NCT01000311|468298800|FG000|Overall Study|Administrative reason|9|||
130094080|NCT01000311|468298801|FG001|Overall Study|Administrative reason|15|||
130094081|NCT01610752|468298804|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
130094082|NCT01610752|468298805|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
130094083|NCT01610752|468298806|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
130094084|NCT01411917|468298807|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
130094085|NCT01411917|468298808|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
130094086|NCT02815670|468298809|FG000|Overall Study|Prematurely discontinued of the trial|1|||
130094087|NCT02354599|468298815|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
130094088|NCT02354599|468298816|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
130094089|NCT02354599|468298817|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
130094090|NCT02354599|468298818|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
130094091|NCT02354599|468298819|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
130094092|NCT02354599|468298820|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
130094093|NCT02354599|468298815|FG000|Overall Study|Withdrawal by Subject|1|||
130094094|NCT02354599|468298816|FG001|Overall Study|Withdrawal by Subject|1|||
130131269|NCT05472038|468442639|FG003|Overall Study|Protocol Violation|0|||
130131270|NCT05472038|468442640|FG004|Overall Study|Protocol Violation|0|||
130131271|NCT05472038|468442641|FG005|Overall Study|Protocol Violation|0|||
130131272|NCT05472038|468442642|FG006|Overall Study|Protocol Violation|0|||
130131273|NCT05472038|468442643|FG007|Overall Study|Protocol Violation|1|||
130131274|NCT05472038|468442644|FG008|Overall Study|Protocol Violation|1|||
130131275|NCT05472038|468442645|FG009|Overall Study|Protocol Violation|1|||
130131276|NCT05472038|468442646|FG010|Overall Study|Protocol Violation|1|||
130131277|NCT05472038|468442647|FG011|Overall Study|Protocol Violation|1|||
130131278|NCT05472038|468442636|FG000|Overall Study|Not vaccinated|0|||
130131279|NCT05472038|468442637|FG001|Overall Study|Not vaccinated|0|||
130131280|NCT05472038|468442638|FG002|Overall Study|Not vaccinated|0|||
130131281|NCT05472038|468442639|FG003|Overall Study|Not vaccinated|1|||
130131282|NCT05472038|468442640|FG004|Overall Study|Not vaccinated|0|||
130131283|NCT05472038|468442641|FG005|Overall Study|Not vaccinated|0|||
130131284|NCT05472038|468442642|FG006|Overall Study|Not vaccinated|0|||
130131285|NCT05472038|468442643|FG007|Overall Study|Not vaccinated|0|||
130131286|NCT05472038|468442644|FG008|Overall Study|Not vaccinated|0|||
130131287|NCT05472038|468442645|FG009|Overall Study|Not vaccinated|0|||
130131288|NCT05472038|468442646|FG010|Overall Study|Not vaccinated|0|||
130131289|NCT05472038|468442647|FG011|Overall Study|Not vaccinated|0|||
130131290|NCT02847650|468442652|FG000|Overall Study|Adverse Event|2|||
130131291|NCT02847650|468442653|FG001|Overall Study|Adverse Event|4|||
130131292|NCT02847650|468442652|FG000|Overall Study|Lost to Follow-up|1|||
130131293|NCT02847650|468442653|FG001|Overall Study|Lost to Follow-up|0|||
130131294|NCT02847650|468442652|FG000|Overall Study|Protocol Violation|0|||
130131295|NCT02847650|468442653|FG001|Overall Study|Protocol Violation|1|||
130131296|NCT02847650|468442652|FG000|Overall Study|Withdrawal by Subject|1|||
130131297|NCT02847650|468442653|FG001|Overall Study|Withdrawal by Subject|1|||
130131298|NCT00834249|468442658|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130131299|NCT00834249|468442659|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130131300|NCT00834249|468442658|FG000|Second Intervention|Adverse Event|1|||
130131301|NCT00834249|468442659|FG001|Second Intervention|Adverse Event|0|||
130131302|NCT01111461|468442660|FG000|Overall Study|Adverse Event|32|||
130131303|NCT01111461|468442660|FG000|Overall Study|Participant choice|11|||
130131304|NCT01111461|468442660|FG000|Overall Study|Lost to Follow-up|1|||
130131305|NCT01111461|468442660|FG000|Overall Study|Withdrawal by Subject|1|||
130131306|NCT01111461|468442660|FG000|Overall Study|Other|6|||
130131307|NCT01015703|468442663|FG000|Overall Study|Withdrawal by Subject|0|||
130131308|NCT01015703|468442664|FG001|Overall Study|Withdrawal by Subject|1|||
130131309|NCT01015703|468442665|FG002|Overall Study|Withdrawal by Subject|0|||
130131310|NCT01015703|468442666|FG003|Overall Study|Withdrawal by Subject|0|||
130131311|NCT01015703|468442667|FG004|Overall Study|Withdrawal by Subject|0|||
130131312|NCT01015703|468442663|FG000|Overall Study|Adverse Event|1|||
130131313|NCT01015703|468442664|FG001|Overall Study|Adverse Event|0|||
130131314|NCT01015703|468442665|FG002|Overall Study|Adverse Event|0|||
130131315|NCT01015703|468442666|FG003|Overall Study|Adverse Event|0|||
130131316|NCT01015703|468442667|FG004|Overall Study|Adverse Event|0|||
130131317|NCT01015703|468442663|FG000|Overall Study|Protocol Violation|1|||
130131318|NCT01015703|468442664|FG001|Overall Study|Protocol Violation|0|||
130131319|NCT01015703|468442665|FG002|Overall Study|Protocol Violation|0|||
130131320|NCT01015703|468442666|FG003|Overall Study|Protocol Violation|0|||
130131321|NCT01015703|468442667|FG004|Overall Study|Protocol Violation|0|||
130131322|NCT03122535|468442668|FG000|Overall Study|Lost to Follow-up|68|||
130131323|NCT03122535|468442669|FG001|Overall Study|Lost to Follow-up|68|||
130131324|NCT03122535|468442668|FG000|Overall Study|Physician Decision|3|||
130131325|NCT03122535|468442669|FG001|Overall Study|Physician Decision|3|||
130131326|NCT03122535|468442668|FG000|Overall Study|Withdrawal by Subject|2|||
129971114|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
129971115|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
129971116|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
130131327|NCT03122535|468442669|FG001|Overall Study|Withdrawal by Subject|2|||
130131328|NCT02718326|468442670|FG000|Overall Study|Adverse Event|4|||
130131329|NCT02718326|468442671|FG001|Overall Study|Adverse Event|9|||
130131330|NCT02718326|468442672|FG002|Overall Study|Adverse Event|0|||
130131331|NCT02718326|468442670|FG000|Overall Study|Death|8|||
130131332|NCT02718326|468442671|FG001|Overall Study|Death|1|||
130131333|NCT02718326|468442672|FG002|Overall Study|Death|2|||
130131334|NCT02718326|468442670|FG000|Overall Study|Withdrawal by Subject|4|||
130131335|NCT02718326|468442671|FG001|Overall Study|Withdrawal by Subject|9|||
130131336|NCT02718326|468442672|FG002|Overall Study|Withdrawal by Subject|6|||
130131337|NCT02718326|468442670|FG000|Overall Study|Lost to Follow-up|18|||
130131338|NCT02718326|468442671|FG001|Overall Study|Lost to Follow-up|5|||
130131339|NCT02718326|468442672|FG002|Overall Study|Lost to Follow-up|14|||
130131340|NCT02718326|468442670|FG000|Overall Study|Protocol Deviation|1|||
130131341|NCT02718326|468442671|FG001|Overall Study|Protocol Deviation|0|||
130131342|NCT02718326|468442672|FG002|Overall Study|Protocol Deviation|0|||
130131343|NCT02718326|468442670|FG000|Overall Study|Pregnancy|1|||
130131344|NCT02718326|468442671|FG001|Overall Study|Pregnancy|0|||
130131345|NCT02718326|468442672|FG002|Overall Study|Pregnancy|0|||
130131346|NCT00834418|468442678|FG000|Overall Study|Adverse Event|0|||
130131347|NCT00834418|468442679|FG001|Overall Study|Adverse Event|2|||
130131348|NCT00777023|468442680|FG000|Overall Study|Adverse Event|15|||
130131349|NCT00777023|468442681|FG001|Overall Study|Adverse Event|21|||
130131350|NCT00777023|468442682|FG002|Overall Study|Adverse Event|8|||
130131351|NCT00777023|468442680|FG000|Overall Study|Lack of Efficacy|1|||
130131352|NCT00777023|468442681|FG001|Overall Study|Lack of Efficacy|0|||
130131353|NCT00777023|468442682|FG002|Overall Study|Lack of Efficacy|14|||
130131354|NCT00777023|468442680|FG000|Overall Study|Protocol Violation|2|||
130131355|NCT00777023|468442681|FG001|Overall Study|Protocol Violation|1|||
130131356|NCT00777023|468442682|FG002|Overall Study|Protocol Violation|1|||
130131357|NCT00777023|468442680|FG000|Overall Study|Lost to Follow-up|2|||
130131358|NCT00777023|468442681|FG001|Overall Study|Lost to Follow-up|3|||
130131359|NCT00777023|468442682|FG002|Overall Study|Lost to Follow-up|3|||
130131360|NCT00777023|468442680|FG000|Overall Study|Death|0|||
130131361|NCT00777023|468442681|FG001|Overall Study|Death|1|||
130131362|NCT00777023|468442682|FG002|Overall Study|Death|0|||
130131363|NCT00777023|468442680|FG000|Overall Study|Withdrawal by Subject|7|||
130131364|NCT00777023|468442681|FG001|Overall Study|Withdrawal by Subject|7|||
130131365|NCT00777023|468442682|FG002|Overall Study|Withdrawal by Subject|8|||
130131366|NCT00777023|468442680|FG000|Overall Study|Missing data|1|||
130131367|NCT00777023|468442681|FG001|Overall Study|Missing data|1|||
130131368|NCT00777023|468442682|FG002|Overall Study|Missing data|0|||
130131369|NCT00777023|468442680|FG000|Overall Study|Reasons not specified|4|||
130131370|NCT00777023|468442681|FG001|Overall Study|Reasons not specified|4|||
130131371|NCT00777023|468442682|FG002|Overall Study|Reasons not specified|2|||
130131372|NCT00777023|468442680|FG000|Overall Study|Last dose date unknown|3|||
130131373|NCT00777023|468442681|FG001|Overall Study|Last dose date unknown|3|||
130131374|NCT00777023|468442682|FG002|Overall Study|Last dose date unknown|1|||
130131375|NCT02659150|468442685|FG000|Subject Enrollment|Physician Decision|3|||
130131376|NCT02659150|468442685|FG000|Subject Enrollment|Withdrawal by Subject|2|||
130131377|NCT02659150|468442685|FG000|Baseline Imaging|Withdrawal by Subject|1|||
130131378|NCT02659150|468442685|FG000|Baseline Imaging|Physician Decision|1|||
130131379|NCT02659150|468442685|FG000|Study Drug Dosing|Adverse Event|1|||
130131380|NCT00448019|468442686|FG000|Overall Study|Withdrawal by Subject|3|||
130131381|NCT00448019|468442686|FG000|Overall Study|Disease progression|1|||
130131382|NCT00448019|468442686|FG000|Overall Study|Death|2|||
130131383|NCT00448019|468442686|FG000|Overall Study|Insurance Issues|1|||
130131384|NCT02714062|468442687|FG000|Overall Study|Adverse Event|0|||
130131385|NCT02714062|468442688|FG001|Overall Study|Adverse Event|0|||
130131386|NCT02714062|468442689|FG002|Overall Study|Adverse Event|2|||
130131387|NCT02714062|468442687|FG000|Overall Study|Withdrawal by Subject|1|||
130131388|NCT02714062|468442688|FG001|Overall Study|Withdrawal by Subject|0|||
130131389|NCT02714062|468442689|FG002|Overall Study|Withdrawal by Subject|1|||
130131390|NCT02714062|468442687|FG000|Overall Study|Protocol Violation|0|||
130131391|NCT02714062|468442688|FG001|Overall Study|Protocol Violation|1|||
130131392|NCT02714062|468442689|FG002|Overall Study|Protocol Violation|0|||
130131393|NCT01200810|468442695|FG000|Overall Study|Physician Decision|1|||
130131394|NCT01200810|468442696|FG001|Overall Study|Physician Decision|0|||
130131395|NCT01200810|468442695|FG000|Overall Study|Withdrawal by Subject|1|||
130131396|NCT01200810|468442696|FG001|Overall Study|Withdrawal by Subject|2|||
130131397|NCT01200810|468442695|FG000|Overall Study|Sponsor stopped making study drug|3|||
130131398|NCT01200810|468442696|FG001|Overall Study|Sponsor stopped making study drug|3|||
130131399|NCT00904215|468442698|FG000|Overall Study|Adverse Event|25|||
130131400|NCT00904215|468442698|FG000|Overall Study|Protocol Violation|10|||
130131401|NCT00904215|468442698|FG000|Overall Study|Lost to Follow-up|63|||
130131402|NCT00904215|468442698|FG000|Overall Study|Withdrawal by Subject|9|||
130131403|NCT00904215|468442698|FG000|Overall Study|Other|28|||
130131404|NCT00960297|468442699|FG000|Overall Study|Physician Decision|1|||
130131405|NCT00960297|468442699|FG000|Overall Study|Venous port infection|1|||
130131406|NCT00960297|468442699|FG000|Overall Study|Disease progression|1|||
130131407|NCT00838630|468442708|FG000|First Intervention|Adverse Event|1|||
130131408|NCT00838630|468442709|FG001|First Intervention|Adverse Event|0|||
130131409|NCT00838630|468442708|FG000|Washout: 7 Days|Protocol Violation|1|||
130131410|NCT00838630|468442709|FG001|Washout: 7 Days|Protocol Violation|0|||
130131411|NCT02159950|468442710|FG000|Overall Study|Adverse Event|0|||
130131412|NCT02159950|468442711|FG001|Overall Study|Adverse Event|1|||
130131413|NCT02159950|468442710|FG000|Overall Study|Progression|0|||
130131414|NCT02159950|468442711|FG001|Overall Study|Progression|1|||
130131415|NCT03925532|468442712|FG000|Overall Study|Lost to Follow-up|1|||
130131416|NCT01208337|468442713|FG000|Overall Study|Death|3|||
130131417|NCT03663179|468442717|FG000|Overall Study|Withdrawal by Subject|2|||
130131418|NCT03663179|468442718|FG001|Overall Study|Withdrawal by Subject|0|||
130131419|NCT03663179|468442717|FG000|Overall Study|Lost to Follow-up|1|||
130131420|NCT03663179|468442718|FG001|Overall Study|Lost to Follow-up|1|||
130131421|NCT03663179|468442717|FG000|Overall Study|Revealed exclusionary condition|1|||
130131422|NCT03663179|468442718|FG001|Overall Study|Revealed exclusionary condition|0|||
130131423|NCT01615198|468442719|FG000|Overall Study|Withdrawal by Subject|5|||
130131424|NCT01615198|468442720|FG001|Overall Study|Withdrawal by Subject|5|||
130131425|NCT01615198|468442719|FG000|Overall Study|Protocol deviation|1|||
130131426|NCT01615198|468442720|FG001|Overall Study|Protocol deviation|1|||
130131427|NCT01615198|468442719|FG000|Overall Study|Physician Decision|5|||
130131428|NCT01615198|468442720|FG001|Overall Study|Physician Decision|1|||
130131429|NCT01615198|468442719|FG000|Overall Study|Lost to Follow-up|1|||
130131430|NCT01615198|468442720|FG001|Overall Study|Lost to Follow-up|1|||
130131431|NCT01615198|468442719|FG000|Overall Study|Lack of Efficacy|1|||
130131432|NCT01615198|468442720|FG001|Overall Study|Lack of Efficacy|6|||
130131433|NCT01615198|468442719|FG000|Overall Study|Adverse Event|11|||
130131434|NCT01615198|468442720|FG001|Overall Study|Adverse Event|5|||
130131435|NCT02414152|468442721|FG000|Overall Study|Withdrawal by Subject|1|||
130131436|NCT02414152|468442721|FG000|Overall Study|Lack of Efficacy|1|||
130131437|NCT01289262|468442722|FG000|Overall Study|Lost to Follow-up|29|||
130131438|NCT01289262|468442723|FG001|Overall Study|Lost to Follow-up|16|||
130131439|NCT01289262|468442722|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
130131440|NCT01289262|468442723|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
130131441|NCT00838279|468442724|FG000|Washout|Protocol Violation|1|||
130131442|NCT00838279|468442725|FG001|Washout|Protocol Violation|0|||
130131443|NCT00838279|468442724|FG000|Washout|Withdrawal by Subject|0|||
130131444|NCT00838279|468442725|FG001|Washout|Withdrawal by Subject|1|||
130131445|NCT03792477|468442728|FG000|Overall Study|Adverse Event|0|||
130131446|NCT03792477|468442729|FG001|Overall Study|Adverse Event|0|||
130131447|NCT03792477|468442730|FG002|Overall Study|Adverse Event|0|||
130131448|NCT03792477|468442731|FG003|Overall Study|Adverse Event|1|||
130131449|NCT03792477|468442732|FG004|Overall Study|Adverse Event|0|||
130131450|NCT03792477|468442728|FG000|Overall Study|Lost to Follow-up|0|||
130131451|NCT03792477|468442729|FG001|Overall Study|Lost to Follow-up|0|||
130131452|NCT03792477|468442730|FG002|Overall Study|Lost to Follow-up|2|||
130131453|NCT03792477|468442731|FG003|Overall Study|Lost to Follow-up|0|||
130131454|NCT03792477|468442732|FG004|Overall Study|Lost to Follow-up|0|||
130131455|NCT03792477|468442728|FG000|Overall Study|Other|0|||
130131456|NCT03792477|468442729|FG001|Overall Study|Other|0|||
130131457|NCT03792477|468442730|FG002|Overall Study|Other|0|||
130131458|NCT03792477|468442731|FG003|Overall Study|Other|0|||
130131459|NCT03792477|468442732|FG004|Overall Study|Other|1|||
130131460|NCT00840411|468442733|FG000|First Intervention|Adverse Event|1|||
130131461|NCT00840411|468442734|FG001|First Intervention|Adverse Event|0|||
130131462|NCT00840411|468442733|FG000|Washout|Withdrawal by Subject|1|||
130131463|NCT00840411|468442734|FG001|Washout|Withdrawal by Subject|0|||
130131464|NCT01921062|468442737|FG000|Overall Study|Withdrawal by Subject|0|||
130131465|NCT01921062|468442738|FG001|Overall Study|Withdrawal by Subject|7|||
130131466|NCT01921062|468442737|FG000|Overall Study|Adverse Event|5|||
130131467|NCT01921062|468442738|FG001|Overall Study|Adverse Event|6|||
130131468|NCT01921062|468442737|FG000|Overall Study|Protocol Violation|0|||
130131469|NCT01921062|468442738|FG001|Overall Study|Protocol Violation|1|||
130131470|NCT01921062|468442737|FG000|Overall Study|VMIQ score > 72|4|||
130131471|NCT01921062|468442738|FG001|Overall Study|VMIQ score > 72|1|||
130131472|NCT01921062|468442737|FG000|Overall Study|Logistic error|0|||
130131473|NCT01921062|468442738|FG001|Overall Study|Logistic error|1|||
130131474|NCT00576056|468442739|FG000|Overall Study|Adverse Event|1|||
130131475|NCT00576056|468442739|FG000|Overall Study|Death|1|||
130131476|NCT00576056|468442739|FG000|Overall Study|Lack of Efficacy|1|||
130131477|NCT00576056|468442739|FG000|Overall Study|Withdrawal by Subject|2|||
130131478|NCT00576056|468442739|FG000|Overall Study|did not meet eligibility criteria|8|||
130131479|NCT00576056|468442739|FG000|Overall Study|Physician Decision|1|||
130131480|NCT01854047|468442740|FG000|Overall Study|Lack of Efficacy|1|||
130131481|NCT01854047|468442741|FG001|Overall Study|Lack of Efficacy|0|||
130131482|NCT01854047|468442742|FG002|Overall Study|Lack of Efficacy|0|||
130131483|NCT01854047|468442743|FG003|Overall Study|Lack of Efficacy|0|||
130131484|NCT01854047|468442744|FG004|Overall Study|Lack of Efficacy|0|||
130131485|NCT01854047|468442740|FG000|Overall Study|Poor compliance to protocol|3|||
130131486|NCT01854047|468442741|FG001|Overall Study|Poor compliance to protocol|0|||
130131487|NCT01854047|468442742|FG002|Overall Study|Poor compliance to protocol|2|||
130131488|NCT01854047|468442743|FG003|Overall Study|Poor compliance to protocol|0|||
130131489|NCT01854047|468442744|FG004|Overall Study|Poor compliance to protocol|0|||
130131490|NCT01854047|468442740|FG000|Overall Study|Adverse Event|5|||
130131491|NCT01854047|468442741|FG001|Overall Study|Adverse Event|4|||
130131492|NCT01854047|468442742|FG002|Overall Study|Adverse Event|6|||
130131493|NCT01854047|468442743|FG003|Overall Study|Adverse Event|10|||
130131494|NCT01854047|468442744|FG004|Overall Study|Adverse Event|7|||
130131495|NCT01854047|468442740|FG000|Overall Study|Randomized but not treated|0|||
130131496|NCT01854047|468442741|FG001|Overall Study|Randomized but not treated|1|||
130131497|NCT01854047|468442742|FG002|Overall Study|Randomized but not treated|2|||
130131498|NCT01854047|468442743|FG003|Overall Study|Randomized but not treated|0|||
130131499|NCT01854047|468442744|FG004|Overall Study|Randomized but not treated|4|||
130131500|NCT01854047|468442740|FG000|Overall Study|Other than specified above|3|||
130131501|NCT01854047|468442741|FG001|Overall Study|Other than specified above|3|||
130131502|NCT01854047|468442742|FG002|Overall Study|Other than specified above|3|||
130131503|NCT01854047|468442743|FG003|Overall Study|Other than specified above|5|||
130131504|NCT01854047|468442744|FG004|Overall Study|Other than specified above|8|||
130131505|NCT03273153|468442745|FG000|Overall Study|Adverse Event|1|||
130131506|NCT03273153|468442746|FG001|Overall Study|Adverse Event|2|||
130131507|NCT03273153|468442745|FG000|Overall Study|Missing|0|||
130131508|NCT03273153|468442746|FG001|Overall Study|Missing|2|||
130131509|NCT03273153|468442745|FG000|Overall Study|Other|3|||
130131510|NCT03273153|468442746|FG001|Overall Study|Other|2|||
130131511|NCT03273153|468442745|FG000|Overall Study|Symptomatic Deterioration|0|||
130131512|NCT03273153|468442746|FG001|Overall Study|Symptomatic Deterioration|1|||
130131513|NCT03273153|468442745|FG000|Overall Study|Progressive Disease|6|||
130131514|NCT03273153|468442746|FG001|Overall Study|Progressive Disease|5|||
130131515|NCT03273153|468442745|FG000|Overall Study|Physician Decision|1|||
130131516|NCT03273153|468442746|FG001|Overall Study|Physician Decision|3|||
130131517|NCT03273153|468442745|FG000|Overall Study|Study Terminated by Sponsor|112|||
130131518|NCT03273153|468442746|FG001|Overall Study|Study Terminated by Sponsor|102|||
130131519|NCT03273153|468442745|FG000|Overall Study|Withdrawal by Subject|26|||
130131520|NCT03273153|468442746|FG001|Overall Study|Withdrawal by Subject|25|||
130131521|NCT03273153|468442745|FG000|Overall Study|Protocol Deviation|3|||
130131522|NCT03273153|468442746|FG001|Overall Study|Protocol Deviation|0|||
130131523|NCT03273153|468442745|FG000|Overall Study|Lost to Follow-up|6|||
130131524|NCT03273153|468442746|FG001|Overall Study|Lost to Follow-up|11|||
130131525|NCT03273153|468442745|FG000|Overall Study|Death|66|||
130131526|NCT03273153|468442746|FG001|Overall Study|Death|69|||
130131527|NCT05323396|468442747|FG000|Overall Study|Lost to Follow-up|1|||
130131528|NCT05323396|468442748|FG001|Overall Study|Lost to Follow-up|35|||
130131529|NCT05323396|468442747|FG000|Overall Study|Pregnancy|1|||
130131530|NCT05323396|468442748|FG001|Overall Study|Pregnancy|0|||
130131531|NCT04646213|468442749|FG000|Overall Study|Physician Decision|3|||
130131532|NCT04646213|468442749|FG000|Overall Study|Withdrawal by Subject|2|||
130131533|NCT00415363|468442754|FG000|Overall Study|Withdrawal by Subject|4|||
130131534|NCT00415363|468442755|FG001|Overall Study|Withdrawal by Subject|4|||
130131535|NCT00415363|468442754|FG000|Overall Study|Adverse Event|4|||
130131536|NCT00415363|468442755|FG001|Overall Study|Adverse Event|4|||
130131537|NCT00415363|468442754|FG000|Overall Study|Lost to Follow-up|2|||
130131538|NCT00415363|468442755|FG001|Overall Study|Lost to Follow-up|1|||
130131539|NCT00415363|468442754|FG000|Overall Study|Physician Decision|3|||
130131540|NCT00415363|468442755|FG001|Overall Study|Physician Decision|1|||
130131541|NCT00415363|468442754|FG000|Overall Study|Death|16|||
130131542|NCT00415363|468442755|FG001|Overall Study|Death|12|||
130131543|NCT00415363|468442754|FG000|Overall Study|Progressive disease|26|||
130131544|NCT00415363|468442755|FG001|Overall Study|Progressive disease|32|||
130131545|NCT00095212|468442756|FG000|Overall Study|Withdrawal by Subject|1|||
130131546|NCT00095212|468442757|FG001|Overall Study|Withdrawal by Subject|3|||
130131547|NCT05341622|468442758|FG000|Overall Study|Death|0|||
130131548|NCT05341622|468442759|FG001|Overall Study|Death|0|||
130131549|NCT05341622|468442760|FG002|Overall Study|Death|0|||
130131550|NCT05341622|468442761|FG003|Overall Study|Death|0|||
130131551|NCT05341622|468442762|FG004|Overall Study|Death|1|||
130131552|NCT05341622|468442763|FG005|Overall Study|Death|0|||
130131553|NCT05341622|468442764|FG006|Overall Study|Death|0|||
130131554|NCT05341622|468442765|FG007|Overall Study|Death|1|||
130131555|NCT05341622|468442758|FG000|Overall Study|Invalid Address|0|||
130131556|NCT05341622|468442759|FG001|Overall Study|Invalid Address|1|||
130131557|NCT05341622|468442760|FG002|Overall Study|Invalid Address|0|||
130131558|NCT05341622|468442761|FG003|Overall Study|Invalid Address|0|||
130131559|NCT05341622|468442762|FG004|Overall Study|Invalid Address|0|||
130131560|NCT05341622|468442763|FG005|Overall Study|Invalid Address|0|||
130131561|NCT05341622|468442764|FG006|Overall Study|Invalid Address|0|||
130131562|NCT05341622|468442765|FG007|Overall Study|Invalid Address|0|||
130131563|NCT05341622|468442758|FG000|Overall Study|Ineligible|26|||
130131564|NCT05341622|468442759|FG001|Overall Study|Ineligible|21|||
130131565|NCT05341622|468442760|FG002|Overall Study|Ineligible|28|||
130131566|NCT05341622|468442761|FG003|Overall Study|Ineligible|24|||
130131567|NCT05341622|468442762|FG004|Overall Study|Ineligible|29|||
130131568|NCT05341622|468442763|FG005|Overall Study|Ineligible|31|||
130131569|NCT05341622|468442764|FG006|Overall Study|Ineligible|28|||
130131570|NCT05341622|468442765|FG007|Overall Study|Ineligible|26|||
130131571|NCT02658084|468442766|FG000|Overall Study|Withdrawal by Subject|1|||
130131572|NCT02658084|468442767|FG001|Overall Study|Withdrawal by Subject|0|||
130131573|NCT02658084|468442766|FG000|Overall Study|Study Termination|1|||
130131574|NCT02658084|468442767|FG001|Overall Study|Study Termination|0|||
130131575|NCT02175095|468444343|FG000|Overall Study|Withdrawal by Subject|3|||
130131576|NCT03255733|468444344|FG000|Overall Study|Lost to Follow-up|4|||
130131577|NCT03653507|468444346|FG000|Overall Study|Miscellaneous|28|||
130131578|NCT03653507|468444347|FG001|Overall Study|Miscellaneous|19|||
130131579|NCT03653507|468444346|FG000|Overall Study|Withdrawal by Subject|37|||
130131580|NCT03653507|468444347|FG001|Overall Study|Withdrawal by Subject|22|||
130131581|NCT03653507|468444346|FG000|Overall Study|Protocol Deviation|2|||
130131582|NCT03653507|468444347|FG001|Overall Study|Protocol Deviation|1|||
130131583|NCT03653507|468444346|FG000|Overall Study|Progressive disease|117|||
130131584|NCT03653507|468444347|FG001|Overall Study|Progressive disease|168|||
130131585|NCT03653507|468444346|FG000|Overall Study|Lost to Follow-up|1|||
130131586|NCT03653507|468444347|FG001|Overall Study|Lost to Follow-up|1|||
130131587|NCT03653507|468444346|FG000|Overall Study|Death|25|||
130131588|NCT03653507|468444347|FG001|Overall Study|Death|22|||
130131589|NCT03653507|468444346|FG000|Overall Study|Adverse Event|35|||
130131590|NCT03653507|468444347|FG001|Overall Study|Adverse Event|14|||
130131591|NCT03697109|468444348|FG000|Open-label (OL) Phase|Adverse Event|24|||
130131592|NCT03697109|468444349|FG001|Open-label (OL) Phase|Adverse Event|0|||
130131593|NCT03697109|468444350|FG002|Open-label (OL) Phase|Adverse Event|0|||
130131594|NCT03697109|468444348|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
130131595|NCT03697109|468444349|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
130131596|NCT03697109|468444350|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
130131597|NCT03697109|468444348|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
130131598|NCT03697109|468444349|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
130131599|NCT03697109|468444350|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
130131600|NCT03697109|468444348|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
130131601|NCT03697109|468444349|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
130131602|NCT03697109|468444350|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
130131603|NCT03697109|468444348|FG000|Open-label (OL) Phase|Physician Decision|2|||
130131604|NCT03697109|468444349|FG001|Open-label (OL) Phase|Physician Decision|0|||
130131605|NCT03697109|468444350|FG002|Open-label (OL) Phase|Physician Decision|0|||
130131606|NCT03697109|468444348|FG000|Open-label (OL) Phase|Death|2|||
130131607|NCT03697109|468444349|FG001|Open-label (OL) Phase|Death|0|||
130131608|NCT03697109|468444350|FG002|Open-label (OL) Phase|Death|0|||
130131609|NCT03697109|468444348|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
130131610|NCT03697109|468444349|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
130131611|NCT03697109|468444350|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
130131612|NCT03697109|468444348|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
130131613|NCT03697109|468444349|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
130131614|NCT03697109|468444350|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
130131615|NCT03697109|468444348|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
130131616|NCT03697109|468444349|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
130131617|NCT03697109|468444350|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
130131618|NCT02096211|468444351|FG000|Overall Study|Death|2|||
130131619|NCT02096211|468444351|FG000|Overall Study|Withdrawal by Subject|8|||
130131620|NCT02096211|468444351|FG000|Overall Study|Revision of implant|7|||
130131621|NCT02096211|468444351|FG000|Overall Study|Lost to Follow-up|43|||
130131622|NCT00834522|468444354|FG000|Washout|Adverse Event|1|||
130131623|NCT00834522|468444355|FG001|Washout|Adverse Event|0|||
130131624|NCT00834522|468444354|FG000|Washout|Withdrawal by Subject|2|||
130131625|NCT00834522|468444355|FG001|Washout|Withdrawal by Subject|1|||
130131626|NCT04516967|468444356|FG000|Core Phase|Adverse Event|2|||
130131627|NCT04516967|468444357|FG001|Core Phase|Adverse Event|1|||
130131628|NCT04516967|468444358|FG002|Core Phase|Adverse Event|0|||
130131629|NCT04516967|468444356|FG000|Core Phase|Physician Decision|1|||
130131630|NCT04516967|468444357|FG001|Core Phase|Physician Decision|1|||
130131631|NCT04516967|468444358|FG002|Core Phase|Physician Decision|0|||
130131632|NCT04516967|468444356|FG000|Core Phase|Lack of Efficacy|7|||
130131633|NCT04516967|468444357|FG001|Core Phase|Lack of Efficacy|18|||
130131634|NCT04516967|468444358|FG002|Core Phase|Lack of Efficacy|0|||
130131635|NCT03165994|468444359|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
130131636|NCT03165994|468444359|FG000|Overall Study|Death|2|||
130131637|NCT03165994|468444359|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
130131638|NCT03165994|468444359|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
130131639|NCT03165994|468444359|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
130131640|NCT03165994|468444359|FG000|Overall Study|Miscellaneous|1|||
130131641|NCT00519194|468444360|FG000|Overall Study|Withdrawal by Subject|9|||
130131642|NCT00519194|468444360|FG000|Overall Study|Death|9|||
130131643|NCT00519194|468444360|FG000|Overall Study|Lost to Follow-up|3|||
130131644|NCT00934050|468444365|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
130131645|NCT00934050|468444366|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130131646|NCT00934050|468444367|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130131647|NCT00934050|468444368|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
130131648|NCT00934050|468444369|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130131649|NCT00934050|468444370|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
130131650|NCT00934050|468444365|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
130131651|NCT00934050|468444366|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
130131652|NCT00934050|468444367|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
130131653|NCT00934050|468444368|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
130131654|NCT00934050|468444369|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
130131655|NCT00934050|468444370|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
130131656|NCT00934050|468444365|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130131657|NCT00934050|468444366|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130131658|NCT00934050|468444367|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
130131659|NCT00934050|468444368|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130131660|NCT00934050|468444369|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130131661|NCT00934050|468444370|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
130131662|NCT00934050|468444365|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
130131663|NCT00934050|468444366|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
130131664|NCT00934050|468444367|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
130131665|NCT00934050|468444368|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
130131666|NCT00934050|468444369|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
130131667|NCT00934050|468444370|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
130131668|NCT00934050|468444365|FG000|Enrolled After 15 Dec 2009|Death|0|||
130131669|NCT00934050|468444366|FG001|Enrolled After 15 Dec 2009|Death|0|||
130131670|NCT00934050|468444367|FG002|Enrolled After 15 Dec 2009|Death|0|||
130131671|NCT00934050|468444368|FG003|Enrolled After 15 Dec 2009|Death|0|||
130131672|NCT00934050|468444369|FG004|Enrolled After 15 Dec 2009|Death|0|||
130131673|NCT00934050|468444370|FG005|Enrolled After 15 Dec 2009|Death|1|||
130131674|NCT00934050|468444365|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130131675|NCT00934050|468444366|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130131676|NCT00934050|468444367|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130131677|NCT00934050|468444368|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130131678|NCT00934050|468444369|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
130131679|NCT00934050|468444370|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
130131680|NCT00934050|468444365|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130131681|NCT00934050|468444366|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130131682|NCT00934050|468444367|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130131683|NCT00934050|468444368|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
130131684|NCT00934050|468444369|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
130131685|NCT00934050|468444370|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
130131686|NCT00461786|468444371|FG000|Overall Study|Entry Criteria Not Met|2|||
130131687|NCT00461786|468444371|FG000|Overall Study|Inevaluable (Never Treated)|1|||
130131688|NCT00835991|468444372|FG000|First Intervention|Adverse Event|0|||
130131689|NCT00835991|468444373|FG001|First Intervention|Adverse Event|1|||
130131690|NCT00835991|468444372|FG000|Washout|Protocol Violation|0|||
130131691|NCT00835991|468444373|FG001|Washout|Protocol Violation|2|||
130131692|NCT00835991|468444372|FG000|Washout|Withdrawal by Subject|3|||
130131693|NCT00835991|468444373|FG001|Washout|Withdrawal by Subject|1|||
130131694|NCT02149420|468444374|FG000|Core Study|Administrative problems|0|||
130131695|NCT02149420|468444375|FG001|Core Study|Administrative problems|1|||
130131696|NCT02149420|468444376|FG002|Core Study|Administrative problems|2|||
130131697|NCT02149420|468444374|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
130131698|NCT02149420|468444375|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
130131699|NCT02149420|468444376|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
130131700|NCT02378935|468444377|FG000|Overall Study|Lack of Efficacy|10|||
130131701|NCT02378935|468444378|FG001|Overall Study|Lack of Efficacy|0|||
130131702|NCT02378935|468444379|FG002|Overall Study|Lack of Efficacy|2|||
130131703|NCT02378935|468444380|FG003|Overall Study|Lack of Efficacy|6|||
130131704|NCT02378935|468444381|FG004|Overall Study|Lack of Efficacy|0|||
130131705|NCT02378935|468444382|FG005|Overall Study|Lack of Efficacy|0|||
130131706|NCT02378935|468444383|FG006|Overall Study|Lack of Efficacy|0|||
130131707|NCT02378935|468444377|FG000|Overall Study|Death|0|||
130131708|NCT02378935|468444378|FG001|Overall Study|Death|0|||
130131709|NCT02378935|468444379|FG002|Overall Study|Death|1|||
130131710|NCT02378935|468444380|FG003|Overall Study|Death|0|||
130131711|NCT02378935|468444381|FG004|Overall Study|Death|0|||
130131712|NCT02378935|468444382|FG005|Overall Study|Death|0|||
130131713|NCT02378935|468444383|FG006|Overall Study|Death|0|||
130131714|NCT03616535|468444384|FG000|Overall Study|Death|2|||
130131715|NCT03616535|468444385|FG001|Overall Study|Death|0|||
130131716|NCT03616535|468444386|FG002|Overall Study|Death|0|||
130131717|NCT03616535|468444387|FG003|Overall Study|Death|1|||
130131718|NCT03616535|468444384|FG000|Overall Study|Lost to Follow-up|2|||
130131719|NCT03616535|468444385|FG001|Overall Study|Lost to Follow-up|1|||
130131720|NCT03616535|468444386|FG002|Overall Study|Lost to Follow-up|0|||
130131721|NCT03616535|468444387|FG003|Overall Study|Lost to Follow-up|2|||
129979963|NCT04372121|467889511|FG001|Overall Study|Withdrawal by Subject|1|||
130131722|NCT03616535|468444384|FG000|Overall Study|Withdrawal by Subject|1|||
130131723|NCT03616535|468444385|FG001|Overall Study|Withdrawal by Subject|2|||
130131724|NCT03616535|468444386|FG002|Overall Study|Withdrawal by Subject|5|||
130131725|NCT03616535|468444387|FG003|Overall Study|Withdrawal by Subject|1|||
130131726|NCT03616535|468444384|FG000|Overall Study|Not specified or change in eligibility|2|||
130131727|NCT03616535|468444385|FG001|Overall Study|Not specified or change in eligibility|3|||
130131728|NCT03616535|468444386|FG002|Overall Study|Not specified or change in eligibility|3|||
130131729|NCT03616535|468444387|FG003|Overall Study|Not specified or change in eligibility|1|||
130131730|NCT02146105|468444390|FG000|Overall Study|Adverse Event|1|||
130131731|NCT02146105|468444390|FG000|Overall Study|Withdrawal by Subject|5|||
130131732|NCT05755282|468444391|FG000|Overall Study|Protocol Violation|0|||
130131733|NCT05755282|468444392|FG001|Overall Study|Protocol Violation|1|||
130131734|NCT03935880|468444394|FG000|Overall Study|Lost to Follow-up|0|||
130131735|NCT03935880|468444395|FG001|Overall Study|Lost to Follow-up|1|||
130131736|NCT02476994|468444396|FG000|Overall Study|Based on feedback from FDA|1|||
130131737|NCT02476994|468444397|FG001|Overall Study|Based on feedback from FDA|0|||
130131738|NCT02563561|468444398|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
130131739|NCT02563561|468444399|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
130131740|NCT02563561|468444400|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
130131741|NCT02563561|468444398|FG000|Overall Study|Withdrew of Consent|1|||
130131742|NCT02563561|468444399|FG001|Overall Study|Withdrew of Consent|1|||
130131743|NCT02563561|468444400|FG002|Overall Study|Withdrew of Consent|2|||
130131744|NCT02563561|468444398|FG000|Overall Study|Lost to Follow-up|1|||
130131745|NCT02563561|468444399|FG001|Overall Study|Lost to Follow-up|1|||
130131746|NCT02563561|468444400|FG002|Overall Study|Lost to Follow-up|0|||
130131747|NCT02563561|468444398|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
130131748|NCT02563561|468444399|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
130131749|NCT02563561|468444400|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
130131750|NCT02563561|468444398|FG000|Overall Study|Investigator Decision|3|||
130131751|NCT02563561|468444399|FG001|Overall Study|Investigator Decision|4|||
130131752|NCT02563561|468444400|FG002|Overall Study|Investigator Decision|2|||
130131753|NCT02563561|468444398|FG000|Overall Study|Sponsor Decision|5|||
130131754|NCT02563561|468444399|FG001|Overall Study|Sponsor Decision|2|||
130131755|NCT02563561|468444400|FG002|Overall Study|Sponsor Decision|4|||
130131756|NCT02563561|468444398|FG000|Overall Study|Other|1|||
130131757|NCT02563561|468444399|FG001|Overall Study|Other|5|||
130131758|NCT02563561|468444400|FG002|Overall Study|Other|2|||
130131759|NCT02646124|468444403|FG000|Overall Study|Lost to Follow-up|0|||
130131760|NCT02646124|468444404|FG001|Overall Study|Lost to Follow-up|2|||
130131761|NCT00857454|468444405|FG000|Overall Study|Withdrawal by Subject|2|||
130131762|NCT00857454|468444405|FG000|Overall Study|Lost to Follow-up|1|||
130131763|NCT00857454|468444405|FG000|Overall Study|Adverse Event|2|||
130131764|NCT00857454|468444405|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
130131765|NCT00857454|468444405|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
130131766|NCT00857454|468444405|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
130131767|NCT03154047|468444406|FG000|Overall Study|Death|1|||
130131768|NCT03154047|468444406|FG000|Overall Study|Study terminated by sponsor|76|||
130131769|NCT03154047|468444406|FG000|Overall Study|Withdrawal by Subject|3|||
130131770|NCT00365365|468444407|FG000|Overall Study|Randomized but not treated|0|||
130131771|NCT00365365|468444408|FG001|Overall Study|Randomized but not treated|2|||
130131772|NCT00365365|468444409|FG002|Overall Study|Randomized but not treated|0|||
130131773|NCT00365365|468444407|FG000|Overall Study|Poor compliance to protocol|0|||
130131774|NCT00365365|468444408|FG001|Overall Study|Poor compliance to protocol|1|||
130131775|NCT00365365|468444409|FG002|Overall Study|Poor compliance to protocol|0|||
130131776|NCT00365365|468444407|FG000|Overall Study|Lost to Follow-up|3|||
130131777|NCT00365365|468444408|FG001|Overall Study|Lost to Follow-up|3|||
130131778|NCT00365365|468444409|FG002|Overall Study|Lost to Follow-up|3|||
130131779|NCT00365365|468444407|FG000|Overall Study|Death|1|||
130131780|NCT00365365|468444408|FG001|Overall Study|Death|3|||
130131781|NCT00365365|468444409|FG002|Overall Study|Death|0|||
130131782|NCT00365365|468444407|FG000|Overall Study|Subject's request|11|||
130131783|NCT00365365|468444408|FG001|Overall Study|Subject's request|13|||
130131784|NCT00365365|468444409|FG002|Overall Study|Subject's request|1|||
130131785|NCT00365365|468444407|FG000|Overall Study|Disease progression/relapse|9|||
130131786|NCT00365365|468444408|FG001|Overall Study|Disease progression/relapse|6|||
130131787|NCT00365365|468444409|FG002|Overall Study|Disease progression/relapse|7|||
130131788|NCT00365365|468444407|FG000|Overall Study|Adverse Event|6|||
130131789|NCT00365365|468444408|FG001|Overall Study|Adverse Event|6|||
130131790|NCT00365365|468444409|FG002|Overall Study|Adverse Event|3|||
130131791|NCT00365365|468444407|FG000|Overall Study|Moved|2|||
130131792|NCT00365365|468444408|FG001|Overall Study|Moved|0|||
130131793|NCT00365365|468444409|FG002|Overall Study|Moved|0|||
130131794|NCT00365365|468444407|FG000|Overall Study|New cancer|1|||
130131795|NCT00365365|468444408|FG001|Overall Study|New cancer|0|||
130131796|NCT00365365|468444409|FG002|Overall Study|New cancer|0|||
130131797|NCT00365365|468444407|FG000|Overall Study|Withdrew consent|1|||
130131798|NCT00365365|468444408|FG001|Overall Study|Withdrew consent|1|||
130131799|NCT00365365|468444409|FG002|Overall Study|Withdrew consent|0|||
130131800|NCT00365365|468444407|FG000|Overall Study|Second malignancy|0|||
130131801|NCT00365365|468444408|FG001|Overall Study|Second malignancy|1|||
130131802|NCT00365365|468444409|FG002|Overall Study|Second malignancy|0|||
130131803|NCT00365365|468444407|FG000|Overall Study|Patient/physician decision|0|||
130131804|NCT00365365|468444408|FG001|Overall Study|Patient/physician decision|0|||
130131805|NCT00365365|468444409|FG002|Overall Study|Patient/physician decision|1|||
130131806|NCT00984022|468444410|FG000|Overall Study|Lost to Follow-up|10|||
130131807|NCT00984022|468444411|FG001|Overall Study|Lost to Follow-up|14|||
130131808|NCT00573443|468444412|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129971117|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
130131809|NCT00573443|468444413|FG001|Double-Blind Phase|Lost to Follow-up|3|||
130131810|NCT00573443|468444414|FG002|Double-Blind Phase|Lost to Follow-up|2|||
130131811|NCT00573443|468444412|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
130131812|NCT00573443|468444413|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
130131813|NCT00573443|468444414|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
130131814|NCT00573443|468444412|FG000|Double-Blind Phase|Adverse Event|1|||
130131815|NCT00573443|468444413|FG001|Double-Blind Phase|Adverse Event|5|||
130131816|NCT00573443|468444414|FG002|Double-Blind Phase|Adverse Event|0|||
130131817|NCT00573443|468444412|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
130131818|NCT00573443|468444413|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
130131819|NCT00573443|468444414|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
130131820|NCT00573443|468444412|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
130131821|NCT00573443|468444413|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
130131822|NCT00573443|468444414|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
130131823|NCT00573443|468444412|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
130131824|NCT00573443|468444413|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
130131825|NCT00573443|468444414|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
130131826|NCT00573443|468444412|FG000|Double-Blind Phase|Protocol Violation|0|||
130131827|NCT00573443|468444413|FG001|Double-Blind Phase|Protocol Violation|2|||
130131828|NCT00573443|468444414|FG002|Double-Blind Phase|Protocol Violation|1|||
130131829|NCT00573443|468444412|FG000|Double-Blind Phase|Other|0|||
130131830|NCT00573443|468444413|FG001|Double-Blind Phase|Other|2|||
130131831|NCT00573443|468444414|FG002|Double-Blind Phase|Other|3|||
130131832|NCT00573443|468444412|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
130131833|NCT00573443|468444413|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
130131834|NCT00573443|468444414|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
130131835|NCT00573443|468444412|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
130131836|NCT00573443|468444413|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
130131837|NCT00573443|468444414|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
130131838|NCT00573443|468444412|FG000|Open-Label Extension Phase|Adverse Event|3|||
130131839|NCT00573443|468444413|FG001|Open-Label Extension Phase|Adverse Event|0|||
130131840|NCT00573443|468444414|FG002|Open-Label Extension Phase|Adverse Event|0|||
130131841|NCT00573443|468444412|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
130131842|NCT00573443|468444413|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
130131843|NCT00573443|468444414|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
130131844|NCT00573443|468444412|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
130131845|NCT00573443|468444413|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
130131846|NCT00573443|468444414|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
130131847|NCT00573443|468444412|FG000|Open-Label Extension Phase|Protocol Violation|2|||
130131848|NCT00573443|468444413|FG001|Open-Label Extension Phase|Protocol Violation|0|||
130131849|NCT00573443|468444414|FG002|Open-Label Extension Phase|Protocol Violation|0|||
130131850|NCT00573443|468444412|FG000|Open-Label Extension Phase|Other|2|||
130131851|NCT00573443|468444413|FG001|Open-Label Extension Phase|Other|0|||
130131852|NCT00573443|468444414|FG002|Open-Label Extension Phase|Other|0|||
130131853|NCT00905606|468444418|FG000|Period 1|Adverse Event|0|||
130131854|NCT00905606|468444419|FG001|Period 1|Adverse Event|1|||
130131855|NCT00905606|468444418|FG000|Washout|Withdrawal by Subject|1|||
130131856|NCT00905606|468444419|FG001|Washout|Withdrawal by Subject|0|||
130131857|NCT00804856|468444422|FG000|Overall Study|Progressive Disease|3|||
130131858|NCT00804856|468444423|FG001|Overall Study|Progressive Disease|2|||
130131859|NCT00804856|468444424|FG002|Overall Study|Progressive Disease|4|||
130131860|NCT00804856|468444425|FG003|Overall Study|Progressive Disease|6|||
130131861|NCT00804856|468444426|FG004|Overall Study|Progressive Disease|4|||
130131862|NCT00804856|468444427|FG005|Overall Study|Progressive Disease|1|||
130131863|NCT00804856|468444428|FG006|Overall Study|Progressive Disease|8|||
130131864|NCT00804856|468444429|FG007|Overall Study|Progressive Disease|2|||
130131865|NCT00804856|468444430|FG008|Overall Study|Progressive Disease|4|||
130131866|NCT00804856|468444431|FG009|Overall Study|Progressive Disease|5|||
130131867|NCT00804856|468444432|FG010|Overall Study|Progressive Disease|12|||
130131868|NCT00804856|468444433|FG011|Overall Study|Progressive Disease|2|||
130131869|NCT00804856|468444434|FG012|Overall Study|Progressive Disease|2|||
130131870|NCT00804856|468444435|FG013|Overall Study|Progressive Disease|26|||
130131871|NCT00804856|468444436|FG014|Overall Study|Progressive Disease|20|||
130131872|NCT00804856|468444422|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131873|NCT00804856|468444423|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131874|NCT00804856|468444424|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131875|NCT00804856|468444425|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131876|NCT00804856|468444426|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130131877|NCT00804856|468444427|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131878|NCT00804856|468444428|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131879|NCT00804856|468444429|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131880|NCT00804856|468444430|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131881|NCT00804856|468444431|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131882|NCT00804856|468444432|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131883|NCT00804856|468444433|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131884|NCT00804856|468444434|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131885|NCT00804856|468444435|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
130131886|NCT00804856|468444436|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
130131887|NCT00804856|468444422|FG000|Overall Study|Other Adverse Event|1|||
130131888|NCT00804856|468444423|FG001|Overall Study|Other Adverse Event|1|||
130131889|NCT00804856|468444424|FG002|Overall Study|Other Adverse Event|1|||
130131890|NCT00804856|468444425|FG003|Overall Study|Other Adverse Event|2|||
130131891|NCT00804856|468444426|FG004|Overall Study|Other Adverse Event|2|||
130131892|NCT00804856|468444427|FG005|Overall Study|Other Adverse Event|1|||
130131893|NCT00804856|468444428|FG006|Overall Study|Other Adverse Event|3|||
130131894|NCT00804856|468444429|FG007|Overall Study|Other Adverse Event|0|||
130131895|NCT00804856|468444430|FG008|Overall Study|Other Adverse Event|0|||
130131896|NCT00804856|468444431|FG009|Overall Study|Other Adverse Event|1|||
130131897|NCT00804856|468444432|FG010|Overall Study|Other Adverse Event|5|||
130131898|NCT00804856|468444433|FG011|Overall Study|Other Adverse Event|2|||
130131899|NCT00804856|468444434|FG012|Overall Study|Other Adverse Event|0|||
130131900|NCT00804856|468444435|FG013|Overall Study|Other Adverse Event|6|||
130131901|NCT00804856|468444436|FG014|Overall Study|Other Adverse Event|13|||
130131902|NCT00804856|468444422|FG000|Overall Study|Non compliance with protocol|0|||
130131903|NCT00804856|468444423|FG001|Overall Study|Non compliance with protocol|0|||
130131904|NCT00804856|468444424|FG002|Overall Study|Non compliance with protocol|0|||
130131905|NCT00804856|468444425|FG003|Overall Study|Non compliance with protocol|0|||
130131906|NCT00804856|468444426|FG004|Overall Study|Non compliance with protocol|0|||
130131907|NCT00804856|468444427|FG005|Overall Study|Non compliance with protocol|0|||
130131908|NCT00804856|468444428|FG006|Overall Study|Non compliance with protocol|0|||
130131909|NCT00804856|468444429|FG007|Overall Study|Non compliance with protocol|0|||
130131910|NCT00804856|468444430|FG008|Overall Study|Non compliance with protocol|0|||
130131911|NCT00804856|468444431|FG009|Overall Study|Non compliance with protocol|0|||
130131912|NCT00804856|468444432|FG010|Overall Study|Non compliance with protocol|0|||
130131913|NCT00804856|468444433|FG011|Overall Study|Non compliance with protocol|0|||
130131914|NCT00804856|468444434|FG012|Overall Study|Non compliance with protocol|0|||
130131915|NCT00804856|468444435|FG013|Overall Study|Non compliance with protocol|2|||
130131916|NCT00804856|468444436|FG014|Overall Study|Non compliance with protocol|0|||
130131917|NCT00804856|468444422|FG000|Overall Study|Refused to continue medication|0|||
130131918|NCT00804856|468444423|FG001|Overall Study|Refused to continue medication|0|||
130131919|NCT00804856|468444424|FG002|Overall Study|Refused to continue medication|0|||
129971118|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
129971119|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
129971120|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
129971121|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
129971122|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
129971123|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
129971124|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
129971125|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
130131920|NCT00804856|468444425|FG003|Overall Study|Refused to continue medication|1|||
130131921|NCT00804856|468444426|FG004|Overall Study|Refused to continue medication|1|||
130131922|NCT00804856|468444427|FG005|Overall Study|Refused to continue medication|0|||
130131923|NCT00804856|468444428|FG006|Overall Study|Refused to continue medication|0|||
130131924|NCT00804856|468444429|FG007|Overall Study|Refused to continue medication|0|||
130131925|NCT00804856|468444430|FG008|Overall Study|Refused to continue medication|0|||
130131926|NCT00804856|468444431|FG009|Overall Study|Refused to continue medication|0|||
130131927|NCT00804856|468444432|FG010|Overall Study|Refused to continue medication|3|||
130131928|NCT00804856|468444433|FG011|Overall Study|Refused to continue medication|0|||
130131929|NCT00804856|468444434|FG012|Overall Study|Refused to continue medication|1|||
130131930|NCT00804856|468444435|FG013|Overall Study|Refused to continue medication|1|||
130131931|NCT00804856|468444436|FG014|Overall Study|Refused to continue medication|5|||
130131932|NCT00804856|468444422|FG000|Overall Study|Other reason than listed above|0|||
130131933|NCT00804856|468444423|FG001|Overall Study|Other reason than listed above|0|||
130131934|NCT00804856|468444424|FG002|Overall Study|Other reason than listed above|0|||
130131935|NCT00804856|468444425|FG003|Overall Study|Other reason than listed above|0|||
130131936|NCT00804856|468444426|FG004|Overall Study|Other reason than listed above|0|||
130131937|NCT00804856|468444427|FG005|Overall Study|Other reason than listed above|1|||
129971126|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
129971127|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
129971128|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
129971129|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
129971130|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
130131938|NCT00804856|468444428|FG006|Overall Study|Other reason than listed above|0|||
130131939|NCT00804856|468444429|FG007|Overall Study|Other reason than listed above|0|||
130131940|NCT00804856|468444430|FG008|Overall Study|Other reason than listed above|1|||
130131941|NCT00804856|468444431|FG009|Overall Study|Other reason than listed above|0|||
130131942|NCT00804856|468444432|FG010|Overall Study|Other reason than listed above|3|||
130131943|NCT00804856|468444433|FG011|Overall Study|Other reason than listed above|1|||
130131944|NCT00804856|468444434|FG012|Overall Study|Other reason than listed above|1|||
130131945|NCT00804856|468444435|FG013|Overall Study|Other reason than listed above|10|||
130131946|NCT00804856|468444436|FG014|Overall Study|Other reason than listed above|3|||
130131947|NCT00418561|468444437|FG000|Overall Study|Participant's (guardian's) decision|0|||
130131948|NCT00418561|468444438|FG001|Overall Study|Participant's (guardian's) decision|1|||
130131949|NCT00418561|468444439|FG002|Overall Study|Participant's (guardian's) decision|0|||
130131950|NCT01796171|468444440|FG000|Enrolled|Death|0|||
130131951|NCT01796171|468444441|FG001|Enrolled|Death|0|||
130131952|NCT01796171|468444442|FG002|Enrolled|Death|0|||
130131953|NCT01796171|468444443|FG003|Enrolled|Death|0|||
130131954|NCT01796171|468444444|FG004|Enrolled|Death|0|||
130131955|NCT01796171|468444445|FG005|Enrolled|Death|0|||
130131956|NCT01796171|468444446|FG006|Enrolled|Death|0|||
130131957|NCT01796171|468444447|FG007|Enrolled|Death|0|||
130131958|NCT01796171|468444448|FG008|Enrolled|Death|0|||
130131959|NCT01796171|468444449|FG009|Enrolled|Death|0|||
130131960|NCT01796171|468444450|FG010|Enrolled|Death|0|||
130131961|NCT01796171|468444451|FG011|Enrolled|Death|0|||
130131962|NCT01796171|468444452|FG012|Enrolled|Death|0|||
130131963|NCT01796171|468444453|FG013|Enrolled|Death|0|||
130131964|NCT01796171|468444454|FG014|Enrolled|Death|1|||
130131965|NCT01796171|468444440|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
130131966|NCT01796171|468444441|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
130131967|NCT01796171|468444442|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
130131968|NCT01796171|468444443|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
130131969|NCT01796171|468444444|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
130131970|NCT01796171|468444445|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
130131971|NCT01796171|468444446|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
130131972|NCT01796171|468444447|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
130131973|NCT01796171|468444448|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
130131974|NCT01796171|468444449|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
130131975|NCT01796171|468444450|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
130131976|NCT01796171|468444451|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
130131977|NCT01796171|468444452|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
130131978|NCT01796171|468444453|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
130131979|NCT01796171|468444454|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
130131980|NCT01796171|468444440|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131981|NCT01796171|468444441|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131982|NCT01796171|468444442|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131983|NCT01796171|468444443|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131984|NCT01796171|468444444|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131985|NCT01796171|468444445|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131986|NCT01796171|468444446|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131987|NCT01796171|468444447|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131988|NCT01796171|468444448|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131989|NCT01796171|468444449|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131990|NCT01796171|468444450|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131991|NCT01796171|468444451|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131992|NCT01796171|468444452|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131993|NCT01796171|468444453|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
130131994|NCT01796171|468444454|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
130131995|NCT01796171|468444440|FG000|Treatment Period With Betalutin|Progressive disease|0|||
130131996|NCT01796171|468444441|FG001|Treatment Period With Betalutin|Progressive disease|1|||
130131997|NCT01796171|468444442|FG002|Treatment Period With Betalutin|Progressive disease|0|||
130131998|NCT01796171|468444443|FG003|Treatment Period With Betalutin|Progressive disease|0|||
130131999|NCT01796171|468444444|FG004|Treatment Period With Betalutin|Progressive disease|0|||
130132000|NCT01796171|468444445|FG005|Treatment Period With Betalutin|Progressive disease|0|||
130132001|NCT01796171|468444446|FG006|Treatment Period With Betalutin|Progressive disease|0|||
130132002|NCT01796171|468444447|FG007|Treatment Period With Betalutin|Progressive disease|0|||
130132003|NCT01796171|468444448|FG008|Treatment Period With Betalutin|Progressive disease|0|||
130132004|NCT01796171|468444449|FG009|Treatment Period With Betalutin|Progressive disease|0|||
130132005|NCT01796171|468444450|FG010|Treatment Period With Betalutin|Progressive disease|0|||
130132006|NCT01796171|468444451|FG011|Treatment Period With Betalutin|Progressive disease|0|||
130132007|NCT01796171|468444452|FG012|Treatment Period With Betalutin|Progressive disease|0|||
129971131|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
129971132|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
129971133|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
130132008|NCT01796171|468444453|FG013|Treatment Period With Betalutin|Progressive disease|0|||
130132009|NCT01796171|468444454|FG014|Treatment Period With Betalutin|Progressive disease|0|||
130132010|NCT01796171|468444440|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132011|NCT01796171|468444441|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132012|NCT01796171|468444442|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132013|NCT01796171|468444443|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132014|NCT01796171|468444444|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132015|NCT01796171|468444445|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132016|NCT01796171|468444446|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132017|NCT01796171|468444447|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132018|NCT01796171|468444448|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130132019|NCT01796171|468444449|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132020|NCT01796171|468444450|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130132021|NCT01796171|468444451|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
130132022|NCT01796171|468444452|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132023|NCT01796171|468444453|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132024|NCT01796171|468444454|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
130132025|NCT01796171|468444440|FG000|Treatment Period With Betalutin|Physician Decision|0|||
130132026|NCT01796171|468444441|FG001|Treatment Period With Betalutin|Physician Decision|0|||
130132027|NCT01796171|468444442|FG002|Treatment Period With Betalutin|Physician Decision|0|||
130132028|NCT01796171|468444443|FG003|Treatment Period With Betalutin|Physician Decision|0|||
130132029|NCT01796171|468444444|FG004|Treatment Period With Betalutin|Physician Decision|0|||
130132030|NCT01796171|468444445|FG005|Treatment Period With Betalutin|Physician Decision|0|||
130132031|NCT01796171|468444446|FG006|Treatment Period With Betalutin|Physician Decision|0|||
130132032|NCT01796171|468444447|FG007|Treatment Period With Betalutin|Physician Decision|0|||
130132033|NCT01796171|468444448|FG008|Treatment Period With Betalutin|Physician Decision|0|||
130132034|NCT01796171|468444449|FG009|Treatment Period With Betalutin|Physician Decision|0|||
130132035|NCT01796171|468444450|FG010|Treatment Period With Betalutin|Physician Decision|5|||
130132036|NCT01796171|468444451|FG011|Treatment Period With Betalutin|Physician Decision|1|||
130132037|NCT01796171|468444452|FG012|Treatment Period With Betalutin|Physician Decision|1|||
130132038|NCT01796171|468444453|FG013|Treatment Period With Betalutin|Physician Decision|0|||
130132039|NCT01796171|468444454|FG014|Treatment Period With Betalutin|Physician Decision|0|||
130132040|NCT01796171|468444440|FG000|Treatment Period With Betalutin|Death|0|||
130132041|NCT01796171|468444441|FG001|Treatment Period With Betalutin|Death|0|||
130132042|NCT01796171|468444442|FG002|Treatment Period With Betalutin|Death|0|||
130132043|NCT01796171|468444443|FG003|Treatment Period With Betalutin|Death|0|||
130132044|NCT01796171|468444444|FG004|Treatment Period With Betalutin|Death|0|||
130132045|NCT01796171|468444445|FG005|Treatment Period With Betalutin|Death|0|||
130132046|NCT01796171|468444446|FG006|Treatment Period With Betalutin|Death|0|||
130132047|NCT01796171|468444447|FG007|Treatment Period With Betalutin|Death|0|||
130132048|NCT01796171|468444448|FG008|Treatment Period With Betalutin|Death|0|||
130132049|NCT01796171|468444449|FG009|Treatment Period With Betalutin|Death|0|||
130132050|NCT01796171|468444450|FG010|Treatment Period With Betalutin|Death|2|||
130132051|NCT01796171|468444451|FG011|Treatment Period With Betalutin|Death|0|||
130132052|NCT01796171|468444452|FG012|Treatment Period With Betalutin|Death|0|||
130132053|NCT01796171|468444453|FG013|Treatment Period With Betalutin|Death|0|||
130132054|NCT01796171|468444454|FG014|Treatment Period With Betalutin|Death|0|||
130132055|NCT01796171|468444440|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
130132056|NCT01796171|468444441|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
130132057|NCT01796171|468444442|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
130132058|NCT01796171|468444443|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
130132059|NCT01796171|468444444|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
130132060|NCT01796171|468444445|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
130132061|NCT01796171|468444446|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
130132062|NCT01796171|468444447|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
130132063|NCT01796171|468444448|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
130132064|NCT01796171|468444449|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
130132065|NCT01796171|468444450|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
130132066|NCT01796171|468444451|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
130132067|NCT01796171|468444452|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
130132068|NCT01796171|468444453|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
130132069|NCT01796171|468444454|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
130132070|NCT01796171|468444440|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132071|NCT01796171|468444441|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132072|NCT01796171|468444442|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132073|NCT01796171|468444443|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132074|NCT01796171|468444444|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132075|NCT01796171|468444445|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132076|NCT01796171|468444446|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132077|NCT01796171|468444447|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132078|NCT01796171|468444448|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132079|NCT01796171|468444449|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132080|NCT01796171|468444450|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
130132081|NCT01796171|468444451|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
130132082|NCT01796171|468444452|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132083|NCT01796171|468444453|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132084|NCT01796171|468444454|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
130132085|NCT01796171|468444440|FG000|Follow-up Period|Start of further anticancer therapy|4|||
130132086|NCT01796171|468444441|FG001|Follow-up Period|Start of further anticancer therapy|25|||
130132087|NCT01796171|468444442|FG002|Follow-up Period|Start of further anticancer therapy|2|||
130132088|NCT01796171|468444443|FG003|Follow-up Period|Start of further anticancer therapy|1|||
130132089|NCT01796171|468444444|FG004|Follow-up Period|Start of further anticancer therapy|2|||
130132090|NCT01796171|468444445|FG005|Follow-up Period|Start of further anticancer therapy|2|||
130132091|NCT01796171|468444446|FG006|Follow-up Period|Start of further anticancer therapy|1|||
130132092|NCT01796171|468444447|FG007|Follow-up Period|Start of further anticancer therapy|15|||
130132093|NCT01796171|468444448|FG008|Follow-up Period|Start of further anticancer therapy|2|||
130132094|NCT01796171|468444449|FG009|Follow-up Period|Start of further anticancer therapy|0|||
130132095|NCT01796171|468444450|FG010|Follow-up Period|Start of further anticancer therapy|0|||
130132096|NCT01796171|468444451|FG011|Follow-up Period|Start of further anticancer therapy|0|||
130132097|NCT01796171|468444452|FG012|Follow-up Period|Start of further anticancer therapy|0|||
130132098|NCT01796171|468444453|FG013|Follow-up Period|Start of further anticancer therapy|0|||
130132099|NCT01796171|468444454|FG014|Follow-up Period|Start of further anticancer therapy|0|||
130132100|NCT01796171|468444440|FG000|Follow-up Period|Progressive disease|0|||
130132101|NCT01796171|468444441|FG001|Follow-up Period|Progressive disease|1|||
130132102|NCT01796171|468444442|FG002|Follow-up Period|Progressive disease|0|||
130132103|NCT01796171|468444443|FG003|Follow-up Period|Progressive disease|0|||
130132104|NCT01796171|468444444|FG004|Follow-up Period|Progressive disease|0|||
130132105|NCT01796171|468444445|FG005|Follow-up Period|Progressive disease|0|||
130132106|NCT01796171|468444446|FG006|Follow-up Period|Progressive disease|0|||
130132107|NCT01796171|468444447|FG007|Follow-up Period|Progressive disease|3|||
130132108|NCT01796171|468444448|FG008|Follow-up Period|Progressive disease|0|||
130132109|NCT01796171|468444449|FG009|Follow-up Period|Progressive disease|0|||
130132110|NCT01796171|468444450|FG010|Follow-up Period|Progressive disease|0|||
130132111|NCT01796171|468444451|FG011|Follow-up Period|Progressive disease|0|||
130132112|NCT01796171|468444452|FG012|Follow-up Period|Progressive disease|0|||
130132113|NCT01796171|468444453|FG013|Follow-up Period|Progressive disease|0|||
130132114|NCT01796171|468444454|FG014|Follow-up Period|Progressive disease|0|||
130132115|NCT01796171|468444440|FG000|Follow-up Period|Physician Decision|0|||
130132116|NCT01796171|468444441|FG001|Follow-up Period|Physician Decision|2|||
130132117|NCT01796171|468444442|FG002|Follow-up Period|Physician Decision|0|||
130132118|NCT01796171|468444443|FG003|Follow-up Period|Physician Decision|0|||
130132119|NCT01796171|468444444|FG004|Follow-up Period|Physician Decision|0|||
130132120|NCT01796171|468444445|FG005|Follow-up Period|Physician Decision|0|||
130132121|NCT01796171|468444446|FG006|Follow-up Period|Physician Decision|0|||
130132122|NCT01796171|468444447|FG007|Follow-up Period|Physician Decision|0|||
130132123|NCT01796171|468444448|FG008|Follow-up Period|Physician Decision|0|||
130132124|NCT01796171|468444449|FG009|Follow-up Period|Physician Decision|0|||
130132125|NCT01796171|468444450|FG010|Follow-up Period|Physician Decision|5|||
130132126|NCT01796171|468444451|FG011|Follow-up Period|Physician Decision|0|||
130132127|NCT01796171|468444452|FG012|Follow-up Period|Physician Decision|0|||
130132128|NCT01796171|468444453|FG013|Follow-up Period|Physician Decision|0|||
130132129|NCT01796171|468444454|FG014|Follow-up Period|Physician Decision|0|||
130132130|NCT01796171|468444440|FG000|Follow-up Period|Withdrawal by Subject|0|||
130132131|NCT01796171|468444441|FG001|Follow-up Period|Withdrawal by Subject|1|||
130132132|NCT01796171|468444442|FG002|Follow-up Period|Withdrawal by Subject|0|||
130132133|NCT01796171|468444443|FG003|Follow-up Period|Withdrawal by Subject|0|||
130132134|NCT01796171|468444444|FG004|Follow-up Period|Withdrawal by Subject|0|||
130132135|NCT01796171|468444445|FG005|Follow-up Period|Withdrawal by Subject|1|||
130132136|NCT01796171|468444446|FG006|Follow-up Period|Withdrawal by Subject|0|||
130132137|NCT01796171|468444447|FG007|Follow-up Period|Withdrawal by Subject|0|||
130132138|NCT01796171|468444448|FG008|Follow-up Period|Withdrawal by Subject|0|||
130132139|NCT01796171|468444449|FG009|Follow-up Period|Withdrawal by Subject|0|||
130132140|NCT01796171|468444450|FG010|Follow-up Period|Withdrawal by Subject|3|||
130132141|NCT01796171|468444451|FG011|Follow-up Period|Withdrawal by Subject|1|||
130132142|NCT01796171|468444452|FG012|Follow-up Period|Withdrawal by Subject|0|||
130132143|NCT01796171|468444453|FG013|Follow-up Period|Withdrawal by Subject|0|||
130132144|NCT01796171|468444454|FG014|Follow-up Period|Withdrawal by Subject|0|||
130132145|NCT01796171|468444440|FG000|Follow-up Period|Death|0|||
129971134|NCT02783573|467858394|FG000|Delayed-Start Period|Sponsor Decision|0|||
129971135|NCT02783573|467858395|FG001|Delayed-Start Period|Sponsor Decision|17|||
129971136|NCT02783573|467858396|FG002|Delayed-Start Period|Sponsor Decision|12|||
129971137|NCT00233480|467858397|FG000|Overall Study|Underwent status II heart transplant|0|||
129971138|NCT00233480|467858398|FG001|Overall Study|Underwent status II heart transplant|1|||
129971139|NCT00581893|467858399|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
129971140|NCT00581893|467858400|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
129971141|NCT02797522|467858408|FG000|Overall Study|Study Terminated by Sponsor|0|||
130132146|NCT01796171|468444441|FG001|Follow-up Period|Death|0|||
130132147|NCT01796171|468444442|FG002|Follow-up Period|Death|0|||
130132148|NCT01796171|468444443|FG003|Follow-up Period|Death|0|||
130132149|NCT01796171|468444444|FG004|Follow-up Period|Death|0|||
130132150|NCT01796171|468444445|FG005|Follow-up Period|Death|0|||
130132151|NCT01796171|468444446|FG006|Follow-up Period|Death|1|||
130132152|NCT01796171|468444447|FG007|Follow-up Period|Death|0|||
130132153|NCT01796171|468444448|FG008|Follow-up Period|Death|0|||
130132154|NCT01796171|468444449|FG009|Follow-up Period|Death|0|||
130132155|NCT01796171|468444450|FG010|Follow-up Period|Death|17|||
130132156|NCT01796171|468444451|FG011|Follow-up Period|Death|9|||
130132157|NCT01796171|468444452|FG012|Follow-up Period|Death|1|||
130132158|NCT01796171|468444453|FG013|Follow-up Period|Death|0|||
130132159|NCT01796171|468444454|FG014|Follow-up Period|Death|0|||
130132160|NCT01796171|468444440|FG000|Follow-up Period|Patient transferred to other hospital|0|||
130132161|NCT01796171|468444441|FG001|Follow-up Period|Patient transferred to other hospital|1|||
130132162|NCT01796171|468444442|FG002|Follow-up Period|Patient transferred to other hospital|0|||
130132163|NCT01796171|468444443|FG003|Follow-up Period|Patient transferred to other hospital|0|||
130132164|NCT01796171|468444444|FG004|Follow-up Period|Patient transferred to other hospital|0|||
130132165|NCT01796171|468444445|FG005|Follow-up Period|Patient transferred to other hospital|0|||
130132166|NCT01796171|468444446|FG006|Follow-up Period|Patient transferred to other hospital|0|||
130132167|NCT01796171|468444447|FG007|Follow-up Period|Patient transferred to other hospital|0|||
130132168|NCT01796171|468444448|FG008|Follow-up Period|Patient transferred to other hospital|0|||
130132169|NCT01796171|468444449|FG009|Follow-up Period|Patient transferred to other hospital|0|||
130132170|NCT01796171|468444450|FG010|Follow-up Period|Patient transferred to other hospital|0|||
130132171|NCT01796171|468444451|FG011|Follow-up Period|Patient transferred to other hospital|0|||
130132172|NCT01796171|468444452|FG012|Follow-up Period|Patient transferred to other hospital|0|||
130132173|NCT01796171|468444453|FG013|Follow-up Period|Patient transferred to other hospital|0|||
130132174|NCT01796171|468444454|FG014|Follow-up Period|Patient transferred to other hospital|0|||
130132175|NCT01796171|468444440|FG000|Follow-up Period|Sponsor Decision|0|||
130132176|NCT01796171|468444441|FG001|Follow-up Period|Sponsor Decision|0|||
130132177|NCT01796171|468444442|FG002|Follow-up Period|Sponsor Decision|0|||
130132178|NCT01796171|468444443|FG003|Follow-up Period|Sponsor Decision|0|||
130132179|NCT01796171|468444444|FG004|Follow-up Period|Sponsor Decision|0|||
130132180|NCT01796171|468444445|FG005|Follow-up Period|Sponsor Decision|0|||
130132181|NCT01796171|468444446|FG006|Follow-up Period|Sponsor Decision|0|||
130132182|NCT01796171|468444447|FG007|Follow-up Period|Sponsor Decision|0|||
130132183|NCT01796171|468444448|FG008|Follow-up Period|Sponsor Decision|0|||
130132184|NCT01796171|468444449|FG009|Follow-up Period|Sponsor Decision|0|||
130132185|NCT01796171|468444450|FG010|Follow-up Period|Sponsor Decision|40|||
130132186|NCT01796171|468444451|FG011|Follow-up Period|Sponsor Decision|15|||
130132187|NCT01796171|468444452|FG012|Follow-up Period|Sponsor Decision|7|||
130132188|NCT01796171|468444453|FG013|Follow-up Period|Sponsor Decision|0|||
130132189|NCT01796171|468444454|FG014|Follow-up Period|Sponsor Decision|0|||
130132190|NCT00829309|468444455|FG000|Washout: 7 Days|Protocol Violation|1|||
130132191|NCT00829309|468444456|FG001|Washout: 7 Days|Protocol Violation|0|||
130132192|NCT01558635|468444459|FG000|Overall Study|Death|1|||
130132193|NCT01558635|468444459|FG000|Overall Study|Withdrawal by Subject|2|||
130132194|NCT01558635|468444459|FG000|Overall Study|Physician Decision|1|||
130132195|NCT01558635|468444459|FG000|Overall Study|Subject received other treatment|1|||
130132196|NCT01558635|468444459|FG000|Overall Study|Reveal XT was explanted|1|||
130132197|NCT00455312|468444460|FG000|Overall Study|Death|0|||
130132198|NCT00455312|468444461|FG001|Overall Study|Death|1|||
130132199|NCT01693523|468444462|FG000|Overall Study|Adverse Event|2|||
130132200|NCT01693523|468444463|FG001|Overall Study|Adverse Event|1|||
130132201|NCT01693523|468444464|FG002|Overall Study|Adverse Event|0|||
130132202|NCT01693523|468444462|FG000|Overall Study|Death|0|||
130132203|NCT01693523|468444463|FG001|Overall Study|Death|1|||
130132204|NCT01693523|468444464|FG002|Overall Study|Death|1|||
130132205|NCT01693523|468444462|FG000|Overall Study|Lost to Follow-up|0|||
130132206|NCT01693523|468444463|FG001|Overall Study|Lost to Follow-up|0|||
130132207|NCT01693523|468444464|FG002|Overall Study|Lost to Follow-up|4|||
130132208|NCT01693523|468444462|FG000|Overall Study|Physician Decision|0|||
130132209|NCT01693523|468444463|FG001|Overall Study|Physician Decision|0|||
130132210|NCT01693523|468444464|FG002|Overall Study|Physician Decision|1|||
130132211|NCT01693523|468444462|FG000|Overall Study|Withdrawal by Subject|1|||
130132212|NCT01693523|468444463|FG001|Overall Study|Withdrawal by Subject|2|||
130132213|NCT01693523|468444464|FG002|Overall Study|Withdrawal by Subject|2|||
130132214|NCT01693523|468444462|FG000|Overall Study|Lack of compliance study medication|1|||
130132215|NCT01693523|468444463|FG001|Overall Study|Lack of compliance study medication|2|||
130132216|NCT01693523|468444464|FG002|Overall Study|Lack of compliance study medication|0|||
130132217|NCT01693523|468444462|FG000|Overall Study|Chemotherapy was held|1|||
130132218|NCT01693523|468444463|FG001|Overall Study|Chemotherapy was held|2|||
130132219|NCT01693523|468444464|FG002|Overall Study|Chemotherapy was held|0|||
130132220|NCT03343535|468444465|FG000|Overall Study|Lost to Follow-up|1|||
130132221|NCT03343535|468444465|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
130132222|NCT03343535|468444465|FG000|Overall Study|Death|12|||
130132223|NCT03699020|468444467|FG000|Overall Study|Withdrawal by Subject|3|||
130132224|NCT03699020|468444468|FG001|Overall Study|Withdrawal by Subject|2|||
130132225|NCT02246920|468444469|FG000|Overall Study|Adverse Event|3|||
130132226|NCT02246920|468444470|FG001|Overall Study|Adverse Event|1|||
130132227|NCT02246920|468444471|FG002|Overall Study|Adverse Event|1|||
130132228|NCT02246920|468444469|FG000|Overall Study|Lost to Follow-up|2|||
130132229|NCT02246920|468444470|FG001|Overall Study|Lost to Follow-up|1|||
130132230|NCT02246920|468444471|FG002|Overall Study|Lost to Follow-up|0|||
130132231|NCT02246920|468444469|FG000|Overall Study|Protocol Violation|2|||
130132232|NCT02246920|468444470|FG001|Overall Study|Protocol Violation|5|||
130132233|NCT02246920|468444471|FG002|Overall Study|Protocol Violation|1|||
130132234|NCT02246920|468444469|FG000|Overall Study|Withdrawal by Subject|0|||
130132235|NCT02246920|468444470|FG001|Overall Study|Withdrawal by Subject|0|||
130132236|NCT02246920|468444471|FG002|Overall Study|Withdrawal by Subject|1|||
130132237|NCT01037114|468444474|FG000|Year 20|Others|1|||
130132238|NCT03620747|468444476|FG000|Overall Study|Participant decision|7|||
130132239|NCT03620747|468444476|FG000|Overall Study|Adverse Event|6|||
130132240|NCT03620747|468444476|FG000|Overall Study|Lack of Efficacy|1|||
130132241|NCT03620747|468444476|FG000|Overall Study|Poor compliance to protocol|2|||
130132242|NCT03620747|468444476|FG000|Overall Study|Other-unspecified|3|||
130132243|NCT00640562|468444479|FG000|Overall Study|Adverse Event|8|||
130132244|NCT00640562|468444480|FG001|Overall Study|Adverse Event|5|||
130132245|NCT00640562|468444479|FG000|Overall Study|Lack of Efficacy|1|||
130132246|NCT00640562|468444480|FG001|Overall Study|Lack of Efficacy|4|||
130132247|NCT00640562|468444479|FG000|Overall Study|Protocol Violation|2|||
130132248|NCT00640562|468444480|FG001|Overall Study|Protocol Violation|4|||
130132249|NCT00640562|468444479|FG000|Overall Study|Withdrawal by Subject|6|||
130132250|NCT00640562|468444480|FG001|Overall Study|Withdrawal by Subject|10|||
130132251|NCT00640562|468444479|FG000|Overall Study|Known risperidone intolerance|0|||
130132252|NCT00640562|468444480|FG001|Overall Study|Known risperidone intolerance|1|||
130132253|NCT00640562|468444479|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
130132254|NCT00640562|468444480|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
130132255|NCT00640562|468444479|FG000|Overall Study|Low study drug dose|0|||
130132256|NCT00640562|468444480|FG001|Overall Study|Low study drug dose|1|||
130132257|NCT00640562|468444479|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
130132258|NCT00640562|468444480|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
130132259|NCT02937870|468444481|FG000|Overall Study|Adverse Event|1|||
130132260|NCT02937870|468444481|FG000|Overall Study|Protocol Deviation|2|||
130132261|NCT03098394|468444482|FG000|Overall Study|Pregnancy|0|||
130132262|NCT03098394|468444483|FG001|Overall Study|Pregnancy|1|||
130132263|NCT00609674|468444484|FG000|Overall Study|Adverse Event|1|||
130132264|NCT00609674|468444485|FG001|Overall Study|Adverse Event|1|||
130132265|NCT00609674|468444484|FG000|Overall Study|Protocol Violation|3|||
130132266|NCT00609674|468444485|FG001|Overall Study|Protocol Violation|5|||
130132267|NCT00609674|468444484|FG000|Overall Study|Lost to Follow-up|1|||
130132268|NCT00609674|468444485|FG001|Overall Study|Lost to Follow-up|0|||
130132269|NCT00609674|468444484|FG000|Overall Study|Withdrew consent|2|||
130132270|NCT00609674|468444485|FG001|Overall Study|Withdrew consent|1|||
130132271|NCT00571064|468444487|FG000|Overall Study|Adverse Event|13|||
130132272|NCT00571064|468444487|FG000|Overall Study|Protocol Violation|4|||
130132273|NCT00571064|468444487|FG000|Overall Study|Withdrawal by Subject|2|||
130132274|NCT00571064|468444487|FG000|Overall Study|Other|2|||
130132275|NCT00244764|468444488|FG000|Overall Study|Adverse Event|37|||
130132276|NCT00244764|468444488|FG000|Overall Study|Lost to Follow-up|23|||
130132277|NCT00244764|468444488|FG000|Overall Study|Withdrawal by Subject|12|||
130132278|NCT00244764|468444488|FG000|Overall Study|Disease Progression|13|||
130132279|NCT00244764|468444488|FG000|Overall Study|Protocol Violation|2|||
130132280|NCT00244764|468444488|FG000|Overall Study|Death|1|||
130132281|NCT00244764|468444488|FG000|Overall Study|Off Study Medication for >21 Days|1|||
130132282|NCT00244764|468444488|FG000|Overall Study|Declining Performance Status|1|||
130132283|NCT00244764|468444488|FG000|Overall Study|Participant was Hospitalized until Death|1|||
130132284|NCT00244764|468444488|FG000|Overall Study|Primary Investigator Discretion|2|||
130132285|NCT00244764|468444488|FG000|Overall Study|Sponsor Terminated Study|2|||
130132286|NCT00244764|468444488|FG000|Overall Study|Developed Secondary Malignancy|1|||
130132287|NCT03872128|468444491|FG000|Overall Study|Dropped out before treatment|1|||
130132288|NCT03872128|468444492|FG001|Overall Study|Dropped out before treatment|0|||
130132289|NCT03872128|468444493|FG002|Overall Study|Dropped out before treatment|4|||
130132290|NCT03872128|468444491|FG000|Overall Study|Lost to Follow-up|2|||
130132291|NCT03872128|468444492|FG001|Overall Study|Lost to Follow-up|5|||
130132292|NCT03872128|468444493|FG002|Overall Study|Lost to Follow-up|8|||
130132293|NCT03285594|468444494|FG000|Overall Study|At the Participant's Own Request|10|||
130132294|NCT03285594|468444495|FG001|Overall Study|At the Participant's Own Request|5|||
130132295|NCT03285594|468444496|FG002|Overall Study|At the Participant's Own Request|21|||
130132296|NCT03285594|468444494|FG000|Overall Study|Adverse Event|2|||
130132297|NCT03285594|468444495|FG001|Overall Study|Adverse Event|2|||
130132298|NCT03285594|468444496|FG002|Overall Study|Adverse Event|6|||
130132299|NCT03285594|468444494|FG000|Overall Study|Poor Compliance to Protocol|0|||
130132300|NCT03285594|468444495|FG001|Overall Study|Poor Compliance to Protocol|0|||
130132301|NCT03285594|468444496|FG002|Overall Study|Poor Compliance to Protocol|1|||
130132302|NCT03285594|468444494|FG000|Overall Study|Lost to Follow-up|0|||
130132303|NCT03285594|468444495|FG001|Overall Study|Lost to Follow-up|0|||
130132304|NCT03285594|468444496|FG002|Overall Study|Lost to Follow-up|1|||
130132305|NCT03285594|468444494|FG000|Overall Study|Reason Not Specified|3|||
130132306|NCT03285594|468444495|FG001|Overall Study|Reason Not Specified|4|||
130132307|NCT03285594|468444496|FG002|Overall Study|Reason Not Specified|8|||
130132308|NCT02648438|468444501|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130132309|NCT02648438|468444502|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130132310|NCT02648438|468444503|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130132311|NCT02648438|468444501|FG000|Overall Study|Protocol Violation|2|||
130132312|NCT02648438|468444502|FG001|Overall Study|Protocol Violation|0|||
130132313|NCT02648438|468444503|FG002|Overall Study|Protocol Violation|0|||
130132314|NCT02648438|468444501|FG000|Overall Study|Withdrawal by Subject|1|||
130132315|NCT02648438|468444502|FG001|Overall Study|Withdrawal by Subject|1|||
130132316|NCT02648438|468444503|FG002|Overall Study|Withdrawal by Subject|0|||
130132317|NCT02258074|468444504|FG000|Overall Study|Withdrawal by Subject|1|||
130132318|NCT02258074|468444505|FG001|Overall Study|Withdrawal by Subject|0|||
130132319|NCT02258074|468444506|FG002|Overall Study|Withdrawal by Subject|0|||
130132320|NCT02258074|468444507|FG003|Overall Study|Withdrawal by Subject|0|||
130132321|NCT02739997|468444508|FG000|Overall Study|Death|1|||
130132322|NCT02739997|468444508|FG000|Overall Study|Withdrawal by Subject|1|||
130132323|NCT03552393|468444511|FG000|Core Period|Kidney Transplant|1|||
130132324|NCT03552393|468444511|FG000|Core Period|Prohibited Medication|1|||
130132325|NCT03552393|468444511|FG000|Safety Extension Period|Kidney Transplant|4|||
130132326|NCT02601625|468444512|FG000|Overall Study|Lost to Follow-up|0|||
130132327|NCT02601625|468444513|FG001|Overall Study|Lost to Follow-up|0|||
130132328|NCT02601625|468444514|FG002|Overall Study|Lost to Follow-up|1|||
130132329|NCT02601625|468444515|FG003|Overall Study|Lost to Follow-up|1|||
130132330|NCT00359281|468444516|FG000|Overall Study|Adverse Event|1|||
130132331|NCT00359281|468444517|FG001|Overall Study|Adverse Event|0|||
130132332|NCT00359281|468444518|FG002|Overall Study|Adverse Event|0|||
130132333|NCT00359281|468444519|FG003|Overall Study|Adverse Event|0|||
130132334|NCT00359281|468444520|FG004|Overall Study|Adverse Event|0|||
130132335|NCT00359281|468444521|FG005|Overall Study|Adverse Event|0|||
130132336|NCT00359281|468444522|FG006|Overall Study|Adverse Event|1|||
130132337|NCT00359281|468444523|FG007|Overall Study|Adverse Event|0|||
130132338|NCT00359281|468444524|FG008|Overall Study|Adverse Event|0|||
130132339|NCT00359281|468444516|FG000|Overall Study|Withdrawal by Subject|0|||
130132340|NCT00359281|468444517|FG001|Overall Study|Withdrawal by Subject|0|||
130132341|NCT00359281|468444518|FG002|Overall Study|Withdrawal by Subject|0|||
130132342|NCT00359281|468444519|FG003|Overall Study|Withdrawal by Subject|0|||
130132343|NCT00359281|468444520|FG004|Overall Study|Withdrawal by Subject|0|||
130132344|NCT00359281|468444521|FG005|Overall Study|Withdrawal by Subject|0|||
130132345|NCT00359281|468444522|FG006|Overall Study|Withdrawal by Subject|1|||
130132346|NCT00359281|468444523|FG007|Overall Study|Withdrawal by Subject|0|||
130132347|NCT00359281|468444524|FG008|Overall Study|Withdrawal by Subject|0|||
130132348|NCT04887415|468444526|FG000|Overall Study|Lost to Follow-up|2|||
130132349|NCT04608188|468444527|FG000|Overall Study|Withdrawal by Subject|4|||
130132350|NCT04608188|468444528|FG001|Overall Study|Withdrawal by Subject|8|||
130132351|NCT01250912|468444532|FG000|Overall Study|Lost to Follow-up|1|||
130132352|NCT03122457|468444533|FG000|Overall Study|Withdrawal by Subject|6|||
130132353|NCT02674152|468445869|FG000|Overall Study|Personal Reasons|1|||
130132354|NCT02674152|468445870|FG001|Overall Study|Personal Reasons|0|||
130132355|NCT02674152|468445871|FG002|Overall Study|Personal Reasons|0|||
130132356|NCT02674152|468445872|FG003|Overall Study|Personal Reasons|1|||
130132357|NCT02674152|468445873|FG004|Overall Study|Personal Reasons|1|||
130132358|NCT02674152|468445869|FG000|Overall Study|Other adverse event or clinical progression|0|||
130132359|NCT02674152|468445870|FG001|Overall Study|Other adverse event or clinical progression|1|||
130132360|NCT02674152|468445871|FG002|Overall Study|Other adverse event or clinical progression|0|||
130132361|NCT02674152|468445872|FG003|Overall Study|Other adverse event or clinical progression|3|||
130132362|NCT02674152|468445873|FG004|Overall Study|Other adverse event or clinical progression|0|||
130132363|NCT02674152|468445869|FG000|Overall Study|Dose-limiting toxicity|0|||
130132364|NCT02674152|468445870|FG001|Overall Study|Dose-limiting toxicity|0|||
130132365|NCT02674152|468445871|FG002|Overall Study|Dose-limiting toxicity|0|||
130132366|NCT02674152|468445872|FG003|Overall Study|Dose-limiting toxicity|0|||
130132367|NCT02674152|468445873|FG004|Overall Study|Dose-limiting toxicity|1|||
130132368|NCT02674152|468445869|FG000|Overall Study|Progressive Disease|2|||
130132369|NCT02674152|468445870|FG001|Overall Study|Progressive Disease|1|||
130132370|NCT02674152|468445871|FG002|Overall Study|Progressive Disease|1|||
130132371|NCT02674152|468445872|FG003|Overall Study|Progressive Disease|13|||
130132372|NCT02674152|468445873|FG004|Overall Study|Progressive Disease|2|||
130132373|NCT02674152|468445869|FG000|Overall Study|Adverse Event|0|||
130132374|NCT02674152|468445870|FG001|Overall Study|Adverse Event|0|||
130132375|NCT02674152|468445871|FG002|Overall Study|Adverse Event|1|||
130132376|NCT02674152|468445872|FG003|Overall Study|Adverse Event|0|||
130132377|NCT02674152|468445873|FG004|Overall Study|Adverse Event|1|||
130132378|NCT04934722|468445874|FG000|Overall Study|Death|4|||
130132379|NCT04934722|468445875|FG001|Overall Study|Death|3|||
130132380|NCT04934722|468445874|FG000|Overall Study|Participants Ongoing|88|||
130132381|NCT04934722|468445875|FG001|Overall Study|Participants Ongoing|91|||
130132382|NCT05265624|468445876|FG000|Overall Study|Lost to Follow-up|3|||
130132383|NCT05265624|468445877|FG001|Overall Study|Lost to Follow-up|0|||
130132384|NCT05265624|468445876|FG000|Overall Study|Withdrawal by Subject|1|||
130132385|NCT05265624|468445877|FG001|Overall Study|Withdrawal by Subject|0|||
130132386|NCT03071575|468445878|FG000|Overall Study|Death|0|||
130132387|NCT03071575|468445879|FG001|Overall Study|Death|1|||
130132388|NCT03071575|468445878|FG000|Overall Study|Lost to Follow-up|5|||
130132389|NCT03071575|468445879|FG001|Overall Study|Lost to Follow-up|11|||
130132390|NCT03071575|468445878|FG000|Overall Study|Withdrawal by Subject|4|||
130132391|NCT03071575|468445879|FG001|Overall Study|Withdrawal by Subject|2|||
130132392|NCT00834795|468445880|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
130132393|NCT00834795|468445881|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
130132394|NCT00834795|468445880|FG000|Second Intervention|Adverse Event|1|||
130132395|NCT00834795|468445881|FG001|Second Intervention|Adverse Event|0|||
130132396|NCT00579345|468445882|FG000|Overall Study|Withdrawal by Subject|2|||
130132397|NCT00579345|468445883|FG001|Overall Study|Withdrawal by Subject|0|||
130132398|NCT00579345|468445884|FG002|Overall Study|Withdrawal by Subject|0|||
130132399|NCT00579345|468445885|FG003|Overall Study|Withdrawal by Subject|0|||
130132400|NCT00579345|468445886|FG004|Overall Study|Withdrawal by Subject|0|||
130132401|NCT00579345|468445887|FG005|Overall Study|Withdrawal by Subject|0|||
130132402|NCT00579345|468445888|FG006|Overall Study|Withdrawal by Subject|0|||
130132403|NCT00579345|468445889|FG007|Overall Study|Withdrawal by Subject|1|||
130132404|NCT00579345|468445882|FG000|Overall Study|Lost to Follow-up|1|||
130132405|NCT00579345|468445883|FG001|Overall Study|Lost to Follow-up|0|||
130132406|NCT00579345|468445884|FG002|Overall Study|Lost to Follow-up|0|||
130132407|NCT00579345|468445885|FG003|Overall Study|Lost to Follow-up|0|||
130132408|NCT00579345|468445886|FG004|Overall Study|Lost to Follow-up|0|||
130132409|NCT00579345|468445887|FG005|Overall Study|Lost to Follow-up|0|||
130132410|NCT00579345|468445888|FG006|Overall Study|Lost to Follow-up|0|||
130132411|NCT00579345|468445889|FG007|Overall Study|Lost to Follow-up|0|||
130132412|NCT00579345|468445882|FG000|Overall Study|Adverse Event|0|||
130132413|NCT00579345|468445883|FG001|Overall Study|Adverse Event|0|||
130132414|NCT00579345|468445884|FG002|Overall Study|Adverse Event|1|||
130132415|NCT00579345|468445885|FG003|Overall Study|Adverse Event|0|||
130132416|NCT00579345|468445886|FG004|Overall Study|Adverse Event|0|||
130132417|NCT00579345|468445887|FG005|Overall Study|Adverse Event|0|||
130132418|NCT00579345|468445888|FG006|Overall Study|Adverse Event|0|||
130132419|NCT00579345|468445889|FG007|Overall Study|Adverse Event|0|||
130132420|NCT00579345|468445882|FG000|Overall Study|Protocol Violation|1|||
130132421|NCT00579345|468445883|FG001|Overall Study|Protocol Violation|0|||
130132422|NCT00579345|468445884|FG002|Overall Study|Protocol Violation|0|||
130132423|NCT00579345|468445885|FG003|Overall Study|Protocol Violation|0|||
130132424|NCT00579345|468445886|FG004|Overall Study|Protocol Violation|0|||
130132425|NCT00579345|468445887|FG005|Overall Study|Protocol Violation|0|||
130132426|NCT00579345|468445888|FG006|Overall Study|Protocol Violation|0|||
130132427|NCT00579345|468445889|FG007|Overall Study|Protocol Violation|1|||
130132428|NCT00579345|468445882|FG000|Overall Study|Death|1|||
130132429|NCT00579345|468445883|FG001|Overall Study|Death|1|||
130132430|NCT00579345|468445884|FG002|Overall Study|Death|1|||
130132431|NCT00579345|468445885|FG003|Overall Study|Death|1|||
130132432|NCT00579345|468445886|FG004|Overall Study|Death|0|||
130132433|NCT00579345|468445887|FG005|Overall Study|Death|0|||
130132434|NCT00579345|468445888|FG006|Overall Study|Death|0|||
130132435|NCT00579345|468445889|FG007|Overall Study|Death|0|||
130132436|NCT05604170|468445893|FG000|Overall Study|Lack of Efficacy|5|||
130132437|NCT05604170|468445893|FG000|Overall Study|Adverse Event|6|||
130132438|NCT05604170|468445893|FG000|Overall Study|Physician Decision|6|||
130132439|NCT05604170|468445893|FG000|Overall Study|Lost to Follow-up|6|||
130132440|NCT05604170|468445893|FG000|Overall Study|Withdrawal by Subject|11|||
130132441|NCT05604170|468445893|FG000|Overall Study|Early study termination by sponsor|77|||
130132442|NCT05604170|468445893|FG000|Overall Study|Other|6|||
130132443|NCT00272779|468445896|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
130132444|NCT00272779|468445897|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
130132445|NCT00272779|468445896|FG000|Baseline Through Week 48|Death before Week 48|4|||
130132446|NCT00272779|468445897|FG001|Baseline Through Week 48|Death before Week 48|4|||
130132447|NCT00272779|468445896|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
130132448|NCT00272779|468445897|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
130132449|NCT00272779|468445896|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
130132450|NCT00272779|468445897|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
130132451|NCT00272779|468445896|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
130132452|NCT00272779|468445897|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
130132453|NCT00272779|468445896|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
130132454|NCT00272779|468445897|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
130132455|NCT00272779|468445896|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
130132456|NCT00272779|468445897|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
130132457|NCT00272779|468445896|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
130132458|NCT00272779|468445897|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
130132459|NCT00272779|468445896|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
130132460|NCT00272779|468445897|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
130132461|NCT00272779|468445896|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
130132462|NCT00272779|468445897|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
130132463|NCT00272779|468445896|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
130132464|NCT00272779|468445897|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
130132465|NCT00272779|468445896|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
130132466|NCT00272779|468445897|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
130132467|NCT00272779|468445896|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
130132468|NCT00272779|468445897|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
130132469|NCT00272779|468445896|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
130132470|NCT00272779|468445897|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
130132471|NCT00272779|468445896|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
130132472|NCT00272779|468445897|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
130132473|NCT00272779|468445896|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
130132474|NCT00272779|468445897|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
130132475|NCT00272779|468445896|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
130132476|NCT00272779|468445897|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
130132477|NCT00272779|468445896|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
130132478|NCT00272779|468445897|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
130132479|NCT00272779|468445896|FG000|Baseline Through Week 48|Continuing treatment|385|||
130132480|NCT00272779|468445897|FG001|Baseline Through Week 48|Continuing treatment|368|||
130132481|NCT00272779|468445896|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
130132482|NCT00272779|468445897|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
130132483|NCT00272779|468445896|FG000|Baseline Through Week 48|Never treated|2|||
130132484|NCT00272779|468445897|FG001|Baseline Through Week 48|Never treated|3|||
130132485|NCT00272779|468445896|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
130132486|NCT00272779|468445897|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
130132487|NCT00272779|468445896|FG000|Baseline Through Week 96|Death before Week 96|6|||
130132488|NCT00272779|468445897|FG001|Baseline Through Week 96|Death before Week 96|5|||
130132489|NCT00272779|468445896|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
130132490|NCT00272779|468445897|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
130132491|NCT00272779|468445896|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
130132492|NCT00272779|468445897|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
130132493|NCT00272779|468445896|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
130132494|NCT00272779|468445897|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
130132495|NCT00272779|468445896|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
130132496|NCT00272779|468445897|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
130132497|NCT00272779|468445896|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
130132498|NCT00272779|468445897|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
130132499|NCT00272779|468445896|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
130132500|NCT00272779|468445897|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
130132501|NCT00272779|468445896|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
130132502|NCT00272779|468445897|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
130132503|NCT00272779|468445896|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
129971142|NCT02797522|467858409|FG001|Overall Study|Study Terminated by Sponsor|0|||
129971143|NCT02797522|467858410|FG002|Overall Study|Study Terminated by Sponsor|0|||
129971144|NCT02797522|467858411|FG003|Overall Study|Study Terminated by Sponsor|0|||
129971145|NCT02797522|467858412|FG004|Overall Study|Study Terminated by Sponsor|0|||
129971146|NCT02797522|467858413|FG005|Overall Study|Study Terminated by Sponsor|0|||
129971147|NCT02797522|467858414|FG006|Overall Study|Study Terminated by Sponsor|0|||
129971148|NCT02797522|467858415|FG007|Overall Study|Study Terminated by Sponsor|4|||
129971149|NCT02797522|467858416|FG008|Overall Study|Study Terminated by Sponsor|2|||
129971150|NCT02797522|467858417|FG009|Overall Study|Study Terminated by Sponsor|4|||
129971151|NCT02797522|467858418|FG010|Overall Study|Study Terminated by Sponsor|1|||
129971152|NCT00725712|467858419|FG000|Overall Study|Withdrawal by Subject|2|||
129971153|NCT00725712|467858420|FG001|Overall Study|Withdrawal by Subject|1|||
129971154|NCT00725712|467858419|FG000|Overall Study|Protocol Violation|1|||
129971155|NCT00725712|467858420|FG001|Overall Study|Protocol Violation|0|||
129971156|NCT00725712|467858419|FG000|Overall Study|Progressive disease|37|||
129971157|NCT00725712|467858420|FG001|Overall Study|Progressive disease|16|||
129971158|NCT00725712|467858419|FG000|Overall Study|Clinical progression not based on RECIST|0|||
129971159|NCT00725712|467858420|FG001|Overall Study|Clinical progression not based on RECIST|3|||
129971160|NCT00725712|467858419|FG000|Overall Study|Adverse Event|5|||
129971161|NCT00725712|467858420|FG001|Overall Study|Adverse Event|5|||
129971162|NCT00725712|467858419|FG000|Overall Study|Death|2|||
129971163|NCT00725712|467858420|FG001|Overall Study|Death|0|||
129971164|NCT00725712|467858419|FG000|Overall Study|Other: Death|1|||
129971165|NCT00725712|467858420|FG001|Overall Study|Other: Death|0|||
129971166|NCT00725712|467858419|FG000|Overall Study|Hospitalized, unable to continue|0|||
129971167|NCT00725712|467858420|FG001|Overall Study|Hospitalized, unable to continue|1|||
129971168|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
129971169|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
129971170|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
129971171|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
129971172|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
129971173|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
129971174|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
130132504|NCT00272779|468445897|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
130132505|NCT00272779|468445896|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
130132506|NCT00272779|468445897|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
130132507|NCT00272779|468445896|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
130132508|NCT00272779|468445897|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
130132509|NCT00272779|468445896|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
130132510|NCT00272779|468445897|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
130132511|NCT00272779|468445896|FG000|Baseline Through Week 96|Never treated|2|||
130132512|NCT00272779|468445897|FG001|Baseline Through Week 96|Never treated|3|||
130132513|NCT00272779|468445896|FG000|Baseline Through Week 96|Continuing on treatment|61|||
130132514|NCT00272779|468445897|FG001|Baseline Through Week 96|Continuing on treatment|38|||
130132515|NCT00440518|468445899|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
130132516|NCT00440518|468445900|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
130132517|NCT00440518|468445901|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
129971175|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
130132518|NCT00440518|468445899|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
130132519|NCT00440518|468445900|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
130132520|NCT00440518|468445901|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
130132521|NCT00440518|468445899|FG000|Randomized /Titration Period|Protocol Deviation|1|||
130132522|NCT00440518|468445900|FG001|Randomized /Titration Period|Protocol Deviation|0|||
130132523|NCT00440518|468445901|FG002|Randomized /Titration Period|Protocol Deviation|0|||
130132524|NCT00440518|468445899|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
130132525|NCT00440518|468445900|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
130132526|NCT00440518|468445901|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
130132527|NCT00440518|468445899|FG000|Randomized /Titration Period|Other|1|||
130132528|NCT00440518|468445900|FG001|Randomized /Titration Period|Other|0|||
130132529|NCT00440518|468445901|FG002|Randomized /Titration Period|Other|0|||
130132530|NCT00440518|468445899|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
130132531|NCT00440518|468445900|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
130132532|NCT00440518|468445901|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
130132533|NCT00440518|468445899|FG000|Randomized /Titration Period|Adverse Event|2|||
130132534|NCT00440518|468445900|FG001|Randomized /Titration Period|Adverse Event|3|||
130132535|NCT00440518|468445901|FG002|Randomized /Titration Period|Adverse Event|0|||
130132536|NCT00440518|468445899|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
130132537|NCT00440518|468445900|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
130132538|NCT00440518|468445901|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
130132539|NCT00440518|468445899|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
130132540|NCT00440518|468445900|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
130132541|NCT00440518|468445901|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
130132542|NCT00440518|468445899|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
130132543|NCT00440518|468445900|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
130132544|NCT00440518|468445901|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
130132545|NCT00440518|468445899|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
130132546|NCT00440518|468445900|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
130132547|NCT00440518|468445901|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
130132548|NCT00440518|468445899|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
130132549|NCT00440518|468445900|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
130132550|NCT00440518|468445901|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
130132551|NCT00440518|468445899|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
130132552|NCT00440518|468445900|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
130132553|NCT00440518|468445901|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
130132554|NCT03570749|468445902|FG000|Overall Study|Ongoing|26|||
129971176|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
129971177|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
129971178|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
130132555|NCT03570749|468445903|FG001|Overall Study|Ongoing|25|||
130132556|NCT03570749|468445904|FG002|Overall Study|Ongoing|25|||
130132557|NCT03570749|468445905|FG003|Overall Study|Ongoing|26|||
130132558|NCT03570749|468445906|FG004|Overall Study|Ongoing|140|||
130132559|NCT03570749|468445907|FG005|Overall Study|Ongoing|142|||
130132560|NCT03570749|468445908|FG006|Overall Study|Ongoing|220|||
130132561|NCT03570749|468445902|FG000|Overall Study|Adverse Event|0|||
130132562|NCT03570749|468445903|FG001|Overall Study|Adverse Event|0|||
130132563|NCT03570749|468445904|FG002|Overall Study|Adverse Event|0|||
130132564|NCT03570749|468445905|FG003|Overall Study|Adverse Event|0|||
130132565|NCT03570749|468445906|FG004|Overall Study|Adverse Event|2|||
130132566|NCT03570749|468445907|FG005|Overall Study|Adverse Event|3|||
130132567|NCT03570749|468445908|FG006|Overall Study|Adverse Event|6|||
130132568|NCT03570749|468445902|FG000|Overall Study|Lack of Efficacy|0|||
130132569|NCT03570749|468445903|FG001|Overall Study|Lack of Efficacy|0|||
130132570|NCT03570749|468445904|FG002|Overall Study|Lack of Efficacy|0|||
130132571|NCT03570749|468445905|FG003|Overall Study|Lack of Efficacy|0|||
130132572|NCT03570749|468445906|FG004|Overall Study|Lack of Efficacy|8|||
130132573|NCT03570749|468445907|FG005|Overall Study|Lack of Efficacy|2|||
130132574|NCT03570749|468445908|FG006|Overall Study|Lack of Efficacy|7|||
130132575|NCT03570749|468445902|FG000|Overall Study|Lost to Follow-up|0|||
130132576|NCT03570749|468445903|FG001|Overall Study|Lost to Follow-up|0|||
130132577|NCT03570749|468445904|FG002|Overall Study|Lost to Follow-up|0|||
130132578|NCT03570749|468445905|FG003|Overall Study|Lost to Follow-up|0|||
130132579|NCT03570749|468445906|FG004|Overall Study|Lost to Follow-up|5|||
130132580|NCT03570749|468445907|FG005|Overall Study|Lost to Follow-up|10|||
130132581|NCT03570749|468445908|FG006|Overall Study|Lost to Follow-up|10|||
130132582|NCT03570749|468445902|FG000|Overall Study|Pregnancy|0|||
130132583|NCT03570749|468445903|FG001|Overall Study|Pregnancy|0|||
130132584|NCT03570749|468445904|FG002|Overall Study|Pregnancy|0|||
130132585|NCT03570749|468445905|FG003|Overall Study|Pregnancy|0|||
130132586|NCT03570749|468445906|FG004|Overall Study|Pregnancy|0|||
130132587|NCT03570749|468445907|FG005|Overall Study|Pregnancy|1|||
130132588|NCT03570749|468445908|FG006|Overall Study|Pregnancy|1|||
130132589|NCT03570749|468445902|FG000|Overall Study|Screen Fail|0|||
130132590|NCT03570749|468445903|FG001|Overall Study|Screen Fail|0|||
130132591|NCT03570749|468445904|FG002|Overall Study|Screen Fail|0|||
130132592|NCT03570749|468445905|FG003|Overall Study|Screen Fail|0|||
130132593|NCT03570749|468445906|FG004|Overall Study|Screen Fail|0|||
130132594|NCT03570749|468445907|FG005|Overall Study|Screen Fail|0|||
130132595|NCT03570749|468445908|FG006|Overall Study|Screen Fail|1|||
130132596|NCT03570749|468445902|FG000|Overall Study|Withdrawal by Subject|2|||
130132597|NCT03570749|468445903|FG001|Overall Study|Withdrawal by Subject|3|||
130132598|NCT03570749|468445904|FG002|Overall Study|Withdrawal by Subject|2|||
130132599|NCT03570749|468445905|FG003|Overall Study|Withdrawal by Subject|1|||
130132600|NCT03570749|468445906|FG004|Overall Study|Withdrawal by Subject|17|||
130132601|NCT03570749|468445907|FG005|Overall Study|Withdrawal by Subject|12|||
130132602|NCT03570749|468445908|FG006|Overall Study|Withdrawal by Subject|15|||
130132603|NCT03570749|468445902|FG000|Overall Study|Other|0|||
130132604|NCT03570749|468445903|FG001|Overall Study|Other|0|||
130132605|NCT03570749|468445904|FG002|Overall Study|Other|0|||
130132606|NCT03570749|468445905|FG003|Overall Study|Other|0|||
130132607|NCT03570749|468445906|FG004|Overall Study|Other|17|||
130132608|NCT03570749|468445907|FG005|Overall Study|Other|14|||
130132609|NCT03570749|468445908|FG006|Overall Study|Other|21|||
130132610|NCT00561015|468445909|FG000|Overall Study|Adverse Event|0|||
130132611|NCT00561015|468445910|FG001|Overall Study|Adverse Event|0|||
130132612|NCT00561015|468445911|FG002|Overall Study|Adverse Event|0|||
130132613|NCT00561015|468445912|FG003|Overall Study|Adverse Event|0|||
130132614|NCT00561015|468445913|FG004|Overall Study|Adverse Event|1|||
130132615|NCT00561015|468445914|FG005|Overall Study|Adverse Event|0|||
130132616|NCT00561015|468445909|FG000|Overall Study|Lost to Follow-up|2|||
130132617|NCT00561015|468445910|FG001|Overall Study|Lost to Follow-up|0|||
130132618|NCT00561015|468445911|FG002|Overall Study|Lost to Follow-up|0|||
130132619|NCT00561015|468445912|FG003|Overall Study|Lost to Follow-up|1|||
130132620|NCT00561015|468445913|FG004|Overall Study|Lost to Follow-up|0|||
130132621|NCT00561015|468445914|FG005|Overall Study|Lost to Follow-up|3|||
130132622|NCT00561015|468445909|FG000|Overall Study|Participant non-compliance|2|||
130132623|NCT00561015|468445910|FG001|Overall Study|Participant non-compliance|0|||
130132624|NCT00561015|468445911|FG002|Overall Study|Participant non-compliance|0|||
130132625|NCT00561015|468445912|FG003|Overall Study|Participant non-compliance|0|||
130132626|NCT00561015|468445913|FG004|Overall Study|Participant non-compliance|0|||
130132627|NCT00561015|468445914|FG005|Overall Study|Participant non-compliance|0|||
130132628|NCT02440711|468445915|FG000|Second Intervention|Lost to Follow-up|1|||
130132629|NCT02440711|468445916|FG001|Second Intervention|Lost to Follow-up|0|||
130132630|NCT00163657|468445919|FG000|Overall Study|Death|12|||
130132631|NCT00163657|468445920|FG001|Overall Study|Death|14|||
130132632|NCT00163657|468445921|FG002|Overall Study|Death|19|||
130132633|NCT00163657|468445919|FG000|Overall Study|graft loss|4|||
130132634|NCT00163657|468445920|FG001|Overall Study|graft loss|1|||
130132635|NCT00163657|468445921|FG002|Overall Study|graft loss|2|||
130132636|NCT00163657|468445919|FG000|Overall Study|Withdrawal by Subject|2|||
130132637|NCT00163657|468445920|FG001|Overall Study|Withdrawal by Subject|3|||
130132638|NCT00163657|468445921|FG002|Overall Study|Withdrawal by Subject|2|||
130132639|NCT00163657|468445919|FG000|Overall Study|Physician Decision|0|||
130132640|NCT00163657|468445920|FG001|Overall Study|Physician Decision|1|||
130132641|NCT00163657|468445921|FG002|Overall Study|Physician Decision|1|||
130132642|NCT00163657|468445919|FG000|Overall Study|Non Compliance|1|||
130132643|NCT00163657|468445920|FG001|Overall Study|Non Compliance|0|||
130132644|NCT00163657|468445921|FG002|Overall Study|Non Compliance|0|||
130132645|NCT00163657|468445919|FG000|Overall Study|Lost to Follow-up|1|||
130132646|NCT00163657|468445920|FG001|Overall Study|Lost to Follow-up|3|||
130132647|NCT00163657|468445921|FG002|Overall Study|Lost to Follow-up|10|||
130132648|NCT00163657|468445919|FG000|Overall Study|Other reason|0|||
130132649|NCT00163657|468445920|FG001|Overall Study|Other reason|1|||
130132650|NCT00163657|468445921|FG002|Overall Study|Other reason|3|||
130132651|NCT02436005|468445922|FG000|Second Intervention|Adverse Event|0|||
130132652|NCT02436005|468445923|FG001|Second Intervention|Adverse Event|1|||
130132653|NCT04247282|468445927|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
130132654|NCT04247282|468445928|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
130132655|NCT04247282|468445929|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
130132656|NCT04247282|468445930|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
130132657|NCT04247282|468445927|FG000|Overall Study|Refused further treatment|0|||
130132658|NCT04247282|468445928|FG001|Overall Study|Refused further treatment|1|||
130132659|NCT04247282|468445929|FG002|Overall Study|Refused further treatment|0|||
130132660|NCT04247282|468445930|FG003|Overall Study|Refused further treatment|0|||
130132661|NCT00968812|468445942|FG000|Overall Study|Adverse Event|30|||
130132662|NCT00968812|468445943|FG001|Overall Study|Adverse Event|46|||
130132663|NCT00968812|468445944|FG002|Overall Study|Adverse Event|33|||
130132664|NCT00968812|468445942|FG000|Overall Study|Death|2|||
130132665|NCT00968812|468445943|FG001|Overall Study|Death|2|||
130132666|NCT00968812|468445944|FG002|Overall Study|Death|1|||
130132667|NCT00968812|468445942|FG000|Overall Study|Lack of Efficacy|9|||
130132668|NCT00968812|468445943|FG001|Overall Study|Lack of Efficacy|7|||
130132669|NCT00968812|468445944|FG002|Overall Study|Lack of Efficacy|16|||
130132670|NCT00968812|468445942|FG000|Overall Study|Lost to Follow-up|17|||
130132671|NCT00968812|468445943|FG001|Overall Study|Lost to Follow-up|12|||
130132672|NCT00968812|468445944|FG002|Overall Study|Lost to Follow-up|11|||
130132673|NCT00968812|468445942|FG000|Overall Study|Physician Decision|8|||
130132674|NCT00968812|468445943|FG001|Overall Study|Physician Decision|5|||
130132675|NCT00968812|468445944|FG002|Overall Study|Physician Decision|9|||
130132676|NCT00968812|468445942|FG000|Overall Study|Protocol Violation|7|||
130132677|NCT00968812|468445943|FG001|Overall Study|Protocol Violation|4|||
130132678|NCT00968812|468445944|FG002|Overall Study|Protocol Violation|3|||
130132679|NCT00968812|468445942|FG000|Overall Study|Withdrawal by Subject|17|||
130132680|NCT00968812|468445943|FG001|Overall Study|Withdrawal by Subject|23|||
130132681|NCT00968812|468445944|FG002|Overall Study|Withdrawal by Subject|25|||
130132682|NCT00968812|468445942|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
130132683|NCT00968812|468445943|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
130132684|NCT00968812|468445944|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
130132685|NCT00968812|468445942|FG000|Overall Study|Noncompliance with study drug|4|||
130132686|NCT00968812|468445943|FG001|Overall Study|Noncompliance with study drug|1|||
130132687|NCT00968812|468445944|FG002|Overall Study|Noncompliance with study drug|6|||
130132688|NCT00968812|468445942|FG000|Overall Study|Unable to take rescue therapy|12|||
130132689|NCT00968812|468445943|FG001|Overall Study|Unable to take rescue therapy|12|||
130132690|NCT00968812|468445944|FG002|Overall Study|Unable to take rescue therapy|17|||
130132691|NCT00968812|468445942|FG000|Overall Study|Other|25|||
130132692|NCT00968812|468445943|FG001|Overall Study|Other|37|||
130132693|NCT00968812|468445944|FG002|Overall Study|Other|40|||
130132694|NCT00448591|468445947|FG000|Overall Study|Withdrawal by Subject|178|||
130132695|NCT00448591|468445947|FG000|Overall Study|Progressive Disease|1382|||
130132696|NCT00448591|468445947|FG000|Overall Study|Adverse Event|382|||
130132697|NCT00448591|468445947|FG000|Overall Study|Protocol Violation|41|||
130132698|NCT00448591|468445947|FG000|Overall Study|Lost to Follow-up|19|||
130132699|NCT00448591|468445947|FG000|Overall Study|Treatment Regimen Completed|70|||
130132700|NCT00448591|468445947|FG000|Overall Study|Other|154|||
130132701|NCT00448591|468445947|FG000|Overall Study|Termination of Study|70|||
130132702|NCT04604275|468445951|FG000|Washout-1 Week|Withdrawal by Subject|1|||
130132703|NCT04604275|468445952|FG001|Washout-1 Week|Withdrawal by Subject|0|||
129971179|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
130132704|NCT05615935|468445953|FG000|Overall Study|Lost to Follow-up|1|||
130132705|NCT05615935|468445954|FG001|Overall Study|Lost to Follow-up|1|||
130132706|NCT05446870|468445955|FG000|Overall Study|Death|6|||
130132707|NCT05446870|468445956|FG001|Overall Study|Death|5|||
130132708|NCT05446870|468445955|FG000|Overall Study|Lost to Follow-up|0|||
130132709|NCT05446870|468445956|FG001|Overall Study|Lost to Follow-up|1|||
130132710|NCT05446870|468445955|FG000|Overall Study|Physician Decision|52|||
130132711|NCT05446870|468445956|FG001|Overall Study|Physician Decision|53|||
130132712|NCT05446870|468445955|FG000|Overall Study|Withdrawal by Subject|3|||
130132713|NCT05446870|468445956|FG001|Overall Study|Withdrawal by Subject|3|||
130132714|NCT02689505|468445958|FG000|Overall Study|Progressive disease|2|||
130132715|NCT02689505|468445959|FG001|Overall Study|Progressive disease|2|||
130132716|NCT02689505|468445960|FG002|Overall Study|Progressive disease|3|||
130132717|NCT02689505|468445961|FG003|Overall Study|Progressive disease|9|||
130132718|NCT02689505|468445962|FG004|Overall Study|Progressive disease|1|||
130132719|NCT02689505|468445958|FG000|Overall Study|Dose Limiting Toxicity|0|||
130132720|NCT02689505|468445959|FG001|Overall Study|Dose Limiting Toxicity|1|||
130132721|NCT02689505|468445960|FG002|Overall Study|Dose Limiting Toxicity|0|||
130132722|NCT02689505|468445961|FG003|Overall Study|Dose Limiting Toxicity|0|||
130132723|NCT02689505|468445962|FG004|Overall Study|Dose Limiting Toxicity|2|||
130132724|NCT02689505|468445958|FG000|Overall Study|Other AE or clinical progression|0|||
130132725|NCT02689505|468445959|FG001|Overall Study|Other AE or clinical progression|2|||
130132726|NCT02689505|468445960|FG002|Overall Study|Other AE or clinical progression|0|||
130132727|NCT02689505|468445961|FG003|Overall Study|Other AE or clinical progression|2|||
130132728|NCT02689505|468445962|FG004|Overall Study|Other AE or clinical progression|0|||
130132729|NCT02446600|468445963|FG000|Overall Study|Never treated|20|||
130132730|NCT02446600|468445964|FG001|Overall Study|Never treated|2|||
130132731|NCT02446600|468445965|FG002|Overall Study|Never treated|6|||
130132732|NCT02446600|468445966|FG003|Overall Study|Never treated|0|||
130132733|NCT02446600|468445963|FG000|Overall Study|Withdrawal by Subject|19|||
130132734|NCT02446600|468445964|FG001|Overall Study|Withdrawal by Subject|5|||
130132735|NCT02446600|468445965|FG002|Overall Study|Withdrawal by Subject|17|||
130132736|NCT02446600|468445966|FG003|Overall Study|Withdrawal by Subject|0|||
130132737|NCT02446600|468445963|FG000|Overall Study|Ineligible|1|||
130132738|NCT02446600|468445964|FG001|Overall Study|Ineligible|4|||
130132739|NCT02446600|468445965|FG002|Overall Study|Ineligible|4|||
130132740|NCT02446600|468445966|FG003|Overall Study|Ineligible|1|||
130132741|NCT02446600|468445963|FG000|Overall Study|Duplicate Enrollment|0|||
130132742|NCT02446600|468445964|FG001|Overall Study|Duplicate Enrollment|1|||
130132743|NCT02446600|468445965|FG002|Overall Study|Duplicate Enrollment|0|||
130132744|NCT02446600|468445966|FG003|Overall Study|Duplicate Enrollment|0|||
130132745|NCT04108858|468445967|FG000|Overall Study|Adverse Event|1|||
130132746|NCT01415986|468445971|FG000|Overall Study|Lost to Follow-up|1|||
130132747|NCT05646251|468445972|FG000|Overall Study|Physician Decision|1|||
130132748|NCT05646251|468445973|FG001|Overall Study|Physician Decision|0|||
130132749|NCT05646251|468445974|FG002|Overall Study|Physician Decision|2|||
130132750|NCT04659603|468445976|FG000|Overall Study|Study terminated by sponsor|0|||
130132751|NCT04659603|468445977|FG001|Overall Study|Study terminated by sponsor|0|||
130132752|NCT04659603|468445978|FG002|Overall Study|Study terminated by sponsor|2|||
130132753|NCT04659603|468445976|FG000|Overall Study|Withdrawal by Subject|0|||
130132754|NCT04659603|468445977|FG001|Overall Study|Withdrawal by Subject|5|||
130132755|NCT04659603|468445978|FG002|Overall Study|Withdrawal by Subject|0|||
130132756|NCT04659603|468445976|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
130132757|NCT04659603|468445977|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
130132758|NCT04659603|468445978|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
130132759|NCT01231906|468445981|FG000|Overall Study|Lack of Efficacy|75|||
130132760|NCT01231906|468445982|FG001|Overall Study|Lack of Efficacy|68|||
130132761|NCT01231906|468445981|FG000|Overall Study|Lost to Follow-up|1|||
130132762|NCT01231906|468445982|FG001|Overall Study|Lost to Follow-up|0|||
130132763|NCT01231906|468445981|FG000|Overall Study|Physician Decision|34|||
130132764|NCT01231906|468445982|FG001|Overall Study|Physician Decision|24|||
130132765|NCT01231906|468445981|FG000|Overall Study|Withdrawal by Subject|0|||
130132766|NCT01231906|468445982|FG001|Overall Study|Withdrawal by Subject|4|||
130132767|NCT01231906|468445981|FG000|Overall Study|Ineligible|10|||
130132768|NCT01231906|468445982|FG001|Overall Study|Ineligible|3|||
130132769|NCT01231906|468445981|FG000|Overall Study|No treatment|1|||
130132770|NCT01231906|468445982|FG001|Overall Study|No treatment|2|||
130132771|NCT02957942|468445988|FG000|Overall Study|Withdrawal by Subject|0|||
130132772|NCT02957942|468445989|FG001|Overall Study|Withdrawal by Subject|1|||
130132773|NCT02957942|468445988|FG000|Overall Study|Practicing experiment protocol|0|||
130132774|NCT02957942|468445989|FG001|Overall Study|Practicing experiment protocol|6|||
130132775|NCT01701674|468446749|FG000|Overall Study|Unable to safely complete treatment|1|||
130132776|NCT03032172|468446750|FG000|Treatment Period|Adverse Event|0|||
130132777|NCT03032172|468446751|FG001|Treatment Period|Adverse Event|1|||
130132778|NCT03032172|468446752|FG002|Treatment Period|Adverse Event|0|||
130132779|NCT03032172|468446753|FG003|Treatment Period|Adverse Event|0|||
130132780|NCT03032172|468446754|FG004|Treatment Period|Adverse Event|0|||
130132781|NCT03032172|468446755|FG005|Treatment Period|Adverse Event|0|||
130132782|NCT03032172|468446756|FG006|Treatment Period|Adverse Event|0|||
130132783|NCT03032172|468446757|FG007|Treatment Period|Adverse Event|0|||
130132784|NCT03032172|468446750|FG000|Treatment Period|Lack of Efficacy|0|||
130132785|NCT03032172|468446751|FG001|Treatment Period|Lack of Efficacy|1|||
130132786|NCT03032172|468446752|FG002|Treatment Period|Lack of Efficacy|0|||
130132787|NCT03032172|468446753|FG003|Treatment Period|Lack of Efficacy|0|||
130132788|NCT03032172|468446754|FG004|Treatment Period|Lack of Efficacy|0|||
130132789|NCT03032172|468446755|FG005|Treatment Period|Lack of Efficacy|0|||
130132790|NCT03032172|468446756|FG006|Treatment Period|Lack of Efficacy|0|||
130132791|NCT03032172|468446757|FG007|Treatment Period|Lack of Efficacy|0|||
130132792|NCT03032172|468446750|FG000|Treatment Period|Non-compliance With Study Drug|0|||
130132793|NCT03032172|468446751|FG001|Treatment Period|Non-compliance With Study Drug|1|||
130132794|NCT03032172|468446752|FG002|Treatment Period|Non-compliance With Study Drug|0|||
130132795|NCT03032172|468446753|FG003|Treatment Period|Non-compliance With Study Drug|0|||
130132796|NCT03032172|468446754|FG004|Treatment Period|Non-compliance With Study Drug|0|||
130132797|NCT03032172|468446755|FG005|Treatment Period|Non-compliance With Study Drug|0|||
130132798|NCT03032172|468446756|FG006|Treatment Period|Non-compliance With Study Drug|0|||
130132799|NCT03032172|468446757|FG007|Treatment Period|Non-compliance With Study Drug|0|||
130132800|NCT03032172|468446750|FG000|Treatment Period|Reason Not Specified|0|||
130132801|NCT03032172|468446751|FG001|Treatment Period|Reason Not Specified|4|||
130132802|NCT03032172|468446752|FG002|Treatment Period|Reason Not Specified|1|||
130132803|NCT03032172|468446753|FG003|Treatment Period|Reason Not Specified|0|||
130132804|NCT03032172|468446754|FG004|Treatment Period|Reason Not Specified|0|||
130132805|NCT03032172|468446755|FG005|Treatment Period|Reason Not Specified|0|||
130132806|NCT03032172|468446756|FG006|Treatment Period|Reason Not Specified|0|||
130132807|NCT03032172|468446757|FG007|Treatment Period|Reason Not Specified|0|||
130132808|NCT03032172|468446750|FG000|Treatment Period|Physician Decision|0|||
130132809|NCT03032172|468446751|FG001|Treatment Period|Physician Decision|2|||
130132810|NCT03032172|468446752|FG002|Treatment Period|Physician Decision|1|||
130132811|NCT03032172|468446753|FG003|Treatment Period|Physician Decision|0|||
130132812|NCT03032172|468446754|FG004|Treatment Period|Physician Decision|0|||
130132813|NCT03032172|468446755|FG005|Treatment Period|Physician Decision|0|||
130132814|NCT03032172|468446756|FG006|Treatment Period|Physician Decision|0|||
130132815|NCT03032172|468446757|FG007|Treatment Period|Physician Decision|0|||
130132816|NCT03032172|468446750|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130132817|NCT03032172|468446751|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
130132818|NCT03032172|468446752|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
130132819|NCT03032172|468446753|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
130132820|NCT03032172|468446754|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130132821|NCT03032172|468446755|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130132822|NCT03032172|468446756|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130132823|NCT03032172|468446757|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
130132824|NCT03032172|468446750|FG000|Treatment Period|Withdrawal by Subject|2|||
130132825|NCT03032172|468446751|FG001|Treatment Period|Withdrawal by Subject|0|||
130132826|NCT03032172|468446752|FG002|Treatment Period|Withdrawal by Subject|3|||
130132827|NCT03032172|468446753|FG003|Treatment Period|Withdrawal by Subject|0|||
130132828|NCT03032172|468446754|FG004|Treatment Period|Withdrawal by Subject|0|||
130132829|NCT03032172|468446755|FG005|Treatment Period|Withdrawal by Subject|0|||
130132830|NCT03032172|468446756|FG006|Treatment Period|Withdrawal by Subject|0|||
130132831|NCT03032172|468446757|FG007|Treatment Period|Withdrawal by Subject|0|||
130132832|NCT03032172|468446750|FG000|Open-label Extension Period|Death|0|||
130132833|NCT03032172|468446751|FG001|Open-label Extension Period|Death|0|||
130132834|NCT03032172|468446752|FG002|Open-label Extension Period|Death|0|||
130132835|NCT03032172|468446753|FG003|Open-label Extension Period|Death|0|||
130132836|NCT03032172|468446754|FG004|Open-label Extension Period|Death|0|||
130132837|NCT03032172|468446755|FG005|Open-label Extension Period|Death|0|||
130132838|NCT03032172|468446756|FG006|Open-label Extension Period|Death|0|||
130132839|NCT03032172|468446757|FG007|Open-label Extension Period|Death|2|||
130132840|NCT03032172|468446750|FG000|Open-label Extension Period|Reason Not Specified|0|||
130132841|NCT03032172|468446751|FG001|Open-label Extension Period|Reason Not Specified|0|||
130132842|NCT03032172|468446752|FG002|Open-label Extension Period|Reason Not Specified|0|||
130132843|NCT03032172|468446753|FG003|Open-label Extension Period|Reason Not Specified|0|||
130132844|NCT03032172|468446754|FG004|Open-label Extension Period|Reason Not Specified|0|||
130132845|NCT03032172|468446755|FG005|Open-label Extension Period|Reason Not Specified|5|||
130132846|NCT03032172|468446756|FG006|Open-label Extension Period|Reason Not Specified|3|||
130132847|NCT03032172|468446757|FG007|Open-label Extension Period|Reason Not Specified|0|||
130132848|NCT03032172|468446750|FG000|Open-label Extension Period|Pregnancy|0|||
130132849|NCT03032172|468446751|FG001|Open-label Extension Period|Pregnancy|0|||
130132850|NCT03032172|468446752|FG002|Open-label Extension Period|Pregnancy|0|||
130132851|NCT03032172|468446753|FG003|Open-label Extension Period|Pregnancy|0|||
130132852|NCT03032172|468446754|FG004|Open-label Extension Period|Pregnancy|0|||
130132853|NCT03032172|468446755|FG005|Open-label Extension Period|Pregnancy|0|||
130132854|NCT03032172|468446756|FG006|Open-label Extension Period|Pregnancy|1|||
130132855|NCT03032172|468446757|FG007|Open-label Extension Period|Pregnancy|0|||
130132856|NCT03032172|468446750|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
130132857|NCT03032172|468446751|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
130132858|NCT03032172|468446752|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
130132859|NCT03032172|468446753|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
130132860|NCT03032172|468446754|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
130132861|NCT03032172|468446755|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
130132862|NCT03032172|468446756|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
130132863|NCT03032172|468446757|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
130132864|NCT02869867|468446760|FG000|Overall Study|Protocol Violation|1|||
130132865|NCT02869867|468446761|FG001|Overall Study|Protocol Violation|0|||
130132866|NCT02869867|468446760|FG000|Overall Study|Lost to Follow-up|5|||
130132867|NCT02869867|468446761|FG001|Overall Study|Lost to Follow-up|5|||
130132868|NCT00583453|468446764|FG000|Overall Study|discontinued intervention|0|||
130132869|NCT00583453|468446765|FG001|Overall Study|discontinued intervention|2|||
130132870|NCT03868891|468446768|FG000|Overall Study|Adverse Event|1|||
130132871|NCT03868891|468446769|FG001|Overall Study|Adverse Event|0|||
130132872|NCT03868891|468446768|FG000|Overall Study|Lost to Follow-up|2|||
130132873|NCT03868891|468446769|FG001|Overall Study|Lost to Follow-up|1|||
130132874|NCT03868891|468446768|FG000|Overall Study|COVID-19 Restrictions|1|||
130132875|NCT03868891|468446769|FG001|Overall Study|COVID-19 Restrictions|2|||
130132876|NCT03123094|468446771|FG000|Overall Study|Withdrawal by Subject|0|||
130132877|NCT03123094|468446772|FG001|Overall Study|Withdrawal by Subject|2|||
130132878|NCT03123094|468446773|FG002|Overall Study|Withdrawal by Subject|1|||
130132879|NCT03123094|468446774|FG003|Overall Study|Withdrawal by Subject|0|||
130132880|NCT03123094|468446775|FG004|Overall Study|Withdrawal by Subject|1|||
130132881|NCT00794963|468446776|FG000|Overall Study|Withdrawal by Subject|1|||
130132882|NCT00794963|468446777|FG001|Overall Study|Withdrawal by Subject|4|||
130132883|NCT03181594|468446783|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
130132884|NCT03181594|468446783|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
130132885|NCT03181594|468446783|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
130132886|NCT03181594|468446783|FG000|Initial Study Protocol (12-month FU)|Death|1|||
130132887|NCT03181594|468446783|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
130132888|NCT03181594|468446783|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
130132889|NCT03247972|468446784|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
130132890|NCT03247972|468446784|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
130132891|NCT01005745|468446785|FG000|Overall Study|No TIL growth|1|||
130132892|NCT01005745|468446785|FG000|Overall Study|Disease progressed during TIL growth|3|||
130132893|NCT01005745|468446785|FG000|Overall Study|Death prior to treatment|1|||
130132894|NCT01005745|468446785|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
129971180|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
129971181|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
129971182|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
129971183|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
129971184|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
130132895|NCT00446563|468446788|FG000|Overall Study|Adverse Event|4|||
130132896|NCT00446563|468446789|FG001|Overall Study|Adverse Event|3|||
130132897|NCT00446563|468446788|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130132898|NCT00446563|468446789|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130132899|NCT00446563|468446788|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130132900|NCT00446563|468446789|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130132901|NCT00446563|468446788|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130132902|NCT00446563|468446789|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
130132903|NCT00446563|468446788|FG000|Overall Study|Withdrawal by Subject|2|||
130132904|NCT00446563|468446789|FG001|Overall Study|Withdrawal by Subject|1|||
130132905|NCT00446563|468446788|FG000|Overall Study|Administrative problems|0|||
130132906|NCT00446563|468446789|FG001|Overall Study|Administrative problems|1|||
130132907|NCT03769025|468446790|FG000|Overall Study|Withdrawal by Subject|1|||
130132908|NCT03769025|468446791|FG001|Overall Study|Withdrawal by Subject|1|||
130132909|NCT03769025|468446790|FG000|Overall Study|Lost to Follow-up|4|||
130132910|NCT03769025|468446791|FG001|Overall Study|Lost to Follow-up|3|||
130132911|NCT01908205|468446792|FG000|Overall Study|Lost to Follow-up|2|||
130132912|NCT01908205|468446793|FG001|Overall Study|Lost to Follow-up|0|||
130132913|NCT01908205|468446792|FG000|Overall Study|Withdrawal by Subject|3|||
130132914|NCT01908205|468446793|FG001|Overall Study|Withdrawal by Subject|1|||
130132915|NCT03482882|468446798|FG000|Overall Study|Adverse Event|3|||
130132916|NCT03482882|468446798|FG000|Overall Study|Lost to Follow-up|1|||
129971185|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
129971186|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
129971187|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
130132917|NCT03482882|468446798|FG000|Overall Study|Protocol Violation|2|||
130132918|NCT03482882|468446798|FG000|Overall Study|Not further specified|1|||
130132919|NCT01136174|468446801|FG000|Overall Study|Adverse Event|0|||
130132920|NCT01136174|468446802|FG001|Overall Study|Adverse Event|0|||
130132921|NCT01136174|468446803|FG002|Overall Study|Adverse Event|0|||
130132922|NCT01136174|468446804|FG003|Overall Study|Adverse Event|4|||
130132923|NCT03238781|468446805|FG000|Overall Study|Adverse Event|1|||
130132924|NCT03238781|468446806|FG001|Overall Study|Adverse Event|1|||
130132925|NCT03238781|468446807|FG002|Overall Study|Adverse Event|2|||
130132926|NCT03238781|468446805|FG000|Overall Study|Lost to Follow-up|2|||
130132927|NCT03238781|468446806|FG001|Overall Study|Lost to Follow-up|1|||
130132928|NCT03238781|468446807|FG002|Overall Study|Lost to Follow-up|2|||
130132929|NCT03238781|468446805|FG000|Overall Study|Withdrawal by Subject|23|||
130132930|NCT03238781|468446806|FG001|Overall Study|Withdrawal by Subject|14|||
130132931|NCT03238781|468446807|FG002|Overall Study|Withdrawal by Subject|16|||
130132932|NCT03238781|468446805|FG000|Overall Study|Decision by sponsor|0|||
130132933|NCT03238781|468446806|FG001|Overall Study|Decision by sponsor|1|||
130132934|NCT03238781|468446807|FG002|Overall Study|Decision by sponsor|0|||
130132935|NCT01754597|468446810|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
130132936|NCT01754597|468446811|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
130132937|NCT01588236|468446812|FG000|Overall Study|Adverse Event|5|||
130132938|NCT01588236|468446813|FG001|Overall Study|Adverse Event|4|||
130132939|NCT01588236|468446814|FG002|Overall Study|Adverse Event|1|||
130132940|NCT01588236|468446812|FG000|Overall Study|Lost to Follow-up|8|||
130132941|NCT01588236|468446813|FG001|Overall Study|Lost to Follow-up|13|||
130132942|NCT01588236|468446814|FG002|Overall Study|Lost to Follow-up|6|||
130132943|NCT01588236|468446812|FG000|Overall Study|Physician Decision|1|||
130132944|NCT01588236|468446813|FG001|Overall Study|Physician Decision|2|||
130132945|NCT01588236|468446814|FG002|Overall Study|Physician Decision|0|||
130132946|NCT01588236|468446812|FG000|Overall Study|Protocol Violation|0|||
130132947|NCT01588236|468446813|FG001|Overall Study|Protocol Violation|1|||
130132948|NCT01588236|468446814|FG002|Overall Study|Protocol Violation|1|||
130132949|NCT01588236|468446812|FG000|Overall Study|Withdrawal by Subject|14|||
130132950|NCT01588236|468446813|FG001|Overall Study|Withdrawal by Subject|16|||
130132951|NCT01588236|468446814|FG002|Overall Study|Withdrawal by Subject|18|||
130132952|NCT01588236|468446812|FG000|Overall Study|Exclusion Criteria met during study|2|||
130132953|NCT01588236|468446813|FG001|Overall Study|Exclusion Criteria met during study|1|||
130132954|NCT01588236|468446814|FG002|Overall Study|Exclusion Criteria met during study|0|||
130132955|NCT01588236|468446812|FG000|Overall Study|sponsor decision|1|||
130132956|NCT01588236|468446813|FG001|Overall Study|sponsor decision|6|||
130132957|NCT01588236|468446814|FG002|Overall Study|sponsor decision|2|||
130132958|NCT04544410|468446815|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130132959|NCT04544410|468446816|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130132960|NCT04544410|468446815|FG000|Double-blind Treatment Period|Adverse Event|1|||
130132961|NCT04544410|468446816|FG001|Double-blind Treatment Period|Adverse Event|0|||
130132962|NCT04544410|468446815|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130132963|NCT04544410|468446816|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
130132964|NCT04544410|468446815|FG000|Double-blind Treatment Period|Protocol Violation|1|||
130132965|NCT04544410|468446816|FG001|Double-blind Treatment Period|Protocol Violation|0|||
130132966|NCT04544410|468446815|FG000|Open-Label Treatment Period|Study Terminated|15|||
130132967|NCT04544410|468446816|FG001|Open-Label Treatment Period|Study Terminated|19|||
130132968|NCT04544410|468446815|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
130132969|NCT04544410|468446816|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
130132970|NCT04544410|468446815|FG000|Open-Label Treatment Period|Adverse Event|0|||
130132971|NCT04544410|468446816|FG001|Open-Label Treatment Period|Adverse Event|1|||
130132972|NCT04544410|468446815|FG000|Open-Label Treatment Period|Physician Decision|1|||
130132973|NCT04544410|468446816|FG001|Open-Label Treatment Period|Physician Decision|0|||
130132974|NCT04544410|468446815|FG000|Open-Label Treatment Period|Other|0|||
130132975|NCT04544410|468446816|FG001|Open-Label Treatment Period|Other|1|||
130132976|NCT03761173|468446817|FG000|Overall Study|Lost to Follow-up|93|||
130132977|NCT03761173|468446817|FG000|Overall Study|Withdrawal by Subject|74|||
130132978|NCT03761173|468446817|FG000|Overall Study|Death|45|||
130132979|NCT03761173|468446817|FG000|Overall Study|Withdrawal for Other Reasons|29|||
130132980|NCT03761173|468446817|FG000|Overall Study|Protocol Violation|1|||
130132981|NCT04299087|468448106|FG000|Overall Study|Lost to Follow-up|2|||
130132982|NCT04299087|468448107|FG001|Overall Study|Lost to Follow-up|1|||
130132983|NCT00594035|468448108|FG000|Overall Study|Lost to Follow-up|1|||
130132984|NCT00594035|468448109|FG001|Overall Study|Lost to Follow-up|1|||
130132985|NCT00594035|468448108|FG000|Overall Study|Withdrawal by Subject|1|||
130132986|NCT00594035|468448109|FG001|Overall Study|Withdrawal by Subject|0|||
130132987|NCT00594035|468448108|FG000|Overall Study|Subject transferred to nursing home|0|||
130132988|NCT00594035|468448109|FG001|Overall Study|Subject transferred to nursing home|1|||
130132989|NCT00594035|468448108|FG000|Overall Study|Subject couldn't return due to job|0|||
130132990|NCT00594035|468448109|FG001|Overall Study|Subject couldn't return due to job|1|||
130132991|NCT00795821|468448110|FG000|Acute Treatment Phase|Adverse Event|23|||
130132992|NCT00795821|468448111|FG001|Acute Treatment Phase|Adverse Event|4|||
130132993|NCT00795821|468448110|FG000|Acute Treatment Phase|Death|1|||
130132994|NCT00795821|468448111|FG001|Acute Treatment Phase|Death|0|||
130132995|NCT00795821|468448110|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
130132996|NCT00795821|468448111|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
130132997|NCT00795821|468448110|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
130132998|NCT00795821|468448111|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
130132999|NCT00795821|468448110|FG000|Acute Treatment Phase|Physician Decision|1|||
130133000|NCT00795821|468448111|FG001|Acute Treatment Phase|Physician Decision|1|||
130133001|NCT00795821|468448110|FG000|Acute Treatment Phase|Protocol Violation|1|||
130133002|NCT00795821|468448111|FG001|Acute Treatment Phase|Protocol Violation|2|||
130133003|NCT00795821|468448110|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
130133004|NCT00795821|468448111|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
130133005|NCT00795821|468448110|FG000|Long-term Extension Phase|Adverse Event|25|||
130133006|NCT00795821|468448111|FG001|Long-term Extension Phase|Adverse Event|32|||
130133007|NCT00795821|468448110|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
130133008|NCT00795821|468448111|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
130133009|NCT00795821|468448110|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
130133010|NCT00795821|468448111|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
130133011|NCT00795821|468448110|FG000|Long-term Extension Phase|Physician Decision|1|||
130133012|NCT00795821|468448111|FG001|Long-term Extension Phase|Physician Decision|2|||
130133013|NCT00795821|468448110|FG000|Long-term Extension Phase|Protocol Violation|3|||
130133014|NCT00795821|468448111|FG001|Long-term Extension Phase|Protocol Violation|5|||
130133015|NCT00795821|468448110|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
130133016|NCT00795821|468448111|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
130133017|NCT00795821|468448110|FG000|Taper Phase|Adverse Event|2|||
130133018|NCT00795821|468448111|FG001|Taper Phase|Adverse Event|0|||
130133019|NCT00795821|468448110|FG000|Taper Phase|Lost to Follow-up|1|||
130133020|NCT00795821|468448111|FG001|Taper Phase|Lost to Follow-up|0|||
130133021|NCT00795821|468448110|FG000|Taper Phase|Physician Decision|2|||
130133022|NCT00795821|468448111|FG001|Taper Phase|Physician Decision|0|||
130133023|NCT00795821|468448110|FG000|Taper Phase|Withdrawal by Subject|4|||
130133024|NCT00795821|468448111|FG001|Taper Phase|Withdrawal by Subject|0|||
130133025|NCT06284525|468448118|FG000|Overall Study|Withdrawal by Subject|1|||
130133026|NCT03049748|468448121|FG000|Overall Study|Lost to Follow-up|1|||
130133027|NCT03049748|468448122|FG001|Overall Study|Lost to Follow-up|0|||
130133028|NCT03049748|468448121|FG000|Overall Study|Death|3|||
130133029|NCT03049748|468448122|FG001|Overall Study|Death|0|||
130133030|NCT03049748|468448121|FG000|Overall Study|Withdrawal by Subject|0|||
130133031|NCT03049748|468448122|FG001|Overall Study|Withdrawal by Subject|3|||
130133032|NCT03049748|468448121|FG000|Overall Study|Protocol Violation|0|||
130133033|NCT03049748|468448122|FG001|Overall Study|Protocol Violation|2|||
130133034|NCT03049748|468448121|FG000|Overall Study|Moved out of state (relocation)|0|||
130133035|NCT03049748|468448122|FG001|Overall Study|Moved out of state (relocation)|1|||
130133036|NCT01175018|468448127|FG000|Overall Study|Adverse Event|3|||
130133037|NCT01175018|468448128|FG001|Overall Study|Adverse Event|1|||
130133038|NCT02838420|468448132|FG000|Overall Study|Ongoing in Study|113|||
130133039|NCT02838420|468448133|FG001|Overall Study|Ongoing in Study|45|||
130133040|NCT02838420|468448132|FG000|Overall Study|Lost to Follow-up|1|||
130133041|NCT02838420|468448133|FG001|Overall Study|Lost to Follow-up|0|||
130133042|NCT02838420|468448132|FG000|Overall Study|Withdrawal by Subject|3|||
130133043|NCT02838420|468448133|FG001|Overall Study|Withdrawal by Subject|4|||
130133044|NCT02838420|468448132|FG000|Overall Study|Death|8|||
130133045|NCT02838420|468448133|FG001|Overall Study|Death|13|||
130133046|NCT02964039|468448134|FG000|Overall Study|Medical reason unrelated to study participation|1|||
130133047|NCT02964039|468448135|FG001|Overall Study|Medical reason unrelated to study participation|0|||
130133048|NCT02964039|468448136|FG002|Overall Study|Medical reason unrelated to study participation|3|||
130133049|NCT02964039|468448134|FG000|Overall Study|Research shutdown due to pandemic|2|||
130133050|NCT02964039|468448135|FG001|Overall Study|Research shutdown due to pandemic|0|||
130133051|NCT02964039|468448136|FG002|Overall Study|Research shutdown due to pandemic|1|||
130133052|NCT02964039|468448134|FG000|Overall Study|Withdrawal by Subject|0|||
130133053|NCT02964039|468448135|FG001|Overall Study|Withdrawal by Subject|1|||
130133054|NCT02964039|468448136|FG002|Overall Study|Withdrawal by Subject|0|||
130133055|NCT02964039|468448134|FG000|Overall Study|Lost to Follow-up|1|||
130133056|NCT02964039|468448135|FG001|Overall Study|Lost to Follow-up|0|||
130133057|NCT02964039|468448136|FG002|Overall Study|Lost to Follow-up|1|||
130133058|NCT00185458|468448137|FG000|Contraception Phase|Adverse Event|37|||
130133059|NCT00185458|468448137|FG000|Contraception Phase|Lost to Follow-up|10|||
130133060|NCT00185458|468448137|FG000|Contraception Phase|Protocol Violation|2|||
130133061|NCT00185458|468448137|FG000|Contraception Phase|Physician Decision|2|||
130133062|NCT00185458|468448137|FG000|Contraception Phase|Withdrawal by Subject|7|||
130133063|NCT00185458|468448137|FG000|HRT Phase|Adverse Event|18|||
130133064|NCT00185458|468448137|FG000|HRT Phase|Lost to Follow-up|4|||
130133065|NCT00185458|468448137|FG000|HRT Phase|Protocol Violation|2|||
130133066|NCT00185458|468448137|FG000|HRT Phase|Withdrawal by Subject|3|||
130133067|NCT00251979|468448138|FG000|Overall Study|Protocol Violation|3|||
130133068|NCT00251979|468448139|FG001|Overall Study|Protocol Violation|5|||
130133069|NCT00251979|468448138|FG000|Overall Study|Adverse Event|11|||
130133070|NCT00251979|468448139|FG001|Overall Study|Adverse Event|17|||
130133071|NCT00251979|468448138|FG000|Overall Study|Withdrawal by Subject|13|||
130133072|NCT00251979|468448139|FG001|Overall Study|Withdrawal by Subject|7|||
130133073|NCT00251979|468448138|FG000|Overall Study|Lost to Follow-up|8|||
130133074|NCT00251979|468448139|FG001|Overall Study|Lost to Follow-up|6|||
130133075|NCT00251979|468448138|FG000|Overall Study|Death|3|||
130133076|NCT00251979|468448139|FG001|Overall Study|Death|5|||
130133077|NCT01576042|468448140|FG000|Overall Study|Physician Decision|2|||
130133078|NCT01576042|468448141|FG001|Overall Study|Physician Decision|0|||
130133079|NCT00835536|468448145|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
130133080|NCT00835536|468448146|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
130133081|NCT03173547|468448150|FG000|Overall Study|Adverse Event|2|||
130133082|NCT03173547|468448151|FG001|Overall Study|Adverse Event|0|||
130133083|NCT03173547|468448150|FG000|Overall Study|Withdrawal by Subject|2|||
130133084|NCT03173547|468448151|FG001|Overall Study|Withdrawal by Subject|2|||
130133085|NCT00657553|468448152|FG000|Overall Study|low accrual, no analysis run|5|||
130133086|NCT00657553|468448153|FG001|Overall Study|low accrual, no analysis run|5|||
130133087|NCT01169558|468448154|FG000|Overall Study|Disease progression|98|||
130133088|NCT01169558|468448154|FG000|Overall Study|Adverse Event|25|||
130133089|NCT01169558|468448154|FG000|Overall Study|Withdrawal of Consent|8|||
130133090|NCT01169558|468448154|FG000|Overall Study|Medical Decision|7|||
130133091|NCT01169558|468448154|FG000|Overall Study|Stable Disease|4|||
130133092|NCT01169558|468448154|FG000|Overall Study|Lost to Follow-up|4|||
130133093|NCT01169558|468448154|FG000|Overall Study|Need for Surgery|4|||
130133094|NCT01169558|468448154|FG000|Overall Study|Non-compliance|2|||
130133095|NCT01169558|468448154|FG000|Overall Study|Protocol Violation|2|||
130133096|NCT01169558|468448154|FG000|Overall Study|Partial response|2|||
130133097|NCT02409355|468448160|FG000|Overall Study|Withdrawal by Subject|1|||
130133098|NCT02409355|468448161|FG001|Overall Study|Withdrawal by Subject|0|||
130133099|NCT02409355|468448160|FG000|Overall Study|Death|1|||
130133100|NCT02409355|468448161|FG001|Overall Study|Death|1|||
130133101|NCT02409355|468448160|FG000|Overall Study|Study terminated by Sponsor|2|||
130133102|NCT02409355|468448161|FG001|Overall Study|Study terminated by Sponsor|3|||
130133103|NCT00838539|468448162|FG000|Overall Study|Disease Progression|2|||
130133104|NCT00838539|468448163|FG001|Overall Study|Disease Progression|4|||
130133105|NCT00838539|468448164|FG002|Overall Study|Disease Progression|3|||
130133106|NCT00838539|468448165|FG003|Overall Study|Disease Progression|2|||
130133107|NCT00838539|468448166|FG004|Overall Study|Disease Progression|4|||
130133108|NCT00838539|468448167|FG005|Overall Study|Disease Progression|2|||
130133109|NCT00838539|468448168|FG006|Overall Study|Disease Progression|3|||
130133110|NCT00838539|468448169|FG007|Overall Study|Disease Progression|4|||
130133111|NCT00838539|468448170|FG008|Overall Study|Disease Progression|4|||
130133112|NCT00838539|468448171|FG009|Overall Study|Disease Progression|5|||
130133113|NCT00838539|468448172|FG010|Overall Study|Disease Progression|1|||
130133114|NCT00838539|468448173|FG011|Overall Study|Disease Progression|4|||
130133115|NCT00838539|468448162|FG000|Overall Study|Adverse Event|1|||
130133116|NCT00838539|468448163|FG001|Overall Study|Adverse Event|1|||
130133117|NCT00838539|468448164|FG002|Overall Study|Adverse Event|1|||
130133118|NCT00838539|468448165|FG003|Overall Study|Adverse Event|1|||
130133119|NCT00838539|468448166|FG004|Overall Study|Adverse Event|2|||
130133120|NCT00838539|468448167|FG005|Overall Study|Adverse Event|1|||
130133121|NCT00838539|468448168|FG006|Overall Study|Adverse Event|0|||
130133122|NCT00838539|468448169|FG007|Overall Study|Adverse Event|2|||
130133123|NCT00838539|468448170|FG008|Overall Study|Adverse Event|0|||
130133124|NCT00838539|468448171|FG009|Overall Study|Adverse Event|1|||
130133125|NCT00838539|468448172|FG010|Overall Study|Adverse Event|2|||
130133126|NCT00838539|468448173|FG011|Overall Study|Adverse Event|0|||
130133127|NCT00838539|468448162|FG000|Overall Study|Withdrawal by Subject|0|||
130133128|NCT00838539|468448163|FG001|Overall Study|Withdrawal by Subject|1|||
130133129|NCT00838539|468448164|FG002|Overall Study|Withdrawal by Subject|0|||
130133130|NCT00838539|468448165|FG003|Overall Study|Withdrawal by Subject|0|||
130133131|NCT00838539|468448166|FG004|Overall Study|Withdrawal by Subject|0|||
130133132|NCT00838539|468448167|FG005|Overall Study|Withdrawal by Subject|0|||
130133133|NCT00838539|468448168|FG006|Overall Study|Withdrawal by Subject|0|||
130133134|NCT00838539|468448169|FG007|Overall Study|Withdrawal by Subject|0|||
130133135|NCT00838539|468448170|FG008|Overall Study|Withdrawal by Subject|0|||
130133136|NCT00838539|468448171|FG009|Overall Study|Withdrawal by Subject|1|||
130133137|NCT00838539|468448172|FG010|Overall Study|Withdrawal by Subject|2|||
130133138|NCT00838539|468448173|FG011|Overall Study|Withdrawal by Subject|0|||
130133139|NCT00838539|468448162|FG000|Overall Study|Death|0|||
130133140|NCT00838539|468448163|FG001|Overall Study|Death|0|||
130133141|NCT00838539|468448164|FG002|Overall Study|Death|0|||
130133142|NCT00838539|468448165|FG003|Overall Study|Death|0|||
130133143|NCT00838539|468448166|FG004|Overall Study|Death|0|||
130133144|NCT00838539|468448167|FG005|Overall Study|Death|0|||
130133145|NCT00838539|468448168|FG006|Overall Study|Death|1|||
130133146|NCT00838539|468448169|FG007|Overall Study|Death|0|||
130133147|NCT00838539|468448170|FG008|Overall Study|Death|0|||
130133148|NCT00838539|468448171|FG009|Overall Study|Death|0|||
130133149|NCT00838539|468448172|FG010|Overall Study|Death|0|||
130133150|NCT00838539|468448173|FG011|Overall Study|Death|0|||
130133151|NCT00838539|468448162|FG000|Overall Study|Physician Decision|0|||
130133152|NCT00838539|468448163|FG001|Overall Study|Physician Decision|0|||
130133153|NCT00838539|468448164|FG002|Overall Study|Physician Decision|0|||
130133154|NCT00838539|468448165|FG003|Overall Study|Physician Decision|0|||
130133155|NCT00838539|468448166|FG004|Overall Study|Physician Decision|0|||
130133156|NCT00838539|468448167|FG005|Overall Study|Physician Decision|0|||
130133157|NCT00838539|468448168|FG006|Overall Study|Physician Decision|0|||
130133158|NCT00838539|468448169|FG007|Overall Study|Physician Decision|0|||
130094095|NCT02354599|468298817|FG002|Overall Study|Withdrawal by Subject|0|||
130094096|NCT02354599|468298818|FG003|Overall Study|Withdrawal by Subject|0|||
130094097|NCT02354599|468298819|FG004|Overall Study|Withdrawal by Subject|0|||
130094098|NCT02354599|468298820|FG005|Overall Study|Withdrawal by Subject|0|||
130094099|NCT01087944|468298840|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
130094100|NCT01087944|468298841|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
130094101|NCT01087944|468298840|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
130094102|NCT01087944|468298841|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
130094103|NCT01159665|468298842|FG000|Overall Study|Withdrawal by Subject|0|||
130094104|NCT01159665|468298843|FG001|Overall Study|Withdrawal by Subject|1|||
130094105|NCT01159665|468298844|FG002|Overall Study|Withdrawal by Subject|0|||
130094106|NCT01159665|468298845|FG003|Overall Study|Withdrawal by Subject|0|||
130094107|NCT01159665|468298846|FG004|Overall Study|Withdrawal by Subject|0|||
130094108|NCT01159665|468298847|FG005|Overall Study|Withdrawal by Subject|0|||
130094109|NCT00540228|468298849|FG000|Overall Study|Adverse Event|2|||
130094110|NCT00540228|468298850|FG001|Overall Study|Adverse Event|0|||
130094111|NCT00540228|468298851|FG002|Overall Study|Adverse Event|0|||
130094112|NCT00540228|468298852|FG003|Overall Study|Adverse Event|0|||
130094113|NCT00540228|468298853|FG004|Overall Study|Adverse Event|0|||
130094114|NCT00540228|468298849|FG000|Overall Study|Lost to Follow-up|1|||
130094115|NCT00540228|468298850|FG001|Overall Study|Lost to Follow-up|1|||
130094116|NCT00540228|468298851|FG002|Overall Study|Lost to Follow-up|0|||
130094117|NCT00540228|468298852|FG003|Overall Study|Lost to Follow-up|0|||
130094118|NCT00540228|468298853|FG004|Overall Study|Lost to Follow-up|0|||
130094119|NCT01377194|468298854|FG000|Overall Study|Adverse Event|3|||
130094120|NCT01377194|468298855|FG001|Overall Study|Adverse Event|12|||
130094121|NCT01377194|468298856|FG002|Overall Study|Adverse Event|19|||
130094122|NCT01377194|468298854|FG000|Overall Study|Lack of Efficacy|3|||
130094123|NCT01377194|468298855|FG001|Overall Study|Lack of Efficacy|3|||
130094124|NCT01377194|468298856|FG002|Overall Study|Lack of Efficacy|3|||
130094125|NCT01377194|468298854|FG000|Overall Study|Protocol Violation|4|||
130094126|NCT01377194|468298855|FG001|Overall Study|Protocol Violation|10|||
130094127|NCT01377194|468298856|FG002|Overall Study|Protocol Violation|6|||
130094128|NCT01377194|468298854|FG000|Overall Study|Withdrawal by Subject|8|||
130094129|NCT01377194|468298855|FG001|Overall Study|Withdrawal by Subject|10|||
130094130|NCT01377194|468298856|FG002|Overall Study|Withdrawal by Subject|7|||
130094131|NCT01377194|468298854|FG000|Overall Study|Lost to Follow-up|14|||
130094132|NCT01377194|468298855|FG001|Overall Study|Lost to Follow-up|8|||
130094133|NCT01377194|468298856|FG002|Overall Study|Lost to Follow-up|11|||
130094134|NCT02451137|468298859|FG000|Overall Study|Randomized but not treated|19|||
130094135|NCT02451137|468298860|FG001|Overall Study|Randomized but not treated|27|||
130094136|NCT02451137|468298859|FG000|Overall Study|Adverse Event|43|||
130094137|NCT02451137|468298860|FG001|Overall Study|Adverse Event|42|||
130094138|NCT02451137|468298859|FG000|Overall Study|Lack of Efficacy|4|||
130094139|NCT02451137|468298860|FG001|Overall Study|Lack of Efficacy|9|||
130094140|NCT02451137|468298859|FG000|Overall Study|Participant decision:discontinue insulin|41|||
130094141|NCT02451137|468298860|FG001|Overall Study|Participant decision:discontinue insulin|43|||
130094142|NCT02451137|468298859|FG000|Overall Study|Hypoglycemia|2|||
130094143|NCT02451137|468298860|FG001|Overall Study|Hypoglycemia|1|||
130094144|NCT02451137|468298859|FG000|Overall Study|Investigator's decision|23|||
130094145|NCT02451137|468298860|FG001|Overall Study|Investigator's decision|19|||
130094146|NCT02451137|468298859|FG000|Overall Study|Lost to Follow-up|53|||
130094147|NCT02451137|468298860|FG001|Overall Study|Lost to Follow-up|61|||
130094148|NCT02451137|468298859|FG000|Overall Study|Physician Decision|6|||
130094149|NCT02451137|468298860|FG001|Overall Study|Physician Decision|5|||
130094150|NCT02451137|468298859|FG000|Overall Study|Sponsor decision|13|||
130094151|NCT02451137|468298860|FG001|Overall Study|Sponsor decision|25|||
130094152|NCT02451137|468298859|FG000|Overall Study|Withdrawal by Subject|40|||
130094153|NCT02451137|468298860|FG001|Overall Study|Withdrawal by Subject|63|||
130094154|NCT02451137|468298859|FG000|Overall Study|Other than specified above|2|||
130094155|NCT02451137|468298860|FG001|Overall Study|Other than specified above|3|||
130094156|NCT01977573|468298863|FG000|Overall Study|Adverse Event|7|||
130094157|NCT01977573|468298864|FG001|Overall Study|Adverse Event|0|||
130094158|NCT01977573|468298865|FG002|Overall Study|Adverse Event|2|||
130094159|NCT01977573|468298866|FG003|Overall Study|Adverse Event|1|||
130094160|NCT01977573|468298863|FG000|Overall Study|Lost to Follow-up|1|||
130094161|NCT01977573|468298864|FG001|Overall Study|Lost to Follow-up|0|||
130094162|NCT01977573|468298865|FG002|Overall Study|Lost to Follow-up|0|||
130094163|NCT01977573|468298866|FG003|Overall Study|Lost to Follow-up|1|||
130094164|NCT01977573|468298863|FG000|Overall Study|Physician Decision|1|||
130094165|NCT01977573|468298864|FG001|Overall Study|Physician Decision|0|||
130094166|NCT01977573|468298865|FG002|Overall Study|Physician Decision|0|||
130094167|NCT01977573|468298866|FG003|Overall Study|Physician Decision|0|||
130094168|NCT01977573|468298863|FG000|Overall Study|Protocol Violation|3|||
130094169|NCT01977573|468298864|FG001|Overall Study|Protocol Violation|1|||
130094170|NCT01977573|468298865|FG002|Overall Study|Protocol Violation|0|||
130094171|NCT01977573|468298866|FG003|Overall Study|Protocol Violation|0|||
130094172|NCT01977573|468298863|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
130094173|NCT01977573|468298864|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
130133159|NCT00838539|468448170|FG008|Overall Study|Physician Decision|1|||
130133160|NCT00838539|468448171|FG009|Overall Study|Physician Decision|0|||
130133161|NCT00838539|468448172|FG010|Overall Study|Physician Decision|0|||
130133162|NCT00838539|468448173|FG011|Overall Study|Physician Decision|0|||
130133163|NCT00838539|468448162|FG000|Overall Study|Clinical Progression|0|||
130133164|NCT00838539|468448163|FG001|Overall Study|Clinical Progression|0|||
130133165|NCT00838539|468448164|FG002|Overall Study|Clinical Progression|0|||
130133166|NCT00838539|468448165|FG003|Overall Study|Clinical Progression|0|||
130133167|NCT00838539|468448166|FG004|Overall Study|Clinical Progression|0|||
130133168|NCT00838539|468448167|FG005|Overall Study|Clinical Progression|0|||
130133169|NCT00838539|468448168|FG006|Overall Study|Clinical Progression|1|||
130133170|NCT00838539|468448169|FG007|Overall Study|Clinical Progression|0|||
130133171|NCT00838539|468448170|FG008|Overall Study|Clinical Progression|0|||
130133172|NCT00838539|468448171|FG009|Overall Study|Clinical Progression|0|||
130133173|NCT00838539|468448172|FG010|Overall Study|Clinical Progression|0|||
130133174|NCT00838539|468448173|FG011|Overall Study|Clinical Progression|0|||
130133175|NCT00838539|468448162|FG000|Overall Study|Symptomatic Deterioration|0|||
130133176|NCT00838539|468448163|FG001|Overall Study|Symptomatic Deterioration|0|||
130133177|NCT00838539|468448164|FG002|Overall Study|Symptomatic Deterioration|1|||
130133178|NCT00838539|468448165|FG003|Overall Study|Symptomatic Deterioration|1|||
130133179|NCT00838539|468448166|FG004|Overall Study|Symptomatic Deterioration|0|||
130133180|NCT00838539|468448167|FG005|Overall Study|Symptomatic Deterioration|1|||
130133181|NCT00838539|468448168|FG006|Overall Study|Symptomatic Deterioration|0|||
130133182|NCT00838539|468448169|FG007|Overall Study|Symptomatic Deterioration|0|||
130133183|NCT00838539|468448170|FG008|Overall Study|Symptomatic Deterioration|0|||
130133184|NCT00838539|468448171|FG009|Overall Study|Symptomatic Deterioration|1|||
130133185|NCT00838539|468448172|FG010|Overall Study|Symptomatic Deterioration|0|||
130133186|NCT00838539|468448173|FG011|Overall Study|Symptomatic Deterioration|0|||
130133187|NCT03134222|468448174|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
130133188|NCT03134222|468448175|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
130133189|NCT03134222|468448176|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
130133190|NCT03134222|468448177|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
130133191|NCT03134222|468448178|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
130133192|NCT03134222|468448174|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130133193|NCT03134222|468448175|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130133194|NCT03134222|468448176|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
130133195|NCT03134222|468448177|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
130133196|NCT03134222|468448178|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
130133197|NCT03134222|468448174|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130133198|NCT03134222|468448175|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
130133199|NCT03134222|468448176|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130133200|NCT03134222|468448177|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130133201|NCT03134222|468448178|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
130133202|NCT03134222|468448174|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130133203|NCT03134222|468448175|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
130133204|NCT03134222|468448176|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
130133205|NCT03134222|468448177|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130133206|NCT03134222|468448178|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
130133207|NCT03134222|468448174|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130133208|NCT03134222|468448175|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
130133209|NCT03134222|468448176|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130133210|NCT03134222|468448177|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
130133211|NCT03134222|468448178|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
130133212|NCT03134222|468448174|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
130133213|NCT03134222|468448175|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130133214|NCT03134222|468448176|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130133215|NCT03134222|468448177|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130133216|NCT03134222|468448178|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
130133217|NCT03134222|468448174|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130133218|NCT03134222|468448175|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130133219|NCT03134222|468448176|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130133220|NCT03134222|468448177|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
130133221|NCT03134222|468448178|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
130133222|NCT03134222|468448174|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130133223|NCT03134222|468448175|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
130133224|NCT03134222|468448176|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130133225|NCT03134222|468448177|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130133226|NCT03134222|468448178|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
130133227|NCT01110005|468448185|FG000|Overall Study|ineligible|1|||
130133228|NCT01110005|468448186|FG001|Overall Study|ineligible|2|||
130133229|NCT01110005|468448185|FG000|Overall Study|missing consent|3|||
130133230|NCT01110005|468448186|FG001|Overall Study|missing consent|2|||
130133231|NCT01110005|468448185|FG000|Overall Study|Withdrawal by Subject|0|||
130133232|NCT01110005|468448186|FG001|Overall Study|Withdrawal by Subject|1|||
130133233|NCT03123471|468448187|FG000|Placebo-controlled Phase|Adverse Event|3|||
130133234|NCT03123471|468448188|FG001|Placebo-controlled Phase|Adverse Event|8|||
130133235|NCT03123471|468448187|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
130133236|NCT03123471|468448188|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
130133237|NCT03123471|468448187|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
130133238|NCT03123471|468448188|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
130133239|NCT03123471|468448187|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
130133240|NCT03123471|468448188|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
130133241|NCT03123471|468448187|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
130133242|NCT03123471|468448188|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
130133243|NCT03123471|468448187|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
130133244|NCT03123471|468448188|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
130133245|NCT03123471|468448187|FG000|Placebo-controlled Phase|Miscellaneous|0|||
130133246|NCT03123471|468448188|FG001|Placebo-controlled Phase|Miscellaneous|1|||
130133247|NCT03123471|468448187|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
130133248|NCT03123471|468448188|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
130133249|NCT03123471|468448187|FG000|Apremilast Extension Phase|Adverse Event|1|||
130133250|NCT03123471|468448188|FG001|Apremilast Extension Phase|Adverse Event|5|||
130133251|NCT03123471|468448187|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
130133252|NCT03123471|468448188|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
130133253|NCT03123471|468448187|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
130133254|NCT03123471|468448188|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
130133255|NCT03681470|468448191|FG000|Overall Study|Lack of Efficacy|3|||
130133256|NCT03681470|468448191|FG000|Overall Study|Lost to Follow-up|1|||
130133257|NCT03681470|468448191|FG000|Overall Study|Protocol Violation|3|||
130133258|NCT03681470|468448191|FG000|Overall Study|Withdrawal by Subject|1|||
130133259|NCT01686477|468448192|FG000|Feeding Intervention|Death|1|||
130133260|NCT01686477|468448193|FG001|Feeding Intervention|Death|0|||
130133261|NCT01686477|468448194|FG002|Feeding Intervention|Death|1|||
130133262|NCT01686477|468448192|FG000|Feeding Intervention|Withdrawal by Subject|0|||
130133263|NCT01686477|468448193|FG001|Feeding Intervention|Withdrawal by Subject|6|||
130133264|NCT01686477|468448194|FG002|Feeding Intervention|Withdrawal by Subject|0|||
130133265|NCT01686477|468448192|FG000|Feeding Intervention|Physician Decision|1|||
130133266|NCT01686477|468448193|FG001|Feeding Intervention|Physician Decision|2|||
130133267|NCT01686477|468448194|FG002|Feeding Intervention|Physician Decision|0|||
130133268|NCT01686477|468448192|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
130133269|NCT01686477|468448193|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
130133270|NCT01686477|468448194|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
130133271|NCT01686477|468448192|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
130133272|NCT01686477|468448193|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
130133273|NCT01686477|468448194|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
130133274|NCT01686477|468448192|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
130133275|NCT01686477|468448193|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
130133276|NCT01686477|468448194|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
130133277|NCT01686477|468448192|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
130133278|NCT01686477|468448193|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
130133279|NCT01686477|468448194|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
130133280|NCT01686477|468448192|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
130133281|NCT01686477|468448193|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
130133282|NCT01686477|468448194|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
130133283|NCT01686477|468448192|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
130133284|NCT01686477|468448193|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
130133285|NCT01686477|468448194|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
130133286|NCT01686477|468448192|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
130133287|NCT01686477|468448193|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
130133288|NCT01686477|468448194|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
130133289|NCT03290781|468448195|FG000|Overall Study|Adverse Event|5|||
130133290|NCT03290781|468448196|FG001|Overall Study|Adverse Event|7|||
130133291|NCT03290781|468448197|FG002|Overall Study|Adverse Event|4|||
130133292|NCT03290781|468448198|FG003|Overall Study|Adverse Event|1|||
130133293|NCT03290781|468448199|FG004|Overall Study|Adverse Event|0|||
130133294|NCT03290781|468448200|FG005|Overall Study|Adverse Event|0|||
130133295|NCT03290781|468448201|FG006|Overall Study|Adverse Event|0|||
130133296|NCT03290781|468448195|FG000|Overall Study|Death|0|||
130133297|NCT03290781|468448196|FG001|Overall Study|Death|0|||
130133298|NCT03290781|468448197|FG002|Overall Study|Death|1|||
130133299|NCT03290781|468448198|FG003|Overall Study|Death|0|||
130133300|NCT03290781|468448199|FG004|Overall Study|Death|1|||
130133301|NCT03290781|468448200|FG005|Overall Study|Death|0|||
130094174|NCT01977573|468298865|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
130094175|NCT01977573|468298866|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
130094176|NCT01977573|468298863|FG000|Overall Study|Withdrawal by Subject|6|||
130094177|NCT01977573|468298864|FG001|Overall Study|Withdrawal by Subject|1|||
130094178|NCT01977573|468298865|FG002|Overall Study|Withdrawal by Subject|1|||
130094179|NCT01977573|468298866|FG003|Overall Study|Withdrawal by Subject|1|||
130094180|NCT02600559|468300555|FG000|Overall Study|Withdrawal by Subject|3|||
130094181|NCT02600559|468300555|FG000|Overall Study|Lost to Follow-up|20|||
130094182|NCT01153971|468300558|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
130094183|NCT01153971|468300558|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
130094184|NCT01153971|468300558|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
130094185|NCT01153971|468300558|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
130094186|NCT01153971|468300558|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
130094187|NCT01153971|468300558|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
130094188|NCT01153971|468300558|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
130094189|NCT03410693|468300559|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
130094190|NCT03410693|468300560|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
130094191|NCT03410693|468300559|FG000|Overall Study|Disc trt: Lost to follow up|0|||
130094192|NCT03410693|468300560|FG001|Overall Study|Disc trt: Lost to follow up|1|||
130094193|NCT03410693|468300559|FG000|Overall Study|Disc trt: radiological progression|58|||
130094194|NCT03410693|468300560|FG001|Overall Study|Disc trt: radiological progression|50|||
130094195|NCT03410693|468300559|FG000|Overall Study|Disc trt: Other|1|||
130094196|NCT03410693|468300560|FG001|Overall Study|Disc trt: Other|0|||
130094197|NCT03410693|468300559|FG000|Overall Study|Study drug never administered|1|||
130094198|NCT03410693|468300560|FG001|Overall Study|Study drug never administered|6|||
130094199|NCT03410693|468300559|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
130094200|NCT03410693|468300560|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
130094201|NCT03410693|468300559|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
130094202|NCT03410693|468300560|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
130094203|NCT03410693|468300559|FG000|Overall Study|Disc trt: Physician decision|0|||
130094204|NCT03410693|468300560|FG001|Overall Study|Disc trt: Physician decision|5|||
130094205|NCT03410693|468300559|FG000|Overall Study|Disc trt: clinical progression|1|||
130094206|NCT03410693|468300560|FG001|Overall Study|Disc trt: clinical progression|5|||
130094207|NCT03410693|468300559|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
130094208|NCT03410693|468300560|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
130094209|NCT00953576|468300561|FG000|Overall Study|Adverse Event|0|||
130094210|NCT00953576|468300562|FG001|Overall Study|Adverse Event|1|||
130094211|NCT00953576|468300561|FG000|Overall Study|Ineligible after Consent|2|||
130094212|NCT00953576|468300562|FG001|Overall Study|Ineligible after Consent|0|||
130094213|NCT03628781|468300567|FG000|Overall Study|Lost to Follow-up|16|||
130094214|NCT03628781|468300568|FG001|Overall Study|Lost to Follow-up|8|||
130094215|NCT03628781|468300567|FG000|Overall Study|Withdrawal by Subject|16|||
130094216|NCT03628781|468300568|FG001|Overall Study|Withdrawal by Subject|1|||
130094217|NCT01545375|468300571|FG000|Overall Study|Adverse Event|2|||
130094218|NCT01545375|468300572|FG001|Overall Study|Adverse Event|1|||
130094219|NCT01545375|468300571|FG000|Overall Study|Lost to Follow-up|34|||
130094220|NCT01545375|468300572|FG001|Overall Study|Lost to Follow-up|31|||
130094221|NCT01545375|468300571|FG000|Overall Study|Protocol Violation|3|||
130094222|NCT01545375|468300572|FG001|Overall Study|Protocol Violation|3|||
130094223|NCT01545375|468300571|FG000|Overall Study|Withdrawal by Subject|58|||
130094224|NCT01545375|468300572|FG001|Overall Study|Withdrawal by Subject|55|||
130094225|NCT02687815|468300573|FG000|Overall Study|Lost to Follow-up|2|||
130094226|NCT02687815|468300574|FG001|Overall Study|Lost to Follow-up|4|||
130094227|NCT02687815|468300573|FG000|Overall Study|Withdrawal by Subject|2|||
130094228|NCT02687815|468300574|FG001|Overall Study|Withdrawal by Subject|4|||
130094229|NCT01846039|468300575|FG000|Overall Study|Protocol Violation|1|||
130094230|NCT01846039|468300575|FG000|Overall Study|Subject Withdrew Consent|1|||
130094231|NCT04854421|468300576|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
130094232|NCT04854421|468300577|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
130094233|NCT03472586|468300583|FG000|Overall Study|Physician Decision|6|||
130094234|NCT03472586|468300583|FG000|Overall Study|Death|6|||
130094235|NCT03472586|468300583|FG000|Overall Study|Adverse Event|1|||
130094236|NCT02528331|468300584|FG000|Overall Study|Withdrawal by Subject|2|||
130094237|NCT00462501|468300587|FG000|Overall Study|Not treated|3|||
130094238|NCT00462501|468300587|FG000|Overall Study|Adverse Event|2|||
130094239|NCT00933543|468300599|FG000|Overall Study|Adverse Event|2|||
130094240|NCT00933543|468300600|FG001|Overall Study|Adverse Event|1|||
130094241|NCT00933543|468300599|FG000|Overall Study|Lost to Follow-up|0|||
130094242|NCT00933543|468300600|FG001|Overall Study|Lost to Follow-up|1|||
130094243|NCT00933543|468300599|FG000|Overall Study|Withdrawal by Subject|0|||
130094244|NCT00933543|468300600|FG001|Overall Study|Withdrawal by Subject|1|||
130094245|NCT00933543|468300599|FG000|Overall Study|Lack of Efficacy|0|||
130094246|NCT00933543|468300600|FG001|Overall Study|Lack of Efficacy|3|||
130094247|NCT00933543|468300599|FG000|Overall Study|Other|1|||
130133302|NCT03290781|468448201|FG006|Overall Study|Death|0|||
130133303|NCT03290781|468448195|FG000|Overall Study|Withdrawal by Subject|6|||
130133304|NCT03290781|468448196|FG001|Overall Study|Withdrawal by Subject|5|||
130133305|NCT03290781|468448197|FG002|Overall Study|Withdrawal by Subject|9|||
130133306|NCT03290781|468448198|FG003|Overall Study|Withdrawal by Subject|10|||
130133307|NCT03290781|468448199|FG004|Overall Study|Withdrawal by Subject|1|||
130133308|NCT03290781|468448200|FG005|Overall Study|Withdrawal by Subject|2|||
130133309|NCT03290781|468448201|FG006|Overall Study|Withdrawal by Subject|0|||
130133310|NCT03290781|468448195|FG000|Overall Study|Physician Decision|0|||
130133311|NCT03290781|468448196|FG001|Overall Study|Physician Decision|1|||
130133312|NCT03290781|468448197|FG002|Overall Study|Physician Decision|0|||
130133313|NCT03290781|468448198|FG003|Overall Study|Physician Decision|0|||
130133314|NCT03290781|468448199|FG004|Overall Study|Physician Decision|0|||
130133315|NCT03290781|468448200|FG005|Overall Study|Physician Decision|0|||
130133316|NCT03290781|468448201|FG006|Overall Study|Physician Decision|0|||
130133317|NCT03290781|468448195|FG000|Overall Study|Site Terminated by Sponsor|1|||
130133318|NCT03290781|468448196|FG001|Overall Study|Site Terminated by Sponsor|0|||
130133319|NCT03290781|468448197|FG002|Overall Study|Site Terminated by Sponsor|2|||
130133320|NCT03290781|468448198|FG003|Overall Study|Site Terminated by Sponsor|1|||
130133321|NCT03290781|468448199|FG004|Overall Study|Site Terminated by Sponsor|0|||
130133322|NCT03290781|468448200|FG005|Overall Study|Site Terminated by Sponsor|0|||
130133323|NCT03290781|468448201|FG006|Overall Study|Site Terminated by Sponsor|0|||
130133324|NCT03290781|468448195|FG000|Overall Study|Lost to Follow-up|0|||
130133325|NCT03290781|468448196|FG001|Overall Study|Lost to Follow-up|0|||
130133326|NCT03290781|468448197|FG002|Overall Study|Lost to Follow-up|0|||
130133327|NCT03290781|468448198|FG003|Overall Study|Lost to Follow-up|1|||
130133328|NCT03290781|468448199|FG004|Overall Study|Lost to Follow-up|0|||
130133329|NCT03290781|468448200|FG005|Overall Study|Lost to Follow-up|0|||
130133330|NCT03290781|468448201|FG006|Overall Study|Lost to Follow-up|0|||
130133331|NCT03290781|468448195|FG000|Overall Study|Protocol Deviation|2|||
130133332|NCT03290781|468448196|FG001|Overall Study|Protocol Deviation|0|||
130133333|NCT03290781|468448197|FG002|Overall Study|Protocol Deviation|0|||
130133334|NCT03290781|468448198|FG003|Overall Study|Protocol Deviation|1|||
130133335|NCT03290781|468448199|FG004|Overall Study|Protocol Deviation|0|||
130133336|NCT03290781|468448200|FG005|Overall Study|Protocol Deviation|0|||
130133337|NCT03290781|468448201|FG006|Overall Study|Protocol Deviation|0|||
130133338|NCT03290781|468448195|FG000|Overall Study|Disease Relapse|32|||
130133339|NCT03290781|468448196|FG001|Overall Study|Disease Relapse|5|||
130133340|NCT03290781|468448197|FG002|Overall Study|Disease Relapse|38|||
130133341|NCT03290781|468448198|FG003|Overall Study|Disease Relapse|7|||
130133342|NCT03290781|468448199|FG004|Overall Study|Disease Relapse|3|||
130133343|NCT03290781|468448200|FG005|Overall Study|Disease Relapse|1|||
130133344|NCT03290781|468448201|FG006|Overall Study|Disease Relapse|4|||
130133345|NCT03290781|468448195|FG000|Overall Study|Other|3|||
130133346|NCT03290781|468448196|FG001|Overall Study|Other|0|||
130133347|NCT03290781|468448197|FG002|Overall Study|Other|2|||
130133348|NCT03290781|468448198|FG003|Overall Study|Other|2|||
130133349|NCT03290781|468448199|FG004|Overall Study|Other|0|||
130133350|NCT03290781|468448200|FG005|Overall Study|Other|0|||
130133351|NCT03290781|468448201|FG006|Overall Study|Other|0|||
130133352|NCT00813592|468448213|FG000|Overall Study|Disease assessment was not completed per|2|||
130133353|NCT00811655|468448214|FG000|Overall Study|Physician Decision|1|||
130133354|NCT02820350|468448217|FG000|Overall Study|Withdrawal by Subject|3|||
130133355|NCT02820350|468448217|FG000|Overall Study|Death|4|||
130133356|NCT03801707|468448221|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
130133357|NCT04852978|468448227|FG000|Overall Study|Physician Decision|0|||
130133358|NCT04852978|468448228|FG001|Overall Study|Physician Decision|1|||
130133359|NCT04852978|468448229|FG002|Overall Study|Physician Decision|0|||
130133360|NCT04852978|468448230|FG003|Overall Study|Physician Decision|0|||
130133361|NCT04852978|468448231|FG004|Overall Study|Physician Decision|0|||
130133362|NCT04852978|468448232|FG005|Overall Study|Physician Decision|0|||
130133363|NCT04852978|468448233|FG006|Overall Study|Physician Decision|0|||
130133364|NCT04852978|468448234|FG007|Overall Study|Physician Decision|2|||
130133365|NCT04852978|468448235|FG008|Overall Study|Physician Decision|0|||
130133366|NCT04852978|468448227|FG000|Overall Study|Sponsor request|0|||
130133367|NCT04852978|468448228|FG001|Overall Study|Sponsor request|0|||
130133368|NCT04852978|468448229|FG002|Overall Study|Sponsor request|1|||
130133369|NCT04852978|468448230|FG003|Overall Study|Sponsor request|0|||
130133370|NCT04852978|468448231|FG004|Overall Study|Sponsor request|0|||
130133371|NCT04852978|468448232|FG005|Overall Study|Sponsor request|0|||
130133372|NCT04852978|468448233|FG006|Overall Study|Sponsor request|0|||
130133373|NCT04852978|468448234|FG007|Overall Study|Sponsor request|0|||
130133374|NCT04852978|468448235|FG008|Overall Study|Sponsor request|0|||
130133375|NCT04852978|468448227|FG000|Overall Study|Death|0|||
130133376|NCT04852978|468448228|FG001|Overall Study|Death|0|||
130133377|NCT04852978|468448229|FG002|Overall Study|Death|0|||
130133378|NCT04852978|468448230|FG003|Overall Study|Death|0|||
130133379|NCT04852978|468448231|FG004|Overall Study|Death|0|||
130133380|NCT04852978|468448232|FG005|Overall Study|Death|0|||
130133381|NCT04852978|468448233|FG006|Overall Study|Death|1|||
130133382|NCT04852978|468448234|FG007|Overall Study|Death|0|||
130133383|NCT04852978|468448235|FG008|Overall Study|Death|0|||
130133384|NCT04852978|468448227|FG000|Overall Study|Lost to Follow-up|3|||
130133385|NCT04852978|468448228|FG001|Overall Study|Lost to Follow-up|2|||
130133386|NCT04852978|468448229|FG002|Overall Study|Lost to Follow-up|2|||
130133387|NCT04852978|468448230|FG003|Overall Study|Lost to Follow-up|0|||
130133388|NCT04852978|468448231|FG004|Overall Study|Lost to Follow-up|2|||
130133389|NCT04852978|468448232|FG005|Overall Study|Lost to Follow-up|4|||
130133390|NCT04852978|468448233|FG006|Overall Study|Lost to Follow-up|1|||
130133391|NCT04852978|468448234|FG007|Overall Study|Lost to Follow-up|2|||
130133392|NCT04852978|468448235|FG008|Overall Study|Lost to Follow-up|2|||
130133393|NCT04852978|468448227|FG000|Overall Study|Withdrawal by Subject|4|||
130133394|NCT04852978|468448228|FG001|Overall Study|Withdrawal by Subject|2|||
130133395|NCT04852978|468448229|FG002|Overall Study|Withdrawal by Subject|2|||
130133396|NCT04852978|468448230|FG003|Overall Study|Withdrawal by Subject|1|||
130133397|NCT04852978|468448231|FG004|Overall Study|Withdrawal by Subject|5|||
130133398|NCT04852978|468448232|FG005|Overall Study|Withdrawal by Subject|3|||
130133399|NCT04852978|468448233|FG006|Overall Study|Withdrawal by Subject|2|||
130133400|NCT04852978|468448234|FG007|Overall Study|Withdrawal by Subject|2|||
130133401|NCT04852978|468448235|FG008|Overall Study|Withdrawal by Subject|1|||
130133402|NCT02301975|468450055|FG000|Overall Study|Adverse Event|8|||
130133403|NCT02301975|468450056|FG001|Overall Study|Adverse Event|3|||
130133404|NCT02301975|468450057|FG002|Overall Study|Adverse Event|2|||
130133405|NCT02301975|468450055|FG000|Overall Study|Lack of Efficacy|1|||
130133406|NCT02301975|468450056|FG001|Overall Study|Lack of Efficacy|1|||
130133407|NCT02301975|468450057|FG002|Overall Study|Lack of Efficacy|1|||
130133408|NCT02301975|468450055|FG000|Overall Study|Protocol Violation|3|||
130133409|NCT02301975|468450056|FG001|Overall Study|Protocol Violation|5|||
130133410|NCT02301975|468450057|FG002|Overall Study|Protocol Violation|3|||
130133411|NCT02301975|468450055|FG000|Overall Study|Lost to Follow-up|0|||
130133412|NCT02301975|468450056|FG001|Overall Study|Lost to Follow-up|2|||
130133413|NCT02301975|468450057|FG002|Overall Study|Lost to Follow-up|2|||
130133414|NCT02301975|468450055|FG000|Overall Study|Physician Decision|4|||
130133415|NCT02301975|468450056|FG001|Overall Study|Physician Decision|2|||
130133416|NCT02301975|468450057|FG002|Overall Study|Physician Decision|3|||
130133417|NCT02301975|468450055|FG000|Overall Study|Withdrawal by Subject|15|||
130133418|NCT02301975|468450056|FG001|Overall Study|Withdrawal by Subject|12|||
130133419|NCT02301975|468450057|FG002|Overall Study|Withdrawal by Subject|11|||
130133420|NCT03733730|468450058|FG000|Overall Study|Lost to Follow-up|1|||
130133421|NCT03733730|468450059|FG001|Overall Study|Lost to Follow-up|32|||
130133422|NCT03733730|468450058|FG000|Overall Study|Other|1|||
130133423|NCT03733730|468450059|FG001|Overall Study|Other|0|||
130133424|NCT03733730|468450058|FG000|Overall Study|Adverse Event|0|||
130133425|NCT03733730|468450059|FG001|Overall Study|Adverse Event|4|||
130133426|NCT03733730|468450058|FG000|Overall Study|Death|0|||
130133427|NCT03733730|468450059|FG001|Overall Study|Death|5|||
130133428|NCT03733730|468450058|FG000|Overall Study|Withdrawal by Subject|0|||
130133429|NCT03733730|468450059|FG001|Overall Study|Withdrawal by Subject|8|||
130133430|NCT01531894|468450064|FG000|Overall Study|Physician Decision|8|||
130133431|NCT01531894|468450064|FG000|Overall Study|Death|1|||
130133432|NCT03086460|468450065|FG000|Study Participants|Lost to Follow-up|2|||
130133433|NCT03086460|468450065|FG000|Study Participants|Protocol Violation|1|||
130133434|NCT03086460|468450065|FG000|Study Participants|Withdrawal by Subject|6|||
130133435|NCT03086460|468450065|FG000|Treatment A|Lost to Follow-up|1|||
130133436|NCT03086460|468450065|FG000|Treatment A|Protocol Violation|1|||
130133437|NCT03086460|468450065|FG000|Treatment A|Withdrawal by Subject|2|||
130133438|NCT03086460|468450065|FG000|Treatment C|Withdrawal by Subject|2|||
130133439|NCT03086460|468450065|FG000|Treatment E|Lost to Follow-up|1|||
130133440|NCT03086460|468450065|FG000|Treatment E|Withdrawal by Subject|3|||
130133441|NCT03635320|468450066|FG000|Overall Study|not implanted the device|1|||
130133442|NCT03635320|468450067|FG001|Overall Study|not implanted the device|2|||
130133443|NCT03635320|468450066|FG000|Overall Study|Withdrawal by Subject|11|||
130133444|NCT03635320|468450067|FG001|Overall Study|Withdrawal by Subject|6|||
130133445|NCT00835575|468450070|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
130133446|NCT00835575|468450071|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
130133447|NCT01440803|468450072|FG000|Overall Study|Met study stopping rule|2|||
130133448|NCT01440803|468450073|FG001|Overall Study|Met study stopping rule|1|||
130133449|NCT01440803|468450072|FG000|Overall Study|Lost to Follow-up|0|||
130133450|NCT01440803|468450073|FG001|Overall Study|Lost to Follow-up|2|||
130133451|NCT01440803|468450072|FG000|Overall Study|Withdrawal by Subject|0|||
130133452|NCT01440803|468450073|FG001|Overall Study|Withdrawal by Subject|1|||
130133453|NCT03606174|468450076|FG000|Overall Study|Death|37|||
130133454|NCT03606174|468450077|FG001|Overall Study|Death|15|||
130133455|NCT03606174|468450078|FG002|Overall Study|Death|15|||
130133456|NCT03606174|468450079|FG003|Overall Study|Death|7|||
130133457|NCT03606174|468450080|FG004|Overall Study|Death|35|||
130133458|NCT03606174|468450081|FG005|Overall Study|Death|12|||
130133459|NCT03606174|468450082|FG006|Overall Study|Death|35|||
130133460|NCT03606174|468450083|FG007|Overall Study|Death|8|||
130133461|NCT03606174|468450084|FG008|Overall Study|Death|5|||
130133462|NCT03606174|468450085|FG009|Overall Study|Death|3|||
130133463|NCT03606174|468450086|FG010|Overall Study|Death|0|||
130133464|NCT03606174|468450076|FG000|Overall Study|Lost to Follow-up|0|||
130133465|NCT03606174|468450077|FG001|Overall Study|Lost to Follow-up|0|||
130133466|NCT03606174|468450078|FG002|Overall Study|Lost to Follow-up|0|||
130133467|NCT03606174|468450079|FG003|Overall Study|Lost to Follow-up|0|||
130133468|NCT03606174|468450080|FG004|Overall Study|Lost to Follow-up|1|||
130133469|NCT03606174|468450081|FG005|Overall Study|Lost to Follow-up|1|||
130133470|NCT03606174|468450082|FG006|Overall Study|Lost to Follow-up|0|||
130133471|NCT03606174|468450083|FG007|Overall Study|Lost to Follow-up|0|||
130133472|NCT03606174|468450084|FG008|Overall Study|Lost to Follow-up|0|||
130133473|NCT03606174|468450085|FG009|Overall Study|Lost to Follow-up|0|||
130133474|NCT03606174|468450086|FG010|Overall Study|Lost to Follow-up|0|||
130133475|NCT03606174|468450076|FG000|Overall Study|Withdrawal by Subject|6|||
130133476|NCT03606174|468450077|FG001|Overall Study|Withdrawal by Subject|0|||
130133477|NCT03606174|468450078|FG002|Overall Study|Withdrawal by Subject|0|||
130133478|NCT03606174|468450079|FG003|Overall Study|Withdrawal by Subject|1|||
130133479|NCT03606174|468450080|FG004|Overall Study|Withdrawal by Subject|2|||
130133480|NCT03606174|468450081|FG005|Overall Study|Withdrawal by Subject|1|||
130133481|NCT03606174|468450082|FG006|Overall Study|Withdrawal by Subject|4|||
130133482|NCT03606174|468450083|FG007|Overall Study|Withdrawal by Subject|0|||
130133483|NCT03606174|468450084|FG008|Overall Study|Withdrawal by Subject|0|||
130133484|NCT03606174|468450085|FG009|Overall Study|Withdrawal by Subject|0|||
130133485|NCT03606174|468450086|FG010|Overall Study|Withdrawal by Subject|1|||
130133486|NCT03606174|468450076|FG000|Overall Study|Study Terminated by Sponsor|5|||
130133487|NCT03606174|468450077|FG001|Overall Study|Study Terminated by Sponsor|7|||
130133488|NCT03606174|468450078|FG002|Overall Study|Study Terminated by Sponsor|3|||
130133489|NCT03606174|468450079|FG003|Overall Study|Study Terminated by Sponsor|0|||
130133490|NCT03606174|468450080|FG004|Overall Study|Study Terminated by Sponsor|11|||
130133491|NCT03606174|468450081|FG005|Overall Study|Study Terminated by Sponsor|6|||
130133492|NCT03606174|468450082|FG006|Overall Study|Study Terminated by Sponsor|12|||
130133493|NCT03606174|468450083|FG007|Overall Study|Study Terminated by Sponsor|1|||
130133494|NCT03606174|468450084|FG008|Overall Study|Study Terminated by Sponsor|3|||
130133495|NCT03606174|468450085|FG009|Overall Study|Study Terminated by Sponsor|1|||
130133496|NCT03606174|468450086|FG010|Overall Study|Study Terminated by Sponsor|2|||
130133497|NCT03606174|468450076|FG000|Overall Study|Miscellaneous|1|||
130133498|NCT03606174|468450077|FG001|Overall Study|Miscellaneous|1|||
130133499|NCT03606174|468450078|FG002|Overall Study|Miscellaneous|0|||
130133500|NCT03606174|468450079|FG003|Overall Study|Miscellaneous|1|||
130133501|NCT03606174|468450080|FG004|Overall Study|Miscellaneous|4|||
130133502|NCT03606174|468450081|FG005|Overall Study|Miscellaneous|7|||
130133503|NCT03606174|468450082|FG006|Overall Study|Miscellaneous|5|||
130133504|NCT03606174|468450083|FG007|Overall Study|Miscellaneous|0|||
130133505|NCT03606174|468450084|FG008|Overall Study|Miscellaneous|0|||
130133506|NCT03606174|468450085|FG009|Overall Study|Miscellaneous|0|||
130133507|NCT03606174|468450086|FG010|Overall Study|Miscellaneous|1|||
130133508|NCT01609257|468450087|FG000|Overall Study|Lost to Follow-up|2|||
130133509|NCT01609257|468450088|FG001|Overall Study|Lost to Follow-up|1|||
130133510|NCT01609257|468450087|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
130133511|NCT01609257|468450088|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
130133512|NCT01609257|468450087|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
130133513|NCT01609257|468450088|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
130133514|NCT02125461|468450091|FG000|Overall Study|Withdrawal by Subject|30|||
130133515|NCT02125461|468450092|FG001|Overall Study|Withdrawal by Subject|16|||
130133516|NCT02125461|468450091|FG000|Overall Study|Lost to Follow-up|8|||
130133517|NCT02125461|468450092|FG001|Overall Study|Lost to Follow-up|3|||
130133518|NCT02125461|468450091|FG000|Overall Study|Death|260|||
130133519|NCT02125461|468450092|FG001|Overall Study|Death|149|||
130133520|NCT02125461|468450091|FG000|Overall Study|Missing Termination Reason|0|||
130133521|NCT02125461|468450092|FG001|Overall Study|Missing Termination Reason|1|||
130133522|NCT03502811|468450096|FG000|Overall Study|Death|157|||
130133523|NCT03502811|468450096|FG000|Overall Study|Withdrawal by Subject|105|||
130133524|NCT03502811|468450096|FG000|Overall Study|Lost to Follow-up|26|||
130133525|NCT03502811|468450096|FG000|Overall Study|No Visits (Missed)|31|||
130133526|NCT01735994|468450097|FG000|Overall Study|Withdrawal by Subject|6|||
130133527|NCT01735994|468450098|FG001|Overall Study|Withdrawal by Subject|4|||
130133528|NCT01735994|468450097|FG000|Overall Study|Injury|2|||
130133529|NCT01735994|468450098|FG001|Overall Study|Injury|0|||
130133530|NCT01735994|468450097|FG000|Overall Study|Kicked off team|5|||
130133531|NCT01735994|468450098|FG001|Overall Study|Kicked off team|0|||
130133532|NCT01735994|468450097|FG000|Overall Study|Lost to Follow-up|50|||
130133533|NCT01735994|468450098|FG001|Overall Study|Lost to Follow-up|62|||
130133534|NCT00905840|468450101|FG000|Overall Study|Lost to Follow-up|11|||
130133535|NCT00905840|468450101|FG000|Overall Study|Death|3|||
130133536|NCT00905840|468450101|FG000|Overall Study|Withdrawal by Subject|1|||
130133537|NCT00905840|468450101|FG000|Overall Study|Adverse Event|1|||
130133538|NCT03496623|468450102|FG000|Run-In Period (2 Weeks)|Death|1|||
130133539|NCT03496623|468450103|FG001|Run-In Period (2 Weeks)|Death|0|||
130133540|NCT03496623|468450104|FG002|Run-In Period (2 Weeks)|Death|0|||
130133541|NCT03496623|468450105|FG003|Run-In Period (2 Weeks)|Death|0|||
130133542|NCT03496623|468450106|FG004|Run-In Period (2 Weeks)|Death|0|||
130133543|NCT03496623|468450102|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
130133544|NCT03496623|468450103|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130133545|NCT03496623|468450104|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130133546|NCT03496623|468450105|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130133547|NCT03496623|468450106|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
130133548|NCT03496623|468450102|FG000|Period 1 (12 Weeks)|Death|0|||
130133549|NCT03496623|468450103|FG001|Period 1 (12 Weeks)|Death|3|||
130133550|NCT03496623|468450104|FG002|Period 1 (12 Weeks)|Death|0|||
130133551|NCT03496623|468450105|FG003|Period 1 (12 Weeks)|Death|0|||
130133552|NCT03496623|468450106|FG004|Period 1 (12 Weeks)|Death|0|||
130133553|NCT03496623|468450102|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130133554|NCT03496623|468450103|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130133555|NCT03496623|468450104|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
130133556|NCT03496623|468450105|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
130133557|NCT03496623|468450106|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
130133558|NCT03496623|468450102|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130133559|NCT03496623|468450103|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130133560|NCT03496623|468450104|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
130133561|NCT03496623|468450105|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130133562|NCT03496623|468450106|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
130133563|NCT03496623|468450102|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130133564|NCT03496623|468450103|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
130133565|NCT03496623|468450104|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
130133566|NCT03496623|468450105|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130133567|NCT03496623|468450106|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
130133568|NCT03496623|468450102|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130133569|NCT03496623|468450103|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130133570|NCT03496623|468450104|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
130133571|NCT03496623|468450105|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130133572|NCT03496623|468450106|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
130133573|NCT03496623|468450102|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130133574|NCT03496623|468450103|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130133575|NCT03496623|468450104|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
130133576|NCT03496623|468450105|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130133577|NCT03496623|468450106|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
130133578|NCT03496623|468450102|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130133579|NCT03496623|468450103|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
130133580|NCT03496623|468450104|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
130133581|NCT03496623|468450105|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130133582|NCT03496623|468450106|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
130133583|NCT01527006|468450110|FG000|Core Study|Adverse Event|0|||
130133584|NCT01527006|468450111|FG001|Core Study|Adverse Event|2|||
130133585|NCT01527006|468450110|FG000|Core Study|Lost to Follow-up|0|||
130133586|NCT01527006|468450111|FG001|Core Study|Lost to Follow-up|1|||
130133587|NCT01527006|468450110|FG000|Core Study|Subject Choice|1|||
130133588|NCT01527006|468450111|FG001|Core Study|Subject Choice|0|||
130133589|NCT01527006|468450110|FG000|Core Study|Inadequate Therapeutic Effect|1|||
130133590|NCT01527006|468450111|FG001|Core Study|Inadequate Therapeutic Effect|0|||
130133591|NCT01527006|468450110|FG000|Core Study|Withdrawal by Subject|0|||
130133592|NCT01527006|468450111|FG001|Core Study|Withdrawal by Subject|1|||
130133593|NCT01527006|468450110|FG000|Core Study|Other|0|||
130133594|NCT01527006|468450111|FG001|Core Study|Other|2|||
130133595|NCT01527006|468450110|FG000|Extension Phase|Adverse Event|4|||
130133596|NCT01527006|468450111|FG001|Extension Phase|Adverse Event|2|||
130133597|NCT01527006|468450110|FG000|Extension Phase|Lost to Follow-up|0|||
130133598|NCT01527006|468450111|FG001|Extension Phase|Lost to Follow-up|1|||
130133599|NCT01527006|468450110|FG000|Extension Phase|Subject Choice|1|||
130133600|NCT01527006|468450111|FG001|Extension Phase|Subject Choice|1|||
130133601|NCT01527006|468450110|FG000|Extension Phase|Inadequate therapeutic effect|1|||
130133602|NCT01527006|468450111|FG001|Extension Phase|Inadequate therapeutic effect|1|||
130133603|NCT01527006|468450110|FG000|Extension Phase|Other|0|||
130133604|NCT01527006|468450111|FG001|Extension Phase|Other|3|||
130133605|NCT00123734|468450112|FG000|Overall Study|Death|3|||
130133606|NCT00123734|468450112|FG000|Overall Study|Lost to Follow-up|3|||
130133607|NCT00123734|468450112|FG000|Overall Study|Dropout|1|||
130133608|NCT00123734|468450112|FG000|Overall Study|Withdrawal by Subject|1|||
130133609|NCT00834340|468450113|FG000|Washout|Adverse Event|1|||
130133610|NCT00834340|468450114|FG001|Washout|Adverse Event|0|||
130133611|NCT00834340|468450113|FG000|Washout|Withdrawal by Subject|1|||
130133612|NCT00834340|468450114|FG001|Washout|Withdrawal by Subject|0|||
130133613|NCT04238754|468450120|FG000|Washout - 1 Week|Lost to Follow-up|1|||
130133614|NCT04238754|468450121|FG001|Washout - 1 Week|Lost to Follow-up|0|||
130133615|NCT00840073|468450125|FG000|Second Intervention|Missed 72 hour blood draw|1|||
130133616|NCT00840073|468450126|FG001|Second Intervention|Missed 72 hour blood draw|1|||
130133617|NCT01103713|468450130|FG000|Overall Study|Lost to Follow-up|2|||
130133618|NCT01103713|468450130|FG000|Overall Study|Withdrawal by Subject|8|||
130133619|NCT01103713|468450130|FG000|Overall Study|Study terminated by sponsor|2|||
130133620|NCT01103713|468450130|FG000|Overall Study|Other|1|||
130133621|NCT00505622|468450133|FG000|Overall Study|Adverse Event|5|||
130133622|NCT00505622|468450134|FG001|Overall Study|Adverse Event|6|||
130133623|NCT00505622|468450135|FG002|Overall Study|Adverse Event|4|||
130133624|NCT00505622|468450133|FG000|Overall Study|Protocol Violation|1|||
130133625|NCT00505622|468450134|FG001|Overall Study|Protocol Violation|1|||
130133626|NCT00505622|468450135|FG002|Overall Study|Protocol Violation|0|||
130133627|NCT00505622|468450133|FG000|Overall Study|Withdrawal by Subject|0|||
130133628|NCT00505622|468450134|FG001|Overall Study|Withdrawal by Subject|3|||
130133629|NCT00505622|468450135|FG002|Overall Study|Withdrawal by Subject|2|||
130133630|NCT00505622|468450133|FG000|Overall Study|Study termination by sponsor|115|||
130133631|NCT00505622|468450134|FG001|Overall Study|Study termination by sponsor|98|||
130133632|NCT00505622|468450135|FG002|Overall Study|Study termination by sponsor|90|||
130133633|NCT03084471|468450138|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
130133634|NCT03084471|468450138|FG000|Overall Study|Condition under investigation worsened|84|||
130133635|NCT03084471|468450138|FG000|Overall Study|Lack of therapeutic response|2|||
130133636|NCT03084471|468450138|FG000|Overall Study|Protocol Violation|1|||
130133637|NCT03084471|468450138|FG000|Overall Study|Adverse Event|73|||
130133638|NCT03084471|468450138|FG000|Overall Study|Withdrawal by Subject|12|||
130133639|NCT03084471|468450138|FG000|Overall Study|Disease relapse|181|||
130133640|NCT03084471|468450138|FG000|Overall Study|Subjective disease progression|359|||
130133641|NCT03084471|468450138|FG000|Overall Study|Other (as recorded)|33|||
130133642|NCT03084471|468450138|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
130133643|NCT00796653|468450139|FG000|Overall Study|Adverse Event|19|||
130133644|NCT00796653|468450140|FG001|Overall Study|Adverse Event|16|||
130133645|NCT00796653|468450141|FG002|Overall Study|Adverse Event|16|||
130133646|NCT00796653|468450142|FG003|Overall Study|Adverse Event|16|||
130133647|NCT00796653|468450139|FG000|Overall Study|Lost to Follow-up|2|||
130133648|NCT00796653|468450140|FG001|Overall Study|Lost to Follow-up|1|||
130133649|NCT00796653|468450141|FG002|Overall Study|Lost to Follow-up|2|||
130133650|NCT00796653|468450142|FG003|Overall Study|Lost to Follow-up|3|||
130133651|NCT00796653|468450139|FG000|Overall Study|Withdrawal by Subject|16|||
130133652|NCT00796653|468450140|FG001|Overall Study|Withdrawal by Subject|8|||
130133653|NCT00796653|468450141|FG002|Overall Study|Withdrawal by Subject|8|||
130133654|NCT00796653|468450142|FG003|Overall Study|Withdrawal by Subject|13|||
130133655|NCT00796653|468450139|FG000|Overall Study|Lack of Efficacy|8|||
130133656|NCT00796653|468450140|FG001|Overall Study|Lack of Efficacy|1|||
130133657|NCT00796653|468450141|FG002|Overall Study|Lack of Efficacy|3|||
130133658|NCT00796653|468450142|FG003|Overall Study|Lack of Efficacy|2|||
130133659|NCT00796653|468450139|FG000|Overall Study|Non compliance with protocol|2|||
130133660|NCT00796653|468450140|FG001|Overall Study|Non compliance with protocol|2|||
130133661|NCT00796653|468450141|FG002|Overall Study|Non compliance with protocol|0|||
130133662|NCT00796653|468450142|FG003|Overall Study|Non compliance with protocol|2|||
130133663|NCT00796653|468450139|FG000|Overall Study|Other reason not described above|4|||
130133664|NCT00796653|468450140|FG001|Overall Study|Other reason not described above|9|||
130133665|NCT00796653|468450141|FG002|Overall Study|Other reason not described above|7|||
130133666|NCT00796653|468450142|FG003|Overall Study|Other reason not described above|4|||
130133667|NCT01848938|468450153|FG000|Overall Study|Lost to Follow-up|1|||
130133668|NCT01848938|468450154|FG001|Overall Study|Lost to Follow-up|1|||
130133669|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
130133670|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
130133671|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
130133672|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
130133673|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
130133674|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
130133675|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130133676|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
130133677|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
130133678|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
130133679|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
130133680|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
130133681|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
130133682|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
130133683|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130133684|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
130133685|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
130133686|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
130133687|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
130133688|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
130133689|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Death|0|||
129971188|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
129971189|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Death|2|||
129971190|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Death|0|||
129971191|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Death|0|||
129971192|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
130094248|NCT00933543|468300600|FG001|Overall Study|Other|1|||
130094249|NCT04988035|468300601|FG000|Overall Study|Death|19|||
130094250|NCT04988035|468300602|FG001|Overall Study|Death|13|||
130094251|NCT04988035|468300601|FG000|Overall Study|Lost to Follow-up|12|||
130094252|NCT04988035|468300602|FG001|Overall Study|Lost to Follow-up|6|||
130094253|NCT04988035|468300601|FG000|Overall Study|Protocol Violation|0|||
130094254|NCT04988035|468300602|FG001|Overall Study|Protocol Violation|1|||
130094255|NCT04988035|468300601|FG000|Overall Study|Withdrawal by Subject|2|||
130094256|NCT04988035|468300602|FG001|Overall Study|Withdrawal by Subject|4|||
130094257|NCT04988035|468300601|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
130094258|NCT04988035|468300602|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
130094259|NCT04626947|468300603|FG000|Overall Study|Study terminated|14|||
130094260|NCT00399542|468300604|FG000|Overall Study|Adverse Event|18|||
130094261|NCT00399542|468300605|FG001|Overall Study|Adverse Event|15|||
130094262|NCT00399542|468300604|FG000|Overall Study|Protocol Violation|13|||
130094263|NCT00399542|468300605|FG001|Overall Study|Protocol Violation|3|||
130094264|NCT00399542|468300604|FG000|Overall Study|Withdrawal by Subject|28|||
130094265|NCT00399542|468300605|FG001|Overall Study|Withdrawal by Subject|10|||
130094266|NCT00399542|468300604|FG000|Overall Study|Lack of Efficacy|18|||
130094267|NCT00399542|468300605|FG001|Overall Study|Lack of Efficacy|8|||
130094268|NCT00399542|468300604|FG000|Overall Study|Lost to Follow-up|6|||
130094269|NCT00399542|468300605|FG001|Overall Study|Lost to Follow-up|6|||
130094270|NCT00399542|468300604|FG000|Overall Study|Other|1|||
130094271|NCT00399542|468300605|FG001|Overall Study|Other|0|||
130094272|NCT00399542|468300604|FG000|Overall Study|Physician Decision|0|||
130094273|NCT00399542|468300605|FG001|Overall Study|Physician Decision|1|||
130094274|NCT03172026|468300606|FG000|Overall Study|Withdrawal by Subject|1|||
130094275|NCT03172026|468300607|FG001|Overall Study|Withdrawal by Subject|0|||
130094276|NCT03172026|468300606|FG000|Overall Study|COVID restrictions|1|||
130094277|NCT03172026|468300607|FG001|Overall Study|COVID restrictions|0|||
130094278|NCT02463097|468300608|FG000|Overall Study|Withdrawal by Subject|1|||
130094279|NCT01757821|468300609|FG000|Overall Study|Adverse Event|1|||
130094280|NCT01552408|468300610|FG000|Overall Study|Lost to Follow-up|2|||
130094281|NCT01552408|468300611|FG001|Overall Study|Lost to Follow-up|0|||
130094282|NCT01552408|468300610|FG000|Overall Study|Relocation|0|||
130094283|NCT01552408|468300611|FG001|Overall Study|Relocation|1|||
130094284|NCT01552408|468300610|FG000|Overall Study|Withdrawal by Subject|2|||
130094285|NCT01552408|468300611|FG001|Overall Study|Withdrawal by Subject|1|||
130094286|NCT00383292|468300614|FG000|Overall Study|Adverse Event|4|||
130094287|NCT00383292|468300615|FG001|Overall Study|Adverse Event|1|||
130094288|NCT00383292|468300616|FG002|Overall Study|Adverse Event|2|||
130094289|NCT00383292|468300614|FG000|Overall Study|Death|3|||
130094290|NCT00383292|468300615|FG001|Overall Study|Death|3|||
130094291|NCT00383292|468300616|FG002|Overall Study|Death|3|||
130094292|NCT00383292|468300614|FG000|Overall Study|Physician Decision|4|||
130094293|NCT00383292|468300615|FG001|Overall Study|Physician Decision|0|||
130094294|NCT00383292|468300616|FG002|Overall Study|Physician Decision|1|||
130094295|NCT00383292|468300614|FG000|Overall Study|Withdrawal by Subject|3|||
130094296|NCT00383292|468300615|FG001|Overall Study|Withdrawal by Subject|2|||
130094297|NCT00383292|468300616|FG002|Overall Study|Withdrawal by Subject|2|||
130094298|NCT00383292|468300614|FG000|Overall Study|Other|1|||
130094299|NCT00383292|468300615|FG001|Overall Study|Other|0|||
130094300|NCT00383292|468300616|FG002|Overall Study|Other|0|||
130094301|NCT01016912|468300617|FG000|End of Treatment Period|Lack of Efficacy|0|||
130094302|NCT01016912|468300618|FG001|End of Treatment Period|Lack of Efficacy|1|||
130094303|NCT01016912|468300619|FG002|End of Treatment Period|Lack of Efficacy|0|||
130094304|NCT01016912|468300620|FG003|End of Treatment Period|Lack of Efficacy|4|||
130094305|NCT01016912|468300621|FG004|End of Treatment Period|Lack of Efficacy|4|||
130094306|NCT01016912|468300617|FG000|End of Treatment Period|Adverse Event|0|||
130094307|NCT01016912|468300618|FG001|End of Treatment Period|Adverse Event|1|||
130094308|NCT01016912|468300619|FG002|End of Treatment Period|Adverse Event|1|||
130094309|NCT01016912|468300620|FG003|End of Treatment Period|Adverse Event|0|||
130094310|NCT01016912|468300621|FG004|End of Treatment Period|Adverse Event|0|||
130094311|NCT01016912|468300617|FG000|End of Treatment Period|Completed double-blind period only|0|||
130094312|NCT01016912|468300618|FG001|End of Treatment Period|Completed double-blind period only|1|||
130094313|NCT01016912|468300619|FG002|End of Treatment Period|Completed double-blind period only|0|||
130094314|NCT01016912|468300620|FG003|End of Treatment Period|Completed double-blind period only|0|||
130094315|NCT01016912|468300621|FG004|End of Treatment Period|Completed double-blind period only|0|||
130094316|NCT01016912|468300617|FG000|Follow-up Period|Other reason|0|||
130133690|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Death|1|||
130133691|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Death|0|||
130133692|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Death|0|||
130133693|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
130133694|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
130133695|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
130133696|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
130133697|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
130133698|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130133699|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130133700|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
130133701|NCT01940341|468450155|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130133702|NCT01940341|468450156|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
130133703|NCT01940341|468450157|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130133704|NCT01940341|468450158|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
130133705|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130133706|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
130133707|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
130133708|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
130133709|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130133710|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
130133711|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
130133712|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
130133713|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130133714|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130133715|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
130133716|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
130133717|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
130133718|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
130133719|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
130133720|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
130133721|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130133722|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130133723|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
130133724|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
130133725|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
130133726|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
130133727|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
130133728|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
130133729|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130133730|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130133731|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
130133732|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
130133733|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130133734|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130133735|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
130133736|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
130133737|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130133738|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130133739|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
130133740|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
129971193|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
129971194|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
129971195|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
130133741|NCT01940341|468450155|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130133742|NCT01940341|468450156|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130133743|NCT01940341|468450157|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
130133744|NCT01940341|468450158|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
130133745|NCT01757392|468450161|FG000|Overall Study|Withdrawal by Subject|1|||
130133746|NCT01757392|468450161|FG000|Overall Study|Screen Fail|3|||
130133747|NCT00207090|468450166|FG000|Overall Study|Study drug toxicity|3|||
130133748|NCT00207090|468450166|FG000|Overall Study|Chest wall mass larger|1|||
130133749|NCT00207090|468450166|FG000|Overall Study|Disease progression/relapse|2|||
130133750|NCT00207090|468450166|FG000|Overall Study|Physician Decision|1|||
130133751|NCT00841698|468450169|FG000|First Intervention|Withdrawal by Subject|1|||
130133752|NCT00841698|468450170|FG001|First Intervention|Withdrawal by Subject|0|||
130133753|NCT00651820|468450181|FG000|Overall Study|Lost to Follow-up|2|||
130133754|NCT00773253|468450183|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
130133755|NCT00773253|468450184|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
130133756|NCT01878292|468450185|FG000|Randomized|Protocol Violation|1|||
130133757|NCT01878292|468450186|FG001|Randomized|Protocol Violation|0|||
130133758|NCT01878292|468450187|FG002|Randomized|Protocol Violation|0|||
130133759|NCT01878292|468450185|FG000|Randomized|Lost to Follow-up|1|||
130133760|NCT01878292|468450186|FG001|Randomized|Lost to Follow-up|0|||
130133761|NCT01878292|468450187|FG002|Randomized|Lost to Follow-up|0|||
130133762|NCT01878292|468450185|FG000|Randomized|Adverse Event|1|||
130133763|NCT01878292|468450186|FG001|Randomized|Adverse Event|0|||
130133764|NCT01878292|468450187|FG002|Randomized|Adverse Event|0|||
130133765|NCT01878292|468450185|FG000|Double-blind Treatment Period|Other Reasons|2|||
130133766|NCT01878292|468450186|FG001|Double-blind Treatment Period|Other Reasons|0|||
130133767|NCT01878292|468450187|FG002|Double-blind Treatment Period|Other Reasons|0|||
130133768|NCT01878292|468450185|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
130133769|NCT01878292|468450186|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
130133770|NCT01878292|468450187|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
130133771|NCT01878292|468450185|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
130133772|NCT01878292|468450186|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
130133773|NCT01878292|468450187|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
130133774|NCT01878292|468450185|FG000|Double-blind Treatment Period|Protocol Violation|3|||
130133775|NCT01878292|468450186|FG001|Double-blind Treatment Period|Protocol Violation|4|||
130133776|NCT01878292|468450187|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130133777|NCT01878292|468450185|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
130133778|NCT01878292|468450186|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
130133779|NCT01878292|468450187|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
130133780|NCT01878292|468450185|FG000|Double-blind Treatment Period|Adverse Event|4|||
130133781|NCT01878292|468450186|FG001|Double-blind Treatment Period|Adverse Event|9|||
130133782|NCT01878292|468450187|FG002|Double-blind Treatment Period|Adverse Event|8|||
130133783|NCT01878292|468450185|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
130133784|NCT01878292|468450186|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
130133785|NCT01878292|468450187|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
130133786|NCT01302548|468450192|FG000|Overall Study|Lost to Follow-up|2|||
130133787|NCT01302548|468450193|FG001|Overall Study|Lost to Follow-up|1|||
130133788|NCT01249651|468450195|FG000|Overall Study|Withdrawal by Subject|4|||
130133789|NCT01249651|468450195|FG000|Overall Study|Adverse Event|1|||
130133790|NCT01249651|468450195|FG000|Overall Study|Protocol Violation|1|||
130133791|NCT01249651|468450195|FG000|Overall Study|Sponsor Decision|1|||
130133792|NCT03873272|468450196|FG000|Overall Study|Withdrawal by Subject|2|||
130133793|NCT03873272|468450197|FG001|Overall Study|Withdrawal by Subject|0|||
130133794|NCT03873272|468450198|FG002|Overall Study|Withdrawal by Subject|1|||
130133795|NCT03873272|468450196|FG000|Overall Study|Death|0|||
130133796|NCT03873272|468450197|FG001|Overall Study|Death|2|||
130133797|NCT03873272|468450198|FG002|Overall Study|Death|1|||
130133798|NCT00787254|468450199|FG000|Overall Study|Adverse Event|24|||
130133799|NCT00787254|468450200|FG001|Overall Study|Adverse Event|23|||
130133800|NCT00787254|468450199|FG000|Overall Study|Protocol Violation|26|||
130133801|NCT00787254|468450200|FG001|Overall Study|Protocol Violation|23|||
130133802|NCT00787254|468450199|FG000|Overall Study|Withdrawal by Subject|16|||
130133803|NCT00787254|468450200|FG001|Overall Study|Withdrawal by Subject|11|||
130133804|NCT00787254|468450199|FG000|Overall Study|Lack of Efficacy|4|||
130133805|NCT00787254|468450200|FG001|Overall Study|Lack of Efficacy|15|||
130133806|NCT00787254|468450199|FG000|Overall Study|NSAIDs discontinuation|1|||
130133807|NCT00787254|468450200|FG001|Overall Study|NSAIDs discontinuation|2|||
130133808|NCT00787254|468450199|FG000|Overall Study|Institution closed|1|||
130133809|NCT00787254|468450200|FG001|Overall Study|Institution closed|0|||
130133810|NCT00787254|468450199|FG000|Overall Study|Physician Decision|4|||
130133811|NCT00787254|468450200|FG001|Overall Study|Physician Decision|8|||
130133812|NCT00859430|468450201|FG000|First Intervention|Withdrawal by Subject|0|||
130133813|NCT00859430|468450202|FG001|First Intervention|Withdrawal by Subject|1|||
130133814|NCT04115293|468452507|FG000|Overall Study|Adverse Event|0|||
130133815|NCT04115293|468452508|FG001|Overall Study|Adverse Event|2|||
130133816|NCT04115293|468452507|FG000|Overall Study|Withdrawal by Subject|2|||
130133817|NCT04115293|468452508|FG001|Overall Study|Withdrawal by Subject|1|||
130133818|NCT04115293|468452507|FG000|Overall Study|Physician Decision|1|||
130133819|NCT04115293|468452508|FG001|Overall Study|Physician Decision|0|||
130133820|NCT04115293|468452507|FG000|Overall Study|Death|1|||
130133821|NCT04115293|468452508|FG001|Overall Study|Death|1|||
130133822|NCT00001703|468452509|FG000|Overall Study|progressed disease|2|||
130133823|NCT00001703|468452509|FG000|Overall Study|No evidence of disease|1|||
130133824|NCT00001703|468452509|FG000|Overall Study|recurrent disease|2|||
130133825|NCT02057835|468452510|FG000|Overall Study|Withdrawal by Subject|0|||
130133826|NCT02057835|468452511|FG001|Overall Study|Withdrawal by Subject|2|||
130133827|NCT02057835|468452512|FG002|Overall Study|Withdrawal by Subject|0|||
130133828|NCT02057835|468452513|FG003|Overall Study|Withdrawal by Subject|0|||
130133829|NCT02057835|468452514|FG004|Overall Study|Withdrawal by Subject|0|||
130133830|NCT02057835|468452515|FG005|Overall Study|Withdrawal by Subject|0|||
130133831|NCT02057835|468452516|FG006|Overall Study|Withdrawal by Subject|0|||
130133832|NCT02057835|468452517|FG007|Overall Study|Withdrawal by Subject|0|||
130133833|NCT02057835|468452518|FG008|Overall Study|Withdrawal by Subject|0|||
130133834|NCT02057835|468452519|FG009|Overall Study|Withdrawal by Subject|0|||
130133835|NCT01660243|468452520|FG000|Overall Study|Adverse Event|1|||
130133836|NCT01660243|468452521|FG001|Overall Study|Adverse Event|0|||
130133837|NCT01660243|468452522|FG002|Overall Study|Adverse Event|1|||
130133838|NCT01660243|468452523|FG003|Overall Study|Adverse Event|0|||
130133839|NCT01660243|468452520|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
130133840|NCT01660243|468452521|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130133841|NCT01660243|468452522|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130133842|NCT01660243|468452523|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
130133843|NCT01660243|468452520|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130133844|NCT01660243|468452521|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130133845|NCT01660243|468452522|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
130133846|NCT01660243|468452523|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
130133847|NCT01660243|468452520|FG000|Overall Study|Randomization error|0|||
130133848|NCT01660243|468452521|FG001|Overall Study|Randomization error|0|||
130133849|NCT01660243|468452522|FG002|Overall Study|Randomization error|0|||
130133850|NCT01660243|468452523|FG003|Overall Study|Randomization error|1|||
130133851|NCT00712959|468452530|FG000|Overall Study|Protocol Violation|3|||
130133852|NCT00712959|468452531|FG001|Overall Study|Protocol Violation|1|||
130133853|NCT00712959|468452530|FG000|Overall Study|Lost to Follow-up|13|||
130133854|NCT00712959|468452531|FG001|Overall Study|Lost to Follow-up|2|||
130133855|NCT00712959|468452530|FG000|Overall Study|Withdrawal by Subject|3|||
130133856|NCT00712959|468452531|FG001|Overall Study|Withdrawal by Subject|0|||
130133857|NCT00508651|468452532|FG000|Overall Study|Lost to Follow-up|3|||
130133858|NCT00508651|468452533|FG001|Overall Study|Lost to Follow-up|1|||
130133859|NCT00508651|468452532|FG000|Overall Study|Withdrawal by Subject|1|||
130133860|NCT00508651|468452533|FG001|Overall Study|Withdrawal by Subject|1|||
130133861|NCT02328040|468452535|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
130133862|NCT02328040|468452536|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
130133863|NCT03121586|468452541|FG000|Overall Study|Study terminated by sponsor|0|||
130133864|NCT03121586|468452542|FG001|Overall Study|Study terminated by sponsor|0|||
130133865|NCT03121586|468452543|FG002|Overall Study|Study terminated by sponsor|99|||
130133866|NCT03121586|468452541|FG000|Overall Study|Withdrawal by Subject|37|||
130133867|NCT03121586|468452542|FG001|Overall Study|Withdrawal by Subject|14|||
130133868|NCT03121586|468452543|FG002|Overall Study|Withdrawal by Subject|9|||
130133869|NCT03121586|468452541|FG000|Overall Study|Not further specified|6|||
130133870|NCT03121586|468452542|FG001|Overall Study|Not further specified|11|||
130133871|NCT03121586|468452543|FG002|Overall Study|Not further specified|10|||
130133872|NCT03121586|468452541|FG000|Overall Study|Adverse Event|16|||
130133873|NCT03121586|468452542|FG001|Overall Study|Adverse Event|5|||
130133874|NCT03121586|468452543|FG002|Overall Study|Adverse Event|6|||
130133875|NCT03121586|468452541|FG000|Overall Study|Protocol Violation|0|||
130133876|NCT03121586|468452542|FG001|Overall Study|Protocol Violation|5|||
130133877|NCT03121586|468452543|FG002|Overall Study|Protocol Violation|0|||
130133878|NCT03121586|468452541|FG000|Overall Study|Lack of Efficacy|3|||
130133879|NCT03121586|468452542|FG001|Overall Study|Lack of Efficacy|3|||
130133880|NCT03121586|468452543|FG002|Overall Study|Lack of Efficacy|1|||
130133881|NCT03121586|468452541|FG000|Overall Study|Physician Decision|2|||
130133882|NCT03121586|468452542|FG001|Overall Study|Physician Decision|2|||
130133883|NCT03121586|468452543|FG002|Overall Study|Physician Decision|0|||
130133884|NCT03121586|468452541|FG000|Overall Study|Noncompliance with study drug|5|||
130133885|NCT03121586|468452542|FG001|Overall Study|Noncompliance with study drug|3|||
130133886|NCT03121586|468452543|FG002|Overall Study|Noncompliance with study drug|5|||
130133887|NCT03121586|468452541|FG000|Overall Study|Lost to Follow-up|4|||
130133888|NCT03121586|468452542|FG001|Overall Study|Lost to Follow-up|2|||
130133889|NCT03121586|468452543|FG002|Overall Study|Lost to Follow-up|0|||
130133890|NCT03121586|468452541|FG000|Overall Study|Death|2|||
130133891|NCT03121586|468452542|FG001|Overall Study|Death|0|||
130133892|NCT03121586|468452543|FG002|Overall Study|Death|0|||
130133893|NCT06381102|468452544|FG000|Washout 5 Days|Withdrawal by Subject|0|||
130133894|NCT06381102|468452545|FG001|Washout 5 Days|Withdrawal by Subject|2|||
130133895|NCT04278560|468452546|FG000|Overall Study|Adverse Event|1|||
130133896|NCT04278560|468452547|FG001|Overall Study|Adverse Event|2|||
130133897|NCT04278560|468452546|FG000|Overall Study|Withdrawal by Subject|0|||
130133898|NCT04278560|468452547|FG001|Overall Study|Withdrawal by Subject|1|||
130133899|NCT02832063|468452548|FG000|Overall Study|Adverse Event|2|||
130133900|NCT02832063|468452549|FG001|Overall Study|Adverse Event|1|||
130133901|NCT02832063|468452548|FG000|Overall Study|Physician Decision|5|||
130133902|NCT02832063|468452549|FG001|Overall Study|Physician Decision|7|||
130133903|NCT02832063|468452548|FG000|Overall Study|Lost to Follow-up|15|||
130133904|NCT02832063|468452549|FG001|Overall Study|Lost to Follow-up|8|||
130133905|NCT02832063|468452548|FG000|Overall Study|Withdrawal by Subject|10|||
130133906|NCT02832063|468452549|FG001|Overall Study|Withdrawal by Subject|21|||
130133907|NCT02832063|468452548|FG000|Overall Study|Other|2|||
130133908|NCT02832063|468452549|FG001|Overall Study|Other|1|||
130133909|NCT04994535|468452550|FG000|Overall Study|Lost to Follow-up|7|||
130133910|NCT04994535|468452551|FG001|Overall Study|Lost to Follow-up|7|||
130133911|NCT04994535|468452550|FG000|Overall Study|Withdrawal by Subject|10|||
130133912|NCT04994535|468452551|FG001|Overall Study|Withdrawal by Subject|7|||
130133913|NCT04994535|468452550|FG000|Overall Study|Other|1|||
130133914|NCT04994535|468452551|FG001|Overall Study|Other|1|||
130133915|NCT01158118|468452552|FG000|Overall Study|Screen failure|1|||
130133916|NCT01158118|468452553|FG001|Overall Study|Screen failure|0|||
130133917|NCT01158118|468452552|FG000|Overall Study|Donor match was a screen failure|0|||
130133918|NCT01158118|468452553|FG001|Overall Study|Donor match was a screen failure|1|||
130133919|NCT01158118|468452552|FG000|Overall Study|Suffered stroke prior to transplant|0|||
130133920|NCT01158118|468452553|FG001|Overall Study|Suffered stroke prior to transplant|1|||
130133921|NCT01158118|468452552|FG000|Overall Study|Death|0|||
130133922|NCT01158118|468452553|FG001|Overall Study|Death|1|||
130133923|NCT00604162|468452554|FG000|Overall Study|Physician Decision|3|||
130133924|NCT00604162|468452554|FG000|Overall Study|Withdrawal by Subject|1|||
130133925|NCT02241551|468452555|FG000|Overall Study|Adverse Event|1|||
130133926|NCT02241551|468452556|FG001|Overall Study|Adverse Event|0|||
130133927|NCT01015287|468452557|FG000|Overall Study|Death|21|||
130133928|NCT01015287|468452558|FG001|Overall Study|Death|16|||
130133929|NCT01015287|468452557|FG000|Overall Study|Adverse Event|1|||
130133930|NCT01015287|468452558|FG001|Overall Study|Adverse Event|0|||
130133931|NCT01015287|468452557|FG000|Overall Study|Sponsor Decision|3|||
130133932|NCT01015287|468452558|FG001|Overall Study|Sponsor Decision|7|||
130133933|NCT01015287|468452557|FG000|Overall Study|Physician Decision|19|||
130133934|NCT01015287|468452558|FG001|Overall Study|Physician Decision|21|||
130133935|NCT01015287|468452557|FG000|Overall Study|Withdrawal by Subject|14|||
130133936|NCT01015287|468452558|FG001|Overall Study|Withdrawal by Subject|19|||
130133937|NCT01015287|468452557|FG000|Overall Study|Entry Criteria not Met|11|||
130133938|NCT01015287|468452558|FG001|Overall Study|Entry Criteria not Met|14|||
130133939|NCT01015287|468452557|FG000|Overall Study|Lost to Follow-up|2|||
130133940|NCT01015287|468452558|FG001|Overall Study|Lost to Follow-up|1|||
130133941|NCT01015287|468452557|FG000|Overall Study|Protocol Violation|1|||
130133942|NCT01015287|468452558|FG001|Overall Study|Protocol Violation|1|||
130133943|NCT00469898|468452559|FG000|Overall Study|Adverse Event|7|||
130133944|NCT00469898|468452559|FG000|Overall Study|Withdrawal by Subject|4|||
130133945|NCT00469898|468452559|FG000|Overall Study|Death|4|||
130133946|NCT00469898|468452559|FG000|Overall Study|Disease progression|9|||
130133947|NCT00469898|468452559|FG000|Overall Study|Decreased performance status|1|||
130133948|NCT01370317|468452560|FG000|Overall Study|Participant withdrew consent|1|||
130133949|NCT01370317|468452561|FG001|Overall Study|Participant withdrew consent|0|||
130133950|NCT01370317|468452560|FG000|Overall Study|Protocol deviation|0|||
130133951|NCT01370317|468452561|FG001|Overall Study|Protocol deviation|1|||
130133952|NCT00113386|468452566|FG000|Overall Study|Withdrawal by Subject|1|||
130133953|NCT00113386|468452567|FG001|Overall Study|Withdrawal by Subject|0|||
130133954|NCT00113386|468452566|FG000|Overall Study|Physician Decision|0|||
130133955|NCT00113386|468452567|FG001|Overall Study|Physician Decision|1|||
130133956|NCT00113386|468452566|FG000|Overall Study|Toxicity|3|||
130133957|NCT00113386|468452567|FG001|Overall Study|Toxicity|0|||
130133958|NCT00113386|468452566|FG000|Overall Study|Ineligible|1|||
130133959|NCT00113386|468452567|FG001|Overall Study|Ineligible|2|||
130133960|NCT00113386|468452566|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
130133961|NCT00113386|468452567|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
130133962|NCT02849457|468452568|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130133963|NCT02849457|468452569|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130133964|NCT02849457|468452570|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
130133965|NCT02849457|468452571|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
130133966|NCT00392665|468452572|FG000|Overall Study|Death|16|||
130133967|NCT00392665|468452573|FG001|Overall Study|Death|14|||
130133968|NCT00392665|468452572|FG000|Overall Study|Lost to Follow-up|1|||
130133969|NCT00392665|468452573|FG001|Overall Study|Lost to Follow-up|1|||
130133970|NCT03673670|468452576|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
130133971|NCT03673670|468452577|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130133972|NCT03673670|468452578|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130133973|NCT03673670|468452579|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130133974|NCT03673670|468452580|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130133975|NCT03673670|468452581|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
130133976|NCT03673670|468452576|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
130133977|NCT03673670|468452577|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
130133978|NCT03673670|468452578|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
130133979|NCT03673670|468452579|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
130133980|NCT03673670|468452580|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
130133981|NCT03673670|468452581|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
130133982|NCT03673670|468452576|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
130133983|NCT03673670|468452577|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
130133984|NCT03673670|468452578|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
130133985|NCT03673670|468452579|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
130133986|NCT03673670|468452580|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
130133987|NCT03673670|468452581|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
130133988|NCT03673670|468452576|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130133989|NCT03673670|468452577|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130133990|NCT03673670|468452578|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130133991|NCT03673670|468452579|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130133992|NCT03673670|468452580|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
130133993|NCT03673670|468452581|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
130133994|NCT03673670|468452576|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
130133995|NCT03673670|468452577|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
130133996|NCT03673670|468452578|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
130133997|NCT03673670|468452579|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
130133998|NCT03673670|468452580|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
130133999|NCT03673670|468452581|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
130134000|NCT03673670|468452576|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130134001|NCT03673670|468452577|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130134002|NCT03673670|468452578|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130134003|NCT03673670|468452579|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130134004|NCT03673670|468452580|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
130134005|NCT03673670|468452581|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
130134006|NCT03673670|468452576|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
130134007|NCT03673670|468452577|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
130134008|NCT03673670|468452578|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
130134009|NCT03673670|468452579|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
130134010|NCT03673670|468452580|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
130134011|NCT03673670|468452581|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
130134012|NCT04408794|468452582|FG000|Overall Study|Adverse Event|43|||
130134013|NCT04408794|468452582|FG000|Overall Study|Infrequent study drug usage|43|||
130134014|NCT04408794|468452582|FG000|Overall Study|Lack of Efficacy|61|||
130134015|NCT04408794|468452582|FG000|Overall Study|Lost to Follow-up|33|||
130134016|NCT04408794|468452582|FG000|Overall Study|Non-compliance|6|||
130134017|NCT04408794|468452582|FG000|Overall Study|Physician Decision|1|||
130134018|NCT04408794|468452582|FG000|Overall Study|Pregnancy|6|||
130134019|NCT04408794|468452582|FG000|Overall Study|Protocol Deviation|9|||
130134020|NCT04408794|468452582|FG000|Overall Study|Sheehan-STS Result|1|||
130134021|NCT04408794|468452582|FG000|Overall Study|Withdrawal by Subject|57|||
130134022|NCT04408794|468452582|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
130134023|NCT04408794|468452582|FG000|Overall Study|Never Treated Migraine|5|||
130134024|NCT02294786|468452587|FG000|Overall Study|Withdrawal by Subject|0|||
130134025|NCT02294786|468452588|FG001|Overall Study|Withdrawal by Subject|1|||
130134026|NCT02294786|468452587|FG000|Overall Study|Physician Decision|6|||
130134027|NCT02294786|468452588|FG001|Overall Study|Physician Decision|7|||
130134028|NCT02294786|468452587|FG000|Overall Study|Lost to Follow-up|1|||
130134029|NCT02294786|468452588|FG001|Overall Study|Lost to Follow-up|2|||
130134030|NCT02294786|468452587|FG000|Overall Study|Protocol Violation|1|||
130134031|NCT02294786|468452588|FG001|Overall Study|Protocol Violation|0|||
130134032|NCT02294786|468452587|FG000|Overall Study|Adverse Event|1|||
130134033|NCT02294786|468452588|FG001|Overall Study|Adverse Event|1|||
130134034|NCT02294786|468452587|FG000|Overall Study|Death|2|||
130134035|NCT02294786|468452588|FG001|Overall Study|Death|3|||
130134036|NCT01778010|468452589|FG000|Overall Study|Withdrawal by Subject|2|||
130134037|NCT01778010|468452589|FG000|Overall Study|abnormal ECG before meds|1|||
130134038|NCT01778010|468452589|FG000|Overall Study|Arrested|1|||
130134039|NCT01778010|468452589|FG000|Overall Study|rash while on placebo|1|||
130134040|NCT01518972|468452593|FG000|Overall Study|Lost to Follow-up|2|||
130134041|NCT01518972|468452594|FG001|Overall Study|Lost to Follow-up|1|||
130134042|NCT01518972|468452593|FG000|Overall Study|Withdrawal by Subject|1|||
130134043|NCT01518972|468452594|FG001|Overall Study|Withdrawal by Subject|0|||
130134044|NCT01518972|468452593|FG000|Overall Study|Moved from area|1|||
130134045|NCT01518972|468452594|FG001|Overall Study|Moved from area|0|||
130134046|NCT01518972|468452593|FG000|Overall Study|Transportation problems|1|||
130134047|NCT01518972|468452594|FG001|Overall Study|Transportation problems|0|||
130134048|NCT01518972|468452593|FG000|Overall Study|Exclusionary medical condition|1|||
129971196|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
129971197|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
129971198|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
129971199|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
129971200|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
129971201|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
129971202|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
130094317|NCT01016912|468300618|FG001|Follow-up Period|Other reason|0|||
130094318|NCT01016912|468300619|FG002|Follow-up Period|Other reason|1|||
130094319|NCT01016912|468300620|FG003|Follow-up Period|Other reason|1|||
130094320|NCT01016912|468300621|FG004|Follow-up Period|Other reason|0|||
130094321|NCT02370173|468300628|FG000|Overall Study|Protocol Violation|1|||
130094322|NCT02370173|468300629|FG001|Overall Study|Protocol Violation|1|||
130094323|NCT02370173|468300628|FG000|Overall Study|Withdrawal by Subject|2|||
130094324|NCT02370173|468300629|FG001|Overall Study|Withdrawal by Subject|2|||
130094325|NCT01326481|468300635|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
130094326|NCT00307736|468300636|FG000|Overall Study|Adverse Event|0|||
130094327|NCT00307736|468300637|FG001|Overall Study|Adverse Event|0|||
130094328|NCT00307736|468300638|FG002|Overall Study|Adverse Event|1|||
130094329|NCT00307736|468300639|FG003|Overall Study|Adverse Event|3|||
130094330|NCT00307736|468300636|FG000|Overall Study|Withdrawal by Subject|0|||
130094331|NCT00307736|468300637|FG001|Overall Study|Withdrawal by Subject|0|||
130094332|NCT00307736|468300638|FG002|Overall Study|Withdrawal by Subject|2|||
130094333|NCT00307736|468300639|FG003|Overall Study|Withdrawal by Subject|0|||
130094334|NCT02260791|468300642|FG000|Overall Study|Lost to Follow-up|4|||
130094335|NCT02260791|468300643|FG001|Overall Study|Lost to Follow-up|4|||
130094336|NCT02260791|468300642|FG000|Overall Study|Lack of Efficacy|2|||
130094337|NCT02260791|468300643|FG001|Overall Study|Lack of Efficacy|1|||
130094338|NCT02260791|468300642|FG000|Overall Study|Adverse Event|13|||
130094339|NCT02260791|468300643|FG001|Overall Study|Adverse Event|9|||
130094340|NCT02260791|468300642|FG000|Overall Study|Death|1|||
130094341|NCT02260791|468300643|FG001|Overall Study|Death|0|||
130094342|NCT02260791|468300642|FG000|Overall Study|Withdrawal by Subject|11|||
130094343|NCT02260791|468300643|FG001|Overall Study|Withdrawal by Subject|16|||
130094344|NCT02260791|468300642|FG000|Overall Study|Screen failure|0|||
130094345|NCT02260791|468300643|FG001|Overall Study|Screen failure|1|||
130094346|NCT02260791|468300642|FG000|Overall Study|Protocol deviation|2|||
130094347|NCT02260791|468300643|FG001|Overall Study|Protocol deviation|3|||
130094348|NCT04246996|468300645|FG000|Overall Study|Physician Decision|1|||
130094349|NCT04246996|468300646|FG001|Overall Study|Physician Decision|1|||
130094350|NCT04246996|468300645|FG000|Overall Study|Did not meet eligibility criteria|1|||
130094351|NCT04246996|468300646|FG001|Overall Study|Did not meet eligibility criteria|4|||
130094352|NCT02442284|468300647|FG000|Overall Study|Adverse Event|1|||
130094353|NCT02442284|468300647|FG000|Overall Study|Withdrew Consent|2|||
130094354|NCT02442284|468300647|FG000|Overall Study|Lost to Follow-up|3|||
130094355|NCT02442284|468300647|FG000|Overall Study|Other|1|||
130094356|NCT00656669|468302337|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
130094357|NCT00656669|468302337|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
130094358|NCT00656669|468302337|FG000|AC (Cycles 6-9)|Adverse Event|1|||
130094359|NCT00656669|468302337|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
130094360|NCT03778021|468302338|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
130094361|NCT03778021|468302339|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
130094362|NCT00679042|468302340|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
130094363|NCT00679042|468302340|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
130094364|NCT00679042|468302340|FG000|5-Year Follow Up|Death|1|||
130094365|NCT00679042|468302340|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
130094366|NCT00679042|468302340|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
130094367|NCT00247416|468302343|FG000|Overall Study|3 patients were found to be ineligible|1|||
130094368|NCT00247416|468302344|FG001|Overall Study|3 patients were found to be ineligible|2|||
130094369|NCT00798161|468302345|FG000|Overall Study|Adverse Event|3|||
130094370|NCT00798161|468302346|FG001|Overall Study|Adverse Event|4|||
130094371|NCT00798161|468302347|FG002|Overall Study|Adverse Event|6|||
130094372|NCT00798161|468302348|FG003|Overall Study|Adverse Event|6|||
130094373|NCT00798161|468302349|FG004|Overall Study|Adverse Event|5|||
130094374|NCT00798161|468302350|FG005|Overall Study|Adverse Event|2|||
130094375|NCT00798161|468302351|FG006|Overall Study|Adverse Event|4|||
130094376|NCT00798161|468302345|FG000|Overall Study|Protocol Violation|2|||
130094377|NCT00798161|468302346|FG001|Overall Study|Protocol Violation|1|||
130094378|NCT00798161|468302347|FG002|Overall Study|Protocol Violation|3|||
130094379|NCT00798161|468302348|FG003|Overall Study|Protocol Violation|3|||
130094380|NCT00798161|468302349|FG004|Overall Study|Protocol Violation|3|||
130094381|NCT00798161|468302350|FG005|Overall Study|Protocol Violation|2|||
130094382|NCT00798161|468302351|FG006|Overall Study|Protocol Violation|0|||
130134049|NCT01518972|468452594|FG001|Overall Study|Exclusionary medical condition|0|||
130134050|NCT01518972|468452593|FG000|Overall Study|Missed safety visits|0|||
130134051|NCT01518972|468452594|FG001|Overall Study|Missed safety visits|1|||
130134052|NCT01518972|468452593|FG000|Overall Study|Exclusionary medication|0|||
130134053|NCT01518972|468452594|FG001|Overall Study|Exclusionary medication|1|||
130134054|NCT01518972|468452593|FG000|Overall Study|Declined medication starting on day 12|0|||
130134055|NCT01518972|468452594|FG001|Overall Study|Declined medication starting on day 12|1|||
130134056|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
130134057|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
130134058|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
129971203|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
129971204|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
129971205|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
129971206|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
129971207|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
129971208|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
129971209|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
129971210|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
129971211|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
129971212|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
129971213|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
129971214|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
129971215|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
129971216|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
129971217|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
129971218|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
129971219|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
129971220|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
129971221|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
129971222|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
129971223|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
129971224|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
129971225|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
129971226|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
129971227|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
129971228|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
129971229|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
129971230|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
129971231|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
129971232|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
129971233|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
129971234|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
129971235|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
129971236|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
129971237|NCT01367847|467858424|FG000|Overall Study|Withdrawal by Subject|2|||
129971238|NCT01367847|467858425|FG001|Overall Study|Withdrawal by Subject|2|||
129971239|NCT02056626|467858426|FG000|Overall Study|patient did not follow directions|3|||
129971240|NCT02056626|467858427|FG001|Overall Study|patient did not follow directions|1|||
129971241|NCT02056626|467858428|FG002|Overall Study|patient did not follow directions|0|||
129971242|NCT02056626|467858429|FG003|Overall Study|patient did not follow directions|0|||
129971243|NCT01454739|467858433|FG000|Overall Study|Protocol Violation|2|||
129971244|NCT01454739|467858434|FG001|Overall Study|Protocol Violation|3|||
129971245|NCT01454739|467858433|FG000|Overall Study|Withdrawal by Subject|2|||
129971246|NCT01454739|467858434|FG001|Overall Study|Withdrawal by Subject|6|||
129971247|NCT01454739|467858433|FG000|Overall Study|Other|3|||
129971248|NCT01454739|467858434|FG001|Overall Study|Other|5|||
129971249|NCT01454739|467858433|FG000|Overall Study|Physician Decision|0|||
129971250|NCT01454739|467858434|FG001|Overall Study|Physician Decision|5|||
129971251|NCT01454739|467858433|FG000|Overall Study|Lost to Follow-up|0|||
130134059|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
130134060|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
130134061|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
129971252|NCT01454739|467858434|FG001|Overall Study|Lost to Follow-up|1|||
129971253|NCT01454739|467858433|FG000|Overall Study|Adverse Event|0|||
129971254|NCT01454739|467858434|FG001|Overall Study|Adverse Event|1|||
129971255|NCT01784523|467858437|FG000|Overall Study|Study closed early|7|||
130134062|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
129971256|NCT01784523|467858438|FG001|Overall Study|Study closed early|4|||
130134063|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
130134064|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
130134065|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
130134066|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
130134067|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
130134068|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
130134069|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
130134070|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
130134071|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
130134072|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
130134073|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
130134074|NCT01667679|468452595|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
130134075|NCT01667679|468452596|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
130134076|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
130134077|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
130134078|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
130134079|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
130134080|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
130134081|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
130134082|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
130134083|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
130134084|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
130134085|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
130134086|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
130134087|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
130134088|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
130134089|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
130134090|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
130134091|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
130134092|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
130134093|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
130134094|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
130134095|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
130134096|NCT01667679|468452595|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
130134097|NCT01667679|468452596|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
130134098|NCT02159183|468452597|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
130134099|NCT02159183|468452598|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
130134100|NCT02159183|468452597|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
130134101|NCT02159183|468452598|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
130134102|NCT02159183|468452597|FG000|Analysis After the 36 Months Follow-up|Death|0|||
130134103|NCT02159183|468452598|FG001|Analysis After the 36 Months Follow-up|Death|1|||
130134104|NCT02159183|468452597|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
130134105|NCT02159183|468452598|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
130134106|NCT02159183|468452597|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
130134107|NCT02159183|468452598|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
130134108|NCT03733444|468452600|FG000|Overall Study|Adverse Event|8|||
130134109|NCT03733444|468452601|FG001|Overall Study|Adverse Event|10|||
130134110|NCT03733444|468452602|FG002|Overall Study|Adverse Event|5|||
130134111|NCT03733444|468452600|FG000|Overall Study|Death|20|||
130134112|NCT03733444|468452601|FG001|Overall Study|Death|19|||
130134113|NCT03733444|468452602|FG002|Overall Study|Death|11|||
130134114|NCT03733444|468452600|FG000|Overall Study|Lost to Follow-up|3|||
130134115|NCT03733444|468452601|FG001|Overall Study|Lost to Follow-up|0|||
130134116|NCT03733444|468452602|FG002|Overall Study|Lost to Follow-up|1|||
130134117|NCT03733444|468452600|FG000|Overall Study|Lack of Efficacy|0|||
130134118|NCT03733444|468452601|FG001|Overall Study|Lack of Efficacy|1|||
130134119|NCT03733444|468452602|FG002|Overall Study|Lack of Efficacy|1|||
130134120|NCT03733444|468452600|FG000|Overall Study|Physician Decision|2|||
130134121|NCT03733444|468452601|FG001|Overall Study|Physician Decision|1|||
130134122|NCT03733444|468452602|FG002|Overall Study|Physician Decision|0|||
130134123|NCT03733444|468452600|FG000|Overall Study|Protocol Violation|2|||
130134124|NCT03733444|468452601|FG001|Overall Study|Protocol Violation|1|||
130134125|NCT03733444|468452602|FG002|Overall Study|Protocol Violation|0|||
130134126|NCT03733444|468452600|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130134127|NCT03733444|468452601|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
130134128|NCT03733444|468452602|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
130134129|NCT03733444|468452600|FG000|Overall Study|Study Terminated by Sponsor|203|||
130134130|NCT03733444|468452601|FG001|Overall Study|Study Terminated by Sponsor|209|||
130134131|NCT03733444|468452602|FG002|Overall Study|Study Terminated by Sponsor|221|||
130134132|NCT03733444|468452600|FG000|Overall Study|Withdrawal by Subject|19|||
130134133|NCT03733444|468452601|FG001|Overall Study|Withdrawal by Subject|18|||
130134134|NCT03733444|468452602|FG002|Overall Study|Withdrawal by Subject|16|||
130134135|NCT03733444|468452600|FG000|Overall Study|Miscellaneous|1|||
130134136|NCT03733444|468452601|FG001|Overall Study|Miscellaneous|0|||
130134137|NCT03733444|468452602|FG002|Overall Study|Miscellaneous|1|||
130134138|NCT03733444|468452600|FG000|Overall Study|Not Treated|1|||
130134139|NCT03733444|468452601|FG001|Overall Study|Not Treated|2|||
130134140|NCT03733444|468452602|FG002|Overall Study|Not Treated|1|||
130134141|NCT00556322|468452603|FG000|Overall Study|Insufficient therapeutic response|158|||
130134142|NCT00556322|468452604|FG001|Overall Study|Insufficient therapeutic response|168|||
130134143|NCT00556322|468452603|FG000|Overall Study|Adverse Event|7|||
130134144|NCT00556322|468452604|FG001|Overall Study|Adverse Event|4|||
130134145|NCT00556322|468452603|FG000|Overall Study|Other|4|||
130134146|NCT00556322|468452604|FG001|Overall Study|Other|1|||
130134147|NCT00556322|468452603|FG000|Overall Study|Lost to Follow-up|5|||
130134148|NCT00556322|468452604|FG001|Overall Study|Lost to Follow-up|3|||
130134149|NCT00556322|468452603|FG000|Overall Study|Withdrawal by Subject|19|||
130134150|NCT00556322|468452604|FG001|Overall Study|Withdrawal by Subject|7|||
130134151|NCT00556322|468452603|FG000|Overall Study|Protocol Violation|5|||
130134152|NCT00556322|468452604|FG001|Overall Study|Protocol Violation|1|||
130134153|NCT00556322|468452603|FG000|Overall Study|Ongoing at data cutoff|3|||
130134154|NCT00556322|468452604|FG001|Overall Study|Ongoing at data cutoff|5|||
130134155|NCT00556322|468452603|FG000|Overall Study|Death|20|||
130134156|NCT00556322|468452604|FG001|Overall Study|Death|14|||
130134157|NCT01788423|468452605|FG000|Overall Study|See Comments in Completed (above)|0|||
130134158|NCT01788423|468452606|FG001|Overall Study|See Comments in Completed (above)|4|||
130134159|NCT01788423|468452607|FG002|Overall Study|See Comments in Completed (above)|5|||
130134160|NCT03637764|468452608|FG000|Overall Study|Adverse Event|2|||
130134161|NCT03637764|468452609|FG001|Overall Study|Adverse Event|0|||
130134162|NCT03637764|468452610|FG002|Overall Study|Adverse Event|0|||
130134163|NCT03637764|468452611|FG003|Overall Study|Adverse Event|1|||
130134164|NCT03637764|468452608|FG000|Overall Study|Progressive Disease|23|||
130134165|NCT03637764|468452609|FG001|Overall Study|Progressive Disease|23|||
130134166|NCT03637764|468452610|FG002|Overall Study|Progressive Disease|18|||
130134167|NCT03637764|468452611|FG003|Overall Study|Progressive Disease|31|||
130134168|NCT03637764|468452608|FG000|Overall Study|Withdrawal by Subject|1|||
130134169|NCT03637764|468452609|FG001|Overall Study|Withdrawal by Subject|3|||
130134170|NCT03637764|468452610|FG002|Overall Study|Withdrawal by Subject|0|||
130134171|NCT03637764|468452611|FG003|Overall Study|Withdrawal by Subject|1|||
130134172|NCT02760927|468452616|FG000|Overall Study|Tube Slippage from Device|1|||
130134173|NCT02105272|468452617|FG000|Overall Study|Adverse Event|1|||
130134174|NCT02105272|468452618|FG001|Overall Study|Adverse Event|2|||
130134175|NCT02105272|468452617|FG000|Overall Study|Physician Decision|0|||
130134176|NCT02105272|468452618|FG001|Overall Study|Physician Decision|1|||
130134177|NCT02105272|468452617|FG000|Overall Study|Protocol Violation|2|||
130134178|NCT02105272|468452618|FG001|Overall Study|Protocol Violation|0|||
130134179|NCT02105272|468452617|FG000|Overall Study|Withdrawal by Subject|2|||
130134180|NCT02105272|468452618|FG001|Overall Study|Withdrawal by Subject|0|||
130134181|NCT03190915|468452620|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
130134182|NCT03190915|468452620|FG000|Overall Study|Progressive Disease|3|||
130134183|NCT01911676|468452621|FG000|Period 1 of Study|Withdrawal by Subject|4|||
130134184|NCT01911676|468452622|FG001|Period 1 of Study|Withdrawal by Subject|2|||
130134185|NCT01911676|468452623|FG002|Period 1 of Study|Withdrawal by Subject|1|||
130134186|NCT01911676|468452624|FG003|Period 1 of Study|Withdrawal by Subject|2|||
130134187|NCT01911676|468452621|FG000|Period 1 of Study|Physician Decision|2|||
130134188|NCT01911676|468452622|FG001|Period 1 of Study|Physician Decision|0|||
130134189|NCT01911676|468452623|FG002|Period 1 of Study|Physician Decision|0|||
130134190|NCT01911676|468452624|FG003|Period 1 of Study|Physician Decision|1|||
130134191|NCT01911676|468452621|FG000|Period 2 of Study|Physician Decision|2|||
130134192|NCT01911676|468452622|FG001|Period 2 of Study|Physician Decision|0|||
129971257|NCT04340947|467858439|FG000|7-day Washout Period|Lost to Follow-up|5|||
129971258|NCT04340947|467858440|FG001|7-day Washout Period|Lost to Follow-up|4|||
130134193|NCT01911676|468452623|FG002|Period 2 of Study|Physician Decision|0|||
130134194|NCT01911676|468452624|FG003|Period 2 of Study|Physician Decision|1|||
130134195|NCT01911676|468452621|FG000|Period 2 of Study|Lost to Follow-up|0|||
130134196|NCT01911676|468452622|FG001|Period 2 of Study|Lost to Follow-up|0|||
130134197|NCT01911676|468452623|FG002|Period 2 of Study|Lost to Follow-up|0|||
130134198|NCT01911676|468452624|FG003|Period 2 of Study|Lost to Follow-up|1|||
130134199|NCT01566721|468452625|FG000|Treatment Period|Withdrawal by Subject|35|||
130134200|NCT01566721|468452626|FG001|Treatment Period|Withdrawal by Subject|9|||
130134201|NCT01566721|468452625|FG000|Treatment Period|Disease Progression/Recurrence|37|||
129971259|NCT01124097|467858444|FG000|Overall Study|Withdrawal by Subject|4|||
129971260|NCT01124097|467858445|FG001|Overall Study|Withdrawal by Subject|3|||
130134202|NCT01566721|468452626|FG001|Treatment Period|Disease Progression/Recurrence|13|||
130134203|NCT01566721|468452625|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
130134204|NCT01566721|468452626|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
130134205|NCT01566721|468452625|FG000|Treatment Period|Other|13|||
130134206|NCT01566721|468452626|FG001|Treatment Period|Other|2|||
130134207|NCT01566721|468452625|FG000|Treatment Period|Lack of Compliance|5|||
130134208|NCT01566721|468452626|FG001|Treatment Period|Lack of Compliance|1|||
130134209|NCT01566721|468452625|FG000|Treatment Period|Adverse Event|100|||
130134210|NCT01566721|468452626|FG001|Treatment Period|Adverse Event|30|||
130134211|NCT01566721|468452625|FG000|Treatment Period|Pregnancy|1|||
130134212|NCT01566721|468452626|FG001|Treatment Period|Pregnancy|0|||
130134213|NCT01566721|468452625|FG000|Safety Follow-up|Physician Decision|6|||
130134214|NCT01566721|468452626|FG001|Safety Follow-up|Physician Decision|4|||
130134215|NCT01566721|468452625|FG000|Safety Follow-up|Lost to Follow-up|101|||
130134216|NCT01566721|468452626|FG001|Safety Follow-up|Lost to Follow-up|48|||
130134217|NCT01566721|468452625|FG000|Safety Follow-up|Withdrawal by Subject|155|||
130134218|NCT01566721|468452626|FG001|Safety Follow-up|Withdrawal by Subject|49|||
130134219|NCT01566721|468452625|FG000|Safety Follow-up|Death|28|||
130134220|NCT01566721|468452626|FG001|Safety Follow-up|Death|4|||
130134221|NCT01566721|468452625|FG000|Safety Follow-up|Non-compliance|7|||
130134222|NCT01566721|468452626|FG001|Safety Follow-up|Non-compliance|3|||
130134223|NCT01566721|468452625|FG000|Safety Follow-up|Protocol Violation|7|||
130134224|NCT01566721|468452626|FG001|Safety Follow-up|Protocol Violation|0|||
130134225|NCT01566721|468452625|FG000|Safety Follow-up|Site closure|2|||
130134226|NCT01566721|468452626|FG001|Safety Follow-up|Site closure|3|||
130134227|NCT01566721|468452625|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
130134228|NCT01566721|468452626|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
130134229|NCT01566721|468452625|FG000|Safety Follow-up|Missing|7|||
130134230|NCT01566721|468452626|FG001|Safety Follow-up|Missing|2|||
130134231|NCT01566721|468452625|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
130134232|NCT01566721|468452626|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
130134233|NCT01566721|468452625|FG000|Safety Follow-up|Sponsor decision|1|||
130134234|NCT01566721|468452626|FG001|Safety Follow-up|Sponsor decision|0|||
130134235|NCT01566721|468452625|FG000|Safety Follow-up|Adverse Event|8|||
130134236|NCT01566721|468452626|FG001|Safety Follow-up|Adverse Event|4|||
130134237|NCT01237054|468452627|FG000|Overall Study|imaging 10C0096|1|||
130134238|NCT02619682|468452628|FG000|Overall Study|Withdrawal by Subject|3|||
130134239|NCT02619682|468452628|FG000|Overall Study|Lack of Efficacy|8|||
130134240|NCT02619682|468452628|FG000|Overall Study|new secondary cancer|1|||
130134241|NCT02619682|468452628|FG000|Overall Study|post surgery complications|2|||
129971261|NCT01124097|467858446|FG002|Overall Study|Withdrawal by Subject|2|||
129971262|NCT01124097|467858447|FG003|Overall Study|Withdrawal by Subject|3|||
129971263|NCT01124097|467858444|FG000|Overall Study|Lack of Efficacy|2|||
129971264|NCT01124097|467858445|FG001|Overall Study|Lack of Efficacy|3|||
129971265|NCT01124097|467858446|FG002|Overall Study|Lack of Efficacy|1|||
129971266|NCT01124097|467858447|FG003|Overall Study|Lack of Efficacy|3|||
129971267|NCT01124097|467858444|FG000|Overall Study|Adverse Event|24|||
129971268|NCT01124097|467858445|FG001|Overall Study|Adverse Event|15|||
129971269|NCT01124097|467858446|FG002|Overall Study|Adverse Event|15|||
129971270|NCT01124097|467858447|FG003|Overall Study|Adverse Event|7|||
129971271|NCT01124097|467858444|FG000|Overall Study|Protocol Violation|2|||
129971272|NCT01124097|467858445|FG001|Overall Study|Protocol Violation|0|||
129971273|NCT01124097|467858446|FG002|Overall Study|Protocol Violation|2|||
130094383|NCT00798161|468302345|FG000|Overall Study|Lost to Follow-up|1|||
130094384|NCT00798161|468302346|FG001|Overall Study|Lost to Follow-up|3|||
130094385|NCT00798161|468302347|FG002|Overall Study|Lost to Follow-up|4|||
130094386|NCT00798161|468302348|FG003|Overall Study|Lost to Follow-up|3|||
130094387|NCT00798161|468302349|FG004|Overall Study|Lost to Follow-up|4|||
130094388|NCT00798161|468302350|FG005|Overall Study|Lost to Follow-up|0|||
130094389|NCT00798161|468302351|FG006|Overall Study|Lost to Follow-up|0|||
130094390|NCT00798161|468302345|FG000|Overall Study|Withdrawal by Subject|5|||
130094391|NCT00798161|468302346|FG001|Overall Study|Withdrawal by Subject|4|||
130094392|NCT00798161|468302347|FG002|Overall Study|Withdrawal by Subject|5|||
130094393|NCT00798161|468302348|FG003|Overall Study|Withdrawal by Subject|4|||
130094394|NCT00798161|468302349|FG004|Overall Study|Withdrawal by Subject|2|||
130094395|NCT00798161|468302350|FG005|Overall Study|Withdrawal by Subject|3|||
130094396|NCT00798161|468302351|FG006|Overall Study|Withdrawal by Subject|1|||
130094397|NCT00798161|468302345|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
130094398|NCT00798161|468302346|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
130094399|NCT00798161|468302347|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
130094400|NCT00798161|468302348|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
130094401|NCT00798161|468302349|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
130094402|NCT00798161|468302350|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
130134242|NCT00268203|468452631|FG000|Overall Study|Lost to Follow-up|92|||
130134243|NCT00268203|468452631|FG000|Overall Study|Withdrawal by Subject|9|||
130134244|NCT00268203|468452631|FG000|Overall Study|Received Other NHL Therapy|7|||
130134245|NCT00268203|468452631|FG000|Overall Study|Progressive Disease|359|||
130134246|NCT00268203|468452631|FG000|Overall Study|Death|84|||
130134247|NCT00268203|468452631|FG000|Overall Study|Reason Not Specified|34|||
130134248|NCT00268203|468452631|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
130134249|NCT00730691|468452638|FG000|Overall Study|Adverse Event|4|||
130134250|NCT00730691|468452639|FG001|Overall Study|Adverse Event|8|||
130134251|NCT00730691|468452640|FG002|Overall Study|Adverse Event|11|||
130134252|NCT00730691|468452641|FG003|Overall Study|Adverse Event|11|||
130134253|NCT00730691|468452642|FG004|Overall Study|Adverse Event|23|||
130134254|NCT00730691|468452638|FG000|Overall Study|Lack of Efficacy|4|||
130134255|NCT00730691|468452639|FG001|Overall Study|Lack of Efficacy|4|||
130134256|NCT00730691|468452640|FG002|Overall Study|Lack of Efficacy|2|||
130134257|NCT00730691|468452641|FG003|Overall Study|Lack of Efficacy|1|||
130134258|NCT00730691|468452642|FG004|Overall Study|Lack of Efficacy|1|||
130134259|NCT00730691|468452638|FG000|Overall Study|Non-compliance with Study Drug|6|||
130134260|NCT00730691|468452639|FG001|Overall Study|Non-compliance with Study Drug|1|||
130134261|NCT00730691|468452640|FG002|Overall Study|Non-compliance with Study Drug|6|||
130134262|NCT00730691|468452641|FG003|Overall Study|Non-compliance with Study Drug|3|||
130134263|NCT00730691|468452642|FG004|Overall Study|Non-compliance with Study Drug|3|||
130134264|NCT00730691|468452638|FG000|Overall Study|Protocol Deviations|3|||
130134265|NCT00730691|468452639|FG001|Overall Study|Protocol Deviations|5|||
130134266|NCT00730691|468452640|FG002|Overall Study|Protocol Deviations|3|||
130134267|NCT00730691|468452641|FG003|Overall Study|Protocol Deviations|7|||
130134268|NCT00730691|468452642|FG004|Overall Study|Protocol Deviations|5|||
130134269|NCT00730691|468452638|FG000|Overall Study|Withdrawal of Consent|7|||
130134270|NCT00730691|468452639|FG001|Overall Study|Withdrawal of Consent|9|||
130134271|NCT00730691|468452640|FG002|Overall Study|Withdrawal of Consent|3|||
130134272|NCT00730691|468452641|FG003|Overall Study|Withdrawal of Consent|6|||
130134273|NCT00730691|468452642|FG004|Overall Study|Withdrawal of Consent|3|||
130134274|NCT00730691|468452638|FG000|Overall Study|Lost to Follow-up|11|||
130134275|NCT00730691|468452639|FG001|Overall Study|Lost to Follow-up|8|||
130134276|NCT00730691|468452640|FG002|Overall Study|Lost to Follow-up|13|||
130134277|NCT00730691|468452641|FG003|Overall Study|Lost to Follow-up|15|||
130134278|NCT00730691|468452642|FG004|Overall Study|Lost to Follow-up|13|||
130134279|NCT00730691|468452638|FG000|Overall Study|Other|1|||
130134280|NCT00730691|468452639|FG001|Overall Study|Other|1|||
130134281|NCT00730691|468452640|FG002|Overall Study|Other|1|||
130134282|NCT00730691|468452641|FG003|Overall Study|Other|2|||
130134283|NCT00730691|468452642|FG004|Overall Study|Other|2|||
130134284|NCT02178787|468452643|FG000|Overall Study|Lost to Follow-up|1|||
130134285|NCT02178787|468452644|FG001|Overall Study|Lost to Follow-up|0|||
130134286|NCT02178787|468452643|FG000|Overall Study|Withdrawal by Subject|0|||
130134287|NCT02178787|468452644|FG001|Overall Study|Withdrawal by Subject|2|||
130134288|NCT02178787|468452643|FG000|Overall Study|No TCD window|3|||
130134289|NCT02178787|468452644|FG001|Overall Study|No TCD window|7|||
130134290|NCT02178787|468452643|FG000|Overall Study|Physician Decision|1|||
130134291|NCT02178787|468452644|FG001|Overall Study|Physician Decision|0|||
130134292|NCT02554890|468452645|FG000|Double-blind|Adverse Event|45|||
130134293|NCT02554890|468452646|FG001|Double-blind|Adverse Event|51|||
130134294|NCT02554890|468452645|FG000|Double-blind|Death|6|||
130134295|NCT02554890|468452646|FG001|Double-blind|Death|4|||
130134296|NCT02554890|468452645|FG000|Double-blind|Protocol Violation|1|||
130134297|NCT02554890|468452646|FG001|Double-blind|Protocol Violation|1|||
130134298|NCT02554890|468452645|FG000|Double-blind|Physician Decision|4|||
130134299|NCT02554890|468452646|FG001|Double-blind|Physician Decision|3|||
130134300|NCT02554890|468452645|FG000|Double-blind|Subject/Guardian decision|21|||
130134301|NCT02554890|468452646|FG001|Double-blind|Subject/Guardian decision|16|||
130134302|NCT02554890|468452645|FG000|Double-blind|Lost to Follow-up|7|||
130134303|NCT02554890|468452646|FG001|Double-blind|Lost to Follow-up|5|||
130134304|NCT02554890|468452645|FG000|Double-blind|Technical problems|1|||
130134305|NCT02554890|468452646|FG001|Double-blind|Technical problems|0|||
130134306|NCT02554890|468452645|FG000|Double-blind|Withdrawal by Subject|5|||
130134307|NCT02554890|468452646|FG001|Double-blind|Withdrawal by Subject|6|||
130134308|NCT02554890|468452645|FG000|Double-blind|Noncompliance with study treatment|6|||
130134309|NCT02554890|468452646|FG001|Double-blind|Noncompliance with study treatment|5|||
130134310|NCT02554890|468452645|FG000|Open-label|Adverse Event|0|||
130134311|NCT02554890|468452646|FG001|Open-label|Adverse Event|30|||
130134312|NCT02554890|468452645|FG000|Open-label|Death|0|||
130134313|NCT02554890|468452646|FG001|Open-label|Death|1|||
130134314|NCT02554890|468452645|FG000|Open-label|Physician Decision|0|||
130134315|NCT02554890|468452646|FG001|Open-label|Physician Decision|1|||
130134316|NCT02554890|468452645|FG000|Open-label|Subject/Guardian decision|0|||
130134317|NCT02554890|468452646|FG001|Open-label|Subject/Guardian decision|11|||
130134318|NCT02554890|468452645|FG000|Open-label|Lost to Follow-up|0|||
130134319|NCT02554890|468452646|FG001|Open-label|Lost to Follow-up|7|||
130134320|NCT02554890|468452645|FG000|Open-label|Technical problems|0|||
130134321|NCT02554890|468452646|FG001|Open-label|Technical problems|1|||
130134322|NCT02554890|468452645|FG000|Open-label|Withdrawal by Subject|0|||
130134323|NCT02554890|468452646|FG001|Open-label|Withdrawal by Subject|1|||
130134324|NCT03649477|468452649|FG000|Overall Study|Adverse Event|2|||
130134325|NCT03649477|468452650|FG001|Overall Study|Adverse Event|0|||
130134326|NCT03649477|468452651|FG002|Overall Study|Adverse Event|0|||
130134327|NCT02430480|468452652|FG000|Overall Study|Death|1|||
130134328|NCT02430480|468452652|FG000|Overall Study|Anesthesia concerns|1|||
130134329|NCT02430480|468452652|FG000|Overall Study|Progressed on treatment|1|||
130134330|NCT01097577|468452653|FG000|Overall Study|Adverse Event|0|||
130134331|NCT01097577|468452654|FG001|Overall Study|Adverse Event|1|||
130134332|NCT00316186|468452664|FG000|Overall Study|Adverse Event|6|||
130134333|NCT00316186|468452664|FG000|Overall Study|Disease Progression|4|||
130134334|NCT00316186|468452664|FG000|Overall Study|Lost to Follow-up|1|||
130134335|NCT00316186|468452664|FG000|Overall Study|Other|1|||
130134336|NCT04493684|468452665|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130134337|NCT04493684|468452666|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134338|NCT04493684|468452667|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130134339|NCT04493684|468452668|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134340|NCT04493684|468452669|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134341|NCT04493684|468452670|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
130134342|NCT04493684|468452671|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134343|NCT04493684|468452672|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134344|NCT04493684|468452673|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134345|NCT04493684|468452674|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134346|NCT04493684|468452675|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134347|NCT04493684|468452676|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134348|NCT04493684|468452677|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134349|NCT04493684|468452678|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134350|NCT04493684|468452679|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134351|NCT04493684|468452680|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134352|NCT04493684|468452681|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
130134353|NCT04493684|468452665|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
130134354|NCT04493684|468452666|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134355|NCT04493684|468452667|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134356|NCT04493684|468452668|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134357|NCT04493684|468452669|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129971274|NCT01124097|467858447|FG003|Overall Study|Protocol Violation|1|||
129971275|NCT01124097|467858444|FG000|Overall Study|Physician Decision|2|||
129971276|NCT01124097|467858445|FG001|Overall Study|Physician Decision|1|||
129971277|NCT01124097|467858446|FG002|Overall Study|Physician Decision|0|||
130134358|NCT04493684|468452670|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134359|NCT04493684|468452671|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134360|NCT04493684|468452672|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134361|NCT04493684|468452673|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134362|NCT04493684|468452674|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134363|NCT04493684|468452675|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134364|NCT04493684|468452676|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134365|NCT04493684|468452677|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134366|NCT04493684|468452678|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134367|NCT04493684|468452679|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134368|NCT04493684|468452680|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134369|NCT04493684|468452681|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
130134370|NCT04493684|468452665|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134371|NCT04493684|468452666|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134372|NCT04493684|468452667|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134373|NCT04493684|468452668|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134374|NCT04493684|468452669|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134375|NCT04493684|468452670|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134376|NCT04493684|468452671|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
130134377|NCT04493684|468452672|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134378|NCT04493684|468452673|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134379|NCT04493684|468452674|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134380|NCT04493684|468452675|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134381|NCT04493684|468452676|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134382|NCT04493684|468452677|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134383|NCT04493684|468452678|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134384|NCT04493684|468452679|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134385|NCT04493684|468452680|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129971278|NCT01124097|467858447|FG003|Overall Study|Physician Decision|0|||
129971279|NCT01677299|467858448|FG000|Overall Study|Adverse Event|0|||
129971280|NCT01677299|467858449|FG001|Overall Study|Adverse Event|2|||
129971281|NCT01677299|467858450|FG002|Overall Study|Adverse Event|1|||
129971282|NCT01677299|467858451|FG003|Overall Study|Adverse Event|0|||
130134386|NCT04493684|468452681|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
130134387|NCT04493684|468452665|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
130134388|NCT04493684|468452666|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134389|NCT04493684|468452667|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134390|NCT04493684|468452668|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134391|NCT04493684|468452669|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134392|NCT04493684|468452670|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134393|NCT04493684|468452671|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134394|NCT04493684|468452672|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134395|NCT04493684|468452673|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134396|NCT04493684|468452674|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134397|NCT04493684|468452675|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134398|NCT04493684|468452676|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134399|NCT04493684|468452677|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134400|NCT04493684|468452678|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134401|NCT04493684|468452679|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134402|NCT04493684|468452680|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134403|NCT04493684|468452681|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
130134404|NCT04493684|468452665|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134405|NCT04493684|468452666|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134406|NCT04493684|468452667|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134407|NCT04493684|468452668|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134408|NCT04493684|468452669|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134409|NCT04493684|468452670|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
130134410|NCT04493684|468452671|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134411|NCT04493684|468452672|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134412|NCT04493684|468452673|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134413|NCT04493684|468452674|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134414|NCT04493684|468452675|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134415|NCT04493684|468452676|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134416|NCT04493684|468452677|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134417|NCT04493684|468452678|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134418|NCT04493684|468452679|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134419|NCT04493684|468452680|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134420|NCT04493684|468452681|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
130134421|NCT04493684|468452665|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134422|NCT04493684|468452666|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134423|NCT04493684|468452667|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134424|NCT04493684|468452668|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134425|NCT04493684|468452669|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134426|NCT04493684|468452670|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134427|NCT04493684|468452671|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134428|NCT04493684|468452672|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134429|NCT04493684|468452673|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134430|NCT04493684|468452674|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134431|NCT04493684|468452675|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134432|NCT04493684|468452676|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
130134433|NCT04493684|468452677|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134434|NCT04493684|468452678|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134435|NCT04493684|468452679|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134436|NCT04493684|468452680|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134437|NCT04493684|468452681|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
130134438|NCT04493684|468452665|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134439|NCT04493684|468452666|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134440|NCT04493684|468452667|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134441|NCT04493684|468452668|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134442|NCT04493684|468452669|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134443|NCT04493684|468452670|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134444|NCT04493684|468452671|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134445|NCT04493684|468452672|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129971283|NCT01677299|467858448|FG000|Overall Study|Withdrawal by Subject|0|||
129971284|NCT01677299|467858449|FG001|Overall Study|Withdrawal by Subject|1|||
129971285|NCT01677299|467858450|FG002|Overall Study|Withdrawal by Subject|0|||
130134446|NCT04493684|468452673|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134447|NCT04493684|468452674|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134448|NCT04493684|468452675|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134449|NCT04493684|468452676|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134450|NCT04493684|468452677|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134451|NCT04493684|468452678|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134452|NCT04493684|468452679|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134453|NCT04493684|468452680|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
130134454|NCT04493684|468452681|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
130134455|NCT04493684|468452665|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134456|NCT04493684|468452666|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134457|NCT04493684|468452667|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134458|NCT04493684|468452668|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134459|NCT04493684|468452669|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134460|NCT04493684|468452670|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134461|NCT04493684|468452671|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134462|NCT04493684|468452672|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134463|NCT04493684|468452673|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134464|NCT04493684|468452674|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134465|NCT04493684|468452675|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134466|NCT04493684|468452676|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134467|NCT04493684|468452677|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134468|NCT04493684|468452678|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134469|NCT04493684|468452679|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134470|NCT04493684|468452680|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
130134471|NCT04493684|468452681|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
130134472|NCT01963728|468452682|FG000|Overall Study|Study terminated early|0|||
130134473|NCT01963728|468452683|FG001|Overall Study|Study terminated early|1|||
130134474|NCT05152576|468452686|FG000|Overall Study|Lost to Follow-up|3|||
130134475|NCT05152576|468452687|FG001|Overall Study|Lost to Follow-up|0|||
130134476|NCT05152576|468452688|FG002|Overall Study|Lost to Follow-up|0|||
130134477|NCT05152576|468452689|FG003|Overall Study|Lost to Follow-up|1|||
130134478|NCT05152576|468452686|FG000|Overall Study|Withdrawal by Subject|0|||
130134479|NCT05152576|468452687|FG001|Overall Study|Withdrawal by Subject|1|||
130134480|NCT05152576|468452688|FG002|Overall Study|Withdrawal by Subject|0|||
130134481|NCT05152576|468452689|FG003|Overall Study|Withdrawal by Subject|1|||
130134482|NCT05152576|468452686|FG000|Overall Study|Other|2|||
130134483|NCT05152576|468452687|FG001|Overall Study|Other|0|||
130134484|NCT05152576|468452688|FG002|Overall Study|Other|0|||
130134485|NCT05152576|468452689|FG003|Overall Study|Other|0|||
130134486|NCT03447353|468454428|FG000|Overall Study|Failure at Screening Visit|2|||
130134487|NCT03447353|468454428|FG000|Overall Study|Lost to Follow-up|4|||
130134488|NCT03447353|468454428|FG000|Overall Study|Scheduling Conflicts|3|||
130134489|NCT03447353|468454428|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
130134490|NCT02642653|468454431|FG000|Overall Study|Adverse Event|2|||
130134491|NCT02642653|468454432|FG001|Overall Study|Adverse Event|0|||
130134492|NCT02267187|468454433|FG000|Overall Study|Physician Decision|2|||
130134493|NCT02267187|468454433|FG000|Overall Study|Screen fail|3|||
130134494|NCT02222818|468454439|FG000|Period 1|Eligibility criteria not met|0|||
130134495|NCT02222818|468454440|FG001|Period 1|Eligibility criteria not met|3|||
130134496|NCT03025087|468454441|FG000|Overall Study|Physician Decision|3|||
130134497|NCT03025087|468454442|FG001|Overall Study|Physician Decision|3|||
130134498|NCT03025087|468454443|FG002|Overall Study|Physician Decision|0|||
130134499|NCT03025087|468454444|FG003|Overall Study|Physician Decision|0|||
130134500|NCT03025087|468454445|FG004|Overall Study|Physician Decision|0|||
130134501|NCT03025087|468454441|FG000|Overall Study|Withdrawal by Subject|1|||
130134502|NCT03025087|468454442|FG001|Overall Study|Withdrawal by Subject|1|||
130134503|NCT03025087|468454443|FG002|Overall Study|Withdrawal by Subject|0|||
130134504|NCT03025087|468454444|FG003|Overall Study|Withdrawal by Subject|0|||
130134505|NCT03025087|468454445|FG004|Overall Study|Withdrawal by Subject|0|||
130134506|NCT03025087|468454441|FG000|Overall Study|Unable to complete MRI|2|||
129971286|NCT01677299|467858451|FG003|Overall Study|Withdrawal by Subject|1|||
129971287|NCT00193479|467858452|FG000|Induction Chemotherapy|Adverse Event|2|||
129971288|NCT00193479|467858452|FG000|Induction Chemotherapy|Disease Progression|1|||
130134507|NCT03025087|468454442|FG001|Overall Study|Unable to complete MRI|2|||
130134508|NCT03025087|468454443|FG002|Overall Study|Unable to complete MRI|0|||
130134509|NCT03025087|468454444|FG003|Overall Study|Unable to complete MRI|0|||
130134510|NCT03025087|468454445|FG004|Overall Study|Unable to complete MRI|0|||
130134511|NCT01376037|468454454|FG000|Overall Study|Lost to Follow-up|0|||
130134512|NCT01376037|468454455|FG001|Overall Study|Lost to Follow-up|2|||
130134513|NCT01294917|468454461|FG000|Overall Study|Relocation|5|||
130134514|NCT01294917|468454461|FG000|Overall Study|Inconvenience|1|||
130134560|NCT01444378|468454471|FG000|Overall Study|Lost to Follow-up|1|||
130134561|NCT01444378|468454471|FG000|Overall Study|Withdrawal by Subject|1|||
130134562|NCT01444378|468454471|FG000|Overall Study|Death|3|||
130134563|NCT01444378|468454471|FG000|Overall Study|Administrative Closure Of The Study|2|||
130134564|NCT01444378|468454471|FG000|Overall Study|Missed Visits|10|||
130134565|NCT00927069|468454472|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
130134566|NCT00927069|468454473|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
130134567|NCT00927069|468454474|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
130134568|NCT00927069|468454475|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
130134569|NCT00927069|468454472|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
130134570|NCT00927069|468454473|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
130134571|NCT00927069|468454474|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
130134572|NCT00927069|468454475|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
130134573|NCT00927069|468454472|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
130134574|NCT00927069|468454473|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
130134575|NCT00927069|468454474|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
130134576|NCT00927069|468454475|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
130134577|NCT00927069|468454472|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
130134578|NCT00927069|468454473|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
130134579|NCT00927069|468454474|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
130134580|NCT00927069|468454475|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
130134581|NCT00927069|468454472|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
130134582|NCT00927069|468454473|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130134583|NCT00927069|468454474|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130134584|NCT00927069|468454475|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
130134585|NCT02911792|468454476|FG000|Overall Study|Lost to Follow-up|3|||
130134586|NCT02911792|468454477|FG001|Overall Study|Lost to Follow-up|3|||
130134587|NCT02911792|468454478|FG002|Overall Study|Lost to Follow-up|3|||
130134588|NCT02911792|468454479|FG003|Overall Study|Lost to Follow-up|3|||
130134589|NCT01244620|468454482|FG000|Overall Study|Study terminated|4|||
130134590|NCT01244620|468454483|FG001|Overall Study|Study terminated|4|||
130134591|NCT01244620|468454484|FG002|Overall Study|Study terminated|4|||
130134592|NCT01244620|468454485|FG003|Overall Study|Study terminated|4|||
130134593|NCT01663233|468454487|FG000|Overall Study|Withdrawal by Subject|3|||
130134594|NCT01663233|468454488|FG001|Overall Study|Withdrawal by Subject|2|||
130134595|NCT01663233|468454487|FG000|Overall Study|Protocol Deviation|1|||
130134596|NCT01663233|468454488|FG001|Overall Study|Protocol Deviation|4|||
130134597|NCT01663233|468454487|FG000|Overall Study|Lost to Follow-up|0|||
130134598|NCT01663233|468454488|FG001|Overall Study|Lost to Follow-up|1|||
130134599|NCT02321098|468454489|FG000|12 Weeks Treament|Lost to Follow-up|1|||
130134600|NCT02321098|468454490|FG001|12 Weeks Treament|Lost to Follow-up|1|||
130134601|NCT02321098|468454491|FG002|12 Weeks Treament|Lost to Follow-up|0|||
130134602|NCT02321098|468454489|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
130134603|NCT02321098|468454490|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
130134604|NCT02321098|468454491|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
130134605|NCT02321098|468454489|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
130134606|NCT02321098|468454490|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
130134607|NCT02321098|468454491|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
130134608|NCT02321098|468454489|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
130134609|NCT02321098|468454490|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
130134610|NCT02321098|468454491|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
130134611|NCT02558491|468454492|FG000|First Invention|Withdrawal by Subject|3|||
130134612|NCT02558491|468454493|FG001|First Invention|Withdrawal by Subject|1|||
130134613|NCT02558491|468454492|FG000|First Invention|Data collection issues|1|||
130134614|NCT02558491|468454493|FG001|First Invention|Data collection issues|0|||
130134615|NCT02558491|468454492|FG000|First Invention|Stopping criteria|0|||
130134616|NCT02558491|468454493|FG001|First Invention|Stopping criteria|1|||
130134617|NCT02558491|468454492|FG000|First Invention|Changed parameters during trial|1|||
130134618|NCT02558491|468454493|FG001|First Invention|Changed parameters during trial|0|||
130134619|NCT02558491|468454492|FG000|Second Intervention|Withdrawal by Subject|1|||
130134620|NCT02558491|468454493|FG001|Second Intervention|Withdrawal by Subject|0|||
130134621|NCT02558491|468454492|FG000|Second Intervention|Stopping Criteria|1|||
130134622|NCT02558491|468454493|FG001|Second Intervention|Stopping Criteria|0|||
130134623|NCT00834431|468454494|FG000|First Intervention|Adverse Event|0|||
130134624|NCT00834431|468454495|FG001|First Intervention|Adverse Event|1|||
130134625|NCT00834431|468454494|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130134626|NCT00834431|468454495|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130134627|NCT05630885|468454501|FG000|Study Completion|Took prohibited medications|2|||
130134628|NCT05630885|468454502|FG001|Study Completion|Took prohibited medications|0|||
130134629|NCT05630885|468454501|FG000|Study Completion|Non-compliance with study drug|1|||
130134630|NCT05630885|468454502|FG001|Study Completion|Non-compliance with study drug|0|||
130134631|NCT05630885|468454501|FG000|Study Completion|Adverse Event|1|||
130134632|NCT05630885|468454502|FG001|Study Completion|Adverse Event|0|||
130134633|NCT05630885|468454501|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
130134634|NCT05630885|468454502|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
130134635|NCT05630885|468454501|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
130134636|NCT05630885|468454502|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
130134637|NCT06539676|468454503|FG000|Overall Study|Early study termination|1|||
130134638|NCT06539676|468454504|FG001|Overall Study|Early study termination|0|||
130134639|NCT06539676|468454505|FG002|Overall Study|Early study termination|6|||
130134640|NCT02645409|468454506|FG000|Overall Study|Withdrawal by Subject|3|||
130134641|NCT02645409|468454507|FG001|Overall Study|Withdrawal by Subject|0|||
130134642|NCT02645409|468454506|FG000|Overall Study|Physician Decision|1|||
130134643|NCT02645409|468454507|FG001|Overall Study|Physician Decision|0|||
130134644|NCT03419403|468454508|FG000|Overall Study|Withdrawal by Subject|5|||
130134645|NCT03419403|468454509|FG001|Overall Study|Withdrawal by Subject|2|||
130134646|NCT03419403|468454510|FG002|Overall Study|Withdrawal by Subject|5|||
130134647|NCT03419403|468454511|FG003|Overall Study|Withdrawal by Subject|1|||
130134648|NCT03419403|468454508|FG000|Overall Study|Progressive disease (per protocol)|0|||
130134649|NCT03419403|468454509|FG001|Overall Study|Progressive disease (per protocol)|2|||
130134650|NCT03419403|468454510|FG002|Overall Study|Progressive disease (per protocol)|2|||
130134651|NCT03419403|468454511|FG003|Overall Study|Progressive disease (per protocol)|0|||
130134652|NCT03419403|468454508|FG000|Overall Study|Other, not specified|6|||
130134653|NCT03419403|468454509|FG001|Overall Study|Other, not specified|4|||
130134654|NCT03419403|468454510|FG002|Overall Study|Other, not specified|5|||
130134655|NCT03419403|468454511|FG003|Overall Study|Other, not specified|1|||
130134656|NCT03419403|468454508|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
130134657|NCT03419403|468454509|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
130134658|NCT03419403|468454510|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
130134659|NCT03419403|468454511|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
130134660|NCT02089685|468454514|FG000|Overall Study|Adverse Event|1|||
130134661|NCT02089685|468454515|FG001|Overall Study|Adverse Event|0|||
130134662|NCT02089685|468454516|FG002|Overall Study|Adverse Event|0|||
130134663|NCT02089685|468454517|FG003|Overall Study|Adverse Event|0|||
129971289|NCT00193479|467858452|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
129971290|NCT00193479|467858452|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
129971291|NCT00872001|467858454|FG000|Overall Study|Adverse Event|34|||
129971292|NCT00872001|467858455|FG001|Overall Study|Adverse Event|23|||
129971293|NCT00872001|467858454|FG000|Overall Study|Protocol Defined Clinical Event|5|||
129971294|NCT00872001|467858455|FG001|Overall Study|Protocol Defined Clinical Event|7|||
129971295|NCT00872001|467858454|FG000|Overall Study|Lost to Follow-up|13|||
129971296|NCT00872001|467858455|FG001|Overall Study|Lost to Follow-up|12|||
129971297|NCT00872001|467858454|FG000|Overall Study|Withdrawal by Subject|18|||
129971298|NCT00872001|467858455|FG001|Overall Study|Withdrawal by Subject|30|||
129971299|NCT00872001|467858454|FG000|Overall Study|Protocol Violation|5|||
129971300|NCT00872001|467858455|FG001|Overall Study|Protocol Violation|8|||
130134664|NCT02089685|468454518|FG004|Overall Study|Adverse Event|1|||
130134665|NCT02089685|468454519|FG005|Overall Study|Adverse Event|0|||
130134666|NCT02089685|468454514|FG000|Overall Study|Clinical Progression|4|||
130134667|NCT02089685|468454515|FG001|Overall Study|Clinical Progression|0|||
130134668|NCT02089685|468454516|FG002|Overall Study|Clinical Progression|0|||
130134669|NCT02089685|468454517|FG003|Overall Study|Clinical Progression|5|||
130134670|NCT02089685|468454518|FG004|Overall Study|Clinical Progression|1|||
130134671|NCT02089685|468454519|FG005|Overall Study|Clinical Progression|2|||
130134672|NCT02089685|468454514|FG000|Overall Study|Excluded Medication|1|||
130134673|NCT02089685|468454515|FG001|Overall Study|Excluded Medication|0|||
130134674|NCT02089685|468454516|FG002|Overall Study|Excluded Medication|0|||
130134675|NCT02089685|468454517|FG003|Overall Study|Excluded Medication|11|||
130134676|NCT02089685|468454518|FG004|Overall Study|Excluded Medication|2|||
130134677|NCT02089685|468454519|FG005|Overall Study|Excluded Medication|1|||
130134678|NCT02089685|468454514|FG000|Overall Study|Progressive disease|13|||
130134679|NCT02089685|468454515|FG001|Overall Study|Progressive disease|10|||
130134680|NCT02089685|468454516|FG002|Overall Study|Progressive disease|3|||
130134681|NCT02089685|468454517|FG003|Overall Study|Progressive disease|51|||
130134682|NCT02089685|468454518|FG004|Overall Study|Progressive disease|17|||
130134683|NCT02089685|468454519|FG005|Overall Study|Progressive disease|12|||
130134684|NCT02089685|468454514|FG000|Overall Study|Follow up ended by sponsor|2|||
130134685|NCT02089685|468454515|FG001|Overall Study|Follow up ended by sponsor|2|||
130134686|NCT02089685|468454516|FG002|Overall Study|Follow up ended by sponsor|0|||
130134687|NCT02089685|468454517|FG003|Overall Study|Follow up ended by sponsor|70|||
130134688|NCT02089685|468454518|FG004|Overall Study|Follow up ended by sponsor|26|||
130134689|NCT02089685|468454519|FG005|Overall Study|Follow up ended by sponsor|26|||
130134690|NCT02089685|468454514|FG000|Overall Study|Withdrawal by Subject|0|||
130134691|NCT02089685|468454515|FG001|Overall Study|Withdrawal by Subject|2|||
130134692|NCT02089685|468454516|FG002|Overall Study|Withdrawal by Subject|0|||
130134693|NCT02089685|468454517|FG003|Overall Study|Withdrawal by Subject|8|||
130134694|NCT02089685|468454518|FG004|Overall Study|Withdrawal by Subject|1|||
130134695|NCT02089685|468454519|FG005|Overall Study|Withdrawal by Subject|1|||
130134696|NCT02089685|468454514|FG000|Overall Study|Status not recorded|1|||
130134697|NCT02089685|468454515|FG001|Overall Study|Status not recorded|0|||
130134698|NCT02089685|468454516|FG002|Overall Study|Status not recorded|0|||
130134699|NCT02089685|468454517|FG003|Overall Study|Status not recorded|0|||
130134700|NCT02089685|468454518|FG004|Overall Study|Status not recorded|1|||
130134701|NCT02089685|468454519|FG005|Overall Study|Status not recorded|0|||
130134702|NCT02089685|468454514|FG000|Overall Study|Death|0|||
130134703|NCT02089685|468454515|FG001|Overall Study|Death|0|||
130134704|NCT02089685|468454516|FG002|Overall Study|Death|0|||
130134705|NCT02089685|468454517|FG003|Overall Study|Death|7|||
130134706|NCT02089685|468454518|FG004|Overall Study|Death|2|||
130134707|NCT02089685|468454519|FG005|Overall Study|Death|5|||
130134708|NCT02089685|468454514|FG000|Overall Study|Lost to Follow-up|0|||
130134709|NCT02089685|468454515|FG001|Overall Study|Lost to Follow-up|0|||
130134710|NCT02089685|468454516|FG002|Overall Study|Lost to Follow-up|0|||
130134711|NCT02089685|468454517|FG003|Overall Study|Lost to Follow-up|1|||
130134712|NCT02089685|468454518|FG004|Overall Study|Lost to Follow-up|0|||
130134713|NCT02089685|468454519|FG005|Overall Study|Lost to Follow-up|0|||
130134714|NCT02089685|468454514|FG000|Overall Study|Physician Decision|0|||
130134715|NCT02089685|468454515|FG001|Overall Study|Physician Decision|0|||
130134716|NCT02089685|468454516|FG002|Overall Study|Physician Decision|0|||
130134717|NCT02089685|468454517|FG003|Overall Study|Physician Decision|0|||
130134718|NCT02089685|468454518|FG004|Overall Study|Physician Decision|0|||
130134719|NCT02089685|468454519|FG005|Overall Study|Physician Decision|4|||
130134720|NCT02089685|468454514|FG000|Overall Study|Screen failure|1|||
130134721|NCT02089685|468454515|FG001|Overall Study|Screen failure|0|||
130134722|NCT02089685|468454516|FG002|Overall Study|Screen failure|0|||
130134723|NCT02089685|468454517|FG003|Overall Study|Screen failure|0|||
130134724|NCT02089685|468454518|FG004|Overall Study|Screen failure|0|||
130134725|NCT02089685|468454519|FG005|Overall Study|Screen failure|0|||
130134726|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Adverse Event|11|||
130134727|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Adverse Event|23|||
130134728|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Adverse Event|29|||
130134729|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Adverse Event|2|||
130134730|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Adverse Event|8|||
130134731|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
130134732|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
130134733|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
130134734|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
130134735|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
130134736|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
130134737|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
130134738|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
130134739|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
130134740|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
130134741|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
130134742|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
130134743|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
130134744|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
130134745|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
130134746|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130134747|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
130134748|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130134749|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130134750|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
130134751|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
130134752|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
130134753|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
130134754|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
130134755|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
130134756|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
130134757|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
130134758|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
130134759|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
130134760|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
130134761|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Move|0|||
130134762|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Move|1|||
130134763|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Move|0|||
130134764|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Move|0|||
130134765|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Move|0|||
130134766|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130134767|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130134768|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130134769|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
130134770|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
130134771|NCT00318461|468454522|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
130134772|NCT00318461|468454523|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130134773|NCT00318461|468454524|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130134774|NCT00318461|468454525|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
130134775|NCT00318461|468454526|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
130134776|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Work commitment|0|||
130134777|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Work commitment|0|||
130134778|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Work commitment|0|||
130134779|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Work commitment|0|||
130134780|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Work commitment|1|||
130134781|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Investigator decision|0|||
130134782|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Investigator decision|0|||
130134783|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Investigator decision|0|||
130134784|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Investigator decision|0|||
130134785|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Investigator decision|1|||
130134786|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Lack of time|1|||
130134787|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Lack of time|0|||
130134788|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Lack of time|0|||
130134789|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Lack of time|0|||
130134790|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Lack of time|0|||
130134791|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130134792|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130134793|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129971301|NCT00872001|467858454|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
129971302|NCT00872001|467858455|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
130134794|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
130134795|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
130134796|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
130134797|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
130134798|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
130134799|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
129971303|NCT00872001|467858454|FG000|Overall Study|Administrative|23|||
129971304|NCT00872001|467858455|FG001|Overall Study|Administrative|15|||
129971305|NCT02030002|467858456|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
129971306|NCT02030002|467858456|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
129971307|NCT02030002|467858456|FG000|Follow-up|Lost to Follow-up|2|||
129971308|NCT03482752|467858462|FG000|Overall Study|Withdrawal by Subject|2|||
129971309|NCT03482752|467858462|FG000|Overall Study|Lost to Follow-up|1|||
130134800|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
130134801|NCT00318461|468454522|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130134802|NCT00318461|468454523|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130134803|NCT00318461|468454524|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
130134804|NCT00318461|468454525|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129971310|NCT03482752|467858462|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
129971311|NCT01080300|467858463|FG000|Overall Study|Adverse Event|49|||
129971312|NCT01080300|467858464|FG001|Overall Study|Adverse Event|35|||
129971313|NCT01080300|467858463|FG000|Overall Study|Lack of Efficacy|12|||
129971314|NCT01080300|467858464|FG001|Overall Study|Lack of Efficacy|15|||
129971315|NCT01080300|467858463|FG000|Overall Study|Protocol Violation|7|||
129971316|NCT01080300|467858464|FG001|Overall Study|Protocol Violation|13|||
129971317|NCT01080300|467858463|FG000|Overall Study|Lost to Follow-up|10|||
129971318|NCT01080300|467858464|FG001|Overall Study|Lost to Follow-up|6|||
129971319|NCT01080300|467858463|FG000|Overall Study|Death|0|||
129971320|NCT01080300|467858464|FG001|Overall Study|Death|1|||
129971321|NCT01080300|467858463|FG000|Overall Study|Withdrawal by Subject|12|||
129971322|NCT01080300|467858464|FG001|Overall Study|Withdrawal by Subject|28|||
129971323|NCT01080300|467858463|FG000|Overall Study|Reasons not specified|4|||
129971324|NCT01080300|467858464|FG001|Overall Study|Reasons not specified|6|||
129971325|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
129971326|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
129971327|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
129971328|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
129971329|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
129971330|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129971331|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
129971332|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
129971333|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
130134805|NCT00318461|468454526|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
130134806|NCT00318461|468454522|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130134807|NCT00318461|468454523|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
130134808|NCT00318461|468454524|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130134809|NCT00318461|468454525|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130134810|NCT00318461|468454526|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
130134811|NCT00318461|468454522|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
130134812|NCT00318461|468454523|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
130134813|NCT00318461|468454524|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
130134814|NCT00318461|468454525|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
130134815|NCT00318461|468454526|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
130134816|NCT00318461|468454522|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
130134817|NCT00318461|468454523|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
130134818|NCT00318461|468454524|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
130134819|NCT00318461|468454525|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
130134820|NCT00318461|468454526|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
130134821|NCT00318461|468454522|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
130134822|NCT00318461|468454523|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
130134823|NCT00318461|468454524|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
129971334|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
129971335|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
129971336|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
129971337|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
129971338|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
129971339|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
129971340|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
129971341|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
129971342|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
129971343|NCT04210843|467858466|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
129971344|NCT04210843|467858467|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
129971345|NCT04210843|467858466|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
129971346|NCT04210843|467858467|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
129971347|NCT04210843|467858466|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
130134824|NCT00318461|468454525|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
130134825|NCT00318461|468454526|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
130134826|NCT00318461|468454522|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
130134827|NCT00318461|468454523|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
130134828|NCT00318461|468454524|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
130134829|NCT00318461|468454525|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
130134830|NCT00318461|468454526|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
130134831|NCT01929863|468454533|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
130134832|NCT01929863|468454534|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
130134833|NCT01929863|468454533|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
130134834|NCT01929863|468454534|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
130134835|NCT01929863|468454533|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
130134836|NCT01929863|468454534|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
130134837|NCT02911701|468454535|FG000|Overall Study|Withdrawal by Subject|2|||
130134838|NCT02911701|468454536|FG001|Overall Study|Withdrawal by Subject|4|||
130134839|NCT02911701|468454535|FG000|Overall Study|Adverse Event|1|||
130134840|NCT02911701|468454536|FG001|Overall Study|Adverse Event|0|||
130134841|NCT00429416|468454537|FG000|Overall Study|Death|1|||
130134842|NCT00830024|468454538|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130134843|NCT00830024|468454539|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130134844|NCT01983969|468454540|FG000|Overall Study|Disease Progression|0|||
130134845|NCT01983969|468454541|FG001|Overall Study|Disease Progression|1|||
130134846|NCT01983969|468454542|FG002|Overall Study|Disease Progression|0|||
130134847|NCT00436163|468454543|FG000|Overall Study|Lost to Follow-up|2|||
130134848|NCT00436163|468454543|FG000|Overall Study|Adverse Event|1|||
130134849|NCT02530905|468454544|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
130134850|NCT02530905|468454545|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
130134851|NCT02530905|468454546|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
130134852|NCT00950989|468454548|FG000|Overall Study|Death|0|||
130134853|NCT00950989|468454549|FG001|Overall Study|Death|0|||
130134854|NCT00950989|468454550|FG002|Overall Study|Death|1|||
130134855|NCT00950989|468454551|FG003|Overall Study|Death|0|||
130134856|NCT00950989|468454548|FG000|Overall Study|Administrative Decision|0|||
130134857|NCT00950989|468454549|FG001|Overall Study|Administrative Decision|1|||
130134858|NCT00950989|468454550|FG002|Overall Study|Administrative Decision|0|||
130134859|NCT00950989|468454551|FG003|Overall Study|Administrative Decision|0|||
130134860|NCT00950989|468454548|FG000|Overall Study|Disease Progression|0|||
130134861|NCT00950989|468454549|FG001|Overall Study|Disease Progression|0|||
130134862|NCT00950989|468454550|FG002|Overall Study|Disease Progression|1|||
130134863|NCT00950989|468454551|FG003|Overall Study|Disease Progression|0|||
130134864|NCT00950989|468454548|FG000|Overall Study|Withdrawal by Subject|2|||
130134865|NCT00950989|468454549|FG001|Overall Study|Withdrawal by Subject|1|||
130134866|NCT00950989|468454550|FG002|Overall Study|Withdrawal by Subject|0|||
130134867|NCT00950989|468454551|FG003|Overall Study|Withdrawal by Subject|0|||
130134868|NCT00950989|468454548|FG000|Overall Study|Adverse Event|2|||
130134869|NCT00950989|468454549|FG001|Overall Study|Adverse Event|1|||
130134870|NCT00950989|468454550|FG002|Overall Study|Adverse Event|1|||
130134871|NCT00950989|468454551|FG003|Overall Study|Adverse Event|0|||
130134872|NCT01841554|468454552|FG000|Overall Study|Death|7|||
130134873|NCT01841554|468454552|FG000|Overall Study|No Implantation|1|||
130134874|NCT01841554|468454552|FG000|Overall Study|Discontinued Follow Up|5|||
130134875|NCT01841554|468454552|FG000|Overall Study|Study exit due to secondary intervention|6|||
130134876|NCT03804983|468454556|FG000|Overall Study|Adverse Event|0|||
130134877|NCT03804983|468454557|FG001|Overall Study|Adverse Event|1|||
130134878|NCT03804983|468454556|FG000|Overall Study|Family Obligation|1|||
130134879|NCT03804983|468454557|FG001|Overall Study|Family Obligation|0|||
130134880|NCT03600376|468454558|FG000|Overall Study|Adverse Event|1|||
130134881|NCT03600376|468454559|FG001|Overall Study|Adverse Event|1|||
130134882|NCT03600376|468454558|FG000|Overall Study|Transferred to other facility|1|||
130134883|NCT03600376|468454559|FG001|Overall Study|Transferred to other facility|0|||
130134884|NCT03600376|468454558|FG000|Overall Study|Investigator Decision|0|||
130134885|NCT03600376|468454559|FG001|Overall Study|Investigator Decision|4|||
130134886|NCT03600376|468454558|FG000|Overall Study|Determined to be ineligible for study|0|||
130134887|NCT03600376|468454559|FG001|Overall Study|Determined to be ineligible for study|1|||
130134888|NCT02152163|468454560|FG000|Overall Study|Physician Decision|12|||
130134889|NCT02152163|468454561|FG001|Overall Study|Physician Decision|13|||
130134890|NCT00796562|468454562|FG000|Overall Study|Death|49|||
130134891|NCT00424047|468454563|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
130134892|NCT00424047|468454564|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
130134893|NCT00424047|468454563|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
130134894|NCT00424047|468454564|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
130134895|NCT00424047|468454563|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
130134896|NCT00424047|468454564|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
130134897|NCT00424047|468454563|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
130134898|NCT00424047|468454564|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
130134899|NCT00424047|468454563|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
130134900|NCT00424047|468454564|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
130134901|NCT00424047|468454563|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
130134902|NCT00424047|468454564|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
130134903|NCT00424047|468454563|FG000|On Study at Time of Unblinding|Adverse Event|22|||
130134904|NCT00424047|468454564|FG001|On Study at Time of Unblinding|Adverse Event|12|||
130134905|NCT00424047|468454563|FG000|On Study at Time of Unblinding|Progression of disease|92|||
130134906|NCT00424047|468454564|FG001|On Study at Time of Unblinding|Progression of disease|128|||
130134907|NCT00424047|468454563|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
130134908|NCT00424047|468454564|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
130134909|NCT00424047|468454563|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
130134910|NCT00424047|468454564|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
130134911|NCT00424047|468454563|FG000|On Study at Time of Unblinding|Death|11|||
130134912|NCT00424047|468454564|FG001|On Study at Time of Unblinding|Death|11|||
130134913|NCT00424047|468454563|FG000|On Study at Time of Unblinding|Other|5|||
130134914|NCT00424047|468454564|FG001|On Study at Time of Unblinding|Other|4|||
130134915|NCT00424047|468454563|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
130134916|NCT00424047|468454564|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
130134917|NCT00424047|468454563|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
130134918|NCT00424047|468454564|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
130134919|NCT00424047|468454563|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
130134920|NCT00424047|468454564|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
130134921|NCT00424047|468454563|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
130134922|NCT00424047|468454564|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
130134923|NCT00424047|468454563|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
130134924|NCT00424047|468454564|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
130134925|NCT00312897|468454567|FG000|Overall Study|Adverse Event|1|||
130134926|NCT00312897|468454568|FG001|Overall Study|Adverse Event|0|||
130134927|NCT00312897|468454567|FG000|Overall Study|Lost to Follow-up|2|||
130134928|NCT00312897|468454568|FG001|Overall Study|Lost to Follow-up|0|||
130134929|NCT00312897|468454567|FG000|Overall Study|Physician Decision|1|||
130134930|NCT00312897|468454568|FG001|Overall Study|Physician Decision|0|||
130134931|NCT00312897|468454567|FG000|Overall Study|Withdrawal by Subject|1|||
130134932|NCT00312897|468454568|FG001|Overall Study|Withdrawal by Subject|3|||
130134933|NCT00312897|468454567|FG000|Overall Study|Pregnancy|1|||
130134934|NCT00312897|468454568|FG001|Overall Study|Pregnancy|0|||
130134935|NCT00312897|468454567|FG000|Overall Study|discontinued prior to getting treatment|0|||
129971348|NCT04210843|467858467|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129971349|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
129971350|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
129971351|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
129971352|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
129971353|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
129971354|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
129971355|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
129971356|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
129971357|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
129971358|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
129971359|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
129971360|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
129971361|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
129971362|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
129971363|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
129971364|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
129971365|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
129971366|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
129971367|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
129971368|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
129971369|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
129971370|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
130134936|NCT00312897|468454568|FG001|Overall Study|discontinued prior to getting treatment|3|||
130134937|NCT03100344|468454569|FG000|Overall Study|Adverse Event|0|||
130134938|NCT03100344|468454570|FG001|Overall Study|Adverse Event|3|||
130134939|NCT03100344|468454571|FG002|Overall Study|Adverse Event|2|||
130134940|NCT03100344|468454572|FG003|Overall Study|Adverse Event|3|||
130134941|NCT03100344|468454569|FG000|Overall Study|Lack of Efficacy|2|||
130134942|NCT03100344|468454570|FG001|Overall Study|Lack of Efficacy|0|||
130134943|NCT03100344|468454571|FG002|Overall Study|Lack of Efficacy|0|||
130134944|NCT03100344|468454572|FG003|Overall Study|Lack of Efficacy|0|||
130134945|NCT03100344|468454569|FG000|Overall Study|Protocol Violation|1|||
130134946|NCT03100344|468454570|FG001|Overall Study|Protocol Violation|0|||
130134947|NCT03100344|468454571|FG002|Overall Study|Protocol Violation|0|||
130134948|NCT03100344|468454572|FG003|Overall Study|Protocol Violation|0|||
130134949|NCT03100344|468454569|FG000|Overall Study|Withdrawal by Subject|10|||
130134950|NCT03100344|468454570|FG001|Overall Study|Withdrawal by Subject|7|||
130134951|NCT03100344|468454571|FG002|Overall Study|Withdrawal by Subject|4|||
130134952|NCT03100344|468454572|FG003|Overall Study|Withdrawal by Subject|8|||
130134953|NCT03100344|468454569|FG000|Overall Study|Lost to Follow-up|1|||
130134954|NCT03100344|468454570|FG001|Overall Study|Lost to Follow-up|1|||
129971371|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
129971372|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
129971373|NCT01776008|467858468|FG000|Overall Study|ineligible|2|||
129971374|NCT00150618|467858470|FG000|Overall Study|Adverse Event|2|||
129971375|NCT00150618|467858471|FG001|Overall Study|Adverse Event|2|||
129971376|NCT00150618|467858472|FG002|Overall Study|Adverse Event|6|||
129971377|NCT00150618|467858473|FG003|Overall Study|Adverse Event|9|||
129971378|NCT00150618|467858474|FG004|Overall Study|Adverse Event|5|||
129971379|NCT00150618|467858470|FG000|Overall Study|Withdrawal by Subject|6|||
129971380|NCT00150618|467858471|FG001|Overall Study|Withdrawal by Subject|8|||
129971381|NCT00150618|467858472|FG002|Overall Study|Withdrawal by Subject|8|||
129971382|NCT00150618|467858473|FG003|Overall Study|Withdrawal by Subject|4|||
129971383|NCT00150618|467858474|FG004|Overall Study|Withdrawal by Subject|5|||
129971384|NCT00150618|467858470|FG000|Overall Study|Lost to Follow-up|4|||
130134955|NCT03100344|468454571|FG002|Overall Study|Lost to Follow-up|1|||
130134956|NCT03100344|468454572|FG003|Overall Study|Lost to Follow-up|1|||
130134957|NCT01010503|468454573|FG000|Overall Study|Adverse Event|1|||
130134958|NCT01010503|468454573|FG000|Overall Study|Death|1|||
130134959|NCT04633564|468454574|FG000|Period 1|Adverse Event|28|||
130134960|NCT04633564|468454575|FG001|Period 1|Adverse Event|19|||
130134961|NCT04633564|468454574|FG000|Period 1|Death|8|||
130134962|NCT04633564|468454575|FG001|Period 1|Death|7|||
130134963|NCT04633564|468454574|FG000|Period 1|Lost to Follow-up|3|||
130134964|NCT04633564|468454575|FG001|Period 1|Lost to Follow-up|5|||
130134965|NCT04633564|468454574|FG000|Period 1|Physician Decision|4|||
130134966|NCT04633564|468454575|FG001|Period 1|Physician Decision|12|||
130134967|NCT04633564|468454574|FG000|Period 1|Protocol Violation|0|||
130134968|NCT04633564|468454575|FG001|Period 1|Protocol Violation|1|||
130134969|NCT04633564|468454574|FG000|Period 1|Withdrawal by Subject|10|||
130134970|NCT04633564|468454575|FG001|Period 1|Withdrawal by Subject|8|||
130134971|NCT04633564|468454574|FG000|Period 1|Progressive disease|47|||
130134972|NCT04633564|468454575|FG001|Period 1|Progressive disease|51|||
130134973|NCT04633564|468454574|FG000|Period 1|Terminated by Sponsor|8|||
130134974|NCT04633564|468454575|FG001|Period 1|Terminated by Sponsor|6|||
130134975|NCT04633564|468454574|FG000|Period 2|Adverse Event|3|||
130134976|NCT04633564|468454575|FG001|Period 2|Adverse Event|4|||
130134977|NCT04633564|468454574|FG000|Period 2|Death|0|||
130134978|NCT04633564|468454575|FG001|Period 2|Death|2|||
130134979|NCT04633564|468454574|FG000|Period 2|Lost to Follow-up|0|||
130134980|NCT04633564|468454575|FG001|Period 2|Lost to Follow-up|1|||
130134981|NCT04633564|468454574|FG000|Period 2|Physician Decision|2|||
130134982|NCT04633564|468454575|FG001|Period 2|Physician Decision|4|||
130134983|NCT04633564|468454574|FG000|Period 2|Withdrawal by Subject|5|||
130134984|NCT04633564|468454575|FG001|Period 2|Withdrawal by Subject|1|||
130134985|NCT04633564|468454574|FG000|Period 2|Progressive Disease|74|||
129971385|NCT00150618|467858471|FG001|Overall Study|Lost to Follow-up|1|||
129971386|NCT00150618|467858472|FG002|Overall Study|Lost to Follow-up|5|||
129971387|NCT00150618|467858473|FG003|Overall Study|Lost to Follow-up|8|||
129971388|NCT00150618|467858474|FG004|Overall Study|Lost to Follow-up|4|||
129971389|NCT00150618|467858470|FG000|Overall Study|Protocol Violation|1|||
129971390|NCT00150618|467858471|FG001|Overall Study|Protocol Violation|0|||
129971391|NCT00150618|467858472|FG002|Overall Study|Protocol Violation|0|||
130134986|NCT04633564|468454575|FG001|Period 2|Progressive Disease|82|||
130134987|NCT04633564|468454574|FG000|Period 2|Terminated by Sponsor|9|||
130134988|NCT04633564|468454575|FG001|Period 2|Terminated by Sponsor|3|||
130134989|NCT03043872|468454581|FG000|Overall Study|Withdrawal by Subject|6|||
130134990|NCT03043872|468454582|FG001|Overall Study|Withdrawal by Subject|6|||
129971392|NCT00150618|467858473|FG003|Overall Study|Protocol Violation|0|||
129971393|NCT00150618|467858474|FG004|Overall Study|Protocol Violation|1|||
130134991|NCT03043872|468454583|FG002|Overall Study|Withdrawal by Subject|15|||
130134992|NCT03043872|468454581|FG000|Overall Study|Lost to Follow-up|2|||
130134993|NCT03043872|468454582|FG001|Overall Study|Lost to Follow-up|1|||
130134994|NCT03043872|468454583|FG002|Overall Study|Lost to Follow-up|1|||
130134995|NCT03043872|468454581|FG000|Overall Study|Death|270|||
130134996|NCT03043872|468454582|FG001|Overall Study|Death|269|||
130134997|NCT03043872|468454583|FG002|Overall Study|Death|296|||
130134998|NCT01154231|468454584|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
130134999|NCT01154231|468454584|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
130135000|NCT04025229|468455750|FG000|Overall Study|Adverse Event|1|||
130135001|NCT04025229|468455751|FG001|Overall Study|Adverse Event|0|||
130135002|NCT04025229|468455750|FG000|Overall Study|Withdrawal by Subject|0|||
130135003|NCT04025229|468455751|FG001|Overall Study|Withdrawal by Subject|2|||
130135004|NCT04025229|468455750|FG000|Overall Study|Death|0|||
130135005|NCT04025229|468455751|FG001|Overall Study|Death|1|||
130135006|NCT04025229|468455750|FG000|Overall Study|Physician Decision|0|||
130135007|NCT04025229|468455751|FG001|Overall Study|Physician Decision|1|||
130135008|NCT02571907|468455752|FG000|Overall Study|Death|4|||
130135009|NCT02571907|468455752|FG000|Overall Study|Lost to Follow-up|3|||
130135010|NCT02571907|468455752|FG000|Overall Study|Withdrawal by Subject|3|||
130135011|NCT02286739|468455757|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
130135012|NCT02286739|468455758|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
130135013|NCT02286739|468455757|FG000|Overall Study|No Verasense type documented|0|||
130135014|NCT02286739|468455758|FG001|Overall Study|No Verasense type documented|23|||
130135015|NCT02286739|468455757|FG000|Overall Study|Adverse Event|1|||
130135016|NCT02286739|468455758|FG001|Overall Study|Adverse Event|2|||
130135017|NCT02286739|468455757|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
130135018|NCT02286739|468455758|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
130135019|NCT00834717|468455759|FG000|First Intervention|Adverse Event|1|||
130135020|NCT00834717|468455760|FG001|First Intervention|Adverse Event|0|||
130135021|NCT00834717|468455759|FG000|First Intervention|Withdrawal by Subject|0|||
130135022|NCT00834717|468455760|FG001|First Intervention|Withdrawal by Subject|1|||
130135023|NCT02255149|468455763|FG000|Overall Study|Lost to Follow-up|2|||
130135024|NCT02255149|468455763|FG000|Overall Study|Withdrawal by Subject|1|||
130135025|NCT02255149|468455763|FG000|Overall Study|Withdrawal by PI|1|||
130135026|NCT02255149|468455763|FG000|Overall Study|Implant Failure|1|||
130135027|NCT05710718|468455769|FG000|Overall Study|Withdrawal by Subject|5|||
130135028|NCT05710718|468455770|FG001|Overall Study|Withdrawal by Subject|1|||
130135029|NCT05710718|468455769|FG000|Overall Study|Lost to Follow-up|0|||
130135030|NCT05710718|468455770|FG001|Overall Study|Lost to Follow-up|1|||
130135031|NCT05710718|468455769|FG000|Overall Study|Death|0|||
130135032|NCT05710718|468455770|FG001|Overall Study|Death|1|||
130135033|NCT01319383|468455771|FG000|Overall Study|No ex vivo or in vivo response|4|||
130135034|NCT01319383|468455772|FG001|Overall Study|No ex vivo or in vivo response|0|||
130135035|NCT01319383|468455771|FG000|Overall Study|Physician Decision|3|||
130135036|NCT01319383|468455772|FG001|Overall Study|Physician Decision|0|||
130135037|NCT01319383|468455771|FG000|Overall Study|Lack of Efficacy|5|||
130135038|NCT01319383|468455772|FG001|Overall Study|Lack of Efficacy|9|||
130135039|NCT01319383|468455771|FG000|Overall Study|No in vivo response to interval doses|0|||
130135040|NCT01319383|468455772|FG001|Overall Study|No in vivo response to interval doses|1|||
130135041|NCT01987765|468455773|FG000|Overall Study|Protocol Violation|65|||
130135042|NCT01987765|468455773|FG000|Overall Study|Lost to Follow-up|37|||
130135043|NCT01528696|468455782|FG000|Overall Study|See detailed description|18|||
130135044|NCT01528696|468455783|FG001|Overall Study|See detailed description|19|||
130135045|NCT03600805|468455784|FG000|Overall Study|Adverse Event|2|||
130135046|NCT03600805|468455785|FG001|Overall Study|Adverse Event|1|||
130135047|NCT03600805|468455786|FG002|Overall Study|Adverse Event|1|||
130135048|NCT03600805|468455787|FG003|Overall Study|Adverse Event|7|||
130135049|NCT03600805|468455784|FG000|Overall Study|Lack of Efficacy|2|||
130135050|NCT03600805|468455785|FG001|Overall Study|Lack of Efficacy|1|||
130135051|NCT03600805|468455786|FG002|Overall Study|Lack of Efficacy|0|||
130135052|NCT03600805|468455787|FG003|Overall Study|Lack of Efficacy|0|||
130135053|NCT03600805|468455784|FG000|Overall Study|Withdrawal by Subject|1|||
130135054|NCT03600805|468455785|FG001|Overall Study|Withdrawal by Subject|0|||
130135055|NCT03600805|468455786|FG002|Overall Study|Withdrawal by Subject|0|||
130135056|NCT03600805|468455787|FG003|Overall Study|Withdrawal by Subject|1|||
130135057|NCT03600805|468455784|FG000|Overall Study|Other unspecified|14|||
130135058|NCT03600805|468455785|FG001|Overall Study|Other unspecified|6|||
130135059|NCT03600805|468455786|FG002|Overall Study|Other unspecified|7|||
130135060|NCT03600805|468455787|FG003|Overall Study|Other unspecified|11|||
130135061|NCT06195579|468455788|FG000|Overall Study|Withdrawal by Subject|1|||
129971394|NCT00150618|467858470|FG000|Overall Study|Lack of Efficacy|1|||
129971395|NCT00150618|467858471|FG001|Overall Study|Lack of Efficacy|4|||
130135062|NCT02545283|468455789|FG000|Overall Study|Lost to Follow-up|2|||
130135063|NCT02545283|468455790|FG001|Overall Study|Lost to Follow-up|4|||
130135064|NCT02545283|468455789|FG000|Overall Study|Withdrawal by Subject|5|||
130135065|NCT02545283|468455790|FG001|Overall Study|Withdrawal by Subject|9|||
130135066|NCT02545283|468455789|FG000|Overall Study|Death|109|||
130135067|NCT02545283|468455790|FG001|Overall Study|Death|211|||
130135068|NCT02545283|468455789|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
130135069|NCT02545283|468455790|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
130135070|NCT02545283|468455789|FG000|Overall Study|Study Terminated By Sponsor|33|||
130135071|NCT02545283|468455790|FG001|Overall Study|Study Terminated By Sponsor|71|||
130135072|NCT01205035|468455806|FG000|Overall Study|Withdrawal by Subject|1|||
130135073|NCT01205035|468455807|FG001|Overall Study|Withdrawal by Subject|0|||
130135074|NCT01205035|468455806|FG000|Overall Study|Physician Decision|1|||
130135075|NCT01205035|468455807|FG001|Overall Study|Physician Decision|0|||
130135076|NCT02663349|468455809|FG000|Overall Study|Withdrawal by Subject|6|||
130135077|NCT00488774|468455810|FG000|Overall Study|Withdrawal of consent|2|||
130135078|NCT00488774|468455811|FG001|Overall Study|Withdrawal of consent|2|||
130135079|NCT00488774|468455812|FG002|Overall Study|Withdrawal of consent|2|||
130135080|NCT00488774|468455813|FG003|Overall Study|Withdrawal of consent|0|||
130135081|NCT00488774|468455810|FG000|Overall Study|Other|6|||
130135082|NCT00488774|468455811|FG001|Overall Study|Other|3|||
130135083|NCT00488774|468455812|FG002|Overall Study|Other|2|||
130135084|NCT00488774|468455813|FG003|Overall Study|Other|2|||
130135085|NCT00488774|468455810|FG000|Overall Study|Lost to Follow-up|0|||
130135086|NCT00488774|468455811|FG001|Overall Study|Lost to Follow-up|0|||
130135087|NCT00488774|468455812|FG002|Overall Study|Lost to Follow-up|1|||
130135088|NCT00488774|468455813|FG003|Overall Study|Lost to Follow-up|1|||
130135089|NCT01204294|468455814|FG000|Overall Study|Adverse Event|2|||
130135090|NCT01204294|468455815|FG001|Overall Study|Adverse Event|6|||
130135091|NCT01204294|468455816|FG002|Overall Study|Adverse Event|0|||
130135092|NCT01204294|468455817|FG003|Overall Study|Adverse Event|7|||
130135093|NCT01204294|468455818|FG004|Overall Study|Adverse Event|1|||
130135094|NCT01204294|468455819|FG005|Overall Study|Adverse Event|4|||
130135095|NCT01204294|468455820|FG006|Overall Study|Adverse Event|0|||
130135096|NCT01204294|468455814|FG000|Overall Study|Protocol Violation|1|||
130135097|NCT01204294|468455815|FG001|Overall Study|Protocol Violation|0|||
130135098|NCT01204294|468455816|FG002|Overall Study|Protocol Violation|2|||
130135099|NCT01204294|468455817|FG003|Overall Study|Protocol Violation|1|||
130135100|NCT01204294|468455818|FG004|Overall Study|Protocol Violation|0|||
130135101|NCT01204294|468455819|FG005|Overall Study|Protocol Violation|0|||
130135102|NCT01204294|468455820|FG006|Overall Study|Protocol Violation|0|||
130135103|NCT01204294|468455814|FG000|Overall Study|Withdrawal by Subject|0|||
130135104|NCT01204294|468455815|FG001|Overall Study|Withdrawal by Subject|2|||
130135105|NCT01204294|468455816|FG002|Overall Study|Withdrawal by Subject|2|||
130135106|NCT01204294|468455817|FG003|Overall Study|Withdrawal by Subject|1|||
130135107|NCT01204294|468455818|FG004|Overall Study|Withdrawal by Subject|1|||
130135108|NCT01204294|468455819|FG005|Overall Study|Withdrawal by Subject|1|||
130135109|NCT01204294|468455820|FG006|Overall Study|Withdrawal by Subject|2|||
130135110|NCT01204294|468455814|FG000|Overall Study|Lack of Efficacy|0|||
130135111|NCT01204294|468455815|FG001|Overall Study|Lack of Efficacy|0|||
130135112|NCT01204294|468455816|FG002|Overall Study|Lack of Efficacy|0|||
130135113|NCT01204294|468455817|FG003|Overall Study|Lack of Efficacy|2|||
130135114|NCT01204294|468455818|FG004|Overall Study|Lack of Efficacy|0|||
130135115|NCT01204294|468455819|FG005|Overall Study|Lack of Efficacy|0|||
130135116|NCT01204294|468455820|FG006|Overall Study|Lack of Efficacy|0|||
130135117|NCT01204294|468455814|FG000|Overall Study|Other (house moving)|0|||
130135118|NCT01204294|468455815|FG001|Overall Study|Other (house moving)|0|||
130135119|NCT01204294|468455816|FG002|Overall Study|Other (house moving)|1|||
130135120|NCT01204294|468455817|FG003|Overall Study|Other (house moving)|0|||
130135121|NCT01204294|468455818|FG004|Overall Study|Other (house moving)|0|||
130135122|NCT01204294|468455819|FG005|Overall Study|Other (house moving)|0|||
130135123|NCT01204294|468455820|FG006|Overall Study|Other (house moving)|0|||
130135124|NCT04590027|468455821|FG000|Overall Study|Lost to Follow-up|17|||
130135125|NCT04590027|468455822|FG001|Overall Study|Lost to Follow-up|14|||
130135126|NCT04590027|468455821|FG000|Overall Study|Protocol Violation|0|||
130135127|NCT04590027|468455822|FG001|Overall Study|Protocol Violation|3|||
130135128|NCT03128723|468455825|FG000|Overall Study|Withdrawal by Subject|2|||
130135129|NCT00075478|468455826|FG000|Overall Study|not eligible|1|||
130135130|NCT00075478|468455827|FG001|Overall Study|not eligible|0|||
130135131|NCT00075478|468455826|FG000|Overall Study|Physician Decision|0|||
130135132|NCT00075478|468455827|FG001|Overall Study|Physician Decision|1|||
130135133|NCT00673660|468455828|FG000|Overall Study|Lost to Follow-up|107|||
130135134|NCT00245063|468455829|FG000|Overall Study|Adverse Event|6|||
130135135|NCT00245063|468455830|FG001|Overall Study|Adverse Event|5|||
130135136|NCT00245063|468455829|FG000|Overall Study|Death|1|||
130135137|NCT00245063|468455830|FG001|Overall Study|Death|0|||
130135138|NCT05099380|468455831|FG000|Overall Study|Subject enrolled in error|1|||
130135139|NCT05099380|468455832|FG001|Overall Study|Subject enrolled in error|0|||
130135140|NCT05099380|468455831|FG000|Overall Study|Study Procedure|1|||
130135141|NCT05099380|468455832|FG001|Overall Study|Study Procedure|0|||
130135142|NCT05099380|468455831|FG000|Overall Study|Protocol Violation|1|||
130135143|NCT05099380|468455832|FG001|Overall Study|Protocol Violation|0|||
130135144|NCT05099380|468455831|FG000|Overall Study|Adverse Event|1|||
130135145|NCT05099380|468455832|FG001|Overall Study|Adverse Event|1|||
130135146|NCT05099380|468455831|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
130135147|NCT05099380|468455832|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
130135148|NCT03276754|468455833|FG000|Overall Study|Withdrawal of informed consent|4|||
130135149|NCT03276754|468455833|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
130135150|NCT03276754|468455833|FG000|Overall Study|Lost to Follow-up|27|||
130135151|NCT03276754|468455833|FG000|Overall Study|No data reported at Month 24|31|||
130135152|NCT03276754|468455833|FG000|Overall Study|Death|39|||
130135153|NCT00835263|468455834|FG000|Second Intervention|Adverse Event|1|||
130135154|NCT00835263|468455835|FG001|Second Intervention|Adverse Event|0|||
130135155|NCT03249454|468455836|FG000|Overall Study|Withdrawal by Subject|0|||
130135156|NCT03249454|468455837|FG001|Overall Study|Withdrawal by Subject|0|||
130135157|NCT03249454|468455838|FG002|Overall Study|Withdrawal by Subject|0|||
130135158|NCT03249454|468455839|FG003|Overall Study|Withdrawal by Subject|0|||
130135159|NCT03249454|468455840|FG004|Overall Study|Withdrawal by Subject|0|||
130135160|NCT03249454|468455841|FG005|Overall Study|Withdrawal by Subject|0|||
130135161|NCT03249454|468455842|FG006|Overall Study|Withdrawal by Subject|0|||
130135162|NCT03249454|468455843|FG007|Overall Study|Withdrawal by Subject|0|||
130135163|NCT03249454|468455844|FG008|Overall Study|Withdrawal by Subject|0|||
130135164|NCT03249454|468455845|FG009|Overall Study|Withdrawal by Subject|1|||
130135165|NCT03249454|468455846|FG010|Overall Study|Withdrawal by Subject|1|||
130135166|NCT01913405|468455847|FG000|Overall Study|Withdrawal by Subject|1|||
130135167|NCT01913405|468455847|FG000|Overall Study|Adverse Event|1|||
130135168|NCT01020474|468455850|FG000|Overall Study|Adverse Event|4|||
130135169|NCT01020474|468455851|FG001|Overall Study|Adverse Event|4|||
130135170|NCT01020474|468455850|FG000|Overall Study|Protocol Violation|0|||
130135171|NCT01020474|468455851|FG001|Overall Study|Protocol Violation|2|||
130135172|NCT01020474|468455850|FG000|Overall Study|Withdrawal by Subject|5|||
130135173|NCT01020474|468455851|FG001|Overall Study|Withdrawal by Subject|7|||
130135174|NCT01020474|468455850|FG000|Overall Study|Other Reasons|1|||
130135175|NCT01020474|468455851|FG001|Overall Study|Other Reasons|1|||
130135176|NCT01020474|468455850|FG000|Overall Study|Insufficient Clinical Response|0|||
130135177|NCT01020474|468455851|FG001|Overall Study|Insufficient Clinical Response|3|||
130135178|NCT03199963|468455854|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
130135179|NCT03199963|468455855|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
130135180|NCT03199963|468455854|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
130135181|NCT03199963|468455855|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
130135182|NCT03199963|468455854|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
130135183|NCT03199963|468455855|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
130135184|NCT03199963|468455854|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
130135185|NCT03199963|468455855|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
130135186|NCT03199963|468455854|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
130135187|NCT03199963|468455855|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
130135188|NCT03199963|468455854|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
130135189|NCT03199963|468455855|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
130135190|NCT00466167|468455856|FG000|Overall Study|Adverse Event|8|||
130135191|NCT00466167|468455857|FG001|Overall Study|Adverse Event|8|||
130135192|NCT00466167|468455858|FG002|Overall Study|Adverse Event|7|||
130135193|NCT00466167|468455856|FG000|Overall Study|Lack of Efficacy|2|||
130135194|NCT00466167|468455857|FG001|Overall Study|Lack of Efficacy|0|||
130135195|NCT00466167|468455858|FG002|Overall Study|Lack of Efficacy|3|||
130135196|NCT00466167|468455856|FG000|Overall Study|Protocol Violation|1|||
130135197|NCT00466167|468455857|FG001|Overall Study|Protocol Violation|1|||
130135198|NCT00466167|468455858|FG002|Overall Study|Protocol Violation|2|||
130135199|NCT00466167|468455856|FG000|Overall Study|Lost to Follow-up|3|||
130135200|NCT00466167|468455857|FG001|Overall Study|Lost to Follow-up|2|||
130135201|NCT00466167|468455858|FG002|Overall Study|Lost to Follow-up|2|||
130135202|NCT00466167|468455856|FG000|Overall Study|Withdrawal by Subject|4|||
130135203|NCT00466167|468455857|FG001|Overall Study|Withdrawal by Subject|1|||
130135204|NCT00466167|468455858|FG002|Overall Study|Withdrawal by Subject|6|||
130135205|NCT00466167|468455856|FG000|Overall Study|patient did not meet inclusion criteria|1|||
130135206|NCT00466167|468455857|FG001|Overall Study|patient did not meet inclusion criteria|0|||
130135207|NCT00466167|468455858|FG002|Overall Study|patient did not meet inclusion criteria|1|||
130135208|NCT00466167|468455856|FG000|Overall Study|Not treated|1|||
130135209|NCT00466167|468455857|FG001|Overall Study|Not treated|0|||
130135210|NCT00466167|468455858|FG002|Overall Study|Not treated|0|||
130135211|NCT03669861|468455861|FG000|Overall Study|Disease Flare|5|||
130135212|NCT03669861|468455861|FG000|Overall Study|Lack of Efficacy|2|||
130135213|NCT05479058|468455871|FG000|Overall Study|Withdrawal by Subject|1|||
130135214|NCT05479058|468455872|FG001|Overall Study|Withdrawal by Subject|1|||
129971396|NCT00150618|467858472|FG002|Overall Study|Lack of Efficacy|7|||
130135215|NCT05479058|468455871|FG000|Overall Study|Study terminated by sponsor|10|||
130135216|NCT05479058|468455872|FG001|Overall Study|Study terminated by sponsor|10|||
129971397|NCT00150618|467858473|FG003|Overall Study|Lack of Efficacy|4|||
130135217|NCT01370733|468455873|FG000|Overall Study|Withdrawal by Subject|8|||
130135218|NCT01370733|468455874|FG001|Overall Study|Withdrawal by Subject|8|||
130135219|NCT01370733|468455873|FG000|Overall Study|Lost to Follow-up|3|||
129971398|NCT00150618|467858474|FG004|Overall Study|Lack of Efficacy|6|||
130135220|NCT01370733|468455874|FG001|Overall Study|Lost to Follow-up|0|||
130135221|NCT01370733|468455873|FG000|Overall Study|Adverse Event|2|||
130135222|NCT01370733|468455874|FG001|Overall Study|Adverse Event|4|||
130135223|NCT01370733|468455873|FG000|Overall Study|Lack of Efficacy|3|||
130135224|NCT01370733|468455874|FG001|Overall Study|Lack of Efficacy|5|||
130135225|NCT01370733|468455873|FG000|Overall Study|Physician Decision|0|||
130135226|NCT01370733|468455874|FG001|Overall Study|Physician Decision|2|||
130135227|NCT01370733|468455873|FG000|Overall Study|Protocol Violation|1|||
130135228|NCT01370733|468455874|FG001|Overall Study|Protocol Violation|3|||
130135229|NCT00463684|468455877|FG000|Overall Study|Withdrawal by Subject|1|||
130135230|NCT00463684|468455877|FG000|Overall Study|Lost to Follow-up|3|||
130135231|NCT00191815|468455878|FG000|Overall Study|Adverse Event|2|||
130135232|NCT00191815|468455878|FG000|Overall Study|Disease progression or relapse|24|||
130135233|NCT00191815|468455878|FG000|Overall Study|Death|2|||
130135234|NCT00191815|468455878|FG000|Overall Study|Protocol Violation|3|||
130135235|NCT00191815|468455878|FG000|Overall Study|Physician Decision|2|||
130135236|NCT00191815|468455878|FG000|Overall Study|Withdrawal by Subject|7|||
130135237|NCT03808376|468455879|FG000|Overall Study|Withdrawal by Subject|10|||
130135238|NCT03644550|468455880|FG000|Overall Study|Withdrawal by Subject|3|||
130135239|NCT03644550|468455880|FG000|Overall Study|Progressive disease|15|||
130135240|NCT00323882|468455881|FG000|Overall Study|Adverse Event|2|||
130135241|NCT00323882|468455882|FG001|Overall Study|Adverse Event|1|||
130135242|NCT00323882|468455883|FG002|Overall Study|Adverse Event|1|||
130094403|NCT00798161|468302351|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
130094404|NCT00761761|468302352|FG000|Overall Study|Lost to Follow-up|3|||
130094405|NCT00761761|468302353|FG001|Overall Study|Lost to Follow-up|1|||
130094406|NCT00761761|468302352|FG000|Overall Study|Withdrawal by Subject|3|||
130094407|NCT00761761|468302353|FG001|Overall Study|Withdrawal by Subject|0|||
130094408|NCT01224171|468302355|FG000|Overall Study|Adverse Event|8|||
130094409|NCT01224171|468302356|FG001|Overall Study|Adverse Event|4|||
130094410|NCT01224171|468302355|FG000|Overall Study|Protocol Violation|0|||
130094411|NCT01224171|468302356|FG001|Overall Study|Protocol Violation|1|||
130094412|NCT01224171|468302355|FG000|Overall Study|Lack of Efficacy|5|||
130094413|NCT01224171|468302356|FG001|Overall Study|Lack of Efficacy|1|||
130094414|NCT01224171|468302355|FG000|Overall Study|Withdrawal of Consent|2|||
130094415|NCT01224171|468302356|FG001|Overall Study|Withdrawal of Consent|4|||
130094416|NCT01224171|468302355|FG000|Overall Study|Lost to Follow-up|0|||
130094417|NCT01224171|468302356|FG001|Overall Study|Lost to Follow-up|3|||
130094418|NCT03737812|468302357|FG000|Overall Study|Withdrawal by Subject|1|||
130094419|NCT03737812|468302358|FG001|Overall Study|Withdrawal by Subject|2|||
130094420|NCT03737812|468302359|FG002|Overall Study|Withdrawal by Subject|1|||
130094421|NCT03737812|468302357|FG000|Overall Study|Sponsor Discontinued the Study|4|||
130094422|NCT03737812|468302358|FG001|Overall Study|Sponsor Discontinued the Study|3|||
130094423|NCT03737812|468302359|FG002|Overall Study|Sponsor Discontinued the Study|2|||
130094424|NCT03737812|468302357|FG000|Overall Study|Adverse Event|0|||
130094425|NCT03737812|468302358|FG001|Overall Study|Adverse Event|1|||
130094426|NCT03737812|468302359|FG002|Overall Study|Adverse Event|0|||
130094427|NCT03737812|468302357|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
130094428|NCT03737812|468302358|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
130094429|NCT03737812|468302359|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
130094430|NCT02624713|468302360|FG000|Overall Study|Lost to Follow-up|14|||
130094431|NCT02624713|468302361|FG001|Overall Study|Lost to Follow-up|0|||
130094432|NCT00285857|468302365|FG000|Overall Study|Withdrawal by Subject|2|||
130094433|NCT00285857|468302365|FG000|Overall Study|Inadequate initial breast cytology|1|||
130094434|NCT00285857|468302365|FG000|Overall Study|Adverse Event|1|||
130094435|NCT01161173|468302371|FG000|Overall Study|Protocol Violation|13|||
130094436|NCT01161173|468302371|FG000|Overall Study|Lost to Follow-up|7|||
130094437|NCT01161173|468302371|FG000|Overall Study|Progressive Disease|82|||
130094438|NCT01161173|468302371|FG000|Overall Study|Withdrawal of Consent|5|||
130094439|NCT01161173|468302371|FG000|Overall Study|Unacceptable Toxicity|21|||
130094440|NCT01161173|468302371|FG000|Overall Study|Death|194|||
130094441|NCT01161173|468302371|FG000|Overall Study|End of Study|2|||
130094442|NCT01161173|468302371|FG000|Overall Study|Reasons Not Specified|23|||
130094443|NCT00792467|468302372|FG000|Overall Study|progression of disease|17|||
130094444|NCT00792467|468302372|FG000|Overall Study|Adverse Event|1|||
130094445|NCT00792467|468302372|FG000|Overall Study|patient request|1|||
130094446|NCT00792467|468302372|FG000|Overall Study|Lost to Follow-up|1|||
130094447|NCT00792467|468302372|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
130094448|NCT00792467|468302372|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
130094449|NCT03911401|468302373|FG000|Overall Study|Adverse Event|1|||
130094450|NCT03911401|468302374|FG001|Overall Study|Adverse Event|2|||
130094451|NCT03911401|468302375|FG002|Overall Study|Adverse Event|5|||
130094452|NCT03911401|468302373|FG000|Overall Study|Lack of Efficacy|1|||
130094453|NCT03911401|468302374|FG001|Overall Study|Lack of Efficacy|1|||
130094454|NCT03911401|468302375|FG002|Overall Study|Lack of Efficacy|8|||
130094455|NCT03911401|468302373|FG000|Overall Study|Physician Decision|0|||
130094456|NCT03911401|468302374|FG001|Overall Study|Physician Decision|0|||
130094457|NCT03911401|468302375|FG002|Overall Study|Physician Decision|1|||
130094458|NCT03911401|468302373|FG000|Overall Study|Withdrawal by Subject|1|||
130094459|NCT03911401|468302374|FG001|Overall Study|Withdrawal by Subject|2|||
130094460|NCT03911401|468302375|FG002|Overall Study|Withdrawal by Subject|0|||
130135243|NCT00323882|468455884|FG003|Overall Study|Adverse Event|1|||
130135244|NCT00323882|468455885|FG004|Overall Study|Adverse Event|3|||
130135245|NCT00323882|468455881|FG000|Overall Study|Disease Progression|6|||
130135246|NCT00323882|468455882|FG001|Overall Study|Disease Progression|4|||
130135247|NCT00323882|468455883|FG002|Overall Study|Disease Progression|10|||
130135248|NCT00323882|468455884|FG003|Overall Study|Disease Progression|5|||
130135249|NCT00323882|468455885|FG004|Overall Study|Disease Progression|22|||
130135250|NCT00323882|468455881|FG000|Overall Study|Death|0|||
130135251|NCT00323882|468455882|FG001|Overall Study|Death|1|||
130135252|NCT00323882|468455883|FG002|Overall Study|Death|1|||
130135253|NCT00323882|468455884|FG003|Overall Study|Death|0|||
130135254|NCT00323882|468455885|FG004|Overall Study|Death|5|||
130135255|NCT00323882|468455881|FG000|Overall Study|Lost to Follow-up|0|||
130135256|NCT00323882|468455882|FG001|Overall Study|Lost to Follow-up|0|||
130135257|NCT00323882|468455883|FG002|Overall Study|Lost to Follow-up|1|||
130135258|NCT00323882|468455884|FG003|Overall Study|Lost to Follow-up|0|||
130135259|NCT00323882|468455885|FG004|Overall Study|Lost to Follow-up|1|||
130135260|NCT00323882|468455881|FG000|Overall Study|Other|0|||
130135261|NCT00323882|468455882|FG001|Overall Study|Other|0|||
130135262|NCT00323882|468455883|FG002|Overall Study|Other|0|||
130135263|NCT00323882|468455884|FG003|Overall Study|Other|1|||
130135264|NCT00323882|468455885|FG004|Overall Study|Other|1|||
130135265|NCT01794845|468455886|FG000|Overall Study|Withdrawal by Subject|1|||
130135266|NCT01456221|468455887|FG000|Overall Study|Withdrawal by Subject|56|||
130135267|NCT01456221|468455888|FG001|Overall Study|Withdrawal by Subject|49|||
130135268|NCT01456221|468455887|FG000|Overall Study|Lost to Follow-up|1|||
130135269|NCT01456221|468455888|FG001|Overall Study|Lost to Follow-up|4|||
130135270|NCT01456221|468455887|FG000|Overall Study|Received medication|3|||
130135271|NCT01456221|468455888|FG001|Overall Study|Received medication|2|||
130135272|NCT01456221|468455887|FG000|Overall Study|Incomplete data|4|||
130135273|NCT01456221|468455888|FG001|Overall Study|Incomplete data|2|||
130135274|NCT06647173|468455889|FG000|Overall Study|Lost to Follow-up|24|||
130135275|NCT06999265|468455890|FG000|Overall Study|Lost to Follow-up|1|||
130135276|NCT06999265|468455891|FG001|Overall Study|Lost to Follow-up|1|||
130135277|NCT03114891|468455896|FG000|First Treatment Round|Lost to Follow-up|0|||
130135278|NCT03114891|468455897|FG001|First Treatment Round|Lost to Follow-up|1|||
130135279|NCT03114891|468455898|FG002|First Treatment Round|Lost to Follow-up|1|||
130135280|NCT03114891|468455899|FG003|First Treatment Round|Lost to Follow-up|0|||
130135281|NCT03114891|468455896|FG000|First Treatment Round|Withdrawal by Subject|0|||
130135282|NCT03114891|468455897|FG001|First Treatment Round|Withdrawal by Subject|2|||
130135283|NCT03114891|468455898|FG002|First Treatment Round|Withdrawal by Subject|0|||
130135284|NCT03114891|468455899|FG003|First Treatment Round|Withdrawal by Subject|1|||
130135285|NCT03114891|468455896|FG000|3 Week Break|Lost to Follow-up|1|||
130135286|NCT03114891|468455897|FG001|3 Week Break|Lost to Follow-up|0|||
130135287|NCT03114891|468455898|FG002|3 Week Break|Lost to Follow-up|0|||
130135288|NCT03114891|468455899|FG003|3 Week Break|Lost to Follow-up|1|||
130135289|NCT03114891|468455896|FG000|3 Week Break|Withdrawal by Subject|0|||
130135290|NCT03114891|468455897|FG001|3 Week Break|Withdrawal by Subject|1|||
130135291|NCT03114891|468455898|FG002|3 Week Break|Withdrawal by Subject|0|||
130135292|NCT03114891|468455899|FG003|3 Week Break|Withdrawal by Subject|0|||
130135293|NCT03114891|468455896|FG000|Second Treatment Round|Lost to Follow-up|1|||
130135294|NCT03114891|468455897|FG001|Second Treatment Round|Lost to Follow-up|0|||
130135295|NCT03114891|468455898|FG002|Second Treatment Round|Lost to Follow-up|0|||
130135296|NCT03114891|468455899|FG003|Second Treatment Round|Lost to Follow-up|0|||
130135297|NCT03114891|468455896|FG000|Second Treatment Round|Physician Decision|1|||
130135298|NCT03114891|468455897|FG001|Second Treatment Round|Physician Decision|0|||
130135299|NCT03114891|468455898|FG002|Second Treatment Round|Physician Decision|0|||
130135300|NCT03114891|468455899|FG003|Second Treatment Round|Physician Decision|0|||
130135301|NCT00772603|468457482|FG000|Overall Study|Withdrawal by Subject|11|||
130135302|NCT00772603|468457483|FG001|Overall Study|Withdrawal by Subject|10|||
130135303|NCT00772603|468457484|FG002|Overall Study|Withdrawal by Subject|6|||
130135304|NCT00772603|468457482|FG000|Overall Study|Adverse Event|37|||
130135305|NCT00772603|468457483|FG001|Overall Study|Adverse Event|18|||
130135306|NCT00772603|468457484|FG002|Overall Study|Adverse Event|10|||
130135307|NCT00772603|468457482|FG000|Overall Study|Subject Non-compliance|1|||
130135308|NCT00772603|468457483|FG001|Overall Study|Subject Non-compliance|6|||
130135309|NCT00772603|468457484|FG002|Overall Study|Subject Non-compliance|4|||
130135310|NCT00772603|468457482|FG000|Overall Study|Protocol Violation|0|||
130135311|NCT00772603|468457483|FG001|Overall Study|Protocol Violation|1|||
130135312|NCT00772603|468457484|FG002|Overall Study|Protocol Violation|1|||
130135313|NCT00772603|468457482|FG000|Overall Study|Lost to Follow-up|1|||
130135314|NCT00772603|468457483|FG001|Overall Study|Lost to Follow-up|5|||
130135315|NCT00772603|468457484|FG002|Overall Study|Lost to Follow-up|2|||
130135316|NCT00772603|468457482|FG000|Overall Study|Physician Decision|0|||
129971399|NCT00150618|467858470|FG000|Overall Study|No study meds|0|||
130135317|NCT00772603|468457483|FG001|Overall Study|Physician Decision|0|||
130135318|NCT00772603|468457484|FG002|Overall Study|Physician Decision|1|||
130135319|NCT00772603|468457482|FG000|Overall Study|Other|2|||
130135320|NCT00772603|468457483|FG001|Overall Study|Other|0|||
130135321|NCT00772603|468457484|FG002|Overall Study|Other|2|||
130135322|NCT01056484|468457487|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
130135323|NCT01056484|468457488|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
130135324|NCT01056484|468457487|FG000|Randomized Controlled Trial|Physician Decision|1|||
130135325|NCT01056484|468457488|FG001|Randomized Controlled Trial|Physician Decision|0|||
130135326|NCT01056484|468457487|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
130135327|NCT01056484|468457488|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
130135328|NCT00446966|468457491|FG000|Overall Study|Lost to Follow-up|10|||
130135329|NCT00446966|468457492|FG001|Overall Study|Lost to Follow-up|7|||
130135330|NCT01564394|468457493|FG000|Overall Study|Withdrawal by Subject|6|||
130135331|NCT01564394|468457494|FG001|Overall Study|Withdrawal by Subject|10|||
130135332|NCT00443651|468457495|FG000|Overall Study|Death|1|||
130135333|NCT00443651|468457496|FG001|Overall Study|Death|5|||
130135334|NCT00443651|468457495|FG000|Overall Study|Adverse Event|5|||
130135335|NCT00443651|468457496|FG001|Overall Study|Adverse Event|6|||
130135336|NCT00443651|468457495|FG000|Overall Study|Lost to Follow-up|18|||
130135337|NCT00443651|468457496|FG001|Overall Study|Lost to Follow-up|12|||
130135338|NCT00443651|468457495|FG000|Overall Study|Patient's/Guardian's Decision|58|||
130135339|NCT00443651|468457496|FG001|Overall Study|Patient's/Guardian's Decision|30|||
130135340|NCT00443651|468457495|FG000|Overall Study|Physician Decision|13|||
130135341|NCT00443651|468457496|FG001|Overall Study|Physician Decision|4|||
130135342|NCT00443651|468457495|FG000|Overall Study|Pregnancy|0|||
130135343|NCT00443651|468457496|FG001|Overall Study|Pregnancy|1|||
130135344|NCT00859521|468457499|FG000|Washout|Withdrawal by Subject|0|||
130135345|NCT00859521|468457500|FG001|Washout|Withdrawal by Subject|1|||
130135346|NCT02888756|468457503|FG000|Analytical Treatment Interruption|Physician Decision|10|||
130135347|NCT02888756|468457504|FG001|Analytical Treatment Interruption|Physician Decision|6|||
130135348|NCT02888756|468457505|FG002|Analytical Treatment Interruption|Physician Decision|5|||
130135349|NCT01547286|468457513|FG000|Overall Study|Did not meet all eligibility criteria|1|||
130135350|NCT01547286|468457513|FG000|Overall Study|Physician Decision|1|||
130135351|NCT03415308|468457516|FG000|Overall Study|Lost to Follow-up|0|||
130135352|NCT03415308|468457517|FG001|Overall Study|Lost to Follow-up|0|||
130135353|NCT03415308|468457518|FG002|Overall Study|Lost to Follow-up|1|||
130135354|NCT03415308|468457516|FG000|Overall Study|Scheduling Conflicts|0|||
130135355|NCT03415308|468457517|FG001|Overall Study|Scheduling Conflicts|0|||
130135356|NCT03415308|468457518|FG002|Overall Study|Scheduling Conflicts|7|||
130135357|NCT01471353|468457519|FG000|Overall Study|remain on study|3|||
130135358|NCT00836472|468457520|FG000|Washout|Adverse Event|1|||
130135359|NCT00836472|468457521|FG001|Washout|Adverse Event|2|||
130135360|NCT00836472|468457520|FG000|Washout|Withdrawal by Subject|1|||
130135361|NCT00836472|468457521|FG001|Washout|Withdrawal by Subject|1|||
130135362|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
130135363|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
130135364|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
130135365|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
130135366|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135367|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135368|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135369|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135370|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135371|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135372|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135373|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135374|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135375|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
130135376|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130135377|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130135378|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
130135379|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
130135380|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135381|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135382|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135383|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135384|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135385|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135386|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135387|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135388|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
130135389|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129971400|NCT00150618|467858471|FG001|Overall Study|No study meds|0|||
130135390|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
130135391|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135392|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
130135393|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135394|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135395|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135396|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135397|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135398|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135399|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129971401|NCT00150618|467858472|FG002|Overall Study|No study meds|0|||
129971402|NCT00150618|467858473|FG003|Overall Study|No study meds|0|||
129971403|NCT00150618|467858474|FG004|Overall Study|No study meds|2|||
129971404|NCT00150618|467858470|FG000|Overall Study|Physician Decision|0|||
129971405|NCT00150618|467858471|FG001|Overall Study|Physician Decision|2|||
129971406|NCT00150618|467858472|FG002|Overall Study|Physician Decision|0|||
129971407|NCT00150618|467858473|FG003|Overall Study|Physician Decision|0|||
129971408|NCT00150618|467858474|FG004|Overall Study|Physician Decision|1|||
129971409|NCT00150618|467858470|FG000|Overall Study|Lack of compliance|2|||
129971410|NCT00150618|467858471|FG001|Overall Study|Lack of compliance|1|||
129971411|NCT00150618|467858472|FG002|Overall Study|Lack of compliance|1|||
129971412|NCT00150618|467858473|FG003|Overall Study|Lack of compliance|0|||
129971413|NCT00150618|467858474|FG004|Overall Study|Lack of compliance|1|||
130135400|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135401|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135402|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135403|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
130135404|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
130135405|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
130135406|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
130135407|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135408|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135409|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135410|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135411|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135412|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135413|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135414|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135415|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135416|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135417|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
130135418|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
130135419|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135420|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
130135421|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135422|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135423|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129971414|NCT00150618|467858470|FG000|Overall Study|Abnormal ECG|1|||
129971415|NCT00150618|467858471|FG001|Overall Study|Abnormal ECG|0|||
129971416|NCT00150618|467858472|FG002|Overall Study|Abnormal ECG|0|||
129971417|NCT00150618|467858473|FG003|Overall Study|Abnormal ECG|0|||
129971418|NCT00150618|467858474|FG004|Overall Study|Abnormal ECG|0|||
129971419|NCT00150618|467858470|FG000|Overall Study|Sponsor's decision|0|||
129971420|NCT00150618|467858471|FG001|Overall Study|Sponsor's decision|0|||
129971421|NCT00150618|467858472|FG002|Overall Study|Sponsor's decision|0|||
129971422|NCT00150618|467858473|FG003|Overall Study|Sponsor's decision|1|||
129971423|NCT00150618|467858474|FG004|Overall Study|Sponsor's decision|0|||
129971424|NCT00762476|467858475|FG000|Overall Study|Adverse Event|7|||
129971425|NCT00762476|467858476|FG001|Overall Study|Adverse Event|1|||
129971426|NCT00762476|467858475|FG000|Overall Study|Lost to Follow-up|2|||
129971427|NCT00762476|467858476|FG001|Overall Study|Lost to Follow-up|0|||
129971428|NCT00762476|467858475|FG000|Overall Study|Protocol Violation|5|||
129971429|NCT00762476|467858476|FG001|Overall Study|Protocol Violation|6|||
129971430|NCT00762476|467858475|FG000|Overall Study|Physician Decision|2|||
129971431|NCT00762476|467858476|FG001|Overall Study|Physician Decision|14|||
129971432|NCT00762476|467858475|FG000|Overall Study|Withdrawal by Subject|6|||
129971433|NCT00762476|467858476|FG001|Overall Study|Withdrawal by Subject|12|||
129971434|NCT00762476|467858475|FG000|Overall Study|antibiotic use|0|||
129971435|NCT00762476|467858476|FG001|Overall Study|antibiotic use|1|||
129971436|NCT00762476|467858475|FG000|Overall Study|non-compliance with study visits|0|||
129971437|NCT00762476|467858476|FG001|Overall Study|non-compliance with study visits|2|||
129971438|NCT00762476|467858475|FG000|Overall Study|Seasonal allergies|1|||
129971439|NCT00762476|467858476|FG001|Overall Study|Seasonal allergies|0|||
129971440|NCT02878603|467858477|FG000|Overall Study|Lost to Follow-up|4|||
129971441|NCT02878603|467858478|FG001|Overall Study|Lost to Follow-up|1|||
129971442|NCT02878603|467858477|FG000|Overall Study|Withdrawal by Subject|1|||
129971443|NCT02878603|467858478|FG001|Overall Study|Withdrawal by Subject|1|||
129971444|NCT02878603|467858477|FG000|Overall Study|Death|1|||
129971445|NCT02878603|467858478|FG001|Overall Study|Death|0|||
129971446|NCT02878603|467858477|FG000|Overall Study|Physician Decision|0|||
129971447|NCT02878603|467858478|FG001|Overall Study|Physician Decision|3|||
129971448|NCT02838134|467858479|FG000|Overall Study|Lost to Follow-up|1|||
129971449|NCT02838134|467858480|FG001|Overall Study|Lost to Follow-up|2|||
129971450|NCT02838134|467858479|FG000|Overall Study|logistic problems|1|||
129971451|NCT02838134|467858480|FG001|Overall Study|logistic problems|1|||
129971452|NCT04674189|467858481|FG000|Overall Study|Adverse Event|0|||
129971453|NCT04674189|467858482|FG001|Overall Study|Adverse Event|0|||
129971454|NCT04674189|467858483|FG002|Overall Study|Adverse Event|1|||
129971455|NCT04674189|467858481|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
129971456|NCT04674189|467858482|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
129971457|NCT04674189|467858483|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
129971458|NCT04674189|467858481|FG000|Overall Study|Physician Decision|1|||
130135424|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135425|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135426|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135427|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135428|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135429|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135430|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135431|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
130135432|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130135433|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135434|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
130135435|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135436|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135437|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135438|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135439|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135440|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135441|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135442|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135443|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135444|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135445|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
130135446|NCT01695239|468457522|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
130135447|NCT01695239|468457523|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135448|NCT01695239|468457524|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135449|NCT01695239|468457525|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135450|NCT01695239|468457526|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135451|NCT01695239|468457527|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135452|NCT01695239|468457528|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135453|NCT01695239|468457529|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135454|NCT01695239|468457530|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135455|NCT01695239|468457531|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135456|NCT01695239|468457532|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135457|NCT01695239|468457533|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135458|NCT01695239|468457534|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135459|NCT01695239|468457535|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
130135460|NCT01695239|468457522|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135461|NCT01695239|468457523|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135462|NCT01695239|468457524|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135463|NCT01695239|468457525|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135464|NCT01695239|468457526|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129971459|NCT04674189|467858482|FG001|Overall Study|Physician Decision|0|||
129971460|NCT04674189|467858483|FG002|Overall Study|Physician Decision|0|||
129971461|NCT04674189|467858481|FG000|Overall Study|Withdrawal by Participant|83|||
129971462|NCT04674189|467858482|FG001|Overall Study|Withdrawal by Participant|71|||
129971463|NCT04674189|467858483|FG002|Overall Study|Withdrawal by Participant|142|||
129971464|NCT04674189|467858481|FG000|Overall Study|Lost to Follow-up|55|||
129971465|NCT04674189|467858482|FG001|Overall Study|Lost to Follow-up|53|||
129971466|NCT04674189|467858483|FG002|Overall Study|Lost to Follow-up|44|||
130135465|NCT01695239|468457527|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135466|NCT01695239|468457528|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135467|NCT01695239|468457529|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
129971467|NCT04674189|467858481|FG000|Overall Study|Miscellaneous|27|||
129971468|NCT04674189|467858482|FG001|Overall Study|Miscellaneous|23|||
129971469|NCT04674189|467858483|FG002|Overall Study|Miscellaneous|207|||
129971470|NCT04674189|467858481|FG000|Overall Study|Did Not Receive Treatment|3|||
129971471|NCT04674189|467858482|FG001|Overall Study|Did Not Receive Treatment|1|||
129971472|NCT04674189|467858483|FG002|Overall Study|Did Not Receive Treatment|2|||
129971473|NCT01564277|467858484|FG000|Overall Study|Protocol Violation|0|||
129971474|NCT01564277|467858485|FG001|Overall Study|Protocol Violation|1|||
129971475|NCT01564277|467858484|FG000|Overall Study|Physician Decision|1|||
129971476|NCT01564277|467858485|FG001|Overall Study|Physician Decision|0|||
129971477|NCT01637077|467858486|FG000|Overall Study|Cancel|1|||
129971478|NCT01637077|467858487|FG001|Overall Study|Cancel|1|||
129971479|NCT01637077|467858486|FG000|Overall Study|Withdrawal by Subject|1|||
129971480|NCT01637077|467858487|FG001|Overall Study|Withdrawal by Subject|0|||
129971481|NCT01637077|467858486|FG000|Overall Study|No cycle 1 questionnaire data|2|||
129971482|NCT01637077|467858487|FG001|Overall Study|No cycle 1 questionnaire data|0|||
129971483|NCT02595372|467858488|FG000|Overall Study|Adverse Event|6|||
129971484|NCT02595372|467858488|FG000|Overall Study|Physician Decision|2|||
129971485|NCT02595372|467858488|FG000|Overall Study|Disease Progression|1|||
129971486|NCT00794924|467858489|FG000|Overall Study|Lost to Follow-up|6|||
129971487|NCT00794924|467858490|FG001|Overall Study|Lost to Follow-up|8|||
129971488|NCT00794924|467858489|FG000|Overall Study|Withdrawal by Subject|48|||
129971489|NCT00794924|467858490|FG001|Overall Study|Withdrawal by Subject|60|||
129971490|NCT00794924|467858489|FG000|Overall Study|Adverse Event|6|||
129971491|NCT00794924|467858490|FG001|Overall Study|Adverse Event|2|||
129971492|NCT01594970|467858491|FG000|Overall Study|Non-Adverse Event Related|4|||
129971493|NCT01594970|467858492|FG001|Overall Study|Non-Adverse Event Related|5|||
129971494|NCT01594970|467858493|FG002|Overall Study|Non-Adverse Event Related|6|||
129971495|NCT01594970|467858491|FG000|Overall Study|Adverse Event|17|||
129971496|NCT01594970|467858492|FG001|Overall Study|Adverse Event|23|||
129971497|NCT01594970|467858493|FG002|Overall Study|Adverse Event|23|||
129971498|NCT01594970|467858491|FG000|Overall Study|Lost to Follow-up|54|||
129971499|NCT01594970|467858492|FG001|Overall Study|Lost to Follow-up|54|||
129971500|NCT01594970|467858493|FG002|Overall Study|Lost to Follow-up|37|||
129971501|NCT00953615|467858494|FG000|Overall Study|Adverse Event|1|||
129971502|NCT01299480|467858495|FG000|Overall Study|No longer willing to participate|19|||
129971503|NCT01299480|467858496|FG001|Overall Study|No longer willing to participate|17|||
129971504|NCT01299480|467858497|FG002|Overall Study|No longer willing to participate|14|||
129971505|NCT01299480|467858498|FG003|Overall Study|No longer willing to participate|13|||
129971506|NCT01299480|467858499|FG004|Overall Study|No longer willing to participate|10|||
129971507|NCT01299480|467858495|FG000|Overall Study|Protocol Violation|7|||
129971508|NCT01299480|467858496|FG001|Overall Study|Protocol Violation|5|||
129971509|NCT01299480|467858497|FG002|Overall Study|Protocol Violation|8|||
129971510|NCT01299480|467858498|FG003|Overall Study|Protocol Violation|1|||
129971511|NCT01299480|467858499|FG004|Overall Study|Protocol Violation|1|||
129971512|NCT01299480|467858495|FG000|Overall Study|Withdrawal by Subject|3|||
129971513|NCT01299480|467858496|FG001|Overall Study|Withdrawal by Subject|4|||
129971514|NCT01299480|467858497|FG002|Overall Study|Withdrawal by Subject|7|||
129971515|NCT01299480|467858498|FG003|Overall Study|Withdrawal by Subject|3|||
129971516|NCT01299480|467858499|FG004|Overall Study|Withdrawal by Subject|4|||
129971517|NCT01299480|467858495|FG000|Overall Study|Adverse Event|6|||
129971518|NCT01299480|467858496|FG001|Overall Study|Adverse Event|4|||
129971519|NCT01299480|467858497|FG002|Overall Study|Adverse Event|5|||
129971520|NCT01299480|467858498|FG003|Overall Study|Adverse Event|4|||
129971521|NCT01299480|467858499|FG004|Overall Study|Adverse Event|0|||
129971522|NCT01299480|467858495|FG000|Overall Study|Withdrawal due to pregnancy|0|||
130135468|NCT01695239|468457530|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135469|NCT01695239|468457531|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135470|NCT01695239|468457532|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135471|NCT01695239|468457533|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135472|NCT01695239|468457534|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135473|NCT01695239|468457535|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
130135474|NCT01695239|468457522|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135475|NCT01695239|468457523|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135476|NCT01695239|468457524|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135477|NCT01695239|468457525|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135478|NCT01695239|468457526|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135479|NCT01695239|468457527|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129971523|NCT01299480|467858496|FG001|Overall Study|Withdrawal due to pregnancy|1|||
129971524|NCT01299480|467858497|FG002|Overall Study|Withdrawal due to pregnancy|1|||
129971525|NCT01299480|467858498|FG003|Overall Study|Withdrawal due to pregnancy|0|||
129971526|NCT01299480|467858499|FG004|Overall Study|Withdrawal due to pregnancy|0|||
129971527|NCT01299480|467858495|FG000|Overall Study|Physician Decision|1|||
129971528|NCT01299480|467858496|FG001|Overall Study|Physician Decision|1|||
129971529|NCT01299480|467858497|FG002|Overall Study|Physician Decision|0|||
129971530|NCT01299480|467858498|FG003|Overall Study|Physician Decision|2|||
130135480|NCT01695239|468457528|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135481|NCT01695239|468457529|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
130135482|NCT01695239|468457530|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135483|NCT01695239|468457531|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129971531|NCT01299480|467858499|FG004|Overall Study|Physician Decision|0|||
129971532|NCT01299480|467858495|FG000|Overall Study|Lost to Follow-up|3|||
129971533|NCT01299480|467858496|FG001|Overall Study|Lost to Follow-up|1|||
129971534|NCT01299480|467858497|FG002|Overall Study|Lost to Follow-up|2|||
129971535|NCT01299480|467858498|FG003|Overall Study|Lost to Follow-up|1|||
129971536|NCT01299480|467858499|FG004|Overall Study|Lost to Follow-up|2|||
129971537|NCT01299480|467858495|FG000|Overall Study|Other|3|||
129971538|NCT01299480|467858496|FG001|Overall Study|Other|2|||
129971539|NCT01299480|467858497|FG002|Overall Study|Other|3|||
129971540|NCT01299480|467858498|FG003|Overall Study|Other|0|||
129971541|NCT01299480|467858499|FG004|Overall Study|Other|3|||
129971542|NCT01299480|467858495|FG000|Overall Study|Started, but not vaccinated|0|||
129971543|NCT01299480|467858496|FG001|Overall Study|Started, but not vaccinated|0|||
129971544|NCT01299480|467858497|FG002|Overall Study|Started, but not vaccinated|1|||
130135484|NCT01695239|468457532|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135485|NCT01695239|468457533|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135486|NCT01695239|468457534|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135487|NCT01695239|468457535|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
130135488|NCT01695239|468457522|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135489|NCT01695239|468457523|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135490|NCT01695239|468457524|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135491|NCT01695239|468457525|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135492|NCT01695239|468457526|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135493|NCT01695239|468457527|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135494|NCT01695239|468457528|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135495|NCT01695239|468457529|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
130135496|NCT01695239|468457530|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135497|NCT01695239|468457531|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135498|NCT01695239|468457532|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135499|NCT01695239|468457533|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135500|NCT01695239|468457534|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135501|NCT01695239|468457535|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
130135502|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135503|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135504|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135505|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135506|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135507|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135508|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135509|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135510|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
130135511|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
130135512|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135513|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135514|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135515|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
130135516|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
130135517|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
130135518|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
130135519|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
130135520|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
130135521|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
130135522|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
130135523|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
130135524|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
130135525|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
130135526|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
130135527|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
130135528|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
129971545|NCT01299480|467858498|FG003|Overall Study|Started, but not vaccinated|1|||
129971546|NCT01299480|467858499|FG004|Overall Study|Started, but not vaccinated|0|||
129971547|NCT02296892|467858500|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
129971548|NCT02296892|467858501|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
130135529|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
130135530|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135531|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135532|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135533|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135534|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135535|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135536|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135537|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135538|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
130135539|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
130135540|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135541|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135542|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135543|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
130135544|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
130135545|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
130135546|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
130135547|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
130135548|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
130135549|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
130135550|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
130135551|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
130135552|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
130135553|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
130135554|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
130135555|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
130135556|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
130135557|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
130135558|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135559|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135560|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135561|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135562|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135563|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135564|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135565|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135566|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
130135567|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
130135568|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135569|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135570|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135571|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
130135572|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135573|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135574|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135575|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135576|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135577|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135578|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135579|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135580|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
130135581|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
130135582|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135583|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135584|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135585|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
130135586|NCT01695239|468457522|FG000|Extension Long-Term Extension Periods|Death|0|||
130135587|NCT01695239|468457523|FG001|Extension Long-Term Extension Periods|Death|0|||
130135588|NCT01695239|468457524|FG002|Extension Long-Term Extension Periods|Death|0|||
130135589|NCT01695239|468457525|FG003|Extension Long-Term Extension Periods|Death|0|||
130135590|NCT01695239|468457526|FG004|Extension Long-Term Extension Periods|Death|0|||
130135591|NCT01695239|468457527|FG005|Extension Long-Term Extension Periods|Death|0|||
130135592|NCT01695239|468457528|FG006|Extension Long-Term Extension Periods|Death|0|||
130135593|NCT01695239|468457529|FG007|Extension Long-Term Extension Periods|Death|0|||
130135594|NCT01695239|468457530|FG008|Extension Long-Term Extension Periods|Death|1|||
130135595|NCT01695239|468457531|FG009|Extension Long-Term Extension Periods|Death|0|||
130135596|NCT01695239|468457532|FG010|Extension Long-Term Extension Periods|Death|0|||
130135597|NCT01695239|468457533|FG011|Extension Long-Term Extension Periods|Death|0|||
130135598|NCT01695239|468457534|FG012|Extension Long-Term Extension Periods|Death|0|||
130135599|NCT01695239|468457535|FG013|Extension Long-Term Extension Periods|Death|0|||
130135600|NCT01695239|468457522|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135601|NCT01695239|468457523|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135602|NCT01695239|468457524|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135603|NCT01695239|468457525|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135604|NCT01695239|468457526|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135605|NCT01695239|468457527|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135606|NCT01695239|468457528|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135607|NCT01695239|468457529|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135608|NCT01695239|468457530|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135609|NCT01695239|468457531|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135610|NCT01695239|468457532|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
130135611|NCT01695239|468457533|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
130135612|NCT01695239|468457534|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
130135613|NCT01695239|468457535|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
130135614|NCT01695239|468457522|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135615|NCT01695239|468457523|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135616|NCT01695239|468457524|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135617|NCT01695239|468457525|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135618|NCT01695239|468457526|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135619|NCT01695239|468457527|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135620|NCT01695239|468457528|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135621|NCT01695239|468457529|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135622|NCT01695239|468457530|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135623|NCT01695239|468457531|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135624|NCT01695239|468457532|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135625|NCT01695239|468457533|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130135626|NCT01695239|468457534|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130135627|NCT01695239|468457535|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
130135628|NCT01695239|468457522|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135629|NCT01695239|468457523|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135630|NCT01695239|468457524|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135631|NCT01695239|468457525|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135632|NCT01695239|468457526|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135633|NCT01695239|468457527|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135634|NCT01695239|468457528|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135635|NCT01695239|468457529|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135636|NCT01695239|468457530|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135637|NCT01695239|468457531|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135638|NCT01695239|468457532|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135639|NCT01695239|468457533|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135640|NCT01695239|468457534|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
130135641|NCT01695239|468457535|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
130135642|NCT01695239|468457522|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135643|NCT01695239|468457523|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135644|NCT01695239|468457524|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135645|NCT01695239|468457525|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135646|NCT01695239|468457526|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135647|NCT01695239|468457527|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135648|NCT01695239|468457528|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135649|NCT01695239|468457529|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135650|NCT01695239|468457530|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135651|NCT01695239|468457531|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135652|NCT01695239|468457532|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135653|NCT01695239|468457533|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135654|NCT01695239|468457534|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
130135655|NCT01695239|468457535|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
130135656|NCT05239195|468457537|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
130135657|NCT05239195|468457538|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
130135658|NCT03552484|468457539|FG000|Overall Study|Death|6|||
130135659|NCT03552484|468457540|FG001|Overall Study|Death|4|||
129971549|NCT02296892|467858502|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
130135660|NCT03552484|468457539|FG000|Overall Study|Lost to Follow-up|0|||
130135661|NCT03552484|468457540|FG001|Overall Study|Lost to Follow-up|16|||
130135662|NCT00736190|468457541|FG000|Overall Study|Pregnancy|1|||
130135663|NCT00736190|468457541|FG000|Overall Study|Withdrawal by Subject|1|||
130135664|NCT00736190|468457541|FG000|Overall Study|Adverse Event|1|||
130135665|NCT03246503|468457542|FG000|Overall Study|Lost to Follow-up|23|||
130135666|NCT03246503|468457542|FG000|Overall Study|Withdrawal by Subject|20|||
130135667|NCT03246503|468457542|FG000|Overall Study|Physician Decision|5|||
130135668|NCT03246503|468457542|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
130135669|NCT00716625|468457544|FG000|Overall Study|Safety was not Assessable|1|||
130135670|NCT01492439|468457545|FG000|Overall Study|Withdrew from RTE|4|||
130135671|NCT01492439|468457546|FG001|Overall Study|Withdrew from RTE|9|||
130135672|NCT02682238|468457547|FG000|Overall Study|Lost to Follow-up|0|||
130135673|NCT02682238|468457548|FG001|Overall Study|Lost to Follow-up|2|||
130135674|NCT02682238|468457547|FG000|Overall Study|Withdrawal by Subject|1|||
130135675|NCT02682238|468457548|FG001|Overall Study|Withdrawal by Subject|0|||
130135676|NCT02682238|468457547|FG000|Overall Study|Adverse Event|1|||
130135677|NCT02682238|468457548|FG001|Overall Study|Adverse Event|0|||
130135678|NCT02682238|468457547|FG000|Overall Study|Non-compliance with Study Drug|1|||
130135679|NCT02682238|468457548|FG001|Overall Study|Non-compliance with Study Drug|0|||
130135680|NCT02682238|468457547|FG000|Overall Study|Non-compliance with Protocol|0|||
130135681|NCT02682238|468457548|FG001|Overall Study|Non-compliance with Protocol|2|||
130135682|NCT02909907|468457549|FG000|Overall Study|Withdrawal by Subject|0|||
130135683|NCT02909907|468457550|FG001|Overall Study|Withdrawal by Subject|1|||
130135684|NCT02075463|468457552|FG000|Overall Study|Adverse Event|3|||
130135685|NCT02075463|468457552|FG000|Overall Study|Par. reached stopping criteria|4|||
130135686|NCT02075463|468457552|FG000|Overall Study|Withdrawal by Subject|1|||
130135687|NCT00824291|468457554|FG000|Overall Study|Adverse Event|15|||
130135688|NCT00824291|468457555|FG001|Overall Study|Adverse Event|6|||
130135689|NCT00824291|468457554|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130135690|NCT00824291|468457555|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
130135691|NCT00824291|468457554|FG000|Overall Study|Lost to Follow-up|11|||
130135692|NCT00824291|468457555|FG001|Overall Study|Lost to Follow-up|9|||
130135693|NCT00824291|468457554|FG000|Overall Study|Non-compliance|1|||
130135694|NCT00824291|468457555|FG001|Overall Study|Non-compliance|1|||
130135695|NCT00824291|468457554|FG000|Overall Study|Protocol Violation|4|||
130135696|NCT00824291|468457555|FG001|Overall Study|Protocol Violation|1|||
130135697|NCT00824291|468457554|FG000|Overall Study|Withdrawal by Subject|14|||
130135698|NCT00824291|468457555|FG001|Overall Study|Withdrawal by Subject|8|||
130135699|NCT00824291|468457554|FG000|Overall Study|Lack of Efficacy|7|||
130135700|NCT00824291|468457555|FG001|Overall Study|Lack of Efficacy|8|||
130135701|NCT00824291|468457554|FG000|Overall Study|Participant on prohibited medication|1|||
130135702|NCT00824291|468457555|FG001|Overall Study|Participant on prohibited medication|0|||
130135703|NCT00933686|468457556|FG000|Overall Study|Protocol Violation|0|||
130135704|NCT00933686|468457557|FG001|Overall Study|Protocol Violation|1|||
130135705|NCT00933686|468457556|FG000|Overall Study|Lost to Follow-up|2|||
130135706|NCT00933686|468457557|FG001|Overall Study|Lost to Follow-up|2|||
130135707|NCT00933686|468457556|FG000|Overall Study|Withdrawal by Subject|6|||
130135708|NCT00933686|468457557|FG001|Overall Study|Withdrawal by Subject|5|||
130135709|NCT00933686|468457556|FG000|Overall Study|Adverse Event|1|||
130135710|NCT00933686|468457557|FG001|Overall Study|Adverse Event|1|||
130135711|NCT00933686|468457556|FG000|Overall Study|Physician Decision|1|||
130135712|NCT00933686|468457557|FG001|Overall Study|Physician Decision|0|||
130135713|NCT00933686|468457556|FG000|Overall Study|Failure to show up at endpoint visits|0|||
130135714|NCT00933686|468457557|FG001|Overall Study|Failure to show up at endpoint visits|2|||
130135715|NCT01383486|468457558|FG000|Overall Study|Lost to Follow-up|10|||
130135716|NCT01383486|468457558|FG000|Overall Study|Incomplete information for analysis|2|||
130135717|NCT01383486|468457558|FG000|Overall Study|Did not take any product|6|||
130135718|NCT01839279|468457560|FG000|Overall Study|Adverse Event|4|||
130135719|NCT01839279|468457561|FG001|Overall Study|Adverse Event|1|||
130135720|NCT01839279|468457562|FG002|Overall Study|Adverse Event|1|||
130135721|NCT01839279|468457560|FG000|Overall Study|Withdrawal by Subject|4|||
130135722|NCT01839279|468457561|FG001|Overall Study|Withdrawal by Subject|1|||
129971550|NCT02296892|467858500|FG000|Overall Study|Lost to Follow-up|5|||
129971551|NCT02296892|467858501|FG001|Overall Study|Lost to Follow-up|0|||
130135723|NCT01839279|468457562|FG002|Overall Study|Withdrawal by Subject|1|||
130135724|NCT01839279|468457560|FG000|Overall Study|Classified as 'Other'|5|||
130135725|NCT01839279|468457561|FG001|Overall Study|Classified as 'Other'|0|||
130135726|NCT01839279|468457562|FG002|Overall Study|Classified as 'Other'|0|||
130135727|NCT01648582|468457565|FG000|Overall Study|Adverse Event|6|||
130135728|NCT01648582|468457566|FG001|Overall Study|Adverse Event|11|||
130135729|NCT01648582|468457567|FG002|Overall Study|Adverse Event|2|||
130135730|NCT01648582|468457565|FG000|Overall Study|Lost to Follow-up|9|||
130135731|NCT01648582|468457566|FG001|Overall Study|Lost to Follow-up|6|||
130135732|NCT01648582|468457567|FG002|Overall Study|Lost to Follow-up|8|||
130135733|NCT01648582|468457565|FG000|Overall Study|Protocol Violation|1|||
130135734|NCT01648582|468457566|FG001|Overall Study|Protocol Violation|2|||
130135735|NCT01648582|468457567|FG002|Overall Study|Protocol Violation|1|||
130135736|NCT01648582|468457565|FG000|Overall Study|Withdrawal by Subject|15|||
130135737|NCT01648582|468457566|FG001|Overall Study|Withdrawal by Subject|17|||
130135738|NCT01648582|468457567|FG002|Overall Study|Withdrawal by Subject|17|||
130135739|NCT01648582|468457565|FG000|Overall Study|Physician Decision|0|||
130135740|NCT01648582|468457566|FG001|Overall Study|Physician Decision|1|||
130135741|NCT01648582|468457567|FG002|Overall Study|Physician Decision|3|||
130135742|NCT01648582|468457565|FG000|Overall Study|Death|1|||
130135743|NCT01648582|468457566|FG001|Overall Study|Death|0|||
130135744|NCT01648582|468457567|FG002|Overall Study|Death|0|||
130135745|NCT01648582|468457565|FG000|Overall Study|Sponsor Decision|0|||
130135746|NCT01648582|468457566|FG001|Overall Study|Sponsor Decision|1|||
130135747|NCT01648582|468457567|FG002|Overall Study|Sponsor Decision|1|||
130135748|NCT02699866|468457568|FG000|Overall Study|Withdrawal by Subject|3|||
130135749|NCT02699866|468457568|FG000|Overall Study|Physician Decision|2|||
130135750|NCT02699866|468457568|FG000|Overall Study|Adverse Event|3|||
130135751|NCT03437265|468457569|FG000|Overall Study|Protocol Violation|6|||
130135752|NCT00316277|468457571|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
129971552|NCT02296892|467858502|FG002|Overall Study|Lost to Follow-up|1|||
130135753|NCT00316277|468457572|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
130135754|NCT00316277|468457571|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
130135755|NCT00316277|468457572|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
130135756|NCT00316277|468457571|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
130135757|NCT00316277|468457572|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
130135758|NCT00316277|468457571|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
130135759|NCT00316277|468457572|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
130135760|NCT00316277|468457571|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
130135761|NCT00316277|468457572|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
130135762|NCT00848536|468457581|FG000|Overall Study|Adverse Event|2|||
130135763|NCT00848536|468457582|FG001|Overall Study|Adverse Event|2|||
130135764|NCT00848536|468457581|FG000|Overall Study|Withdrawal by Subject|0|||
130135765|NCT00848536|468457582|FG001|Overall Study|Withdrawal by Subject|1|||
130135766|NCT00848536|468457581|FG000|Overall Study|Protocol Violation|0|||
130135767|NCT00848536|468457582|FG001|Overall Study|Protocol Violation|1|||
130135768|NCT00848536|468457581|FG000|Overall Study|Noncompliance|1|||
130135769|NCT00848536|468457582|FG001|Overall Study|Noncompliance|0|||
130135770|NCT00848536|468457581|FG000|Overall Study|Inadequate Control of IOP|1|||
130135771|NCT00848536|468457582|FG001|Overall Study|Inadequate Control of IOP|1|||
130135772|NCT00848536|468457581|FG000|Overall Study|Patient Moved|0|||
130135773|NCT00848536|468457582|FG001|Overall Study|Patient Moved|2|||
130135774|NCT03987191|468457583|FG000|Overall Study|COVID-19 related research disruption|0|||
130135775|NCT03987191|468457584|FG001|Overall Study|COVID-19 related research disruption|2|||
130135776|NCT03261167|468457585|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
130135777|NCT03261167|468457586|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
130135778|NCT03261167|468457585|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
130135779|NCT03261167|468457586|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
130135780|NCT03261167|468457585|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
130135781|NCT03261167|468457586|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
130135782|NCT03261167|468457585|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
130135783|NCT03261167|468457586|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
130135784|NCT03261167|468457585|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
130135785|NCT03261167|468457586|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
130135786|NCT01572662|468457587|FG000|Overall Study|Withdrawal by Subject|1|||
130135787|NCT01572662|468457588|FG001|Overall Study|Withdrawal by Subject|0|||
130135788|NCT01572662|468457587|FG000|Overall Study|Physician Decision|0|||
130135789|NCT01572662|468457588|FG001|Overall Study|Physician Decision|1|||
130135790|NCT03364192|468457589|FG000|Overall Study|Ineligible|10|||
130135791|NCT03364192|468457589|FG000|Overall Study|Withdrawal by Subject|5|||
130135792|NCT03364192|468457589|FG000|Overall Study|Lost to Follow-up|1|||
130135793|NCT00918645|468457590|FG000|Overall Study|Withdrawal by Subject|1|||
130135794|NCT03446768|468457591|FG000|Overall Study|Withdrawal by Subject|0|||
130135795|NCT03446768|468457592|FG001|Overall Study|Withdrawal by Subject|1|||
130135796|NCT05133180|468457593|FG000|Overall Study|Withdrawal of consent|1|||
130135797|NCT05133180|468457594|FG001|Overall Study|Withdrawal of consent|1|||
130135798|NCT05133180|468457593|FG000|Overall Study|Lost to Follow-up|1|||
130135799|NCT05133180|468457594|FG001|Overall Study|Lost to Follow-up|1|||
130135800|NCT05133180|468457593|FG000|Overall Study|Documented disease progression|0|||
130135801|NCT05133180|468457594|FG001|Overall Study|Documented disease progression|1|||
129971553|NCT02336425|467858505|FG000|Overall Study|Study terminated.|2|||
129971554|NCT02336425|467858506|FG001|Overall Study|Study terminated.|2|||
130135802|NCT01535222|468457595|FG000|Overall Study|Inclusion/exclusion|0|||
130135803|NCT01535222|468457596|FG001|Overall Study|Inclusion/exclusion|0|||
130135804|NCT01535222|468457597|FG002|Overall Study|Inclusion/exclusion|1|||
130135805|NCT01535222|468457598|FG003|Overall Study|Inclusion/exclusion|0|||
130135806|NCT01535222|468457599|FG004|Overall Study|Inclusion/exclusion|0|||
130135807|NCT01535222|468457600|FG005|Overall Study|Inclusion/exclusion|0|||
130135808|NCT01604941|468457603|FG000|Overall Study|Adverse Event|1|||
130135809|NCT01604941|468457604|FG001|Overall Study|Adverse Event|2|||
130135810|NCT01604941|468457605|FG002|Overall Study|Adverse Event|0|||
130135811|NCT01604941|468457606|FG003|Overall Study|Adverse Event|0|||
130135812|NCT01604941|468457607|FG004|Overall Study|Adverse Event|1|||
130135813|NCT01604941|468457608|FG005|Overall Study|Adverse Event|5|||
130135814|NCT01604941|468457603|FG000|Overall Study|Non-compliance|1|||
130135815|NCT01604941|468457604|FG001|Overall Study|Non-compliance|0|||
130135816|NCT01604941|468457605|FG002|Overall Study|Non-compliance|0|||
130135817|NCT01604941|468457606|FG003|Overall Study|Non-compliance|0|||
130135818|NCT01604941|468457607|FG004|Overall Study|Non-compliance|0|||
130135819|NCT01604941|468457608|FG005|Overall Study|Non-compliance|0|||
130135820|NCT01604941|468457603|FG000|Overall Study|Participant Decision|0|||
130135821|NCT01604941|468457604|FG001|Overall Study|Participant Decision|0|||
130135822|NCT01604941|468457605|FG002|Overall Study|Participant Decision|0|||
130135823|NCT01604941|468457606|FG003|Overall Study|Participant Decision|0|||
130135824|NCT01604941|468457607|FG004|Overall Study|Participant Decision|0|||
130135825|NCT01604941|468457608|FG005|Overall Study|Participant Decision|2|||
130135826|NCT01604941|468457603|FG000|Overall Study|Early Study Termination|9|||
130135827|NCT01604941|468457604|FG001|Overall Study|Early Study Termination|2|||
130135828|NCT01604941|468457605|FG002|Overall Study|Early Study Termination|3|||
130135829|NCT01604941|468457606|FG003|Overall Study|Early Study Termination|3|||
130135830|NCT01604941|468457607|FG004|Overall Study|Early Study Termination|0|||
130135831|NCT01604941|468457608|FG005|Overall Study|Early Study Termination|0|||
130135832|NCT04078022|468457611|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
130135833|NCT04078022|468457612|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
130135834|NCT01895335|468457613|FG000|Overall Study|Adverse Event|106|||
130135835|NCT01895335|468457613|FG000|Overall Study|Lack of Efficacy|53|||
130135836|NCT01895335|468457613|FG000|Overall Study|Poor Compliance to Protocol|11|||
130135837|NCT01895335|468457613|FG000|Overall Study|Included But Not treated|1|||
130135838|NCT01895335|468457613|FG000|Overall Study|Other than Specified Above|44|||
130135839|NCT00115063|468457614|FG000|Overall Study|Lost to Follow-up|98|||
130135840|NCT00115063|468457615|FG001|Overall Study|Lost to Follow-up|104|||
130135841|NCT00115063|468457614|FG000|Overall Study|Death|1|||
130135842|NCT00115063|468457615|FG001|Overall Study|Death|0|||
130135843|NCT01075282|468457616|FG000|Overall Study|Withdrawal by Subject|11|||
130135844|NCT01075282|468457617|FG001|Overall Study|Withdrawal by Subject|7|||
130135845|NCT01075282|468457618|FG002|Overall Study|Withdrawal by Subject|11|||
130135846|NCT01075282|468457616|FG000|Overall Study|Adverse Event|9|||
130135847|NCT01075282|468457617|FG001|Overall Study|Adverse Event|8|||
130135848|NCT01075282|468457618|FG002|Overall Study|Adverse Event|5|||
130135849|NCT01075282|468457616|FG000|Overall Study|Entry Criteria Not Met|3|||
129971555|NCT02336425|467858507|FG002|Overall Study|Study terminated.|3|||
129971556|NCT02336425|467858508|FG003|Overall Study|Study terminated.|3|||
129971557|NCT00978562|467858509|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
129971558|NCT01782690|467858510|FG000|Overall Study|Not reported|7|||
129971559|NCT01782690|467858510|FG000|Overall Study|Toxicity of gemcitabine|1|||
129971560|NCT01782690|467858510|FG000|Overall Study|Toxicity of erlotinib|1|||
129971561|NCT01782690|467858510|FG000|Overall Study|Lost to Follow-up|31|||
129971562|NCT01782690|467858510|FG000|Overall Study|Withdrawal of informed consent|2|||
129971563|NCT01782690|467858510|FG000|Overall Study|Absent rash|9|||
129971564|NCT01782690|467858510|FG000|Overall Study|Physician Decision|13|||
129971565|NCT01782690|467858510|FG000|Overall Study|Patient's wish|21|||
129971566|NCT01782690|467858510|FG000|Overall Study|Tumor progression|74|||
129971567|NCT01782690|467858510|FG000|Overall Study|Death|133|||
129971568|NCT01782690|467858510|FG000|Overall Study|Study completion unknown|7|||
129971569|NCT04946942|467858512|FG000|Overall Study|Lost to Follow-up|6|||
129971570|NCT04946942|467858513|FG001|Overall Study|Lost to Follow-up|2|||
129971571|NCT04946942|467858514|FG002|Overall Study|Lost to Follow-up|0|||
129971572|NCT04907357|467858515|FG000|Overall Study|Death|0|||
129971573|NCT04907357|467858516|FG001|Overall Study|Death|1|||
129971574|NCT04907357|467858515|FG000|Overall Study|Lost to Follow-up|9|||
129971575|NCT04907357|467858516|FG001|Overall Study|Lost to Follow-up|18|||
129971576|NCT04907357|467858515|FG000|Overall Study|Physician Decision|1|||
129971577|NCT04907357|467858516|FG001|Overall Study|Physician Decision|0|||
130135850|NCT01075282|468457617|FG001|Overall Study|Entry Criteria Not Met|2|||
130135851|NCT01075282|468457618|FG002|Overall Study|Entry Criteria Not Met|0|||
130135852|NCT01075282|468457616|FG000|Overall Study|Lost to Follow-up|3|||
130135853|NCT01075282|468457617|FG001|Overall Study|Lost to Follow-up|3|||
129971578|NCT04907357|467858515|FG000|Overall Study|Withdrawal by Subject|0|||
129971579|NCT04907357|467858516|FG001|Overall Study|Withdrawal by Subject|1|||
129971580|NCT04907357|467858515|FG000|Overall Study|Unable to attend visits|1|||
129971581|NCT04907357|467858516|FG001|Overall Study|Unable to attend visits|0|||
129971582|NCT04907357|467858515|FG000|Overall Study|Incarcerated|1|||
129971583|NCT04907357|467858516|FG001|Overall Study|Incarcerated|1|||
130135854|NCT01075282|468457618|FG002|Overall Study|Lost to Follow-up|3|||
129971584|NCT04277507|467858518|FG000|Overall Study|Lost to Follow-up|17|||
129971585|NCT04277507|467858518|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
129971586|NCT04277507|467858518|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
129971587|NCT04277507|467858518|FG000|Overall Study|Withdrawal by Subject|3|||
130135855|NCT01075282|468457616|FG000|Overall Study|Physician Decision|3|||
130135856|NCT01075282|468457617|FG001|Overall Study|Physician Decision|3|||
130135857|NCT01075282|468457618|FG002|Overall Study|Physician Decision|3|||
130135858|NCT01075282|468457616|FG000|Overall Study|Lack of Efficacy|1|||
130135859|NCT01075282|468457617|FG001|Overall Study|Lack of Efficacy|1|||
130135860|NCT01075282|468457618|FG002|Overall Study|Lack of Efficacy|0|||
130135861|NCT01075282|468457616|FG000|Overall Study|Treatment Non-compliance|1|||
130135862|NCT01075282|468457617|FG001|Overall Study|Treatment Non-compliance|2|||
130135863|NCT01075282|468457618|FG002|Overall Study|Treatment Non-compliance|2|||
130135864|NCT01075282|468457616|FG000|Overall Study|Protocol Violation|0|||
130135865|NCT01075282|468457617|FG001|Overall Study|Protocol Violation|2|||
130135866|NCT01075282|468457618|FG002|Overall Study|Protocol Violation|1|||
130135867|NCT01075282|468457616|FG000|Overall Study|Death|0|||
130135868|NCT01075282|468457617|FG001|Overall Study|Death|1|||
130135869|NCT01075282|468457618|FG002|Overall Study|Death|2|||
130135870|NCT00003470|468457619|FG000|Overall Study|Not evaluable|6|||
130135871|NCT03503318|468457620|FG000|Overall Study|Death|1|||
130135872|NCT03503318|468457621|FG001|Overall Study|Death|0|||
130135873|NCT03503318|468457622|FG002|Overall Study|Death|4|||
130135874|NCT03503318|468457620|FG000|Overall Study|Adverse Event|3|||
130135875|NCT03503318|468457621|FG001|Overall Study|Adverse Event|4|||
130135876|NCT03503318|468457622|FG002|Overall Study|Adverse Event|2|||
130135877|NCT03503318|468457620|FG000|Overall Study|Withdrawal by Subject|12|||
130135878|NCT03503318|468457621|FG001|Overall Study|Withdrawal by Subject|17|||
130135879|NCT03503318|468457622|FG002|Overall Study|Withdrawal by Subject|16|||
130135880|NCT03503318|468457620|FG000|Overall Study|Protocol Violation|5|||
130135881|NCT03503318|468457621|FG001|Overall Study|Protocol Violation|0|||
130135882|NCT03503318|468457622|FG002|Overall Study|Protocol Violation|3|||
130135883|NCT03503318|468457620|FG000|Overall Study|Lost to Follow-up|17|||
130135884|NCT03503318|468457621|FG001|Overall Study|Lost to Follow-up|15|||
130135885|NCT03503318|468457622|FG002|Overall Study|Lost to Follow-up|12|||
130135886|NCT03503318|468457620|FG000|Overall Study|Other than specified|1|||
130135887|NCT03503318|468457621|FG001|Overall Study|Other than specified|3|||
130135888|NCT03503318|468457622|FG002|Overall Study|Other than specified|3|||
130135889|NCT02139826|468457625|FG000|Overall Study|Adverse Event|1|||
130135890|NCT01473953|468457629|FG000|Overall Study|Other|1|||
130135891|NCT01473953|468457630|FG001|Overall Study|Other|0|||
130135892|NCT01473953|468457631|FG002|Overall Study|Other|0|||
130135893|NCT01473953|468457632|FG003|Overall Study|Other|0|||
130135894|NCT01473953|468457633|FG004|Overall Study|Other|0|||
130135895|NCT01494532|468457634|FG000|Overall Study|Adverse Event|4|||
130135896|NCT01494532|468457635|FG001|Overall Study|Adverse Event|1|||
130135897|NCT01494532|468457636|FG002|Overall Study|Adverse Event|8|||
130135898|NCT01494532|468457637|FG003|Overall Study|Adverse Event|6|||
130135899|NCT01494532|468457638|FG004|Overall Study|Adverse Event|5|||
130135900|NCT01494532|468457639|FG005|Overall Study|Adverse Event|0|||
130135901|NCT01494532|468457634|FG000|Overall Study|Lack of Efficacy|0|||
130135902|NCT01494532|468457635|FG001|Overall Study|Lack of Efficacy|0|||
130135903|NCT01494532|468457636|FG002|Overall Study|Lack of Efficacy|0|||
130135904|NCT01494532|468457637|FG003|Overall Study|Lack of Efficacy|0|||
130135905|NCT01494532|468457638|FG004|Overall Study|Lack of Efficacy|2|||
130135906|NCT01494532|468457639|FG005|Overall Study|Lack of Efficacy|0|||
130135907|NCT01494532|468457634|FG000|Overall Study|Protocol deviation|2|||
130135908|NCT01494532|468457635|FG001|Overall Study|Protocol deviation|1|||
130135909|NCT01494532|468457636|FG002|Overall Study|Protocol deviation|3|||
130135910|NCT01494532|468457637|FG003|Overall Study|Protocol deviation|2|||
130135911|NCT01494532|468457638|FG004|Overall Study|Protocol deviation|3|||
130135912|NCT01494532|468457639|FG005|Overall Study|Protocol deviation|0|||
130135913|NCT01494532|468457634|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130135914|NCT01494532|468457635|FG001|Overall Study|Protocol-defined stopping criteria|0|||
130135915|NCT01494532|468457636|FG002|Overall Study|Protocol-defined stopping criteria|1|||
130135916|NCT01494532|468457637|FG003|Overall Study|Protocol-defined stopping criteria|0|||
130135917|NCT01494532|468457638|FG004|Overall Study|Protocol-defined stopping criteria|0|||
130135918|NCT01494532|468457639|FG005|Overall Study|Protocol-defined stopping criteria|0|||
130135919|NCT01494532|468457634|FG000|Overall Study|Lost to Follow-up|1|||
130135920|NCT01494532|468457635|FG001|Overall Study|Lost to Follow-up|0|||
130135921|NCT01494532|468457636|FG002|Overall Study|Lost to Follow-up|0|||
130135922|NCT01494532|468457637|FG003|Overall Study|Lost to Follow-up|2|||
130135923|NCT01494532|468457638|FG004|Overall Study|Lost to Follow-up|0|||
130135924|NCT01494532|468457639|FG005|Overall Study|Lost to Follow-up|0|||
130135925|NCT01494532|468457634|FG000|Overall Study|Physician Decision|0|||
130135926|NCT01494532|468457635|FG001|Overall Study|Physician Decision|1|||
130135927|NCT01494532|468457636|FG002|Overall Study|Physician Decision|1|||
130135928|NCT01494532|468457637|FG003|Overall Study|Physician Decision|2|||
130135929|NCT01494532|468457638|FG004|Overall Study|Physician Decision|0|||
130135930|NCT01494532|468457639|FG005|Overall Study|Physician Decision|0|||
130135931|NCT01494532|468457634|FG000|Overall Study|Withdrawal by Subject|3|||
130135932|NCT01494532|468457635|FG001|Overall Study|Withdrawal by Subject|1|||
130135933|NCT01494532|468457636|FG002|Overall Study|Withdrawal by Subject|4|||
130135934|NCT01494532|468457637|FG003|Overall Study|Withdrawal by Subject|3|||
130135935|NCT01494532|468457638|FG004|Overall Study|Withdrawal by Subject|2|||
130135936|NCT01494532|468457639|FG005|Overall Study|Withdrawal by Subject|0|||
130135937|NCT01117623|468459155|FG000|Overall Study|Adverse Event|0|||
130135938|NCT01117623|468459156|FG001|Overall Study|Adverse Event|2|||
130135939|NCT01117623|468459157|FG002|Overall Study|Adverse Event|4|||
130135940|NCT01117623|468459158|FG003|Overall Study|Adverse Event|0|||
129971588|NCT04277507|467858518|FG000|Overall Study|Death due to COVID-19|1|||
129971589|NCT04277507|467858518|FG000|Overall Study|Data missing for full evaluation|5|||
129971590|NCT00738283|467858524|FG000|Overall Study|Death|1|||
129971591|NCT00738283|467858524|FG000|Overall Study|Transfer to another facility|2|||
129971592|NCT00738283|467858524|FG000|Overall Study|Discharge home prior to end of study|1|||
129971593|NCT00486252|467858525|FG000|Overall Study|Adverse Event|7|||
129971594|NCT00486252|467858525|FG000|Overall Study|Lack of Efficacy|9|||
129971595|NCT00486252|467858525|FG000|Overall Study|Lost to Follow-up|24|||
129971596|NCT00486252|467858525|FG000|Overall Study|Other|18|||
129971597|NCT01261247|467858528|FG000|Overall Study|Ineligible|2|||
129971598|NCT01210651|467858529|FG000|Overall Study|Lost to Follow-up|1|||
129971599|NCT01210651|467858530|FG001|Overall Study|Lost to Follow-up|1|||
129971600|NCT01210651|467858529|FG000|Overall Study|schedule conflicts|1|||
129971601|NCT01210651|467858530|FG001|Overall Study|schedule conflicts|5|||
129971602|NCT01210651|467858529|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
129971603|NCT01210651|467858530|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
129971604|NCT01210651|467858529|FG000|Overall Study|Withdrawal by Subject|1|||
129971605|NCT01210651|467858530|FG001|Overall Study|Withdrawal by Subject|1|||
129971606|NCT01210651|467858529|FG000|Overall Study|Injury outside study|2|||
129971607|NCT01210651|467858530|FG001|Overall Study|Injury outside study|0|||
129971608|NCT02592707|467858531|FG000|Overall Study|Consent Withdrawn|0|||
129971609|NCT02592707|467858532|FG001|Overall Study|Consent Withdrawn|1|||
130135941|NCT01117623|468459159|FG004|Overall Study|Adverse Event|2|||
130135942|NCT01117623|468459160|FG005|Overall Study|Adverse Event|0|||
130135943|NCT01117623|468459161|FG006|Overall Study|Adverse Event|0|||
130135944|NCT01117623|468459162|FG007|Overall Study|Adverse Event|2|||
130135945|NCT01117623|468459155|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
130135946|NCT01117623|468459156|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
130135947|NCT01117623|468459157|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
130135948|NCT01117623|468459158|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
130135949|NCT01117623|468459159|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
130135950|NCT01117623|468459160|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
130135951|NCT01117623|468459161|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
130135952|NCT01117623|468459162|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
130135953|NCT01117623|468459155|FG000|Overall Study|Withdrawal by Subject|0|||
130135954|NCT01117623|468459156|FG001|Overall Study|Withdrawal by Subject|0|||
130135955|NCT01117623|468459157|FG002|Overall Study|Withdrawal by Subject|2|||
130135956|NCT01117623|468459158|FG003|Overall Study|Withdrawal by Subject|0|||
130135957|NCT01117623|468459159|FG004|Overall Study|Withdrawal by Subject|0|||
130135958|NCT01117623|468459160|FG005|Overall Study|Withdrawal by Subject|1|||
130135959|NCT01117623|468459161|FG006|Overall Study|Withdrawal by Subject|1|||
130135960|NCT01117623|468459162|FG007|Overall Study|Withdrawal by Subject|1|||
130135961|NCT01117623|468459155|FG000|Overall Study|Non-compliance with study medication|0|||
130135962|NCT01117623|468459156|FG001|Overall Study|Non-compliance with study medication|0|||
130135963|NCT01117623|468459157|FG002|Overall Study|Non-compliance with study medication|0|||
130135964|NCT01117623|468459158|FG003|Overall Study|Non-compliance with study medication|0|||
130135965|NCT01117623|468459159|FG004|Overall Study|Non-compliance with study medication|0|||
129971610|NCT02592707|467858533|FG002|Overall Study|Consent Withdrawn|2|||
129971611|NCT02592707|467858534|FG003|Overall Study|Consent Withdrawn|0|||
129971612|NCT02592707|467858531|FG000|Overall Study|Death|1|||
129971613|NCT02592707|467858532|FG001|Overall Study|Death|0|||
130135966|NCT01117623|468459160|FG005|Overall Study|Non-compliance with study medication|0|||
130135967|NCT01117623|468459161|FG006|Overall Study|Non-compliance with study medication|0|||
130135968|NCT01117623|468459162|FG007|Overall Study|Non-compliance with study medication|1|||
130135969|NCT01117623|468459155|FG000|Overall Study|Invest. text: completed all planned txs|0|||
130135970|NCT01117623|468459156|FG001|Overall Study|Invest. text: completed all planned txs|0|||
130135971|NCT01117623|468459157|FG002|Overall Study|Invest. text: completed all planned txs|0|||
129971614|NCT02592707|467858533|FG002|Overall Study|Death|0|||
129971615|NCT02592707|467858534|FG003|Overall Study|Death|0|||
129971616|NCT02592707|467858531|FG000|Overall Study|Progressive Disease|4|||
129971617|NCT02592707|467858532|FG001|Overall Study|Progressive Disease|4|||
129971618|NCT02592707|467858533|FG002|Overall Study|Progressive Disease|3|||
129971619|NCT02592707|467858534|FG003|Overall Study|Progressive Disease|3|||
130135972|NCT01117623|468459158|FG003|Overall Study|Invest. text: completed all planned txs|0|||
130135973|NCT01117623|468459159|FG004|Overall Study|Invest. text: completed all planned txs|0|||
130135974|NCT01117623|468459160|FG005|Overall Study|Invest. text: completed all planned txs|1|||
130135975|NCT01117623|468459161|FG006|Overall Study|Invest. text: completed all planned txs|0|||
130135976|NCT01117623|468459162|FG007|Overall Study|Invest. text: completed all planned txs|0|||
130135977|NCT00395694|468459168|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
130135978|NCT00395694|468459169|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
130135979|NCT00395694|468459168|FG000|Continuation Phase|Adverse Event|1|||
130135980|NCT00395694|468459169|FG001|Continuation Phase|Adverse Event|0|||
129971620|NCT02592707|467858531|FG000|Overall Study|Other|0|||
129971621|NCT02592707|467858532|FG001|Overall Study|Other|0|||
129971622|NCT02592707|467858533|FG002|Overall Study|Other|1|||
129971623|NCT02592707|467858534|FG003|Overall Study|Other|2|||
129971624|NCT02592707|467858531|FG000|Overall Study|Never entered LTFU period|1|||
129971625|NCT02592707|467858532|FG001|Overall Study|Never entered LTFU period|0|||
129971626|NCT02592707|467858533|FG002|Overall Study|Never entered LTFU period|0|||
129971627|NCT02592707|467858534|FG003|Overall Study|Never entered LTFU period|2|||
129971628|NCT04124471|467858535|FG000|Overall Study|screen failure|1|||
129971629|NCT04855734|467858536|FG000|Overall Study|Lost to Follow-up|2|||
129971630|NCT04855734|467858537|FG001|Overall Study|Lost to Follow-up|2|||
129971631|NCT04577573|467858538|FG000|Overall Study|Technical - invalid protocol|0|||
129971632|NCT04577573|467858539|FG001|Overall Study|Technical - invalid protocol|2|||
129971633|NCT04577573|467858540|FG002|Overall Study|Technical - invalid protocol|0|||
129971634|NCT02065882|467858541|FG000|Part I: PK/PD|Screening failure|5|||
129971635|NCT02065882|467858541|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
129971636|NCT02065882|467858541|FG000|Part I: PK/PD|Adverse Event|1|||
129971637|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Screening failure|7|||
129971638|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
129971639|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
129971640|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
129971641|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
129971642|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
129971643|NCT06840769|467858542|FG000|Overall Study|Withdrawal by Subject|1|||
129971644|NCT06840769|467858543|FG001|Overall Study|Withdrawal by Subject|0|||
129971645|NCT06840769|467858544|FG002|Overall Study|Withdrawal by Subject|0|||
129971646|NCT06840769|467858545|FG003|Overall Study|Withdrawal by Subject|0|||
129971647|NCT06840769|467858546|FG004|Overall Study|Withdrawal by Subject|0|||
129971648|NCT00592293|467860260|FG000|Overall Study|Withdrawal by Subject|1|||
129971649|NCT01606319|467860261|FG000|Overall Study|Lost to Follow-up|17|||
129971650|NCT01606319|467860262|FG001|Overall Study|Lost to Follow-up|14|||
129971651|NCT01606319|467860261|FG000|Overall Study|Withdrawal by Subject|9|||
129971652|NCT01606319|467860262|FG001|Overall Study|Withdrawal by Subject|12|||
129971653|NCT01606319|467860261|FG000|Overall Study|Physician Decision|1|||
129971654|NCT01606319|467860262|FG001|Overall Study|Physician Decision|2|||
129971655|NCT01606319|467860261|FG000|Overall Study|Lack of Efficacy|6|||
129971656|NCT01606319|467860262|FG001|Overall Study|Lack of Efficacy|8|||
129971657|NCT01606319|467860261|FG000|Overall Study|Adverse Event|1|||
129971658|NCT01606319|467860262|FG001|Overall Study|Adverse Event|4|||
129971659|NCT01594827|467860264|FG000|Overall Study|Adverse Event|1|||
129971660|NCT01594827|467860265|FG001|Overall Study|Adverse Event|0|||
129971661|NCT01594827|467860264|FG000|Overall Study|Physician Decision|3|||
129971662|NCT01594827|467860265|FG001|Overall Study|Physician Decision|0|||
129971663|NCT01821937|467860267|FG000|Overall Study|Adverse Event|0|||
129971664|NCT01821937|467860268|FG001|Overall Study|Adverse Event|3|||
129971665|NCT02153905|467860269|FG000|Overall Study|Death|1|||
129971666|NCT02153905|467860270|FG001|Overall Study|Death|0|||
129971667|NCT01516749|467860275|FG000|Active Therapy|Lost to Follow-up|1|||
129971668|NCT01516749|467860275|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
129971669|NCT00351377|467860276|FG000|Overall Study|Adverse Event|5|||
129971670|NCT00351377|467860276|FG000|Overall Study|Death|1|||
129971671|NCT00351377|467860276|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129971672|NCT01607879|467860277|FG000|Overall Study|Death|1|||
129971673|NCT01607879|467860278|FG001|Overall Study|Death|0|||
129971674|NCT03994731|467860284|FG000|Pegloticase + IMM Period|Death|2|||
129971675|NCT03994731|467860285|FG001|Pegloticase + IMM Period|Death|0|||
129971676|NCT03994731|467860284|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
129971677|NCT03994731|467860285|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
129971678|NCT03994731|467860284|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
129971679|NCT03994731|467860285|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
129971680|NCT00609947|467860290|FG000|Overall Study|Death|1|||
129971681|NCT02406248|467860291|FG000|Overall Study|Death|7|||
129971682|NCT02406248|467860291|FG000|Overall Study|Withdrawal by Subject|2|||
129971683|NCT00790205|467860292|FG000|Overall Study|Lost to Follow-up|61|||
129971684|NCT00790205|467860293|FG001|Overall Study|Lost to Follow-up|71|||
129971685|NCT00790205|467860292|FG000|Overall Study|Withdrawal by Subject|299|||
129971686|NCT00790205|467860293|FG001|Overall Study|Withdrawal by Subject|363|||
129971687|NCT01304498|467860294|FG000|Overall Study|Adverse Event|1|||
129971688|NCT01304498|467860295|FG001|Overall Study|Adverse Event|1|||
129971689|NCT01304498|467860294|FG000|Overall Study|Withdrawal by Subject|2|||
130135981|NCT00395694|468459168|FG000|Continuation Phase|Lack of Efficacy|12|||
130135982|NCT00395694|468459169|FG001|Continuation Phase|Lack of Efficacy|11|||
130135983|NCT00395694|468459168|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
130135984|NCT00395694|468459169|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
130135985|NCT00395694|468459168|FG000|Continuation Phase|Poor Compliance|1|||
130135986|NCT00395694|468459169|FG001|Continuation Phase|Poor Compliance|0|||
130135987|NCT00395694|468459168|FG000|Continuation Phase|Withdrawal by Subject|0|||
130135988|NCT00395694|468459169|FG001|Continuation Phase|Withdrawal by Subject|2|||
129971690|NCT01304498|467860295|FG001|Overall Study|Withdrawal by Subject|3|||
129971691|NCT01304498|467860294|FG000|Overall Study|Protocol Violation|1|||
129971692|NCT01304498|467860295|FG001|Overall Study|Protocol Violation|0|||
129971693|NCT01304498|467860294|FG000|Overall Study|Lost to Follow-up|2|||
129971694|NCT01304498|467860295|FG001|Overall Study|Lost to Follow-up|1|||
129971695|NCT01834586|467860304|FG000|Overall Study|Adverse Event|1|||
129971696|NCT01667549|467860305|FG000|Overall Study|Withdrawal by Subject|3|||
129971697|NCT01667549|467860306|FG001|Overall Study|Withdrawal by Subject|5|||
129971698|NCT01667549|467860307|FG002|Overall Study|Withdrawal by Subject|7|||
129971699|NCT01667549|467860308|FG003|Overall Study|Withdrawal by Subject|6|||
129971700|NCT01667549|467860309|FG004|Overall Study|Withdrawal by Subject|1|||
129971701|NCT02844777|467860310|FG000|Overall Study|Withdrawal by Subject|2|||
129971702|NCT02844777|467860311|FG001|Overall Study|Withdrawal by Subject|0|||
129971703|NCT02844777|467860312|FG002|Overall Study|Withdrawal by Subject|0|||
129971704|NCT02127125|467860313|FG000|Overall Study|Lost to Follow-up|0|||
129971705|NCT02127125|467860314|FG001|Overall Study|Lost to Follow-up|0|||
129971706|NCT02127125|467860315|FG002|Overall Study|Lost to Follow-up|0|||
129971707|NCT02127125|467860316|FG003|Overall Study|Lost to Follow-up|0|||
129971708|NCT02127125|467860317|FG004|Overall Study|Lost to Follow-up|2|||
129971709|NCT02127125|467860318|FG005|Overall Study|Lost to Follow-up|1|||
129971710|NCT02127125|467860319|FG006|Overall Study|Lost to Follow-up|0|||
129971711|NCT02127125|467860320|FG007|Overall Study|Lost to Follow-up|0|||
129971712|NCT02127125|467860321|FG008|Overall Study|Lost to Follow-up|0|||
129971713|NCT02127125|467860313|FG000|Overall Study|Withdrawal by Subject|0|||
129971714|NCT02127125|467860314|FG001|Overall Study|Withdrawal by Subject|0|||
129971715|NCT02127125|467860315|FG002|Overall Study|Withdrawal by Subject|0|||
129971716|NCT02127125|467860316|FG003|Overall Study|Withdrawal by Subject|1|||
129971717|NCT02127125|467860317|FG004|Overall Study|Withdrawal by Subject|0|||
129971718|NCT02127125|467860318|FG005|Overall Study|Withdrawal by Subject|0|||
129971719|NCT02127125|467860319|FG006|Overall Study|Withdrawal by Subject|0|||
129971720|NCT02127125|467860320|FG007|Overall Study|Withdrawal by Subject|0|||
129971721|NCT02127125|467860321|FG008|Overall Study|Withdrawal by Subject|0|||
129971722|NCT02127125|467860313|FG000|Overall Study|Physician Decision|0|||
129971723|NCT02127125|467860314|FG001|Overall Study|Physician Decision|0|||
129971724|NCT02127125|467860315|FG002|Overall Study|Physician Decision|1|||
129971725|NCT02127125|467860316|FG003|Overall Study|Physician Decision|0|||
129971726|NCT02127125|467860317|FG004|Overall Study|Physician Decision|1|||
129971727|NCT02127125|467860318|FG005|Overall Study|Physician Decision|2|||
130135989|NCT00840216|468459170|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
130135990|NCT00840216|468459171|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
130135991|NCT01058668|468459172|FG000|Double-blind Treatment Phase|Adverse Event|8|||
130135992|NCT01058668|468459173|FG001|Double-blind Treatment Phase|Adverse Event|15|||
130135993|NCT01058668|468459174|FG002|Double-blind Treatment Phase|Adverse Event|25|||
130135994|NCT01058668|468459172|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
130135995|NCT01058668|468459173|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
130135996|NCT01058668|468459174|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
130135997|NCT01058668|468459172|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
130135998|NCT01058668|468459173|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
130135999|NCT01058668|468459174|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
130136000|NCT01058668|468459172|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
130136001|NCT01058668|468459173|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
130136002|NCT01058668|468459174|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
130136003|NCT01058668|468459172|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
130136004|NCT01058668|468459173|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
130136005|NCT01058668|468459174|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
130136006|NCT01058668|468459172|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
130136007|NCT01058668|468459173|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
130136008|NCT01058668|468459174|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
129971728|NCT02127125|467860319|FG006|Overall Study|Physician Decision|0|||
129971729|NCT02127125|467860320|FG007|Overall Study|Physician Decision|0|||
129971730|NCT02127125|467860321|FG008|Overall Study|Physician Decision|0|||
129971731|NCT02353468|467860323|FG000|Overall Study|Study terminated|3|||
129971732|NCT02493946|467860324|FG000|DB Period|Withdrawal by Subject|8|||
129971733|NCT02493946|467860325|FG001|DB Period|Withdrawal by Subject|5|||
130136009|NCT00935012|468459179|FG000|Overall Study|Death|19|||
129971734|NCT02493946|467860326|FG002|DB Period|Withdrawal by Subject|0|||
129971735|NCT02493946|467860324|FG000|Open Label Period|Withdrawal by Subject|0|||
129971736|NCT02493946|467860325|FG001|Open Label Period|Withdrawal by Subject|0|||
130136010|NCT00935012|468459179|FG000|Overall Study|Withdrawal by Subject|3|||
130136011|NCT00935012|468459179|FG000|Overall Study|Other|5|||
130136012|NCT00935012|468459179|FG000|Overall Study|Adverse Event|2|||
130136013|NCT01442155|468459180|FG000|Overall Study|Complete remission|35|||
130136014|NCT01442155|468459180|FG000|Overall Study|Recurrence|26|||
130136015|NCT01442155|468459180|FG000|Overall Study|Adverse Event|2|||
130136016|NCT01442155|468459180|FG000|Overall Study|Lost to Follow-up|2|||
130136017|NCT00705666|468459181|FG000|Overall Study|No post-treatment questionnaire|279|||
130136018|NCT00705666|468459181|FG000|Overall Study|Withdrawal by Subject|21|||
130136019|NCT00705666|468459181|FG000|Overall Study|Physician Decision|7|||
130136020|NCT00705666|468459181|FG000|Overall Study|Lost to Follow-up|5|||
130136021|NCT00705666|468459181|FG000|Overall Study|Death|1|||
130136022|NCT00705666|468459181|FG000|Overall Study|Adverse Event|4|||
130136023|NCT00705666|468459181|FG000|Overall Study|Other|12|||
130136024|NCT00705666|468459181|FG000|Overall Study|Other|2|||
130136025|NCT00705666|468459181|FG000|Overall Study|Lack of data|3|||
130136026|NCT00705666|468459181|FG000|Overall Study|Untreated|5|||
130136027|NCT01590563|468459190|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
130136028|NCT03256695|468459191|FG000|Overall Study|Adverse Event|8|||
130136029|NCT03256695|468459191|FG000|Overall Study|Death|2|||
130136030|NCT03256695|468459191|FG000|Overall Study|Withdrawal by Subject|14|||
130136031|NCT03256695|468459191|FG000|Overall Study|Non-compliance with study drug|1|||
130136032|NCT03256695|468459191|FG000|Overall Study|Lost to Follow-up|3|||
130136033|NCT03256695|468459191|FG000|Overall Study|Lack of Efficacy|3|||
130136034|NCT03256695|468459191|FG000|Overall Study|Protocol Violation|5|||
130136035|NCT03256695|468459191|FG000|Overall Study|Other than specified|3|||
130136036|NCT03930732|468459192|FG000|Overall Study|Adverse Event|9|||
130136037|NCT03930732|468459193|FG001|Overall Study|Adverse Event|7|||
130136038|NCT03930732|468459192|FG000|Overall Study|Poor compliance to protocol|0|||
130136039|NCT03930732|468459193|FG001|Overall Study|Poor compliance to protocol|1|||
130136040|NCT03930732|468459192|FG000|Overall Study|Withdrawal by Subject|23|||
130136041|NCT03930732|468459193|FG001|Overall Study|Withdrawal by Subject|11|||
130136042|NCT03930732|468459192|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
130136043|NCT03930732|468459193|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
130136044|NCT03930732|468459192|FG000|Overall Study|Other reason not related to COVID-19|5|||
130136045|NCT03930732|468459193|FG001|Overall Study|Other reason not related to COVID-19|8|||
130136046|NCT03406156|468459194|FG000|Overall Study|Death|9|||
130136047|NCT03406156|468459195|FG001|Overall Study|Death|3|||
130136048|NCT03406156|468459194|FG000|Overall Study|Withdrawal by Subject|1|||
130136049|NCT03406156|468459195|FG001|Overall Study|Withdrawal by Subject|2|||
130136050|NCT03406156|468459194|FG000|Overall Study|COVID-19 infection|1|||
130136051|NCT03406156|468459195|FG001|Overall Study|COVID-19 infection|0|||
130136052|NCT03406156|468459194|FG000|Overall Study|Non-compliance with study procedures|1|||
130136053|NCT03406156|468459195|FG001|Overall Study|Non-compliance with study procedures|1|||
130136054|NCT03406156|468459194|FG000|Overall Study|Lost to Follow-up|0|||
130136055|NCT03406156|468459195|FG001|Overall Study|Lost to Follow-up|2|||
130136056|NCT03406156|468459194|FG000|Overall Study|Other, not specified|72|||
130136057|NCT03406156|468459195|FG001|Overall Study|Other, not specified|28|||
130136058|NCT03366792|468459198|FG000|Overall Study|Withdrawal by Subject|7|||
130136059|NCT03366792|468459198|FG000|Overall Study|Lost to Follow-up|2|||
130136060|NCT03366792|468459198|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
130136061|NCT03366792|468459198|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
130136062|NCT02450539|468459199|FG000|Overall Study|Withdrawal by Subject|12|||
130136063|NCT02450539|468459200|FG001|Overall Study|Withdrawal by Subject|6|||
130136064|NCT02450539|468459199|FG000|Overall Study|Lost to Follow-up|4|||
130136065|NCT02450539|468459200|FG001|Overall Study|Lost to Follow-up|1|||
130136066|NCT02699463|468459201|FG000|Overall Study|Lost to Follow-up|11|||
130136067|NCT02699463|468459202|FG001|Overall Study|Lost to Follow-up|8|||
130136068|NCT02699463|468459201|FG000|Overall Study|Withdrawal by Subject|4|||
130136069|NCT02699463|468459202|FG001|Overall Study|Withdrawal by Subject|1|||
129971737|NCT02493946|467860326|FG002|Open Label Period|Withdrawal by Subject|74|||
129971738|NCT02493946|467860324|FG000|Open Label Period|Adverse Event|0|||
129971739|NCT02493946|467860325|FG001|Open Label Period|Adverse Event|0|||
129971740|NCT02493946|467860326|FG002|Open Label Period|Adverse Event|4|||
129971741|NCT02493946|467860324|FG000|Open Label Period|Lost to Follow-up|0|||
130136070|NCT01808651|468459203|FG000|Study Period 1|Lost to Follow-up|1|||
130136071|NCT01808651|468459204|FG001|Study Period 1|Lost to Follow-up|3|||
130136072|NCT01808651|468459205|FG002|Study Period 1|Lost to Follow-up|0|||
130136073|NCT01808651|468459203|FG000|Study Period 1|Protocol Violation|1|||
130136074|NCT01808651|468459204|FG001|Study Period 1|Protocol Violation|0|||
130136075|NCT01808651|468459205|FG002|Study Period 1|Protocol Violation|1|||
130136076|NCT01808651|468459203|FG000|Study Period 1|Physician Decision|3|||
130136077|NCT01808651|468459204|FG001|Study Period 1|Physician Decision|2|||
130136078|NCT01808651|468459205|FG002|Study Period 1|Physician Decision|0|||
129971742|NCT02493946|467860325|FG001|Open Label Period|Lost to Follow-up|0|||
129971743|NCT02493946|467860326|FG002|Open Label Period|Lost to Follow-up|1|||
129971744|NCT02493946|467860324|FG000|Open Label Period|Investigator decision, non-compliance|0|||
129971745|NCT02493946|467860325|FG001|Open Label Period|Investigator decision, non-compliance|0|||
129971746|NCT02493946|467860326|FG002|Open Label Period|Investigator decision, non-compliance|2|||
129971747|NCT02493946|467860324|FG000|Open Label Period|Investigator decision, non-availability|0|||
129971748|NCT02493946|467860325|FG001|Open Label Period|Investigator decision, non-availability|0|||
129971749|NCT02493946|467860326|FG002|Open Label Period|Investigator decision, non-availability|1|||
129971750|NCT02493946|467860324|FG000|Open Label Period|Pregnancy|0|||
129971751|NCT02493946|467860325|FG001|Open Label Period|Pregnancy|0|||
129971752|NCT02493946|467860326|FG002|Open Label Period|Pregnancy|3|||
129971753|NCT02493946|467860324|FG000|Open Label Period|Site error|0|||
129971754|NCT02493946|467860325|FG001|Open Label Period|Site error|0|||
129971755|NCT02493946|467860326|FG002|Open Label Period|Site error|1|||
129971756|NCT00848484|467860327|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
130136079|NCT01808651|468459203|FG000|Study Period 1|Lack of Efficacy|2|||
130136080|NCT01808651|468459204|FG001|Study Period 1|Lack of Efficacy|1|||
130136081|NCT01808651|468459205|FG002|Study Period 1|Lack of Efficacy|0|||
130136082|NCT01808651|468459203|FG000|Study Period 1|Adverse Event|10|||
130136083|NCT01808651|468459204|FG001|Study Period 1|Adverse Event|4|||
129971757|NCT00848484|467860328|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
129971758|NCT00848484|467860327|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
129971759|NCT00848484|467860328|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
129971760|NCT00848484|467860327|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
129971761|NCT00848484|467860328|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
129971762|NCT00848484|467860327|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
129971763|NCT00848484|467860328|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
129971764|NCT00848484|467860327|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
129971765|NCT00848484|467860328|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
129971766|NCT03017742|467860335|FG000|Overall Study|Protocol Violation|36|||
129971767|NCT03017742|467860335|FG000|Overall Study|Withdrawal by Subject|37|||
129971768|NCT02975102|467860336|FG000|Overall Study|Adverse Event|2|||
129971769|NCT02975102|467860337|FG001|Overall Study|Adverse Event|1|||
130136084|NCT01808651|468459205|FG002|Study Period 1|Adverse Event|1|||
130136085|NCT01808651|468459203|FG000|Study Period 1|Participant Decision|9|||
130136086|NCT01808651|468459204|FG001|Study Period 1|Participant Decision|7|||
130136087|NCT01808651|468459205|FG002|Study Period 1|Participant Decision|3|||
130136088|NCT00585286|468459209|FG000|Overall Study|Lost to Follow-up|1|||
130136089|NCT03957551|468459210|FG000|Overall Study|Adverse Event|2|||
130136090|NCT03957551|468459211|FG001|Overall Study|Adverse Event|2|||
130136091|NCT03957551|468459212|FG002|Overall Study|Adverse Event|6|||
130136092|NCT03957551|468459210|FG000|Overall Study|Physician Decision|1|||
130136093|NCT03957551|468459211|FG001|Overall Study|Physician Decision|0|||
130136094|NCT03957551|468459212|FG002|Overall Study|Physician Decision|2|||
130136095|NCT03957551|468459210|FG000|Overall Study|Withdrawal by Subject|1|||
130136096|NCT03957551|468459211|FG001|Overall Study|Withdrawal by Subject|0|||
130136097|NCT03957551|468459212|FG002|Overall Study|Withdrawal by Subject|2|||
130136098|NCT03957551|468459210|FG000|Overall Study|Disease progression|1|||
130136099|NCT03957551|468459211|FG001|Overall Study|Disease progression|0|||
130136100|NCT03957551|468459212|FG002|Overall Study|Disease progression|8|||
130136101|NCT00606281|468459220|FG000|Overall Study|Adverse Event|11|||
130136102|NCT00606281|468459221|FG001|Overall Study|Adverse Event|12|||
130136103|NCT00606281|468459220|FG000|Overall Study|Death|1|||
130136104|NCT00606281|468459221|FG001|Overall Study|Death|0|||
130136105|NCT00606281|468459220|FG000|Overall Study|Lack of Efficacy|28|||
130136106|NCT00606281|468459221|FG001|Overall Study|Lack of Efficacy|35|||
130136107|NCT00606281|468459220|FG000|Overall Study|Physician Decision|0|||
130136108|NCT00606281|468459221|FG001|Overall Study|Physician Decision|1|||
130136109|NCT00606281|468459220|FG000|Overall Study|Protocol Violation|3|||
130136110|NCT00606281|468459221|FG001|Overall Study|Protocol Violation|3|||
130136111|NCT00606281|468459220|FG000|Overall Study|Withdrawal by Subject|11|||
130136112|NCT00606281|468459221|FG001|Overall Study|Withdrawal by Subject|13|||
130136113|NCT00606281|468459220|FG000|Overall Study|Progression to depressive phase|1|||
130136114|NCT00606281|468459221|FG001|Overall Study|Progression to depressive phase|1|||
130136115|NCT00606281|468459220|FG000|Overall Study|Change of residence or other commitments|1|||
130136116|NCT00606281|468459221|FG001|Overall Study|Change of residence or other commitments|1|||
130136117|NCT00829712|468459222|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130136118|NCT00829712|468459223|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130136119|NCT02294981|468459224|FG000|Overall Study|Lost to Follow-up|1|||
130136120|NCT00263588|468459225|FG000|Overall Study|Death|54|||
130136121|NCT00263588|468459226|FG001|Overall Study|Death|90|||
130136122|NCT00263588|468459225|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
130136123|NCT00263588|468459226|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
130136124|NCT00263588|468459225|FG000|Overall Study|Lost to Follow-up|7|||
130136125|NCT00263588|468459226|FG001|Overall Study|Lost to Follow-up|10|||
130136126|NCT00263588|468459225|FG000|Overall Study|Withdrawal by Subject|3|||
130136127|NCT00263588|468459226|FG001|Overall Study|Withdrawal by Subject|4|||
130136128|NCT00263588|468459225|FG000|Overall Study|Protocol Violation|0|||
130136129|NCT00263588|468459226|FG001|Overall Study|Protocol Violation|1|||
130136130|NCT00263588|468459225|FG000|Overall Study|Investigator decision|7|||
130136131|NCT00263588|468459226|FG001|Overall Study|Investigator decision|15|||
130136132|NCT00263588|468459225|FG000|Overall Study|Sponsor terminated study|0|||
130136133|NCT00263588|468459226|FG001|Overall Study|Sponsor terminated study|1|||
130136134|NCT00918684|468459227|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
130136135|NCT00918684|468459227|FG000|Treatment Phase|Lack of Efficacy|6|||
130136136|NCT00918684|468459227|FG000|Treatment Phase|Lost to Follow-up|2|||
130136137|NCT00918684|468459227|FG000|Treatment Phase|Physician Decision|8|||
130136138|NCT00918684|468459227|FG000|Treatment Phase|Protocol Violation|1|||
130136139|NCT00918684|468459227|FG000|Treatment Phase|Withdrawal by Subject|8|||
130136140|NCT00909038|468459228|FG000|Overall Study|Protocol Violation|187|||
130136141|NCT00909038|468459228|FG000|Overall Study|Non-evaluable Subjects|230|||
130136142|NCT00402103|468459229|FG000|Overall Study|Adverse Event|60|||
129971770|NCT01727505|467860339|FG000|First 24 Hours|Adverse Event|0|||
129971771|NCT01727505|467860340|FG001|First 24 Hours|Adverse Event|1|||
129971772|NCT01727505|467860339|FG000|Second 24 Hours|Missing data|0|||
129971773|NCT01727505|467860340|FG001|Second 24 Hours|Missing data|1|||
129971774|NCT01441635|467860344|FG000|Overall Study|Adverse Event|4|||
129971775|NCT01441635|467860345|FG001|Overall Study|Adverse Event|3|||
129971776|NCT01441635|467860346|FG002|Overall Study|Adverse Event|1|||
129971777|NCT01441635|467860347|FG003|Overall Study|Adverse Event|5|||
129971778|NCT01441635|467860348|FG004|Overall Study|Adverse Event|1|||
129971779|NCT01441635|467860349|FG005|Overall Study|Adverse Event|2|||
129971780|NCT01441635|467860350|FG006|Overall Study|Adverse Event|2|||
129971781|NCT01441635|467860351|FG007|Overall Study|Adverse Event|2|||
129971782|NCT01441635|467860352|FG008|Overall Study|Adverse Event|1|||
129971783|NCT01441635|467860353|FG009|Overall Study|Adverse Event|0|||
129971784|NCT01441635|467860344|FG000|Overall Study|Withdrawal by Subject|1|||
129971785|NCT01441635|467860345|FG001|Overall Study|Withdrawal by Subject|1|||
129971786|NCT01441635|467860346|FG002|Overall Study|Withdrawal by Subject|0|||
129971787|NCT01441635|467860347|FG003|Overall Study|Withdrawal by Subject|1|||
129971788|NCT01441635|467860348|FG004|Overall Study|Withdrawal by Subject|0|||
129971789|NCT01441635|467860349|FG005|Overall Study|Withdrawal by Subject|0|||
129971790|NCT01441635|467860350|FG006|Overall Study|Withdrawal by Subject|2|||
129971791|NCT01441635|467860351|FG007|Overall Study|Withdrawal by Subject|0|||
129971792|NCT01441635|467860352|FG008|Overall Study|Withdrawal by Subject|1|||
129971793|NCT01441635|467860353|FG009|Overall Study|Withdrawal by Subject|1|||
129971794|NCT01441635|467860344|FG000|Overall Study|Lost to Follow-up|0|||
129971795|NCT01441635|467860345|FG001|Overall Study|Lost to Follow-up|1|||
129971796|NCT01441635|467860346|FG002|Overall Study|Lost to Follow-up|1|||
129971797|NCT01441635|467860347|FG003|Overall Study|Lost to Follow-up|1|||
129971798|NCT01441635|467860348|FG004|Overall Study|Lost to Follow-up|1|||
129971799|NCT01441635|467860349|FG005|Overall Study|Lost to Follow-up|3|||
129971800|NCT01441635|467860350|FG006|Overall Study|Lost to Follow-up|1|||
129971801|NCT01441635|467860351|FG007|Overall Study|Lost to Follow-up|1|||
129971802|NCT01441635|467860352|FG008|Overall Study|Lost to Follow-up|0|||
129971803|NCT01441635|467860353|FG009|Overall Study|Lost to Follow-up|1|||
129971804|NCT01441635|467860344|FG000|Overall Study|Noncompliance|0|||
129971805|NCT01441635|467860345|FG001|Overall Study|Noncompliance|1|||
129971806|NCT01441635|467860346|FG002|Overall Study|Noncompliance|0|||
129971807|NCT01441635|467860347|FG003|Overall Study|Noncompliance|0|||
129971808|NCT01441635|467860348|FG004|Overall Study|Noncompliance|0|||
129971809|NCT01441635|467860349|FG005|Overall Study|Noncompliance|0|||
129971810|NCT01441635|467860350|FG006|Overall Study|Noncompliance|1|||
129971811|NCT01441635|467860351|FG007|Overall Study|Noncompliance|0|||
129971812|NCT01441635|467860352|FG008|Overall Study|Noncompliance|0|||
129971813|NCT01441635|467860353|FG009|Overall Study|Noncompliance|0|||
129971814|NCT01441635|467860344|FG000|Overall Study|Surgery or Invasive Intervention|0|||
129971815|NCT01441635|467860345|FG001|Overall Study|Surgery or Invasive Intervention|0|||
129971816|NCT01441635|467860346|FG002|Overall Study|Surgery or Invasive Intervention|1|||
129971817|NCT01441635|467860347|FG003|Overall Study|Surgery or Invasive Intervention|0|||
129971818|NCT01441635|467860348|FG004|Overall Study|Surgery or Invasive Intervention|0|||
129971819|NCT01441635|467860349|FG005|Overall Study|Surgery or Invasive Intervention|0|||
129971820|NCT01441635|467860350|FG006|Overall Study|Surgery or Invasive Intervention|0|||
129971821|NCT01441635|467860351|FG007|Overall Study|Surgery or Invasive Intervention|0|||
129971822|NCT01441635|467860352|FG008|Overall Study|Surgery or Invasive Intervention|0|||
129971823|NCT01441635|467860353|FG009|Overall Study|Surgery or Invasive Intervention|0|||
129971824|NCT01441635|467860344|FG000|Overall Study|Received Exclusionary Medication|1|||
129971825|NCT01441635|467860345|FG001|Overall Study|Received Exclusionary Medication|0|||
129971826|NCT01441635|467860346|FG002|Overall Study|Received Exclusionary Medication|0|||
129971827|NCT01441635|467860347|FG003|Overall Study|Received Exclusionary Medication|0|||
129971828|NCT01441635|467860348|FG004|Overall Study|Received Exclusionary Medication|0|||
130136143|NCT00402103|468459230|FG001|Overall Study|Adverse Event|7|||
129971829|NCT01441635|467860349|FG005|Overall Study|Received Exclusionary Medication|0|||
129971830|NCT01441635|467860350|FG006|Overall Study|Received Exclusionary Medication|0|||
129971831|NCT01441635|467860351|FG007|Overall Study|Received Exclusionary Medication|0|||
129971832|NCT01441635|467860352|FG008|Overall Study|Received Exclusionary Medication|0|||
129971833|NCT01441635|467860353|FG009|Overall Study|Received Exclusionary Medication|0|||
129971834|NCT01441635|467860344|FG000|Overall Study|Other|0|||
129971835|NCT01441635|467860345|FG001|Overall Study|Other|0|||
129971836|NCT01441635|467860346|FG002|Overall Study|Other|0|||
129971837|NCT01441635|467860347|FG003|Overall Study|Other|0|||
129971838|NCT01441635|467860348|FG004|Overall Study|Other|0|||
129971839|NCT01441635|467860349|FG005|Overall Study|Other|0|||
129971840|NCT01441635|467860350|FG006|Overall Study|Other|0|||
129971841|NCT01441635|467860351|FG007|Overall Study|Other|1|||
129971842|NCT01441635|467860352|FG008|Overall Study|Other|0|||
129971843|NCT01441635|467860353|FG009|Overall Study|Other|0|||
129971844|NCT03274895|467860356|FG000|Overall Study|Lack of Efficacy|1|||
129971845|NCT03274895|467860357|FG001|Overall Study|Lack of Efficacy|0|||
129971846|NCT03274895|467860356|FG000|Overall Study|Adverse Event|8|||
129971847|NCT03274895|467860357|FG001|Overall Study|Adverse Event|7|||
129971848|NCT03274895|467860356|FG000|Overall Study|Lost to Follow-up|1|||
129971849|NCT03274895|467860357|FG001|Overall Study|Lost to Follow-up|0|||
129971850|NCT03274895|467860356|FG000|Overall Study|Diagnosis not confirmed|3|||
129971851|NCT03274895|467860357|FG001|Overall Study|Diagnosis not confirmed|4|||
129971852|NCT01969851|467860366|FG000|Overall Study|Adverse Event|0|||
129971853|NCT01969851|467860367|FG001|Overall Study|Adverse Event|0|||
129971854|NCT01969851|467860368|FG002|Overall Study|Adverse Event|3|||
129971855|NCT01969851|467860366|FG000|Overall Study|Lack of Efficacy|0|||
129971856|NCT01969851|467860367|FG001|Overall Study|Lack of Efficacy|3|||
129971857|NCT01969851|467860368|FG002|Overall Study|Lack of Efficacy|1|||
129971858|NCT01969851|467860366|FG000|Overall Study|Withdrawal by Subject|1|||
129971859|NCT01969851|467860367|FG001|Overall Study|Withdrawal by Subject|0|||
129971860|NCT01969851|467860368|FG002|Overall Study|Withdrawal by Subject|1|||
129971861|NCT01969851|467860366|FG000|Overall Study|No effective dose in Titration period|0|||
129971862|NCT01969851|467860367|FG001|Overall Study|No effective dose in Titration period|0|||
129971863|NCT01969851|467860368|FG002|Overall Study|No effective dose in Titration period|1|||
129971864|NCT01969851|467860366|FG000|Overall Study|Sponsor decision|0|||
129971865|NCT01969851|467860367|FG001|Overall Study|Sponsor decision|0|||
129971866|NCT01969851|467860368|FG002|Overall Study|Sponsor decision|1|||
129971867|NCT02389764|467860375|FG000|Overall Study|Lack of Efficacy|9|||
129971868|NCT00617929|467860376|FG000|Overall Study|Physician Decision|1|||
129971869|NCT02498236|467860377|FG000|Overall Study|Did not show for testing|1|||
129971870|NCT02498236|467860378|FG001|Overall Study|Did not show for testing|0|||
129971871|NCT02498236|467860379|FG002|Overall Study|Did not show for testing|0|||
129971872|NCT02498236|467860380|FG003|Overall Study|Did not show for testing|0|||
129971873|NCT02498236|467860381|FG004|Overall Study|Did not show for testing|0|||
129971874|NCT02498236|467860382|FG005|Overall Study|Did not show for testing|0|||
129971875|NCT02498236|467860383|FG006|Overall Study|Did not show for testing|0|||
129971876|NCT02498236|467860384|FG007|Overall Study|Did not show for testing|1|||
129971877|NCT02498236|467860377|FG000|Overall Study|Equipment failure|0|||
129971878|NCT02498236|467860378|FG001|Overall Study|Equipment failure|0|||
129971879|NCT02498236|467860379|FG002|Overall Study|Equipment failure|0|||
129971880|NCT02498236|467860380|FG003|Overall Study|Equipment failure|0|||
129971881|NCT02498236|467860381|FG004|Overall Study|Equipment failure|0|||
129971882|NCT02498236|467860382|FG005|Overall Study|Equipment failure|0|||
129971883|NCT02498236|467860383|FG006|Overall Study|Equipment failure|1|||
129971884|NCT02498236|467860384|FG007|Overall Study|Equipment failure|0|||
129971885|NCT02498236|467860377|FG000|Overall Study|Withdrawal by Subject|0|||
129971886|NCT02498236|467860378|FG001|Overall Study|Withdrawal by Subject|0|||
129971887|NCT02498236|467860379|FG002|Overall Study|Withdrawal by Subject|0|||
129971888|NCT02498236|467860380|FG003|Overall Study|Withdrawal by Subject|0|||
129971889|NCT02498236|467860381|FG004|Overall Study|Withdrawal by Subject|1|||
129971890|NCT02498236|467860382|FG005|Overall Study|Withdrawal by Subject|0|||
129971891|NCT02498236|467860383|FG006|Overall Study|Withdrawal by Subject|0|||
129971892|NCT02498236|467860384|FG007|Overall Study|Withdrawal by Subject|0|||
129971893|NCT01814072|467860385|FG000|Overall Study|Lost to Follow-up|2|||
129971894|NCT01814072|467860386|FG001|Overall Study|Lost to Follow-up|2|||
129971895|NCT01814072|467860387|FG002|Overall Study|Lost to Follow-up|2|||
129971896|NCT01814072|467860388|FG003|Overall Study|Lost to Follow-up|0|||
129971897|NCT01814072|467860389|FG004|Overall Study|Lost to Follow-up|2|||
129971898|NCT01814072|467860390|FG005|Overall Study|Lost to Follow-up|3|||
129971899|NCT01814072|467860391|FG006|Overall Study|Lost to Follow-up|3|||
129971900|NCT01814072|467860392|FG007|Overall Study|Lost to Follow-up|1|||
129971901|NCT01814072|467860393|FG008|Overall Study|Lost to Follow-up|2|||
129971902|NCT01814072|467860394|FG009|Overall Study|Lost to Follow-up|3|||
129971903|NCT01814072|467860395|FG010|Overall Study|Lost to Follow-up|1|||
129971904|NCT01814072|467860396|FG011|Overall Study|Lost to Follow-up|2|||
129971905|NCT01814072|467860397|FG012|Overall Study|Lost to Follow-up|2|||
129971906|NCT01814072|467860398|FG013|Overall Study|Lost to Follow-up|1|||
129971907|NCT01814072|467860399|FG014|Overall Study|Lost to Follow-up|2|||
129971908|NCT01814072|467860400|FG015|Overall Study|Lost to Follow-up|1|||
129971909|NCT01814072|467860401|FG016|Overall Study|Lost to Follow-up|3|||
129971910|NCT01814072|467860402|FG017|Overall Study|Lost to Follow-up|1|||
129971911|NCT01814072|467860403|FG018|Overall Study|Lost to Follow-up|3|||
129971912|NCT01814072|467860404|FG019|Overall Study|Lost to Follow-up|3|||
129971913|NCT01814072|467860405|FG020|Overall Study|Lost to Follow-up|2|||
129971914|NCT01814072|467860406|FG021|Overall Study|Lost to Follow-up|1|||
129971915|NCT01814072|467860407|FG022|Overall Study|Lost to Follow-up|3|||
129971916|NCT01814072|467860408|FG023|Overall Study|Lost to Follow-up|1|||
129971917|NCT01814072|467860409|FG024|Overall Study|Lost to Follow-up|4|||
129971918|NCT01814072|467860410|FG025|Overall Study|Lost to Follow-up|1|||
129971919|NCT01814072|467860411|FG026|Overall Study|Lost to Follow-up|1|||
129971920|NCT01814072|467860412|FG027|Overall Study|Lost to Follow-up|2|||
129971921|NCT01814072|467860413|FG028|Overall Study|Lost to Follow-up|3|||
129971922|NCT01814072|467860414|FG029|Overall Study|Lost to Follow-up|3|||
129971923|NCT01814072|467860415|FG030|Overall Study|Lost to Follow-up|2|||
129971924|NCT01814072|467860416|FG031|Overall Study|Lost to Follow-up|0|||
129971925|NCT01814072|467860385|FG000|Overall Study|Withdrawal by Subject|2|||
129971926|NCT01814072|467860386|FG001|Overall Study|Withdrawal by Subject|0|||
129971927|NCT01814072|467860387|FG002|Overall Study|Withdrawal by Subject|1|||
129971928|NCT01814072|467860388|FG003|Overall Study|Withdrawal by Subject|0|||
129971929|NCT01814072|467860389|FG004|Overall Study|Withdrawal by Subject|2|||
129971930|NCT01814072|467860390|FG005|Overall Study|Withdrawal by Subject|3|||
129971931|NCT01814072|467860391|FG006|Overall Study|Withdrawal by Subject|1|||
129971932|NCT01814072|467860392|FG007|Overall Study|Withdrawal by Subject|0|||
129971933|NCT01814072|467860393|FG008|Overall Study|Withdrawal by Subject|1|||
129971934|NCT01814072|467860394|FG009|Overall Study|Withdrawal by Subject|2|||
129971935|NCT01814072|467860395|FG010|Overall Study|Withdrawal by Subject|0|||
129971936|NCT01814072|467860396|FG011|Overall Study|Withdrawal by Subject|0|||
129971937|NCT01814072|467860397|FG012|Overall Study|Withdrawal by Subject|1|||
129971938|NCT01814072|467860398|FG013|Overall Study|Withdrawal by Subject|1|||
129971939|NCT01814072|467860399|FG014|Overall Study|Withdrawal by Subject|1|||
129971940|NCT01814072|467860400|FG015|Overall Study|Withdrawal by Subject|1|||
129971941|NCT01814072|467860401|FG016|Overall Study|Withdrawal by Subject|0|||
129971942|NCT01814072|467860402|FG017|Overall Study|Withdrawal by Subject|0|||
129971943|NCT01814072|467860403|FG018|Overall Study|Withdrawal by Subject|0|||
129971944|NCT01814072|467860404|FG019|Overall Study|Withdrawal by Subject|2|||
129971945|NCT01814072|467860405|FG020|Overall Study|Withdrawal by Subject|0|||
129971946|NCT01814072|467860406|FG021|Overall Study|Withdrawal by Subject|0|||
129971947|NCT01814072|467860407|FG022|Overall Study|Withdrawal by Subject|1|||
129971948|NCT01814072|467860408|FG023|Overall Study|Withdrawal by Subject|0|||
129971949|NCT01814072|467860409|FG024|Overall Study|Withdrawal by Subject|2|||
129971950|NCT01814072|467860410|FG025|Overall Study|Withdrawal by Subject|1|||
129971951|NCT01814072|467860411|FG026|Overall Study|Withdrawal by Subject|1|||
129971952|NCT01814072|467860412|FG027|Overall Study|Withdrawal by Subject|2|||
129971953|NCT01814072|467860413|FG028|Overall Study|Withdrawal by Subject|1|||
129971954|NCT01814072|467860414|FG029|Overall Study|Withdrawal by Subject|0|||
129971955|NCT01814072|467860415|FG030|Overall Study|Withdrawal by Subject|0|||
129971956|NCT01814072|467860416|FG031|Overall Study|Withdrawal by Subject|0|||
129971957|NCT00383123|467860417|FG000|Overall Study|Adverse Event|1|||
129971958|NCT00383123|467860418|FG001|Overall Study|Adverse Event|0|||
129971959|NCT00383123|467860417|FG000|Overall Study|Lost to Follow-up|68|||
129971960|NCT00383123|467860418|FG001|Overall Study|Lost to Follow-up|61|||
129971961|NCT00383123|467860417|FG000|Overall Study|Protocol Violation|5|||
129971962|NCT00383123|467860418|FG001|Overall Study|Protocol Violation|1|||
129971963|NCT00383123|467860417|FG000|Overall Study|Withdrawal by Subject|27|||
129971964|NCT00383123|467860418|FG001|Overall Study|Withdrawal by Subject|18|||
129971965|NCT00383123|467860417|FG000|Overall Study|Other reason|10|||
129971966|NCT00383123|467860418|FG001|Overall Study|Other reason|6|||
129971967|NCT03566979|467860419|FG000|Overall Study|Withdrawal by Subject|2|||
129971968|NCT03566979|467860420|FG001|Overall Study|Withdrawal by Subject|0|||
129971969|NCT03566979|467860421|FG002|Overall Study|Withdrawal by Subject|1|||
129971970|NCT03566979|467860422|FG003|Overall Study|Withdrawal by Subject|1|||
129971971|NCT03566979|467860419|FG000|Overall Study|Lost to Follow-up|2|||
129971972|NCT03566979|467860420|FG001|Overall Study|Lost to Follow-up|7|||
129971973|NCT03566979|467860421|FG002|Overall Study|Lost to Follow-up|9|||
130136144|NCT00402103|468459229|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129971974|NCT03566979|467860422|FG003|Overall Study|Lost to Follow-up|5|||
129971975|NCT03566979|467860419|FG000|Overall Study|Adverse Event|1|||
129971976|NCT03566979|467860420|FG001|Overall Study|Adverse Event|0|||
129971977|NCT03566979|467860421|FG002|Overall Study|Adverse Event|0|||
129971978|NCT03566979|467860422|FG003|Overall Study|Adverse Event|0|||
129971979|NCT01011868|467860423|FG000|After Week 18 Follow-up|Adverse Event|8|||
129971980|NCT01011868|467860424|FG001|After Week 18 Follow-up|Adverse Event|6|||
129971981|NCT01011868|467860425|FG002|After Week 18 Follow-up|Adverse Event|13|||
129971982|NCT01011868|467860423|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
129971983|NCT01011868|467860424|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
129971984|NCT01011868|467860425|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
129971985|NCT01011868|467860423|FG000|After Week 18 Follow-up|Protocol Violation|1|||
129971986|NCT01011868|467860424|FG001|After Week 18 Follow-up|Protocol Violation|1|||
129971987|NCT01011868|467860425|FG002|After Week 18 Follow-up|Protocol Violation|1|||
129971988|NCT01011868|467860423|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
129971989|NCT01011868|467860424|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
129971990|NCT01011868|467860425|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
129971991|NCT01011868|467860423|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
129971992|NCT01011868|467860424|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
129971993|NCT01011868|467860425|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
129971994|NCT01011868|467860423|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
129971995|NCT01011868|467860424|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
129971996|NCT01011868|467860425|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
129971997|NCT01011868|467860423|FG000|After Week 78 Follow-up|Adverse Event|14|||
129971998|NCT01011868|467860424|FG001|After Week 78 Follow-up|Adverse Event|18|||
129971999|NCT01011868|467860425|FG002|After Week 78 Follow-up|Adverse Event|21|||
129972000|NCT01011868|467860423|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
129972001|NCT01011868|467860424|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
129972002|NCT01011868|467860425|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
129972003|NCT01011868|467860423|FG000|After Week 78 Follow-up|Protocol Violation|9|||
129972004|NCT01011868|467860424|FG001|After Week 78 Follow-up|Protocol Violation|1|||
129972005|NCT01011868|467860425|FG002|After Week 78 Follow-up|Protocol Violation|2|||
129972006|NCT01011868|467860423|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
129972007|NCT01011868|467860424|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
129972008|NCT01011868|467860425|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
129972009|NCT01011868|467860423|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
129972010|NCT01011868|467860424|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
129972011|NCT01011868|467860425|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
129972012|NCT01011868|467860423|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
129972013|NCT01011868|467860424|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
129972014|NCT01011868|467860425|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
129972015|NCT01948076|467860426|FG000|Overall Study|Withdrawal by Subject|0|||
129972016|NCT01948076|467860427|FG001|Overall Study|Withdrawal by Subject|1|||
129972017|NCT03732677|467860431|FG000|Overall Study|Terminated the study|154|||
129972018|NCT03732677|467860432|FG001|Overall Study|Terminated the study|197|||
129972019|NCT03732677|467860431|FG000|Overall Study|Continuing study off treatment|379|||
129972020|NCT03732677|467860432|FG001|Overall Study|Continuing study off treatment|333|||
129972021|NCT04013971|467860433|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
129972022|NCT04013971|467860434|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
129972023|NCT04013971|467860433|FG000|Overall Study|Missing biomechanical data|0|||
129972024|NCT04013971|467860434|FG001|Overall Study|Missing biomechanical data|1|||
129972025|NCT00344032|467860440|FG000|Overall Study|Adverse Event|0|||
129972026|NCT00344032|467860441|FG001|Overall Study|Adverse Event|1|||
129972027|NCT00344032|467860440|FG000|Overall Study|Withdrawal by Subject|6|||
129972028|NCT00344032|467860441|FG001|Overall Study|Withdrawal by Subject|2|||
129972029|NCT00344032|467860440|FG000|Overall Study|Lost to Follow-up|4|||
129972030|NCT00344032|467860441|FG001|Overall Study|Lost to Follow-up|6|||
129972031|NCT00344032|467860440|FG000|Overall Study|Physician Decision|4|||
129972032|NCT00344032|467860441|FG001|Overall Study|Physician Decision|1|||
129972033|NCT04949802|467862842|FG000|Overall Study|Lost to Follow-up|3|||
129972034|NCT02473965|467862843|FG000|Overall Study|Adverse Event|6|||
129972035|NCT02473965|467862844|FG001|Overall Study|Adverse Event|4|||
129972036|NCT02473965|467862843|FG000|Overall Study|MG worsening|4|||
129972037|NCT02473965|467862844|FG001|Overall Study|MG worsening|1|||
129972038|NCT02473965|467862843|FG000|Overall Study|Withdrawal by Subject|2|||
129972039|NCT02473965|467862844|FG001|Overall Study|Withdrawal by Subject|3|||
129972040|NCT02473965|467862843|FG000|Overall Study|Physician Decision|0|||
129972041|NCT02473965|467862844|FG001|Overall Study|Physician Decision|2|||
129972042|NCT03192462|467862845|FG000|Overall Study|Death|13|||
129972043|NCT03192462|467862846|FG001|Overall Study|Death|11|||
129972044|NCT03192462|467862847|FG002|Overall Study|Death|9|||
129972045|NCT03192462|467862845|FG000|Overall Study|Lost to Follow-up|0|||
129972046|NCT03192462|467862846|FG001|Overall Study|Lost to Follow-up|1|||
129972047|NCT03192462|467862847|FG002|Overall Study|Lost to Follow-up|0|||
129972048|NCT03192462|467862845|FG000|Overall Study|On follow up|0|||
129972049|NCT03192462|467862846|FG001|Overall Study|On follow up|0|||
129972050|NCT03192462|467862847|FG002|Overall Study|On follow up|3|||
129972051|NCT03816761|467862848|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972052|NCT03816761|467862849|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972053|NCT03816761|467862850|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972054|NCT03816761|467862851|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972055|NCT03816761|467862852|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972056|NCT03816761|467862853|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
129972057|NCT03816761|467862848|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
129972058|NCT03816761|467862849|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
129972059|NCT03816761|467862850|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
129972060|NCT03816761|467862851|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
129972061|NCT03816761|467862852|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
129972062|NCT03816761|467862853|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
129972063|NCT02419417|467862854|FG000|Overall Study|Disease progression|5|||
129972064|NCT02419417|467862855|FG001|Overall Study|Disease progression|4|||
129972065|NCT02419417|467862856|FG002|Overall Study|Disease progression|13|||
129972066|NCT02419417|467862857|FG003|Overall Study|Disease progression|10|||
129972067|NCT02419417|467862858|FG004|Overall Study|Disease progression|10|||
129972068|NCT02419417|467862859|FG005|Overall Study|Disease progression|3|||
129972069|NCT02419417|467862860|FG006|Overall Study|Disease progression|4|||
129972070|NCT02419417|467862861|FG007|Overall Study|Disease progression|5|||
129972071|NCT02419417|467862862|FG008|Overall Study|Disease progression|13|||
129972072|NCT02419417|467862863|FG009|Overall Study|Disease progression|9|||
129972073|NCT02419417|467862864|FG010|Overall Study|Disease progression|0|||
129972074|NCT02419417|467862854|FG000|Overall Study|Study drug toxicity|0|||
129972075|NCT02419417|467862855|FG001|Overall Study|Study drug toxicity|0|||
129972076|NCT02419417|467862856|FG002|Overall Study|Study drug toxicity|0|||
129972077|NCT02419417|467862857|FG003|Overall Study|Study drug toxicity|0|||
129972078|NCT02419417|467862858|FG004|Overall Study|Study drug toxicity|1|||
129972079|NCT02419417|467862859|FG005|Overall Study|Study drug toxicity|0|||
129972080|NCT02419417|467862860|FG006|Overall Study|Study drug toxicity|0|||
129972081|NCT02419417|467862861|FG007|Overall Study|Study drug toxicity|0|||
129972082|NCT02419417|467862862|FG008|Overall Study|Study drug toxicity|0|||
129972083|NCT02419417|467862863|FG009|Overall Study|Study drug toxicity|0|||
129972084|NCT02419417|467862864|FG010|Overall Study|Study drug toxicity|0|||
129972085|NCT02419417|467862854|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129972086|NCT02419417|467862855|FG001|Overall Study|Adverse event unrelated to study drug|0|||
129972087|NCT02419417|467862856|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129972088|NCT02419417|467862857|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129972089|NCT02419417|467862858|FG004|Overall Study|Adverse event unrelated to study drug|2|||
129972090|NCT02419417|467862859|FG005|Overall Study|Adverse event unrelated to study drug|1|||
129972091|NCT02419417|467862860|FG006|Overall Study|Adverse event unrelated to study drug|0|||
129972092|NCT02419417|467862861|FG007|Overall Study|Adverse event unrelated to study drug|1|||
129972093|NCT02419417|467862862|FG008|Overall Study|Adverse event unrelated to study drug|0|||
129972094|NCT02419417|467862863|FG009|Overall Study|Adverse event unrelated to study drug|0|||
129972095|NCT02419417|467862864|FG010|Overall Study|Adverse event unrelated to study drug|0|||
129972096|NCT02419417|467862854|FG000|Overall Study|Participant request to discontinue|0|||
129972097|NCT02419417|467862855|FG001|Overall Study|Participant request to discontinue|0|||
129972098|NCT02419417|467862856|FG002|Overall Study|Participant request to discontinue|0|||
129972099|NCT02419417|467862857|FG003|Overall Study|Participant request to discontinue|0|||
129972100|NCT02419417|467862858|FG004|Overall Study|Participant request to discontinue|0|||
129972101|NCT02419417|467862859|FG005|Overall Study|Participant request to discontinue|0|||
129972102|NCT02419417|467862860|FG006|Overall Study|Participant request to discontinue|0|||
129972103|NCT02419417|467862861|FG007|Overall Study|Participant request to discontinue|0|||
129972104|NCT02419417|467862862|FG008|Overall Study|Participant request to discontinue|0|||
129972105|NCT02419417|467862863|FG009|Overall Study|Participant request to discontinue|1|||
129972106|NCT02419417|467862864|FG010|Overall Study|Participant request to discontinue|0|||
129972107|NCT02419417|467862854|FG000|Overall Study|Withdrawal by Subject|0|||
129972108|NCT02419417|467862855|FG001|Overall Study|Withdrawal by Subject|0|||
129972109|NCT02419417|467862856|FG002|Overall Study|Withdrawal by Subject|0|||
129972110|NCT02419417|467862857|FG003|Overall Study|Withdrawal by Subject|0|||
129972111|NCT02419417|467862858|FG004|Overall Study|Withdrawal by Subject|0|||
129972112|NCT02419417|467862859|FG005|Overall Study|Withdrawal by Subject|0|||
129972113|NCT02419417|467862860|FG006|Overall Study|Withdrawal by Subject|0|||
129972114|NCT02419417|467862861|FG007|Overall Study|Withdrawal by Subject|0|||
129972115|NCT02419417|467862862|FG008|Overall Study|Withdrawal by Subject|0|||
129972116|NCT02419417|467862863|FG009|Overall Study|Withdrawal by Subject|0|||
129972117|NCT02419417|467862864|FG010|Overall Study|Withdrawal by Subject|1|||
129972118|NCT01240551|467862865|FG000|Overall Study|Refused further treatment|3|||
129972119|NCT01240551|467862866|FG001|Overall Study|Refused further treatment|2|||
129972120|NCT01240551|467862865|FG000|Overall Study|Lost to Follow-up|1|||
129972121|NCT01240551|467862866|FG001|Overall Study|Lost to Follow-up|1|||
129972122|NCT00078377|467862870|FG000|Overall Study|Adverse Event|2|||
129972123|NCT00078377|467862871|FG001|Overall Study|Adverse Event|5|||
129972124|NCT00078377|467862872|FG002|Overall Study|Adverse Event|1|||
129972125|NCT00078377|467862870|FG000|Overall Study|Lack of Efficacy|2|||
129972126|NCT00078377|467862871|FG001|Overall Study|Lack of Efficacy|0|||
129972127|NCT00078377|467862872|FG002|Overall Study|Lack of Efficacy|2|||
129972128|NCT00078377|467862870|FG000|Overall Study|Lost to Follow-up|0|||
129972129|NCT00078377|467862871|FG001|Overall Study|Lost to Follow-up|1|||
129972130|NCT00078377|467862872|FG002|Overall Study|Lost to Follow-up|1|||
129972131|NCT00078377|467862870|FG000|Overall Study|Physician Decision|2|||
129972132|NCT00078377|467862871|FG001|Overall Study|Physician Decision|0|||
129972133|NCT00078377|467862872|FG002|Overall Study|Physician Decision|0|||
129972134|NCT00078377|467862870|FG000|Overall Study|Withdrawal by Subject|3|||
129972135|NCT00078377|467862871|FG001|Overall Study|Withdrawal by Subject|4|||
129972136|NCT00078377|467862872|FG002|Overall Study|Withdrawal by Subject|4|||
129972137|NCT00078377|467862870|FG000|Overall Study|Miscellaneous|2|||
129972138|NCT00078377|467862871|FG001|Overall Study|Miscellaneous|6|||
129972139|NCT00078377|467862872|FG002|Overall Study|Miscellaneous|1|||
129972140|NCT01200342|467862873|FG000|Overall Study|Disease Progression|1|||
129972141|NCT00953147|467862874|FG000|Overall Study|Adverse Event|8|||
129972142|NCT00953147|467862875|FG001|Overall Study|Adverse Event|16|||
129972143|NCT00953147|467862876|FG002|Overall Study|Adverse Event|6|||
129972144|NCT00953147|467862874|FG000|Overall Study|Protocol Violation|2|||
129972145|NCT00953147|467862875|FG001|Overall Study|Protocol Violation|8|||
129972146|NCT00953147|467862876|FG002|Overall Study|Protocol Violation|4|||
129972147|NCT00953147|467862874|FG000|Overall Study|Withdrawal by Subject|13|||
129972148|NCT00953147|467862875|FG001|Overall Study|Withdrawal by Subject|15|||
129972149|NCT00953147|467862876|FG002|Overall Study|Withdrawal by Subject|12|||
129972150|NCT00953147|467862874|FG000|Overall Study|Lost to Follow-up|8|||
129972151|NCT00953147|467862875|FG001|Overall Study|Lost to Follow-up|9|||
129972152|NCT00953147|467862876|FG002|Overall Study|Lost to Follow-up|4|||
129972153|NCT00953147|467862874|FG000|Overall Study|Physician Decision|2|||
129972154|NCT00953147|467862875|FG001|Overall Study|Physician Decision|7|||
129972155|NCT00953147|467862876|FG002|Overall Study|Physician Decision|3|||
129972156|NCT00953147|467862874|FG000|Overall Study|Other|4|||
129972157|NCT00953147|467862875|FG001|Overall Study|Other|11|||
129972158|NCT00953147|467862876|FG002|Overall Study|Other|13|||
129972159|NCT01484431|467862877|FG000|Period 1: High Dose|Physician Decision|0|||
129972160|NCT01484431|467862878|FG001|Period 1: High Dose|Physician Decision|1|||
129972161|NCT01484431|467862879|FG002|Period 1: High Dose|Physician Decision|0|||
129972162|NCT01484431|467862877|FG000|Period 2|Death|0|||
129972163|NCT01484431|467862878|FG001|Period 2|Death|1|||
129972164|NCT01484431|467862879|FG002|Period 2|Death|1|||
129972165|NCT01484431|467862877|FG000|Period 2|Physician Decision|0|||
129972166|NCT01484431|467862878|FG001|Period 2|Physician Decision|0|||
129972167|NCT01484431|467862879|FG002|Period 2|Physician Decision|1|||
129972168|NCT01484431|467862877|FG000|Period 2|Non-Compliance with Study Drug|1|||
129972169|NCT01484431|467862878|FG001|Period 2|Non-Compliance with Study Drug|0|||
129972170|NCT01484431|467862879|FG002|Period 2|Non-Compliance with Study Drug|0|||
129972171|NCT02763215|467862882|FG000|Overall Study|Participants withdrew from study|3|||
129972172|NCT02763215|467862882|FG000|Overall Study|Missed visit|1|||
129972173|NCT02763215|467862882|FG000|Overall Study|Visit outside visit-window|1|||
129972174|NCT02763215|467862882|FG000|Overall Study|Death|1|||
129972175|NCT02763215|467862882|FG000|Overall Study|Lost to Follow-up|1|||
129972176|NCT00475644|467862883|FG000|Overall Study|Protocol Violation|13|||
129972177|NCT01411241|467862884|FG000|Overall Study|Protocol Violation|0|||
129972178|NCT01411241|467862885|FG001|Overall Study|Protocol Violation|5|||
129972179|NCT01411241|467862884|FG000|Overall Study|Withdrawal by Subject|9|||
129972180|NCT01411241|467862885|FG001|Overall Study|Withdrawal by Subject|10|||
129972181|NCT01411241|467862884|FG000|Overall Study|Serious Adverse Event|0|||
129972182|NCT01411241|467862885|FG001|Overall Study|Serious Adverse Event|3|||
129972183|NCT01411241|467862884|FG000|Overall Study|Lost to Follow-up|2|||
129972184|NCT01411241|467862885|FG001|Overall Study|Lost to Follow-up|4|||
129972185|NCT02980042|467862890|FG000|Overall Study|Lost to Follow-up|5|||
129972186|NCT02980042|467862891|FG001|Overall Study|Lost to Follow-up|0|||
129972187|NCT02980042|467862890|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
129972188|NCT02980042|467862891|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
129972189|NCT01020877|467862894|FG000|Second Intervention|Withdrawal by Subject|1|||
129972190|NCT01020877|467862895|FG001|Second Intervention|Withdrawal by Subject|0|||
129972191|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
129972192|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
129972193|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
129972194|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
129972195|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
129972196|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
129972197|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
129972198|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
129972199|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
129972200|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
129972201|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
129972202|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
129972203|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Death|1|||
129972204|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Death|0|||
129972205|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
129972206|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
129972207|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
129972208|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
129972209|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
129972210|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
129972211|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
129972212|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
129972213|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
129972214|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
129972215|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Death|1|||
129972216|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Death|0|||
129972217|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
129972218|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
129972219|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
129972220|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
130136145|NCT00402103|468459230|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130136146|NCT00402103|468459229|FG000|Overall Study|Condition no longer requires study drug|2|||
129972221|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
129972222|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
129972223|NCT00078338|467862899|FG000|Overall Study|Adverse Event|31|||
129972224|NCT00078338|467862900|FG001|Overall Study|Adverse Event|24|||
129972225|NCT00078338|467862899|FG000|Overall Study|Lost to Follow-up|17|||
129972226|NCT00078338|467862900|FG001|Overall Study|Lost to Follow-up|2|||
129972227|NCT00078338|467862899|FG000|Overall Study|Protocol Violation|2|||
129972228|NCT00078338|467862900|FG001|Overall Study|Protocol Violation|2|||
129972229|NCT00078338|467862899|FG000|Overall Study|Disease Progression|4|||
129972230|NCT00078338|467862900|FG001|Overall Study|Disease Progression|7|||
129972231|NCT00078338|467862899|FG000|Overall Study|Other|28|||
129972232|NCT00078338|467862900|FG001|Overall Study|Other|16|||
129972233|NCT00078338|467862899|FG000|Overall Study|Subjects randomized, but not treated|3|||
129972234|NCT00078338|467862900|FG001|Overall Study|Subjects randomized, but not treated|3|||
129972235|NCT01483144|467862901|FG000|Overall Study|Adverse Event|9|||
129972236|NCT01483144|467862902|FG001|Overall Study|Adverse Event|4|||
129972237|NCT01483144|467862903|FG002|Overall Study|Adverse Event|6|||
129972238|NCT01483144|467862901|FG000|Overall Study|Withdrawal by Subject|0|||
129972239|NCT01483144|467862902|FG001|Overall Study|Withdrawal by Subject|2|||
129972240|NCT01483144|467862903|FG002|Overall Study|Withdrawal by Subject|5|||
129972241|NCT01483144|467862901|FG000|Overall Study|Physician Decision|1|||
129972242|NCT01483144|467862902|FG001|Overall Study|Physician Decision|0|||
129972243|NCT01483144|467862903|FG002|Overall Study|Physician Decision|0|||
129972244|NCT01483144|467862901|FG000|Overall Study|Lost to Follow-up|2|||
129972245|NCT01483144|467862902|FG001|Overall Study|Lost to Follow-up|4|||
129972246|NCT01483144|467862903|FG002|Overall Study|Lost to Follow-up|1|||
129972247|NCT01483144|467862901|FG000|Overall Study|Protocol Violation|3|||
129972248|NCT01483144|467862902|FG001|Overall Study|Protocol Violation|3|||
129972249|NCT01483144|467862903|FG002|Overall Study|Protocol Violation|3|||
129972250|NCT03258723|467862906|FG000|Overall Study|COVID Interruption of study|54|||
129972251|NCT03258723|467862906|FG000|Overall Study|Lost to Follow-up|8|||
129972252|NCT01107899|467862910|FG000|Overall Study|Physician Decision|5|||
129972253|NCT01107899|467862911|FG001|Overall Study|Physician Decision|0|||
129972254|NCT01107899|467862912|FG002|Overall Study|Physician Decision|3|||
129972255|NCT01107899|467862910|FG000|Overall Study|Withdrawal by Subject|0|||
129972256|NCT01107899|467862911|FG001|Overall Study|Withdrawal by Subject|0|||
129972257|NCT01107899|467862912|FG002|Overall Study|Withdrawal by Subject|1|||
129972258|NCT00974259|467862913|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
129972259|NCT00974259|467862914|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
129972260|NCT00944229|467862917|FG000|Overall Study|Withdrawal by Subject|11|||
129972261|NCT00944229|467862917|FG000|Overall Study|Physician Decision|14|||
129972262|NCT04292470|467862918|FG000|Overall Study|Withdrawal by Subject|0|||
129972263|NCT04292470|467862919|FG001|Overall Study|Withdrawal by Subject|1|||
129972264|NCT02906020|467862937|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
129972265|NCT02906020|467862938|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
129972266|NCT02906020|467862939|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
129972267|NCT02906020|467862940|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
129972268|NCT02906020|467862941|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
129972269|NCT02906020|467862942|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
129972270|NCT02906020|467862943|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
129972271|NCT02906020|467862944|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
129972272|NCT02906020|467862945|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
129972273|NCT02906020|467862946|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
129972274|NCT02906020|467862947|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
129972275|NCT02906020|467862948|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
129972276|NCT02906020|467862949|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
129972277|NCT02906020|467862950|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
129972278|NCT02906020|467862951|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
130136147|NCT00402103|468459230|FG001|Overall Study|Condition no longer requires study drug|0|||
129972279|NCT02906020|467862952|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
129972280|NCT02906020|467862937|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972281|NCT02906020|467862938|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972282|NCT02906020|467862939|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972283|NCT02906020|467862940|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972284|NCT02906020|467862941|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972285|NCT02906020|467862942|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972286|NCT02906020|467862943|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972287|NCT02906020|467862944|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972288|NCT02906020|467862945|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
129972289|NCT02906020|467862946|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
129972290|NCT02906020|467862947|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972291|NCT02906020|467862948|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
130136148|NCT00402103|468459229|FG000|Overall Study|Protocol Deviation|8|||
130136149|NCT00402103|468459230|FG001|Overall Study|Protocol Deviation|0|||
129972292|NCT02906020|467862949|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972293|NCT02906020|467862950|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972294|NCT02906020|467862951|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972295|NCT02906020|467862952|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972296|NCT02906020|467862937|FG000|Part 2: Double-blind Treatment Period|Other|0|||
129972297|NCT02906020|467862938|FG001|Part 2: Double-blind Treatment Period|Other|0|||
129972298|NCT02906020|467862939|FG002|Part 2: Double-blind Treatment Period|Other|0|||
129972299|NCT02906020|467862940|FG003|Part 2: Double-blind Treatment Period|Other|0|||
129972300|NCT02906020|467862941|FG004|Part 2: Double-blind Treatment Period|Other|0|||
129972301|NCT02906020|467862942|FG005|Part 2: Double-blind Treatment Period|Other|0|||
129972302|NCT02906020|467862943|FG006|Part 2: Double-blind Treatment Period|Other|0|||
129972303|NCT02906020|467862944|FG007|Part 2: Double-blind Treatment Period|Other|0|||
129972304|NCT02906020|467862945|FG008|Part 2: Double-blind Treatment Period|Other|6|||
129972305|NCT02906020|467862946|FG009|Part 2: Double-blind Treatment Period|Other|10|||
129972306|NCT02906020|467862947|FG010|Part 2: Double-blind Treatment Period|Other|0|||
129972307|NCT02906020|467862948|FG011|Part 2: Double-blind Treatment Period|Other|0|||
129972308|NCT02906020|467862949|FG012|Part 2: Double-blind Treatment Period|Other|0|||
129972309|NCT02906020|467862950|FG013|Part 2: Double-blind Treatment Period|Other|0|||
129972310|NCT02906020|467862951|FG014|Part 2: Double-blind Treatment Period|Other|0|||
129972311|NCT02906020|467862952|FG015|Part 2: Double-blind Treatment Period|Other|0|||
129972312|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972313|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972314|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972315|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972316|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972317|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972318|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972319|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972320|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972321|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972322|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972323|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972324|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
129972325|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
129972326|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972327|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972328|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972329|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972330|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972331|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972332|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972333|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972334|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972335|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972336|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972337|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972338|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972339|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972340|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
129972341|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
129972342|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972343|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
130136150|NCT00402103|468459229|FG000|Overall Study|Patient withdrew consent|12|||
129972344|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972345|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
130136151|NCT00402103|468459230|FG001|Overall Study|Patient withdrew consent|1|||
130136152|NCT00402103|468459229|FG000|Overall Study|Lost to Follow-up|6|||
130136153|NCT00402103|468459230|FG001|Overall Study|Lost to Follow-up|3|||
130136154|NCT00402103|468459229|FG000|Overall Study|Administrative problems|2|||
130136155|NCT00402103|468459230|FG001|Overall Study|Administrative problems|0|||
129972346|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972347|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972348|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972349|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972350|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972351|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972352|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972353|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972354|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972355|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972356|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
129972357|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
129972358|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972359|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972360|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972361|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972362|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972363|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972364|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972365|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972366|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972367|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972368|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972369|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972370|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972371|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972372|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
129972373|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
129972374|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972375|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972376|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972377|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972378|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972379|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972380|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972381|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972382|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972383|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972384|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972385|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972386|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972387|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972388|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
129972389|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
129972390|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
129972391|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
129972392|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Other|0|||
129972393|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Other|0|||
129972394|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Other|0|||
129972395|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Other|0|||
129972396|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Other|0|||
129972397|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Other|0|||
129972398|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Other|0|||
129972399|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Other|0|||
129972400|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Other|0|||
129972401|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Other|0|||
129972402|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Other|0|||
129972403|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Other|0|||
130136156|NCT00484679|468459231|FG000|Overall Study|Withdrawal by Subject|3|||
129972404|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Other|13|||
129972405|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Other|8|||
129972406|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Other|3|||
129972407|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Other|2|||
129972408|NCT01810939|467862953|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
129972409|NCT01810939|467862954|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
129972410|NCT01810939|467862955|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
129972411|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol Violation|2|||
129972412|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol Violation|0|||
129972413|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol Violation|0|||
129972414|NCT01810939|467862953|FG000|Part A Treatment Period|Adverse Event|10|||
129972415|NCT01810939|467862954|FG001|Part A Treatment Period|Adverse Event|0|||
129972416|NCT01810939|467862955|FG002|Part A Treatment Period|Adverse Event|0|||
129972417|NCT01810939|467862953|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
129972418|NCT01810939|467862954|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
129972419|NCT01810939|467862955|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
129972420|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
129972421|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
129972422|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
129972423|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
129972424|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
129972425|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
129972426|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
129972427|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
129972428|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
129972429|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
129972430|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
129972431|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
129972432|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
129972433|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
129972434|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
129972435|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
129972436|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
129972437|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
129972438|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
129972439|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
129972440|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
129972441|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
129972442|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
129972443|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
129972444|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
129972445|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
129972446|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
129972447|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
129972448|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
129972449|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
129972450|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
129972451|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
129972452|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
129972453|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
129972454|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
129972455|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
129972456|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
129972457|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
129972458|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
129972459|NCT01375673|467862956|FG000|Overall Study|Withdrawal by Subject|0|||
129972460|NCT01375673|467862957|FG001|Overall Study|Withdrawal by Subject|1|||
129972461|NCT02179177|467862958|FG000|Overall Study|Lost to Follow-up|1|||
129972462|NCT02179177|467862959|FG001|Overall Study|Lost to Follow-up|1|||
129972463|NCT02179177|467862958|FG000|Overall Study|Withdrawal by Subject|1|||
129972464|NCT02179177|467862959|FG001|Overall Study|Withdrawal by Subject|1|||
129972465|NCT03845140|467862966|FG000|Overall Study|Participant travelled outside study area|0|||
129972466|NCT03845140|467862967|FG001|Overall Study|Participant travelled outside study area|1|||
129972467|NCT03845140|467862968|FG002|Overall Study|Participant travelled outside study area|0|||
129972468|NCT03845140|467862969|FG003|Overall Study|Participant travelled outside study area|0|||
129972469|NCT03845140|467862970|FG004|Overall Study|Participant travelled outside study area|0|||
129972470|NCT03845140|467862971|FG005|Overall Study|Participant travelled outside study area|0|||
129972471|NCT01592045|467862972|FG000|Overall Study|Disease Progression|1|||
129972472|NCT01592045|467862973|FG001|Overall Study|Disease Progression|1|||
129972473|NCT01592045|467862972|FG000|Overall Study|Adverse Event|1|||
129972474|NCT01592045|467862973|FG001|Overall Study|Adverse Event|1|||
129972475|NCT01592045|467862972|FG000|Overall Study|Withdrawal by Subject|1|||
129972476|NCT01592045|467862973|FG001|Overall Study|Withdrawal by Subject|0|||
129972477|NCT01592045|467862972|FG000|Overall Study|Moved out of country|2|||
129972478|NCT01592045|467862973|FG001|Overall Study|Moved out of country|0|||
129972479|NCT03812029|467862977|FG000|Overall Study|Protocol Violation|1|||
129972480|NCT03812029|467862978|FG001|Overall Study|Protocol Violation|0|||
129972481|NCT03812029|467862979|FG002|Overall Study|Protocol Violation|0|||
129972482|NCT03812029|467862980|FG003|Overall Study|Protocol Violation|1|||
129972483|NCT03812029|467862981|FG004|Overall Study|Protocol Violation|0|||
129972484|NCT03812029|467862977|FG000|Overall Study|Withdrawal by Subject|1|||
129972485|NCT03812029|467862978|FG001|Overall Study|Withdrawal by Subject|0|||
129972486|NCT03812029|467862979|FG002|Overall Study|Withdrawal by Subject|0|||
129972487|NCT03812029|467862980|FG003|Overall Study|Withdrawal by Subject|2|||
129972488|NCT03812029|467862981|FG004|Overall Study|Withdrawal by Subject|2|||
129972489|NCT03812029|467862977|FG000|Overall Study|Stopping rules|0|||
129972490|NCT03812029|467862978|FG001|Overall Study|Stopping rules|1|||
129972491|NCT03812029|467862979|FG002|Overall Study|Stopping rules|0|||
129972492|NCT03812029|467862980|FG003|Overall Study|Stopping rules|0|||
129972493|NCT03812029|467862981|FG004|Overall Study|Stopping rules|0|||
129972494|NCT03812029|467862977|FG000|Overall Study|Adverse Event|0|||
130136157|NCT00835692|468459232|FG000|First Intervention|Withdrawal by Subject|1|||
130136158|NCT00835692|468459233|FG001|First Intervention|Withdrawal by Subject|0|||
130136159|NCT04345653|468459236|FG000|Overall Study|Withdrawal by Subject|2|||
130136160|NCT00418938|468459241|FG000|Overall Study|Reimbursement|1|||
130136161|NCT00418938|468459242|FG001|Overall Study|Reimbursement|0|||
130136162|NCT00418938|468459241|FG000|Overall Study|Administrative decision|3|||
130136163|NCT00418938|468459242|FG001|Overall Study|Administrative decision|3|||
129972495|NCT03812029|467862978|FG001|Overall Study|Adverse Event|9|||
129972496|NCT03812029|467862979|FG002|Overall Study|Adverse Event|0|||
129972497|NCT03812029|467862980|FG003|Overall Study|Adverse Event|3|||
129972498|NCT03812029|467862981|FG004|Overall Study|Adverse Event|5|||
129972499|NCT03812029|467862977|FG000|Overall Study|Lost to Follow-up|0|||
129972500|NCT03812029|467862978|FG001|Overall Study|Lost to Follow-up|0|||
129972501|NCT03812029|467862979|FG002|Overall Study|Lost to Follow-up|0|||
129972502|NCT03812029|467862980|FG003|Overall Study|Lost to Follow-up|0|||
129972503|NCT03812029|467862981|FG004|Overall Study|Lost to Follow-up|3|||
129972504|NCT03149042|467862982|FG000|Overall Study|Invasive FFR not performed|21|||
129972505|NCT03149042|467862982|FG000|Overall Study|Poor CT Image Quality|1|||
129972506|NCT03149042|467862982|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
129972507|NCT02643628|467862983|FG000|Overall Study|Lost to Follow-up|1|||
129972508|NCT02643628|467862984|FG001|Overall Study|Lost to Follow-up|4|||
129972509|NCT02643628|467862983|FG000|Overall Study|Withdrawal by Subject|0|||
129972510|NCT02643628|467862984|FG001|Overall Study|Withdrawal by Subject|1|||
129972511|NCT02643628|467862983|FG000|Overall Study|Relocated out of state|0|||
129972512|NCT02643628|467862984|FG001|Overall Study|Relocated out of state|1|||
129972513|NCT04092452|467862985|FG000|Overall Study|Adverse Event|1|||
129972514|NCT04092452|467862986|FG001|Overall Study|Adverse Event|3|||
129972515|NCT04092452|467862987|FG002|Overall Study|Adverse Event|3|||
129972516|NCT04092452|467862988|FG003|Overall Study|Adverse Event|7|||
129972517|NCT04092452|467862985|FG000|Overall Study|Lack of Efficacy|1|||
129972518|NCT04092452|467862986|FG001|Overall Study|Lack of Efficacy|1|||
129972519|NCT04092452|467862987|FG002|Overall Study|Lack of Efficacy|1|||
129972520|NCT04092452|467862988|FG003|Overall Study|Lack of Efficacy|0|||
129972521|NCT04092452|467862985|FG000|Overall Study|Lost to Follow-up|4|||
129972522|NCT04092452|467862986|FG001|Overall Study|Lost to Follow-up|3|||
129972523|NCT04092452|467862987|FG002|Overall Study|Lost to Follow-up|5|||
129972524|NCT04092452|467862988|FG003|Overall Study|Lost to Follow-up|1|||
129972525|NCT04092452|467862985|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129972526|NCT04092452|467862986|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129972527|NCT04092452|467862987|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129972528|NCT04092452|467862988|FG003|Overall Study|Non-Compliance With Study Drug|1|||
129972529|NCT04092452|467862985|FG000|Overall Study|Physician Decision|1|||
129972530|NCT04092452|467862986|FG001|Overall Study|Physician Decision|0|||
129972531|NCT04092452|467862987|FG002|Overall Study|Physician Decision|1|||
129972532|NCT04092452|467862988|FG003|Overall Study|Physician Decision|0|||
129972533|NCT04092452|467862985|FG000|Overall Study|Pregnancy|2|||
129972534|NCT04092452|467862986|FG001|Overall Study|Pregnancy|0|||
129972535|NCT04092452|467862987|FG002|Overall Study|Pregnancy|0|||
129972536|NCT04092452|467862988|FG003|Overall Study|Pregnancy|0|||
129972537|NCT04092452|467862985|FG000|Overall Study|Protocol Deviation|1|||
129972538|NCT04092452|467862986|FG001|Overall Study|Protocol Deviation|0|||
129972539|NCT04092452|467862987|FG002|Overall Study|Protocol Deviation|0|||
129972540|NCT04092452|467862988|FG003|Overall Study|Protocol Deviation|0|||
130136164|NCT00418938|468459241|FG000|Overall Study|Withdrawal by Subject|16|||
129972541|NCT04092452|467862985|FG000|Overall Study|Withdrawal by Subject|3|||
129972542|NCT04092452|467862986|FG001|Overall Study|Withdrawal by Subject|10|||
129972543|NCT04092452|467862987|FG002|Overall Study|Withdrawal by Subject|3|||
129972544|NCT04092452|467862988|FG003|Overall Study|Withdrawal by Subject|5|||
129972545|NCT04092452|467862985|FG000|Overall Study|Other|0|||
129972546|NCT04092452|467862986|FG001|Overall Study|Other|0|||
129972547|NCT04092452|467862987|FG002|Overall Study|Other|1|||
129972548|NCT04092452|467862988|FG003|Overall Study|Other|2|||
130136165|NCT00418938|468459242|FG001|Overall Study|Withdrawal by Subject|15|||
130136166|NCT00418938|468459241|FG000|Overall Study|Lost to Follow-up|1|||
130136167|NCT00418938|468459242|FG001|Overall Study|Lost to Follow-up|3|||
130136168|NCT00418938|468459241|FG000|Overall Study|Adverse Event|1|||
130136169|NCT00418938|468459242|FG001|Overall Study|Adverse Event|1|||
130136170|NCT00418938|468459241|FG000|Overall Study|On-going|1|||
130136171|NCT00418938|468459242|FG001|Overall Study|On-going|1|||
130136172|NCT00418938|468459241|FG000|Overall Study|Ineligibility Determined|1|||
130136173|NCT00418938|468459242|FG001|Overall Study|Ineligibility Determined|0|||
130136174|NCT00700739|468459243|FG000|Overall Study|Lost to Follow-up|4|||
130136175|NCT00700739|468459244|FG001|Overall Study|Lost to Follow-up|4|||
130136176|NCT01316055|468459252|FG000|Overall Study|Lost to Follow-up|1|||
130136177|NCT01316055|468459253|FG001|Overall Study|Lost to Follow-up|0|||
130136178|NCT01316055|468459254|FG002|Overall Study|Lost to Follow-up|0|||
130136179|NCT02679729|468459255|FG000|Overall Study|Lost to Follow-up|0|||
130136180|NCT02679729|468459256|FG001|Overall Study|Lost to Follow-up|1|||
130136181|NCT02679729|468459257|FG002|Overall Study|Lost to Follow-up|0|||
130136182|NCT02679729|468459258|FG003|Overall Study|Lost to Follow-up|0|||
130136183|NCT02679729|468459259|FG004|Overall Study|Lost to Follow-up|1|||
130136184|NCT02679729|468459260|FG005|Overall Study|Lost to Follow-up|0|||
130136185|NCT02679729|468459261|FG006|Overall Study|Lost to Follow-up|0|||
130136186|NCT02679729|468459262|FG007|Overall Study|Lost to Follow-up|0|||
130136187|NCT02679729|468459263|FG008|Overall Study|Lost to Follow-up|0|||
130136188|NCT02679729|468459255|FG000|Overall Study|Participant decision|0|||
130136189|NCT02679729|468459256|FG001|Overall Study|Participant decision|1|||
130136190|NCT02679729|468459257|FG002|Overall Study|Participant decision|0|||
130136191|NCT02679729|468459258|FG003|Overall Study|Participant decision|0|||
130136192|NCT02679729|468459259|FG004|Overall Study|Participant decision|0|||
130136193|NCT02679729|468459260|FG005|Overall Study|Participant decision|0|||
130136194|NCT02679729|468459261|FG006|Overall Study|Participant decision|1|||
130136195|NCT02679729|468459262|FG007|Overall Study|Participant decision|0|||
129972549|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
129972550|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
129972551|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
129972552|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
129972553|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
129972554|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
129972555|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Death|0|||
129972556|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Death|0|||
129972557|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Death|1|||
129972558|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Death|0|||
129972559|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Death|0|||
129972560|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Death|0|||
129972561|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
129972562|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
129972563|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
129972564|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
129972565|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
129972566|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
129972567|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
129972568|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
129972569|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
129972570|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129972571|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129972572|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129972573|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
129972574|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
129972575|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
130136196|NCT02679729|468459263|FG008|Overall Study|Participant decision|0|||
130136197|NCT03488108|468459270|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129972576|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
130136198|NCT03488108|468459271|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130136199|NCT03488108|468459270|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
130136200|NCT03488108|468459271|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
129972577|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
129972578|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
129972579|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972580|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
129972581|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972582|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972583|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972584|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972585|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
129972586|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
129972587|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
129972588|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
129972589|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
129972590|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
129972591|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
129972592|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
129972593|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
129972594|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
129972595|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
129972596|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
129972597|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
129972598|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
129972599|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
129972600|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129972601|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
129972602|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129972603|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972604|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972605|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972606|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
129972607|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972608|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
129972609|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
129972610|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972611|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
129972612|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972613|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972614|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972615|NCT01825577|467862996|FG000|Overall Study|Physician Decision|2|||
129972616|NCT01825577|467862996|FG000|Overall Study|Withdrawal by Subject|1|||
129972617|NCT01825577|467862996|FG000|Overall Study|Withdrawn by family members|2|||
129972618|NCT01825577|467862996|FG000|Overall Study|Lack of Efficacy|3|||
129972619|NCT00358644|467862997|FG000|Overall Study|Progressive Disease|21|||
129972620|NCT00358644|467862997|FG000|Overall Study|Adverse Event|7|||
129972621|NCT00358644|467862997|FG000|Overall Study|Death|11|||
129972622|NCT00358644|467862997|FG000|Overall Study|Withdrawal by Subject|4|||
129972623|NCT00358644|467862997|FG000|Overall Study|Physician Decision|6|||
129972624|NCT00358644|467862997|FG000|Overall Study|Patient not eligible for study|1|||
129972625|NCT01358331|467862998|FG000|Overall Study|Lost to Follow-up|0|||
129972626|NCT01358331|467862999|FG001|Overall Study|Lost to Follow-up|0|||
129972627|NCT01358331|467863000|FG002|Overall Study|Lost to Follow-up|0|||
129972628|NCT01358331|467863001|FG003|Overall Study|Lost to Follow-up|1|||
129972629|NCT01358331|467863002|FG004|Overall Study|Lost to Follow-up|0|||
129972630|NCT01358331|467863003|FG005|Overall Study|Lost to Follow-up|0|||
129972631|NCT01358331|467862998|FG000|Overall Study|Withdrawal by Subject|0|||
129972632|NCT01358331|467862999|FG001|Overall Study|Withdrawal by Subject|0|||
129972633|NCT01358331|467863000|FG002|Overall Study|Withdrawal by Subject|0|||
129972634|NCT01358331|467863001|FG003|Overall Study|Withdrawal by Subject|1|||
129972635|NCT01358331|467863002|FG004|Overall Study|Withdrawal by Subject|1|||
129972636|NCT01358331|467863003|FG005|Overall Study|Withdrawal by Subject|1|||
129972637|NCT01358331|467862998|FG000|Overall Study|Adverse Events|1|||
129972638|NCT01358331|467862999|FG001|Overall Study|Adverse Events|1|||
129972639|NCT01358331|467863000|FG002|Overall Study|Adverse Events|1|||
129972640|NCT01358331|467863001|FG003|Overall Study|Adverse Events|0|||
129972641|NCT01358331|467863002|FG004|Overall Study|Adverse Events|1|||
129972642|NCT01358331|467863003|FG005|Overall Study|Adverse Events|5|||
129972643|NCT01358331|467862998|FG000|Overall Study|Symptomatic Deterioration|0|||
129972644|NCT01358331|467862999|FG001|Overall Study|Symptomatic Deterioration|0|||
129972645|NCT01358331|467863000|FG002|Overall Study|Symptomatic Deterioration|0|||
129972646|NCT01358331|467863001|FG003|Overall Study|Symptomatic Deterioration|0|||
129972647|NCT01358331|467863002|FG004|Overall Study|Symptomatic Deterioration|1|||
129972648|NCT01358331|467863003|FG005|Overall Study|Symptomatic Deterioration|0|||
130136201|NCT01348789|468459273|FG000|Overall Study|Protocol Violation|2|||
129972649|NCT01358331|467862998|FG000|Overall Study|Participants did not wish to continue|0|||
129972650|NCT01358331|467862999|FG001|Overall Study|Participants did not wish to continue|0|||
129972651|NCT01358331|467863000|FG002|Overall Study|Participants did not wish to continue|0|||
129972652|NCT01358331|467863001|FG003|Overall Study|Participants did not wish to continue|0|||
129972653|NCT01358331|467863002|FG004|Overall Study|Participants did not wish to continue|1|||
129972654|NCT01358331|467863003|FG005|Overall Study|Participants did not wish to continue|0|||
129972655|NCT01358331|467862998|FG000|Overall Study|Progress of disease under investigation|1|||
129972656|NCT01358331|467862999|FG001|Overall Study|Progress of disease under investigation|2|||
129972657|NCT01358331|467863000|FG002|Overall Study|Progress of disease under investigation|3|||
129972658|NCT01358331|467863001|FG003|Overall Study|Progress of disease under investigation|1|||
129972659|NCT01358331|467863002|FG004|Overall Study|Progress of disease under investigation|3|||
129972660|NCT01358331|467863003|FG005|Overall Study|Progress of disease under investigation|0|||
129972661|NCT03327831|467863004|FG000|Overall Study|Lost to Follow-up|2|||
129972662|NCT03332784|467863005|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972663|NCT03332784|467863006|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
129972664|NCT03332784|467863007|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972665|NCT03332784|467863008|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972666|NCT03332784|467863009|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972667|NCT03332784|467863010|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972668|NCT03332784|467863011|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972669|NCT03332784|467863012|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972670|NCT03332784|467863013|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972671|NCT03332784|467863014|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972672|NCT03332784|467863015|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972673|NCT03332784|467863016|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972674|NCT03332784|467863017|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972675|NCT03332784|467863018|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972676|NCT03332784|467863019|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
129972677|NCT03332784|467863020|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972678|NCT03332784|467863021|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972679|NCT03332784|467863022|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972680|NCT03332784|467863023|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972681|NCT03332784|467863024|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972682|NCT00401258|467863025|FG000|Overall Study|Adverse Event|7|||
129972683|NCT01430468|467863032|FG000|Overall Study|Physician Decision|2|||
129972684|NCT01430468|467863033|FG001|Overall Study|Physician Decision|1|||
129972685|NCT01430468|467863032|FG000|Overall Study|Withdrawal by Subject|5|||
129972686|NCT01430468|467863033|FG001|Overall Study|Withdrawal by Subject|5|||
129972687|NCT04982575|467863043|FG000|Overall Study|Withdrawal by Subject|2|||
129972688|NCT04982575|467863044|FG001|Overall Study|Withdrawal by Subject|0|||
129972689|NCT04982575|467863045|FG002|Overall Study|Withdrawal by Subject|2|||
129972690|NCT01151423|467863046|FG000|Overall Study|Study terminated by Sponsor|9|||
129972691|NCT01151423|467863047|FG001|Overall Study|Study terminated by Sponsor|10|||
129972692|NCT01151423|467863046|FG000|Overall Study|Protocol Violation|0|||
129972693|NCT01151423|467863047|FG001|Overall Study|Protocol Violation|1|||
129972694|NCT01151423|467863046|FG000|Overall Study|Physician Decision|1|||
129972695|NCT01151423|467863047|FG001|Overall Study|Physician Decision|1|||
129972696|NCT01151423|467863046|FG000|Overall Study|Pregnancy|0|||
129972697|NCT01151423|467863047|FG001|Overall Study|Pregnancy|1|||
129972698|NCT01151423|467863046|FG000|Overall Study|Death|0|||
129972699|NCT01151423|467863047|FG001|Overall Study|Death|1|||
129972700|NCT01151423|467863046|FG000|Overall Study|Adverse Event|3|||
129972701|NCT01151423|467863047|FG001|Overall Study|Adverse Event|0|||
129972702|NCT01151423|467863046|FG000|Overall Study|Withdrawal by Subject|1|||
129972703|NCT01151423|467863047|FG001|Overall Study|Withdrawal by Subject|3|||
129972704|NCT01151423|467863046|FG000|Overall Study|Lost to Follow-up|1|||
129972705|NCT01151423|467863047|FG001|Overall Study|Lost to Follow-up|0|||
129972706|NCT01151423|467863046|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
129972707|NCT01151423|467863047|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
129972708|NCT01151423|467863046|FG000|Overall Study|Participated in other clinical trial|1|||
129972709|NCT01151423|467863047|FG001|Overall Study|Participated in other clinical trial|0|||
129972710|NCT01183390|467865457|FG000|First Intervention|Adverse Event|0|||
129972711|NCT01183390|467865458|FG001|First Intervention|Adverse Event|1|||
129972712|NCT02358668|467865459|FG000|Overall Study|Adverse Event|2|||
129972713|NCT02358668|467865460|FG001|Overall Study|Adverse Event|0|||
129972714|NCT02358668|467865461|FG002|Overall Study|Adverse Event|0|||
129972715|NCT02358668|467865459|FG000|Overall Study|Withdrawal by Subject|0|||
129972716|NCT02358668|467865460|FG001|Overall Study|Withdrawal by Subject|1|||
129972717|NCT02358668|467865461|FG002|Overall Study|Withdrawal by Subject|0|||
129972718|NCT02568397|467865462|FG000|Period 2|Withdrawal by Subject|0|||
129972719|NCT02568397|467865463|FG001|Period 2|Withdrawal by Subject|1|||
129972720|NCT02568397|467865462|FG000|Period 2|Physician Decision|0|||
129972721|NCT02568397|467865463|FG001|Period 2|Physician Decision|1|||
129972722|NCT01317875|467865464|FG000|Overall Study|Other|0|||
129972723|NCT01317875|467865465|FG001|Overall Study|Other|0|||
129972724|NCT01317875|467865466|FG002|Overall Study|Other|1|||
129972725|NCT01317875|467865467|FG003|Overall Study|Other|0|||
129972726|NCT01317875|467865468|FG004|Overall Study|Other|0|||
129972727|NCT01317875|467865469|FG005|Overall Study|Other|0|||
129972728|NCT01317875|467865470|FG006|Overall Study|Other|0|||
129972729|NCT01317875|467865471|FG007|Overall Study|Other|0|||
129972730|NCT01317875|467865472|FG008|Overall Study|Other|0|||
129972731|NCT01317875|467865473|FG009|Overall Study|Other|0|||
129972732|NCT01317875|467865464|FG000|Overall Study|Noncompliance with study drug|0|||
129972733|NCT01317875|467865465|FG001|Overall Study|Noncompliance with study drug|0|||
129972734|NCT01317875|467865466|FG002|Overall Study|Noncompliance with study drug|1|||
129972735|NCT01317875|467865467|FG003|Overall Study|Noncompliance with study drug|0|||
129972736|NCT01317875|467865468|FG004|Overall Study|Noncompliance with study drug|0|||
129972737|NCT01317875|467865469|FG005|Overall Study|Noncompliance with study drug|0|||
129972738|NCT01317875|467865470|FG006|Overall Study|Noncompliance with study drug|0|||
129972739|NCT01317875|467865471|FG007|Overall Study|Noncompliance with study drug|0|||
129972740|NCT01317875|467865472|FG008|Overall Study|Noncompliance with study drug|0|||
129972741|NCT01317875|467865473|FG009|Overall Study|Noncompliance with study drug|0|||
129972742|NCT01317875|467865464|FG000|Overall Study|Progressive Disease|1|||
129972743|NCT01317875|467865465|FG001|Overall Study|Progressive Disease|0|||
129972744|NCT01317875|467865466|FG002|Overall Study|Progressive Disease|2|||
129972745|NCT01317875|467865467|FG003|Overall Study|Progressive Disease|0|||
129972746|NCT01317875|467865468|FG004|Overall Study|Progressive Disease|1|||
129972747|NCT01317875|467865469|FG005|Overall Study|Progressive Disease|0|||
129972748|NCT01317875|467865470|FG006|Overall Study|Progressive Disease|0|||
129972749|NCT01317875|467865471|FG007|Overall Study|Progressive Disease|1|||
129972750|NCT01317875|467865472|FG008|Overall Study|Progressive Disease|0|||
129972751|NCT01317875|467865473|FG009|Overall Study|Progressive Disease|0|||
129972752|NCT01317875|467865464|FG000|Overall Study|Withdrawal by Subject|0|||
129972753|NCT01317875|467865465|FG001|Overall Study|Withdrawal by Subject|0|||
129972754|NCT01317875|467865466|FG002|Overall Study|Withdrawal by Subject|0|||
129972755|NCT01317875|467865467|FG003|Overall Study|Withdrawal by Subject|0|||
129972756|NCT01317875|467865468|FG004|Overall Study|Withdrawal by Subject|1|||
129972757|NCT01317875|467865469|FG005|Overall Study|Withdrawal by Subject|0|||
129972758|NCT01317875|467865470|FG006|Overall Study|Withdrawal by Subject|0|||
129972759|NCT01317875|467865471|FG007|Overall Study|Withdrawal by Subject|3|||
129972760|NCT01317875|467865472|FG008|Overall Study|Withdrawal by Subject|0|||
129972761|NCT01317875|467865473|FG009|Overall Study|Withdrawal by Subject|0|||
129972762|NCT01317875|467865464|FG000|Overall Study|Physician Decision|0|||
129972763|NCT01317875|467865465|FG001|Overall Study|Physician Decision|1|||
129972764|NCT01317875|467865466|FG002|Overall Study|Physician Decision|1|||
129972765|NCT01317875|467865467|FG003|Overall Study|Physician Decision|0|||
129972766|NCT01317875|467865468|FG004|Overall Study|Physician Decision|2|||
129972767|NCT01317875|467865469|FG005|Overall Study|Physician Decision|0|||
129972768|NCT01317875|467865470|FG006|Overall Study|Physician Decision|0|||
129972769|NCT01317875|467865471|FG007|Overall Study|Physician Decision|2|||
129972770|NCT01317875|467865472|FG008|Overall Study|Physician Decision|0|||
129972771|NCT01317875|467865473|FG009|Overall Study|Physician Decision|0|||
129972772|NCT01317875|467865464|FG000|Overall Study|Death|0|||
129972773|NCT01317875|467865465|FG001|Overall Study|Death|0|||
129972774|NCT01317875|467865466|FG002|Overall Study|Death|2|||
129972775|NCT01317875|467865467|FG003|Overall Study|Death|1|||
129972776|NCT01317875|467865468|FG004|Overall Study|Death|0|||
129972777|NCT01317875|467865469|FG005|Overall Study|Death|1|||
129972778|NCT01317875|467865470|FG006|Overall Study|Death|0|||
129972779|NCT01317875|467865471|FG007|Overall Study|Death|4|||
129972780|NCT01317875|467865472|FG008|Overall Study|Death|0|||
129972781|NCT01317875|467865473|FG009|Overall Study|Death|0|||
129972782|NCT01317875|467865464|FG000|Overall Study|Adverse Event|2|||
129972783|NCT01317875|467865465|FG001|Overall Study|Adverse Event|1|||
129972784|NCT01317875|467865466|FG002|Overall Study|Adverse Event|2|||
129972785|NCT01317875|467865467|FG003|Overall Study|Adverse Event|1|||
129972786|NCT01317875|467865468|FG004|Overall Study|Adverse Event|5|||
129972787|NCT01317875|467865469|FG005|Overall Study|Adverse Event|1|||
129972788|NCT01317875|467865470|FG006|Overall Study|Adverse Event|2|||
129972789|NCT01317875|467865471|FG007|Overall Study|Adverse Event|5|||
129972790|NCT01317875|467865472|FG008|Overall Study|Adverse Event|0|||
129972791|NCT01317875|467865473|FG009|Overall Study|Adverse Event|0|||
129972792|NCT01381575|467865474|FG000|Overall Study|Serious Adverse Event|1|||
129972793|NCT01381575|467865475|FG001|Overall Study|Serious Adverse Event|0|||
129972794|NCT01381575|467865476|FG002|Overall Study|Serious Adverse Event|0|||
129972795|NCT01381575|467865474|FG000|Overall Study|Non-Serious Adverse Event|0|||
129972796|NCT01381575|467865475|FG001|Overall Study|Non-Serious Adverse Event|0|||
129972797|NCT01381575|467865476|FG002|Overall Study|Non-Serious Adverse Event|1|||
129972798|NCT01381575|467865474|FG000|Overall Study|Protocol Violation|0|||
129972799|NCT01381575|467865475|FG001|Overall Study|Protocol Violation|1|||
129972800|NCT01381575|467865476|FG002|Overall Study|Protocol Violation|1|||
129972801|NCT01381575|467865474|FG000|Overall Study|Withdrawal by Subject|15|||
129972802|NCT01381575|467865475|FG001|Overall Study|Withdrawal by Subject|9|||
129972803|NCT01381575|467865476|FG002|Overall Study|Withdrawal by Subject|7|||
129972804|NCT01381575|467865474|FG000|Overall Study|Migrated/moved from study area|2|||
129972805|NCT01381575|467865475|FG001|Overall Study|Migrated/moved from study area|12|||
129972806|NCT01381575|467865476|FG002|Overall Study|Migrated/moved from study area|2|||
129972807|NCT01381575|467865474|FG000|Overall Study|Lost to Follow-up|8|||
129972808|NCT01381575|467865475|FG001|Overall Study|Lost to Follow-up|17|||
129972809|NCT01381575|467865476|FG002|Overall Study|Lost to Follow-up|9|||
129972810|NCT01443403|467865477|FG000|Overall Study|Adverse Event|1|||
129972811|NCT01443403|467865478|FG001|Overall Study|Adverse Event|1|||
129972812|NCT01443403|467865479|FG002|Overall Study|Adverse Event|4|||
129972813|NCT01443403|467865480|FG003|Overall Study|Adverse Event|5|||
129972814|NCT01443403|467865477|FG000|Overall Study|Withdrawal by Subject|0|||
129972815|NCT01443403|467865478|FG001|Overall Study|Withdrawal by Subject|1|||
129972816|NCT01443403|467865479|FG002|Overall Study|Withdrawal by Subject|2|||
129972817|NCT01443403|467865480|FG003|Overall Study|Withdrawal by Subject|1|||
129972818|NCT01443403|467865477|FG000|Overall Study|Lost to Follow-up|0|||
129972819|NCT01443403|467865478|FG001|Overall Study|Lost to Follow-up|0|||
129972820|NCT01443403|467865479|FG002|Overall Study|Lost to Follow-up|0|||
129972821|NCT01443403|467865480|FG003|Overall Study|Lost to Follow-up|1|||
129972822|NCT01443403|467865477|FG000|Overall Study|Protocol Violation|2|||
129972823|NCT01443403|467865478|FG001|Overall Study|Protocol Violation|1|||
129972824|NCT01443403|467865479|FG002|Overall Study|Protocol Violation|1|||
129972825|NCT01443403|467865480|FG003|Overall Study|Protocol Violation|1|||
129972826|NCT01443403|467865477|FG000|Overall Study|Use of Prohibited Treatment|2|||
129972827|NCT01443403|467865478|FG001|Overall Study|Use of Prohibited Treatment|3|||
129972828|NCT01443403|467865479|FG002|Overall Study|Use of Prohibited Treatment|0|||
129972829|NCT01443403|467865480|FG003|Overall Study|Use of Prohibited Treatment|0|||
129972830|NCT01443403|467865477|FG000|Overall Study|Other - Miscellaneous|1|||
129972831|NCT01443403|467865478|FG001|Overall Study|Other - Miscellaneous|0|||
129972832|NCT01443403|467865479|FG002|Overall Study|Other - Miscellaneous|0|||
129972833|NCT01443403|467865480|FG003|Overall Study|Other - Miscellaneous|1|||
129972834|NCT04546217|467865483|FG000|Overall Study|Withdrawal by Subject|2|||
129972835|NCT04546217|467865484|FG001|Overall Study|Withdrawal by Subject|0|||
129972836|NCT04546217|467865483|FG000|Overall Study|Uncontrolled hypertension|1|||
129972837|NCT04546217|467865484|FG001|Overall Study|Uncontrolled hypertension|0|||
129972838|NCT02550938|467865485|FG000|Overall Study|Lost to Follow-up|8|||
129972839|NCT02550938|467865486|FG001|Overall Study|Lost to Follow-up|7|||
129972840|NCT02550938|467865487|FG002|Overall Study|Lost to Follow-up|12|||
129972841|NCT02550938|467865488|FG003|Overall Study|Lost to Follow-up|11|||
129972842|NCT02514239|467865492|FG000|Overall Study|Refused to continue trial medication|0|||
129972843|NCT02514239|467865493|FG001|Overall Study|Refused to continue trial medication|0|||
129972844|NCT02514239|467865494|FG002|Overall Study|Refused to continue trial medication|0|||
129972845|NCT02514239|467865495|FG003|Overall Study|Refused to continue trial medication|0|||
129972846|NCT02514239|467865496|FG004|Overall Study|Refused to continue trial medication|0|||
129972847|NCT02514239|467865497|FG005|Overall Study|Refused to continue trial medication|0|||
129972848|NCT02514239|467865498|FG006|Overall Study|Refused to continue trial medication|0|||
129972849|NCT02514239|467865499|FG007|Overall Study|Refused to continue trial medication|0|||
129972850|NCT02514239|467865500|FG008|Overall Study|Refused to continue trial medication|0|||
129972851|NCT02514239|467865501|FG009|Overall Study|Refused to continue trial medication|1|||
129972852|NCT02514239|467865492|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972853|NCT02514239|467865493|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972854|NCT02514239|467865494|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972855|NCT02514239|467865495|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972856|NCT02514239|467865496|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972857|NCT02514239|467865497|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972858|NCT02514239|467865498|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972859|NCT02514239|467865499|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972860|NCT02514239|467865500|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
129972861|NCT02514239|467865501|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
129972862|NCT02514239|467865492|FG000|Overall Study|Not treated|0|||
129972863|NCT02514239|467865493|FG001|Overall Study|Not treated|1|||
129972864|NCT02514239|467865494|FG002|Overall Study|Not treated|0|||
129972865|NCT02514239|467865495|FG003|Overall Study|Not treated|0|||
129972866|NCT02514239|467865496|FG004|Overall Study|Not treated|0|||
129972867|NCT02514239|467865497|FG005|Overall Study|Not treated|0|||
130136202|NCT01348789|468459273|FG000|Overall Study|Withdrawal by Subject|2|||
130136203|NCT01825798|468459280|FG000|Overall Study|Adverse Event|1|||
129972868|NCT02514239|467865498|FG006|Overall Study|Not treated|0|||
129972869|NCT02514239|467865499|FG007|Overall Study|Not treated|0|||
129972870|NCT02514239|467865500|FG008|Overall Study|Not treated|0|||
129972871|NCT02514239|467865501|FG009|Overall Study|Not treated|0|||
129972872|NCT02514239|467865492|FG000|Overall Study|Other Adverse Events|2|||
129972873|NCT02514239|467865493|FG001|Overall Study|Other Adverse Events|0|||
129972874|NCT02514239|467865494|FG002|Overall Study|Other Adverse Events|0|||
129972875|NCT02514239|467865495|FG003|Overall Study|Other Adverse Events|1|||
129972876|NCT02514239|467865496|FG004|Overall Study|Other Adverse Events|0|||
129972877|NCT02514239|467865497|FG005|Overall Study|Other Adverse Events|1|||
129972878|NCT02514239|467865498|FG006|Overall Study|Other Adverse Events|0|||
129972879|NCT02514239|467865499|FG007|Overall Study|Other Adverse Events|1|||
129972880|NCT02514239|467865500|FG008|Overall Study|Other Adverse Events|2|||
129972881|NCT02514239|467865501|FG009|Overall Study|Other Adverse Events|0|||
129972882|NCT02514239|467865492|FG000|Overall Study|Progressive disease|3|||
129972883|NCT02514239|467865493|FG001|Overall Study|Progressive disease|3|||
129972884|NCT02514239|467865494|FG002|Overall Study|Progressive disease|2|||
129972885|NCT02514239|467865495|FG003|Overall Study|Progressive disease|2|||
129972886|NCT02514239|467865496|FG004|Overall Study|Progressive disease|3|||
129972887|NCT02514239|467865497|FG005|Overall Study|Progressive disease|3|||
129972888|NCT02514239|467865498|FG006|Overall Study|Progressive disease|4|||
129972889|NCT02514239|467865499|FG007|Overall Study|Progressive disease|2|||
129972890|NCT02514239|467865500|FG008|Overall Study|Progressive disease|5|||
129972891|NCT02514239|467865501|FG009|Overall Study|Progressive disease|0|||
129972892|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
129972893|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
129972894|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
129972895|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
129972896|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
129972897|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
129972898|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
129972899|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
129972900|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
129972901|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
129972902|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
129972903|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
129972904|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
129972905|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
129972906|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972907|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972908|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972909|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972910|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972911|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972912|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
129972913|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
129972914|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
129972915|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
129972916|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
129972917|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
129972918|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
129972919|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
129972920|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972921|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972922|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972923|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972924|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
129972925|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972926|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972927|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972928|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
129972929|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972930|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972931|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972932|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972933|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972934|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972935|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
129972936|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972937|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972938|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972939|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
129972940|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972941|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
129972942|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
129972943|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
130136204|NCT01825798|468459281|FG001|Overall Study|Adverse Event|5|||
129972944|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129972945|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
129972946|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129972947|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129972948|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972949|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972950|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972951|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972952|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
129972953|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972954|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972955|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972956|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972957|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
129972958|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972959|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972960|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
129972961|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972962|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972963|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972964|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
129972965|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972966|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972967|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972968|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972969|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
129972970|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
129972971|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
129972972|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
129972973|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
129972974|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
129972975|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
129972976|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972977|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
129972978|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972979|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972980|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972981|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
129972982|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972983|NCT00953771|467865510|FG000|Overall Study|Death|1|||
129972984|NCT00953771|467865511|FG001|Overall Study|Death|0|||
129972985|NCT00884650|467865514|FG000|Overall Study|Did not return complete pain diaries|7|||
129972986|NCT00884650|467865515|FG001|Overall Study|Did not return complete pain diaries|7|||
129972987|NCT00884650|467865514|FG000|Overall Study|Admitted Post-Op|1|||
129972988|NCT00884650|467865515|FG001|Overall Study|Admitted Post-Op|0|||
129972989|NCT00884650|467865514|FG000|Overall Study|Femoral Stress Fracture|1|||
129972990|NCT00884650|467865515|FG001|Overall Study|Femoral Stress Fracture|0|||
129972991|NCT00884650|467865514|FG000|Overall Study|Pain Pump Complication|0|||
129972992|NCT00884650|467865515|FG001|Overall Study|Pain Pump Complication|1|||
130136205|NCT01825798|468459280|FG000|Overall Study|Lost to Follow-up|1|||
130136206|NCT01825798|468459281|FG001|Overall Study|Lost to Follow-up|0|||
130136207|NCT00834873|468459282|FG000|First Intervention|Adverse Event|0|||
130136208|NCT00834873|468459283|FG001|First Intervention|Adverse Event|1|||
130136209|NCT05098743|468459285|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
130136210|NCT05098743|468459286|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
130136211|NCT05098743|468459285|FG000|Overall Study|Lost to Follow-up|1|||
130136212|NCT05098743|468459286|FG001|Overall Study|Lost to Follow-up|2|||
130136213|NCT02911025|468459291|FG000|Overall Study|Lost to Follow-up|3|||
130136214|NCT04063878|468459292|FG000|Overall Study|Withdrawal by Subject|2|||
130136215|NCT04063878|468459292|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
130136216|NCT02358538|468459295|FG000|Through Week 26|Adverse Event|0|||
130136217|NCT02358538|468459296|FG001|Through Week 26|Adverse Event|1|||
130136218|NCT02358538|468459297|FG002|Through Week 26|Adverse Event|1|||
130136219|NCT02358538|468459298|FG003|Through Week 26|Adverse Event|2|||
130136220|NCT02358538|468459295|FG000|Through Week 26|Lack of Efficacy|1|||
130136221|NCT02358538|468459296|FG001|Through Week 26|Lack of Efficacy|1|||
130136222|NCT02358538|468459297|FG002|Through Week 26|Lack of Efficacy|3|||
129972993|NCT00979953|467865516|FG000|Overall Study|Adverse Event|5|||
130136223|NCT02358538|468459298|FG003|Through Week 26|Lack of Efficacy|3|||
130136224|NCT02358538|468459295|FG000|Through Week 26|Withdrawal by Subject|1|||
129972994|NCT00979953|467865517|FG001|Overall Study|Adverse Event|2|||
129972995|NCT00979953|467865518|FG002|Overall Study|Adverse Event|17|||
129972996|NCT00979953|467865519|FG003|Overall Study|Adverse Event|4|||
129972997|NCT00979953|467865516|FG000|Overall Study|Lack of Efficacy|1|||
129972998|NCT00979953|467865517|FG001|Overall Study|Lack of Efficacy|2|||
129972999|NCT00979953|467865518|FG002|Overall Study|Lack of Efficacy|0|||
129973000|NCT00979953|467865519|FG003|Overall Study|Lack of Efficacy|0|||
129973001|NCT00979953|467865516|FG000|Overall Study|Lost to Follow-up|1|||
129973002|NCT00979953|467865517|FG001|Overall Study|Lost to Follow-up|1|||
129973003|NCT00979953|467865518|FG002|Overall Study|Lost to Follow-up|1|||
129973004|NCT00979953|467865519|FG003|Overall Study|Lost to Follow-up|0|||
129973005|NCT00979953|467865516|FG000|Overall Study|Withdrawal by Subject|0|||
129973006|NCT00979953|467865517|FG001|Overall Study|Withdrawal by Subject|0|||
129973007|NCT00979953|467865518|FG002|Overall Study|Withdrawal by Subject|2|||
129973008|NCT00979953|467865519|FG003|Overall Study|Withdrawal by Subject|1|||
129973009|NCT00979953|467865516|FG000|Overall Study|Protocol Violation|1|||
129973010|NCT00979953|467865517|FG001|Overall Study|Protocol Violation|0|||
129973011|NCT00979953|467865518|FG002|Overall Study|Protocol Violation|2|||
129973012|NCT00979953|467865519|FG003|Overall Study|Protocol Violation|2|||
130136225|NCT02358538|468459296|FG001|Through Week 26|Withdrawal by Subject|0|||
130136226|NCT02358538|468459297|FG002|Through Week 26|Withdrawal by Subject|0|||
130136227|NCT02358538|468459298|FG003|Through Week 26|Withdrawal by Subject|0|||
130136228|NCT02358538|468459295|FG000|Through Week 26|Non-Compliance|0|||
130136229|NCT02358538|468459296|FG001|Through Week 26|Non-Compliance|0|||
130136230|NCT02358538|468459297|FG002|Through Week 26|Non-Compliance|1|||
130136231|NCT02358538|468459298|FG003|Through Week 26|Non-Compliance|0|||
130136232|NCT02358538|468459295|FG000|Through Week 26|Family did not see benefit from IP|1|||
130136233|NCT02358538|468459296|FG001|Through Week 26|Family did not see benefit from IP|0|||
130136234|NCT02358538|468459297|FG002|Through Week 26|Family did not see benefit from IP|0|||
130136235|NCT02358538|468459298|FG003|Through Week 26|Family did not see benefit from IP|0|||
130136236|NCT02358538|468459295|FG000|52 Week Extension Period|Lack of Efficacy|0|||
130136237|NCT02358538|468459296|FG001|52 Week Extension Period|Lack of Efficacy|0|||
130136238|NCT02358538|468459297|FG002|52 Week Extension Period|Lack of Efficacy|2|||
130136239|NCT02358538|468459298|FG003|52 Week Extension Period|Lack of Efficacy|4|||
130136240|NCT04827394|468459302|FG000|Overall Study|Physician Decision|0|||
130136241|NCT04827394|468459303|FG001|Overall Study|Physician Decision|2|||
130136242|NCT03500094|468459304|FG000|Overall Study|Withdrawal by Subject|1|||
130136243|NCT03500094|468459304|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
130136244|NCT03500094|468459304|FG000|Overall Study|Lost to Follow-up|1|||
130136245|NCT01030133|468459307|FG000|Overall Study|failed to experience pain at level 7/10|2|||
130136246|NCT01030133|468459308|FG001|Overall Study|failed to experience pain at level 7/10|2|||
130136247|NCT00477594|468459309|FG000|Year 1 and Year 2|Adverse Event|4|||
129973013|NCT04052425|467865522|FG000|24-Week Double-blind Period|Adverse Event|0|||
129973014|NCT04052425|467865523|FG001|24-Week Double-blind Period|Adverse Event|1|||
129973015|NCT04052425|467865524|FG002|24-Week Double-blind Period|Adverse Event|0|||
129973016|NCT04052425|467865525|FG003|24-Week Double-blind Period|Adverse Event|0|||
129973017|NCT04052425|467865522|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
129973018|NCT04052425|467865523|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
129973019|NCT04052425|467865524|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
129973020|NCT04052425|467865525|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
129973021|NCT04052425|467865522|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
129973022|NCT04052425|467865523|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
129973023|NCT04052425|467865524|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
129973024|NCT04052425|467865525|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
129973025|NCT04052425|467865522|FG000|24-Week Double-blind Period|Physician Decision|1|||
129973026|NCT04052425|467865523|FG001|24-Week Double-blind Period|Physician Decision|0|||
129973027|NCT04052425|467865524|FG002|24-Week Double-blind Period|Physician Decision|0|||
129973028|NCT04052425|467865525|FG003|24-Week Double-blind Period|Physician Decision|0|||
129973029|NCT04052425|467865522|FG000|24-Week Double-blind Period|Protocol Violation|1|||
129973030|NCT04052425|467865523|FG001|24-Week Double-blind Period|Protocol Violation|0|||
129973031|NCT04052425|467865524|FG002|24-Week Double-blind Period|Protocol Violation|0|||
129973032|NCT04052425|467865525|FG003|24-Week Double-blind Period|Protocol Violation|0|||
129973033|NCT04052425|467865522|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
129973034|NCT04052425|467865523|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
129973035|NCT04052425|467865524|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
130136248|NCT00477594|468459310|FG001|Year 1 and Year 2|Adverse Event|2|||
130136249|NCT00477594|468459309|FG000|Year 1 and Year 2|Physician Decision|2|||
130136250|NCT00477594|468459310|FG001|Year 1 and Year 2|Physician Decision|1|||
129973036|NCT04052425|467865525|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
129973037|NCT04052425|467865522|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
129973038|NCT04052425|467865523|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
130136251|NCT00477594|468459309|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
130136252|NCT00477594|468459310|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
130136253|NCT00477594|468459309|FG000|Year 1 and Year 2|Other|1|||
130136254|NCT00477594|468459310|FG001|Year 1 and Year 2|Other|0|||
130136255|NCT00477594|468459309|FG000|Year 3|Adverse Event|1|||
130136256|NCT00477594|468459310|FG001|Year 3|Adverse Event|0|||
130136257|NCT00477594|468459309|FG000|Year 3|Withdrawal by Subject|1|||
130136258|NCT00477594|468459310|FG001|Year 3|Withdrawal by Subject|0|||
130136259|NCT00477594|468459309|FG000|Follow-up Period|Withdrawal by Subject|2|||
130136260|NCT00477594|468459310|FG001|Follow-up Period|Withdrawal by Subject|1|||
130136261|NCT00477594|468459309|FG000|Follow-up Period|Other|1|||
129973039|NCT04052425|467865524|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
129973040|NCT04052425|467865525|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
129973041|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
129973042|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
129973043|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
129973044|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
129973045|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
129973046|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
129973047|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
129973048|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
129973049|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129973050|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129973051|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
129973052|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
129973053|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
129973054|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
129973055|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
129973056|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
129973057|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129973058|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129973059|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
129973060|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
129973061|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
129973062|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
129973063|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
129973064|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
129973065|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
129973066|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
129973067|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
129973068|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
129973069|NCT04334278|467865526|FG000|Overall Study|Lost to Follow-up|0|||
129973070|NCT04334278|467865527|FG001|Overall Study|Lost to Follow-up|3|||
129973071|NCT04334278|467865526|FG000|Overall Study|Withdrawal by Subject|4|||
129973072|NCT04334278|467865527|FG001|Overall Study|Withdrawal by Subject|2|||
129973073|NCT04829747|467865530|FG000|Overall Study|Protocol Violation|1|||
129973074|NCT02615509|467865533|FG000|Overall Study|Lost to Follow-up|134|||
129973075|NCT02615509|467865533|FG000|Overall Study|Death|4|||
129973076|NCT02615509|467865533|FG000|Overall Study|Withdrawal by Subject|8|||
129973077|NCT00425607|467865534|FG000|Overall Study|Death|1|||
130136262|NCT00477594|468459310|FG001|Follow-up Period|Other|0|||
130136263|NCT02068794|468461649|FG000|Overall Study|Withdrawal by Subject|0|||
130136264|NCT02068794|468461650|FG001|Overall Study|Withdrawal by Subject|1|||
130136265|NCT02068794|468461651|FG002|Overall Study|Withdrawal by Subject|2|||
130136266|NCT02068794|468461649|FG000|Overall Study|Early Progression|1|||
130136267|NCT02068794|468461650|FG001|Overall Study|Early Progression|0|||
129973078|NCT00425607|467865534|FG000|Overall Study|Withdrawal by Subject|1|||
129973079|NCT00079339|467865535|FG000|Overall Study|Adverse Event|1|||
129973080|NCT00079339|467865536|FG001|Overall Study|Adverse Event|7|||
129973081|NCT00079339|467865537|FG002|Overall Study|Adverse Event|2|||
129973082|NCT00079339|467865535|FG000|Overall Study|Death|1|||
129973083|NCT00079339|467865536|FG001|Overall Study|Death|0|||
129973084|NCT00079339|467865537|FG002|Overall Study|Death|0|||
129973085|NCT00079339|467865535|FG000|Overall Study|Non-compliance|0|||
129973086|NCT00079339|467865536|FG001|Overall Study|Non-compliance|0|||
129973087|NCT00079339|467865537|FG002|Overall Study|Non-compliance|1|||
129973088|NCT00079339|467865535|FG000|Overall Study|Withdrawal by Subject|0|||
129973089|NCT00079339|467865536|FG001|Overall Study|Withdrawal by Subject|4|||
129973090|NCT00079339|467865537|FG002|Overall Study|Withdrawal by Subject|1|||
129973091|NCT00079339|467865535|FG000|Overall Study|Disease progression|3|||
130136268|NCT02068794|468461651|FG002|Overall Study|Early Progression|1|||
130136269|NCT02068794|468461649|FG000|Overall Study|Ineligible|0|||
130136270|NCT02068794|468461650|FG001|Overall Study|Ineligible|0|||
130136271|NCT02068794|468461651|FG002|Overall Study|Ineligible|1|||
129973092|NCT00079339|467865536|FG001|Overall Study|Disease progression|28|||
129973093|NCT00079339|467865537|FG002|Overall Study|Disease progression|2|||
129973094|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
129973095|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
129973096|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130136272|NCT02316548|468461653|FG000|Overall Study|Protocol Violation|0|||
130136273|NCT02316548|468461654|FG001|Overall Study|Protocol Violation|1|||
130136274|NCT01958294|468461655|FG000|Overall Study|Clinical Circumstances|2|||
130136275|NCT02566850|468461657|FG000|Overall Study|Protocol Violation|1|||
130136276|NCT02635750|468461658|FG000|Part 1, Period 2|Adverse Event|1|||
130136277|NCT02635750|468461659|FG001|Part 1, Period 2|Adverse Event|0|||
130136278|NCT02635750|468461660|FG002|Part 1, Period 2|Adverse Event|0|||
130136279|NCT00830258|468461663|FG000|First Intervention|Adverse Event|1|||
130136280|NCT00830258|468461664|FG001|First Intervention|Adverse Event|0|||
130136281|NCT00830258|468461663|FG000|Washout: 7 Days|Protocol Violation|1|||
130136282|NCT00830258|468461664|FG001|Washout: 7 Days|Protocol Violation|0|||
130136283|NCT00682461|468461668|FG000|Overall Study|Adverse Event|5|||
130136284|NCT00682461|468461669|FG001|Overall Study|Adverse Event|7|||
130136285|NCT00682461|468461668|FG000|Overall Study|Lost to Follow-up|8|||
130136286|NCT00682461|468461669|FG001|Overall Study|Lost to Follow-up|5|||
130136287|NCT00682461|468461668|FG000|Overall Study|Withdrawal by Subject|12|||
130136288|NCT00682461|468461669|FG001|Overall Study|Withdrawal by Subject|19|||
130136289|NCT00665925|468461671|FG000|Overall Study|Lack of Efficacy|10|||
130136290|NCT00665925|468461672|FG001|Overall Study|Lack of Efficacy|8|||
130136291|NCT00665925|468461673|FG002|Overall Study|Lack of Efficacy|9|||
130136292|NCT00665925|468461674|FG003|Overall Study|Lack of Efficacy|8|||
130136293|NCT00665925|468461671|FG000|Overall Study|Lost to Follow-up|1|||
130136294|NCT00665925|468461672|FG001|Overall Study|Lost to Follow-up|2|||
130136295|NCT00665925|468461673|FG002|Overall Study|Lost to Follow-up|2|||
130136296|NCT00665925|468461674|FG003|Overall Study|Lost to Follow-up|2|||
130136297|NCT00665925|468461671|FG000|Overall Study|Withdrawal by Subject|2|||
130136298|NCT00665925|468461672|FG001|Overall Study|Withdrawal by Subject|2|||
130136299|NCT00665925|468461673|FG002|Overall Study|Withdrawal by Subject|3|||
130136300|NCT00665925|468461674|FG003|Overall Study|Withdrawal by Subject|2|||
130136301|NCT00665925|468461671|FG000|Overall Study|Physician Decision|0|||
130136302|NCT00665925|468461672|FG001|Overall Study|Physician Decision|0|||
130136303|NCT00665925|468461673|FG002|Overall Study|Physician Decision|1|||
130136304|NCT00665925|468461674|FG003|Overall Study|Physician Decision|2|||
130136305|NCT00665925|468461671|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
130136306|NCT00665925|468461672|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
130136307|NCT00665925|468461673|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130136308|NCT00665925|468461674|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
130136309|NCT00665925|468461671|FG000|Overall Study|Adverse Event|1|||
130136310|NCT00665925|468461672|FG001|Overall Study|Adverse Event|5|||
130136311|NCT00665925|468461673|FG002|Overall Study|Adverse Event|10|||
130136312|NCT00665925|468461674|FG003|Overall Study|Adverse Event|5|||
130136313|NCT00665925|468461671|FG000|Overall Study|Enrolled by mistake|0|||
130136314|NCT00665925|468461672|FG001|Overall Study|Enrolled by mistake|0|||
130136315|NCT00665925|468461673|FG002|Overall Study|Enrolled by mistake|0|||
130136316|NCT00665925|468461674|FG003|Overall Study|Enrolled by mistake|1|||
130136317|NCT00665925|468461671|FG000|Overall Study|Due to exclusion criteria|1|||
130136318|NCT00665925|468461672|FG001|Overall Study|Due to exclusion criteria|0|||
130136319|NCT00665925|468461673|FG002|Overall Study|Due to exclusion criteria|0|||
130136320|NCT00665925|468461674|FG003|Overall Study|Due to exclusion criteria|0|||
130136321|NCT04035187|468461677|FG000|Overall Study|Withdrawal by Subject|2|||
130136322|NCT04035187|468461678|FG001|Overall Study|Withdrawal by Subject|1|||
130136323|NCT04035187|468461679|FG002|Overall Study|Withdrawal by Subject|0|||
130136324|NCT04035187|468461680|FG003|Overall Study|Withdrawal by Subject|0|||
130136325|NCT04035187|468461677|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
130136326|NCT04035187|468461678|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
130136327|NCT04035187|468461679|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
130136328|NCT04035187|468461680|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
130136329|NCT01116739|468461681|FG000|Overall Study|Child had 2 years of HS|110|||
129973097|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
129973098|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130136330|NCT01116739|468461682|FG001|Overall Study|Child had 2 years of HS|128|||
130136331|NCT01116739|468461681|FG000|Overall Study|Withdrawal by Subject|6|||
130136332|NCT01116739|468461682|FG001|Overall Study|Withdrawal by Subject|0|||
130136333|NCT01116739|468461681|FG000|Overall Study|child too young|2|||
130136334|NCT01116739|468461682|FG001|Overall Study|child too young|6|||
130136335|NCT01116739|468461681|FG000|Overall Study|child not enrolled in head start|10|||
130136336|NCT01116739|468461682|FG001|Overall Study|child not enrolled in head start|2|||
129973099|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
130136337|NCT01116739|468461681|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
130136338|NCT01116739|468461682|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
130136339|NCT05511935|468461683|FG000|Overall Study|Lost to Follow-up|9|||
129973100|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
129973101|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
129973102|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
129973103|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
129973104|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
129973105|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
129973106|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
130136340|NCT05511935|468461684|FG001|Overall Study|Lost to Follow-up|27|||
130136341|NCT05090839|468461687|FG000|Overall Study|Lost to Follow-up|2|||
130136342|NCT05090839|468461688|FG001|Overall Study|Lost to Follow-up|3|||
130136343|NCT05090839|468461689|FG002|Overall Study|Lost to Follow-up|1|||
130136344|NCT05090839|468461690|FG003|Overall Study|Lost to Follow-up|1|||
130136345|NCT00334815|468461691|FG000|Overall Study|Adverse Event|3|||
130136346|NCT00334815|468461692|FG001|Overall Study|Adverse Event|2|||
130136347|NCT00334815|468461691|FG000|Overall Study|Death|0|||
130136348|NCT00334815|468461692|FG001|Overall Study|Death|2|||
130136349|NCT00334815|468461691|FG000|Overall Study|Progression|1|||
130136350|NCT00334815|468461692|FG001|Overall Study|Progression|0|||
130136351|NCT00334815|468461691|FG000|Overall Study|ineligible|1|||
130136352|NCT00334815|468461692|FG001|Overall Study|ineligible|1|||
129973107|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973108|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
129973109|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973110|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973111|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973112|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973113|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973114|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
129973115|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
130136353|NCT00334815|468461691|FG000|Overall Study|patient refused treatment|0|||
130136354|NCT00334815|468461692|FG001|Overall Study|patient refused treatment|1|||
130136355|NCT00334815|468461691|FG000|Overall Study|Physician Decision|2|||
130136356|NCT00334815|468461692|FG001|Overall Study|Physician Decision|4|||
130136357|NCT03913377|468461693|FG000|Period 1|Test Article no longer available|0|||
130136358|NCT03913377|468461694|FG001|Period 1|Test Article no longer available|1|||
130136359|NCT03913377|468461695|FG002|Period 1|Test Article no longer available|0|||
130136360|NCT03913377|468461693|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
130136361|NCT03913377|468461694|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
130136362|NCT03913377|468461695|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
130136363|NCT03499353|468461696|FG000|Treatment|Adverse Event|3|||
130136364|NCT03499353|468461696|FG000|Treatment|Progressive Disease|10|||
130136365|NCT03499353|468461696|FG000|Treatment|Other|1|||
130136366|NCT03499353|468461696|FG000|Treatment|Withdrawal by Subject|2|||
130136367|NCT03499353|468461696|FG000|Long-Term Follow-up|Death|2|||
130136368|NCT03499353|468461696|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
130136369|NCT03499353|468461696|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
130136370|NCT01592240|468461697|FG000|Overall Study|Adverse Event|1|||
130136371|NCT01592240|468461698|FG001|Overall Study|Adverse Event|0|||
130136372|NCT01592240|468461699|FG002|Overall Study|Adverse Event|0|||
130136373|NCT01592240|468461700|FG003|Overall Study|Adverse Event|1|||
130136374|NCT01592240|468461701|FG004|Overall Study|Adverse Event|1|||
130136375|NCT01592240|468461702|FG005|Overall Study|Adverse Event|0|||
130136376|NCT01592240|468461703|FG006|Overall Study|Adverse Event|0|||
130136377|NCT01592240|468461697|FG000|Overall Study|Death|0|||
130136378|NCT01592240|468461698|FG001|Overall Study|Death|1|||
130136379|NCT01592240|468461699|FG002|Overall Study|Death|0|||
130136380|NCT01592240|468461700|FG003|Overall Study|Death|0|||
130136381|NCT01592240|468461701|FG004|Overall Study|Death|0|||
130136382|NCT01592240|468461702|FG005|Overall Study|Death|0|||
130136383|NCT01592240|468461703|FG006|Overall Study|Death|0|||
130136384|NCT01592240|468461697|FG000|Overall Study|Lost to Follow-up|1|||
130136385|NCT01592240|468461698|FG001|Overall Study|Lost to Follow-up|3|||
130136386|NCT01592240|468461699|FG002|Overall Study|Lost to Follow-up|1|||
130136387|NCT01592240|468461700|FG003|Overall Study|Lost to Follow-up|0|||
130136388|NCT01592240|468461701|FG004|Overall Study|Lost to Follow-up|3|||
130136389|NCT01592240|468461702|FG005|Overall Study|Lost to Follow-up|2|||
130136390|NCT01592240|468461703|FG006|Overall Study|Lost to Follow-up|0|||
130136391|NCT01592240|468461697|FG000|Overall Study|Protocol Violation|0|||
130136392|NCT01592240|468461698|FG001|Overall Study|Protocol Violation|0|||
130136393|NCT01592240|468461699|FG002|Overall Study|Protocol Violation|0|||
130136394|NCT01592240|468461700|FG003|Overall Study|Protocol Violation|0|||
130136395|NCT01592240|468461701|FG004|Overall Study|Protocol Violation|0|||
130136396|NCT01592240|468461702|FG005|Overall Study|Protocol Violation|1|||
130136397|NCT01592240|468461703|FG006|Overall Study|Protocol Violation|0|||
130136398|NCT01592240|468461697|FG000|Overall Study|Withdrawal by Subject|0|||
130136399|NCT01592240|468461698|FG001|Overall Study|Withdrawal by Subject|4|||
130136400|NCT01592240|468461699|FG002|Overall Study|Withdrawal by Subject|4|||
130136401|NCT01592240|468461700|FG003|Overall Study|Withdrawal by Subject|1|||
130136402|NCT01592240|468461701|FG004|Overall Study|Withdrawal by Subject|3|||
130136403|NCT01592240|468461702|FG005|Overall Study|Withdrawal by Subject|0|||
130136404|NCT01592240|468461703|FG006|Overall Study|Withdrawal by Subject|2|||
130136405|NCT01592240|468461697|FG000|Overall Study|Other|0|||
130136406|NCT01592240|468461698|FG001|Overall Study|Other|3|||
130136407|NCT01592240|468461699|FG002|Overall Study|Other|1|||
130136408|NCT01592240|468461700|FG003|Overall Study|Other|1|||
130136409|NCT01592240|468461701|FG004|Overall Study|Other|0|||
129973116|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973117|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973118|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973119|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973120|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973121|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973122|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
129973123|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
129973124|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973125|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973126|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973127|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973128|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
129973129|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
129973130|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973131|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973132|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973133|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973134|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
129973135|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973136|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973137|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973138|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973139|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973140|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
129973141|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
129973142|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973143|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973144|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973145|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973146|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973147|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
129973148|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973149|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973150|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973151|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973152|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973153|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
129973154|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973155|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973156|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973157|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973158|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973159|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
129973160|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973161|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973162|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973163|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973164|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
129973165|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
130136410|NCT01592240|468461702|FG005|Overall Study|Other|0|||
130136411|NCT01592240|468461703|FG006|Overall Study|Other|1|||
130136412|NCT01592240|468461697|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129973166|NCT00520845|467865544|FG000|Overall Study|Death|3|||
129973167|NCT00520845|467865544|FG000|Overall Study|Adverse Event|4|||
130136413|NCT01592240|468461698|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
130136414|NCT01592240|468461699|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
130136415|NCT01592240|468461700|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
129973168|NCT00520845|467865544|FG000|Overall Study|Disease Progression, relapse|13|||
129973169|NCT00520845|467865544|FG000|Overall Study|Withdrawal by Subject|1|||
129973170|NCT00520845|467865544|FG000|Overall Study|Alternative Therapy|1|||
129973171|NCT03274453|467865545|FG000|Overall Study|Lost to Follow-up|2|||
129973172|NCT03274453|467865546|FG001|Overall Study|Lost to Follow-up|5|||
129973173|NCT03274453|467865547|FG002|Overall Study|Lost to Follow-up|4|||
129973174|NCT03274453|467865548|FG003|Overall Study|Lost to Follow-up|1|||
129973175|NCT03274453|467865545|FG000|Overall Study|Physician Decision|2|||
129973176|NCT03274453|467865546|FG001|Overall Study|Physician Decision|0|||
129973177|NCT03274453|467865547|FG002|Overall Study|Physician Decision|0|||
129973178|NCT03274453|467865548|FG003|Overall Study|Physician Decision|3|||
129973179|NCT03274453|467865545|FG000|Overall Study|Surgery Cancelled|0|||
129973180|NCT03274453|467865546|FG001|Overall Study|Surgery Cancelled|1|||
129973181|NCT03274453|467865547|FG002|Overall Study|Surgery Cancelled|0|||
129973182|NCT03274453|467865548|FG003|Overall Study|Surgery Cancelled|0|||
129973183|NCT01732549|467865550|FG000|Overall Study|Adverse Event|13|||
129973184|NCT01732549|467865551|FG001|Overall Study|Adverse Event|3|||
129973185|NCT01732549|467865550|FG000|Overall Study|Consent withdrawn|13|||
129973186|NCT01732549|467865551|FG001|Overall Study|Consent withdrawn|6|||
129973187|NCT01732549|467865550|FG000|Overall Study|Disease progression|37|||
129973188|NCT01732549|467865551|FG001|Overall Study|Disease progression|50|||
129973189|NCT01732549|467865550|FG000|Overall Study|Other|8|||
129973190|NCT01732549|467865551|FG001|Overall Study|Other|14|||
129973191|NCT00945672|467865553|FG000|Overall Study|Withdrawal by Subject|0|||
129973192|NCT00945672|467865554|FG001|Overall Study|Withdrawal by Subject|0|||
129973193|NCT00945672|467865555|FG002|Overall Study|Withdrawal by Subject|0|||
129973194|NCT00945672|467865556|FG003|Overall Study|Withdrawal by Subject|1|||
129973195|NCT01681992|467865561|FG000|Overall Study|Adverse Event|3|||
129973196|NCT01681992|467865562|FG001|Overall Study|Adverse Event|2|||
129973197|NCT01681992|467865563|FG002|Overall Study|Adverse Event|3|||
129973198|NCT01681992|467865561|FG000|Overall Study|Lost to Follow-up|36|||
129973199|NCT01681992|467865562|FG001|Overall Study|Lost to Follow-up|38|||
129973200|NCT01681992|467865563|FG002|Overall Study|Lost to Follow-up|53|||
129973201|NCT01681992|467865561|FG000|Overall Study|As Per Sponsor Decision|0|||
129973202|NCT01681992|467865562|FG001|Overall Study|As Per Sponsor Decision|0|||
129973203|NCT01681992|467865563|FG002|Overall Study|As Per Sponsor Decision|1|||
129973204|NCT01681992|467865561|FG000|Overall Study|Protocol Violation|0|||
129973205|NCT01681992|467865562|FG001|Overall Study|Protocol Violation|0|||
129973206|NCT01681992|467865563|FG002|Overall Study|Protocol Violation|1|||
129973207|NCT01681992|467865561|FG000|Overall Study|Withdrawal by Subject|27|||
129973208|NCT01681992|467865562|FG001|Overall Study|Withdrawal by Subject|30|||
129973209|NCT01681992|467865563|FG002|Overall Study|Withdrawal by Subject|25|||
129973210|NCT00447590|467865564|FG000|Overall Study|Withdrawal by Subject|26|||
129973211|NCT00447590|467865564|FG000|Overall Study|Lost to Follow-up|24|||
129973212|NCT00447590|467865564|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
129973213|NCT01967069|467865565|FG000|Overall Study|Adverse Event|2|||
129973214|NCT01967069|467865566|FG001|Overall Study|Adverse Event|2|||
129973215|NCT01967069|467865565|FG000|Overall Study|Lost to Follow-up|5|||
129973216|NCT01967069|467865566|FG001|Overall Study|Lost to Follow-up|2|||
129973217|NCT01967069|467865565|FG000|Overall Study|Withdrawal by Subject|1|||
129973218|NCT01967069|467865566|FG001|Overall Study|Withdrawal by Subject|3|||
129973219|NCT01967069|467865565|FG000|Overall Study|Lack of Efficacy|0|||
129973220|NCT01967069|467865566|FG001|Overall Study|Lack of Efficacy|1|||
129973221|NCT01661205|467865570|FG000|Overall Study|Physician Decision|2|||
129973222|NCT03111095|467865574|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
129973223|NCT03111095|467865575|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
129973224|NCT03111095|467865574|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
129973225|NCT03111095|467865575|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
129973226|NCT00504075|467865576|FG000|Overall Study|Adverse Event|1|||
129973227|NCT00504075|467865576|FG000|Overall Study|Lost to Follow-up|5|||
129973228|NCT00504075|467865576|FG000|Overall Study|Withdrawal by Subject|1|||
129973229|NCT00504075|467865576|FG000|Overall Study|Required other therapeutic intervention|1|||
129973230|NCT04245345|467865592|FG000|Overall Study|Death|1|||
129973231|NCT04245345|467865592|FG000|Overall Study|Exited prior to implant|5|||
129973232|NCT04245345|467865592|FG000|Overall Study|Exited prior to 1-month|9|||
129973233|NCT04245345|467865592|FG000|Overall Study|Missed 1-month visit|3|||
129973234|NCT04245345|467865592|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
129973235|NCT04245345|467865592|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
129973236|NCT00732992|467865593|FG000|Overall Study|Adverse Event|1|||
129973237|NCT00732992|467865594|FG001|Overall Study|Adverse Event|1|||
129973238|NCT00732992|467865593|FG000|Overall Study|Objective Progression or Relapse|3|||
129973239|NCT00732992|467865594|FG001|Overall Study|Objective Progression or Relapse|5|||
129973240|NCT00732992|467865593|FG000|Overall Study|Global Deterioration of Health Status|1|||
129973241|NCT00732992|467865594|FG001|Overall Study|Global Deterioration of Health Status|0|||
129973242|NCT00732992|467865593|FG000|Overall Study|Withdrawal by Subject|1|||
129973243|NCT00732992|467865594|FG001|Overall Study|Withdrawal by Subject|0|||
129973244|NCT02344342|467865595|FG000|Overall Study|Industry partner dropped out|11|||
129973245|NCT02344342|467865596|FG001|Overall Study|Industry partner dropped out|9|||
129973246|NCT02344342|467865597|FG002|Overall Study|Industry partner dropped out|14|||
129973247|NCT02344342|467865598|FG003|Overall Study|Industry partner dropped out|10|||
129973248|NCT03690427|467865603|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
129973249|NCT03690427|467865604|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
129973250|NCT02609672|467865608|FG000|Overall Study|Lost to Follow-up|3|||
129973251|NCT02609672|467865609|FG001|Overall Study|Lost to Follow-up|1|||
129973252|NCT02956837|467865611|FG000|Overall Study|Serious Adverse Events|0|||
129973253|NCT02956837|467865612|FG001|Overall Study|Serious Adverse Events|1|||
129973254|NCT02956837|467865613|FG002|Overall Study|Serious Adverse Events|0|||
129973255|NCT02956837|467865614|FG003|Overall Study|Serious Adverse Events|0|||
129973256|NCT02956837|467865611|FG000|Overall Study|Withdrawal by Subject|0|||
129973257|NCT02956837|467865612|FG001|Overall Study|Withdrawal by Subject|1|||
129973258|NCT02956837|467865613|FG002|Overall Study|Withdrawal by Subject|0|||
129973259|NCT02956837|467865614|FG003|Overall Study|Withdrawal by Subject|3|||
129973260|NCT02956837|467865611|FG000|Overall Study|Lost to Follow-up|0|||
129973261|NCT02956837|467865612|FG001|Overall Study|Lost to Follow-up|1|||
129973262|NCT02956837|467865613|FG002|Overall Study|Lost to Follow-up|2|||
129973263|NCT02956837|467865614|FG003|Overall Study|Lost to Follow-up|0|||
129973264|NCT02597712|467865615|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
129973265|NCT02597712|467865616|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
129973266|NCT02597712|467865615|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
129973267|NCT02597712|467865616|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
129973268|NCT02597712|467865615|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
129973269|NCT02597712|467865616|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
129973270|NCT02637323|467865617|FG000|Overall Study|Lost to Follow-up|2|||
129973271|NCT02637323|467865618|FG001|Overall Study|Lost to Follow-up|0|||
129973272|NCT02637323|467865617|FG000|Overall Study|Protocol Violation|0|||
129973273|NCT02637323|467865618|FG001|Overall Study|Protocol Violation|1|||
129973274|NCT00513708|467865619|FG000|Overall Study|Lost to Follow-up|4|||
129973275|NCT00513708|467865620|FG001|Overall Study|Lost to Follow-up|4|||
129973276|NCT00513708|467865621|FG002|Overall Study|Lost to Follow-up|4|||
129973277|NCT01162486|467865622|FG000|Overall Study|low ANC|1|||
129973278|NCT01162486|467865623|FG001|Overall Study|low ANC|0|||
129973279|NCT01162486|467865624|FG002|Overall Study|low ANC|0|||
129973280|NCT01162486|467865625|FG003|Overall Study|low ANC|0|||
129973281|NCT01162486|467865626|FG004|Overall Study|low ANC|0|||
129973282|NCT01162486|467865622|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
129973283|NCT01162486|467865623|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973284|NCT01162486|467865624|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973285|NCT01162486|467865625|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973286|NCT01162486|467865626|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973287|NCT01162486|467865622|FG000|Overall Study|elevated LFTs|0|||
129973288|NCT01162486|467865623|FG001|Overall Study|elevated LFTs|0|||
129973289|NCT01162486|467865624|FG002|Overall Study|elevated LFTs|1|||
129973290|NCT01162486|467865625|FG003|Overall Study|elevated LFTs|0|||
129973291|NCT01162486|467865626|FG004|Overall Study|elevated LFTs|0|||
129973292|NCT01162486|467865622|FG000|Overall Study|Pregnancy|0|||
129973293|NCT01162486|467865623|FG001|Overall Study|Pregnancy|0|||
129973294|NCT01162486|467865624|FG002|Overall Study|Pregnancy|0|||
129973295|NCT01162486|467865625|FG003|Overall Study|Pregnancy|1|||
129973296|NCT01162486|467865626|FG004|Overall Study|Pregnancy|0|||
129973297|NCT00760747|467865633|FG000|Study Period II|Adverse Event|3|||
129973298|NCT00760747|467865634|FG001|Study Period II|Adverse Event|4|||
129973299|NCT00760747|467865633|FG000|Study Period II|Lack of Efficacy|0|||
129973300|NCT00760747|467865634|FG001|Study Period II|Lack of Efficacy|6|||
129973301|NCT00760747|467865633|FG000|Study Period II|Parent/Caregiver Decision|3|||
129973302|NCT00760747|467865634|FG001|Study Period II|Parent/Caregiver Decision|0|||
129973303|NCT00760747|467865633|FG000|Study Period II|Protocol Violation|6|||
129973304|NCT00760747|467865634|FG001|Study Period II|Protocol Violation|3|||
129973305|NCT00760747|467865633|FG000|Study Period II|Withdrawal by Subject|1|||
129973306|NCT00760747|467865634|FG001|Study Period II|Withdrawal by Subject|0|||
129973307|NCT00760747|467865633|FG000|Study Period II|No drug administered|0|||
129973308|NCT00760747|467865634|FG001|Study Period II|No drug administered|1|||
129973309|NCT00760747|467865633|FG000|Study Period III|Adverse Event|1|||
129973310|NCT00760747|467865634|FG001|Study Period III|Adverse Event|0|||
129973311|NCT00760747|467865633|FG000|Study Period III|Lack of Efficacy|1|||
129973312|NCT00760747|467865634|FG001|Study Period III|Lack of Efficacy|0|||
129973313|NCT00760747|467865633|FG000|Study Period III|Parent/Caregiver Decision|0|||
129973314|NCT00760747|467865634|FG001|Study Period III|Parent/Caregiver Decision|1|||
129973315|NCT00760747|467865633|FG000|Study Period III|Protocol Violation|1|||
129973316|NCT00760747|467865634|FG001|Study Period III|Protocol Violation|1|||
129973317|NCT00760747|467865633|FG000|Study Period III|Physician Decision|0|||
129973318|NCT00760747|467865634|FG001|Study Period III|Physician Decision|1|||
130136416|NCT01592240|468461701|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
130136417|NCT01592240|468461702|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
129973319|NCT01443923|467865635|FG000|Overall Study|Adverse Event|1|||
129973320|NCT01443923|467865636|FG001|Overall Study|Adverse Event|0|||
129973321|NCT00108745|467865637|FG000|Overall Study|Withdrawal by Subject|19|||
129973322|NCT00108745|467865638|FG001|Overall Study|Withdrawal by Subject|12|||
129973323|NCT00108745|467865639|FG002|Overall Study|Withdrawal by Subject|12|||
129973324|NCT00108745|467865637|FG000|Overall Study|Never Treated|8|||
129973325|NCT00108745|467865638|FG001|Overall Study|Never Treated|10|||
129973326|NCT00108745|467865639|FG002|Overall Study|Never Treated|12|||
129973327|NCT00108745|467865637|FG000|Overall Study|Ineligible|7|||
129973328|NCT00108745|467865638|FG001|Overall Study|Ineligible|13|||
129973329|NCT00108745|467865639|FG002|Overall Study|Ineligible|13|||
129973330|NCT01889069|467865640|FG000|Overall Study|Death|18|||
129973331|NCT01889069|467865640|FG000|Overall Study|Progression of Disease|14|||
129973332|NCT01889069|467865640|FG000|Overall Study|Lost to Follow-up|6|||
129973333|NCT01889069|467865640|FG000|Overall Study|Other|4|||
129973334|NCT01889069|467865640|FG000|Overall Study|Consent Withdrawal|3|||
129973335|NCT01426347|467865642|FG000|Overall Study|Lost to Follow-up|0|||
129973336|NCT01426347|467865643|FG001|Overall Study|Lost to Follow-up|3|||
129973337|NCT01426347|467865642|FG000|Overall Study|Protocol Violation|2|||
129973338|NCT01426347|467865643|FG001|Overall Study|Protocol Violation|0|||
129973339|NCT01426347|467865642|FG000|Overall Study|Withdrawal by Subject|5|||
129973340|NCT01426347|467865643|FG001|Overall Study|Withdrawal by Subject|0|||
129973341|NCT00455741|467865644|FG000|Overall Study|Physician Decision|0|||
129973342|NCT00455741|467865645|FG001|Overall Study|Physician Decision|1|||
129973343|NCT01245374|467865648|FG000|Overall Study|Protocol Violation|1|||
129973344|NCT01245374|467865648|FG000|Overall Study|Withdrawal by Subject|3|||
129973345|NCT00935532|467865649|FG000|Overall Study|Adverse Event|11|||
129973346|NCT00935532|467865650|FG001|Overall Study|Adverse Event|6|||
129973347|NCT00935532|467865649|FG000|Overall Study|Death|1|||
129973348|NCT00935532|467865650|FG001|Overall Study|Death|0|||
129973349|NCT00935532|467865649|FG000|Overall Study|Lost to Follow-up|1|||
129973350|NCT00935532|467865650|FG001|Overall Study|Lost to Follow-up|0|||
129973351|NCT00935532|467865649|FG000|Overall Study|Physician Decision|1|||
129973352|NCT00935532|467865650|FG001|Overall Study|Physician Decision|2|||
129973353|NCT00935532|467865649|FG000|Overall Study|Protocol Violation|2|||
129973354|NCT00935532|467865650|FG001|Overall Study|Protocol Violation|1|||
129973355|NCT00935532|467865649|FG000|Overall Study|Subject Decision|2|||
129973356|NCT00935532|467865650|FG001|Overall Study|Subject Decision|1|||
129973357|NCT00935532|467865649|FG000|Overall Study|Sponsor Decision|0|||
129973358|NCT00935532|467865650|FG001|Overall Study|Sponsor Decision|1|||
129973359|NCT00935532|467865649|FG000|Overall Study|Loss Glucose Control|4|||
129973360|NCT00935532|467865650|FG001|Overall Study|Loss Glucose Control|0|||
129973361|NCT04954326|467865651|FG000|Overall Study|Protocol Violation|0|||
129973362|NCT04954326|467865652|FG001|Overall Study|Protocol Violation|1|||
129973363|NCT04954326|467865651|FG000|Overall Study|Death|0|||
129973364|NCT04954326|467865652|FG001|Overall Study|Death|2|||
129973365|NCT04954326|467865651|FG000|Overall Study|Physician Decision|0|||
129973366|NCT04954326|467865652|FG001|Overall Study|Physician Decision|1|||
129973367|NCT00475228|467865653|FG000|Overall Study|Lost to Follow-up|17|||
129973368|NCT00475228|467865654|FG001|Overall Study|Lost to Follow-up|17|||
129973369|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Adverse Event|2|||
129973370|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Adverse Event|0|||
129973371|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Adverse Event|0|||
129973372|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Adverse Event|0|||
129973373|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
129973374|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
129973375|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
129973376|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
129973377|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
129973378|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
129973379|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
129973380|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
129973381|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Physician Decision|1|||
129973382|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Physician Decision|0|||
129973383|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Physician Decision|0|||
129973384|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Physician Decision|0|||
129973385|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Pregnancy|1|||
129973386|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Pregnancy|0|||
129973387|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Pregnancy|0|||
129973388|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Pregnancy|0|||
129973389|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
129973390|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
129973391|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129973392|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129973393|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
129973394|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
129973395|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
129973396|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
129973397|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
129973398|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
129973399|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
129973400|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
129973401|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
129973402|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
129973403|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
129973404|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
129973405|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Not Treated|1|||
129973406|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Not Treated|0|||
129973407|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Not Treated|0|||
129973408|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Not Treated|0|||
129973409|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
129973410|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
129973411|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
129973412|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
129973413|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
129973414|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
129973415|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
129973416|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
129973417|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
129973418|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
129973419|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
129973420|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
129973421|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
129973422|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
129973423|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
129973424|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
129973425|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
129973426|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
129973427|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
129973428|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
129973429|NCT01730950|467867784|FG000|Overall Study|Protocol Violation|6|||
129973430|NCT01730950|467867785|FG001|Overall Study|Protocol Violation|6|||
129973431|NCT00667459|467867786|FG000|Overall Study|Death|0|||
129973432|NCT00667459|467867787|FG001|Overall Study|Death|2|||
129973433|NCT00667459|467867786|FG000|Overall Study|Lost to Follow-up|8|||
129973434|NCT00667459|467867787|FG001|Overall Study|Lost to Follow-up|43|||
129973435|NCT00474526|467867788|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
129973436|NCT00474526|467867789|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
129973437|NCT00474526|467867790|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
129973438|NCT00474526|467867791|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
129973439|NCT00474526|467867792|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
129973440|NCT00474526|467867793|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
129973441|NCT00474526|467867794|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
129973442|NCT00474526|467867795|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
129973443|NCT00474526|467867796|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
129973444|NCT00474526|467867797|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
129973445|NCT00474526|467867798|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
129973446|NCT00474526|467867799|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
129973447|NCT00474526|467867800|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
129973448|NCT00474526|467867801|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
129973449|NCT00474526|467867802|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
129973450|NCT00474526|467867803|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
129973451|NCT00474526|467867804|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
129973452|NCT00474526|467867788|FG000|Overall Study|Adverse Event|2|||
129973453|NCT00474526|467867789|FG001|Overall Study|Adverse Event|0|||
129973454|NCT00474526|467867790|FG002|Overall Study|Adverse Event|2|||
129973455|NCT00474526|467867791|FG003|Overall Study|Adverse Event|4|||
129973456|NCT00474526|467867792|FG004|Overall Study|Adverse Event|2|||
129973457|NCT00474526|467867793|FG005|Overall Study|Adverse Event|1|||
129973458|NCT00474526|467867794|FG006|Overall Study|Adverse Event|1|||
129973459|NCT00474526|467867795|FG007|Overall Study|Adverse Event|0|||
129973460|NCT00474526|467867796|FG008|Overall Study|Adverse Event|0|||
129973461|NCT00474526|467867797|FG009|Overall Study|Adverse Event|0|||
129973462|NCT00474526|467867798|FG010|Overall Study|Adverse Event|0|||
129973463|NCT00474526|467867799|FG011|Overall Study|Adverse Event|0|||
129973464|NCT00474526|467867800|FG012|Overall Study|Adverse Event|0|||
129973465|NCT00474526|467867801|FG013|Overall Study|Adverse Event|0|||
129973466|NCT00474526|467867802|FG014|Overall Study|Adverse Event|1|||
129973467|NCT00474526|467867803|FG015|Overall Study|Adverse Event|1|||
129973468|NCT00474526|467867804|FG016|Overall Study|Adverse Event|0|||
129973469|NCT00474526|467867788|FG000|Overall Study|Death|0|||
129973470|NCT00474526|467867789|FG001|Overall Study|Death|0|||
129973471|NCT00474526|467867790|FG002|Overall Study|Death|0|||
129973472|NCT00474526|467867791|FG003|Overall Study|Death|0|||
129973473|NCT00474526|467867792|FG004|Overall Study|Death|0|||
129973474|NCT00474526|467867793|FG005|Overall Study|Death|0|||
129973475|NCT00474526|467867794|FG006|Overall Study|Death|0|||
129973476|NCT00474526|467867795|FG007|Overall Study|Death|0|||
129973477|NCT00474526|467867796|FG008|Overall Study|Death|0|||
129973478|NCT00474526|467867797|FG009|Overall Study|Death|0|||
129973479|NCT00474526|467867798|FG010|Overall Study|Death|0|||
129973480|NCT00474526|467867799|FG011|Overall Study|Death|0|||
129973481|NCT00474526|467867800|FG012|Overall Study|Death|0|||
129973482|NCT00474526|467867801|FG013|Overall Study|Death|3|||
129973483|NCT00474526|467867802|FG014|Overall Study|Death|0|||
129973484|NCT00474526|467867803|FG015|Overall Study|Death|0|||
129973485|NCT00474526|467867804|FG016|Overall Study|Death|0|||
129973486|NCT00474526|467867788|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973487|NCT00474526|467867789|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
129973488|NCT00474526|467867790|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973489|NCT00474526|467867791|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
129973490|NCT00474526|467867792|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
129973491|NCT00474526|467867793|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973492|NCT00474526|467867794|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973493|NCT00474526|467867795|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973494|NCT00474526|467867796|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973495|NCT00474526|467867797|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973496|NCT00474526|467867798|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973497|NCT00474526|467867799|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973498|NCT00474526|467867800|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973499|NCT00474526|467867801|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
129973500|NCT00474526|467867802|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
129973501|NCT00474526|467867803|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973502|NCT00474526|467867804|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973503|NCT00474526|467867788|FG000|Overall Study|Lost to Follow-up|8|||
129973504|NCT00474526|467867789|FG001|Overall Study|Lost to Follow-up|6|||
129973505|NCT00474526|467867790|FG002|Overall Study|Lost to Follow-up|13|||
129973506|NCT00474526|467867791|FG003|Overall Study|Lost to Follow-up|29|||
129973507|NCT00474526|467867792|FG004|Overall Study|Lost to Follow-up|11|||
129973508|NCT00474526|467867793|FG005|Overall Study|Lost to Follow-up|5|||
129973509|NCT00474526|467867794|FG006|Overall Study|Lost to Follow-up|8|||
129973510|NCT00474526|467867795|FG007|Overall Study|Lost to Follow-up|1|||
129973511|NCT00474526|467867796|FG008|Overall Study|Lost to Follow-up|0|||
129973512|NCT00474526|467867797|FG009|Overall Study|Lost to Follow-up|6|||
129973513|NCT00474526|467867798|FG010|Overall Study|Lost to Follow-up|2|||
129973514|NCT00474526|467867799|FG011|Overall Study|Lost to Follow-up|4|||
129973515|NCT00474526|467867800|FG012|Overall Study|Lost to Follow-up|6|||
129973516|NCT00474526|467867801|FG013|Overall Study|Lost to Follow-up|74|||
129973517|NCT00474526|467867802|FG014|Overall Study|Lost to Follow-up|29|||
129973518|NCT00474526|467867803|FG015|Overall Study|Lost to Follow-up|4|||
129973519|NCT00474526|467867804|FG016|Overall Study|Lost to Follow-up|5|||
129973520|NCT00474526|467867788|FG000|Overall Study|Protocol Violation|2|||
129973521|NCT00474526|467867789|FG001|Overall Study|Protocol Violation|6|||
129973522|NCT00474526|467867790|FG002|Overall Study|Protocol Violation|4|||
129973523|NCT00474526|467867791|FG003|Overall Study|Protocol Violation|12|||
129973524|NCT00474526|467867792|FG004|Overall Study|Protocol Violation|3|||
129973525|NCT00474526|467867793|FG005|Overall Study|Protocol Violation|1|||
129973526|NCT00474526|467867794|FG006|Overall Study|Protocol Violation|3|||
129973527|NCT00474526|467867795|FG007|Overall Study|Protocol Violation|0|||
129973528|NCT00474526|467867796|FG008|Overall Study|Protocol Violation|0|||
129973529|NCT00474526|467867797|FG009|Overall Study|Protocol Violation|4|||
129973530|NCT00474526|467867798|FG010|Overall Study|Protocol Violation|2|||
129973531|NCT00474526|467867799|FG011|Overall Study|Protocol Violation|2|||
129973532|NCT00474526|467867800|FG012|Overall Study|Protocol Violation|4|||
129973533|NCT00474526|467867801|FG013|Overall Study|Protocol Violation|19|||
129973534|NCT00474526|467867802|FG014|Overall Study|Protocol Violation|9|||
129973535|NCT00474526|467867803|FG015|Overall Study|Protocol Violation|6|||
129973536|NCT00474526|467867804|FG016|Overall Study|Protocol Violation|2|||
129973537|NCT00474526|467867788|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
129973538|NCT00474526|467867789|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
129973539|NCT00474526|467867790|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
129973540|NCT00474526|467867791|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
129973541|NCT00474526|467867792|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
129973542|NCT00474526|467867793|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
129973543|NCT00474526|467867794|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
129973544|NCT00474526|467867795|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
129973545|NCT00474526|467867796|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
129973546|NCT00474526|467867797|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
129973547|NCT00474526|467867798|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
129973548|NCT00474526|467867799|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
129973549|NCT00474526|467867800|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
129973550|NCT00474526|467867801|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
129973551|NCT00474526|467867802|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
129973552|NCT00474526|467867803|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
129973553|NCT00474526|467867804|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
129973554|NCT00474526|467867788|FG000|Overall Study|Withdrawal by Subject|9|||
129973555|NCT00474526|467867789|FG001|Overall Study|Withdrawal by Subject|24|||
129973556|NCT00474526|467867790|FG002|Overall Study|Withdrawal by Subject|21|||
129973557|NCT00474526|467867791|FG003|Overall Study|Withdrawal by Subject|52|||
129973558|NCT00474526|467867792|FG004|Overall Study|Withdrawal by Subject|38|||
129973559|NCT00474526|467867793|FG005|Overall Study|Withdrawal by Subject|6|||
129973560|NCT00474526|467867794|FG006|Overall Study|Withdrawal by Subject|12|||
129973561|NCT00474526|467867795|FG007|Overall Study|Withdrawal by Subject|4|||
129973562|NCT00474526|467867796|FG008|Overall Study|Withdrawal by Subject|4|||
129973563|NCT00474526|467867797|FG009|Overall Study|Withdrawal by Subject|13|||
129973564|NCT00474526|467867798|FG010|Overall Study|Withdrawal by Subject|5|||
129973565|NCT00474526|467867799|FG011|Overall Study|Withdrawal by Subject|4|||
129973566|NCT00474526|467867800|FG012|Overall Study|Withdrawal by Subject|4|||
129973567|NCT00474526|467867801|FG013|Overall Study|Withdrawal by Subject|37|||
129973568|NCT00474526|467867802|FG014|Overall Study|Withdrawal by Subject|22|||
129973569|NCT00474526|467867803|FG015|Overall Study|Withdrawal by Subject|1|||
129973570|NCT00474526|467867804|FG016|Overall Study|Withdrawal by Subject|1|||
129973571|NCT01251770|467867807|FG000|Overall Study|Protocol Violation|13|||
129973572|NCT01251770|467867808|FG001|Overall Study|Protocol Violation|7|||
129973573|NCT02460575|467867812|FG000|Overall Study|Lost to Follow-up|1|||
129973574|NCT02460575|467867813|FG001|Overall Study|Lost to Follow-up|0|||
129973575|NCT04307940|467867814|FG000|Overall Study|Adverse Event|1|||
129973576|NCT04307940|467867815|FG001|Overall Study|Adverse Event|0|||
129973577|NCT04307940|467867816|FG002|Overall Study|Adverse Event|0|||
129973578|NCT04307940|467867814|FG000|Overall Study|Withdrawal by Subject|2|||
129973579|NCT04307940|467867815|FG001|Overall Study|Withdrawal by Subject|3|||
129973580|NCT04307940|467867816|FG002|Overall Study|Withdrawal by Subject|1|||
129973581|NCT04307940|467867814|FG000|Overall Study|Lost to Follow-up|2|||
129973582|NCT04307940|467867815|FG001|Overall Study|Lost to Follow-up|0|||
129973583|NCT04307940|467867816|FG002|Overall Study|Lost to Follow-up|1|||
129973584|NCT05543174|467867817|FG000|Overall Study|Ongoing|7|||
129973585|NCT01270828|467867818|FG000|Pregabalin CR SB|Reason Unspecified|0|||
129973586|NCT01270828|467867819|FG001|Pregabalin CR SB|Reason Unspecified|0|||
129973587|NCT01270828|467867820|FG002|Pregabalin CR SB|Reason Unspecified|8|||
129973588|NCT01270828|467867818|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
129973589|NCT01270828|467867819|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
129973590|NCT01270828|467867820|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
129973591|NCT01270828|467867818|FG000|Pregabalin CR SB|Related adverse event|0|||
129973592|NCT01270828|467867819|FG001|Pregabalin CR SB|Related adverse event|0|||
129973593|NCT01270828|467867820|FG002|Pregabalin CR SB|Related adverse event|46|||
129973594|NCT01270828|467867818|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
129973595|NCT01270828|467867819|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
129973596|NCT01270828|467867820|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
129973597|NCT01270828|467867818|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
129973598|NCT01270828|467867819|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
129973599|NCT01270828|467867820|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
129973600|NCT01270828|467867818|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
129973601|NCT01270828|467867819|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
129973602|NCT01270828|467867820|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
129973603|NCT01270828|467867818|FG000|Pregabalin CR SB|Unrelated AE|0|||
129973604|NCT01270828|467867819|FG001|Pregabalin CR SB|Unrelated AE|0|||
129973605|NCT01270828|467867820|FG002|Pregabalin CR SB|Unrelated AE|8|||
129973606|NCT01270828|467867818|FG000|Pregabalin CR SB|Protocol Violation|0|||
129973607|NCT01270828|467867819|FG001|Pregabalin CR SB|Protocol Violation|0|||
129973608|NCT01270828|467867820|FG002|Pregabalin CR SB|Protocol Violation|8|||
129973609|NCT01270828|467867818|FG000|Double Blind Phase|Death|0|||
129973610|NCT01270828|467867819|FG001|Double Blind Phase|Death|1|||
130136418|NCT01592240|468461703|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
129973611|NCT01270828|467867820|FG002|Double Blind Phase|Death|0|||
129973612|NCT01270828|467867818|FG000|Double Blind Phase|Protocol Violation|0|||
129973613|NCT01270828|467867819|FG001|Double Blind Phase|Protocol Violation|1|||
129973614|NCT01270828|467867820|FG002|Double Blind Phase|Protocol Violation|0|||
129973615|NCT01270828|467867818|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
129973616|NCT01270828|467867819|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
129973617|NCT01270828|467867820|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
129973618|NCT01270828|467867818|FG000|Double Blind Phase|Reason Unspecified|7|||
129973619|NCT01270828|467867819|FG001|Double Blind Phase|Reason Unspecified|4|||
129973620|NCT01270828|467867820|FG002|Double Blind Phase|Reason Unspecified|0|||
129973621|NCT01270828|467867818|FG000|Double Blind Phase|Withdrawal by Subject|6|||
129973622|NCT01270828|467867819|FG001|Double Blind Phase|Withdrawal by Subject|15|||
129973623|NCT01270828|467867820|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129973624|NCT01270828|467867818|FG000|Double Blind Phase|Lost to Follow-up|1|||
129973625|NCT01270828|467867819|FG001|Double Blind Phase|Lost to Follow-up|2|||
129973626|NCT01270828|467867820|FG002|Double Blind Phase|Lost to Follow-up|0|||
129973627|NCT01270828|467867818|FG000|Double Blind Phase|Lack of Efficacy|2|||
129973628|NCT01270828|467867819|FG001|Double Blind Phase|Lack of Efficacy|11|||
129973629|NCT01270828|467867820|FG002|Double Blind Phase|Lack of Efficacy|0|||
129973630|NCT01270828|467867818|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
129973631|NCT01270828|467867819|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
129973632|NCT01270828|467867820|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
129973633|NCT01270828|467867818|FG000|Double Blind Phase|Adverse event related to study drug|5|||
129973634|NCT01270828|467867819|FG001|Double Blind Phase|Adverse event related to study drug|7|||
129973635|NCT01270828|467867820|FG002|Double Blind Phase|Adverse event related to study drug|0|||
129973636|NCT02963090|467867821|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
129973637|NCT02963090|467867822|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
129973638|NCT04497389|467867823|FG000|Overall Study|Withdrawal by Subject|1|||
129973639|NCT04497389|467867824|FG001|Overall Study|Withdrawal by Subject|0|||
129973640|NCT03322540|467867826|FG000|Overall Study|Death|21|||
129973641|NCT03322540|467867827|FG001|Overall Study|Death|28|||
129973642|NCT03322540|467867826|FG000|Overall Study|Lost to Follow-up|0|||
129973643|NCT03322540|467867827|FG001|Overall Study|Lost to Follow-up|1|||
129973644|NCT03322540|467867826|FG000|Overall Study|Physician Decision|7|||
129973645|NCT03322540|467867827|FG001|Overall Study|Physician Decision|6|||
129973646|NCT03322540|467867826|FG000|Overall Study|Withdrawal by Subject|3|||
129973647|NCT03322540|467867827|FG001|Overall Study|Withdrawal by Subject|1|||
130136419|NCT02751424|468461704|FG000|Part 2|Adverse Event|0|||
130136420|NCT02751424|468461705|FG001|Part 2|Adverse Event|0|||
130136421|NCT02751424|468461706|FG002|Part 2|Adverse Event|0|||
130136422|NCT02751424|468461707|FG003|Part 2|Adverse Event|0|||
130136423|NCT02751424|468461708|FG004|Part 2|Adverse Event|0|||
130136424|NCT02751424|468461709|FG005|Part 2|Adverse Event|0|||
130136425|NCT02751424|468461710|FG006|Part 2|Adverse Event|0|||
130136426|NCT02751424|468461711|FG007|Part 2|Adverse Event|5|||
130136427|NCT02751424|468461712|FG008|Part 2|Adverse Event|0|||
130136428|NCT01896934|468461713|FG000|Overall Study|Adverse Event|1|||
130136429|NCT01896934|468461713|FG000|Overall Study|Withdrawal by Subject|1|||
130136430|NCT02197416|468461714|FG000|Overall Study|Other reasons|0|||
130136431|NCT02197416|468461715|FG001|Overall Study|Other reasons|2|||
130136432|NCT02197416|468461716|FG002|Overall Study|Other reasons|5|||
130136433|NCT02197416|468461714|FG000|Overall Study|Withdrawal by Subject|0|||
130136434|NCT02197416|468461715|FG001|Overall Study|Withdrawal by Subject|2|||
130136435|NCT02197416|468461716|FG002|Overall Study|Withdrawal by Subject|1|||
130136436|NCT02197416|468461714|FG000|Overall Study|Protocol Violation|1|||
130136437|NCT02197416|468461715|FG001|Overall Study|Protocol Violation|0|||
130136438|NCT02197416|468461716|FG002|Overall Study|Protocol Violation|1|||
130136439|NCT02197416|468461714|FG000|Overall Study|Adverse Event|0|||
130136440|NCT02197416|468461715|FG001|Overall Study|Adverse Event|0|||
130136441|NCT02197416|468461716|FG002|Overall Study|Adverse Event|1|||
130136442|NCT02451696|468461717|FG000|Overall Study|Surgery postponed|1|||
130136443|NCT02451696|468461718|FG001|Overall Study|Surgery postponed|0|||
130136444|NCT05014828|468461719|FG000|Overall Study|Study Completed by Sponsor|16|||
130136445|NCT05014828|468461720|FG001|Overall Study|Study Completed by Sponsor|16|||
130136446|NCT05014828|468461721|FG002|Overall Study|Study Completed by Sponsor|3|||
130136447|NCT05014828|468461722|FG003|Overall Study|Study Completed by Sponsor|3|||
130136448|NCT05014828|468461719|FG000|Overall Study|Death|11|||
130136449|NCT05014828|468461720|FG001|Overall Study|Death|6|||
130136450|NCT05014828|468461721|FG002|Overall Study|Death|0|||
130136451|NCT05014828|468461722|FG003|Overall Study|Death|0|||
130136452|NCT05014828|468461719|FG000|Overall Study|Lost to Follow-up|0|||
130136453|NCT05014828|468461720|FG001|Overall Study|Lost to Follow-up|0|||
130136454|NCT05014828|468461721|FG002|Overall Study|Lost to Follow-up|2|||
130136455|NCT05014828|468461722|FG003|Overall Study|Lost to Follow-up|0|||
130136456|NCT05014828|468461719|FG000|Overall Study|Miscellaneous.|0|||
130136457|NCT05014828|468461720|FG001|Overall Study|Miscellaneous.|1|||
130136458|NCT05014828|468461721|FG002|Overall Study|Miscellaneous.|0|||
130136459|NCT05014828|468461722|FG003|Overall Study|Miscellaneous.|0|||
130136460|NCT05523895|468461723|FG000|Overall Study|Adverse Event|2|||
130136461|NCT05523895|468461724|FG001|Overall Study|Adverse Event|1|||
130136462|NCT05523895|468461725|FG002|Overall Study|Adverse Event|1|||
130136463|NCT05523895|468461723|FG000|Overall Study|Lost to Follow-up|0|||
130136464|NCT05523895|468461724|FG001|Overall Study|Lost to Follow-up|1|||
129973648|NCT03322540|467867826|FG000|Overall Study|Study terminated by sponsor|0|||
130136465|NCT05523895|468461725|FG002|Overall Study|Lost to Follow-up|2|||
130136466|NCT05523895|468461723|FG000|Overall Study|Noncompliance with study drug|1|||
130136467|NCT05523895|468461724|FG001|Overall Study|Noncompliance with study drug|1|||
130136468|NCT05523895|468461725|FG002|Overall Study|Noncompliance with study drug|1|||
130136469|NCT05523895|468461723|FG000|Overall Study|Protocol Violation|0|||
130136470|NCT05523895|468461724|FG001|Overall Study|Protocol Violation|2|||
130136471|NCT05523895|468461725|FG002|Overall Study|Protocol Violation|0|||
130136472|NCT05523895|468461723|FG000|Overall Study|Withdrawal by Subject|1|||
130136473|NCT05523895|468461724|FG001|Overall Study|Withdrawal by Subject|3|||
130136474|NCT05523895|468461725|FG002|Overall Study|Withdrawal by Subject|1|||
130136475|NCT05523895|468461723|FG000|Overall Study|Not further specified|0|||
130136476|NCT05523895|468461724|FG001|Overall Study|Not further specified|3|||
130136477|NCT05523895|468461725|FG002|Overall Study|Not further specified|1|||
130136478|NCT03674892|468461726|FG000|Overall Study|Lack of Efficacy|5|||
130136479|NCT03674892|468461726|FG000|Overall Study|Lost to Follow-up|3|||
130136480|NCT03674892|468461726|FG000|Overall Study|Migraine|2|||
130136481|NCT03674892|468461726|FG000|Overall Study|Excessive Tearing|1|||
130136482|NCT03674892|468461726|FG000|Overall Study|Increased Eye Pain|1|||
130136483|NCT03674892|468461726|FG000|Overall Study|Increased Facial Pain|1|||
130136484|NCT03674892|468461726|FG000|Overall Study|Sinus Irritation|1|||
130136485|NCT03674892|468461726|FG000|Overall Study|Sinus Infection|1|||
130136486|NCT01959672|468461731|FG000|Overall Study|Death|1|||
130136487|NCT05041361|468461734|FG000|Overall Study|Lost to Follow-up|1|||
130136488|NCT05041361|468461735|FG001|Overall Study|Lost to Follow-up|3|||
130136489|NCT01642277|468461736|FG000|Overall Study|Adverse Event|10|||
130136490|NCT01642277|468461737|FG001|Overall Study|Adverse Event|0|||
130136491|NCT01642277|468461736|FG000|Overall Study|Physician Decision|2|||
130136492|NCT01642277|468461737|FG001|Overall Study|Physician Decision|0|||
130136493|NCT01642277|468461736|FG000|Overall Study|Protocol Violation|1|||
130136494|NCT01642277|468461737|FG001|Overall Study|Protocol Violation|0|||
130136495|NCT01642277|468461736|FG000|Overall Study|Withdrawal by Subject|11|||
130136496|NCT01642277|468461737|FG001|Overall Study|Withdrawal by Subject|0|||
130136497|NCT03605342|468461738|FG000|Overall Study|Withdrawal by Subject|9|||
130136498|NCT03605342|468461739|FG001|Overall Study|Withdrawal by Subject|7|||
130136499|NCT03605342|468461738|FG000|Overall Study|Lost to Follow-up|1|||
130136500|NCT03605342|468461739|FG001|Overall Study|Lost to Follow-up|1|||
130136501|NCT00796328|468461742|FG000|Overall Study|experienced hypotension requiring tx|6|||
130136502|NCT02842853|468461743|FG000|Overall Study|Non-compliance with the protocol|3|||
130136503|NCT02842853|468461744|FG001|Overall Study|Non-compliance with the protocol|7|||
130136504|NCT02842853|468461745|FG002|Overall Study|Non-compliance with the protocol|2|||
130136505|NCT02842853|468461746|FG003|Overall Study|Non-compliance with the protocol|5|||
130136506|NCT02842853|468461743|FG000|Overall Study|Subject met exclusion criteria|0|||
130136507|NCT02842853|468461744|FG001|Overall Study|Subject met exclusion criteria|1|||
130136508|NCT02842853|468461745|FG002|Overall Study|Subject met exclusion criteria|0|||
130136509|NCT02842853|468461746|FG003|Overall Study|Subject met exclusion criteria|0|||
130136510|NCT02842853|468461743|FG000|Overall Study|Withdrawal by Subject|11|||
130136511|NCT02842853|468461744|FG001|Overall Study|Withdrawal by Subject|13|||
130136512|NCT02842853|468461745|FG002|Overall Study|Withdrawal by Subject|9|||
130136513|NCT02842853|468461746|FG003|Overall Study|Withdrawal by Subject|8|||
130136514|NCT02842853|468461743|FG000|Overall Study|Lost to Follow-up|9|||
130136515|NCT02842853|468461744|FG001|Overall Study|Lost to Follow-up|13|||
130136516|NCT02842853|468461745|FG002|Overall Study|Lost to Follow-up|10|||
130136517|NCT02842853|468461746|FG003|Overall Study|Lost to Follow-up|11|||
130136518|NCT04089553|468461747|FG000|Overall Study|Death|1|||
130136519|NCT04089553|468461748|FG001|Overall Study|Death|1|||
130136520|NCT04089553|468461747|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
130136521|NCT04089553|468461748|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
130136522|NCT04089553|468461747|FG000|Overall Study|Withdrawal by Subject|3|||
130136523|NCT04089553|468461748|FG001|Overall Study|Withdrawal by Subject|3|||
130136524|NCT04089553|468461747|FG000|Overall Study|Physician Decision|1|||
130136525|NCT04089553|468461748|FG001|Overall Study|Physician Decision|0|||
130136526|NCT04089553|468461747|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
130136527|NCT04089553|468461748|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
130136528|NCT04089553|468461747|FG000|Overall Study|Other|1|||
130136529|NCT04089553|468461748|FG001|Overall Study|Other|0|||
130136530|NCT04089553|468461747|FG000|Overall Study|Adverse Event|1|||
130136531|NCT04089553|468461748|FG001|Overall Study|Adverse Event|1|||
130136532|NCT01403194|468461756|FG000|Overall Study|Screen Failure|2|||
130136533|NCT01403194|468461756|FG000|Overall Study|Lost to Follow-up|8|||
130136534|NCT00107991|468461761|FG000|Eligibility Assessment|Disease not severe enough|7|||
130136535|NCT00107991|468461761|FG000|Eligibility Assessment|Unwilling to participate|7|||
130136536|NCT00107991|468461761|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
130136537|NCT00107991|468461761|FG000|Eligibility Assessment|Abnormal labs|2|||
130136538|NCT00107991|468461761|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
130136539|NCT00107991|468461761|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
130136540|NCT00107991|468461761|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
130136541|NCT00107991|468461761|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
130136542|NCT00107991|468461761|FG000|12 Week Treatment Period|Adverse Event|1|||
130136543|NCT00107991|468461761|FG000|12 Week Treatment Period|Protocol Violation|1|||
130136544|NCT00107991|468461761|FG000|12 Week Treatment Period|Incarcerated|1|||
130136545|NCT00107991|468461761|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
130136546|NCT00506831|468461768|FG000|Overall Study|Death|1|||
130136547|NCT00506831|468461768|FG000|Overall Study|Withdrawal by Subject|1|||
130136548|NCT02488239|468461772|FG000|Overall Study|Death|3|||
130136549|NCT02488239|468461772|FG000|Overall Study|Withdrawal by Subject|3|||
130136550|NCT02488239|468461772|FG000|Overall Study|Physician Decision|2|||
130136551|NCT02488239|468461772|FG000|Overall Study|Consent ineligible|1|||
130136552|NCT02488239|468461772|FG000|Overall Study|Did not undergo implant procedure|1|||
130136553|NCT00608322|468461775|FG000|Overall Study|Death|2|||
130136554|NCT00608322|468461776|FG001|Overall Study|Death|1|||
130136555|NCT00834444|468461777|FG000|First Intervention|Adverse Event|1|||
130136556|NCT00834444|468461778|FG001|First Intervention|Adverse Event|0|||
130136557|NCT00834444|468461777|FG000|First Intervention|Intolerance to Venopuncture|0|||
130136558|NCT00834444|468461778|FG001|First Intervention|Intolerance to Venopuncture|1|||
130136559|NCT00834444|468461777|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
130136560|NCT00834444|468461778|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
130136561|NCT00834444|468461777|FG000|Second Intervention|Adverse Event|1|||
130136562|NCT00834444|468461778|FG001|Second Intervention|Adverse Event|0|||
130136563|NCT02213263|468461782|FG000|Overall Study|Insufficient clinical response|4|||
130136564|NCT02213263|468461783|FG001|Overall Study|Insufficient clinical response|3|||
130136565|NCT02213263|468461782|FG000|Overall Study|Lost to Follow-up|0|||
130136566|NCT02213263|468461783|FG001|Overall Study|Lost to Follow-up|1|||
130136567|NCT02213263|468461782|FG000|Overall Study|No longer willing to participate|3|||
130136568|NCT02213263|468461783|FG001|Overall Study|No longer willing to participate|4|||
130136569|NCT02213263|468461782|FG000|Overall Study|Progressive disease|20|||
130136570|NCT02213263|468461783|FG001|Overall Study|Progressive disease|14|||
130136571|NCT02213263|468461782|FG000|Overall Study|Protocol Violation|0|||
130136572|NCT02213263|468461783|FG001|Overall Study|Protocol Violation|1|||
130136573|NCT02213263|468461782|FG000|Overall Study|Adverse Event|1|||
130136574|NCT02213263|468461783|FG001|Overall Study|Adverse Event|3|||
130136575|NCT05752721|468461784|FG000|Overall Study|Lost to Follow-up|22|||
130136576|NCT05752721|468461785|FG001|Overall Study|Lost to Follow-up|20|||
130136577|NCT05752721|468461784|FG000|Overall Study|Withdrawal by Subject|15|||
130136578|NCT05752721|468461785|FG001|Overall Study|Withdrawal by Subject|12|||
130136579|NCT01188681|468461786|FG000|Overall Study|bladder cancer|0|||
130136580|NCT01188681|468461787|FG001|Overall Study|bladder cancer|0|||
130136581|NCT01188681|468461788|FG002|Overall Study|bladder cancer|1|||
130136582|NCT01188681|468461789|FG003|Overall Study|bladder cancer|0|||
130136583|NCT01188681|468461786|FG000|Overall Study|Withdrawal by Subject|0|||
130136584|NCT01188681|468461787|FG001|Overall Study|Withdrawal by Subject|0|||
130136585|NCT01188681|468461788|FG002|Overall Study|Withdrawal by Subject|0|||
130136586|NCT01188681|468461789|FG003|Overall Study|Withdrawal by Subject|1|||
130136587|NCT02280863|468461790|FG000|Integrated Platform|Met stopping criteria|0|||
130136588|NCT02280863|468461791|FG001|Integrated Platform|Met stopping criteria|1|||
130136589|NCT02622386|468461794|FG000|First Assignment|Withdrawal by Subject|3|||
130136590|NCT02622386|468461795|FG001|First Assignment|Withdrawal by Subject|2|||
130136591|NCT02622386|468461794|FG000|Washout|Withdrawal by Subject|4|||
130136592|NCT02622386|468461795|FG001|Washout|Withdrawal by Subject|4|||
130136593|NCT02622386|468461794|FG000|Second Assignment|Withdrawal by Subject|0|||
130136594|NCT02622386|468461795|FG001|Second Assignment|Withdrawal by Subject|2|||
130136595|NCT02890992|468461796|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136596|NCT02890992|468461797|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
130136597|NCT02890992|468461798|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136598|NCT02890992|468461799|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136599|NCT02890992|468461800|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136600|NCT02890992|468461801|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136601|NCT02890992|468461802|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136602|NCT02890992|468461803|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
130136603|NCT02890992|468461796|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130136604|NCT02890992|468461797|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130136605|NCT02890992|468461798|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130136606|NCT02890992|468461799|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130136607|NCT02890992|468461800|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130136608|NCT02890992|468461801|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
130136609|NCT02890992|468461802|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
130136610|NCT02890992|468461803|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
130136611|NCT02890992|468461796|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136612|NCT02890992|468461797|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
130136613|NCT02890992|468461798|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136614|NCT02890992|468461799|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136615|NCT02890992|468461800|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136616|NCT02890992|468461801|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136617|NCT02890992|468461802|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136618|NCT02890992|468461803|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
130136619|NCT03236311|468461804|FG000|Overall Study|Study terminated by sponsor|0|||
130136620|NCT03236311|468461805|FG001|Overall Study|Study terminated by sponsor|2|||
130136621|NCT03236311|468461804|FG000|Overall Study|Adverse Event|0|||
130136622|NCT03236311|468461805|FG001|Overall Study|Adverse Event|1|||
130136623|NCT02336074|468461806|FG000|Overall Study|Adverse Event|0|||
130136624|NCT02336074|468461807|FG001|Overall Study|Adverse Event|2|||
130136625|NCT00858780|468461811|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
130136626|NCT00858780|468461812|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130136627|NCT00858780|468461813|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130136628|NCT00858780|468461814|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130136629|NCT00858780|468461815|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
130136630|NCT00858780|468461811|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130136631|NCT00858780|468461812|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130136632|NCT00858780|468461813|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
130136633|NCT00858780|468461814|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130136634|NCT00858780|468461815|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
130136635|NCT00858780|468461811|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
130136636|NCT00858780|468461812|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130136637|NCT00858780|468461813|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130136638|NCT00858780|468461814|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
130136639|NCT00858780|468461815|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
130136640|NCT00858780|468461811|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130136641|NCT00858780|468461812|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
130136642|NCT00858780|468461813|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130136643|NCT00858780|468461814|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130136644|NCT00858780|468461815|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
130136645|NCT00858780|468461811|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130136646|NCT00858780|468461812|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130136647|NCT00858780|468461813|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130136648|NCT00858780|468461814|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
130136649|NCT00858780|468461815|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
130136650|NCT00858780|468461811|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
130136651|NCT00858780|468461812|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
130136652|NCT00858780|468461813|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
130136653|NCT00858780|468461814|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
130136654|NCT00858780|468461815|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
130136655|NCT00863330|468461816|FG000|Overall Study|study terminated early due to administra|6|||
130136656|NCT03602339|468461817|FG000|Overall Study|Withdrawal by Subject|9|||
130136657|NCT03602339|468461817|FG000|Overall Study|Physician Decision|2|||
130136658|NCT03602339|468461817|FG000|Overall Study|Other reason|4|||
130136659|NCT03719040|468461824|FG000|Overall Study|Withdrawal by Subject|177|||
130136660|NCT03719040|468461824|FG000|Overall Study|Lost to Follow-up|26|||
130136661|NCT02923349|468461825|FG000|Overall Study|Other|1|||
130136662|NCT02923349|468461826|FG001|Overall Study|Other|2|||
130136663|NCT02923349|468461827|FG002|Overall Study|Other|4|||
130136664|NCT02923349|468461828|FG003|Overall Study|Other|1|||
130136665|NCT02923349|468461829|FG004|Overall Study|Other|3|||
130136666|NCT02923349|468461830|FG005|Overall Study|Other|0|||
130136667|NCT02923349|468461831|FG006|Overall Study|Other|1|||
130136668|NCT02923349|468461825|FG000|Overall Study|Withdrawal by Subject|2|||
130136669|NCT02923349|468461826|FG001|Overall Study|Withdrawal by Subject|2|||
130136670|NCT02923349|468461827|FG002|Overall Study|Withdrawal by Subject|8|||
130136671|NCT02923349|468461828|FG003|Overall Study|Withdrawal by Subject|10|||
130136672|NCT02923349|468461829|FG004|Overall Study|Withdrawal by Subject|12|||
130136673|NCT02923349|468461830|FG005|Overall Study|Withdrawal by Subject|3|||
130136674|NCT02923349|468461831|FG006|Overall Study|Withdrawal by Subject|0|||
130136675|NCT02923349|468461825|FG000|Overall Study|Physician Decision|0|||
130136676|NCT02923349|468461826|FG001|Overall Study|Physician Decision|0|||
130136677|NCT02923349|468461827|FG002|Overall Study|Physician Decision|0|||
130136678|NCT02923349|468461828|FG003|Overall Study|Physician Decision|1|||
130136679|NCT02923349|468461829|FG004|Overall Study|Physician Decision|1|||
130136680|NCT02923349|468461830|FG005|Overall Study|Physician Decision|0|||
129973649|NCT03322540|467867827|FG001|Overall Study|Study terminated by sponsor|1|||
130136681|NCT02923349|468461831|FG006|Overall Study|Physician Decision|2|||
130136682|NCT02923349|468461825|FG000|Overall Study|Lost to Follow-up|0|||
130136683|NCT02923349|468461826|FG001|Overall Study|Lost to Follow-up|0|||
130136684|NCT02923349|468461827|FG002|Overall Study|Lost to Follow-up|3|||
130136685|NCT02923349|468461828|FG003|Overall Study|Lost to Follow-up|0|||
130136686|NCT02923349|468461829|FG004|Overall Study|Lost to Follow-up|1|||
130136687|NCT02923349|468461830|FG005|Overall Study|Lost to Follow-up|1|||
130136688|NCT02923349|468461831|FG006|Overall Study|Lost to Follow-up|0|||
130136689|NCT02923349|468461825|FG000|Overall Study|Death|1|||
130136690|NCT02923349|468461826|FG001|Overall Study|Death|0|||
130136691|NCT02923349|468461827|FG002|Overall Study|Death|2|||
130136692|NCT02923349|468461828|FG003|Overall Study|Death|4|||
130136693|NCT02923349|468461829|FG004|Overall Study|Death|2|||
130136694|NCT02923349|468461830|FG005|Overall Study|Death|3|||
130136695|NCT02923349|468461831|FG006|Overall Study|Death|0|||
130136696|NCT02751827|468461832|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
130136697|NCT02751827|468461833|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
130136698|NCT02751827|468461834|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
130136699|NCT02875392|468463485|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
130136700|NCT02875392|468463486|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
130136701|NCT03599193|468463487|FG000|Overall Study|Adverse Event|0|||
130136702|NCT03599193|468463488|FG001|Overall Study|Adverse Event|2|||
130136703|NCT03599193|468463487|FG000|Overall Study|Withdrawal by Subject|1|||
130136704|NCT03599193|468463488|FG001|Overall Study|Withdrawal by Subject|0|||
130136705|NCT03599193|468463487|FG000|Overall Study|Protocol Violation|1|||
130136706|NCT03599193|468463488|FG001|Overall Study|Protocol Violation|0|||
130136707|NCT03599193|468463487|FG000|Overall Study|Lost to Follow-up|0|||
130136708|NCT03599193|468463488|FG001|Overall Study|Lost to Follow-up|1|||
130136709|NCT00835705|468463489|FG000|First Intervention|Difficulty with vein|1|||
130136710|NCT00835705|468463490|FG001|First Intervention|Difficulty with vein|0|||
130136711|NCT00835705|468463489|FG000|Second Intervention|Difficulty with vein|1|||
130136712|NCT00835705|468463490|FG001|Second Intervention|Difficulty with vein|0|||
130136713|NCT01750294|468463491|FG000|Overall Study|Withdrawal by Subject|1|||
130136714|NCT01750294|468463491|FG000|Overall Study|Safety Endpoint|1|||
130136715|NCT04372238|468463494|FG000|Overall Study|Duplicate|3|||
130136716|NCT04372238|468463495|FG001|Overall Study|Duplicate|3|||
130136717|NCT04372238|468463494|FG000|Overall Study|Did not consent for data linkage|6|||
130136718|NCT04372238|468463495|FG001|Overall Study|Did not consent for data linkage|10|||
130136719|NCT03206749|468463505|FG000|Overall Study|Withdrawal of consent|5|||
130136720|NCT03206749|468463506|FG001|Overall Study|Withdrawal of consent|3|||
130136721|NCT03206749|468463507|FG002|Overall Study|Withdrawal of consent|6|||
130136722|NCT03206749|468463505|FG000|Overall Study|Lost to Follow-up|0|||
130136723|NCT03206749|468463506|FG001|Overall Study|Lost to Follow-up|0|||
130136724|NCT03206749|468463507|FG002|Overall Study|Lost to Follow-up|1|||
130136725|NCT03779334|468463511|FG000|Overall Study|Withdrawal by Subject|3|||
130136726|NCT03779334|468463512|FG001|Overall Study|Withdrawal by Subject|0|||
130136727|NCT03779334|468463513|FG002|Overall Study|Withdrawal by Subject|0|||
130136728|NCT03779334|468463511|FG000|Overall Study|Ongoing in Study|5|||
130136729|NCT03779334|468463512|FG001|Overall Study|Ongoing in Study|13|||
130136730|NCT03779334|468463513|FG002|Overall Study|Ongoing in Study|5|||
130136731|NCT01175135|468463514|FG000|Overall Study|Adverse Event|2|||
130136732|NCT01175135|468463515|FG001|Overall Study|Adverse Event|5|||
130136733|NCT01175135|468463516|FG002|Overall Study|Adverse Event|3|||
130136734|NCT01175135|468463517|FG003|Overall Study|Adverse Event|4|||
130136735|NCT01175135|468463514|FG000|Overall Study|Death|1|||
130136736|NCT01175135|468463515|FG001|Overall Study|Death|0|||
130136737|NCT01175135|468463516|FG002|Overall Study|Death|0|||
130136738|NCT01175135|468463517|FG003|Overall Study|Death|0|||
130136739|NCT01175135|468463514|FG000|Overall Study|Lack of Efficacy|4|||
130136740|NCT01175135|468463515|FG001|Overall Study|Lack of Efficacy|5|||
130136741|NCT01175135|468463516|FG002|Overall Study|Lack of Efficacy|0|||
130136742|NCT01175135|468463517|FG003|Overall Study|Lack of Efficacy|5|||
130136743|NCT01175135|468463514|FG000|Overall Study|Lost to Follow-up|1|||
130136744|NCT01175135|468463515|FG001|Overall Study|Lost to Follow-up|2|||
130136745|NCT01175135|468463516|FG002|Overall Study|Lost to Follow-up|0|||
130136746|NCT01175135|468463517|FG003|Overall Study|Lost to Follow-up|0|||
130136747|NCT01175135|468463514|FG000|Overall Study|Protocol Violation|1|||
130136748|NCT01175135|468463515|FG001|Overall Study|Protocol Violation|1|||
130136749|NCT01175135|468463516|FG002|Overall Study|Protocol Violation|0|||
130136750|NCT01175135|468463517|FG003|Overall Study|Protocol Violation|0|||
130136751|NCT01175135|468463514|FG000|Overall Study|Withdrawal by Subject|4|||
130136752|NCT01175135|468463515|FG001|Overall Study|Withdrawal by Subject|8|||
130136753|NCT01175135|468463516|FG002|Overall Study|Withdrawal by Subject|5|||
130136754|NCT01175135|468463517|FG003|Overall Study|Withdrawal by Subject|5|||
130136755|NCT01175135|468463514|FG000|Overall Study|Other|3|||
130136756|NCT01175135|468463515|FG001|Overall Study|Other|1|||
130136757|NCT01175135|468463516|FG002|Overall Study|Other|3|||
129973650|NCT03054337|467867833|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
129973651|NCT03054337|467867834|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
130136758|NCT01175135|468463517|FG003|Overall Study|Other|0|||
130136759|NCT01175135|468463514|FG000|Overall Study|Randomized But Not Treated|0|||
130136760|NCT01175135|468463515|FG001|Overall Study|Randomized But Not Treated|0|||
130136761|NCT01175135|468463516|FG002|Overall Study|Randomized But Not Treated|1|||
130136762|NCT01175135|468463517|FG003|Overall Study|Randomized But Not Treated|0|||
130136763|NCT04692155|468463521|FG000|Overall Study|Death|1|||
130136764|NCT03325881|468463525|FG000|Overall Study|Protocol Violation|0|||
130136765|NCT03325881|468463526|FG001|Overall Study|Protocol Violation|1|||
130136766|NCT03325881|468463525|FG000|Overall Study|Withdrawal by Subject|0|||
129973652|NCT03054337|467867835|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
129973653|NCT03054337|467867836|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
129973654|NCT03054337|467867837|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
130136767|NCT03325881|468463526|FG001|Overall Study|Withdrawal by Subject|2|||
130136768|NCT03325881|468463525|FG000|Overall Study|Lack of Efficacy|2|||
130136769|NCT03325881|468463526|FG001|Overall Study|Lack of Efficacy|0|||
130136770|NCT03325881|468463525|FG000|Overall Study|Not treated|1|||
130136771|NCT03325881|468463526|FG001|Overall Study|Not treated|0|||
130136772|NCT03676634|468463529|FG000|Overall Study|Red blood cell loss|1|||
130136773|NCT03676634|468463529|FG000|Overall Study|Out-of-limit pulse|2|||
130136774|NCT03131895|468463535|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
130136775|NCT03131895|468463536|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
130136776|NCT03131895|468463537|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
130136777|NCT03131895|468463538|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
130136778|NCT03131895|468463535|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
130136779|NCT03131895|468463536|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
130136780|NCT03131895|468463537|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
130136781|NCT03131895|468463538|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
130136782|NCT03131895|468463535|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130136783|NCT03131895|468463536|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
130136784|NCT03131895|468463537|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130136785|NCT03131895|468463538|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130136786|NCT03131895|468463535|FG000|Washout Period (at Least 5 Days)|Other|0|||
130136787|NCT03131895|468463536|FG001|Washout Period (at Least 5 Days)|Other|0|||
130136788|NCT03131895|468463537|FG002|Washout Period (at Least 5 Days)|Other|2|||
130136789|NCT03131895|468463538|FG003|Washout Period (at Least 5 Days)|Other|0|||
130136790|NCT03131895|468463535|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130136791|NCT03131895|468463536|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
130136792|NCT03131895|468463537|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130136793|NCT03131895|468463538|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
130136794|NCT03131895|468463535|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
130136795|NCT03131895|468463536|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130136796|NCT03131895|468463537|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130136797|NCT03131895|468463538|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
130136798|NCT00540423|468463539|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130136799|NCT00540423|468463540|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130136800|NCT00540423|468463541|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130136801|NCT00540423|468463539|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
130136802|NCT00540423|468463540|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
130136803|NCT00540423|468463541|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
130136804|NCT00216736|468463548|FG000|Overall Study|Lost to Follow-up|1|||
130136805|NCT00216736|468463549|FG001|Overall Study|Lost to Follow-up|1|||
130136806|NCT00807495|468463553|FG000|Overall Study|Adverse Event|6|||
130136807|NCT00807495|468463554|FG001|Overall Study|Adverse Event|3|||
130136808|NCT00807495|468463555|FG002|Overall Study|Adverse Event|1|||
130136809|NCT00807495|468463556|FG003|Overall Study|Adverse Event|1|||
130136810|NCT00807495|468463557|FG004|Overall Study|Adverse Event|2|||
130136811|NCT00807495|468463553|FG000|Overall Study|Withdrawal by Patient|2|||
130136812|NCT00807495|468463554|FG001|Overall Study|Withdrawal by Patient|0|||
130136813|NCT00807495|468463555|FG002|Overall Study|Withdrawal by Patient|1|||
130136814|NCT00807495|468463556|FG003|Overall Study|Withdrawal by Patient|0|||
130136815|NCT00807495|468463557|FG004|Overall Study|Withdrawal by Patient|0|||
130136816|NCT00807495|468463553|FG000|Overall Study|Reason Not Specified|0|||
130136817|NCT00807495|468463554|FG001|Overall Study|Reason Not Specified|3|||
130136818|NCT00807495|468463555|FG002|Overall Study|Reason Not Specified|2|||
129973655|NCT03054337|467867838|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
129973656|NCT03004404|467867844|FG000|Period 2|Adverse Event|0|||
129973657|NCT03004404|467867845|FG001|Period 2|Adverse Event|0|||
130136819|NCT00807495|468463556|FG003|Overall Study|Reason Not Specified|0|||
129973658|NCT03004404|467867846|FG002|Period 2|Adverse Event|0|||
129973659|NCT03004404|467867847|FG003|Period 2|Adverse Event|0|||
129973660|NCT03004404|467867848|FG004|Period 2|Adverse Event|0|||
129973661|NCT03004404|467867849|FG005|Period 2|Adverse Event|0|||
129973662|NCT03004404|467867850|FG006|Period 2|Adverse Event|0|||
129973663|NCT03004404|467867851|FG007|Period 2|Adverse Event|0|||
129973664|NCT03004404|467867852|FG008|Period 2|Adverse Event|1|||
129973665|NCT03004404|467867853|FG009|Period 2|Adverse Event|0|||
129973666|NCT03004404|467867854|FG010|Period 2|Adverse Event|0|||
129973667|NCT03004404|467867855|FG011|Period 2|Adverse Event|0|||
130136820|NCT00807495|468463557|FG004|Overall Study|Reason Not Specified|3|||
130136821|NCT01174186|468463558|FG000|Overall Study|Lost to Follow-up|0|||
130136822|NCT01174186|468463559|FG001|Overall Study|Lost to Follow-up|1|||
129973668|NCT03004404|467867856|FG012|Period 2|Adverse Event|0|||
130136823|NCT01174186|468463558|FG000|Overall Study|Withdrawal by Subject|0|||
130136824|NCT01174186|468463559|FG001|Overall Study|Withdrawal by Subject|2|||
130136825|NCT05274763|468463560|FG000|Overall Study|Lost to Follow-up|1|||
130136826|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
130136827|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
130136828|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
130136829|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
130136830|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
130136831|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
130136832|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Death|9|||
130136833|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Death|7|||
130136834|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Death|14|||
130136835|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Death|7|||
130136836|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Death|0|||
130136837|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Death|0|||
130136838|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
130136839|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
130136840|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
130136841|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
130136842|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
130136843|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
130136844|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Other Event|49|||
130136845|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Other Event|52|||
130136846|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Other Event|41|||
130136847|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Other Event|58|||
130136848|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Other Event|0|||
130136849|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Other Event|0|||
130136850|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
130136851|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
130136852|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
130136853|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
130136854|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
130136855|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
130136856|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
130136857|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
130136858|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
130136859|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
129973669|NCT03004404|467867857|FG013|Period 2|Adverse Event|0|||
130136860|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
130136861|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
130136862|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
130136863|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
130136864|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
130136865|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
130136866|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
130136867|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
130136868|NCT00205777|468463566|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
130136869|NCT00205777|468463567|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
130136870|NCT00205777|468463568|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
130136871|NCT00205777|468463569|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
130136872|NCT00205777|468463570|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
130136873|NCT00205777|468463571|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
130136874|NCT00205777|468463566|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
130136875|NCT00205777|468463567|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
130136876|NCT00205777|468463568|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
129973670|NCT03004404|467867858|FG014|Period 2|Adverse Event|0|||
129973671|NCT03004404|467867859|FG015|Period 2|Adverse Event|1|||
129973672|NCT03933462|467867860|FG000|Overall Study|Adverse Event|2|||
129973673|NCT03933462|467867861|FG001|Overall Study|Adverse Event|0|||
129973674|NCT01099917|467867866|FG000|Overall Study|Adverse Event|3|||
129973675|NCT01099917|467867866|FG000|Overall Study|Not Treated|24|||
129973676|NCT00706654|467867873|FG000|Conversion Phase|Lost to Follow-up|4|||
129973677|NCT00706654|467867874|FG001|Conversion Phase|Lost to Follow-up|0|||
129973678|NCT00706654|467867875|FG002|Conversion Phase|Lost to Follow-up|0|||
130136877|NCT00205777|468463569|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
130136878|NCT00205777|468463570|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
130136879|NCT00205777|468463571|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
130136880|NCT00205777|468463566|FG000|Completed Core Study, Entered SE I|Other Event|52|||
130136881|NCT00205777|468463567|FG001|Completed Core Study, Entered SE I|Other Event|46|||
129973679|NCT00706654|467867876|FG003|Conversion Phase|Lost to Follow-up|0|||
129973680|NCT00706654|467867873|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
129973681|NCT00706654|467867874|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
130136882|NCT00205777|468463568|FG002|Completed Core Study, Entered SE I|Other Event|47|||
130136883|NCT00205777|468463569|FG003|Completed Core Study, Entered SE I|Other Event|50|||
130136884|NCT00205777|468463570|FG004|Completed Core Study, Entered SE I|Other Event|0|||
130136885|NCT00205777|468463571|FG005|Completed Core Study, Entered SE I|Other Event|0|||
130136886|NCT00205777|468463566|FG000|Study Extension I|Adverse Event|57|||
130136887|NCT00205777|468463567|FG001|Study Extension I|Adverse Event|0|||
130136888|NCT00205777|468463568|FG002|Study Extension I|Adverse Event|0|||
130136889|NCT00205777|468463569|FG003|Study Extension I|Adverse Event|61|||
130136890|NCT00205777|468463570|FG004|Study Extension I|Adverse Event|58|||
130136891|NCT00205777|468463571|FG005|Study Extension I|Adverse Event|0|||
130136892|NCT00205777|468463566|FG000|Study Extension I|Death|5|||
130136893|NCT00205777|468463567|FG001|Study Extension I|Death|0|||
130136894|NCT00205777|468463568|FG002|Study Extension I|Death|0|||
130136895|NCT00205777|468463569|FG003|Study Extension I|Death|1|||
130136896|NCT00205777|468463570|FG004|Study Extension I|Death|2|||
130136897|NCT00205777|468463571|FG005|Study Extension I|Death|0|||
130136898|NCT00205777|468463566|FG000|Study Extension I|Withdrawal by Subject|99|||
130136899|NCT00205777|468463567|FG001|Study Extension I|Withdrawal by Subject|0|||
130136900|NCT00205777|468463568|FG002|Study Extension I|Withdrawal by Subject|0|||
130136901|NCT00205777|468463569|FG003|Study Extension I|Withdrawal by Subject|106|||
130136902|NCT00205777|468463570|FG004|Study Extension I|Withdrawal by Subject|89|||
130136903|NCT00205777|468463571|FG005|Study Extension I|Withdrawal by Subject|0|||
130136904|NCT00205777|468463566|FG000|Study Extension I|Protocol Violation|4|||
130136905|NCT00205777|468463567|FG001|Study Extension I|Protocol Violation|0|||
130136906|NCT00205777|468463568|FG002|Study Extension I|Protocol Violation|0|||
130136907|NCT00205777|468463569|FG003|Study Extension I|Protocol Violation|8|||
130136908|NCT00205777|468463570|FG004|Study Extension I|Protocol Violation|8|||
130136909|NCT00205777|468463571|FG005|Study Extension I|Protocol Violation|0|||
130136910|NCT00205777|468463566|FG000|Study Extension I|Lack of Efficacy|0|||
130136911|NCT00205777|468463567|FG001|Study Extension I|Lack of Efficacy|0|||
130136912|NCT00205777|468463568|FG002|Study Extension I|Lack of Efficacy|0|||
130136913|NCT00205777|468463569|FG003|Study Extension I|Lack of Efficacy|1|||
130136914|NCT00205777|468463570|FG004|Study Extension I|Lack of Efficacy|2|||
130136915|NCT00205777|468463571|FG005|Study Extension I|Lack of Efficacy|0|||
130136916|NCT00205777|468463566|FG000|Study Extension I|Failed to return|15|||
130136917|NCT00205777|468463567|FG001|Study Extension I|Failed to return|0|||
130136918|NCT00205777|468463568|FG002|Study Extension I|Failed to return|0|||
130136919|NCT00205777|468463569|FG003|Study Extension I|Failed to return|17|||
130136920|NCT00205777|468463570|FG004|Study Extension I|Failed to return|13|||
130136921|NCT00205777|468463571|FG005|Study Extension I|Failed to return|0|||
130136922|NCT00205777|468463566|FG000|Study Extension I|Other Event|34|||
130136923|NCT00205777|468463567|FG001|Study Extension I|Other Event|0|||
130136924|NCT00205777|468463568|FG002|Study Extension I|Other Event|0|||
130136925|NCT00205777|468463569|FG003|Study Extension I|Other Event|34|||
130136926|NCT00205777|468463570|FG004|Study Extension I|Other Event|29|||
130136927|NCT00205777|468463571|FG005|Study Extension I|Other Event|0|||
129973682|NCT00706654|467867875|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
129973683|NCT00706654|467867876|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
129973684|NCT00706654|467867873|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
129973685|NCT00706654|467867874|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
129973686|NCT00706654|467867875|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
129973687|NCT00706654|467867876|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
129973688|NCT00706654|467867873|FG000|Conversion Phase|Withdrawn by Investigator|14|||
129973689|NCT00706654|467867874|FG001|Conversion Phase|Withdrawn by Investigator|0|||
130136928|NCT00205777|468463566|FG000|Study Extension I|Withdrawn as per protocol|0|||
130136929|NCT00205777|468463567|FG001|Study Extension I|Withdrawn as per protocol|0|||
130136930|NCT00205777|468463568|FG002|Study Extension I|Withdrawn as per protocol|1070|||
130136931|NCT00205777|468463569|FG003|Study Extension I|Withdrawn as per protocol|0|||
130136932|NCT00205777|468463570|FG004|Study Extension I|Withdrawn as per protocol|0|||
130136933|NCT00205777|468463571|FG005|Study Extension I|Withdrawn as per protocol|0|||
130136934|NCT00205777|468463566|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
130136935|NCT00205777|468463567|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130136936|NCT00205777|468463568|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
130136937|NCT00205777|468463569|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
130136938|NCT00205777|468463570|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
130136939|NCT00205777|468463571|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129973690|NCT00706654|467867875|FG002|Conversion Phase|Withdrawn by Investigator|0|||
129973691|NCT00706654|467867876|FG003|Conversion Phase|Withdrawn by Investigator|0|||
130136940|NCT00205777|468463566|FG000|Study Extension II|Adverse Event|0|||
130136941|NCT00205777|468463567|FG001|Study Extension II|Adverse Event|0|||
130136942|NCT00205777|468463568|FG002|Study Extension II|Adverse Event|0|||
130136943|NCT00205777|468463569|FG003|Study Extension II|Adverse Event|14|||
130136944|NCT00205777|468463570|FG004|Study Extension II|Adverse Event|0|||
129973692|NCT00706654|467867873|FG000|Conversion Phase|Withdrew Consent|38|||
130136945|NCT00205777|468463571|FG005|Study Extension II|Adverse Event|30|||
130136946|NCT00205777|468463566|FG000|Study Extension II|Death|0|||
130136947|NCT00205777|468463567|FG001|Study Extension II|Death|0|||
130136948|NCT00205777|468463568|FG002|Study Extension II|Death|0|||
130136949|NCT00205777|468463569|FG003|Study Extension II|Death|2|||
130136950|NCT00205777|468463570|FG004|Study Extension II|Death|0|||
130136951|NCT00205777|468463571|FG005|Study Extension II|Death|5|||
130136952|NCT00205777|468463566|FG000|Study Extension II|Withdrawal by Subject|0|||
130136953|NCT00205777|468463567|FG001|Study Extension II|Withdrawal by Subject|0|||
130136954|NCT00205777|468463568|FG002|Study Extension II|Withdrawal by Subject|0|||
130136955|NCT00205777|468463569|FG003|Study Extension II|Withdrawal by Subject|35|||
130136956|NCT00205777|468463570|FG004|Study Extension II|Withdrawal by Subject|0|||
130136957|NCT00205777|468463571|FG005|Study Extension II|Withdrawal by Subject|59|||
130136958|NCT00205777|468463566|FG000|Study Extension II|Protocol Violation|0|||
130136959|NCT00205777|468463567|FG001|Study Extension II|Protocol Violation|0|||
130136960|NCT00205777|468463568|FG002|Study Extension II|Protocol Violation|0|||
130136961|NCT00205777|468463569|FG003|Study Extension II|Protocol Violation|1|||
130136962|NCT00205777|468463570|FG004|Study Extension II|Protocol Violation|0|||
130136963|NCT00205777|468463571|FG005|Study Extension II|Protocol Violation|10|||
130136964|NCT00205777|468463566|FG000|Study Extension II|Lack of Efficacy|0|||
130136965|NCT00205777|468463567|FG001|Study Extension II|Lack of Efficacy|0|||
130136966|NCT00205777|468463568|FG002|Study Extension II|Lack of Efficacy|0|||
130136967|NCT00205777|468463569|FG003|Study Extension II|Lack of Efficacy|0|||
130136968|NCT00205777|468463570|FG004|Study Extension II|Lack of Efficacy|0|||
130136969|NCT00205777|468463571|FG005|Study Extension II|Lack of Efficacy|1|||
130136970|NCT00205777|468463566|FG000|Study Extension II|Failed to return|0|||
130136971|NCT00205777|468463567|FG001|Study Extension II|Failed to return|0|||
130136972|NCT00205777|468463568|FG002|Study Extension II|Failed to return|0|||
130136973|NCT00205777|468463569|FG003|Study Extension II|Failed to return|14|||
130136974|NCT00205777|468463570|FG004|Study Extension II|Failed to return|0|||
130136975|NCT00205777|468463571|FG005|Study Extension II|Failed to return|26|||
130136976|NCT00205777|468463566|FG000|Study Extension II|Other Event|0|||
130136977|NCT00205777|468463567|FG001|Study Extension II|Other Event|0|||
130136978|NCT00205777|468463568|FG002|Study Extension II|Other Event|0|||
130136979|NCT00205777|468463569|FG003|Study Extension II|Other Event|12|||
130136980|NCT00205777|468463570|FG004|Study Extension II|Other Event|0|||
130136981|NCT00205777|468463571|FG005|Study Extension II|Other Event|20|||
130136982|NCT00205777|468463566|FG000|Study Extension II|Enrolled but not treated|0|||
130136983|NCT00205777|468463567|FG001|Study Extension II|Enrolled but not treated|0|||
130136984|NCT00205777|468463568|FG002|Study Extension II|Enrolled but not treated|0|||
129973693|NCT00706654|467867874|FG001|Conversion Phase|Withdrew Consent|0|||
129973694|NCT00706654|467867875|FG002|Conversion Phase|Withdrew Consent|0|||
129973695|NCT00706654|467867876|FG003|Conversion Phase|Withdrew Consent|0|||
129973696|NCT00706654|467867873|FG000|Conversion Phase|Adverse Event|18|||
130136985|NCT00205777|468463569|FG003|Study Extension II|Enrolled but not treated|71|||
130136986|NCT00205777|468463570|FG004|Study Extension II|Enrolled but not treated|0|||
130136987|NCT00205777|468463571|FG005|Study Extension II|Enrolled but not treated|131|||
129973697|NCT00706654|467867874|FG001|Conversion Phase|Adverse Event|0|||
129973698|NCT00706654|467867875|FG002|Conversion Phase|Adverse Event|0|||
129973699|NCT00706654|467867876|FG003|Conversion Phase|Adverse Event|0|||
129973700|NCT00706654|467867873|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
130136988|NCT00367133|468463574|FG000|2 Years|Death|20|||
130136989|NCT00367133|468463575|FG001|2 Years|Death|12|||
130136990|NCT00367133|468463576|FG002|2 Years|Death|12|||
130136991|NCT00367133|468463574|FG000|2 Years|Dropped|34|||
130136992|NCT00367133|468463575|FG001|2 Years|Dropped|19|||
130136993|NCT00367133|468463576|FG002|2 Years|Dropped|33|||
130136994|NCT00367133|468463574|FG000|2 Years|Missed visit|4|||
130136995|NCT00367133|468463575|FG001|2 Years|Missed visit|5|||
130136996|NCT00367133|468463576|FG002|2 Years|Missed visit|4|||
130136997|NCT00906399|468463577|FG000|Year 1|Randomized But Not Treated|0|||
130136998|NCT00906399|468463578|FG001|Year 1|Randomized But Not Treated|1|||
129973701|NCT00706654|467867874|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130136999|NCT00906399|468463579|FG002|Year 1|Randomized But Not Treated|3|||
130137000|NCT00906399|468463580|FG003|Year 1|Randomized But Not Treated|0|||
130137001|NCT00906399|468463581|FG004|Year 1|Randomized But Not Treated|0|||
130137002|NCT00906399|468463582|FG005|Year 1|Randomized But Not Treated|0|||
130137003|NCT00906399|468463583|FG006|Year 1|Randomized But Not Treated|0|||
130137004|NCT00906399|468463577|FG000|Year 1|Adverse Event|4|||
130137005|NCT00906399|468463578|FG001|Year 1|Adverse Event|22|||
130137006|NCT00906399|468463579|FG002|Year 1|Adverse Event|24|||
130137007|NCT00906399|468463580|FG003|Year 1|Adverse Event|0|||
129973702|NCT00706654|467867875|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
129973703|NCT00706654|467867876|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
130137008|NCT00906399|468463581|FG004|Year 1|Adverse Event|0|||
130137009|NCT00906399|468463582|FG005|Year 1|Adverse Event|0|||
130137010|NCT00906399|468463583|FG006|Year 1|Adverse Event|0|||
130137011|NCT00906399|468463577|FG000|Year 1|Lost to Follow-up|4|||
130137012|NCT00906399|468463578|FG001|Year 1|Lost to Follow-up|4|||
130137013|NCT00906399|468463579|FG002|Year 1|Lost to Follow-up|2|||
130137014|NCT00906399|468463580|FG003|Year 1|Lost to Follow-up|0|||
130137015|NCT00906399|468463581|FG004|Year 1|Lost to Follow-up|0|||
130137016|NCT00906399|468463582|FG005|Year 1|Lost to Follow-up|0|||
129973704|NCT00706654|467867873|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
129973705|NCT00706654|467867874|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129973706|NCT00706654|467867875|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129973707|NCT00706654|467867876|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129973708|NCT00706654|467867873|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
129973709|NCT00706654|467867874|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
129973710|NCT00706654|467867875|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
129973711|NCT00706654|467867876|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
129973712|NCT00706654|467867873|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
129973713|NCT00706654|467867874|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
129973714|NCT00706654|467867875|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
130137017|NCT00906399|468463583|FG006|Year 1|Lost to Follow-up|0|||
130137018|NCT00906399|468463577|FG000|Year 1|Withdrawal by Subject|30|||
130137019|NCT00906399|468463578|FG001|Year 1|Withdrawal by Subject|32|||
130137020|NCT00906399|468463579|FG002|Year 1|Withdrawal by Subject|36|||
130137021|NCT00906399|468463580|FG003|Year 1|Withdrawal by Subject|0|||
130137022|NCT00906399|468463581|FG004|Year 1|Withdrawal by Subject|0|||
130137023|NCT00906399|468463582|FG005|Year 1|Withdrawal by Subject|0|||
130137024|NCT00906399|468463583|FG006|Year 1|Withdrawal by Subject|0|||
130137025|NCT00906399|468463577|FG000|Year 1|Physician Decision|0|||
130137026|NCT00906399|468463578|FG001|Year 1|Physician Decision|1|||
130137027|NCT00906399|468463579|FG002|Year 1|Physician Decision|3|||
130137028|NCT00906399|468463580|FG003|Year 1|Physician Decision|0|||
130137029|NCT00906399|468463581|FG004|Year 1|Physician Decision|0|||
130137030|NCT00906399|468463582|FG005|Year 1|Physician Decision|0|||
130137031|NCT00906399|468463583|FG006|Year 1|Physician Decision|0|||
130137032|NCT00906399|468463577|FG000|Year 1|Death|2|||
130137033|NCT00906399|468463578|FG001|Year 1|Death|1|||
130137034|NCT00906399|468463579|FG002|Year 1|Death|1|||
130137035|NCT00906399|468463580|FG003|Year 1|Death|0|||
130137036|NCT00906399|468463581|FG004|Year 1|Death|0|||
130137037|NCT00906399|468463582|FG005|Year 1|Death|0|||
130137038|NCT00906399|468463583|FG006|Year 1|Death|0|||
130137039|NCT00906399|468463577|FG000|Year 1|Other|4|||
130137040|NCT00906399|468463578|FG001|Year 1|Other|2|||
130137041|NCT00906399|468463579|FG002|Year 1|Other|7|||
130137042|NCT00906399|468463580|FG003|Year 1|Other|0|||
130137043|NCT00906399|468463581|FG004|Year 1|Other|0|||
130137044|NCT00906399|468463582|FG005|Year 1|Other|0|||
130137045|NCT00906399|468463583|FG006|Year 1|Other|0|||
130137046|NCT00906399|468463577|FG000|Year 2|Adverse Event|0|||
130137047|NCT00906399|468463578|FG001|Year 2|Adverse Event|0|||
130137048|NCT00906399|468463579|FG002|Year 2|Adverse Event|0|||
130137049|NCT00906399|468463580|FG003|Year 2|Adverse Event|9|||
130137050|NCT00906399|468463581|FG004|Year 2|Adverse Event|8|||
130137051|NCT00906399|468463582|FG005|Year 2|Adverse Event|11|||
129973715|NCT00706654|467867876|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
129973716|NCT00706654|467867873|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
130137052|NCT00906399|468463583|FG006|Year 2|Adverse Event|6|||
130137053|NCT00906399|468463577|FG000|Year 2|Lost to Follow-up|0|||
130137054|NCT00906399|468463578|FG001|Year 2|Lost to Follow-up|0|||
130137055|NCT00906399|468463579|FG002|Year 2|Lost to Follow-up|0|||
130137056|NCT00906399|468463580|FG003|Year 2|Lost to Follow-up|1|||
130137057|NCT00906399|468463581|FG004|Year 2|Lost to Follow-up|4|||
130137058|NCT00906399|468463582|FG005|Year 2|Lost to Follow-up|2|||
130137059|NCT00906399|468463583|FG006|Year 2|Lost to Follow-up|4|||
130137060|NCT00906399|468463577|FG000|Year 2|Withdrawal by Subject|0|||
130137061|NCT00906399|468463578|FG001|Year 2|Withdrawal by Subject|0|||
130137062|NCT00906399|468463579|FG002|Year 2|Withdrawal by Subject|0|||
130137063|NCT00906399|468463580|FG003|Year 2|Withdrawal by Subject|17|||
130137064|NCT00906399|468463581|FG004|Year 2|Withdrawal by Subject|18|||
130137065|NCT00906399|468463582|FG005|Year 2|Withdrawal by Subject|27|||
130137066|NCT00906399|468463583|FG006|Year 2|Withdrawal by Subject|13|||
130137067|NCT00906399|468463577|FG000|Year 2|Physician Decision|0|||
130137068|NCT00906399|468463578|FG001|Year 2|Physician Decision|0|||
130137069|NCT00906399|468463579|FG002|Year 2|Physician Decision|0|||
130137070|NCT00906399|468463580|FG003|Year 2|Physician Decision|0|||
130137071|NCT00906399|468463581|FG004|Year 2|Physician Decision|2|||
130137072|NCT00906399|468463582|FG005|Year 2|Physician Decision|6|||
130137073|NCT00906399|468463583|FG006|Year 2|Physician Decision|3|||
130137074|NCT00906399|468463577|FG000|Year 2|Death|0|||
130137075|NCT00906399|468463578|FG001|Year 2|Death|0|||
130137076|NCT00906399|468463579|FG002|Year 2|Death|0|||
130137077|NCT00906399|468463580|FG003|Year 2|Death|1|||
130137078|NCT00906399|468463581|FG004|Year 2|Death|0|||
130137079|NCT00906399|468463582|FG005|Year 2|Death|0|||
130137080|NCT00906399|468463583|FG006|Year 2|Death|3|||
130137081|NCT00906399|468463577|FG000|Year 2|Other|0|||
130137082|NCT00906399|468463578|FG001|Year 2|Other|0|||
130137083|NCT00906399|468463579|FG002|Year 2|Other|0|||
130137084|NCT00906399|468463580|FG003|Year 2|Other|2|||
130137085|NCT00906399|468463581|FG004|Year 2|Other|3|||
130137086|NCT00906399|468463582|FG005|Year 2|Other|1|||
130137087|NCT00906399|468463583|FG006|Year 2|Other|0|||
130137088|NCT01297504|468463595|FG000|Overall Study|Invalid Consent|1|||
130137089|NCT01297504|468463595|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
130137090|NCT01297504|468463595|FG000|Overall Study|No Study Visits|4|||
130137091|NCT01297504|468463595|FG000|Overall Study|Death|3|||
130137092|NCT01297504|468463595|FG000|Overall Study|Lost to Follow-up|43|||
130137093|NCT01297504|468463595|FG000|Overall Study|Withdrawal by Subject|9|||
130137094|NCT01297504|468463595|FG000|Overall Study|Site Closure|3|||
130137095|NCT01297504|468463595|FG000|Overall Study|Protocol Violation|3|||
129973717|NCT00706654|467867874|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129973718|NCT00706654|467867875|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129973719|NCT00706654|467867876|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129973720|NCT00706654|467867873|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
129973721|NCT00706654|467867874|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129973722|NCT00706654|467867875|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
130137096|NCT02615249|468463596|FG000|Overall Study|Withdrawal by Subject|1|||
130137097|NCT00574847|468463597|FG000|Overall Study|Adverse Event|2|||
130137098|NCT00574847|468463598|FG001|Overall Study|Adverse Event|0|||
130137099|NCT00574847|468463597|FG000|Overall Study|Death|1|||
130137100|NCT00574847|468463598|FG001|Overall Study|Death|0|||
130137101|NCT00574847|468463597|FG000|Overall Study|Withdrawal by Subject|2|||
130137102|NCT00574847|468463598|FG001|Overall Study|Withdrawal by Subject|2|||
130137103|NCT00574847|468463597|FG000|Overall Study|Physician Decision|1|||
130137104|NCT00574847|468463598|FG001|Overall Study|Physician Decision|0|||
130137105|NCT00574847|468463597|FG000|Overall Study|Did not receive medication (declined)|2|||
130137106|NCT00574847|468463598|FG001|Overall Study|Did not receive medication (declined)|5|||
130137107|NCT02055547|468463599|FG000|Overall Study|Protocol Violation|0|||
129973723|NCT00706654|467867876|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129973724|NCT00706654|467867873|FG000|Oral Stabilization Phase|Withdrew consent|55|||
129973725|NCT00706654|467867874|FG001|Oral Stabilization Phase|Withdrew consent|0|||
129973726|NCT00706654|467867875|FG002|Oral Stabilization Phase|Withdrew consent|0|||
129973727|NCT00706654|467867876|FG003|Oral Stabilization Phase|Withdrew consent|0|||
129973728|NCT00706654|467867873|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
130137108|NCT02055547|468463600|FG001|Overall Study|Protocol Violation|0|||
130137109|NCT02055547|468463601|FG002|Overall Study|Protocol Violation|1|||
130137110|NCT02055547|468463602|FG003|Overall Study|Protocol Violation|0|||
130137111|NCT02055547|468463603|FG004|Overall Study|Protocol Violation|0|||
129973729|NCT00706654|467867874|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
129973730|NCT00706654|467867875|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
129973731|NCT00706654|467867876|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
129973732|NCT00706654|467867873|FG000|Oral Stabilization Phase|Adverse Event|21|||
129973733|NCT00706654|467867874|FG001|Oral Stabilization Phase|Adverse Event|0|||
130137112|NCT02055547|468463604|FG005|Overall Study|Protocol Violation|0|||
130137113|NCT02055547|468463605|FG006|Overall Study|Protocol Violation|1|||
130137114|NCT02055547|468463606|FG007|Overall Study|Protocol Violation|0|||
130137115|NCT02055547|468463607|FG008|Overall Study|Protocol Violation|0|||
129973734|NCT00706654|467867875|FG002|Oral Stabilization Phase|Adverse Event|0|||
129973735|NCT00706654|467867876|FG003|Oral Stabilization Phase|Adverse Event|0|||
129973736|NCT00706654|467867873|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
129973737|NCT00706654|467867874|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129973738|NCT00706654|467867875|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
130137116|NCT02055547|468463608|FG009|Overall Study|Protocol Violation|0|||
130137117|NCT02055547|468463609|FG010|Overall Study|Protocol Violation|0|||
130137118|NCT02055547|468463610|FG011|Overall Study|Protocol Violation|0|||
130137119|NCT02055547|468463611|FG012|Overall Study|Protocol Violation|0|||
130137120|NCT02055547|468463612|FG013|Overall Study|Protocol Violation|0|||
130137121|NCT02055547|468463613|FG014|Overall Study|Protocol Violation|0|||
130137122|NCT02055547|468463614|FG015|Overall Study|Protocol Violation|0|||
130137123|NCT02055547|468463615|FG016|Overall Study|Protocol Violation|0|||
130137124|NCT02055547|468463616|FG017|Overall Study|Protocol Violation|0|||
130137125|NCT02055547|468463617|FG018|Overall Study|Protocol Violation|0|||
130137126|NCT02055547|468463599|FG000|Overall Study|Physician Decision|0|||
130137127|NCT02055547|468463600|FG001|Overall Study|Physician Decision|1|||
130137128|NCT02055547|468463601|FG002|Overall Study|Physician Decision|1|||
130137129|NCT02055547|468463602|FG003|Overall Study|Physician Decision|0|||
130137130|NCT02055547|468463603|FG004|Overall Study|Physician Decision|1|||
130137131|NCT02055547|468463604|FG005|Overall Study|Physician Decision|0|||
130137132|NCT02055547|468463605|FG006|Overall Study|Physician Decision|0|||
130137133|NCT02055547|468463606|FG007|Overall Study|Physician Decision|0|||
130137134|NCT02055547|468463607|FG008|Overall Study|Physician Decision|0|||
130137135|NCT02055547|468463608|FG009|Overall Study|Physician Decision|1|||
130137136|NCT02055547|468463609|FG010|Overall Study|Physician Decision|1|||
130137137|NCT02055547|468463610|FG011|Overall Study|Physician Decision|0|||
130137138|NCT02055547|468463611|FG012|Overall Study|Physician Decision|0|||
130137139|NCT02055547|468463612|FG013|Overall Study|Physician Decision|0|||
130137140|NCT02055547|468463613|FG014|Overall Study|Physician Decision|0|||
130137141|NCT02055547|468463614|FG015|Overall Study|Physician Decision|0|||
130137142|NCT02055547|468463615|FG016|Overall Study|Physician Decision|0|||
130137143|NCT02055547|468463616|FG017|Overall Study|Physician Decision|0|||
130137144|NCT02055547|468463617|FG018|Overall Study|Physician Decision|0|||
130137145|NCT02055547|468463599|FG000|Overall Study|Adverse Event|0|||
130137146|NCT02055547|468463600|FG001|Overall Study|Adverse Event|0|||
130137147|NCT02055547|468463601|FG002|Overall Study|Adverse Event|0|||
130137148|NCT02055547|468463602|FG003|Overall Study|Adverse Event|0|||
130137149|NCT02055547|468463603|FG004|Overall Study|Adverse Event|0|||
130137150|NCT02055547|468463604|FG005|Overall Study|Adverse Event|0|||
130137151|NCT02055547|468463605|FG006|Overall Study|Adverse Event|1|||
130137152|NCT02055547|468463606|FG007|Overall Study|Adverse Event|0|||
130137153|NCT02055547|468463607|FG008|Overall Study|Adverse Event|1|||
130137154|NCT02055547|468463608|FG009|Overall Study|Adverse Event|0|||
130137155|NCT02055547|468463609|FG010|Overall Study|Adverse Event|0|||
130137156|NCT02055547|468463610|FG011|Overall Study|Adverse Event|0|||
130137157|NCT02055547|468463611|FG012|Overall Study|Adverse Event|0|||
130137158|NCT02055547|468463612|FG013|Overall Study|Adverse Event|0|||
130137159|NCT02055547|468463613|FG014|Overall Study|Adverse Event|0|||
130137160|NCT02055547|468463614|FG015|Overall Study|Adverse Event|0|||
130137161|NCT02055547|468463615|FG016|Overall Study|Adverse Event|0|||
130137162|NCT02055547|468463616|FG017|Overall Study|Adverse Event|0|||
130137163|NCT02055547|468463617|FG018|Overall Study|Adverse Event|0|||
130137164|NCT02055547|468463599|FG000|Overall Study|Withdrawal by Subject|0|||
129973739|NCT00706654|467867876|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129973740|NCT00706654|467867873|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
129973741|NCT00706654|467867874|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129973742|NCT00706654|467867875|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129973743|NCT00706654|467867876|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129973744|NCT00706654|467867873|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
129973745|NCT00706654|467867874|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
129973746|NCT00706654|467867875|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
130137165|NCT02055547|468463600|FG001|Overall Study|Withdrawal by Subject|0|||
130137166|NCT02055547|468463601|FG002|Overall Study|Withdrawal by Subject|0|||
130137167|NCT02055547|468463602|FG003|Overall Study|Withdrawal by Subject|0|||
130137168|NCT02055547|468463603|FG004|Overall Study|Withdrawal by Subject|0|||
130137169|NCT02055547|468463604|FG005|Overall Study|Withdrawal by Subject|1|||
130137170|NCT02055547|468463605|FG006|Overall Study|Withdrawal by Subject|0|||
130137171|NCT02055547|468463606|FG007|Overall Study|Withdrawal by Subject|0|||
130137172|NCT02055547|468463607|FG008|Overall Study|Withdrawal by Subject|1|||
130137173|NCT02055547|468463608|FG009|Overall Study|Withdrawal by Subject|0|||
130137174|NCT02055547|468463609|FG010|Overall Study|Withdrawal by Subject|0|||
130137175|NCT02055547|468463610|FG011|Overall Study|Withdrawal by Subject|0|||
130137176|NCT02055547|468463611|FG012|Overall Study|Withdrawal by Subject|0|||
130137177|NCT02055547|468463612|FG013|Overall Study|Withdrawal by Subject|1|||
130137178|NCT02055547|468463613|FG014|Overall Study|Withdrawal by Subject|0|||
130137179|NCT02055547|468463614|FG015|Overall Study|Withdrawal by Subject|1|||
130137180|NCT02055547|468463615|FG016|Overall Study|Withdrawal by Subject|0|||
130137181|NCT02055547|468463616|FG017|Overall Study|Withdrawal by Subject|0|||
130137182|NCT02055547|468463617|FG018|Overall Study|Withdrawal by Subject|0|||
130137183|NCT02055547|468463599|FG000|Overall Study|Lost to Follow-up|0|||
130137184|NCT02055547|468463600|FG001|Overall Study|Lost to Follow-up|0|||
130137185|NCT02055547|468463601|FG002|Overall Study|Lost to Follow-up|1|||
130137186|NCT02055547|468463602|FG003|Overall Study|Lost to Follow-up|0|||
130137187|NCT02055547|468463603|FG004|Overall Study|Lost to Follow-up|0|||
130137188|NCT02055547|468463604|FG005|Overall Study|Lost to Follow-up|0|||
130137189|NCT02055547|468463605|FG006|Overall Study|Lost to Follow-up|0|||
130137190|NCT02055547|468463606|FG007|Overall Study|Lost to Follow-up|0|||
130137191|NCT02055547|468463607|FG008|Overall Study|Lost to Follow-up|0|||
130137192|NCT02055547|468463608|FG009|Overall Study|Lost to Follow-up|0|||
130137193|NCT02055547|468463609|FG010|Overall Study|Lost to Follow-up|0|||
130137194|NCT02055547|468463610|FG011|Overall Study|Lost to Follow-up|0|||
130137195|NCT02055547|468463611|FG012|Overall Study|Lost to Follow-up|0|||
130137196|NCT02055547|468463612|FG013|Overall Study|Lost to Follow-up|0|||
130137197|NCT02055547|468463613|FG014|Overall Study|Lost to Follow-up|0|||
130137198|NCT02055547|468463614|FG015|Overall Study|Lost to Follow-up|0|||
130137199|NCT02055547|468463615|FG016|Overall Study|Lost to Follow-up|0|||
130137200|NCT02055547|468463616|FG017|Overall Study|Lost to Follow-up|0|||
130137201|NCT02055547|468463617|FG018|Overall Study|Lost to Follow-up|0|||
130137202|NCT01248728|468463622|FG000|Overall Study|Adverse Event|1|||
130137203|NCT01248728|468463623|FG001|Overall Study|Adverse Event|1|||
130137204|NCT01248728|468463622|FG000|Overall Study|Withdrawal by Subject|2|||
130137205|NCT01248728|468463623|FG001|Overall Study|Withdrawal by Subject|1|||
130137206|NCT01248728|468463622|FG000|Overall Study|Lack of Efficacy|1|||
130137207|NCT01248728|468463623|FG001|Overall Study|Lack of Efficacy|0|||
130137208|NCT00147498|468463624|FG000|Overall Study|Adverse Event|1|||
130137209|NCT00147498|468463625|FG001|Overall Study|Adverse Event|6|||
130137210|NCT00147498|468463626|FG002|Overall Study|Adverse Event|7|||
130137211|NCT00147498|468463627|FG003|Overall Study|Adverse Event|3|||
130137212|NCT00147498|468463624|FG000|Overall Study|Lack of Efficacy|1|||
130137213|NCT00147498|468463625|FG001|Overall Study|Lack of Efficacy|1|||
130137214|NCT00147498|468463626|FG002|Overall Study|Lack of Efficacy|1|||
130137215|NCT00147498|468463627|FG003|Overall Study|Lack of Efficacy|8|||
130137216|NCT00147498|468463624|FG000|Overall Study|Laboratory abnormality|0|||
130137217|NCT00147498|468463625|FG001|Overall Study|Laboratory abnormality|0|||
130137218|NCT00147498|468463626|FG002|Overall Study|Laboratory abnormality|2|||
130137219|NCT00147498|468463627|FG003|Overall Study|Laboratory abnormality|0|||
130137220|NCT00147498|468463624|FG000|Overall Study|Participant defaulted|0|||
130137221|NCT00147498|468463625|FG001|Overall Study|Participant defaulted|1|||
130137222|NCT00147498|468463626|FG002|Overall Study|Participant defaulted|4|||
130137223|NCT00147498|468463627|FG003|Overall Study|Participant defaulted|3|||
130137224|NCT00147498|468463624|FG000|Overall Study|Other|1|||
130137225|NCT00147498|468463625|FG001|Overall Study|Other|1|||
130137226|NCT00147498|468463626|FG002|Overall Study|Other|3|||
130137227|NCT00147498|468463627|FG003|Overall Study|Other|3|||
130137228|NCT01229150|468463628|FG000|Overall Study|Toxicity|2|||
130137229|NCT01229150|468463629|FG001|Overall Study|Toxicity|2|||
130137230|NCT01229150|468463630|FG002|Overall Study|Toxicity|0|||
130137231|NCT01229150|468463631|FG003|Overall Study|Toxicity|0|||
130137232|NCT00902538|468463632|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
130137233|NCT00902538|468463633|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130137234|NCT00902538|468463634|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130137235|NCT00902538|468463635|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130137236|NCT00902538|468463636|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130137237|NCT00902538|468463637|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
130137238|NCT00902538|468463632|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
130137239|NCT00902538|468463633|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130137240|NCT00902538|468463634|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130137241|NCT00902538|468463635|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130137242|NCT00902538|468463636|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130137243|NCT00902538|468463637|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
130137244|NCT00902538|468463632|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
130137245|NCT00902538|468463633|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130137246|NCT00902538|468463634|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130137247|NCT00902538|468463635|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130137248|NCT00902538|468463636|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130137249|NCT00902538|468463637|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
130137250|NCT00902538|468463632|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
130137251|NCT00902538|468463633|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130137252|NCT00902538|468463634|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130137253|NCT00902538|468463635|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130137254|NCT00902538|468463636|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
130137255|NCT00902538|468463637|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129973747|NCT00706654|467867876|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
129973748|NCT00706654|467867873|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
129973749|NCT00706654|467867874|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
129973750|NCT00706654|467867875|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
129973751|NCT00706654|467867876|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
129973752|NCT00706654|467867873|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
129973753|NCT00706654|467867874|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
129973754|NCT00706654|467867875|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
129973755|NCT00706654|467867876|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
129973756|NCT00706654|467867873|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
129973757|NCT00706654|467867874|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
129973758|NCT00706654|467867875|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
129973759|NCT00706654|467867876|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
129973760|NCT00706654|467867873|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
129973761|NCT00706654|467867874|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
129973762|NCT00706654|467867875|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
129973763|NCT00706654|467867876|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
129973764|NCT00706654|467867873|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
129973765|NCT00706654|467867874|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
130137256|NCT00902538|468463632|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
130137257|NCT00902538|468463633|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130137258|NCT00902538|468463634|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130137259|NCT00902538|468463635|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129973766|NCT00706654|467867875|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
129973767|NCT00706654|467867876|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
130137260|NCT00902538|468463636|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130137261|NCT00902538|468463637|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
130137262|NCT00902538|468463632|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
130137263|NCT00902538|468463633|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
130137264|NCT00902538|468463634|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
130137265|NCT00902538|468463635|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130137266|NCT00902538|468463636|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130137267|NCT00902538|468463637|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
130137268|NCT00902538|468463632|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
130137269|NCT00902538|468463633|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
130137270|NCT00902538|468463634|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
130137271|NCT00902538|468463635|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130137272|NCT00902538|468463636|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130137273|NCT00902538|468463637|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
130137274|NCT00902538|468463632|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
130137275|NCT00902538|468463633|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130137276|NCT00902538|468463634|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
130137277|NCT00902538|468463635|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130137278|NCT00902538|468463636|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130137279|NCT00902538|468463637|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
130137280|NCT00902538|468463632|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
130137281|NCT00902538|468463633|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
130137282|NCT00902538|468463634|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
130137283|NCT00902538|468463635|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
130137284|NCT00902538|468463636|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
130137285|NCT00902538|468463637|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
130137286|NCT00902538|468463632|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
130137287|NCT00902538|468463633|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
130137288|NCT00902538|468463634|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
130137289|NCT00902538|468463635|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130137290|NCT00902538|468463636|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130137291|NCT00902538|468463637|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
130137292|NCT00902538|468463632|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
130137293|NCT00902538|468463633|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
130137294|NCT00902538|468463634|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
130137295|NCT00902538|468463635|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
130137296|NCT00902538|468463636|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
130137297|NCT00902538|468463637|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
130137298|NCT00902538|468463632|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
130137299|NCT00902538|468463633|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
130137300|NCT00902538|468463634|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
130137301|NCT00902538|468463635|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
130137302|NCT00902538|468463636|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
130137303|NCT00902538|468463637|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
130137304|NCT00902538|468463632|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130137305|NCT00902538|468463633|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
130137306|NCT00902538|468463634|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130137307|NCT00902538|468463635|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130137308|NCT00902538|468463636|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130137309|NCT00902538|468463637|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
130137310|NCT00902538|468463632|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130137311|NCT00902538|468463633|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
130137312|NCT00902538|468463634|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130137313|NCT00902538|468463635|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130137314|NCT00902538|468463636|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129973768|NCT00706654|467867873|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
129973769|NCT00706654|467867874|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
130137315|NCT00902538|468463637|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
130137316|NCT00902538|468463632|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130137317|NCT00902538|468463633|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130137318|NCT00902538|468463634|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
130137319|NCT00902538|468463635|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
130137320|NCT00902538|468463636|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
130137321|NCT00902538|468463637|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
130137322|NCT00902538|468463632|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130137323|NCT00902538|468463633|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130137324|NCT00902538|468463634|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130137325|NCT00902538|468463635|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
130137326|NCT00902538|468463636|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
130137327|NCT00902538|468463637|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
130137328|NCT00902538|468463632|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130137329|NCT00902538|468463633|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130137330|NCT00902538|468463634|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130137331|NCT00902538|468463635|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
130137332|NCT00902538|468463636|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129973770|NCT00706654|467867875|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
129973771|NCT00706654|467867876|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
129973772|NCT00706654|467867873|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
129973773|NCT00706654|467867874|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
130137333|NCT00902538|468463637|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
130137334|NCT03531827|468463638|FG000|Overall Study|Adverse Event|2|||
130137335|NCT03531827|468463639|FG001|Overall Study|Adverse Event|0|||
130137336|NCT03531827|468463638|FG000|Overall Study|Progressive disease|1|||
130137337|NCT03531827|468463639|FG001|Overall Study|Progressive disease|0|||
130137338|NCT00679081|468463640|FG000|Overall Study|Lost to Follow-up|1|||
130137339|NCT00725322|468463641|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
130137340|NCT00725322|468463642|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
130137341|NCT00725322|468463641|FG000|Washout (28 Days)|Protocol Violation|0|||
130137342|NCT00725322|468463642|FG001|Washout (28 Days)|Protocol Violation|1|||
130137343|NCT03578809|468465246|FG000|Overall Study|Death|0|||
130137344|NCT03578809|468465247|FG001|Overall Study|Death|2|||
130137345|NCT03578809|468465248|FG002|Overall Study|Death|0|||
130137346|NCT03578809|468465249|FG003|Overall Study|Death|1|||
130137347|NCT03578809|468465246|FG000|Overall Study|Lost to Follow-up|0|||
130137348|NCT03578809|468465247|FG001|Overall Study|Lost to Follow-up|1|||
130137349|NCT03578809|468465248|FG002|Overall Study|Lost to Follow-up|0|||
130137350|NCT03578809|468465249|FG003|Overall Study|Lost to Follow-up|0|||
130137351|NCT03578809|468465246|FG000|Overall Study|Withdrawal by Subject|3|||
130137352|NCT03578809|468465247|FG001|Overall Study|Withdrawal by Subject|5|||
130137353|NCT03578809|468465248|FG002|Overall Study|Withdrawal by Subject|2|||
130137354|NCT03578809|468465249|FG003|Overall Study|Withdrawal by Subject|0|||
130137355|NCT03578809|468465246|FG000|Overall Study|Other|3|||
130137356|NCT03578809|468465247|FG001|Overall Study|Other|6|||
130137357|NCT03578809|468465248|FG002|Overall Study|Other|2|||
130137358|NCT03578809|468465249|FG003|Overall Study|Other|8|||
130137359|NCT01624233|468465252|FG000|Period 2 - Induction|Adverse Event|1|||
130137360|NCT01624233|468465252|FG000|Period 3 - Maintenance|Adverse Event|2|||
130137361|NCT01624233|468465252|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
130137362|NCT01624233|468465252|FG000|Period 3 - Maintenance|Physician Decision|2|||
130137363|NCT01624233|468465252|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
129973774|NCT00706654|467867875|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
129973775|NCT00706654|467867876|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
129973776|NCT01001390|467867882|FG000|Overall Study|Failure to wear AFO device|2|||
129973777|NCT01001390|467867883|FG001|Overall Study|Failure to wear AFO device|0|||
129973778|NCT01151215|467867884|FG000|Overall Study|Worsening of condition under study|1|||
129973779|NCT01151215|467867885|FG001|Overall Study|Worsening of condition under study|1|||
129973780|NCT01151215|467867886|FG002|Overall Study|Worsening of condition under study|1|||
129973781|NCT01151215|467867884|FG000|Overall Study|Death|16|||
129973782|NCT01151215|467867885|FG001|Overall Study|Death|20|||
129973783|NCT01151215|467867886|FG002|Overall Study|Death|11|||
129973784|NCT01151215|467867884|FG000|Overall Study|Lost to Follow-up|0|||
129973785|NCT01151215|467867885|FG001|Overall Study|Lost to Follow-up|0|||
129973786|NCT01151215|467867886|FG002|Overall Study|Lost to Follow-up|3|||
129973787|NCT01151215|467867884|FG000|Overall Study|Withdrawal by Subject|3|||
129973788|NCT01151215|467867885|FG001|Overall Study|Withdrawal by Subject|1|||
129973789|NCT01151215|467867886|FG002|Overall Study|Withdrawal by Subject|2|||
129973790|NCT01151215|467867884|FG000|Overall Study|Disease progression|0|||
129973791|NCT01151215|467867885|FG001|Overall Study|Disease progression|1|||
129973792|NCT01151215|467867886|FG002|Overall Study|Disease progression|1|||
129973793|NCT01151215|467867884|FG000|Overall Study|Safety as judged by the investigator|0|||
129973794|NCT01151215|467867885|FG001|Overall Study|Safety as judged by the investigator|0|||
130137364|NCT01624233|468465252|FG000|Period 4 - Drug Free Period|Relapsed|61|||
130137365|NCT01624233|468465252|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
130137366|NCT01624233|468465252|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
130137367|NCT01624233|468465252|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
130137368|NCT01624233|468465252|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
130137369|NCT01624233|468465252|FG000|Period 6: Follow-up|Adverse Event|3|||
130137370|NCT01624233|468465252|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
130137371|NCT01624233|468465252|FG000|Period 6: Follow-up|Physician Decision|1|||
129973795|NCT01151215|467867886|FG002|Overall Study|Safety as judged by the investigator|1|||
129973796|NCT01721954|467867889|FG000|Overall Study|Death|58|||
129973797|NCT01721954|467867890|FG001|Overall Study|Death|64|||
129973798|NCT01721954|467867889|FG000|Overall Study|Withdrawal by Subject|8|||
129973799|NCT01721954|467867890|FG001|Overall Study|Withdrawal by Subject|4|||
129973800|NCT01721954|467867889|FG000|Overall Study|Adverse Event|2|||
129973801|NCT01721954|467867890|FG001|Overall Study|Adverse Event|0|||
129973802|NCT01721954|467867889|FG000|Overall Study|Lost to Follow-up|2|||
129973803|NCT01721954|467867890|FG001|Overall Study|Lost to Follow-up|1|||
129973804|NCT03392168|467867891|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
129973805|NCT03392168|467867892|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
129973806|NCT03392168|467867893|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
129973807|NCT03392168|467867894|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
129973808|NCT03392168|467867891|FG000|Period 2: Cohort 2|Other|0|||
129973809|NCT03392168|467867892|FG001|Period 2: Cohort 2|Other|1|||
129973810|NCT03392168|467867893|FG002|Period 2: Cohort 2|Other|0|||
129973811|NCT03392168|467867894|FG003|Period 2: Cohort 2|Other|0|||
129973812|NCT00368875|467867899|FG000|Overall Study|Adverse Event|0|||
129973813|NCT00368875|467867900|FG001|Overall Study|Adverse Event|12|||
129973814|NCT00368875|467867899|FG000|Overall Study|Progressive disease|3|||
129973815|NCT00368875|467867900|FG001|Overall Study|Progressive disease|27|||
129973816|NCT00368875|467867899|FG000|Overall Study|Withdrawal by Subject|2|||
129973817|NCT00368875|467867900|FG001|Overall Study|Withdrawal by Subject|6|||
129973818|NCT00368875|467867899|FG000|Overall Study|Other Reason|0|||
129973819|NCT00368875|467867900|FG001|Overall Study|Other Reason|2|||
129973820|NCT00368875|467867899|FG000|Overall Study|Alternative Therapy|1|||
129973821|NCT00368875|467867900|FG001|Overall Study|Alternative Therapy|1|||
129973822|NCT01305239|467867901|FG000|Overall Study|Adverse Event|22|||
129973823|NCT01305239|467867901|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
129973824|NCT03229486|467867902|FG000|Overall Study|Protocol Violation|0|||
129973825|NCT03229486|467867903|FG001|Overall Study|Protocol Violation|1|||
129973826|NCT01461005|467867907|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
129973827|NCT04160988|467867912|FG000|Overall Study|poor image quality|28|||
129973828|NCT00844597|467867913|FG000|Overall Study|Adverse Event|0|||
129973829|NCT00844597|467867914|FG001|Overall Study|Adverse Event|0|||
129973830|NCT00844597|467867915|FG002|Overall Study|Adverse Event|0|||
129973831|NCT00844597|467867916|FG003|Overall Study|Adverse Event|1|||
129973832|NCT00844597|467867917|FG004|Overall Study|Adverse Event|0|||
129973833|NCT00844597|467867918|FG005|Overall Study|Adverse Event|0|||
129973834|NCT02670122|467867919|FG000|Overall Study|Lost to Follow-up|4|||
130137372|NCT01624233|468465252|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
130137373|NCT04241458|468465253|FG000|Overall Study|Withdrawal by Subject|0|||
130137374|NCT04241458|468465254|FG001|Overall Study|Withdrawal by Subject|0|||
130137375|NCT04241458|468465255|FG002|Overall Study|Withdrawal by Subject|0|||
130137376|NCT04241458|468465256|FG003|Overall Study|Withdrawal by Subject|0|||
130137377|NCT04241458|468465257|FG004|Overall Study|Withdrawal by Subject|1|||
130137378|NCT03428750|468465265|FG000|Overall Study|Withdrawal by Subject|11|||
130137379|NCT03428750|468465266|FG001|Overall Study|Withdrawal by Subject|10|||
130137380|NCT03428750|468465265|FG000|Overall Study|Lost to Follow-up|3|||
130137381|NCT03428750|468465266|FG001|Overall Study|Lost to Follow-up|9|||
130137382|NCT03428750|468465265|FG000|Overall Study|Adverse Event|9|||
130137383|NCT03428750|468465266|FG001|Overall Study|Adverse Event|1|||
130137384|NCT03428750|468465265|FG000|Overall Study|Protocol Violation|1|||
130137385|NCT03428750|468465266|FG001|Overall Study|Protocol Violation|0|||
130137386|NCT03428750|468465265|FG000|Overall Study|Administrative|0|||
130137387|NCT03428750|468465266|FG001|Overall Study|Administrative|1|||
130137388|NCT04547192|468465267|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
130137389|NCT04547192|468465268|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
130137390|NCT04547192|468465269|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
130137391|NCT04547192|468465270|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
130137392|NCT04547192|468465267|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
130137393|NCT04547192|468465268|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
130137394|NCT04547192|468465269|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
130137395|NCT04547192|468465270|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
130137396|NCT04547192|468465267|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
130137397|NCT04547192|468465268|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
130137398|NCT04547192|468465269|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
130137399|NCT04547192|468465270|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
130137400|NCT04547192|468465267|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
129973835|NCT02762903|467867925|FG000|Overall Study|Lost to Follow-up|0|||
129973836|NCT02762903|467867926|FG001|Overall Study|Lost to Follow-up|1|||
129973837|NCT01228175|467867927|FG000|Overall Study|Lost to Follow-up|64|||
130137401|NCT04547192|468465268|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
130137402|NCT04547192|468465269|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
130137403|NCT04547192|468465270|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
130137404|NCT04547192|468465267|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
130137405|NCT04547192|468465268|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
130137406|NCT04547192|468465269|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
130137407|NCT04547192|468465270|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
130137408|NCT04723693|468465271|FG000|Overall Study|Withdrawal by Subject|2|||
130137409|NCT01410227|468465272|FG000|Overall Study|Adverse Event|1|||
130137410|NCT01410227|468465273|FG001|Overall Study|Adverse Event|0|||
130137411|NCT01410227|468465274|FG002|Overall Study|Adverse Event|0|||
130137412|NCT01410227|468465275|FG003|Overall Study|Adverse Event|0|||
130137413|NCT01410227|468465272|FG000|Overall Study|Withdrawal by Subject|3|||
130137414|NCT01410227|468465273|FG001|Overall Study|Withdrawal by Subject|0|||
130137415|NCT01410227|468465274|FG002|Overall Study|Withdrawal by Subject|1|||
130137416|NCT01410227|468465275|FG003|Overall Study|Withdrawal by Subject|0|||
130137417|NCT01410227|468465272|FG000|Overall Study|Pregnancy|0|||
130137418|NCT01410227|468465273|FG001|Overall Study|Pregnancy|0|||
130137419|NCT01410227|468465274|FG002|Overall Study|Pregnancy|0|||
130137420|NCT01410227|468465275|FG003|Overall Study|Pregnancy|1|||
130137421|NCT01410227|468465272|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
130137422|NCT01410227|468465273|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
130137423|NCT01410227|468465274|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
130137424|NCT01410227|468465275|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
130137425|NCT03497130|468465276|FG000|Overall Study|Lost to Follow-up|1|||
130137426|NCT03497130|468465277|FG001|Overall Study|Lost to Follow-up|1|||
130137427|NCT04002648|468465278|FG000|Overall Study|Lost to Follow-up|2|||
130137428|NCT04002648|468465279|FG001|Overall Study|Lost to Follow-up|0|||
130137429|NCT00669162|468465283|FG000|Overall Study|Withdrawal by Subject|1|||
130137430|NCT02412852|468465284|FG000|Overall Study|Withdrawal by Subject|0|||
130137431|NCT02412852|468465285|FG001|Overall Study|Withdrawal by Subject|1|||
130137432|NCT02412852|468465286|FG002|Overall Study|Withdrawal by Subject|0|||
130137433|NCT02412852|468465287|FG003|Overall Study|Withdrawal by Subject|0|||
130137434|NCT02412852|468465284|FG000|Overall Study|Physician Decision|0|||
130137435|NCT02412852|468465285|FG001|Overall Study|Physician Decision|0|||
130137436|NCT02412852|468465286|FG002|Overall Study|Physician Decision|0|||
130137437|NCT02412852|468465287|FG003|Overall Study|Physician Decision|1|||
130137438|NCT01051349|468465288|FG000|Overall Study|Adverse Event|88|||
130137439|NCT01051349|468465288|FG000|Overall Study|Consent Withdrawn|54|||
130137440|NCT01051349|468465288|FG000|Overall Study|Investigator Decision|6|||
130137441|NCT01051349|468465288|FG000|Overall Study|Lost to Follow-up|6|||
130137442|NCT01051349|468465288|FG000|Overall Study|Subject non-compliance|7|||
130137443|NCT01051349|468465288|FG000|Overall Study|Reason not Specified|12|||
130137444|NCT00909753|468465289|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
130137445|NCT00909753|468465290|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
130137446|NCT00909753|468465289|FG000|Period: Second Intervention|Protocol Violation|1|||
130137447|NCT00909753|468465290|FG001|Period: Second Intervention|Protocol Violation|0|||
130137448|NCT00841542|468465293|FG000|Period 1|Adverse Event|1|||
130137449|NCT00841542|468465294|FG001|Period 1|Adverse Event|0|||
130137450|NCT00418145|468465295|FG000|Overall Study|study terminated|6|||
130137451|NCT03214588|468465296|FG000|Overall Study|Adverse Event|1|||
130137452|NCT03214588|468465297|FG001|Overall Study|Adverse Event|0|||
130137453|NCT03214588|468465298|FG002|Overall Study|Adverse Event|2|||
130137454|NCT03214588|468465296|FG000|Overall Study|Reason Not Specified|0|||
130137455|NCT03214588|468465297|FG001|Overall Study|Reason Not Specified|1|||
130137456|NCT03214588|468465298|FG002|Overall Study|Reason Not Specified|0|||
130137457|NCT00472212|468465299|FG000|Overall Study|Lost to Follow-up|6|||
130137458|NCT00472212|468465300|FG001|Overall Study|Lost to Follow-up|4|||
130137459|NCT03480763|468465305|FG000|Overall Study|Withdrawal by Subject|18|||
130137460|NCT03480763|468465306|FG001|Overall Study|Withdrawal by Subject|10|||
130137461|NCT03480763|468465305|FG000|Overall Study|Lost to Follow-up|4|||
130137462|NCT03480763|468465306|FG001|Overall Study|Lost to Follow-up|7|||
130137463|NCT03480763|468465305|FG000|Overall Study|non-study pneumococcal vaccine|1|||
130137464|NCT03480763|468465306|FG001|Overall Study|non-study pneumococcal vaccine|0|||
130137465|NCT03480763|468465305|FG000|Overall Study|oncological treatment|0|||
130137466|NCT03480763|468465306|FG001|Overall Study|oncological treatment|2|||
130137467|NCT03480763|468465305|FG000|Overall Study|pain with vaccination|1|||
130137468|NCT03480763|468465306|FG001|Overall Study|pain with vaccination|0|||
130137469|NCT01647828|468465307|FG000|Overall Study|Death|3|||
130137470|NCT01647828|468465308|FG001|Overall Study|Death|4|||
130137471|NCT01647828|468465309|FG002|Overall Study|Death|4|||
130137472|NCT01647828|468465310|FG003|Overall Study|Death|5|||
130137473|NCT01647828|468465311|FG004|Overall Study|Death|6|||
130137474|NCT01647828|468465312|FG005|Overall Study|Death|3|||
130137475|NCT01647828|468465313|FG006|Overall Study|Death|10|||
130137476|NCT01647828|468465314|FG007|Overall Study|Death|60|||
130137477|NCT01647828|468465315|FG008|Overall Study|Death|71|||
130137478|NCT01647828|468465307|FG000|Overall Study|Withdrawal by Subject|2|||
130137479|NCT01647828|468465308|FG001|Overall Study|Withdrawal by Subject|0|||
130137480|NCT01647828|468465309|FG002|Overall Study|Withdrawal by Subject|0|||
130137481|NCT01647828|468465310|FG003|Overall Study|Withdrawal by Subject|1|||
130137482|NCT01647828|468465311|FG004|Overall Study|Withdrawal by Subject|0|||
130137483|NCT01647828|468465312|FG005|Overall Study|Withdrawal by Subject|0|||
130137484|NCT01647828|468465313|FG006|Overall Study|Withdrawal by Subject|1|||
130137485|NCT01647828|468465314|FG007|Overall Study|Withdrawal by Subject|0|||
130137486|NCT01647828|468465315|FG008|Overall Study|Withdrawal by Subject|2|||
130137487|NCT01647828|468465307|FG000|Overall Study|Study terminated by Sponsor|0|||
130137488|NCT01647828|468465308|FG001|Overall Study|Study terminated by Sponsor|0|||
130137489|NCT01647828|468465309|FG002|Overall Study|Study terminated by Sponsor|0|||
130137490|NCT01647828|468465310|FG003|Overall Study|Study terminated by Sponsor|0|||
130137491|NCT01647828|468465311|FG004|Overall Study|Study terminated by Sponsor|0|||
130137492|NCT01647828|468465312|FG005|Overall Study|Study terminated by Sponsor|0|||
130137493|NCT01647828|468465313|FG006|Overall Study|Study terminated by Sponsor|1|||
130137494|NCT01647828|468465314|FG007|Overall Study|Study terminated by Sponsor|26|||
130137495|NCT01647828|468465315|FG008|Overall Study|Study terminated by Sponsor|16|||
130137496|NCT01647828|468465307|FG000|Overall Study|Lost to Follow-up|0|||
130137497|NCT01647828|468465308|FG001|Overall Study|Lost to Follow-up|0|||
130137498|NCT01647828|468465309|FG002|Overall Study|Lost to Follow-up|0|||
130137499|NCT01647828|468465310|FG003|Overall Study|Lost to Follow-up|0|||
130137500|NCT01647828|468465311|FG004|Overall Study|Lost to Follow-up|0|||
130137501|NCT01647828|468465312|FG005|Overall Study|Lost to Follow-up|0|||
130137502|NCT01647828|468465313|FG006|Overall Study|Lost to Follow-up|0|||
130137503|NCT01647828|468465314|FG007|Overall Study|Lost to Follow-up|2|||
130137504|NCT01647828|468465315|FG008|Overall Study|Lost to Follow-up|0|||
130137505|NCT01906372|468465316|FG000|Overall Study|Withdrawal by Subject|2|||
130137506|NCT03629054|468465318|FG000|Period 2 (4 Days)|Not treated|0|||
130137507|NCT03629054|468465319|FG001|Period 2 (4 Days)|Not treated|1|||
130137508|NCT00624286|468465326|FG000|Overall Study|Protocol Deviation|7|||
130137509|NCT00624286|468465327|FG001|Overall Study|Protocol Deviation|9|||
130137510|NCT00624286|468465326|FG000|Overall Study|Adverse Event|6|||
130137511|NCT00624286|468465327|FG001|Overall Study|Adverse Event|3|||
129973838|NCT01228175|467867928|FG001|Overall Study|Lost to Follow-up|50|||
129973839|NCT01228175|467867927|FG000|Overall Study|Withdrawal by Subject|1|||
129973840|NCT01228175|467867928|FG001|Overall Study|Withdrawal by Subject|2|||
129973841|NCT01228175|467867927|FG000|Overall Study|Physician Decision|1|||
129973842|NCT01228175|467867928|FG001|Overall Study|Physician Decision|1|||
129973843|NCT00243074|467867929|FG000|Overall Study|Ineligible|6|||
129973844|NCT00243074|467867929|FG000|Overall Study|Adverse Event|6|||
129973845|NCT00243074|467867929|FG000|Overall Study|Withdrawal by Subject|2|||
129973846|NCT00243074|467867929|FG000|Overall Study|Lack of Efficacy|36|||
129973847|NCT00243074|467867929|FG000|Overall Study|Death|2|||
130137512|NCT00624286|468465326|FG000|Overall Study|Withdrawal by Subject|5|||
130137513|NCT00624286|468465327|FG001|Overall Study|Withdrawal by Subject|4|||
130137514|NCT00624286|468465326|FG000|Overall Study|Lost to Follow-up|3|||
130137515|NCT00624286|468465327|FG001|Overall Study|Lost to Follow-up|2|||
130137516|NCT00624286|468465326|FG000|Overall Study|Administrative problems|3|||
130137517|NCT00624286|468465327|FG001|Overall Study|Administrative problems|0|||
130137518|NCT00624286|468465326|FG000|Overall Study|Lack of Efficacy|1|||
130137519|NCT00624286|468465327|FG001|Overall Study|Lack of Efficacy|6|||
130137520|NCT00624286|468465326|FG000|Overall Study|Not stated|0|||
130137521|NCT00624286|468465327|FG001|Overall Study|Not stated|1|||
130137522|NCT00624286|468465326|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130137523|NCT00624286|468465327|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129973848|NCT00243074|467867929|FG000|Overall Study|not protocol specified|1|||
129973849|NCT00243074|467867929|FG000|Overall Study|Did not receive any treatment|1|||
129973850|NCT00664534|467867930|FG000|Overall Study|Adverse Event|2|||
129973851|NCT00664534|467867931|FG001|Overall Study|Adverse Event|3|||
129973852|NCT00664534|467867930|FG000|Overall Study|Lost to Follow-up|6|||
129973853|NCT00664534|467867931|FG001|Overall Study|Lost to Follow-up|10|||
129973854|NCT00664534|467867930|FG000|Overall Study|Protocol Violation|10|||
129973855|NCT00664534|467867931|FG001|Overall Study|Protocol Violation|8|||
129973856|NCT00664534|467867930|FG000|Overall Study|Withdrawal by Subject|7|||
129973857|NCT00664534|467867931|FG001|Overall Study|Withdrawal by Subject|6|||
129973858|NCT00664534|467867930|FG000|Overall Study|Physician Decision|8|||
129973859|NCT00664534|467867931|FG001|Overall Study|Physician Decision|0|||
129973860|NCT00664534|467867930|FG000|Overall Study|Sponsor decision|8|||
129973861|NCT00664534|467867931|FG001|Overall Study|Sponsor decision|6|||
129973862|NCT03041792|467867934|FG000|Overall Study|Adverse Event|4|||
129973863|NCT03041792|467867935|FG001|Overall Study|Adverse Event|0|||
129973864|NCT03041792|467867934|FG000|Overall Study|Death in the family|0|||
129973865|NCT03041792|467867935|FG001|Overall Study|Death in the family|2|||
129973866|NCT03041792|467867934|FG000|Overall Study|Randomized but not treated|0|||
129973867|NCT03041792|467867935|FG001|Overall Study|Randomized but not treated|1|||
129973868|NCT04978090|467867936|FG000|Overall Study|unable to adequately fit device|2|||
130137524|NCT00624286|468465326|FG000|Overall Study|Death|0|||
130137525|NCT00624286|468465327|FG001|Overall Study|Death|1|||
130137526|NCT04404725|468465328|FG000|First Intervention|Withdrawal by Subject|0|||
130137527|NCT04404725|468465329|FG001|First Intervention|Withdrawal by Subject|2|||
129973869|NCT02227992|467867937|FG000|Overall Study|Lost to Follow-up|1|||
129973870|NCT02227992|467867938|FG001|Overall Study|Lost to Follow-up|1|||
129973871|NCT00996606|467867941|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
130137528|NCT04404725|468465328|FG000|Second Intervention|Adverse Event|1|||
130137529|NCT04404725|468465329|FG001|Second Intervention|Adverse Event|1|||
129973872|NCT00996606|467867941|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129973873|NCT00996606|467867941|FG000|Overall Study|Protocol Violation|1|||
129973874|NCT00996606|467867941|FG000|Overall Study|Withdrawal by Subject|3|||
129973875|NCT00632502|467867943|FG000|Overall Study|Adverse Event|0|||
129973876|NCT00632502|467867944|FG001|Overall Study|Adverse Event|1|||
129973877|NCT00632502|467867943|FG000|Overall Study|Randomized not treated|3|||
129973878|NCT00632502|467867944|FG001|Overall Study|Randomized not treated|0|||
129973879|NCT03075527|467867945|FG000|Overall Study|Death|1|||
129973880|NCT03075527|467867945|FG000|Overall Study|Withdrawal by Subject|1|||
129973881|NCT03075527|467867945|FG000|Overall Study|Physician Decision|3|||
129973882|NCT03075527|467867945|FG000|Overall Study|Progression/Relapse|14|||
129973883|NCT00681668|467867946|FG000|Overall Study|Protocol Violation|1|||
129973884|NCT00681668|467867946|FG000|Overall Study|Withdrawal by Subject|1|||
129973885|NCT02209181|467867947|FG000|Overall Study|Adverse Event|1|||
129973886|NCT02209181|467867948|FG001|Overall Study|Adverse Event|0|||
129973887|NCT02209181|467867949|FG002|Overall Study|Adverse Event|1|||
129973888|NCT02209181|467867950|FG003|Overall Study|Adverse Event|0|||
129973889|NCT02209181|467867947|FG000|Overall Study|Withdrawal by Subject|0|||
129973890|NCT02209181|467867948|FG001|Overall Study|Withdrawal by Subject|1|||
129973891|NCT02209181|467867949|FG002|Overall Study|Withdrawal by Subject|0|||
129973892|NCT02209181|467867950|FG003|Overall Study|Withdrawal by Subject|0|||
129973893|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
129973894|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
129973895|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
129973896|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
129973897|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
129973898|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973899|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973900|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973901|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
129973902|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973903|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
129973904|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
129973905|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
129973906|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
129973907|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
129973908|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Death|1|||
129973909|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Death|0|||
129973910|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Death|0|||
129973911|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Death|0|||
129973912|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Death|0|||
129973913|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
129973914|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
129973915|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
129973916|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
130137530|NCT04404725|468465328|FG000|Second Intervention|Withdrawal by Subject|0|||
130137531|NCT04404725|468465329|FG001|Second Intervention|Withdrawal by Subject|1|||
130137532|NCT01075516|468465330|FG000|Overall Study|Death|5|||
129973917|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
129973918|NCT04641962|467867956|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
129973919|NCT04641962|467867957|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
129973920|NCT04641962|467867958|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
129973921|NCT04641962|467867959|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
129973922|NCT04641962|467867960|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
129973923|NCT04641962|467867956|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129973924|NCT04641962|467867957|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129973925|NCT04641962|467867958|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
129973926|NCT04641962|467867959|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129973927|NCT04641962|467867960|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
130137533|NCT01075516|468465331|FG001|Overall Study|Death|9|||
130137534|NCT01075516|468465330|FG000|Overall Study|Lost to Follow-up|10|||
130137535|NCT01075516|468465331|FG001|Overall Study|Lost to Follow-up|2|||
130137536|NCT01075516|468465330|FG000|Overall Study|Withdrawal by Subject|3|||
130137537|NCT01075516|468465331|FG001|Overall Study|Withdrawal by Subject|5|||
130137538|NCT02252016|468465332|FG000|Overall Study|Lost to Follow-up|2|||
130137539|NCT02252016|468465333|FG001|Overall Study|Lost to Follow-up|1|||
130137540|NCT02252016|468465332|FG000|Overall Study|Physician Decision|1|||
130137541|NCT02252016|468465333|FG001|Overall Study|Physician Decision|0|||
130137542|NCT02252016|468465332|FG000|Overall Study|Withdrawal by Subject|0|||
130137543|NCT02252016|468465333|FG001|Overall Study|Withdrawal by Subject|2|||
129973928|NCT00862836|467867961|FG000|Overall Study|Withdrawal by Subject|1|||
129973929|NCT06926673|467867962|FG000|Overall Study|Lost to Follow-up|0|||
129973930|NCT06926673|467867963|FG001|Overall Study|Lost to Follow-up|0|||
129973931|NCT06926673|467867964|FG002|Overall Study|Lost to Follow-up|0|||
129973932|NCT06926673|467867965|FG003|Overall Study|Lost to Follow-up|1|||
129973933|NCT06926673|467867966|FG004|Overall Study|Lost to Follow-up|0|||
129973934|NCT06926673|467867967|FG005|Overall Study|Lost to Follow-up|0|||
129973935|NCT06926673|467867968|FG006|Overall Study|Lost to Follow-up|0|||
130137544|NCT04631562|468465336|FG000|Overall Study|Withdrawal by Subject|0|||
130137545|NCT04631562|468465337|FG001|Overall Study|Withdrawal by Subject|0|||
130137546|NCT04631562|468465338|FG002|Overall Study|Withdrawal by Subject|0|||
130137547|NCT04631562|468465339|FG003|Overall Study|Withdrawal by Subject|0|||
130137548|NCT04631562|468465340|FG004|Overall Study|Withdrawal by Subject|0|||
130137549|NCT04631562|468465341|FG005|Overall Study|Withdrawal by Subject|0|||
130137550|NCT04631562|468465342|FG006|Overall Study|Withdrawal by Subject|0|||
130137551|NCT04631562|468465343|FG007|Overall Study|Withdrawal by Subject|1|||
130137552|NCT04631562|468465344|FG008|Overall Study|Withdrawal by Subject|0|||
130137553|NCT04631562|468465336|FG000|Overall Study|Other|0|||
130137554|NCT04631562|468465337|FG001|Overall Study|Other|0|||
130137555|NCT04631562|468465338|FG002|Overall Study|Other|0|||
130137556|NCT04631562|468465339|FG003|Overall Study|Other|0|||
130137557|NCT04631562|468465340|FG004|Overall Study|Other|0|||
130137558|NCT04631562|468465341|FG005|Overall Study|Other|0|||
130137559|NCT04631562|468465342|FG006|Overall Study|Other|0|||
130137560|NCT04631562|468465343|FG007|Overall Study|Other|0|||
130137561|NCT04631562|468465344|FG008|Overall Study|Other|1|||
130137562|NCT04631562|468465336|FG000|Overall Study|Lost to Follow-up|0|||
130137563|NCT04631562|468465337|FG001|Overall Study|Lost to Follow-up|0|||
130137564|NCT04631562|468465338|FG002|Overall Study|Lost to Follow-up|0|||
130137565|NCT04631562|468465339|FG003|Overall Study|Lost to Follow-up|1|||
130137566|NCT04631562|468465340|FG004|Overall Study|Lost to Follow-up|0|||
130137567|NCT04631562|468465341|FG005|Overall Study|Lost to Follow-up|0|||
130137568|NCT04631562|468465342|FG006|Overall Study|Lost to Follow-up|0|||
130137569|NCT04631562|468465343|FG007|Overall Study|Lost to Follow-up|0|||
130137570|NCT04631562|468465344|FG008|Overall Study|Lost to Follow-up|0|||
130137571|NCT04631562|468465336|FG000|Overall Study|Adverse Event|0|||
130137572|NCT04631562|468465337|FG001|Overall Study|Adverse Event|0|||
130137573|NCT04631562|468465338|FG002|Overall Study|Adverse Event|0|||
130137574|NCT04631562|468465339|FG003|Overall Study|Adverse Event|0|||
130137575|NCT04631562|468465340|FG004|Overall Study|Adverse Event|0|||
130137576|NCT04631562|468465341|FG005|Overall Study|Adverse Event|0|||
130137577|NCT04631562|468465342|FG006|Overall Study|Adverse Event|1|||
130137578|NCT04631562|468465343|FG007|Overall Study|Adverse Event|0|||
130137579|NCT04631562|468465344|FG008|Overall Study|Adverse Event|0|||
130137580|NCT01190865|468465350|FG000|Overall Study|Withdrawal by Subject|1|||
130137581|NCT01190865|468465350|FG000|Overall Study|Non-compliance|2|||
130137582|NCT02436200|468465357|FG000|Overall Study|Significant outlier|1|||
130137583|NCT00868998|468465373|FG000|Overall Study|Screen Failure|1|||
130137584|NCT00868998|468465373|FG000|Overall Study|Withdrawal by Subject|1|||
130137585|NCT00868998|468465373|FG000|Overall Study|Progression of disease|2|||
130137586|NCT00868998|468465373|FG000|Overall Study|Death|1|||
130137587|NCT01483820|468465374|FG000|Overall Study|Lack of Efficacy|6|||
130137588|NCT01483820|468465374|FG000|Overall Study|Adverse Event|1|||
130137589|NCT01483820|468465374|FG000|Overall Study|Death|1|||
130137590|NCT00867360|468465375|FG000|Overall Study|Withdrawal by Subject|1|||
130137591|NCT00867360|468465376|FG001|Overall Study|Withdrawal by Subject|0|||
130137592|NCT00867360|468465375|FG000|Overall Study|Physician Decision|0|||
130137593|NCT00867360|468465376|FG001|Overall Study|Physician Decision|1|||
130137594|NCT00842309|468465377|FG000|Overall Study|Withdrawal by Subject|3|||
130137595|NCT00842309|468465378|FG001|Overall Study|Withdrawal by Subject|1|||
130137596|NCT03218787|468465379|FG000|Overall Study|Lost to Follow-up|12|||
130137597|NCT03218787|468465379|FG000|Overall Study|Withdrawal by Subject|72|||
130137598|NCT03218787|468465379|FG000|Overall Study|Physician Decision|11|||
130137599|NCT03218787|468465379|FG000|Overall Study|Death|111|||
130137600|NCT02264977|468465380|FG000|Overall Study|Death|3|||
130137601|NCT02264977|468465380|FG000|Overall Study|Physician Decision|1|||
130137602|NCT02264977|468465380|FG000|Overall Study|Refuse to return|1|||
130137603|NCT03573544|468465381|FG000|Overall Study|Adverse Event|0|||
130137604|NCT03573544|468465382|FG001|Overall Study|Adverse Event|0|||
130137605|NCT03573544|468465383|FG002|Overall Study|Adverse Event|0|||
130137606|NCT03573544|468465384|FG003|Overall Study|Adverse Event|3|||
130137607|NCT03573544|468465385|FG004|Overall Study|Adverse Event|1|||
130137608|NCT03573544|468465386|FG005|Overall Study|Adverse Event|0|||
130137609|NCT03573544|468465387|FG006|Overall Study|Adverse Event|2|||
130137610|NCT03573544|468465388|FG007|Overall Study|Adverse Event|0|||
130137611|NCT03573544|468465381|FG000|Overall Study|Physician Decision|0|||
129973936|NCT06926673|467867962|FG000|Overall Study|Physician Decision|0|||
130137612|NCT03573544|468465382|FG001|Overall Study|Physician Decision|0|||
129973937|NCT06926673|467867963|FG001|Overall Study|Physician Decision|0|||
130137613|NCT03573544|468465383|FG002|Overall Study|Physician Decision|0|||
130137614|NCT03573544|468465384|FG003|Overall Study|Physician Decision|0|||
130137615|NCT03573544|468465385|FG004|Overall Study|Physician Decision|0|||
130137616|NCT03573544|468465386|FG005|Overall Study|Physician Decision|0|||
130137617|NCT03573544|468465387|FG006|Overall Study|Physician Decision|1|||
130137618|NCT03573544|468465388|FG007|Overall Study|Physician Decision|0|||
130137619|NCT03573544|468465381|FG000|Overall Study|Withdrawal by Subject|2|||
130137620|NCT03573544|468465382|FG001|Overall Study|Withdrawal by Subject|0|||
130137621|NCT03573544|468465383|FG002|Overall Study|Withdrawal by Subject|0|||
130137622|NCT03573544|468465384|FG003|Overall Study|Withdrawal by Subject|1|||
130137623|NCT03573544|468465385|FG004|Overall Study|Withdrawal by Subject|1|||
129973938|NCT06926673|467867964|FG002|Overall Study|Physician Decision|0|||
129973939|NCT06926673|467867965|FG003|Overall Study|Physician Decision|0|||
129973940|NCT06926673|467867966|FG004|Overall Study|Physician Decision|0|||
129973941|NCT06926673|467867967|FG005|Overall Study|Physician Decision|0|||
129973942|NCT06926673|467867968|FG006|Overall Study|Physician Decision|1|||
129973943|NCT06926673|467867962|FG000|Overall Study|Withdrawal by Subject|0|||
129973944|NCT06926673|467867963|FG001|Overall Study|Withdrawal by Subject|3|||
129973945|NCT06926673|467867964|FG002|Overall Study|Withdrawal by Subject|2|||
129973946|NCT06926673|467867965|FG003|Overall Study|Withdrawal by Subject|1|||
129973947|NCT06926673|467867966|FG004|Overall Study|Withdrawal by Subject|0|||
130137624|NCT03573544|468465386|FG005|Overall Study|Withdrawal by Subject|1|||
130137625|NCT03573544|468465387|FG006|Overall Study|Withdrawal by Subject|0|||
130137626|NCT03573544|468465388|FG007|Overall Study|Withdrawal by Subject|1|||
130137627|NCT03573544|468465381|FG000|Overall Study|Disease progression|3|||
130137628|NCT03573544|468465382|FG001|Overall Study|Disease progression|3|||
130137629|NCT03573544|468465383|FG002|Overall Study|Disease progression|6|||
130137630|NCT03573544|468465384|FG003|Overall Study|Disease progression|4|||
130137631|NCT03573544|468465385|FG004|Overall Study|Disease progression|5|||
130137632|NCT03573544|468465386|FG005|Overall Study|Disease progression|7|||
130137633|NCT03573544|468465387|FG006|Overall Study|Disease progression|6|||
130137634|NCT03573544|468465388|FG007|Overall Study|Disease progression|7|||
130137635|NCT01838681|468465389|FG000|Period A|Adverse Event|39|||
130137636|NCT01838681|468465390|FG001|Period A|Adverse Event|0|||
130137637|NCT01838681|468465391|FG002|Period A|Adverse Event|0|||
130137638|NCT01838681|468465392|FG003|Period A|Adverse Event|0|||
130137639|NCT01838681|468465389|FG000|Period A|Lack of Efficacy|21|||
130137640|NCT01838681|468465390|FG001|Period A|Lack of Efficacy|0|||
130137641|NCT01838681|468465391|FG002|Period A|Lack of Efficacy|0|||
130137642|NCT01838681|468465392|FG003|Period A|Lack of Efficacy|0|||
130137643|NCT01838681|468465389|FG000|Period A|Early response|148|||
130137644|NCT01838681|468465390|FG001|Period A|Early response|0|||
130137645|NCT01838681|468465391|FG002|Period A|Early response|0|||
130137646|NCT01838681|468465392|FG003|Period A|Early response|0|||
130137647|NCT01838681|468465389|FG000|Period A|Withdrawal by Subject|70|||
130137648|NCT01838681|468465390|FG001|Period A|Withdrawal by Subject|0|||
130137649|NCT01838681|468465391|FG002|Period A|Withdrawal by Subject|0|||
130137650|NCT01838681|468465392|FG003|Period A|Withdrawal by Subject|0|||
130137651|NCT01838681|468465389|FG000|Period A|Protocol Violation|16|||
130137652|NCT01838681|468465390|FG001|Period A|Protocol Violation|0|||
130137653|NCT01838681|468465391|FG002|Period A|Protocol Violation|0|||
130137654|NCT01838681|468465392|FG003|Period A|Protocol Violation|0|||
130137655|NCT01838681|468465389|FG000|Period A|Non-compliance with IMP|6|||
130137656|NCT01838681|468465390|FG001|Period A|Non-compliance with IMP|0|||
130137657|NCT01838681|468465391|FG002|Period A|Non-compliance with IMP|0|||
130137658|NCT01838681|468465392|FG003|Period A|Non-compliance with IMP|0|||
130137659|NCT01838681|468465389|FG000|Period A|Lost to Follow-up|4|||
130137660|NCT01838681|468465390|FG001|Period A|Lost to Follow-up|0|||
130137661|NCT01838681|468465391|FG002|Period A|Lost to Follow-up|0|||
130137662|NCT01838681|468465392|FG003|Period A|Lost to Follow-up|0|||
130137663|NCT01838681|468465389|FG000|Period A|Withdrawal before treatment|4|||
130137664|NCT01838681|468465390|FG001|Period A|Withdrawal before treatment|0|||
130137665|NCT01838681|468465391|FG002|Period A|Withdrawal before treatment|0|||
130137666|NCT01838681|468465392|FG003|Period A|Withdrawal before treatment|0|||
130137667|NCT01838681|468465389|FG000|Period A|Administrative or other reasons|17|||
130137668|NCT01838681|468465390|FG001|Period A|Administrative or other reasons|0|||
130137669|NCT01838681|468465391|FG002|Period A|Administrative or other reasons|0|||
130137670|NCT01838681|468465392|FG003|Period A|Administrative or other reasons|0|||
130137671|NCT01838681|468465389|FG000|Period B/A+|Adverse Event|0|||
130137672|NCT01838681|468465390|FG001|Period B/A+|Adverse Event|13|||
129973948|NCT06926673|467867967|FG005|Overall Study|Withdrawal by Subject|2|||
129973949|NCT06926673|467867968|FG006|Overall Study|Withdrawal by Subject|0|||
130137673|NCT01838681|468465391|FG002|Period B/A+|Adverse Event|27|||
130137674|NCT01838681|468465392|FG003|Period B/A+|Adverse Event|16|||
130137675|NCT01838681|468465389|FG000|Period B/A+|Lack of Efficacy|0|||
130137676|NCT01838681|468465390|FG001|Period B/A+|Lack of Efficacy|9|||
130137677|NCT01838681|468465391|FG002|Period B/A+|Lack of Efficacy|11|||
130137678|NCT01838681|468465392|FG003|Period B/A+|Lack of Efficacy|6|||
130137679|NCT01838681|468465389|FG000|Period B/A+|Withdrawal by Subject|0|||
130137680|NCT01838681|468465390|FG001|Period B/A+|Withdrawal by Subject|28|||
130137681|NCT01838681|468465391|FG002|Period B/A+|Withdrawal by Subject|35|||
129973950|NCT03374488|467869575|FG000|Overall Study|Death|13|||
129973951|NCT03374488|467869576|FG001|Overall Study|Death|13|||
129973952|NCT03374488|467869575|FG000|Overall Study|Withdrawal by Subject|3|||
130137682|NCT01838681|468465392|FG003|Period B/A+|Withdrawal by Subject|47|||
130137683|NCT01838681|468465389|FG000|Period B/A+|Protocol Violation|0|||
130137684|NCT01838681|468465390|FG001|Period B/A+|Protocol Violation|1|||
130137685|NCT01838681|468465391|FG002|Period B/A+|Protocol Violation|4|||
130137686|NCT01838681|468465392|FG003|Period B/A+|Protocol Violation|6|||
130137687|NCT01838681|468465389|FG000|Period B/A+|Non-compliance with IMP|0|||
130137688|NCT01838681|468465390|FG001|Period B/A+|Non-compliance with IMP|2|||
130137689|NCT01838681|468465391|FG002|Period B/A+|Non-compliance with IMP|3|||
130137690|NCT01838681|468465392|FG003|Period B/A+|Non-compliance with IMP|3|||
130137691|NCT01838681|468465389|FG000|Period B/A+|Lost to Follow-up|0|||
130137692|NCT01838681|468465390|FG001|Period B/A+|Lost to Follow-up|2|||
130137693|NCT01838681|468465391|FG002|Period B/A+|Lost to Follow-up|5|||
130137694|NCT01838681|468465392|FG003|Period B/A+|Lost to Follow-up|11|||
130137695|NCT01838681|468465389|FG000|Period B/A+|Withdrawal before treatment|0|||
130137696|NCT01838681|468465390|FG001|Period B/A+|Withdrawal before treatment|1|||
130137697|NCT01838681|468465391|FG002|Period B/A+|Withdrawal before treatment|0|||
130137698|NCT01838681|468465392|FG003|Period B/A+|Withdrawal before treatment|0|||
130137699|NCT01838681|468465389|FG000|Period B/A+|Administrative or other reasons|0|||
130137700|NCT01838681|468465390|FG001|Period B/A+|Administrative or other reasons|6|||
130137701|NCT01838681|468465391|FG002|Period B/A+|Administrative or other reasons|10|||
130137702|NCT01838681|468465392|FG003|Period B/A+|Administrative or other reasons|28|||
130137703|NCT02011945|468465393|FG000|Overall Study|Participant requested to Discontinue|0|||
130137704|NCT02011945|468465394|FG001|Overall Study|Participant requested to Discontinue|1|||
130137705|NCT02011945|468465395|FG002|Overall Study|Participant requested to Discontinue|1|||
130137706|NCT02011945|468465393|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
130137707|NCT02011945|468465394|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
130137708|NCT02011945|468465395|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
130137709|NCT02011945|468465393|FG000|Overall Study|Study Drug Toxicity|0|||
130137710|NCT02011945|468465394|FG001|Overall Study|Study Drug Toxicity|0|||
130137711|NCT02011945|468465395|FG002|Overall Study|Study Drug Toxicity|1|||
130137712|NCT02011945|468465393|FG000|Overall Study|Treatment Failure|0|||
130137713|NCT02011945|468465394|FG001|Overall Study|Treatment Failure|7|||
130137714|NCT02011945|468465395|FG002|Overall Study|Treatment Failure|6|||
130137715|NCT02011945|468465393|FG000|Overall Study|No Longer Meets Study Criteria|1|||
130137716|NCT02011945|468465394|FG001|Overall Study|No Longer Meets Study Criteria|0|||
130137717|NCT02011945|468465395|FG002|Overall Study|No Longer Meets Study Criteria|0|||
130137718|NCT02011945|468465393|FG000|Overall Study|Proceeded to stem cell transplant|0|||
130137719|NCT02011945|468465394|FG001|Overall Study|Proceeded to stem cell transplant|0|||
130137720|NCT02011945|468465395|FG002|Overall Study|Proceeded to stem cell transplant|1|||
130137721|NCT02011945|468465393|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
130137722|NCT02011945|468465394|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
130137723|NCT02011945|468465395|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
130137724|NCT00849797|468465396|FG000|First Intervention|bad veins|1|||
130137725|NCT00849797|468465397|FG001|First Intervention|bad veins|0|||
130137726|NCT00849797|468465396|FG000|First Intervention|Adverse Event|0|||
130137727|NCT00849797|468465397|FG001|First Intervention|Adverse Event|1|||
130137728|NCT00849797|468465396|FG000|Washout: One Week|Withdrawal by Subject|0|||
130137729|NCT00849797|468465397|FG001|Washout: One Week|Withdrawal by Subject|2|||
130137730|NCT01279486|468465398|FG000|Overall Study|Lost to Follow-up|1|||
130137731|NCT04198363|468465402|FG000|Overall Study|Adverse Event|1|||
130137732|NCT04198363|468465403|FG001|Overall Study|Adverse Event|1|||
130137733|NCT04198363|468465402|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
130137734|NCT04198363|468465403|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
130137735|NCT04198363|468465402|FG000|Overall Study|Reason not Specified|1|||
130137736|NCT04198363|468465403|FG001|Overall Study|Reason not Specified|0|||
130137737|NCT03067987|468465405|FG000|Overall Study|Lost to Follow-up|7|||
130137738|NCT03067987|468465406|FG001|Overall Study|Lost to Follow-up|10|||
130137739|NCT03067987|468465405|FG000|Overall Study|Protocol Violation|1|||
130137740|NCT03067987|468465406|FG001|Overall Study|Protocol Violation|2|||
130137741|NCT03067987|468465405|FG000|Overall Study|Withdrawal by Subject|2|||
130137742|NCT03067987|468465406|FG001|Overall Study|Withdrawal by Subject|1|||
130137743|NCT01404988|468465409|FG000|Overall Study|Death|2|||
130137744|NCT01404988|468465410|FG001|Overall Study|Death|0|||
130137745|NCT01404988|468465411|FG002|Overall Study|Death|2|||
130137746|NCT01404988|468465409|FG000|Overall Study|Adverse Event|1|||
130137747|NCT01404988|468465410|FG001|Overall Study|Adverse Event|0|||
130137748|NCT01404988|468465411|FG002|Overall Study|Adverse Event|0|||
130137749|NCT01404988|468465409|FG000|Overall Study|Withdrawal by Subject|2|||
130137750|NCT01404988|468465410|FG001|Overall Study|Withdrawal by Subject|2|||
130137751|NCT01404988|468465411|FG002|Overall Study|Withdrawal by Subject|0|||
130137752|NCT01404988|468465409|FG000|Overall Study|Lost to Follow-up|1|||
130137753|NCT01404988|468465410|FG001|Overall Study|Lost to Follow-up|2|||
130137754|NCT01404988|468465411|FG002|Overall Study|Lost to Follow-up|1|||
130137755|NCT00829764|468465412|FG000|First Intervention|Adverse Event|1|||
130137756|NCT00829764|468465413|FG001|First Intervention|Adverse Event|0|||
130137757|NCT00829764|468465412|FG000|First Intervention|Withdrawal by Subject|1|||
130137758|NCT00829764|468465413|FG001|First Intervention|Withdrawal by Subject|1|||
130137759|NCT04594252|468465414|FG000|Overall Study|Adverse Event|0|||
130137760|NCT04594252|468465415|FG001|Overall Study|Adverse Event|2|||
130137761|NCT01952691|468467565|FG000|Overall Study|Lost to Follow-up|2|||
130137762|NCT00199901|468467566|FG000|Overall Study|Protocol Violation|2|||
130137763|NCT00199901|468467567|FG001|Overall Study|Protocol Violation|0|||
130137764|NCT00199901|468467566|FG000|Overall Study|Withdrawal by Subject|1|||
130137765|NCT00199901|468467567|FG001|Overall Study|Withdrawal by Subject|0|||
130137766|NCT00199901|468467566|FG000|Overall Study|Progressive Disease|24|||
130137767|NCT00199901|468467567|FG001|Overall Study|Progressive Disease|24|||
130137768|NCT05776901|468467570|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
130137769|NCT02997176|468467573|FG000|Overall Study|Adverse Event|0|||
130137770|NCT02997176|468467574|FG001|Overall Study|Adverse Event|0|||
130137771|NCT02997176|468467575|FG002|Overall Study|Adverse Event|0|||
130137772|NCT02997176|468467576|FG003|Overall Study|Adverse Event|8|||
130137773|NCT02997176|468467573|FG000|Overall Study|Progressive Disease|1|||
130137774|NCT02997176|468467574|FG001|Overall Study|Progressive Disease|0|||
130137775|NCT02997176|468467575|FG002|Overall Study|Progressive Disease|1|||
130137776|NCT02997176|468467576|FG003|Overall Study|Progressive Disease|1|||
130137777|NCT02997176|468467573|FG000|Overall Study|Death|0|||
130137778|NCT02997176|468467574|FG001|Overall Study|Death|0|||
130137779|NCT02997176|468467575|FG002|Overall Study|Death|1|||
130137780|NCT02997176|468467576|FG003|Overall Study|Death|1|||
130137781|NCT02997176|468467573|FG000|Overall Study|Withdrawal by Subject|0|||
130137782|NCT02997176|468467574|FG001|Overall Study|Withdrawal by Subject|2|||
130137783|NCT02997176|468467575|FG002|Overall Study|Withdrawal by Subject|0|||
130137784|NCT02997176|468467576|FG003|Overall Study|Withdrawal by Subject|1|||
130137785|NCT00373256|468467577|FG000|Overall Study|Adverse Event (AE)|1|||
130137786|NCT00373256|468467578|FG001|Overall Study|Adverse Event (AE)|5|||
130137787|NCT00373256|468467577|FG000|Overall Study|Lost to Follow-up|2|||
130137788|NCT00373256|468467578|FG001|Overall Study|Lost to Follow-up|1|||
130137789|NCT00373256|468467577|FG000|Overall Study|Death|9|||
130137790|NCT00373256|468467578|FG001|Overall Study|Death|8|||
130137791|NCT00373256|468467577|FG000|Overall Study|Objective Progression or Relapse|111|||
130137792|NCT00373256|468467578|FG001|Overall Study|Objective Progression or Relapse|104|||
130137793|NCT00373256|468467577|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
130137794|NCT00373256|468467578|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
130137795|NCT00373256|468467577|FG000|Overall Study|Other|73|||
130137796|NCT00373256|468467578|FG001|Overall Study|Other|107|||
130137797|NCT00373256|468467577|FG000|Overall Study|Protocol Violation|0|||
130137798|NCT00373256|468467578|FG001|Overall Study|Protocol Violation|2|||
130137799|NCT00373256|468467577|FG000|Overall Study|Study Terminated by Sponsor|41|||
130137800|NCT00373256|468467578|FG001|Overall Study|Study Terminated by Sponsor|13|||
130137801|NCT06144424|468467579|FG000|Overall Study|Withdrawal by Subject|2|||
130137802|NCT06144424|468467580|FG001|Overall Study|Withdrawal by Subject|0|||
130137803|NCT06144424|468467579|FG000|Overall Study|Incarceration|1|||
130137804|NCT06144424|468467580|FG001|Overall Study|Incarceration|0|||
130137805|NCT02727192|468467583|FG000|Overall Study|Lost to Follow-up|1|||
130137806|NCT02727192|468467584|FG001|Overall Study|Lost to Follow-up|0|||
130137807|NCT02727192|468467585|FG002|Overall Study|Lost to Follow-up|0|||
130137808|NCT00928057|468467586|FG000|Overall Study|Adverse Event|1|||
130137809|NCT00928057|468467587|FG001|Overall Study|Adverse Event|2|||
130137810|NCT00928057|468467586|FG000|Overall Study|Withdrawal by Subject|1|||
130137811|NCT00928057|468467587|FG001|Overall Study|Withdrawal by Subject|0|||
130137812|NCT00928057|468467586|FG000|Overall Study|Lost to Follow-up|0|||
130137813|NCT00928057|468467587|FG001|Overall Study|Lost to Follow-up|1|||
130137814|NCT00928057|468467586|FG000|Overall Study|Protocol Violation|0|||
130137815|NCT00928057|468467587|FG001|Overall Study|Protocol Violation|1|||
130137816|NCT05497557|468467590|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
130137817|NCT05497557|468467591|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
130137818|NCT05497557|468467592|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
130137819|NCT02752074|468467593|FG000|Overall Study|Lost to Follow-up|1|||
130137820|NCT02752074|468467594|FG001|Overall Study|Lost to Follow-up|4|||
130137821|NCT02752074|468467593|FG000|Overall Study|Death|146|||
130137822|NCT02752074|468467594|FG001|Overall Study|Death|129|||
130137823|NCT02752074|468467593|FG000|Overall Study|Withdrawal by Subject|9|||
130137824|NCT02752074|468467594|FG001|Overall Study|Withdrawal by Subject|10|||
130137825|NCT02392195|468467597|FG000|Overall Study|Lost to Follow-up|4|||
130137826|NCT02392195|468467597|FG000|Overall Study|Withdrawal by Subject|4|||
130137827|NCT00545792|468467598|FG000|Overall Study|Withdrawal by Subject|1|||
129973953|NCT03374488|467869576|FG001|Overall Study|Withdrawal by Subject|1|||
129973954|NCT03374488|467869575|FG000|Overall Study|Physician Decision|3|||
130137828|NCT03679598|468467600|FG000|Overall Study|Adverse Event|2|||
130137829|NCT03679598|468467601|FG001|Overall Study|Adverse Event|0|||
130137830|NCT01380782|468467606|FG000|Overall Study|Adverse Event|0|||
130137831|NCT01380782|468467607|FG001|Overall Study|Adverse Event|1|||
130137832|NCT01380782|468467608|FG002|Overall Study|Adverse Event|0|||
130137833|NCT01380782|468467609|FG003|Overall Study|Adverse Event|0|||
130137834|NCT01380782|468467606|FG000|Overall Study|Death|1|||
130137835|NCT01380782|468467607|FG001|Overall Study|Death|0|||
130137836|NCT01380782|468467608|FG002|Overall Study|Death|0|||
130137837|NCT01380782|468467609|FG003|Overall Study|Death|0|||
129973955|NCT03374488|467869576|FG001|Overall Study|Physician Decision|0|||
129973956|NCT03104075|467869577|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
129973957|NCT03104075|467869578|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
129973958|NCT04024462|467869579|FG000|Overall Study|Withdrawal by Subject|6|||
129973959|NCT04024462|467869580|FG001|Overall Study|Withdrawal by Subject|7|||
129973960|NCT04024462|467869579|FG000|Overall Study|Progressive Disease|0|||
129973961|NCT04024462|467869580|FG001|Overall Study|Progressive Disease|1|||
129973962|NCT04024462|467869579|FG000|Overall Study|Adverse Event|0|||
129973963|NCT04024462|467869580|FG001|Overall Study|Adverse Event|1|||
129973964|NCT04024462|467869579|FG000|Overall Study|Death|0|||
129973965|NCT04024462|467869580|FG001|Overall Study|Death|1|||
129973966|NCT04024462|467869579|FG000|Overall Study|Lost to Follow-up|1|||
129973967|NCT04024462|467869580|FG001|Overall Study|Lost to Follow-up|0|||
129973968|NCT04024462|467869579|FG000|Overall Study|Ongoing in the Study|94|||
129973969|NCT04024462|467869580|FG001|Overall Study|Ongoing in the Study|89|||
129973970|NCT04896008|467869581|FG000|Overall Study|Ongoing|70|||
129973971|NCT04896008|467869582|FG001|Overall Study|Ongoing|38|||
129973972|NCT04896008|467869581|FG000|Overall Study|Adverse Event|0|||
129973973|NCT04896008|467869582|FG001|Overall Study|Adverse Event|2|||
129973974|NCT04896008|467869581|FG000|Overall Study|Death|5|||
129973975|NCT04896008|467869582|FG001|Overall Study|Death|10|||
129973976|NCT04896008|467869581|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
129973977|NCT04896008|467869582|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
129973978|NCT04896008|467869581|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
129973979|NCT04896008|467869582|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
129973980|NCT04896008|467869581|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
129973981|NCT04896008|467869582|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
129973982|NCT04896008|467869581|FG000|Overall Study|Withdrawal by Subject|1|||
129973983|NCT04896008|467869582|FG001|Overall Study|Withdrawal by Subject|4|||
129973984|NCT04896008|467869581|FG000|Overall Study|Investigator Decision|2|||
129973985|NCT04896008|467869582|FG001|Overall Study|Investigator Decision|0|||
129973986|NCT04896008|467869581|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
129973987|NCT04896008|467869582|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
129973988|NCT00709228|467869594|FG000|Overall Study|Not treated|14|||
129973989|NCT00709228|467869594|FG000|Overall Study|Eligibility criteria not met|281|||
129973990|NCT00709228|467869594|FG000|Overall Study|Adverse events|2|||
129973991|NCT00709228|467869594|FG000|Overall Study|Discontinued treatment|14|||
129973992|NCT00709228|467869594|FG000|Overall Study|Did not enter follow-up|4|||
129973993|NCT00709228|467869594|FG000|Overall Study|Discontinued follow-up|5|||
129973994|NCT00709228|467869594|FG000|Overall Study|Disease progression|1|||
129973995|NCT00709228|467869594|FG000|Overall Study|Lost to Follow-up|6|||
129973996|NCT00709228|467869594|FG000|Overall Study|Non-compliance|5|||
129973997|NCT02870972|467869595|FG000|Overall Study|Adverse Event|1|||
129973998|NCT02870972|467869596|FG001|Overall Study|Adverse Event|0|||
129973999|NCT02870972|467869597|FG002|Overall Study|Adverse Event|0|||
129974000|NCT02870972|467869598|FG003|Overall Study|Adverse Event|0|||
129974001|NCT02870972|467869599|FG004|Overall Study|Adverse Event|0|||
129974002|NCT00789360|467869602|FG000|Overall Study|Protocol Violation|3|||
129974003|NCT00789360|467869603|FG001|Overall Study|Protocol Violation|1|||
129974004|NCT04400487|467869604|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129974005|NCT04400487|467869604|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
129974006|NCT04400487|467869604|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
129974007|NCT00022659|467869605|FG000|Overall Study|Ineligible: wrong primary|1|||
129974008|NCT00022659|467869605|FG000|Overall Study|Never treated|1|||
129974009|NCT03559062|467869606|FG000|Overall Study|Other|0|||
129974010|NCT03559062|467869607|FG001|Overall Study|Other|1|||
129974011|NCT03559062|467869608|FG002|Overall Study|Other|0|||
129974012|NCT03445533|467869609|FG000|Overall Study|Progressive Disease|48|||
130137838|NCT01380782|468467606|FG000|Overall Study|Lack of Efficacy|10|||
130137839|NCT01380782|468467607|FG001|Overall Study|Lack of Efficacy|9|||
130137840|NCT01380782|468467608|FG002|Overall Study|Lack of Efficacy|10|||
130137841|NCT01380782|468467609|FG003|Overall Study|Lack of Efficacy|3|||
130137842|NCT01380782|468467606|FG000|Overall Study|Physician Decision|1|||
130137843|NCT01380782|468467607|FG001|Overall Study|Physician Decision|0|||
130137844|NCT01380782|468467608|FG002|Overall Study|Physician Decision|0|||
130137845|NCT01380782|468467609|FG003|Overall Study|Physician Decision|0|||
130137846|NCT01380782|468467606|FG000|Overall Study|Withdrawal by Subject|0|||
129974013|NCT03445533|467869610|FG001|Overall Study|Progressive Disease|81|||
129974014|NCT03445533|467869609|FG000|Overall Study|Adverse Event|60|||
129974015|NCT03445533|467869610|FG001|Overall Study|Adverse Event|64|||
129974016|NCT03445533|467869609|FG000|Overall Study|Death|9|||
129974017|NCT03445533|467869610|FG001|Overall Study|Death|19|||
129974018|NCT03445533|467869609|FG000|Overall Study|Miscellaneous|0|||
129974019|NCT03445533|467869610|FG001|Overall Study|Miscellaneous|16|||
129974020|NCT03445533|467869609|FG000|Overall Study|Withdrawal by Subject|3|||
129974021|NCT03445533|467869610|FG001|Overall Study|Withdrawal by Subject|4|||
130137847|NCT01380782|468467607|FG001|Overall Study|Withdrawal by Subject|0|||
129974022|NCT03445533|467869609|FG000|Overall Study|Physician Decision|1|||
129974023|NCT03445533|467869610|FG001|Overall Study|Physician Decision|3|||
129974024|NCT03445533|467869609|FG000|Overall Study|Sponsor Decision|0|||
129974025|NCT03445533|467869610|FG001|Overall Study|Sponsor Decision|1|||
129974026|NCT03445533|467869609|FG000|Overall Study|Lost to Follow-up|0|||
129974027|NCT03445533|467869610|FG001|Overall Study|Lost to Follow-up|1|||
129974028|NCT03445533|467869609|FG000|Overall Study|Never Received any Study Treatment|7|||
129974029|NCT03445533|467869610|FG001|Overall Study|Never Received any Study Treatment|4|||
129974030|NCT00968526|467869611|FG000|Overall Study|Adverse Event|2|||
129974031|NCT00968526|467869612|FG001|Overall Study|Adverse Event|0|||
129974032|NCT00968526|467869611|FG000|Overall Study|Migrated/moved from study area|1|||
129974033|NCT00968526|467869612|FG001|Overall Study|Migrated/moved from study area|0|||
129974034|NCT02493062|467869613|FG000|Overall Study|Physician Decision|12|||
129974035|NCT03926195|467869614|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
129974036|NCT03926195|467869615|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
129974037|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
129974038|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
129974039|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
129974040|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
129974041|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
129974042|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
129974043|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
129974044|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
129974045|NCT03926195|467869614|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
129974046|NCT03926195|467869615|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
129974047|NCT01327612|467869617|FG000|Overall Study|Withdrawal by Subject|0|||
129974048|NCT01327612|467869618|FG001|Overall Study|Withdrawal by Subject|0|||
129974049|NCT01327612|467869619|FG002|Overall Study|Withdrawal by Subject|0|||
129974050|NCT01327612|467869620|FG003|Overall Study|Withdrawal by Subject|0|||
129974051|NCT01327612|467869621|FG004|Overall Study|Withdrawal by Subject|0|||
129974052|NCT01327612|467869622|FG005|Overall Study|Withdrawal by Subject|1|||
129974053|NCT01327612|467869623|FG006|Overall Study|Withdrawal by Subject|0|||
129974054|NCT01327612|467869617|FG000|Overall Study|Disease Progression|1|||
129974055|NCT01327612|467869618|FG001|Overall Study|Disease Progression|1|||
129974056|NCT01327612|467869619|FG002|Overall Study|Disease Progression|1|||
129974057|NCT01327612|467869620|FG003|Overall Study|Disease Progression|0|||
129974058|NCT01327612|467869621|FG004|Overall Study|Disease Progression|1|||
129974059|NCT01327612|467869622|FG005|Overall Study|Disease Progression|2|||
129974060|NCT01327612|467869623|FG006|Overall Study|Disease Progression|2|||
129974061|NCT01327612|467869617|FG000|Overall Study|Administrative Decision|0|||
129974062|NCT01327612|467869618|FG001|Overall Study|Administrative Decision|0|||
129974063|NCT01327612|467869619|FG002|Overall Study|Administrative Decision|0|||
129974064|NCT01327612|467869620|FG003|Overall Study|Administrative Decision|1|||
129974065|NCT01327612|467869621|FG004|Overall Study|Administrative Decision|0|||
129974066|NCT01327612|467869622|FG005|Overall Study|Administrative Decision|0|||
129974067|NCT01327612|467869623|FG006|Overall Study|Administrative Decision|0|||
129974068|NCT01327612|467869617|FG000|Overall Study|Death|0|||
129974069|NCT01327612|467869618|FG001|Overall Study|Death|0|||
129974070|NCT01327612|467869619|FG002|Overall Study|Death|0|||
129974071|NCT01327612|467869620|FG003|Overall Study|Death|0|||
129974072|NCT01327612|467869621|FG004|Overall Study|Death|1|||
129974073|NCT01327612|467869622|FG005|Overall Study|Death|0|||
129974074|NCT01327612|467869623|FG006|Overall Study|Death|0|||
129974075|NCT00426127|467869624|FG000|Overall Study|Adverse Event|1|||
129974076|NCT00426127|467869624|FG000|Overall Study|Removed due to disease progression|1|||
129974077|NCT05569421|467869625|FG000|Overall Study|Withdrawal by Subject|1|||
129974078|NCT05569421|467869626|FG001|Overall Study|Withdrawal by Subject|0|||
130094461|NCT03911401|468302373|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129974079|NCT05569421|467869627|FG002|Overall Study|Withdrawal by Subject|0|||
129974080|NCT01689857|467869628|FG000|Overall Study|Lost to Follow-up|5|||
129974081|NCT01689857|467869629|FG001|Overall Study|Lost to Follow-up|2|||
130094462|NCT03911401|468302374|FG001|Overall Study|Withdrawal by parent/guardian|4|||
130094463|NCT03911401|468302375|FG002|Overall Study|Withdrawal by parent/guardian|11|||
130094464|NCT02918968|468302376|FG000|1st Line AAT|Progressive disease|9|||
130094465|NCT02918968|468302377|FG001|1st Line AAT|Progressive disease|4|||
130094466|NCT02918968|468302376|FG000|1st Line AAT|Adverse Event|12|||
130094467|NCT02918968|468302377|FG001|1st Line AAT|Adverse Event|3|||
130094468|NCT02918968|468302376|FG000|1st Line AAT|Physician Decision|4|||
130094469|NCT02918968|468302377|FG001|1st Line AAT|Physician Decision|2|||
130094470|NCT02918968|468302376|FG000|1st Line AAT|Withdrawal by Subject|2|||
130094471|NCT02918968|468302377|FG001|1st Line AAT|Withdrawal by Subject|1|||
130094472|NCT02918968|468302376|FG000|1st Line AAT|Lost to Follow-up|0|||
130094473|NCT02918968|468302377|FG001|1st Line AAT|Lost to Follow-up|1|||
130094474|NCT02918968|468302376|FG000|1st Line AAT|Death|1|||
130094475|NCT02918968|468302377|FG001|1st Line AAT|Death|0|||
130094476|NCT02918968|468302376|FG000|1st Line AAT|Miscellaneous|1|||
130137848|NCT01380782|468467608|FG002|Overall Study|Withdrawal by Subject|1|||
130137849|NCT01380782|468467609|FG003|Overall Study|Withdrawal by Subject|1|||
130137850|NCT01701063|468467612|FG000|Overall Study|Lost to Follow-up|0|||
130137851|NCT01701063|468467613|FG001|Overall Study|Lost to Follow-up|1|||
130137852|NCT01701063|468467614|FG002|Overall Study|Lost to Follow-up|0|||
130137853|NCT01701063|468467612|FG000|Overall Study|Withdrawal by Subject|0|||
130137854|NCT01701063|468467613|FG001|Overall Study|Withdrawal by Subject|0|||
129974082|NCT05105087|467869630|FG000|Overall Study|Withdrawal by Subject|2|||
129974083|NCT05105087|467869630|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
129974084|NCT03738475|467869631|FG000|Overall Study|Participant Non-Compliance|1|||
129974085|NCT03738475|467869632|FG001|Overall Study|Participant Non-Compliance|0|||
129974086|NCT00737477|467869633|FG000|Overall Study|Adverse Event|9|||
129974087|NCT00737477|467869633|FG000|Overall Study|Death|9|||
129974088|NCT00737477|467869633|FG000|Overall Study|Treatment Refusal|1|||
129974089|NCT00737477|467869633|FG000|Overall Study|Withdrawal by Subject|1|||
129974090|NCT00737477|467869633|FG000|Overall Study|Renal Transplantation|10|||
129974091|NCT00737477|467869633|FG000|Overall Study|Other|4|||
129974092|NCT00581477|467869634|FG000|Overall Study|Physician Decision|2|||
129974093|NCT03106753|467869635|FG000|Overall Study|Withdrawal by Subject|0|||
129974094|NCT03106753|467869636|FG001|Overall Study|Withdrawal by Subject|1|||
129974095|NCT01853475|467869643|FG000|Overall Study|Withdrawal by Subject|0|||
129974096|NCT01853475|467869644|FG001|Overall Study|Withdrawal by Subject|1|||
129974097|NCT01853475|467869645|FG002|Overall Study|Withdrawal by Subject|0|||
129974098|NCT01023958|467869650|FG000|Overall Study|Progressive disease|48|||
129974099|NCT01023958|467869650|FG000|Overall Study|Other adverse event|1|||
129974100|NCT01023958|467869650|FG000|Overall Study|Refused to continue medication|1|||
129974101|NCT02159040|467869651|FG000|Overall Study|Death|1|||
129974102|NCT03080493|467869652|FG000|Overall Study|Did not provide NRS pain results|1|||
129974103|NCT03080493|467869653|FG001|Overall Study|Did not provide NRS pain results|0|||
130137855|NCT01701063|468467614|FG002|Overall Study|Withdrawal by Subject|1|||
130137856|NCT01701063|468467612|FG000|Overall Study|Other|0|||
130137857|NCT01701063|468467613|FG001|Overall Study|Other|0|||
130137858|NCT01701063|468467614|FG002|Overall Study|Other|1|||
130137859|NCT05387408|468467615|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
129974104|NCT03080493|467869652|FG000|Overall Study|Adverse Event|0|||
129974105|NCT03080493|467869653|FG001|Overall Study|Adverse Event|1|||
129974106|NCT03080493|467869652|FG000|Overall Study|Randomization error (parity group)|0|||
129974107|NCT03080493|467869653|FG001|Overall Study|Randomization error (parity group)|1|||
129974108|NCT00755417|467869655|FG000|Overall Study|Adverse Event|28|||
129974109|NCT00755417|467869656|FG001|Overall Study|Adverse Event|20|||
130137860|NCT01919112|468467616|FG000|Secondary Analysis-day 30|Death|1|||
130137861|NCT01919112|468467617|FG001|Secondary Analysis-day 30|Death|1|||
130137862|NCT01919112|468467618|FG002|Secondary Analysis-day 30|Death|1|||
130137863|NCT01919112|468467616|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
130137864|NCT01919112|468467617|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
130137865|NCT01919112|468467618|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
130137866|NCT02043132|468467619|FG000|Overall Study|Lost to Follow-up|1|||
130137867|NCT02043132|468467620|FG001|Overall Study|Lost to Follow-up|1|||
130137868|NCT02043132|468467619|FG000|Overall Study|screen failures|4|||
130137869|NCT02043132|468467620|FG001|Overall Study|screen failures|8|||
130137870|NCT02554877|468467621|FG000|Overall Study|Adverse Event|2|||
130137871|NCT02554877|468467622|FG001|Overall Study|Adverse Event|0|||
130137872|NCT02554877|468467623|FG002|Overall Study|Adverse Event|0|||
130137873|NCT02554877|468467624|FG003|Overall Study|Adverse Event|1|||
129974110|NCT00755417|467869657|FG002|Overall Study|Adverse Event|7|||
129974111|NCT00755417|467869655|FG000|Overall Study|Lack of Efficacy|8|||
129974112|NCT00755417|467869656|FG001|Overall Study|Lack of Efficacy|4|||
129974113|NCT00755417|467869657|FG002|Overall Study|Lack of Efficacy|9|||
129974114|NCT00755417|467869655|FG000|Overall Study|Protocol Violation|2|||
129974115|NCT00755417|467869656|FG001|Overall Study|Protocol Violation|1|||
129974116|NCT00755417|467869657|FG002|Overall Study|Protocol Violation|1|||
129974117|NCT00755417|467869655|FG000|Overall Study|Lost to Follow-up|3|||
129974118|NCT00755417|467869656|FG001|Overall Study|Lost to Follow-up|0|||
129974119|NCT00755417|467869657|FG002|Overall Study|Lost to Follow-up|1|||
130137874|NCT02554877|468467621|FG000|Overall Study|Lost to Follow-up|1|||
130137875|NCT02554877|468467622|FG001|Overall Study|Lost to Follow-up|1|||
130137876|NCT02554877|468467623|FG002|Overall Study|Lost to Follow-up|1|||
129974120|NCT00755417|467869655|FG000|Overall Study|Withdrawal by Subject|12|||
129974121|NCT00755417|467869656|FG001|Overall Study|Withdrawal by Subject|12|||
129974122|NCT00755417|467869657|FG002|Overall Study|Withdrawal by Subject|12|||
129974123|NCT00755417|467869655|FG000|Overall Study|Not specified or missing data|9|||
129974124|NCT00755417|467869656|FG001|Overall Study|Not specified or missing data|18|||
129974125|NCT00755417|467869657|FG002|Overall Study|Not specified or missing data|12|||
129974126|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
130137877|NCT02554877|468467624|FG003|Overall Study|Lost to Follow-up|2|||
130137878|NCT02554877|468467621|FG000|Overall Study|Did not meet entrance criteria|0|||
130137879|NCT02554877|468467622|FG001|Overall Study|Did not meet entrance criteria|0|||
129974127|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
129974128|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
129974129|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|Death|1|||
129974130|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|Death|0|||
129974131|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|Death|0|||
129974132|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
129974133|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
129974134|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
129974135|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
129974136|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
129974137|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
129974138|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
129974139|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
129974140|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
129974141|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
129974142|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
129974143|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
129974144|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
129974145|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
129974146|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
129974147|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
129974148|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
129974149|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
129974150|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
129974151|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
129974152|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
129974153|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
129974154|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
129974155|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
129974156|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
129974157|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
129974158|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
129974159|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
129974160|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
129974161|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
129974162|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
129974163|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
129974164|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
129974165|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
129974166|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
129974167|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
129974168|NCT02803593|467869661|FG000|Overall Study|Lost to Follow-up|17|||
129974169|NCT02803593|467869662|FG001|Overall Study|Lost to Follow-up|35|||
129974170|NCT05143138|467869663|FG000|Overall Study|Death|5|||
129974171|NCT05143138|467869664|FG001|Overall Study|Death|35|||
129974172|NCT05143138|467869665|FG002|Overall Study|Death|1|||
129974173|NCT05143138|467869663|FG000|Overall Study|Lost to Follow-up|2|||
129974174|NCT05143138|467869664|FG001|Overall Study|Lost to Follow-up|4|||
129974175|NCT05143138|467869665|FG002|Overall Study|Lost to Follow-up|0|||
129974176|NCT05143138|467869663|FG000|Overall Study|withdrawal|1|||
129974177|NCT05143138|467869664|FG001|Overall Study|withdrawal|1|||
129974178|NCT05143138|467869665|FG002|Overall Study|withdrawal|0|||
129974179|NCT02195479|467869668|FG000|Overall Study|Lost to Follow-up|18|||
129974180|NCT02195479|467869669|FG001|Overall Study|Lost to Follow-up|15|||
129974181|NCT02195479|467869668|FG000|Overall Study|Death|217|||
129974182|NCT02195479|467869669|FG001|Overall Study|Death|171|||
129974183|NCT02195479|467869668|FG000|Overall Study|Physician Decision|1|||
129974184|NCT02195479|467869669|FG001|Overall Study|Physician Decision|0|||
129974185|NCT02195479|467869668|FG000|Overall Study|Withdrawal by Subject|30|||
129974186|NCT02195479|467869669|FG001|Overall Study|Withdrawal by Subject|30|||
129974187|NCT02195479|467869668|FG000|Overall Study|Other|3|||
129974188|NCT02195479|467869669|FG001|Overall Study|Other|4|||
129974189|NCT02195479|467869668|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
129974190|NCT02195479|467869669|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
129974191|NCT03443414|467869670|FG000|Overall Study|Adverse Event|6|||
129974192|NCT03443414|467869671|FG001|Overall Study|Adverse Event|0|||
129974193|NCT03443414|467869672|FG002|Overall Study|Adverse Event|4|||
129974194|NCT03443414|467869673|FG003|Overall Study|Adverse Event|2|||
129974195|NCT03443414|467869674|FG004|Overall Study|Adverse Event|3|||
129974196|NCT03443414|467869670|FG000|Overall Study|Withdrawal by Subject|3|||
129974197|NCT03443414|467869671|FG001|Overall Study|Withdrawal by Subject|2|||
129974198|NCT03443414|467869672|FG002|Overall Study|Withdrawal by Subject|2|||
129974199|NCT03443414|467869673|FG003|Overall Study|Withdrawal by Subject|2|||
129974200|NCT03443414|467869674|FG004|Overall Study|Withdrawal by Subject|1|||
129974201|NCT03443414|467869670|FG000|Overall Study|Death|0|||
129974202|NCT03443414|467869671|FG001|Overall Study|Death|1|||
129974203|NCT03443414|467869672|FG002|Overall Study|Death|0|||
129974204|NCT03443414|467869673|FG003|Overall Study|Death|1|||
129974205|NCT03443414|467869674|FG004|Overall Study|Death|0|||
129974206|NCT03443414|467869670|FG000|Overall Study|Reason not specified|2|||
129974207|NCT03443414|467869671|FG001|Overall Study|Reason not specified|0|||
129974208|NCT03443414|467869672|FG002|Overall Study|Reason not specified|0|||
129974209|NCT03443414|467869673|FG003|Overall Study|Reason not specified|0|||
129974210|NCT03443414|467869674|FG004|Overall Study|Reason not specified|1|||
129974211|NCT03325777|467869677|FG000|Overall Study|Lost to Follow-up|9|||
129974212|NCT03325777|467869678|FG001|Overall Study|Lost to Follow-up|12|||
129974213|NCT02522728|467869681|FG000|Overall Study|Withdrawal by Subject|6|||
129974214|NCT02522728|467869682|FG001|Overall Study|Withdrawal by Subject|6|||
129974215|NCT02522728|467869681|FG000|Overall Study|Death|4|||
129974216|NCT02522728|467869682|FG001|Overall Study|Death|3|||
129974217|NCT02522728|467869681|FG000|Overall Study|Adverse Event|2|||
129974218|NCT02522728|467869682|FG001|Overall Study|Adverse Event|1|||
129974219|NCT02522728|467869681|FG000|Overall Study|Did not receive randomized study device|0|||
129974220|NCT02522728|467869682|FG001|Overall Study|Did not receive randomized study device|1|||
129974221|NCT01485120|467869688|FG000|Overall Study|Withdrawal by Subject|2|||
129974222|NCT00422734|467869689|FG000|Overall Study|Physician Decision|1|||
129974223|NCT00422734|467869690|FG001|Overall Study|Physician Decision|1|||
129974224|NCT00422734|467869689|FG000|Overall Study|Protocol Violation|1|||
129974225|NCT00422734|467869690|FG001|Overall Study|Protocol Violation|6|||
129974226|NCT00422734|467869689|FG000|Overall Study|Withdrawal by Subject|12|||
129974227|NCT00422734|467869690|FG001|Overall Study|Withdrawal by Subject|8|||
129974228|NCT00422734|467869689|FG000|Overall Study|Adverse Event|0|||
129974229|NCT00422734|467869690|FG001|Overall Study|Adverse Event|3|||
129974230|NCT00422734|467869689|FG000|Overall Study|Partner Decision|0|||
129974231|NCT00422734|467869690|FG001|Overall Study|Partner Decision|3|||
129974232|NCT01081886|467869691|FG000|Overall Study|Study termination|11|||
129974233|NCT01081886|467869692|FG001|Overall Study|Study termination|13|||
129974234|NCT02567708|467869693|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
129974235|NCT02567708|467869694|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
129974236|NCT02567708|467869693|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
129974237|NCT02567708|467869694|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
129974238|NCT02567708|467869693|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
129974239|NCT02567708|467869694|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
129974240|NCT02567708|467869693|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
129974241|NCT02567708|467869694|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
129974242|NCT04148651|467869695|FG000|Overall Study|Lost to Follow-up|2|||
129974243|NCT05262751|467869696|FG000|Washout Period 2|Adverse Event|1|||
129974244|NCT05262751|467869697|FG001|Washout Period 2|Adverse Event|0|||
129974245|NCT05262751|467869698|FG002|Washout Period 2|Adverse Event|0|||
129974246|NCT05262751|467869699|FG003|Washout Period 2|Adverse Event|0|||
129974247|NCT05262751|467869700|FG004|Washout Period 2|Adverse Event|0|||
129974248|NCT05262751|467869701|FG005|Washout Period 2|Adverse Event|0|||
129974249|NCT05262751|467869696|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
129974250|NCT05262751|467869697|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
129974251|NCT05262751|467869698|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
129974252|NCT05262751|467869699|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
129974253|NCT05262751|467869700|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
129974254|NCT05262751|467869701|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
129974255|NCT01154140|467869703|FG000|Overall Study|Death|71|||
129974256|NCT01154140|467869704|FG001|Overall Study|Death|81|||
130137880|NCT02554877|468467623|FG002|Overall Study|Did not meet entrance criteria|1|||
130137881|NCT02554877|468467624|FG003|Overall Study|Did not meet entrance criteria|0|||
130137882|NCT02554877|468467621|FG000|Overall Study|No longer met eligibility criteria|1|||
130137883|NCT02554877|468467622|FG001|Overall Study|No longer met eligibility criteria|0|||
130137884|NCT02554877|468467623|FG002|Overall Study|No longer met eligibility criteria|1|||
129974257|NCT01154140|467869703|FG000|Overall Study|Lost to Follow-up|4|||
129974258|NCT01154140|467869704|FG001|Overall Study|Lost to Follow-up|5|||
130137885|NCT02554877|468467624|FG003|Overall Study|No longer met eligibility criteria|1|||
130137886|NCT02554877|468467621|FG000|Overall Study|Protocol Violation|3|||
130137887|NCT02554877|468467622|FG001|Overall Study|Protocol Violation|1|||
129974259|NCT01154140|467869703|FG000|Overall Study|Withdrawal by Subject|12|||
129974260|NCT01154140|467869704|FG001|Overall Study|Withdrawal by Subject|13|||
129974261|NCT01154140|467869703|FG000|Overall Study|Other|3|||
129974262|NCT01154140|467869704|FG001|Overall Study|Other|1|||
129974263|NCT01154140|467869703|FG000|Overall Study|Randomized but not treated|1|||
129974264|NCT01154140|467869704|FG001|Overall Study|Randomized but not treated|2|||
129974265|NCT02992691|467869708|FG000|Overall Study|Adverse Event|2|||
129974266|NCT02992691|467869708|FG000|Overall Study|Withdrawal by Subject|1|||
130137888|NCT02554877|468467623|FG002|Overall Study|Protocol Violation|1|||
130137889|NCT02554877|468467624|FG003|Overall Study|Protocol Violation|0|||
130137890|NCT02554877|468467621|FG000|Overall Study|Other|1|||
130137891|NCT02554877|468467622|FG001|Overall Study|Other|3|||
130137892|NCT02554877|468467623|FG002|Overall Study|Other|0|||
130137893|NCT02554877|468467624|FG003|Overall Study|Other|3|||
130137894|NCT02554877|468467621|FG000|Overall Study|Insufficient clinical response|4|||
130137895|NCT02554877|468467622|FG001|Overall Study|Insufficient clinical response|0|||
130137896|NCT02554877|468467623|FG002|Overall Study|Insufficient clinical response|0|||
130137897|NCT02554877|468467624|FG003|Overall Study|Insufficient clinical response|0|||
130137898|NCT02554877|468467621|FG000|Overall Study|No longer willing to participate|0|||
130137899|NCT02554877|468467622|FG001|Overall Study|No longer willing to participate|2|||
130137900|NCT02554877|468467623|FG002|Overall Study|No longer willing to participate|2|||
130137901|NCT02554877|468467624|FG003|Overall Study|No longer willing to participate|0|||
130137902|NCT00274651|468467625|FG000|Overall Study|Adverse Event|6|||
130137903|NCT00274651|468467626|FG001|Overall Study|Adverse Event|3|||
130137904|NCT00274651|468467625|FG000|Overall Study|Lack of Efficacy|13|||
130137905|NCT00274651|468467626|FG001|Overall Study|Lack of Efficacy|6|||
130137906|NCT00274651|468467625|FG000|Overall Study|Death|1|||
130137907|NCT00274651|468467626|FG001|Overall Study|Death|3|||
130137908|NCT00274651|468467625|FG000|Overall Study|Withdrawal by Subject|0|||
130137909|NCT00274651|468467626|FG001|Overall Study|Withdrawal by Subject|1|||
130137910|NCT00274651|468467625|FG000|Overall Study|Physician Decision|8|||
130137911|NCT00274651|468467626|FG001|Overall Study|Physician Decision|7|||
130137912|NCT04474405|468467627|FG000|Overall Study|Withdrawal by Subject|0|||
130137913|NCT04474405|468467628|FG001|Overall Study|Withdrawal by Subject|0|||
130137914|NCT04474405|468467629|FG002|Overall Study|Withdrawal by Subject|1|||
130137915|NCT04474405|468467630|FG003|Overall Study|Withdrawal by Subject|0|||
130137916|NCT04474405|468467631|FG004|Overall Study|Withdrawal by Subject|1|||
130137917|NCT04474405|468467632|FG005|Overall Study|Withdrawal by Subject|0|||
130137918|NCT04474405|468467627|FG000|Overall Study|Other|0|||
130137919|NCT04474405|468467628|FG001|Overall Study|Other|0|||
130137920|NCT04474405|468467629|FG002|Overall Study|Other|0|||
130137921|NCT04474405|468467630|FG003|Overall Study|Other|0|||
130137922|NCT04474405|468467631|FG004|Overall Study|Other|3|||
130137923|NCT04474405|468467632|FG005|Overall Study|Other|0|||
130137924|NCT00635648|468467633|FG000|Overall Study|Adverse Event|12|||
130137925|NCT00635648|468467633|FG000|Overall Study|Withdrawal by Subject|9|||
130137926|NCT00635648|468467633|FG000|Overall Study|Physician Decision|4|||
130137927|NCT00635648|468467633|FG000|Overall Study|Rapid progression of baseline disease|4|||
130137928|NCT00635648|468467633|FG000|Overall Study|Use of other antifungal agent needed|1|||
130137929|NCT00635648|468467633|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
130137930|NCT00635648|468467633|FG000|Overall Study|Noncompliance with protocol|1|||
130137931|NCT00635648|468467633|FG000|Overall Study|Other reason|2|||
130137932|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
130137933|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
130137934|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
130137935|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
130137936|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
130137937|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
130137938|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
130137939|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
130137940|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
130137941|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
130137942|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
130137943|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
130137944|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
130137945|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
130137946|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
130137947|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
130137948|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
130137949|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
130137950|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
130137951|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
130137952|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
130137953|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
130137954|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
130137955|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
130137956|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
130137957|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
130137958|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
130137959|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
130137960|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
130137961|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
130137962|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
130137963|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
130137964|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
130137965|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
130137966|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
130137967|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
130137968|NCT04194801|468467634|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
130137969|NCT04194801|468467635|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
130137970|NCT04194801|468467636|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
130137971|NCT04194801|468467634|FG000|Part Ib/II End of Study|Death|2|||
130137972|NCT04194801|468467635|FG001|Part Ib/II End of Study|Death|3|||
130137973|NCT04194801|468467636|FG002|Part Ib/II End of Study|Death|3|||
130137974|NCT04194801|468467634|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
130137975|NCT04194801|468467635|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
130137976|NCT04194801|468467636|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
130137977|NCT04194801|468467634|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
130137978|NCT04194801|468467635|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
130137979|NCT04194801|468467636|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
130137980|NCT04194801|468467634|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
130137981|NCT04194801|468467635|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
130137982|NCT04194801|468467636|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
130137983|NCT04194801|468467634|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
130137984|NCT04194801|468467635|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
130137985|NCT04194801|468467636|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
130137986|NCT03827395|468467637|FG000|Overall Study|Lost to Follow-up|1|||
130137987|NCT03827395|468467638|FG001|Overall Study|Lost to Follow-up|0|||
130137988|NCT03827395|468467637|FG000|Overall Study|Protocol Violation|1|||
130137989|NCT03827395|468467638|FG001|Overall Study|Protocol Violation|0|||
130137990|NCT03827395|468467637|FG000|Overall Study|Became ineligible after enrollment|1|||
130137991|NCT03827395|468467638|FG001|Overall Study|Became ineligible after enrollment|2|||
130137992|NCT01923740|468467639|FG000|Overall Study|Lost to Follow-up|4|||
130137993|NCT01923740|468467640|FG001|Overall Study|Lost to Follow-up|9|||
130137994|NCT01923740|468467639|FG000|Overall Study|Withdrawal by Subject|2|||
130137995|NCT01923740|468467640|FG001|Overall Study|Withdrawal by Subject|0|||
130137996|NCT00294047|468467641|FG000|Month 48|Adverse Event|28|||
130137997|NCT00294047|468467642|FG001|Month 48|Adverse Event|13|||
130137998|NCT00294047|468467641|FG000|Month 48|Protocol Violation|4|||
130137999|NCT00294047|468467642|FG001|Month 48|Protocol Violation|4|||
130138000|NCT00294047|468467641|FG000|Month 48|Withdrawal by Subject|111|||
130138001|NCT00294047|468467642|FG001|Month 48|Withdrawal by Subject|115|||
130138002|NCT00294047|468467641|FG000|Month 48|Lost to Follow-up|272|||
130138003|NCT00294047|468467642|FG001|Month 48|Lost to Follow-up|287|||
130138004|NCT00294047|468467641|FG000|Month 48|Other|10|||
130138005|NCT00294047|468467642|FG001|Month 48|Other|14|||
130138006|NCT00294047|468467641|FG000|Month 84|Adverse Event|4|||
130138007|NCT00294047|468467642|FG001|Month 84|Adverse Event|2|||
130138008|NCT00294047|468467641|FG000|Month 84|Protocol Violation|1|||
130138009|NCT00294047|468467642|FG001|Month 84|Protocol Violation|1|||
130138010|NCT00294047|468467641|FG000|Month 84|Withdrawal by Subject|33|||
130138011|NCT00294047|468467642|FG001|Month 84|Withdrawal by Subject|31|||
130138012|NCT00294047|468467641|FG000|Month 84|Lost to Follow-up|187|||
130138013|NCT00294047|468467642|FG001|Month 84|Lost to Follow-up|190|||
130138014|NCT00294047|468467641|FG000|Month 84|Absent Cervix|2|||
130138015|NCT00294047|468467642|FG001|Month 84|Absent Cervix|0|||
130138016|NCT00294047|468467641|FG000|Month 84|Work related reasons|4|||
130138017|NCT00294047|468467642|FG001|Month 84|Work related reasons|2|||
130138018|NCT00294047|468467641|FG000|Month 84|Center closed, subject did not transfer|1|||
130138019|NCT00294047|468467642|FG001|Month 84|Center closed, subject did not transfer|0|||
130138020|NCT00294047|468467641|FG000|Month 84|Family problems|2|||
130138021|NCT00294047|468467642|FG001|Month 84|Family problems|2|||
130138022|NCT00294047|468467641|FG000|Month 84|Lack of time|3|||
130138023|NCT00294047|468467642|FG001|Month 84|Lack of time|1|||
129974267|NCT04276051|467869709|FG000|Overall Study|Lost to Follow-up|0|||
130138024|NCT00294047|468467641|FG000|Month 84|Personal reason|2|||
130138025|NCT00294047|468467642|FG001|Month 84|Personal reason|4|||
130138026|NCT00294047|468467641|FG000|Month 84|Subject does not want male physician|1|||
130138027|NCT00294047|468467642|FG001|Month 84|Subject does not want male physician|0|||
130138028|NCT00294047|468467641|FG000|Month 84|Transport reimbursement delayed|0|||
130138029|NCT00294047|468467642|FG001|Month 84|Transport reimbursement delayed|1|||
130138030|NCT00294047|468467641|FG000|Month 84|Unable to reach study site|1|||
130138031|NCT00294047|468467642|FG001|Month 84|Unable to reach study site|0|||
130138032|NCT00294047|468467641|FG000|Month 84|Under investigation locally|1|||
130138033|NCT00294047|468467642|FG001|Month 84|Under investigation locally|0|||
130138034|NCT00294047|468467641|FG000|Month 84|Visit missed|0|||
130138035|NCT00294047|468467642|FG001|Month 84|Visit missed|1|||
130138036|NCT00294047|468467641|FG000|Month 84|No consent for Month 84 Follow-up|731|||
130138037|NCT00294047|468467642|FG001|Month 84|No consent for Month 84 Follow-up|754|||
130138038|NCT02157974|468467643|FG000|Overall Study|Withdrawal by Subject|0|||
130138039|NCT02157974|468467644|FG001|Overall Study|Withdrawal by Subject|1|||
130138040|NCT02157974|468467645|FG002|Overall Study|Withdrawal by Subject|0|||
130138041|NCT02157974|468467646|FG003|Overall Study|Withdrawal by Subject|0|||
130138042|NCT02157974|468467647|FG004|Overall Study|Withdrawal by Subject|0|||
129974268|NCT04276051|467869710|FG001|Overall Study|Lost to Follow-up|1|||
129974269|NCT04276051|467869709|FG000|Overall Study|Physician Decision|0|||
129974270|NCT04276051|467869710|FG001|Overall Study|Physician Decision|1|||
129974271|NCT04276051|467869709|FG000|Overall Study|Withdrawal by Subject|1|||
129974272|NCT04276051|467869710|FG001|Overall Study|Withdrawal by Subject|1|||
129974273|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
129974274|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
129974275|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
129974276|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
129974277|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
129974278|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
129974279|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
129974280|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
129974281|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
129974282|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
129974283|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
129974284|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
129974285|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
129974286|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
129974287|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
129974288|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
129974289|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
130138043|NCT02157974|468467643|FG000|Overall Study|Screen Failure|0|||
130138044|NCT02157974|468467644|FG001|Overall Study|Screen Failure|1|||
130138045|NCT02157974|468467645|FG002|Overall Study|Screen Failure|0|||
130138046|NCT02157974|468467646|FG003|Overall Study|Screen Failure|0|||
130138047|NCT02157974|468467647|FG004|Overall Study|Screen Failure|0|||
130138048|NCT02157974|468467643|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130138049|NCT02157974|468467644|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
130138050|NCT02157974|468467645|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130138051|NCT02157974|468467646|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130138052|NCT02157974|468467647|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
130138053|NCT01484912|468467650|FG000|Overall Study|Withdrawal by Subject|1|||
130138054|NCT01484912|468467651|FG001|Overall Study|Withdrawal by Subject|0|||
130138055|NCT01484912|468467650|FG000|Overall Study|Physician Decision|0|||
130138056|NCT01484912|468467651|FG001|Overall Study|Physician Decision|1|||
130138057|NCT03158727|468467652|FG000|Overall Study|Withdrawal by Subject|2|||
130138058|NCT03158727|468467653|FG001|Overall Study|Withdrawal by Subject|6|||
130138059|NCT03158727|468467652|FG000|Overall Study|Death|11|||
130138060|NCT03158727|468467653|FG001|Overall Study|Death|12|||
129974290|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
129974291|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
130094477|NCT02918968|468302377|FG001|1st Line AAT|Miscellaneous|0|||
130094478|NCT02918968|468302376|FG000|2nd Line AAT|Progressive disease|21|||
130094479|NCT02918968|468302377|FG001|2nd Line AAT|Progressive disease|3|||
130094480|NCT02918968|468302376|FG000|2nd Line AAT|Adverse Event|2|||
130094481|NCT02918968|468302377|FG001|2nd Line AAT|Adverse Event|5|||
130094482|NCT02918968|468302376|FG000|2nd Line AAT|Physician Decision|0|||
130094483|NCT02918968|468302377|FG001|2nd Line AAT|Physician Decision|1|||
130094484|NCT02918968|468302376|FG000|2nd Line AAT|Withdrawal by Subject|2|||
130094485|NCT02918968|468302377|FG001|2nd Line AAT|Withdrawal by Subject|2|||
130094486|NCT02918968|468302376|FG000|2nd Line AAT|Death|0|||
130094487|NCT02918968|468302377|FG001|2nd Line AAT|Death|1|||
130094488|NCT03781167|468302387|FG000|Overall Study|Adverse Event|23|||
130094489|NCT03781167|468302388|FG001|Overall Study|Adverse Event|25|||
130094490|NCT03781167|468302387|FG000|Overall Study|Withdrew consent|16|||
130094491|NCT03781167|468302388|FG001|Overall Study|Withdrew consent|12|||
130094492|NCT03781167|468302387|FG000|Overall Study|Lost to Follow-up|0|||
130094493|NCT03781167|468302388|FG001|Overall Study|Lost to Follow-up|1|||
130094494|NCT03781167|468302387|FG000|Overall Study|Lack of Efficacy|4|||
130094495|NCT03781167|468302388|FG001|Overall Study|Lack of Efficacy|5|||
130094496|NCT03781167|468302387|FG000|Overall Study|Difficulty with drug delivery system|2|||
130094497|NCT03781167|468302388|FG001|Overall Study|Difficulty with drug delivery system|3|||
130138061|NCT03158727|468467652|FG000|Overall Study|Lost to Follow-up|1|||
130138062|NCT03158727|468467653|FG001|Overall Study|Lost to Follow-up|0|||
130138063|NCT03158727|468467652|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
130138064|NCT03158727|468467653|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
130138065|NCT03158727|468467652|FG000|Overall Study|Visit 11 not done by mistake|0|||
130138066|NCT03158727|468467653|FG001|Overall Study|Visit 11 not done by mistake|1|||
130138067|NCT03158727|468467652|FG000|Overall Study|Enrolled, not treated|1|||
130138068|NCT03158727|468467653|FG001|Overall Study|Enrolled, not treated|0|||
130138069|NCT00985439|468467654|FG000|Overall Study|Adverse Event|0|||
130138070|NCT00985439|468467655|FG001|Overall Study|Adverse Event|0|||
130138071|NCT00985439|468467656|FG002|Overall Study|Adverse Event|1|||
130138072|NCT00985439|468467657|FG003|Overall Study|Adverse Event|0|||
130138073|NCT02462837|468467658|FG000|Overall Study|pt developed hives|1|||
130138074|NCT02462837|468467659|FG001|Overall Study|pt developed hives|0|||
130138075|NCT02462837|468467658|FG000|Overall Study|Withdrawal by Subject|1|||
130138076|NCT02462837|468467659|FG001|Overall Study|Withdrawal by Subject|0|||
130138077|NCT05562011|468467667|FG000|Overall Study|Withdrawal by Subject|3|||
130138078|NCT05562011|468467667|FG000|Overall Study|Lost to Follow-up|1|||
130138079|NCT05562011|468467667|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
130138080|NCT05562011|468467667|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
130138081|NCT05562011|468467667|FG000|Overall Study|Device malfunction|13|||
130138082|NCT00841659|468467670|FG000|Washout: 2 Weeks|Protocol Violation|1|||
130138083|NCT00841659|468467671|FG001|Washout: 2 Weeks|Protocol Violation|0|||
130138084|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Refused|1|||
130138085|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Refused|3|||
130138086|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Medical|0|||
130138087|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Medical|1|||
130138088|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
130138089|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
130138090|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
130138091|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
130138092|NCT02054715|468467672|FG000|Baseline/Follow-up 1|No Reason|0|||
130138093|NCT02054715|468467673|FG001|Baseline/Follow-up 1|No Reason|1|||
130138094|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
130138095|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
130138096|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Ineligible|3|||
130138097|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Ineligible|0|||
130138098|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Hospitalization|1|||
130138099|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Hospitalization|0|||
130138100|NCT02054715|468467672|FG000|Baseline/Follow-up 1|Changed Mind|1|||
130138101|NCT02054715|468467673|FG001|Baseline/Follow-up 1|Changed Mind|0|||
130138102|NCT02054715|468467672|FG000|Follow-up 2|Lost to Followup|3|||
130138103|NCT02054715|468467673|FG001|Follow-up 2|Lost to Followup|1|||
130138104|NCT02054715|468467672|FG000|Follow-up 2|Refused|3|||
130138105|NCT02054715|468467673|FG001|Follow-up 2|Refused|2|||
130138106|NCT02054715|468467672|FG000|Follow-up 2|Followup Not Completed|3|||
130138107|NCT02054715|468467673|FG001|Follow-up 2|Followup Not Completed|4|||
130138108|NCT02054715|468467672|FG000|Follow-up 2|Ineligible|4|||
130138109|NCT02054715|468467673|FG001|Follow-up 2|Ineligible|5|||
130138110|NCT02054715|468467672|FG000|Follow-up 2|Death|3|||
130138111|NCT02054715|468467673|FG001|Follow-up 2|Death|3|||
130138112|NCT02054715|468467672|FG000|Follow-up 2|Hospitalization|0|||
130138113|NCT02054715|468467673|FG001|Follow-up 2|Hospitalization|2|||
130138114|NCT02054715|468467672|FG000|Follow-up 2|Changed MD/Facility|0|||
130138115|NCT02054715|468467673|FG001|Follow-up 2|Changed MD/Facility|1|||
130138116|NCT02054715|468467672|FG000|Follow-up 2|Changed Mind|0|||
130138117|NCT02054715|468467673|FG001|Follow-up 2|Changed Mind|1|||
130138118|NCT02054715|468467672|FG000|Follow-up 2|No Reason|2|||
130138119|NCT02054715|468467673|FG001|Follow-up 2|No Reason|0|||
130138120|NCT02054715|468467672|FG000|Follow-up 2|Treatment Change or Delay|1|||
130138121|NCT02054715|468467673|FG001|Follow-up 2|Treatment Change or Delay|0|||
130138122|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
130138123|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
130138124|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
130138125|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
130138126|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
130138127|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
130138128|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
130138129|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
130138130|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
130138131|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
130138132|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
130138133|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
130138134|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
130138135|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
130138136|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
130138137|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
130138138|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
130138139|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
130138140|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
130138141|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
130138142|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
130138143|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
130138144|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
130138145|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
130138146|NCT00073307|468467681|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
130138147|NCT00073307|468467682|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
130138148|NCT00073307|468467683|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
130138149|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
130138150|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
130138151|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
130138152|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
130138153|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
130138154|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
130138155|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
130138156|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
130138157|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
130138158|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
130138159|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
130138160|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
130138161|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
130138162|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
130138163|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
130138164|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
130138165|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
130138166|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
130138167|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
130138168|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
130138169|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
130138170|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
130138171|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
130138172|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
130138173|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
130138174|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
130138175|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
130138176|NCT00073307|468467681|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
130138177|NCT00073307|468467682|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
130138178|NCT00073307|468467683|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
130138179|NCT01438060|468467684|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
130138180|NCT01438060|468467685|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
130138181|NCT01438060|468467684|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
130138182|NCT01438060|468467685|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
130138183|NCT01438060|468467684|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
130138184|NCT01438060|468467685|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
130138185|NCT01438060|468467684|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
130138186|NCT01438060|468467685|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
130138187|NCT01438060|468467684|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
130138188|NCT01438060|468467685|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
130138189|NCT01438060|468467684|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
130138190|NCT01438060|468467685|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
130138191|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
130138192|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
130138193|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
130138194|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
130138195|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
130138196|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
130138197|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
130138198|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
130138199|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
130138200|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
130138201|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
130138202|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
130138203|NCT01438060|468467684|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
130138204|NCT01438060|468467685|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
130138205|NCT01438060|468467684|FG000|On Study Beyond Week 140|Adverse Event|0|||
130138206|NCT01438060|468467685|FG001|On Study Beyond Week 140|Adverse Event|2|||
130138207|NCT01438060|468467684|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
130138208|NCT01438060|468467685|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
130138209|NCT01438060|468467684|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
130138210|NCT01438060|468467685|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
130138211|NCT01438060|468467684|FG000|On Study Beyond Week 140|Death|0|||
130138212|NCT01438060|468467685|FG001|On Study Beyond Week 140|Death|1|||
130138213|NCT01438060|468467684|FG000|On Study Beyond Week 140|Other Reason|0|||
130138214|NCT01438060|468467685|FG001|On Study Beyond Week 140|Other Reason|3|||
130138215|NCT01442376|468467687|FG000|Overall Study|Adverse Event|0|||
130138216|NCT01442376|468467688|FG001|Overall Study|Adverse Event|3|||
130138217|NCT01442376|468467689|FG002|Overall Study|Adverse Event|2|||
130138218|NCT01442376|468467687|FG000|Overall Study|Death|0|||
130138219|NCT01442376|468467688|FG001|Overall Study|Death|1|||
130138220|NCT01442376|468467689|FG002|Overall Study|Death|1|||
130138221|NCT01442376|468467687|FG000|Overall Study|Withdrawal of consent|0|||
130138222|NCT01442376|468467688|FG001|Overall Study|Withdrawal of consent|0|||
130138223|NCT01442376|468467689|FG002|Overall Study|Withdrawal of consent|1|||
130138224|NCT01442376|468467687|FG000|Overall Study|Patients not treated|2|||
130138225|NCT01442376|468467688|FG001|Overall Study|Patients not treated|3|||
130138226|NCT01442376|468467689|FG002|Overall Study|Patients not treated|1|||
130138227|NCT01442376|468467687|FG000|Overall Study|Not eligible for subsequent cycles|1|||
130138228|NCT01442376|468467688|FG001|Overall Study|Not eligible for subsequent cycles|2|||
130138229|NCT01442376|468467689|FG002|Overall Study|Not eligible for subsequent cycles|0|||
130138230|NCT01964950|468467690|FG000|Overall Study|Protocol Violation|25|||
130138231|NCT03499873|468467691|FG000|Overall Study|Withdrawal by Subject|4|||
130138232|NCT03499873|468467692|FG001|Overall Study|Withdrawal by Subject|6|||
130138233|NCT03499873|468467693|FG002|Overall Study|Withdrawal by Subject|1|||
130138234|NCT03499873|468467691|FG000|Overall Study|Subjects condition worsened|0|||
130138235|NCT03499873|468467692|FG001|Overall Study|Subjects condition worsened|3|||
130138236|NCT03499873|468467693|FG002|Overall Study|Subjects condition worsened|11|||
130138237|NCT03499873|468467691|FG000|Overall Study|Adverse Event|8|||
130138238|NCT03499873|468467692|FG001|Overall Study|Adverse Event|3|||
130138239|NCT03499873|468467693|FG002|Overall Study|Adverse Event|6|||
130138240|NCT03499873|468467691|FG000|Overall Study|Physician Decision|1|||
130138241|NCT03499873|468467692|FG001|Overall Study|Physician Decision|0|||
130138242|NCT03499873|468467693|FG002|Overall Study|Physician Decision|0|||
130138243|NCT03499873|468467691|FG000|Overall Study|Administrative reasons|0|||
130138244|NCT03499873|468467692|FG001|Overall Study|Administrative reasons|1|||
130138245|NCT03499873|468467693|FG002|Overall Study|Administrative reasons|0|||
130138246|NCT03499873|468467691|FG000|Overall Study|Concomitant therapy|5|||
130138247|NCT03499873|468467692|FG001|Overall Study|Concomitant therapy|4|||
130138248|NCT03499873|468467693|FG002|Overall Study|Concomitant therapy|7|||
130138249|NCT03499873|468467691|FG000|Overall Study|Miscellaneous|1|||
130138250|NCT03499873|468467692|FG001|Overall Study|Miscellaneous|2|||
130138251|NCT03499873|468467693|FG002|Overall Study|Miscellaneous|2|||
130138252|NCT03499873|468467691|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
130138253|NCT03499873|468467692|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
130138254|NCT03499873|468467693|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
130138255|NCT02471807|468467704|FG000|Overall Study|Death|14|||
130138256|NCT02471807|468467704|FG000|Overall Study|Withdrawal by Subject|2|||
130138257|NCT02471807|468467704|FG000|Overall Study|Explant|5|||
130138258|NCT02471807|468467704|FG000|Overall Study|Lost to Follow-up|1|||
130138259|NCT00957021|468467705|FG000|Overall Study|Death|5|||
130138260|NCT00957021|468467705|FG000|Overall Study|Lost to Follow-up|8|||
130138261|NCT00957021|468467705|FG000|Overall Study|Withdrawal by Subject|34|||
130138262|NCT00957021|468467705|FG000|Overall Study|No 2 yr ROM data|35|||
130138263|NCT00957021|468467705|FG000|Overall Study|Revised study component by 2 yr visit|8|||
130138264|NCT00957021|468467705|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
130138265|NCT00957021|468467705|FG000|Overall Study|Surgery Cancelled|9|||
130138266|NCT00957021|468467705|FG000|Overall Study|Termination due to language issue|2|||
130138267|NCT04025021|468467706|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
130138268|NCT04025021|468467707|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
130138269|NCT01986647|468467708|FG000|Overall Study|Lost to Follow-up|4|||
130138270|NCT01986647|468467709|FG001|Overall Study|Lost to Follow-up|1|||
130138271|NCT01986647|468467710|FG002|Overall Study|Lost to Follow-up|4|||
130138272|NCT01986647|468467711|FG003|Overall Study|Lost to Follow-up|4|||
130138273|NCT01986647|468467708|FG000|Overall Study|Withdrawal by Subject|1|||
130138274|NCT01986647|468467709|FG001|Overall Study|Withdrawal by Subject|3|||
130138275|NCT01986647|468467710|FG002|Overall Study|Withdrawal by Subject|2|||
130138276|NCT01986647|468467711|FG003|Overall Study|Withdrawal by Subject|3|||
130138277|NCT01986647|468467708|FG000|Overall Study|Health|5|||
130138278|NCT01986647|468467709|FG001|Overall Study|Health|3|||
130138279|NCT01986647|468467710|FG002|Overall Study|Health|6|||
130138280|NCT01986647|468467711|FG003|Overall Study|Health|4|||
130138281|NCT02905435|468467712|FG000|Overall Study|Death|2|||
130138282|NCT02905435|468467712|FG000|Overall Study|Physician Decision|1|||
130138283|NCT02905435|468467712|FG000|Overall Study|Lost to Follow-up|4|||
130138284|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
130138285|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
130138286|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
130138287|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
130138288|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
130138289|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138290|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138291|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138292|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138293|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138294|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138295|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138296|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138297|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138298|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138299|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138300|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138301|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138302|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
130094498|NCT03781167|468302387|FG000|Overall Study|Other, not specified|2|||
130094499|NCT03781167|468302388|FG001|Overall Study|Other, not specified|2|||
130094500|NCT01590628|468302390|FG000|Overall Study|Death|2|||
130094501|NCT01590628|468302391|FG001|Overall Study|Death|0|||
130094502|NCT00475657|468302392|FG000|Overall Study|Death|1|||
130094503|NCT00475657|468302392|FG000|Overall Study|Sponsor's Decision|3|||
130094504|NCT00381680|468302393|FG000|Overall Study|Adverse Event|9|||
130094505|NCT00381680|468302394|FG001|Overall Study|Adverse Event|3|||
130094506|NCT00381680|468302393|FG000|Overall Study|Death|10|||
130094507|NCT00381680|468302394|FG001|Overall Study|Death|7|||
130094508|NCT00381680|468302393|FG000|Overall Study|Lost to Follow-up|3|||
130094509|NCT00381680|468302394|FG001|Overall Study|Lost to Follow-up|2|||
130094510|NCT00381680|468302393|FG000|Overall Study|Physician Decision|25|||
130094511|NCT00381680|468302394|FG001|Overall Study|Physician Decision|6|||
130094512|NCT00381680|468302393|FG000|Overall Study|Withdrawal by Subject|3|||
130094513|NCT00381680|468302394|FG001|Overall Study|Withdrawal by Subject|1|||
130094514|NCT00381680|468302393|FG000|Overall Study|Entry onto another COG Trial|1|||
130094515|NCT00381680|468302394|FG001|Overall Study|Entry onto another COG Trial|2|||
130094516|NCT00381680|468302393|FG000|Overall Study|Alternative Therapy|11|||
130094517|NCT00381680|468302394|FG001|Overall Study|Alternative Therapy|5|||
130094518|NCT00381680|468302393|FG000|Overall Study|Secondary Malignancy|3|||
130094519|NCT00381680|468302394|FG001|Overall Study|Secondary Malignancy|0|||
130094520|NCT00381680|468302393|FG000|Overall Study|Delay initiation|1|||
130094521|NCT00381680|468302394|FG001|Overall Study|Delay initiation|0|||
130094522|NCT00381680|468302393|FG000|Overall Study|Stem Cell Transplant|26|||
130094523|NCT00381680|468302394|FG001|Overall Study|Stem Cell Transplant|10|||
130094524|NCT00381680|468302393|FG000|Overall Study|Relapse|18|||
130094525|NCT00381680|468302394|FG001|Overall Study|Relapse|9|||
130094526|NCT00381680|468302393|FG000|Overall Study|Induction Failure|4|||
130094527|NCT00381680|468302394|FG001|Overall Study|Induction Failure|1|||
130094528|NCT00381680|468302393|FG000|Overall Study|Progression|1|||
130094529|NCT00381680|468302394|FG001|Overall Study|Progression|1|||
130094530|NCT00381680|468302393|FG000|Overall Study|Other not otherwise specified|7|||
130094531|NCT00381680|468302394|FG001|Overall Study|Other not otherwise specified|2|||
130094532|NCT00381680|468302393|FG000|Overall Study|Ineligible|3|||
130094533|NCT00381680|468302394|FG001|Overall Study|Ineligible|1|||
130094534|NCT03831282|468302401|FG000|Overall Study|Could not place sensor|1|||
130094535|NCT00334893|468302402|FG000|Overall Study|Not Treated|1|||
130094536|NCT00334893|468302403|FG001|Overall Study|Not Treated|0|||
130094537|NCT01258803|468302404|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
130094538|NCT01258803|468302405|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
130094539|NCT01258803|468302406|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
130094540|NCT01258803|468302407|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
130094541|NCT01258803|468302408|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
130138303|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138304|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138305|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138306|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138307|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138308|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138309|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
130138310|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138311|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
130138312|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138313|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138314|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138315|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138316|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138317|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138318|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138319|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138320|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138321|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138322|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138323|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138324|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138325|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138326|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138327|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138328|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138329|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138330|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138331|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138332|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138333|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138334|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138335|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
130138336|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138337|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
130138338|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138339|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138340|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138341|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138342|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138343|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138344|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138345|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138346|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138347|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138348|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138349|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138350|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138351|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138352|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138353|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138354|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138355|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138356|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138357|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138358|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138359|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138360|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138361|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
130138362|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130138363|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138364|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
130138365|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130138366|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
130138367|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138368|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138369|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138370|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138371|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138372|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138373|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138374|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138375|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138376|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138377|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138378|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138379|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138380|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138381|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138382|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138383|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138384|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138385|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138386|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138387|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
130138388|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
130138389|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
130138390|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
130138391|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
130138392|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
130138393|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138394|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138395|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138396|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138397|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138398|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138399|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138400|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138401|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138402|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138403|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138404|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138405|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138406|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138407|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138408|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138409|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138410|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138411|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138412|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138413|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
130138414|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|moved|0|||
130138415|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|moved|1|||
130138416|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|moved|1|||
130138417|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|moved|0|||
130138418|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|moved|0|||
130138419|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|moved|0|||
130138420|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|moved|0|||
130138421|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|moved|0|||
130138422|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|moved|0|||
130138423|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|moved|0|||
130138424|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|moved|0|||
130138425|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|moved|0|||
130138426|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|moved|0|||
130138427|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|moved|0|||
130138428|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|moved|0|||
130138429|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|moved|0|||
129974292|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
129974293|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
129974294|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
129974295|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
130138430|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|moved|0|||
130138431|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|moved|0|||
130138432|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|moved|0|||
130138433|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|moved|0|||
130138434|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|moved|0|||
130138435|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|moved|0|||
130138436|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|moved|0|||
130138437|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|moved|0|||
130138438|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|moved|0|||
130138439|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|moved|0|||
129974296|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
130138440|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138441|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138442|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138443|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
130138444|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138445|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138446|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138447|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138448|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138449|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138450|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138451|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138452|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138453|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129974297|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
129974298|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
129974299|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
129974300|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
129974301|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
129974302|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
129974303|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
129974304|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
129974305|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
129974306|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
129974307|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
129974308|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
129974309|NCT02579772|467869715|FG000|Overall Study|Withdrawal by Subject|0|||
129974310|NCT02579772|467869716|FG001|Overall Study|Withdrawal by Subject|1|||
129974311|NCT02579772|467869715|FG000|Overall Study|Usage of additional antioxidants|1|||
129974312|NCT02579772|467869716|FG001|Overall Study|Usage of additional antioxidants|0|||
129974313|NCT02579772|467869715|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
129974314|NCT02579772|467869716|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
129974315|NCT03128671|467869717|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
129974316|NCT03128671|467869718|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
129974317|NCT03128671|467869717|FG000|Allocation|Death|1|||
129974318|NCT03128671|467869718|FG001|Allocation|Death|0|||
129974319|NCT03128671|467869717|FG000|Allocation|Withdrawal by Subject|4|||
129974320|NCT03128671|467869718|FG001|Allocation|Withdrawal by Subject|0|||
129974321|NCT03128671|467869717|FG000|Intervention|Withdrawal by Subject|11|||
129974322|NCT03128671|467869718|FG001|Intervention|Withdrawal by Subject|10|||
129974323|NCT03128671|467869717|FG000|Intervention|Palliative/hospice care initiated|9|||
129974324|NCT03128671|467869718|FG001|Intervention|Palliative/hospice care initiated|10|||
129974325|NCT03128671|467869717|FG000|Intervention|Death|13|||
129974326|NCT03128671|467869718|FG001|Intervention|Death|11|||
129974327|NCT03128671|467869717|FG000|Intervention|Interrupted by hurricane|1|||
129974328|NCT03128671|467869718|FG001|Intervention|Interrupted by hurricane|0|||
129974329|NCT03128671|467869717|FG000|Intervention|Physician Decision|2|||
129974330|NCT03128671|467869718|FG001|Intervention|Physician Decision|3|||
129974331|NCT04463680|467869719|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
129974332|NCT04463680|467869719|FG000|Overall Study|Not eligible due to implant duration of use|1|||
129974333|NCT04463680|467869719|FG000|Overall Study|Withdrawal by Subject|3|||
129974334|NCT05239598|467869722|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
129974335|NCT05239598|467869723|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
129974336|NCT05239598|467869722|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
129974337|NCT05239598|467869723|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
130138454|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138455|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138456|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138457|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138458|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138459|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138460|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129974338|NCT04147195|467869728|FG000|Overall Study|Adverse Event|0|||
129974339|NCT04147195|467869729|FG001|Overall Study|Adverse Event|3|||
129974340|NCT04147195|467869728|FG000|Overall Study|Study Terminated by Sponsor|4|||
129974341|NCT04147195|467869729|FG001|Overall Study|Study Terminated by Sponsor|2|||
130138461|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138462|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138463|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138464|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138465|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
130138466|NCT00112437|468467721|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138467|NCT00112437|468467722|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138468|NCT00112437|468467723|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138469|NCT00112437|468467724|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138470|NCT00112437|468467725|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
130138471|NCT00112437|468467726|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138472|NCT00112437|468467727|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138473|NCT00112437|468467728|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138474|NCT00112437|468467729|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138475|NCT00112437|468467730|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138476|NCT00112437|468467731|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138477|NCT00112437|468467732|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138478|NCT00112437|468467733|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138479|NCT00112437|468467734|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138480|NCT00112437|468467735|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138481|NCT00112437|468467736|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138482|NCT00112437|468467737|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138483|NCT00112437|468467738|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138484|NCT00112437|468467739|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138485|NCT00112437|468467740|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138486|NCT00112437|468467741|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138487|NCT00112437|468467742|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138488|NCT00112437|468467743|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129974342|NCT04147195|467869728|FG000|Overall Study|Withdrawal by Subject|0|||
129974343|NCT04147195|467869729|FG001|Overall Study|Withdrawal by Subject|1|||
129974344|NCT05823012|467869730|FG000|Titration Period|Adverse Event|1|||
129974345|NCT05823012|467869730|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
129974346|NCT05823012|467869730|FG000|Maintenance Period|Adverse Event|1|||
129974347|NCT05823012|467869730|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
129974348|NCT05823012|467869730|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
129974349|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Adverse Event|10|||
129974350|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Adverse Event|9|||
129974351|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Adverse Event|7|||
129974352|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
129974353|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
129974354|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
129974355|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
129974356|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
129974357|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
129974358|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Physician Decision|7|||
129974359|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Physician Decision|3|||
129974360|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Physician Decision|2|||
129974361|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Pregnancy|2|||
129974362|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Pregnancy|1|||
129974363|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Pregnancy|3|||
129974364|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
129974365|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
129974366|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
129974367|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
129974368|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
129974369|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
129974370|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
129974371|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
129974372|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
129974373|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
130138489|NCT00112437|468467744|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138490|NCT00112437|468467745|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
130138491|NCT00112437|468467746|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129974374|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
129974375|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
129974376|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
129974377|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
129974378|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
129974379|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
129974380|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
129974381|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
129974382|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
129974383|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
129974384|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
129974385|NCT01920477|467871378|FG000|Overall Study|Adverse Event|0|||
129974386|NCT01920477|467871379|FG001|Overall Study|Adverse Event|1|||
129974387|NCT01920477|467871378|FG000|Overall Study|Lack of Efficacy|1|||
129974388|NCT01920477|467871379|FG001|Overall Study|Lack of Efficacy|0|||
129974389|NCT01920477|467871378|FG000|Overall Study|Study closed/terminated|14|||
129974390|NCT01920477|467871379|FG001|Overall Study|Study closed/terminated|15|||
129974391|NCT01920477|467871378|FG000|Overall Study|Withdrawal by Subject|0|||
129974392|NCT01920477|467871379|FG001|Overall Study|Withdrawal by Subject|1|||
129974393|NCT01681277|467871382|FG000|Overall Study|Adverse Event|1|||
129974394|NCT01681277|467871383|FG001|Overall Study|Adverse Event|0|||
129974395|NCT01681277|467871384|FG002|Overall Study|Adverse Event|0|||
129974396|NCT01681277|467871385|FG003|Overall Study|Adverse Event|0|||
129974397|NCT01681277|467871386|FG004|Overall Study|Adverse Event|0|||
129974398|NCT02113124|467871387|FG000|Overall Study|Unable to retrieve blood sample|1|||
129974399|NCT02113124|467871388|FG001|Overall Study|Unable to retrieve blood sample|1|||
129974400|NCT02271984|467871394|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974401|NCT02271984|467871395|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974402|NCT02271984|467871396|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974403|NCT02271984|467871397|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974404|NCT02271984|467871398|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974405|NCT02271984|467871399|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
129974406|NCT02271984|467871400|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974407|NCT02271984|467871401|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
129974408|NCT02271984|467871402|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974409|NCT02271984|467871403|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974410|NCT02271984|467871404|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974411|NCT02271984|467871405|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974412|NCT02521363|467871406|FG000|Overall Study|Withdrawal by Subject|1|||
129974413|NCT02521363|467871407|FG001|Overall Study|Withdrawal by Subject|2|||
129974414|NCT04624243|467871408|FG000|Overall Study|Death|0|||
129974415|NCT04624243|467871409|FG001|Overall Study|Death|1|||
129974416|NCT04624243|467871410|FG002|Overall Study|Death|0|||
129974417|NCT04624243|467871411|FG003|Overall Study|Death|0|||
129974418|NCT04624243|467871412|FG004|Overall Study|Death|0|||
129974419|NCT04624243|467871408|FG000|Overall Study|Lost to Follow-up|2|||
129974420|NCT04624243|467871409|FG001|Overall Study|Lost to Follow-up|3|||
129974421|NCT04624243|467871410|FG002|Overall Study|Lost to Follow-up|7|||
129974422|NCT04624243|467871411|FG003|Overall Study|Lost to Follow-up|1|||
129974423|NCT04624243|467871412|FG004|Overall Study|Lost to Follow-up|3|||
129974424|NCT04624243|467871408|FG000|Overall Study|Physician Decision|3|||
129974425|NCT04624243|467871409|FG001|Overall Study|Physician Decision|8|||
129974426|NCT04624243|467871410|FG002|Overall Study|Physician Decision|15|||
129974427|NCT04624243|467871411|FG003|Overall Study|Physician Decision|2|||
129974428|NCT04624243|467871412|FG004|Overall Study|Physician Decision|11|||
129974429|NCT04624243|467871408|FG000|Overall Study|Withdrawal by Subject|19|||
129974430|NCT04624243|467871409|FG001|Overall Study|Withdrawal by Subject|44|||
129974431|NCT04624243|467871410|FG002|Overall Study|Withdrawal by Subject|40|||
129974432|NCT04624243|467871411|FG003|Overall Study|Withdrawal by Subject|21|||
129974433|NCT04624243|467871412|FG004|Overall Study|Withdrawal by Subject|39|||
129974434|NCT04624243|467871408|FG000|Overall Study|Miscellaneous|3|||
129974435|NCT04624243|467871409|FG001|Overall Study|Miscellaneous|12|||
129974436|NCT04624243|467871410|FG002|Overall Study|Miscellaneous|9|||
129974437|NCT04624243|467871411|FG003|Overall Study|Miscellaneous|4|||
129974438|NCT04624243|467871412|FG004|Overall Study|Miscellaneous|6|||
129974439|NCT01923662|467871413|FG000|Overall Study|Withdrawal by Subject|1|||
129974440|NCT01294397|467871414|FG000|Overall Study|Withdrawal by Subject|1|||
129974441|NCT01294397|467871414|FG000|Overall Study|Administrative Decision|1|||
129974442|NCT01939353|467871415|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
129974443|NCT01939353|467871415|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
129974444|NCT01939353|467871415|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
129974445|NCT01939353|467871415|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
129974446|NCT01939353|467871415|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
129974447|NCT05048238|467871423|FG000|Overall Study|Withdrawal by Subject|1|||
129974448|NCT01730378|467871424|FG000|Overall Study|Lost to Follow-up|1|||
129974449|NCT01730378|467871425|FG001|Overall Study|Lost to Follow-up|0|||
129974450|NCT00874731|467871427|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
129974451|NCT00874731|467871428|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
129974452|NCT00874731|467871429|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
129974453|NCT00874731|467871427|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
129974454|NCT00874731|467871428|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
129974455|NCT00874731|467871429|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
129974456|NCT00874731|467871427|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
129974457|NCT00874731|467871428|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
129974458|NCT00874731|467871429|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
129974459|NCT00955708|467871430|FG000|Overall Study|Death|269|||
129974460|NCT00955708|467871430|FG000|Overall Study|Lost to Follow-up|72|||
129974461|NCT00955708|467871430|FG000|Overall Study|Physician Decision|36|||
129974462|NCT00955708|467871430|FG000|Overall Study|Protocol Violation|134|||
129974463|NCT00955708|467871430|FG000|Overall Study|Registry Conclusion|186|||
129974464|NCT00955708|467871430|FG000|Overall Study|Product removed from service|94|||
129974465|NCT00955708|467871430|FG000|Overall Study|Patient Refused to participate further|116|||
129974466|NCT00955708|467871430|FG000|Overall Study|Closure of study location|60|||
129974467|NCT00955708|467871430|FG000|Overall Study|Patient changed care provider/moved|91|||
129974468|NCT01016262|467871433|FG000|Double-blind Phase|Adverse Event|0|||
129974469|NCT01016262|467871434|FG001|Double-blind Phase|Adverse Event|0|||
129974470|NCT01016262|467871435|FG002|Double-blind Phase|Adverse Event|1|||
129974471|NCT01016262|467871436|FG003|Double-blind Phase|Adverse Event|0|||
129974472|NCT01016262|467871437|FG004|Double-blind Phase|Adverse Event|0|||
129974473|NCT01016262|467871438|FG005|Double-blind Phase|Adverse Event|0|||
129974474|NCT01016262|467871433|FG000|Double-blind Phase|Lack of Efficacy|1|||
129974475|NCT01016262|467871434|FG001|Double-blind Phase|Lack of Efficacy|0|||
129974476|NCT01016262|467871435|FG002|Double-blind Phase|Lack of Efficacy|5|||
129974477|NCT01016262|467871436|FG003|Double-blind Phase|Lack of Efficacy|0|||
129974478|NCT01016262|467871437|FG004|Double-blind Phase|Lack of Efficacy|0|||
129974479|NCT01016262|467871438|FG005|Double-blind Phase|Lack of Efficacy|0|||
129974480|NCT01016262|467871433|FG000|Double-blind Phase|Disease Progression|0|||
129974481|NCT01016262|467871434|FG001|Double-blind Phase|Disease Progression|1|||
129974482|NCT01016262|467871435|FG002|Double-blind Phase|Disease Progression|2|||
129974483|NCT01016262|467871436|FG003|Double-blind Phase|Disease Progression|0|||
129974484|NCT01016262|467871437|FG004|Double-blind Phase|Disease Progression|0|||
129974485|NCT01016262|467871438|FG005|Double-blind Phase|Disease Progression|0|||
129974486|NCT01016262|467871433|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
129974487|NCT01016262|467871434|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
129974488|NCT01016262|467871435|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
129974489|NCT01016262|467871436|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
129974490|NCT01016262|467871437|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
130138492|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
130138493|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
130138494|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
130138495|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
130138496|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
130138497|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
130138498|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
130138499|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
130138500|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
130138501|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
130138502|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
130138503|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
130138504|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
130138505|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
130138506|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
130138507|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
130138508|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
130138509|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
130138510|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
130138511|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
130138512|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
130138513|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
130138514|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
130138515|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
130138516|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
130138517|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
129974491|NCT01016262|467871438|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
130138518|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138519|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138520|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129974492|NCT01016262|467871433|FG000|Open-Label Phase|Adverse Event|0|||
129974493|NCT01016262|467871434|FG001|Open-Label Phase|Adverse Event|0|||
129974494|NCT01016262|467871435|FG002|Open-Label Phase|Adverse Event|0|||
129974495|NCT01016262|467871436|FG003|Open-Label Phase|Adverse Event|1|||
129974496|NCT01016262|467871437|FG004|Open-Label Phase|Adverse Event|0|||
129974497|NCT01016262|467871438|FG005|Open-Label Phase|Adverse Event|0|||
129974498|NCT01016262|467871433|FG000|Open-Label Phase|Lost to Follow-up|0|||
129974499|NCT01016262|467871434|FG001|Open-Label Phase|Lost to Follow-up|0|||
129974500|NCT01016262|467871435|FG002|Open-Label Phase|Lost to Follow-up|0|||
129974501|NCT01016262|467871436|FG003|Open-Label Phase|Lost to Follow-up|0|||
129974502|NCT01016262|467871437|FG004|Open-Label Phase|Lost to Follow-up|1|||
129974503|NCT01016262|467871438|FG005|Open-Label Phase|Lost to Follow-up|0|||
129974504|NCT01016262|467871433|FG000|Open-Label Phase|Lack of Efficacy|0|||
129974505|NCT01016262|467871434|FG001|Open-Label Phase|Lack of Efficacy|0|||
129974506|NCT01016262|467871435|FG002|Open-Label Phase|Lack of Efficacy|0|||
129974507|NCT01016262|467871436|FG003|Open-Label Phase|Lack of Efficacy|1|||
129974508|NCT01016262|467871437|FG004|Open-Label Phase|Lack of Efficacy|0|||
129974509|NCT01016262|467871438|FG005|Open-Label Phase|Lack of Efficacy|0|||
129974510|NCT01016262|467871433|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974511|NCT01016262|467871434|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974512|NCT01016262|467871435|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974513|NCT01016262|467871436|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974514|NCT01016262|467871437|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
129974515|NCT01016262|467871438|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974516|NCT01736540|467871439|FG000|Overall Study|Did not complete scan within 45 days|2|||
129974517|NCT01736540|467871439|FG000|Overall Study|Death|1|||
129974518|NCT01736540|467871439|FG000|Overall Study|Abnormal test procedure|1|||
129974519|NCT01736540|467871439|FG000|Overall Study|Withdrawal by Subject|5|||
129974520|NCT01736540|467871439|FG000|Overall Study|Protocol Violation|1|||
129974521|NCT01736540|467871439|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
129974522|NCT01736540|467871439|FG000|Overall Study|No show for MRI appointment|1|||
129974523|NCT01736540|467871439|FG000|Overall Study|Unable to make MRI appointment|3|||
129974524|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
129974525|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
129974526|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
129974527|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
129974528|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
129974529|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
129974530|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
129974531|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
129974532|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
129974533|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
129974534|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
129974535|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
129974536|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
129974537|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
129974538|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
129974539|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
129974540|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
129974541|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
129974542|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
129974543|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
130138521|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138522|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138523|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
130138524|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
130138525|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138526|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138527|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
130138528|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138529|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138530|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138531|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138532|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138533|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138534|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138535|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138536|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138537|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129974544|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
129974545|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
129974546|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
130138538|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138539|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138540|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129974547|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
129974548|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
129974549|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
129974550|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
129974551|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
129974552|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
129974553|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
129974554|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
129974555|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
129974556|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
129974557|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
129974558|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
129974559|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
129974560|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
129974561|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
129974562|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
129974563|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
129974564|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
129974565|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
129974566|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
129974567|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
129974568|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
129974569|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
129974570|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
129974571|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
129974572|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
129974573|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
129974574|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
129974575|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
129974576|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
129974577|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
129974578|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
129974579|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
129974580|NCT01132820|467871444|FG000|Overall Study|Ineligible: wrong cell type|1|||
129974581|NCT01132820|467871444|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
129974582|NCT01132820|467871444|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
129974583|NCT01132820|467871444|FG000|Overall Study|Never treated|1|||
129974584|NCT01132820|467871444|FG000|Overall Study|Inadequate data|1|||
129974585|NCT01370655|467871447|FG000|Period 1|Adverse Event|2|||
129974586|NCT01370655|467871448|FG001|Period 1|Adverse Event|0|||
129974587|NCT01370655|467871449|FG002|Period 1|Adverse Event|0|||
129974588|NCT01370655|467871450|FG003|Period 1|Adverse Event|0|||
129974589|NCT01370655|467871451|FG004|Period 1|Adverse Event|0|||
129974590|NCT01370655|467871452|FG005|Period 1|Adverse Event|0|||
129974591|NCT01370655|467871453|FG006|Period 1|Adverse Event|1|||
129974592|NCT01370655|467871454|FG007|Period 1|Adverse Event|0|||
129974593|NCT01370655|467871455|FG008|Period 1|Adverse Event|0|||
129974594|NCT01370655|467871456|FG009|Period 1|Adverse Event|0|||
129974595|NCT01370655|467871457|FG010|Period 1|Adverse Event|0|||
129974596|NCT01370655|467871458|FG011|Period 1|Adverse Event|0|||
129974597|NCT01370655|467871447|FG000|Period 2|Adverse Event|0|||
129974598|NCT01370655|467871448|FG001|Period 2|Adverse Event|0|||
129974599|NCT01370655|467871449|FG002|Period 2|Adverse Event|1|||
129974600|NCT01370655|467871450|FG003|Period 2|Adverse Event|0|||
129974601|NCT01370655|467871451|FG004|Period 2|Adverse Event|1|||
129974602|NCT01370655|467871452|FG005|Period 2|Adverse Event|0|||
129974603|NCT01370655|467871453|FG006|Period 2|Adverse Event|0|||
129974604|NCT01370655|467871454|FG007|Period 2|Adverse Event|1|||
130138541|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138542|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
130138543|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129974605|NCT01370655|467871455|FG008|Period 2|Adverse Event|0|||
129974606|NCT01370655|467871456|FG009|Period 2|Adverse Event|0|||
129974607|NCT01370655|467871457|FG010|Period 2|Adverse Event|0|||
129974608|NCT01370655|467871458|FG011|Period 2|Adverse Event|0|||
129974609|NCT01370655|467871447|FG000|Period 2|met protocol specified stopping criteria|0|||
129974610|NCT01370655|467871448|FG001|Period 2|met protocol specified stopping criteria|0|||
129974611|NCT01370655|467871449|FG002|Period 2|met protocol specified stopping criteria|1|||
129974612|NCT01370655|467871450|FG003|Period 2|met protocol specified stopping criteria|0|||
129974613|NCT01370655|467871451|FG004|Period 2|met protocol specified stopping criteria|0|||
129974614|NCT01370655|467871452|FG005|Period 2|met protocol specified stopping criteria|0|||
129974615|NCT01370655|467871453|FG006|Period 2|met protocol specified stopping criteria|1|||
130138544|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129974616|NCT01370655|467871454|FG007|Period 2|met protocol specified stopping criteria|0|||
129974617|NCT01370655|467871455|FG008|Period 2|met protocol specified stopping criteria|1|||
129974618|NCT01370655|467871456|FG009|Period 2|met protocol specified stopping criteria|0|||
129974619|NCT01370655|467871457|FG010|Period 2|met protocol specified stopping criteria|1|||
129974620|NCT01370655|467871458|FG011|Period 2|met protocol specified stopping criteria|0|||
129974621|NCT01370655|467871447|FG000|Period 2|Withdrawal by Subject|0|||
129974622|NCT01370655|467871448|FG001|Period 2|Withdrawal by Subject|0|||
129974623|NCT01370655|467871449|FG002|Period 2|Withdrawal by Subject|0|||
129974624|NCT01370655|467871450|FG003|Period 2|Withdrawal by Subject|0|||
129974625|NCT01370655|467871451|FG004|Period 2|Withdrawal by Subject|0|||
129974626|NCT01370655|467871452|FG005|Period 2|Withdrawal by Subject|0|||
129974627|NCT01370655|467871453|FG006|Period 2|Withdrawal by Subject|0|||
129974628|NCT01370655|467871454|FG007|Period 2|Withdrawal by Subject|0|||
129974629|NCT01370655|467871455|FG008|Period 2|Withdrawal by Subject|1|||
129974630|NCT01370655|467871456|FG009|Period 2|Withdrawal by Subject|0|||
129974631|NCT01370655|467871457|FG010|Period 2|Withdrawal by Subject|0|||
129974632|NCT01370655|467871458|FG011|Period 2|Withdrawal by Subject|0|||
129974633|NCT05000216|467871460|FG000|Stage 1|Lost to Follow-up|0|||
129974634|NCT05000216|467871461|FG001|Stage 1|Lost to Follow-up|0|||
129974635|NCT05000216|467871462|FG002|Stage 1|Lost to Follow-up|0|||
129974636|NCT05000216|467871463|FG003|Stage 1|Lost to Follow-up|0|||
129974637|NCT05000216|467871464|FG004|Stage 1|Lost to Follow-up|0|||
129974638|NCT05000216|467871465|FG005|Stage 1|Lost to Follow-up|0|||
129974639|NCT05000216|467871466|FG006|Stage 1|Lost to Follow-up|1|||
129974640|NCT05000216|467871467|FG007|Stage 1|Lost to Follow-up|1|||
129974641|NCT05000216|467871468|FG008|Stage 1|Lost to Follow-up|0|||
129974642|NCT05000216|467871469|FG009|Stage 1|Lost to Follow-up|2|||
129974643|NCT05000216|467871470|FG010|Stage 1|Lost to Follow-up|3|||
129974644|NCT05000216|467871471|FG011|Stage 1|Lost to Follow-up|0|||
129974645|NCT05000216|467871472|FG012|Stage 1|Lost to Follow-up|0|||
129974646|NCT05000216|467871473|FG013|Stage 1|Lost to Follow-up|0|||
129974647|NCT05000216|467871474|FG014|Stage 1|Lost to Follow-up|0|||
129974648|NCT05000216|467871475|FG015|Stage 1|Lost to Follow-up|0|||
129974649|NCT05000216|467871476|FG016|Stage 1|Lost to Follow-up|0|||
129974650|NCT05000216|467871477|FG017|Stage 1|Lost to Follow-up|0|||
129974651|NCT05000216|467871478|FG018|Stage 1|Lost to Follow-up|0|||
129974652|NCT05000216|467871479|FG019|Stage 1|Lost to Follow-up|0|||
129974653|NCT05000216|467871480|FG020|Stage 1|Lost to Follow-up|0|||
129974654|NCT05000216|467871481|FG021|Stage 1|Lost to Follow-up|0|||
129974655|NCT05000216|467871460|FG000|Stage 1|Physician Decision|0|||
129974656|NCT05000216|467871461|FG001|Stage 1|Physician Decision|0|||
129974657|NCT05000216|467871462|FG002|Stage 1|Physician Decision|0|||
129974658|NCT05000216|467871463|FG003|Stage 1|Physician Decision|0|||
129974659|NCT05000216|467871464|FG004|Stage 1|Physician Decision|0|||
129974660|NCT05000216|467871465|FG005|Stage 1|Physician Decision|0|||
129974661|NCT05000216|467871466|FG006|Stage 1|Physician Decision|0|||
129974662|NCT05000216|467871467|FG007|Stage 1|Physician Decision|1|||
129974663|NCT05000216|467871468|FG008|Stage 1|Physician Decision|1|||
129974664|NCT05000216|467871469|FG009|Stage 1|Physician Decision|0|||
129974665|NCT05000216|467871470|FG010|Stage 1|Physician Decision|0|||
129974666|NCT05000216|467871471|FG011|Stage 1|Physician Decision|0|||
129974667|NCT05000216|467871472|FG012|Stage 1|Physician Decision|0|||
129974668|NCT05000216|467871473|FG013|Stage 1|Physician Decision|0|||
129974669|NCT05000216|467871474|FG014|Stage 1|Physician Decision|0|||
129974670|NCT05000216|467871475|FG015|Stage 1|Physician Decision|0|||
129974671|NCT05000216|467871476|FG016|Stage 1|Physician Decision|0|||
129974672|NCT05000216|467871477|FG017|Stage 1|Physician Decision|0|||
129974673|NCT05000216|467871478|FG018|Stage 1|Physician Decision|0|||
129974674|NCT05000216|467871479|FG019|Stage 1|Physician Decision|0|||
129974675|NCT05000216|467871480|FG020|Stage 1|Physician Decision|0|||
129974676|NCT05000216|467871481|FG021|Stage 1|Physician Decision|0|||
129974677|NCT05000216|467871460|FG000|Stage 1|Withdrawal by Subject|0|||
129974678|NCT05000216|467871461|FG001|Stage 1|Withdrawal by Subject|1|||
129974679|NCT05000216|467871462|FG002|Stage 1|Withdrawal by Subject|0|||
129974680|NCT05000216|467871463|FG003|Stage 1|Withdrawal by Subject|0|||
129974681|NCT05000216|467871464|FG004|Stage 1|Withdrawal by Subject|0|||
129974682|NCT05000216|467871465|FG005|Stage 1|Withdrawal by Subject|0|||
129974683|NCT05000216|467871466|FG006|Stage 1|Withdrawal by Subject|0|||
129974684|NCT05000216|467871467|FG007|Stage 1|Withdrawal by Subject|0|||
129974685|NCT05000216|467871468|FG008|Stage 1|Withdrawal by Subject|0|||
129974686|NCT05000216|467871469|FG009|Stage 1|Withdrawal by Subject|3|||
129974687|NCT05000216|467871470|FG010|Stage 1|Withdrawal by Subject|10|||
129974688|NCT05000216|467871471|FG011|Stage 1|Withdrawal by Subject|0|||
129974689|NCT05000216|467871472|FG012|Stage 1|Withdrawal by Subject|0|||
129974690|NCT05000216|467871473|FG013|Stage 1|Withdrawal by Subject|0|||
129974691|NCT05000216|467871474|FG014|Stage 1|Withdrawal by Subject|0|||
129974692|NCT05000216|467871475|FG015|Stage 1|Withdrawal by Subject|0|||
129974693|NCT05000216|467871476|FG016|Stage 1|Withdrawal by Subject|0|||
129974694|NCT05000216|467871477|FG017|Stage 1|Withdrawal by Subject|0|||
129974695|NCT05000216|467871478|FG018|Stage 1|Withdrawal by Subject|0|||
129974696|NCT05000216|467871479|FG019|Stage 1|Withdrawal by Subject|0|||
129974697|NCT05000216|467871480|FG020|Stage 1|Withdrawal by Subject|0|||
129974698|NCT05000216|467871481|FG021|Stage 1|Withdrawal by Subject|0|||
129974699|NCT05000216|467871460|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
129974700|NCT05000216|467871461|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
129974701|NCT05000216|467871462|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
129974702|NCT05000216|467871463|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
129974703|NCT05000216|467871464|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
129974704|NCT05000216|467871465|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
129974705|NCT05000216|467871466|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
129974706|NCT05000216|467871467|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
129974707|NCT05000216|467871468|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
129974708|NCT05000216|467871469|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
129974709|NCT05000216|467871470|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
129974710|NCT05000216|467871471|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
129974711|NCT05000216|467871472|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
129974712|NCT05000216|467871473|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
129974713|NCT05000216|467871474|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
129974714|NCT05000216|467871475|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
129974715|NCT05000216|467871476|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
129974716|NCT05000216|467871477|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
129974717|NCT05000216|467871478|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
129974718|NCT05000216|467871479|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
129974719|NCT05000216|467871480|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
129974720|NCT05000216|467871481|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
129974721|NCT05000216|467871460|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974722|NCT05000216|467871461|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974723|NCT05000216|467871462|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974724|NCT05000216|467871463|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974725|NCT05000216|467871464|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974726|NCT05000216|467871465|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974727|NCT05000216|467871466|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974728|NCT05000216|467871467|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974729|NCT05000216|467871468|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
129974730|NCT05000216|467871469|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974731|NCT05000216|467871470|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974732|NCT05000216|467871471|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974733|NCT05000216|467871472|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974734|NCT05000216|467871473|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974735|NCT05000216|467871474|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974736|NCT05000216|467871475|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974737|NCT05000216|467871476|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974738|NCT05000216|467871477|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974739|NCT05000216|467871478|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974740|NCT05000216|467871479|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974741|NCT05000216|467871480|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974742|NCT05000216|467871481|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974743|NCT05000216|467871460|FG000|Stage 1|Other|0|||
129974744|NCT05000216|467871461|FG001|Stage 1|Other|0|||
129974745|NCT05000216|467871462|FG002|Stage 1|Other|0|||
129974746|NCT05000216|467871463|FG003|Stage 1|Other|0|||
129974747|NCT05000216|467871464|FG004|Stage 1|Other|1|||
129974748|NCT05000216|467871465|FG005|Stage 1|Other|0|||
129974749|NCT05000216|467871466|FG006|Stage 1|Other|0|||
129974750|NCT05000216|467871467|FG007|Stage 1|Other|2|||
130138545|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138546|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138547|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138548|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138549|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138550|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138551|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138552|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
130138553|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129974751|NCT05000216|467871468|FG008|Stage 1|Other|0|||
129974752|NCT05000216|467871469|FG009|Stage 1|Other|0|||
129974753|NCT05000216|467871470|FG010|Stage 1|Other|1|||
129974754|NCT05000216|467871471|FG011|Stage 1|Other|1|||
129974755|NCT05000216|467871472|FG012|Stage 1|Other|0|||
129974756|NCT05000216|467871473|FG013|Stage 1|Other|0|||
129974757|NCT05000216|467871474|FG014|Stage 1|Other|0|||
129974758|NCT05000216|467871475|FG015|Stage 1|Other|0|||
129974759|NCT05000216|467871476|FG016|Stage 1|Other|0|||
129974760|NCT05000216|467871477|FG017|Stage 1|Other|0|||
129974761|NCT05000216|467871478|FG018|Stage 1|Other|0|||
129974762|NCT05000216|467871479|FG019|Stage 1|Other|0|||
129974763|NCT05000216|467871480|FG020|Stage 1|Other|0|||
129974764|NCT05000216|467871481|FG021|Stage 1|Other|0|||
130138554|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138555|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138556|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138557|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138558|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138559|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138560|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138561|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138562|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138563|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138564|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138565|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138566|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138567|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138568|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138569|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
130138570|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138571|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138572|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138573|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138574|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138575|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138576|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138577|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138578|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
130138579|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138580|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138581|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138582|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138583|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138584|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138585|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138586|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138587|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138588|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138589|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138590|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138591|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138592|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
129974765|NCT05000216|467871460|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
129974766|NCT05000216|467871461|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
129974767|NCT05000216|467871462|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
129974768|NCT05000216|467871463|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
129974769|NCT05000216|467871464|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
129974770|NCT05000216|467871465|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
129974771|NCT05000216|467871466|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
129974772|NCT05000216|467871467|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
129974773|NCT05000216|467871468|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
129974774|NCT05000216|467871469|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
129974775|NCT05000216|467871470|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
129974776|NCT05000216|467871471|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
129974777|NCT05000216|467871472|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
129974778|NCT05000216|467871473|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
129974779|NCT05000216|467871474|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
129974780|NCT05000216|467871475|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
130138593|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138594|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
130138595|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
129974781|NCT05000216|467871476|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
129974782|NCT05000216|467871477|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
130138596|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138597|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138598|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138599|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129974783|NCT05000216|467871478|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
129974784|NCT05000216|467871479|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
130138600|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138601|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130138602|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130138603|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
130138604|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
130138605|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
130138606|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138607|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138608|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138609|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138610|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138611|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138612|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138613|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138614|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138615|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138616|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138617|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138618|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138619|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138620|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138621|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
130138622|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138623|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138624|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138625|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138626|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138627|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138628|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138629|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138630|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138631|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
130138632|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138633|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138634|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138635|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138636|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138637|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138638|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138639|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138640|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138641|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138642|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138643|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138644|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138645|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138646|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138647|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
130138648|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138649|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138650|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138651|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138652|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138653|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138654|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138655|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138656|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138657|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
130138658|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138659|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138660|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138661|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138662|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138663|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138664|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138665|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138666|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
129974785|NCT05000216|467871480|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
129974786|NCT05000216|467871481|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
129974787|NCT05000216|467871460|FG000|Stage 2|Lost to Follow-up|0|||
130138667|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138668|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138669|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138670|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138671|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138672|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138673|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
130138674|NCT00112437|468467721|FG000|Year 2 (12-Month Extension)|Moved|0|||
130138675|NCT00112437|468467722|FG001|Year 2 (12-Month Extension)|Moved|0|||
130138676|NCT00112437|468467723|FG002|Year 2 (12-Month Extension)|Moved|0|||
130138677|NCT00112437|468467724|FG003|Year 2 (12-Month Extension)|Moved|0|||
130138678|NCT00112437|468467725|FG004|Year 2 (12-Month Extension)|Moved|0|||
130138679|NCT00112437|468467726|FG005|Year 2 (12-Month Extension)|Moved|0|||
130138680|NCT00112437|468467727|FG006|Year 2 (12-Month Extension)|Moved|0|||
130138681|NCT00112437|468467728|FG007|Year 2 (12-Month Extension)|Moved|0|||
130138682|NCT00112437|468467729|FG008|Year 2 (12-Month Extension)|Moved|0|||
130138683|NCT00112437|468467730|FG009|Year 2 (12-Month Extension)|Moved|1|||
130138684|NCT00112437|468467731|FG010|Year 2 (12-Month Extension)|Moved|0|||
130138685|NCT00112437|468467732|FG011|Year 2 (12-Month Extension)|Moved|0|||
130138686|NCT00112437|468467733|FG012|Year 2 (12-Month Extension)|Moved|0|||
130138687|NCT00112437|468467734|FG013|Year 2 (12-Month Extension)|Moved|0|||
130138688|NCT00112437|468467735|FG014|Year 2 (12-Month Extension)|Moved|0|||
130138689|NCT00112437|468467736|FG015|Year 2 (12-Month Extension)|Moved|0|||
130138690|NCT00112437|468467737|FG016|Year 2 (12-Month Extension)|Moved|0|||
130138691|NCT00112437|468467738|FG017|Year 2 (12-Month Extension)|Moved|0|||
130138692|NCT00112437|468467739|FG018|Year 2 (12-Month Extension)|Moved|0|||
130138693|NCT00112437|468467740|FG019|Year 2 (12-Month Extension)|Moved|0|||
130138694|NCT00112437|468467741|FG020|Year 2 (12-Month Extension)|Moved|0|||
130138695|NCT00112437|468467742|FG021|Year 2 (12-Month Extension)|Moved|0|||
130138696|NCT00112437|468467743|FG022|Year 2 (12-Month Extension)|Moved|0|||
129974788|NCT05000216|467871461|FG001|Stage 2|Lost to Follow-up|0|||
129974789|NCT05000216|467871462|FG002|Stage 2|Lost to Follow-up|0|||
130138697|NCT00112437|468467744|FG023|Year 2 (12-Month Extension)|Moved|0|||
130138698|NCT00112437|468467745|FG024|Year 2 (12-Month Extension)|Moved|0|||
130138699|NCT00112437|468467746|FG025|Year 2 (12-Month Extension)|Moved|0|||
130138700|NCT00112437|468467721|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
130138701|NCT00112437|468467722|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
130138702|NCT00112437|468467723|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
130138703|NCT00112437|468467724|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
130138704|NCT00112437|468467725|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
130138705|NCT00112437|468467726|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
130138706|NCT00112437|468467727|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
129974790|NCT05000216|467871463|FG003|Stage 2|Lost to Follow-up|0|||
129974791|NCT05000216|467871464|FG004|Stage 2|Lost to Follow-up|0|||
129974792|NCT05000216|467871465|FG005|Stage 2|Lost to Follow-up|0|||
129974793|NCT05000216|467871466|FG006|Stage 2|Lost to Follow-up|0|||
129974794|NCT05000216|467871467|FG007|Stage 2|Lost to Follow-up|0|||
129974795|NCT05000216|467871468|FG008|Stage 2|Lost to Follow-up|0|||
129974796|NCT05000216|467871469|FG009|Stage 2|Lost to Follow-up|0|||
129974797|NCT05000216|467871470|FG010|Stage 2|Lost to Follow-up|0|||
129974798|NCT05000216|467871471|FG011|Stage 2|Lost to Follow-up|0|||
129974799|NCT05000216|467871472|FG012|Stage 2|Lost to Follow-up|0|||
129974800|NCT05000216|467871473|FG013|Stage 2|Lost to Follow-up|0|||
129974801|NCT05000216|467871474|FG014|Stage 2|Lost to Follow-up|0|||
129974802|NCT05000216|467871475|FG015|Stage 2|Lost to Follow-up|0|||
129974803|NCT05000216|467871476|FG016|Stage 2|Lost to Follow-up|4|||
129974804|NCT05000216|467871477|FG017|Stage 2|Lost to Follow-up|0|||
129974805|NCT05000216|467871478|FG018|Stage 2|Lost to Follow-up|0|||
129974806|NCT05000216|467871479|FG019|Stage 2|Lost to Follow-up|0|||
129974807|NCT05000216|467871480|FG020|Stage 2|Lost to Follow-up|0|||
129974808|NCT05000216|467871481|FG021|Stage 2|Lost to Follow-up|0|||
129974809|NCT05000216|467871460|FG000|Stage 2|Physician Decision|0|||
129974810|NCT05000216|467871461|FG001|Stage 2|Physician Decision|0|||
129974811|NCT05000216|467871462|FG002|Stage 2|Physician Decision|0|||
129974812|NCT05000216|467871463|FG003|Stage 2|Physician Decision|0|||
130138707|NCT00112437|468467728|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
130138708|NCT00112437|468467729|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
130138709|NCT00112437|468467730|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
130138710|NCT00112437|468467731|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
130138711|NCT00112437|468467732|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
130138712|NCT00112437|468467733|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
129974813|NCT05000216|467871464|FG004|Stage 2|Physician Decision|0|||
129974814|NCT05000216|467871465|FG005|Stage 2|Physician Decision|0|||
129974815|NCT05000216|467871466|FG006|Stage 2|Physician Decision|0|||
129974816|NCT05000216|467871467|FG007|Stage 2|Physician Decision|0|||
129974817|NCT05000216|467871468|FG008|Stage 2|Physician Decision|0|||
129974818|NCT05000216|467871469|FG009|Stage 2|Physician Decision|0|||
129974819|NCT05000216|467871470|FG010|Stage 2|Physician Decision|0|||
130138713|NCT00112437|468467734|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
130138714|NCT00112437|468467735|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
130138715|NCT00112437|468467736|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
129974820|NCT05000216|467871471|FG011|Stage 2|Physician Decision|0|||
129974821|NCT05000216|467871472|FG012|Stage 2|Physician Decision|1|||
129974822|NCT05000216|467871473|FG013|Stage 2|Physician Decision|0|||
129974823|NCT05000216|467871474|FG014|Stage 2|Physician Decision|0|||
129974824|NCT05000216|467871475|FG015|Stage 2|Physician Decision|0|||
129974825|NCT05000216|467871476|FG016|Stage 2|Physician Decision|0|||
129974826|NCT05000216|467871477|FG017|Stage 2|Physician Decision|0|||
129974827|NCT05000216|467871478|FG018|Stage 2|Physician Decision|0|||
129974828|NCT05000216|467871479|FG019|Stage 2|Physician Decision|0|||
129974829|NCT05000216|467871480|FG020|Stage 2|Physician Decision|0|||
129974830|NCT05000216|467871481|FG021|Stage 2|Physician Decision|0|||
129974831|NCT05000216|467871460|FG000|Stage 2|Withdrawal by Subject|0|||
129974832|NCT05000216|467871461|FG001|Stage 2|Withdrawal by Subject|0|||
129974833|NCT05000216|467871462|FG002|Stage 2|Withdrawal by Subject|0|||
129974834|NCT05000216|467871463|FG003|Stage 2|Withdrawal by Subject|0|||
129974835|NCT05000216|467871464|FG004|Stage 2|Withdrawal by Subject|0|||
129974836|NCT05000216|467871465|FG005|Stage 2|Withdrawal by Subject|0|||
129974837|NCT05000216|467871466|FG006|Stage 2|Withdrawal by Subject|0|||
129974838|NCT05000216|467871467|FG007|Stage 2|Withdrawal by Subject|0|||
129974839|NCT05000216|467871468|FG008|Stage 2|Withdrawal by Subject|0|||
129974840|NCT05000216|467871469|FG009|Stage 2|Withdrawal by Subject|0|||
129974841|NCT05000216|467871470|FG010|Stage 2|Withdrawal by Subject|0|||
129974842|NCT05000216|467871471|FG011|Stage 2|Withdrawal by Subject|0|||
129974843|NCT05000216|467871472|FG012|Stage 2|Withdrawal by Subject|0|||
129974844|NCT05000216|467871473|FG013|Stage 2|Withdrawal by Subject|0|||
129974845|NCT05000216|467871474|FG014|Stage 2|Withdrawal by Subject|2|||
129974846|NCT05000216|467871475|FG015|Stage 2|Withdrawal by Subject|0|||
129974847|NCT05000216|467871476|FG016|Stage 2|Withdrawal by Subject|9|||
129974848|NCT05000216|467871477|FG017|Stage 2|Withdrawal by Subject|0|||
129974849|NCT05000216|467871478|FG018|Stage 2|Withdrawal by Subject|0|||
129974850|NCT05000216|467871479|FG019|Stage 2|Withdrawal by Subject|0|||
129974851|NCT05000216|467871480|FG020|Stage 2|Withdrawal by Subject|0|||
129974852|NCT05000216|467871481|FG021|Stage 2|Withdrawal by Subject|0|||
129974853|NCT05000216|467871460|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
129974854|NCT05000216|467871461|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
129974855|NCT05000216|467871462|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
129974856|NCT05000216|467871463|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
129974857|NCT05000216|467871464|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
129974858|NCT05000216|467871465|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
129974859|NCT05000216|467871466|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
129974860|NCT05000216|467871467|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
129974861|NCT05000216|467871468|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
129974862|NCT05000216|467871469|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
129974863|NCT05000216|467871470|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
129974864|NCT05000216|467871471|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
129974865|NCT05000216|467871472|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
129974866|NCT05000216|467871473|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
129974867|NCT05000216|467871474|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
129974868|NCT05000216|467871475|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
129974869|NCT05000216|467871476|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
129974870|NCT05000216|467871477|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
129974871|NCT05000216|467871478|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
129974872|NCT05000216|467871479|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
129974873|NCT05000216|467871480|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
129974874|NCT05000216|467871481|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
129974875|NCT05000216|467871460|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974876|NCT05000216|467871461|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974877|NCT05000216|467871462|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974878|NCT05000216|467871463|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974879|NCT05000216|467871464|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974880|NCT05000216|467871465|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974881|NCT05000216|467871466|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974882|NCT05000216|467871467|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974883|NCT05000216|467871468|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974884|NCT05000216|467871469|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974885|NCT05000216|467871470|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974886|NCT05000216|467871471|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974887|NCT05000216|467871472|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974888|NCT05000216|467871473|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974889|NCT05000216|467871474|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
129974890|NCT05000216|467871475|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974891|NCT05000216|467871476|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
129974892|NCT05000216|467871477|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974893|NCT05000216|467871478|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974894|NCT05000216|467871479|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974895|NCT05000216|467871480|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974896|NCT05000216|467871481|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974897|NCT05000216|467871460|FG000|Stage 2|Other reason|0|||
129974898|NCT05000216|467871461|FG001|Stage 2|Other reason|0|||
129974899|NCT05000216|467871462|FG002|Stage 2|Other reason|0|||
129974900|NCT05000216|467871463|FG003|Stage 2|Other reason|0|||
129974901|NCT05000216|467871464|FG004|Stage 2|Other reason|0|||
129974902|NCT05000216|467871465|FG005|Stage 2|Other reason|0|||
129974903|NCT05000216|467871466|FG006|Stage 2|Other reason|0|||
129974904|NCT05000216|467871467|FG007|Stage 2|Other reason|0|||
129974905|NCT05000216|467871468|FG008|Stage 2|Other reason|0|||
129974906|NCT05000216|467871469|FG009|Stage 2|Other reason|0|||
129974907|NCT05000216|467871470|FG010|Stage 2|Other reason|0|||
129974908|NCT05000216|467871471|FG011|Stage 2|Other reason|0|||
129974909|NCT05000216|467871472|FG012|Stage 2|Other reason|0|||
129974910|NCT05000216|467871473|FG013|Stage 2|Other reason|0|||
129974911|NCT05000216|467871474|FG014|Stage 2|Other reason|0|||
129974912|NCT05000216|467871475|FG015|Stage 2|Other reason|0|||
129974913|NCT05000216|467871476|FG016|Stage 2|Other reason|1|||
129974914|NCT05000216|467871477|FG017|Stage 2|Other reason|0|||
129974915|NCT05000216|467871478|FG018|Stage 2|Other reason|0|||
129974916|NCT05000216|467871479|FG019|Stage 2|Other reason|0|||
129974917|NCT05000216|467871480|FG020|Stage 2|Other reason|0|||
129974918|NCT05000216|467871481|FG021|Stage 2|Other reason|0|||
129974919|NCT05000216|467871460|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
129974920|NCT05000216|467871461|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
129974921|NCT05000216|467871462|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
129974922|NCT05000216|467871463|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
129974923|NCT05000216|467871464|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
129974924|NCT05000216|467871465|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
129974925|NCT05000216|467871466|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
129974926|NCT05000216|467871467|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
129974927|NCT05000216|467871468|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
129974928|NCT05000216|467871469|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
129974929|NCT05000216|467871470|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
130138716|NCT00112437|468467737|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
130138717|NCT00112437|468467738|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
130138718|NCT00112437|468467739|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
130138719|NCT00112437|468467740|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
130138720|NCT00112437|468467741|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
130138721|NCT00112437|468467742|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
130138722|NCT00112437|468467743|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
130138723|NCT00112437|468467744|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
130138724|NCT00112437|468467745|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
130138725|NCT00112437|468467746|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
130138726|NCT00112437|468467721|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138727|NCT00112437|468467722|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138728|NCT00112437|468467723|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138729|NCT00112437|468467724|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138730|NCT00112437|468467725|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138731|NCT00112437|468467726|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138732|NCT00112437|468467727|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138733|NCT00112437|468467728|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138734|NCT00112437|468467729|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138735|NCT00112437|468467730|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138736|NCT00112437|468467731|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138737|NCT00112437|468467732|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130138738|NCT00112437|468467733|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138739|NCT00112437|468467734|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130138740|NCT00112437|468467735|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138741|NCT00112437|468467736|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
130138742|NCT00112437|468467737|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138743|NCT00112437|468467738|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138744|NCT00112437|468467739|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
130138745|NCT00112437|468467740|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138746|NCT00112437|468467741|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138747|NCT00112437|468467742|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138748|NCT00112437|468467743|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138749|NCT00112437|468467744|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129974930|NCT05000216|467871471|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
129974931|NCT05000216|467871472|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
129974932|NCT05000216|467871473|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
130138750|NCT00112437|468467745|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129974933|NCT05000216|467871474|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
129974934|NCT05000216|467871475|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
129974935|NCT05000216|467871476|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
129974936|NCT05000216|467871477|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
129974937|NCT05000216|467871478|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
129974938|NCT05000216|467871479|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
129974939|NCT05000216|467871480|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
129974940|NCT05000216|467871481|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
129974941|NCT05000216|467871460|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974942|NCT05000216|467871461|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974943|NCT05000216|467871462|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974944|NCT05000216|467871463|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974945|NCT05000216|467871464|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974946|NCT05000216|467871465|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974947|NCT05000216|467871466|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974948|NCT05000216|467871467|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974949|NCT05000216|467871468|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974950|NCT05000216|467871469|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974951|NCT05000216|467871470|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974952|NCT05000216|467871471|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974953|NCT05000216|467871472|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974954|NCT05000216|467871473|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974955|NCT05000216|467871474|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974956|NCT05000216|467871475|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
129974957|NCT05000216|467871476|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974958|NCT05000216|467871477|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974959|NCT05000216|467871478|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974960|NCT05000216|467871479|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974961|NCT05000216|467871480|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974962|NCT05000216|467871481|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974963|NCT05000216|467871460|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974964|NCT05000216|467871461|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974965|NCT05000216|467871462|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974966|NCT05000216|467871463|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974967|NCT05000216|467871464|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974968|NCT05000216|467871465|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974969|NCT05000216|467871466|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974970|NCT05000216|467871467|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974971|NCT05000216|467871468|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974972|NCT05000216|467871469|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974973|NCT05000216|467871470|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974974|NCT05000216|467871471|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974975|NCT05000216|467871472|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974976|NCT05000216|467871473|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
129974977|NCT05000216|467871474|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974978|NCT05000216|467871475|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
129974979|NCT05000216|467871476|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974980|NCT05000216|467871477|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974981|NCT05000216|467871478|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
129974982|NCT05000216|467871479|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974983|NCT05000216|467871480|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974984|NCT05000216|467871481|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974985|NCT02057575|467871483|FG000|Overall Study|Adverse Event|0|||
129974986|NCT02057575|467871484|FG001|Overall Study|Adverse Event|2|||
129974987|NCT02057575|467871485|FG002|Overall Study|Adverse Event|0|||
129974988|NCT02057575|467871486|FG003|Overall Study|Adverse Event|1|||
129974989|NCT02057575|467871483|FG000|Overall Study|Withdrawal by Subject|1|||
129974990|NCT02057575|467871484|FG001|Overall Study|Withdrawal by Subject|0|||
129974991|NCT02057575|467871485|FG002|Overall Study|Withdrawal by Subject|0|||
129974992|NCT02057575|467871486|FG003|Overall Study|Withdrawal by Subject|0|||
129974993|NCT02057575|467871483|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
129974994|NCT02057575|467871484|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
129974995|NCT02057575|467871485|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
129974996|NCT02057575|467871486|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
129974997|NCT02057575|467871483|FG000|Overall Study|Protocol Violation|0|||
129974998|NCT02057575|467871484|FG001|Overall Study|Protocol Violation|1|||
129974999|NCT02057575|467871485|FG002|Overall Study|Protocol Violation|0|||
129975000|NCT02057575|467871486|FG003|Overall Study|Protocol Violation|0|||
129975001|NCT00332462|467871487|FG000|Overall Study|Adverse Event|5|||
129975002|NCT00332462|467871487|FG000|Overall Study|Abnormal Lab Value|1|||
129975003|NCT00332462|467871487|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129975004|NCT00332462|467871487|FG000|Overall Study|no longer requires study drug|1|||
129975005|NCT00332462|467871487|FG000|Overall Study|Death|3|||
129975006|NCT00332462|467871487|FG000|Overall Study|Graft Loss|2|||
129975007|NCT01643044|467871488|FG000|Overall Study|Lost to Follow-up|1|||
129975008|NCT01643044|467871489|FG001|Overall Study|Lost to Follow-up|1|||
129975009|NCT01643044|467871488|FG000|Overall Study|Miscarried baby|2|||
129975010|NCT01643044|467871489|FG001|Overall Study|Miscarried baby|2|||
129975011|NCT01643044|467871488|FG000|Overall Study|Delivered outside of hospital|1|||
129975012|NCT01643044|467871489|FG001|Overall Study|Delivered outside of hospital|2|||
129975013|NCT01735175|467871490|FG000|Overall Study|Withdrawal by Subject|9|||
129975014|NCT01735175|467871491|FG001|Overall Study|Withdrawal by Subject|2|||
129975015|NCT01735175|467871490|FG000|Overall Study|Lost to Follow-up|4|||
129975016|NCT01735175|467871491|FG001|Overall Study|Lost to Follow-up|2|||
129975017|NCT01735175|467871490|FG000|Overall Study|Death|3|||
129975018|NCT01735175|467871491|FG001|Overall Study|Death|2|||
129975019|NCT01735175|467871490|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
129975020|NCT01735175|467871491|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
129975021|NCT00659880|467871492|FG000|Overall Study|Lost to Follow-up|5|||
129975022|NCT01886287|467871493|FG000|Overall Study|Radiographic disease progression|1|||
129975023|NCT01886287|467871493|FG000|Overall Study|Clinical progression due to disease|1|||
129975024|NCT01031628|467871494|FG000|Overall Study|Study terminated early|0|||
129975025|NCT01031628|467871495|FG001|Overall Study|Study terminated early|1|||
129975026|NCT01031628|467871496|FG002|Overall Study|Study terminated early|3|||
129975027|NCT01031628|467871497|FG003|Overall Study|Study terminated early|0|||
129975028|NCT01266161|467871501|FG000|Overall Study|Ineligible|1|||
129975029|NCT01266161|467871502|FG001|Overall Study|Ineligible|0|||
129975030|NCT01266161|467871501|FG000|Overall Study|Lack of Efficacy|0|||
130138751|NCT00112437|468467746|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
130138752|NCT00112437|468467721|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138753|NCT00112437|468467722|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138754|NCT00112437|468467723|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129975031|NCT01266161|467871502|FG001|Overall Study|Lack of Efficacy|1|||
129975032|NCT01266161|467871501|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
129975033|NCT01266161|467871502|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
129975034|NCT02990468|467871503|FG000|Phase 2: MTD|Change in treatment|0|||
129975035|NCT02990468|467871504|FG001|Phase 2: MTD|Change in treatment|0|||
129975036|NCT02990468|467871505|FG002|Phase 2: MTD|Change in treatment|1|||
129975037|NCT01436305|467871507|FG000|Overall Study|Death|1|||
129975038|NCT01436305|467871508|FG001|Overall Study|Death|0|||
129975039|NCT01436305|467871509|FG002|Overall Study|Death|0|||
129975040|NCT01436305|467871507|FG000|Overall Study|Lost to Follow-up|0|||
129975041|NCT01436305|467871508|FG001|Overall Study|Lost to Follow-up|1|||
129975042|NCT01436305|467871509|FG002|Overall Study|Lost to Follow-up|0|||
129975043|NCT01436305|467871507|FG000|Overall Study|Withdrawal by Subject|1|||
129975044|NCT01436305|467871508|FG001|Overall Study|Withdrawal by Subject|3|||
129975045|NCT01436305|467871509|FG002|Overall Study|Withdrawal by Subject|0|||
129975046|NCT01602510|467871514|FG000|Open Label Phase|Adverse Event|46|||
129975047|NCT01602510|467871515|FG001|Open Label Phase|Adverse Event|0|||
129975048|NCT01602510|467871516|FG002|Open Label Phase|Adverse Event|0|||
129975049|NCT01602510|467871514|FG000|Open Label Phase|Lack of Efficacy|22|||
129975050|NCT01602510|467871515|FG001|Open Label Phase|Lack of Efficacy|0|||
129975051|NCT01602510|467871516|FG002|Open Label Phase|Lack of Efficacy|0|||
129975052|NCT01602510|467871514|FG000|Open Label Phase|Protocol Violation|15|||
129975053|NCT01602510|467871515|FG001|Open Label Phase|Protocol Violation|0|||
129975054|NCT01602510|467871516|FG002|Open Label Phase|Protocol Violation|0|||
129975055|NCT01602510|467871514|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
129975056|NCT01602510|467871515|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
129975057|NCT01602510|467871516|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
129975058|NCT01602510|467871514|FG000|Open Label Phase|Lost to Follow-up|22|||
129975059|NCT01602510|467871515|FG001|Open Label Phase|Lost to Follow-up|0|||
129975060|NCT01602510|467871516|FG002|Open Label Phase|Lost to Follow-up|0|||
129975061|NCT01602510|467871514|FG000|Open Label Phase|Physician Decision|19|||
129975062|NCT01602510|467871515|FG001|Open Label Phase|Physician Decision|0|||
129975063|NCT01602510|467871516|FG002|Open Label Phase|Physician Decision|0|||
129975064|NCT01602510|467871514|FG000|Open Label Phase|Withdrawal by Subject|57|||
129975065|NCT01602510|467871515|FG001|Open Label Phase|Withdrawal by Subject|0|||
129975066|NCT01602510|467871516|FG002|Open Label Phase|Withdrawal by Subject|0|||
129975067|NCT01602510|467871514|FG000|Randomized Phase|Adverse Event|0|||
130138755|NCT00112437|468467724|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129975068|NCT01602510|467871515|FG001|Randomized Phase|Adverse Event|2|||
129975069|NCT01602510|467871516|FG002|Randomized Phase|Adverse Event|6|||
129975070|NCT01602510|467871514|FG000|Randomized Phase|Lack of Efficacy|0|||
129975071|NCT01602510|467871515|FG001|Randomized Phase|Lack of Efficacy|4|||
130138756|NCT00112437|468467725|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138757|NCT00112437|468467726|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129975072|NCT01602510|467871516|FG002|Randomized Phase|Lack of Efficacy|4|||
129975073|NCT01602510|467871514|FG000|Randomized Phase|Protocol Violation|0|||
129975074|NCT01602510|467871515|FG001|Randomized Phase|Protocol Violation|3|||
129975075|NCT01602510|467871516|FG002|Randomized Phase|Protocol Violation|3|||
129975076|NCT01602510|467871514|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
129975077|NCT01602510|467871515|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
129975078|NCT01602510|467871516|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
129975079|NCT01602510|467871514|FG000|Randomized Phase|Lost to Follow-up|0|||
129975080|NCT01602510|467871515|FG001|Randomized Phase|Lost to Follow-up|1|||
129975081|NCT01602510|467871516|FG002|Randomized Phase|Lost to Follow-up|3|||
129975082|NCT01602510|467871514|FG000|Randomized Phase|Physician Decision|0|||
129975083|NCT01602510|467871515|FG001|Randomized Phase|Physician Decision|0|||
129975084|NCT01602510|467871516|FG002|Randomized Phase|Physician Decision|2|||
129975085|NCT01602510|467871514|FG000|Randomized Phase|Withdrawal by Subject|0|||
129975086|NCT01602510|467871515|FG001|Randomized Phase|Withdrawal by Subject|6|||
129975087|NCT01602510|467871516|FG002|Randomized Phase|Withdrawal by Subject|7|||
129975088|NCT03519204|467871517|FG000|Overall Study|Lost to Follow-up|3|||
129975089|NCT03519204|467871518|FG001|Overall Study|Lost to Follow-up|8|||
129975090|NCT03519204|467871517|FG000|Overall Study|Withdrawal by Subject|9|||
129975091|NCT03519204|467871518|FG001|Overall Study|Withdrawal by Subject|7|||
129975092|NCT03519204|467871517|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129975093|NCT03519204|467871518|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129975094|NCT01424813|467871523|FG000|Overall Study|Withdrawal by Subject|3|||
129975095|NCT01424813|467871524|FG001|Overall Study|Withdrawal by Subject|0|||
129975096|NCT01424813|467871523|FG000|Overall Study|Protocol Violation|1|||
129975097|NCT01424813|467871524|FG001|Overall Study|Protocol Violation|0|||
129975098|NCT01424813|467871523|FG000|Overall Study|Other|1|||
129975099|NCT01424813|467871524|FG001|Overall Study|Other|2|||
129975100|NCT04991753|467873263|FG000|Overall Study|Withdrawal by Subject|0|||
129975101|NCT04991753|467873264|FG001|Overall Study|Withdrawal by Subject|1|||
129975102|NCT03299049|467873265|FG000|Overall Study|On-going|486|||
129975103|NCT03299049|467873266|FG001|Overall Study|On-going|481|||
129975104|NCT03299049|467873265|FG000|Overall Study|Withdrawal by Subject|6|||
129975105|NCT03299049|467873266|FG001|Overall Study|Withdrawal by Subject|21|||
129975106|NCT03299049|467873265|FG000|Overall Study|Physician Decision|5|||
129975107|NCT03299049|467873266|FG001|Overall Study|Physician Decision|1|||
129975108|NCT03299049|467873265|FG000|Overall Study|Lost to Follow-up|2|||
129975109|NCT03299049|467873266|FG001|Overall Study|Lost to Follow-up|0|||
129975110|NCT03299049|467873265|FG000|Overall Study|Pregnancy|1|||
129975111|NCT03299049|467873266|FG001|Overall Study|Pregnancy|3|||
129975112|NCT03299049|467873265|FG000|Overall Study|Protocol Violation|1|||
129975113|NCT03299049|467873266|FG001|Overall Study|Protocol Violation|1|||
129975114|NCT03299049|467873265|FG000|Overall Study|Lack of Efficacy|9|||
129975115|NCT03299049|467873266|FG001|Overall Study|Lack of Efficacy|3|||
129975116|NCT03299049|467873265|FG000|Overall Study|Adverse Event|12|||
129975117|NCT03299049|467873266|FG001|Overall Study|Adverse Event|13|||
129975118|NCT01901419|467873267|FG000|Overall Study|Protocol Violation|2|||
129975119|NCT01901419|467873268|FG001|Overall Study|Protocol Violation|6|||
129975120|NCT01901419|467873267|FG000|Overall Study|unavailable researchers|6|||
129975121|NCT01901419|467873268|FG001|Overall Study|unavailable researchers|3|||
129975122|NCT01667926|467873273|FG000|Overall Study|Withdrawal by Subject|1|||
129975123|NCT01667926|467873274|FG001|Overall Study|Withdrawal by Subject|2|||
129975124|NCT01667926|467873275|FG002|Overall Study|Withdrawal by Subject|2|||
129975125|NCT01667926|467873273|FG000|Overall Study|Physician Decision|0|||
129975126|NCT01667926|467873274|FG001|Overall Study|Physician Decision|0|||
129975127|NCT01667926|467873275|FG002|Overall Study|Physician Decision|1|||
129975128|NCT01667926|467873273|FG000|Overall Study|Time committment|0|||
129975129|NCT01667926|467873274|FG001|Overall Study|Time committment|0|||
129975130|NCT01667926|467873275|FG002|Overall Study|Time committment|2|||
129975131|NCT01667926|467873273|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
129975132|NCT01667926|467873274|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
129975133|NCT01667926|467873275|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
129975134|NCT01667926|467873273|FG000|Overall Study|Lost to Follow-up|1|||
129975135|NCT01667926|467873274|FG001|Overall Study|Lost to Follow-up|2|||
129975136|NCT01667926|467873275|FG002|Overall Study|Lost to Follow-up|1|||
129975137|NCT01667926|467873273|FG000|Overall Study|Side effects|3|||
129975138|NCT01667926|467873274|FG001|Overall Study|Side effects|0|||
129975139|NCT01667926|467873275|FG002|Overall Study|Side effects|0|||
129975140|NCT02412735|467873276|FG000|Overall Study|Adverse Event|0|||
129975141|NCT02412735|467873277|FG001|Overall Study|Adverse Event|1|||
129975142|NCT02412735|467873278|FG002|Overall Study|Adverse Event|2|||
129975143|NCT02412735|467873276|FG000|Overall Study|Withdrawal by Subject|23|||
129975144|NCT02412735|467873277|FG001|Overall Study|Withdrawal by Subject|27|||
129975145|NCT02412735|467873278|FG002|Overall Study|Withdrawal by Subject|22|||
129975146|NCT02412735|467873276|FG000|Overall Study|Investigator Decision|3|||
129975147|NCT02412735|467873277|FG001|Overall Study|Investigator Decision|3|||
129975148|NCT02412735|467873278|FG002|Overall Study|Investigator Decision|2|||
129975149|NCT02412735|467873276|FG000|Overall Study|Lost to Follow-up|17|||
129975150|NCT02412735|467873277|FG001|Overall Study|Lost to Follow-up|11|||
129975151|NCT02412735|467873278|FG002|Overall Study|Lost to Follow-up|18|||
129975152|NCT02412735|467873276|FG000|Overall Study|Reason not Specified|3|||
129975153|NCT02412735|467873277|FG001|Overall Study|Reason not Specified|2|||
129975154|NCT02412735|467873278|FG002|Overall Study|Reason not Specified|2|||
129975155|NCT04043143|467873279|FG000|Overall Study|Lost to Follow-up|5|||
129975156|NCT04043143|467873280|FG001|Overall Study|Lost to Follow-up|5|||
129975157|NCT04043143|467873279|FG000|Overall Study|screen failure|1|||
129975158|NCT04043143|467873280|FG001|Overall Study|screen failure|0|||
129975159|NCT03480932|467873281|FG000|Overall Study|Death|1|||
129975160|NCT03480932|467873282|FG001|Overall Study|Death|1|||
129975161|NCT03480932|467873283|FG002|Overall Study|Death|0|||
129975162|NCT03480932|467873281|FG000|Overall Study|Lost to Follow-up|0|||
129975163|NCT03480932|467873282|FG001|Overall Study|Lost to Follow-up|2|||
129975164|NCT03480932|467873283|FG002|Overall Study|Lost to Follow-up|3|||
129975165|NCT03480932|467873281|FG000|Overall Study|Incarcerated|2|||
129975166|NCT03480932|467873282|FG001|Overall Study|Incarcerated|2|||
129975167|NCT03480932|467873283|FG002|Overall Study|Incarcerated|2|||
129975168|NCT04703192|467873287|FG000|Overall Study|Withdrawal by Subject|2|||
129975169|NCT04703192|467873288|FG001|Overall Study|Withdrawal by Subject|0|||
129975170|NCT04703192|467873287|FG000|Overall Study|Death|3|||
129975171|NCT04703192|467873288|FG001|Overall Study|Death|1|||
129975172|NCT04703192|467873287|FG000|Overall Study|Adverse Event|13|||
129975173|NCT04703192|467873288|FG001|Overall Study|Adverse Event|2|||
130138758|NCT00112437|468467727|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138759|NCT00112437|468467728|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138760|NCT00112437|468467729|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138761|NCT00112437|468467730|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129975174|NCT04703192|467873287|FG000|Overall Study|Progressive or Relapsed Disease|46|||
129975175|NCT04703192|467873288|FG001|Overall Study|Progressive or Relapsed Disease|7|||
129975176|NCT04703192|467873287|FG000|Overall Study|Clinical Progression|19|||
129975177|NCT04703192|467873288|FG001|Overall Study|Clinical Progression|8|||
129975178|NCT04703192|467873287|FG000|Overall Study|Lost to Follow-up|1|||
129975179|NCT04703192|467873288|FG001|Overall Study|Lost to Follow-up|0|||
129975180|NCT04703192|467873287|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
129975181|NCT04703192|467873288|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
129975182|NCT04703192|467873287|FG000|Overall Study|Other|5|||
129975183|NCT04703192|467873288|FG001|Overall Study|Other|1|||
129975184|NCT00678301|467873289|FG000|Overall Study|Non-compliance with study procedures|0|||
129975185|NCT00678301|467873290|FG001|Overall Study|Non-compliance with study procedures|1|||
130138762|NCT00112437|468467731|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138763|NCT00112437|468467732|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138764|NCT00112437|468467733|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138765|NCT00112437|468467734|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138766|NCT00112437|468467735|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138767|NCT00112437|468467736|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
129975186|NCT00678301|467873289|FG000|Overall Study|Adverse Event|1|||
129975187|NCT00678301|467873290|FG001|Overall Study|Adverse Event|0|||
129975188|NCT00678301|467873289|FG000|Overall Study|Withdrawal by Subject|4|||
129975189|NCT00678301|467873290|FG001|Overall Study|Withdrawal by Subject|0|||
129975190|NCT00678301|467873289|FG000|Overall Study|Lost to Follow-up|3|||
129975191|NCT00678301|467873290|FG001|Overall Study|Lost to Follow-up|1|||
129975192|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
129975193|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
129975194|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
129975195|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
129975196|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129975197|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
129975198|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129975199|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129975200|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129975201|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129975202|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129975203|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129975204|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
129975205|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
129975206|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129975207|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129975208|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
129975209|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
129975210|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
129975211|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
129975212|NCT05071053|467873305|FG000|Overall Study|Progressive disease|30|||
129975213|NCT05071053|467873305|FG000|Overall Study|Adverse Event|5|||
129975214|NCT01572740|467873306|FG000|Overall Study|Adverse Event|1|||
129975215|NCT01572740|467873307|FG001|Overall Study|Adverse Event|1|||
129975216|NCT01572740|467873306|FG000|Overall Study|Withdrawal by Subject|1|||
129975217|NCT01572740|467873307|FG001|Overall Study|Withdrawal by Subject|1|||
129975218|NCT01572740|467873306|FG000|Overall Study|unclassified|4|||
129975219|NCT01572740|467873307|FG001|Overall Study|unclassified|3|||
129975220|NCT01289210|467873308|FG000|Overall Study|Adverse Event|1|||
129975221|NCT01818531|467873309|FG000|Overall Study|Withdrawn for case delay after block|1|||
129975222|NCT01818531|467873310|FG001|Overall Study|Withdrawn for case delay after block|0|||
129975223|NCT01818531|467873309|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
129975224|NCT01818531|467873310|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
129975225|NCT01818531|467873309|FG000|Overall Study|Withdrawn for failure to place block|0|||
129975226|NCT01818531|467873310|FG001|Overall Study|Withdrawn for failure to place block|1|||
129975227|NCT01110408|467873313|FG000|Overall Study|Protocol Violation|1|||
129975228|NCT01110408|467873314|FG001|Overall Study|Protocol Violation|0|||
129975229|NCT01465763|467873315|FG000|Overall Study|Withdrawal by Subject|4|||
129975230|NCT01465763|467873316|FG001|Overall Study|Withdrawal by Subject|0|||
129975231|NCT01465763|467873317|FG002|Overall Study|Withdrawal by Subject|1|||
129975232|NCT01465763|467873315|FG000|Overall Study|Insufficient Clinical Response|11|||
129975233|NCT01465763|467873316|FG001|Overall Study|Insufficient Clinical Response|0|||
129975234|NCT01465763|467873317|FG002|Overall Study|Insufficient Clinical Response|1|||
129975235|NCT01465763|467873315|FG000|Overall Study|Adverse Event|9|||
129975236|NCT01465763|467873316|FG001|Overall Study|Adverse Event|0|||
129975237|NCT01465763|467873317|FG002|Overall Study|Adverse Event|1|||
129975238|NCT01465763|467873315|FG000|Overall Study|Other|2|||
129975239|NCT01465763|467873316|FG001|Overall Study|Other|0|||
129975240|NCT01465763|467873317|FG002|Overall Study|Other|0|||
129975241|NCT01465763|467873315|FG000|Overall Study|Protocol Violation|4|||
129975242|NCT01465763|467873316|FG001|Overall Study|Protocol Violation|1|||
129975243|NCT01465763|467873317|FG002|Overall Study|Protocol Violation|1|||
129975244|NCT01465763|467873315|FG000|Overall Study|Death|1|||
129975245|NCT01465763|467873316|FG001|Overall Study|Death|0|||
129975246|NCT01465763|467873317|FG002|Overall Study|Death|0|||
129975247|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
129975248|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
129975249|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
129975250|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
129975251|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975252|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975253|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975254|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975255|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975256|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975257|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975258|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975259|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
129975260|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
129975261|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
129975262|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
129975263|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975264|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975265|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
130138768|NCT00112437|468467737|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138769|NCT00112437|468467738|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138770|NCT00112437|468467739|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138771|NCT00112437|468467740|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138772|NCT00112437|468467741|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138773|NCT00112437|468467742|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129975266|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975267|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975268|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975269|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975270|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975271|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
129975272|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
129975273|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
129975274|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
129975275|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975276|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975277|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975278|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975279|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975280|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975281|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975282|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
130138774|NCT00112437|468467743|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138775|NCT00112437|468467744|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129975283|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
129975284|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
129975285|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
129975286|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
129975287|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975288|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975289|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975290|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975291|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975292|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975293|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975294|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975295|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975296|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975297|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
129975298|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
129975299|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975300|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975301|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975302|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975303|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975304|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975305|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975306|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975307|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
129975308|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
129975309|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
129975310|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975311|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975312|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975313|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975314|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975315|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975316|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975317|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975318|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975319|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975320|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975321|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975322|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975323|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
129975324|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
129975325|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
129975326|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
129975327|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975328|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975329|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975330|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975331|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975332|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975333|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975334|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975335|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
129975336|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
129975337|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
129975338|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
129975339|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975340|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975341|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975342|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975343|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975344|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975345|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975346|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975347|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
129975348|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
129975349|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
129975350|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
129975351|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975352|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975353|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975354|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975355|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975356|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975357|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975358|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975359|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
129975360|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
129975361|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
129975362|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
129975363|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
130138776|NCT00112437|468467745|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138777|NCT00112437|468467746|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
130138778|NCT00112437|468467721|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138779|NCT00112437|468467722|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138780|NCT00112437|468467723|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138781|NCT00112437|468467724|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
129975364|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975365|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975366|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975367|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975368|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975369|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975370|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975371|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
129975372|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
129975373|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
129975374|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
129975375|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975376|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975377|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975378|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975379|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975380|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975381|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975382|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975383|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
129975384|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
129975385|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975386|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
130138782|NCT00112437|468467725|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138783|NCT00112437|468467726|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138784|NCT00112437|468467727|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138785|NCT00112437|468467728|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138786|NCT00112437|468467729|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138787|NCT00112437|468467730|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138788|NCT00112437|468467731|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138789|NCT00112437|468467732|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138790|NCT00112437|468467733|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138791|NCT00112437|468467734|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138792|NCT00112437|468467735|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138793|NCT00112437|468467736|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
130138794|NCT00112437|468467737|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138795|NCT00112437|468467738|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138796|NCT00112437|468467739|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138797|NCT00112437|468467740|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138798|NCT00112437|468467741|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138799|NCT00112437|468467742|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138800|NCT00112437|468467743|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138801|NCT00112437|468467744|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138802|NCT00112437|468467745|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138803|NCT00112437|468467746|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
130138804|NCT00112437|468467721|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975387|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975388|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975389|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975390|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975391|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975392|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975393|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975394|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975395|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
129975396|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
129975397|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
129975398|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
129975399|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975400|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975401|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975402|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975403|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
129975404|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
129975405|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
129975406|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
129975407|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
129975408|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
129975409|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
129975410|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
129975411|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
129975412|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
129975413|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
129975414|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
129975415|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975416|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975417|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975418|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975419|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
129975420|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
129975421|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
129975422|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
129975423|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975424|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975425|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975426|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975427|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975428|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975429|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975430|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975431|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975432|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975433|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975434|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
129975435|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975436|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
130138805|NCT00112437|468467722|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138806|NCT00112437|468467723|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138807|NCT00112437|468467724|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975437|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975438|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975439|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975440|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975441|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130138808|NCT00112437|468467725|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975442|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
130138809|NCT00112437|468467726|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975443|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975444|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
129975445|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
129975446|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
129975447|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975448|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975449|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975450|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975451|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975452|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975453|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975454|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975455|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975456|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975457|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975458|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975459|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
129975460|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
129975461|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
129975462|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
129975463|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975464|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975465|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975466|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975467|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975468|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975469|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975470|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975471|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
129975472|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
129975473|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
129975474|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
129975475|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975476|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975477|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975478|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975479|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975480|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975481|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975482|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975483|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
129975484|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
129975485|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
129975486|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
129975487|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975488|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975489|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975490|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975491|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975492|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975493|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975494|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975495|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
129975496|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
130094542|NCT01258803|468302409|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
129975497|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
129975498|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
129975499|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975500|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975501|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975502|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975503|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975504|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
130094543|NCT01258803|468302404|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130138810|NCT00112437|468467727|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138811|NCT00112437|468467728|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138812|NCT00112437|468467729|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138813|NCT00112437|468467730|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975505|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975506|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975507|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
129975508|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
129975509|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
129975510|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
129975511|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975512|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975513|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975514|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975515|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975516|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975517|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975518|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975519|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
129975520|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
129975521|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
129975522|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
129975523|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975524|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975525|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975526|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975527|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975528|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975529|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975530|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975531|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975532|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
129975533|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
129975534|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
129975535|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975536|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975537|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975538|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975539|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975540|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975541|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975542|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975543|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975544|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
129975545|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
129975546|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
129975547|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975548|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975549|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975550|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130138814|NCT00112437|468467731|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138815|NCT00112437|468467732|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
130138816|NCT00112437|468467733|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138817|NCT00112437|468467734|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138818|NCT00112437|468467735|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
130138819|NCT00112437|468467736|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138820|NCT00112437|468467737|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138821|NCT00112437|468467738|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975551|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975552|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
130138822|NCT00112437|468467739|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138823|NCT00112437|468467740|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129975553|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975554|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975555|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
129975556|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975557|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
129975558|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
129975559|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975560|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975561|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975562|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975563|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975564|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975565|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975566|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975567|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975568|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975569|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
129975570|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
129975571|NCT02920970|467873330|FG000|First Intervention|Protocol Violation|0|||
129975572|NCT02920970|467873331|FG001|First Intervention|Protocol Violation|1|||
129975573|NCT02920970|467873330|FG000|First Intervention|Adverse Event|0|||
129975574|NCT02920970|467873331|FG001|First Intervention|Adverse Event|1|||
129975575|NCT02920970|467873330|FG000|Second Intervention|Poor Lens Fit|1|||
129975576|NCT02920970|467873331|FG001|Second Intervention|Poor Lens Fit|0|||
129975577|NCT01711853|467873334|FG000|Overall Study|Not treated|3|||
129975578|NCT01374568|467873336|FG000|Overall Study|Lab unable to analyze BTM|0|||
129975579|NCT01374568|467873337|FG001|Overall Study|Lab unable to analyze BTM|2|||
129975580|NCT01912404|467873338|FG000|Overall Study|Due to personal reasons|1|||
129975581|NCT01912404|467873339|FG001|Overall Study|Due to personal reasons|0|||
129975582|NCT02269423|467873344|FG000|Overall Study|Discontinued due to change in residence|0|||
129975583|NCT02269423|467873345|FG001|Overall Study|Discontinued due to change in residence|1|||
129975584|NCT02269423|467873346|FG002|Overall Study|Discontinued due to change in residence|0|||
129975585|NCT02269423|467873347|FG003|Overall Study|Discontinued due to change in residence|1|||
129975586|NCT00755105|467873350|FG000|Overall Study|Withdrawal by Subject|9|||
129975587|NCT00755105|467873351|FG001|Overall Study|Withdrawal by Subject|11|||
129975588|NCT00755105|467873352|FG002|Overall Study|Withdrawal by Subject|4|||
129975589|NCT01281839|467873353|FG000|Overall Study|Lost to Follow-up|6|||
129975590|NCT01281839|467873354|FG001|Overall Study|Lost to Follow-up|3|||
129975591|NCT01281839|467873353|FG000|Overall Study|Withdrawal by Subject|4|||
130138824|NCT00112437|468467741|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138825|NCT00112437|468467742|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138826|NCT00112437|468467743|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138827|NCT00112437|468467744|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138828|NCT00112437|468467745|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138829|NCT00112437|468467746|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
130138830|NCT00112437|468467721|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138831|NCT00112437|468467722|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129975592|NCT01281839|467873354|FG001|Overall Study|Withdrawal by Subject|10|||
129975593|NCT01281839|467873353|FG000|Overall Study|Reason not specified|0|||
129975594|NCT01281839|467873354|FG001|Overall Study|Reason not specified|1|||
129975595|NCT01518153|467873355|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
130138832|NCT00112437|468467723|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138833|NCT00112437|468467724|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138834|NCT00112437|468467725|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138835|NCT00112437|468467726|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138836|NCT00112437|468467727|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138837|NCT00112437|468467728|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138838|NCT00112437|468467729|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138839|NCT00112437|468467730|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138840|NCT00112437|468467731|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
130138841|NCT00112437|468467732|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
130138842|NCT00112437|468467733|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138843|NCT00112437|468467734|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129975596|NCT01518153|467873356|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
129975597|NCT01518153|467873357|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
129975598|NCT01518153|467873355|FG000|Stem Cell Transplant|Death|2|||
130138844|NCT00112437|468467735|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129975599|NCT01518153|467873356|FG001|Stem Cell Transplant|Death|0|||
129975600|NCT01518153|467873357|FG002|Stem Cell Transplant|Death|0|||
129975601|NCT01518153|467873355|FG000|Stem Cell Transplant|Secondary graft failure|1|||
129975602|NCT01518153|467873356|FG001|Stem Cell Transplant|Secondary graft failure|0|||
129975603|NCT01518153|467873357|FG002|Stem Cell Transplant|Secondary graft failure|0|||
129975604|NCT01518153|467873355|FG000|Stem Cell Transplant|Adverse Event|1|||
129975605|NCT01518153|467873356|FG001|Stem Cell Transplant|Adverse Event|0|||
129975606|NCT01518153|467873357|FG002|Stem Cell Transplant|Adverse Event|0|||
129975607|NCT01518153|467873355|FG000|Donor Lymphocyte Infusion|Death|0|||
129975608|NCT01518153|467873356|FG001|Donor Lymphocyte Infusion|Death|2|||
129975609|NCT01518153|467873357|FG002|Donor Lymphocyte Infusion|Death|1|||
129975610|NCT00600613|467873358|FG000|Overall Study|Protocol Deviation|1|||
129975611|NCT01509547|467873361|FG000|Overall Study|Lost to Follow-up|24|||
129975612|NCT01509547|467873362|FG001|Overall Study|Lost to Follow-up|14|||
129975613|NCT01509547|467873361|FG000|Overall Study|Withdrawal by Subject|11|||
129975614|NCT01509547|467873362|FG001|Overall Study|Withdrawal by Subject|24|||
129975615|NCT01509547|467873361|FG000|Overall Study|Physician Decision|0|||
129975616|NCT01509547|467873362|FG001|Overall Study|Physician Decision|1|||
129975617|NCT00402051|467873367|FG000|Overall Study|Progressive Disease|13|||
129975618|NCT00402051|467873368|FG001|Overall Study|Progressive Disease|20|||
129975619|NCT00402051|467873367|FG000|Overall Study|Adverse Event|11|||
129975620|NCT00402051|467873368|FG001|Overall Study|Adverse Event|4|||
129975621|NCT00402051|467873367|FG000|Overall Study|Physician Decision|7|||
129975622|NCT00402051|467873368|FG001|Overall Study|Physician Decision|3|||
129975623|NCT00402051|467873367|FG000|Overall Study|Withdrawal by Subject|3|||
129975624|NCT00402051|467873368|FG001|Overall Study|Withdrawal by Subject|3|||
129975625|NCT00402051|467873367|FG000|Overall Study|Death - Related to Study Drug|1|||
129975626|NCT00402051|467873368|FG001|Overall Study|Death - Related to Study Drug|2|||
129975627|NCT00402051|467873367|FG000|Overall Study|Death Due to Study Disease|2|||
129975628|NCT00402051|467873368|FG001|Overall Study|Death Due to Study Disease|1|||
129975629|NCT00402051|467873367|FG000|Overall Study|Death Due to Adverse Event|0|||
129975630|NCT00402051|467873368|FG001|Overall Study|Death Due to Adverse Event|2|||
129975631|NCT00402051|467873367|FG000|Overall Study|Lost to Follow-up|1|||
129975632|NCT00402051|467873368|FG001|Overall Study|Lost to Follow-up|0|||
129975633|NCT02514551|467873369|FG000|Overall Study|Lost to Follow-up|0|||
129975634|NCT02514551|467873370|FG001|Overall Study|Lost to Follow-up|1|||
129975635|NCT02514551|467873369|FG000|Overall Study|Participant Never Treated|0|||
129975636|NCT02514551|467873370|FG001|Overall Study|Participant Never Treated|2|||
129975637|NCT00570908|467873385|FG000|Overall Study|Adverse Event|5|||
129975638|NCT00570908|467873385|FG000|Overall Study|Withdrawal by Subject|2|||
129975639|NCT01213524|467873386|FG000|Baseline|Withdrawal by Subject|5|||
129975640|NCT01213524|467873386|FG000|Baseline|high breath alcohol levels|1|||
129975641|NCT01213524|467873386|FG000|Baseline|Physician Decision|1|||
129975642|NCT01213524|467873386|FG000|Session 2|Withdrawal by Subject|5|||
129975643|NCT01213524|467873386|FG000|Session 3|Withdrawal by Subject|4|||
129975644|NCT01213524|467873386|FG000|Session 4|Physician Decision|1|||
129975645|NCT01213524|467873386|FG000|Session 4|Withdrawal by Subject|2|||
129975646|NCT05415748|467873395|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
129975647|NCT05415748|467873396|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
129975648|NCT05415748|467873397|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
129975649|NCT05415748|467873398|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
129975650|NCT05415748|467873395|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
129975651|NCT05415748|467873396|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
129975652|NCT05415748|467873397|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
129975653|NCT05415748|467873398|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
129975660|NCT00281320|467873405|FG000|Overall Study|Adverse Event|12|||
129975661|NCT00281320|467873406|FG001|Overall Study|Adverse Event|9|||
129975662|NCT00281320|467873405|FG000|Overall Study|Lack of Efficacy|4|||
129975663|NCT00281320|467873406|FG001|Overall Study|Lack of Efficacy|3|||
130138845|NCT00112437|468467736|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138846|NCT00112437|468467737|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138847|NCT00112437|468467738|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138848|NCT00112437|468467739|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138849|NCT00112437|468467740|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138850|NCT00112437|468467741|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129975664|NCT00281320|467873405|FG000|Overall Study|Withdrawal by Subject|5|||
129975665|NCT00281320|467873406|FG001|Overall Study|Withdrawal by Subject|6|||
129975666|NCT00281320|467873405|FG000|Overall Study|Lost to Follow-up|1|||
129975667|NCT00281320|467873406|FG001|Overall Study|Lost to Follow-up|2|||
129975668|NCT00281320|467873405|FG000|Overall Study|Other|3|||
129975669|NCT00281320|467873406|FG001|Overall Study|Other|1|||
129975670|NCT01447576|467873415|FG000|Overall Study|Lost to Follow-up|52|||
129975671|NCT01447576|467873415|FG000|Overall Study|Adverse Event|127|||
129975672|NCT01447576|467873415|FG000|Overall Study|Participant met withdrawal criteria|40|||
129975673|NCT01447576|467873415|FG000|Overall Study|Withdrawal by Subject|100|||
129975674|NCT01447576|467873415|FG000|Overall Study|Protocol deviation|83|||
129975675|NCT01447576|467873415|FG000|Overall Study|Lack of Efficacy|68|||
129975676|NCT01447576|467873415|FG000|Overall Study|Physician Decision|6|||
129975677|NCT00975676|467873416|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
129975678|NCT00975676|467873417|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
129975679|NCT02548078|467873418|FG000|Overall Study|Serious adverse event/Adverse event|1|||
129975680|NCT02548078|467873419|FG001|Overall Study|Serious adverse event/Adverse event|0|||
129975681|NCT02548078|467873418|FG000|Overall Study|Moved from study area|3|||
129975682|NCT02548078|467873419|FG001|Overall Study|Moved from study area|3|||
129975683|NCT02548078|467873418|FG000|Overall Study|Lost to Follow-up|1|||
129975684|NCT02548078|467873419|FG001|Overall Study|Lost to Follow-up|3|||
129975685|NCT02998476|467873425|FG000|Overall Study|Lost to Follow-up|1|||
129975686|NCT02998476|467873426|FG001|Overall Study|Lost to Follow-up|0|||
129975687|NCT02998476|467873425|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
129975688|NCT02998476|467873426|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
129975689|NCT02998476|467873425|FG000|Overall Study|Withdrawal by Subject|1|||
129975690|NCT02998476|467873426|FG001|Overall Study|Withdrawal by Subject|2|||
129975691|NCT02998476|467873425|FG000|Overall Study|Death|45|||
129975692|NCT02998476|467873426|FG001|Overall Study|Death|2|||
129975693|NCT02998476|467873425|FG000|Overall Study|Other|6|||
129975694|NCT02998476|467873426|FG001|Overall Study|Other|1|||
129975695|NCT03277352|467873427|FG000|Overall Study|Study Terminated By Sponsor|2|||
129975696|NCT03277352|467873427|FG000|Overall Study|Withdrawal by Subject|4|||
129975697|NCT03277352|467873427|FG000|Overall Study|Death|4|||
129975698|NCT01435772|467873428|FG000|Overall Study|Adverse Event|1|||
129975699|NCT01435772|467873429|FG001|Overall Study|Adverse Event|0|||
129975700|NCT01435772|467873430|FG002|Overall Study|Adverse Event|2|||
129975701|NCT01435772|467873428|FG000|Overall Study|Withdrawal by Subject|0|||
130138851|NCT00112437|468467742|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138852|NCT00112437|468467743|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138853|NCT00112437|468467744|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129975702|NCT01435772|467873429|FG001|Overall Study|Withdrawal by Subject|1|||
129975703|NCT01435772|467873430|FG002|Overall Study|Withdrawal by Subject|3|||
129975704|NCT01435772|467873428|FG000|Overall Study|Other - study termination|2|||
129975705|NCT01435772|467873429|FG001|Overall Study|Other - study termination|2|||
129975706|NCT01435772|467873430|FG002|Overall Study|Other - study termination|10|||
129975707|NCT03238963|467873431|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
129975708|NCT03238963|467873432|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
129975709|NCT03238963|467873431|FG000|Overall Study|Withdrawal by Subject|1|||
129975710|NCT03238963|467873432|FG001|Overall Study|Withdrawal by Subject|1|||
129975711|NCT03238963|467873431|FG000|Overall Study|Lost to Follow-up|1|||
130138854|NCT00112437|468467745|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138855|NCT00112437|468467746|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
130138856|NCT00112437|468467721|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138857|NCT00112437|468467722|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138858|NCT00112437|468467723|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138859|NCT00112437|468467724|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129975712|NCT03238963|467873432|FG001|Overall Study|Lost to Follow-up|0|||
129975713|NCT03238963|467873431|FG000|Overall Study|Protocol Violation|1|||
129975714|NCT03238963|467873432|FG001|Overall Study|Protocol Violation|1|||
129975715|NCT03238963|467873431|FG000|Overall Study|Adverse Event|1|||
129975716|NCT03238963|467873432|FG001|Overall Study|Adverse Event|0|||
129975717|NCT03838731|467875649|FG000|Overall Study|Pregnancy|0|||
129975718|NCT03838731|467875650|FG001|Overall Study|Pregnancy|1|||
129975719|NCT03838731|467875649|FG000|Overall Study|Withdrawal of consent|1|||
129975720|NCT03838731|467875650|FG001|Overall Study|Withdrawal of consent|0|||
129975721|NCT01088984|467875653|FG000|Phase 1|Death|2|||
129975722|NCT01088984|467875654|FG001|Phase 1|Death|1|||
129975723|NCT01088984|467875653|FG000|Phase 1|Disease Progression|2|||
129975724|NCT01088984|467875654|FG001|Phase 1|Disease Progression|4|||
129975725|NCT01088984|467875653|FG000|Phase 1|Other|1|||
129975726|NCT01088984|467875654|FG001|Phase 1|Other|1|||
129975727|NCT01088984|467875653|FG000|Phase 2|Death|0|||
129975728|NCT01088984|467875654|FG001|Phase 2|Death|5|||
129975729|NCT01088984|467875653|FG000|Phase 2|Withdrawal by Subject|0|||
129975730|NCT01088984|467875654|FG001|Phase 2|Withdrawal by Subject|1|||
129975731|NCT01088984|467875653|FG000|Phase 2|DIsease Progression|0|||
129975732|NCT01088984|467875654|FG001|Phase 2|DIsease Progression|25|||
129975733|NCT01088984|467875653|FG000|Phase 2|Other|0|||
129975734|NCT01088984|467875654|FG001|Phase 2|Other|1|||
129975735|NCT04707664|467875655|FG000|Overall Study|Adverse Event|2|||
129975736|NCT04707664|467875656|FG001|Overall Study|Adverse Event|0|||
129975737|NCT04707664|467875655|FG000|Overall Study|Death|1|||
129975738|NCT04707664|467875656|FG001|Overall Study|Death|2|||
129975739|NCT04707664|467875655|FG000|Overall Study|Withdrawal by Subject|13|||
129975740|NCT04707664|467875656|FG001|Overall Study|Withdrawal by Subject|21|||
129975741|NCT04707664|467875655|FG000|Overall Study|Lost to Follow-up|11|||
129975742|NCT04707664|467875656|FG001|Overall Study|Lost to Follow-up|13|||
129975743|NCT04707664|467875655|FG000|Overall Study|Not treated|2|||
129975744|NCT04707664|467875656|FG001|Overall Study|Not treated|0|||
129975745|NCT00699153|467875657|FG000|Overall Study|Lost to Follow-up|1|||
129975746|NCT00699153|467875658|FG001|Overall Study|Lost to Follow-up|0|||
129975747|NCT00699153|467875657|FG000|Overall Study|Adverse Event|0|||
129975748|NCT00699153|467875658|FG001|Overall Study|Adverse Event|2|||
129975749|NCT00699153|467875657|FG000|Overall Study|Protocol Violation|1|||
129975750|NCT00699153|467875658|FG001|Overall Study|Protocol Violation|0|||
129975751|NCT00699153|467875657|FG000|Overall Study|Travel Problem|1|||
129975752|NCT00699153|467875658|FG001|Overall Study|Travel Problem|0|||
129975753|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
129975754|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
129975755|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
129975756|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
129975757|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Death|13|||
129975758|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Death|12|||
129975759|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Progression|257|||
129975760|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Progression|218|||
129975761|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
129975762|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
129975763|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
129975764|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
129975765|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
129975766|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
129975767|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
129975768|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
129975769|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
129975770|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
129975771|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
129975772|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
129975773|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
129975774|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
129975775|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
129975776|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
129975777|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
129975778|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
129975779|NCT02706405|467875672|FG000|Overall Study|Death|3|||
129975780|NCT02706405|467875673|FG001|Overall Study|Death|2|||
129975781|NCT02706405|467875674|FG002|Overall Study|Death|0|||
129975782|NCT02706405|467875675|FG003|Overall Study|Death|1|||
129975783|NCT02706405|467875676|FG004|Overall Study|Death|0|||
129975784|NCT02706405|467875677|FG005|Overall Study|Death|0|||
129975785|NCT02706405|467875678|FG006|Overall Study|Death|3|||
129975786|NCT02706405|467875679|FG007|Overall Study|Death|4|||
129975787|NCT02706405|467875672|FG000|Overall Study|Disease progression|0|||
129975788|NCT02706405|467875673|FG001|Overall Study|Disease progression|0|||
129975789|NCT02706405|467875674|FG002|Overall Study|Disease progression|0|||
129975790|NCT02706405|467875675|FG003|Overall Study|Disease progression|0|||
129975791|NCT02706405|467875676|FG004|Overall Study|Disease progression|0|||
129975792|NCT02706405|467875677|FG005|Overall Study|Disease progression|0|||
129975793|NCT02706405|467875678|FG006|Overall Study|Disease progression|0|||
129975794|NCT02706405|467875679|FG007|Overall Study|Disease progression|1|||
129975795|NCT02706405|467875672|FG000|Overall Study|Pt moved to new therapy|0|||
129975796|NCT02706405|467875673|FG001|Overall Study|Pt moved to new therapy|0|||
129975797|NCT02706405|467875674|FG002|Overall Study|Pt moved to new therapy|0|||
129975798|NCT02706405|467875675|FG003|Overall Study|Pt moved to new therapy|0|||
129975799|NCT02706405|467875676|FG004|Overall Study|Pt moved to new therapy|0|||
129975800|NCT02706405|467875677|FG005|Overall Study|Pt moved to new therapy|1|||
129975801|NCT02706405|467875678|FG006|Overall Study|Pt moved to new therapy|0|||
130138860|NCT00112437|468467725|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138861|NCT00112437|468467726|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138862|NCT00112437|468467727|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129975802|NCT02706405|467875679|FG007|Overall Study|Pt moved to new therapy|1|||
129975803|NCT02706405|467875672|FG000|Overall Study|Physician Decision|1|||
129975804|NCT02706405|467875673|FG001|Overall Study|Physician Decision|0|||
129975805|NCT02706405|467875674|FG002|Overall Study|Physician Decision|0|||
129975806|NCT02706405|467875675|FG003|Overall Study|Physician Decision|0|||
129975807|NCT02706405|467875676|FG004|Overall Study|Physician Decision|0|||
129975808|NCT02706405|467875677|FG005|Overall Study|Physician Decision|0|||
129975809|NCT02706405|467875678|FG006|Overall Study|Physician Decision|0|||
129975810|NCT02706405|467875679|FG007|Overall Study|Physician Decision|0|||
129975811|NCT01228318|467875680|FG000|Overall Study|Clinic no show to receive intervention|1|||
130138863|NCT00112437|468467728|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129975812|NCT01228318|467875681|FG001|Overall Study|Clinic no show to receive intervention|0|||
129975813|NCT01228318|467875680|FG000|Overall Study|Unable to contact|2|||
129975814|NCT01228318|467875681|FG001|Overall Study|Unable to contact|5|||
129975815|NCT01228318|467875680|FG000|Overall Study|Moved|0|||
129975816|NCT01228318|467875681|FG001|Overall Study|Moved|2|||
129975817|NCT01228318|467875680|FG000|Overall Study|Incarcerated|1|||
129975818|NCT01228318|467875681|FG001|Overall Study|Incarcerated|0|||
129975819|NCT01182441|467875686|FG000|Overall Study|Patient Still in Follow-up|152|||
129975820|NCT01182441|467875687|FG001|Overall Study|Patient Still in Follow-up|72|||
129975821|NCT01182441|467875686|FG000|Overall Study|Death|37|||
129975822|NCT01182441|467875687|FG001|Overall Study|Death|25|||
129975823|NCT01182441|467875686|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
129975824|NCT01182441|467875687|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
129975825|NCT01182441|467875686|FG000|Overall Study|Lost to Follow-up|5|||
129975826|NCT01182441|467875687|FG001|Overall Study|Lost to Follow-up|8|||
129975827|NCT01182441|467875686|FG000|Overall Study|Withdrawal by Subject|6|||
129975828|NCT01182441|467875687|FG001|Overall Study|Withdrawal by Subject|13|||
129975829|NCT01182441|467875686|FG000|Overall Study|Implant Not Attempted|4|||
129975830|NCT01182441|467875687|FG001|Overall Study|Implant Not Attempted|0|||
129975831|NCT01182441|467875686|FG000|Overall Study|Adverse Event|2|||
129975832|NCT01182441|467875687|FG001|Overall Study|Adverse Event|0|||
129975833|NCT01182441|467875686|FG000|Overall Study|Physician Decision|1|||
129975834|NCT01182441|467875687|FG001|Overall Study|Physician Decision|1|||
129975835|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
129975836|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
129975837|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129975838|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
129975839|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129975840|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129975841|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
129975842|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
129975843|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129975844|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129975845|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
129975846|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129975847|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
129975848|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
129975849|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129975850|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
129975851|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
129975852|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
129975853|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
129975854|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
129975855|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
129975856|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
129975857|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
129975858|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
129975859|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
129975860|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
129975861|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
129975862|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
129975863|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
129975864|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
129975865|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
129975866|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
129975867|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
129975868|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
129975869|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
129975870|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
129975871|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
129975872|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
129975873|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
129975874|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
129975875|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
129975876|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
129975877|NCT00603525|467875688|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
129975878|NCT00603525|467875689|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
129975879|NCT00603525|467875690|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
129975880|NCT02304705|467875691|FG000|Overall Study|Withdrawal by Subject|2|||
129975881|NCT02304705|467875692|FG001|Overall Study|Withdrawal by Subject|0|||
129975882|NCT02304705|467875691|FG000|Overall Study|Physician Decision|2|||
129975883|NCT02304705|467875692|FG001|Overall Study|Physician Decision|4|||
129975884|NCT02304705|467875691|FG000|Overall Study|Death|0|||
129975885|NCT02304705|467875692|FG001|Overall Study|Death|1|||
129975886|NCT02304705|467875691|FG000|Overall Study|Lost to Follow-up|0|||
129975887|NCT02304705|467875692|FG001|Overall Study|Lost to Follow-up|2|||
129975888|NCT01195948|467875693|FG000|Overall Study|Lost to Follow-up|0|||
129975889|NCT01195948|467875694|FG001|Overall Study|Lost to Follow-up|1|||
129975890|NCT01195948|467875695|FG002|Overall Study|Lost to Follow-up|2|||
129975891|NCT00770029|467875696|FG000|Overall Study|Lost to Follow-up|2|||
129975892|NCT00770029|467875697|FG001|Overall Study|Lost to Follow-up|0|||
129975893|NCT00770029|467875696|FG000|Overall Study|Withdrawal by Subject|3|||
129975894|NCT00770029|467875697|FG001|Overall Study|Withdrawal by Subject|3|||
129975895|NCT00770029|467875696|FG000|Overall Study|Adverse Event|1|||
129975896|NCT00770029|467875697|FG001|Overall Study|Adverse Event|0|||
129975897|NCT02124811|467875698|FG000|Overall Study|Early termination|2|||
129975898|NCT02124811|467875699|FG001|Overall Study|Early termination|2|||
129975899|NCT02124811|467875698|FG000|Overall Study|Withdrawal by Subject|1|||
129975900|NCT02124811|467875699|FG001|Overall Study|Withdrawal by Subject|0|||
129975901|NCT01757197|467875702|FG000|Overall Study|Death|2|||
129975902|NCT01174446|467875706|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
129975903|NCT01174446|467875707|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
129975904|NCT01174446|467875708|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
129975905|NCT01174446|467875709|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
129975906|NCT01174446|467875706|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
129975907|NCT01174446|467875707|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
129975908|NCT01174446|467875708|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
129975909|NCT01174446|467875709|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
129975910|NCT01174446|467875706|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
129975911|NCT01174446|467875707|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
129975912|NCT01174446|467875708|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
129975913|NCT01174446|467875709|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
129975914|NCT01174446|467875706|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
129975915|NCT01174446|467875707|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
129975916|NCT01174446|467875708|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
129975917|NCT01174446|467875709|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
129975918|NCT01077128|467875710|FG000|Overall Study|Adverse Event|8|||
129975919|NCT01077128|467875710|FG000|Overall Study|Lack of Efficacy|1|||
129975920|NCT01077128|467875710|FG000|Overall Study|Disease exacerbation|1|||
129975921|NCT01077128|467875710|FG000|Overall Study|Adverse event and consent withdrawal|1|||
129975922|NCT01077128|467875710|FG000|Overall Study|Adverse event and disease exacerbation|1|||
129975923|NCT01077128|467875710|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
129975924|NCT01077128|467875710|FG000|Overall Study|Other|54|||
129975925|NCT00847626|467875713|FG000|Overall Study|Adverse Event|10|||
129975926|NCT00847626|467875714|FG001|Overall Study|Adverse Event|10|||
129975927|NCT00847626|467875715|FG002|Overall Study|Adverse Event|6|||
129975928|NCT00847626|467875716|FG003|Overall Study|Adverse Event|19|||
129975929|NCT00847626|467875717|FG004|Overall Study|Adverse Event|11|||
129975930|NCT00847626|467875718|FG005|Overall Study|Adverse Event|22|||
129975931|NCT00847626|467875719|FG006|Overall Study|Adverse Event|4|||
129975932|NCT00847626|467875720|FG007|Overall Study|Adverse Event|6|||
129975933|NCT00847626|467875721|FG008|Overall Study|Adverse Event|3|||
129975934|NCT00847626|467875722|FG009|Overall Study|Adverse Event|6|||
129975935|NCT00847626|467875723|FG010|Overall Study|Adverse Event|6|||
129975936|NCT00847626|467875713|FG000|Overall Study|Protocol Violation|2|||
129975937|NCT00847626|467875714|FG001|Overall Study|Protocol Violation|1|||
129975938|NCT00847626|467875715|FG002|Overall Study|Protocol Violation|2|||
129975939|NCT00847626|467875716|FG003|Overall Study|Protocol Violation|1|||
129975940|NCT00847626|467875717|FG004|Overall Study|Protocol Violation|1|||
129975941|NCT00847626|467875718|FG005|Overall Study|Protocol Violation|1|||
129975942|NCT00847626|467875719|FG006|Overall Study|Protocol Violation|1|||
129975943|NCT00847626|467875720|FG007|Overall Study|Protocol Violation|1|||
129975944|NCT00847626|467875721|FG008|Overall Study|Protocol Violation|0|||
129975945|NCT00847626|467875722|FG009|Overall Study|Protocol Violation|1|||
129975946|NCT00847626|467875723|FG010|Overall Study|Protocol Violation|1|||
129975947|NCT00847626|467875713|FG000|Overall Study|Lost to Follow-up|0|||
129975948|NCT00847626|467875714|FG001|Overall Study|Lost to Follow-up|1|||
130138864|NCT00112437|468467729|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138865|NCT00112437|468467730|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129975949|NCT00847626|467875715|FG002|Overall Study|Lost to Follow-up|1|||
129975950|NCT00847626|467875716|FG003|Overall Study|Lost to Follow-up|1|||
129975951|NCT00847626|467875717|FG004|Overall Study|Lost to Follow-up|0|||
129975952|NCT00847626|467875718|FG005|Overall Study|Lost to Follow-up|3|||
129975953|NCT00847626|467875719|FG006|Overall Study|Lost to Follow-up|1|||
129975954|NCT00847626|467875720|FG007|Overall Study|Lost to Follow-up|3|||
129975955|NCT00847626|467875721|FG008|Overall Study|Lost to Follow-up|1|||
129975956|NCT00847626|467875722|FG009|Overall Study|Lost to Follow-up|0|||
129975957|NCT00847626|467875723|FG010|Overall Study|Lost to Follow-up|1|||
129975958|NCT00847626|467875713|FG000|Overall Study|Withdrawal by Subject|5|||
129975959|NCT00847626|467875714|FG001|Overall Study|Withdrawal by Subject|5|||
129975960|NCT00847626|467875715|FG002|Overall Study|Withdrawal by Subject|3|||
129975961|NCT00847626|467875716|FG003|Overall Study|Withdrawal by Subject|8|||
130138866|NCT00112437|468467731|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138867|NCT00112437|468467732|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138868|NCT00112437|468467733|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138869|NCT00112437|468467734|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138870|NCT00112437|468467735|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138871|NCT00112437|468467736|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138872|NCT00112437|468467737|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138873|NCT00112437|468467738|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138874|NCT00112437|468467739|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138875|NCT00112437|468467740|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138876|NCT00112437|468467741|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
130138877|NCT00112437|468467742|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
130138878|NCT00112437|468467743|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138879|NCT00112437|468467744|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138880|NCT00112437|468467745|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
130138881|NCT00112437|468467746|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129975962|NCT00847626|467875717|FG004|Overall Study|Withdrawal by Subject|12|||
129975963|NCT00847626|467875718|FG005|Overall Study|Withdrawal by Subject|9|||
129975964|NCT00847626|467875719|FG006|Overall Study|Withdrawal by Subject|8|||
129975965|NCT00847626|467875720|FG007|Overall Study|Withdrawal by Subject|4|||
129975966|NCT00847626|467875721|FG008|Overall Study|Withdrawal by Subject|4|||
129975967|NCT00847626|467875722|FG009|Overall Study|Withdrawal by Subject|5|||
129975968|NCT00847626|467875723|FG010|Overall Study|Withdrawal by Subject|2|||
129975969|NCT00847626|467875713|FG000|Overall Study|Lack of Efficacy|3|||
129975970|NCT00847626|467875714|FG001|Overall Study|Lack of Efficacy|1|||
129975971|NCT00847626|467875715|FG002|Overall Study|Lack of Efficacy|0|||
129975972|NCT00847626|467875716|FG003|Overall Study|Lack of Efficacy|1|||
129975973|NCT00847626|467875717|FG004|Overall Study|Lack of Efficacy|2|||
129975974|NCT00847626|467875718|FG005|Overall Study|Lack of Efficacy|0|||
129975975|NCT00847626|467875719|FG006|Overall Study|Lack of Efficacy|6|||
129975976|NCT00847626|467875720|FG007|Overall Study|Lack of Efficacy|2|||
129975977|NCT00847626|467875721|FG008|Overall Study|Lack of Efficacy|5|||
129975978|NCT00847626|467875722|FG009|Overall Study|Lack of Efficacy|1|||
129975979|NCT00847626|467875723|FG010|Overall Study|Lack of Efficacy|7|||
129975980|NCT00847626|467875713|FG000|Overall Study|Other|1|||
129975981|NCT00847626|467875714|FG001|Overall Study|Other|5|||
129975982|NCT00847626|467875715|FG002|Overall Study|Other|4|||
129975983|NCT00847626|467875716|FG003|Overall Study|Other|1|||
129975984|NCT00847626|467875717|FG004|Overall Study|Other|2|||
129975985|NCT00847626|467875718|FG005|Overall Study|Other|2|||
129975986|NCT00847626|467875719|FG006|Overall Study|Other|2|||
129975987|NCT00847626|467875720|FG007|Overall Study|Other|3|||
129975988|NCT00847626|467875721|FG008|Overall Study|Other|1|||
129975989|NCT00847626|467875722|FG009|Overall Study|Other|1|||
129975990|NCT00847626|467875723|FG010|Overall Study|Other|3|||
129975991|NCT03057847|467875724|FG000|Overall Study|Lost to Follow-up|16|||
129975992|NCT01706705|467875726|FG000|Overall Study|Death|1|||
129975993|NCT01706705|467875726|FG000|Overall Study|Lack of Efficacy|13|||
129975994|NCT01706705|467875726|FG000|Overall Study|Non-clinical|6|||
129975995|NCT05627258|467875727|FG000|Overall Study|Lost to Follow-up|1|||
129975996|NCT05627258|467875728|FG001|Overall Study|Lost to Follow-up|0|||
129975997|NCT05627258|467875729|FG002|Overall Study|Lost to Follow-up|0|||
129975998|NCT05627258|467875730|FG003|Overall Study|Lost to Follow-up|0|||
129975999|NCT05627258|467875731|FG004|Overall Study|Lost to Follow-up|0|||
129976000|NCT05627258|467875732|FG005|Overall Study|Lost to Follow-up|0|||
129976001|NCT05627258|467875727|FG000|Overall Study|Withdrawal by Subject|0|||
129976002|NCT05627258|467875728|FG001|Overall Study|Withdrawal by Subject|0|||
129976003|NCT05627258|467875729|FG002|Overall Study|Withdrawal by Subject|0|||
129976004|NCT05627258|467875730|FG003|Overall Study|Withdrawal by Subject|0|||
129976005|NCT05627258|467875731|FG004|Overall Study|Withdrawal by Subject|2|||
130138882|NCT00112437|468467721|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138883|NCT00112437|468467722|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129976006|NCT05627258|467875732|FG005|Overall Study|Withdrawal by Subject|0|||
129976007|NCT05627258|467875727|FG000|Overall Study|Enrolled, but product not administered|1|||
129976008|NCT05627258|467875728|FG001|Overall Study|Enrolled, but product not administered|0|||
129976009|NCT05627258|467875729|FG002|Overall Study|Enrolled, but product not administered|0|||
129976010|NCT05627258|467875730|FG003|Overall Study|Enrolled, but product not administered|0|||
129976011|NCT05627258|467875731|FG004|Overall Study|Enrolled, but product not administered|0|||
129976012|NCT05627258|467875732|FG005|Overall Study|Enrolled, but product not administered|0|||
129976013|NCT05627258|467875727|FG000|Overall Study|Other subject illness/injury|1|||
129976014|NCT05627258|467875728|FG001|Overall Study|Other subject illness/injury|0|||
129976015|NCT05627258|467875729|FG002|Overall Study|Other subject illness/injury|0|||
130138884|NCT00112437|468467723|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138885|NCT00112437|468467724|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138886|NCT00112437|468467725|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138887|NCT00112437|468467726|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138888|NCT00112437|468467727|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138889|NCT00112437|468467728|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138890|NCT00112437|468467729|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138891|NCT00112437|468467730|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138892|NCT00112437|468467731|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138893|NCT00112437|468467732|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138894|NCT00112437|468467733|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138895|NCT00112437|468467734|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138896|NCT00112437|468467735|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138897|NCT00112437|468467736|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138898|NCT00112437|468467737|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138899|NCT00112437|468467738|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138900|NCT00112437|468467739|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138901|NCT00112437|468467740|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138902|NCT00112437|468467741|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
130138903|NCT00112437|468467742|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138904|NCT00112437|468467743|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138905|NCT00112437|468467744|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138906|NCT00112437|468467745|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138907|NCT00112437|468467746|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
130138908|NCT00112437|468467721|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138909|NCT00112437|468467722|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138910|NCT00112437|468467723|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138911|NCT00112437|468467724|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138912|NCT00112437|468467725|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138913|NCT00112437|468467726|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129976016|NCT05627258|467875730|FG003|Overall Study|Other subject illness/injury|0|||
129976017|NCT05627258|467875731|FG004|Overall Study|Other subject illness/injury|0|||
129976018|NCT05627258|467875732|FG005|Overall Study|Other subject illness/injury|0|||
129976019|NCT05627258|467875727|FG000|Overall Study|Subject moved from area|0|||
130138914|NCT00112437|468467727|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138915|NCT00112437|468467728|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138916|NCT00112437|468467729|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138917|NCT00112437|468467730|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138918|NCT00112437|468467731|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138919|NCT00112437|468467732|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138920|NCT00112437|468467733|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138921|NCT00112437|468467734|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138922|NCT00112437|468467735|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138923|NCT00112437|468467736|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138924|NCT00112437|468467737|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138925|NCT00112437|468467738|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138926|NCT00112437|468467739|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138927|NCT00112437|468467740|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138928|NCT00112437|468467741|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138929|NCT00112437|468467742|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
130138930|NCT00112437|468467743|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138931|NCT00112437|468467744|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138932|NCT00112437|468467745|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138933|NCT00112437|468467746|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
130138934|NCT00112437|468467721|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138935|NCT00112437|468467722|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138936|NCT00112437|468467723|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138937|NCT00112437|468467724|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138938|NCT00112437|468467725|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138939|NCT00112437|468467726|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138940|NCT00112437|468467727|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138941|NCT00112437|468467728|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138942|NCT00112437|468467729|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138943|NCT00112437|468467730|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
129976020|NCT05627258|467875728|FG001|Overall Study|Subject moved from area|0|||
129976021|NCT05627258|467875729|FG002|Overall Study|Subject moved from area|1|||
130138944|NCT00112437|468467731|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138945|NCT00112437|468467732|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138946|NCT00112437|468467733|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138947|NCT00112437|468467734|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138948|NCT00112437|468467735|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138949|NCT00112437|468467736|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138950|NCT00112437|468467737|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138951|NCT00112437|468467738|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138952|NCT00112437|468467739|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138953|NCT00112437|468467740|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138954|NCT00112437|468467741|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138955|NCT00112437|468467742|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
130138956|NCT00112437|468467743|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138957|NCT00112437|468467744|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138958|NCT00112437|468467745|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138959|NCT00112437|468467746|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
130138960|NCT00112437|468467721|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138961|NCT00112437|468467722|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138962|NCT00112437|468467723|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138963|NCT00112437|468467724|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138964|NCT00112437|468467725|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138965|NCT00112437|468467726|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138966|NCT00112437|468467727|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138967|NCT00112437|468467728|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138968|NCT00112437|468467729|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138969|NCT00112437|468467730|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138970|NCT00112437|468467731|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138971|NCT00112437|468467732|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138972|NCT00112437|468467733|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138973|NCT00112437|468467734|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138974|NCT00112437|468467735|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138975|NCT00112437|468467736|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138976|NCT00112437|468467737|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138977|NCT00112437|468467738|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129976022|NCT05627258|467875730|FG003|Overall Study|Subject moved from area|0|||
129976023|NCT05627258|467875731|FG004|Overall Study|Subject moved from area|0|||
129976024|NCT05627258|467875732|FG005|Overall Study|Subject moved from area|0|||
129976025|NCT02138786|467875733|FG000|Overall Study|Adverse Event|0|||
129976026|NCT02138786|467875734|FG001|Overall Study|Adverse Event|2|||
129976027|NCT02138786|467875735|FG002|Overall Study|Adverse Event|1|||
129976028|NCT02138786|467875733|FG000|Overall Study|Death|1|||
129976029|NCT02138786|467875734|FG001|Overall Study|Death|7|||
129976030|NCT02138786|467875735|FG002|Overall Study|Death|2|||
129976031|NCT02138786|467875733|FG000|Overall Study|Disease Progression|1|||
129976032|NCT02138786|467875734|FG001|Overall Study|Disease Progression|1|||
129976033|NCT02138786|467875735|FG002|Overall Study|Disease Progression|3|||
129976034|NCT02138786|467875733|FG000|Overall Study|Withdrawal by Subject|1|||
129976035|NCT02138786|467875734|FG001|Overall Study|Withdrawal by Subject|2|||
129976036|NCT02138786|467875735|FG002|Overall Study|Withdrawal by Subject|0|||
129976037|NCT02138786|467875733|FG000|Overall Study|Patient's Wish|0|||
129976038|NCT02138786|467875734|FG001|Overall Study|Patient's Wish|2|||
129976039|NCT02138786|467875735|FG002|Overall Study|Patient's Wish|0|||
129976040|NCT02138786|467875733|FG000|Overall Study|Sponsor Terminated Study|0|||
129976041|NCT02138786|467875734|FG001|Overall Study|Sponsor Terminated Study|1|||
129976042|NCT02138786|467875735|FG002|Overall Study|Sponsor Terminated Study|1|||
129976043|NCT02138786|467875733|FG000|Overall Study|Non-Compliance|0|||
129976044|NCT02138786|467875734|FG001|Overall Study|Non-Compliance|0|||
129976045|NCT02138786|467875735|FG002|Overall Study|Non-Compliance|1|||
129976046|NCT02088957|467875736|FG000|Overall Study|Lack of Efficacy|1|||
129976047|NCT02088957|467875737|FG001|Overall Study|Lack of Efficacy|0|||
129976048|NCT01199068|467875738|FG000|Overall Study|Unacceptable toxicity|0|||
129976049|NCT01199068|467875739|FG001|Overall Study|Unacceptable toxicity|0|||
129976050|NCT01199068|467875740|FG002|Overall Study|Unacceptable toxicity|2|||
129976051|NCT01199068|467875738|FG000|Overall Study|Progressive disease|3|||
129976052|NCT01199068|467875739|FG001|Overall Study|Progressive disease|3|||
129976053|NCT01199068|467875740|FG002|Overall Study|Progressive disease|6|||
129976054|NCT01199068|467875738|FG000|Overall Study|Withdrawal by Subject|0|||
129976055|NCT01199068|467875739|FG001|Overall Study|Withdrawal by Subject|0|||
129976056|NCT01199068|467875740|FG002|Overall Study|Withdrawal by Subject|1|||
129976057|NCT03338296|467875741|FG000|Overall Study|Adverse Event|0|||
129976058|NCT03338296|467875742|FG001|Overall Study|Adverse Event|1|||
129976059|NCT03338296|467875741|FG000|Overall Study|Withdrawal by Subject|14|||
129976060|NCT03338296|467875742|FG001|Overall Study|Withdrawal by Subject|13|||
130138978|NCT00112437|468467739|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129976061|NCT03338296|467875741|FG000|Overall Study|Lost to Follow-up|10|||
129976062|NCT03338296|467875742|FG001|Overall Study|Lost to Follow-up|10|||
129976063|NCT03338296|467875741|FG000|Overall Study|Study Terminated by Sponsor|77|||
129976064|NCT03338296|467875742|FG001|Overall Study|Study Terminated by Sponsor|76|||
129976065|NCT03338296|467875741|FG000|Overall Study|Other|2|||
129976066|NCT03338296|467875742|FG001|Overall Study|Other|7|||
129976067|NCT03338296|467875741|FG000|Overall Study|Missing|0|||
129976068|NCT03338296|467875742|FG001|Overall Study|Missing|1|||
129976069|NCT02687035|467875747|FG000|Overall Study|Withdrawal by Subject|1|||
129976070|NCT02687035|467875747|FG000|Overall Study|Death|87|||
129976071|NCT02687035|467875747|FG000|Overall Study|Lost to Follow-up|1|||
129976072|NCT02687035|467875747|FG000|Overall Study|Missed Visit|87|||
129976073|NCT02687035|467875747|FG000|Overall Study|Did not receive Study Device|8|||
129976074|NCT00667394|467875748|FG000|Overall Study|Adverse Event|3|||
129976075|NCT00667394|467875749|FG001|Overall Study|Adverse Event|0|||
129976076|NCT00667394|467875748|FG000|Overall Study|Progressive disease|1|||
129976077|NCT00667394|467875749|FG001|Overall Study|Progressive disease|0|||
129976078|NCT04076943|467875751|FG000|Overall Study|Withdrawal by Subject|12|||
129976079|NCT04076943|467875751|FG000|Overall Study|Adverse Event|1|||
129976080|NCT04076943|467875751|FG000|Overall Study|Progressive Disease|2|||
129976081|NCT04076943|467875751|FG000|Overall Study|Death|13|||
129976082|NCT04076943|467875751|FG000|Overall Study|Other than specified|6|||
129976083|NCT02224703|467875757|FG000|Overall Study|Adverse Event|0|||
129976084|NCT02224703|467875758|FG001|Overall Study|Adverse Event|5|||
129976085|NCT02224703|467875759|FG002|Overall Study|Adverse Event|0|||
129976086|NCT02224703|467875757|FG000|Overall Study|Withdrawn by investigator|1|||
129976087|NCT02224703|467875758|FG001|Overall Study|Withdrawn by investigator|0|||
129976088|NCT02224703|467875759|FG002|Overall Study|Withdrawn by investigator|0|||
129976089|NCT02224703|467875757|FG000|Overall Study|Advised by medical monitor|1|||
129976090|NCT02224703|467875758|FG001|Overall Study|Advised by medical monitor|0|||
129976091|NCT02224703|467875759|FG002|Overall Study|Advised by medical monitor|0|||
129976092|NCT02224703|467875757|FG000|Overall Study|Withdrawn by parent/guardian|0|||
129976093|NCT02224703|467875758|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129976094|NCT02224703|467875759|FG002|Overall Study|Withdrawn by parent/guardian|0|||
129976095|NCT02224703|467875757|FG000|Overall Study|Lack of Efficacy|1|||
129976096|NCT02224703|467875758|FG001|Overall Study|Lack of Efficacy|0|||
129976097|NCT02224703|467875759|FG002|Overall Study|Lack of Efficacy|0|||
129976098|NCT02922023|467875760|FG000|Overall Study|Lost to Follow-up|2|||
129976099|NCT02922023|467875761|FG001|Overall Study|Lost to Follow-up|0|||
129976100|NCT03596762|467875762|FG000|Overall Study|Protocol Violation|0|||
129976101|NCT03596762|467875763|FG001|Overall Study|Protocol Violation|0|||
129976102|NCT03596762|467875764|FG002|Overall Study|Protocol Violation|0|||
129976103|NCT03596762|467875765|FG003|Overall Study|Protocol Violation|0|||
129976104|NCT03596762|467875766|FG004|Overall Study|Protocol Violation|1|||
129976105|NCT03596762|467875762|FG000|Overall Study|Adverse Event|2|||
129976106|NCT03596762|467875763|FG001|Overall Study|Adverse Event|0|||
129976107|NCT03596762|467875764|FG002|Overall Study|Adverse Event|1|||
129976108|NCT03596762|467875765|FG003|Overall Study|Adverse Event|0|||
129976109|NCT03596762|467875766|FG004|Overall Study|Adverse Event|5|||
129976110|NCT03596762|467875762|FG000|Overall Study|Withdrawal by Subject|2|||
129976111|NCT03596762|467875763|FG001|Overall Study|Withdrawal by Subject|1|||
129976112|NCT03596762|467875764|FG002|Overall Study|Withdrawal by Subject|0|||
129976113|NCT03596762|467875765|FG003|Overall Study|Withdrawal by Subject|1|||
129976114|NCT03596762|467875766|FG004|Overall Study|Withdrawal by Subject|1|||
129976115|NCT02593123|467875767|FG000|Overall Study|Physician Decision|2|||
129976116|NCT02593123|467875768|FG001|Overall Study|Physician Decision|1|||
129976117|NCT02593123|467875767|FG000|Overall Study|Relapse|1|||
129976118|NCT02593123|467875768|FG001|Overall Study|Relapse|1|||
130138979|NCT00112437|468467740|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129976119|NCT01261000|467875771|FG000|Overall Study|Screen failure|1|||
129976120|NCT00504777|467875772|FG000|Overall Study|Adverse Event|1|||
129976121|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
129976122|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
129976123|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
129976124|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
129976125|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
129976126|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
129976127|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
129976128|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
129976129|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
129976130|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
129976131|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976132|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976133|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
129976134|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
129976135|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976136|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976137|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976138|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976139|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
129976140|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976141|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976142|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976143|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
129976144|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976145|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976146|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976147|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976148|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
129976149|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
129976150|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
129976151|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
129976152|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
129976153|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129976154|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
130138980|NCT00112437|468467741|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
130138981|NCT00112437|468467742|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
130138982|NCT00112437|468467743|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138983|NCT00112437|468467744|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138984|NCT00112437|468467745|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138985|NCT00112437|468467746|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
130138986|NCT00112437|468467721|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138987|NCT00112437|468467722|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138988|NCT00112437|468467723|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138989|NCT00112437|468467724|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138990|NCT00112437|468467725|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138991|NCT00112437|468467726|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138992|NCT00112437|468467727|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138993|NCT00112437|468467728|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138994|NCT00112437|468467729|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138995|NCT00112437|468467730|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138996|NCT00112437|468467731|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138997|NCT00112437|468467732|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138998|NCT00112437|468467733|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130138999|NCT00112437|468467734|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139000|NCT00112437|468467735|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139001|NCT00112437|468467736|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139002|NCT00112437|468467737|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139003|NCT00112437|468467738|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139004|NCT00112437|468467739|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139005|NCT00112437|468467740|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139006|NCT00112437|468467741|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139007|NCT00112437|468467742|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139008|NCT00112437|468467743|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
130139009|NCT00112437|468467744|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
130139010|NCT00112437|468467745|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
130139011|NCT00112437|468467746|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
130139012|NCT00112437|468467721|FG000|Years 6-10 (60-Month Extension)|Death|0|||
130139013|NCT00112437|468467722|FG001|Years 6-10 (60-Month Extension)|Death|0|||
130139014|NCT00112437|468467723|FG002|Years 6-10 (60-Month Extension)|Death|0|||
130139015|NCT00112437|468467724|FG003|Years 6-10 (60-Month Extension)|Death|0|||
130139016|NCT00112437|468467725|FG004|Years 6-10 (60-Month Extension)|Death|0|||
130139017|NCT00112437|468467726|FG005|Years 6-10 (60-Month Extension)|Death|0|||
130139018|NCT00112437|468467727|FG006|Years 6-10 (60-Month Extension)|Death|0|||
130139019|NCT00112437|468467728|FG007|Years 6-10 (60-Month Extension)|Death|0|||
130139020|NCT00112437|468467729|FG008|Years 6-10 (60-Month Extension)|Death|0|||
129976155|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129976156|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129976157|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
129976158|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
129976159|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
129976160|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
130139021|NCT00112437|468467730|FG009|Years 6-10 (60-Month Extension)|Death|0|||
130139022|NCT00112437|468467731|FG010|Years 6-10 (60-Month Extension)|Death|0|||
130139023|NCT00112437|468467732|FG011|Years 6-10 (60-Month Extension)|Death|0|||
130139024|NCT00112437|468467733|FG012|Years 6-10 (60-Month Extension)|Death|0|||
130139025|NCT00112437|468467734|FG013|Years 6-10 (60-Month Extension)|Death|0|||
130139026|NCT00112437|468467735|FG014|Years 6-10 (60-Month Extension)|Death|0|||
130139027|NCT00112437|468467736|FG015|Years 6-10 (60-Month Extension)|Death|0|||
130139028|NCT00112437|468467737|FG016|Years 6-10 (60-Month Extension)|Death|0|||
130139029|NCT00112437|468467738|FG017|Years 6-10 (60-Month Extension)|Death|0|||
130139030|NCT00112437|468467739|FG018|Years 6-10 (60-Month Extension)|Death|0|||
130139031|NCT00112437|468467740|FG019|Years 6-10 (60-Month Extension)|Death|0|||
130139032|NCT00112437|468467741|FG020|Years 6-10 (60-Month Extension)|Death|0|||
130139033|NCT00112437|468467742|FG021|Years 6-10 (60-Month Extension)|Death|0|||
130139034|NCT00112437|468467743|FG022|Years 6-10 (60-Month Extension)|Death|0|||
130139035|NCT00112437|468467744|FG023|Years 6-10 (60-Month Extension)|Death|2|||
130139036|NCT00112437|468467745|FG024|Years 6-10 (60-Month Extension)|Death|0|||
130139037|NCT00112437|468467746|FG025|Years 6-10 (60-Month Extension)|Death|0|||
130139038|NCT00112437|468467721|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139039|NCT00112437|468467722|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139040|NCT00112437|468467723|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139041|NCT00112437|468467724|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139042|NCT00112437|468467725|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139043|NCT00112437|468467726|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139044|NCT00112437|468467727|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139045|NCT00112437|468467728|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139046|NCT00112437|468467729|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139047|NCT00112437|468467730|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139048|NCT00112437|468467731|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139049|NCT00112437|468467732|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139050|NCT00112437|468467733|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139051|NCT00112437|468467734|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139052|NCT00112437|468467735|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139053|NCT00112437|468467736|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139054|NCT00112437|468467737|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139055|NCT00112437|468467738|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139056|NCT00112437|468467739|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139057|NCT00112437|468467740|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139058|NCT00112437|468467741|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139059|NCT00112437|468467742|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139060|NCT00112437|468467743|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139061|NCT00112437|468467744|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139062|NCT00112437|468467745|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
130139063|NCT00112437|468467746|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
130139064|NCT00112437|468467721|FG000|Years 6-10 (60-Month Extension)|Other|0|||
130139065|NCT00112437|468467722|FG001|Years 6-10 (60-Month Extension)|Other|0|||
130139066|NCT00112437|468467723|FG002|Years 6-10 (60-Month Extension)|Other|0|||
130139067|NCT00112437|468467724|FG003|Years 6-10 (60-Month Extension)|Other|0|||
130139068|NCT00112437|468467725|FG004|Years 6-10 (60-Month Extension)|Other|0|||
130139069|NCT00112437|468467726|FG005|Years 6-10 (60-Month Extension)|Other|0|||
130139070|NCT00112437|468467727|FG006|Years 6-10 (60-Month Extension)|Other|0|||
130139071|NCT00112437|468467728|FG007|Years 6-10 (60-Month Extension)|Other|0|||
130139072|NCT00112437|468467729|FG008|Years 6-10 (60-Month Extension)|Other|0|||
130139073|NCT00112437|468467730|FG009|Years 6-10 (60-Month Extension)|Other|0|||
130139074|NCT00112437|468467731|FG010|Years 6-10 (60-Month Extension)|Other|0|||
130139075|NCT00112437|468467732|FG011|Years 6-10 (60-Month Extension)|Other|0|||
130139076|NCT00112437|468467733|FG012|Years 6-10 (60-Month Extension)|Other|0|||
130139077|NCT00112437|468467734|FG013|Years 6-10 (60-Month Extension)|Other|0|||
130139078|NCT00112437|468467735|FG014|Years 6-10 (60-Month Extension)|Other|0|||
130139079|NCT00112437|468467736|FG015|Years 6-10 (60-Month Extension)|Other|0|||
130139080|NCT00112437|468467737|FG016|Years 6-10 (60-Month Extension)|Other|0|||
130139081|NCT00112437|468467738|FG017|Years 6-10 (60-Month Extension)|Other|0|||
130139082|NCT00112437|468467739|FG018|Years 6-10 (60-Month Extension)|Other|0|||
130139083|NCT00112437|468467740|FG019|Years 6-10 (60-Month Extension)|Other|0|||
129976161|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
129976162|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976163|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976164|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976165|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976166|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
129976167|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
130139084|NCT00112437|468467741|FG020|Years 6-10 (60-Month Extension)|Other|0|||
130139085|NCT00112437|468467742|FG021|Years 6-10 (60-Month Extension)|Other|0|||
129976168|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
129976169|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
129976170|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
130139086|NCT00112437|468467743|FG022|Years 6-10 (60-Month Extension)|Other|0|||
130139087|NCT00112437|468467744|FG023|Years 6-10 (60-Month Extension)|Other|0|||
130139088|NCT00112437|468467745|FG024|Years 6-10 (60-Month Extension)|Other|1|||
130139089|NCT00112437|468467746|FG025|Years 6-10 (60-Month Extension)|Other|0|||
130139090|NCT00112437|468467721|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139091|NCT00112437|468467722|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139092|NCT00112437|468467723|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139093|NCT00112437|468467724|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139094|NCT00112437|468467725|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139095|NCT00112437|468467726|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139096|NCT00112437|468467727|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139097|NCT00112437|468467728|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139098|NCT00112437|468467729|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139099|NCT00112437|468467730|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139100|NCT00112437|468467731|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139101|NCT00112437|468467732|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139102|NCT00112437|468467733|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139103|NCT00112437|468467734|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139104|NCT00112437|468467735|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139105|NCT00112437|468467736|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139106|NCT00112437|468467737|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139107|NCT00112437|468467738|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139108|NCT00112437|468467739|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139109|NCT00112437|468467740|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139110|NCT00112437|468467741|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139111|NCT00112437|468467742|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139112|NCT00112437|468467743|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139113|NCT00112437|468467744|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
130139114|NCT00112437|468467745|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139115|NCT00112437|468467746|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
130139116|NCT00112437|468467721|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139117|NCT00112437|468467722|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139118|NCT00112437|468467723|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139119|NCT00112437|468467724|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139120|NCT00112437|468467725|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139121|NCT00112437|468467726|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139122|NCT00112437|468467727|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139123|NCT00112437|468467728|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139124|NCT00112437|468467729|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139125|NCT00112437|468467730|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139126|NCT00112437|468467731|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139127|NCT00112437|468467732|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139128|NCT00112437|468467733|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139129|NCT00112437|468467734|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139130|NCT00112437|468467735|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139131|NCT00112437|468467736|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139132|NCT00112437|468467737|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139133|NCT00112437|468467738|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139134|NCT00112437|468467739|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139135|NCT00112437|468467740|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139136|NCT00112437|468467741|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139137|NCT00112437|468467742|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139138|NCT00112437|468467743|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
130139139|NCT00112437|468467744|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
130139140|NCT00112437|468467745|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
130139141|NCT00112437|468467746|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
130139142|NCT03541252|468467747|FG000|Overall Study|Withdrawal by Subject|1|||
130139143|NCT00227370|468467748|FG000|Overall Study|Withdrawal by Subject|1|||
130139144|NCT00227370|468467749|FG001|Overall Study|Withdrawal by Subject|2|||
130139145|NCT00227370|468467748|FG000|Overall Study|Death|3|||
130139146|NCT00227370|468467749|FG001|Overall Study|Death|4|||
130139147|NCT00227370|468467748|FG000|Overall Study|Adverse Event|6|||
130139148|NCT00227370|468467749|FG001|Overall Study|Adverse Event|11|||
130139149|NCT00227370|468467748|FG000|Overall Study|Physician Decision|9|||
130139150|NCT00227370|468467749|FG001|Overall Study|Physician Decision|6|||
130139151|NCT00227370|468467748|FG000|Overall Study|Other reasons|2|||
130139152|NCT00227370|468467749|FG001|Overall Study|Other reasons|1|||
130139153|NCT03846193|468467750|FG000|Overall Study|Physician Decision|0|||
130139154|NCT03846193|468467751|FG001|Overall Study|Physician Decision|0|||
130139155|NCT03846193|468467752|FG002|Overall Study|Physician Decision|1|||
130139156|NCT03846193|468467753|FG003|Overall Study|Physician Decision|0|||
130139157|NCT03846193|468467754|FG004|Overall Study|Physician Decision|0|||
130139158|NCT03846193|468467750|FG000|Overall Study|Lost to Follow-up|0|||
130139159|NCT03846193|468467751|FG001|Overall Study|Lost to Follow-up|0|||
130139160|NCT03846193|468467752|FG002|Overall Study|Lost to Follow-up|0|||
130139161|NCT03846193|468467753|FG003|Overall Study|Lost to Follow-up|0|||
130139162|NCT03846193|468467754|FG004|Overall Study|Lost to Follow-up|1|||
130139163|NCT03846193|468467750|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130139164|NCT03846193|468467751|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130139165|NCT03846193|468467752|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130139166|NCT03846193|468467753|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
130139167|NCT03846193|468467754|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
130139168|NCT02588339|468467756|FG000|Overall Study|Withdrawal by Subject|1|||
130139169|NCT02588339|468467756|FG000|Overall Study|GVHD Progression prior to treatment|2|||
130139170|NCT02302716|468468981|FG000|Overall Study|Adverse Event|1|||
130139171|NCT02302716|468468982|FG001|Overall Study|Adverse Event|1|||
130139172|NCT02302716|468468981|FG000|Overall Study|Death|0|||
130139173|NCT02302716|468468982|FG001|Overall Study|Death|1|||
130139174|NCT02302716|468468981|FG000|Overall Study|Lack of Efficacy|0|||
130139175|NCT02302716|468468982|FG001|Overall Study|Lack of Efficacy|1|||
130139176|NCT02302716|468468981|FG000|Overall Study|Lost to Follow-up|2|||
130139177|NCT02302716|468468982|FG001|Overall Study|Lost to Follow-up|4|||
130139178|NCT02302716|468468981|FG000|Overall Study|Physician Decision|3|||
130139179|NCT02302716|468468982|FG001|Overall Study|Physician Decision|4|||
130139180|NCT02302716|468468981|FG000|Overall Study|Withdrawal by Subject|13|||
130139181|NCT02302716|468468982|FG001|Overall Study|Withdrawal by Subject|7|||
130139182|NCT02302716|468468981|FG000|Overall Study|Protocol Violation|0|||
130139183|NCT02302716|468468982|FG001|Overall Study|Protocol Violation|1|||
130139184|NCT00557245|468468986|FG000|Overall Study|Lost to Follow-up|7|||
130139185|NCT00557245|468468987|FG001|Overall Study|Lost to Follow-up|8|||
130139186|NCT00557245|468468988|FG002|Overall Study|Lost to Follow-up|10|||
130139187|NCT00557245|468468986|FG000|Overall Study|Ineligible|5|||
130139188|NCT00557245|468468987|FG001|Overall Study|Ineligible|4|||
130139189|NCT00557245|468468988|FG002|Overall Study|Ineligible|2|||
130139190|NCT00798603|468468991|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
130139191|NCT00798603|468468991|FG000|Overall Study|Withdrawal by Subject|10|||
130139192|NCT00798603|468468991|FG000|Overall Study|Adverse Event|22|||
130139193|NCT00798603|468468991|FG000|Overall Study|Physician Decision|1|||
130139194|NCT00798603|468468991|FG000|Overall Study|Lack of insurance coverage|1|||
130139195|NCT00660660|468468993|FG000|Overall Study|Adverse Event|1|||
130139196|NCT00660660|468468994|FG001|Overall Study|Adverse Event|0|||
130139197|NCT00660660|468468993|FG000|Overall Study|Lost to Follow-up|0|||
130139198|NCT00660660|468468994|FG001|Overall Study|Lost to Follow-up|6|||
130139199|NCT00660660|468468993|FG000|Overall Study|Lack of Efficacy|0|||
130139200|NCT00660660|468468994|FG001|Overall Study|Lack of Efficacy|2|||
130139201|NCT00660660|468468993|FG000|Overall Study|Withdrawal by Subject|3|||
130139202|NCT00660660|468468994|FG001|Overall Study|Withdrawal by Subject|0|||
130139203|NCT00660660|468468993|FG000|Overall Study|Incorrect enrollment and other|0|||
130139204|NCT00660660|468468994|FG001|Overall Study|Incorrect enrollment and other|1|||
130139205|NCT00660660|468468993|FG000|Overall Study|New medication after randomization|1|||
130139206|NCT00660660|468468994|FG001|Overall Study|New medication after randomization|0|||
130139207|NCT00924638|468469007|FG000|Overall Study|Death|3|||
130139208|NCT00924638|468469008|FG001|Overall Study|Death|2|||
130139209|NCT00924638|468469007|FG000|Overall Study|Lost to Follow-up|1|||
130139210|NCT00924638|468469008|FG001|Overall Study|Lost to Follow-up|1|||
130139211|NCT00924638|468469007|FG000|Overall Study|Withdrawal by Subject|5|||
130139212|NCT00924638|468469008|FG001|Overall Study|Withdrawal by Subject|7|||
130139213|NCT00924638|468469007|FG000|Overall Study|Physician Decision|3|||
130139214|NCT00924638|468469008|FG001|Overall Study|Physician Decision|3|||
130139215|NCT00847535|468469009|FG000|Overall Study|Withdrawal by Subject|2|||
130139216|NCT00847535|468469010|FG001|Overall Study|Withdrawal by Subject|1|||
130139217|NCT00847535|468469011|FG002|Overall Study|Withdrawal by Subject|1|||
130139218|NCT00847535|468469009|FG000|Overall Study|Lost to Follow-up|0|||
130139219|NCT00847535|468469010|FG001|Overall Study|Lost to Follow-up|1|||
130139220|NCT00847535|468469011|FG002|Overall Study|Lost to Follow-up|0|||
130139221|NCT01252953|468469012|FG000|Overall Study|Withdrawal by Subject|16|||
130139222|NCT01252953|468469013|FG001|Overall Study|Withdrawal by Subject|17|||
130139223|NCT01252953|468469012|FG000|Overall Study|Lost to Follow-up|22|||
130139224|NCT01252953|468469013|FG001|Overall Study|Lost to Follow-up|21|||
130139225|NCT00958724|468469017|FG000|Overall Study|Disease Progression|6|||
130139226|NCT05604014|468469018|FG000|Overall Study|Lost to Follow-up|13|||
130139227|NCT02121184|468469036|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
130139228|NCT02121184|468469037|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
130139229|NCT02121184|468469036|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
130139230|NCT02121184|468469037|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
130139231|NCT02121184|468469036|FG000|Overall Study|Emergency cesarean section required|0|||
130139232|NCT02121184|468469037|FG001|Overall Study|Emergency cesarean section required|2|||
130139233|NCT02121184|468469036|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
130139234|NCT02121184|468469037|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
130139235|NCT00840203|468469038|FG000|First Intervention|Protocol Violation|1|||
130139236|NCT00840203|468469039|FG001|First Intervention|Protocol Violation|1|||
130139237|NCT00840203|468469038|FG000|Washout|Protocol Violation|1|||
130139238|NCT00840203|468469039|FG001|Washout|Protocol Violation|0|||
130139239|NCT04411680|468469042|FG000|Treatment Period|Adverse Event|3|||
130139240|NCT04411680|468469043|FG001|Treatment Period|Adverse Event|0|||
130139241|NCT04411680|468469042|FG000|Treatment Period|Discharged from hospital|18|||
130139242|NCT04411680|468469043|FG001|Treatment Period|Discharged from hospital|7|||
130139243|NCT04411680|468469042|FG000|Treatment Period|Missed 1 or more doses|8|||
130139244|NCT04411680|468469043|FG001|Treatment Period|Missed 1 or more doses|0|||
130139245|NCT04411680|468469042|FG000|Treatment Period|Transferred to another hospital|0|||
130139246|NCT04411680|468469043|FG001|Treatment Period|Transferred to another hospital|1|||
130139247|NCT04411680|468469042|FG000|Follow up Period|Withdrawal by Subject|2|||
130139248|NCT04411680|468469043|FG001|Follow up Period|Withdrawal by Subject|0|||
130139249|NCT04411680|468469042|FG000|Follow up Period|Lost to Follow-up|5|||
130139250|NCT04411680|468469043|FG001|Follow up Period|Lost to Follow-up|6|||
130139251|NCT04411680|468469042|FG000|Follow up Period|Death|11|||
130139252|NCT04411680|468469043|FG001|Follow up Period|Death|8|||
130139253|NCT00748566|468469044|FG000|Overall Study|Adverse Event|49|||
130139254|NCT00748566|468469044|FG000|Overall Study|Death|1|||
130139255|NCT00748566|468469044|FG000|Overall Study|Lack of Efficacy|12|||
130139256|NCT00748566|468469044|FG000|Overall Study|Lost to Follow-up|1|||
130139257|NCT00748566|468469044|FG000|Overall Study|Protocol Violation|13|||
130139258|NCT00748566|468469044|FG000|Overall Study|Withdrawal by Subject|22|||
130139259|NCT00748566|468469044|FG000|Overall Study|Study terminated by sponsor|5|||
130139260|NCT00748566|468469044|FG000|Overall Study|Other|9|||
130139261|NCT00674128|468469045|FG000|Overall Study|Withdrawal by Subject|25|||
130139262|NCT00674128|468469046|FG001|Overall Study|Withdrawal by Subject|23|||
130139263|NCT00829452|468469047|FG000|First Intervention|Withdrawal by Subject|0|||
130139264|NCT00829452|468469048|FG001|First Intervention|Withdrawal by Subject|1|||
130139265|NCT00829452|468469047|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
130139266|NCT00829452|468469048|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
130139267|NCT00829452|468469047|FG000|Second Intervention|Physician Decision|0|||
130139268|NCT00829452|468469048|FG001|Second Intervention|Physician Decision|1|||
130139269|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
130139270|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
130139271|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
130139272|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
130139273|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
130139274|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
130139275|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
130139276|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
130139277|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
130139278|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
130139279|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
130139280|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
130139281|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
130139282|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
130139283|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
130139284|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130139285|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
130139286|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
130139287|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
130139288|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
130139289|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
130139290|NCT02227238|468469054|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
130139291|NCT02227238|468469055|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
130139292|NCT02227238|468469056|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
130139293|NCT02227238|468469054|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
129976171|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
130139294|NCT02227238|468469055|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
129976172|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
129976173|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
130139295|NCT02227238|468469056|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
130139296|NCT02227238|468469054|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
130139297|NCT02227238|468469055|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
130139298|NCT02227238|468469056|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
130139299|NCT02227238|468469054|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
129976174|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
130139300|NCT02227238|468469055|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
130139301|NCT02227238|468469056|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
130139302|NCT02227238|468469054|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
130139303|NCT02227238|468469055|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
130139304|NCT02227238|468469056|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
130139305|NCT02227238|468469054|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
130139306|NCT02227238|468469055|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
130139307|NCT02227238|468469056|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
130139308|NCT02227238|468469054|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
130139309|NCT02227238|468469055|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
130139310|NCT02227238|468469056|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
130139311|NCT03966911|468469057|FG000|Overall Study|Adverse Event|1|||
130139312|NCT03966911|468469058|FG001|Overall Study|Adverse Event|1|||
130139313|NCT03966911|468469057|FG000|Overall Study|Withdrawal by Subject|8|||
130139314|NCT03966911|468469058|FG001|Overall Study|Withdrawal by Subject|2|||
130139315|NCT03966911|468469057|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
130139316|NCT03966911|468469058|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
130139317|NCT03498560|468469060|FG000|Overall Study|Found Ineligible|2|||
130139318|NCT03498560|468469060|FG000|Overall Study|Withdrawal by Subject|14|||
130139319|NCT03498560|468469060|FG000|Overall Study|Lost to Follow-up|4|||
130139320|NCT03498560|468469060|FG000|Overall Study|Death|1|||
130139321|NCT01507662|468469061|FG000|Overall Study|Death|26|||
130139322|NCT01507662|468469062|FG001|Overall Study|Death|18|||
130139323|NCT01507662|468469061|FG000|Overall Study|Withdrawal by Subject|290|||
130139324|NCT01507662|468469062|FG001|Overall Study|Withdrawal by Subject|287|||
130139325|NCT01507662|468469061|FG000|Overall Study|Lost to Follow-up|498|||
130139326|NCT01507662|468469062|FG001|Overall Study|Lost to Follow-up|523|||
130139327|NCT01507662|468469061|FG000|Overall Study|Proxy interview done|2|||
130139328|NCT01507662|468469062|FG001|Overall Study|Proxy interview done|3|||
130139329|NCT01395017|468469067|FG000|Overall Study|Lost to Follow-up|1|||
130139330|NCT01395017|468469068|FG001|Overall Study|Lost to Follow-up|0|||
130139331|NCT01395017|468469067|FG000|Overall Study|Adverse Event|26|||
130139332|NCT01395017|468469068|FG001|Overall Study|Adverse Event|12|||
130139333|NCT01395017|468469067|FG000|Overall Study|Physician Decision|11|||
130139334|NCT01395017|468469068|FG001|Overall Study|Physician Decision|15|||
130139335|NCT01395017|468469067|FG000|Overall Study|Withdrawal by Subject|14|||
130139336|NCT01395017|468469068|FG001|Overall Study|Withdrawal by Subject|8|||
130139337|NCT01395017|468469067|FG000|Overall Study|Protocol deviation|1|||
130139338|NCT01395017|468469068|FG001|Overall Study|Protocol deviation|2|||
130139339|NCT01395017|468469067|FG000|Overall Study|Death|4|||
130139340|NCT01395017|468469068|FG001|Overall Study|Death|3|||
130139341|NCT01395017|468469067|FG000|Overall Study|Disease progression|42|||
130139342|NCT01395017|468469068|FG001|Overall Study|Disease progression|58|||
130139343|NCT01395017|468469067|FG000|Overall Study|Sponsor discontinued study|1|||
130139344|NCT01395017|468469068|FG001|Overall Study|Sponsor discontinued study|4|||
130139345|NCT01004510|468469069|FG000|Overall Study|Adverse Event|1|||
130139346|NCT01960296|468469070|FG000|Overall Study|Postponed surgery|1|||
130139347|NCT01960296|468469071|FG001|Overall Study|Postponed surgery|0|||
130139348|NCT01960296|468469070|FG000|Overall Study|Received different procedure|1|||
130139349|NCT01960296|468469071|FG001|Overall Study|Received different procedure|3|||
130139350|NCT02003391|468469072|FG000|Overall Study|Withdrawal by Subject|2|||
130139351|NCT02003391|468469073|FG001|Overall Study|Withdrawal by Subject|1|||
130139352|NCT02003391|468469072|FG000|Overall Study|Protocol Violation|0|||
130139353|NCT02003391|468469073|FG001|Overall Study|Protocol Violation|1|||
130139354|NCT02003391|468469072|FG000|Overall Study|Adverse Event|1|||
130139355|NCT02003391|468469073|FG001|Overall Study|Adverse Event|0|||
130139356|NCT02272803|468469074|FG000|Overall Study|Disease progression|16|||
130139357|NCT02272803|468469075|FG001|Overall Study|Disease progression|8|||
130139358|NCT02272803|468469074|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
130139359|NCT02272803|468469075|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
130139360|NCT02272803|468469074|FG000|Overall Study|Study drug toxicity|4|||
130139361|NCT02272803|468469075|FG001|Overall Study|Study drug toxicity|9|||
130139362|NCT02272803|468469074|FG000|Overall Study|Participant request to discontinue study treatment|3|||
130139363|NCT02272803|468469075|FG001|Overall Study|Participant request to discontinue study treatment|7|||
130139364|NCT02272803|468469074|FG000|Overall Study|Maximum clinical benefit|4|||
130139365|NCT02272803|468469075|FG001|Overall Study|Maximum clinical benefit|2|||
130139366|NCT02272803|468469074|FG000|Overall Study|Poor/non-compliance|2|||
130139367|NCT02272803|468469075|FG001|Overall Study|Poor/non-compliance|2|||
130139368|NCT02272803|468469074|FG000|Overall Study|Withdrawal by Subject|2|||
130139369|NCT02272803|468469075|FG001|Overall Study|Withdrawal by Subject|1|||
130139370|NCT02272803|468469074|FG000|Overall Study|Death|0|||
130139371|NCT02272803|468469075|FG001|Overall Study|Death|1|||
130139372|NCT02272803|468469074|FG000|Overall Study|Other reasons|1|||
130139373|NCT02272803|468469075|FG001|Overall Study|Other reasons|3|||
130139374|NCT02272803|468469074|FG000|Overall Study|Administrative reason by sponsor|5|||
130139375|NCT02272803|468469075|FG001|Overall Study|Administrative reason by sponsor|4|||
130139376|NCT01566435|468469079|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
130139377|NCT03684928|468469080|FG000|First Intervention|Lost to Follow-up|0|||
130139378|NCT03684928|468469081|FG001|First Intervention|Lost to Follow-up|1|||
130139379|NCT03684928|468469080|FG000|First Intervention|Withdrawal by Subject|0|||
130139380|NCT03684928|468469081|FG001|First Intervention|Withdrawal by Subject|2|||
130139381|NCT03684928|468469080|FG000|Second Intervention|Soft Tissue Injury|1|||
130139382|NCT03684928|468469081|FG001|Second Intervention|Soft Tissue Injury|0|||
130139383|NCT03733145|468469085|FG000|Overall Study|screenfail|3|||
130139384|NCT03733145|468469086|FG001|Overall Study|screenfail|3|||
130139385|NCT03733145|468469087|FG002|Overall Study|screenfail|2|||
130139386|NCT02316223|468470162|FG000|Overall Study|Lack of Efficacy|0|||
130139387|NCT02316223|468470163|FG001|Overall Study|Lack of Efficacy|1|||
130139388|NCT02316223|468470164|FG002|Overall Study|Lack of Efficacy|1|||
130139389|NCT02316223|468470162|FG000|Overall Study|Lost to Follow-up|27|||
130139390|NCT02316223|468470163|FG001|Overall Study|Lost to Follow-up|34|||
130139391|NCT02316223|468470164|FG002|Overall Study|Lost to Follow-up|36|||
130139392|NCT02316223|468470162|FG000|Overall Study|COPD Diagnosis|3|||
130139393|NCT02316223|468470163|FG001|Overall Study|COPD Diagnosis|2|||
130139394|NCT02316223|468470164|FG002|Overall Study|COPD Diagnosis|3|||
130139395|NCT02316223|468470162|FG000|Overall Study|Reside outside study area|1|||
130139396|NCT02316223|468470163|FG001|Overall Study|Reside outside study area|1|||
130139397|NCT02316223|468470164|FG002|Overall Study|Reside outside study area|1|||
130139398|NCT02316223|468470162|FG000|Overall Study|No asthma|2|||
130139399|NCT02316223|468470163|FG001|Overall Study|No asthma|0|||
130139400|NCT02316223|468470164|FG002|Overall Study|No asthma|0|||
130139401|NCT02316223|468470162|FG000|Overall Study|Discontinued by PI|11|||
130139402|NCT02316223|468470163|FG001|Overall Study|Discontinued by PI|19|||
130139403|NCT02316223|468470164|FG002|Overall Study|Discontinued by PI|3|||
130139404|NCT00529763|468470166|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
130139405|NCT00529763|468470167|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
130139406|NCT00529763|468470168|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
130139407|NCT00529763|468470166|FG000|Overall Study|Death|1|||
130139408|NCT00529763|468470167|FG001|Overall Study|Death|1|||
130139409|NCT00529763|468470168|FG002|Overall Study|Death|1|||
130139410|NCT00529763|468470166|FG000|Overall Study|Disease Progression|10|||
130139411|NCT00529763|468470167|FG001|Overall Study|Disease Progression|16|||
130139412|NCT00529763|468470168|FG002|Overall Study|Disease Progression|11|||
130139413|NCT00529763|468470166|FG000|Overall Study|Lost to Follow-up|1|||
130139414|NCT00529763|468470167|FG001|Overall Study|Lost to Follow-up|2|||
130139415|NCT00529763|468470168|FG002|Overall Study|Lost to Follow-up|3|||
130139416|NCT00529763|468470166|FG000|Overall Study|Stem Cell Transplant|0|||
130139417|NCT00529763|468470167|FG001|Overall Study|Stem Cell Transplant|3|||
130139418|NCT00529763|468470168|FG002|Overall Study|Stem Cell Transplant|1|||
130139419|NCT00529763|468470166|FG000|Overall Study|Study Drug Toxicity|3|||
130139420|NCT00529763|468470167|FG001|Overall Study|Study Drug Toxicity|6|||
130139421|NCT00529763|468470168|FG002|Overall Study|Study Drug Toxicity|4|||
130139422|NCT00529763|468470166|FG000|Overall Study|Participant Withdrew Consent|2|||
130139423|NCT00529763|468470167|FG001|Overall Study|Participant Withdrew Consent|3|||
130139424|NCT00529763|468470168|FG002|Overall Study|Participant Withdrew Consent|4|||
130139425|NCT00529763|468470166|FG000|Overall Study|Other reasons|2|||
130139426|NCT00529763|468470167|FG001|Overall Study|Other reasons|0|||
130139427|NCT00529763|468470168|FG002|Overall Study|Other reasons|2|||
130139428|NCT00529763|468470166|FG000|Overall Study|Participant request to discontinue treatment|1|||
130139429|NCT00529763|468470167|FG001|Overall Study|Participant request to discontinue treatment|1|||
130139430|NCT00529763|468470168|FG002|Overall Study|Participant request to discontinue treatment|3|||
130139431|NCT03669250|468470169|FG000|Overall Study|Adverse Event|0|||
130139432|NCT03669250|468470170|FG001|Overall Study|Adverse Event|0|||
130139433|NCT03669250|468470171|FG002|Overall Study|Adverse Event|0|||
130139434|NCT03669250|468470172|FG003|Overall Study|Adverse Event|0|||
130139435|NCT03669250|468470173|FG004|Overall Study|Adverse Event|1|||
130139436|NCT03669250|468470174|FG005|Overall Study|Adverse Event|0|||
130139437|NCT03669250|468470169|FG000|Overall Study|Withdrawal by Subject|0|||
130139438|NCT03669250|468470170|FG001|Overall Study|Withdrawal by Subject|1|||
129976175|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
130139439|NCT03669250|468470171|FG002|Overall Study|Withdrawal by Subject|0|||
130139440|NCT03669250|468470172|FG003|Overall Study|Withdrawal by Subject|1|||
130139441|NCT03669250|468470173|FG004|Overall Study|Withdrawal by Subject|0|||
130139442|NCT03669250|468470174|FG005|Overall Study|Withdrawal by Subject|0|||
130139443|NCT00828321|468470175|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
130139444|NCT00828321|468470176|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
130139445|NCT00828321|468470175|FG000|Second Intervention|Protocol Violation|0|||
130139446|NCT00828321|468470176|FG001|Second Intervention|Protocol Violation|1|||
130139447|NCT02034513|468470177|FG000|Overall Study|Adverse Event|11|||
130139448|NCT02034513|468470178|FG001|Overall Study|Adverse Event|10|||
130139449|NCT02034513|468470177|FG000|Overall Study|Lack of Efficacy|0|||
130139450|NCT02034513|468470178|FG001|Overall Study|Lack of Efficacy|1|||
130139451|NCT02034513|468470177|FG000|Overall Study|Lost to Follow-up|6|||
130139452|NCT02034513|468470178|FG001|Overall Study|Lost to Follow-up|7|||
130139453|NCT02034513|468470177|FG000|Overall Study|Pregnancy|0|||
130139454|NCT02034513|468470178|FG001|Overall Study|Pregnancy|3|||
130139455|NCT02034513|468470177|FG000|Overall Study|Protocol Violation|7|||
130139456|NCT02034513|468470178|FG001|Overall Study|Protocol Violation|10|||
130139457|NCT02034513|468470177|FG000|Overall Study|Withdrawal by Subject|25|||
130139458|NCT02034513|468470178|FG001|Overall Study|Withdrawal by Subject|25|||
130139459|NCT02034513|468470177|FG000|Overall Study|Unclassified|0|||
130139460|NCT02034513|468470178|FG001|Overall Study|Unclassified|1|||
130139461|NCT03119662|468470181|FG000|Overall Study|Withdrawal by Subject|0|||
130139462|NCT03119662|468470182|FG001|Overall Study|Withdrawal by Subject|1|||
130139463|NCT04158687|468470184|FG000|Overall Study|Adverse Event|2|||
130139464|NCT04158687|468470185|FG001|Overall Study|Adverse Event|3|||
130139465|NCT04158687|468470186|FG002|Overall Study|Adverse Event|0|||
130139466|NCT04158687|468470187|FG003|Overall Study|Adverse Event|3|||
130139467|NCT04158687|468470184|FG000|Overall Study|Lost to Follow-up|5|||
130139468|NCT04158687|468470185|FG001|Overall Study|Lost to Follow-up|12|||
130139469|NCT04158687|468470186|FG002|Overall Study|Lost to Follow-up|4|||
130139470|NCT04158687|468470187|FG003|Overall Study|Lost to Follow-up|5|||
130139471|NCT04158687|468470184|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
130139472|NCT04158687|468470185|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
130139473|NCT04158687|468470186|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
130139474|NCT04158687|468470187|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
130139475|NCT04158687|468470184|FG000|Overall Study|Non-Compliance with Study Medication|2|||
130139476|NCT04158687|468470185|FG001|Overall Study|Non-Compliance with Study Medication|2|||
130139477|NCT04158687|468470186|FG002|Overall Study|Non-Compliance with Study Medication|3|||
130139478|NCT04158687|468470187|FG003|Overall Study|Non-Compliance with Study Medication|0|||
130139479|NCT04158687|468470184|FG000|Overall Study|Investigator Decision|0|||
130139480|NCT04158687|468470185|FG001|Overall Study|Investigator Decision|0|||
130139481|NCT04158687|468470186|FG002|Overall Study|Investigator Decision|2|||
130139482|NCT04158687|468470187|FG003|Overall Study|Investigator Decision|0|||
130139483|NCT04158687|468470184|FG000|Overall Study|Protocol Violation|0|||
130139484|NCT04158687|468470185|FG001|Overall Study|Protocol Violation|2|||
130139485|NCT04158687|468470186|FG002|Overall Study|Protocol Violation|1|||
130139486|NCT04158687|468470187|FG003|Overall Study|Protocol Violation|0|||
130139487|NCT04158687|468470184|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
130139488|NCT04158687|468470185|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
130139489|NCT04158687|468470186|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
130139490|NCT04158687|468470187|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
130139491|NCT04158687|468470184|FG000|Overall Study|Reason not Specified|3|||
130139492|NCT04158687|468470185|FG001|Overall Study|Reason not Specified|2|||
130139493|NCT04158687|468470186|FG002|Overall Study|Reason not Specified|4|||
130139494|NCT04158687|468470187|FG003|Overall Study|Reason not Specified|4|||
130139495|NCT04523480|468470188|FG000|Overall Study|Lost to Follow-up|30|||
130139496|NCT04523480|468470189|FG001|Overall Study|Lost to Follow-up|35|||
130139497|NCT04523480|468470190|FG002|Overall Study|Lost to Follow-up|0|||
130139498|NCT00081653|468470194|FG000|Overall Study|Adverse Event|23|||
130139499|NCT00081653|468470195|FG001|Overall Study|Adverse Event|17|||
130139500|NCT00081653|468470194|FG000|Overall Study|Lost to Follow-up|2|||
130139501|NCT00081653|468470195|FG001|Overall Study|Lost to Follow-up|4|||
130139502|NCT00081653|468470194|FG000|Overall Study|Refused Treatment|18|||
130139503|NCT00081653|468470195|FG001|Overall Study|Refused Treatment|14|||
130139504|NCT00081653|468470194|FG000|Overall Study|Low bone mineral density|1|||
130139505|NCT00081653|468470195|FG001|Overall Study|Low bone mineral density|0|||
130139506|NCT00081653|468470194|FG000|Overall Study|Bone loss|2|||
130139507|NCT00081653|468470195|FG001|Overall Study|Bone loss|0|||
130139508|NCT00081653|468470194|FG000|Overall Study|Participant leaving country|1|||
130139509|NCT00081653|468470195|FG001|Overall Study|Participant leaving country|0|||
130139510|NCT00081653|468470194|FG000|Overall Study|Loss of bone mass|0|||
130139511|NCT00081653|468470195|FG001|Overall Study|Loss of bone mass|2|||
130139512|NCT02694536|468470198|FG000|Overall Study|Progressive Disease|40|||
130139513|NCT02694536|468470198|FG000|Overall Study|Lost to Follow-up|1|||
130139514|NCT02694536|468470198|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
130139515|NCT02694536|468470198|FG000|Overall Study|Withdrawal by Subject|8|||
130139516|NCT02694536|468470198|FG000|Overall Study|Death|8|||
130139517|NCT02694536|468470198|FG000|Overall Study|Other|22|||
130139518|NCT01911429|468470203|FG000|Overall Study|Adverse Event|5|||
130139519|NCT01911429|468470204|FG001|Overall Study|Adverse Event|3|||
130139520|NCT01911429|468470205|FG002|Overall Study|Adverse Event|9|||
130139521|NCT01911429|468470203|FG000|Overall Study|Lack of Efficacy|1|||
130139522|NCT01911429|468470204|FG001|Overall Study|Lack of Efficacy|2|||
130139523|NCT01911429|468470205|FG002|Overall Study|Lack of Efficacy|4|||
130139524|NCT01911429|468470203|FG000|Overall Study|Lost to Follow-up|0|||
130139525|NCT01911429|468470204|FG001|Overall Study|Lost to Follow-up|0|||
130139526|NCT01911429|468470205|FG002|Overall Study|Lost to Follow-up|1|||
130139527|NCT01911429|468470203|FG000|Overall Study|Protocol Violation|0|||
130139528|NCT01911429|468470204|FG001|Overall Study|Protocol Violation|0|||
130139529|NCT01911429|468470205|FG002|Overall Study|Protocol Violation|1|||
130139530|NCT01911429|468470203|FG000|Overall Study|Withdrawal by Subject|5|||
130139531|NCT01911429|468470204|FG001|Overall Study|Withdrawal by Subject|5|||
130139532|NCT01911429|468470205|FG002|Overall Study|Withdrawal by Subject|4|||
130139533|NCT01911429|468470203|FG000|Overall Study|Accidental randomization|0|||
130139534|NCT01911429|468470204|FG001|Overall Study|Accidental randomization|0|||
130139535|NCT01911429|468470205|FG002|Overall Study|Accidental randomization|1|||
130139536|NCT01911429|468470203|FG000|Overall Study|subject left study|1|||
130139537|NCT01911429|468470204|FG001|Overall Study|subject left study|0|||
130139538|NCT01911429|468470205|FG002|Overall Study|subject left study|0|||
130139539|NCT01557751|468470211|FG000|Overall Study|Physician Decision|3|||
130139540|NCT01168856|468470218|FG000|Overall Study|Lost to Follow-up|4|||
130139541|NCT01168856|468470219|FG001|Overall Study|Lost to Follow-up|34|||
130139542|NCT01168856|468470218|FG000|Overall Study|Withdrawal by Subject|6|||
130139543|NCT01168856|468470219|FG001|Overall Study|Withdrawal by Subject|8|||
130139544|NCT01168856|468470218|FG000|Overall Study|Physician Decision|2|||
130139545|NCT01168856|468470219|FG001|Overall Study|Physician Decision|1|||
130139546|NCT01168856|468470218|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
130139547|NCT01168856|468470219|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
130139548|NCT01168856|468470218|FG000|Overall Study|Participant received anti-HCV treatment|1|||
130139549|NCT01168856|468470219|FG001|Overall Study|Participant received anti-HCV treatment|0|||
130139550|NCT01168856|468470218|FG000|Overall Study|Death|0|||
130139551|NCT01168856|468470219|FG001|Overall Study|Death|2|||
130139552|NCT01168856|468470218|FG000|Overall Study|Other|1|||
130139553|NCT01168856|468470219|FG001|Overall Study|Other|291|||
130139554|NCT01168856|468470218|FG000|Overall Study|Protocol Violation|4|||
130139555|NCT01168856|468470219|FG001|Overall Study|Protocol Violation|6|||
130139556|NCT04567329|468470224|FG000|Overall Study|Withdrawal by Subject|5|||
130139557|NCT04567329|468470225|FG001|Overall Study|Withdrawal by Subject|6|||
130139558|NCT04567329|468470224|FG000|Overall Study|Protocol Violation|2|||
130139559|NCT04567329|468470225|FG001|Overall Study|Protocol Violation|3|||
130139560|NCT04567329|468470224|FG000|Overall Study|Discontinued|2|||
130139561|NCT04567329|468470225|FG001|Overall Study|Discontinued|2|||
130139562|NCT04567329|468470224|FG000|Overall Study|Lost to Follow-up|0|||
130139563|NCT04567329|468470225|FG001|Overall Study|Lost to Follow-up|1|||
130139564|NCT04567329|468470224|FG000|Overall Study|Lack of Efficacy|0|||
130139565|NCT04567329|468470225|FG001|Overall Study|Lack of Efficacy|1|||
130139566|NCT01559363|468470243|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
130139567|NCT01559363|468470244|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
130139568|NCT01559363|468470245|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
130139569|NCT01559363|468470246|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130139570|NCT01559363|468470247|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130139571|NCT01559363|468470248|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
130139572|NCT01559363|468470243|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
130139573|NCT01559363|468470244|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
130139574|NCT01559363|468470245|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
130139575|NCT01559363|468470246|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
130139576|NCT01559363|468470247|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
130139577|NCT01559363|468470248|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
130139578|NCT01559363|468470243|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
130139579|NCT01559363|468470244|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
130139580|NCT01559363|468470245|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130139581|NCT01559363|468470246|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130139582|NCT01559363|468470247|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130139583|NCT01559363|468470248|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
130139584|NCT01559363|468470243|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
130139585|NCT01559363|468470244|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130139586|NCT01559363|468470245|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
129976176|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
129976177|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
129976178|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
129976179|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
129976180|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
129976181|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
130139587|NCT01559363|468470246|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130139588|NCT01559363|468470247|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130139589|NCT01559363|468470248|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
130139590|NCT01559363|468470243|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130139591|NCT01559363|468470244|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
130139592|NCT01559363|468470245|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130139593|NCT01559363|468470246|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129976182|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
129976183|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
130139594|NCT01559363|468470247|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130139595|NCT01559363|468470248|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
130139596|NCT01559363|468470243|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130139597|NCT01559363|468470244|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130139598|NCT01559363|468470245|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130139599|NCT01559363|468470246|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
130139600|NCT01559363|468470247|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
130139601|NCT01559363|468470248|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
130139602|NCT01559363|468470243|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130139603|NCT01559363|468470244|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130139604|NCT01559363|468470245|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130139605|NCT01559363|468470246|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
130139606|NCT01559363|468470247|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130139607|NCT01559363|468470248|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
130139608|NCT00672984|468470249|FG000|First Intervention|Adverse Event|5|||
130139609|NCT00672984|468470250|FG001|First Intervention|Adverse Event|0|||
130139610|NCT00672984|468470251|FG002|First Intervention|Adverse Event|0|||
130139611|NCT00672984|468470249|FG000|First Intervention|Withdrawal by Subject|1|||
130139612|NCT00672984|468470250|FG001|First Intervention|Withdrawal by Subject|2|||
130139613|NCT00672984|468470251|FG002|First Intervention|Withdrawal by Subject|2|||
130139614|NCT00672984|468470249|FG000|First Intervention|Sponsor decision|3|||
130139615|NCT00672984|468470250|FG001|First Intervention|Sponsor decision|0|||
130139616|NCT00672984|468470251|FG002|First Intervention|Sponsor decision|0|||
130139617|NCT00672984|468470249|FG000|Second Intervention|Non-compliance with facility policies|0|||
130139618|NCT00672984|468470250|FG001|Second Intervention|Non-compliance with facility policies|2|||
130139619|NCT00672984|468470251|FG002|Second Intervention|Non-compliance with facility policies|0|||
130139620|NCT00672984|468470249|FG000|Second Intervention|Withdrawal by Subject|0|||
130139621|NCT00672984|468470250|FG001|Second Intervention|Withdrawal by Subject|3|||
130139622|NCT00672984|468470251|FG002|Second Intervention|Withdrawal by Subject|0|||
130139623|NCT00672984|468470249|FG000|Second Intervention|Protocol Violation|0|||
130139624|NCT00672984|468470250|FG001|Second Intervention|Protocol Violation|1|||
130139625|NCT00672984|468470251|FG002|Second Intervention|Protocol Violation|1|||
130139626|NCT00672984|468470249|FG000|Third Intervention|Adverse Event|1|||
130139627|NCT00672984|468470250|FG001|Third Intervention|Adverse Event|0|||
129976184|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
129976185|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
129976186|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
129976187|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
129976188|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
129976189|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
129976190|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
129976191|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
129976192|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
130139628|NCT00672984|468470251|FG002|Third Intervention|Adverse Event|1|||
130139629|NCT04060251|468470252|FG000|Overall Study|Study terminated due to low enrollment.|7|||
130139630|NCT04060251|468470253|FG001|Overall Study|Study terminated due to low enrollment.|5|||
130139631|NCT04060251|468470254|FG002|Overall Study|Study terminated due to low enrollment.|7|||
130139632|NCT04060251|468470252|FG000|Overall Study|Adverse Event|1|||
130139633|NCT04060251|468470253|FG001|Overall Study|Adverse Event|1|||
130139634|NCT04060251|468470254|FG002|Overall Study|Adverse Event|0|||
130139635|NCT00487435|468470255|FG000|Overall Study|Adverse Event|146|||
130139636|NCT00487435|468470255|FG000|Overall Study|Death|2|||
130139637|NCT00487435|468470255|FG000|Overall Study|Lack of Efficacy|33|||
130139638|NCT00487435|468470255|FG000|Overall Study|Lost to Follow-up|54|||
130139639|NCT00487435|468470255|FG000|Overall Study|Pregnancy|2|||
129976193|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
129976194|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
129976195|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
130139640|NCT00487435|468470255|FG000|Overall Study|Withdrawal by Subject|132|||
130139641|NCT00487435|468470255|FG000|Overall Study|Resolution Of Pain|1|||
130139642|NCT00487435|468470255|FG000|Overall Study|Study Medication Non-Compliant|32|||
130139643|NCT00487435|468470255|FG000|Overall Study|Other|83|||
130139644|NCT02705716|468470256|FG000|Overall Study|Adverse Event|0|||
130139645|NCT02705716|468470257|FG001|Overall Study|Adverse Event|1|||
130139646|NCT02705716|468470256|FG000|Overall Study|Protocol Violation|3|||
130139647|NCT02705716|468470257|FG001|Overall Study|Protocol Violation|0|||
130139648|NCT02705716|468470256|FG000|Overall Study|Withdrawal of Consent|1|||
130139649|NCT02705716|468470257|FG001|Overall Study|Withdrawal of Consent|1|||
130139650|NCT00562718|468470258|FG000|Overall Study|Death|1|||
130139651|NCT00562718|468470258|FG000|Overall Study|Withdrawal by Subject|3|||
130139652|NCT00562718|468470258|FG000|Overall Study|Adverse Event|4|||
130139653|NCT00562718|468470258|FG000|Overall Study|Lack of Efficacy|2|||
130139654|NCT00562718|468470258|FG000|Overall Study|not stated|1|||
130139655|NCT01868243|468470259|FG000|Overall Study|Death|0|||
130139656|NCT01868243|468470260|FG001|Overall Study|Death|1|||
130139657|NCT00985751|468470261|FG000|Overall Study|Adverse Event|0|||
130139658|NCT00985751|468470262|FG001|Overall Study|Adverse Event|0|||
130139659|NCT00985751|468470263|FG002|Overall Study|Adverse Event|0|||
130139660|NCT00985751|468470264|FG003|Overall Study|Adverse Event|0|||
130139661|NCT00985751|468470265|FG004|Overall Study|Adverse Event|1|||
130139662|NCT00999687|468470274|FG000|First Intervention|Withdrawal by Subject|1|||
130139663|NCT00999687|468470274|FG000|Second Intervention|Withdrawal by Subject|2|||
130139664|NCT00999687|468470274|FG000|Second Intervention|Lack of Efficacy|1|||
130139665|NCT00474188|468470275|FG000|Overall Study|Withdrawal by Subject|1|||
130139666|NCT00474188|468470275|FG000|Overall Study|Study discontinued by sponsor|5|||
130139667|NCT00858403|468470277|FG000|Overall Study|Withdrawal by Subject|1|||
130139668|NCT00858403|468470277|FG000|Overall Study|Death|3|||
130139669|NCT00858403|468470277|FG000|Overall Study|Disease Progression|1|||
130139670|NCT03961204|468470282|FG000|Overall Study|Withdrawal by Subject|2|||
130139671|NCT03961204|468470282|FG000|Overall Study|Lost to Follow-up|3|||
130139672|NCT03961204|468470282|FG000|Overall Study|Other|1|||
130139673|NCT03961204|468470282|FG000|Overall Study|Missing|1|||
130139674|NCT03867760|468470283|FG000|Overall Study|Lost to Follow-up|2|||
130139675|NCT03867760|468470284|FG001|Overall Study|Lost to Follow-up|3|||
130139676|NCT03867760|468470283|FG000|Overall Study|Withdrawal by Subject|1|||
130139677|NCT03867760|468470284|FG001|Overall Study|Withdrawal by Subject|2|||
130139678|NCT03867760|468470283|FG000|Overall Study|subject could not meet study logistics|3|||
130139679|NCT03867760|468470284|FG001|Overall Study|subject could not meet study logistics|3|||
130139680|NCT01968031|468470290|FG000|Overall Study|Adverse Event|13|||
130139681|NCT01968031|468470291|FG001|Overall Study|Adverse Event|10|||
130139682|NCT01968031|468470292|FG002|Overall Study|Adverse Event|22|||
130139683|NCT01968031|468470290|FG000|Overall Study|Withdrawal by Subject|3|||
130139684|NCT01968031|468470291|FG001|Overall Study|Withdrawal by Subject|7|||
130139685|NCT01968031|468470292|FG002|Overall Study|Withdrawal by Subject|3|||
130139686|NCT01968031|468470290|FG000|Overall Study|Did not meet entry criteria|1|||
130139687|NCT01968031|468470291|FG001|Overall Study|Did not meet entry criteria|1|||
130139688|NCT01968031|468470292|FG002|Overall Study|Did not meet entry criteria|1|||
130139689|NCT01968031|468470290|FG000|Overall Study|Noncompliance|0|||
130139690|NCT01968031|468470291|FG001|Overall Study|Noncompliance|0|||
130139691|NCT01968031|468470292|FG002|Overall Study|Noncompliance|2|||
130139692|NCT01968031|468470290|FG000|Overall Study|Failed inclusion criteria|0|||
130139693|NCT01968031|468470291|FG001|Overall Study|Failed inclusion criteria|2|||
130139694|NCT01968031|468470292|FG002|Overall Study|Failed inclusion criteria|0|||
130139695|NCT01968031|468470290|FG000|Overall Study|Death|0|||
130139696|NCT01968031|468470291|FG001|Overall Study|Death|0|||
130139697|NCT01968031|468470292|FG002|Overall Study|Death|1|||
130139698|NCT01968031|468470290|FG000|Overall Study|Prohibited concomitant medication|1|||
130139699|NCT01968031|468470291|FG001|Overall Study|Prohibited concomitant medication|0|||
130139700|NCT01968031|468470292|FG002|Overall Study|Prohibited concomitant medication|0|||
130139701|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Subject request|8|||
130139702|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Subject request|11|||
130139703|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
130139704|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
130139705|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
130139706|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
130139707|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
130139708|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
130139709|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
130139710|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
130139711|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
130139712|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
130139713|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Death|1|||
129976196|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129976197|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129976198|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130139714|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Death|0|||
130139715|NCT00521586|468472026|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
130139716|NCT00521586|468472027|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
130139717|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
130139718|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
130139719|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
130139720|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
129976199|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130139721|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
130139722|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
130139723|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
130139724|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
130139725|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
130139726|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
130139727|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
130139728|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
130139729|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
130139730|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
130139731|NCT00521586|468472026|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
130139732|NCT00521586|468472027|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
130139733|NCT00521586|468472026|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
130139734|NCT00521586|468472027|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
130139735|NCT00521586|468472026|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
130139736|NCT00521586|468472027|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
130139737|NCT00521586|468472026|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
130139738|NCT00521586|468472027|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
130139739|NCT03234907|468472028|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
130139740|NCT03234907|468472029|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
130139741|NCT03234907|468472030|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130139742|NCT03234907|468472031|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130139743|NCT03234907|468472032|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130139744|NCT03234907|468472033|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
130139745|NCT03234907|468472028|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
130139746|NCT03234907|468472029|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
130139747|NCT03234907|468472030|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130139748|NCT03234907|468472031|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130139749|NCT03234907|468472032|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130139750|NCT03234907|468472033|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
130139751|NCT03234907|468472028|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
130139752|NCT03234907|468472029|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130139753|NCT03234907|468472030|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130139754|NCT03234907|468472031|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130139755|NCT03234907|468472032|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130139756|NCT03234907|468472033|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
130139757|NCT03234907|468472028|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
130139758|NCT03234907|468472029|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
130139759|NCT03234907|468472030|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130139760|NCT03234907|468472031|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130139761|NCT03234907|468472032|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130139762|NCT03234907|468472033|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
130139763|NCT03234907|468472028|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130139764|NCT03234907|468472029|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130139765|NCT03234907|468472030|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
130139766|NCT03234907|468472031|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
130139767|NCT03234907|468472032|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
130139768|NCT03234907|468472033|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
130139769|NCT03234907|468472028|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
130139770|NCT03234907|468472029|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
130139771|NCT03234907|468472030|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
130139772|NCT03234907|468472031|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
130139773|NCT03234907|468472032|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
130139774|NCT03234907|468472033|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
130139775|NCT03234907|468472028|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130139776|NCT03234907|468472029|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130139777|NCT03234907|468472030|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
130139778|NCT03234907|468472031|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
130139779|NCT03234907|468472032|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
130139780|NCT03234907|468472033|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
130139781|NCT00642993|468472034|FG000|Overall Study|Adverse Event|85|||
130139782|NCT00642993|468472035|FG001|Overall Study|Adverse Event|4|||
130139783|NCT00642993|468472034|FG000|Overall Study|Lost to Follow-up|8|||
130139784|NCT00642993|468472035|FG001|Overall Study|Lost to Follow-up|4|||
130139785|NCT00642993|468472034|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
130139786|NCT00642993|468472035|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
130139787|NCT00642993|468472034|FG000|Overall Study|Protocol Violation|1|||
129976200|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
130139788|NCT00642993|468472035|FG001|Overall Study|Protocol Violation|4|||
130139789|NCT00642993|468472034|FG000|Overall Study|Did not meet protocol eligibility|0|||
130139790|NCT00642993|468472035|FG001|Overall Study|Did not meet protocol eligibility|1|||
130139791|NCT00642993|468472034|FG000|Overall Study|Administrative|1|||
130139792|NCT00642993|468472035|FG001|Overall Study|Administrative|0|||
130139793|NCT02664415|468472036|FG000|Overall Study|Adverse Event|1|||
130139794|NCT02664415|468472037|FG001|Overall Study|Adverse Event|0|||
130139795|NCT02986139|468472041|FG000|Overall Study|Sponsor Decision|1|||
130139796|NCT02986139|468472042|FG001|Overall Study|Sponsor Decision|2|||
130139797|NCT02986139|468472041|FG000|Overall Study|Withdrawal by Subject|0|||
130139798|NCT02986139|468472042|FG001|Overall Study|Withdrawal by Subject|1|||
130139799|NCT02986139|468472041|FG000|Overall Study|Lost to Follow-up|0|||
130139800|NCT02986139|468472042|FG001|Overall Study|Lost to Follow-up|1|||
130139801|NCT00414726|468472043|FG000|Overall Study|Withdrawal by Subject|0|||
130139802|NCT00414726|468472044|FG001|Overall Study|Withdrawal by Subject|1|||
130139803|NCT02107196|468472045|FG000|12-week Treatment Period|Adverse Event|6|||
130139804|NCT02107196|468472046|FG001|12-week Treatment Period|Adverse Event|3|||
130139805|NCT02107196|468472045|FG000|12-week Treatment Period|Lack of Efficacy|2|||
130139806|NCT02107196|468472046|FG001|12-week Treatment Period|Lack of Efficacy|1|||
130139807|NCT02107196|468472045|FG000|12-week Treatment Period|Lost to Follow-up|3|||
130139808|NCT02107196|468472046|FG001|12-week Treatment Period|Lost to Follow-up|6|||
130139809|NCT02107196|468472045|FG000|12-week Treatment Period|Physician Decision|0|||
130139810|NCT02107196|468472046|FG001|12-week Treatment Period|Physician Decision|1|||
130139811|NCT02107196|468472045|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
130139812|NCT02107196|468472046|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
130139813|NCT02107196|468472045|FG000|12-week Treatment Period|Protocol Violation|7|||
130139814|NCT02107196|468472046|FG001|12-week Treatment Period|Protocol Violation|8|||
130139815|NCT02107196|468472045|FG000|12-week Treatment Period|Reason Missing|11|||
130139816|NCT02107196|468472046|FG001|12-week Treatment Period|Reason Missing|8|||
130139817|NCT02107196|468472045|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
130139818|NCT02107196|468472046|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
130139819|NCT02107196|468472045|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
130139820|NCT02107196|468472046|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
130139821|NCT02107196|468472045|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
130139822|NCT02107196|468472046|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
130139823|NCT02107196|468472045|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
130139824|NCT02107196|468472046|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
130139825|NCT00516295|468472047|FG000|Overall Study|Lack of Efficacy|2|||
130139826|NCT00516295|468472048|FG001|Overall Study|Lack of Efficacy|0|||
130139827|NCT00516295|468472049|FG002|Overall Study|Lack of Efficacy|0|||
130139828|NCT00516295|468472047|FG000|Overall Study|Ineligible|1|||
130139829|NCT00516295|468472048|FG001|Overall Study|Ineligible|0|||
130139830|NCT00516295|468472049|FG002|Overall Study|Ineligible|0|||
130139831|NCT01630616|468472054|FG000|Overall Study|Adverse Event|0|||
130139832|NCT01630616|468472055|FG001|Overall Study|Adverse Event|0|||
130139833|NCT01630616|468472056|FG002|Overall Study|Adverse Event|0|||
130139834|NCT01630616|468472057|FG003|Overall Study|Adverse Event|1|||
130139835|NCT01630616|468472058|FG004|Overall Study|Adverse Event|0|||
130139836|NCT01630616|468472059|FG005|Overall Study|Adverse Event|0|||
130139837|NCT01630616|468472054|FG000|Overall Study|Withdrawal by Subject|0|||
130139838|NCT01630616|468472055|FG001|Overall Study|Withdrawal by Subject|0|||
130139839|NCT01630616|468472056|FG002|Overall Study|Withdrawal by Subject|0|||
130139840|NCT01630616|468472057|FG003|Overall Study|Withdrawal by Subject|2|||
130139841|NCT01630616|468472058|FG004|Overall Study|Withdrawal by Subject|0|||
130139842|NCT01630616|468472059|FG005|Overall Study|Withdrawal by Subject|0|||
130139843|NCT02218541|468472060|FG000|Overall Study|Lost to Follow-up|2|||
130139844|NCT02218541|468472061|FG001|Overall Study|Lost to Follow-up|1|||
130139845|NCT02218541|468472060|FG000|Overall Study|Implant Failure|4|||
130139846|NCT02218541|468472061|FG001|Overall Study|Implant Failure|1|||
130139847|NCT01993186|468472062|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
130139848|NCT01993186|468472063|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
130139849|NCT01993186|468472062|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
129976201|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
130139850|NCT01993186|468472063|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
130139851|NCT01993186|468472062|FG000|Open-Label Extension Period|Other, Not Specified|0|||
130139852|NCT01993186|468472063|FG001|Open-Label Extension Period|Other, Not Specified|1|||
130139853|NCT01993186|468472062|FG000|Open-Label Extension Period|Adverse Event|1|||
130139854|NCT01993186|468472063|FG001|Open-Label Extension Period|Adverse Event|0|||
130139855|NCT01993186|468472062|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
130139856|NCT01993186|468472063|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
130139857|NCT01993186|468472062|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
130139858|NCT01993186|468472063|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
130139859|NCT01993186|468472062|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
130139860|NCT01993186|468472063|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
130139861|NCT00691704|468472064|FG000|Induction Therapy|Disease Progression|1|||
130139862|NCT00691704|468472064|FG000|Induction Therapy|Active Hepatitis|1|||
130139863|NCT00691704|468472064|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
130139864|NCT00691704|468472064|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
130139865|NCT00691704|468472064|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
130139866|NCT04661202|468472066|FG000|Overall Study|Withdrawal by Subject|1|||
130139867|NCT04661202|468472067|FG001|Overall Study|Withdrawal by Subject|1|||
130139868|NCT04661202|468472066|FG000|Overall Study|Lack of Efficacy|2|||
130139869|NCT04661202|468472067|FG001|Overall Study|Lack of Efficacy|0|||
130139870|NCT02313558|468472068|FG000|Overall Study|Withdrawal by Subject|2|||
130139871|NCT02313558|468472069|FG001|Overall Study|Withdrawal by Subject|0|||
130139872|NCT02313558|468472068|FG000|Overall Study|Lost to Follow-up|4|||
130139873|NCT02313558|468472069|FG001|Overall Study|Lost to Follow-up|4|||
130139874|NCT04102345|468472070|FG000|Overall Study|Withdrawal by Subject|1|||
130139875|NCT04102345|468472071|FG001|Overall Study|Withdrawal by Subject|0|||
130139876|NCT00385736|468472072|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
130139877|NCT00385736|468472073|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
130139878|NCT00385736|468472074|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
130139879|NCT00385736|468472072|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
130139880|NCT00385736|468472073|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
130139881|NCT00385736|468472074|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
130139882|NCT00385736|468472072|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
130139883|NCT00385736|468472073|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
130139884|NCT00385736|468472074|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
130139885|NCT00385736|468472072|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
130139886|NCT00385736|468472073|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
130139887|NCT00385736|468472074|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
130139888|NCT00385736|468472072|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
130139889|NCT00385736|468472073|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
130139890|NCT00385736|468472074|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
130139891|NCT00385736|468472072|FG000|Efficacy Analysis Set - Induction|Other|0|||
130139892|NCT00385736|468472073|FG001|Efficacy Analysis Set - Induction|Other|0|||
130139893|NCT00385736|468472074|FG002|Efficacy Analysis Set - Induction|Other|1|||
130139894|NCT00385736|468472072|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
130139895|NCT00385736|468472073|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
130139896|NCT00385736|468472074|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
130139897|NCT00385736|468472072|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
130139898|NCT00385736|468472073|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
130139899|NCT00385736|468472074|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
130139900|NCT00385736|468472072|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
130139901|NCT00385736|468472073|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
130139902|NCT00385736|468472074|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
130139903|NCT00385736|468472072|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
130139904|NCT00385736|468472073|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
130139905|NCT00385736|468472074|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
130139906|NCT00385736|468472072|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
130139907|NCT00385736|468472073|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
130139908|NCT00385736|468472074|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
130139909|NCT00385736|468472072|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
130139910|NCT00385736|468472073|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
130139911|NCT00385736|468472074|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
130139912|NCT00385736|468472072|FG000|Safety Analysis Set|Adverse Event|23|||
130139913|NCT00385736|468472073|FG001|Safety Analysis Set|Adverse Event|15|||
130139914|NCT00385736|468472074|FG002|Safety Analysis Set|Adverse Event|23|||
130139915|NCT00385736|468472072|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
130139916|NCT00385736|468472073|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
130139917|NCT00385736|468472074|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
130139918|NCT00385736|468472072|FG000|Safety Analysis Set|Lost to Follow-up|0|||
129976202|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130139919|NCT00385736|468472073|FG001|Safety Analysis Set|Lost to Follow-up|2|||
130139920|NCT00385736|468472074|FG002|Safety Analysis Set|Lost to Follow-up|2|||
130139921|NCT00385736|468472072|FG000|Safety Analysis Set|Lack of Efficacy|38|||
130139922|NCT00385736|468472073|FG001|Safety Analysis Set|Lack of Efficacy|16|||
130139923|NCT00385736|468472074|FG002|Safety Analysis Set|Lack of Efficacy|31|||
130139924|NCT00385736|468472072|FG000|Safety Analysis Set|Protocol Violation|2|||
130139925|NCT00385736|468472073|FG001|Safety Analysis Set|Protocol Violation|1|||
130139926|NCT00385736|468472074|FG002|Safety Analysis Set|Protocol Violation|6|||
130139927|NCT00385736|468472072|FG000|Safety Analysis Set|Other|1|||
130139928|NCT00385736|468472073|FG001|Safety Analysis Set|Other|4|||
130139929|NCT00385736|468472074|FG002|Safety Analysis Set|Other|4|||
130139930|NCT00198133|468472075|FG000|Overall Study|Disease progression|2|||
130139931|NCT00198133|468472076|FG001|Overall Study|Disease progression|5|||
130139932|NCT00198133|468472075|FG000|Overall Study|Adverse Event|1|||
130139933|NCT00198133|468472076|FG001|Overall Study|Adverse Event|3|||
130139934|NCT00198133|468472075|FG000|Overall Study|Withdrawal by Subject|1|||
130139935|NCT00198133|468472076|FG001|Overall Study|Withdrawal by Subject|0|||
130139936|NCT00198133|468472075|FG000|Overall Study|Physician Decision|1|||
130139937|NCT00198133|468472076|FG001|Overall Study|Physician Decision|0|||
130139938|NCT00835666|468472080|FG000|Washout|Protocol Violation|1|||
130139939|NCT00835666|468472081|FG001|Washout|Protocol Violation|0|||
130139940|NCT00835666|468472080|FG000|Washout|Withdrawal by Subject|1|||
130139941|NCT00835666|468472081|FG001|Washout|Withdrawal by Subject|0|||
130139942|NCT03599362|468472082|FG000|Overall Study|Screen Failure|3|||
130139943|NCT03707587|468472083|FG000|Overall Study|Death|0|||
130139944|NCT03707587|468472084|FG001|Overall Study|Death|1|||
130139945|NCT01537887|468472085|FG000|Period 1|Physician Decision|0|||
130139946|NCT01537887|468472086|FG001|Period 1|Physician Decision|0|||
130139947|NCT01537887|468472087|FG002|Period 1|Physician Decision|0|||
130139948|NCT01537887|468472088|FG003|Period 1|Physician Decision|0|||
130139949|NCT01537887|468472089|FG004|Period 1|Physician Decision|1|||
130139950|NCT01537887|468472090|FG005|Period 1|Physician Decision|1|||
130139951|NCT01537887|468472085|FG000|Period 1|Did not receive treatment|0|||
130139952|NCT01537887|468472086|FG001|Period 1|Did not receive treatment|0|||
130139953|NCT01537887|468472087|FG002|Period 1|Did not receive treatment|1|||
130139954|NCT01537887|468472088|FG003|Period 1|Did not receive treatment|0|||
130139955|NCT01537887|468472089|FG004|Period 1|Did not receive treatment|0|||
130139956|NCT01537887|468472090|FG005|Period 1|Did not receive treatment|0|||
130139957|NCT01537887|468472085|FG000|Period 2|Withdrawal by Subject|0|||
130139958|NCT01537887|468472086|FG001|Period 2|Withdrawal by Subject|1|||
130139959|NCT01537887|468472087|FG002|Period 2|Withdrawal by Subject|0|||
130139960|NCT01537887|468472088|FG003|Period 2|Withdrawal by Subject|0|||
130139961|NCT01537887|468472089|FG004|Period 2|Withdrawal by Subject|0|||
130139962|NCT01537887|468472090|FG005|Period 2|Withdrawal by Subject|0|||
130139963|NCT01537887|468472085|FG000|Period 3|Adverse Event|0|||
130139964|NCT01537887|468472086|FG001|Period 3|Adverse Event|0|||
130139965|NCT01537887|468472087|FG002|Period 3|Adverse Event|1|||
130139966|NCT01537887|468472088|FG003|Period 3|Adverse Event|0|||
130139967|NCT01537887|468472089|FG004|Period 3|Adverse Event|0|||
130139968|NCT01537887|468472090|FG005|Period 3|Adverse Event|0|||
130139969|NCT01537887|468472085|FG000|Period 3|Withdrawal by Subject|0|||
130139970|NCT01537887|468472086|FG001|Period 3|Withdrawal by Subject|1|||
130139971|NCT01537887|468472087|FG002|Period 3|Withdrawal by Subject|0|||
130139972|NCT01537887|468472088|FG003|Period 3|Withdrawal by Subject|0|||
130139973|NCT01537887|468472089|FG004|Period 3|Withdrawal by Subject|0|||
130139974|NCT01537887|468472090|FG005|Period 3|Withdrawal by Subject|0|||
130139975|NCT01634139|468472092|FG000|Overall Study|Non compliant with protocol|1|||
130139976|NCT01634139|468472093|FG001|Overall Study|Non compliant with protocol|0|||
130139977|NCT01634139|468472094|FG002|Overall Study|Non compliant with protocol|0|||
130139978|NCT01634139|468472092|FG000|Overall Study|Consent withdrawn not due to AE|4|||
130139979|NCT01634139|468472093|FG001|Overall Study|Consent withdrawn not due to AE|3|||
130139980|NCT01634139|468472094|FG002|Overall Study|Consent withdrawn not due to AE|2|||
130139981|NCT01634139|468472092|FG000|Overall Study|Other|4|||
130139982|NCT01634139|468472093|FG001|Overall Study|Other|0|||
130139983|NCT01634139|468472094|FG002|Overall Study|Other|3|||
130139984|NCT01634139|468472092|FG000|Overall Study|Lost to Follow-up|0|||
130139985|NCT01634139|468472093|FG001|Overall Study|Lost to Follow-up|2|||
130139986|NCT01634139|468472094|FG002|Overall Study|Lost to Follow-up|0|||
130139987|NCT01634139|468472092|FG000|Overall Study|Not treated|1|||
130139988|NCT01634139|468472093|FG001|Overall Study|Not treated|1|||
130139989|NCT01634139|468472094|FG002|Overall Study|Not treated|0|||
130139990|NCT00425308|468472102|FG000|Overall Study|Adverse Event|2|||
130139991|NCT00425308|468472103|FG001|Overall Study|Adverse Event|1|||
130139992|NCT00425308|468472102|FG000|Overall Study|Withdrawal by Subject|1|||
130139993|NCT00425308|468472103|FG001|Overall Study|Withdrawal by Subject|0|||
130139994|NCT00425308|468472102|FG000|Overall Study|Death|1|||
130139995|NCT00425308|468472103|FG001|Overall Study|Death|0|||
130139996|NCT04442503|468472106|FG000|Overall Study|Adverse Event|1|||
130139997|NCT04442503|468472107|FG001|Overall Study|Adverse Event|1|||
130139998|NCT04442503|468472106|FG000|Overall Study|Lost to Follow-up|8|||
130139999|NCT04442503|468472107|FG001|Overall Study|Lost to Follow-up|6|||
130140000|NCT04442503|468472106|FG000|Overall Study|Physician Decision|0|||
130140001|NCT04442503|468472107|FG001|Overall Study|Physician Decision|2|||
130140002|NCT04442503|468472106|FG000|Overall Study|Withdrawal by Subject|3|||
130140003|NCT04442503|468472107|FG001|Overall Study|Withdrawal by Subject|4|||
130140004|NCT04442503|468472106|FG000|Overall Study|Reason not Specified|0|||
130140005|NCT04442503|468472107|FG001|Overall Study|Reason not Specified|1|||
130140006|NCT04442503|468472106|FG000|Overall Study|Randomized but not Treated|3|||
130140007|NCT04442503|468472107|FG001|Overall Study|Randomized but not Treated|1|||
130140008|NCT02933060|468472108|FG000|Overall Study|Withdrawal by Subject|0|||
130140009|NCT02933060|468472109|FG001|Overall Study|Withdrawal by Subject|1|||
130140010|NCT01945580|468472110|FG000|Overall Study|Withdrawal by Subject|13|||
130140011|NCT01945580|468472111|FG001|Overall Study|Withdrawal by Subject|35|||
130140012|NCT01945580|468472110|FG000|Overall Study|Physician Decision|3|||
130140013|NCT01945580|468472111|FG001|Overall Study|Physician Decision|2|||
130140014|NCT01945580|468472110|FG000|Overall Study|Lost to Follow-up|26|||
130140015|NCT01945580|468472111|FG001|Overall Study|Lost to Follow-up|39|||
130140016|NCT01945580|468472110|FG000|Overall Study|Death|7|||
130140017|NCT01945580|468472111|FG001|Overall Study|Death|2|||
130140018|NCT01945580|468472110|FG000|Overall Study|Patient moved out of state|0|||
130140019|NCT01945580|468472111|FG001|Overall Study|Patient moved out of state|1|||
130140020|NCT01945580|468472110|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
130140021|NCT01945580|468472111|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
130140022|NCT01945580|468472110|FG000|Overall Study|Family illness - unable to return|0|||
130140023|NCT01945580|468472111|FG001|Overall Study|Family illness - unable to return|1|||
130140024|NCT01945580|468472110|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
130140025|NCT01945580|468472111|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
130140026|NCT01945580|468472110|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
130140027|NCT01945580|468472111|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
130140028|NCT01945580|468472110|FG000|Overall Study|Noncompliance with 36 month visit|1|||
130140029|NCT01945580|468472111|FG001|Overall Study|Noncompliance with 36 month visit|0|||
130140030|NCT01945580|468472110|FG000|Overall Study|The patient moved.|1|||
130140031|NCT01945580|468472111|FG001|Overall Study|The patient moved.|0|||
130140032|NCT01945580|468472110|FG000|Overall Study|No data available|0|||
130140033|NCT01945580|468472111|FG001|Overall Study|No data available|2|||
130140034|NCT05034874|468472114|FG000|Overall Study|Withdrawal by Subject|6|||
130140035|NCT05034874|468472115|FG001|Overall Study|Withdrawal by Subject|6|||
130140036|NCT05034874|468472114|FG000|Overall Study|Lost to Follow-up|18|||
130140037|NCT05034874|468472115|FG001|Overall Study|Lost to Follow-up|8|||
130140038|NCT05034874|468472114|FG000|Overall Study|Physician Decision|0|||
130140039|NCT05034874|468472115|FG001|Overall Study|Physician Decision|1|||
130140040|NCT05034874|468472114|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
130140041|NCT05034874|468472115|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
130140042|NCT00989950|468472116|FG000|Randomized Phase|Protocol Violation|1|||
130140043|NCT00989950|468472117|FG001|Randomized Phase|Protocol Violation|0|||
130140044|NCT00989950|468472118|FG002|Randomized Phase|Protocol Violation|0|||
130140045|NCT00989950|468472119|FG003|Randomized Phase|Protocol Violation|0|||
130140046|NCT00989950|468472116|FG000|Randomized Phase|Adverse Event|0|||
130140047|NCT00989950|468472117|FG001|Randomized Phase|Adverse Event|1|||
130140048|NCT00989950|468472118|FG002|Randomized Phase|Adverse Event|0|||
130140049|NCT00989950|468472119|FG003|Randomized Phase|Adverse Event|0|||
130140050|NCT00101439|468472120|FG000|Period 2|Withdrawal by Subject|0|||
130140051|NCT00101439|468472121|FG001|Period 2|Withdrawal by Subject|2|||
130140052|NCT00840658|468472123|FG000|Overall Study|Death|2|||
130140053|NCT00840658|468472124|FG001|Overall Study|Death|2|||
130140054|NCT00840658|468472125|FG002|Overall Study|Death|3|||
130140055|NCT00840658|468472126|FG003|Overall Study|Death|3|||
130140056|NCT00840658|468472123|FG000|Overall Study|Lost to Follow-up|3|||
130140057|NCT00840658|468472124|FG001|Overall Study|Lost to Follow-up|1|||
130140058|NCT00840658|468472125|FG002|Overall Study|Lost to Follow-up|2|||
130140059|NCT00840658|468472126|FG003|Overall Study|Lost to Follow-up|1|||
130140060|NCT01867658|468472127|FG000|Overall Study|Withdrawal by Subject|6|||
130140061|NCT01867658|468472127|FG000|Overall Study|Death|2|||
130140062|NCT01867658|468472127|FG000|Overall Study|Subject could not be contacted|1|||
130140063|NCT00474058|468472128|FG000|Overall Study|Adverse Event|11|||
130140064|NCT00474058|468472129|FG001|Overall Study|Adverse Event|6|||
130140065|NCT00474058|468472128|FG000|Overall Study|Lack of Efficacy|0|||
130140066|NCT00474058|468472129|FG001|Overall Study|Lack of Efficacy|4|||
130140067|NCT00474058|468472128|FG000|Overall Study|Withdrawal by Subject|11|||
130140068|NCT00474058|468472129|FG001|Overall Study|Withdrawal by Subject|7|||
130140069|NCT00474058|468472128|FG000|Overall Study|Other|2|||
130140070|NCT00474058|468472129|FG001|Overall Study|Other|0|||
130140071|NCT03101358|468472130|FG000|Overall Study|Non-compliance with study schedule|1|||
130140072|NCT03101358|468472131|FG001|Overall Study|Non-compliance with study schedule|0|||
130140073|NCT03101358|468472132|FG002|Overall Study|Non-compliance with study schedule|0|||
130140074|NCT03101358|468472133|FG003|Overall Study|Non-compliance with study schedule|1|||
130140075|NCT03101358|468472130|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130140076|NCT03101358|468472131|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130140077|NCT03101358|468472132|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
130140078|NCT03101358|468472133|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
130140079|NCT03101358|468472130|FG000|Overall Study|Physician Decision|1|||
130140080|NCT03101358|468472131|FG001|Overall Study|Physician Decision|0|||
130140081|NCT03101358|468472132|FG002|Overall Study|Physician Decision|0|||
130140082|NCT03101358|468472133|FG003|Overall Study|Physician Decision|3|||
130140083|NCT03101358|468472130|FG000|Overall Study|Adverse Event|0|||
130140084|NCT03101358|468472131|FG001|Overall Study|Adverse Event|0|||
130140085|NCT03101358|468472132|FG002|Overall Study|Adverse Event|1|||
130140086|NCT03101358|468472133|FG003|Overall Study|Adverse Event|0|||
130140087|NCT03101358|468472130|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130140088|NCT03101358|468472131|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130140089|NCT03101358|468472132|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
130140090|NCT03101358|468472133|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
130140091|NCT03101358|468472130|FG000|Overall Study|Lost to Follow-up|1|||
130140092|NCT03101358|468472131|FG001|Overall Study|Lost to Follow-up|0|||
130140093|NCT03101358|468472132|FG002|Overall Study|Lost to Follow-up|0|||
130140094|NCT03101358|468472133|FG003|Overall Study|Lost to Follow-up|1|||
130140095|NCT02426918|468472138|FG000|Overall Study|Adverse Event|2|||
130140096|NCT02426918|468472139|FG001|Overall Study|Adverse Event|2|||
130140097|NCT02426918|468472140|FG002|Overall Study|Adverse Event|0|||
130140098|NCT02426918|468472138|FG000|Overall Study|Physician Decision|1|||
130140099|NCT02426918|468472139|FG001|Overall Study|Physician Decision|1|||
130140100|NCT02426918|468472140|FG002|Overall Study|Physician Decision|1|||
130140101|NCT02426918|468472138|FG000|Overall Study|Withdrawal by Subject|5|||
130140102|NCT02426918|468472139|FG001|Overall Study|Withdrawal by Subject|5|||
130140103|NCT02426918|468472140|FG002|Overall Study|Withdrawal by Subject|4|||
130140104|NCT02426918|468472138|FG000|Overall Study|Other|9|||
130140105|NCT02426918|468472139|FG001|Overall Study|Other|11|||
130140106|NCT02426918|468472140|FG002|Overall Study|Other|9|||
130140107|NCT02845336|468472141|FG000|Overall Study|Lost to Follow-up|3|||
130140108|NCT02845336|468472142|FG001|Overall Study|Lost to Follow-up|1|||
130140109|NCT02845336|468472141|FG000|Overall Study|Inability to get medication|2|||
130140110|NCT02845336|468472142|FG001|Overall Study|Inability to get medication|0|||
130140111|NCT01496118|468472143|FG000|Overall Study|Disease progression|3|||
130140112|NCT01496118|468472144|FG001|Overall Study|Disease progression|2|||
130140113|NCT01496118|468472145|FG002|Overall Study|Disease progression|3|||
130140114|NCT01496118|468472146|FG003|Overall Study|Disease progression|1|||
130140115|NCT01496118|468472147|FG004|Overall Study|Disease progression|2|||
130140116|NCT01496118|468472148|FG005|Overall Study|Disease progression|2|||
130140117|NCT01496118|468472149|FG006|Overall Study|Disease progression|14|||
130140118|NCT01496118|468472150|FG007|Overall Study|Disease progression|10|||
130140119|NCT01496118|468472143|FG000|Overall Study|Physician Decision|0|||
130140120|NCT01496118|468472144|FG001|Overall Study|Physician Decision|0|||
130140121|NCT01496118|468472145|FG002|Overall Study|Physician Decision|0|||
130140122|NCT01496118|468472146|FG003|Overall Study|Physician Decision|0|||
130140123|NCT01496118|468472147|FG004|Overall Study|Physician Decision|1|||
130140124|NCT01496118|468472148|FG005|Overall Study|Physician Decision|0|||
130140125|NCT01496118|468472149|FG006|Overall Study|Physician Decision|3|||
130140126|NCT01496118|468472150|FG007|Overall Study|Physician Decision|6|||
130140127|NCT01496118|468472143|FG000|Overall Study|Adverse Event|1|||
130140128|NCT01496118|468472144|FG001|Overall Study|Adverse Event|1|||
130140129|NCT01496118|468472145|FG002|Overall Study|Adverse Event|0|||
130140130|NCT01496118|468472146|FG003|Overall Study|Adverse Event|0|||
130140131|NCT01496118|468472147|FG004|Overall Study|Adverse Event|0|||
130140132|NCT01496118|468472148|FG005|Overall Study|Adverse Event|0|||
130140133|NCT01496118|468472149|FG006|Overall Study|Adverse Event|6|||
130140134|NCT01496118|468472150|FG007|Overall Study|Adverse Event|10|||
130140135|NCT01496118|468472143|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140136|NCT01496118|468472144|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140137|NCT01496118|468472145|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140138|NCT01496118|468472146|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140139|NCT01496118|468472147|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140140|NCT01496118|468472148|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140141|NCT01496118|468472149|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
130140142|NCT01496118|468472150|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
130140143|NCT01496118|468472143|FG000|Overall Study|Death|0|||
130140144|NCT01496118|468472144|FG001|Overall Study|Death|0|||
130140145|NCT01496118|468472145|FG002|Overall Study|Death|0|||
130140146|NCT01496118|468472146|FG003|Overall Study|Death|0|||
130140147|NCT01496118|468472147|FG004|Overall Study|Death|0|||
130140148|NCT01496118|468472148|FG005|Overall Study|Death|0|||
130140149|NCT01496118|468472149|FG006|Overall Study|Death|1|||
130140150|NCT01496118|468472150|FG007|Overall Study|Death|1|||
130140151|NCT01496118|468472143|FG000|Overall Study|Withdrawal by Subject|0|||
130140152|NCT01496118|468472144|FG001|Overall Study|Withdrawal by Subject|0|||
130140153|NCT01496118|468472145|FG002|Overall Study|Withdrawal by Subject|0|||
130140154|NCT01496118|468472146|FG003|Overall Study|Withdrawal by Subject|2|||
130140155|NCT01496118|468472147|FG004|Overall Study|Withdrawal by Subject|0|||
130140156|NCT01496118|468472148|FG005|Overall Study|Withdrawal by Subject|1|||
130140157|NCT01496118|468472149|FG006|Overall Study|Withdrawal by Subject|6|||
130140158|NCT01496118|468472150|FG007|Overall Study|Withdrawal by Subject|3|||
130140159|NCT05616728|468472157|FG000|Overall Study|Lost to Follow-up|0|||
130140160|NCT05616728|468472158|FG001|Overall Study|Lost to Follow-up|0|||
130140161|NCT05616728|468472159|FG002|Overall Study|Lost to Follow-up|1|||
130140162|NCT05616728|468472157|FG000|Overall Study|Withdrawal by Subject|1|||
130140163|NCT05616728|468472158|FG001|Overall Study|Withdrawal by Subject|1|||
130140164|NCT05616728|468472159|FG002|Overall Study|Withdrawal by Subject|0|||
130140165|NCT05616728|468472157|FG000|Overall Study|Physician Decision|1|||
130140166|NCT05616728|468472158|FG001|Overall Study|Physician Decision|1|||
130140167|NCT05616728|468472159|FG002|Overall Study|Physician Decision|1|||
130140168|NCT05616728|468472157|FG000|Overall Study|Other|0|||
130140169|NCT05616728|468472158|FG001|Overall Study|Other|2|||
130140170|NCT05616728|468472159|FG002|Overall Study|Other|0|||
130140171|NCT01024855|468472162|FG000|Overall Study|Inclusion/exclusion criteria|1|||
130140172|NCT03306277|468472167|FG000|Overall Study|Death|1|||
130140173|NCT03306277|468472167|FG000|Overall Study|Adverse Event|1|||
130140174|NCT03306277|468472167|FG000|Overall Study|Withdrawal by Subject|1|||
130140175|NCT00875524|468472168|FG000|Overall Study|Serious adverse event|0|||
130140176|NCT00875524|468472169|FG001|Overall Study|Serious adverse event|1|||
130140177|NCT00875524|468472168|FG000|Overall Study|Protocol Violation|4|||
130140178|NCT00875524|468472169|FG001|Overall Study|Protocol Violation|0|||
130140179|NCT00875524|468472168|FG000|Overall Study|Lost to Follow-up|1|||
130140180|NCT00875524|468472169|FG001|Overall Study|Lost to Follow-up|0|||
130140181|NCT00875524|468472168|FG000|Overall Study|Withdrawal by Subject|3|||
130140182|NCT00875524|468472169|FG001|Overall Study|Withdrawal by Subject|5|||
130140183|NCT00881751|468472170|FG000|Overall Study|Physician Decision|0|||
130140184|NCT00881751|468472171|FG001|Overall Study|Physician Decision|1|||
130140185|NCT00881751|468472170|FG000|Overall Study|Adverse Event|0|||
130140186|NCT00881751|468472171|FG001|Overall Study|Adverse Event|2|||
130140187|NCT00881751|468472170|FG000|Overall Study|Withdrawal by Subject|0|||
130140188|NCT00881751|468472171|FG001|Overall Study|Withdrawal by Subject|2|||
130140189|NCT02385708|468472172|FG000|Overall Study|Withdrawal by Subject|0|||
130140190|NCT02385708|468472173|FG001|Overall Study|Withdrawal by Subject|2|||
130140191|NCT02385708|468472172|FG000|Overall Study|Withdrawn - surgery canceled|2|||
130140192|NCT02385708|468472173|FG001|Overall Study|Withdrawn - surgery canceled|5|||
130140193|NCT02385708|468472172|FG000|Overall Study|Investigator decision|5|||
130140194|NCT02385708|468472173|FG001|Overall Study|Investigator decision|7|||
130140195|NCT02385708|468472172|FG000|Overall Study|Protocol Violation|1|||
130140196|NCT02385708|468472173|FG001|Overall Study|Protocol Violation|1|||
130140197|NCT02761915|468472174|FG000|Overall Study|Death|3|||
130140198|NCT02761915|468472175|FG001|Overall Study|Death|1|||
130140199|NCT02761915|468472176|FG002|Overall Study|Death|1|||
130140200|NCT02761915|468472177|FG003|Overall Study|Death|1|||
130140201|NCT02761915|468472178|FG004|Overall Study|Death|0|||
130140202|NCT02761915|468472179|FG005|Overall Study|Death|1|||
130140203|NCT02761915|468472174|FG000|Overall Study|Withdrawal by Subject|1|||
130140204|NCT02761915|468472175|FG001|Overall Study|Withdrawal by Subject|0|||
130140205|NCT02761915|468472176|FG002|Overall Study|Withdrawal by Subject|0|||
130140206|NCT02761915|468472177|FG003|Overall Study|Withdrawal by Subject|0|||
130140207|NCT02761915|468472178|FG004|Overall Study|Withdrawal by Subject|1|||
130140208|NCT02761915|468472179|FG005|Overall Study|Withdrawal by Subject|2|||
130140209|NCT02761915|468472174|FG000|Overall Study|Disease Progression|0|||
130140210|NCT02761915|468472175|FG001|Overall Study|Disease Progression|0|||
130140211|NCT02761915|468472176|FG002|Overall Study|Disease Progression|0|||
130140212|NCT02761915|468472177|FG003|Overall Study|Disease Progression|2|||
130140213|NCT02761915|468472178|FG004|Overall Study|Disease Progression|2|||
130140214|NCT02761915|468472179|FG005|Overall Study|Disease Progression|2|||
130140215|NCT00645853|468472184|FG000|Overall Study|Adverse Event|18|||
130140216|NCT00645853|468472185|FG001|Overall Study|Adverse Event|7|||
130140217|NCT00645853|468472184|FG000|Overall Study|AZ study closure in Hungary|60|||
130140218|NCT00645853|468472185|FG001|Overall Study|AZ study closure in Hungary|40|||
130140219|NCT00645853|468472184|FG000|Overall Study|Withdrawal by Subject|5|||
130140220|NCT00645853|468472185|FG001|Overall Study|Withdrawal by Subject|2|||
130140221|NCT00645853|468472184|FG000|Overall Study|Protocol Violation|0|||
130140222|NCT00645853|468472185|FG001|Overall Study|Protocol Violation|2|||
130140223|NCT00645853|468472184|FG000|Overall Study|Discontinuation criteria|2|||
130140224|NCT00645853|468472185|FG001|Overall Study|Discontinuation criteria|2|||
130140225|NCT00645853|468472184|FG000|Overall Study|recall of ICF, planned operation, death|7|||
130140226|NCT00645853|468472185|FG001|Overall Study|recall of ICF, planned operation, death|4|||
130140227|NCT01087502|468472186|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
130140228|NCT01087502|468472187|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
130140229|NCT01087502|468472186|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
130140230|NCT01087502|468472187|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
130140231|NCT01087502|468472186|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
130140232|NCT01087502|468472187|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
130140233|NCT01087502|468472186|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
130140234|NCT01087502|468472187|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
130140235|NCT01087502|468472186|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
130140236|NCT01087502|468472187|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
130140237|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
130140238|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
130140239|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
130140240|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
130140241|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
130140242|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
130140243|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
130140244|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
130140245|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
130140246|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
130140247|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
130140248|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
130140249|NCT01087502|468472186|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
130140250|NCT01087502|468472187|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
130140251|NCT00380588|468472188|FG000|Overall Study|Unequivocal Disease Progression|25|||
130140252|NCT00380588|468472189|FG001|Overall Study|Unequivocal Disease Progression|34|||
130140253|NCT00380588|468472188|FG000|Overall Study|Next Cycle Not Started|4|||
130140254|NCT00380588|468472189|FG001|Overall Study|Next Cycle Not Started|0|||
130140255|NCT00380588|468472188|FG000|Overall Study|Adverse Event|7|||
130140256|NCT00380588|468472189|FG001|Overall Study|Adverse Event|3|||
130140257|NCT00380588|468472188|FG000|Overall Study|Withdrawal by Subject|1|||
130140258|NCT00380588|468472189|FG001|Overall Study|Withdrawal by Subject|3|||
130140259|NCT00380588|468472188|FG000|Overall Study|Physician Decision|2|||
130140260|NCT00380588|468472189|FG001|Overall Study|Physician Decision|0|||
130140261|NCT01120028|468472193|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130140262|NCT01120028|468472194|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
130140263|NCT01120028|468472195|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130140264|NCT01120028|468472196|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
130140265|NCT01120028|468472193|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
130140266|NCT01120028|468472194|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
130140267|NCT01120028|468472195|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
130140268|NCT01120028|468472196|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
130140269|NCT01401062|468472197|FG000|Overall Study|Death|9|||
130140270|NCT01401062|468472198|FG001|Overall Study|Death|7|||
130140271|NCT01401062|468472197|FG000|Overall Study|Physician Decision|1|||
130140272|NCT01401062|468472198|FG001|Overall Study|Physician Decision|0|||
130140273|NCT01401062|468472197|FG000|Overall Study|Withdrawal by Subject|1|||
130140274|NCT01401062|468472198|FG001|Overall Study|Withdrawal by Subject|1|||
130140275|NCT01131260|468472201|FG000|Overall Study|Randomization error|5|||
130140276|NCT01131260|468472202|FG001|Overall Study|Randomization error|1|||
130140277|NCT01131260|468472201|FG000|Overall Study|Declined to continue participation|8|||
130140278|NCT01131260|468472202|FG001|Overall Study|Declined to continue participation|13|||
130140279|NCT01131260|468472201|FG000|Overall Study|Physician Decision|22|||
130140280|NCT01131260|468472202|FG001|Overall Study|Physician Decision|24|||
130140281|NCT01131260|468472201|FG000|Overall Study|Technical problems|7|||
130140282|NCT01131260|468472202|FG001|Overall Study|Technical problems|6|||
130140283|NCT01131260|468472201|FG000|Overall Study|Staff error|2|||
130140284|NCT01131260|468472202|FG001|Overall Study|Staff error|1|||
130140285|NCT01131260|468472201|FG000|Overall Study|Ineligible|0|||
130140286|NCT01131260|468472202|FG001|Overall Study|Ineligible|2|||
130140287|NCT00757172|468472203|FG000|Overall Study|Withdrawal by Subject|4|||
130140288|NCT00757172|468472203|FG000|Overall Study|Physician Decision|3|||
130140289|NCT00757172|468472203|FG000|Overall Study|Progression|4|||
130140290|NCT01018862|468472210|FG000|Overall Study|Adverse Event|2|||
130140291|NCT01018862|468472211|FG001|Overall Study|Adverse Event|0|||
130140292|NCT01018862|468472212|FG002|Overall Study|Adverse Event|6|||
130140293|NCT01018862|468472210|FG000|Overall Study|Lack of Efficacy|1|||
130140294|NCT01018862|468472211|FG001|Overall Study|Lack of Efficacy|0|||
130140295|NCT01018862|468472212|FG002|Overall Study|Lack of Efficacy|2|||
130140296|NCT01018862|468472210|FG000|Overall Study|Lost to Follow-up|3|||
130140297|NCT01018862|468472211|FG001|Overall Study|Lost to Follow-up|1|||
130140298|NCT01018862|468472212|FG002|Overall Study|Lost to Follow-up|0|||
130140299|NCT01018862|468472210|FG000|Overall Study|Protocol Violation|1|||
130140300|NCT01018862|468472211|FG001|Overall Study|Protocol Violation|3|||
130140301|NCT01018862|468472212|FG002|Overall Study|Protocol Violation|3|||
130140302|NCT01018862|468472210|FG000|Overall Study|Withdrawal by Subject|1|||
130140303|NCT01018862|468472211|FG001|Overall Study|Withdrawal by Subject|2|||
130140304|NCT01018862|468472212|FG002|Overall Study|Withdrawal by Subject|1|||
130140305|NCT01018862|468472210|FG000|Overall Study|administrative problems|5|||
130140306|NCT01018862|468472211|FG001|Overall Study|administrative problems|4|||
130140307|NCT01018862|468472212|FG002|Overall Study|administrative problems|4|||
130140308|NCT00840879|468472213|FG000|Second Intervention|Withdrawal by Subject|1|||
130140309|NCT00840879|468472214|FG001|Second Intervention|Withdrawal by Subject|0|||
130140310|NCT04236596|468472215|FG000|Overall Study|Withdrawal by Subject|1|||
130140311|NCT04236596|468472215|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
130140312|NCT04236596|468472215|FG000|Overall Study|Participants did not receive implant at all|4|||
130140313|NCT02957331|468472220|FG000|Overall Study|Protocol Violation|1|||
130140314|NCT02957331|468472221|FG001|Overall Study|Protocol Violation|0|||
130140315|NCT02583048|468473987|FG000|Overall Study|Withdrawal by Subject|0|||
130140316|NCT02583048|468473988|FG001|Overall Study|Withdrawal by Subject|1|||
130140317|NCT02583048|468473989|FG002|Overall Study|Withdrawal by Subject|0|||
130140318|NCT02583048|468473987|FG000|Overall Study|Failed to meet eligibility criterion|0|||
130140319|NCT02583048|468473988|FG001|Overall Study|Failed to meet eligibility criterion|0|||
130140320|NCT02583048|468473989|FG002|Overall Study|Failed to meet eligibility criterion|1|||
130140321|NCT01151280|468473995|FG000|Overall Study|Adverse Event|1|||
130140322|NCT01151280|468473995|FG000|Overall Study|Lack of Efficacy|3|||
130140323|NCT01243151|468473996|FG000|Overall Study|Adverse Event|0|||
130140324|NCT01243151|468473997|FG001|Overall Study|Adverse Event|1|||
130140325|NCT01243151|468473998|FG002|Overall Study|Adverse Event|0|||
130140326|NCT01243151|468473999|FG003|Overall Study|Adverse Event|0|||
130140327|NCT01243151|468474000|FG004|Overall Study|Adverse Event|0|||
130140328|NCT01243151|468473996|FG000|Overall Study|Protocol Violation|0|||
130140329|NCT01243151|468473997|FG001|Overall Study|Protocol Violation|0|||
130140330|NCT01243151|468473998|FG002|Overall Study|Protocol Violation|1|||
130140331|NCT01243151|468473999|FG003|Overall Study|Protocol Violation|0|||
130140332|NCT01243151|468474000|FG004|Overall Study|Protocol Violation|0|||
130140333|NCT01243151|468473996|FG000|Overall Study|Other|0|||
130140334|NCT01243151|468473997|FG001|Overall Study|Other|0|||
130140335|NCT01243151|468473998|FG002|Overall Study|Other|0|||
130140336|NCT01243151|468473999|FG003|Overall Study|Other|1|||
130140337|NCT01243151|468474000|FG004|Overall Study|Other|0|||
130140338|NCT01243151|468473996|FG000|Overall Study|Randomized but not treated|0|||
130140339|NCT01243151|468473997|FG001|Overall Study|Randomized but not treated|0|||
130140340|NCT01243151|468473998|FG002|Overall Study|Randomized but not treated|0|||
130140341|NCT01243151|468473999|FG003|Overall Study|Randomized but not treated|1|||
130140342|NCT01243151|468474000|FG004|Overall Study|Randomized but not treated|0|||
130140343|NCT02308241|468474003|FG000|Overall Study|Withdrawal by Subject|3|||
130140344|NCT04408924|468474004|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
130140345|NCT04408924|468474004|FG000|Overall Study|Lost to Follow-up|3|||
130140346|NCT04408924|468474004|FG000|Overall Study|Withdrawal by Subject|5|||
130140347|NCT04408924|468474004|FG000|Overall Study|Sponsor Decision|2|||
130140348|NCT02578641|468474005|FG000|Overall Study|Adverse Event|5|||
130140349|NCT02578641|468474006|FG001|Overall Study|Adverse Event|15|||
130140350|NCT02578641|468474005|FG000|Overall Study|Death|16|||
130140351|NCT02578641|468474006|FG001|Overall Study|Death|8|||
130140352|NCT02578641|468474005|FG000|Overall Study|Lost to Follow-up|0|||
130140353|NCT02578641|468474006|FG001|Overall Study|Lost to Follow-up|1|||
130140354|NCT02578641|468474005|FG000|Overall Study|Withdrawal by Subject|14|||
130140355|NCT02578641|468474006|FG001|Overall Study|Withdrawal by Subject|7|||
130140356|NCT02578641|468474005|FG000|Overall Study|Progressive Disease|69|||
130140357|NCT02578641|468474006|FG001|Overall Study|Progressive Disease|21|||
130140358|NCT02578641|468474005|FG000|Overall Study|No Study Drug|2|||
130140359|NCT02578641|468474006|FG001|Overall Study|No Study Drug|0|||
130140360|NCT02578641|468474005|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
130140361|NCT02578641|468474006|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
130140362|NCT02578641|468474005|FG000|Overall Study|Non-compliance with Study Schedule|1|||
130140363|NCT02578641|468474006|FG001|Overall Study|Non-compliance with Study Schedule|0|||
130140364|NCT02578641|468474005|FG000|Overall Study|Other|1|||
130140365|NCT02578641|468474006|FG001|Overall Study|Other|10|||
130140366|NCT02578641|468474005|FG000|Overall Study|Not treated|1|||
130140367|NCT02578641|468474006|FG001|Overall Study|Not treated|4|||
130140368|NCT00084864|468474009|FG000|Overall Study|Adverse Event|1|||
130140369|NCT00084864|468474010|FG001|Overall Study|Adverse Event|0|||
130140370|NCT00084864|468474011|FG002|Overall Study|Adverse Event|0|||
130140371|NCT00084864|468474012|FG003|Overall Study|Adverse Event|0|||
130140372|NCT01741545|468474013|FG000|Treatment Period|Lack of Efficacy|0|||
130140373|NCT01741545|468474014|FG001|Treatment Period|Lack of Efficacy|1|||
130140374|NCT01741545|468474013|FG000|Treatment Period|Adverse event, non-fatal|1|||
130140375|NCT01741545|468474014|FG001|Treatment Period|Adverse event, non-fatal|3|||
130140376|NCT01741545|468474013|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
130140377|NCT01741545|468474014|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
130140378|NCT01741545|468474013|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130140379|NCT01741545|468474014|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130140380|NCT01456962|468474015|FG000|Overall Study|Lost to Follow-up|2|||
130140381|NCT01456962|468474016|FG001|Overall Study|Lost to Follow-up|1|||
130140382|NCT01853176|468474017|FG000|Overall Study|Study terminated|4|||
130140383|NCT01853176|468474018|FG001|Overall Study|Study terminated|0|||
130140384|NCT01370083|468474021|FG000|Overall Study|Lost to Follow-up|2|||
130140385|NCT01370083|468474022|FG001|Overall Study|Lost to Follow-up|0|||
130140386|NCT01370083|468474021|FG000|Overall Study|Adverse Event|0|||
130140387|NCT01370083|468474022|FG001|Overall Study|Adverse Event|1|||
130140388|NCT00731939|468474024|FG000|Overall Study|Adverse Event|6|||
130140389|NCT00731939|468474024|FG000|Overall Study|Lost to Follow-up|15|||
130140390|NCT00731939|468474024|FG000|Overall Study|Not implanted with study device|9|||
130140391|NCT00731939|468474024|FG000|Overall Study|Withdrawal by Subject|2|||
130140392|NCT00731939|468474024|FG000|Overall Study|Did not meet enrollment criteria|2|||
130140393|NCT02072096|468474025|FG000|Overall Study|Lack of Efficacy|18|||
130140394|NCT02072096|468474026|FG001|Overall Study|Lack of Efficacy|29|||
130140395|NCT02072096|468474025|FG000|Overall Study|Protocol Violation|7|||
130140396|NCT02072096|468474026|FG001|Overall Study|Protocol Violation|7|||
130140397|NCT02072096|468474025|FG000|Overall Study|Withdrawal by Subject|5|||
130140398|NCT02072096|468474026|FG001|Overall Study|Withdrawal by Subject|7|||
130140399|NCT02072096|468474025|FG000|Overall Study|Adverse Event|5|||
130140400|NCT02072096|468474026|FG001|Overall Study|Adverse Event|2|||
130140401|NCT02072096|468474025|FG000|Overall Study|No Reason Provided|4|||
130140402|NCT02072096|468474026|FG001|Overall Study|No Reason Provided|2|||
130140403|NCT02072096|468474025|FG000|Overall Study|Death|2|||
130140404|NCT02072096|468474026|FG001|Overall Study|Death|0|||
130140405|NCT02072096|468474025|FG000|Overall Study|Physician Decision|0|||
130140406|NCT02072096|468474026|FG001|Overall Study|Physician Decision|1|||
130140407|NCT02072096|468474025|FG000|Overall Study|Study Terminated by Sponsor|43|||
130140408|NCT02072096|468474026|FG001|Overall Study|Study Terminated by Sponsor|30|||
130140409|NCT02072096|468474025|FG000|Overall Study|Lost to Follow-up|1|||
130140410|NCT02072096|468474026|FG001|Overall Study|Lost to Follow-up|0|||
130140411|NCT01266902|468474028|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
130140412|NCT01266902|468474029|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
130140413|NCT01266902|468474030|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
130140414|NCT01266902|468474028|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
130140415|NCT01266902|468474029|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
130140416|NCT01266902|468474030|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
130140417|NCT01266902|468474028|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
130140418|NCT01266902|468474029|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
130140419|NCT01266902|468474030|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
130140420|NCT01266902|468474028|FG000|Period 1 (Main Study)|Adverse Event|3|||
130140421|NCT01266902|468474029|FG001|Period 1 (Main Study)|Adverse Event|11|||
130140422|NCT01266902|468474030|FG002|Period 1 (Main Study)|Adverse Event|0|||
130140423|NCT01266902|468474028|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
130140424|NCT01266902|468474029|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
130140425|NCT01266902|468474030|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
130140426|NCT01266902|468474028|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
130140427|NCT01266902|468474029|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
130140428|NCT01266902|468474030|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
130140429|NCT01266902|468474028|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
130140430|NCT01266902|468474029|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
130140431|NCT01266902|468474030|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
130140432|NCT01266902|468474028|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
130140433|NCT01266902|468474029|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
130140434|NCT01266902|468474030|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
130140435|NCT01266902|468474028|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
130140436|NCT01266902|468474029|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
130140437|NCT01266902|468474030|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
130140438|NCT01266902|468474028|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
130140439|NCT01266902|468474029|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
130140440|NCT01266902|468474030|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
130140441|NCT00387153|468474031|FG000|Overall Study|Adverse Event|1|||
130140442|NCT00387153|468474031|FG000|Overall Study|Disease Progression|3|||
130140443|NCT00387153|468474031|FG000|Overall Study|Lack of Response|4|||
130140444|NCT02420353|468474034|FG000|Overall Study|Withdrawal by Subject|0|||
130140445|NCT02420353|468474035|FG001|Overall Study|Withdrawal by Subject|1|||
130140446|NCT04608448|468474036|FG000|Overall Study|Withdrawal by Subject|1|||
130140447|NCT04608448|468474036|FG000|Overall Study|Adverse Event|1|||
130140448|NCT01149057|468474037|FG000|Overall Study|Lack of Efficacy|16|||
130140449|NCT01149057|468474037|FG000|Overall Study|Adverse Event|13|||
130140450|NCT01149057|468474037|FG000|Overall Study|Withdrawal by Subject|9|||
130140451|NCT01149057|468474037|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
130140452|NCT01149057|468474037|FG000|Overall Study|B Cell Depletion|4|||
130140453|NCT01149057|468474037|FG000|Overall Study|Participant Non-Compliance|2|||
130140454|NCT01149057|468474037|FG000|Overall Study|Lost to Follow-up|1|||
130140455|NCT01149057|468474037|FG000|Overall Study|High Parathyroid Hormone Value|1|||
130140456|NCT01149057|468474037|FG000|Overall Study|Other|6|||
130140457|NCT00654186|468474038|FG000|Overall Study|Withdrawal by Subject|5|||
130140458|NCT00577655|468474040|FG000|Overall Study|Patient Request|0|||
130140459|NCT00577655|468474041|FG001|Overall Study|Patient Request|2|||
130140460|NCT00577655|468474040|FG000|Overall Study|Protocol Violation|0|||
130140461|NCT00577655|468474041|FG001|Overall Study|Protocol Violation|1|||
130140462|NCT00577655|468474040|FG000|Overall Study|Lost to Follow-up|1|||
130140463|NCT00577655|468474041|FG001|Overall Study|Lost to Follow-up|1|||
130140464|NCT01370863|468474042|FG000|Overall Study|Adverse Event|1|||
130140465|NCT01370863|468474043|FG001|Overall Study|Adverse Event|1|||
130140466|NCT01370863|468474042|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
130140467|NCT01370863|468474043|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
130140468|NCT01370863|468474042|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
130140469|NCT01370863|468474043|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
130140470|NCT01143337|468474044|FG000|Overall Study|Adverse Event|3|||
130140471|NCT01143337|468474045|FG001|Overall Study|Adverse Event|9|||
130140472|NCT01143337|468474046|FG002|Overall Study|Adverse Event|5|||
130140473|NCT01143337|468474044|FG000|Overall Study|Lack of Efficacy|6|||
130140474|NCT01143337|468474045|FG001|Overall Study|Lack of Efficacy|2|||
130140475|NCT01143337|468474046|FG002|Overall Study|Lack of Efficacy|1|||
130140476|NCT01143337|468474044|FG000|Overall Study|Protocol Violation|1|||
130140477|NCT01143337|468474045|FG001|Overall Study|Protocol Violation|0|||
130140478|NCT01143337|468474046|FG002|Overall Study|Protocol Violation|0|||
130140479|NCT01143337|468474044|FG000|Overall Study|Withdrawal by Subject|0|||
130140480|NCT01143337|468474045|FG001|Overall Study|Withdrawal by Subject|0|||
130140481|NCT01143337|468474046|FG002|Overall Study|Withdrawal by Subject|1|||
130140482|NCT01143337|468474044|FG000|Overall Study|Other reason|0|||
130140483|NCT01143337|468474045|FG001|Overall Study|Other reason|0|||
130140484|NCT01143337|468474046|FG002|Overall Study|Other reason|5|||
130140485|NCT00406393|468474056|FG000|Overall Study|Did not undergo transplantation|2|||
130140486|NCT00406393|468474057|FG001|Overall Study|Did not undergo transplantation|1|||
130140487|NCT01597791|468474058|FG000|Overall Study|Physician Decision|2|||
130140488|NCT01597791|468474059|FG001|Overall Study|Physician Decision|1|||
130140489|NCT01597791|468474058|FG000|Overall Study|Cesarean Section|6|||
130140490|NCT01597791|468474059|FG001|Overall Study|Cesarean Section|7|||
130140491|NCT01597791|468474058|FG000|Overall Study|Subject withdrawal|0|||
130140492|NCT01597791|468474059|FG001|Overall Study|Subject withdrawal|1|||
130140493|NCT01597791|468474058|FG000|Overall Study|Protocol Violation|0|||
130140494|NCT01597791|468474059|FG001|Overall Study|Protocol Violation|1|||
130140495|NCT01151618|468474060|FG000|Overall Study|Adverse Event|2|||
130140496|NCT01151618|468474060|FG000|Overall Study|Withdrawal by Subject|7|||
130140497|NCT01632306|468474061|FG000|Overall Study|Protocol Violation|1|||
130140498|NCT01632306|468474062|FG001|Overall Study|Protocol Violation|0|||
130140499|NCT01632306|468474063|FG002|Overall Study|Protocol Violation|0|||
130140500|NCT01663896|468474066|FG000|Overall Study|Various reasons|43|||
130140501|NCT01451541|468474067|FG000|Overall Study|Adverse Event|4|||
130140502|NCT01451541|468474068|FG001|Overall Study|Adverse Event|3|||
130140503|NCT01451541|468474069|FG002|Overall Study|Adverse Event|6|||
130140504|NCT01451541|468474067|FG000|Overall Study|Lack of Efficacy|2|||
130140505|NCT01451541|468474068|FG001|Overall Study|Lack of Efficacy|0|||
130140506|NCT01451541|468474069|FG002|Overall Study|Lack of Efficacy|0|||
130140507|NCT01451541|468474067|FG000|Overall Study|Lost to Follow-up|4|||
130140508|NCT01451541|468474068|FG001|Overall Study|Lost to Follow-up|4|||
130140509|NCT01451541|468474069|FG002|Overall Study|Lost to Follow-up|7|||
130140510|NCT01451541|468474067|FG000|Overall Study|Withdrawal by Subject|15|||
130140511|NCT01451541|468474068|FG001|Overall Study|Withdrawal by Subject|8|||
130140512|NCT01451541|468474069|FG002|Overall Study|Withdrawal by Subject|6|||
130140513|NCT01451541|468474067|FG000|Overall Study|randomization error, noncompliance|11|||
130140514|NCT01451541|468474068|FG001|Overall Study|randomization error, noncompliance|10|||
130140515|NCT01451541|468474069|FG002|Overall Study|randomization error, noncompliance|8|||
130140516|NCT03366428|468474070|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
130140517|NCT03366428|468474070|FG000|Overall Study|Adverse Event|12|||
130140518|NCT03366428|468474070|FG000|Overall Study|Clinical progression|2|||
130140519|NCT03366428|468474070|FG000|Overall Study|Withdrawal by Subject|4|||
130140520|NCT01046084|468474074|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
130140521|NCT01046084|468474075|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
130140522|NCT03614728|468474076|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
130140523|NCT03614728|468474077|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130140524|NCT03614728|468474078|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130140525|NCT03614728|468474079|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
130140526|NCT03614728|468474076|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130140527|NCT03614728|468474077|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
130140528|NCT03614728|468474078|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130140529|NCT03614728|468474079|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
130140530|NCT00379353|468474080|FG000|Overall Study|Hospitalization|3|||
130140531|NCT00379353|468474081|FG001|Overall Study|Hospitalization|3|||
130140532|NCT00379353|468474080|FG000|Overall Study|Withdrawal by Subject|5|||
130140533|NCT00379353|468474081|FG001|Overall Study|Withdrawal by Subject|2|||
130140534|NCT00379353|468474080|FG000|Overall Study|Death|1|||
130140535|NCT00379353|468474081|FG001|Overall Study|Death|0|||
130140536|NCT00379353|468474080|FG000|Overall Study|Cardiac Tamponade|1|||
130140537|NCT00379353|468474081|FG001|Overall Study|Cardiac Tamponade|0|||
130140538|NCT00379353|468474080|FG000|Overall Study|Non-compliance|1|||
130140539|NCT00379353|468474081|FG001|Overall Study|Non-compliance|0|||
130140540|NCT00379353|468474080|FG000|Overall Study|Conflicting drug treatment|0|||
130140541|NCT00379353|468474081|FG001|Overall Study|Conflicting drug treatment|1|||
130140542|NCT01958476|468474082|FG000|Overall Study|Parent requested exclusion from analysis|1|||
130140543|NCT01958476|468474083|FG001|Overall Study|Parent requested exclusion from analysis|0|||
130140544|NCT01824576|468474084|FG000|Overall Study|Device deficiency|2|||
130140545|NCT05412121|468474085|FG000|Overall Study|Withdrawal by Subject|4|||
130140546|NCT05412121|468474085|FG000|Overall Study|Physician Decision|1|||
130140547|NCT05412121|468474085|FG000|Overall Study|Lost to Follow-up|5|||
130140548|NCT03727139|468474086|FG000|Overall Study|Protocol Violation|60|||
130140549|NCT00566722|468474087|FG000|Overall Study|Adverse Event|0|||
130140550|NCT00566722|468474088|FG001|Overall Study|Adverse Event|1|||
130140551|NCT00566722|468474089|FG002|Overall Study|Adverse Event|0|||
130140552|NCT00566722|468474087|FG000|Overall Study|Withdrawal by Subject|0|||
130140553|NCT00566722|468474088|FG001|Overall Study|Withdrawal by Subject|0|||
130140554|NCT00566722|468474089|FG002|Overall Study|Withdrawal by Subject|1|||
130140555|NCT00566722|468474087|FG000|Overall Study|Lost to Follow-up|1|||
130140556|NCT00566722|468474088|FG001|Overall Study|Lost to Follow-up|1|||
130140557|NCT00566722|468474089|FG002|Overall Study|Lost to Follow-up|1|||
130140558|NCT00566722|468474087|FG000|Overall Study|Lack of Efficacy|1|||
130140559|NCT00566722|468474088|FG001|Overall Study|Lack of Efficacy|2|||
130140560|NCT00566722|468474089|FG002|Overall Study|Lack of Efficacy|4|||
130140561|NCT00566722|468474087|FG000|Overall Study|Did not meet exclusion criteria|0|||
130140562|NCT00566722|468474088|FG001|Overall Study|Did not meet exclusion criteria|0|||
130140563|NCT00566722|468474089|FG002|Overall Study|Did not meet exclusion criteria|2|||
130140564|NCT00566722|468474087|FG000|Overall Study|Serious adverse event|0|||
130140565|NCT00566722|468474088|FG001|Overall Study|Serious adverse event|1|||
130140566|NCT00566722|468474089|FG002|Overall Study|Serious adverse event|0|||
130140567|NCT00566722|468474087|FG000|Overall Study|Noncompliant with drug administration|0|||
130140568|NCT00566722|468474088|FG001|Overall Study|Noncompliant with drug administration|0|||
130140569|NCT00566722|468474089|FG002|Overall Study|Noncompliant with drug administration|1|||
130140570|NCT02611323|468474090|FG000|Overall Study|Death|3|||
130140571|NCT02611323|468474091|FG001|Overall Study|Death|1|||
130140572|NCT02611323|468474092|FG002|Overall Study|Death|0|||
130140573|NCT02611323|468474093|FG003|Overall Study|Death|0|||
130140574|NCT02611323|468474094|FG004|Overall Study|Death|1|||
130140575|NCT02611323|468474095|FG005|Overall Study|Death|1|||
130140576|NCT02611323|468474096|FG006|Overall Study|Death|8|||
130140577|NCT02611323|468474097|FG007|Overall Study|Death|0|||
130140578|NCT02611323|468474098|FG008|Overall Study|Death|4|||
130140579|NCT02611323|468474099|FG009|Overall Study|Death|6|||
130140580|NCT02611323|468474100|FG010|Overall Study|Death|26|||
130140581|NCT02611323|468474090|FG000|Overall Study|Lost to Follow-up|1|||
130140582|NCT02611323|468474091|FG001|Overall Study|Lost to Follow-up|0|||
130140583|NCT02611323|468474092|FG002|Overall Study|Lost to Follow-up|0|||
130140584|NCT02611323|468474093|FG003|Overall Study|Lost to Follow-up|0|||
130140585|NCT02611323|468474094|FG004|Overall Study|Lost to Follow-up|0|||
130140586|NCT02611323|468474095|FG005|Overall Study|Lost to Follow-up|0|||
130140587|NCT02611323|468474096|FG006|Overall Study|Lost to Follow-up|3|||
130140588|NCT02611323|468474097|FG007|Overall Study|Lost to Follow-up|0|||
130140589|NCT02611323|468474098|FG008|Overall Study|Lost to Follow-up|0|||
130140590|NCT02611323|468474099|FG009|Overall Study|Lost to Follow-up|0|||
130140591|NCT02611323|468474100|FG010|Overall Study|Lost to Follow-up|2|||
130140592|NCT02611323|468474090|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140593|NCT02611323|468474091|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140594|NCT02611323|468474092|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140595|NCT02611323|468474093|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140596|NCT02611323|468474094|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140597|NCT02611323|468474095|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140598|NCT02611323|468474096|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140599|NCT02611323|468474097|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140600|NCT02611323|468474098|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140601|NCT02611323|468474099|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
130140602|NCT02611323|468474100|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
130140603|NCT02611323|468474090|FG000|Overall Study|Progressive Disease|0|||
130140604|NCT02611323|468474091|FG001|Overall Study|Progressive Disease|0|||
130140605|NCT02611323|468474092|FG002|Overall Study|Progressive Disease|0|||
130140606|NCT02611323|468474093|FG003|Overall Study|Progressive Disease|0|||
130140607|NCT02611323|468474094|FG004|Overall Study|Progressive Disease|0|||
130140608|NCT02611323|468474095|FG005|Overall Study|Progressive Disease|0|||
130140609|NCT02611323|468474096|FG006|Overall Study|Progressive Disease|0|||
130140610|NCT02611323|468474097|FG007|Overall Study|Progressive Disease|0|||
130140611|NCT02611323|468474098|FG008|Overall Study|Progressive Disease|0|||
130140612|NCT02611323|468474099|FG009|Overall Study|Progressive Disease|0|||
130140613|NCT02611323|468474100|FG010|Overall Study|Progressive Disease|1|||
130140614|NCT02611323|468474090|FG000|Overall Study|Withdrawal by Subject|1|||
130140615|NCT02611323|468474091|FG001|Overall Study|Withdrawal by Subject|0|||
130140616|NCT02611323|468474092|FG002|Overall Study|Withdrawal by Subject|0|||
130140617|NCT02611323|468474093|FG003|Overall Study|Withdrawal by Subject|0|||
130140618|NCT02611323|468474094|FG004|Overall Study|Withdrawal by Subject|0|||
130140619|NCT02611323|468474095|FG005|Overall Study|Withdrawal by Subject|0|||
130140620|NCT02611323|468474096|FG006|Overall Study|Withdrawal by Subject|0|||
130140621|NCT02611323|468474097|FG007|Overall Study|Withdrawal by Subject|1|||
130140622|NCT02611323|468474098|FG008|Overall Study|Withdrawal by Subject|0|||
130140623|NCT02611323|468474099|FG009|Overall Study|Withdrawal by Subject|1|||
130140624|NCT02611323|468474100|FG010|Overall Study|Withdrawal by Subject|0|||
130140625|NCT02597049|468474101|FG000|Overall Study|Lost to Follow-up|0|||
130140626|NCT02597049|468474102|FG001|Overall Study|Lost to Follow-up|3|||
130140627|NCT02597049|468474103|FG002|Overall Study|Lost to Follow-up|2|||
130140628|NCT02597049|468474101|FG000|Overall Study|Withdrawal by Subject|2|||
130140629|NCT02597049|468474102|FG001|Overall Study|Withdrawal by Subject|2|||
130140630|NCT02597049|468474103|FG002|Overall Study|Withdrawal by Subject|1|||
130140631|NCT02597049|468474101|FG000|Overall Study|Adverse Event|2|||
130140632|NCT02597049|468474102|FG001|Overall Study|Adverse Event|0|||
130140633|NCT02597049|468474103|FG002|Overall Study|Adverse Event|0|||
130140634|NCT02597049|468474101|FG000|Overall Study|Death|2|||
130140635|NCT02597049|468474102|FG001|Overall Study|Death|0|||
130140636|NCT02597049|468474103|FG002|Overall Study|Death|0|||
130140637|NCT02597049|468474101|FG000|Overall Study|Noncompliant with Study Visits|1|||
130140638|NCT02597049|468474102|FG001|Overall Study|Noncompliant with Study Visits|0|||
130140639|NCT02597049|468474103|FG002|Overall Study|Noncompliant with Study Visits|0|||
130140640|NCT00243347|468474107|FG000|Overall Study|Lack of Efficacy|4|||
130140641|NCT00243347|468474107|FG000|Overall Study|Adverse Event|2|||
130140642|NCT00243347|468474107|FG000|Overall Study|Death|1|||
130140643|NCT00243347|468474107|FG000|Overall Study|Withdrawal by Subject|5|||
130140644|NCT00243347|468474107|FG000|Overall Study|Condition worsened|7|||
130140645|NCT01390948|468474108|FG000|Overall Study|End of Study|1|||
130140646|NCT01390948|468474109|FG001|Overall Study|End of Study|0|||
130140647|NCT01390948|468474110|FG002|Overall Study|End of Study|0|||
130140648|NCT01390948|468474108|FG000|Overall Study|Withdrew consent|2|||
130140649|NCT01390948|468474109|FG001|Overall Study|Withdrew consent|2|||
130140650|NCT01390948|468474110|FG002|Overall Study|Withdrew consent|0|||
130140651|NCT01390948|468474108|FG000|Overall Study|Progressive Disease|2|||
130140652|NCT01390948|468474109|FG001|Overall Study|Progressive Disease|5|||
130140653|NCT01390948|468474110|FG002|Overall Study|Progressive Disease|0|||
130140654|NCT01390948|468474108|FG000|Overall Study|Death during follow-up|10|||
130140655|NCT01390948|468474109|FG001|Overall Study|Death during follow-up|11|||
130140656|NCT01390948|468474110|FG002|Overall Study|Death during follow-up|1|||
130140657|NCT03250117|468474113|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
130140658|NCT03250117|468474114|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130140659|NCT03250117|468474115|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130140660|NCT03250117|468474116|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
130140661|NCT00556673|468474118|FG000|Overall Study|Protocol deviation|3|||
130140662|NCT00556673|468474119|FG001|Overall Study|Protocol deviation|2|||
130140663|NCT03555695|468474120|FG000|Overall Study|Withdrawal by Subject|1|||
130140664|NCT03555695|468474120|FG000|Overall Study|Lost to Follow-up|1|||
130140665|NCT03555695|468474120|FG000|Overall Study|appendicitis (unrelated)|1|||
130140666|NCT03555695|468474120|FG000|Overall Study|pre-existing sciatica|1|||
130140667|NCT03247686|468475922|FG000|Overall Study|Withdrawal by Subject|1|||
130140668|NCT03247686|468475923|FG001|Overall Study|Withdrawal by Subject|2|||
130140669|NCT00754052|468475935|FG000|Overall Study|Study terminated by Sponsor|5|||
130140670|NCT00754052|468475936|FG001|Overall Study|Study terminated by Sponsor|3|||
130140671|NCT02658019|468475938|FG000|Overall Study|Adverse Event|1|||
130140672|NCT04364854|468475942|FG000|Overall Study|Withdrawal by Subject|1|||
130140673|NCT04364854|468475943|FG001|Overall Study|Withdrawal by Subject|0|||
130140674|NCT04364854|468475944|FG002|Overall Study|Withdrawal by Subject|1|||
130140675|NCT04364854|468475945|FG003|Overall Study|Withdrawal by Subject|3|||
130140676|NCT04364854|468475942|FG000|Overall Study|Death|1|||
130140677|NCT04364854|468475943|FG001|Overall Study|Death|0|||
130140678|NCT04364854|468475944|FG002|Overall Study|Death|0|||
130140679|NCT04364854|468475945|FG003|Overall Study|Death|0|||
130140680|NCT04364854|468475942|FG000|Overall Study|Lost to Follow-up|0|||
130140681|NCT04364854|468475943|FG001|Overall Study|Lost to Follow-up|0|||
130140682|NCT04364854|468475944|FG002|Overall Study|Lost to Follow-up|0|||
130140683|NCT04364854|468475945|FG003|Overall Study|Lost to Follow-up|1|||
130140684|NCT02435433|468475946|FG000|Overall Study|Withdrawal by Subject|2|||
130140685|NCT02435433|468475947|FG001|Overall Study|Withdrawal by Subject|3|||
130140686|NCT02435433|468475948|FG002|Overall Study|Withdrawal by Subject|1|||
130140687|NCT02435433|468475949|FG003|Overall Study|Withdrawal by Subject|0|||
130140688|NCT02435433|468475950|FG004|Overall Study|Withdrawal by Subject|0|||
130140689|NCT02435433|468475946|FG000|Overall Study|Lost to Follow-up|2|||
130140690|NCT02435433|468475947|FG001|Overall Study|Lost to Follow-up|2|||
130140691|NCT02435433|468475948|FG002|Overall Study|Lost to Follow-up|4|||
130140692|NCT02435433|468475949|FG003|Overall Study|Lost to Follow-up|1|||
130140693|NCT02435433|468475950|FG004|Overall Study|Lost to Follow-up|0|||
130140694|NCT00757705|468475951|FG000|Overall Study|Adverse Event|19|||
130140695|NCT00757705|468475951|FG000|Overall Study|Lost to Follow-up|16|||
130140696|NCT00757705|468475951|FG000|Overall Study|Withdrawal by Subject|25|||
130140697|NCT00757705|468475951|FG000|Overall Study|Insufficient Response|26|||
130140698|NCT00757705|468475951|FG000|Overall Study|Ineligible to continue|8|||
130140699|NCT00757705|468475951|FG000|Overall Study|Non-compliant|9|||
130140700|NCT00757705|468475951|FG000|Overall Study|Other|18|||
130140701|NCT00659815|468475952|FG000|Overall Study|Study related symptoms and complaints|2|||
130140702|NCT00659815|468475953|FG001|Overall Study|Study related symptoms and complaints|1|||
130140703|NCT00659815|468475952|FG000|Overall Study|Inability to maintain wearing schedule|1|||
130140704|NCT00659815|468475953|FG001|Overall Study|Inability to maintain wearing schedule|2|||
130140705|NCT00659815|468475952|FG000|Overall Study|Withdrawal by Subject|1|||
130140706|NCT00659815|468475953|FG001|Overall Study|Withdrawal by Subject|1|||
130140707|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
130140708|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
130140709|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
130140710|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
130140711|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
130140712|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
130140713|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
130140714|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
130140715|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
130140716|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
130140717|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
130140718|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
130140719|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
130140720|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
130140721|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
130140722|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
130140723|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
130140724|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
130140725|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
130140726|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
130140727|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
130140728|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
130140729|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
130140730|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
130140731|NCT01710358|468475954|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
130140732|NCT01710358|468475955|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
130140733|NCT01710358|468475956|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
130140734|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
130140735|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
130140736|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
130140737|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
130140738|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
130140739|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
130140740|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
130140741|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
130140742|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
130140743|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
130140744|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
130140745|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
130140746|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
130140747|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
130140748|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
130140749|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
130140750|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
129976203|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
130140751|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
130140752|NCT01710358|468475954|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
130140753|NCT01710358|468475955|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
130140754|NCT01710358|468475956|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
130140755|NCT01710358|468475954|FG000|Rescue Period|Adverse Event|0|||
130140756|NCT01710358|468475955|FG001|Rescue Period|Adverse Event|15|||
130140757|NCT01710358|468475956|FG002|Rescue Period|Adverse Event|0|||
130140758|NCT01710358|468475954|FG000|Rescue Period|Death|0|||
130140759|NCT01710358|468475955|FG001|Rescue Period|Death|1|||
130140760|NCT01710358|468475956|FG002|Rescue Period|Death|0|||
130140761|NCT01710358|468475954|FG000|Rescue Period|Lack of Efficacy|0|||
130140762|NCT01710358|468475955|FG001|Rescue Period|Lack of Efficacy|7|||
130140763|NCT01710358|468475956|FG002|Rescue Period|Lack of Efficacy|0|||
130140764|NCT01710358|468475954|FG000|Rescue Period|Withdrawal by Subject|0|||
130140765|NCT01710358|468475955|FG001|Rescue Period|Withdrawal by Subject|8|||
130140766|NCT01710358|468475956|FG002|Rescue Period|Withdrawal by Subject|0|||
130140767|NCT00640393|468475963|FG000|Part 1|Lost to Follow-up|2|||
130140768|NCT00640393|468475964|FG001|Part 1|Lost to Follow-up|0|||
130140769|NCT00640393|468475965|FG002|Part 1|Lost to Follow-up|0|||
130140770|NCT00640393|468475963|FG000|Part 1|Withdrawal by Subject|3|||
130140771|NCT00640393|468475964|FG001|Part 1|Withdrawal by Subject|0|||
130140772|NCT00640393|468475965|FG002|Part 1|Withdrawal by Subject|0|||
130140773|NCT00640393|468475963|FG000|Randomization|Withdrawn per protocol|17|||
130140774|NCT00640393|468475964|FG001|Randomization|Withdrawn per protocol|0|||
130140775|NCT00640393|468475965|FG002|Randomization|Withdrawn per protocol|0|||
130140776|NCT00640393|468475963|FG000|Randomization|Never randomized by site|2|||
130140777|NCT00640393|468475964|FG001|Randomization|Never randomized by site|0|||
130140778|NCT00640393|468475965|FG002|Randomization|Never randomized by site|0|||
130140779|NCT00640393|468475963|FG000|Part 2|Lost to Follow-up|0|||
130140780|NCT00640393|468475964|FG001|Part 2|Lost to Follow-up|2|||
130140781|NCT00640393|468475965|FG002|Part 2|Lost to Follow-up|2|||
130140782|NCT00640393|468475963|FG000|Part 2|Withdrawal by Subject|0|||
130140783|NCT00640393|468475964|FG001|Part 2|Withdrawal by Subject|6|||
130140784|NCT00640393|468475965|FG002|Part 2|Withdrawal by Subject|1|||
130140785|NCT00640393|468475963|FG000|Part 2|Non-adherence|0|||
130140786|NCT00640393|468475964|FG001|Part 2|Non-adherence|1|||
130140787|NCT00640393|468475965|FG002|Part 2|Non-adherence|0|||
130140788|NCT00640393|468475963|FG000|Part 2|Adverse Event|0|||
130140789|NCT00640393|468475964|FG001|Part 2|Adverse Event|1|||
130140790|NCT00640393|468475965|FG002|Part 2|Adverse Event|0|||
130140791|NCT04406194|468475967|FG000|Period 1|Withdrawal by Subject|0|||
130140792|NCT04406194|468475968|FG001|Period 1|Withdrawal by Subject|1|||
130140793|NCT00396162|468475969|FG000|Overall Study|Withdrawal by Subject|2|||
130140794|NCT00396162|468475970|FG001|Overall Study|Withdrawal by Subject|3|||
130140795|NCT03540160|468475972|FG000|Overall Study|Protocol Violation|1|||
130140796|NCT03540160|468475972|FG000|Overall Study|Physician Decision|8|||
130140797|NCT03540160|468475972|FG000|Overall Study|Lack of Efficacy|60|||
130140798|NCT03540160|468475972|FG000|Overall Study|Pregnancy|1|||
130140799|NCT03540160|468475972|FG000|Overall Study|Adverse Event|20|||
130140800|NCT03540160|468475972|FG000|Overall Study|Withdrawal by Subject|68|||
130140801|NCT03540160|468475972|FG000|Overall Study|COVID-19|2|||
130140802|NCT03540160|468475972|FG000|Overall Study|Study Closure|10|||
130140803|NCT03540160|468475972|FG000|Overall Study|Lost to Follow-up|18|||
130140804|NCT03540160|468475972|FG000|Overall Study|Sponsor decision|191|||
130140805|NCT01664039|468475975|FG000|Overall Study|Adverse Event|3|||
130140806|NCT01664039|468475976|FG001|Overall Study|Adverse Event|4|||
130140807|NCT01664039|468475975|FG000|Overall Study|Lost to Follow-up|1|||
130140808|NCT01664039|468475976|FG001|Overall Study|Lost to Follow-up|1|||
130140809|NCT01664039|468475975|FG000|Overall Study|Withdrawal by Subject|1|||
130140810|NCT01664039|468475976|FG001|Overall Study|Withdrawal by Subject|3|||
130140811|NCT01664039|468475975|FG000|Overall Study|Noncompliance|1|||
130140812|NCT01664039|468475976|FG001|Overall Study|Noncompliance|1|||
130140813|NCT03358147|468475982|FG000|Overall Study|Withdrawal by Subject|13|||
130140814|NCT03358147|468475983|FG001|Overall Study|Withdrawal by Subject|19|||
130140815|NCT03358147|468475984|FG002|Overall Study|Withdrawal by Subject|16|||
130140816|NCT03358147|468475985|FG003|Overall Study|Withdrawal by Subject|10|||
130140817|NCT03358147|468475986|FG004|Overall Study|Withdrawal by Subject|5|||
130140818|NCT03358147|468475982|FG000|Overall Study|Adverse Event|3|||
130140819|NCT03358147|468475983|FG001|Overall Study|Adverse Event|9|||
129976204|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
130140820|NCT03358147|468475984|FG002|Overall Study|Adverse Event|7|||
130140821|NCT03358147|468475985|FG003|Overall Study|Adverse Event|5|||
130140822|NCT03358147|468475986|FG004|Overall Study|Adverse Event|2|||
130140823|NCT03358147|468475982|FG000|Overall Study|Lost to Follow-up|4|||
130140824|NCT03358147|468475983|FG001|Overall Study|Lost to Follow-up|3|||
130140825|NCT03358147|468475984|FG002|Overall Study|Lost to Follow-up|7|||
130140826|NCT03358147|468475985|FG003|Overall Study|Lost to Follow-up|6|||
130140827|NCT03358147|468475986|FG004|Overall Study|Lost to Follow-up|4|||
130140828|NCT03358147|468475982|FG000|Overall Study|Major Protocol Deviation|11|||
130140829|NCT03358147|468475983|FG001|Overall Study|Major Protocol Deviation|3|||
130140830|NCT03358147|468475984|FG002|Overall Study|Major Protocol Deviation|2|||
130140831|NCT03358147|468475985|FG003|Overall Study|Major Protocol Deviation|3|||
130140832|NCT03358147|468475986|FG004|Overall Study|Major Protocol Deviation|1|||
130140833|NCT03358147|468475982|FG000|Overall Study|Protocol specified criteria|2|||
130140834|NCT03358147|468475983|FG001|Overall Study|Protocol specified criteria|3|||
130140835|NCT03358147|468475984|FG002|Overall Study|Protocol specified criteria|0|||
130140836|NCT03358147|468475985|FG003|Overall Study|Protocol specified criteria|3|||
130140837|NCT03358147|468475986|FG004|Overall Study|Protocol specified criteria|1|||
130140838|NCT03358147|468475982|FG000|Overall Study|Physician Decision|1|||
130140839|NCT03358147|468475983|FG001|Overall Study|Physician Decision|0|||
130140840|NCT03358147|468475984|FG002|Overall Study|Physician Decision|1|||
130140841|NCT03358147|468475985|FG003|Overall Study|Physician Decision|6|||
130140842|NCT03358147|468475986|FG004|Overall Study|Physician Decision|1|||
130140843|NCT03358147|468475982|FG000|Overall Study|Administrative reasons|0|||
130140844|NCT03358147|468475983|FG001|Overall Study|Administrative reasons|1|||
130140845|NCT03358147|468475984|FG002|Overall Study|Administrative reasons|0|||
130140846|NCT03358147|468475985|FG003|Overall Study|Administrative reasons|3|||
130140847|NCT03358147|468475986|FG004|Overall Study|Administrative reasons|0|||
130140848|NCT03358147|468475982|FG000|Overall Study|Lack of Efficacy|0|||
130140849|NCT03358147|468475983|FG001|Overall Study|Lack of Efficacy|1|||
130140850|NCT03358147|468475984|FG002|Overall Study|Lack of Efficacy|1|||
130140851|NCT03358147|468475985|FG003|Overall Study|Lack of Efficacy|0|||
130140852|NCT03358147|468475986|FG004|Overall Study|Lack of Efficacy|0|||
130140853|NCT02704091|468475987|FG000|Overall Study|Adverse Event|4|||
130140854|NCT02704091|468475988|FG001|Overall Study|Adverse Event|3|||
130140855|NCT02704091|468475987|FG000|Overall Study|Protocol Violation|5|||
130140856|NCT02704091|468475988|FG001|Overall Study|Protocol Violation|3|||
130140857|NCT02704091|468475987|FG000|Overall Study|Consent withdrawn|4|||
130140858|NCT02704091|468475988|FG001|Overall Study|Consent withdrawn|4|||
130140859|NCT02704091|468475987|FG000|Overall Study|Lost to Follow-up|13|||
130140860|NCT02704091|468475988|FG001|Overall Study|Lost to Follow-up|5|||
130140861|NCT02704091|468475987|FG000|Overall Study|Other|2|||
130140862|NCT02704091|468475988|FG001|Overall Study|Other|8|||
130140863|NCT03073798|468475991|FG000|Overall Study|Adverse Event|1|||
130140864|NCT03073798|468475991|FG000|Overall Study|Withdrawal by Subject|1|||
130140865|NCT01186458|468475995|FG000|Overall Study|Adverse Event|1|||
130140866|NCT02640235|468475996|FG000|Overall Study|Withdrawal by Subject|7|||
130140867|NCT02640235|468475997|FG001|Overall Study|Withdrawal by Subject|6|||
130140868|NCT02640235|468475996|FG000|Overall Study|Lost to Follow-up|4|||
130140869|NCT02640235|468475997|FG001|Overall Study|Lost to Follow-up|3|||
130140870|NCT02640235|468475996|FG000|Overall Study|Death|2|||
130140871|NCT02640235|468475997|FG001|Overall Study|Death|3|||
130140872|NCT02640235|468475996|FG000|Overall Study|Other|1|||
130140873|NCT02640235|468475997|FG001|Overall Study|Other|2|||
130140874|NCT00301964|468475998|FG000|Overall Study|Second primary|2|||
130140875|NCT00301964|468475998|FG000|Overall Study|Wrong primary|1|||
130140876|NCT00301964|468475998|FG000|Overall Study|Inadequate pathology|1|||
130140877|NCT01968551|468476003|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
130140878|NCT01968551|468476004|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
130140879|NCT01968551|468476005|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
130140880|NCT01968551|468476003|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
130140881|NCT01968551|468476004|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
130140882|NCT01968551|468476005|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
130140883|NCT01968551|468476003|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
130140884|NCT01968551|468476004|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
130140885|NCT01968551|468476005|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
130140886|NCT01968551|468476003|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
130140887|NCT01968551|468476004|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
130140888|NCT01968551|468476005|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
130140889|NCT01968551|468476003|FG000|Extension Phase|Adverse Event|0|||
130140890|NCT01968551|468476004|FG001|Extension Phase|Adverse Event|0|||
130140891|NCT01968551|468476005|FG002|Extension Phase|Adverse Event|2|||
130140892|NCT01968551|468476003|FG000|Extension Phase|Death|0|||
130140893|NCT01968551|468476004|FG001|Extension Phase|Death|1|||
130140894|NCT01968551|468476005|FG002|Extension Phase|Death|0|||
130140895|NCT01968551|468476003|FG000|Extension Phase|Withdrew Consent|0|||
130140896|NCT01968551|468476004|FG001|Extension Phase|Withdrew Consent|0|||
130140897|NCT01968551|468476005|FG002|Extension Phase|Withdrew Consent|1|||
130140898|NCT01968551|468476003|FG000|Extension Phase|Lost to Follow-up|1|||
130140899|NCT01968551|468476004|FG001|Extension Phase|Lost to Follow-up|0|||
130140900|NCT01968551|468476005|FG002|Extension Phase|Lost to Follow-up|1|||
129976205|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130140901|NCT00819169|468476006|FG000|Overall Study|Withdrawal by Subject|2|||
130140902|NCT00819169|468476007|FG001|Overall Study|Withdrawal by Subject|0|||
130140903|NCT00819169|468476008|FG002|Overall Study|Withdrawal by Subject|0|||
130140904|NCT00819169|468476009|FG003|Overall Study|Withdrawal by Subject|1|||
130140905|NCT00819169|468476010|FG004|Overall Study|Withdrawal by Subject|1|||
130140906|NCT00819169|468476011|FG005|Overall Study|Withdrawal by Subject|1|||
130140907|NCT00819169|468476012|FG006|Overall Study|Withdrawal by Subject|5|||
130140908|NCT00819169|468476013|FG007|Overall Study|Withdrawal by Subject|1|||
129976206|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
129976207|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
130140909|NCT00819169|468476014|FG008|Overall Study|Withdrawal by Subject|4|||
130140910|NCT00819169|468476006|FG000|Overall Study|Lost to Follow-up|0|||
130140911|NCT00819169|468476007|FG001|Overall Study|Lost to Follow-up|2|||
130140912|NCT00819169|468476008|FG002|Overall Study|Lost to Follow-up|0|||
130140913|NCT00819169|468476009|FG003|Overall Study|Lost to Follow-up|1|||
130140914|NCT00819169|468476010|FG004|Overall Study|Lost to Follow-up|0|||
130140915|NCT00819169|468476011|FG005|Overall Study|Lost to Follow-up|6|||
130140916|NCT00819169|468476012|FG006|Overall Study|Lost to Follow-up|2|||
130140917|NCT00819169|468476013|FG007|Overall Study|Lost to Follow-up|2|||
130140918|NCT00819169|468476014|FG008|Overall Study|Lost to Follow-up|1|||
130140919|NCT00819169|468476006|FG000|Overall Study|Death|1|||
130140920|NCT00819169|468476007|FG001|Overall Study|Death|1|||
130140921|NCT00819169|468476008|FG002|Overall Study|Death|3|||
130140922|NCT00819169|468476009|FG003|Overall Study|Death|8|||
130140923|NCT00819169|468476010|FG004|Overall Study|Death|5|||
130140924|NCT00819169|468476011|FG005|Overall Study|Death|7|||
130140925|NCT00819169|468476012|FG006|Overall Study|Death|9|||
130140926|NCT00819169|468476013|FG007|Overall Study|Death|4|||
130140927|NCT00819169|468476014|FG008|Overall Study|Death|7|||
130140928|NCT00819169|468476006|FG000|Overall Study|Ineligibility determined|0|||
130140929|NCT00819169|468476007|FG001|Overall Study|Ineligibility determined|0|||
130140930|NCT00819169|468476008|FG002|Overall Study|Ineligibility determined|0|||
130140931|NCT00819169|468476009|FG003|Overall Study|Ineligibility determined|2|||
130140932|NCT00819169|468476010|FG004|Overall Study|Ineligibility determined|0|||
130140933|NCT00819169|468476011|FG005|Overall Study|Ineligibility determined|0|||
130140934|NCT00819169|468476012|FG006|Overall Study|Ineligibility determined|0|||
130140935|NCT00819169|468476013|FG007|Overall Study|Ineligibility determined|0|||
130140936|NCT00819169|468476014|FG008|Overall Study|Ineligibility determined|1|||
130140937|NCT00819169|468476006|FG000|Overall Study|Adverse Event|0|||
130140938|NCT00819169|468476007|FG001|Overall Study|Adverse Event|0|||
130140939|NCT00819169|468476008|FG002|Overall Study|Adverse Event|0|||
130140940|NCT00819169|468476009|FG003|Overall Study|Adverse Event|0|||
130140941|NCT00819169|468476010|FG004|Overall Study|Adverse Event|1|||
130140942|NCT00819169|468476011|FG005|Overall Study|Adverse Event|0|||
130140943|NCT00819169|468476012|FG006|Overall Study|Adverse Event|0|||
130140944|NCT00819169|468476013|FG007|Overall Study|Adverse Event|0|||
130140945|NCT00819169|468476014|FG008|Overall Study|Adverse Event|0|||
130140946|NCT00819169|468476006|FG000|Overall Study|Administrative Decision|0|||
130140947|NCT00819169|468476007|FG001|Overall Study|Administrative Decision|0|||
130140948|NCT00819169|468476008|FG002|Overall Study|Administrative Decision|0|||
130140949|NCT00819169|468476009|FG003|Overall Study|Administrative Decision|0|||
130140950|NCT00819169|468476010|FG004|Overall Study|Administrative Decision|1|||
130140951|NCT00819169|468476011|FG005|Overall Study|Administrative Decision|2|||
130140952|NCT00819169|468476012|FG006|Overall Study|Administrative Decision|0|||
130140953|NCT00819169|468476013|FG007|Overall Study|Administrative Decision|2|||
130140954|NCT00819169|468476014|FG008|Overall Study|Administrative Decision|0|||
130140955|NCT00573313|468476015|FG000|Overall Study|Protocol Violation|5|||
130140956|NCT00573313|468476016|FG001|Overall Study|Protocol Violation|0|||
130140957|NCT00573313|468476017|FG002|Overall Study|Protocol Violation|6|||
130140958|NCT00573313|468476018|FG003|Overall Study|Protocol Violation|0|||
130140959|NCT00467597|468476029|FG000|Overall Study|Withdrawal by Subject|2|||
130140960|NCT00467597|468476030|FG001|Overall Study|Withdrawal by Subject|0|||
130140961|NCT02096705|468476031|FG000|Treatment|Adverse Event|6|||
130140962|NCT02096705|468476032|FG001|Treatment|Adverse Event|3|||
130140963|NCT02096705|468476031|FG000|Treatment|Subject request to discontinue treatment|1|||
130140964|NCT02096705|468476032|FG001|Treatment|Subject request to discontinue treatment|1|||
130140965|NCT02096705|468476031|FG000|Treatment|Withdrawal by Subject|1|||
130140966|NCT02096705|468476032|FG001|Treatment|Withdrawal by Subject|0|||
130140967|NCT02096705|468476031|FG000|Treatment|Other|1|||
130140968|NCT02096705|468476032|FG001|Treatment|Other|1|||
130140969|NCT02096705|468476031|FG000|Follow-up|Withdrawal by Subject|1|||
130140970|NCT02096705|468476032|FG001|Follow-up|Withdrawal by Subject|0|||
130140971|NCT02096705|468476031|FG000|Follow-up|Adverse Event|2|||
130140972|NCT02096705|468476032|FG001|Follow-up|Adverse Event|2|||
130140973|NCT02096705|468476031|FG000|Follow-up|Subjects not reporting status|1|||
130140974|NCT02096705|468476032|FG001|Follow-up|Subjects not reporting status|2|||
130140975|NCT02166606|468476035|FG000|Overall Study|Adverse Event|3|||
130140976|NCT02166606|468476035|FG000|Overall Study|Death|31|||
130140977|NCT02166606|468476035|FG000|Overall Study|Protocol Violation|7|||
130140978|NCT02166606|468476035|FG000|Overall Study|Lost to Follow-up|30|||
130140979|NCT02166606|468476035|FG000|Overall Study|Withdrawal by Subject|1|||
130140980|NCT02166606|468476035|FG000|Overall Study|Physician Decision|1|||
130140981|NCT02166606|468476035|FG000|Overall Study|Device upgrade|1|||
130140982|NCT02166606|468476035|FG000|Overall Study|Enrolled after End of Enrollment|4|||
130140983|NCT00537095|468476040|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
130140984|NCT00537095|468476041|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
130140985|NCT00537095|468476040|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
130140986|NCT00537095|468476041|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
129976208|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
130140987|NCT00537095|468476040|FG000|Randomized Treatment Period (433 Days)|Death|3|||
130140988|NCT00537095|468476041|FG001|Randomized Treatment Period (433 Days)|Death|1|||
130140989|NCT00537095|468476040|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
130140990|NCT00537095|468476041|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
130140991|NCT00537095|468476040|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
130140992|NCT00537095|468476041|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
130140993|NCT00537095|468476040|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
130140994|NCT00537095|468476041|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
130140995|NCT00537095|468476040|FG000|Open-label Period (590 Days)|Adverse Event|2|||
130140996|NCT00537095|468476041|FG001|Open-label Period (590 Days)|Adverse Event|11|||
130140997|NCT00537095|468476040|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
130140998|NCT00537095|468476041|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
130140999|NCT00537095|468476040|FG000|Open-label Period (590 Days)|Death|2|||
130141000|NCT00537095|468476041|FG001|Open-label Period (590 Days)|Death|2|||
130141001|NCT00537095|468476040|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
130141002|NCT00537095|468476041|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
130141003|NCT00537095|468476040|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
130141004|NCT00537095|468476041|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
130141005|NCT01899053|468476043|FG000|Overall Study|Progressive Disease|4|||
130141006|NCT01899053|468476044|FG001|Overall Study|Progressive Disease|0|||
130141007|NCT01899053|468476045|FG002|Overall Study|Progressive Disease|3|||
130141008|NCT01899053|468476046|FG003|Overall Study|Progressive Disease|0|||
130141009|NCT01899053|468476047|FG004|Overall Study|Progressive Disease|3|||
130141010|NCT01899053|468476048|FG005|Overall Study|Progressive Disease|1|||
130141011|NCT01899053|468476049|FG006|Overall Study|Progressive Disease|1|||
130141012|NCT01899053|468476050|FG007|Overall Study|Progressive Disease|1|||
130141013|NCT01899053|468476051|FG008|Overall Study|Progressive Disease|4|||
130141014|NCT01899053|468476052|FG009|Overall Study|Progressive Disease|3|||
130141015|NCT01899053|468476053|FG010|Overall Study|Progressive Disease|12|||
130141016|NCT01899053|468476054|FG011|Overall Study|Progressive Disease|5|||
130141017|NCT01899053|468476055|FG012|Overall Study|Progressive Disease|8|||
130141018|NCT01899053|468476056|FG013|Overall Study|Progressive Disease|17|||
130141019|NCT01899053|468476043|FG000|Overall Study|Adverse Event|1|||
130141020|NCT01899053|468476044|FG001|Overall Study|Adverse Event|1|||
130141021|NCT01899053|468476045|FG002|Overall Study|Adverse Event|1|||
130141022|NCT01899053|468476046|FG003|Overall Study|Adverse Event|3|||
130141023|NCT01899053|468476047|FG004|Overall Study|Adverse Event|1|||
130141024|NCT01899053|468476048|FG005|Overall Study|Adverse Event|1|||
130141025|NCT01899053|468476049|FG006|Overall Study|Adverse Event|1|||
130141026|NCT01899053|468476050|FG007|Overall Study|Adverse Event|0|||
130141027|NCT01899053|468476051|FG008|Overall Study|Adverse Event|2|||
130141028|NCT01899053|468476052|FG009|Overall Study|Adverse Event|0|||
130141029|NCT01899053|468476053|FG010|Overall Study|Adverse Event|3|||
130141030|NCT01899053|468476054|FG011|Overall Study|Adverse Event|1|||
130141031|NCT01899053|468476055|FG012|Overall Study|Adverse Event|2|||
130141032|NCT01899053|468476056|FG013|Overall Study|Adverse Event|2|||
130141033|NCT01899053|468476043|FG000|Overall Study|Reason Not Specified|0|||
130141034|NCT01899053|468476044|FG001|Overall Study|Reason Not Specified|0|||
130141035|NCT01899053|468476045|FG002|Overall Study|Reason Not Specified|0|||
130141036|NCT01899053|468476046|FG003|Overall Study|Reason Not Specified|0|||
130141037|NCT01899053|468476047|FG004|Overall Study|Reason Not Specified|0|||
130141038|NCT01899053|468476048|FG005|Overall Study|Reason Not Specified|0|||
130141039|NCT01899053|468476049|FG006|Overall Study|Reason Not Specified|1|||
130141040|NCT01899053|468476050|FG007|Overall Study|Reason Not Specified|0|||
130141041|NCT01899053|468476051|FG008|Overall Study|Reason Not Specified|0|||
130141042|NCT01899053|468476052|FG009|Overall Study|Reason Not Specified|0|||
130141043|NCT01899053|468476053|FG010|Overall Study|Reason Not Specified|0|||
130141044|NCT01899053|468476054|FG011|Overall Study|Reason Not Specified|0|||
130141045|NCT01899053|468476055|FG012|Overall Study|Reason Not Specified|1|||
130141046|NCT01899053|468476056|FG013|Overall Study|Reason Not Specified|0|||
130141047|NCT01899053|468476043|FG000|Overall Study|Withdrawal by Subject|1|||
130141048|NCT01899053|468476044|FG001|Overall Study|Withdrawal by Subject|1|||
130141049|NCT01899053|468476045|FG002|Overall Study|Withdrawal by Subject|2|||
130141050|NCT01899053|468476046|FG003|Overall Study|Withdrawal by Subject|0|||
130141051|NCT01899053|468476047|FG004|Overall Study|Withdrawal by Subject|2|||
130141052|NCT01899053|468476048|FG005|Overall Study|Withdrawal by Subject|0|||
130141053|NCT01899053|468476049|FG006|Overall Study|Withdrawal by Subject|0|||
130141054|NCT01899053|468476050|FG007|Overall Study|Withdrawal by Subject|1|||
130141055|NCT01899053|468476051|FG008|Overall Study|Withdrawal by Subject|0|||
130141056|NCT01899053|468476052|FG009|Overall Study|Withdrawal by Subject|0|||
130141057|NCT01899053|468476053|FG010|Overall Study|Withdrawal by Subject|0|||
130141058|NCT01899053|468476054|FG011|Overall Study|Withdrawal by Subject|0|||
130141059|NCT01899053|468476055|FG012|Overall Study|Withdrawal by Subject|1|||
130141060|NCT01899053|468476056|FG013|Overall Study|Withdrawal by Subject|1|||
130141061|NCT01899053|468476043|FG000|Overall Study|Protocol Violation|0|||
130141062|NCT01899053|468476044|FG001|Overall Study|Protocol Violation|0|||
130141063|NCT01899053|468476045|FG002|Overall Study|Protocol Violation|1|||
130141064|NCT01899053|468476046|FG003|Overall Study|Protocol Violation|0|||
130141065|NCT01899053|468476047|FG004|Overall Study|Protocol Violation|0|||
130141066|NCT01899053|468476048|FG005|Overall Study|Protocol Violation|0|||
130141067|NCT01899053|468476049|FG006|Overall Study|Protocol Violation|0|||
130141068|NCT01899053|468476050|FG007|Overall Study|Protocol Violation|0|||
130141069|NCT01899053|468476051|FG008|Overall Study|Protocol Violation|0|||
130141070|NCT01899053|468476052|FG009|Overall Study|Protocol Violation|0|||
130141071|NCT01899053|468476053|FG010|Overall Study|Protocol Violation|0|||
130141072|NCT01899053|468476054|FG011|Overall Study|Protocol Violation|0|||
130141073|NCT01899053|468476055|FG012|Overall Study|Protocol Violation|0|||
130141074|NCT01899053|468476056|FG013|Overall Study|Protocol Violation|0|||
130141075|NCT01899053|468476043|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
130141076|NCT01899053|468476044|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
130141077|NCT01899053|468476045|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141078|NCT01899053|468476046|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141079|NCT01899053|468476047|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141080|NCT01899053|468476048|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141081|NCT01899053|468476049|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141082|NCT01899053|468476050|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141083|NCT01899053|468476051|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141084|NCT01899053|468476052|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141085|NCT01899053|468476053|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
130141086|NCT01899053|468476054|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141087|NCT01899053|468476055|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141088|NCT01899053|468476056|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
130141089|NCT01899053|468476043|FG000|Overall Study|Symptomatic Deterioration|0|||
130141090|NCT01899053|468476044|FG001|Overall Study|Symptomatic Deterioration|0|||
130141091|NCT01899053|468476045|FG002|Overall Study|Symptomatic Deterioration|0|||
130141092|NCT01899053|468476046|FG003|Overall Study|Symptomatic Deterioration|0|||
130141093|NCT01899053|468476047|FG004|Overall Study|Symptomatic Deterioration|0|||
130141094|NCT01899053|468476048|FG005|Overall Study|Symptomatic Deterioration|1|||
130141095|NCT01899053|468476049|FG006|Overall Study|Symptomatic Deterioration|0|||
130141096|NCT01899053|468476050|FG007|Overall Study|Symptomatic Deterioration|1|||
130141097|NCT01899053|468476051|FG008|Overall Study|Symptomatic Deterioration|0|||
130141098|NCT01899053|468476052|FG009|Overall Study|Symptomatic Deterioration|0|||
130141099|NCT01899053|468476053|FG010|Overall Study|Symptomatic Deterioration|0|||
130141100|NCT01899053|468476054|FG011|Overall Study|Symptomatic Deterioration|1|||
130141101|NCT01899053|468476055|FG012|Overall Study|Symptomatic Deterioration|2|||
130141102|NCT01899053|468476056|FG013|Overall Study|Symptomatic Deterioration|0|||
130141103|NCT03105297|468476057|FG000|Baseline Phase (Day 1)|Other|21|||
130141104|NCT03105297|468476057|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
130141105|NCT03105297|468476057|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
130141106|NCT05315713|468476059|FG000|Overall Study|Death|5|||
130141107|NCT05315713|468476059|FG000|Overall Study|Progressive disease|1|||
130141108|NCT05315713|468476059|FG000|Overall Study|Withdrawal by Subject|1|||
130141109|NCT05315713|468476059|FG000|Overall Study|Study terminated by sponsor|1|||
130141110|NCT04194151|468476060|FG000|Overall Study|Physician Decision|1|||
130141111|NCT04194151|468476061|FG001|Overall Study|Physician Decision|1|||
130141112|NCT04194151|468476062|FG002|Overall Study|Physician Decision|1|||
130141113|NCT04194151|468476063|FG003|Overall Study|Physician Decision|1|||
130141114|NCT04194151|468476064|FG004|Overall Study|Physician Decision|0|||
130141115|NCT04194151|468476065|FG005|Overall Study|Physician Decision|1|||
130141116|NCT04194151|468476060|FG000|Overall Study|Monitorization problem|0|||
130141117|NCT04194151|468476061|FG001|Overall Study|Monitorization problem|1|||
130141118|NCT04194151|468476062|FG002|Overall Study|Monitorization problem|0|||
130141119|NCT04194151|468476063|FG003|Overall Study|Monitorization problem|0|||
130141120|NCT04194151|468476064|FG004|Overall Study|Monitorization problem|0|||
130141121|NCT04194151|468476065|FG005|Overall Study|Monitorization problem|0|||
130141122|NCT01499043|468476066|FG000|Overall Study|Progressive disease (radiographic)|2|||
130141123|NCT01499043|468476066|FG000|Overall Study|Progressive disease (clinical)|1|||
130141124|NCT01499043|468476066|FG000|Overall Study|Withdrawal by Subject|2|||
130141125|NCT01499043|468476066|FG000|Overall Study|Adverse Event|1|||
130141126|NCT04203823|468476067|FG000|Overall Study|Withdrawal by Subject|2|||
130141127|NCT04203823|468476068|FG001|Overall Study|Withdrawal by Subject|2|||
130141128|NCT04203823|468476067|FG000|Overall Study|Adverse Event|1|||
130141129|NCT04203823|468476068|FG001|Overall Study|Adverse Event|1|||
130141130|NCT04203823|468476067|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130141131|NCT04203823|468476068|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
130141132|NCT00438633|468476070|FG000|Overall Study|Withdrawal by Subject|1|||
130141133|NCT00438633|468476071|FG001|Overall Study|Withdrawal by Subject|0|||
130141134|NCT00438633|468476070|FG000|Overall Study|Lost to Follow-up|15|||
130141135|NCT00438633|468476071|FG001|Overall Study|Lost to Follow-up|17|||
130141136|NCT02286466|468476072|FG000|Overall Study|Death|1|||
130141137|NCT02286466|468476073|FG001|Overall Study|Death|3|||
130141138|NCT02286466|468476072|FG000|Overall Study|Withdrawal by Subject|5|||
130141139|NCT02286466|468476073|FG001|Overall Study|Withdrawal by Subject|2|||
130141140|NCT02286466|468476072|FG000|Overall Study|Lost to Follow-up|1|||
130141141|NCT02286466|468476073|FG001|Overall Study|Lost to Follow-up|4|||
130141142|NCT02286466|468476072|FG000|Overall Study|Declined Clinician Assessment|0|||
130141143|NCT02286466|468476073|FG001|Overall Study|Declined Clinician Assessment|1|||
130141144|NCT00835081|468476074|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
130141145|NCT00835081|468476075|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129976209|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129976210|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129976211|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976212|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976213|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976214|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976215|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
129976216|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
130141146|NCT00421304|468476076|FG000|Overall Study|Lost to Follow-up|5|||
130141147|NCT00421304|468476077|FG001|Overall Study|Lost to Follow-up|2|||
130141148|NCT00421304|468476078|FG002|Overall Study|Lost to Follow-up|5|||
130141149|NCT00421304|468476076|FG000|Overall Study|Withdrawal by Subject|2|||
130141150|NCT00421304|468476077|FG001|Overall Study|Withdrawal by Subject|2|||
130141151|NCT00421304|468476078|FG002|Overall Study|Withdrawal by Subject|2|||
130141152|NCT00421304|468476076|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
130141153|NCT00421304|468476077|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
130141154|NCT00421304|468476078|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
130141155|NCT00421304|468476076|FG000|Overall Study|Did not attend Day 360 visit|0|||
130141156|NCT00421304|468476077|FG001|Overall Study|Did not attend Day 360 visit|0|||
130141157|NCT00421304|468476078|FG002|Overall Study|Did not attend Day 360 visit|1|||
130141158|NCT03196284|468476079|FG000|Main Part|Withdrawal by Subject|0|||
130141159|NCT03196284|468476080|FG001|Main Part|Withdrawal by Subject|1|||
130141160|NCT03196284|468476081|FG002|Main Part|Withdrawal by Subject|0|||
130141161|NCT03196284|468476079|FG000|Extension Part|Lack of Efficacy|0|||
130141162|NCT03196284|468476080|FG001|Extension Part|Lack of Efficacy|0|||
130141163|NCT03196284|468476081|FG002|Extension Part|Lack of Efficacy|1|||
130141164|NCT03196284|468476079|FG000|Extension Part|Withdrawal by Subject|0|||
130141165|NCT03196284|468476080|FG001|Extension Part|Withdrawal by Subject|0|||
130141166|NCT03196284|468476081|FG002|Extension Part|Withdrawal by Subject|1|||
130141167|NCT03196284|468476079|FG000|Extension Part|Physician Decision|0|||
130141168|NCT03196284|468476080|FG001|Extension Part|Physician Decision|0|||
130141169|NCT03196284|468476081|FG002|Extension Part|Physician Decision|1|||
130141170|NCT01912807|468476082|FG000|Overall Study|Did not meet elegibility criteria|6|||
130141171|NCT01912807|468476083|FG001|Overall Study|Did not meet elegibility criteria|4|||
130141172|NCT01912807|468476082|FG000|Overall Study|Lost to Follow-up|36|||
130141173|NCT01912807|468476083|FG001|Overall Study|Lost to Follow-up|37|||
130141174|NCT02535923|468476085|FG000|Overall Study|Lost to Follow-up|5|||
130141175|NCT02535923|468476086|FG001|Overall Study|Lost to Follow-up|5|||
130141176|NCT02535923|468476085|FG000|Overall Study|Withdrawal by Subject|4|||
130141177|NCT02535923|468476086|FG001|Overall Study|Withdrawal by Subject|3|||
130141178|NCT00874276|468476092|FG000|Overall Study|Withdrawal by Subject|1|||
130141179|NCT00874276|468476093|FG001|Overall Study|Withdrawal by Subject|1|||
130141180|NCT01253564|468476096|FG000|Overall Study|Disease Progression|22|||
129976217|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976218|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
130141181|NCT01253564|468476096|FG000|Overall Study|Withdrawal by Subject|1|||
130141182|NCT01253564|468476096|FG000|Overall Study|Serious Adverse Event|1|||
130141183|NCT03694197|468476099|FG000|Overall Study|Adverse Event|9|||
130141184|NCT03694197|468476099|FG000|Overall Study|Protocol became inconvenient to participate|1|||
130141185|NCT03694197|468476099|FG000|Overall Study|Physician Decision|4|||
130141186|NCT03694197|468476099|FG000|Overall Study|Study terminated by sponsor|1350|||
130141187|NCT03694197|468476099|FG000|Overall Study|Participant moved|5|||
130141188|NCT03694197|468476099|FG000|Overall Study|Participant withdrew consent|10|||
130141189|NCT03694197|468476099|FG000|Overall Study|Related to IMP administration|1|||
130141190|NCT03694197|468476099|FG000|Overall Study|Not disclosed|5|||
130141191|NCT03506633|468477589|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
130141192|NCT03506633|468477590|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
130141193|NCT04573309|468477592|FG000|Overall Study|Protocol Violation|1|||
130141194|NCT04573309|468477593|FG001|Overall Study|Protocol Violation|0|||
130141195|NCT01109849|468477596|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
130141196|NCT01109849|468477597|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
130141197|NCT01109849|468477598|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130141198|NCT01109849|468477599|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130141199|NCT01109849|468477600|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
130141200|NCT01109849|468477596|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
130141201|NCT01109849|468477597|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130141202|NCT01109849|468477598|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130141203|NCT01109849|468477599|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130141204|NCT01109849|468477600|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
130141205|NCT01109849|468477596|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
130141206|NCT01109849|468477597|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
130141207|NCT01109849|468477598|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130141208|NCT01109849|468477599|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130141209|NCT01109849|468477600|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
130141210|NCT01109849|468477596|FG000|Initial Randomization: ADHD Treatment|move away|2|||
130141211|NCT01109849|468477597|FG001|Initial Randomization: ADHD Treatment|move away|7|||
130141212|NCT01109849|468477598|FG002|Initial Randomization: ADHD Treatment|move away|0|||
130141213|NCT01109849|468477599|FG003|Initial Randomization: ADHD Treatment|move away|0|||
130141214|NCT01109849|468477600|FG004|Initial Randomization: ADHD Treatment|move away|0|||
130141215|NCT01109849|468477596|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
130141216|NCT01109849|468477597|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
130141217|NCT01109849|468477598|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130141218|NCT01109849|468477599|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130141219|NCT01109849|468477600|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
130141220|NCT01109849|468477596|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
130141221|NCT01109849|468477597|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
130141222|NCT01109849|468477598|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
130141223|NCT01109849|468477599|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
130141224|NCT01109849|468477600|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
130141225|NCT03969641|468477601|FG000|Overall Study|Lost to Follow-up|5|||
130141226|NCT03969641|468477602|FG001|Overall Study|Lost to Follow-up|3|||
130141227|NCT03969641|468477601|FG000|Overall Study|Withdrawal by Subject|1|||
130141228|NCT03969641|468477602|FG001|Overall Study|Withdrawal by Subject|2|||
130141229|NCT03969641|468477601|FG000|Overall Study|Found to be ineligible|1|||
130141230|NCT03969641|468477602|FG001|Overall Study|Found to be ineligible|1|||
130141231|NCT03969641|468477601|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
130141232|NCT03969641|468477602|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
130141233|NCT03969641|468477601|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
130141234|NCT03969641|468477602|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
130141235|NCT03969641|468477601|FG000|Overall Study|Elective termination|0|||
130141236|NCT03969641|468477602|FG001|Overall Study|Elective termination|1|||
130141237|NCT01541215|468477603|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
130141238|NCT01541215|468477604|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
130141239|NCT01541215|468477603|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
130141240|NCT01541215|468477604|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
130141241|NCT01541215|468477603|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
130141242|NCT01541215|468477604|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
130141243|NCT01541215|468477603|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
130141244|NCT01541215|468477604|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
130141245|NCT01541215|468477603|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
130141246|NCT01541215|468477604|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
130141247|NCT01541215|468477603|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
130141248|NCT01541215|468477604|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
130141249|NCT00735696|468477610|FG000|Overall Study|Withdrawal by Subject|1|||
130141250|NCT00735696|468477610|FG000|Overall Study|Enrolled but never Treated|1|||
130141251|NCT02998541|468477611|FG000|Overall Study|Adverse Event|4|||
130141252|NCT02998541|468477612|FG001|Overall Study|Adverse Event|5|||
130141253|NCT02998541|468477613|FG002|Overall Study|Adverse Event|1|||
130141254|NCT02998541|468477611|FG000|Overall Study|Protocol Violation|1|||
130141255|NCT02998541|468477612|FG001|Overall Study|Protocol Violation|0|||
130141256|NCT02998541|468477613|FG002|Overall Study|Protocol Violation|0|||
130141257|NCT02998541|468477611|FG000|Overall Study|Withdrawal by Subject|3|||
130141258|NCT02998541|468477612|FG001|Overall Study|Withdrawal by Subject|1|||
130141259|NCT02998541|468477613|FG002|Overall Study|Withdrawal by Subject|0|||
130141260|NCT02998541|468477611|FG000|Overall Study|Lost to Follow-up|0|||
130141261|NCT02998541|468477612|FG001|Overall Study|Lost to Follow-up|3|||
130141262|NCT02998541|468477613|FG002|Overall Study|Lost to Follow-up|1|||
130141263|NCT02998541|468477611|FG000|Overall Study|Physician Decision|0|||
130141264|NCT02998541|468477612|FG001|Overall Study|Physician Decision|0|||
130141265|NCT02998541|468477613|FG002|Overall Study|Physician Decision|3|||
130141266|NCT02998541|468477611|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
130141267|NCT02998541|468477612|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130141268|NCT02998541|468477613|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
130141269|NCT00354835|468477617|FG000|Overall Study|Death|1|||
130141270|NCT00354835|468477618|FG001|Overall Study|Death|1|||
130141271|NCT00354835|468477617|FG000|Overall Study|Physician Decision|8|||
130141272|NCT00354835|468477618|FG001|Overall Study|Physician Decision|13|||
130141273|NCT00354835|468477617|FG000|Overall Study|Withdrawal by Subject|2|||
130141274|NCT00354835|468477618|FG001|Overall Study|Withdrawal by Subject|1|||
130141275|NCT00354835|468477617|FG000|Overall Study|Ineligible|17|||
130141276|NCT00354835|468477618|FG001|Overall Study|Ineligible|16|||
130141277|NCT00354835|468477617|FG000|Overall Study|Disease progression or relapse|15|||
130141278|NCT00354835|468477618|FG001|Overall Study|Disease progression or relapse|22|||
130141279|NCT00354835|468477617|FG000|Overall Study|Adverse Event|6|||
130141280|NCT00354835|468477618|FG001|Overall Study|Adverse Event|0|||
130141281|NCT00354835|468477617|FG000|Overall Study|Refusal of further therapy|3|||
130141282|NCT00354835|468477618|FG001|Overall Study|Refusal of further therapy|8|||
130141283|NCT03141151|468477630|FG000|Overall Study|Lost to Follow-up|3|||
130141284|NCT03141151|468477631|FG001|Overall Study|Lost to Follow-up|2|||
130141285|NCT03141151|468477630|FG000|Overall Study|Withdrawal by Subject|3|||
130141286|NCT03141151|468477631|FG001|Overall Study|Withdrawal by Subject|2|||
130141287|NCT03277248|468477632|FG000|Overall Study|Adverse Event|3|||
130141288|NCT03277248|468477633|FG001|Overall Study|Adverse Event|1|||
130141289|NCT03277248|468477632|FG000|Overall Study|Subject Withdrawal of Consent|6|||
130141290|NCT03277248|468477633|FG001|Overall Study|Subject Withdrawal of Consent|23|||
130141291|NCT03277248|468477632|FG000|Overall Study|Investigator/Sponsor Decision|2|||
130141292|NCT03277248|468477633|FG001|Overall Study|Investigator/Sponsor Decision|2|||
130141293|NCT03277248|468477632|FG000|Overall Study|Pregnancy|4|||
130141294|NCT03277248|468477633|FG001|Overall Study|Pregnancy|1|||
130141295|NCT03277248|468477632|FG000|Overall Study|Lost to Follow-up|0|||
130141296|NCT03277248|468477633|FG001|Overall Study|Lost to Follow-up|2|||
130141297|NCT03277248|468477632|FG000|Overall Study|Lack of Efficacy|0|||
130141298|NCT03277248|468477633|FG001|Overall Study|Lack of Efficacy|2|||
130141299|NCT03277248|468477632|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
130141300|NCT03277248|468477633|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
130141301|NCT00884390|468477636|FG000|Overall Study|Adverse Event|0|||
130141302|NCT00884390|468477637|FG001|Overall Study|Adverse Event|1|||
130141303|NCT00884390|468477636|FG000|Overall Study|Lost to Follow-up|0|||
130141304|NCT00884390|468477637|FG001|Overall Study|Lost to Follow-up|1|||
130141305|NCT00884390|468477636|FG000|Overall Study|Physician Decision|2|||
130141306|NCT00884390|468477637|FG001|Overall Study|Physician Decision|1|||
130141307|NCT00884390|468477636|FG000|Overall Study|Protocol Violation|4|||
130141308|NCT00884390|468477637|FG001|Overall Study|Protocol Violation|1|||
130141309|NCT00884390|468477636|FG000|Overall Study|Withdrawal by Subject|4|||
130141310|NCT00884390|468477637|FG001|Overall Study|Withdrawal by Subject|1|||
130141311|NCT00884390|468477636|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
130141312|NCT00884390|468477637|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
130141313|NCT00884390|468477636|FG000|Overall Study|Other|11|||
130141314|NCT00884390|468477637|FG001|Overall Study|Other|1|||
130141315|NCT01691612|468477638|FG000|Overall Study|deemed ineligible after 1st visit|6|||
130141316|NCT01691612|468477638|FG000|Overall Study|Adverse Event|1|||
130141317|NCT02670551|468477641|FG000|Overall Study|Adverse Event|4|||
130141318|NCT02670551|468477642|FG001|Overall Study|Adverse Event|7|||
130141319|NCT02670551|468477643|FG002|Overall Study|Adverse Event|9|||
130141320|NCT02670551|468477641|FG000|Overall Study|Lack of Efficacy|2|||
130141321|NCT02670551|468477642|FG001|Overall Study|Lack of Efficacy|0|||
130141322|NCT02670551|468477643|FG002|Overall Study|Lack of Efficacy|3|||
130141323|NCT02670551|468477641|FG000|Overall Study|Withdrawal of Consent|6|||
130141324|NCT02670551|468477642|FG001|Overall Study|Withdrawal of Consent|3|||
130141325|NCT02670551|468477643|FG002|Overall Study|Withdrawal of Consent|8|||
130141326|NCT02670551|468477641|FG000|Overall Study|Lost to Follow-up|5|||
130141327|NCT02670551|468477642|FG001|Overall Study|Lost to Follow-up|7|||
130141328|NCT02670551|468477643|FG002|Overall Study|Lost to Follow-up|6|||
130141329|NCT02670551|468477641|FG000|Overall Study|Protocol Violation|1|||
130141330|NCT02670551|468477642|FG001|Overall Study|Protocol Violation|0|||
130141331|NCT02670551|468477643|FG002|Overall Study|Protocol Violation|0|||
130141332|NCT02670551|468477641|FG000|Overall Study|Noncompliance with study drug|3|||
130141333|NCT02670551|468477642|FG001|Overall Study|Noncompliance with study drug|3|||
130141334|NCT02670551|468477643|FG002|Overall Study|Noncompliance with study drug|2|||
130141335|NCT02670551|468477641|FG000|Overall Study|Other Miscellaneous Reasons|2|||
130141336|NCT02670551|468477642|FG001|Overall Study|Other Miscellaneous Reasons|3|||
130141337|NCT02670551|468477643|FG002|Overall Study|Other Miscellaneous Reasons|3|||
130141338|NCT02670551|468477641|FG000|Overall Study|Did Not Receive Treatment|5|||
130141339|NCT02670551|468477642|FG001|Overall Study|Did Not Receive Treatment|3|||
130141340|NCT02670551|468477643|FG002|Overall Study|Did Not Receive Treatment|0|||
130141341|NCT04476277|468477645|FG000|Overall Study|Withdrawal by Subject|0|||
130141342|NCT04476277|468477646|FG001|Overall Study|Withdrawal by Subject|0|||
130141343|NCT04476277|468477647|FG002|Overall Study|Withdrawal by Subject|1|||
130141344|NCT04476277|468477648|FG003|Overall Study|Withdrawal by Subject|0|||
130141345|NCT01971645|468477649|FG000|Overall Study|Adverse Event|1|||
130141346|NCT01971645|468477650|FG001|Overall Study|Adverse Event|0|||
130141347|NCT01971645|468477651|FG002|Overall Study|Adverse Event|0|||
130141348|NCT01971645|468477649|FG000|Overall Study|Lost to Follow-up|1|||
130141349|NCT01971645|468477650|FG001|Overall Study|Lost to Follow-up|0|||
130141350|NCT01971645|468477651|FG002|Overall Study|Lost to Follow-up|1|||
130141351|NCT01971645|468477649|FG000|Overall Study|Protocol Violation|0|||
130141352|NCT01971645|468477650|FG001|Overall Study|Protocol Violation|0|||
130141353|NCT01971645|468477651|FG002|Overall Study|Protocol Violation|1|||
130141354|NCT01962298|468477652|FG000|Overall Study|Protocol Violation|1|||
130141355|NCT01962298|468477653|FG001|Overall Study|Protocol Violation|0|||
130141356|NCT01962298|468477654|FG002|Overall Study|Protocol Violation|1|||
130141357|NCT01962298|468477655|FG003|Overall Study|Protocol Violation|1|||
130141358|NCT01962298|468477656|FG004|Overall Study|Protocol Violation|0|||
130141359|NCT01962298|468477652|FG000|Overall Study|Data quality insufficient|2|||
130141360|NCT01962298|468477653|FG001|Overall Study|Data quality insufficient|0|||
130141361|NCT01962298|468477654|FG002|Overall Study|Data quality insufficient|3|||
130141362|NCT01962298|468477655|FG003|Overall Study|Data quality insufficient|1|||
130141363|NCT01962298|468477656|FG004|Overall Study|Data quality insufficient|4|||
130141364|NCT01962298|468477652|FG000|Overall Study|Insufficient data|0|||
130141365|NCT01962298|468477653|FG001|Overall Study|Insufficient data|2|||
130141366|NCT01962298|468477654|FG002|Overall Study|Insufficient data|1|||
130141367|NCT01962298|468477655|FG003|Overall Study|Insufficient data|0|||
130141368|NCT01962298|468477656|FG004|Overall Study|Insufficient data|1|||
130141369|NCT01962298|468477652|FG000|Overall Study|Incorrect data recorded|0|||
130141370|NCT01962298|468477653|FG001|Overall Study|Incorrect data recorded|1|||
130141371|NCT01962298|468477654|FG002|Overall Study|Incorrect data recorded|0|||
130141372|NCT01962298|468477655|FG003|Overall Study|Incorrect data recorded|0|||
130141373|NCT01962298|468477656|FG004|Overall Study|Incorrect data recorded|0|||
130141374|NCT01962298|468477652|FG000|Overall Study|Physician Decision|0|||
130141375|NCT01962298|468477653|FG001|Overall Study|Physician Decision|1|||
130141376|NCT01962298|468477654|FG002|Overall Study|Physician Decision|0|||
130141377|NCT01962298|468477655|FG003|Overall Study|Physician Decision|0|||
130141378|NCT01962298|468477656|FG004|Overall Study|Physician Decision|1|||
130141379|NCT00533507|468477657|FG000|Overall Study|Withdrawal by Subject|1|||
130141380|NCT01576705|468477658|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
130141381|NCT01576705|468477659|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
130141382|NCT01576705|468477660|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
130141383|NCT01576705|468477661|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
130141384|NCT01576705|468477658|FG000|Overall Study|invalid ICF|0|||
130141385|NCT01576705|468477659|FG001|Overall Study|invalid ICF|1|||
130141386|NCT01576705|468477660|FG002|Overall Study|invalid ICF|0|||
130141387|NCT01576705|468477661|FG003|Overall Study|invalid ICF|0|||
130141388|NCT02896296|468477662|FG000|Overall Study|Adverse Event|1|||
130141389|NCT02896296|468477662|FG000|Overall Study|Lost to Follow-up|19|||
130141390|NCT02896296|468477662|FG000|Overall Study|Pregnancy|1|||
130141391|NCT02896296|468477662|FG000|Overall Study|Physician Decision|2|||
130141392|NCT02896296|468477662|FG000|Overall Study|Withdrawal by Subject|10|||
130141393|NCT02896296|468477662|FG000|Overall Study|Site closing|7|||
130141394|NCT02896296|468477662|FG000|Overall Study|Incarceration|1|||
130141395|NCT02896296|468477662|FG000|Overall Study|Relocation|1|||
130141396|NCT01874535|468477663|FG000|Overall Study|Lost to Follow-up|10|||
130141397|NCT01874535|468477664|FG001|Overall Study|Lost to Follow-up|9|||
130141398|NCT01874535|468477663|FG000|Overall Study|incomplete symptom resolution|45|||
130141399|NCT01874535|468477664|FG001|Overall Study|incomplete symptom resolution|35|||
130141400|NCT01215721|468477665|FG000|Overall Study|Adverse Event|2|||
130141401|NCT00045162|468477666|FG000|Overall Study|Ineligible|12|||
130141402|NCT00045162|468477667|FG001|Overall Study|Ineligible|8|||
130141403|NCT00045162|468477666|FG000|Overall Study|Not treated|7|||
130141404|NCT00045162|468477667|FG001|Overall Study|Not treated|2|||
130141405|NCT00045162|468477666|FG000|Overall Study|Adverse Event|55|||
130141406|NCT00045162|468477667|FG001|Overall Study|Adverse Event|50|||
130141407|NCT00045162|468477666|FG000|Overall Study|Lack of Efficacy|32|||
130141408|NCT00045162|468477667|FG001|Overall Study|Lack of Efficacy|29|||
130141409|NCT00045162|468477666|FG000|Overall Study|Death|10|||
130141410|NCT00045162|468477667|FG001|Overall Study|Death|10|||
130141411|NCT00045162|468477666|FG000|Overall Study|Withdrawal by Subject|5|||
130141412|NCT00045162|468477667|FG001|Overall Study|Withdrawal by Subject|3|||
130141413|NCT00045162|468477666|FG000|Overall Study|Other|21|||
130141414|NCT00045162|468477667|FG001|Overall Study|Other|16|||
130141415|NCT01044433|468477668|FG000|Overall Study|Lost to Follow-up|3|||
130141416|NCT01044433|468477668|FG000|Overall Study|Withdrawal by Subject|3|||
130141417|NCT02943096|468477669|FG000|Overall Study|Lack of Efficacy|0|||
130141418|NCT02943096|468477670|FG001|Overall Study|Lack of Efficacy|1|||
130141419|NCT05065619|468477671|FG000|Up to Day 42|Lost to Follow-up|1|||
130141420|NCT05065619|468477672|FG001|Up to Day 42|Lost to Follow-up|0|||
130141421|NCT05065619|468477671|FG000|Up to Day 42|Withdrawal by Subject|1|||
130141422|NCT05065619|468477672|FG001|Up to Day 42|Withdrawal by Subject|0|||
130141423|NCT05065619|468477671|FG000|After Day 43|Lost to Follow-up|1|||
130141424|NCT05065619|468477672|FG001|After Day 43|Lost to Follow-up|0|||
130141425|NCT05065619|468477671|FG000|After Day 43|Physician Decision|3|||
130141426|NCT05065619|468477672|FG001|After Day 43|Physician Decision|0|||
130141427|NCT05065619|468477671|FG000|After Day 43|Withdrawal by Subject|1|||
130141428|NCT05065619|468477672|FG001|After Day 43|Withdrawal by Subject|2|||
130141429|NCT05065619|468477671|FG000|After Day 43|Public vaccination|6|||
130141430|NCT05065619|468477672|FG001|After Day 43|Public vaccination|8|||
130141431|NCT05065619|468477671|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
130141432|NCT05065619|468477672|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
130141433|NCT05065619|468477671|FG000|After Day 43|Study Terminated by Sponsor|88|||
130141434|NCT05065619|468477672|FG001|After Day 43|Study Terminated by Sponsor|16|||
130141435|NCT00714051|468477678|FG000|Overall Study|Withdrawal by Subject|1|||
130141436|NCT00714051|468477679|FG001|Overall Study|Withdrawal by Subject|0|||
130141437|NCT00714051|468477678|FG000|Overall Study|Death|0|||
130141438|NCT00714051|468477679|FG001|Overall Study|Death|1|||
130141439|NCT02119936|468477688|FG000|Overall Study|Lost to Follow-up|10|||
130141440|NCT00570128|468477689|FG000|Overall Study|Adverse Event|1|||
130141441|NCT00570128|468477690|FG001|Overall Study|Adverse Event|0|||
130141442|NCT00570128|468477689|FG000|Overall Study|Lost to Follow-up|1|||
130141443|NCT00570128|468477690|FG001|Overall Study|Lost to Follow-up|0|||
130141444|NCT00570128|468477689|FG000|Overall Study|Withdrawal by Subject|2|||
130141445|NCT00570128|468477690|FG001|Overall Study|Withdrawal by Subject|0|||
130141446|NCT03868631|468477691|FG000|Baseline to Week 6|Adverse Event|0|||
130141447|NCT03868631|468477692|FG001|Baseline to Week 6|Adverse Event|3|||
130141448|NCT03868631|468477691|FG000|Baseline to Week 6|Protocol Violation|1|||
130141449|NCT03868631|468477692|FG001|Baseline to Week 6|Protocol Violation|1|||
130141450|NCT03868631|468477691|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
130141451|NCT03868631|468477692|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
130141452|NCT03868631|468477691|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
130141453|NCT03868631|468477692|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
130141454|NCT03868631|468477691|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
130141455|NCT03868631|468477692|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
130141456|NCT03868631|468477691|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
130141457|NCT03868631|468477692|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
130141458|NCT01929681|468477694|FG000|Overall Study|Withdrawal by Subject|1|||
130141459|NCT01929681|468477695|FG001|Overall Study|Withdrawal by Subject|0|||
130141460|NCT01929681|468477694|FG000|Overall Study|Physician Decision|1|||
130141461|NCT01929681|468477695|FG001|Overall Study|Physician Decision|1|||
130141462|NCT02218216|468477696|FG000|Overall Study|Study terminated before completed|6|||
130141463|NCT02218216|468477697|FG001|Overall Study|Study terminated before completed|0|||
130141464|NCT02218216|468477698|FG002|Overall Study|Study terminated before completed|0|||
130141465|NCT02452463|468477703|FG000|Overall Study|Death|1|||
130141466|NCT02452463|468477704|FG001|Overall Study|Death|0|||
130141467|NCT02452463|468477705|FG002|Overall Study|Death|0|||
130141468|NCT02452463|468477703|FG000|Overall Study|Study Suspended|1|||
130141469|NCT02452463|468477704|FG001|Overall Study|Study Suspended|0|||
130141470|NCT02452463|468477705|FG002|Overall Study|Study Suspended|0|||
130141471|NCT02452463|468477703|FG000|Overall Study|Recommended by DSMB|0|||
130141472|NCT02452463|468477704|FG001|Overall Study|Recommended by DSMB|1|||
130141473|NCT02452463|468477705|FG002|Overall Study|Recommended by DSMB|0|||
130141474|NCT02452463|468477703|FG000|Overall Study|Withdrawal by Subject|0|||
130141475|NCT02452463|468477704|FG001|Overall Study|Withdrawal by Subject|1|||
130141476|NCT02452463|468477705|FG002|Overall Study|Withdrawal by Subject|0|||
130141477|NCT05740098|468477706|FG000|Overall Study|Lost to Follow-up|26|||
130141478|NCT05740098|468477707|FG001|Overall Study|Lost to Follow-up|17|||
130141479|NCT05740098|468477708|FG002|Overall Study|Lost to Follow-up|21|||
130141480|NCT01073631|468477709|FG000|Overall Study|Death|82|||
130141481|NCT01073631|468477709|FG000|Overall Study|Adverse Event|24|||
130141482|NCT01073631|468477709|FG000|Overall Study|Other|63|||
130141483|NCT01528735|468477710|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
130141484|NCT01528735|468477711|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
130141485|NCT01528735|468477710|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
130141486|NCT01528735|468477711|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
130141487|NCT01426854|468477712|FG000|Overall Study|Adverse Event|1|||
130141488|NCT01426854|468477713|FG001|Overall Study|Adverse Event|5|||
130141489|NCT01426854|468477712|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
130141490|NCT01426854|468477713|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
130141491|NCT01426854|468477712|FG000|Overall Study|Lost to Follow-up|3|||
130141492|NCT01426854|468477713|FG001|Overall Study|Lost to Follow-up|0|||
130141493|NCT01426854|468477712|FG000|Overall Study|Noncompliance|0|||
130141494|NCT01426854|468477713|FG001|Overall Study|Noncompliance|1|||
130141495|NCT01426854|468477712|FG000|Overall Study|Treatment Failure|0|||
130141496|NCT01426854|468477713|FG001|Overall Study|Treatment Failure|16|||
130141497|NCT01426854|468477712|FG000|Overall Study|Protocol Deviation|0|||
130141498|NCT01426854|468477713|FG001|Overall Study|Protocol Deviation|1|||
130141499|NCT01426854|468477712|FG000|Overall Study|Other|3|||
130141500|NCT01426854|468477713|FG001|Overall Study|Other|2|||
130141501|NCT01971554|468477716|FG000|Overall Study|Lost to Follow-up|1|||
130141502|NCT01971554|468477717|FG001|Overall Study|Lost to Follow-up|0|||
130141503|NCT01971554|468477718|FG002|Overall Study|Lost to Follow-up|0|||
130141504|NCT01971554|468477719|FG003|Overall Study|Lost to Follow-up|0|||
130141505|NCT01942135|468477723|FG000|Overall Study|Adverse Event|21|||
130141506|NCT01942135|468477724|FG001|Overall Study|Adverse Event|7|||
130141507|NCT01942135|468477723|FG000|Overall Study|Global Deterioration of Health Status|9|||
130141508|NCT01942135|468477724|FG001|Overall Study|Global Deterioration of Health Status|6|||
130141509|NCT01942135|468477723|FG000|Overall Study|Randomized Not Treated|2|||
130141510|NCT01942135|468477724|FG001|Overall Study|Randomized Not Treated|2|||
130141511|NCT01942135|468477723|FG000|Overall Study|Death|2|||
130141512|NCT01942135|468477724|FG001|Overall Study|Death|1|||
130141513|NCT01942135|468477723|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
130141514|NCT01942135|468477724|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
130141515|NCT01942135|468477723|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
130141516|NCT01942135|468477724|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
130141517|NCT01942135|468477723|FG000|Overall Study|Withdrawal by Subject|4|||
130141518|NCT01942135|468477724|FG001|Overall Study|Withdrawal by Subject|3|||
130141519|NCT01942135|468477723|FG000|Overall Study|Protocol Violation|1|||
130141520|NCT01942135|468477724|FG001|Overall Study|Protocol Violation|0|||
130141521|NCT01942135|468477723|FG000|Overall Study|Other|19|||
130141522|NCT01942135|468477724|FG001|Overall Study|Other|4|||
130141523|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
130141524|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
130141525|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
130141526|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
130141527|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
130141528|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
130141529|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
130141530|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
130141531|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
130141532|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
130141533|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
130141534|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
130141535|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
130141536|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
130141537|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
130141538|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
130141539|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
130141540|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
130141541|NCT00950300|468477725|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
130141542|NCT00950300|468477726|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
130141543|NCT00950300|468477725|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
130141544|NCT00950300|468477726|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
130141545|NCT00950300|468477725|FG000|TFFU Period|Death|4|||
130141546|NCT00950300|468477726|FG001|TFFU Period|Death|1|||
130141547|NCT00950300|468477725|FG000|TFFU Period|Refused Treatment|10|||
130141548|NCT00950300|468477726|FG001|TFFU Period|Refused Treatment|11|||
130141549|NCT00950300|468477725|FG000|TFFU Period|Failure to Return|16|||
130141550|NCT00950300|468477726|FG001|TFFU Period|Failure to Return|16|||
130141551|NCT00950300|468477725|FG000|TFFU Period|Recurrence of Disease|63|||
130141552|NCT00950300|468477726|FG001|TFFU Period|Recurrence of Disease|72|||
130141553|NCT00950300|468477725|FG000|TFFU Period|Other|4|||
130141554|NCT00950300|468477726|FG001|TFFU Period|Other|3|||
130141555|NCT00950300|468477725|FG000|SFU Period|Death|44|||
130141556|NCT00950300|468477726|FG001|SFU Period|Death|42|||
130141557|NCT00950300|468477725|FG000|SFU Period|Lost to Follow-up|30|||
130141558|NCT00950300|468477726|FG001|SFU Period|Lost to Follow-up|28|||
130141559|NCT00950300|468477725|FG000|SFU Period|Withdrawal by Subject|4|||
130141560|NCT00950300|468477726|FG001|SFU Period|Withdrawal by Subject|8|||
130141561|NCT01717040|468477727|FG000|Overall Study|Lost to Follow-up|2|||
130141562|NCT01717040|468477728|FG001|Overall Study|Lost to Follow-up|3|||
130141563|NCT01717040|468477727|FG000|Overall Study|Lack of Efficacy|1|||
130141564|NCT01717040|468477728|FG001|Overall Study|Lack of Efficacy|1|||
130141565|NCT01717040|468477727|FG000|Overall Study|Adverse Event|1|||
130141566|NCT01717040|468477728|FG001|Overall Study|Adverse Event|0|||
130141567|NCT01717040|468477727|FG000|Overall Study|Required Medication Change|0|||
130141568|NCT01717040|468477728|FG001|Overall Study|Required Medication Change|1|||
130141569|NCT01717040|468477727|FG000|Overall Study|New Substance Use Disorder|1|||
130141570|NCT01717040|468477728|FG001|Overall Study|New Substance Use Disorder|0|||
130141571|NCT00494013|468477729|FG000|Overall Study|Adverse Event|0|||
130141572|NCT00494013|468477730|FG001|Overall Study|Adverse Event|1|||
130141573|NCT00494013|468477729|FG000|Overall Study|Entry Criteria Not Met|1|||
130141574|NCT00494013|468477730|FG001|Overall Study|Entry Criteria Not Met|4|||
130141575|NCT00494013|468477729|FG000|Overall Study|Lost to Follow-up|5|||
130141576|NCT00494013|468477730|FG001|Overall Study|Lost to Follow-up|6|||
130141577|NCT00494013|468477729|FG000|Overall Study|Physician Decision|3|||
130141578|NCT00494013|468477730|FG001|Overall Study|Physician Decision|5|||
130141579|NCT00494013|468477729|FG000|Overall Study|Protocol Violation|8|||
130141580|NCT00494013|468477730|FG001|Overall Study|Protocol Violation|5|||
130141581|NCT00494013|468477729|FG000|Overall Study|Withdrawal by Subject|13|||
130141582|NCT00494013|468477730|FG001|Overall Study|Withdrawal by Subject|14|||
130141583|NCT00494013|468477729|FG000|Overall Study|Sponsor Decision|0|||
130141584|NCT00494013|468477730|FG001|Overall Study|Sponsor Decision|1|||
130141585|NCT03193021|468477731|FG000|Overall Study|Lost to Follow-up|1|||
130141586|NCT03193021|468477732|FG001|Overall Study|Lost to Follow-up|1|||
130141587|NCT01139762|468477733|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
130141588|NCT01139762|468477734|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
130141589|NCT01139762|468477735|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
130141590|NCT01139762|468477733|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
130141591|NCT01139762|468477734|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
130141592|NCT01139762|468477735|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
130141593|NCT01139762|468477733|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
130141594|NCT01139762|468477734|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
130141595|NCT01139762|468477735|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
130141596|NCT01139762|468477733|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
130141597|NCT01139762|468477734|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
130141598|NCT01139762|468477735|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
130141599|NCT01139762|468477733|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
130141600|NCT01139762|468477734|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
130141601|NCT01139762|468477735|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
130141602|NCT01139762|468477733|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
130141603|NCT01139762|468477734|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
130141604|NCT01139762|468477735|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
130141605|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
130141606|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
130141607|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
130141608|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Death|0|||
130141609|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Death|1|||
130141610|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Death|1|||
130141611|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
130141612|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
130141613|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
130141614|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
130141615|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
130141616|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
130141617|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
130141618|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
130141619|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
130141620|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
130141621|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
130141622|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
130141623|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
130141624|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
130141625|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
130141626|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
130141627|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
130141628|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
130141629|NCT01139762|468477733|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
130141630|NCT01139762|468477734|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
130141631|NCT01139762|468477735|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
130141632|NCT04750239|468477736|FG000|Overall Study|Withdrawal by Subject|2|||
130141633|NCT04750239|468477736|FG000|Overall Study|Trial terminated by sponsor|1|||
130141634|NCT00903877|468477737|FG000|Overall Study|Did not meet study criteria|33|||
130141635|NCT00903877|468477737|FG000|Overall Study|Withdrawal by Subject|3|||
130141636|NCT00903877|468477737|FG000|Overall Study|Adverse Event|2|||
130141637|NCT00903877|468477737|FG000|Overall Study|Lost to Follow-up|1|||
130141638|NCT00903877|468477737|FG000|Overall Study|Participation put on hold|4|||
129976219|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
130141639|NCT00919711|468477738|FG000|Overall Study|Withdrawal by Subject|15|||
130141640|NCT00919711|468477739|FG001|Overall Study|Withdrawal by Subject|7|||
130141641|NCT00919711|468477738|FG000|Overall Study|Adverse Event|13|||
130141642|NCT00919711|468477739|FG001|Overall Study|Adverse Event|3|||
130141643|NCT00919711|468477738|FG000|Overall Study|Other|1|||
130141644|NCT00919711|468477739|FG001|Overall Study|Other|2|||
130141645|NCT00919711|468477738|FG000|Overall Study|Administrative Decision|0|||
130141646|NCT00919711|468477739|FG001|Overall Study|Administrative Decision|1|||
130141647|NCT00919711|468477738|FG000|Overall Study|Lost to Follow-up|2|||
130141648|NCT00919711|468477739|FG001|Overall Study|Lost to Follow-up|0|||
130141649|NCT00919711|468477738|FG000|Overall Study|Death|1|||
130141650|NCT00919711|468477739|FG001|Overall Study|Death|0|||
130141651|NCT00919711|468477738|FG000|Overall Study|Noncompliance|1|||
130141652|NCT00919711|468477739|FG001|Overall Study|Noncompliance|0|||
130141653|NCT00087529|468477740|FG000|Overall Study|Death|1|||
130141654|NCT00087529|468477741|FG001|Overall Study|Death|0|||
130141655|NCT00087529|468477740|FG000|Overall Study|Adverse Event|0|||
130141656|NCT00087529|468477741|FG001|Overall Study|Adverse Event|8|||
130141657|NCT00087529|468477740|FG000|Overall Study|Pregnancy|0|||
130141658|NCT00087529|468477741|FG001|Overall Study|Pregnancy|1|||
130141659|NCT00087529|468477740|FG000|Overall Study|Lost to Follow-up|2|||
130141660|NCT00087529|468477741|FG001|Overall Study|Lost to Follow-up|3|||
130141661|NCT00087529|468477740|FG000|Overall Study|Participant Decision|14|||
130141662|NCT00087529|468477741|FG001|Overall Study|Participant Decision|37|||
130141663|NCT00087529|468477740|FG000|Overall Study|Physician Decision|4|||
130141664|NCT00087529|468477741|FG001|Overall Study|Physician Decision|8|||
130141665|NCT00087529|468477740|FG000|Overall Study|Initiation of Excluded Therapy|0|||
130141666|NCT00087529|468477741|FG001|Overall Study|Initiation of Excluded Therapy|1|||
130141667|NCT00087529|468477740|FG000|Overall Study|Participant Noncompliance|0|||
130141668|NCT00087529|468477741|FG001|Overall Study|Participant Noncompliance|1|||
130141669|NCT00087529|468477740|FG000|Overall Study|Disease Progression|5|||
130141670|NCT00087529|468477741|FG001|Overall Study|Disease Progression|4|||
130141671|NCT00087529|468477740|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
130141672|NCT00087529|468477741|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
130141673|NCT00685334|468477744|FG000|Overall Study|Withdrawal by Subject|5|||
130141674|NCT00685334|468477745|FG001|Overall Study|Withdrawal by Subject|6|||
130141675|NCT00685334|468477744|FG000|Overall Study|Lost to Follow-up|4|||
130141676|NCT00685334|468477745|FG001|Overall Study|Lost to Follow-up|0|||
130141677|NCT00685334|468477744|FG000|Overall Study|Chose to enter hospital|1|||
130141678|NCT00685334|468477745|FG001|Overall Study|Chose to enter hospital|1|||
130141679|NCT01891357|468477746|FG000|Overall Study|Protocol Violation|3|||
130141680|NCT01894230|468479112|FG000|Overall Study|Lost to Follow-up|2|||
130141681|NCT01894230|468479113|FG001|Overall Study|Lost to Follow-up|2|||
130141682|NCT01894230|468479112|FG000|Overall Study|Withdrawal by Subject|4|||
130141683|NCT01894230|468479113|FG001|Overall Study|Withdrawal by Subject|4|||
130141684|NCT01894230|468479112|FG000|Overall Study|Non-adherent|0|||
130141685|NCT01894230|468479113|FG001|Overall Study|Non-adherent|1|||
130141686|NCT01894230|468479112|FG000|Overall Study|Death|1|||
130141687|NCT01894230|468479113|FG001|Overall Study|Death|0|||
130141688|NCT02300987|468479114|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
130141689|NCT02300987|468479115|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
130141690|NCT02300987|468479114|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
130141691|NCT02300987|468479115|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
130141692|NCT02300987|468479114|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
130141693|NCT02300987|468479115|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
130141694|NCT02300987|468479114|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
130141695|NCT02300987|468479115|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
130141696|NCT02300987|468479114|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
130141697|NCT02300987|468479115|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
130141698|NCT02488109|468479116|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
130141699|NCT02488109|468479117|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
130141700|NCT02488109|468479116|FG000|12-month Follow-Up|Lost to Follow-up|4|||
129976220|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976221|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
129976222|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976223|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976224|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976225|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130141701|NCT02488109|468479117|FG001|12-month Follow-Up|Lost to Follow-up|7|||
130141702|NCT01023061|468479118|FG000|Overall Study|Withdrawal prior to treatment|2|||
130141703|NCT02966340|468479119|FG000|Overall Study|Adverse Event|0|||
130141704|NCT02966340|468479120|FG001|Overall Study|Adverse Event|1|||
130141705|NCT02966340|468479119|FG000|Overall Study|Lost to Follow-up|0|||
130141706|NCT02966340|468479120|FG001|Overall Study|Lost to Follow-up|1|||
130141707|NCT02966340|468479119|FG000|Overall Study|Withdrawal by Subject|1|||
130141708|NCT02966340|468479120|FG001|Overall Study|Withdrawal by Subject|0|||
130141709|NCT02966340|468479119|FG000|Overall Study|data acquisition error|1|||
130141710|NCT02966340|468479120|FG001|Overall Study|data acquisition error|0|||
130141711|NCT02966340|468479119|FG000|Overall Study|startle non-responder|1|||
130141712|NCT02966340|468479120|FG001|Overall Study|startle non-responder|1|||
130141713|NCT00442351|468479123|FG000|Overall Study|Administrative|6|||
130141714|NCT00442351|468479124|FG001|Overall Study|Administrative|5|||
130141715|NCT00442351|468479123|FG000|Overall Study|Did not meet protocol eligibility|1|||
130141716|NCT00442351|468479124|FG001|Overall Study|Did not meet protocol eligibility|0|||
130141717|NCT00442351|468479123|FG000|Overall Study|Other|0|||
130141718|NCT00442351|468479124|FG001|Overall Study|Other|1|||
130141719|NCT02817828|468479127|FG000|Overall Study|Lost to Follow-up|41|||
130141720|NCT02817828|468479127|FG000|Overall Study|Adverse event not related to bleeding|104|||
130141721|NCT02817828|468479127|FG000|Overall Study|Adverse event related to bleeding|53|||
130141722|NCT02817828|468479127|FG000|Overall Study|Protocol Violation|11|||
130141723|NCT02817828|468479127|FG000|Overall Study|Pregnancy|7|||
130141724|NCT02817828|468479127|FG000|Overall Study|Pregnancy wish|15|||
130141725|NCT02817828|468479127|FG000|Overall Study|Withdrawal by Subject|78|||
130141726|NCT02817828|468479127|FG000|Overall Study|Other|26|||
130141727|NCT02651987|468479128|FG000|Overall Study|Adverse Event|2|||
130141728|NCT02651987|468479129|FG001|Overall Study|Adverse Event|2|||
130141729|NCT02651987|468479128|FG000|Overall Study|Consent Withdrawn|2|||
130141730|NCT02651987|468479129|FG001|Overall Study|Consent Withdrawn|0|||
130141731|NCT02651987|468479128|FG000|Overall Study|Local PD|0|||
130141732|NCT02651987|468479129|FG001|Overall Study|Local PD|2|||
130141733|NCT02651987|468479128|FG000|Overall Study|Investigator Decision|1|||
130141734|NCT02651987|468479129|FG001|Overall Study|Investigator Decision|1|||
130141735|NCT00522041|468479130|FG000|Overall Study|Adverse Event|9|||
130141736|NCT00522041|468479131|FG001|Overall Study|Adverse Event|3|||
130141737|NCT00522041|468479130|FG000|Overall Study|Protocol Violation|2|||
130141738|NCT00522041|468479131|FG001|Overall Study|Protocol Violation|0|||
130141739|NCT00522041|468479130|FG000|Overall Study|Lost to Follow-up|1|||
130141740|NCT00522041|468479131|FG001|Overall Study|Lost to Follow-up|4|||
130141741|NCT00522041|468479130|FG000|Overall Study|Voluntary withdrawal|5|||
130141742|NCT00522041|468479131|FG001|Overall Study|Voluntary withdrawal|4|||
130141743|NCT00522041|468479130|FG000|Overall Study|Did not receive treatment|0|||
130141744|NCT00522041|468479131|FG001|Overall Study|Did not receive treatment|1|||
130141745|NCT00486434|468479132|FG000|Overall Study|Withdrawal by Subject|34|||
130141746|NCT00486434|468479133|FG001|Overall Study|Withdrawal by Subject|39|||
130141747|NCT00486434|468479132|FG000|Overall Study|Adverse Event|118|||
130141748|NCT00486434|468479133|FG001|Overall Study|Adverse Event|44|||
130141749|NCT00486434|468479132|FG000|Overall Study|Protocol Violation|22|||
130141750|NCT00486434|468479133|FG001|Overall Study|Protocol Violation|21|||
130141751|NCT00486434|468479132|FG000|Overall Study|Lack of Efficacy|12|||
130141752|NCT00486434|468479133|FG001|Overall Study|Lack of Efficacy|19|||
130141753|NCT00486434|468479132|FG000|Overall Study|Lost to Follow-up|2|||
130141754|NCT00486434|468479133|FG001|Overall Study|Lost to Follow-up|3|||
130141755|NCT00486434|468479132|FG000|Overall Study|Death|1|||
130141756|NCT00486434|468479133|FG001|Overall Study|Death|2|||
130141757|NCT00486434|468479132|FG000|Overall Study|Personal reasons|5|||
130141758|NCT00486434|468479133|FG001|Overall Study|Personal reasons|6|||
130141759|NCT03387462|468479143|FG000|Overall Study|Lost to Follow-up|1|||
130141760|NCT01944722|468479148|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
130141761|NCT01944722|468479148|FG000|Overall Study|Specimen Shipping Issues|34|||
130141762|NCT01944722|468479148|FG000|Overall Study|Improper Storage/Transport|5|||
130141763|NCT01944722|468479148|FG000|Overall Study|Insufficient Volume for Test|1|||
130141764|NCT01944722|468479148|FG000|Overall Study|Missing Specimens|3|||
130141765|NCT01944722|468479148|FG000|Overall Study|Specimens Mislabeled|2|||
130141766|NCT01944722|468479148|FG000|Overall Study|Withdrawal by Subject|8|||
130141767|NCT01944722|468479148|FG000|Overall Study|NILM Subjects <30 years old|8106|||
130141768|NCT01944722|468479148|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
130141769|NCT01944722|468479148|FG000|Overall Study|>ASCUS Cytology|1122|||
130141770|NCT02906917|468479149|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
130141771|NCT02906917|468479150|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
129976226|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976227|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
130141772|NCT02906917|468479149|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
130141773|NCT02906917|468479150|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
130141774|NCT02906917|468479149|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
130141775|NCT02906917|468479150|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
130141776|NCT02906917|468479149|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
130141777|NCT02906917|468479150|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
130141778|NCT02906917|468479149|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
130141779|NCT02906917|468479150|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
130141780|NCT02906917|468479149|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
130141781|NCT02906917|468479150|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
130141782|NCT02906917|468479149|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
130141783|NCT02906917|468479150|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
130141784|NCT02906917|468479149|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
130141785|NCT02906917|468479150|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
130141786|NCT00210639|468479151|FG000|Overall Study|Lost to Follow-up|37|||
130141787|NCT00210639|468479152|FG001|Overall Study|Lost to Follow-up|29|||
130141788|NCT00210639|468479151|FG000|Overall Study|Withdrawal by Subject|8|||
130141789|NCT00210639|468479152|FG001|Overall Study|Withdrawal by Subject|1|||
130141790|NCT00210639|468479151|FG000|Overall Study|Other|18|||
130141791|NCT00210639|468479152|FG001|Overall Study|Other|12|||
130141792|NCT00874822|468479156|FG000|Overall Study|excluded by criteria|8|||
130141793|NCT02854800|468479157|FG000|Overall Study|Protocol Violation|16|||
130141794|NCT02854800|468479158|FG001|Overall Study|Protocol Violation|11|||
130141795|NCT02854800|468479159|FG002|Overall Study|Protocol Violation|3|||
130141796|NCT02854800|468479157|FG000|Overall Study|Withdrawal by Subject|4|||
130141797|NCT02854800|468479158|FG001|Overall Study|Withdrawal by Subject|2|||
130141798|NCT02854800|468479159|FG002|Overall Study|Withdrawal by Subject|3|||
130141799|NCT02627963|468479166|FG000|Overall Study|Randomized but not treated|2|||
130141800|NCT02627963|468479167|FG001|Overall Study|Randomized but not treated|6|||
130141801|NCT05278858|468479168|FG000|Overall Study|Withdrawal by Subject|1|||
130141802|NCT00503867|468479174|FG000|Overall Study|Lost to Follow-up|1|||
130141803|NCT00503867|468479174|FG000|Overall Study|Adverse Event|1|||
130141804|NCT04697173|468479177|FG000|Overall Study|Withdrawal by Subject|34|||
130141805|NCT04697173|468479178|FG001|Overall Study|Withdrawal by Subject|38|||
130141806|NCT03807440|468479179|FG000|Overall Study|No documentation of index date 2|320|||
130141807|NCT03807440|468479179|FG000|Overall Study|No informed consent for index date 2|117|||
130141808|NCT00323258|468479180|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
130141809|NCT00323258|468479181|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
130141810|NCT00323258|468479180|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
130141811|NCT00323258|468479181|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
130141812|NCT00323258|468479180|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
130141813|NCT00323258|468479181|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
130141814|NCT00323258|468479180|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
130141815|NCT00323258|468479181|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
130141816|NCT00323258|468479180|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
130141817|NCT00323258|468479181|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
130141818|NCT00323258|468479180|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
130141819|NCT00323258|468479181|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
130141820|NCT00323258|468479180|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
130141821|NCT00323258|468479181|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
130141822|NCT02372006|468479189|FG000|Overall Study|Progressive disease|8|||
130141823|NCT02372006|468479190|FG001|Overall Study|Progressive disease|7|||
130141824|NCT02372006|468479191|FG002|Overall Study|Progressive disease|34|||
130141825|NCT02372006|468479189|FG000|Overall Study|Dose limiting toxicity|0|||
130141826|NCT02372006|468479190|FG001|Overall Study|Dose limiting toxicity|1|||
130141827|NCT02372006|468479191|FG002|Overall Study|Dose limiting toxicity|0|||
130141828|NCT02372006|468479189|FG000|Overall Study|Adverse Event|0|||
130141829|NCT02372006|468479190|FG001|Overall Study|Adverse Event|0|||
129976228|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976229|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
129976230|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
129976231|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
129976232|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
129976233|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
129976234|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
129976235|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
129976236|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
129976237|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
129976238|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976239|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
129976240|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
129976241|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130141830|NCT02372006|468479191|FG002|Overall Study|Adverse Event|3|||
130141831|NCT02372006|468479189|FG000|Overall Study|Withdrawal by Subject|0|||
130141832|NCT02372006|468479190|FG001|Overall Study|Withdrawal by Subject|1|||
130141833|NCT02372006|468479191|FG002|Overall Study|Withdrawal by Subject|1|||
130141834|NCT02372006|468479189|FG000|Overall Study|Other reason for not completing|0|||
130141835|NCT02372006|468479190|FG001|Overall Study|Other reason for not completing|0|||
130141836|NCT02372006|468479191|FG002|Overall Study|Other reason for not completing|1|||
130141837|NCT03504085|468479194|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
130141838|NCT03504085|468479195|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
130141839|NCT03504085|468479194|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
130141840|NCT03504085|468479195|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
130141841|NCT04133311|468479196|FG000|Period 1 Double Masked Treatment Period|Death|1|||
130141842|NCT04133311|468479197|FG001|Period 1 Double Masked Treatment Period|Death|0|||
130141843|NCT04133311|468479198|FG002|Period 1 Double Masked Treatment Period|Death|0|||
130141844|NCT04133311|468479199|FG003|Period 1 Double Masked Treatment Period|Death|0|||
130141845|NCT04133311|468479196|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
130141846|NCT04133311|468479197|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
130141847|NCT04133311|468479198|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
130141848|NCT04133311|468479199|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
130141849|NCT04133311|468479196|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
130141850|NCT04133311|468479197|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
130141851|NCT04133311|468479198|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
130141852|NCT04133311|468479199|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
130141853|NCT04133311|468479196|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130141854|NCT04133311|468479197|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
130141855|NCT04133311|468479198|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130141856|NCT04133311|468479199|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
130141857|NCT04133311|468479196|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
130141858|NCT04133311|468479197|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
130141859|NCT04133311|468479198|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
130141860|NCT04133311|468479199|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
130141861|NCT04133311|468479196|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130141862|NCT04133311|468479197|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
130141863|NCT04133311|468479198|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
130141864|NCT04133311|468479199|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
130141865|NCT04133311|468479196|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
130141866|NCT04133311|468479197|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
130141867|NCT04133311|468479198|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
130141868|NCT04133311|468479199|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
130141869|NCT04133311|468479196|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
130141870|NCT04133311|468479197|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
130141871|NCT04133311|468479198|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
130141872|NCT04133311|468479199|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
130141873|NCT01926119|468479202|FG000|Overall Study|Withdrawal by Subject|1|||
130141874|NCT01859598|468479205|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
130141875|NCT03255980|468479208|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
130141876|NCT03255980|468479209|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
130141877|NCT03255980|468479210|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
130141878|NCT03255980|468479211|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
130141879|NCT03255980|468479208|FG000|Overall Study|Adverse Event|1|||
130141880|NCT03255980|468479209|FG001|Overall Study|Adverse Event|1|||
130141881|NCT03255980|468479210|FG002|Overall Study|Adverse Event|0|||
130141882|NCT03255980|468479211|FG003|Overall Study|Adverse Event|1|||
130141883|NCT03255980|468479208|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
130141884|NCT03255980|468479209|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
130141885|NCT03255980|468479210|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
130141886|NCT03255980|468479211|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
130141887|NCT03255980|468479208|FG000|Overall Study|Lost to Follow-up|1|||
130141888|NCT03255980|468479209|FG001|Overall Study|Lost to Follow-up|1|||
130141889|NCT03255980|468479210|FG002|Overall Study|Lost to Follow-up|0|||
130141890|NCT03255980|468479211|FG003|Overall Study|Lost to Follow-up|3|||
130141891|NCT03255980|468479208|FG000|Overall Study|Withdrawal by Subject|0|||
130141892|NCT03255980|468479209|FG001|Overall Study|Withdrawal by Subject|1|||
130141893|NCT03255980|468479210|FG002|Overall Study|Withdrawal by Subject|0|||
130141894|NCT03255980|468479211|FG003|Overall Study|Withdrawal by Subject|3|||
130141895|NCT02611362|468479212|FG000|Overall Study|Withdrawal by Subject|7|||
130141896|NCT02611362|468479213|FG001|Overall Study|Withdrawal by Subject|2|||
130141897|NCT02611362|468479212|FG000|Overall Study|Lost to Follow-up|2|||
130141898|NCT02611362|468479213|FG001|Overall Study|Lost to Follow-up|4|||
130141899|NCT01155531|468479214|FG000|Overall Study|Adverse Event|0|||
130141900|NCT01155531|468479215|FG001|Overall Study|Adverse Event|0|||
130141901|NCT01155531|468479216|FG002|Overall Study|Adverse Event|1|||
130141902|NCT01155531|468479217|FG003|Overall Study|Adverse Event|0|||
130141903|NCT01155531|468479214|FG000|Overall Study|Lost to Follow-up|0|||
130141904|NCT01155531|468479215|FG001|Overall Study|Lost to Follow-up|0|||
130141905|NCT01155531|468479216|FG002|Overall Study|Lost to Follow-up|0|||
130141906|NCT01155531|468479217|FG003|Overall Study|Lost to Follow-up|1|||
129976242|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
129976243|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976244|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
130141907|NCT01155531|468479214|FG000|Overall Study|Withdrawal by Subject|1|||
130141908|NCT01155531|468479215|FG001|Overall Study|Withdrawal by Subject|0|||
130141909|NCT01155531|468479216|FG002|Overall Study|Withdrawal by Subject|1|||
130141910|NCT01155531|468479217|FG003|Overall Study|Withdrawal by Subject|0|||
130141911|NCT00354159|468479218|FG000|Randomized Study Period|Withdrawal by Subject|5|||
130141912|NCT00354159|468479219|FG001|Randomized Study Period|Withdrawal by Subject|3|||
130141913|NCT00354159|468479218|FG000|Randomized Study Period|Physician Decision|6|||
130141914|NCT00354159|468479219|FG001|Randomized Study Period|Physician Decision|10|||
130141915|NCT00354159|468479218|FG000|Randomized Study Period|Lost to Follow-up|4|||
130141916|NCT00354159|468479219|FG001|Randomized Study Period|Lost to Follow-up|0|||
130141917|NCT00354159|468479218|FG000|Randomized Study Period|Death|7|||
130141918|NCT00354159|468479219|FG001|Randomized Study Period|Death|9|||
130141919|NCT00354159|468479218|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
130141920|NCT00354159|468479219|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
130141921|NCT00354159|468479218|FG000|Long-term Follow-up|Physician Decision|127|||
130141922|NCT00354159|468479219|FG001|Long-term Follow-up|Physician Decision|122|||
130141923|NCT00354159|468479218|FG000|Long-term Follow-up|Lost to Follow-up|1|||
130141924|NCT00354159|468479219|FG001|Long-term Follow-up|Lost to Follow-up|0|||
130141925|NCT00354159|468479218|FG000|Long-term Follow-up|Death|14|||
130141926|NCT00354159|468479219|FG001|Long-term Follow-up|Death|11|||
130141927|NCT00354159|468479218|FG000|Long-term Follow-up|Study Closed|29|||
130141928|NCT00354159|468479219|FG001|Long-term Follow-up|Study Closed|34|||
130141929|NCT01653704|468479220|FG000|Overall Study|Technical failure during recording|1|||
130141930|NCT01653704|468479221|FG001|Overall Study|Technical failure during recording|1|||
130141931|NCT01653704|468479220|FG000|Overall Study|Performance not reflective of training|1|||
130141932|NCT01653704|468479221|FG001|Overall Study|Performance not reflective of training|0|||
130141933|NCT01728116|468479224|FG000|Overall Study|Sponsor Terminated Study|106|||
130141934|NCT01728116|468479225|FG001|Overall Study|Sponsor Terminated Study|35|||
130141935|NCT01728116|468479224|FG000|Overall Study|Withdrawal by Subject|16|||
130141936|NCT01728116|468479225|FG001|Overall Study|Withdrawal by Subject|9|||
130141937|NCT01728116|468479224|FG000|Overall Study|Adverse Event|13|||
130141938|NCT01728116|468479225|FG001|Overall Study|Adverse Event|0|||
130141939|NCT01728116|468479224|FG000|Overall Study|Procedure/device failure|7|||
130141940|NCT01728116|468479225|FG001|Overall Study|Procedure/device failure|0|||
130141941|NCT01728116|468479224|FG000|Overall Study|Lost to Follow-up|9|||
130141942|NCT01728116|468479225|FG001|Overall Study|Lost to Follow-up|2|||
130141943|NCT01728116|468479224|FG000|Overall Study|Physician Decision|2|||
130141944|NCT01728116|468479225|FG001|Overall Study|Physician Decision|0|||
130141945|NCT01728116|468479224|FG000|Overall Study|Subject Non-Compliance|2|||
130141946|NCT01728116|468479225|FG001|Overall Study|Subject Non-Compliance|0|||
130141947|NCT01728116|468479224|FG000|Overall Study|Inter-current finding at procedure|1|||
130141948|NCT01728116|468479225|FG001|Overall Study|Inter-current finding at procedure|0|||
130141949|NCT01728116|468479224|FG000|Overall Study|Incorrectly enrolled in Study|0|||
130141950|NCT01728116|468479225|FG001|Overall Study|Incorrectly enrolled in Study|1|||
130141951|NCT01728116|468479224|FG000|Overall Study|various not noted previously|5|||
130141952|NCT01728116|468479225|FG001|Overall Study|various not noted previously|0|||
130141953|NCT00640341|468480545|FG000|Overall Study|Adverse Event|0|||
130141954|NCT00640341|468480546|FG001|Overall Study|Adverse Event|0|||
130141955|NCT00640341|468480547|FG002|Overall Study|Adverse Event|1|||
130141956|NCT00640341|468480545|FG000|Overall Study|Positive Slit Lamp Findings|0|||
130141957|NCT00640341|468480546|FG001|Overall Study|Positive Slit Lamp Findings|0|||
130141958|NCT00640341|468480547|FG002|Overall Study|Positive Slit Lamp Findings|1|||
130141959|NCT00640341|468480545|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
130141960|NCT00640341|468480546|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
130141961|NCT00640341|468480547|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
130141962|NCT00640341|468480545|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
130141963|NCT00640341|468480546|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
130141964|NCT00640341|468480547|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
130141965|NCT00640341|468480545|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
130141966|NCT00640341|468480546|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
130141967|NCT00640341|468480547|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
130141968|NCT00640341|468480545|FG000|Overall Study|Lost to Follow-up|2|||
130141969|NCT00640341|468480546|FG001|Overall Study|Lost to Follow-up|0|||
130141970|NCT00640341|468480547|FG002|Overall Study|Lost to Follow-up|0|||
130141971|NCT00640341|468480545|FG000|Overall Study|Withdrawal by Subject|4|||
130141972|NCT00640341|468480546|FG001|Overall Study|Withdrawal by Subject|0|||
130141973|NCT00640341|468480547|FG002|Overall Study|Withdrawal by Subject|1|||
130141974|NCT00640341|468480545|FG000|Overall Study|Unacceptable Lens Movement|1|||
130141975|NCT00640341|468480546|FG001|Overall Study|Unacceptable Lens Movement|0|||
130141976|NCT00640341|468480547|FG002|Overall Study|Unacceptable Lens Movement|0|||
130141977|NCT00640341|468480545|FG000|Overall Study|Poor fit/Uncomfortable|4|||
130141978|NCT00640341|468480546|FG001|Overall Study|Poor fit/Uncomfortable|0|||
130141979|NCT00640341|468480547|FG002|Overall Study|Poor fit/Uncomfortable|0|||
130141980|NCT00640341|468480545|FG000|Overall Study|Ineligable at Baseline|5|||
130141981|NCT00640341|468480546|FG001|Overall Study|Ineligable at Baseline|3|||
130141982|NCT00640341|468480547|FG002|Overall Study|Ineligable at Baseline|2|||
130141983|NCT00640341|468480545|FG000|Overall Study|Adverse event and positive slit lamp|1|||
130141984|NCT00640341|468480546|FG001|Overall Study|Adverse event and positive slit lamp|0|||
130141985|NCT00640341|468480547|FG002|Overall Study|Adverse event and positive slit lamp|0|||
130141986|NCT00660387|468480555|FG000|Overall Study|Adverse Event|1|||
130141987|NCT00660387|468480556|FG001|Overall Study|Adverse Event|2|||
130141988|NCT00660387|468480555|FG000|Overall Study|Lack of Efficacy|0|||
130141989|NCT00660387|468480556|FG001|Overall Study|Lack of Efficacy|1|||
130141990|NCT00660387|468480555|FG000|Overall Study|Protocol Violation|1|||
130141991|NCT00660387|468480556|FG001|Overall Study|Protocol Violation|0|||
130141992|NCT03086135|468480557|FG000|Overall Study|Adverse Event|1|||
130141993|NCT03086135|468480557|FG000|Overall Study|Lost to Follow-up|2|||
130141994|NCT01622660|468480560|FG000|Overall Study|Adverse Event|1|||
130141995|NCT04556734|468480561|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
130141996|NCT04556734|468480562|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130141997|NCT04556734|468480563|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
130141998|NCT04556734|468480564|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130141999|NCT04556734|468480565|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130142000|NCT04556734|468480566|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130142001|NCT04556734|468480567|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130142002|NCT04556734|468480568|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130142003|NCT04556734|468480561|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
130142004|NCT04556734|468480562|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142005|NCT04556734|468480563|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142006|NCT04556734|468480564|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142007|NCT04556734|468480565|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142008|NCT04556734|468480566|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142009|NCT04556734|468480567|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142010|NCT04556734|468480568|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
130142011|NCT04556734|468480561|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130142012|NCT04556734|468480562|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130142013|NCT04556734|468480563|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
130142014|NCT04556734|468480564|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130142015|NCT04556734|468480565|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130142016|NCT04556734|468480566|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130142017|NCT04556734|468480567|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130142018|NCT04556734|468480568|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
130142019|NCT04556734|468480561|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
130142020|NCT04556734|468480562|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142021|NCT04556734|468480563|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142022|NCT04556734|468480564|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142023|NCT04556734|468480565|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142024|NCT04556734|468480566|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142025|NCT04556734|468480567|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142026|NCT04556734|468480568|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
130142027|NCT04556734|468480561|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142028|NCT04556734|468480562|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142029|NCT04556734|468480563|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
130142030|NCT04556734|468480564|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142031|NCT04556734|468480565|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142032|NCT04556734|468480566|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142033|NCT04556734|468480567|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142034|NCT04556734|468480568|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
130142035|NCT04556734|468480561|FG000|OLE Period (28 Weeks)|Not reported|0|||
130142036|NCT04556734|468480562|FG001|OLE Period (28 Weeks)|Not reported|0|||
130142037|NCT04556734|468480563|FG002|OLE Period (28 Weeks)|Not reported|0|||
130142038|NCT04556734|468480564|FG003|OLE Period (28 Weeks)|Not reported|0|||
130142039|NCT04556734|468480565|FG004|OLE Period (28 Weeks)|Not reported|0|||
130142040|NCT04556734|468480566|FG005|OLE Period (28 Weeks)|Not reported|1|||
130142041|NCT04556734|468480567|FG006|OLE Period (28 Weeks)|Not reported|0|||
130142042|NCT04556734|468480568|FG007|OLE Period (28 Weeks)|Not reported|0|||
130142043|NCT04556734|468480561|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130142044|NCT04556734|468480562|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130142045|NCT04556734|468480563|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129976245|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976246|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976247|NCT00669877|467875782|FG000|Overall Study|Disease Progression/Death|4|||
129976248|NCT01427725|467875785|FG000|Overall Study|Lost to Follow-up|17|||
130142046|NCT04556734|468480564|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130142047|NCT04556734|468480565|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130142048|NCT04556734|468480566|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130142049|NCT04556734|468480567|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
130142050|NCT04556734|468480568|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
130142051|NCT04556734|468480561|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
129976249|NCT01427725|467875785|FG000|Overall Study|Protocol Violation|1|||
130142052|NCT04556734|468480562|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
130142053|NCT04556734|468480563|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
130142054|NCT04556734|468480564|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
130142055|NCT04556734|468480565|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
130142056|NCT04556734|468480566|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
130142057|NCT04556734|468480567|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
130142058|NCT04556734|468480568|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
130142059|NCT04556734|468480561|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130142060|NCT04556734|468480562|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130142061|NCT04556734|468480563|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130142062|NCT04556734|468480564|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130142063|NCT04556734|468480565|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
130142064|NCT04556734|468480566|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
130142065|NCT04556734|468480567|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
130142066|NCT04556734|468480568|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
130142067|NCT00820599|468480569|FG000|Overall Study|Death|129|||
130142068|NCT00820599|468480569|FG000|Overall Study|Withdrawal by Subject|2|||
130142069|NCT01120899|468480570|FG000|Overall Study|Withdrawal by Subject|3|||
130142070|NCT00202839|468480573|FG000|Overall Study|Adverse Event|1|||
130142071|NCT00202839|468480574|FG001|Overall Study|Adverse Event|5|||
130142072|NCT00202839|468480573|FG000|Overall Study|Physician Decision|12|||
130142073|NCT00202839|468480574|FG001|Overall Study|Physician Decision|0|||
130142074|NCT00202839|468480573|FG000|Overall Study|Withdrawal by Subject|6|||
130142075|NCT00202839|468480574|FG001|Overall Study|Withdrawal by Subject|2|||
130142076|NCT00202839|468480573|FG000|Overall Study|Protocol Violation|2|||
130142077|NCT00202839|468480574|FG001|Overall Study|Protocol Violation|1|||
130142078|NCT00202839|468480573|FG000|Overall Study|Lost to Follow-up|3|||
130142079|NCT00202839|468480574|FG001|Overall Study|Lost to Follow-up|2|||
130142080|NCT01813435|468480580|FG000|Overall Study|did not finish experimental regimen|1902|||
130142081|NCT01813435|468480581|FG001|Overall Study|did not finish experimental regimen|770|||
130142082|NCT01813435|468480580|FG000|Overall Study|Lost to Follow-up|268|||
130142083|NCT01813435|468480581|FG001|Overall Study|Lost to Follow-up|237|||
130142084|NCT03035890|468480582|FG000|Overall Study|Death|1|||
130142085|NCT00377156|468480585|FG000|Overall Study|Death|23|||
130142086|NCT00377156|468480586|FG001|Overall Study|Death|19|||
130142087|NCT00377156|468480585|FG000|Overall Study|Withdrawal by Subject|16|||
130142088|NCT00377156|468480586|FG001|Overall Study|Withdrawal by Subject|24|||
130142089|NCT00377156|468480585|FG000|Overall Study|Had follow-up <90 d|3|||
130142090|NCT00377156|468480586|FG001|Overall Study|Had follow-up <90 d|6|||
130142091|NCT00377156|468480585|FG000|Overall Study|Cancellation|1|||
130142092|NCT00377156|468480586|FG001|Overall Study|Cancellation|0|||
130142093|NCT00377156|468480585|FG000|Overall Study|Refused testing|0|||
130142094|NCT00377156|468480586|FG001|Overall Study|Refused testing|1|||
130142095|NCT00377156|468480585|FG000|Overall Study|Ineligible|0|||
130142096|NCT00377156|468480586|FG001|Overall Study|Ineligible|1|||
130142097|NCT00377156|468480585|FG000|Overall Study|Disability or language problem|0|||
130142098|NCT00377156|468480586|FG001|Overall Study|Disability or language problem|1|||
130142099|NCT00377156|468480585|FG000|Overall Study|Other|5|||
130142100|NCT00377156|468480586|FG001|Overall Study|Other|2|||
130142101|NCT00544167|468480587|FG000|Overall Study|Adverse Event|21|||
130142102|NCT00544167|468480587|FG000|Overall Study|Physician Decision|8|||
130142103|NCT00874549|468480588|FG000|Overall Study|Adverse Event|0|||
130142104|NCT00874549|468480589|FG001|Overall Study|Adverse Event|0|||
130142105|NCT00874549|468480590|FG002|Overall Study|Adverse Event|1|||
130142106|NCT00874549|468480591|FG003|Overall Study|Adverse Event|0|||
130142107|NCT00874549|468480588|FG000|Overall Study|Protocol Violation|1|||
130142108|NCT00874549|468480589|FG001|Overall Study|Protocol Violation|0|||
130142109|NCT00874549|468480590|FG002|Overall Study|Protocol Violation|2|||
130142110|NCT00874549|468480591|FG003|Overall Study|Protocol Violation|1|||
130142111|NCT00874549|468480588|FG000|Overall Study|Lost to Follow-up|0|||
130142112|NCT00874549|468480589|FG001|Overall Study|Lost to Follow-up|0|||
130142113|NCT00874549|468480590|FG002|Overall Study|Lost to Follow-up|1|||
130142114|NCT00874549|468480591|FG003|Overall Study|Lost to Follow-up|0|||
130142115|NCT00874549|468480588|FG000|Overall Study|Withdrawal by Subject|0|||
130142116|NCT00874549|468480589|FG001|Overall Study|Withdrawal by Subject|1|||
130142117|NCT00874549|468480590|FG002|Overall Study|Withdrawal by Subject|0|||
130142118|NCT00874549|468480591|FG003|Overall Study|Withdrawal by Subject|1|||
130142119|NCT01460628|468480597|FG000|Overall Study|Adverse Event|3|||
130142120|NCT01460628|468480597|FG000|Overall Study|Withdrawal by Subject|2|||
130142121|NCT04281472|468480598|FG000|Stage A|Lack of Efficacy|8|||
130142122|NCT04281472|468480599|FG001|Stage A|Lack of Efficacy|0|||
130142123|NCT04281472|468480600|FG002|Stage A|Lack of Efficacy|0|||
130142124|NCT04281472|468480598|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
130142125|NCT04281472|468480599|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130142126|NCT04281472|468480600|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130142127|NCT04281472|468480598|FG000|Stage A|Adverse Event|20|||
130142128|NCT04281472|468480599|FG001|Stage A|Adverse Event|0|||
130142129|NCT04281472|468480600|FG002|Stage A|Adverse Event|0|||
130142130|NCT04281472|468480598|FG000|Stage A|Death|1|||
130142131|NCT04281472|468480599|FG001|Stage A|Death|0|||
130142132|NCT04281472|468480600|FG002|Stage A|Death|0|||
130142133|NCT04281472|468480598|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
130142134|NCT04281472|468480599|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
130142135|NCT04281472|468480600|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
130142136|NCT04281472|468480598|FG000|Stage A|Lost to Follow-up|2|||
130142137|NCT04281472|468480599|FG001|Stage A|Lost to Follow-up|0|||
130142138|NCT04281472|468480600|FG002|Stage A|Lost to Follow-up|0|||
130142139|NCT04281472|468480598|FG000|Stage A|Non-compliance with study drug|1|||
130142140|NCT04281472|468480599|FG001|Stage A|Non-compliance with study drug|0|||
130142141|NCT04281472|468480600|FG002|Stage A|Non-compliance with study drug|0|||
130142142|NCT04281472|468480598|FG000|Stage A|Physician Decision|1|||
130142143|NCT04281472|468480599|FG001|Stage A|Physician Decision|0|||
130142144|NCT04281472|468480600|FG002|Stage A|Physician Decision|0|||
130142145|NCT04281472|468480598|FG000|Stage A|Prohibited medications|2|||
130142146|NCT04281472|468480599|FG001|Stage A|Prohibited medications|0|||
130142147|NCT04281472|468480600|FG002|Stage A|Prohibited medications|0|||
130142148|NCT04281472|468480598|FG000|Stage A|Withdrawal by Subject|11|||
130142149|NCT04281472|468480599|FG001|Stage A|Withdrawal by Subject|0|||
130142150|NCT04281472|468480600|FG002|Stage A|Withdrawal by Subject|0|||
130142151|NCT04281472|468480598|FG000|Stage A|Other|5|||
130142152|NCT04281472|468480599|FG001|Stage A|Other|0|||
130142153|NCT04281472|468480600|FG002|Stage A|Other|0|||
130142154|NCT04281472|468480598|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
130142155|NCT04281472|468480599|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
130142156|NCT04281472|468480600|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
130142157|NCT04281472|468480598|FG000|Stage B|Adverse Event|0|||
130142158|NCT04281472|468480599|FG001|Stage B|Adverse Event|3|||
130142159|NCT04281472|468480600|FG002|Stage B|Adverse Event|0|||
130142160|NCT04281472|468480598|FG000|Stage B|Death|0|||
130142161|NCT04281472|468480599|FG001|Stage B|Death|0|||
130142162|NCT04281472|468480600|FG002|Stage B|Death|1|||
130142163|NCT04281472|468480598|FG000|Stage B|Lack of Efficacy|0|||
130142164|NCT04281472|468480599|FG001|Stage B|Lack of Efficacy|0|||
130142165|NCT04281472|468480600|FG002|Stage B|Lack of Efficacy|1|||
130142166|NCT04281472|468480598|FG000|Stage B|Lost to Follow-up|0|||
130142167|NCT04281472|468480599|FG001|Stage B|Lost to Follow-up|0|||
130142168|NCT04281472|468480600|FG002|Stage B|Lost to Follow-up|2|||
130142169|NCT04281472|468480598|FG000|Stage B|Prohibited medications|0|||
130142170|NCT04281472|468480599|FG001|Stage B|Prohibited medications|2|||
130142171|NCT04281472|468480600|FG002|Stage B|Prohibited medications|1|||
130142172|NCT04281472|468480598|FG000|Stage B|Protocol Violation|0|||
130142173|NCT04281472|468480599|FG001|Stage B|Protocol Violation|1|||
130142174|NCT04281472|468480600|FG002|Stage B|Protocol Violation|1|||
130142175|NCT04281472|468480598|FG000|Stage B|Sponsor decision|0|||
130142176|NCT04281472|468480599|FG001|Stage B|Sponsor decision|0|||
130142177|NCT04281472|468480600|FG002|Stage B|Sponsor decision|1|||
130142178|NCT04281472|468480598|FG000|Stage B|Withdrawal by Subject|0|||
130142179|NCT04281472|468480599|FG001|Stage B|Withdrawal by Subject|3|||
130142180|NCT04281472|468480600|FG002|Stage B|Withdrawal by Subject|3|||
130142181|NCT04281472|468480598|FG000|Stage B|Other|0|||
130142182|NCT04281472|468480599|FG001|Stage B|Other|3|||
130142183|NCT04281472|468480600|FG002|Stage B|Other|0|||
130142184|NCT00152451|468480601|FG000|Overall Study|Adverse Event|4|||
130142185|NCT01055834|468480605|FG000|Treatment Period I|Adverse Event|1|||
130142186|NCT01055834|468480606|FG001|Treatment Period I|Adverse Event|0|||
130142187|NCT01717313|468480610|FG000|Phase A (Weeks 0 to 24)|Death|0|||
129976250|NCT01427725|467875785|FG000|Overall Study|Drug not administered|1|||
129976251|NCT01427725|467875785|FG000|Overall Study|Failure to visit|7|||
129976252|NCT01427725|467875785|FG000|Overall Study|Adverse Event|46|||
129976253|NCT01427725|467875785|FG000|Overall Study|Failure to visit after administration|40|||
129976254|NCT01427725|467875785|FG000|Overall Study|Patient's rejection|27|||
130142188|NCT01717313|468480611|FG001|Phase A (Weeks 0 to 24)|Death|1|||
130142189|NCT01717313|468480610|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
129976255|NCT01427725|467875785|FG000|Overall Study|Transfer to a different hospital|17|||
130142190|NCT01717313|468480611|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
130142191|NCT01717313|468480610|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
130142192|NCT01717313|468480611|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
130142193|NCT01717313|468480610|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
130142194|NCT01717313|468480611|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
130142195|NCT01717313|468480610|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
130142196|NCT01717313|468480611|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
130142197|NCT01717313|468480610|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
130142198|NCT01717313|468480611|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
130142199|NCT01717313|468480610|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
130142200|NCT01717313|468480611|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
130142201|NCT01717313|468480610|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
130142202|NCT01717313|468480611|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
130142203|NCT01717313|468480610|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
130142204|NCT01717313|468480611|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
130142205|NCT05004649|468480612|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
130142206|NCT05004649|468480612|FG000|Overall Study|Lost to Follow-up|1|||
130142207|NCT05004649|468480612|FG000|Overall Study|Withdrawal by Subject|2|||
130142208|NCT05004649|468480612|FG000|Overall Study|COVID-19|1|||
130142209|NCT00728754|468480613|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
130142210|NCT00728754|468480614|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
129976256|NCT01427725|467875785|FG000|Overall Study|Lack of Efficacy|8|||
129976257|NCT01427725|467875785|FG000|Overall Study|Death|7|||
130142211|NCT00728754|468480613|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
130142212|NCT00728754|468480614|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
130142213|NCT00728754|468480613|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
130142214|NCT00728754|468480614|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
130142215|NCT00009945|468480619|FG000|Overall Study|no follow up data|7|||
130142216|NCT00009945|468480620|FG001|Overall Study|no follow up data|5|||
130142217|NCT02654145|468480621|FG000|Overall Study|Lack of Efficacy|1|||
130142218|NCT02654145|468480621|FG000|Overall Study|Protocol Violation|1|||
130142219|NCT02654145|468480621|FG000|Overall Study|Withdrawal by Subject|5|||
130142220|NCT02637141|468480622|FG000|Overall Study|Adverse Event|1|||
130142221|NCT02637141|468480623|FG001|Overall Study|Adverse Event|1|||
130142222|NCT02637141|468480624|FG002|Overall Study|Adverse Event|0|||
130142223|NCT02637141|468480622|FG000|Overall Study|Withdrawal by Subject|1|||
130142224|NCT02637141|468480623|FG001|Overall Study|Withdrawal by Subject|1|||
130142225|NCT02637141|468480624|FG002|Overall Study|Withdrawal by Subject|1|||
130142226|NCT01943435|468480628|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
130142227|NCT01943435|468480629|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
130142228|NCT01943435|468480630|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
130142229|NCT01943435|468480628|FG000|Intervention Period|Withdrawal by Subject|3|||
130142230|NCT01943435|468480629|FG001|Intervention Period|Withdrawal by Subject|3|||
130142231|NCT01943435|468480630|FG002|Intervention Period|Withdrawal by Subject|4|||
130142232|NCT01943435|468480628|FG000|2 Month Follow up|Lost to Follow-up|2|||
130142233|NCT01943435|468480629|FG001|2 Month Follow up|Lost to Follow-up|3|||
130142234|NCT01943435|468480630|FG002|2 Month Follow up|Lost to Follow-up|0|||
130142235|NCT01943435|468480628|FG000|6 Month Follow up|Lost to Follow-up|12|||
130142236|NCT01943435|468480629|FG001|6 Month Follow up|Lost to Follow-up|7|||
130142237|NCT01943435|468480630|FG002|6 Month Follow up|Lost to Follow-up|15|||
130142238|NCT00295490|468480631|FG000|Overall Study|Protocol Violation|0|||
130142239|NCT00295490|468480632|FG001|Overall Study|Protocol Violation|0|||
130142240|NCT00295490|468480633|FG002|Overall Study|Protocol Violation|3|||
130142241|NCT00295490|468480634|FG003|Overall Study|Protocol Violation|3|||
130142242|NCT00295490|468480631|FG000|Overall Study|Withdrawal by Subject|0|||
130142243|NCT00295490|468480632|FG001|Overall Study|Withdrawal by Subject|2|||
130142244|NCT00295490|468480633|FG002|Overall Study|Withdrawal by Subject|0|||
130142245|NCT00295490|468480634|FG003|Overall Study|Withdrawal by Subject|1|||
130142246|NCT00295490|468480631|FG000|Overall Study|Lost to Follow-up|0|||
130142247|NCT00295490|468480632|FG001|Overall Study|Lost to Follow-up|0|||
130142248|NCT00295490|468480633|FG002|Overall Study|Lost to Follow-up|1|||
130142249|NCT00295490|468480634|FG003|Overall Study|Lost to Follow-up|0|||
130142250|NCT00295490|468480631|FG000|Overall Study|Adverse Event|1|||
130142251|NCT00295490|468480632|FG001|Overall Study|Adverse Event|0|||
130142252|NCT00295490|468480633|FG002|Overall Study|Adverse Event|0|||
130142253|NCT00295490|468480634|FG003|Overall Study|Adverse Event|0|||
130142254|NCT00295490|468480631|FG000|Overall Study|Other|0|||
130142255|NCT00295490|468480632|FG001|Overall Study|Other|2|||
130142256|NCT00295490|468480633|FG002|Overall Study|Other|0|||
130142257|NCT00295490|468480634|FG003|Overall Study|Other|1|||
130142258|NCT03885934|468480639|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
130142259|NCT03885934|468480640|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
130142260|NCT03885934|468480641|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
130142261|NCT03885934|468480642|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
130142262|NCT03885934|468480643|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
130142263|NCT03885934|468480644|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
130142264|NCT01617096|468480645|FG000|Overall Study|Withdrawal by Subject|96|||
130142265|NCT01617096|468480646|FG001|Overall Study|Withdrawal by Subject|81|||
130142266|NCT01617096|468480645|FG000|Overall Study|Lost to Follow-up|37|||
130142267|NCT01617096|468480646|FG001|Overall Study|Lost to Follow-up|32|||
130142268|NCT01617096|468480645|FG000|Overall Study|Physician Decision|10|||
130142269|NCT01617096|468480646|FG001|Overall Study|Physician Decision|18|||
130142270|NCT01617096|468480645|FG000|Overall Study|Death|4|||
130142271|NCT01617096|468480646|FG001|Overall Study|Death|3|||
130142272|NCT01617096|468480645|FG000|Overall Study|Other|1|||
130142273|NCT01617096|468480646|FG001|Overall Study|Other|3|||
130142274|NCT04473326|468480651|FG000|Overall Study|Death|0|||
130142275|NCT04473326|468480652|FG001|Overall Study|Death|1|||
130142276|NCT04473326|468480651|FG000|Overall Study|Withdrawal by Subject|1|||
130142277|NCT04473326|468480652|FG001|Overall Study|Withdrawal by Subject|2|||
130142278|NCT02046122|468480653|FG000|Overall Study|Physician Decision|8|||
130142279|NCT02046122|468480653|FG000|Overall Study|Withdrawal by Subject|1|||
130142280|NCT01532908|468480656|FG000|Overall Study|Not Transplanted|1|||
130142281|NCT01532908|468480657|FG001|Overall Study|Not Transplanted|0|||
130142282|NCT01196390|468480658|FG000|Overall Study|Protocol Violation|4|||
130142283|NCT01196390|468480659|FG001|Overall Study|Protocol Violation|5|||
130142284|NCT01559116|468480660|FG000|Overall Study|Adverse Event|10|||
130142285|NCT01559116|468480660|FG000|Overall Study|Lack of Efficacy|1|||
130142286|NCT01559116|468480660|FG000|Overall Study|Lost to Follow-up|1|||
130142287|NCT01559116|468480660|FG000|Overall Study|Protocol Violation|1|||
130142288|NCT01559116|468480660|FG000|Overall Study|Withdrawal by Subject|4|||
130142289|NCT01559116|468480660|FG000|Overall Study|other than stated above|9|||
130142290|NCT04610580|468480661|FG000|Two-way Crossover Period|Adverse Event|1|||
130142291|NCT04610580|468480662|FG001|Two-way Crossover Period|Adverse Event|0|||
130142292|NCT04610580|468480663|FG002|Two-way Crossover Period|Adverse Event|0|||
130142293|NCT04610580|468480664|FG003|Two-way Crossover Period|Adverse Event|0|||
130142294|NCT04610580|468480665|FG004|Two-way Crossover Period|Adverse Event|0|||
130142295|NCT04610580|468480666|FG005|Two-way Crossover Period|Adverse Event|0|||
130142296|NCT04610580|468480661|FG000|Two-way Crossover Period|Physician Decision|1|||
130142297|NCT04610580|468480662|FG001|Two-way Crossover Period|Physician Decision|0|||
130142298|NCT04610580|468480663|FG002|Two-way Crossover Period|Physician Decision|0|||
130142299|NCT04610580|468480664|FG003|Two-way Crossover Period|Physician Decision|0|||
130142300|NCT04610580|468480665|FG004|Two-way Crossover Period|Physician Decision|0|||
130142301|NCT04610580|468480666|FG005|Two-way Crossover Period|Physician Decision|0|||
130142302|NCT04610580|468480661|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
130142303|NCT04610580|468480662|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
130142304|NCT04610580|468480663|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
130142305|NCT04610580|468480664|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
130142306|NCT04610580|468480665|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
130142307|NCT04610580|468480666|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
130142308|NCT04610580|468480661|FG000|Two-way Crossover Period|Other than specified|0|||
130142309|NCT04610580|468480662|FG001|Two-way Crossover Period|Other than specified|1|||
130142310|NCT04610580|468480663|FG002|Two-way Crossover Period|Other than specified|0|||
130142311|NCT04610580|468480664|FG003|Two-way Crossover Period|Other than specified|0|||
130142312|NCT04610580|468480665|FG004|Two-way Crossover Period|Other than specified|0|||
130142313|NCT04610580|468480666|FG005|Two-way Crossover Period|Other than specified|0|||
130142314|NCT04610580|468480661|FG000|Washout Before Extension Period|Other than specified|0|||
130142315|NCT04610580|468480662|FG001|Washout Before Extension Period|Other than specified|1|||
130142316|NCT04610580|468480663|FG002|Washout Before Extension Period|Other than specified|0|||
130142317|NCT04610580|468480664|FG003|Washout Before Extension Period|Other than specified|0|||
130142318|NCT04610580|468480665|FG004|Washout Before Extension Period|Other than specified|0|||
130142319|NCT04610580|468480666|FG005|Washout Before Extension Period|Other than specified|0|||
130142320|NCT04610580|468480661|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
130142321|NCT04610580|468480662|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
130142322|NCT04610580|468480663|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
130142323|NCT04610580|468480664|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
130142324|NCT04610580|468480665|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
130142325|NCT04610580|468480666|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
130142326|NCT04610580|468480661|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130142327|NCT04610580|468480662|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130142328|NCT04610580|468480663|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130142329|NCT04610580|468480664|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130142330|NCT04610580|468480665|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
130142331|NCT04610580|468480666|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
130142332|NCT01097694|468480667|FG000|Overall Study|Adverse Event|5|||
130142333|NCT01097694|468480668|FG001|Overall Study|Adverse Event|0|||
130142334|NCT01097694|468480667|FG000|Overall Study|Lost to Follow-up|0|||
129976258|NCT01427725|467875785|FG000|Overall Study|Symptom improvement|6|||
130142335|NCT01097694|468480668|FG001|Overall Study|Lost to Follow-up|3|||
130142336|NCT01097694|468480667|FG000|Overall Study|Withdrawal by Subject|3|||
130142337|NCT01097694|468480668|FG001|Overall Study|Withdrawal by Subject|1|||
130142338|NCT02179190|468480669|FG000|Enrollment|Exit Prior to Device Attempt|11|||
130142339|NCT02179190|468480669|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
130142340|NCT02179190|468480669|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
130142341|NCT02179190|468480669|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
130142342|NCT02179190|468480669|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
130142343|NCT02179190|468480669|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
130142344|NCT02377349|468480670|FG000|Overall Study|Serious Adverse Event|1|||
130142345|NCT02377349|468480671|FG001|Overall Study|Serious Adverse Event|0|||
130142346|NCT02377349|468480670|FG000|Overall Study|Protocol Violation|3|||
130142347|NCT02377349|468480671|FG001|Overall Study|Protocol Violation|2|||
130142348|NCT02377349|468480670|FG000|Overall Study|Withdrawal by Subject|5|||
130142349|NCT02377349|468480671|FG001|Overall Study|Withdrawal by Subject|3|||
130142350|NCT02377349|468480670|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
130142351|NCT02377349|468480671|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
130142352|NCT02377349|468480670|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
130142353|NCT02377349|468480671|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
130142354|NCT02377349|468480670|FG000|Overall Study|Other|0|||
130142355|NCT02377349|468480671|FG001|Overall Study|Other|1|||
130142356|NCT01993940|468480674|FG000|Overall Study|Adverse Event|16|||
130142357|NCT01993940|468480675|FG001|Overall Study|Adverse Event|11|||
130142358|NCT01993940|468480674|FG000|Overall Study|Withdrawal by Subject|15|||
130142359|NCT01993940|468480675|FG001|Overall Study|Withdrawal by Subject|19|||
130142360|NCT01993940|468480674|FG000|Overall Study|Lost to Follow-up|2|||
130142361|NCT01993940|468480675|FG001|Overall Study|Lost to Follow-up|5|||
130142362|NCT01993940|468480674|FG000|Overall Study|Protocol Violation|5|||
130142363|NCT01993940|468480675|FG001|Overall Study|Protocol Violation|8|||
130142364|NCT01993940|468480674|FG000|Overall Study|Death|1|||
130142365|NCT01993940|468480675|FG001|Overall Study|Death|0|||
130142366|NCT01993940|468480674|FG000|Overall Study|Other - Miscellaneous|1|||
130142367|NCT01993940|468480675|FG001|Overall Study|Other - Miscellaneous|1|||
130142368|NCT03259165|468480676|FG000|Overall Study|COVID 19 pandemic|1|||
130142369|NCT03259165|468480677|FG001|Overall Study|COVID 19 pandemic|1|||
130142370|NCT01949532|468480678|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
130142371|NCT01949532|468480679|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
130142372|NCT00939523|468480684|FG000|Overall Study|Lack of Efficacy|1|||
130142373|NCT00939523|468480684|FG000|Overall Study|Physician Decision|2|||
130142374|NCT00024258|468480685|FG000|Overall Study|Withdrawal by Subject|1|||
130142375|NCT00024258|468480685|FG000|Overall Study|Disease Progression|8|||
130142376|NCT01050764|468480686|FG000|Overall Study|Death, before HSCT|1|||
130142377|NCT01050764|468480686|FG000|Overall Study|Donor mobilization failure, death|1|||
130142378|NCT01050764|468480686|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
130142379|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Adverse Event|8|||
130142380|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Adverse Event|5|||
130142381|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Adverse Event|9|||
130142382|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Adverse Event|0|||
130142383|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Adverse Event|0|||
130142384|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Adverse Event|0|||
130142385|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
130142386|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
130142387|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
130142388|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
130142389|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
130142390|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
130142391|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
130142392|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
130142393|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
130142394|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
130142395|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
130142396|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
130142397|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Physician Decision|4|||
130142398|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Physician Decision|0|||
130142399|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Physician Decision|2|||
130142400|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Physician Decision|0|||
130142401|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Physician Decision|0|||
130142402|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Physician Decision|0|||
130142403|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Pregnancy|1|||
130142404|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Pregnancy|2|||
130142405|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Pregnancy|0|||
130142406|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Pregnancy|0|||
130142407|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Pregnancy|0|||
130142408|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Pregnancy|0|||
130142409|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
130142410|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
130142411|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
130142412|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
130142413|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
130142414|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
130142415|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
130142416|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
130142417|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
130142418|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
130142419|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
130142420|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
130142421|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
130142422|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
130142423|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
130142424|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
130142425|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130142426|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
130142427|NCT02614196|468480689|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
130142428|NCT02614196|468480690|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
130142429|NCT02614196|468480691|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
130142430|NCT02614196|468480692|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
130142431|NCT02614196|468480693|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
130142432|NCT02614196|468480694|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
130142433|NCT02614196|468480689|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
130142434|NCT02614196|468480690|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130142435|NCT02614196|468480691|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
130142436|NCT02614196|468480692|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130142437|NCT02614196|468480693|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
130142438|NCT02614196|468480694|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
130142439|NCT02614196|468480689|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
130142440|NCT02614196|468480690|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
130142441|NCT02614196|468480691|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
130142442|NCT02614196|468480692|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
130142443|NCT02614196|468480693|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
130142444|NCT02614196|468480694|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
130142445|NCT02614196|468480689|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
130142446|NCT02614196|468480690|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
130142447|NCT02614196|468480691|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
130142448|NCT02614196|468480692|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
130142449|NCT02614196|468480693|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
130142450|NCT02614196|468480694|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
130142451|NCT02614196|468480689|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
130142452|NCT02614196|468480690|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130142453|NCT02614196|468480691|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
130142454|NCT02614196|468480692|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
130142455|NCT02614196|468480693|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130142456|NCT02614196|468480694|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
130142457|NCT00258856|468482373|FG000|Overall Study|Lost to Follow-up|1|||
130142458|NCT00258856|468482374|FG001|Overall Study|Lost to Follow-up|0|||
130142459|NCT00258856|468482375|FG002|Overall Study|Lost to Follow-up|2|||
130142460|NCT00258856|468482376|FG003|Overall Study|Lost to Follow-up|0|||
130142461|NCT00258856|468482373|FG000|Overall Study|Non-compliance|2|||
130142462|NCT00258856|468482374|FG001|Overall Study|Non-compliance|0|||
130142463|NCT00258856|468482375|FG002|Overall Study|Non-compliance|0|||
130142464|NCT00258856|468482376|FG003|Overall Study|Non-compliance|1|||
130142465|NCT01691430|468482377|FG000|Overall Study|Death|17|||
130142466|NCT01691430|468482378|FG001|Overall Study|Death|16|||
130142467|NCT01691430|468482377|FG000|Overall Study|Withdrawal by Subject|5|||
130142468|NCT01691430|468482378|FG001|Overall Study|Withdrawal by Subject|1|||
130142469|NCT01691430|468482377|FG000|Overall Study|Lost to Follow-up|0|||
130142470|NCT01691430|468482378|FG001|Overall Study|Lost to Follow-up|3|||
130142471|NCT02219009|468482381|FG000|Overall Study|Withdrawal by Subject|5|||
130142472|NCT02219009|468482382|FG001|Overall Study|Withdrawal by Subject|1|||
130142473|NCT02219009|468482381|FG000|Overall Study|Adverse Event|2|||
130142474|NCT02219009|468482382|FG001|Overall Study|Adverse Event|4|||
130142475|NCT02219009|468482381|FG000|Overall Study|Lost to Follow-up|2|||
130142476|NCT02219009|468482382|FG001|Overall Study|Lost to Follow-up|2|||
130142477|NCT02219009|468482381|FG000|Overall Study|Protocol deviation|1|||
130142478|NCT02219009|468482382|FG001|Overall Study|Protocol deviation|0|||
130142479|NCT02219009|468482381|FG000|Overall Study|Physician Decision|0|||
130142480|NCT02219009|468482382|FG001|Overall Study|Physician Decision|1|||
130142481|NCT00762411|468482383|FG000|Initial Treatment|Death|7|||
129976259|NCT01427725|467875785|FG000|Overall Study|AE and Patient's rejection|5|||
129976260|NCT01427725|467875785|FG000|Overall Study|Physician Decision|5|||
130142482|NCT00762411|468482384|FG001|Initial Treatment|Death|6|||
129976261|NCT01427725|467875785|FG000|Overall Study|Exacerbation of underlying disease|5|||
129976262|NCT01427725|467875785|FG000|Overall Study|Oral feeding difficulty|5|||
130142483|NCT00762411|468482383|FG000|Initial Treatment|Adverse Event|132|||
130142484|NCT00762411|468482384|FG001|Initial Treatment|Adverse Event|40|||
130142485|NCT00762411|468482383|FG000|Initial Treatment|Protocol Violation|4|||
130142486|NCT00762411|468482384|FG001|Initial Treatment|Protocol Violation|1|||
130142487|NCT00762411|468482383|FG000|Initial Treatment|Withdrawal by Subject|65|||
130142488|NCT00762411|468482384|FG001|Initial Treatment|Withdrawal by Subject|52|||
129976263|NCT01427725|467875785|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
130142489|NCT00762411|468482383|FG000|Initial Treatment|Physician Decision|1|||
130142490|NCT00762411|468482384|FG001|Initial Treatment|Physician Decision|0|||
130142491|NCT00762411|468482383|FG000|Initial Treatment|Sponsor Decision|293|||
130142492|NCT00762411|468482384|FG001|Initial Treatment|Sponsor Decision|401|||
130142493|NCT00762411|468482383|FG000|Initial Treatment|Lost to Follow-up|5|||
130142494|NCT00762411|468482384|FG001|Initial Treatment|Lost to Follow-up|0|||
130142495|NCT00762411|468482383|FG000|Initial Treatment|Caregiver Decision|21|||
130142496|NCT00762411|468482384|FG001|Initial Treatment|Caregiver Decision|16|||
130142497|NCT00762411|468482383|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
130142498|NCT00762411|468482384|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
130142499|NCT00762411|468482383|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
130142500|NCT00762411|468482384|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
130142501|NCT00762411|468482383|FG000|Delayed Start|Adverse Event|0|||
130142502|NCT00762411|468482384|FG001|Delayed Start|Adverse Event|4|||
130142503|NCT00762411|468482383|FG000|Delayed Start|Protocol Violation|0|||
130142504|NCT00762411|468482384|FG001|Delayed Start|Protocol Violation|1|||
130142505|NCT00762411|468482383|FG000|Delayed Start|Sponsor Decision|16|||
130142506|NCT00762411|468482384|FG001|Delayed Start|Sponsor Decision|20|||
130142507|NCT00762411|468482383|FG000|Delayed Start|Caregiver Decision|1|||
130142508|NCT00762411|468482384|FG001|Delayed Start|Caregiver Decision|1|||
130142509|NCT00762411|468482383|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
130142510|NCT00762411|468482384|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
130142511|NCT00762411|468482383|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
130142512|NCT00762411|468482384|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
130142513|NCT00762411|468482383|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
130142514|NCT00762411|468482384|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
130142515|NCT00762411|468482383|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
130142516|NCT00762411|468482384|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
130142517|NCT00762411|468482383|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
130142518|NCT00762411|468482384|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
130142519|NCT00762411|468482383|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
130142520|NCT00762411|468482384|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
130142521|NCT02259348|468482387|FG000|Overall Study|Donors|6|||
130142522|NCT02259348|468482387|FG000|Overall Study|Death|4|||
130142523|NCT04211766|468482388|FG000|Overall Study|Withdrawal by Subject|5|||
130142524|NCT04211766|468482389|FG001|Overall Study|Withdrawal by Subject|1|||
130142525|NCT04590781|468482391|FG000|Overall Study|Death|0|||
130142526|NCT04590781|468482392|FG001|Overall Study|Death|2|||
130142527|NCT04590781|468482391|FG000|Overall Study|Withdrawal by Subject|2|||
130142528|NCT04590781|468482392|FG001|Overall Study|Withdrawal by Subject|0|||
130142529|NCT01680016|468482395|FG000|Overall Study|Adverse Event|0|||
130142530|NCT01680016|468482396|FG001|Overall Study|Adverse Event|0|||
130142531|NCT01680016|468482397|FG002|Overall Study|Adverse Event|1|||
130142532|NCT01680016|468482398|FG003|Overall Study|Adverse Event|4|||
130142533|NCT01680016|468482395|FG000|Overall Study|The Subject went out of The Trial|1|||
130142534|NCT01680016|468482396|FG001|Overall Study|The Subject went out of The Trial|0|||
130142535|NCT01680016|468482397|FG002|Overall Study|The Subject went out of The Trial|3|||
130142536|NCT01680016|468482398|FG003|Overall Study|The Subject went out of The Trial|0|||
130142537|NCT01680016|468482395|FG000|Overall Study|Protocol Violation|0|||
130142538|NCT01680016|468482396|FG001|Overall Study|Protocol Violation|1|||
130142539|NCT01680016|468482397|FG002|Overall Study|Protocol Violation|0|||
130142540|NCT01680016|468482398|FG003|Overall Study|Protocol Violation|0|||
130142541|NCT01680016|468482395|FG000|Overall Study|Withdrawal by Subject|5|||
130142542|NCT01680016|468482396|FG001|Overall Study|Withdrawal by Subject|7|||
130142543|NCT01680016|468482397|FG002|Overall Study|Withdrawal by Subject|1|||
130142544|NCT01680016|468482398|FG003|Overall Study|Withdrawal by Subject|1|||
130142545|NCT03686215|468482399|FG000|Overall Study|Adverse Event|0|||
130142546|NCT03686215|468482400|FG001|Overall Study|Adverse Event|0|||
130142547|NCT03686215|468482401|FG002|Overall Study|Adverse Event|7|||
130142548|NCT03686215|468482399|FG000|Overall Study|Physician Decision|0|||
130142549|NCT03686215|468482400|FG001|Overall Study|Physician Decision|0|||
130142550|NCT03686215|468482401|FG002|Overall Study|Physician Decision|1|||
130142551|NCT03686215|468482399|FG000|Overall Study|Protocol Violation|0|||
130142552|NCT03686215|468482400|FG001|Overall Study|Protocol Violation|0|||
130142553|NCT03686215|468482401|FG002|Overall Study|Protocol Violation|4|||
130142554|NCT03686215|468482399|FG000|Overall Study|Device issue|1|||
130142555|NCT03686215|468482400|FG001|Overall Study|Device issue|0|||
130142556|NCT03686215|468482401|FG002|Overall Study|Device issue|2|||
130142557|NCT02485158|468482402|FG000|Overall Study|Withdrawal by Subject|3|||
130142558|NCT02485158|468482402|FG000|Overall Study|expected drug side effect|1|||
130142559|NCT02846883|468482405|FG000|Overall Study|Death|0|||
130142560|NCT02846883|468482406|FG001|Overall Study|Death|1|||
130142561|NCT02846883|468482407|FG002|Overall Study|Death|1|||
130142562|NCT02846883|468482405|FG000|Overall Study|Lost to Follow-up|0|||
130142563|NCT02846883|468482406|FG001|Overall Study|Lost to Follow-up|0|||
130142564|NCT02846883|468482407|FG002|Overall Study|Lost to Follow-up|1|||
130142565|NCT02846883|468482405|FG000|Overall Study|Withdrawal by Subject|1|||
130142566|NCT02846883|468482406|FG001|Overall Study|Withdrawal by Subject|0|||
130142567|NCT02846883|468482407|FG002|Overall Study|Withdrawal by Subject|0|||
130142568|NCT02846883|468482405|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
130142569|NCT02846883|468482406|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
130142570|NCT02846883|468482407|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
130142571|NCT02846883|468482405|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
130142572|NCT02846883|468482406|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
130142573|NCT02846883|468482407|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
130142574|NCT00927251|468482408|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
130142575|NCT01098851|468482409|FG000|Overall Study|Equipment failure|1|||
130142576|NCT01098851|468482410|FG001|Overall Study|Equipment failure|0|||
130142577|NCT00452348|468482413|FG000|Overall Study|Adverse Event|6|||
130142578|NCT00452348|468482414|FG001|Overall Study|Adverse Event|9|||
130142579|NCT00452348|468482413|FG000|Overall Study|Lack of Efficacy|10|||
130142580|NCT00452348|468482414|FG001|Overall Study|Lack of Efficacy|9|||
130142581|NCT00452348|468482413|FG000|Overall Study|Lost to Follow-up|14|||
130142582|NCT00452348|468482414|FG001|Overall Study|Lost to Follow-up|8|||
130142583|NCT00452348|468482413|FG000|Overall Study|Protocol Violation|22|||
130142584|NCT00452348|468482414|FG001|Overall Study|Protocol Violation|28|||
130142585|NCT00452348|468482413|FG000|Overall Study|Withdrawal by Subject|18|||
130142586|NCT00452348|468482414|FG001|Overall Study|Withdrawal by Subject|21|||
130142587|NCT00452348|468482413|FG000|Overall Study|Other|9|||
130142588|NCT00452348|468482414|FG001|Overall Study|Other|9|||
130142589|NCT01490190|468482415|FG000|Overall Study|Withdrawal by Subject|9|||
130142590|NCT01490190|468482415|FG000|Overall Study|Adverse Event|17|||
130142591|NCT01490190|468482415|FG000|Overall Study|Protocol Violation|5|||
130142592|NCT01490190|468482415|FG000|Overall Study|Lost to Follow-up|13|||
130142593|NCT01490190|468482415|FG000|Overall Study|Relocation|1|||
130142594|NCT01490190|468482415|FG000|Overall Study|Inconvenience|1|||
130142595|NCT01490190|468482415|FG000|Overall Study|Ring expulsion|2|||
130142596|NCT00960154|468482421|FG000|Overall Study|Study termination|25|||
130142597|NCT00960154|468482422|FG001|Overall Study|Study termination|25|||
130142598|NCT00288704|468482425|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
130142599|NCT00288704|468482426|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
130142600|NCT00288704|468482427|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
130142601|NCT00288704|468482425|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
130142602|NCT00288704|468482426|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
130142603|NCT00288704|468482427|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
130142604|NCT00288704|468482425|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
130142605|NCT00288704|468482426|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
130142606|NCT00288704|468482427|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
130142607|NCT00288704|468482425|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
130142608|NCT00288704|468482426|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
130142609|NCT00288704|468482427|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
130142610|NCT00288704|468482425|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
130142611|NCT00288704|468482426|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
130142612|NCT00288704|468482427|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
130142613|NCT00288704|468482425|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
130142614|NCT00288704|468482426|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
130142615|NCT00288704|468482427|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
130142616|NCT00288704|468482425|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
130142617|NCT00288704|468482426|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
130142618|NCT00288704|468482427|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
130142619|NCT01579006|468482428|FG000|Overall Study|Lack of Efficacy|10|||
130142620|NCT01579006|468482428|FG000|Overall Study|Adverse Event|13|||
130142621|NCT01579006|468482428|FG000|Overall Study|Withdrawal by Subject|5|||
130142622|NCT01579006|468482428|FG000|Overall Study|Non-compliance|3|||
130142623|NCT01579006|468482428|FG000|Overall Study|Due to participant's health fund|1|||
130142624|NCT01579006|468482428|FG000|Overall Study|Scheduled surgery|1|||
130142625|NCT00856349|468482429|FG000|Overall Study|Death|418|||
130142626|NCT00856349|468482429|FG000|Overall Study|Withdrawal by Subject|116|||
130142627|NCT00856349|468482429|FG000|Overall Study|Lost to Follow-up|91|||
130142628|NCT00856349|468482429|FG000|Overall Study|Protocol Violation|38|||
130142629|NCT00856349|468482429|FG000|Overall Study|Physician Decision|13|||
130142630|NCT00856349|468482429|FG000|Overall Study|Subject relocation|104|||
130142631|NCT00856349|468482429|FG000|Overall Study|Device explant|33|||
130142632|NCT00856349|468482429|FG000|Overall Study|Site closure|78|||
130142633|NCT00856349|468482429|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
130142634|NCT02725515|468482430|FG000|Overall Study|Refused infusion (no study treatment)|1|||
130142635|NCT02725515|468482431|FG001|Overall Study|Refused infusion (no study treatment)|0|||
130142636|NCT02725515|468482430|FG000|Overall Study|Loss of Improvement per Protocol|14|||
130142637|NCT02725515|468482431|FG001|Overall Study|Loss of Improvement per Protocol|25|||
130142638|NCT02725515|468482430|FG000|Overall Study|Withdrawal by Subject|2|||
130142639|NCT02725515|468482431|FG001|Overall Study|Withdrawal by Subject|1|||
130142640|NCT02725515|468482430|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130142641|NCT02725515|468482431|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130142642|NCT02725515|468482430|FG000|Overall Study|Lost to Follow-up|1|||
130142643|NCT02725515|468482431|FG001|Overall Study|Lost to Follow-up|1|||
130142644|NCT02725515|468482430|FG000|Overall Study|Adverse Event|7|||
130142645|NCT02725515|468482431|FG001|Overall Study|Adverse Event|2|||
130142646|NCT02725515|468482430|FG000|Overall Study|No Documented Disease Improvement|0|||
130142647|NCT02725515|468482431|FG001|Overall Study|No Documented Disease Improvement|1|||
130142648|NCT02725515|468482430|FG000|Overall Study|Completed Study Under Original Protocol|0|||
130142649|NCT02725515|468482431|FG001|Overall Study|Completed Study Under Original Protocol|1|||
130142650|NCT02725515|468482430|FG000|Overall Study|Lack of Response|0|||
130142651|NCT02725515|468482431|FG001|Overall Study|Lack of Response|1|||
130142652|NCT02697617|468482441|FG000|Overall Study|Withdrawal by Subject|0|||
130142653|NCT02697617|468482442|FG001|Overall Study|Withdrawal by Subject|2|||
130142654|NCT02697617|468482441|FG000|Overall Study|Pregnancy|1|||
130142655|NCT02697617|468482442|FG001|Overall Study|Pregnancy|0|||
130142656|NCT02460835|468482443|FG000|Overall Study|Disease progression prior to treatment|3|||
130142657|NCT02460835|468482443|FG000|Overall Study|Unable to complete planning scans|2|||
130142658|NCT02460835|468482443|FG000|Overall Study|Decrease in performance status|1|||
130142659|NCT02460835|468482443|FG000|Overall Study|Withdrawal by Subject|3|||
130142660|NCT02460835|468482443|FG000|Overall Study|Underwent fractionated RT|10|||
130142661|NCT02460835|468482443|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
130142662|NCT01157234|468482444|FG000|Overall Study|Withdrawal by Subject|1|||
130142663|NCT01157234|468482445|FG001|Overall Study|Withdrawal by Subject|0|||
130142664|NCT00517192|468482449|FG000|Overall Study|Adverse Event|1|||
130142665|NCT00517192|468482450|FG001|Overall Study|Adverse Event|1|||
130142666|NCT00517192|468482449|FG000|Overall Study|Lost to Follow-up|1|||
130142667|NCT00517192|468482450|FG001|Overall Study|Lost to Follow-up|1|||
130142668|NCT00517192|468482449|FG000|Overall Study|Withdrawal by Subject|1|||
130142669|NCT00517192|468482450|FG001|Overall Study|Withdrawal by Subject|0|||
130142670|NCT00517192|468482449|FG000|Overall Study|Early termination of the trial|16|||
130142671|NCT00517192|468482450|FG001|Overall Study|Early termination of the trial|18|||
130142672|NCT02733627|468482451|FG000|Overall Study|Adverse Event|0|||
130142673|NCT02733627|468482452|FG001|Overall Study|Adverse Event|1|||
130142674|NCT02733627|468482453|FG002|Overall Study|Adverse Event|1|||
130142675|NCT02733627|468482454|FG003|Overall Study|Adverse Event|0|||
130142676|NCT02733627|468482451|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130142677|NCT02733627|468482452|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130142678|NCT02733627|468482453|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
130142679|NCT02733627|468482454|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
130142680|NCT00183196|468482455|FG000|Overall Study|Withdrawal by Subject|18|||
130142681|NCT00183196|468482456|FG001|Overall Study|Withdrawal by Subject|11|||
130142682|NCT00183196|468482457|FG002|Overall Study|Withdrawal by Subject|13|||
130142683|NCT00183196|468482455|FG000|Overall Study|Adverse Event|1|||
130142684|NCT00183196|468482456|FG001|Overall Study|Adverse Event|2|||
130142685|NCT00183196|468482457|FG002|Overall Study|Adverse Event|2|||
130142686|NCT00183196|468482455|FG000|Overall Study|Legal event|1|||
130142687|NCT00183196|468482456|FG001|Overall Study|Legal event|1|||
130142688|NCT00183196|468482457|FG002|Overall Study|Legal event|1|||
130142689|NCT00183196|468482455|FG000|Overall Study|Required more intensive care|0|||
130142690|NCT00183196|468482456|FG001|Overall Study|Required more intensive care|1|||
130142691|NCT00183196|468482457|FG002|Overall Study|Required more intensive care|2|||
130142692|NCT01513239|468482458|FG000|Period 1: Main Phase|Adverse Event|1|||
130142693|NCT01513239|468482459|FG001|Period 1: Main Phase|Adverse Event|1|||
130142694|NCT01513239|468482460|FG002|Period 1: Main Phase|Adverse Event|2|||
130142695|NCT01513239|468482461|FG003|Period 1: Main Phase|Adverse Event|0|||
129976264|NCT01427725|467875785|FG000|Overall Study|Forgetting prescription|1|||
129976265|NCT01427725|467875785|FG000|Overall Study|Other|2|||
129976266|NCT01277887|467875787|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
130142696|NCT01513239|468482462|FG004|Period 1: Main Phase|Adverse Event|0|||
130142697|NCT01513239|468482463|FG005|Period 1: Main Phase|Adverse Event|0|||
130142698|NCT01513239|468482458|FG000|Period 1: Main Phase|Death|29|||
130142699|NCT01513239|468482459|FG001|Period 1: Main Phase|Death|22|||
130142700|NCT01513239|468482460|FG002|Period 1: Main Phase|Death|32|||
130142701|NCT01513239|468482461|FG003|Period 1: Main Phase|Death|0|||
130142702|NCT01513239|468482462|FG004|Period 1: Main Phase|Death|0|||
130142703|NCT01513239|468482463|FG005|Period 1: Main Phase|Death|0|||
130142704|NCT01513239|468482458|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
130142705|NCT01513239|468482459|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
129976267|NCT01277887|467875788|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
129976268|NCT01277887|467875787|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
130142706|NCT01513239|468482460|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
130142707|NCT01513239|468482461|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
130142708|NCT01513239|468482462|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
130142709|NCT01513239|468482463|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
130142710|NCT01513239|468482458|FG000|Period 1: Main Phase|Physician Decision|4|||
130142711|NCT01513239|468482459|FG001|Period 1: Main Phase|Physician Decision|4|||
130142712|NCT01513239|468482460|FG002|Period 1: Main Phase|Physician Decision|4|||
130142713|NCT01513239|468482461|FG003|Period 1: Main Phase|Physician Decision|0|||
130142714|NCT01513239|468482462|FG004|Period 1: Main Phase|Physician Decision|0|||
130142715|NCT01513239|468482463|FG005|Period 1: Main Phase|Physician Decision|0|||
130142716|NCT01513239|468482458|FG000|Period 1: Main Phase|Protocol Violation|2|||
130142717|NCT01513239|468482459|FG001|Period 1: Main Phase|Protocol Violation|2|||
130142718|NCT01513239|468482460|FG002|Period 1: Main Phase|Protocol Violation|2|||
130142719|NCT01513239|468482461|FG003|Period 1: Main Phase|Protocol Violation|0|||
130142720|NCT01513239|468482462|FG004|Period 1: Main Phase|Protocol Violation|0|||
130142721|NCT01513239|468482463|FG005|Period 1: Main Phase|Protocol Violation|0|||
130142722|NCT01513239|468482458|FG000|Period 1: Main Phase|Technical Problems|1|||
130142723|NCT01513239|468482459|FG001|Period 1: Main Phase|Technical Problems|2|||
129976269|NCT01277887|467875788|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
129976270|NCT01277887|467875787|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
129976271|NCT01277887|467875788|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
129976272|NCT00415051|467875789|FG000|Overall Study|Protocol Violation|1|||
129976273|NCT01754753|467875794|FG000|Overall Study|Study close|43|||
129976274|NCT01754753|467875795|FG001|Overall Study|Study close|44|||
129976275|NCT01754753|467875794|FG000|Overall Study|Lost to Follow-up|9|||
129976276|NCT01754753|467875795|FG001|Overall Study|Lost to Follow-up|5|||
129976277|NCT00856245|467875797|FG000|Overall Study|Was not transplanted|5|||
129976278|NCT01250509|467875798|FG000|Overall Study|Lost to Follow-up|5|||
129976279|NCT01250509|467875799|FG001|Overall Study|Lost to Follow-up|2|||
129976280|NCT00203268|467875803|FG000|Early Treatment|only treated one headache|2|||
129976281|NCT00203268|467875803|FG000|Early Treatment|Lost to Follow-up|1|||
129976282|NCT00203268|467875803|FG000|Early Treatment|Withdrawal by Subject|1|||
129976283|NCT01371708|467875806|FG000|Overall Study|Insufficient clinical response|3|||
129976284|NCT01371708|467875807|FG001|Overall Study|Insufficient clinical response|2|||
129976285|NCT01371708|467875808|FG002|Overall Study|Insufficient clinical response|0|||
129976286|NCT01371708|467875806|FG000|Overall Study|Lost to Follow-up|5|||
129976287|NCT01371708|467875807|FG001|Overall Study|Lost to Follow-up|9|||
129976288|NCT01371708|467875808|FG002|Overall Study|Lost to Follow-up|7|||
129976289|NCT01371708|467875806|FG000|Overall Study|Protocol Violation|2|||
129976290|NCT01371708|467875807|FG001|Overall Study|Protocol Violation|1|||
129976291|NCT01371708|467875808|FG002|Overall Study|Protocol Violation|2|||
129976292|NCT01371708|467875806|FG000|Overall Study|No longer willing to participate|7|||
129976293|NCT01371708|467875807|FG001|Overall Study|No longer willing to participate|7|||
129976294|NCT01371708|467875808|FG002|Overall Study|No longer willing to participate|13|||
129976295|NCT01371708|467875806|FG000|Overall Study|Medication error/not related to AE|0|||
129976296|NCT01371708|467875807|FG001|Overall Study|Medication error/not related to AE|1|||
129976297|NCT01371708|467875808|FG002|Overall Study|Medication error/not related to AE|0|||
129976298|NCT01371708|467875806|FG000|Overall Study|Other|3|||
129976299|NCT01371708|467875807|FG001|Overall Study|Other|2|||
129976300|NCT01371708|467875808|FG002|Overall Study|Other|4|||
129976301|NCT01371708|467875806|FG000|Overall Study|Adverse Event|5|||
129976302|NCT01371708|467875807|FG001|Overall Study|Adverse Event|8|||
129976303|NCT01371708|467875808|FG002|Overall Study|Adverse Event|12|||
129976304|NCT01371708|467875806|FG000|Overall Study|Started but did not receive treatment|1|||
129976305|NCT01371708|467875807|FG001|Overall Study|Started but did not receive treatment|0|||
129976306|NCT01371708|467875808|FG002|Overall Study|Started but did not receive treatment|1|||
129976307|NCT02819024|467875810|FG000|Overall Study|Withdrawal by Subject|1|||
129976308|NCT00792948|467875811|FG000|Overall Study|Adverse Event|6|||
130142724|NCT01513239|468482460|FG002|Period 1: Main Phase|Technical Problems|0|||
130142725|NCT01513239|468482461|FG003|Period 1: Main Phase|Technical Problems|0|||
130142726|NCT01513239|468482462|FG004|Period 1: Main Phase|Technical Problems|0|||
130142727|NCT01513239|468482463|FG005|Period 1: Main Phase|Technical Problems|0|||
130142728|NCT01513239|468482458|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
130142729|NCT01513239|468482459|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
130142730|NCT01513239|468482460|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
130142731|NCT01513239|468482461|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
130142732|NCT01513239|468482462|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
130142733|NCT01513239|468482463|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
130142734|NCT01513239|468482458|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130142735|NCT01513239|468482459|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129976309|NCT00792948|467875811|FG000|Overall Study|Death|4|||
129976310|NCT00792948|467875811|FG000|Overall Study|Withdrawal by Subject|3|||
129976311|NCT00792948|467875811|FG000|Overall Study|Ineligible|2|||
129976312|NCT00792948|467875811|FG000|Overall Study|Insurance denial - not treated|1|||
130142736|NCT01513239|468482460|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
130142737|NCT01513239|468482461|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
130142738|NCT01513239|468482462|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
130142739|NCT01513239|468482463|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
130142740|NCT01513239|468482458|FG000|Period 2: 9 Month Extension Phase|Death|0|||
130142741|NCT01513239|468482459|FG001|Period 2: 9 Month Extension Phase|Death|0|||
130142742|NCT01513239|468482460|FG002|Period 2: 9 Month Extension Phase|Death|0|||
130142743|NCT01513239|468482461|FG003|Period 2: 9 Month Extension Phase|Death|2|||
130142744|NCT01513239|468482462|FG004|Period 2: 9 Month Extension Phase|Death|5|||
130142745|NCT01513239|468482463|FG005|Period 2: 9 Month Extension Phase|Death|2|||
130142746|NCT01513239|468482458|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130142747|NCT01513239|468482459|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130142748|NCT01513239|468482460|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130142749|NCT01513239|468482461|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
130142750|NCT01513239|468482462|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
130142751|NCT01513239|468482463|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
130142752|NCT01513239|468482458|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130142753|NCT01513239|468482459|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130142754|NCT01513239|468482460|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130142755|NCT01513239|468482461|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
130142756|NCT01513239|468482462|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130142757|NCT01513239|468482463|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
130142758|NCT01513239|468482458|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130142759|NCT01513239|468482459|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130142760|NCT01513239|468482460|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130142761|NCT01513239|468482461|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
130142762|NCT01513239|468482462|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
130142763|NCT01513239|468482463|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
130142764|NCT03167606|468482466|FG000|Overall Study|Lost to Follow-up|73|||
130142765|NCT03167606|468482467|FG001|Overall Study|Lost to Follow-up|64|||
130142766|NCT03167606|468482466|FG000|Overall Study|Withdrawal by Subject|6|||
130142767|NCT03167606|468482467|FG001|Overall Study|Withdrawal by Subject|5|||
130142768|NCT03167606|468482466|FG000|Overall Study|Withdrawal by Investigator|0|||
130142769|NCT03167606|468482467|FG001|Overall Study|Withdrawal by Investigator|2|||
130142770|NCT00059332|468482468|FG000|Overall Study|Withdrawal by Subject|2|||
130142771|NCT00059332|468482469|FG001|Overall Study|Withdrawal by Subject|1|||
130142772|NCT00059332|468482468|FG000|Overall Study|Lost to Follow-up|1|||
130142773|NCT00059332|468482469|FG001|Overall Study|Lost to Follow-up|1|||
130142774|NCT00413049|468482471|FG000|Overall Study|Adverse Event|10|||
130142775|NCT00413049|468482472|FG001|Overall Study|Adverse Event|8|||
130142776|NCT00413049|468482471|FG000|Overall Study|Withdrawal by Subject|7|||
130142777|NCT00413049|468482472|FG001|Overall Study|Withdrawal by Subject|5|||
130142778|NCT00413049|468482471|FG000|Overall Study|Lost to Follow-up|2|||
130142779|NCT00413049|468482472|FG001|Overall Study|Lost to Follow-up|3|||
130142780|NCT00413049|468482471|FG000|Overall Study|Protocol Violation|3|||
130142781|NCT00413049|468482472|FG001|Overall Study|Protocol Violation|1|||
130142782|NCT00413049|468482471|FG000|Overall Study|Subject no longer requires study drug|0|||
130142783|NCT00413049|468482472|FG001|Overall Study|Subject no longer requires study drug|1|||
130142784|NCT00413049|468482471|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130142785|NCT00413049|468482472|FG001|Overall Study|Abnormal laboratory value(s)|0|||
130142786|NCT00413049|468482471|FG000|Overall Study|Lack of Efficacy|1|||
130142787|NCT00413049|468482472|FG001|Overall Study|Lack of Efficacy|0|||
130142788|NCT02587143|468482473|FG000|Overall Study|Adverse Event|1|||
130142789|NCT02587143|468482474|FG001|Overall Study|Adverse Event|0|||
130142790|NCT03314857|468482477|FG000|Overall Study|Death|4|||
130142791|NCT03314857|468482477|FG000|Overall Study|Physician Decision|1|||
130142792|NCT01119625|468482478|FG000|Overall Study|Lost to Follow-up|1|||
130142793|NCT01119625|468482479|FG001|Overall Study|Lost to Follow-up|2|||
130142794|NCT01119625|468482478|FG000|Overall Study|Withdrawal by Subject|2|||
129976313|NCT00792948|467875811|FG000|Overall Study|Physician Decision|11|||
129976314|NCT00792948|467875811|FG000|Overall Study|Protocol Violation|1|||
129976315|NCT03832595|467875819|FG000|Overall Study|Death|142|||
130142795|NCT01119625|468482479|FG001|Overall Study|Withdrawal by Subject|1|||
130142796|NCT01119625|468482478|FG000|Overall Study|Other|0|||
130142797|NCT01119625|468482479|FG001|Overall Study|Other|1|||
130142798|NCT01721772|468482486|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
130142799|NCT01721772|468482487|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
130142800|NCT01721772|468482486|FG000|Pre-Treatment|Poor/non-compliance|0|||
130142801|NCT01721772|468482487|FG001|Pre-Treatment|Poor/non-compliance|1|||
130142802|NCT01721772|468482486|FG000|Pre-Treatment|Participant withdrew consent|0|||
129976316|NCT03832595|467875820|FG001|Overall Study|Death|130|||
130142803|NCT01721772|468482487|FG001|Pre-Treatment|Participant withdrew consent|1|||
130142804|NCT01721772|468482486|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
130142805|NCT01721772|468482487|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
130142806|NCT01721772|468482486|FG000|Treatment|Disease progression|119|||
130142807|NCT01721772|468482487|FG001|Treatment|Disease progression|168|||
130142808|NCT01721772|468482486|FG000|Treatment|Study drug toxicity|19|||
130142809|NCT01721772|468482487|FG001|Treatment|Study drug toxicity|10|||
130142810|NCT01721772|468482486|FG000|Treatment|Adverse event unrelated to study drug|7|||
130142811|NCT01721772|468482487|FG001|Treatment|Adverse event unrelated to study drug|7|||
130142812|NCT01721772|468482486|FG000|Treatment|Maximum clinical benefit|16|||
130142813|NCT01721772|468482487|FG001|Treatment|Maximum clinical benefit|4|||
130142814|NCT01721772|468482486|FG000|Treatment|Other|19|||
130142815|NCT01721772|468482487|FG001|Treatment|Other|2|||
130142816|NCT01721772|468482486|FG000|Treatment|Participant withdrew consent|2|||
130142817|NCT01721772|468482487|FG001|Treatment|Participant withdrew consent|5|||
130142818|NCT01721772|468482486|FG000|Treatment|Participant request to discontinue study treatment|21|||
130142819|NCT01721772|468482487|FG001|Treatment|Participant request to discontinue study treatment|8|||
130142820|NCT01721772|468482486|FG000|Treatment|Death|1|||
130142821|NCT01721772|468482487|FG001|Treatment|Death|0|||
130142822|NCT01721772|468482486|FG000|Treatment|Not reported|1|||
130142823|NCT01721772|468482487|FG001|Treatment|Not reported|0|||
130142824|NCT01721772|468482486|FG000|Treatment|Poor/non-compliance|1|||
130142825|NCT01721772|468482487|FG001|Treatment|Poor/non-compliance|0|||
130142826|NCT01721772|468482486|FG000|Treatment|Lost to Follow-up|0|||
130142827|NCT01721772|468482487|FG001|Treatment|Lost to Follow-up|1|||
130142828|NCT00397254|468482495|FG000|Overall Study|Lost to Follow-up|2|||
130142829|NCT00397254|468482496|FG001|Overall Study|Lost to Follow-up|2|||
130142830|NCT02340780|468482497|FG000|Overall Study|Ineligible|1|||
130142831|NCT04535986|468482501|FG000|Overall Study|Death|4|||
130142832|NCT04535986|468482502|FG001|Overall Study|Death|5|||
130142833|NCT04535986|468482501|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
130142834|NCT04535986|468482502|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
130142835|NCT04535986|468482501|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
130142836|NCT04535986|468482502|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
130142837|NCT04535986|468482501|FG000|Overall Study|Adverse Event|10|||
130142838|NCT04535986|468482502|FG001|Overall Study|Adverse Event|1|||
130142839|NCT04535986|468482501|FG000|Overall Study|Lack of Efficacy|3|||
130142840|NCT04535986|468482502|FG001|Overall Study|Lack of Efficacy|2|||
130142841|NCT04535986|468482501|FG000|Overall Study|Investigator discretion|3|||
130142842|NCT04535986|468482502|FG001|Overall Study|Investigator discretion|0|||
130142843|NCT04535986|468482501|FG000|Overall Study|Withdrawal by Subject|32|||
130142844|NCT04535986|468482502|FG001|Overall Study|Withdrawal by Subject|14|||
130142845|NCT04535986|468482501|FG000|Overall Study|Lost to Follow-up|5|||
130142846|NCT04535986|468482502|FG001|Overall Study|Lost to Follow-up|3|||
130142847|NCT04535986|468482501|FG000|Overall Study|Other|7|||
130142848|NCT04535986|468482502|FG001|Overall Study|Other|3|||
130142849|NCT01567527|468482503|FG000|Conversion Phase.|Protocol deviation|3|||
130142850|NCT01567527|468482504|FG001|Conversion Phase.|Protocol deviation|0|||
130142851|NCT01567527|468482505|FG002|Conversion Phase.|Protocol deviation|0|||
130142852|NCT01567527|468482506|FG003|Conversion Phase.|Protocol deviation|0|||
130142853|NCT01567527|468482507|FG004|Conversion Phase.|Protocol deviation|0|||
130142854|NCT01567527|468482503|FG000|Conversion Phase.|Met withdrawal criteria|10|||
130142855|NCT01567527|468482504|FG001|Conversion Phase.|Met withdrawal criteria|0|||
130142856|NCT01567527|468482505|FG002|Conversion Phase.|Met withdrawal criteria|0|||
130142857|NCT01567527|468482506|FG003|Conversion Phase.|Met withdrawal criteria|0|||
130142858|NCT01567527|468482507|FG004|Conversion Phase.|Met withdrawal criteria|0|||
130142859|NCT01567527|468482503|FG000|Conversion Phase.|Withdrawal by Subject|32|||
130142860|NCT01567527|468482504|FG001|Conversion Phase.|Withdrawal by Subject|0|||
130142861|NCT01567527|468482505|FG002|Conversion Phase.|Withdrawal by Subject|0|||
130142862|NCT01567527|468482506|FG003|Conversion Phase.|Withdrawal by Subject|0|||
130142863|NCT01567527|468482507|FG004|Conversion Phase.|Withdrawal by Subject|0|||
130142864|NCT01567527|468482503|FG000|Conversion Phase.|Lost to Follow-up|16|||
130142865|NCT01567527|468482504|FG001|Conversion Phase.|Lost to Follow-up|0|||
129976317|NCT03832595|467875819|FG000|Overall Study|Medical management without dialysis|37|||
129976318|NCT03832595|467875820|FG001|Overall Study|Medical management without dialysis|1|||
129976319|NCT02397447|467875821|FG000|Overall Study|Lost to Follow-up|2|||
130142866|NCT01567527|468482505|FG002|Conversion Phase.|Lost to Follow-up|0|||
130142867|NCT01567527|468482506|FG003|Conversion Phase.|Lost to Follow-up|0|||
130142868|NCT01567527|468482507|FG004|Conversion Phase.|Lost to Follow-up|0|||
130142869|NCT01567527|468482503|FG000|Conversion Phase.|Lack of Efficacy|2|||
130142870|NCT01567527|468482504|FG001|Conversion Phase.|Lack of Efficacy|0|||
130142871|NCT01567527|468482505|FG002|Conversion Phase.|Lack of Efficacy|0|||
129976320|NCT02397447|467875822|FG001|Overall Study|Lost to Follow-up|2|||
129976321|NCT04942366|467877728|FG000|Overall Study|Withdrawal by Subject|5|||
129976322|NCT04942366|467877729|FG001|Overall Study|Withdrawal by Subject|5|||
129976323|NCT04996004|467877730|FG000|Phase I|Death|1|||
130142872|NCT01567527|468482506|FG003|Conversion Phase.|Lack of Efficacy|0|||
130142873|NCT01567527|468482507|FG004|Conversion Phase.|Lack of Efficacy|0|||
130142874|NCT01567527|468482503|FG000|Conversion Phase.|Adverse Event|33|||
130142875|NCT01567527|468482504|FG001|Conversion Phase.|Adverse Event|0|||
130142876|NCT01567527|468482505|FG002|Conversion Phase.|Adverse Event|0|||
130142877|NCT01567527|468482506|FG003|Conversion Phase.|Adverse Event|0|||
130142878|NCT01567527|468482507|FG004|Conversion Phase.|Adverse Event|0|||
130142879|NCT01567527|468482503|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
130142880|NCT01567527|468482504|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
130142881|NCT01567527|468482505|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
130142882|NCT01567527|468482506|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
130142883|NCT01567527|468482507|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
130142884|NCT01567527|468482503|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130142885|NCT01567527|468482504|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
130142886|NCT01567527|468482505|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130142887|NCT01567527|468482506|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130142888|NCT01567527|468482507|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
130142889|NCT01567527|468482503|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130142890|NCT01567527|468482504|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
130142891|NCT01567527|468482505|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130142892|NCT01567527|468482506|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130142893|NCT01567527|468482507|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
130142894|NCT01567527|468482503|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130142895|NCT01567527|468482504|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
130142896|NCT01567527|468482505|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130142897|NCT01567527|468482506|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130142898|NCT01567527|468482507|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
130142899|NCT01567527|468482503|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130142900|NCT01567527|468482504|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
130142901|NCT01567527|468482505|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130142902|NCT01567527|468482506|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130142903|NCT01567527|468482507|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
130142904|NCT01567527|468482503|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130142905|NCT01567527|468482504|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
130142906|NCT01567527|468482505|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130142907|NCT01567527|468482506|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130142908|NCT01567527|468482507|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
130142909|NCT01567527|468482503|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130142910|NCT01567527|468482504|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
130142911|NCT01567527|468482505|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130142912|NCT01567527|468482506|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130142913|NCT01567527|468482507|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
130142914|NCT01567527|468482503|FG000|IM Depot Stabilization.|Protocol deviation|0|||
130142915|NCT01567527|468482504|FG001|IM Depot Stabilization.|Protocol deviation|0|||
130142916|NCT01567527|468482505|FG002|IM Depot Stabilization.|Protocol deviation|5|||
130142917|NCT01567527|468482506|FG003|IM Depot Stabilization.|Protocol deviation|0|||
130142918|NCT01567527|468482507|FG004|IM Depot Stabilization.|Protocol deviation|0|||
130142919|NCT01567527|468482503|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
130142920|NCT01567527|468482504|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
130142921|NCT01567527|468482505|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
130142922|NCT01567527|468482506|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
130142923|NCT01567527|468482507|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
130142924|NCT01567527|468482503|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
130142925|NCT01567527|468482504|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
130142926|NCT01567527|468482505|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
130142927|NCT01567527|468482506|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
130142928|NCT01567527|468482507|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
130142929|NCT01567527|468482503|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
130142930|NCT01567527|468482504|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
130142931|NCT01567527|468482505|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
130142932|NCT01567527|468482506|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
130142933|NCT01567527|468482507|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
130142934|NCT01567527|468482503|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
130142935|NCT01567527|468482504|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
130142936|NCT01567527|468482505|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
130142937|NCT01567527|468482506|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
130142938|NCT01567527|468482507|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
130142939|NCT01567527|468482503|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
130142940|NCT01567527|468482504|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
130142941|NCT01567527|468482505|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
130142942|NCT01567527|468482506|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
130142943|NCT01567527|468482507|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
130142944|NCT01567527|468482503|FG000|IM Depot Stabilization.|Adverse Event|0|||
130142945|NCT01567527|468482504|FG001|IM Depot Stabilization.|Adverse Event|0|||
130142946|NCT01567527|468482505|FG002|IM Depot Stabilization.|Adverse Event|37|||
130142947|NCT01567527|468482506|FG003|IM Depot Stabilization.|Adverse Event|0|||
130142948|NCT01567527|468482507|FG004|IM Depot Stabilization.|Adverse Event|0|||
130142949|NCT01567527|468482503|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130142950|NCT01567527|468482504|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130142951|NCT01567527|468482505|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
130142952|NCT01567527|468482506|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130142953|NCT01567527|468482507|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
130142954|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130142955|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130142956|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
130142957|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
130142958|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
130142959|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130142960|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130142961|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
130142962|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
130142963|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
130142964|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130142965|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130142966|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
130142967|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
130142968|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
130142969|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130142970|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130142971|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
130142972|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
130142973|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
130142974|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130142975|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130142976|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
130142977|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
130142978|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
130142979|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130142980|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130142981|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
130142982|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
130142983|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
130142984|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130142985|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130142986|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
130142987|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
130142988|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
130142989|NCT01567527|468482503|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130142990|NCT01567527|468482504|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130142991|NCT01567527|468482505|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
130142992|NCT01567527|468482506|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
130142993|NCT01567527|468482507|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
130142994|NCT02004691|468482508|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
130142995|NCT02004691|468482509|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
130142996|NCT02004691|468482508|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
130142997|NCT02004691|468482509|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
130142998|NCT02004691|468482508|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
130142999|NCT02004691|468482509|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
130143000|NCT02004691|468482508|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
130143001|NCT02004691|468482509|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
130143002|NCT02004691|468482508|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
130143003|NCT02004691|468482509|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
130143004|NCT02004691|468482508|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
130143005|NCT02004691|468482509|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
130143006|NCT00021541|468482510|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
130143007|NCT00021541|468482511|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
130143008|NCT00021541|468482510|FG000|Period 1-First Treatment|Adverse Event|2|||
130143009|NCT00021541|468482511|FG001|Period 1-First Treatment|Adverse Event|1|||
130143010|NCT00021541|468482510|FG000|Period 1-First Treatment|non-adherence|3|||
130143011|NCT00021541|468482511|FG001|Period 1-First Treatment|non-adherence|0|||
130143012|NCT00021541|468482510|FG000|Period 1-First Treatment|Death|1|||
130143013|NCT00021541|468482511|FG001|Period 1-First Treatment|Death|0|||
130143014|NCT00021541|468482510|FG000|Period 1-First Treatment|Pts that did not progress|2|||
130143015|NCT00021541|468482511|FG001|Period 1-First Treatment|Pts that did not progress|2|||
130143016|NCT00021541|468482510|FG000|Period 1-First Treatment|Ineligible|0|||
130143017|NCT00021541|468482511|FG001|Period 1-First Treatment|Ineligible|2|||
130143018|NCT00021541|468482510|FG000|Period 2-crossover|refused phase B|2|||
130143019|NCT00021541|468482511|FG001|Period 2-crossover|refused phase B|2|||
130143020|NCT00021541|468482510|FG000|Period 2-crossover|Withdrawal by Subject|3|||
130143021|NCT00021541|468482511|FG001|Period 2-crossover|Withdrawal by Subject|4|||
130143022|NCT00021541|468482510|FG000|Period 2-crossover|Adverse Event|2|||
130143023|NCT00021541|468482511|FG001|Period 2-crossover|Adverse Event|2|||
130143024|NCT00021541|468482510|FG000|Period 2-crossover|non-adherence|1|||
130143025|NCT00021541|468482511|FG001|Period 2-crossover|non-adherence|0|||
130143026|NCT00021541|468482510|FG000|Period 2-crossover|Pts that did not progress|2|||
130143027|NCT00021541|468482511|FG001|Period 2-crossover|Pts that did not progress|3|||
130143028|NCT01547728|468482515|FG000|Overall Study|Change in procedure and equipment|1|||
130143029|NCT01547728|468482515|FG000|Overall Study|Drug not ready for subject|1|||
130143030|NCT01547728|468482515|FG000|Overall Study|Screen failure|39|||
130143031|NCT03828539|468482516|FG000|Overall Study|Adverse Event|3|||
130143032|NCT03828539|468482517|FG001|Overall Study|Adverse Event|12|||
130143033|NCT03828539|468482516|FG000|Overall Study|Patient's/guardian's decision|3|||
130143034|NCT03828539|468482517|FG001|Overall Study|Patient's/guardian's decision|5|||
130143035|NCT03828539|468482516|FG000|Overall Study|Lost to Follow-up|4|||
130143036|NCT03828539|468482517|FG001|Overall Study|Lost to Follow-up|2|||
130143037|NCT03828539|468482516|FG000|Overall Study|Protocol Violation|3|||
130143038|NCT03828539|468482517|FG001|Overall Study|Protocol Violation|2|||
130143039|NCT03828539|468482516|FG000|Overall Study|Withdrawal of informed consent|2|||
130143040|NCT03828539|468482517|FG001|Overall Study|Withdrawal of informed consent|1|||
130143041|NCT03828539|468482516|FG000|Overall Study|New therapy for study indication|1|||
130143042|NCT03828539|468482517|FG001|Overall Study|New therapy for study indication|0|||
130143043|NCT01341405|468482518|FG000|Overall Study|Adverse Event|0|||
130143044|NCT01341405|468482519|FG001|Overall Study|Adverse Event|1|||
130143045|NCT01341405|468482520|FG002|Overall Study|Adverse Event|1|||
130143046|NCT01341405|468482518|FG000|Overall Study|Withdrawal by Subject|3|||
130143047|NCT01341405|468482519|FG001|Overall Study|Withdrawal by Subject|2|||
130143048|NCT01341405|468482520|FG002|Overall Study|Withdrawal by Subject|1|||
130143049|NCT00826241|468482521|FG000|Overall Study|Withdrawal from Follow-up|1|||
130143050|NCT00826241|468482521|FG000|Overall Study|Withdrew consent|2|||
130143051|NCT00826241|468482521|FG000|Overall Study|Death|4|||
130143052|NCT00826241|468482521|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
130143053|NCT00826241|468482521|FG000|Overall Study|Non-compliance|1|||
130143054|NCT00826241|468482521|FG000|Overall Study|Progression of disease|1|||
130143055|NCT00826241|468482521|FG000|Overall Study|Patient refused follow-up|3|||
130143056|NCT00826241|468482521|FG000|Overall Study|Lost to Follow-up|9|||
130143057|NCT00826241|468482521|FG000|Overall Study|Could not obtain records|1|||
130143058|NCT00826241|468482521|FG000|Overall Study|Screen failure|2|||
130143059|NCT00826241|468482521|FG000|Overall Study|Pt unable to proceed to registration|1|||
130143060|NCT00826241|468482521|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
130143061|NCT04142658|468482522|FG000|Overall Study|Death|2|||
130143062|NCT04142658|468482523|FG001|Overall Study|Death|1|||
130143063|NCT04142658|468482522|FG000|Overall Study|Lost to Follow-up|4|||
130143064|NCT04142658|468482523|FG001|Overall Study|Lost to Follow-up|13|||
130143065|NCT04142658|468482522|FG000|Overall Study|Withdrawal by Subject|9|||
130143066|NCT04142658|468482523|FG001|Overall Study|Withdrawal by Subject|16|||
130143067|NCT04194008|468482528|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
130143068|NCT04194008|468482528|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
130143069|NCT04194008|468482528|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
130143070|NCT04194008|468482528|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
130143071|NCT04194008|468482528|FG000|Treatment Phase With Nerivio|Missing data|4|||
130143072|NCT04194008|468482528|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
130143073|NCT01675596|468482531|FG000|Overall Study|Death|6|||
130143074|NCT01675596|468482531|FG000|Overall Study|Exit with other reason|1|||
130143075|NCT01675596|468482531|FG000|Overall Study|Missed Visit|1|||
130143076|NCT01539239|468482532|FG000|Overall Study|Death|5|||
130143077|NCT01539239|468482533|FG001|Overall Study|Death|5|||
130143078|NCT01539239|468482532|FG000|Overall Study|Lost to Follow-up|7|||
130143079|NCT01539239|468482533|FG001|Overall Study|Lost to Follow-up|12|||
130143080|NCT03201003|468482538|FG000|Overall Study|Adverse Event|14|||
130143081|NCT03201003|468482539|FG001|Overall Study|Adverse Event|1|||
130143082|NCT03201003|468482538|FG000|Overall Study|Other reasons|5|||
130143083|NCT03201003|468482539|FG001|Overall Study|Other reasons|1|||
130143084|NCT03201003|468482538|FG000|Overall Study|Withdrawal by Subject|4|||
130143085|NCT03201003|468482539|FG001|Overall Study|Withdrawal by Subject|1|||
130143086|NCT03201003|468482538|FG000|Overall Study|Lost to Follow-up|2|||
130143087|NCT03201003|468482539|FG001|Overall Study|Lost to Follow-up|0|||
130143088|NCT03201003|468482538|FG000|Overall Study|Protocol Violation|1|||
130143089|NCT03201003|468482539|FG001|Overall Study|Protocol Violation|0|||
130143090|NCT00834613|468482540|FG000|First Intervention|Protocol Violation|1|||
130143091|NCT00834613|468482541|FG001|First Intervention|Protocol Violation|0|||
130143092|NCT01751087|468482542|FG000|Overall Study|Withdrawal by Subject|1|||
130143093|NCT01751087|468482543|FG001|Overall Study|Withdrawal by Subject|0|||
130143094|NCT01751087|468482544|FG002|Overall Study|Withdrawal by Subject|0|||
130143095|NCT01751087|468482542|FG000|Overall Study|Physician Decision|0|||
130143096|NCT01751087|468482543|FG001|Overall Study|Physician Decision|0|||
130143097|NCT01751087|468482544|FG002|Overall Study|Physician Decision|1|||
130143098|NCT00697619|468482545|FG000|Overall Study|Lack of Efficacy|2|||
130143099|NCT00697619|468482546|FG001|Overall Study|Lack of Efficacy|2|||
130143100|NCT00697619|468482545|FG000|Overall Study|Adverse Event|4|||
130143101|NCT00697619|468482546|FG001|Overall Study|Adverse Event|6|||
130143102|NCT02005562|468484278|FG000|Overall Study|Death|2|||
130143103|NCT02005562|468484279|FG001|Overall Study|Death|2|||
130143104|NCT02005562|468484278|FG000|Overall Study|Graft loss|7|||
130143105|NCT02005562|468484279|FG001|Overall Study|Graft loss|6|||
130143106|NCT02005562|468484278|FG000|Overall Study|Withdrawal by Subject|2|||
130143107|NCT02005562|468484279|FG001|Overall Study|Withdrawal by Subject|2|||
130143108|NCT02005562|468484278|FG000|Overall Study|No transplant|1|||
130143109|NCT02005562|468484279|FG001|Overall Study|No transplant|4|||
130143110|NCT02005562|468484278|FG000|Overall Study|Physician Decision|0|||
130143111|NCT02005562|468484279|FG001|Overall Study|Physician Decision|1|||
130143112|NCT04264819|468484280|FG000|Overall Study|Physician Decision|19|||
130143113|NCT04264819|468484280|FG000|Overall Study|Adverse Event|12|||
130143114|NCT04264819|468484280|FG000|Overall Study|Withdrawal by Subject|11|||
130143115|NCT04264819|468484280|FG000|Overall Study|Lost to Follow-up|2|||
130143116|NCT04264819|468484280|FG000|Overall Study|Death|2|||
130143117|NCT00799708|468484281|FG000|Overall Study|non-compliance|1|||
130143118|NCT00799708|468484282|FG001|Overall Study|non-compliance|0|||
130143119|NCT00799708|468484283|FG002|Overall Study|non-compliance|0|||
130143120|NCT03343639|468484284|FG000|Overall Study|Withdrawal by Subject|10|||
130143121|NCT03343639|468484285|FG001|Overall Study|Withdrawal by Subject|6|||
130143122|NCT03343639|468484284|FG000|Overall Study|Lost to Follow-up|4|||
130143123|NCT03343639|468484285|FG001|Overall Study|Lost to Follow-up|5|||
130143124|NCT03343639|468484284|FG000|Overall Study|Protocol Violation|0|||
130143125|NCT03343639|468484285|FG001|Overall Study|Protocol Violation|1|||
130143126|NCT05061992|468484290|FG000|Overall Study|Excess bowel movements|1|||
130143127|NCT05061992|468484291|FG001|Overall Study|Excess bowel movements|0|||
130143128|NCT05061992|468484290|FG000|Overall Study|Complications of Medical Care|1|||
130143129|NCT05061992|468484291|FG001|Overall Study|Complications of Medical Care|0|||
130143130|NCT05061992|468484290|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
130143131|NCT05061992|468484291|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
130143132|NCT05061992|468484290|FG000|Overall Study|Withdrawal by Subject|0|||
130143133|NCT05061992|468484291|FG001|Overall Study|Withdrawal by Subject|1|||
130143134|NCT02473393|468484292|FG000|Overall Study|Adverse Event|0|||
130143135|NCT02473393|468484293|FG001|Overall Study|Adverse Event|0|||
130143136|NCT02473393|468484294|FG002|Overall Study|Adverse Event|1|||
130143137|NCT02473393|468484295|FG003|Overall Study|Adverse Event|0|||
130143138|NCT02473393|468484292|FG000|Overall Study|Withdrawal by Subject|0|||
130143139|NCT02473393|468484293|FG001|Overall Study|Withdrawal by Subject|0|||
130143140|NCT02473393|468484294|FG002|Overall Study|Withdrawal by Subject|1|||
130143141|NCT02473393|468484295|FG003|Overall Study|Withdrawal by Subject|1|||
130143142|NCT05393271|468484301|FG000|Overall Study|Physician Decision|0|||
130143143|NCT05393271|468484302|FG001|Overall Study|Physician Decision|0|||
130143144|NCT05393271|468484303|FG002|Overall Study|Physician Decision|0|||
130143145|NCT05393271|468484304|FG003|Overall Study|Physician Decision|0|||
130143146|NCT05393271|468484305|FG004|Overall Study|Physician Decision|0|||
130143147|NCT05393271|468484306|FG005|Overall Study|Physician Decision|0|||
130143148|NCT05393271|468484307|FG006|Overall Study|Physician Decision|1|||
130143149|NCT05393271|468484308|FG007|Overall Study|Physician Decision|0|||
130143150|NCT05393271|468484309|FG008|Overall Study|Physician Decision|0|||
130143151|NCT05393271|468484310|FG009|Overall Study|Physician Decision|0|||
130143152|NCT05393271|468484311|FG010|Overall Study|Physician Decision|0|||
130143153|NCT02943993|468484314|FG000|Overall Study|Withdrawal by Subject|52|||
130143154|NCT02943993|468484314|FG000|Overall Study|Transfer to another institution|6|||
130143155|NCT02943993|468484314|FG000|Overall Study|Lost to Follow-up|135|||
130143156|NCT02943993|468484314|FG000|Overall Study|Death|98|||
130143157|NCT02943993|468484314|FG000|Overall Study|Other reason for premature termination|32|||
130143158|NCT02943993|468484314|FG000|Overall Study|Missing reason for termination|7|||
130143159|NCT02483416|468484315|FG000|Overall Study|Other reason|0|||
130143160|NCT02483416|468484316|FG001|Overall Study|Other reason|1|||
130143161|NCT02483416|468484315|FG000|Overall Study|Treatment stop|3|||
130143162|NCT02483416|468484316|FG001|Overall Study|Treatment stop|0|||
130143163|NCT04968925|468484317|FG000|Phase I- Period 1|COVID-19 related|0|||
130143164|NCT04968925|468484318|FG001|Phase I- Period 1|COVID-19 related|1|||
130143165|NCT04968925|468484319|FG002|Phase I- Period 1|COVID-19 related|0|||
130143166|NCT04968925|468484320|FG003|Phase I- Period 1|COVID-19 related|0|||
130143167|NCT04968925|468484317|FG000|Phase I- Period 1|Subject enrolled in error|1|||
130143168|NCT04968925|468484318|FG001|Phase I- Period 1|Subject enrolled in error|1|||
130143169|NCT04968925|468484319|FG002|Phase I- Period 1|Subject enrolled in error|0|||
130143170|NCT04968925|468484320|FG003|Phase I- Period 1|Subject enrolled in error|0|||
130143171|NCT04968925|468484317|FG000|Phase II- Period 1|COVID-19 Related|0|||
130143172|NCT04968925|468484318|FG001|Phase II- Period 1|COVID-19 Related|0|||
130143173|NCT04968925|468484319|FG002|Phase II- Period 1|COVID-19 Related|6|||
129976324|NCT04996004|467877731|FG001|Phase I|Death|2|||
129976325|NCT04996004|467877732|FG002|Phase I|Death|1|||
129976326|NCT04996004|467877733|FG003|Phase I|Death|0|||
129976327|NCT04996004|467877734|FG004|Phase I|Death|0|||
129976328|NCT04996004|467877735|FG005|Phase I|Death|0|||
129976329|NCT04996004|467877730|FG000|Phase I|Study terminated by sponsor|2|||
129976330|NCT04996004|467877731|FG001|Phase I|Study terminated by sponsor|1|||
129976331|NCT04996004|467877732|FG002|Phase I|Study terminated by sponsor|2|||
129976332|NCT04996004|467877733|FG003|Phase I|Study terminated by sponsor|0|||
129976333|NCT04996004|467877734|FG004|Phase I|Study terminated by sponsor|0|||
129976334|NCT04996004|467877735|FG005|Phase I|Study terminated by sponsor|0|||
129976335|NCT04996004|467877730|FG000|Phase II|Study terminated by sponsor|0|||
129976336|NCT04996004|467877731|FG001|Phase II|Study terminated by sponsor|0|||
129976337|NCT04996004|467877732|FG002|Phase II|Study terminated by sponsor|0|||
129976338|NCT04996004|467877733|FG003|Phase II|Study terminated by sponsor|20|||
129976339|NCT04996004|467877734|FG004|Phase II|Study terminated by sponsor|10|||
129976340|NCT04996004|467877735|FG005|Phase II|Study terminated by sponsor|10|||
129976341|NCT04996004|467877730|FG000|Phase II|Withdrawal by Subject|0|||
129976342|NCT04996004|467877731|FG001|Phase II|Withdrawal by Subject|0|||
129976343|NCT04996004|467877732|FG002|Phase II|Withdrawal by Subject|0|||
129976344|NCT04996004|467877733|FG003|Phase II|Withdrawal by Subject|0|||
129976345|NCT04996004|467877734|FG004|Phase II|Withdrawal by Subject|1|||
129976346|NCT04996004|467877735|FG005|Phase II|Withdrawal by Subject|2|||
129976347|NCT04996004|467877730|FG000|Phase II|Death|0|||
129976348|NCT04996004|467877731|FG001|Phase II|Death|0|||
129976349|NCT04996004|467877732|FG002|Phase II|Death|0|||
129976350|NCT04996004|467877733|FG003|Phase II|Death|12|||
129976351|NCT04996004|467877734|FG004|Phase II|Death|2|||
129976352|NCT04996004|467877735|FG005|Phase II|Death|9|||
129976353|NCT04996004|467877730|FG000|Phase II|Other|0|||
129976354|NCT04996004|467877731|FG001|Phase II|Other|0|||
129976355|NCT04996004|467877732|FG002|Phase II|Other|0|||
129976356|NCT04996004|467877733|FG003|Phase II|Other|0|||
129976357|NCT04996004|467877734|FG004|Phase II|Other|0|||
129976358|NCT04996004|467877735|FG005|Phase II|Other|1|||
129976359|NCT01736189|467877736|FG000|Overall Study|Violation of registration criteria|41|||
129976360|NCT01736189|467877736|FG000|Overall Study|Protocol Violation|4|||
129976361|NCT01736189|467877736|FG000|Overall Study|Criteria and protocol violations|1|||
129976362|NCT03809039|467877737|FG000|Part 1|Withdrawal by Subject|1|||
129976363|NCT03809039|467877738|FG001|Part 1|Withdrawal by Subject|0|||
129976364|NCT03809039|467877739|FG002|Part 1|Withdrawal by Subject|0|||
129976365|NCT03809039|467877740|FG003|Part 1|Withdrawal by Subject|1|||
129976366|NCT03809039|467877741|FG004|Part 1|Withdrawal by Subject|0|||
129976367|NCT03809039|467877742|FG005|Part 1|Withdrawal by Subject|0|||
129976368|NCT03809039|467877743|FG006|Part 1|Withdrawal by Subject|0|||
129976369|NCT03809039|467877744|FG007|Part 1|Withdrawal by Subject|0|||
129976370|NCT03809039|467877745|FG008|Part 1|Withdrawal by Subject|0|||
129976371|NCT03809039|467877737|FG000|Part 3|Withdrawn by study termination|0|||
129976372|NCT03809039|467877738|FG001|Part 3|Withdrawn by study termination|0|||
129976373|NCT03809039|467877739|FG002|Part 3|Withdrawn by study termination|0|||
129976374|NCT03809039|467877740|FG003|Part 3|Withdrawn by study termination|0|||
129976375|NCT03809039|467877741|FG004|Part 3|Withdrawn by study termination|0|||
129976376|NCT03809039|467877742|FG005|Part 3|Withdrawn by study termination|0|||
130143174|NCT04968925|468484320|FG003|Phase II- Period 1|COVID-19 Related|6|||
130143175|NCT04968925|468484317|FG000|Phase II- Period 1|Subject enrolled in error|0|||
129976377|NCT03809039|467877743|FG006|Part 3|Withdrawn by study termination|0|||
129976378|NCT03809039|467877744|FG007|Part 3|Withdrawn by study termination|2|||
129976379|NCT03809039|467877745|FG008|Part 3|Withdrawn by study termination|6|||
129976380|NCT01250925|467877748|FG000|Overall Study|Lost to Follow-up|1|||
129976381|NCT01250925|467877749|FG001|Overall Study|Lost to Follow-up|1|||
129976382|NCT01250925|467877750|FG002|Overall Study|Lost to Follow-up|0|||
129976383|NCT01250925|467877748|FG000|Overall Study|Withdrawal by Subject|2|||
129976384|NCT01250925|467877749|FG001|Overall Study|Withdrawal by Subject|0|||
130143176|NCT04968925|468484318|FG001|Phase II- Period 1|Subject enrolled in error|0|||
129976385|NCT01250925|467877750|FG002|Overall Study|Withdrawal by Subject|0|||
129976386|NCT01250925|467877748|FG000|Overall Study|Protocol Violation|2|||
129976387|NCT01250925|467877749|FG001|Overall Study|Protocol Violation|0|||
129976388|NCT01250925|467877750|FG002|Overall Study|Protocol Violation|0|||
129976389|NCT01250925|467877748|FG000|Overall Study|Physician Decision|0|||
129976390|NCT01250925|467877749|FG001|Overall Study|Physician Decision|2|||
129976391|NCT01250925|467877750|FG002|Overall Study|Physician Decision|1|||
129976392|NCT01250925|467877748|FG000|Overall Study|Adverse Event|0|||
129976393|NCT01250925|467877749|FG001|Overall Study|Adverse Event|0|||
129976394|NCT01250925|467877750|FG002|Overall Study|Adverse Event|1|||
129976395|NCT04421950|467877751|FG000|Overall Study|Dropped or lost to follow up|4|||
129976396|NCT04421950|467877752|FG001|Overall Study|Dropped or lost to follow up|2|||
129976397|NCT01252355|467877753|FG000|Overall Study|Adverse Event|9|||
129976398|NCT01252355|467877754|FG001|Overall Study|Adverse Event|17|||
129976399|NCT01252355|467877755|FG002|Overall Study|Adverse Event|22|||
129976400|NCT01252355|467877753|FG000|Overall Study|Lack of Efficacy|6|||
129976401|NCT01252355|467877754|FG001|Overall Study|Lack of Efficacy|4|||
129976402|NCT01252355|467877755|FG002|Overall Study|Lack of Efficacy|2|||
129976403|NCT01252355|467877753|FG000|Overall Study|Lost to Follow-up|0|||
130143177|NCT04968925|468484319|FG002|Phase II- Period 1|Subject enrolled in error|1|||
130143178|NCT04968925|468484320|FG003|Phase II- Period 1|Subject enrolled in error|0|||
130143179|NCT04968925|468484317|FG000|Phase II -Period 2|COVID-19 related|0|||
130143180|NCT04968925|468484318|FG001|Phase II -Period 2|COVID-19 related|0|||
130143181|NCT04968925|468484319|FG002|Phase II -Period 2|COVID-19 related|4|||
130143182|NCT04968925|468484320|FG003|Phase II -Period 2|COVID-19 related|3|||
130143183|NCT04968925|468484317|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
130143184|NCT04968925|468484318|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
130143185|NCT04968925|468484319|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
130143186|NCT04968925|468484320|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
130143187|NCT00876265|468484321|FG000|Overall Study|Miscellaneous reasons|4|||
130143188|NCT00876265|468484321|FG000|Overall Study|Lost to Follow-up|6|||
130143189|NCT00876265|468484321|FG000|Overall Study|Withdrawal by Subject|2|||
130143190|NCT00487695|468484322|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
130143191|NCT00487695|468484323|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
130143192|NCT00487695|468484322|FG000|First Procedure|active wheezing (did not have procedure)|1|||
130143193|NCT00487695|468484323|FG001|First Procedure|active wheezing (did not have procedure)|0|||
130143194|NCT00487695|468484322|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
130143195|NCT00487695|468484323|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
130143196|NCT00487695|468484322|FG000|Second Procedure|active wheezing|0|||
130143197|NCT00487695|468484323|FG001|Second Procedure|active wheezing|1|||
130143198|NCT00487695|468484322|FG000|Second Procedure|Withdrawal by Subject|1|||
130143199|NCT00487695|468484323|FG001|Second Procedure|Withdrawal by Subject|2|||
130143200|NCT03433703|468484326|FG000|Overall Study|Study terminated by Sponsor|2|||
130143201|NCT02786953|468484329|FG000|Overall Study|Withdrawal by Subject|3|||
130143202|NCT02786953|468484330|FG001|Overall Study|Withdrawal by Subject|0|||
130143203|NCT02786953|468484329|FG000|Overall Study|Physician Decision|0|||
130143204|NCT02786953|468484330|FG001|Overall Study|Physician Decision|1|||
130143205|NCT01698554|468484332|FG000|Overall Study|Adverse Event|2|||
130143206|NCT01698554|468484333|FG001|Overall Study|Adverse Event|5|||
130143207|NCT01698554|468484334|FG002|Overall Study|Adverse Event|0|||
130143208|NCT01698554|468484335|FG003|Overall Study|Adverse Event|1|||
130143209|NCT01698554|468484332|FG000|Overall Study|Lost to Follow-up|1|||
130143210|NCT01698554|468484333|FG001|Overall Study|Lost to Follow-up|0|||
130143211|NCT01698554|468484334|FG002|Overall Study|Lost to Follow-up|0|||
130143212|NCT01698554|468484335|FG003|Overall Study|Lost to Follow-up|0|||
130143213|NCT01698554|468484332|FG000|Overall Study|Personal Reasons|0|||
130143214|NCT01698554|468484333|FG001|Overall Study|Personal Reasons|5|||
130143215|NCT01698554|468484334|FG002|Overall Study|Personal Reasons|1|||
130143216|NCT01698554|468484335|FG003|Overall Study|Personal Reasons|1|||
130143217|NCT01698554|468484332|FG000|Overall Study|Protocol Violation|2|||
130143218|NCT01698554|468484333|FG001|Overall Study|Protocol Violation|0|||
129976404|NCT01252355|467877754|FG001|Overall Study|Lost to Follow-up|0|||
129976405|NCT01252355|467877755|FG002|Overall Study|Lost to Follow-up|1|||
129976406|NCT01252355|467877753|FG000|Overall Study|Poor Compliance to Protocol|1|||
129976407|NCT01252355|467877754|FG001|Overall Study|Poor Compliance to Protocol|1|||
129976408|NCT01252355|467877755|FG002|Overall Study|Poor Compliance to Protocol|1|||
129976409|NCT01252355|467877753|FG000|Overall Study|Progressive Disease|2|||
130143219|NCT01698554|468484334|FG002|Overall Study|Protocol Violation|1|||
130143220|NCT01698554|468484335|FG003|Overall Study|Protocol Violation|0|||
130143221|NCT01698554|468484332|FG000|Overall Study|Other Miscellaneous Reasons|1|||
130143222|NCT01698554|468484333|FG001|Overall Study|Other Miscellaneous Reasons|0|||
130143223|NCT01698554|468484334|FG002|Overall Study|Other Miscellaneous Reasons|0|||
130143224|NCT01698554|468484335|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129976410|NCT01252355|467877754|FG001|Overall Study|Progressive Disease|0|||
129976411|NCT01252355|467877755|FG002|Overall Study|Progressive Disease|0|||
129976412|NCT01252355|467877753|FG000|Overall Study|Sponsor Early Termination of Study|149|||
129976413|NCT01252355|467877754|FG001|Overall Study|Sponsor Early Termination of Study|149|||
129976414|NCT01252355|467877755|FG002|Overall Study|Sponsor Early Termination of Study|146|||
130143225|NCT02229084|468484336|FG000|Overall Study|Adverse Event|1|||
130143226|NCT02229084|468484337|FG001|Overall Study|Adverse Event|0|||
130143227|NCT02229084|468484338|FG002|Overall Study|Adverse Event|0|||
130143228|NCT02229084|468484339|FG003|Overall Study|Adverse Event|0|||
130143229|NCT02229084|468484340|FG004|Overall Study|Adverse Event|0|||
130143230|NCT02229084|468484341|FG005|Overall Study|Adverse Event|0|||
130143231|NCT02229084|468484342|FG006|Overall Study|Adverse Event|0|||
130143232|NCT02229084|468484336|FG000|Overall Study|Lost to Follow-up|0|||
130143233|NCT02229084|468484337|FG001|Overall Study|Lost to Follow-up|0|||
130143234|NCT02229084|468484338|FG002|Overall Study|Lost to Follow-up|1|||
130143235|NCT02229084|468484339|FG003|Overall Study|Lost to Follow-up|1|||
130143236|NCT02229084|468484340|FG004|Overall Study|Lost to Follow-up|0|||
130143237|NCT02229084|468484341|FG005|Overall Study|Lost to Follow-up|0|||
130143238|NCT02229084|468484342|FG006|Overall Study|Lost to Follow-up|1|||
130143239|NCT02229084|468484336|FG000|Overall Study|Physician Decision|0|||
130143240|NCT02229084|468484337|FG001|Overall Study|Physician Decision|0|||
130143241|NCT02229084|468484338|FG002|Overall Study|Physician Decision|0|||
130143242|NCT02229084|468484339|FG003|Overall Study|Physician Decision|1|||
130143243|NCT02229084|468484340|FG004|Overall Study|Physician Decision|3|||
130143244|NCT02229084|468484341|FG005|Overall Study|Physician Decision|0|||
130143245|NCT02229084|468484342|FG006|Overall Study|Physician Decision|1|||
130143246|NCT02229084|468484336|FG000|Overall Study|Withdrawal by Subject|0|||
130143247|NCT02229084|468484337|FG001|Overall Study|Withdrawal by Subject|0|||
130143248|NCT02229084|468484338|FG002|Overall Study|Withdrawal by Subject|1|||
130143249|NCT02229084|468484339|FG003|Overall Study|Withdrawal by Subject|0|||
130143250|NCT02229084|468484340|FG004|Overall Study|Withdrawal by Subject|1|||
130143251|NCT02229084|468484341|FG005|Overall Study|Withdrawal by Subject|1|||
130143252|NCT02229084|468484342|FG006|Overall Study|Withdrawal by Subject|1|||
130143253|NCT02229084|468484336|FG000|Overall Study|Death|0|||
130143254|NCT02229084|468484337|FG001|Overall Study|Death|0|||
130143255|NCT02229084|468484338|FG002|Overall Study|Death|0|||
130143256|NCT02229084|468484339|FG003|Overall Study|Death|0|||
130143257|NCT02229084|468484340|FG004|Overall Study|Death|0|||
130143258|NCT02229084|468484341|FG005|Overall Study|Death|0|||
130143259|NCT02229084|468484342|FG006|Overall Study|Death|1|||
130143260|NCT04561115|468484353|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
130143261|NCT04561115|468484354|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
130143262|NCT04561115|468484353|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
130143263|NCT04561115|468484354|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
130143264|NCT04561115|468484353|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
130143265|NCT04561115|468484354|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
130143266|NCT00743145|468484355|FG000|Overall Study|Withdrawal by Subject|1|||
130143267|NCT00743145|468484355|FG000|Overall Study|Adverse Event|2|||
130143268|NCT00743145|468484355|FG000|Overall Study|Pregnancy|1|||
130143269|NCT02416180|468484356|FG000|Overall Study|Withdrawal by Subject|1|||
130143270|NCT01745094|468484357|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
130143271|NCT01745094|468484358|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
130143272|NCT01745094|468484359|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
130143273|NCT01745094|468484360|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
130143274|NCT01745094|468484357|FG000|Overall Study|Adverse Event|0|||
130143275|NCT01745094|468484358|FG001|Overall Study|Adverse Event|0|||
130143276|NCT01745094|468484359|FG002|Overall Study|Adverse Event|3|||
130143277|NCT01745094|468484360|FG003|Overall Study|Adverse Event|0|||
130143278|NCT01745094|468484357|FG000|Overall Study|Withdrawal by Subject|2|||
130143279|NCT01745094|468484358|FG001|Overall Study|Withdrawal by Subject|0|||
130143280|NCT01745094|468484359|FG002|Overall Study|Withdrawal by Subject|1|||
130143281|NCT01745094|468484360|FG003|Overall Study|Withdrawal by Subject|2|||
130143282|NCT01745094|468484357|FG000|Overall Study|Protocol Violation|1|||
130143283|NCT01745094|468484358|FG001|Overall Study|Protocol Violation|0|||
130143284|NCT01745094|468484359|FG002|Overall Study|Protocol Violation|3|||
130143285|NCT01745094|468484360|FG003|Overall Study|Protocol Violation|1|||
130143286|NCT01745094|468484357|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
130143287|NCT01745094|468484358|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
130143288|NCT01745094|468484359|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
130143289|NCT01745094|468484360|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
130143290|NCT01745094|468484357|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
130143291|NCT01745094|468484358|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
130143292|NCT01745094|468484359|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
130143293|NCT01745094|468484360|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
130143294|NCT01745094|468484357|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
130143295|NCT01745094|468484358|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130143296|NCT01745094|468484359|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130143297|NCT01745094|468484360|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
130143298|NCT00881569|468484364|FG000|Overall Study|Disease progression|1|||
130143299|NCT00881569|468484365|FG001|Overall Study|Disease progression|1|||
130143300|NCT02623218|468484376|FG000|Overall Study|Lost to Follow-up|0|||
130143301|NCT02623218|468484377|FG001|Overall Study|Lost to Follow-up|1|||
130143302|NCT02623218|468484378|FG002|Overall Study|Lost to Follow-up|0|||
130143303|NCT02623218|468484379|FG003|Overall Study|Lost to Follow-up|0|||
130143304|NCT02623218|468484380|FG004|Overall Study|Lost to Follow-up|0|||
130143305|NCT01726803|468484381|FG000|Overall Study|Lost to Follow-up|6|||
130143306|NCT01726803|468484382|FG001|Overall Study|Lost to Follow-up|1|||
130143307|NCT01726803|468484381|FG000|Overall Study|Withdrawal by Subject|1|||
130143308|NCT01726803|468484382|FG001|Overall Study|Withdrawal by Subject|0|||
130143309|NCT01685008|468484384|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
130143310|NCT01685008|468484385|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
130143311|NCT01685008|468484386|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
130143312|NCT01685008|468484387|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
130143313|NCT01685008|468484384|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130143314|NCT01685008|468484385|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
130143315|NCT01685008|468484386|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130143316|NCT01685008|468484387|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
130143317|NCT01685008|468484384|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130143318|NCT01685008|468484385|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
130143319|NCT01685008|468484386|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130143320|NCT01685008|468484387|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
130143321|NCT01685008|468484384|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
130143322|NCT01685008|468484385|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
130143323|NCT01685008|468484386|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
130143324|NCT01685008|468484387|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
130143325|NCT01685008|468484384|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
130143326|NCT01685008|468484385|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
130143327|NCT01685008|468484386|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
130143328|NCT01685008|468484387|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
130143329|NCT01970592|468484388|FG000|Overall Study|Withdrawal by Subject|4|||
130143330|NCT01970592|468484388|FG000|Overall Study|Physician Decision|1|||
130143331|NCT01970592|468484388|FG000|Overall Study|Adverse Event|1|||
130143332|NCT01320722|468484391|FG000|Overall Study|Did not Receive Intervention|3|||
130143333|NCT01320722|468484392|FG001|Overall Study|Did not Receive Intervention|2|||
130143334|NCT01320722|468484393|FG002|Overall Study|Did not Receive Intervention|1|||
130143335|NCT01320722|468484394|FG003|Overall Study|Did not Receive Intervention|1|||
130143336|NCT01320722|468484395|FG004|Overall Study|Did not Receive Intervention|2|||
130143337|NCT01320722|468484391|FG000|Overall Study|Lost to Follow-up|0|||
130143338|NCT01320722|468484392|FG001|Overall Study|Lost to Follow-up|1|||
130143339|NCT01320722|468484393|FG002|Overall Study|Lost to Follow-up|0|||
130143340|NCT01320722|468484394|FG003|Overall Study|Lost to Follow-up|1|||
130143341|NCT01320722|468484395|FG004|Overall Study|Lost to Follow-up|3|||
130143342|NCT01320722|468484391|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
130143343|NCT01320722|468484392|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
130143344|NCT01320722|468484393|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
130143345|NCT01320722|468484394|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
130143346|NCT01320722|468484395|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
130143347|NCT01320722|468484391|FG000|Overall Study|Participant Developed a Rash|0|||
130143348|NCT01320722|468484392|FG001|Overall Study|Participant Developed a Rash|0|||
130143349|NCT01320722|468484393|FG002|Overall Study|Participant Developed a Rash|2|||
130143350|NCT01320722|468484394|FG003|Overall Study|Participant Developed a Rash|1|||
130143351|NCT01320722|468484395|FG004|Overall Study|Participant Developed a Rash|1|||
130143352|NCT01320722|468484391|FG000|Overall Study|Non-compliant with Medication|0|||
130143353|NCT01320722|468484392|FG001|Overall Study|Non-compliant with Medication|0|||
130143354|NCT01320722|468484393|FG002|Overall Study|Non-compliant with Medication|1|||
130143355|NCT01320722|468484394|FG003|Overall Study|Non-compliant with Medication|0|||
130143356|NCT01320722|468484395|FG004|Overall Study|Non-compliant with Medication|0|||
130143357|NCT01320722|468484391|FG000|Overall Study|Adverse Event|0|||
130143358|NCT01320722|468484392|FG001|Overall Study|Adverse Event|0|||
130143359|NCT01320722|468484393|FG002|Overall Study|Adverse Event|3|||
130143360|NCT01320722|468484394|FG003|Overall Study|Adverse Event|6|||
130143361|NCT01320722|468484395|FG004|Overall Study|Adverse Event|0|||
130143362|NCT01320722|468484391|FG000|Overall Study|Not Compliant with Study Procedures|0|||
130143363|NCT01320722|468484392|FG001|Overall Study|Not Compliant with Study Procedures|0|||
130143364|NCT01320722|468484393|FG002|Overall Study|Not Compliant with Study Procedures|0|||
130143365|NCT01320722|468484394|FG003|Overall Study|Not Compliant with Study Procedures|4|||
130143366|NCT01320722|468484395|FG004|Overall Study|Not Compliant with Study Procedures|0|||
130143367|NCT01320722|468484391|FG000|Overall Study|Pregnancy|0|||
130143368|NCT01320722|468484392|FG001|Overall Study|Pregnancy|0|||
130143369|NCT01320722|468484393|FG002|Overall Study|Pregnancy|0|||
130143370|NCT01320722|468484394|FG003|Overall Study|Pregnancy|1|||
130143371|NCT01320722|468484395|FG004|Overall Study|Pregnancy|0|||
130143372|NCT01320722|468484391|FG000|Overall Study|Started an Exclusionary Medication|0|||
130143373|NCT01320722|468484392|FG001|Overall Study|Started an Exclusionary Medication|0|||
130143374|NCT01320722|468484393|FG002|Overall Study|Started an Exclusionary Medication|0|||
130143375|NCT01320722|468484394|FG003|Overall Study|Started an Exclusionary Medication|0|||
130143376|NCT01320722|468484395|FG004|Overall Study|Started an Exclusionary Medication|1|||
130143377|NCT01320722|468484391|FG000|Overall Study|Withdrew due to Health Condition|0|||
130143378|NCT01320722|468484392|FG001|Overall Study|Withdrew due to Health Condition|0|||
130143379|NCT01320722|468484393|FG002|Overall Study|Withdrew due to Health Condition|0|||
130143380|NCT01320722|468484394|FG003|Overall Study|Withdrew due to Health Condition|0|||
130143381|NCT01320722|468484395|FG004|Overall Study|Withdrew due to Health Condition|1|||
130143382|NCT00160524|468484396|FG000|Overall Study|Adverse Event|119|||
130143383|NCT00160524|468484396|FG000|Overall Study|Adverse Event and Other|94|||
130143384|NCT00160524|468484396|FG000|Overall Study|Protocol Violation|16|||
130143385|NCT00160524|468484396|FG000|Overall Study|Protocol Violation and Other|2|||
130143386|NCT00160524|468484396|FG000|Overall Study|Withdrawal by Subject|141|||
130143387|NCT00160524|468484396|FG000|Overall Study|Withdrawal by Subject and Other|17|||
130143388|NCT00160524|468484396|FG000|Overall Study|Physician Decision|27|||
130143389|NCT00160524|468484396|FG000|Overall Study|Physician Decision and Other|6|||
130143390|NCT00160524|468484396|FG000|Overall Study|Lost to Follow-up|13|||
130143391|NCT00160524|468484396|FG000|Overall Study|Lost to Follow-up and Other|1|||
130143392|NCT00160524|468484396|FG000|Overall Study|Lack of Efficacy|21|||
130143393|NCT00160524|468484396|FG000|Overall Study|Lack of Efficacy and Other|1|||
130143394|NCT00160524|468484396|FG000|Overall Study|Other|20|||
130143395|NCT00057941|468484406|FG000|Overall Study|Death|1|||
130143396|NCT00057941|468484407|FG001|Overall Study|Death|2|||
130143397|NCT00057941|468484406|FG000|Overall Study|Adverse Event|7|||
130143398|NCT00057941|468484407|FG001|Overall Study|Adverse Event|9|||
130143399|NCT00057941|468484406|FG000|Overall Study|Lack of Efficacy|54|||
130143400|NCT00057941|468484407|FG001|Overall Study|Lack of Efficacy|53|||
130143401|NCT00057941|468484406|FG000|Overall Study|Withdrawal by Subject|6|||
130143402|NCT00057941|468484407|FG001|Overall Study|Withdrawal by Subject|1|||
130143403|NCT00057941|468484406|FG000|Overall Study|still on treatment|3|||
130143404|NCT00057941|468484407|FG001|Overall Study|still on treatment|1|||
130143405|NCT00057941|468484406|FG000|Overall Study|insurance, symptomatic deterioration|1|||
130143406|NCT00057941|468484407|FG001|Overall Study|insurance, symptomatic deterioration|3|||
130143407|NCT00057941|468484406|FG000|Overall Study|Ineligible|2|||
130143408|NCT00057941|468484407|FG001|Overall Study|Ineligible|5|||
130143409|NCT02616380|468484408|FG000|Overall Study|Lost to Follow-up|1|||
130143410|NCT02616380|468484408|FG000|Overall Study|Other|2|||
130143411|NCT03407729|468484410|FG000|Overall Study|Lost to Follow-up|2|||
130143412|NCT03407729|468484411|FG001|Overall Study|Lost to Follow-up|0|||
130143413|NCT03407729|468484410|FG000|Overall Study|Unable to schedule|0|||
130143414|NCT03407729|468484411|FG001|Overall Study|Unable to schedule|3|||
130143415|NCT03950674|468484412|FG000|Overall Study|Death|16|||
130143416|NCT03950674|468484413|FG001|Overall Study|Death|15|||
130143417|NCT03950674|468484412|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
130143418|NCT03950674|468484413|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
130143419|NCT00830167|468484416|FG000|Overall Study|Lack of Efficacy|26|||
130143420|NCT00830167|468484417|FG001|Overall Study|Lack of Efficacy|10|||
130143421|NCT00830167|468484416|FG000|Overall Study|Adverse Event|8|||
130143422|NCT00830167|468484417|FG001|Overall Study|Adverse Event|24|||
130143423|NCT00830167|468484416|FG000|Overall Study|Not meeting entrance criteria|2|||
130143424|NCT00830167|468484417|FG001|Overall Study|Not meeting entrance criteria|5|||
130143425|NCT00830167|468484416|FG000|Overall Study|Withdrawal by Subject|2|||
130143426|NCT00830167|468484417|FG001|Overall Study|Withdrawal by Subject|0|||
130143427|NCT00830167|468484416|FG000|Overall Study|Lost to Follow-up|0|||
130143428|NCT00830167|468484417|FG001|Overall Study|Lost to Follow-up|1|||
130143429|NCT00830167|468484416|FG000|Overall Study|Protocol Violation|0|||
130143430|NCT00830167|468484417|FG001|Overall Study|Protocol Violation|1|||
130143431|NCT00830167|468484416|FG000|Overall Study|Other|2|||
130143432|NCT00830167|468484417|FG001|Overall Study|Other|2|||
130143433|NCT00609154|468484418|FG000|Overall Study|Protocol Violation|1|||
130143434|NCT00609154|468484419|FG001|Overall Study|Protocol Violation|2|||
130143435|NCT00609154|468484418|FG000|Overall Study|Unable to establish IV access|0|||
130143436|NCT00609154|468484419|FG001|Overall Study|Unable to establish IV access|4|||
130143437|NCT00609154|468484418|FG000|Overall Study|Adverse Event|0|||
130143438|NCT00609154|468484419|FG001|Overall Study|Adverse Event|2|||
130143439|NCT02224053|468484420|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
129976415|NCT01252355|467877753|FG000|Overall Study|Randomized but not Treated|2|||
129976416|NCT01252355|467877754|FG001|Overall Study|Randomized but not Treated|0|||
130143440|NCT02224053|468484420|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
130143441|NCT02224053|468484420|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
130143442|NCT02224053|468484420|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
130143443|NCT02224053|468484420|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
130143444|NCT01898598|468484424|FG000|Overall Study|Adverse Event|1|||
130143445|NCT01898598|468484425|FG001|Overall Study|Adverse Event|0|||
130143446|NCT01898598|468484424|FG000|Overall Study|Withdrawal by Subject|3|||
130143447|NCT01898598|468484425|FG001|Overall Study|Withdrawal by Subject|0|||
130143448|NCT01898598|468484424|FG000|Overall Study|Lost to Follow-up|0|||
130143449|NCT01898598|468484425|FG001|Overall Study|Lost to Follow-up|1|||
130143450|NCT01898598|468484424|FG000|Overall Study|Other|0|||
130143451|NCT01898598|468484425|FG001|Overall Study|Other|1|||
130143452|NCT00860262|468484426|FG000|Overall Study|Adverse Event|9|||
130143453|NCT00860262|468484427|FG001|Overall Study|Adverse Event|6|||
130143454|NCT00860262|468484428|FG002|Overall Study|Adverse Event|7|||
130143455|NCT00860262|468484426|FG000|Overall Study|Protocol Violation|0|||
130143456|NCT00860262|468484427|FG001|Overall Study|Protocol Violation|1|||
130143457|NCT00860262|468484428|FG002|Overall Study|Protocol Violation|0|||
130143458|NCT00860262|468484426|FG000|Overall Study|Lost to Follow-up|2|||
130143459|NCT00860262|468484427|FG001|Overall Study|Lost to Follow-up|0|||
130143460|NCT00860262|468484428|FG002|Overall Study|Lost to Follow-up|1|||
130143461|NCT00860262|468484426|FG000|Overall Study|Withdrawal by Subject|4|||
130143462|NCT00860262|468484427|FG001|Overall Study|Withdrawal by Subject|8|||
130143463|NCT00860262|468484428|FG002|Overall Study|Withdrawal by Subject|6|||
130143464|NCT00860262|468484426|FG000|Overall Study|Lack of Efficacy|0|||
130143465|NCT00860262|468484427|FG001|Overall Study|Lack of Efficacy|4|||
130143466|NCT00860262|468484428|FG002|Overall Study|Lack of Efficacy|3|||
130143467|NCT00860262|468484426|FG000|Overall Study|Other|5|||
130143468|NCT00860262|468484427|FG001|Overall Study|Other|3|||
130143469|NCT00860262|468484428|FG002|Overall Study|Other|1|||
130143470|NCT00124618|468484429|FG000|Overall Study|Ineligible|1|||
130143471|NCT01596127|468484430|FG000|Overall Study|Patient Ineligible|1|||
130143472|NCT00633022|468484431|FG000|Overall Study|Adverse Event|1|||
130143473|NCT00633022|468484432|FG001|Overall Study|Adverse Event|0|||
130143474|NCT00633022|468484433|FG002|Overall Study|Adverse Event|5|||
130143475|NCT00633022|468484431|FG000|Overall Study|Physician Decision|0|||
130143476|NCT00633022|468484432|FG001|Overall Study|Physician Decision|1|||
130143477|NCT00633022|468484433|FG002|Overall Study|Physician Decision|0|||
130143478|NCT04388787|468484434|FG000|Blinded Period|Patient could not follow instructions|1|||
130143479|NCT04388787|468484434|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
130143480|NCT00688844|468484435|FG000|Overall Study|Lost to Follow-up|10|||
130143481|NCT01374451|468484436|FG000|Overall Study|Administrative problems|1|||
130143482|NCT01374451|468484437|FG001|Overall Study|Administrative problems|0|||
130143483|NCT01223027|468484438|FG000|Overall Study|Adverse Event|20|||
130143484|NCT01223027|468484439|FG001|Overall Study|Adverse Event|10|||
130143485|NCT01223027|468484438|FG000|Overall Study|Death|42|||
130143486|NCT01223027|468484439|FG001|Overall Study|Death|42|||
130143487|NCT01223027|468484438|FG000|Overall Study|Lost to Follow-up|2|||
130143488|NCT01223027|468484439|FG001|Overall Study|Lost to Follow-up|1|||
130143489|NCT01223027|468484438|FG000|Overall Study|Physician Decision|4|||
130143490|NCT01223027|468484439|FG001|Overall Study|Physician Decision|8|||
130143491|NCT01223027|468484438|FG000|Overall Study|Progressive Disease|167|||
130143492|NCT01223027|468484439|FG001|Overall Study|Progressive Disease|183|||
130143493|NCT01223027|468484438|FG000|Overall Study|Protocol Violation|2|||
130143494|NCT01223027|468484439|FG001|Overall Study|Protocol Violation|1|||
130143495|NCT01223027|468484438|FG000|Overall Study|Subject/guardian decicion|18|||
130143496|NCT01223027|468484439|FG001|Overall Study|Subject/guardian decicion|16|||
130143497|NCT01223027|468484438|FG000|Overall Study|New therapy for study indication|17|||
130143498|NCT01223027|468484439|FG001|Overall Study|New therapy for study indication|8|||
130143499|NCT01223027|468484438|FG000|Overall Study|Study terminated by sponsor|2|||
130143500|NCT01223027|468484439|FG001|Overall Study|Study terminated by sponsor|8|||
130143501|NCT02061280|468484440|FG000|Overall Study|Protocol Violation|12|||
130143502|NCT02061280|468484441|FG001|Overall Study|Protocol Violation|8|||
130143503|NCT02061280|468484440|FG000|Overall Study|moved out of state|0|||
130143504|NCT02061280|468484441|FG001|Overall Study|moved out of state|1|||
130143505|NCT02061280|468484440|FG000|Overall Study|Withdrawal by Subject|1|||
130143506|NCT02061280|468484441|FG001|Overall Study|Withdrawal by Subject|2|||
130143507|NCT02061280|468484440|FG000|Overall Study|Lost to Follow-up|5|||
130143508|NCT02061280|468484441|FG001|Overall Study|Lost to Follow-up|1|||
130143509|NCT00724958|468484442|FG000|Overall Study|Adverse Event|28|||
130143510|NCT00724958|468484442|FG000|Overall Study|Loss of Response|40|||
130143511|NCT00724958|468484442|FG000|Overall Study|No Response|18|||
130143512|NCT00724958|468484442|FG000|Overall Study|Remission|7|||
130143513|NCT00724958|468484442|FG000|Overall Study|Other Reason|76|||
130143514|NCT00724958|468484442|FG000|Overall Study|No documentation for end of therapy|13|||
130143515|NCT01520987|468486073|FG000|Overall Study|Withdrawal by Subject|1|||
130143516|NCT01520987|468486074|FG001|Overall Study|Withdrawal by Subject|0|||
130143517|NCT01520987|468486075|FG002|Overall Study|Withdrawal by Subject|0|||
130143518|NCT01520987|468486076|FG003|Overall Study|Withdrawal by Subject|0|||
130143519|NCT01520987|468486077|FG004|Overall Study|Withdrawal by Subject|0|||
130143520|NCT01520987|468486078|FG005|Overall Study|Withdrawal by Subject|1|||
130143521|NCT01520987|468486079|FG006|Overall Study|Withdrawal by Subject|0|||
130143522|NCT01520987|468486080|FG007|Overall Study|Withdrawal by Subject|0|||
130143523|NCT04729101|468486081|FG000|Overall Study|Adverse Event|1|||
130143524|NCT04729101|468486082|FG001|Overall Study|Adverse Event|0|||
130143525|NCT04729101|468486081|FG000|Overall Study|Physician Decision|1|||
130143526|NCT04729101|468486082|FG001|Overall Study|Physician Decision|0|||
130143527|NCT04729101|468486081|FG000|Overall Study|Withdrawal by Subject|1|||
130143528|NCT04729101|468486082|FG001|Overall Study|Withdrawal by Subject|0|||
130143529|NCT02940522|468486083|FG000|Overall Study|Lost to Follow-up|1|||
130143530|NCT02940522|468486084|FG001|Overall Study|Lost to Follow-up|2|||
130143531|NCT02940522|468486083|FG000|Overall Study|Withdrawal by Subject|1|||
130143532|NCT02940522|468486084|FG001|Overall Study|Withdrawal by Subject|0|||
130143533|NCT00274625|468486085|FG000|Overall Study|Lost to Follow-up|46|||
130143534|NCT00274625|468486086|FG001|Overall Study|Lost to Follow-up|54|||
130143535|NCT00274625|468486085|FG000|Overall Study|Excluded from analysis|14|||
130143536|NCT00274625|468486086|FG001|Overall Study|Excluded from analysis|8|||
130143537|NCT01754376|468486090|FG000|Overall Study|Adverse Event|1|||
130143538|NCT01754376|468486090|FG000|Overall Study|Lack of Efficacy|2|||
130143539|NCT04768296|468486091|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
130143540|NCT04768296|468486092|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
130143541|NCT03087786|468486093|FG000|Overall Study|Withdrawal by Subject|2|||
130143542|NCT03087786|468486094|FG001|Overall Study|Withdrawal by Subject|0|||
130143543|NCT01453153|468486099|FG000|Overall Study|Physician Decision|0|||
130143544|NCT01453153|468486100|FG001|Overall Study|Physician Decision|0|||
130143545|NCT01453153|468486101|FG002|Overall Study|Physician Decision|1|||
130143546|NCT01453153|468486099|FG000|Overall Study|Progressive Disease|3|||
130143547|NCT01453153|468486100|FG001|Overall Study|Progressive Disease|2|||
130143548|NCT01453153|468486101|FG002|Overall Study|Progressive Disease|16|||
130143549|NCT01453153|468486099|FG000|Overall Study|Withdrawal by Subject|0|||
130143550|NCT01453153|468486100|FG001|Overall Study|Withdrawal by Subject|1|||
130143551|NCT01453153|468486101|FG002|Overall Study|Withdrawal by Subject|2|||
130143552|NCT01453153|468486099|FG000|Overall Study|Adverse Event|1|||
130143553|NCT01453153|468486100|FG001|Overall Study|Adverse Event|1|||
130143554|NCT01453153|468486101|FG002|Overall Study|Adverse Event|1|||
130143555|NCT01802216|468486103|FG000|4 Month Visit|Participant did not show to visit|3|||
130143556|NCT01802216|468486104|FG001|4 Month Visit|Participant did not show to visit|4|||
130143557|NCT01802216|468486103|FG000|8 Month Visit|Participant did not show to visit|3|||
130143558|NCT01802216|468486104|FG001|8 Month Visit|Participant did not show to visit|5|||
130143559|NCT01802216|468486103|FG000|12 Month Visit|Participant did not show to visit|3|||
130143560|NCT01802216|468486104|FG001|12 Month Visit|Participant did not show to visit|4|||
130143561|NCT00880334|468486105|FG000|Randomized Phase|Physician Decision|1|||
130143562|NCT00880334|468486106|FG001|Randomized Phase|Physician Decision|0|||
130143563|NCT00880334|468486105|FG000|Randomized Phase|Withdrawal by Subject|2|||
130143564|NCT00880334|468486106|FG001|Randomized Phase|Withdrawal by Subject|1|||
130143565|NCT00880334|468486105|FG000|Randomized Phase|Inadequate Labs|1|||
130143566|NCT00880334|468486106|FG001|Randomized Phase|Inadequate Labs|1|||
130143567|NCT00880334|468486105|FG000|Randomized Phase|Brain Metastasis|0|||
130143568|NCT00880334|468486106|FG001|Randomized Phase|Brain Metastasis|1|||
130143569|NCT00880334|468486105|FG000|Randomized Phase|Crossover Participants|0|||
130143570|NCT00880334|468486106|FG001|Randomized Phase|Crossover Participants|37|||
130143571|NCT02274558|468486107|FG000|Overall Study|Adverse Event|2|||
130143572|NCT02274558|468486108|FG001|Overall Study|Adverse Event|4|||
130143573|NCT02274558|468486109|FG002|Overall Study|Adverse Event|2|||
130143574|NCT02274558|468486107|FG000|Overall Study|Non-compliance|2|||
130143575|NCT02274558|468486108|FG001|Overall Study|Non-compliance|1|||
130143576|NCT02274558|468486109|FG002|Overall Study|Non-compliance|0|||
130143577|NCT02274558|468486107|FG000|Overall Study|Withdrawal by Subject|1|||
130143578|NCT02274558|468486108|FG001|Overall Study|Withdrawal by Subject|5|||
130143579|NCT02274558|468486109|FG002|Overall Study|Withdrawal by Subject|4|||
130143580|NCT02274558|468486107|FG000|Overall Study|Death|0|||
130143581|NCT02274558|468486108|FG001|Overall Study|Death|0|||
130143582|NCT02274558|468486109|FG002|Overall Study|Death|1|||
130143583|NCT02274558|468486107|FG000|Overall Study|Lost to Follow-up|2|||
130143584|NCT02274558|468486108|FG001|Overall Study|Lost to Follow-up|1|||
130143585|NCT02274558|468486109|FG002|Overall Study|Lost to Follow-up|1|||
130143586|NCT02274558|468486107|FG000|Overall Study|Physician Decision|0|||
130143587|NCT02274558|468486108|FG001|Overall Study|Physician Decision|2|||
130143588|NCT02274558|468486109|FG002|Overall Study|Physician Decision|1|||
130143589|NCT04542694|468486122|FG000|Overall Study|The need for prohibited therapy|2|||
130143590|NCT04542694|468486123|FG001|Overall Study|The need for prohibited therapy|0|||
130143591|NCT04542694|468486122|FG000|Overall Study|Adverse Event|1|||
130143592|NCT04542694|468486123|FG001|Overall Study|Adverse Event|0|||
130143593|NCT04542694|468486122|FG000|Overall Study|Protocol Violation|1|||
130143594|NCT04542694|468486123|FG001|Overall Study|Protocol Violation|0|||
130143595|NCT00969124|468486124|FG000|Overall Study|Protocol Violation|2|||
130143596|NCT00969124|468486124|FG000|Overall Study|Inadequate bowel preparation|15|||
130143597|NCT00969124|468486124|FG000|Overall Study|Inability to reach cecum|9|||
130143598|NCT00969124|468486124|FG000|Overall Study|Previously unrecognized disease|3|||
130143599|NCT00969124|468486124|FG000|Overall Study|Technical error|1|||
130143600|NCT00687739|468486125|FG000|Overall Study|Lost to Follow-up|2|||
130143601|NCT00687739|468486126|FG001|Overall Study|Lost to Follow-up|2|||
130143602|NCT00687739|468486127|FG002|Overall Study|Lost to Follow-up|1|||
130143603|NCT00687739|468486128|FG003|Overall Study|Lost to Follow-up|2|||
130143604|NCT00687739|468486125|FG000|Overall Study|Adverse Event|0|||
130143605|NCT00687739|468486126|FG001|Overall Study|Adverse Event|1|||
130143606|NCT00687739|468486127|FG002|Overall Study|Adverse Event|1|||
130143607|NCT00687739|468486128|FG003|Overall Study|Adverse Event|0|||
130143608|NCT01957150|468486130|FG000|Overall Study|Adverse Event|23|||
130143609|NCT01957150|468486131|FG001|Overall Study|Adverse Event|20|||
130143610|NCT01957150|468486130|FG000|Overall Study|Withdrawal by Subject|13|||
130143611|NCT01957150|468486131|FG001|Overall Study|Withdrawal by Subject|17|||
130143612|NCT01957150|468486130|FG000|Overall Study|Physician Decision|3|||
130143613|NCT01957150|468486131|FG001|Overall Study|Physician Decision|6|||
130143614|NCT01957150|468486130|FG000|Overall Study|Lost to Follow-up|4|||
130143615|NCT01957150|468486131|FG001|Overall Study|Lost to Follow-up|4|||
130143616|NCT01957150|468486130|FG000|Overall Study|Protocol Violation|1|||
130143617|NCT01957150|468486131|FG001|Overall Study|Protocol Violation|0|||
130143618|NCT01957150|468486130|FG000|Overall Study|Lack of Efficacy|11|||
130143619|NCT01957150|468486131|FG001|Overall Study|Lack of Efficacy|11|||
130143620|NCT02451358|468486134|FG000|Overall Study|Withdrawal by Subject|1|||
130143621|NCT02451358|468486135|FG001|Overall Study|Withdrawal by Subject|1|||
130143622|NCT02451358|468486136|FG002|Overall Study|Withdrawal by Subject|0|||
130143623|NCT02451358|468486137|FG003|Overall Study|Withdrawal by Subject|0|||
130143624|NCT02451358|468486134|FG000|Overall Study|Protocol Violation|0|||
130143625|NCT02451358|468486135|FG001|Overall Study|Protocol Violation|1|||
130143626|NCT02451358|468486136|FG002|Overall Study|Protocol Violation|1|||
130143627|NCT02451358|468486137|FG003|Overall Study|Protocol Violation|0|||
130143628|NCT00252564|468486142|FG000|Overall Study|Adverse Event|17|||
130143629|NCT00252564|468486143|FG001|Overall Study|Adverse Event|13|||
130143630|NCT00252564|468486142|FG000|Overall Study|Unrelated Complication|2|||
130143631|NCT00252564|468486143|FG001|Overall Study|Unrelated Complication|1|||
130143632|NCT00252564|468486142|FG000|Overall Study|Disease Progression|14|||
130143633|NCT00252564|468486143|FG001|Overall Study|Disease Progression|20|||
130143634|NCT00252564|468486142|FG000|Overall Study|Death|0|||
130143635|NCT00252564|468486143|FG001|Overall Study|Death|3|||
130143636|NCT00252564|468486142|FG000|Overall Study|Physician Decision|1|||
130143637|NCT00252564|468486143|FG001|Overall Study|Physician Decision|0|||
130143638|NCT00252564|468486142|FG000|Overall Study|Lost to Follow-up|1|||
130143639|NCT00252564|468486143|FG001|Overall Study|Lost to Follow-up|0|||
130143640|NCT00252564|468486142|FG000|Overall Study|Patient Request|4|||
130143641|NCT00252564|468486143|FG001|Overall Study|Patient Request|5|||
130143642|NCT00252564|468486142|FG000|Overall Study|Withdrawal by Subject|0|||
130143643|NCT00252564|468486143|FG001|Overall Study|Withdrawal by Subject|2|||
130143644|NCT01583530|468486145|FG000|Overall Study|Adverse Event|0|||
130143645|NCT01583530|468486146|FG001|Overall Study|Adverse Event|0|||
130143646|NCT01583530|468486147|FG002|Overall Study|Adverse Event|0|||
130143647|NCT01583530|468486148|FG003|Overall Study|Adverse Event|0|||
130143648|NCT01583530|468486149|FG004|Overall Study|Adverse Event|0|||
130143649|NCT01583530|468486150|FG005|Overall Study|Adverse Event|1|||
130143650|NCT01583530|468486145|FG000|Overall Study|Withdrawal by Subject|0|||
130143651|NCT01583530|468486146|FG001|Overall Study|Withdrawal by Subject|3|||
130143652|NCT01583530|468486147|FG002|Overall Study|Withdrawal by Subject|0|||
130143653|NCT01583530|468486148|FG003|Overall Study|Withdrawal by Subject|1|||
130143654|NCT01583530|468486149|FG004|Overall Study|Withdrawal by Subject|1|||
130143655|NCT01583530|468486150|FG005|Overall Study|Withdrawal by Subject|2|||
130143656|NCT01583530|468486145|FG000|Overall Study|Lost to Follow-up|0|||
130143657|NCT01583530|468486146|FG001|Overall Study|Lost to Follow-up|0|||
130143658|NCT01583530|468486147|FG002|Overall Study|Lost to Follow-up|0|||
130143659|NCT01583530|468486148|FG003|Overall Study|Lost to Follow-up|0|||
130143660|NCT01583530|468486149|FG004|Overall Study|Lost to Follow-up|3|||
130143661|NCT01583530|468486150|FG005|Overall Study|Lost to Follow-up|0|||
130143662|NCT01583530|468486145|FG000|Overall Study|Lack of compliance|0|||
130143663|NCT01583530|468486146|FG001|Overall Study|Lack of compliance|0|||
130143664|NCT01583530|468486147|FG002|Overall Study|Lack of compliance|0|||
130143665|NCT01583530|468486148|FG003|Overall Study|Lack of compliance|0|||
130143666|NCT01583530|468486149|FG004|Overall Study|Lack of compliance|1|||
130143667|NCT01583530|468486150|FG005|Overall Study|Lack of compliance|0|||
130143668|NCT03414034|468486153|FG000|Overall Study|Adverse Event|6|||
130143669|NCT03414034|468486154|FG001|Overall Study|Adverse Event|1|||
130143670|NCT03414034|468486155|FG002|Overall Study|Adverse Event|1|||
130143671|NCT03414034|468486153|FG000|Overall Study|Death|0|||
130143672|NCT03414034|468486154|FG001|Overall Study|Death|0|||
130143673|NCT03414034|468486155|FG002|Overall Study|Death|1|||
130143674|NCT03414034|468486153|FG000|Overall Study|Non-compliance With Study Drug|0|||
130143675|NCT03414034|468486154|FG001|Overall Study|Non-compliance With Study Drug|0|||
130143676|NCT03414034|468486155|FG002|Overall Study|Non-compliance With Study Drug|1|||
130143677|NCT03414034|468486153|FG000|Overall Study|Physician Decision|1|||
130143678|NCT03414034|468486154|FG001|Overall Study|Physician Decision|3|||
130143679|NCT03414034|468486155|FG002|Overall Study|Physician Decision|2|||
130143680|NCT03414034|468486153|FG000|Overall Study|Withdrawal of Informed Consent|2|||
130143681|NCT03414034|468486154|FG001|Overall Study|Withdrawal of Informed Consent|1|||
130143682|NCT03414034|468486155|FG002|Overall Study|Withdrawal of Informed Consent|4|||
130143683|NCT03414034|468486153|FG000|Overall Study|Progressive Disease|15|||
130143684|NCT03414034|468486154|FG001|Overall Study|Progressive Disease|15|||
130143685|NCT03414034|468486155|FG002|Overall Study|Progressive Disease|17|||
130143686|NCT03414034|468486153|FG000|Overall Study|Miscellaneous|0|||
130143687|NCT03414034|468486154|FG001|Overall Study|Miscellaneous|0|||
130143688|NCT03414034|468486155|FG002|Overall Study|Miscellaneous|2|||
130143689|NCT01332968|468486156|FG000|Induction Period|Adverse Event|23|||
130143690|NCT01332968|468486157|FG001|Induction Period|Adverse Event|26|||
130143691|NCT01332968|468486158|FG002|Induction Period|Adverse Event|0|||
130143692|NCT01332968|468486159|FG003|Induction Period|Adverse Event|0|||
130143693|NCT01332968|468486160|FG004|Induction Period|Adverse Event|0|||
130143694|NCT01332968|468486161|FG005|Induction Period|Adverse Event|0|||
130143695|NCT01332968|468486162|FG006|Induction Period|Adverse Event|0|||
130143696|NCT01332968|468486163|FG007|Induction Period|Adverse Event|0|||
130143697|NCT01332968|468486156|FG000|Induction Period|Death|1|||
130143698|NCT01332968|468486157|FG001|Induction Period|Death|4|||
130143699|NCT01332968|468486158|FG002|Induction Period|Death|0|||
130143700|NCT01332968|468486159|FG003|Induction Period|Death|0|||
130143701|NCT01332968|468486160|FG004|Induction Period|Death|0|||
130143702|NCT01332968|468486161|FG005|Induction Period|Death|0|||
130143703|NCT01332968|468486162|FG006|Induction Period|Death|0|||
130143704|NCT01332968|468486163|FG007|Induction Period|Death|0|||
130143705|NCT01332968|468486156|FG000|Induction Period|Non-compliance|1|||
130143706|NCT01332968|468486157|FG001|Induction Period|Non-compliance|0|||
130143707|NCT01332968|468486158|FG002|Induction Period|Non-compliance|0|||
130143708|NCT01332968|468486159|FG003|Induction Period|Non-compliance|0|||
130143709|NCT01332968|468486160|FG004|Induction Period|Non-compliance|0|||
130143710|NCT01332968|468486161|FG005|Induction Period|Non-compliance|0|||
130143711|NCT01332968|468486162|FG006|Induction Period|Non-compliance|0|||
130143712|NCT01332968|468486163|FG007|Induction Period|Non-compliance|0|||
130143713|NCT01332968|468486156|FG000|Induction Period|Other|2|||
130143714|NCT01332968|468486157|FG001|Induction Period|Other|2|||
130143715|NCT01332968|468486158|FG002|Induction Period|Other|0|||
130143716|NCT01332968|468486159|FG003|Induction Period|Other|0|||
130143717|NCT01332968|468486160|FG004|Induction Period|Other|0|||
130143718|NCT01332968|468486161|FG005|Induction Period|Other|0|||
130143719|NCT01332968|468486162|FG006|Induction Period|Other|0|||
130143720|NCT01332968|468486163|FG007|Induction Period|Other|0|||
130143721|NCT01332968|468486156|FG000|Induction Period|Physician Decision|6|||
130143722|NCT01332968|468486157|FG001|Induction Period|Physician Decision|1|||
130143723|NCT01332968|468486158|FG002|Induction Period|Physician Decision|0|||
130143724|NCT01332968|468486159|FG003|Induction Period|Physician Decision|0|||
130143725|NCT01332968|468486160|FG004|Induction Period|Physician Decision|0|||
129976417|NCT01252355|467877755|FG002|Overall Study|Randomized but not Treated|0|||
129976418|NCT01252355|467877753|FG000|Overall Study|Other Than Above|8|||
129976419|NCT01252355|467877754|FG001|Overall Study|Other Than Above|7|||
130143726|NCT01332968|468486161|FG005|Induction Period|Physician Decision|0|||
130143727|NCT01332968|468486162|FG006|Induction Period|Physician Decision|0|||
130143728|NCT01332968|468486163|FG007|Induction Period|Physician Decision|0|||
130143729|NCT01332968|468486156|FG000|Induction Period|Progressive Disease|15|||
130143730|NCT01332968|468486157|FG001|Induction Period|Progressive Disease|7|||
130143731|NCT01332968|468486158|FG002|Induction Period|Progressive Disease|0|||
130143732|NCT01332968|468486159|FG003|Induction Period|Progressive Disease|0|||
130143733|NCT01332968|468486160|FG004|Induction Period|Progressive Disease|0|||
130143734|NCT01332968|468486161|FG005|Induction Period|Progressive Disease|0|||
130143735|NCT01332968|468486162|FG006|Induction Period|Progressive Disease|0|||
130143736|NCT01332968|468486163|FG007|Induction Period|Progressive Disease|0|||
130143737|NCT01332968|468486156|FG000|Induction Period|Protocol Violation|3|||
130143738|NCT01332968|468486157|FG001|Induction Period|Protocol Violation|4|||
130143739|NCT01332968|468486158|FG002|Induction Period|Protocol Violation|0|||
130143740|NCT01332968|468486159|FG003|Induction Period|Protocol Violation|0|||
130143741|NCT01332968|468486160|FG004|Induction Period|Protocol Violation|0|||
130143742|NCT01332968|468486161|FG005|Induction Period|Protocol Violation|0|||
130143743|NCT01332968|468486162|FG006|Induction Period|Protocol Violation|0|||
130143744|NCT01332968|468486163|FG007|Induction Period|Protocol Violation|0|||
130143745|NCT01332968|468486156|FG000|Induction Period|Withdrawal by Subject|3|||
130143746|NCT01332968|468486157|FG001|Induction Period|Withdrawal by Subject|5|||
130143747|NCT01332968|468486158|FG002|Induction Period|Withdrawal by Subject|0|||
130143748|NCT01332968|468486159|FG003|Induction Period|Withdrawal by Subject|0|||
130143749|NCT01332968|468486160|FG004|Induction Period|Withdrawal by Subject|0|||
130143750|NCT01332968|468486161|FG005|Induction Period|Withdrawal by Subject|0|||
130143751|NCT01332968|468486162|FG006|Induction Period|Withdrawal by Subject|0|||
130143752|NCT01332968|468486163|FG007|Induction Period|Withdrawal by Subject|0|||
130143753|NCT01332968|468486156|FG000|Induction Period|Randomised but not treated|4|||
130143754|NCT01332968|468486157|FG001|Induction Period|Randomised but not treated|7|||
130143755|NCT01332968|468486158|FG002|Induction Period|Randomised but not treated|0|||
130143756|NCT01332968|468486159|FG003|Induction Period|Randomised but not treated|0|||
130143757|NCT01332968|468486160|FG004|Induction Period|Randomised but not treated|0|||
130143758|NCT01332968|468486161|FG005|Induction Period|Randomised but not treated|0|||
130143759|NCT01332968|468486162|FG006|Induction Period|Randomised but not treated|0|||
130143760|NCT01332968|468486163|FG007|Induction Period|Randomised but not treated|0|||
130143761|NCT01332968|468486156|FG000|Maintenance/Observation Period|Adverse Event|0|||
130143762|NCT01332968|468486157|FG001|Maintenance/Observation Period|Adverse Event|0|||
130143763|NCT01332968|468486158|FG002|Maintenance/Observation Period|Adverse Event|53|||
130143764|NCT01332968|468486159|FG003|Maintenance/Observation Period|Adverse Event|66|||
130143765|NCT01332968|468486160|FG004|Maintenance/Observation Period|Adverse Event|0|||
130143766|NCT01332968|468486161|FG005|Maintenance/Observation Period|Adverse Event|0|||
130143767|NCT01332968|468486162|FG006|Maintenance/Observation Period|Adverse Event|0|||
130143768|NCT01332968|468486163|FG007|Maintenance/Observation Period|Adverse Event|0|||
130143769|NCT01332968|468486156|FG000|Maintenance/Observation Period|Death|0|||
130143770|NCT01332968|468486157|FG001|Maintenance/Observation Period|Death|0|||
130143771|NCT01332968|468486158|FG002|Maintenance/Observation Period|Death|5|||
130143772|NCT01332968|468486159|FG003|Maintenance/Observation Period|Death|6|||
130143773|NCT01332968|468486160|FG004|Maintenance/Observation Period|Death|0|||
130143774|NCT01332968|468486161|FG005|Maintenance/Observation Period|Death|0|||
130143775|NCT01332968|468486162|FG006|Maintenance/Observation Period|Death|0|||
130143776|NCT01332968|468486163|FG007|Maintenance/Observation Period|Death|0|||
130143777|NCT01332968|468486156|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
130143778|NCT01332968|468486157|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
130143779|NCT01332968|468486158|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
130143780|NCT01332968|468486159|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
130143781|NCT01332968|468486160|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
130143782|NCT01332968|468486161|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
130143783|NCT01332968|468486162|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
130143784|NCT01332968|468486163|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
130143785|NCT01332968|468486156|FG000|Maintenance/Observation Period|Non-compliance|0|||
130143786|NCT01332968|468486157|FG001|Maintenance/Observation Period|Non-compliance|0|||
130143787|NCT01332968|468486158|FG002|Maintenance/Observation Period|Non-compliance|4|||
130143788|NCT01332968|468486159|FG003|Maintenance/Observation Period|Non-compliance|3|||
130143789|NCT01332968|468486160|FG004|Maintenance/Observation Period|Non-compliance|0|||
130143790|NCT01332968|468486161|FG005|Maintenance/Observation Period|Non-compliance|0|||
130143791|NCT01332968|468486162|FG006|Maintenance/Observation Period|Non-compliance|0|||
130143792|NCT01332968|468486163|FG007|Maintenance/Observation Period|Non-compliance|0|||
130143793|NCT01332968|468486156|FG000|Maintenance/Observation Period|Other|0|||
130143794|NCT01332968|468486157|FG001|Maintenance/Observation Period|Other|0|||
130143795|NCT01332968|468486158|FG002|Maintenance/Observation Period|Other|4|||
130143796|NCT01332968|468486159|FG003|Maintenance/Observation Period|Other|7|||
130143797|NCT01332968|468486160|FG004|Maintenance/Observation Period|Other|0|||
130143798|NCT01332968|468486161|FG005|Maintenance/Observation Period|Other|0|||
130143799|NCT01332968|468486162|FG006|Maintenance/Observation Period|Other|0|||
130143800|NCT01332968|468486163|FG007|Maintenance/Observation Period|Other|0|||
130143801|NCT01332968|468486156|FG000|Maintenance/Observation Period|Physician Decision|0|||
130143802|NCT01332968|468486157|FG001|Maintenance/Observation Period|Physician Decision|0|||
130143803|NCT01332968|468486158|FG002|Maintenance/Observation Period|Physician Decision|14|||
130143804|NCT01332968|468486159|FG003|Maintenance/Observation Period|Physician Decision|19|||
130143805|NCT01332968|468486160|FG004|Maintenance/Observation Period|Physician Decision|0|||
130143806|NCT01332968|468486161|FG005|Maintenance/Observation Period|Physician Decision|1|||
130143807|NCT01332968|468486162|FG006|Maintenance/Observation Period|Physician Decision|0|||
130143808|NCT01332968|468486163|FG007|Maintenance/Observation Period|Physician Decision|0|||
130143809|NCT01332968|468486156|FG000|Maintenance/Observation Period|Progressive Disease|0|||
130143810|NCT01332968|468486157|FG001|Maintenance/Observation Period|Progressive Disease|0|||
130143811|NCT01332968|468486158|FG002|Maintenance/Observation Period|Progressive Disease|72|||
130143812|NCT01332968|468486159|FG003|Maintenance/Observation Period|Progressive Disease|40|||
130143813|NCT01332968|468486160|FG004|Maintenance/Observation Period|Progressive Disease|0|||
130143814|NCT01332968|468486161|FG005|Maintenance/Observation Period|Progressive Disease|0|||
130143815|NCT01332968|468486162|FG006|Maintenance/Observation Period|Progressive Disease|0|||
130143816|NCT01332968|468486163|FG007|Maintenance/Observation Period|Progressive Disease|0|||
130143817|NCT01332968|468486156|FG000|Maintenance/Observation Period|Protocol Violation|0|||
130143818|NCT01332968|468486157|FG001|Maintenance/Observation Period|Protocol Violation|0|||
130143819|NCT01332968|468486158|FG002|Maintenance/Observation Period|Protocol Violation|1|||
130143820|NCT01332968|468486159|FG003|Maintenance/Observation Period|Protocol Violation|1|||
130143821|NCT01332968|468486160|FG004|Maintenance/Observation Period|Protocol Violation|0|||
130143822|NCT01332968|468486161|FG005|Maintenance/Observation Period|Protocol Violation|0|||
130143823|NCT01332968|468486162|FG006|Maintenance/Observation Period|Protocol Violation|0|||
130143824|NCT01332968|468486163|FG007|Maintenance/Observation Period|Protocol Violation|0|||
130143825|NCT01332968|468486156|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
130143826|NCT01332968|468486157|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
130143827|NCT01332968|468486158|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
130143828|NCT01332968|468486159|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
130143829|NCT01332968|468486160|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
130143830|NCT01332968|468486161|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
130143831|NCT01332968|468486162|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
130143832|NCT01332968|468486163|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
130143833|NCT01332968|468486156|FG000|Follow-Up Period|Adverse Event|0|||
130143834|NCT01332968|468486157|FG001|Follow-Up Period|Adverse Event|0|||
130143835|NCT01332968|468486158|FG002|Follow-Up Period|Adverse Event|0|||
130143836|NCT01332968|468486159|FG003|Follow-Up Period|Adverse Event|0|||
130143837|NCT01332968|468486160|FG004|Follow-Up Period|Adverse Event|0|||
130143838|NCT01332968|468486161|FG005|Follow-Up Period|Adverse Event|0|||
129976420|NCT01252355|467877755|FG002|Overall Study|Other Than Above|7|||
129976421|NCT00335140|467877758|FG000|Overall Study|Ineligible|1|||
129976422|NCT01725126|467877759|FG000|Overall Study|Protocol Violation|0|||
129976423|NCT01725126|467877760|FG001|Overall Study|Protocol Violation|1|||
129976424|NCT01725126|467877761|FG002|Overall Study|Protocol Violation|0|||
129976425|NCT01725126|467877762|FG003|Overall Study|Protocol Violation|0|||
129976426|NCT01725126|467877763|FG004|Overall Study|Protocol Violation|0|||
129976427|NCT01725126|467877764|FG005|Overall Study|Protocol Violation|0|||
129976428|NCT01725126|467877759|FG000|Overall Study|Withdrawal by Subject|0|||
129976429|NCT01725126|467877760|FG001|Overall Study|Withdrawal by Subject|0|||
129976430|NCT01725126|467877761|FG002|Overall Study|Withdrawal by Subject|0|||
129976431|NCT01725126|467877762|FG003|Overall Study|Withdrawal by Subject|1|||
129976432|NCT01725126|467877763|FG004|Overall Study|Withdrawal by Subject|0|||
129976433|NCT01725126|467877764|FG005|Overall Study|Withdrawal by Subject|0|||
129976434|NCT00895895|467877768|FG000|Period 1|Adverse Event|7|||
129976435|NCT00895895|467877769|FG001|Period 1|Adverse Event|6|||
130143839|NCT01332968|468486162|FG006|Follow-Up Period|Adverse Event|0|||
130143840|NCT01332968|468486163|FG007|Follow-Up Period|Adverse Event|4|||
130143841|NCT01332968|468486156|FG000|Follow-Up Period|Death|0|||
130143842|NCT01332968|468486157|FG001|Follow-Up Period|Death|0|||
130143843|NCT01332968|468486158|FG002|Follow-Up Period|Death|0|||
130143844|NCT01332968|468486159|FG003|Follow-Up Period|Death|0|||
130143845|NCT01332968|468486160|FG004|Follow-Up Period|Death|0|||
130143846|NCT01332968|468486161|FG005|Follow-Up Period|Death|0|||
130143847|NCT01332968|468486162|FG006|Follow-Up Period|Death|27|||
130143848|NCT01332968|468486163|FG007|Follow-Up Period|Death|30|||
130143849|NCT01332968|468486156|FG000|Follow-Up Period|Lost to Follow-up|0|||
130143850|NCT01332968|468486157|FG001|Follow-Up Period|Lost to Follow-up|0|||
130143851|NCT01332968|468486158|FG002|Follow-Up Period|Lost to Follow-up|0|||
130143852|NCT01332968|468486159|FG003|Follow-Up Period|Lost to Follow-up|0|||
130143853|NCT01332968|468486160|FG004|Follow-Up Period|Lost to Follow-up|0|||
130143854|NCT01332968|468486161|FG005|Follow-Up Period|Lost to Follow-up|0|||
130143855|NCT01332968|468486162|FG006|Follow-Up Period|Lost to Follow-up|11|||
130143856|NCT01332968|468486163|FG007|Follow-Up Period|Lost to Follow-up|15|||
130143857|NCT01332968|468486156|FG000|Follow-Up Period|Non-compliance|0|||
130143858|NCT01332968|468486157|FG001|Follow-Up Period|Non-compliance|0|||
130143859|NCT01332968|468486158|FG002|Follow-Up Period|Non-compliance|0|||
130143860|NCT01332968|468486159|FG003|Follow-Up Period|Non-compliance|0|||
130143861|NCT01332968|468486160|FG004|Follow-Up Period|Non-compliance|0|||
130143862|NCT01332968|468486161|FG005|Follow-Up Period|Non-compliance|0|||
130143863|NCT01332968|468486162|FG006|Follow-Up Period|Non-compliance|4|||
130143864|NCT01332968|468486163|FG007|Follow-Up Period|Non-compliance|9|||
130143865|NCT01332968|468486156|FG000|Follow-Up Period|Other|0|||
130143866|NCT01332968|468486157|FG001|Follow-Up Period|Other|0|||
130143867|NCT01332968|468486158|FG002|Follow-Up Period|Other|0|||
130143868|NCT01332968|468486159|FG003|Follow-Up Period|Other|0|||
130143869|NCT01332968|468486160|FG004|Follow-Up Period|Other|0|||
130143870|NCT01332968|468486161|FG005|Follow-Up Period|Other|0|||
130143871|NCT01332968|468486162|FG006|Follow-Up Period|Other|18|||
130143872|NCT01332968|468486163|FG007|Follow-Up Period|Other|21|||
130143873|NCT01332968|468486156|FG000|Follow-Up Period|Physician Decision|0|||
130143874|NCT01332968|468486157|FG001|Follow-Up Period|Physician Decision|0|||
130143875|NCT01332968|468486158|FG002|Follow-Up Period|Physician Decision|0|||
130143876|NCT01332968|468486159|FG003|Follow-Up Period|Physician Decision|0|||
130143877|NCT01332968|468486160|FG004|Follow-Up Period|Physician Decision|0|||
130143878|NCT01332968|468486161|FG005|Follow-Up Period|Physician Decision|0|||
130143879|NCT01332968|468486162|FG006|Follow-Up Period|Physician Decision|12|||
130143880|NCT01332968|468486163|FG007|Follow-Up Period|Physician Decision|15|||
130143881|NCT01332968|468486156|FG000|Follow-Up Period|Progressive Disease|0|||
130143882|NCT01332968|468486157|FG001|Follow-Up Period|Progressive Disease|0|||
130143883|NCT01332968|468486158|FG002|Follow-Up Period|Progressive Disease|0|||
129976436|NCT00895895|467877770|FG002|Period 1|Adverse Event|4|||
129976437|NCT00895895|467877771|FG003|Period 1|Adverse Event|6|||
129976438|NCT00895895|467877772|FG004|Period 1|Adverse Event|7|||
129976439|NCT00895895|467877768|FG000|Period 1|Death|0|||
129976440|NCT00895895|467877769|FG001|Period 1|Death|0|||
129976441|NCT00895895|467877770|FG002|Period 1|Death|0|||
130143884|NCT01332968|468486159|FG003|Follow-Up Period|Progressive Disease|0|||
130143885|NCT01332968|468486160|FG004|Follow-Up Period|Progressive Disease|0|||
130143886|NCT01332968|468486161|FG005|Follow-Up Period|Progressive Disease|0|||
130143887|NCT01332968|468486162|FG006|Follow-Up Period|Progressive Disease|126|||
130143888|NCT01332968|468486163|FG007|Follow-Up Period|Progressive Disease|106|||
130143889|NCT01332968|468486156|FG000|Follow-Up Period|Protocol Violation|0|||
130143890|NCT01332968|468486157|FG001|Follow-Up Period|Protocol Violation|0|||
130143891|NCT01332968|468486158|FG002|Follow-Up Period|Protocol Violation|0|||
130143892|NCT01332968|468486159|FG003|Follow-Up Period|Protocol Violation|0|||
130143893|NCT01332968|468486160|FG004|Follow-Up Period|Protocol Violation|0|||
130143894|NCT01332968|468486161|FG005|Follow-Up Period|Protocol Violation|0|||
130143895|NCT01332968|468486162|FG006|Follow-Up Period|Protocol Violation|1|||
130143896|NCT01332968|468486163|FG007|Follow-Up Period|Protocol Violation|0|||
130143897|NCT01332968|468486156|FG000|Follow-Up Period|Withdrawal by Subject|0|||
130143898|NCT01332968|468486157|FG001|Follow-Up Period|Withdrawal by Subject|0|||
130143899|NCT01332968|468486158|FG002|Follow-Up Period|Withdrawal by Subject|0|||
130143900|NCT01332968|468486159|FG003|Follow-Up Period|Withdrawal by Subject|0|||
130143901|NCT01332968|468486160|FG004|Follow-Up Period|Withdrawal by Subject|0|||
130143902|NCT01332968|468486161|FG005|Follow-Up Period|Withdrawal by Subject|0|||
130143903|NCT01332968|468486162|FG006|Follow-Up Period|Withdrawal by Subject|29|||
130143904|NCT01332968|468486163|FG007|Follow-Up Period|Withdrawal by Subject|32|||
130143905|NCT01332968|468486156|FG000|Follow-Up Period|No reason provided|0|||
130143906|NCT01332968|468486157|FG001|Follow-Up Period|No reason provided|0|||
130143907|NCT01332968|468486158|FG002|Follow-Up Period|No reason provided|0|||
130143908|NCT01332968|468486159|FG003|Follow-Up Period|No reason provided|0|||
130143909|NCT01332968|468486160|FG004|Follow-Up Period|No reason provided|0|||
130143910|NCT01332968|468486161|FG005|Follow-Up Period|No reason provided|0|||
130143911|NCT01332968|468486162|FG006|Follow-Up Period|No reason provided|2|||
130143912|NCT01332968|468486163|FG007|Follow-Up Period|No reason provided|3|||
130143913|NCT04010227|468486164|FG000|Overall Study|Death|1|||
130143914|NCT04010227|468486165|FG001|Overall Study|Death|2|||
130143915|NCT04010227|468486164|FG000|Overall Study|Medical Reasons|4|||
130143916|NCT04010227|468486165|FG001|Overall Study|Medical Reasons|3|||
130143917|NCT04010227|468486164|FG000|Overall Study|Withdrawal by Subject|2|||
130143918|NCT04010227|468486165|FG001|Overall Study|Withdrawal by Subject|0|||
130143919|NCT04010227|468486164|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
130143920|NCT04010227|468486165|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
130143921|NCT03480022|468486166|FG000|Overall Study|Pregnancy|2|||
130143922|NCT03480022|468486167|FG001|Overall Study|Pregnancy|0|||
130143923|NCT03480022|468486166|FG000|Overall Study|Adverse Event|6|||
130143924|NCT03480022|468486167|FG001|Overall Study|Adverse Event|0|||
130143925|NCT03480022|468486166|FG000|Overall Study|Lack of Efficacy|0|||
130143926|NCT03480022|468486167|FG001|Overall Study|Lack of Efficacy|2|||
130143927|NCT03480022|468486166|FG000|Overall Study|Physician Decision|0|||
130143928|NCT03480022|468486167|FG001|Overall Study|Physician Decision|1|||
130143929|NCT03480022|468486166|FG000|Overall Study|Withdrawal by Subject|2|||
130143930|NCT03480022|468486167|FG001|Overall Study|Withdrawal by Subject|0|||
130143931|NCT03480022|468486166|FG000|Overall Study|Medication concerns|1|||
130143932|NCT03480022|468486167|FG001|Overall Study|Medication concerns|0|||
130143933|NCT03480022|468486166|FG000|Overall Study|Family member COVID exposure|0|||
130143934|NCT03480022|468486167|FG001|Overall Study|Family member COVID exposure|1|||
130143935|NCT00640926|468486168|FG000|Overall Study|Adverse Event|2|||
129976442|NCT00895895|467877771|FG003|Period 1|Death|0|||
129976443|NCT00895895|467877772|FG004|Period 1|Death|1|||
129976444|NCT00895895|467877768|FG000|Period 1|discontinued by sponsor|2|||
129976445|NCT00895895|467877769|FG001|Period 1|discontinued by sponsor|1|||
129976446|NCT00895895|467877770|FG002|Period 1|discontinued by sponsor|2|||
129976447|NCT00895895|467877771|FG003|Period 1|discontinued by sponsor|1|||
129976448|NCT00895895|467877772|FG004|Period 1|discontinued by sponsor|1|||
129976449|NCT00895895|467877768|FG000|Period 1|failed to return|0|||
129976450|NCT00895895|467877769|FG001|Period 1|failed to return|0|||
129976451|NCT00895895|467877770|FG002|Period 1|failed to return|1|||
129976452|NCT00895895|467877771|FG003|Period 1|failed to return|0|||
129976453|NCT00895895|467877772|FG004|Period 1|failed to return|1|||
129976454|NCT00895895|467877768|FG000|Period 1|investigator request|0|||
129976455|NCT00895895|467877769|FG001|Period 1|investigator request|1|||
129976456|NCT00895895|467877770|FG002|Period 1|investigator request|0|||
130143936|NCT00640926|468486169|FG001|Overall Study|Adverse Event|3|||
129976457|NCT00895895|467877771|FG003|Period 1|investigator request|0|||
130143937|NCT00640926|468486170|FG002|Overall Study|Adverse Event|2|||
130143938|NCT00640926|468486168|FG000|Overall Study|Lack of Efficacy|0|||
130143939|NCT00640926|468486169|FG001|Overall Study|Lack of Efficacy|2|||
130143940|NCT00640926|468486170|FG002|Overall Study|Lack of Efficacy|1|||
130143941|NCT00640926|468486168|FG000|Overall Study|Protocol Violation|2|||
129976458|NCT00895895|467877772|FG004|Period 1|investigator request|0|||
129976459|NCT00895895|467877768|FG000|Period 1|Lost to Follow-up|2|||
129976460|NCT00895895|467877769|FG001|Period 1|Lost to Follow-up|1|||
129976461|NCT00895895|467877770|FG002|Period 1|Lost to Follow-up|3|||
129976462|NCT00895895|467877771|FG003|Period 1|Lost to Follow-up|2|||
129976463|NCT00895895|467877772|FG004|Period 1|Lost to Follow-up|3|||
130143942|NCT00640926|468486169|FG001|Overall Study|Protocol Violation|0|||
129976464|NCT00895895|467877768|FG000|Period 1|Other|1|||
130143943|NCT00640926|468486170|FG002|Overall Study|Protocol Violation|2|||
130143944|NCT00640926|468486168|FG000|Overall Study|Lost to Follow-up|3|||
130143945|NCT00640926|468486169|FG001|Overall Study|Lost to Follow-up|1|||
130143946|NCT00640926|468486170|FG002|Overall Study|Lost to Follow-up|2|||
130143947|NCT00640926|468486168|FG000|Overall Study|Withdrawal by Subject|1|||
130143948|NCT00640926|468486169|FG001|Overall Study|Withdrawal by Subject|0|||
130143949|NCT00640926|468486170|FG002|Overall Study|Withdrawal by Subject|1|||
130143950|NCT03922750|468486171|FG000|Overall Study|Unclassified|0|||
130143951|NCT03922750|468486172|FG001|Overall Study|Unclassified|0|||
130143952|NCT03922750|468486173|FG002|Overall Study|Unclassified|1|||
130143953|NCT03922750|468486171|FG000|Overall Study|Adverse Event|0|||
130143954|NCT03922750|468486172|FG001|Overall Study|Adverse Event|1|||
130143955|NCT03922750|468486173|FG002|Overall Study|Adverse Event|0|||
130143956|NCT02985398|468486174|FG000|Overall Study|Adverse Event|1|||
130143957|NCT02985398|468486174|FG000|Overall Study|Lost to Follow-up|4|||
130143958|NCT02985398|468486174|FG000|Overall Study|Withdrawal by Subject|8|||
130143959|NCT02985398|468486174|FG000|Overall Study|Study Burden|9|||
130143960|NCT01841073|468486175|FG000|Overall Study|Adverse Event|1|||
130143961|NCT01841073|468486176|FG001|Overall Study|Adverse Event|1|||
130143962|NCT01841073|468486175|FG000|Overall Study|Physician Decision|1|||
130143963|NCT01841073|468486176|FG001|Overall Study|Physician Decision|0|||
130143964|NCT01841073|468486175|FG000|Overall Study|Lost to Follow-up|0|||
130143965|NCT01841073|468486176|FG001|Overall Study|Lost to Follow-up|2|||
130143966|NCT04164758|468486177|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
130143967|NCT04164758|468486178|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
130143968|NCT04164758|468486179|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
130143969|NCT04164758|468486177|FG000|Overall Study|Adverse Event|0|||
130143970|NCT04164758|468486178|FG001|Overall Study|Adverse Event|1|||
130143971|NCT04164758|468486179|FG002|Overall Study|Adverse Event|0|||
130143972|NCT01670097|468486184|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
130143973|NCT01670097|468486185|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
130143974|NCT01670097|468486184|FG000|Overall Study|Study burden|1|||
130143975|NCT01670097|468486185|FG001|Overall Study|Study burden|0|||
130143976|NCT01670097|468486184|FG000|Overall Study|COPD exacerbation|0|||
130143977|NCT01670097|468486185|FG001|Overall Study|COPD exacerbation|1|||
130143978|NCT01670097|468486184|FG000|Overall Study|Neutropenia|0|||
130143979|NCT01670097|468486185|FG001|Overall Study|Neutropenia|1|||
130143980|NCT01670097|468486184|FG000|Overall Study|Clinical deterioration|0|||
130143981|NCT01670097|468486185|FG001|Overall Study|Clinical deterioration|1|||
130143982|NCT01670097|468486184|FG000|Overall Study|Disease progression|0|||
130143983|NCT01670097|468486185|FG001|Overall Study|Disease progression|1|||
130143984|NCT00697827|468486186|FG000|Overall Study|enrolled but not treated|2|||
130143985|NCT00697827|468486187|FG001|Overall Study|enrolled but not treated|1|||
130143986|NCT05665387|468486190|FG000|Overall Study|Withdrawal by Subject|1|||
130143987|NCT05665387|468486191|FG001|Overall Study|Withdrawal by Subject|0|||
130143988|NCT05665387|468486192|FG002|Overall Study|Withdrawal by Subject|1|||
130143989|NCT03732833|468486195|FG000|Overall Study|Adverse Event|0|||
130143990|NCT03732833|468486196|FG001|Overall Study|Adverse Event|3|||
130143991|NCT03732833|468486197|FG002|Overall Study|Adverse Event|1|||
130143992|NCT03732833|468486195|FG000|Overall Study|Withdrawal by Subject|11|||
130143993|NCT03732833|468486196|FG001|Overall Study|Withdrawal by Subject|13|||
130143994|NCT03732833|468486197|FG002|Overall Study|Withdrawal by Subject|8|||
130143995|NCT03732833|468486195|FG000|Overall Study|Lost to Follow-up|3|||
130143996|NCT03732833|468486196|FG001|Overall Study|Lost to Follow-up|5|||
130143997|NCT03732833|468486197|FG002|Overall Study|Lost to Follow-up|4|||
129976465|NCT00895895|467877769|FG001|Period 1|Other|2|||
129976466|NCT00895895|467877770|FG002|Period 1|Other|1|||
129976467|NCT00895895|467877771|FG003|Period 1|Other|1|||
129976468|NCT00895895|467877772|FG004|Period 1|Other|1|||
129976469|NCT00895895|467877768|FG000|Period 1|Protocol Violation|0|||
129976470|NCT00895895|467877769|FG001|Period 1|Protocol Violation|1|||
129976471|NCT00895895|467877770|FG002|Period 1|Protocol Violation|0|||
129976472|NCT00895895|467877771|FG003|Period 1|Protocol Violation|0|||
129976473|NCT00895895|467877772|FG004|Period 1|Protocol Violation|0|||
129976474|NCT00895895|467877768|FG000|Period 1|Withdrawal by Subject|6|||
129976475|NCT00895895|467877769|FG001|Period 1|Withdrawal by Subject|6|||
129976476|NCT00895895|467877770|FG002|Period 1|Withdrawal by Subject|8|||
129976477|NCT00895895|467877771|FG003|Period 1|Withdrawal by Subject|2|||
130143998|NCT03732833|468486195|FG000|Overall Study|Pregnancy|0|||
130143999|NCT03732833|468486196|FG001|Overall Study|Pregnancy|2|||
130144000|NCT03732833|468486197|FG002|Overall Study|Pregnancy|0|||
130144001|NCT03732833|468486195|FG000|Overall Study|Physician Decision|2|||
130144002|NCT03732833|468486196|FG001|Overall Study|Physician Decision|3|||
129976478|NCT00895895|467877772|FG004|Period 1|Withdrawal by Subject|4|||
129976479|NCT00895895|467877768|FG000|Period 1|unsatisfactory response-efficacy|2|||
129976480|NCT00895895|467877769|FG001|Period 1|unsatisfactory response-efficacy|0|||
129976481|NCT00895895|467877770|FG002|Period 1|unsatisfactory response-efficacy|0|||
129976482|NCT00895895|467877771|FG003|Period 1|unsatisfactory response-efficacy|0|||
130144003|NCT03732833|468486197|FG002|Overall Study|Physician Decision|1|||
130144004|NCT03732833|468486195|FG000|Overall Study|Covid-19 related and other reasons|2|||
130144005|NCT03732833|468486196|FG001|Overall Study|Covid-19 related and other reasons|7|||
129976483|NCT00895895|467877772|FG004|Period 1|unsatisfactory response-efficacy|0|||
129976484|NCT00895895|467877768|FG000|Period 1|randomized and not treated|1|||
129976485|NCT00895895|467877769|FG001|Period 1|randomized and not treated|3|||
129976486|NCT00895895|467877770|FG002|Period 1|randomized and not treated|1|||
129976487|NCT00895895|467877771|FG003|Period 1|randomized and not treated|1|||
129976488|NCT00895895|467877772|FG004|Period 1|randomized and not treated|2|||
129976489|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
129976490|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
129976491|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
129976492|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
129976493|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
129976494|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Other|0|||
130144006|NCT03732833|468486197|FG002|Overall Study|Covid-19 related and other reasons|3|||
130144007|NCT00550147|468486198|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
130144008|NCT00550147|468486198|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
130144009|NCT00550147|468486198|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
130144010|NCT00550147|468486198|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
130144011|NCT00550147|468486198|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
130144012|NCT04320745|468486199|FG000|Overall Study|Adverse Event|26|||
130144013|NCT04320745|468486199|FG000|Overall Study|Withdrawal by Subject|4|||
130144014|NCT04320745|468486199|FG000|Overall Study|Lost to Follow-up|12|||
130144015|NCT04320745|468486199|FG000|Overall Study|Protocol Deviation|2|||
130144016|NCT04320745|468486199|FG000|Overall Study|Non-compliance With Study Drug|2|||
130144017|NCT04320745|468486199|FG000|Overall Study|Reason Not Specified|1|||
130144018|NCT01824498|468486200|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
130144019|NCT01824498|468486201|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
130144020|NCT01824498|468486202|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
130144021|NCT01824498|468486203|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
130144022|NCT01824498|468486204|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
130144023|NCT01824498|468486205|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
130144024|NCT02311894|468486207|FG000|Overall Study|Discontinued in error|1|||
130144025|NCT02311894|468486207|FG000|Overall Study|Lost to Follow-up|1|||
130144026|NCT02311894|468486207|FG000|Overall Study|Adverse Event|1|||
130144027|NCT02311894|468486207|FG000|Overall Study|Withdrawal by Subject|1|||
130144028|NCT00751023|468486208|FG000|Overall Study|Lost to Follow-up|11|||
130144029|NCT00751023|468486209|FG001|Overall Study|Lost to Follow-up|7|||
130144030|NCT01277510|468486213|FG000|Double-blind Phase|Non-compliance|0|||
130144031|NCT01277510|468486214|FG001|Double-blind Phase|Non-compliance|1|||
130144032|NCT01277510|468486213|FG000|Double-blind Phase|Adverse Event|1|||
130144033|NCT01277510|468486214|FG001|Double-blind Phase|Adverse Event|0|||
130144034|NCT01277510|468486213|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130144035|NCT01277510|468486214|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130144036|NCT01277510|468486213|FG000|Double-blind Phase|Administrative decision|7|||
130144037|NCT01277510|468486214|FG001|Double-blind Phase|Administrative decision|9|||
130144038|NCT01277510|468486213|FG000|Double-blind Phase|Death|0|||
130144039|NCT01277510|468486214|FG001|Double-blind Phase|Death|1|||
130144040|NCT01277510|468486213|FG000|Double-blind Phase|Protocol-specified criteria|2|||
130144041|NCT01277510|468486214|FG001|Double-blind Phase|Protocol-specified criteria|6|||
130144042|NCT01277510|468486213|FG000|Double-blind Phase|Other|1|||
130144043|NCT01277510|468486214|FG001|Double-blind Phase|Other|1|||
130144044|NCT01277510|468486213|FG000|Open-label Phase|Administrative decision|4|||
130144045|NCT01277510|468486214|FG001|Open-label Phase|Administrative decision|3|||
130144046|NCT01277510|468486213|FG000|Open-label Phase|Protocol-specified criteria|1|||
130144047|NCT01277510|468486214|FG001|Open-label Phase|Protocol-specified criteria|0|||
130144048|NCT01277510|468486213|FG000|Open-label Phase|Never received investigational product|2|||
130144049|NCT01277510|468486214|FG001|Open-label Phase|Never received investigational product|0|||
130144050|NCT05263505|468486215|FG000|Overall Study|Adverse Event|0|||
130144051|NCT05263505|468486216|FG001|Overall Study|Adverse Event|1|||
130144052|NCT03833427|468486217|FG000|Overall Study|Death|4|||
130144053|NCT03833427|468486218|FG001|Overall Study|Death|2|||
130144054|NCT03833427|468486219|FG002|Overall Study|Death|9|||
130144055|NCT03833427|468486220|FG003|Overall Study|Death|11|||
130144056|NCT03833427|468486221|FG004|Overall Study|Death|0|||
130144057|NCT03833427|468486222|FG005|Overall Study|Death|0|||
130144058|NCT03833427|468486223|FG006|Overall Study|Death|0|||
130144059|NCT03833427|468486217|FG000|Overall Study|Withdrawal by Subject|0|||
130144060|NCT03833427|468486218|FG001|Overall Study|Withdrawal by Subject|1|||
130144061|NCT03833427|468486219|FG002|Overall Study|Withdrawal by Subject|1|||
130144062|NCT03833427|468486220|FG003|Overall Study|Withdrawal by Subject|0|||
130144063|NCT03833427|468486221|FG004|Overall Study|Withdrawal by Subject|0|||
130144064|NCT03833427|468486222|FG005|Overall Study|Withdrawal by Subject|0|||
130144065|NCT03833427|468486223|FG006|Overall Study|Withdrawal by Subject|0|||
130144066|NCT03833427|468486217|FG000|Overall Study|Sponsor Decision|0|||
129976495|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Other|0|||
129976496|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Other|1|||
130144067|NCT03833427|468486218|FG001|Overall Study|Sponsor Decision|0|||
130144068|NCT03833427|468486219|FG002|Overall Study|Sponsor Decision|1|||
130144069|NCT03833427|468486220|FG003|Overall Study|Sponsor Decision|3|||
130144070|NCT03833427|468486221|FG004|Overall Study|Sponsor Decision|0|||
130144071|NCT03833427|468486222|FG005|Overall Study|Sponsor Decision|0|||
130144072|NCT03833427|468486223|FG006|Overall Study|Sponsor Decision|0|||
130144073|NCT01499160|468486228|FG000|Overall Study|Adverse Event|1|||
130144074|NCT01499160|468486228|FG000|Overall Study|Withdrawal by Subject|1|||
130144075|NCT03448692|468486229|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
130144076|NCT03448692|468486230|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
130144077|NCT03448692|468486229|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
130144078|NCT03448692|468486230|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
130144079|NCT03448692|468486229|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
130144080|NCT03448692|468486230|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
130144081|NCT03448692|468486229|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
130144082|NCT03448692|468486230|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
130144083|NCT03448692|468486229|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
130144084|NCT03448692|468486230|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
130144085|NCT00593827|468486233|FG000|Overall Study|On Active Treatment/Pending|0|||
130144086|NCT00593827|468486234|FG001|Overall Study|On Active Treatment/Pending|2|||
130144087|NCT00663234|468486235|FG000|Overall Study|Not willing to adhere to requirements|1|||
130144088|NCT01709903|468486238|FG000|Overall Study|administrative problems|2|||
130144089|NCT01709903|468486239|FG001|Overall Study|administrative problems|6|||
130144090|NCT01709903|468486238|FG000|Overall Study|Abnormal test procedure results|1|||
130144091|NCT01709903|468486239|FG001|Overall Study|Abnormal test procedure results|0|||
130144092|NCT01709903|468486238|FG000|Overall Study|In ability to use device|1|||
130144093|NCT01709903|468486239|FG001|Overall Study|In ability to use device|1|||
130144094|NCT01709903|468486238|FG000|Overall Study|no longer needed study drug|0|||
130144095|NCT01709903|468486239|FG001|Overall Study|no longer needed study drug|1|||
130144096|NCT01709903|468486238|FG000|Overall Study|Lost to Follow-up|0|||
130144097|NCT01709903|468486239|FG001|Overall Study|Lost to Follow-up|2|||
130144098|NCT01709903|468486238|FG000|Overall Study|Death|2|||
130144099|NCT01709903|468486239|FG001|Overall Study|Death|0|||
130144100|NCT01709903|468486238|FG000|Overall Study|Protocol Violation|3|||
130144101|NCT01709903|468486239|FG001|Overall Study|Protocol Violation|2|||
130144102|NCT01709903|468486238|FG000|Overall Study|Lack of Efficacy|3|||
130144103|NCT01709903|468486239|FG001|Overall Study|Lack of Efficacy|3|||
130144104|NCT01709903|468486238|FG000|Overall Study|Withdrawal by Subject|6|||
130144105|NCT01709903|468486239|FG001|Overall Study|Withdrawal by Subject|6|||
130144106|NCT01709903|468486238|FG000|Overall Study|Adverse Event|11|||
130144107|NCT01709903|468486239|FG001|Overall Study|Adverse Event|18|||
130144108|NCT05135273|468487932|FG000|Overall Study|Recruited into the army|0|||
130144109|NCT05135273|468487933|FG001|Overall Study|Recruited into the army|0|||
130144110|NCT05135273|468487934|FG002|Overall Study|Recruited into the army|0|||
130144111|NCT05135273|468487935|FG003|Overall Study|Recruited into the army|0|||
130144112|NCT05135273|468487936|FG004|Overall Study|Recruited into the army|1|||
130144113|NCT05135273|468487937|FG005|Overall Study|Recruited into the army|0|||
130144114|NCT05135273|468487938|FG006|Overall Study|Recruited into the army|0|||
130144115|NCT05135273|468487939|FG007|Overall Study|Recruited into the army|0|||
130144116|NCT05135273|468487932|FG000|Overall Study|Moved away from study site|0|||
130144117|NCT05135273|468487933|FG001|Overall Study|Moved away from study site|0|||
130144118|NCT05135273|468487934|FG002|Overall Study|Moved away from study site|0|||
130144119|NCT05135273|468487935|FG003|Overall Study|Moved away from study site|0|||
130144120|NCT05135273|468487936|FG004|Overall Study|Moved away from study site|0|||
130144121|NCT05135273|468487937|FG005|Overall Study|Moved away from study site|1|||
130144122|NCT05135273|468487938|FG006|Overall Study|Moved away from study site|1|||
130144123|NCT05135273|468487939|FG007|Overall Study|Moved away from study site|0|||
130144124|NCT05135273|468487932|FG000|Overall Study|Travel|0|||
130144125|NCT05135273|468487933|FG001|Overall Study|Travel|0|||
130144126|NCT05135273|468487934|FG002|Overall Study|Travel|0|||
130144127|NCT05135273|468487935|FG003|Overall Study|Travel|0|||
130144128|NCT05135273|468487936|FG004|Overall Study|Travel|0|||
129976497|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Other|0|||
129976498|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Other|0|||
130144129|NCT05135273|468487937|FG005|Overall Study|Travel|0|||
130144130|NCT05135273|468487938|FG006|Overall Study|Travel|0|||
130144131|NCT05135273|468487939|FG007|Overall Study|Travel|1|||
130144132|NCT02710214|468487940|FG000|Overall Study|Lost to Follow-up|1|||
130144133|NCT02710214|468487941|FG001|Overall Study|Lost to Follow-up|0|||
130144134|NCT02710214|468487940|FG000|Overall Study|Lack of Efficacy|0|||
130144135|NCT02710214|468487941|FG001|Overall Study|Lack of Efficacy|1|||
130144136|NCT02710214|468487940|FG000|Overall Study|Death|0|||
130144137|NCT02710214|468487941|FG001|Overall Study|Death|1|||
130144138|NCT01705717|468487949|FG000|Overall Study|Adverse Event|2|||
130144139|NCT01705717|468487950|FG001|Overall Study|Adverse Event|2|||
130144140|NCT01705717|468487949|FG000|Overall Study|Lack of Efficacy|0|||
129976499|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
130144141|NCT01705717|468487950|FG001|Overall Study|Lack of Efficacy|1|||
130144142|NCT01705717|468487949|FG000|Overall Study|Other|0|||
130144143|NCT01705717|468487950|FG001|Overall Study|Other|2|||
130144144|NCT01188226|468487958|FG000|Overall Study|Withdrawal by Subject|4|||
130144145|NCT01662024|468487959|FG000|Overall Study|Pregnancy|2|||
130144146|NCT01662024|468487959|FG000|Overall Study|Withdrawal by Subject|3|||
130144147|NCT04832971|468487960|FG000|Overall Study|Death|1|||
130144148|NCT04832971|468487961|FG001|Overall Study|Death|0|||
130144149|NCT04832971|468487962|FG002|Overall Study|Death|0|||
130144150|NCT04832971|468487963|FG003|Overall Study|Death|0|||
130144151|NCT04832971|468487960|FG000|Overall Study|Lost to Follow-up|1|||
130144152|NCT04832971|468487961|FG001|Overall Study|Lost to Follow-up|1|||
130144153|NCT04832971|468487962|FG002|Overall Study|Lost to Follow-up|1|||
130144154|NCT04832971|468487963|FG003|Overall Study|Lost to Follow-up|0|||
130144155|NCT04832971|468487960|FG000|Overall Study|Withdrawal by Subject|1|||
130144156|NCT04832971|468487961|FG001|Overall Study|Withdrawal by Subject|3|||
130144157|NCT04832971|468487962|FG002|Overall Study|Withdrawal by Subject|2|||
130144158|NCT04832971|468487963|FG003|Overall Study|Withdrawal by Subject|2|||
130144159|NCT04832971|468487960|FG000|Overall Study|Other, Not Specified|0|||
130144160|NCT04832971|468487961|FG001|Overall Study|Other, Not Specified|0|||
130144161|NCT04832971|468487962|FG002|Overall Study|Other, Not Specified|1|||
130144162|NCT04832971|468487963|FG003|Overall Study|Other, Not Specified|0|||
130144163|NCT04980456|468487964|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
130144164|NCT04980456|468487965|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
130144165|NCT04980456|468487964|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
130144166|NCT04980456|468487965|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
130144167|NCT04980456|468487964|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
130144168|NCT04980456|468487965|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
130144169|NCT04980456|468487964|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
130144170|NCT04980456|468487965|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
130144171|NCT02293460|468487966|FG000|Overall Study|Protocol Violation|1|||
130144172|NCT02293460|468487966|FG000|Overall Study|Lack of Efficacy|2|||
130144173|NCT02293460|468487966|FG000|Overall Study|Adverse Event|2|||
130144174|NCT02293460|468487966|FG000|Overall Study|Withdrawal by Subject|1|||
130144175|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
130144176|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
130144177|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
130144178|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
130144179|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
130144180|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
130144181|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
130144182|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
130144183|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
130144184|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
130144185|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
130144186|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
130144187|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
130144188|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
130144189|NCT04592419|468487970|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
130144190|NCT04592419|468487971|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
130144191|NCT04592419|468487970|FG000|Open-Label Extension Period|Adverse Event|1|||
130144192|NCT04592419|468487971|FG001|Open-Label Extension Period|Adverse Event|2|||
130144193|NCT04592419|468487970|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
130144194|NCT04592419|468487971|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
130144195|NCT04592419|468487970|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
130144196|NCT04592419|468487971|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
130144197|NCT04592419|468487970|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
130144198|NCT04592419|468487971|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
130144199|NCT04592419|468487970|FG000|Open-Label Extension Period|Sponsor Request|73|||
130144200|NCT04592419|468487971|FG001|Open-Label Extension Period|Sponsor Request|84|||
130144201|NCT04129944|468487974|FG000|Overall Study|Death|0|||
130144202|NCT04129944|468487975|FG001|Overall Study|Death|0|||
130144203|NCT04129944|468487976|FG002|Overall Study|Death|0|||
130144204|NCT04129944|468487977|FG003|Overall Study|Death|1|||
130144205|NCT04129944|468487974|FG000|Overall Study|Lost to Follow-up|1|||
130144206|NCT04129944|468487975|FG001|Overall Study|Lost to Follow-up|0|||
130144207|NCT04129944|468487976|FG002|Overall Study|Lost to Follow-up|0|||
130144208|NCT04129944|468487977|FG003|Overall Study|Lost to Follow-up|0|||
130144209|NCT04129944|468487974|FG000|Overall Study|Withdrawal by Subject|1|||
130144210|NCT04129944|468487975|FG001|Overall Study|Withdrawal by Subject|0|||
130144211|NCT04129944|468487976|FG002|Overall Study|Withdrawal by Subject|1|||
130144212|NCT04129944|468487977|FG003|Overall Study|Withdrawal by Subject|2|||
130144213|NCT02419573|468487978|FG000|Overall Study|Lost to Follow-up|3|||
130144214|NCT02419573|468487979|FG001|Overall Study|Lost to Follow-up|0|||
130144215|NCT02419573|468487978|FG000|Overall Study|Withdrawal by Subject|1|||
130144216|NCT02419573|468487979|FG001|Overall Study|Withdrawal by Subject|0|||
130144217|NCT00493792|468487980|FG000|Overall Study|Death|55|||
130144218|NCT00493792|468487981|FG001|Overall Study|Death|50|||
130144219|NCT00493792|468487980|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
130144220|NCT00493792|468487981|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
130144221|NCT02246764|468487994|FG000|Overall Study|Adverse Event|15|||
130144222|NCT02246764|468487995|FG001|Overall Study|Adverse Event|29|||
130144223|NCT02246764|468487996|FG002|Overall Study|Adverse Event|1|||
129976500|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
129976501|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
129976502|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
129976503|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
129976504|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129976505|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129976506|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
130144224|NCT02246764|468487994|FG000|Overall Study|Withdrawal by Subject|0|||
130144225|NCT02246764|468487995|FG001|Overall Study|Withdrawal by Subject|0|||
130144226|NCT02246764|468487996|FG002|Overall Study|Withdrawal by Subject|1|||
130144227|NCT02246764|468487994|FG000|Overall Study|Disallowed Concomitant Medication|1|||
130144228|NCT02246764|468487995|FG001|Overall Study|Disallowed Concomitant Medication|0|||
130144229|NCT02246764|468487996|FG002|Overall Study|Disallowed Concomitant Medication|0|||
130144230|NCT02246764|468487994|FG000|Overall Study|Physician Decision|0|||
130144231|NCT02246764|468487995|FG001|Overall Study|Physician Decision|2|||
130144232|NCT02246764|468487996|FG002|Overall Study|Physician Decision|1|||
130144233|NCT02246764|468487994|FG000|Overall Study|Protocol Violation|2|||
130144234|NCT02246764|468487995|FG001|Overall Study|Protocol Violation|1|||
130144235|NCT02246764|468487996|FG002|Overall Study|Protocol Violation|1|||
130144236|NCT02754492|468487999|FG000|Overall Study|Protocol Violation|2|||
130144237|NCT02754492|468488000|FG001|Overall Study|Protocol Violation|2|||
130144238|NCT02754492|468488001|FG002|Overall Study|Protocol Violation|0|||
130144239|NCT02754492|468488002|FG003|Overall Study|Protocol Violation|1|||
130144240|NCT02754492|468487999|FG000|Overall Study|Withdrawal by Subject|2|||
130144241|NCT02754492|468488000|FG001|Overall Study|Withdrawal by Subject|0|||
130144242|NCT02754492|468488001|FG002|Overall Study|Withdrawal by Subject|0|||
130144243|NCT02754492|468488002|FG003|Overall Study|Withdrawal by Subject|0|||
130144244|NCT02754492|468487999|FG000|Overall Study|Equipment malfuntion|0|||
130144245|NCT02754492|468488000|FG001|Overall Study|Equipment malfuntion|0|||
130144246|NCT02754492|468488001|FG002|Overall Study|Equipment malfuntion|2|||
130144247|NCT02754492|468488002|FG003|Overall Study|Equipment malfuntion|5|||
130144248|NCT02754492|468487999|FG000|Overall Study|Adverse Event|0|||
130144249|NCT02754492|468488000|FG001|Overall Study|Adverse Event|0|||
130144250|NCT02754492|468488001|FG002|Overall Study|Adverse Event|0|||
130144251|NCT02754492|468488002|FG003|Overall Study|Adverse Event|13|||
130144252|NCT02754492|468487999|FG000|Overall Study|Venous access issues not resulting in AE|0|||
130144253|NCT02754492|468488000|FG001|Overall Study|Venous access issues not resulting in AE|0|||
130144254|NCT02754492|468488001|FG002|Overall Study|Venous access issues not resulting in AE|0|||
130144255|NCT02754492|468488002|FG003|Overall Study|Venous access issues not resulting in AE|4|||
130144256|NCT01408888|468488003|FG000|First Intervention|Adverse Event|0|||
130144257|NCT01408888|468488004|FG001|First Intervention|Adverse Event|1|||
130144258|NCT01408888|468488003|FG000|First Intervention|Withdrawal by Subject|0|||
130144259|NCT01408888|468488004|FG001|First Intervention|Withdrawal by Subject|2|||
130144260|NCT01408888|468488003|FG000|Second Intervention|Withdrawal by Subject|1|||
130144261|NCT01408888|468488004|FG001|Second Intervention|Withdrawal by Subject|0|||
130144262|NCT01408888|468488003|FG000|Second Intervention|Adverse Event|1|||
130144263|NCT01408888|468488004|FG001|Second Intervention|Adverse Event|0|||
130144264|NCT00695110|468488005|FG000|Treatment Period 1|Adverse Event|1|||
130144265|NCT00695110|468488005|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130144266|NCT00695110|468488005|FG000|Treatment Period 3|Withdrawal by Subject|1|||
130144267|NCT00695110|468488005|FG000|Treatment Period 4|Adverse Event|1|||
129976507|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129976508|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
129976509|NCT00895895|467877768|FG000|Period 2|Adverse Event|3|||
130144268|NCT00611884|468488010|FG000|Overall Study|Adverse Event|1|||
130144269|NCT00611884|468488011|FG001|Overall Study|Adverse Event|0|||
130144270|NCT00611884|468488012|FG002|Overall Study|Adverse Event|0|||
130144271|NCT00611884|468488013|FG003|Overall Study|Adverse Event|1|||
130144272|NCT00611884|468488010|FG000|Overall Study|Non-Compliance|1|||
130144273|NCT00611884|468488011|FG001|Overall Study|Non-Compliance|4|||
130144274|NCT00611884|468488012|FG002|Overall Study|Non-Compliance|2|||
130144275|NCT00611884|468488013|FG003|Overall Study|Non-Compliance|2|||
129976510|NCT00895895|467877769|FG001|Period 2|Adverse Event|3|||
130144276|NCT00611884|468488010|FG000|Overall Study|Lack of Efficacy|0|||
130144277|NCT00611884|468488011|FG001|Overall Study|Lack of Efficacy|1|||
130144278|NCT00611884|468488012|FG002|Overall Study|Lack of Efficacy|0|||
130144279|NCT00611884|468488013|FG003|Overall Study|Lack of Efficacy|0|||
130144280|NCT00611884|468488010|FG000|Overall Study|Unclassified|7|||
130144281|NCT00611884|468488011|FG001|Overall Study|Unclassified|4|||
130144282|NCT00611884|468488012|FG002|Overall Study|Unclassified|2|||
130144283|NCT00611884|468488013|FG003|Overall Study|Unclassified|3|||
130144284|NCT00981799|468488014|FG000|Overall Study|Adverse Event|1|||
130144285|NCT00981799|468488015|FG001|Overall Study|Adverse Event|1|||
130144286|NCT00981799|468488016|FG002|Overall Study|Adverse Event|0|||
130144287|NCT00981799|468488017|FG003|Overall Study|Adverse Event|0|||
130144288|NCT01190930|468488018|FG000|Induction|Adverse Event|17|||
130144289|NCT01190930|468488019|FG001|Induction|Adverse Event|0|||
130144290|NCT01190930|468488020|FG002|Induction|Adverse Event|0|||
130144291|NCT01190930|468488021|FG003|Induction|Adverse Event|0|||
130144292|NCT01190930|468488022|FG004|Induction|Adverse Event|0|||
130144293|NCT01190930|468488023|FG005|Induction|Adverse Event|0|||
130144294|NCT01190930|468488024|FG006|Induction|Adverse Event|0|||
130144295|NCT01190930|468488025|FG007|Induction|Adverse Event|0|||
130144296|NCT01190930|468488026|FG008|Induction|Adverse Event|0|||
130144297|NCT01190930|468488027|FG009|Induction|Adverse Event|0|||
130144298|NCT01190930|468488018|FG000|Induction|Death|34|||
130144299|NCT01190930|468488019|FG001|Induction|Death|0|||
130144300|NCT01190930|468488020|FG002|Induction|Death|0|||
130144301|NCT01190930|468488021|FG003|Induction|Death|0|||
130144302|NCT01190930|468488022|FG004|Induction|Death|0|||
130144303|NCT01190930|468488023|FG005|Induction|Death|0|||
130144304|NCT01190930|468488024|FG006|Induction|Death|0|||
130144305|NCT01190930|468488025|FG007|Induction|Death|0|||
130144306|NCT01190930|468488026|FG008|Induction|Death|0|||
130144307|NCT01190930|468488027|FG009|Induction|Death|0|||
130144308|NCT01190930|468488018|FG000|Induction|Lost to Follow-up|1|||
130144309|NCT01190930|468488019|FG001|Induction|Lost to Follow-up|0|||
130144310|NCT01190930|468488020|FG002|Induction|Lost to Follow-up|0|||
130144311|NCT01190930|468488021|FG003|Induction|Lost to Follow-up|0|||
130144312|NCT01190930|468488022|FG004|Induction|Lost to Follow-up|0|||
130144313|NCT01190930|468488023|FG005|Induction|Lost to Follow-up|0|||
130144314|NCT01190930|468488024|FG006|Induction|Lost to Follow-up|0|||
130144315|NCT01190930|468488025|FG007|Induction|Lost to Follow-up|0|||
130144316|NCT01190930|468488026|FG008|Induction|Lost to Follow-up|0|||
130144317|NCT01190930|468488027|FG009|Induction|Lost to Follow-up|0|||
130144318|NCT01190930|468488018|FG000|Induction|Physician Decision|125|||
130144319|NCT01190930|468488019|FG001|Induction|Physician Decision|3|||
130144320|NCT01190930|468488020|FG002|Induction|Physician Decision|0|||
130144321|NCT01190930|468488021|FG003|Induction|Physician Decision|0|||
130144322|NCT01190930|468488022|FG004|Induction|Physician Decision|0|||
130144323|NCT01190930|468488023|FG005|Induction|Physician Decision|0|||
130144324|NCT01190930|468488024|FG006|Induction|Physician Decision|0|||
130144325|NCT01190930|468488025|FG007|Induction|Physician Decision|0|||
130144326|NCT01190930|468488026|FG008|Induction|Physician Decision|0|||
130144327|NCT01190930|468488027|FG009|Induction|Physician Decision|0|||
130144328|NCT01190930|468488018|FG000|Induction|Withdrawal by Subject|9|||
130144329|NCT01190930|468488019|FG001|Induction|Withdrawal by Subject|0|||
130144330|NCT01190930|468488020|FG002|Induction|Withdrawal by Subject|0|||
130144331|NCT01190930|468488021|FG003|Induction|Withdrawal by Subject|0|||
130144332|NCT01190930|468488022|FG004|Induction|Withdrawal by Subject|0|||
130144333|NCT01190930|468488023|FG005|Induction|Withdrawal by Subject|0|||
130144334|NCT01190930|468488024|FG006|Induction|Withdrawal by Subject|0|||
130144335|NCT01190930|468488025|FG007|Induction|Withdrawal by Subject|0|||
130144336|NCT01190930|468488026|FG008|Induction|Withdrawal by Subject|0|||
130144337|NCT01190930|468488027|FG009|Induction|Withdrawal by Subject|0|||
130144338|NCT01190930|468488018|FG000|Induction|Refusal|235|||
130144339|NCT01190930|468488019|FG001|Induction|Refusal|0|||
130144340|NCT01190930|468488020|FG002|Induction|Refusal|0|||
130144341|NCT01190930|468488021|FG003|Induction|Refusal|0|||
130144342|NCT01190930|468488022|FG004|Induction|Refusal|0|||
130144343|NCT01190930|468488023|FG005|Induction|Refusal|0|||
130144344|NCT01190930|468488024|FG006|Induction|Refusal|0|||
130144345|NCT01190930|468488025|FG007|Induction|Refusal|0|||
130144346|NCT01190930|468488026|FG008|Induction|Refusal|0|||
130144347|NCT01190930|468488027|FG009|Induction|Refusal|0|||
130144348|NCT01190930|468488018|FG000|Induction|Inevaluable|23|||
130144349|NCT01190930|468488019|FG001|Induction|Inevaluable|1|||
130144350|NCT01190930|468488020|FG002|Induction|Inevaluable|0|||
130144351|NCT01190930|468488021|FG003|Induction|Inevaluable|0|||
130144352|NCT01190930|468488022|FG004|Induction|Inevaluable|0|||
130144353|NCT01190930|468488023|FG005|Induction|Inevaluable|0|||
130144354|NCT01190930|468488024|FG006|Induction|Inevaluable|0|||
130144355|NCT01190930|468488025|FG007|Induction|Inevaluable|0|||
130144356|NCT01190930|468488026|FG008|Induction|Inevaluable|0|||
130144357|NCT01190930|468488027|FG009|Induction|Inevaluable|0|||
130144358|NCT01190930|468488018|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
130144359|NCT01190930|468488019|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144360|NCT01190930|468488020|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144361|NCT01190930|468488021|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144362|NCT01190930|468488022|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144363|NCT01190930|468488023|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144364|NCT01190930|468488024|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144365|NCT01190930|468488025|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144366|NCT01190930|468488026|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144367|NCT01190930|468488027|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
130144368|NCT01190930|468488018|FG000|Induction|High Risk Downs|80|||
130144369|NCT01190930|468488019|FG001|Induction|High Risk Downs|0|||
130144370|NCT01190930|468488020|FG002|Induction|High Risk Downs|0|||
130144371|NCT01190930|468488021|FG003|Induction|High Risk Downs|0|||
130144372|NCT01190930|468488022|FG004|Induction|High Risk Downs|0|||
130144373|NCT01190930|468488023|FG005|Induction|High Risk Downs|0|||
130144374|NCT01190930|468488024|FG006|Induction|High Risk Downs|0|||
130144375|NCT01190930|468488025|FG007|Induction|High Risk Downs|0|||
130144376|NCT01190930|468488026|FG008|Induction|High Risk Downs|0|||
130144377|NCT01190930|468488027|FG009|Induction|High Risk Downs|0|||
130144378|NCT01190930|468488018|FG000|Induction|Enrollment onto another COG Protocol|1|||
130144379|NCT01190930|468488019|FG001|Induction|Enrollment onto another COG Protocol|0|||
130144380|NCT01190930|468488020|FG002|Induction|Enrollment onto another COG Protocol|0|||
130144381|NCT01190930|468488021|FG003|Induction|Enrollment onto another COG Protocol|0|||
130144382|NCT01190930|468488022|FG004|Induction|Enrollment onto another COG Protocol|0|||
130144383|NCT01190930|468488023|FG005|Induction|Enrollment onto another COG Protocol|0|||
130144384|NCT01190930|468488024|FG006|Induction|Enrollment onto another COG Protocol|0|||
130144385|NCT01190930|468488025|FG007|Induction|Enrollment onto another COG Protocol|0|||
130144386|NCT01190930|468488026|FG008|Induction|Enrollment onto another COG Protocol|0|||
130144387|NCT01190930|468488027|FG009|Induction|Enrollment onto another COG Protocol|0|||
130144388|NCT01190930|468488018|FG000|Induction|Average Risk|1847|||
130144389|NCT01190930|468488019|FG001|Induction|Average Risk|0|||
130144390|NCT01190930|468488020|FG002|Induction|Average Risk|0|||
130144391|NCT01190930|468488021|FG003|Induction|Average Risk|0|||
130144392|NCT01190930|468488022|FG004|Induction|Average Risk|0|||
130144393|NCT01190930|468488023|FG005|Induction|Average Risk|0|||
130144394|NCT01190930|468488024|FG006|Induction|Average Risk|0|||
130144395|NCT01190930|468488025|FG007|Induction|Average Risk|0|||
130144396|NCT01190930|468488026|FG008|Induction|Average Risk|0|||
130144397|NCT01190930|468488027|FG009|Induction|Average Risk|0|||
130144398|NCT01190930|468488018|FG000|Induction|High Risk|1227|||
130144399|NCT01190930|468488019|FG001|Induction|High Risk|0|||
130144400|NCT01190930|468488020|FG002|Induction|High Risk|0|||
130144401|NCT01190930|468488021|FG003|Induction|High Risk|0|||
130144402|NCT01190930|468488022|FG004|Induction|High Risk|0|||
130144403|NCT01190930|468488023|FG005|Induction|High Risk|0|||
130144404|NCT01190930|468488024|FG006|Induction|High Risk|0|||
130144405|NCT01190930|468488025|FG007|Induction|High Risk|0|||
130144406|NCT01190930|468488026|FG008|Induction|High Risk|0|||
130144407|NCT01190930|468488027|FG009|Induction|High Risk|0|||
130144408|NCT01190930|468488018|FG000|Induction|Low Risk|443|||
130144409|NCT01190930|468488019|FG001|Induction|Low Risk|0|||
130144410|NCT01190930|468488020|FG002|Induction|Low Risk|0|||
130144411|NCT01190930|468488021|FG003|Induction|Low Risk|0|||
130144412|NCT01190930|468488022|FG004|Induction|Low Risk|0|||
130144413|NCT01190930|468488023|FG005|Induction|Low Risk|0|||
130144414|NCT01190930|468488024|FG006|Induction|Low Risk|0|||
130144415|NCT01190930|468488025|FG007|Induction|Low Risk|0|||
130144416|NCT01190930|468488026|FG008|Induction|Low Risk|0|||
130144417|NCT01190930|468488027|FG009|Induction|Low Risk|0|||
130144418|NCT01190930|468488018|FG000|Induction|Very High Risk|1012|||
130144419|NCT01190930|468488019|FG001|Induction|Very High Risk|0|||
130144420|NCT01190930|468488020|FG002|Induction|Very High Risk|0|||
130144421|NCT01190930|468488021|FG003|Induction|Very High Risk|0|||
130144422|NCT01190930|468488022|FG004|Induction|Very High Risk|0|||
130144423|NCT01190930|468488023|FG005|Induction|Very High Risk|0|||
130144424|NCT01190930|468488024|FG006|Induction|Very High Risk|0|||
129976511|NCT00895895|467877770|FG002|Period 2|Adverse Event|5|||
129976512|NCT00895895|467877771|FG003|Period 2|Adverse Event|2|||
129976513|NCT00895895|467877772|FG004|Period 2|Adverse Event|5|||
129976514|NCT00895895|467877768|FG000|Period 2|Death|0|||
130144425|NCT01190930|468488025|FG007|Induction|Very High Risk|0|||
130144426|NCT01190930|468488026|FG008|Induction|Very High Risk|0|||
130144427|NCT01190930|468488027|FG009|Induction|Very High Risk|0|||
130144428|NCT01190930|468488018|FG000|Induction|Philadelphia chromosome-positive|99|||
130144429|NCT01190930|468488019|FG001|Induction|Philadelphia chromosome-positive|0|||
130144430|NCT01190930|468488020|FG002|Induction|Philadelphia chromosome-positive|0|||
130144431|NCT01190930|468488021|FG003|Induction|Philadelphia chromosome-positive|0|||
130144432|NCT01190930|468488022|FG004|Induction|Philadelphia chromosome-positive|0|||
130144433|NCT01190930|468488023|FG005|Induction|Philadelphia chromosome-positive|0|||
130144434|NCT01190930|468488024|FG006|Induction|Philadelphia chromosome-positive|0|||
129976515|NCT00895895|467877769|FG001|Period 2|Death|0|||
129976516|NCT00895895|467877770|FG002|Period 2|Death|1|||
130144435|NCT01190930|468488025|FG007|Induction|Philadelphia chromosome-positive|0|||
130144436|NCT01190930|468488026|FG008|Induction|Philadelphia chromosome-positive|0|||
130144437|NCT01190930|468488027|FG009|Induction|Philadelphia chromosome-positive|0|||
130144438|NCT01190930|468488018|FG000|Induction|Incomplete Induction data|63|||
130144439|NCT01190930|468488019|FG001|Induction|Incomplete Induction data|0|||
130144440|NCT01190930|468488020|FG002|Induction|Incomplete Induction data|0|||
130144441|NCT01190930|468488021|FG003|Induction|Incomplete Induction data|0|||
130144442|NCT01190930|468488022|FG004|Induction|Incomplete Induction data|0|||
130144443|NCT01190930|468488023|FG005|Induction|Incomplete Induction data|0|||
130144444|NCT01190930|468488024|FG006|Induction|Incomplete Induction data|0|||
130144445|NCT01190930|468488025|FG007|Induction|Incomplete Induction data|0|||
130144446|NCT01190930|468488026|FG008|Induction|Incomplete Induction data|0|||
130144447|NCT01190930|468488027|FG009|Induction|Incomplete Induction data|0|||
129976517|NCT00895895|467877771|FG003|Period 2|Death|0|||
129976518|NCT00895895|467877772|FG004|Period 2|Death|0|||
129976519|NCT00895895|467877768|FG000|Period 2|discontinued by sponsor|44|||
129976520|NCT00895895|467877769|FG001|Period 2|discontinued by sponsor|44|||
130144448|NCT01190930|468488018|FG000|Induction|Progressive disease|0|||
130144449|NCT01190930|468488019|FG001|Induction|Progressive disease|1|||
130144450|NCT01190930|468488020|FG002|Induction|Progressive disease|0|||
130144451|NCT01190930|468488021|FG003|Induction|Progressive disease|0|||
130144452|NCT01190930|468488022|FG004|Induction|Progressive disease|0|||
130144453|NCT01190930|468488023|FG005|Induction|Progressive disease|0|||
130144454|NCT01190930|468488024|FG006|Induction|Progressive disease|0|||
130144455|NCT01190930|468488025|FG007|Induction|Progressive disease|0|||
130144456|NCT01190930|468488026|FG008|Induction|Progressive disease|0|||
130144457|NCT01190930|468488027|FG009|Induction|Progressive disease|0|||
130144458|NCT01190930|468488018|FG000|Induction|No treatment|3|||
130144459|NCT01190930|468488019|FG001|Induction|No treatment|0|||
130144460|NCT01190930|468488020|FG002|Induction|No treatment|0|||
130144461|NCT01190930|468488021|FG003|Induction|No treatment|0|||
130144462|NCT01190930|468488022|FG004|Induction|No treatment|0|||
130144463|NCT01190930|468488023|FG005|Induction|No treatment|0|||
130144464|NCT01190930|468488024|FG006|Induction|No treatment|0|||
130144465|NCT01190930|468488025|FG007|Induction|No treatment|0|||
130144466|NCT01190930|468488026|FG008|Induction|No treatment|0|||
130144467|NCT01190930|468488027|FG009|Induction|No treatment|0|||
130144468|NCT01190930|468488018|FG000|Induction|Ineligible|69|||
130144469|NCT01190930|468488019|FG001|Induction|Ineligible|4|||
130144470|NCT01190930|468488020|FG002|Induction|Ineligible|0|||
130144471|NCT01190930|468488021|FG003|Induction|Ineligible|0|||
130144472|NCT01190930|468488022|FG004|Induction|Ineligible|0|||
130144473|NCT01190930|468488023|FG005|Induction|Ineligible|0|||
130144474|NCT01190930|468488024|FG006|Induction|Ineligible|0|||
130144475|NCT01190930|468488025|FG007|Induction|Ineligible|0|||
130144476|NCT01190930|468488026|FG008|Induction|Ineligible|0|||
130144477|NCT01190930|468488027|FG009|Induction|Ineligible|0|||
130144478|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
130144479|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
130144480|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
130144481|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
130144482|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
130144483|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
130144484|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
130144485|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
130144486|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
130144487|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
130144488|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Death|0|||
130144489|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Death|0|||
130144490|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Death|8|||
130144491|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Death|4|||
130144492|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Death|0|||
130144493|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Death|0|||
130144494|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Death|0|||
130144495|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Death|0|||
130144496|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Death|0|||
130144497|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Death|0|||
130144498|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
130144499|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
130144500|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
130144501|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
130144502|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
130144503|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
129976521|NCT00895895|467877770|FG002|Period 2|discontinued by sponsor|38|||
129976522|NCT00895895|467877771|FG003|Period 2|discontinued by sponsor|46|||
130144504|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
130144505|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
130144506|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
130144507|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
130144508|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144509|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
130144510|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
129976523|NCT00895895|467877772|FG004|Period 2|discontinued by sponsor|37|||
130144511|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
130144512|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144513|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144514|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144515|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144516|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144517|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
130144518|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Refusal|0|||
130144519|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Refusal|2|||
130144520|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Refusal|694|||
130144521|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Refusal|4|||
130144522|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Refusal|0|||
130144523|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Refusal|3|||
130144524|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Refusal|0|||
130144525|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Refusal|0|||
130144526|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Refusal|0|||
130144527|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Refusal|0|||
130144528|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
130144529|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
130144530|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
130144531|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
130144532|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
130144533|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
130144534|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
130144535|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
130144536|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
130144537|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
130144538|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144539|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
130144540|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144541|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144542|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144543|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144544|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144545|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144546|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144547|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
130144548|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
130144549|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
130144550|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
130144551|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
130144552|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
130144553|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
130144554|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
130144555|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
130144556|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
130144557|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
130144558|NCT01190930|468488018|FG000|Post Induction Pre-Maintenance|Relapse|0|||
130144559|NCT01190930|468488019|FG001|Post Induction Pre-Maintenance|Relapse|0|||
130144560|NCT01190930|468488020|FG002|Post Induction Pre-Maintenance|Relapse|1|||
130144561|NCT01190930|468488021|FG003|Post Induction Pre-Maintenance|Relapse|0|||
130144562|NCT01190930|468488022|FG004|Post Induction Pre-Maintenance|Relapse|0|||
130144563|NCT01190930|468488023|FG005|Post Induction Pre-Maintenance|Relapse|0|||
130144564|NCT01190930|468488024|FG006|Post Induction Pre-Maintenance|Relapse|0|||
130144565|NCT01190930|468488025|FG007|Post Induction Pre-Maintenance|Relapse|0|||
130144566|NCT01190930|468488026|FG008|Post Induction Pre-Maintenance|Relapse|0|||
130144567|NCT01190930|468488027|FG009|Post Induction Pre-Maintenance|Relapse|0|||
130144568|NCT01190930|468488018|FG000|Maintenance|Adverse Event|0|||
130144569|NCT01190930|468488019|FG001|Maintenance|Adverse Event|0|||
130144570|NCT01190930|468488020|FG002|Maintenance|Adverse Event|0|||
130144571|NCT01190930|468488021|FG003|Maintenance|Adverse Event|0|||
130144572|NCT01190930|468488022|FG004|Maintenance|Adverse Event|0|||
130144573|NCT01190930|468488023|FG005|Maintenance|Adverse Event|1|||
130144574|NCT01190930|468488024|FG006|Maintenance|Adverse Event|1|||
130144575|NCT01190930|468488025|FG007|Maintenance|Adverse Event|3|||
130144576|NCT01190930|468488026|FG008|Maintenance|Adverse Event|3|||
129976524|NCT00895895|467877768|FG000|Period 2|failed to return|2|||
129976525|NCT00895895|467877769|FG001|Period 2|failed to return|0|||
129976526|NCT00895895|467877770|FG002|Period 2|failed to return|0|||
129976527|NCT00895895|467877771|FG003|Period 2|failed to return|0|||
129976528|NCT00895895|467877772|FG004|Period 2|failed to return|0|||
130144577|NCT01190930|468488027|FG009|Maintenance|Adverse Event|0|||
130144578|NCT01190930|468488018|FG000|Maintenance|Death|0|||
130144579|NCT01190930|468488019|FG001|Maintenance|Death|0|||
130144580|NCT01190930|468488020|FG002|Maintenance|Death|0|||
130144581|NCT01190930|468488021|FG003|Maintenance|Death|1|||
130144582|NCT01190930|468488022|FG004|Maintenance|Death|0|||
130144583|NCT01190930|468488023|FG005|Maintenance|Death|0|||
130144584|NCT01190930|468488024|FG006|Maintenance|Death|2|||
130144585|NCT01190930|468488025|FG007|Maintenance|Death|2|||
130144586|NCT01190930|468488026|FG008|Maintenance|Death|2|||
130144587|NCT01190930|468488027|FG009|Maintenance|Death|2|||
130144588|NCT01190930|468488018|FG000|Maintenance|Lost to Follow-up|0|||
130144589|NCT01190930|468488019|FG001|Maintenance|Lost to Follow-up|0|||
130144590|NCT01190930|468488020|FG002|Maintenance|Lost to Follow-up|0|||
130144591|NCT01190930|468488021|FG003|Maintenance|Lost to Follow-up|0|||
130144592|NCT01190930|468488022|FG004|Maintenance|Lost to Follow-up|0|||
130144593|NCT01190930|468488023|FG005|Maintenance|Lost to Follow-up|0|||
130144594|NCT01190930|468488024|FG006|Maintenance|Lost to Follow-up|1|||
130144595|NCT01190930|468488025|FG007|Maintenance|Lost to Follow-up|1|||
130144596|NCT01190930|468488026|FG008|Maintenance|Lost to Follow-up|1|||
130144597|NCT01190930|468488027|FG009|Maintenance|Lost to Follow-up|0|||
130144598|NCT01190930|468488018|FG000|Maintenance|Physician Decision|0|||
130144599|NCT01190930|468488019|FG001|Maintenance|Physician Decision|1|||
130144600|NCT01190930|468488020|FG002|Maintenance|Physician Decision|0|||
130144601|NCT01190930|468488021|FG003|Maintenance|Physician Decision|5|||
130144602|NCT01190930|468488022|FG004|Maintenance|Physician Decision|9|||
130144603|NCT01190930|468488023|FG005|Maintenance|Physician Decision|4|||
130144604|NCT01190930|468488024|FG006|Maintenance|Physician Decision|8|||
130144605|NCT01190930|468488025|FG007|Maintenance|Physician Decision|8|||
130144606|NCT01190930|468488026|FG008|Maintenance|Physician Decision|10|||
130144607|NCT01190930|468488027|FG009|Maintenance|Physician Decision|17|||
130144608|NCT01190930|468488018|FG000|Maintenance|Withdrawal by Subject|0|||
130144609|NCT01190930|468488019|FG001|Maintenance|Withdrawal by Subject|0|||
130144610|NCT01190930|468488020|FG002|Maintenance|Withdrawal by Subject|0|||
130144611|NCT01190930|468488021|FG003|Maintenance|Withdrawal by Subject|0|||
130144612|NCT01190930|468488022|FG004|Maintenance|Withdrawal by Subject|0|||
130144613|NCT01190930|468488023|FG005|Maintenance|Withdrawal by Subject|0|||
130144614|NCT01190930|468488024|FG006|Maintenance|Withdrawal by Subject|2|||
130144615|NCT01190930|468488025|FG007|Maintenance|Withdrawal by Subject|1|||
130144616|NCT01190930|468488026|FG008|Maintenance|Withdrawal by Subject|4|||
130144617|NCT01190930|468488027|FG009|Maintenance|Withdrawal by Subject|1|||
130144618|NCT01190930|468488018|FG000|Maintenance|Refusal|0|||
130144619|NCT01190930|468488019|FG001|Maintenance|Refusal|1|||
130144620|NCT01190930|468488020|FG002|Maintenance|Refusal|0|||
130144621|NCT01190930|468488021|FG003|Maintenance|Refusal|2|||
130144622|NCT01190930|468488022|FG004|Maintenance|Refusal|0|||
130144623|NCT01190930|468488023|FG005|Maintenance|Refusal|4|||
130144624|NCT01190930|468488024|FG006|Maintenance|Refusal|5|||
130144625|NCT01190930|468488025|FG007|Maintenance|Refusal|17|||
130144626|NCT01190930|468488026|FG008|Maintenance|Refusal|13|||
130144627|NCT01190930|468488027|FG009|Maintenance|Refusal|6|||
130144628|NCT01190930|468488018|FG000|Maintenance|second malignant neoplasm|0|||
130144629|NCT01190930|468488019|FG001|Maintenance|second malignant neoplasm|0|||
129976529|NCT00895895|467877768|FG000|Period 2|investigator request|2|||
129976530|NCT00895895|467877769|FG001|Period 2|investigator request|0|||
129976531|NCT00895895|467877770|FG002|Period 2|investigator request|0|||
129976532|NCT00895895|467877771|FG003|Period 2|investigator request|0|||
129976533|NCT00895895|467877772|FG004|Period 2|investigator request|0|||
129976534|NCT00895895|467877768|FG000|Period 2|Lost to Follow-up|1|||
129976535|NCT00895895|467877769|FG001|Period 2|Lost to Follow-up|2|||
129976536|NCT00895895|467877770|FG002|Period 2|Lost to Follow-up|1|||
129976537|NCT00895895|467877771|FG003|Period 2|Lost to Follow-up|1|||
129976538|NCT00895895|467877772|FG004|Period 2|Lost to Follow-up|0|||
129976539|NCT00895895|467877768|FG000|Period 2|Other|1|||
129976540|NCT00895895|467877769|FG001|Period 2|Other|1|||
129976541|NCT00895895|467877770|FG002|Period 2|Other|3|||
129976542|NCT00895895|467877771|FG003|Period 2|Other|1|||
129976543|NCT00895895|467877772|FG004|Period 2|Other|1|||
129976544|NCT00895895|467877768|FG000|Period 2|Protocol Violation|1|||
129976545|NCT00895895|467877769|FG001|Period 2|Protocol Violation|0|||
130144630|NCT01190930|468488020|FG002|Maintenance|second malignant neoplasm|0|||
130144631|NCT01190930|468488021|FG003|Maintenance|second malignant neoplasm|1|||
130144632|NCT01190930|468488022|FG004|Maintenance|second malignant neoplasm|0|||
130144633|NCT01190930|468488023|FG005|Maintenance|second malignant neoplasm|1|||
130144634|NCT01190930|468488024|FG006|Maintenance|second malignant neoplasm|0|||
130144635|NCT01190930|468488025|FG007|Maintenance|second malignant neoplasm|0|||
130144636|NCT01190930|468488026|FG008|Maintenance|second malignant neoplasm|1|||
130144637|NCT01190930|468488027|FG009|Maintenance|second malignant neoplasm|0|||
130144638|NCT01190930|468488018|FG000|Maintenance|Inevaluable|0|||
130144639|NCT01190930|468488019|FG001|Maintenance|Inevaluable|0|||
130144640|NCT01190930|468488020|FG002|Maintenance|Inevaluable|0|||
130144641|NCT01190930|468488021|FG003|Maintenance|Inevaluable|0|||
130144642|NCT01190930|468488022|FG004|Maintenance|Inevaluable|0|||
130144643|NCT01190930|468488023|FG005|Maintenance|Inevaluable|1|||
130144644|NCT01190930|468488024|FG006|Maintenance|Inevaluable|1|||
130144645|NCT01190930|468488025|FG007|Maintenance|Inevaluable|1|||
130144646|NCT01190930|468488026|FG008|Maintenance|Inevaluable|0|||
130144647|NCT01190930|468488027|FG009|Maintenance|Inevaluable|0|||
130144648|NCT01190930|468488018|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
130144649|NCT01190930|468488019|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
130144650|NCT01190930|468488020|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
130144651|NCT01190930|468488021|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
130144652|NCT01190930|468488022|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
130144653|NCT01190930|468488023|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
130144654|NCT01190930|468488024|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
130144655|NCT01190930|468488025|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
130144656|NCT01190930|468488026|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
130144657|NCT01190930|468488027|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
130144658|NCT01190930|468488018|FG000|Maintenance|Relapse|0|||
130144659|NCT01190930|468488019|FG001|Maintenance|Relapse|0|||
130144660|NCT01190930|468488020|FG002|Maintenance|Relapse|0|||
130144661|NCT01190930|468488021|FG003|Maintenance|Relapse|2|||
130144662|NCT01190930|468488022|FG004|Maintenance|Relapse|0|||
130144663|NCT01190930|468488023|FG005|Maintenance|Relapse|1|||
130144664|NCT01190930|468488024|FG006|Maintenance|Relapse|6|||
130144665|NCT01190930|468488025|FG007|Maintenance|Relapse|13|||
130144666|NCT01190930|468488026|FG008|Maintenance|Relapse|11|||
130144667|NCT01190930|468488027|FG009|Maintenance|Relapse|11|||
130144668|NCT01190930|468488018|FG000|Maintenance|Still on therapy|0|||
130144669|NCT01190930|468488019|FG001|Maintenance|Still on therapy|8|||
130144670|NCT01190930|468488020|FG002|Maintenance|Still on therapy|0|||
130144671|NCT01190930|468488021|FG003|Maintenance|Still on therapy|29|||
130144672|NCT01190930|468488022|FG004|Maintenance|Still on therapy|0|||
130144673|NCT01190930|468488023|FG005|Maintenance|Still on therapy|0|||
130144674|NCT01190930|468488024|FG006|Maintenance|Still on therapy|0|||
130144675|NCT01190930|468488025|FG007|Maintenance|Still on therapy|0|||
130144676|NCT01190930|468488026|FG008|Maintenance|Still on therapy|0|||
130144677|NCT01190930|468488027|FG009|Maintenance|Still on therapy|0|||
130144678|NCT02167594|468488028|FG000|Overall Study|Withdrawal by Subject|2|||
130144679|NCT02167594|468488029|FG001|Overall Study|Withdrawal by Subject|0|||
130144680|NCT02167594|468488030|FG002|Overall Study|Withdrawal by Subject|0|||
130144681|NCT02167594|468488028|FG000|Overall Study|Death|0|||
130144682|NCT02167594|468488029|FG001|Overall Study|Death|1|||
130144683|NCT02167594|468488030|FG002|Overall Study|Death|0|||
130144684|NCT02161549|468488031|FG000|Overall Study|Physician Decision|6|||
130144685|NCT02161549|468488032|FG001|Overall Study|Physician Decision|2|||
130144686|NCT00283842|468488037|FG000|Overall Study|Adverse Event|8|||
130144687|NCT00283842|468488038|FG001|Overall Study|Adverse Event|7|||
130144688|NCT00283842|468488039|FG002|Overall Study|Adverse Event|21|||
130144689|NCT00283842|468488040|FG003|Overall Study|Adverse Event|21|||
130144690|NCT00283842|468488041|FG004|Overall Study|Adverse Event|5|||
130144691|NCT00283842|468488037|FG000|Overall Study|Protocol Violation|1|||
130144692|NCT00283842|468488038|FG001|Overall Study|Protocol Violation|5|||
130144693|NCT00283842|468488039|FG002|Overall Study|Protocol Violation|4|||
130144694|NCT00283842|468488040|FG003|Overall Study|Protocol Violation|0|||
130144695|NCT00283842|468488041|FG004|Overall Study|Protocol Violation|0|||
130144696|NCT00283842|468488037|FG000|Overall Study|Protocol deviation|0|||
130144697|NCT00283842|468488038|FG001|Overall Study|Protocol deviation|0|||
130144698|NCT00283842|468488039|FG002|Overall Study|Protocol deviation|0|||
130144699|NCT00283842|468488040|FG003|Overall Study|Protocol deviation|0|||
130144700|NCT00283842|468488041|FG004|Overall Study|Protocol deviation|2|||
130144701|NCT00283842|468488037|FG000|Overall Study|Withdrawal by Subject|2|||
130144702|NCT00283842|468488038|FG001|Overall Study|Withdrawal by Subject|1|||
130144703|NCT00283842|468488039|FG002|Overall Study|Withdrawal by Subject|1|||
130144704|NCT00283842|468488040|FG003|Overall Study|Withdrawal by Subject|5|||
130144705|NCT00283842|468488041|FG004|Overall Study|Withdrawal by Subject|4|||
130144706|NCT00283842|468488037|FG000|Overall Study|Lack of Efficacy|1|||
130144707|NCT00283842|468488038|FG001|Overall Study|Lack of Efficacy|3|||
130144708|NCT00283842|468488039|FG002|Overall Study|Lack of Efficacy|1|||
130144709|NCT00283842|468488040|FG003|Overall Study|Lack of Efficacy|0|||
130144710|NCT00283842|468488041|FG004|Overall Study|Lack of Efficacy|3|||
130144711|NCT00283842|468488037|FG000|Overall Study|Lost to Follow-up|0|||
130144712|NCT00283842|468488038|FG001|Overall Study|Lost to Follow-up|2|||
130144713|NCT00283842|468488039|FG002|Overall Study|Lost to Follow-up|4|||
130144714|NCT00283842|468488040|FG003|Overall Study|Lost to Follow-up|1|||
130144715|NCT00283842|468488041|FG004|Overall Study|Lost to Follow-up|1|||
129976546|NCT00895895|467877770|FG002|Period 2|Protocol Violation|1|||
130144716|NCT02472639|468488043|FG000|Overall Study|Physician Decision|4|||
130144717|NCT02472639|468488044|FG001|Overall Study|Physician Decision|3|||
130144718|NCT00046839|468488045|FG000|Overall Study|Ineligible / No protocol treatment|0|||
130144719|NCT00046839|468488046|FG001|Overall Study|Ineligible / No protocol treatment|2|||
130144720|NCT00046839|468488045|FG000|Overall Study|Withdrawal of consent|1|||
130144721|NCT00046839|468488046|FG001|Overall Study|Withdrawal of consent|0|||
130144722|NCT00702507|468488049|FG000|Initial Treatment Phase|Adverse Event|2|||
130144723|NCT00702507|468488049|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
130144724|NCT00702507|468488049|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
130144725|NCT00702507|468488049|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
130144726|NCT00702507|468488049|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
130144727|NCT00702507|468488049|FG000|Follow-up Phase|Protocol Violation|2|||
130144728|NCT00702507|468488049|FG000|Follow-up Phase|Lost to Follow-up|23|||
130144729|NCT00702507|468488049|FG000|Follow-up Phase|Late Enrollment|1|||
130144730|NCT02308696|468488050|FG000|Overall Study|Lost to Follow-up|28|||
130144731|NCT02308696|468488051|FG001|Overall Study|Lost to Follow-up|21|||
130144732|NCT02308696|468488050|FG000|Overall Study|Death|8|||
130144733|NCT02308696|468488051|FG001|Overall Study|Death|4|||
130144734|NCT02308696|468488050|FG000|Overall Study|Moved to a Higher Level of Care|17|||
130144735|NCT02308696|468488051|FG001|Overall Study|Moved to a Higher Level of Care|6|||
130144736|NCT01211262|468488054|FG000|Overall Study|Progressive Disease|18|||
130144737|NCT01211262|468488055|FG001|Overall Study|Progressive Disease|9|||
130144738|NCT01211262|468488054|FG000|Overall Study|Adverse Event|4|||
130144739|NCT01211262|468488055|FG001|Overall Study|Adverse Event|0|||
130144740|NCT01211262|468488054|FG000|Overall Study|Withdrawal of Consent|1|||
130144741|NCT01211262|468488055|FG001|Overall Study|Withdrawal of Consent|0|||
130144742|NCT01211262|468488054|FG000|Overall Study|Other|0|||
130144743|NCT01211262|468488055|FG001|Overall Study|Other|1|||
130144744|NCT04768114|468488056|FG000|Overall Study|Lost to Follow-up|5|||
130144745|NCT04768114|468488057|FG001|Overall Study|Lost to Follow-up|10|||
130144746|NCT04768114|468488056|FG000|Overall Study|Withdrawal by Subject|0|||
130144747|NCT04768114|468488057|FG001|Overall Study|Withdrawal by Subject|1|||
130144748|NCT04049097|468488061|FG000|Overall Study|Adverse Event|18|||
130144749|NCT04049097|468488061|FG000|Overall Study|Death|2|||
130144750|NCT04049097|468488061|FG000|Overall Study|Lost to Follow-up|1|||
130144751|NCT04049097|468488061|FG000|Overall Study|Physician Decision|2|||
130144752|NCT04049097|468488061|FG000|Overall Study|Withdrawal by Subject|9|||
130144753|NCT04049097|468488061|FG000|Overall Study|Protocol Violation|2|||
130144754|NCT04049097|468488061|FG000|Overall Study|Other|1|||
130144755|NCT04049097|468488061|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
130144756|NCT03980522|468488067|FG000|Treatment Period|Adverse Event|1|||
130144757|NCT03980522|468488068|FG001|Treatment Period|Adverse Event|0|||
130144758|NCT03980522|468488069|FG002|Treatment Period|Adverse Event|0|||
130144759|NCT03980522|468488070|FG003|Treatment Period|Adverse Event|0|||
130144760|NCT03980522|468488071|FG004|Treatment Period|Adverse Event|0|||
130144761|NCT04892147|468488072|FG000|Overall Study|Withdrawal by Subject|2|||
130144762|NCT04892147|468488073|FG001|Overall Study|Withdrawal by Subject|0|||
130144763|NCT02661022|468488074|FG000|Overall Study|Withdrawal by Subject|3|||
130144764|NCT02661022|468488075|FG001|Overall Study|Withdrawal by Subject|0|||
130144765|NCT02661022|468488074|FG000|Overall Study|Adverse Event|1|||
130144766|NCT02661022|468488075|FG001|Overall Study|Adverse Event|1|||
130144767|NCT02661022|468488074|FG000|Overall Study|Physician Decision|1|||
130144768|NCT02661022|468488075|FG001|Overall Study|Physician Decision|0|||
130144769|NCT02661022|468488074|FG000|Overall Study|Progressive Disease|2|||
130144770|NCT02661022|468488075|FG001|Overall Study|Progressive Disease|1|||
130144771|NCT01785615|468488083|FG000|Dietary Phase|Lost to Follow-up|0|||
130144772|NCT01785615|468488084|FG001|Dietary Phase|Lost to Follow-up|0|||
130144773|NCT01785615|468488085|FG002|Dietary Phase|Lost to Follow-up|0|||
130144774|NCT01785615|468488086|FG003|Dietary Phase|Lost to Follow-up|24|||
130144775|NCT03428945|468488087|FG000|Overall Study|Lost to Follow-up|5|||
130144776|NCT03428945|468488088|FG001|Overall Study|Lost to Follow-up|3|||
130144777|NCT03428945|468488087|FG000|Overall Study|Withdrawal by Subject|10|||
130144778|NCT03428945|468488088|FG001|Overall Study|Withdrawal by Subject|10|||
130144779|NCT01266603|468488089|FG000|Overall Study|Adverse Event|1|||
130144780|NCT01266603|468488089|FG000|Overall Study|Lack of Efficacy|14|||
130144781|NCT01266603|468488089|FG000|Overall Study|Withdrawal by Subject|1|||
130144782|NCT01266603|468488089|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
130144783|NCT01598896|468488091|FG000|Overall Study|Withdrawal by Subject|0|||
130144784|NCT01598896|468488092|FG001|Overall Study|Withdrawal by Subject|1|||
130144785|NCT01598896|468488091|FG000|Overall Study|Lack of Efficacy|0|||
130144786|NCT01598896|468488092|FG001|Overall Study|Lack of Efficacy|1|||
130144787|NCT01120691|468488095|FG000|Overall Study|Adverse Event|59|||
130144788|NCT01120691|468488096|FG001|Overall Study|Adverse Event|67|||
130144789|NCT01120691|468488097|FG002|Overall Study|Adverse Event|47|||
130144790|NCT01120691|468488095|FG000|Overall Study|Subject withdrew consent|33|||
130144791|NCT01120691|468488096|FG001|Overall Study|Subject withdrew consent|50|||
130144792|NCT01120691|468488097|FG002|Overall Study|Subject withdrew consent|44|||
130144793|NCT01120691|468488095|FG000|Overall Study|Death|21|||
130144794|NCT01120691|468488096|FG001|Overall Study|Death|22|||
130144795|NCT01120691|468488097|FG002|Overall Study|Death|24|||
130144796|NCT01120691|468488095|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
130144797|NCT01120691|468488096|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
130144798|NCT01120691|468488097|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
130144799|NCT01120691|468488095|FG000|Overall Study|Administrative problems|15|||
130144800|NCT01120691|468488096|FG001|Overall Study|Administrative problems|8|||
130144801|NCT01120691|468488097|FG002|Overall Study|Administrative problems|9|||
130144802|NCT01120691|468488095|FG000|Overall Study|Protocol deviation|13|||
130144803|NCT01120691|468488096|FG001|Overall Study|Protocol deviation|12|||
130144804|NCT01120691|468488097|FG002|Overall Study|Protocol deviation|12|||
130144805|NCT01120691|468488095|FG000|Overall Study|Lost to Follow-up|5|||
130144806|NCT01120691|468488096|FG001|Overall Study|Lost to Follow-up|6|||
130144807|NCT01120691|468488097|FG002|Overall Study|Lost to Follow-up|4|||
130144808|NCT01120691|468488095|FG000|Overall Study|Abnormal test procedure result(s)|3|||
130144809|NCT01120691|468488096|FG001|Overall Study|Abnormal test procedure result(s)|2|||
130144810|NCT01120691|468488097|FG002|Overall Study|Abnormal test procedure result(s)|1|||
130144811|NCT01120691|468488095|FG000|Overall Study|Patient's inability to use the device|3|||
130144812|NCT01120691|468488096|FG001|Overall Study|Patient's inability to use the device|1|||
130144813|NCT01120691|468488097|FG002|Overall Study|Patient's inability to use the device|0|||
130144814|NCT01120691|468488095|FG000|Overall Study|Abnormal laboratory value(s)|1|||
130144815|NCT01120691|468488096|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130144816|NCT01120691|468488097|FG002|Overall Study|Abnormal laboratory value(s)|4|||
130144817|NCT04553406|468488098|FG000|Overall Study|Study Discontinuation|0|||
130144818|NCT04553406|468488099|FG001|Overall Study|Study Discontinuation|1|||
130144819|NCT03370510|468488100|FG000|Overall Study|COVID-19|2|||
130144820|NCT03370510|468488101|FG001|Overall Study|COVID-19|0|||
130144821|NCT00772148|468488102|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
130144822|NCT00772148|468488103|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
130144823|NCT00772148|468488102|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
130144824|NCT00772148|468488103|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
130144825|NCT00772148|468488102|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
130144826|NCT00772148|468488103|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
130144827|NCT00772148|468488102|FG000|Maintenance Phase (Week 52)|Death|2|||
130144828|NCT00772148|468488103|FG001|Maintenance Phase (Week 52)|Death|2|||
130144829|NCT00772148|468488102|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
130144830|NCT00772148|468488103|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
130144831|NCT00772148|468488102|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
130144832|NCT00772148|468488103|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
130144833|NCT00772148|468488102|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
130144834|NCT00772148|468488103|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
130144835|NCT01562613|468488104|FG000|Overall Study|Lost to Follow-up|2|||
130144836|NCT01562613|468488104|FG000|Overall Study|Withdrawal by Subject|2|||
130144837|NCT01525628|468488109|FG000|Overall Study|Adverse Event|1|||
130144838|NCT01525628|468488110|FG001|Overall Study|Adverse Event|1|||
130144839|NCT01525628|468488111|FG002|Overall Study|Adverse Event|2|||
130144840|NCT01525628|468488112|FG003|Overall Study|Adverse Event|0|||
130144841|NCT01525628|468488113|FG004|Overall Study|Adverse Event|1|||
130144842|NCT01525628|468488109|FG000|Overall Study|Lack of Efficacy|0|||
130144843|NCT01525628|468488110|FG001|Overall Study|Lack of Efficacy|2|||
130144844|NCT01525628|468488111|FG002|Overall Study|Lack of Efficacy|2|||
130144845|NCT01525628|468488112|FG003|Overall Study|Lack of Efficacy|1|||
130144846|NCT01525628|468488113|FG004|Overall Study|Lack of Efficacy|2|||
130144847|NCT01525628|468488109|FG000|Overall Study|Protocol Violation|0|||
130144848|NCT01525628|468488110|FG001|Overall Study|Protocol Violation|0|||
130144849|NCT01525628|468488111|FG002|Overall Study|Protocol Violation|1|||
130144850|NCT01525628|468488112|FG003|Overall Study|Protocol Violation|0|||
130144851|NCT01525628|468488113|FG004|Overall Study|Protocol Violation|0|||
129976547|NCT00895895|467877771|FG003|Period 2|Protocol Violation|1|||
129976548|NCT00895895|467877772|FG004|Period 2|Protocol Violation|1|||
130144852|NCT01525628|468488109|FG000|Overall Study|Lost to Follow-up|1|||
130144853|NCT01525628|468488110|FG001|Overall Study|Lost to Follow-up|1|||
130144854|NCT01525628|468488111|FG002|Overall Study|Lost to Follow-up|0|||
130144855|NCT01525628|468488112|FG003|Overall Study|Lost to Follow-up|0|||
130144856|NCT01525628|468488113|FG004|Overall Study|Lost to Follow-up|0|||
130144857|NCT01525628|468488109|FG000|Overall Study|Withdrawal by Subject|0|||
130144858|NCT01525628|468488110|FG001|Overall Study|Withdrawal by Subject|1|||
130144859|NCT01525628|468488111|FG002|Overall Study|Withdrawal by Subject|0|||
130144860|NCT01525628|468488112|FG003|Overall Study|Withdrawal by Subject|0|||
130144861|NCT01525628|468488113|FG004|Overall Study|Withdrawal by Subject|0|||
130144862|NCT01525628|468488109|FG000|Overall Study|Other reason not defined above|0|||
130144863|NCT01525628|468488110|FG001|Overall Study|Other reason not defined above|0|||
130144864|NCT01525628|468488111|FG002|Overall Study|Other reason not defined above|0|||
130144865|NCT01525628|468488112|FG003|Overall Study|Other reason not defined above|3|||
130144866|NCT01525628|468488113|FG004|Overall Study|Other reason not defined above|0|||
130144867|NCT03573336|468488114|FG000|Overall Study|Study terminated|2|||
130144868|NCT03573336|468488115|FG001|Overall Study|Study terminated|4|||
129976549|NCT00895895|467877768|FG000|Period 2|Withdrawal by Subject|0|||
129976550|NCT00895895|467877769|FG001|Period 2|Withdrawal by Subject|2|||
130144869|NCT03573336|468488116|FG002|Overall Study|Study terminated|2|||
130144870|NCT03493919|468488118|FG000|Overall Study|Other|2|||
130144871|NCT03493919|468488119|FG001|Overall Study|Other|0|||
130144872|NCT03493919|468488120|FG002|Overall Study|Other|1|||
130144873|NCT03493919|468488121|FG003|Overall Study|Other|0|||
130144874|NCT03493919|468488118|FG000|Overall Study|Withdrawal by Subject|9|||
130144875|NCT03493919|468488119|FG001|Overall Study|Withdrawal by Subject|3|||
130144876|NCT03493919|468488120|FG002|Overall Study|Withdrawal by Subject|1|||
130144877|NCT03493919|468488121|FG003|Overall Study|Withdrawal by Subject|1|||
130144878|NCT03493919|468488118|FG000|Overall Study|Lost to Follow-up|5|||
130144879|NCT03493919|468488119|FG001|Overall Study|Lost to Follow-up|0|||
130144880|NCT03493919|468488120|FG002|Overall Study|Lost to Follow-up|0|||
130144881|NCT03493919|468488121|FG003|Overall Study|Lost to Follow-up|3|||
130144882|NCT03493919|468488118|FG000|Overall Study|Adverse Event|0|||
130144883|NCT03493919|468488119|FG001|Overall Study|Adverse Event|1|||
130144884|NCT03493919|468488120|FG002|Overall Study|Adverse Event|0|||
130144885|NCT03493919|468488121|FG003|Overall Study|Adverse Event|0|||
130144886|NCT04640194|468488122|FG000|Overall Study|Adverse Event|3|||
130144887|NCT04640194|468488123|FG001|Overall Study|Adverse Event|7|||
130144888|NCT04640194|468488124|FG002|Overall Study|Adverse Event|0|||
130144889|NCT04640194|468488125|FG003|Overall Study|Adverse Event|5|||
130144890|NCT04640194|468488126|FG004|Overall Study|Adverse Event|0|||
130144891|NCT04640194|468488127|FG005|Overall Study|Adverse Event|4|||
130144892|NCT04640194|468488128|FG006|Overall Study|Adverse Event|0|||
130144893|NCT04640194|468488122|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
130144894|NCT04640194|468488123|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
130144895|NCT04640194|468488124|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
130144896|NCT04640194|468488125|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
130144897|NCT04640194|468488126|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
130144898|NCT04640194|468488127|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
130144899|NCT04640194|468488128|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
130144900|NCT04640194|468488122|FG000|Overall Study|fibrinogen level too low|0|||
130144901|NCT04640194|468488123|FG001|Overall Study|fibrinogen level too low|0|||
130144902|NCT04640194|468488124|FG002|Overall Study|fibrinogen level too low|0|||
130144903|NCT04640194|468488125|FG003|Overall Study|fibrinogen level too low|1|||
130144904|NCT04640194|468488126|FG004|Overall Study|fibrinogen level too low|0|||
130144905|NCT04640194|468488127|FG005|Overall Study|fibrinogen level too low|0|||
130144906|NCT04640194|468488128|FG006|Overall Study|fibrinogen level too low|0|||
130144907|NCT04640194|468488122|FG000|Overall Study|mild bleeding|0|||
130144908|NCT04640194|468488123|FG001|Overall Study|mild bleeding|0|||
130144909|NCT04640194|468488124|FG002|Overall Study|mild bleeding|0|||
130144910|NCT04640194|468488125|FG003|Overall Study|mild bleeding|1|||
130144911|NCT04640194|468488126|FG004|Overall Study|mild bleeding|0|||
130144912|NCT04640194|468488127|FG005|Overall Study|mild bleeding|0|||
130144913|NCT04640194|468488128|FG006|Overall Study|mild bleeding|0|||
130144914|NCT04640194|468488122|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130144915|NCT04640194|468488123|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
130144916|NCT04640194|468488124|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130144917|NCT04640194|468488125|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130144918|NCT04640194|468488126|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130144919|NCT04640194|468488127|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130144920|NCT04640194|468488128|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
130144921|NCT04773600|468488130|FG000|Overall Study|Withdrawal by Subject|15|||
130144922|NCT04773600|468488131|FG001|Overall Study|Withdrawal by Subject|9|||
130144923|NCT04773600|468488130|FG000|Overall Study|Lost to Follow-up|10|||
130144924|NCT04773600|468488131|FG001|Overall Study|Lost to Follow-up|6|||
130144925|NCT04773600|468488130|FG000|Overall Study|Adverse Event|8|||
130144926|NCT04773600|468488131|FG001|Overall Study|Adverse Event|2|||
130144927|NCT04773600|468488130|FG000|Overall Study|Lack of Efficacy|2|||
130144928|NCT04773600|468488131|FG001|Overall Study|Lack of Efficacy|3|||
130144929|NCT04773600|468488130|FG000|Overall Study|Noncompliance|2|||
130144930|NCT04773600|468488131|FG001|Overall Study|Noncompliance|0|||
130144931|NCT04773600|468488130|FG000|Overall Study|Protocol Violation|2|||
129976551|NCT00895895|467877770|FG002|Period 2|Withdrawal by Subject|0|||
129976552|NCT00895895|467877771|FG003|Period 2|Withdrawal by Subject|3|||
129976553|NCT00895895|467877772|FG004|Period 2|Withdrawal by Subject|5|||
130144932|NCT04773600|468488131|FG001|Overall Study|Protocol Violation|0|||
130144933|NCT04773600|468488130|FG000|Overall Study|Physician Decision|0|||
130144934|NCT04773600|468488131|FG001|Overall Study|Physician Decision|1|||
130144935|NCT04773600|468488130|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
130144936|NCT04773600|468488131|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
130144937|NCT04773600|468488130|FG000|Overall Study|Emergency Travel Out of Country|1|||
130144938|NCT04773600|468488131|FG001|Overall Study|Emergency Travel Out of Country|0|||
129976554|NCT00895895|467877768|FG000|Period 2|unsatisfactory response-efficacy|2|||
130144939|NCT00500318|468489734|FG000|Overall Study|Adverse Event|3|||
130144940|NCT00500318|468489735|FG001|Overall Study|Adverse Event|8|||
130144941|NCT00500318|468489734|FG000|Overall Study|Protocol Violation|1|||
130144942|NCT00500318|468489735|FG001|Overall Study|Protocol Violation|3|||
130144943|NCT00500318|468489734|FG000|Overall Study|Withdrawal by Subject|1|||
130144944|NCT00500318|468489735|FG001|Overall Study|Withdrawal by Subject|2|||
130144945|NCT00500318|468489734|FG000|Overall Study|Lack of Efficacy|0|||
130144946|NCT00500318|468489735|FG001|Overall Study|Lack of Efficacy|3|||
130144947|NCT00500318|468489734|FG000|Overall Study|Other Reason|0|||
130144948|NCT00500318|468489735|FG001|Overall Study|Other Reason|1|||
130144949|NCT03243396|468489738|FG000|Overall Study|Lost to Follow-up|2|||
130144950|NCT03243396|468489739|FG001|Overall Study|Lost to Follow-up|3|||
130144951|NCT03243396|468489740|FG002|Overall Study|Lost to Follow-up|15|||
130144952|NCT03243396|468489741|FG003|Overall Study|Lost to Follow-up|8|||
130144953|NCT03243396|468489742|FG004|Overall Study|Lost to Follow-up|1|||
130144954|NCT03243396|468489743|FG005|Overall Study|Lost to Follow-up|4|||
130144955|NCT03243396|468489744|FG006|Overall Study|Lost to Follow-up|9|||
130144956|NCT03687242|468489745|FG000|Overall Study|Adverse Event|1|||
130144957|NCT02655224|468489746|FG000|Overall Study|Adverse Event|1|||
130144958|NCT02655224|468489747|FG001|Overall Study|Adverse Event|1|||
130144959|NCT01257581|468489748|FG000|Overall Study|Early Termination|3|||
130144960|NCT01257581|468489749|FG001|Overall Study|Early Termination|1|||
130144961|NCT01257581|468489750|FG002|Overall Study|Early Termination|2|||
130144962|NCT01257581|468489748|FG000|Overall Study|Death|2|||
130144963|NCT01257581|468489749|FG001|Overall Study|Death|2|||
130144964|NCT01257581|468489750|FG002|Overall Study|Death|4|||
130144965|NCT02104817|468489754|FG000|Overall Study|Death|363|||
130144966|NCT02104817|468489755|FG001|Overall Study|Death|330|||
130144967|NCT02104817|468489754|FG000|Overall Study|Lost to Follow-up|3|||
130144968|NCT02104817|468489755|FG001|Overall Study|Lost to Follow-up|2|||
130144969|NCT02104817|468489754|FG000|Overall Study|Protocol Violation|0|||
130144970|NCT02104817|468489755|FG001|Overall Study|Protocol Violation|1|||
130144971|NCT02104817|468489754|FG000|Overall Study|Study terminated by sponsor|5854|||
130144972|NCT02104817|468489755|FG001|Overall Study|Study terminated by sponsor|5901|||
130144973|NCT02104817|468489754|FG000|Overall Study|Withdrawal by Subject|111|||
130144974|NCT02104817|468489755|FG001|Overall Study|Withdrawal by Subject|78|||
130144975|NCT02104817|468489754|FG000|Overall Study|Other reasons|128|||
130144976|NCT02104817|468489755|FG001|Overall Study|Other reasons|135|||
130144977|NCT02575339|468489762|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
130144978|NCT02575339|468489763|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130144979|NCT02575339|468489764|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
130144980|NCT02575339|468489762|FG000|Study Treatment|Disease Progression|5|||
130144981|NCT02575339|468489763|FG001|Study Treatment|Disease Progression|2|||
130144982|NCT02575339|468489764|FG002|Study Treatment|Disease Progression|0|||
130144983|NCT02575339|468489762|FG000|Study Treatment|Adverse Event|1|||
130144984|NCT02575339|468489763|FG001|Study Treatment|Adverse Event|2|||
130144985|NCT02575339|468489764|FG002|Study Treatment|Adverse Event|0|||
130144986|NCT02575339|468489762|FG000|Follow up|Death|6|||
130144987|NCT02575339|468489763|FG001|Follow up|Death|2|||
130144988|NCT02575339|468489764|FG002|Follow up|Death|0|||
130144989|NCT02575339|468489762|FG000|Follow up|Study Terminated|0|||
130144990|NCT02575339|468489763|FG001|Follow up|Study Terminated|2|||
130144991|NCT02575339|468489764|FG002|Follow up|Study Terminated|0|||
130144992|NCT02575339|468489762|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
130144993|NCT02575339|468489763|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
130144994|NCT02575339|468489764|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
130144995|NCT04633642|468489765|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
130144996|NCT04633642|468489766|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
130144997|NCT04675775|468489767|FG000|Overall Study|Withdrawal by Subject|7|||
130144998|NCT00348816|468489768|FG000|Overall Study|Noncompliance with radiation treatment|1|||
130144999|NCT03223909|468489769|FG000|Overall Study|Protocol Violation|48|||
130145000|NCT03223909|468489770|FG001|Overall Study|Protocol Violation|45|||
130145001|NCT03223909|468489771|FG002|Overall Study|Protocol Violation|16|||
130145002|NCT01628549|468489776|FG000|Overall Study|Adverse Event|1|||
130145003|NCT01628549|468489777|FG001|Overall Study|Adverse Event|1|||
130145004|NCT01628549|468489778|FG002|Overall Study|Adverse Event|0|||
130145005|NCT01628549|468489779|FG003|Overall Study|Adverse Event|4|||
130145006|NCT01628549|468489776|FG000|Overall Study|Lost to Follow-up|3|||
130145007|NCT01628549|468489777|FG001|Overall Study|Lost to Follow-up|4|||
130145008|NCT01628549|468489778|FG002|Overall Study|Lost to Follow-up|3|||
130145009|NCT01628549|468489779|FG003|Overall Study|Lost to Follow-up|3|||
130145010|NCT01628549|468489776|FG000|Overall Study|Withdrawal by Subject|3|||
130145011|NCT01628549|468489777|FG001|Overall Study|Withdrawal by Subject|4|||
129976555|NCT00895895|467877769|FG001|Period 2|unsatisfactory response-efficacy|1|||
130145012|NCT01628549|468489778|FG002|Overall Study|Withdrawal by Subject|4|||
130145013|NCT01628549|468489779|FG003|Overall Study|Withdrawal by Subject|1|||
130145014|NCT01628549|468489776|FG000|Overall Study|Protocol Violation|2|||
130145015|NCT01628549|468489777|FG001|Overall Study|Protocol Violation|1|||
130145016|NCT01628549|468489778|FG002|Overall Study|Protocol Violation|1|||
130145017|NCT01628549|468489779|FG003|Overall Study|Protocol Violation|0|||
130145018|NCT01628549|468489776|FG000|Overall Study|withdrawn for noncompliance|0|||
130145019|NCT01628549|468489777|FG001|Overall Study|withdrawn for noncompliance|2|||
130145020|NCT01628549|468489778|FG002|Overall Study|withdrawn for noncompliance|1|||
130145021|NCT01628549|468489779|FG003|Overall Study|withdrawn for noncompliance|0|||
130145022|NCT01628549|468489776|FG000|Overall Study|abnormal laboratory test results|0|||
130145023|NCT01628549|468489777|FG001|Overall Study|abnormal laboratory test results|0|||
130145024|NCT01628549|468489778|FG002|Overall Study|abnormal laboratory test results|1|||
130145025|NCT01628549|468489779|FG003|Overall Study|abnormal laboratory test results|0|||
130145026|NCT01628549|468489776|FG000|Overall Study|positive pregnancy test|0|||
130145027|NCT01628549|468489777|FG001|Overall Study|positive pregnancy test|0|||
130145028|NCT01628549|468489778|FG002|Overall Study|positive pregnancy test|0|||
130145029|NCT01628549|468489779|FG003|Overall Study|positive pregnancy test|1|||
130145030|NCT00177164|468489783|FG000|Overall Study|Protocol Violation|0|||
130145031|NCT00177164|468489784|FG001|Overall Study|Protocol Violation|7|||
130145032|NCT00177164|468489783|FG000|Overall Study|Lost to Follow-up|4|||
130145033|NCT00177164|468489784|FG001|Overall Study|Lost to Follow-up|5|||
130145034|NCT00177164|468489783|FG000|Overall Study|increase in alcohol and drug use|1|||
130145035|NCT00177164|468489784|FG001|Overall Study|increase in alcohol and drug use|2|||
130145036|NCT00177164|468489783|FG000|Overall Study|Adverse Event|1|||
130145037|NCT00177164|468489784|FG001|Overall Study|Adverse Event|0|||
130145038|NCT00177164|468489783|FG000|Overall Study|discharge from hospital|1|||
130145039|NCT00177164|468489784|FG001|Overall Study|discharge from hospital|0|||
130145040|NCT00177164|468489783|FG000|Overall Study|Lack of Efficacy|2|||
130145041|NCT00177164|468489784|FG001|Overall Study|Lack of Efficacy|1|||
130145042|NCT00177164|468489783|FG000|Overall Study|Pregnancy|0|||
130145043|NCT00177164|468489784|FG001|Overall Study|Pregnancy|1|||
130145044|NCT00965757|468489785|FG000|Double-blind Phase|Progression of concomitant disease|1|||
130145045|NCT00965757|468489786|FG001|Double-blind Phase|Progression of concomitant disease|2|||
130145046|NCT00965757|468489787|FG002|Double-blind Phase|Progression of concomitant disease|0|||
130145047|NCT00965757|468489788|FG003|Double-blind Phase|Progression of concomitant disease|0|||
130145048|NCT00965757|468489785|FG000|Double-blind Phase|Adverse drug reaction|2|||
130145049|NCT00965757|468489786|FG001|Double-blind Phase|Adverse drug reaction|1|||
130145050|NCT00965757|468489787|FG002|Double-blind Phase|Adverse drug reaction|0|||
130145051|NCT00965757|468489788|FG003|Double-blind Phase|Adverse drug reaction|0|||
130145052|NCT00965757|468489785|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
130145053|NCT00965757|468489786|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
130145054|NCT00965757|468489787|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
130145055|NCT00965757|468489788|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
130145056|NCT00965757|468489785|FG000|Double-blind Phase|Lack of Efficacy|7|||
130145057|NCT00965757|468489786|FG001|Double-blind Phase|Lack of Efficacy|11|||
130145058|NCT00965757|468489787|FG002|Double-blind Phase|Lack of Efficacy|0|||
130145059|NCT00965757|468489788|FG003|Double-blind Phase|Lack of Efficacy|0|||
130145060|NCT00965757|468489785|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
130145061|NCT00965757|468489786|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130145062|NCT00965757|468489787|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130145063|NCT00965757|468489788|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
130145064|NCT00965757|468489785|FG000|Double-blind Phase|Lost to Follow-up|0|||
130145065|NCT00965757|468489786|FG001|Double-blind Phase|Lost to Follow-up|1|||
130145066|NCT00965757|468489787|FG002|Double-blind Phase|Lost to Follow-up|0|||
130145067|NCT00965757|468489788|FG003|Double-blind Phase|Lost to Follow-up|0|||
130145068|NCT00965757|468489785|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
130145069|NCT00965757|468489786|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
130145070|NCT00965757|468489787|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
130145071|NCT00965757|468489788|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
130145072|NCT00965757|468489785|FG000|Double-blind Phase|Other|1|||
130145073|NCT00965757|468489786|FG001|Double-blind Phase|Other|0|||
130145074|NCT00965757|468489787|FG002|Double-blind Phase|Other|0|||
130145075|NCT00965757|468489788|FG003|Double-blind Phase|Other|0|||
130145076|NCT00965757|468489785|FG000|Extension Phase|Progression of concomitant disease|0|||
130145077|NCT00965757|468489786|FG001|Extension Phase|Progression of concomitant disease|0|||
130145078|NCT00965757|468489787|FG002|Extension Phase|Progression of concomitant disease|4|||
130145079|NCT00965757|468489788|FG003|Extension Phase|Progression of concomitant disease|2|||
130145080|NCT00965757|468489785|FG000|Extension Phase|Adverse drug reaction|0|||
130145081|NCT00965757|468489786|FG001|Extension Phase|Adverse drug reaction|0|||
130145082|NCT00965757|468489787|FG002|Extension Phase|Adverse drug reaction|6|||
130145083|NCT00965757|468489788|FG003|Extension Phase|Adverse drug reaction|3|||
130145084|NCT00965757|468489785|FG000|Extension Phase|Abnormal Laboratory Value|0|||
130145085|NCT00965757|468489786|FG001|Extension Phase|Abnormal Laboratory Value|0|||
130145086|NCT00965757|468489787|FG002|Extension Phase|Abnormal Laboratory Value|6|||
130145087|NCT00965757|468489788|FG003|Extension Phase|Abnormal Laboratory Value|1|||
130145088|NCT00965757|468489785|FG000|Extension Phase|Lack of Efficacy|0|||
130145089|NCT00965757|468489786|FG001|Extension Phase|Lack of Efficacy|0|||
130145090|NCT00965757|468489787|FG002|Extension Phase|Lack of Efficacy|8|||
130145091|NCT00965757|468489788|FG003|Extension Phase|Lack of Efficacy|12|||
130145092|NCT00965757|468489785|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130145093|NCT00965757|468489786|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130145094|NCT00965757|468489787|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
130145095|NCT00965757|468489788|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
130145096|NCT00965757|468489785|FG000|Extension Phase|Lost to Follow-up|0|||
130145097|NCT00965757|468489786|FG001|Extension Phase|Lost to Follow-up|0|||
130145098|NCT00965757|468489787|FG002|Extension Phase|Lost to Follow-up|0|||
130145099|NCT00965757|468489788|FG003|Extension Phase|Lost to Follow-up|1|||
130145100|NCT00965757|468489785|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
130145101|NCT00965757|468489786|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
130145102|NCT00965757|468489787|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
130145103|NCT00965757|468489788|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
130145104|NCT00965757|468489785|FG000|Extension Phase|Protocol Violation|0|||
130145105|NCT00965757|468489786|FG001|Extension Phase|Protocol Violation|0|||
130145106|NCT00965757|468489787|FG002|Extension Phase|Protocol Violation|0|||
130145107|NCT00965757|468489788|FG003|Extension Phase|Protocol Violation|1|||
130145108|NCT00965757|468489785|FG000|Extension Phase|Other|0|||
130145109|NCT00965757|468489786|FG001|Extension Phase|Other|0|||
130145110|NCT00965757|468489787|FG002|Extension Phase|Other|2|||
130145111|NCT00965757|468489788|FG003|Extension Phase|Other|1|||
130145112|NCT01344018|468489794|FG000|Overall Study|Death|22|||
130145113|NCT01344018|468489795|FG001|Overall Study|Death|25|||
130145114|NCT01344018|468489794|FG000|Overall Study|Lost to Follow-up|4|||
130145115|NCT01344018|468489795|FG001|Overall Study|Lost to Follow-up|7|||
130145116|NCT05070754|468489796|FG000|Overall Study|Withdrawal by Subject|0|||
130145117|NCT05070754|468489797|FG001|Overall Study|Withdrawal by Subject|0|||
130145118|NCT05070754|468489798|FG002|Overall Study|Withdrawal by Subject|0|||
130145119|NCT05070754|468489799|FG003|Overall Study|Withdrawal by Subject|1|||
130145120|NCT05070754|468489796|FG000|Overall Study|Protocol Violation|0|||
130145121|NCT05070754|468489797|FG001|Overall Study|Protocol Violation|0|||
130145122|NCT05070754|468489798|FG002|Overall Study|Protocol Violation|0|||
130145123|NCT05070754|468489799|FG003|Overall Study|Protocol Violation|1|||
130145124|NCT01398787|468489800|FG000|Overall Study|Adverse Event|1|||
130145125|NCT02351167|468489801|FG000|Overall Study|Withdrawal by Subject|19|||
130145126|NCT02351167|468489802|FG001|Overall Study|Withdrawal by Subject|18|||
130145127|NCT02351167|468489803|FG002|Overall Study|Withdrawal by Subject|21|||
130145128|NCT00668395|468489806|FG000|Overall Study|Withdrawal by Subject|4|||
130145129|NCT00668395|468489807|FG001|Overall Study|Withdrawal by Subject|4|||
130145130|NCT00668395|468489808|FG002|Overall Study|Withdrawal by Subject|1|||
130145131|NCT00668395|468489806|FG000|Overall Study|Adverse Event|1|||
130145132|NCT00668395|468489807|FG001|Overall Study|Adverse Event|1|||
130145133|NCT00668395|468489808|FG002|Overall Study|Adverse Event|0|||
130145134|NCT00668395|468489806|FG000|Overall Study|Physician Decision|1|||
130145135|NCT00668395|468489807|FG001|Overall Study|Physician Decision|1|||
130145136|NCT00668395|468489808|FG002|Overall Study|Physician Decision|0|||
130145137|NCT02858037|468489809|FG000|Overall Study|Death|1|||
130145138|NCT02858037|468489809|FG000|Overall Study|Withdrawal by Subject|18|||
130145139|NCT02858037|468489809|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
130145140|NCT02858037|468489809|FG000|Overall Study|Lost to Follow-up|3|||
130145141|NCT02858037|468489809|FG000|Overall Study|Other|4|||
130145142|NCT02050321|468489816|FG000|Overall Study|Withdrawal by Subject|1|||
130145143|NCT02050321|468489816|FG000|Overall Study|Adverse Event|1|||
130145144|NCT00113919|468489817|FG000|Overall Study|Physician Decision|8|||
130145145|NCT00113919|468489817|FG000|Overall Study|Death|6|||
130145146|NCT00715676|468489821|FG000|Overall Study|Adverse Event|3|||
130145147|NCT00715676|468489822|FG001|Overall Study|Adverse Event|5|||
130145148|NCT00715676|468489823|FG002|Overall Study|Adverse Event|21|||
130145149|NCT00715676|468489821|FG000|Overall Study|Withdrawal by Subject|1|||
130145150|NCT00715676|468489822|FG001|Overall Study|Withdrawal by Subject|3|||
130145151|NCT00715676|468489823|FG002|Overall Study|Withdrawal by Subject|8|||
130145152|NCT00715676|468489821|FG000|Overall Study|Lost to Follow-up|1|||
130145153|NCT00715676|468489822|FG001|Overall Study|Lost to Follow-up|2|||
130145154|NCT00715676|468489823|FG002|Overall Study|Lost to Follow-up|1|||
130145155|NCT00715676|468489821|FG000|Overall Study|Terminated by Sponsor|1|||
130145156|NCT00715676|468489822|FG001|Overall Study|Terminated by Sponsor|0|||
129976556|NCT00895895|467877770|FG002|Period 2|unsatisfactory response-efficacy|0|||
130145157|NCT00715676|468489823|FG002|Overall Study|Terminated by Sponsor|0|||
130145158|NCT00715676|468489821|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
130145159|NCT00715676|468489822|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
130145160|NCT00715676|468489823|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
130145161|NCT00715676|468489821|FG000|Overall Study|Use of Exclusionary Medication|0|||
130145162|NCT00715676|468489822|FG001|Overall Study|Use of Exclusionary Medication|0|||
130145163|NCT00715676|468489823|FG002|Overall Study|Use of Exclusionary Medication|1|||
130145164|NCT00715676|468489821|FG000|Overall Study|Elevated Blood Glucose|0|||
130145165|NCT00715676|468489822|FG001|Overall Study|Elevated Blood Glucose|1|||
130145166|NCT00715676|468489823|FG002|Overall Study|Elevated Blood Glucose|0|||
130145167|NCT01963260|468489824|FG000|Overall Study|Withdrawal by Subject|2|||
130145168|NCT01963260|468489825|FG001|Overall Study|Withdrawal by Subject|0|||
130145169|NCT01963260|468489826|FG002|Overall Study|Withdrawal by Subject|0|||
130145170|NCT01963260|468489827|FG003|Overall Study|Withdrawal by Subject|1|||
130145171|NCT01963260|468489828|FG004|Overall Study|Withdrawal by Subject|2|||
130145172|NCT01963260|468489829|FG005|Overall Study|Withdrawal by Subject|0|||
130145173|NCT01963260|468489830|FG006|Overall Study|Withdrawal by Subject|0|||
130145174|NCT01963260|468489831|FG007|Overall Study|Withdrawal by Subject|0|||
130145175|NCT01963260|468489832|FG008|Overall Study|Withdrawal by Subject|0|||
130145176|NCT01963260|468489833|FG009|Overall Study|Withdrawal by Subject|0|||
130145177|NCT01091363|468489834|FG000|Overall Study|Withdrawal by Subject|11|||
130145178|NCT01091363|468489835|FG001|Overall Study|Withdrawal by Subject|15|||
130145179|NCT01091363|468489834|FG000|Overall Study|Lost to Follow-up|2|||
130145180|NCT01091363|468489835|FG001|Overall Study|Lost to Follow-up|2|||
130145181|NCT01781234|468489836|FG000|Overall Study|Adverse Event|2|||
130145182|NCT01781234|468489837|FG001|Overall Study|Adverse Event|0|||
130145183|NCT01781234|468489836|FG000|Overall Study|Protocol Violation|3|||
130145184|NCT01781234|468489837|FG001|Overall Study|Protocol Violation|0|||
130145185|NCT01781234|468489836|FG000|Overall Study|Withdrawal by Subject|4|||
130145186|NCT01781234|468489837|FG001|Overall Study|Withdrawal by Subject|3|||
130145187|NCT05889039|468489840|FG000|Overall Study|error in completing survey|0|||
130145188|NCT05889039|468489841|FG001|Overall Study|error in completing survey|2|||
130145189|NCT05889039|468489842|FG002|Overall Study|error in completing survey|0|||
130145190|NCT05889039|468489843|FG003|Overall Study|error in completing survey|0|||
130145191|NCT05889039|468489840|FG000|Overall Study|Lost to Follow-up|4|||
130145192|NCT05889039|468489841|FG001|Overall Study|Lost to Follow-up|0|||
130145193|NCT05889039|468489842|FG002|Overall Study|Lost to Follow-up|0|||
130145194|NCT05889039|468489843|FG003|Overall Study|Lost to Follow-up|0|||
130145195|NCT01881737|468489844|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
130145196|NCT01881737|468489844|FG000|Overall Study|Withdrawal by Subject|1|||
130145197|NCT01881737|468489844|FG000|Overall Study|Worsening of baseline behavior|1|||
130145198|NCT02260635|468489849|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
130145199|NCT02260635|468489850|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
130145200|NCT02260635|468489849|FG000|Open-Label Extension|Study Termination|25|||
130145201|NCT02260635|468489850|FG001|Open-Label Extension|Study Termination|25|||
130145202|NCT02260635|468489849|FG000|Open-Label Extension|Withdrawal by Subject|1|||
130145203|NCT02260635|468489850|FG001|Open-Label Extension|Withdrawal by Subject|0|||
130145204|NCT04106817|468489851|FG000|Overall Study|Lost to Follow-up|1|||
130145205|NCT04106817|468489852|FG001|Overall Study|Lost to Follow-up|0|||
130145206|NCT04106817|468489853|FG002|Overall Study|Lost to Follow-up|0|||
130145207|NCT00152516|468489854|FG000|Overall Study|Adverse Event|18|||
130145208|NCT00152516|468489854|FG000|Overall Study|Lack and Loss of Efficacy|30|||
130145209|NCT00152516|468489854|FG000|Overall Study|Lost to Follow-up|5|||
130145210|NCT00152516|468489854|FG000|Overall Study|Withdrawal by Subject|8|||
130145211|NCT00152516|468489854|FG000|Overall Study|Protocol Violation|3|||
130145212|NCT00152516|468489854|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
130145213|NCT00152516|468489854|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
130145214|NCT00152516|468489854|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
130145215|NCT00152516|468489854|FG000|Overall Study|Other: Non-Compliance|2|||
130145216|NCT00152516|468489854|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
130145217|NCT00152516|468489854|FG000|Overall Study|Other: Moved Out Of State|1|||
130145218|NCT00152516|468489854|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
130145219|NCT00152516|468489854|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
130145220|NCT00360490|468489855|FG000|Overall Study|Adverse Event|4|||
130145221|NCT00360490|468489856|FG001|Overall Study|Adverse Event|2|||
130145222|NCT00360490|468489855|FG000|Overall Study|Lost to Follow-up|2|||
130145223|NCT00360490|468489856|FG001|Overall Study|Lost to Follow-up|1|||
130145224|NCT00360490|468489855|FG000|Overall Study|Physician Decision|2|||
130145225|NCT00360490|468489856|FG001|Overall Study|Physician Decision|1|||
130145226|NCT00360490|468489855|FG000|Overall Study|Protocol Violation|0|||
130145227|NCT00360490|468489856|FG001|Overall Study|Protocol Violation|4|||
130145228|NCT00360490|468489855|FG000|Overall Study|Withdrawal by Subject|1|||
130145229|NCT00360490|468489856|FG001|Overall Study|Withdrawal by Subject|3|||
130145230|NCT01517867|468489857|FG000|Overall Study|never started treatment|29|||
130145231|NCT01517867|468489858|FG001|Overall Study|never started treatment|32|||
130145232|NCT01517867|468489857|FG000|Overall Study|Withdrawal by Subject|34|||
130145233|NCT01517867|468489858|FG001|Overall Study|Withdrawal by Subject|30|||
130145234|NCT01517867|468489857|FG000|Overall Study|Still in treatment at study end|0|||
130145235|NCT01517867|468489858|FG001|Overall Study|Still in treatment at study end|3|||
130145236|NCT03294317|468489860|FG000|Overall Study|Physician Decision|1|||
130145237|NCT03294317|468489860|FG000|Overall Study|Withdrawal by Subject|6|||
130145238|NCT03294317|468489860|FG000|Overall Study|Lost to Follow-up|1|||
130145239|NCT03294317|468489860|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
129976557|NCT00895895|467877771|FG003|Period 2|unsatisfactory response-efficacy|0|||
130145240|NCT03294317|468489860|FG000|Overall Study|Failed HB lead implant|8|||
130145241|NCT03294317|468489860|FG000|Overall Study|Received CRT instead|1|||
130145242|NCT03294317|468489860|FG000|Overall Study|Exited after lead revision|2|||
130145243|NCT02466386|468489861|FG000|Overall Study|Adverse Event|5|||
130145244|NCT02466386|468489861|FG000|Overall Study|Protocol Violation|2|||
130145245|NCT02466386|468489861|FG000|Overall Study|Withdrawal by Subject|14|||
130145246|NCT02466386|468489861|FG000|Overall Study|Lost to Follow-up|5|||
130145247|NCT02466386|468489861|FG000|Overall Study|Lack of Efficacy|8|||
130145248|NCT02466386|468489861|FG000|Overall Study|Other|10|||
130145249|NCT05317195|468489862|FG000|Randomization|Withdrawal by Subject|1|||
130145250|NCT05317195|468489862|FG000|Randomization|Discontinued|6|||
130145251|NCT05317195|468489862|FG000|Admission|Withdrawal by Subject|2|||
130145252|NCT03919695|468489863|FG000|3-month Follow-up|Death|1|||
130145253|NCT03919695|468489864|FG001|3-month Follow-up|Death|1|||
130145254|NCT03919695|468489863|FG000|3-month Follow-up|unable to contact|0|||
130145255|NCT03919695|468489864|FG001|3-month Follow-up|unable to contact|3|||
130145256|NCT03919695|468489863|FG000|3-month Follow-up|in prison|0|||
130145257|NCT03919695|468489864|FG001|3-month Follow-up|in prison|1|||
130145258|NCT03919695|468489863|FG000|6-month Follow-up|Death|0|||
130145259|NCT03919695|468489864|FG001|6-month Follow-up|Death|1|||
129976558|NCT00895895|467877772|FG004|Period 2|unsatisfactory response-efficacy|0|||
129976559|NCT00820170|467877775|FG000|Overall Study|Adverse Event|0|||
129976560|NCT00820170|467877776|FG001|Overall Study|Adverse Event|0|||
129976561|NCT00820170|467877777|FG002|Overall Study|Adverse Event|0|||
129976562|NCT00820170|467877778|FG003|Overall Study|Adverse Event|0|||
129976563|NCT00820170|467877779|FG004|Overall Study|Adverse Event|2|||
129976564|NCT00820170|467877775|FG000|Overall Study|Progressive Disease|0|||
129976565|NCT00820170|467877776|FG001|Overall Study|Progressive Disease|0|||
129976566|NCT00820170|467877777|FG002|Overall Study|Progressive Disease|0|||
129976567|NCT00820170|467877778|FG003|Overall Study|Progressive Disease|0|||
129976568|NCT00820170|467877779|FG004|Overall Study|Progressive Disease|2|||
129976569|NCT03538938|467877780|FG000|Overall Study|Death|0|||
129976570|NCT03538938|467877781|FG001|Overall Study|Death|0|||
129976571|NCT03538938|467877782|FG002|Overall Study|Death|2|||
129976572|NCT03538938|467877783|FG003|Overall Study|Death|0|||
129976573|NCT03538938|467877784|FG004|Overall Study|Death|0|||
130145260|NCT03919695|468489863|FG000|6-month Follow-up|Lost to Follow-up|1|||
130145261|NCT03919695|468489864|FG001|6-month Follow-up|Lost to Follow-up|2|||
130145262|NCT03919695|468489863|FG000|6-month Follow-up|in prison|0|||
130145263|NCT03919695|468489864|FG001|6-month Follow-up|in prison|2|||
130145264|NCT03919695|468489863|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
130145265|NCT03919695|468489864|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
130145266|NCT03919695|468489863|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
130145267|NCT03919695|468489864|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
130145268|NCT01688882|468489865|FG000|Overall Study|Adverse Event|1|||
130145269|NCT01688882|468489866|FG001|Overall Study|Adverse Event|0|||
130145270|NCT01688882|468489865|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130145271|NCT01688882|468489866|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130145272|NCT01688882|468489865|FG000|Overall Study|Administrative problems|1|||
130145273|NCT01688882|468489866|FG001|Overall Study|Administrative problems|0|||
130145274|NCT02387762|468489868|FG000|Overall Study|Withdrawal by Subject|1|||
130145275|NCT02387762|468489869|FG001|Overall Study|Withdrawal by Subject|0|||
130145276|NCT00642811|468489877|FG000|Overall Study|Adverse Event|2|||
130145277|NCT00642811|468489878|FG001|Overall Study|Adverse Event|3|||
130145278|NCT00642811|468489879|FG002|Overall Study|Adverse Event|0|||
130145279|NCT00642811|468489880|FG003|Overall Study|Adverse Event|0|||
130145280|NCT00642811|468489881|FG004|Overall Study|Adverse Event|0|||
130145281|NCT00642811|468489882|FG005|Overall Study|Adverse Event|1|||
130145282|NCT00642811|468489877|FG000|Overall Study|Developement of discontinuation criteria|0|||
130145283|NCT00642811|468489878|FG001|Overall Study|Developement of discontinuation criteria|0|||
130145284|NCT00642811|468489879|FG002|Overall Study|Developement of discontinuation criteria|0|||
130145285|NCT00642811|468489880|FG003|Overall Study|Developement of discontinuation criteria|0|||
130145286|NCT00642811|468489881|FG004|Overall Study|Developement of discontinuation criteria|1|||
130145287|NCT00642811|468489882|FG005|Overall Study|Developement of discontinuation criteria|0|||
130145288|NCT00642811|468489877|FG000|Overall Study|Severe Non-compliance to protocol|1|||
130145289|NCT00642811|468489878|FG001|Overall Study|Severe Non-compliance to protocol|0|||
130145290|NCT00642811|468489879|FG002|Overall Study|Severe Non-compliance to protocol|0|||
130145291|NCT00642811|468489880|FG003|Overall Study|Severe Non-compliance to protocol|0|||
130145292|NCT00642811|468489881|FG004|Overall Study|Severe Non-compliance to protocol|0|||
130145293|NCT00642811|468489882|FG005|Overall Study|Severe Non-compliance to protocol|0|||
130145294|NCT00642811|468489877|FG000|Overall Study|Other|0|||
130145295|NCT00642811|468489878|FG001|Overall Study|Other|1|||
129976574|NCT03538938|467877785|FG005|Overall Study|Death|1|||
129976575|NCT03538938|467877786|FG006|Overall Study|Death|0|||
130145296|NCT00642811|468489879|FG002|Overall Study|Other|0|||
130145297|NCT00642811|468489880|FG003|Overall Study|Other|1|||
130145298|NCT00642811|468489881|FG004|Overall Study|Other|0|||
130145299|NCT00642811|468489882|FG005|Overall Study|Other|0|||
130145300|NCT02614898|468489887|FG000|Overall Study|Participated until study termination|10|||
130145301|NCT02614898|468489888|FG001|Overall Study|Participated until study termination|26|||
130145302|NCT02614898|468489887|FG000|Overall Study|Lost to Follow-up|0|||
130145303|NCT02614898|468489888|FG001|Overall Study|Lost to Follow-up|2|||
130145304|NCT02614898|468489887|FG000|Overall Study|Physician Decision|1|||
130145305|NCT02614898|468489888|FG001|Overall Study|Physician Decision|8|||
130145306|NCT02614898|468489887|FG000|Overall Study|Study Terminated by Sponsor|3|||
130145307|NCT02614898|468489888|FG001|Overall Study|Study Terminated by Sponsor|0|||
130145308|NCT02614898|468489887|FG000|Overall Study|Withdrawal by Subject|0|||
130145309|NCT02614898|468489888|FG001|Overall Study|Withdrawal by Subject|2|||
130145310|NCT02614898|468489887|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130145311|NCT02614898|468489888|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
130145312|NCT02614898|468489887|FG000|Overall Study|Other-Additional Information Unavailable|0|||
130145313|NCT02614898|468489888|FG001|Overall Study|Other-Additional Information Unavailable|11|||
130145314|NCT02614898|468489887|FG000|Overall Study|Missing|0|||
130145315|NCT02614898|468489888|FG001|Overall Study|Missing|1|||
130145316|NCT00239005|468489889|FG000|Overall Study|Adverse Event|6|||
130145317|NCT00239005|468489890|FG001|Overall Study|Adverse Event|6|||
130145318|NCT00239005|468489889|FG000|Overall Study|Withdrawal by Subject|3|||
130145319|NCT00239005|468489890|FG001|Overall Study|Withdrawal by Subject|4|||
130145320|NCT00239005|468489889|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
130145321|NCT00239005|468489890|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
130145322|NCT00239005|468489889|FG000|Overall Study|Protocol Violation|1|||
130145323|NCT00239005|468489890|FG001|Overall Study|Protocol Violation|0|||
130145324|NCT00239005|468489889|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
130145325|NCT00239005|468489890|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
130145326|NCT00239005|468489889|FG000|Overall Study|Lost to Follow-up|0|||
130145327|NCT00239005|468489890|FG001|Overall Study|Lost to Follow-up|1|||
130145328|NCT03382041|468489891|FG000|Overall Study|Consent Form Lost|2|||
130145329|NCT03382041|468489892|FG001|Overall Study|Consent Form Lost|1|||
130145330|NCT03382041|468489891|FG000|Overall Study|Withdrawal by Subject|1|||
130145331|NCT03382041|468489892|FG001|Overall Study|Withdrawal by Subject|4|||
130145332|NCT03382041|468489891|FG000|Overall Study|Lost to Follow-up|1|||
130145333|NCT03382041|468489892|FG001|Overall Study|Lost to Follow-up|4|||
130145334|NCT00787605|468489893|FG000|Overall Study|Administrative Problems|3|||
130145335|NCT00787605|468489894|FG001|Overall Study|Administrative Problems|0|||
130145336|NCT00787605|468489893|FG000|Overall Study|Adverse Event|14|||
130145337|NCT00787605|468489894|FG001|Overall Study|Adverse Event|25|||
130145338|NCT00787605|468489893|FG000|Overall Study|Lost to Follow-up|3|||
130145339|NCT00787605|468489894|FG001|Overall Study|Lost to Follow-up|6|||
130145340|NCT00787605|468489893|FG000|Overall Study|Protocol Violation|7|||
130145341|NCT00787605|468489894|FG001|Overall Study|Protocol Violation|3|||
130145342|NCT00787605|468489893|FG000|Overall Study|Withdrawal by Subject|6|||
130145343|NCT00787605|468489894|FG001|Overall Study|Withdrawal by Subject|13|||
130145344|NCT00787605|468489893|FG000|Overall Study|Lack of Efficacy|13|||
130145345|NCT00787605|468489894|FG001|Overall Study|Lack of Efficacy|9|||
130145346|NCT04428645|468489900|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
130145347|NCT00965731|468489912|FG000|Overall Study|Death|0|||
130145348|NCT00965731|468489913|FG001|Overall Study|Death|4|||
130145349|NCT00965731|468489912|FG000|Overall Study|Withdrawal by Subject|0|||
130145350|NCT00965731|468489913|FG001|Overall Study|Withdrawal by Subject|1|||
130145351|NCT00965731|468489912|FG000|Overall Study|Other|7|||
130145352|NCT00965731|468489913|FG001|Overall Study|Other|15|||
130145353|NCT00559637|468491895|FG000|Overall Study|Adverse Event|22|||
130145354|NCT00559637|468491895|FG000|Overall Study|Withdrawal by Subject|4|||
130145355|NCT00559637|468491895|FG000|Overall Study|Protocol Violation|6|||
130145356|NCT00559637|468491895|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
130145357|NCT00559637|468491895|FG000|Overall Study|Failure to return|6|||
130145358|NCT00559637|468491895|FG000|Overall Study|Insufficient response|3|||
130145359|NCT00559637|468491895|FG000|Overall Study|Started requiring dialysis after month 7|2|||
130145360|NCT00559637|468491895|FG000|Overall Study|Suspected lung cancer|1|||
130145361|NCT00559637|468491895|FG000|Overall Study|Participation in another study|1|||
130145362|NCT00559637|468491895|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
130145363|NCT00559637|468491895|FG000|Overall Study|Change of center|1|||
130145364|NCT00559637|468491895|FG000|Overall Study|Change of home|1|||
130145365|NCT00559637|468491895|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
130145366|NCT02832167|468491896|FG000|Treatment Period 1|Disease progression|90|||
130145367|NCT02832167|468491896|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
130145368|NCT02832167|468491896|FG000|Treatment Period 1|Death|2|||
130145369|NCT02832167|468491896|FG000|Treatment Period 1|Study Drug Toxicity|6|||
130145370|NCT02832167|468491896|FG000|Treatment Period 1|Participant request to discontinue|9|||
129976576|NCT03538938|467877787|FG007|Overall Study|Death|1|||
130145371|NCT02832167|468491896|FG000|Treatment Period 1|No longer meet study criteria|1|||
130145372|NCT02832167|468491896|FG000|Treatment Period 1|Participant withdrew consent|3|||
130145373|NCT02832167|468491896|FG000|Treatment Period 1|Other reasons|6|||
130145374|NCT02832167|468491896|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
130145375|NCT02832167|468491896|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
130145376|NCT02832167|468491896|FG000|Transition From Period 1 to Period 2|Death|2|||
130145377|NCT02832167|468491896|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
130145378|NCT02832167|468491896|FG000|Treatment Period 2|Disease progression|69|||
130145379|NCT02832167|468491896|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
130145380|NCT02832167|468491896|FG000|Treatment Period 2|Maximum clinical benefit|1|||
130145381|NCT02832167|468491896|FG000|Treatment Period 2|Study Drug Toxicity|5|||
130145382|NCT02832167|468491896|FG000|Treatment Period 2|Participant request to discontinue|2|||
130145383|NCT02832167|468491896|FG000|Treatment Period 2|Participant withdrew consent|3|||
130145384|NCT02832167|468491896|FG000|Treatment Period 2|Other reasons|3|||
130145385|NCT00224484|468491897|FG000|Overall Study|Serious Adverse Event|1|||
130145386|NCT00224484|468491898|FG001|Overall Study|Serious Adverse Event|1|||
130145387|NCT00224484|468491899|FG002|Overall Study|Serious Adverse Event|0|||
130145388|NCT00224484|468491897|FG000|Overall Study|Non-Serious Adverse Event|5|||
130145389|NCT00224484|468491898|FG001|Overall Study|Non-Serious Adverse Event|7|||
130145390|NCT00224484|468491899|FG002|Overall Study|Non-Serious Adverse Event|3|||
130145391|NCT00224484|468491897|FG000|Overall Study|Protocol Violation|2|||
130145392|NCT00224484|468491898|FG001|Overall Study|Protocol Violation|2|||
130145393|NCT00224484|468491899|FG002|Overall Study|Protocol Violation|0|||
130145394|NCT00224484|468491897|FG000|Overall Study|Withdrawal by Subject|49|||
130145395|NCT00224484|468491898|FG001|Overall Study|Withdrawal by Subject|18|||
130145396|NCT00224484|468491899|FG002|Overall Study|Withdrawal by Subject|16|||
130145397|NCT00224484|468491897|FG000|Overall Study|Migrated/moved from study area|18|||
130145398|NCT00224484|468491898|FG001|Overall Study|Migrated/moved from study area|5|||
130145399|NCT00224484|468491899|FG002|Overall Study|Migrated/moved from study area|5|||
129976577|NCT03538938|467877788|FG008|Overall Study|Death|1|||
129976578|NCT03538938|467877789|FG009|Overall Study|Death|1|||
129976579|NCT03538938|467877790|FG010|Overall Study|Death|0|||
129976580|NCT03538938|467877791|FG011|Overall Study|Death|0|||
130145400|NCT00224484|468491897|FG000|Overall Study|Lost to Follow-up|66|||
130145401|NCT00224484|468491898|FG001|Overall Study|Lost to Follow-up|28|||
130145402|NCT00224484|468491899|FG002|Overall Study|Lost to Follow-up|36|||
130145403|NCT00224484|468491897|FG000|Overall Study|Reason not specified|5|||
130145404|NCT00224484|468491898|FG001|Overall Study|Reason not specified|4|||
130145405|NCT00224484|468491899|FG002|Overall Study|Reason not specified|2|||
130145406|NCT02805309|468491900|FG000|Overall Study|Lost to Follow-up|2|||
130145407|NCT02805309|468491901|FG001|Overall Study|Lost to Follow-up|2|||
130145408|NCT02805309|468491902|FG002|Overall Study|Lost to Follow-up|2|||
130145409|NCT02805309|468491900|FG000|Overall Study|Post-Randomization Exclusion|0|||
130145410|NCT02805309|468491901|FG001|Overall Study|Post-Randomization Exclusion|2|||
130145411|NCT02805309|468491902|FG002|Overall Study|Post-Randomization Exclusion|1|||
130145412|NCT04241133|468491907|FG000|Overall Study|COVID19 Precautions|14|||
130145413|NCT04241133|468491908|FG001|Overall Study|COVID19 Precautions|34|||
130145414|NCT03653026|468491909|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
130145415|NCT03653026|468491910|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
130145416|NCT03653026|468491911|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
130145417|NCT03653026|468491912|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
130145418|NCT03653026|468491909|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
130145419|NCT03653026|468491910|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
130145420|NCT03653026|468491911|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130145421|NCT03653026|468491912|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
130145422|NCT03653026|468491909|FG000|Part 1: Placebo-controlled Period|Other|0|||
130145423|NCT03653026|468491910|FG001|Part 1: Placebo-controlled Period|Other|3|||
130145424|NCT03653026|468491911|FG002|Part 1: Placebo-controlled Period|Other|0|||
130145425|NCT03653026|468491912|FG003|Part 1: Placebo-controlled Period|Other|0|||
130145426|NCT03653026|468491909|FG000|Part 2: Open-label Extension|Adverse Event|0|||
130145427|NCT03653026|468491910|FG001|Part 2: Open-label Extension|Adverse Event|0|||
130145428|NCT03653026|468491911|FG002|Part 2: Open-label Extension|Adverse Event|1|||
130145429|NCT03653026|468491912|FG003|Part 2: Open-label Extension|Adverse Event|1|||
130145430|NCT03653026|468491909|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130145431|NCT03653026|468491910|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
130145432|NCT03653026|468491911|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
130145433|NCT03653026|468491912|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
130145434|NCT03653026|468491909|FG000|Part 2: Open-label Extension|Other|0|||
130145435|NCT03653026|468491910|FG001|Part 2: Open-label Extension|Other|0|||
130145436|NCT03653026|468491911|FG002|Part 2: Open-label Extension|Other|1|||
130145437|NCT03653026|468491912|FG003|Part 2: Open-label Extension|Other|2|||
130145438|NCT02457819|468491913|FG000|Overall Study|reason not given|8|||
130145439|NCT02457819|468491913|FG000|Overall Study|Withdrawal by Subject|24|||
130145440|NCT02457819|468491913|FG000|Overall Study|Protocol Violation|1|||
129976581|NCT03538938|467877792|FG012|Overall Study|Death|1|||
129976582|NCT03538938|467877793|FG013|Overall Study|Death|1|||
130145441|NCT02457819|468491913|FG000|Overall Study|non compliance with study drug|4|||
130145442|NCT02457819|468491913|FG000|Overall Study|Lost to Follow-up|10|||
130145443|NCT02457819|468491913|FG000|Overall Study|Lack of Efficacy|19|||
130145444|NCT02457819|468491913|FG000|Overall Study|Adverse Event|33|||
130145445|NCT01045707|468491914|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
130145446|NCT01045707|468491915|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
130145447|NCT01045707|468491914|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
130145448|NCT01045707|468491915|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
130145449|NCT01045707|468491914|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
130145450|NCT01045707|468491915|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
130145451|NCT01045707|468491914|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
130145452|NCT01045707|468491915|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
130145453|NCT01045707|468491914|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
130145454|NCT01045707|468491915|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
130145455|NCT01045707|468491914|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
130145456|NCT01045707|468491915|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
130145457|NCT01045707|468491914|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
130145458|NCT01045707|468491915|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
130145459|NCT01045707|468491914|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
130145460|NCT01045707|468491915|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
130145461|NCT01045707|468491914|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
130145462|NCT01045707|468491915|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
130145463|NCT04886063|468491918|FG000|Overall Study|Adverse Event|50|||
130145464|NCT04886063|468491918|FG000|Overall Study|Lack of Efficacy|31|||
130145465|NCT04886063|468491918|FG000|Overall Study|Withdrawal by Subject|45|||
130145466|NCT04886063|468491918|FG000|Overall Study|Physician Decision|3|||
130145467|NCT04886063|468491918|FG000|Overall Study|Protocol Violation|3|||
130145468|NCT04886063|468491918|FG000|Overall Study|Site closure|4|||
130145469|NCT04886063|468491918|FG000|Overall Study|Nursing home replacement|3|||
130145470|NCT04886063|468491918|FG000|Overall Study|Lost to Follow-up|5|||
130145471|NCT04886063|468491918|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
130145472|NCT04886063|468491918|FG000|Overall Study|>1 reason|20|||
130145473|NCT04994431|468491919|FG000|Overall Study|Adverse Event|1|||
130145474|NCT04994431|468491920|FG001|Overall Study|Adverse Event|0|||
130145475|NCT00372996|468491921|FG000|Overall Study|Death|11|||
130145476|NCT00372996|468491922|FG001|Overall Study|Death|4|||
130145477|NCT00372996|468491923|FG002|Overall Study|Death|8|||
130145478|NCT00372996|468491924|FG003|Overall Study|Death|7|||
130145479|NCT00372996|468491921|FG000|Overall Study|Lost to Follow-up|0|||
130145480|NCT00372996|468491922|FG001|Overall Study|Lost to Follow-up|2|||
130145481|NCT00372996|468491923|FG002|Overall Study|Lost to Follow-up|0|||
130145482|NCT00372996|468491924|FG003|Overall Study|Lost to Follow-up|1|||
130145483|NCT00372996|468491921|FG000|Overall Study|Withdrawal by Subject|12|||
130145484|NCT00372996|468491922|FG001|Overall Study|Withdrawal by Subject|6|||
130145485|NCT00372996|468491923|FG002|Overall Study|Withdrawal by Subject|9|||
130145486|NCT00372996|468491924|FG003|Overall Study|Withdrawal by Subject|5|||
130145487|NCT00372996|468491921|FG000|Overall Study|Study Terminated by Sponsor|4|||
130145488|NCT00372996|468491922|FG001|Overall Study|Study Terminated by Sponsor|0|||
130145489|NCT00372996|468491923|FG002|Overall Study|Study Terminated by Sponsor|4|||
130145490|NCT00372996|468491924|FG003|Overall Study|Study Terminated by Sponsor|0|||
130145491|NCT00372996|468491921|FG000|Overall Study|Other|10|||
130145492|NCT00372996|468491922|FG001|Overall Study|Other|2|||
130145493|NCT00372996|468491923|FG002|Overall Study|Other|7|||
130145494|NCT00372996|468491924|FG003|Overall Study|Other|7|||
130145495|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
130145496|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
130145497|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
130145498|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
130145499|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
130145500|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
130145501|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
130145502|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
130145503|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
130145504|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
130145505|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
130145506|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
130145507|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
129976583|NCT03538938|467877794|FG014|Overall Study|Death|0|||
129976584|NCT03538938|467877795|FG015|Overall Study|Death|1|||
130145508|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
130145509|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
130145510|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
130145511|NCT01067521|468491928|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
130145512|NCT01067521|468491929|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
129976585|NCT03538938|467877780|FG000|Overall Study|Withdrawal by Subject|4|||
129976586|NCT03538938|467877781|FG001|Overall Study|Withdrawal by Subject|6|||
130145513|NCT01067521|468491928|FG000|Open-Label Period|Death|3|||
130145514|NCT01067521|468491929|FG001|Open-Label Period|Death|1|||
130145515|NCT01067521|468491928|FG000|Open-Label Period|Adverse Event|30|||
130145516|NCT01067521|468491929|FG001|Open-Label Period|Adverse Event|28|||
130145517|NCT01067521|468491928|FG000|Open-Label Period|Withdrawal by Subject|160|||
130145518|NCT01067521|468491929|FG001|Open-Label Period|Withdrawal by Subject|88|||
130145519|NCT01067521|468491928|FG000|Open-Label Period|Physician Decision|13|||
130145520|NCT01067521|468491929|FG001|Open-Label Period|Physician Decision|11|||
130145521|NCT01067521|468491928|FG000|Open-Label Period|Non-compliance with study drug|5|||
130145522|NCT01067521|468491929|FG001|Open-Label Period|Non-compliance with study drug|0|||
130145523|NCT01067521|468491928|FG000|Open-Label Period|Protocol Violation|3|||
130145524|NCT01067521|468491929|FG001|Open-Label Period|Protocol Violation|0|||
130145525|NCT01067521|468491928|FG000|Open-Label Period|Pregnancy|14|||
130145526|NCT01067521|468491929|FG001|Open-Label Period|Pregnancy|8|||
130145527|NCT01067521|468491928|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
130145528|NCT01067521|468491929|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
130145529|NCT01067521|468491928|FG000|Open-Label Period|Lost to Follow-up|21|||
130145530|NCT01067521|468491929|FG001|Open-Label Period|Lost to Follow-up|20|||
130145531|NCT02760433|468491931|FG000|Overall Study|Lost to Follow-up|1|||
130145532|NCT02760433|468491932|FG001|Overall Study|Lost to Follow-up|0|||
130145533|NCT02760433|468491933|FG002|Overall Study|Lost to Follow-up|1|||
130145534|NCT02760433|468491934|FG003|Overall Study|Lost to Follow-up|0|||
130145535|NCT02760433|468491935|FG004|Overall Study|Lost to Follow-up|0|||
130145536|NCT02760433|468491931|FG000|Overall Study|Withdrawal by Subject|23|||
130145537|NCT02760433|468491932|FG001|Overall Study|Withdrawal by Subject|9|||
130145538|NCT02760433|468491933|FG002|Overall Study|Withdrawal by Subject|0|||
130145539|NCT02760433|468491934|FG003|Overall Study|Withdrawal by Subject|2|||
130145540|NCT02760433|468491935|FG004|Overall Study|Withdrawal by Subject|9|||
130145541|NCT02760433|468491931|FG000|Overall Study|Lack of Response At Week 14|0|||
130145542|NCT02760433|468491932|FG001|Overall Study|Lack of Response At Week 14|0|||
130145543|NCT02760433|468491933|FG002|Overall Study|Lack of Response At Week 14|0|||
130145544|NCT02760433|468491934|FG003|Overall Study|Lack of Response At Week 14|0|||
130145545|NCT02760433|468491935|FG004|Overall Study|Lack of Response At Week 14|1|||
130145546|NCT02760433|468491931|FG000|Overall Study|Subject refused to continue the study|1|||
130145547|NCT02760433|468491932|FG001|Overall Study|Subject refused to continue the study|0|||
130145548|NCT02760433|468491933|FG002|Overall Study|Subject refused to continue the study|0|||
130145549|NCT02760433|468491934|FG003|Overall Study|Subject refused to continue the study|0|||
130145550|NCT02760433|468491935|FG004|Overall Study|Subject refused to continue the study|0|||
130145551|NCT02760433|468491931|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
130145552|NCT02760433|468491932|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130145553|NCT02760433|468491933|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130145554|NCT02760433|468491934|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130145555|NCT02760433|468491935|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
130145556|NCT02760433|468491931|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130145557|NCT02760433|468491932|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
130145558|NCT02760433|468491933|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130145559|NCT02760433|468491934|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130145560|NCT02760433|468491935|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
130145561|NCT02151149|468491936|FG000|Treatment Period|Death|2|||
130145562|NCT02151149|468491937|FG001|Treatment Period|Death|3|||
130145563|NCT02151149|468491936|FG000|Treatment Period|Adverse Event|17|||
130145564|NCT02151149|468491937|FG001|Treatment Period|Adverse Event|14|||
130145565|NCT02151149|468491936|FG000|Treatment Period|Progressive Disease|25|||
130145566|NCT02151149|468491937|FG001|Treatment Period|Progressive Disease|24|||
130145567|NCT02151149|468491936|FG000|Treatment Period|Symptomatic Deterioration|2|||
130145568|NCT02151149|468491937|FG001|Treatment Period|Symptomatic Deterioration|10|||
130145569|NCT02151149|468491936|FG000|Treatment Period|Withdrawal by Subject|13|||
130145570|NCT02151149|468491937|FG001|Treatment Period|Withdrawal by Subject|11|||
130145571|NCT02151149|468491936|FG000|Treatment Period|Miscellaneous|8|||
130145572|NCT02151149|468491937|FG001|Treatment Period|Miscellaneous|7|||
130145573|NCT02151149|468491936|FG000|Treatment Period|Participants randomized but not treated|3|||
130145574|NCT02151149|468491937|FG001|Treatment Period|Participants randomized but not treated|2|||
130145575|NCT02151149|468491936|FG000|Follow-Up Period|Lost to Follow-up|2|||
130145576|NCT02151149|468491937|FG001|Follow-Up Period|Lost to Follow-up|3|||
130145577|NCT02151149|468491936|FG000|Follow-Up Period|Death|37|||
130145578|NCT02151149|468491937|FG001|Follow-Up Period|Death|34|||
130145579|NCT00766493|468491938|FG000|30 Days Post-Procedure|Discontinued|7|||
130145580|NCT00766493|468491938|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
130145581|NCT00766493|468491938|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
130145582|NCT03419962|468491941|FG000|Overall Study|Change to other medication|1|||
129976587|NCT03538938|467877782|FG002|Overall Study|Withdrawal by Subject|5|||
130145583|NCT03419962|468491941|FG000|Overall Study|Refusal of continuing with trial drug|1|||
130145584|NCT03419962|468491941|FG000|Overall Study|Lost to Follow-up|3|||
130145585|NCT03419962|468491941|FG000|Overall Study|Difficulty in inhaling the doses|1|||
130145586|NCT03419962|468491941|FG000|Overall Study|Missing completion data|31|||
130145587|NCT02914457|468491942|FG000|Overall Study|Withdrawal by Subject|1|||
130145588|NCT02914457|468491942|FG000|Overall Study|Physician Decision|1|||
130145589|NCT02914457|468491942|FG000|Overall Study|No veins available for lead placement|1|||
130145590|NCT02914457|468491942|FG000|Overall Study|Electrical instability of patient|1|||
130145591|NCT02914457|468491942|FG000|Overall Study|ECG acquisition error due to sweating|1|||
130145592|NCT02914457|468491942|FG000|Overall Study|Protocol Violation|1|||
130145593|NCT03439085|468491946|FG000|Overall Study|Death|2|||
130145594|NCT03439085|468491946|FG000|Overall Study|Screen Failure|20|||
130145595|NCT01863433|468491947|FG000|Overall Study|Protocol Violation|1|||
130145596|NCT01292837|468491948|FG000|Overall Study|Adverse Event|1|||
130145597|NCT01292837|468491948|FG000|Overall Study|Further treatment determined|1|||
130145598|NCT01206439|468491949|FG000|Overall Study|subject did not meet inclusion criteria|1|||
130145599|NCT04531527|468491952|FG000|Overall Study|Found to be Ineligible|3|||
130145600|NCT00982228|468491964|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
130145601|NCT00982228|468491965|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
130145602|NCT00982228|468491964|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
130145603|NCT00982228|468491965|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
130145604|NCT00982228|468491964|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
130145605|NCT00982228|468491965|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
130145606|NCT00982228|468491964|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
130145607|NCT00982228|468491965|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
130145608|NCT00982228|468491964|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
130145609|NCT00982228|468491965|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
130145610|NCT00982228|468491964|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
130145611|NCT00982228|468491965|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
130145612|NCT00982228|468491964|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
130145613|NCT00982228|468491965|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
130145614|NCT00982228|468491964|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
130145615|NCT00982228|468491965|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
130145616|NCT00982228|468491964|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
130145617|NCT00982228|468491965|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
130145618|NCT00982228|468491964|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
130145619|NCT00982228|468491965|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
130145620|NCT02250651|468491966|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
130145621|NCT02250651|468491967|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
130145622|NCT02250651|468491968|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
130145623|NCT02250651|468491966|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
130145624|NCT02250651|468491967|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130145625|NCT02250651|468491968|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
130145626|NCT02250651|468491966|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
130145627|NCT02250651|468491967|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
130145628|NCT02250651|468491968|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
130145629|NCT02250651|468491966|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
130145630|NCT02250651|468491967|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
130145631|NCT02250651|468491968|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
130145632|NCT02250651|468491966|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
130145633|NCT02250651|468491967|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
130145634|NCT02250651|468491968|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
130145635|NCT02250651|468491966|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
130145636|NCT02250651|468491967|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
130145637|NCT02250651|468491968|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
130145638|NCT02250651|468491966|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
130145639|NCT02250651|468491967|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
130145640|NCT02250651|468491968|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
130145641|NCT02250651|468491966|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
130145642|NCT02250651|468491967|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
130145643|NCT02250651|468491968|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
130145644|NCT02250651|468491966|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
130145645|NCT02250651|468491967|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
130145646|NCT02250651|468491968|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
130145647|NCT02250651|468491966|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
130145648|NCT02250651|468491967|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
130145649|NCT02250651|468491968|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
130145650|NCT02250651|468491966|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
130145651|NCT02250651|468491967|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
130145652|NCT02250651|468491968|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
130145653|NCT02250651|468491966|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
130145654|NCT02250651|468491967|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
130145655|NCT02250651|468491968|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
130145656|NCT02250651|468491966|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
130145657|NCT02250651|468491967|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
130145658|NCT02250651|468491968|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
130145659|NCT02250651|468491966|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
130145660|NCT02250651|468491967|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
130145661|NCT02250651|468491968|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
130145662|NCT02250651|468491966|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
130145663|NCT02250651|468491967|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
130145664|NCT02250651|468491968|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
130145665|NCT03496298|468491969|FG000|Overall Study|Adverse Event|49|||
130145666|NCT03496298|468491970|FG001|Overall Study|Adverse Event|68|||
130145667|NCT03496298|468491971|FG002|Overall Study|Adverse Event|79|||
130145668|NCT03496298|468491969|FG000|Overall Study|Study terminated by Sponsor|1050|||
130145669|NCT03496298|468491970|FG001|Overall Study|Study terminated by Sponsor|1063|||
130145670|NCT03496298|468491971|FG002|Overall Study|Study terminated by Sponsor|1071|||
130145671|NCT03496298|468491969|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
130145672|NCT03496298|468491970|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
130145673|NCT03496298|468491971|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
130145674|NCT03496298|468491969|FG000|Overall Study|Withdrawal by Subject|176|||
130145675|NCT03496298|468491970|FG001|Overall Study|Withdrawal by Subject|154|||
130145676|NCT03496298|468491971|FG002|Overall Study|Withdrawal by Subject|151|||
130145677|NCT03496298|468491969|FG000|Overall Study|Other|29|||
130145678|NCT03496298|468491970|FG001|Overall Study|Other|20|||
130145679|NCT03496298|468491971|FG002|Overall Study|Other|23|||
130145680|NCT03496298|468491969|FG000|Overall Study|Randomized and not treated|1|||
129976588|NCT03538938|467877783|FG003|Overall Study|Withdrawal by Subject|3|||
129976589|NCT03538938|467877784|FG004|Overall Study|Withdrawal by Subject|0|||
129976590|NCT03538938|467877785|FG005|Overall Study|Withdrawal by Subject|0|||
129976591|NCT03538938|467877786|FG006|Overall Study|Withdrawal by Subject|3|||
130145681|NCT03496298|468491970|FG001|Overall Study|Randomized and not treated|1|||
130145682|NCT03496298|468491971|FG002|Overall Study|Randomized and not treated|1|||
130145683|NCT01438476|468491974|FG000|Overall Study|Protocol Violation|1|||
130145684|NCT01438476|468491975|FG001|Overall Study|Protocol Violation|0|||
130145685|NCT01438476|468491974|FG000|Overall Study|Withdrawal by Subject|1|||
130145686|NCT01438476|468491975|FG001|Overall Study|Withdrawal by Subject|0|||
129976592|NCT03538938|467877787|FG007|Overall Study|Withdrawal by Subject|1|||
129976593|NCT03538938|467877788|FG008|Overall Study|Withdrawal by Subject|5|||
129976594|NCT03538938|467877789|FG009|Overall Study|Withdrawal by Subject|1|||
129976595|NCT03538938|467877790|FG010|Overall Study|Withdrawal by Subject|2|||
129976596|NCT03538938|467877791|FG011|Overall Study|Withdrawal by Subject|1|||
129976597|NCT03538938|467877792|FG012|Overall Study|Withdrawal by Subject|3|||
130145687|NCT01438476|468491974|FG000|Overall Study|No Surgery- Disease|8|||
130145688|NCT01438476|468491975|FG001|Overall Study|No Surgery- Disease|10|||
130145689|NCT01438476|468491974|FG000|Overall Study|Communication barrier|0|||
130145690|NCT01438476|468491975|FG001|Overall Study|Communication barrier|1|||
130145691|NCT02522780|468491980|FG000|Overall Study|Consent withdrawn by subject|5|||
130145692|NCT02522780|468491981|FG001|Overall Study|Consent withdrawn by subject|7|||
130145693|NCT02522780|468491980|FG000|Overall Study|Protocol deviation|1|||
130145694|NCT02522780|468491981|FG001|Overall Study|Protocol deviation|3|||
130145695|NCT02522780|468491980|FG000|Overall Study|Subject refused endoscopic procedure|0|||
130145696|NCT02522780|468491981|FG001|Overall Study|Subject refused endoscopic procedure|1|||
130145697|NCT02522780|468491980|FG000|Overall Study|Adverse event, non-fatal|11|||
130145698|NCT02522780|468491981|FG001|Overall Study|Adverse event, non-fatal|16|||
130145699|NCT02058160|468491982|FG000|Overall Study|Randomized but not treated|2|||
130145700|NCT02058160|468491983|FG001|Overall Study|Randomized but not treated|4|||
130145701|NCT02058160|468491982|FG000|Overall Study|Poor compliance to protocol|4|||
129976598|NCT03538938|467877793|FG013|Overall Study|Withdrawal by Subject|0|||
129976599|NCT03538938|467877794|FG014|Overall Study|Withdrawal by Subject|2|||
129976600|NCT03538938|467877795|FG015|Overall Study|Withdrawal by Subject|4|||
130145702|NCT02058160|468491983|FG001|Overall Study|Poor compliance to protocol|1|||
130145703|NCT02058160|468491982|FG000|Overall Study|Adverse Event|12|||
130145704|NCT02058160|468491983|FG001|Overall Study|Adverse Event|3|||
129976601|NCT03538938|467877780|FG000|Overall Study|Incarcerated|0|||
130145705|NCT02058160|468491982|FG000|Overall Study|Lost to Follow-up|1|||
130145706|NCT02058160|468491983|FG001|Overall Study|Lost to Follow-up|0|||
130145707|NCT02058160|468491982|FG000|Overall Study|Other than specified above|12|||
130145708|NCT02058160|468491983|FG001|Overall Study|Other than specified above|6|||
130145709|NCT03310619|468491984|FG000|Pre-Treatment Period|Death|1|||
130145710|NCT03310619|468491985|FG001|Pre-Treatment Period|Death|0|||
130145711|NCT03310619|468491986|FG002|Pre-Treatment Period|Death|0|||
130145712|NCT03310619|468491987|FG003|Pre-Treatment Period|Death|0|||
130145713|NCT03310619|468491988|FG004|Pre-Treatment Period|Death|1|||
130145714|NCT03310619|468491989|FG005|Pre-Treatment Period|Death|0|||
130145715|NCT03310619|468491990|FG006|Pre-Treatment Period|Death|0|||
130145716|NCT03310619|468491991|FG007|Pre-Treatment Period|Death|0|||
130145717|NCT03310619|468491984|FG000|Pre-Treatment Period|Other reasons|2|||
130145718|NCT03310619|468491985|FG001|Pre-Treatment Period|Other reasons|1|||
130145719|NCT03310619|468491986|FG002|Pre-Treatment Period|Other reasons|2|||
130145720|NCT03310619|468491987|FG003|Pre-Treatment Period|Other reasons|0|||
130145721|NCT03310619|468491988|FG004|Pre-Treatment Period|Other reasons|0|||
130145722|NCT03310619|468491989|FG005|Pre-Treatment Period|Other reasons|0|||
130145723|NCT03310619|468491990|FG006|Pre-Treatment Period|Other reasons|2|||
130145724|NCT03310619|468491991|FG007|Pre-Treatment Period|Other reasons|0|||
130145725|NCT03310619|468491984|FG000|Treatment Period|Death|1|||
130145726|NCT03310619|468491985|FG001|Treatment Period|Death|2|||
130145727|NCT03310619|468491986|FG002|Treatment Period|Death|0|||
130145728|NCT03310619|468491987|FG003|Treatment Period|Death|0|||
130145729|NCT03310619|468491988|FG004|Treatment Period|Death|1|||
130145730|NCT03310619|468491989|FG005|Treatment Period|Death|0|||
130145731|NCT03310619|468491990|FG006|Treatment Period|Death|2|||
130145732|NCT03310619|468491991|FG007|Treatment Period|Death|0|||
130145733|NCT03310619|468491984|FG000|Treatment Period|Adverse Event|0|||
130145734|NCT03310619|468491985|FG001|Treatment Period|Adverse Event|1|||
130145735|NCT03310619|468491986|FG002|Treatment Period|Adverse Event|4|||
130145736|NCT03310619|468491987|FG003|Treatment Period|Adverse Event|1|||
130145737|NCT03310619|468491988|FG004|Treatment Period|Adverse Event|0|||
130145738|NCT03310619|468491989|FG005|Treatment Period|Adverse Event|0|||
130145739|NCT03310619|468491990|FG006|Treatment Period|Adverse Event|0|||
130145740|NCT03310619|468491991|FG007|Treatment Period|Adverse Event|0|||
130145741|NCT03310619|468491984|FG000|Treatment Period|Withdrawal by participant|0|||
130145742|NCT03310619|468491985|FG001|Treatment Period|Withdrawal by participant|0|||
130145743|NCT03310619|468491986|FG002|Treatment Period|Withdrawal by participant|1|||
130145744|NCT03310619|468491987|FG003|Treatment Period|Withdrawal by participant|0|||
130145745|NCT03310619|468491988|FG004|Treatment Period|Withdrawal by participant|0|||
130145746|NCT03310619|468491989|FG005|Treatment Period|Withdrawal by participant|0|||
130145747|NCT03310619|468491990|FG006|Treatment Period|Withdrawal by participant|0|||
130145748|NCT03310619|468491991|FG007|Treatment Period|Withdrawal by participant|0|||
130145749|NCT03310619|468491984|FG000|Treatment Period|Lost to Follow-up|0|||
130145750|NCT03310619|468491985|FG001|Treatment Period|Lost to Follow-up|0|||
130145751|NCT03310619|468491986|FG002|Treatment Period|Lost to Follow-up|0|||
130145752|NCT03310619|468491987|FG003|Treatment Period|Lost to Follow-up|0|||
130145753|NCT03310619|468491988|FG004|Treatment Period|Lost to Follow-up|0|||
130145754|NCT03310619|468491989|FG005|Treatment Period|Lost to Follow-up|0|||
130145755|NCT03310619|468491990|FG006|Treatment Period|Lost to Follow-up|0|||
130145756|NCT03310619|468491991|FG007|Treatment Period|Lost to Follow-up|1|||
130145757|NCT03310619|468491984|FG000|Treatment Period|Study terminated by sponsor|0|||
130145758|NCT03310619|468491985|FG001|Treatment Period|Study terminated by sponsor|0|||
130145759|NCT03310619|468491986|FG002|Treatment Period|Study terminated by sponsor|0|||
130145760|NCT03310619|468491987|FG003|Treatment Period|Study terminated by sponsor|0|||
130145761|NCT03310619|468491988|FG004|Treatment Period|Study terminated by sponsor|0|||
130145762|NCT03310619|468491989|FG005|Treatment Period|Study terminated by sponsor|0|||
130145763|NCT03310619|468491990|FG006|Treatment Period|Study terminated by sponsor|0|||
130145764|NCT03310619|468491991|FG007|Treatment Period|Study terminated by sponsor|1|||
130145765|NCT03310619|468491984|FG000|Treatment Period|Physician Decision|0|||
130145766|NCT03310619|468491985|FG001|Treatment Period|Physician Decision|0|||
130145767|NCT03310619|468491986|FG002|Treatment Period|Physician Decision|0|||
130145768|NCT03310619|468491987|FG003|Treatment Period|Physician Decision|0|||
130145769|NCT03310619|468491988|FG004|Treatment Period|Physician Decision|3|||
130145770|NCT03310619|468491989|FG005|Treatment Period|Physician Decision|0|||
130145771|NCT03310619|468491990|FG006|Treatment Period|Physician Decision|0|||
130145772|NCT03310619|468491991|FG007|Treatment Period|Physician Decision|0|||
130145773|NCT03310619|468491984|FG000|Treatment Period|Other reasons|1|||
130145774|NCT03310619|468491985|FG001|Treatment Period|Other reasons|0|||
130145775|NCT03310619|468491986|FG002|Treatment Period|Other reasons|2|||
130145776|NCT03310619|468491987|FG003|Treatment Period|Other reasons|0|||
130145777|NCT03310619|468491988|FG004|Treatment Period|Other reasons|0|||
130145778|NCT03310619|468491989|FG005|Treatment Period|Other reasons|0|||
130145779|NCT03310619|468491990|FG006|Treatment Period|Other reasons|0|||
130145780|NCT03310619|468491991|FG007|Treatment Period|Other reasons|0|||
130145781|NCT02427399|468491992|FG000|Overall Study|Protocol Violation|14|||
130145782|NCT02427399|468491993|FG001|Overall Study|Protocol Violation|16|||
130145783|NCT02427399|468491994|FG002|Overall Study|Protocol Violation|12|||
130145784|NCT02427399|468491995|FG003|Overall Study|Protocol Violation|18|||
130145785|NCT02427399|468491996|FG004|Overall Study|Protocol Violation|15|||
130145786|NCT02289820|468491997|FG000|Overall Study|Withdrawal by Subject|2|||
130145787|NCT02289820|468491998|FG001|Overall Study|Withdrawal by Subject|1|||
130145788|NCT02289820|468491999|FG002|Overall Study|Withdrawal by Subject|2|||
130145789|NCT02289820|468492000|FG003|Overall Study|Withdrawal by Subject|1|||
130145790|NCT02289820|468492001|FG004|Overall Study|Withdrawal by Subject|0|||
130145791|NCT02289820|468492002|FG005|Overall Study|Withdrawal by Subject|0|||
130145792|NCT02289820|468492003|FG006|Overall Study|Withdrawal by Subject|1|||
130145793|NCT02289820|468491997|FG000|Overall Study|Death|0|||
130145794|NCT02289820|468491998|FG001|Overall Study|Death|0|||
130145795|NCT02289820|468491999|FG002|Overall Study|Death|1|||
130145796|NCT02289820|468492000|FG003|Overall Study|Death|0|||
130145797|NCT02289820|468492001|FG004|Overall Study|Death|0|||
130145798|NCT02289820|468492002|FG005|Overall Study|Death|0|||
130145799|NCT02289820|468492003|FG006|Overall Study|Death|0|||
130145800|NCT02289820|468491997|FG000|Overall Study|Lost to Follow-up|0|||
130145801|NCT02289820|468491998|FG001|Overall Study|Lost to Follow-up|0|||
130145802|NCT02289820|468491999|FG002|Overall Study|Lost to Follow-up|3|||
130145803|NCT02289820|468492000|FG003|Overall Study|Lost to Follow-up|1|||
130145804|NCT02289820|468492001|FG004|Overall Study|Lost to Follow-up|0|||
130145805|NCT02289820|468492002|FG005|Overall Study|Lost to Follow-up|1|||
130145806|NCT02289820|468492003|FG006|Overall Study|Lost to Follow-up|1|||
130145807|NCT02289820|468491997|FG000|Overall Study|withdrawal of consent|0|||
130145808|NCT02289820|468491998|FG001|Overall Study|withdrawal of consent|1|||
130145809|NCT02289820|468491999|FG002|Overall Study|withdrawal of consent|0|||
130145810|NCT02289820|468492000|FG003|Overall Study|withdrawal of consent|0|||
130145811|NCT02289820|468492001|FG004|Overall Study|withdrawal of consent|0|||
130145812|NCT02289820|468492002|FG005|Overall Study|withdrawal of consent|0|||
130145813|NCT02289820|468492003|FG006|Overall Study|withdrawal of consent|0|||
130145814|NCT00926367|468492006|FG000|Overall Study|Withdrawal by Subject|0|||
130145815|NCT00926367|468492007|FG001|Overall Study|Withdrawal by Subject|1|||
130145816|NCT00926367|468492006|FG000|Overall Study|Lost to Follow-up|1|||
130145817|NCT00926367|468492007|FG001|Overall Study|Lost to Follow-up|0|||
130145818|NCT00926367|468492006|FG000|Overall Study|Skin Irritation|1|||
130145819|NCT00926367|468492007|FG001|Overall Study|Skin Irritation|2|||
130145820|NCT02725411|468492008|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
130145821|NCT02725411|468492009|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
130145822|NCT02725411|468492010|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
130145823|NCT02725411|468492008|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
130145824|NCT02725411|468492009|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
130145825|NCT02725411|468492010|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
130145826|NCT02725411|468492008|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
130145827|NCT02725411|468492009|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
130145828|NCT02725411|468492010|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
130145829|NCT02725411|468492008|FG000|Treatment Period (56 Weeks)|Other|1|||
130145830|NCT02725411|468492009|FG001|Treatment Period (56 Weeks)|Other|4|||
130145831|NCT02725411|468492010|FG002|Treatment Period (56 Weeks)|Other|5|||
130145832|NCT02725411|468492008|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
130145833|NCT02725411|468492009|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
130145834|NCT02725411|468492010|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
130145835|NCT02725411|468492008|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
130145836|NCT02725411|468492009|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
130145837|NCT02725411|468492010|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
130145838|NCT02725411|468492008|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
130145839|NCT02725411|468492009|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
130145840|NCT02725411|468492010|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
130145841|NCT02725411|468492008|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
130145842|NCT02725411|468492009|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
130145843|NCT02725411|468492010|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
130145844|NCT02725411|468492008|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
130145845|NCT02725411|468492009|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
130145846|NCT02725411|468492010|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
130145847|NCT02725411|468492008|FG000|Follow-up Period (24 Weeks)|Other|1|||
130145848|NCT02725411|468492009|FG001|Follow-up Period (24 Weeks)|Other|4|||
130145849|NCT02725411|468492010|FG002|Follow-up Period (24 Weeks)|Other|2|||
130145850|NCT02725411|468492008|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
130145851|NCT02725411|468492009|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
130145852|NCT02725411|468492010|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
130145853|NCT03847974|468492017|FG000|Overall Study|relocated out of region|3|||
130145854|NCT03847974|468492017|FG000|Overall Study|Withdrawal by Subject|2|||
130145855|NCT03847974|468492017|FG000|Overall Study|Adverse Event|1|||
130145856|NCT01924364|468492018|FG000|Overall Study|Physician Decision|3|||
130145857|NCT02911935|468492019|FG000|Overall Study|Lost to Follow-up|5|||
130145858|NCT02911935|468492020|FG001|Overall Study|Lost to Follow-up|7|||
130145859|NCT01685216|468492023|FG000|Overall Study|Did not receive study drug|1|||
130145860|NCT00756717|468492024|FG000|Overall Study|Withdrawal by Subject|2|||
130145861|NCT00685750|468492025|FG000|Overall Study|Tumor sampling failure|0|||
130145862|NCT00685750|468492026|FG001|Overall Study|Tumor sampling failure|0|||
130145863|NCT00685750|468492027|FG002|Overall Study|Tumor sampling failure|1|||
130145864|NCT00685750|468492028|FG003|Overall Study|Tumor sampling failure|0|||
130145865|NCT00685750|468492029|FG004|Overall Study|Tumor sampling failure|0|||
130145866|NCT00685750|468492030|FG005|Overall Study|Tumor sampling failure|0|||
130145867|NCT00685750|468492031|FG006|Overall Study|Tumor sampling failure|0|||
130145868|NCT00685750|468492025|FG000|Overall Study|Patient didn't receive the treatment|0|||
130145869|NCT00685750|468492026|FG001|Overall Study|Patient didn't receive the treatment|0|||
130145870|NCT00685750|468492027|FG002|Overall Study|Patient didn't receive the treatment|0|||
130145871|NCT00685750|468492028|FG003|Overall Study|Patient didn't receive the treatment|0|||
130145872|NCT00685750|468492029|FG004|Overall Study|Patient didn't receive the treatment|0|||
130145873|NCT00685750|468492030|FG005|Overall Study|Patient didn't receive the treatment|0|||
130145874|NCT00685750|468492031|FG006|Overall Study|Patient didn't receive the treatment|1|||
130145875|NCT00685750|468492025|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130145876|NCT00685750|468492026|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130145877|NCT00685750|468492027|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130145878|NCT00685750|468492028|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
130145879|NCT00685750|468492029|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
130145880|NCT00685750|468492030|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
130145881|NCT00685750|468492031|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
130145882|NCT04979858|468492032|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
130145883|NCT04979858|468492033|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
130145884|NCT02654015|468492034|FG000|Overall Study|Death|12|||
130145885|NCT02654015|468492034|FG000|Overall Study|Lost to Follow-up|3|||
130145886|NCT01896505|468492037|FG000|Overall Study|Adverse Event|1|||
130145887|NCT01896505|468492038|FG001|Overall Study|Adverse Event|0|||
130145888|NCT01896505|468492039|FG002|Overall Study|Adverse Event|2|||
130145889|NCT01896505|468492040|FG003|Overall Study|Adverse Event|1|||
130145890|NCT01896505|468492041|FG004|Overall Study|Adverse Event|1|||
130145891|NCT01896505|468492042|FG005|Overall Study|Adverse Event|0|||
130145892|NCT01896505|468492037|FG000|Overall Study|Physician Decision|1|||
130145893|NCT01896505|468492038|FG001|Overall Study|Physician Decision|3|||
130145894|NCT01896505|468492039|FG002|Overall Study|Physician Decision|2|||
130145895|NCT01896505|468492040|FG003|Overall Study|Physician Decision|0|||
130145896|NCT01896505|468492041|FG004|Overall Study|Physician Decision|0|||
130145897|NCT01896505|468492042|FG005|Overall Study|Physician Decision|1|||
130145898|NCT01896505|468492037|FG000|Overall Study|Withdrawal by Subject|1|||
130145899|NCT01896505|468492038|FG001|Overall Study|Withdrawal by Subject|0|||
130145900|NCT01896505|468492039|FG002|Overall Study|Withdrawal by Subject|3|||
130145901|NCT01896505|468492040|FG003|Overall Study|Withdrawal by Subject|1|||
130145902|NCT01896505|468492041|FG004|Overall Study|Withdrawal by Subject|0|||
130145903|NCT01896505|468492042|FG005|Overall Study|Withdrawal by Subject|0|||
130145904|NCT01896505|468492037|FG000|Overall Study|Disease Progression|7|||
130145905|NCT01896505|468492038|FG001|Overall Study|Disease Progression|5|||
130145906|NCT01896505|468492039|FG002|Overall Study|Disease Progression|8|||
130145907|NCT01896505|468492040|FG003|Overall Study|Disease Progression|4|||
130145908|NCT01896505|468492041|FG004|Overall Study|Disease Progression|4|||
130145909|NCT01896505|468492042|FG005|Overall Study|Disease Progression|4|||
130145910|NCT01896505|468492037|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
130145911|NCT01896505|468492038|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
130145912|NCT01896505|468492039|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
130145913|NCT01896505|468492040|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
130145914|NCT01896505|468492041|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
130145915|NCT01896505|468492042|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
130145916|NCT01896505|468492037|FG000|Overall Study|Intercurrent illness|0|||
130145917|NCT01896505|468492038|FG001|Overall Study|Intercurrent illness|1|||
130145918|NCT01896505|468492039|FG002|Overall Study|Intercurrent illness|0|||
130145919|NCT01896505|468492040|FG003|Overall Study|Intercurrent illness|0|||
130145920|NCT01896505|468492041|FG004|Overall Study|Intercurrent illness|0|||
130145921|NCT01896505|468492042|FG005|Overall Study|Intercurrent illness|0|||
130145922|NCT01896505|468492037|FG000|Overall Study|Death|0|||
130145923|NCT01896505|468492038|FG001|Overall Study|Death|0|||
130145924|NCT01896505|468492039|FG002|Overall Study|Death|1|||
130145925|NCT01896505|468492040|FG003|Overall Study|Death|1|||
130145926|NCT01896505|468492041|FG004|Overall Study|Death|0|||
130145927|NCT01896505|468492042|FG005|Overall Study|Death|1|||
130145928|NCT02418754|468492043|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130145929|NCT02418754|468492044|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
130145930|NCT02418754|468492045|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130145931|NCT02418754|468492046|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130145932|NCT02418754|468492047|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
130145933|NCT02418754|468492043|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
130145934|NCT02418754|468492044|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
130145935|NCT02418754|468492045|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
130145936|NCT02418754|468492046|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
130145937|NCT02418754|468492047|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
130145938|NCT02418754|468492043|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
130145939|NCT02418754|468492044|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130145940|NCT02418754|468492045|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130145941|NCT02418754|468492046|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130145942|NCT02418754|468492047|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
130145943|NCT02418754|468492043|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130145944|NCT02418754|468492044|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
130145945|NCT02418754|468492045|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
130145946|NCT02418754|468492046|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130145947|NCT02418754|468492047|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
130145948|NCT02418754|468492043|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130145949|NCT02418754|468492044|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130145950|NCT02418754|468492045|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
130145951|NCT02418754|468492046|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130145952|NCT02418754|468492047|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
130145953|NCT02418754|468492043|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
130145954|NCT02418754|468492044|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
130145955|NCT02418754|468492045|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
130145956|NCT02418754|468492046|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
130145957|NCT02418754|468492047|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
130145958|NCT02418754|468492043|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
130145959|NCT02418754|468492044|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130145960|NCT02418754|468492045|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130145961|NCT02418754|468492046|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130145962|NCT02418754|468492047|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
130145963|NCT02418754|468492043|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
130145964|NCT02418754|468492044|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
130145965|NCT02418754|468492045|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
130145966|NCT02418754|468492046|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
130145967|NCT02418754|468492047|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
130145968|NCT02418754|468492043|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
130145969|NCT02418754|468492044|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
130145970|NCT02418754|468492045|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
130145971|NCT02418754|468492046|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
130145972|NCT02418754|468492047|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
130145973|NCT02418754|468492043|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
130145974|NCT02418754|468492044|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
130145975|NCT02418754|468492045|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
130145976|NCT02418754|468492046|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
130145977|NCT02418754|468492047|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
130145978|NCT02418754|468492043|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130145979|NCT02418754|468492044|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
130145980|NCT02418754|468492045|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130145981|NCT02418754|468492046|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
130145982|NCT02418754|468492047|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
130145983|NCT04974580|468492048|FG000|Overall Study|Lost to Follow-up|33|||
130145984|NCT04974580|468492049|FG001|Overall Study|Lost to Follow-up|39|||
130145985|NCT04974580|468492050|FG002|Overall Study|Lost to Follow-up|30|||
130145986|NCT04974580|468492051|FG003|Overall Study|Lost to Follow-up|29|||
130145987|NCT00250705|468492052|FG000|Overall Study|Lack of Efficacy|2|||
130145988|NCT03259789|468492062|FG000|Overall Study|Adverse Event|3|||
130145989|NCT03259789|468492063|FG001|Overall Study|Adverse Event|2|||
130145990|NCT03259789|468492064|FG002|Overall Study|Adverse Event|1|||
130145991|NCT03259789|468492062|FG000|Overall Study|Withdrawal by Subject|9|||
130145992|NCT03259789|468492063|FG001|Overall Study|Withdrawal by Subject|5|||
130145993|NCT03259789|468492064|FG002|Overall Study|Withdrawal by Subject|1|||
130145994|NCT03259789|468492062|FG000|Overall Study|Lost to Follow-up|5|||
130145995|NCT03259789|468492063|FG001|Overall Study|Lost to Follow-up|9|||
130145996|NCT03259789|468492064|FG002|Overall Study|Lost to Follow-up|4|||
130145997|NCT03259789|468492062|FG000|Overall Study|Physician Decision|0|||
130145998|NCT03259789|468492063|FG001|Overall Study|Physician Decision|1|||
130145999|NCT03259789|468492064|FG002|Overall Study|Physician Decision|0|||
130146000|NCT02063217|468492065|FG000|Overall Study|Withdrawal by Subject|1|||
130146001|NCT02063217|468492066|FG001|Overall Study|Withdrawal by Subject|0|||
130146002|NCT02063217|468492067|FG002|Overall Study|Withdrawal by Subject|0|||
130146003|NCT00889252|468492068|FG000|Overall Study|Adverse Event|2|||
130146004|NCT00889252|468492069|FG001|Overall Study|Adverse Event|4|||
130146005|NCT00889252|468492068|FG000|Overall Study|Withdrawal by Subject|3|||
130146006|NCT00889252|468492069|FG001|Overall Study|Withdrawal by Subject|0|||
130146007|NCT00889252|468492068|FG000|Overall Study|Protocol Violation|2|||
130146008|NCT00889252|468492069|FG001|Overall Study|Protocol Violation|0|||
130146009|NCT01160640|468492073|FG000|Overall Study|Physician Decision|3|||
130146010|NCT01160640|468492074|FG001|Overall Study|Physician Decision|3|||
130146011|NCT01160640|468492073|FG000|Overall Study|Incarceration|1|||
130146012|NCT01160640|468492074|FG001|Overall Study|Incarceration|0|||
130146013|NCT01160640|468492073|FG000|Overall Study|Withdrawal by Subject|0|||
130146014|NCT01160640|468492074|FG001|Overall Study|Withdrawal by Subject|3|||
130146015|NCT03108820|468492076|FG000|Overall Study|Lost to Follow-up|30|||
130146016|NCT03108820|468492077|FG001|Overall Study|Lost to Follow-up|28|||
130146017|NCT03108820|468492076|FG000|Overall Study|Withdrawal by Subject|32|||
130146018|NCT03108820|468492077|FG001|Overall Study|Withdrawal by Subject|24|||
130146019|NCT03108820|468492076|FG000|Overall Study|Death|6|||
130146020|NCT03108820|468492077|FG001|Overall Study|Death|11|||
130146021|NCT00089973|468492080|FG000|Overall Study|Adverse Event|3|||
130146022|NCT00089973|468492080|FG000|Overall Study|Withdrawal by Subject|1|||
130146023|NCT00089973|468492080|FG000|Overall Study|Disease progression|45|||
130146024|NCT00089973|468492080|FG000|Overall Study|Death|1|||
130146025|NCT01992094|468492081|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
130146026|NCT01992094|468492082|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
130146027|NCT01992094|468492083|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
130146028|NCT01992094|468492081|FG000|Overall Study|Adverse Event|1|||
130146029|NCT01992094|468492082|FG001|Overall Study|Adverse Event|0|||
130146030|NCT01992094|468492083|FG002|Overall Study|Adverse Event|0|||
130146031|NCT01992094|468492081|FG000|Overall Study|Death|5|||
130146032|NCT01992094|468492082|FG001|Overall Study|Death|5|||
130146033|NCT01992094|468492083|FG002|Overall Study|Death|2|||
130146034|NCT01992094|468492081|FG000|Overall Study|Lost to Follow-up|26|||
130146035|NCT01992094|468492082|FG001|Overall Study|Lost to Follow-up|9|||
130146036|NCT01992094|468492083|FG002|Overall Study|Lost to Follow-up|13|||
130146037|NCT01992094|468492081|FG000|Overall Study|OTHER|4|||
130146038|NCT01992094|468492082|FG001|Overall Study|OTHER|0|||
130146039|NCT01992094|468492083|FG002|Overall Study|OTHER|0|||
130146040|NCT01992094|468492081|FG000|Overall Study|Protocol Violation|1|||
130146041|NCT01992094|468492082|FG001|Overall Study|Protocol Violation|0|||
130146042|NCT01992094|468492083|FG002|Overall Study|Protocol Violation|1|||
130146043|NCT01992094|468492081|FG000|Overall Study|Withdrawal by Subject|7|||
130146044|NCT01992094|468492082|FG001|Overall Study|Withdrawal by Subject|3|||
130146045|NCT01992094|468492083|FG002|Overall Study|Withdrawal by Subject|4|||
130146046|NCT01214239|468492084|FG000|Overall Study|Adverse Event|3|||
130146047|NCT01214239|468492085|FG001|Overall Study|Adverse Event|4|||
130146048|NCT01214239|468492084|FG000|Overall Study|Protocol Violation|2|||
130146049|NCT01214239|468492085|FG001|Overall Study|Protocol Violation|1|||
130146050|NCT01214239|468492084|FG000|Overall Study|Lost to Follow-up|1|||
130146051|NCT01214239|468492085|FG001|Overall Study|Lost to Follow-up|1|||
130146052|NCT01214239|468492084|FG000|Overall Study|Withdrawal by Subject|4|||
130146053|NCT01214239|468492085|FG001|Overall Study|Withdrawal by Subject|9|||
130146054|NCT01214239|468492084|FG000|Overall Study|Lack of Efficacy|1|||
130146055|NCT01214239|468492085|FG001|Overall Study|Lack of Efficacy|2|||
130146056|NCT01214239|468492084|FG000|Overall Study|patient's private reason|1|||
130146057|NCT01214239|468492085|FG001|Overall Study|patient's private reason|1|||
130146058|NCT01049581|468492086|FG000|Overall Study|Lost to Follow-up|2|||
130146059|NCT01049581|468492087|FG001|Overall Study|Lost to Follow-up|1|||
130146060|NCT03203642|468492088|FG000|Overall Study|Adverse Event|3|||
130146061|NCT03203642|468492089|FG001|Overall Study|Adverse Event|1|||
130146062|NCT03203642|468492088|FG000|Overall Study|Withdrawal by Subject|6|||
130146063|NCT03203642|468492089|FG001|Overall Study|Withdrawal by Subject|6|||
130146064|NCT03203642|468492088|FG000|Overall Study|Lost to Follow-up|2|||
130146065|NCT03203642|468492089|FG001|Overall Study|Lost to Follow-up|1|||
130146066|NCT03203642|468492088|FG000|Overall Study|Termination of the study by sponsor|1|||
130146067|NCT03203642|468492089|FG001|Overall Study|Termination of the study by sponsor|1|||
130146068|NCT03203642|468492088|FG000|Overall Study|Participant moved|0|||
130146069|NCT03203642|468492089|FG001|Overall Study|Participant moved|1|||
130146070|NCT03203642|468492088|FG000|Overall Study|Investigator's decision|3|||
130146071|NCT03203642|468492089|FG001|Overall Study|Investigator's decision|0|||
130146072|NCT03203642|468492088|FG000|Overall Study|Other than above specified|0|||
130146073|NCT03203642|468492089|FG001|Overall Study|Other than above specified|1|||
130146074|NCT05068284|468492094|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
130146075|NCT05068284|468492095|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
130146076|NCT05068284|468492096|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130146077|NCT05068284|468492097|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130146078|NCT05068284|468492098|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130146079|NCT05068284|468492099|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130146080|NCT05068284|468492100|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130146081|NCT05068284|468492101|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
130146082|NCT05068284|468492094|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146083|NCT05068284|468492095|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146084|NCT05068284|468492096|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
130146085|NCT05068284|468492097|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146086|NCT05068284|468492098|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146087|NCT05068284|468492099|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146088|NCT05068284|468492100|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146089|NCT05068284|468492101|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
130146090|NCT05068284|468492094|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
130146091|NCT05068284|468492095|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
130146092|NCT05068284|468492096|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
130146093|NCT05068284|468492097|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
130146094|NCT05068284|468492098|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
130146095|NCT05068284|468492099|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130146096|NCT05068284|468492100|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130146097|NCT05068284|468492101|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
130146098|NCT05068284|468492094|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130146099|NCT05068284|468492095|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130146100|NCT05068284|468492096|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
130146101|NCT05068284|468492097|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130146102|NCT05068284|468492098|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
130146103|NCT05068284|468492099|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130146104|NCT05068284|468492100|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130146105|NCT05068284|468492101|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
130146106|NCT05068284|468492094|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146107|NCT05068284|468492095|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146108|NCT05068284|468492096|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146109|NCT05068284|468492097|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
130146110|NCT05068284|468492098|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146111|NCT05068284|468492099|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146112|NCT05068284|468492100|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146113|NCT05068284|468492101|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
130146114|NCT05068284|468492094|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130146115|NCT05068284|468492095|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130146116|NCT05068284|468492096|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
130146117|NCT05068284|468492097|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
130146118|NCT05068284|468492098|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130146119|NCT05068284|468492099|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130146120|NCT05068284|468492100|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130146121|NCT05068284|468492101|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
130146122|NCT05068284|468492094|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146123|NCT05068284|468492095|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146124|NCT05068284|468492096|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
130146125|NCT05068284|468492097|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146126|NCT05068284|468492098|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146127|NCT05068284|468492099|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146128|NCT05068284|468492100|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146129|NCT05068284|468492101|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
130146130|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
130146131|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146132|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146133|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146134|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146135|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146136|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146137|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
130146138|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
130146139|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130146140|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130146141|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130146142|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130154899|NCT01470612|468526639|FG001|Overall Study|Did not meet entrance criteria|1|||
129976602|NCT03538938|467877781|FG001|Overall Study|Incarcerated|0|||
129976603|NCT03538938|467877782|FG002|Overall Study|Incarcerated|0|||
130146143|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
130146144|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
130146145|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
130146146|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
130146147|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130146148|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130146149|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130146150|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130146151|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130146152|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
130146153|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
130146154|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
130146155|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146156|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146157|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146158|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146159|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146160|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146161|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
130146162|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
130146163|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146164|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146165|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146166|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146167|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146168|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146169|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
130146170|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
130146171|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130146172|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130146173|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130146174|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
130146175|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
130146176|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
130146177|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
130146178|NCT05068284|468492094|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146179|NCT05068284|468492095|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146180|NCT05068284|468492096|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146181|NCT05068284|468492097|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146182|NCT05068284|468492098|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146183|NCT05068284|468492099|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146184|NCT05068284|468492100|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
130146185|NCT05068284|468492101|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
130146186|NCT01958060|468494327|FG000|Overall Study|Not treated|2|||
130146187|NCT01958060|468494328|FG001|Overall Study|Not treated|0|||
130146188|NCT01958060|468494329|FG002|Overall Study|Not treated|0|||
130146189|NCT01958060|468494330|FG003|Overall Study|Not treated|0|||
130146190|NCT01958060|468494331|FG004|Overall Study|Not treated|1|||
130146191|NCT01958060|468494332|FG005|Overall Study|Not treated|0|||
130146192|NCT01074008|468494335|FG000|Overall Study|Adverse Event|0|||
130146193|NCT01074008|468494336|FG001|Overall Study|Adverse Event|1|||
130146194|NCT01074008|468494337|FG002|Overall Study|Adverse Event|0|||
130146195|NCT01074008|468494338|FG003|Overall Study|Adverse Event|0|||
130146196|NCT01074008|468494339|FG004|Overall Study|Adverse Event|0|||
130146197|NCT01074008|468494340|FG005|Overall Study|Adverse Event|0|||
130146198|NCT01074008|468494341|FG006|Overall Study|Adverse Event|0|||
130146199|NCT01074008|468494342|FG007|Overall Study|Adverse Event|0|||
130146200|NCT01074008|468494343|FG008|Overall Study|Adverse Event|0|||
130146201|NCT01074008|468494335|FG000|Overall Study|Withdrawal by Subject|1|||
130146202|NCT01074008|468494336|FG001|Overall Study|Withdrawal by Subject|1|||
130146203|NCT01074008|468494337|FG002|Overall Study|Withdrawal by Subject|1|||
130146204|NCT01074008|468494338|FG003|Overall Study|Withdrawal by Subject|0|||
130146205|NCT01074008|468494339|FG004|Overall Study|Withdrawal by Subject|1|||
130146206|NCT01074008|468494340|FG005|Overall Study|Withdrawal by Subject|0|||
130146207|NCT01074008|468494341|FG006|Overall Study|Withdrawal by Subject|0|||
130146208|NCT01074008|468494342|FG007|Overall Study|Withdrawal by Subject|0|||
130146209|NCT01074008|468494343|FG008|Overall Study|Withdrawal by Subject|0|||
130146210|NCT01074008|468494335|FG000|Overall Study|Lost to Follow-up|0|||
130146211|NCT01074008|468494336|FG001|Overall Study|Lost to Follow-up|1|||
130146212|NCT01074008|468494337|FG002|Overall Study|Lost to Follow-up|1|||
130146213|NCT01074008|468494338|FG003|Overall Study|Lost to Follow-up|1|||
130146214|NCT01074008|468494339|FG004|Overall Study|Lost to Follow-up|1|||
130146215|NCT01074008|468494340|FG005|Overall Study|Lost to Follow-up|0|||
130146216|NCT01074008|468494341|FG006|Overall Study|Lost to Follow-up|1|||
130146217|NCT01074008|468494342|FG007|Overall Study|Lost to Follow-up|0|||
130146218|NCT01074008|468494343|FG008|Overall Study|Lost to Follow-up|4|||
130146219|NCT00108628|468494349|FG000|Overall Study|Withdrawal by Subject|17|||
130146220|NCT00108628|468494350|FG001|Overall Study|Withdrawal by Subject|9|||
130146221|NCT00108628|468494349|FG000|Overall Study|Lack of Efficacy|2|||
130146222|NCT00108628|468494350|FG001|Overall Study|Lack of Efficacy|1|||
130146223|NCT00108628|468494349|FG000|Overall Study|Death|1|||
130146224|NCT00108628|468494350|FG001|Overall Study|Death|0|||
130146225|NCT01350934|468494353|FG000|Base Study|Adverse Event|6|||
130146226|NCT01350934|468494354|FG001|Base Study|Adverse Event|0|||
130146227|NCT01350934|468494353|FG000|Base Study|Lost to Follow-up|1|||
130146228|NCT01350934|468494354|FG001|Base Study|Lost to Follow-up|0|||
130146229|NCT01350934|468494353|FG000|Base Study|Protocol Violation|1|||
130146230|NCT01350934|468494354|FG001|Base Study|Protocol Violation|1|||
130146231|NCT01350934|468494353|FG000|Base Study|Withdrawal by Subject|1|||
130146232|NCT01350934|468494354|FG001|Base Study|Withdrawal by Subject|2|||
130146233|NCT01350934|468494353|FG000|Base Study|Non-Compliance With Study Drug|2|||
130146234|NCT01350934|468494354|FG001|Base Study|Non-Compliance With Study Drug|0|||
130146235|NCT01350934|468494353|FG000|Extension Study|Adverse Event|2|||
130146236|NCT01350934|468494354|FG001|Extension Study|Adverse Event|1|||
130146237|NCT01350934|468494353|FG000|Extension Study|Lost to Follow-up|2|||
130146238|NCT01350934|468494354|FG001|Extension Study|Lost to Follow-up|0|||
130146239|NCT01350934|468494353|FG000|Extension Study|Protocol Violation|1|||
130146240|NCT01350934|468494354|FG001|Extension Study|Protocol Violation|1|||
130146241|NCT01350934|468494353|FG000|Extension Study|Lack of Efficacy|0|||
130146242|NCT01350934|468494354|FG001|Extension Study|Lack of Efficacy|1|||
130146243|NCT01350934|468494353|FG000|Extension Study|Withdrawal by Subject|0|||
130146244|NCT01350934|468494354|FG001|Extension Study|Withdrawal by Subject|1|||
130146245|NCT03547635|468494355|FG000|Overall Study|Adverse Event|5|||
130146246|NCT03547635|468494356|FG001|Overall Study|Adverse Event|2|||
130146247|NCT03547635|468494357|FG002|Overall Study|Adverse Event|3|||
130146248|NCT03547635|468494355|FG000|Overall Study|Lost to Follow-up|1|||
130146249|NCT03547635|468494356|FG001|Overall Study|Lost to Follow-up|3|||
130146250|NCT03547635|468494357|FG002|Overall Study|Lost to Follow-up|4|||
130146251|NCT03547635|468494355|FG000|Overall Study|Withdrawal by Subject|1|||
130146252|NCT03547635|468494356|FG001|Overall Study|Withdrawal by Subject|0|||
130146253|NCT03547635|468494357|FG002|Overall Study|Withdrawal by Subject|0|||
130146254|NCT03547635|468494355|FG000|Overall Study|Withdrawal By PI|0|||
130146255|NCT03547635|468494356|FG001|Overall Study|Withdrawal By PI|1|||
130146256|NCT03547635|468494357|FG002|Overall Study|Withdrawal By PI|0|||
130146257|NCT03547635|468494355|FG000|Overall Study|Withdrawal by Sponsor|0|||
130146258|NCT03547635|468494356|FG001|Overall Study|Withdrawal by Sponsor|0|||
130146259|NCT03547635|468494357|FG002|Overall Study|Withdrawal by Sponsor|1|||
130146260|NCT03547635|468494355|FG000|Overall Study|Errant Randomization before Treatment|0|||
130146261|NCT03547635|468494356|FG001|Overall Study|Errant Randomization before Treatment|1|||
130146262|NCT03547635|468494357|FG002|Overall Study|Errant Randomization before Treatment|0|||
130146263|NCT03547635|468494355|FG000|Overall Study|Withdrawal by Subject|1|||
130146264|NCT03547635|468494356|FG001|Overall Study|Withdrawal by Subject|0|||
130146265|NCT03547635|468494357|FG002|Overall Study|Withdrawal by Subject|0|||
130146266|NCT00676650|468494360|FG000|Overall Study|Death|45|||
130146267|NCT00676650|468494361|FG001|Overall Study|Death|14|||
130146268|NCT00676650|468494360|FG000|Overall Study|Adverse Event|159|||
130146269|NCT00676650|468494361|FG001|Overall Study|Adverse Event|21|||
130146270|NCT00676650|468494360|FG000|Overall Study|Global deterioration of health status|66|||
130146271|NCT00676650|468494361|FG001|Overall Study|Global deterioration of health status|31|||
130146272|NCT00676650|468494360|FG000|Overall Study|Lost to Follow-up|0|||
130146273|NCT00676650|468494361|FG001|Overall Study|Lost to Follow-up|1|||
130146274|NCT00676650|468494360|FG000|Overall Study|Objective progression or relapse|189|||
130146275|NCT00676650|468494361|FG001|Overall Study|Objective progression or relapse|140|||
130146276|NCT00676650|468494360|FG000|Overall Study|Other|14|||
130146277|NCT00676650|468494361|FG001|Overall Study|Other|10|||
130146278|NCT00676650|468494360|FG000|Overall Study|Protocol Violation|3|||
130146279|NCT00676650|468494361|FG001|Overall Study|Protocol Violation|1|||
130146280|NCT00676650|468494360|FG000|Overall Study|Study terminated by sponsor|57|||
130146281|NCT00676650|468494361|FG001|Overall Study|Study terminated by sponsor|43|||
130146282|NCT00676650|468494360|FG000|Overall Study|Withdrawal by Subject|48|||
130146283|NCT00676650|468494361|FG001|Overall Study|Withdrawal by Subject|24|||
130146284|NCT00676650|468494360|FG000|Overall Study|Randomized but not treated|3|||
130146285|NCT00676650|468494361|FG001|Overall Study|Randomized but not treated|4|||
130146286|NCT02297841|468494362|FG000|Overall Study|Withdrawal by Subject|1|||
130146287|NCT02297841|468494362|FG000|Overall Study|Protocol Violation|7|||
130146288|NCT00683592|468494363|FG000|Overall Study|Adverse Event|12|||
130146289|NCT00683592|468494364|FG001|Overall Study|Adverse Event|4|||
130146290|NCT00683592|468494363|FG000|Overall Study|Withdrawal by Subject|11|||
130146291|NCT00683592|468494364|FG001|Overall Study|Withdrawal by Subject|11|||
130146292|NCT00683592|468494363|FG000|Overall Study|Lost to Follow-up|17|||
130146293|NCT00683592|468494364|FG001|Overall Study|Lost to Follow-up|17|||
130146294|NCT00683592|468494363|FG000|Overall Study|Lack of Efficacy|3|||
130146295|NCT00683592|468494364|FG001|Overall Study|Lack of Efficacy|7|||
130146296|NCT00683592|468494363|FG000|Overall Study|Physician Decision|0|||
130146297|NCT00683592|468494364|FG001|Overall Study|Physician Decision|1|||
130146298|NCT00683592|468494363|FG000|Overall Study|Non-compliance|3|||
130146299|NCT00683592|468494364|FG001|Overall Study|Non-compliance|5|||
130146300|NCT00683592|468494363|FG000|Overall Study|Other|1|||
130146301|NCT00683592|468494364|FG001|Overall Study|Other|1|||
130146302|NCT01765270|468494372|FG000|Overall Study|Physician Decision|1|||
130146303|NCT01765270|468494373|FG001|Overall Study|Physician Decision|0|||
130146304|NCT01765270|468494372|FG000|Overall Study|Withdrawal by Subject|0|||
130146305|NCT01765270|468494373|FG001|Overall Study|Withdrawal by Subject|1|||
130146306|NCT03431337|468494374|FG000|Overall Study|Lost to Follow-up|21|||
130146307|NCT03431337|468494375|FG001|Overall Study|Lost to Follow-up|19|||
130146308|NCT03431337|468494374|FG000|Overall Study|Withdrawal by Subject|8|||
130146309|NCT03431337|468494375|FG001|Overall Study|Withdrawal by Subject|3|||
130146310|NCT00329160|468494378|FG000|Overall Study|Adverse Event|27|||
130146311|NCT00329160|468494378|FG000|Overall Study|Withdrawal by Subject|13|||
130146312|NCT00329160|468494378|FG000|Overall Study|Protocol Violation|2|||
130146313|NCT00329160|468494378|FG000|Overall Study|Did not Receive Study Drug|1|||
130146314|NCT00329160|468494378|FG000|Overall Study|Incomplete IVUS|45|||
130146315|NCT04501094|468494379|FG000|Overall Study|Death (unrelated to research)|1|||
130146316|NCT04501094|468494380|FG001|Overall Study|Death (unrelated to research)|0|||
130146317|NCT00063258|468494384|FG000|Overall Study|Physician Decision|2|||
130146318|NCT00063258|468494385|FG001|Overall Study|Physician Decision|0|||
130146319|NCT00063258|468494384|FG000|Overall Study|Lack of Efficacy|2|||
130146320|NCT00063258|468494385|FG001|Overall Study|Lack of Efficacy|0|||
130146321|NCT00685035|468494386|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
130146322|NCT00685035|468494387|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
130146323|NCT00784979|468494388|FG000|Overall Study|incomplete data|6|||
130146324|NCT01235715|468494393|FG000|Overall Study|Physician Decision|0|||
130146325|NCT01235715|468494394|FG001|Overall Study|Physician Decision|2|||
130146326|NCT02994394|468494395|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
130146327|NCT02994394|468494396|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
130146328|NCT02994394|468494397|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
130146329|NCT02994394|468494398|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
130146330|NCT02994394|468494399|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
130146331|NCT02994394|468494400|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
130146332|NCT02994394|468494395|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
130146333|NCT02994394|468494396|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
130146334|NCT02994394|468494397|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
130146335|NCT02994394|468494398|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
130146336|NCT02994394|468494399|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
130146337|NCT02994394|468494400|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
130146338|NCT04982445|468494401|FG000|Overall Study|Protocol Violation|1|||
130146339|NCT04982445|468494401|FG000|Overall Study|Withdrawal by Subject|4|||
130146340|NCT04982445|468494401|FG000|Overall Study|Lost to Follow-up|1|||
130146341|NCT00396630|468494402|FG000|Overall Study|Lost to Follow-up|1|||
130146342|NCT00396630|468494403|FG001|Overall Study|Lost to Follow-up|1|||
130146343|NCT00396630|468494402|FG000|Overall Study|Withdrawal by Subject|1|||
130146344|NCT00396630|468494403|FG001|Overall Study|Withdrawal by Subject|1|||
130146345|NCT00396630|468494402|FG000|Overall Study|Not vaccinated at Visit 3|3|||
130146346|NCT00396630|468494403|FG001|Overall Study|Not vaccinated at Visit 3|3|||
130146347|NCT02327325|468494404|FG000|Overall Study|Withdrawal by Subject|1|||
130146348|NCT02327325|468494405|FG001|Overall Study|Withdrawal by Subject|4|||
130146349|NCT02327325|468494406|FG002|Overall Study|Withdrawal by Subject|4|||
129976604|NCT03538938|467877783|FG003|Overall Study|Incarcerated|0|||
129976605|NCT03538938|467877784|FG004|Overall Study|Incarcerated|0|||
130146350|NCT02327325|468494404|FG000|Overall Study|Excluded by Study Team|0|||
130146351|NCT02327325|468494405|FG001|Overall Study|Excluded by Study Team|0|||
130146352|NCT02327325|468494406|FG002|Overall Study|Excluded by Study Team|1|||
130146353|NCT01755975|468494409|FG000|Overall Study|Adverse Event|0|||
130146354|NCT01755975|468494410|FG001|Overall Study|Adverse Event|0|||
130146355|NCT01755975|468494411|FG002|Overall Study|Adverse Event|1|||
130146356|NCT01755975|468494412|FG003|Overall Study|Adverse Event|0|||
130146357|NCT01755975|468494413|FG004|Overall Study|Adverse Event|2|||
130146358|NCT01729026|468494417|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
130146359|NCT01729026|468494418|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
130146360|NCT01729026|468494417|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
130146361|NCT01729026|468494418|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
130146362|NCT00852917|468494419|FG000|Overall Study|Adverse Event|13|||
130146363|NCT00852917|468494420|FG001|Overall Study|Adverse Event|20|||
130146364|NCT00852917|468494421|FG002|Overall Study|Adverse Event|35|||
130146365|NCT00852917|468494422|FG003|Overall Study|Adverse Event|17|||
130146366|NCT00852917|468494419|FG000|Overall Study|Lack of Efficacy|21|||
130146367|NCT00852917|468494420|FG001|Overall Study|Lack of Efficacy|11|||
130146368|NCT00852917|468494421|FG002|Overall Study|Lack of Efficacy|11|||
130146369|NCT00852917|468494422|FG003|Overall Study|Lack of Efficacy|47|||
130146370|NCT00852917|468494419|FG000|Overall Study|Withdrawal by Subject|4|||
130146371|NCT00852917|468494420|FG001|Overall Study|Withdrawal by Subject|8|||
130146372|NCT00852917|468494421|FG002|Overall Study|Withdrawal by Subject|10|||
130146373|NCT00852917|468494422|FG003|Overall Study|Withdrawal by Subject|9|||
130146374|NCT00852917|468494419|FG000|Overall Study|Physician Decision|6|||
130146375|NCT00852917|468494420|FG001|Overall Study|Physician Decision|7|||
130146376|NCT00852917|468494421|FG002|Overall Study|Physician Decision|2|||
130146377|NCT00852917|468494422|FG003|Overall Study|Physician Decision|19|||
130146378|NCT00852917|468494419|FG000|Overall Study|Death|0|||
130146379|NCT00852917|468494420|FG001|Overall Study|Death|0|||
130146380|NCT00852917|468494421|FG002|Overall Study|Death|0|||
130146381|NCT00852917|468494422|FG003|Overall Study|Death|1|||
130146382|NCT03710590|468494423|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
130146383|NCT03710590|468494424|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
130146384|NCT02005276|468494427|FG000|Overall Study|No longer interested|5|||
130146385|NCT02005276|468494428|FG001|Overall Study|No longer interested|2|||
130146386|NCT02005276|468494429|FG002|Overall Study|No longer interested|3|||
130146387|NCT02005276|468494430|FG003|Overall Study|No longer interested|3|||
130146388|NCT01849458|468494435|FG000|Overall Study|Lost to Follow-up|4|||
130146389|NCT01115933|468494438|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
130146390|NCT01294449|468494439|FG000|Overall Study|Death|11|||
130146391|NCT01294449|468494440|FG001|Overall Study|Death|12|||
130146392|NCT01294449|468494439|FG000|Overall Study|Withdrawal by Subject|1|||
130146393|NCT01294449|468494440|FG001|Overall Study|Withdrawal by Subject|3|||
130146394|NCT00603512|468494441|FG000|Overall Study|Adverse Event|0|||
130146395|NCT00603512|468494442|FG001|Overall Study|Adverse Event|2|||
130146396|NCT00603512|468494443|FG002|Overall Study|Adverse Event|4|||
130146397|NCT00603512|468494444|FG003|Overall Study|Adverse Event|4|||
130146398|NCT00603512|468494445|FG004|Overall Study|Adverse Event|2|||
130146399|NCT00603512|468494441|FG000|Overall Study|Lack of Efficacy|0|||
130146400|NCT00603512|468494442|FG001|Overall Study|Lack of Efficacy|1|||
130146401|NCT00603512|468494443|FG002|Overall Study|Lack of Efficacy|0|||
130146402|NCT00603512|468494444|FG003|Overall Study|Lack of Efficacy|0|||
130146403|NCT00603512|468494445|FG004|Overall Study|Lack of Efficacy|1|||
129976606|NCT03538938|467877785|FG005|Overall Study|Incarcerated|0|||
129976607|NCT03538938|467877786|FG006|Overall Study|Incarcerated|0|||
129976608|NCT03538938|467877787|FG007|Overall Study|Incarcerated|0|||
129976609|NCT03538938|467877788|FG008|Overall Study|Incarcerated|0|||
129976610|NCT03538938|467877789|FG009|Overall Study|Incarcerated|0|||
129976611|NCT03538938|467877790|FG010|Overall Study|Incarcerated|0|||
129976612|NCT03538938|467877791|FG011|Overall Study|Incarcerated|1|||
129976613|NCT03538938|467877792|FG012|Overall Study|Incarcerated|0|||
129976614|NCT03538938|467877793|FG013|Overall Study|Incarcerated|0|||
129976615|NCT03538938|467877794|FG014|Overall Study|Incarcerated|0|||
129976616|NCT03538938|467877795|FG015|Overall Study|Incarcerated|0|||
129976617|NCT03995316|467877796|FG000|Overall Study|Lost to Follow-up|10|||
129976618|NCT03995316|467877797|FG001|Overall Study|Lost to Follow-up|3|||
129976619|NCT01361594|467877798|FG000|Overall Study|Withdrawal by Subject|1|||
129976620|NCT01361594|467877799|FG001|Overall Study|Withdrawal by Subject|2|||
130146404|NCT00603512|468494441|FG000|Overall Study|Other|2|||
129976621|NCT00780559|467877801|FG000|Overall Study|Lost to Follow-up|2|||
129976622|NCT00780559|467877802|FG001|Overall Study|Lost to Follow-up|7|||
129976623|NCT00780559|467877801|FG000|Overall Study|Death|1|||
130146405|NCT00603512|468494442|FG001|Overall Study|Other|1|||
130146406|NCT00603512|468494443|FG002|Overall Study|Other|0|||
130146407|NCT00603512|468494444|FG003|Overall Study|Other|1|||
129976624|NCT00780559|467877802|FG001|Overall Study|Death|0|||
130146408|NCT00603512|468494445|FG004|Overall Study|Other|1|||
130146409|NCT00603512|468494441|FG000|Overall Study|Withdrawal by Subject|0|||
130146410|NCT00603512|468494442|FG001|Overall Study|Withdrawal by Subject|0|||
130146411|NCT00603512|468494443|FG002|Overall Study|Withdrawal by Subject|0|||
130146412|NCT00603512|468494444|FG003|Overall Study|Withdrawal by Subject|0|||
130146413|NCT00603512|468494445|FG004|Overall Study|Withdrawal by Subject|1|||
130146414|NCT00603512|468494441|FG000|Overall Study|Randomized but not treated|0|||
130146415|NCT00603512|468494442|FG001|Overall Study|Randomized but not treated|1|||
129976625|NCT00839956|467877810|FG000|Overall Study|Adverse Event|2|||
130146416|NCT00603512|468494443|FG002|Overall Study|Randomized but not treated|1|||
130146417|NCT00603512|468494444|FG003|Overall Study|Randomized but not treated|2|||
129976626|NCT00839956|467877810|FG000|Overall Study|Lack of Efficacy|6|||
129976627|NCT00839956|467877810|FG000|Overall Study|Physician Decision|1|||
129976628|NCT00839956|467877810|FG000|Overall Study|Withdrawal by Subject|3|||
129976629|NCT02807883|467877811|FG000|Overall Study|Withdrawal by Subject|2|||
129976630|NCT01399918|467877815|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
129976631|NCT03197766|467877820|FG000|Overall Study|Withdrawal by Subject|2|||
129976632|NCT03197766|467877821|FG001|Overall Study|Withdrawal by Subject|0|||
129976633|NCT00972322|467877823|FG000|Overall Study|Adverse Event|2|||
129976634|NCT00972322|467877824|FG001|Overall Study|Adverse Event|1|||
129976635|NCT00972322|467877823|FG000|Overall Study|Positive drug screen|0|||
129976636|NCT00972322|467877824|FG001|Overall Study|Positive drug screen|1|||
129976637|NCT00972322|467877823|FG000|Overall Study|Lost to Follow-up|0|||
129976638|NCT00972322|467877824|FG001|Overall Study|Lost to Follow-up|1|||
130146418|NCT00603512|468494445|FG004|Overall Study|Randomized but not treated|0|||
130146419|NCT02416934|468494463|FG000|Overall Study|given steroids|1|||
130146420|NCT02416934|468494464|FG001|Overall Study|given steroids|2|||
130146421|NCT02416934|468494463|FG000|Overall Study|Lost to Follow-up|0|||
130146422|NCT02416934|468494464|FG001|Overall Study|Lost to Follow-up|2|||
130146423|NCT02416934|468494463|FG000|Overall Study|Withdrawal by Subject|1|||
130146424|NCT02416934|468494464|FG001|Overall Study|Withdrawal by Subject|0|||
130146425|NCT02416934|468494463|FG000|Overall Study|recruited during continuing renewal proc|0|||
130146426|NCT02416934|468494464|FG001|Overall Study|recruited during continuing renewal proc|1|||
130146427|NCT02416934|468494463|FG000|Overall Study|Protocol Violation|0|||
130146428|NCT02416934|468494464|FG001|Overall Study|Protocol Violation|1|||
130146429|NCT02416934|468494463|FG000|Overall Study|surgery started late|0|||
130146430|NCT02416934|468494464|FG001|Overall Study|surgery started late|1|||
130146431|NCT02416934|468494463|FG000|Overall Study|re-operation|1|||
130146432|NCT02416934|468494464|FG001|Overall Study|re-operation|0|||
130146433|NCT01020526|468494465|FG000|Overall Study|Withdrawal by Subject|5|||
130146434|NCT01020526|468494465|FG000|Overall Study|Other reasons|3|||
130146435|NCT01020526|468494465|FG000|Overall Study|Insufficient clinical response|3|||
130146436|NCT01020526|468494465|FG000|Overall Study|Lost to Follow-up|1|||
130146437|NCT01020526|468494465|FG000|Overall Study|Adverse Event|2|||
130146438|NCT00398073|468494466|FG000|Overall Study|Withdrawal by Subject|1|||
130146439|NCT00398073|468494467|FG001|Overall Study|Withdrawal by Subject|0|||
130146440|NCT00105157|468494472|FG000|Double-Blind (DB)|Never Treated|1|||
130146441|NCT00105157|468494473|FG001|Double-Blind (DB)|Never Treated|0|||
130146442|NCT00105157|468494474|FG002|Double-Blind (DB)|Never Treated|0|||
130146443|NCT00105157|468494475|FG003|Double-Blind (DB)|Never Treated|0|||
130146444|NCT00105157|468494472|FG000|Double-Blind (DB)|Adverse Event|2|||
130146445|NCT00105157|468494473|FG001|Double-Blind (DB)|Adverse Event|0|||
130146446|NCT00105157|468494474|FG002|Double-Blind (DB)|Adverse Event|1|||
130146447|NCT00105157|468494475|FG003|Double-Blind (DB)|Adverse Event|1|||
130146448|NCT00105157|468494472|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
130146449|NCT00105157|468494473|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
130146450|NCT00105157|468494474|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
130146451|NCT00105157|468494475|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
130146452|NCT00105157|468494472|FG000|Open-Label Continuation of DB|Adverse Event|3|||
130146453|NCT00105157|468494473|FG001|Open-Label Continuation of DB|Adverse Event|1|||
130146454|NCT00105157|468494474|FG002|Open-Label Continuation of DB|Adverse Event|0|||
130146455|NCT00105157|468494475|FG003|Open-Label Continuation of DB|Adverse Event|0|||
130146456|NCT00105157|468494472|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
130146457|NCT00105157|468494473|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
130146458|NCT00105157|468494474|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
130146459|NCT00105157|468494475|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
130146460|NCT00105157|468494472|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
130146461|NCT00105157|468494473|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
130146462|NCT00105157|468494474|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
130146463|NCT00105157|468494475|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
130146464|NCT00105157|468494472|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
130146465|NCT00105157|468494473|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
130146466|NCT00105157|468494474|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
130146467|NCT00105157|468494475|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
129976639|NCT00972322|467877823|FG000|Overall Study|Consistently high glucose values|1|||
129976640|NCT00972322|467877824|FG001|Overall Study|Consistently high glucose values|0|||
130146468|NCT00105157|468494472|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
130146469|NCT00105157|468494473|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129976641|NCT00277095|467877827|FG000|Overall Study|Death|2|||
129976642|NCT00277095|467877827|FG000|Overall Study|Explanted|7|||
129976643|NCT00277095|467877827|FG000|Overall Study|Lost to Follow-up|2|||
129976644|NCT00277095|467877827|FG000|Overall Study|Missed Follow-up|9|||
129976645|NCT00277095|467877827|FG000|Overall Study|Physician Decision|1|||
130146470|NCT00105157|468494474|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130146471|NCT00105157|468494475|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
130146472|NCT00105157|468494472|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
130146473|NCT00105157|468494473|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
130146474|NCT00105157|468494474|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
130146475|NCT00105157|468494475|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
130146476|NCT00105157|468494472|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130146477|NCT00105157|468494473|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130146478|NCT00105157|468494474|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
130146479|NCT00105157|468494475|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
130146480|NCT00105157|468494472|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
130146481|NCT00105157|468494473|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
130146482|NCT00105157|468494474|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
130146483|NCT00105157|468494475|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
130146484|NCT00105157|468494472|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
130146485|NCT00105157|468494473|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
130146486|NCT00105157|468494474|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
130146487|NCT00105157|468494475|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
130146488|NCT00105157|468494472|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130146489|NCT00105157|468494473|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130146490|NCT00105157|468494474|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
130146491|NCT00105157|468494475|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
130146492|NCT00105157|468494472|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130146493|NCT00105157|468494473|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
130146494|NCT00105157|468494474|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130146495|NCT00105157|468494475|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
130146496|NCT02169336|468494480|FG000|Overall Study|Lack of Efficacy|1|||
130146497|NCT02169336|468494481|FG001|Overall Study|Lack of Efficacy|1|||
130146498|NCT02169336|468494482|FG002|Overall Study|Lack of Efficacy|0|||
130146499|NCT02169336|468494480|FG000|Overall Study|Adverse Event|2|||
130146500|NCT02169336|468494481|FG001|Overall Study|Adverse Event|3|||
130146501|NCT02169336|468494482|FG002|Overall Study|Adverse Event|1|||
130146502|NCT02169336|468494480|FG000|Overall Study|Withdrawal by Subject|1|||
130146503|NCT02169336|468494481|FG001|Overall Study|Withdrawal by Subject|0|||
130146504|NCT02169336|468494482|FG002|Overall Study|Withdrawal by Subject|0|||
130146505|NCT02169336|468494480|FG000|Overall Study|Physician Decision|0|||
130146506|NCT02169336|468494481|FG001|Overall Study|Physician Decision|0|||
130146507|NCT02169336|468494482|FG002|Overall Study|Physician Decision|1|||
130146508|NCT02169336|468494480|FG000|Overall Study|Subject declined to continue dosing|0|||
130146509|NCT02169336|468494481|FG001|Overall Study|Subject declined to continue dosing|0|||
130146510|NCT02169336|468494482|FG002|Overall Study|Subject declined to continue dosing|1|||
130146511|NCT01148225|468494483|FG000|Overall Study|Other|185|||
130146512|NCT02212457|468494484|FG000|Overall Study|Adverse Event|1|||
130146513|NCT02212457|468494485|FG001|Overall Study|Adverse Event|2|||
130146514|NCT02212457|468494486|FG002|Overall Study|Adverse Event|2|||
130146515|NCT02212457|468494487|FG003|Overall Study|Adverse Event|2|||
130146516|NCT02212457|468494488|FG004|Overall Study|Adverse Event|0|||
130146517|NCT02212457|468494489|FG005|Overall Study|Adverse Event|1|||
130146518|NCT02212457|468494484|FG000|Overall Study|Withdrawal by Subject|8|||
130146519|NCT02212457|468494485|FG001|Overall Study|Withdrawal by Subject|10|||
130146520|NCT02212457|468494486|FG002|Overall Study|Withdrawal by Subject|8|||
130146521|NCT02212457|468494487|FG003|Overall Study|Withdrawal by Subject|6|||
130146522|NCT02212457|468494488|FG004|Overall Study|Withdrawal by Subject|5|||
130146523|NCT02212457|468494489|FG005|Overall Study|Withdrawal by Subject|4|||
130146524|NCT02212457|468494484|FG000|Overall Study|Lost to Follow-up|6|||
130146525|NCT02212457|468494485|FG001|Overall Study|Lost to Follow-up|7|||
130146526|NCT02212457|468494486|FG002|Overall Study|Lost to Follow-up|4|||
130146527|NCT02212457|468494487|FG003|Overall Study|Lost to Follow-up|1|||
129976646|NCT05140915|467877829|FG000|Overall Study|Lost to Follow-up|2|||
130146528|NCT02212457|468494488|FG004|Overall Study|Lost to Follow-up|8|||
130146529|NCT02212457|468494489|FG005|Overall Study|Lost to Follow-up|4|||
130146530|NCT02212457|468494484|FG000|Overall Study|Protocol Violation|2|||
130146531|NCT02212457|468494485|FG001|Overall Study|Protocol Violation|1|||
130146532|NCT02212457|468494486|FG002|Overall Study|Protocol Violation|0|||
130146533|NCT02212457|468494487|FG003|Overall Study|Protocol Violation|1|||
130146534|NCT02212457|468494488|FG004|Overall Study|Protocol Violation|2|||
130146535|NCT02212457|468494489|FG005|Overall Study|Protocol Violation|3|||
130146536|NCT02212457|468494484|FG000|Overall Study|Other|2|||
130146537|NCT02212457|468494485|FG001|Overall Study|Other|1|||
130146538|NCT02212457|468494486|FG002|Overall Study|Other|2|||
130146539|NCT02212457|468494487|FG003|Overall Study|Other|1|||
130146540|NCT02212457|468494488|FG004|Overall Study|Other|0|||
130146541|NCT02212457|468494489|FG005|Overall Study|Other|1|||
130146542|NCT02490800|468494490|FG000|Overall Study|Adverse Event|0|||
130146543|NCT02490800|468494491|FG001|Overall Study|Adverse Event|0|||
130146544|NCT02490800|468494492|FG002|Overall Study|Adverse Event|0|||
130146545|NCT02490800|468494493|FG003|Overall Study|Adverse Event|2|||
130146546|NCT02490800|468494494|FG004|Overall Study|Adverse Event|3|||
130146547|NCT02490800|468494495|FG005|Overall Study|Adverse Event|2|||
130146548|NCT02490800|468494496|FG006|Overall Study|Adverse Event|0|||
130146549|NCT02490800|468494497|FG007|Overall Study|Adverse Event|0|||
130146550|NCT02490800|468494498|FG008|Overall Study|Adverse Event|0|||
130146551|NCT02490800|468494499|FG009|Overall Study|Adverse Event|0|||
130146552|NCT02490800|468494500|FG010|Overall Study|Adverse Event|0|||
130146553|NCT02490800|468494501|FG011|Overall Study|Adverse Event|2|||
130146554|NCT02490800|468494502|FG012|Overall Study|Adverse Event|2|||
130146555|NCT02490800|468494490|FG000|Overall Study|Withdrawal by Subject|0|||
130146556|NCT02490800|468494491|FG001|Overall Study|Withdrawal by Subject|0|||
130146557|NCT02490800|468494492|FG002|Overall Study|Withdrawal by Subject|0|||
130146558|NCT02490800|468494493|FG003|Overall Study|Withdrawal by Subject|1|||
130146559|NCT02490800|468494494|FG004|Overall Study|Withdrawal by Subject|0|||
130146560|NCT02490800|468494495|FG005|Overall Study|Withdrawal by Subject|0|||
130146561|NCT02490800|468494496|FG006|Overall Study|Withdrawal by Subject|0|||
130146562|NCT02490800|468494497|FG007|Overall Study|Withdrawal by Subject|0|||
130146563|NCT02490800|468494498|FG008|Overall Study|Withdrawal by Subject|1|||
130146564|NCT02490800|468494499|FG009|Overall Study|Withdrawal by Subject|0|||
130146565|NCT02490800|468494500|FG010|Overall Study|Withdrawal by Subject|0|||
130146566|NCT02490800|468494501|FG011|Overall Study|Withdrawal by Subject|0|||
130146567|NCT02490800|468494502|FG012|Overall Study|Withdrawal by Subject|0|||
130146568|NCT02490800|468494490|FG000|Overall Study|Progressive disease|3|||
130146569|NCT02490800|468494491|FG001|Overall Study|Progressive disease|3|||
130146570|NCT02490800|468494492|FG002|Overall Study|Progressive disease|3|||
130146571|NCT02490800|468494493|FG003|Overall Study|Progressive disease|4|||
130146572|NCT02490800|468494494|FG004|Overall Study|Progressive disease|4|||
130146573|NCT02490800|468494495|FG005|Overall Study|Progressive disease|1|||
130146574|NCT02490800|468494496|FG006|Overall Study|Progressive disease|4|||
130146575|NCT02490800|468494497|FG007|Overall Study|Progressive disease|3|||
130146576|NCT02490800|468494498|FG008|Overall Study|Progressive disease|6|||
130146577|NCT02490800|468494499|FG009|Overall Study|Progressive disease|2|||
130146578|NCT02490800|468494500|FG010|Overall Study|Progressive disease|7|||
130146579|NCT02490800|468494501|FG011|Overall Study|Progressive disease|1|||
130146580|NCT02490800|468494502|FG012|Overall Study|Progressive disease|10|||
130146581|NCT02490800|468494490|FG000|Overall Study|Patient enrolled in post-trial access|0|||
130146582|NCT02490800|468494491|FG001|Overall Study|Patient enrolled in post-trial access|0|||
130146583|NCT02490800|468494492|FG002|Overall Study|Patient enrolled in post-trial access|0|||
130146584|NCT02490800|468494493|FG003|Overall Study|Patient enrolled in post-trial access|0|||
130146585|NCT02490800|468494494|FG004|Overall Study|Patient enrolled in post-trial access|0|||
130146586|NCT02490800|468494495|FG005|Overall Study|Patient enrolled in post-trial access|0|||
130146587|NCT02490800|468494496|FG006|Overall Study|Patient enrolled in post-trial access|0|||
130146588|NCT02490800|468494497|FG007|Overall Study|Patient enrolled in post-trial access|0|||
130146589|NCT02490800|468494498|FG008|Overall Study|Patient enrolled in post-trial access|0|||
130146590|NCT02490800|468494499|FG009|Overall Study|Patient enrolled in post-trial access|1|||
130146591|NCT02490800|468494500|FG010|Overall Study|Patient enrolled in post-trial access|1|||
130146592|NCT02490800|468494501|FG011|Overall Study|Patient enrolled in post-trial access|0|||
130146593|NCT02490800|468494502|FG012|Overall Study|Patient enrolled in post-trial access|6|||
130146594|NCT00654641|468494504|FG000|Overall Study|Lost to Follow-up|2|||
130146595|NCT00654641|468494505|FG001|Overall Study|Lost to Follow-up|3|||
130146596|NCT01337596|468494506|FG000|Overall Study|Withdrawal by Subject|0|||
130146597|NCT01337596|468494507|FG001|Overall Study|Withdrawal by Subject|0|||
130146598|NCT01337596|468494508|FG002|Overall Study|Withdrawal by Subject|0|||
130146599|NCT01337596|468494509|FG003|Overall Study|Withdrawal by Subject|0|||
130146600|NCT01337596|468494510|FG004|Overall Study|Withdrawal by Subject|2|||
130146601|NCT01337596|468494511|FG005|Overall Study|Withdrawal by Subject|0|||
130146602|NCT01337596|468494512|FG006|Overall Study|Withdrawal by Subject|0|||
130146603|NCT01337596|468494513|FG007|Overall Study|Withdrawal by Subject|0|||
130146604|NCT01337596|468494514|FG008|Overall Study|Withdrawal by Subject|0|||
130146605|NCT03693950|468494515|FG000|Overall Study|Withdrawal by Subject|1|||
130146606|NCT03693950|468494516|FG001|Overall Study|Withdrawal by Subject|0|||
130146607|NCT01636934|468495834|FG000|Overall Study|Withdrawal by Subject|3|||
130146608|NCT01636934|468495835|FG001|Overall Study|Withdrawal by Subject|2|||
130146609|NCT01636934|468495834|FG000|Overall Study|Chemo cancel|1|||
130146610|NCT01636934|468495835|FG001|Overall Study|Chemo cancel|0|||
130146611|NCT01636934|468495834|FG000|Overall Study|Too ill to continue|1|||
130146612|NCT01636934|468495835|FG001|Overall Study|Too ill to continue|0|||
130146613|NCT01636934|468495834|FG000|Overall Study|Never started study medication|1|||
130146614|NCT01636934|468495835|FG001|Overall Study|Never started study medication|1|||
130146615|NCT01011335|468495836|FG000|Overall Study|Lost to Follow-up|0|||
130146616|NCT01011335|468495837|FG001|Overall Study|Lost to Follow-up|0|||
130146617|NCT01011335|468495838|FG002|Overall Study|Lost to Follow-up|1|||
130146618|NCT01011335|468495839|FG003|Overall Study|Lost to Follow-up|1|||
130146619|NCT01011335|468495840|FG004|Overall Study|Lost to Follow-up|1|||
130146620|NCT01011335|468495841|FG005|Overall Study|Lost to Follow-up|1|||
130146621|NCT01011335|468495842|FG006|Overall Study|Lost to Follow-up|2|||
130146622|NCT01011335|468495843|FG007|Overall Study|Lost to Follow-up|2|||
130146623|NCT01011335|468495844|FG008|Overall Study|Lost to Follow-up|1|||
130146624|NCT01011335|468495845|FG009|Overall Study|Lost to Follow-up|0|||
130146625|NCT01011335|468495846|FG010|Overall Study|Lost to Follow-up|0|||
130146626|NCT01011335|468495847|FG011|Overall Study|Lost to Follow-up|1|||
130146627|NCT01011335|468495848|FG012|Overall Study|Lost to Follow-up|2|||
130146628|NCT01011335|468495836|FG000|Overall Study|Protocol Violation|0|||
130146629|NCT01011335|468495837|FG001|Overall Study|Protocol Violation|1|||
130146630|NCT01011335|468495838|FG002|Overall Study|Protocol Violation|0|||
130146631|NCT01011335|468495839|FG003|Overall Study|Protocol Violation|0|||
130146632|NCT01011335|468495840|FG004|Overall Study|Protocol Violation|0|||
130146633|NCT01011335|468495841|FG005|Overall Study|Protocol Violation|0|||
130146634|NCT01011335|468495842|FG006|Overall Study|Protocol Violation|0|||
130146635|NCT01011335|468495843|FG007|Overall Study|Protocol Violation|0|||
130146636|NCT01011335|468495844|FG008|Overall Study|Protocol Violation|0|||
130146637|NCT01011335|468495845|FG009|Overall Study|Protocol Violation|0|||
130146638|NCT01011335|468495846|FG010|Overall Study|Protocol Violation|0|||
130146639|NCT01011335|468495847|FG011|Overall Study|Protocol Violation|0|||
130146640|NCT01011335|468495848|FG012|Overall Study|Protocol Violation|0|||
130146641|NCT01011335|468495836|FG000|Overall Study|Moved/deployed or no booster|1|||
130146642|NCT01011335|468495837|FG001|Overall Study|Moved/deployed or no booster|0|||
130146643|NCT01011335|468495838|FG002|Overall Study|Moved/deployed or no booster|0|||
130146644|NCT01011335|468495839|FG003|Overall Study|Moved/deployed or no booster|1|||
130146645|NCT01011335|468495840|FG004|Overall Study|Moved/deployed or no booster|0|||
130146646|NCT01011335|468495841|FG005|Overall Study|Moved/deployed or no booster|0|||
130146647|NCT01011335|468495842|FG006|Overall Study|Moved/deployed or no booster|1|||
130146648|NCT01011335|468495843|FG007|Overall Study|Moved/deployed or no booster|0|||
130146649|NCT01011335|468495844|FG008|Overall Study|Moved/deployed or no booster|1|||
130146650|NCT01011335|468495845|FG009|Overall Study|Moved/deployed or no booster|0|||
130146651|NCT01011335|468495846|FG010|Overall Study|Moved/deployed or no booster|2|||
130146652|NCT01011335|468495847|FG011|Overall Study|Moved/deployed or no booster|0|||
130146653|NCT01011335|468495848|FG012|Overall Study|Moved/deployed or no booster|0|||
130146654|NCT01011335|468495836|FG000|Overall Study|Adverse Event|0|||
130146655|NCT01011335|468495837|FG001|Overall Study|Adverse Event|0|||
130146656|NCT01011335|468495838|FG002|Overall Study|Adverse Event|0|||
130146657|NCT01011335|468495839|FG003|Overall Study|Adverse Event|0|||
130146658|NCT01011335|468495840|FG004|Overall Study|Adverse Event|0|||
130146659|NCT01011335|468495841|FG005|Overall Study|Adverse Event|0|||
130146660|NCT01011335|468495842|FG006|Overall Study|Adverse Event|0|||
130146661|NCT01011335|468495843|FG007|Overall Study|Adverse Event|0|||
130146662|NCT01011335|468495844|FG008|Overall Study|Adverse Event|0|||
130146663|NCT01011335|468495845|FG009|Overall Study|Adverse Event|0|||
130146664|NCT01011335|468495846|FG010|Overall Study|Adverse Event|4|||
130146665|NCT01011335|468495847|FG011|Overall Study|Adverse Event|0|||
130146666|NCT01011335|468495848|FG012|Overall Study|Adverse Event|1|||
130146667|NCT02415387|468495858|FG000|Overall Study|Withdrawal by Subject|6|||
130146668|NCT02415387|468495859|FG001|Overall Study|Withdrawal by Subject|1|||
130146669|NCT02415387|468495858|FG000|Overall Study|blood draw problem|0|||
130146670|NCT02415387|468495859|FG001|Overall Study|blood draw problem|1|||
130146671|NCT02415387|468495858|FG000|Overall Study|Protocol Violation|1|||
130146672|NCT02415387|468495859|FG001|Overall Study|Protocol Violation|0|||
130146673|NCT01765751|468495868|FG000|Overall Study|Lost to Follow-up|0|||
130146674|NCT01765751|468495869|FG001|Overall Study|Lost to Follow-up|2|||
130146675|NCT01765751|468495870|FG002|Overall Study|Lost to Follow-up|1|||
130146676|NCT03429049|468495875|FG000|Overall Study|Adverse Event|2|||
130146677|NCT03429049|468495876|FG001|Overall Study|Adverse Event|3|||
130146678|NCT03429049|468495875|FG000|Overall Study|Death|0|||
130146679|NCT03429049|468495876|FG001|Overall Study|Death|1|||
130146680|NCT03429049|468495875|FG000|Overall Study|Lack of Efficacy|4|||
130146681|NCT03429049|468495876|FG001|Overall Study|Lack of Efficacy|2|||
129976647|NCT05140915|467877830|FG001|Overall Study|Lost to Follow-up|1|||
129976648|NCT04520659|467877831|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
129976649|NCT04520659|467877832|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
129976650|NCT04520659|467877833|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
129976651|NCT04520659|467877834|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
129976652|NCT04879849|467877839|FG000|Overall Study|Lost to Follow-up|0|||
130146682|NCT03429049|468495875|FG000|Overall Study|Lost to Follow-up|9|||
130146683|NCT03429049|468495876|FG001|Overall Study|Lost to Follow-up|8|||
130146684|NCT03429049|468495875|FG000|Overall Study|Physician Decision|1|||
130146685|NCT03429049|468495876|FG001|Overall Study|Physician Decision|0|||
130146686|NCT03429049|468495875|FG000|Overall Study|Protocol Violation|3|||
130146687|NCT03429049|468495876|FG001|Overall Study|Protocol Violation|0|||
130146688|NCT03429049|468495875|FG000|Overall Study|Sponsor Decision|2|||
130146689|NCT03429049|468495876|FG001|Overall Study|Sponsor Decision|0|||
130146690|NCT03429049|468495875|FG000|Overall Study|Withdrawal by Subject|4|||
130146691|NCT03429049|468495876|FG001|Overall Study|Withdrawal by Subject|20|||
129976653|NCT04879849|467877840|FG001|Overall Study|Lost to Follow-up|0|||
129976654|NCT04879849|467877841|FG002|Overall Study|Lost to Follow-up|0|||
129976655|NCT04879849|467877842|FG003|Overall Study|Lost to Follow-up|1|||
129976656|NCT04879849|467877843|FG004|Overall Study|Lost to Follow-up|0|||
130146692|NCT03429049|468495875|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
130146693|NCT03429049|468495876|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
130146694|NCT02459418|468495880|FG000|Overall Study|Exclusion Criteria|4|||
130146695|NCT02459418|468495881|FG001|Overall Study|Exclusion Criteria|0|||
130146696|NCT02459418|468495880|FG000|Overall Study|Protocol Violation|0|||
130146697|NCT02459418|468495881|FG001|Overall Study|Protocol Violation|2|||
130146698|NCT02459418|468495880|FG000|Overall Study|Physician Decision|0|||
130146699|NCT02459418|468495881|FG001|Overall Study|Physician Decision|2|||
130146700|NCT02459418|468495880|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
130146701|NCT02459418|468495881|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
130146702|NCT02459418|468495880|FG000|Overall Study|Adverse Event|0|||
130146703|NCT02459418|468495881|FG001|Overall Study|Adverse Event|1|||
130146704|NCT02459418|468495880|FG000|Overall Study|Withdrawal by Subject|1|||
130146705|NCT02459418|468495881|FG001|Overall Study|Withdrawal by Subject|1|||
130146706|NCT02459418|468495880|FG000|Overall Study|Elevated Creatine Kinase|1|||
130146707|NCT02459418|468495881|FG001|Overall Study|Elevated Creatine Kinase|0|||
130146708|NCT02459418|468495880|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
130146709|NCT02459418|468495881|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
130146710|NCT01872715|468495882|FG000|Overall Study|Adverse Event|1|||
130146711|NCT01872715|468495882|FG000|Overall Study|Protocol Violation|1|||
130146712|NCT01872715|468495882|FG000|Overall Study|Withdrawal by Subject|2|||
130146713|NCT03303417|468495883|FG000|Overall Study|Withdrawal by Subject|1|||
130146714|NCT03303417|468495884|FG001|Overall Study|Withdrawal by Subject|1|||
130146715|NCT03619876|468495887|FG000|Overall Study|Withdrawal by Subject|1|||
130146716|NCT03619876|468495888|FG001|Overall Study|Withdrawal by Subject|2|||
130146717|NCT03619876|468495887|FG000|Overall Study|Withdrawal due to incidental finding|0|||
130146718|NCT03619876|468495888|FG001|Overall Study|Withdrawal due to incidental finding|2|||
130146719|NCT00835796|468495892|FG000|First Intervention|Withdrawal by Subject|0|||
130146720|NCT00835796|468495893|FG001|First Intervention|Withdrawal by Subject|1|||
130146721|NCT00651183|468495896|FG000|Overall Study|Lack of Efficacy|1|||
130146722|NCT00651183|468495897|FG001|Overall Study|Lack of Efficacy|0|||
130146723|NCT00651183|468495896|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
130146724|NCT00651183|468495897|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
130146725|NCT00651183|468495896|FG000|Overall Study|Tolerability insufficient|5|||
130146726|NCT00651183|468495897|FG001|Overall Study|Tolerability insufficient|2|||
130146727|NCT00651183|468495896|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
130146728|NCT00651183|468495897|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
130146729|NCT00651183|468495896|FG000|Overall Study|Withdrawal by Subject|6|||
130146730|NCT00651183|468495897|FG001|Overall Study|Withdrawal by Subject|3|||
130146731|NCT00651183|468495896|FG000|Overall Study|Lost to Follow-up|3|||
130146732|NCT00651183|468495897|FG001|Overall Study|Lost to Follow-up|1|||
130146733|NCT00651183|468495896|FG000|Overall Study|Other reasons|4|||
130146734|NCT00651183|468495897|FG001|Overall Study|Other reasons|2|||
130146735|NCT00651183|468495896|FG000|Overall Study|missing|1|||
130146736|NCT00651183|468495897|FG001|Overall Study|missing|0|||
130146737|NCT03330236|468495901|FG000|Overall Study|Death|2|||
130146738|NCT03330236|468495902|FG001|Overall Study|Death|1|||
130146739|NCT03330236|468495901|FG000|Overall Study|Withdrawal by Subject|2|||
130146740|NCT03330236|468495902|FG001|Overall Study|Withdrawal by Subject|4|||
130146741|NCT03330236|468495901|FG000|Overall Study|Lost to Follow-up|0|||
130146742|NCT03330236|468495902|FG001|Overall Study|Lost to Follow-up|2|||
130146743|NCT03330236|468495901|FG000|Overall Study|Physician Decision|2|||
130146744|NCT03330236|468495902|FG001|Overall Study|Physician Decision|0|||
130146745|NCT03330236|468495901|FG000|Overall Study|Protocol Violation|4|||
130146746|NCT03330236|468495902|FG001|Overall Study|Protocol Violation|3|||
130146747|NCT03330236|468495901|FG000|Overall Study|SedLine malfunction/blinding|19|||
130146748|NCT03330236|468495902|FG001|Overall Study|SedLine malfunction/blinding|14|||
130146749|NCT03330236|468495901|FG000|Overall Study|Volatile anesthetics used|11|||
130146750|NCT03330236|468495902|FG001|Overall Study|Volatile anesthetics used|8|||
130146751|NCT03330236|468495901|FG000|Overall Study|Surgery aborted/converted to open|60|||
130146752|NCT03330236|468495902|FG001|Overall Study|Surgery aborted/converted to open|52|||
130146753|NCT01901848|468495903|FG000|Randomized and Treated|Lost to Follow-up|3|||
130146754|NCT01901848|468495904|FG001|Randomized and Treated|Lost to Follow-up|6|||
130146755|NCT01901848|468495903|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
130146756|NCT01901848|468495904|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
130146757|NCT00763555|468495905|FG000|Overall Study|Adverse Event|2|||
130146758|NCT00763555|468495906|FG001|Overall Study|Adverse Event|1|||
130146759|NCT00763555|468495905|FG000|Overall Study|Withdrawal by Subject|2|||
129976657|NCT04879849|467877844|FG005|Overall Study|Lost to Follow-up|0|||
129976658|NCT04879849|467877845|FG006|Overall Study|Lost to Follow-up|0|||
129976659|NCT04879849|467877846|FG007|Overall Study|Lost to Follow-up|0|||
130146760|NCT00763555|468495906|FG001|Overall Study|Withdrawal by Subject|6|||
130146761|NCT00763555|468495905|FG000|Overall Study|Lost to Follow-up|0|||
130146762|NCT00763555|468495906|FG001|Overall Study|Lost to Follow-up|3|||
130146763|NCT02488824|468495907|FG000|Overall Study|Adverse Event|1|||
130146764|NCT02488824|468495908|FG001|Overall Study|Adverse Event|1|||
130146765|NCT01201759|468495910|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
130146766|NCT01201759|468495911|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
130146767|NCT01201759|468495910|FG000|Visit 3 - Washout|Adverse Event|0|||
130146768|NCT01201759|468495911|FG001|Visit 3 - Washout|Adverse Event|3|||
130146769|NCT01201759|468495910|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
130146770|NCT01201759|468495911|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
130146771|NCT01201759|468495910|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
130146772|NCT01201759|468495911|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
130146773|NCT00848042|468495912|FG000|Overall Study|Death|1|||
130146774|NCT00848042|468495913|FG001|Overall Study|Death|2|||
130146775|NCT00848042|468495914|FG002|Overall Study|Death|0|||
130146776|NCT00848042|468495912|FG000|Overall Study|Other Therapy|3|||
130146777|NCT00848042|468495913|FG001|Overall Study|Other Therapy|0|||
130146778|NCT00848042|468495914|FG002|Overall Study|Other Therapy|0|||
130146779|NCT00979212|468495917|FG000|Overall Study|Protocol Violation|1|||
130146780|NCT00979212|468495918|FG001|Overall Study|Protocol Violation|8|||
130146781|NCT00979212|468495917|FG000|Overall Study|No protocol therapy received|1|||
130146782|NCT00979212|468495918|FG001|Overall Study|No protocol therapy received|0|||
130146783|NCT02448563|468495925|FG000|Overall Study|Lost to Follow-up|16|||
130146784|NCT02448563|468495926|FG001|Overall Study|Lost to Follow-up|10|||
130146785|NCT02448563|468495925|FG000|Overall Study|Withdrawal by Subject|0|||
130146786|NCT02448563|468495926|FG001|Overall Study|Withdrawal by Subject|1|||
130146787|NCT02340962|468495927|FG000|Overall Study|Lost to Follow-up|1|||
130146788|NCT02340962|468495928|FG001|Overall Study|Lost to Follow-up|0|||
130146789|NCT02174276|468495929|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
130146790|NCT02174276|468495930|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130146791|NCT02174276|468495931|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130146792|NCT02174276|468495932|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
130146793|NCT02174276|468495929|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130146794|NCT02174276|468495930|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130146795|NCT02174276|468495931|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
130146796|NCT02174276|468495932|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
130146797|NCT02174276|468495929|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
130146798|NCT02174276|468495930|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
130146799|NCT02174276|468495931|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
130146800|NCT02174276|468495932|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
130146801|NCT02174276|468495929|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130146802|NCT02174276|468495930|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130146803|NCT02174276|468495931|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
130146804|NCT02174276|468495932|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
130146805|NCT02174276|468495929|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130146806|NCT02174276|468495930|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130146807|NCT02174276|468495931|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
130146808|NCT02174276|468495932|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
130146809|NCT02174276|468495929|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
130146810|NCT02174276|468495930|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
130146811|NCT02174276|468495931|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
130146812|NCT02174276|468495932|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
130146813|NCT00434837|468495940|FG000|Overall Study|Lost to Follow-up|20|||
130146814|NCT00434837|468495941|FG001|Overall Study|Lost to Follow-up|23|||
130146815|NCT00434837|468495942|FG002|Overall Study|Lost to Follow-up|30|||
130146816|NCT00515216|468495943|FG000|Overall Study|Withdrawal by Subject|1|||
130146817|NCT02786927|468495945|FG000|Overall Study|Adverse Event|1|||
130146818|NCT02786927|468495945|FG000|Overall Study|Protocol Violation|4|||
130146819|NCT01801917|468495946|FG000|Period 1 - Randomized|Adverse Event|1|||
130146820|NCT01801917|468495947|FG001|Period 1 - Randomized|Adverse Event|0|||
130146821|NCT01801917|468495948|FG002|Period 1 - Randomized|Adverse Event|1|||
130146822|NCT01801917|468495949|FG003|Period 1 - Randomized|Adverse Event|0|||
130146823|NCT04307849|468495950|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130146824|NCT04307849|468495951|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130146825|NCT04307849|468495952|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
130146826|NCT04307849|468495953|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
130146827|NCT04307849|468495954|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
130146828|NCT04307849|468495955|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
130146829|NCT04307849|468495950|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130146830|NCT04307849|468495951|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130146831|NCT04307849|468495952|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
130146832|NCT04307849|468495953|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130146833|NCT04307849|468495954|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130146834|NCT04307849|468495955|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
130146835|NCT04307849|468495950|FG000|Overall Study|Family member did not want them to continue|0|||
130146836|NCT04307849|468495951|FG001|Overall Study|Family member did not want them to continue|0|||
130146837|NCT04307849|468495952|FG002|Overall Study|Family member did not want them to continue|1|||
130146838|NCT04307849|468495953|FG003|Overall Study|Family member did not want them to continue|0|||
130146839|NCT04307849|468495954|FG004|Overall Study|Family member did not want them to continue|0|||
129976660|NCT04879849|467877839|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
129976661|NCT04879849|467877840|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
129976662|NCT04879849|467877841|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
129976663|NCT04879849|467877842|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
129976664|NCT04879849|467877843|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
129976665|NCT04879849|467877844|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
129976666|NCT04879849|467877845|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
129976667|NCT04879849|467877846|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
129976668|NCT04879849|467877839|FG000|Overall Study|Withdrawal by Subject|0|||
129976669|NCT04879849|467877840|FG001|Overall Study|Withdrawal by Subject|0|||
129976670|NCT04879849|467877841|FG002|Overall Study|Withdrawal by Subject|0|||
129976671|NCT04879849|467877842|FG003|Overall Study|Withdrawal by Subject|0|||
129976672|NCT04879849|467877843|FG004|Overall Study|Withdrawal by Subject|2|||
129976673|NCT04879849|467877844|FG005|Overall Study|Withdrawal by Subject|0|||
129976674|NCT04879849|467877845|FG006|Overall Study|Withdrawal by Subject|1|||
129976675|NCT04879849|467877846|FG007|Overall Study|Withdrawal by Subject|0|||
129976676|NCT04879849|467877839|FG000|Overall Study|Progressive Disease|0|||
129976677|NCT04879849|467877840|FG001|Overall Study|Progressive Disease|0|||
130146840|NCT04307849|468495955|FG005|Overall Study|Family member did not want them to continue|0|||
130146841|NCT04307849|468495950|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
130146842|NCT04307849|468495951|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
130146843|NCT04307849|468495952|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
130146844|NCT04307849|468495953|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
130146845|NCT04307849|468495954|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
130146846|NCT04307849|468495955|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
130146847|NCT05467982|468495958|FG000|Overall Study|Death|0|||
130146848|NCT05467982|468495959|FG001|Overall Study|Death|1|||
130146849|NCT05467982|468495958|FG000|Overall Study|Lost to Follow-up|3|||
130146850|NCT05467982|468495959|FG001|Overall Study|Lost to Follow-up|1|||
130146851|NCT01833169|468495963|FG000|Overall Study|Disease Progression|99|||
130146852|NCT01833169|468495963|FG000|Overall Study|Adverse Event|33|||
130146853|NCT01833169|468495963|FG000|Overall Study|Withdrawal by Subject|9|||
130146854|NCT01833169|468495963|FG000|Overall Study|Death|3|||
130146855|NCT01833169|468495963|FG000|Overall Study|Physician Decision|2|||
130146856|NCT00879684|468495967|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
130146857|NCT00879684|468495968|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
130146858|NCT00879684|468495969|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
130146859|NCT00879684|468495970|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
130146860|NCT00879684|468495971|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
130146861|NCT00879684|468495972|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
130146862|NCT00879684|468495973|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
130146863|NCT00879684|468495967|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
130146864|NCT00879684|468495968|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
130146865|NCT00879684|468495969|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
130146866|NCT00879684|468495970|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
130146867|NCT00879684|468495971|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
130146868|NCT00879684|468495972|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
130146869|NCT00879684|468495973|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
130146870|NCT00879684|468495967|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
130146871|NCT00879684|468495968|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
130146872|NCT00879684|468495969|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
130146873|NCT00879684|468495970|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
130146874|NCT00879684|468495971|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
130146875|NCT00879684|468495972|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
130146876|NCT00879684|468495973|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
130146877|NCT00879684|468495967|FG000|Stage 1: Dose Escalation|Death|0|||
130146878|NCT00879684|468495968|FG001|Stage 1: Dose Escalation|Death|0|||
130146879|NCT00879684|468495969|FG002|Stage 1: Dose Escalation|Death|1|||
130146880|NCT00879684|468495970|FG003|Stage 1: Dose Escalation|Death|0|||
130146881|NCT00879684|468495971|FG004|Stage 1: Dose Escalation|Death|0|||
130146882|NCT00879684|468495972|FG005|Stage 1: Dose Escalation|Death|0|||
130146883|NCT00879684|468495973|FG006|Stage 1: Dose Escalation|Death|0|||
130146884|NCT00879684|468495967|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130154900|NCT01470612|468526638|FG000|Overall Study|Pregnancy|2|||
130146885|NCT00879684|468495968|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130146886|NCT00879684|468495969|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130146887|NCT00879684|468495970|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130146888|NCT00879684|468495971|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130146889|NCT00879684|468495972|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
130146890|NCT00879684|468495973|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
130146891|NCT00879684|468495967|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
130146892|NCT00879684|468495968|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
130146893|NCT00879684|468495969|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
130146894|NCT00879684|468495970|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
130146895|NCT00879684|468495971|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
130146896|NCT00879684|468495972|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
130146897|NCT00879684|468495973|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
130146898|NCT00879684|468495967|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130146899|NCT00879684|468495968|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130146900|NCT00879684|468495969|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130146901|NCT00879684|468495970|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130146902|NCT00879684|468495971|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130146903|NCT00879684|468495972|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
130146904|NCT00879684|468495973|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
130146905|NCT00420095|468495974|FG000|Overall Study|Adverse Event|1|||
130146906|NCT00420095|468495975|FG001|Overall Study|Adverse Event|0|||
130146907|NCT00420095|468495974|FG000|Overall Study|Protocol Violation|1|||
130146908|NCT00420095|468495975|FG001|Overall Study|Protocol Violation|1|||
130146909|NCT00420095|468495974|FG000|Overall Study|Lost to Follow-up|1|||
130146910|NCT00420095|468495975|FG001|Overall Study|Lost to Follow-up|0|||
130146911|NCT00393705|468495976|FG000|Overall Study|Adverse Event|0|||
130146912|NCT00393705|468495977|FG001|Overall Study|Adverse Event|2|||
130146913|NCT00393705|468495976|FG000|Overall Study|Death|0|||
130146914|NCT00393705|468495977|FG001|Overall Study|Death|1|||
130146915|NCT00393705|468495976|FG000|Overall Study|Lost to Follow-up|2|||
130146916|NCT00393705|468495977|FG001|Overall Study|Lost to Follow-up|2|||
130146917|NCT00393705|468495976|FG000|Overall Study|Entry Criteria Not Met|10|||
130146918|NCT00393705|468495977|FG001|Overall Study|Entry Criteria Not Met|10|||
130146919|NCT00393705|468495976|FG000|Overall Study|Protocol Violation|4|||
130146920|NCT00393705|468495977|FG001|Overall Study|Protocol Violation|3|||
130146921|NCT00393705|468495976|FG000|Overall Study|Withdrawal by Subject|5|||
130146922|NCT00393705|468495977|FG001|Overall Study|Withdrawal by Subject|3|||
130146923|NCT00393705|468495976|FG000|Overall Study|Physician Decision|2|||
130146924|NCT00393705|468495977|FG001|Overall Study|Physician Decision|2|||
130146925|NCT03185741|468495978|FG000|Baseline|Withdrawal by Subject|1|||
130146926|NCT03185741|468495979|FG001|Baseline|Withdrawal by Subject|3|||
130146927|NCT03185741|468495980|FG002|Baseline|Withdrawal by Subject|2|||
130146928|NCT03185741|468495978|FG000|Baseline|Lost to Follow-up|1|||
130146929|NCT03185741|468495979|FG001|Baseline|Lost to Follow-up|2|||
130146930|NCT03185741|468495980|FG002|Baseline|Lost to Follow-up|3|||
130146931|NCT03185741|468495978|FG000|3Month|Death|1|||
130146932|NCT03185741|468495979|FG001|3Month|Death|1|||
130146933|NCT03185741|468495980|FG002|3Month|Death|2|||
130146934|NCT03185741|468495978|FG000|3Month|Withdrawal by Subject|1|||
130146935|NCT03185741|468495979|FG001|3Month|Withdrawal by Subject|5|||
130146936|NCT03185741|468495980|FG002|3Month|Withdrawal by Subject|1|||
130146937|NCT03185741|468495978|FG000|3Month|Lost to Follow-up|7|||
130146938|NCT03185741|468495979|FG001|3Month|Lost to Follow-up|9|||
130146939|NCT03185741|468495980|FG002|3Month|Lost to Follow-up|8|||
130146940|NCT03185741|468495978|FG000|3Month|Unavailable for 3Month|11|||
130146941|NCT03185741|468495979|FG001|3Month|Unavailable for 3Month|10|||
130146942|NCT03185741|468495980|FG002|3Month|Unavailable for 3Month|11|||
130146943|NCT03185741|468495978|FG000|3Month|Protocol Violation|0|||
130146944|NCT03185741|468495979|FG001|3Month|Protocol Violation|0|||
130146945|NCT03185741|468495980|FG002|3Month|Protocol Violation|3|||
130146946|NCT03185741|468495978|FG000|6Month|Death|1|||
130146947|NCT03185741|468495979|FG001|6Month|Death|1|||
129976678|NCT04879849|467877841|FG002|Overall Study|Progressive Disease|1|||
130146948|NCT03185741|468495980|FG002|6Month|Death|2|||
130146949|NCT03185741|468495978|FG000|6Month|Withdrawal by Subject|2|||
129976679|NCT04879849|467877842|FG003|Overall Study|Progressive Disease|0|||
129976680|NCT04879849|467877843|FG004|Overall Study|Progressive Disease|0|||
130146950|NCT03185741|468495979|FG001|6Month|Withdrawal by Subject|3|||
130146951|NCT03185741|468495980|FG002|6Month|Withdrawal by Subject|1|||
130146952|NCT03185741|468495978|FG000|6Month|Lost to Follow-up|16|||
130146953|NCT03185741|468495979|FG001|6Month|Lost to Follow-up|15|||
130146954|NCT03185741|468495980|FG002|6Month|Lost to Follow-up|16|||
130146955|NCT03365791|468495981|FG000|Overall Study|Adverse Event|5|||
130146956|NCT03365791|468495981|FG000|Overall Study|Death|1|||
129976681|NCT04879849|467877844|FG005|Overall Study|Progressive Disease|0|||
130146957|NCT03365791|468495981|FG000|Overall Study|Lost to Follow-up|1|||
130146958|NCT03365791|468495981|FG000|Overall Study|Physician Decision|9|||
130146959|NCT03365791|468495981|FG000|Overall Study|Progressive disease|51|||
130146960|NCT03365791|468495981|FG000|Overall Study|Subject/guardian decision|5|||
130146961|NCT02129062|468497256|FG000|Overall Study|Death|1|||
130146962|NCT02129062|468497256|FG000|Overall Study|Disease Progression|2|||
130146963|NCT02722616|468497257|FG000|Overall Study|Sponsor closed study after one month|2|||
130146964|NCT02722616|468497258|FG001|Overall Study|Sponsor closed study after one month|0|||
130146965|NCT02722616|468497259|FG002|Overall Study|Sponsor closed study after one month|0|||
130146966|NCT01923311|468497260|FG000|Overall Study|Pregnancy|1|||
130146967|NCT01923311|468497261|FG001|Overall Study|Pregnancy|0|||
130146968|NCT01923311|468497260|FG000|Overall Study|Investigator's Discretion|1|||
130146969|NCT01923311|468497261|FG001|Overall Study|Investigator's Discretion|0|||
130146970|NCT01923311|468497260|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130146971|NCT01923311|468497261|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130146972|NCT01923311|468497260|FG000|Overall Study|Withdrew Consent|1|||
130146973|NCT01923311|468497261|FG001|Overall Study|Withdrew Consent|0|||
130146974|NCT01923311|468497260|FG000|Overall Study|Study Terminated by Sponsor|12|||
130146975|NCT01923311|468497261|FG001|Overall Study|Study Terminated by Sponsor|0|||
130146976|NCT02031237|468497262|FG000|Overall Study|Death|1|||
130146977|NCT02031237|468497263|FG001|Overall Study|Death|5|||
130146978|NCT02031237|468497264|FG002|Overall Study|Death|0|||
130146979|NCT02031237|468497262|FG000|Overall Study|Physician Decision|0|||
130146980|NCT02031237|468497263|FG001|Overall Study|Physician Decision|1|||
130146981|NCT02031237|468497264|FG002|Overall Study|Physician Decision|0|||
130146982|NCT02031237|468497262|FG000|Overall Study|Withdrawal by Subject|2|||
130146983|NCT02031237|468497263|FG001|Overall Study|Withdrawal by Subject|2|||
130146984|NCT02031237|468497264|FG002|Overall Study|Withdrawal by Subject|0|||
130146985|NCT02031237|468497262|FG000|Overall Study|Protocol Violation|2|||
130146986|NCT02031237|468497263|FG001|Overall Study|Protocol Violation|6|||
130146987|NCT02031237|468497264|FG002|Overall Study|Protocol Violation|0|||
130146988|NCT02031237|468497262|FG000|Overall Study|Alternate Treatment Given|0|||
130146989|NCT02031237|468497263|FG001|Overall Study|Alternate Treatment Given|0|||
130146990|NCT02031237|468497264|FG002|Overall Study|Alternate Treatment Given|3|||
130146991|NCT01841060|468497268|FG000|Overall Study|Protocol Violation|10|||
130146992|NCT00653159|468497269|FG000|Overall Study|Adverse Event|4|||
130146993|NCT00653159|468497270|FG001|Overall Study|Adverse Event|1|||
130146994|NCT00653159|468497269|FG000|Overall Study|Lost to Follow-up|1|||
130146995|NCT00653159|468497270|FG001|Overall Study|Lost to Follow-up|2|||
130146996|NCT05258630|468497271|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
130146997|NCT05258630|468497272|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
130146998|NCT05258630|468497271|FG000|Overall Study|Lost to Follow-up|0|||
130146999|NCT05258630|468497272|FG001|Overall Study|Lost to Follow-up|2|||
130147000|NCT00109837|468497273|FG000|Overall Study|Adverse Event|2|||
130147001|NCT00109837|468497273|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
130147002|NCT00109837|468497273|FG000|Overall Study|Death|1|||
130147003|NCT00109837|468497273|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
130147004|NCT00109837|468497273|FG000|Overall Study|Not treated|1|||
130147005|NCT00109837|468497273|FG000|Overall Study|Ineligible|1|||
130147006|NCT01848210|468497274|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
130147007|NCT01848210|468497275|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
130147008|NCT01848210|468497274|FG000|Overall Study|Lost to Follow-up|24|||
130147009|NCT01848210|468497275|FG001|Overall Study|Lost to Follow-up|12|||
130147010|NCT01848210|468497274|FG000|Overall Study|Protocol Violation|3|||
130147011|NCT01848210|468497275|FG001|Overall Study|Protocol Violation|5|||
130147012|NCT01848210|468497274|FG000|Overall Study|Use of Forbidden Drugs|9|||
130147013|NCT01848210|468497275|FG001|Overall Study|Use of Forbidden Drugs|10|||
130147014|NCT01848210|468497274|FG000|Overall Study|Impedition Condition|5|||
130147015|NCT01848210|468497275|FG001|Overall Study|Impedition Condition|9|||
130147016|NCT01848210|468497274|FG000|Overall Study|Adverse Event|7|||
130147017|NCT01848210|468497275|FG001|Overall Study|Adverse Event|9|||
129976682|NCT04879849|467877845|FG006|Overall Study|Progressive Disease|0|||
130147018|NCT01848210|468497274|FG000|Overall Study|Discontinuation Criterion|5|||
130147019|NCT01848210|468497275|FG001|Overall Study|Discontinuation Criterion|7|||
129976683|NCT04879849|467877846|FG007|Overall Study|Progressive Disease|0|||
129976684|NCT04879849|467877839|FG000|Overall Study|Death|0|||
129976685|NCT04879849|467877840|FG001|Overall Study|Death|0|||
130147020|NCT01848210|468497274|FG000|Overall Study|Hypesensitivity|1|||
130147021|NCT01848210|468497275|FG001|Overall Study|Hypesensitivity|0|||
130147022|NCT01848210|468497274|FG000|Overall Study|Hepatic Function Alteration|4|||
130147023|NCT01848210|468497275|FG001|Overall Study|Hepatic Function Alteration|0|||
130147024|NCT01848210|468497274|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
130147025|NCT01848210|468497275|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
130147026|NCT01848210|468497274|FG000|Overall Study|Administrative|1|||
130147027|NCT01848210|468497275|FG001|Overall Study|Administrative|0|||
130147028|NCT00381849|468497276|FG000|Wash Out|Withdrawal by Subject|0|||
130147029|NCT00381849|468497277|FG001|Wash Out|Withdrawal by Subject|1|||
130147030|NCT00894933|468497283|FG000|Overall Study|Lost to Follow-up|2|||
130147031|NCT00894933|468497283|FG000|Overall Study|Cancelled Procedure|1|||
130147032|NCT00894933|468497283|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
130147033|NCT00631007|468497284|FG000|Overall Study|Adverse Event|0|||
130147034|NCT00631007|468497285|FG001|Overall Study|Adverse Event|2|||
130147035|NCT00631007|468497286|FG002|Overall Study|Adverse Event|0|||
130147036|NCT00631007|468497287|FG003|Overall Study|Adverse Event|2|||
130147037|NCT00631007|468497288|FG004|Overall Study|Adverse Event|3|||
130147038|NCT00631007|468497289|FG005|Overall Study|Adverse Event|2|||
130147039|NCT00631007|468497284|FG000|Overall Study|Lost to Follow-up|2|||
130147040|NCT00631007|468497285|FG001|Overall Study|Lost to Follow-up|1|||
130147041|NCT00631007|468497286|FG002|Overall Study|Lost to Follow-up|2|||
130147042|NCT00631007|468497287|FG003|Overall Study|Lost to Follow-up|4|||
130147043|NCT00631007|468497288|FG004|Overall Study|Lost to Follow-up|5|||
130147044|NCT00631007|468497289|FG005|Overall Study|Lost to Follow-up|3|||
130147045|NCT00631007|468497284|FG000|Overall Study|Physician Decision|1|||
130147046|NCT00631007|468497285|FG001|Overall Study|Physician Decision|0|||
130147047|NCT00631007|468497286|FG002|Overall Study|Physician Decision|1|||
130147048|NCT00631007|468497287|FG003|Overall Study|Physician Decision|0|||
130147049|NCT00631007|468497288|FG004|Overall Study|Physician Decision|0|||
130147050|NCT00631007|468497289|FG005|Overall Study|Physician Decision|2|||
130147051|NCT00631007|468497284|FG000|Overall Study|Persistent Hyperglycemia|2|||
130147052|NCT00631007|468497285|FG001|Overall Study|Persistent Hyperglycemia|2|||
130147053|NCT00631007|468497286|FG002|Overall Study|Persistent Hyperglycemia|5|||
130147054|NCT00631007|468497287|FG003|Overall Study|Persistent Hyperglycemia|1|||
130147055|NCT00631007|468497288|FG004|Overall Study|Persistent Hyperglycemia|2|||
130147056|NCT00631007|468497289|FG005|Overall Study|Persistent Hyperglycemia|5|||
130147057|NCT00631007|468497284|FG000|Overall Study|Withdrawal by Subject|4|||
130147058|NCT00631007|468497285|FG001|Overall Study|Withdrawal by Subject|5|||
130147059|NCT00631007|468497286|FG002|Overall Study|Withdrawal by Subject|2|||
130147060|NCT00631007|468497287|FG003|Overall Study|Withdrawal by Subject|2|||
130147061|NCT00631007|468497288|FG004|Overall Study|Withdrawal by Subject|1|||
130147062|NCT00631007|468497289|FG005|Overall Study|Withdrawal by Subject|3|||
130147063|NCT00631007|468497284|FG000|Overall Study|Other|2|||
130147064|NCT00631007|468497285|FG001|Overall Study|Other|1|||
130147065|NCT00631007|468497286|FG002|Overall Study|Other|0|||
130147066|NCT00631007|468497287|FG003|Overall Study|Other|0|||
130147067|NCT00631007|468497288|FG004|Overall Study|Other|1|||
130147068|NCT00631007|468497289|FG005|Overall Study|Other|0|||
130147069|NCT00683787|468497290|FG000|Overall Study|Progression|3|||
130147070|NCT00683787|468497291|FG001|Overall Study|Progression|3|||
130147071|NCT00683787|468497292|FG002|Overall Study|Progression|0|||
130147072|NCT00683787|468497290|FG000|Overall Study|Adverse Event|0|||
130147073|NCT00683787|468497291|FG001|Overall Study|Adverse Event|0|||
130147074|NCT00683787|468497292|FG002|Overall Study|Adverse Event|2|||
130147075|NCT04167618|468497293|FG000|Overall Study|Trial terminated by sponsor|1|||
130147076|NCT04167618|468497294|FG001|Overall Study|Trial terminated by sponsor|1|||
130147077|NCT00996437|468497295|FG000|Overall Study|Death|1|||
130147078|NCT00996437|468497296|FG001|Overall Study|Death|0|||
130147079|NCT00996437|468497295|FG000|Overall Study|Dropped|2|||
130147080|NCT00996437|468497296|FG001|Overall Study|Dropped|2|||
130147081|NCT00996437|468497295|FG000|Overall Study|Missed|2|||
130147082|NCT00996437|468497296|FG001|Overall Study|Missed|5|||
130147083|NCT02576717|468497299|FG000|Overall Study|Other Reasons|16|||
130147084|NCT02576717|468497300|FG001|Overall Study|Other Reasons|18|||
130147085|NCT02576717|468497301|FG002|Overall Study|Other Reasons|15|||
130147086|NCT02576717|468497299|FG000|Overall Study|Covid-19 Pandemic|0|||
130147087|NCT02576717|468497300|FG001|Overall Study|Covid-19 Pandemic|1|||
130147088|NCT02576717|468497301|FG002|Overall Study|Covid-19 Pandemic|1|||
130147089|NCT02576717|468497299|FG000|Overall Study|Sponsor Decision|0|||
130147090|NCT02576717|468497300|FG001|Overall Study|Sponsor Decision|0|||
130147091|NCT02576717|468497301|FG002|Overall Study|Sponsor Decision|1|||
130147092|NCT02576717|468497299|FG000|Overall Study|Physician Decision|3|||
130147093|NCT02576717|468497300|FG001|Overall Study|Physician Decision|8|||
130147094|NCT02576717|468497301|FG002|Overall Study|Physician Decision|9|||
130147095|NCT02576717|468497299|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
130147096|NCT02576717|468497300|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
130147097|NCT02576717|468497301|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
130147098|NCT02576717|468497299|FG000|Overall Study|Death|3|||
130147099|NCT02576717|468497300|FG001|Overall Study|Death|5|||
130147100|NCT02576717|468497301|FG002|Overall Study|Death|3|||
130147101|NCT02576717|468497299|FG000|Overall Study|Lost to Follow-up|9|||
130147102|NCT02576717|468497300|FG001|Overall Study|Lost to Follow-up|10|||
130147103|NCT02576717|468497301|FG002|Overall Study|Lost to Follow-up|19|||
130147104|NCT02576717|468497299|FG000|Overall Study|Protocol Violation|4|||
130147105|NCT02576717|468497300|FG001|Overall Study|Protocol Violation|0|||
130147106|NCT02576717|468497301|FG002|Overall Study|Protocol Violation|5|||
130147107|NCT02576717|468497299|FG000|Overall Study|Lack of Efficacy|24|||
130147108|NCT02576717|468497300|FG001|Overall Study|Lack of Efficacy|28|||
130147109|NCT02576717|468497301|FG002|Overall Study|Lack of Efficacy|20|||
130147110|NCT02576717|468497299|FG000|Overall Study|Adverse Event|26|||
130147111|NCT02576717|468497300|FG001|Overall Study|Adverse Event|32|||
130147112|NCT02576717|468497301|FG002|Overall Study|Adverse Event|26|||
130147113|NCT01363011|468497302|FG000|Main Study|Adverse Event|2|||
130147114|NCT01363011|468497303|FG001|Main Study|Adverse Event|3|||
130147115|NCT01363011|468497302|FG000|Main Study|Investigator's Discretion|1|||
130147116|NCT01363011|468497303|FG001|Main Study|Investigator's Discretion|1|||
130147117|NCT01363011|468497302|FG000|Main Study|Withdrew Consent|1|||
130147118|NCT01363011|468497303|FG001|Main Study|Withdrew Consent|4|||
130147119|NCT01363011|468497302|FG000|Main Study|Protocol Violation|0|||
130147120|NCT01363011|468497303|FG001|Main Study|Protocol Violation|1|||
130147121|NCT01363011|468497302|FG000|Extension Phase|Adverse Event|1|||
130147122|NCT01363011|468497303|FG001|Extension Phase|Adverse Event|1|||
130147123|NCT01363011|468497302|FG000|Extension Phase|Lack of Efficacy|0|||
130147124|NCT01363011|468497303|FG001|Extension Phase|Lack of Efficacy|1|||
130147125|NCT01363011|468497302|FG000|Extension Phase|Investigator's Discretion|2|||
130147126|NCT01363011|468497303|FG001|Extension Phase|Investigator's Discretion|2|||
130147127|NCT01363011|468497302|FG000|Extension Phase|Withdrew Consent|0|||
130147128|NCT01363011|468497303|FG001|Extension Phase|Withdrew Consent|1|||
130147129|NCT01363011|468497302|FG000|Extension Phase|Lost to Follow-up|0|||
130147130|NCT01363011|468497303|FG001|Extension Phase|Lost to Follow-up|2|||
130147131|NCT01363011|468497302|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
130147132|NCT01363011|468497303|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
130147133|NCT00399893|468497304|FG000|Overall Study|Withdrawal by Subject|1|||
130147134|NCT00399893|468497305|FG001|Overall Study|Withdrawal by Subject|0|||
130147135|NCT01961882|468497310|FG000|Overall Study|Adverse Event|3|||
130147136|NCT01961882|468497311|FG001|Overall Study|Adverse Event|2|||
130147137|NCT01961882|468497310|FG000|Overall Study|Physician Decision|1|||
130147138|NCT01961882|468497311|FG001|Overall Study|Physician Decision|0|||
130147139|NCT01961882|468497310|FG000|Overall Study|Withdrawal by Subject|4|||
130147140|NCT01961882|468497311|FG001|Overall Study|Withdrawal by Subject|1|||
130147141|NCT01961882|468497310|FG000|Overall Study|Relapse of AML|39|||
130147142|NCT01961882|468497311|FG001|Overall Study|Relapse of AML|37|||
130147143|NCT01961882|468497310|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
130147144|NCT01961882|468497311|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
130147145|NCT01961882|468497310|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
130147146|NCT01961882|468497311|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
130147147|NCT00407745|468497312|FG000|Overall Study|Lack of Efficacy|1|||
130147148|NCT00407745|468497313|FG001|Overall Study|Lack of Efficacy|2|||
130147149|NCT00407745|468497312|FG000|Overall Study|Withdrawal by Subject|3|||
130147150|NCT00407745|468497313|FG001|Overall Study|Withdrawal by Subject|3|||
130147151|NCT00407745|468497312|FG000|Overall Study|Protocol Violation|5|||
130147152|NCT00407745|468497313|FG001|Overall Study|Protocol Violation|3|||
130147153|NCT00407745|468497312|FG000|Overall Study|Adverse Event|8|||
130147154|NCT00407745|468497313|FG001|Overall Study|Adverse Event|8|||
130147155|NCT00407745|468497312|FG000|Overall Study|Other|2|||
130147156|NCT00407745|468497313|FG001|Overall Study|Other|0|||
130147157|NCT00407745|468497312|FG000|Overall Study|Randomized, unknown if treated|0|||
130147158|NCT00407745|468497313|FG001|Overall Study|Randomized, unknown if treated|1|||
130147159|NCT00108082|468497314|FG000|Overall Study|Adverse Event|14|||
130147160|NCT00108082|468497315|FG001|Overall Study|Adverse Event|12|||
130147161|NCT00108082|468497316|FG002|Overall Study|Adverse Event|17|||
130147162|NCT00108082|468497314|FG000|Overall Study|Lost to Follow-up|6|||
130147163|NCT00108082|468497315|FG001|Overall Study|Lost to Follow-up|3|||
130147164|NCT00108082|468497316|FG002|Overall Study|Lost to Follow-up|7|||
130147165|NCT00108082|468497314|FG000|Overall Study|Consent Withdrawn|3|||
130147166|NCT00108082|468497315|FG001|Overall Study|Consent Withdrawn|3|||
130147167|NCT00108082|468497316|FG002|Overall Study|Consent Withdrawn|5|||
130147168|NCT00108082|468497314|FG000|Overall Study|Protocol Violation|1|||
130147169|NCT00108082|468497315|FG001|Overall Study|Protocol Violation|2|||
129976686|NCT04879849|467877841|FG002|Overall Study|Death|1|||
129976687|NCT04879849|467877842|FG003|Overall Study|Death|1|||
129976688|NCT04879849|467877843|FG004|Overall Study|Death|1|||
129976689|NCT04879849|467877844|FG005|Overall Study|Death|2|||
129976690|NCT04879849|467877845|FG006|Overall Study|Death|1|||
129976691|NCT04879849|467877846|FG007|Overall Study|Death|2|||
130147170|NCT00108082|468497316|FG002|Overall Study|Protocol Violation|0|||
130147171|NCT00108082|468497314|FG000|Overall Study|Lack of Efficacy|3|||
130147172|NCT00108082|468497315|FG001|Overall Study|Lack of Efficacy|1|||
130147173|NCT00108082|468497316|FG002|Overall Study|Lack of Efficacy|2|||
130147174|NCT00108082|468497314|FG000|Overall Study|Amendment 4: > Month 12|5|||
130147175|NCT00108082|468497315|FG001|Overall Study|Amendment 4: > Month 12|7|||
130147176|NCT00108082|468497316|FG002|Overall Study|Amendment 4: > Month 12|5|||
130147177|NCT00108082|468497314|FG000|Overall Study|Woman of Child-bearing Potential|2|||
130147178|NCT00108082|468497315|FG001|Overall Study|Woman of Child-bearing Potential|0|||
130147179|NCT00108082|468497316|FG002|Overall Study|Woman of Child-bearing Potential|2|||
130147180|NCT00108082|468497314|FG000|Overall Study|Incorrectly Randomized|0|||
130147181|NCT00108082|468497315|FG001|Overall Study|Incorrectly Randomized|0|||
130147182|NCT00108082|468497316|FG002|Overall Study|Incorrectly Randomized|2|||
130147183|NCT00108082|468497314|FG000|Overall Study|Non-compliance|1|||
129976692|NCT04879849|467877839|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
130147184|NCT00108082|468497315|FG001|Overall Study|Non-compliance|0|||
130147185|NCT00108082|468497316|FG002|Overall Study|Non-compliance|2|||
130147186|NCT00108082|468497314|FG000|Overall Study|Stopped Study Medication|0|||
130147187|NCT00108082|468497315|FG001|Overall Study|Stopped Study Medication|0|||
130147188|NCT00108082|468497316|FG002|Overall Study|Stopped Study Medication|1|||
130147189|NCT00108082|468497314|FG000|Overall Study|Site Closed Study|0|||
130147190|NCT00108082|468497315|FG001|Overall Study|Site Closed Study|2|||
130147191|NCT00108082|468497316|FG002|Overall Study|Site Closed Study|0|||
130147192|NCT00108082|468497314|FG000|Overall Study|Protocol Amendment|0|||
130147193|NCT00108082|468497315|FG001|Overall Study|Protocol Amendment|1|||
130147194|NCT00108082|468497316|FG002|Overall Study|Protocol Amendment|0|||
130147195|NCT00108082|468497314|FG000|Overall Study|Study Medication Not Tapered|0|||
130147196|NCT00108082|468497315|FG001|Overall Study|Study Medication Not Tapered|1|||
130147197|NCT00108082|468497316|FG002|Overall Study|Study Medication Not Tapered|0|||
130147198|NCT00108082|468497314|FG000|Overall Study|Subject Left Site Location|1|||
130147199|NCT00108082|468497315|FG001|Overall Study|Subject Left Site Location|0|||
130147200|NCT00108082|468497316|FG002|Overall Study|Subject Left Site Location|0|||
130147201|NCT00108082|468497314|FG000|Overall Study|Investigator Not at Site|1|||
130147202|NCT00108082|468497315|FG001|Overall Study|Investigator Not at Site|0|||
130147203|NCT00108082|468497316|FG002|Overall Study|Investigator Not at Site|0|||
130147204|NCT00108082|468497314|FG000|Overall Study|Blood Pressure Not Controlled|1|||
130147205|NCT00108082|468497315|FG001|Overall Study|Blood Pressure Not Controlled|0|||
130147206|NCT00108082|468497316|FG002|Overall Study|Blood Pressure Not Controlled|0|||
130147207|NCT02940730|468497321|FG000|Intervention 2|Physician Decision|7|||
130147208|NCT02940730|468497322|FG001|Intervention 2|Physician Decision|0|||
130147209|NCT03036839|468497323|FG000|Overall Study|Adverse Event|0|||
130147210|NCT03036839|468497324|FG001|Overall Study|Adverse Event|0|||
130147211|NCT03036839|468497325|FG002|Overall Study|Adverse Event|1|||
130147212|NCT03036839|468497323|FG000|Overall Study|Death|3|||
130147213|NCT03036839|468497324|FG001|Overall Study|Death|0|||
130147214|NCT03036839|468497325|FG002|Overall Study|Death|3|||
130147215|NCT03036839|468497323|FG000|Overall Study|Withdrew Consent|0|||
130147216|NCT03036839|468497324|FG001|Overall Study|Withdrew Consent|0|||
130147217|NCT03036839|468497325|FG002|Overall Study|Withdrew Consent|1|||
130147218|NCT00412737|468497327|FG000|Overall Study|Death|1|||
130147219|NCT00412737|468497328|FG001|Overall Study|Death|0|||
130147220|NCT00412737|468497327|FG000|Overall Study|Adverse Event|3|||
130147221|NCT00412737|468497328|FG001|Overall Study|Adverse Event|2|||
130147222|NCT00412737|468497327|FG000|Overall Study|Refused Treatment|6|||
130147223|NCT00412737|468497328|FG001|Overall Study|Refused Treatment|2|||
130147224|NCT00412737|468497327|FG000|Overall Study|Failure to Return|6|||
130147225|NCT00412737|468497328|FG001|Overall Study|Failure to Return|2|||
130147226|NCT00906373|468497329|FG000|Overall Study|Withdrawal by Subject|0|||
130147227|NCT00906373|468497330|FG001|Overall Study|Withdrawal by Subject|5|||
130147228|NCT00906373|468497329|FG000|Overall Study|Other|0|||
130147229|NCT00906373|468497330|FG001|Overall Study|Other|1|||
130147230|NCT00906373|468497329|FG000|Overall Study|Still on treatment at cutoff date|0|||
130147231|NCT00906373|468497330|FG001|Overall Study|Still on treatment at cutoff date|2|||
130147232|NCT01597479|468497331|FG000|Overall Study|Protocol Violation|1|||
130147233|NCT01597479|468497332|FG001|Overall Study|Protocol Violation|0|||
130147234|NCT01597479|468497331|FG000|Overall Study|Lost to Follow-up|1|||
130147235|NCT01597479|468497332|FG001|Overall Study|Lost to Follow-up|0|||
130147236|NCT04317599|468497337|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
130147237|NCT04317599|468497337|FG000|Overall Study|treatment outside standard of care|4|||
130147238|NCT01186016|468497338|FG000|Overall Study|Withdrawal by Subject|46|||
130147239|NCT01186016|468497339|FG001|Overall Study|Withdrawal by Subject|29|||
130147240|NCT01098539|468497340|FG000|Overall Study|Adverse Event|26|||
130147241|NCT01098539|468497341|FG001|Overall Study|Adverse Event|26|||
130147242|NCT01098539|468497340|FG000|Overall Study|Protocol Violation|1|||
130147243|NCT01098539|468497341|FG001|Overall Study|Protocol Violation|4|||
129976693|NCT04879849|467877840|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
129976694|NCT04879849|467877841|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
129976695|NCT04879849|467877842|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
129976696|NCT04879849|467877843|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
130147244|NCT01098539|468497340|FG000|Overall Study|Noncompliance|3|||
130147245|NCT01098539|468497341|FG001|Overall Study|Noncompliance|5|||
130147246|NCT01098539|468497340|FG000|Overall Study|Lost to Follow-up|4|||
130147247|NCT01098539|468497341|FG001|Overall Study|Lost to Follow-up|4|||
130147248|NCT01098539|468497340|FG000|Overall Study|Withdrawal by Subject|12|||
130147249|NCT01098539|468497341|FG001|Overall Study|Withdrawal by Subject|26|||
130147250|NCT01098539|468497340|FG000|Overall Study|Physician Decision|5|||
130147251|NCT01098539|468497341|FG001|Overall Study|Physician Decision|3|||
130147252|NCT00721955|468497342|FG000|Overall Study|Adverse Event|0|||
130147253|NCT00721955|468497343|FG001|Overall Study|Adverse Event|0|||
130147254|NCT00721955|468497344|FG002|Overall Study|Adverse Event|2|||
130147255|NCT01055886|468497346|FG000|Overall Study|Withdrawal by Subject|4|||
130147256|NCT01055886|468497347|FG001|Overall Study|Withdrawal by Subject|9|||
130147257|NCT01055886|468497346|FG000|Overall Study|Lost to Follow-up|1|||
130147258|NCT01055886|468497347|FG001|Overall Study|Lost to Follow-up|1|||
130147259|NCT01055886|468497346|FG000|Overall Study|Withdrawal by PI|0|||
130147260|NCT01055886|468497347|FG001|Overall Study|Withdrawal by PI|1|||
130147261|NCT01077258|468497350|FG000|Overall Study|Lost to Follow-up|1390|||
130147262|NCT01077258|468497350|FG000|Overall Study|Adverse drug reaction|218|||
129976697|NCT04879849|467877844|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
129976698|NCT04879849|467877845|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
129976699|NCT04879849|467877846|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
129976700|NCT04879849|467877839|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976701|NCT04879849|467877840|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130147263|NCT01077258|468497350|FG000|Overall Study|Lack of Efficacy|663|||
130147264|NCT01077258|468497350|FG000|Overall Study|Clinical remission|37|||
130147265|NCT01077258|468497350|FG000|Overall Study|Other reasons|260|||
130147266|NCT00726895|468497351|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130147267|NCT00726895|468497352|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
130147268|NCT00265785|468497355|FG000|Overall Study|Adverse Event|4|||
130147269|NCT00265785|468497355|FG000|Overall Study|Withdrawal by Subject|3|||
130147270|NCT00265785|468497355|FG000|Overall Study|Progression/Relapse|15|||
130147271|NCT00265785|468497355|FG000|Overall Study|Not protocol specified|2|||
130147272|NCT00265785|468497355|FG000|Overall Study|Ineligible|1|||
130147273|NCT00265785|468497355|FG000|Overall Study|Did not receive protocol treatment|2|||
130147274|NCT00585312|468497371|FG000|Overall Study|Adverse Event|3|||
130147275|NCT00585312|468497372|FG001|Overall Study|Adverse Event|0|||
130147276|NCT00585312|468497371|FG000|Overall Study|Lack of Efficacy|6|||
130147277|NCT00585312|468497372|FG001|Overall Study|Lack of Efficacy|11|||
130147278|NCT00585312|468497371|FG000|Overall Study|Lost to Follow-up|1|||
130147279|NCT00585312|468497372|FG001|Overall Study|Lost to Follow-up|1|||
130147280|NCT00585312|468497371|FG000|Overall Study|Reason not specified|2|||
130147281|NCT00585312|468497372|FG001|Overall Study|Reason not specified|0|||
130147282|NCT00585312|468497371|FG000|Overall Study|Withdrawal by Subject|5|||
130147283|NCT00585312|468497372|FG001|Overall Study|Withdrawal by Subject|1|||
130147284|NCT00585312|468497371|FG000|Overall Study|Study terminated by the sponsor|34|||
130147285|NCT00585312|468497372|FG001|Overall Study|Study terminated by the sponsor|31|||
130147286|NCT01634854|468497378|FG000|Overall Study|Cesarean delivery|2|||
130147287|NCT01634854|468497379|FG001|Overall Study|Cesarean delivery|7|||
130147288|NCT01169038|468497380|FG000|Overall Study|Death|1|||
130147289|NCT01169038|468497380|FG000|Overall Study|Adverse Event|5|||
130147290|NCT01169038|468497380|FG000|Overall Study|Required antibiotic administration|1|||
130147291|NCT01488448|468497381|FG000|Overall Study|Withdrawal by Subject|3|||
130147292|NCT01488448|468497382|FG001|Overall Study|Withdrawal by Subject|1|||
130147293|NCT01488448|468497381|FG000|Overall Study|Adverse Event|9|||
130147294|NCT01488448|468497382|FG001|Overall Study|Adverse Event|4|||
130147295|NCT01488448|468497381|FG000|Overall Study|Physician Decision|4|||
130147296|NCT01488448|468497382|FG001|Overall Study|Physician Decision|9|||
130147297|NCT01488448|468497381|FG000|Overall Study|Protocol Violation|4|||
130147298|NCT01488448|468497382|FG001|Overall Study|Protocol Violation|3|||
130147299|NCT02329431|468497383|FG000|Overall Study|Lost to Follow-up|20|||
130147300|NCT02329431|468497384|FG001|Overall Study|Lost to Follow-up|13|||
130147301|NCT01475487|468497385|FG000|Overall Study|had to leave early for personal reasons|2|||
130147302|NCT01475487|468497386|FG001|Overall Study|had to leave early for personal reasons|1|||
130147303|NCT01977456|468497387|FG000|Overall Study|Death|5|||
130147304|NCT01142661|468497388|FG000|Overall Study|Adverse Event|2|||
130147305|NCT01142661|468497388|FG000|Overall Study|Withdrawal by Subject|1|||
130147306|NCT01142661|468497388|FG000|Overall Study|Physician Decision|1|||
130147307|NCT02426541|468499323|FG000|Overall Study|Protocol Violation|1|||
130147308|NCT02426541|468499324|FG001|Overall Study|Protocol Violation|0|||
130147309|NCT02674633|468499325|FG000|Overall Study|Lost to Follow-up|3|||
130147310|NCT02674633|468499326|FG001|Overall Study|Lost to Follow-up|2|||
130147311|NCT02674633|468499325|FG000|Overall Study|Physician Decision|1|||
130147312|NCT02674633|468499326|FG001|Overall Study|Physician Decision|0|||
130147313|NCT02674633|468499325|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
130147314|NCT02674633|468499326|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
130147315|NCT00460109|468499327|FG000|Overall Study|Death|1|||
130147316|NCT05996198|468499328|FG000|Overall Study|Withdrawal by Subject|1|||
130147317|NCT05996198|468499329|FG001|Overall Study|Withdrawal by Subject|0|||
130147318|NCT02014441|468499330|FG000|Overall Study|Withdrawal by Subject|12|||
130147319|NCT04412057|468499332|FG000|Overall Study|Death|3|||
130147320|NCT04412057|468499333|FG001|Overall Study|Death|7|||
130147321|NCT04412057|468499332|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
130147322|NCT04412057|468499333|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
130147323|NCT01064531|468499344|FG000|Overall Study|Lost to Follow-up|0|||
130147324|NCT01064531|468499345|FG001|Overall Study|Lost to Follow-up|2|||
130147325|NCT01064531|468499344|FG000|Overall Study|Physician Decision|0|||
130147326|NCT01064531|468499345|FG001|Overall Study|Physician Decision|1|||
130147327|NCT01064531|468499344|FG000|Overall Study|Withdrawal by Subject|2|||
130147328|NCT01064531|468499345|FG001|Overall Study|Withdrawal by Subject|2|||
130147329|NCT01064531|468499344|FG000|Overall Study|Revision due to femoral stem loosening|1|||
130147330|NCT01064531|468499345|FG001|Overall Study|Revision due to femoral stem loosening|0|||
130147331|NCT01064531|468499344|FG000|Overall Study|Revision due to dislocation|0|||
130147332|NCT01064531|468499345|FG001|Overall Study|Revision due to dislocation|1|||
130147333|NCT01064531|468499344|FG000|Overall Study|Death|0|||
130147334|NCT01064531|468499345|FG001|Overall Study|Death|1|||
130147335|NCT03449199|468499349|FG000|Overall Study|Lost to Follow-up|1|||
130147336|NCT03449199|468499350|FG001|Overall Study|Lost to Follow-up|1|||
130147337|NCT03449199|468499351|FG002|Overall Study|Lost to Follow-up|0|||
130147338|NCT03449199|468499349|FG000|Overall Study|Protocol Deviation|0|||
130147339|NCT03449199|468499350|FG001|Overall Study|Protocol Deviation|0|||
130147340|NCT03449199|468499351|FG002|Overall Study|Protocol Deviation|1|||
130147341|NCT03449199|468499349|FG000|Overall Study|Withdrawal by Subject|0|||
130147342|NCT03449199|468499350|FG001|Overall Study|Withdrawal by Subject|0|||
130147343|NCT03449199|468499351|FG002|Overall Study|Withdrawal by Subject|1|||
130147344|NCT01091103|468499352|FG000|Overall Study|Adverse Event|1|||
130147345|NCT01091103|468499352|FG000|Overall Study|Progressive Disease|3|||
130147346|NCT01270620|468499353|FG000|Overall Study|Withdrawal by Subject|1|||
130147347|NCT01270620|468499354|FG001|Overall Study|Withdrawal by Subject|3|||
130147348|NCT00809965|468499357|FG000|Overall Study|Death|194|||
130147349|NCT00809965|468499358|FG001|Overall Study|Death|147|||
130147350|NCT00809965|468499359|FG002|Overall Study|Death|196|||
130147351|NCT00809965|468499357|FG000|Overall Study|Lost to Follow-up|17|||
130147352|NCT00809965|468499358|FG001|Overall Study|Lost to Follow-up|10|||
130147353|NCT00809965|468499359|FG002|Overall Study|Lost to Follow-up|18|||
130147354|NCT00809965|468499357|FG000|Overall Study|Withdrawal by Subject|405|||
130147355|NCT00809965|468499358|FG001|Overall Study|Withdrawal by Subject|448|||
130147356|NCT00809965|468499359|FG002|Overall Study|Withdrawal by Subject|441|||
130147357|NCT00809965|468499357|FG000|Overall Study|Other Reason|167|||
130147358|NCT00809965|468499358|FG001|Overall Study|Other Reason|170|||
130147359|NCT00809965|468499359|FG002|Overall Study|Other Reason|189|||
130147360|NCT02780167|468499360|FG000|Overall Study|Adverse Event|9|||
130147361|NCT02780167|468499361|FG001|Overall Study|Adverse Event|8|||
130147362|NCT02780167|468499362|FG002|Overall Study|Adverse Event|8|||
130147363|NCT02780167|468499363|FG003|Overall Study|Adverse Event|12|||
130147364|NCT02780167|468499364|FG004|Overall Study|Adverse Event|8|||
130147365|NCT02780167|468499360|FG000|Overall Study|Lack of Efficacy|6|||
130147366|NCT02780167|468499361|FG001|Overall Study|Lack of Efficacy|5|||
130147367|NCT02780167|468499362|FG002|Overall Study|Lack of Efficacy|6|||
130147368|NCT02780167|468499363|FG003|Overall Study|Lack of Efficacy|1|||
130147369|NCT02780167|468499364|FG004|Overall Study|Lack of Efficacy|0|||
130147370|NCT02780167|468499360|FG000|Overall Study|Lost to Follow-up|2|||
130147371|NCT02780167|468499361|FG001|Overall Study|Lost to Follow-up|0|||
130147372|NCT02780167|468499362|FG002|Overall Study|Lost to Follow-up|1|||
130147373|NCT02780167|468499363|FG003|Overall Study|Lost to Follow-up|0|||
130147374|NCT02780167|468499364|FG004|Overall Study|Lost to Follow-up|0|||
130147375|NCT02780167|468499360|FG000|Overall Study|Does not meet entrance criteria|0|||
130147376|NCT02780167|468499361|FG001|Overall Study|Does not meet entrance criteria|0|||
130147377|NCT02780167|468499362|FG002|Overall Study|Does not meet entrance criteria|1|||
130147378|NCT02780167|468499363|FG003|Overall Study|Does not meet entrance criteria|0|||
130147379|NCT02780167|468499364|FG004|Overall Study|Does not meet entrance criteria|0|||
130147380|NCT02780167|468499360|FG000|Overall Study|No longer meets eligibility criteria|0|||
130147381|NCT02780167|468499361|FG001|Overall Study|No longer meets eligibility criteria|0|||
130147382|NCT02780167|468499362|FG002|Overall Study|No longer meets eligibility criteria|0|||
130147383|NCT02780167|468499363|FG003|Overall Study|No longer meets eligibility criteria|1|||
130147384|NCT02780167|468499364|FG004|Overall Study|No longer meets eligibility criteria|1|||
130147385|NCT02780167|468499360|FG000|Overall Study|Protocol Violation|5|||
130147386|NCT02780167|468499361|FG001|Overall Study|Protocol Violation|5|||
130147387|NCT02780167|468499362|FG002|Overall Study|Protocol Violation|1|||
130147388|NCT02780167|468499363|FG003|Overall Study|Protocol Violation|1|||
129979964|NCT04372121|467889512|FG002|Overall Study|Withdrawal by Subject|0|||
130147389|NCT02780167|468499364|FG004|Overall Study|Protocol Violation|2|||
130147390|NCT02780167|468499360|FG000|Overall Study|Withdrawal by Subject|6|||
130147391|NCT02780167|468499361|FG001|Overall Study|Withdrawal by Subject|4|||
130147392|NCT02780167|468499362|FG002|Overall Study|Withdrawal by Subject|4|||
130147393|NCT02780167|468499363|FG003|Overall Study|Withdrawal by Subject|3|||
130147394|NCT02780167|468499364|FG004|Overall Study|Withdrawal by Subject|4|||
130147395|NCT02780167|468499360|FG000|Overall Study|Other|0|||
130147396|NCT02780167|468499361|FG001|Overall Study|Other|0|||
130147397|NCT02780167|468499362|FG002|Overall Study|Other|3|||
130147398|NCT02780167|468499363|FG003|Overall Study|Other|1|||
130147399|NCT02780167|468499364|FG004|Overall Study|Other|2|||
130147400|NCT02315066|468499365|FG000|Overall Study|Lost to Follow-up|0|||
130147401|NCT02315066|468499366|FG001|Overall Study|Lost to Follow-up|1|||
130147402|NCT02315066|468499367|FG002|Overall Study|Lost to Follow-up|1|||
130147403|NCT02315066|468499368|FG003|Overall Study|Lost to Follow-up|0|||
130147404|NCT02315066|468499369|FG004|Overall Study|Lost to Follow-up|1|||
130147405|NCT02315066|468499370|FG005|Overall Study|Lost to Follow-up|0|||
130147406|NCT02315066|468499371|FG006|Overall Study|Lost to Follow-up|2|||
130147407|NCT02315066|468499372|FG007|Overall Study|Lost to Follow-up|1|||
130147408|NCT02315066|468499373|FG008|Overall Study|Lost to Follow-up|0|||
130147409|NCT02315066|468499374|FG009|Overall Study|Lost to Follow-up|0|||
130147410|NCT02315066|468499375|FG010|Overall Study|Lost to Follow-up|1|||
130147411|NCT02315066|468499376|FG011|Overall Study|Lost to Follow-up|2|||
130147412|NCT02315066|468499377|FG012|Overall Study|Lost to Follow-up|0|||
130147413|NCT02315066|468499378|FG013|Overall Study|Lost to Follow-up|4|||
130147414|NCT02315066|468499365|FG000|Overall Study|Death|2|||
130147415|NCT02315066|468499366|FG001|Overall Study|Death|7|||
130147416|NCT02315066|468499367|FG002|Overall Study|Death|6|||
130147417|NCT02315066|468499368|FG003|Overall Study|Death|11|||
130147418|NCT02315066|468499369|FG004|Overall Study|Death|10|||
130147419|NCT02315066|468499370|FG005|Overall Study|Death|3|||
130147420|NCT02315066|468499371|FG006|Overall Study|Death|9|||
130147421|NCT02315066|468499372|FG007|Overall Study|Death|9|||
130147422|NCT02315066|468499373|FG008|Overall Study|Death|10|||
130147423|NCT02315066|468499374|FG009|Overall Study|Death|8|||
130147424|NCT02315066|468499375|FG010|Overall Study|Death|10|||
130147425|NCT02315066|468499376|FG011|Overall Study|Death|7|||
130147426|NCT02315066|468499377|FG012|Overall Study|Death|8|||
130147427|NCT02315066|468499378|FG013|Overall Study|Death|21|||
130147428|NCT02315066|468499365|FG000|Overall Study|Other|0|||
130147429|NCT02315066|468499366|FG001|Overall Study|Other|0|||
130147430|NCT02315066|468499367|FG002|Overall Study|Other|0|||
130147431|NCT02315066|468499368|FG003|Overall Study|Other|0|||
130147432|NCT02315066|468499369|FG004|Overall Study|Other|0|||
130147433|NCT02315066|468499370|FG005|Overall Study|Other|0|||
130147434|NCT02315066|468499371|FG006|Overall Study|Other|0|||
130147435|NCT02315066|468499372|FG007|Overall Study|Other|1|||
130147436|NCT02315066|468499373|FG008|Overall Study|Other|1|||
130147437|NCT02315066|468499374|FG009|Overall Study|Other|2|||
130147438|NCT02315066|468499375|FG010|Overall Study|Other|0|||
130147439|NCT02315066|468499376|FG011|Overall Study|Other|0|||
130147440|NCT02315066|468499377|FG012|Overall Study|Other|0|||
130147441|NCT02315066|468499378|FG013|Overall Study|Other|0|||
130147442|NCT02315066|468499365|FG000|Overall Study|Subject refused further follow-up|0|||
130147443|NCT02315066|468499366|FG001|Overall Study|Subject refused further follow-up|2|||
130147444|NCT02315066|468499367|FG002|Overall Study|Subject refused further follow-up|2|||
130147445|NCT02315066|468499368|FG003|Overall Study|Subject refused further follow-up|0|||
130147446|NCT02315066|468499369|FG004|Overall Study|Subject refused further follow-up|0|||
130147447|NCT02315066|468499370|FG005|Overall Study|Subject refused further follow-up|0|||
130147448|NCT02315066|468499371|FG006|Overall Study|Subject refused further follow-up|2|||
130147449|NCT02315066|468499372|FG007|Overall Study|Subject refused further follow-up|3|||
130147450|NCT02315066|468499373|FG008|Overall Study|Subject refused further follow-up|0|||
130147451|NCT02315066|468499374|FG009|Overall Study|Subject refused further follow-up|1|||
130147452|NCT02315066|468499375|FG010|Overall Study|Subject refused further follow-up|1|||
130147453|NCT02315066|468499376|FG011|Overall Study|Subject refused further follow-up|2|||
130147454|NCT02315066|468499377|FG012|Overall Study|Subject refused further follow-up|2|||
130147455|NCT02315066|468499378|FG013|Overall Study|Subject refused further follow-up|4|||
130147456|NCT02315066|468499365|FG000|Overall Study|Study ongoing at date of cut-off|0|||
130147457|NCT02315066|468499366|FG001|Overall Study|Study ongoing at date of cut-off|0|||
130147458|NCT02315066|468499367|FG002|Overall Study|Study ongoing at date of cut-off|0|||
130147459|NCT02315066|468499368|FG003|Overall Study|Study ongoing at date of cut-off|0|||
130147460|NCT02315066|468499369|FG004|Overall Study|Study ongoing at date of cut-off|0|||
130147461|NCT02315066|468499370|FG005|Overall Study|Study ongoing at date of cut-off|0|||
130147462|NCT02315066|468499371|FG006|Overall Study|Study ongoing at date of cut-off|0|||
130147463|NCT02315066|468499372|FG007|Overall Study|Study ongoing at date of cut-off|0|||
130147464|NCT02315066|468499373|FG008|Overall Study|Study ongoing at date of cut-off|0|||
130147465|NCT02315066|468499374|FG009|Overall Study|Study ongoing at date of cut-off|0|||
130147466|NCT02315066|468499375|FG010|Overall Study|Study ongoing at date of cut-off|0|||
130147467|NCT02315066|468499376|FG011|Overall Study|Study ongoing at date of cut-off|0|||
130147468|NCT02315066|468499377|FG012|Overall Study|Study ongoing at date of cut-off|0|||
130147469|NCT02315066|468499378|FG013|Overall Study|Study ongoing at date of cut-off|1|||
130147470|NCT03180801|468499379|FG000|Overall Study|Physician Decision|3|||
130147471|NCT03180801|468499380|FG001|Overall Study|Physician Decision|3|||
130147472|NCT03180801|468499381|FG002|Overall Study|Physician Decision|1|||
130147473|NCT03180801|468499379|FG000|Overall Study|Non-compliance|1|||
130147474|NCT03180801|468499380|FG001|Overall Study|Non-compliance|4|||
130147475|NCT03180801|468499381|FG002|Overall Study|Non-compliance|0|||
130147476|NCT03180801|468499379|FG000|Overall Study|Inoculation Target Reached|1|||
130147477|NCT03180801|468499380|FG001|Overall Study|Inoculation Target Reached|1|||
130147478|NCT03180801|468499381|FG002|Overall Study|Inoculation Target Reached|3|||
130147479|NCT03180801|468499379|FG000|Overall Study|Adverse Event|1|||
130147480|NCT03180801|468499380|FG001|Overall Study|Adverse Event|0|||
130147481|NCT03180801|468499381|FG002|Overall Study|Adverse Event|2|||
130147482|NCT03180801|468499379|FG000|Overall Study|Withdrawal by Subject|2|||
130147483|NCT03180801|468499380|FG001|Overall Study|Withdrawal by Subject|2|||
130147484|NCT03180801|468499381|FG002|Overall Study|Withdrawal by Subject|1|||
130147485|NCT03180801|468499379|FG000|Overall Study|Lost to Follow-up|0|||
130147486|NCT03180801|468499380|FG001|Overall Study|Lost to Follow-up|2|||
130147487|NCT03180801|468499381|FG002|Overall Study|Lost to Follow-up|3|||
130147488|NCT00112294|468499383|FG000|Overall Study|Still on study|5|||
130147489|NCT00112294|468499384|FG001|Overall Study|Still on study|0|||
130147490|NCT01142908|468499385|FG000|Overall Study|Lost to Follow-up|19|||
130147491|NCT01142908|468499386|FG001|Overall Study|Lost to Follow-up|13|||
130147492|NCT01142908|468499385|FG000|Overall Study|Death|1|||
130147493|NCT01142908|468499386|FG001|Overall Study|Death|4|||
130147494|NCT01142908|468499385|FG000|Overall Study|Excluded - did not meet criteria|9|||
130147495|NCT01142908|468499386|FG001|Overall Study|Excluded - did not meet criteria|5|||
130147496|NCT01142908|468499385|FG000|Overall Study|Withdrawal by Subject|3|||
130147497|NCT01142908|468499386|FG001|Overall Study|Withdrawal by Subject|0|||
130147498|NCT00035555|468499387|FG000|Overall Study|Adverse Event|5|||
130147499|NCT00035555|468499388|FG001|Overall Study|Adverse Event|8|||
130147500|NCT00035555|468499389|FG002|Overall Study|Adverse Event|9|||
130147501|NCT00035555|468499387|FG000|Overall Study|Allograft loss|1|||
130147502|NCT00035555|468499388|FG001|Overall Study|Allograft loss|1|||
130147503|NCT00035555|468499389|FG002|Overall Study|Allograft loss|2|||
130147504|NCT00035555|468499387|FG000|Overall Study|Death|0|||
130147505|NCT00035555|468499388|FG001|Overall Study|Death|0|||
130147506|NCT00035555|468499389|FG002|Overall Study|Death|2|||
130147507|NCT00035555|468499387|FG000|Overall Study|Lost to Follow-up|0|||
130147508|NCT00035555|468499388|FG001|Overall Study|Lost to Follow-up|0|||
130147509|NCT00035555|468499389|FG002|Overall Study|Lost to Follow-up|1|||
130147510|NCT00035555|468499387|FG000|Overall Study|Noncompliance|0|||
130147511|NCT00035555|468499388|FG001|Overall Study|Noncompliance|1|||
130147512|NCT00035555|468499389|FG002|Overall Study|Noncompliance|1|||
130147513|NCT00035555|468499387|FG000|Overall Study|Prohibited medication|1|||
130147514|NCT00035555|468499388|FG001|Overall Study|Prohibited medication|1|||
130147515|NCT00035555|468499389|FG002|Overall Study|Prohibited medication|0|||
130147516|NCT00035555|468499387|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
130147517|NCT00035555|468499388|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
130147518|NCT00035555|468499389|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
130147519|NCT00035555|468499387|FG000|Overall Study|Withdrawal by Subject|2|||
130147520|NCT00035555|468499388|FG001|Overall Study|Withdrawal by Subject|0|||
130147521|NCT00035555|468499389|FG002|Overall Study|Withdrawal by Subject|2|||
130147522|NCT00035555|468499387|FG000|Overall Study|Investigator deemed not a good candidate|0|||
130147523|NCT00035555|468499388|FG001|Overall Study|Investigator deemed not a good candidate|0|||
130147524|NCT00035555|468499389|FG002|Overall Study|Investigator deemed not a good candidate|1|||
130147525|NCT00035555|468499387|FG000|Overall Study|Received cyclosporin in error|0|||
130147526|NCT00035555|468499388|FG001|Overall Study|Received cyclosporin in error|0|||
130147527|NCT00035555|468499389|FG002|Overall Study|Received cyclosporin in error|1|||
130147528|NCT02972515|468499392|FG000|Overall Study|Lost to Follow-up|78|||
130147529|NCT01450800|468499393|FG000|Overall Study|Protocol Violation|1|||
130147530|NCT01450800|468499394|FG001|Overall Study|Protocol Violation|3|||
130147531|NCT01086969|468499402|FG000|Overall Study|Withdrawal by Subject|1|||
130147532|NCT01086969|468499403|FG001|Overall Study|Withdrawal by Subject|2|||
130147533|NCT01086969|468499404|FG002|Overall Study|Withdrawal by Subject|0|||
130147534|NCT04253236|468499405|FG000|Overall Study|Adverse Event|1|||
130147535|NCT04253236|468499406|FG001|Overall Study|Adverse Event|0|||
130147536|NCT04253236|468499405|FG000|Overall Study|Safety Concerns|1|||
130147537|NCT04253236|468499406|FG001|Overall Study|Safety Concerns|0|||
130147538|NCT04253236|468499405|FG000|Overall Study|Study Terminated by Sponsor|1|||
130147539|NCT04253236|468499406|FG001|Overall Study|Study Terminated by Sponsor|0|||
130147540|NCT00587431|468499407|FG000|Overall Study|Adverse Event|1|||
130147541|NCT00587431|468499408|FG001|Overall Study|Adverse Event|0|||
130147542|NCT00587431|468499407|FG000|Overall Study|Withdrawal by Subject|0|||
130147543|NCT00587431|468499408|FG001|Overall Study|Withdrawal by Subject|1|||
130147544|NCT04291508|468499412|FG000|Overall Study|Withdrawal by Subject|1|||
130147545|NCT04291508|468499413|FG001|Overall Study|Withdrawal by Subject|0|||
130147546|NCT04291508|468499414|FG002|Overall Study|Withdrawal by Subject|1|||
130147547|NCT04291508|468499415|FG003|Overall Study|Withdrawal by Subject|0|||
130147548|NCT04291508|468499412|FG000|Overall Study|lost to follow up|4|||
130147549|NCT04291508|468499413|FG001|Overall Study|lost to follow up|0|||
130147550|NCT04291508|468499414|FG002|Overall Study|lost to follow up|1|||
130147551|NCT04291508|468499415|FG003|Overall Study|lost to follow up|0|||
130147552|NCT03566238|468499416|FG000|Overall Study|Adverse Event|0|||
130147553|NCT03566238|468499417|FG001|Overall Study|Adverse Event|1|||
130147554|NCT03566238|468499418|FG002|Overall Study|Adverse Event|0|||
130147555|NCT03566238|468499416|FG000|Overall Study|Lack of Efficacy|4|||
130147556|NCT03566238|468499417|FG001|Overall Study|Lack of Efficacy|2|||
130147557|NCT03566238|468499418|FG002|Overall Study|Lack of Efficacy|5|||
130147558|NCT03566238|468499416|FG000|Overall Study|Other|1|||
130147559|NCT03566238|468499417|FG001|Overall Study|Other|0|||
130147560|NCT03566238|468499418|FG002|Overall Study|Other|0|||
130147561|NCT04203667|468499426|FG000|Overall Study|Withdrawal by Subject|1|||
130147562|NCT04203667|468499426|FG000|Overall Study|Lost to Follow-up|1|||
130147563|NCT04203667|468499426|FG000|Overall Study|Death|1|||
130147564|NCT04203667|468499426|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
130147565|NCT01183884|468499427|FG000|Overall Study|Progressive Disease|26|||
130147566|NCT01183884|468499427|FG000|Overall Study|Adverse Event|3|||
130147567|NCT01183884|468499427|FG000|Overall Study|Withdrawal by Subject|1|||
130147568|NCT01183884|468499427|FG000|Overall Study|Other Complicating Disease|3|||
130147569|NCT01183884|468499427|FG000|Overall Study|Not Treated|1|||
130147570|NCT01183884|468499427|FG000|Overall Study|Other|4|||
130147571|NCT00127166|468499428|FG000|Period I|Protocol Violation|0|||
130147572|NCT00127166|468499429|FG001|Period I|Protocol Violation|2|||
130147573|NCT00127166|468499428|FG000|Period I|Withdrawal by Subject|2|||
130147574|NCT00127166|468499429|FG001|Period I|Withdrawal by Subject|0|||
130147575|NCT00127166|468499428|FG000|Period I|Patient did not meet inclusion criteria|1|||
130147576|NCT00127166|468499429|FG001|Period I|Patient did not meet inclusion criteria|0|||
130147577|NCT00127166|468499428|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
130147578|NCT00127166|468499429|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
130147579|NCT00127166|468499428|FG000|Period II|Withdrawal by Subject|2|||
130147580|NCT00127166|468499429|FG001|Period II|Withdrawal by Subject|0|||
130147581|NCT00127166|468499428|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
130147582|NCT00127166|468499429|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
130147583|NCT00708682|468499434|FG000|Infant Series|Adverse Event|1|||
130147584|NCT00708682|468499434|FG000|Infant Series|Lost to Follow-up|4|||
130147585|NCT00708682|468499434|FG000|Infant Series|Protocol Violation|1|||
130147586|NCT00708682|468499434|FG000|Infant Series|Parent/legal guardian request|6|||
130147587|NCT00708682|468499434|FG000|Infant Series|Failed to return|2|||
130147588|NCT00708682|468499434|FG000|Infant Series|Other|19|||
130147589|NCT00708682|468499434|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
130147590|NCT00708682|468499434|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
130147591|NCT00708682|468499434|FG000|Toddler Dose|Lost to Follow-up|3|||
130147592|NCT00708682|468499434|FG000|Toddler Dose|Failed to Return|4|||
130147593|NCT03689894|468499436|FG000|Overall Study|Adverse Event|1|||
130147594|NCT04718129|468499441|FG000|Overall Study|Lost to Follow-up|6|||
130147595|NCT04718129|468499442|FG001|Overall Study|Lost to Follow-up|7|||
130147596|NCT01588548|468499446|FG000|Overall Study|Withdrawal by Subject|0|||
130147597|NCT01588548|468499447|FG001|Overall Study|Withdrawal by Subject|1|||
130147598|NCT01588548|468499448|FG002|Overall Study|Withdrawal by Subject|1|||
130147599|NCT01588548|468499449|FG003|Overall Study|Withdrawal by Subject|1|||
130147600|NCT01588548|468499450|FG004|Overall Study|Withdrawal by Subject|2|||
130147601|NCT01588548|468499451|FG005|Overall Study|Withdrawal by Subject|3|||
130147602|NCT01588548|468499446|FG000|Overall Study|Adverse Event|0|||
130147603|NCT01588548|468499447|FG001|Overall Study|Adverse Event|0|||
130147604|NCT01588548|468499448|FG002|Overall Study|Adverse Event|1|||
130147605|NCT01588548|468499449|FG003|Overall Study|Adverse Event|2|||
130147606|NCT01588548|468499450|FG004|Overall Study|Adverse Event|1|||
130147607|NCT01588548|468499451|FG005|Overall Study|Adverse Event|0|||
130147608|NCT01588548|468499446|FG000|Overall Study|Condition Under Investigation Worsened|3|||
130147609|NCT01588548|468499447|FG001|Overall Study|Condition Under Investigation Worsened|6|||
130147610|NCT01588548|468499448|FG002|Overall Study|Condition Under Investigation Worsened|4|||
130147611|NCT01588548|468499449|FG003|Overall Study|Condition Under Investigation Worsened|4|||
130147612|NCT01588548|468499450|FG004|Overall Study|Condition Under Investigation Worsened|3|||
130147613|NCT01588548|468499451|FG005|Overall Study|Condition Under Investigation Worsened|3|||
130147614|NCT01835548|468499452|FG000|Dose Optimization Period|Adverse Event|0|||
130147615|NCT01835548|468499453|FG001|Dose Optimization Period|Adverse Event|0|||
130147616|NCT01835548|468499454|FG002|Dose Optimization Period|Adverse Event|1|||
130147617|NCT01835548|468499452|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
130147618|NCT01835548|468499453|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
130147619|NCT01835548|468499454|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
130147620|NCT01835548|468499452|FG000|Double-Blind Treatment Period|Adverse Event|0|||
130147621|NCT01835548|468499453|FG001|Double-Blind Treatment Period|Adverse Event|1|||
130147622|NCT01835548|468499454|FG002|Double-Blind Treatment Period|Adverse Event|0|||
130147623|NCT01835548|468499452|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129976702|NCT04879849|467877841|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976703|NCT04879849|467877842|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976704|NCT04879849|467877843|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
130147624|NCT01835548|468499453|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
130147625|NCT01835548|468499454|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
130147626|NCT00537017|468499455|FG000|Treatment Phase|Adverse Event|19|||
130147627|NCT00537017|468499455|FG000|Treatment Phase|Withdrawal by Subject|13|||
130147628|NCT00537017|468499455|FG000|Treatment Phase|Protocol Violation|2|||
130147629|NCT00537017|468499455|FG000|Follow-up Phase|Withdrawal by Subject|9|||
130147630|NCT03257254|468499456|FG000|Overall Study|Withdrawal by Subject|7|||
130147631|NCT03257254|468499456|FG000|Overall Study|Lost to Follow-up|9|||
130147632|NCT03257254|468499456|FG000|Overall Study|Study discontinued by sponsor|5|||
130147633|NCT01362296|468499457|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
130147634|NCT01362296|468499458|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
130147635|NCT01362296|468499459|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
130147636|NCT01362296|468499460|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
130147637|NCT01362296|468499457|FG000|Randomized Phase (RP)|Physician Decision|1|||
130147638|NCT01362296|468499458|FG001|Randomized Phase (RP)|Physician Decision|9|||
130147639|NCT01362296|468499459|FG002|Randomized Phase (RP)|Physician Decision|0|||
130147640|NCT01362296|468499460|FG003|Randomized Phase (RP)|Physician Decision|0|||
130147641|NCT01362296|468499457|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
130147642|NCT01362296|468499458|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
130147643|NCT01362296|468499459|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
130147644|NCT01362296|468499460|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
130147645|NCT01362296|468499457|FG000|Randomized Phase (RP)|Adverse Event|20|||
130147646|NCT01362296|468499458|FG001|Randomized Phase (RP)|Adverse Event|4|||
130147647|NCT01362296|468499459|FG002|Randomized Phase (RP)|Adverse Event|0|||
130147648|NCT01362296|468499460|FG003|Randomized Phase (RP)|Adverse Event|0|||
130147649|NCT01362296|468499457|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
130147650|NCT01362296|468499458|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
130147651|NCT01362296|468499459|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
130147652|NCT01362296|468499460|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
130147653|NCT01362296|468499457|FG000|Crossover Phase|PD including Death due to PD|0|||
130147654|NCT01362296|468499458|FG001|Crossover Phase|PD including Death due to PD|0|||
130147655|NCT01362296|468499459|FG002|Crossover Phase|PD including Death due to PD|16|||
130147656|NCT01362296|468499460|FG003|Crossover Phase|PD including Death due to PD|1|||
130147657|NCT01362296|468499457|FG000|Crossover Phase|Withdrawal by Subject|0|||
130147658|NCT01362296|468499458|FG001|Crossover Phase|Withdrawal by Subject|0|||
130147659|NCT01362296|468499459|FG002|Crossover Phase|Withdrawal by Subject|2|||
130147660|NCT01362296|468499460|FG003|Crossover Phase|Withdrawal by Subject|1|||
130147661|NCT01362296|468499457|FG000|Crossover Phase|Adverse Event|0|||
130147662|NCT01362296|468499458|FG001|Crossover Phase|Adverse Event|0|||
130147663|NCT01362296|468499459|FG002|Crossover Phase|Adverse Event|4|||
130147664|NCT01362296|468499460|FG003|Crossover Phase|Adverse Event|0|||
130147665|NCT01362296|468499457|FG000|Crossover Phase|Study Closed/Terminated|0|||
130147666|NCT01362296|468499458|FG001|Crossover Phase|Study Closed/Terminated|0|||
130147667|NCT01362296|468499459|FG002|Crossover Phase|Study Closed/Terminated|1|||
130147668|NCT01362296|468499460|FG003|Crossover Phase|Study Closed/Terminated|0|||
130147669|NCT03168906|468499463|FG000|Overall Study|Lack of Efficacy|6|||
130147670|NCT03168906|468499464|FG001|Overall Study|Lack of Efficacy|6|||
130147671|NCT01321697|468499465|FG000|Overall Study|Study Terminated|7|||
130147672|NCT00857818|468499468|FG000|Overall Study|Lack of Efficacy|1|||
130147673|NCT00857818|468499469|FG001|Overall Study|Lack of Efficacy|0|||
130147674|NCT00857818|468499468|FG000|Overall Study|Adverse Event|3|||
130147675|NCT00857818|468499469|FG001|Overall Study|Adverse Event|0|||
130147676|NCT00857818|468499468|FG000|Overall Study|Withdrawal by Subject|0|||
130147677|NCT00857818|468499469|FG001|Overall Study|Withdrawal by Subject|4|||
130147678|NCT00857818|468499468|FG000|Overall Study|Sponsor terminated study|6|||
130147679|NCT00857818|468499469|FG001|Overall Study|Sponsor terminated study|4|||
130147680|NCT00857818|468499468|FG000|Overall Study|Investigator decision|1|||
130147681|NCT00857818|468499469|FG001|Overall Study|Investigator decision|0|||
130147682|NCT02625974|468499471|FG000|Part 1|Lost to Follow-up|9|||
130147683|NCT02625974|468499472|FG001|Part 1|Lost to Follow-up|3|||
130147684|NCT02625974|468499471|FG000|Part 2|Lost to Follow-up|4|||
130147685|NCT02625974|468499472|FG001|Part 2|Lost to Follow-up|6|||
130147686|NCT02625974|468499471|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
130147687|NCT02625974|468499472|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
130147688|NCT00434590|468499473|FG000|Overall Study|Administrative problems|5|||
130147689|NCT00434590|468499474|FG001|Overall Study|Administrative problems|5|||
130147690|NCT04149535|468499476|FG000|Overall Study|Death|11|||
130147691|NCT04149535|468499477|FG001|Overall Study|Death|7|||
130147692|NCT04149535|468499476|FG000|Overall Study|Physician Decision|10|||
130147693|NCT04149535|468499477|FG001|Overall Study|Physician Decision|4|||
130147694|NCT04149535|468499476|FG000|Overall Study|Withdrawal by Subject|6|||
130147695|NCT04149535|468499477|FG001|Overall Study|Withdrawal by Subject|7|||
130147696|NCT04149535|468499476|FG000|Overall Study|Not described|2|||
130147697|NCT04149535|468499477|FG001|Overall Study|Not described|0|||
130147698|NCT02175368|468499478|FG000|Overall Study|Lost to Follow-up|1|||
130147699|NCT02875028|468499479|FG000|Washout Period|Withdrawal by Subject|0|||
130147700|NCT02875028|468499480|FG001|Washout Period|Withdrawal by Subject|1|||
130147701|NCT02447887|468501096|FG000|Overall Study|Study was terminated|3|||
130147702|NCT03180528|468501097|FG000|Overall Study|Adverse Event|1|||
130147703|NCT03180528|468501097|FG000|Overall Study|Withdrawal by Subject|1|||
130147704|NCT03180528|468501097|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
130147705|NCT02839798|468501098|FG000|Overall Study|Withdrawal by Subject|2|||
130147706|NCT04703855|468501099|FG000|Overall Study|Heart Transplant|1|||
130147707|NCT00401245|468501102|FG000|Double Blind Titration Phase|Adverse Event|3|||
130147708|NCT00401245|468501103|FG001|Double Blind Titration Phase|Adverse Event|2|||
130147709|NCT00401245|468501104|FG002|Double Blind Titration Phase|Adverse Event|5|||
130147710|NCT00401245|468501105|FG003|Double Blind Titration Phase|Adverse Event|12|||
130147711|NCT00401245|468501106|FG004|Double Blind Titration Phase|Adverse Event|0|||
130147712|NCT00401245|468501107|FG005|Double Blind Titration Phase|Adverse Event|0|||
130147713|NCT00401245|468501108|FG006|Double Blind Titration Phase|Adverse Event|0|||
130147714|NCT00401245|468501109|FG007|Double Blind Titration Phase|Adverse Event|0|||
130147715|NCT00401245|468501102|FG000|Double Blind Titration Phase|Other|0|||
130147716|NCT00401245|468501103|FG001|Double Blind Titration Phase|Other|0|||
130147717|NCT00401245|468501104|FG002|Double Blind Titration Phase|Other|1|||
130147718|NCT00401245|468501105|FG003|Double Blind Titration Phase|Other|0|||
130147719|NCT00401245|468501106|FG004|Double Blind Titration Phase|Other|0|||
130147720|NCT00401245|468501107|FG005|Double Blind Titration Phase|Other|0|||
130147721|NCT00401245|468501108|FG006|Double Blind Titration Phase|Other|0|||
130147722|NCT00401245|468501109|FG007|Double Blind Titration Phase|Other|0|||
130147723|NCT00401245|468501102|FG000|Double Blind Titration Phase|Protocol Violation|0|||
130147724|NCT00401245|468501103|FG001|Double Blind Titration Phase|Protocol Violation|0|||
130147725|NCT00401245|468501104|FG002|Double Blind Titration Phase|Protocol Violation|0|||
130147726|NCT00401245|468501105|FG003|Double Blind Titration Phase|Protocol Violation|1|||
130147727|NCT00401245|468501106|FG004|Double Blind Titration Phase|Protocol Violation|0|||
130147728|NCT00401245|468501107|FG005|Double Blind Titration Phase|Protocol Violation|0|||
130147729|NCT00401245|468501108|FG006|Double Blind Titration Phase|Protocol Violation|0|||
130147730|NCT00401245|468501109|FG007|Double Blind Titration Phase|Protocol Violation|0|||
130147731|NCT00401245|468501102|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
130147732|NCT00401245|468501103|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
130147733|NCT00401245|468501104|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
130147734|NCT00401245|468501105|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
130147735|NCT00401245|468501106|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
130147736|NCT00401245|468501107|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
130147737|NCT00401245|468501108|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
130147738|NCT00401245|468501109|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
130147739|NCT00401245|468501102|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130147740|NCT00401245|468501103|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
130147741|NCT00401245|468501104|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130147742|NCT00401245|468501105|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
130147743|NCT00401245|468501106|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130147744|NCT00401245|468501107|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130147745|NCT00401245|468501108|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130147746|NCT00401245|468501109|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
130147747|NCT00401245|468501102|FG000|Open Label Phase|Adverse Event|5|||
130147748|NCT00401245|468501103|FG001|Open Label Phase|Adverse Event|14|||
130147749|NCT00401245|468501104|FG002|Open Label Phase|Adverse Event|6|||
130147750|NCT00401245|468501105|FG003|Open Label Phase|Adverse Event|7|||
130147751|NCT00401245|468501106|FG004|Open Label Phase|Adverse Event|0|||
129976705|NCT04879849|467877844|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976706|NCT04879849|467877845|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
129976707|NCT04879849|467877846|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976708|NCT04879849|467877839|FG000|Overall Study|Reason Not Specified|1|||
129976709|NCT04879849|467877840|FG001|Overall Study|Reason Not Specified|0|||
129976710|NCT04879849|467877841|FG002|Overall Study|Reason Not Specified|0|||
129976711|NCT04879849|467877842|FG003|Overall Study|Reason Not Specified|0|||
129976712|NCT04879849|467877843|FG004|Overall Study|Reason Not Specified|0|||
129976713|NCT04879849|467877844|FG005|Overall Study|Reason Not Specified|0|||
129976714|NCT04879849|467877845|FG006|Overall Study|Reason Not Specified|0|||
129976715|NCT04879849|467877846|FG007|Overall Study|Reason Not Specified|0|||
129976716|NCT03361865|467877847|FG000|Overall Study|Death|17|||
129976717|NCT03361865|467877848|FG001|Overall Study|Death|18|||
129976718|NCT03361865|467877847|FG000|Overall Study|Physician Decision|1|||
129976719|NCT03361865|467877848|FG001|Overall Study|Physician Decision|9|||
129976720|NCT03361865|467877847|FG000|Overall Study|Withdrawal by Subject|1|||
129976721|NCT03361865|467877848|FG001|Overall Study|Withdrawal by Subject|0|||
129976722|NCT03852719|467877849|FG000|Overall Study|Withdrawal of consent|8|||
130147752|NCT00401245|468501107|FG005|Open Label Phase|Adverse Event|0|||
130147753|NCT00401245|468501108|FG006|Open Label Phase|Adverse Event|0|||
130147754|NCT00401245|468501109|FG007|Open Label Phase|Adverse Event|0|||
130147755|NCT00401245|468501102|FG000|Open Label Phase|Lost to Follow-up|5|||
130147756|NCT00401245|468501103|FG001|Open Label Phase|Lost to Follow-up|7|||
129976723|NCT03852719|467877850|FG001|Overall Study|Withdrawal of consent|8|||
129976724|NCT03852719|467877851|FG002|Overall Study|Withdrawal of consent|9|||
129976725|NCT03852719|467877849|FG000|Overall Study|Physician Decision|5|||
129976726|NCT03852719|467877850|FG001|Overall Study|Physician Decision|4|||
129976727|NCT03852719|467877851|FG002|Overall Study|Physician Decision|1|||
129976728|NCT03852719|467877849|FG000|Overall Study|Pregnancy|2|||
129976729|NCT03852719|467877850|FG001|Overall Study|Pregnancy|1|||
129976730|NCT03852719|467877851|FG002|Overall Study|Pregnancy|0|||
129976731|NCT03852719|467877849|FG000|Overall Study|Death|1|||
129976732|NCT03852719|467877850|FG001|Overall Study|Death|0|||
129976733|NCT03852719|467877851|FG002|Overall Study|Death|0|||
129976734|NCT03852719|467877849|FG000|Overall Study|Reason not Specified|3|||
129976735|NCT03852719|467877850|FG001|Overall Study|Reason not Specified|3|||
129976736|NCT03852719|467877851|FG002|Overall Study|Reason not Specified|5|||
129976737|NCT03852719|467877849|FG000|Overall Study|Adverse Event|2|||
129976738|NCT03852719|467877850|FG001|Overall Study|Adverse Event|1|||
129976739|NCT03852719|467877851|FG002|Overall Study|Adverse Event|4|||
129976740|NCT03852719|467877849|FG000|Overall Study|Progressive disease|1|||
129976741|NCT03852719|467877850|FG001|Overall Study|Progressive disease|4|||
129976742|NCT03852719|467877851|FG002|Overall Study|Progressive disease|1|||
129976743|NCT03852719|467877849|FG000|Overall Study|Lost to Follow-up|1|||
129976744|NCT03852719|467877850|FG001|Overall Study|Lost to Follow-up|0|||
129976745|NCT03852719|467877851|FG002|Overall Study|Lost to Follow-up|0|||
129976746|NCT05543187|467877854|FG000|Overall Study|Ongoing|3|||
129976747|NCT05543187|467877855|FG001|Overall Study|Ongoing|2|||
129976748|NCT03810235|467877856|FG000|Overall Study|Withdrawal by Subject|2|||
129976749|NCT03810235|467877857|FG001|Overall Study|Withdrawal by Subject|0|||
129976750|NCT04777864|467877858|FG000|Overall Study|Lost to Follow-up|8|||
129976751|NCT04777864|467877859|FG001|Overall Study|Lost to Follow-up|19|||
129976752|NCT01647542|467877860|FG000|Overall Study|Major Protocol Deviation|1|||
129976753|NCT01647542|467877861|FG001|Overall Study|Major Protocol Deviation|0|||
129976754|NCT01647542|467877862|FG002|Overall Study|Major Protocol Deviation|0|||
129976755|NCT01647542|467877860|FG000|Overall Study|Adverse Event|4|||
129976756|NCT01647542|467877861|FG001|Overall Study|Adverse Event|5|||
129976757|NCT01647542|467877862|FG002|Overall Study|Adverse Event|4|||
129976758|NCT01647542|467877860|FG000|Overall Study|Lost to Follow-up|0|||
129976759|NCT01647542|467877861|FG001|Overall Study|Lost to Follow-up|2|||
129976760|NCT01647542|467877862|FG002|Overall Study|Lost to Follow-up|2|||
129976761|NCT01647542|467877860|FG000|Overall Study|Withdrawal by Subject|6|||
129976762|NCT01647542|467877861|FG001|Overall Study|Withdrawal by Subject|4|||
129976763|NCT01647542|467877862|FG002|Overall Study|Withdrawal by Subject|0|||
129976764|NCT01647542|467877860|FG000|Overall Study|Study Termination|64|||
129976765|NCT01647542|467877861|FG001|Overall Study|Study Termination|61|||
129976766|NCT01647542|467877862|FG002|Overall Study|Study Termination|65|||
129976767|NCT01647542|467877860|FG000|Overall Study|Lack of Efficacy|1|||
129976768|NCT01647542|467877861|FG001|Overall Study|Lack of Efficacy|1|||
129976769|NCT01647542|467877862|FG002|Overall Study|Lack of Efficacy|0|||
129976770|NCT01647542|467877860|FG000|Overall Study|Death|0|||
129976771|NCT01647542|467877861|FG001|Overall Study|Death|0|||
129976772|NCT01647542|467877862|FG002|Overall Study|Death|1|||
129976773|NCT03086655|467877863|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
129976774|NCT03086655|467877864|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
129976775|NCT03086655|467877863|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
129976776|NCT03086655|467877864|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
129976777|NCT03086655|467877863|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
129976778|NCT03086655|467877864|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
129976779|NCT03086655|467877863|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
129976780|NCT03086655|467877864|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
129976781|NCT03086655|467877863|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
129976782|NCT03086655|467877864|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
130147757|NCT00401245|468501104|FG002|Open Label Phase|Lost to Follow-up|5|||
130147758|NCT00401245|468501105|FG003|Open Label Phase|Lost to Follow-up|4|||
130147759|NCT00401245|468501106|FG004|Open Label Phase|Lost to Follow-up|0|||
130147760|NCT00401245|468501107|FG005|Open Label Phase|Lost to Follow-up|0|||
129976783|NCT03086655|467877863|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
129976784|NCT03086655|467877864|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
129976785|NCT03086655|467877863|FG000|12 Month Follow-up = Final Assessment|Death|0|||
129976786|NCT03086655|467877864|FG001|12 Month Follow-up = Final Assessment|Death|1|||
129976787|NCT05576662|467877865|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
129976788|NCT05576662|467877866|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
129976789|NCT05576662|467877865|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
130147761|NCT00401245|468501108|FG006|Open Label Phase|Lost to Follow-up|0|||
130154901|NCT01470612|468526639|FG001|Overall Study|Pregnancy|10|||
129976790|NCT05576662|467877866|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
129976791|NCT05576662|467877865|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
129976792|NCT05576662|467877866|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
129976793|NCT05576662|467877865|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
129976794|NCT05576662|467877866|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
129976795|NCT03008005|467877867|FG000|Overall Study|Physician Decision|1|||
129976796|NCT03008005|467877868|FG001|Overall Study|Physician Decision|0|||
129976797|NCT03008005|467877869|FG002|Overall Study|Physician Decision|0|||
129976798|NCT03008005|467877867|FG000|Overall Study|Withdrawal by Subject|1|||
129976799|NCT03008005|467877868|FG001|Overall Study|Withdrawal by Subject|0|||
129976800|NCT03008005|467877869|FG002|Overall Study|Withdrawal by Subject|0|||
129976801|NCT03008005|467877867|FG000|Overall Study|Ineligible|0|||
129976802|NCT03008005|467877868|FG001|Overall Study|Ineligible|1|||
129976803|NCT03008005|467877869|FG002|Overall Study|Ineligible|0|||
129976804|NCT01040169|467877885|FG000|Overall Study|Lost to Follow-up|3|||
129976805|NCT01040169|467877886|FG001|Overall Study|Lost to Follow-up|8|||
129976806|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Adverse Event|4|||
129976807|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Adverse Event|0|||
129976808|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Adverse Event|0|||
129976809|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
129976810|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
129976811|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
129976812|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Death|1|||
129976813|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Death|0|||
129976814|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Death|0|||
129976815|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Physician Decision|1|||
129976816|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Physician Decision|0|||
129976817|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Physician Decision|0|||
129976818|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
129976819|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
129976820|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
129976821|NCT00350727|467877887|FG000|Phase II|Disease Progression|0|||
129976822|NCT00350727|467877888|FG001|Phase II|Disease Progression|15|||
129976823|NCT00350727|467877889|FG002|Phase II|Disease Progression|16|||
129976824|NCT00350727|467877887|FG000|Phase II|Clinical Deterioration|0|||
129976825|NCT00350727|467877888|FG001|Phase II|Clinical Deterioration|1|||
129976826|NCT00350727|467877889|FG002|Phase II|Clinical Deterioration|0|||
129976827|NCT00350727|467877887|FG000|Phase II|Withdrawal by Subject|0|||
129976828|NCT00350727|467877888|FG001|Phase II|Withdrawal by Subject|2|||
129976829|NCT00350727|467877889|FG002|Phase II|Withdrawal by Subject|1|||
129976830|NCT00350727|467877887|FG000|Phase II|Adverse Event|0|||
129976831|NCT00350727|467877888|FG001|Phase II|Adverse Event|1|||
129976832|NCT00350727|467877889|FG002|Phase II|Adverse Event|1|||
129976833|NCT00350727|467877887|FG000|Phase II|Death|0|||
129976834|NCT00350727|467877888|FG001|Phase II|Death|0|||
129976835|NCT00350727|467877889|FG002|Phase II|Death|2|||
129976836|NCT00350727|467877887|FG000|Phase II|Sponsor Terminated Study|0|||
129976837|NCT00350727|467877888|FG001|Phase II|Sponsor Terminated Study|0|||
129976838|NCT00350727|467877889|FG002|Phase II|Sponsor Terminated Study|1|||
129976839|NCT00350727|467877887|FG000|Phase II|Enrolled in Rollover Study|0|||
129976840|NCT00350727|467877888|FG001|Phase II|Enrolled in Rollover Study|0|||
129976841|NCT00350727|467877889|FG002|Phase II|Enrolled in Rollover Study|1|||
129976842|NCT03633799|467877894|FG000|Overall Study|Adverse Event|349|||
129976843|NCT03633799|467877894|FG000|Overall Study|Withdrawal by Subject|288|||
129976844|NCT03633799|467877894|FG000|Overall Study|Lost to Follow-up|97|||
129976845|NCT03633799|467877894|FG000|Overall Study|Physician Decision|9|||
129976846|NCT03633799|467877894|FG000|Overall Study|Protocol Violation|4|||
129976847|NCT03633799|467877894|FG000|Overall Study|Pregnancy|20|||
129976848|NCT03633799|467877894|FG000|Overall Study|other|39|||
129976849|NCT03633799|467877894|FG000|Overall Study|ongoing within third year of study|106|||
129976850|NCT03633799|467877894|FG000|Overall Study|unsuccessful study drug placement|19|||
129976851|NCT03551691|467877895|FG000|Overall Study|Withdrawal by Subject|3|||
129976852|NCT03551691|467877896|FG001|Overall Study|Withdrawal by Subject|3|||
129976853|NCT03520712|467877897|FG000|Overall Study|Early termination of the study by Sponsor|2|||
129976854|NCT05855967|467877898|FG000|Overall Study|Withdrawal by Subject|7|||
129976855|NCT05855967|467877899|FG001|Overall Study|Withdrawal by Subject|5|||
129976856|NCT05855967|467877898|FG000|Overall Study|Lost to Follow-up|2|||
129976857|NCT05855967|467877899|FG001|Overall Study|Lost to Follow-up|1|||
129976858|NCT02446821|467877900|FG000|Overall Study|Adverse Event|28|||
129976859|NCT02446821|467877900|FG000|Overall Study|Withdrawal by Subject|6|||
129976860|NCT02446821|467877900|FG000|Overall Study|Lost to Follow-up|22|||
129976861|NCT02446821|467877900|FG000|Overall Study|other|9|||
129976862|NCT02446821|467877900|FG000|Overall Study|insertion failure|3|||
129976863|NCT04427280|467879465|FG000|Overall Study|Withdrawal by Subject|0|||
129976864|NCT04427280|467879466|FG001|Overall Study|Withdrawal by Subject|2|||
129976865|NCT02942277|467879474|FG000|Year 1|Withdrawal by Subject|0|||
129976866|NCT02942277|467879475|FG001|Year 1|Withdrawal by Subject|0|||
129976867|NCT02942277|467879476|FG002|Year 1|Withdrawal by Subject|0|||
129976868|NCT02942277|467879477|FG003|Year 1|Withdrawal by Subject|0|||
129976869|NCT02942277|467879478|FG004|Year 1|Withdrawal by Subject|1|||
129976870|NCT02942277|467879479|FG005|Year 1|Withdrawal by Subject|3|||
129976871|NCT02942277|467879480|FG006|Year 1|Withdrawal by Subject|0|||
129976872|NCT02942277|467879481|FG007|Year 1|Withdrawal by Subject|1|||
129976873|NCT02942277|467879482|FG008|Year 1|Withdrawal by Subject|0|||
129976874|NCT02942277|467879483|FG009|Year 1|Withdrawal by Subject|0|||
129976875|NCT02942277|467879484|FG010|Year 1|Withdrawal by Subject|3|||
129976876|NCT02942277|467879474|FG000|Year 1|Travel|0|||
129976877|NCT02942277|467879475|FG001|Year 1|Travel|1|||
129976878|NCT02942277|467879476|FG002|Year 1|Travel|0|||
129976879|NCT02942277|467879477|FG003|Year 1|Travel|0|||
129976880|NCT02942277|467879478|FG004|Year 1|Travel|4|||
129976881|NCT02942277|467879479|FG005|Year 1|Travel|5|||
129976882|NCT02942277|467879480|FG006|Year 1|Travel|0|||
129976883|NCT02942277|467879481|FG007|Year 1|Travel|0|||
129976884|NCT02942277|467879482|FG008|Year 1|Travel|0|||
129976885|NCT02942277|467879483|FG009|Year 1|Travel|0|||
129976886|NCT02942277|467879484|FG010|Year 1|Travel|8|||
129976887|NCT02942277|467879474|FG000|Year 1|Joined Army|0|||
129976888|NCT02942277|467879475|FG001|Year 1|Joined Army|1|||
129976889|NCT02942277|467879476|FG002|Year 1|Joined Army|0|||
129976890|NCT02942277|467879477|FG003|Year 1|Joined Army|0|||
129976891|NCT02942277|467879478|FG004|Year 1|Joined Army|0|||
129976892|NCT02942277|467879479|FG005|Year 1|Joined Army|0|||
129976893|NCT02942277|467879480|FG006|Year 1|Joined Army|0|||
129976894|NCT02942277|467879481|FG007|Year 1|Joined Army|0|||
129976895|NCT02942277|467879482|FG008|Year 1|Joined Army|0|||
129976896|NCT02942277|467879483|FG009|Year 1|Joined Army|0|||
129976897|NCT02942277|467879484|FG010|Year 1|Joined Army|0|||
129976898|NCT02942277|467879474|FG000|Year 1|Subject met withdrawal criteria|0|||
129976899|NCT02942277|467879475|FG001|Year 1|Subject met withdrawal criteria|0|||
129976900|NCT02942277|467879476|FG002|Year 1|Subject met withdrawal criteria|0|||
129976901|NCT02942277|467879477|FG003|Year 1|Subject met withdrawal criteria|1|||
129976902|NCT02942277|467879478|FG004|Year 1|Subject met withdrawal criteria|0|||
129976903|NCT02942277|467879479|FG005|Year 1|Subject met withdrawal criteria|0|||
129976904|NCT02942277|467879480|FG006|Year 1|Subject met withdrawal criteria|0|||
129976905|NCT02942277|467879481|FG007|Year 1|Subject met withdrawal criteria|0|||
129976906|NCT02942277|467879482|FG008|Year 1|Subject met withdrawal criteria|0|||
129976907|NCT02942277|467879483|FG009|Year 1|Subject met withdrawal criteria|0|||
129976908|NCT02942277|467879484|FG010|Year 1|Subject met withdrawal criteria|0|||
129976909|NCT02942277|467879474|FG000|Year 1|Lost to Follow-up|0|||
129976910|NCT02942277|467879475|FG001|Year 1|Lost to Follow-up|0|||
129976911|NCT02942277|467879476|FG002|Year 1|Lost to Follow-up|0|||
129976912|NCT02942277|467879477|FG003|Year 1|Lost to Follow-up|0|||
129976913|NCT02942277|467879478|FG004|Year 1|Lost to Follow-up|1|||
129976914|NCT02942277|467879479|FG005|Year 1|Lost to Follow-up|0|||
129976915|NCT02942277|467879480|FG006|Year 1|Lost to Follow-up|0|||
129976916|NCT02942277|467879481|FG007|Year 1|Lost to Follow-up|0|||
129976917|NCT02942277|467879482|FG008|Year 1|Lost to Follow-up|0|||
129976918|NCT02942277|467879483|FG009|Year 1|Lost to Follow-up|0|||
129976919|NCT02942277|467879484|FG010|Year 1|Lost to Follow-up|2|||
129976920|NCT02942277|467879474|FG000|Year 1|Protocol Violation|0|||
129976921|NCT02942277|467879475|FG001|Year 1|Protocol Violation|0|||
129976922|NCT02942277|467879476|FG002|Year 1|Protocol Violation|0|||
129976923|NCT02942277|467879477|FG003|Year 1|Protocol Violation|0|||
129976924|NCT02942277|467879478|FG004|Year 1|Protocol Violation|1|||
129976925|NCT02942277|467879479|FG005|Year 1|Protocol Violation|1|||
129976926|NCT02942277|467879480|FG006|Year 1|Protocol Violation|0|||
129976927|NCT02942277|467879481|FG007|Year 1|Protocol Violation|0|||
129976928|NCT02942277|467879482|FG008|Year 1|Protocol Violation|0|||
129976929|NCT02942277|467879483|FG009|Year 1|Protocol Violation|0|||
129976930|NCT02942277|467879484|FG010|Year 1|Protocol Violation|2|||
129976931|NCT02942277|467879474|FG000|Year 1|Pregnancy|0|||
129976932|NCT02942277|467879475|FG001|Year 1|Pregnancy|0|||
129976933|NCT02942277|467879476|FG002|Year 1|Pregnancy|0|||
129976934|NCT02942277|467879477|FG003|Year 1|Pregnancy|0|||
129976935|NCT02942277|467879478|FG004|Year 1|Pregnancy|0|||
129976936|NCT02942277|467879479|FG005|Year 1|Pregnancy|1|||
129976937|NCT02942277|467879480|FG006|Year 1|Pregnancy|0|||
129976938|NCT02942277|467879481|FG007|Year 1|Pregnancy|0|||
129976939|NCT02942277|467879482|FG008|Year 1|Pregnancy|0|||
129976940|NCT02942277|467879483|FG009|Year 1|Pregnancy|0|||
129976941|NCT02942277|467879484|FG010|Year 1|Pregnancy|0|||
129976942|NCT02942277|467879474|FG000|Year 2|Lost to Follow-up|0|||
129976943|NCT02942277|467879475|FG001|Year 2|Lost to Follow-up|0|||
130094544|NCT01258803|468302405|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
129976944|NCT02942277|467879476|FG002|Year 2|Lost to Follow-up|0|||
129976945|NCT02942277|467879477|FG003|Year 2|Lost to Follow-up|0|||
129976946|NCT02942277|467879478|FG004|Year 2|Lost to Follow-up|2|||
129976947|NCT02942277|467879479|FG005|Year 2|Lost to Follow-up|1|||
129976948|NCT02942277|467879480|FG006|Year 2|Lost to Follow-up|0|||
129976949|NCT02942277|467879481|FG007|Year 2|Lost to Follow-up|0|||
129976950|NCT02942277|467879482|FG008|Year 2|Lost to Follow-up|0|||
129976951|NCT02942277|467879483|FG009|Year 2|Lost to Follow-up|0|||
129976952|NCT02942277|467879484|FG010|Year 2|Lost to Follow-up|0|||
129976953|NCT02942277|467879474|FG000|Year 2|Did not rescreen|0|||
129976954|NCT02942277|467879475|FG001|Year 2|Did not rescreen|0|||
129976955|NCT02942277|467879476|FG002|Year 2|Did not rescreen|1|||
129976956|NCT02942277|467879477|FG003|Year 2|Did not rescreen|1|||
129976957|NCT02942277|467879478|FG004|Year 2|Did not rescreen|9|||
129976958|NCT02942277|467879479|FG005|Year 2|Did not rescreen|6|||
129976959|NCT02942277|467879480|FG006|Year 2|Did not rescreen|0|||
129976960|NCT02942277|467879481|FG007|Year 2|Did not rescreen|1|||
129976961|NCT02942277|467879482|FG008|Year 2|Did not rescreen|0|||
129976962|NCT02942277|467879483|FG009|Year 2|Did not rescreen|0|||
129976963|NCT02942277|467879484|FG010|Year 2|Did not rescreen|21|||
129976964|NCT02942277|467879474|FG000|Year 2|Met withdrawal criteria|0|||
129976965|NCT02942277|467879475|FG001|Year 2|Met withdrawal criteria|0|||
129976966|NCT02942277|467879476|FG002|Year 2|Met withdrawal criteria|0|||
129976967|NCT02942277|467879477|FG003|Year 2|Met withdrawal criteria|0|||
129976968|NCT02942277|467879478|FG004|Year 2|Met withdrawal criteria|1|||
129976969|NCT02942277|467879479|FG005|Year 2|Met withdrawal criteria|2|||
129976970|NCT02942277|467879480|FG006|Year 2|Met withdrawal criteria|0|||
129976971|NCT02942277|467879481|FG007|Year 2|Met withdrawal criteria|0|||
129976972|NCT02942277|467879482|FG008|Year 2|Met withdrawal criteria|0|||
129976973|NCT02942277|467879483|FG009|Year 2|Met withdrawal criteria|0|||
129976974|NCT02942277|467879484|FG010|Year 2|Met withdrawal criteria|1|||
129976975|NCT02942277|467879474|FG000|Year 2|Travel|0|||
129976976|NCT02942277|467879475|FG001|Year 2|Travel|1|||
129976977|NCT02942277|467879476|FG002|Year 2|Travel|0|||
129976978|NCT02942277|467879477|FG003|Year 2|Travel|0|||
129976979|NCT02942277|467879478|FG004|Year 2|Travel|0|||
129976980|NCT02942277|467879479|FG005|Year 2|Travel|1|||
129976981|NCT02942277|467879480|FG006|Year 2|Travel|0|||
129976982|NCT02942277|467879481|FG007|Year 2|Travel|0|||
129976983|NCT02942277|467879482|FG008|Year 2|Travel|0|||
129976984|NCT02942277|467879483|FG009|Year 2|Travel|1|||
129976985|NCT02942277|467879484|FG010|Year 2|Travel|3|||
129976986|NCT02942277|467879474|FG000|Year 2|Non-compliant|0|||
129976987|NCT02942277|467879475|FG001|Year 2|Non-compliant|0|||
129976988|NCT02942277|467879476|FG002|Year 2|Non-compliant|0|||
129976989|NCT02942277|467879477|FG003|Year 2|Non-compliant|0|||
129976990|NCT02942277|467879478|FG004|Year 2|Non-compliant|1|||
129976991|NCT02942277|467879479|FG005|Year 2|Non-compliant|1|||
129976992|NCT02942277|467879480|FG006|Year 2|Non-compliant|0|||
129976993|NCT02942277|467879481|FG007|Year 2|Non-compliant|0|||
129976994|NCT02942277|467879482|FG008|Year 2|Non-compliant|0|||
129976995|NCT02942277|467879483|FG009|Year 2|Non-compliant|0|||
129976996|NCT02942277|467879484|FG010|Year 2|Non-compliant|0|||
129976997|NCT02942277|467879474|FG000|Year 2|Withdrawal by Subject|0|||
129976998|NCT02942277|467879475|FG001|Year 2|Withdrawal by Subject|0|||
129976999|NCT02942277|467879476|FG002|Year 2|Withdrawal by Subject|0|||
129977000|NCT02942277|467879477|FG003|Year 2|Withdrawal by Subject|0|||
129977001|NCT02942277|467879478|FG004|Year 2|Withdrawal by Subject|0|||
129977002|NCT02942277|467879479|FG005|Year 2|Withdrawal by Subject|0|||
129977003|NCT02942277|467879480|FG006|Year 2|Withdrawal by Subject|1|||
129977004|NCT02942277|467879481|FG007|Year 2|Withdrawal by Subject|0|||
129977005|NCT02942277|467879482|FG008|Year 2|Withdrawal by Subject|0|||
129977006|NCT02942277|467879483|FG009|Year 2|Withdrawal by Subject|0|||
129977007|NCT02942277|467879484|FG010|Year 2|Withdrawal by Subject|0|||
129977008|NCT05577715|467879485|FG000|Overall Study|Withdrawal by Subject|1|||
129977009|NCT05577715|467879485|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
129977010|NCT05577715|467879485|FG000|Overall Study|Lost to Follow-up|1|||
129977011|NCT05577715|467879485|FG000|Overall Study|Death|6|||
129977012|NCT05282121|467879489|FG000|Overall Study|Adverse Event|1|||
129977013|NCT05282121|467879490|FG001|Overall Study|Adverse Event|1|||
129977014|NCT05282121|467879491|FG002|Overall Study|Adverse Event|4|||
129977015|NCT05282121|467879492|FG003|Overall Study|Adverse Event|1|||
129977016|NCT05282121|467879489|FG000|Overall Study|Study Terminated by Sponsor|1|||
129977017|NCT05282121|467879490|FG001|Overall Study|Study Terminated by Sponsor|2|||
129977018|NCT05282121|467879491|FG002|Overall Study|Study Terminated by Sponsor|2|||
129977019|NCT05282121|467879492|FG003|Overall Study|Study Terminated by Sponsor|2|||
129977020|NCT05282121|467879489|FG000|Overall Study|Other than listed|0|||
129977021|NCT05282121|467879490|FG001|Overall Study|Other than listed|0|||
129977022|NCT05282121|467879491|FG002|Overall Study|Other than listed|1|||
129977023|NCT05282121|467879492|FG003|Overall Study|Other than listed|0|||
129977024|NCT05282121|467879489|FG000|Overall Study|No reason available|0|||
129977025|NCT05282121|467879490|FG001|Overall Study|No reason available|0|||
129977026|NCT05282121|467879491|FG002|Overall Study|No reason available|1|||
129977027|NCT05282121|467879492|FG003|Overall Study|No reason available|0|||
129977028|NCT00608868|467879495|FG000|Overall Study|Withdrawal by Subject|7|||
129977029|NCT00608868|467879495|FG000|Overall Study|Protocol Violation|3|||
129977030|NCT00608868|467879495|FG000|Overall Study|Lost to Follow-up|2|||
129977031|NCT00608868|467879495|FG000|Overall Study|Adverse Event|1|||
129977032|NCT00608868|467879495|FG000|Overall Study|Physician Decision|2|||
129977033|NCT04546425|467879496|FG000|Overall Study|Protocol Violation|1|||
129977034|NCT04546425|467879497|FG001|Overall Study|Protocol Violation|1|||
129977035|NCT04546425|467879498|FG002|Overall Study|Protocol Violation|0|||
129977036|NCT04546425|467879499|FG003|Overall Study|Protocol Violation|0|||
129977037|NCT04546425|467879496|FG000|Overall Study|Adverse Event|3|||
129977038|NCT04546425|467879497|FG001|Overall Study|Adverse Event|0|||
129977039|NCT04546425|467879498|FG002|Overall Study|Adverse Event|0|||
129977040|NCT04546425|467879499|FG003|Overall Study|Adverse Event|0|||
129977041|NCT04546425|467879496|FG000|Overall Study|Lost to Follow-up|5|||
129977042|NCT04546425|467879497|FG001|Overall Study|Lost to Follow-up|4|||
129977043|NCT04546425|467879498|FG002|Overall Study|Lost to Follow-up|0|||
129977044|NCT04546425|467879499|FG003|Overall Study|Lost to Follow-up|0|||
129977045|NCT04546425|467879496|FG000|Overall Study|No Longer met eligibility criteria|3|||
129977046|NCT04546425|467879497|FG001|Overall Study|No Longer met eligibility criteria|3|||
129977047|NCT04546425|467879498|FG002|Overall Study|No Longer met eligibility criteria|1|||
129977048|NCT04546425|467879499|FG003|Overall Study|No Longer met eligibility criteria|1|||
129977049|NCT04546425|467879496|FG000|Overall Study|Withdrawal by parent/guardian|6|||
129977050|NCT04546425|467879497|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129977051|NCT04546425|467879498|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129977052|NCT04546425|467879499|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129977053|NCT00677534|467879500|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
129977054|NCT00677534|467879500|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
129977055|NCT00677534|467879500|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
129977056|NCT00863681|467879507|FG000|Overall Study|Other|2|||
129977057|NCT00863681|467879508|FG001|Overall Study|Other|0|||
129977058|NCT00863681|467879509|FG002|Overall Study|Other|0|||
129977059|NCT00863681|467879507|FG000|Overall Study|Missing|1|||
129977060|NCT00863681|467879508|FG001|Overall Study|Missing|0|||
129977061|NCT00863681|467879509|FG002|Overall Study|Missing|0|||
129977062|NCT00863681|467879507|FG000|Overall Study|Death|40|||
129977063|NCT00863681|467879508|FG001|Overall Study|Death|23|||
129977064|NCT00863681|467879509|FG002|Overall Study|Death|6|||
129977065|NCT00863681|467879507|FG000|Overall Study|Withdrawal by Subject|12|||
129977066|NCT00863681|467879508|FG001|Overall Study|Withdrawal by Subject|5|||
129977067|NCT00863681|467879509|FG002|Overall Study|Withdrawal by Subject|2|||
129977068|NCT00863681|467879507|FG000|Overall Study|Protocol Violation|2|||
129977069|NCT00863681|467879508|FG001|Overall Study|Protocol Violation|0|||
129977070|NCT00863681|467879509|FG002|Overall Study|Protocol Violation|0|||
129977071|NCT00863681|467879507|FG000|Overall Study|Lost to Follow-up|3|||
129977072|NCT00863681|467879508|FG001|Overall Study|Lost to Follow-up|0|||
129977073|NCT00863681|467879509|FG002|Overall Study|Lost to Follow-up|3|||
129977074|NCT00863681|467879507|FG000|Overall Study|Adverse Event|28|||
129977075|NCT00863681|467879508|FG001|Overall Study|Adverse Event|10|||
129977076|NCT00863681|467879509|FG002|Overall Study|Adverse Event|6|||
129977077|NCT00863681|467879507|FG000|Overall Study|Lack of Efficacy|2|||
129977078|NCT00863681|467879508|FG001|Overall Study|Lack of Efficacy|2|||
129977079|NCT00863681|467879509|FG002|Overall Study|Lack of Efficacy|1|||
129977080|NCT00863681|467879507|FG000|Overall Study|Non-compliance with study drug|1|||
129977081|NCT00863681|467879508|FG001|Overall Study|Non-compliance with study drug|3|||
129977082|NCT00863681|467879509|FG002|Overall Study|Non-compliance with study drug|0|||
129977083|NCT03031496|467879510|FG000|Period 1|Adverse Event|2|||
129977084|NCT03031496|467879511|FG001|Period 1|Adverse Event|0|||
129977085|NCT03031496|467879510|FG000|Period 1|Withdrawal by Subject|0|||
129977086|NCT03031496|467879511|FG001|Period 1|Withdrawal by Subject|2|||
129977087|NCT02979249|467879513|FG000|Overall Study|Lost to Follow-up|2|||
129977088|NCT02979249|467879513|FG000|Overall Study|Withdrawal by Subject|4|||
129977089|NCT01125046|467879514|FG000|First 6 Months of Treatment|Death|1|||
129977090|NCT01125046|467879514|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
129977091|NCT01125046|467879514|FG000|First 6 Months of Treatment|Non-compliance|1|||
129977092|NCT01125046|467879514|FG000|First 6 Months of Treatment|Surgery|1|||
129977093|NCT01125046|467879514|FG000|First 6 Months of Treatment|Progressive Disease|7|||
129977094|NCT01125046|467879514|FG000|First 6 Months of Treatment|Adverse Event|2|||
129977095|NCT01125046|467879514|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
129977096|NCT01125046|467879514|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
129977097|NCT01125046|467879514|FG000|Follow-up/Data Cut Off Point|Death|29|||
129977098|NCT01125046|467879514|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
129977099|NCT01685229|467879516|FG000|Overall Study|Subjects missing Study Exit form|3|||
129977100|NCT01685229|467879517|FG001|Overall Study|Subjects missing Study Exit form|1|||
129977101|NCT01685229|467879516|FG000|Overall Study|Lost to Follow-up|16|||
129977102|NCT01685229|467879517|FG001|Overall Study|Lost to Follow-up|10|||
129977103|NCT01685229|467879516|FG000|Overall Study|Withdrawal by Subject|6|||
129977104|NCT01685229|467879517|FG001|Overall Study|Withdrawal by Subject|5|||
129977105|NCT01685229|467879516|FG000|Overall Study|Death|1|||
129977106|NCT01685229|467879517|FG001|Overall Study|Death|0|||
129977107|NCT01399697|467879518|FG000|Overall Study|Adverse Event|13|||
129977108|NCT01399697|467879519|FG001|Overall Study|Adverse Event|3|||
129977109|NCT01399697|467879520|FG002|Overall Study|Adverse Event|1|||
129977110|NCT01399697|467879518|FG000|Overall Study|Lost to Follow-up|2|||
129977111|NCT01399697|467879519|FG001|Overall Study|Lost to Follow-up|0|||
129977112|NCT01399697|467879520|FG002|Overall Study|Lost to Follow-up|0|||
129977113|NCT01399697|467879518|FG000|Overall Study|Withdrawal by Subject|8|||
129977114|NCT01399697|467879519|FG001|Overall Study|Withdrawal by Subject|0|||
129977115|NCT01399697|467879520|FG002|Overall Study|Withdrawal by Subject|0|||
129977116|NCT01399697|467879518|FG000|Overall Study|Investigator Decisión|1|||
129977117|NCT01399697|467879519|FG001|Overall Study|Investigator Decisión|0|||
129977118|NCT01399697|467879520|FG002|Overall Study|Investigator Decisión|2|||
129977119|NCT01399697|467879518|FG000|Overall Study|Lack of Efficacy|9|||
129977120|NCT01399697|467879519|FG001|Overall Study|Lack of Efficacy|0|||
129977121|NCT01399697|467879520|FG002|Overall Study|Lack of Efficacy|1|||
129977122|NCT01399697|467879518|FG000|Overall Study|Protocol Violation|2|||
129977123|NCT01399697|467879519|FG001|Overall Study|Protocol Violation|0|||
129977124|NCT01399697|467879520|FG002|Overall Study|Protocol Violation|0|||
129977125|NCT01399697|467879518|FG000|Overall Study|Non-Compliant|1|||
129977126|NCT01399697|467879519|FG001|Overall Study|Non-Compliant|0|||
129977127|NCT01399697|467879520|FG002|Overall Study|Non-Compliant|0|||
129977128|NCT01399697|467879518|FG000|Overall Study|Inclusion Error|2|||
129977129|NCT01399697|467879519|FG001|Overall Study|Inclusion Error|0|||
129977130|NCT01399697|467879520|FG002|Overall Study|Inclusion Error|0|||
129977131|NCT01399697|467879518|FG000|Overall Study|Positive result for hepatitis B|1|||
129977132|NCT01399697|467879519|FG001|Overall Study|Positive result for hepatitis B|0|||
129977133|NCT01399697|467879520|FG002|Overall Study|Positive result for hepatitis B|0|||
129977134|NCT01399697|467879518|FG000|Overall Study|Clinical RA remission|1|||
129977135|NCT01399697|467879519|FG001|Overall Study|Clinical RA remission|0|||
129977136|NCT01399697|467879520|FG002|Overall Study|Clinical RA remission|0|||
129977137|NCT01399697|467879518|FG000|Overall Study|Sponsor Decision|1|||
129977138|NCT01399697|467879519|FG001|Overall Study|Sponsor Decision|0|||
129977139|NCT01399697|467879520|FG002|Overall Study|Sponsor Decision|0|||
129977140|NCT02766777|467879525|FG000|Overall Study|Adverse Event|12|||
129977141|NCT02766777|467879525|FG000|Overall Study|Lost to Follow-up|16|||
129977142|NCT02766777|467879525|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129977143|NCT02766777|467879525|FG000|Overall Study|Protocol Violation|1|||
129977144|NCT02766777|467879525|FG000|Overall Study|Withdrawal by Subject|4|||
129977145|NCT00967005|467879528|FG000|Overall Study|Lost to Follow-up|7|||
129977146|NCT00967005|467879529|FG001|Overall Study|Lost to Follow-up|10|||
129977147|NCT03019640|467879530|FG000|Overall Study|Screen Failures|4|||
129977148|NCT03019640|467879530|FG000|Overall Study|Adverse Event|3|||
129977149|NCT03019640|467879530|FG000|Overall Study|Participant Relapsed|1|||
129977150|NCT01162863|467879531|FG000|Overall Study|Lack of Efficacy|1|||
129977151|NCT01162863|467879532|FG001|Overall Study|Lack of Efficacy|0|||
129977152|NCT01162863|467879533|FG002|Overall Study|Lack of Efficacy|0|||
129977153|NCT01162863|467879531|FG000|Overall Study|Adverse Event|0|||
129977154|NCT01162863|467879532|FG001|Overall Study|Adverse Event|1|||
129977155|NCT01162863|467879533|FG002|Overall Study|Adverse Event|0|||
129977156|NCT00588692|467879534|FG000|Overall Study|Withdrawal by Subject|4|||
129977157|NCT00588692|467879535|FG001|Overall Study|Withdrawal by Subject|2|||
129977158|NCT00588692|467879534|FG000|Overall Study|Hip Surgery|0|||
129977159|NCT00588692|467879535|FG001|Overall Study|Hip Surgery|1|||
129977160|NCT00588692|467879534|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
129977161|NCT00588692|467879535|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
129977162|NCT00588692|467879534|FG000|Overall Study|Cancer|1|||
129977163|NCT00588692|467879535|FG001|Overall Study|Cancer|0|||
129977164|NCT00588692|467879534|FG000|Overall Study|Death|1|||
129977165|NCT00588692|467879535|FG001|Overall Study|Death|0|||
129977166|NCT03552523|467879536|FG000|Overall Study|Withdrawal by Subject|1|||
129977167|NCT03552523|467879537|FG001|Overall Study|Withdrawal by Subject|1|||
129977168|NCT04462289|467879538|FG000|Overall Study|Lost to Follow-up|4|||
129977169|NCT04462289|467879539|FG001|Overall Study|Lost to Follow-up|5|||
129977170|NCT04462289|467879538|FG000|Overall Study|Death|0|||
129977171|NCT04462289|467879539|FG001|Overall Study|Death|3|||
129977172|NCT04462289|467879538|FG000|Overall Study|Withdrawal by Subject|1|||
129977173|NCT04462289|467879539|FG001|Overall Study|Withdrawal by Subject|3|||
130147762|NCT00401245|468501109|FG007|Open Label Phase|Lost to Follow-up|0|||
130147763|NCT00401245|468501102|FG000|Open Label Phase|Other|4|||
130147764|NCT00401245|468501103|FG001|Open Label Phase|Other|8|||
130147765|NCT00401245|468501104|FG002|Open Label Phase|Other|7|||
129977174|NCT03686423|467879540|FG000|Overall Study|Withdrawal by Subject|9|||
129977175|NCT03686423|467879540|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
130147766|NCT00401245|468501105|FG003|Open Label Phase|Other|8|||
130147767|NCT00401245|468501106|FG004|Open Label Phase|Other|0|||
130147768|NCT00401245|468501107|FG005|Open Label Phase|Other|0|||
129977176|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
129977177|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
129977178|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
129977179|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
130147769|NCT00401245|468501108|FG006|Open Label Phase|Other|0|||
130147770|NCT00401245|468501109|FG007|Open Label Phase|Other|0|||
130147771|NCT00401245|468501102|FG000|Open Label Phase|Protocol Violation|0|||
129977180|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
129977181|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
129977182|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
129977183|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
129977184|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
129977185|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
130147772|NCT00401245|468501103|FG001|Open Label Phase|Protocol Violation|1|||
130147773|NCT00401245|468501104|FG002|Open Label Phase|Protocol Violation|0|||
130147774|NCT00401245|468501105|FG003|Open Label Phase|Protocol Violation|1|||
129977186|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
129977187|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
129977188|NCT01077518|467879541|FG000|Optional Ofa Phase|Physician Decision|0|||
129977189|NCT01077518|467879542|FG001|Optional Ofa Phase|Physician Decision|0|||
129977190|NCT01077518|467879543|FG002|Optional Ofa Phase|Physician Decision|1|||
129977191|NCT01077518|467879541|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
129977192|NCT01077518|467879542|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
129977193|NCT01077518|467879543|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
129977194|NCT01077518|467879541|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
129977195|NCT01077518|467879542|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
129977196|NCT01077518|467879543|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
129977197|NCT02387970|467879544|FG000|Overall Study|Did not complete 1-year follow up|1|||
129977198|NCT02387970|467879545|FG001|Overall Study|Did not complete 1-year follow up|2|||
129977199|NCT01436253|467879550|FG000|Overall Study|Lost to Follow-up|182|||
129977200|NCT01436253|467879550|FG000|Overall Study|Not meeting all eligibility criteria|117|||
129977201|NCT01495598|467879552|FG000|Overall Study|Death during follow up period|2|||
129977202|NCT01495598|467879552|FG000|Overall Study|Death on study|1|||
129977203|NCT01495598|467879552|FG000|Overall Study|Lost to Follow-up|3|||
129977204|NCT01495598|467879552|FG000|Overall Study|Physician Decision|8|||
129977205|NCT02671500|467879555|FG000|Overall Study|Lack of Efficacy|12|||
129977206|NCT02671500|467879555|FG000|Overall Study|Lost to Follow-up|2|||
129977207|NCT05511038|467879557|FG000|Overall|Withdrawal by Subject|5|||
129977208|NCT05511038|467879558|FG001|Overall|Withdrawal by Subject|3|||
129977209|NCT05511038|467879557|FG000|Overall|Screen Failure|20|||
129977210|NCT05511038|467879558|FG001|Overall|Screen Failure|1|||
129977211|NCT05511038|467879557|FG000|Overall|Physician Decision|3|||
129977212|NCT05511038|467879558|FG001|Overall|Physician Decision|0|||
129977213|NCT05511038|467879557|FG000|Overall|Lost to Follow-up|3|||
129977214|NCT05511038|467879558|FG001|Overall|Lost to Follow-up|0|||
129977215|NCT05511038|467879557|FG000|Overall|Death|1|||
129977216|NCT05511038|467879558|FG001|Overall|Death|0|||
129977217|NCT05511038|467879557|FG000|Screening|Withdrawal by Subject|1|||
129977218|NCT05511038|467879558|FG001|Screening|Withdrawal by Subject|0|||
129977219|NCT05511038|467879557|FG000|Screening|Lost to Follow Up (1 participant)|1|||
129977220|NCT05511038|467879558|FG001|Screening|Lost to Follow Up (1 participant)|0|||
129977221|NCT05511038|467879557|FG000|Screening|Screen Failure|3|||
129977222|NCT05511038|467879558|FG001|Screening|Screen Failure|0|||
129977223|NCT05511038|467879557|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
129977224|NCT05511038|467879558|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
129977225|NCT05511038|467879557|FG000|Treatment|Withdrawal by Subject|5|||
129977226|NCT05511038|467879558|FG001|Treatment|Withdrawal by Subject|3|||
129977227|NCT05511038|467879557|FG000|Treatment|Physician Decision|4|||
129977228|NCT05511038|467879558|FG001|Treatment|Physician Decision|0|||
129977229|NCT05511038|467879557|FG000|Treatment|Lost to Follow-up|2|||
129977230|NCT05511038|467879558|FG001|Treatment|Lost to Follow-up|0|||
129977231|NCT05511038|467879557|FG000|Treatment|Death|1|||
129977232|NCT05511038|467879558|FG001|Treatment|Death|0|||
129977233|NCT05511038|467879557|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
129977234|NCT05511038|467879558|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
129977235|NCT05511038|467879557|FG000|Treatment|Refuse by subject|1|||
129977236|NCT05511038|467879558|FG001|Treatment|Refuse by subject|0|||
129977237|NCT05511038|467879557|FG000|Treatment|Subject did not go to the site for visit|1|||
129977238|NCT05511038|467879558|FG001|Treatment|Subject did not go to the site for visit|0|||
129977239|NCT04485611|467879559|FG000|Prehabilitation|Physician Decision|1|||
129977240|NCT05292586|467879562|FG000|Overall Study|Withdrawal by Subject|3|||
129977241|NCT05292586|467879563|FG001|Overall Study|Withdrawal by Subject|10|||
129977242|NCT05292586|467879562|FG000|Overall Study|Randomization error|3|||
129977243|NCT05292586|467879563|FG001|Overall Study|Randomization error|7|||
129977244|NCT05292586|467879562|FG000|Overall Study|Adverse Event|3|||
129977245|NCT05292586|467879563|FG001|Overall Study|Adverse Event|0|||
129977246|NCT05292586|467879562|FG000|Overall Study|Lost to Follow-up|0|||
129977247|NCT05292586|467879563|FG001|Overall Study|Lost to Follow-up|1|||
129977248|NCT05292586|467879562|FG000|Overall Study|Patient refused treatment|1|||
129977249|NCT05292586|467879563|FG001|Overall Study|Patient refused treatment|0|||
129977250|NCT05292586|467879562|FG000|Overall Study|Patient could not travel to the study site|1|||
129977251|NCT05292586|467879563|FG001|Overall Study|Patient could not travel to the study site|0|||
129977252|NCT05292586|467879562|FG000|Overall Study|Technical issues with the masterscope|0|||
129977253|NCT05292586|467879563|FG001|Overall Study|Technical issues with the masterscope|3|||
129977254|NCT05292586|467879562|FG000|Overall Study|Patient moved to a different state|0|||
129977255|NCT05292586|467879563|FG001|Overall Study|Patient moved to a different state|1|||
129977256|NCT03682185|467879566|FG000|Overall Study|Lost to Follow-up|4|||
129977257|NCT03682185|467879567|FG001|Overall Study|Lost to Follow-up|7|||
129977258|NCT03682185|467879568|FG002|Overall Study|Lost to Follow-up|4|||
129977259|NCT03682185|467879569|FG003|Overall Study|Lost to Follow-up|7|||
129977260|NCT03682185|467879570|FG004|Overall Study|Lost to Follow-up|1|||
129977261|NCT03682185|467879566|FG000|Overall Study|Withdrawal by Subject|7|||
129977262|NCT03682185|467879567|FG001|Overall Study|Withdrawal by Subject|3|||
129977263|NCT03682185|467879568|FG002|Overall Study|Withdrawal by Subject|7|||
129977264|NCT03682185|467879569|FG003|Overall Study|Withdrawal by Subject|3|||
129977265|NCT03682185|467879570|FG004|Overall Study|Withdrawal by Subject|0|||
129977266|NCT04908631|467879571|FG000|Overall Study|Lost to Follow-up|1|||
129977267|NCT04908631|467879571|FG000|Overall Study|Physician Decision|1|||
129977268|NCT04908631|467879571|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
129977269|NCT02284009|467879572|FG000|Overall Study|Adverse Event|3|||
129977270|NCT02284009|467879573|FG001|Overall Study|Adverse Event|0|||
129977271|NCT02284009|467879572|FG000|Overall Study|Lost to Follow-up|1|||
129977272|NCT02284009|467879573|FG001|Overall Study|Lost to Follow-up|3|||
129977273|NCT02284009|467879572|FG000|Overall Study|Physician Decision|0|||
129977274|NCT02284009|467879573|FG001|Overall Study|Physician Decision|2|||
129977275|NCT02284009|467879572|FG000|Overall Study|Withdrawal by Subject|2|||
129977276|NCT02284009|467879573|FG001|Overall Study|Withdrawal by Subject|5|||
129977277|NCT04047862|467879586|FG000|Overall Study|Death|0|||
129977278|NCT04047862|467879587|FG001|Overall Study|Death|0|||
130147775|NCT00401245|468501106|FG004|Open Label Phase|Protocol Violation|0|||
130147776|NCT00401245|468501107|FG005|Open Label Phase|Protocol Violation|0|||
130147777|NCT00401245|468501108|FG006|Open Label Phase|Protocol Violation|0|||
130147778|NCT00401245|468501109|FG007|Open Label Phase|Protocol Violation|0|||
130147779|NCT00401245|468501102|FG000|Open Label Phase|Withdrawal by Subject|3|||
130147780|NCT00401245|468501103|FG001|Open Label Phase|Withdrawal by Subject|3|||
130147781|NCT00401245|468501104|FG002|Open Label Phase|Withdrawal by Subject|2|||
129977279|NCT04047862|467879588|FG002|Overall Study|Death|4|||
129977280|NCT04047862|467879589|FG003|Overall Study|Death|7|||
129977281|NCT04047862|467879590|FG004|Overall Study|Death|2|||
129977282|NCT04047862|467879591|FG005|Overall Study|Death|4|||
129977283|NCT04047862|467879592|FG006|Overall Study|Death|3|||
129977284|NCT04047862|467879593|FG007|Overall Study|Death|24|||
129977285|NCT04047862|467879594|FG008|Overall Study|Death|24|||
129977286|NCT04047862|467879595|FG009|Overall Study|Death|22|||
129977287|NCT04047862|467879596|FG010|Overall Study|Death|35|||
129977288|NCT04047862|467879597|FG011|Overall Study|Death|18|||
129977289|NCT04047862|467879598|FG012|Overall Study|Death|14|||
129977290|NCT04047862|467879599|FG013|Overall Study|Death|6|||
129977291|NCT04047862|467879600|FG014|Overall Study|Death|19|||
129977292|NCT04047862|467879601|FG015|Overall Study|Death|42|||
129977293|NCT04047862|467879602|FG016|Overall Study|Death|9|||
129977294|NCT04047862|467879603|FG017|Overall Study|Death|8|||
129977295|NCT04047862|467879604|FG018|Overall Study|Death|10|||
129977296|NCT04047862|467879586|FG000|Overall Study|Withdrawal by Subject|0|||
129977297|NCT04047862|467879587|FG001|Overall Study|Withdrawal by Subject|0|||
129977298|NCT04047862|467879588|FG002|Overall Study|Withdrawal by Subject|0|||
129977299|NCT04047862|467879589|FG003|Overall Study|Withdrawal by Subject|5|||
129977300|NCT04047862|467879590|FG004|Overall Study|Withdrawal by Subject|2|||
129977301|NCT04047862|467879591|FG005|Overall Study|Withdrawal by Subject|0|||
129977302|NCT04047862|467879592|FG006|Overall Study|Withdrawal by Subject|1|||
129977303|NCT04047862|467879593|FG007|Overall Study|Withdrawal by Subject|0|||
129977304|NCT04047862|467879594|FG008|Overall Study|Withdrawal by Subject|4|||
129977305|NCT04047862|467879595|FG009|Overall Study|Withdrawal by Subject|4|||
129977306|NCT04047862|467879596|FG010|Overall Study|Withdrawal by Subject|4|||
129977307|NCT04047862|467879597|FG011|Overall Study|Withdrawal by Subject|2|||
129977308|NCT04047862|467879598|FG012|Overall Study|Withdrawal by Subject|3|||
129977309|NCT04047862|467879599|FG013|Overall Study|Withdrawal by Subject|0|||
129977310|NCT04047862|467879600|FG014|Overall Study|Withdrawal by Subject|9|||
129977311|NCT04047862|467879601|FG015|Overall Study|Withdrawal by Subject|5|||
129977312|NCT04047862|467879602|FG016|Overall Study|Withdrawal by Subject|1|||
129977313|NCT04047862|467879603|FG017|Overall Study|Withdrawal by Subject|3|||
129977314|NCT04047862|467879604|FG018|Overall Study|Withdrawal by Subject|1|||
129977315|NCT04047862|467879586|FG000|Overall Study|Lost to Follow-up|0|||
130147782|NCT00401245|468501105|FG003|Open Label Phase|Withdrawal by Subject|1|||
129977316|NCT04047862|467879587|FG001|Overall Study|Lost to Follow-up|0|||
129977317|NCT04047862|467879588|FG002|Overall Study|Lost to Follow-up|1|||
129977318|NCT04047862|467879589|FG003|Overall Study|Lost to Follow-up|0|||
129977319|NCT04047862|467879590|FG004|Overall Study|Lost to Follow-up|0|||
129977320|NCT04047862|467879591|FG005|Overall Study|Lost to Follow-up|0|||
129977321|NCT04047862|467879592|FG006|Overall Study|Lost to Follow-up|0|||
129977322|NCT04047862|467879593|FG007|Overall Study|Lost to Follow-up|1|||
129977323|NCT04047862|467879594|FG008|Overall Study|Lost to Follow-up|0|||
130147783|NCT00401245|468501106|FG004|Open Label Phase|Withdrawal by Subject|0|||
130147784|NCT00401245|468501107|FG005|Open Label Phase|Withdrawal by Subject|0|||
129977324|NCT04047862|467879595|FG009|Overall Study|Lost to Follow-up|1|||
129977325|NCT04047862|467879596|FG010|Overall Study|Lost to Follow-up|0|||
129977326|NCT04047862|467879597|FG011|Overall Study|Lost to Follow-up|3|||
130147785|NCT00401245|468501108|FG006|Open Label Phase|Withdrawal by Subject|0|||
129977327|NCT04047862|467879598|FG012|Overall Study|Lost to Follow-up|0|||
129977328|NCT04047862|467879599|FG013|Overall Study|Lost to Follow-up|0|||
129977329|NCT04047862|467879600|FG014|Overall Study|Lost to Follow-up|2|||
129977330|NCT04047862|467879601|FG015|Overall Study|Lost to Follow-up|2|||
129977331|NCT04047862|467879602|FG016|Overall Study|Lost to Follow-up|1|||
129977332|NCT04047862|467879603|FG017|Overall Study|Lost to Follow-up|0|||
129977333|NCT04047862|467879604|FG018|Overall Study|Lost to Follow-up|0|||
129977334|NCT04047862|467879586|FG000|Overall Study|Physician Decision|0|||
129977335|NCT04047862|467879587|FG001|Overall Study|Physician Decision|0|||
129977336|NCT04047862|467879588|FG002|Overall Study|Physician Decision|0|||
129977337|NCT04047862|467879589|FG003|Overall Study|Physician Decision|1|||
129977338|NCT04047862|467879590|FG004|Overall Study|Physician Decision|0|||
129977339|NCT04047862|467879591|FG005|Overall Study|Physician Decision|0|||
129977340|NCT04047862|467879592|FG006|Overall Study|Physician Decision|0|||
129977341|NCT04047862|467879593|FG007|Overall Study|Physician Decision|0|||
129977342|NCT04047862|467879594|FG008|Overall Study|Physician Decision|0|||
129977343|NCT04047862|467879595|FG009|Overall Study|Physician Decision|0|||
129977344|NCT04047862|467879596|FG010|Overall Study|Physician Decision|0|||
129977345|NCT04047862|467879597|FG011|Overall Study|Physician Decision|0|||
129977346|NCT04047862|467879598|FG012|Overall Study|Physician Decision|0|||
129977347|NCT04047862|467879599|FG013|Overall Study|Physician Decision|0|||
129977348|NCT04047862|467879600|FG014|Overall Study|Physician Decision|1|||
129977349|NCT04047862|467879601|FG015|Overall Study|Physician Decision|0|||
129977350|NCT04047862|467879602|FG016|Overall Study|Physician Decision|1|||
129977351|NCT04047862|467879603|FG017|Overall Study|Physician Decision|0|||
129977352|NCT04047862|467879604|FG018|Overall Study|Physician Decision|0|||
129977353|NCT04047862|467879586|FG000|Overall Study|Completed all Assessments|1|||
129977354|NCT04047862|467879587|FG001|Overall Study|Completed all Assessments|3|||
129977355|NCT04047862|467879588|FG002|Overall Study|Completed all Assessments|1|||
129977356|NCT04047862|467879589|FG003|Overall Study|Completed all Assessments|3|||
129977357|NCT04047862|467879590|FG004|Overall Study|Completed all Assessments|2|||
129977358|NCT04047862|467879591|FG005|Overall Study|Completed all Assessments|5|||
129977359|NCT04047862|467879592|FG006|Overall Study|Completed all Assessments|7|||
129977360|NCT04047862|467879593|FG007|Overall Study|Completed all Assessments|0|||
129977361|NCT04047862|467879594|FG008|Overall Study|Completed all Assessments|0|||
129977362|NCT04047862|467879595|FG009|Overall Study|Completed all Assessments|0|||
129977363|NCT04047862|467879596|FG010|Overall Study|Completed all Assessments|0|||
129977364|NCT04047862|467879597|FG011|Overall Study|Completed all Assessments|0|||
129977365|NCT04047862|467879598|FG012|Overall Study|Completed all Assessments|0|||
129977366|NCT04047862|467879599|FG013|Overall Study|Completed all Assessments|0|||
129977367|NCT04047862|467879600|FG014|Overall Study|Completed all Assessments|0|||
129977368|NCT04047862|467879601|FG015|Overall Study|Completed all Assessments|0|||
129977369|NCT04047862|467879602|FG016|Overall Study|Completed all Assessments|0|||
129977370|NCT04047862|467879603|FG017|Overall Study|Completed all Assessments|0|||
129977371|NCT04047862|467879604|FG018|Overall Study|Completed all Assessments|0|||
129977372|NCT04047862|467879586|FG000|Overall Study|Sponsor Decision|0|||
129977373|NCT04047862|467879587|FG001|Overall Study|Sponsor Decision|0|||
129977374|NCT04047862|467879588|FG002|Overall Study|Sponsor Decision|0|||
129977375|NCT04047862|467879589|FG003|Overall Study|Sponsor Decision|0|||
129977376|NCT04047862|467879590|FG004|Overall Study|Sponsor Decision|0|||
129977377|NCT04047862|467879591|FG005|Overall Study|Sponsor Decision|0|||
129977378|NCT04047862|467879592|FG006|Overall Study|Sponsor Decision|0|||
129977379|NCT04047862|467879593|FG007|Overall Study|Sponsor Decision|13|||
130147786|NCT00401245|468501109|FG007|Open Label Phase|Withdrawal by Subject|0|||
130147787|NCT00401245|468501102|FG000|Open Label Phase|Lack of Efficacy|4|||
130147788|NCT00401245|468501103|FG001|Open Label Phase|Lack of Efficacy|2|||
130147789|NCT00401245|468501104|FG002|Open Label Phase|Lack of Efficacy|3|||
130147790|NCT00401245|468501105|FG003|Open Label Phase|Lack of Efficacy|0|||
130147791|NCT00401245|468501106|FG004|Open Label Phase|Lack of Efficacy|0|||
130147792|NCT00401245|468501107|FG005|Open Label Phase|Lack of Efficacy|0|||
130147793|NCT00401245|468501108|FG006|Open Label Phase|Lack of Efficacy|0|||
129977380|NCT04047862|467879594|FG008|Overall Study|Sponsor Decision|10|||
129977381|NCT04047862|467879595|FG009|Overall Study|Sponsor Decision|18|||
129977382|NCT04047862|467879596|FG010|Overall Study|Sponsor Decision|3|||
129977383|NCT04047862|467879597|FG011|Overall Study|Sponsor Decision|3|||
129977384|NCT04047862|467879598|FG012|Overall Study|Sponsor Decision|4|||
129977385|NCT04047862|467879599|FG013|Overall Study|Sponsor Decision|0|||
129977386|NCT04047862|467879600|FG014|Overall Study|Sponsor Decision|7|||
129977387|NCT04047862|467879601|FG015|Overall Study|Sponsor Decision|8|||
129977388|NCT04047862|467879602|FG016|Overall Study|Sponsor Decision|9|||
129977389|NCT04047862|467879603|FG017|Overall Study|Sponsor Decision|7|||
129977390|NCT04047862|467879604|FG018|Overall Study|Sponsor Decision|8|||
129977391|NCT04047862|467879586|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130147794|NCT00401245|468501109|FG007|Open Label Phase|Lack of Efficacy|0|||
129977392|NCT04047862|467879587|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
130147795|NCT00401245|468501102|FG000|Double Blind Tapering Phase|Adverse Event|0|||
130147796|NCT00401245|468501103|FG001|Double Blind Tapering Phase|Adverse Event|0|||
130147797|NCT00401245|468501104|FG002|Double Blind Tapering Phase|Adverse Event|0|||
129977393|NCT04047862|467879588|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977394|NCT04047862|467879589|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977395|NCT04047862|467879590|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977396|NCT04047862|467879591|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977397|NCT04047862|467879592|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977398|NCT04047862|467879593|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
129977399|NCT04047862|467879594|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
129977400|NCT04047862|467879595|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977401|NCT04047862|467879596|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
129977402|NCT04047862|467879597|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977403|NCT04047862|467879598|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977404|NCT04047862|467879599|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977405|NCT04047862|467879600|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
129977406|NCT04047862|467879601|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
129977407|NCT04047862|467879602|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
129977408|NCT04047862|467879603|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
129977409|NCT04047862|467879604|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
129977410|NCT04047862|467879586|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977411|NCT04047862|467879587|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977412|NCT04047862|467879588|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977413|NCT04047862|467879589|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977414|NCT04047862|467879590|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977415|NCT04047862|467879591|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977416|NCT04047862|467879592|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977417|NCT04047862|467879593|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977418|NCT04047862|467879594|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977419|NCT04047862|467879595|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977420|NCT04047862|467879596|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977421|NCT04047862|467879597|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977422|NCT04047862|467879598|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977423|NCT04047862|467879599|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977424|NCT04047862|467879600|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977425|NCT04047862|467879601|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
129977426|NCT04047862|467879602|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
130147798|NCT00401245|468501105|FG003|Double Blind Tapering Phase|Adverse Event|0|||
130147799|NCT00401245|468501106|FG004|Double Blind Tapering Phase|Adverse Event|1|||
130147800|NCT00401245|468501107|FG005|Double Blind Tapering Phase|Adverse Event|1|||
130147801|NCT00401245|468501108|FG006|Double Blind Tapering Phase|Adverse Event|2|||
130147802|NCT00401245|468501109|FG007|Double Blind Tapering Phase|Adverse Event|4|||
130147803|NCT00401245|468501102|FG000|Double Blind Tapering Phase|Investigator request|0|||
130147804|NCT00401245|468501103|FG001|Double Blind Tapering Phase|Investigator request|0|||
130147805|NCT00401245|468501104|FG002|Double Blind Tapering Phase|Investigator request|0|||
130147806|NCT00401245|468501105|FG003|Double Blind Tapering Phase|Investigator request|0|||
130147807|NCT00401245|468501106|FG004|Double Blind Tapering Phase|Investigator request|0|||
129977427|NCT04047862|467879603|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977428|NCT04047862|467879604|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
129977429|NCT04047862|467879586|FG000|Overall Study|Other|0|||
129977430|NCT04047862|467879587|FG001|Overall Study|Other|0|||
129977431|NCT04047862|467879588|FG002|Overall Study|Other|0|||
129977432|NCT04047862|467879589|FG003|Overall Study|Other|0|||
129977433|NCT04047862|467879590|FG004|Overall Study|Other|0|||
129977434|NCT04047862|467879591|FG005|Overall Study|Other|0|||
129977435|NCT04047862|467879592|FG006|Overall Study|Other|0|||
129977436|NCT04047862|467879593|FG007|Overall Study|Other|0|||
129977437|NCT04047862|467879594|FG008|Overall Study|Other|0|||
129977438|NCT04047862|467879595|FG009|Overall Study|Other|0|||
129977439|NCT04047862|467879596|FG010|Overall Study|Other|0|||
129977440|NCT04047862|467879597|FG011|Overall Study|Other|0|||
129977441|NCT04047862|467879598|FG012|Overall Study|Other|0|||
129977442|NCT04047862|467879599|FG013|Overall Study|Other|0|||
129977443|NCT04047862|467879600|FG014|Overall Study|Other|2|||
129977444|NCT04047862|467879601|FG015|Overall Study|Other|1|||
129977445|NCT04047862|467879602|FG016|Overall Study|Other|1|||
129977446|NCT04047862|467879603|FG017|Overall Study|Other|1|||
129977447|NCT04047862|467879604|FG018|Overall Study|Other|0|||
130147808|NCT00401245|468501107|FG005|Double Blind Tapering Phase|Investigator request|0|||
129977448|NCT01876082|467881048|FG000|Overall Study|Withdrawal by Subject|0|||
129977449|NCT01876082|467881049|FG001|Overall Study|Withdrawal by Subject|2|||
129977450|NCT01876082|467881048|FG000|Overall Study|Protocol Violation|1|||
129977451|NCT01876082|467881049|FG001|Overall Study|Protocol Violation|0|||
129977452|NCT01876082|467881048|FG000|Overall Study|Adverse Event|1|||
130147809|NCT00401245|468501108|FG006|Double Blind Tapering Phase|Investigator request|0|||
130147810|NCT00401245|468501109|FG007|Double Blind Tapering Phase|Investigator request|1|||
129977453|NCT01876082|467881049|FG001|Overall Study|Adverse Event|1|||
129977454|NCT01876082|467881048|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
129977455|NCT01876082|467881049|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
129977456|NCT00626197|467881055|FG000|Overall Study|Did not cooperate|2|||
129977457|NCT00626197|467881056|FG001|Overall Study|Did not cooperate|6|||
129977458|NCT00626197|467881057|FG002|Overall Study|Did not cooperate|1|||
129977459|NCT00626197|467881055|FG000|Overall Study|Failure to return|6|||
130147811|NCT00401245|468501102|FG000|Double Blind Tapering Phase|Other|0|||
130147812|NCT00401245|468501103|FG001|Double Blind Tapering Phase|Other|0|||
130147813|NCT00401245|468501104|FG002|Double Blind Tapering Phase|Other|0|||
130147814|NCT00401245|468501105|FG003|Double Blind Tapering Phase|Other|0|||
130147815|NCT00401245|468501106|FG004|Double Blind Tapering Phase|Other|1|||
130147816|NCT00401245|468501107|FG005|Double Blind Tapering Phase|Other|0|||
130147817|NCT00401245|468501108|FG006|Double Blind Tapering Phase|Other|2|||
130147818|NCT00401245|468501109|FG007|Double Blind Tapering Phase|Other|2|||
130147819|NCT00401245|468501102|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130147820|NCT00401245|468501103|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130147821|NCT00401245|468501104|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130147822|NCT00401245|468501105|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130147823|NCT00401245|468501106|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
130147824|NCT00401245|468501107|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
130147825|NCT00401245|468501108|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
130147826|NCT00401245|468501109|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
130147827|NCT00401245|468501102|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147828|NCT00401245|468501103|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147829|NCT00401245|468501104|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147830|NCT00401245|468501105|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147831|NCT00401245|468501106|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147832|NCT00401245|468501107|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
129977460|NCT00626197|467881056|FG001|Overall Study|Failure to return|5|||
129977461|NCT00626197|467881057|FG002|Overall Study|Failure to return|6|||
129977462|NCT00626197|467881055|FG000|Overall Study|Adverse event, serious fatal|3|||
129977463|NCT00626197|467881056|FG001|Overall Study|Adverse event, serious fatal|6|||
129977464|NCT00626197|467881057|FG002|Overall Study|Adverse event, serious fatal|6|||
129977465|NCT00626197|467881055|FG000|Overall Study|Adverse Event|1|||
129977466|NCT00626197|467881056|FG001|Overall Study|Adverse Event|1|||
129977467|NCT00626197|467881057|FG002|Overall Study|Adverse Event|2|||
129977468|NCT00626197|467881055|FG000|Overall Study|Withdrawal by Subject|17|||
129977469|NCT00626197|467881056|FG001|Overall Study|Withdrawal by Subject|17|||
129977470|NCT00626197|467881057|FG002|Overall Study|Withdrawal by Subject|7|||
129977471|NCT00626197|467881055|FG000|Overall Study|Administrative reasons|15|||
129977472|NCT00626197|467881056|FG001|Overall Study|Administrative reasons|19|||
129977473|NCT00626197|467881057|FG002|Overall Study|Administrative reasons|55|||
129977474|NCT04833127|467881058|FG000|Overall Study|Lost to Follow-up|1|||
129977475|NCT04833127|467881059|FG001|Overall Study|Lost to Follow-up|1|||
129977476|NCT00461981|467881065|FG000|Overall Study|Lost to Follow-up|9|||
129977477|NCT00461981|467881066|FG001|Overall Study|Lost to Follow-up|6|||
129977478|NCT00461981|467881065|FG000|Overall Study|Withdrawal by Subject|2|||
129977479|NCT00461981|467881066|FG001|Overall Study|Withdrawal by Subject|3|||
129977480|NCT03301155|467881070|FG000|Overall Study|Сompliance with exclusion criteria|8|||
129977481|NCT03301155|467881071|FG001|Overall Study|Сompliance with exclusion criteria|7|||
129977482|NCT00731133|467881072|FG000|Overall Study|Withdrawal by Subject|10|||
129977483|NCT03510455|467881073|FG000|Overall Study|Physician Decision|1|||
129977484|NCT00384189|467881074|FG000|Overall Study|Reason Not Specified|50|||
129977485|NCT00384189|467881075|FG001|Overall Study|Reason Not Specified|57|||
129977486|NCT00384189|467881076|FG002|Overall Study|Reason Not Specified|58|||
129977487|NCT00384189|467881077|FG003|Overall Study|Reason Not Specified|40|||
129977488|NCT04958642|467881078|FG000|Overall Study|Transferred to OLEX program|3|||
129977489|NCT04958642|467881079|FG001|Overall Study|Transferred to OLEX program|0|||
129977490|NCT04958642|467881080|FG002|Overall Study|Transferred to OLEX program|5|||
129977491|NCT04958642|467881078|FG000|Overall Study|Death|0|||
130147833|NCT00401245|468501108|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147834|NCT00401245|468501109|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
130147835|NCT01989676|468501110|FG000|Overall Study|Death|52|||
129977492|NCT04958642|467881079|FG001|Overall Study|Death|0|||
129977493|NCT04958642|467881080|FG002|Overall Study|Death|1|||
129977494|NCT04958642|467881078|FG000|Overall Study|Withdrawal by Subject|4|||
130147836|NCT01989676|468501111|FG001|Overall Study|Death|60|||
130147837|NCT01989676|468501110|FG000|Overall Study|Protocol Violation|2|||
130147838|NCT01989676|468501111|FG001|Overall Study|Protocol Violation|1|||
130147839|NCT01989676|468501110|FG000|Overall Study|Lost to Follow-up|8|||
129977495|NCT04958642|467881079|FG001|Overall Study|Withdrawal by Subject|9|||
129977496|NCT04958642|467881080|FG002|Overall Study|Withdrawal by Subject|13|||
129977497|NCT04958642|467881078|FG000|Overall Study|Investigator's Decision|0|||
129977498|NCT04958642|467881079|FG001|Overall Study|Investigator's Decision|0|||
129977499|NCT04958642|467881080|FG002|Overall Study|Investigator's Decision|1|||
129977500|NCT04958642|467881078|FG000|Overall Study|Adverse Event|1|||
129977501|NCT04958642|467881079|FG001|Overall Study|Adverse Event|0|||
129977502|NCT04958642|467881080|FG002|Overall Study|Adverse Event|1|||
129977503|NCT04958642|467881078|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
129977504|NCT04958642|467881079|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
129977505|NCT04958642|467881080|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
129977506|NCT04958642|467881078|FG000|Overall Study|Lost to Follow-up|1|||
129977507|NCT04958642|467881079|FG001|Overall Study|Lost to Follow-up|0|||
129977508|NCT04958642|467881080|FG002|Overall Study|Lost to Follow-up|0|||
129977509|NCT04958642|467881078|FG000|Overall Study|Transferred to EAP following study termination|0|||
129977510|NCT04958642|467881079|FG001|Overall Study|Transferred to EAP following study termination|0|||
129977511|NCT04958642|467881080|FG002|Overall Study|Transferred to EAP following study termination|1|||
129977512|NCT04958642|467881078|FG000|Overall Study|Transferred to Expanded Access Program|1|||
129977513|NCT04958642|467881079|FG001|Overall Study|Transferred to Expanded Access Program|0|||
129977514|NCT04958642|467881080|FG002|Overall Study|Transferred to Expanded Access Program|0|||
129977515|NCT02476175|467881084|FG000|Overall Study|Adverse Event|2|||
129977516|NCT03868787|467881089|FG000|Overall Study|Withdrawal by Subject|2|||
129977517|NCT03868787|467881090|FG001|Overall Study|Withdrawal by Subject|1|||
129977518|NCT04313608|467881103|FG000|Overall Study|Death|12|||
129977519|NCT04313608|467881104|FG001|Overall Study|Death|3|||
129977520|NCT02964325|467881105|FG000|Overall Study|Lost to Follow-up|3|||
129977521|NCT02964325|467881106|FG001|Overall Study|Lost to Follow-up|3|||
129977522|NCT02964325|467881105|FG000|Overall Study|Physician Decision|5|||
129977523|NCT02964325|467881106|FG001|Overall Study|Physician Decision|4|||
129977524|NCT02964325|467881105|FG000|Overall Study|Death|1|||
129977525|NCT02964325|467881106|FG001|Overall Study|Death|3|||
129977526|NCT02964325|467881105|FG000|Overall Study|Withdrawal by Subject|2|||
129977527|NCT02964325|467881106|FG001|Overall Study|Withdrawal by Subject|1|||
129977528|NCT02964325|467881105|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
129977529|NCT02964325|467881106|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
129977530|NCT02510040|467881107|FG000|Overall Study|Deemed no longer eligible|18|||
129977531|NCT02510040|467881108|FG001|Overall Study|Deemed no longer eligible|3|||
129977532|NCT02510040|467881109|FG002|Overall Study|Deemed no longer eligible|1|||
129977533|NCT01371825|467881117|FG000|Overall Study|Death|4|||
129977534|NCT00534495|467881123|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
129977535|NCT00534495|467881124|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
129977536|NCT00534495|467881125|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
129977537|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
129977538|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
129977539|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
129977540|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
129977541|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
129977542|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
129977543|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
129977544|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
129977545|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
129977546|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
129977547|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
129977548|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
129977549|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
129977550|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
129977551|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
129977552|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
129977553|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
129977554|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
129977555|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
129977556|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
129977557|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
129977558|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
129977559|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
129977560|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
129977561|NCT02440425|467881126|FG000|Overall Study|Death likely due to disease progression|1|||
129977562|NCT02440425|467881126|FG000|Overall Study|Withdrawal by Subject|2|||
129977563|NCT02440425|467881126|FG000|Overall Study|Adverse Event|1|||
130147840|NCT01989676|468501111|FG001|Overall Study|Lost to Follow-up|18|||
129977564|NCT02440425|467881126|FG000|Overall Study|Adverse Event/Ineligible|1|||
129977565|NCT01068665|467881127|FG000|Overall Study|Adverse Event|5|||
129977566|NCT01068665|467881128|FG001|Overall Study|Adverse Event|4|||
129977567|NCT01068665|467881127|FG000|Overall Study|Lack of Efficacy|0|||
129977568|NCT01068665|467881128|FG001|Overall Study|Lack of Efficacy|2|||
129977569|NCT01068665|467881127|FG000|Overall Study|Protocol Violation|5|||
129977570|NCT01068665|467881128|FG001|Overall Study|Protocol Violation|2|||
129977571|NCT01068665|467881127|FG000|Overall Study|Withdrawal Criteria|3|||
129977572|NCT01068665|467881128|FG001|Overall Study|Withdrawal Criteria|9|||
129977573|NCT01068665|467881127|FG000|Overall Study|Other|17|||
129977574|NCT01068665|467881128|FG001|Overall Study|Other|12|||
129977575|NCT02807272|467881129|FG000|Overall Study|Death|9|||
129977576|NCT02807272|467881130|FG001|Overall Study|Death|5|||
129977577|NCT02807272|467881131|FG002|Overall Study|Death|2|||
129977578|NCT02807272|467881132|FG003|Overall Study|Death|0|||
129977579|NCT02807272|467881133|FG004|Overall Study|Death|1|||
129977580|NCT02807272|467881129|FG000|Overall Study|Lost to Follow-up|1|||
129977581|NCT02807272|467881130|FG001|Overall Study|Lost to Follow-up|0|||
129977582|NCT02807272|467881131|FG002|Overall Study|Lost to Follow-up|0|||
129977583|NCT02807272|467881132|FG003|Overall Study|Lost to Follow-up|0|||
130147841|NCT01989676|468501110|FG000|Overall Study|No longer willing to participate in study|26|||
130147842|NCT01989676|468501111|FG001|Overall Study|No longer willing to participate in study|26|||
130147843|NCT01989676|468501110|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
130147844|NCT01989676|468501111|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
130147845|NCT01989676|468501110|FG000|Overall Study|Other|4|||
130147846|NCT01989676|468501111|FG001|Overall Study|Other|3|||
129977584|NCT02807272|467881133|FG004|Overall Study|Lost to Follow-up|0|||
129977585|NCT02807272|467881129|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
130147847|NCT03941834|468501112|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
130147848|NCT03941834|468501113|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
130147849|NCT03941834|468501114|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
130147850|NCT03941834|468501112|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
130147851|NCT03941834|468501113|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
130147852|NCT03941834|468501114|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
130147853|NCT03941834|468501112|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
130147854|NCT03941834|468501113|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
130147855|NCT03941834|468501114|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
130147856|NCT03941834|468501112|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
130147857|NCT03941834|468501113|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
130147858|NCT03941834|468501114|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
130147859|NCT03941834|468501112|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
130147860|NCT03941834|468501113|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
130147861|NCT03941834|468501114|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
130147862|NCT03941834|468501112|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
130147863|NCT03941834|468501113|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
130147864|NCT03941834|468501114|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
130147865|NCT01560819|468501118|FG000|Overall Study|Physician Decision|1|||
130147866|NCT01560819|468501119|FG001|Overall Study|Physician Decision|0|||
130147867|NCT02344745|468501120|FG000|Overall Study|Data collection sheets were lost|2|||
130147868|NCT02344745|468501121|FG001|Overall Study|Data collection sheets were lost|0|||
130147869|NCT02788513|468501122|FG000|Overall Study|Withdrawal by Subject|3|||
130147870|NCT02788513|468501123|FG001|Overall Study|Withdrawal by Subject|0|||
130147871|NCT02788513|468501124|FG002|Overall Study|Withdrawal by Subject|2|||
130147872|NCT02788513|468501125|FG003|Overall Study|Withdrawal by Subject|3|||
130147873|NCT02788513|468501126|FG004|Overall Study|Withdrawal by Subject|1|||
130147874|NCT02788513|468501122|FG000|Overall Study|Lost to Follow-up|1|||
129977586|NCT02807272|467881130|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
129977587|NCT02807272|467881131|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
129977588|NCT02807272|467881132|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
129977589|NCT02807272|467881133|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
129977590|NCT02807272|467881129|FG000|Overall Study|Protocol-defined Disease Progression|0|||
129977591|NCT02807272|467881130|FG001|Overall Study|Protocol-defined Disease Progression|1|||
129977592|NCT02807272|467881131|FG002|Overall Study|Protocol-defined Disease Progression|0|||
129977593|NCT02807272|467881132|FG003|Overall Study|Protocol-defined Disease Progression|0|||
129977594|NCT02807272|467881133|FG004|Overall Study|Protocol-defined Disease Progression|1|||
130147875|NCT02788513|468501123|FG001|Overall Study|Lost to Follow-up|0|||
130147876|NCT02788513|468501124|FG002|Overall Study|Lost to Follow-up|0|||
130147877|NCT02788513|468501125|FG003|Overall Study|Lost to Follow-up|0|||
130147878|NCT02788513|468501126|FG004|Overall Study|Lost to Follow-up|1|||
129977595|NCT02807272|467881129|FG000|Overall Study|Study Terminated by Sponsor|1|||
129977596|NCT02807272|467881130|FG001|Overall Study|Study Terminated by Sponsor|0|||
129977597|NCT02807272|467881131|FG002|Overall Study|Study Terminated by Sponsor|0|||
129977598|NCT02807272|467881132|FG003|Overall Study|Study Terminated by Sponsor|1|||
129977599|NCT02807272|467881133|FG004|Overall Study|Study Terminated by Sponsor|0|||
129977600|NCT02807272|467881129|FG000|Overall Study|Other|1|||
129977601|NCT02807272|467881130|FG001|Overall Study|Other|0|||
129977602|NCT02807272|467881131|FG002|Overall Study|Other|0|||
129977603|NCT02807272|467881132|FG003|Overall Study|Other|0|||
129977604|NCT02807272|467881133|FG004|Overall Study|Other|1|||
129977605|NCT01038427|467881134|FG000|Overall Study|Lost to follow up|1|||
129977606|NCT01038427|467881135|FG001|Overall Study|Lost to follow up|1|||
129977607|NCT01038427|467881136|FG002|Overall Study|Lost to follow up|0|||
129977608|NCT01038427|467881134|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
129977609|NCT01038427|467881135|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
129977610|NCT01038427|467881136|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
129977611|NCT01038427|467881134|FG000|Overall Study|Withdrew consent|0|||
129977612|NCT01038427|467881135|FG001|Overall Study|Withdrew consent|0|||
129977613|NCT01038427|467881136|FG002|Overall Study|Withdrew consent|1|||
129977614|NCT01038427|467881134|FG000|Overall Study|Adverse Event|2|||
129977615|NCT01038427|467881135|FG001|Overall Study|Adverse Event|2|||
129977616|NCT01038427|467881136|FG002|Overall Study|Adverse Event|1|||
129977617|NCT01038427|467881134|FG000|Overall Study|Enrolled in error|0|||
129977618|NCT01038427|467881135|FG001|Overall Study|Enrolled in error|1|||
129977619|NCT01038427|467881136|FG002|Overall Study|Enrolled in error|1|||
129977620|NCT01038427|467881134|FG000|Overall Study|Other|0|||
129977621|NCT01038427|467881135|FG001|Overall Study|Other|2|||
129977622|NCT01038427|467881136|FG002|Overall Study|Other|0|||
129977623|NCT04230122|467881137|FG000|Overall Study|Lost to Follow-up|1|||
129977624|NCT04230122|467881138|FG001|Overall Study|Lost to Follow-up|0|||
129977625|NCT00604708|467881139|FG000|Overall Study|Withdrawal by Subject|9|||
129977626|NCT00604708|467881140|FG001|Overall Study|Withdrawal by Subject|10|||
129977627|NCT00604708|467881139|FG000|Overall Study|Protocol Violation|2|||
129977628|NCT00604708|467881140|FG001|Overall Study|Protocol Violation|8|||
129977629|NCT00604708|467881139|FG000|Overall Study|Lost to Follow-up|5|||
129977630|NCT00604708|467881140|FG001|Overall Study|Lost to Follow-up|5|||
129977631|NCT00604708|467881139|FG000|Overall Study|administrative reasons|9|||
129977632|NCT00604708|467881140|FG001|Overall Study|administrative reasons|11|||
129977633|NCT00604708|467881139|FG000|Overall Study|Adverse Event|6|||
129977634|NCT00604708|467881140|FG001|Overall Study|Adverse Event|6|||
129977635|NCT02202785|467881141|FG000|Overall Study|Study Terminated by Sponsor|1|||
129977636|NCT02202785|467881142|FG001|Overall Study|Study Terminated by Sponsor|6|||
129977637|NCT02202785|467881143|FG002|Overall Study|Study Terminated by Sponsor|4|||
129977638|NCT02202785|467881141|FG000|Overall Study|Withdrawal by Subject|0|||
129977639|NCT02202785|467881142|FG001|Overall Study|Withdrawal by Subject|1|||
129977640|NCT02202785|467881143|FG002|Overall Study|Withdrawal by Subject|0|||
129977641|NCT02202785|467881141|FG000|Overall Study|Lost to Follow-up|0|||
129977642|NCT02202785|467881142|FG001|Overall Study|Lost to Follow-up|1|||
129977643|NCT02202785|467881143|FG002|Overall Study|Lost to Follow-up|0|||
129977644|NCT02202785|467881141|FG000|Overall Study|Reason not Specified|10|||
129977645|NCT02202785|467881142|FG001|Overall Study|Reason not Specified|7|||
129977646|NCT02202785|467881143|FG002|Overall Study|Reason not Specified|13|||
129977647|NCT01137578|467881144|FG000|Overall Study|Participant requested to Discontinue|3|||
129977648|NCT01137578|467881145|FG001|Overall Study|Participant requested to Discontinue|0|||
129977649|NCT01137578|467881146|FG002|Overall Study|Participant requested to Discontinue|0|||
129977650|NCT01137578|467881144|FG000|Overall Study|Withdrawal by Subject|1|||
129977651|NCT01137578|467881145|FG001|Overall Study|Withdrawal by Subject|0|||
129977652|NCT01137578|467881146|FG002|Overall Study|Withdrawal by Subject|0|||
129977653|NCT01137578|467881144|FG000|Overall Study|Other|12|||
129977654|NCT01137578|467881145|FG001|Overall Study|Other|2|||
129977655|NCT01137578|467881146|FG002|Overall Study|Other|6|||
129977656|NCT04145700|467881147|FG000|Overall Study|Withdrawal by Subject|8|||
129977657|NCT04145700|467881148|FG001|Overall Study|Withdrawal by Subject|3|||
129977658|NCT00818779|467881149|FG000|Overall Study|Protocol Violation|1|||
129977659|NCT00818779|467881150|FG001|Overall Study|Protocol Violation|0|||
129977660|NCT00818779|467881149|FG000|Overall Study|Lost to Follow-up|1|||
130147879|NCT02788513|468501122|FG000|Overall Study|Adverse Event|5|||
130147880|NCT02788513|468501123|FG001|Overall Study|Adverse Event|8|||
130147881|NCT02788513|468501124|FG002|Overall Study|Adverse Event|4|||
130147882|NCT02788513|468501125|FG003|Overall Study|Adverse Event|2|||
130147883|NCT02788513|468501126|FG004|Overall Study|Adverse Event|2|||
130147884|NCT02788513|468501122|FG000|Overall Study|Protocol Violation|0|||
130147885|NCT02788513|468501123|FG001|Overall Study|Protocol Violation|0|||
130147886|NCT02788513|468501124|FG002|Overall Study|Protocol Violation|1|||
129977661|NCT00818779|467881150|FG001|Overall Study|Lost to Follow-up|0|||
130147887|NCT02788513|468501125|FG003|Overall Study|Protocol Violation|1|||
129977662|NCT00818779|467881149|FG000|Overall Study|Adverse Event|4|||
129977663|NCT00818779|467881150|FG001|Overall Study|Adverse Event|1|||
129977664|NCT04978493|467881151|FG000|Overall Study|No reason available|0|||
129977665|NCT04978493|467881152|FG001|Overall Study|No reason available|1|||
129977666|NCT04978493|467881151|FG000|Overall Study|Adverse Event|1|||
129977667|NCT04978493|467881152|FG001|Overall Study|Adverse Event|0|||
129977668|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital status: missing)|1|||
129977669|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital status: missing)|2|||
129977670|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital status: missing)|2|||
129977671|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital status: missing)|1|||
129977672|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
129977673|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
129977674|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
129977675|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
129977676|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
129977677|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
129977678|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
129977679|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
129977680|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
129977681|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
129977682|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
129977683|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
129977684|NCT01327846|467881155|FG000|Core Phase|Lost to Follow-up|3|||
129977685|NCT01327846|467881156|FG001|Core Phase|Lost to Follow-up|3|||
129977686|NCT01327846|467881157|FG002|Core Phase|Lost to Follow-up|4|||
129977687|NCT01327846|467881158|FG003|Core Phase|Lost to Follow-up|5|||
129977688|NCT01327846|467881155|FG000|Extension Phase|Study terminated by sponsor|1073|||
129977689|NCT01327846|467881156|FG001|Extension Phase|Study terminated by sponsor|1124|||
129977690|NCT01327846|467881157|FG002|Extension Phase|Study terminated by sponsor|1067|||
129977691|NCT01327846|467881158|FG003|Extension Phase|Study terminated by sponsor|1660|||
129977692|NCT01327846|467881155|FG000|Extension Phase|Withdrawal by Subject|20|||
129977693|NCT01327846|467881156|FG001|Extension Phase|Withdrawal by Subject|13|||
129977694|NCT01327846|467881157|FG002|Extension Phase|Withdrawal by Subject|19|||
129977695|NCT01327846|467881158|FG003|Extension Phase|Withdrawal by Subject|37|||
129977696|NCT01327846|467881155|FG000|Extension Phase|Lost to Follow-up|4|||
129977697|NCT01327846|467881156|FG001|Extension Phase|Lost to Follow-up|3|||
129977698|NCT01327846|467881157|FG002|Extension Phase|Lost to Follow-up|4|||
129977699|NCT01327846|467881158|FG003|Extension Phase|Lost to Follow-up|7|||
129977700|NCT01327846|467881155|FG000|Extension Phase|Technical Problems|2|||
129977701|NCT01327846|467881156|FG001|Extension Phase|Technical Problems|4|||
129977702|NCT01327846|467881157|FG002|Extension Phase|Technical Problems|2|||
130147888|NCT02788513|468501126|FG004|Overall Study|Protocol Violation|0|||
130147889|NCT02788513|468501122|FG000|Overall Study|Subject decided to stop taking treatment|0|||
130147890|NCT02788513|468501123|FG001|Overall Study|Subject decided to stop taking treatment|0|||
130147891|NCT02788513|468501124|FG002|Overall Study|Subject decided to stop taking treatment|1|||
130147892|NCT02788513|468501125|FG003|Overall Study|Subject decided to stop taking treatment|0|||
130147893|NCT02788513|468501126|FG004|Overall Study|Subject decided to stop taking treatment|0|||
130147894|NCT02788513|468501122|FG000|Overall Study|Decision by the study team|0|||
130147895|NCT02788513|468501123|FG001|Overall Study|Decision by the study team|0|||
130147896|NCT02788513|468501124|FG002|Overall Study|Decision by the study team|0|||
130147897|NCT02788513|468501125|FG003|Overall Study|Decision by the study team|0|||
129977703|NCT01327846|467881158|FG003|Extension Phase|Technical Problems|2|||
129977704|NCT04343976|467881159|FG000|Overall Study|Withdrawal by Subject|0|||
129977705|NCT04343976|467881160|FG001|Overall Study|Withdrawal by Subject|1|||
129977706|NCT00594880|467881161|FG000|Overall Study|Withdrawal by Subject|1|||
129977707|NCT00594880|467881162|FG001|Overall Study|Withdrawal by Subject|1|||
129977708|NCT00594880|467881161|FG000|Overall Study|Lost to Follow-up|1|||
129977709|NCT00594880|467881162|FG001|Overall Study|Lost to Follow-up|0|||
129977710|NCT00694109|467881163|FG000|Overall Study|Physician Decision|3|||
129977711|NCT00694109|467881163|FG000|Overall Study|Adverse Event|74|||
129977712|NCT00694109|467881163|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
129977713|NCT00694109|467881163|FG000|Overall Study|Lack of Efficacy|2|||
129977714|NCT00694109|467881163|FG000|Overall Study|Withdrawal by Subject|13|||
129977715|NCT00694109|467881163|FG000|Overall Study|Pregnancy|1|||
129977716|NCT00694109|467881163|FG000|Overall Study|Enrolled but not treated|1|||
129977717|NCT00694109|467881163|FG000|Overall Study|Other|2|||
129977718|NCT00694109|467881163|FG000|Overall Study|Consented but no additional treatment|3|||
129977719|NCT01254747|467881164|FG000|Overall Study|Unacceptable subjective vision|0|||
129977720|NCT01254747|467881165|FG001|Overall Study|Unacceptable subjective vision|0|||
129977721|NCT01254747|467881166|FG002|Overall Study|Unacceptable subjective vision|0|||
129977722|NCT01254747|467881167|FG003|Overall Study|Unacceptable subjective vision|2|||
129977723|NCT01254747|467881164|FG000|Overall Study|Difficult removal handling|0|||
130147898|NCT02788513|468501126|FG004|Overall Study|Decision by the study team|1|||
130147899|NCT00114231|468501128|FG000|Overall Study|No consent|2|||
130147900|NCT00114231|468501129|FG001|Overall Study|No consent|0|||
129977724|NCT01254747|467881165|FG001|Overall Study|Difficult removal handling|0|||
129977725|NCT01254747|467881166|FG002|Overall Study|Difficult removal handling|1|||
129977726|NCT01254747|467881167|FG003|Overall Study|Difficult removal handling|0|||
129977727|NCT01254747|467881164|FG000|Overall Study|Symptoms and problems|0|||
129977728|NCT01254747|467881165|FG001|Overall Study|Symptoms and problems|2|||
129977729|NCT01254747|467881166|FG002|Overall Study|Symptoms and problems|1|||
129977730|NCT01254747|467881167|FG003|Overall Study|Symptoms and problems|0|||
129977731|NCT01254747|467881164|FG000|Overall Study|Lost to Follow-up|0|||
129977732|NCT01254747|467881165|FG001|Overall Study|Lost to Follow-up|0|||
129977733|NCT01254747|467881166|FG002|Overall Study|Lost to Follow-up|1|||
129977734|NCT01254747|467881167|FG003|Overall Study|Lost to Follow-up|0|||
129977735|NCT01254747|467881164|FG000|Overall Study|Biomicroscopy|0|||
129977736|NCT01254747|467881165|FG001|Overall Study|Biomicroscopy|0|||
129977737|NCT01254747|467881166|FG002|Overall Study|Biomicroscopy|1|||
129977738|NCT01254747|467881167|FG003|Overall Study|Biomicroscopy|0|||
129977739|NCT01254747|467881164|FG000|Overall Study|Discomfort|0|||
129977740|NCT01254747|467881165|FG001|Overall Study|Discomfort|4|||
129977741|NCT01254747|467881166|FG002|Overall Study|Discomfort|0|||
129977742|NCT01254747|467881167|FG003|Overall Study|Discomfort|0|||
129977743|NCT00846807|467881168|FG000|Overall Study|Adverse Event|270|||
129977744|NCT00846807|467881168|FG000|Overall Study|Lost to Follow-up|94|||
129977745|NCT00846807|467881168|FG000|Overall Study|Withdrawal by Subject|56|||
129977746|NCT00846807|467881168|FG000|Overall Study|Non compliant with European label|7|||
129977747|NCT00846807|467881168|FG000|Overall Study|Switch to other anticoagulants|89|||
129977748|NCT00846807|467881168|FG000|Overall Study|No prescription after hospital discharge|56|||
129977749|NCT00846807|467881168|FG000|Overall Study|Other|60|||
129977750|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
129977751|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
129977752|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
129977753|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
129977754|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
129977755|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
129977756|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
129977757|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
129977758|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
129977759|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
129977760|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
129977761|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
129977762|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
129977763|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
129977764|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
129977765|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
129977766|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
129977767|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
129977768|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
129977769|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
129977770|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
129977771|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
129977772|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
129977773|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
129977774|NCT00737698|467881171|FG000|Overall Study|Withdrawal by Subject|6|||
129977775|NCT00737698|467881172|FG001|Overall Study|Withdrawal by Subject|5|||
129977776|NCT00737698|467881173|FG002|Overall Study|Withdrawal by Subject|3|||
129977777|NCT00737698|467881171|FG000|Overall Study|Death|0|||
129977778|NCT00737698|467881172|FG001|Overall Study|Death|0|||
129977779|NCT00737698|467881173|FG002|Overall Study|Death|1|||
129977780|NCT01067846|467881174|FG000|Overall Study|Lost to Follow-up|17|||
129977781|NCT01067846|467881175|FG001|Overall Study|Lost to Follow-up|19|||
129977782|NCT01067846|467881174|FG000|Overall Study|Withdrawal by Subject|1|||
129977783|NCT01067846|467881175|FG001|Overall Study|Withdrawal by Subject|0|||
129977784|NCT01067846|467881174|FG000|Overall Study|participation in other tx study|1|||
129977785|NCT01067846|467881175|FG001|Overall Study|participation in other tx study|0|||
129977786|NCT02817906|467881176|FG000|Overall Study|Adverse Event|3|||
129977787|NCT02817906|467881177|FG001|Overall Study|Adverse Event|0|||
129977788|NCT02817906|467881176|FG000|Overall Study|Lack of Efficacy|1|||
129977789|NCT02817906|467881177|FG001|Overall Study|Lack of Efficacy|0|||
129977790|NCT02817906|467881176|FG000|Overall Study|Protocol Violation|1|||
129977791|NCT02817906|467881177|FG001|Overall Study|Protocol Violation|1|||
129977792|NCT02817906|467881176|FG000|Overall Study|Study Terminated by Sponsor|2|||
130147901|NCT00114231|468501128|FG000|Overall Study|QARC requirement not met|1|||
130147902|NCT00114231|468501129|FG001|Overall Study|QARC requirement not met|0|||
130147903|NCT00114231|468501128|FG000|Overall Study|Suspected metastatic disease|1|||
129977793|NCT02817906|467881177|FG001|Overall Study|Study Terminated by Sponsor|2|||
129977794|NCT02817906|467881176|FG000|Overall Study|Withdrawal by Subject|7|||
129977795|NCT02817906|467881177|FG001|Overall Study|Withdrawal by Subject|0|||
130147904|NCT00114231|468501129|FG001|Overall Study|Suspected metastatic disease|0|||
130147905|NCT00114231|468501128|FG000|Overall Study|No adenocarcinoma|1|||
129977796|NCT02817906|467881176|FG000|Overall Study|Other|2|||
129977797|NCT02817906|467881177|FG001|Overall Study|Other|2|||
129977798|NCT04608773|467881179|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
129977799|NCT04608773|467881180|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
129977800|NCT04608773|467881179|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
129977801|NCT04608773|467881180|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
129977802|NCT04608773|467881179|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
129977803|NCT04608773|467881180|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
129977804|NCT04608773|467881179|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
129977805|NCT04608773|467881180|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
129977806|NCT04608773|467881179|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
129977807|NCT04608773|467881180|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
129977808|NCT02833077|467881181|FG000|Overall Study|Adverse Event|1|||
129977809|NCT02833077|467881182|FG001|Overall Study|Adverse Event|2|||
129977810|NCT02833077|467881181|FG000|Overall Study|Lost to Follow-up|10|||
129977811|NCT02833077|467881182|FG001|Overall Study|Lost to Follow-up|1|||
129977812|NCT02833077|467881181|FG000|Overall Study|Personal Reasons|6|||
129977813|NCT02833077|467881182|FG001|Overall Study|Personal Reasons|4|||
129977814|NCT02833077|467881181|FG000|Overall Study|Protocol Deviation|0|||
129977815|NCT02833077|467881182|FG001|Overall Study|Protocol Deviation|1|||
129977816|NCT00316017|467881183|FG000|Overall Study|Protocol Violation|11|||
129977817|NCT00316017|467881184|FG001|Overall Study|Protocol Violation|13|||
129977818|NCT00316017|467881185|FG002|Overall Study|Protocol Violation|19|||
129977819|NCT04531982|467881186|FG000|Overall Study|Withdrawal by Subject|10|||
129977820|NCT04531982|467881187|FG001|Overall Study|Withdrawal by Subject|11|||
129977821|NCT04531982|467881186|FG000|Overall Study|Adverse Event|6|||
129977822|NCT04531982|467881187|FG001|Overall Study|Adverse Event|14|||
129977823|NCT04531982|467881186|FG000|Overall Study|Protocol Violation|6|||
129977824|NCT04531982|467881187|FG001|Overall Study|Protocol Violation|9|||
129977825|NCT04531982|467881186|FG000|Overall Study|Non-compliance with study drug|3|||
129977826|NCT04531982|467881187|FG001|Overall Study|Non-compliance with study drug|2|||
129977827|NCT04531982|467881186|FG000|Overall Study|Use of prohibited medication|2|||
129977828|NCT04531982|467881187|FG001|Overall Study|Use of prohibited medication|0|||
129977829|NCT04531982|467881186|FG000|Overall Study|Lost to Follow-up|0|||
129977830|NCT04531982|467881187|FG001|Overall Study|Lost to Follow-up|1|||
129977831|NCT04531982|467881186|FG000|Overall Study|Geopolitical conflict|2|||
129977832|NCT04531982|467881187|FG001|Overall Study|Geopolitical conflict|0|||
129977833|NCT04531982|467881186|FG000|Overall Study|Lack of Efficacy|3|||
129977834|NCT04531982|467881187|FG001|Overall Study|Lack of Efficacy|1|||
129977835|NCT03841526|467881189|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
129977836|NCT03841526|467881190|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977837|NCT03841526|467881191|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977838|NCT03841526|467881192|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
129977839|NCT03841526|467881193|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977840|NCT03841526|467881194|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977841|NCT03841526|467881189|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
129977842|NCT03841526|467881190|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
129977843|NCT03841526|467881191|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
130147906|NCT00114231|468501129|FG001|Overall Study|No adenocarcinoma|0|||
130147907|NCT00114231|468501128|FG000|Overall Study|Low creatinine clearance|0|||
130147908|NCT00114231|468501129|FG001|Overall Study|Low creatinine clearance|1|||
130147909|NCT00114231|468501128|FG000|Overall Study|Tumor size > 4cm|1|||
130147910|NCT00114231|468501129|FG001|Overall Study|Tumor size > 4cm|0|||
130147911|NCT00114231|468501128|FG000|Overall Study|Tumor fixed on digital exam|0|||
130147912|NCT00114231|468501129|FG001|Overall Study|Tumor fixed on digital exam|1|||
130147913|NCT00114231|468501128|FG000|Overall Study|No Absolute Neutrophil Count|2|||
130147914|NCT00114231|468501129|FG001|Overall Study|No Absolute Neutrophil Count|0|||
130147915|NCT00114231|468501128|FG000|Overall Study|Biopsy done after registration|1|||
130147916|NCT00114231|468501129|FG001|Overall Study|Biopsy done after registration|0|||
130147917|NCT01933919|468501130|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
130147918|NCT01933919|468501131|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
130147919|NCT01933919|468501130|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
130147920|NCT01933919|468501131|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
129977844|NCT03841526|467881192|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
129977845|NCT03841526|467881193|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
130147921|NCT01933919|468501130|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
130147922|NCT01933919|468501131|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
130147923|NCT01933919|468501130|FG000|Open-label Long-term Phase|Adverse Event|2|||
130154902|NCT01470612|468526638|FG000|Overall Study|Protocol Violation|2|||
129977846|NCT03841526|467881194|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
129977847|NCT03841526|467881189|FG000|Outpatient Phase Treatment|Physician Decision|0|||
129977848|NCT03841526|467881190|FG001|Outpatient Phase Treatment|Physician Decision|1|||
129977849|NCT03841526|467881191|FG002|Outpatient Phase Treatment|Physician Decision|0|||
129977850|NCT03841526|467881192|FG003|Outpatient Phase Treatment|Physician Decision|0|||
129977851|NCT03841526|467881193|FG004|Outpatient Phase Treatment|Physician Decision|0|||
129977852|NCT03841526|467881194|FG005|Outpatient Phase Treatment|Physician Decision|0|||
129977853|NCT03841526|467881189|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129977854|NCT03841526|467881190|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129977855|NCT03841526|467881191|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
129977856|NCT03841526|467881192|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
130147924|NCT01933919|468501131|FG001|Open-label Long-term Phase|Adverse Event|0|||
130147925|NCT01933919|468501130|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
130147926|NCT01933919|468501131|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
130147927|NCT01933919|468501130|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
130147928|NCT01933919|468501131|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
130147929|NCT01933919|468501130|FG000|Open-label Long-term Phase|Other|1|||
130147930|NCT01933919|468501131|FG001|Open-label Long-term Phase|Other|2|||
130147931|NCT02510261|468501138|FG000|Overall Study|Adverse Event|5|||
130147932|NCT02510261|468501139|FG001|Overall Study|Adverse Event|8|||
130147933|NCT02510261|468501140|FG002|Overall Study|Adverse Event|0|||
130147934|NCT02510261|468501138|FG000|Overall Study|Physician Decision|1|||
130147935|NCT02510261|468501139|FG001|Overall Study|Physician Decision|5|||
130147936|NCT02510261|468501140|FG002|Overall Study|Physician Decision|0|||
130147937|NCT02510261|468501138|FG000|Overall Study|Death|19|||
130147938|NCT02510261|468501139|FG001|Overall Study|Death|19|||
130147939|NCT02510261|468501140|FG002|Overall Study|Death|0|||
130147940|NCT02510261|468501138|FG000|Overall Study|Withdrawal by Subject|3|||
130147941|NCT02510261|468501139|FG001|Overall Study|Withdrawal by Subject|10|||
130147942|NCT02510261|468501140|FG002|Overall Study|Withdrawal by Subject|3|||
130147943|NCT02618382|468501142|FG000|Overall Study|Physician Decision|1|||
130147944|NCT02618382|468501142|FG000|Overall Study|Withdrawal by Subject|1|||
130147945|NCT02618382|468501142|FG000|Overall Study|Protocol Violation|1|||
130147946|NCT03235479|468501145|FG000|Overall Study|Lost to Follow-up|8|||
130147947|NCT03235479|468501146|FG001|Overall Study|Lost to Follow-up|11|||
130147948|NCT03235479|468501145|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
130147949|NCT03235479|468501146|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
130147950|NCT03235479|468501145|FG000|Overall Study|Pregnancy|1|||
130147951|NCT03235479|468501146|FG001|Overall Study|Pregnancy|0|||
130147952|NCT03235479|468501145|FG000|Overall Study|Protocol Deviation|1|||
130147953|NCT03235479|468501146|FG001|Overall Study|Protocol Deviation|3|||
129977857|NCT03841526|467881193|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129977858|NCT03841526|467881194|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
129977859|NCT03829501|467882561|FG000|Overall Study|Withdrawal of Consent|2|||
129977860|NCT03829501|467882562|FG001|Overall Study|Withdrawal of Consent|0|||
129977861|NCT03829501|467882563|FG002|Overall Study|Withdrawal of Consent|3|||
129977862|NCT03829501|467882564|FG003|Overall Study|Withdrawal of Consent|0|||
129977863|NCT03829501|467882565|FG004|Overall Study|Withdrawal of Consent|1|||
129977864|NCT03829501|467882566|FG005|Overall Study|Withdrawal of Consent|1|||
129977865|NCT03829501|467882567|FG006|Overall Study|Withdrawal of Consent|0|||
129977866|NCT03829501|467882568|FG007|Overall Study|Withdrawal of Consent|10|||
129977867|NCT03829501|467882569|FG008|Overall Study|Withdrawal of Consent|10|||
129977868|NCT03829501|467882570|FG009|Overall Study|Withdrawal of Consent|3|||
129977869|NCT03829501|467882571|FG010|Overall Study|Withdrawal of Consent|4|||
129977870|NCT03829501|467882572|FG011|Overall Study|Withdrawal of Consent|4|||
129977871|NCT03829501|467882573|FG012|Overall Study|Withdrawal of Consent|4|||
129977872|NCT03829501|467882574|FG013|Overall Study|Withdrawal of Consent|0|||
129977873|NCT03829501|467882575|FG014|Overall Study|Withdrawal of Consent|3|||
129977874|NCT03829501|467882576|FG015|Overall Study|Withdrawal of Consent|0|||
129977875|NCT03829501|467882577|FG016|Overall Study|Withdrawal of Consent|1|||
129977876|NCT03829501|467882578|FG017|Overall Study|Withdrawal of Consent|1|||
129977877|NCT03829501|467882579|FG018|Overall Study|Withdrawal of Consent|0|||
129977878|NCT03829501|467882580|FG019|Overall Study|Withdrawal of Consent|0|||
129977879|NCT03829501|467882581|FG020|Overall Study|Withdrawal of Consent|3|||
129977880|NCT03829501|467882582|FG021|Overall Study|Withdrawal of Consent|0|||
129977881|NCT03829501|467882583|FG022|Overall Study|Withdrawal of Consent|1|||
129977882|NCT03829501|467882561|FG000|Overall Study|PD|0|||
129977883|NCT03829501|467882562|FG001|Overall Study|PD|0|||
129977884|NCT03829501|467882563|FG002|Overall Study|PD|0|||
129977885|NCT03829501|467882564|FG003|Overall Study|PD|2|||
129977886|NCT03829501|467882565|FG004|Overall Study|PD|0|||
129977887|NCT03829501|467882566|FG005|Overall Study|PD|0|||
129977888|NCT03829501|467882567|FG006|Overall Study|PD|0|||
130147954|NCT03235479|468501145|FG000|Overall Study|Technical Problems|3|||
130147955|NCT03235479|468501146|FG001|Overall Study|Technical Problems|2|||
130147956|NCT03235479|468501145|FG000|Overall Study|Withdrawal by Subject|2|||
130147957|NCT03235479|468501146|FG001|Overall Study|Withdrawal by Subject|2|||
129977889|NCT03829501|467882568|FG007|Overall Study|PD|0|||
129977890|NCT03829501|467882569|FG008|Overall Study|PD|0|||
129977891|NCT03829501|467882570|FG009|Overall Study|PD|0|||
129977892|NCT03829501|467882571|FG010|Overall Study|PD|0|||
129977893|NCT03829501|467882572|FG011|Overall Study|PD|0|||
129977894|NCT03829501|467882573|FG012|Overall Study|PD|0|||
129977895|NCT03829501|467882574|FG013|Overall Study|PD|0|||
130147958|NCT03235479|468501145|FG000|Overall Study|Other Reasons|3|||
130147959|NCT03235479|468501146|FG001|Overall Study|Other Reasons|5|||
129977896|NCT03829501|467882575|FG014|Overall Study|PD|0|||
130147960|NCT00309985|468501149|FG000|Overall Study|Disease progression|12|||
130147961|NCT00309985|468501150|FG001|Overall Study|Disease progression|0|||
130147962|NCT00309985|468501149|FG000|Overall Study|Adverse Event|30|||
129977897|NCT03829501|467882576|FG015|Overall Study|PD|1|||
129977898|NCT03829501|467882577|FG016|Overall Study|PD|0|||
129977899|NCT03829501|467882578|FG017|Overall Study|PD|0|||
129977900|NCT03829501|467882579|FG018|Overall Study|PD|0|||
129977901|NCT03829501|467882580|FG019|Overall Study|PD|0|||
129977902|NCT03829501|467882581|FG020|Overall Study|PD|1|||
129977903|NCT03829501|467882582|FG021|Overall Study|PD|0|||
129977904|NCT03829501|467882583|FG022|Overall Study|PD|0|||
129977905|NCT03829501|467882561|FG000|Overall Study|Study Terminated by Sponsor|0|||
129977906|NCT03829501|467882562|FG001|Overall Study|Study Terminated by Sponsor|0|||
129977907|NCT03829501|467882563|FG002|Overall Study|Study Terminated by Sponsor|0|||
129977908|NCT03829501|467882564|FG003|Overall Study|Study Terminated by Sponsor|0|||
129977909|NCT03829501|467882565|FG004|Overall Study|Study Terminated by Sponsor|0|||
129977910|NCT03829501|467882566|FG005|Overall Study|Study Terminated by Sponsor|0|||
129977911|NCT03829501|467882567|FG006|Overall Study|Study Terminated by Sponsor|0|||
129977912|NCT03829501|467882568|FG007|Overall Study|Study Terminated by Sponsor|3|||
129977913|NCT03829501|467882569|FG008|Overall Study|Study Terminated by Sponsor|1|||
129977914|NCT03829501|467882570|FG009|Overall Study|Study Terminated by Sponsor|0|||
129977915|NCT03829501|467882571|FG010|Overall Study|Study Terminated by Sponsor|0|||
129977916|NCT03829501|467882572|FG011|Overall Study|Study Terminated by Sponsor|0|||
129977917|NCT03829501|467882573|FG012|Overall Study|Study Terminated by Sponsor|0|||
129977918|NCT03829501|467882574|FG013|Overall Study|Study Terminated by Sponsor|0|||
129977919|NCT03829501|467882575|FG014|Overall Study|Study Terminated by Sponsor|3|||
129977920|NCT03829501|467882576|FG015|Overall Study|Study Terminated by Sponsor|2|||
129977921|NCT03829501|467882577|FG016|Overall Study|Study Terminated by Sponsor|2|||
129977922|NCT03829501|467882578|FG017|Overall Study|Study Terminated by Sponsor|0|||
129977923|NCT03829501|467882579|FG018|Overall Study|Study Terminated by Sponsor|0|||
129977924|NCT03829501|467882580|FG019|Overall Study|Study Terminated by Sponsor|0|||
129977925|NCT03829501|467882581|FG020|Overall Study|Study Terminated by Sponsor|1|||
129977926|NCT03829501|467882582|FG021|Overall Study|Study Terminated by Sponsor|0|||
129977927|NCT03829501|467882583|FG022|Overall Study|Study Terminated by Sponsor|3|||
129977928|NCT03829501|467882561|FG000|Overall Study|Lost to Follow Up|0|||
129977929|NCT03829501|467882562|FG001|Overall Study|Lost to Follow Up|0|||
129977930|NCT03829501|467882563|FG002|Overall Study|Lost to Follow Up|0|||
129977931|NCT03829501|467882564|FG003|Overall Study|Lost to Follow Up|0|||
129977932|NCT03829501|467882565|FG004|Overall Study|Lost to Follow Up|1|||
129977933|NCT03829501|467882566|FG005|Overall Study|Lost to Follow Up|0|||
129977934|NCT03829501|467882567|FG006|Overall Study|Lost to Follow Up|0|||
129977935|NCT03829501|467882568|FG007|Overall Study|Lost to Follow Up|2|||
129977936|NCT03829501|467882569|FG008|Overall Study|Lost to Follow Up|2|||
129977937|NCT03829501|467882570|FG009|Overall Study|Lost to Follow Up|0|||
129977938|NCT03829501|467882571|FG010|Overall Study|Lost to Follow Up|2|||
129977939|NCT03829501|467882572|FG011|Overall Study|Lost to Follow Up|1|||
129977940|NCT03829501|467882573|FG012|Overall Study|Lost to Follow Up|0|||
129977941|NCT03829501|467882574|FG013|Overall Study|Lost to Follow Up|1|||
129977942|NCT03829501|467882575|FG014|Overall Study|Lost to Follow Up|1|||
129977943|NCT03829501|467882576|FG015|Overall Study|Lost to Follow Up|0|||
129977944|NCT03829501|467882577|FG016|Overall Study|Lost to Follow Up|0|||
129977945|NCT03829501|467882578|FG017|Overall Study|Lost to Follow Up|0|||
129977946|NCT03829501|467882579|FG018|Overall Study|Lost to Follow Up|0|||
129977947|NCT03829501|467882580|FG019|Overall Study|Lost to Follow Up|0|||
129977948|NCT03829501|467882581|FG020|Overall Study|Lost to Follow Up|0|||
129977949|NCT03829501|467882582|FG021|Overall Study|Lost to Follow Up|0|||
129977950|NCT03829501|467882583|FG022|Overall Study|Lost to Follow Up|1|||
129977951|NCT03829501|467882561|FG000|Overall Study|Death|2|||
129977952|NCT03829501|467882562|FG001|Overall Study|Death|4|||
129977953|NCT03829501|467882563|FG002|Overall Study|Death|5|||
129977954|NCT03829501|467882564|FG003|Overall Study|Death|6|||
129977955|NCT03829501|467882565|FG004|Overall Study|Death|5|||
129977956|NCT03829501|467882566|FG005|Overall Study|Death|4|||
129977957|NCT03829501|467882567|FG006|Overall Study|Death|5|||
129977958|NCT03829501|467882568|FG007|Overall Study|Death|24|||
130147963|NCT00309985|468501150|FG001|Overall Study|Adverse Event|0|||
130147964|NCT00309985|468501149|FG000|Overall Study|Death|2|||
129977959|NCT03829501|467882569|FG008|Overall Study|Death|22|||
129977960|NCT03829501|467882570|FG009|Overall Study|Death|6|||
129977961|NCT03829501|467882571|FG010|Overall Study|Death|3|||
129977962|NCT03829501|467882572|FG011|Overall Study|Death|10|||
129977963|NCT03829501|467882573|FG012|Overall Study|Death|10|||
129977964|NCT03829501|467882574|FG013|Overall Study|Death|5|||
129977965|NCT03829501|467882575|FG014|Overall Study|Death|7|||
130147965|NCT00309985|468501150|FG001|Overall Study|Death|0|||
129977966|NCT03829501|467882576|FG015|Overall Study|Death|2|||
129977967|NCT03829501|467882577|FG016|Overall Study|Death|2|||
129977968|NCT03829501|467882578|FG017|Overall Study|Death|1|||
129977969|NCT03829501|467882579|FG018|Overall Study|Death|1|||
129977970|NCT03829501|467882580|FG019|Overall Study|Death|1|||
129977971|NCT03829501|467882581|FG020|Overall Study|Death|1|||
129977972|NCT03829501|467882582|FG021|Overall Study|Death|2|||
129977973|NCT03829501|467882583|FG022|Overall Study|Death|3|||
129977974|NCT03829501|467882561|FG000|Overall Study|Miscellaneous|0|||
129977975|NCT03829501|467882562|FG001|Overall Study|Miscellaneous|0|||
129977976|NCT03829501|467882563|FG002|Overall Study|Miscellaneous|1|||
129977977|NCT03829501|467882564|FG003|Overall Study|Miscellaneous|0|||
129977978|NCT03829501|467882565|FG004|Overall Study|Miscellaneous|0|||
129977979|NCT03829501|467882566|FG005|Overall Study|Miscellaneous|0|||
129977980|NCT03829501|467882567|FG006|Overall Study|Miscellaneous|0|||
129977981|NCT03829501|467882568|FG007|Overall Study|Miscellaneous|1|||
129977982|NCT03829501|467882569|FG008|Overall Study|Miscellaneous|0|||
129977983|NCT03829501|467882570|FG009|Overall Study|Miscellaneous|0|||
129977984|NCT03829501|467882571|FG010|Overall Study|Miscellaneous|0|||
129977985|NCT03829501|467882572|FG011|Overall Study|Miscellaneous|0|||
129977986|NCT03829501|467882573|FG012|Overall Study|Miscellaneous|0|||
129977987|NCT03829501|467882574|FG013|Overall Study|Miscellaneous|0|||
129977988|NCT03829501|467882575|FG014|Overall Study|Miscellaneous|0|||
129977989|NCT03829501|467882576|FG015|Overall Study|Miscellaneous|0|||
129977990|NCT03829501|467882577|FG016|Overall Study|Miscellaneous|0|||
129977991|NCT03829501|467882578|FG017|Overall Study|Miscellaneous|0|||
129977992|NCT03829501|467882579|FG018|Overall Study|Miscellaneous|0|||
129977993|NCT03829501|467882580|FG019|Overall Study|Miscellaneous|0|||
129977994|NCT03829501|467882581|FG020|Overall Study|Miscellaneous|0|||
129977995|NCT03829501|467882582|FG021|Overall Study|Miscellaneous|0|||
129977996|NCT03829501|467882583|FG022|Overall Study|Miscellaneous|1|||
129977997|NCT01123070|467882584|FG000|Part B Double Blind Period|Protocol Violation|0|||
129977998|NCT01123070|467882585|FG001|Part B Double Blind Period|Protocol Violation|0|||
129977999|NCT01123070|467882586|FG002|Part B Double Blind Period|Protocol Violation|0|||
129978000|NCT01123070|467882587|FG003|Part B Double Blind Period|Protocol Violation|1|||
129978001|NCT01123070|467882584|FG000|Part B Double Blind Period|Adverse Event|0|||
129978002|NCT01123070|467882585|FG001|Part B Double Blind Period|Adverse Event|0|||
129978003|NCT01123070|467882586|FG002|Part B Double Blind Period|Adverse Event|2|||
129978004|NCT01123070|467882587|FG003|Part B Double Blind Period|Adverse Event|0|||
129978005|NCT01123070|467882584|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
129978006|NCT01123070|467882585|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
129978007|NCT01123070|467882586|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
129978008|NCT01123070|467882587|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
129978009|NCT03284229|467882588|FG000|Overall Study|Lost to Follow-up|3|||
129978010|NCT04165031|467882589|FG000|Overall Study|Adverse Event|1|||
129978011|NCT04165031|467882590|FG001|Overall Study|Adverse Event|1|||
129978012|NCT04165031|467882591|FG002|Overall Study|Adverse Event|0|||
129978013|NCT04165031|467882592|FG003|Overall Study|Adverse Event|0|||
129978014|NCT04165031|467882593|FG004|Overall Study|Adverse Event|0|||
129978015|NCT04165031|467882594|FG005|Overall Study|Adverse Event|0|||
129978016|NCT04165031|467882589|FG000|Overall Study|Withdrawal by Subject|0|||
129978017|NCT04165031|467882590|FG001|Overall Study|Withdrawal by Subject|0|||
129978018|NCT04165031|467882591|FG002|Overall Study|Withdrawal by Subject|1|||
129978019|NCT04165031|467882592|FG003|Overall Study|Withdrawal by Subject|0|||
129978020|NCT04165031|467882593|FG004|Overall Study|Withdrawal by Subject|0|||
129978021|NCT04165031|467882594|FG005|Overall Study|Withdrawal by Subject|0|||
129978022|NCT01332630|467882595|FG000|Overall Study|Withdrawal by Subject|3|||
129978023|NCT03140280|467882596|FG000|Overall Study|Physician Decision|5|||
129978024|NCT00663702|467882605|FG000|Overall Study|Adverse Event|8|||
129978025|NCT00663702|467882606|FG001|Overall Study|Adverse Event|4|||
129978026|NCT00663702|467882605|FG000|Overall Study|Withdrawal by Subject|3|||
129978027|NCT00663702|467882606|FG001|Overall Study|Withdrawal by Subject|1|||
129978028|NCT00663702|467882605|FG000|Overall Study|Pregnancy|0|||
129978029|NCT00663702|467882606|FG001|Overall Study|Pregnancy|1|||
129978030|NCT00663702|467882605|FG000|Overall Study|Lost to Follow-up|3|||
129978031|NCT00663702|467882606|FG001|Overall Study|Lost to Follow-up|0|||
129978032|NCT00663702|467882605|FG000|Overall Study|Death|1|||
129978033|NCT00663702|467882606|FG001|Overall Study|Death|1|||
129978034|NCT00663702|467882605|FG000|Overall Study|Lack of Efficacy|3|||
129978035|NCT00663702|467882606|FG001|Overall Study|Lack of Efficacy|3|||
129978036|NCT01977677|467882609|FG000|Overall Study|Unrelated Adverse Event|0|||
129978037|NCT01977677|467882610|FG001|Overall Study|Unrelated Adverse Event|0|||
129978038|NCT01977677|467882611|FG002|Overall Study|Unrelated Adverse Event|1|||
129978039|NCT01498887|467882612|FG000|Overall Study|Administrative problems|1|||
129978040|NCT01498887|467882613|FG001|Overall Study|Administrative problems|0|||
129978041|NCT01498887|467882612|FG000|Overall Study|Lost to Follow-up|1|||
129978042|NCT01498887|467882613|FG001|Overall Study|Lost to Follow-up|1|||
129978043|NCT01498887|467882612|FG000|Overall Study|Withdrawal by Subject|1|||
129978044|NCT01498887|467882613|FG001|Overall Study|Withdrawal by Subject|0|||
129978045|NCT01498887|467882612|FG000|Overall Study|Protocol Violation|1|||
129978046|NCT01498887|467882613|FG001|Overall Study|Protocol Violation|3|||
129978047|NCT01498887|467882612|FG000|Overall Study|Lack of Efficacy|5|||
130147966|NCT00309985|468501149|FG000|Overall Study|Withdrawal by Subject|5|||
129978048|NCT01498887|467882613|FG001|Overall Study|Lack of Efficacy|3|||
129978049|NCT01498887|467882612|FG000|Overall Study|Abnormal result from test procedure|1|||
129978050|NCT01498887|467882613|FG001|Overall Study|Abnormal result from test procedure|1|||
129978051|NCT01498887|467882612|FG000|Overall Study|Abnormal laboratory value|2|||
129978052|NCT01498887|467882613|FG001|Overall Study|Abnormal laboratory value|2|||
129978053|NCT01498887|467882612|FG000|Overall Study|Adverse Event|4|||
129978054|NCT01498887|467882613|FG001|Overall Study|Adverse Event|1|||
129978055|NCT00667225|467882616|FG000|Overall Study|Subject had no more lesions to treat.|1|||
129978056|NCT00667225|467882617|FG001|Overall Study|Subject had no more lesions to treat.|0|||
129978057|NCT00667225|467882616|FG000|Overall Study|Lost to Follow-up|0|||
129978058|NCT00667225|467882617|FG001|Overall Study|Lost to Follow-up|1|||
129978059|NCT02993406|467882618|FG000|Overall Study|Withdrawal by Subject|170|||
129978060|NCT02993406|467882619|FG001|Overall Study|Withdrawal by Subject|196|||
129978061|NCT02993406|467882618|FG000|Overall Study|Physician Decision|3|||
129978062|NCT02993406|467882619|FG001|Overall Study|Physician Decision|5|||
129978063|NCT02993406|467882618|FG000|Overall Study|Lost to Follow-up|12|||
129978064|NCT02993406|467882619|FG001|Overall Study|Lost to Follow-up|13|||
129978065|NCT02993406|467882618|FG000|Overall Study|Unclassifiable Response|105|||
129978066|NCT02993406|467882619|FG001|Overall Study|Unclassifiable Response|139|||
129978067|NCT02993406|467882618|FG000|Overall Study|Administrative decision|1|||
129978068|NCT02993406|467882619|FG001|Overall Study|Administrative decision|0|||
129978069|NCT02993406|467882618|FG000|Overall Study|Sponsor decision|4|||
129978070|NCT02993406|467882619|FG001|Overall Study|Sponsor decision|5|||
129978071|NCT02248818|467882620|FG000|Screening|Protocol Violation|0|||
129978072|NCT02248818|467882621|FG001|Screening|Protocol Violation|0|||
129978073|NCT02248818|467882622|FG002|Screening|Protocol Violation|0|||
129978074|NCT02248818|467882623|FG003|Screening|Protocol Violation|0|||
129978075|NCT02248818|467882624|FG004|Screening|Protocol Violation|0|||
129978076|NCT02248818|467882625|FG005|Screening|Protocol Violation|0|||
129978077|NCT02248818|467882626|FG006|Screening|Protocol Violation|0|||
129978078|NCT02248818|467882627|FG007|Screening|Protocol Violation|0|||
129978079|NCT02248818|467882628|FG008|Screening|Protocol Violation|7|||
129978080|NCT02248818|467882620|FG000|Screening|Study fully enrolled|0|||
129978081|NCT02248818|467882621|FG001|Screening|Study fully enrolled|0|||
129978082|NCT02248818|467882622|FG002|Screening|Study fully enrolled|0|||
129978083|NCT02248818|467882623|FG003|Screening|Study fully enrolled|0|||
129978084|NCT02248818|467882624|FG004|Screening|Study fully enrolled|0|||
129978085|NCT02248818|467882625|FG005|Screening|Study fully enrolled|0|||
129978086|NCT02248818|467882626|FG006|Screening|Study fully enrolled|0|||
129978087|NCT02248818|467882627|FG007|Screening|Study fully enrolled|0|||
129978088|NCT02248818|467882628|FG008|Screening|Study fully enrolled|14|||
129978089|NCT02248818|467882620|FG000|Screening|Physician Decision|0|||
129978090|NCT02248818|467882621|FG001|Screening|Physician Decision|0|||
129978091|NCT02248818|467882622|FG002|Screening|Physician Decision|0|||
129978092|NCT02248818|467882623|FG003|Screening|Physician Decision|0|||
129978093|NCT02248818|467882624|FG004|Screening|Physician Decision|0|||
129978094|NCT02248818|467882625|FG005|Screening|Physician Decision|0|||
129978095|NCT02248818|467882626|FG006|Screening|Physician Decision|0|||
129978096|NCT02248818|467882627|FG007|Screening|Physician Decision|0|||
129978097|NCT02248818|467882628|FG008|Screening|Physician Decision|73|||
129978098|NCT02248818|467882620|FG000|Screening|Withdrawal by Subject|0|||
129978099|NCT02248818|467882621|FG001|Screening|Withdrawal by Subject|0|||
129978100|NCT02248818|467882622|FG002|Screening|Withdrawal by Subject|0|||
129978101|NCT02248818|467882623|FG003|Screening|Withdrawal by Subject|0|||
129978102|NCT02248818|467882624|FG004|Screening|Withdrawal by Subject|0|||
129978103|NCT02248818|467882625|FG005|Screening|Withdrawal by Subject|0|||
129978104|NCT02248818|467882626|FG006|Screening|Withdrawal by Subject|0|||
129978105|NCT02248818|467882627|FG007|Screening|Withdrawal by Subject|0|||
129978106|NCT02248818|467882628|FG008|Screening|Withdrawal by Subject|6|||
129978107|NCT02248818|467882620|FG000|Screening|Lost to Follow-up|0|||
129978108|NCT02248818|467882621|FG001|Screening|Lost to Follow-up|0|||
129978109|NCT02248818|467882622|FG002|Screening|Lost to Follow-up|0|||
129978110|NCT02248818|467882623|FG003|Screening|Lost to Follow-up|0|||
129978111|NCT02248818|467882624|FG004|Screening|Lost to Follow-up|0|||
129978112|NCT02248818|467882625|FG005|Screening|Lost to Follow-up|0|||
129978113|NCT02248818|467882626|FG006|Screening|Lost to Follow-up|0|||
129978114|NCT02248818|467882627|FG007|Screening|Lost to Follow-up|0|||
129978115|NCT02248818|467882628|FG008|Screening|Lost to Follow-up|7|||
129978116|NCT02248818|467882620|FG000|Randomised Study|Administrative - randomization error|0|||
129978117|NCT02248818|467882621|FG001|Randomised Study|Administrative - randomization error|0|||
129978118|NCT02248818|467882622|FG002|Randomised Study|Administrative - randomization error|0|||
129978119|NCT02248818|467882623|FG003|Randomised Study|Administrative - randomization error|0|||
129978120|NCT02248818|467882624|FG004|Randomised Study|Administrative - randomization error|0|||
129978121|NCT02248818|467882625|FG005|Randomised Study|Administrative - randomization error|8|||
129978122|NCT02248818|467882626|FG006|Randomised Study|Administrative - randomization error|0|||
129978123|NCT02248818|467882627|FG007|Randomised Study|Administrative - randomization error|0|||
129978124|NCT02248818|467882628|FG008|Randomised Study|Administrative - randomization error|0|||
129978125|NCT05262517|467882629|FG000|Overall Study|Randomized but not treated|5|||
129978126|NCT05262517|467882630|FG001|Overall Study|Randomized but not treated|11|||
129978127|NCT04325282|467882631|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129978128|NCT04325282|467882632|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129978129|NCT04325282|467882631|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
129978130|NCT04325282|467882632|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
129978131|NCT02643303|467882634|FG000|Overall Study|Progressive Disease|4|||
129978132|NCT02643303|467882635|FG001|Overall Study|Progressive Disease|4|||
129978133|NCT02643303|467882636|FG002|Overall Study|Progressive Disease|1|||
129978134|NCT02643303|467882637|FG003|Overall Study|Progressive Disease|12|||
129978135|NCT02643303|467882638|FG004|Overall Study|Progressive Disease|6|||
129978136|NCT02643303|467882639|FG005|Overall Study|Progressive Disease|4|||
129978137|NCT02643303|467882640|FG006|Overall Study|Progressive Disease|8|||
129978138|NCT02643303|467882641|FG007|Overall Study|Progressive Disease|2|||
129978139|NCT02643303|467882642|FG008|Overall Study|Progressive Disease|6|||
129978140|NCT02643303|467882634|FG000|Overall Study|Adverse Event|0|||
129978141|NCT02643303|467882635|FG001|Overall Study|Adverse Event|1|||
129978142|NCT02643303|467882636|FG002|Overall Study|Adverse Event|0|||
129978143|NCT02643303|467882637|FG003|Overall Study|Adverse Event|0|||
129978144|NCT02643303|467882638|FG004|Overall Study|Adverse Event|1|||
129978145|NCT02643303|467882639|FG005|Overall Study|Adverse Event|0|||
129978146|NCT02643303|467882640|FG006|Overall Study|Adverse Event|0|||
129978147|NCT02643303|467882641|FG007|Overall Study|Adverse Event|0|||
129978148|NCT02643303|467882642|FG008|Overall Study|Adverse Event|0|||
129978149|NCT02643303|467882634|FG000|Overall Study|Withdrawal by Subject|0|||
129978150|NCT02643303|467882635|FG001|Overall Study|Withdrawal by Subject|0|||
129978151|NCT02643303|467882636|FG002|Overall Study|Withdrawal by Subject|0|||
129978152|NCT02643303|467882637|FG003|Overall Study|Withdrawal by Subject|1|||
129978153|NCT02643303|467882638|FG004|Overall Study|Withdrawal by Subject|0|||
129978154|NCT02643303|467882639|FG005|Overall Study|Withdrawal by Subject|0|||
129978155|NCT02643303|467882640|FG006|Overall Study|Withdrawal by Subject|1|||
129978156|NCT02643303|467882641|FG007|Overall Study|Withdrawal by Subject|1|||
129978157|NCT02643303|467882642|FG008|Overall Study|Withdrawal by Subject|1|||
129978158|NCT04552899|467882645|FG000|Overall Study|Adverse Event|4|||
129978159|NCT04552899|467882646|FG001|Overall Study|Adverse Event|3|||
129978160|NCT04552899|467882645|FG000|Overall Study|Death|4|||
129978161|NCT04552899|467882646|FG001|Overall Study|Death|4|||
129978162|NCT04552899|467882645|FG000|Overall Study|Lost to Follow-up|8|||
129978163|NCT04552899|467882646|FG001|Overall Study|Lost to Follow-up|13|||
129978164|NCT04552899|467882645|FG000|Overall Study|Lung Transplant|4|||
129978165|NCT04552899|467882646|FG001|Overall Study|Lung Transplant|3|||
129978166|NCT04552899|467882645|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
129978167|NCT04552899|467882646|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
129978168|NCT04552899|467882645|FG000|Overall Study|Physician Decision|3|||
129978169|NCT04552899|467882646|FG001|Overall Study|Physician Decision|4|||
129978170|NCT04552899|467882645|FG000|Overall Study|Study Terminated By Sponsor|237|||
129978171|NCT04552899|467882646|FG001|Overall Study|Study Terminated By Sponsor|239|||
129978172|NCT04552899|467882645|FG000|Overall Study|Withdrawal by Subject|15|||
129978173|NCT04552899|467882646|FG001|Overall Study|Withdrawal by Subject|17|||
129978174|NCT01499303|467882647|FG000|Overall Study|Ongoing|2|||
129978175|NCT01499303|467882648|FG001|Overall Study|Ongoing|1|||
129978176|NCT01499303|467882647|FG000|Overall Study|Withdrawal by Subject|0|||
129978177|NCT01499303|467882648|FG001|Overall Study|Withdrawal by Subject|1|||
129978178|NCT01499303|467882647|FG000|Overall Study|Adverse Event|1|||
129978179|NCT01499303|467882648|FG001|Overall Study|Adverse Event|4|||
129978180|NCT01499303|467882647|FG000|Overall Study|Other|0|||
129978181|NCT01499303|467882648|FG001|Overall Study|Other|1|||
129978182|NCT04308590|467882655|FG000|Overall Study|Adverse Event|12|||
129978183|NCT04308590|467882656|FG001|Overall Study|Adverse Event|2|||
129978184|NCT04308590|467882655|FG000|Overall Study|Withdrawal by Subject|10|||
129978185|NCT04308590|467882656|FG001|Overall Study|Withdrawal by Subject|4|||
129978186|NCT04308590|467882655|FG000|Overall Study|Death|1|||
129978187|NCT04308590|467882656|FG001|Overall Study|Death|0|||
129978188|NCT04308590|467882655|FG000|Overall Study|Lost to Follow-up|1|||
129978189|NCT04308590|467882656|FG001|Overall Study|Lost to Follow-up|1|||
129978190|NCT04308590|467882655|FG000|Overall Study|Physician Decision|1|||
129978191|NCT04308590|467882656|FG001|Overall Study|Physician Decision|0|||
129978192|NCT04308590|467882655|FG000|Overall Study|Subject does not want to continue with Pi|0|||
129978193|NCT04308590|467882656|FG001|Overall Study|Subject does not want to continue with Pi|1|||
129978194|NCT03853551|467882657|FG000|Overall Study|Death|2|||
129978195|NCT03853551|467882657|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
129978196|NCT01401153|467882658|FG000|First Test Day|Learning disabilities; illness|1|||
129978197|NCT01401153|467882659|FG001|First Test Day|Learning disabilities; illness|10|||
129978198|NCT01401153|467882658|FG000|Second Test Day|illness|0|||
129978199|NCT01401153|467882659|FG001|Second Test Day|illness|5|||
129978200|NCT00214019|467882660|FG000|Overall Study|Lost to Follow-up|11|||
129978201|NCT00214019|467882660|FG000|Overall Study|Withdrawal by Subject|2|||
129978202|NCT00214019|467882660|FG000|Overall Study|Screen Failed prior to randomization|17|||
129978203|NCT03635099|467882663|FG000|Period 1|Adverse Event|1|||
129978204|NCT03635099|467882664|FG001|Period 1|Adverse Event|0|||
129978205|NCT03635099|467882665|FG002|Period 1|Adverse Event|0|||
129978206|NCT03635099|467882666|FG003|Period 1|Adverse Event|1|||
129978207|NCT03635099|467882667|FG004|Period 1|Adverse Event|0|||
129978208|NCT03635099|467882668|FG005|Period 1|Adverse Event|0|||
129978209|NCT03635099|467882669|FG006|Period 1|Adverse Event|0|||
129978210|NCT03635099|467882670|FG007|Period 1|Adverse Event|0|||
129978211|NCT03635099|467882663|FG000|Period 1|Protocol Violation|0|||
129978212|NCT03635099|467882664|FG001|Period 1|Protocol Violation|0|||
129978213|NCT03635099|467882665|FG002|Period 1|Protocol Violation|1|||
129978214|NCT03635099|467882666|FG003|Period 1|Protocol Violation|0|||
129978215|NCT03635099|467882667|FG004|Period 1|Protocol Violation|0|||
129978216|NCT03635099|467882668|FG005|Period 1|Protocol Violation|0|||
129978217|NCT03635099|467882669|FG006|Period 1|Protocol Violation|0|||
129978218|NCT03635099|467882670|FG007|Period 1|Protocol Violation|0|||
129978219|NCT03635099|467882663|FG000|Period 1|Lost to Follow-up|0|||
129978220|NCT03635099|467882664|FG001|Period 1|Lost to Follow-up|0|||
129978221|NCT03635099|467882665|FG002|Period 1|Lost to Follow-up|1|||
129978222|NCT03635099|467882666|FG003|Period 1|Lost to Follow-up|2|||
129978223|NCT03635099|467882667|FG004|Period 1|Lost to Follow-up|1|||
129978224|NCT03635099|467882668|FG005|Period 1|Lost to Follow-up|0|||
129978225|NCT03635099|467882669|FG006|Period 1|Lost to Follow-up|1|||
129978226|NCT03635099|467882670|FG007|Period 1|Lost to Follow-up|2|||
129978227|NCT03635099|467882663|FG000|Period 1|Withdrawal by Subject|3|||
129978228|NCT03635099|467882664|FG001|Period 1|Withdrawal by Subject|3|||
129978229|NCT03635099|467882665|FG002|Period 1|Withdrawal by Subject|5|||
129978230|NCT03635099|467882666|FG003|Period 1|Withdrawal by Subject|2|||
129978231|NCT03635099|467882667|FG004|Period 1|Withdrawal by Subject|2|||
129978232|NCT03635099|467882668|FG005|Period 1|Withdrawal by Subject|0|||
129978233|NCT03635099|467882669|FG006|Period 1|Withdrawal by Subject|3|||
129978234|NCT03635099|467882670|FG007|Period 1|Withdrawal by Subject|0|||
129978235|NCT03635099|467882663|FG000|Period 1|History of suicidal ideation|0|||
129978236|NCT03635099|467882664|FG001|Period 1|History of suicidal ideation|0|||
129978237|NCT03635099|467882665|FG002|Period 1|History of suicidal ideation|1|||
129978238|NCT03635099|467882666|FG003|Period 1|History of suicidal ideation|0|||
129978239|NCT03635099|467882667|FG004|Period 1|History of suicidal ideation|0|||
129978240|NCT03635099|467882668|FG005|Period 1|History of suicidal ideation|0|||
129978241|NCT03635099|467882669|FG006|Period 1|History of suicidal ideation|0|||
129978242|NCT03635099|467882670|FG007|Period 1|History of suicidal ideation|0|||
129978243|NCT03635099|467882663|FG000|Period 1|pursue other treatment options|0|||
129978244|NCT03635099|467882664|FG001|Period 1|pursue other treatment options|0|||
129978245|NCT03635099|467882665|FG002|Period 1|pursue other treatment options|0|||
129978246|NCT03635099|467882666|FG003|Period 1|pursue other treatment options|0|||
129978247|NCT03635099|467882667|FG004|Period 1|pursue other treatment options|0|||
129978248|NCT03635099|467882668|FG005|Period 1|pursue other treatment options|1|||
129978249|NCT03635099|467882669|FG006|Period 1|pursue other treatment options|0|||
129978250|NCT03635099|467882670|FG007|Period 1|pursue other treatment options|0|||
129978251|NCT03635099|467882663|FG000|Not Eligible for Period 2|Pregnancy|0|||
129978252|NCT03635099|467882664|FG001|Not Eligible for Period 2|Pregnancy|0|||
129978253|NCT03635099|467882665|FG002|Not Eligible for Period 2|Pregnancy|0|||
129978254|NCT03635099|467882666|FG003|Not Eligible for Period 2|Pregnancy|1|||
129978255|NCT03635099|467882667|FG004|Not Eligible for Period 2|Pregnancy|0|||
129978256|NCT03635099|467882668|FG005|Not Eligible for Period 2|Pregnancy|0|||
129978257|NCT03635099|467882669|FG006|Not Eligible for Period 2|Pregnancy|0|||
129978258|NCT03635099|467882670|FG007|Not Eligible for Period 2|Pregnancy|0|||
129978259|NCT03635099|467882663|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
129978260|NCT03635099|467882664|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978261|NCT03635099|467882665|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978262|NCT03635099|467882666|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978263|NCT03635099|467882667|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978264|NCT03635099|467882668|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978265|NCT03635099|467882669|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978266|NCT03635099|467882670|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978267|NCT03635099|467882663|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978268|NCT03635099|467882664|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978269|NCT03635099|467882665|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978270|NCT03635099|467882666|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978271|NCT03635099|467882667|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978272|NCT03635099|467882668|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
129978273|NCT03635099|467882669|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
129978274|NCT03635099|467882670|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
129978275|NCT03635099|467882663|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
129978276|NCT03635099|467882664|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
129978277|NCT03635099|467882665|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
129978278|NCT03635099|467882666|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
129978279|NCT03635099|467882667|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978280|NCT03635099|467882668|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978281|NCT03635099|467882669|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
130154903|NCT01470612|468526639|FG001|Overall Study|Protocol Violation|7|||
129978282|NCT03635099|467882670|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978283|NCT03635099|467882663|FG000|Period 2|Adverse Event|0|||
129978284|NCT03635099|467882664|FG001|Period 2|Adverse Event|0|||
129978285|NCT03635099|467882665|FG002|Period 2|Adverse Event|1|||
129978286|NCT03635099|467882666|FG003|Period 2|Adverse Event|0|||
129978287|NCT03635099|467882667|FG004|Period 2|Adverse Event|1|||
129978288|NCT03635099|467882668|FG005|Period 2|Adverse Event|0|||
129978289|NCT03635099|467882669|FG006|Period 2|Adverse Event|0|||
129978290|NCT03635099|467882670|FG007|Period 2|Adverse Event|0|||
129978291|NCT03635099|467882663|FG000|Period 2|Lost to Follow-up|0|||
129978292|NCT03635099|467882664|FG001|Period 2|Lost to Follow-up|0|||
129978293|NCT03635099|467882665|FG002|Period 2|Lost to Follow-up|1|||
129978294|NCT03635099|467882666|FG003|Period 2|Lost to Follow-up|0|||
129978295|NCT03635099|467882667|FG004|Period 2|Lost to Follow-up|4|||
129978296|NCT03635099|467882668|FG005|Period 2|Lost to Follow-up|0|||
129978297|NCT03635099|467882669|FG006|Period 2|Lost to Follow-up|0|||
129978298|NCT03635099|467882670|FG007|Period 2|Lost to Follow-up|0|||
129978299|NCT03635099|467882663|FG000|Period 2|Withdrawal by Subject|0|||
129978300|NCT03635099|467882664|FG001|Period 2|Withdrawal by Subject|0|||
129978301|NCT03635099|467882665|FG002|Period 2|Withdrawal by Subject|7|||
129978302|NCT03635099|467882666|FG003|Period 2|Withdrawal by Subject|4|||
129978303|NCT03635099|467882667|FG004|Period 2|Withdrawal by Subject|7|||
129978304|NCT03635099|467882668|FG005|Period 2|Withdrawal by Subject|0|||
129978305|NCT03635099|467882669|FG006|Period 2|Withdrawal by Subject|0|||
129978306|NCT03635099|467882670|FG007|Period 2|Withdrawal by Subject|0|||
129978307|NCT04191616|467882673|FG000|Pre-assignment Period|Did not receive study treatment|2|||
129978308|NCT04191616|467882673|FG000|Treatment Period|Death|37|||
129978309|NCT04191616|467882673|FG000|Treatment Period|Sponsor decision|11|||
129978310|NCT04191616|467882673|FG000|Treatment Period|Withdrawal by Subject|4|||
129978311|NCT02180243|467882674|FG000|Overall Study|Withdrawal by Subject|12|||
129978312|NCT02180243|467882675|FG001|Overall Study|Withdrawal by Subject|12|||
129978313|NCT02180243|467882674|FG000|Overall Study|Lost to Follow-up|12|||
129978314|NCT02180243|467882675|FG001|Overall Study|Lost to Follow-up|2|||
129978315|NCT01840410|467882678|FG000|Overall Study|Physician Decision|1|||
129978316|NCT01840410|467882679|FG001|Overall Study|Physician Decision|2|||
129978317|NCT01840410|467882678|FG000|Overall Study|Pregnancy|1|||
129978318|NCT01840410|467882679|FG001|Overall Study|Pregnancy|0|||
129978319|NCT01840410|467882678|FG000|Overall Study|Protocol deviation|1|||
129978320|NCT01840410|467882679|FG001|Overall Study|Protocol deviation|0|||
129978321|NCT01840410|467882678|FG000|Overall Study|Lost to Follow-up|1|||
129978322|NCT01840410|467882679|FG001|Overall Study|Lost to Follow-up|0|||
129978323|NCT01840410|467882678|FG000|Overall Study|Withdrawal by Subject|2|||
129978324|NCT01840410|467882679|FG001|Overall Study|Withdrawal by Subject|1|||
129978325|NCT01840410|467882678|FG000|Overall Study|Adverse Event|1|||
129978326|NCT01840410|467882679|FG001|Overall Study|Adverse Event|1|||
129978327|NCT01217437|467882680|FG000|Overall Study|Adverse Event|0|||
129978328|NCT01217437|467882681|FG001|Overall Study|Adverse Event|8|||
129978329|NCT01217437|467882680|FG000|Overall Study|Death|5|||
129978330|NCT01217437|467882681|FG001|Overall Study|Death|0|||
129978331|NCT01217437|467882680|FG000|Overall Study|Lack of Efficacy|29|||
129978332|NCT01217437|467882681|FG001|Overall Study|Lack of Efficacy|25|||
129978333|NCT01217437|467882680|FG000|Overall Study|Physician Decision|8|||
129978334|NCT01217437|467882681|FG001|Overall Study|Physician Decision|5|||
129978335|NCT01217437|467882680|FG000|Overall Study|Withdrawal by Subject|0|||
129978336|NCT01217437|467882681|FG001|Overall Study|Withdrawal by Subject|2|||
129978337|NCT01217437|467882680|FG000|Overall Study|Ineligible|1|||
129978338|NCT01217437|467882681|FG001|Overall Study|Ineligible|1|||
129978339|NCT06748729|467882683|FG000|Overall Study|Withdrawal by Subject|1|||
129978340|NCT01283152|467883689|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
129978341|NCT01283152|467883690|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
129978342|NCT01283152|467883689|FG000|Overall Study|Refused HESA|1|||
129978343|NCT01283152|467883690|FG001|Overall Study|Refused HESA|0|||
129978344|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
129978345|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
129978346|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
129978347|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
129978348|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
129978349|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
129978350|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
129978351|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
129978352|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
129978353|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
129978354|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
129978355|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
129978356|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
129978357|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
129978358|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
129978359|NCT04939701|467883699|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
129978360|NCT04939701|467883700|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
129978361|NCT04939701|467883701|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
130147967|NCT00309985|468501150|FG001|Overall Study|Withdrawal by Subject|1|||
130147968|NCT00309985|468501149|FG000|Overall Study|Physician Decision|3|||
130147969|NCT00309985|468501150|FG001|Overall Study|Physician Decision|0|||
130147970|NCT00309985|468501149|FG000|Overall Study|Never started treatment|7|||
130147971|NCT00309985|468501150|FG001|Overall Study|Never started treatment|0|||
130147972|NCT00309985|468501149|FG000|Overall Study|Complicating disease|1|||
130147973|NCT00309985|468501150|FG001|Overall Study|Complicating disease|0|||
130147974|NCT00309985|468501149|FG000|Overall Study|Non-compliance|1|||
130147975|NCT00309985|468501150|FG001|Overall Study|Non-compliance|0|||
130147976|NCT00309985|468501149|FG000|Overall Study|Chemotherapy discontinued only|1|||
130147977|NCT00309985|468501150|FG001|Overall Study|Chemotherapy discontinued only|0|||
130147978|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
130147979|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
130147980|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130147981|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130147982|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
130147983|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
130147984|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130147985|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
130147986|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
130147987|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
130147988|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130147989|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130147990|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
130147991|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
130147992|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130147993|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130147994|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Death|2|||
130147995|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Death|1|||
130147996|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Death|0|||
130147997|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Death|0|||
130147998|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
130147999|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
130148000|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
130148001|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
130148002|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
130148003|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130148004|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130148005|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130148006|NCT03110380|468501160|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130148007|NCT03110380|468501161|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
130148008|NCT03110380|468501162|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130148009|NCT03110380|468501163|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
130148010|NCT03110380|468501160|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130148011|NCT03110380|468501161|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
130148012|NCT03110380|468501162|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
130148013|NCT03110380|468501163|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
130148014|NCT03110380|468501160|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
130148015|NCT03110380|468501161|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
130148016|NCT03110380|468501162|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
130148017|NCT03110380|468501163|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
130148018|NCT03110380|468501160|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130148019|NCT03110380|468501161|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130148020|NCT03110380|468501162|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
130148021|NCT03110380|468501163|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
130148022|NCT01355302|468501166|FG000|Phase 1b|Death|4|||
130148023|NCT01355302|468501167|FG001|Phase 1b|Death|0|||
130148024|NCT01355302|468501168|FG002|Phase 1b|Death|0|||
130148025|NCT01355302|468501166|FG000|Phase 1b|Study terminated by sponsor|2|||
130148026|NCT01355302|468501167|FG001|Phase 1b|Study terminated by sponsor|0|||
130148027|NCT01355302|468501168|FG002|Phase 1b|Study terminated by sponsor|0|||
130148028|NCT00693225|468501169|FG000|Overall Study|Lost to Follow-up|1|||
129978362|NCT04939701|467883699|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
130148029|NCT00693225|468501170|FG001|Overall Study|Lost to Follow-up|2|||
130148030|NCT00693225|468501169|FG000|Overall Study|Adverse Event|1|||
130148031|NCT00693225|468501170|FG001|Overall Study|Adverse Event|3|||
130148032|NCT02531594|468501171|FG000|Overall Study|Withdrawal by Subject|7|||
130148033|NCT02531594|468501172|FG001|Overall Study|Withdrawal by Subject|8|||
130148034|NCT03750695|468501175|FG000|Overall Study|Lost to Follow-up|0|||
130148035|NCT03750695|468501176|FG001|Overall Study|Lost to Follow-up|1|||
130148036|NCT03843125|468501177|FG000|Overall Study|Adverse Event|17|||
130148037|NCT03843125|468501178|FG001|Overall Study|Adverse Event|13|||
130148038|NCT03843125|468501179|FG002|Overall Study|Adverse Event|5|||
130148039|NCT03843125|468501180|FG003|Overall Study|Adverse Event|9|||
130148040|NCT03843125|468501177|FG000|Overall Study|Death|0|||
130148041|NCT03843125|468501178|FG001|Overall Study|Death|6|||
130148042|NCT03843125|468501179|FG002|Overall Study|Death|2|||
130148043|NCT03843125|468501180|FG003|Overall Study|Death|0|||
130148044|NCT03843125|468501177|FG000|Overall Study|Lack of Efficacy|14|||
130148045|NCT03843125|468501178|FG001|Overall Study|Lack of Efficacy|11|||
130148046|NCT03843125|468501179|FG002|Overall Study|Lack of Efficacy|9|||
130148047|NCT03843125|468501180|FG003|Overall Study|Lack of Efficacy|4|||
130148048|NCT03843125|468501177|FG000|Overall Study|Lost to Follow-up|3|||
130148049|NCT03843125|468501178|FG001|Overall Study|Lost to Follow-up|4|||
130148050|NCT03843125|468501179|FG002|Overall Study|Lost to Follow-up|0|||
130148051|NCT03843125|468501180|FG003|Overall Study|Lost to Follow-up|2|||
130148052|NCT03843125|468501177|FG000|Overall Study|Other|12|||
130148053|NCT03843125|468501178|FG001|Overall Study|Other|14|||
130148054|NCT03843125|468501179|FG002|Overall Study|Other|3|||
130148055|NCT03843125|468501180|FG003|Overall Study|Other|4|||
130148056|NCT03843125|468501177|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
130148057|NCT03843125|468501178|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
130148058|NCT03843125|468501179|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
130148059|NCT03843125|468501180|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
130148060|NCT03843125|468501177|FG000|Overall Study|Study Terminated by Sponsor|318|||
130148061|NCT03843125|468501178|FG001|Overall Study|Study Terminated by Sponsor|318|||
130148062|NCT03843125|468501179|FG002|Overall Study|Study Terminated by Sponsor|163|||
130148063|NCT03843125|468501180|FG003|Overall Study|Study Terminated by Sponsor|163|||
130148064|NCT03843125|468501177|FG000|Overall Study|Withdrawal by Subject|23|||
130148065|NCT03843125|468501178|FG001|Overall Study|Withdrawal by Subject|12|||
130148066|NCT03843125|468501179|FG002|Overall Study|Withdrawal by Subject|6|||
130148067|NCT03843125|468501180|FG003|Overall Study|Withdrawal by Subject|9|||
130148068|NCT03843125|468501177|FG000|Overall Study|Missing data|0|||
130148069|NCT03843125|468501178|FG001|Overall Study|Missing data|1|||
130148070|NCT03843125|468501179|FG002|Overall Study|Missing data|1|||
130148071|NCT03843125|468501180|FG003|Overall Study|Missing data|0|||
130148072|NCT03173560|468501181|FG000|Overall Study|Death|70|||
130148073|NCT03173560|468501182|FG001|Overall Study|Death|60|||
130148074|NCT03173560|468501181|FG000|Overall Study|Lost to Follow-up|1|||
130148075|NCT03173560|468501182|FG001|Overall Study|Lost to Follow-up|4|||
130148076|NCT03173560|468501181|FG000|Overall Study|Withdrawal by Subject|10|||
130148077|NCT03173560|468501182|FG001|Overall Study|Withdrawal by Subject|5|||
130148078|NCT03173560|468501181|FG000|Overall Study|Other|0|||
130148079|NCT03173560|468501182|FG001|Overall Study|Other|1|||
130148080|NCT04254809|468501184|FG000|Overall Study|Lost to Follow-up|5|||
130148081|NCT04254809|468501185|FG001|Overall Study|Lost to Follow-up|10|||
130148082|NCT04480307|468501186|FG000|Overall Study|Withdrawal by Subject|0|||
130148083|NCT04480307|468501187|FG001|Overall Study|Withdrawal by Subject|1|||
130148084|NCT04480307|468501188|FG002|Overall Study|Withdrawal by Subject|0|||
130148085|NCT04480307|468501189|FG003|Overall Study|Withdrawal by Subject|0|||
130148086|NCT04480307|468501186|FG000|Overall Study|Adverse Event|0|||
130148087|NCT04480307|468501187|FG001|Overall Study|Adverse Event|0|||
130148088|NCT04480307|468501188|FG002|Overall Study|Adverse Event|0|||
130148089|NCT04480307|468501189|FG003|Overall Study|Adverse Event|1|||
130148090|NCT03023137|468501190|FG000|Overall Study|Multiple pregnancy|2|||
130148091|NCT03023137|468501191|FG001|Overall Study|Multiple pregnancy|4|||
130148092|NCT03023137|468501190|FG000|Overall Study|Lost to Follow-up|1|||
130148093|NCT03023137|468501191|FG001|Overall Study|Lost to Follow-up|1|||
129978363|NCT04939701|467883700|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
130148094|NCT03023137|468501190|FG000|Overall Study|Protocol Violation|0|||
130148095|NCT03023137|468501191|FG001|Overall Study|Protocol Violation|4|||
130148096|NCT03023137|468501190|FG000|Overall Study|Lost the baby in a car accident|1|||
130148097|NCT03023137|468501191|FG001|Overall Study|Lost the baby in a car accident|0|||
130148098|NCT02795676|468501192|FG000|Overall Study|Adverse Event|2|||
130148099|NCT02795676|468501193|FG001|Overall Study|Adverse Event|0|||
130148100|NCT02795676|468501192|FG000|Overall Study|Withdrawal by Subject|3|||
130148101|NCT02795676|468501193|FG001|Overall Study|Withdrawal by Subject|1|||
130148102|NCT02608476|468501194|FG000|Overall Study|Withdrawal by Subject|30|||
130148103|NCT02608476|468501195|FG001|Overall Study|Withdrawal by Subject|37|||
130148104|NCT02608476|468501194|FG000|Overall Study|Lost to Follow-up|24|||
130148105|NCT02608476|468501195|FG001|Overall Study|Lost to Follow-up|24|||
130148106|NCT02608476|468501194|FG000|Overall Study|Adverse Event|2|||
130148107|NCT02608476|468501195|FG001|Overall Study|Adverse Event|8|||
130148108|NCT02608476|468501194|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
130148109|NCT02608476|468501195|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
130148110|NCT02608476|468501194|FG000|Overall Study|Noncompliance with treatment|1|||
130148111|NCT02608476|468501195|FG001|Overall Study|Noncompliance with treatment|5|||
130148112|NCT02608476|468501194|FG000|Overall Study|Lack of Efficacy|3|||
130148113|NCT02608476|468501195|FG001|Overall Study|Lack of Efficacy|1|||
130148114|NCT02608476|468501194|FG000|Overall Study|Other|0|||
130148115|NCT02608476|468501195|FG001|Overall Study|Other|1|||
130148116|NCT02608476|468501194|FG000|Overall Study|Physician Decision|1|||
130148117|NCT02608476|468501195|FG001|Overall Study|Physician Decision|0|||
130148118|NCT02608476|468501194|FG000|Overall Study|Pregnancy|0|||
130148119|NCT02608476|468501195|FG001|Overall Study|Pregnancy|1|||
130148120|NCT02608476|468501194|FG000|Overall Study|Progressive disease|1|||
130148121|NCT02608476|468501195|FG001|Overall Study|Progressive disease|0|||
130148122|NCT01203917|468501197|FG000|Overall Study|Death|29|||
130148123|NCT01203917|468501197|FG000|Overall Study|Lost to Follow-up|2|||
130148124|NCT01203917|468501197|FG000|Overall Study|Withdrawal by Subject|3|||
130148125|NCT01203917|468501197|FG000|Overall Study|Due to objective disease progression|1|||
130148126|NCT01203917|468501197|FG000|Overall Study|Due to EGFR M+I patient|1|||
130148127|NCT01609582|468501208|FG000|Overall Study|Adverse Event|20|||
130148128|NCT01609582|468501209|FG001|Overall Study|Adverse Event|18|||
130148129|NCT01609582|468501208|FG000|Overall Study|Lost to Follow-up|10|||
130148130|NCT01609582|468501209|FG001|Overall Study|Lost to Follow-up|10|||
130148131|NCT01609582|468501208|FG000|Overall Study|Withdrawal by Subject|21|||
130148132|NCT01609582|468501209|FG001|Overall Study|Withdrawal by Subject|15|||
130148133|NCT01609582|468501208|FG000|Overall Study|Study Terminated by Sponsor|1543|||
130148134|NCT01609582|468501209|FG001|Overall Study|Study Terminated by Sponsor|1548|||
130148135|NCT01609582|468501208|FG000|Overall Study|Other|9|||
130148136|NCT01609582|468501209|FG001|Overall Study|Other|10|||
130148137|NCT01609582|468501208|FG000|Overall Study|Randomized, but not treated|0|||
130148138|NCT01609582|468501209|FG001|Overall Study|Randomized, but not treated|3|||
130148139|NCT00819767|468501210|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130148140|NCT00819767|468501211|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
130148141|NCT00808509|468501221|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
130148142|NCT00808509|468501222|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
130148143|NCT00808509|468501221|FG000|Randomized Phase|Reduced methotrexate dose|1|||
130148144|NCT00808509|468501222|FG001|Randomized Phase|Reduced methotrexate dose|2|||
130148145|NCT00808509|468501221|FG000|Randomized Phase|Patient refused rescue therapy|0|||
130148146|NCT00808509|468501222|FG001|Randomized Phase|Patient refused rescue therapy|3|||
130148147|NCT02169791|468501223|FG000|Overall Study|Death|6|||
130148148|NCT02169791|468501223|FG000|Overall Study|patient withdrew consent|1|||
130148149|NCT02762994|468501224|FG000|Overall Study|Withdrawal by Subject|0|||
130148150|NCT02762994|468501225|FG001|Overall Study|Withdrawal by Subject|1|||
130148151|NCT02762994|468501226|FG002|Overall Study|Withdrawal by Subject|2|||
130148152|NCT02762994|468501227|FG003|Overall Study|Withdrawal by Subject|0|||
130148153|NCT02762994|468501224|FG000|Overall Study|Protocol Violation|1|||
130148154|NCT02762994|468501225|FG001|Overall Study|Protocol Violation|0|||
130148155|NCT02762994|468501226|FG002|Overall Study|Protocol Violation|0|||
130148156|NCT02762994|468501227|FG003|Overall Study|Protocol Violation|2|||
130148157|NCT04234464|468501230|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
130148158|NCT04234464|468501231|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
130148159|NCT01701973|468501232|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148160|NCT01701973|468501233|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
130148161|NCT01701973|468501234|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148162|NCT01701973|468501235|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148163|NCT01701973|468501236|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148164|NCT01701973|468501237|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148165|NCT01701973|468501238|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148166|NCT01701973|468501239|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
130148167|NCT04330157|468501242|FG000|Overall Study|Protocol Violation|4|||
130148168|NCT04330157|468501242|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
130148169|NCT01899326|468501243|FG000|Overall Study|Withdrawal by Subject|1|||
129978364|NCT04939701|467883701|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
129978365|NCT02383940|467883702|FG000|Overall Study|Adverse Event|1|||
129978366|NCT02383940|467883703|FG001|Overall Study|Adverse Event|0|||
129978367|NCT02383940|467883702|FG000|Overall Study|Lost to Follow-up|2|||
130148170|NCT01899326|468501243|FG000|Overall Study|Adverse Event|2|||
130148171|NCT01899326|468501243|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
129978368|NCT02383940|467883703|FG001|Overall Study|Lost to Follow-up|2|||
130148172|NCT00373425|468501244|FG000|Overall Study|Relapse of NSCLC|116|||
130148173|NCT00373425|468501245|FG001|Overall Study|Relapse of NSCLC|104|||
130148174|NCT00373425|468501246|FG002|Overall Study|Relapse of NSCLC|19|||
130148175|NCT00373425|468501247|FG003|Overall Study|Relapse of NSCLC|2|||
130148176|NCT00373425|468501248|FG004|Overall Study|Relapse of NSCLC|26|||
130148177|NCT00373425|468501244|FG000|Overall Study|Adverse Event|191|||
130148178|NCT00373425|468501245|FG001|Overall Study|Adverse Event|22|||
130148179|NCT00373425|468501246|FG002|Overall Study|Adverse Event|59|||
130148180|NCT00373425|468501247|FG003|Overall Study|Adverse Event|0|||
130148181|NCT00373425|468501248|FG004|Overall Study|Adverse Event|34|||
130148182|NCT00373425|468501244|FG000|Overall Study|Patient request|35|||
130148183|NCT00373425|468501245|FG001|Overall Study|Patient request|18|||
130148184|NCT00373425|468501246|FG002|Overall Study|Patient request|43|||
130148185|NCT00373425|468501247|FG003|Overall Study|Patient request|6|||
130148186|NCT00373425|468501248|FG004|Overall Study|Patient request|7|||
130148187|NCT00373425|468501244|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
130148188|NCT00373425|468501245|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
130148189|NCT00373425|468501246|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
130148190|NCT00373425|468501247|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
130148191|NCT00373425|468501248|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
130148192|NCT00373425|468501244|FG000|Overall Study|Death|7|||
130148193|NCT00373425|468501245|FG001|Overall Study|Death|0|||
130148194|NCT00373425|468501246|FG002|Overall Study|Death|3|||
130148195|NCT00373425|468501247|FG003|Overall Study|Death|1|||
130148196|NCT00373425|468501248|FG004|Overall Study|Death|0|||
130148197|NCT00551616|468501251|FG000|Overall Study|Lost to Follow-up|48|||
130148198|NCT00551616|468501252|FG001|Overall Study|Lost to Follow-up|40|||
130148199|NCT01263561|468501253|FG000|Overall Study|Death|1|||
130148200|NCT01263561|468501254|FG001|Overall Study|Death|2|||
130148201|NCT03942211|468501255|FG000|Overall Study|Death|1|||
130148202|NCT03942211|468501256|FG001|Overall Study|Death|0|||
130148203|NCT03942211|468501255|FG000|Overall Study|Study terminated by sponsor|5|||
130148204|NCT03942211|468501256|FG001|Overall Study|Study terminated by sponsor|3|||
130148205|NCT03942211|468501255|FG000|Overall Study|Adverse Event|0|||
130148206|NCT03942211|468501256|FG001|Overall Study|Adverse Event|1|||
130148207|NCT01396421|468501257|FG000|Overall Study|Lost to Follow-up|0|||
130148208|NCT01396421|468501258|FG001|Overall Study|Lost to Follow-up|0|||
130148209|NCT01396421|468501259|FG002|Overall Study|Lost to Follow-up|0|||
130148210|NCT01396421|468501260|FG003|Overall Study|Lost to Follow-up|1|||
130148211|NCT01396421|468501257|FG000|Overall Study|Adverse Event|17|||
130148212|NCT01396421|468501258|FG001|Overall Study|Adverse Event|15|||
130148213|NCT01396421|468501259|FG002|Overall Study|Adverse Event|12|||
130148214|NCT01396421|468501260|FG003|Overall Study|Adverse Event|32|||
130148215|NCT01396421|468501257|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
130148216|NCT01396421|468501258|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
130148217|NCT01396421|468501259|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
130148218|NCT01396421|468501260|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
130148219|NCT01396421|468501257|FG000|Overall Study|Physician Decision|1|||
130148220|NCT01396421|468501258|FG001|Overall Study|Physician Decision|1|||
130148221|NCT01396421|468501259|FG002|Overall Study|Physician Decision|0|||
130148222|NCT01396421|468501260|FG003|Overall Study|Physician Decision|3|||
130148223|NCT01396421|468501257|FG000|Overall Study|Withdrawal by Subject|31|||
130148224|NCT01396421|468501258|FG001|Overall Study|Withdrawal by Subject|24|||
130148225|NCT01396421|468501259|FG002|Overall Study|Withdrawal by Subject|13|||
130148226|NCT01396421|468501260|FG003|Overall Study|Withdrawal by Subject|21|||
130148227|NCT01396421|468501257|FG000|Overall Study|Protocol Deviation|2|||
130148228|NCT01396421|468501258|FG001|Overall Study|Protocol Deviation|1|||
130148229|NCT01396421|468501259|FG002|Overall Study|Protocol Deviation|1|||
130148230|NCT01396421|468501260|FG003|Overall Study|Protocol Deviation|0|||
130148231|NCT01396421|468501257|FG000|Overall Study|Lack of Efficacy|7|||
130148232|NCT01396421|468501258|FG001|Overall Study|Lack of Efficacy|17|||
130148233|NCT01396421|468501259|FG002|Overall Study|Lack of Efficacy|7|||
130148234|NCT01396421|468501260|FG003|Overall Study|Lack of Efficacy|18|||
130148235|NCT00569777|468501264|FG000|Overall Study|Withdrawal by Subject|4|||
130148236|NCT00569777|468501265|FG001|Overall Study|Withdrawal by Subject|0|||
130148237|NCT00569777|468501264|FG000|Overall Study|Adverse Event|3|||
130148238|NCT00569777|468501265|FG001|Overall Study|Adverse Event|0|||
130148239|NCT00569777|468501264|FG000|Overall Study|Lost to Follow-up|1|||
130148240|NCT00569777|468501265|FG001|Overall Study|Lost to Follow-up|0|||
130148241|NCT00569777|468501264|FG000|Overall Study|scheduled eye surgery|0|||
130148242|NCT00569777|468501265|FG001|Overall Study|scheduled eye surgery|1|||
130148243|NCT00569777|468501264|FG000|Overall Study|did not meet exclusion criteria|1|||
130148244|NCT00569777|468501265|FG001|Overall Study|did not meet exclusion criteria|2|||
130148245|NCT00569777|468501264|FG000|Overall Study|pregnant|1|||
130148246|NCT00569777|468501265|FG001|Overall Study|pregnant|0|||
130148247|NCT02030535|468501266|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
130148248|NCT00991510|468502523|FG000|Period I (Days 1-14)|Adverse Event|1|||
130148249|NCT00991510|468502524|FG001|Period I (Days 1-14)|Adverse Event|0|||
130148250|NCT00991510|468502523|FG000|Period III (Days 29-112)|Adverse Event|1|||
130148251|NCT00991510|468502524|FG001|Period III (Days 29-112)|Adverse Event|1|||
130148252|NCT01563237|468502527|FG000|Overall Study|Lost to Follow-up|6|||
130148253|NCT01563237|468502528|FG001|Overall Study|Lost to Follow-up|0|||
130148254|NCT01563237|468502527|FG000|Overall Study|Withdrawal by Subject|1|||
130148255|NCT01563237|468502528|FG001|Overall Study|Withdrawal by Subject|0|||
130148256|NCT01563237|468502527|FG000|Overall Study|Adverse Event|1|||
130148257|NCT01563237|468502528|FG001|Overall Study|Adverse Event|0|||
130148258|NCT01563237|468502527|FG000|Overall Study|Medical Reasons|1|||
130148259|NCT01563237|468502528|FG001|Overall Study|Medical Reasons|0|||
130148260|NCT01563237|468502527|FG000|Overall Study|Death|1|||
130148261|NCT01563237|468502528|FG001|Overall Study|Death|0|||
130148262|NCT01124695|468502529|FG000|Overall Study|Disease progression|77|||
130148263|NCT01124695|468502529|FG000|Overall Study|Adverse Event|11|||
130148264|NCT01124695|468502529|FG000|Overall Study|Death|1|||
130148265|NCT01124695|468502529|FG000|Overall Study|Withdrawal by Subject|7|||
130148266|NCT01124695|468502529|FG000|Overall Study|Physician Decision|3|||
130148267|NCT01124695|468502529|FG000|Overall Study|Alternative therapy|9|||
130148268|NCT01124695|468502529|FG000|Overall Study|No documentation that patient went off treatment|4|||
130148269|NCT01124695|468502529|FG000|Overall Study|Ineligible|9|||
130148270|NCT01124695|468502529|FG000|Overall Study|Ineligible and never start treatment|2|||
130148271|NCT02443324|468502533|FG000|Overall Study|Death|4|||
130148272|NCT02443324|468502534|FG001|Overall Study|Death|1|||
130148273|NCT02443324|468502535|FG002|Overall Study|Death|0|||
130148274|NCT02443324|468502536|FG003|Overall Study|Death|3|||
130148275|NCT02443324|468502537|FG004|Overall Study|Death|1|||
130148276|NCT02443324|468502538|FG005|Overall Study|Death|3|||
130148277|NCT02443324|468502539|FG006|Overall Study|Death|2|||
130148278|NCT02443324|468502533|FG000|Overall Study|Lost to Follow-up|0|||
130148279|NCT02443324|468502534|FG001|Overall Study|Lost to Follow-up|0|||
130148280|NCT02443324|468502535|FG002|Overall Study|Lost to Follow-up|0|||
130148281|NCT02443324|468502536|FG003|Overall Study|Lost to Follow-up|1|||
130148282|NCT02443324|468502537|FG004|Overall Study|Lost to Follow-up|0|||
130148283|NCT02443324|468502538|FG005|Overall Study|Lost to Follow-up|1|||
130148284|NCT02443324|468502539|FG006|Overall Study|Lost to Follow-up|0|||
130148285|NCT02443324|468502533|FG000|Overall Study|Physician Decision|0|||
130148286|NCT02443324|468502534|FG001|Overall Study|Physician Decision|3|||
130148287|NCT02443324|468502535|FG002|Overall Study|Physician Decision|5|||
130148288|NCT02443324|468502536|FG003|Overall Study|Physician Decision|1|||
130148289|NCT02443324|468502537|FG004|Overall Study|Physician Decision|1|||
130148290|NCT02443324|468502538|FG005|Overall Study|Physician Decision|0|||
130148291|NCT02443324|468502539|FG006|Overall Study|Physician Decision|2|||
130148292|NCT02443324|468502533|FG000|Overall Study|Progressive Disease|20|||
130148293|NCT02443324|468502534|FG001|Overall Study|Progressive Disease|20|||
130148294|NCT02443324|468502535|FG002|Overall Study|Progressive Disease|13|||
130148295|NCT02443324|468502536|FG003|Overall Study|Progressive Disease|10|||
130148296|NCT02443324|468502537|FG004|Overall Study|Progressive Disease|13|||
130148297|NCT02443324|468502538|FG005|Overall Study|Progressive Disease|17|||
130148298|NCT02443324|468502539|FG006|Overall Study|Progressive Disease|10|||
130148299|NCT02443324|468502533|FG000|Overall Study|Withdrawal by Subject|0|||
130148300|NCT02443324|468502534|FG001|Overall Study|Withdrawal by Subject|0|||
130148301|NCT02443324|468502535|FG002|Overall Study|Withdrawal by Subject|3|||
130148302|NCT02443324|468502536|FG003|Overall Study|Withdrawal by Subject|1|||
130148303|NCT02443324|468502537|FG004|Overall Study|Withdrawal by Subject|1|||
130148304|NCT02443324|468502538|FG005|Overall Study|Withdrawal by Subject|0|||
130148305|NCT02443324|468502539|FG006|Overall Study|Withdrawal by Subject|1|||
130148306|NCT02443324|468502533|FG000|Overall Study|Adverse Event|0|||
130148307|NCT02443324|468502534|FG001|Overall Study|Adverse Event|1|||
130148308|NCT02443324|468502535|FG002|Overall Study|Adverse Event|3|||
130148309|NCT02443324|468502536|FG003|Overall Study|Adverse Event|0|||
130148310|NCT02443324|468502537|FG004|Overall Study|Adverse Event|4|||
130148311|NCT02443324|468502538|FG005|Overall Study|Adverse Event|3|||
130148312|NCT02443324|468502539|FG006|Overall Study|Adverse Event|3|||
130148313|NCT02443324|468502533|FG000|Overall Study|Enrolled but Never Treated|0|||
130148314|NCT02443324|468502534|FG001|Overall Study|Enrolled but Never Treated|0|||
130148315|NCT02443324|468502535|FG002|Overall Study|Enrolled but Never Treated|1|||
130148316|NCT02443324|468502536|FG003|Overall Study|Enrolled but Never Treated|0|||
130148317|NCT02443324|468502537|FG004|Overall Study|Enrolled but Never Treated|1|||
130148318|NCT02443324|468502538|FG005|Overall Study|Enrolled but Never Treated|0|||
130148319|NCT02443324|468502539|FG006|Overall Study|Enrolled but Never Treated|1|||
130148320|NCT00298740|468502540|FG000|Overall Study|Lack of Efficacy|6|||
130148321|NCT00298740|468502540|FG000|Overall Study|Withdrawal by Subject|3|||
130148322|NCT00684567|468502541|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
130148323|NCT00684567|468502541|FG000|Monotherapy Period|Adverse Event|2|||
130148324|NCT00684567|468502541|FG000|Monotherapy Period|Death|1|||
130148325|NCT00684567|468502541|FG000|Monotherapy Period|Progression of primary disease|11|||
130148326|NCT03136406|468502547|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
130148327|NCT00988208|468502550|FG000|Overall Study|Adverse Event|71|||
130148328|NCT00988208|468502551|FG001|Overall Study|Adverse Event|122|||
130148329|NCT00988208|468502550|FG000|Overall Study|Disease Progression|103|||
130148330|NCT00988208|468502551|FG001|Overall Study|Disease Progression|89|||
130148331|NCT00988208|468502550|FG000|Overall Study|Withdrawal by Subject|50|||
130148332|NCT00988208|468502551|FG001|Overall Study|Withdrawal by Subject|57|||
130148333|NCT00988208|468502550|FG000|Overall Study|Death|9|||
130148334|NCT00988208|468502551|FG001|Overall Study|Death|15|||
130148335|NCT00988208|468502550|FG000|Overall Study|Lost to Follow-up|2|||
130148336|NCT00988208|468502551|FG001|Overall Study|Lost to Follow-up|3|||
130148337|NCT00988208|468502550|FG000|Overall Study|Protocol Violation|9|||
130148338|NCT00988208|468502551|FG001|Overall Study|Protocol Violation|2|||
130148339|NCT00988208|468502550|FG000|Overall Study|Sponsor Decision|102|||
130148340|NCT00988208|468502551|FG001|Overall Study|Sponsor Decision|78|||
130148341|NCT00988208|468502550|FG000|Overall Study|Clinical Progression|17|||
130148342|NCT00988208|468502551|FG001|Overall Study|Clinical Progression|16|||
130148343|NCT00988208|468502550|FG000|Overall Study|Biochemical Progression|21|||
130148344|NCT00988208|468502551|FG001|Overall Study|Biochemical Progression|7|||
130148345|NCT00988208|468502550|FG000|Overall Study|Clinical Deterioration|7|||
130148346|NCT00988208|468502551|FG001|Overall Study|Clinical Deterioration|14|||
130148347|NCT00988208|468502550|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
130148348|NCT00988208|468502551|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
130148349|NCT00988208|468502550|FG000|Overall Study|Other|8|||
130148350|NCT00988208|468502551|FG001|Overall Study|Other|3|||
130148351|NCT01546519|468502555|FG000|Overall Study|Adverse Event|0|||
130148352|NCT01546519|468502556|FG001|Overall Study|Adverse Event|0|||
130148353|NCT01546519|468502557|FG002|Overall Study|Adverse Event|1|||
130148354|NCT01546519|468502558|FG003|Overall Study|Adverse Event|1|||
130148355|NCT01546519|468502555|FG000|Overall Study|Death|0|||
130148356|NCT01546519|468502556|FG001|Overall Study|Death|1|||
130148357|NCT01546519|468502557|FG002|Overall Study|Death|3|||
130148358|NCT01546519|468502558|FG003|Overall Study|Death|1|||
130148359|NCT01546519|468502555|FG000|Overall Study|related to disease progression|2|||
130148360|NCT01546519|468502556|FG001|Overall Study|related to disease progression|2|||
130148361|NCT01546519|468502557|FG002|Overall Study|related to disease progression|2|||
130148362|NCT01546519|468502558|FG003|Overall Study|related to disease progression|1|||
130148363|NCT01546519|468502555|FG000|Overall Study|Physician Decision|6|||
130148364|NCT01546519|468502556|FG001|Overall Study|Physician Decision|5|||
130148365|NCT01546519|468502557|FG002|Overall Study|Physician Decision|2|||
130148366|NCT01546519|468502558|FG003|Overall Study|Physician Decision|3|||
130148367|NCT01546519|468502555|FG000|Overall Study|Withdrawal by Subject|1|||
130148368|NCT01546519|468502556|FG001|Overall Study|Withdrawal by Subject|0|||
130148369|NCT01546519|468502557|FG002|Overall Study|Withdrawal by Subject|0|||
130148370|NCT01546519|468502558|FG003|Overall Study|Withdrawal by Subject|0|||
130148371|NCT01315028|468502559|FG000|Overall Study|Lost to Follow-up|1|||
130148372|NCT01315028|468502560|FG001|Overall Study|Lost to Follow-up|0|||
130148373|NCT01315028|468502559|FG000|Overall Study|Death|0|||
130148374|NCT01315028|468502560|FG001|Overall Study|Death|1|||
130148375|NCT00725764|468502563|FG000|Overall Study|Withdrawal by Subject|2|||
130148376|NCT00725764|468502563|FG000|Overall Study|Physician Decision|1|||
130148377|NCT00725764|468502563|FG000|Overall Study|Progressive Disease|7|||
130148378|NCT00725764|468502563|FG000|Overall Study|Lost to Follow-up|1|||
130148379|NCT00725764|468502563|FG000|Overall Study|Death|1|||
130148380|NCT00725764|468502563|FG000|Overall Study|Participant non compliant with protocol|1|||
130148381|NCT00725764|468502563|FG000|Overall Study|Decline in performance status|1|||
130148382|NCT01928615|468502565|FG000|Overall Study|Study Terminated by Sponsor|2|||
130148383|NCT00732160|468502569|FG000|Overall Study|Adverse Event|1|||
130148384|NCT00732160|468502570|FG001|Overall Study|Adverse Event|0|||
130148385|NCT00732160|468502571|FG002|Overall Study|Adverse Event|1|||
130148386|NCT00732160|468502572|FG003|Overall Study|Adverse Event|1|||
130148387|NCT00732160|468502569|FG000|Overall Study|scheduling|4|||
130148388|NCT00732160|468502570|FG001|Overall Study|scheduling|4|||
130148389|NCT00732160|468502571|FG002|Overall Study|scheduling|2|||
130148390|NCT00732160|468502572|FG003|Overall Study|scheduling|1|||
130148391|NCT00676494|468502573|FG000|Overall Study|Missed Visit|8|||
130148392|NCT00676494|468502573|FG000|Overall Study|Withdrawal by Subject|6|||
130148393|NCT01264835|468502574|FG000|Overall Study|Lost to Follow-up|1|||
130148394|NCT04660032|468502585|FG000|Overall Study|Protocol Violation|1|||
130148395|NCT04660032|468502586|FG001|Overall Study|Protocol Violation|1|||
130148396|NCT00090753|468502587|FG000|First Treatment Period|Adverse Event|20|||
130148397|NCT00090753|468502588|FG001|First Treatment Period|Adverse Event|8|||
130148398|NCT00090753|468502587|FG000|First Treatment Period|Death|88|||
130148399|NCT00090753|468502588|FG001|First Treatment Period|Death|62|||
130148400|NCT00090753|468502587|FG000|First Treatment Period|Lack of Efficacy|2|||
130148401|NCT00090753|468502588|FG001|First Treatment Period|Lack of Efficacy|1|||
130148402|NCT00090753|468502587|FG000|First Treatment Period|Refused Treatment|32|||
130148403|NCT00090753|468502588|FG001|First Treatment Period|Refused Treatment|25|||
130148404|NCT00090753|468502587|FG000|First Treatment Period|Lost to Follow-up|4|||
130148405|NCT00090753|468502588|FG001|First Treatment Period|Lost to Follow-up|4|||
130148406|NCT00090753|468502587|FG000|First Treatment Period|Renal Transplant|70|||
130148407|NCT00090753|468502588|FG001|First Treatment Period|Renal Transplant|50|||
130148408|NCT00090753|468502587|FG000|First Treatment Period|Mircera Commercialization|1|||
130148409|NCT00090753|468502588|FG001|First Treatment Period|Mircera Commercialization|0|||
130148410|NCT00090753|468502587|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
130148411|NCT00090753|468502588|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
130148412|NCT00090753|468502587|FG000|Extended Treatment Period|Adverse Event|11|||
130148413|NCT00090753|468502588|FG001|Extended Treatment Period|Adverse Event|0|||
130148414|NCT00090753|468502587|FG000|Extended Treatment Period|Death|58|||
130148415|NCT00090753|468502588|FG001|Extended Treatment Period|Death|30|||
130148416|NCT00090753|468502587|FG000|Extended Treatment Period|Lack of Efficacy|1|||
130148417|NCT00090753|468502588|FG001|Extended Treatment Period|Lack of Efficacy|0|||
130148418|NCT00090753|468502587|FG000|Extended Treatment Period|Refused Treatment|18|||
130148419|NCT00090753|468502588|FG001|Extended Treatment Period|Refused Treatment|12|||
130148420|NCT00090753|468502587|FG000|Extended Treatment Period|Lost to Follow-up|3|||
130148421|NCT00090753|468502588|FG001|Extended Treatment Period|Lost to Follow-up|1|||
130148422|NCT00090753|468502587|FG000|Extended Treatment Period|Renal Transplant|15|||
130148423|NCT00090753|468502588|FG001|Extended Treatment Period|Renal Transplant|12|||
130148424|NCT00090753|468502587|FG000|Extended Treatment Period|Mircera Commercialization|188|||
130148425|NCT00090753|468502588|FG001|Extended Treatment Period|Mircera Commercialization|93|||
130148426|NCT00090753|468502587|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
130148427|NCT00090753|468502588|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
130148428|NCT00605176|468502591|FG000|Overall Study|Adverse Event|2|||
130148429|NCT00605176|468502592|FG001|Overall Study|Adverse Event|1|||
130148430|NCT00605176|468502593|FG002|Overall Study|Adverse Event|3|||
130148431|NCT00605176|468502591|FG000|Overall Study|Withdrawal by Subject|4|||
130148432|NCT00605176|468502592|FG001|Overall Study|Withdrawal by Subject|2|||
130148433|NCT00605176|468502593|FG002|Overall Study|Withdrawal by Subject|4|||
130148434|NCT00605176|468502591|FG000|Overall Study|Lost to Follow-up|2|||
130148435|NCT00605176|468502592|FG001|Overall Study|Lost to Follow-up|2|||
130148436|NCT00605176|468502593|FG002|Overall Study|Lost to Follow-up|1|||
130148437|NCT00605176|468502591|FG000|Overall Study|Non-complicance with study procedures|1|||
130148438|NCT00605176|468502592|FG001|Overall Study|Non-complicance with study procedures|0|||
130148439|NCT00605176|468502593|FG002|Overall Study|Non-complicance with study procedures|0|||
130148440|NCT00605176|468502591|FG000|Overall Study|Use of concomitant therapy|1|||
130148441|NCT00605176|468502592|FG001|Overall Study|Use of concomitant therapy|0|||
130148442|NCT00605176|468502593|FG002|Overall Study|Use of concomitant therapy|1|||
130148443|NCT00605176|468502591|FG000|Overall Study|Other (not due to AE)|1|||
130148444|NCT00605176|468502592|FG001|Overall Study|Other (not due to AE)|1|||
130148445|NCT00605176|468502593|FG002|Overall Study|Other (not due to AE)|0|||
130148446|NCT01256060|468502594|FG000|Overall Study|Lost to Follow-up|0|||
130148447|NCT01256060|468502595|FG001|Overall Study|Lost to Follow-up|1|||
130148448|NCT01256060|468502596|FG002|Overall Study|Lost to Follow-up|0|||
130148449|NCT01256060|468502597|FG003|Overall Study|Lost to Follow-up|0|||
130148450|NCT01466036|468502602|FG000|Overall Study|Death|1|||
130148451|NCT01466036|468502603|FG001|Overall Study|Death|1|||
130148452|NCT01466036|468502602|FG000|Overall Study|Physician Decision|0|||
130148453|NCT01466036|468502603|FG001|Overall Study|Physician Decision|4|||
130148454|NCT01466036|468502602|FG000|Overall Study|Adverse Event|2|||
130148455|NCT01466036|468502603|FG001|Overall Study|Adverse Event|6|||
130148456|NCT01466036|468502602|FG000|Overall Study|Withdrawal by Subject|2|||
130148457|NCT01466036|468502603|FG001|Overall Study|Withdrawal by Subject|8|||
130148458|NCT01466036|468502602|FG000|Overall Study|progression/relapse|14|||
130148459|NCT01466036|468502603|FG001|Overall Study|progression/relapse|21|||
130148460|NCT01466036|468502602|FG000|Overall Study|prolonged treatment delay|1|||
130148461|NCT01466036|468502603|FG001|Overall Study|prolonged treatment delay|1|||
130148462|NCT00985231|468502610|FG000|Overall Study|ineligible|1|||
130148463|NCT00985231|468502611|FG001|Overall Study|ineligible|0|||
130148464|NCT00985231|468502610|FG000|Overall Study|Protocol Violation|1|||
130148465|NCT00985231|468502611|FG001|Overall Study|Protocol Violation|0|||
130148466|NCT00985231|468502610|FG000|Overall Study|Withdrawal by Subject|1|||
130148467|NCT00985231|468502611|FG001|Overall Study|Withdrawal by Subject|0|||
130148468|NCT00985231|468502610|FG000|Overall Study|Lost to Follow-up|0|||
130148469|NCT00985231|468502611|FG001|Overall Study|Lost to Follow-up|1|||
130148470|NCT00985231|468502610|FG000|Overall Study|Study related symptoms & complaints|0|||
130148471|NCT00985231|468502611|FG001|Overall Study|Study related symptoms & complaints|2|||
130148472|NCT00436917|468502612|FG000|Overall Study|Withdrawal by Subject|13|||
130148473|NCT00436917|468502612|FG000|Overall Study|Adverse Event|2|||
130148474|NCT00436917|468502612|FG000|Overall Study|Physician Decision|1|||
130148475|NCT00436917|468502612|FG000|Overall Study|Death|1|||
130148476|NCT00436917|468502612|FG000|Overall Study|Lost to Follow-up|1|||
130148477|NCT00436917|468502612|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
130148478|NCT00436917|468502612|FG000|Overall Study|Increased creatinine|1|||
130148479|NCT00436917|468502612|FG000|Overall Study|Personal conflicts of patient|1|||
130148480|NCT00220727|468502619|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
130148481|NCT00220727|468502620|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
130148482|NCT00761176|468502621|FG000|Overall Study|Death|1|||
130148483|NCT00761176|468502622|FG001|Overall Study|Death|0|||
130148484|NCT00761176|468502621|FG000|Overall Study|Withdrawal by Subject|1|||
130148485|NCT00761176|468502622|FG001|Overall Study|Withdrawal by Subject|1|||
130148486|NCT05103657|468502623|FG000|Overall Study|Other reasons than listed|9|||
130148487|NCT05103657|468502624|FG001|Overall Study|Other reasons than listed|8|||
130148488|NCT05103657|468502623|FG000|Overall Study|Protocol deviation|2|||
130148489|NCT05103657|468502624|FG001|Overall Study|Protocol deviation|2|||
130148490|NCT05103657|468502623|FG000|Overall Study|No reason available|5|||
130148491|NCT05103657|468502624|FG001|Overall Study|No reason available|4|||
130148492|NCT05103657|468502623|FG000|Overall Study|Burden of study procedures|3|||
130148493|NCT05103657|468502624|FG001|Overall Study|Burden of study procedures|1|||
130148494|NCT05103657|468502623|FG000|Overall Study|Perceived lack of efficacy|1|||
130148495|NCT05103657|468502624|FG001|Overall Study|Perceived lack of efficacy|1|||
130148496|NCT05103657|468502623|FG000|Overall Study|Adverse Event|6|||
130148497|NCT05103657|468502624|FG001|Overall Study|Adverse Event|14|||
130148498|NCT05103657|468502623|FG000|Overall Study|Not Treated|1|||
130148499|NCT05103657|468502624|FG001|Overall Study|Not Treated|1|||
130148500|NCT03635983|468502628|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130148501|NCT03635983|468502629|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
130148502|NCT03635983|468502628|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130148503|NCT03635983|468502629|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130148504|NCT03635983|468502628|FG000|Pre-Treatment Period|Other reasons|0|||
130148505|NCT03635983|468502629|FG001|Pre-Treatment Period|Other reasons|1|||
130148506|NCT03635983|468502628|FG000|Pre-Treatment Period|Disease Progression|0|||
130148507|NCT03635983|468502629|FG001|Pre-Treatment Period|Disease Progression|1|||
130148508|NCT03635983|468502628|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
130148509|NCT03635983|468502629|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
130148510|NCT03635983|468502628|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
130148511|NCT03635983|468502629|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
130148512|NCT03635983|468502628|FG000|Treatment Period|Withdrawal by Subject|3|||
130148513|NCT03635983|468502629|FG001|Treatment Period|Withdrawal by Subject|5|||
130148514|NCT03635983|468502628|FG000|Treatment Period|Death|3|||
130148515|NCT03635983|468502629|FG001|Treatment Period|Death|5|||
130148516|NCT03635983|468502628|FG000|Treatment Period|Poor/Non-compliance|2|||
130148517|NCT03635983|468502629|FG001|Treatment Period|Poor/Non-compliance|1|||
130148518|NCT03635983|468502628|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
130148519|NCT03635983|468502629|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
130148520|NCT03635983|468502628|FG000|Treatment Period|Other reasons|7|||
130148521|NCT03635983|468502629|FG001|Treatment Period|Other reasons|4|||
130148522|NCT03635983|468502628|FG000|Treatment Period|Disease progression|230|||
130148523|NCT03635983|468502629|FG001|Treatment Period|Disease progression|201|||
130148524|NCT03635983|468502628|FG000|Treatment Period|Study drug toxicity|35|||
130148525|NCT03635983|468502629|FG001|Treatment Period|Study drug toxicity|36|||
130148526|NCT03635983|468502628|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
130148527|NCT03635983|468502629|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
130148528|NCT03635983|468502628|FG000|Treatment Period|Maximum clinical benefit|3|||
130148529|NCT03635983|468502629|FG001|Treatment Period|Maximum clinical benefit|5|||
130148530|NCT03635983|468502628|FG000|Treatment Period|Administrative reason by the sponsor|1|||
130148531|NCT03635983|468502629|FG001|Treatment Period|Administrative reason by the sponsor|2|||
130148532|NCT03635983|468502628|FG000|Treatment Period|Lost to Follow-up|0|||
130148533|NCT03635983|468502629|FG001|Treatment Period|Lost to Follow-up|1|||
130148534|NCT03430011|468502631|FG000|Pre-Treatment|Death|1|||
130148535|NCT03430011|468502632|FG001|Pre-Treatment|Death|0|||
130148536|NCT03430011|468502633|FG002|Pre-Treatment|Death|0|||
130148537|NCT03430011|468502634|FG003|Pre-Treatment|Death|0|||
130148538|NCT03430011|468502635|FG004|Pre-Treatment|Death|1|||
130148539|NCT03430011|468502636|FG005|Pre-Treatment|Death|0|||
130148540|NCT03430011|468502637|FG006|Pre-Treatment|Death|1|||
130148541|NCT03430011|468502638|FG007|Pre-Treatment|Death|0|||
130148542|NCT03430011|468502631|FG000|Pre-Treatment|Screen Fail|0|||
130148543|NCT03430011|468502632|FG001|Pre-Treatment|Screen Fail|0|||
130148544|NCT03430011|468502633|FG002|Pre-Treatment|Screen Fail|0|||
130148545|NCT03430011|468502634|FG003|Pre-Treatment|Screen Fail|0|||
130148546|NCT03430011|468502635|FG004|Pre-Treatment|Screen Fail|1|||
130148547|NCT03430011|468502636|FG005|Pre-Treatment|Screen Fail|0|||
130148548|NCT03430011|468502637|FG006|Pre-Treatment|Screen Fail|0|||
130148549|NCT03430011|468502638|FG007|Pre-Treatment|Screen Fail|0|||
130148550|NCT03430011|468502631|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148551|NCT03430011|468502632|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148552|NCT03430011|468502633|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
130148553|NCT03430011|468502634|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148554|NCT03430011|468502635|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148555|NCT03430011|468502636|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148556|NCT03430011|468502637|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148557|NCT03430011|468502638|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
130148558|NCT03430011|468502631|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
130148559|NCT03430011|468502632|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
130148560|NCT03430011|468502633|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
130148561|NCT03430011|468502634|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
130148562|NCT03430011|468502635|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
130148563|NCT03430011|468502636|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
130148564|NCT03430011|468502637|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
130148565|NCT03430011|468502638|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
130148566|NCT03430011|468502631|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
130148567|NCT03430011|468502632|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
130148568|NCT03430011|468502633|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
130148569|NCT03430011|468502634|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
130148570|NCT03430011|468502635|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
130148571|NCT03430011|468502636|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
130148572|NCT03430011|468502637|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
130148573|NCT03430011|468502638|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
130148574|NCT03430011|468502631|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
130148575|NCT03430011|468502632|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
130148576|NCT03430011|468502633|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
130148577|NCT03430011|468502634|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
130148578|NCT03430011|468502635|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
130148579|NCT03430011|468502636|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
130148580|NCT03430011|468502637|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
130148581|NCT03430011|468502638|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
130148582|NCT03430011|468502631|FG000|JCARH125 Treatment|Death|4|||
130148583|NCT03430011|468502632|FG001|JCARH125 Treatment|Death|19|||
130148584|NCT03430011|468502633|FG002|JCARH125 Treatment|Death|10|||
130148585|NCT03430011|468502634|FG003|JCARH125 Treatment|Death|8|||
130148586|NCT03430011|468502635|FG004|JCARH125 Treatment|Death|5|||
130148587|NCT03430011|468502636|FG005|JCARH125 Treatment|Death|3|||
130148588|NCT03430011|468502637|FG006|JCARH125 Treatment|Death|4|||
130148589|NCT03430011|468502638|FG007|JCARH125 Treatment|Death|2|||
130148590|NCT03430011|468502631|FG000|JCARH125 Treatment|Other reasons|1|||
130148591|NCT03430011|468502632|FG001|JCARH125 Treatment|Other reasons|0|||
130148592|NCT03430011|468502633|FG002|JCARH125 Treatment|Other reasons|4|||
130148593|NCT03430011|468502634|FG003|JCARH125 Treatment|Other reasons|2|||
130148594|NCT03430011|468502635|FG004|JCARH125 Treatment|Other reasons|2|||
130148595|NCT03430011|468502636|FG005|JCARH125 Treatment|Other reasons|1|||
130148596|NCT03430011|468502637|FG006|JCARH125 Treatment|Other reasons|3|||
130148597|NCT03430011|468502638|FG007|JCARH125 Treatment|Other reasons|2|||
130148598|NCT04126343|468502639|FG000|Overall Study|Adverse Event|0|||
130148599|NCT04126343|468502640|FG001|Overall Study|Adverse Event|0|||
130148600|NCT04126343|468502641|FG002|Overall Study|Adverse Event|0|||
130148601|NCT04126343|468502642|FG003|Overall Study|Adverse Event|0|||
130148602|NCT04126343|468502643|FG004|Overall Study|Adverse Event|0|||
130148603|NCT04126343|468502644|FG005|Overall Study|Adverse Event|1|||
130148604|NCT04126343|468502639|FG000|Overall Study|Withdrawal by Subject|0|||
130148605|NCT04126343|468502640|FG001|Overall Study|Withdrawal by Subject|0|||
130148606|NCT04126343|468502641|FG002|Overall Study|Withdrawal by Subject|0|||
130148607|NCT04126343|468502642|FG003|Overall Study|Withdrawal by Subject|1|||
130148608|NCT04126343|468502643|FG004|Overall Study|Withdrawal by Subject|0|||
130148609|NCT04126343|468502644|FG005|Overall Study|Withdrawal by Subject|0|||
130148610|NCT04126343|468502639|FG000|Overall Study|Related to COVID-19 pandemic|3|||
130148611|NCT04126343|468502640|FG001|Overall Study|Related to COVID-19 pandemic|4|||
130148612|NCT04126343|468502641|FG002|Overall Study|Related to COVID-19 pandemic|3|||
130148613|NCT04126343|468502642|FG003|Overall Study|Related to COVID-19 pandemic|3|||
130148614|NCT04126343|468502643|FG004|Overall Study|Related to COVID-19 pandemic|3|||
130148615|NCT04126343|468502644|FG005|Overall Study|Related to COVID-19 pandemic|3|||
130148616|NCT01235442|468502645|FG000|Overall Study|Lost to Follow-up|12|||
130148617|NCT01235442|468502646|FG001|Overall Study|Lost to Follow-up|10|||
130148618|NCT01235442|468502645|FG000|Overall Study|Death|0|||
130148619|NCT01235442|468502646|FG001|Overall Study|Death|2|||
130148620|NCT01235442|468502645|FG000|Overall Study|Pregnancy|1|||
130148621|NCT01235442|468502646|FG001|Overall Study|Pregnancy|1|||
130148622|NCT01235442|468502645|FG000|Overall Study|Ineligibility determined|5|||
130148623|NCT01235442|468502646|FG001|Overall Study|Ineligibility determined|4|||
130148624|NCT01235442|468502645|FG000|Overall Study|Protocol Violation|3|||
130148625|NCT01235442|468502646|FG001|Overall Study|Protocol Violation|3|||
130148626|NCT01235442|468502645|FG000|Overall Study|Adverse Event|4|||
130148627|NCT01235442|468502646|FG001|Overall Study|Adverse Event|6|||
130148628|NCT01235442|468502645|FG000|Overall Study|Withdrawal by Subject|15|||
130148629|NCT01235442|468502646|FG001|Overall Study|Withdrawal by Subject|9|||
130148630|NCT01235442|468502645|FG000|Overall Study|Lack of Efficacy|1|||
130148631|NCT01235442|468502646|FG001|Overall Study|Lack of Efficacy|3|||
130148632|NCT01235442|468502645|FG000|Overall Study|Noncompliance|1|||
130148633|NCT01235442|468502646|FG001|Overall Study|Noncompliance|2|||
130148634|NCT01235442|468502645|FG000|Overall Study|Administrative decision|1|||
130148635|NCT01235442|468502646|FG001|Overall Study|Administrative decision|2|||
130148636|NCT01235442|468502645|FG000|Overall Study|Other unspecified|1|||
130148637|NCT01235442|468502646|FG001|Overall Study|Other unspecified|2|||
130148638|NCT00084799|468502647|FG000|Overall Study|Disease Progression|1|||
130148639|NCT00084799|468502648|FG001|Overall Study|Disease Progression|0|||
130148640|NCT03712124|468502651|FG000|Overall Study|Protocol Violation|1|||
130148641|NCT03712124|468502652|FG001|Overall Study|Protocol Violation|0|||
130148642|NCT02412722|468502654|FG000|Overall Study|Adverse Event|0|||
130148643|NCT02412722|468502655|FG001|Overall Study|Adverse Event|2|||
130148644|NCT02412722|468502656|FG002|Overall Study|Adverse Event|0|||
130148645|NCT02412722|468502657|FG003|Overall Study|Adverse Event|3|||
130148646|NCT02412722|468502658|FG004|Overall Study|Adverse Event|0|||
129978369|NCT02383940|467883702|FG000|Overall Study|Physician Decision|2|||
129978370|NCT02383940|467883703|FG001|Overall Study|Physician Decision|0|||
129978371|NCT02383940|467883702|FG000|Overall Study|Withdrawal by Subject|1|||
129978372|NCT02383940|467883703|FG001|Overall Study|Withdrawal by Subject|1|||
129978373|NCT02383940|467883702|FG000|Overall Study|Randomized but not treated|2|||
129978374|NCT02383940|467883703|FG001|Overall Study|Randomized but not treated|0|||
129978375|NCT02383940|467883702|FG000|Overall Study|Other than specified above|1|||
129978376|NCT02383940|467883703|FG001|Overall Study|Other than specified above|0|||
129978377|NCT02672852|467883705|FG000|Part A1|Disease Worsening|1|||
129978378|NCT02672852|467883706|FG001|Part A1|Disease Worsening|0|||
129978379|NCT02672852|467883707|FG002|Part A1|Disease Worsening|0|||
129978380|NCT02672852|467883708|FG003|Part A1|Disease Worsening|0|||
129978381|NCT02672852|467883709|FG004|Part A1|Disease Worsening|0|||
129978382|NCT02672852|467883710|FG005|Part A1|Disease Worsening|0|||
129978383|NCT02672852|467883711|FG006|Part A1|Disease Worsening|0|||
129978384|NCT02672852|467883705|FG000|Part A1|Adverse Event|0|||
129978385|NCT02672852|467883706|FG001|Part A1|Adverse Event|1|||
129978386|NCT02672852|467883707|FG002|Part A1|Adverse Event|0|||
129978387|NCT02672852|467883708|FG003|Part A1|Adverse Event|0|||
129978388|NCT02672852|467883709|FG004|Part A1|Adverse Event|0|||
129978389|NCT02672852|467883710|FG005|Part A1|Adverse Event|0|||
129978390|NCT02672852|467883711|FG006|Part A1|Adverse Event|0|||
129978391|NCT02672852|467883705|FG000|Part A1|Lost to Follow-up|1|||
129978392|NCT02672852|467883706|FG001|Part A1|Lost to Follow-up|2|||
129978393|NCT02672852|467883707|FG002|Part A1|Lost to Follow-up|0|||
129978394|NCT02672852|467883708|FG003|Part A1|Lost to Follow-up|0|||
129978395|NCT02672852|467883709|FG004|Part A1|Lost to Follow-up|0|||
129978396|NCT02672852|467883710|FG005|Part A1|Lost to Follow-up|0|||
129978397|NCT02672852|467883711|FG006|Part A1|Lost to Follow-up|0|||
129978398|NCT02672852|467883705|FG000|Part A1|Withdrawal by Subject|1|||
129978399|NCT02672852|467883706|FG001|Part A1|Withdrawal by Subject|1|||
129978400|NCT02672852|467883707|FG002|Part A1|Withdrawal by Subject|0|||
129978401|NCT02672852|467883708|FG003|Part A1|Withdrawal by Subject|0|||
129978402|NCT02672852|467883709|FG004|Part A1|Withdrawal by Subject|0|||
129978403|NCT02672852|467883710|FG005|Part A1|Withdrawal by Subject|0|||
129978404|NCT02672852|467883711|FG006|Part A1|Withdrawal by Subject|0|||
129978405|NCT02672852|467883705|FG000|Part A2|Disease worsening|0|||
129978406|NCT02672852|467883706|FG001|Part A2|Disease worsening|0|||
129978407|NCT02672852|467883707|FG002|Part A2|Disease worsening|1|||
130148647|NCT02412722|468502659|FG005|Overall Study|Adverse Event|3|||
130148648|NCT02412722|468502654|FG000|Overall Study|Progressive Disease|6|||
130148649|NCT02412722|468502655|FG001|Overall Study|Progressive Disease|4|||
130148650|NCT02412722|468502656|FG002|Overall Study|Progressive Disease|4|||
130148651|NCT02412722|468502657|FG003|Overall Study|Progressive Disease|9|||
130148652|NCT02412722|468502658|FG004|Overall Study|Progressive Disease|3|||
130148653|NCT02412722|468502659|FG005|Overall Study|Progressive Disease|3|||
130148654|NCT02412722|468502654|FG000|Overall Study|Withdrawal by Subject|2|||
130148655|NCT02412722|468502655|FG001|Overall Study|Withdrawal by Subject|0|||
130148656|NCT02412722|468502656|FG002|Overall Study|Withdrawal by Subject|1|||
130148657|NCT02412722|468502657|FG003|Overall Study|Withdrawal by Subject|2|||
130148658|NCT02412722|468502658|FG004|Overall Study|Withdrawal by Subject|1|||
130148659|NCT02412722|468502659|FG005|Overall Study|Withdrawal by Subject|1|||
130148660|NCT02412722|468502654|FG000|Overall Study|Lost to Follow-up|0|||
130148661|NCT02412722|468502655|FG001|Overall Study|Lost to Follow-up|0|||
130148662|NCT02412722|468502656|FG002|Overall Study|Lost to Follow-up|0|||
130148663|NCT02412722|468502657|FG003|Overall Study|Lost to Follow-up|0|||
130148664|NCT02412722|468502658|FG004|Overall Study|Lost to Follow-up|1|||
130148665|NCT02412722|468502659|FG005|Overall Study|Lost to Follow-up|0|||
130148666|NCT02412722|468502654|FG000|Overall Study|Received drug in run-in and discontinued|0|||
130148667|NCT02412722|468502655|FG001|Overall Study|Received drug in run-in and discontinued|2|||
130148668|NCT02412722|468502656|FG002|Overall Study|Received drug in run-in and discontinued|0|||
130148669|NCT02412722|468502657|FG003|Overall Study|Received drug in run-in and discontinued|0|||
130148670|NCT02412722|468502658|FG004|Overall Study|Received drug in run-in and discontinued|0|||
129978408|NCT02672852|467883708|FG003|Part A2|Disease worsening|0|||
130148671|NCT02412722|468502659|FG005|Overall Study|Received drug in run-in and discontinued|0|||
130148672|NCT02412722|468502654|FG000|Overall Study|Reason not Specified|3|||
129978409|NCT02672852|467883709|FG004|Part A2|Disease worsening|0|||
129978410|NCT02672852|467883710|FG005|Part A2|Disease worsening|0|||
129978411|NCT02672852|467883711|FG006|Part A2|Disease worsening|0|||
129978412|NCT02672852|467883705|FG000|Part A2|Adverse Event|0|||
129978413|NCT02672852|467883706|FG001|Part A2|Adverse Event|0|||
129978414|NCT02672852|467883707|FG002|Part A2|Adverse Event|3|||
129978415|NCT02672852|467883708|FG003|Part A2|Adverse Event|0|||
129978416|NCT02672852|467883709|FG004|Part A2|Adverse Event|0|||
129978417|NCT02672852|467883710|FG005|Part A2|Adverse Event|0|||
129978418|NCT02672852|467883711|FG006|Part A2|Adverse Event|0|||
129978419|NCT02672852|467883705|FG000|Part A2|Lost to Follow-up|0|||
129978420|NCT02672852|467883706|FG001|Part A2|Lost to Follow-up|0|||
129978421|NCT02672852|467883707|FG002|Part A2|Lost to Follow-up|2|||
130148673|NCT02412722|468502655|FG001|Overall Study|Reason not Specified|0|||
130148674|NCT02412722|468502656|FG002|Overall Study|Reason not Specified|2|||
129978422|NCT02672852|467883708|FG003|Part A2|Lost to Follow-up|0|||
129978423|NCT02672852|467883709|FG004|Part A2|Lost to Follow-up|0|||
129978424|NCT02672852|467883710|FG005|Part A2|Lost to Follow-up|0|||
129978425|NCT02672852|467883711|FG006|Part A2|Lost to Follow-up|0|||
129978426|NCT02672852|467883705|FG000|Part A2|Withdrawal by Subject|0|||
129978427|NCT02672852|467883706|FG001|Part A2|Withdrawal by Subject|0|||
129978428|NCT02672852|467883707|FG002|Part A2|Withdrawal by Subject|1|||
129978429|NCT02672852|467883708|FG003|Part A2|Withdrawal by Subject|0|||
129978430|NCT02672852|467883709|FG004|Part A2|Withdrawal by Subject|0|||
129978431|NCT02672852|467883710|FG005|Part A2|Withdrawal by Subject|0|||
129978432|NCT02672852|467883711|FG006|Part A2|Withdrawal by Subject|0|||
129978433|NCT02672852|467883705|FG000|Part A2|Other|0|||
129978434|NCT02672852|467883706|FG001|Part A2|Other|0|||
129978435|NCT02672852|467883707|FG002|Part A2|Other|3|||
129978436|NCT02672852|467883708|FG003|Part A2|Other|0|||
129978437|NCT02672852|467883709|FG004|Part A2|Other|0|||
129978438|NCT02672852|467883710|FG005|Part A2|Other|0|||
129978439|NCT02672852|467883711|FG006|Part A2|Other|0|||
129978440|NCT02672852|467883705|FG000|Part A2|Not entered in Part B|0|||
129978441|NCT02672852|467883706|FG001|Part A2|Not entered in Part B|0|||
129978442|NCT02672852|467883707|FG002|Part A2|Not entered in Part B|0|||
129978443|NCT02672852|467883708|FG003|Part A2|Not entered in Part B|4|||
129978444|NCT02672852|467883709|FG004|Part A2|Not entered in Part B|0|||
129978445|NCT02672852|467883710|FG005|Part A2|Not entered in Part B|0|||
129978446|NCT02672852|467883711|FG006|Part A2|Not entered in Part B|0|||
129978447|NCT02672852|467883705|FG000|Part B|Disease worsening|0|||
129978448|NCT02672852|467883706|FG001|Part B|Disease worsening|0|||
129978449|NCT02672852|467883707|FG002|Part B|Disease worsening|0|||
129978450|NCT02672852|467883708|FG003|Part B|Disease worsening|0|||
129978451|NCT02672852|467883709|FG004|Part B|Disease worsening|1|||
129978452|NCT02672852|467883710|FG005|Part B|Disease worsening|0|||
129978453|NCT02672852|467883711|FG006|Part B|Disease worsening|1|||
129978454|NCT02672852|467883705|FG000|Part B|Worsening pre-existing condition|0|||
129978455|NCT02672852|467883706|FG001|Part B|Worsening pre-existing condition|0|||
129978456|NCT02672852|467883707|FG002|Part B|Worsening pre-existing condition|0|||
129978457|NCT02672852|467883708|FG003|Part B|Worsening pre-existing condition|0|||
129978458|NCT02672852|467883709|FG004|Part B|Worsening pre-existing condition|0|||
129978459|NCT02672852|467883710|FG005|Part B|Worsening pre-existing condition|1|||
129978460|NCT02672852|467883711|FG006|Part B|Worsening pre-existing condition|0|||
129978461|NCT02672852|467883705|FG000|Part B|Other adverse event|0|||
129978462|NCT02672852|467883706|FG001|Part B|Other adverse event|0|||
129978463|NCT02672852|467883707|FG002|Part B|Other adverse event|0|||
129978464|NCT02672852|467883708|FG003|Part B|Other adverse event|0|||
129978465|NCT02672852|467883709|FG004|Part B|Other adverse event|3|||
129978466|NCT02672852|467883710|FG005|Part B|Other adverse event|5|||
129978467|NCT02672852|467883711|FG006|Part B|Other adverse event|1|||
129978468|NCT02672852|467883705|FG000|Part B|Lost to Follow-up|0|||
129978469|NCT02672852|467883706|FG001|Part B|Lost to Follow-up|0|||
129978470|NCT02672852|467883707|FG002|Part B|Lost to Follow-up|0|||
129978471|NCT02672852|467883708|FG003|Part B|Lost to Follow-up|0|||
129978472|NCT02672852|467883709|FG004|Part B|Lost to Follow-up|3|||
129978473|NCT02672852|467883710|FG005|Part B|Lost to Follow-up|4|||
129978474|NCT02672852|467883711|FG006|Part B|Lost to Follow-up|1|||
129978475|NCT02672852|467883705|FG000|Part B|Withdrawal by Subject|0|||
129978476|NCT02672852|467883706|FG001|Part B|Withdrawal by Subject|0|||
129978477|NCT02672852|467883707|FG002|Part B|Withdrawal by Subject|0|||
129978478|NCT02672852|467883708|FG003|Part B|Withdrawal by Subject|0|||
129978479|NCT02672852|467883709|FG004|Part B|Withdrawal by Subject|5|||
129978480|NCT02672852|467883710|FG005|Part B|Withdrawal by Subject|0|||
129978481|NCT02672852|467883711|FG006|Part B|Withdrawal by Subject|7|||
129978482|NCT02672852|467883705|FG000|Part B|Other|0|||
129978483|NCT02672852|467883706|FG001|Part B|Other|0|||
129978484|NCT02672852|467883707|FG002|Part B|Other|0|||
130094545|NCT01258803|468302406|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130094546|NCT01258803|468302407|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130094547|NCT01258803|468302408|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130094548|NCT01258803|468302409|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
130094549|NCT01258803|468302404|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130094550|NCT01258803|468302405|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130094551|NCT01258803|468302406|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
129978485|NCT02672852|467883708|FG003|Part B|Other|0|||
130094552|NCT01258803|468302407|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129978486|NCT02672852|467883709|FG004|Part B|Other|4|||
130094553|NCT01258803|468302408|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129978487|NCT02672852|467883710|FG005|Part B|Other|1|||
129978488|NCT02672852|467883711|FG006|Part B|Other|2|||
129978489|NCT00702962|467883712|FG000|Overall Study|Progressive disease|0|||
129978490|NCT00702962|467883713|FG001|Overall Study|Progressive disease|1|||
129978491|NCT00702962|467883712|FG000|Overall Study|Hospitalized for other health disorder|1|||
129978492|NCT00702962|467883713|FG001|Overall Study|Hospitalized for other health disorder|0|||
129978493|NCT02175641|467883714|FG000|Overall Study|Death|3|||
129978494|NCT02175641|467883715|FG001|Overall Study|Death|4|||
129978495|NCT02175641|467883714|FG000|Overall Study|Lost to Follow-up|4|||
129978496|NCT02175641|467883715|FG001|Overall Study|Lost to Follow-up|4|||
129978497|NCT02175641|467883714|FG000|Overall Study|Withdrawal by Subject|7|||
129978498|NCT02175641|467883715|FG001|Overall Study|Withdrawal by Subject|4|||
129978499|NCT02175641|467883714|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
129978500|NCT02175641|467883715|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
129978501|NCT02175641|467883714|FG000|Overall Study|Developed Contraindicated Condition|8|||
129978502|NCT02175641|467883715|FG001|Overall Study|Developed Contraindicated Condition|0|||
129978503|NCT01923467|467883717|FG000|Overall Study|Lost to Follow-up|62|||
129978504|NCT01923467|467883717|FG000|Overall Study|Subject non-interest|479|||
129978505|NCT01876901|467883718|FG000|Overall Study|Protocol Violation|10|||
129978506|NCT01876901|467883719|FG001|Overall Study|Protocol Violation|2|||
129978507|NCT01876901|467883718|FG000|Overall Study|No or other surgical intervention|7|||
130148675|NCT02412722|468502657|FG003|Overall Study|Reason not Specified|1|||
130148676|NCT02412722|468502658|FG004|Overall Study|Reason not Specified|2|||
130148677|NCT02412722|468502659|FG005|Overall Study|Reason not Specified|6|||
130148678|NCT02941523|468502660|FG000|Monotherapy|Withdrawal by Subject|0|||
130148679|NCT02941523|468502661|FG001|Monotherapy|Withdrawal by Subject|1|||
130148680|NCT02941523|468502660|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
130148681|NCT02941523|468502661|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
130148682|NCT02941523|468502660|FG000|Carboplatin Combination Therapy|Death|1|||
130148683|NCT02941523|468502661|FG001|Carboplatin Combination Therapy|Death|2|||
130148684|NCT02941523|468502660|FG000|Carboplatin Combination Therapy|Disease progression|2|||
130148685|NCT02941523|468502661|FG001|Carboplatin Combination Therapy|Disease progression|0|||
130148686|NCT02941523|468502660|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
130148687|NCT02941523|468502661|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
130148688|NCT04449341|468502662|FG000|Overall Study|Protocol Violation|1|||
130148689|NCT04449341|468502663|FG001|Overall Study|Protocol Violation|0|||
130148690|NCT04499482|468502664|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
130148691|NCT01083680|468502665|FG000|Overall Study|Lost to Follow-up|2758|||
130148692|NCT01083680|468502665|FG000|Overall Study|Withdrawal by Subject|1086|||
130148693|NCT02219308|468502666|FG000|Overall Study|Withdrawal by Subject|1|||
130148694|NCT02219308|468502667|FG001|Overall Study|Withdrawal by Subject|2|||
130148695|NCT01976728|468504129|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
130148696|NCT01976728|468504130|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
130148697|NCT01976728|468504131|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
130148698|NCT01976728|468504132|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
130148699|NCT02356211|468504133|FG000|Overall Study|Withdrawal by Subject|2|||
130148700|NCT02356211|468504134|FG001|Overall Study|Withdrawal by Subject|2|||
130148701|NCT02356211|468504133|FG000|Overall Study|ineligible|1|||
130148702|NCT02356211|468504134|FG001|Overall Study|ineligible|8|||
130148703|NCT00966381|468504138|FG000|Overall Study|Withdrawal by Subject|2|||
130148704|NCT00966381|468504139|FG001|Overall Study|Withdrawal by Subject|2|||
130148705|NCT00097786|468504143|FG000|Overall Study|lost to follow-up for all-cause death|296|||
130148706|NCT00097786|468504144|FG001|Overall Study|lost to follow-up for all-cause death|292|||
130148707|NCT00097786|468504145|FG002|Overall Study|lost to follow-up for all-cause death|313|||
130148708|NCT00097786|468504146|FG003|Overall Study|lost to follow-up for all-cause death|310|||
130148709|NCT02668822|468504147|FG000|Overall Study|Protocol Violation|2|||
130148710|NCT02668822|468504148|FG001|Overall Study|Protocol Violation|0|||
130148711|NCT02668822|468504147|FG000|Overall Study|Study Terminated by Sponsor|7|||
130148712|NCT02668822|468504148|FG001|Overall Study|Study Terminated by Sponsor|9|||
130148713|NCT01522950|468504149|FG000|Overall Study|Withdrawal by Subject|3|||
130148714|NCT01522950|468504150|FG001|Overall Study|Withdrawal by Subject|2|||
130148715|NCT01522950|468504151|FG002|Overall Study|Withdrawal by Subject|1|||
130148716|NCT01522950|468504149|FG000|Overall Study|Adverse Event|3|||
130148717|NCT01522950|468504150|FG001|Overall Study|Adverse Event|1|||
130148718|NCT01522950|468504151|FG002|Overall Study|Adverse Event|1|||
130148719|NCT01522950|468504149|FG000|Overall Study|Protocol Violation|0|||
130148720|NCT01522950|468504150|FG001|Overall Study|Protocol Violation|0|||
130148721|NCT01522950|468504151|FG002|Overall Study|Protocol Violation|2|||
129978508|NCT01876901|467883719|FG001|Overall Study|No or other surgical intervention|5|||
130148722|NCT01522950|468504149|FG000|Overall Study|Death|0|||
130148723|NCT01522950|468504150|FG001|Overall Study|Death|1|||
130148724|NCT01522950|468504151|FG002|Overall Study|Death|1|||
129978509|NCT01598662|467883720|FG000|Overall Study|Lost to Follow-up|10|||
129978510|NCT01598662|467883721|FG001|Overall Study|Lost to Follow-up|17|||
129978511|NCT01598662|467883720|FG000|Overall Study|Physician Decision|1|||
130148725|NCT01522950|468504149|FG000|Overall Study|Study Medication Sensitivity|0|||
130148726|NCT01522950|468504150|FG001|Overall Study|Study Medication Sensitivity|1|||
130148727|NCT01522950|468504151|FG002|Overall Study|Study Medication Sensitivity|0|||
129978512|NCT01598662|467883721|FG001|Overall Study|Physician Decision|2|||
130148728|NCT01844531|468504152|FG000|Overall Study|Withdrawal by Subject|0|||
130148729|NCT01844531|468504153|FG001|Overall Study|Withdrawal by Subject|1|||
130148730|NCT01844531|468504154|FG002|Overall Study|Withdrawal by Subject|0|||
130148731|NCT01844531|468504155|FG003|Overall Study|Withdrawal by Subject|0|||
130148732|NCT02000531|468504157|FG000|Overall Study|Lost to Follow-up|1|||
130148733|NCT02000531|468504158|FG001|Overall Study|Lost to Follow-up|0|||
130148734|NCT02000531|468504157|FG000|Overall Study|Discontinued due to data cut-off|3|||
130148735|NCT02000531|468504158|FG001|Overall Study|Discontinued due to data cut-off|8|||
130148736|NCT01345318|468504161|FG000|Overall Study|Adverse Event|16|||
130148737|NCT01345318|468504161|FG000|Overall Study|Lack of Efficacy|17|||
130148738|NCT01345318|468504161|FG000|Overall Study|Lost to Follow-up|2|||
130148739|NCT01345318|468504161|FG000|Overall Study|Protocol Violation|1|||
130148740|NCT01345318|468504161|FG000|Overall Study|Withdrawal by Subject|41|||
130148741|NCT01345318|468504161|FG000|Overall Study|Other|3|||
130148742|NCT00317642|468504162|FG000|Overall Study|Not Received Either Study Drug|1|||
130148743|NCT00317642|468504163|FG001|Overall Study|Not Received Either Study Drug|3|||
130148744|NCT00317642|468504162|FG000|Overall Study|Physician Decision|15|||
130148745|NCT00317642|468504163|FG001|Overall Study|Physician Decision|7|||
130148746|NCT00317642|468504162|FG000|Overall Study|Participant declined treatment|14|||
130148747|NCT00317642|468504163|FG001|Overall Study|Participant declined treatment|3|||
130148748|NCT00317642|468504162|FG000|Overall Study|Adverse Event|17|||
130148749|NCT00317642|468504163|FG001|Overall Study|Adverse Event|5|||
130148750|NCT00317642|468504162|FG000|Overall Study|Treatment Failure|56|||
130148751|NCT00317642|468504163|FG001|Overall Study|Treatment Failure|102|||
130148752|NCT00317642|468504162|FG000|Overall Study|Disease Recurrence|1|||
130148753|NCT00317642|468504163|FG001|Overall Study|Disease Recurrence|2|||
130148754|NCT00317642|468504162|FG000|Overall Study|Death|14|||
130148755|NCT00317642|468504163|FG001|Overall Study|Death|7|||
130148756|NCT00317642|468504162|FG000|Overall Study|Not Continue to Consolidation|2|||
130148757|NCT00317642|468504163|FG001|Overall Study|Not Continue to Consolidation|0|||
130148758|NCT00317642|468504162|FG000|Overall Study|Withdrawal by Subject|0|||
130148759|NCT00317642|468504163|FG001|Overall Study|Withdrawal by Subject|1|||
130148760|NCT00317642|468504162|FG000|Overall Study|Referred For Transplantation|1|||
130148761|NCT00317642|468504163|FG001|Overall Study|Referred For Transplantation|0|||
130148762|NCT00317642|468504162|FG000|Overall Study|AML Not Centrally Confirmed|1|||
130148763|NCT00317642|468504163|FG001|Overall Study|AML Not Centrally Confirmed|5|||
130148764|NCT01239472|468504168|FG000|Overall Study|Withdrawal by Subject|5|||
130148765|NCT01239472|468504169|FG001|Overall Study|Withdrawal by Subject|1|||
130148766|NCT01239472|468504168|FG000|Overall Study|Adverse Event|0|||
130148767|NCT01239472|468504169|FG001|Overall Study|Adverse Event|1|||
130148768|NCT01239472|468504168|FG000|Overall Study|Lack of Efficacy|0|||
130148769|NCT01239472|468504169|FG001|Overall Study|Lack of Efficacy|1|||
130148770|NCT01049412|468504173|FG000|Period I|Withdrawal by Subject|4|||
130148771|NCT01049412|468504174|FG001|Period I|Withdrawal by Subject|6|||
130148772|NCT01049412|468504173|FG000|Period I|Lost to Follow-up|2|||
130148773|NCT01049412|468504174|FG001|Period I|Lost to Follow-up|2|||
130148774|NCT01049412|468504173|FG000|Period I|Physician Decision|0|||
130148775|NCT01049412|468504174|FG001|Period I|Physician Decision|3|||
130148776|NCT01049412|468504173|FG000|Period I|Protocol Violation|1|||
130148777|NCT01049412|468504174|FG001|Period I|Protocol Violation|2|||
130148778|NCT01049412|468504173|FG000|Period I|Adverse Event|1|||
130148779|NCT01049412|468504174|FG001|Period I|Adverse Event|0|||
130148780|NCT01049412|468504173|FG000|Period II|Withdrawal by Subject|2|||
130148781|NCT01049412|468504174|FG001|Period II|Withdrawal by Subject|3|||
130148782|NCT01049412|468504173|FG000|Period II|Adverse Event|1|||
130148783|NCT01049412|468504174|FG001|Period II|Adverse Event|0|||
130148784|NCT01049412|468504173|FG000|Period II|Lost to Follow-up|1|||
130148785|NCT01049412|468504174|FG001|Period II|Lost to Follow-up|0|||
130148786|NCT01280617|468504175|FG000|Overall Study|Adverse Event|0|||
130148787|NCT01280617|468504176|FG001|Overall Study|Adverse Event|1|||
130148788|NCT05966090|468504177|FG000|Overall Study|Lost to Follow-up|6|||
130148789|NCT05966090|468504178|FG001|Overall Study|Lost to Follow-up|6|||
130148790|NCT05966090|468504177|FG000|Overall Study|Adverse Event|1|||
130148791|NCT05966090|468504178|FG001|Overall Study|Adverse Event|1|||
130148792|NCT05966090|468504177|FG000|Overall Study|Withdrawal by Subject|1|||
130148793|NCT05966090|468504178|FG001|Overall Study|Withdrawal by Subject|1|||
130148794|NCT05966090|468504177|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130148795|NCT05966090|468504178|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130148796|NCT05966090|468504177|FG000|Overall Study|Other|1|||
130148797|NCT05966090|468504178|FG001|Overall Study|Other|1|||
130148798|NCT03756883|468504179|FG000|Overall Study|Adverse Event|2|||
130148799|NCT03756883|468504180|FG001|Overall Study|Adverse Event|2|||
130148800|NCT03756883|468504181|FG002|Overall Study|Adverse Event|2|||
130148801|NCT03756883|468504179|FG000|Overall Study|Lack of Efficacy|0|||
130148802|NCT03756883|468504180|FG001|Overall Study|Lack of Efficacy|1|||
130148803|NCT03756883|468504181|FG002|Overall Study|Lack of Efficacy|2|||
130148804|NCT03756883|468504179|FG000|Overall Study|Lost to Follow-up|3|||
130148805|NCT03756883|468504180|FG001|Overall Study|Lost to Follow-up|3|||
130148806|NCT03756883|468504181|FG002|Overall Study|Lost to Follow-up|0|||
130148807|NCT03756883|468504179|FG000|Overall Study|Protocol Violation|2|||
130148808|NCT03756883|468504180|FG001|Overall Study|Protocol Violation|0|||
130148809|NCT03756883|468504181|FG002|Overall Study|Protocol Violation|1|||
130148810|NCT03756883|468504179|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
130148811|NCT03756883|468504180|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
130148812|NCT03756883|468504181|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
130148813|NCT03756883|468504179|FG000|Overall Study|Withdrawal by Subject|4|||
130148814|NCT03756883|468504180|FG001|Overall Study|Withdrawal by Subject|1|||
130148815|NCT03756883|468504181|FG002|Overall Study|Withdrawal by Subject|0|||
130148816|NCT03756883|468504179|FG000|Overall Study|Other Reasons|2|||
130148817|NCT03756883|468504180|FG001|Overall Study|Other Reasons|4|||
130148818|NCT03756883|468504181|FG002|Overall Study|Other Reasons|0|||
130148819|NCT00337428|468504182|FG000|Overall Study|Withdrawal by Subject|1|||
130148820|NCT00337428|468504183|FG001|Overall Study|Withdrawal by Subject|2|||
130148821|NCT00337428|468504182|FG000|Overall Study|Lack of Time|1|||
130148822|NCT00337428|468504183|FG001|Overall Study|Lack of Time|1|||
130148823|NCT00337428|468504182|FG000|Overall Study|Unwilling to Continue|1|||
130148824|NCT00337428|468504183|FG001|Overall Study|Unwilling to Continue|0|||
130148825|NCT00337428|468504182|FG000|Overall Study|Anorexia|1|||
130148826|NCT00337428|468504183|FG001|Overall Study|Anorexia|0|||
130148827|NCT00529217|468504190|FG000|Overall Study|Lack of Efficacy|2|||
130148828|NCT00529217|468504190|FG000|Overall Study|Unable to adhere to study schedule|2|||
130148829|NCT01999894|468504191|FG000|Overall Study|Adverse Event|9|||
130148830|NCT01999894|468504191|FG000|Overall Study|Lack of Efficacy|5|||
130148831|NCT01999894|468504191|FG000|Overall Study|Protocol Violation|1|||
130148832|NCT01999894|468504191|FG000|Overall Study|Withdrawal by Subject|7|||
130148833|NCT01999894|468504191|FG000|Overall Study|Lost to Follow-up|10|||
130148834|NCT01999894|468504191|FG000|Overall Study|Other Reason|3|||
130148835|NCT01999894|468504191|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
130148836|NCT01098110|468504192|FG000|Overall Study|Withdrawal by Subject|14|||
130148837|NCT01098110|468504193|FG001|Overall Study|Withdrawal by Subject|24|||
130148838|NCT01098110|468504194|FG002|Overall Study|Withdrawal by Subject|19|||
130148839|NCT01098110|468504192|FG000|Overall Study|Adverse Event|30|||
130148840|NCT01098110|468504193|FG001|Overall Study|Adverse Event|32|||
130148841|NCT01098110|468504194|FG002|Overall Study|Adverse Event|43|||
130148842|NCT01098110|468504192|FG000|Overall Study|Lack of Efficacy|13|||
130148843|NCT01098110|468504193|FG001|Overall Study|Lack of Efficacy|9|||
130148844|NCT01098110|468504194|FG002|Overall Study|Lack of Efficacy|27|||
130148845|NCT01098110|468504192|FG000|Overall Study|Other|4|||
130148846|NCT01098110|468504193|FG001|Overall Study|Other|7|||
130148847|NCT01098110|468504194|FG002|Overall Study|Other|5|||
130148848|NCT01098110|468504192|FG000|Overall Study|Untreated|1|||
130148849|NCT01098110|468504193|FG001|Overall Study|Untreated|1|||
130148850|NCT01098110|468504194|FG002|Overall Study|Untreated|0|||
130148851|NCT00263887|468504197|FG000|Overall Study|Withdrawal by Subject|1|||
130148852|NCT00263887|468504198|FG001|Overall Study|Withdrawal by Subject|1|||
130148853|NCT00263887|468504197|FG000|Overall Study|Lung transplantation|1|||
130148854|NCT00263887|468504198|FG001|Overall Study|Lung transplantation|2|||
130148855|NCT00263887|468504197|FG000|Overall Study|Too ill to attend visit|1|||
130148856|NCT00263887|468504198|FG001|Overall Study|Too ill to attend visit|0|||
130148857|NCT00263887|468504197|FG000|Overall Study|Adverse Event|0|||
130148858|NCT00263887|468504198|FG001|Overall Study|Adverse Event|2|||
130148859|NCT00263887|468504197|FG000|Overall Study|Disease progression|0|||
130148860|NCT00263887|468504198|FG001|Overall Study|Disease progression|1|||
130148861|NCT00263887|468504197|FG000|Overall Study|Lack of Efficacy|0|||
130148862|NCT00263887|468504198|FG001|Overall Study|Lack of Efficacy|1|||
130148863|NCT00779402|468504199|FG000|Treatment Phase 1|Disease Progression|1|||
130148864|NCT00779402|468504200|FG001|Treatment Phase 1|Disease Progression|0|||
130148865|NCT00779402|468504199|FG000|Treatment Phase 1|Adverse Event|2|||
130148866|NCT00779402|468504200|FG001|Treatment Phase 1|Adverse Event|0|||
130148867|NCT00779402|468504199|FG000|Treatment Phase 1|Protocol Violation|1|||
130148868|NCT00779402|468504200|FG001|Treatment Phase 1|Protocol Violation|0|||
130148869|NCT00779402|468504199|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
130148870|NCT00779402|468504200|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
130148871|NCT00779402|468504199|FG000|Treatment Phase 1|Lost to Follow-up|0|||
130148872|NCT00779402|468504200|FG001|Treatment Phase 1|Lost to Follow-up|1|||
130148873|NCT00779402|468504199|FG000|Treatment Phase 1|Death|0|||
130148874|NCT00779402|468504200|FG001|Treatment Phase 1|Death|1|||
130148875|NCT00779402|468504199|FG000|Treatment Phase 1|Intercurrent Illness|1|||
130148876|NCT00779402|468504200|FG001|Treatment Phase 1|Intercurrent Illness|1|||
130148877|NCT00779402|468504199|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
130148878|NCT00779402|468504200|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
130148879|NCT00779402|468504199|FG000|Treatment Phase 1|Other|4|||
130148880|NCT00779402|468504200|FG001|Treatment Phase 1|Other|2|||
130148881|NCT00779402|468504199|FG000|Treatment Phase 1|Closure of Study|3|||
130148882|NCT00779402|468504200|FG001|Treatment Phase 1|Closure of Study|2|||
130148883|NCT00779402|468504199|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
130148884|NCT00779402|468504200|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
130148885|NCT00779402|468504199|FG000|Surveillance Phase|Protocol Violation|0|||
130148886|NCT00779402|468504200|FG001|Surveillance Phase|Protocol Violation|1|||
130148887|NCT00779402|468504199|FG000|Surveillance Phase|Patient refused to continue|22|||
130148888|NCT00779402|468504200|FG001|Surveillance Phase|Patient refused to continue|14|||
130148889|NCT00779402|468504199|FG000|Surveillance Phase|Lost to Follow-up|2|||
130148890|NCT00779402|468504200|FG001|Surveillance Phase|Lost to Follow-up|1|||
130148891|NCT00779402|468504199|FG000|Surveillance Phase|Death|0|||
130148892|NCT00779402|468504200|FG001|Surveillance Phase|Death|1|||
130148893|NCT00779402|468504199|FG000|Surveillance Phase|Intercurrent Illness|2|||
130148894|NCT00779402|468504200|FG001|Surveillance Phase|Intercurrent Illness|0|||
130148895|NCT00779402|468504199|FG000|Surveillance Phase|Other|5|||
130148896|NCT00779402|468504200|FG001|Surveillance Phase|Other|5|||
130148897|NCT00779402|468504199|FG000|Surveillance Phase|Withdrawal by Subject|4|||
130148898|NCT00779402|468504200|FG001|Surveillance Phase|Withdrawal by Subject|1|||
130148899|NCT00779402|468504199|FG000|Surveillance Phase|Closure of study|5|||
130148900|NCT00779402|468504200|FG001|Surveillance Phase|Closure of study|6|||
130148901|NCT00779402|468504199|FG000|Surveillance Phase|Completed Protocol Visits|3|||
130148902|NCT00779402|468504200|FG001|Surveillance Phase|Completed Protocol Visits|2|||
130148903|NCT00779402|468504199|FG000|Long-term Follow-up|Patient refused to continue|2|||
130148904|NCT00779402|468504200|FG001|Long-term Follow-up|Patient refused to continue|0|||
130148905|NCT00779402|468504199|FG000|Long-term Follow-up|Other|5|||
130148906|NCT00779402|468504200|FG001|Long-term Follow-up|Other|0|||
130148907|NCT00779402|468504199|FG000|Long-term Follow-up|Closure of Study|8|||
130148908|NCT00779402|468504200|FG001|Long-term Follow-up|Closure of Study|4|||
130148909|NCT00779402|468504199|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
130148910|NCT00779402|468504200|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
130148911|NCT01519947|468504205|FG000|Overall Study|Death|0|||
130148912|NCT01519947|468504206|FG001|Overall Study|Death|0|||
130148913|NCT01519947|468504207|FG002|Overall Study|Death|0|||
130148914|NCT01519947|468504208|FG003|Overall Study|Death|1|||
130148915|NCT01519947|468504205|FG000|Overall Study|Protocol Violation|0|||
130148916|NCT01519947|468504206|FG001|Overall Study|Protocol Violation|0|||
130148917|NCT01519947|468504207|FG002|Overall Study|Protocol Violation|2|||
130148918|NCT01519947|468504208|FG003|Overall Study|Protocol Violation|1|||
130148919|NCT01519947|468504205|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
130148920|NCT01519947|468504206|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
130148921|NCT01519947|468504207|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
130148922|NCT01519947|468504208|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
130148923|NCT01519947|468504205|FG000|Overall Study|Development of Anemia|0|||
130148924|NCT01519947|468504206|FG001|Overall Study|Development of Anemia|1|||
130148925|NCT01519947|468504207|FG002|Overall Study|Development of Anemia|0|||
130148926|NCT01519947|468504208|FG003|Overall Study|Development of Anemia|1|||
130148927|NCT01519947|468504205|FG000|Overall Study|Blood Transfusion|0|||
130148928|NCT01519947|468504206|FG001|Overall Study|Blood Transfusion|1|||
130148929|NCT01519947|468504207|FG002|Overall Study|Blood Transfusion|1|||
130148930|NCT01519947|468504208|FG003|Overall Study|Blood Transfusion|0|||
130148931|NCT01519947|468504205|FG000|Overall Study|Withdrawal by Subject|0|||
130148932|NCT01519947|468504206|FG001|Overall Study|Withdrawal by Subject|1|||
130148933|NCT01519947|468504207|FG002|Overall Study|Withdrawal by Subject|0|||
130148934|NCT01519947|468504208|FG003|Overall Study|Withdrawal by Subject|1|||
130148935|NCT01519947|468504205|FG000|Overall Study|Lost to Follow-up|0|||
130148936|NCT01519947|468504206|FG001|Overall Study|Lost to Follow-up|0|||
130148937|NCT01519947|468504207|FG002|Overall Study|Lost to Follow-up|3|||
130148938|NCT01519947|468504208|FG003|Overall Study|Lost to Follow-up|2|||
130148939|NCT01519947|468504205|FG000|Overall Study|Poor Response|1|||
130148940|NCT01519947|468504206|FG001|Overall Study|Poor Response|0|||
130148941|NCT01519947|468504207|FG002|Overall Study|Poor Response|0|||
130148942|NCT01519947|468504208|FG003|Overall Study|Poor Response|1|||
130148943|NCT01519947|468504205|FG000|Overall Study|Adverse Event|1|||
130148944|NCT01519947|468504206|FG001|Overall Study|Adverse Event|0|||
130148945|NCT01519947|468504207|FG002|Overall Study|Adverse Event|1|||
130148946|NCT01519947|468504208|FG003|Overall Study|Adverse Event|1|||
130148947|NCT02274948|468504213|FG000|Overall Study|Lost to Follow-up|28|||
130148948|NCT02274948|468504214|FG001|Overall Study|Lost to Follow-up|25|||
130148949|NCT02274948|468504213|FG000|Overall Study|Withdrawal by Subject|64|||
130148950|NCT02274948|468504214|FG001|Overall Study|Withdrawal by Subject|58|||
130148951|NCT02274948|468504213|FG000|Overall Study|Stopped on family Practitioner advice|2|||
130148952|NCT02274948|468504214|FG001|Overall Study|Stopped on family Practitioner advice|5|||
130148953|NCT02274948|468504213|FG000|Overall Study|Left the area|4|||
130148954|NCT02274948|468504214|FG001|Overall Study|Left the area|3|||
130148955|NCT00707434|468504215|FG000|Overall Study|Adverse Event|1|||
130148956|NCT01386125|468504216|FG000|Overall Study|Lost to Follow-up|3|||
130148957|NCT01386125|468504217|FG001|Overall Study|Lost to Follow-up|9|||
130148958|NCT01386125|468504216|FG000|Overall Study|Physician Decision|0|||
130148959|NCT01386125|468504217|FG001|Overall Study|Physician Decision|1|||
130148960|NCT01386125|468504216|FG000|Overall Study|Protocol Violation|5|||
130148961|NCT01386125|468504217|FG001|Overall Study|Protocol Violation|7|||
130148962|NCT01386125|468504216|FG000|Overall Study|Disease Progress|1|||
130148963|NCT01386125|468504217|FG001|Overall Study|Disease Progress|2|||
130148964|NCT01386125|468504216|FG000|Overall Study|Withdrawal by Subject|13|||
130148965|NCT01386125|468504217|FG001|Overall Study|Withdrawal by Subject|12|||
130148966|NCT01386125|468504216|FG000|Overall Study|Adverse Event|2|||
130148967|NCT01386125|468504217|FG001|Overall Study|Adverse Event|5|||
130148968|NCT01386125|468504216|FG000|Overall Study|Lack of Efficacy|0|||
130148969|NCT01386125|468504217|FG001|Overall Study|Lack of Efficacy|1|||
130148970|NCT01386125|468504216|FG000|Overall Study|Participant Leaving Country|1|||
130148971|NCT01386125|468504217|FG001|Overall Study|Participant Leaving Country|0|||
130148972|NCT01808248|468504218|FG000|Overall Study|Lack of Efficacy|3|||
130148973|NCT01808248|468504218|FG000|Overall Study|Withdrawal by Subject|1|||
130148974|NCT01808248|468504218|FG000|Overall Study|Lost to Follow-up|1|||
130148975|NCT03507686|468504220|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
130148976|NCT03507686|468504221|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
130148977|NCT03507686|468504220|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
130148978|NCT03507686|468504221|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
130148979|NCT03507686|468504220|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
130148980|NCT03507686|468504221|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
130148981|NCT03507686|468504220|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
130148982|NCT03507686|468504221|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
130148983|NCT03507686|468504220|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
130148984|NCT03507686|468504221|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
130148985|NCT03507686|468504220|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
130148986|NCT03507686|468504221|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
130148987|NCT02508116|468504222|FG000|Overall Study|Lost to Follow-up|2|||
130148988|NCT02508116|468504223|FG001|Overall Study|Lost to Follow-up|3|||
130148989|NCT02508116|468504222|FG000|Overall Study|Withdrawal by Subject|3|||
130148990|NCT02508116|468504223|FG001|Overall Study|Withdrawal by Subject|2|||
130148991|NCT02508116|468504222|FG000|Overall Study|Protocol Violation|1|||
130148992|NCT02508116|468504223|FG001|Overall Study|Protocol Violation|2|||
130148993|NCT02508116|468504222|FG000|Overall Study|Physician Decision|2|||
130148994|NCT02508116|468504223|FG001|Overall Study|Physician Decision|0|||
130148995|NCT00109850|468504226|FG000|Overall Study|Adverse Event|1|||
130148996|NCT00109850|468504226|FG000|Overall Study|Death|2|||
130148997|NCT00109850|468504226|FG000|Overall Study|Ineligible|1|||
130148998|NCT00476593|468504227|FG000|Overall Study|Lost to Follow-up|10|||
130148999|NCT00476593|468504228|FG001|Overall Study|Lost to Follow-up|2|||
130149000|NCT00476593|468504229|FG002|Overall Study|Lost to Follow-up|8|||
130149001|NCT00476593|468504230|FG003|Overall Study|Lost to Follow-up|22|||
130149002|NCT00983528|468504231|FG000|Overall Study|Death|4|||
130149003|NCT00983528|468504231|FG000|Overall Study|Lost to Follow-up|1|||
130149004|NCT00983528|468504231|FG000|Overall Study|Study Terminated|1|||
130149005|NCT00575380|468504232|FG000|Overall Study|Withdrawal by Subject|1|||
130149006|NCT00575380|468504233|FG001|Overall Study|Withdrawal by Subject|0|||
130149007|NCT00575380|468504232|FG000|Overall Study|Adverse Event|0|||
130149008|NCT00575380|468504233|FG001|Overall Study|Adverse Event|1|||
130149009|NCT00575380|468504232|FG000|Overall Study|Various|0|||
130149010|NCT00575380|468504233|FG001|Overall Study|Various|2|||
130149011|NCT00559364|468504234|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
130149012|NCT00559364|468504235|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
130149013|NCT00330460|468504236|FG000|Overall Study|Physician Decision|1|||
130149014|NCT00330460|468504237|FG001|Overall Study|Physician Decision|0|||
130149015|NCT00330460|468504236|FG000|Overall Study|Adverse Event|10|||
130149016|NCT00330460|468504237|FG001|Overall Study|Adverse Event|8|||
130149017|NCT00330460|468504236|FG000|Overall Study|Withdrawal by Subject|18|||
130149018|NCT00330460|468504237|FG001|Overall Study|Withdrawal by Subject|17|||
130149019|NCT00330460|468504236|FG000|Overall Study|Death|1|||
130149020|NCT00330460|468504237|FG001|Overall Study|Death|1|||
130149021|NCT00330460|468504236|FG000|Overall Study|Ineligibility determined|1|||
130149022|NCT00330460|468504237|FG001|Overall Study|Ineligibility determined|3|||
130149023|NCT00330460|468504236|FG000|Overall Study|Lost to Follow-up|8|||
130149024|NCT00330460|468504237|FG001|Overall Study|Lost to Follow-up|3|||
130149025|NCT00330460|468504236|FG000|Overall Study|Noncompliance|2|||
130149026|NCT00330460|468504237|FG001|Overall Study|Noncompliance|1|||
130149027|NCT00330460|468504236|FG000|Overall Study|Other|1|||
130149028|NCT00330460|468504237|FG001|Overall Study|Other|0|||
130149029|NCT00388037|468504238|FG000|Overall Study|Protocol Violation|1|||
130149030|NCT04314843|468504243|FG000|Overall Study|Death|2|||
130149031|NCT04314843|468504244|FG001|Overall Study|Death|2|||
130149032|NCT04314843|468504243|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
130149033|NCT04314843|468504244|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
130149034|NCT01644149|468504251|FG000|Overall Study|Withdrawal by Subject|1|||
130149035|NCT01644149|468504252|FG001|Overall Study|Withdrawal by Subject|0|||
130149036|NCT01644149|468504251|FG000|Overall Study|Lost to Follow-up|3|||
130149037|NCT01644149|468504252|FG001|Overall Study|Lost to Follow-up|1|||
130149038|NCT05766787|468504253|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
130149039|NCT05766787|468504254|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
130149040|NCT05766787|468504253|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
130149041|NCT05766787|468504254|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
130149042|NCT05766787|468504253|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
130149043|NCT05766787|468504254|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
130149044|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
130149045|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
130149046|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
130149047|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
130149048|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
130149049|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
130149050|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
130149051|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
130149052|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
130149053|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
130149054|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
130149055|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
130149056|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
130149057|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
130149058|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
130149059|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
130149060|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
130149061|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
130149062|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
130149063|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
130149064|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
130149065|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
130149066|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
130149067|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
130149068|NCT01435928|468504255|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
130149069|NCT01435928|468504256|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
130149070|NCT01435928|468504257|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
130149071|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
130149072|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
130149073|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
130149074|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
130149075|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
130149076|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
130149077|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
130149078|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
130149079|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
130149080|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
130149081|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
130149082|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
130149083|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
130149084|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
130149085|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
130149086|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
130149087|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
130149088|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
130149089|NCT01435928|468504255|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
130149090|NCT01435928|468504256|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
130149091|NCT01435928|468504257|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
130149092|NCT00442546|468504260|FG000|Overall Study|Adverse Event|11|||
130149093|NCT00442546|468504261|FG001|Overall Study|Adverse Event|17|||
130149094|NCT00442546|468504262|FG002|Overall Study|Adverse Event|13|||
130149095|NCT00442546|468504260|FG000|Overall Study|Lost to Follow-up|1|||
130149096|NCT00442546|468504261|FG001|Overall Study|Lost to Follow-up|2|||
130149097|NCT00442546|468504262|FG002|Overall Study|Lost to Follow-up|1|||
130149098|NCT00442546|468504260|FG000|Overall Study|Other|4|||
130149099|NCT00442546|468504261|FG001|Overall Study|Other|9|||
130149100|NCT00442546|468504262|FG002|Overall Study|Other|6|||
130149101|NCT00442546|468504260|FG000|Overall Study|Withdrawal by Subject|5|||
130149102|NCT00442546|468504261|FG001|Overall Study|Withdrawal by Subject|5|||
130149103|NCT00442546|468504262|FG002|Overall Study|Withdrawal by Subject|7|||
130149104|NCT00442546|468504260|FG000|Overall Study|Randomized But Not Treated|5|||
130149105|NCT00442546|468504261|FG001|Overall Study|Randomized But Not Treated|4|||
130149106|NCT00442546|468504262|FG002|Overall Study|Randomized But Not Treated|6|||
130149107|NCT01557582|468504263|FG000|Overall Study|Protocol Violation|4|||
130149108|NCT01557582|468504263|FG000|Overall Study|Operator error|2|||
130149109|NCT03840382|468504264|FG000|Overall Study|Lost to Follow-up|11|||
130149110|NCT02843659|468504265|FG000|Overall Study|Subject Withdrew Consent|0|||
130149111|NCT02843659|468504266|FG001|Overall Study|Subject Withdrew Consent|0|||
130149112|NCT02843659|468504267|FG002|Overall Study|Subject Withdrew Consent|1|||
130149113|NCT02843659|468504265|FG000|Overall Study|Administrative Reason by Sponsor|4|||
130149114|NCT02843659|468504266|FG001|Overall Study|Administrative Reason by Sponsor|5|||
130149115|NCT02843659|468504267|FG002|Overall Study|Administrative Reason by Sponsor|4|||
130149116|NCT02843659|468504265|FG000|Overall Study|Adverse Event|0|||
130149117|NCT02843659|468504266|FG001|Overall Study|Adverse Event|1|||
130149118|NCT02843659|468504267|FG002|Overall Study|Adverse Event|0|||
130149119|NCT02413294|468504268|FG000|Overall Study|Withdrawal by Subject|1|||
130149120|NCT00802178|468506586|FG000|Overall Study|Lack of Efficacy|36|||
130149121|NCT00802178|468506586|FG000|Overall Study|Insufficient tolerability (IT)|17|||
130149122|NCT00802178|468506586|FG000|Overall Study|Withdrawal by Subject|18|||
130149123|NCT00802178|468506586|FG000|Overall Study|Other|32|||
130149124|NCT00802178|468506586|FG000|Overall Study|Lack of efficacy and patient wish|1|||
130149125|NCT00802178|468506586|FG000|Overall Study|IT and patient wish|8|||
130149126|NCT00802178|468506586|FG000|Overall Study|Patients wish and other reason|1|||
130149127|NCT04100096|468506588|FG000|Overall Study|Adverse Event|19|||
130149128|NCT04100096|468506589|FG001|Overall Study|Adverse Event|7|||
130149129|NCT04100096|468506588|FG000|Overall Study|Lack of Efficacy|0|||
130149130|NCT04100096|468506589|FG001|Overall Study|Lack of Efficacy|1|||
130149131|NCT04100096|468506588|FG000|Overall Study|Lost to Follow-up|13|||
130149132|NCT04100096|468506589|FG001|Overall Study|Lost to Follow-up|11|||
130149133|NCT04100096|468506588|FG000|Overall Study|Non-Compliance With Study Drug|1|||
130149134|NCT04100096|468506589|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130149135|NCT04100096|468506588|FG000|Overall Study|Protocol Deviation|1|||
130149136|NCT04100096|468506589|FG001|Overall Study|Protocol Deviation|1|||
130149137|NCT04100096|468506588|FG000|Overall Study|Withdrawal by Participant|13|||
130149138|NCT04100096|468506589|FG001|Overall Study|Withdrawal by Participant|15|||
130149139|NCT00831233|468506593|FG000|Overall Study|Adverse Event|0|||
130149140|NCT00831233|468506594|FG001|Overall Study|Adverse Event|1|||
130149141|NCT00831233|468506593|FG000|Overall Study|Protocol Violation|1|||
130149142|NCT00831233|468506594|FG001|Overall Study|Protocol Violation|0|||
130149143|NCT00831233|468506593|FG000|Overall Study|Selection Criteria Not Met|2|||
130149144|NCT00831233|468506594|FG001|Overall Study|Selection Criteria Not Met|0|||
130149145|NCT02211014|468506595|FG000|Overall Study|Adverse Event|0|||
130149146|NCT02211014|468506596|FG001|Overall Study|Adverse Event|2|||
130149147|NCT02211014|468506595|FG000|Overall Study|Physician Decision|1|||
130149148|NCT02211014|468506596|FG001|Overall Study|Physician Decision|2|||
130149149|NCT02211014|468506595|FG000|Overall Study|Started another cancer therapy|1|||
130149150|NCT02211014|468506596|FG001|Overall Study|Started another cancer therapy|0|||
130149151|NCT02211014|468506595|FG000|Overall Study|Withdrawal by Subject|0|||
130149152|NCT02211014|468506596|FG001|Overall Study|Withdrawal by Subject|1|||
130149153|NCT02211014|468506595|FG000|Overall Study|In agreement with patient, no benefit|0|||
130149154|NCT02211014|468506596|FG001|Overall Study|In agreement with patient, no benefit|1|||
130149155|NCT01796964|468506603|FG000|Overall Study|Adverse Event|1|||
130149156|NCT01796964|468506604|FG001|Overall Study|Adverse Event|1|||
130149157|NCT01796964|468506603|FG000|Overall Study|Death|1|||
130149158|NCT01796964|468506604|FG001|Overall Study|Death|0|||
130149159|NCT01796964|468506603|FG000|Overall Study|Protocol Violation|0|||
130149160|NCT01796964|468506604|FG001|Overall Study|Protocol Violation|1|||
130149161|NCT01796964|468506603|FG000|Overall Study|Withdrawal by Subject|1|||
130149162|NCT01796964|468506604|FG001|Overall Study|Withdrawal by Subject|1|||
130149163|NCT04025684|468506605|FG000|Overall Study|Withdrawal by Subject|1|||
129978513|NCT01598662|467883720|FG000|Overall Study|IUD expelled before month 6|0|||
129978514|NCT01598662|467883721|FG001|Overall Study|IUD expelled before month 6|2|||
129978515|NCT00643617|467883722|FG000|Overall Study|Death|6|||
129978516|NCT00643617|467883723|FG001|Overall Study|Death|9|||
129978517|NCT00643617|467883722|FG000|Overall Study|Lost to Follow-up|42|||
129978518|NCT00643617|467883723|FG001|Overall Study|Lost to Follow-up|51|||
129978519|NCT02683785|467883726|FG000|Overall Study|Withdrawal by Subject|1|||
129978520|NCT02683785|467883727|FG001|Overall Study|Withdrawal by Subject|1|||
129978521|NCT02683785|467883726|FG000|Overall Study|Lost to Follow-up|0|||
129978522|NCT02683785|467883727|FG001|Overall Study|Lost to Follow-up|1|||
129978523|NCT02683785|467883726|FG000|Overall Study|Adverse Event|0|||
130149164|NCT04025684|468506606|FG001|Overall Study|Withdrawal by Subject|1|||
129978524|NCT02683785|467883727|FG001|Overall Study|Adverse Event|2|||
129978525|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
129978526|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
130149165|NCT04025684|468506607|FG002|Overall Study|Withdrawal by Subject|0|||
130149166|NCT04025684|468506608|FG003|Overall Study|Withdrawal by Subject|0|||
130149167|NCT04025684|468506605|FG000|Overall Study|Multiple reasons|1|||
130149168|NCT04025684|468506606|FG001|Overall Study|Multiple reasons|3|||
130149169|NCT04025684|468506607|FG002|Overall Study|Multiple reasons|0|||
130149170|NCT04025684|468506608|FG003|Overall Study|Multiple reasons|1|||
130149171|NCT02070757|468506609|FG000|Overall Study|Adverse Event|107|||
130149172|NCT02070757|468506610|FG001|Overall Study|Adverse Event|99|||
130149173|NCT02070757|468506609|FG000|Overall Study|Lost to Follow-up|7|||
130149174|NCT02070757|468506610|FG001|Overall Study|Lost to Follow-up|4|||
130149175|NCT02070757|468506609|FG000|Overall Study|Protocol Violation|0|||
130149176|NCT02070757|468506610|FG001|Overall Study|Protocol Violation|4|||
130149177|NCT02070757|468506609|FG000|Overall Study|Withdrawal by Subject|1|||
130149178|NCT02070757|468506610|FG001|Overall Study|Withdrawal by Subject|3|||
130149179|NCT02070757|468506609|FG000|Overall Study|Investigator Decision|0|||
130149180|NCT02070757|468506610|FG001|Overall Study|Investigator Decision|2|||
130149181|NCT02070757|468506609|FG000|Overall Study|Discharged from Study Hospital|2|||
130149182|NCT02070757|468506610|FG001|Overall Study|Discharged from Study Hospital|2|||
130149183|NCT01546922|468506611|FG000|First Period of 10 Weeks|Protocol Violation|3|||
130149184|NCT01546922|468506612|FG001|First Period of 10 Weeks|Protocol Violation|1|||
130149185|NCT01546922|468506611|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
130149186|NCT01546922|468506612|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
130149187|NCT01546922|468506611|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
130149188|NCT01546922|468506612|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
130149189|NCT01546922|468506611|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
130149190|NCT01546922|468506612|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
130149191|NCT01546922|468506611|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
130149192|NCT01546922|468506612|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
130149193|NCT00792623|468506625|FG000|Overall Study|Adverse Event|2|||
130149194|NCT00792623|468506625|FG000|Overall Study|Withdrawal by Subject|5|||
130149195|NCT02744755|468506626|FG000|Study Period 1|Protocol Violation|2|||
130149196|NCT02744755|468506627|FG001|Study Period 1|Protocol Violation|1|||
130149197|NCT02744755|468506626|FG000|Study Period 1|not defined|0|||
130149198|NCT02744755|468506627|FG001|Study Period 1|not defined|1|||
130149199|NCT02744755|468506626|FG000|Study Period 1|Pregnancy|1|||
130149200|NCT02744755|468506627|FG001|Study Period 1|Pregnancy|0|||
130149201|NCT02744755|468506626|FG000|Study Period 1|Adverse Event|1|||
130149202|NCT02744755|468506627|FG001|Study Period 1|Adverse Event|1|||
130149203|NCT02744755|468506626|FG000|Study Period 1|Lost to Follow-up|1|||
130149204|NCT02744755|468506627|FG001|Study Period 1|Lost to Follow-up|1|||
130149205|NCT02744755|468506626|FG000|Study Period 1|Lack of Efficacy|1|||
130149206|NCT02744755|468506627|FG001|Study Period 1|Lack of Efficacy|0|||
130149207|NCT02744755|468506626|FG000|Study Period 1|Withdrawal by Subject|8|||
130149208|NCT02744755|468506627|FG001|Study Period 1|Withdrawal by Subject|4|||
130149209|NCT02744755|468506626|FG000|Study Period 2|Adverse Event|5|||
130149210|NCT02744755|468506627|FG001|Study Period 2|Adverse Event|0|||
130149211|NCT02744755|468506626|FG000|Study Period 2|Protocol Violation|1|||
130149212|NCT02744755|468506627|FG001|Study Period 2|Protocol Violation|0|||
130149213|NCT02744755|468506626|FG000|Study Period 2|not defined|3|||
130149214|NCT02744755|468506627|FG001|Study Period 2|not defined|2|||
130149215|NCT02744755|468506626|FG000|Study Period 2|Lost to Follow-up|0|||
130149216|NCT02744755|468506627|FG001|Study Period 2|Lost to Follow-up|2|||
130149217|NCT02744755|468506626|FG000|Study Period 2|Withdrawal by Subject|2|||
130149218|NCT02744755|468506627|FG001|Study Period 2|Withdrawal by Subject|2|||
130149219|NCT02744755|468506626|FG000|Study Period 2|Lack of Efficacy|3|||
130149220|NCT02744755|468506627|FG001|Study Period 2|Lack of Efficacy|2|||
130149221|NCT00880087|468506628|FG000|Overall Study|Lost to Follow-up|0|||
130149222|NCT00880087|468506629|FG001|Overall Study|Lost to Follow-up|2|||
130149223|NCT02916693|468506630|FG000|Overall Study|Lost to Follow-up|7|||
130149232|NCT02001051|468506637|FG000|Overall Study|Deemed not eligible following enrollment|0|||
129978527|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
129978528|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
129978529|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
130149233|NCT02001051|468506638|FG001|Overall Study|Deemed not eligible following enrollment|1|||
130149234|NCT04205162|468506644|FG000|Overall Study|Lost to Follow-up|1|||
130149235|NCT04205162|468506645|FG001|Overall Study|Lost to Follow-up|0|||
130149236|NCT04205162|468506644|FG000|Overall Study|Withdrawal by Subject|2|||
130149237|NCT04205162|468506645|FG001|Overall Study|Withdrawal by Subject|0|||
130149238|NCT04205162|468506644|FG000|Overall Study|University closure due to COVID-19|1|||
130149239|NCT04205162|468506645|FG001|Overall Study|University closure due to COVID-19|0|||
130149240|NCT02147587|468506646|FG000|Overall Study|Adverse Event|9|||
130149241|NCT02147587|468506647|FG001|Overall Study|Adverse Event|4|||
130149242|NCT02147587|468506646|FG000|Overall Study|Lack of Efficacy|2|||
130149243|NCT02147587|468506647|FG001|Overall Study|Lack of Efficacy|1|||
130149244|NCT00530348|468506650|FG000|Overall Study|Adverse Event|5|||
130149245|NCT00530348|468506651|FG001|Overall Study|Adverse Event|1|||
130149246|NCT00530348|468506650|FG000|Overall Study|Death|0|||
130149247|NCT00530348|468506651|FG001|Overall Study|Death|1|||
130149248|NCT00530348|468506650|FG000|Overall Study|Lack of Efficacy|2|||
130149249|NCT00530348|468506651|FG001|Overall Study|Lack of Efficacy|0|||
130149250|NCT00530348|468506650|FG000|Overall Study|Lost to Follow-up|0|||
130149251|NCT00530348|468506651|FG001|Overall Study|Lost to Follow-up|2|||
130149252|NCT00530348|468506650|FG000|Overall Study|Physician Decision|1|||
130149253|NCT00530348|468506651|FG001|Overall Study|Physician Decision|2|||
130149254|NCT00530348|468506650|FG000|Overall Study|Pregnancy|1|||
130149255|NCT00530348|468506651|FG001|Overall Study|Pregnancy|0|||
130149256|NCT00530348|468506650|FG000|Overall Study|Withdrawal by Subject|12|||
130149257|NCT00530348|468506651|FG001|Overall Study|Withdrawal by Subject|12|||
130149258|NCT00530348|468506650|FG000|Overall Study|Randomised in error|1|||
130149259|NCT00530348|468506651|FG001|Overall Study|Randomised in error|0|||
130149260|NCT00530348|468506650|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
130149261|NCT00530348|468506651|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
130149262|NCT04364763|468506652|FG000|Overall Study|Death|1|||
130149263|NCT04364763|468506653|FG001|Overall Study|Death|2|||
130149264|NCT04364763|468506652|FG000|Overall Study|Lost to Follow-up|1|||
130149265|NCT04364763|468506653|FG001|Overall Study|Lost to Follow-up|0|||
130149266|NCT02359864|468506654|FG000|Overall Study|Withdrawal by Subject|1|||
130149267|NCT02359864|468506655|FG001|Overall Study|Withdrawal by Subject|0|||
130149268|NCT01740791|468506656|FG000|Overall Study|Randomized but never treated|5|||
130149269|NCT01740791|468506657|FG001|Overall Study|Randomized but never treated|3|||
130149270|NCT01740791|468506658|FG002|Overall Study|Randomized but never treated|2|||
130149271|NCT01740791|468506659|FG003|Overall Study|Randomized but never treated|2|||
130149272|NCT01740791|468506660|FG004|Overall Study|Randomized but never treated|1|||
130149273|NCT01740791|468506661|FG005|Overall Study|Randomized but never treated|3|||
130149274|NCT01740791|468506656|FG000|Overall Study|Lost to Follow-up|2|||
130149275|NCT01740791|468506657|FG001|Overall Study|Lost to Follow-up|0|||
130149276|NCT01740791|468506658|FG002|Overall Study|Lost to Follow-up|2|||
130149277|NCT01740791|468506659|FG003|Overall Study|Lost to Follow-up|3|||
130149278|NCT01740791|468506660|FG004|Overall Study|Lost to Follow-up|2|||
130149279|NCT01740791|468506661|FG005|Overall Study|Lost to Follow-up|3|||
130149280|NCT01740791|468506656|FG000|Overall Study|Withdrew Consent|4|||
130149281|NCT01740791|468506657|FG001|Overall Study|Withdrew Consent|0|||
130149282|NCT01740791|468506658|FG002|Overall Study|Withdrew Consent|1|||
130149283|NCT01740791|468506659|FG003|Overall Study|Withdrew Consent|2|||
130149284|NCT01740791|468506660|FG004|Overall Study|Withdrew Consent|0|||
130149285|NCT01740791|468506661|FG005|Overall Study|Withdrew Consent|3|||
130149286|NCT01740791|468506656|FG000|Overall Study|Investigator's discretion|1|||
130149287|NCT01740791|468506657|FG001|Overall Study|Investigator's discretion|0|||
130149288|NCT01740791|468506658|FG002|Overall Study|Investigator's discretion|1|||
130149289|NCT01740791|468506659|FG003|Overall Study|Investigator's discretion|0|||
130149290|NCT01740791|468506660|FG004|Overall Study|Investigator's discretion|0|||
130149291|NCT01740791|468506661|FG005|Overall Study|Investigator's discretion|1|||
130149292|NCT01740791|468506656|FG000|Overall Study|Adverse Event|0|||
130149293|NCT01740791|468506657|FG001|Overall Study|Adverse Event|0|||
130149294|NCT01740791|468506658|FG002|Overall Study|Adverse Event|0|||
130149295|NCT01740791|468506659|FG003|Overall Study|Adverse Event|0|||
130149296|NCT01740791|468506660|FG004|Overall Study|Adverse Event|0|||
130149297|NCT01740791|468506661|FG005|Overall Study|Adverse Event|1|||
130149298|NCT02020967|468506662|FG000|Overall Study|Withdrawal by Subject|51|||
130149299|NCT02663882|468506669|FG000|Overall Study|Lost to Follow-up|4|||
130149300|NCT02663882|468506670|FG001|Overall Study|Lost to Follow-up|2|||
130149301|NCT00602537|468506673|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
130149302|NCT00602537|468506674|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
130149303|NCT00602537|468506673|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
130149304|NCT00602537|468506674|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
130149305|NCT00602537|468506673|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
130149306|NCT00602537|468506674|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
130149307|NCT00602537|468506673|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
130149308|NCT00602537|468506674|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
130149309|NCT00602537|468506673|FG000|Follow Up Study Comparison|Adverse Event|1|||
130149310|NCT00602537|468506674|FG001|Follow Up Study Comparison|Adverse Event|0|||
130149311|NCT00602537|468506673|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
130149312|NCT00602537|468506674|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
130149313|NCT00602537|468506673|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
130149314|NCT00602537|468506674|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
130149315|NCT02539368|468506679|FG000|Overall Study|Death|4|||
130149316|NCT02539368|468506680|FG001|Overall Study|Death|2|||
130149317|NCT02539368|468506681|FG002|Overall Study|Death|1|||
130149318|NCT02539368|468506682|FG003|Overall Study|Death|0|||
130149319|NCT02539368|468506683|FG004|Overall Study|Death|0|||
130149320|NCT02539368|468506679|FG000|Overall Study|Withdrawal by Subject|44|||
130149321|NCT02539368|468506680|FG001|Overall Study|Withdrawal by Subject|35|||
130149322|NCT02539368|468506681|FG002|Overall Study|Withdrawal by Subject|9|||
130149323|NCT02539368|468506682|FG003|Overall Study|Withdrawal by Subject|1|||
130149324|NCT02539368|468506683|FG004|Overall Study|Withdrawal by Subject|3|||
130149325|NCT02539368|468506679|FG000|Overall Study|Physician Decision|49|||
130149326|NCT02539368|468506680|FG001|Overall Study|Physician Decision|15|||
130149327|NCT02539368|468506681|FG002|Overall Study|Physician Decision|7|||
130149328|NCT02539368|468506682|FG003|Overall Study|Physician Decision|0|||
130149329|NCT02539368|468506683|FG004|Overall Study|Physician Decision|2|||
130149330|NCT02539368|468506679|FG000|Overall Study|Lost to Follow-up|96|||
130149331|NCT02539368|468506680|FG001|Overall Study|Lost to Follow-up|21|||
130149332|NCT02539368|468506681|FG002|Overall Study|Lost to Follow-up|16|||
130149333|NCT02539368|468506682|FG003|Overall Study|Lost to Follow-up|4|||
130149334|NCT02539368|468506683|FG004|Overall Study|Lost to Follow-up|3|||
130149335|NCT02539368|468506679|FG000|Overall Study|Adverse Event|44|||
130149336|NCT02539368|468506680|FG001|Overall Study|Adverse Event|5|||
130149337|NCT02539368|468506681|FG002|Overall Study|Adverse Event|9|||
130149338|NCT02539368|468506682|FG003|Overall Study|Adverse Event|0|||
130149339|NCT02539368|468506683|FG004|Overall Study|Adverse Event|3|||
130149340|NCT02539368|468506679|FG000|Overall Study|Participant Non-compliant|13|||
130149341|NCT02539368|468506680|FG001|Overall Study|Participant Non-compliant|2|||
130149342|NCT02539368|468506681|FG002|Overall Study|Participant Non-compliant|1|||
130149343|NCT02539368|468506682|FG003|Overall Study|Participant Non-compliant|1|||
130149344|NCT02539368|468506683|FG004|Overall Study|Participant Non-compliant|0|||
130149345|NCT02539368|468506679|FG000|Overall Study|Other|145|||
130149346|NCT02539368|468506680|FG001|Overall Study|Other|18|||
130149347|NCT02539368|468506681|FG002|Overall Study|Other|24|||
130149348|NCT02539368|468506682|FG003|Overall Study|Other|1|||
130149349|NCT02539368|468506683|FG004|Overall Study|Other|3|||
130149350|NCT02539368|468506679|FG000|Overall Study|Missing|10|||
130149351|NCT02539368|468506680|FG001|Overall Study|Missing|3|||
130149352|NCT02539368|468506681|FG002|Overall Study|Missing|0|||
130149353|NCT02539368|468506682|FG003|Overall Study|Missing|0|||
130149354|NCT02539368|468506683|FG004|Overall Study|Missing|0|||
130149355|NCT00869440|468506684|FG000|Overall Study|Withdrawal by Subject|1|||
130149356|NCT00869440|468506685|FG001|Overall Study|Withdrawal by Subject|0|||
130149357|NCT00869440|468506686|FG002|Overall Study|Withdrawal by Subject|0|||
130149358|NCT00869440|468506687|FG003|Overall Study|Withdrawal by Subject|0|||
130149359|NCT00869440|468506684|FG000|Overall Study|Physician Decision|1|||
130149360|NCT00869440|468506685|FG001|Overall Study|Physician Decision|1|||
130149361|NCT00869440|468506686|FG002|Overall Study|Physician Decision|0|||
130149362|NCT00869440|468506687|FG003|Overall Study|Physician Decision|0|||
130149363|NCT03558139|468506689|FG000|Overall Study|Consent Withdrawn|1|||
130149364|NCT03558139|468506690|FG001|Overall Study|Consent Withdrawn|1|||
130149365|NCT03558139|468506691|FG002|Overall Study|Consent Withdrawn|4|||
130149366|NCT03558139|468506689|FG000|Overall Study|Death|5|||
130149367|NCT03558139|468506690|FG001|Overall Study|Death|3|||
130149368|NCT03558139|468506691|FG002|Overall Study|Death|8|||
130149369|NCT03558139|468506689|FG000|Overall Study|Lost to Follow-up|0|||
130149370|NCT03558139|468506690|FG001|Overall Study|Lost to Follow-up|0|||
130149371|NCT03558139|468506691|FG002|Overall Study|Lost to Follow-up|3|||
130149372|NCT03558139|468506689|FG000|Overall Study|Study Ended Per Protocol|0|||
130149373|NCT03558139|468506690|FG001|Overall Study|Study Ended Per Protocol|3|||
130149374|NCT03558139|468506691|FG002|Overall Study|Study Ended Per Protocol|6|||
130149375|NCT03573817|468506692|FG000|Overall Study|Adverse Event|0|||
130149376|NCT03573817|468506693|FG001|Overall Study|Adverse Event|2|||
130149377|NCT03573817|468506692|FG000|Overall Study|Protocol Violation|0|||
129978530|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
129978531|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
129978532|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
129978533|NCT02233803|467883730|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
129978534|NCT02233803|467883731|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
129978535|NCT02233803|467883730|FG000|Washout Period (4-Wks)|Physician Decision|1|||
129978536|NCT02233803|467883731|FG001|Washout Period (4-Wks)|Physician Decision|0|||
129978537|NCT02233803|467883730|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
129978538|NCT02233803|467883731|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
130149378|NCT03573817|468506693|FG001|Overall Study|Protocol Violation|1|||
130149379|NCT03573817|468506692|FG000|Overall Study|Withdrawal by Subject|1|||
130149380|NCT03573817|468506693|FG001|Overall Study|Withdrawal by Subject|1|||
130149381|NCT02013531|468506694|FG000|Overall Study|Lost to Follow-up|3|||
130149382|NCT02013531|468506694|FG000|Overall Study|Met Withdrawal Criteria|1|||
130149383|NCT02013531|468506694|FG000|Overall Study|Withdrawal by Subject|1|||
129978539|NCT02233803|467883730|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
130149384|NCT04569786|468506695|FG000|Overall Study|Lost to Follow-up|1|||
130149385|NCT04569786|468506696|FG001|Overall Study|Lost to Follow-up|0|||
130149386|NCT04569786|468506697|FG002|Overall Study|Lost to Follow-up|4|||
130149387|NCT04569786|468506698|FG003|Overall Study|Lost to Follow-up|1|||
130149388|NCT04569786|468506699|FG004|Overall Study|Lost to Follow-up|0|||
130149389|NCT04569786|468506695|FG000|Overall Study|Withdrawal by Subject|0|||
130149390|NCT04569786|468506696|FG001|Overall Study|Withdrawal by Subject|0|||
130149391|NCT04569786|468506697|FG002|Overall Study|Withdrawal by Subject|0|||
129978540|NCT02233803|467883731|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
129978541|NCT02233803|467883730|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
129978542|NCT02233803|467883731|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
130149392|NCT04569786|468506698|FG003|Overall Study|Withdrawal by Subject|5|||
130149393|NCT04569786|468506699|FG004|Overall Study|Withdrawal by Subject|1|||
130149394|NCT04569786|468506695|FG000|Overall Study|Physician Decision|0|||
130149395|NCT04569786|468506696|FG001|Overall Study|Physician Decision|0|||
130149396|NCT04569786|468506697|FG002|Overall Study|Physician Decision|0|||
130149397|NCT04569786|468506698|FG003|Overall Study|Physician Decision|1|||
130149398|NCT04569786|468506699|FG004|Overall Study|Physician Decision|0|||
130149399|NCT02692482|468506700|FG000|Overall Study|Death|2|||
130149400|NCT02692482|468506701|FG001|Overall Study|Death|2|||
130149401|NCT02692482|468506700|FG000|Overall Study|Withdrawal by Subject|1|||
130149402|NCT02692482|468506701|FG001|Overall Study|Withdrawal by Subject|2|||
130149403|NCT01435031|468506702|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
130149404|NCT01435031|468506702|FG000|ITT at 1 Month|Death|1|||
130149405|NCT01435031|468506702|FG000|ITT at 1 Month|Lost to Follow-up|4|||
130149406|NCT01435031|468506702|FG000|ITT at 6 Months|Death|2|||
130149407|NCT01435031|468506702|FG000|ITT at 6 Months|Lost to Follow-up|3|||
130149408|NCT01435031|468506702|FG000|ITT at 1 Year|Death|1|||
130149409|NCT01435031|468506702|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
130149410|NCT01435031|468506702|FG000|ITT at 1 Year|Lost to Follow-up|6|||
130149411|NCT01435031|468506702|FG000|ITT at 2 Years|Death|7|||
130149412|NCT01435031|468506702|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
130149413|NCT01435031|468506702|FG000|ITT at 2 Years|Lost to Follow-up|4|||
130149414|NCT01435031|468506702|FG000|ITT at 3 Years|Death|5|||
130149415|NCT01435031|468506702|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
130149416|NCT01435031|468506702|FG000|ITT at 3 Years|Lost to Follow-up|4|||
130149417|NCT01435031|468506702|FG000|ITT at 4 Years|Death|4|||
130149418|NCT01435031|468506702|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
130149419|NCT01435031|468506702|FG000|ITT at 4 Years|Lost to Follow-up|1|||
130149420|NCT00613730|468506703|FG000|Overall Study|Disease progression|2|||
130149421|NCT00613730|468506703|FG000|Overall Study|Administrative decision|1|||
130149422|NCT00479388|468506704|FG000|Overall Study|Adverse Event|90|||
130149423|NCT00479388|468506705|FG001|Overall Study|Adverse Event|45|||
130149424|NCT00479388|468506704|FG000|Overall Study|Lost to Follow-up|0|||
130149425|NCT00479388|468506705|FG001|Overall Study|Lost to Follow-up|2|||
130149426|NCT00479388|468506704|FG000|Overall Study|Protocol Violation|10|||
130149427|NCT00479388|468506705|FG001|Overall Study|Protocol Violation|9|||
130149428|NCT00479388|468506704|FG000|Overall Study|Withdrawal by Subject|32|||
130149429|NCT00479388|468506705|FG001|Overall Study|Withdrawal by Subject|17|||
130149430|NCT01876368|468506708|FG000|Overall Study|Adverse Event|2|||
130149431|NCT01876368|468506709|FG001|Overall Study|Adverse Event|5|||
130149432|NCT01876368|468506708|FG000|Overall Study|Lack of Efficacy|1|||
130149433|NCT01876368|468506709|FG001|Overall Study|Lack of Efficacy|0|||
130149434|NCT01876368|468506708|FG000|Overall Study|Lost to Follow-up|0|||
130149435|NCT01876368|468506709|FG001|Overall Study|Lost to Follow-up|1|||
130149436|NCT01876368|468506708|FG000|Overall Study|Non-compliance with study treatment|0|||
130149437|NCT01876368|468506709|FG001|Overall Study|Non-compliance with study treatment|1|||
130149438|NCT01876368|468506708|FG000|Overall Study|Physician Decision|0|||
130149439|NCT01876368|468506709|FG001|Overall Study|Physician Decision|2|||
130149440|NCT01876368|468506708|FG000|Overall Study|Protocol deviation|3|||
130149441|NCT01876368|468506709|FG001|Overall Study|Protocol deviation|3|||
130149442|NCT01876368|468506708|FG000|Overall Study|Subject/guardian decision|3|||
130149443|NCT01876368|468506709|FG001|Overall Study|Subject/guardian decision|1|||
130149444|NCT01955044|468506710|FG000|Overall Study|Death|1|||
130149445|NCT01955044|468506711|FG001|Overall Study|Death|1|||
130149446|NCT01955044|468506712|FG002|Overall Study|Death|0|||
130149447|NCT01867606|468506713|FG000|Overall Study|Withdrawal by Subject|10|||
130149448|NCT01867606|468506714|FG001|Overall Study|Withdrawal by Subject|14|||
130149449|NCT01867606|468506713|FG000|Overall Study|Protocol Violation|0|||
129978543|NCT00468143|467883732|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
129978544|NCT00468143|467883733|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
130149450|NCT01867606|468506714|FG001|Overall Study|Protocol Violation|1|||
130149451|NCT01378962|468506715|FG000|Overall Study|Death|14|||
130149452|NCT01378962|468506715|FG000|Overall Study|Lost to Follow-up|1|||
129978545|NCT00468143|467883732|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
130149453|NCT01378962|468506715|FG000|Overall Study|Other|2|||
130149454|NCT00292227|468506718|FG000|Patch Period|Adverse Event|1|||
130149455|NCT00292227|468506719|FG001|Patch Period|Adverse Event|0|||
130149456|NCT00292227|468506720|FG002|Patch Period|Adverse Event|2|||
130149457|NCT00292227|468506718|FG000|Patch Period|Withdrawal by Subject|0|||
130149458|NCT00292227|468506719|FG001|Patch Period|Withdrawal by Subject|0|||
130149459|NCT00292227|468506720|FG002|Patch Period|Withdrawal by Subject|1|||
129978546|NCT00468143|467883733|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
130149460|NCT02093923|468506721|FG000|Overall Study|Lost to Follow-up|0|||
130149461|NCT02093923|468506722|FG001|Overall Study|Lost to Follow-up|0|||
130149462|NCT02093923|468506723|FG002|Overall Study|Lost to Follow-up|0|||
130149463|NCT02093923|468506724|FG003|Overall Study|Lost to Follow-up|1|||
130149464|NCT02093923|468506725|FG004|Overall Study|Lost to Follow-up|0|||
130149465|NCT02093923|468506721|FG000|Overall Study|Screen failure after randomization|0|||
130149466|NCT02093923|468506722|FG001|Overall Study|Screen failure after randomization|0|||
130149467|NCT02093923|468506723|FG002|Overall Study|Screen failure after randomization|0|||
130149468|NCT02093923|468506724|FG003|Overall Study|Screen failure after randomization|1|||
130149469|NCT02093923|468506725|FG004|Overall Study|Screen failure after randomization|0|||
130149470|NCT00248170|468506726|FG000|Overall Study|Withdrawal by Subject|71|||
130149471|NCT00248170|468506727|FG001|Overall Study|Withdrawal by Subject|79|||
130149472|NCT00248170|468506726|FG000|Overall Study|Protocol Violation|35|||
130149473|NCT00248170|468506727|FG001|Overall Study|Protocol Violation|30|||
130149474|NCT00248170|468506726|FG000|Overall Study|Lost to Follow-up|28|||
130149475|NCT00248170|468506727|FG001|Overall Study|Lost to Follow-up|35|||
130149476|NCT00248170|468506726|FG000|Overall Study|Disease progression|196|||
130149477|NCT00248170|468506727|FG001|Overall Study|Disease progression|216|||
130149478|NCT00248170|468506726|FG000|Overall Study|Death|28|||
130149479|NCT00248170|468506727|FG001|Overall Study|Death|47|||
130149480|NCT00248170|468506726|FG000|Overall Study|Adverse Event|311|||
130149481|NCT00248170|468506727|FG001|Overall Study|Adverse Event|296|||
130149482|NCT00248170|468506726|FG000|Overall Study|Administrative problems|22|||
130149483|NCT00248170|468506727|FG001|Overall Study|Administrative problems|25|||
130149484|NCT00248170|468506726|FG000|Overall Study|Abnormal test procedure(s) result|49|||
130149485|NCT00248170|468506727|FG001|Overall Study|Abnormal test procedure(s) result|61|||
130149486|NCT00248170|468506726|FG000|Overall Study|Abnormal laboratory values|4|||
130149487|NCT00248170|468506727|FG001|Overall Study|Abnormal laboratory values|0|||
130149488|NCT00248170|468506726|FG000|Overall Study|Protocol deviation|17|||
130149489|NCT00248170|468506727|FG001|Overall Study|Protocol deviation|19|||
130149490|NCT01253317|468506742|FG000|Overall Study|Adverse Event|2|||
130149491|NCT01647711|468508496|FG000|Overall Study|Progressive disease|6|||
130149492|NCT01647711|468508497|FG001|Overall Study|Progressive disease|2|||
130149493|NCT01647711|468508498|FG002|Overall Study|Progressive disease|6|||
130149494|NCT01647711|468508499|FG003|Overall Study|Progressive disease|8|||
130149495|NCT01647711|468508500|FG004|Overall Study|Progressive disease|2|||
130149496|NCT01647711|468508496|FG000|Overall Study|Other adverse event|0|||
130149497|NCT01647711|468508497|FG001|Overall Study|Other adverse event|0|||
130149498|NCT01647711|468508498|FG002|Overall Study|Other adverse event|2|||
130149499|NCT01647711|468508499|FG003|Overall Study|Other adverse event|0|||
130149500|NCT01647711|468508500|FG004|Overall Study|Other adverse event|2|||
130149501|NCT01647711|468508496|FG000|Overall Study|Protocol Violation|0|||
130149502|NCT01647711|468508497|FG001|Overall Study|Protocol Violation|0|||
130149503|NCT01647711|468508498|FG002|Overall Study|Protocol Violation|0|||
130149504|NCT01647711|468508499|FG003|Overall Study|Protocol Violation|0|||
130149505|NCT01647711|468508500|FG004|Overall Study|Protocol Violation|1|||
130149506|NCT01647711|468508496|FG000|Overall Study|Refused to continue taking medication|0|||
130149507|NCT01647711|468508497|FG001|Overall Study|Refused to continue taking medication|0|||
130149508|NCT01647711|468508498|FG002|Overall Study|Refused to continue taking medication|0|||
130149509|NCT01647711|468508499|FG003|Overall Study|Refused to continue taking medication|2|||
130149510|NCT01647711|468508500|FG004|Overall Study|Refused to continue taking medication|1|||
129978547|NCT01559129|467883736|FG000|Treatment Phase|Adverse Event|0|||
129978548|NCT01559129|467883737|FG001|Treatment Phase|Adverse Event|2|||
129978549|NCT01559129|467883736|FG000|Treatment Phase|Progressive Disease|1|||
129978550|NCT01559129|467883737|FG001|Treatment Phase|Progressive Disease|1|||
129978551|NCT01559129|467883736|FG000|Treatment Phase|Lack of Efficacy|0|||
129978552|NCT01559129|467883737|FG001|Treatment Phase|Lack of Efficacy|1|||
129978553|NCT01559129|467883736|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
129978554|NCT01559129|467883737|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
129978555|NCT01559129|467883736|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
129978556|NCT01559129|467883737|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
130149511|NCT01647711|468508496|FG000|Overall Study|Other reason not defined|0|||
130149512|NCT01647711|468508497|FG001|Overall Study|Other reason not defined|1|||
130149513|NCT01647711|468508498|FG002|Overall Study|Other reason not defined|1|||
130149514|NCT01647711|468508499|FG003|Overall Study|Other reason not defined|1|||
130149515|NCT01647711|468508500|FG004|Overall Study|Other reason not defined|0|||
129978557|NCT01559129|467883736|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
129978558|NCT01559129|467883737|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
129978559|NCT01559129|467883736|FG000|Open-label Extension Period|Adverse Event|1|||
130149516|NCT01613378|468508508|FG000|Overall Study|Lack of Efficacy|13|||
130149517|NCT01613378|468508508|FG000|Overall Study|Adverse Event|11|||
130149518|NCT01613378|468508508|FG000|Overall Study|Withdrawal by Subject|8|||
130149519|NCT01613378|468508508|FG000|Overall Study|Death|2|||
130149520|NCT01613378|468508508|FG000|Overall Study|Lost to Follow-up|1|||
130149521|NCT01613378|468508508|FG000|Overall Study|Other Reason|4|||
130149522|NCT01011556|468508509|FG000|Overall Study|Adverse Event|1|||
130149523|NCT01011556|468508510|FG001|Overall Study|Adverse Event|3|||
130149524|NCT01011556|468508511|FG002|Overall Study|Adverse Event|2|||
130149525|NCT01011556|468508512|FG003|Overall Study|Adverse Event|1|||
130149526|NCT01011556|468508509|FG000|Overall Study|Lost to Follow-up|1|||
130149527|NCT01011556|468508510|FG001|Overall Study|Lost to Follow-up|0|||
130149528|NCT01011556|468508511|FG002|Overall Study|Lost to Follow-up|0|||
130149529|NCT01011556|468508512|FG003|Overall Study|Lost to Follow-up|0|||
130149530|NCT01011556|468508509|FG000|Overall Study|Physician Decision|1|||
130149531|NCT01011556|468508510|FG001|Overall Study|Physician Decision|0|||
130149532|NCT01011556|468508511|FG002|Overall Study|Physician Decision|0|||
130149533|NCT01011556|468508512|FG003|Overall Study|Physician Decision|1|||
130149534|NCT01011556|468508509|FG000|Overall Study|Protocol Violation|0|||
130149535|NCT01011556|468508510|FG001|Overall Study|Protocol Violation|1|||
130149536|NCT01011556|468508511|FG002|Overall Study|Protocol Violation|0|||
130149537|NCT01011556|468508512|FG003|Overall Study|Protocol Violation|0|||
130149538|NCT01011556|468508509|FG000|Overall Study|Withdrawal by Subject|1|||
130149539|NCT01011556|468508510|FG001|Overall Study|Withdrawal by Subject|2|||
130149540|NCT01011556|468508511|FG002|Overall Study|Withdrawal by Subject|4|||
130149541|NCT01011556|468508512|FG003|Overall Study|Withdrawal by Subject|4|||
130149542|NCT01011556|468508509|FG000|Overall Study|Sponsor decision|0|||
130149543|NCT01011556|468508510|FG001|Overall Study|Sponsor decision|1|||
130149544|NCT01011556|468508511|FG002|Overall Study|Sponsor decision|1|||
130149545|NCT01011556|468508512|FG003|Overall Study|Sponsor decision|2|||
130149546|NCT01011556|468508509|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
130149547|NCT01011556|468508510|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
130149548|NCT01011556|468508511|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
130149549|NCT01011556|468508512|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
130149550|NCT00194792|468508514|FG000|Overall Study|Withdrawal by Subject|1|||
130149551|NCT01714739|468508515|FG000|Overall Study|Disease progression|3|||
130149552|NCT01714739|468508516|FG001|Overall Study|Disease progression|5|||
130149553|NCT01714739|468508517|FG002|Overall Study|Disease progression|5|||
130149554|NCT01714739|468508518|FG003|Overall Study|Disease progression|204|||
130149555|NCT01714739|468508519|FG004|Overall Study|Disease progression|1|||
130149556|NCT01714739|468508520|FG005|Overall Study|Disease progression|3|||
130149557|NCT01714739|468508521|FG006|Overall Study|Disease progression|5|||
130149558|NCT01714739|468508515|FG000|Overall Study|Study drug toxicity|1|||
130149559|NCT01714739|468508516|FG001|Overall Study|Study drug toxicity|1|||
130149560|NCT01714739|468508517|FG002|Overall Study|Study drug toxicity|1|||
130149561|NCT01714739|468508518|FG003|Overall Study|Study drug toxicity|15|||
130149562|NCT01714739|468508519|FG004|Overall Study|Study drug toxicity|0|||
130149563|NCT01714739|468508520|FG005|Overall Study|Study drug toxicity|0|||
130149564|NCT01714739|468508521|FG006|Overall Study|Study drug toxicity|5|||
130149565|NCT01714739|468508515|FG000|Overall Study|Death|0|||
130149566|NCT01714739|468508516|FG001|Overall Study|Death|0|||
130149567|NCT01714739|468508517|FG002|Overall Study|Death|0|||
130149568|NCT01714739|468508518|FG003|Overall Study|Death|1|||
130149569|NCT01714739|468508519|FG004|Overall Study|Death|0|||
130149570|NCT01714739|468508520|FG005|Overall Study|Death|0|||
130149571|NCT01714739|468508521|FG006|Overall Study|Death|0|||
130149572|NCT01714739|468508515|FG000|Overall Study|Adverse Event unrelated to drug|0|||
130149573|NCT01714739|468508516|FG001|Overall Study|Adverse Event unrelated to drug|0|||
130149574|NCT01714739|468508517|FG002|Overall Study|Adverse Event unrelated to drug|3|||
130149575|NCT01714739|468508518|FG003|Overall Study|Adverse Event unrelated to drug|21|||
130149576|NCT01714739|468508519|FG004|Overall Study|Adverse Event unrelated to drug|0|||
130149577|NCT01714739|468508520|FG005|Overall Study|Adverse Event unrelated to drug|0|||
130149578|NCT01714739|468508521|FG006|Overall Study|Adverse Event unrelated to drug|0|||
130149579|NCT01714739|468508515|FG000|Overall Study|Participant request to stop therapy|0|||
130149580|NCT01714739|468508516|FG001|Overall Study|Participant request to stop therapy|1|||
130149581|NCT01714739|468508517|FG002|Overall Study|Participant request to stop therapy|0|||
130149582|NCT01714739|468508518|FG003|Overall Study|Participant request to stop therapy|6|||
130149583|NCT01714739|468508519|FG004|Overall Study|Participant request to stop therapy|0|||
130149584|NCT01714739|468508520|FG005|Overall Study|Participant request to stop therapy|0|||
130149585|NCT01714739|468508521|FG006|Overall Study|Participant request to stop therapy|0|||
130149586|NCT01714739|468508515|FG000|Overall Study|Participant withdrew consent|0|||
130149587|NCT01714739|468508516|FG001|Overall Study|Participant withdrew consent|1|||
130149588|NCT01714739|468508517|FG002|Overall Study|Participant withdrew consent|0|||
130149589|NCT01714739|468508518|FG003|Overall Study|Participant withdrew consent|8|||
129978560|NCT01559129|467883737|FG001|Open-label Extension Period|Adverse Event|0|||
130149590|NCT01714739|468508519|FG004|Overall Study|Participant withdrew consent|0|||
130149591|NCT01714739|468508520|FG005|Overall Study|Participant withdrew consent|0|||
130149592|NCT01714739|468508521|FG006|Overall Study|Participant withdrew consent|0|||
130149593|NCT01714739|468508515|FG000|Overall Study|Lost to Follow-up|0|||
130149594|NCT01714739|468508516|FG001|Overall Study|Lost to Follow-up|0|||
130149595|NCT01714739|468508517|FG002|Overall Study|Lost to Follow-up|0|||
130149596|NCT01714739|468508518|FG003|Overall Study|Lost to Follow-up|1|||
130149597|NCT01714739|468508519|FG004|Overall Study|Lost to Follow-up|0|||
130149598|NCT01714739|468508520|FG005|Overall Study|Lost to Follow-up|0|||
130149599|NCT01714739|468508521|FG006|Overall Study|Lost to Follow-up|0|||
130149600|NCT01714739|468508515|FG000|Overall Study|Maximum clinical benefit|0|||
130149601|NCT01714739|468508516|FG001|Overall Study|Maximum clinical benefit|1|||
130149602|NCT01714739|468508517|FG002|Overall Study|Maximum clinical benefit|1|||
130149603|NCT01714739|468508518|FG003|Overall Study|Maximum clinical benefit|3|||
130149604|NCT01714739|468508519|FG004|Overall Study|Maximum clinical benefit|0|||
130149605|NCT01714739|468508520|FG005|Overall Study|Maximum clinical benefit|0|||
130149606|NCT01714739|468508521|FG006|Overall Study|Maximum clinical benefit|0|||
130149607|NCT01714739|468508515|FG000|Overall Study|Poor/non-comliance|0|||
130149608|NCT01714739|468508516|FG001|Overall Study|Poor/non-comliance|1|||
130149609|NCT01714739|468508517|FG002|Overall Study|Poor/non-comliance|0|||
130149610|NCT01714739|468508518|FG003|Overall Study|Poor/non-comliance|1|||
130149611|NCT01714739|468508519|FG004|Overall Study|Poor/non-comliance|0|||
130149612|NCT01714739|468508520|FG005|Overall Study|Poor/non-comliance|0|||
130149613|NCT01714739|468508521|FG006|Overall Study|Poor/non-comliance|0|||
130149614|NCT01714739|468508515|FG000|Overall Study|No longer meets study criteria|0|||
130149615|NCT01714739|468508516|FG001|Overall Study|No longer meets study criteria|0|||
130149616|NCT01714739|468508517|FG002|Overall Study|No longer meets study criteria|0|||
130149617|NCT01714739|468508518|FG003|Overall Study|No longer meets study criteria|1|||
130149618|NCT01714739|468508519|FG004|Overall Study|No longer meets study criteria|0|||
130149619|NCT01714739|468508520|FG005|Overall Study|No longer meets study criteria|0|||
130149620|NCT01714739|468508521|FG006|Overall Study|No longer meets study criteria|0|||
130149621|NCT01714739|468508515|FG000|Overall Study|Other reason|0|||
130149622|NCT01714739|468508516|FG001|Overall Study|Other reason|0|||
130149623|NCT01714739|468508517|FG002|Overall Study|Other reason|0|||
130149624|NCT01714739|468508518|FG003|Overall Study|Other reason|3|||
130149625|NCT01714739|468508519|FG004|Overall Study|Other reason|1|||
130149626|NCT01714739|468508520|FG005|Overall Study|Other reason|0|||
130149627|NCT01714739|468508521|FG006|Overall Study|Other reason|0|||
130149628|NCT03585959|468508522|FG000|Overall Study|Physician Decision|1|||
130149629|NCT03585959|468508522|FG000|Overall Study|Unsuccessful Procedure|2|||
130149630|NCT00865514|468508523|FG000|Overall Study|Infusion cost exceeded funding|2|||
130149631|NCT01463982|468508524|FG000|Overall Study|Withdrawal by Subject|0|||
130149632|NCT01463982|468508525|FG001|Overall Study|Withdrawal by Subject|1|||
130149633|NCT01463982|468508526|FG002|Overall Study|Withdrawal by Subject|1|||
130149634|NCT01463982|468508527|FG003|Overall Study|Withdrawal by Subject|0|||
130149635|NCT01463982|468508524|FG000|Overall Study|Treatment delay over 5 week|0|||
130149636|NCT01463982|468508525|FG001|Overall Study|Treatment delay over 5 week|0|||
130149637|NCT01463982|468508526|FG002|Overall Study|Treatment delay over 5 week|1|||
130149638|NCT01463982|468508527|FG003|Overall Study|Treatment delay over 5 week|0|||
130149639|NCT04220775|468508530|FG000|Overall Study|Adverse Event|1|||
130149640|NCT04220775|468508531|FG001|Overall Study|Adverse Event|0|||
130149641|NCT04220775|468508530|FG000|Overall Study|Disease Progression|1|||
130149642|NCT04220775|468508531|FG001|Overall Study|Disease Progression|0|||
130149643|NCT00089076|468508532|FG000|Overall Study|Alternate Therapy|1|||
130149644|NCT00089076|468508532|FG000|Overall Study|Withdrawal by Subject|2|||
130149645|NCT00089076|468508532|FG000|Overall Study|Progression|7|||
130149646|NCT00931463|468508533|FG000|Overall Study|Death|8|||
130149647|NCT00931463|468508534|FG001|Overall Study|Death|4|||
130149648|NCT00931463|468508533|FG000|Overall Study|Withdrawal by Subject|5|||
130149649|NCT00931463|468508534|FG001|Overall Study|Withdrawal by Subject|0|||
130149650|NCT00931463|468508533|FG000|Overall Study|Lost to Follow-up|4|||
130149651|NCT00931463|468508534|FG001|Overall Study|Lost to Follow-up|1|||
130149652|NCT03170869|468508535|FG000|Overall Study|Protocol Violation|5|||
130149653|NCT03170869|468508535|FG000|Overall Study|Early study termination|3|||
130149654|NCT01009515|468508536|FG000|Overall Study|Withdrawal by Subject|3|||
130149655|NCT00983476|468508542|FG000|Overall Study|Did not receive intervention|17|||
130149656|NCT00983476|468508543|FG001|Overall Study|Did not receive intervention|22|||
130149657|NCT00983476|468508544|FG002|Overall Study|Did not receive intervention|0|||
130149658|NCT01175473|468508546|FG000|Overall Study|Adverse Event|2|||
130149659|NCT01175473|468508547|FG001|Overall Study|Adverse Event|2|||
130149660|NCT01857206|468508548|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
130149661|NCT01857206|468508549|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
130149662|NCT01857206|468508548|FG000|Overall Study|Lost to Follow-up|9|||
130149663|NCT01857206|468508549|FG001|Overall Study|Lost to Follow-up|6|||
130149664|NCT01857206|468508548|FG000|Overall Study|Unclassified|3|||
130149665|NCT01857206|468508549|FG001|Overall Study|Unclassified|3|||
130149666|NCT01857206|468508548|FG000|Overall Study|Withdrawal by Subject|1|||
130149667|NCT01857206|468508549|FG001|Overall Study|Withdrawal by Subject|0|||
130149668|NCT01857973|468508550|FG000|Overall Study|Subject did not meet required BG range|3|||
130149669|NCT01857973|468508550|FG000|Overall Study|drop out after 3 failed attempts|1|||
130149670|NCT01857973|468508550|FG000|Overall Study|Physician Decision|1|||
130149671|NCT00129116|468508553|FG000|Primary Phase|Lost to Follow-up|1|||
130149672|NCT00129116|468508554|FG001|Primary Phase|Lost to Follow-up|1|||
130149673|NCT00129116|468508555|FG002|Primary Phase|Lost to Follow-up|0|||
130149674|NCT00129116|468508556|FG003|Primary Phase|Lost to Follow-up|1|||
130149675|NCT00129116|468508557|FG004|Primary Phase|Lost to Follow-up|1|||
130149676|NCT00129116|468508553|FG000|Primary Phase|Protocol Violation|0|||
130149677|NCT00129116|468508554|FG001|Primary Phase|Protocol Violation|1|||
130149678|NCT00129116|468508555|FG002|Primary Phase|Protocol Violation|0|||
130149679|NCT00129116|468508556|FG003|Primary Phase|Protocol Violation|0|||
130149680|NCT00129116|468508557|FG004|Primary Phase|Protocol Violation|0|||
130149681|NCT00129116|468508553|FG000|Primary Phase|Adverse Event|1|||
130149682|NCT00129116|468508554|FG001|Primary Phase|Adverse Event|1|||
130149683|NCT00129116|468508555|FG002|Primary Phase|Adverse Event|0|||
130149684|NCT00129116|468508556|FG003|Primary Phase|Adverse Event|0|||
130149685|NCT00129116|468508557|FG004|Primary Phase|Adverse Event|0|||
130149686|NCT00129116|468508553|FG000|Primary Phase|Withdrawal by Subject|0|||
130149687|NCT00129116|468508554|FG001|Primary Phase|Withdrawal by Subject|1|||
130149688|NCT00129116|468508555|FG002|Primary Phase|Withdrawal by Subject|0|||
130149689|NCT00129116|468508556|FG003|Primary Phase|Withdrawal by Subject|0|||
130149690|NCT00129116|468508557|FG004|Primary Phase|Withdrawal by Subject|0|||
130149691|NCT00129116|468508553|FG000|Primary Phase|Other|0|||
130149692|NCT00129116|468508554|FG001|Primary Phase|Other|0|||
130149693|NCT00129116|468508555|FG002|Primary Phase|Other|1|||
130149694|NCT00129116|468508556|FG003|Primary Phase|Other|0|||
130149695|NCT00129116|468508557|FG004|Primary Phase|Other|0|||
130149696|NCT00129116|468508553|FG000|Booster Phase|Lost to Follow-up|2|||
130149697|NCT00129116|468508554|FG001|Booster Phase|Lost to Follow-up|0|||
130149698|NCT00129116|468508555|FG002|Booster Phase|Lost to Follow-up|0|||
130149699|NCT00129116|468508556|FG003|Booster Phase|Lost to Follow-up|0|||
130149700|NCT00129116|468508557|FG004|Booster Phase|Lost to Follow-up|1|||
130149701|NCT02752802|468508560|FG000|Overall Study|Contrast Volume Not Collected|1|||
130149702|NCT02752802|468508561|FG001|Overall Study|Contrast Volume Not Collected|0|||
130149703|NCT02808819|468508562|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
130149704|NCT02808819|468508563|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
130149705|NCT02808819|468508562|FG000|Overall Study|Withdrawal by Subject|10|||
130149706|NCT02808819|468508563|FG001|Overall Study|Withdrawal by Subject|13|||
130149707|NCT02808819|468508562|FG000|Overall Study|Site terminated by sponsor|2|||
130149708|NCT02808819|468508563|FG001|Overall Study|Site terminated by sponsor|0|||
130149709|NCT02808819|468508562|FG000|Overall Study|Pregnancy|1|||
130149710|NCT02808819|468508563|FG001|Overall Study|Pregnancy|0|||
130149711|NCT02808819|468508562|FG000|Overall Study|Lost to Follow-up|1|||
130149712|NCT02808819|468508563|FG001|Overall Study|Lost to Follow-up|6|||
130149713|NCT02808819|468508562|FG000|Overall Study|Protocol Violation|0|||
130149714|NCT02808819|468508563|FG001|Overall Study|Protocol Violation|1|||
130149715|NCT02808819|468508562|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
130149716|NCT02808819|468508563|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
130149717|NCT02808819|468508562|FG000|Overall Study|Death|1|||
130149718|NCT02808819|468508563|FG001|Overall Study|Death|0|||
130149719|NCT02808819|468508562|FG000|Overall Study|Adverse Event|3|||
130149720|NCT02808819|468508563|FG001|Overall Study|Adverse Event|4|||
130149721|NCT03546647|468508564|FG000|Overall Study|Adverse Event|1|||
130149722|NCT03546647|468508565|FG001|Overall Study|Adverse Event|0|||
130149723|NCT02400476|468508566|FG000|Overall Study|Adverse Event|57|||
130149724|NCT02400476|468508567|FG001|Overall Study|Adverse Event|10|||
130149725|NCT02400476|468508568|FG002|Overall Study|Adverse Event|22|||
130149726|NCT02400476|468508569|FG003|Overall Study|Adverse Event|19|||
130149727|NCT02400476|468508570|FG004|Overall Study|Adverse Event|5|||
130149728|NCT02400476|468508571|FG005|Overall Study|Adverse Event|8|||
130149729|NCT02400476|468508566|FG000|Overall Study|Withdrawal by Subject|4|||
130149730|NCT02400476|468508567|FG001|Overall Study|Withdrawal by Subject|1|||
130149731|NCT02400476|468508568|FG002|Overall Study|Withdrawal by Subject|12|||
130149732|NCT02400476|468508569|FG003|Overall Study|Withdrawal by Subject|7|||
130149733|NCT02400476|468508570|FG004|Overall Study|Withdrawal by Subject|5|||
130149734|NCT02400476|468508571|FG005|Overall Study|Withdrawal by Subject|5|||
130149735|NCT02400476|468508566|FG000|Overall Study|Lost to Follow-up|0|||
130149736|NCT02400476|468508567|FG001|Overall Study|Lost to Follow-up|0|||
130149737|NCT02400476|468508568|FG002|Overall Study|Lost to Follow-up|0|||
130149738|NCT02400476|468508569|FG003|Overall Study|Lost to Follow-up|1|||
130149739|NCT02400476|468508570|FG004|Overall Study|Lost to Follow-up|3|||
130149740|NCT02400476|468508571|FG005|Overall Study|Lost to Follow-up|1|||
130149741|NCT02400476|468508566|FG000|Overall Study|Physician Decision|0|||
130149742|NCT02400476|468508567|FG001|Overall Study|Physician Decision|0|||
130149743|NCT02400476|468508568|FG002|Overall Study|Physician Decision|1|||
129978561|NCT01559129|467883736|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
130149744|NCT02400476|468508569|FG003|Overall Study|Physician Decision|1|||
130149745|NCT02400476|468508570|FG004|Overall Study|Physician Decision|0|||
130149746|NCT02400476|468508571|FG005|Overall Study|Physician Decision|1|||
130149747|NCT02400476|468508566|FG000|Overall Study|Other, Disease Progression|0|||
130149748|NCT02400476|468508567|FG001|Overall Study|Other, Disease Progression|1|||
130149749|NCT02400476|468508568|FG002|Overall Study|Other, Disease Progression|2|||
130149750|NCT02400476|468508569|FG003|Overall Study|Other, Disease Progression|1|||
130149751|NCT02400476|468508570|FG004|Overall Study|Other, Disease Progression|2|||
130149752|NCT02400476|468508571|FG005|Overall Study|Other, Disease Progression|1|||
130149753|NCT02400476|468508566|FG000|Overall Study|Other, Decreased Quality of Life|0|||
130149754|NCT02400476|468508567|FG001|Overall Study|Other, Decreased Quality of Life|0|||
130149755|NCT02400476|468508568|FG002|Overall Study|Other, Decreased Quality of Life|2|||
130149756|NCT02400476|468508569|FG003|Overall Study|Other, Decreased Quality of Life|0|||
130149757|NCT02400476|468508570|FG004|Overall Study|Other, Decreased Quality of Life|0|||
130149758|NCT02400476|468508571|FG005|Overall Study|Other, Decreased Quality of Life|0|||
130149759|NCT02400476|468508566|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130149760|NCT02400476|468508567|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130149761|NCT02400476|468508568|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
130149762|NCT02400476|468508569|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
130149763|NCT02400476|468508570|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130149764|NCT02400476|468508571|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
130149765|NCT00003531|468508572|FG000|Overall Study|Not evaluable|10|||
130149766|NCT00588731|468508575|FG000|Overall Study|Withdrawal by Subject|3|||
130149767|NCT00588731|468508576|FG001|Overall Study|Withdrawal by Subject|2|||
130149768|NCT00251316|468508577|FG000|Overall Study|Physician Decision|2|||
130149769|NCT00251316|468508578|FG001|Overall Study|Physician Decision|3|||
130149770|NCT00346164|468508579|FG000|Overall Study|Adverse Event|0|||
130149771|NCT00346164|468508580|FG001|Overall Study|Adverse Event|0|||
130149772|NCT00346164|468508581|FG002|Overall Study|Adverse Event|0|||
130149773|NCT00346164|468508582|FG003|Overall Study|Adverse Event|1|||
130149774|NCT00346164|468508579|FG000|Overall Study|Lack of Efficacy|0|||
130149775|NCT00346164|468508580|FG001|Overall Study|Lack of Efficacy|1|||
130149776|NCT00346164|468508581|FG002|Overall Study|Lack of Efficacy|7|||
130149777|NCT00346164|468508582|FG003|Overall Study|Lack of Efficacy|25|||
130149778|NCT00346164|468508579|FG000|Overall Study|Physician Decision|0|||
130149779|NCT00346164|468508580|FG001|Overall Study|Physician Decision|1|||
130149780|NCT00346164|468508581|FG002|Overall Study|Physician Decision|2|||
130149781|NCT00346164|468508582|FG003|Overall Study|Physician Decision|27|||
130149782|NCT00346164|468508579|FG000|Overall Study|Protocol Violation|6|||
130149783|NCT00346164|468508580|FG001|Overall Study|Protocol Violation|2|||
130149784|NCT00346164|468508581|FG002|Overall Study|Protocol Violation|10|||
130149785|NCT00346164|468508582|FG003|Overall Study|Protocol Violation|4|||
130149786|NCT00346164|468508579|FG000|Overall Study|Withdrawal by Subject|0|||
130149787|NCT00346164|468508580|FG001|Overall Study|Withdrawal by Subject|0|||
130149788|NCT00346164|468508581|FG002|Overall Study|Withdrawal by Subject|2|||
130149789|NCT00346164|468508582|FG003|Overall Study|Withdrawal by Subject|0|||
130149790|NCT00346164|468508579|FG000|Overall Study|Ineligible|11|||
130149791|NCT00346164|468508580|FG001|Overall Study|Ineligible|2|||
130149792|NCT00346164|468508581|FG002|Overall Study|Ineligible|2|||
130149793|NCT00346164|468508582|FG003|Overall Study|Ineligible|23|||
130149794|NCT00346164|468508579|FG000|Overall Study|Refusal of further protocol therapy|0|||
130149795|NCT00346164|468508580|FG001|Overall Study|Refusal of further protocol therapy|1|||
130149796|NCT00346164|468508581|FG002|Overall Study|Refusal of further protocol therapy|3|||
130149797|NCT00346164|468508582|FG003|Overall Study|Refusal of further protocol therapy|15|||
130149798|NCT00346164|468508579|FG000|Overall Study|Inability to start week 16 tx on time|0|||
130149799|NCT00346164|468508580|FG001|Overall Study|Inability to start week 16 tx on time|0|||
130149800|NCT00346164|468508581|FG002|Overall Study|Inability to start week 16 tx on time|0|||
130149801|NCT00346164|468508582|FG003|Overall Study|Inability to start week 16 tx on time|11|||
130149802|NCT00612677|468508585|FG000|Overall Study|study closed before treatment started|1|||
130149803|NCT03417830|468508586|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
130149804|NCT03417830|468508587|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
130149805|NCT00823199|468508588|FG000|Overall Study|Withdrawal by Subject|2|||
130149806|NCT01998243|468508589|FG000|Overall Study|Pregnancy|0|||
130149807|NCT01998243|468508590|FG001|Overall Study|Pregnancy|1|||
130149808|NCT01998243|468508589|FG000|Overall Study|Protocol Violation|5|||
130149809|NCT01998243|468508590|FG001|Overall Study|Protocol Violation|2|||
130149810|NCT01998243|468508589|FG000|Overall Study|Withdrawal by Subject|3|||
130149811|NCT01998243|468508590|FG001|Overall Study|Withdrawal by Subject|4|||
130149812|NCT01640184|468508593|FG000|Overall Study|Death|1|||
130149813|NCT01640184|468508594|FG001|Overall Study|Death|0|||
130149814|NCT01640184|468508595|FG002|Overall Study|Death|0|||
130149815|NCT01640184|468508593|FG000|Overall Study|Lost to Follow-up|4|||
130149816|NCT01640184|468508594|FG001|Overall Study|Lost to Follow-up|1|||
130149817|NCT01640184|468508595|FG002|Overall Study|Lost to Follow-up|0|||
130149818|NCT01640184|468508593|FG000|Overall Study|Physician Decision|3|||
130149819|NCT01640184|468508594|FG001|Overall Study|Physician Decision|0|||
130149820|NCT01640184|468508595|FG002|Overall Study|Physician Decision|0|||
130149821|NCT01640184|468508593|FG000|Overall Study|Withdrawal by Subject|0|||
130149822|NCT01640184|468508594|FG001|Overall Study|Withdrawal by Subject|1|||
130149823|NCT01640184|468508595|FG002|Overall Study|Withdrawal by Subject|1|||
130149824|NCT01640184|468508593|FG000|Overall Study|Protocol Violation|0|||
130149825|NCT01640184|468508594|FG001|Overall Study|Protocol Violation|0|||
130149826|NCT01640184|468508595|FG002|Overall Study|Protocol Violation|1|||
130149827|NCT01684878|468508599|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
130149828|NCT01684878|468508600|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
130149829|NCT01684878|468508601|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
130149830|NCT01684878|468508602|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
130149831|NCT01684878|468508599|FG000|Part 1: Safety Run in Phase|Death|15|||
130149832|NCT01684878|468508600|FG001|Part 1: Safety Run in Phase|Death|20|||
130149833|NCT01684878|468508601|FG002|Part 1: Safety Run in Phase|Death|0|||
130149834|NCT01684878|468508602|FG003|Part 1: Safety Run in Phase|Death|0|||
130149835|NCT01684878|468508599|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130149836|NCT01684878|468508600|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
130149837|NCT01684878|468508601|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130149838|NCT01684878|468508602|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
130149839|NCT01684878|468508599|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
130149840|NCT01684878|468508600|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
130149841|NCT01684878|468508601|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
130149842|NCT01684878|468508602|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
130149843|NCT01684878|468508599|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
130149844|NCT01684878|468508600|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
130149845|NCT01684878|468508601|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
130149846|NCT01684878|468508602|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
130149847|NCT01684878|468508599|FG000|Part 2: Randomized Phase|Death|0|||
130149848|NCT01684878|468508600|FG001|Part 2: Randomized Phase|Death|0|||
130149849|NCT01684878|468508601|FG002|Part 2: Randomized Phase|Death|62|||
130149850|NCT01684878|468508602|FG003|Part 2: Randomized Phase|Death|68|||
130149851|NCT01684878|468508599|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
130149852|NCT01684878|468508600|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
130149853|NCT01684878|468508601|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
130149854|NCT01684878|468508602|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
130149855|NCT01684878|468508599|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
130149856|NCT01684878|468508600|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
130149857|NCT01684878|468508601|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
130149858|NCT01684878|468508602|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
130149859|NCT02927834|468508603|FG000|Overall Study|Lost to Follow-up|1|||
130149860|NCT02927834|468508604|FG001|Overall Study|Lost to Follow-up|2|||
130149861|NCT02927834|468508605|FG002|Overall Study|Lost to Follow-up|2|||
130149862|NCT03234608|468508618|FG000|Overall Study|Lost to Follow-up|23|||
130149863|NCT03234608|468508619|FG001|Overall Study|Lost to Follow-up|21|||
130149864|NCT01662362|468508625|FG000|Overall Study|Lost to Follow-up|38|||
130149865|NCT01181531|468508630|FG000|Overall Study|Other|17|||
130149866|NCT01181531|468508631|FG001|Overall Study|Other|12|||
130149867|NCT01181531|468508630|FG000|Overall Study|Partial consent by subject withdrawn|0|||
130149868|NCT01181531|468508631|FG001|Overall Study|Partial consent by subject withdrawn|1|||
130149869|NCT01181531|468508630|FG000|Overall Study|Physician Decision|3|||
130149870|NCT01181531|468508631|FG001|Overall Study|Physician Decision|1|||
130149871|NCT01181531|468508630|FG000|Overall Study|Noncompliance|2|||
130149872|NCT01181531|468508631|FG001|Overall Study|Noncompliance|2|||
130149873|NCT01181531|468508630|FG000|Overall Study|Ineligibility determined|1|||
130149874|NCT01181531|468508631|FG001|Overall Study|Ineligibility determined|2|||
130149875|NCT01181531|468508630|FG000|Overall Study|Protocol Specified Criteria|15|||
130149876|NCT01181531|468508631|FG001|Overall Study|Protocol Specified Criteria|8|||
130149877|NCT01181531|468508630|FG000|Overall Study|Pregnancy|0|||
130149878|NCT01181531|468508631|FG001|Overall Study|Pregnancy|1|||
130149879|NCT01181531|468508630|FG000|Overall Study|Withdrawal by Subject|8|||
130149880|NCT01181531|468508631|FG001|Overall Study|Withdrawal by Subject|7|||
130149881|NCT01181531|468508630|FG000|Overall Study|Protocol Violation|6|||
130149882|NCT01181531|468508631|FG001|Overall Study|Protocol Violation|6|||
130149883|NCT01181531|468508630|FG000|Overall Study|Death|9|||
130149884|NCT01181531|468508631|FG001|Overall Study|Death|12|||
130149885|NCT01181531|468508630|FG000|Overall Study|Adverse Event|0|||
130149886|NCT01181531|468508631|FG001|Overall Study|Adverse Event|1|||
130149887|NCT00987831|468508632|FG000|Overall Study|Never flared in 12 months|1|||
130149888|NCT00987831|468508633|FG001|Overall Study|Never flared in 12 months|0|||
130149889|NCT00987831|468508634|FG002|Overall Study|Never flared in 12 months|0|||
130149890|NCT00987831|468508632|FG000|Overall Study|Lost to Follow-up|0|||
130149891|NCT00987831|468508633|FG001|Overall Study|Lost to Follow-up|3|||
130149892|NCT00987831|468508634|FG002|Overall Study|Lost to Follow-up|0|||
130149893|NCT02792218|468508636|FG000|Overall Study|Patient/guardian decision|15|||
130149894|NCT02792218|468508637|FG001|Overall Study|Patient/guardian decision|42|||
130149895|NCT02792218|468508636|FG000|Overall Study|Adverse Event|15|||
130149896|NCT02792218|468508637|FG001|Overall Study|Adverse Event|14|||
129978562|NCT01559129|467883737|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
129978563|NCT00368927|467883738|FG000|Overall Study|Lost to Follow-up|2|||
130149897|NCT02792218|468508636|FG000|Overall Study|Lost to Follow-up|10|||
130149898|NCT02792218|468508637|FG001|Overall Study|Lost to Follow-up|5|||
130149899|NCT02792218|468508636|FG000|Overall Study|Lack of Efficacy|1|||
130149900|NCT02792218|468508637|FG001|Overall Study|Lack of Efficacy|12|||
130149901|NCT02792218|468508636|FG000|Overall Study|Physician Decision|4|||
130149902|NCT02792218|468508637|FG001|Overall Study|Physician Decision|4|||
130149903|NCT02792218|468508636|FG000|Overall Study|Protocol deviation|3|||
130149904|NCT02792218|468508637|FG001|Overall Study|Protocol deviation|2|||
130149905|NCT02792218|468508636|FG000|Overall Study|New therapy for study indication|0|||
130149906|NCT02792218|468508637|FG001|Overall Study|New therapy for study indication|1|||
130149907|NCT02792218|468508636|FG000|Overall Study|Non-compliance with study treatment|0|||
130149908|NCT02792218|468508637|FG001|Overall Study|Non-compliance with study treatment|1|||
130149909|NCT02792218|468508636|FG000|Overall Study|Pregnancy|1|||
130149910|NCT02792218|468508637|FG001|Overall Study|Pregnancy|0|||
130149911|NCT00810602|468508638|FG000|Overall Study|Withdrawal by Subject|8|||
130149912|NCT00810602|468508639|FG001|Overall Study|Withdrawal by Subject|3|||
130149913|NCT00824369|468508640|FG000|Overall Study|Nolonger willing to participate in study|1|||
130149914|NCT00824369|468508641|FG001|Overall Study|Nolonger willing to participate in study|0|||
130149915|NCT00824369|468508642|FG002|Overall Study|Nolonger willing to participate in study|1|||
130149916|NCT00824369|468508643|FG003|Overall Study|Nolonger willing to participate in study|2|||
130149917|NCT00824369|468508644|FG004|Overall Study|Nolonger willing to participate in study|0|||
130149918|NCT00824369|468508645|FG005|Overall Study|Nolonger willing to participate in study|1|||
130149919|NCT00824369|468508640|FG000|Overall Study|Lost to Follow-up|0|||
130149920|NCT00824369|468508641|FG001|Overall Study|Lost to Follow-up|0|||
130149921|NCT00824369|468508642|FG002|Overall Study|Lost to Follow-up|0|||
130149922|NCT00824369|468508643|FG003|Overall Study|Lost to Follow-up|0|||
130149923|NCT00824369|468508644|FG004|Overall Study|Lost to Follow-up|1|||
130149924|NCT00824369|468508645|FG005|Overall Study|Lost to Follow-up|0|||
130149925|NCT03183141|468508652|FG000|Overall Study|Withdrawal by Subject|2|||
130149926|NCT03183141|468508653|FG001|Overall Study|Withdrawal by Subject|4|||
130149927|NCT03183141|468508652|FG000|Overall Study|Death|0|||
130149928|NCT03183141|468508653|FG001|Overall Study|Death|8|||
130149929|NCT02756637|468508655|FG000|Overall Study|Not eligible for initial SWOG study|10|||
130149930|NCT02756637|468508656|FG001|Overall Study|Not eligible for initial SWOG study|10|||
130149931|NCT02756637|468508655|FG000|Overall Study|No available NLR value|44|||
130149932|NCT02756637|468508656|FG001|Overall Study|No available NLR value|44|||
130149933|NCT02756637|468508655|FG000|Overall Study|Did not complete curative therapy|33|||
130149934|NCT02756637|468508656|FG001|Overall Study|Did not complete curative therapy|0|||
130149935|NCT01619579|468511144|FG000|Overall Study|Withdrawal by Subject|0|||
130149936|NCT01619579|468511145|FG001|Overall Study|Withdrawal by Subject|3|||
130149937|NCT02124902|468511146|FG000|Overall Study|Adverse Event|7|||
130149938|NCT02124902|468511147|FG001|Overall Study|Adverse Event|2|||
130149939|NCT02124902|468511146|FG000|Overall Study|Went to alternative treatment|4|||
130149940|NCT02124902|468511147|FG001|Overall Study|Went to alternative treatment|0|||
130149941|NCT02124902|468511146|FG000|Overall Study|Withdrawal by Subject|2|||
130149942|NCT02124902|468511147|FG001|Overall Study|Withdrawal by Subject|1|||
130149943|NCT02124902|468511146|FG000|Overall Study|Physician Decision|2|||
130149944|NCT02124902|468511147|FG001|Overall Study|Physician Decision|0|||
130149945|NCT02124902|468511146|FG000|Overall Study|Not eligible|1|||
130149946|NCT02124902|468511147|FG001|Overall Study|Not eligible|0|||
130149947|NCT02124902|468511146|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
130149948|NCT02124902|468511147|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
130149949|NCT02012452|468511151|FG000|Overall Study|Lost to Follow-up|2|||
130149950|NCT02012452|468511152|FG001|Overall Study|Lost to Follow-up|1|||
130149951|NCT02012452|468511151|FG000|Overall Study|Withdrawal by Subject|4|||
130149952|NCT02012452|468511152|FG001|Overall Study|Withdrawal by Subject|0|||
130149953|NCT02688387|468511153|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149954|NCT02688387|468511154|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149955|NCT02688387|468511155|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
130149956|NCT02688387|468511156|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149957|NCT02688387|468511157|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149958|NCT02688387|468511158|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149959|NCT02688387|468511159|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149960|NCT02688387|468511160|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149961|NCT02688387|468511161|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149962|NCT02688387|468511162|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149963|NCT02688387|468511163|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149964|NCT02688387|468511164|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149965|NCT02688387|468511165|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149966|NCT02688387|468511166|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149967|NCT02688387|468511167|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149968|NCT02688387|468511168|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149969|NCT02688387|468511169|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149970|NCT02688387|468511170|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149971|NCT02688387|468511171|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149972|NCT02688387|468511172|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149973|NCT02688387|468511173|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149974|NCT02688387|468511174|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
130149975|NCT02688387|468511153|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149976|NCT02688387|468511154|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149977|NCT02688387|468511155|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149978|NCT02688387|468511156|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
130149979|NCT02688387|468511157|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149980|NCT02688387|468511158|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149981|NCT02688387|468511159|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149982|NCT02688387|468511160|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149983|NCT02688387|468511161|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149984|NCT02688387|468511162|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149985|NCT02688387|468511163|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149986|NCT02688387|468511164|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149987|NCT02688387|468511165|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149988|NCT02688387|468511166|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149989|NCT02688387|468511167|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149990|NCT02688387|468511168|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149991|NCT02688387|468511169|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149992|NCT02688387|468511170|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149993|NCT02688387|468511171|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149994|NCT02688387|468511172|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149995|NCT02688387|468511173|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149996|NCT02688387|468511174|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130149997|NCT02688387|468511153|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130149998|NCT02688387|468511154|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
130149999|NCT02688387|468511155|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150000|NCT02688387|468511156|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150001|NCT02688387|468511157|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150002|NCT02688387|468511158|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150003|NCT02688387|468511159|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150004|NCT02688387|468511160|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150005|NCT02688387|468511161|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150006|NCT02688387|468511162|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150007|NCT02688387|468511163|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150008|NCT02688387|468511164|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150009|NCT02688387|468511165|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150010|NCT02688387|468511166|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150011|NCT02688387|468511167|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150012|NCT02688387|468511168|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150013|NCT02688387|468511169|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150014|NCT02688387|468511170|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150015|NCT02688387|468511171|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150016|NCT02688387|468511172|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150017|NCT02688387|468511173|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150018|NCT02688387|468511174|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
130150019|NCT02688387|468511153|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150020|NCT02688387|468511154|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150021|NCT02688387|468511155|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
130150022|NCT02688387|468511156|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150023|NCT02688387|468511157|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
130150024|NCT02688387|468511158|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150025|NCT02688387|468511159|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150026|NCT02688387|468511160|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150027|NCT02688387|468511161|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150028|NCT02688387|468511162|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150029|NCT02688387|468511163|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150030|NCT02688387|468511164|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150031|NCT02688387|468511165|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150032|NCT02688387|468511166|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150033|NCT02688387|468511167|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150034|NCT02688387|468511168|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150035|NCT02688387|468511169|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150036|NCT02688387|468511170|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150037|NCT02688387|468511171|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150038|NCT02688387|468511172|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150039|NCT02688387|468511173|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150040|NCT02688387|468511174|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
130150041|NCT02688387|468511153|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
130150042|NCT02688387|468511154|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150043|NCT02688387|468511155|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150044|NCT02688387|468511156|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150045|NCT02688387|468511157|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150046|NCT02688387|468511158|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150047|NCT02688387|468511159|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150048|NCT02688387|468511160|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150049|NCT02688387|468511161|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150050|NCT02688387|468511162|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150051|NCT02688387|468511163|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150052|NCT02688387|468511164|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150053|NCT02688387|468511165|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150054|NCT02688387|468511166|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150055|NCT02688387|468511167|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150056|NCT02688387|468511168|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150057|NCT02688387|468511169|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150058|NCT02688387|468511170|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150059|NCT02688387|468511171|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150060|NCT02688387|468511172|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150061|NCT02688387|468511173|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150062|NCT02688387|468511174|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
130150063|NCT02688387|468511153|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150064|NCT02688387|468511154|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150065|NCT02688387|468511155|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150066|NCT02688387|468511156|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150067|NCT02688387|468511157|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150068|NCT02688387|468511158|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150069|NCT02688387|468511159|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150070|NCT02688387|468511160|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150071|NCT02688387|468511161|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150072|NCT02688387|468511162|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150073|NCT02688387|468511163|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
130150074|NCT02688387|468511164|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150075|NCT02688387|468511165|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150076|NCT02688387|468511166|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150077|NCT02688387|468511167|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150078|NCT02688387|468511168|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150079|NCT02688387|468511169|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150080|NCT02688387|468511170|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150081|NCT02688387|468511171|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150082|NCT02688387|468511172|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150083|NCT02688387|468511173|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150084|NCT02688387|468511174|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
130150085|NCT02688387|468511153|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150086|NCT02688387|468511154|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150087|NCT02688387|468511155|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150088|NCT02688387|468511156|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150089|NCT02688387|468511157|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150090|NCT02688387|468511158|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150091|NCT02688387|468511159|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150092|NCT02688387|468511160|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150093|NCT02688387|468511161|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150094|NCT02688387|468511162|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150095|NCT02688387|468511163|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150096|NCT02688387|468511164|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150097|NCT02688387|468511165|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150098|NCT02688387|468511166|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150099|NCT02688387|468511167|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
130150100|NCT02688387|468511168|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150101|NCT02688387|468511169|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150102|NCT02688387|468511170|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150103|NCT02688387|468511171|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150104|NCT02688387|468511172|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150105|NCT02688387|468511173|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150106|NCT02688387|468511174|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
130150107|NCT02688387|468511153|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150108|NCT02688387|468511154|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150109|NCT02688387|468511155|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150110|NCT02688387|468511156|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150111|NCT02688387|468511157|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150112|NCT02688387|468511158|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150113|NCT02688387|468511159|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150114|NCT02688387|468511160|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150115|NCT02688387|468511161|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150116|NCT02688387|468511162|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150117|NCT02688387|468511163|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150118|NCT02688387|468511164|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150119|NCT02688387|468511165|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150120|NCT02688387|468511166|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150121|NCT02688387|468511167|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150122|NCT02688387|468511168|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150123|NCT02688387|468511169|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150124|NCT02688387|468511170|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150125|NCT02688387|468511171|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150126|NCT02688387|468511172|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150127|NCT02688387|468511173|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
130150128|NCT02688387|468511174|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
130150129|NCT02688387|468511153|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150130|NCT02688387|468511154|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150131|NCT02688387|468511155|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150132|NCT02688387|468511156|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150133|NCT02688387|468511157|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150134|NCT02688387|468511158|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150135|NCT02688387|468511159|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150136|NCT02688387|468511160|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150137|NCT02688387|468511161|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150138|NCT02688387|468511162|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150139|NCT02688387|468511163|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150140|NCT02688387|468511164|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150141|NCT02688387|468511165|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150142|NCT02688387|468511166|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150143|NCT02688387|468511167|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150144|NCT02688387|468511168|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150145|NCT02688387|468511169|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150146|NCT02688387|468511170|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150147|NCT02688387|468511171|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
130150148|NCT02688387|468511172|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150149|NCT02688387|468511173|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
130150150|NCT02688387|468511174|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
130150151|NCT02688387|468511153|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150152|NCT02688387|468511154|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150153|NCT02688387|468511155|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150154|NCT02688387|468511156|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150155|NCT02688387|468511157|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150156|NCT02688387|468511158|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150157|NCT02688387|468511159|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150158|NCT02688387|468511160|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150159|NCT02688387|468511161|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150160|NCT02688387|468511162|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150161|NCT02688387|468511163|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150162|NCT02688387|468511164|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150163|NCT02688387|468511165|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150164|NCT02688387|468511166|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150165|NCT02688387|468511167|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150166|NCT02688387|468511168|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150167|NCT02688387|468511169|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150168|NCT02688387|468511170|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150169|NCT02688387|468511171|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150170|NCT02688387|468511172|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
130150171|NCT02688387|468511173|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150172|NCT02688387|468511174|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
130150173|NCT02190279|468511175|FG000|Overall Study|Withdrawal consent|1|||
130150174|NCT02190279|468511176|FG001|Overall Study|Withdrawal consent|0|||
130150175|NCT02190279|468511177|FG002|Overall Study|Withdrawal consent|1|||
130150176|NCT02190279|468511175|FG000|Overall Study|Lost to Follow-up|2|||
130150177|NCT02190279|468511176|FG001|Overall Study|Lost to Follow-up|0|||
130150178|NCT02190279|468511177|FG002|Overall Study|Lost to Follow-up|0|||
130150179|NCT02190279|468511175|FG000|Overall Study|Refused further treatment|0|||
130150180|NCT02190279|468511176|FG001|Overall Study|Refused further treatment|0|||
130150181|NCT02190279|468511177|FG002|Overall Study|Refused further treatment|1|||
130150182|NCT02190279|468511175|FG000|Overall Study|Screening failure|0|||
130150183|NCT02190279|468511176|FG001|Overall Study|Screening failure|0|||
130150184|NCT02190279|468511177|FG002|Overall Study|Screening failure|1|||
130150185|NCT02938442|468511180|FG000|Overall Study|Death|0|||
130150186|NCT02938442|468511181|FG001|Overall Study|Death|1|||
130150187|NCT02938442|468511180|FG000|Overall Study|Lost to Follow-up|0|||
130150188|NCT02938442|468511181|FG001|Overall Study|Lost to Follow-up|1|||
130150189|NCT02938442|468511180|FG000|Overall Study|Physician Decision|0|||
130150190|NCT02938442|468511181|FG001|Overall Study|Physician Decision|1|||
130150191|NCT02938442|468511180|FG000|Overall Study|Withdrawal by Subject|2|||
130150192|NCT02938442|468511181|FG001|Overall Study|Withdrawal by Subject|0|||
130150193|NCT04403399|468511182|FG000|Period 2|Physician Decision|0|||
130150194|NCT04403399|468511183|FG001|Period 2|Physician Decision|1|||
130150195|NCT01606228|468511185|FG000|Overall Study|Lost to Follow-up|20|||
130150196|NCT01606228|468511185|FG000|Overall Study|Withdrawal by Subject|3|||
130150197|NCT01606228|468511185|FG000|Overall Study|Non-compliant|3|||
130150198|NCT01606228|468511185|FG000|Overall Study|Lack of Efficacy|2|||
130150199|NCT01606228|468511185|FG000|Overall Study|Adverse Event|1|||
130150200|NCT00546910|468511186|FG000|Overall Study|Adverse Event|2|||
130150201|NCT00546910|468511187|FG001|Overall Study|Adverse Event|3|||
130150202|NCT00546910|468511186|FG000|Overall Study|Lack of Efficacy|5|||
130150203|NCT00546910|468511187|FG001|Overall Study|Lack of Efficacy|7|||
130150204|NCT00546910|468511186|FG000|Overall Study|Physician Decision|0|||
130150205|NCT00546910|468511187|FG001|Overall Study|Physician Decision|1|||
130150206|NCT00546910|468511186|FG000|Overall Study|Withdrawal by Subject|2|||
130150207|NCT00546910|468511187|FG001|Overall Study|Withdrawal by Subject|0|||
130150208|NCT01115855|468511188|FG000|Overall Study|Adverse Event|16|||
130150209|NCT01115855|468511189|FG001|Overall Study|Adverse Event|18|||
130150210|NCT01115855|468511188|FG000|Overall Study|Death|6|||
130150211|NCT01115855|468511189|FG001|Overall Study|Death|5|||
130150212|NCT01115855|468511188|FG000|Overall Study|Lab Abnormality|1|||
130150213|NCT01115855|468511189|FG001|Overall Study|Lab Abnormality|1|||
130150214|NCT01115855|468511188|FG000|Overall Study|Protocol Violation|0|||
130150215|NCT01115855|468511189|FG001|Overall Study|Protocol Violation|1|||
130150216|NCT01115855|468511188|FG000|Overall Study|Withdrawal by Subject|5|||
130150217|NCT01115855|468511189|FG001|Overall Study|Withdrawal by Subject|5|||
130150218|NCT01115855|468511188|FG000|Overall Study|Other|8|||
130150219|NCT01115855|468511189|FG001|Overall Study|Other|6|||
130150220|NCT02284347|468511190|FG000|Overall Study|Lost to Follow-up|2|||
130150221|NCT02284347|468511190|FG000|Overall Study|Withdrawn prior to treatment|1|||
130150222|NCT02960438|468511194|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
130150223|NCT02960438|468511195|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
130150224|NCT02960438|468511196|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
130150225|NCT02960438|468511197|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
130150226|NCT02960438|468511194|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
130150227|NCT02960438|468511195|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
130150228|NCT02960438|468511196|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
130150229|NCT02960438|468511197|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
130150230|NCT02960438|468511194|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
130150231|NCT02960438|468511195|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130150232|NCT02960438|468511196|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130150233|NCT02960438|468511197|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
130150234|NCT02960438|468511194|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
130150235|NCT02960438|468511195|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
130150236|NCT02960438|468511196|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
130150237|NCT02960438|468511197|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
130150238|NCT02960438|468511194|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130150239|NCT02960438|468511195|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130150240|NCT02960438|468511196|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
130150241|NCT02960438|468511197|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
130150242|NCT02960438|468511194|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
130150243|NCT02960438|468511195|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
130150244|NCT02960438|468511196|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
130150245|NCT02960438|468511197|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
130150246|NCT02960438|468511194|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
130150247|NCT02960438|468511195|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
130150248|NCT02960438|468511196|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
130150249|NCT02960438|468511197|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
130150250|NCT02960438|468511194|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130150251|NCT02960438|468511195|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130150252|NCT02960438|468511196|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
130150253|NCT02960438|468511197|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
130150254|NCT02960438|468511194|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130150255|NCT02960438|468511195|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130150256|NCT02960438|468511196|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
130150257|NCT02960438|468511197|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
130150258|NCT02960438|468511194|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
130150259|NCT02960438|468511195|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
130150260|NCT02960438|468511196|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
130150261|NCT02960438|468511197|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
130150262|NCT02960438|468511194|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
130150263|NCT02960438|468511195|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
130150264|NCT02960438|468511196|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
130150265|NCT02960438|468511197|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
130150266|NCT02960438|468511194|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
130150267|NCT02960438|468511195|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
130150268|NCT02960438|468511196|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
130150269|NCT02960438|468511197|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
130150270|NCT01316419|468511205|FG000|Overall Study|Not treated|103|||
130150271|NCT01316419|468511205|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
130150272|NCT01316419|468511205|FG000|Overall Study|Lost to Follow-up|19|||
130150273|NCT04039919|468511208|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130150274|NCT04039919|468511209|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130150275|NCT04039919|468511210|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130150276|NCT04039919|468511211|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130150277|NCT04039919|468511212|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130150278|NCT04039919|468511208|FG000|Treatment Period 1|Sponsor's decision|0|||
130150279|NCT04039919|468511209|FG001|Treatment Period 1|Sponsor's decision|0|||
130150280|NCT04039919|468511210|FG002|Treatment Period 1|Sponsor's decision|0|||
130150281|NCT04039919|468511211|FG003|Treatment Period 1|Sponsor's decision|0|||
130150282|NCT04039919|468511212|FG004|Treatment Period 1|Sponsor's decision|16|||
130150283|NCT04039919|468511208|FG000|Treatment Period 5|Withdrawal by Subject|1|||
130150284|NCT04039919|468511209|FG001|Treatment Period 5|Withdrawal by Subject|0|||
130150285|NCT04039919|468511210|FG002|Treatment Period 5|Withdrawal by Subject|0|||
130150286|NCT04039919|468511211|FG003|Treatment Period 5|Withdrawal by Subject|0|||
130150287|NCT04039919|468511212|FG004|Treatment Period 5|Withdrawal by Subject|0|||
130150288|NCT00754013|468511213|FG000|Overall Study|Lost to Follow-up|1|||
130150289|NCT00754013|468511214|FG001|Overall Study|Lost to Follow-up|1|||
130150290|NCT00754013|468511213|FG000|Overall Study|didn't return after study termed|3|||
130150291|NCT00754013|468511214|FG001|Overall Study|didn't return after study termed|4|||
130150292|NCT02310789|468511215|FG000|Overall Study|Adverse Event|1|||
130150293|NCT00983918|468511216|FG000|Overall Study|conversion to open cholecystectomy|0|||
130150294|NCT00983918|468511217|FG001|Overall Study|conversion to open cholecystectomy|2|||
130150295|NCT00983918|468511218|FG002|Overall Study|conversion to open cholecystectomy|2|||
130150296|NCT00983918|468511219|FG003|Overall Study|conversion to open cholecystectomy|2|||
130150297|NCT00794417|468511222|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130150298|NCT00794417|468511223|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130150299|NCT00794417|468511224|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
130150300|NCT00794417|468511225|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
130150301|NCT00794417|468511222|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
130150302|NCT00794417|468511223|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
130150303|NCT00794417|468511224|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
130150304|NCT00794417|468511225|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
130150305|NCT00794417|468511222|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130150306|NCT00794417|468511223|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130150307|NCT00794417|468511224|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
130150308|NCT00794417|468511225|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
130150309|NCT00794417|468511222|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130150310|NCT00794417|468511223|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130150311|NCT00794417|468511224|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
130150312|NCT00794417|468511225|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
130150313|NCT00794417|468511222|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130150314|NCT00794417|468511223|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130150315|NCT00794417|468511224|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
130150316|NCT00794417|468511225|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
130150317|NCT00794417|468511222|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130150318|NCT00794417|468511223|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130150319|NCT00794417|468511224|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
130150320|NCT00794417|468511225|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
130150321|NCT00804141|468511228|FG000|Overall Study|Adverse Event|157|||
130150322|NCT00804141|468511228|FG000|Overall Study|Death|4|||
130150323|NCT00804141|468511228|FG000|Overall Study|Failed to return|96|||
130150324|NCT00804141|468511228|FG000|Overall Study|Investigator request|8|||
130150325|NCT00804141|468511228|FG000|Overall Study|Protocol Violation|85|||
130150326|NCT00804141|468511228|FG000|Overall Study|Withdrawal by Subject|131|||
130150327|NCT00804141|468511228|FG000|Overall Study|Lack of Efficacy|46|||
130150328|NCT00804141|468511228|FG000|Overall Study|Other than specified|30|||
130150329|NCT00804141|468511228|FG000|Overall Study|Enrolled but not treated|6|||
130150330|NCT00572039|468511229|FG000|Overall Study|Withdrawal by Subject|9|||
130150331|NCT00572039|468511230|FG001|Overall Study|Withdrawal by Subject|6|||
130150332|NCT00572039|468511229|FG000|Overall Study|Death|2|||
130150333|NCT00572039|468511230|FG001|Overall Study|Death|3|||
130150334|NCT00572039|468511229|FG000|Overall Study|Ill|5|||
130150335|NCT00572039|468511230|FG001|Overall Study|Ill|1|||
130150336|NCT01470417|468511233|FG000|Overall Study|Disease progression|0|||
130150337|NCT01470417|468511234|FG001|Overall Study|Disease progression|2|||
130150338|NCT02973321|468511235|FG000|Overall Study|Other than specified|0|||
130150339|NCT02973321|468511236|FG001|Overall Study|Other than specified|5|||
130150340|NCT02973321|468511237|FG002|Overall Study|Other than specified|3|||
130150341|NCT02973321|468511238|FG003|Overall Study|Other than specified|3|||
130150342|NCT02973321|468511239|FG004|Overall Study|Other than specified|1|||
130150343|NCT02973321|468511235|FG000|Overall Study|Lack of Efficacy|0|||
130150344|NCT02973321|468511236|FG001|Overall Study|Lack of Efficacy|0|||
130150345|NCT02973321|468511237|FG002|Overall Study|Lack of Efficacy|0|||
130150346|NCT02973321|468511238|FG003|Overall Study|Lack of Efficacy|0|||
130150347|NCT02973321|468511239|FG004|Overall Study|Lack of Efficacy|1|||
130150348|NCT02973321|468511235|FG000|Overall Study|Adverse Event|1|||
130150349|NCT02973321|468511236|FG001|Overall Study|Adverse Event|10|||
130150350|NCT02973321|468511237|FG002|Overall Study|Adverse Event|11|||
130150351|NCT02973321|468511238|FG003|Overall Study|Adverse Event|13|||
130150352|NCT02973321|468511239|FG004|Overall Study|Adverse Event|3|||
130150353|NCT01790113|468511246|FG000|Overall Study|Adverse Event|2|||
130150354|NCT01790113|468511247|FG001|Overall Study|Adverse Event|7|||
130150355|NCT01790113|468511246|FG000|Overall Study|Study ended due to FDA clearance|1|||
130150356|NCT01790113|468511247|FG001|Overall Study|Study ended due to FDA clearance|68|||
130150357|NCT03920280|468511248|FG000|Overall Study|Adverse Event|2|||
130150358|NCT03920280|468511249|FG001|Overall Study|Adverse Event|3|||
130150359|NCT03920280|468511248|FG000|Overall Study|Lost to Follow-up|0|||
130150360|NCT03920280|468511249|FG001|Overall Study|Lost to Follow-up|1|||
130150361|NCT03920280|468511248|FG000|Overall Study|Withdrawal by Subject|1|||
130150362|NCT03920280|468511249|FG001|Overall Study|Withdrawal by Subject|1|||
130150363|NCT03920280|468511248|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
130150364|NCT03920280|468511249|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
130150365|NCT02487082|468511250|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
130150366|NCT02487082|468511251|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
130150367|NCT02487082|468511250|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
130150368|NCT02487082|468511251|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
130150369|NCT03297294|468511252|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
130150370|NCT03297294|468511253|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
130150371|NCT03297294|468511254|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130150372|NCT03297294|468511255|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130150373|NCT03297294|468511256|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
130150374|NCT03297294|468511252|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
130150375|NCT03297294|468511253|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
130150376|NCT03297294|468511254|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130150377|NCT03297294|468511255|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130150378|NCT03297294|468511256|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
130150379|NCT03297294|468511252|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
130150380|NCT03297294|468511253|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
130150381|NCT03297294|468511254|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130150382|NCT03297294|468511255|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130150383|NCT03297294|468511256|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
130150384|NCT03297294|468511252|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130150385|NCT03297294|468511253|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
130150386|NCT03297294|468511254|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130150387|NCT03297294|468511255|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130150388|NCT03297294|468511256|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
130150389|NCT03297294|468511252|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130150390|NCT03297294|468511253|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130150391|NCT03297294|468511254|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130150392|NCT03297294|468511255|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
130150393|NCT03297294|468511256|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
130150394|NCT01198873|468511257|FG000|Overall Study|Adverse Event|4|||
130150395|NCT01198873|468511258|FG001|Overall Study|Adverse Event|7|||
130150396|NCT01198873|468511257|FG000|Overall Study|Study closure|29|||
130150397|NCT01198873|468511258|FG001|Overall Study|Study closure|23|||
130150398|NCT01198873|468511257|FG000|Overall Study|Other than above|4|||
130150399|NCT01198873|468511258|FG001|Overall Study|Other than above|2|||
130150400|NCT03139240|468511259|FG000|Overall Study|Lost to Follow-up|0|||
130150401|NCT03139240|468511260|FG001|Overall Study|Lost to Follow-up|1|||
130150402|NCT03139240|468511261|FG002|Overall Study|Lost to Follow-up|1|||
130150403|NCT03139240|468511262|FG003|Overall Study|Lost to Follow-up|0|||
130150404|NCT00268892|468511263|FG000|Overall Study|Adverse Event|14|||
130150405|NCT00268892|468511264|FG001|Overall Study|Adverse Event|17|||
130150406|NCT00268892|468511265|FG002|Overall Study|Adverse Event|20|||
130150407|NCT00268892|468511263|FG000|Overall Study|Lack of Efficacy|1|||
130150408|NCT00268892|468511264|FG001|Overall Study|Lack of Efficacy|3|||
130150409|NCT00268892|468511265|FG002|Overall Study|Lack of Efficacy|0|||
130150410|NCT00268892|468511263|FG000|Overall Study|Withdrawal by Subject|14|||
130150411|NCT00268892|468511264|FG001|Overall Study|Withdrawal by Subject|15|||
130150412|NCT00268892|468511265|FG002|Overall Study|Withdrawal by Subject|13|||
130150413|NCT00268892|468511263|FG000|Overall Study|Physician Decision|0|||
130150414|NCT00268892|468511264|FG001|Overall Study|Physician Decision|1|||
130150415|NCT00268892|468511265|FG002|Overall Study|Physician Decision|0|||
130150416|NCT00268892|468511263|FG000|Overall Study|Lost to Follow-up|5|||
130150417|NCT00268892|468511264|FG001|Overall Study|Lost to Follow-up|2|||
130150418|NCT00268892|468511265|FG002|Overall Study|Lost to Follow-up|4|||
130150419|NCT00268892|468511263|FG000|Overall Study|Protocol Violation|0|||
130150420|NCT00268892|468511264|FG001|Overall Study|Protocol Violation|1|||
130150421|NCT00268892|468511265|FG002|Overall Study|Protocol Violation|0|||
130150422|NCT00268892|468511263|FG000|Overall Study|Disease Progression|1|||
130150423|NCT00268892|468511264|FG001|Overall Study|Disease Progression|1|||
130150424|NCT00268892|468511265|FG002|Overall Study|Disease Progression|0|||
130150425|NCT00268892|468511263|FG000|Overall Study|Trial Site Closed|4|||
130150426|NCT00268892|468511264|FG001|Overall Study|Trial Site Closed|2|||
130150427|NCT00268892|468511265|FG002|Overall Study|Trial Site Closed|2|||
130150428|NCT02492841|468511266|FG000|Overall Study|Lost to Follow-up|34|||
130150429|NCT02492841|468511267|FG001|Overall Study|Lost to Follow-up|31|||
130150430|NCT02492841|468511268|FG002|Overall Study|Lost to Follow-up|35|||
130150431|NCT02260258|468511273|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
130150432|NCT02260258|468511274|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
130150433|NCT02563769|468511275|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
130150434|NCT02563769|468511276|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
130150435|NCT02563769|468511277|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
130150436|NCT00690482|468511280|FG000|Overall Study|Adverse Event|2|||
130150437|NCT00690482|468511281|FG001|Overall Study|Adverse Event|1|||
130150438|NCT00690482|468511280|FG000|Overall Study|Incorrect enrolment|0|||
130150439|NCT00690482|468511281|FG001|Overall Study|Incorrect enrolment|1|||
130150440|NCT00690482|468511280|FG000|Overall Study|Study-specific discontinuation criteria|1|||
130150441|NCT00690482|468511281|FG001|Overall Study|Study-specific discontinuation criteria|0|||
130150442|NCT00690482|468511280|FG000|Overall Study|Intake of prohibited medicine|1|||
130150443|NCT00690482|468511281|FG001|Overall Study|Intake of prohibited medicine|0|||
130150444|NCT00690482|468511280|FG000|Overall Study|withdrew consent at rand.day|0|||
130150445|NCT00690482|468511281|FG001|Overall Study|withdrew consent at rand.day|1|||
130150446|NCT01610063|468511282|FG000|Overall Study|Lost to Follow-up|42|||
130150447|NCT01610063|468511283|FG001|Overall Study|Lost to Follow-up|20|||
130150448|NCT04405739|468511284|FG000|Overall Study|Adverse Event|0|||
130150449|NCT04405739|468511285|FG001|Overall Study|Adverse Event|1|||
130150450|NCT04405739|468511286|FG002|Overall Study|Adverse Event|0|||
130150451|NCT04405739|468511287|FG003|Overall Study|Adverse Event|0|||
130150452|NCT04405739|468511284|FG000|Overall Study|Lost to Follow-up|0|||
130150453|NCT04405739|468511285|FG001|Overall Study|Lost to Follow-up|2|||
130150454|NCT04405739|468511286|FG002|Overall Study|Lost to Follow-up|1|||
130150455|NCT04405739|468511287|FG003|Overall Study|Lost to Follow-up|3|||
130150456|NCT04405739|468511284|FG000|Overall Study|Withdrawal by Subject|0|||
130150457|NCT04405739|468511285|FG001|Overall Study|Withdrawal by Subject|2|||
130150458|NCT04405739|468511286|FG002|Overall Study|Withdrawal by Subject|1|||
130150459|NCT04405739|468511287|FG003|Overall Study|Withdrawal by Subject|1|||
130150460|NCT04405739|468511284|FG000|Overall Study|Death|0|||
130150461|NCT04405739|468511285|FG001|Overall Study|Death|0|||
130150462|NCT04405739|468511286|FG002|Overall Study|Death|1|||
130150463|NCT04405739|468511287|FG003|Overall Study|Death|0|||
130150464|NCT04405739|468511284|FG000|Overall Study|Transferred to rehab|0|||
130150465|NCT04405739|468511285|FG001|Overall Study|Transferred to rehab|0|||
130150466|NCT04405739|468511286|FG002|Overall Study|Transferred to rehab|0|||
130150467|NCT04405739|468511287|FG003|Overall Study|Transferred to rehab|1|||
130150468|NCT04405739|468511284|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
130150469|NCT04405739|468511285|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
130150470|NCT04405739|468511286|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
130150471|NCT04405739|468511287|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
130150472|NCT01436643|468511288|FG000|2-week Pre-treatment|Abnormal test result|0|||
130150473|NCT01436643|468511289|FG001|2-week Pre-treatment|Abnormal test result|0|||
130150474|NCT01436643|468511290|FG002|2-week Pre-treatment|Abnormal test result|0|||
130150475|NCT01436643|468511291|FG003|2-week Pre-treatment|Abnormal test result|1|||
130150476|NCT01436643|468511288|FG000|2-week Pre-treatment|Adverse Event|0|||
130150477|NCT01436643|468511289|FG001|2-week Pre-treatment|Adverse Event|0|||
130150478|NCT01436643|468511290|FG002|2-week Pre-treatment|Adverse Event|0|||
130150479|NCT01436643|468511291|FG003|2-week Pre-treatment|Adverse Event|5|||
130150480|NCT01436643|468511288|FG000|2-week Pre-treatment|Protocol Violation|0|||
130150481|NCT01436643|468511289|FG001|2-week Pre-treatment|Protocol Violation|0|||
130150482|NCT01436643|468511290|FG002|2-week Pre-treatment|Protocol Violation|0|||
130150483|NCT01436643|468511291|FG003|2-week Pre-treatment|Protocol Violation|4|||
130150484|NCT01436643|468511288|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
130150485|NCT01436643|468511289|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
130150486|NCT01436643|468511290|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
130150487|NCT01436643|468511291|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
130150488|NCT01436643|468511288|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
130150489|NCT01436643|468511289|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
130150490|NCT01436643|468511290|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
130150491|NCT01436643|468511291|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
130150492|NCT01436643|468511288|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
130150493|NCT01436643|468511289|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
130150494|NCT01436643|468511290|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
130150495|NCT01436643|468511291|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
130150496|NCT03718117|468511292|FG000|Overall Study|Death|12|||
130150497|NCT03718117|468511293|FG001|Overall Study|Death|11|||
130150498|NCT03718117|468511294|FG002|Overall Study|Death|0|||
130150499|NCT03718117|468511292|FG000|Overall Study|Other|0|||
130150500|NCT03718117|468511293|FG001|Overall Study|Other|1|||
130150501|NCT03718117|468511294|FG002|Overall Study|Other|0|||
130150502|NCT03718117|468511292|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
130150503|NCT03718117|468511293|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
130150504|NCT03718117|468511294|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
130150505|NCT03718117|468511292|FG000|Overall Study|Participant not met eligibility criteria|0|||
130150506|NCT03718117|468511293|FG001|Overall Study|Participant not met eligibility criteria|0|||
130150507|NCT03718117|468511294|FG002|Overall Study|Participant not met eligibility criteria|2|||
130150508|NCT02056652|468511297|FG000|Overall Study|Withdrawal by Subject|1|||
130150509|NCT02056652|468511298|FG001|Overall Study|Withdrawal by Subject|0|||
130150510|NCT02056652|468511297|FG000|Overall Study|Lost to Follow-up|0|||
130150511|NCT02056652|468511298|FG001|Overall Study|Lost to Follow-up|3|||
130150512|NCT04232540|468511299|FG000|Overall Study|Lost to Follow-up|1|||
130150513|NCT04232540|468511300|FG001|Overall Study|Lost to Follow-up|0|||
130150514|NCT02105701|468511301|FG000|Overall Study|Lost to Follow-up|1|||
130150515|NCT02105701|468511302|FG001|Overall Study|Lost to Follow-up|0|||
130150516|NCT02105701|468511303|FG002|Overall Study|Lost to Follow-up|2|||
130150517|NCT02105701|468511304|FG003|Overall Study|Lost to Follow-up|1|||
130150518|NCT02105701|468511301|FG000|Overall Study|Protocol Violation|0|||
130150519|NCT02105701|468511302|FG001|Overall Study|Protocol Violation|0|||
130150520|NCT02105701|468511303|FG002|Overall Study|Protocol Violation|1|||
130150521|NCT02105701|468511304|FG003|Overall Study|Protocol Violation|0|||
130150522|NCT02105701|468511301|FG000|Overall Study|Withdrawal by Subject|2|||
130150523|NCT02105701|468511302|FG001|Overall Study|Withdrawal by Subject|1|||
130150524|NCT02105701|468511303|FG002|Overall Study|Withdrawal by Subject|0|||
130150525|NCT02105701|468511304|FG003|Overall Study|Withdrawal by Subject|1|||
130150526|NCT02105701|468511301|FG000|Overall Study|Death|1|||
130150527|NCT02105701|468511302|FG001|Overall Study|Death|0|||
130150528|NCT02105701|468511303|FG002|Overall Study|Death|0|||
130150529|NCT02105701|468511304|FG003|Overall Study|Death|0|||
130150530|NCT02148445|468511305|FG000|Overall Study|Death|1|||
130150531|NCT02148445|468511306|FG001|Overall Study|Death|3|||
130150532|NCT03450629|468511307|FG000|Overall Study|Adverse Event|15|||
130150533|NCT03450629|468511308|FG001|Overall Study|Adverse Event|14|||
130150534|NCT03450629|468511307|FG000|Overall Study|Physician Decision|2|||
130150535|NCT03450629|468511308|FG001|Overall Study|Physician Decision|2|||
130150536|NCT03450629|468511307|FG000|Overall Study|Lack of Efficacy|2|||
130150537|NCT03450629|468511308|FG001|Overall Study|Lack of Efficacy|0|||
130150538|NCT03450629|468511307|FG000|Overall Study|Lost to Follow-up|4|||
130150539|NCT03450629|468511308|FG001|Overall Study|Lost to Follow-up|2|||
130150540|NCT03450629|468511307|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
130150541|NCT03450629|468511308|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130150542|NCT03450629|468511307|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130150543|NCT03450629|468511308|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130150544|NCT03450629|468511307|FG000|Overall Study|Protocol Violation|11|||
130150545|NCT03450629|468511308|FG001|Overall Study|Protocol Violation|8|||
130150546|NCT03450629|468511307|FG000|Overall Study|Withdrawal by Subject|12|||
130150547|NCT03450629|468511308|FG001|Overall Study|Withdrawal by Subject|6|||
130150548|NCT04230876|468511309|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
130150549|NCT04230876|468511310|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
130150550|NCT03438006|468511314|FG000|Overall Study|Adverse Event|1|||
130150551|NCT03438006|468511314|FG000|Overall Study|Lost to Follow-up|67|||
130150552|NCT03438006|468511314|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
130150553|NCT03438006|468511314|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
130150554|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
130150555|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150556|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150557|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150558|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150559|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150560|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150561|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150562|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
130150563|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
130150564|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150565|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150566|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150567|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150568|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150569|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150570|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150571|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
130150572|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
130150573|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150574|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150575|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150576|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150577|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150578|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150579|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150580|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
130150581|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
130150582|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150583|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150584|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150585|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150586|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150587|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150588|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150589|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
130150590|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
130150591|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150592|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150593|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150594|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150595|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150596|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150597|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150598|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
130150599|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
130150600|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150601|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150602|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150603|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150604|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129978564|NCT00368927|467883739|FG001|Overall Study|Lost to Follow-up|0|||
130150605|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150606|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150607|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
130150608|NCT00739973|468511325|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
130150609|NCT00739973|468511326|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150610|NCT00739973|468511327|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150611|NCT00739973|468511328|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150612|NCT00739973|468511329|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150613|NCT00739973|468511330|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150614|NCT00739973|468511331|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150615|NCT00739973|468511332|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150616|NCT00739973|468511333|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
130150617|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130150618|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130150619|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
130150620|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
130150621|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
130150622|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
130150623|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
130150624|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
130150625|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
130150626|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150627|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150628|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150629|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150630|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
130150631|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150632|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150633|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
130150634|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
130150635|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
130150636|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
130150637|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150638|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150639|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150640|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150641|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150642|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150643|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
130150644|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
130150645|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
130150646|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
130150647|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
130150648|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130150649|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130150650|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
130150651|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
130150652|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
130150653|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150654|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150655|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
130150656|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150657|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150658|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150659|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150660|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150661|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
130150662|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130150663|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
130150664|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130150665|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
130150666|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130150667|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130150668|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
130150669|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
130150670|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
130150671|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
130150672|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130150673|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
130150674|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
130150675|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130150676|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
130150677|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
130150678|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
130150679|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
130150680|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150681|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150682|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150683|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150684|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150685|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150686|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
130150687|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150688|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
130150689|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
130150690|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130150691|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
130150692|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130150693|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130150694|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
130150695|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130150696|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
130150697|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
130150698|NCT00739973|468511325|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150699|NCT00739973|468511326|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
130150700|NCT00739973|468511327|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150701|NCT00739973|468511328|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150702|NCT00739973|468511329|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150703|NCT00739973|468511330|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150704|NCT00739973|468511331|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
130150705|NCT00739973|468511332|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150706|NCT00739973|468511333|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
130150707|NCT03078478|468511334|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
130150708|NCT03078478|468511335|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
130150709|NCT03078478|468511334|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
130150710|NCT03078478|468511335|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
130150711|NCT03078478|468511334|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
130150712|NCT03078478|468511335|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
130150713|NCT03078478|468511334|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
130150714|NCT03078478|468511335|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
130150715|NCT03078478|468511334|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
130150716|NCT03078478|468511335|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
130150717|NCT03078478|468511334|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
130150718|NCT03078478|468511335|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
130150719|NCT03078478|468511334|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
130150720|NCT03078478|468511335|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
130150721|NCT03078478|468511334|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
130150722|NCT03078478|468511335|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
130150723|NCT03253094|468511337|FG000|Overall Study|Adverse Event|2|||
130150724|NCT03253094|468511338|FG001|Overall Study|Adverse Event|0|||
130150725|NCT03253094|468511339|FG002|Overall Study|Adverse Event|0|||
130150726|NCT03253094|468511340|FG003|Overall Study|Adverse Event|0|||
130150727|NCT03253094|468511341|FG004|Overall Study|Adverse Event|0|||
130150728|NCT03253094|468511342|FG005|Overall Study|Adverse Event|0|||
130150729|NCT03253094|468511337|FG000|Overall Study|Lack of Efficacy|0|||
130150730|NCT03253094|468511338|FG001|Overall Study|Lack of Efficacy|0|||
130150731|NCT03253094|468511339|FG002|Overall Study|Lack of Efficacy|2|||
130150732|NCT03253094|468511340|FG003|Overall Study|Lack of Efficacy|1|||
130150733|NCT03253094|468511341|FG004|Overall Study|Lack of Efficacy|2|||
130150734|NCT03253094|468511342|FG005|Overall Study|Lack of Efficacy|1|||
130150735|NCT03253094|468511337|FG000|Overall Study|Lost to Follow-up|0|||
130150736|NCT03253094|468511338|FG001|Overall Study|Lost to Follow-up|0|||
130150737|NCT03253094|468511339|FG002|Overall Study|Lost to Follow-up|1|||
130150738|NCT03253094|468511340|FG003|Overall Study|Lost to Follow-up|1|||
130150739|NCT03253094|468511341|FG004|Overall Study|Lost to Follow-up|0|||
130150740|NCT03253094|468511342|FG005|Overall Study|Lost to Follow-up|1|||
130150741|NCT03253094|468511337|FG000|Overall Study|Physician Decision|1|||
130150742|NCT03253094|468511338|FG001|Overall Study|Physician Decision|0|||
130150743|NCT03253094|468511339|FG002|Overall Study|Physician Decision|0|||
130150744|NCT03253094|468511340|FG003|Overall Study|Physician Decision|1|||
130150745|NCT03253094|468511341|FG004|Overall Study|Physician Decision|0|||
130150746|NCT03253094|468511342|FG005|Overall Study|Physician Decision|2|||
130150747|NCT03253094|468511337|FG000|Overall Study|Withdrawal by Subject|1|||
130150748|NCT03253094|468511338|FG001|Overall Study|Withdrawal by Subject|2|||
130150749|NCT03253094|468511339|FG002|Overall Study|Withdrawal by Subject|1|||
130150750|NCT03253094|468511340|FG003|Overall Study|Withdrawal by Subject|0|||
130150751|NCT03253094|468511341|FG004|Overall Study|Withdrawal by Subject|3|||
130150752|NCT03253094|468511342|FG005|Overall Study|Withdrawal by Subject|0|||
130150753|NCT03253094|468511337|FG000|Overall Study|Other|0|||
130150754|NCT03253094|468511338|FG001|Overall Study|Other|1|||
130150755|NCT03253094|468511339|FG002|Overall Study|Other|2|||
130150756|NCT03253094|468511340|FG003|Overall Study|Other|1|||
130150757|NCT03253094|468511341|FG004|Overall Study|Other|0|||
130150758|NCT03253094|468511342|FG005|Overall Study|Other|0|||
130150759|NCT02339090|468511343|FG000|Overall Study|Adverse Event|1|||
130150760|NCT02339090|468511344|FG001|Overall Study|Adverse Event|0|||
130150761|NCT02339090|468511343|FG000|Overall Study|Lost to Follow-up|0|||
130150762|NCT02339090|468511344|FG001|Overall Study|Lost to Follow-up|1|||
130150763|NCT02339090|468511343|FG000|Overall Study|Non-compliance With Study Drug|0|||
130150764|NCT02339090|468511344|FG001|Overall Study|Non-compliance With Study Drug|1|||
130150765|NCT02339090|468511343|FG000|Overall Study|Withdrawal by Subject|2|||
130150766|NCT02339090|468511344|FG001|Overall Study|Withdrawal by Subject|1|||
130150767|NCT02339090|468511343|FG000|Overall Study|Poor Growth|3|||
130150768|NCT02339090|468511344|FG001|Overall Study|Poor Growth|0|||
130150769|NCT02339090|468511343|FG000|Overall Study|Randomized but not treated|0|||
130150770|NCT02339090|468511344|FG001|Overall Study|Randomized but not treated|2|||
130150771|NCT02737592|468511347|FG000|Overall Study|Withdrawal by Subject|1|||
130150772|NCT00576303|468511348|FG000|Dose Titration Period|Early withdrawal|17|||
130150773|NCT00576303|468511348|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
130150774|NCT00576303|468511348|FG000|Long Term Safety Period|Early withdrawal|16|||
130150775|NCT00955721|468511349|FG000|Overall Study|Physician Decision|1|||
130150776|NCT00955721|468511350|FG001|Overall Study|Physician Decision|0|||
130150777|NCT00955721|468511349|FG000|Overall Study|Death|1|||
130150778|NCT00955721|468511350|FG001|Overall Study|Death|0|||
130150779|NCT00955721|468511349|FG000|Overall Study|Withdrawal by Subject|1|||
130150780|NCT00955721|468511350|FG001|Overall Study|Withdrawal by Subject|0|||
130150781|NCT00749411|468511354|FG000|Overall Study|Adverse Event|0|||
130150782|NCT00749411|468511355|FG001|Overall Study|Adverse Event|2|||
130150783|NCT00749411|468511354|FG000|Overall Study|Lack of Efficacy|0|||
130150784|NCT00749411|468511355|FG001|Overall Study|Lack of Efficacy|1|||
130150785|NCT00749411|468511354|FG000|Overall Study|Protocol Violation|1|||
130150786|NCT00749411|468511355|FG001|Overall Study|Protocol Violation|1|||
130150787|NCT00749411|468511354|FG000|Overall Study|Protocol-defined stopping criteria|0|||
130150788|NCT00749411|468511355|FG001|Overall Study|Protocol-defined stopping criteria|1|||
130150789|NCT04034355|468511358|FG000|Overall Study|Study terminated by Sponsor|10|||
130150790|NCT04034355|468511359|FG001|Overall Study|Study terminated by Sponsor|17|||
130150791|NCT04034355|468511358|FG000|Overall Study|Withdrawal by Subject|12|||
130150792|NCT04034355|468511359|FG001|Overall Study|Withdrawal by Subject|11|||
130150793|NCT04034355|468511358|FG000|Overall Study|Site terminated by Sponsor|4|||
130150794|NCT04034355|468511359|FG001|Overall Study|Site terminated by Sponsor|5|||
130150795|NCT04034355|468511358|FG000|Overall Study|Adverse Event|2|||
130150796|NCT04034355|468511359|FG001|Overall Study|Adverse Event|0|||
130150797|NCT04034355|468511358|FG000|Overall Study|Death|1|||
130150798|NCT04034355|468511359|FG001|Overall Study|Death|1|||
130150799|NCT04034355|468511358|FG000|Overall Study|Not reported|2|||
130150800|NCT04034355|468511359|FG001|Overall Study|Not reported|0|||
130150801|NCT04034355|468511358|FG000|Overall Study|Lost to Follow-up|1|||
130150802|NCT04034355|468511359|FG001|Overall Study|Lost to Follow-up|0|||
130150803|NCT04034355|468511358|FG000|Overall Study|Physician Decision|1|||
130150804|NCT04034355|468511359|FG001|Overall Study|Physician Decision|0|||
130150805|NCT04034355|468511358|FG000|Overall Study|Protocol Violation|0|||
130150806|NCT04034355|468511359|FG001|Overall Study|Protocol Violation|1|||
130150807|NCT04034355|468511358|FG000|Overall Study|Progressive disease|1|||
130150808|NCT04034355|468511359|FG001|Overall Study|Progressive disease|0|||
130150809|NCT03581188|468512917|FG000|Overall Study|Inclusion criteria not met|3|||
129978565|NCT00368927|467883738|FG000|Overall Study|Adverse Event|1|||
129978566|NCT00368927|467883739|FG001|Overall Study|Adverse Event|1|||
129978567|NCT00368927|467883738|FG000|Overall Study|Withdrawal by Subject|1|||
129978568|NCT00368927|467883739|FG001|Overall Study|Withdrawal by Subject|2|||
129978569|NCT00368927|467883738|FG000|Overall Study|Physician Decision|1|||
129978570|NCT00368927|467883739|FG001|Overall Study|Physician Decision|0|||
129978571|NCT03525392|467883740|FG000|Overall Study|Adverse Event|1|||
129978572|NCT03525392|467883741|FG001|Overall Study|Adverse Event|0|||
129978573|NCT03525392|467883742|FG002|Overall Study|Adverse Event|2|||
129978574|NCT03525392|467883743|FG003|Overall Study|Adverse Event|0|||
129978575|NCT03525392|467883744|FG004|Overall Study|Adverse Event|0|||
129978576|NCT03525392|467883740|FG000|Overall Study|Progressive disease|0|||
129978577|NCT03525392|467883741|FG001|Overall Study|Progressive disease|1|||
129978578|NCT03525392|467883742|FG002|Overall Study|Progressive disease|1|||
129978579|NCT03525392|467883743|FG003|Overall Study|Progressive disease|3|||
129978580|NCT03525392|467883744|FG004|Overall Study|Progressive disease|1|||
129978581|NCT04187326|467883747|FG000|Overall Study|Lost to Follow-up|2|||
129978582|NCT04187326|467883748|FG001|Overall Study|Lost to Follow-up|1|||
129978583|NCT04187326|467883747|FG000|Overall Study|Computer error- task was only partially completed.|0|||
129978584|NCT04187326|467883748|FG001|Overall Study|Computer error- task was only partially completed.|1|||
130150810|NCT03581188|468512918|FG001|Overall Study|Inclusion criteria not met|2|||
130150811|NCT03581188|468512917|FG000|Overall Study|Lost to Follow-up|5|||
130150812|NCT03581188|468512918|FG001|Overall Study|Lost to Follow-up|5|||
130150813|NCT03581188|468512917|FG000|Overall Study|Discontinued intervention|11|||
130150814|NCT03581188|468512918|FG001|Overall Study|Discontinued intervention|8|||
130150815|NCT03064438|468512921|FG000|Overall Study|Lost to Follow-up|1|||
130150816|NCT03064438|468512922|FG001|Overall Study|Lost to Follow-up|0|||
130150817|NCT03064438|468512921|FG000|Overall Study|Withdrawal by Subject|0|||
130150818|NCT03064438|468512922|FG001|Overall Study|Withdrawal by Subject|1|||
130150819|NCT01961687|468512923|FG000|Overall Study|Lost to Follow-up|19|||
130150820|NCT01961687|468512923|FG000|Overall Study|Re-operation|17|||
130150821|NCT01961687|468512923|FG000|Overall Study|Death|7|||
130150822|NCT01961687|468512923|FG000|Overall Study|Withdrawal by Subject|6|||
130150823|NCT01961687|468512923|FG000|Overall Study|Adverse Event|6|||
130150824|NCT01961687|468512923|FG000|Overall Study|Moved to area without study site|2|||
130150825|NCT01961687|468512923|FG000|Overall Study|Sponsor decision|2|||
130150826|NCT01961687|468512923|FG000|Overall Study|Physician Decision|1|||
130150827|NCT01961687|468512923|FG000|Overall Study|Unable to meet follow-up requirements|1|||
130150828|NCT01467479|468512924|FG000|Overall Study|No Study Medication|1|||
130150829|NCT01467479|468512925|FG001|Overall Study|No Study Medication|0|||
130150830|NCT01467479|468512926|FG002|Overall Study|No Study Medication|2|||
130150831|NCT01467479|468512924|FG000|Overall Study|Adverse Event|1|||
130150832|NCT01467479|468512925|FG001|Overall Study|Adverse Event|2|||
130150833|NCT01467479|468512926|FG002|Overall Study|Adverse Event|0|||
130150834|NCT01467479|468512924|FG000|Overall Study|Death|0|||
130150835|NCT01467479|468512925|FG001|Overall Study|Death|0|||
130150836|NCT01467479|468512926|FG002|Overall Study|Death|1|||
130150837|NCT01467479|468512924|FG000|Overall Study|Lost to Follow-up|2|||
130150838|NCT01467479|468512925|FG001|Overall Study|Lost to Follow-up|5|||
130150839|NCT01467479|468512926|FG002|Overall Study|Lost to Follow-up|3|||
130150840|NCT01467479|468512924|FG000|Overall Study|Withdrawal of Consent|3|||
130150841|NCT01467479|468512925|FG001|Overall Study|Withdrawal of Consent|7|||
130150842|NCT01467479|468512926|FG002|Overall Study|Withdrawal of Consent|7|||
130150843|NCT01467479|468512924|FG000|Overall Study|Study Terminated by Sponsor|1|||
130150844|NCT01467479|468512925|FG001|Overall Study|Study Terminated by Sponsor|3|||
130150845|NCT01467479|468512926|FG002|Overall Study|Study Terminated by Sponsor|3|||
130150846|NCT01467479|468512924|FG000|Overall Study|Other|1|||
130150847|NCT01467479|468512925|FG001|Overall Study|Other|0|||
130150848|NCT01467479|468512926|FG002|Overall Study|Other|0|||
130150849|NCT01915940|468512936|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
130150850|NCT01915940|468512937|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
130150851|NCT01915940|468512938|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
130150852|NCT01915940|468512936|FG000|Treatment Period|Decision of Participant|0|||
130150853|NCT01915940|468512937|FG001|Treatment Period|Decision of Participant|1|||
130150854|NCT01915940|468512938|FG002|Treatment Period|Decision of Participant|3|||
130150855|NCT01915940|468512936|FG000|Treatment Period|Adverse Event|0|||
130150856|NCT01915940|468512937|FG001|Treatment Period|Adverse Event|9|||
130150857|NCT01915940|468512938|FG002|Treatment Period|Adverse Event|1|||
130150858|NCT01915940|468512936|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
130150859|NCT01915940|468512937|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
129978585|NCT05235269|467883755|FG000|Overall Study|Adverse Event|1|||
129978586|NCT05235269|467883755|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
129978587|NCT05235269|467883755|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
130150860|NCT01915940|468512938|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
130150861|NCT02999984|468512939|FG000|Overall Study|Treatment Failure|1|||
130150862|NCT01197417|468512940|FG000|Overall Study|Physician Decision|3|||
130150863|NCT01197417|468512941|FG001|Overall Study|Physician Decision|2|||
130150864|NCT01197417|468512940|FG000|Overall Study|Withdrawal by Subject|2|||
130150865|NCT01197417|468512941|FG001|Overall Study|Withdrawal by Subject|4|||
130150866|NCT01197417|468512940|FG000|Overall Study|Site miscommunication|0|||
130150867|NCT01197417|468512941|FG001|Overall Study|Site miscommunication|1|||
129978588|NCT00798434|467883756|FG000|Double-Blind|Adverse Event|22|||
129978589|NCT00798434|467883757|FG001|Double-Blind|Adverse Event|46|||
129978590|NCT00798434|467883756|FG000|Double-Blind|Death|0|||
129978591|NCT00798434|467883757|FG001|Double-Blind|Death|1|||
129978592|NCT00798434|467883756|FG000|Double-Blind|Lost to Follow-up|1|||
129978593|NCT00798434|467883757|FG001|Double-Blind|Lost to Follow-up|0|||
129978594|NCT00798434|467883756|FG000|Double-Blind|Lack of Efficacy|8|||
129978595|NCT00798434|467883757|FG001|Double-Blind|Lack of Efficacy|12|||
129978596|NCT00798434|467883756|FG000|Double-Blind|Withdrawal by Subject|17|||
129978597|NCT00798434|467883757|FG001|Double-Blind|Withdrawal by Subject|14|||
129978598|NCT00798434|467883756|FG000|Double-Blind|Protocol Violation|1|||
129978599|NCT00798434|467883757|FG001|Double-Blind|Protocol Violation|4|||
129978600|NCT00798434|467883756|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
129978601|NCT00798434|467883757|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
129978602|NCT00798434|467883756|FG000|Double-Blind|Other|1|||
129978603|NCT00798434|467883757|FG001|Double-Blind|Other|0|||
129978604|NCT00798434|467883756|FG000|Double-Blind|Not Treated|3|||
129978605|NCT00798434|467883757|FG001|Double-Blind|Not Treated|6|||
129978606|NCT00798434|467883756|FG000|Open-Label|Adverse Event|33|||
129978607|NCT00798434|467883757|FG001|Open-Label|Adverse Event|11|||
129978608|NCT00798434|467883756|FG000|Open-Label|Lack of Efficacy|5|||
129978609|NCT00798434|467883757|FG001|Open-Label|Lack of Efficacy|11|||
129978610|NCT00798434|467883756|FG000|Open-Label|Withdrawal by Subject|2|||
129978611|NCT00798434|467883757|FG001|Open-Label|Withdrawal by Subject|7|||
129978612|NCT00798434|467883756|FG000|Open-Label|Protocol Violation|1|||
129978613|NCT00798434|467883757|FG001|Open-Label|Protocol Violation|0|||
129978614|NCT00798434|467883756|FG000|Open-Label|Other|1|||
129978615|NCT00798434|467883757|FG001|Open-Label|Other|2|||
130150868|NCT01197417|468512940|FG000|Overall Study|Subject transferred to intensive care|0|||
130150869|NCT01197417|468512941|FG001|Overall Study|Subject transferred to intensive care|1|||
130150870|NCT01197417|468512940|FG000|Overall Study|Not consented in time to receive drug|0|||
130150871|NCT01197417|468512941|FG001|Overall Study|Not consented in time to receive drug|1|||
130150872|NCT01197417|468512940|FG000|Overall Study|Hypotension|1|||
130150873|NCT01197417|468512941|FG001|Overall Study|Hypotension|2|||
130150874|NCT01197417|468512940|FG000|Overall Study|Found to be ineligible|2|||
130150875|NCT01197417|468512941|FG001|Overall Study|Found to be ineligible|5|||
130150876|NCT01197417|468512940|FG000|Overall Study|No 25-hour magnesium level|0|||
130150877|NCT01197417|468512941|FG001|Overall Study|No 25-hour magnesium level|2|||
130150878|NCT03919448|468512942|FG000|Overall Study|Withdrawal by Subject|1|||
130150879|NCT03919448|468512943|FG001|Overall Study|Withdrawal by Subject|0|||
130150880|NCT03919448|468512944|FG002|Overall Study|Withdrawal by Subject|0|||
130150881|NCT03438539|468512945|FG000|Overall Study|Lost to Follow-up|8|||
130150882|NCT03438539|468512946|FG001|Overall Study|Lost to Follow-up|4|||
130150883|NCT03438539|468512947|FG002|Overall Study|Lost to Follow-up|10|||
130150884|NCT03438539|468512948|FG003|Overall Study|Lost to Follow-up|9|||
130150885|NCT03438539|468512949|FG004|Overall Study|Lost to Follow-up|3|||
130150886|NCT03438539|468512950|FG005|Overall Study|Lost to Follow-up|8|||
130150887|NCT02065713|468512951|FG000|Overall Study|Adverse Event|0|||
130150888|NCT02065713|468512952|FG001|Overall Study|Adverse Event|1|||
130150889|NCT02065713|468512951|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130150890|NCT02065713|468512952|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
130150891|NCT01652729|468512953|FG000|Overall Study|Withdrawal by Subject|14|||
130150892|NCT01652729|468512954|FG001|Overall Study|Withdrawal by Subject|7|||
130150893|NCT01652729|468512955|FG002|Overall Study|Withdrawal by Subject|7|||
130150894|NCT01652729|468512953|FG000|Overall Study|Adverse Event|4|||
130150895|NCT01652729|468512954|FG001|Overall Study|Adverse Event|0|||
130150896|NCT01652729|468512955|FG002|Overall Study|Adverse Event|3|||
130150897|NCT01652729|468512953|FG000|Overall Study|Physician Decision|1|||
130150898|NCT01652729|468512954|FG001|Overall Study|Physician Decision|0|||
130150899|NCT01652729|468512955|FG002|Overall Study|Physician Decision|1|||
130150900|NCT01652729|468512953|FG000|Overall Study|Protocol Violation|1|||
130150901|NCT01652729|468512954|FG001|Overall Study|Protocol Violation|0|||
130150902|NCT01652729|468512955|FG002|Overall Study|Protocol Violation|0|||
130150903|NCT01652729|468512953|FG000|Overall Study|Lost to Follow-up|6|||
129978616|NCT00798434|467883756|FG000|Open-Label|Not Treated|0|||
129978617|NCT00798434|467883757|FG001|Open-Label|Not Treated|1|||
129978618|NCT03898167|467883758|FG000|Overall Study|Terminated phone call early|7|||
129978619|NCT03898167|467883759|FG001|Overall Study|Terminated phone call early|0|||
129978620|NCT03898167|467883760|FG002|Overall Study|Terminated phone call early|0|||
130150904|NCT01652729|468512954|FG001|Overall Study|Lost to Follow-up|6|||
130150905|NCT01652729|468512955|FG002|Overall Study|Lost to Follow-up|3|||
130150906|NCT01652729|468512953|FG000|Overall Study|Administrative|1|||
130150907|NCT01652729|468512954|FG001|Overall Study|Administrative|0|||
130150908|NCT01652729|468512955|FG002|Overall Study|Administrative|0|||
130150909|NCT01223235|468512956|FG000|Overall Study|Withdrawal by Subject|1|||
130150910|NCT04364737|468512957|FG000|Overall Study|Withdrawal by Subject|4|||
130150911|NCT04364737|468512958|FG001|Overall Study|Withdrawal by Subject|9|||
130150912|NCT04364737|468512957|FG000|Overall Study|Lost to Follow-up|1|||
130150913|NCT04364737|468512958|FG001|Overall Study|Lost to Follow-up|1|||
130150914|NCT01220609|468512959|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
130150915|NCT01220609|468512959|FG000|Overall Study|Ineligible- Wrong cell type|1|||
130150916|NCT01220609|468512959|FG000|Overall Study|Ineligible-Never treated|1|||
130150917|NCT02225665|468512960|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
130150918|NCT02225665|468512961|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
130150919|NCT02225665|468512960|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
130150920|NCT02225665|468512961|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
130150921|NCT01311557|468512962|FG000|Overall Study|Serious adverse event|0|||
130150922|NCT01311557|468512963|FG001|Overall Study|Serious adverse event|1|||
130150923|NCT01311557|468512962|FG000|Overall Study|Protocol Violation|4|||
130150924|NCT01311557|468512963|FG001|Overall Study|Protocol Violation|2|||
130150925|NCT01311557|468512962|FG000|Overall Study|Lost to Follow-up|0|||
130150926|NCT01311557|468512963|FG001|Overall Study|Lost to Follow-up|1|||
130150927|NCT01311557|468512962|FG000|Overall Study|Withdrawal by Subject|1|||
130150928|NCT01311557|468512963|FG001|Overall Study|Withdrawal by Subject|2|||
130150929|NCT02418455|468512966|FG000|48-Week Treatment Period|Other- Not Specified|1|||
130150930|NCT02418455|468512966|FG000|Continuation Period|Sponsor Decision|7|||
130150931|NCT00614822|468512970|FG000|Overall Study|Adverse Event|3|||
130150932|NCT01557920|468512971|FG000|Overall Study|Withdrawal by Subject|2|||
130150933|NCT01557920|468512972|FG001|Overall Study|Withdrawal by Subject|3|||
130150934|NCT01557920|468512971|FG000|Overall Study|Lack of Efficacy|1|||
130150935|NCT01557920|468512972|FG001|Overall Study|Lack of Efficacy|0|||
130150936|NCT02075606|468512975|FG000|Overall Study|Adverse Event|5|||
130150937|NCT02075606|468512975|FG000|Overall Study|Withdrawal by Subject|1|||
130150938|NCT02075606|468512975|FG000|Overall Study|Death|1|||
130150939|NCT02075606|468512975|FG000|Overall Study|Investigator's decision|1|||
130150940|NCT02075606|468512975|FG000|Overall Study|Symptom management|1|||
130150941|NCT02075606|468512975|FG000|Overall Study|Increasing Symptoms|1|||
130150942|NCT02310763|468512980|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130150943|NCT02310763|468512981|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130150944|NCT02310763|468512982|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
130150945|NCT02310763|468512980|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
130150946|NCT02310763|468512981|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
130150947|NCT02310763|468512982|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
130150948|NCT02310763|468512980|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
130150949|NCT02310763|468512981|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130150950|NCT02310763|468512982|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
130150951|NCT02310763|468512980|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
130150952|NCT02310763|468512981|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
130150953|NCT02310763|468512982|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
130150954|NCT02310763|468512980|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130150955|NCT02310763|468512981|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130150956|NCT02310763|468512982|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
130150957|NCT01731886|468512988|FG000|Overall Study|Death|1|||
130150958|NCT01731886|468512989|FG001|Overall Study|Death|0|||
130150959|NCT01731886|468512988|FG000|Overall Study|Never started treatment|0|||
130150960|NCT01731886|468512989|FG001|Overall Study|Never started treatment|1|||
130150961|NCT01731886|468512988|FG000|Overall Study|Non-compliant|1|||
130150962|NCT01731886|468512989|FG001|Overall Study|Non-compliant|0|||
130150963|NCT00271024|468512990|FG000|Overall Study|Lost Interest|3|||
130150964|NCT00271024|468512991|FG001|Overall Study|Lost Interest|4|||
130150965|NCT00271024|468512992|FG002|Overall Study|Lost Interest|2|||
130150966|NCT00271024|468512993|FG003|Overall Study|Lost Interest|3|||
130150967|NCT00271024|468512990|FG000|Overall Study|Unknown/Unspecified|11|||
130150968|NCT00271024|468512991|FG001|Overall Study|Unknown/Unspecified|11|||
130150969|NCT00271024|468512992|FG002|Overall Study|Unknown/Unspecified|8|||
130150970|NCT00271024|468512993|FG003|Overall Study|Unknown/Unspecified|4|||
130150971|NCT00271024|468512990|FG000|Overall Study|Protocol Violation|1|||
130150972|NCT00271024|468512991|FG001|Overall Study|Protocol Violation|6|||
130150973|NCT00271024|468512992|FG002|Overall Study|Protocol Violation|5|||
130150974|NCT00271024|468512993|FG003|Overall Study|Protocol Violation|11|||
130150975|NCT00271024|468512990|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
130150976|NCT00271024|468512991|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
130150977|NCT00271024|468512992|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
130150978|NCT00271024|468512993|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
130150979|NCT00271024|468512990|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
130150980|NCT00271024|468512991|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
130150981|NCT00271024|468512992|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
130150982|NCT00271024|468512993|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
130150983|NCT01040793|468512994|FG000|Overall Study|Adverse Event|5|||
130150984|NCT01040793|468512995|FG001|Overall Study|Adverse Event|3|||
130150985|NCT01040793|468512996|FG002|Overall Study|Adverse Event|0|||
130150986|NCT01040793|468512997|FG003|Overall Study|Adverse Event|2|||
130150987|NCT01040793|468512998|FG004|Overall Study|Adverse Event|2|||
130150988|NCT01040793|468512999|FG005|Overall Study|Adverse Event|1|||
130150989|NCT01040793|468512994|FG000|Overall Study|Protocol Violation|1|||
129978621|NCT03898167|467883758|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
129978622|NCT03898167|467883759|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
129978623|NCT03898167|467883760|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
129978624|NCT05177354|467883761|FG000|Implant to 30-day Visit|Physician Decision|1|||
129978625|NCT05177354|467883761|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
129978626|NCT05177354|467883761|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
129978627|NCT05177354|467883761|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
129978628|NCT03548220|467883763|FG000|Overall Study|Lost to Follow-up|1|||
129978629|NCT03548220|467883764|FG001|Overall Study|Lost to Follow-up|0|||
129978630|NCT03548220|467883765|FG002|Overall Study|Lost to Follow-up|0|||
129978631|NCT03548220|467883766|FG003|Overall Study|Lost to Follow-up|0|||
129978632|NCT02906007|467883767|FG000|Overall Study|Physician Decision|0|||
129978633|NCT02906007|467883768|FG001|Overall Study|Physician Decision|0|||
129978634|NCT02906007|467883769|FG002|Overall Study|Physician Decision|1|||
129978635|NCT02906007|467883767|FG000|Overall Study|Died|1|||
129978636|NCT02906007|467883768|FG001|Overall Study|Died|0|||
129978637|NCT02906007|467883769|FG002|Overall Study|Died|0|||
129978638|NCT01946529|467883770|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
129978639|NCT01946529|467883771|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
129978640|NCT01946529|467883772|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
129978641|NCT01946529|467883770|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
129978642|NCT01946529|467883771|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
129978643|NCT01946529|467883772|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
129978644|NCT06655558|467883773|FG000|Overall Study|Protocol Violation|1|||
129978645|NCT03570892|467883774|FG000|Overall Study|Death|51|||
129978646|NCT03570892|467883775|FG001|Overall Study|Death|45|||
129978647|NCT03570892|467883774|FG000|Overall Study|Subject decision|5|||
129978648|NCT03570892|467883775|FG001|Overall Study|Subject decision|3|||
129978649|NCT03570892|467883774|FG000|Overall Study|Protocol Violation|1|||
129978650|NCT03570892|467883775|FG001|Overall Study|Protocol Violation|4|||
129978651|NCT03570892|467883774|FG000|Overall Study|Physician Decision|0|||
129978652|NCT03570892|467883775|FG001|Overall Study|Physician Decision|2|||
129978653|NCT01099215|467885148|FG000|Overall Study|Withdrawal by Subject|1|||
129978654|NCT01099215|467885149|FG001|Overall Study|Withdrawal by Subject|0|||
129978655|NCT01099215|467885148|FG000|Overall Study|Adverse Event|0|||
129978656|NCT01099215|467885149|FG001|Overall Study|Adverse Event|1|||
129978657|NCT00747227|467885151|FG000|Overall Study|Death|3|||
129978658|NCT00747227|467885152|FG001|Overall Study|Death|1|||
129978659|NCT00747227|467885151|FG000|Overall Study|Withdrawal by Subject|1|||
129978660|NCT00747227|467885152|FG001|Overall Study|Withdrawal by Subject|0|||
129978661|NCT00747227|467885151|FG000|Overall Study|Lost to Follow-up|1|||
129978662|NCT00747227|467885152|FG001|Overall Study|Lost to Follow-up|2|||
129978663|NCT00747227|467885151|FG000|Overall Study|Illness|1|||
129978664|NCT00747227|467885152|FG001|Overall Study|Illness|1|||
129978665|NCT03554629|467885153|FG000|Overall Study|Inadequate data|6|||
129978666|NCT01901432|467885154|FG000|Overall Study|Adverse Event|0|||
129978667|NCT01901432|467885155|FG001|Overall Study|Adverse Event|1|||
129978668|NCT01901432|467885156|FG002|Overall Study|Adverse Event|1|||
129978669|NCT01901432|467885157|FG003|Overall Study|Adverse Event|0|||
129978670|NCT01901432|467885158|FG004|Overall Study|Adverse Event|1|||
129978671|NCT01901432|467885154|FG000|Overall Study|Withdrawal by Subject|0|||
129978672|NCT01901432|467885155|FG001|Overall Study|Withdrawal by Subject|0|||
129978673|NCT01901432|467885156|FG002|Overall Study|Withdrawal by Subject|1|||
130150990|NCT01040793|468512995|FG001|Overall Study|Protocol Violation|1|||
130150991|NCT01040793|468512996|FG002|Overall Study|Protocol Violation|1|||
129978674|NCT01901432|467885157|FG003|Overall Study|Withdrawal by Subject|0|||
129978675|NCT01901432|467885158|FG004|Overall Study|Withdrawal by Subject|5|||
129978676|NCT01901432|467885154|FG000|Overall Study|Physician Decision|0|||
129978677|NCT01901432|467885155|FG001|Overall Study|Physician Decision|0|||
129978678|NCT01901432|467885156|FG002|Overall Study|Physician Decision|0|||
129978679|NCT01901432|467885157|FG003|Overall Study|Physician Decision|0|||
129978680|NCT01901432|467885158|FG004|Overall Study|Physician Decision|2|||
129978681|NCT01901432|467885154|FG000|Overall Study|Patient decision to stop study drug|0|||
129978682|NCT01901432|467885155|FG001|Overall Study|Patient decision to stop study drug|0|||
130150992|NCT01040793|468512997|FG003|Overall Study|Protocol Violation|0|||
130150993|NCT01040793|468512998|FG004|Overall Study|Protocol Violation|1|||
130150994|NCT01040793|468512999|FG005|Overall Study|Protocol Violation|0|||
129978683|NCT01901432|467885156|FG002|Overall Study|Patient decision to stop study drug|0|||
129978684|NCT01901432|467885157|FG003|Overall Study|Patient decision to stop study drug|0|||
129978685|NCT01901432|467885158|FG004|Overall Study|Patient decision to stop study drug|1|||
129978686|NCT00379288|467885159|FG000|Overall Study|Adverse Event|5|||
129978687|NCT00379288|467885160|FG001|Overall Study|Adverse Event|6|||
129978688|NCT00379288|467885161|FG002|Overall Study|Adverse Event|2|||
129978689|NCT00379288|467885162|FG003|Overall Study|Adverse Event|0|||
129978690|NCT00379288|467885159|FG000|Overall Study|Treatment Failure|0|||
129978691|NCT00379288|467885160|FG001|Overall Study|Treatment Failure|1|||
129978692|NCT00379288|467885161|FG002|Overall Study|Treatment Failure|0|||
129978693|NCT00379288|467885162|FG003|Overall Study|Treatment Failure|1|||
129978694|NCT00379288|467885159|FG000|Overall Study|Lost to Follow-up|3|||
129978695|NCT00379288|467885160|FG001|Overall Study|Lost to Follow-up|3|||
129978696|NCT00379288|467885161|FG002|Overall Study|Lost to Follow-up|2|||
129978697|NCT00379288|467885162|FG003|Overall Study|Lost to Follow-up|0|||
129978698|NCT00379288|467885159|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
129978699|NCT00379288|467885160|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
129978700|NCT00379288|467885161|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
129978701|NCT00379288|467885162|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
129978702|NCT00379288|467885159|FG000|Overall Study|Subject withdrew-related to study drug|1|||
129978703|NCT00379288|467885160|FG001|Overall Study|Subject withdrew-related to study drug|0|||
129978704|NCT00379288|467885161|FG002|Overall Study|Subject withdrew-related to study drug|0|||
129978705|NCT00379288|467885162|FG003|Overall Study|Subject withdrew-related to study drug|1|||
129978706|NCT00379288|467885159|FG000|Overall Study|Noncompliance with protocol|8|||
129978707|NCT00379288|467885160|FG001|Overall Study|Noncompliance with protocol|6|||
130150995|NCT01040793|468512994|FG000|Overall Study|Lost to Follow-up|0|||
130150996|NCT01040793|468512995|FG001|Overall Study|Lost to Follow-up|1|||
130150997|NCT01040793|468512996|FG002|Overall Study|Lost to Follow-up|1|||
130150998|NCT01040793|468512997|FG003|Overall Study|Lost to Follow-up|0|||
130150999|NCT01040793|468512998|FG004|Overall Study|Lost to Follow-up|0|||
130151000|NCT01040793|468512999|FG005|Overall Study|Lost to Follow-up|0|||
130151001|NCT01040793|468512994|FG000|Overall Study|Withdrawal by Subject|0|||
130151002|NCT01040793|468512995|FG001|Overall Study|Withdrawal by Subject|0|||
130151003|NCT01040793|468512996|FG002|Overall Study|Withdrawal by Subject|0|||
130151004|NCT01040793|468512997|FG003|Overall Study|Withdrawal by Subject|2|||
130151005|NCT01040793|468512998|FG004|Overall Study|Withdrawal by Subject|0|||
130151006|NCT01040793|468512999|FG005|Overall Study|Withdrawal by Subject|0|||
130151007|NCT01040793|468512994|FG000|Overall Study|Other reasons not listed above|0|||
130151008|NCT01040793|468512995|FG001|Overall Study|Other reasons not listed above|0|||
130151009|NCT01040793|468512996|FG002|Overall Study|Other reasons not listed above|1|||
130151010|NCT01040793|468512997|FG003|Overall Study|Other reasons not listed above|0|||
130151011|NCT01040793|468512998|FG004|Overall Study|Other reasons not listed above|1|||
130151012|NCT01040793|468512999|FG005|Overall Study|Other reasons not listed above|0|||
130151013|NCT00939627|468513010|FG000|Overall Study|Disease Progression|16|||
130151014|NCT00939627|468513011|FG001|Overall Study|Disease Progression|12|||
130151015|NCT00939627|468513012|FG002|Overall Study|Disease Progression|0|||
130151016|NCT00939627|468513010|FG000|Overall Study|Adverse Event|6|||
130151017|NCT00939627|468513011|FG001|Overall Study|Adverse Event|7|||
130151018|NCT00939627|468513012|FG002|Overall Study|Adverse Event|0|||
130151019|NCT00939627|468513010|FG000|Overall Study|Death|0|||
130151020|NCT00939627|468513011|FG001|Overall Study|Death|2|||
130151021|NCT00939627|468513012|FG002|Overall Study|Death|0|||
130151022|NCT00939627|468513010|FG000|Overall Study|Withdrawal by Subject|2|||
130151023|NCT00939627|468513011|FG001|Overall Study|Withdrawal by Subject|4|||
130151024|NCT00939627|468513012|FG002|Overall Study|Withdrawal by Subject|0|||
130151025|NCT00939627|468513010|FG000|Overall Study|Other complicating disease|1|||
130151026|NCT00939627|468513011|FG001|Overall Study|Other complicating disease|1|||
130151027|NCT00939627|468513012|FG002|Overall Study|Other complicating disease|0|||
130151028|NCT00939627|468513010|FG000|Overall Study|Not compliant|2|||
130151029|NCT00939627|468513011|FG001|Overall Study|Not compliant|0|||
130151030|NCT00939627|468513012|FG002|Overall Study|Not compliant|0|||
130151031|NCT00939627|468513010|FG000|Overall Study|No off-tx reason given|0|||
130151032|NCT00939627|468513011|FG001|Overall Study|No off-tx reason given|2|||
130151033|NCT00939627|468513012|FG002|Overall Study|No off-tx reason given|0|||
129978708|NCT00379288|467885161|FG002|Overall Study|Noncompliance with protocol|2|||
129978709|NCT00379288|467885162|FG003|Overall Study|Noncompliance with protocol|1|||
129978710|NCT00379288|467885159|FG000|Overall Study|Did not meet protocol eligibility|0|||
129978711|NCT00379288|467885160|FG001|Overall Study|Did not meet protocol eligibility|1|||
129978712|NCT00379288|467885161|FG002|Overall Study|Did not meet protocol eligibility|0|||
130151034|NCT00124462|468513013|FG000|Overall Study|Lost to Follow-up|3|||
130151035|NCT00124462|468513014|FG001|Overall Study|Lost to Follow-up|3|||
130151036|NCT00124462|468513013|FG000|Overall Study|Physician Decision|3|||
130151037|NCT00124462|468513014|FG001|Overall Study|Physician Decision|4|||
130151038|NCT00124462|468513013|FG000|Overall Study|Withdrawal by Subject|4|||
130151039|NCT00124462|468513014|FG001|Overall Study|Withdrawal by Subject|5|||
130151040|NCT00124462|468513013|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
129978713|NCT00379288|467885162|FG003|Overall Study|Did not meet protocol eligibility|2|||
129978714|NCT00379288|467885159|FG000|Overall Study|Administrative|2|||
129978715|NCT00379288|467885160|FG001|Overall Study|Administrative|2|||
129978716|NCT00379288|467885161|FG002|Overall Study|Administrative|0|||
129978717|NCT00379288|467885162|FG003|Overall Study|Administrative|1|||
129978718|NCT00515671|467885173|FG000|Overall Study|Lost to Follow-up|13|||
129978719|NCT00515671|467885174|FG001|Overall Study|Lost to Follow-up|10|||
129978720|NCT00515671|467885173|FG000|Overall Study|Withdrawal by Subject|3|||
129978721|NCT00515671|467885174|FG001|Overall Study|Withdrawal by Subject|5|||
129978722|NCT00515671|467885173|FG000|Overall Study|incarcerated|1|||
129978723|NCT00515671|467885174|FG001|Overall Study|incarcerated|2|||
129978724|NCT00288639|467885177|FG000|Overall Study|Adverse Event|5|||
129978725|NCT00288639|467885177|FG000|Overall Study|Lack of Efficacy|4|||
129978726|NCT00288639|467885177|FG000|Overall Study|Withdrawal by Subject|2|||
129978727|NCT00288639|467885177|FG000|Overall Study|Other|1|||
129978728|NCT01014208|467885186|FG000|Overall Study|Lost to Follow-up|2|||
129978729|NCT01014208|467885187|FG001|Overall Study|Lost to Follow-up|5|||
129978730|NCT01014208|467885186|FG000|Overall Study|Participant Withdrew Consent|12|||
129978731|NCT01014208|467885187|FG001|Overall Study|Participant Withdrew Consent|12|||
129978732|NCT01014208|467885186|FG000|Overall Study|Did Not Receive Study Drug|2|||
129978733|NCT01014208|467885187|FG001|Overall Study|Did Not Receive Study Drug|0|||
129978734|NCT01014208|467885186|FG000|Overall Study|Study Closed/terminated|78|||
129978735|NCT01014208|467885187|FG001|Overall Study|Study Closed/terminated|83|||
129978736|NCT05602727|467885194|FG000|Overall Study|Physician Decision|0|||
129978737|NCT05602727|467885195|FG001|Overall Study|Physician Decision|1|||
129978738|NCT05602727|467885196|FG002|Overall Study|Physician Decision|0|||
129978739|NCT05602727|467885194|FG000|Overall Study|Randomized by mistake without study medication|1|||
129978740|NCT05602727|467885195|FG001|Overall Study|Randomized by mistake without study medication|0|||
129978741|NCT05602727|467885196|FG002|Overall Study|Randomized by mistake without study medication|0|||
129978742|NCT05602727|467885194|FG000|Overall Study|Study termination by Sponsor|18|||
129978743|NCT05602727|467885195|FG001|Overall Study|Study termination by Sponsor|15|||
129978744|NCT05602727|467885196|FG002|Overall Study|Study termination by Sponsor|19|||
129978745|NCT05602727|467885194|FG000|Overall Study|Withdrawal by Subject|2|||
129978746|NCT05602727|467885195|FG001|Overall Study|Withdrawal by Subject|1|||
129978747|NCT05602727|467885196|FG002|Overall Study|Withdrawal by Subject|1|||
129978748|NCT05602727|467885194|FG000|Overall Study|Various reasons|1|||
129978749|NCT05602727|467885195|FG001|Overall Study|Various reasons|6|||
129978750|NCT05602727|467885196|FG002|Overall Study|Various reasons|1|||
129978751|NCT04020185|467885197|FG000|Overall Study|Death|0|||
129978752|NCT04020185|467885198|FG001|Overall Study|Death|0|||
129978753|NCT04020185|467885199|FG002|Overall Study|Death|1|||
129978754|NCT04020185|467885200|FG003|Overall Study|Death|2|||
129978755|NCT04020185|467885201|FG004|Overall Study|Death|1|||
129978756|NCT04020185|467885202|FG005|Overall Study|Death|0|||
129978757|NCT04020185|467885203|FG006|Overall Study|Death|1|||
129978758|NCT04020185|467885204|FG007|Overall Study|Death|0|||
129978759|NCT04020185|467885197|FG000|Overall Study|Consent withdrawn|1|||
129978760|NCT04020185|467885198|FG001|Overall Study|Consent withdrawn|0|||
129978761|NCT04020185|467885199|FG002|Overall Study|Consent withdrawn|0|||
129978762|NCT04020185|467885200|FG003|Overall Study|Consent withdrawn|0|||
129978763|NCT04020185|467885201|FG004|Overall Study|Consent withdrawn|2|||
129978764|NCT04020185|467885202|FG005|Overall Study|Consent withdrawn|0|||
129978765|NCT04020185|467885203|FG006|Overall Study|Consent withdrawn|1|||
129978766|NCT04020185|467885204|FG007|Overall Study|Consent withdrawn|1|||
129978767|NCT04020185|467885197|FG000|Overall Study|Patient in hospice|0|||
129978768|NCT04020185|467885198|FG001|Overall Study|Patient in hospice|1|||
129978769|NCT04020185|467885199|FG002|Overall Study|Patient in hospice|0|||
129978770|NCT04020185|467885200|FG003|Overall Study|Patient in hospice|0|||
129978771|NCT04020185|467885201|FG004|Overall Study|Patient in hospice|0|||
129978772|NCT04020185|467885202|FG005|Overall Study|Patient in hospice|0|||
129978773|NCT04020185|467885203|FG006|Overall Study|Patient in hospice|0|||
130151041|NCT00124462|468513014|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
130151042|NCT02039063|468513016|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
130151043|NCT02039063|468513017|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
130151044|NCT02039063|468513018|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
129978774|NCT04020185|467885204|FG007|Overall Study|Patient in hospice|0|||
129978775|NCT04020185|467885197|FG000|Overall Study|Continuing on expanded access|0|||
129978776|NCT04020185|467885198|FG001|Overall Study|Continuing on expanded access|0|||
129978777|NCT04020185|467885199|FG002|Overall Study|Continuing on expanded access|0|||
129978778|NCT04020185|467885200|FG003|Overall Study|Continuing on expanded access|0|||
129978779|NCT04020185|467885201|FG004|Overall Study|Continuing on expanded access|0|||
129978780|NCT04020185|467885202|FG005|Overall Study|Continuing on expanded access|0|||
129978781|NCT04020185|467885203|FG006|Overall Study|Continuing on expanded access|1|||
129978782|NCT04020185|467885204|FG007|Overall Study|Continuing on expanded access|1|||
129978783|NCT00527787|467885206|FG000|Overall Study|Adverse Event|14|||
130151045|NCT02039063|468513019|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
129978784|NCT00527787|467885207|FG001|Overall Study|Adverse Event|24|||
129978785|NCT00527787|467885206|FG000|Overall Study|Withdrawal by Subject|13|||
130151046|NCT02039063|468513016|FG000|Treatment Phase|Progression of disease|0|||
130151047|NCT02039063|468513017|FG001|Treatment Phase|Progression of disease|0|||
130151048|NCT02039063|468513018|FG002|Treatment Phase|Progression of disease|1|||
130151049|NCT02039063|468513019|FG003|Treatment Phase|Progression of disease|1|||
130151050|NCT02039063|468513016|FG000|Extension Phase|Inadequate therapeutic effect|0|||
130151051|NCT02039063|468513017|FG001|Extension Phase|Inadequate therapeutic effect|1|||
130151052|NCT02039063|468513018|FG002|Extension Phase|Inadequate therapeutic effect|2|||
130151053|NCT02039063|468513019|FG003|Extension Phase|Inadequate therapeutic effect|0|||
130151054|NCT02039063|468513016|FG000|Extension Phase|Progression of disease|0|||
130151055|NCT02039063|468513017|FG001|Extension Phase|Progression of disease|0|||
130151056|NCT02039063|468513018|FG002|Extension Phase|Progression of disease|0|||
130151057|NCT02039063|468513019|FG003|Extension Phase|Progression of disease|1|||
130151058|NCT02039063|468513016|FG000|Extension Phase|Adverse Event|0|||
130151059|NCT02039063|468513017|FG001|Extension Phase|Adverse Event|0|||
130151060|NCT02039063|468513018|FG002|Extension Phase|Adverse Event|1|||
129978786|NCT00527787|467885207|FG001|Overall Study|Withdrawal by Subject|25|||
129978787|NCT00527787|467885206|FG000|Overall Study|Lost to Follow-up|5|||
129978788|NCT00527787|467885207|FG001|Overall Study|Lost to Follow-up|2|||
129978789|NCT00527787|467885206|FG000|Overall Study|Duodenal Ulcer|1|||
129978790|NCT00527787|467885207|FG001|Overall Study|Duodenal Ulcer|10|||
130151061|NCT02039063|468513019|FG003|Extension Phase|Adverse Event|0|||
130151062|NCT00104247|468513029|FG000|Overall Study|Withdrawal by Subject|1|||
130151063|NCT00104247|468513030|FG001|Overall Study|Withdrawal by Subject|0|||
130151064|NCT00104247|468513029|FG000|Overall Study|Noncompliant with dosing|0|||
130151065|NCT00104247|468513030|FG001|Overall Study|Noncompliant with dosing|1|||
130151066|NCT03314662|468513036|FG000|Overall Study|Withdrawal by Subject|1|||
130151067|NCT03314662|468513037|FG001|Overall Study|Withdrawal by Subject|1|||
130151068|NCT03314662|468513038|FG002|Overall Study|Withdrawal by Subject|1|||
129978791|NCT00527787|467885206|FG000|Overall Study|misc|5|||
129978792|NCT00527787|467885207|FG001|Overall Study|misc|2|||
130151069|NCT03314662|468513036|FG000|Overall Study|Lost to Follow-up|5|||
130151070|NCT03314662|468513037|FG001|Overall Study|Lost to Follow-up|4|||
130151071|NCT03314662|468513038|FG002|Overall Study|Lost to Follow-up|4|||
130151072|NCT03314662|468513036|FG000|Overall Study|Death|2|||
130151073|NCT03314662|468513037|FG001|Overall Study|Death|0|||
130151074|NCT03314662|468513038|FG002|Overall Study|Death|0|||
130151075|NCT00925301|468513041|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130151076|NCT00925301|468513042|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
130151077|NCT00925301|468513043|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130151078|NCT00925301|468513044|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
130151079|NCT00925301|468513041|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130151080|NCT00925301|468513042|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
130151081|NCT00925301|468513043|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130151082|NCT00925301|468513044|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
130151083|NCT00925301|468513041|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130151084|NCT00925301|468513042|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130151085|NCT00925301|468513043|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
130151086|NCT00925301|468513044|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
130151087|NCT00925301|468513041|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
130151088|NCT00925301|468513042|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
130151089|NCT00925301|468513043|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
130151090|NCT00925301|468513044|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
130151091|NCT00925301|468513041|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130151092|NCT00925301|468513042|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
130151093|NCT00925301|468513043|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129978793|NCT03433677|467885208|FG000|Period 1|Protocol Violation|1|||
129978794|NCT03433677|467885209|FG001|Period 1|Protocol Violation|0|||
129978795|NCT03433677|467885208|FG000|Period 2|Withdrawal by Subject|1|||
129978796|NCT03433677|467885209|FG001|Period 2|Withdrawal by Subject|1|||
129978797|NCT03330405|467885210|FG000|Overall Study|Other|1|||
129978798|NCT03330405|467885211|FG001|Overall Study|Other|3|||
129978799|NCT03330405|467885212|FG002|Overall Study|Other|1|||
130151094|NCT00925301|468513044|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
130151095|NCT00925301|468513041|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130151096|NCT00925301|468513042|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129978800|NCT03330405|467885213|FG003|Overall Study|Other|0|||
129978801|NCT03330405|467885214|FG004|Overall Study|Other|2|||
130151097|NCT00925301|468513043|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
130151098|NCT00925301|468513044|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
130151099|NCT00925301|468513041|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
130151100|NCT00925301|468513042|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129978802|NCT03330405|467885215|FG005|Overall Study|Other|0|||
129978803|NCT03330405|467885216|FG006|Overall Study|Other|1|||
129978804|NCT03330405|467885217|FG007|Overall Study|Other|0|||
129978805|NCT03330405|467885218|FG008|Overall Study|Other|0|||
129978806|NCT03330405|467885219|FG009|Overall Study|Other|0|||
129978807|NCT03330405|467885220|FG010|Overall Study|Other|0|||
129978808|NCT03330405|467885210|FG000|Overall Study|Progressive disease|8|||
129978809|NCT03330405|467885211|FG001|Overall Study|Progressive disease|27|||
129978810|NCT03330405|467885212|FG002|Overall Study|Progressive disease|4|||
129978811|NCT03330405|467885213|FG003|Overall Study|Progressive disease|18|||
129978812|NCT03330405|467885214|FG004|Overall Study|Progressive disease|16|||
129978813|NCT03330405|467885215|FG005|Overall Study|Progressive disease|14|||
129978814|NCT03330405|467885216|FG006|Overall Study|Progressive disease|7|||
129978815|NCT03330405|467885217|FG007|Overall Study|Progressive disease|29|||
129978816|NCT03330405|467885218|FG008|Overall Study|Progressive disease|9|||
129978817|NCT03330405|467885219|FG009|Overall Study|Progressive disease|11|||
129978818|NCT03330405|467885220|FG010|Overall Study|Progressive disease|5|||
129978819|NCT03330405|467885210|FG000|Overall Study|Withdrawal by Subject|1|||
129978820|NCT03330405|467885211|FG001|Overall Study|Withdrawal by Subject|4|||
129978821|NCT03330405|467885212|FG002|Overall Study|Withdrawal by Subject|0|||
129978822|NCT03330405|467885213|FG003|Overall Study|Withdrawal by Subject|1|||
129978823|NCT03330405|467885214|FG004|Overall Study|Withdrawal by Subject|1|||
129978824|NCT03330405|467885215|FG005|Overall Study|Withdrawal by Subject|1|||
129978825|NCT03330405|467885216|FG006|Overall Study|Withdrawal by Subject|0|||
129978826|NCT03330405|467885217|FG007|Overall Study|Withdrawal by Subject|2|||
129978827|NCT03330405|467885218|FG008|Overall Study|Withdrawal by Subject|2|||
129978828|NCT03330405|467885219|FG009|Overall Study|Withdrawal by Subject|1|||
129978829|NCT03330405|467885220|FG010|Overall Study|Withdrawal by Subject|1|||
129978830|NCT03330405|467885210|FG000|Overall Study|Global deterioration of health status|2|||
129978831|NCT03330405|467885211|FG001|Overall Study|Global deterioration of health status|3|||
129978832|NCT03330405|467885212|FG002|Overall Study|Global deterioration of health status|0|||
130151101|NCT00925301|468513043|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129978833|NCT03330405|467885213|FG003|Overall Study|Global deterioration of health status|2|||
129978834|NCT03330405|467885214|FG004|Overall Study|Global deterioration of health status|3|||
129978835|NCT03330405|467885215|FG005|Overall Study|Global deterioration of health status|3|||
129978836|NCT03330405|467885216|FG006|Overall Study|Global deterioration of health status|0|||
129978837|NCT03330405|467885217|FG007|Overall Study|Global deterioration of health status|2|||
129978838|NCT03330405|467885218|FG008|Overall Study|Global deterioration of health status|8|||
129978839|NCT03330405|467885219|FG009|Overall Study|Global deterioration of health status|4|||
129978840|NCT03330405|467885220|FG010|Overall Study|Global deterioration of health status|1|||
130151102|NCT00925301|468513044|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
130151103|NCT01117766|468513045|FG000|First Intervention|Adverse Event|0|||
130151104|NCT01117766|468513046|FG001|First Intervention|Adverse Event|1|||
130151105|NCT01117766|468513045|FG000|First Intervention|Protocol Violation|1|||
130151106|NCT01117766|468513046|FG001|First Intervention|Protocol Violation|0|||
130151107|NCT01117766|468513045|FG000|Washout Period|Protocol Violation|0|||
130151108|NCT01117766|468513046|FG001|Washout Period|Protocol Violation|2|||
130151109|NCT01117766|468513045|FG000|Second Intervention|Lost to Follow-up|1|||
130151110|NCT01117766|468513046|FG001|Second Intervention|Lost to Follow-up|0|||
129978841|NCT03330405|467885210|FG000|Overall Study|Adverse Event|0|||
129978842|NCT03330405|467885211|FG001|Overall Study|Adverse Event|1|||
129978843|NCT03330405|467885212|FG002|Overall Study|Adverse Event|0|||
129978844|NCT03330405|467885213|FG003|Overall Study|Adverse Event|1|||
129978845|NCT03330405|467885214|FG004|Overall Study|Adverse Event|1|||
129978846|NCT03330405|467885215|FG005|Overall Study|Adverse Event|1|||
129978847|NCT03330405|467885216|FG006|Overall Study|Adverse Event|3|||
129978848|NCT03330405|467885217|FG007|Overall Study|Adverse Event|4|||
130151111|NCT01117766|468513045|FG000|Second Intervention|Other|1|||
129978849|NCT03330405|467885218|FG008|Overall Study|Adverse Event|2|||
129978850|NCT03330405|467885219|FG009|Overall Study|Adverse Event|2|||
129978851|NCT03330405|467885220|FG010|Overall Study|Adverse Event|2|||
129978852|NCT03330405|467885210|FG000|Overall Study|Death|0|||
129978853|NCT03330405|467885211|FG001|Overall Study|Death|4|||
130151112|NCT01117766|468513046|FG001|Second Intervention|Other|2|||
129978854|NCT03330405|467885212|FG002|Overall Study|Death|0|||
129978855|NCT03330405|467885213|FG003|Overall Study|Death|0|||
129978856|NCT03330405|467885214|FG004|Overall Study|Death|0|||
129978857|NCT03330405|467885215|FG005|Overall Study|Death|1|||
129978858|NCT03330405|467885216|FG006|Overall Study|Death|0|||
129978859|NCT03330405|467885217|FG007|Overall Study|Death|2|||
129978860|NCT03330405|467885218|FG008|Overall Study|Death|0|||
129978861|NCT03330405|467885219|FG009|Overall Study|Death|0|||
129978862|NCT03330405|467885220|FG010|Overall Study|Death|0|||
129978863|NCT03330405|467885210|FG000|Overall Study|Physician Decision|0|||
129978864|NCT03330405|467885211|FG001|Overall Study|Physician Decision|0|||
129978865|NCT03330405|467885212|FG002|Overall Study|Physician Decision|0|||
129978866|NCT03330405|467885213|FG003|Overall Study|Physician Decision|0|||
129978867|NCT03330405|467885214|FG004|Overall Study|Physician Decision|0|||
129978868|NCT03330405|467885215|FG005|Overall Study|Physician Decision|0|||
129978869|NCT03330405|467885216|FG006|Overall Study|Physician Decision|0|||
129978870|NCT03330405|467885217|FG007|Overall Study|Physician Decision|1|||
129978871|NCT03330405|467885218|FG008|Overall Study|Physician Decision|0|||
129978872|NCT03330405|467885219|FG009|Overall Study|Physician Decision|0|||
129978873|NCT03330405|467885220|FG010|Overall Study|Physician Decision|0|||
129978874|NCT03889704|467885221|FG000|Overall Study|Study terminated due to pandemic|1|||
129978875|NCT02060370|467885222|FG000|Overall Study|Physician Decision|1|||
129978876|NCT00356408|467885223|FG000|Overall Study|Adverse Event|9|||
129978877|NCT00356408|467885223|FG000|Overall Study|Lack of Efficacy|36|||
129978878|NCT00356408|467885223|FG000|Overall Study|Lost to Follow-up|2|||
129978879|NCT00356408|467885223|FG000|Overall Study|Withdrawal by Subject|6|||
129978880|NCT00356408|467885223|FG000|Overall Study|Other: Principal investigator discretion|3|||
129978881|NCT00356408|467885223|FG000|Overall Study|Other: Sponsor request|1|||
129978882|NCT00356408|467885223|FG000|Overall Study|Other: Azathioprine stopped|1|||
129978883|NCT00356408|467885223|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
129978884|NCT00356408|467885223|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
129978885|NCT05487586|467885224|FG000|Overall Study|Death|22|||
129978886|NCT05487586|467885224|FG000|Overall Study|Physician Decision|1|||
129978887|NCT05487586|467885224|FG000|Overall Study|Transfer to another hospital|4|||
129978888|NCT05487586|467885224|FG000|Overall Study|Other|1|||
129978889|NCT01493427|467885225|FG000|Overall Study|Adverse Event|10|||
129978890|NCT01493427|467885225|FG000|Overall Study|Personal Reasons|4|||
129978891|NCT01493427|467885225|FG000|Overall Study|Lost to Follow-up|2|||
129978892|NCT01493427|467885225|FG000|Overall Study|Inability to Follow Instructions|2|||
129978893|NCT01493427|467885225|FG000|Overall Study|Other|2|||
129978894|NCT00565773|467885226|FG000|Overall Study|Withdrawal by Subject|1|||
129978895|NCT00565773|467885226|FG000|Overall Study|Physician Decision|1|||
129978896|NCT04798781|467885227|FG000|Overall Study|Withdrawal by Subject|1|||
129978897|NCT03921723|467885230|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
129978898|NCT03921723|467885230|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
129978899|NCT03015129|467885231|FG000|Overall Study|Death|2|||
129978900|NCT03015129|467885232|FG001|Overall Study|Death|2|||
129978901|NCT03015129|467885231|FG000|Overall Study|Lost to Follow-up|0|||
129978902|NCT03015129|467885232|FG001|Overall Study|Lost to Follow-up|1|||
129978903|NCT03015129|467885231|FG000|Overall Study|Progression of disease|38|||
129978904|NCT03015129|467885232|FG001|Overall Study|Progression of disease|33|||
130094554|NCT01258803|468302409|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
130094555|NCT04652245|468302416|FG000|Wash-Out Period|Adverse Event|0|||
130094556|NCT04652245|468302417|FG001|Wash-Out Period|Adverse Event|2|||
130094557|NCT04652245|468302416|FG000|Wash-Out Period|Withdrawal by Subject|0|||
130094558|NCT04652245|468302417|FG001|Wash-Out Period|Withdrawal by Subject|2|||
130094559|NCT03556202|468302420|FG000|Extension Treatment Period|Adverse Event|18|||
130094560|NCT03556202|468302421|FG001|Extension Treatment Period|Adverse Event|14|||
130094561|NCT03556202|468302422|FG002|Extension Treatment Period|Adverse Event|9|||
130094562|NCT03556202|468302420|FG000|Extension Treatment Period|Death|2|||
130094563|NCT03556202|468302421|FG001|Extension Treatment Period|Death|6|||
130094564|NCT03556202|468302422|FG002|Extension Treatment Period|Death|0|||
130094565|NCT03556202|468302420|FG000|Extension Treatment Period|Lack of Efficacy|5|||
130094566|NCT03556202|468302421|FG001|Extension Treatment Period|Lack of Efficacy|12|||
130094567|NCT03556202|468302422|FG002|Extension Treatment Period|Lack of Efficacy|18|||
130094568|NCT03556202|468302420|FG000|Extension Treatment Period|Lost to Follow-up|9|||
130094569|NCT03556202|468302421|FG001|Extension Treatment Period|Lost to Follow-up|20|||
130094570|NCT03556202|468302422|FG002|Extension Treatment Period|Lost to Follow-up|2|||
130094571|NCT03556202|468302420|FG000|Extension Treatment Period|Pregnancy|2|||
130094572|NCT03556202|468302421|FG001|Extension Treatment Period|Pregnancy|4|||
130094573|NCT03556202|468302422|FG002|Extension Treatment Period|Pregnancy|3|||
130094574|NCT03556202|468302420|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
130094575|NCT03556202|468302421|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
130094576|NCT03556202|468302422|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
130094577|NCT03556202|468302420|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
130094578|NCT03556202|468302421|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
130094579|NCT03556202|468302422|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
130094580|NCT03556202|468302420|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
130094581|NCT03556202|468302421|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
130094582|NCT03556202|468302422|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
130094583|NCT03556202|468302420|FG000|Extension Treatment Period|Physician Decision|0|||
130094584|NCT03556202|468302421|FG001|Extension Treatment Period|Physician Decision|8|||
130094585|NCT03556202|468302422|FG002|Extension Treatment Period|Physician Decision|2|||
130151113|NCT01117766|468513045|FG000|Second Intervention|Adverse Event|0|||
130151114|NCT01117766|468513046|FG001|Second Intervention|Adverse Event|2|||
130151115|NCT01117766|468513045|FG000|Second Intervention|Withdrawal by Subject|0|||
130151116|NCT01117766|468513046|FG001|Second Intervention|Withdrawal by Subject|1|||
130151117|NCT00438659|468513047|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
129978905|NCT03015129|467885231|FG000|Overall Study|Adverse Event|0|||
130094586|NCT03556202|468302420|FG000|Extension Treatment Period|Protocol Violation|0|||
129978906|NCT03015129|467885232|FG001|Overall Study|Adverse Event|4|||
129978907|NCT02242097|467885233|FG000|Ibrutinib Treatment|Adverse Event|16|||
129978908|NCT02242097|467885233|FG000|Ibrutinib Treatment|Physician Decision|1|||
129978909|NCT02242097|467885233|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
129978910|NCT02242097|467885233|FG000|Ibrutinib Treatment|Death|1|||
129978911|NCT02242097|467885233|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
129978912|NCT02242097|467885233|FG000|Post Therapy Follow Up|Death|3|||
129978913|NCT02242097|467885233|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
129978914|NCT02574845|467885236|FG000|Overall Study|Consent withdrawn further participation|0|||
129978915|NCT02574845|467885237|FG001|Overall Study|Consent withdrawn further participation|0|||
129978916|NCT02574845|467885238|FG002|Overall Study|Consent withdrawn further participation|0|||
129978917|NCT02574845|467885239|FG003|Overall Study|Consent withdrawn further participation|0|||
129978918|NCT02574845|467885240|FG004|Overall Study|Consent withdrawn further participation|1|||
129978919|NCT02574845|467885241|FG005|Overall Study|Consent withdrawn further participation|0|||
129978920|NCT02574845|467885236|FG000|Overall Study|Adverse Event|0|||
129978921|NCT02574845|467885237|FG001|Overall Study|Adverse Event|1|||
129978922|NCT02574845|467885238|FG002|Overall Study|Adverse Event|0|||
129978923|NCT02574845|467885239|FG003|Overall Study|Adverse Event|0|||
129978924|NCT02574845|467885240|FG004|Overall Study|Adverse Event|0|||
129978925|NCT02574845|467885241|FG005|Overall Study|Adverse Event|1|||
129978926|NCT03435692|467885243|FG000|Overall Study|Lack of Efficacy|2|||
129978927|NCT03435692|467885244|FG001|Overall Study|Lack of Efficacy|2|||
129978928|NCT03435692|467885245|FG002|Overall Study|Lack of Efficacy|0|||
129978929|NCT00821587|467885250|FG000|Overall Study|Physician Decision|0|||
129978930|NCT00821587|467885251|FG001|Overall Study|Physician Decision|1|||
129978931|NCT02781090|467885254|FG000|3-Month Follow-Up|Missed Visit|20|||
129978932|NCT02781090|467885255|FG001|3-Month Follow-Up|Missed Visit|20|||
129978933|NCT02781090|467885254|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
129978934|NCT02781090|467885255|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
129978935|NCT02781090|467885254|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
129978936|NCT02781090|467885255|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
129978937|NCT02781090|467885254|FG000|3-Month Follow-Up|Death|1|||
129978938|NCT02781090|467885255|FG001|3-Month Follow-Up|Death|0|||
129978939|NCT02781090|467885254|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
129978940|NCT02781090|467885255|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
129978941|NCT02781090|467885254|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
129978942|NCT02781090|467885255|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
129978943|NCT02781090|467885254|FG000|6-Month Follow-Up|Death|0|||
129978944|NCT02781090|467885255|FG001|6-Month Follow-Up|Death|1|||
129978945|NCT01145898|467885256|FG000|3-year Treatment|medication change by treating physician|3|||
129978946|NCT01145898|467885257|FG001|3-year Treatment|medication change by treating physician|16|||
130151118|NCT00438659|468513048|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
130151119|NCT00438659|468513047|FG000|Overall Study|Cancel|5|||
130151120|NCT00438659|468513048|FG001|Overall Study|Cancel|2|||
130151121|NCT00440115|468513049|FG000|Overall Study|Death|7|||
130151122|NCT00440115|468513050|FG001|Overall Study|Death|9|||
130151123|NCT00440115|468513051|FG002|Overall Study|Death|5|||
130151124|NCT00440115|468513049|FG000|Overall Study|Incarceration|0|||
130151125|NCT00440115|468513050|FG001|Overall Study|Incarceration|2|||
130151126|NCT00440115|468513051|FG002|Overall Study|Incarceration|1|||
130151127|NCT01117987|468513053|FG000|Overall Study|Protocol deviation|0|||
130151128|NCT01117987|468513054|FG001|Overall Study|Protocol deviation|1|||
130151129|NCT01117987|468513053|FG000|Overall Study|Subject no longer requires study drug|1|||
130151130|NCT01117987|468513054|FG001|Overall Study|Subject no longer requires study drug|0|||
130151131|NCT01117987|468513053|FG000|Overall Study|Lost to Follow-up|1|||
130151132|NCT01117987|468513054|FG001|Overall Study|Lost to Follow-up|1|||
130151133|NCT01117987|468513053|FG000|Overall Study|Abnormal test procedure result|2|||
129978947|NCT01712061|467885258|FG000|Overall Study|Adverse Event|4|||
129978948|NCT01712061|467885259|FG001|Overall Study|Adverse Event|9|||
129978949|NCT01712061|467885260|FG002|Overall Study|Adverse Event|5|||
129978950|NCT01712061|467885258|FG000|Overall Study|Death|0|||
129978951|NCT01712061|467885259|FG001|Overall Study|Death|0|||
129978952|NCT01712061|467885260|FG002|Overall Study|Death|1|||
129978953|NCT01712061|467885258|FG000|Overall Study|Lost to Follow-up|1|||
129978954|NCT01712061|467885259|FG001|Overall Study|Lost to Follow-up|0|||
129978955|NCT01712061|467885260|FG002|Overall Study|Lost to Follow-up|1|||
129978956|NCT01712061|467885258|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
129978957|NCT01712061|467885259|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
130151134|NCT01117987|468513054|FG001|Overall Study|Abnormal test procedure result|0|||
130151135|NCT01117987|468513053|FG000|Overall Study|Lack of Efficacy|3|||
129978958|NCT01712061|467885260|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
129978959|NCT01712061|467885258|FG000|Overall Study|Medication Error Without Associated AE|0|||
129978960|NCT01712061|467885259|FG001|Overall Study|Medication Error Without Associated AE|1|||
129978961|NCT01712061|467885260|FG002|Overall Study|Medication Error Without Associated AE|0|||
130151136|NCT01117987|468513054|FG001|Overall Study|Lack of Efficacy|4|||
130151137|NCT01117987|468513053|FG000|Overall Study|Death|5|||
130151138|NCT01117987|468513054|FG001|Overall Study|Death|10|||
129978962|NCT01712061|467885258|FG000|Overall Study|Withdrawal by Subject|1|||
129978963|NCT01712061|467885259|FG001|Overall Study|Withdrawal by Subject|7|||
129978964|NCT01712061|467885260|FG002|Overall Study|Withdrawal by Subject|1|||
129978965|NCT01712061|467885258|FG000|Overall Study|Other|0|||
129978966|NCT01712061|467885259|FG001|Overall Study|Other|3|||
129978967|NCT01712061|467885260|FG002|Overall Study|Other|0|||
129978968|NCT00879775|467885261|FG000|Overall Study|Lost to Follow-up|2|||
129978969|NCT00879775|467885262|FG001|Overall Study|Lost to Follow-up|1|||
129978970|NCT01195623|467885263|FG000|Overall Study|Lost to Follow-up|35|||
129978971|NCT01195623|467885264|FG001|Overall Study|Lost to Follow-up|37|||
129978972|NCT01677767|467885268|FG000|Overall Study|Adverse Event|1|||
129978973|NCT01677767|467885268|FG000|Overall Study|Death|4|||
129978974|NCT01677767|467885268|FG000|Overall Study|Protocol Violation|4|||
129978975|NCT01677767|467885268|FG000|Overall Study|Withdrawal by Subject|10|||
129978976|NCT01677767|467885268|FG000|Overall Study|Non-compliance by the participants|3|||
129978977|NCT00842244|467885269|FG000|Overall Study|Death|3|||
129978978|NCT00842244|467885269|FG000|Overall Study|Withdrawal by Subject|1|||
129978979|NCT00842244|467885269|FG000|Overall Study|Other|17|||
129978980|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
129978981|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
129978982|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
129978983|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
129978984|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
129978985|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
129978986|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
129978987|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
129978988|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
129978989|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Other|2|||
129978990|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Other|0|||
129978991|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Other|0|||
129978992|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
129978993|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
129978994|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
129978995|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
129978996|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
129978997|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
129978998|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
129978999|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
129979000|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
129979001|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
129979002|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
129979003|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
129979004|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
129979005|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
129979006|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
129979007|NCT00757627|467885277|FG000|Overall Study|Adverse Event|15|||
129979008|NCT00757627|467885277|FG000|Overall Study|Lack of Efficacy|10|||
129979009|NCT00757627|467885277|FG000|Overall Study|Lost to Follow-up|28|||
129979010|NCT00757627|467885277|FG000|Overall Study|Withdrawal by Subject|27|||
129979011|NCT00757627|467885277|FG000|Overall Study|Other|1|||
129979012|NCT00635661|467885278|FG000|Overall Study|Withdrawal by Subject|4|||
129979013|NCT01606670|467885281|FG000|Overall Study|Adverse Event|6|||
129979014|NCT01606670|467885281|FG000|Overall Study|Lack of Efficacy|2|||
129979015|NCT01606670|467885281|FG000|Overall Study|Lost to Follow-up|3|||
129979016|NCT01606670|467885281|FG000|Overall Study|Withdrawal by Subject|3|||
129979017|NCT01606670|467885281|FG000|Overall Study|Other Reason|2|||
129979018|NCT03578887|467885295|FG000|Overall Study|Withdrawal by Subject|7|||
129979019|NCT03578887|467885296|FG001|Overall Study|Withdrawal by Subject|2|||
129979020|NCT03578887|467885297|FG002|Overall Study|Withdrawal by Subject|1|||
129979021|NCT03578887|467885295|FG000|Overall Study|Lost to Follow-up|13|||
129979022|NCT03578887|467885296|FG001|Overall Study|Lost to Follow-up|1|||
129979023|NCT03578887|467885297|FG002|Overall Study|Lost to Follow-up|4|||
130151139|NCT01117987|468513053|FG000|Overall Study|Withdrawal by Subject|5|||
129979024|NCT03578887|467885295|FG000|Overall Study|Physician Decision|0|||
129979025|NCT03578887|467885296|FG001|Overall Study|Physician Decision|1|||
129979026|NCT03578887|467885297|FG002|Overall Study|Physician Decision|1|||
129979027|NCT05718466|467887373|FG000|Overall Study|Withdrawal by Subject|1|||
129979028|NCT05718466|467887374|FG001|Overall Study|Withdrawal by Subject|2|||
129979029|NCT05718466|467887373|FG000|Overall Study|Death|0|||
129979030|NCT05718466|467887374|FG001|Overall Study|Death|1|||
129979031|NCT00387426|467887376|FG000|Overall Study|Lack of Response|7|||
129979032|NCT00387426|467887376|FG000|Overall Study|Toxicities|4|||
129979033|NCT00387426|467887376|FG000|Overall Study|Disease Progression|3|||
129979034|NCT01253135|467887383|FG000|Original Protocol|Protocol Amendment|15|||
129979035|NCT01253135|467887383|FG000|Amended Protocol|Non-compliance|1|||
129979036|NCT00918879|467887390|FG000|Overall Study|Withdrawal by Subject|4|||
129979037|NCT00918879|467887391|FG001|Overall Study|Withdrawal by Subject|4|||
129979038|NCT00918879|467887390|FG000|Overall Study|Lost to Follow-up|1|||
129979039|NCT00918879|467887391|FG001|Overall Study|Lost to Follow-up|1|||
129979040|NCT00918879|467887390|FG000|Overall Study|Severe non-compliance to protocol|1|||
129979041|NCT00918879|467887391|FG001|Overall Study|Severe non-compliance to protocol|1|||
129979042|NCT00833261|467887392|FG000|Overall Study|Withdrawal by Subject|4|||
129979043|NCT00357110|467887393|FG000|Overall Study|Early study termination|5|||
129979044|NCT00357110|467887394|FG001|Overall Study|Early study termination|5|||
129979045|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Physician Decision|2|||
129979046|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Physician Decision|0|||
129979047|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Physician Decision|0|||
129979048|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Adverse Event|33|||
129979049|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Adverse Event|0|||
129979050|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Adverse Event|0|||
129979051|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
129979052|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129979053|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129979054|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
129979055|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
129979056|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
129979057|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
129979058|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129979059|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129979060|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
129979061|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
129979062|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
129979063|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
129979064|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
129979065|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
129979066|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
129979067|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
129979068|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
129979069|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
129979070|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
129979071|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
129979072|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
129979073|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
129979074|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
129979075|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
129979076|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
129979077|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
129979078|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
129979079|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
129979080|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
129979081|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129979082|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129979083|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
129979084|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
129979085|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
129979086|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
129979087|NCT01008410|467887399|FG000|Overall Study|Adverse Event|13|||
129979088|NCT01008410|467887400|FG001|Overall Study|Adverse Event|7|||
129979089|NCT01008410|467887399|FG000|Overall Study|Withdrawal by Subject|6|||
129979090|NCT01008410|467887400|FG001|Overall Study|Withdrawal by Subject|2|||
129979091|NCT01008410|467887399|FG000|Overall Study|Lost to Follow-up|1|||
129979092|NCT01008410|467887400|FG001|Overall Study|Lost to Follow-up|0|||
129979093|NCT01008410|467887399|FG000|Overall Study|Noncompliance|1|||
129979094|NCT01008410|467887400|FG001|Overall Study|Noncompliance|0|||
129979095|NCT01008410|467887399|FG000|Overall Study|Low Cortisol|2|||
129979096|NCT01008410|467887400|FG001|Overall Study|Low Cortisol|0|||
129979097|NCT01008410|467887399|FG000|Overall Study|Lack of Efficacy|2|||
129979098|NCT01008410|467887400|FG001|Overall Study|Lack of Efficacy|6|||
129979099|NCT01008410|467887399|FG000|Overall Study|Met Exclusion Criterion|0|||
130151140|NCT01117987|468513054|FG001|Overall Study|Withdrawal by Subject|10|||
129979100|NCT01008410|467887400|FG001|Overall Study|Met Exclusion Criterion|1|||
129979101|NCT03056300|467887403|FG000|Overall Study|Surgical reason per study protocol|3|||
129979102|NCT03563157|467887404|FG000|Overall Study|Progressive Disease|2|||
129979103|NCT02187159|467887407|FG000|Overall Study|Protocol Violation|4|||
130151141|NCT01117987|468513053|FG000|Overall Study|Adverse Event|19|||
130151142|NCT01117987|468513054|FG001|Overall Study|Adverse Event|26|||
130151143|NCT01117987|468513053|FG000|Overall Study|Administrative problems|25|||
130151144|NCT01117987|468513054|FG001|Overall Study|Administrative problems|22|||
130151145|NCT03069417|468513055|FG000|Overall Study|Lost to Follow-up|2|||
130151146|NCT03069417|468513056|FG001|Overall Study|Lost to Follow-up|0|||
130151147|NCT03069417|468513055|FG000|Overall Study|Reason Unknown|4|||
130151148|NCT03069417|468513056|FG001|Overall Study|Reason Unknown|7|||
130151149|NCT02244424|468513057|FG000|Overall Study|Lost to Follow-up|20|||
130151150|NCT02244424|468513058|FG001|Overall Study|Lost to Follow-up|10|||
130151151|NCT00206102|468513059|FG000|Overall Study|Adverse Event|119|||
130151152|NCT00206102|468513060|FG001|Overall Study|Adverse Event|82|||
130151153|NCT00206102|468513059|FG000|Overall Study|Protocol Violation|0|||
130151154|NCT00206102|468513060|FG001|Overall Study|Protocol Violation|2|||
130151155|NCT00206102|468513059|FG000|Overall Study|Lack of therapeutic response|16|||
130151156|NCT00206102|468513060|FG001|Overall Study|Lack of therapeutic response|11|||
130151157|NCT00206102|468513059|FG000|Overall Study|Lost to Follow-up|95|||
130151158|NCT00206102|468513060|FG001|Overall Study|Lost to Follow-up|66|||
130151159|NCT00206102|468513059|FG000|Overall Study|Withdrawal by Subject|118|||
130151160|NCT00206102|468513060|FG001|Overall Study|Withdrawal by Subject|101|||
130151161|NCT00206102|468513059|FG000|Overall Study|Study-specific discontinuation criteria|18|||
130151162|NCT00206102|468513060|FG001|Overall Study|Study-specific discontinuation criteria|17|||
130151163|NCT00206102|468513059|FG000|Overall Study|None of those categories|42|||
130151164|NCT00206102|468513060|FG001|Overall Study|None of those categories|36|||
130151165|NCT04117945|468513061|FG000|Overall Study|Death|1|||
130151166|NCT04117945|468513062|FG001|Overall Study|Death|0|||
130151167|NCT04117945|468513061|FG000|Overall Study|Withdrawal by Subject|3|||
130151168|NCT04117945|468513062|FG001|Overall Study|Withdrawal by Subject|1|||
130151169|NCT04117945|468513061|FG000|Overall Study|Disease Progression|0|||
130151170|NCT04117945|468513062|FG001|Overall Study|Disease Progression|2|||
130151171|NCT04117945|468513061|FG000|Overall Study|Ineligible|8|||
130151172|NCT04117945|468513062|FG001|Overall Study|Ineligible|7|||
130151173|NCT00402025|468513063|FG000|Overall Study|Adverse Event|0|||
130151174|NCT00402025|468513064|FG001|Overall Study|Adverse Event|0|||
130151175|NCT00402025|468513065|FG002|Overall Study|Adverse Event|2|||
130151176|NCT00402025|468513063|FG000|Overall Study|Death|0|||
130151177|NCT00402025|468513064|FG001|Overall Study|Death|1|||
130151178|NCT00402025|468513065|FG002|Overall Study|Death|5|||
130151179|NCT00402025|468513063|FG000|Overall Study|Disease Progression|1|||
130151180|NCT00402025|468513064|FG001|Overall Study|Disease Progression|1|||
130151181|NCT00402025|468513065|FG002|Overall Study|Disease Progression|2|||
130151182|NCT00402025|468513063|FG000|Overall Study|Physician Decision|1|||
130151183|NCT00402025|468513064|FG001|Overall Study|Physician Decision|1|||
129979104|NCT02187159|467887408|FG001|Overall Study|Protocol Violation|6|||
129979105|NCT02187159|467887409|FG002|Overall Study|Protocol Violation|3|||
129979106|NCT02187159|467887410|FG003|Overall Study|Protocol Violation|4|||
129979107|NCT02187159|467887407|FG000|Overall Study|Lack of Efficacy|10|||
129979108|NCT02187159|467887408|FG001|Overall Study|Lack of Efficacy|5|||
129979109|NCT02187159|467887409|FG002|Overall Study|Lack of Efficacy|4|||
129979110|NCT02187159|467887410|FG003|Overall Study|Lack of Efficacy|7|||
129979111|NCT02187159|467887407|FG000|Overall Study|Adverse Event|28|||
129979112|NCT02187159|467887408|FG001|Overall Study|Adverse Event|33|||
129979113|NCT02187159|467887409|FG002|Overall Study|Adverse Event|42|||
129979114|NCT02187159|467887410|FG003|Overall Study|Adverse Event|50|||
129979115|NCT02187159|467887407|FG000|Overall Study|Withdrawal by Subject|24|||
129979116|NCT02187159|467887408|FG001|Overall Study|Withdrawal by Subject|28|||
129979117|NCT02187159|467887409|FG002|Overall Study|Withdrawal by Subject|25|||
129979118|NCT02187159|467887410|FG003|Overall Study|Withdrawal by Subject|26|||
129979119|NCT02187159|467887407|FG000|Overall Study|Other|3|||
129979120|NCT02187159|467887408|FG001|Overall Study|Other|7|||
129979121|NCT02187159|467887409|FG002|Overall Study|Other|3|||
129979122|NCT02187159|467887410|FG003|Overall Study|Other|9|||
130151184|NCT00402025|468513065|FG002|Overall Study|Physician Decision|0|||
130151185|NCT00402025|468513063|FG000|Overall Study|Participant Decision|0|||
130151186|NCT00402025|468513064|FG001|Overall Study|Participant Decision|0|||
130151187|NCT00402025|468513065|FG002|Overall Study|Participant Decision|1|||
130151188|NCT01917968|468513067|FG000|Overall Study|Death|3|||
130151189|NCT01917968|468513068|FG001|Overall Study|Death|2|||
130151190|NCT01917968|468513067|FG000|Overall Study|Lost to Follow-up|21|||
130151191|NCT01917968|468513068|FG001|Overall Study|Lost to Follow-up|39|||
130151192|NCT01917968|468513067|FG000|Overall Study|Physician Decision|1|||
130151193|NCT01917968|468513068|FG001|Overall Study|Physician Decision|2|||
129979123|NCT00567567|467887411|FG000|Overall Study|Adverse Event|0|||
129979124|NCT00567567|467887412|FG001|Overall Study|Adverse Event|2|||
129979125|NCT00567567|467887413|FG002|Overall Study|Adverse Event|5|||
129979126|NCT00567567|467887411|FG000|Overall Study|Death|8|||
129979127|NCT00567567|467887412|FG001|Overall Study|Death|1|||
129979128|NCT00567567|467887413|FG002|Overall Study|Death|5|||
130151194|NCT01917968|468513067|FG000|Overall Study|Withdrawal by Subject|20|||
129979129|NCT00567567|467887411|FG000|Overall Study|Lack of Efficacy|16|||
129979130|NCT00567567|467887412|FG001|Overall Study|Lack of Efficacy|17|||
129979131|NCT00567567|467887413|FG002|Overall Study|Lack of Efficacy|48|||
129979132|NCT00567567|467887411|FG000|Overall Study|Lost to Follow-up|0|||
129979133|NCT00567567|467887412|FG001|Overall Study|Lost to Follow-up|0|||
129979134|NCT00567567|467887413|FG002|Overall Study|Lost to Follow-up|1|||
130151195|NCT01917968|468513068|FG001|Overall Study|Withdrawal by Subject|35|||
130151196|NCT01917968|468513067|FG000|Overall Study|Subject Relocation|5|||
129979135|NCT00567567|467887411|FG000|Overall Study|Physician Decision|16|||
129979136|NCT00567567|467887412|FG001|Overall Study|Physician Decision|18|||
129979137|NCT00567567|467887413|FG002|Overall Study|Physician Decision|84|||
129979138|NCT00567567|467887411|FG000|Overall Study|Withdrawal by Subject|0|||
129979139|NCT00567567|467887412|FG001|Overall Study|Withdrawal by Subject|0|||
129979140|NCT00567567|467887413|FG002|Overall Study|Withdrawal by Subject|2|||
129979141|NCT00567567|467887411|FG000|Overall Study|Ineligible|4|||
129979142|NCT00567567|467887412|FG001|Overall Study|Ineligible|0|||
129979143|NCT00567567|467887413|FG002|Overall Study|Ineligible|9|||
129979144|NCT00567567|467887411|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
129979145|NCT00567567|467887412|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
129979146|NCT00567567|467887413|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
129979147|NCT00567567|467887411|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
129979148|NCT00567567|467887412|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
129979149|NCT00567567|467887413|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
129979150|NCT00567567|467887411|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
129979151|NCT00567567|467887412|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
129979152|NCT00567567|467887413|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
129979153|NCT03482466|467887414|FG000|Overall Study|Protocol Violation|2|||
129979154|NCT04335591|467887415|FG000|Overall Study|Adverse Event|5|||
129979155|NCT04335591|467887416|FG001|Overall Study|Adverse Event|2|||
129979156|NCT04335591|467887417|FG002|Overall Study|Adverse Event|3|||
129979157|NCT04335591|467887418|FG003|Overall Study|Adverse Event|2|||
129979158|NCT04335591|467887415|FG000|Overall Study|Protocol Violation|1|||
129979159|NCT04335591|467887416|FG001|Overall Study|Protocol Violation|0|||
129979160|NCT04335591|467887417|FG002|Overall Study|Protocol Violation|0|||
129979161|NCT04335591|467887418|FG003|Overall Study|Protocol Violation|0|||
129979162|NCT04335591|467887415|FG000|Overall Study|Withdrawal by Subject|8|||
129979163|NCT04335591|467887416|FG001|Overall Study|Withdrawal by Subject|4|||
129979164|NCT04335591|467887417|FG002|Overall Study|Withdrawal by Subject|4|||
129979165|NCT04335591|467887418|FG003|Overall Study|Withdrawal by Subject|5|||
129979166|NCT04335591|467887415|FG000|Overall Study|Subject planning pregnancy|0|||
129979167|NCT04335591|467887416|FG001|Overall Study|Subject planning pregnancy|1|||
129979168|NCT04335591|467887417|FG002|Overall Study|Subject planning pregnancy|0|||
129979169|NCT04335591|467887418|FG003|Overall Study|Subject planning pregnancy|0|||
129979170|NCT04335591|467887415|FG000|Overall Study|Ukrainian Russian war conflict|4|||
129979171|NCT04335591|467887416|FG001|Overall Study|Ukrainian Russian war conflict|5|||
129979172|NCT04335591|467887417|FG002|Overall Study|Ukrainian Russian war conflict|2|||
129979173|NCT04335591|467887418|FG003|Overall Study|Ukrainian Russian war conflict|0|||
129979174|NCT03268603|467887419|FG000|Overall Study|Withdrawal by Subject|6|||
129979175|NCT03268603|467887419|FG000|Overall Study|Physician Decision|1|||
129979176|NCT03268603|467887419|FG000|Overall Study|Withdrawn due to disease progression|2|||
129979177|NCT05775991|467887421|FG000|Overall Study|Withdrawal by Subject|0|||
129979178|NCT05775991|467887422|FG001|Overall Study|Withdrawal by Subject|0|||
130151197|NCT01917968|468513068|FG001|Overall Study|Subject Relocation|1|||
130151198|NCT01917968|468513067|FG000|Overall Study|36M Missed Visit|3|||
130151199|NCT01917968|468513068|FG001|Overall Study|36M Missed Visit|2|||
130151200|NCT01917968|468513067|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
129979179|NCT05775991|467887423|FG002|Overall Study|Withdrawal by Subject|2|||
129979180|NCT01461811|467887424|FG000|Overall Study|Adverse Event|2|||
129979181|NCT01461811|467887425|FG001|Overall Study|Adverse Event|1|||
129979182|NCT01461811|467887424|FG000|Overall Study|Subject decision unrelated to an AE|1|||
129979183|NCT01461811|467887425|FG001|Overall Study|Subject decision unrelated to an AE|1|||
129979184|NCT01461811|467887424|FG000|Overall Study|Noncompliance|1|||
129979185|NCT01461811|467887425|FG001|Overall Study|Noncompliance|1|||
129979186|NCT01075958|467887426|FG000|Overall Study|Blood sample could not be obtained|44|||
129979187|NCT03733314|467887427|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
129979188|NCT03733314|467887428|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
129979189|NCT03733314|467887427|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
129979190|NCT03733314|467887428|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
129979191|NCT03733314|467887427|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
129979192|NCT03733314|467887428|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
129979193|NCT03733314|467887427|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
129979194|NCT03733314|467887428|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
130151201|NCT01917968|468513068|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
130151202|NCT01917968|468513067|FG000|Overall Study|Change in Family Circumstances|0|||
129979195|NCT03733314|467887427|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
129979196|NCT03733314|467887428|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
129979197|NCT03733314|467887427|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
129979198|NCT03733314|467887428|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
129979199|NCT01240915|467887429|FG000|Overall Study|Adverse Event|0|||
129979200|NCT01240915|467887430|FG001|Overall Study|Adverse Event|0|||
129979201|NCT01240915|467887431|FG002|Overall Study|Adverse Event|0|||
129979202|NCT01240915|467887432|FG003|Overall Study|Adverse Event|1|||
129979203|NCT01240915|467887433|FG004|Overall Study|Adverse Event|0|||
129979204|NCT01240915|467887434|FG005|Overall Study|Adverse Event|2|||
129979205|NCT01240915|467887435|FG006|Overall Study|Adverse Event|0|||
129979206|NCT01240915|467887436|FG007|Overall Study|Adverse Event|0|||
129979207|NCT01240915|467887437|FG008|Overall Study|Adverse Event|1|||
129979208|NCT01240915|467887429|FG000|Overall Study|Lost to Follow-up|0|||
129979209|NCT01240915|467887430|FG001|Overall Study|Lost to Follow-up|0|||
129979210|NCT01240915|467887431|FG002|Overall Study|Lost to Follow-up|0|||
129979211|NCT01240915|467887432|FG003|Overall Study|Lost to Follow-up|0|||
130151203|NCT01917968|468513068|FG001|Overall Study|Change in Family Circumstances|1|||
130151204|NCT01917968|468513067|FG000|Overall Study|No Data Available|0|||
130151205|NCT01917968|468513068|FG001|Overall Study|No Data Available|2|||
130151206|NCT01507090|468513071|FG000|Overall Study|incomplete dataset|18|||
130151207|NCT04678817|468514654|FG000|Overall Study|Lost to Follow-up|28|||
130151208|NCT04678817|468514655|FG001|Overall Study|Lost to Follow-up|0|||
130151209|NCT04678817|468514656|FG002|Overall Study|Lost to Follow-up|0|||
130151210|NCT01937351|468514659|FG000|Overall Study|Withdrawal by Subject|4|||
130151211|NCT01937351|468514660|FG001|Overall Study|Withdrawal by Subject|2|||
130151212|NCT01937351|468514659|FG000|Overall Study|Death|1|||
129979212|NCT01240915|467887433|FG004|Overall Study|Lost to Follow-up|1|||
129979213|NCT01240915|467887434|FG005|Overall Study|Lost to Follow-up|1|||
129979214|NCT01240915|467887435|FG006|Overall Study|Lost to Follow-up|0|||
129979215|NCT01240915|467887436|FG007|Overall Study|Lost to Follow-up|1|||
129979216|NCT01240915|467887437|FG008|Overall Study|Lost to Follow-up|1|||
129979217|NCT01240915|467887429|FG000|Overall Study|Withdrawal by Subject|2|||
129979218|NCT01240915|467887430|FG001|Overall Study|Withdrawal by Subject|1|||
129979219|NCT01240915|467887431|FG002|Overall Study|Withdrawal by Subject|0|||
130151213|NCT01937351|468514660|FG001|Overall Study|Death|0|||
130151214|NCT01937351|468514659|FG000|Overall Study|Not treated w device, per protocol fail|4|||
130151215|NCT01937351|468514660|FG001|Overall Study|Not treated w device, per protocol fail|0|||
130151216|NCT04086641|468514663|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
130151217|NCT04086641|468514664|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
130151218|NCT01042535|468514665|FG000|Overall Study|disease progression prior to treatment|3|||
130151219|NCT01042535|468514665|FG000|Overall Study|disease progression during treatment|3|||
130151220|NCT01042535|468514665|FG000|Overall Study|complications from other disease|2|||
130151221|NCT04213209|468514674|FG000|Overall Study|Protocol Violation|1|||
130151222|NCT04213209|468514675|FG001|Overall Study|Protocol Violation|0|||
130151223|NCT04213209|468514676|FG002|Overall Study|Protocol Violation|0|||
130151224|NCT04213209|468514677|FG003|Overall Study|Protocol Violation|0|||
130151225|NCT04213209|468514678|FG004|Overall Study|Protocol Violation|0|||
130151226|NCT04213209|468514679|FG005|Overall Study|Protocol Violation|0|||
130151227|NCT00743509|468514682|FG000|Overall Study|Withdrawal by Subject|2|||
130151228|NCT00418522|468514690|FG000|Overall Study|Adverse Event|7|||
130151229|NCT00418522|468514691|FG001|Overall Study|Adverse Event|1|||
130151230|NCT00418522|468514690|FG000|Overall Study|Lack of Efficacy|1|||
130151231|NCT00418522|468514691|FG001|Overall Study|Lack of Efficacy|3|||
130151232|NCT00418522|468514690|FG000|Overall Study|Lost to Follow-up|10|||
130151233|NCT00418522|468514691|FG001|Overall Study|Lost to Follow-up|4|||
129979220|NCT01240915|467887432|FG003|Overall Study|Withdrawal by Subject|2|||
129979221|NCT01240915|467887433|FG004|Overall Study|Withdrawal by Subject|0|||
129979222|NCT01240915|467887434|FG005|Overall Study|Withdrawal by Subject|4|||
129979223|NCT01240915|467887435|FG006|Overall Study|Withdrawal by Subject|2|||
129979224|NCT01240915|467887436|FG007|Overall Study|Withdrawal by Subject|3|||
129979225|NCT01240915|467887437|FG008|Overall Study|Withdrawal by Subject|3|||
130151234|NCT00418522|468514690|FG000|Overall Study|Withdrawal by Subject|31|||
130151235|NCT00418522|468514691|FG001|Overall Study|Withdrawal by Subject|7|||
130151236|NCT00418522|468514690|FG000|Overall Study|Other|27|||
130151237|NCT00418522|468514691|FG001|Overall Study|Other|23|||
130151238|NCT00418522|468514690|FG000|Overall Study|Randomized but did not receive treatment|7|||
129979226|NCT01240915|467887429|FG000|Overall Study|Other|0|||
129979227|NCT01240915|467887430|FG001|Overall Study|Other|0|||
129979228|NCT01240915|467887431|FG002|Overall Study|Other|0|||
129979229|NCT01240915|467887432|FG003|Overall Study|Other|0|||
130151239|NCT00418522|468514691|FG001|Overall Study|Randomized but did not receive treatment|4|||
130151240|NCT02695719|468514692|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
130151241|NCT02695719|468514693|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
130151242|NCT02695719|468514692|FG000|Overall Study|Significant Protocol Deviation|0|||
130151243|NCT02695719|468514693|FG001|Overall Study|Significant Protocol Deviation|1|||
130151244|NCT02695719|468514692|FG000|Overall Study|Voluntary Withdrawal|1|||
130151245|NCT02695719|468514693|FG001|Overall Study|Voluntary Withdrawal|0|||
130151246|NCT00483548|468514694|FG000|Overall Study|Randomized; not treated with study drug|1|||
130151247|NCT00483548|468514695|FG001|Overall Study|Randomized; not treated with study drug|3|||
130151248|NCT00483548|468514694|FG000|Overall Study|Adverse Event|25|||
130151249|NCT00483548|468514695|FG001|Overall Study|Adverse Event|14|||
130151250|NCT00483548|468514694|FG000|Overall Study|Laboratory abnormality|1|||
130151251|NCT00483548|468514695|FG001|Overall Study|Laboratory abnormality|2|||
130151252|NCT00483548|468514694|FG000|Overall Study|Lack of Efficacy|4|||
130151253|NCT00483548|468514695|FG001|Overall Study|Lack of Efficacy|8|||
130151254|NCT00483548|468514694|FG000|Overall Study|Protocol Violation|11|||
130151255|NCT00483548|468514695|FG001|Overall Study|Protocol Violation|7|||
130151256|NCT00483548|468514694|FG000|Overall Study|Pregnancy|1|||
129979230|NCT01240915|467887433|FG004|Overall Study|Other|2|||
129979231|NCT01240915|467887434|FG005|Overall Study|Other|0|||
129979232|NCT01240915|467887435|FG006|Overall Study|Other|0|||
129979233|NCT01240915|467887436|FG007|Overall Study|Other|0|||
129979234|NCT01240915|467887437|FG008|Overall Study|Other|0|||
129979235|NCT01240915|467887429|FG000|Overall Study|Insufficient Clinical Response|0|||
129979236|NCT01240915|467887430|FG001|Overall Study|Insufficient Clinical Response|0|||
129979237|NCT01240915|467887431|FG002|Overall Study|Insufficient Clinical Response|0|||
129979238|NCT01240915|467887432|FG003|Overall Study|Insufficient Clinical Response|0|||
130151257|NCT00483548|468514695|FG001|Overall Study|Pregnancy|0|||
130151258|NCT00483548|468514694|FG000|Overall Study|Protocol required discontinuation|6|||
130151259|NCT00483548|468514695|FG001|Overall Study|Protocol required discontinuation|6|||
130151260|NCT00483548|468514694|FG000|Overall Study|Unable to comply with protocol schedule|1|||
130151261|NCT00483548|468514695|FG001|Overall Study|Unable to comply with protocol schedule|0|||
130151262|NCT00483548|468514694|FG000|Overall Study|Non-compliance with medication|2|||
130151263|NCT00483548|468514695|FG001|Overall Study|Non-compliance with medication|0|||
130151264|NCT00483548|468514694|FG000|Overall Study|Lost to Follow-up|3|||
130151265|NCT00483548|468514695|FG001|Overall Study|Lost to Follow-up|4|||
130151266|NCT00483548|468514694|FG000|Overall Study|Withdrawal by Subject|5|||
130151267|NCT00483548|468514695|FG001|Overall Study|Withdrawal by Subject|2|||
130151268|NCT00126126|468514696|FG000|Overall Study|Lost to Follow-up|0|||
130151269|NCT00126126|468514697|FG001|Overall Study|Lost to Follow-up|2|||
130151270|NCT02694549|468514698|FG000|Overall Study|screen failures|2|||
129979239|NCT01240915|467887433|FG004|Overall Study|Insufficient Clinical Response|1|||
129979240|NCT01240915|467887434|FG005|Overall Study|Insufficient Clinical Response|3|||
129979241|NCT01240915|467887435|FG006|Overall Study|Insufficient Clinical Response|6|||
129979242|NCT01240915|467887436|FG007|Overall Study|Insufficient Clinical Response|0|||
129979243|NCT01240915|467887437|FG008|Overall Study|Insufficient Clinical Response|3|||
129979244|NCT04514510|467887438|FG000|Overall Study|Lost to Follow-up|0|||
129979245|NCT04514510|467887439|FG001|Overall Study|Lost to Follow-up|1|||
129979246|NCT04514510|467887438|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
129979247|NCT04514510|467887439|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
129979248|NCT00406692|467887440|FG000|Overall Study|Withdrawal by Subject|4|||
129979249|NCT00406692|467887440|FG000|Overall Study|Physician Decision|1|||
129979250|NCT00406692|467887440|FG000|Overall Study|Adverse Event|1|||
129979251|NCT00406692|467887440|FG000|Overall Study|Lack of Efficacy|1|||
129979252|NCT02636725|467887443|FG000|Overall Study|Adverse Event|1|||
129979253|NCT05330676|467887444|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
129979254|NCT05330676|467887445|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
129979255|NCT03284203|467887446|FG000|Overall Study|Lost to Follow-up|3|||
129979256|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
129979257|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
129979258|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
129979259|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
129979260|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
129979261|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
129979262|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
129979263|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979264|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
129979265|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979266|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979267|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979268|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979269|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979270|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
129979271|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
130151271|NCT01534078|468514699|FG000|Overall Study|Death|1|||
130151272|NCT01534078|468514699|FG000|Overall Study|Withdrawal by Subject|1|||
130151273|NCT02459665|468514700|FG000|Overall Study|Withdrawal by Subject|0|||
130151274|NCT02459665|468514701|FG001|Overall Study|Withdrawal by Subject|1|||
130151275|NCT02459665|468514702|FG002|Overall Study|Withdrawal by Subject|1|||
130151276|NCT02459665|468514703|FG003|Overall Study|Withdrawal by Subject|2|||
129979272|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
129979273|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979274|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979275|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979276|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979277|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979278|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979279|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
129979280|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979281|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979282|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979283|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979284|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Death|1|||
129979285|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Death|1|||
129979286|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Death|0|||
129979287|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Death|0|||
129979288|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Death|0|||
129979289|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Death|0|||
129979290|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Death|0|||
129979291|NCT02229851|467887447|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979292|NCT02229851|467887448|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979293|NCT02229851|467887449|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979294|NCT02229851|467887450|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979295|NCT02229851|467887451|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
129979296|NCT02229851|467887452|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
129979297|NCT02229851|467887453|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
129979298|NCT02229851|467887447|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
129979299|NCT02229851|467887448|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
129979300|NCT02229851|467887449|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
129979301|NCT02229851|467887450|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
129979302|NCT02229851|467887451|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
129979303|NCT02229851|467887452|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
129979304|NCT02229851|467887453|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
129979305|NCT02229851|467887447|FG000|Extension Phase (Open-label Phase)|Death|0|||
129979306|NCT02229851|467887448|FG001|Extension Phase (Open-label Phase)|Death|0|||
129979307|NCT02229851|467887449|FG002|Extension Phase (Open-label Phase)|Death|0|||
129979308|NCT02229851|467887450|FG003|Extension Phase (Open-label Phase)|Death|1|||
129979309|NCT02229851|467887451|FG004|Extension Phase (Open-label Phase)|Death|0|||
129979310|NCT02229851|467887452|FG005|Extension Phase (Open-label Phase)|Death|1|||
129979311|NCT02229851|467887453|FG006|Extension Phase (Open-label Phase)|Death|1|||
129979312|NCT01111240|467887454|FG000|Overall Study|Adverse Event|190|||
129979313|NCT01111240|467887454|FG000|Overall Study|Lack of Efficacy|545|||
129979314|NCT01111240|467887454|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
129979315|NCT01111240|467887454|FG000|Overall Study|Other|312|||
129979316|NCT02206061|467887455|FG000|Overall Study|Withdrawal by Subject|4|||
129979317|NCT02206061|467887456|FG001|Overall Study|Withdrawal by Subject|7|||
129979318|NCT02206061|467887457|FG002|Overall Study|Withdrawal by Subject|1|||
129979319|NCT02206061|467887455|FG000|Overall Study|Lost to Follow-up|14|||
129979320|NCT02206061|467887456|FG001|Overall Study|Lost to Follow-up|7|||
129979321|NCT02206061|467887457|FG002|Overall Study|Lost to Follow-up|20|||
129979322|NCT01607476|467887458|FG000|Overall Study|Withdrawal by Subject|1|||
129979323|NCT01607476|467887459|FG001|Overall Study|Withdrawal by Subject|0|||
129979324|NCT01607476|467887460|FG002|Overall Study|Withdrawal by Subject|1|||
129979325|NCT01607476|467887458|FG000|Overall Study|Lost to Follow-up|0|||
129979326|NCT01607476|467887459|FG001|Overall Study|Lost to Follow-up|0|||
129979327|NCT01607476|467887460|FG002|Overall Study|Lost to Follow-up|2|||
129979328|NCT04958200|467887467|FG000|Overall Study|Withdrawal by Subject|0|||
129979329|NCT04958200|467887468|FG001|Overall Study|Withdrawal by Subject|2|||
129979330|NCT04958200|467887467|FG000|Overall Study|Lost to Follow-up|3|||
129979331|NCT04958200|467887468|FG001|Overall Study|Lost to Follow-up|2|||
129979332|NCT04531098|467887469|FG000|Stage I|Adverse Event|0|||
129979333|NCT04531098|467887470|FG001|Stage I|Adverse Event|0|||
129979334|NCT04531098|467887471|FG002|Stage I|Adverse Event|3|||
129979335|NCT04531098|467887469|FG000|Stage I|Protocol Violation|0|||
130094587|NCT03556202|468302421|FG001|Extension Treatment Period|Protocol Violation|1|||
129979336|NCT04531098|467887470|FG001|Stage I|Protocol Violation|0|||
129979337|NCT04531098|467887471|FG002|Stage I|Protocol Violation|5|||
130094588|NCT03556202|468302422|FG002|Extension Treatment Period|Protocol Violation|1|||
130094589|NCT03556202|468302420|FG000|Extension Treatment Period|Sponsor Decision|0|||
130094590|NCT03556202|468302421|FG001|Extension Treatment Period|Sponsor Decision|1|||
130094591|NCT03556202|468302422|FG002|Extension Treatment Period|Sponsor Decision|0|||
130094592|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
129979338|NCT04531098|467887469|FG000|Stage I|Withdrawal by Subject|0|||
129979339|NCT04531098|467887470|FG001|Stage I|Withdrawal by Subject|5|||
129979340|NCT04531098|467887471|FG002|Stage I|Withdrawal by Subject|10|||
129979341|NCT04531098|467887469|FG000|Stage II|Adverse Event|1|||
129979342|NCT04531098|467887470|FG001|Stage II|Adverse Event|2|||
129979343|NCT04531098|467887471|FG002|Stage II|Adverse Event|0|||
129979344|NCT04531098|467887469|FG000|Stage II|Protocol Violation|1|||
129979345|NCT04531098|467887470|FG001|Stage II|Protocol Violation|2|||
129979346|NCT04531098|467887471|FG002|Stage II|Protocol Violation|0|||
130151277|NCT00868296|468514708|FG000|Overall Study|Adverse Event|0|||
130151278|NCT00868296|468514709|FG001|Overall Study|Adverse Event|2|||
130151279|NCT00868296|468514708|FG000|Overall Study|Withdrawal by Subject|0|||
130151280|NCT00868296|468514709|FG001|Overall Study|Withdrawal by Subject|1|||
130151281|NCT00573170|468514714|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
130151282|NCT00573170|468514715|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
129979347|NCT04531098|467887469|FG000|Stage II|Withdrawal by Subject|3|||
129979348|NCT04531098|467887470|FG001|Stage II|Withdrawal by Subject|1|||
129979349|NCT04531098|467887471|FG002|Stage II|Withdrawal by Subject|0|||
129979350|NCT04531098|467887469|FG000|Stage II|Moved from study area|8|||
129979351|NCT04531098|467887470|FG001|Stage II|Moved from study area|5|||
129979352|NCT04531098|467887471|FG002|Stage II|Moved from study area|0|||
129979353|NCT02628028|467887472|FG000|Dosing Period|Withdrawal by Subject|0|||
129979354|NCT02628028|467887473|FG001|Dosing Period|Withdrawal by Subject|0|||
130151283|NCT00573170|468514716|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
130151284|NCT00573170|468514717|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
130151285|NCT00573170|468514718|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
130151286|NCT00573170|468514719|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
130151287|NCT00573170|468514714|FG000|First Washout Period|Adverse Event|1|||
130151288|NCT00573170|468514715|FG001|First Washout Period|Adverse Event|1|||
129979355|NCT02628028|467887474|FG002|Dosing Period|Withdrawal by Subject|1|||
129979356|NCT02628028|467887475|FG003|Dosing Period|Withdrawal by Subject|0|||
129979357|NCT02628028|467887476|FG004|Dosing Period|Withdrawal by Subject|2|||
129979358|NCT02628028|467887477|FG005|Dosing Period|Withdrawal by Subject|4|||
129979359|NCT02628028|467887478|FG006|Dosing Period|Withdrawal by Subject|1|||
129979360|NCT02628028|467887479|FG007|Dosing Period|Withdrawal by Subject|1|||
129979361|NCT02628028|467887472|FG000|Dosing Period|Adverse Event|0|||
129979362|NCT02628028|467887473|FG001|Dosing Period|Adverse Event|0|||
129979363|NCT02628028|467887474|FG002|Dosing Period|Adverse Event|0|||
129979364|NCT02628028|467887475|FG003|Dosing Period|Adverse Event|0|||
129979365|NCT02628028|467887476|FG004|Dosing Period|Adverse Event|2|||
129979366|NCT02628028|467887477|FG005|Dosing Period|Adverse Event|1|||
129979367|NCT02628028|467887478|FG006|Dosing Period|Adverse Event|3|||
129979368|NCT02628028|467887479|FG007|Dosing Period|Adverse Event|2|||
129979369|NCT02628028|467887472|FG000|Dosing Period|Death|0|||
129979370|NCT02628028|467887473|FG001|Dosing Period|Death|0|||
129979371|NCT02628028|467887474|FG002|Dosing Period|Death|0|||
130151289|NCT00573170|468514716|FG002|First Washout Period|Adverse Event|0|||
130151290|NCT00573170|468514717|FG003|First Washout Period|Adverse Event|0|||
130151291|NCT00573170|468514718|FG004|First Washout Period|Adverse Event|0|||
130151292|NCT00573170|468514719|FG005|First Washout Period|Adverse Event|1|||
130151293|NCT00573170|468514714|FG000|First Washout Period|Lack of Efficacy|0|||
130151294|NCT00573170|468514715|FG001|First Washout Period|Lack of Efficacy|0|||
130151295|NCT00573170|468514716|FG002|First Washout Period|Lack of Efficacy|0|||
130151296|NCT00573170|468514717|FG003|First Washout Period|Lack of Efficacy|0|||
130151297|NCT00573170|468514718|FG004|First Washout Period|Lack of Efficacy|0|||
130151298|NCT00573170|468514719|FG005|First Washout Period|Lack of Efficacy|1|||
130151299|NCT00573170|468514714|FG000|First Washout Period|Lost to Follow-up|1|||
129979372|NCT02628028|467887475|FG003|Dosing Period|Death|0|||
129979373|NCT02628028|467887476|FG004|Dosing Period|Death|0|||
129979374|NCT02628028|467887477|FG005|Dosing Period|Death|0|||
129979375|NCT02628028|467887478|FG006|Dosing Period|Death|0|||
129979376|NCT02628028|467887479|FG007|Dosing Period|Death|1|||
129979377|NCT02628028|467887472|FG000|Dosing Period|Lack of Efficacy|0|||
129979378|NCT02628028|467887473|FG001|Dosing Period|Lack of Efficacy|0|||
130151300|NCT00573170|468514715|FG001|First Washout Period|Lost to Follow-up|1|||
130151301|NCT00573170|468514716|FG002|First Washout Period|Lost to Follow-up|0|||
130151302|NCT00573170|468514717|FG003|First Washout Period|Lost to Follow-up|2|||
130151303|NCT00573170|468514718|FG004|First Washout Period|Lost to Follow-up|0|||
130151304|NCT00573170|468514719|FG005|First Washout Period|Lost to Follow-up|2|||
130151305|NCT00573170|468514714|FG000|First Washout Period|Withdrawal by Subject|2|||
129979379|NCT02628028|467887474|FG002|Dosing Period|Lack of Efficacy|0|||
129979380|NCT02628028|467887475|FG003|Dosing Period|Lack of Efficacy|0|||
129979381|NCT02628028|467887476|FG004|Dosing Period|Lack of Efficacy|3|||
129979382|NCT02628028|467887477|FG005|Dosing Period|Lack of Efficacy|0|||
129979383|NCT02628028|467887478|FG006|Dosing Period|Lack of Efficacy|1|||
129979384|NCT02628028|467887479|FG007|Dosing Period|Lack of Efficacy|0|||
129979385|NCT02628028|467887472|FG000|Dosing Period|Study Terminated by Sponsor|0|||
129979386|NCT02628028|467887473|FG001|Dosing Period|Study Terminated by Sponsor|0|||
129979387|NCT02628028|467887474|FG002|Dosing Period|Study Terminated by Sponsor|0|||
129979388|NCT02628028|467887475|FG003|Dosing Period|Study Terminated by Sponsor|0|||
129979389|NCT02628028|467887476|FG004|Dosing Period|Study Terminated by Sponsor|7|||
129979390|NCT02628028|467887477|FG005|Dosing Period|Study Terminated by Sponsor|6|||
129979391|NCT02628028|467887478|FG006|Dosing Period|Study Terminated by Sponsor|7|||
129979392|NCT02628028|467887479|FG007|Dosing Period|Study Terminated by Sponsor|7|||
129979393|NCT02628028|467887472|FG000|Dosing Period|Physician Decision|0|||
129979394|NCT02628028|467887473|FG001|Dosing Period|Physician Decision|0|||
129979395|NCT02628028|467887474|FG002|Dosing Period|Physician Decision|0|||
129979396|NCT02628028|467887475|FG003|Dosing Period|Physician Decision|0|||
129979397|NCT02628028|467887476|FG004|Dosing Period|Physician Decision|0|||
129979398|NCT02628028|467887477|FG005|Dosing Period|Physician Decision|1|||
129979399|NCT02628028|467887478|FG006|Dosing Period|Physician Decision|0|||
129979400|NCT02628028|467887479|FG007|Dosing Period|Physician Decision|0|||
129979401|NCT02628028|467887472|FG000|Dosing Period|Site Terminated by Sponsor|0|||
129979402|NCT02628028|467887473|FG001|Dosing Period|Site Terminated by Sponsor|0|||
129979403|NCT02628028|467887474|FG002|Dosing Period|Site Terminated by Sponsor|0|||
129979404|NCT02628028|467887475|FG003|Dosing Period|Site Terminated by Sponsor|0|||
129979405|NCT02628028|467887476|FG004|Dosing Period|Site Terminated by Sponsor|0|||
129979406|NCT02628028|467887477|FG005|Dosing Period|Site Terminated by Sponsor|1|||
129979407|NCT02628028|467887478|FG006|Dosing Period|Site Terminated by Sponsor|1|||
129979408|NCT02628028|467887479|FG007|Dosing Period|Site Terminated by Sponsor|0|||
129979409|NCT02628028|467887472|FG000|Dosing Period|Lost to Follow-up|0|||
129979410|NCT02628028|467887473|FG001|Dosing Period|Lost to Follow-up|0|||
129979411|NCT02628028|467887474|FG002|Dosing Period|Lost to Follow-up|0|||
129979412|NCT02628028|467887475|FG003|Dosing Period|Lost to Follow-up|0|||
129979413|NCT02628028|467887476|FG004|Dosing Period|Lost to Follow-up|0|||
129979414|NCT02628028|467887477|FG005|Dosing Period|Lost to Follow-up|0|||
129979415|NCT02628028|467887478|FG006|Dosing Period|Lost to Follow-up|1|||
129979416|NCT02628028|467887479|FG007|Dosing Period|Lost to Follow-up|0|||
129979417|NCT02628028|467887472|FG000|Dosing Period|Other|0|||
129979418|NCT02628028|467887473|FG001|Dosing Period|Other|0|||
129979419|NCT02628028|467887474|FG002|Dosing Period|Other|0|||
129979420|NCT02628028|467887475|FG003|Dosing Period|Other|0|||
129979421|NCT02628028|467887476|FG004|Dosing Period|Other|2|||
129979422|NCT02628028|467887477|FG005|Dosing Period|Other|1|||
129979423|NCT02628028|467887478|FG006|Dosing Period|Other|2|||
129979424|NCT02628028|467887479|FG007|Dosing Period|Other|4|||
129979425|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
129979426|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
129979427|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
129979428|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
129979429|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
129979430|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
129979431|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
129979432|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
129979433|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979434|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979435|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979436|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979437|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979438|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
130094593|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
130094594|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
130094595|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Death|1|||
130094596|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Death|0|||
130094597|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Death|0|||
130094598|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
130094599|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
130094600|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
130094601|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
130094602|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
130094603|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
130094604|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
130094605|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
130094606|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
130094607|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
130094608|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
130094609|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
130094610|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
130094611|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
130094612|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
130094613|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
130094614|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
130094615|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
129979439|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979440|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
129979441|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979442|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979443|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979444|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979445|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979446|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
129979447|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
129979448|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
129979449|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979450|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979451|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979452|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979453|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979454|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
129979455|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
129979456|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
129979457|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Other|0|||
129979458|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Other|0|||
129979459|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Other|0|||
129979460|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Other|0|||
129979461|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Other|0|||
129979462|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Other|3|||
129979463|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Other|4|||
129979464|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Other|3|||
129979465|NCT02145468|467887480|FG000|Overall Study|Withdrawal by Subject|5|||
129979466|NCT02145468|467887481|FG001|Overall Study|Withdrawal by Subject|8|||
129979467|NCT04157400|467887482|FG000|Overall Study|Withdrawal by Subject|1|||
129979468|NCT04157400|467887482|FG000|Overall Study|Lost to Follow-up|3|||
129979469|NCT00623805|467887483|FG000|Overall Study|Adverse Event|9|||
129979470|NCT00623805|467887484|FG001|Overall Study|Adverse Event|6|||
129979471|NCT00623805|467887483|FG000|Overall Study|Death|2|||
129979472|NCT00623805|467887484|FG001|Overall Study|Death|0|||
129979473|NCT00623805|467887483|FG000|Overall Study|Lack of Efficacy|3|||
129979474|NCT00623805|467887484|FG001|Overall Study|Lack of Efficacy|7|||
129979475|NCT00623805|467887483|FG000|Overall Study|Lost to Follow-up|2|||
129979476|NCT00623805|467887484|FG001|Overall Study|Lost to Follow-up|2|||
129979477|NCT00623805|467887483|FG000|Overall Study|Protocol Violation|1|||
129979478|NCT00623805|467887484|FG001|Overall Study|Protocol Violation|1|||
129979479|NCT00623805|467887483|FG000|Overall Study|Reason not Specified|3|||
129979480|NCT00623805|467887484|FG001|Overall Study|Reason not Specified|6|||
129979481|NCT04655027|467887500|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
129979482|NCT04655027|467887501|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
129979483|NCT03519997|467887504|FG000|Overall Study|Adverse Event|4|||
129979484|NCT03519997|467887504|FG000|Overall Study|Withdrawal by Subject|2|||
129979485|NCT03519997|467887504|FG000|Overall Study|Protocol Violation|1|||
129979486|NCT05543707|467887505|FG000|Overall Study|Study drug non-compliance/|5|||
129979487|NCT05543707|467887506|FG001|Overall Study|Study drug non-compliance/|0|||
129979488|NCT05543707|467887505|FG000|Overall Study|Withdrawal by Subject|1|||
129979489|NCT05543707|467887506|FG001|Overall Study|Withdrawal by Subject|1|||
129979490|NCT05543707|467887505|FG000|Overall Study|Adverse Event|1|||
129979491|NCT05543707|467887506|FG001|Overall Study|Adverse Event|0|||
129979492|NCT05543707|467887505|FG000|Overall Study|concurrent illness|0|||
129979493|NCT05543707|467887506|FG001|Overall Study|concurrent illness|1|||
129979494|NCT05543707|467887505|FG000|Overall Study|Pregnancy|1|||
129979495|NCT05543707|467887506|FG001|Overall Study|Pregnancy|1|||
129979496|NCT00186888|467887507|FG000|Overall Study|Toxicity|0|||
129979497|NCT00186888|467887508|FG001|Overall Study|Toxicity|1|||
129979498|NCT00186888|467887509|FG002|Overall Study|Toxicity|0|||
129979499|NCT00186888|467887507|FG000|Overall Study|Relapse or progression of disease|4|||
129979500|NCT00186888|467887508|FG001|Overall Study|Relapse or progression of disease|2|||
129979501|NCT00186888|467887509|FG002|Overall Study|Relapse or progression of disease|0|||
129979502|NCT02336451|467887510|FG000|Overall Study|Adverse Event|1|||
129979503|NCT02336451|467887511|FG001|Overall Study|Adverse Event|2|||
129979504|NCT02336451|467887512|FG002|Overall Study|Adverse Event|0|||
129979505|NCT02336451|467887513|FG003|Overall Study|Adverse Event|6|||
129979506|NCT02336451|467887514|FG004|Overall Study|Adverse Event|4|||
129979507|NCT02336451|467887510|FG000|Overall Study|Death|6|||
129979508|NCT02336451|467887511|FG001|Overall Study|Death|2|||
129979509|NCT02336451|467887512|FG002|Overall Study|Death|3|||
129979510|NCT02336451|467887513|FG003|Overall Study|Death|6|||
129979511|NCT02336451|467887514|FG004|Overall Study|Death|6|||
129979512|NCT02336451|467887510|FG000|Overall Study|Physician Decision|9|||
129979513|NCT02336451|467887511|FG001|Overall Study|Physician Decision|6|||
129979514|NCT02336451|467887512|FG002|Overall Study|Physician Decision|7|||
129979515|NCT02336451|467887513|FG003|Overall Study|Physician Decision|16|||
129979516|NCT02336451|467887514|FG004|Overall Study|Physician Decision|3|||
129979517|NCT02336451|467887510|FG000|Overall Study|Progressive disease|23|||
129979518|NCT02336451|467887511|FG001|Overall Study|Progressive disease|26|||
129979519|NCT02336451|467887512|FG002|Overall Study|Progressive disease|2|||
129979520|NCT02336451|467887513|FG003|Overall Study|Progressive disease|14|||
129979521|NCT02336451|467887514|FG004|Overall Study|Progressive disease|4|||
129979522|NCT02336451|467887510|FG000|Overall Study|Protocol Violation|1|||
129979523|NCT02336451|467887511|FG001|Overall Study|Protocol Violation|0|||
129979524|NCT02336451|467887512|FG002|Overall Study|Protocol Violation|0|||
129979525|NCT02336451|467887513|FG003|Overall Study|Protocol Violation|0|||
129979526|NCT02336451|467887514|FG004|Overall Study|Protocol Violation|0|||
129979527|NCT02336451|467887510|FG000|Overall Study|Patient/guardian decision|2|||
129979528|NCT02336451|467887511|FG001|Overall Study|Patient/guardian decision|4|||
129979529|NCT02336451|467887512|FG002|Overall Study|Patient/guardian decision|0|||
129979530|NCT02336451|467887513|FG003|Overall Study|Patient/guardian decision|2|||
129979531|NCT02336451|467887514|FG004|Overall Study|Patient/guardian decision|1|||
129979532|NCT02344290|467887522|FG000|Overall Study|Withdrawal by Subject|315|||
129979533|NCT02344290|467887523|FG001|Overall Study|Withdrawal by Subject|324|||
130151306|NCT00573170|468514715|FG001|First Washout Period|Withdrawal by Subject|0|||
130151307|NCT00573170|468514716|FG002|First Washout Period|Withdrawal by Subject|0|||
130151308|NCT00573170|468514717|FG003|First Washout Period|Withdrawal by Subject|2|||
130151309|NCT00573170|468514718|FG004|First Washout Period|Withdrawal by Subject|3|||
130151310|NCT00573170|468514719|FG005|First Washout Period|Withdrawal by Subject|3|||
130151311|NCT00573170|468514714|FG000|First Washout Period|Other|4|||
130151312|NCT00573170|468514715|FG001|First Washout Period|Other|0|||
130151313|NCT00573170|468514716|FG002|First Washout Period|Other|1|||
130151314|NCT00573170|468514717|FG003|First Washout Period|Other|1|||
130151315|NCT00573170|468514718|FG004|First Washout Period|Other|0|||
130151316|NCT00573170|468514719|FG005|First Washout Period|Other|0|||
130151317|NCT00573170|468514714|FG000|Second Washout Period|Adverse Event|1|||
130151318|NCT00573170|468514715|FG001|Second Washout Period|Adverse Event|0|||
130151319|NCT00573170|468514716|FG002|Second Washout Period|Adverse Event|0|||
130151320|NCT00573170|468514717|FG003|Second Washout Period|Adverse Event|0|||
130151321|NCT00573170|468514718|FG004|Second Washout Period|Adverse Event|1|||
130151322|NCT00573170|468514719|FG005|Second Washout Period|Adverse Event|0|||
130151323|NCT00573170|468514714|FG000|Second Washout Period|Protocol Violation|2|||
130151324|NCT00573170|468514715|FG001|Second Washout Period|Protocol Violation|1|||
130151325|NCT00573170|468514716|FG002|Second Washout Period|Protocol Violation|1|||
130151326|NCT00573170|468514717|FG003|Second Washout Period|Protocol Violation|0|||
130151327|NCT00573170|468514718|FG004|Second Washout Period|Protocol Violation|0|||
130151328|NCT00573170|468514719|FG005|Second Washout Period|Protocol Violation|0|||
130151329|NCT00573170|468514714|FG000|Second Washout Period|Withdrawal by Subject|1|||
130151330|NCT00573170|468514715|FG001|Second Washout Period|Withdrawal by Subject|1|||
130151331|NCT00573170|468514716|FG002|Second Washout Period|Withdrawal by Subject|2|||
130151332|NCT00573170|468514717|FG003|Second Washout Period|Withdrawal by Subject|0|||
130151333|NCT00573170|468514718|FG004|Second Washout Period|Withdrawal by Subject|1|||
130151334|NCT00573170|468514719|FG005|Second Washout Period|Withdrawal by Subject|0|||
130151335|NCT00573170|468514714|FG000|Second Washout Period|Lost to Follow-up|0|||
130151336|NCT00573170|468514715|FG001|Second Washout Period|Lost to Follow-up|0|||
130151337|NCT00573170|468514716|FG002|Second Washout Period|Lost to Follow-up|0|||
130151338|NCT00573170|468514717|FG003|Second Washout Period|Lost to Follow-up|1|||
130151339|NCT00573170|468514718|FG004|Second Washout Period|Lost to Follow-up|0|||
130151340|NCT00573170|468514719|FG005|Second Washout Period|Lost to Follow-up|0|||
130151341|NCT00573170|468514714|FG000|Second Washout Period|Other|1|||
130151342|NCT00573170|468514715|FG001|Second Washout Period|Other|2|||
130151343|NCT00573170|468514716|FG002|Second Washout Period|Other|1|||
130151344|NCT00573170|468514717|FG003|Second Washout Period|Other|4|||
130151345|NCT00573170|468514718|FG004|Second Washout Period|Other|6|||
130151346|NCT00573170|468514719|FG005|Second Washout Period|Other|2|||
130151347|NCT00573170|468514714|FG000|Third Treatment Period|Withdrawal by Subject|1|||
130151348|NCT00573170|468514715|FG001|Third Treatment Period|Withdrawal by Subject|0|||
130151349|NCT00573170|468514716|FG002|Third Treatment Period|Withdrawal by Subject|0|||
130151350|NCT00573170|468514717|FG003|Third Treatment Period|Withdrawal by Subject|0|||
129979534|NCT02344290|467887522|FG000|Overall Study|Lost to Follow-up|258|||
130151351|NCT00573170|468514718|FG004|Third Treatment Period|Withdrawal by Subject|0|||
130151352|NCT00573170|468514719|FG005|Third Treatment Period|Withdrawal by Subject|0|||
129979535|NCT02344290|467887523|FG001|Overall Study|Lost to Follow-up|249|||
129979536|NCT02344290|467887522|FG000|Overall Study|Unable to get to clinic|69|||
129979537|NCT02344290|467887523|FG001|Overall Study|Unable to get to clinic|60|||
129979538|NCT02344290|467887522|FG000|Overall Study|Physician Decision|25|||
129979539|NCT02344290|467887523|FG001|Overall Study|Physician Decision|25|||
130151353|NCT00573170|468514714|FG000|Third Treatment Period|Lost to Follow-up|0|||
130151354|NCT00573170|468514715|FG001|Third Treatment Period|Lost to Follow-up|0|||
130151355|NCT00573170|468514716|FG002|Third Treatment Period|Lost to Follow-up|0|||
130151356|NCT00573170|468514717|FG003|Third Treatment Period|Lost to Follow-up|0|||
130151357|NCT00573170|468514718|FG004|Third Treatment Period|Lost to Follow-up|0|||
130151358|NCT00573170|468514719|FG005|Third Treatment Period|Lost to Follow-up|2|||
130151359|NCT00986570|468514720|FG000|Overall Study|Lost to Follow-up|6|||
130151360|NCT00986570|468514720|FG000|Overall Study|Potential bias for objective assessment|1|||
130151361|NCT00493454|468514722|FG000|Overall Study|Withdrawal by Subject|1|||
130151362|NCT00103038|468514723|FG000|Overall Study|Withdrawal by Subject|8|||
130151363|NCT00103038|468514723|FG000|Overall Study|Screen failure|3|||
129979540|NCT02344290|467887522|FG000|Overall Study|Site Closure|15|||
129979541|NCT02344290|467887523|FG001|Overall Study|Site Closure|19|||
129979542|NCT02344290|467887522|FG000|Overall Study|Other|5|||
130151364|NCT00103038|468514723|FG000|Overall Study|Death|1|||
130151365|NCT00103038|468514723|FG000|Overall Study|Physician Decision|1|||
130151366|NCT03649412|468514730|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
130151367|NCT03649412|468514731|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
130151368|NCT03649412|468514730|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
130151369|NCT03649412|468514731|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
130151370|NCT03649412|468514730|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
130151371|NCT03649412|468514731|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
130151372|NCT03649412|468514730|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
130151373|NCT03649412|468514731|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
130151374|NCT03649412|468514730|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
130151375|NCT03649412|468514731|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
130151376|NCT03649412|468514730|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
130151377|NCT03649412|468514731|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
130151378|NCT02865395|468514732|FG000|Overall Study|Physician Decision|6|||
130151379|NCT02865395|468514733|FG001|Overall Study|Physician Decision|10|||
130151380|NCT02865395|468514734|FG002|Overall Study|Physician Decision|7|||
130151381|NCT01501110|468514735|FG000|Overall Study|Death|0|||
130151382|NCT01501110|468514736|FG001|Overall Study|Death|1|||
130151383|NCT02674386|468514739|FG000|Overall Study|Lost to Follow-up|0|||
130151384|NCT02674386|468514740|FG001|Overall Study|Lost to Follow-up|1|||
130151385|NCT02674386|468514741|FG002|Overall Study|Lost to Follow-up|1|||
130151386|NCT02674386|468514739|FG000|Overall Study|Withdrawal by Subject|0|||
130151387|NCT02674386|468514740|FG001|Overall Study|Withdrawal by Subject|4|||
130151388|NCT02674386|468514741|FG002|Overall Study|Withdrawal by Subject|0|||
130151389|NCT02674386|468514739|FG000|Overall Study|Other|0|||
130151390|NCT02674386|468514740|FG001|Overall Study|Other|1|||
130151391|NCT02674386|468514741|FG002|Overall Study|Other|0|||
130151392|NCT02674386|468514739|FG000|Overall Study|Enrolled but not evaluated|0|||
130151393|NCT02674386|468514740|FG001|Overall Study|Enrolled but not evaluated|4|||
130151394|NCT02674386|468514741|FG002|Overall Study|Enrolled but not evaluated|0|||
130151395|NCT02462486|468514746|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130151396|NCT02462486|468514747|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
130151397|NCT02462486|468514748|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
130151398|NCT02462486|468514746|FG000|Overall Study|Adverse Event|53|||
130151399|NCT02462486|468514747|FG001|Overall Study|Adverse Event|48|||
130151400|NCT02462486|468514748|FG002|Overall Study|Adverse Event|21|||
130151401|NCT02462486|468514746|FG000|Overall Study|Lack of Efficacy|6|||
130151402|NCT02462486|468514747|FG001|Overall Study|Lack of Efficacy|12|||
130151403|NCT02462486|468514748|FG002|Overall Study|Lack of Efficacy|3|||
130151404|NCT02462486|468514746|FG000|Overall Study|Lost to Follow-up|3|||
130151405|NCT02462486|468514747|FG001|Overall Study|Lost to Follow-up|4|||
130151406|NCT02462486|468514748|FG002|Overall Study|Lost to Follow-up|2|||
130151407|NCT02462486|468514746|FG000|Overall Study|Withdrawal by Subject|25|||
130151408|NCT02462486|468514747|FG001|Overall Study|Withdrawal by Subject|22|||
130151409|NCT02462486|468514748|FG002|Overall Study|Withdrawal by Subject|19|||
130151410|NCT02462486|468514746|FG000|Overall Study|Protocol Violation|3|||
130151411|NCT02462486|468514747|FG001|Overall Study|Protocol Violation|1|||
130151412|NCT02462486|468514748|FG002|Overall Study|Protocol Violation|1|||
130151413|NCT02462486|468514746|FG000|Overall Study|Reason not Specified|3|||
130151414|NCT02462486|468514747|FG001|Overall Study|Reason not Specified|4|||
130151415|NCT02462486|468514748|FG002|Overall Study|Reason not Specified|3|||
130151416|NCT01439724|468514749|FG000|Overall Study|missing consultation|9|||
130151417|NCT01439724|468514750|FG001|Overall Study|missing consultation|8|||
130151418|NCT04019054|468514752|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
130151419|NCT04019054|468514753|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
130151420|NCT04019054|468514752|FG000|Overall Study|Withdrawal by Subject|3|||
130151421|NCT04019054|468514753|FG001|Overall Study|Withdrawal by Subject|1|||
130151422|NCT02094261|468514754|FG000|Overall Study|Death|24|||
130151423|NCT02094261|468514754|FG000|Overall Study|Lost to Follow-up|1|||
130151424|NCT02094261|468514754|FG000|Overall Study|Withdrawal by Subject|4|||
130151425|NCT02094261|468514754|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
130151426|NCT03877926|468514759|FG000|Overall Study|Adverse Event|1|||
130151427|NCT03877926|468514760|FG001|Overall Study|Adverse Event|0|||
130151428|NCT03877926|468514761|FG002|Overall Study|Adverse Event|0|||
130151429|NCT03877926|468514762|FG003|Overall Study|Adverse Event|0|||
130151430|NCT03877926|468514759|FG000|Overall Study|Death|2|||
130151431|NCT03877926|468514760|FG001|Overall Study|Death|2|||
130151432|NCT03877926|468514761|FG002|Overall Study|Death|2|||
130151433|NCT03877926|468514762|FG003|Overall Study|Death|0|||
130151434|NCT03877926|468514759|FG000|Overall Study|Lost to Follow-up|41|||
130151435|NCT03877926|468514760|FG001|Overall Study|Lost to Follow-up|52|||
130151436|NCT03877926|468514761|FG002|Overall Study|Lost to Follow-up|45|||
130151437|NCT03877926|468514762|FG003|Overall Study|Lost to Follow-up|17|||
130151438|NCT03877926|468514759|FG000|Overall Study|Physician Decision|2|||
130151439|NCT03877926|468514760|FG001|Overall Study|Physician Decision|0|||
130151440|NCT03877926|468514761|FG002|Overall Study|Physician Decision|2|||
130151441|NCT03877926|468514762|FG003|Overall Study|Physician Decision|0|||
130151442|NCT03877926|468514759|FG000|Overall Study|Withdrawal by Subject|18|||
130151443|NCT03877926|468514760|FG001|Overall Study|Withdrawal by Subject|21|||
130151444|NCT03877926|468514761|FG002|Overall Study|Withdrawal by Subject|12|||
130151445|NCT03877926|468514762|FG003|Overall Study|Withdrawal by Subject|4|||
130151446|NCT03877926|468514759|FG000|Overall Study|Other - Various|4|||
130151447|NCT03877926|468514760|FG001|Overall Study|Other - Various|1|||
130151448|NCT03877926|468514761|FG002|Overall Study|Other - Various|1|||
130151449|NCT03877926|468514762|FG003|Overall Study|Other - Various|0|||
130151450|NCT03877926|468514759|FG000|Overall Study|Not Treated|3|||
130151451|NCT03877926|468514760|FG001|Overall Study|Not Treated|1|||
130151452|NCT03877926|468514761|FG002|Overall Study|Not Treated|1|||
130151453|NCT03877926|468514762|FG003|Overall Study|Not Treated|0|||
130151454|NCT03554317|468514764|FG000|Overall Study|Withdrawal by Subject|1|||
130151455|NCT03554317|468514764|FG000|Overall Study|PSA Progression|3|||
130151456|NCT03554317|468514764|FG000|Overall Study|Radiographic Progression|4|||
130151457|NCT00537199|468514765|FG000|Overall Study|Study Terminated|1|||
130151458|NCT00467831|468514766|FG000|Overall Study|Death|2|||
130151459|NCT00467831|468514766|FG000|Overall Study|Withdrawal by Subject|1|||
130151460|NCT00860743|468514769|FG000|Overall Study|Withdrawal by Subject|3|||
130151461|NCT00860743|468514770|FG001|Overall Study|Withdrawal by Subject|0|||
130151462|NCT02776553|468514774|FG000|Overall Study|Lost to Follow-up|1|||
130151463|NCT02776553|468514775|FG001|Overall Study|Lost to Follow-up|0|||
130151464|NCT02776553|468514774|FG000|Overall Study|got liver transplant|1|||
130151465|NCT02776553|468514775|FG001|Overall Study|got liver transplant|2|||
130151466|NCT02776553|468514774|FG000|Overall Study|had other surgery|1|||
130151467|NCT02776553|468514775|FG001|Overall Study|had other surgery|0|||
130151468|NCT02776553|468514774|FG000|Overall Study|Protocol Violation|0|||
130151469|NCT02776553|468514775|FG001|Overall Study|Protocol Violation|1|||
130151470|NCT00171340|468514777|FG000|Overall Study|Adverse Event|46|||
130151471|NCT00171340|468514778|FG001|Overall Study|Adverse Event|42|||
130151472|NCT00171340|468514777|FG000|Overall Study|Lack of Efficacy|29|||
130151473|NCT00171340|468514778|FG001|Overall Study|Lack of Efficacy|41|||
130151474|NCT00171340|468514777|FG000|Overall Study|Protocol Violation|7|||
130151475|NCT00171340|468514778|FG001|Overall Study|Protocol Violation|8|||
130151476|NCT00171340|468514777|FG000|Overall Study|Withdrawal by Subject|22|||
130151477|NCT00171340|468514778|FG001|Overall Study|Withdrawal by Subject|19|||
130151478|NCT00171340|468514777|FG000|Overall Study|Lost to Follow-up|0|||
130151479|NCT00171340|468514778|FG001|Overall Study|Lost to Follow-up|5|||
130151480|NCT00171340|468514777|FG000|Overall Study|Abnormal Laboratory Results|2|||
130151481|NCT00171340|468514778|FG001|Overall Study|Abnormal Laboratory Results|0|||
130151482|NCT00171340|468514777|FG000|Overall Study|Abnormal Test Procedure Results|6|||
130151483|NCT00171340|468514778|FG001|Overall Study|Abnormal Test Procedure Results|11|||
130151484|NCT00171340|468514777|FG000|Overall Study|No Longer Required Study Drug|1|||
130151485|NCT00171340|468514778|FG001|Overall Study|No Longer Required Study Drug|1|||
130151486|NCT00171340|468514777|FG000|Overall Study|Administrative Problems|5|||
130151487|NCT00171340|468514778|FG001|Overall Study|Administrative Problems|2|||
130151488|NCT00171340|468514777|FG000|Overall Study|Death|6|||
130151489|NCT00171340|468514778|FG001|Overall Study|Death|6|||
130151490|NCT01056640|468514779|FG000|Overall Study|Withdrawal by Subject|11|||
130151491|NCT01056640|468514780|FG001|Overall Study|Withdrawal by Subject|8|||
130151492|NCT01056640|468514779|FG000|Overall Study|Death|15|||
130151493|NCT01056640|468514780|FG001|Overall Study|Death|4|||
130151494|NCT02087176|468514781|FG000|Overall Study|Withdrawal by Subject|1|||
130151495|NCT02087176|468514781|FG000|Overall Study|Death|10|||
130151496|NCT02087176|468514781|FG000|Overall Study|Censored|19|||
130151497|NCT02087176|468514781|FG000|Overall Study|Study Terminated by Sponsor|2|||
130151498|NCT03648879|468514782|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
130151499|NCT03812991|468514783|FG000|Overall Study|Lost to Follow-up|3|||
130151500|NCT03812991|468514784|FG001|Overall Study|Lost to Follow-up|1|||
130151501|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
130151502|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
130151503|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
130151504|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
130151505|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
130151506|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
130151507|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
130151508|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
130151509|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130151510|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
130151511|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
130151512|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
130151513|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
130151514|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
130151515|NCT04740931|468514785|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
130151516|NCT04740931|468514786|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
130151517|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
130151518|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
130151519|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
130151520|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
130151521|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
130151522|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
130151523|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
130151524|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
130151525|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
130151526|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
130151527|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
130151528|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
130151529|NCT04740931|468514785|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
130151530|NCT04740931|468514786|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
130151531|NCT04099641|468514789|FG000|Overall Study|Death|46|||
130151532|NCT04099641|468514790|FG001|Overall Study|Death|12|||
130151533|NCT04099641|468514789|FG000|Overall Study|Lost to Follow-up|1|||
130151534|NCT04099641|468514790|FG001|Overall Study|Lost to Follow-up|0|||
130151535|NCT04099641|468514789|FG000|Overall Study|Withdrawal by Subject|2|||
130151536|NCT04099641|468514790|FG001|Overall Study|Withdrawal by Subject|0|||
130151537|NCT00895037|468514791|FG000|Overall Study|Death|0|||
130151538|NCT00895037|468514792|FG001|Overall Study|Death|2|||
130151539|NCT00895037|468514793|FG002|Overall Study|Death|1|||
130151540|NCT04798482|468514809|FG000|Overall Study|Physician Decision|1|||
130151541|NCT04798482|468514809|FG000|Overall Study|Lost eligibility|1|||
130151542|NCT01192399|468514810|FG000|Overall Study|Lack of Efficacy|2|||
130151543|NCT01930175|468514811|FG000|Core Study|Lost to Follow-up|0|||
130151544|NCT01930175|468514812|FG001|Core Study|Lost to Follow-up|1|||
130151545|NCT01930175|468514813|FG002|Core Study|Lost to Follow-up|0|||
130151546|NCT01930175|468514811|FG000|Core Study|Adverse Event|0|||
130151547|NCT01930175|468514812|FG001|Core Study|Adverse Event|0|||
130151548|NCT01930175|468514813|FG002|Core Study|Adverse Event|1|||
130151549|NCT02820740|468514814|FG000|Overall Study|Did not have procedure|2|||
130151550|NCT03043560|468514820|FG000|Overall Study|Discontinued Intervention|1|||
130151551|NCT03043560|468514821|FG001|Overall Study|Discontinued Intervention|2|||
130151552|NCT03043560|468514820|FG000|Overall Study|Lost to Follow-up|0|||
130151553|NCT03043560|468514821|FG001|Overall Study|Lost to Follow-up|1|||
130151554|NCT02953678|468514822|FG000|Overall Study|Adverse Event|20|||
130151555|NCT02953678|468514822|FG000|Overall Study|Death|7|||
130151556|NCT02953678|468514822|FG000|Overall Study|Physician Decision|23|||
130151557|NCT02953678|468514822|FG000|Overall Study|Progressive Disease of GVHD|7|||
130151558|NCT02953678|468514822|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
130151559|NCT02953678|468514822|FG000|Overall Study|Withdrawal by participant|3|||
130151560|NCT02953678|468514822|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
130151561|NCT02953678|468514822|FG000|Overall Study|Participants were transferred to commercial product.|3|||
130151562|NCT00952276|468514825|FG000|Overall Study|Withdrawal by Subject|1|||
130151563|NCT00952276|468514826|FG001|Overall Study|Withdrawal by Subject|0|||
130151564|NCT00952276|468514827|FG002|Overall Study|Withdrawal by Subject|0|||
130151565|NCT00952276|468514828|FG003|Overall Study|Withdrawal by Subject|1|||
130151566|NCT00952276|468514829|FG004|Overall Study|Withdrawal by Subject|0|||
130151567|NCT01730040|468516451|FG000|Overall Study|Randomized but not treated|0|||
130151568|NCT01730040|468516452|FG001|Overall Study|Randomized but not treated|0|||
130151569|NCT01730040|468516453|FG002|Overall Study|Randomized but not treated|0|||
130151570|NCT01730040|468516454|FG003|Overall Study|Randomized but not treated|0|||
130151571|NCT01730040|468516455|FG004|Overall Study|Randomized but not treated|0|||
130151572|NCT01730040|468516456|FG005|Overall Study|Randomized but not treated|1|||
130151573|NCT01730040|468516457|FG006|Overall Study|Randomized but not treated|0|||
130151574|NCT01730040|468516451|FG000|Overall Study|Subject moved|0|||
130151575|NCT01730040|468516452|FG001|Overall Study|Subject moved|0|||
130151576|NCT01730040|468516453|FG002|Overall Study|Subject moved|1|||
130151577|NCT01730040|468516454|FG003|Overall Study|Subject moved|0|||
130151578|NCT01730040|468516455|FG004|Overall Study|Subject moved|0|||
130151579|NCT01730040|468516456|FG005|Overall Study|Subject moved|0|||
130151580|NCT01730040|468516457|FG006|Overall Study|Subject moved|1|||
130151581|NCT01730040|468516451|FG000|Overall Study|Physician Decision|0|||
130151582|NCT01730040|468516452|FG001|Overall Study|Physician Decision|0|||
130151583|NCT01730040|468516453|FG002|Overall Study|Physician Decision|0|||
130151584|NCT01730040|468516454|FG003|Overall Study|Physician Decision|0|||
130151585|NCT01730040|468516455|FG004|Overall Study|Physician Decision|0|||
130151586|NCT01730040|468516456|FG005|Overall Study|Physician Decision|1|||
130151587|NCT01730040|468516457|FG006|Overall Study|Physician Decision|1|||
130151588|NCT01730040|468516451|FG000|Overall Study|Other than specified|7|||
130151589|NCT01730040|468516452|FG001|Overall Study|Other than specified|8|||
130151590|NCT01730040|468516453|FG002|Overall Study|Other than specified|5|||
130151591|NCT01730040|468516454|FG003|Overall Study|Other than specified|5|||
130151592|NCT01730040|468516455|FG004|Overall Study|Other than specified|5|||
130151593|NCT01730040|468516456|FG005|Overall Study|Other than specified|4|||
130151594|NCT01730040|468516457|FG006|Overall Study|Other than specified|4|||
130151595|NCT01730040|468516451|FG000|Overall Study|Adverse Event|4|||
130151596|NCT01730040|468516452|FG001|Overall Study|Adverse Event|3|||
130151597|NCT01730040|468516453|FG002|Overall Study|Adverse Event|5|||
130151598|NCT01730040|468516454|FG003|Overall Study|Adverse Event|3|||
130151599|NCT01730040|468516455|FG004|Overall Study|Adverse Event|1|||
130151600|NCT01730040|468516456|FG005|Overall Study|Adverse Event|1|||
130151601|NCT01730040|468516457|FG006|Overall Study|Adverse Event|2|||
130151602|NCT01730040|468516451|FG000|Overall Study|Poor compliance to protocol|2|||
130151603|NCT01730040|468516452|FG001|Overall Study|Poor compliance to protocol|4|||
130151604|NCT01730040|468516453|FG002|Overall Study|Poor compliance to protocol|0|||
130151605|NCT01730040|468516454|FG003|Overall Study|Poor compliance to protocol|0|||
130151606|NCT01730040|468516455|FG004|Overall Study|Poor compliance to protocol|0|||
130151607|NCT01730040|468516456|FG005|Overall Study|Poor compliance to protocol|0|||
130151608|NCT01730040|468516457|FG006|Overall Study|Poor compliance to protocol|1|||
130151609|NCT01684215|468516458|FG000|Phase 1, Part 1|Adverse Event|1|||
130151610|NCT01684215|468516459|FG001|Phase 1, Part 1|Adverse Event|0|||
130151611|NCT01684215|468516460|FG002|Phase 1, Part 1|Adverse Event|0|||
130151612|NCT01684215|468516461|FG003|Phase 1, Part 1|Adverse Event|0|||
130151613|NCT01684215|468516458|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
130151614|NCT01684215|468516459|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
130151615|NCT01684215|468516460|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
130151616|NCT01684215|468516461|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
130151617|NCT01684215|468516458|FG000|Phase 1, Part 2|Adverse Event|0|||
130151618|NCT01684215|468516459|FG001|Phase 1, Part 2|Adverse Event|0|||
130151619|NCT01684215|468516460|FG002|Phase 1, Part 2|Adverse Event|1|||
130151620|NCT01684215|468516461|FG003|Phase 1, Part 2|Adverse Event|0|||
130151621|NCT01684215|468516458|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130151622|NCT01684215|468516459|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130151623|NCT01684215|468516460|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
130151624|NCT01684215|468516461|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
130151625|NCT01684215|468516458|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
130151626|NCT01684215|468516459|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
130151627|NCT01684215|468516460|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
130151628|NCT01684215|468516461|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
130151629|NCT01684215|468516458|FG000|Phase 2|Death|0|||
130151630|NCT01684215|468516459|FG001|Phase 2|Death|0|||
130151631|NCT01684215|468516460|FG002|Phase 2|Death|0|||
130151632|NCT01684215|468516461|FG003|Phase 2|Death|8|||
130151633|NCT01684215|468516458|FG000|Phase 2|Study terminated by sponsor|0|||
130151634|NCT01684215|468516459|FG001|Phase 2|Study terminated by sponsor|0|||
130151635|NCT01684215|468516460|FG002|Phase 2|Study terminated by sponsor|0|||
130151636|NCT01684215|468516461|FG003|Phase 2|Study terminated by sponsor|30|||
130151637|NCT01684215|468516458|FG000|Phase 2|Enrolled but not treated|0|||
130151638|NCT01684215|468516459|FG001|Phase 2|Enrolled but not treated|0|||
130151639|NCT01684215|468516460|FG002|Phase 2|Enrolled but not treated|0|||
130151640|NCT01684215|468516461|FG003|Phase 2|Enrolled but not treated|1|||
130151641|NCT01684215|468516458|FG000|Phase 2|Lost to Follow-up|0|||
130151642|NCT01684215|468516459|FG001|Phase 2|Lost to Follow-up|0|||
130151643|NCT01684215|468516460|FG002|Phase 2|Lost to Follow-up|0|||
130151644|NCT01684215|468516461|FG003|Phase 2|Lost to Follow-up|4|||
130151645|NCT01301482|468516462|FG000|Overall Study|Withdrawal by Subject|1|||
130151646|NCT00480324|468516463|FG000|Overall Study|Adverse Event|1|||
130151647|NCT00480324|468516464|FG001|Overall Study|Adverse Event|1|||
130151648|NCT00480324|468516463|FG000|Overall Study|Protocol Violation|0|||
130151649|NCT00480324|468516464|FG001|Overall Study|Protocol Violation|1|||
130151650|NCT00480324|468516463|FG000|Overall Study|Withdrawal by Subject|14|||
130151651|NCT00480324|468516464|FG001|Overall Study|Withdrawal by Subject|5|||
130151652|NCT00480324|468516463|FG000|Overall Study|Lost to Follow-up|17|||
130151653|NCT00480324|468516464|FG001|Overall Study|Lost to Follow-up|8|||
130151654|NCT00480324|468516463|FG000|Overall Study|Subject's mother pregnant|0|||
130151655|NCT00480324|468516464|FG001|Overall Study|Subject's mother pregnant|1|||
130151656|NCT00784134|468516465|FG000|Overall Study|Lost to Follow-up|3|||
130151657|NCT00784134|468516466|FG001|Overall Study|Lost to Follow-up|6|||
130151658|NCT03785145|468516467|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
130151659|NCT03785145|468516468|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
130151660|NCT03785145|468516467|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
130151661|NCT03785145|468516468|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
130151662|NCT03785145|468516467|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
130151663|NCT03785145|468516468|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
130151664|NCT03785145|468516467|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
130151665|NCT03785145|468516468|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
130151666|NCT03785145|468516467|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
130151667|NCT03785145|468516468|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
130151668|NCT03785145|468516467|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
130151669|NCT03785145|468516468|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
130151670|NCT03785145|468516467|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
130151671|NCT03785145|468516468|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
130151672|NCT03785145|468516467|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
130151673|NCT03785145|468516468|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
130151674|NCT03785145|468516467|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
130151675|NCT03785145|468516468|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
130151676|NCT03785145|468516467|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
130151677|NCT03785145|468516468|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
130151678|NCT03785145|468516467|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
130151679|NCT03785145|468516468|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
130151680|NCT01552369|468516469|FG000|Overall Study|Did not consent to extended follow up|8|||
130151681|NCT01552369|468516470|FG001|Overall Study|Did not consent to extended follow up|9|||
130151682|NCT03250299|468516474|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
130151683|NCT03250299|468516475|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
130151684|NCT03250299|468516476|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
130151685|NCT03250299|468516477|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
130151686|NCT03250299|468516478|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
130151687|NCT03250299|468516474|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
130151688|NCT03250299|468516475|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
130151689|NCT03250299|468516476|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
130151690|NCT03250299|468516477|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
130151691|NCT03250299|468516478|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
130151692|NCT03250299|468516474|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130151693|NCT03250299|468516475|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130151694|NCT03250299|468516476|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
130151695|NCT03250299|468516477|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130151696|NCT03250299|468516478|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
130151697|NCT03250299|468516474|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
130151698|NCT03250299|468516475|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
130151699|NCT03250299|468516476|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
130151700|NCT03250299|468516477|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
130151701|NCT03250299|468516478|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
130151702|NCT03346070|468516483|FG000|Overall Study|Death|0|||
130151703|NCT03346070|468516484|FG001|Overall Study|Death|0|||
130151704|NCT03346070|468516485|FG002|Overall Study|Death|0|||
130151705|NCT03346070|468516486|FG003|Overall Study|Death|0|||
130151706|NCT03346070|468516487|FG004|Overall Study|Death|1|||
130151707|NCT03346070|468516483|FG000|Overall Study|Lost to Follow-up|0|||
130151708|NCT03346070|468516484|FG001|Overall Study|Lost to Follow-up|1|||
130151709|NCT03346070|468516485|FG002|Overall Study|Lost to Follow-up|2|||
130151710|NCT03346070|468516486|FG003|Overall Study|Lost to Follow-up|0|||
130151711|NCT03346070|468516487|FG004|Overall Study|Lost to Follow-up|0|||
130151712|NCT03346070|468516483|FG000|Overall Study|Physician Decision|0|||
130151713|NCT03346070|468516484|FG001|Overall Study|Physician Decision|0|||
130151714|NCT03346070|468516485|FG002|Overall Study|Physician Decision|0|||
130151715|NCT03346070|468516486|FG003|Overall Study|Physician Decision|1|||
130151716|NCT03346070|468516487|FG004|Overall Study|Physician Decision|1|||
130151717|NCT03346070|468516483|FG000|Overall Study|Withdrawal by Subject|1|||
130151718|NCT03346070|468516484|FG001|Overall Study|Withdrawal by Subject|0|||
130151719|NCT03346070|468516485|FG002|Overall Study|Withdrawal by Subject|0|||
130151720|NCT03346070|468516486|FG003|Overall Study|Withdrawal by Subject|1|||
130151721|NCT03346070|468516487|FG004|Overall Study|Withdrawal by Subject|0|||
130151722|NCT03346070|468516483|FG000|Overall Study|Study medication not received as planned|2|||
130151723|NCT03346070|468516484|FG001|Overall Study|Study medication not received as planned|3|||
130151724|NCT03346070|468516485|FG002|Overall Study|Study medication not received as planned|2|||
130151725|NCT03346070|468516486|FG003|Overall Study|Study medication not received as planned|3|||
130151726|NCT03346070|468516487|FG004|Overall Study|Study medication not received as planned|2|||
130151727|NCT03346070|468516483|FG000|Overall Study|Screen Failure|0|||
130151728|NCT03346070|468516484|FG001|Overall Study|Screen Failure|0|||
130151729|NCT03346070|468516485|FG002|Overall Study|Screen Failure|0|||
130151730|NCT03346070|468516486|FG003|Overall Study|Screen Failure|1|||
130151731|NCT03346070|468516487|FG004|Overall Study|Screen Failure|1|||
130151732|NCT00977548|468516488|FG000|Overall Study|Ineligible|4|||
130151733|NCT00977548|468516488|FG000|Overall Study|Adverse Event|8|||
130151734|NCT00977548|468516488|FG000|Overall Study|Withdrawal by Subject|1|||
130151735|NCT01546142|468516492|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
130151736|NCT01546142|468516493|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
130151737|NCT01546142|468516492|FG000|Overall Study|Subject Noncompliance|1|||
130151738|NCT01546142|468516493|FG001|Overall Study|Subject Noncompliance|1|||
130151739|NCT01546142|468516492|FG000|Overall Study|Adverse Event|6|||
130151740|NCT01546142|468516493|FG001|Overall Study|Adverse Event|3|||
130151741|NCT01546142|468516492|FG000|Overall Study|Lost to Follow-up|20|||
130151742|NCT01546142|468516493|FG001|Overall Study|Lost to Follow-up|15|||
130151743|NCT01546142|468516492|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
130151744|NCT01546142|468516493|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
130151745|NCT01546142|468516492|FG000|Overall Study|Subject Randomized but Not Treated|1|||
130151746|NCT01546142|468516493|FG001|Overall Study|Subject Randomized but Not Treated|0|||
130151747|NCT00440466|468516494|FG000|Overall Study|Death|3|||
130151748|NCT00440466|468516495|FG001|Overall Study|Death|2|||
130151749|NCT00440466|468516496|FG002|Overall Study|Death|9|||
130151750|NCT00440466|468516494|FG000|Overall Study|Adverse Event|3|||
130151751|NCT00440466|468516495|FG001|Overall Study|Adverse Event|4|||
130151752|NCT00440466|468516496|FG002|Overall Study|Adverse Event|11|||
130151753|NCT00440466|468516494|FG000|Overall Study|Lost to Follow-up|1|||
130151754|NCT00440466|468516495|FG001|Overall Study|Lost to Follow-up|0|||
130151755|NCT00440466|468516496|FG002|Overall Study|Lost to Follow-up|2|||
130151756|NCT00440466|468516494|FG000|Overall Study|Physician Decision|2|||
130151757|NCT00440466|468516495|FG001|Overall Study|Physician Decision|0|||
130151758|NCT00440466|468516496|FG002|Overall Study|Physician Decision|1|||
130151759|NCT00440466|468516494|FG000|Overall Study|Protocol Violation|2|||
130151760|NCT00440466|468516495|FG001|Overall Study|Protocol Violation|0|||
130151761|NCT00440466|468516496|FG002|Overall Study|Protocol Violation|4|||
130151762|NCT00440466|468516494|FG000|Overall Study|Withdrawal by Subject|2|||
130151763|NCT00440466|468516495|FG001|Overall Study|Withdrawal by Subject|5|||
130151764|NCT00440466|468516496|FG002|Overall Study|Withdrawal by Subject|9|||
130151765|NCT00440466|468516494|FG000|Overall Study|Began Dialysis|0|||
130151766|NCT00440466|468516495|FG001|Overall Study|Began Dialysis|0|||
130151767|NCT00440466|468516496|FG002|Overall Study|Began Dialysis|1|||
130151768|NCT00440466|468516494|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
130151769|NCT00440466|468516495|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
130151770|NCT00440466|468516496|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
130151771|NCT01005329|468516499|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
130151772|NCT00608517|468516500|FG000|Overall Study|Death|1|||
130151773|NCT00608517|468516501|FG001|Overall Study|Death|0|||
130151774|NCT00608517|468516502|FG002|Overall Study|Death|0|||
130151775|NCT01261624|468516503|FG000|Week 0 to Week 12|Disease Progression|1|||
130151776|NCT01261624|468516504|FG001|Week 0 to Week 12|Disease Progression|1|||
130151777|NCT01261624|468516503|FG000|Week 0 to Week 12|Insufficient Response|0|||
130151778|NCT01261624|468516504|FG001|Week 0 to Week 12|Insufficient Response|2|||
130151779|NCT01261624|468516503|FG000|Week 13 to Week 24|Insufficient Response|0|||
130151780|NCT01261624|468516504|FG001|Week 13 to Week 24|Insufficient Response|1|||
130151781|NCT02363439|468516507|FG000|Overall Study|Lack of Efficacy|4|||
130151782|NCT00508027|468516508|FG000|Dose Level 1|Lost to Follow-up|4|||
130151783|NCT00508027|468516508|FG000|Dose Level 1|Withdrawal by Subject|2|||
130151784|NCT00508027|468516508|FG000|Dose Level 1|Physician Decision|2|||
130151785|NCT00508027|468516508|FG000|Dose Level 2|Lost to Follow-up|2|||
130151786|NCT00508027|468516508|FG000|Dose Level 2|Withdrawal by Subject|2|||
130151787|NCT01719562|468516509|FG000|Overall Study|Lost to Follow-up|1|||
130151788|NCT01719562|468516510|FG001|Overall Study|Lost to Follow-up|0|||
130151789|NCT01719562|468516509|FG000|Overall Study|Death|1|||
130151790|NCT01719562|468516510|FG001|Overall Study|Death|0|||
130151791|NCT01719562|468516509|FG000|Overall Study|New cancer diagnosis|1|||
130151792|NCT01719562|468516510|FG001|Overall Study|New cancer diagnosis|0|||
130151793|NCT00941720|468516515|FG000|Overall Study|Withdrawal by Subject|1|||
130151794|NCT00941720|468516515|FG000|Overall Study|Insurance denied participation|11|||
130151795|NCT00941720|468516515|FG000|Overall Study|ineligible|2|||
130151796|NCT01682148|468516516|FG000|Overall Study|Withdrawal by Subject|2|||
130151797|NCT01682148|468516517|FG001|Overall Study|Withdrawal by Subject|0|||
130151798|NCT01682148|468516516|FG000|Overall Study|Lost to Follow-up|1|||
130151799|NCT01682148|468516517|FG001|Overall Study|Lost to Follow-up|2|||
130151800|NCT01682148|468516516|FG000|Overall Study|Protocol Violation|1|||
130151801|NCT01682148|468516517|FG001|Overall Study|Protocol Violation|1|||
130151802|NCT03827018|468516520|FG000|Overall Study|Adverse Event|1|||
130151803|NCT03827018|468516521|FG001|Overall Study|Adverse Event|0|||
130151804|NCT03827018|468516520|FG000|Overall Study|Withdrawal by Subject|2|||
130151805|NCT03827018|468516521|FG001|Overall Study|Withdrawal by Subject|2|||
130151806|NCT03827018|468516520|FG000|Overall Study|Lack of Efficacy|0|||
130151807|NCT03827018|468516521|FG001|Overall Study|Lack of Efficacy|1|||
130151808|NCT00775528|468516523|FG000|Overall Study|Protocol Violation|1|||
130151809|NCT01884688|468516526|FG000|Overall Study|Screen Failure|2|||
130151810|NCT01029392|468516529|FG000|Overall Study|Withdrawal by Subject|18|||
130151811|NCT01029392|468516530|FG001|Overall Study|Withdrawal by Subject|11|||
130151812|NCT01029392|468516529|FG000|Overall Study|Physician Decision|2|||
130151813|NCT01029392|468516530|FG001|Overall Study|Physician Decision|0|||
130151814|NCT00063882|468516531|FG000|Overall Study|Protocol Violation|3|||
130151815|NCT00063882|468516532|FG001|Overall Study|Protocol Violation|3|||
130151816|NCT00063882|468516531|FG000|Overall Study|Withdrawal by Subject|2|||
130151817|NCT00063882|468516532|FG001|Overall Study|Withdrawal by Subject|1|||
130151818|NCT01103479|468516533|FG000|Overall Study|Up to date with CRC screening|1|||
130151819|NCT01103479|468516534|FG001|Overall Study|Up to date with CRC screening|9|||
130151820|NCT01103479|468516535|FG002|Overall Study|Up to date with CRC screening|12|||
130151821|NCT01103479|468516533|FG000|Overall Study|Family history of CRC|1|||
130151822|NCT01103479|468516534|FG001|Overall Study|Family history of CRC|0|||
130151823|NCT01103479|468516535|FG002|Overall Study|Family history of CRC|2|||
130151824|NCT01103479|468516533|FG000|Overall Study|Active cancer|1|||
130151825|NCT01103479|468516534|FG001|Overall Study|Active cancer|0|||
130151826|NCT01103479|468516535|FG002|Overall Study|Active cancer|0|||
130151827|NCT01103479|468516533|FG000|Overall Study|Saw non-study physician|2|||
130151828|NCT01103479|468516534|FG001|Overall Study|Saw non-study physician|0|||
130151829|NCT01103479|468516535|FG002|Overall Study|Saw non-study physician|0|||
130151830|NCT01534637|468516536|FG000|Overall Study|Physician Decision|3|||
130151831|NCT01534637|468516536|FG000|Overall Study|Lack of Efficacy|3|||
130151832|NCT01534637|468516536|FG000|Overall Study|Withdrawal by Subject|1|||
130151833|NCT01534637|468516536|FG000|Overall Study|Adverse Event|1|||
130151834|NCT01534637|468516536|FG000|Overall Study|Liver Mets before treatment|1|||
130151835|NCT00834899|468516537|FG000|Overall Study|Withdrawal by Subject|1|||
130151836|NCT00834899|468516538|FG001|Overall Study|Withdrawal by Subject|1|||
130151837|NCT00605917|468516539|FG000|Overall Study|Protocol Violation|79|||
130151838|NCT00890552|468516541|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
130151839|NCT00890552|468516541|FG000|On-treatment|Early prog disease/ death|10|||
130151840|NCT04965389|468516542|FG000|Overall Study|Other reasons|1|||
130151841|NCT04965389|468516543|FG001|Overall Study|Other reasons|0|||
130151842|NCT04965389|468516544|FG002|Overall Study|Other reasons|0|||
130151843|NCT04965389|468516545|FG003|Overall Study|Other reasons|0|||
130151844|NCT04965389|468516542|FG000|Overall Study|Participant withdrew consent|0|||
130151845|NCT04965389|468516543|FG001|Overall Study|Participant withdrew consent|1|||
130151846|NCT04965389|468516544|FG002|Overall Study|Participant withdrew consent|0|||
130151847|NCT04965389|468516545|FG003|Overall Study|Participant withdrew consent|0|||
130151848|NCT04965389|468516542|FG000|Overall Study|Poor/Non-compliance|0|||
130151849|NCT04965389|468516543|FG001|Overall Study|Poor/Non-compliance|1|||
130151850|NCT04965389|468516544|FG002|Overall Study|Poor/Non-compliance|0|||
130151851|NCT04965389|468516545|FG003|Overall Study|Poor/Non-compliance|0|||
130151852|NCT03903159|468516548|FG000|Overall Study|Discharged with Staff Approval|2|||
130151853|NCT03903159|468516548|FG000|Overall Study|Discharged at Staff Request|2|||
130151854|NCT03903159|468516548|FG000|Overall Study|Discharged Against Staff Advice|1|||
130151855|NCT02443545|468516549|FG000|Overall Study|Adverse Event|1|||
130151856|NCT02443545|468516550|FG001|Overall Study|Adverse Event|1|||
130151857|NCT02443545|468516549|FG000|Overall Study|Lost to Follow-up|0|||
130151858|NCT02443545|468516550|FG001|Overall Study|Lost to Follow-up|2|||
130151859|NCT02443545|468516549|FG000|Overall Study|Physician Decision|3|||
130151860|NCT02443545|468516550|FG001|Overall Study|Physician Decision|0|||
130151861|NCT02443545|468516549|FG000|Overall Study|Protocol Violation|8|||
130151862|NCT02443545|468516550|FG001|Overall Study|Protocol Violation|1|||
130151863|NCT02443545|468516549|FG000|Overall Study|Pregnancy|1|||
130151864|NCT02443545|468516550|FG001|Overall Study|Pregnancy|1|||
130151865|NCT02443545|468516549|FG000|Overall Study|Withdrawal by Subject|6|||
130151866|NCT02443545|468516550|FG001|Overall Study|Withdrawal by Subject|3|||
130151867|NCT02443545|468516549|FG000|Overall Study|Termination of study|20|||
130151868|NCT02443545|468516550|FG001|Overall Study|Termination of study|11|||
130151869|NCT00724373|468516551|FG000|Overall Study|Adverse Event|41|||
130151870|NCT00724373|468516551|FG000|Overall Study|Lack of Efficacy|82|||
130151871|NCT00724373|468516551|FG000|Overall Study|Lost to Follow-up|7|||
130151872|NCT00724373|468516551|FG000|Overall Study|Non-compliance|2|||
130151873|NCT00724373|468516551|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
130151874|NCT00724373|468516551|FG000|Overall Study|Participant moved away|1|||
130151875|NCT00724373|468516551|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
130151876|NCT00724373|468516551|FG000|Overall Study|Only to have 24 week regimen|1|||
130151877|NCT00724373|468516551|FG000|Overall Study|Viral Relapse|1|||
130151878|NCT00724373|468516551|FG000|Overall Study|Acute HCV infection|1|||
130151879|NCT00724373|468516551|FG000|Overall Study|Drug Relapse|1|||
130151880|NCT00724373|468516551|FG000|Overall Study|Tolerability|23|||
130151881|NCT00536484|468516552|FG000|Overall Study|Adverse Event|21|||
130151882|NCT00536484|468516553|FG001|Overall Study|Adverse Event|34|||
130151883|NCT00536484|468516552|FG000|Overall Study|Withdrawal by Subject|11|||
130151884|NCT00536484|468516553|FG001|Overall Study|Withdrawal by Subject|11|||
130151885|NCT00536484|468516552|FG000|Overall Study|Lost to Follow-up|8|||
130151886|NCT00536484|468516553|FG001|Overall Study|Lost to Follow-up|6|||
130151887|NCT00536484|468516552|FG000|Overall Study|Lack of Efficacy|16|||
130151888|NCT00536484|468516553|FG001|Overall Study|Lack of Efficacy|5|||
130151889|NCT00536484|468516552|FG000|Overall Study|Other|4|||
130151890|NCT00536484|468516553|FG001|Overall Study|Other|0|||
130151891|NCT01506908|468516554|FG000|Overall Study|Adverse Event|1|||
130151892|NCT01506908|468516555|FG001|Overall Study|Adverse Event|0|||
130151893|NCT01382251|468516559|FG000|Overall Study|Surgeries cancelled or delayed|16|||
130151894|NCT01382251|468516560|FG001|Overall Study|Surgeries cancelled or delayed|16|||
130151895|NCT01382251|468516559|FG000|Overall Study|Lost to Follow-up|4|||
130151896|NCT01382251|468516560|FG001|Overall Study|Lost to Follow-up|4|||
130151897|NCT01382251|468516559|FG000|Overall Study|Contacted after study closed|1|||
130151898|NCT01382251|468516560|FG001|Overall Study|Contacted after study closed|1|||
130151899|NCT00562120|468516561|FG000|First Intervention Period|Adverse Event|1|||
130151900|NCT00562120|468516562|FG001|First Intervention Period|Adverse Event|0|||
130151901|NCT00562120|468516563|FG002|First Intervention Period|Adverse Event|0|||
130151902|NCT00562120|468516564|FG003|First Intervention Period|Adverse Event|0|||
130151903|NCT00562120|468516561|FG000|First Intervention Period|Randomized but not Treated|1|||
130151904|NCT00562120|468516562|FG001|First Intervention Period|Randomized but not Treated|0|||
130151905|NCT00562120|468516563|FG002|First Intervention Period|Randomized but not Treated|0|||
130151906|NCT00562120|468516564|FG003|First Intervention Period|Randomized but not Treated|0|||
130151907|NCT03366194|468516568|FG000|Overall Study|Lost to Follow-up|2|||
130151908|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130151909|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
130151910|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130151911|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
130151912|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130151913|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130151914|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
130151915|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
130151916|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
130151917|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130151918|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130151919|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
130151920|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Death|0|||
130151921|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Death|1|||
130151922|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Death|0|||
130151923|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Death|0|||
130151924|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
130151925|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
130151926|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
130151927|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
130151928|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
130151929|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130151930|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130151931|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
130151932|NCT00545688|468516571|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
130151933|NCT00545688|468516572|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
130151934|NCT00545688|468516573|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
130151935|NCT00545688|468516574|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
130151936|NCT00545688|468516571|FG000|Adjuvant Treatment Period|Disease Progression|3|||
130151937|NCT00545688|468516572|FG001|Adjuvant Treatment Period|Disease Progression|3|||
130151938|NCT00545688|468516573|FG002|Adjuvant Treatment Period|Disease Progression|0|||
130151939|NCT00545688|468516574|FG003|Adjuvant Treatment Period|Disease Progression|7|||
130151940|NCT00545688|468516571|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
130151941|NCT00545688|468516572|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
130151942|NCT00545688|468516573|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
130151943|NCT00545688|468516574|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
130151944|NCT00545688|468516571|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
130151945|NCT00545688|468516572|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
130151946|NCT00545688|468516573|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
130151947|NCT00545688|468516574|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
130151948|NCT00545688|468516571|FG000|Adjuvant Treatment Period|Adverse Event|0|||
130151949|NCT00545688|468516572|FG001|Adjuvant Treatment Period|Adverse Event|3|||
130151950|NCT00545688|468516573|FG002|Adjuvant Treatment Period|Adverse Event|2|||
130151951|NCT00545688|468516574|FG003|Adjuvant Treatment Period|Adverse Event|2|||
130151952|NCT00545688|468516571|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
130151953|NCT00545688|468516572|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
130151954|NCT00545688|468516573|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
130151955|NCT00545688|468516574|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
130151956|NCT00545688|468516571|FG000|Follow-Up Period|Death|4|||
130151957|NCT00545688|468516572|FG001|Follow-Up Period|Death|2|||
130151958|NCT00545688|468516573|FG002|Follow-Up Period|Death|2|||
130151959|NCT00545688|468516574|FG003|Follow-Up Period|Death|6|||
130151960|NCT00545688|468516571|FG000|Follow-Up Period|Disease Progression|6|||
130151961|NCT00545688|468516572|FG001|Follow-Up Period|Disease Progression|5|||
130151962|NCT00545688|468516573|FG002|Follow-Up Period|Disease Progression|9|||
130151963|NCT00545688|468516574|FG003|Follow-Up Period|Disease Progression|9|||
130151964|NCT00545688|468516571|FG000|Follow-Up Period|Refused Treatment|6|||
130151965|NCT00545688|468516572|FG001|Follow-Up Period|Refused Treatment|2|||
130151966|NCT00545688|468516573|FG002|Follow-Up Period|Refused Treatment|0|||
130151967|NCT00545688|468516574|FG003|Follow-Up Period|Refused Treatment|2|||
130151968|NCT00545688|468516571|FG000|Follow-Up Period|Lost to Follow-up|3|||
130151969|NCT00545688|468516572|FG001|Follow-Up Period|Lost to Follow-up|3|||
130151970|NCT00545688|468516573|FG002|Follow-Up Period|Lost to Follow-up|3|||
130151971|NCT00545688|468516574|FG003|Follow-Up Period|Lost to Follow-up|1|||
130151972|NCT00545688|468516571|FG000|Follow-Up Period|Unspecified Reason|2|||
130151973|NCT00545688|468516572|FG001|Follow-Up Period|Unspecified Reason|5|||
130151974|NCT00545688|468516573|FG002|Follow-Up Period|Unspecified Reason|6|||
130151975|NCT00545688|468516574|FG003|Follow-Up Period|Unspecified Reason|8|||
130151976|NCT00545688|468516571|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
130151977|NCT00545688|468516572|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
130151978|NCT00545688|468516573|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
130151979|NCT00545688|468516574|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
130151980|NCT03123783|468516575|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130151981|NCT03123783|468516576|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
130151982|NCT03123783|468516577|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130151983|NCT03123783|468516578|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130151984|NCT03123783|468516579|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130151985|NCT03123783|468516580|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130151986|NCT03123783|468516581|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
130151987|NCT03123783|468516575|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
130151988|NCT03123783|468516576|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
130151989|NCT03123783|468516577|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
130151990|NCT03123783|468516578|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
130151991|NCT03123783|468516579|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
130151992|NCT03123783|468516580|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
130151993|NCT03123783|468516581|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
130151994|NCT03123783|468516575|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
130151995|NCT03123783|468516576|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
130151996|NCT03123783|468516577|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
130151997|NCT03123783|468516578|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
130151998|NCT03123783|468516579|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
130151999|NCT03123783|468516580|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
130152000|NCT03123783|468516581|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
130152001|NCT03123783|468516575|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130152002|NCT03123783|468516576|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130152003|NCT03123783|468516577|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130152004|NCT03123783|468516578|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130152005|NCT03123783|468516579|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
130152006|NCT03123783|468516580|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130152007|NCT03123783|468516581|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
130152008|NCT01647958|468518012|FG000|Initial Study|Lost to Follow-up|2|||
130152009|NCT01647958|468518013|FG001|Initial Study|Lost to Follow-up|3|||
130152010|NCT01647958|468518012|FG000|Continuation Phase|treatment received during Overall Study|39|||
130152011|NCT01647958|468518013|FG001|Continuation Phase|treatment received during Overall Study|0|||
130152012|NCT01647958|468518012|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
130152013|NCT01647958|468518013|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
130152014|NCT00544817|468518014|FG000|Combined Modality|Lack of Efficacy|2|||
130152015|NCT00544817|468518014|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
130152016|NCT00544817|468518014|FG000|Combined Modality|Adverse Event|2|||
130152017|NCT00544817|468518014|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
130152018|NCT00544817|468518014|FG000|No Treatment Interval|Lack of Efficacy|8|||
130152019|NCT00544817|468518014|FG000|No Treatment Interval|Physician Decision|3|||
130152020|NCT00544817|468518014|FG000|No Treatment Interval|Adverse Event|1|||
130152021|NCT00544817|468518014|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
130152022|NCT00544817|468518014|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
130152023|NCT00544817|468518014|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
130152024|NCT01131299|468518015|FG000|Overall Study|Withdrawal by Subject|4|||
130152025|NCT01131299|468518016|FG001|Overall Study|Withdrawal by Subject|7|||
130152026|NCT01221090|468518017|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
130152027|NCT01221090|468518018|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
130152028|NCT01221090|468518019|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
130152029|NCT01221090|468518020|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
130152030|NCT01221090|468518017|FG000|Overall Study|Withdrawal by Subject|0|||
130152031|NCT01221090|468518018|FG001|Overall Study|Withdrawal by Subject|22|||
130152032|NCT01221090|468518019|FG002|Overall Study|Withdrawal by Subject|27|||
130152033|NCT01221090|468518020|FG003|Overall Study|Withdrawal by Subject|2|||
130152034|NCT00708708|468518021|FG000|Overall Study|Another therapy instead of Enbrel|141|||
130152035|NCT00708708|468518021|FG000|Overall Study|Lost to Follow-up|52|||
130152036|NCT00708708|468518021|FG000|Overall Study|Withdrawal by Subject|51|||
130152037|NCT00708708|468518021|FG000|Overall Study|Intolerance|42|||
130152038|NCT00708708|468518021|FG000|Overall Study|Another therapy along with Enbrel|15|||
130152039|NCT00708708|468518021|FG000|Overall Study|Other unspecified|11|||
130152040|NCT00708708|468518021|FG000|Overall Study|Good effectiveness|9|||
130152041|NCT00708708|468518021|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
130152042|NCT00708708|468518021|FG000|Overall Study|Administrative reasons|7|||
130152043|NCT00708708|468518021|FG000|Overall Study|Lack of effectiveness|4|||
130152044|NCT00708708|468518021|FG000|Overall Study|Lack of compliance|3|||
130152045|NCT00708708|468518021|FG000|Overall Study|Pregnancy|3|||
130152046|NCT00708708|468518021|FG000|Overall Study|Adverse Event|3|||
130152047|NCT00708708|468518021|FG000|Overall Study|Missing values|392|||
130152048|NCT04776746|468518028|FG000|Overall Study|Study terminated by sponsor|61|||
130152049|NCT04776746|468518028|FG000|Overall Study|Adverse Event|5|||
130152050|NCT04776746|468518028|FG000|Overall Study|Death|4|||
130152051|NCT04776746|468518028|FG000|Overall Study|Lack of Efficacy|3|||
130152052|NCT04776746|468518028|FG000|Overall Study|Noncompliance with study drug|2|||
130152053|NCT04776746|468518028|FG000|Overall Study|Not related to COVID-19|2|||
130152054|NCT03768726|468518033|FG000|Treatment Phase|Adverse Event|2|||
130152055|NCT03768726|468518034|FG001|Treatment Phase|Adverse Event|2|||
130152056|NCT03768726|468518033|FG000|Treatment Phase|Lost to Follow-up|1|||
130152057|NCT03768726|468518034|FG001|Treatment Phase|Lost to Follow-up|0|||
130152058|NCT03768726|468518033|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
130152059|NCT03768726|468518034|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
130152060|NCT03768726|468518033|FG000|Treatment Phase|Withdrawal by Subject|3|||
130152061|NCT03768726|468518034|FG001|Treatment Phase|Withdrawal by Subject|1|||
130152062|NCT03768726|468518033|FG000|Follow-Up|Adverse Event|2|||
130152063|NCT03768726|468518034|FG001|Follow-Up|Adverse Event|2|||
130152064|NCT03768726|468518033|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
130152065|NCT03768726|468518034|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
130152066|NCT03768726|468518033|FG000|Follow-Up|Withdrawal by Subject|2|||
130152067|NCT03768726|468518034|FG001|Follow-Up|Withdrawal by Subject|0|||
130152068|NCT03768726|468518033|FG000|Follow-Up|Other|1|||
130152069|NCT03768726|468518034|FG001|Follow-Up|Other|0|||
130152070|NCT01286558|468518035|FG000|Overall Study|Adverse Event|1|||
130152071|NCT01286558|468518036|FG001|Overall Study|Adverse Event|1|||
130152072|NCT01286558|468518035|FG000|Overall Study|Withdrawal by Subject|0|||
130152073|NCT01286558|468518036|FG001|Overall Study|Withdrawal by Subject|1|||
130152074|NCT01787279|468518038|FG000|Overall Study|Lost to Follow-up|2|||
130152075|NCT01787279|468518038|FG000|Overall Study|Lack of Efficacy|1|||
130152076|NCT04109313|468518044|FG000|Overall Study|Pregnancy|1|||
130152077|NCT04109313|468518044|FG000|Overall Study|Adverse Event|11|||
130152078|NCT04109313|468518044|FG000|Overall Study|Lack of Efficacy|11|||
130152079|NCT04109313|468518044|FG000|Overall Study|Lost to Follow-up|1|||
130152080|NCT04109313|468518044|FG000|Overall Study|Physician Decision|2|||
130152081|NCT04109313|468518044|FG000|Overall Study|Subject Decision|13|||
130152082|NCT04109313|468518044|FG000|Overall Study|Covid-19 situation|2|||
130152083|NCT01272921|468518045|FG000|Overall Study|Protocol Violation|2|||
130152084|NCT01272921|468518046|FG001|Overall Study|Protocol Violation|1|||
130152085|NCT01132664|468518047|FG000|Phase lb|Adverse Event|0|||
130152086|NCT01132664|468518048|FG001|Phase lb|Adverse Event|1|||
130152087|NCT01132664|468518049|FG002|Phase lb|Adverse Event|0|||
130152088|NCT01132664|468518050|FG003|Phase lb|Adverse Event|0|||
130152089|NCT01132664|468518051|FG004|Phase lb|Adverse Event|0|||
130152090|NCT01132664|468518047|FG000|Phase lb|Withdrawal by Subject|1|||
130152091|NCT01132664|468518048|FG001|Phase lb|Withdrawal by Subject|2|||
130152092|NCT01132664|468518049|FG002|Phase lb|Withdrawal by Subject|0|||
130152093|NCT01132664|468518050|FG003|Phase lb|Withdrawal by Subject|0|||
130152094|NCT01132664|468518051|FG004|Phase lb|Withdrawal by Subject|0|||
130152095|NCT01132664|468518047|FG000|Phase lb|Disease Progression|4|||
130152096|NCT01132664|468518048|FG001|Phase lb|Disease Progression|9|||
130152097|NCT01132664|468518049|FG002|Phase lb|Disease Progression|0|||
130152098|NCT01132664|468518050|FG003|Phase lb|Disease Progression|0|||
130152099|NCT01132664|468518051|FG004|Phase lb|Disease Progression|0|||
129979543|NCT02344290|467887523|FG001|Overall Study|Other|3|||
130152100|NCT01132664|468518047|FG000|Phase ll|Death|0|||
130152101|NCT01132664|468518048|FG001|Phase ll|Death|0|||
130152102|NCT01132664|468518049|FG002|Phase ll|Death|2|||
130152103|NCT01132664|468518050|FG003|Phase ll|Death|0|||
130152104|NCT01132664|468518051|FG004|Phase ll|Death|0|||
130152105|NCT01132664|468518047|FG000|Phase ll|Adverse Event|0|||
130152106|NCT01132664|468518048|FG001|Phase ll|Adverse Event|0|||
130152107|NCT01132664|468518049|FG002|Phase ll|Adverse Event|10|||
130152108|NCT01132664|468518050|FG003|Phase ll|Adverse Event|0|||
130152109|NCT01132664|468518051|FG004|Phase ll|Adverse Event|0|||
130152110|NCT01132664|468518047|FG000|Phase ll|Withdrawal by Subject|0|||
130152111|NCT01132664|468518048|FG001|Phase ll|Withdrawal by Subject|0|||
130152112|NCT01132664|468518049|FG002|Phase ll|Withdrawal by Subject|3|||
130152113|NCT01132664|468518050|FG003|Phase ll|Withdrawal by Subject|0|||
130152114|NCT01132664|468518051|FG004|Phase ll|Withdrawal by Subject|0|||
130152115|NCT01132664|468518047|FG000|Phase ll|Disease progression|0|||
130152116|NCT01132664|468518048|FG001|Phase ll|Disease progression|0|||
130152117|NCT01132664|468518049|FG002|Phase ll|Disease progression|35|||
130152118|NCT01132664|468518050|FG003|Phase ll|Disease progression|0|||
130152119|NCT01132664|468518051|FG004|Phase ll|Disease progression|0|||
130152120|NCT01132664|468518047|FG000|BM Cohort|Disease progression|0|||
130152121|NCT01132664|468518048|FG001|BM Cohort|Disease progression|0|||
130152122|NCT01132664|468518049|FG002|BM Cohort|Disease progression|0|||
130152123|NCT01132664|468518050|FG003|BM Cohort|Disease progression|3|||
130152124|NCT01132664|468518051|FG004|BM Cohort|Disease progression|4|||
130152125|NCT01132664|468518047|FG000|BM Cohort|Adverse Event|0|||
130152126|NCT01132664|468518048|FG001|BM Cohort|Adverse Event|0|||
130152127|NCT01132664|468518049|FG002|BM Cohort|Adverse Event|0|||
130152128|NCT01132664|468518050|FG003|BM Cohort|Adverse Event|0|||
130152129|NCT01132664|468518051|FG004|BM Cohort|Adverse Event|1|||
130152130|NCT01132664|468518047|FG000|BM Cohort|Withdrawal by Subject|0|||
130152131|NCT01132664|468518048|FG001|BM Cohort|Withdrawal by Subject|0|||
130152132|NCT01132664|468518049|FG002|BM Cohort|Withdrawal by Subject|0|||
130152133|NCT01132664|468518050|FG003|BM Cohort|Withdrawal by Subject|0|||
130152134|NCT01132664|468518051|FG004|BM Cohort|Withdrawal by Subject|1|||
130152135|NCT00892281|468518055|FG000|Overall Study|Adverse Event|65|||
130152136|NCT00892281|468518056|FG001|Overall Study|Adverse Event|8|||
130152137|NCT00892281|468518055|FG000|Overall Study|Lost to Follow-up|81|||
130152138|NCT00892281|468518056|FG001|Overall Study|Lost to Follow-up|8|||
130152139|NCT00892281|468518055|FG000|Overall Study|Pregnancy|1|||
130152140|NCT00892281|468518056|FG001|Overall Study|Pregnancy|0|||
130152141|NCT00892281|468518055|FG000|Overall Study|Protocol Violation|7|||
130152142|NCT00892281|468518056|FG001|Overall Study|Protocol Violation|2|||
130152143|NCT00892281|468518055|FG000|Overall Study|Withdrawal by Subject|86|||
130152144|NCT00892281|468518056|FG001|Overall Study|Withdrawal by Subject|14|||
130152145|NCT00892281|468518055|FG000|Overall Study|Subject failed to return for final visit|2|||
130152146|NCT00892281|468518056|FG001|Overall Study|Subject failed to return for final visit|0|||
130152147|NCT00892281|468518055|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
130152148|NCT00892281|468518056|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
130152149|NCT00892281|468518055|FG000|Overall Study|Final visit completed 4 weeks late|0|||
130152150|NCT00892281|468518056|FG001|Overall Study|Final visit completed 4 weeks late|1|||
130152151|NCT00892281|468518055|FG000|Overall Study|Subject completed day after study closed|1|||
130152152|NCT00892281|468518056|FG001|Overall Study|Subject completed day after study closed|0|||
130152153|NCT00892281|468518055|FG000|Overall Study|Family emergency|1|||
130152154|NCT00892281|468518056|FG001|Overall Study|Family emergency|0|||
130152155|NCT00892281|468518055|FG000|Overall Study|Last visit not done - death in family|1|||
130152156|NCT00892281|468518056|FG001|Overall Study|Last visit not done - death in family|0|||
130152157|NCT00892281|468518055|FG000|Overall Study|Did not meet incl/excl criteria|1|||
130152158|NCT00892281|468518056|FG001|Overall Study|Did not meet incl/excl criteria|0|||
130152159|NCT00892281|468518055|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
130152160|NCT00892281|468518056|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
130152161|NCT00892281|468518055|FG000|Overall Study|Unable to redeem the drug voucher|1|||
130152162|NCT00892281|468518056|FG001|Overall Study|Unable to redeem the drug voucher|0|||
130152163|NCT00892281|468518055|FG000|Overall Study|Subject not good candidate for study|1|||
130152164|NCT00892281|468518056|FG001|Overall Study|Subject not good candidate for study|0|||
130152165|NCT00892281|468518055|FG000|Overall Study|Subject did not return for any visits|1|||
130152166|NCT00892281|468518056|FG001|Overall Study|Subject did not return for any visits|0|||
130152167|NCT00892281|468518055|FG000|Overall Study|Subject missed several visits/lost meds|1|||
130152168|NCT00892281|468518056|FG001|Overall Study|Subject missed several visits/lost meds|0|||
130152169|NCT00892281|468518055|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
130152170|NCT00892281|468518056|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
130152171|NCT00892281|468518055|FG000|Overall Study|Scheduled for knee replacement|0|||
130152172|NCT00892281|468518056|FG001|Overall Study|Scheduled for knee replacement|1|||
130152173|NCT00892281|468518055|FG000|Overall Study|PI complained of inadequate compensation|3|||
130152174|NCT00892281|468518056|FG001|Overall Study|PI complained of inadequate compensation|0|||
130152175|NCT00892281|468518055|FG000|Overall Study|Subject lost interest in program|0|||
130152176|NCT00892281|468518056|FG001|Overall Study|Subject lost interest in program|1|||
130152177|NCT00892281|468518055|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
130152178|NCT00892281|468518056|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
130152179|NCT00892281|468518055|FG000|Overall Study|Death in family|1|||
130152180|NCT00892281|468518056|FG001|Overall Study|Death in family|0|||
130152181|NCT00892281|468518055|FG000|Overall Study|Lack of efficacy of study product|2|||
130152182|NCT00892281|468518056|FG001|Overall Study|Lack of efficacy of study product|0|||
130152183|NCT00892281|468518055|FG000|Overall Study|Subject not seen by PI at final visit|1|||
130152184|NCT00892281|468518056|FG001|Overall Study|Subject not seen by PI at final visit|0|||
130152185|NCT00892281|468518055|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
130152186|NCT00892281|468518056|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
130152187|NCT00892281|468518055|FG000|Overall Study|Missed multiple visits|1|||
130152188|NCT00892281|468518056|FG001|Overall Study|Missed multiple visits|0|||
130152189|NCT00892281|468518055|FG000|Overall Study|Missed visits rescheduled out of window|1|||
130152190|NCT00892281|468518056|FG001|Overall Study|Missed visits rescheduled out of window|0|||
130152191|NCT00892281|468518055|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
130152192|NCT00892281|468518056|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
130152193|NCT00892281|468518055|FG000|Overall Study|Subject had history of drug abuse|1|||
130152194|NCT00892281|468518056|FG001|Overall Study|Subject had history of drug abuse|0|||
130152195|NCT00892281|468518055|FG000|Overall Study|Rash on hand|1|||
130152196|NCT00892281|468518056|FG001|Overall Study|Rash on hand|0|||
130152197|NCT00892281|468518055|FG000|Overall Study|Visit 4 date out of window|1|||
130152198|NCT00892281|468518056|FG001|Overall Study|Visit 4 date out of window|0|||
130152199|NCT00655850|468518057|FG000|Overall Study|Death|2|||
130152200|NCT00655850|468518057|FG000|Overall Study|Withdrawal by Subject|1|||
130152201|NCT01567826|468518060|FG000|Overall Study|Lost to Follow-up|3|||
130152202|NCT01567826|468518061|FG001|Overall Study|Lost to Follow-up|2|||
130152203|NCT01360866|468518075|FG000|Overall Study|Lost to Follow-up|11|||
130152204|NCT01360866|468518076|FG001|Overall Study|Lost to Follow-up|28|||
130152205|NCT01360866|468518077|FG002|Overall Study|Lost to Follow-up|41|||
130152206|NCT01360866|468518078|FG003|Overall Study|Lost to Follow-up|0|||
130152207|NCT01360866|468518075|FG000|Overall Study|Adverse Event|56|||
130152208|NCT01360866|468518076|FG001|Overall Study|Adverse Event|61|||
130152209|NCT01360866|468518077|FG002|Overall Study|Adverse Event|134|||
130152210|NCT01360866|468518078|FG003|Overall Study|Adverse Event|6|||
130152211|NCT01360866|468518075|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
130152212|NCT01360866|468518076|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
130152213|NCT01360866|468518077|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
130152214|NCT01360866|468518078|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
130152215|NCT01360866|468518075|FG000|Overall Study|Withdrawn by Investigator|9|||
130152216|NCT01360866|468518076|FG001|Overall Study|Withdrawn by Investigator|8|||
130152217|NCT01360866|468518077|FG002|Overall Study|Withdrawn by Investigator|31|||
130152218|NCT01360866|468518078|FG003|Overall Study|Withdrawn by Investigator|2|||
130152219|NCT01360866|468518075|FG000|Overall Study|Withdrawal by participant|79|||
130152220|NCT01360866|468518076|FG001|Overall Study|Withdrawal by participant|89|||
130152221|NCT01360866|468518077|FG002|Overall Study|Withdrawal by participant|168|||
130152222|NCT01360866|468518078|FG003|Overall Study|Withdrawal by participant|8|||
130152223|NCT01360866|468518075|FG000|Overall Study|Protocol Deviation|25|||
130152224|NCT01360866|468518076|FG001|Overall Study|Protocol Deviation|33|||
130152225|NCT01360866|468518077|FG002|Overall Study|Protocol Deviation|61|||
130152226|NCT01360866|468518078|FG003|Overall Study|Protocol Deviation|2|||
130152227|NCT01360866|468518075|FG000|Overall Study|Lack of Efficacy|30|||
130152228|NCT01360866|468518076|FG001|Overall Study|Lack of Efficacy|40|||
130152229|NCT01360866|468518077|FG002|Overall Study|Lack of Efficacy|30|||
130152230|NCT01360866|468518078|FG003|Overall Study|Lack of Efficacy|4|||
130152231|NCT03702049|468518082|FG000|Overall Study|Lost to Follow-up|4|||
130152232|NCT03702049|468518082|FG000|Overall Study|Physician Decision|1|||
130152233|NCT01715896|468518083|FG000|Overall Study|Lost to Follow-up|0|||
130152234|NCT01715896|468518084|FG001|Overall Study|Lost to Follow-up|2|||
130152235|NCT01715896|468518083|FG000|Overall Study|Withdrawal by Subject|1|||
130152236|NCT01715896|468518084|FG001|Overall Study|Withdrawal by Subject|4|||
130152237|NCT01715896|468518083|FG000|Overall Study|Other|2|||
130152238|NCT01715896|468518084|FG001|Overall Study|Other|5|||
130152239|NCT01833533|468518086|FG000|Overall Study|Adverse Event|0|||
130152240|NCT01833533|468518087|FG001|Overall Study|Adverse Event|1|||
130152241|NCT01833533|468518086|FG000|Overall Study|Lost to Follow-up|4|||
130152242|NCT01833533|468518087|FG001|Overall Study|Lost to Follow-up|9|||
130152243|NCT01833533|468518086|FG000|Overall Study|To Enter an Extension Study|0|||
130152244|NCT01833533|468518087|FG001|Overall Study|To Enter an Extension Study|4|||
130152245|NCT01833533|468518086|FG000|Overall Study|Other|2|||
130152246|NCT01833533|468518087|FG001|Overall Study|Other|7|||
130152247|NCT01048502|468518088|FG000|Overall Study|Lost to Follow-up|2|||
130152248|NCT01048502|468518089|FG001|Overall Study|Lost to Follow-up|0|||
130152249|NCT01048502|468518090|FG002|Overall Study|Lost to Follow-up|0|||
130152250|NCT01048502|468518091|FG003|Overall Study|Lost to Follow-up|0|||
130152251|NCT01048502|468518088|FG000|Overall Study|Adverse Event|1|||
130152252|NCT01048502|468518089|FG001|Overall Study|Adverse Event|0|||
130152253|NCT01048502|468518090|FG002|Overall Study|Adverse Event|0|||
130152254|NCT01048502|468518091|FG003|Overall Study|Adverse Event|0|||
130094616|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
130094617|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
130094618|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
130094619|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
130094620|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
130094621|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
130094622|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
130094623|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
130094624|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
130094625|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
130094626|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
130094811|NCT03996694|468303849|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
130094812|NCT03996694|468303850|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
130094813|NCT03996694|468303851|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
130094814|NCT03996694|468303852|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
130094815|NCT03996694|468303853|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
130094816|NCT03996694|468303848|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
130094817|NCT03996694|468303849|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
130094818|NCT03996694|468303850|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
130094819|NCT03996694|468303851|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
130094820|NCT03996694|468303852|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
130094821|NCT03996694|468303853|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
130094822|NCT03053102|468303856|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
130094823|NCT03053102|468303856|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
130094824|NCT01458535|468303857|FG000|Overall Study|Other|0|||
130094825|NCT01458535|468303858|FG001|Overall Study|Other|0|||
130094826|NCT01458535|468303859|FG002|Overall Study|Other|0|||
130094827|NCT01458535|468303860|FG003|Overall Study|Other|0|||
130094828|NCT01458535|468303861|FG004|Overall Study|Other|1|||
130094829|NCT01458535|468303862|FG005|Overall Study|Other|1|||
130094830|NCT01458535|468303857|FG000|Overall Study|Withdrawal by Subject|0|||
130094831|NCT01458535|468303858|FG001|Overall Study|Withdrawal by Subject|0|||
130094832|NCT01458535|468303859|FG002|Overall Study|Withdrawal by Subject|2|||
130094833|NCT01458535|468303860|FG003|Overall Study|Withdrawal by Subject|0|||
130094834|NCT01458535|468303861|FG004|Overall Study|Withdrawal by Subject|1|||
130094835|NCT01458535|468303862|FG005|Overall Study|Withdrawal by Subject|1|||
130094836|NCT01458535|468303857|FG000|Overall Study|Lost to Follow-up|0|||
130094837|NCT01458535|468303858|FG001|Overall Study|Lost to Follow-up|2|||
130094838|NCT01458535|468303859|FG002|Overall Study|Lost to Follow-up|0|||
130094839|NCT01458535|468303860|FG003|Overall Study|Lost to Follow-up|3|||
130094840|NCT01458535|468303861|FG004|Overall Study|Lost to Follow-up|2|||
130094841|NCT01458535|468303862|FG005|Overall Study|Lost to Follow-up|2|||
130094842|NCT01458535|468303857|FG000|Overall Study|Adverse Event|0|||
130094843|NCT01458535|468303858|FG001|Overall Study|Adverse Event|0|||
130094844|NCT01458535|468303859|FG002|Overall Study|Adverse Event|0|||
130094845|NCT01458535|468303860|FG003|Overall Study|Adverse Event|1|||
130094846|NCT01458535|468303861|FG004|Overall Study|Adverse Event|0|||
130094847|NCT01458535|468303862|FG005|Overall Study|Adverse Event|0|||
130094848|NCT01238861|468303863|FG000|Overall Study|Lost to Follow-up|4|||
130094849|NCT01238861|468303864|FG001|Overall Study|Lost to Follow-up|2|||
130094850|NCT01238861|468303865|FG002|Overall Study|Lost to Follow-up|3|||
130094851|NCT01238861|468303866|FG003|Overall Study|Lost to Follow-up|1|||
130094852|NCT01238861|468303867|FG004|Overall Study|Lost to Follow-up|1|||
130094853|NCT01238861|468303868|FG005|Overall Study|Lost to Follow-up|2|||
130094854|NCT01238861|468303863|FG000|Overall Study|Unplanned surgery|1|||
130094855|NCT01238861|468303864|FG001|Overall Study|Unplanned surgery|0|||
130094856|NCT01238861|468303865|FG002|Overall Study|Unplanned surgery|0|||
130094857|NCT01238861|468303866|FG003|Overall Study|Unplanned surgery|0|||
130094858|NCT01238861|468303867|FG004|Overall Study|Unplanned surgery|0|||
130094859|NCT01238861|468303868|FG005|Overall Study|Unplanned surgery|0|||
130094860|NCT01238861|468303863|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
130094861|NCT01238861|468303864|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
130094862|NCT01238861|468303865|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
130094863|NCT01238861|468303866|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
130094864|NCT01238861|468303867|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
130094865|NCT01238861|468303868|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
130094866|NCT01238861|468303863|FG000|Overall Study|Incorrect enrollment/randomization|0|||
130094867|NCT01238861|468303864|FG001|Overall Study|Incorrect enrollment/randomization|0|||
130094868|NCT01238861|468303865|FG002|Overall Study|Incorrect enrollment/randomization|1|||
130094869|NCT01238861|468303866|FG003|Overall Study|Incorrect enrollment/randomization|0|||
130094870|NCT01238861|468303867|FG004|Overall Study|Incorrect enrollment/randomization|1|||
130152255|NCT01048502|468518088|FG000|Overall Study|Withdrawal by Subject|1|||
130152256|NCT01048502|468518089|FG001|Overall Study|Withdrawal by Subject|4|||
130152257|NCT01048502|468518090|FG002|Overall Study|Withdrawal by Subject|5|||
130152258|NCT01048502|468518091|FG003|Overall Study|Withdrawal by Subject|3|||
130152259|NCT01048502|468518088|FG000|Overall Study|Physician Decision|0|||
130152260|NCT01048502|468518089|FG001|Overall Study|Physician Decision|3|||
130152261|NCT01048502|468518090|FG002|Overall Study|Physician Decision|0|||
130152262|NCT01048502|468518091|FG003|Overall Study|Physician Decision|1|||
130152263|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
130152264|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
130152265|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
130152266|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
130152267|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
130152268|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
130152269|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
130152270|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
130152271|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
130152272|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
130152273|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
130152274|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
130152275|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
130152276|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
130152277|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
130152278|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
130152279|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
130152280|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
130152281|NCT00384293|468518092|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
129979544|NCT04998812|467887524|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
129979545|NCT04998812|467887525|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
129979546|NCT04998812|467887524|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
129979547|NCT04998812|467887525|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
129979548|NCT04998812|467887524|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
129979549|NCT04998812|467887525|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
129979550|NCT04998812|467887524|FG000|Vaccination Period|Ongoing in study|23|||
129979551|NCT04998812|467887525|FG001|Vaccination Period|Ongoing in study|23|||
129979552|NCT04893460|467887528|FG000|Overall Study|Lost to Follow-up|18|||
129979553|NCT03248882|467889386|FG000|Overall Study|Adverse Event|3|||
129979554|NCT03248882|467889387|FG001|Overall Study|Adverse Event|3|||
129979555|NCT03248882|467889388|FG002|Overall Study|Adverse Event|2|||
129979556|NCT03248882|467889389|FG003|Overall Study|Adverse Event|6|||
129979557|NCT03248882|467889390|FG004|Overall Study|Adverse Event|9|||
129979558|NCT03248882|467889386|FG000|Overall Study|Lost to Follow-up|0|||
129979559|NCT03248882|467889387|FG001|Overall Study|Lost to Follow-up|0|||
129979560|NCT03248882|467889388|FG002|Overall Study|Lost to Follow-up|0|||
129979561|NCT03248882|467889389|FG003|Overall Study|Lost to Follow-up|0|||
129979562|NCT03248882|467889390|FG004|Overall Study|Lost to Follow-up|1|||
129979563|NCT03248882|467889386|FG000|Overall Study|Protocol Violation|2|||
129979564|NCT03248882|467889387|FG001|Overall Study|Protocol Violation|0|||
129979565|NCT03248882|467889388|FG002|Overall Study|Protocol Violation|2|||
130152282|NCT00384293|468518093|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
130152283|NCT00384293|468518094|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
130152284|NCT00384293|468518092|FG000|Post-randomization Period|Adverse Event|0|||
130152285|NCT00384293|468518093|FG001|Post-randomization Period|Adverse Event|23|||
130152286|NCT00384293|468518094|FG002|Post-randomization Period|Adverse Event|7|||
130152287|NCT00384293|468518092|FG000|Post-randomization Period|Lost to Follow-up|0|||
130152288|NCT00384293|468518093|FG001|Post-randomization Period|Lost to Follow-up|2|||
130152289|NCT00384293|468518094|FG002|Post-randomization Period|Lost to Follow-up|1|||
130152290|NCT00384293|468518092|FG000|Post-randomization Period|Protocol Violation|0|||
130152291|NCT00384293|468518093|FG001|Post-randomization Period|Protocol Violation|1|||
130152292|NCT00384293|468518094|FG002|Post-randomization Period|Protocol Violation|0|||
130152293|NCT00384293|468518092|FG000|Post-randomization Period|Withdrawal by Subject|0|||
130152294|NCT00384293|468518093|FG001|Post-randomization Period|Withdrawal by Subject|8|||
130152295|NCT00384293|468518094|FG002|Post-randomization Period|Withdrawal by Subject|6|||
130152296|NCT00384293|468518092|FG000|Post-randomization Period|Trial Termination|0|||
130152297|NCT00384293|468518093|FG001|Post-randomization Period|Trial Termination|180|||
130152298|NCT00384293|468518094|FG002|Post-randomization Period|Trial Termination|204|||
130152299|NCT00384293|468518092|FG000|Post-randomization Period|Patient Randomized in Error|0|||
130152300|NCT00384293|468518093|FG001|Post-randomization Period|Patient Randomized in Error|0|||
130152301|NCT00384293|468518094|FG002|Post-randomization Period|Patient Randomized in Error|1|||
130152302|NCT05212883|468518095|FG000|Overall Study|Invalid test result|125|||
130152303|NCT02502734|468518096|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
130152304|NCT02502734|468518097|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
130152305|NCT02502734|468518096|FG000|Washout Period|Adverse Event|1|||
130152306|NCT02502734|468518097|FG001|Washout Period|Adverse Event|0|||
130152307|NCT01483625|468518100|FG000|Overall Study|Adverse Event|1|||
130152308|NCT01483625|468518101|FG001|Overall Study|Adverse Event|1|||
130152309|NCT01483625|468518100|FG000|Overall Study|Refused to continue medication|2|||
130152310|NCT01483625|468518101|FG001|Overall Study|Refused to continue medication|1|||
130152311|NCT01483625|468518100|FG000|Overall Study|Due to other reason|1|||
130152312|NCT01483625|468518101|FG001|Overall Study|Due to other reason|0|||
130152313|NCT05444543|468518105|FG000|Overall Study|Withdrawal by Subject|1|||
130152314|NCT05444543|468518106|FG001|Overall Study|Withdrawal by Subject|0|||
130152315|NCT05444543|468518105|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
130152316|NCT05444543|468518106|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
130152317|NCT05444543|468518105|FG000|Overall Study|Adverse Event|0|||
130152318|NCT05444543|468518106|FG001|Overall Study|Adverse Event|1|||
130152319|NCT05444543|468518105|FG000|Overall Study|Family relocating at a distance from study site|0|||
130152320|NCT05444543|468518106|FG001|Overall Study|Family relocating at a distance from study site|1|||
130152321|NCT02280187|468518107|FG000|Overall Study|Lost to Follow-up|218|||
130152322|NCT04668274|468518108|FG000|Part 1 Study Period 1|Adverse Event|3|||
130152323|NCT04668274|468518109|FG001|Part 1 Study Period 1|Adverse Event|0|||
130152324|NCT04668274|468518110|FG002|Part 1 Study Period 1|Adverse Event|0|||
130152325|NCT04668274|468518111|FG003|Part 1 Study Period 1|Adverse Event|0|||
130152326|NCT04668274|468518108|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
130152327|NCT04668274|468518109|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
130152328|NCT04668274|468518110|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
130152329|NCT04668274|468518111|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
130152330|NCT04668274|468518108|FG000|Part 1 Study Period 2|Other|0|||
130152331|NCT04668274|468518109|FG001|Part 1 Study Period 2|Other|1|||
130152332|NCT04668274|468518110|FG002|Part 1 Study Period 2|Other|0|||
130152333|NCT04668274|468518111|FG003|Part 1 Study Period 2|Other|0|||
130152334|NCT04668274|468518108|FG000|Part 1 Study Period 3|Adverse Event|0|||
130152335|NCT04668274|468518109|FG001|Part 1 Study Period 3|Adverse Event|0|||
130152336|NCT04668274|468518110|FG002|Part 1 Study Period 3|Adverse Event|1|||
130152337|NCT04668274|468518111|FG003|Part 1 Study Period 3|Adverse Event|0|||
130152338|NCT04668274|468518108|FG000|Part 1 Study Period 3|Other|0|||
130152339|NCT04668274|468518109|FG001|Part 1 Study Period 3|Other|0|||
130152340|NCT04668274|468518110|FG002|Part 1 Study Period 3|Other|2|||
130152341|NCT04668274|468518111|FG003|Part 1 Study Period 3|Other|0|||
130152342|NCT04668274|468518108|FG000|Part 2 Study Period 4|Other|0|||
130152343|NCT04668274|468518109|FG001|Part 2 Study Period 4|Other|0|||
130152344|NCT04668274|468518110|FG002|Part 2 Study Period 4|Other|0|||
130152345|NCT04668274|468518111|FG003|Part 2 Study Period 4|Other|1|||
130152346|NCT01832402|468518114|FG000|Overall Study|Lost to Follow-up|2|||
130152347|NCT01832402|468518115|FG001|Overall Study|Lost to Follow-up|0|||
130152348|NCT01832402|468518114|FG000|Overall Study|Withdrawal by Subject|3|||
130152349|NCT01832402|468518115|FG001|Overall Study|Withdrawal by Subject|3|||
130152350|NCT01832402|468518114|FG000|Overall Study|Declining Performance status|2|||
130152351|NCT01832402|468518115|FG001|Overall Study|Declining Performance status|1|||
130152352|NCT01803269|468518118|FG000|Overall Study|Withdrawal by Subject|3|||
130152353|NCT01803269|468518119|FG001|Overall Study|Withdrawal by Subject|0|||
130152354|NCT01803269|468518120|FG002|Overall Study|Withdrawal by Subject|0|||
130152355|NCT01202877|468518121|FG000|Overall Study|Disease Progression|0|||
130152356|NCT01202877|468518122|FG001|Overall Study|Disease Progression|1|||
130152357|NCT01202877|468518123|FG002|Overall Study|Disease Progression|2|||
130152358|NCT01202877|468518121|FG000|Overall Study|Adverse Event|0|||
130152359|NCT01202877|468518122|FG001|Overall Study|Adverse Event|0|||
130152360|NCT01202877|468518123|FG002|Overall Study|Adverse Event|2|||
130152361|NCT01202877|468518121|FG000|Overall Study|Withdrawal by Subject|0|||
130152362|NCT01202877|468518122|FG001|Overall Study|Withdrawal by Subject|0|||
130152363|NCT01202877|468518123|FG002|Overall Study|Withdrawal by Subject|1|||
130152364|NCT01202877|468518121|FG000|Overall Study|Death|0|||
130152365|NCT01202877|468518122|FG001|Overall Study|Death|0|||
130152366|NCT01202877|468518123|FG002|Overall Study|Death|1|||
130152367|NCT00396331|468518124|FG000|Overall Study|Failed to mobilize - no transplant|8|||
130152368|NCT00396331|468518124|FG000|Overall Study|Did not go on to transplant|5|||
130152369|NCT00396331|468518124|FG000|Overall Study|Lost to Follow-up|3|||
130152370|NCT00396331|468518124|FG000|Overall Study|Death|16|||
130152371|NCT00350402|468518125|FG000|Overall Study|Lost to Follow-up|1|||
130152372|NCT00350402|468518126|FG001|Overall Study|Lost to Follow-up|1|||
130152373|NCT02709486|468518134|FG000|Overall Study|Adverse Event|2|||
130152374|NCT02709486|468518135|FG001|Overall Study|Adverse Event|5|||
130152375|NCT02709486|468518136|FG002|Overall Study|Adverse Event|3|||
130152376|NCT02709486|468518134|FG000|Overall Study|Death|0|||
130152377|NCT02709486|468518135|FG001|Overall Study|Death|0|||
130152378|NCT02709486|468518136|FG002|Overall Study|Death|2|||
130152379|NCT02709486|468518134|FG000|Overall Study|Insufficient clinical response|7|||
130152380|NCT02709486|468518135|FG001|Overall Study|Insufficient clinical response|3|||
130152381|NCT02709486|468518136|FG002|Overall Study|Insufficient clinical response|3|||
130152382|NCT02709486|468518134|FG000|Overall Study|Lost to Follow-up|3|||
130152383|NCT02709486|468518135|FG001|Overall Study|Lost to Follow-up|2|||
130152384|NCT02709486|468518136|FG002|Overall Study|Lost to Follow-up|2|||
130152385|NCT02709486|468518134|FG000|Overall Study|Other|0|||
130152386|NCT02709486|468518135|FG001|Overall Study|Other|2|||
130152387|NCT02709486|468518136|FG002|Overall Study|Other|3|||
130152388|NCT02709486|468518134|FG000|Overall Study|Withdrawal by Subject|32|||
130152389|NCT02709486|468518135|FG001|Overall Study|Withdrawal by Subject|22|||
130152390|NCT02709486|468518136|FG002|Overall Study|Withdrawal by Subject|32|||
130152391|NCT02377921|468518140|FG000|Overall Study|Subject non-compliance|1|||
130152392|NCT02377921|468518141|FG001|Overall Study|Subject non-compliance|1|||
130152393|NCT02549573|468518146|FG000|Overall Study|Withdrawal by Subject|0|||
130152394|NCT02549573|468518147|FG001|Overall Study|Withdrawal by Subject|2|||
130152395|NCT02549573|468518146|FG000|Overall Study|Protocol Violation|0|||
130152396|NCT02549573|468518147|FG001|Overall Study|Protocol Violation|1|||
130152397|NCT01010126|468519721|FG000|Overall Study|Withdrawal by Subject|1|||
130152398|NCT01010126|468519722|FG001|Overall Study|Withdrawal by Subject|0|||
130152399|NCT01010126|468519723|FG002|Overall Study|Withdrawal by Subject|1|||
130152400|NCT01010126|468519724|FG003|Overall Study|Withdrawal by Subject|0|||
130152401|NCT01010126|468519725|FG004|Overall Study|Withdrawal by Subject|3|||
130152402|NCT01010126|468519726|FG005|Overall Study|Withdrawal by Subject|0|||
130152403|NCT00595335|468519729|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
130152404|NCT00595335|468519730|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
130152405|NCT00595335|468519729|FG000|Baseline to Six Months|Disease Progression|1|||
130152406|NCT00595335|468519730|FG001|Baseline to Six Months|Disease Progression|1|||
130152407|NCT00595335|468519729|FG000|Baseline to Six Months|Adverse Event|1|||
130152408|NCT00595335|468519730|FG001|Baseline to Six Months|Adverse Event|0|||
130152409|NCT00595335|468519729|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
130152410|NCT00595335|468519730|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
130152411|NCT00595335|468519729|FG000|Six Months to Twelve Months|Disease Progression|1|||
130152412|NCT00595335|468519730|FG001|Six Months to Twelve Months|Disease Progression|0|||
130152413|NCT02658487|468519736|FG000|Overall Study|Death|2|||
130152414|NCT02658487|468519736|FG000|Overall Study|Disease progression|10|||
130152415|NCT02658487|468519736|FG000|Overall Study|Alternative therapy|1|||
130152416|NCT02658487|468519736|FG000|Overall Study|Adverse Event|1|||
130152417|NCT02658487|468519736|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
130152418|NCT02658487|468519736|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
130152419|NCT03686150|468519743|FG000|Overall Study|Withdrawal by Subject|1|||
130152420|NCT03686150|468519744|FG001|Overall Study|Withdrawal by Subject|1|||
130152421|NCT03686150|468519745|FG002|Overall Study|Withdrawal by Subject|1|||
130152422|NCT03686150|468519746|FG003|Overall Study|Withdrawal by Subject|0|||
130152423|NCT03686150|468519747|FG004|Overall Study|Withdrawal by Subject|1|||
130152424|NCT03686150|468519748|FG005|Overall Study|Withdrawal by Subject|2|||
130152425|NCT03686150|468519743|FG000|Overall Study|Physician Decision|1|||
130152426|NCT03686150|468519744|FG001|Overall Study|Physician Decision|0|||
130152427|NCT03686150|468519745|FG002|Overall Study|Physician Decision|0|||
130152428|NCT03686150|468519746|FG003|Overall Study|Physician Decision|0|||
130152429|NCT03686150|468519747|FG004|Overall Study|Physician Decision|0|||
130152430|NCT03686150|468519748|FG005|Overall Study|Physician Decision|1|||
130152431|NCT03686150|468519743|FG000|Overall Study|Lost to Follow-up|0|||
130152432|NCT03686150|468519744|FG001|Overall Study|Lost to Follow-up|1|||
130152433|NCT03686150|468519745|FG002|Overall Study|Lost to Follow-up|0|||
130152434|NCT03686150|468519746|FG003|Overall Study|Lost to Follow-up|0|||
130152435|NCT03686150|468519747|FG004|Overall Study|Lost to Follow-up|0|||
130152436|NCT03686150|468519748|FG005|Overall Study|Lost to Follow-up|0|||
130152437|NCT00614926|468519751|FG000|Overall Study|Burden of travel|1|||
130152438|NCT00614926|468519752|FG001|Overall Study|Burden of travel|0|||
130152439|NCT00614926|468519751|FG000|Overall Study|Adverse Event|3|||
130152440|NCT00614926|468519752|FG001|Overall Study|Adverse Event|0|||
130152441|NCT03341000|468519753|FG000|Overall Study|Adverse Event|1|||
130152442|NCT02813421|468519756|FG000|Overall Study|Withdrawal by Subject|1|||
130152443|NCT02813421|468519757|FG001|Overall Study|Withdrawal by Subject|2|||
130152444|NCT02813421|468519756|FG000|Overall Study|Lost to Follow-up|1|||
130152445|NCT02813421|468519757|FG001|Overall Study|Lost to Follow-up|1|||
130152446|NCT01213836|468519775|FG000|Period 1, First Intervention|Adverse Event|2|||
130152447|NCT01213836|468519776|FG001|Period 1, First Intervention|Adverse Event|1|||
130152448|NCT01213836|468519775|FG000|Period 1, First Intervention|Protocol Violation|0|||
130152449|NCT01213836|468519776|FG001|Period 1, First Intervention|Protocol Violation|1|||
130152450|NCT01213836|468519775|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
130152451|NCT01213836|468519776|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
130152452|NCT00255151|468519777|FG000|Overall Study|Adverse Event|10|||
130152453|NCT00255151|468519778|FG001|Overall Study|Adverse Event|6|||
130152454|NCT00255151|468519779|FG002|Overall Study|Adverse Event|9|||
130152455|NCT00255151|468519777|FG000|Overall Study|Lost to Follow-up|4|||
130152456|NCT00255151|468519778|FG001|Overall Study|Lost to Follow-up|3|||
130152457|NCT00255151|468519779|FG002|Overall Study|Lost to Follow-up|4|||
130152458|NCT00255151|468519777|FG000|Overall Study|Withdrawal by Subject|18|||
130152459|NCT00255151|468519778|FG001|Overall Study|Withdrawal by Subject|17|||
130152460|NCT00255151|468519779|FG002|Overall Study|Withdrawal by Subject|8|||
130152461|NCT00255151|468519777|FG000|Overall Study|Noncompliance|0|||
130152462|NCT00255151|468519778|FG001|Overall Study|Noncompliance|1|||
130152463|NCT00255151|468519779|FG002|Overall Study|Noncompliance|2|||
130152464|NCT00255151|468519777|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
130152465|NCT00255151|468519778|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
130152466|NCT00255151|468519779|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
130152467|NCT00255151|468519777|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
130152468|NCT00255151|468519778|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
130152469|NCT00255151|468519779|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
130152470|NCT00255151|468519777|FG000|Overall Study|Possible Barrett's Esophagus|1|||
130152471|NCT00255151|468519778|FG001|Overall Study|Possible Barrett's Esophagus|3|||
130152472|NCT00255151|468519779|FG002|Overall Study|Possible Barrett's Esophagus|8|||
130152473|NCT00255151|468519777|FG000|Overall Study|Esophageal Stricture|0|||
130152474|NCT00255151|468519778|FG001|Overall Study|Esophageal Stricture|0|||
130152475|NCT00255151|468519779|FG002|Overall Study|Esophageal Stricture|1|||
130152476|NCT00255151|468519777|FG000|Overall Study|Therapeutic Failure|11|||
130152477|NCT00255151|468519778|FG001|Overall Study|Therapeutic Failure|2|||
130152478|NCT00255151|468519779|FG002|Overall Study|Therapeutic Failure|3|||
130152479|NCT00706095|468519780|FG000|Overall Study|Progressive Disease|4|||
130152480|NCT00706095|468519781|FG001|Overall Study|Progressive Disease|5|||
130152481|NCT00706095|468519782|FG002|Overall Study|Progressive Disease|3|||
130152482|NCT00706095|468519780|FG000|Overall Study|Clinical Progression|1|||
130152483|NCT00706095|468519781|FG001|Overall Study|Clinical Progression|2|||
130152484|NCT00706095|468519782|FG002|Overall Study|Clinical Progression|2|||
130152485|NCT00706095|468519780|FG000|Overall Study|Withdrawal by Subject|1|||
130152486|NCT00706095|468519781|FG001|Overall Study|Withdrawal by Subject|0|||
130152487|NCT00706095|468519782|FG002|Overall Study|Withdrawal by Subject|0|||
130152488|NCT02676284|468519783|FG000|Overall Study|Withdrawal by Subject|1|||
130152489|NCT01685073|468519784|FG000|Overall Study|Lost to Follow-up|6|||
130152490|NCT01685073|468519785|FG001|Overall Study|Lost to Follow-up|8|||
130152491|NCT01685073|468519784|FG000|Overall Study|Withdrawal by Subject|24|||
130152492|NCT01685073|468519785|FG001|Overall Study|Withdrawal by Subject|24|||
130152493|NCT00107042|468519790|FG000|Overall Study|Lost to Follow-up|9|||
130152494|NCT00107042|468519791|FG001|Overall Study|Lost to Follow-up|7|||
130152495|NCT00107042|468519790|FG000|Overall Study|Withdrawal by Subject|6|||
130152496|NCT00107042|468519791|FG001|Overall Study|Withdrawal by Subject|1|||
130152497|NCT00107042|468519790|FG000|Overall Study|Moved out of area|5|||
130152498|NCT00107042|468519791|FG001|Overall Study|Moved out of area|3|||
130152499|NCT00107042|468519790|FG000|Overall Study|Pregnancy|1|||
130152500|NCT00107042|468519791|FG001|Overall Study|Pregnancy|1|||
130152501|NCT00107042|468519790|FG000|Overall Study|Inadvertent enrollment|0|||
130152502|NCT00107042|468519791|FG001|Overall Study|Inadvertent enrollment|1|||
130152503|NCT00107042|468519790|FG000|Overall Study|vaccinated outside window|1|||
130152504|NCT00107042|468519791|FG001|Overall Study|vaccinated outside window|1|||
130152505|NCT00107042|468519790|FG000|Overall Study|Disallowed medications|0|||
130152506|NCT00107042|468519791|FG001|Overall Study|Disallowed medications|2|||
130152507|NCT00856830|468519793|FG000|Irinotecan & Bendamustine|Death|0|||
130152508|NCT00856830|468519794|FG001|Irinotecan & Bendamustine|Death|0|||
130152509|NCT00856830|468519795|FG002|Irinotecan & Bendamustine|Death|0|||
130152510|NCT00856830|468519796|FG003|Irinotecan & Bendamustine|Death|2|||
130152511|NCT00856830|468519793|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
130152512|NCT00856830|468519794|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
130152513|NCT00856830|468519795|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
130152514|NCT00856830|468519796|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
130152515|NCT00140413|468519797|FG000|Overall Study|Lost to Follow-up|1|||
130152516|NCT00140413|468519798|FG001|Overall Study|Lost to Follow-up|0|||
130152517|NCT00140413|468519797|FG000|Overall Study|Withdrawal by Subject|2|||
130152518|NCT00140413|468519798|FG001|Overall Study|Withdrawal by Subject|0|||
130152519|NCT00865098|468519799|FG000|Overall Study|Progressive disease|1|||
130152520|NCT01304693|468519800|FG000|Overall Study|Adverse Event|0|||
130152521|NCT01304693|468519801|FG001|Overall Study|Adverse Event|0|||
130152522|NCT01304693|468519802|FG002|Overall Study|Adverse Event|0|||
130152523|NCT01304693|468519803|FG003|Overall Study|Adverse Event|0|||
130152524|NCT01304693|468519804|FG004|Overall Study|Adverse Event|1|||
130152525|NCT01304693|468519800|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
130152526|NCT01304693|468519801|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
130152527|NCT01304693|468519802|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
130152528|NCT01304693|468519803|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
130152529|NCT01304693|468519804|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
130152530|NCT02129647|468519805|FG000|Overall Study|Adverse Event|2|||
130152531|NCT02129647|468519805|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
130152532|NCT01138826|468519816|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130152533|NCT01138826|468519817|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130152534|NCT01138826|468519818|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130152535|NCT01138826|468519819|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130152536|NCT01138826|468519820|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
130152537|NCT01138826|468519821|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
130152538|NCT01333072|468519825|FG000|Overall Study|Lost to Follow-up|3|||
130152539|NCT01333072|468519826|FG001|Overall Study|Lost to Follow-up|0|||
130152540|NCT01333072|468519825|FG000|Overall Study|Adverse Event|2|||
130152541|NCT01333072|468519826|FG001|Overall Study|Adverse Event|4|||
130152542|NCT01333072|468519825|FG000|Overall Study|Physician Decision|1|||
130152543|NCT01333072|468519826|FG001|Overall Study|Physician Decision|0|||
130152544|NCT01557842|468519827|FG000|Overall Study|Lost to Follow-up|0|||
130152545|NCT01557842|468519828|FG001|Overall Study|Lost to Follow-up|1|||
130152546|NCT01557842|468519827|FG000|Overall Study|Death|1|||
130152547|NCT01557842|468519828|FG001|Overall Study|Death|0|||
130152548|NCT01557842|468519827|FG000|Overall Study|Lack of Efficacy|0|||
130152549|NCT01557842|468519828|FG001|Overall Study|Lack of Efficacy|1|||
130152550|NCT01557842|468519827|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
130152551|NCT01557842|468519828|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
130152552|NCT01557842|468519827|FG000|Overall Study|Study Terminated by Sponsor|3|||
130152553|NCT01557842|468519828|FG001|Overall Study|Study Terminated by Sponsor|4|||
130152554|NCT01557842|468519827|FG000|Overall Study|Not Ablated|2|||
130152555|NCT01557842|468519828|FG001|Overall Study|Not Ablated|0|||
130152556|NCT02457611|468519832|FG000|Overall Study|Lost to Follow-up|3|||
130152557|NCT03005067|468519833|FG000|Overall Study|Withdrawal by Subject|3|||
130152558|NCT03005067|468519834|FG001|Overall Study|Withdrawal by Subject|2|||
130152559|NCT03005067|468519833|FG000|Overall Study|Adverse Event|4|||
130152560|NCT03005067|468519834|FG001|Overall Study|Adverse Event|3|||
130152561|NCT03005067|468519833|FG000|Overall Study|Other (reason not specified)|3|||
130152562|NCT03005067|468519834|FG001|Overall Study|Other (reason not specified)|1|||
130152563|NCT03005067|468519833|FG000|Overall Study|Protocol Violation|0|||
130152564|NCT03005067|468519834|FG001|Overall Study|Protocol Violation|1|||
130152565|NCT00619359|468519839|FG000|Overall Study|Adverse Event|32|||
130152566|NCT00619359|468519840|FG001|Overall Study|Adverse Event|36|||
130152567|NCT00619359|468519839|FG000|Overall Study|Lost to Follow-up|12|||
130152568|NCT00619359|468519840|FG001|Overall Study|Lost to Follow-up|16|||
130152569|NCT00619359|468519839|FG000|Overall Study|Physician Decision|0|||
130152570|NCT00619359|468519840|FG001|Overall Study|Physician Decision|7|||
130152571|NCT00619359|468519839|FG000|Overall Study|Protocol Violation|1|||
130152572|NCT00619359|468519840|FG001|Overall Study|Protocol Violation|1|||
130152573|NCT00619359|468519839|FG000|Overall Study|Withdrawal by Subject|19|||
130152574|NCT00619359|468519840|FG001|Overall Study|Withdrawal by Subject|20|||
130152575|NCT00619359|468519839|FG000|Overall Study|Progressive Disease|3|||
130152576|NCT00619359|468519840|FG001|Overall Study|Progressive Disease|1|||
130152577|NCT03891329|468519854|FG000|Overall Study|Death|5|||
130152578|NCT03891329|468519854|FG000|Overall Study|Lost to Follow-up|4|||
130152579|NCT03891329|468519854|FG000|Overall Study|Physician Decision|4|||
130152580|NCT03891329|468519854|FG000|Overall Study|Device explanted|3|||
130152581|NCT03891329|468519854|FG000|Overall Study|No study device implanted|3|||
130152582|NCT03176784|468519855|FG000|Overall Study|Lost to Follow-up|77|||
130152583|NCT03176784|468519856|FG001|Overall Study|Lost to Follow-up|79|||
130152584|NCT03176784|468519857|FG002|Overall Study|Lost to Follow-up|79|||
130152585|NCT03176784|468519858|FG003|Overall Study|Lost to Follow-up|49|||
130152586|NCT03176784|468519855|FG000|Overall Study|Withdrawal by Subject|28|||
130152587|NCT03176784|468519856|FG001|Overall Study|Withdrawal by Subject|34|||
130152588|NCT03176784|468519857|FG002|Overall Study|Withdrawal by Subject|34|||
130152589|NCT03176784|468519858|FG003|Overall Study|Withdrawal by Subject|21|||
130152590|NCT01351350|468519859|FG000|Overall Study|Disease Progression|5|||
130152591|NCT01351350|468519860|FG001|Overall Study|Disease Progression|13|||
130152592|NCT01351350|468519861|FG002|Overall Study|Disease Progression|6|||
130152593|NCT01351350|468519862|FG003|Overall Study|Disease Progression|8|||
130152594|NCT01351350|468519863|FG004|Overall Study|Disease Progression|5|||
130152595|NCT01351350|468519859|FG000|Overall Study|Adverse Event|1|||
130152596|NCT01351350|468519860|FG001|Overall Study|Adverse Event|10|||
130152597|NCT01351350|468519861|FG002|Overall Study|Adverse Event|1|||
130152598|NCT01351350|468519862|FG003|Overall Study|Adverse Event|2|||
130152599|NCT01351350|468519863|FG004|Overall Study|Adverse Event|0|||
130152600|NCT01351350|468519859|FG000|Overall Study|Participant Decision|2|||
130152601|NCT01351350|468519860|FG001|Overall Study|Participant Decision|6|||
130152602|NCT01351350|468519861|FG002|Overall Study|Participant Decision|3|||
130152603|NCT01351350|468519862|FG003|Overall Study|Participant Decision|3|||
130152604|NCT01351350|468519863|FG004|Overall Study|Participant Decision|2|||
130152605|NCT01351350|468519859|FG000|Overall Study|Enrolled but not Treated|0|||
130152606|NCT01351350|468519860|FG001|Overall Study|Enrolled but not Treated|0|||
130152607|NCT01351350|468519861|FG002|Overall Study|Enrolled but not Treated|1|||
130152608|NCT01351350|468519862|FG003|Overall Study|Enrolled but not Treated|0|||
130152609|NCT01351350|468519863|FG004|Overall Study|Enrolled but not Treated|0|||
130152610|NCT04647383|468519868|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
130152611|NCT04647383|468519869|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
130152612|NCT04647383|468519870|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
130152613|NCT04647383|468519871|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
130152614|NCT01258101|468519872|FG000|Overall Study|Adverse Event|5|||
130152615|NCT01258101|468519873|FG001|Overall Study|Adverse Event|6|||
130152616|NCT01258101|468519874|FG002|Overall Study|Adverse Event|0|||
130152617|NCT01258101|468519875|FG003|Overall Study|Adverse Event|0|||
130152618|NCT01258101|468519872|FG000|Overall Study|Extra exclusion criterion amended|2|||
130152619|NCT01258101|468519873|FG001|Overall Study|Extra exclusion criterion amended|1|||
130152620|NCT01258101|468519874|FG002|Overall Study|Extra exclusion criterion amended|1|||
130152621|NCT01258101|468519875|FG003|Overall Study|Extra exclusion criterion amended|1|||
130152622|NCT01258101|468519872|FG000|Overall Study|Informed consent has been withdrawn|2|||
130152623|NCT01258101|468519873|FG001|Overall Study|Informed consent has been withdrawn|2|||
130152624|NCT01258101|468519874|FG002|Overall Study|Informed consent has been withdrawn|1|||
130152625|NCT01258101|468519875|FG003|Overall Study|Informed consent has been withdrawn|1|||
130152626|NCT01258101|468519872|FG000|Overall Study|Patient is not able to attend visits|8|||
130152627|NCT01258101|468519873|FG001|Overall Study|Patient is not able to attend visits|9|||
130152628|NCT01258101|468519874|FG002|Overall Study|Patient is not able to attend visits|7|||
130152629|NCT01258101|468519875|FG003|Overall Study|Patient is not able to attend visits|6|||
130152630|NCT01258101|468519872|FG000|Overall Study|Patient´s compliance|4|||
130152631|NCT01258101|468519873|FG001|Overall Study|Patient´s compliance|3|||
130152632|NCT01258101|468519874|FG002|Overall Study|Patient´s compliance|1|||
130152633|NCT01258101|468519875|FG003|Overall Study|Patient´s compliance|2|||
130152634|NCT01258101|468519872|FG000|Overall Study|Lost to Follow-up|5|||
130152635|NCT01258101|468519873|FG001|Overall Study|Lost to Follow-up|5|||
130152636|NCT01258101|468519874|FG002|Overall Study|Lost to Follow-up|0|||
130152637|NCT01258101|468519875|FG003|Overall Study|Lost to Follow-up|6|||
130152638|NCT01258101|468519872|FG000|Overall Study|PCR positive at week 24|0|||
130152639|NCT01258101|468519873|FG001|Overall Study|PCR positive at week 24|0|||
130152640|NCT01258101|468519874|FG002|Overall Study|PCR positive at week 24|0|||
130152641|NCT01258101|468519875|FG003|Overall Study|PCR positive at week 24|1|||
130152642|NCT01258101|468519872|FG000|Overall Study|Other reason|7|||
130152643|NCT01258101|468519873|FG001|Overall Study|Other reason|8|||
130152644|NCT01258101|468519874|FG002|Overall Study|Other reason|1|||
130152645|NCT01258101|468519875|FG003|Overall Study|Other reason|8|||
130152646|NCT00303667|468519876|FG000|Overall Study|Death|0|||
130152647|NCT00303667|468519877|FG001|Overall Study|Death|4|||
130152648|NCT01807117|468519879|FG000|Overall Study|Physician Decision|2|||
130152649|NCT01807117|468519879|FG000|Overall Study|Disease diagnosis not a study disease|1|||
130152650|NCT01298778|468519880|FG000|Overall Study|Lost to Follow-up|2|||
130152651|NCT01298778|468519881|FG001|Overall Study|Lost to Follow-up|3|||
130152652|NCT01298778|468519880|FG000|Overall Study|Incorrect use of VAS|1|||
130152653|NCT01298778|468519881|FG001|Overall Study|Incorrect use of VAS|0|||
130152654|NCT01298778|468519880|FG000|Overall Study|Withdrawal by Subject|0|||
130152655|NCT01298778|468519881|FG001|Overall Study|Withdrawal by Subject|1|||
130152656|NCT01298778|468519880|FG000|Overall Study|Protocol Violation|0|||
130152657|NCT01298778|468519881|FG001|Overall Study|Protocol Violation|1|||
130152658|NCT01298778|468519880|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
130152659|NCT01298778|468519881|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
130152660|NCT00706355|468519885|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
130152661|NCT00706355|468519886|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130152662|NCT00706355|468519887|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130152663|NCT00706355|468519888|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
130152664|NCT00706355|468519885|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
130152665|NCT00706355|468519886|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130152666|NCT00706355|468519887|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130152667|NCT00706355|468519888|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
130152668|NCT00706355|468519885|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130152669|NCT00706355|468519886|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
130152670|NCT00706355|468519887|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130152671|NCT00706355|468519888|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
130152672|NCT00706355|468519885|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130152673|NCT00706355|468519886|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
130152674|NCT00706355|468519887|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130152675|NCT00706355|468519888|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
130152676|NCT00706355|468519885|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130152677|NCT00706355|468519886|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
130152678|NCT00706355|468519887|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130152679|NCT00706355|468519888|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
130152680|NCT00706355|468519885|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130152681|NCT00706355|468519886|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130152682|NCT00706355|468519887|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
130152683|NCT00706355|468519888|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
130152684|NCT00706355|468519885|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130152685|NCT00706355|468519886|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130152686|NCT00706355|468519887|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
130152687|NCT00706355|468519888|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
130152688|NCT00706355|468519885|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130152689|NCT00706355|468519886|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130152690|NCT00706355|468519887|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
130152691|NCT00706355|468519888|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
130152692|NCT00706355|468519885|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130152693|NCT00706355|468519886|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130152694|NCT00706355|468519887|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
130152695|NCT00706355|468519888|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
130152696|NCT04179019|468519889|FG000|Overall Study|Lost to Follow-up|2|||
130152697|NCT04179019|468519889|FG000|Overall Study|Physician Decision|2|||
130152698|NCT04179019|468519889|FG000|Overall Study|Withdrawal by Subject|5|||
130152699|NCT04179019|468519889|FG000|Overall Study|Adverse Event|4|||
130152700|NCT02139124|468519892|FG000|Overall Study|Adverse Event|2|||
130152701|NCT02139124|468519893|FG001|Overall Study|Adverse Event|0|||
130152702|NCT02139124|468519894|FG002|Overall Study|Adverse Event|1|||
130152703|NCT02139124|468519895|FG003|Overall Study|Adverse Event|2|||
130152704|NCT02139124|468519896|FG004|Overall Study|Adverse Event|5|||
130152705|NCT02139124|468519892|FG000|Overall Study|Withdrawal by Subject|2|||
130152706|NCT02139124|468519893|FG001|Overall Study|Withdrawal by Subject|2|||
130152707|NCT02139124|468519894|FG002|Overall Study|Withdrawal by Subject|2|||
130152708|NCT02139124|468519895|FG003|Overall Study|Withdrawal by Subject|2|||
130152709|NCT02139124|468519896|FG004|Overall Study|Withdrawal by Subject|3|||
130152710|NCT02139124|468519892|FG000|Overall Study|Protocol Violation|0|||
130152711|NCT02139124|468519893|FG001|Overall Study|Protocol Violation|0|||
130152712|NCT02139124|468519894|FG002|Overall Study|Protocol Violation|0|||
130152713|NCT02139124|468519895|FG003|Overall Study|Protocol Violation|1|||
130152714|NCT02139124|468519896|FG004|Overall Study|Protocol Violation|1|||
130152715|NCT02139124|468519892|FG000|Overall Study|non-compliant|1|||
130152716|NCT02139124|468519893|FG001|Overall Study|non-compliant|0|||
130152717|NCT02139124|468519894|FG002|Overall Study|non-compliant|0|||
130152718|NCT02139124|468519895|FG003|Overall Study|non-compliant|2|||
130152719|NCT02139124|468519896|FG004|Overall Study|non-compliant|0|||
130152720|NCT02139124|468519892|FG000|Overall Study|incarceration|0|||
130152721|NCT02139124|468519893|FG001|Overall Study|incarceration|0|||
130152722|NCT02139124|468519894|FG002|Overall Study|incarceration|1|||
130152723|NCT02139124|468519895|FG003|Overall Study|incarceration|0|||
130152724|NCT02139124|468519896|FG004|Overall Study|incarceration|0|||
130152725|NCT02139124|468519892|FG000|Overall Study|subject moved|1|||
130152726|NCT02139124|468519893|FG001|Overall Study|subject moved|0|||
130152727|NCT02139124|468519894|FG002|Overall Study|subject moved|0|||
130152728|NCT02139124|468519895|FG003|Overall Study|subject moved|0|||
130152729|NCT02139124|468519896|FG004|Overall Study|subject moved|0|||
130152730|NCT02139124|468519892|FG000|Overall Study|Lost to Follow-up|3|||
130152731|NCT02139124|468519893|FG001|Overall Study|Lost to Follow-up|2|||
130152732|NCT02139124|468519894|FG002|Overall Study|Lost to Follow-up|0|||
130152733|NCT02139124|468519895|FG003|Overall Study|Lost to Follow-up|5|||
130152734|NCT02139124|468519896|FG004|Overall Study|Lost to Follow-up|4|||
130152735|NCT03465436|468519897|FG000|Period 1|Protocol Violation|0|||
130152736|NCT03465436|468519898|FG001|Period 1|Protocol Violation|0|||
130152737|NCT03465436|468519899|FG002|Period 1|Protocol Violation|1|||
130152738|NCT03465436|468519900|FG003|Period 1|Protocol Violation|0|||
130152739|NCT03465436|468519897|FG000|Period 2|Protocol Violation|0|||
130152740|NCT03465436|468519898|FG001|Period 2|Protocol Violation|1|||
130152741|NCT03465436|468519899|FG002|Period 2|Protocol Violation|0|||
130152742|NCT03465436|468519900|FG003|Period 2|Protocol Violation|0|||
130152743|NCT03465436|468519897|FG000|Period 3|Protocol Violation|1|||
130152744|NCT03465436|468519898|FG001|Period 3|Protocol Violation|1|||
130152745|NCT03465436|468519899|FG002|Period 3|Protocol Violation|0|||
130152746|NCT03465436|468519900|FG003|Period 3|Protocol Violation|0|||
130152747|NCT03465436|468519897|FG000|Period 4|Protocol Violation|0|||
130152748|NCT03465436|468519898|FG001|Period 4|Protocol Violation|0|||
130152749|NCT03465436|468519899|FG002|Period 4|Protocol Violation|1|||
130152750|NCT03465436|468519900|FG003|Period 4|Protocol Violation|0|||
130152751|NCT00842530|468519901|FG000|Overall Study|Serious adverse event|0|||
130152752|NCT00842530|468519902|FG001|Overall Study|Serious adverse event|6|||
130152753|NCT00842530|468519901|FG000|Overall Study|Other adverse event|6|||
130152754|NCT00842530|468519902|FG001|Overall Study|Other adverse event|1|||
130152755|NCT00842530|468519901|FG000|Overall Study|Protocol Violation|32|||
130152756|NCT00842530|468519902|FG001|Overall Study|Protocol Violation|14|||
130152757|NCT00842530|468519901|FG000|Overall Study|Lost to Follow-up|6|||
130152758|NCT00842530|468519902|FG001|Overall Study|Lost to Follow-up|8|||
130152759|NCT00842530|468519901|FG000|Overall Study|Withdrawal by Subject|73|||
130152760|NCT00842530|468519902|FG001|Overall Study|Withdrawal by Subject|28|||
130152761|NCT02243293|468519903|FG000|Overall Study|Adverse Event|1|||
130152762|NCT02243293|468519904|FG001|Overall Study|Adverse Event|0|||
130152763|NCT02243293|468519905|FG002|Overall Study|Adverse Event|0|||
130152764|NCT02243293|468519906|FG003|Overall Study|Adverse Event|0|||
130152765|NCT02243293|468519907|FG004|Overall Study|Adverse Event|0|||
130152766|NCT02243293|468519908|FG005|Overall Study|Adverse Event|0|||
130152767|NCT02243293|468519909|FG006|Overall Study|Adverse Event|0|||
130152768|NCT02243293|468519910|FG007|Overall Study|Adverse Event|0|||
130152769|NCT02243293|468519911|FG008|Overall Study|Adverse Event|0|||
130152770|NCT02243293|468519912|FG009|Overall Study|Adverse Event|0|||
130152771|NCT02243293|468519913|FG010|Overall Study|Adverse Event|0|||
130152772|NCT02243293|468519914|FG011|Overall Study|Adverse Event|0|||
130152773|NCT02243293|468519915|FG012|Overall Study|Adverse Event|0|||
130152774|NCT02243293|468519916|FG013|Overall Study|Adverse Event|0|||
130152775|NCT02243293|468519917|FG014|Overall Study|Adverse Event|0|||
130152776|NCT02243293|468519918|FG015|Overall Study|Adverse Event|1|||
130152777|NCT02243293|468519919|FG016|Overall Study|Adverse Event|0|||
130152778|NCT02243293|468519920|FG017|Overall Study|Adverse Event|0|||
130152779|NCT02243293|468519921|FG018|Overall Study|Adverse Event|0|||
130152780|NCT02243293|468519922|FG019|Overall Study|Adverse Event|0|||
130152781|NCT02243293|468519923|FG020|Overall Study|Adverse Event|1|||
130152782|NCT02243293|468519924|FG021|Overall Study|Adverse Event|0|||
130152783|NCT02243293|468519903|FG000|Overall Study|Withdrawal by Subject|1|||
130152784|NCT02243293|468519904|FG001|Overall Study|Withdrawal by Subject|0|||
130152785|NCT02243293|468519905|FG002|Overall Study|Withdrawal by Subject|0|||
130152786|NCT02243293|468519906|FG003|Overall Study|Withdrawal by Subject|0|||
130152787|NCT02243293|468519907|FG004|Overall Study|Withdrawal by Subject|0|||
130152788|NCT02243293|468519908|FG005|Overall Study|Withdrawal by Subject|0|||
130152789|NCT02243293|468519909|FG006|Overall Study|Withdrawal by Subject|0|||
130152790|NCT02243293|468519910|FG007|Overall Study|Withdrawal by Subject|0|||
130152791|NCT02243293|468519911|FG008|Overall Study|Withdrawal by Subject|0|||
130152792|NCT02243293|468519912|FG009|Overall Study|Withdrawal by Subject|1|||
130152793|NCT02243293|468519913|FG010|Overall Study|Withdrawal by Subject|0|||
130152794|NCT02243293|468519914|FG011|Overall Study|Withdrawal by Subject|1|||
130152795|NCT02243293|468519915|FG012|Overall Study|Withdrawal by Subject|0|||
130152796|NCT02243293|468519916|FG013|Overall Study|Withdrawal by Subject|0|||
130152797|NCT02243293|468519917|FG014|Overall Study|Withdrawal by Subject|0|||
130152798|NCT02243293|468519918|FG015|Overall Study|Withdrawal by Subject|0|||
130152799|NCT02243293|468519919|FG016|Overall Study|Withdrawal by Subject|0|||
130152800|NCT02243293|468519920|FG017|Overall Study|Withdrawal by Subject|0|||
130152801|NCT02243293|468519921|FG018|Overall Study|Withdrawal by Subject|0|||
130152802|NCT02243293|468519922|FG019|Overall Study|Withdrawal by Subject|0|||
130152803|NCT02243293|468519923|FG020|Overall Study|Withdrawal by Subject|0|||
130152804|NCT02243293|468519924|FG021|Overall Study|Withdrawal by Subject|1|||
130152805|NCT02243293|468519903|FG000|Overall Study|Lost to Follow-up|0|||
130152806|NCT02243293|468519904|FG001|Overall Study|Lost to Follow-up|1|||
130152807|NCT02243293|468519905|FG002|Overall Study|Lost to Follow-up|1|||
130152808|NCT02243293|468519906|FG003|Overall Study|Lost to Follow-up|1|||
130152809|NCT02243293|468519907|FG004|Overall Study|Lost to Follow-up|0|||
130152810|NCT02243293|468519908|FG005|Overall Study|Lost to Follow-up|0|||
130152811|NCT02243293|468519909|FG006|Overall Study|Lost to Follow-up|3|||
130152812|NCT02243293|468519910|FG007|Overall Study|Lost to Follow-up|0|||
130152813|NCT02243293|468519911|FG008|Overall Study|Lost to Follow-up|0|||
130152814|NCT02243293|468519912|FG009|Overall Study|Lost to Follow-up|0|||
130152815|NCT02243293|468519913|FG010|Overall Study|Lost to Follow-up|0|||
130152816|NCT02243293|468519914|FG011|Overall Study|Lost to Follow-up|2|||
130152817|NCT02243293|468519915|FG012|Overall Study|Lost to Follow-up|0|||
130152818|NCT02243293|468519916|FG013|Overall Study|Lost to Follow-up|0|||
130152819|NCT02243293|468519917|FG014|Overall Study|Lost to Follow-up|0|||
130152820|NCT02243293|468519918|FG015|Overall Study|Lost to Follow-up|0|||
130152821|NCT02243293|468519919|FG016|Overall Study|Lost to Follow-up|3|||
130152822|NCT02243293|468519920|FG017|Overall Study|Lost to Follow-up|1|||
129979566|NCT03248882|467889389|FG003|Overall Study|Protocol Violation|0|||
129979567|NCT03248882|467889390|FG004|Overall Study|Protocol Violation|1|||
130152823|NCT02243293|468519921|FG018|Overall Study|Lost to Follow-up|0|||
130152824|NCT02243293|468519922|FG019|Overall Study|Lost to Follow-up|0|||
130152825|NCT02243293|468519923|FG020|Overall Study|Lost to Follow-up|1|||
130152826|NCT02243293|468519924|FG021|Overall Study|Lost to Follow-up|2|||
130152827|NCT02243293|468519903|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
130152828|NCT02243293|468519904|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
130152829|NCT02243293|468519905|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
130152830|NCT02243293|468519906|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
130152831|NCT02243293|468519907|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
130152832|NCT02243293|468519908|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
130152833|NCT02243293|468519909|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
130152834|NCT02243293|468519910|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
130152835|NCT02243293|468519911|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
130152836|NCT02243293|468519912|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
130152837|NCT02243293|468519913|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
130152838|NCT02243293|468519914|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
130152839|NCT02243293|468519915|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
130152840|NCT02243293|468519916|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
130152841|NCT02243293|468519917|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
130152842|NCT02243293|468519918|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
130152843|NCT02243293|468519919|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
130152844|NCT02243293|468519920|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
130152845|NCT02243293|468519921|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
130152846|NCT02243293|468519922|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
130152847|NCT02243293|468519923|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
130152848|NCT02243293|468519924|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
130152849|NCT02243293|468519903|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
130152850|NCT02243293|468519904|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
130152851|NCT02243293|468519905|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
130152852|NCT02243293|468519906|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
130152853|NCT02243293|468519907|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
130152854|NCT02243293|468519908|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
130152855|NCT02243293|468519909|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
130152856|NCT02243293|468519910|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
130152857|NCT02243293|468519911|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
130152858|NCT02243293|468519912|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
130152859|NCT02243293|468519913|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
130152860|NCT02243293|468519914|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
130152861|NCT02243293|468519915|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
130152862|NCT02243293|468519916|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
130152863|NCT02243293|468519917|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
130152864|NCT02243293|468519918|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
130152865|NCT02243293|468519919|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
130152866|NCT02243293|468519920|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
130152867|NCT02243293|468519921|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
130152868|NCT02243293|468519922|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
130152869|NCT02243293|468519923|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
130152870|NCT02243293|468519924|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
130152871|NCT02985879|468519925|FG000|Overall Study|Adverse Event|7|||
130152872|NCT02985879|468519926|FG001|Overall Study|Adverse Event|9|||
130152873|NCT02985879|468519927|FG002|Overall Study|Adverse Event|7|||
130152874|NCT02985879|468519925|FG000|Overall Study|Withdrew consent|6|||
130152875|NCT02985879|468519926|FG001|Overall Study|Withdrew consent|8|||
130152876|NCT02985879|468519927|FG002|Overall Study|Withdrew consent|10|||
130152877|NCT02985879|468519925|FG000|Overall Study|Lost to Follow-up|1|||
130152878|NCT02985879|468519926|FG001|Overall Study|Lost to Follow-up|0|||
130152879|NCT02985879|468519927|FG002|Overall Study|Lost to Follow-up|2|||
130152880|NCT02985879|468519925|FG000|Overall Study|Other, not specified|62|||
130152881|NCT02985879|468519926|FG001|Overall Study|Other, not specified|58|||
130152882|NCT02985879|468519927|FG002|Overall Study|Other, not specified|58|||
130154904|NCT01470612|468526638|FG000|Overall Study|Withdrawal by Subject|24|||
130154905|NCT01470612|468526639|FG001|Overall Study|Withdrawal by Subject|79|||
130154906|NCT01470612|468526638|FG000|Overall Study|Other|14|||
130154907|NCT01470612|468526639|FG001|Overall Study|Other|156|||
130154908|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
130154909|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
130154910|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
130154911|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
130154912|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
130154913|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
130154914|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
130154915|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
130154916|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
130154917|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
130154918|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
130154919|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
130154920|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
130154921|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
130154922|NCT02510014|468526643|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
130152883|NCT01475253|468521888|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
130152884|NCT01475253|468521889|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
130152885|NCT01475253|468521890|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
130152886|NCT01475253|468521891|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
130152887|NCT01475253|468521888|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
130152888|NCT01475253|468521889|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
130152889|NCT01475253|468521890|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
130152890|NCT01475253|468521891|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
130152891|NCT03135899|468521892|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152892|NCT03135899|468521893|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152893|NCT03135899|468521894|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152894|NCT03135899|468521895|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152895|NCT03135899|468521896|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152896|NCT03135899|468521897|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152897|NCT03135899|468521898|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
130152898|NCT03135899|468521899|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
130152899|NCT03135899|468521892|FG000|Overall Study|Withdrawal by Subject|0|||
130152900|NCT03135899|468521893|FG001|Overall Study|Withdrawal by Subject|0|||
130152901|NCT03135899|468521894|FG002|Overall Study|Withdrawal by Subject|0|||
130152902|NCT03135899|468521895|FG003|Overall Study|Withdrawal by Subject|0|||
130152903|NCT03135899|468521896|FG004|Overall Study|Withdrawal by Subject|0|||
130152904|NCT03135899|468521897|FG005|Overall Study|Withdrawal by Subject|2|||
130152905|NCT03135899|468521898|FG006|Overall Study|Withdrawal by Subject|0|||
130152906|NCT03135899|468521899|FG007|Overall Study|Withdrawal by Subject|0|||
130152907|NCT00918463|468521900|FG000|Overall Study|Death|1|||
130152908|NCT00918463|468521900|FG000|Overall Study|Lack of Efficacy|1|||
130152909|NCT01014624|468521905|FG000|Overall Study|Adverse Event|0|||
130152910|NCT01014624|468521906|FG001|Overall Study|Adverse Event|1|||
130152911|NCT01014624|468521905|FG000|Overall Study|Protocol Violation|1|||
130152912|NCT01014624|468521906|FG001|Overall Study|Protocol Violation|0|||
130152913|NCT01014624|468521905|FG000|Overall Study|Withdrawal by Subject|1|||
130152914|NCT01014624|468521906|FG001|Overall Study|Withdrawal by Subject|0|||
130152915|NCT02954159|468521907|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
130152916|NCT02954159|468521908|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
130152917|NCT02954159|468521907|FG000|Overall Study|Withdrawal by Subject|0|||
130152918|NCT02954159|468521908|FG001|Overall Study|Withdrawal by Subject|1|||
130152919|NCT01117337|468521910|FG000|Overall Study|Lost to Follow-up|4|||
130152920|NCT01117337|468521911|FG001|Overall Study|Lost to Follow-up|0|||
130152921|NCT03575871|468521912|FG000|Overall Study|Adverse Event|5|||
130152922|NCT03575871|468521913|FG001|Overall Study|Adverse Event|5|||
130152923|NCT03575871|468521914|FG002|Overall Study|Adverse Event|8|||
130152924|NCT03575871|468521912|FG000|Overall Study|Death|1|||
130152925|NCT03575871|468521913|FG001|Overall Study|Death|0|||
130152926|NCT03575871|468521914|FG002|Overall Study|Death|0|||
130152927|NCT03575871|468521912|FG000|Overall Study|Lack of Efficacy|5|||
130152928|NCT03575871|468521913|FG001|Overall Study|Lack of Efficacy|4|||
130152929|NCT03575871|468521914|FG002|Overall Study|Lack of Efficacy|7|||
130152930|NCT03575871|468521912|FG000|Overall Study|Lost to Follow-up|1|||
130152931|NCT03575871|468521913|FG001|Overall Study|Lost to Follow-up|1|||
130152932|NCT03575871|468521914|FG002|Overall Study|Lost to Follow-up|1|||
130152933|NCT03575871|468521912|FG000|Overall Study|Protocol Deviation|1|||
130152934|NCT03575871|468521913|FG001|Overall Study|Protocol Deviation|1|||
130152935|NCT03575871|468521914|FG002|Overall Study|Protocol Deviation|1|||
130152936|NCT03575871|468521912|FG000|Overall Study|Withdrawal by Subject|6|||
130152937|NCT03575871|468521913|FG001|Overall Study|Withdrawal by Subject|1|||
130152938|NCT03575871|468521914|FG002|Overall Study|Withdrawal by Subject|9|||
130152939|NCT03575871|468521912|FG000|Overall Study|Other than specified|2|||
130152940|NCT03575871|468521913|FG001|Overall Study|Other than specified|2|||
130152941|NCT03575871|468521914|FG002|Overall Study|Other than specified|0|||
130152942|NCT01659736|468521915|FG000|Treatment Period|Adverse Event|1|||
130152943|NCT01659736|468521916|FG001|Treatment Period|Adverse Event|1|||
130152944|NCT01659736|468521915|FG000|Treatment Period|Protocol Violation|3|||
130152945|NCT01659736|468521916|FG001|Treatment Period|Protocol Violation|1|||
130152946|NCT01659736|468521915|FG000|Treatment Period|Withdrawal by Subject|1|||
130152947|NCT01659736|468521916|FG001|Treatment Period|Withdrawal by Subject|0|||
130152948|NCT01659736|468521915|FG000|3-month Follow-up|Lost to Follow-up|0|||
130152949|NCT01659736|468521916|FG001|3-month Follow-up|Lost to Follow-up|1|||
130152950|NCT01744093|468521924|FG000|Overall Study|Withdrawal by Subject|6|||
130152951|NCT01744093|468521925|FG001|Overall Study|Withdrawal by Subject|1|||
130152952|NCT01570283|468521926|FG000|Cohort 1: Dose Level 1|Death|0|||
130152953|NCT01570283|468521927|FG001|Cohort 1: Dose Level 1|Death|1|||
130152954|NCT01570283|468521928|FG002|Cohort 1: Dose Level 1|Death|0|||
130152955|NCT01570283|468521929|FG003|Cohort 1: Dose Level 1|Death|0|||
130152956|NCT01570283|468521930|FG004|Cohort 1: Dose Level 1|Death|0|||
130152957|NCT01570283|468521931|FG005|Cohort 1: Dose Level 1|Death|0|||
130152958|NCT01570283|468521926|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130152959|NCT01570283|468521927|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
130152960|NCT01570283|468521928|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130152961|NCT01570283|468521929|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130152962|NCT01570283|468521930|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130152963|NCT01570283|468521931|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
130152964|NCT01570283|468521926|FG000|Cohort 2: Dose Level 2|Death|0|||
130152965|NCT01570283|468521927|FG001|Cohort 2: Dose Level 2|Death|0|||
130152966|NCT01570283|468521928|FG002|Cohort 2: Dose Level 2|Death|1|||
130152967|NCT01570283|468521929|FG003|Cohort 2: Dose Level 2|Death|0|||
130152968|NCT01570283|468521930|FG004|Cohort 2: Dose Level 2|Death|0|||
130152969|NCT01570283|468521931|FG005|Cohort 2: Dose Level 2|Death|0|||
130152970|NCT01570283|468521926|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130152971|NCT01570283|468521927|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130152972|NCT01570283|468521928|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130152973|NCT01570283|468521929|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
130152974|NCT01570283|468521930|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130152975|NCT01570283|468521931|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
130152976|NCT01570283|468521926|FG000|Cohort 3: Dose Level 3|Death|0|||
130152977|NCT01570283|468521927|FG001|Cohort 3: Dose Level 3|Death|0|||
130152978|NCT01570283|468521928|FG002|Cohort 3: Dose Level 3|Death|0|||
130152979|NCT01570283|468521929|FG003|Cohort 3: Dose Level 3|Death|0|||
130152980|NCT01570283|468521930|FG004|Cohort 3: Dose Level 3|Death|0|||
130152981|NCT01570283|468521931|FG005|Cohort 3: Dose Level 3|Death|1|||
130152982|NCT01570283|468521926|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130152983|NCT01570283|468521927|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130152984|NCT01570283|468521928|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130152985|NCT01570283|468521929|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130152986|NCT01570283|468521930|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
130152987|NCT01570283|468521931|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
130152988|NCT01173471|468521934|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130152989|NCT01173471|468521935|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130152990|NCT01173471|468521936|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130152991|NCT01173471|468521937|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
130152992|NCT01173471|468521934|FG000|Overall Study|Condition under investigation worsened|2|||
130152993|NCT01173471|468521935|FG001|Overall Study|Condition under investigation worsened|0|||
130152994|NCT01173471|468521936|FG002|Overall Study|Condition under investigation worsened|0|||
130152995|NCT01173471|468521937|FG003|Overall Study|Condition under investigation worsened|0|||
130152996|NCT01173471|468521934|FG000|Overall Study|Lost to Follow-up|0|||
130152997|NCT01173471|468521935|FG001|Overall Study|Lost to Follow-up|0|||
130152998|NCT01173471|468521936|FG002|Overall Study|Lost to Follow-up|1|||
130152999|NCT01173471|468521937|FG003|Overall Study|Lost to Follow-up|0|||
130153000|NCT01173471|468521934|FG000|Overall Study|Reason given as Other|0|||
130153001|NCT01173471|468521935|FG001|Overall Study|Reason given as Other|0|||
130153002|NCT01173471|468521936|FG002|Overall Study|Reason given as Other|1|||
130153003|NCT01173471|468521937|FG003|Overall Study|Reason given as Other|0|||
130153004|NCT03028740|468521938|FG000|Overall Study|Did not Receive Study Drug|4|||
130153005|NCT03028740|468521939|FG001|Overall Study|Did not Receive Study Drug|5|||
130153006|NCT03028740|468521938|FG000|Overall Study|Adverse Event|8|||
130153007|NCT03028740|468521939|FG001|Overall Study|Adverse Event|26|||
130153008|NCT03028740|468521938|FG000|Overall Study|Lack of Efficacy|0|||
130153009|NCT03028740|468521939|FG001|Overall Study|Lack of Efficacy|1|||
130153010|NCT03028740|468521938|FG000|Overall Study|Withdrawal by Subject|48|||
130153011|NCT03028740|468521939|FG001|Overall Study|Withdrawal by Subject|101|||
130153012|NCT03028740|468521938|FG000|Overall Study|Lost to Follow-up|30|||
130153013|NCT03028740|468521939|FG001|Overall Study|Lost to Follow-up|54|||
130153014|NCT03028740|468521938|FG000|Overall Study|Physician Decision|4|||
130153015|NCT03028740|468521939|FG001|Overall Study|Physician Decision|11|||
130153016|NCT03028740|468521938|FG000|Overall Study|Protocol Violation|4|||
130153017|NCT03028740|468521939|FG001|Overall Study|Protocol Violation|8|||
130153018|NCT03028740|468521938|FG000|Overall Study|Non-compliance with Study Drug|0|||
130153019|NCT03028740|468521939|FG001|Overall Study|Non-compliance with Study Drug|2|||
130153020|NCT03028740|468521938|FG000|Overall Study|Study Terminated by Sponsor|467|||
129979568|NCT03248882|467889386|FG000|Overall Study|Withdrawal by Subject|2|||
130153021|NCT03028740|468521939|FG001|Overall Study|Study Terminated by Sponsor|917|||
130153022|NCT03028740|468521938|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
130153023|NCT03028740|468521939|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
130153024|NCT03028740|468521938|FG000|Overall Study|Reason not Specified|1|||
130153025|NCT03028740|468521939|FG001|Overall Study|Reason not Specified|5|||
130153026|NCT00685802|468521945|FG000|Washout Period of 7 Days|Protocol Violation|2|||
130153027|NCT00685802|468521946|FG001|Washout Period of 7 Days|Protocol Violation|0|||
130153028|NCT00685802|468521945|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
130153029|NCT00685802|468521946|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129979569|NCT03248882|467889387|FG001|Overall Study|Withdrawal by Subject|2|||
130153030|NCT03336242|468521950|FG000|Overall Study|Adverse Event|0|||
130153031|NCT03336242|468521951|FG001|Overall Study|Adverse Event|1|||
130153032|NCT02224573|468521954|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
130153033|NCT02224573|468521955|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
130153034|NCT02224573|468521954|FG000|Treatment Phase|Started on Other IMP|1|||
130153035|NCT02224573|468521955|FG001|Treatment Phase|Started on Other IMP|0|||
130153036|NCT02224573|468521954|FG000|Treatment Phase|Participant Discontinued IMP|0|||
130153037|NCT02224573|468521955|FG001|Treatment Phase|Participant Discontinued IMP|1|||
130153038|NCT02224573|468521954|FG000|Treatment Phase|Lack of Efficacy|15|||
130153039|NCT02224573|468521955|FG001|Treatment Phase|Lack of Efficacy|8|||
130153040|NCT02224573|468521954|FG000|Treatment Phase|Began Commercial Product|1|||
130153041|NCT02224573|468521955|FG001|Treatment Phase|Began Commercial Product|0|||
130153042|NCT02224573|468521954|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
130153043|NCT02224573|468521955|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
130153044|NCT02224573|468521954|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
130153045|NCT02224573|468521955|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
130153046|NCT02224573|468521954|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
130153047|NCT02224573|468521955|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
130153048|NCT02224573|468521954|FG000|Treatment Phase|Continued Compassionate Use|1|||
130153049|NCT02224573|468521955|FG001|Treatment Phase|Continued Compassionate Use|0|||
130153050|NCT02224573|468521954|FG000|Treatment Phase|Lack of Efficiency|2|||
130153051|NCT02224573|468521955|FG001|Treatment Phase|Lack of Efficiency|1|||
130153052|NCT02224573|468521954|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
130153053|NCT02224573|468521955|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
130153054|NCT02224573|468521954|FG000|Treatment Phase|Participant Moved|2|||
130153055|NCT02224573|468521955|FG001|Treatment Phase|Participant Moved|0|||
130153056|NCT02224573|468521954|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
130153057|NCT02224573|468521955|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
130153058|NCT02224573|468521954|FG000|Treatment Phase|Refused Medication|1|||
130153059|NCT02224573|468521955|FG001|Treatment Phase|Refused Medication|1|||
130153060|NCT02224573|468521954|FG000|Treatment Phase|Adverse Event|26|||
130153061|NCT02224573|468521955|FG001|Treatment Phase|Adverse Event|38|||
130153062|NCT02224573|468521954|FG000|Treatment Phase|Placed in Group Home|0|||
130153063|NCT02224573|468521955|FG001|Treatment Phase|Placed in Group Home|1|||
130153064|NCT02224573|468521954|FG000|Treatment Phase|Pursued Other Trials|1|||
130153065|NCT02224573|468521955|FG001|Treatment Phase|Pursued Other Trials|0|||
130153066|NCT02224573|468521954|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
130153067|NCT02224573|468521955|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
130153068|NCT02224573|468521954|FG000|Treatment Phase|Lost to Follow-up|2|||
130153069|NCT02224573|468521955|FG001|Treatment Phase|Lost to Follow-up|1|||
130153070|NCT02224573|468521954|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
130153071|NCT02224573|468521955|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
130153072|NCT02224573|468521954|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
130153073|NCT02224573|468521955|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
130153074|NCT02224573|468521954|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
130153075|NCT02224573|468521955|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
130153076|NCT02224573|468521954|FG000|Taper Phase|Adverse Event|1|||
130153077|NCT02224573|468521955|FG001|Taper Phase|Adverse Event|1|||
130153078|NCT02546362|468521956|FG000|4-week Treatment Period|Lost to Follow-up|1|||
130153079|NCT02546362|468521956|FG000|4-week Treatment Period|Change in medication|2|||
130153080|NCT02546362|468521956|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
130153081|NCT02546362|468521956|FG000|12-week Treatment Period|Lost to Follow-up|2|||
130153082|NCT02546362|468521956|FG000|12-week Treatment Period|Change in medication|1|||
130153083|NCT05206448|468521957|FG000|Overall Study|Lost to Follow-up|2|||
130153084|NCT05206448|468521958|FG001|Overall Study|Lost to Follow-up|2|||
130153085|NCT05206448|468521957|FG000|Overall Study|Withdrawal by Subject|2|||
130153086|NCT05206448|468521958|FG001|Overall Study|Withdrawal by Subject|0|||
130153087|NCT05206448|468521957|FG000|Overall Study|found ineligible after randomization|1|||
130153088|NCT05206448|468521958|FG001|Overall Study|found ineligible after randomization|1|||
130153089|NCT05206448|468521957|FG000|Overall Study|unable to complete study due to personal constraints|1|||
130153090|NCT05206448|468521958|FG001|Overall Study|unable to complete study due to personal constraints|0|||
130153091|NCT05206448|468521957|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
130153092|NCT05206448|468521958|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
130153093|NCT02025010|468521959|FG000|Overall Study|Symptomatic or radiographic progression|36|||
130153094|NCT02025010|468521959|FG000|Overall Study|Adverse Event|6|||
130153095|NCT02025010|468521959|FG000|Overall Study|Physician Decision|7|||
130153096|NCT02025010|468521959|FG000|Overall Study|Withdrawal by Subject|3|||
130153097|NCT02025010|468521959|FG000|Overall Study|Intercurrent illness|3|||
130153098|NCT02025010|468521959|FG000|Overall Study|Patients still on treatment|3|||
130153099|NCT02025010|468521959|FG000|Overall Study|Never initiate the treatment|2|||
130153100|NCT01661881|468521961|FG000|Overall Study|Disease Progression|1|||
130153101|NCT00949988|468521966|FG000|Overall Study|Withdrawal by Subject|3|||
130153102|NCT00484419|468521973|FG000|Overall Study|Adverse Event|3|||
130153103|NCT00484419|468521974|FG001|Overall Study|Adverse Event|0|||
130153104|NCT00484419|468521975|FG002|Overall Study|Adverse Event|0|||
130153105|NCT00484419|468521973|FG000|Overall Study|Lost to Follow-up|1|||
130153106|NCT00484419|468521974|FG001|Overall Study|Lost to Follow-up|0|||
130153107|NCT00484419|468521975|FG002|Overall Study|Lost to Follow-up|2|||
130153108|NCT00484419|468521973|FG000|Overall Study|Withdrawal by Subject|3|||
130153109|NCT00484419|468521974|FG001|Overall Study|Withdrawal by Subject|1|||
130153110|NCT00484419|468521975|FG002|Overall Study|Withdrawal by Subject|1|||
130153111|NCT00484419|468521973|FG000|Overall Study|subject met discontinuation criteria|2|||
130153112|NCT00484419|468521974|FG001|Overall Study|subject met discontinuation criteria|2|||
130153113|NCT00484419|468521975|FG002|Overall Study|subject met discontinuation criteria|4|||
130153114|NCT00484419|468521973|FG000|Overall Study|required restricted medication|1|||
130153115|NCT00484419|468521974|FG001|Overall Study|required restricted medication|0|||
130153116|NCT00484419|468521975|FG002|Overall Study|required restricted medication|1|||
130153117|NCT00484419|468521973|FG000|Overall Study|Physician Decision|1|||
130153118|NCT00484419|468521974|FG001|Overall Study|Physician Decision|1|||
130153119|NCT00484419|468521975|FG002|Overall Study|Physician Decision|1|||
130153120|NCT00484419|468521973|FG000|Overall Study|subject unable to receive medication|1|||
130153121|NCT00484419|468521974|FG001|Overall Study|subject unable to receive medication|0|||
130153122|NCT00484419|468521975|FG002|Overall Study|subject unable to receive medication|0|||
130153123|NCT00484419|468521973|FG000|Overall Study|subject relocated|0|||
130153124|NCT00484419|468521974|FG001|Overall Study|subject relocated|1|||
130153125|NCT00484419|468521975|FG002|Overall Study|subject relocated|0|||
130153126|NCT00484419|468521973|FG000|Overall Study|sponsor decision, randomized in error|0|||
130153127|NCT00484419|468521974|FG001|Overall Study|sponsor decision, randomized in error|0|||
130153128|NCT00484419|468521975|FG002|Overall Study|sponsor decision, randomized in error|2|||
130153129|NCT00355472|468521978|FG000|Overall Study|Physician Decision|1|||
130153130|NCT03095118|468521979|FG000|Overall Study|Adverse Event|1|||
130153131|NCT03095118|468521979|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
130153132|NCT03847194|468521982|FG000|Overall Study|Lost to Follow-up|2|||
130153133|NCT03847194|468521983|FG001|Overall Study|Lost to Follow-up|5|||
130153134|NCT03847194|468521982|FG000|Overall Study|Withdrawal by Subject|1|||
130153135|NCT03847194|468521983|FG001|Overall Study|Withdrawal by Subject|2|||
130153136|NCT03847194|468521982|FG000|Overall Study|Death|0|||
130153137|NCT03847194|468521983|FG001|Overall Study|Death|1|||
130153138|NCT02408120|468521984|FG000|Overall Study|Withdrawal by Subject|0|||
130153139|NCT02408120|468521985|FG001|Overall Study|Withdrawal by Subject|1|||
130153140|NCT02408120|468521984|FG000|Overall Study|Treatment Refusal|1|||
130153141|NCT02408120|468521985|FG001|Overall Study|Treatment Refusal|0|||
130153142|NCT02408120|468521984|FG000|Overall Study|Received Steroids|1|||
130153143|NCT02408120|468521985|FG001|Overall Study|Received Steroids|1|||
130153144|NCT02408120|468521984|FG000|Overall Study|Discharged same day|1|||
130153145|NCT02408120|468521985|FG001|Overall Study|Discharged same day|1|||
130153146|NCT02408120|468521984|FG000|Overall Study|Did not receive insulin|1|||
130153147|NCT02408120|468521985|FG001|Overall Study|Did not receive insulin|2|||
130153148|NCT01144403|468521986|FG000|Overall Study|Lost to Follow-up|3|||
130153149|NCT01144403|468521986|FG000|Overall Study|Death|1|||
130153150|NCT01144403|468521986|FG000|Overall Study|Adverse Event|1|||
130153151|NCT00680186|468521991|FG000|Overall Study|Adverse Event|47|||
130153152|NCT00680186|468521992|FG001|Overall Study|Adverse Event|44|||
130153153|NCT00680186|468521991|FG000|Overall Study|Protocol Violation|31|||
130153154|NCT00680186|468521992|FG001|Overall Study|Protocol Violation|26|||
130153155|NCT00680186|468521991|FG000|Overall Study|Lost to Follow-up|11|||
130153156|NCT00680186|468521992|FG001|Overall Study|Lost to Follow-up|6|||
130153157|NCT00680186|468521991|FG000|Overall Study|Withdrawal by Subject|32|||
130153158|NCT00680186|468521992|FG001|Overall Study|Withdrawal by Subject|39|||
130153159|NCT00680186|468521991|FG000|Overall Study|Other|4|||
130153160|NCT00680186|468521992|FG001|Overall Study|Other|1|||
130153161|NCT00873119|468522000|FG000|Overall Study|Patient request|4|||
130153162|NCT00873119|468522001|FG001|Overall Study|Patient request|2|||
130153163|NCT00873119|468522000|FG000|Overall Study|Adverse Event|8|||
130153164|NCT00873119|468522001|FG001|Overall Study|Adverse Event|0|||
130153165|NCT00873119|468522000|FG000|Overall Study|Progressive disease|26|||
130153166|NCT00873119|468522001|FG001|Overall Study|Progressive disease|18|||
130153167|NCT00873119|468522000|FG000|Overall Study|Death|2|||
130153168|NCT00873119|468522001|FG001|Overall Study|Death|1|||
130153169|NCT00873119|468522000|FG000|Overall Study|Other|2|||
130153170|NCT00873119|468522001|FG001|Overall Study|Other|5|||
130153171|NCT00873119|468522000|FG000|Overall Study|Not treated|2|||
130153172|NCT00873119|468522001|FG001|Overall Study|Not treated|0|||
130153173|NCT00285584|468522002|FG000|Month 3|Lost to Follow-up|3|||
130153174|NCT00285584|468522003|FG001|Month 3|Lost to Follow-up|3|||
130153175|NCT00285584|468522002|FG000|Month 3|Withdrawal by Subject|1|||
130153176|NCT00285584|468522003|FG001|Month 3|Withdrawal by Subject|0|||
130153177|NCT00285584|468522002|FG000|Month 6|Lost to Follow-up|0|||
130153178|NCT00285584|468522003|FG001|Month 6|Lost to Follow-up|1|||
130153179|NCT00466726|468522004|FG000|Overall Study|Not evaluable for response|14|||
130153180|NCT04403763|468522005|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
130153181|NCT04403763|468522006|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
130153182|NCT04403763|468522007|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
130153183|NCT04403763|468522008|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
130153184|NCT04403763|468522009|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
130153185|NCT04403763|468522010|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
130153186|NCT04403763|468522011|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
130153187|NCT04403763|468522005|FG000|Stage 1|Early termination due to PK tube failure|0|||
130153188|NCT04403763|468522006|FG001|Stage 1|Early termination due to PK tube failure|0|||
130153189|NCT04403763|468522007|FG002|Stage 1|Early termination due to PK tube failure|1|||
130153190|NCT04403763|468522008|FG003|Stage 1|Early termination due to PK tube failure|0|||
130153191|NCT04403763|468522009|FG004|Stage 1|Early termination due to PK tube failure|0|||
130153192|NCT04403763|468522010|FG005|Stage 1|Early termination due to PK tube failure|0|||
130153193|NCT04403763|468522011|FG006|Stage 1|Early termination due to PK tube failure|0|||
130153194|NCT04403763|468522005|FG000|Stage 2A|Adverse Event|0|||
130153195|NCT04403763|468522006|FG001|Stage 2A|Adverse Event|0|||
130153196|NCT04403763|468522007|FG002|Stage 2A|Adverse Event|0|||
130153197|NCT04403763|468522008|FG003|Stage 2A|Adverse Event|0|||
130153198|NCT04403763|468522009|FG004|Stage 2A|Adverse Event|0|||
130153199|NCT04403763|468522010|FG005|Stage 2A|Adverse Event|0|||
130153200|NCT04403763|468522011|FG006|Stage 2A|Adverse Event|1|||
130153201|NCT01376310|468522012|FG000|Overall Study|Study closed/terminated|1|||
130153202|NCT01376310|468522013|FG001|Overall Study|Study closed/terminated|2|||
130153203|NCT01376310|468522012|FG000|Overall Study|Withdrawal by Subject|8|||
130153204|NCT01376310|468522013|FG001|Overall Study|Withdrawal by Subject|2|||
130153205|NCT01376310|468522012|FG000|Overall Study|Physician Decision|26|||
130153206|NCT01376310|468522013|FG001|Overall Study|Physician Decision|7|||
130153207|NCT01376310|468522012|FG000|Overall Study|Lost to Follow-up|1|||
130153208|NCT01376310|468522013|FG001|Overall Study|Lost to Follow-up|0|||
130153209|NCT02339740|468522016|FG000|Overall Study|Death|1|||
130153210|NCT02339740|468522017|FG001|Overall Study|Death|0|||
130153211|NCT02339740|468522016|FG000|Overall Study|Physician Decision|0|||
130153212|NCT02339740|468522017|FG001|Overall Study|Physician Decision|2|||
130153213|NCT02339740|468522016|FG000|Overall Study|Withdrawal by Subject|5|||
130153214|NCT02339740|468522017|FG001|Overall Study|Withdrawal by Subject|1|||
130153215|NCT02339740|468522016|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
130153216|NCT02339740|468522017|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
130153217|NCT00645944|468522018|FG000|Randomized|Withdrawal by Subject|1|||
130153218|NCT00645944|468522019|FG001|Randomized|Withdrawal by Subject|2|||
130153219|NCT00645944|468522018|FG000|Received Medication|Adverse Event|2|||
130153220|NCT00645944|468522019|FG001|Received Medication|Adverse Event|1|||
130153221|NCT00645944|468522018|FG000|Received Medication|Withdrawal by Subject|1|||
130153222|NCT00645944|468522019|FG001|Received Medication|Withdrawal by Subject|1|||
130153223|NCT00645944|468522018|FG000|Received Medication|Lost to Follow-up|1|||
130153224|NCT00645944|468522019|FG001|Received Medication|Lost to Follow-up|0|||
130153225|NCT00645944|468522018|FG000|Received Medication|Protocol Violation|2|||
130153226|NCT00645944|468522019|FG001|Received Medication|Protocol Violation|1|||
130153227|NCT02096588|468522020|FG000|Overall Study|Lack of Efficacy|2|||
130153228|NCT02096588|468522021|FG001|Overall Study|Lack of Efficacy|0|||
130153229|NCT02096588|468522020|FG000|Overall Study|Withdrawal by Subject|0|||
130153230|NCT02096588|468522021|FG001|Overall Study|Withdrawal by Subject|1|||
130153231|NCT02470091|468522022|FG000|Overall Study|Withdrawal by Subject|1|||
130153232|NCT02470091|468522023|FG001|Overall Study|Withdrawal by Subject|0|||
130153233|NCT02470091|468522022|FG000|Overall Study|Ineligible|0|||
130153234|NCT02470091|468522023|FG001|Overall Study|Ineligible|2|||
130153235|NCT01523587|468522025|FG000|Overall Study|Other than listed|5|||
130153236|NCT01523587|468522026|FG001|Overall Study|Other than listed|5|||
130153237|NCT01523587|468522025|FG000|Overall Study|Worsening of underlying cancer disease|19|||
130153238|NCT01523587|468522026|FG001|Overall Study|Worsening of underlying cancer disease|34|||
130153239|NCT01523587|468522025|FG000|Overall Study|Adverse Event|68|||
130153240|NCT01523587|468522026|FG001|Overall Study|Adverse Event|52|||
130153241|NCT01523587|468522025|FG000|Overall Study|Protocol Violation|5|||
130153242|NCT01523587|468522026|FG001|Overall Study|Protocol Violation|3|||
129979570|NCT03248882|467889388|FG002|Overall Study|Withdrawal by Subject|3|||
129979571|NCT03248882|467889389|FG003|Overall Study|Withdrawal by Subject|4|||
129979572|NCT03248882|467889390|FG004|Overall Study|Withdrawal by Subject|2|||
130153243|NCT01523587|468522025|FG000|Overall Study|Lost to Follow-up|2|||
130153244|NCT01523587|468522026|FG001|Overall Study|Lost to Follow-up|2|||
130153245|NCT01523587|468522025|FG000|Overall Study|Withdrawal by Subject|28|||
130153246|NCT01523587|468522026|FG001|Overall Study|Withdrawal by Subject|20|||
130153247|NCT01523587|468522025|FG000|Overall Study|Withdrew due to Progressive disease|265|||
130153248|NCT01523587|468522026|FG001|Overall Study|Withdrew due to Progressive disease|279|||
129979573|NCT01156376|467889393|FG000|Overall Study|Adverse Event|1|||
130153249|NCT01523587|468522025|FG000|Overall Study|Randomised but bot treated|6|||
130153250|NCT01523587|468522026|FG001|Overall Study|Randomised but bot treated|2|||
130153251|NCT01020799|468522042|FG000|Overall Study|Adverse Event|4|||
130153252|NCT01020799|468522043|FG001|Overall Study|Adverse Event|3|||
130153253|NCT01020799|468522044|FG002|Overall Study|Adverse Event|2|||
130153254|NCT01020799|468522042|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
130153255|NCT01020799|468522043|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
130153256|NCT01020799|468522044|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
130153257|NCT01020799|468522042|FG000|Overall Study|Protocol Violation|3|||
130153258|NCT01020799|468522043|FG001|Overall Study|Protocol Violation|2|||
130153259|NCT01020799|468522044|FG002|Overall Study|Protocol Violation|0|||
130153260|NCT01020799|468522042|FG000|Overall Study|Withdrawal by Subject|2|||
130153261|NCT01020799|468522043|FG001|Overall Study|Withdrawal by Subject|2|||
130153262|NCT01020799|468522044|FG002|Overall Study|Withdrawal by Subject|3|||
130153263|NCT01020799|468522042|FG000|Overall Study|Lost to Follow-up|6|||
130153264|NCT01020799|468522043|FG001|Overall Study|Lost to Follow-up|4|||
130153265|NCT01020799|468522044|FG002|Overall Study|Lost to Follow-up|2|||
130153266|NCT02610816|468522045|FG000|Phase 1|Withdrawal by Subject|2|||
130153267|NCT02610816|468522046|FG001|Phase 1|Withdrawal by Subject|6|||
130153268|NCT02610816|468522047|FG002|Phase 1|Withdrawal by Subject|0|||
130153269|NCT02610816|468522048|FG003|Phase 1|Withdrawal by Subject|0|||
130153270|NCT02610816|468522045|FG000|Phase 1|Lost to Follow-up|2|||
130153271|NCT02610816|468522046|FG001|Phase 1|Lost to Follow-up|1|||
130153272|NCT02610816|468522047|FG002|Phase 1|Lost to Follow-up|0|||
130153273|NCT02610816|468522048|FG003|Phase 1|Lost to Follow-up|0|||
130153274|NCT02610816|468522045|FG000|Phase 1|Physician Decision|0|||
130153275|NCT02610816|468522046|FG001|Phase 1|Physician Decision|1|||
130153276|NCT02610816|468522047|FG002|Phase 1|Physician Decision|0|||
130153277|NCT02610816|468522048|FG003|Phase 1|Physician Decision|0|||
130153278|NCT02610816|468522045|FG000|Phase 2|Withdrawal by Subject|0|||
130153279|NCT02610816|468522046|FG001|Phase 2|Withdrawal by Subject|0|||
130153280|NCT02610816|468522047|FG002|Phase 2|Withdrawal by Subject|9|||
130153281|NCT02610816|468522048|FG003|Phase 2|Withdrawal by Subject|3|||
130153282|NCT02610816|468522045|FG000|Phase 2|Lost to Follow-up|0|||
130153283|NCT02610816|468522046|FG001|Phase 2|Lost to Follow-up|0|||
130153284|NCT02610816|468522047|FG002|Phase 2|Lost to Follow-up|2|||
130153285|NCT02610816|468522048|FG003|Phase 2|Lost to Follow-up|0|||
130153286|NCT02610816|468522045|FG000|Phase 2|Physician Decision|0|||
130153287|NCT02610816|468522046|FG001|Phase 2|Physician Decision|0|||
130153288|NCT02610816|468522047|FG002|Phase 2|Physician Decision|0|||
130153289|NCT02610816|468522048|FG003|Phase 2|Physician Decision|2|||
130153290|NCT02610816|468522045|FG000|Phase 2|Pregnancy|0|||
130153291|NCT02610816|468522046|FG001|Phase 2|Pregnancy|0|||
130153292|NCT02610816|468522047|FG002|Phase 2|Pregnancy|0|||
130153293|NCT02610816|468522048|FG003|Phase 2|Pregnancy|1|||
130153294|NCT03438227|468522049|FG000|Overall Study|Withdrawal by Subject|10|||
130153295|NCT03438227|468522050|FG001|Overall Study|Withdrawal by Subject|5|||
130153296|NCT01855048|468522051|FG000|Overall Study|Withdrawal by Subject|0|||
130153297|NCT01855048|468522052|FG001|Overall Study|Withdrawal by Subject|1|||
130153298|NCT01855048|468522053|FG002|Overall Study|Withdrawal by Subject|0|||
130153299|NCT01855048|468522054|FG003|Overall Study|Withdrawal by Subject|0|||
130153300|NCT01855048|468522055|FG004|Overall Study|Withdrawal by Subject|1|||
130153301|NCT01855048|468522056|FG005|Overall Study|Withdrawal by Subject|0|||
130153302|NCT02691741|468522057|FG000|Overall Study|Adverse Event|0|||
130153303|NCT02691741|468522058|FG001|Overall Study|Adverse Event|2|||
130153304|NCT02691741|468522057|FG000|Overall Study|Lost to Follow-up|1|||
130153305|NCT02691741|468522058|FG001|Overall Study|Lost to Follow-up|0|||
130153306|NCT02691741|468522057|FG000|Overall Study|Physician Decision|0|||
130153307|NCT02691741|468522058|FG001|Overall Study|Physician Decision|1|||
130153308|NCT02691741|468522057|FG000|Overall Study|Withdrawal by Subject|0|||
130153309|NCT02691741|468522058|FG001|Overall Study|Withdrawal by Subject|4|||
130153310|NCT01813071|468522059|FG000|Overall Study|Protocol Violation|0|||
130153311|NCT01813071|468522060|FG001|Overall Study|Protocol Violation|0|||
130153312|NCT01813071|468522061|FG002|Overall Study|Protocol Violation|0|||
130153313|NCT01813071|468522062|FG003|Overall Study|Protocol Violation|0|||
130153314|NCT01813071|468522063|FG004|Overall Study|Protocol Violation|1|||
130153315|NCT01813071|468522064|FG005|Overall Study|Protocol Violation|4|||
130153316|NCT01813071|468522065|FG006|Overall Study|Protocol Violation|2|||
130153317|NCT01813071|468522066|FG007|Overall Study|Protocol Violation|4|||
130153318|NCT01813071|468522067|FG008|Overall Study|Protocol Violation|2|||
130153319|NCT01813071|468522059|FG000|Overall Study|Withdrawal by Subject|0|||
130153320|NCT01813071|468522060|FG001|Overall Study|Withdrawal by Subject|0|||
130153321|NCT01813071|468522061|FG002|Overall Study|Withdrawal by Subject|0|||
130153322|NCT01813071|468522062|FG003|Overall Study|Withdrawal by Subject|0|||
130153323|NCT01813071|468522063|FG004|Overall Study|Withdrawal by Subject|0|||
130153324|NCT01813071|468522064|FG005|Overall Study|Withdrawal by Subject|1|||
130153325|NCT01813071|468522065|FG006|Overall Study|Withdrawal by Subject|0|||
130153326|NCT01813071|468522066|FG007|Overall Study|Withdrawal by Subject|0|||
130153327|NCT01813071|468522067|FG008|Overall Study|Withdrawal by Subject|0|||
130153328|NCT01813071|468522059|FG000|Overall Study|Adverse Event|0|||
130153329|NCT01813071|468522060|FG001|Overall Study|Adverse Event|0|||
130153330|NCT01813071|468522061|FG002|Overall Study|Adverse Event|0|||
129979574|NCT01156376|467889394|FG001|Overall Study|Adverse Event|0|||
129979575|NCT01156376|467889395|FG002|Overall Study|Adverse Event|1|||
130094627|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
130094628|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
130094629|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
130094630|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
130094631|NCT03556202|468302420|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
130094632|NCT03556202|468302421|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
130094633|NCT03556202|468302422|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
130094634|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Adverse Event|6|||
130094635|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Adverse Event|6|||
130094636|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Death|14|||
130094637|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Death|11|||
130094638|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
130153331|NCT01813071|468522062|FG003|Overall Study|Adverse Event|0|||
130153332|NCT01813071|468522063|FG004|Overall Study|Adverse Event|0|||
130153333|NCT01813071|468522064|FG005|Overall Study|Adverse Event|1|||
130153334|NCT01813071|468522065|FG006|Overall Study|Adverse Event|0|||
130153335|NCT01813071|468522066|FG007|Overall Study|Adverse Event|0|||
130153336|NCT01813071|468522067|FG008|Overall Study|Adverse Event|0|||
130153337|NCT01813071|468522059|FG000|Overall Study|Physician Decision|0|||
130153338|NCT01813071|468522060|FG001|Overall Study|Physician Decision|0|||
130153339|NCT01813071|468522061|FG002|Overall Study|Physician Decision|0|||
130153340|NCT01813071|468522062|FG003|Overall Study|Physician Decision|0|||
130153341|NCT01813071|468522063|FG004|Overall Study|Physician Decision|0|||
130153342|NCT01813071|468522064|FG005|Overall Study|Physician Decision|0|||
130153343|NCT01813071|468522065|FG006|Overall Study|Physician Decision|1|||
130153344|NCT01813071|468522066|FG007|Overall Study|Physician Decision|0|||
130153345|NCT01813071|468522067|FG008|Overall Study|Physician Decision|0|||
130153346|NCT01813071|468522059|FG000|Overall Study|Met inc/exc criteria|0|||
130153347|NCT01813071|468522060|FG001|Overall Study|Met inc/exc criteria|0|||
130153348|NCT01813071|468522061|FG002|Overall Study|Met inc/exc criteria|0|||
130153349|NCT01813071|468522062|FG003|Overall Study|Met inc/exc criteria|0|||
130153350|NCT01813071|468522063|FG004|Overall Study|Met inc/exc criteria|0|||
130153351|NCT01813071|468522064|FG005|Overall Study|Met inc/exc criteria|1|||
130153352|NCT01813071|468522065|FG006|Overall Study|Met inc/exc criteria|0|||
130153353|NCT01813071|468522066|FG007|Overall Study|Met inc/exc criteria|1|||
130153354|NCT01813071|468522067|FG008|Overall Study|Met inc/exc criteria|1|||
130153355|NCT01425528|468522068|FG000|Overall Study|Withdrawal by Subject|1|||
130153356|NCT01425528|468522069|FG001|Overall Study|Withdrawal by Subject|1|||
130153357|NCT02939950|468522070|FG000|Overall Study|Lost to Follow-up|13|||
130153358|NCT02939950|468522071|FG001|Overall Study|Lost to Follow-up|16|||
130153359|NCT02939950|468522070|FG000|Overall Study|Positive slit lamp findings|0|||
130153360|NCT02939950|468522071|FG001|Overall Study|Positive slit lamp findings|1|||
130153361|NCT02939950|468522070|FG000|Overall Study|Chalazion upper lid|0|||
130153362|NCT02939950|468522071|FG001|Overall Study|Chalazion upper lid|1|||
130153363|NCT02939950|468522070|FG000|Overall Study|Lack of motivation|0|||
130153364|NCT02939950|468522071|FG001|Overall Study|Lack of motivation|2|||
130153365|NCT02939950|468522070|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
130153366|NCT02939950|468522071|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
130153367|NCT02939950|468522070|FG000|Overall Study|Military orders|1|||
130153368|NCT02939950|468522071|FG001|Overall Study|Military orders|0|||
130153369|NCT02939950|468522070|FG000|Overall Study|Participant Relocated|5|||
130153370|NCT02939950|468522071|FG001|Overall Study|Participant Relocated|3|||
130153371|NCT02939950|468522070|FG000|Overall Study|Study related symptoms|8|||
130153372|NCT02939950|468522071|FG001|Overall Study|Study related symptoms|8|||
130153373|NCT02939950|468522070|FG000|Overall Study|Unacceptable lens movement|2|||
130153374|NCT02939950|468522071|FG001|Overall Study|Unacceptable lens movement|0|||
130153375|NCT02939950|468522070|FG000|Overall Study|Protocol Violation|6|||
130153376|NCT02939950|468522071|FG001|Overall Study|Protocol Violation|3|||
130153377|NCT02939950|468522070|FG000|Overall Study|Physician Decision|2|||
130153378|NCT02939950|468522071|FG001|Overall Study|Physician Decision|0|||
130153379|NCT02939950|468522070|FG000|Overall Study|Pregnancy|6|||
130153380|NCT02939950|468522071|FG001|Overall Study|Pregnancy|7|||
130153381|NCT02939950|468522070|FG000|Overall Study|Withdrawal by Subject|12|||
130153382|NCT02939950|468522071|FG001|Overall Study|Withdrawal by Subject|28|||
130153383|NCT02939950|468522070|FG000|Overall Study|Adverse Event|7|||
130153384|NCT02939950|468522071|FG001|Overall Study|Adverse Event|3|||
130153385|NCT02939950|468522070|FG000|Overall Study|Randomized, not dispensed|1|||
130153386|NCT02939950|468522071|FG001|Overall Study|Randomized, not dispensed|0|||
130153387|NCT02939950|468522070|FG000|Overall Study|Ineligible at Baseline|2|||
130153388|NCT02939950|468522071|FG001|Overall Study|Ineligible at Baseline|8|||
130153389|NCT04974619|468523675|FG000|Overall Study|Lost to Follow-up|0|||
130153390|NCT04974619|468523676|FG001|Overall Study|Lost to Follow-up|0|||
130153391|NCT04974619|468523677|FG002|Overall Study|Lost to Follow-up|1|||
130153392|NCT04974619|468523675|FG000|Overall Study|Withdrawal by Subject|0|||
130153393|NCT04974619|468523676|FG001|Overall Study|Withdrawal by Subject|0|||
130153394|NCT04974619|468523677|FG002|Overall Study|Withdrawal by Subject|1|||
130153395|NCT04974619|468523675|FG000|Overall Study|Protocol Violation|0|||
130153396|NCT04974619|468523676|FG001|Overall Study|Protocol Violation|1|||
130153397|NCT04974619|468523677|FG002|Overall Study|Protocol Violation|0|||
130153398|NCT00493779|468523684|FG000|Overall Study|Logistical issue at site|1|||
130153399|NCT01885182|468523686|FG000|Overall Study|Adverse Event|11|||
130153400|NCT01885182|468523687|FG001|Overall Study|Adverse Event|13|||
130153401|NCT01885182|468523686|FG000|Overall Study|Withdrawal by Subject|13|||
130153402|NCT01885182|468523687|FG001|Overall Study|Withdrawal by Subject|6|||
130153403|NCT01885182|468523686|FG000|Overall Study|Lost to Follow-up|2|||
130153404|NCT01885182|468523687|FG001|Overall Study|Lost to Follow-up|2|||
130153405|NCT01885182|468523686|FG000|Overall Study|Lack of Efficacy|8|||
130153406|NCT01885182|468523687|FG001|Overall Study|Lack of Efficacy|1|||
130153407|NCT01207440|468523694|FG000|Overall Study|Adverse Event|46|||
130153408|NCT01207440|468523695|FG001|Overall Study|Adverse Event|11|||
130153409|NCT01207440|468523696|FG002|Overall Study|Adverse Event|7|||
130153410|NCT01207440|468523697|FG003|Overall Study|Adverse Event|2|||
130153411|NCT01207440|468523698|FG004|Overall Study|Adverse Event|6|||
130153412|NCT01207440|468523699|FG005|Overall Study|Adverse Event|6|||
130153413|NCT01207440|468523700|FG006|Overall Study|Adverse Event|2|||
130153414|NCT01207440|468523694|FG000|Overall Study|Death|6|||
130153415|NCT01207440|468523695|FG001|Overall Study|Death|3|||
130153416|NCT01207440|468523696|FG002|Overall Study|Death|2|||
130153417|NCT01207440|468523697|FG003|Overall Study|Death|2|||
130153418|NCT01207440|468523698|FG004|Overall Study|Death|7|||
130153419|NCT01207440|468523699|FG005|Overall Study|Death|5|||
130153420|NCT01207440|468523700|FG006|Overall Study|Death|1|||
130153421|NCT01207440|468523694|FG000|Overall Study|Lack of Efficacy|13|||
130153422|NCT01207440|468523695|FG001|Overall Study|Lack of Efficacy|2|||
130153423|NCT01207440|468523696|FG002|Overall Study|Lack of Efficacy|5|||
130153424|NCT01207440|468523697|FG003|Overall Study|Lack of Efficacy|1|||
130153425|NCT01207440|468523698|FG004|Overall Study|Lack of Efficacy|2|||
130153426|NCT01207440|468523699|FG005|Overall Study|Lack of Efficacy|3|||
130153427|NCT01207440|468523700|FG006|Overall Study|Lack of Efficacy|0|||
130153428|NCT01207440|468523694|FG000|Overall Study|Lost to Follow-up|0|||
130153429|NCT01207440|468523695|FG001|Overall Study|Lost to Follow-up|0|||
130153430|NCT01207440|468523696|FG002|Overall Study|Lost to Follow-up|2|||
130153431|NCT01207440|468523697|FG003|Overall Study|Lost to Follow-up|1|||
130153432|NCT01207440|468523698|FG004|Overall Study|Lost to Follow-up|0|||
130153433|NCT01207440|468523699|FG005|Overall Study|Lost to Follow-up|0|||
130153434|NCT01207440|468523700|FG006|Overall Study|Lost to Follow-up|0|||
130153435|NCT01207440|468523694|FG000|Overall Study|Non-compliance with Study Drug|3|||
130153436|NCT01207440|468523695|FG001|Overall Study|Non-compliance with Study Drug|0|||
130153437|NCT01207440|468523696|FG002|Overall Study|Non-compliance with Study Drug|1|||
130153438|NCT01207440|468523697|FG003|Overall Study|Non-compliance with Study Drug|0|||
130153439|NCT01207440|468523698|FG004|Overall Study|Non-compliance with Study Drug|0|||
130153440|NCT01207440|468523699|FG005|Overall Study|Non-compliance with Study Drug|0|||
130153441|NCT01207440|468523700|FG006|Overall Study|Non-compliance with Study Drug|0|||
130153442|NCT01207440|468523694|FG000|Overall Study|Physician Decision|6|||
130153443|NCT01207440|468523695|FG001|Overall Study|Physician Decision|5|||
130153444|NCT01207440|468523696|FG002|Overall Study|Physician Decision|5|||
130153445|NCT01207440|468523697|FG003|Overall Study|Physician Decision|0|||
130153446|NCT01207440|468523698|FG004|Overall Study|Physician Decision|1|||
130153447|NCT01207440|468523699|FG005|Overall Study|Physician Decision|0|||
130153448|NCT01207440|468523700|FG006|Overall Study|Physician Decision|0|||
130153449|NCT01207440|468523694|FG000|Overall Study|Progressive Disease|19|||
130153450|NCT01207440|468523695|FG001|Overall Study|Progressive Disease|10|||
129979576|NCT01156376|467889393|FG000|Overall Study|Withdrawal by Subject|0|||
130153451|NCT01207440|468523696|FG002|Overall Study|Progressive Disease|19|||
130153452|NCT01207440|468523697|FG003|Overall Study|Progressive Disease|7|||
130153453|NCT01207440|468523698|FG004|Overall Study|Progressive Disease|23|||
130153454|NCT01207440|468523699|FG005|Overall Study|Progressive Disease|27|||
130153455|NCT01207440|468523700|FG006|Overall Study|Progressive Disease|0|||
130153456|NCT01207440|468523694|FG000|Overall Study|Protocol Violation|2|||
130153457|NCT01207440|468523695|FG001|Overall Study|Protocol Violation|0|||
130153458|NCT01207440|468523696|FG002|Overall Study|Protocol Violation|0|||
130153459|NCT01207440|468523697|FG003|Overall Study|Protocol Violation|0|||
130153460|NCT01207440|468523698|FG004|Overall Study|Protocol Violation|0|||
130153461|NCT01207440|468523699|FG005|Overall Study|Protocol Violation|0|||
130153462|NCT01207440|468523700|FG006|Overall Study|Protocol Violation|0|||
130153463|NCT01207440|468523694|FG000|Overall Study|Site Terminated by Sponsor|69|||
130153464|NCT01207440|468523695|FG001|Overall Study|Site Terminated by Sponsor|19|||
130153465|NCT01207440|468523696|FG002|Overall Study|Site Terminated by Sponsor|12|||
130153466|NCT01207440|468523697|FG003|Overall Study|Site Terminated by Sponsor|2|||
130153467|NCT01207440|468523698|FG004|Overall Study|Site Terminated by Sponsor|3|||
130153468|NCT01207440|468523699|FG005|Overall Study|Site Terminated by Sponsor|0|||
130153469|NCT01207440|468523700|FG006|Overall Study|Site Terminated by Sponsor|2|||
130153470|NCT01207440|468523694|FG000|Overall Study|Withdrawal by Subject|29|||
130153471|NCT01207440|468523695|FG001|Overall Study|Withdrawal by Subject|4|||
130153472|NCT01207440|468523696|FG002|Overall Study|Withdrawal by Subject|5|||
130153473|NCT01207440|468523697|FG003|Overall Study|Withdrawal by Subject|3|||
130153474|NCT01207440|468523698|FG004|Overall Study|Withdrawal by Subject|2|||
130153475|NCT01207440|468523699|FG005|Overall Study|Withdrawal by Subject|2|||
130153476|NCT01207440|468523700|FG006|Overall Study|Withdrawal by Subject|0|||
130153477|NCT01207440|468523694|FG000|Overall Study|Reason Not Specified|10|||
130153478|NCT01207440|468523695|FG001|Overall Study|Reason Not Specified|10|||
130153479|NCT01207440|468523696|FG002|Overall Study|Reason Not Specified|7|||
130153480|NCT01207440|468523697|FG003|Overall Study|Reason Not Specified|0|||
130153481|NCT01207440|468523698|FG004|Overall Study|Reason Not Specified|4|||
130153482|NCT01207440|468523699|FG005|Overall Study|Reason Not Specified|3|||
130153483|NCT01207440|468523700|FG006|Overall Study|Reason Not Specified|0|||
130153484|NCT01592721|468523701|FG000|Long-term Follow-up|Death|1|||
130153485|NCT01432574|468523702|FG000|Overall Study|Moved|2|||
130153486|NCT01432574|468523702|FG000|Overall Study|Not interested|1|||
130153487|NCT02516410|468523703|FG000|Overall Study|Adverse Event|0|||
130153488|NCT02516410|468523704|FG001|Overall Study|Adverse Event|1|||
130153489|NCT02516410|468523703|FG000|Overall Study|Withdrawal by Subject|0|||
130153490|NCT02516410|468523704|FG001|Overall Study|Withdrawal by Subject|1|||
130153491|NCT04146363|468523708|FG000|Induction Period|Adverse Event|1|||
130153492|NCT04146363|468523709|FG001|Induction Period|Adverse Event|2|||
130153493|NCT04146363|468523710|FG002|Induction Period|Adverse Event|0|||
130153494|NCT04146363|468523711|FG003|Induction Period|Adverse Event|0|||
130153495|NCT04146363|468523712|FG004|Induction Period|Adverse Event|0|||
130153496|NCT04146363|468523713|FG005|Induction Period|Adverse Event|0|||
130153497|NCT04146363|468523714|FG006|Induction Period|Adverse Event|0|||
130153498|NCT04146363|468523715|FG007|Induction Period|Adverse Event|0|||
130153499|NCT04146363|468523716|FG008|Induction Period|Adverse Event|0|||
130153500|NCT04146363|468523717|FG009|Induction Period|Adverse Event|0|||
130153501|NCT04146363|468523718|FG010|Induction Period|Adverse Event|0|||
130153502|NCT04146363|468523708|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
130153503|NCT04146363|468523709|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
130153504|NCT04146363|468523710|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
130153505|NCT04146363|468523711|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
130153506|NCT04146363|468523712|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
130153507|NCT04146363|468523713|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
130153508|NCT04146363|468523714|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
130153509|NCT04146363|468523715|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
130153510|NCT04146363|468523716|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
130153511|NCT04146363|468523717|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
130153512|NCT04146363|468523718|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
130153513|NCT04146363|468523708|FG000|Induction Period|Lack of Efficacy|7|||
130153514|NCT04146363|468523709|FG001|Induction Period|Lack of Efficacy|2|||
130153515|NCT04146363|468523710|FG002|Induction Period|Lack of Efficacy|0|||
130153516|NCT04146363|468523711|FG003|Induction Period|Lack of Efficacy|0|||
130153517|NCT04146363|468523712|FG004|Induction Period|Lack of Efficacy|0|||
130153518|NCT04146363|468523713|FG005|Induction Period|Lack of Efficacy|0|||
130153519|NCT04146363|468523714|FG006|Induction Period|Lack of Efficacy|0|||
130153520|NCT04146363|468523715|FG007|Induction Period|Lack of Efficacy|0|||
130153521|NCT04146363|468523716|FG008|Induction Period|Lack of Efficacy|0|||
130153522|NCT04146363|468523717|FG009|Induction Period|Lack of Efficacy|0|||
130153523|NCT04146363|468523718|FG010|Induction Period|Lack of Efficacy|0|||
130153524|NCT04146363|468523708|FG000|Induction Period|Lost to Follow-up|1|||
130153525|NCT04146363|468523709|FG001|Induction Period|Lost to Follow-up|4|||
130153526|NCT04146363|468523710|FG002|Induction Period|Lost to Follow-up|0|||
129979577|NCT01156376|467889394|FG001|Overall Study|Withdrawal by Subject|0|||
129979578|NCT01156376|467889395|FG002|Overall Study|Withdrawal by Subject|3|||
130153527|NCT04146363|468523711|FG003|Induction Period|Lost to Follow-up|0|||
129979579|NCT04488770|467889396|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979580|NCT04488770|467889397|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979581|NCT04488770|467889398|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979582|NCT04488770|467889399|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
129979583|NCT04488770|467889400|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130153528|NCT04146363|468523712|FG004|Induction Period|Lost to Follow-up|0|||
129979584|NCT04488770|467889401|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979585|NCT04488770|467889402|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130153529|NCT04146363|468523713|FG005|Induction Period|Lost to Follow-up|0|||
130153530|NCT04146363|468523714|FG006|Induction Period|Lost to Follow-up|0|||
130153531|NCT04146363|468523715|FG007|Induction Period|Lost to Follow-up|0|||
130153532|NCT04146363|468523716|FG008|Induction Period|Lost to Follow-up|0|||
130153533|NCT04146363|468523717|FG009|Induction Period|Lost to Follow-up|0|||
130153534|NCT04146363|468523718|FG010|Induction Period|Lost to Follow-up|0|||
130153535|NCT04146363|468523708|FG000|Induction Period|Positive quantiferon test|0|||
130153536|NCT04146363|468523709|FG001|Induction Period|Positive quantiferon test|1|||
130094639|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
130094640|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
130094641|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
130094642|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
130094643|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
130094644|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Disease Progression|1|||
130094645|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Disease Progression|0|||
130094646|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
130094647|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
130094648|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
130094649|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
130094650|NCT04419558|468302423|FG000|DB Period (48 Weeks)|Participant Decision|4|||
130094651|NCT04419558|468302424|FG001|DB Period (48 Weeks)|Participant Decision|3|||
130094652|NCT04419558|468302423|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
130094653|NCT04419558|468302424|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
130094654|NCT04419558|468302423|FG000|OLE Period (48 Weeks)|Death|4|||
130094655|NCT04419558|468302424|FG001|OLE Period (48 Weeks)|Death|6|||
130094656|NCT04419558|468302423|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
130094657|NCT04419558|468302424|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
130094658|NCT04419558|468302423|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
130094659|NCT04419558|468302424|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
130094660|NCT00903357|468302425|FG000|First Intervention|Withdrawal by Subject|5|||
130094661|NCT00903357|468302426|FG001|First Intervention|Withdrawal by Subject|3|||
130094662|NCT00903357|468302425|FG000|First Intervention|Flu|0|||
130094663|NCT00903357|468302426|FG001|First Intervention|Flu|1|||
130094664|NCT00903357|468302425|FG000|Wash Out Period of 2 Weeks|Flu|0|||
130094665|NCT00903357|468302426|FG001|Wash Out Period of 2 Weeks|Flu|1|||
130094666|NCT00903357|468302425|FG000|Second Intervention|Lost to Follow-up|1|||
130094667|NCT00903357|468302426|FG001|Second Intervention|Lost to Follow-up|0|||
130094668|NCT05146999|468302427|FG000|Overall Study|Withdrew consent|6|||
130094669|NCT05146999|468302428|FG001|Overall Study|Withdrew consent|1|||
130094670|NCT05146999|468302427|FG000|Overall Study|Lost to Follow-up|3|||
130094671|NCT05146999|468302428|FG001|Overall Study|Lost to Follow-up|2|||
130094672|NCT05146999|468302427|FG000|Overall Study|Other|1|||
130094673|NCT05146999|468302428|FG001|Overall Study|Other|3|||
130094674|NCT02221882|468302429|FG000|Overall Study|Withdrawal by Subject|0|||
130094675|NCT02221882|468302430|FG001|Overall Study|Withdrawal by Subject|0|||
130094676|NCT02221882|468302431|FG002|Overall Study|Withdrawal by Subject|4|||
130094677|NCT02221882|468302432|FG003|Overall Study|Withdrawal by Subject|2|||
130094678|NCT02221882|468302433|FG004|Overall Study|Withdrawal by Subject|2|||
130094679|NCT02221882|468302434|FG005|Overall Study|Withdrawal by Subject|2|||
130094680|NCT02221882|468302429|FG000|Overall Study|Death|0|||
130094681|NCT02221882|468302430|FG001|Overall Study|Death|1|||
130094682|NCT02221882|468302431|FG002|Overall Study|Death|0|||
130094683|NCT02221882|468302432|FG003|Overall Study|Death|0|||
130094684|NCT02221882|468302433|FG004|Overall Study|Death|0|||
130094685|NCT02221882|468302434|FG005|Overall Study|Death|0|||
130094686|NCT05664672|468302435|FG000|Overall Study|Adverse Event|0|||
130094687|NCT05664672|468302436|FG001|Overall Study|Adverse Event|0|||
130094688|NCT05664672|468302437|FG002|Overall Study|Adverse Event|0|||
130094689|NCT05664672|468302438|FG003|Overall Study|Adverse Event|0|||
130094690|NCT05664672|468302439|FG004|Overall Study|Adverse Event|0|||
130094691|NCT05664672|468302440|FG005|Overall Study|Adverse Event|1|||
130094692|NCT05664672|468302435|FG000|Overall Study|Withdrawal by Subject|0|||
130094693|NCT05664672|468302436|FG001|Overall Study|Withdrawal by Subject|1|||
130094694|NCT05664672|468302437|FG002|Overall Study|Withdrawal by Subject|3|||
130094695|NCT05664672|468302438|FG003|Overall Study|Withdrawal by Subject|0|||
130094696|NCT05664672|468302439|FG004|Overall Study|Withdrawal by Subject|5|||
130094697|NCT05664672|468302440|FG005|Overall Study|Withdrawal by Subject|6|||
130094698|NCT05664672|468302435|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
130094699|NCT05664672|468302436|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130094700|NCT05664672|468302437|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130094701|NCT05664672|468302438|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
130094702|NCT05664672|468302439|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130094703|NCT05664672|468302440|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
130094704|NCT05664672|468302435|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
130094705|NCT05664672|468302436|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130094706|NCT05664672|468302437|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130094707|NCT05664672|468302438|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130094708|NCT05664672|468302439|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130094709|NCT05664672|468302440|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
130094710|NCT04236986|468302445|FG000|Overall Study|Withdrawal by Subject|3|||
130094711|NCT04236986|468302446|FG001|Overall Study|Withdrawal by Subject|1|||
130094712|NCT04034225|468302447|FG000|Overall Study|Death|3|||
130094713|NCT04034225|468302447|FG000|Overall Study|Withdrawal by Subject|2|||
130153537|NCT04146363|468523710|FG002|Induction Period|Positive quantiferon test|0|||
130153538|NCT04146363|468523711|FG003|Induction Period|Positive quantiferon test|0|||
130153539|NCT04146363|468523712|FG004|Induction Period|Positive quantiferon test|0|||
130153540|NCT04146363|468523713|FG005|Induction Period|Positive quantiferon test|0|||
130153541|NCT04146363|468523714|FG006|Induction Period|Positive quantiferon test|0|||
130153542|NCT04146363|468523715|FG007|Induction Period|Positive quantiferon test|0|||
130153543|NCT04146363|468523716|FG008|Induction Period|Positive quantiferon test|0|||
130153544|NCT04146363|468523717|FG009|Induction Period|Positive quantiferon test|0|||
130153545|NCT04146363|468523718|FG010|Induction Period|Positive quantiferon test|0|||
130153546|NCT04146363|468523708|FG000|Induction Period|Protocol Deviation|5|||
130153547|NCT04146363|468523709|FG001|Induction Period|Protocol Deviation|6|||
130153548|NCT04146363|468523710|FG002|Induction Period|Protocol Deviation|0|||
130153549|NCT04146363|468523711|FG003|Induction Period|Protocol Deviation|0|||
130153550|NCT04146363|468523712|FG004|Induction Period|Protocol Deviation|0|||
130153551|NCT04146363|468523713|FG005|Induction Period|Protocol Deviation|0|||
130153552|NCT04146363|468523714|FG006|Induction Period|Protocol Deviation|0|||
130153553|NCT04146363|468523715|FG007|Induction Period|Protocol Deviation|0|||
130153554|NCT04146363|468523716|FG008|Induction Period|Protocol Deviation|0|||
130153555|NCT04146363|468523717|FG009|Induction Period|Protocol Deviation|0|||
130153556|NCT04146363|468523718|FG010|Induction Period|Protocol Deviation|0|||
130153557|NCT04146363|468523708|FG000|Induction Period|Withdrawal by Subject|6|||
130153558|NCT04146363|468523709|FG001|Induction Period|Withdrawal by Subject|3|||
130153559|NCT04146363|468523710|FG002|Induction Period|Withdrawal by Subject|0|||
130153560|NCT04146363|468523711|FG003|Induction Period|Withdrawal by Subject|0|||
130153561|NCT04146363|468523712|FG004|Induction Period|Withdrawal by Subject|0|||
130153562|NCT04146363|468523713|FG005|Induction Period|Withdrawal by Subject|0|||
130153563|NCT04146363|468523714|FG006|Induction Period|Withdrawal by Subject|0|||
130153564|NCT04146363|468523715|FG007|Induction Period|Withdrawal by Subject|0|||
130153565|NCT04146363|468523716|FG008|Induction Period|Withdrawal by Subject|0|||
130153566|NCT04146363|468523717|FG009|Induction Period|Withdrawal by Subject|0|||
130153567|NCT04146363|468523718|FG010|Induction Period|Withdrawal by Subject|0|||
130153568|NCT04146363|468523708|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153569|NCT04146363|468523709|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153570|NCT04146363|468523710|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153571|NCT04146363|468523711|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153572|NCT04146363|468523712|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153573|NCT04146363|468523713|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153574|NCT04146363|468523714|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
130153575|NCT04146363|468523715|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
130153576|NCT04146363|468523716|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153577|NCT04146363|468523717|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153578|NCT04146363|468523718|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
130153579|NCT04146363|468523708|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153580|NCT04146363|468523709|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153581|NCT04146363|468523710|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153582|NCT04146363|468523711|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153583|NCT04146363|468523712|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153584|NCT04146363|468523713|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153585|NCT04146363|468523714|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153586|NCT04146363|468523715|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
130153587|NCT04146363|468523716|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153588|NCT04146363|468523717|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153589|NCT04146363|468523718|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
130153590|NCT04146363|468523708|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153591|NCT04146363|468523709|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153592|NCT04146363|468523710|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153593|NCT04146363|468523711|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153594|NCT04146363|468523712|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153595|NCT04146363|468523713|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153596|NCT04146363|468523714|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130153597|NCT04146363|468523715|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
130153598|NCT04146363|468523716|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153599|NCT04146363|468523717|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153600|NCT04146363|468523718|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
130153601|NCT04146363|468523708|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153602|NCT04146363|468523709|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153603|NCT04146363|468523710|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
130153604|NCT04146363|468523711|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153605|NCT04146363|468523712|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153606|NCT04146363|468523713|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
130153607|NCT04146363|468523714|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153608|NCT04146363|468523715|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153609|NCT04146363|468523716|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153610|NCT04146363|468523717|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153611|NCT04146363|468523718|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
130153612|NCT04146363|468523708|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153613|NCT04146363|468523709|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153614|NCT04146363|468523710|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153615|NCT04146363|468523711|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153616|NCT04146363|468523712|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
130153617|NCT04146363|468523713|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
130153618|NCT04146363|468523714|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
130153619|NCT04146363|468523715|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
130153620|NCT04146363|468523716|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153621|NCT04146363|468523717|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153622|NCT04146363|468523718|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
130153623|NCT04146363|468523708|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153624|NCT04146363|468523709|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153625|NCT04146363|468523710|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
130153626|NCT04146363|468523711|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153627|NCT04146363|468523712|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153628|NCT04146363|468523713|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
130153629|NCT04146363|468523714|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
130153630|NCT04146363|468523715|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
130153631|NCT04146363|468523716|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153632|NCT04146363|468523717|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153633|NCT04146363|468523718|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
130153634|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153635|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153636|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153637|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153638|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153639|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153640|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153641|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153642|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
130153643|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
130153644|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
130153645|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153646|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153647|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153648|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153649|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153650|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153651|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153652|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
130153653|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
130153654|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
130153655|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
130153656|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153657|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153658|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153659|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153660|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153661|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153662|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153663|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153664|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
130153665|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
130153666|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
130153667|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153668|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153669|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153670|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153671|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153672|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153673|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153674|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153675|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
130153676|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
130153677|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
130153678|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153679|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153680|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153681|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153682|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153683|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153684|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153685|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
130153686|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
130153687|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
130153688|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
130153689|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153690|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153691|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153692|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153693|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153694|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153695|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153696|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153697|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153698|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
130153699|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
130153700|NCT04146363|468523708|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153701|NCT04146363|468523709|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153702|NCT04146363|468523710|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153703|NCT04146363|468523711|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153704|NCT04146363|468523712|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153705|NCT04146363|468523713|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153706|NCT04146363|468523714|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153707|NCT04146363|468523715|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153708|NCT04146363|468523716|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153709|NCT04146363|468523717|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
130153710|NCT04146363|468523718|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
130153711|NCT02914236|468523720|FG000|Overall Study|Lost to Follow-up|1|||
130153712|NCT02148913|468523725|FG000|Overall Study|Death|0|||
130153713|NCT02148913|468523726|FG001|Overall Study|Death|1|||
130153714|NCT02148913|468523727|FG002|Overall Study|Death|0|||
130153715|NCT02148913|468523728|FG003|Overall Study|Death|0|||
130153716|NCT01045993|468523736|FG000|Overall Study|Treated-later found eligibility not met|0|||
130153717|NCT01045993|468523737|FG001|Overall Study|Treated-later found eligibility not met|1|||
130153718|NCT01045993|468523738|FG002|Overall Study|Treated-later found eligibility not met|0|||
130153719|NCT01045993|468523739|FG003|Overall Study|Treated-later found eligibility not met|0|||
130153720|NCT05506358|468523740|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
130153721|NCT05506358|468523741|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130153722|NCT05506358|468523742|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130153723|NCT05506358|468523743|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130153724|NCT05506358|468523744|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
130153725|NCT05506358|468523740|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
130153726|NCT05506358|468523741|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130153727|NCT05506358|468523742|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130153728|NCT05506358|468523743|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
130153729|NCT05506358|468523744|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129979586|NCT04488770|467889403|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130153730|NCT05506358|468523740|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130153731|NCT05506358|468523741|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130153732|NCT05506358|468523742|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130153733|NCT05506358|468523743|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
129979587|NCT04488770|467889404|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130153734|NCT05506358|468523744|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
130153735|NCT05506358|468523740|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
130153736|NCT05506358|468523741|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
130153737|NCT05506358|468523742|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
130153738|NCT05506358|468523743|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
130153739|NCT05506358|468523744|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
130153740|NCT05506358|468523740|FG000|Overall Study|HbE trait|0|||
130153741|NCT05506358|468523741|FG001|Overall Study|HbE trait|0|||
130153742|NCT05506358|468523742|FG002|Overall Study|HbE trait|0|||
130153743|NCT05506358|468523743|FG003|Overall Study|HbE trait|1|||
130153744|NCT05506358|468523744|FG004|Overall Study|HbE trait|0|||
130153745|NCT00252174|468523746|FG000|Overall Study|Withdrawal by Subject|0|||
130153746|NCT00252174|468523747|FG001|Overall Study|Withdrawal by Subject|1|||
130153747|NCT00252174|468523748|FG002|Overall Study|Withdrawal by Subject|0|||
130153748|NCT00102687|468523750|FG000|Initial Period|Withdrawal by Subject|6|||
130153749|NCT00102687|468523751|FG001|Initial Period|Withdrawal by Subject|3|||
130153750|NCT00102687|468523752|FG002|Initial Period|Withdrawal by Subject|5|||
130153751|NCT00102687|468523753|FG003|Initial Period|Withdrawal by Subject|0|||
130153752|NCT00102687|468523754|FG004|Initial Period|Withdrawal by Subject|0|||
130153753|NCT00102687|468523750|FG000|Initial Period|Adverse Event|4|||
130153754|NCT00102687|468523751|FG001|Initial Period|Adverse Event|7|||
130153755|NCT00102687|468523752|FG002|Initial Period|Adverse Event|9|||
130153756|NCT00102687|468523753|FG003|Initial Period|Adverse Event|0|||
130153757|NCT00102687|468523754|FG004|Initial Period|Adverse Event|0|||
130153758|NCT00102687|468523750|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
130153759|NCT00102687|468523751|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
130153760|NCT00102687|468523752|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
130153761|NCT00102687|468523753|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
130153762|NCT00102687|468523754|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
130153763|NCT00102687|468523750|FG000|Initial Period|Protocol Violation|0|||
130153764|NCT00102687|468523751|FG001|Initial Period|Protocol Violation|0|||
130153765|NCT00102687|468523752|FG002|Initial Period|Protocol Violation|2|||
130153766|NCT00102687|468523753|FG003|Initial Period|Protocol Violation|0|||
130153767|NCT00102687|468523754|FG004|Initial Period|Protocol Violation|0|||
130153768|NCT00102687|468523750|FG000|Initial Period|Physician Decision|2|||
130153769|NCT00102687|468523751|FG001|Initial Period|Physician Decision|9|||
130153770|NCT00102687|468523752|FG002|Initial Period|Physician Decision|6|||
130153771|NCT00102687|468523753|FG003|Initial Period|Physician Decision|0|||
130153772|NCT00102687|468523754|FG004|Initial Period|Physician Decision|0|||
130153773|NCT00102687|468523750|FG000|Initial Period|Sponsor's decision|0|||
130153774|NCT00102687|468523751|FG001|Initial Period|Sponsor's decision|1|||
130153775|NCT00102687|468523752|FG002|Initial Period|Sponsor's decision|1|||
130153776|NCT00102687|468523753|FG003|Initial Period|Sponsor's decision|0|||
130153777|NCT00102687|468523754|FG004|Initial Period|Sponsor's decision|0|||
130153778|NCT00102687|468523750|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
130153779|NCT00102687|468523751|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
130153780|NCT00102687|468523752|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
130153781|NCT00102687|468523753|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
130153782|NCT00102687|468523754|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
130153783|NCT00102687|468523750|FG000|Initial Period|Death|1|||
130153784|NCT00102687|468523751|FG001|Initial Period|Death|1|||
130153785|NCT00102687|468523752|FG002|Initial Period|Death|1|||
130153786|NCT00102687|468523753|FG003|Initial Period|Death|0|||
130153787|NCT00102687|468523754|FG004|Initial Period|Death|0|||
130153788|NCT00102687|468523750|FG000|Maintenance Period|Withdrawal by Subject|4|||
130153789|NCT00102687|468523751|FG001|Maintenance Period|Withdrawal by Subject|0|||
130153790|NCT00102687|468523752|FG002|Maintenance Period|Withdrawal by Subject|2|||
130153791|NCT00102687|468523753|FG003|Maintenance Period|Withdrawal by Subject|3|||
130153792|NCT00102687|468523754|FG004|Maintenance Period|Withdrawal by Subject|1|||
130153793|NCT00102687|468523750|FG000|Maintenance Period|Adverse Event|1|||
130153794|NCT00102687|468523751|FG001|Maintenance Period|Adverse Event|0|||
130153795|NCT00102687|468523752|FG002|Maintenance Period|Adverse Event|0|||
130153796|NCT00102687|468523753|FG003|Maintenance Period|Adverse Event|1|||
130153797|NCT00102687|468523754|FG004|Maintenance Period|Adverse Event|3|||
130153798|NCT00102687|468523750|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129979588|NCT04488770|467889405|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
130153799|NCT00102687|468523751|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
130153800|NCT00102687|468523752|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130153801|NCT00102687|468523753|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
130153802|NCT00102687|468523754|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
130153803|NCT00102687|468523750|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130153804|NCT00102687|468523751|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130153805|NCT00102687|468523752|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
130153806|NCT00102687|468523753|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
130153807|NCT00102687|468523754|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
130153808|NCT00102687|468523750|FG000|Maintenance Period|Death|0|||
130153809|NCT00102687|468523751|FG001|Maintenance Period|Death|0|||
130153810|NCT00102687|468523752|FG002|Maintenance Period|Death|0|||
130153811|NCT00102687|468523753|FG003|Maintenance Period|Death|1|||
130153812|NCT00102687|468523754|FG004|Maintenance Period|Death|1|||
130153813|NCT00102687|468523750|FG000|Maintenance Period|Physician Decision|1|||
130153814|NCT00102687|468523751|FG001|Maintenance Period|Physician Decision|2|||
130153815|NCT00102687|468523752|FG002|Maintenance Period|Physician Decision|3|||
130153816|NCT00102687|468523753|FG003|Maintenance Period|Physician Decision|0|||
130153817|NCT00102687|468523754|FG004|Maintenance Period|Physician Decision|4|||
130153818|NCT00351351|468523755|FG000|Overall Study|surgical access pbs; device issues|9|||
130153819|NCT00351351|468523756|FG001|Overall Study|surgical access pbs; device issues|4|||
130153820|NCT01341587|468523757|FG000|Overall Study|Lost to Follow-up|2|||
130153821|NCT01341587|468523758|FG001|Overall Study|Lost to Follow-up|0|||
130153822|NCT01341587|468523757|FG000|Overall Study|stopped using the meters|2|||
130153823|NCT01341587|468523758|FG001|Overall Study|stopped using the meters|10|||
130153824|NCT00606502|468523759|FG000|Randomization|Randomized but not treated|3|||
130153825|NCT00606502|468523760|FG001|Randomization|Randomized but not treated|0|||
130153826|NCT00606502|468523759|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
130153827|NCT00606502|468523760|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
130153828|NCT02083926|468523763|FG000|Overall Study|Withdrawal by Subject|1|||
130153829|NCT02083926|468523764|FG001|Overall Study|Withdrawal by Subject|0|||
130153830|NCT00384176|468523765|FG000|Overall Study|Death|239|||
130153831|NCT00384176|468523766|FG001|Overall Study|Death|247|||
130153832|NCT00384176|468523767|FG002|Overall Study|Death|105|||
130153833|NCT00384176|468523765|FG000|Overall Study|Withdrawal by Subject|52|||
130153834|NCT00384176|468523766|FG001|Overall Study|Withdrawal by Subject|48|||
130153835|NCT00384176|468523767|FG002|Overall Study|Withdrawal by Subject|22|||
130153836|NCT00384176|468523765|FG000|Overall Study|Lost to Follow-up|16|||
130153837|NCT00384176|468523766|FG001|Overall Study|Lost to Follow-up|18|||
130153838|NCT00384176|468523767|FG002|Overall Study|Lost to Follow-up|4|||
130153839|NCT00384176|468523765|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
130153840|NCT00384176|468523766|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
130153841|NCT00384176|468523767|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
130153842|NCT00384176|468523765|FG000|Overall Study|Longer QTC as Visit 1|1|||
130153843|NCT00384176|468523766|FG001|Overall Study|Longer QTC as Visit 1|0|||
130153844|NCT00384176|468523767|FG002|Overall Study|Longer QTC as Visit 1|0|||
130153845|NCT00384176|468523765|FG000|Overall Study|Toxicity of treatment|1|||
130153846|NCT00384176|468523766|FG001|Overall Study|Toxicity of treatment|0|||
130153847|NCT00384176|468523767|FG002|Overall Study|Toxicity of treatment|0|||
130153848|NCT00384176|468523765|FG000|Overall Study|Did not receive study treatment|0|||
130153849|NCT00384176|468523766|FG001|Overall Study|Did not receive study treatment|1|||
130153850|NCT00384176|468523767|FG002|Overall Study|Did not receive study treatment|1|||
130153851|NCT00384176|468523765|FG000|Overall Study|Physician Decision|0|||
130153852|NCT00384176|468523766|FG001|Overall Study|Physician Decision|2|||
130153853|NCT00384176|468523767|FG002|Overall Study|Physician Decision|0|||
130153854|NCT00384176|468523765|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
130153855|NCT00384176|468523766|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
130153856|NCT00384176|468523767|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
130153857|NCT00049842|468523768|FG000|Treatment Phase|Adverse Event|47|||
130153858|NCT00049842|468523769|FG001|Treatment Phase|Adverse Event|12|||
130153859|NCT00049842|468523768|FG000|Treatment Phase|Withdrawal by Subject|35|||
130153860|NCT00049842|468523769|FG001|Treatment Phase|Withdrawal by Subject|46|||
130153861|NCT00049842|468523768|FG000|Treatment Phase|Non-compliance with protocol|7|||
130153862|NCT00049842|468523769|FG001|Treatment Phase|Non-compliance with protocol|8|||
130153863|NCT00049842|468523768|FG000|Treatment Phase|Lost to Follow-up|4|||
130153864|NCT00049842|468523769|FG001|Treatment Phase|Lost to Follow-up|8|||
130153865|NCT00049842|468523768|FG000|Treatment Phase|Administrative|0|||
130153866|NCT00049842|468523769|FG001|Treatment Phase|Administrative|3|||
130153867|NCT00049842|468523768|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
129979589|NCT04488770|467889406|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979590|NCT04488770|467889407|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979591|NCT04488770|467889408|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979592|NCT04488770|467889396|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
130153868|NCT00049842|468523769|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
130153869|NCT00049842|468523768|FG000|Follow-up Phase|Adverse Event|6|||
130153870|NCT00049842|468523769|FG001|Follow-up Phase|Adverse Event|1|||
130153871|NCT00049842|468523768|FG000|Follow-up Phase|Other|1|||
130153872|NCT00049842|468523769|FG001|Follow-up Phase|Other|4|||
130153873|NCT00854373|468523770|FG000|Overall Study|Withdrawal by Subject|1|||
130153874|NCT00854373|468523771|FG001|Overall Study|Withdrawal by Subject|3|||
130153875|NCT00854373|468523770|FG000|Overall Study|Forgot to take study drug|1|||
130153876|NCT00854373|468523771|FG001|Overall Study|Forgot to take study drug|1|||
130153877|NCT00307931|468523772|FG000|Overall Study|Adverse Event|1|||
129979593|NCT04488770|467889397|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130153878|NCT02697773|468523773|FG000|Overall Study|Adverse Event|2|||
130153879|NCT02697773|468523774|FG001|Overall Study|Adverse Event|1|||
130153880|NCT02697773|468523775|FG002|Overall Study|Adverse Event|2|||
130153881|NCT02697773|468523773|FG000|Overall Study|Death|0|||
130153882|NCT02697773|468523774|FG001|Overall Study|Death|0|||
130153883|NCT02697773|468523775|FG002|Overall Study|Death|2|||
130153884|NCT02697773|468523773|FG000|Overall Study|Lack of Efficacy|4|||
130153885|NCT02697773|468523774|FG001|Overall Study|Lack of Efficacy|6|||
130153886|NCT02697773|468523775|FG002|Overall Study|Lack of Efficacy|6|||
130153887|NCT02697773|468523773|FG000|Overall Study|Lost to Follow-up|5|||
130153888|NCT02697773|468523774|FG001|Overall Study|Lost to Follow-up|5|||
130153889|NCT02697773|468523775|FG002|Overall Study|Lost to Follow-up|7|||
130153890|NCT02697773|468523773|FG000|Overall Study|Other|15|||
130153891|NCT02697773|468523774|FG001|Overall Study|Other|11|||
130153892|NCT02697773|468523775|FG002|Overall Study|Other|10|||
130153893|NCT02697773|468523773|FG000|Overall Study|Protocol Violation|1|||
130153894|NCT02697773|468523774|FG001|Overall Study|Protocol Violation|1|||
130153895|NCT02697773|468523775|FG002|Overall Study|Protocol Violation|0|||
130153896|NCT02697773|468523773|FG000|Overall Study|Withdrawal by Subject|10|||
130153897|NCT02697773|468523774|FG001|Overall Study|Withdrawal by Subject|13|||
130153898|NCT02697773|468523775|FG002|Overall Study|Withdrawal by Subject|13|||
130153899|NCT02697773|468523773|FG000|Overall Study|Randomized but not treated|1|||
130153900|NCT02697773|468523774|FG001|Overall Study|Randomized but not treated|1|||
130153901|NCT02697773|468523775|FG002|Overall Study|Randomized but not treated|0|||
130153902|NCT00613834|468523776|FG000|Overall Study|Withdrawal by Subject|0|||
130153903|NCT00613834|468523777|FG001|Overall Study|Withdrawal by Subject|3|||
130153904|NCT00293202|468523778|FG000|Overall Study|Withdrawal by Subject|1|||
130153905|NCT00293202|468523779|FG001|Overall Study|Withdrawal by Subject|2|||
130153906|NCT00293202|468523778|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
130153907|NCT00293202|468523779|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
130153908|NCT00293202|468523778|FG000|Overall Study|on-hold due to fistula maturation time|1|||
130153909|NCT00293202|468523779|FG001|Overall Study|on-hold due to fistula maturation time|0|||
130153910|NCT02442271|468523780|FG000|Overall Study|Adverse Event|1|||
130153911|NCT02442271|468523780|FG000|Overall Study|Withdrew Consent|1|||
130153912|NCT02442271|468523780|FG000|Overall Study|Lost to Follow-up|1|||
130153913|NCT02442271|468523780|FG000|Overall Study|Other|1|||
130153914|NCT01560507|468523783|FG000|Overall Study|Lost to Follow-up|3|||
130153915|NCT01560507|468523784|FG001|Overall Study|Lost to Follow-up|1|||
130153916|NCT01560507|468523785|FG002|Overall Study|Lost to Follow-up|2|||
130153917|NCT01560507|468523783|FG000|Overall Study|Withdrawal by Subject|1|||
130153918|NCT01560507|468523784|FG001|Overall Study|Withdrawal by Subject|1|||
130153919|NCT01560507|468523785|FG002|Overall Study|Withdrawal by Subject|0|||
130153920|NCT02080832|468523786|FG000|Overall Study|Excluded from analysis by MRI|9|||
130153921|NCT02080832|468523787|FG001|Overall Study|Excluded from analysis by MRI|10|||
130153922|NCT02080832|468523788|FG002|Overall Study|Excluded from analysis by MRI|14|||
130153923|NCT02080832|468523786|FG000|Overall Study|Lost to Follow-up|0|||
130153924|NCT02080832|468523787|FG001|Overall Study|Lost to Follow-up|2|||
130153925|NCT02080832|468523788|FG002|Overall Study|Lost to Follow-up|2|||
130153926|NCT01118117|468523789|FG000|Overall Study|Death|8|||
130153927|NCT01118117|468523790|FG001|Overall Study|Death|0|||
130153928|NCT01118117|468523789|FG000|Overall Study|Lost to Follow-up|6|||
130153929|NCT01118117|468523790|FG001|Overall Study|Lost to Follow-up|0|||
130153930|NCT01118117|468523789|FG000|Overall Study|Missed 12 Month Visit|7|||
130153931|NCT01118117|468523790|FG001|Overall Study|Missed 12 Month Visit|0|||
130153932|NCT01660022|468523791|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
130153933|NCT01660022|468523792|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
130153934|NCT01660022|468523793|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
130153935|NCT01660022|468523794|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
130153936|NCT01660022|468523795|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
130153937|NCT01660022|468523796|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
130153938|NCT01660022|468523791|FG000|First Sequence (7 Days)|Adverse Event|0|||
130153939|NCT01660022|468523792|FG001|First Sequence (7 Days)|Adverse Event|0|||
130153940|NCT01660022|468523793|FG002|First Sequence (7 Days)|Adverse Event|0|||
130153941|NCT01660022|468523794|FG003|First Sequence (7 Days)|Adverse Event|0|||
130153942|NCT01660022|468523795|FG004|First Sequence (7 Days)|Adverse Event|1|||
130153943|NCT01660022|468523796|FG005|First Sequence (7 Days)|Adverse Event|3|||
130153944|NCT01660022|468523791|FG000|First Sequence (7 Days)|Protocol Violation|0|||
130153945|NCT01660022|468523792|FG001|First Sequence (7 Days)|Protocol Violation|0|||
130153946|NCT01660022|468523793|FG002|First Sequence (7 Days)|Protocol Violation|0|||
130153947|NCT01660022|468523794|FG003|First Sequence (7 Days)|Protocol Violation|0|||
130153948|NCT01660022|468523795|FG004|First Sequence (7 Days)|Protocol Violation|0|||
130153949|NCT01660022|468523796|FG005|First Sequence (7 Days)|Protocol Violation|1|||
130153950|NCT02427984|468523797|FG000|Overall Study|Lost to Follow-up|13|||
130153951|NCT02427984|468523798|FG001|Overall Study|Lost to Follow-up|5|||
130153952|NCT02427984|468523799|FG002|Overall Study|Lost to Follow-up|18|||
130153953|NCT03545191|468523801|FG000|Overall Study|Death|1|||
130153954|NCT03545191|468523802|FG001|Overall Study|Death|0|||
130153955|NCT03545191|468523803|FG002|Overall Study|Death|0|||
130153956|NCT03545191|468523801|FG000|Overall Study|Adverse Event|4|||
130153957|NCT03545191|468523802|FG001|Overall Study|Adverse Event|2|||
130153958|NCT03545191|468523803|FG002|Overall Study|Adverse Event|7|||
130153959|NCT03545191|468523801|FG000|Overall Study|Other reasons|3|||
130153960|NCT03545191|468523802|FG001|Overall Study|Other reasons|11|||
130153961|NCT03545191|468523803|FG002|Overall Study|Other reasons|8|||
130153962|NCT03545191|468523801|FG000|Overall Study|Withdrawal by Subject|13|||
130153963|NCT03545191|468523802|FG001|Overall Study|Withdrawal by Subject|10|||
130153964|NCT03545191|468523803|FG002|Overall Study|Withdrawal by Subject|12|||
130153965|NCT03545191|468523801|FG000|Overall Study|Lost to Follow-up|1|||
130153966|NCT03545191|468523802|FG001|Overall Study|Lost to Follow-up|2|||
130153967|NCT03545191|468523803|FG002|Overall Study|Lost to Follow-up|3|||
130153968|NCT02181296|468523808|FG000|Overall Study|Lost to Follow-up|7|||
130153969|NCT02181296|468523809|FG001|Overall Study|Lost to Follow-up|6|||
130153970|NCT02149121|468523810|FG000|Main Study Period|Lack of Efficacy|2|||
130153971|NCT02149121|468523811|FG001|Main Study Period|Lack of Efficacy|2|||
130153972|NCT02149121|468523812|FG002|Main Study Period|Lack of Efficacy|1|||
130153973|NCT02149121|468523813|FG003|Main Study Period|Lack of Efficacy|0|||
130153974|NCT02149121|468523814|FG004|Main Study Period|Lack of Efficacy|0|||
130153975|NCT02149121|468523815|FG005|Main Study Period|Lack of Efficacy|0|||
130153976|NCT02149121|468523816|FG006|Main Study Period|Lack of Efficacy|0|||
130153977|NCT02149121|468523810|FG000|Main Study Period|Withdrawal by Subject|9|||
130153978|NCT02149121|468523811|FG001|Main Study Period|Withdrawal by Subject|5|||
130153979|NCT02149121|468523812|FG002|Main Study Period|Withdrawal by Subject|1|||
130153980|NCT02149121|468523813|FG003|Main Study Period|Withdrawal by Subject|0|||
130153981|NCT02149121|468523814|FG004|Main Study Period|Withdrawal by Subject|0|||
130153982|NCT02149121|468523815|FG005|Main Study Period|Withdrawal by Subject|0|||
130153983|NCT02149121|468523816|FG006|Main Study Period|Withdrawal by Subject|0|||
130153984|NCT02149121|468523810|FG000|Main Study Period|Adverse Event|2|||
130153985|NCT02149121|468523811|FG001|Main Study Period|Adverse Event|5|||
130153986|NCT02149121|468523812|FG002|Main Study Period|Adverse Event|1|||
130153987|NCT02149121|468523813|FG003|Main Study Period|Adverse Event|0|||
130153988|NCT02149121|468523814|FG004|Main Study Period|Adverse Event|0|||
130153989|NCT02149121|468523815|FG005|Main Study Period|Adverse Event|0|||
130153990|NCT02149121|468523816|FG006|Main Study Period|Adverse Event|0|||
130153991|NCT02149121|468523810|FG000|Main Study Period|Protocol Violation|2|||
130153992|NCT02149121|468523811|FG001|Main Study Period|Protocol Violation|0|||
130153993|NCT02149121|468523812|FG002|Main Study Period|Protocol Violation|0|||
130153994|NCT02149121|468523813|FG003|Main Study Period|Protocol Violation|0|||
130153995|NCT02149121|468523814|FG004|Main Study Period|Protocol Violation|0|||
130153996|NCT02149121|468523815|FG005|Main Study Period|Protocol Violation|0|||
130153997|NCT02149121|468523816|FG006|Main Study Period|Protocol Violation|0|||
130153998|NCT02149121|468523810|FG000|Main Study Period|Lost to Follow-up|2|||
130153999|NCT02149121|468523811|FG001|Main Study Period|Lost to Follow-up|1|||
130154000|NCT02149121|468523812|FG002|Main Study Period|Lost to Follow-up|0|||
130154001|NCT02149121|468523813|FG003|Main Study Period|Lost to Follow-up|0|||
130154002|NCT02149121|468523814|FG004|Main Study Period|Lost to Follow-up|0|||
130154003|NCT02149121|468523815|FG005|Main Study Period|Lost to Follow-up|0|||
130154004|NCT02149121|468523816|FG006|Main Study Period|Lost to Follow-up|0|||
130154005|NCT02149121|468523810|FG000|Main Study Period|Death|1|||
130154006|NCT02149121|468523811|FG001|Main Study Period|Death|0|||
130154007|NCT02149121|468523812|FG002|Main Study Period|Death|0|||
130154008|NCT02149121|468523813|FG003|Main Study Period|Death|0|||
130154009|NCT02149121|468523814|FG004|Main Study Period|Death|0|||
130154010|NCT02149121|468523815|FG005|Main Study Period|Death|0|||
130154011|NCT02149121|468523816|FG006|Main Study Period|Death|0|||
130154012|NCT02149121|468523810|FG000|Main Study Period|Physician Decision|1|||
130154013|NCT02149121|468523811|FG001|Main Study Period|Physician Decision|0|||
130154014|NCT02149121|468523812|FG002|Main Study Period|Physician Decision|0|||
130154015|NCT02149121|468523813|FG003|Main Study Period|Physician Decision|0|||
130154016|NCT02149121|468523814|FG004|Main Study Period|Physician Decision|0|||
130154017|NCT02149121|468523815|FG005|Main Study Period|Physician Decision|0|||
130154018|NCT02149121|468523816|FG006|Main Study Period|Physician Decision|0|||
130154019|NCT02149121|468523810|FG000|Main Study Period|Developed any malignancy|0|||
130154020|NCT02149121|468523811|FG001|Main Study Period|Developed any malignancy|1|||
130154021|NCT02149121|468523812|FG002|Main Study Period|Developed any malignancy|1|||
130154022|NCT02149121|468523813|FG003|Main Study Period|Developed any malignancy|0|||
130154023|NCT02149121|468523814|FG004|Main Study Period|Developed any malignancy|0|||
130154024|NCT02149121|468523815|FG005|Main Study Period|Developed any malignancy|0|||
130154025|NCT02149121|468523816|FG006|Main Study Period|Developed any malignancy|0|||
130154026|NCT02149121|468523810|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
130154027|NCT02149121|468523811|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
130154028|NCT02149121|468523812|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
130154029|NCT02149121|468523813|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
130154030|NCT02149121|468523814|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
130154031|NCT02149121|468523815|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
130154032|NCT02149121|468523816|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
130154033|NCT02149121|468523810|FG000|Main Study Period|Disease progression|0|||
130154034|NCT02149121|468523811|FG001|Main Study Period|Disease progression|1|||
130154035|NCT02149121|468523812|FG002|Main Study Period|Disease progression|0|||
130154036|NCT02149121|468523813|FG003|Main Study Period|Disease progression|0|||
130154037|NCT02149121|468523814|FG004|Main Study Period|Disease progression|0|||
130154038|NCT02149121|468523815|FG005|Main Study Period|Disease progression|0|||
130154039|NCT02149121|468523816|FG006|Main Study Period|Disease progression|0|||
130154040|NCT02149121|468523810|FG000|Extension Study Period|Withdrawal by Subject|0|||
130154041|NCT02149121|468523811|FG001|Extension Study Period|Withdrawal by Subject|0|||
130154042|NCT02149121|468523812|FG002|Extension Study Period|Withdrawal by Subject|0|||
130154043|NCT02149121|468523813|FG003|Extension Study Period|Withdrawal by Subject|1|||
130154044|NCT02149121|468523814|FG004|Extension Study Period|Withdrawal by Subject|0|||
130154045|NCT02149121|468523815|FG005|Extension Study Period|Withdrawal by Subject|2|||
130154046|NCT02149121|468523816|FG006|Extension Study Period|Withdrawal by Subject|0|||
130154047|NCT00766831|468523817|FG000|Overall Study|Withdrawal by Subject|4|||
130154048|NCT00766831|468523817|FG000|Overall Study|Lost to Follow-up|3|||
130154049|NCT00766831|468523817|FG000|Overall Study|Adverse Event|20|||
130154050|NCT00766831|468523817|FG000|Overall Study|Protocol Violation|15|||
130154051|NCT00766831|468523817|FG000|Overall Study|Physician Decision|5|||
130154052|NCT00766831|468523817|FG000|Overall Study|Withdrawal of consent|26|||
130154053|NCT00766831|468523817|FG000|Overall Study|Non cooperation by participants|14|||
130154054|NCT00766831|468523817|FG000|Overall Study|Other|28|||
130154055|NCT03166124|468523818|FG000|Treatment Period 1|Adverse Event|0|||
130154056|NCT03166124|468523819|FG001|Treatment Period 1|Adverse Event|0|||
130154057|NCT03166124|468523820|FG002|Treatment Period 1|Adverse Event|1|||
130154058|NCT03166124|468523821|FG003|Treatment Period 1|Adverse Event|0|||
130154059|NCT03166124|468523818|FG000|Wash-out Period|Withdrawal by Subject|0|||
130154060|NCT03166124|468523819|FG001|Wash-out Period|Withdrawal by Subject|1|||
130154061|NCT03166124|468523820|FG002|Wash-out Period|Withdrawal by Subject|0|||
130154062|NCT03166124|468523821|FG003|Wash-out Period|Withdrawal by Subject|1|||
130154063|NCT03166124|468523818|FG000|Wash-out Period|Adverse Event|0|||
130154064|NCT03166124|468523819|FG001|Wash-out Period|Adverse Event|1|||
130154065|NCT03166124|468523820|FG002|Wash-out Period|Adverse Event|1|||
130154066|NCT03166124|468523821|FG003|Wash-out Period|Adverse Event|0|||
130154067|NCT01172821|468523824|FG000|Overall Study|Adverse Event|5|||
130154068|NCT01172821|468523825|FG001|Overall Study|Adverse Event|2|||
130154069|NCT01172821|468523826|FG002|Overall Study|Adverse Event|2|||
130154070|NCT01172821|468523827|FG003|Overall Study|Adverse Event|7|||
130154071|NCT01172821|468523824|FG000|Overall Study|Protocol Violation|0|||
130154072|NCT01172821|468523825|FG001|Overall Study|Protocol Violation|2|||
130154073|NCT01172821|468523826|FG002|Overall Study|Protocol Violation|1|||
130154074|NCT01172821|468523827|FG003|Overall Study|Protocol Violation|2|||
130154075|NCT01172821|468523824|FG000|Overall Study|Lost to Follow-up|4|||
130154076|NCT01172821|468523825|FG001|Overall Study|Lost to Follow-up|1|||
130154077|NCT01172821|468523826|FG002|Overall Study|Lost to Follow-up|2|||
130154078|NCT01172821|468523827|FG003|Overall Study|Lost to Follow-up|2|||
130154079|NCT01172821|468523824|FG000|Overall Study|Withdrawal by Subject|2|||
130154080|NCT01172821|468523825|FG001|Overall Study|Withdrawal by Subject|3|||
130154081|NCT01172821|468523826|FG002|Overall Study|Withdrawal by Subject|3|||
130154082|NCT01172821|468523827|FG003|Overall Study|Withdrawal by Subject|3|||
130154083|NCT01172821|468523824|FG000|Overall Study|Other|3|||
130154084|NCT01172821|468523825|FG001|Overall Study|Other|4|||
130154085|NCT01172821|468523826|FG002|Overall Study|Other|5|||
130154086|NCT01172821|468523827|FG003|Overall Study|Other|3|||
130154087|NCT00094094|468523828|FG000|Overall Study|Death|2|||
130154088|NCT00094094|468523828|FG000|Overall Study|Lack of Efficacy|23|||
130154089|NCT00094094|468523828|FG000|Overall Study|Adverse Event|7|||
130154090|NCT00710749|468523829|FG000|First Intervention|Withdrawal by Subject|1|||
130154091|NCT00710749|468523830|FG001|First Intervention|Withdrawal by Subject|0|||
130154092|NCT05626803|468526473|FG000|Overall Study|Lost to Follow-up|0|||
130154093|NCT05626803|468526474|FG001|Overall Study|Lost to Follow-up|1|||
130154094|NCT05626803|468526475|FG002|Overall Study|Lost to Follow-up|0|||
130154095|NCT05626803|468526476|FG003|Overall Study|Lost to Follow-up|0|||
130154096|NCT01000610|468526481|FG000|Overall Study|Adverse Event|1|||
130154097|NCT01000610|468526481|FG000|Overall Study|Lost to Follow-up|4|||
130154098|NCT01000610|468526481|FG000|Overall Study|Treatment failure|1|||
130154099|NCT00493246|468526482|FG000|Overall Study|Withdrawal by Subject|0|||
130154100|NCT00493246|468526483|FG001|Overall Study|Withdrawal by Subject|0|||
130154101|NCT00493246|468526484|FG002|Overall Study|Withdrawal by Subject|0|||
130154102|NCT00493246|468526485|FG003|Overall Study|Withdrawal by Subject|0|||
130154103|NCT00493246|468526486|FG004|Overall Study|Withdrawal by Subject|1|||
130154104|NCT00493246|468526487|FG005|Overall Study|Withdrawal by Subject|0|||
130154105|NCT00493246|468526488|FG006|Overall Study|Withdrawal by Subject|0|||
130154106|NCT00493246|468526489|FG007|Overall Study|Withdrawal by Subject|0|||
130154107|NCT00493246|468526482|FG000|Overall Study|No access to draw blood|0|||
130154108|NCT00493246|468526483|FG001|Overall Study|No access to draw blood|0|||
130154109|NCT00493246|468526484|FG002|Overall Study|No access to draw blood|0|||
130154110|NCT00493246|468526485|FG003|Overall Study|No access to draw blood|0|||
130154111|NCT00493246|468526486|FG004|Overall Study|No access to draw blood|0|||
130154112|NCT00493246|468526487|FG005|Overall Study|No access to draw blood|1|||
130154113|NCT00493246|468526488|FG006|Overall Study|No access to draw blood|0|||
130154114|NCT00493246|468526489|FG007|Overall Study|No access to draw blood|0|||
130154115|NCT00493246|468526482|FG000|Overall Study|Lost to Follow-up|0|||
130154116|NCT00493246|468526483|FG001|Overall Study|Lost to Follow-up|0|||
130154117|NCT00493246|468526484|FG002|Overall Study|Lost to Follow-up|0|||
130154118|NCT00493246|468526485|FG003|Overall Study|Lost to Follow-up|0|||
130154119|NCT00493246|468526486|FG004|Overall Study|Lost to Follow-up|0|||
130154120|NCT00493246|468526487|FG005|Overall Study|Lost to Follow-up|0|||
130154121|NCT00493246|468526488|FG006|Overall Study|Lost to Follow-up|1|||
130154122|NCT00493246|468526489|FG007|Overall Study|Lost to Follow-up|0|||
130154123|NCT02698865|468526491|FG000|Overall Study|Other|11|||
130154124|NCT02698865|468526492|FG001|Overall Study|Other|11|||
130154125|NCT02698865|468526491|FG000|Overall Study|Withdrawal by Subject|20|||
130154126|NCT02698865|468526492|FG001|Overall Study|Withdrawal by Subject|16|||
130154127|NCT02698865|468526491|FG000|Overall Study|Physician Decision|0|||
130154128|NCT02698865|468526492|FG001|Overall Study|Physician Decision|4|||
130154129|NCT02698865|468526491|FG000|Overall Study|Lost to Follow-up|4|||
130154130|NCT02698865|468526492|FG001|Overall Study|Lost to Follow-up|2|||
130154131|NCT03861481|468526493|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
130154132|NCT03861481|468526494|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
130154133|NCT03861481|468526493|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
130154134|NCT03861481|468526494|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
130154135|NCT03861481|468526493|FG000|Overall Study|Relapse|1|||
130154136|NCT03861481|468526494|FG001|Overall Study|Relapse|0|||
130154137|NCT03861481|468526493|FG000|Overall Study|Withdrawal by Subject|0|||
130154138|NCT03861481|468526494|FG001|Overall Study|Withdrawal by Subject|1|||
130154139|NCT03861481|468526493|FG000|Overall Study|Lack of Efficacy|4|||
130154140|NCT03861481|468526494|FG001|Overall Study|Lack of Efficacy|5|||
130154141|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
130154142|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
130154143|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
130154144|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
129979594|NCT04488770|467889398|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979595|NCT04488770|467889399|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130154145|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
130154146|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
130154147|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
130154148|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
130154149|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
130154150|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
130154151|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
130154152|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
130154153|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
130154154|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
130154155|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
130154156|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
130154157|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130154158|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
130154159|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
130154160|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130154161|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130154162|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130154163|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130154164|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
130154165|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
130154166|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130154167|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130154168|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
130154169|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130154170|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
130154171|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
130154172|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
130154173|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
130154174|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130154175|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130154176|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
130154177|NCT00773734|468526495|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130154178|NCT00773734|468526496|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130154179|NCT00773734|468526497|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130154180|NCT00773734|468526498|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
130154181|NCT00773734|468526499|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
130154182|NCT00773734|468526500|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
130154183|NCT00773734|468526495|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130154184|NCT00773734|468526496|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
130154185|NCT00773734|468526497|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130154186|NCT00773734|468526498|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
130154187|NCT00773734|468526499|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
130154188|NCT00773734|468526500|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
130154189|NCT00773734|468526495|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130154190|NCT00773734|468526496|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
130154191|NCT00773734|468526497|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
130154192|NCT00773734|468526498|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
130154193|NCT00773734|468526499|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130154194|NCT00773734|468526500|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
130154195|NCT00773734|468526495|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130154196|NCT00773734|468526496|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
130154197|NCT00773734|468526497|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
130154198|NCT00773734|468526498|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130154199|NCT00773734|468526499|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
130154200|NCT00773734|468526500|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
130154201|NCT00773734|468526495|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130154202|NCT00773734|468526496|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
130154203|NCT00773734|468526497|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
130154204|NCT00773734|468526498|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130154205|NCT00773734|468526499|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130154206|NCT00773734|468526500|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
130154207|NCT00773734|468526495|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
130154208|NCT00773734|468526496|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130154209|NCT00773734|468526497|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130154210|NCT00773734|468526498|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130154211|NCT00773734|468526499|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
130154212|NCT00773734|468526500|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
130154213|NCT00773734|468526495|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
130154214|NCT00773734|468526496|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
130154215|NCT00773734|468526497|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
130154216|NCT00773734|468526498|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
130154217|NCT00773734|468526499|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
130154218|NCT00773734|468526500|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
130154219|NCT00773734|468526495|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129979596|NCT04488770|467889400|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979597|NCT04488770|467889401|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130154220|NCT00773734|468526496|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130154221|NCT00773734|468526497|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130154222|NCT00773734|468526498|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
130154223|NCT00773734|468526499|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
130154224|NCT00773734|468526500|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
130154225|NCT00773734|468526495|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
130154226|NCT00773734|468526496|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
130154227|NCT00773734|468526497|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
130154228|NCT00773734|468526498|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
130154229|NCT00773734|468526499|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
130154230|NCT00773734|468526500|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
130154231|NCT00773734|468526495|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
130154232|NCT00773734|468526496|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
130154233|NCT00773734|468526497|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
130154234|NCT00773734|468526498|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
129979598|NCT04488770|467889402|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130154235|NCT00773734|468526499|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
130154236|NCT00773734|468526500|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
130154237|NCT00773734|468526495|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
130154238|NCT00773734|468526496|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
130154239|NCT00773734|468526497|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
130154240|NCT00773734|468526498|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
130154241|NCT00773734|468526499|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
130154242|NCT00773734|468526500|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
130154243|NCT00773734|468526495|FG000|Extension: Active Treatment Week 24-52|Other|0|||
130154244|NCT00773734|468526496|FG001|Extension: Active Treatment Week 24-52|Other|0|||
130154245|NCT00773734|468526497|FG002|Extension: Active Treatment Week 24-52|Other|1|||
130154246|NCT00773734|468526498|FG003|Extension: Active Treatment Week 24-52|Other|2|||
130154247|NCT00773734|468526499|FG004|Extension: Active Treatment Week 24-52|Other|0|||
130154248|NCT00773734|468526500|FG005|Extension: Active Treatment Week 24-52|Other|1|||
130154249|NCT00773734|468526495|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130154250|NCT00773734|468526496|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130154251|NCT00773734|468526497|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130154252|NCT00773734|468526498|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
130154253|NCT00773734|468526499|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130154254|NCT00773734|468526500|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
130154255|NCT00773734|468526495|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130154256|NCT00773734|468526496|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130154257|NCT00773734|468526497|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
130154258|NCT00773734|468526498|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
130154259|NCT00773734|468526499|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130154260|NCT00773734|468526500|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
130154261|NCT00773734|468526495|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130154262|NCT00773734|468526496|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130154263|NCT00773734|468526497|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
130154264|NCT00773734|468526498|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
130154265|NCT00773734|468526499|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130154266|NCT00773734|468526500|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
130154267|NCT00773734|468526495|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130154268|NCT00773734|468526496|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130154269|NCT00773734|468526497|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
130154270|NCT00773734|468526498|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
130154271|NCT00773734|468526499|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130154272|NCT00773734|468526500|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
130154273|NCT01220297|468526503|FG000|Overall Study|Death|2|||
130154274|NCT01220297|468526503|FG000|Overall Study|Lost to Follow-up|1|||
130154275|NCT01287039|468526504|FG000|Overall Study|Noncompliance with study procedures|0|||
130154276|NCT01287039|468526505|FG001|Overall Study|Noncompliance with study procedures|1|||
130154277|NCT01287039|468526504|FG000|Overall Study|Change of location/residence|0|||
130154278|NCT01287039|468526505|FG001|Overall Study|Change of location/residence|3|||
130154279|NCT01287039|468526504|FG000|Overall Study|Elective surgery|0|||
130154280|NCT01287039|468526505|FG001|Overall Study|Elective surgery|1|||
130154281|NCT01287039|468526504|FG000|Overall Study|Protocol Violation|2|||
130154282|NCT01287039|468526505|FG001|Overall Study|Protocol Violation|3|||
130154283|NCT01287039|468526504|FG000|Overall Study|Excluded medication taken|1|||
130154284|NCT01287039|468526505|FG001|Overall Study|Excluded medication taken|0|||
130154285|NCT01287039|468526504|FG000|Overall Study|Noncompliance with study medication|0|||
130154286|NCT01287039|468526505|FG001|Overall Study|Noncompliance with study medication|1|||
130154287|NCT01287039|468526504|FG000|Overall Study|Problem with travel|0|||
130154288|NCT01287039|468526505|FG001|Overall Study|Problem with travel|1|||
130154289|NCT01287039|468526504|FG000|Overall Study|Death|1|||
130154290|NCT01287039|468526505|FG001|Overall Study|Death|0|||
130154291|NCT01287039|468526504|FG000|Overall Study|Change of residence|1|||
130154292|NCT01287039|468526505|FG001|Overall Study|Change of residence|0|||
130154293|NCT01287039|468526504|FG000|Overall Study|Adverse Event|7|||
130154294|NCT01287039|468526505|FG001|Overall Study|Adverse Event|4|||
130154295|NCT01287039|468526504|FG000|Overall Study|Withdrawal by Subject|14|||
130154296|NCT01287039|468526505|FG001|Overall Study|Withdrawal by Subject|11|||
130154297|NCT01287039|468526504|FG000|Overall Study|Lost to Follow-up|3|||
130154298|NCT01287039|468526505|FG001|Overall Study|Lost to Follow-up|2|||
130154299|NCT05016622|468526506|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
130154300|NCT05016622|468526506|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
130154301|NCT02581163|468526509|FG000|Overall Study|Failure to return|15|||
130154302|NCT02581163|468526509|FG000|Overall Study|Insufficient virological response|3|||
130154303|NCT02581163|468526509|FG000|Overall Study|Withdrew consent|1|||
130154304|NCT02581163|468526509|FG000|Overall Study|Death|1|||
130154305|NCT02581163|468526509|FG000|Overall Study|Other, not specified|9|||
130154306|NCT02791893|468526510|FG000|Blinded Phase|Lost to Follow-up|2|||
130154307|NCT02791893|468526511|FG001|Blinded Phase|Lost to Follow-up|2|||
130154308|NCT02791893|468526510|FG000|Blinded Phase|Withdrawal by Subject|1|||
130154309|NCT02791893|468526511|FG001|Blinded Phase|Withdrawal by Subject|2|||
130154310|NCT02791893|468526510|FG000|Open Label Phase|Lost to Follow-up|3|||
130154311|NCT02791893|468526511|FG001|Open Label Phase|Lost to Follow-up|0|||
130154312|NCT02791893|468526510|FG000|Open Label Phase|Withdrawal by Subject|0|||
130154313|NCT02791893|468526511|FG001|Open Label Phase|Withdrawal by Subject|2|||
130154314|NCT03438396|468526512|FG000|Overall Study|Reason Not Specified|9|||
130154315|NCT03438396|468526512|FG000|Overall Study|Withdrawal by Subject|5|||
130154316|NCT03438396|468526512|FG000|Overall Study|Lost to Follow-up|2|||
130154317|NCT03438396|468526512|FG000|Overall Study|Death|85|||
130154318|NCT03438396|468526512|FG000|Overall Study|Not treated|1|||
130154319|NCT02006628|468526513|FG000|Overall Study|Adverse Event|1|||
130154320|NCT02006628|468526514|FG001|Overall Study|Adverse Event|1|||
130154321|NCT02006628|468526513|FG000|Overall Study|Withdrawal by Subject|2|||
130154322|NCT02006628|468526514|FG001|Overall Study|Withdrawal by Subject|1|||
130154323|NCT00262041|468526515|FG000|Overall Study|Withdrawal by Subject|0|||
130154324|NCT00262041|468526516|FG001|Overall Study|Withdrawal by Subject|3|||
130154325|NCT00262041|468526517|FG002|Overall Study|Withdrawal by Subject|1|||
130154326|NCT00262041|468526515|FG000|Overall Study|Lost to Follow-up|1|||
130154327|NCT00262041|468526516|FG001|Overall Study|Lost to Follow-up|1|||
130154328|NCT00262041|468526517|FG002|Overall Study|Lost to Follow-up|5|||
130154329|NCT00262041|468526515|FG000|Overall Study|Unable to classify|1|||
130154330|NCT00262041|468526516|FG001|Overall Study|Unable to classify|0|||
130154331|NCT00262041|468526517|FG002|Overall Study|Unable to classify|0|||
130154332|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
130154333|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
130154334|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
130154335|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
130154336|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
130154337|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
130154338|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
130154339|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
130154340|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
130154341|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
130154342|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
130154343|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
130154344|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
130154345|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
130154346|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
130154347|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
130154348|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
130154349|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
130154350|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
130154351|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
130154352|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
130154353|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
130154354|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
130154355|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
130154356|NCT01421342|468526518|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
130154357|NCT01421342|468526519|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
130154358|NCT01421342|468526520|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
130154359|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
130154360|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
130154361|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
130154362|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
130154363|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
130154364|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
130154365|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
130154366|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
130154367|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
130154368|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
130154369|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
130154370|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
130154371|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
130154372|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
130154373|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
130154374|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
130154375|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
130154376|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
130154377|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
130154378|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
130154379|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
130154380|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
130154381|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
130154382|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
130154383|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
130154384|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
130154385|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
130154386|NCT01421342|468526518|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
130154387|NCT01421342|468526519|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
130154388|NCT01421342|468526520|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
130154389|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
130154390|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
130154391|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
130154392|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
130154393|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
130154394|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
130154395|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
130154396|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
130154397|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
130154398|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
130154399|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
130154400|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
130154401|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
130154402|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
130154403|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
130154404|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
130154405|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
130154406|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
130154407|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
130154408|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
130154409|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
130154410|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130154411|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130154412|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
130154413|NCT01421342|468526518|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
130154414|NCT01421342|468526519|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
130154415|NCT01421342|468526520|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
130154416|NCT02017860|468526527|FG000|Overall Study|Adverse Event|1|||
130154417|NCT02017860|468526527|FG000|Overall Study|Withdrawal by Subject|1|||
130154418|NCT02488330|468526528|FG000|Overall Study|Adverse Event|1|||
130154419|NCT02488330|468526528|FG000|Overall Study|Physician Decision|2|||
130154420|NCT02488330|468526528|FG000|Overall Study|Death|2|||
130154421|NCT02488330|468526528|FG000|Overall Study|Disease Progression|3|||
130154422|NCT02488330|468526528|FG000|Overall Study|Study Termination by Sponsor|4|||
130154423|NCT01206816|468526532|FG000|Overall Study|Protocol Violation|0|||
130154424|NCT01206816|468526533|FG001|Overall Study|Protocol Violation|0|||
130154425|NCT01206816|468526534|FG002|Overall Study|Protocol Violation|1|||
130154426|NCT01206816|468526535|FG003|Overall Study|Protocol Violation|0|||
130154427|NCT01206816|468526536|FG004|Overall Study|Protocol Violation|0|||
130154428|NCT01206816|468526537|FG005|Overall Study|Protocol Violation|0|||
130154429|NCT01206816|468526538|FG006|Overall Study|Protocol Violation|0|||
130154430|NCT01206816|468526532|FG000|Overall Study|Withdrawal by Subject|0|||
130154431|NCT01206816|468526533|FG001|Overall Study|Withdrawal by Subject|0|||
130154432|NCT01206816|468526534|FG002|Overall Study|Withdrawal by Subject|1|||
130154433|NCT01206816|468526535|FG003|Overall Study|Withdrawal by Subject|0|||
130154434|NCT01206816|468526536|FG004|Overall Study|Withdrawal by Subject|0|||
130154435|NCT01206816|468526537|FG005|Overall Study|Withdrawal by Subject|0|||
130154436|NCT01206816|468526538|FG006|Overall Study|Withdrawal by Subject|0|||
130154437|NCT01206816|468526532|FG000|Overall Study|Progressive disease|3|||
130154438|NCT01206816|468526533|FG001|Overall Study|Progressive disease|3|||
130154439|NCT01206816|468526534|FG002|Overall Study|Progressive disease|13|||
130154440|NCT01206816|468526535|FG003|Overall Study|Progressive disease|3|||
130154441|NCT01206816|468526536|FG004|Overall Study|Progressive disease|3|||
130154442|NCT01206816|468526537|FG005|Overall Study|Progressive disease|16|||
130154443|NCT01206816|468526538|FG006|Overall Study|Progressive disease|3|||
130154444|NCT01206816|468526532|FG000|Overall Study|Other AE|0|||
130154445|NCT01206816|468526533|FG001|Overall Study|Other AE|0|||
130154446|NCT01206816|468526534|FG002|Overall Study|Other AE|4|||
130154447|NCT01206816|468526535|FG003|Overall Study|Other AE|0|||
130154448|NCT01206816|468526536|FG004|Overall Study|Other AE|0|||
130154449|NCT01206816|468526537|FG005|Overall Study|Other AE|3|||
130154450|NCT01206816|468526538|FG006|Overall Study|Other AE|2|||
130154451|NCT01206816|468526532|FG000|Overall Study|other than stated above|0|||
130154452|NCT01206816|468526533|FG001|Overall Study|other than stated above|0|||
130154453|NCT01206816|468526534|FG002|Overall Study|other than stated above|1|||
130154454|NCT01206816|468526535|FG003|Overall Study|other than stated above|0|||
130154455|NCT01206816|468526536|FG004|Overall Study|other than stated above|0|||
130154456|NCT01206816|468526537|FG005|Overall Study|other than stated above|0|||
130154457|NCT01206816|468526538|FG006|Overall Study|other than stated above|1|||
130154458|NCT02384941|468526541|FG000|Overall Study|Adverse Event|11|||
130154459|NCT02384941|468526542|FG001|Overall Study|Adverse Event|13|||
130154460|NCT02384941|468526543|FG002|Overall Study|Adverse Event|17|||
130154461|NCT02384941|468526541|FG000|Overall Study|Lost to Follow-up|3|||
130154462|NCT02384941|468526542|FG001|Overall Study|Lost to Follow-up|2|||
130154463|NCT02384941|468526543|FG002|Overall Study|Lost to Follow-up|1|||
130154464|NCT02384941|468526541|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130154465|NCT02384941|468526542|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130154466|NCT02384941|468526543|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130154467|NCT02384941|468526541|FG000|Overall Study|Physician Decision|1|||
130154468|NCT02384941|468526542|FG001|Overall Study|Physician Decision|1|||
130154469|NCT02384941|468526543|FG002|Overall Study|Physician Decision|0|||
130154470|NCT02384941|468526541|FG000|Overall Study|Protocol Violation|3|||
130154471|NCT02384941|468526542|FG001|Overall Study|Protocol Violation|0|||
130154472|NCT02384941|468526543|FG002|Overall Study|Protocol Violation|0|||
130154473|NCT02384941|468526541|FG000|Overall Study|Withdrawal by Subject|26|||
130154474|NCT02384941|468526542|FG001|Overall Study|Withdrawal by Subject|19|||
130154475|NCT02384941|468526543|FG002|Overall Study|Withdrawal by Subject|20|||
130154476|NCT02384941|468526541|FG000|Overall Study|Pregnancy|0|||
130154477|NCT02384941|468526542|FG001|Overall Study|Pregnancy|0|||
130154478|NCT02384941|468526543|FG002|Overall Study|Pregnancy|1|||
130154479|NCT02384941|468526541|FG000|Overall Study|Other than specified above|4|||
130154480|NCT02384941|468526542|FG001|Overall Study|Other than specified above|0|||
130154481|NCT02384941|468526543|FG002|Overall Study|Other than specified above|1|||
130154482|NCT02493777|468526544|FG000|Overall Study|Lost to Follow-up|0|||
130154483|NCT02493777|468526545|FG001|Overall Study|Lost to Follow-up|1|||
130154484|NCT01642914|468526546|FG000|Overall Study|Adverse Event|11|||
130154485|NCT01642914|468526547|FG001|Overall Study|Adverse Event|7|||
130154486|NCT01642914|468526548|FG002|Overall Study|Adverse Event|15|||
130154487|NCT01642914|468526546|FG000|Overall Study|Lack of Efficacy|9|||
130154488|NCT01642914|468526547|FG001|Overall Study|Lack of Efficacy|4|||
130154489|NCT01642914|468526548|FG002|Overall Study|Lack of Efficacy|2|||
130154490|NCT01642914|468526546|FG000|Overall Study|Protocol Violation|15|||
130154491|NCT01642914|468526547|FG001|Overall Study|Protocol Violation|13|||
130154492|NCT01642914|468526548|FG002|Overall Study|Protocol Violation|6|||
130154493|NCT01642914|468526546|FG000|Overall Study|Withdrawal by Subject|5|||
130154494|NCT01642914|468526547|FG001|Overall Study|Withdrawal by Subject|5|||
130154495|NCT01642914|468526548|FG002|Overall Study|Withdrawal by Subject|10|||
130154496|NCT01642914|468526546|FG000|Overall Study|Lost to Follow-up|5|||
130154497|NCT01642914|468526547|FG001|Overall Study|Lost to Follow-up|3|||
130154498|NCT01642914|468526548|FG002|Overall Study|Lost to Follow-up|7|||
130154499|NCT01642914|468526546|FG000|Overall Study|Other Reason|1|||
130154500|NCT01642914|468526547|FG001|Overall Study|Other Reason|0|||
130154501|NCT01642914|468526548|FG002|Overall Study|Other Reason|0|||
130154502|NCT01705236|468526549|FG000|Overall Study|Lost to Follow-up|1|||
130154503|NCT01705236|468526549|FG000|Overall Study|Administrative problems|2|||
130154504|NCT01705236|468526549|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
130154505|NCT01705236|468526549|FG000|Overall Study|Protocol Violation|3|||
130154506|NCT01705236|468526549|FG000|Overall Study|Abnormal test procedure result(s)|4|||
130154507|NCT01705236|468526549|FG000|Overall Study|Abnormal laboratory value(s)|4|||
130154508|NCT01705236|468526549|FG000|Overall Study|Withdrawal by Subject|5|||
130154509|NCT01705236|468526549|FG000|Overall Study|Adverse Event|5|||
130154510|NCT02370914|468526550|FG000|Overall Study|Protocol Violation|2|||
130154511|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
130154512|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
130154513|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
130154514|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
130154515|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
130154516|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
130154517|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
130154518|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
130154519|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
130154520|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
130154521|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
130154522|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
130154523|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130154524|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130154525|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130154526|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130154527|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
130154528|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
130154529|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
130154530|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
130154531|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
130154532|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
130154533|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
130154534|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
130154535|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
130154536|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
130154537|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
130154538|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
130154539|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Death|0|||
130154540|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Death|1|||
130154541|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Death|0|||
130154542|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Death|0|||
130154543|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130154544|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
130154545|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130154546|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
130154547|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
130154548|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
130154549|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
130154550|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
130154551|NCT02990806|468526554|FG000|Stage 1 (22 Weeks)|Other|1|||
130154552|NCT02990806|468526555|FG001|Stage 1 (22 Weeks)|Other|3|||
130154553|NCT02990806|468526556|FG002|Stage 1 (22 Weeks)|Other|0|||
130154554|NCT02990806|468526557|FG003|Stage 1 (22 Weeks)|Other|0|||
130154555|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
130154556|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
130154557|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
130154558|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
130154559|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Death|1|||
130154560|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Death|0|||
130154561|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Death|0|||
130154562|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Death|0|||
130154563|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
130154564|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
130154565|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
130154566|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
130154567|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
130154568|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
130154569|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
130154570|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
130154571|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130154572|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
130154573|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130154574|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
130154575|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
130154576|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
130154577|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
130154578|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
130154579|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130154580|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130154581|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
130154582|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
130154583|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
130154584|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
130154585|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
130154586|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
130154587|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
130154588|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
130154589|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
130154590|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
130154591|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
130154592|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
130154593|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
130154594|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
130154595|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
130154596|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
130154597|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
130154598|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
130154599|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Other|3|||
130154600|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Other|0|||
130154601|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Other|4|||
130154602|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Other|1|||
130154603|NCT02990806|468526554|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130154604|NCT02990806|468526555|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130154605|NCT02990806|468526556|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
130154606|NCT02990806|468526557|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
130154607|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
130154608|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
130154609|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
130154610|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
130154611|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130154612|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
130154613|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130154614|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
130154615|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130154616|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
130154617|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130154618|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
130154619|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
130154620|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
130154621|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
130154622|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
130154623|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
130154624|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
130154625|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
130154626|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
130154627|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130154628|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130154629|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
130154630|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
130154631|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130154632|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130154633|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
130154634|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
130154635|NCT02990806|468526554|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130154636|NCT02990806|468526555|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130154637|NCT02990806|468526556|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
130154638|NCT02990806|468526557|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
130154639|NCT00977431|468526558|FG000|Overall Study|Other than listed|1|||
130154640|NCT00977431|468526559|FG001|Overall Study|Other than listed|0|||
130154641|NCT00977431|468526560|FG002|Overall Study|Other than listed|0|||
130154642|NCT00977431|468526561|FG003|Overall Study|Other than listed|0|||
130154643|NCT00977431|468526562|FG004|Overall Study|Other than listed|2|||
130154644|NCT00977431|468526558|FG000|Overall Study|Protocol Violation|0|||
130154645|NCT00977431|468526559|FG001|Overall Study|Protocol Violation|0|||
130154646|NCT00977431|468526560|FG002|Overall Study|Protocol Violation|1|||
130154647|NCT00977431|468526561|FG003|Overall Study|Protocol Violation|0|||
130154648|NCT00977431|468526562|FG004|Overall Study|Protocol Violation|0|||
130154649|NCT00977431|468526558|FG000|Overall Study|Adverse Event|3|||
130154650|NCT00977431|468526559|FG001|Overall Study|Adverse Event|0|||
130154651|NCT00977431|468526560|FG002|Overall Study|Adverse Event|4|||
130154652|NCT00977431|468526561|FG003|Overall Study|Adverse Event|0|||
130154653|NCT00977431|468526562|FG004|Overall Study|Adverse Event|6|||
130154654|NCT00977431|468526558|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
130154655|NCT00977431|468526559|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
130154656|NCT00977431|468526560|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
130154657|NCT00977431|468526561|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
130154658|NCT00977431|468526562|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
130154659|NCT00977431|468526558|FG000|Overall Study|Progressive disease|2|||
130154660|NCT00977431|468526559|FG001|Overall Study|Progressive disease|6|||
130154661|NCT00977431|468526560|FG002|Overall Study|Progressive disease|1|||
130154662|NCT00977431|468526561|FG003|Overall Study|Progressive disease|3|||
130154663|NCT00977431|468526562|FG004|Overall Study|Progressive disease|5|||
130154664|NCT01010750|468526563|FG000|Second Intervention|Adverse Event|0|||
130154665|NCT01010750|468526564|FG001|Second Intervention|Adverse Event|1|||
130154666|NCT01010750|468526565|FG002|Second Intervention|Adverse Event|0|||
130154667|NCT01010750|468526566|FG003|Second Intervention|Adverse Event|0|||
130154668|NCT01010750|468526567|FG004|Second Intervention|Adverse Event|0|||
130154669|NCT01010750|468526568|FG005|Second Intervention|Adverse Event|0|||
130154670|NCT03739138|468526570|FG000|Overall Study|Death|0|||
130154671|NCT03739138|468526571|FG001|Overall Study|Death|7|||
130154672|NCT03739138|468526572|FG002|Overall Study|Death|4|||
130154673|NCT03739138|468526573|FG003|Overall Study|Death|13|||
130154674|NCT03739138|468526574|FG004|Overall Study|Death|0|||
130154675|NCT03739138|468526570|FG000|Overall Study|Lost to Follow-up|0|||
130154676|NCT03739138|468526571|FG001|Overall Study|Lost to Follow-up|0|||
130154677|NCT03739138|468526572|FG002|Overall Study|Lost to Follow-up|1|||
130154678|NCT03739138|468526573|FG003|Overall Study|Lost to Follow-up|0|||
130154679|NCT03739138|468526574|FG004|Overall Study|Lost to Follow-up|0|||
130154680|NCT03739138|468526570|FG000|Overall Study|Study Terminated By Sponsor|0|||
130154681|NCT03739138|468526571|FG001|Overall Study|Study Terminated By Sponsor|0|||
130154682|NCT03739138|468526572|FG002|Overall Study|Study Terminated By Sponsor|0|||
130154683|NCT03739138|468526573|FG003|Overall Study|Study Terminated By Sponsor|4|||
130154684|NCT03739138|468526574|FG004|Overall Study|Study Terminated By Sponsor|0|||
130154685|NCT03739138|468526570|FG000|Overall Study|Withdrawal by Subject|0|||
130154686|NCT03739138|468526571|FG001|Overall Study|Withdrawal by Subject|0|||
130154687|NCT03739138|468526572|FG002|Overall Study|Withdrawal by Subject|0|||
130154688|NCT03739138|468526573|FG003|Overall Study|Withdrawal by Subject|1|||
130154689|NCT03739138|468526574|FG004|Overall Study|Withdrawal by Subject|0|||
130154690|NCT02654587|468526575|FG000|Overall Study|patient alive at end of study|22|||
130154691|NCT02654587|468526576|FG001|Overall Study|patient alive at end of study|8|||
130154692|NCT02654587|468526575|FG000|Overall Study|Withdrawal by Subject|1|||
130154693|NCT02654587|468526576|FG001|Overall Study|Withdrawal by Subject|7|||
130154694|NCT01825837|468526577|FG000|PART I|Withdrawal by Subject|0|||
130154695|NCT01825837|468526578|FG001|PART I|Withdrawal by Subject|0|||
130154696|NCT01825837|468526579|FG002|PART I|Withdrawal by Subject|0|||
130154697|NCT01825837|468526580|FG003|PART I|Withdrawal by Subject|6|||
130154698|NCT01825837|468526577|FG000|PART I|Patient non-compliance|0|||
130154699|NCT01825837|468526578|FG001|PART I|Patient non-compliance|0|||
130154700|NCT01825837|468526579|FG002|PART I|Patient non-compliance|0|||
130154701|NCT01825837|468526580|FG003|PART I|Patient non-compliance|1|||
130154702|NCT01825837|468526577|FG000|PART I|Treatment failure|0|||
130154703|NCT01825837|468526578|FG001|PART I|Treatment failure|0|||
130154704|NCT01825837|468526579|FG002|PART I|Treatment failure|0|||
130154705|NCT01825837|468526580|FG003|PART I|Treatment failure|7|||
130154706|NCT01825837|468526577|FG000|PART I|reason unspecified|0|||
130154707|NCT01825837|468526578|FG001|PART I|reason unspecified|0|||
130154708|NCT01825837|468526579|FG002|PART I|reason unspecified|0|||
130154709|NCT01825837|468526580|FG003|PART I|reason unspecified|3|||
130154710|NCT01825837|468526577|FG000|PART II|Withdrawal by Subject|3|||
130154711|NCT01825837|468526578|FG001|PART II|Withdrawal by Subject|3|||
130154712|NCT01825837|468526579|FG002|PART II|Withdrawal by Subject|7|||
130154713|NCT01825837|468526580|FG003|PART II|Withdrawal by Subject|0|||
130154714|NCT01825837|468526577|FG000|PART II|Patient non-compliance|5|||
130154715|NCT01825837|468526578|FG001|PART II|Patient non-compliance|2|||
130154716|NCT01825837|468526579|FG002|PART II|Patient non-compliance|4|||
130154717|NCT01825837|468526580|FG003|PART II|Patient non-compliance|0|||
130154718|NCT01825837|468526577|FG000|PART II|Adverse Event|3|||
130154719|NCT01825837|468526578|FG001|PART II|Adverse Event|3|||
130154720|NCT01825837|468526579|FG002|PART II|Adverse Event|1|||
130154721|NCT01825837|468526580|FG003|PART II|Adverse Event|0|||
130154722|NCT01825837|468526577|FG000|PART II|Treatment failure|6|||
130154723|NCT01825837|468526578|FG001|PART II|Treatment failure|4|||
130154724|NCT01825837|468526579|FG002|PART II|Treatment failure|5|||
130154725|NCT01825837|468526580|FG003|PART II|Treatment failure|0|||
130154726|NCT01825837|468526577|FG000|PART II|reason unspecified|2|||
130154727|NCT01825837|468526578|FG001|PART II|reason unspecified|2|||
130154728|NCT01825837|468526579|FG002|PART II|reason unspecified|2|||
130154729|NCT01825837|468526580|FG003|PART II|reason unspecified|0|||
130154730|NCT00904748|468526581|FG000|Overall Study|Withdrawal by Subject|1|||
130154731|NCT00904748|468526582|FG001|Overall Study|Withdrawal by Subject|1|||
130154732|NCT00904748|468526583|FG002|Overall Study|Withdrawal by Subject|1|||
130154733|NCT00904748|468526584|FG003|Overall Study|Withdrawal by Subject|2|||
130154734|NCT00904748|468526585|FG004|Overall Study|Withdrawal by Subject|0|||
130154735|NCT00904748|468526586|FG005|Overall Study|Withdrawal by Subject|0|||
130154736|NCT00904748|468526581|FG000|Overall Study|Adverse Event|0|||
130154737|NCT00904748|468526582|FG001|Overall Study|Adverse Event|0|||
130154738|NCT00904748|468526583|FG002|Overall Study|Adverse Event|0|||
130154739|NCT00904748|468526584|FG003|Overall Study|Adverse Event|0|||
130154740|NCT00904748|468526585|FG004|Overall Study|Adverse Event|1|||
130154741|NCT00904748|468526586|FG005|Overall Study|Adverse Event|0|||
129979599|NCT04488770|467889403|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130154742|NCT02903238|468526593|FG000|Overall Study|Lost to Follow-up|4|||
130154743|NCT00700817|468526597|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
130154744|NCT00700817|468526598|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
130154745|NCT00700817|468526599|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
130154746|NCT00700817|468526600|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
130154747|NCT00700817|468526601|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
130154748|NCT00700817|468526597|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
130154749|NCT00700817|468526598|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130154750|NCT00700817|468526599|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
130154751|NCT00700817|468526600|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130154752|NCT00700817|468526601|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
130154753|NCT00700817|468526597|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
130154754|NCT00700817|468526598|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
130154755|NCT00700817|468526599|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
130154756|NCT00700817|468526600|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
130154757|NCT00700817|468526601|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
130154758|NCT00700817|468526597|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
130154759|NCT00700817|468526598|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
130154760|NCT00700817|468526599|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
130154761|NCT00700817|468526600|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
130154762|NCT00700817|468526601|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
130154763|NCT00700817|468526597|FG000|Week 0-26 (Main Period)|Unclassified|14|||
129979600|NCT04488770|467889404|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979601|NCT04488770|467889405|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
130154764|NCT00700817|468526598|FG001|Week 0-26 (Main Period)|Unclassified|4|||
130154765|NCT00700817|468526599|FG002|Week 0-26 (Main Period)|Unclassified|8|||
130154766|NCT00700817|468526600|FG003|Week 0-26 (Main Period)|Unclassified|0|||
130154767|NCT00700817|468526601|FG004|Week 0-26 (Main Period)|Unclassified|0|||
130154768|NCT00700817|468526597|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
130154769|NCT00700817|468526598|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
130154770|NCT00700817|468526599|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
130154771|NCT00700817|468526600|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
130154772|NCT00700817|468526601|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
130154773|NCT00700817|468526597|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
130154774|NCT00700817|468526598|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
130154775|NCT00700817|468526599|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
130154776|NCT00700817|468526600|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
130154777|NCT00700817|468526601|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
130154778|NCT00700817|468526597|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
130154779|NCT00700817|468526598|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
130154780|NCT00700817|468526599|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
130154781|NCT00700817|468526600|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
130154782|NCT00700817|468526601|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
130154783|NCT00700817|468526597|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
130154784|NCT00700817|468526598|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
130154785|NCT00700817|468526599|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
130154786|NCT00700817|468526600|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
130154787|NCT00700817|468526601|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
130154788|NCT00700817|468526597|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
130154789|NCT00700817|468526598|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
130154790|NCT00700817|468526599|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
130154791|NCT00700817|468526600|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
130154792|NCT00700817|468526601|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
130154793|NCT00700817|468526597|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130154794|NCT00700817|468526598|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
130154795|NCT00700817|468526599|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130154796|NCT00700817|468526600|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
130154797|NCT00700817|468526601|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
130154798|NCT00700817|468526597|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130154799|NCT00700817|468526598|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
130154800|NCT00700817|468526599|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
130154801|NCT00700817|468526600|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130154802|NCT00700817|468526601|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
130154803|NCT00700817|468526597|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
130154804|NCT00700817|468526598|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
130154805|NCT00700817|468526599|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130154806|NCT00700817|468526600|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130154807|NCT00700817|468526601|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
130154808|NCT00700817|468526597|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
130154809|NCT00700817|468526598|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
130154810|NCT00700817|468526599|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
130154811|NCT00700817|468526600|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
130154812|NCT00700817|468526601|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
130154813|NCT00700817|468526597|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
130154814|NCT00700817|468526598|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
130154815|NCT00700817|468526599|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
130154816|NCT00700817|468526600|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
130154817|NCT00700817|468526601|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
130154818|NCT00767520|468526604|FG000|Overall Study|Participants still on treatment|11|||
130154819|NCT00767520|468526605|FG001|Overall Study|Participants still on treatment|15|||
130154820|NCT00767520|468526604|FG000|Overall Study|Randomized in error and Never treated|0|||
130154821|NCT00767520|468526605|FG001|Overall Study|Randomized in error and Never treated|2|||
130154822|NCT01338987|468526606|FG000|Overall Study|enrolled on new protocol|0|||
130154823|NCT01338987|468526607|FG001|Overall Study|enrolled on new protocol|0|||
130154824|NCT01338987|468526608|FG002|Overall Study|enrolled on new protocol|1|||
130154825|NCT01338987|468526609|FG003|Overall Study|enrolled on new protocol|0|||
130154826|NCT01338987|468526610|FG004|Overall Study|enrolled on new protocol|0|||
130154827|NCT01338987|468526606|FG000|Overall Study|Disease progression on study|2|||
130154828|NCT01338987|468526607|FG001|Overall Study|Disease progression on study|1|||
130154829|NCT01338987|468526608|FG002|Overall Study|Disease progression on study|1|||
130154830|NCT01338987|468526609|FG003|Overall Study|Disease progression on study|0|||
130154831|NCT01338987|468526610|FG004|Overall Study|Disease progression on study|0|||
129979602|NCT04488770|467889406|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979603|NCT04488770|467889407|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979604|NCT04488770|467889408|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979605|NCT04488770|467889396|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979606|NCT04488770|467889397|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979607|NCT04488770|467889398|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979608|NCT04488770|467889399|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979609|NCT04488770|467889400|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979610|NCT04488770|467889401|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
129979611|NCT04488770|467889402|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
129979612|NCT04488770|467889403|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979613|NCT04488770|467889404|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979614|NCT04488770|467889405|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979615|NCT04488770|467889406|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979616|NCT04488770|467889407|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979617|NCT04488770|467889408|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979618|NCT04488770|467889396|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979619|NCT04488770|467889397|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979620|NCT04488770|467889398|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979621|NCT04488770|467889399|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979622|NCT04488770|467889400|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
129979623|NCT04488770|467889401|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979624|NCT04488770|467889402|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979625|NCT04488770|467889403|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979626|NCT04488770|467889404|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979627|NCT04488770|467889405|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979628|NCT04488770|467889406|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979629|NCT04488770|467889407|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979630|NCT04488770|467889408|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979631|NCT01867333|467889409|FG000|Overall Study|Withdrawal by Subject|1|||
129979632|NCT01867333|467889410|FG001|Overall Study|Withdrawal by Subject|0|||
129979633|NCT01867333|467889409|FG000|Overall Study|Adverse Event|1|||
129979634|NCT01867333|467889410|FG001|Overall Study|Adverse Event|0|||
129979635|NCT01867333|467889409|FG000|Overall Study|Participant choice|1|||
129979636|NCT01867333|467889410|FG001|Overall Study|Participant choice|2|||
129979637|NCT01867333|467889409|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
129979638|NCT01867333|467889410|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
129979639|NCT01867333|467889409|FG000|Overall Study|Death|0|||
129979640|NCT01867333|467889410|FG001|Overall Study|Death|1|||
129979641|NCT01867333|467889409|FG000|Overall Study|Physician Decision|3|||
129979642|NCT01867333|467889410|FG001|Overall Study|Physician Decision|2|||
129979643|NCT01867333|467889409|FG000|Overall Study|Switched to alternative treatment|1|||
129979644|NCT01867333|467889410|FG001|Overall Study|Switched to alternative treatment|0|||
129979645|NCT03361605|467889413|FG000|Overall Study|Analyzable data not available|3|||
129979646|NCT00403767|467889417|FG000|Overall Study|Adverse Event|993|||
129979647|NCT00403767|467889418|FG001|Overall Study|Adverse Event|919|||
129979648|NCT00403767|467889417|FG000|Overall Study|Non-compliant with study medication|134|||
129979649|NCT00403767|467889418|FG001|Overall Study|Non-compliant with study medication|164|||
129979650|NCT00403767|467889417|FG000|Overall Study|Consent withdrawn|671|||
129979651|NCT00403767|467889418|FG001|Overall Study|Consent withdrawn|673|||
130154832|NCT00720226|468526619|FG000|Overall Study|Withdrawal by Subject|7|||
130154833|NCT00720226|468526620|FG001|Overall Study|Withdrawal by Subject|4|||
130154834|NCT00958126|468526621|FG000|Overall Study|Serious Adverse Event|0|||
130154835|NCT00958126|468526622|FG001|Overall Study|Serious Adverse Event|2|||
130154836|NCT00958126|468526623|FG002|Overall Study|Serious Adverse Event|0|||
130154837|NCT00958126|468526624|FG003|Overall Study|Serious Adverse Event|0|||
130154838|NCT00958126|468526625|FG004|Overall Study|Serious Adverse Event|0|||
130154839|NCT00958126|468526626|FG005|Overall Study|Serious Adverse Event|0|||
130154840|NCT00958126|468526627|FG006|Overall Study|Serious Adverse Event|1|||
130094714|NCT04034225|468302447|FG000|Overall Study|Study termination by Sponsor|18|||
130094715|NCT04034225|468302447|FG000|Overall Study|Physician Decision|1|||
130094716|NCT04034225|468302447|FG000|Overall Study|Lack of Efficacy|1|||
130094717|NCT01365182|468302448|FG000|Overall Study|Withdrawal by Subject|10|||
130094718|NCT01365182|468302449|FG001|Overall Study|Withdrawal by Subject|13|||
130094719|NCT01365182|468302450|FG002|Overall Study|Withdrawal by Subject|12|||
130094720|NCT01728194|468302457|FG000|Overall Study|Lost to Follow-up|4|||
130094721|NCT01728194|468302458|FG001|Overall Study|Lost to Follow-up|3|||
130094722|NCT01728194|468302457|FG000|Overall Study|Physician Decision|4|||
130094723|NCT01728194|468302458|FG001|Overall Study|Physician Decision|0|||
130094724|NCT01728194|468302457|FG000|Overall Study|Withdrawal by Subject|7|||
130094725|NCT01728194|468302458|FG001|Overall Study|Withdrawal by Subject|3|||
130094726|NCT01728194|468302457|FG000|Overall Study|Perceived Medication Side Effects|4|||
130094727|NCT01728194|468302458|FG001|Overall Study|Perceived Medication Side Effects|0|||
130154841|NCT00958126|468526628|FG007|Overall Study|Serious Adverse Event|0|||
130154842|NCT00958126|468526621|FG000|Overall Study|Withdrawal by Subject|0|||
130154843|NCT00958126|468526622|FG001|Overall Study|Withdrawal by Subject|2|||
130154844|NCT00958126|468526623|FG002|Overall Study|Withdrawal by Subject|0|||
130154845|NCT00958126|468526624|FG003|Overall Study|Withdrawal by Subject|0|||
130154846|NCT00958126|468526625|FG004|Overall Study|Withdrawal by Subject|0|||
130154847|NCT00958126|468526626|FG005|Overall Study|Withdrawal by Subject|0|||
130154848|NCT00958126|468526627|FG006|Overall Study|Withdrawal by Subject|0|||
130154849|NCT00958126|468526628|FG007|Overall Study|Withdrawal by Subject|0|||
130154850|NCT00958126|468526621|FG000|Overall Study|Moved away from study area|0|||
130154851|NCT00958126|468526622|FG001|Overall Study|Moved away from study area|0|||
130154852|NCT00958126|468526623|FG002|Overall Study|Moved away from study area|1|||
130094728|NCT01728194|468302457|FG000|Overall Study|Family Member Request|1|||
130094729|NCT01728194|468302458|FG001|Overall Study|Family Member Request|0|||
130094730|NCT02309372|468302459|FG000|Overall Study|Lost to Follow-up|3|||
130094731|NCT02309372|468302460|FG001|Overall Study|Lost to Follow-up|2|||
130094732|NCT01590810|468302463|FG000|Overall Study|Physician Decision|0|||
130094733|NCT01590810|468302464|FG001|Overall Study|Physician Decision|1|||
130094734|NCT01590810|468302465|FG002|Overall Study|Physician Decision|1|||
130094735|NCT01590810|468302466|FG003|Overall Study|Physician Decision|0|||
130094736|NCT01590810|468302467|FG004|Overall Study|Physician Decision|0|||
130094737|NCT04604015|468302468|FG000|Overall Study|Incomplete Data Collection|33|||
130094738|NCT02129192|468302469|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
130094739|NCT02129192|468302470|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
130094740|NCT01231620|468302471|FG000|Overall Study|Physician Decision|3|||
130094741|NCT01231620|468302472|FG001|Overall Study|Physician Decision|5|||
130094742|NCT01231620|468302473|FG002|Overall Study|Physician Decision|10|||
130154853|NCT00958126|468526624|FG003|Overall Study|Moved away from study area|1|||
130094743|NCT01231620|468302471|FG000|Overall Study|Death|12|||
130094744|NCT01231620|468302472|FG001|Overall Study|Death|14|||
130094745|NCT01231620|468302473|FG002|Overall Study|Death|11|||
130094746|NCT01231620|468302471|FG000|Overall Study|Adverse Event|2|||
130094747|NCT01231620|468302472|FG001|Overall Study|Adverse Event|2|||
130094748|NCT01231620|468302473|FG002|Overall Study|Adverse Event|1|||
130094749|NCT01231620|468302471|FG000|Overall Study|Withdrawal by Subject|6|||
130094750|NCT01231620|468302472|FG001|Overall Study|Withdrawal by Subject|6|||
130094751|NCT01231620|468302473|FG002|Overall Study|Withdrawal by Subject|8|||
130094752|NCT01231620|468302471|FG000|Overall Study|Lost to Follow-up|3|||
130094753|NCT01231620|468302472|FG001|Overall Study|Lost to Follow-up|4|||
130094754|NCT01231620|468302473|FG002|Overall Study|Lost to Follow-up|9|||
130094755|NCT02400281|468302475|FG000|Overall Study|Adverse Event|0|||
130094756|NCT02400281|468302476|FG001|Overall Study|Adverse Event|0|||
130094757|NCT02400281|468302477|FG002|Overall Study|Adverse Event|1|||
130094758|NCT02400281|468302478|FG003|Overall Study|Adverse Event|0|||
130094759|NCT02400281|468302479|FG004|Overall Study|Adverse Event|1|||
130094760|NCT02400281|468302480|FG005|Overall Study|Adverse Event|0|||
130094761|NCT02400281|468302475|FG000|Overall Study|Physician Decision|0|||
130094762|NCT02400281|468302476|FG001|Overall Study|Physician Decision|0|||
130094763|NCT02400281|468302477|FG002|Overall Study|Physician Decision|1|||
130094764|NCT02400281|468302478|FG003|Overall Study|Physician Decision|0|||
130094765|NCT02400281|468302479|FG004|Overall Study|Physician Decision|0|||
130094766|NCT02400281|468302480|FG005|Overall Study|Physician Decision|0|||
130094767|NCT02576652|468302483|FG000|Overall Study|Withdrawal by Subject|2|||
130094768|NCT02441517|468302492|FG000|Overall Study|Lost to Follow-up|1|||
130094769|NCT02441517|468302492|FG000|Overall Study|Withdrawal by Subject|2|||
130094871|NCT01238861|468303868|FG005|Overall Study|Incorrect enrollment/randomization|0|||
130094872|NCT01238861|468303863|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
130094873|NCT01238861|468303864|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
130094874|NCT01238861|468303865|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
130094875|NCT01238861|468303866|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
130094876|NCT01238861|468303867|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
130094877|NCT01238861|468303868|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
130094878|NCT01238861|468303863|FG000|Overall Study|Subject moved out of state/area|0|||
130094879|NCT01238861|468303864|FG001|Overall Study|Subject moved out of state/area|0|||
130094880|NCT01238861|468303865|FG002|Overall Study|Subject moved out of state/area|1|||
130094881|NCT01238861|468303866|FG003|Overall Study|Subject moved out of state/area|1|||
130094882|NCT01238861|468303867|FG004|Overall Study|Subject moved out of state/area|0|||
130094883|NCT01238861|468303868|FG005|Overall Study|Subject moved out of state/area|0|||
130094884|NCT01238861|468303863|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
130094885|NCT01238861|468303864|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
130094886|NCT01238861|468303865|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
130094887|NCT01238861|468303866|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
130094888|NCT01238861|468303867|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
130094889|NCT01238861|468303868|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
130094890|NCT01238861|468303863|FG000|Overall Study|Personal problems|0|||
130094891|NCT01238861|468303864|FG001|Overall Study|Personal problems|0|||
130094892|NCT01238861|468303865|FG002|Overall Study|Personal problems|0|||
130094893|NCT01238861|468303866|FG003|Overall Study|Personal problems|1|||
130094894|NCT01238861|468303867|FG004|Overall Study|Personal problems|0|||
130094895|NCT01238861|468303868|FG005|Overall Study|Personal problems|0|||
130094896|NCT01238861|468303863|FG000|Overall Study|Unable to continue visits|0|||
130094897|NCT01238861|468303864|FG001|Overall Study|Unable to continue visits|0|||
130094898|NCT01238861|468303865|FG002|Overall Study|Unable to continue visits|0|||
130094899|NCT01238861|468303866|FG003|Overall Study|Unable to continue visits|1|||
130094900|NCT01238861|468303867|FG004|Overall Study|Unable to continue visits|0|||
130094901|NCT01238861|468303868|FG005|Overall Study|Unable to continue visits|1|||
130094902|NCT01238861|468303863|FG000|Overall Study|Serious adverse event|0|||
130094903|NCT01238861|468303864|FG001|Overall Study|Serious adverse event|0|||
130094904|NCT01238861|468303865|FG002|Overall Study|Serious adverse event|0|||
130094905|NCT01238861|468303866|FG003|Overall Study|Serious adverse event|0|||
130094906|NCT01238861|468303867|FG004|Overall Study|Serious adverse event|0|||
130094907|NCT01238861|468303868|FG005|Overall Study|Serious adverse event|1|||
130094908|NCT01238861|468303863|FG000|Overall Study|Lack of compliance|0|||
130094909|NCT01238861|468303864|FG001|Overall Study|Lack of compliance|0|||
130094910|NCT01238861|468303865|FG002|Overall Study|Lack of compliance|0|||
130094911|NCT01238861|468303866|FG003|Overall Study|Lack of compliance|0|||
130094912|NCT01238861|468303867|FG004|Overall Study|Lack of compliance|0|||
130094913|NCT01238861|468303868|FG005|Overall Study|Lack of compliance|1|||
130094914|NCT01238861|468303863|FG000|Overall Study|Adverse Event|0|||
130094915|NCT01238861|468303864|FG001|Overall Study|Adverse Event|1|||
130094916|NCT01238861|468303865|FG002|Overall Study|Adverse Event|0|||
130094917|NCT01238861|468303866|FG003|Overall Study|Adverse Event|0|||
130094918|NCT01238861|468303867|FG004|Overall Study|Adverse Event|0|||
130094919|NCT01238861|468303868|FG005|Overall Study|Adverse Event|0|||
130094920|NCT01238861|468303863|FG000|Overall Study|Withdrawal by Subject|6|||
130094921|NCT01238861|468303864|FG001|Overall Study|Withdrawal by Subject|5|||
130094922|NCT01238861|468303865|FG002|Overall Study|Withdrawal by Subject|4|||
130094923|NCT01238861|468303866|FG003|Overall Study|Withdrawal by Subject|8|||
130094924|NCT01238861|468303867|FG004|Overall Study|Withdrawal by Subject|10|||
130094925|NCT01238861|468303868|FG005|Overall Study|Withdrawal by Subject|9|||
130094926|NCT01269346|468303869|FG000|Treatment Phase|Disease progression|3|||
130154923|NCT02510014|468526644|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
130154924|NCT02510014|468526643|FG000|Treatment Period|Adverse Event|11|||
130154925|NCT02510014|468526644|FG001|Treatment Period|Adverse Event|4|||
130154926|NCT02510014|468526643|FG000|Treatment Period|Withdrawal symptoms|3|||
130154927|NCT02510014|468526644|FG001|Treatment Period|Withdrawal symptoms|0|||
130154928|NCT02510014|468526643|FG000|Treatment Period|Lost to Follow-up|80|||
130094927|NCT01269346|468303869|FG000|Treatment Phase|Adverse Event|3|||
130094928|NCT01269346|468303869|FG000|Treatment Phase|Withdrawal by Subject|1|||
130094929|NCT01269346|468303869|FG000|Treatment Phase|Other|2|||
130094930|NCT01269346|468303869|FG000|Extension Phase|Adverse Event|6|||
130094931|NCT01269346|468303869|FG000|Extension Phase|Withdrawal by Subject|4|||
130094932|NCT01269346|468303869|FG000|Extension Phase|Disease progression|22|||
130094933|NCT01269346|468303869|FG000|Extension Phase|Physician decision or participant choice|9|||
130094934|NCT01269346|468303869|FG000|Extension Phase|Clinical progression|1|||
130094935|NCT01269346|468303869|FG000|Extension Phase|Started a prohibited con med|1|||
130094936|NCT01855607|468303870|FG000|Overall Study|Withdrawal by Subject|1|||
130094937|NCT01855607|468303870|FG000|Overall Study|Study was terminated|11|||
130154929|NCT02510014|468526644|FG001|Treatment Period|Lost to Follow-up|19|||
130154930|NCT02510014|468526643|FG000|Treatment Period|Physician Decision|5|||
130154931|NCT02510014|468526644|FG001|Treatment Period|Physician Decision|0|||
130154932|NCT02510014|468526643|FG000|Treatment Period|Withdrawal by Subject|67|||
130154933|NCT02510014|468526644|FG001|Treatment Period|Withdrawal by Subject|24|||
130154934|NCT02510014|468526643|FG000|Treatment Period|Withdrawn by the investigator|7|||
130094938|NCT04511533|468303879|FG000|Treatment|Other|2|||
130094939|NCT04511533|468303879|FG000|Treatment|Withdrawal by Subject|11|||
130094940|NCT04511533|468303879|FG000|Treatment|Death|5|||
130094941|NCT04511533|468303879|FG000|Treatment|Physician Decision|1|||
130094942|NCT04511533|468303879|FG000|Treatment|Progressive Disease|61|||
130094943|NCT04511533|468303879|FG000|Follow-Up|Other|7|||
130094944|NCT04511533|468303879|FG000|Follow-Up|Withdrawal by Subject|5|||
130094945|NCT04511533|468303879|FG000|Follow-Up|Lost to Follow-up|2|||
130094946|NCT04511533|468303879|FG000|Follow-Up|Death|4|||
130094947|NCT04576702|468303880|FG000|Overall Study|Death|1|||
130094948|NCT04576702|468303881|FG001|Overall Study|Death|0|||
130094949|NCT04576702|468303882|FG002|Overall Study|Death|0|||
130094950|NCT04576702|468303883|FG003|Overall Study|Death|0|||
130094951|NCT04576702|468303880|FG000|Overall Study|Withdrawal by Subject|0|||
130094952|NCT04576702|468303881|FG001|Overall Study|Withdrawal by Subject|2|||
130094953|NCT04576702|468303882|FG002|Overall Study|Withdrawal by Subject|1|||
130094954|NCT04576702|468303883|FG003|Overall Study|Withdrawal by Subject|0|||
130094955|NCT04576702|468303880|FG000|Overall Study|Lost to Follow-up|3|||
130094956|NCT04576702|468303881|FG001|Overall Study|Lost to Follow-up|3|||
130094957|NCT04576702|468303882|FG002|Overall Study|Lost to Follow-up|3|||
130094958|NCT04576702|468303883|FG003|Overall Study|Lost to Follow-up|4|||
130094959|NCT01319422|468303886|FG000|Overall Study|Withdrawal by Subject|1|||
130094960|NCT01319422|468303887|FG001|Overall Study|Withdrawal by Subject|0|||
130094961|NCT06104423|468303890|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
130094962|NCT06104423|468303891|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
130094963|NCT06104423|468303892|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
130094964|NCT06104423|468303890|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
130094965|NCT06104423|468303891|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
130094966|NCT06104423|468303892|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
130094967|NCT00727246|468303893|FG000|Overall Study|could not complete MRI|0|||
130094968|NCT00727246|468303894|FG001|Overall Study|could not complete MRI|1|||
130094969|NCT00727246|468303895|FG002|Overall Study|could not complete MRI|0|||
130094970|NCT00727246|468303896|FG003|Overall Study|could not complete MRI|1|||
130094971|NCT00727246|468303893|FG000|Overall Study|incidental finding|0|||
130094972|NCT00727246|468303894|FG001|Overall Study|incidental finding|0|||
129979965|NCT04372121|467889513|FG003|Overall Study|Withdrawal by Subject|0|||
129979966|NCT04372121|467889510|FG000|Overall Study|Study termination|6|||
129979967|NCT04372121|467889511|FG001|Overall Study|Study termination|5|||
129979968|NCT04372121|467889512|FG002|Overall Study|Study termination|1|||
129979969|NCT04372121|467889513|FG003|Overall Study|Study termination|1|||
129979970|NCT04372121|467889510|FG000|Overall Study|Hysterectomy planned|1|||
129979971|NCT04372121|467889511|FG001|Overall Study|Hysterectomy planned|0|||
129979972|NCT04372121|467889512|FG002|Overall Study|Hysterectomy planned|0|||
130094973|NCT00727246|468303895|FG002|Overall Study|incidental finding|0|||
130094974|NCT00727246|468303896|FG003|Overall Study|incidental finding|1|||
130094975|NCT00727246|468303893|FG000|Overall Study|withdrawn|0|||
130094976|NCT00727246|468303894|FG001|Overall Study|withdrawn|0|||
130094977|NCT00727246|468303895|FG002|Overall Study|withdrawn|1|||
130094978|NCT00727246|468303896|FG003|Overall Study|withdrawn|0|||
130094979|NCT02696382|468303899|FG000|Overall Study|Death|7|||
130094980|NCT02696382|468303900|FG001|Overall Study|Death|2|||
130094981|NCT02696382|468303899|FG000|Overall Study|Withdrawal by Subject|5|||
129979973|NCT04372121|467889513|FG003|Overall Study|Hysterectomy planned|0|||
130094982|NCT02696382|468303900|FG001|Overall Study|Withdrawal by Subject|12|||
130094983|NCT02696382|468303899|FG000|Overall Study|Lost to Follow-up|4|||
130094984|NCT02696382|468303900|FG001|Overall Study|Lost to Follow-up|7|||
130094985|NCT01428882|468303910|FG000|Overall Study|Lack of Efficacy|2|||
130094986|NCT01428882|468303911|FG001|Overall Study|Lack of Efficacy|7|||
130094987|NCT01428882|468303910|FG000|Overall Study|Protocol Violation|4|||
129979974|NCT03826030|467889514|FG000|Overall Study|Withdrawal by Subject|2|||
129979975|NCT03826030|467889515|FG001|Overall Study|Withdrawal by Subject|0|||
129979976|NCT03826030|467889516|FG002|Overall Study|Withdrawal by Subject|1|||
130094988|NCT01428882|468303911|FG001|Overall Study|Protocol Violation|3|||
130094989|NCT00429026|468303914|FG000|Overall Study|Inevaluable for response.|40|||
130094990|NCT01539512|468303919|FG000|Overall Study|Adverse Event|9|||
130094991|NCT01539512|468303920|FG001|Overall Study|Adverse Event|7|||
130094992|NCT01539512|468303919|FG000|Overall Study|Physician Decision|1|||
130094993|NCT01539512|468303920|FG001|Overall Study|Physician Decision|1|||
130094994|NCT01539512|468303919|FG000|Overall Study|Withdrawal by Subject|12|||
130094995|NCT01539512|468303920|FG001|Overall Study|Withdrawal by Subject|5|||
130094996|NCT01539512|468303919|FG000|Overall Study|Richter's Transformation|1|||
130094997|NCT01539512|468303920|FG001|Overall Study|Richter's Transformation|0|||
130154935|NCT02510014|468526644|FG001|Treatment Period|Withdrawn by the investigator|1|||
130094998|NCT04668157|468303921|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
130094999|NCT04668157|468303922|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
130095000|NCT04668157|468303921|FG000|Treatment Period (52 Weeks)|Other|0|||
130095001|NCT04668157|468303922|FG001|Treatment Period (52 Weeks)|Other|2|||
130095002|NCT04479358|468303929|FG000|Overall Study|Withdrawal by Subject|0|||
130095003|NCT04479358|468303930|FG001|Overall Study|Withdrawal by Subject|0|||
130095004|NCT04479358|468303931|FG002|Overall Study|Withdrawal by Subject|1|||
130095005|NCT04479358|468303932|FG003|Overall Study|Withdrawal by Subject|0|||
130095006|NCT04479358|468303933|FG004|Overall Study|Withdrawal by Subject|0|||
130095007|NCT04479358|468303934|FG005|Overall Study|Withdrawal by Subject|1|||
130095008|NCT00764465|468303935|FG000|Overall Study|Adverse Event|2|||
130095009|NCT00764465|468303936|FG001|Overall Study|Adverse Event|0|||
130095010|NCT00764465|468303937|FG002|Overall Study|Adverse Event|0|||
130095011|NCT00764465|468303938|FG003|Overall Study|Adverse Event|1|||
130095012|NCT00764465|468303939|FG004|Overall Study|Adverse Event|1|||
130095013|NCT00764465|468303940|FG005|Overall Study|Adverse Event|1|||
130095014|NCT00764465|468303935|FG000|Overall Study|Withdrawal by Subject|0|||
130095015|NCT00764465|468303936|FG001|Overall Study|Withdrawal by Subject|1|||
130095016|NCT00764465|468303937|FG002|Overall Study|Withdrawal by Subject|1|||
130095017|NCT00764465|468303938|FG003|Overall Study|Withdrawal by Subject|0|||
130095018|NCT00764465|468303939|FG004|Overall Study|Withdrawal by Subject|0|||
130095019|NCT00764465|468303940|FG005|Overall Study|Withdrawal by Subject|0|||
130095020|NCT01333501|468303941|FG000|Overall Study|Adverse Event|3|||
130095021|NCT01333501|468303942|FG001|Overall Study|Adverse Event|1|||
130095022|NCT01333501|468303941|FG000|Overall Study|Abnormal laboratory value|2|||
130095023|NCT01333501|468303942|FG001|Overall Study|Abnormal laboratory value|1|||
130095024|NCT01333501|468303941|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130095025|NCT01333501|468303942|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
130095026|NCT01333501|468303941|FG000|Overall Study|Withdrawn consent|3|||
130095027|NCT01333501|468303942|FG001|Overall Study|Withdrawn consent|12|||
130095028|NCT00674440|468303943|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
130095029|NCT00674440|468303943|FG000|Overall Study|did not have surgery, so unevaluable|7|||
130095030|NCT00674440|468303943|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
130095031|NCT03329404|468303944|FG000|Overall Study|The study was suspended.|1|||
130095032|NCT03329404|468303945|FG001|Overall Study|The study was suspended.|4|||
130095033|NCT00914940|468303946|FG000|D0 to D100 Post-transplant|Death|2|||
130095034|NCT00914940|468303946|FG000|D101 to 2 Years Post-transplant|Death|8|||
130095035|NCT00914940|468303946|FG000|2 Years to 5 Years Post-transplant|Death|3|||
130095036|NCT00796367|468303947|FG000|Overall Study|Adverse Event|6|||
130095037|NCT00796367|468303948|FG001|Overall Study|Adverse Event|4|||
130095038|NCT00796367|468303949|FG002|Overall Study|Adverse Event|7|||
130095039|NCT00796367|468303947|FG000|Overall Study|Lost to Follow-up|5|||
130095040|NCT00796367|468303948|FG001|Overall Study|Lost to Follow-up|4|||
130095041|NCT00796367|468303949|FG002|Overall Study|Lost to Follow-up|21|||
130095042|NCT00796367|468303947|FG000|Overall Study|Withdrawal by Subject|9|||
130095043|NCT00796367|468303948|FG001|Overall Study|Withdrawal by Subject|11|||
130095044|NCT00796367|468303949|FG002|Overall Study|Withdrawal by Subject|12|||
130095045|NCT00796367|468303947|FG000|Overall Study|Lack of Efficacy|2|||
130095046|NCT00796367|468303948|FG001|Overall Study|Lack of Efficacy|1|||
130095047|NCT00796367|468303949|FG002|Overall Study|Lack of Efficacy|0|||
130095048|NCT00796367|468303947|FG000|Overall Study|non compliance|3|||
130095049|NCT00796367|468303948|FG001|Overall Study|non compliance|1|||
130095050|NCT00796367|468303949|FG002|Overall Study|non compliance|1|||
130095051|NCT00796367|468303947|FG000|Overall Study|Pregnancy|1|||
130095052|NCT00796367|468303948|FG001|Overall Study|Pregnancy|0|||
130095053|NCT00796367|468303949|FG002|Overall Study|Pregnancy|1|||
130095054|NCT00796367|468303947|FG000|Overall Study|Requirement for restricted medication|2|||
130095055|NCT00796367|468303948|FG001|Overall Study|Requirement for restricted medication|0|||
130095056|NCT00796367|468303949|FG002|Overall Study|Requirement for restricted medication|2|||
130095057|NCT00796367|468303947|FG000|Overall Study|other|2|||
130095058|NCT00796367|468303948|FG001|Overall Study|other|4|||
130095059|NCT00796367|468303949|FG002|Overall Study|other|3|||
130095060|NCT00553319|468303952|FG000|Overall Study|Lost to Follow-up|10|||
130095061|NCT00553319|468303953|FG001|Overall Study|Lost to Follow-up|9|||
130095062|NCT00553319|468303954|FG002|Overall Study|Lost to Follow-up|5|||
130095063|NCT00553319|468303952|FG000|Overall Study|wanted treatment elsewhere|2|||
130095064|NCT00553319|468303953|FG001|Overall Study|wanted treatment elsewhere|1|||
130095065|NCT00553319|468303954|FG002|Overall Study|wanted treatment elsewhere|1|||
130095066|NCT00553319|468303952|FG000|Overall Study|non-compliance|0|||
130095067|NCT00553319|468303953|FG001|Overall Study|non-compliance|0|||
130095068|NCT00553319|468303954|FG002|Overall Study|non-compliance|2|||
130095069|NCT00553319|468303952|FG000|Overall Study|incarceration|1|||
130095070|NCT00553319|468303953|FG001|Overall Study|incarceration|0|||
130095071|NCT00553319|468303954|FG002|Overall Study|incarceration|0|||
130095072|NCT00553319|468303952|FG000|Overall Study|moved|1|||
130095073|NCT00553319|468303953|FG001|Overall Study|moved|0|||
130095074|NCT00553319|468303954|FG002|Overall Study|moved|1|||
130095075|NCT01078974|468303955|FG000|Overall Study|Adverse Event|3|||
129979977|NCT03826030|467889514|FG000|Overall Study|Lost to Follow-up|1|||
129979978|NCT03826030|467889515|FG001|Overall Study|Lost to Follow-up|1|||
129979979|NCT03826030|467889516|FG002|Overall Study|Lost to Follow-up|1|||
129979980|NCT03826030|467889514|FG000|Overall Study|Too busy to return for visits|1|||
129979981|NCT03826030|467889515|FG001|Overall Study|Too busy to return for visits|0|||
129979982|NCT03826030|467889516|FG002|Overall Study|Too busy to return for visits|0|||
129979983|NCT03820947|467889521|FG000|Overall Study|Physician Decision|0|||
129979984|NCT03820947|467889522|FG001|Overall Study|Physician Decision|1|||
129979985|NCT03820947|467889523|FG002|Overall Study|Physician Decision|1|||
129979986|NCT03820947|467889524|FG003|Overall Study|Physician Decision|0|||
129979987|NCT03820947|467889525|FG004|Overall Study|Physician Decision|3|||
129979988|NCT03820947|467889521|FG000|Overall Study|Withdrawal by Subject|6|||
129979989|NCT03820947|467889522|FG001|Overall Study|Withdrawal by Subject|10|||
129979990|NCT03820947|467889523|FG002|Overall Study|Withdrawal by Subject|3|||
129979991|NCT03820947|467889524|FG003|Overall Study|Withdrawal by Subject|8|||
129979992|NCT03820947|467889525|FG004|Overall Study|Withdrawal by Subject|5|||
129979993|NCT03820947|467889521|FG000|Overall Study|Procedure Not Attempted|0|||
129979994|NCT03820947|467889522|FG001|Overall Study|Procedure Not Attempted|2|||
129979995|NCT03820947|467889523|FG002|Overall Study|Procedure Not Attempted|1|||
129979996|NCT03820947|467889524|FG003|Overall Study|Procedure Not Attempted|0|||
129979997|NCT03820947|467889525|FG004|Overall Study|Procedure Not Attempted|0|||
129979998|NCT03820947|467889521|FG000|Overall Study|Other Exit|1|||
129979999|NCT03820947|467889522|FG001|Overall Study|Other Exit|3|||
129980000|NCT03820947|467889523|FG002|Overall Study|Other Exit|3|||
129980001|NCT03820947|467889524|FG003|Overall Study|Other Exit|3|||
129980002|NCT03820947|467889525|FG004|Overall Study|Other Exit|0|||
129980003|NCT03820947|467889521|FG000|Overall Study|Follow-up Not Done|10|||
129980004|NCT03820947|467889522|FG001|Overall Study|Follow-up Not Done|13|||
129980005|NCT03820947|467889523|FG002|Overall Study|Follow-up Not Done|2|||
129980006|NCT03820947|467889524|FG003|Overall Study|Follow-up Not Done|3|||
129980007|NCT03820947|467889525|FG004|Overall Study|Follow-up Not Done|12|||
129980008|NCT03820947|467889521|FG000|Overall Study|Death|0|||
129980009|NCT03820947|467889522|FG001|Overall Study|Death|0|||
129980010|NCT03820947|467889523|FG002|Overall Study|Death|0|||
129980011|NCT03820947|467889524|FG003|Overall Study|Death|0|||
129980012|NCT03820947|467889525|FG004|Overall Study|Death|9|||
129980013|NCT03820947|467889521|FG000|Overall Study|Lost to Follow-up|4|||
129980014|NCT03820947|467889522|FG001|Overall Study|Lost to Follow-up|6|||
129980015|NCT03820947|467889523|FG002|Overall Study|Lost to Follow-up|0|||
129980016|NCT03820947|467889524|FG003|Overall Study|Lost to Follow-up|0|||
129980017|NCT03820947|467889525|FG004|Overall Study|Lost to Follow-up|9|||
129980018|NCT04500769|467891501|FG000|Overall Study|Withdrawal by Subject|5|||
129980019|NCT01967147|467891502|FG000|Overall Study|Adverse Event|5|||
129980020|NCT01967147|467891503|FG001|Overall Study|Adverse Event|2|||
129980021|NCT01967147|467891502|FG000|Overall Study|Lack of Efficacy|1|||
129980022|NCT01967147|467891503|FG001|Overall Study|Lack of Efficacy|4|||
129980023|NCT01967147|467891502|FG000|Overall Study|Lost to Follow-up|1|||
129980024|NCT01967147|467891503|FG001|Overall Study|Lost to Follow-up|2|||
129980025|NCT01967147|467891502|FG000|Overall Study|Withdrawal by Subject|2|||
129980026|NCT01967147|467891503|FG001|Overall Study|Withdrawal by Subject|4|||
129980027|NCT01967147|467891502|FG000|Overall Study|Non-compliance with Study Drug|0|||
129980028|NCT01967147|467891503|FG001|Overall Study|Non-compliance with Study Drug|3|||
129980029|NCT01967147|467891502|FG000|Overall Study|Other|4|||
129980030|NCT01967147|467891503|FG001|Overall Study|Other|5|||
129980031|NCT02218606|467891504|FG000|Overall Study|Adverse Event|1|||
129980032|NCT02218606|467891505|FG001|Overall Study|Adverse Event|1|||
129980033|NCT02218606|467891504|FG000|Overall Study|Death|15|||
129980034|NCT02218606|467891505|FG001|Overall Study|Death|28|||
129980035|NCT02218606|467891504|FG000|Overall Study|Physician Decision|0|||
129980036|NCT02218606|467891505|FG001|Overall Study|Physician Decision|1|||
129980037|NCT02218606|467891504|FG000|Overall Study|Withdrawal by Subject|4|||
129980038|NCT02218606|467891505|FG001|Overall Study|Withdrawal by Subject|0|||
129980039|NCT02218606|467891504|FG000|Overall Study|Noncompliance|1|||
129980040|NCT02218606|467891505|FG001|Overall Study|Noncompliance|0|||
129980041|NCT02218606|467891504|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
129980042|NCT02218606|467891505|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
129980043|NCT02218606|467891504|FG000|Overall Study|Other|2|||
129980044|NCT02218606|467891505|FG001|Overall Study|Other|1|||
129980045|NCT02218606|467891504|FG000|Overall Study|Never started treatment|0|||
129980046|NCT02218606|467891505|FG001|Overall Study|Never started treatment|1|||
129980047|NCT03203473|467891506|FG000|Induction Phase|Never started primary treatment|2|||
129980048|NCT03203473|467891507|FG001|Induction Phase|Never started primary treatment|0|||
129980049|NCT03203473|467891508|FG002|Induction Phase|Never started primary treatment|0|||
129980050|NCT03203473|467891506|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
129980051|NCT03203473|467891507|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
129980052|NCT03203473|467891508|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
129980053|NCT03203473|467891506|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
129980054|NCT03203473|467891507|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
129980055|NCT03203473|467891508|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
129980056|NCT03203473|467891506|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
129980057|NCT03203473|467891507|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
129980058|NCT03203473|467891508|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
129980059|NCT03203473|467891506|FG000|Arm Allocation Phase|started salvage therapy|0|||
129980060|NCT03203473|467891507|FG001|Arm Allocation Phase|started salvage therapy|5|||
129980061|NCT03203473|467891508|FG002|Arm Allocation Phase|started salvage therapy|0|||
129980062|NCT03203473|467891506|FG000|Arm Allocation Phase|Disease progression|0|||
129980063|NCT03203473|467891507|FG001|Arm Allocation Phase|Disease progression|0|||
129980064|NCT03203473|467891508|FG002|Arm Allocation Phase|Disease progression|37|||
129980065|NCT03203473|467891506|FG000|Arm Allocation Phase|Adverse Event|0|||
129980066|NCT03203473|467891507|FG001|Arm Allocation Phase|Adverse Event|0|||
129980067|NCT03203473|467891508|FG002|Arm Allocation Phase|Adverse Event|11|||
129980068|NCT03203473|467891506|FG000|Arm Allocation Phase|Physician Decision|0|||
129980069|NCT03203473|467891507|FG001|Arm Allocation Phase|Physician Decision|0|||
129980070|NCT03203473|467891508|FG002|Arm Allocation Phase|Physician Decision|3|||
129980071|NCT03203473|467891506|FG000|Arm Allocation Phase|Death|0|||
129980072|NCT03203473|467891507|FG001|Arm Allocation Phase|Death|0|||
129980073|NCT03203473|467891508|FG002|Arm Allocation Phase|Death|1|||
129980074|NCT03203473|467891506|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
129980075|NCT03203473|467891507|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
129980076|NCT03203473|467891508|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
129980077|NCT03203473|467891506|FG000|Arm Allocation Phase|Intercurrent illness|0|||
129980078|NCT03203473|467891507|FG001|Arm Allocation Phase|Intercurrent illness|0|||
129980079|NCT03203473|467891508|FG002|Arm Allocation Phase|Intercurrent illness|1|||
129980080|NCT03203473|467891506|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
129980081|NCT03203473|467891507|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
129980082|NCT03203473|467891508|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
129980083|NCT00890695|467891509|FG000|Overall Study|Protocol Violation|1|||
129980084|NCT00890695|467891510|FG001|Overall Study|Protocol Violation|0|||
129980085|NCT01732822|467891515|FG000|Overall Study|Withdrawal by Subject|123|||
129980086|NCT01732822|467891516|FG001|Overall Study|Withdrawal by Subject|113|||
129980087|NCT02314780|467891517|FG000|Overall Study|organizational reasons|0|||
129980088|NCT02314780|467891518|FG001|Overall Study|organizational reasons|2|||
129980089|NCT02314780|467891519|FG002|Overall Study|organizational reasons|0|||
129980090|NCT02314780|467891517|FG000|Overall Study|Adverse Event|0|||
129980091|NCT02314780|467891518|FG001|Overall Study|Adverse Event|1|||
129980092|NCT02314780|467891519|FG002|Overall Study|Adverse Event|0|||
129980093|NCT00215137|467891523|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
129980094|NCT00215137|467891524|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
129980095|NCT00215137|467891525|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
129980096|NCT00215137|467891523|FG000|Randomization Period|Lost to Follow-up|0|||
129980097|NCT00215137|467891524|FG001|Randomization Period|Lost to Follow-up|1|||
129980098|NCT00215137|467891525|FG002|Randomization Period|Lost to Follow-up|0|||
129980099|NCT00215137|467891523|FG000|Randomization Period|Withdrawal by Subject|0|||
129980100|NCT00215137|467891524|FG001|Randomization Period|Withdrawal by Subject|1|||
129980101|NCT00215137|467891525|FG002|Randomization Period|Withdrawal by Subject|0|||
129980102|NCT03002220|467891527|FG000|Overall Study|Lack of Efficacy|2|||
129980103|NCT03002220|467891527|FG000|Overall Study|Withdrawal by Subject|3|||
129980104|NCT03002220|467891527|FG000|Overall Study|Adverse Event|2|||
129980105|NCT03002220|467891527|FG000|Overall Study|Disease progression|13|||
129980106|NCT03002220|467891527|FG000|Overall Study|Physician Decision|1|||
129980107|NCT01183260|467891530|FG000|Overall Study|Intraop screen failure|2|||
129980108|NCT01183260|467891531|FG001|Overall Study|Intraop screen failure|0|||
129980109|NCT01183260|467891530|FG000|Overall Study|Withdrawal by Subject|1|||
129980110|NCT01183260|467891531|FG001|Overall Study|Withdrawal by Subject|1|||
129980111|NCT01183260|467891530|FG000|Overall Study|Revised within 30 days|0|||
129980112|NCT01183260|467891531|FG001|Overall Study|Revised within 30 days|1|||
129980113|NCT01183260|467891530|FG000|Overall Study|Death|1|||
129980114|NCT01183260|467891531|FG001|Overall Study|Death|0|||
129980115|NCT01255631|467891532|FG000|Overall Study|poor enrollment, no data analyzed|9|||
129980116|NCT01255631|467891533|FG001|Overall Study|poor enrollment, no data analyzed|6|||
129980117|NCT00568178|467891543|FG000|Double Blind Base Study|Adverse Event|0|||
129980118|NCT00568178|467891544|FG001|Double Blind Base Study|Adverse Event|2|||
129980119|NCT00568178|467891545|FG002|Double Blind Base Study|Adverse Event|1|||
129980120|NCT00568178|467891546|FG003|Double Blind Base Study|Adverse Event|2|||
129980121|NCT00568178|467891547|FG004|Double Blind Base Study|Adverse Event|0|||
129980122|NCT00568178|467891548|FG005|Double Blind Base Study|Adverse Event|0|||
129980123|NCT00568178|467891543|FG000|Double Blind Base Study|Lost to Follow-up|1|||
129980124|NCT00568178|467891544|FG001|Double Blind Base Study|Lost to Follow-up|0|||
129980125|NCT00568178|467891545|FG002|Double Blind Base Study|Lost to Follow-up|0|||
129980126|NCT00568178|467891546|FG003|Double Blind Base Study|Lost to Follow-up|1|||
129980127|NCT00568178|467891547|FG004|Double Blind Base Study|Lost to Follow-up|0|||
129980128|NCT00568178|467891548|FG005|Double Blind Base Study|Lost to Follow-up|0|||
130095076|NCT03575975|468303957|FG000|Overall Study|Lost to Follow-up|1|||
130095077|NCT03575975|468303958|FG001|Overall Study|Lost to Follow-up|0|||
130095078|NCT03575975|468303959|FG002|Overall Study|Lost to Follow-up|0|||
130095079|NCT00495794|468303960|FG000|Overall Study|Pharmacist did not activate patient|522|||
130095080|NCT00495794|468303961|FG001|Overall Study|Pharmacist did not activate patient|0|||
130095081|NCT01393444|468303962|FG000|Overall Study|Withdrawal by Subject|1|||
130095082|NCT01393444|468303962|FG000|Overall Study|Determined ineligible during screening.|2|||
130095083|NCT03039699|468303964|FG000|Overall Study|Incorrect inclusion|5|||
130095084|NCT03039699|468303965|FG001|Overall Study|Incorrect inclusion|4|||
130095085|NCT03039699|468303964|FG000|Overall Study|Lack of data to assess study endpoint|5|||
130095086|NCT03039699|468303965|FG001|Overall Study|Lack of data to assess study endpoint|3|||
130095087|NCT03039699|468303964|FG000|Overall Study|Bacterial infection|12|||
130095088|NCT03039699|468303965|FG001|Overall Study|Bacterial infection|28|||
130095089|NCT00129220|468303966|FG000|Study Period II|Adverse Event|9|||
130095090|NCT00129220|468303967|FG001|Study Period II|Adverse Event|5|||
130095091|NCT00129220|468303968|FG002|Study Period II|Adverse Event|7|||
130095092|NCT00129220|468303966|FG000|Study Period II|Lack of Efficacy|15|||
130095093|NCT00129220|468303967|FG001|Study Period II|Lack of Efficacy|1|||
130095094|NCT00129220|468303968|FG002|Study Period II|Lack of Efficacy|28|||
130095095|NCT00129220|468303966|FG000|Study Period II|Entry Criteria Not Met|2|||
130095096|NCT00129220|468303967|FG001|Study Period II|Entry Criteria Not Met|0|||
130095097|NCT00129220|468303968|FG002|Study Period II|Entry Criteria Not Met|2|||
130095098|NCT00129220|468303966|FG000|Study Period II|Protocol Violation|4|||
130095099|NCT00129220|468303967|FG001|Study Period II|Protocol Violation|2|||
130095100|NCT00129220|468303968|FG002|Study Period II|Protocol Violation|1|||
130095101|NCT00129220|468303966|FG000|Study Period II|Physician Decision|0|||
130095102|NCT00129220|468303967|FG001|Study Period II|Physician Decision|1|||
130095103|NCT00129220|468303968|FG002|Study Period II|Physician Decision|0|||
130095104|NCT00129220|468303966|FG000|Study Period II|Withdrawal by Subject|1|||
130095105|NCT00129220|468303967|FG001|Study Period II|Withdrawal by Subject|3|||
130095106|NCT00129220|468303968|FG002|Study Period II|Withdrawal by Subject|4|||
130095107|NCT00129220|468303966|FG000|Study Period II|Reason Not Specified|2|||
130095108|NCT00129220|468303967|FG001|Study Period II|Reason Not Specified|0|||
130095109|NCT00129220|468303968|FG002|Study Period II|Reason Not Specified|5|||
130095110|NCT00129220|468303966|FG000|Study Period III|Adverse Event|1|||
130095111|NCT00129220|468303967|FG001|Study Period III|Adverse Event|0|||
130095112|NCT00129220|468303968|FG002|Study Period III|Adverse Event|3|||
130095113|NCT00129220|468303966|FG000|Study Period III|Protocol Violation|1|||
130095114|NCT00129220|468303967|FG001|Study Period III|Protocol Violation|1|||
130095115|NCT00129220|468303968|FG002|Study Period III|Protocol Violation|2|||
130095116|NCT00129220|468303966|FG000|Study Period III|Withdrawal by Subject|1|||
130095117|NCT00129220|468303967|FG001|Study Period III|Withdrawal by Subject|0|||
130095118|NCT00129220|468303968|FG002|Study Period III|Withdrawal by Subject|3|||
130095119|NCT00129220|468303966|FG000|Study Period III|Sponsor Decision|1|||
130095120|NCT00129220|468303967|FG001|Study Period III|Sponsor Decision|0|||
130095121|NCT00129220|468303968|FG002|Study Period III|Sponsor Decision|0|||
130095122|NCT00129220|468303966|FG000|Study Period III|Reason Not Specified|9|||
130095123|NCT00129220|468303967|FG001|Study Period III|Reason Not Specified|0|||
130095124|NCT00129220|468303968|FG002|Study Period III|Reason Not Specified|2|||
130095125|NCT01883362|468303969|FG000|Treatment|Adverse Event|1|||
130095126|NCT01883362|468303970|FG001|Treatment|Adverse Event|8|||
130095127|NCT01883362|468303969|FG000|Treatment|Withdrawal by Subject|6|||
130095128|NCT01883362|468303970|FG001|Treatment|Withdrawal by Subject|2|||
130095129|NCT01883362|468303969|FG000|Treatment|Administrative problems|4|||
130095130|NCT01883362|468303970|FG001|Treatment|Administrative problems|1|||
130095131|NCT01883362|468303969|FG000|Treatment|Relapse|4|||
130095132|NCT01883362|468303970|FG001|Treatment|Relapse|2|||
130095133|NCT01883362|468303969|FG000|Treatment|Randomized, not treated|1|||
130095134|NCT01883362|468303970|FG001|Treatment|Randomized, not treated|1|||
130095135|NCT01883362|468303969|FG000|Post Treatment Follow-up|Protocol Violation|0|||
130095136|NCT01883362|468303970|FG001|Post Treatment Follow-up|Protocol Violation|1|||
130095137|NCT01883362|468303969|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
130095138|NCT01883362|468303970|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
130095139|NCT01883362|468303969|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
130095140|NCT01883362|468303970|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
130095141|NCT01883362|468303969|FG000|Post Treatment Follow-up|Administrative problems|2|||
130095142|NCT01883362|468303970|FG001|Post Treatment Follow-up|Administrative problems|0|||
130095143|NCT01883362|468303969|FG000|Post Treatment Follow-up|Death|8|||
130095144|NCT01883362|468303970|FG001|Post Treatment Follow-up|Death|4|||
130095145|NCT01883362|468303969|FG000|Post Treatment Follow-up|Relapse|1|||
130095146|NCT01883362|468303970|FG001|Post Treatment Follow-up|Relapse|2|||
130095147|NCT01349816|468303971|FG000|Overall Study|Withdrawal by Subject|4|||
130095148|NCT01349816|468303971|FG000|Overall Study|Physician Decision|1|||
130095149|NCT01349816|468303971|FG000|Overall Study|Adverse Event|14|||
130095150|NCT01349816|468303971|FG000|Overall Study|Lost to Follow-up|2|||
130095151|NCT01349816|468303971|FG000|Overall Study|Protocol Violation|1|||
130095152|NCT01349816|468303971|FG000|Overall Study|Protocol-specified criteria|8|||
130095153|NCT02911285|468303975|FG000|Overall Study|Lost to Follow-up|8|||
130095154|NCT02911285|468303976|FG001|Overall Study|Lost to Follow-up|5|||
129980129|NCT00568178|467891543|FG000|Double Blind Base Study|Physician Decision|1|||
129980130|NCT00568178|467891544|FG001|Double Blind Base Study|Physician Decision|1|||
129980131|NCT00568178|467891545|FG002|Double Blind Base Study|Physician Decision|0|||
129980132|NCT00568178|467891546|FG003|Double Blind Base Study|Physician Decision|1|||
129980133|NCT00568178|467891547|FG004|Double Blind Base Study|Physician Decision|0|||
129980134|NCT00568178|467891548|FG005|Double Blind Base Study|Physician Decision|0|||
129980135|NCT00568178|467891543|FG000|Double Blind Base Study|Protocol Violation|3|||
129980136|NCT00568178|467891544|FG001|Double Blind Base Study|Protocol Violation|2|||
129980137|NCT00568178|467891545|FG002|Double Blind Base Study|Protocol Violation|0|||
129980138|NCT00568178|467891546|FG003|Double Blind Base Study|Protocol Violation|0|||
129980139|NCT00568178|467891547|FG004|Double Blind Base Study|Protocol Violation|0|||
129980140|NCT00568178|467891548|FG005|Double Blind Base Study|Protocol Violation|0|||
129980141|NCT00568178|467891543|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
129980142|NCT00568178|467891544|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
129980143|NCT00568178|467891545|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
129980144|NCT00568178|467891546|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
129980145|NCT00568178|467891547|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
129980146|NCT00568178|467891548|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
130095155|NCT02911285|468303975|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
130095156|NCT02911285|468303976|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
130095157|NCT01230489|468303977|FG000|Overall Study|Death|2|||
130095158|NCT01230489|468303977|FG000|Overall Study|Adverse Event|2|||
130095159|NCT01230489|468303977|FG000|Overall Study|Treatment modality changed|1|||
130095160|NCT01791543|468303978|FG000|Overall Study|Lost to Follow-up|1|||
130095161|NCT01791543|468303978|FG000|Overall Study|Adverse Event|1|||
130154936|NCT02510014|468526643|FG000|Treatment Period|Protocol Violation|4|||
130154937|NCT02510014|468526644|FG001|Treatment Period|Protocol Violation|4|||
130154938|NCT02510014|468526643|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
130154939|NCT02510014|468526644|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
130154940|NCT02556307|468526648|FG000|Overall Study|Premature treatment interruption|11|||
130154941|NCT02556307|468526648|FG000|Overall Study|Lost to Follow-up|36|||
130154942|NCT02556307|468526648|FG000|Overall Study|Change to triple therapy|4|||
130154943|NCT02556307|468526648|FG000|Overall Study|Enrolled but not treated|2|||
130154944|NCT01277718|468526653|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
130154945|NCT01277718|468526654|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
130154946|NCT01277718|468526653|FG000|Period 2 - Second Intervention|Physician Decision|0|||
130154947|NCT01277718|468526654|FG001|Period 2 - Second Intervention|Physician Decision|2|||
130154948|NCT01524913|468526655|FG000|Overall Study|Lost to Follow-up|4|||
130154949|NCT01524913|468526656|FG001|Overall Study|Lost to Follow-up|0|||
130154950|NCT01524913|468526657|FG002|Overall Study|Lost to Follow-up|0|||
130154951|NCT00788593|468526660|FG000|Placebo Run-in Phase|Adverse Event|2|||
130154952|NCT00788593|468526661|FG001|Placebo Run-in Phase|Adverse Event|0|||
130154953|NCT00788593|468526662|FG002|Placebo Run-in Phase|Adverse Event|0|||
130154954|NCT00788593|468526660|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
130154955|NCT00788593|468526661|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
130154956|NCT00788593|468526662|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
130154957|NCT00788593|468526660|FG000|Placebo Run-in Phase|Protocol Violation|2|||
130154958|NCT00788593|468526661|FG001|Placebo Run-in Phase|Protocol Violation|0|||
130154959|NCT00788593|468526662|FG002|Placebo Run-in Phase|Protocol Violation|0|||
130154960|NCT00788593|468526660|FG000|First Intervention Period|Adverse Event|0|||
130154961|NCT00788593|468526661|FG001|First Intervention Period|Adverse Event|1|||
130154962|NCT00788593|468526662|FG002|First Intervention Period|Adverse Event|0|||
130154963|NCT00788593|468526660|FG000|Second Intervention Period|Lost to Follow-up|0|||
130154964|NCT00788593|468526661|FG001|Second Intervention Period|Lost to Follow-up|1|||
130154965|NCT00788593|468526662|FG002|Second Intervention Period|Lost to Follow-up|0|||
130154966|NCT00788593|468526660|FG000|Second Intervention Period|Other|0|||
130154967|NCT00788593|468526661|FG001|Second Intervention Period|Other|0|||
130154968|NCT00788593|468526662|FG002|Second Intervention Period|Other|1|||
130154969|NCT00515034|468526663|FG000|Overall Study|Adverse Event|2|||
130154970|NCT00515034|468526664|FG001|Overall Study|Adverse Event|0|||
130154971|NCT00515034|468526665|FG002|Overall Study|Adverse Event|1|||
130154972|NCT00515034|468526666|FG003|Overall Study|Adverse Event|0|||
130154973|NCT00515034|468526663|FG000|Overall Study|Death|4|||
130154974|NCT00515034|468526664|FG001|Overall Study|Death|2|||
130154975|NCT00515034|468526665|FG002|Overall Study|Death|1|||
130154976|NCT00515034|468526666|FG003|Overall Study|Death|3|||
130154977|NCT00515034|468526663|FG000|Overall Study|Withdrawal by Subject|1|||
130154978|NCT00515034|468526664|FG001|Overall Study|Withdrawal by Subject|0|||
130154979|NCT00515034|468526665|FG002|Overall Study|Withdrawal by Subject|3|||
130154980|NCT00515034|468526666|FG003|Overall Study|Withdrawal by Subject|0|||
130154981|NCT00515034|468526663|FG000|Overall Study|Physician Decision|0|||
130154982|NCT00515034|468526664|FG001|Overall Study|Physician Decision|0|||
129980147|NCT00568178|467891543|FG000|Double Blind Base Study|Progressive Disease|0|||
129980148|NCT00568178|467891544|FG001|Double Blind Base Study|Progressive Disease|0|||
129980149|NCT00568178|467891545|FG002|Double Blind Base Study|Progressive Disease|0|||
129980150|NCT00568178|467891546|FG003|Double Blind Base Study|Progressive Disease|1|||
129980151|NCT00568178|467891547|FG004|Double Blind Base Study|Progressive Disease|0|||
129980152|NCT00568178|467891548|FG005|Double Blind Base Study|Progressive Disease|0|||
129980153|NCT00568178|467891543|FG000|Open Label Extension|Adverse Event|0|||
129980154|NCT00568178|467891544|FG001|Open Label Extension|Adverse Event|0|||
129980155|NCT00568178|467891545|FG002|Open Label Extension|Adverse Event|0|||
129980156|NCT00568178|467891546|FG003|Open Label Extension|Adverse Event|0|||
129980157|NCT00568178|467891547|FG004|Open Label Extension|Adverse Event|11|||
129980158|NCT00568178|467891548|FG005|Open Label Extension|Adverse Event|8|||
129980159|NCT00568178|467891543|FG000|Open Label Extension|Protocol Violation|0|||
129980160|NCT00568178|467891544|FG001|Open Label Extension|Protocol Violation|0|||
129980161|NCT00568178|467891545|FG002|Open Label Extension|Protocol Violation|0|||
129980162|NCT00568178|467891546|FG003|Open Label Extension|Protocol Violation|0|||
129980163|NCT00568178|467891547|FG004|Open Label Extension|Protocol Violation|1|||
129980164|NCT00568178|467891548|FG005|Open Label Extension|Protocol Violation|0|||
129980165|NCT00568178|467891543|FG000|Open Label Extension|Lost to Follow-up|0|||
129980166|NCT00568178|467891544|FG001|Open Label Extension|Lost to Follow-up|0|||
129980167|NCT00568178|467891545|FG002|Open Label Extension|Lost to Follow-up|0|||
129980168|NCT00568178|467891546|FG003|Open Label Extension|Lost to Follow-up|0|||
129980169|NCT00568178|467891547|FG004|Open Label Extension|Lost to Follow-up|6|||
129980170|NCT00568178|467891548|FG005|Open Label Extension|Lost to Follow-up|11|||
129980171|NCT00568178|467891543|FG000|Open Label Extension|Physician Decision|0|||
129980172|NCT00568178|467891544|FG001|Open Label Extension|Physician Decision|0|||
129980173|NCT00568178|467891545|FG002|Open Label Extension|Physician Decision|0|||
129980174|NCT00568178|467891546|FG003|Open Label Extension|Physician Decision|0|||
129980175|NCT00568178|467891547|FG004|Open Label Extension|Physician Decision|9|||
129980176|NCT00568178|467891548|FG005|Open Label Extension|Physician Decision|8|||
129980177|NCT00568178|467891543|FG000|Open Label Extension|Pregnancy|0|||
129980178|NCT00568178|467891544|FG001|Open Label Extension|Pregnancy|0|||
129980179|NCT00568178|467891545|FG002|Open Label Extension|Pregnancy|0|||
129980180|NCT00568178|467891546|FG003|Open Label Extension|Pregnancy|0|||
129980181|NCT00568178|467891547|FG004|Open Label Extension|Pregnancy|0|||
129980182|NCT00568178|467891548|FG005|Open Label Extension|Pregnancy|1|||
129980183|NCT00568178|467891543|FG000|Open Label Extension|Progressive Disease|0|||
129980184|NCT00568178|467891544|FG001|Open Label Extension|Progressive Disease|0|||
129980185|NCT00568178|467891545|FG002|Open Label Extension|Progressive Disease|0|||
129980186|NCT00568178|467891546|FG003|Open Label Extension|Progressive Disease|0|||
129980187|NCT00568178|467891547|FG004|Open Label Extension|Progressive Disease|3|||
129980188|NCT00568178|467891548|FG005|Open Label Extension|Progressive Disease|1|||
129980189|NCT00568178|467891543|FG000|Open Label Extension|Termination of Trial|0|||
129980190|NCT00568178|467891544|FG001|Open Label Extension|Termination of Trial|0|||
129980191|NCT00568178|467891545|FG002|Open Label Extension|Termination of Trial|0|||
129980192|NCT00568178|467891546|FG003|Open Label Extension|Termination of Trial|0|||
129980193|NCT00568178|467891547|FG004|Open Label Extension|Termination of Trial|45|||
129980194|NCT00568178|467891548|FG005|Open Label Extension|Termination of Trial|47|||
129980195|NCT00568178|467891543|FG000|Open Label Extension|Withdrawal by Subject|0|||
129980196|NCT00568178|467891544|FG001|Open Label Extension|Withdrawal by Subject|0|||
129980197|NCT00568178|467891545|FG002|Open Label Extension|Withdrawal by Subject|0|||
129980198|NCT00568178|467891546|FG003|Open Label Extension|Withdrawal by Subject|0|||
129980199|NCT00568178|467891547|FG004|Open Label Extension|Withdrawal by Subject|4|||
129980200|NCT00568178|467891548|FG005|Open Label Extension|Withdrawal by Subject|4|||
129980201|NCT01531673|467891549|FG000|Overall Study|Non-Compliance|0|||
129980202|NCT01531673|467891550|FG001|Overall Study|Non-Compliance|0|||
129980203|NCT01531673|467891551|FG002|Overall Study|Non-Compliance|0|||
129980204|NCT01531673|467891552|FG003|Overall Study|Non-Compliance|0|||
129980205|NCT01531673|467891553|FG004|Overall Study|Non-Compliance|0|||
129980206|NCT01531673|467891554|FG005|Overall Study|Non-Compliance|1|||
129980207|NCT01531673|467891555|FG006|Overall Study|Non-Compliance|0|||
129980208|NCT01531673|467891556|FG007|Overall Study|Non-Compliance|0|||
129980209|NCT01531673|467891557|FG008|Overall Study|Non-Compliance|0|||
129980210|NCT01531673|467891558|FG009|Overall Study|Non-Compliance|0|||
129980211|NCT01531673|467891559|FG010|Overall Study|Non-Compliance|0|||
129980212|NCT01531673|467891560|FG011|Overall Study|Non-Compliance|0|||
129980213|NCT01531673|467891561|FG012|Overall Study|Non-Compliance|0|||
129980214|NCT01531673|467891549|FG000|Overall Study|Adverse Event|0|||
129980215|NCT01531673|467891550|FG001|Overall Study|Adverse Event|1|||
129980216|NCT01531673|467891551|FG002|Overall Study|Adverse Event|0|||
129980217|NCT01531673|467891552|FG003|Overall Study|Adverse Event|0|||
129980218|NCT01531673|467891553|FG004|Overall Study|Adverse Event|0|||
129980219|NCT01531673|467891554|FG005|Overall Study|Adverse Event|0|||
129980220|NCT01531673|467891555|FG006|Overall Study|Adverse Event|0|||
129980221|NCT01531673|467891556|FG007|Overall Study|Adverse Event|0|||
129980222|NCT01531673|467891557|FG008|Overall Study|Adverse Event|0|||
130154983|NCT00515034|468526665|FG002|Overall Study|Physician Decision|1|||
130154984|NCT00515034|468526666|FG003|Overall Study|Physician Decision|1|||
130154985|NCT00515034|468526663|FG000|Overall Study|Other|1|||
130154986|NCT00515034|468526664|FG001|Overall Study|Other|0|||
130154987|NCT00515034|468526665|FG002|Overall Study|Other|2|||
130154988|NCT00515034|468526666|FG003|Overall Study|Other|1|||
130154989|NCT01688726|468526671|FG000|Overall Study|Adverse Event|1|||
130154990|NCT01688726|468526672|FG001|Overall Study|Adverse Event|0|||
130154991|NCT01688726|468526671|FG000|Overall Study|Relocated abroad|0|||
130154992|NCT01688726|468526672|FG001|Overall Study|Relocated abroad|1|||
130154993|NCT03499119|468526673|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
130154994|NCT03499119|468526674|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
130154995|NCT03499119|468526675|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
130154996|NCT03499119|468526676|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
130154997|NCT03499119|468526673|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
129980223|NCT01531673|467891558|FG009|Overall Study|Adverse Event|0|||
129980224|NCT01531673|467891559|FG010|Overall Study|Adverse Event|0|||
129980225|NCT01531673|467891560|FG011|Overall Study|Adverse Event|0|||
129980226|NCT01531673|467891561|FG012|Overall Study|Adverse Event|0|||
129980227|NCT01531673|467891549|FG000|Overall Study|Lost to Follow-up|0|||
129980228|NCT01531673|467891550|FG001|Overall Study|Lost to Follow-up|0|||
129980229|NCT01531673|467891551|FG002|Overall Study|Lost to Follow-up|0|||
129980230|NCT01531673|467891552|FG003|Overall Study|Lost to Follow-up|0|||
129980231|NCT01531673|467891553|FG004|Overall Study|Lost to Follow-up|1|||
129980232|NCT01531673|467891554|FG005|Overall Study|Lost to Follow-up|0|||
129980233|NCT01531673|467891555|FG006|Overall Study|Lost to Follow-up|0|||
129980234|NCT01531673|467891556|FG007|Overall Study|Lost to Follow-up|0|||
129980235|NCT01531673|467891557|FG008|Overall Study|Lost to Follow-up|0|||
129980236|NCT01531673|467891558|FG009|Overall Study|Lost to Follow-up|0|||
129980237|NCT01531673|467891559|FG010|Overall Study|Lost to Follow-up|0|||
129980238|NCT01531673|467891560|FG011|Overall Study|Lost to Follow-up|0|||
129980239|NCT01531673|467891561|FG012|Overall Study|Lost to Follow-up|0|||
129980240|NCT01531673|467891549|FG000|Overall Study|Other|0|||
129980241|NCT01531673|467891550|FG001|Overall Study|Other|0|||
129980242|NCT01531673|467891551|FG002|Overall Study|Other|0|||
129980243|NCT01531673|467891552|FG003|Overall Study|Other|1|||
129980244|NCT01531673|467891553|FG004|Overall Study|Other|0|||
129980245|NCT01531673|467891554|FG005|Overall Study|Other|0|||
129980246|NCT01531673|467891555|FG006|Overall Study|Other|0|||
129980247|NCT01531673|467891556|FG007|Overall Study|Other|0|||
129980248|NCT01531673|467891557|FG008|Overall Study|Other|0|||
129980249|NCT01531673|467891558|FG009|Overall Study|Other|1|||
129980250|NCT01531673|467891559|FG010|Overall Study|Other|0|||
129980251|NCT01531673|467891560|FG011|Overall Study|Other|0|||
129980252|NCT01531673|467891561|FG012|Overall Study|Other|0|||
129980253|NCT02815579|467891562|FG000|Overall Study|Non-payment of loan down-payment|16|||
129980254|NCT02815579|467891563|FG001|Overall Study|Non-payment of loan down-payment|0|||
129980255|NCT02815579|467891562|FG000|Overall Study|Withdrawal by Subject|7|||
129980256|NCT02815579|467891563|FG001|Overall Study|Withdrawal by Subject|1|||
129980257|NCT02815579|467891562|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
129980258|NCT02815579|467891563|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
129980259|NCT02815579|467891562|FG000|Overall Study|Lost to Follow-up|7|||
129980260|NCT02815579|467891563|FG001|Overall Study|Lost to Follow-up|4|||
129980261|NCT02815579|467891562|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
129980262|NCT02815579|467891563|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
129980263|NCT02815579|467891562|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
129980264|NCT02815579|467891563|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
129980265|NCT02815579|467891562|FG000|Overall Study|Death|5|||
129980266|NCT02815579|467891563|FG001|Overall Study|Death|4|||
129980267|NCT02815579|467891562|FG000|Overall Study|Imprisoned|0|||
129980268|NCT02815579|467891563|FG001|Overall Study|Imprisoned|2|||
129980269|NCT02815579|467891562|FG000|Overall Study|Did not meet enrollment criteria|0|||
129980270|NCT02815579|467891563|FG001|Overall Study|Did not meet enrollment criteria|1|||
129980271|NCT00264303|467891564|FG000|Overall Study|Adverse Event|4|||
129980272|NCT00264303|467891565|FG001|Overall Study|Adverse Event|3|||
129980273|NCT00264303|467891564|FG000|Overall Study|Lack of Efficacy|10|||
129980274|NCT00264303|467891565|FG001|Overall Study|Lack of Efficacy|13|||
129980275|NCT00264303|467891564|FG000|Overall Study|Lost to Follow-up|3|||
129980276|NCT00264303|467891565|FG001|Overall Study|Lost to Follow-up|3|||
129980277|NCT00264303|467891564|FG000|Overall Study|Withdrawal by Subject|2|||
129980278|NCT00264303|467891565|FG001|Overall Study|Withdrawal by Subject|3|||
129980279|NCT00264303|467891564|FG000|Overall Study|Various reasons listed in study report|6|||
129980280|NCT00264303|467891565|FG001|Overall Study|Various reasons listed in study report|7|||
129980281|NCT02389452|467891566|FG000|Overall Study|Lost to Follow-up|13|||
129980282|NCT02389452|467891566|FG000|Overall Study|Adverse Event|1|||
130154998|NCT03499119|468526674|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
130154999|NCT03499119|468526675|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
130155000|NCT03499119|468526676|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
130155001|NCT03499119|468526673|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
130155002|NCT03499119|468526674|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
130155003|NCT03499119|468526675|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
130155004|NCT03499119|468526676|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
130155005|NCT03499119|468526673|FG000|Optional Extension Phase|Lost to Follow-up|0|||
130155006|NCT03499119|468526674|FG001|Optional Extension Phase|Lost to Follow-up|0|||
130155007|NCT03499119|468526675|FG002|Optional Extension Phase|Lost to Follow-up|0|||
130155008|NCT03499119|468526676|FG003|Optional Extension Phase|Lost to Follow-up|1|||
130155009|NCT03499119|468526673|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
130155010|NCT03499119|468526674|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
130155011|NCT03499119|468526675|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
130155012|NCT03499119|468526676|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
130155013|NCT03499119|468526673|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
130155014|NCT03499119|468526674|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
130155015|NCT03499119|468526675|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
130155016|NCT03499119|468526676|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
130155017|NCT04553913|468526677|FG000|Overall Study|patient's block resolved prior to PACU|1|||
130155018|NCT04553913|468526677|FG000|Overall Study|did not use the device properly|5|||
130155019|NCT01481324|468526679|FG000|Overall Study|Missing Data|0|||
130155020|NCT01481324|468526680|FG001|Overall Study|Missing Data|2|||
130155021|NCT01481324|468526681|FG002|Overall Study|Missing Data|2|||
130155022|NCT04189445|468528405|FG000|Overall Study|Withdrawal of consent|8|||
130155023|NCT04189445|468528406|FG001|Overall Study|Withdrawal of consent|1|||
130155024|NCT04189445|468528407|FG002|Overall Study|Withdrawal of consent|0|||
130155025|NCT04189445|468528405|FG000|Overall Study|Study Terminated by Sponsor|25|||
130155026|NCT04189445|468528406|FG001|Overall Study|Study Terminated by Sponsor|3|||
130155027|NCT04189445|468528407|FG002|Overall Study|Study Terminated by Sponsor|0|||
130155028|NCT04189445|468528405|FG000|Overall Study|Death|54|||
130155029|NCT04189445|468528406|FG001|Overall Study|Death|24|||
130155030|NCT04189445|468528407|FG002|Overall Study|Death|0|||
130155031|NCT03959527|468528408|FG000|Overall Study|Withdrawal by Subject|8|||
130155032|NCT03959527|468528409|FG001|Overall Study|Withdrawal by Subject|3|||
130155033|NCT03959527|468528408|FG000|Overall Study|Lost to Follow-up|31|||
130155034|NCT03959527|468528409|FG001|Overall Study|Lost to Follow-up|15|||
130155035|NCT03959527|468528408|FG000|Overall Study|Did not meet eligibility criteria|1|||
130155036|NCT03959527|468528409|FG001|Overall Study|Did not meet eligibility criteria|1|||
130155037|NCT03959527|468528408|FG000|Overall Study|Protocol Violation|10|||
130155038|NCT03959527|468528409|FG001|Overall Study|Protocol Violation|5|||
130155039|NCT01688466|468528410|FG000|Overall Study|Withdrawal by Subject|2|||
129980283|NCT02389452|467891566|FG000|Overall Study|Withdrawal by Subject|5|||
129980284|NCT02389452|467891566|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
129980285|NCT02311673|467891567|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
129980286|NCT02311673|467891568|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
129980287|NCT02311673|467891569|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
129980288|NCT02311673|467891570|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
129980289|NCT00414908|467891581|FG000|Overall Study|Protocol Violation|1|||
129980290|NCT00414908|467891582|FG001|Overall Study|Protocol Violation|1|||
129980291|NCT01076153|467891583|FG000|Overall Study|Symptoms improved/resolved|10|||
129980292|NCT01076153|467891583|FG000|Overall Study|Adverse Event|1|||
129980293|NCT00818168|467891584|FG000|Overall Study|Lack of Efficacy|18|||
129980294|NCT00818168|467891584|FG000|Overall Study|Pregnancy|2|||
129980295|NCT00818168|467891584|FG000|Overall Study|Withdrawal by Subject|16|||
129980296|NCT00818168|467891584|FG000|Overall Study|Lost to Follow-up|7|||
129980297|NCT00818168|467891584|FG000|Overall Study|Adverse Event|19|||
129980298|NCT00818168|467891584|FG000|Overall Study|Reason for Non-completion Not reported|6|||
129980299|NCT00818168|467891584|FG000|Overall Study|Participant Moved|2|||
129980300|NCT02040259|467891587|FG000|Overall Study|Death|280|||
129980301|NCT02040259|467891587|FG000|Overall Study|Lost to Follow-up|76|||
129980302|NCT02040259|467891587|FG000|Overall Study|Assessment not completed|3|||
129980303|NCT02040259|467891587|FG000|Overall Study|Withdrawal by Subject|4|||
129980304|NCT04476251|467891588|FG000|Overall Study|Not treated|1|||
129980305|NCT00316602|467891599|FG000|Overall Study|Withdrawal by Subject|3|||
129980306|NCT00316602|467891600|FG001|Overall Study|Withdrawal by Subject|2|||
129980307|NCT00316602|467891599|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
129980308|NCT00316602|467891600|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
129980309|NCT00316602|467891599|FG000|Overall Study|Adverse Event|1|||
129980310|NCT00316602|467891600|FG001|Overall Study|Adverse Event|0|||
129980311|NCT00316602|467891599|FG000|Overall Study|Other|3|||
129980312|NCT00316602|467891600|FG001|Overall Study|Other|6|||
129980313|NCT01142232|467891601|FG000|Overall Study|Adverse Event|1|||
129980314|NCT01142232|467891602|FG001|Overall Study|Adverse Event|2|||
129980315|NCT01142232|467891603|FG002|Overall Study|Adverse Event|1|||
129980316|NCT01142232|467891604|FG003|Overall Study|Adverse Event|0|||
129980317|NCT01142232|467891605|FG004|Overall Study|Adverse Event|4|||
129980318|NCT01142232|467891601|FG000|Overall Study|Death|0|||
129980319|NCT01142232|467891602|FG001|Overall Study|Death|0|||
129980320|NCT01142232|467891603|FG002|Overall Study|Death|0|||
129980321|NCT01142232|467891604|FG003|Overall Study|Death|0|||
129980322|NCT01142232|467891605|FG004|Overall Study|Death|1|||
129980323|NCT01142232|467891601|FG000|Overall Study|Disease Progression|2|||
129980324|NCT01142232|467891602|FG001|Overall Study|Disease Progression|0|||
129980325|NCT01142232|467891603|FG002|Overall Study|Disease Progression|1|||
129980326|NCT01142232|467891604|FG003|Overall Study|Disease Progression|2|||
129980327|NCT01142232|467891605|FG004|Overall Study|Disease Progression|12|||
129980328|NCT01142232|467891601|FG000|Overall Study|Withdrawal by Subject|0|||
129980329|NCT01142232|467891602|FG001|Overall Study|Withdrawal by Subject|0|||
129980330|NCT01142232|467891603|FG002|Overall Study|Withdrawal by Subject|0|||
129980331|NCT01142232|467891604|FG003|Overall Study|Withdrawal by Subject|1|||
129980332|NCT01142232|467891605|FG004|Overall Study|Withdrawal by Subject|3|||
129980333|NCT01142232|467891601|FG000|Overall Study|Physician Decision|0|||
129980334|NCT01142232|467891602|FG001|Overall Study|Physician Decision|1|||
129980335|NCT01142232|467891603|FG002|Overall Study|Physician Decision|0|||
129980336|NCT01142232|467891604|FG003|Overall Study|Physician Decision|2|||
129980337|NCT01142232|467891605|FG004|Overall Study|Physician Decision|10|||
129980338|NCT01142232|467891601|FG000|Overall Study|Alternative Therapy|0|||
129980339|NCT01142232|467891602|FG001|Overall Study|Alternative Therapy|1|||
129980340|NCT01142232|467891603|FG002|Overall Study|Alternative Therapy|1|||
129980341|NCT01142232|467891604|FG003|Overall Study|Alternative Therapy|0|||
129980342|NCT01142232|467891605|FG004|Overall Study|Alternative Therapy|1|||
129980343|NCT01142232|467891601|FG000|Overall Study|Off Trt for other complicating disease|0|||
129980344|NCT01142232|467891602|FG001|Overall Study|Off Trt for other complicating disease|0|||
129980345|NCT01142232|467891603|FG002|Overall Study|Off Trt for other complicating disease|0|||
129980346|NCT01142232|467891604|FG003|Overall Study|Off Trt for other complicating disease|0|||
129980347|NCT01142232|467891605|FG004|Overall Study|Off Trt for other complicating disease|1|||
129980348|NCT01142232|467891601|FG000|Overall Study|Noncompliance|0|||
129980349|NCT01142232|467891602|FG001|Overall Study|Noncompliance|0|||
129980350|NCT01142232|467891603|FG002|Overall Study|Noncompliance|0|||
129980351|NCT01142232|467891604|FG003|Overall Study|Noncompliance|0|||
129980352|NCT01142232|467891605|FG004|Overall Study|Noncompliance|2|||
129980353|NCT00626990|467891608|FG000|Overall Study|Lack of Efficacy|6|||
129980354|NCT00626990|467891609|FG001|Overall Study|Lack of Efficacy|7|||
129980355|NCT00626990|467891610|FG002|Overall Study|Lack of Efficacy|49|||
129980356|NCT00626990|467891611|FG003|Overall Study|Lack of Efficacy|40|||
129980357|NCT00626990|467891608|FG000|Overall Study|Adverse Event|1|||
129980358|NCT00626990|467891609|FG001|Overall Study|Adverse Event|7|||
129980359|NCT00626990|467891610|FG002|Overall Study|Adverse Event|14|||
129980360|NCT00626990|467891611|FG003|Overall Study|Adverse Event|28|||
129980361|NCT00626990|467891608|FG000|Overall Study|Death|0|||
129980362|NCT00626990|467891609|FG001|Overall Study|Death|1|||
129980363|NCT00626990|467891610|FG002|Overall Study|Death|0|||
129980364|NCT00626990|467891611|FG003|Overall Study|Death|0|||
129980365|NCT00626990|467891608|FG000|Overall Study|Withdrawal by Subject|3|||
129980366|NCT00626990|467891609|FG001|Overall Study|Withdrawal by Subject|1|||
129980367|NCT00626990|467891610|FG002|Overall Study|Withdrawal by Subject|5|||
129980368|NCT00626990|467891611|FG003|Overall Study|Withdrawal by Subject|11|||
129980369|NCT00626990|467891608|FG000|Overall Study|Protocol Violation|0|||
129980370|NCT00626990|467891609|FG001|Overall Study|Protocol Violation|1|||
129980371|NCT00626990|467891610|FG002|Overall Study|Protocol Violation|1|||
129980372|NCT00626990|467891611|FG003|Overall Study|Protocol Violation|0|||
129980373|NCT00626990|467891608|FG000|Overall Study|Various different reasons/missing|4|||
129980374|NCT00626990|467891609|FG001|Overall Study|Various different reasons/missing|8|||
129980375|NCT00626990|467891610|FG002|Overall Study|Various different reasons/missing|8|||
129980376|NCT00626990|467891611|FG003|Overall Study|Various different reasons/missing|16|||
129980377|NCT04138576|467891616|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
129980378|NCT00297427|467891617|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
129980379|NCT00297427|467891618|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
129980380|NCT00297427|467891617|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
129980381|NCT00297427|467891618|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
129980382|NCT00297427|467891617|FG000|Phase 1: Initial Intervention|Death|0|||
129980383|NCT00297427|467891618|FG001|Phase 1: Initial Intervention|Death|1|||
129980384|NCT00297427|467891617|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
129980385|NCT00297427|467891618|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
129980386|NCT00297427|467891617|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
129980387|NCT00297427|467891618|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
129980388|NCT00297427|467891617|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
129980389|NCT00297427|467891618|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
129980390|NCT00297427|467891617|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
129980391|NCT00297427|467891618|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
130155040|NCT01688466|468528411|FG001|Overall Study|Withdrawal by Subject|1|||
130155041|NCT01688466|468528410|FG000|Overall Study|Death|0|||
130155042|NCT01688466|468528411|FG001|Overall Study|Death|1|||
130155043|NCT01688466|468528410|FG000|Overall Study|Adverse Event|0|||
130155044|NCT01688466|468528411|FG001|Overall Study|Adverse Event|4|||
130155045|NCT01688466|468528410|FG000|Overall Study|Not evaluable|0|||
130155046|NCT01688466|468528411|FG001|Overall Study|Not evaluable|1|||
130155047|NCT06029959|468528412|FG000|Overall Study|Physician Decision|6|||
130155048|NCT02960893|468528413|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
130155049|NCT02960893|468528414|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
130155050|NCT02960893|468528415|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
130155051|NCT02960893|468528416|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
130155052|NCT02960893|468528413|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
130155053|NCT02960893|468528414|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
130155054|NCT02960893|468528415|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
130155055|NCT02960893|468528416|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
130155056|NCT02960893|468528413|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130155057|NCT02960893|468528414|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
130155058|NCT02960893|468528415|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130155059|NCT02960893|468528416|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
130155060|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
130155061|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
130155062|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
130155063|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
130155064|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
130155065|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
130155066|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
130155067|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
130155068|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
130155069|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
130155070|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
130155071|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
130155072|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
130155073|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
130155074|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
130155075|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
130155076|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
130155077|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
130155078|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
130155079|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
130155080|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
130155081|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
130155082|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
130155083|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
130155084|NCT02960893|468528413|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
130155085|NCT02960893|468528414|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
130155086|NCT02960893|468528415|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
130155087|NCT02960893|468528416|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
130155088|NCT00099268|468528419|FG000|Overall Study|Withdrawal by Subject|46|||
130155089|NCT00099268|468528420|FG001|Overall Study|Withdrawal by Subject|28|||
130155090|NCT00099268|468528419|FG000|Overall Study|Adverse Event|19|||
130155091|NCT00099268|468528420|FG001|Overall Study|Adverse Event|19|||
129980392|NCT00297427|467891617|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
129980393|NCT00297427|467891618|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
129980394|NCT02787044|467891621|FG000|Overall Study|Lost to Follow-up|15|||
129980395|NCT02787044|467891622|FG001|Overall Study|Lost to Follow-up|19|||
130155092|NCT00099268|468528419|FG000|Overall Study|Protocol Violation|9|||
130155093|NCT00099268|468528420|FG001|Overall Study|Protocol Violation|8|||
130155094|NCT00099268|468528419|FG000|Overall Study|Lost to Follow-up|6|||
130155095|NCT00099268|468528420|FG001|Overall Study|Lost to Follow-up|4|||
130155096|NCT00099268|468528419|FG000|Overall Study|Lack of Efficacy|5|||
130155097|NCT00099268|468528420|FG001|Overall Study|Lack of Efficacy|18|||
130155098|NCT00099268|468528419|FG000|Overall Study|Administrative problems|4|||
130155099|NCT00099268|468528420|FG001|Overall Study|Administrative problems|4|||
129980396|NCT02591953|467891624|FG000|Overall Study|Lost to Follow-up|6|||
129980397|NCT02591953|467891625|FG001|Overall Study|Lost to Follow-up|6|||
129980398|NCT01517295|467891628|FG000|Overall Study|Physician Decision|1|||
129980399|NCT01517295|467891629|FG001|Overall Study|Physician Decision|0|||
130155100|NCT00099268|468528419|FG000|Overall Study|Death|3|||
130155101|NCT00099268|468528420|FG001|Overall Study|Death|1|||
129980400|NCT02182947|467891630|FG000|Overall Study|Withdrawal by Subject|7|||
129980401|NCT02182947|467891630|FG000|Overall Study|Lost to Follow-up|3|||
129980402|NCT02182947|467891630|FG000|Overall Study|Failed screening activities|8|||
129980403|NCT01656200|467891631|FG000|Overall Study|Withdrawal by Subject|1|||
129980404|NCT04155047|467891637|FG000|Overall Study|Adverse Event|1|||
129980405|NCT04155047|467891638|FG001|Overall Study|Adverse Event|0|||
129980406|NCT04155047|467891637|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
129980407|NCT04155047|467891638|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
129980408|NCT03174431|467891642|FG000|Overall Study|Withdrawal by Subject|14|||
129980409|NCT03174431|467891643|FG001|Overall Study|Withdrawal by Subject|11|||
129980410|NCT03174431|467891642|FG000|Overall Study|alternative treatment|2|||
129980411|NCT03174431|467891643|FG001|Overall Study|alternative treatment|0|||
129980412|NCT03174431|467891642|FG000|Overall Study|Lost to Follow-up|1|||
129980413|NCT03174431|467891643|FG001|Overall Study|Lost to Follow-up|5|||
129980414|NCT02075073|467891644|FG000|Overall Study|Withdrawal by Subject|0|||
129980415|NCT02075073|467891645|FG001|Overall Study|Withdrawal by Subject|1|||
129980416|NCT02075073|467891646|FG002|Overall Study|Withdrawal by Subject|0|||
129980417|NCT02797080|467891652|FG000|Overall Study|Lost to Follow-up|1|||
129980418|NCT02797080|467891652|FG000|Overall Study|Withdrawal by Subject|1|||
129980419|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Adverse Event|1|||
129980420|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Adverse Event|1|||
129980421|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Adverse Event|2|||
129980422|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Adverse Event|5|||
129980423|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Adverse Event|0|||
129980424|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
129980425|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
129980426|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
129980427|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
129980428|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
129980429|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
129980430|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
129980431|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
129980432|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
129980433|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
129980434|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980435|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980436|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980437|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
129980438|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980439|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
129980440|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
129980441|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
129980442|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
129980443|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
129980444|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
129980445|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
129980446|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
129980447|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
129980448|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
129980449|NCT00951015|467891655|FG000|Open-label Phase|Adverse Event|0|||
129980450|NCT00951015|467891656|FG001|Open-label Phase|Adverse Event|0|||
129980451|NCT00951015|467891657|FG002|Open-label Phase|Adverse Event|0|||
129980452|NCT00951015|467891658|FG003|Open-label Phase|Adverse Event|0|||
129980453|NCT00951015|467891659|FG004|Open-label Phase|Adverse Event|3|||
129980454|NCT00951015|467891655|FG000|Open-label Phase|Lack of Efficacy|0|||
129980455|NCT00951015|467891656|FG001|Open-label Phase|Lack of Efficacy|0|||
129980456|NCT00951015|467891657|FG002|Open-label Phase|Lack of Efficacy|0|||
129980457|NCT00951015|467891658|FG003|Open-label Phase|Lack of Efficacy|0|||
129980458|NCT00951015|467891659|FG004|Open-label Phase|Lack of Efficacy|1|||
129980459|NCT00951015|467891655|FG000|Open-label Phase|Protocol Violation|0|||
129980460|NCT00951015|467891656|FG001|Open-label Phase|Protocol Violation|0|||
129980461|NCT00951015|467891657|FG002|Open-label Phase|Protocol Violation|0|||
129980462|NCT00951015|467891658|FG003|Open-label Phase|Protocol Violation|0|||
129980463|NCT00951015|467891659|FG004|Open-label Phase|Protocol Violation|12|||
129980464|NCT00951015|467891655|FG000|Open-label Phase|Lost to Follow-up|0|||
129980465|NCT00951015|467891656|FG001|Open-label Phase|Lost to Follow-up|0|||
129980466|NCT00951015|467891657|FG002|Open-label Phase|Lost to Follow-up|0|||
129980467|NCT00951015|467891658|FG003|Open-label Phase|Lost to Follow-up|0|||
129980468|NCT00951015|467891659|FG004|Open-label Phase|Lost to Follow-up|12|||
129980469|NCT00951015|467891655|FG000|Open-label Phase|Withdrawal by Subject|0|||
129980470|NCT00951015|467891656|FG001|Open-label Phase|Withdrawal by Subject|0|||
129980471|NCT00951015|467891657|FG002|Open-label Phase|Withdrawal by Subject|0|||
129980472|NCT00951015|467891658|FG003|Open-label Phase|Withdrawal by Subject|0|||
129980473|NCT00951015|467891659|FG004|Open-label Phase|Withdrawal by Subject|14|||
130155102|NCT00171301|468528422|FG000|Overall Study|Death|1|||
130155103|NCT00171301|468528423|FG001|Overall Study|Death|2|||
130155104|NCT00171301|468528422|FG000|Overall Study|Adverse Event|1|||
130155105|NCT00171301|468528423|FG001|Overall Study|Adverse Event|2|||
130155106|NCT00171301|468528422|FG000|Overall Study|Lost to Follow-up|6|||
130155107|NCT00171301|468528423|FG001|Overall Study|Lost to Follow-up|2|||
130155108|NCT00171301|468528422|FG000|Overall Study|Protocol Violation|0|||
130155109|NCT00171301|468528423|FG001|Overall Study|Protocol Violation|2|||
129980474|NCT00951015|467891655|FG000|Open-label Phase|Physician Decision|0|||
129980475|NCT00951015|467891656|FG001|Open-label Phase|Physician Decision|0|||
129980476|NCT00951015|467891657|FG002|Open-label Phase|Physician Decision|0|||
129980477|NCT00951015|467891658|FG003|Open-label Phase|Physician Decision|0|||
129980478|NCT00951015|467891659|FG004|Open-label Phase|Physician Decision|8|||
129980479|NCT01208103|467891661|FG000|Overall Study|Adverse Event|1|||
129980480|NCT01208103|467891661|FG000|Overall Study|Withdrawal by Subject|1|||
129980481|NCT03819634|467891662|FG000|Overall Study|Physician Decision|2|||
129980482|NCT00299494|467891663|FG000|Overall Study|Withdrawal by Subject|0|||
129980483|NCT00299494|467891664|FG001|Overall Study|Withdrawal by Subject|0|||
129980484|NCT00299494|467891665|FG002|Overall Study|Withdrawal by Subject|0|||
129980485|NCT00299494|467891666|FG003|Overall Study|Withdrawal by Subject|3|||
129980486|NCT00299494|467891667|FG004|Overall Study|Withdrawal by Subject|1|||
129980487|NCT00299494|467891668|FG005|Overall Study|Withdrawal by Subject|4|||
129980488|NCT00299494|467891663|FG000|Overall Study|Physician Decision|0|||
129980489|NCT00299494|467891664|FG001|Overall Study|Physician Decision|0|||
129980490|NCT00299494|467891665|FG002|Overall Study|Physician Decision|0|||
129980491|NCT00299494|467891666|FG003|Overall Study|Physician Decision|0|||
129980492|NCT00299494|467891667|FG004|Overall Study|Physician Decision|1|||
129980493|NCT00299494|467891668|FG005|Overall Study|Physician Decision|0|||
129980494|NCT00299494|467891663|FG000|Overall Study|Death|3|||
129980495|NCT00299494|467891664|FG001|Overall Study|Death|1|||
129980496|NCT00299494|467891665|FG002|Overall Study|Death|4|||
129980497|NCT00299494|467891666|FG003|Overall Study|Death|6|||
129980498|NCT00299494|467891667|FG004|Overall Study|Death|18|||
129980499|NCT00299494|467891668|FG005|Overall Study|Death|19|||
129980500|NCT00299494|467891663|FG000|Overall Study|Lost to Follow-up|0|||
129980501|NCT00299494|467891664|FG001|Overall Study|Lost to Follow-up|0|||
129980502|NCT00299494|467891665|FG002|Overall Study|Lost to Follow-up|0|||
129980503|NCT00299494|467891666|FG003|Overall Study|Lost to Follow-up|0|||
129980504|NCT00299494|467891667|FG004|Overall Study|Lost to Follow-up|3|||
129980505|NCT00299494|467891668|FG005|Overall Study|Lost to Follow-up|1|||
129980506|NCT00299494|467891663|FG000|Overall Study|Other - Unspecified|0|||
129980507|NCT00299494|467891664|FG001|Overall Study|Other - Unspecified|0|||
129980508|NCT00299494|467891665|FG002|Overall Study|Other - Unspecified|0|||
129980509|NCT00299494|467891666|FG003|Overall Study|Other - Unspecified|0|||
129980510|NCT00299494|467891667|FG004|Overall Study|Other - Unspecified|3|||
129980511|NCT00299494|467891668|FG005|Overall Study|Other - Unspecified|1|||
129980512|NCT00299494|467891663|FG000|Overall Study|Other - site closure|0|||
129980513|NCT00299494|467891664|FG001|Overall Study|Other - site closure|0|||
129980514|NCT00299494|467891665|FG002|Overall Study|Other - site closure|0|||
129980515|NCT00299494|467891666|FG003|Overall Study|Other - site closure|1|||
129980516|NCT00299494|467891667|FG004|Overall Study|Other - site closure|1|||
129980517|NCT00299494|467891668|FG005|Overall Study|Other - site closure|1|||
129980518|NCT01417104|467891669|FG000|Overall Study|Withdrawal by Subject|5|||
129980519|NCT01417104|467891670|FG001|Overall Study|Withdrawal by Subject|1|||
129980520|NCT01417104|467891669|FG000|Overall Study|Failure to make contact|0|||
129980521|NCT01417104|467891670|FG001|Overall Study|Failure to make contact|1|||
129980522|NCT01417104|467891669|FG000|Overall Study|Adverse Event|1|||
129980523|NCT01417104|467891670|FG001|Overall Study|Adverse Event|0|||
129980524|NCT03101462|467891671|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
129980525|NCT03101462|467891672|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
129980526|NCT02003222|467891678|FG000|Induction|Never started treatment|0|||
129980527|NCT02003222|467891679|FG001|Induction|Never started treatment|0|||
129980528|NCT02003222|467891680|FG002|Induction|Never started treatment|0|||
129980529|NCT02003222|467891681|FG003|Induction|Never started treatment|0|||
129980530|NCT02003222|467891682|FG004|Induction|Never started treatment|8|||
129980531|NCT02003222|467891678|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980532|NCT02003222|467891679|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980533|NCT02003222|467891680|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980534|NCT02003222|467891681|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980535|NCT02003222|467891682|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
129980536|NCT02003222|467891678|FG000|Induction|Adverse Event|0|||
129980537|NCT02003222|467891679|FG001|Induction|Adverse Event|0|||
129980538|NCT02003222|467891680|FG002|Induction|Adverse Event|0|||
129980539|NCT02003222|467891681|FG003|Induction|Adverse Event|0|||
129980540|NCT02003222|467891682|FG004|Induction|Adverse Event|13|||
129980541|NCT02003222|467891678|FG000|Induction|Alternative therapy|0|||
130155110|NCT00171301|468528422|FG000|Overall Study|Withdrawal by Subject|0|||
130155111|NCT00171301|468528423|FG001|Overall Study|Withdrawal by Subject|1|||
130155112|NCT04319159|468528424|FG000|Overall Study|Screening failure|13|||
130155113|NCT04319159|468528424|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
130155114|NCT04319159|468528424|FG000|Overall Study|Withdrawal by Subject|1|||
130155115|NCT06005597|468528425|FG000|Overall Study|Lost to Follow-up|1|||
130155116|NCT06005597|468528426|FG001|Overall Study|Lost to Follow-up|2|||
130155117|NCT06005597|468528427|FG002|Overall Study|Lost to Follow-up|1|||
130155118|NCT06005597|468528428|FG003|Overall Study|Lost to Follow-up|2|||
130155119|NCT06005597|468528425|FG000|Overall Study|Death|1|||
130155120|NCT06005597|468528426|FG001|Overall Study|Death|1|||
130155121|NCT06005597|468528427|FG002|Overall Study|Death|1|||
130155122|NCT06005597|468528428|FG003|Overall Study|Death|0|||
130155123|NCT02100319|468528429|FG000|Overall Study|Case Report Forms Uncollected|11|||
130155124|NCT02100319|468528429|FG000|Overall Study|Protocol Deviation|5|||
130155125|NCT00754442|468528430|FG000|Overall Study|Withdrawal by Subject|5|||
130155126|NCT00754442|468528431|FG001|Overall Study|Withdrawal by Subject|3|||
130155127|NCT04479475|468528432|FG000|Overall Study|Withdrawal by Subject|7|||
130155128|NCT00296491|468528433|FG000|Overall Study|Low Pollen Counts|18|||
130155129|NCT00296491|468528434|FG001|Overall Study|Low Pollen Counts|26|||
130155130|NCT00296491|468528435|FG002|Overall Study|Low Pollen Counts|25|||
130155131|NCT00296491|468528436|FG003|Overall Study|Low Pollen Counts|16|||
130155132|NCT00296491|468528433|FG000|Overall Study|Protocol Violation|4|||
130155133|NCT00296491|468528434|FG001|Overall Study|Protocol Violation|6|||
130155134|NCT00296491|468528435|FG002|Overall Study|Protocol Violation|2|||
130155135|NCT00296491|468528436|FG003|Overall Study|Protocol Violation|3|||
130155136|NCT00296491|468528433|FG000|Overall Study|Adverse Event|1|||
130155137|NCT00296491|468528434|FG001|Overall Study|Adverse Event|3|||
130155138|NCT00296491|468528435|FG002|Overall Study|Adverse Event|1|||
130155139|NCT00296491|468528436|FG003|Overall Study|Adverse Event|4|||
130155140|NCT00296491|468528433|FG000|Overall Study|Withdrawn due to Asthma|0|||
130155141|NCT00296491|468528434|FG001|Overall Study|Withdrawn due to Asthma|0|||
130155142|NCT00296491|468528435|FG002|Overall Study|Withdrawn due to Asthma|0|||
130155143|NCT00296491|468528436|FG003|Overall Study|Withdrawn due to Asthma|4|||
130155144|NCT00296491|468528433|FG000|Overall Study|Withdrawal by Subject|7|||
130155145|NCT00296491|468528434|FG001|Overall Study|Withdrawal by Subject|3|||
130155146|NCT00296491|468528435|FG002|Overall Study|Withdrawal by Subject|3|||
130155147|NCT00296491|468528436|FG003|Overall Study|Withdrawal by Subject|2|||
130155148|NCT00296491|468528433|FG000|Overall Study|Non-Compliance|12|||
130155149|NCT00296491|468528434|FG001|Overall Study|Non-Compliance|13|||
130155150|NCT00296491|468528435|FG002|Overall Study|Non-Compliance|10|||
130155151|NCT00296491|468528436|FG003|Overall Study|Non-Compliance|14|||
130155152|NCT00296491|468528433|FG000|Overall Study|Lost to Follow-up|0|||
130155153|NCT00296491|468528434|FG001|Overall Study|Lost to Follow-up|2|||
130155154|NCT00296491|468528435|FG002|Overall Study|Lost to Follow-up|2|||
130155155|NCT00296491|468528436|FG003|Overall Study|Lost to Follow-up|0|||
130155156|NCT01300052|468528437|FG000|Overall Study|Adverse Event|3|||
130155157|NCT01300052|468528438|FG001|Overall Study|Adverse Event|0|||
130155158|NCT01300052|468528437|FG000|Overall Study|Withdrawal by Subject|2|||
130155159|NCT01300052|468528438|FG001|Overall Study|Withdrawal by Subject|2|||
130155160|NCT01300052|468528437|FG000|Overall Study|Protocol Violation|1|||
130155161|NCT01300052|468528438|FG001|Overall Study|Protocol Violation|1|||
130155162|NCT06972251|468528439|FG000|Overall Study|Withdrawal by Subject|1|||
130155163|NCT06972251|468528440|FG001|Overall Study|Withdrawal by Subject|0|||
130155164|NCT06972251|468528439|FG000|Overall Study|Lost to Follow-up|10|||
130155165|NCT06972251|468528440|FG001|Overall Study|Lost to Follow-up|2|||
130155166|NCT01231373|468528441|FG000|Overall Study|Withdrew consent prior to randomization|2|||
130155167|NCT01231373|468528442|FG001|Overall Study|Withdrew consent prior to randomization|1|||
130155168|NCT01231373|468528443|FG002|Overall Study|Withdrew consent prior to randomization|0|||
130155169|NCT01231373|468528444|FG003|Overall Study|Withdrew consent prior to randomization|0|||
130155170|NCT01231373|468528441|FG000|Overall Study|Lost to Follow-up|0|||
130155171|NCT01231373|468528442|FG001|Overall Study|Lost to Follow-up|0|||
130155172|NCT01231373|468528443|FG002|Overall Study|Lost to Follow-up|0|||
130155173|NCT01231373|468528444|FG003|Overall Study|Lost to Follow-up|1|||
130155174|NCT01231373|468528441|FG000|Overall Study|Withdrew Consent|1|||
130155175|NCT01231373|468528442|FG001|Overall Study|Withdrew Consent|0|||
130155176|NCT01231373|468528443|FG002|Overall Study|Withdrew Consent|0|||
130155177|NCT01231373|468528444|FG003|Overall Study|Withdrew Consent|0|||
130155178|NCT03451006|468528445|FG000|Overall Study|Withdrawal by Subject|2|||
130155179|NCT03451006|468528446|FG001|Overall Study|Withdrawal by Subject|2|||
130155180|NCT01929395|468528447|FG000|Overall Study|Did not complete - non-related toxicity|1|||
130155181|NCT01929395|468528448|FG001|Overall Study|Did not complete - non-related toxicity|0|||
130155182|NCT01929395|468528449|FG002|Overall Study|Did not complete - non-related toxicity|0|||
130155183|NCT01929395|468528447|FG000|Overall Study|Withdrawal by Subject|0|||
130155184|NCT01929395|468528448|FG001|Overall Study|Withdrawal by Subject|1|||
130155185|NCT01929395|468528449|FG002|Overall Study|Withdrawal by Subject|0|||
130155186|NCT01929395|468528447|FG000|Overall Study|Screen Fail|0|||
130155187|NCT01929395|468528448|FG001|Overall Study|Screen Fail|0|||
130155188|NCT01929395|468528449|FG002|Overall Study|Screen Fail|1|||
130155189|NCT02547766|468528450|FG000|Overall Study|Withdrawal by Subject|1|||
130155190|NCT03604341|468528451|FG000|Overall Study|Withdrawal by Subject|1|||
130155191|NCT03604341|468528452|FG001|Overall Study|Withdrawal by Subject|1|||
130155192|NCT03604341|468528451|FG000|Overall Study|Adverse Event|1|||
130155193|NCT03604341|468528452|FG001|Overall Study|Adverse Event|0|||
130155194|NCT03604341|468528451|FG000|Overall Study|Protocol Violation|0|||
130155195|NCT03604341|468528452|FG001|Overall Study|Protocol Violation|1|||
130155196|NCT01829113|468528456|FG000|Overall Study|Disease Progression|37|||
130155197|NCT01829113|468528457|FG001|Overall Study|Disease Progression|48|||
130155198|NCT01829113|468528456|FG000|Overall Study|Adverse Event|14|||
130155199|NCT01829113|468528457|FG001|Overall Study|Adverse Event|10|||
130155200|NCT01829113|468528456|FG000|Overall Study|Withdrawal by Subject|17|||
130155201|NCT01829113|468528457|FG001|Overall Study|Withdrawal by Subject|10|||
130155202|NCT01829113|468528456|FG000|Overall Study|Death|4|||
130155203|NCT01829113|468528457|FG001|Overall Study|Death|6|||
130155204|NCT01829113|468528456|FG000|Overall Study|Sponsor Decision|1|||
130155205|NCT01829113|468528457|FG001|Overall Study|Sponsor Decision|1|||
130155206|NCT01829113|468528456|FG000|Overall Study|No Study Treatment Received|3|||
130155207|NCT01829113|468528457|FG001|Overall Study|No Study Treatment Received|2|||
130155208|NCT01829113|468528456|FG000|Overall Study|Physician Decision|1|||
130155209|NCT01829113|468528457|FG001|Overall Study|Physician Decision|1|||
130155210|NCT03253744|468528462|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
130155211|NCT03253744|468528463|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
130155212|NCT03253744|468528464|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
130155213|NCT03253744|468528465|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
130155214|NCT04134845|468528466|FG000|Overall Study|withdrawl by PI|5|||
130155215|NCT04134845|468528467|FG001|Overall Study|withdrawl by PI|12|||
130155216|NCT02010255|468528468|FG000|Overall Study|Death|0|||
130155217|NCT02010255|468528469|FG001|Overall Study|Death|1|||
130155218|NCT02010255|468528470|FG002|Overall Study|Death|4|||
130155219|NCT02010255|468528471|FG003|Overall Study|Death|4|||
130155220|NCT02010255|468528472|FG004|Overall Study|Death|2|||
130155221|NCT02010255|468528473|FG005|Overall Study|Death|0|||
130155222|NCT02010255|468528474|FG006|Overall Study|Death|1|||
130155223|NCT02010255|468528475|FG007|Overall Study|Death|1|||
130155224|NCT02010255|468528476|FG008|Overall Study|Death|1|||
130155225|NCT02010255|468528477|FG009|Overall Study|Death|0|||
130155226|NCT02010255|468528478|FG010|Overall Study|Death|1|||
130155227|NCT02010255|468528479|FG011|Overall Study|Death|1|||
130155228|NCT02010255|468528480|FG012|Overall Study|Death|0|||
130155229|NCT02010255|468528481|FG013|Overall Study|Death|0|||
130155230|NCT02010255|468528468|FG000|Overall Study|Lack of Efficacy|4|||
130155231|NCT02010255|468528469|FG001|Overall Study|Lack of Efficacy|1|||
130155232|NCT02010255|468528470|FG002|Overall Study|Lack of Efficacy|2|||
130155233|NCT02010255|468528471|FG003|Overall Study|Lack of Efficacy|1|||
130155234|NCT02010255|468528472|FG004|Overall Study|Lack of Efficacy|1|||
130155235|NCT02010255|468528473|FG005|Overall Study|Lack of Efficacy|0|||
130155236|NCT02010255|468528474|FG006|Overall Study|Lack of Efficacy|0|||
130155237|NCT02010255|468528475|FG007|Overall Study|Lack of Efficacy|0|||
130155238|NCT02010255|468528476|FG008|Overall Study|Lack of Efficacy|0|||
130155239|NCT02010255|468528477|FG009|Overall Study|Lack of Efficacy|0|||
130155240|NCT02010255|468528478|FG010|Overall Study|Lack of Efficacy|1|||
130155241|NCT02010255|468528479|FG011|Overall Study|Lack of Efficacy|0|||
130155242|NCT02010255|468528480|FG012|Overall Study|Lack of Efficacy|0|||
130155243|NCT02010255|468528481|FG013|Overall Study|Lack of Efficacy|0|||
130155244|NCT02010255|468528468|FG000|Overall Study|Withdrew Consent|1|||
130155245|NCT02010255|468528469|FG001|Overall Study|Withdrew Consent|0|||
130155246|NCT02010255|468528470|FG002|Overall Study|Withdrew Consent|0|||
130155247|NCT02010255|468528471|FG003|Overall Study|Withdrew Consent|1|||
130155248|NCT02010255|468528472|FG004|Overall Study|Withdrew Consent|0|||
130155249|NCT02010255|468528473|FG005|Overall Study|Withdrew Consent|0|||
130155250|NCT02010255|468528474|FG006|Overall Study|Withdrew Consent|0|||
130155251|NCT02010255|468528475|FG007|Overall Study|Withdrew Consent|0|||
130155252|NCT02010255|468528476|FG008|Overall Study|Withdrew Consent|0|||
130155253|NCT02010255|468528477|FG009|Overall Study|Withdrew Consent|0|||
130155254|NCT02010255|468528478|FG010|Overall Study|Withdrew Consent|0|||
130155255|NCT02010255|468528479|FG011|Overall Study|Withdrew Consent|0|||
130155256|NCT02010255|468528480|FG012|Overall Study|Withdrew Consent|0|||
130155257|NCT02010255|468528481|FG013|Overall Study|Withdrew Consent|0|||
130155258|NCT02010255|468528468|FG000|Overall Study|Adverse Event|1|||
130155259|NCT02010255|468528469|FG001|Overall Study|Adverse Event|0|||
130155260|NCT02010255|468528470|FG002|Overall Study|Adverse Event|0|||
130155261|NCT02010255|468528471|FG003|Overall Study|Adverse Event|0|||
130155262|NCT02010255|468528472|FG004|Overall Study|Adverse Event|0|||
130155263|NCT02010255|468528473|FG005|Overall Study|Adverse Event|0|||
130155264|NCT02010255|468528474|FG006|Overall Study|Adverse Event|0|||
130155265|NCT02010255|468528475|FG007|Overall Study|Adverse Event|0|||
130155266|NCT02010255|468528476|FG008|Overall Study|Adverse Event|0|||
130155267|NCT02010255|468528477|FG009|Overall Study|Adverse Event|0|||
130155268|NCT02010255|468528478|FG010|Overall Study|Adverse Event|0|||
130155269|NCT02010255|468528479|FG011|Overall Study|Adverse Event|0|||
130155270|NCT02010255|468528480|FG012|Overall Study|Adverse Event|0|||
130155271|NCT02010255|468528481|FG013|Overall Study|Adverse Event|0|||
130155272|NCT02010255|468528468|FG000|Overall Study|Lost to Follow-up|0|||
130155273|NCT02010255|468528469|FG001|Overall Study|Lost to Follow-up|0|||
130155274|NCT02010255|468528470|FG002|Overall Study|Lost to Follow-up|1|||
130155275|NCT02010255|468528471|FG003|Overall Study|Lost to Follow-up|0|||
130155276|NCT02010255|468528472|FG004|Overall Study|Lost to Follow-up|1|||
130155277|NCT02010255|468528473|FG005|Overall Study|Lost to Follow-up|0|||
130155278|NCT02010255|468528474|FG006|Overall Study|Lost to Follow-up|0|||
130155279|NCT02010255|468528475|FG007|Overall Study|Lost to Follow-up|0|||
130155280|NCT02010255|468528476|FG008|Overall Study|Lost to Follow-up|0|||
130155281|NCT02010255|468528477|FG009|Overall Study|Lost to Follow-up|0|||
130155282|NCT02010255|468528478|FG010|Overall Study|Lost to Follow-up|0|||
130155283|NCT02010255|468528479|FG011|Overall Study|Lost to Follow-up|0|||
130155284|NCT02010255|468528480|FG012|Overall Study|Lost to Follow-up|0|||
130155285|NCT02010255|468528481|FG013|Overall Study|Lost to Follow-up|0|||
130155286|NCT02010255|468528468|FG000|Overall Study|Randomized but Not Treated|0|||
130155287|NCT02010255|468528469|FG001|Overall Study|Randomized but Not Treated|0|||
130155288|NCT02010255|468528470|FG002|Overall Study|Randomized but Not Treated|0|||
130155289|NCT02010255|468528471|FG003|Overall Study|Randomized but Not Treated|0|||
130155290|NCT02010255|468528472|FG004|Overall Study|Randomized but Not Treated|0|||
130155291|NCT02010255|468528473|FG005|Overall Study|Randomized but Not Treated|0|||
130155292|NCT02010255|468528474|FG006|Overall Study|Randomized but Not Treated|0|||
130155293|NCT02010255|468528475|FG007|Overall Study|Randomized but Not Treated|0|||
130155294|NCT02010255|468528476|FG008|Overall Study|Randomized but Not Treated|0|||
130155295|NCT02010255|468528477|FG009|Overall Study|Randomized but Not Treated|0|||
130155296|NCT02010255|468528478|FG010|Overall Study|Randomized but Not Treated|0|||
130155297|NCT02010255|468528479|FG011|Overall Study|Randomized but Not Treated|0|||
130155298|NCT02010255|468528480|FG012|Overall Study|Randomized but Not Treated|0|||
130155299|NCT02010255|468528481|FG013|Overall Study|Randomized but Not Treated|1|||
130155300|NCT02777918|468528485|FG000|Overall Study|Medical reasons|1|||
130155301|NCT02777918|468528486|FG001|Overall Study|Medical reasons|2|||
130155302|NCT02777918|468528485|FG000|Overall Study|Too busy / stressed|1|||
130155303|NCT02777918|468528486|FG001|Overall Study|Too busy / stressed|1|||
130155304|NCT02777918|468528485|FG000|Overall Study|Withdrawal by Subject|1|||
130155305|NCT02777918|468528486|FG001|Overall Study|Withdrawal by Subject|1|||
130155306|NCT00757848|468528487|FG000|Overall Study|Voluntary discontinuation|1|||
130155307|NCT00757848|468528488|FG001|Overall Study|Voluntary discontinuation|0|||
130155308|NCT00757848|468528487|FG000|Overall Study|Adverse Event|1|||
130155309|NCT00757848|468528488|FG001|Overall Study|Adverse Event|2|||
130155310|NCT00757848|468528487|FG000|Overall Study|Incorrect enrolment|1|||
130155311|NCT00757848|468528488|FG001|Overall Study|Incorrect enrolment|0|||
130155312|NCT00058214|468528489|FG000|Overall Study|Adverse Event|1|||
130155313|NCT03856593|468528493|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
130155314|NCT03856593|468528494|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
130155315|NCT01949116|468528496|FG000|Overall Study|Death|2|||
130155316|NCT01949116|468528497|FG001|Overall Study|Death|0|||
130155317|NCT01949116|468528496|FG000|Overall Study|Lost to Follow-up|1|||
130155318|NCT01949116|468528497|FG001|Overall Study|Lost to Follow-up|3|||
130155319|NCT01949116|468528496|FG000|Overall Study|Withdrawal by Subject|5|||
130155320|NCT01949116|468528497|FG001|Overall Study|Withdrawal by Subject|3|||
130155321|NCT00706992|468528501|FG000|Overall Study|Study termination|5|||
130155322|NCT00706992|468528502|FG001|Overall Study|Study termination|5|||
130155323|NCT00706992|468528503|FG002|Overall Study|Study termination|6|||
130155324|NCT00706992|468528504|FG003|Overall Study|Study termination|2|||
130155325|NCT00706992|468528505|FG004|Overall Study|Study termination|3|||
130155326|NCT00706992|468528506|FG005|Overall Study|Study termination|2|||
130155327|NCT00706992|468528507|FG006|Overall Study|Study termination|3|||
130155328|NCT00706992|468528501|FG000|Overall Study|Disease progression before treatment|0|||
130155329|NCT00706992|468528502|FG001|Overall Study|Disease progression before treatment|0|||
130155330|NCT00706992|468528503|FG002|Overall Study|Disease progression before treatment|0|||
130155331|NCT00706992|468528504|FG003|Overall Study|Disease progression before treatment|0|||
130155332|NCT00706992|468528505|FG004|Overall Study|Disease progression before treatment|1|||
130155333|NCT00706992|468528506|FG005|Overall Study|Disease progression before treatment|0|||
130155334|NCT00706992|468528507|FG006|Overall Study|Disease progression before treatment|0|||
130155335|NCT02377063|468528511|FG000|Overall Study|Non-compliance|5|||
130155336|NCT00702208|468528512|FG000|Overall Study|Lost to Follow-up|28|||
130155337|NCT00702208|468528512|FG000|Overall Study|Did not self-lavage|1|||
130155338|NCT00702208|468528512|FG000|Overall Study|Unsatisfactory colposcopy|2|||
130155339|NCT02746627|468528513|FG000|Overall Study|Withdrawal by Subject|1|||
130155340|NCT02746627|468528514|FG001|Overall Study|Withdrawal by Subject|1|||
130155341|NCT02746627|468528515|FG002|Overall Study|Withdrawal by Subject|1|||
130155342|NCT02858726|468528518|FG000|Overall Study|Adverse Event|4|||
130155343|NCT02858726|468528519|FG001|Overall Study|Adverse Event|4|||
130155344|NCT02858726|468528520|FG002|Overall Study|Adverse Event|9|||
130155345|NCT02858726|468528521|FG003|Overall Study|Adverse Event|1|||
130155346|NCT02858726|468528518|FG000|Overall Study|Physician Decision|0|||
130155347|NCT02858726|468528519|FG001|Overall Study|Physician Decision|0|||
130155348|NCT02858726|468528520|FG002|Overall Study|Physician Decision|1|||
130155349|NCT02858726|468528521|FG003|Overall Study|Physician Decision|0|||
130155350|NCT02858726|468528518|FG000|Overall Study|Protocol Violation|0|||
130155351|NCT02858726|468528519|FG001|Overall Study|Protocol Violation|0|||
130155352|NCT02858726|468528520|FG002|Overall Study|Protocol Violation|0|||
130155353|NCT02858726|468528521|FG003|Overall Study|Protocol Violation|1|||
130155354|NCT02858726|468528518|FG000|Overall Study|Study Terminated by Sponsor|0|||
130155355|NCT02858726|468528519|FG001|Overall Study|Study Terminated by Sponsor|0|||
130155356|NCT02858726|468528520|FG002|Overall Study|Study Terminated by Sponsor|0|||
130155357|NCT02858726|468528521|FG003|Overall Study|Study Terminated by Sponsor|1|||
130155358|NCT02858726|468528518|FG000|Overall Study|Withdrawal by Subject|1|||
130155359|NCT02858726|468528519|FG001|Overall Study|Withdrawal by Subject|2|||
130155360|NCT02858726|468528520|FG002|Overall Study|Withdrawal by Subject|1|||
130155361|NCT02858726|468528521|FG003|Overall Study|Withdrawal by Subject|0|||
130155362|NCT02858726|468528518|FG000|Overall Study|Noncompliance|0|||
130155363|NCT02858726|468528519|FG001|Overall Study|Noncompliance|1|||
130155364|NCT02858726|468528520|FG002|Overall Study|Noncompliance|0|||
130155365|NCT02858726|468528521|FG003|Overall Study|Noncompliance|0|||
130155366|NCT01392326|468528524|FG000|Overall Study|Death|2|||
130155367|NCT01392326|468528525|FG001|Overall Study|Death|0|||
130155368|NCT01392326|468528526|FG002|Overall Study|Death|0|||
130155369|NCT01392326|468528524|FG000|Overall Study|Withdrawal by Subject|12|||
130155370|NCT01392326|468528525|FG001|Overall Study|Withdrawal by Subject|11|||
130155371|NCT01392326|468528526|FG002|Overall Study|Withdrawal by Subject|15|||
130155372|NCT01392326|468528524|FG000|Overall Study|Protocol Violation|2|||
130155373|NCT01392326|468528525|FG001|Overall Study|Protocol Violation|0|||
130155374|NCT01392326|468528526|FG002|Overall Study|Protocol Violation|0|||
130155375|NCT01392326|468528524|FG000|Overall Study|Pregnancy|0|||
130155376|NCT01392326|468528525|FG001|Overall Study|Pregnancy|0|||
130155377|NCT01392326|468528526|FG002|Overall Study|Pregnancy|1|||
130155378|NCT01392326|468528524|FG000|Overall Study|Physician Decision|7|||
130155379|NCT01392326|468528525|FG001|Overall Study|Physician Decision|5|||
130155380|NCT01392326|468528526|FG002|Overall Study|Physician Decision|2|||
130155381|NCT01392326|468528524|FG000|Overall Study|Lost to Follow-up|1|||
130155382|NCT01392326|468528525|FG001|Overall Study|Lost to Follow-up|3|||
130155383|NCT01392326|468528526|FG002|Overall Study|Lost to Follow-up|4|||
130155384|NCT01392326|468528524|FG000|Overall Study|Lack of Efficacy|14|||
130155385|NCT01392326|468528525|FG001|Overall Study|Lack of Efficacy|10|||
130155386|NCT01392326|468528526|FG002|Overall Study|Lack of Efficacy|15|||
130155387|NCT01392326|468528524|FG000|Overall Study|Adverse Event|9|||
130155388|NCT01392326|468528525|FG001|Overall Study|Adverse Event|6|||
130155389|NCT01392326|468528526|FG002|Overall Study|Adverse Event|11|||
130155390|NCT00233987|468528529|FG000|Overall Study|Withdrawal by Subject|1|||
130155391|NCT00233987|468528529|FG000|Overall Study|Lack of Efficacy|2|||
130155392|NCT00233987|468528529|FG000|Overall Study|Reason Under Review|1|||
130155393|NCT00233987|468528529|FG000|Overall Study|Other - Not Protocol Specified|5|||
130155394|NCT00233987|468528529|FG000|Overall Study|Eligible but No Treatment Received|2|||
130155395|NCT00233987|468528529|FG000|Overall Study|Ineligible|4|||
130155396|NCT00518622|468528532|FG000|Overall Study|Lost to Follow-up|0|||
130155397|NCT00518622|468528533|FG001|Overall Study|Lost to Follow-up|0|||
130155398|NCT00518622|468528534|FG002|Overall Study|Lost to Follow-up|1|||
130155399|NCT00518622|468528535|FG003|Overall Study|Lost to Follow-up|0|||
130155400|NCT00518622|468528536|FG004|Overall Study|Lost to Follow-up|0|||
130155401|NCT00518622|468528537|FG005|Overall Study|Lost to Follow-up|0|||
130155402|NCT00518622|468528538|FG006|Overall Study|Lost to Follow-up|0|||
130155403|NCT00518622|468528539|FG007|Overall Study|Lost to Follow-up|0|||
130155404|NCT00518622|468528532|FG000|Overall Study|Study medication taken incorrectly|0|||
130155405|NCT00518622|468528533|FG001|Overall Study|Study medication taken incorrectly|1|||
130155406|NCT00518622|468528534|FG002|Overall Study|Study medication taken incorrectly|0|||
130155407|NCT00518622|468528535|FG003|Overall Study|Study medication taken incorrectly|0|||
130155408|NCT00518622|468528536|FG004|Overall Study|Study medication taken incorrectly|0|||
130155409|NCT00518622|468528537|FG005|Overall Study|Study medication taken incorrectly|0|||
130155410|NCT00518622|468528538|FG006|Overall Study|Study medication taken incorrectly|0|||
130155411|NCT00518622|468528539|FG007|Overall Study|Study medication taken incorrectly|0|||
130155412|NCT03821272|468529155|FG000|Overall Study|Death|1|||
130155413|NCT03821272|468529156|FG001|Overall Study|Death|0|||
130155414|NCT03821272|468529155|FG000|Overall Study|Physician Decision|1|||
130155415|NCT03821272|468529156|FG001|Overall Study|Physician Decision|0|||
129980542|NCT02003222|467891679|FG001|Induction|Alternative therapy|0|||
129980543|NCT02003222|467891680|FG002|Induction|Alternative therapy|0|||
129980544|NCT02003222|467891681|FG003|Induction|Alternative therapy|0|||
130155416|NCT03821272|468529155|FG000|Overall Study|Withdrawal by Subject|1|||
130155417|NCT03821272|468529156|FG001|Overall Study|Withdrawal by Subject|0|||
130155418|NCT05904769|468529157|FG000|Overall Study|Physician Decision|0|||
130155419|NCT05904769|468529158|FG001|Overall Study|Physician Decision|6|||
130155420|NCT01013649|468529163|FG000|First Step|Withdrawal by Subject|36|||
130155421|NCT01013649|468529164|FG001|First Step|Withdrawal by Subject|19|||
130155422|NCT01013649|468529165|FG002|First Step|Withdrawal by Subject|0|||
130155423|NCT01013649|468529166|FG003|First Step|Withdrawal by Subject|0|||
130155424|NCT01013649|468529163|FG000|First Step|Progression|58|||
130155425|NCT01013649|468529164|FG001|First Step|Progression|23|||
130155426|NCT01013649|468529165|FG002|First Step|Progression|0|||
130155427|NCT01013649|468529166|FG003|First Step|Progression|0|||
130155428|NCT01013649|468529163|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
130155429|NCT01013649|468529164|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
130155430|NCT01013649|468529165|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
130155431|NCT01013649|468529166|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
130155432|NCT01013649|468529163|FG000|First Step|Death|3|||
130155433|NCT01013649|468529164|FG001|First Step|Death|4|||
130155434|NCT01013649|468529165|FG002|First Step|Death|0|||
130155435|NCT01013649|468529166|FG003|First Step|Death|0|||
130155436|NCT01013649|468529163|FG000|First Step|Adverse Event|9|||
130155437|NCT01013649|468529164|FG001|First Step|Adverse Event|5|||
130155438|NCT01013649|468529165|FG002|First Step|Adverse Event|0|||
130155439|NCT01013649|468529166|FG003|First Step|Adverse Event|0|||
130155440|NCT01013649|468529163|FG000|First Step|Other|4|||
130155441|NCT01013649|468529164|FG001|First Step|Other|6|||
130155442|NCT01013649|468529165|FG002|First Step|Other|0|||
130155443|NCT01013649|468529166|FG003|First Step|Other|0|||
130155444|NCT04285567|468529167|FG000|Overall Study|Death|3|||
130155445|NCT04285567|468529168|FG001|Overall Study|Death|3|||
130155446|NCT04285567|468529167|FG000|Overall Study|Lost to Follow-up|1|||
130155447|NCT04285567|468529168|FG001|Overall Study|Lost to Follow-up|1|||
130155448|NCT04285567|468529167|FG000|Overall Study|Reason Not Specified|1|||
130155449|NCT04285567|468529168|FG001|Overall Study|Reason Not Specified|1|||
130155450|NCT04285567|468529167|FG000|Overall Study|Physician Decision|2|||
130155451|NCT04285567|468529168|FG001|Overall Study|Physician Decision|1|||
130155452|NCT04285567|468529167|FG000|Overall Study|Withdrawal by Subject|2|||
130155453|NCT04285567|468529168|FG001|Overall Study|Withdrawal by Subject|6|||
130155454|NCT04285567|468529167|FG000|Overall Study|Adverse Event|1|||
130155455|NCT04285567|468529168|FG001|Overall Study|Adverse Event|0|||
130155456|NCT04285567|468529167|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
130155457|NCT04285567|468529168|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
130155458|NCT03578237|468529175|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
130155459|NCT03578237|468529176|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
130155460|NCT00973765|468529177|FG000|Overall Study|Lost to Follow-up|8|||
130155461|NCT00973765|468529178|FG001|Overall Study|Lost to Follow-up|14|||
130155462|NCT02011113|468529179|FG000|Overall Study|Adverse Event|4|||
130155463|NCT02011113|468529179|FG000|Overall Study|Disease Progression (DP)|16|||
130155464|NCT02011113|468529179|FG000|Overall Study|Death|1|||
130155465|NCT02011113|468529179|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
130155466|NCT02011113|468529179|FG000|Overall Study|Investigator's judgement- DP|3|||
130155467|NCT02011113|468529179|FG000|Overall Study|Study terminated by sponsor|11|||
130155468|NCT03375320|468529180|FG000|Overall Study|Adverse Event|34|||
130155469|NCT03375320|468529181|FG001|Overall Study|Adverse Event|9|||
130155470|NCT03375320|468529182|FG002|Overall Study|Adverse Event|10|||
129980545|NCT02003222|467891682|FG004|Induction|Alternative therapy|12|||
129980546|NCT02003222|467891678|FG000|Induction|Disease progression|0|||
129980547|NCT02003222|467891679|FG001|Induction|Disease progression|0|||
129980548|NCT02003222|467891680|FG002|Induction|Disease progression|0|||
129980549|NCT02003222|467891681|FG003|Induction|Disease progression|0|||
129980550|NCT02003222|467891682|FG004|Induction|Disease progression|22|||
129980551|NCT02003222|467891678|FG000|Induction|Death|0|||
129980552|NCT02003222|467891679|FG001|Induction|Death|0|||
129980553|NCT02003222|467891680|FG002|Induction|Death|0|||
129980554|NCT02003222|467891681|FG003|Induction|Death|0|||
129980555|NCT02003222|467891682|FG004|Induction|Death|3|||
129980556|NCT02003222|467891678|FG000|Induction|Withdrawal by Subject|0|||
129980557|NCT02003222|467891679|FG001|Induction|Withdrawal by Subject|0|||
129980558|NCT02003222|467891680|FG002|Induction|Withdrawal by Subject|0|||
129980559|NCT02003222|467891681|FG003|Induction|Withdrawal by Subject|0|||
129980560|NCT02003222|467891682|FG004|Induction|Withdrawal by Subject|8|||
129980561|NCT02003222|467891678|FG000|Induction|Other reasons|0|||
129980562|NCT02003222|467891679|FG001|Induction|Other reasons|0|||
129980563|NCT02003222|467891680|FG002|Induction|Other reasons|0|||
129980564|NCT02003222|467891681|FG003|Induction|Other reasons|0|||
129980565|NCT02003222|467891682|FG004|Induction|Other reasons|22|||
129980566|NCT02003222|467891678|FG000|Intensification|Never started treatment|0|||
129980567|NCT02003222|467891679|FG001|Intensification|Never started treatment|0|||
129980568|NCT02003222|467891680|FG002|Intensification|Never started treatment|0|||
129980569|NCT02003222|467891681|FG003|Intensification|Never started treatment|0|||
129980570|NCT02003222|467891682|FG004|Intensification|Never started treatment|2|||
129980571|NCT02003222|467891678|FG000|Intensification|Adverse Event|0|||
129980572|NCT02003222|467891679|FG001|Intensification|Adverse Event|0|||
129980573|NCT02003222|467891680|FG002|Intensification|Adverse Event|0|||
129980574|NCT02003222|467891681|FG003|Intensification|Adverse Event|0|||
129980575|NCT02003222|467891682|FG004|Intensification|Adverse Event|6|||
129980576|NCT02003222|467891678|FG000|Intensification|Alternative therapy|0|||
130155471|NCT03375320|468529183|FG003|Overall Study|Adverse Event|0|||
130155472|NCT03375320|468529180|FG000|Overall Study|Death|6|||
130155473|NCT03375320|468529181|FG001|Overall Study|Death|3|||
130155474|NCT03375320|468529182|FG002|Overall Study|Death|0|||
130155475|NCT03375320|468529183|FG003|Overall Study|Death|0|||
130155476|NCT03375320|468529180|FG000|Overall Study|Withdrawal by Subject|7|||
130155477|NCT03375320|468529181|FG001|Overall Study|Withdrawal by Subject|4|||
130155478|NCT03375320|468529182|FG002|Overall Study|Withdrawal by Subject|5|||
130155479|NCT03375320|468529183|FG003|Overall Study|Withdrawal by Subject|4|||
130155480|NCT03375320|468529180|FG000|Overall Study|Progressive disease|55|||
130155481|NCT03375320|468529181|FG001|Overall Study|Progressive disease|41|||
130155482|NCT03375320|468529182|FG002|Overall Study|Progressive disease|29|||
130155483|NCT03375320|468529183|FG003|Overall Study|Progressive disease|24|||
130155484|NCT03375320|468529180|FG000|Overall Study|Alternative treatment|6|||
130155485|NCT03375320|468529181|FG001|Overall Study|Alternative treatment|1|||
130155486|NCT03375320|468529182|FG002|Overall Study|Alternative treatment|1|||
130155487|NCT03375320|468529183|FG003|Overall Study|Alternative treatment|0|||
130155488|NCT03375320|468529180|FG000|Overall Study|Other disease|1|||
130155489|NCT03375320|468529181|FG001|Overall Study|Other disease|1|||
130155490|NCT03375320|468529182|FG002|Overall Study|Other disease|3|||
130155491|NCT03375320|468529183|FG003|Overall Study|Other disease|0|||
130155492|NCT03375320|468529180|FG000|Overall Study|Withdrawal prior to initiation|2|||
130155493|NCT03375320|468529181|FG001|Overall Study|Withdrawal prior to initiation|2|||
130155494|NCT03375320|468529182|FG002|Overall Study|Withdrawal prior to initiation|1|||
130155495|NCT03375320|468529183|FG003|Overall Study|Withdrawal prior to initiation|0|||
130155496|NCT03375320|468529180|FG000|Overall Study|Physician Decision|1|||
130155497|NCT03375320|468529181|FG001|Overall Study|Physician Decision|1|||
130155498|NCT03375320|468529182|FG002|Overall Study|Physician Decision|1|||
130155499|NCT03375320|468529183|FG003|Overall Study|Physician Decision|1|||
130155500|NCT03375320|468529180|FG000|Overall Study|Non-compliance|1|||
130155501|NCT03375320|468529181|FG001|Overall Study|Non-compliance|0|||
130155502|NCT03375320|468529182|FG002|Overall Study|Non-compliance|0|||
130155503|NCT03375320|468529183|FG003|Overall Study|Non-compliance|0|||
130155504|NCT02589522|468529186|FG000|Overall Study|Physician Decision|1|||
130155505|NCT02589522|468529187|FG001|Overall Study|Physician Decision|2|||
130155506|NCT02589522|468529188|FG002|Overall Study|Physician Decision|0|||
130155507|NCT02589522|468529186|FG000|Overall Study|Did not start treatment|1|||
130155508|NCT02589522|468529187|FG001|Overall Study|Did not start treatment|0|||
130155509|NCT02589522|468529188|FG002|Overall Study|Did not start treatment|0|||
130155510|NCT05611996|468529189|FG000|Overall Study|Ineligible|1|||
130155511|NCT05611996|468529189|FG000|Overall Study|Withdrawal by Subject|9|||
130155512|NCT05560763|468529190|FG000|Overall Study|Withdrawal by Subject|4|||
130155513|NCT03228537|468529191|FG000|Neoadjuvant|Adverse Event|2|||
130155514|NCT03228537|468529191|FG000|Neoadjuvant|Progression/Relapse|4|||
130155515|NCT03228537|468529191|FG000|Neoadjuvant|Death|1|||
130155516|NCT03228537|468529191|FG000|Surgery|Death|1|||
130155517|NCT03228537|468529191|FG000|Surgery|Other - Not Protocol Specified|2|||
130155518|NCT03228537|468529191|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
130155519|NCT03228537|468529191|FG000|Maintenance|Progression/Relapse|10|||
130155520|NCT04572243|468529192|FG000|Core Study: 14 Weeks|Adverse Event|1|||
130155521|NCT04572243|468529193|FG001|Core Study: 14 Weeks|Adverse Event|2|||
130155522|NCT04572243|468529194|FG002|Core Study: 14 Weeks|Adverse Event|0|||
130155523|NCT04572243|468529195|FG003|Core Study: 14 Weeks|Adverse Event|0|||
130155524|NCT04572243|468529192|FG000|Core Study: 14 Weeks|Subject choice|0|||
130155525|NCT04572243|468529193|FG001|Core Study: 14 Weeks|Subject choice|2|||
130155526|NCT04572243|468529194|FG002|Core Study: 14 Weeks|Subject choice|0|||
130155527|NCT04572243|468529195|FG003|Core Study: 14 Weeks|Subject choice|0|||
130155528|NCT04572243|468529192|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
130155529|NCT04572243|468529193|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
130155530|NCT04572243|468529194|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
130155531|NCT04572243|468529195|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
130155532|NCT04572243|468529192|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
130155533|NCT04572243|468529193|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
130155534|NCT04572243|468529194|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
130155535|NCT04572243|468529195|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
130155536|NCT05420012|468529196|FG000|Overall Study|Lost to Follow-up|0|||
130155537|NCT05420012|468529197|FG001|Overall Study|Lost to Follow-up|1|||
130155538|NCT02999477|468529199|FG000|Overall Study|found ineligible after first dose|0|||
130155539|NCT02999477|468529200|FG001|Overall Study|found ineligible after first dose|1|||
130155540|NCT02999477|468529199|FG000|Overall Study|Withdrawal by Subject|1|||
130155541|NCT02999477|468529200|FG001|Overall Study|Withdrawal by Subject|1|||
130155542|NCT04266795|468529201|FG000|Overall Study|Adverse Event|10|||
130155543|NCT04266795|468529202|FG001|Overall Study|Adverse Event|19|||
130155544|NCT04266795|468529201|FG000|Overall Study|Death|7|||
130155545|NCT04266795|468529202|FG001|Overall Study|Death|8|||
130155546|NCT04266795|468529201|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
130155547|NCT04266795|468529202|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
130155548|NCT04266795|468529201|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130155549|NCT04266795|468529202|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130155550|NCT04266795|468529201|FG000|Overall Study|Progressive Disease|12|||
130155551|NCT04266795|468529202|FG001|Overall Study|Progressive Disease|9|||
130155552|NCT04266795|468529201|FG000|Overall Study|Withdrawal by Patient|5|||
130155553|NCT04266795|468529202|FG001|Overall Study|Withdrawal by Patient|6|||
130155554|NCT04266795|468529201|FG000|Overall Study|Disease Relapse|3|||
130155555|NCT04266795|468529202|FG001|Overall Study|Disease Relapse|6|||
130155556|NCT04266795|468529201|FG000|Overall Study|Reason not Specified|12|||
130155557|NCT04266795|468529202|FG001|Overall Study|Reason not Specified|10|||
130155558|NCT04266795|468529201|FG000|Overall Study|Participants Ongoing on Treatment|25|||
130155559|NCT04266795|468529202|FG001|Overall Study|Participants Ongoing on Treatment|23|||
130155560|NCT02655016|468529205|FG000|Overall Study|Disease progression|6|||
130155561|NCT02655016|468529206|FG001|Overall Study|Disease progression|4|||
130155562|NCT02655016|468529205|FG000|Overall Study|Site closed|0|||
130155563|NCT02655016|468529206|FG001|Overall Study|Site closed|1|||
130155564|NCT02655016|468529205|FG000|Overall Study|Death|30|||
130155565|NCT02655016|468529206|FG001|Overall Study|Death|48|||
130155566|NCT02655016|468529205|FG000|Overall Study|Lost to Follow-up|1|||
130155567|NCT02655016|468529206|FG001|Overall Study|Lost to Follow-up|1|||
130155568|NCT02655016|468529205|FG000|Overall Study|Withdrawal by Subject|18|||
130155569|NCT02655016|468529206|FG001|Overall Study|Withdrawal by Subject|36|||
130155570|NCT04459715|468529207|FG000|Overall Study|Adverse Event|3|||
130155571|NCT04459715|468529208|FG001|Overall Study|Adverse Event|3|||
130155572|NCT04459715|468529207|FG000|Overall Study|Death|111|||
130155573|NCT04459715|468529208|FG001|Overall Study|Death|93|||
130155574|NCT04459715|468529207|FG000|Overall Study|Lost to Follow-up|10|||
130155575|NCT04459715|468529208|FG001|Overall Study|Lost to Follow-up|9|||
130155576|NCT04459715|468529207|FG000|Overall Study|Other Reasons|4|||
130155577|NCT04459715|468529208|FG001|Overall Study|Other Reasons|5|||
130155578|NCT04459715|468529207|FG000|Overall Study|PROTOCOL DEVIATION|0|||
130155579|NCT04459715|468529208|FG001|Overall Study|PROTOCOL DEVIATION|1|||
130155580|NCT04459715|468529207|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
130155581|NCT04459715|468529208|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
130155582|NCT04459715|468529207|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
130155583|NCT04459715|468529208|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
130155584|NCT04459715|468529207|FG000|Overall Study|Withdrawal by Subject|22|||
130155585|NCT04459715|468529208|FG001|Overall Study|Withdrawal by Subject|22|||
130155586|NCT04495283|468531158|FG000|Overall Study|Physician Decision|0|||
130155587|NCT04495283|468531159|FG001|Overall Study|Physician Decision|0|||
130155588|NCT04495283|468531160|FG002|Overall Study|Physician Decision|1|||
130155589|NCT04495283|468531158|FG000|Overall Study|Withdrawal by Subject|0|||
130155590|NCT04495283|468531159|FG001|Overall Study|Withdrawal by Subject|1|||
130155591|NCT04495283|468531160|FG002|Overall Study|Withdrawal by Subject|1|||
130155592|NCT04495283|468531158|FG000|Overall Study|Other|1|||
130155593|NCT04495283|468531159|FG001|Overall Study|Other|0|||
130155594|NCT04495283|468531160|FG002|Overall Study|Other|1|||
130155595|NCT02631876|468531165|FG000|Overall Study|Death|96|||
130155596|NCT02631876|468531166|FG001|Overall Study|Death|50|||
130155597|NCT02631876|468531165|FG000|Overall Study|Investigator's discretion|1|||
130155598|NCT02631876|468531166|FG001|Overall Study|Investigator's discretion|0|||
130155599|NCT02631876|468531165|FG000|Overall Study|Lost to Follow-up|2|||
130155600|NCT02631876|468531166|FG001|Overall Study|Lost to Follow-up|0|||
130155601|NCT02631876|468531165|FG000|Overall Study|Withdrawal by Subject|16|||
130155602|NCT02631876|468531166|FG001|Overall Study|Withdrawal by Subject|9|||
130155603|NCT02631876|468531165|FG000|Overall Study|Other than specified|4|||
130155604|NCT02631876|468531166|FG001|Overall Study|Other than specified|4|||
130155605|NCT01408563|468531171|FG000|Overall Study|Ineligible after consent/ registration|2|||
130155606|NCT00380692|468531172|FG000|Study Period II - Double Blind|Adverse Event|1|||
130155607|NCT00380692|468531173|FG001|Study Period II - Double Blind|Adverse Event|0|||
130155608|NCT00380692|468531172|FG000|Study Period II - Double Blind|Protocol Violation|2|||
130155609|NCT00380692|468531173|FG001|Study Period II - Double Blind|Protocol Violation|2|||
130155610|NCT00380692|468531172|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
129980577|NCT02003222|467891679|FG001|Intensification|Alternative therapy|0|||
129980578|NCT02003222|467891680|FG002|Intensification|Alternative therapy|0|||
129980579|NCT02003222|467891681|FG003|Intensification|Alternative therapy|0|||
129980580|NCT02003222|467891682|FG004|Intensification|Alternative therapy|8|||
129980581|NCT02003222|467891678|FG000|Intensification|Disease progression|0|||
130155611|NCT00380692|468531173|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
130155612|NCT00380692|468531172|FG000|Study Period II - Double Blind|Physician Decision|0|||
130155613|NCT00380692|468531173|FG001|Study Period II - Double Blind|Physician Decision|1|||
130155614|NCT00380692|468531172|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
130155615|NCT00380692|468531173|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
130155616|NCT00380692|468531172|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
130155617|NCT00380692|468531173|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
130155618|NCT00380692|468531172|FG000|Study Period III - Open Label|Adverse Event|5|||
130155619|NCT00380692|468531173|FG001|Study Period III - Open Label|Adverse Event|3|||
130155620|NCT00380692|468531172|FG000|Study Period III - Open Label|Protocol Violation|0|||
130155621|NCT00380692|468531173|FG001|Study Period III - Open Label|Protocol Violation|0|||
130155622|NCT00380692|468531172|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
130155623|NCT00380692|468531173|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
130155624|NCT00380692|468531172|FG000|Study Period III - Open Label|Physician Decision|0|||
130155625|NCT00380692|468531173|FG001|Study Period III - Open Label|Physician Decision|3|||
130155626|NCT00380692|468531172|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
130155627|NCT00380692|468531173|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
130155628|NCT00380692|468531172|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
130155629|NCT00380692|468531173|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
130155630|NCT02177136|468531182|FG000|DB Phase|Withdrawal by Subject|2|||
130155631|NCT02177136|468531183|FG001|DB Phase|Withdrawal by Subject|0|||
130155632|NCT02177136|468531184|FG002|DB Phase|Withdrawal by Subject|0|||
130155633|NCT02177136|468531185|FG003|DB Phase|Withdrawal by Subject|0|||
130155634|NCT02177136|468531182|FG000|DB Phase|Discontinued Due to Pruritus|1|||
130155635|NCT02177136|468531183|FG001|DB Phase|Discontinued Due to Pruritus|3|||
130155636|NCT02177136|468531184|FG002|DB Phase|Discontinued Due to Pruritus|0|||
130155637|NCT02177136|468531185|FG003|DB Phase|Discontinued Due to Pruritus|0|||
130155638|NCT02177136|468531182|FG000|DB Phase|Adverse Event|3|||
130155639|NCT02177136|468531183|FG001|DB Phase|Adverse Event|2|||
130155640|NCT02177136|468531184|FG002|DB Phase|Adverse Event|3|||
130155641|NCT02177136|468531185|FG003|DB Phase|Adverse Event|0|||
130155642|NCT02177136|468531182|FG000|DB Phase|Protocol Violation|0|||
130155643|NCT02177136|468531183|FG001|DB Phase|Protocol Violation|0|||
130155644|NCT02177136|468531184|FG002|DB Phase|Protocol Violation|1|||
130155645|NCT02177136|468531185|FG003|DB Phase|Protocol Violation|0|||
130155646|NCT02177136|468531182|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
130155647|NCT02177136|468531183|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
130155648|NCT02177136|468531184|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
130155649|NCT02177136|468531185|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
130155650|NCT02177136|468531182|FG000|LTSE Phase|Withdrawal by Subject|0|||
130155651|NCT02177136|468531183|FG001|LTSE Phase|Withdrawal by Subject|0|||
130155652|NCT02177136|468531184|FG002|LTSE Phase|Withdrawal by Subject|0|||
130155653|NCT02177136|468531185|FG003|LTSE Phase|Withdrawal by Subject|6|||
130155654|NCT02177136|468531182|FG000|LTSE Phase|Adverse Event|0|||
130155655|NCT02177136|468531183|FG001|LTSE Phase|Adverse Event|0|||
130155656|NCT02177136|468531184|FG002|LTSE Phase|Adverse Event|0|||
130155657|NCT02177136|468531185|FG003|LTSE Phase|Adverse Event|10|||
130155658|NCT02177136|468531182|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
130155659|NCT02177136|468531183|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
130155660|NCT02177136|468531184|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
130155661|NCT02177136|468531185|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
130155662|NCT02177136|468531182|FG000|LTSE Phase|Physician Decision|0|||
130155663|NCT02177136|468531183|FG001|LTSE Phase|Physician Decision|0|||
130155664|NCT02177136|468531184|FG002|LTSE Phase|Physician Decision|0|||
130155665|NCT02177136|468531185|FG003|LTSE Phase|Physician Decision|2|||
130155666|NCT02177136|468531182|FG000|LTSE Phase|Lost to Follow-up|0|||
130155667|NCT02177136|468531183|FG001|LTSE Phase|Lost to Follow-up|0|||
130155668|NCT02177136|468531184|FG002|LTSE Phase|Lost to Follow-up|0|||
130155669|NCT02177136|468531185|FG003|LTSE Phase|Lost to Follow-up|1|||
130155670|NCT02177136|468531182|FG000|LTSE Phase|Participant Moved|0|||
130155671|NCT02177136|468531183|FG001|LTSE Phase|Participant Moved|0|||
130155672|NCT02177136|468531184|FG002|LTSE Phase|Participant Moved|0|||
130155673|NCT02177136|468531185|FG003|LTSE Phase|Participant Moved|1|||
130155674|NCT02054130|468531186|FG000|Overall Study|Withdrawal by Subject|4|||
130155675|NCT02054130|468531187|FG001|Overall Study|Withdrawal by Subject|4|||
130155676|NCT02054130|468531188|FG002|Overall Study|Withdrawal by Subject|7|||
130155677|NCT02054130|468531189|FG003|Overall Study|Withdrawal by Subject|10|||
130155678|NCT02054130|468531186|FG000|Overall Study|Death|0|||
130155679|NCT02054130|468531187|FG001|Overall Study|Death|1|||
130155680|NCT02054130|468531188|FG002|Overall Study|Death|0|||
130155681|NCT02054130|468531189|FG003|Overall Study|Death|0|||
130155682|NCT02054130|468531186|FG000|Overall Study|Lost to Follow-up|0|||
130155683|NCT02054130|468531187|FG001|Overall Study|Lost to Follow-up|0|||
130155684|NCT02054130|468531188|FG002|Overall Study|Lost to Follow-up|1|||
129980582|NCT02003222|467891679|FG001|Intensification|Disease progression|0|||
129980583|NCT02003222|467891680|FG002|Intensification|Disease progression|0|||
130155685|NCT02054130|468531189|FG003|Overall Study|Lost to Follow-up|2|||
130155686|NCT02054130|468531186|FG000|Overall Study|Missed dose|4|||
129980584|NCT02003222|467891681|FG003|Intensification|Disease progression|0|||
130155687|NCT02054130|468531187|FG001|Overall Study|Missed dose|6|||
130155688|NCT02054130|468531188|FG002|Overall Study|Missed dose|7|||
130155689|NCT02054130|468531189|FG003|Overall Study|Missed dose|10|||
130155690|NCT01386684|468531190|FG000|Overall Study|Lost to Follow-up|51|||
130155691|NCT01386684|468531190|FG000|Overall Study|Other|51|||
130155692|NCT01386684|468531190|FG000|Overall Study|Death|47|||
130155693|NCT01386684|468531190|FG000|Overall Study|Withdrawal of Consent|44|||
130155694|NCT01386684|468531190|FG000|Overall Study|Alternative Therapy Required|37|||
130155695|NCT01386684|468531190|FG000|Overall Study|Disease Progression|28|||
130155696|NCT01386684|468531190|FG000|Overall Study|Adverse Event|20|||
130155697|NCT01386684|468531190|FG000|Overall Study|Noncompliance|8|||
130155698|NCT01386684|468531190|FG000|Overall Study|Protocol Violation|4|||
130155699|NCT01386684|468531190|FG000|Overall Study|Missing|3|||
130155700|NCT01032018|468531191|FG000|Overall Study|Lost to Follow-up|6|||
130155701|NCT01032018|468531192|FG001|Overall Study|Lost to Follow-up|5|||
130155702|NCT01032018|468531191|FG000|Overall Study|Death|0|||
130155703|NCT01032018|468531192|FG001|Overall Study|Death|1|||
130155704|NCT00094458|468531193|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
130155705|NCT00094458|468531194|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
130155706|NCT00094458|468531195|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
130155707|NCT00094458|468531196|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
130155708|NCT00094458|468531197|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
130155709|NCT00094458|468531198|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
130155710|NCT00094458|468531193|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
130155711|NCT00094458|468531194|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
130155712|NCT00094458|468531195|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
130155713|NCT00094458|468531196|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
130155714|NCT00094458|468531197|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
130155715|NCT00094458|468531198|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
130155716|NCT00094458|468531193|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
130155717|NCT00094458|468531194|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
130155718|NCT00094458|468531195|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
130155719|NCT00094458|468531196|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
130155720|NCT00094458|468531197|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
130155721|NCT00094458|468531198|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
130155722|NCT00094458|468531193|FG000|Main Study: Through Week 30|Adverse Event|38|||
130155723|NCT00094458|468531194|FG001|Main Study: Through Week 30|Adverse Event|20|||
129980585|NCT02003222|467891682|FG004|Intensification|Disease progression|18|||
129980586|NCT02003222|467891678|FG000|Intensification|Withdrawal by Subject|0|||
130155724|NCT00094458|468531195|FG002|Main Study: Through Week 30|Adverse Event|28|||
130155725|NCT00094458|468531196|FG003|Main Study: Through Week 30|Adverse Event|0|||
130155726|NCT00094458|468531197|FG004|Main Study: Through Week 30|Adverse Event|0|||
130155727|NCT00094458|468531198|FG005|Main Study: Through Week 30|Adverse Event|0|||
130155728|NCT00094458|468531193|FG000|Main Study: Through Week 30|Death|1|||
130155729|NCT00094458|468531194|FG001|Main Study: Through Week 30|Death|0|||
130155730|NCT00094458|468531195|FG002|Main Study: Through Week 30|Death|0|||
130155731|NCT00094458|468531196|FG003|Main Study: Through Week 30|Death|0|||
129980587|NCT02003222|467891679|FG001|Intensification|Withdrawal by Subject|0|||
129980588|NCT02003222|467891680|FG002|Intensification|Withdrawal by Subject|0|||
129980589|NCT02003222|467891681|FG003|Intensification|Withdrawal by Subject|0|||
129980590|NCT02003222|467891682|FG004|Intensification|Withdrawal by Subject|5|||
129980591|NCT02003222|467891678|FG000|Intensification|Other reasons|0|||
129980592|NCT02003222|467891679|FG001|Intensification|Other reasons|0|||
129980593|NCT02003222|467891680|FG002|Intensification|Other reasons|0|||
129980594|NCT02003222|467891681|FG003|Intensification|Other reasons|0|||
129980595|NCT02003222|467891682|FG004|Intensification|Other reasons|8|||
129980596|NCT01365481|467891683|FG000|Overall Study|Adverse Event|6|||
129980597|NCT01365481|467891684|FG001|Overall Study|Adverse Event|9|||
129980598|NCT01365481|467891685|FG002|Overall Study|Adverse Event|0|||
129980599|NCT01365481|467891686|FG003|Overall Study|Adverse Event|2|||
129980600|NCT01365481|467891683|FG000|Overall Study|Withdrawal by Subject|0|||
129980601|NCT01365481|467891684|FG001|Overall Study|Withdrawal by Subject|2|||
129980602|NCT01365481|467891685|FG002|Overall Study|Withdrawal by Subject|1|||
129980603|NCT01365481|467891686|FG003|Overall Study|Withdrawal by Subject|1|||
129980604|NCT01365481|467891683|FG000|Overall Study|Lost to Follow-up|1|||
129980605|NCT01365481|467891684|FG001|Overall Study|Lost to Follow-up|1|||
130155732|NCT00094458|468531197|FG004|Main Study: Through Week 30|Death|0|||
130155733|NCT00094458|468531198|FG005|Main Study: Through Week 30|Death|0|||
130155734|NCT00094458|468531193|FG000|Main Study: Through Week 30|Other|19|||
130155735|NCT00094458|468531194|FG001|Main Study: Through Week 30|Other|16|||
130155736|NCT00094458|468531195|FG002|Main Study: Through Week 30|Other|9|||
130155737|NCT00094458|468531196|FG003|Main Study: Through Week 30|Other|0|||
129980606|NCT01365481|467891685|FG002|Overall Study|Lost to Follow-up|2|||
130155738|NCT00094458|468531197|FG004|Main Study: Through Week 30|Other|0|||
130155739|NCT00094458|468531198|FG005|Main Study: Through Week 30|Other|0|||
130155740|NCT00094458|468531193|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
129980607|NCT01365481|467891686|FG003|Overall Study|Lost to Follow-up|3|||
130155741|NCT00094458|468531194|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
130155742|NCT00094458|468531195|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
130155743|NCT00094458|468531196|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130155744|NCT00094458|468531197|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
130155745|NCT00094458|468531198|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129980608|NCT01365481|467891683|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130155746|NCT00094458|468531193|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
130155747|NCT00094458|468531194|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130155748|NCT00094458|468531195|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
130155749|NCT00094458|468531196|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130155750|NCT00094458|468531197|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130155751|NCT00094458|468531198|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
130155752|NCT00094458|468531193|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
130155753|NCT00094458|468531194|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
130155754|NCT00094458|468531195|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
130155755|NCT00094458|468531196|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130155756|NCT00094458|468531197|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130155757|NCT00094458|468531198|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
130155758|NCT00094458|468531193|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
130155759|NCT00094458|468531194|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
130155760|NCT00094458|468531195|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
130155761|NCT00094458|468531196|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
130155762|NCT00094458|468531197|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
130155763|NCT00094458|468531198|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
130155764|NCT00094458|468531193|FG000|OLE: Open-Label Extension|Adverse Event|0|||
130155765|NCT00094458|468531194|FG001|OLE: Open-Label Extension|Adverse Event|0|||
130155766|NCT00094458|468531195|FG002|OLE: Open-Label Extension|Adverse Event|0|||
130155767|NCT00094458|468531196|FG003|OLE: Open-Label Extension|Adverse Event|0|||
130155768|NCT00094458|468531197|FG004|OLE: Open-Label Extension|Adverse Event|3|||
130155769|NCT00094458|468531198|FG005|OLE: Open-Label Extension|Adverse Event|4|||
130155770|NCT00094458|468531193|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130155771|NCT00094458|468531194|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130155772|NCT00094458|468531195|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130155773|NCT00094458|468531196|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
130155774|NCT00094458|468531197|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
130155775|NCT00094458|468531198|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
130155776|NCT00094458|468531193|FG000|OLE: Open-Label Extension|Patient decision|0|||
130155777|NCT00094458|468531194|FG001|OLE: Open-Label Extension|Patient decision|0|||
130155778|NCT00094458|468531195|FG002|OLE: Open-Label Extension|Patient decision|0|||
130155779|NCT00094458|468531196|FG003|OLE: Open-Label Extension|Patient decision|0|||
130155780|NCT00094458|468531197|FG004|OLE: Open-Label Extension|Patient decision|1|||
130155781|NCT00094458|468531198|FG005|OLE: Open-Label Extension|Patient decision|0|||
130155782|NCT03265288|468531199|FG000|Overall Study|Adverse Event|0|||
130155783|NCT03265288|468531200|FG001|Overall Study|Adverse Event|1|||
130155784|NCT03265288|468531199|FG000|Overall Study|Withdrawal by Subject|13|||
130155785|NCT03265288|468531200|FG001|Overall Study|Withdrawal by Subject|5|||
130155786|NCT03265288|468531199|FG000|Overall Study|Drug Withdrawn|3|||
130155787|NCT03265288|468531200|FG001|Overall Study|Drug Withdrawn|3|||
130155788|NCT03265288|468531199|FG000|Overall Study|Any Other Reason|7|||
130155789|NCT03265288|468531200|FG001|Overall Study|Any Other Reason|3|||
130155790|NCT03197558|468531201|FG000|Overall Study|Tubes not placed|1|||
130155791|NCT01892657|468531204|FG000|Overall Study|Withdrawal by Subject|6|||
130155792|NCT01892657|468531204|FG000|Overall Study|Protocol Violation|12|||
130155793|NCT00468728|468531207|FG000|Treatment|criteria for mITT population|4|||
130155794|NCT00468728|468531208|FG001|Treatment|criteria for mITT population|11|||
130155795|NCT00468728|468531207|FG000|Follow-up|mITT failure|34|||
130155796|NCT00468728|468531208|FG001|Follow-up|mITT failure|31|||
130155797|NCT02712333|468531210|FG000|First Period|Withdrawal by Subject|3|||
130155798|NCT02712333|468531211|FG001|First Period|Withdrawal by Subject|2|||
130155799|NCT03463993|468531212|FG000|Overall Study|Lost to Follow-up|7|||
130155800|NCT03463993|468531213|FG001|Overall Study|Lost to Follow-up|8|||
130155801|NCT03463993|468531212|FG000|Overall Study|Withdrawal by Subject|2|||
130155802|NCT03463993|468531213|FG001|Overall Study|Withdrawal by Subject|0|||
130155803|NCT03463993|468531212|FG000|Overall Study|Protocol Violation|4|||
130155804|NCT03463993|468531213|FG001|Overall Study|Protocol Violation|1|||
130155805|NCT03463993|468531212|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
130155806|NCT03463993|468531213|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
130155807|NCT03463993|468531212|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
130155808|NCT03463993|468531213|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
130155809|NCT01478828|468531214|FG000|Overall Study|Adverse Event|1|||
130155810|NCT02278718|468531215|FG000|Overall Study|Adverse Event|1|||
129980609|NCT01365481|467891684|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130155811|NCT02278718|468531216|FG001|Overall Study|Adverse Event|0|||
130155812|NCT02278718|468531215|FG000|Overall Study|Lost to Follow-up|2|||
130155813|NCT02278718|468531216|FG001|Overall Study|Lost to Follow-up|4|||
130155814|NCT02278718|468531215|FG000|Overall Study|Withdrawal by Subject|1|||
130155815|NCT02278718|468531216|FG001|Overall Study|Withdrawal by Subject|4|||
130155816|NCT02278718|468531215|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
130155817|NCT02278718|468531216|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
130155818|NCT02278718|468531215|FG000|Overall Study|Missing|0|||
130155819|NCT02278718|468531216|FG001|Overall Study|Missing|1|||
130155820|NCT04440449|468531217|FG000|Overall Study|Lost to Follow-up|2|||
130155821|NCT04440449|468531218|FG001|Overall Study|Lost to Follow-up|0|||
130155822|NCT01763918|468531219|FG000|Overall Study|Withdrawal by Subject|2|||
130155823|NCT01763918|468531220|FG001|Overall Study|Withdrawal by Subject|1|||
130155824|NCT01763918|468531221|FG002|Overall Study|Withdrawal by Subject|1|||
130155825|NCT01763918|468531222|FG003|Overall Study|Withdrawal by Subject|2|||
130155826|NCT01763918|468531219|FG000|Overall Study|Sponsor Decision|4|||
130155827|NCT01763918|468531220|FG001|Overall Study|Sponsor Decision|0|||
130155828|NCT01763918|468531221|FG002|Overall Study|Sponsor Decision|9|||
130155829|NCT01763918|468531222|FG003|Overall Study|Sponsor Decision|0|||
130155830|NCT00897949|468531223|FG000|Overall Study|Adverse Event|1|||
130155831|NCT00897949|468531224|FG001|Overall Study|Adverse Event|1|||
130155832|NCT00897949|468531225|FG002|Overall Study|Adverse Event|0|||
130155833|NCT00897949|468531223|FG000|Overall Study|Lost to Follow-up|0|||
130155834|NCT00897949|468531224|FG001|Overall Study|Lost to Follow-up|2|||
130155835|NCT00897949|468531225|FG002|Overall Study|Lost to Follow-up|1|||
130155836|NCT00897949|468531223|FG000|Overall Study|Protocol Violation|6|||
130155837|NCT00897949|468531224|FG001|Overall Study|Protocol Violation|3|||
130155838|NCT00897949|468531225|FG002|Overall Study|Protocol Violation|1|||
130155839|NCT00897949|468531223|FG000|Overall Study|Withdrawal by Subject|1|||
130155840|NCT00897949|468531224|FG001|Overall Study|Withdrawal by Subject|2|||
130155841|NCT00897949|468531225|FG002|Overall Study|Withdrawal by Subject|0|||
130155842|NCT00897949|468531223|FG000|Overall Study|Patient Uncoorperative|0|||
130155843|NCT00897949|468531224|FG001|Overall Study|Patient Uncoorperative|2|||
130155844|NCT00897949|468531225|FG002|Overall Study|Patient Uncoorperative|1|||
130155845|NCT00897949|468531223|FG000|Overall Study|Lost to Follow-up|30|||
130155846|NCT00897949|468531224|FG001|Overall Study|Lost to Follow-up|23|||
130155847|NCT00897949|468531225|FG002|Overall Study|Lost to Follow-up|17|||
130155848|NCT00897949|468531223|FG000|Overall Study|Withdrawal by Subject|24|||
130155849|NCT00897949|468531224|FG001|Overall Study|Withdrawal by Subject|31|||
130155850|NCT00897949|468531225|FG002|Overall Study|Withdrawal by Subject|17|||
130155851|NCT00897949|468531223|FG000|Overall Study|Abnormal Prestudy Labs|2|||
130155852|NCT00897949|468531224|FG001|Overall Study|Abnormal Prestudy Labs|3|||
130155853|NCT00897949|468531225|FG002|Overall Study|Abnormal Prestudy Labs|4|||
130155854|NCT00897949|468531223|FG000|Overall Study|Abnormal Baseline ECG|2|||
130155855|NCT00897949|468531224|FG001|Overall Study|Abnormal Baseline ECG|2|||
130155856|NCT00897949|468531225|FG002|Overall Study|Abnormal Baseline ECG|4|||
130155857|NCT00897949|468531223|FG000|Overall Study|Need for Concom. Med.|0|||
130155858|NCT00897949|468531224|FG001|Overall Study|Need for Concom. Med.|1|||
130155859|NCT00897949|468531225|FG002|Overall Study|Need for Concom. Med.|1|||
130155860|NCT00897949|468531223|FG000|Overall Study|Lack of Migraine Attack|29|||
130155861|NCT00897949|468531224|FG001|Overall Study|Lack of Migraine Attack|30|||
130155862|NCT00897949|468531225|FG002|Overall Study|Lack of Migraine Attack|19|||
130155863|NCT00897949|468531223|FG000|Overall Study|Did not take study drug|9|||
130155864|NCT00897949|468531224|FG001|Overall Study|Did not take study drug|3|||
130155865|NCT00897949|468531225|FG002|Overall Study|Did not take study drug|4|||
130155866|NCT01553747|468531226|FG000|Overall Study|Protocol Violation|0|||
130155867|NCT01553747|468531227|FG001|Overall Study|Protocol Violation|2|||
130155868|NCT01553747|468531228|FG002|Overall Study|Protocol Violation|0|||
130155869|NCT01553747|468531226|FG000|Overall Study|Voluntarily withdrew|70|||
130155870|NCT01553747|468531227|FG001|Overall Study|Voluntarily withdrew|66|||
130155871|NCT01553747|468531228|FG002|Overall Study|Voluntarily withdrew|74|||
130155872|NCT01553747|468531226|FG000|Overall Study|Adverse event or SAE|32|||
130155873|NCT01553747|468531227|FG001|Overall Study|Adverse event or SAE|28|||
129980610|NCT01365481|467891685|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129980611|NCT01365481|467891686|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129980612|NCT01365481|467891683|FG000|Overall Study|Administrative problems|0|||
129980613|NCT01365481|467891684|FG001|Overall Study|Administrative problems|1|||
130155874|NCT01553747|468531228|FG002|Overall Study|Adverse event or SAE|19|||
130155875|NCT01553747|468531226|FG000|Overall Study|Physician decision: other|10|||
130155876|NCT01553747|468531227|FG001|Overall Study|Physician decision: other|8|||
130155877|NCT01553747|468531228|FG002|Overall Study|Physician decision: other|7|||
130155878|NCT01553747|468531226|FG000|Overall Study|Lost to Follow-up|11|||
130155879|NCT01553747|468531227|FG001|Overall Study|Lost to Follow-up|5|||
130155880|NCT01553747|468531228|FG002|Overall Study|Lost to Follow-up|6|||
130155881|NCT01553747|468531226|FG000|Overall Study|Sponsor decision, specify|7|||
130155882|NCT01553747|468531227|FG001|Overall Study|Sponsor decision, specify|5|||
130155883|NCT01553747|468531228|FG002|Overall Study|Sponsor decision, specify|0|||
130155884|NCT01553747|468531226|FG000|Overall Study|Physician decision: lack of efficacy|1|||
130155885|NCT01553747|468531227|FG001|Overall Study|Physician decision: lack of efficacy|5|||
130155886|NCT01553747|468531228|FG002|Overall Study|Physician decision: lack of efficacy|3|||
130155887|NCT01875471|468531238|FG000|Overall Study|Adverse Event|0|||
130155888|NCT01875471|468531239|FG001|Overall Study|Adverse Event|1|||
130155889|NCT01875471|468531238|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
130155890|NCT01875471|468531239|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
130155891|NCT03407118|468531240|FG000|Period 2|Withdrawal by Subject|1|||
130155892|NCT03407118|468531241|FG001|Period 2|Withdrawal by Subject|0|||
130155893|NCT02972502|468531245|FG000|Overall Study|Lost to Follow-up|3|||
130155894|NCT02972502|468531246|FG001|Overall Study|Lost to Follow-up|1|||
130155895|NCT02972502|468531245|FG000|Overall Study|Withdrawal by Subject|1|||
130155896|NCT02972502|468531246|FG001|Overall Study|Withdrawal by Subject|1|||
130155897|NCT03832738|468531247|FG000|Overall Study|Withdrawal by Subject|6|||
130155898|NCT03832738|468531248|FG001|Overall Study|Withdrawal by Subject|7|||
130155899|NCT03832738|468531249|FG002|Overall Study|Withdrawal by Subject|16|||
130155900|NCT03832738|468531247|FG000|Overall Study|Physician Decision|0|||
130155901|NCT03832738|468531248|FG001|Overall Study|Physician Decision|1|||
130155902|NCT03832738|468531249|FG002|Overall Study|Physician Decision|2|||
130155903|NCT03832738|468531247|FG000|Overall Study|Adverse Event|2|||
130155904|NCT03832738|468531248|FG001|Overall Study|Adverse Event|3|||
130155905|NCT03832738|468531249|FG002|Overall Study|Adverse Event|1|||
130155906|NCT03832738|468531247|FG000|Overall Study|Pregnancy|0|||
130155907|NCT03832738|468531248|FG001|Overall Study|Pregnancy|1|||
130155908|NCT03832738|468531249|FG002|Overall Study|Pregnancy|0|||
130155909|NCT01347866|468531252|FG000|Overall Study|Death|0|||
130155910|NCT01347866|468531253|FG001|Overall Study|Death|0|||
130155911|NCT01347866|468531254|FG002|Overall Study|Death|0|||
130155912|NCT01347866|468531255|FG003|Overall Study|Death|1|||
130155913|NCT01347866|468531256|FG004|Overall Study|Death|2|||
130155914|NCT01347866|468531257|FG005|Overall Study|Death|2|||
130155915|NCT01347866|468531258|FG006|Overall Study|Death|1|||
130155916|NCT01347866|468531259|FG007|Overall Study|Death|0|||
130155917|NCT01347866|468531260|FG008|Overall Study|Death|4|||
130155918|NCT01347866|468531261|FG009|Overall Study|Death|1|||
130155919|NCT01347866|468531262|FG010|Overall Study|Death|3|||
130155920|NCT01347866|468531263|FG011|Overall Study|Death|1|||
130155921|NCT01347866|468531264|FG012|Overall Study|Death|2|||
130155922|NCT01347866|468531265|FG013|Overall Study|Death|0|||
130155923|NCT01347866|468531266|FG014|Overall Study|Death|0|||
130155924|NCT01347866|468531267|FG015|Overall Study|Death|1|||
130155925|NCT01347866|468531268|FG016|Overall Study|Death|0|||
130155926|NCT01347866|468531252|FG000|Overall Study|Lost to Follow-up|0|||
130155927|NCT01347866|468531253|FG001|Overall Study|Lost to Follow-up|0|||
130155928|NCT01347866|468531254|FG002|Overall Study|Lost to Follow-up|0|||
130155929|NCT01347866|468531255|FG003|Overall Study|Lost to Follow-up|0|||
130155930|NCT01347866|468531256|FG004|Overall Study|Lost to Follow-up|0|||
130155931|NCT01347866|468531257|FG005|Overall Study|Lost to Follow-up|0|||
130155932|NCT01347866|468531258|FG006|Overall Study|Lost to Follow-up|0|||
130155933|NCT01347866|468531259|FG007|Overall Study|Lost to Follow-up|1|||
130155934|NCT01347866|468531260|FG008|Overall Study|Lost to Follow-up|1|||
130155935|NCT01347866|468531261|FG009|Overall Study|Lost to Follow-up|0|||
130155936|NCT01347866|468531262|FG010|Overall Study|Lost to Follow-up|0|||
130155937|NCT01347866|468531263|FG011|Overall Study|Lost to Follow-up|0|||
130155938|NCT01347866|468531264|FG012|Overall Study|Lost to Follow-up|0|||
130155939|NCT01347866|468531265|FG013|Overall Study|Lost to Follow-up|0|||
130155940|NCT01347866|468531266|FG014|Overall Study|Lost to Follow-up|0|||
130155941|NCT01347866|468531267|FG015|Overall Study|Lost to Follow-up|0|||
130155942|NCT01347866|468531268|FG016|Overall Study|Lost to Follow-up|0|||
130155943|NCT01347866|468531252|FG000|Overall Study|Other|3|||
130155944|NCT01347866|468531253|FG001|Overall Study|Other|1|||
130155945|NCT01347866|468531254|FG002|Overall Study|Other|1|||
130155946|NCT01347866|468531255|FG003|Overall Study|Other|4|||
130155947|NCT01347866|468531256|FG004|Overall Study|Other|5|||
130155948|NCT01347866|468531257|FG005|Overall Study|Other|0|||
130155949|NCT01347866|468531258|FG006|Overall Study|Other|5|||
130155950|NCT01347866|468531259|FG007|Overall Study|Other|3|||
130155951|NCT01347866|468531260|FG008|Overall Study|Other|22|||
130155952|NCT01347866|468531261|FG009|Overall Study|Other|5|||
130155953|NCT01347866|468531262|FG010|Overall Study|Other|0|||
130155954|NCT01347866|468531263|FG011|Overall Study|Other|3|||
130155955|NCT01347866|468531264|FG012|Overall Study|Other|4|||
130155956|NCT01347866|468531265|FG013|Overall Study|Other|4|||
130155957|NCT01347866|468531266|FG014|Overall Study|Other|2|||
130155958|NCT01347866|468531267|FG015|Overall Study|Other|3|||
130155959|NCT01347866|468531268|FG016|Overall Study|Other|0|||
130155960|NCT01347866|468531252|FG000|Overall Study|Subject refused further follow-up|2|||
130155961|NCT01347866|468531253|FG001|Overall Study|Subject refused further follow-up|0|||
130155962|NCT01347866|468531254|FG002|Overall Study|Subject refused further follow-up|0|||
130155963|NCT01347866|468531255|FG003|Overall Study|Subject refused further follow-up|2|||
130155964|NCT01347866|468531256|FG004|Overall Study|Subject refused further follow-up|0|||
130155965|NCT01347866|468531257|FG005|Overall Study|Subject refused further follow-up|1|||
130155966|NCT01347866|468531258|FG006|Overall Study|Subject refused further follow-up|0|||
130155967|NCT01347866|468531259|FG007|Overall Study|Subject refused further follow-up|0|||
130155968|NCT01347866|468531260|FG008|Overall Study|Subject refused further follow-up|4|||
130155969|NCT01347866|468531261|FG009|Overall Study|Subject refused further follow-up|1|||
130155970|NCT01347866|468531262|FG010|Overall Study|Subject refused further follow-up|0|||
130155971|NCT01347866|468531263|FG011|Overall Study|Subject refused further follow-up|0|||
130155972|NCT01347866|468531264|FG012|Overall Study|Subject refused further follow-up|1|||
130155973|NCT01347866|468531265|FG013|Overall Study|Subject refused further follow-up|3|||
130155974|NCT01347866|468531266|FG014|Overall Study|Subject refused further follow-up|1|||
130155975|NCT01347866|468531267|FG015|Overall Study|Subject refused further follow-up|0|||
130155976|NCT01347866|468531268|FG016|Overall Study|Subject refused further follow-up|2|||
130155977|NCT00430950|468531269|FG000|Overall Study|Adverse Event|7|||
130155978|NCT00430950|468531270|FG001|Overall Study|Adverse Event|6|||
130155979|NCT00430950|468531269|FG000|Overall Study|Withdrawal by Subject|1|||
130155980|NCT00430950|468531270|FG001|Overall Study|Withdrawal by Subject|0|||
130155981|NCT00430950|468531269|FG000|Overall Study|concomitant medication,etc.|5|||
130155982|NCT00430950|468531270|FG001|Overall Study|concomitant medication,etc.|7|||
130155983|NCT02429934|468531271|FG000|Overall Study|Withdrawal by Subject|0|||
130155984|NCT02429934|468531272|FG001|Overall Study|Withdrawal by Subject|2|||
130155985|NCT02429934|468531271|FG000|Overall Study|Adverse Event|2|||
130155986|NCT02429934|468531272|FG001|Overall Study|Adverse Event|0|||
130155987|NCT02429934|468531271|FG000|Overall Study|Lost to Follow-up|1|||
130155988|NCT02429934|468531272|FG001|Overall Study|Lost to Follow-up|1|||
130155989|NCT02429934|468531271|FG000|Overall Study|Physician Decision|1|||
130155990|NCT02429934|468531272|FG001|Overall Study|Physician Decision|0|||
130155991|NCT01564459|468531273|FG000|Run-In|Adverse Event|7|||
130155992|NCT01564459|468531274|FG001|Run-In|Adverse Event|0|||
130155993|NCT01564459|468531275|FG002|Run-In|Adverse Event|0|||
130155994|NCT01564459|468531273|FG000|Run-In|Lost to Follow-up|1|||
130155995|NCT01564459|468531274|FG001|Run-In|Lost to Follow-up|0|||
130155996|NCT01564459|468531275|FG002|Run-In|Lost to Follow-up|0|||
130155997|NCT01564459|468531273|FG000|Run-In|Non-compliance with study drug|2|||
130155998|NCT01564459|468531274|FG001|Run-In|Non-compliance with study drug|0|||
130155999|NCT01564459|468531275|FG002|Run-In|Non-compliance with study drug|0|||
130156000|NCT01564459|468531273|FG000|Run-In|Protocol Violation|1|||
130156001|NCT01564459|468531274|FG001|Run-In|Protocol Violation|0|||
130156002|NCT01564459|468531275|FG002|Run-In|Protocol Violation|0|||
130156003|NCT01564459|468531273|FG000|Run-In|Withdrawal by Subject|1|||
130156004|NCT01564459|468531274|FG001|Run-In|Withdrawal by Subject|0|||
130156005|NCT01564459|468531275|FG002|Run-In|Withdrawal by Subject|0|||
130156006|NCT01564459|468531273|FG000|Double-blind Treatment|Adverse Event|0|||
130156007|NCT01564459|468531274|FG001|Double-blind Treatment|Adverse Event|0|||
130156008|NCT01564459|468531275|FG002|Double-blind Treatment|Adverse Event|1|||
130156009|NCT01138111|468531281|FG000|Overall Study|Withdrawal by Subject|5|||
130156010|NCT01138111|468531281|FG000|Overall Study|Adverse Event|1|||
130156011|NCT01138111|468531281|FG000|Overall Study|Death|1|||
130156012|NCT01138111|468531281|FG000|Overall Study|Lost to Follow-up|2|||
130156013|NCT01491035|468531282|FG000|Overall Study|Lost to Follow-up|0|||
130156014|NCT01491035|468531283|FG001|Overall Study|Lost to Follow-up|0|||
130156015|NCT01491035|468531284|FG002|Overall Study|Lost to Follow-up|0|||
130156016|NCT01491035|468531285|FG003|Overall Study|Lost to Follow-up|0|||
130156017|NCT01491035|468531286|FG004|Overall Study|Lost to Follow-up|1|||
130156018|NCT01491035|468531287|FG005|Overall Study|Lost to Follow-up|0|||
130156019|NCT01491035|468531288|FG006|Overall Study|Lost to Follow-up|0|||
130156020|NCT01491035|468531289|FG007|Overall Study|Lost to Follow-up|0|||
130156021|NCT03351231|468531309|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
130156022|NCT03351231|468531309|FG000|Combination Therapy Period|Disease progression|2|||
130156023|NCT03351231|468531309|FG000|Combination Therapy Period|Study drug toxicity|1|||
130156024|NCT03351231|468531309|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
130156025|NCT03351231|468531309|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
130156026|NCT03351231|468531309|FG000|Safety Follow-Up Period|Other reason|2|||
130156027|NCT02340221|468531312|FG000|Overall Study|Death|100|||
130156028|NCT02340221|468531313|FG001|Overall Study|Death|197|||
130156029|NCT02340221|468531312|FG000|Overall Study|Withdrawal by Participant|24|||
130156030|NCT02340221|468531313|FG001|Overall Study|Withdrawal by Participant|37|||
129980614|NCT01365481|467891685|FG002|Overall Study|Administrative problems|0|||
130156031|NCT02340221|468531312|FG000|Overall Study|Lost to Follow-up|4|||
130156032|NCT02340221|468531313|FG001|Overall Study|Lost to Follow-up|15|||
130156033|NCT02340221|468531312|FG000|Overall Study|Reason Not Specified|85|||
130156034|NCT02340221|468531313|FG001|Overall Study|Reason Not Specified|165|||
130156035|NCT02340221|468531312|FG000|Overall Study|Study Terminated by Sponsor|1|||
130156036|NCT02340221|468531313|FG001|Overall Study|Study Terminated by Sponsor|3|||
130156037|NCT03487848|468531314|FG000|Overall Study|Lost to Follow-up|1|||
130156038|NCT00731549|468531315|FG000|Overall Study|Lost to Follow-up|19|||
130156039|NCT00731549|468531315|FG000|Overall Study|Met withdrawal criteria|24|||
130156040|NCT00731549|468531315|FG000|Overall Study|Physician Decision|16|||
130156041|NCT00731549|468531315|FG000|Overall Study|Withdrawal by Subject|89|||
130156042|NCT00731549|468531315|FG000|Overall Study|Protocol deviation|1|||
130156043|NCT00731549|468531315|FG000|Overall Study|Adverse Event|31|||
130156044|NCT00731549|468531315|FG000|Overall Study|Lack of efficacy with AE|37|||
130156045|NCT00731549|468531315|FG000|Overall Study|Lack of efficacy without AE|6|||
130156046|NCT00588640|468531316|FG000|Overall Study|Physician Decision|1|||
130156047|NCT00588640|468531316|FG000|Overall Study|Ineligible Patient|1|||
130156048|NCT00003138|468533259|FG000|Step 1|Reasons off treatment not documented|60|||
130156049|NCT00003138|468533260|FG001|Step 1|Reasons off treatment not documented|57|||
130156050|NCT00003138|468533259|FG000|Step 1|Never started treatment|1|||
130156051|NCT00003138|468533260|FG001|Step 1|Never started treatment|0|||
130156052|NCT00003138|468533259|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
130156053|NCT00003138|468533260|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
130156054|NCT00003138|468533259|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
130156055|NCT00003138|468533260|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
130156056|NCT00003138|468533259|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
130156057|NCT00003138|468533260|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
130156058|NCT00003138|468533259|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
130156059|NCT00003138|468533260|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
130156060|NCT05142566|468533261|FG000|Overall Study|Protocol Violation|1|||
130156061|NCT03247517|468533270|FG000|Overall Study|Adverse Event|0|||
130156062|NCT03247517|468533271|FG001|Overall Study|Adverse Event|4|||
130156063|NCT03247517|468533272|FG002|Overall Study|Adverse Event|2|||
130156064|NCT03247517|468533270|FG000|Overall Study|Lost to Follow-up|2|||
130156065|NCT03247517|468533271|FG001|Overall Study|Lost to Follow-up|6|||
130156066|NCT03247517|468533272|FG002|Overall Study|Lost to Follow-up|4|||
130156067|NCT03247517|468533270|FG000|Overall Study|Consent withdrawn by caregiver|1|||
130156068|NCT03247517|468533271|FG001|Overall Study|Consent withdrawn by caregiver|4|||
130156069|NCT03247517|468533272|FG002|Overall Study|Consent withdrawn by caregiver|7|||
130156070|NCT03247517|468533270|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
130156071|NCT03247517|468533271|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
130156072|NCT03247517|468533272|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
130156073|NCT03247517|468533270|FG000|Overall Study|Protocol Violation|0|||
130156074|NCT03247517|468533271|FG001|Overall Study|Protocol Violation|2|||
130156075|NCT03247517|468533272|FG002|Overall Study|Protocol Violation|0|||
130156076|NCT03247517|468533270|FG000|Overall Study|Multiple reasons|3|||
130156077|NCT03247517|468533271|FG001|Overall Study|Multiple reasons|1|||
130156078|NCT03247517|468533272|FG002|Overall Study|Multiple reasons|0|||
130156079|NCT02072148|468533283|FG000|Overall Study|withdrew prior to surgery|23|||
130156080|NCT02072148|468533284|FG001|Overall Study|withdrew prior to surgery|0|||
130156081|NCT02072148|468533285|FG002|Overall Study|withdrew prior to surgery|0|||
130156082|NCT02072148|468533283|FG000|Overall Study|Death|0|||
130156083|NCT02072148|468533284|FG001|Overall Study|Death|0|||
130156084|NCT02072148|468533285|FG002|Overall Study|Death|1|||
130156085|NCT02072148|468533283|FG000|Overall Study|Withdrawal by Subject|0|||
130156086|NCT02072148|468533284|FG001|Overall Study|Withdrawal by Subject|13|||
130156087|NCT02072148|468533285|FG002|Overall Study|Withdrawal by Subject|12|||
130156088|NCT02145026|468533287|FG000|Overall Study|Adverse Event|2|||
130156089|NCT02145026|468533287|FG000|Overall Study|Death|4|||
130156090|NCT02145026|468533287|FG000|Overall Study|Withdrawal by Subject|2|||
130156091|NCT02145026|468533287|FG000|Overall Study|Physician Decision|4|||
130156092|NCT04132336|468533288|FG000|Overall Study|Investigator Decision|0|||
130156093|NCT04132336|468533289|FG001|Overall Study|Investigator Decision|1|||
130156094|NCT04132336|468533290|FG002|Overall Study|Investigator Decision|0|||
130156095|NCT04132336|468533291|FG003|Overall Study|Investigator Decision|0|||
130156096|NCT04132336|468533292|FG004|Overall Study|Investigator Decision|0|||
130156097|NCT04132336|468533293|FG005|Overall Study|Investigator Decision|0|||
130156098|NCT04132336|468533294|FG006|Overall Study|Investigator Decision|0|||
130156099|NCT00584844|468533295|FG000|Overall Study|Withdrawal by Subject|59|||
130156100|NCT00584844|468533295|FG000|Overall Study|Screen Failure|20|||
130156101|NCT01939496|468533296|FG000|Overall Study|Adverse Event|2|||
130156102|NCT01939496|468533297|FG001|Overall Study|Adverse Event|0|||
130156103|NCT01939496|468533298|FG002|Overall Study|Adverse Event|0|||
130156104|NCT01939496|468533296|FG000|Overall Study|Lost to Follow-up|1|||
130156105|NCT01939496|468533297|FG001|Overall Study|Lost to Follow-up|1|||
130156106|NCT01939496|468533298|FG002|Overall Study|Lost to Follow-up|0|||
130156107|NCT01939496|468533296|FG000|Overall Study|Physician Decision|1|||
130156108|NCT01939496|468533297|FG001|Overall Study|Physician Decision|0|||
130156109|NCT01939496|468533298|FG002|Overall Study|Physician Decision|0|||
130156110|NCT01939496|468533296|FG000|Overall Study|Protocol Violation|3|||
130156111|NCT01939496|468533297|FG001|Overall Study|Protocol Violation|0|||
130156112|NCT01939496|468533298|FG002|Overall Study|Protocol Violation|0|||
130156113|NCT01939496|468533296|FG000|Overall Study|Withdrawal by Subject|0|||
130156114|NCT01939496|468533297|FG001|Overall Study|Withdrawal by Subject|1|||
130156115|NCT01939496|468533298|FG002|Overall Study|Withdrawal by Subject|1|||
130156116|NCT01939496|468533296|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
130156117|NCT01939496|468533297|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
130156118|NCT01939496|468533298|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
130156119|NCT01939496|468533296|FG000|Overall Study|Other|2|||
130156120|NCT01939496|468533297|FG001|Overall Study|Other|0|||
130156121|NCT01939496|468533298|FG002|Overall Study|Other|1|||
130156122|NCT03052322|468533299|FG000|Overall Study|Other un-specified|1|||
130156123|NCT03052322|468533300|FG001|Overall Study|Other un-specified|2|||
130156124|NCT03052322|468533299|FG000|Overall Study|Withdrawal by Subject|10|||
130156125|NCT03052322|468533300|FG001|Overall Study|Withdrawal by Subject|9|||
130156126|NCT03052322|468533299|FG000|Overall Study|Death|0|||
130156127|NCT03052322|468533300|FG001|Overall Study|Death|2|||
130156128|NCT03052322|468533299|FG000|Overall Study|Lack of Efficacy|1|||
130156129|NCT03052322|468533300|FG001|Overall Study|Lack of Efficacy|2|||
130156130|NCT03052322|468533299|FG000|Overall Study|Protocol Violation|1|||
130156131|NCT03052322|468533300|FG001|Overall Study|Protocol Violation|0|||
130156132|NCT03052322|468533299|FG000|Overall Study|Lost to Follow-up|2|||
130156133|NCT03052322|468533300|FG001|Overall Study|Lost to Follow-up|4|||
130156134|NCT03052322|468533299|FG000|Overall Study|Adverse Event|6|||
130156135|NCT03052322|468533300|FG001|Overall Study|Adverse Event|13|||
130156136|NCT04920916|468533301|FG000|Phase IIa 60 Day Study|Death|2|||
130156137|NCT04920916|468533302|FG001|Phase IIa 60 Day Study|Death|5|||
130156138|NCT04920916|468533301|FG000|1 Year Follow up (Phone Call)|Death|1|||
130156139|NCT04920916|468533302|FG001|1 Year Follow up (Phone Call)|Death|3|||
130156140|NCT04920916|468533301|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
130156141|NCT04920916|468533302|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
130156142|NCT03251963|468533311|FG000|Overall Study|inappropriate Xa level timing|6|||
130156143|NCT03251963|468533312|FG001|Overall Study|inappropriate Xa level timing|3|||
130156144|NCT03251963|468533311|FG000|Overall Study|no peak Xa level drawn|2|||
130156145|NCT03251963|468533312|FG001|Overall Study|no peak Xa level drawn|0|||
130156146|NCT03251963|468533311|FG000|Overall Study|bled prior to Xa level|1|||
130156147|NCT03251963|468533312|FG001|Overall Study|bled prior to Xa level|2|||
130156148|NCT00136318|468533313|FG000|Overall Study|Adverse Event|5|||
130156149|NCT00136318|468533314|FG001|Overall Study|Adverse Event|5|||
130156150|NCT00136318|468533313|FG000|Overall Study|Withdrawal by Subject|2|||
130156151|NCT00136318|468533314|FG001|Overall Study|Withdrawal by Subject|2|||
130156152|NCT01546649|468533319|FG000|Overall Study|Adverse Event|4|||
130156153|NCT01546649|468533320|FG001|Overall Study|Adverse Event|5|||
130156154|NCT01546649|468533319|FG000|Overall Study|Protocol Violation|1|||
130156155|NCT01546649|468533320|FG001|Overall Study|Protocol Violation|0|||
130156156|NCT01546649|468533319|FG000|Overall Study|Lack of Efficacy|1|||
130156157|NCT01546649|468533320|FG001|Overall Study|Lack of Efficacy|0|||
130156158|NCT01546649|468533319|FG000|Overall Study|Recurrence|1|||
130156159|NCT01546649|468533320|FG001|Overall Study|Recurrence|1|||
130156160|NCT01546649|468533319|FG000|Overall Study|Discovery of secondary cancer|0|||
130156161|NCT01546649|468533320|FG001|Overall Study|Discovery of secondary cancer|1|||
130156162|NCT01546649|468533319|FG000|Overall Study|Withdrawal by Subject|1|||
130156163|NCT01546649|468533320|FG001|Overall Study|Withdrawal by Subject|2|||
130156164|NCT01134627|468533325|FG000|Overall Study|Adverse Event|47|||
130156165|NCT01134627|468533326|FG001|Overall Study|Adverse Event|31|||
130156166|NCT01134627|468533325|FG000|Overall Study|Lost to Follow-up|1|||
130156167|NCT01134627|468533326|FG001|Overall Study|Lost to Follow-up|2|||
130156168|NCT01134627|468533325|FG000|Overall Study|Protocol Violation|3|||
130156169|NCT01134627|468533326|FG001|Overall Study|Protocol Violation|5|||
130156170|NCT01134627|468533325|FG000|Overall Study|Lack of Efficacy|2|||
130156171|NCT01134627|468533326|FG001|Overall Study|Lack of Efficacy|12|||
130156172|NCT01134627|468533325|FG000|Overall Study|Withdrawal by Subject|4|||
130156173|NCT01134627|468533326|FG001|Overall Study|Withdrawal by Subject|3|||
130156174|NCT01134627|468533325|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
130156175|NCT01134627|468533326|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
130156176|NCT01134627|468533325|FG000|Overall Study|Other|11|||
130156177|NCT01134627|468533326|FG001|Overall Study|Other|14|||
130156178|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
129980615|NCT01365481|467891686|FG003|Overall Study|Administrative problems|0|||
129980616|NCT01365481|467891683|FG000|Overall Study|Protocol deviation|0|||
130156179|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
130156180|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
130156181|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
130156182|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
130156183|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
130156184|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
130156185|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
130156186|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
130156187|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
130156188|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Subject decision|1|||
130156189|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Subject decision|1|||
130156190|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
130156191|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
130156192|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
130156193|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
130156194|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
130156195|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
130156196|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
130156197|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
130156198|NCT00518882|468533332|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
130156199|NCT00518882|468533333|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
130156200|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
130156201|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
130156202|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
130156203|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
130156204|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
130156205|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
130156206|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
130156207|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
130156208|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
130156209|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
130156210|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
130156211|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
130156212|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
130156213|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
130156214|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
130156215|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
130156216|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
130156217|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
130156218|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
130156219|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
130156220|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
130156221|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
130156222|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
130156223|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
130156224|NCT00518882|468533332|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
130156225|NCT00518882|468533333|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
130156226|NCT03395639|468533334|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
130156227|NCT03395639|468533335|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
130156228|NCT03395639|468533336|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
130156229|NCT03395639|468533334|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
130156230|NCT03395639|468533335|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
130156231|NCT03395639|468533336|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
130156232|NCT03395639|468533334|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
130156233|NCT03395639|468533335|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
130156234|NCT03395639|468533336|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
130156235|NCT03395639|468533334|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
130156236|NCT03395639|468533335|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
130156237|NCT03395639|468533336|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
130156238|NCT03395639|468533334|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
130156239|NCT03395639|468533335|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
130156240|NCT03395639|468533336|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
130156241|NCT00942331|468533337|FG000|Overall Study|Did not start treatment|15|||
130156242|NCT00942331|468533338|FG001|Overall Study|Did not start treatment|22|||
130156243|NCT00567476|468533343|FG000|Overall Study|Adverse Event|2|||
130156244|NCT00567476|468533344|FG001|Overall Study|Adverse Event|0|||
130156245|NCT00567476|468533343|FG000|Overall Study|Pregnancy|1|||
130156246|NCT00567476|468533344|FG001|Overall Study|Pregnancy|0|||
130156247|NCT00567476|468533343|FG000|Overall Study|Protocol Violation|4|||
130156248|NCT00567476|468533344|FG001|Overall Study|Protocol Violation|1|||
130156249|NCT00567476|468533343|FG000|Overall Study|Lost to Follow-up|0|||
130156250|NCT00567476|468533344|FG001|Overall Study|Lost to Follow-up|1|||
130156251|NCT00567476|468533343|FG000|Overall Study|Administrative issues|1|||
130156252|NCT00567476|468533344|FG001|Overall Study|Administrative issues|0|||
130156253|NCT00567476|468533343|FG000|Overall Study|Medical Decision|0|||
130156254|NCT00567476|468533344|FG001|Overall Study|Medical Decision|1|||
130156255|NCT00567476|468533343|FG000|Overall Study|Non-adherence to protocol|0|||
130156256|NCT00567476|468533344|FG001|Overall Study|Non-adherence to protocol|1|||
130156257|NCT02696031|468533346|FG000|Up to Week 24|Adverse Event|2|||
130156258|NCT02696031|468533347|FG001|Up to Week 24|Adverse Event|4|||
130156259|NCT02696031|468533348|FG002|Up to Week 24|Adverse Event|2|||
130156260|NCT02696031|468533349|FG003|Up to Week 24|Adverse Event|0|||
130156261|NCT02696031|468533350|FG004|Up to Week 24|Adverse Event|0|||
130156262|NCT02696031|468533351|FG005|Up to Week 24|Adverse Event|0|||
130156263|NCT02696031|468533346|FG000|Up to Week 24|Lack of Efficacy|2|||
130156264|NCT02696031|468533347|FG001|Up to Week 24|Lack of Efficacy|1|||
130156265|NCT02696031|468533348|FG002|Up to Week 24|Lack of Efficacy|2|||
130156266|NCT02696031|468533349|FG003|Up to Week 24|Lack of Efficacy|0|||
130156267|NCT02696031|468533350|FG004|Up to Week 24|Lack of Efficacy|0|||
130156268|NCT02696031|468533351|FG005|Up to Week 24|Lack of Efficacy|0|||
130156269|NCT02696031|468533346|FG000|Up to Week 24|Lost to Follow-up|0|||
130156270|NCT02696031|468533347|FG001|Up to Week 24|Lost to Follow-up|1|||
130156271|NCT02696031|468533348|FG002|Up to Week 24|Lost to Follow-up|1|||
130156272|NCT02696031|468533349|FG003|Up to Week 24|Lost to Follow-up|0|||
130156273|NCT02696031|468533350|FG004|Up to Week 24|Lost to Follow-up|0|||
130156274|NCT02696031|468533351|FG005|Up to Week 24|Lost to Follow-up|0|||
130156275|NCT02696031|468533346|FG000|Up to Week 24|Physician Decision|1|||
130156276|NCT02696031|468533347|FG001|Up to Week 24|Physician Decision|0|||
130156277|NCT02696031|468533348|FG002|Up to Week 24|Physician Decision|1|||
130156278|NCT02696031|468533349|FG003|Up to Week 24|Physician Decision|0|||
130156279|NCT02696031|468533350|FG004|Up to Week 24|Physician Decision|0|||
130156280|NCT02696031|468533351|FG005|Up to Week 24|Physician Decision|0|||
130156281|NCT02696031|468533346|FG000|Up to Week 24|Protocol Violation|1|||
130156282|NCT02696031|468533347|FG001|Up to Week 24|Protocol Violation|0|||
130156283|NCT02696031|468533348|FG002|Up to Week 24|Protocol Violation|0|||
130156284|NCT02696031|468533349|FG003|Up to Week 24|Protocol Violation|0|||
130156285|NCT02696031|468533350|FG004|Up to Week 24|Protocol Violation|0|||
130156286|NCT02696031|468533351|FG005|Up to Week 24|Protocol Violation|0|||
130156287|NCT02696031|468533346|FG000|Up to Week 24|Withdrawal by Subject|4|||
130156288|NCT02696031|468533347|FG001|Up to Week 24|Withdrawal by Subject|1|||
130156289|NCT02696031|468533348|FG002|Up to Week 24|Withdrawal by Subject|5|||
130156290|NCT02696031|468533349|FG003|Up to Week 24|Withdrawal by Subject|0|||
130156291|NCT02696031|468533350|FG004|Up to Week 24|Withdrawal by Subject|0|||
130156292|NCT02696031|468533351|FG005|Up to Week 24|Withdrawal by Subject|0|||
130156293|NCT02696031|468533346|FG000|Up to Week 52|Adverse Event|4|||
130156294|NCT02696031|468533347|FG001|Up to Week 52|Adverse Event|5|||
130156295|NCT02696031|468533348|FG002|Up to Week 52|Adverse Event|3|||
130156296|NCT02696031|468533349|FG003|Up to Week 52|Adverse Event|0|||
130156297|NCT02696031|468533350|FG004|Up to Week 52|Adverse Event|0|||
130156298|NCT02696031|468533351|FG005|Up to Week 52|Adverse Event|0|||
130156299|NCT02696031|468533346|FG000|Up to Week 52|Lack of Efficacy|10|||
130156300|NCT02696031|468533347|FG001|Up to Week 52|Lack of Efficacy|7|||
130156301|NCT02696031|468533348|FG002|Up to Week 52|Lack of Efficacy|11|||
130156302|NCT02696031|468533349|FG003|Up to Week 52|Lack of Efficacy|0|||
130156303|NCT02696031|468533350|FG004|Up to Week 52|Lack of Efficacy|0|||
130156304|NCT02696031|468533351|FG005|Up to Week 52|Lack of Efficacy|0|||
130156305|NCT02696031|468533346|FG000|Up to Week 52|Lost to Follow-up|1|||
130156306|NCT02696031|468533347|FG001|Up to Week 52|Lost to Follow-up|1|||
130156307|NCT02696031|468533348|FG002|Up to Week 52|Lost to Follow-up|1|||
130156308|NCT02696031|468533349|FG003|Up to Week 52|Lost to Follow-up|0|||
130156309|NCT02696031|468533350|FG004|Up to Week 52|Lost to Follow-up|0|||
130156310|NCT02696031|468533351|FG005|Up to Week 52|Lost to Follow-up|0|||
130156311|NCT02696031|468533346|FG000|Up to Week 52|Physician Decision|1|||
130156312|NCT02696031|468533347|FG001|Up to Week 52|Physician Decision|1|||
130156313|NCT02696031|468533348|FG002|Up to Week 52|Physician Decision|2|||
130156314|NCT02696031|468533349|FG003|Up to Week 52|Physician Decision|0|||
130156315|NCT02696031|468533350|FG004|Up to Week 52|Physician Decision|0|||
130156316|NCT02696031|468533351|FG005|Up to Week 52|Physician Decision|0|||
130156317|NCT02696031|468533346|FG000|Up to Week 52|Pregnancy|0|||
130156318|NCT02696031|468533347|FG001|Up to Week 52|Pregnancy|2|||
130156319|NCT02696031|468533348|FG002|Up to Week 52|Pregnancy|0|||
130156320|NCT02696031|468533349|FG003|Up to Week 52|Pregnancy|0|||
130156321|NCT02696031|468533350|FG004|Up to Week 52|Pregnancy|0|||
130156322|NCT02696031|468533351|FG005|Up to Week 52|Pregnancy|0|||
130156323|NCT02696031|468533346|FG000|Up to Week 52|Protocol Violation|1|||
130156324|NCT02696031|468533347|FG001|Up to Week 52|Protocol Violation|0|||
130156325|NCT02696031|468533348|FG002|Up to Week 52|Protocol Violation|0|||
130156326|NCT02696031|468533349|FG003|Up to Week 52|Protocol Violation|0|||
130156327|NCT02696031|468533350|FG004|Up to Week 52|Protocol Violation|0|||
130156328|NCT02696031|468533351|FG005|Up to Week 52|Protocol Violation|0|||
130156329|NCT02696031|468533346|FG000|Up to Week 52|Withdrawal by Subject|12|||
130156330|NCT02696031|468533347|FG001|Up to Week 52|Withdrawal by Subject|3|||
129980617|NCT01365481|467891684|FG001|Overall Study|Protocol deviation|1|||
130156331|NCT02696031|468533348|FG002|Up to Week 52|Withdrawal by Subject|9|||
130156332|NCT02696031|468533349|FG003|Up to Week 52|Withdrawal by Subject|0|||
130156333|NCT02696031|468533350|FG004|Up to Week 52|Withdrawal by Subject|0|||
130156334|NCT02696031|468533351|FG005|Up to Week 52|Withdrawal by Subject|0|||
129980618|NCT01365481|467891685|FG002|Overall Study|Protocol deviation|0|||
130156335|NCT02696031|468533346|FG000|Up to Week 104|Pregnancy|0|||
130156336|NCT02696031|468533347|FG001|Up to Week 104|Pregnancy|2|||
130156337|NCT02696031|468533348|FG002|Up to Week 104|Pregnancy|1|||
130156338|NCT02696031|468533349|FG003|Up to Week 104|Pregnancy|0|||
130156339|NCT02696031|468533350|FG004|Up to Week 104|Pregnancy|0|||
130156340|NCT02696031|468533351|FG005|Up to Week 104|Pregnancy|0|||
130156341|NCT02696031|468533346|FG000|Up to Week 104|Withdrawal by Subject|15|||
130156342|NCT02696031|468533347|FG001|Up to Week 104|Withdrawal by Subject|10|||
130156343|NCT02696031|468533348|FG002|Up to Week 104|Withdrawal by Subject|16|||
130156344|NCT02696031|468533349|FG003|Up to Week 104|Withdrawal by Subject|0|||
130156345|NCT02696031|468533350|FG004|Up to Week 104|Withdrawal by Subject|0|||
130156346|NCT02696031|468533351|FG005|Up to Week 104|Withdrawal by Subject|0|||
130156347|NCT02696031|468533346|FG000|Up to Week 104|Protocol Violation|1|||
130156348|NCT02696031|468533347|FG001|Up to Week 104|Protocol Violation|0|||
130156349|NCT02696031|468533348|FG002|Up to Week 104|Protocol Violation|0|||
130156350|NCT02696031|468533349|FG003|Up to Week 104|Protocol Violation|0|||
130156351|NCT02696031|468533350|FG004|Up to Week 104|Protocol Violation|0|||
130156352|NCT02696031|468533351|FG005|Up to Week 104|Protocol Violation|0|||
130156353|NCT02696031|468533346|FG000|Up to Week 104|Physician Decision|1|||
130156354|NCT02696031|468533347|FG001|Up to Week 104|Physician Decision|2|||
130156355|NCT02696031|468533348|FG002|Up to Week 104|Physician Decision|3|||
130156356|NCT02696031|468533349|FG003|Up to Week 104|Physician Decision|0|||
130156357|NCT02696031|468533350|FG004|Up to Week 104|Physician Decision|0|||
130156358|NCT02696031|468533351|FG005|Up to Week 104|Physician Decision|0|||
130156359|NCT02696031|468533346|FG000|Up to Week 104|Lost to Follow-up|2|||
130156360|NCT02696031|468533347|FG001|Up to Week 104|Lost to Follow-up|3|||
130156361|NCT02696031|468533348|FG002|Up to Week 104|Lost to Follow-up|1|||
130156362|NCT02696031|468533349|FG003|Up to Week 104|Lost to Follow-up|0|||
130156363|NCT02696031|468533350|FG004|Up to Week 104|Lost to Follow-up|0|||
130156364|NCT02696031|468533351|FG005|Up to Week 104|Lost to Follow-up|0|||
130156365|NCT02696031|468533346|FG000|Up to Week 104|Lack of Efficacy|13|||
130156366|NCT02696031|468533347|FG001|Up to Week 104|Lack of Efficacy|12|||
130156367|NCT02696031|468533348|FG002|Up to Week 104|Lack of Efficacy|11|||
130156368|NCT02696031|468533349|FG003|Up to Week 104|Lack of Efficacy|0|||
130156369|NCT02696031|468533350|FG004|Up to Week 104|Lack of Efficacy|0|||
130156370|NCT02696031|468533351|FG005|Up to Week 104|Lack of Efficacy|0|||
130156371|NCT02696031|468533346|FG000|Up to Week 104|Adverse Event|7|||
130156372|NCT02696031|468533347|FG001|Up to Week 104|Adverse Event|11|||
130156373|NCT02696031|468533348|FG002|Up to Week 104|Adverse Event|5|||
130156374|NCT02696031|468533349|FG003|Up to Week 104|Adverse Event|0|||
130156375|NCT02696031|468533350|FG004|Up to Week 104|Adverse Event|0|||
130156376|NCT02696031|468533351|FG005|Up to Week 104|Adverse Event|0|||
130156377|NCT02696031|468533346|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130156378|NCT02696031|468533347|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
130156379|NCT02696031|468533348|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130156380|NCT02696031|468533349|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130156381|NCT02696031|468533350|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130156382|NCT02696031|468533351|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
130156383|NCT02696031|468533346|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130156384|NCT02696031|468533347|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130156385|NCT02696031|468533348|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
130156386|NCT02696031|468533349|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
130156387|NCT02696031|468533350|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
130156388|NCT02696031|468533351|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
130156389|NCT02696031|468533346|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130156390|NCT02696031|468533347|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130156391|NCT02696031|468533348|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130156392|NCT02696031|468533349|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
130156393|NCT02696031|468533350|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
130156394|NCT02696031|468533351|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
130156395|NCT02696031|468533346|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130156396|NCT02696031|468533347|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130156397|NCT02696031|468533348|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130156398|NCT02696031|468533349|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
130156399|NCT02696031|468533350|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130156400|NCT02696031|468533351|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
130156401|NCT02696031|468533346|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130156402|NCT02696031|468533347|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130156403|NCT02696031|468533348|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130156404|NCT02696031|468533349|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130156405|NCT02696031|468533350|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
130156406|NCT02696031|468533351|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
130156407|NCT02696031|468533346|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130156408|NCT02696031|468533347|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130156409|NCT02696031|468533348|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
130156410|NCT02696031|468533349|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
130156411|NCT02696031|468533350|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
130156412|NCT02696031|468533351|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
129980619|NCT01365481|467891686|FG003|Overall Study|Protocol deviation|1|||
129980620|NCT01365481|467891683|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130156413|NCT02696031|468533346|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130156414|NCT02696031|468533347|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130156415|NCT02696031|468533348|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
130156416|NCT02696031|468533349|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
130156417|NCT02696031|468533350|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
130156418|NCT02696031|468533351|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
130156419|NCT00597116|468533352|FG000|Overall Study|Adverse Event|2|||
130156420|NCT00597116|468533353|FG001|Overall Study|Adverse Event|1|||
130156421|NCT00597116|468533352|FG000|Overall Study|Withdrawal by Subject|0|||
130156422|NCT00597116|468533353|FG001|Overall Study|Withdrawal by Subject|2|||
130156423|NCT00597116|468533352|FG000|Overall Study|Physician Decision|0|||
130156424|NCT00597116|468533353|FG001|Overall Study|Physician Decision|1|||
130156425|NCT00597116|468533352|FG000|Overall Study|Death|0|||
130156426|NCT00597116|468533353|FG001|Overall Study|Death|1|||
130156427|NCT00597116|468533352|FG000|Overall Study|Lost to Follow-up|1|||
130156428|NCT00597116|468533353|FG001|Overall Study|Lost to Follow-up|0|||
130156429|NCT00597116|468533352|FG000|Overall Study|Progressive disease|11|||
130156430|NCT00597116|468533353|FG001|Overall Study|Progressive disease|6|||
130156431|NCT01901874|468533356|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
130156432|NCT01901874|468533356|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
130156433|NCT01901874|468533356|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
130156434|NCT01901874|468533356|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
130156435|NCT01901874|468533356|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
130156436|NCT01901874|468533356|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
130156437|NCT03978091|468533357|FG000|Overall Study|Lost to Follow-up|0|||
130156438|NCT03978091|468533358|FG001|Overall Study|Lost to Follow-up|0|||
130156439|NCT03978091|468533359|FG002|Overall Study|Lost to Follow-up|1|||
130156440|NCT03978091|468533360|FG003|Overall Study|Lost to Follow-up|0|||
130156441|NCT03978091|468533361|FG004|Overall Study|Lost to Follow-up|0|||
130156442|NCT03978091|468533362|FG005|Overall Study|Lost to Follow-up|0|||
130156443|NCT03978091|468533357|FG000|Overall Study|Withdrawal by Subject|0|||
130156444|NCT03978091|468533358|FG001|Overall Study|Withdrawal by Subject|0|||
130156445|NCT03978091|468533359|FG002|Overall Study|Withdrawal by Subject|0|||
130156446|NCT03978091|468533360|FG003|Overall Study|Withdrawal by Subject|1|||
130156447|NCT03978091|468533361|FG004|Overall Study|Withdrawal by Subject|1|||
130156448|NCT03978091|468533362|FG005|Overall Study|Withdrawal by Subject|0|||
130156449|NCT02595008|468533367|FG000|Overall Study|Enrolled In Error|1|||
130156450|NCT02595008|468533368|FG001|Overall Study|Enrolled In Error|0|||
130156451|NCT03078582|468533375|FG000|Overall Study|Adverse Event|0|||
130156452|NCT03078582|468533376|FG001|Overall Study|Adverse Event|8|||
130156453|NCT01843348|468533379|FG000|Overall Study|Withdrawal by Subject|4|||
130156454|NCT01843348|468533380|FG001|Overall Study|Withdrawal by Subject|16|||
130156455|NCT01843348|468533381|FG002|Overall Study|Withdrawal by Subject|18|||
130156456|NCT01843348|468533379|FG000|Overall Study|Lost to Follow-up|5|||
130156457|NCT01843348|468533380|FG001|Overall Study|Lost to Follow-up|4|||
130156458|NCT01843348|468533381|FG002|Overall Study|Lost to Follow-up|2|||
130156459|NCT01843348|468533379|FG000|Overall Study|Death|5|||
130156460|NCT01843348|468533380|FG001|Overall Study|Death|3|||
130156461|NCT01843348|468533381|FG002|Overall Study|Death|4|||
130156462|NCT01843348|468533379|FG000|Overall Study|Graft loss/retransplantation|5|||
130156463|NCT01843348|468533380|FG001|Overall Study|Graft loss/retransplantation|8|||
130156464|NCT01843348|468533381|FG002|Overall Study|Graft loss/retransplantation|11|||
130156465|NCT01843348|468533379|FG000|Overall Study|Various reasons|4|||
130156466|NCT01843348|468533380|FG001|Overall Study|Various reasons|9|||
130156467|NCT01843348|468533381|FG002|Overall Study|Various reasons|6|||
130156468|NCT02039414|468533388|FG000|Overall Study|Delivered|1|||
130156469|NCT02039414|468533389|FG001|Overall Study|Delivered|1|||
130156470|NCT02039414|468533388|FG000|Overall Study|Lost to Follow-up|2|||
130156471|NCT02039414|468533389|FG001|Overall Study|Lost to Follow-up|0|||
130156472|NCT02039414|468533388|FG000|Overall Study|Protocol Violation|3|||
130156473|NCT02039414|468533389|FG001|Overall Study|Protocol Violation|1|||
130156474|NCT03977701|468533392|FG000|Overall Study|COVID-19 pandemic|0|||
130156475|NCT03977701|468533393|FG001|Overall Study|COVID-19 pandemic|0|||
130156476|NCT03977701|468533394|FG002|Overall Study|COVID-19 pandemic|0|||
130156477|NCT03977701|468533395|FG003|Overall Study|COVID-19 pandemic|0|||
130156478|NCT03977701|468533396|FG004|Overall Study|COVID-19 pandemic|0|||
130156479|NCT03977701|468533397|FG005|Overall Study|COVID-19 pandemic|1|||
130156480|NCT03977701|468533398|FG006|Overall Study|COVID-19 pandemic|0|||
130156481|NCT03977701|468533399|FG007|Overall Study|COVID-19 pandemic|1|||
130156482|NCT03977701|468533400|FG008|Overall Study|COVID-19 pandemic|0|||
130156483|NCT03977701|468533401|FG009|Overall Study|COVID-19 pandemic|0|||
130156484|NCT00869024|468533402|FG000|Overall Study|Death|2|||
130156485|NCT00869024|468533403|FG001|Overall Study|Death|3|||
130156486|NCT00869024|468533402|FG000|Overall Study|Lost to Follow-up|0|||
130156487|NCT00869024|468533403|FG001|Overall Study|Lost to Follow-up|1|||
130156488|NCT00869024|468533402|FG000|Overall Study|Protocol Violation|0|||
130156489|NCT00869024|468533403|FG001|Overall Study|Protocol Violation|1|||
130156490|NCT00831623|468533408|FG000|Overall Study|Withdrawal by Subject|9|||
130156491|NCT00831623|468533408|FG000|Overall Study|Lost to Follow-up|1|||
130156492|NCT00831623|468533408|FG000|Overall Study|Not 2 years post-treatment|12|||
130156493|NCT00653991|468533411|FG000|3 Month Follow-up|Participant would not respond|150|||
130156494|NCT00653991|468533412|FG001|3 Month Follow-up|Participant would not respond|157|||
130156495|NCT00653991|468533411|FG000|6 Month Follow-up|Participant would not respond|133|||
130156496|NCT00653991|468533412|FG001|6 Month Follow-up|Participant would not respond|141|||
130156497|NCT02939014|468533415|FG000|Overall Study|Lost to Follow-up|1|||
130156498|NCT02939014|468533416|FG001|Overall Study|Lost to Follow-up|0|||
130156499|NCT02939014|468533415|FG000|Overall Study|Death|4|||
130156500|NCT02939014|468533416|FG001|Overall Study|Death|3|||
130156501|NCT03864042|468533417|FG000|DDI Phase|Adverse Event|2|||
130156502|NCT03864042|468533418|FG001|DDI Phase|Adverse Event|0|||
130156503|NCT03864042|468533419|FG002|DDI Phase|Adverse Event|0|||
130156504|NCT03864042|468533417|FG000|DDI Phase|Physician Decision|1|||
130156505|NCT03864042|468533418|FG001|DDI Phase|Physician Decision|0|||
130156506|NCT03864042|468533419|FG002|DDI Phase|Physician Decision|0|||
130156507|NCT03864042|468533417|FG000|DDI Phase|Progressive Disease|1|||
130156508|NCT03864042|468533418|FG001|DDI Phase|Progressive Disease|0|||
130156509|NCT03864042|468533419|FG002|DDI Phase|Progressive Disease|0|||
130156510|NCT03864042|468533417|FG000|Post-DDI Phase|Adverse Event|5|||
130156511|NCT03864042|468533418|FG001|Post-DDI Phase|Adverse Event|3|||
130156512|NCT03864042|468533419|FG002|Post-DDI Phase|Adverse Event|2|||
130156513|NCT03864042|468533417|FG000|Post-DDI Phase|Progressive Disease|11|||
130156514|NCT03864042|468533418|FG001|Post-DDI Phase|Progressive Disease|6|||
130156515|NCT03864042|468533419|FG002|Post-DDI Phase|Progressive Disease|13|||
130156516|NCT03864042|468533417|FG000|Post-DDI Phase|Discretion of investigator|1|||
130156517|NCT03864042|468533418|FG001|Post-DDI Phase|Discretion of investigator|1|||
130156518|NCT03864042|468533419|FG002|Post-DDI Phase|Discretion of investigator|0|||
130156519|NCT03864042|468533417|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
130156520|NCT03864042|468533418|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
130156521|NCT03864042|468533419|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
130156522|NCT03864042|468533417|FG000|Post-DDI Phase|Withdrawal of consent|1|||
130156523|NCT03864042|468533418|FG001|Post-DDI Phase|Withdrawal of consent|2|||
130156524|NCT03864042|468533419|FG002|Post-DDI Phase|Withdrawal of consent|0|||
130156525|NCT02220725|468533420|FG000|Overall Study|Lost to Follow-up|0|||
130156526|NCT02220725|468533421|FG001|Overall Study|Lost to Follow-up|0|||
130156527|NCT02220725|468533422|FG002|Overall Study|Lost to Follow-up|0|||
130156528|NCT02220725|468533423|FG003|Overall Study|Lost to Follow-up|1|||
130156529|NCT02220725|468533420|FG000|Overall Study|Withdrawal by Subject|0|||
130156530|NCT02220725|468533421|FG001|Overall Study|Withdrawal by Subject|0|||
130156531|NCT02220725|468533422|FG002|Overall Study|Withdrawal by Subject|0|||
130156532|NCT02220725|468533423|FG003|Overall Study|Withdrawal by Subject|1|||
130156533|NCT00103402|468533424|FG000|Overall Study|Adverse Event|3|||
130156534|NCT00103402|468533425|FG001|Overall Study|Adverse Event|4|||
130156535|NCT00103402|468533424|FG000|Overall Study|Lost to Follow-up|8|||
130156536|NCT00103402|468533425|FG001|Overall Study|Lost to Follow-up|7|||
130156537|NCT00103402|468533424|FG000|Overall Study|Dissatisfied/No longer interested|6|||
130156538|NCT00103402|468533425|FG001|Overall Study|Dissatisfied/No longer interested|6|||
130156539|NCT00103402|468533424|FG000|Overall Study|Personal constraints/Other|5|||
130156540|NCT00103402|468533425|FG001|Overall Study|Personal constraints/Other|0|||
130156541|NCT01393730|468533426|FG000|Overall Study|Withdrawal by Subject|3|||
130156542|NCT01393730|468533426|FG000|Overall Study|Other|2|||
130156543|NCT01393730|468533426|FG000|Overall Study|Adverse Event|1|||
130156544|NCT02333487|468533427|FG000|Overall Study|Adverse Event|0|||
130156545|NCT02333487|468533428|FG001|Overall Study|Adverse Event|2|||
130156546|NCT02333487|468533429|FG002|Overall Study|Adverse Event|0|||
130156547|NCT01297322|468533430|FG000|Overall Study|Lost to Follow-up|1|||
130156548|NCT01297322|468533431|FG001|Overall Study|Lost to Follow-up|0|||
130156549|NCT01297322|468533430|FG000|Overall Study|Withdrawal by Subject|0|||
130156550|NCT01297322|468533431|FG001|Overall Study|Withdrawal by Subject|1|||
130156551|NCT01297322|468533430|FG000|Overall Study|Protocol Violation|0|||
130156552|NCT01297322|468533431|FG001|Overall Study|Protocol Violation|3|||
130156553|NCT01111019|468533432|FG000|Overall Study|Withdrew Prematurely|2|||
130156554|NCT01111019|468533432|FG000|Overall Study|Other|1|||
130156555|NCT01583218|468533435|FG000|Overall Study|Withdrawal by Subject|43|||
130156556|NCT01583218|468533436|FG001|Overall Study|Withdrawal by Subject|29|||
130156557|NCT01583218|468533435|FG000|Overall Study|Death|206|||
130156558|NCT01583218|468533436|FG001|Overall Study|Death|211|||
130156559|NCT01583218|468533435|FG000|Overall Study|Lost to Follow-up|11|||
130156560|NCT01583218|468533436|FG001|Overall Study|Lost to Follow-up|17|||
130156561|NCT01583218|468533435|FG000|Overall Study|Adverse event or serious adverse event|3|||
130156562|NCT01583218|468533436|FG001|Overall Study|Adverse event or serious adverse event|3|||
130156563|NCT01583218|468533435|FG000|Overall Study|Patient /Family decision|3|||
130156564|NCT01583218|468533436|FG001|Overall Study|Patient /Family decision|0|||
130156565|NCT01583218|468533435|FG000|Overall Study|Cannot contact patient directly|1|||
130156566|NCT01583218|468533436|FG001|Overall Study|Cannot contact patient directly|2|||
130156567|NCT01583218|468533435|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
130156568|NCT01583218|468533436|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
130156569|NCT01583218|468533435|FG000|Overall Study|Patient did not wish to attend visits|0|||
130156570|NCT01583218|468533436|FG001|Overall Study|Patient did not wish to attend visits|1|||
130156571|NCT01583218|468533435|FG000|Overall Study|Patient randomized but not dosed|17|||
130156572|NCT01583218|468533436|FG001|Overall Study|Patient randomized but not dosed|16|||
130156573|NCT01583218|468533435|FG000|Overall Study|Patient was assessed via phone in person|1|||
130156574|NCT01583218|468533436|FG001|Overall Study|Patient was assessed via phone in person|0|||
130156575|NCT01583218|468533435|FG000|Overall Study|Patient deemed ineligible after random|2|||
130156576|NCT01583218|468533436|FG001|Overall Study|Patient deemed ineligible after random|0|||
130156577|NCT01583218|468533435|FG000|Overall Study|Patient was early terminated from study|0|||
130156578|NCT01583218|468533436|FG001|Overall Study|Patient was early terminated from study|1|||
130156579|NCT01583218|468533435|FG000|Overall Study|Patient was randomized due to mistake|1|||
130156580|NCT01583218|468533436|FG001|Overall Study|Patient was randomized due to mistake|0|||
130156581|NCT01583218|468533435|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
130156582|NCT01583218|468533436|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
130156583|NCT01583218|468533435|FG000|Overall Study|Withdraw of consent on day of random|1|||
130156584|NCT01583218|468533436|FG001|Overall Study|Withdraw of consent on day of random|0|||
130156585|NCT03334721|468533440|FG000|Overall Study|Withdrawal by Subject|1|||
130156586|NCT03334721|468533441|FG001|Overall Study|Withdrawal by Subject|0|||
130156587|NCT03334721|468533440|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
130156588|NCT03334721|468533441|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
130156589|NCT04718194|468534918|FG000|Overall Study|Withdrawal by Subject|3|||
130156590|NCT04718194|468534919|FG001|Overall Study|Withdrawal by Subject|0|||
130156591|NCT04718194|468534918|FG000|Overall Study|Lost to Follow-up|3|||
130156592|NCT04718194|468534919|FG001|Overall Study|Lost to Follow-up|0|||
130156593|NCT02091141|468534921|FG000|Overall Study|Death|280|||
130156594|NCT02091141|468534922|FG001|Overall Study|Death|118|||
130156595|NCT02091141|468534923|FG002|Overall Study|Death|46|||
130156596|NCT02091141|468534924|FG003|Overall Study|Death|13|||
130156597|NCT02091141|468534925|FG004|Overall Study|Death|31|||
130156598|NCT02091141|468534926|FG005|Overall Study|Death|16|||
130156599|NCT02091141|468534927|FG006|Overall Study|Death|12|||
130156600|NCT02091141|468534921|FG000|Overall Study|Withdrawal by Subject|21|||
130156601|NCT02091141|468534922|FG001|Overall Study|Withdrawal by Subject|13|||
130156602|NCT02091141|468534923|FG002|Overall Study|Withdrawal by Subject|3|||
130156603|NCT02091141|468534924|FG003|Overall Study|Withdrawal by Subject|2|||
130156604|NCT02091141|468534925|FG004|Overall Study|Withdrawal by Subject|2|||
130156605|NCT02091141|468534926|FG005|Overall Study|Withdrawal by Subject|3|||
130156606|NCT02091141|468534927|FG006|Overall Study|Withdrawal by Subject|0|||
130156607|NCT02091141|468534921|FG000|Overall Study|Lost to Follow-up|21|||
130156608|NCT02091141|468534922|FG001|Overall Study|Lost to Follow-up|5|||
130156609|NCT02091141|468534923|FG002|Overall Study|Lost to Follow-up|1|||
130156610|NCT02091141|468534924|FG003|Overall Study|Lost to Follow-up|0|||
130156611|NCT02091141|468534925|FG004|Overall Study|Lost to Follow-up|1|||
130156612|NCT02091141|468534926|FG005|Overall Study|Lost to Follow-up|2|||
130156613|NCT02091141|468534927|FG006|Overall Study|Lost to Follow-up|0|||
130156614|NCT02091141|468534921|FG000|Overall Study|Reason Not Specified|6|||
130156615|NCT02091141|468534922|FG001|Overall Study|Reason Not Specified|5|||
129980621|NCT01365481|467891684|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129980622|NCT01365481|467891685|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
129980623|NCT01365481|467891686|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129980624|NCT01641159|467891689|FG000|Overall Study|Lost to Follow-up|2|||
129980625|NCT01641159|467891690|FG001|Overall Study|Lost to Follow-up|1|||
129980626|NCT01641159|467891689|FG000|Overall Study|Withdrawal by Subject|0|||
129980627|NCT01641159|467891690|FG001|Overall Study|Withdrawal by Subject|1|||
129980628|NCT00831129|467891694|FG000|Overall Study|Adverse Event|0|||
129980629|NCT00831129|467891695|FG001|Overall Study|Adverse Event|1|||
129980630|NCT00831129|467891694|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
129980631|NCT00831129|467891695|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
129980632|NCT01214642|467891696|FG000|Overall Study|Progressive Disease|3|||
129980633|NCT01214642|467891697|FG001|Overall Study|Progressive Disease|2|||
130156616|NCT02091141|468534923|FG002|Overall Study|Reason Not Specified|2|||
130156617|NCT02091141|468534924|FG003|Overall Study|Reason Not Specified|0|||
130156618|NCT02091141|468534925|FG004|Overall Study|Reason Not Specified|0|||
130156619|NCT02091141|468534926|FG005|Overall Study|Reason Not Specified|0|||
130156620|NCT02091141|468534927|FG006|Overall Study|Reason Not Specified|1|||
129980634|NCT01214642|467891698|FG002|Overall Study|Progressive Disease|3|||
130156621|NCT02091141|468534921|FG000|Overall Study|Study Ended by Sponsor|1|||
130156622|NCT02091141|468534922|FG001|Overall Study|Study Ended by Sponsor|9|||
130156623|NCT02091141|468534923|FG002|Overall Study|Study Ended by Sponsor|0|||
130156624|NCT02091141|468534924|FG003|Overall Study|Study Ended by Sponsor|0|||
130156625|NCT02091141|468534925|FG004|Overall Study|Study Ended by Sponsor|0|||
130156626|NCT02091141|468534926|FG005|Overall Study|Study Ended by Sponsor|0|||
130156627|NCT02091141|468534927|FG006|Overall Study|Study Ended by Sponsor|0|||
130156628|NCT02091141|468534921|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
130156629|NCT02091141|468534922|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
130156630|NCT02091141|468534923|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
130156631|NCT02091141|468534924|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
130156632|NCT02091141|468534925|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
130156633|NCT02091141|468534926|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
130156634|NCT02091141|468534927|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
130156635|NCT02246439|468534928|FG000|Overall Study|Adverse Event|3|||
130156636|NCT02246439|468534929|FG001|Overall Study|Adverse Event|0|||
130156637|NCT02246439|468534928|FG000|Overall Study|Lost to Follow-up|7|||
130156638|NCT02246439|468534929|FG001|Overall Study|Lost to Follow-up|5|||
130156639|NCT02246439|468534928|FG000|Overall Study|Protocol Violation|0|||
130156640|NCT02246439|468534929|FG001|Overall Study|Protocol Violation|2|||
130156641|NCT02246439|468534928|FG000|Overall Study|Physician Decision|0|||
130156642|NCT02246439|468534929|FG001|Overall Study|Physician Decision|1|||
130156643|NCT02246439|468534928|FG000|Overall Study|Unkonwn|1|||
130156644|NCT02246439|468534929|FG001|Overall Study|Unkonwn|3|||
130156645|NCT02246439|468534928|FG000|Overall Study|Withdrawal by Subject|1|||
130156646|NCT02246439|468534929|FG001|Overall Study|Withdrawal by Subject|0|||
130156647|NCT03439852|468534930|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
130156648|NCT03439852|468534931|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
130156649|NCT03439852|468534930|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
130156650|NCT03439852|468534931|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
130156651|NCT03439852|468534930|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
130156652|NCT03439852|468534931|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
130156653|NCT01215513|468534932|FG000|Overall Study|Not completed CS42|9|||
130156654|NCT01215513|468534932|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
130156655|NCT01215513|468534932|FG000|Overall Study|Adverse event (CS42A)|2|||
130156656|NCT01215513|468534932|FG000|Overall Study|Physician decision (CS42A)|6|||
130156657|NCT01215513|468534932|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
130156658|NCT01215513|468534932|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
130156659|NCT01553279|468534933|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
130156660|NCT01553279|468534934|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
130156661|NCT01553279|468534933|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
130156662|NCT01553279|468534934|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
130156663|NCT01553279|468534933|FG000|Interim Period|Withdrawal by Subject|2|||
130156664|NCT01553279|468534934|FG001|Interim Period|Withdrawal by Subject|2|||
130156665|NCT01553279|468534933|FG000|Interim Period|Lost to Follow-up|1|||
130156666|NCT01553279|468534934|FG001|Interim Period|Lost to Follow-up|0|||
130156667|NCT01553279|468534933|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
130156668|NCT01553279|468534934|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
130156669|NCT01553279|468534933|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
130156670|NCT01553279|468534934|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
130156671|NCT03955471|468534935|FG000|Overall Study|Death|22|||
130156672|NCT03955471|468534935|FG000|Overall Study|Lost to Follow-up|1|||
130156673|NCT03955471|468534935|FG000|Overall Study|Withdrawal by Subject|6|||
130156674|NCT03955471|468534935|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
130156675|NCT01996332|468534946|FG000|Overall Study|Adverse Event|117|||
130156676|NCT01996332|468534946|FG000|Overall Study|Lack of Efficacy|1245|||
130156677|NCT01996332|468534946|FG000|Overall Study|Death|264|||
130156678|NCT01996332|468534946|FG000|Overall Study|Protocol Violation|9|||
130156679|NCT01996332|468534946|FG000|Overall Study|Withdrawal by Subject|71|||
130156680|NCT01996332|468534946|FG000|Overall Study|Other|20|||
130156681|NCT01996332|468534946|FG000|Overall Study|Clinical Deterioration|28|||
130156682|NCT01996332|468534946|FG000|Overall Study|Physician Decision|17|||
130156683|NCT01996332|468534946|FG000|Overall Study|Lost to Follow-up|34|||
130156684|NCT02113189|468534947|FG000|Overall Study|Lost to follow up|2|||
130156685|NCT02113189|468534948|FG001|Overall Study|Lost to follow up|1|||
130156686|NCT02113189|468534949|FG002|Overall Study|Lost to follow up|3|||
130156687|NCT00931268|468534950|FG000|Overall Study|Lost to Follow-up|6|||
130156688|NCT01388166|468534951|FG000|Overall Study|Adverse Event|16|||
130156689|NCT01388166|468534951|FG000|Overall Study|Lost to Follow-up|30|||
130156690|NCT01388166|468534951|FG000|Overall Study|Others than specified above|13|||
130156691|NCT00430495|468534952|FG000|Overall Study|Adverse Event|2|||
130156692|NCT00430495|468534953|FG001|Overall Study|Adverse Event|3|||
130156693|NCT00430495|468534954|FG002|Overall Study|Adverse Event|2|||
130156694|NCT00430495|468534955|FG003|Overall Study|Adverse Event|0|||
130156695|NCT00430495|468534952|FG000|Overall Study|Death|0|||
130156696|NCT00430495|468534953|FG001|Overall Study|Death|0|||
130156697|NCT00430495|468534954|FG002|Overall Study|Death|1|||
130156698|NCT00430495|468534955|FG003|Overall Study|Death|0|||
130156699|NCT00430495|468534952|FG000|Overall Study|Lost to Follow-up|0|||
130156700|NCT00430495|468534953|FG001|Overall Study|Lost to Follow-up|1|||
130156701|NCT00430495|468534954|FG002|Overall Study|Lost to Follow-up|4|||
130156702|NCT00430495|468534955|FG003|Overall Study|Lost to Follow-up|0|||
130156703|NCT00430495|468534952|FG000|Overall Study|Protocol Violation|1|||
130156704|NCT00430495|468534953|FG001|Overall Study|Protocol Violation|0|||
130156705|NCT00430495|468534954|FG002|Overall Study|Protocol Violation|1|||
130156706|NCT00430495|468534955|FG003|Overall Study|Protocol Violation|0|||
130156707|NCT00430495|468534952|FG000|Overall Study|Disease Progression|1|||
130156708|NCT00430495|468534953|FG001|Overall Study|Disease Progression|1|||
130156709|NCT00430495|468534954|FG002|Overall Study|Disease Progression|0|||
130156710|NCT00430495|468534955|FG003|Overall Study|Disease Progression|0|||
130156711|NCT00430495|468534952|FG000|Overall Study|Other|8|||
130156712|NCT00430495|468534953|FG001|Overall Study|Other|2|||
130156713|NCT00430495|468534954|FG002|Overall Study|Other|5|||
130156714|NCT00430495|468534955|FG003|Overall Study|Other|4|||
130156715|NCT00430495|468534952|FG000|Overall Study|Randomized but not Treated|2|||
130156716|NCT00430495|468534953|FG001|Overall Study|Randomized but not Treated|0|||
130156717|NCT00430495|468534954|FG002|Overall Study|Randomized but not Treated|0|||
130156718|NCT00430495|468534955|FG003|Overall Study|Randomized but not Treated|0|||
130156719|NCT00158756|468534960|FG000|Overall Study|Withdrawal by Subject|5|||
130156720|NCT00158756|468534961|FG001|Overall Study|Withdrawal by Subject|0|||
130156721|NCT00158756|468534962|FG002|Overall Study|Withdrawal by Subject|6|||
130156722|NCT00158756|468534963|FG003|Overall Study|Withdrawal by Subject|1|||
130156723|NCT00158756|468534964|FG004|Overall Study|Withdrawal by Subject|3|||
130156724|NCT00158756|468534960|FG000|Overall Study|Adverse Event|0|||
130156725|NCT00158756|468534961|FG001|Overall Study|Adverse Event|0|||
130156726|NCT00158756|468534962|FG002|Overall Study|Adverse Event|1|||
130156727|NCT00158756|468534963|FG003|Overall Study|Adverse Event|0|||
130156728|NCT00158756|468534964|FG004|Overall Study|Adverse Event|0|||
130156729|NCT00158756|468534960|FG000|Overall Study|Serious adverse event|0|||
130156730|NCT00158756|468534961|FG001|Overall Study|Serious adverse event|0|||
130156731|NCT00158756|468534962|FG002|Overall Study|Serious adverse event|1|||
130156732|NCT00158756|468534963|FG003|Overall Study|Serious adverse event|0|||
130156733|NCT00158756|468534964|FG004|Overall Study|Serious adverse event|0|||
130156734|NCT01429051|468534967|FG000|Titration Phase|Death|1|||
130156735|NCT01429051|468534967|FG000|Titration Phase|Withdrawal by Subject|7|||
130156736|NCT01429051|468534967|FG000|Titration Phase|Physician Decision|1|||
130156737|NCT01429051|468534967|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
130156738|NCT01429051|468534967|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
130156739|NCT01429051|468534967|FG000|Efficacy Phase|Adverse Event|1|||
130156740|NCT01429051|468534967|FG000|Efficacy Phase|Death|1|||
130156741|NCT01429051|468534967|FG000|Tolerability Phase|Death|5|||
130156742|NCT01429051|468534967|FG000|Tolerability Phase|Adverse Event|2|||
130156743|NCT01429051|468534967|FG000|Tolerability Phase|Withdrawal by Subject|5|||
130156744|NCT01429051|468534967|FG000|Tolerability Phase|Physician Decision|1|||
130156745|NCT01429051|468534967|FG000|Tolerability Phase|Other|2|||
130156746|NCT03656874|468534969|FG000|Overall Study|Lost to Follow-up|3|||
130156747|NCT03656874|468534970|FG001|Overall Study|Lost to Follow-up|17|||
130156748|NCT00857792|468534971|FG000|Overall Study|inadequate image quality for analysis|12|||
130156749|NCT01797835|468534972|FG000|Overall Study|Lost to Follow-up|31|||
130156750|NCT01797835|468534973|FG001|Overall Study|Lost to Follow-up|27|||
130156751|NCT02528123|468534975|FG000|Overall Study|Lost to Follow-up|1|||
130156752|NCT04421586|468534983|FG000|Overall Study|Death|0|||
130156753|NCT04421586|468534984|FG001|Overall Study|Death|1|||
130156754|NCT04421586|468534983|FG000|Overall Study|Lost to Follow-up|2|||
130156755|NCT04421586|468534984|FG001|Overall Study|Lost to Follow-up|2|||
130156756|NCT04421586|468534983|FG000|Overall Study|Withdrawn by PI|1|||
130156757|NCT04421586|468534984|FG001|Overall Study|Withdrawn by PI|0|||
130156758|NCT04421586|468534983|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
130156759|NCT04421586|468534984|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
130156760|NCT04505293|468534985|FG000|Overall Study|Lost to Follow-up|2|||
130156761|NCT04505293|468534985|FG000|Overall Study|Withdrawal by Subject|6|||
130156762|NCT04505293|468534985|FG000|Overall Study|CT scan unreadable|277|||
130156763|NCT04295135|468534986|FG000|Overall Study|Withdrawal by Subject|2|||
130156764|NCT04295135|468534987|FG001|Overall Study|Withdrawal by Subject|1|||
130156765|NCT04295135|468534986|FG000|Overall Study|Subject left organization|8|||
130156766|NCT04295135|468534987|FG001|Overall Study|Subject left organization|4|||
130156767|NCT03484117|468534989|FG000|Overall Study|Lost to Follow-up|1|||
130156768|NCT03484117|468534990|FG001|Overall Study|Lost to Follow-up|3|||
130156769|NCT03484117|468534989|FG000|Overall Study|Declined participation in exit assess|1|||
130156770|NCT03484117|468534990|FG001|Overall Study|Declined participation in exit assess|1|||
130156771|NCT00289874|468534991|FG000|Overall Study|Adverse Event|1|||
130156772|NCT00289874|468534992|FG001|Overall Study|Adverse Event|5|||
130156773|NCT00289874|468534991|FG000|Overall Study|Lost to Follow-up|1|||
130156774|NCT00289874|468534992|FG001|Overall Study|Lost to Follow-up|1|||
130156775|NCT00289874|468534991|FG000|Overall Study|Protocol Violation|3|||
130156776|NCT00289874|468534992|FG001|Overall Study|Protocol Violation|2|||
130156777|NCT00289874|468534991|FG000|Overall Study|Did not meet eligibility|1|||
130156778|NCT00289874|468534992|FG001|Overall Study|Did not meet eligibility|0|||
130156779|NCT03835325|468534993|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
130156780|NCT03835325|468534993|FG000|Overall Study|Selection failure|1|||
130156781|NCT00775606|468534994|FG000|Overall Study|Study sponsor terminated funding|3|||
130156782|NCT00775606|468534995|FG001|Overall Study|Study sponsor terminated funding|0|||
130156783|NCT03212794|468534996|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
130156784|NCT03212794|468534997|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
130156785|NCT03212794|468534996|FG000|Overall Study|Lost to Follow-up|5|||
130156786|NCT03212794|468534997|FG001|Overall Study|Lost to Follow-up|6|||
130156787|NCT03212794|468534996|FG000|Overall Study|Incarcerated; unable to participate|2|||
130156788|NCT03212794|468534997|FG001|Overall Study|Incarcerated; unable to participate|0|||
130156789|NCT03212794|468534996|FG000|Overall Study|Withdrawal by Subject|1|||
130156790|NCT03212794|468534997|FG001|Overall Study|Withdrawal by Subject|0|||
130156791|NCT03212794|468534996|FG000|Overall Study|Death|0|||
130156792|NCT03212794|468534997|FG001|Overall Study|Death|1|||
130156793|NCT03212794|468534996|FG000|Overall Study|Found to be ineligible after allocation|0|||
130156794|NCT03212794|468534997|FG001|Overall Study|Found to be ineligible after allocation|1|||
130156795|NCT03212794|468534996|FG000|Overall Study|Relocated out of area|2|||
130156796|NCT03212794|468534997|FG001|Overall Study|Relocated out of area|0|||
130156797|NCT00257920|468534999|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
130156798|NCT00257920|468535000|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
130156799|NCT00257920|468534999|FG000|Period: Second Intervention|Other|2|||
130156800|NCT00257920|468535000|FG001|Period: Second Intervention|Other|1|||
130156801|NCT00770692|468535003|FG000|Overall Study|Withdrawal by Subject|7|||
130156802|NCT00770692|468535004|FG001|Overall Study|Withdrawal by Subject|9|||
130156803|NCT00770692|468535005|FG002|Overall Study|Withdrawal by Subject|9|||
130156804|NCT00770692|468535006|FG003|Overall Study|Withdrawal by Subject|6|||
130156805|NCT00770692|468535003|FG000|Overall Study|Adverse Event|3|||
130156806|NCT00770692|468535004|FG001|Overall Study|Adverse Event|0|||
130156807|NCT00770692|468535005|FG002|Overall Study|Adverse Event|4|||
130156808|NCT00770692|468535006|FG003|Overall Study|Adverse Event|4|||
130156809|NCT00770692|468535003|FG000|Overall Study|Investigator judgment|2|||
130156810|NCT00770692|468535004|FG001|Overall Study|Investigator judgment|0|||
130156811|NCT00770692|468535005|FG002|Overall Study|Investigator judgment|1|||
130156812|NCT00770692|468535006|FG003|Overall Study|Investigator judgment|1|||
130156813|NCT00560937|468535008|FG000|Overall Study|Withdrawal by Subject|0|||
130156814|NCT00560937|468535009|FG001|Overall Study|Withdrawal by Subject|1|||
130156815|NCT00560937|468535008|FG000|Overall Study|Physician Decision|1|||
130156816|NCT00560937|468535009|FG001|Overall Study|Physician Decision|1|||
130156817|NCT03629028|468535012|FG000|Overall Study|Lost to Follow-up|26|||
130156818|NCT03629028|468535013|FG001|Overall Study|Lost to Follow-up|23|||
130156819|NCT03629028|468535012|FG000|Overall Study|Pregnancy|4|||
130156820|NCT03629028|468535013|FG001|Overall Study|Pregnancy|2|||
130156821|NCT03629028|468535012|FG000|Overall Study|intolerance to examination|2|||
130156822|NCT03629028|468535013|FG001|Overall Study|intolerance to examination|0|||
130156823|NCT02025751|468535016|FG000|Overall Study|Lost to Follow-up|1|||
130156824|NCT02025751|468535017|FG001|Overall Study|Lost to Follow-up|0|||
130156825|NCT02025751|468535016|FG000|Overall Study|Adverse Event|0|||
130156826|NCT02025751|468535017|FG001|Overall Study|Adverse Event|1|||
130156827|NCT02025751|468535016|FG000|Overall Study|Physician Decision|0|||
130156828|NCT02025751|468535017|FG001|Overall Study|Physician Decision|1|||
130156829|NCT02025751|468535016|FG000|Overall Study|Withdrawal by Subject|0|||
130156830|NCT02025751|468535017|FG001|Overall Study|Withdrawal by Subject|1|||
130156831|NCT01846273|468535018|FG000|Overall Study|Adverse Event|9|||
130156832|NCT01846273|468535019|FG001|Overall Study|Adverse Event|7|||
130156833|NCT01846273|468535020|FG002|Overall Study|Adverse Event|0|||
130156834|NCT01846273|468535018|FG000|Overall Study|Subject withdrew consent|5|||
130156835|NCT01846273|468535019|FG001|Overall Study|Subject withdrew consent|8|||
130156836|NCT01846273|468535020|FG002|Overall Study|Subject withdrew consent|0|||
130156837|NCT01846273|468535018|FG000|Overall Study|Lost to Follow-up|2|||
130156838|NCT01846273|468535019|FG001|Overall Study|Lost to Follow-up|1|||
130156839|NCT01846273|468535020|FG002|Overall Study|Lost to Follow-up|0|||
130156840|NCT01846273|468535018|FG000|Overall Study|Administrative problems|1|||
130156841|NCT01846273|468535019|FG001|Overall Study|Administrative problems|0|||
130156842|NCT01846273|468535020|FG002|Overall Study|Administrative problems|0|||
130156843|NCT01846273|468535018|FG000|Overall Study|Death|2|||
130156844|NCT01846273|468535019|FG001|Overall Study|Death|1|||
130156845|NCT01846273|468535020|FG002|Overall Study|Death|0|||
130156846|NCT01846273|468535018|FG000|Overall Study|Disease Progression|0|||
130156847|NCT01846273|468535019|FG001|Overall Study|Disease Progression|4|||
130156848|NCT01846273|468535020|FG002|Overall Study|Disease Progression|0|||
130156849|NCT01846273|468535018|FG000|Overall Study|Protocol Deviation|2|||
130156850|NCT01846273|468535019|FG001|Overall Study|Protocol Deviation|3|||
130156851|NCT01846273|468535020|FG002|Overall Study|Protocol Deviation|0|||
130156852|NCT01846273|468535018|FG000|Overall Study|Physician Decision|1|||
130156853|NCT01846273|468535019|FG001|Overall Study|Physician Decision|2|||
130156854|NCT01846273|468535020|FG002|Overall Study|Physician Decision|0|||
130156855|NCT00891839|468535021|FG000|Overall Study|Adverse Event|2|||
130156856|NCT00891839|468535021|FG000|Overall Study|Withdrawal by Subject|2|||
130156857|NCT00891839|468535021|FG000|Overall Study|Disease progression|3|||
130156858|NCT05069155|468535022|FG000|Overall Study|Withdrawal by Subject|1|||
130156859|NCT05069155|468535023|FG001|Overall Study|Withdrawal by Subject|3|||
130156860|NCT00712985|468535024|FG000|Overall Study|1 withdrew prior to start of drug|1|||
130156861|NCT00712985|468535024|FG000|Overall Study|1 patient moved out of state|1|||
130156862|NCT00712985|468535024|FG000|Overall Study|Lack of Efficacy|3|||
130156863|NCT02674061|468535025|FG000|Overall Study|Death|229|||
130156864|NCT02674061|468535026|FG001|Overall Study|Death|77|||
130156865|NCT02674061|468535025|FG000|Overall Study|Lost to Follow-up|3|||
130156866|NCT02674061|468535026|FG001|Overall Study|Lost to Follow-up|3|||
130156867|NCT02674061|468535025|FG000|Overall Study|Withdrawal by Subject|9|||
130156868|NCT02674061|468535026|FG001|Overall Study|Withdrawal by Subject|1|||
130156869|NCT02674061|468535025|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
130156870|NCT02674061|468535026|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
130156871|NCT01299805|468535029|FG000|Overall Study|Adverse Event|2|||
130156872|NCT01299805|468535030|FG001|Overall Study|Adverse Event|0|||
130156873|NCT00123955|468535034|FG000|Overall Study|Adverse Event|1|||
130156874|NCT00123955|468535035|FG001|Overall Study|Adverse Event|0|||
130156875|NCT00123955|468535034|FG000|Overall Study|Withdrawal by Subject|4|||
130156876|NCT00123955|468535035|FG001|Overall Study|Withdrawal by Subject|3|||
130156877|NCT00123955|468535034|FG000|Overall Study|Death|0|||
130156878|NCT00123955|468535035|FG001|Overall Study|Death|1|||
130156879|NCT04969861|468535037|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
130156880|NCT04969861|468535038|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
130156881|NCT04556552|468536582|FG000|Overall Study|Lost to Follow-up|1|||
130156882|NCT04556552|468536583|FG001|Overall Study|Lost to Follow-up|0|||
130156883|NCT04556552|468536582|FG000|Overall Study|Claustrophobia|0|||
130156884|NCT04556552|468536583|FG001|Overall Study|Claustrophobia|1|||
130156885|NCT04556552|468536582|FG000|Overall Study|Inability to continue|0|||
130156886|NCT04556552|468536583|FG001|Overall Study|Inability to continue|1|||
130156887|NCT00605865|468536584|FG000|Overall Study|Protocol Violation|115|||
130156888|NCT00793780|468536587|FG000|Overall Study|Withdrawal by Subject|2|||
130156889|NCT00793780|468536588|FG001|Overall Study|Withdrawal by Subject|1|||
130156890|NCT02858492|468536589|FG000|Overall Study|Withdrawal by Subject|0|||
130156891|NCT02858492|468536590|FG001|Overall Study|Withdrawal by Subject|1|||
130156892|NCT02858492|468536591|FG002|Overall Study|Withdrawal by Subject|0|||
130156893|NCT02858492|468536592|FG003|Overall Study|Withdrawal by Subject|1|||
130156894|NCT02858492|468536589|FG000|Overall Study|Adverse Event|0|||
130156895|NCT02858492|468536590|FG001|Overall Study|Adverse Event|0|||
130156896|NCT02858492|468536591|FG002|Overall Study|Adverse Event|0|||
130156897|NCT02858492|468536592|FG003|Overall Study|Adverse Event|3|||
130156898|NCT02858492|468536589|FG000|Overall Study|Lack of Efficacy|0|||
130156899|NCT02858492|468536590|FG001|Overall Study|Lack of Efficacy|0|||
130156900|NCT02858492|468536591|FG002|Overall Study|Lack of Efficacy|0|||
130156901|NCT02858492|468536592|FG003|Overall Study|Lack of Efficacy|1|||
130156902|NCT02858492|468536589|FG000|Overall Study|Protocol defined stopping criteria|0|||
130156903|NCT02858492|468536590|FG001|Overall Study|Protocol defined stopping criteria|0|||
130156904|NCT02858492|468536591|FG002|Overall Study|Protocol defined stopping criteria|0|||
130156905|NCT02858492|468536592|FG003|Overall Study|Protocol defined stopping criteria|1|||
130156906|NCT02119286|468536597|FG000|Overall Study|Adverse Event|9|||
130156907|NCT02119286|468536598|FG001|Overall Study|Adverse Event|7|||
130156908|NCT02119286|468536599|FG002|Overall Study|Adverse Event|2|||
130156909|NCT02119286|468536597|FG000|Overall Study|Lack of Efficacy|11|||
130156910|NCT02119286|468536598|FG001|Overall Study|Lack of Efficacy|3|||
130156911|NCT02119286|468536599|FG002|Overall Study|Lack of Efficacy|4|||
130156912|NCT02119286|468536597|FG000|Overall Study|Lost to Follow-up|2|||
129980635|NCT01214642|467891699|FG003|Overall Study|Progressive Disease|5|||
129980636|NCT01214642|467891700|FG004|Overall Study|Progressive Disease|5|||
129980637|NCT01214642|467891701|FG005|Overall Study|Progressive Disease|3|||
129980638|NCT01214642|467891702|FG006|Overall Study|Progressive Disease|5|||
129980639|NCT01214642|467891703|FG007|Overall Study|Progressive Disease|3|||
129980640|NCT01214642|467891704|FG008|Overall Study|Progressive Disease|10|||
130156913|NCT02119286|468536598|FG001|Overall Study|Lost to Follow-up|0|||
130156914|NCT02119286|468536599|FG002|Overall Study|Lost to Follow-up|1|||
130156915|NCT02119286|468536597|FG000|Overall Study|Withdrawal by Subject|4|||
130156916|NCT02119286|468536598|FG001|Overall Study|Withdrawal by Subject|1|||
130156917|NCT02119286|468536599|FG002|Overall Study|Withdrawal by Subject|0|||
130156918|NCT03310411|468536600|FG000|Period 1|Adverse Event|0|||
130156919|NCT03310411|468536601|FG001|Period 1|Adverse Event|0|||
130156920|NCT03310411|468536602|FG002|Period 1|Adverse Event|0|||
130156921|NCT03310411|468536603|FG003|Period 1|Adverse Event|1|||
130156922|NCT00619112|468536604|FG000|Overall Study|Adverse Event|1|||
130156923|NCT00619112|468536605|FG001|Overall Study|Adverse Event|2|||
130156924|NCT03623386|468536608|FG000|Overall Study|Protocol Violation|3|||
130156925|NCT03623386|468536609|FG001|Overall Study|Protocol Violation|2|||
130156926|NCT03623386|468536610|FG002|Overall Study|Protocol Violation|0|||
130156927|NCT03623386|468536608|FG000|Overall Study|Physician Decision|1|||
130156928|NCT03623386|468536609|FG001|Overall Study|Physician Decision|1|||
130156929|NCT03623386|468536610|FG002|Overall Study|Physician Decision|0|||
130156930|NCT03623386|468536608|FG000|Overall Study|Lost to Follow-up|0|||
130156931|NCT03623386|468536609|FG001|Overall Study|Lost to Follow-up|2|||
130156932|NCT03623386|468536610|FG002|Overall Study|Lost to Follow-up|0|||
130156933|NCT03623386|468536608|FG000|Overall Study|COVID-19|0|||
130156934|NCT03623386|468536609|FG001|Overall Study|COVID-19|1|||
130156935|NCT03623386|468536610|FG002|Overall Study|COVID-19|0|||
130156936|NCT04271735|468536615|FG000|Overall Study|Physician Decision|2|||
130156937|NCT04271735|468536616|FG001|Overall Study|Physician Decision|0|||
130156938|NCT00515541|468536617|FG000|Overall Study|Physician Decision|0|||
130156939|NCT00515541|468536618|FG001|Overall Study|Physician Decision|2|||
130156940|NCT00515541|468536619|FG002|Overall Study|Physician Decision|0|||
130156941|NCT00515541|468536620|FG003|Overall Study|Physician Decision|1|||
130156942|NCT00515541|468536617|FG000|Overall Study|No show for appointments|0|||
130156943|NCT00515541|468536618|FG001|Overall Study|No show for appointments|1|||
130156944|NCT00515541|468536619|FG002|Overall Study|No show for appointments|0|||
130156945|NCT00515541|468536620|FG003|Overall Study|No show for appointments|2|||
130156946|NCT00515541|468536617|FG000|Overall Study|Withdrawal by Subject|0|||
130156947|NCT00515541|468536618|FG001|Overall Study|Withdrawal by Subject|2|||
130156948|NCT00515541|468536619|FG002|Overall Study|Withdrawal by Subject|0|||
130156949|NCT00515541|468536620|FG003|Overall Study|Withdrawal by Subject|2|||
130156950|NCT02040779|468536622|FG000|Overall Study|Adverse Event|1|||
130156951|NCT02040779|468536623|FG001|Overall Study|Adverse Event|0|||
130156952|NCT02040779|468536624|FG002|Overall Study|Adverse Event|0|||
130156953|NCT02040779|468536622|FG000|Overall Study|Withdrawal by Subject|4|||
130156954|NCT02040779|468536623|FG001|Overall Study|Withdrawal by Subject|1|||
130156955|NCT02040779|468536624|FG002|Overall Study|Withdrawal by Subject|3|||
130156956|NCT02040779|468536622|FG000|Overall Study|Non-compliance|0|||
130156957|NCT02040779|468536623|FG001|Overall Study|Non-compliance|1|||
130156958|NCT02040779|468536624|FG002|Overall Study|Non-compliance|0|||
130156959|NCT02040779|468536622|FG000|Overall Study|Protocol Violation|2|||
130156960|NCT02040779|468536623|FG001|Overall Study|Protocol Violation|1|||
130156961|NCT02040779|468536624|FG002|Overall Study|Protocol Violation|0|||
130156962|NCT02040779|468536622|FG000|Overall Study|Lost to Follow-up|1|||
130156963|NCT02040779|468536623|FG001|Overall Study|Lost to Follow-up|2|||
130156964|NCT02040779|468536624|FG002|Overall Study|Lost to Follow-up|1|||
130156965|NCT02040779|468536622|FG000|Overall Study|Lack of Efficacy|4|||
130156966|NCT02040779|468536623|FG001|Overall Study|Lack of Efficacy|2|||
130156967|NCT02040779|468536624|FG002|Overall Study|Lack of Efficacy|0|||
130156968|NCT02132637|468536625|FG000|Study Period 1|Withdrawal by Subject|0|||
130156969|NCT02132637|468536626|FG001|Study Period 1|Withdrawal by Subject|4|||
130156970|NCT02132637|468536625|FG000|Study Period 1|Physician Decision|1|||
130156971|NCT02132637|468536626|FG001|Study Period 1|Physician Decision|0|||
130156972|NCT02132637|468536625|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
130156973|NCT02132637|468536626|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
130156974|NCT02132637|468536625|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
130156975|NCT02132637|468536626|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
130156976|NCT00922272|468536629|FG000|Open-label Phase|Adverse Event|5|||
130156977|NCT00922272|468536630|FG001|Open-label Phase|Adverse Event|0|||
130156978|NCT00922272|468536629|FG000|Open-label Phase|Protocol Violation|1|||
130156979|NCT00922272|468536630|FG001|Open-label Phase|Protocol Violation|0|||
130156980|NCT00922272|468536629|FG000|Open-label Phase|Withdrawal by Subject|11|||
130156981|NCT00922272|468536630|FG001|Open-label Phase|Withdrawal by Subject|0|||
130156982|NCT00922272|468536629|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
130156983|NCT00922272|468536630|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
130156984|NCT00922272|468536629|FG000|Open-label Phase|Withdrawal criteria met|5|||
130156985|NCT00922272|468536630|FG001|Open-label Phase|Withdrawal criteria met|0|||
130156986|NCT00922272|468536629|FG000|Double-blind Phase|Adverse Event|1|||
130156987|NCT00922272|468536630|FG001|Double-blind Phase|Adverse Event|1|||
130156988|NCT00922272|468536629|FG000|Double-blind Phase|Withdrawal by Subject|1|||
130156989|NCT00922272|468536630|FG001|Double-blind Phase|Withdrawal by Subject|1|||
130156990|NCT00922272|468536629|FG000|Double-blind Phase|Lost to Follow-up|2|||
130156991|NCT00922272|468536630|FG001|Double-blind Phase|Lost to Follow-up|1|||
130156992|NCT00922272|468536629|FG000|Double-blind Phase|Withdrawal criteria met|1|||
130156993|NCT00922272|468536630|FG001|Double-blind Phase|Withdrawal criteria met|1|||
130156994|NCT00922272|468536629|FG000|Double-blind Phase|Noncompliance|1|||
130156995|NCT00922272|468536630|FG001|Double-blind Phase|Noncompliance|1|||
130156996|NCT00922272|468536629|FG000|Double-blind Phase|Positive urine drug screen|1|||
130156997|NCT00922272|468536630|FG001|Double-blind Phase|Positive urine drug screen|1|||
130156998|NCT02588950|468536631|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
130156999|NCT02588950|468536632|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
130157000|NCT02588950|468536633|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
130157001|NCT02588950|468536634|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
130157002|NCT02588950|468536631|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
130157003|NCT02588950|468536632|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
130157004|NCT02588950|468536633|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
130157005|NCT02588950|468536634|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
130157006|NCT00652028|468536637|FG000|Overall Study|Adverse Event|1|||
130157007|NCT00652028|468536638|FG001|Overall Study|Adverse Event|0|||
130157008|NCT00652028|468536639|FG002|Overall Study|Adverse Event|0|||
130157009|NCT00652028|468536640|FG003|Overall Study|Adverse Event|0|||
130157010|NCT00652028|468536637|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
130157011|NCT00652028|468536638|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
130157012|NCT00652028|468536639|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
130157013|NCT00652028|468536640|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
130157014|NCT00652028|468536637|FG000|Overall Study|Physician Decision|0|||
130157015|NCT00652028|468536638|FG001|Overall Study|Physician Decision|0|||
130157016|NCT00652028|468536639|FG002|Overall Study|Physician Decision|1|||
130157017|NCT00652028|468536640|FG003|Overall Study|Physician Decision|0|||
130157018|NCT02751359|468536644|FG000|Overall Study|Lost to Follow-up|1|||
130157019|NCT00912093|468536645|FG000|The Controlled Phase|Death|0|||
130157020|NCT00912093|468536646|FG001|The Controlled Phase|Death|1|||
130157021|NCT00912093|468536647|FG002|The Controlled Phase|Death|0|||
130157022|NCT00912093|468536648|FG003|The Controlled Phase|Death|0|||
130157023|NCT00912093|468536649|FG004|The Controlled Phase|Death|0|||
130157024|NCT00912093|468536645|FG000|The Controlled Phase|Medical Condition|0|||
130157025|NCT00912093|468536646|FG001|The Controlled Phase|Medical Condition|1|||
130157026|NCT00912093|468536647|FG002|The Controlled Phase|Medical Condition|0|||
130157027|NCT00912093|468536648|FG003|The Controlled Phase|Medical Condition|0|||
130157028|NCT00912093|468536649|FG004|The Controlled Phase|Medical Condition|0|||
130157029|NCT00912093|468536645|FG000|The Controlled Phase|Lost to Follow-up|0|||
130157030|NCT00912093|468536646|FG001|The Controlled Phase|Lost to Follow-up|0|||
130157031|NCT00912093|468536647|FG002|The Controlled Phase|Lost to Follow-up|0|||
130157032|NCT00912093|468536648|FG003|The Controlled Phase|Lost to Follow-up|0|||
130157033|NCT00912093|468536649|FG004|The Controlled Phase|Lost to Follow-up|1|||
130157034|NCT02400671|468536650|FG000|Overall Study|Death|5|||
130157035|NCT02400671|468536651|FG001|Overall Study|Death|3|||
130157036|NCT02400671|468536652|FG002|Overall Study|Death|4|||
130157037|NCT02400671|468536650|FG000|Overall Study|Lost to Follow-up|20|||
130157038|NCT02400671|468536651|FG001|Overall Study|Lost to Follow-up|27|||
130157039|NCT02400671|468536652|FG002|Overall Study|Lost to Follow-up|24|||
130157040|NCT02400671|468536650|FG000|Overall Study|Withdrawal by Subject|2|||
130157041|NCT02400671|468536651|FG001|Overall Study|Withdrawal by Subject|2|||
130157042|NCT02400671|468536652|FG002|Overall Study|Withdrawal by Subject|0|||
130157043|NCT04397445|468536658|FG000|Overall Study|Withdrawal by Subject|1|||
130157044|NCT04397445|468536659|FG001|Overall Study|Withdrawal by Subject|0|||
130157045|NCT04397445|468536660|FG002|Overall Study|Withdrawal by Subject|0|||
130157046|NCT04397445|468536661|FG003|Overall Study|Withdrawal by Subject|0|||
130157047|NCT03001219|468536666|FG000|Proof of Concept|Study Termination by Sponsor|0|||
130157048|NCT03001219|468536667|FG001|Proof of Concept|Study Termination by Sponsor|1|||
130157049|NCT03001219|468536666|FG000|Proof of Concept|Withdrawal by Subject|0|||
130157050|NCT03001219|468536667|FG001|Proof of Concept|Withdrawal by Subject|4|||
130157051|NCT03001219|468536666|FG000|Proof of Concept|Protocol Deviation|0|||
130157052|NCT03001219|468536667|FG001|Proof of Concept|Protocol Deviation|1|||
130157053|NCT03001219|468536666|FG000|Proof of Concept|Adverse Event|1|||
130157054|NCT03001219|468536667|FG001|Proof of Concept|Adverse Event|1|||
130157055|NCT03001219|468536666|FG000|Proof of Concept|Physician Decision|1|||
130157056|NCT03001219|468536667|FG001|Proof of Concept|Physician Decision|0|||
130157057|NCT03001219|468536666|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
130157058|NCT03001219|468536667|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
130157059|NCT03001219|468536666|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
130157060|NCT03001219|468536667|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
130157061|NCT03001219|468536666|FG000|Extension Period Analysis|Physician Decision|0|||
130157062|NCT03001219|468536667|FG001|Extension Period Analysis|Physician Decision|1|||
130157063|NCT03001219|468536666|FG000|Extension Period Analysis|Adverse Event|1|||
130157064|NCT03001219|468536667|FG001|Extension Period Analysis|Adverse Event|1|||
130157065|NCT03001219|468536666|FG000|Extension Period Analysis|Protocol Deviation|0|||
130157066|NCT03001219|468536667|FG001|Extension Period Analysis|Protocol Deviation|1|||
130157067|NCT03001219|468536666|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
130157068|NCT03001219|468536667|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
130157069|NCT01195103|468536668|FG000|Overall Study|Withdrawal by Subject|1|||
130157070|NCT01195103|468536669|FG001|Overall Study|Withdrawal by Subject|0|||
130157071|NCT01195103|468536670|FG002|Overall Study|Withdrawal by Subject|0|||
130157072|NCT03760250|468536671|FG000|Overall Study|Withdrawal by Subject|1|||
130157073|NCT03760250|468536671|FG000|Overall Study|Physician Decision|1|||
130157074|NCT03733210|468536672|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
130157075|NCT03733210|468536673|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
130157076|NCT02963441|468536674|FG000|Overall Study|Protocol violation or withdrawn|8|||
130157077|NCT02963441|468536674|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
130157078|NCT02963441|468536674|FG000|Overall Study|IDx-DR insufficient quality|33|||
130157079|NCT02669940|468536677|FG000|Overall Study|Failure to return|0|||
130157080|NCT02669940|468536678|FG001|Overall Study|Failure to return|3|||
130157081|NCT02669940|468536677|FG000|Overall Study|Insufficient follow-up data|1|||
130157082|NCT02669940|468536678|FG001|Overall Study|Insufficient follow-up data|0|||
130157083|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Adverse Event|9|||
130157084|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Adverse Event|4|||
130157085|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Adverse Event|5|||
130157086|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Adverse Event|9|||
130157087|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Adverse Event|8|||
130157088|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Adverse Event|0|||
130157089|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Adverse Event|0|||
130157090|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
130157091|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
130157092|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
130157093|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
130157094|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
130157095|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
130157096|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
130157097|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Death|1|||
130157098|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Death|1|||
130157099|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Death|1|||
130157100|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Death|1|||
130157101|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Death|0|||
130157102|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Death|0|||
130157103|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Death|0|||
130157104|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
130157105|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130157106|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130157107|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
130157108|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
130157109|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
130157110|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
130157111|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130157112|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130157113|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
130157114|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130157115|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130157116|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130157117|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
130157118|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
130157119|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
130157120|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
130157121|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
130157122|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
130157123|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
130157124|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
130157125|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Other|2|||
130157126|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Other|9|||
130157127|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Other|9|||
130157128|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Other|3|||
130157129|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Other|2|||
130157130|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Other|0|||
130157131|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Other|0|||
130157132|NCT00361335|468536680|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
130157133|NCT00361335|468536681|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
130157134|NCT00361335|468536682|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
130157135|NCT00361335|468536683|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
130157136|NCT00361335|468536684|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
130157137|NCT00361335|468536685|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
130157138|NCT00361335|468536686|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
130157139|NCT00361335|468536680|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
130157140|NCT00361335|468536681|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
130157141|NCT00361335|468536682|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
130157142|NCT00361335|468536683|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
130157143|NCT00361335|468536684|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
130157144|NCT00361335|468536685|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
130157145|NCT00361335|468536686|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
130157146|NCT00361335|468536680|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130157147|NCT00361335|468536681|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130157148|NCT00361335|468536682|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130157149|NCT00361335|468536683|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130157150|NCT00361335|468536684|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130157151|NCT00361335|468536685|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
130157152|NCT00361335|468536686|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
130157153|NCT00361335|468536680|FG000|SC Period: Week E0 to Week E24|Death|0|||
130157154|NCT00361335|468536681|FG001|SC Period: Week E0 to Week E24|Death|0|||
130157155|NCT00361335|468536682|FG002|SC Period: Week E0 to Week E24|Death|0|||
130157156|NCT00361335|468536683|FG003|SC Period: Week E0 to Week E24|Death|0|||
130157157|NCT00361335|468536684|FG004|SC Period: Week E0 to Week E24|Death|0|||
130157158|NCT00361335|468536685|FG005|SC Period: Week E0 to Week E24|Death|0|||
130157159|NCT00361335|468536686|FG006|SC Period: Week E0 to Week E24|Death|1|||
130157160|NCT00361335|468536680|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130157161|NCT00361335|468536681|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130157162|NCT00361335|468536682|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130157163|NCT00361335|468536683|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
130157164|NCT00361335|468536684|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130157165|NCT00361335|468536685|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130157166|NCT00361335|468536686|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
130157167|NCT00361335|468536680|FG000|SC Period: Week E0 to Week E24|Other|1|||
130157168|NCT00361335|468536681|FG001|SC Period: Week E0 to Week E24|Other|0|||
130157169|NCT00361335|468536682|FG002|SC Period: Week E0 to Week E24|Other|0|||
130157170|NCT00361335|468536683|FG003|SC Period: Week E0 to Week E24|Other|1|||
130157171|NCT00361335|468536684|FG004|SC Period: Week E0 to Week E24|Other|0|||
130157172|NCT00361335|468536685|FG005|SC Period: Week E0 to Week E24|Other|1|||
130157173|NCT00361335|468536686|FG006|SC Period: Week E0 to Week E24|Other|2|||
130157174|NCT00361335|468536680|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130157175|NCT00361335|468536681|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130157176|NCT00361335|468536682|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
130157177|NCT00361335|468536683|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130157178|NCT00361335|468536684|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130157179|NCT00361335|468536685|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
130157180|NCT00361335|468536686|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
130157181|NCT05065983|468536687|FG000|Overall Study|Lost to Follow-up|2|||
130157182|NCT01765582|468536688|FG000|Overall Study|Other|3|||
130157183|NCT01765582|468536689|FG001|Overall Study|Other|6|||
130157184|NCT01765582|468536690|FG002|Overall Study|Other|9|||
130157185|NCT01765582|468536688|FG000|Overall Study|Lost to Follow-up|2|||
130157186|NCT01765582|468536689|FG001|Overall Study|Lost to Follow-up|2|||
130157187|NCT01765582|468536690|FG002|Overall Study|Lost to Follow-up|1|||
130157188|NCT01765582|468536688|FG000|Overall Study|Death|31|||
130157189|NCT01765582|468536689|FG001|Overall Study|Death|36|||
130157190|NCT01765582|468536690|FG002|Overall Study|Death|33|||
130157191|NCT01765582|468536688|FG000|Overall Study|Sponsor Decision|46|||
130157192|NCT01765582|468536689|FG001|Overall Study|Sponsor Decision|42|||
130157193|NCT01765582|468536690|FG002|Overall Study|Sponsor Decision|42|||
130157194|NCT01765582|468536688|FG000|Overall Study|Withdrawal of Consent|11|||
130157195|NCT01765582|468536689|FG001|Overall Study|Withdrawal of Consent|6|||
130157196|NCT01765582|468536690|FG002|Overall Study|Withdrawal of Consent|10|||
130157197|NCT00986180|468536691|FG000|Overall Study|Adverse Event|21|||
130157198|NCT00986180|468536692|FG001|Overall Study|Adverse Event|23|||
130157199|NCT00986180|468536691|FG000|Overall Study|Lack of Efficacy|4|||
129980641|NCT01214642|467891705|FG009|Overall Study|Progressive Disease|2|||
129980642|NCT01214642|467891706|FG010|Overall Study|Progressive Disease|1|||
129980643|NCT01214642|467891707|FG011|Overall Study|Progressive Disease|4|||
129980644|NCT01214642|467891696|FG000|Overall Study|Adverse Event|0|||
129980645|NCT01214642|467891697|FG001|Overall Study|Adverse Event|1|||
129980646|NCT01214642|467891698|FG002|Overall Study|Adverse Event|0|||
129980647|NCT01214642|467891699|FG003|Overall Study|Adverse Event|0|||
129980648|NCT01214642|467891700|FG004|Overall Study|Adverse Event|0|||
129980649|NCT01214642|467891701|FG005|Overall Study|Adverse Event|0|||
129980650|NCT01214642|467891702|FG006|Overall Study|Adverse Event|1|||
129980651|NCT01214642|467891703|FG007|Overall Study|Adverse Event|0|||
129980652|NCT01214642|467891704|FG008|Overall Study|Adverse Event|0|||
129980653|NCT01214642|467891705|FG009|Overall Study|Adverse Event|1|||
129980654|NCT01214642|467891706|FG010|Overall Study|Adverse Event|1|||
129980655|NCT01214642|467891707|FG011|Overall Study|Adverse Event|0|||
129980656|NCT01214642|467891696|FG000|Overall Study|Death|0|||
129980657|NCT01214642|467891697|FG001|Overall Study|Death|0|||
129980658|NCT01214642|467891698|FG002|Overall Study|Death|1|||
129980659|NCT01214642|467891699|FG003|Overall Study|Death|0|||
130157200|NCT00986180|468536692|FG001|Overall Study|Lack of Efficacy|3|||
130157201|NCT00986180|468536691|FG000|Overall Study|Lost to Follow-up|5|||
130157202|NCT00986180|468536692|FG001|Overall Study|Lost to Follow-up|7|||
130157203|NCT00986180|468536691|FG000|Overall Study|Physician Decision|1|||
129980660|NCT01214642|467891700|FG004|Overall Study|Death|0|||
129980661|NCT01214642|467891701|FG005|Overall Study|Death|0|||
130157204|NCT00986180|468536692|FG001|Overall Study|Physician Decision|3|||
130157205|NCT00986180|468536691|FG000|Overall Study|Protocol Violation|2|||
129980662|NCT01214642|467891702|FG006|Overall Study|Death|0|||
129980663|NCT01214642|467891703|FG007|Overall Study|Death|0|||
130157206|NCT00986180|468536692|FG001|Overall Study|Protocol Violation|0|||
129980664|NCT01214642|467891704|FG008|Overall Study|Death|0|||
129980665|NCT01214642|467891705|FG009|Overall Study|Death|0|||
130157207|NCT00986180|468536691|FG000|Overall Study|Withdrawal by Subject|1|||
130157208|NCT00986180|468536692|FG001|Overall Study|Withdrawal by Subject|9|||
130157209|NCT00986180|468536691|FG000|Overall Study|Miscellanies|10|||
130157210|NCT00986180|468536692|FG001|Overall Study|Miscellanies|11|||
130157211|NCT01691820|468536693|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
130157212|NCT01691820|468536694|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
130157213|NCT01691820|468536693|FG000|Overall Study|Migrated/moved from study area|7|||
130157214|NCT01691820|468536694|FG001|Overall Study|Migrated/moved from study area|4|||
130157215|NCT01691820|468536693|FG000|Overall Study|Lost to Follow-up|6|||
130157216|NCT01691820|468536694|FG001|Overall Study|Lost to Follow-up|17|||
130157217|NCT01691820|468536693|FG000|Overall Study|Other (unspecified)|4|||
130157218|NCT01691820|468536694|FG001|Overall Study|Other (unspecified)|1|||
130157219|NCT00076804|468536699|FG000|Overall Study|Death|9|||
130157220|NCT00076804|468536700|FG001|Overall Study|Death|20|||
130157221|NCT00076804|468536699|FG000|Overall Study|Lost to Follow-up|9|||
130157222|NCT00076804|468536700|FG001|Overall Study|Lost to Follow-up|9|||
130157223|NCT00076804|468536699|FG000|Overall Study|Withdrawal by Subject|10|||
130157224|NCT00076804|468536700|FG001|Overall Study|Withdrawal by Subject|8|||
130157225|NCT00076804|468536699|FG000|Overall Study|Early study Closure|32|||
130157226|NCT00076804|468536700|FG001|Overall Study|Early study Closure|32|||
130157227|NCT02408068|468536702|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
130157228|NCT02408068|468536703|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
130157229|NCT02408068|468536704|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
130157230|NCT02408068|468536705|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
130157231|NCT02408068|468536706|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
130157232|NCT02408068|468536707|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
130157233|NCT02303041|468536708|FG000|Overall Study|Adverse Event|1|||
130157234|NCT02303041|468536709|FG001|Overall Study|Adverse Event|2|||
130157235|NCT02458092|468536715|FG000|Overall Study|Withdrawal by Subject|1|||
130157236|NCT02458092|468536716|FG001|Overall Study|Withdrawal by Subject|0|||
130157237|NCT03852459|468536719|FG000|Overall Study|Adverse Event|2|||
130157238|NCT03852459|468536720|FG001|Overall Study|Adverse Event|2|||
130157239|NCT03852459|468536719|FG000|Overall Study|Withdrawal by Subject|1|||
130157240|NCT03852459|468536720|FG001|Overall Study|Withdrawal by Subject|1|||
130157241|NCT03097588|468536721|FG000|Overall Study|Adverse Event|1|||
130157242|NCT02687360|468536722|FG000|Overall Study|Withdrawal by Subject|3|||
130157243|NCT02687360|468536723|FG001|Overall Study|Withdrawal by Subject|0|||
130157244|NCT03828448|468536724|FG000|Overall Study|Sponsor's Discretion|34|||
130157245|NCT02037165|468536725|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130157246|NCT02037165|468536726|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130157247|NCT02037165|468536727|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130157248|NCT02037165|468536728|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
130157249|NCT02037165|468536729|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
130157250|NCT00456495|468536730|FG000|Overall Study|Physician Decision|2|||
130157251|NCT01663727|468536733|FG000|Overall Study|Death|161|||
130157252|NCT01663727|468536734|FG001|Overall Study|Death|155|||
130157253|NCT01663727|468536733|FG000|Overall Study|Lost to Follow-up|10|||
130157254|NCT01663727|468536734|FG001|Overall Study|Lost to Follow-up|8|||
130157255|NCT01663727|468536733|FG000|Overall Study|Withdrawal by Subject|18|||
130157256|NCT01663727|468536734|FG001|Overall Study|Withdrawal by Subject|25|||
130157257|NCT01663727|468536733|FG000|Overall Study|Study Terminated|51|||
130157258|NCT01663727|468536734|FG001|Overall Study|Study Terminated|50|||
130157259|NCT01663727|468536733|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
130157260|NCT01663727|468536734|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
130157261|NCT01663727|468536733|FG000|Overall Study|Withdrawal prior to dosing.|1|||
130157262|NCT01663727|468536734|FG001|Overall Study|Withdrawal prior to dosing.|0|||
130157263|NCT01902628|468536735|FG000|Overall Study|Withdrawal of participant's consent|7|||
130157264|NCT01902628|468536735|FG000|Overall Study|Adverse Event|41|||
130157265|NCT01902628|468536735|FG000|Overall Study|Lost to Follow-up|35|||
130157266|NCT02932228|468536740|FG000|Overall Study|Death|8|||
130157267|NCT02932228|468536741|FG001|Overall Study|Death|23|||
130157268|NCT02932228|468536740|FG000|Overall Study|not eligible upon chart review|2|||
130157269|NCT02932228|468536741|FG001|Overall Study|not eligible upon chart review|5|||
130157270|NCT02522403|468538279|FG000|Overall Study|Lost to Follow-up|2|||
130157271|NCT02522403|468538280|FG001|Overall Study|Lost to Follow-up|2|||
130157272|NCT02522403|468538279|FG000|Overall Study|Withdrawal by Subject|2|||
130157273|NCT02522403|468538280|FG001|Overall Study|Withdrawal by Subject|4|||
130157274|NCT03340064|468538281|FG000|First Period|Adverse Event, non-fatal|2|||
130157275|NCT03340064|468538282|FG001|First Period|Adverse Event, non-fatal|0|||
130157276|NCT03340064|468538281|FG000|First Period|Lack of Efficacy|3|||
130157277|NCT03340064|468538282|FG001|First Period|Lack of Efficacy|0|||
130157278|NCT03340064|468538281|FG000|Second Period|Adverse Event, non-fatal|1|||
130157279|NCT03340064|468538282|FG001|Second Period|Adverse Event, non-fatal|1|||
130157280|NCT03340064|468538281|FG000|Second Period|Lack of Efficacy|11|||
130157281|NCT03340064|468538282|FG001|Second Period|Lack of Efficacy|0|||
130157282|NCT03340064|468538281|FG000|Second Period|Physician Decision|3|||
130157283|NCT03340064|468538282|FG001|Second Period|Physician Decision|0|||
130157284|NCT03340064|468538281|FG000|Second Period|Withdrawal by Subject|2|||
130157285|NCT03340064|468538282|FG001|Second Period|Withdrawal by Subject|1|||
130157286|NCT03340064|468538281|FG000|Second Period|Approved Drug Available For Indication|1|||
130157287|NCT03340064|468538282|FG001|Second Period|Approved Drug Available For Indication|0|||
130157288|NCT03340064|468538281|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
130157289|NCT03340064|468538282|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
130157290|NCT00856973|468538285|FG000|Overall Study|Adverse Event|5|||
130157291|NCT00856973|468538286|FG001|Overall Study|Adverse Event|5|||
130157292|NCT00856973|468538287|FG002|Overall Study|Adverse Event|3|||
130157293|NCT00856973|468538285|FG000|Overall Study|Lost to Follow-up|6|||
130157294|NCT00856973|468538286|FG001|Overall Study|Lost to Follow-up|3|||
130157295|NCT00856973|468538287|FG002|Overall Study|Lost to Follow-up|5|||
130157296|NCT00856973|468538285|FG000|Overall Study|Physician Decision|0|||
130157297|NCT00856973|468538286|FG001|Overall Study|Physician Decision|3|||
130157298|NCT00856973|468538287|FG002|Overall Study|Physician Decision|1|||
130157299|NCT00856973|468538285|FG000|Overall Study|Protocol Violation|1|||
130157300|NCT00856973|468538286|FG001|Overall Study|Protocol Violation|2|||
130157301|NCT00856973|468538287|FG002|Overall Study|Protocol Violation|1|||
130157302|NCT00856973|468538285|FG000|Overall Study|Withdrawal by Subject|13|||
130157303|NCT00856973|468538286|FG001|Overall Study|Withdrawal by Subject|16|||
130157304|NCT00856973|468538287|FG002|Overall Study|Withdrawal by Subject|15|||
130157305|NCT00856973|468538285|FG000|Overall Study|Other|11|||
130157306|NCT00856973|468538286|FG001|Overall Study|Other|12|||
130157307|NCT00856973|468538287|FG002|Overall Study|Other|13|||
130157308|NCT02667288|468538291|FG000|Overall Study|Protocol Violation|5|||
130157309|NCT02667288|468538291|FG000|Overall Study|Lost to Follow-up|3|||
130157310|NCT02667288|468538291|FG000|Overall Study|Withdrawal by Subject|5|||
130157311|NCT03921151|468538292|FG000|Overall Study|Withdrawal by Subject|11|||
130157312|NCT03921151|468538293|FG001|Overall Study|Withdrawal by Subject|16|||
130157313|NCT00616941|468538294|FG000|Overall Study|Progressive Disease|1|||
130157314|NCT00616941|468538295|FG001|Overall Study|Progressive Disease|2|||
130157315|NCT00616941|468538296|FG002|Overall Study|Progressive Disease|1|||
130157316|NCT00616941|468538294|FG000|Overall Study|Adverse Event|0|||
130157317|NCT00616941|468538295|FG001|Overall Study|Adverse Event|1|||
130157318|NCT00616941|468538296|FG002|Overall Study|Adverse Event|1|||
130157319|NCT00616941|468538294|FG000|Overall Study|Subject Non-compliance|0|||
130157320|NCT00616941|468538295|FG001|Overall Study|Subject Non-compliance|0|||
130157321|NCT00616941|468538296|FG002|Overall Study|Subject Non-compliance|1|||
130157322|NCT00616941|468538294|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
130157323|NCT00616941|468538295|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
130157324|NCT00616941|468538296|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
130157325|NCT00616941|468538294|FG000|Overall Study|Vaccination Suspended|0|||
130157326|NCT00616941|468538295|FG001|Overall Study|Vaccination Suspended|0|||
130157327|NCT00616941|468538296|FG002|Overall Study|Vaccination Suspended|3|||
130157328|NCT00354341|468538304|FG000|Overall Study|Adverse Event|1|||
130157329|NCT00354341|468538305|FG001|Overall Study|Adverse Event|0|||
130157330|NCT00354341|468538304|FG000|Overall Study|Death|0|||
130157331|NCT00354341|468538305|FG001|Overall Study|Death|2|||
130157332|NCT00354341|468538304|FG000|Overall Study|Refused treatment|1|||
130157333|NCT00354341|468538305|FG001|Overall Study|Refused treatment|2|||
130157334|NCT00354341|468538304|FG000|Overall Study|Failure to return|0|||
130157335|NCT00354341|468538305|FG001|Overall Study|Failure to return|1|||
130157336|NCT00354341|468538304|FG000|Overall Study|Other|1|||
130157337|NCT00354341|468538305|FG001|Overall Study|Other|2|||
130157338|NCT01732874|468538306|FG000|Overall Study|Withdrawal by Subject|5|||
130157339|NCT01732874|468538307|FG001|Overall Study|Withdrawal by Subject|1|||
130157340|NCT01732874|468538306|FG000|Overall Study|Death of Infant|3|||
129980666|NCT01214642|467891706|FG010|Overall Study|Death|1|||
129980667|NCT01214642|467891707|FG011|Overall Study|Death|0|||
129980668|NCT01214642|467891696|FG000|Overall Study|Withdrawal by Subject|0|||
130157341|NCT01732874|468538307|FG001|Overall Study|Death of Infant|2|||
130157342|NCT00557076|468538308|FG000|Overall Study|Unblinding|0|||
130157343|NCT00557076|468538309|FG001|Overall Study|Unblinding|1|||
129980669|NCT01214642|467891697|FG001|Overall Study|Withdrawal by Subject|0|||
129980670|NCT01214642|467891698|FG002|Overall Study|Withdrawal by Subject|1|||
129980671|NCT01214642|467891699|FG003|Overall Study|Withdrawal by Subject|0|||
130157344|NCT01370213|468538310|FG000|Overall Study|Early Death|1|||
130157345|NCT01370213|468538311|FG001|Overall Study|Early Death|0|||
130157346|NCT01370213|468538312|FG002|Overall Study|Early Death|0|||
130157347|NCT01370213|468538310|FG000|Overall Study|Not evaluable|0|||
130157348|NCT01370213|468538311|FG001|Overall Study|Not evaluable|2|||
130157349|NCT01370213|468538312|FG002|Overall Study|Not evaluable|0|||
130157350|NCT00160641|468538313|FG000|Overall Study|Adverse Event|102|||
130157351|NCT00160641|468538313|FG000|Overall Study|Withdrawal by Subject|87|||
130157352|NCT00160641|468538313|FG000|Overall Study|Lost to Follow-up|8|||
130157353|NCT00160641|468538313|FG000|Overall Study|Lack of Efficacy|12|||
130157354|NCT00160641|468538313|FG000|Overall Study|Protocol Violation|3|||
130157355|NCT00160641|468538313|FG000|Overall Study|Other|9|||
130157356|NCT01782482|468538316|FG000|Overall Study|Adverse Event|2|||
130157357|NCT01782482|468538317|FG001|Overall Study|Adverse Event|1|||
130157358|NCT01782482|468538316|FG000|Overall Study|Lost to Follow-up|2|||
130157359|NCT01782482|468538317|FG001|Overall Study|Lost to Follow-up|3|||
130157360|NCT01782482|468538316|FG000|Overall Study|Physician Decision|1|||
130157361|NCT01782482|468538317|FG001|Overall Study|Physician Decision|0|||
130157362|NCT01782482|468538316|FG000|Overall Study|Protocol Violation|1|||
130157363|NCT01782482|468538317|FG001|Overall Study|Protocol Violation|0|||
130157364|NCT01782482|468538316|FG000|Overall Study|Withdrawal by Subject|2|||
130157365|NCT01782482|468538317|FG001|Overall Study|Withdrawal by Subject|3|||
130157366|NCT01782482|468538316|FG000|Overall Study|Randomized in Error|2|||
130157367|NCT01782482|468538317|FG001|Overall Study|Randomized in Error|2|||
130157368|NCT01782482|468538316|FG000|Overall Study|Habitually wearing toric lens OS|0|||
130157369|NCT01782482|468538317|FG001|Overall Study|Habitually wearing toric lens OS|1|||
130157370|NCT01640873|468538318|FG000|Overall Study|Protocol Violation|2|||
130157371|NCT01640873|468538319|FG001|Overall Study|Protocol Violation|1|||
130157372|NCT01321008|468538320|FG000|Overall Study|Early Study Termination|1|||
130157373|NCT02749292|468538323|FG000|Overall Study|Physician Decision|1|||
130157374|NCT02749292|468538324|FG001|Overall Study|Physician Decision|0|||
130157375|NCT02749292|468538323|FG000|Overall Study|Withdrawal by Subject|5|||
130157376|NCT02749292|468538324|FG001|Overall Study|Withdrawal by Subject|7|||
130157377|NCT02749292|468538323|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
130157378|NCT02749292|468538324|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
130157379|NCT02749292|468538323|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
130157380|NCT02749292|468538324|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
130157381|NCT02749292|468538323|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
130157382|NCT02749292|468538324|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
130157383|NCT02749292|468538323|FG000|Overall Study|Adverse Event|4|||
130157384|NCT02749292|468538324|FG001|Overall Study|Adverse Event|1|||
130157385|NCT02749292|468538323|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
130157386|NCT02749292|468538324|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
130157387|NCT02749292|468538323|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
130157388|NCT02749292|468538324|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
130157389|NCT02749292|468538323|FG000|Overall Study|Requiring glucocorticoids|0|||
130157390|NCT02749292|468538324|FG001|Overall Study|Requiring glucocorticoids|3|||
130157391|NCT02749292|468538323|FG000|Overall Study|Cancer|1|||
130157392|NCT02749292|468538324|FG001|Overall Study|Cancer|0|||
130157393|NCT00251641|468538325|FG000|Overall Study|Adverse Event|80|||
130157394|NCT00251641|468538326|FG001|Overall Study|Adverse Event|8|||
130157395|NCT00251641|468538325|FG000|Overall Study|Lack of Efficacy|2|||
130157396|NCT00251641|468538326|FG001|Overall Study|Lack of Efficacy|1|||
130157397|NCT00251641|468538325|FG000|Overall Study|Progression of Disease|0|||
130157398|NCT00251641|468538326|FG001|Overall Study|Progression of Disease|2|||
130157399|NCT00251641|468538325|FG000|Overall Study|Lost to Follow-up|3|||
130157400|NCT00251641|468538326|FG001|Overall Study|Lost to Follow-up|3|||
130157401|NCT00251641|468538325|FG000|Overall Study|Withdrawal by Subject|6|||
130157402|NCT00251641|468538326|FG001|Overall Study|Withdrawal by Subject|8|||
130157403|NCT00251641|468538325|FG000|Overall Study|Protocol Violation|10|||
130157404|NCT00251641|468538326|FG001|Overall Study|Protocol Violation|2|||
130157405|NCT00251641|468538325|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
130157406|NCT00251641|468538326|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
130157407|NCT00251641|468538325|FG000|Overall Study|Switched Treatment|9|||
130157408|NCT00251641|468538326|FG001|Overall Study|Switched Treatment|63|||
130157409|NCT02093221|468538329|FG000|Overall Study|Adverse Event|1|||
130157410|NCT02093221|468538330|FG001|Overall Study|Adverse Event|0|||
130157411|NCT02093221|468538331|FG002|Overall Study|Adverse Event|0|||
130157412|NCT02093221|468538332|FG003|Overall Study|Adverse Event|0|||
130157413|NCT02093221|468538333|FG004|Overall Study|Adverse Event|0|||
130157414|NCT02093221|468538329|FG000|Overall Study|Withdrawal by Subject|1|||
130157415|NCT02093221|468538330|FG001|Overall Study|Withdrawal by Subject|1|||
130157416|NCT02093221|468538331|FG002|Overall Study|Withdrawal by Subject|4|||
130157417|NCT02093221|468538332|FG003|Overall Study|Withdrawal by Subject|1|||
130157418|NCT02093221|468538333|FG004|Overall Study|Withdrawal by Subject|1|||
130157419|NCT02093221|468538329|FG000|Overall Study|Lost to Follow-up|2|||
130157420|NCT02093221|468538330|FG001|Overall Study|Lost to Follow-up|0|||
129980672|NCT01214642|467891700|FG004|Overall Study|Withdrawal by Subject|0|||
129980673|NCT01214642|467891701|FG005|Overall Study|Withdrawal by Subject|0|||
130157421|NCT02093221|468538331|FG002|Overall Study|Lost to Follow-up|1|||
130157422|NCT02093221|468538332|FG003|Overall Study|Lost to Follow-up|1|||
130157423|NCT02093221|468538333|FG004|Overall Study|Lost to Follow-up|0|||
130157424|NCT02093221|468538329|FG000|Overall Study|Death|0|||
130157425|NCT02093221|468538330|FG001|Overall Study|Death|1|||
130157426|NCT02093221|468538331|FG002|Overall Study|Death|0|||
130157427|NCT02093221|468538332|FG003|Overall Study|Death|0|||
130157428|NCT02093221|468538333|FG004|Overall Study|Death|0|||
130157429|NCT02093221|468538329|FG000|Overall Study|Protocol Violation|0|||
130157430|NCT02093221|468538330|FG001|Overall Study|Protocol Violation|1|||
130157431|NCT02093221|468538331|FG002|Overall Study|Protocol Violation|0|||
130157432|NCT02093221|468538332|FG003|Overall Study|Protocol Violation|0|||
130157433|NCT02093221|468538333|FG004|Overall Study|Protocol Violation|0|||
130157434|NCT02093221|468538329|FG000|Overall Study|Study termination|6|||
130157435|NCT02093221|468538330|FG001|Overall Study|Study termination|5|||
130157436|NCT02093221|468538331|FG002|Overall Study|Study termination|4|||
130157437|NCT02093221|468538332|FG003|Overall Study|Study termination|6|||
130157438|NCT02093221|468538333|FG004|Overall Study|Study termination|7|||
130157439|NCT02989168|468538350|FG000|Overall Study|Withdrawal by Subject|2|||
130157440|NCT02989168|468538351|FG001|Overall Study|Withdrawal by Subject|0|||
130157441|NCT02989168|468538350|FG000|Overall Study|Physician Decision|0|||
130157442|NCT02989168|468538351|FG001|Overall Study|Physician Decision|1|||
130157443|NCT02989168|468538350|FG000|Overall Study|Adverse Event|1|||
130157444|NCT02989168|468538351|FG001|Overall Study|Adverse Event|2|||
130157445|NCT02989168|468538350|FG000|Overall Study|Sponsor stopped study.|1|||
130157446|NCT02989168|468538351|FG001|Overall Study|Sponsor stopped study.|0|||
130157447|NCT03456960|468538352|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130157448|NCT03456960|468538353|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130157449|NCT03456960|468538354|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
130157450|NCT03456960|468538355|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
130157451|NCT03456960|468538356|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130157452|NCT03456960|468538357|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
130157453|NCT03456960|468538352|FG000|Period 2 (1 Day)|Adverse Event|1|||
130157454|NCT03456960|468538353|FG001|Period 2 (1 Day)|Adverse Event|0|||
130157455|NCT03456960|468538354|FG002|Period 2 (1 Day)|Adverse Event|0|||
130157456|NCT03456960|468538355|FG003|Period 2 (1 Day)|Adverse Event|1|||
130157457|NCT03456960|468538356|FG004|Period 2 (1 Day)|Adverse Event|0|||
130157458|NCT03456960|468538357|FG005|Period 2 (1 Day)|Adverse Event|0|||
130157459|NCT00532935|468538358|FG000|Overall Study|Adverse Event|11|||
130157460|NCT00532935|468538359|FG001|Overall Study|Adverse Event|12|||
130157461|NCT00532935|468538358|FG000|Overall Study|Lack of Efficacy|0|||
130157462|NCT00532935|468538359|FG001|Overall Study|Lack of Efficacy|3|||
130157463|NCT00532935|468538358|FG000|Overall Study|Lost to Follow-up|10|||
130157464|NCT00532935|468538359|FG001|Overall Study|Lost to Follow-up|6|||
130157465|NCT00532935|468538358|FG000|Overall Study|Physician Decision|4|||
130157466|NCT00532935|468538359|FG001|Overall Study|Physician Decision|5|||
130157467|NCT00532935|468538358|FG000|Overall Study|Pregnancy|1|||
130157468|NCT00532935|468538359|FG001|Overall Study|Pregnancy|0|||
130157469|NCT00532935|468538358|FG000|Overall Study|Protocol Violation|4|||
130157470|NCT00532935|468538359|FG001|Overall Study|Protocol Violation|2|||
130157471|NCT00532935|468538358|FG000|Overall Study|Withdrawal by Subject|10|||
130157472|NCT00532935|468538359|FG001|Overall Study|Withdrawal by Subject|9|||
130157473|NCT00532935|468538358|FG000|Overall Study|Protocol Specific Criteria|11|||
130157474|NCT00532935|468538359|FG001|Overall Study|Protocol Specific Criteria|15|||
130157475|NCT02192164|468538360|FG000|Overall Study|Other|8|||
130157476|NCT02192164|468538360|FG000|Overall Study|Withdrawal by Subject|1|||
130157477|NCT02192164|468538360|FG000|Overall Study|Physician Decision|4|||
130157478|NCT02192164|468538360|FG000|Overall Study|Did not meet the exclusion criteria|1|||
130157479|NCT01300923|468538361|FG000|Overall Study|Physician Decision|0|||
130157480|NCT01300923|468538362|FG001|Overall Study|Physician Decision|2|||
130157481|NCT01568866|468538363|FG000|Overall Study|Disease Progression|208|||
130157482|NCT01568866|468538364|FG001|Overall Study|Disease Progression|183|||
130157483|NCT01568866|468538363|FG000|Overall Study|Adverse Event|94|||
130157484|NCT01568866|468538364|FG001|Overall Study|Adverse Event|96|||
130157485|NCT01568866|468538363|FG000|Overall Study|Patient Request|55|||
130157486|NCT01568866|468538364|FG001|Overall Study|Patient Request|71|||
130157487|NCT01568866|468538363|FG000|Overall Study|Physician Decision|40|||
130157488|NCT01568866|468538364|FG001|Overall Study|Physician Decision|32|||
130157489|NCT01568866|468538363|FG000|Overall Study|Withdrawal by Subject|19|||
130157490|NCT01568866|468538364|FG001|Overall Study|Withdrawal by Subject|11|||
130157491|NCT01568866|468538363|FG000|Overall Study|Death|10|||
130157492|NCT01568866|468538364|FG001|Overall Study|Death|18|||
130157493|NCT01568866|468538363|FG000|Overall Study|Protocol Non-compliance|2|||
130157494|NCT01568866|468538364|FG001|Overall Study|Protocol Non-compliance|4|||
130157495|NCT01568866|468538363|FG000|Overall Study|Lost to Follow-up|1|||
130157496|NCT01568866|468538364|FG001|Overall Study|Lost to Follow-up|0|||
130157497|NCT01568866|468538363|FG000|Overall Study|Randomized but Not Dosed|9|||
130157498|NCT01568866|468538364|FG001|Overall Study|Randomized but Not Dosed|1|||
130157499|NCT01698775|468538367|FG000|Phase A|Adverse Event|2|||
130157500|NCT01698775|468538368|FG001|Phase A|Adverse Event|1|||
130157501|NCT01698775|468538367|FG000|Phase A|Death|1|||
130157502|NCT01698775|468538368|FG001|Phase A|Death|1|||
130157503|NCT01698775|468538367|FG000|Phase A|Lack of Efficacy|1|||
130157504|NCT01698775|468538368|FG001|Phase A|Lack of Efficacy|0|||
130157505|NCT01698775|468538367|FG000|Phase A|Lost to Follow-up|1|||
130157506|NCT01698775|468538368|FG001|Phase A|Lost to Follow-up|2|||
130157507|NCT01698775|468538367|FG000|Phase A|Protocol Violation|1|||
130157508|NCT01698775|468538368|FG001|Phase A|Protocol Violation|0|||
130157509|NCT01698775|468538367|FG000|Phase A|Withdrawal by Subject|3|||
130157510|NCT01698775|468538368|FG001|Phase A|Withdrawal by Subject|4|||
130157511|NCT01698775|468538367|FG000|Phase A|Kidney [transplant]|0|||
130157512|NCT01698775|468538368|FG001|Phase A|Kidney [transplant]|1|||
130157513|NCT01698775|468538367|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
130157514|NCT01698775|468538368|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
130157515|NCT01698775|468538367|FG000|Phase B|Adverse Event|6|||
130157516|NCT01698775|468538368|FG001|Phase B|Adverse Event|3|||
130157517|NCT01698775|468538367|FG000|Phase B|Death|0|||
130157518|NCT01698775|468538368|FG001|Phase B|Death|1|||
130157519|NCT01698775|468538367|FG000|Phase B|Lack of Efficacy|0|||
130157520|NCT01698775|468538368|FG001|Phase B|Lack of Efficacy|1|||
130157521|NCT01698775|468538367|FG000|Phase B|Lost to Follow-up|0|||
130157522|NCT01698775|468538368|FG001|Phase B|Lost to Follow-up|1|||
130157523|NCT01698775|468538367|FG000|Phase B|Physician Decision|1|||
130157524|NCT01698775|468538368|FG001|Phase B|Physician Decision|1|||
130157525|NCT01698775|468538367|FG000|Phase B|Protocol Violation|1|||
130157526|NCT01698775|468538368|FG001|Phase B|Protocol Violation|1|||
130157527|NCT01698775|468538367|FG000|Phase B|Withdrawal by Subject|6|||
130157528|NCT01698775|468538368|FG001|Phase B|Withdrawal by Subject|2|||
130157529|NCT00359788|468538369|FG000|Overall Study|Adverse Event|11|||
130157530|NCT00359788|468538370|FG001|Overall Study|Adverse Event|10|||
130157531|NCT00359788|468538369|FG000|Overall Study|Lack of Efficacy|1|||
130157532|NCT00359788|468538370|FG001|Overall Study|Lack of Efficacy|2|||
130157533|NCT00359788|468538369|FG000|Overall Study|Lost to Follow-up|3|||
130157534|NCT00359788|468538370|FG001|Overall Study|Lost to Follow-up|2|||
130157535|NCT00359788|468538369|FG000|Overall Study|Withdrawal by Subject|4|||
130157536|NCT00359788|468538370|FG001|Overall Study|Withdrawal by Subject|1|||
130157537|NCT00359788|468538369|FG000|Overall Study|Protocol Violation|4|||
130157538|NCT00359788|468538370|FG001|Overall Study|Protocol Violation|2|||
130157539|NCT01244061|468538371|FG000|Overall Study|Death|1|||
130157540|NCT01244061|468538372|FG001|Overall Study|Death|0|||
130157541|NCT01244061|468538371|FG000|Overall Study|Did not meet entrance criteria|1|||
130157542|NCT01244061|468538372|FG001|Overall Study|Did not meet entrance criteria|0|||
130157543|NCT01244061|468538371|FG000|Overall Study|Lack of Efficacy|1|||
130157544|NCT01244061|468538372|FG001|Overall Study|Lack of Efficacy|3|||
130157545|NCT01244061|468538371|FG000|Overall Study|Lost to Follow-up|34|||
130157546|NCT01244061|468538372|FG001|Overall Study|Lost to Follow-up|30|||
130157547|NCT01244061|468538371|FG000|Overall Study|Withdrawal by Subject|29|||
130157548|NCT01244061|468538372|FG001|Overall Study|Withdrawal by Subject|46|||
130157549|NCT01244061|468538371|FG000|Overall Study|Other|8|||
130157550|NCT01244061|468538372|FG001|Overall Study|Other|19|||
130157551|NCT01244061|468538371|FG000|Overall Study|Protocol Violation|1|||
130157552|NCT01244061|468538372|FG001|Overall Study|Protocol Violation|1|||
130157553|NCT01244061|468538371|FG000|Overall Study|Adverse Event|5|||
130157554|NCT01244061|468538372|FG001|Overall Study|Adverse Event|2|||
130157555|NCT01244061|468538371|FG000|Overall Study|Randomized but not treated|2|||
130157556|NCT01244061|468538372|FG001|Overall Study|Randomized but not treated|2|||
130157557|NCT02143583|468538373|FG000|Overall Study|Withdrawal by Subject|1|||
130157558|NCT02143583|468538374|FG001|Overall Study|Withdrawal by Subject|0|||
130157559|NCT02143583|468538375|FG002|Overall Study|Withdrawal by Subject|1|||
130157560|NCT02143583|468538373|FG000|Overall Study|husband illness|0|||
130157561|NCT02143583|468538374|FG001|Overall Study|husband illness|0|||
130157562|NCT02143583|468538375|FG002|Overall Study|husband illness|1|||
130157563|NCT00673933|468538376|FG000|Overall Study|Withdrawal by Subject|2|||
130157564|NCT00673933|468538376|FG000|Overall Study|Lost to Follow-up|1|||
130157565|NCT04932941|468538379|FG000|Overall Study|Lost to Follow-up|3|||
130157566|NCT04932941|468538380|FG001|Overall Study|Lost to Follow-up|1|||
130157567|NCT04932941|468538379|FG000|Overall Study|Withdrawal by Subject|7|||
130157568|NCT04932941|468538380|FG001|Overall Study|Withdrawal by Subject|4|||
130157569|NCT04932941|468538379|FG000|Overall Study|Other|4|||
130157570|NCT04932941|468538380|FG001|Overall Study|Other|2|||
130157571|NCT01929031|468538381|FG000|Overall Study|Adverse Event|3|||
130157572|NCT01929031|468538382|FG001|Overall Study|Adverse Event|1|||
130157573|NCT01929031|468538383|FG002|Overall Study|Adverse Event|1|||
130157574|NCT01929031|468538384|FG003|Overall Study|Adverse Event|0|||
130157575|NCT01929031|468538385|FG004|Overall Study|Adverse Event|0|||
130157576|NCT01929031|468538386|FG005|Overall Study|Adverse Event|0|||
130157577|NCT01929031|468538381|FG000|Overall Study|Protocol Violation|1|||
130157578|NCT01929031|468538382|FG001|Overall Study|Protocol Violation|0|||
130157579|NCT01929031|468538383|FG002|Overall Study|Protocol Violation|0|||
130157580|NCT01929031|468538384|FG003|Overall Study|Protocol Violation|0|||
129980674|NCT01214642|467891702|FG006|Overall Study|Withdrawal by Subject|0|||
129980675|NCT01214642|467891703|FG007|Overall Study|Withdrawal by Subject|0|||
130157581|NCT01929031|468538385|FG004|Overall Study|Protocol Violation|0|||
130157582|NCT01929031|468538386|FG005|Overall Study|Protocol Violation|1|||
130157583|NCT01929031|468538381|FG000|Overall Study|Reason other than specified above|0|||
130157584|NCT01929031|468538382|FG001|Overall Study|Reason other than specified above|1|||
130157585|NCT01929031|468538383|FG002|Overall Study|Reason other than specified above|0|||
130157586|NCT01929031|468538384|FG003|Overall Study|Reason other than specified above|0|||
130157587|NCT01929031|468538385|FG004|Overall Study|Reason other than specified above|1|||
130157588|NCT01929031|468538386|FG005|Overall Study|Reason other than specified above|0|||
130157589|NCT01366443|468538389|FG000|Overall Study|Lost to Follow-up|2|||
130157590|NCT01366443|468538389|FG000|Overall Study|Under 18 yo|1|||
130157591|NCT05816200|468538390|FG000|Overall Study|Lost to Follow-up|2|||
130157592|NCT05816200|468538391|FG001|Overall Study|Lost to Follow-up|1|||
130157593|NCT02394730|468538397|FG000|Overall Study|Lost to Follow-up|1|||
130157594|NCT02394730|468538398|FG001|Overall Study|Lost to Follow-up|0|||
130157595|NCT02394730|468538397|FG000|Overall Study|Withdrawal by Subject|0|||
130157596|NCT02394730|468538398|FG001|Overall Study|Withdrawal by Subject|1|||
130157597|NCT00369382|468538399|FG000|Overall Study|Death|0|||
130157598|NCT00369382|468538400|FG001|Overall Study|Death|2|||
130157599|NCT00369382|468538399|FG000|Overall Study|Physician Decision|2|||
130157600|NCT00369382|468538400|FG001|Overall Study|Physician Decision|1|||
130157601|NCT00369382|468538399|FG000|Overall Study|Withdrawal by Subject|5|||
130157602|NCT00369382|468538400|FG001|Overall Study|Withdrawal by Subject|0|||
130157603|NCT00369382|468538399|FG000|Overall Study|Randomized, not treated|2|||
130157604|NCT00369382|468538400|FG001|Overall Study|Randomized, not treated|0|||
130157605|NCT00369382|468538399|FG000|Overall Study|Other|1|||
130157606|NCT00369382|468538400|FG001|Overall Study|Other|0|||
130157607|NCT01673698|468538404|FG000|Overall Study|Lost to Follow-up|51|||
130157608|NCT01673698|468538405|FG001|Overall Study|Lost to Follow-up|13|||
130157609|NCT02384850|468538406|FG000|Overall Study|Withdrawal by Subject|2|||
130157610|NCT02384850|468538407|FG001|Overall Study|Withdrawal by Subject|2|||
130157611|NCT00507546|468538408|FG000|Overall Study|Withdrawal by Subject|1|||
130157612|NCT00507546|468538409|FG001|Overall Study|Withdrawal by Subject|0|||
130157613|NCT00507546|468538408|FG000|Overall Study|Protocol Violation|1|||
130157614|NCT00507546|468538409|FG001|Overall Study|Protocol Violation|0|||
130157615|NCT00507546|468538408|FG000|Overall Study|Physician Decision|0|||
130157616|NCT00507546|468538409|FG001|Overall Study|Physician Decision|1|||
130157617|NCT00448136|468538410|FG000|Overall Study|Death|3|||
130157618|NCT00448136|468538411|FG001|Overall Study|Death|8|||
130157619|NCT00448136|468538410|FG000|Overall Study|Investigator's decision (progression)|1|||
130157620|NCT00448136|468538411|FG001|Overall Study|Investigator's decision (progression)|0|||
130157621|NCT02013375|468538412|FG000|Overall Study|Did not engraft|1|||
130157622|NCT02013375|468538412|FG000|Overall Study|Did not engraft|1|||
130157623|NCT03510182|468538415|FG000|Overall Study|Withdrawal by Subject|2|||
130157624|NCT01334710|468538422|FG000|Overall Study|Trial was terminated|3|||
130157625|NCT01558297|468538423|FG000|Overall Study|Withdrawal by Subject|2|||
130157626|NCT01558297|468538424|FG001|Overall Study|Withdrawal by Subject|2|||
130157627|NCT01558297|468538425|FG002|Overall Study|Withdrawal by Subject|1|||
130157628|NCT00375492|468538426|FG000|Overall Study|Adverse Event|4|||
130157629|NCT00375492|468538427|FG001|Overall Study|Adverse Event|5|||
130157630|NCT00375492|468538426|FG000|Overall Study|Entry Criteria Not Met|0|||
130157631|NCT00375492|468538427|FG001|Overall Study|Entry Criteria Not Met|1|||
130157632|NCT00375492|468538426|FG000|Overall Study|Loss of Glucose Control|0|||
130157633|NCT00375492|468538427|FG001|Overall Study|Loss of Glucose Control|1|||
130157634|NCT00375492|468538426|FG000|Overall Study|Lost to Follow-up|10|||
130157635|NCT00375492|468538427|FG001|Overall Study|Lost to Follow-up|5|||
130157636|NCT00375492|468538426|FG000|Overall Study|Physician Decision|0|||
130157637|NCT00375492|468538427|FG001|Overall Study|Physician Decision|4|||
130157638|NCT00375492|468538426|FG000|Overall Study|Protocol Violation|6|||
130157639|NCT00375492|468538427|FG001|Overall Study|Protocol Violation|3|||
130157640|NCT00375492|468538426|FG000|Overall Study|Sponsor Decision|0|||
130157641|NCT00375492|468538427|FG001|Overall Study|Sponsor Decision|1|||
130157642|NCT00375492|468538426|FG000|Overall Study|Withdrawal by Subject|6|||
130157643|NCT00375492|468538427|FG001|Overall Study|Withdrawal by Subject|6|||
130157644|NCT01232491|468538428|FG000|Overall Study|Adverse Event|13|||
130157645|NCT01232491|468538429|FG001|Overall Study|Adverse Event|8|||
130157646|NCT01232491|468538428|FG000|Overall Study|Lack of Efficacy|1|||
130157647|NCT01232491|468538429|FG001|Overall Study|Lack of Efficacy|5|||
130157648|NCT01232491|468538428|FG000|Overall Study|Protocol Violation|13|||
130157649|NCT01232491|468538429|FG001|Overall Study|Protocol Violation|11|||
130157650|NCT01232491|468538428|FG000|Overall Study|Withdrawal Criteria|12|||
130157651|NCT01232491|468538429|FG001|Overall Study|Withdrawal Criteria|21|||
130157652|NCT01232491|468538428|FG000|Overall Study|Other|21|||
130157653|NCT01232491|468538429|FG001|Overall Study|Other|18|||
130157654|NCT04905290|468539857|FG000|Overall Study|Adverse Event|4|||
130157655|NCT04905290|468539857|FG000|Overall Study|Death|2|||
130157656|NCT04905290|468539857|FG000|Overall Study|Withdrawal by Subject|4|||
130157657|NCT04905290|468539857|FG000|Overall Study|Physician Decision|2|||
130157658|NCT04905290|468539857|FG000|Overall Study|Lost to Follow-up|2|||
130157659|NCT04905290|468539857|FG000|Overall Study|Screen Failure|2|||
130157660|NCT04905290|468539857|FG000|Overall Study|Unsuccessful Procedure|2|||
130157661|NCT06204887|468539858|FG000|Overall Study|Lost to Follow-up|3|||
130157662|NCT06204887|468539859|FG001|Overall Study|Lost to Follow-up|4|||
130157663|NCT06204887|468539860|FG002|Overall Study|Lost to Follow-up|1|||
130157664|NCT06204887|468539861|FG003|Overall Study|Lost to Follow-up|6|||
130157665|NCT00821873|468539862|FG000|Overall Study|Lost to Follow-up|4|||
130157666|NCT01995266|468539865|FG000|Overall Study|Death|1|||
130157667|NCT01995266|468539865|FG000|Overall Study|Lack of Efficacy|6|||
130157668|NCT01995266|468539865|FG000|Overall Study|Adverse Event|2|||
130157669|NCT03596151|468539866|FG000|Overall Study|Withdrawal by Subject|1|||
130157670|NCT00729248|468539868|FG000|Overall Study|Physician Decision|2|||
130157671|NCT04280705|468539873|FG000|Overall Study|Enrolled but not treated|4|||
130157672|NCT04280705|468539874|FG001|Overall Study|Enrolled but not treated|10|||
130157673|NCT04280705|468539873|FG000|Overall Study|Physician Decision|1|||
130157674|NCT04280705|468539874|FG001|Overall Study|Physician Decision|0|||
130157675|NCT04280705|468539873|FG000|Overall Study|Withdrawal by Subject|7|||
130157676|NCT04280705|468539874|FG001|Overall Study|Withdrawal by Subject|9|||
130157677|NCT04280705|468539873|FG000|Overall Study|Adverse Event|0|||
130157678|NCT04280705|468539874|FG001|Overall Study|Adverse Event|4|||
130157679|NCT04280705|468539873|FG000|Overall Study|Transferred to another hospital|1|||
130157680|NCT04280705|468539874|FG001|Overall Study|Transferred to another hospital|1|||
130157681|NCT03222583|468539875|FG000|Overall Study|Withdrawal by Subject|3|||
130157682|NCT03222583|468539876|FG001|Overall Study|Withdrawal by Subject|3|||
130157683|NCT03222583|468539875|FG000|Overall Study|Lost to Follow-up|1|||
130157684|NCT03222583|468539876|FG001|Overall Study|Lost to Follow-up|0|||
130157685|NCT03222583|468539875|FG000|Overall Study|Other|1|||
130157686|NCT03222583|468539876|FG001|Overall Study|Other|3|||
130157687|NCT03573505|468539877|FG000|Overall Study|Adverse Event|1|||
130157688|NCT03573505|468539878|FG001|Overall Study|Adverse Event|1|||
130157689|NCT03573505|468539877|FG000|Overall Study|Consent withdrawn|0|||
130157690|NCT03573505|468539878|FG001|Overall Study|Consent withdrawn|1|||
130157691|NCT03573505|468539877|FG000|Overall Study|Disease progression|0|||
130157692|NCT03573505|468539878|FG001|Overall Study|Disease progression|1|||
130157693|NCT03573505|468539877|FG000|Overall Study|Site Terminated by Sponsor|1|||
130157694|NCT03573505|468539878|FG001|Overall Study|Site Terminated by Sponsor|1|||
130157695|NCT03573505|468539877|FG000|Overall Study|Study terminated by sponsor|50|||
130157696|NCT03573505|468539878|FG001|Overall Study|Study terminated by sponsor|45|||
130157697|NCT03573505|468539877|FG000|Overall Study|Reason not specified|0|||
130157698|NCT03573505|468539878|FG001|Overall Study|Reason not specified|1|||
130157699|NCT03573505|468539877|FG000|Overall Study|Death|0|||
130157700|NCT03573505|468539878|FG001|Overall Study|Death|4|||
130157701|NCT04268316|468539881|FG000|Overall Study|Withdrawal by Subject|2|||
130157702|NCT04268316|468539882|FG001|Overall Study|Withdrawal by Subject|1|||
130157703|NCT04268316|468539883|FG002|Overall Study|Withdrawal by Subject|0|||
130157704|NCT03188718|468539890|FG000|Overall Study|Participant noncompliance|4|||
130157705|NCT03188718|468539890|FG000|Overall Study|Withdrawal by Subject|1|||
130157706|NCT03188718|468539890|FG000|Overall Study|Device failure|3|||
130157707|NCT04032158|468539891|FG000|Overall Study|Study Termination|2|||
130157708|NCT04032158|468539892|FG001|Overall Study|Study Termination|1|||
130157709|NCT02072824|468539893|FG000|Overall Study|Insufficient clinical response|1|||
130157710|NCT02072824|468539894|FG001|Overall Study|Insufficient clinical response|0|||
130157711|NCT02072824|468539895|FG002|Overall Study|Insufficient clinical response|1|||
130157712|NCT02072824|468539893|FG000|Overall Study|No longer willing to participate|1|||
130157713|NCT02072824|468539894|FG001|Overall Study|No longer willing to participate|0|||
130157714|NCT02072824|468539895|FG002|Overall Study|No longer willing to participate|1|||
130157715|NCT02072824|468539893|FG000|Overall Study|Medication error|0|||
130157716|NCT02072824|468539894|FG001|Overall Study|Medication error|1|||
130157717|NCT02072824|468539895|FG002|Overall Study|Medication error|0|||
130157718|NCT02072824|468539893|FG000|Overall Study|Adverse Event|0|||
130157719|NCT02072824|468539894|FG001|Overall Study|Adverse Event|0|||
130157720|NCT02072824|468539895|FG002|Overall Study|Adverse Event|1|||
130157721|NCT03084367|468539896|FG000|Overall Study|Lost to Follow-up|32|||
130157722|NCT03084367|468539896|FG000|Overall Study|Withdrawal by Subject|4|||
130157723|NCT03084367|468539896|FG000|Overall Study|Other|1|||
130157724|NCT00841906|468539897|FG000|Overall Study|Withdrawal by Subject|2|||
130157725|NCT00841906|468539898|FG001|Overall Study|Withdrawal by Subject|0|||
130157726|NCT01196078|468539901|FG000|Overall Study|Withdrawal by Subject|3|||
130157727|NCT01196078|468539902|FG001|Overall Study|Withdrawal by Subject|5|||
130157728|NCT01196078|468539901|FG000|Overall Study|Adverse Event|4|||
130157729|NCT01196078|468539902|FG001|Overall Study|Adverse Event|4|||
130157730|NCT01196078|468539901|FG000|Overall Study|Protocol Violation|2|||
130157731|NCT01196078|468539902|FG001|Overall Study|Protocol Violation|1|||
130157732|NCT01196078|468539901|FG000|Overall Study|Lack of Efficacy|17|||
130157733|NCT01196078|468539902|FG001|Overall Study|Lack of Efficacy|23|||
130157734|NCT01196078|468539901|FG000|Overall Study|Lost to Follow-up|1|||
130157735|NCT01196078|468539902|FG001|Overall Study|Lost to Follow-up|0|||
130157736|NCT01196078|468539901|FG000|Overall Study|Death|6|||
130157737|NCT01196078|468539902|FG001|Overall Study|Death|4|||
130157738|NCT00127036|468539903|FG000|Overall Study|Insufficient Data for Analysis|6|||
130157739|NCT00127036|468539904|FG001|Overall Study|Insufficient Data for Analysis|11|||
130157740|NCT00127036|468539903|FG000|Overall Study|Screen Failure|2|||
130157741|NCT00127036|468539904|FG001|Overall Study|Screen Failure|0|||
130157742|NCT00270257|468539911|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
130157743|NCT00270257|468539912|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
130157744|NCT01403064|468539913|FG000|Overall Study|Death|0|||
130157745|NCT01403064|468539914|FG001|Overall Study|Death|0|||
130157746|NCT01403064|468539915|FG002|Overall Study|Death|1|||
130157747|NCT01403064|468539916|FG003|Overall Study|Death|1|||
130157748|NCT01403064|468539913|FG000|Overall Study|Withdrawal by Subject|0|||
130157749|NCT01403064|468539914|FG001|Overall Study|Withdrawal by Subject|0|||
130157750|NCT01403064|468539915|FG002|Overall Study|Withdrawal by Subject|1|||
130157751|NCT01403064|468539916|FG003|Overall Study|Withdrawal by Subject|1|||
130157752|NCT01403064|468539913|FG000|Overall Study|Other|1|||
130157753|NCT01403064|468539914|FG001|Overall Study|Other|0|||
130157754|NCT01403064|468539915|FG002|Overall Study|Other|2|||
130157755|NCT01403064|468539916|FG003|Overall Study|Other|1|||
130157756|NCT02621034|468539917|FG000|Overall Study|Lost to Follow-up|3|||
130157757|NCT02621034|468539918|FG001|Overall Study|Lost to Follow-up|2|||
130157758|NCT02621034|468539919|FG002|Overall Study|Lost to Follow-up|5|||
130157759|NCT04688931|468539925|FG000|Overall Study|Adverse Event|4|||
130157760|NCT04688931|468539926|FG001|Overall Study|Adverse Event|1|||
130157761|NCT04688931|468539925|FG000|Overall Study|Withdrawal by Subject|5|||
130157762|NCT04688931|468539926|FG001|Overall Study|Withdrawal by Subject|16|||
130157763|NCT04688931|468539925|FG000|Overall Study|Physician Decision|3|||
130157764|NCT04688931|468539926|FG001|Overall Study|Physician Decision|5|||
130157765|NCT04688931|468539925|FG000|Overall Study|Noncompliance|0|||
130157766|NCT04688931|468539926|FG001|Overall Study|Noncompliance|1|||
130157767|NCT04688931|468539925|FG000|Overall Study|Lost to Follow-up|1|||
130157768|NCT04688931|468539926|FG001|Overall Study|Lost to Follow-up|3|||
130157769|NCT04688931|468539925|FG000|Overall Study|Randomization Error|3|||
130157770|NCT04688931|468539926|FG001|Overall Study|Randomization Error|0|||
130157771|NCT04688931|468539925|FG000|Overall Study|Not Eligible|1|||
130157772|NCT04688931|468539926|FG001|Overall Study|Not Eligible|3|||
130157773|NCT04688931|468539925|FG000|Overall Study|Disease Progression|0|||
130157774|NCT04688931|468539926|FG001|Overall Study|Disease Progression|2|||
130157775|NCT04688931|468539925|FG000|Overall Study|Sponsor Requirement|1|||
130157776|NCT04688931|468539926|FG001|Overall Study|Sponsor Requirement|1|||
130157777|NCT04688931|468539925|FG000|Overall Study|Other Reason|1|||
130157778|NCT04688931|468539926|FG001|Overall Study|Other Reason|2|||
130157779|NCT00450619|468539927|FG000|Overall Study|refused treatment after randomization|2|||
130157780|NCT00450619|468539928|FG001|Overall Study|refused treatment after randomization|0|||
130157781|NCT00450619|468539927|FG000|Overall Study|did not progress; refused further trmt|1|||
130157782|NCT00450619|468539928|FG001|Overall Study|did not progress; refused further trmt|1|||
130157783|NCT00450619|468539927|FG000|Overall Study|Adverse Event|1|||
130157784|NCT00450619|468539928|FG001|Overall Study|Adverse Event|0|||
130157785|NCT02372071|468539940|FG000|Overall Study|Protocol Violation|18|||
130157786|NCT00714493|468539941|FG000|Overall Study|Adverse Event|11|||
130157787|NCT00714493|468539941|FG000|Overall Study|Death|3|||
130157788|NCT00714493|468539941|FG000|Overall Study|Lack of Efficacy|10|||
130157789|NCT00714493|468539941|FG000|Overall Study|Lost to Follow-up|3|||
130157790|NCT00714493|468539941|FG000|Overall Study|Protocol Violation|12|||
130157791|NCT00714493|468539941|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
130157792|NCT00714493|468539941|FG000|Overall Study|OTHER|2|||
130157793|NCT00506129|468539942|FG000|Overall Study|Disease Progression/Relapse|15|||
130157794|NCT00506129|468539942|FG000|Overall Study|Death|7|||
130157795|NCT01968694|468539943|FG000|Washout (1 Month)|Lost to Follow-up|0|||
130157796|NCT01968694|468539944|FG001|Washout (1 Month)|Lost to Follow-up|1|||
130157797|NCT00251719|468539945|FG000|Overall Study|Adverse Event|14|||
130157798|NCT00251719|468539946|FG001|Overall Study|Adverse Event|8|||
130157799|NCT00251719|468539947|FG002|Overall Study|Adverse Event|7|||
130157800|NCT00251719|468539945|FG000|Overall Study|Protocol Violation|1|||
130157801|NCT00251719|468539946|FG001|Overall Study|Protocol Violation|1|||
130157802|NCT00251719|468539947|FG002|Overall Study|Protocol Violation|1|||
130157803|NCT00251719|468539945|FG000|Overall Study|Lost to Follow-up|5|||
130157804|NCT00251719|468539946|FG001|Overall Study|Lost to Follow-up|11|||
130157805|NCT00251719|468539947|FG002|Overall Study|Lost to Follow-up|8|||
130157806|NCT00251719|468539945|FG000|Overall Study|Withdrawal by Subject|14|||
130157807|NCT00251719|468539946|FG001|Overall Study|Withdrawal by Subject|12|||
130157808|NCT00251719|468539947|FG002|Overall Study|Withdrawal by Subject|11|||
129980676|NCT01214642|467891704|FG008|Overall Study|Withdrawal by Subject|3|||
130157809|NCT00251719|468539945|FG000|Overall Study|Lack of Efficacy|2|||
130157810|NCT00251719|468539946|FG001|Overall Study|Lack of Efficacy|1|||
130157811|NCT00251719|468539947|FG002|Overall Study|Lack of Efficacy|0|||
130157812|NCT00251719|468539945|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
130157813|NCT00251719|468539946|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
130157814|NCT00251719|468539947|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
130157815|NCT00251719|468539945|FG000|Overall Study|Investigator decision|1|||
130157816|NCT00251719|468539946|FG001|Overall Study|Investigator decision|1|||
129980677|NCT01214642|467891705|FG009|Overall Study|Withdrawal by Subject|1|||
130157817|NCT00251719|468539947|FG002|Overall Study|Investigator decision|0|||
130157818|NCT00251719|468539945|FG000|Overall Study|Noncompliance|2|||
130157819|NCT00251719|468539946|FG001|Overall Study|Noncompliance|3|||
130157820|NCT00251719|468539947|FG002|Overall Study|Noncompliance|1|||
129980678|NCT01214642|467891706|FG010|Overall Study|Withdrawal by Subject|1|||
130157821|NCT00251719|468539945|FG000|Overall Study|Barrett's esophagus|2|||
130157822|NCT00251719|468539946|FG001|Overall Study|Barrett's esophagus|2|||
130157823|NCT00251719|468539947|FG002|Overall Study|Barrett's esophagus|0|||
130157824|NCT00688376|468539952|FG000|Double-Blind Phase|Adverse Event|4|||
130157825|NCT00688376|468539953|FG001|Double-Blind Phase|Adverse Event|4|||
130157826|NCT00688376|468539952|FG000|Double-Blind Phase|Protocol Violation|1|||
130157827|NCT00688376|468539953|FG001|Double-Blind Phase|Protocol Violation|2|||
129980679|NCT01214642|467891707|FG011|Overall Study|Withdrawal by Subject|0|||
129980680|NCT01214642|467891696|FG000|Overall Study|Physician Decision|0|||
130157828|NCT00688376|468539952|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
130157829|NCT00688376|468539953|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
130157830|NCT00688376|468539952|FG000|Double-Blind Phase|Not treated|0|||
130157831|NCT00688376|468539953|FG001|Double-Blind Phase|Not treated|1|||
130157832|NCT00688376|468539952|FG000|Blinded Extension Phase|Adverse Event|3|||
129980681|NCT01214642|467891697|FG001|Overall Study|Physician Decision|0|||
129980682|NCT01214642|467891698|FG002|Overall Study|Physician Decision|1|||
129980683|NCT01214642|467891699|FG003|Overall Study|Physician Decision|1|||
129980684|NCT01214642|467891700|FG004|Overall Study|Physician Decision|1|||
129980685|NCT01214642|467891701|FG005|Overall Study|Physician Decision|0|||
130157833|NCT00688376|468539953|FG001|Blinded Extension Phase|Adverse Event|4|||
130157834|NCT00688376|468539952|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
130157835|NCT00688376|468539953|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
130157836|NCT00688376|468539952|FG000|Blinded Extension Phase|Physician Decision|1|||
130157837|NCT00688376|468539953|FG001|Blinded Extension Phase|Physician Decision|0|||
130157838|NCT00688376|468539952|FG000|Blinded Extension Phase|Other|1|||
130157839|NCT00688376|468539953|FG001|Blinded Extension Phase|Other|0|||
130157840|NCT04392583|468539954|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
130157841|NCT01070771|468539958|FG000|Overall Study|Adverse Event|2|||
130157842|NCT01070771|468539958|FG000|Overall Study|Protocol Violation|1|||
130157843|NCT00857259|468539961|FG000|Overall Study|Protocol Violation|1|||
130157844|NCT00857259|468539962|FG001|Overall Study|Protocol Violation|0|||
130157845|NCT00857259|468539963|FG002|Overall Study|Protocol Violation|1|||
130157846|NCT02701413|468539964|FG000|Overall Study|Withdrawal by Subject|7|||
130157847|NCT02701413|468539965|FG001|Overall Study|Withdrawal by Subject|11|||
130157848|NCT01621191|468539968|FG000|Overall Study|Adverse Event|9|||
130157849|NCT01621191|468539968|FG000|Overall Study|Withdrawal by Subject|8|||
130157850|NCT01621191|468539968|FG000|Overall Study|Lack of Efficacy|6|||
130157851|NCT01621191|468539968|FG000|Overall Study|Lost to Follow-up|1|||
130157852|NCT01621191|468539968|FG000|Overall Study|Site Removed From Study|1|||
130157853|NCT00706381|468539969|FG000|Overall Study|Lost to Follow-up|0|||
130157854|NCT00706381|468539970|FG001|Overall Study|Lost to Follow-up|1|||
130157855|NCT00706381|468539971|FG002|Overall Study|Lost to Follow-up|1|||
130157856|NCT00706381|468539972|FG003|Overall Study|Lost to Follow-up|0|||
130157857|NCT00038649|468539979|FG000|Overall Study|Adverse Event|9|||
130157858|NCT00995085|468539980|FG000|Overall Study|Withdrawal by Subject|5|||
130157859|NCT03096847|468539986|FG000|Overall Study|Other|2|||
130157860|NCT03096847|468539987|FG001|Overall Study|Other|1|||
130157861|NCT03096847|468539988|FG002|Overall Study|Other|2|||
130157862|NCT03096847|468539986|FG000|Overall Study|Lost to Follow-up|1|||
130157863|NCT03096847|468539987|FG001|Overall Study|Lost to Follow-up|0|||
130157864|NCT03096847|468539988|FG002|Overall Study|Lost to Follow-up|1|||
130157865|NCT03096847|468539986|FG000|Overall Study|Death|6|||
130157866|NCT03096847|468539987|FG001|Overall Study|Death|0|||
130157867|NCT03096847|468539988|FG002|Overall Study|Death|2|||
130157868|NCT03096847|468539986|FG000|Overall Study|Protocol Violation|3|||
130157869|NCT03096847|468539987|FG001|Overall Study|Protocol Violation|0|||
130157870|NCT03096847|468539988|FG002|Overall Study|Protocol Violation|6|||
130157871|NCT03096847|468539986|FG000|Overall Study|Physician Decision|12|||
130157872|NCT03096847|468539987|FG001|Overall Study|Physician Decision|2|||
130157873|NCT03096847|468539988|FG002|Overall Study|Physician Decision|8|||
130157874|NCT03096847|468539986|FG000|Overall Study|Withdrawal by Subject|24|||
129980686|NCT01214642|467891702|FG006|Overall Study|Physician Decision|0|||
129980687|NCT01214642|467891703|FG007|Overall Study|Physician Decision|0|||
130157875|NCT03096847|468539987|FG001|Overall Study|Withdrawal by Subject|1|||
130157876|NCT03096847|468539988|FG002|Overall Study|Withdrawal by Subject|12|||
130157877|NCT03096847|468539986|FG000|Overall Study|Adverse Event|72|||
130157878|NCT03096847|468539987|FG001|Overall Study|Adverse Event|6|||
130157879|NCT03096847|468539988|FG002|Overall Study|Adverse Event|28|||
130157880|NCT03096847|468539986|FG000|Overall Study|Progressive disease|97|||
130157881|NCT03096847|468539987|FG001|Overall Study|Progressive disease|10|||
130157882|NCT03096847|468539988|FG002|Overall Study|Progressive disease|78|||
130157883|NCT03096847|468539986|FG000|Overall Study|Non-compliance with study medication|1|||
130157884|NCT03096847|468539987|FG001|Overall Study|Non-compliance with study medication|0|||
130157885|NCT03096847|468539988|FG002|Overall Study|Non-compliance with study medication|0|||
130157886|NCT03096847|468539986|FG000|Overall Study|New therapy for study indication|1|||
130157887|NCT03096847|468539987|FG001|Overall Study|New therapy for study indication|0|||
130157888|NCT03096847|468539988|FG002|Overall Study|New therapy for study indication|1|||
129980688|NCT01214642|467891704|FG008|Overall Study|Physician Decision|0|||
130157889|NCT00062751|468539989|FG000|Overall Study|Disease progression|24|||
130157890|NCT00062751|468539990|FG001|Overall Study|Disease progression|17|||
130157891|NCT00062751|468539991|FG002|Overall Study|Disease progression|24|||
130157892|NCT00062751|468539992|FG003|Overall Study|Disease progression|2|||
130157893|NCT00062751|468539993|FG004|Overall Study|Disease progression|2|||
130157894|NCT00062751|468539989|FG000|Overall Study|Adverse Event|4|||
130157895|NCT00062751|468539990|FG001|Overall Study|Adverse Event|7|||
130157896|NCT00062751|468539991|FG002|Overall Study|Adverse Event|2|||
130157897|NCT00062751|468539992|FG003|Overall Study|Adverse Event|2|||
130157898|NCT00062751|468539993|FG004|Overall Study|Adverse Event|2|||
130157899|NCT00062751|468539989|FG000|Overall Study|Other|2|||
130157900|NCT00062751|468539990|FG001|Overall Study|Other|3|||
130157901|NCT00062751|468539991|FG002|Overall Study|Other|1|||
130157902|NCT00062751|468539992|FG003|Overall Study|Other|0|||
130157903|NCT00062751|468539993|FG004|Overall Study|Other|1|||
130157904|NCT00062751|468539989|FG000|Overall Study|Withdrawal by Subject|1|||
130157905|NCT00062751|468539990|FG001|Overall Study|Withdrawal by Subject|2|||
130157906|NCT00062751|468539991|FG002|Overall Study|Withdrawal by Subject|2|||
130157907|NCT00062751|468539992|FG003|Overall Study|Withdrawal by Subject|1|||
130157908|NCT00062751|468539993|FG004|Overall Study|Withdrawal by Subject|0|||
130157909|NCT00062751|468539989|FG000|Overall Study|Symptomatic deterioration|1|||
130157910|NCT00062751|468539990|FG001|Overall Study|Symptomatic deterioration|1|||
130157911|NCT00062751|468539991|FG002|Overall Study|Symptomatic deterioration|0|||
130157912|NCT00062751|468539992|FG003|Overall Study|Symptomatic deterioration|0|||
130157913|NCT00062751|468539993|FG004|Overall Study|Symptomatic deterioration|1|||
130157914|NCT00062751|468539989|FG000|Overall Study|Death|1|||
130157915|NCT00062751|468539990|FG001|Overall Study|Death|0|||
130157916|NCT00062751|468539991|FG002|Overall Study|Death|1|||
130157917|NCT00062751|468539992|FG003|Overall Study|Death|0|||
130157918|NCT00062751|468539993|FG004|Overall Study|Death|0|||
130157919|NCT00851643|468540000|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
130157920|NCT00851643|468540001|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130157921|NCT00851643|468540002|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130157922|NCT00851643|468540003|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130157923|NCT00851643|468540004|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130157924|NCT00851643|468540005|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
130157925|NCT00851643|468540000|FG000|Base Study (Up to 12 Months)|Other|0|||
130157926|NCT00851643|468540001|FG001|Base Study (Up to 12 Months)|Other|0|||
130157927|NCT00851643|468540002|FG002|Base Study (Up to 12 Months)|Other|0|||
130157928|NCT00851643|468540003|FG003|Base Study (Up to 12 Months)|Other|0|||
130157929|NCT00851643|468540004|FG004|Base Study (Up to 12 Months)|Other|0|||
130157930|NCT00851643|468540005|FG005|Base Study (Up to 12 Months)|Other|1|||
130157931|NCT00851643|468540000|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
130157932|NCT00851643|468540001|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
130157933|NCT00851643|468540002|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
130157934|NCT00851643|468540003|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
130157935|NCT00851643|468540004|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
130157936|NCT00851643|468540005|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
130157937|NCT00851643|468540000|FG000|Extension Study (Up to 36 Months)|Moved|0|||
130157938|NCT00851643|468540001|FG001|Extension Study (Up to 36 Months)|Moved|2|||
130157939|NCT00851643|468540002|FG002|Extension Study (Up to 36 Months)|Moved|1|||
130157940|NCT00851643|468540003|FG003|Extension Study (Up to 36 Months)|Moved|1|||
130157941|NCT00851643|468540004|FG004|Extension Study (Up to 36 Months)|Moved|0|||
130157942|NCT00851643|468540005|FG005|Extension Study (Up to 36 Months)|Moved|1|||
130157943|NCT01641133|468540008|FG000|Overall Study|Protocol Violation|0|||
130157944|NCT01641133|468540009|FG001|Overall Study|Protocol Violation|1|||
130157945|NCT01641133|468540010|FG002|Overall Study|Protocol Violation|1|||
130157946|NCT01641133|468540008|FG000|Overall Study|Migrated/moved from study area|5|||
130157947|NCT01641133|468540009|FG001|Overall Study|Migrated/moved from study area|3|||
130157948|NCT01641133|468540010|FG002|Overall Study|Migrated/moved from study area|1|||
130157949|NCT01641133|468540008|FG000|Overall Study|Adverse Event|0|||
130157950|NCT01641133|468540009|FG001|Overall Study|Adverse Event|0|||
130157951|NCT01641133|468540010|FG002|Overall Study|Adverse Event|1|||
130157952|NCT01641133|468540008|FG000|Overall Study|Withdrawal by Subject|5|||
130157953|NCT01641133|468540009|FG001|Overall Study|Withdrawal by Subject|3|||
130157954|NCT01641133|468540010|FG002|Overall Study|Withdrawal by Subject|3|||
130157955|NCT01641133|468540008|FG000|Overall Study|Lost to Follow-up|0|||
130157956|NCT01641133|468540009|FG001|Overall Study|Lost to Follow-up|2|||
130157957|NCT01641133|468540010|FG002|Overall Study|Lost to Follow-up|2|||
130157958|NCT00609466|468540011|FG000|Overall Study|Withdrawal by Subject|0|||
130157959|NCT00609466|468540012|FG001|Overall Study|Withdrawal by Subject|1|||
130157960|NCT00609466|468540013|FG002|Overall Study|Withdrawal by Subject|1|||
130157961|NCT00609466|468540011|FG000|Overall Study|Adverse Event|2|||
130157962|NCT00609466|468540012|FG001|Overall Study|Adverse Event|3|||
130157963|NCT00609466|468540013|FG002|Overall Study|Adverse Event|1|||
130157964|NCT00609466|468540011|FG000|Overall Study|Lack of Efficacy|0|||
130157965|NCT00609466|468540012|FG001|Overall Study|Lack of Efficacy|2|||
130157966|NCT00609466|468540013|FG002|Overall Study|Lack of Efficacy|2|||
130157967|NCT03512262|468540014|FG000|Overall Study|Adverse Event|8|||
130157968|NCT03512262|468540015|FG001|Overall Study|Adverse Event|3|||
130157969|NCT03512262|468540014|FG000|Overall Study|Death (non-treatment emergent)|1|||
130157970|NCT03512262|468540015|FG001|Overall Study|Death (non-treatment emergent)|0|||
130157971|NCT03512262|468540014|FG000|Overall Study|Withdrawal by Subject|17|||
130157972|NCT03512262|468540015|FG001|Overall Study|Withdrawal by Subject|9|||
130157973|NCT03512262|468540014|FG000|Overall Study|Lost to Follow-up|7|||
130157974|NCT03512262|468540015|FG001|Overall Study|Lost to Follow-up|1|||
130157975|NCT03512262|468540014|FG000|Overall Study|Other than Specified|2|||
130157976|NCT03512262|468540015|FG001|Overall Study|Other than Specified|2|||
130157977|NCT03407430|468540016|FG000|Washout|Protocol Violation|1|||
130157978|NCT03407430|468540017|FG001|Washout|Protocol Violation|0|||
130157979|NCT01195272|468540018|FG000|Overall Study|Adverse Event|1|||
130157980|NCT01195272|468540018|FG000|Overall Study|Lack of Efficacy|3|||
130157981|NCT03295318|468541437|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
130157982|NCT03295318|468541438|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
130157983|NCT03295318|468541439|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
130157984|NCT03295318|468541437|FG000|Overall Study|Death|1|||
130157985|NCT03295318|468541438|FG001|Overall Study|Death|1|||
130157986|NCT03295318|468541439|FG002|Overall Study|Death|1|||
130157987|NCT03295318|468541437|FG000|Overall Study|Protocol Violation|4|||
130157988|NCT03295318|468541438|FG001|Overall Study|Protocol Violation|3|||
130157989|NCT03295318|468541439|FG002|Overall Study|Protocol Violation|3|||
130157990|NCT03295318|468541437|FG000|Overall Study|Withdrawal by Subject|0|||
130157991|NCT03295318|468541438|FG001|Overall Study|Withdrawal by Subject|0|||
130157992|NCT03295318|468541439|FG002|Overall Study|Withdrawal by Subject|1|||
130157993|NCT03295318|468541437|FG000|Overall Study|Subject discontinued due to travel|0|||
130157994|NCT03295318|468541438|FG001|Overall Study|Subject discontinued due to travel|1|||
130157995|NCT03295318|468541439|FG002|Overall Study|Subject discontinued due to travel|0|||
130157996|NCT04319718|468541440|FG000|Overall Study|Adverse Event|0|||
130157997|NCT04319718|468541441|FG001|Overall Study|Adverse Event|2|||
130157998|NCT04319718|468541440|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
130157999|NCT04319718|468541441|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
130158000|NCT01288053|468541442|FG000|Overall Study|Death|1|||
130158001|NCT00144781|468541443|FG000|Overall Study|Adverse Event|0|||
130158002|NCT00144781|468541444|FG001|Overall Study|Adverse Event|1|||
130158003|NCT00144781|468541445|FG002|Overall Study|Adverse Event|0|||
130158004|NCT00144781|468541446|FG003|Overall Study|Adverse Event|0|||
130158005|NCT00144781|468541443|FG000|Overall Study|Non-compliant|0|||
130158006|NCT00144781|468541444|FG001|Overall Study|Non-compliant|1|||
130158007|NCT00144781|468541445|FG002|Overall Study|Non-compliant|0|||
130158008|NCT00144781|468541446|FG003|Overall Study|Non-compliant|0|||
130158009|NCT02068092|468541447|FG000|Overall Study|Physician Decision|2|||
130158010|NCT02068092|468541447|FG000|Overall Study|Adverse Event|2|||
130158011|NCT02068092|468541447|FG000|Overall Study|Lost to Follow-up|4|||
130158012|NCT02068092|468541447|FG000|Overall Study|Withdrawal by Subject|2|||
130158013|NCT01045421|468541448|FG000|Phase 1|Progressive Disease|0|||
130158014|NCT01045421|468541449|FG001|Phase 1|Progressive Disease|0|||
130158015|NCT01045421|468541450|FG002|Phase 1|Progressive Disease|0|||
130158016|NCT01045421|468541451|FG003|Phase 1|Progressive Disease|0|||
130158017|NCT01045421|468541452|FG004|Phase 1|Progressive Disease|1|||
130158018|NCT01045421|468541453|FG005|Phase 1|Progressive Disease|0|||
130158019|NCT01045421|468541454|FG006|Phase 1|Progressive Disease|0|||
130158020|NCT01045421|468541455|FG007|Phase 1|Progressive Disease|0|||
130158021|NCT01045421|468541456|FG008|Phase 1|Progressive Disease|0|||
130158022|NCT01045421|468541457|FG009|Phase 1|Progressive Disease|0|||
130158023|NCT01045421|468541458|FG010|Phase 1|Progressive Disease|0|||
129980689|NCT01214642|467891705|FG009|Overall Study|Physician Decision|0|||
130158024|NCT01045421|468541448|FG000|Phase 1|Withdrawal by Subject|0|||
130158025|NCT01045421|468541449|FG001|Phase 1|Withdrawal by Subject|0|||
130158026|NCT01045421|468541450|FG002|Phase 1|Withdrawal by Subject|0|||
130158027|NCT01045421|468541451|FG003|Phase 1|Withdrawal by Subject|1|||
130158028|NCT01045421|468541452|FG004|Phase 1|Withdrawal by Subject|0|||
130158029|NCT01045421|468541453|FG005|Phase 1|Withdrawal by Subject|0|||
130158030|NCT01045421|468541454|FG006|Phase 1|Withdrawal by Subject|0|||
130158031|NCT01045421|468541455|FG007|Phase 1|Withdrawal by Subject|0|||
130158032|NCT01045421|468541456|FG008|Phase 1|Withdrawal by Subject|0|||
129980690|NCT01214642|467891706|FG010|Overall Study|Physician Decision|0|||
130158033|NCT01045421|468541457|FG009|Phase 1|Withdrawal by Subject|0|||
130158034|NCT01045421|468541458|FG010|Phase 1|Withdrawal by Subject|0|||
130158035|NCT01045421|468541448|FG000|Phase 2|Progressive Disease|0|||
130158036|NCT01045421|468541449|FG001|Phase 2|Progressive Disease|0|||
129980691|NCT01214642|467891707|FG011|Overall Study|Physician Decision|2|||
130158037|NCT01045421|468541450|FG002|Phase 2|Progressive Disease|0|||
130158038|NCT01045421|468541451|FG003|Phase 2|Progressive Disease|0|||
130158039|NCT01045421|468541452|FG004|Phase 2|Progressive Disease|0|||
130158040|NCT01045421|468541453|FG005|Phase 2|Progressive Disease|0|||
130158041|NCT01045421|468541454|FG006|Phase 2|Progressive Disease|0|||
130158042|NCT01045421|468541455|FG007|Phase 2|Progressive Disease|1|||
130158043|NCT01045421|468541456|FG008|Phase 2|Progressive Disease|1|||
130158044|NCT01045421|468541457|FG009|Phase 2|Progressive Disease|1|||
130158045|NCT01045421|468541458|FG010|Phase 2|Progressive Disease|1|||
130158046|NCT01045421|468541448|FG000|Phase 2|Death|0|||
130158047|NCT01045421|468541449|FG001|Phase 2|Death|0|||
130158048|NCT01045421|468541450|FG002|Phase 2|Death|0|||
130158049|NCT01045421|468541451|FG003|Phase 2|Death|0|||
130158050|NCT01045421|468541452|FG004|Phase 2|Death|0|||
130158051|NCT01045421|468541453|FG005|Phase 2|Death|0|||
130158052|NCT01045421|468541454|FG006|Phase 2|Death|0|||
130158053|NCT01045421|468541455|FG007|Phase 2|Death|1|||
130158054|NCT01045421|468541456|FG008|Phase 2|Death|1|||
130158055|NCT01045421|468541457|FG009|Phase 2|Death|2|||
130158056|NCT01045421|468541458|FG010|Phase 2|Death|0|||
130158057|NCT01045421|468541448|FG000|Phase 2|Other|0|||
130158058|NCT01045421|468541449|FG001|Phase 2|Other|0|||
130158059|NCT01045421|468541450|FG002|Phase 2|Other|0|||
130158060|NCT01045421|468541451|FG003|Phase 2|Other|0|||
130158061|NCT01045421|468541452|FG004|Phase 2|Other|0|||
130158062|NCT01045421|468541453|FG005|Phase 2|Other|0|||
130158063|NCT01045421|468541454|FG006|Phase 2|Other|0|||
130158064|NCT01045421|468541455|FG007|Phase 2|Other|3|||
130158065|NCT01045421|468541456|FG008|Phase 2|Other|0|||
130158066|NCT01045421|468541457|FG009|Phase 2|Other|0|||
130158067|NCT01045421|468541458|FG010|Phase 2|Other|1|||
130158068|NCT04551911|468541459|FG000|Overall Study|Lost to Follow-up|2|||
130158069|NCT04551911|468541460|FG001|Overall Study|Lost to Follow-up|1|||
130158070|NCT04551911|468541459|FG000|Overall Study|Withdrawal by Subject|10|||
130158071|NCT04551911|468541460|FG001|Overall Study|Withdrawal by Subject|10|||
130158072|NCT04551911|468541459|FG000|Overall Study|Did not receive the study drug|3|||
130158073|NCT04551911|468541460|FG001|Overall Study|Did not receive the study drug|4|||
130158074|NCT01030341|468541461|FG000|Overall Study|Withdrawal by Subject|1|||
130158075|NCT01030341|468541461|FG000|Overall Study|Lost to Follow-up|2|||
130158076|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Death|89|||
130158077|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Death|193|||
130158078|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Death|198|||
130158079|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
130158080|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
130158081|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
130158082|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
130158083|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
130158084|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
130158085|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
130158086|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
130158087|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
130158088|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
130158089|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
130158090|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
130158091|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
130158092|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
130158093|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
130158094|NCT02031458|468541462|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
130158095|NCT02031458|468541463|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
130158096|NCT02031458|468541464|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
130158097|NCT02031458|468541462|FG000|Baseline to May 8, 2015|Death|36|||
130158098|NCT02031458|468541463|FG001|Baseline to May 8, 2015|Death|87|||
130158099|NCT02031458|468541464|FG002|Baseline to May 8, 2015|Death|100|||
130158100|NCT02031458|468541462|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
130158101|NCT02031458|468541463|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
130158102|NCT02031458|468541464|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
130158103|NCT02031458|468541462|FG000|Baseline to May 8, 2015|Physician Decision|0|||
130158104|NCT02031458|468541463|FG001|Baseline to May 8, 2015|Physician Decision|1|||
130158105|NCT02031458|468541464|FG002|Baseline to May 8, 2015|Physician Decision|0|||
130158106|NCT02031458|468541462|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
130158107|NCT02031458|468541463|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
130158108|NCT02031458|468541464|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
130158109|NCT02031458|468541462|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
130158110|NCT02031458|468541463|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
130158111|NCT02031458|468541464|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
130158112|NCT02031458|468541462|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
130158113|NCT02031458|468541463|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
130158114|NCT02031458|468541464|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
130158115|NCT02031458|468541462|FG000|Baseline to May 8, 2015|On Treatment|43|||
130158116|NCT02031458|468541463|FG001|Baseline to May 8, 2015|On Treatment|81|||
130158117|NCT02031458|468541464|FG002|Baseline to May 8, 2015|On Treatment|73|||
130158118|NCT02031458|468541462|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
130158119|NCT02031458|468541463|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
130158120|NCT02031458|468541464|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
130158121|NCT01959035|468541468|FG000|Overall Study|Adverse Event|5|||
130158122|NCT01959035|468541468|FG000|Overall Study|Withdrawal by Subject|4|||
130158123|NCT01959035|468541468|FG000|Overall Study|Lost to Follow-up|1|||
130158124|NCT01959035|468541468|FG000|Overall Study|Other (no primary reason given)|1|||
130158125|NCT02034058|468541469|FG000|Overall Study|Death|3|||
130158126|NCT02963311|468541470|FG000|Overall Study|Withdrawal by Subject|1|||
130158127|NCT02963311|468541470|FG000|Overall Study|Screen Failure|4|||
130158128|NCT01400919|468541472|FG000|Overall Study|Withdrawal by Subject|4|||
130158129|NCT01400919|468541472|FG000|Overall Study|Lost to Follow-up|2|||
130158130|NCT01400919|468541472|FG000|Overall Study|Missed visit|2|||
130158131|NCT02923674|468541473|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
130158132|NCT02923674|468541474|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
130158133|NCT02923674|468541475|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
130158134|NCT02923674|468541473|FG000|Overall Study|Lost to Follow-up|7|||
130158135|NCT02923674|468541474|FG001|Overall Study|Lost to Follow-up|12|||
130158136|NCT02923674|468541475|FG002|Overall Study|Lost to Follow-up|7|||
130158137|NCT02923674|468541473|FG000|Overall Study|Problem with intervention|2|||
130158138|NCT02923674|468541474|FG001|Overall Study|Problem with intervention|2|||
130158139|NCT02923674|468541475|FG002|Overall Study|Problem with intervention|1|||
130158140|NCT02923674|468541473|FG000|Overall Study|Adverse Event|3|||
130158141|NCT02923674|468541474|FG001|Overall Study|Adverse Event|1|||
130158142|NCT02923674|468541475|FG002|Overall Study|Adverse Event|1|||
130158143|NCT02923674|468541473|FG000|Overall Study|Withdrawal by Subject|2|||
130158144|NCT02923674|468541474|FG001|Overall Study|Withdrawal by Subject|2|||
130158145|NCT02923674|468541475|FG002|Overall Study|Withdrawal by Subject|2|||
130158146|NCT00158600|468541478|FG000|Overall Study|unable to commit time to study|0|||
130158147|NCT00158600|468541479|FG001|Overall Study|unable to commit time to study|1|||
130158148|NCT00158600|468541478|FG000|Overall Study|Adverse Event|2|||
130158149|NCT00158600|468541479|FG001|Overall Study|Adverse Event|1|||
130158150|NCT00158600|468541478|FG000|Overall Study|Death|1|||
130158151|NCT00158600|468541479|FG001|Overall Study|Death|0|||
130158152|NCT00158600|468541478|FG000|Overall Study|Withdrawal by Subject|2|||
130158153|NCT00158600|468541479|FG001|Overall Study|Withdrawal by Subject|2|||
130158154|NCT00846521|468541488|FG000|Overall Study|Withdrawal by Subject|5|||
130158155|NCT00846521|468541488|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
130158156|NCT00846521|468541488|FG000|Overall Study|Protocol Violation|1|||
130158157|NCT02618408|468541489|FG000|Overall Study|Withdrawal by Subject|1|||
130158158|NCT02618408|468541490|FG001|Overall Study|Withdrawal by Subject|0|||
130158159|NCT02618408|468541491|FG002|Overall Study|Withdrawal by Subject|4|||
130158160|NCT02618408|468541489|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
130158161|NCT02618408|468541490|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
130158162|NCT02618408|468541491|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
130158163|NCT02618408|468541489|FG000|Overall Study|Lost to Follow-up|4|||
130158164|NCT02618408|468541490|FG001|Overall Study|Lost to Follow-up|2|||
130158165|NCT02618408|468541491|FG002|Overall Study|Lost to Follow-up|6|||
130158166|NCT02618408|468541489|FG000|Overall Study|Adverse Event|4|||
130158167|NCT02618408|468541490|FG001|Overall Study|Adverse Event|0|||
130158168|NCT02618408|468541491|FG002|Overall Study|Adverse Event|10|||
130158169|NCT02618408|468541489|FG000|Overall Study|Physician Decision|1|||
130158170|NCT02618408|468541490|FG001|Overall Study|Physician Decision|1|||
130158171|NCT02618408|468541491|FG002|Overall Study|Physician Decision|2|||
130158172|NCT02618408|468541489|FG000|Overall Study|Protocol Violation|1|||
130158173|NCT02618408|468541490|FG001|Overall Study|Protocol Violation|1|||
130158174|NCT02618408|468541491|FG002|Overall Study|Protocol Violation|2|||
130158175|NCT02618408|468541489|FG000|Overall Study|Other, Multiple Categories|0|||
130158176|NCT02618408|468541490|FG001|Overall Study|Other, Multiple Categories|0|||
130158177|NCT02618408|468541491|FG002|Overall Study|Other, Multiple Categories|4|||
130158178|NCT01246011|468541493|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
130158179|NCT01246011|468541494|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
130158180|NCT01246011|468541495|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
130158181|NCT01246011|468541493|FG000|Overall Study|Withdrawal by Subject|0|||
130158182|NCT01246011|468541494|FG001|Overall Study|Withdrawal by Subject|0|||
130158183|NCT01246011|468541495|FG002|Overall Study|Withdrawal by Subject|1|||
130158184|NCT04492020|468541496|FG000|Overall Study|Adverse Event|1|||
130158185|NCT04492020|468541497|FG001|Overall Study|Adverse Event|3|||
130158186|NCT04492020|468541496|FG000|Overall Study|Withdrawal by Subject|4|||
130158187|NCT04492020|468541497|FG001|Overall Study|Withdrawal by Subject|3|||
130158188|NCT04492020|468541496|FG000|Overall Study|Lost to Follow-up|4|||
130158189|NCT04492020|468541497|FG001|Overall Study|Lost to Follow-up|3|||
130158190|NCT04492020|468541496|FG000|Overall Study|Protocol Violation|5|||
130158191|NCT04492020|468541497|FG001|Overall Study|Protocol Violation|2|||
130158192|NCT04492020|468541496|FG000|Overall Study|Lack of Qualifying Event|25|||
130158193|NCT04492020|468541497|FG001|Overall Study|Lack of Qualifying Event|27|||
130158194|NCT04492020|468541496|FG000|Overall Study|Non-compliance with Study Drug|2|||
130158195|NCT04492020|468541497|FG001|Overall Study|Non-compliance with Study Drug|1|||
130158196|NCT02792959|468541499|FG000|Overall Study|Protocol Violation|1|||
130158197|NCT00003875|468541511|FG000|Overall Study|Screen Failed|1|||
130158198|NCT01780987|468541512|FG000|Overall Study|Adverse Event|0|||
130158199|NCT01780987|468541513|FG001|Overall Study|Adverse Event|4|||
130158200|NCT01780987|468541512|FG000|Overall Study|Withdrawal by Subject|2|||
130158201|NCT01780987|468541513|FG001|Overall Study|Withdrawal by Subject|0|||
130158202|NCT01780987|468541512|FG000|Overall Study|Request of Changing Hospital|0|||
130158203|NCT01780987|468541513|FG001|Overall Study|Request of Changing Hospital|1|||
130158204|NCT01780987|468541512|FG000|Overall Study|Changing Residence|1|||
130158205|NCT01780987|468541513|FG001|Overall Study|Changing Residence|0|||
130158206|NCT01780987|468541512|FG000|Overall Study|Not Receiving any Study Medication|0|||
130158207|NCT01780987|468541513|FG001|Overall Study|Not Receiving any Study Medication|1|||
130158208|NCT04168190|468541514|FG000|Overall Study|Lost to Follow-up|0|||
130158209|NCT04168190|468541515|FG001|Overall Study|Lost to Follow-up|1|||
130158210|NCT04168190|468541516|FG002|Overall Study|Lost to Follow-up|0|||
130158211|NCT04168190|468541517|FG003|Overall Study|Lost to Follow-up|7|||
130158212|NCT04168190|468541518|FG004|Overall Study|Lost to Follow-up|5|||
130158213|NCT04168190|468541514|FG000|Overall Study|Withdrawal by Subject|1|||
130158214|NCT04168190|468541515|FG001|Overall Study|Withdrawal by Subject|0|||
130158215|NCT04168190|468541516|FG002|Overall Study|Withdrawal by Subject|0|||
130158216|NCT04168190|468541517|FG003|Overall Study|Withdrawal by Subject|2|||
130158217|NCT04168190|468541518|FG004|Overall Study|Withdrawal by Subject|4|||
130158218|NCT04168190|468541514|FG000|Overall Study|Death|0|||
130158219|NCT04168190|468541515|FG001|Overall Study|Death|0|||
130158220|NCT04168190|468541516|FG002|Overall Study|Death|0|||
130158221|NCT04168190|468541517|FG003|Overall Study|Death|1|||
130158222|NCT04168190|468541518|FG004|Overall Study|Death|0|||
130158223|NCT00629265|468541519|FG000|Overall Study|Lost to Follow-up|4|||
130158224|NCT00629265|468541520|FG001|Overall Study|Lost to Follow-up|5|||
130158225|NCT00629265|468541519|FG000|Overall Study|Withdrawal by Subject|11|||
130158226|NCT00629265|468541520|FG001|Overall Study|Withdrawal by Subject|8|||
130158227|NCT00629265|468541519|FG000|Overall Study|Death|1|||
130158228|NCT00629265|468541520|FG001|Overall Study|Death|0|||
130158229|NCT00629265|468541519|FG000|Overall Study|Adverse Event|2|||
130158230|NCT00629265|468541520|FG001|Overall Study|Adverse Event|0|||
130158231|NCT00629265|468541519|FG000|Overall Study|HNC Recurrence|4|||
130158232|NCT00629265|468541520|FG001|Overall Study|HNC Recurrence|0|||
130158233|NCT00629265|468541519|FG000|Overall Study|Other CA Requiring Treatment|1|||
130158234|NCT00629265|468541520|FG001|Overall Study|Other CA Requiring Treatment|3|||
130158235|NCT00629265|468541519|FG000|Overall Study|Needed Esophageal Dilation|4|||
130158236|NCT00629265|468541520|FG001|Overall Study|Needed Esophageal Dilation|1|||
130158237|NCT00629265|468541519|FG000|Overall Study|Unrelated Medical Complications|3|||
130158238|NCT00629265|468541520|FG001|Overall Study|Unrelated Medical Complications|1|||
130158239|NCT00629265|468541519|FG000|Overall Study|Unknown Reason|2|||
130158240|NCT00629265|468541520|FG001|Overall Study|Unknown Reason|2|||
130158241|NCT04465630|468541521|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
130158242|NCT04465630|468541521|FG000|Overall Study|Screen failure|8|||
130158243|NCT04465630|468541521|FG000|Overall Study|Baseline failure|16|||
130158244|NCT02032706|468541524|FG000|Overall Study|Did not qualify|5|||
130158245|NCT02032706|468541524|FG000|Overall Study|Protocol Violation|1|||
130158246|NCT00895947|468541525|FG000|Overall Study|Adverse Event|3|||
130158247|NCT00895947|468541526|FG001|Overall Study|Adverse Event|4|||
130158248|NCT00895947|468541525|FG000|Overall Study|Lost to Follow-up|3|||
130158249|NCT00895947|468541526|FG001|Overall Study|Lost to Follow-up|4|||
130158250|NCT00895947|468541525|FG000|Overall Study|Protocol Violation|4|||
130158251|NCT00895947|468541526|FG001|Overall Study|Protocol Violation|2|||
130158252|NCT00895947|468541525|FG000|Overall Study|Withdrawal by Subject|2|||
130158253|NCT00895947|468541526|FG001|Overall Study|Withdrawal by Subject|0|||
130158254|NCT04620135|468541529|FG000|Study Completion|Adverse Event|2|||
130158255|NCT04620135|468541530|FG001|Study Completion|Adverse Event|3|||
130158256|NCT04620135|468541529|FG000|Study Completion|Withdrawal by Subject|2|||
130158257|NCT04620135|468541530|FG001|Study Completion|Withdrawal by Subject|0|||
130158258|NCT02005887|468541534|FG000|Overall Study|Protocol Violation|0|||
130158259|NCT02005887|468541535|FG001|Overall Study|Protocol Violation|2|||
130158260|NCT01615263|468541536|FG000|Overall Study|Post-randomization exclusion|0|||
130158261|NCT01615263|468541537|FG001|Overall Study|Post-randomization exclusion|2|||
130158262|NCT02138136|468541538|FG000|Overall Study|Protocol Violation|4|||
130158263|NCT02138136|468541538|FG000|Overall Study|Physician Decision|7|||
130158264|NCT02138136|468541538|FG000|Overall Study|Lack of Efficacy|35|||
130158265|NCT02138136|468541538|FG000|Overall Study|Pregnancy|2|||
130158266|NCT02138136|468541538|FG000|Overall Study|Adverse Event|18|||
130158267|NCT02138136|468541538|FG000|Overall Study|Withdrawal by Subject|36|||
130158268|NCT02138136|468541538|FG000|Overall Study|Lost to Follow-up|32|||
130158269|NCT02138136|468541538|FG000|Overall Study|Withdrawn by Sponsor|5|||
130158270|NCT01660334|468541541|FG000|Overall Study|Lost to Follow-up|1|||
130158271|NCT03979820|468541543|FG000|Overall Study|Protocol Violation|1|||
130158272|NCT03979820|468541544|FG001|Overall Study|Protocol Violation|0|||
130158273|NCT03979820|468541545|FG002|Overall Study|Protocol Violation|0|||
130158274|NCT03979820|468541546|FG003|Overall Study|Protocol Violation|0|||
130158275|NCT03979820|468541543|FG000|Overall Study|Withdrawal by Subject|0|||
130158276|NCT03979820|468541544|FG001|Overall Study|Withdrawal by Subject|0|||
130158277|NCT03979820|468541545|FG002|Overall Study|Withdrawal by Subject|1|||
130158278|NCT03979820|468541546|FG003|Overall Study|Withdrawal by Subject|0|||
130158279|NCT03979820|468541543|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
130158280|NCT03979820|468541544|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
130158281|NCT03979820|468541545|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
130158282|NCT03979820|468541546|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
130158283|NCT04355663|468541547|FG000|Overall Study|Physician Decision|2|||
130158284|NCT04355663|468541548|FG001|Overall Study|Physician Decision|7|||
130158285|NCT04355663|468541549|FG002|Overall Study|Physician Decision|0|||
130158286|NCT04355663|468541547|FG000|Overall Study|Adverse Event|0|||
130158287|NCT04355663|468541548|FG001|Overall Study|Adverse Event|0|||
130158288|NCT04355663|468541549|FG002|Overall Study|Adverse Event|1|||
130158289|NCT04355663|468541547|FG000|Overall Study|Withdrawal by Subject|0|||
130158290|NCT04355663|468541548|FG001|Overall Study|Withdrawal by Subject|8|||
130158291|NCT04355663|468541549|FG002|Overall Study|Withdrawal by Subject|3|||
130158292|NCT00876018|468541552|FG000|Overall Study|Lost to Follow-up|0|||
130158293|NCT00876018|468541553|FG001|Overall Study|Lost to Follow-up|1|||
130158294|NCT00876018|468541554|FG002|Overall Study|Lost to Follow-up|1|||
130158295|NCT00876018|468541552|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
130158296|NCT00876018|468541553|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
130158297|NCT00876018|468541554|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
130158298|NCT01230892|468541555|FG000|Overall Study|Withdrawal by Subject|1|||
130158299|NCT01230892|468541556|FG001|Overall Study|Withdrawal by Subject|1|||
130158300|NCT01230892|468541555|FG000|Overall Study|Lost to Follow-up|2|||
130158301|NCT01230892|468541556|FG001|Overall Study|Lost to Follow-up|0|||
130158302|NCT00679913|468541557|FG000|Overall Study|Protocol Violation|18|||
130158303|NCT00679913|468541558|FG001|Overall Study|Protocol Violation|13|||
130158304|NCT00725621|468541559|FG000|Overall Study|Adverse Event|25|||
130158305|NCT00725621|468541559|FG000|Overall Study|Lack of Efficacy|46|||
130158306|NCT00725621|468541559|FG000|Overall Study|Withdrawal by Subject|57|||
130158307|NCT00725621|468541559|FG000|Overall Study|Physician Decision|19|||
130158308|NCT00725621|468541559|FG000|Overall Study|Lost to Follow-up|52|||
130158309|NCT00725621|468541559|FG000|Overall Study|Non-compliance|8|||
130158310|NCT00725621|468541559|FG000|Overall Study|Continued treatment by other physician|6|||
130158311|NCT00725621|468541559|FG000|Overall Study|Switched to other study|1|||
130158312|NCT00725621|468541559|FG000|Overall Study|Switched to other drug|1|||
130158313|NCT00725621|468541559|FG000|Overall Study|Prepared for elective surgery|1|||
130158314|NCT00725621|468541559|FG000|Overall Study|Reason not specified|55|||
130158315|NCT01189500|468541560|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
130158316|NCT01189500|468541560|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
130158317|NCT01144364|468541564|FG000|Induction Phase|Disease progression|14|||
130158318|NCT01144364|468541565|FG001|Induction Phase|Disease progression|0|||
130158319|NCT01144364|468541566|FG002|Induction Phase|Disease progression|0|||
130158320|NCT01144364|468541564|FG000|Induction Phase|Adverse Event|9|||
130158321|NCT01144364|468541565|FG001|Induction Phase|Adverse Event|0|||
130158322|NCT01144364|468541566|FG002|Induction Phase|Adverse Event|0|||
130158323|NCT01144364|468541564|FG000|Induction Phase|Death|1|||
130158324|NCT01144364|468541565|FG001|Induction Phase|Death|0|||
130158325|NCT01144364|468541566|FG002|Induction Phase|Death|0|||
130158326|NCT01144364|468541564|FG000|Induction Phase|Withdrawal by Subject|1|||
130158327|NCT01144364|468541565|FG001|Induction Phase|Withdrawal by Subject|0|||
130158328|NCT01144364|468541566|FG002|Induction Phase|Withdrawal by Subject|0|||
130158329|NCT01144364|468541564|FG000|Induction Phase|Lost to Follow-up|2|||
130158330|NCT01144364|468541565|FG001|Induction Phase|Lost to Follow-up|0|||
130158331|NCT01144364|468541566|FG002|Induction Phase|Lost to Follow-up|0|||
130158332|NCT01144364|468541564|FG000|Induction Phase|Physician Decision|1|||
130158333|NCT01144364|468541565|FG001|Induction Phase|Physician Decision|0|||
130158334|NCT01144364|468541566|FG002|Induction Phase|Physician Decision|0|||
130158335|NCT01144364|468541564|FG000|Induction Phase|Stable disease|2|||
130158336|NCT01144364|468541565|FG001|Induction Phase|Stable disease|0|||
130158337|NCT01144364|468541566|FG002|Induction Phase|Stable disease|0|||
130158338|NCT01144364|468541564|FG000|Induction Phase|Secondary neoplasia|1|||
130158339|NCT01144364|468541565|FG001|Induction Phase|Secondary neoplasia|0|||
130158340|NCT01144364|468541566|FG002|Induction Phase|Secondary neoplasia|0|||
130158341|NCT01144364|468541564|FG000|Induction Phase|Protocol Violation|1|||
130158342|NCT01144364|468541565|FG001|Induction Phase|Protocol Violation|0|||
130158343|NCT01144364|468541566|FG002|Induction Phase|Protocol Violation|0|||
130158344|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
130158345|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
130158346|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
130158347|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
130158348|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
130158349|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
130158350|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Death|0|||
130158351|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Death|2|||
130158352|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Death|0|||
130158353|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
130158354|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
130158355|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
130158356|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
130158357|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
130158358|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
130158359|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
130158360|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
130158361|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
130158362|NCT01144364|468541564|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
130158363|NCT01144364|468541565|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
130158364|NCT01144364|468541566|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
130158365|NCT01301508|468541569|FG000|Overall Study|Withdrawal by Subject|1|||
130158366|NCT01301508|468541570|FG001|Overall Study|Withdrawal by Subject|2|||
130158367|NCT01301508|468541569|FG000|Overall Study|Lost to Follow-up|0|||
130158368|NCT01301508|468541570|FG001|Overall Study|Lost to Follow-up|1|||
130158369|NCT01940497|468541571|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
130158370|NCT01940497|468541572|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
130158371|NCT01940497|468541571|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
130158372|NCT01940497|468541572|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
130158373|NCT01940497|468541571|FG000|Overall Study|Violation of Entry Criteria|1|||
130158374|NCT01940497|468541572|FG001|Overall Study|Violation of Entry Criteria|1|||
130158375|NCT01940497|468541571|FG000|Overall Study|Refused Treatment|1|||
130158376|NCT01940497|468541572|FG001|Overall Study|Refused Treatment|3|||
130158377|NCT01940497|468541571|FG000|Overall Study|Withdrew Consent|6|||
130158378|NCT01940497|468541572|FG001|Overall Study|Withdrew Consent|2|||
130158379|NCT01940497|468541571|FG000|Overall Study|Administrative/Other|1|||
130158380|NCT01940497|468541572|FG001|Overall Study|Administrative/Other|1|||
130158381|NCT02707861|468541573|FG000|Overall Study|Went onto commercial drug|30|||
130158382|NCT02707861|468541574|FG001|Overall Study|Went onto commercial drug|23|||
130158383|NCT02707861|468541573|FG000|Overall Study|Adverse Event|2|||
130158384|NCT02707861|468541574|FG001|Overall Study|Adverse Event|3|||
130158385|NCT02707861|468541573|FG000|Overall Study|Death|5|||
130158386|NCT02707861|468541574|FG001|Overall Study|Death|2|||
130158387|NCT02707861|468541573|FG000|Overall Study|Lack of Efficacy|0|||
130158388|NCT02707861|468541574|FG001|Overall Study|Lack of Efficacy|2|||
130158389|NCT02707861|468541573|FG000|Overall Study|Physician Decision|1|||
130158390|NCT02707861|468541574|FG001|Overall Study|Physician Decision|4|||
130158391|NCT02707861|468541573|FG000|Overall Study|Withdrawal by Subject|2|||
130158392|NCT02707861|468541574|FG001|Overall Study|Withdrawal by Subject|1|||
130158393|NCT02707861|468541573|FG000|Overall Study|Lost to Follow-up|1|||
130158394|NCT02707861|468541574|FG001|Overall Study|Lost to Follow-up|3|||
130158395|NCT03123861|468541575|FG000|Overall Study|Protocol Violation|1|||
130158396|NCT03123861|468541576|FG001|Overall Study|Protocol Violation|1|||
130158397|NCT03123861|468541575|FG000|Overall Study|Withdrawal by Subject|2|||
130158398|NCT03123861|468541576|FG001|Overall Study|Withdrawal by Subject|2|||
130158399|NCT02206620|468541577|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130158400|NCT02206620|468541578|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
130158401|NCT02206620|468541577|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
130158402|NCT02206620|468541578|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
130158403|NCT03188666|468542955|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130158404|NCT03188666|468542956|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
130158405|NCT03188666|468542957|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130158406|NCT03188666|468542958|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
130158407|NCT03188666|468542955|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
130158408|NCT03188666|468542956|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
130158409|NCT03188666|468542957|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
130158410|NCT03188666|468542958|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
130158411|NCT03188666|468542955|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130158412|NCT03188666|468542956|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130158413|NCT03188666|468542957|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
130158414|NCT03188666|468542958|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
130158415|NCT03188666|468542955|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
130158416|NCT03188666|468542956|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
130158417|NCT03188666|468542957|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
130158418|NCT03188666|468542958|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
130158419|NCT03696953|468542959|FG000|Overall Study|Withdrawal by Subject|6|||
130158420|NCT03696953|468542960|FG001|Overall Study|Withdrawal by Subject|1|||
130158421|NCT03696953|468542959|FG000|Overall Study|missed GBS swabs|2|||
130158422|NCT03696953|468542960|FG001|Overall Study|missed GBS swabs|2|||
130158423|NCT03696953|468542959|FG000|Overall Study|lost study bottle containing capsules|2|||
130158424|NCT03696953|468542960|FG001|Overall Study|lost study bottle containing capsules|0|||
130158425|NCT03696953|468542959|FG000|Overall Study|Premature birth|1|||
130158426|NCT03696953|468542960|FG001|Overall Study|Premature birth|4|||
130158427|NCT03696953|468542959|FG000|Overall Study|Gestational hypertension|1|||
130158428|NCT03696953|468542960|FG001|Overall Study|Gestational hypertension|1|||
130158429|NCT03696953|468542959|FG000|Overall Study|Gestational diabetes|2|||
130158430|NCT03696953|468542960|FG001|Overall Study|Gestational diabetes|1|||
130158431|NCT03696953|468542959|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
130158432|NCT03696953|468542960|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
130158433|NCT03696953|468542959|FG000|Overall Study|Changed prenatal provider|1|||
130158434|NCT03696953|468542960|FG001|Overall Study|Changed prenatal provider|1|||
130158435|NCT03502707|468542961|FG000|Overall Study|Adverse Event|0|||
130158436|NCT03502707|468542962|FG001|Overall Study|Adverse Event|0|||
130158437|NCT03502707|468542963|FG002|Overall Study|Adverse Event|0|||
130158438|NCT03502707|468542964|FG003|Overall Study|Adverse Event|0|||
130158439|NCT03502707|468542965|FG004|Overall Study|Adverse Event|0|||
130158440|NCT03502707|468542966|FG005|Overall Study|Adverse Event|0|||
130158441|NCT03502707|468542967|FG006|Overall Study|Adverse Event|0|||
130158442|NCT03502707|468542968|FG007|Overall Study|Adverse Event|0|||
130158443|NCT03502707|468542969|FG008|Overall Study|Adverse Event|0|||
130158444|NCT03502707|468542970|FG009|Overall Study|Adverse Event|0|||
130158445|NCT03502707|468542971|FG010|Overall Study|Adverse Event|0|||
130158446|NCT03502707|468542972|FG011|Overall Study|Adverse Event|0|||
130158447|NCT03502707|468542973|FG012|Overall Study|Adverse Event|0|||
130158448|NCT03502707|468542974|FG013|Overall Study|Adverse Event|0|||
130158449|NCT03502707|468542975|FG014|Overall Study|Adverse Event|0|||
130158450|NCT03502707|468542976|FG015|Overall Study|Adverse Event|1|||
130158451|NCT03502707|468542977|FG016|Overall Study|Adverse Event|5|||
130158452|NCT03502707|468542978|FG017|Overall Study|Adverse Event|0|||
130158453|NCT03502707|468542961|FG000|Overall Study|Death|0|||
130158454|NCT03502707|468542962|FG001|Overall Study|Death|0|||
130158455|NCT03502707|468542963|FG002|Overall Study|Death|0|||
130158456|NCT03502707|468542964|FG003|Overall Study|Death|1|||
130158457|NCT03502707|468542965|FG004|Overall Study|Death|0|||
130158458|NCT03502707|468542966|FG005|Overall Study|Death|0|||
130158459|NCT03502707|468542967|FG006|Overall Study|Death|0|||
130158460|NCT03502707|468542968|FG007|Overall Study|Death|0|||
130158461|NCT03502707|468542969|FG008|Overall Study|Death|1|||
130158462|NCT03502707|468542970|FG009|Overall Study|Death|1|||
130158463|NCT03502707|468542971|FG010|Overall Study|Death|0|||
130158464|NCT03502707|468542972|FG011|Overall Study|Death|0|||
130158465|NCT03502707|468542973|FG012|Overall Study|Death|1|||
130158466|NCT03502707|468542974|FG013|Overall Study|Death|0|||
130158467|NCT03502707|468542975|FG014|Overall Study|Death|0|||
130158468|NCT03502707|468542976|FG015|Overall Study|Death|1|||
130158469|NCT03502707|468542977|FG016|Overall Study|Death|0|||
130158470|NCT03502707|468542978|FG017|Overall Study|Death|0|||
130158471|NCT03502707|468542961|FG000|Overall Study|Lost to Follow-up|0|||
130158472|NCT03502707|468542962|FG001|Overall Study|Lost to Follow-up|0|||
130158473|NCT03502707|468542963|FG002|Overall Study|Lost to Follow-up|0|||
130158474|NCT03502707|468542964|FG003|Overall Study|Lost to Follow-up|0|||
130158475|NCT03502707|468542965|FG004|Overall Study|Lost to Follow-up|0|||
130158476|NCT03502707|468542966|FG005|Overall Study|Lost to Follow-up|0|||
130158477|NCT03502707|468542967|FG006|Overall Study|Lost to Follow-up|0|||
130158478|NCT03502707|468542968|FG007|Overall Study|Lost to Follow-up|5|||
130158479|NCT03502707|468542969|FG008|Overall Study|Lost to Follow-up|0|||
130158480|NCT03502707|468542970|FG009|Overall Study|Lost to Follow-up|2|||
130158481|NCT03502707|468542971|FG010|Overall Study|Lost to Follow-up|1|||
130158482|NCT03502707|468542972|FG011|Overall Study|Lost to Follow-up|2|||
130158483|NCT03502707|468542973|FG012|Overall Study|Lost to Follow-up|1|||
130158484|NCT03502707|468542974|FG013|Overall Study|Lost to Follow-up|1|||
130158485|NCT03502707|468542975|FG014|Overall Study|Lost to Follow-up|0|||
130158486|NCT03502707|468542976|FG015|Overall Study|Lost to Follow-up|4|||
130158487|NCT03502707|468542977|FG016|Overall Study|Lost to Follow-up|9|||
130158488|NCT03502707|468542978|FG017|Overall Study|Lost to Follow-up|2|||
130158489|NCT03502707|468542961|FG000|Overall Study|Physician Decision|0|||
130158490|NCT03502707|468542962|FG001|Overall Study|Physician Decision|0|||
130158491|NCT03502707|468542963|FG002|Overall Study|Physician Decision|0|||
130158492|NCT03502707|468542964|FG003|Overall Study|Physician Decision|0|||
130158493|NCT03502707|468542965|FG004|Overall Study|Physician Decision|0|||
130158494|NCT03502707|468542966|FG005|Overall Study|Physician Decision|0|||
130158495|NCT03502707|468542967|FG006|Overall Study|Physician Decision|0|||
130158496|NCT03502707|468542968|FG007|Overall Study|Physician Decision|0|||
130158497|NCT03502707|468542969|FG008|Overall Study|Physician Decision|2|||
130158498|NCT03502707|468542970|FG009|Overall Study|Physician Decision|1|||
130158499|NCT03502707|468542971|FG010|Overall Study|Physician Decision|0|||
130158500|NCT03502707|468542972|FG011|Overall Study|Physician Decision|0|||
130158501|NCT03502707|468542973|FG012|Overall Study|Physician Decision|0|||
130158502|NCT03502707|468542974|FG013|Overall Study|Physician Decision|0|||
130158503|NCT03502707|468542975|FG014|Overall Study|Physician Decision|1|||
130158504|NCT03502707|468542976|FG015|Overall Study|Physician Decision|3|||
130158505|NCT03502707|468542977|FG016|Overall Study|Physician Decision|0|||
130158506|NCT03502707|468542978|FG017|Overall Study|Physician Decision|0|||
130158507|NCT03502707|468542961|FG000|Overall Study|Protocol Violation|0|||
130158508|NCT03502707|468542962|FG001|Overall Study|Protocol Violation|0|||
130158509|NCT03502707|468542963|FG002|Overall Study|Protocol Violation|0|||
130158510|NCT03502707|468542964|FG003|Overall Study|Protocol Violation|0|||
130158511|NCT03502707|468542965|FG004|Overall Study|Protocol Violation|0|||
130158512|NCT03502707|468542966|FG005|Overall Study|Protocol Violation|0|||
130158513|NCT03502707|468542967|FG006|Overall Study|Protocol Violation|0|||
130158514|NCT03502707|468542968|FG007|Overall Study|Protocol Violation|0|||
130158515|NCT03502707|468542969|FG008|Overall Study|Protocol Violation|0|||
130158516|NCT03502707|468542970|FG009|Overall Study|Protocol Violation|0|||
130158517|NCT03502707|468542971|FG010|Overall Study|Protocol Violation|0|||
130158518|NCT03502707|468542972|FG011|Overall Study|Protocol Violation|0|||
130158519|NCT03502707|468542973|FG012|Overall Study|Protocol Violation|0|||
130158520|NCT03502707|468542974|FG013|Overall Study|Protocol Violation|0|||
130158521|NCT03502707|468542975|FG014|Overall Study|Protocol Violation|0|||
130158522|NCT03502707|468542976|FG015|Overall Study|Protocol Violation|1|||
130158523|NCT03502707|468542977|FG016|Overall Study|Protocol Violation|0|||
130158524|NCT03502707|468542978|FG017|Overall Study|Protocol Violation|0|||
130158525|NCT03502707|468542961|FG000|Overall Study|Withdrawal by Subject|1|||
130158526|NCT03502707|468542962|FG001|Overall Study|Withdrawal by Subject|1|||
130158527|NCT03502707|468542963|FG002|Overall Study|Withdrawal by Subject|0|||
130158528|NCT03502707|468542964|FG003|Overall Study|Withdrawal by Subject|0|||
130158529|NCT03502707|468542965|FG004|Overall Study|Withdrawal by Subject|0|||
130158530|NCT03502707|468542966|FG005|Overall Study|Withdrawal by Subject|2|||
130158531|NCT03502707|468542967|FG006|Overall Study|Withdrawal by Subject|0|||
130158532|NCT03502707|468542968|FG007|Overall Study|Withdrawal by Subject|3|||
130158533|NCT03502707|468542969|FG008|Overall Study|Withdrawal by Subject|1|||
130158534|NCT03502707|468542970|FG009|Overall Study|Withdrawal by Subject|2|||
130158535|NCT03502707|468542971|FG010|Overall Study|Withdrawal by Subject|12|||
130158536|NCT03502707|468542972|FG011|Overall Study|Withdrawal by Subject|23|||
130158537|NCT03502707|468542973|FG012|Overall Study|Withdrawal by Subject|5|||
130158538|NCT03502707|468542974|FG013|Overall Study|Withdrawal by Subject|3|||
130158539|NCT03502707|468542975|FG014|Overall Study|Withdrawal by Subject|3|||
130158540|NCT03502707|468542976|FG015|Overall Study|Withdrawal by Subject|43|||
130158541|NCT03502707|468542977|FG016|Overall Study|Withdrawal by Subject|44|||
130158542|NCT03502707|468542978|FG017|Overall Study|Withdrawal by Subject|18|||
130158543|NCT03502707|468542961|FG000|Overall Study|Sponsor's Decision|1|||
130158544|NCT03502707|468542962|FG001|Overall Study|Sponsor's Decision|0|||
130158545|NCT03502707|468542963|FG002|Overall Study|Sponsor's Decision|0|||
130158546|NCT03502707|468542964|FG003|Overall Study|Sponsor's Decision|0|||
130158547|NCT03502707|468542965|FG004|Overall Study|Sponsor's Decision|0|||
130158548|NCT03502707|468542966|FG005|Overall Study|Sponsor's Decision|0|||
130158549|NCT03502707|468542967|FG006|Overall Study|Sponsor's Decision|0|||
130158550|NCT03502707|468542968|FG007|Overall Study|Sponsor's Decision|0|||
130158551|NCT03502707|468542969|FG008|Overall Study|Sponsor's Decision|0|||
130158552|NCT03502707|468542970|FG009|Overall Study|Sponsor's Decision|1|||
130158553|NCT03502707|468542971|FG010|Overall Study|Sponsor's Decision|0|||
130158554|NCT03502707|468542972|FG011|Overall Study|Sponsor's Decision|0|||
130158555|NCT03502707|468542973|FG012|Overall Study|Sponsor's Decision|0|||
130158556|NCT03502707|468542974|FG013|Overall Study|Sponsor's Decision|0|||
130158557|NCT03502707|468542975|FG014|Overall Study|Sponsor's Decision|0|||
130158558|NCT03502707|468542976|FG015|Overall Study|Sponsor's Decision|2|||
130158559|NCT03502707|468542977|FG016|Overall Study|Sponsor's Decision|1|||
130158560|NCT03502707|468542978|FG017|Overall Study|Sponsor's Decision|0|||
130158561|NCT03502707|468542961|FG000|Overall Study|Initiated Prohibited Medication|0|||
130158562|NCT03502707|468542962|FG001|Overall Study|Initiated Prohibited Medication|0|||
130158563|NCT03502707|468542963|FG002|Overall Study|Initiated Prohibited Medication|0|||
129980696|NCT00730275|467893303|FG000|Overall Study|Withdrawal by Subject|0|||
129980697|NCT00730275|467893304|FG001|Overall Study|Withdrawal by Subject|0|||
129980698|NCT00730275|467893305|FG002|Overall Study|Withdrawal by Subject|0|||
129980699|NCT00730275|467893306|FG003|Overall Study|Withdrawal by Subject|1|||
130158564|NCT03502707|468542964|FG003|Overall Study|Initiated Prohibited Medication|0|||
130158565|NCT03502707|468542965|FG004|Overall Study|Initiated Prohibited Medication|0|||
130158566|NCT03502707|468542966|FG005|Overall Study|Initiated Prohibited Medication|0|||
130158567|NCT03502707|468542967|FG006|Overall Study|Initiated Prohibited Medication|0|||
130158568|NCT03502707|468542968|FG007|Overall Study|Initiated Prohibited Medication|0|||
130158569|NCT03502707|468542969|FG008|Overall Study|Initiated Prohibited Medication|0|||
130158570|NCT03502707|468542970|FG009|Overall Study|Initiated Prohibited Medication|0|||
130158571|NCT03502707|468542971|FG010|Overall Study|Initiated Prohibited Medication|0|||
130158572|NCT03502707|468542972|FG011|Overall Study|Initiated Prohibited Medication|0|||
130158573|NCT03502707|468542973|FG012|Overall Study|Initiated Prohibited Medication|0|||
130158574|NCT03502707|468542974|FG013|Overall Study|Initiated Prohibited Medication|0|||
130158575|NCT03502707|468542975|FG014|Overall Study|Initiated Prohibited Medication|0|||
130158576|NCT03502707|468542976|FG015|Overall Study|Initiated Prohibited Medication|0|||
130158577|NCT03502707|468542977|FG016|Overall Study|Initiated Prohibited Medication|1|||
130158578|NCT03502707|468542978|FG017|Overall Study|Initiated Prohibited Medication|0|||
130158579|NCT03502707|468542961|FG000|Overall Study|Other|0|||
130158580|NCT03502707|468542962|FG001|Overall Study|Other|0|||
130158581|NCT03502707|468542963|FG002|Overall Study|Other|0|||
130158582|NCT03502707|468542964|FG003|Overall Study|Other|0|||
130158583|NCT03502707|468542965|FG004|Overall Study|Other|0|||
130158584|NCT03502707|468542966|FG005|Overall Study|Other|0|||
130158585|NCT03502707|468542967|FG006|Overall Study|Other|0|||
130158586|NCT03502707|468542968|FG007|Overall Study|Other|0|||
130158587|NCT03502707|468542969|FG008|Overall Study|Other|1|||
130158588|NCT03502707|468542970|FG009|Overall Study|Other|1|||
130158589|NCT03502707|468542971|FG010|Overall Study|Other|2|||
130158590|NCT03502707|468542972|FG011|Overall Study|Other|0|||
130158591|NCT03502707|468542973|FG012|Overall Study|Other|0|||
130158592|NCT03502707|468542974|FG013|Overall Study|Other|0|||
130158593|NCT03502707|468542975|FG014|Overall Study|Other|0|||
130158594|NCT03502707|468542976|FG015|Overall Study|Other|4|||
130158595|NCT03502707|468542977|FG016|Overall Study|Other|1|||
130158596|NCT03502707|468542978|FG017|Overall Study|Other|0|||
130158597|NCT03502707|468542961|FG000|Overall Study|Randomized but not vaccinated|0|||
130158598|NCT03502707|468542962|FG001|Overall Study|Randomized but not vaccinated|0|||
130158599|NCT03502707|468542963|FG002|Overall Study|Randomized but not vaccinated|0|||
130158600|NCT03502707|468542964|FG003|Overall Study|Randomized but not vaccinated|0|||
130158601|NCT03502707|468542965|FG004|Overall Study|Randomized but not vaccinated|0|||
130158602|NCT03502707|468542966|FG005|Overall Study|Randomized but not vaccinated|0|||
130158603|NCT03502707|468542967|FG006|Overall Study|Randomized but not vaccinated|0|||
130158604|NCT03502707|468542968|FG007|Overall Study|Randomized but not vaccinated|0|||
130158605|NCT03502707|468542969|FG008|Overall Study|Randomized but not vaccinated|0|||
130158606|NCT03502707|468542970|FG009|Overall Study|Randomized but not vaccinated|0|||
130158607|NCT03502707|468542971|FG010|Overall Study|Randomized but not vaccinated|0|||
130158608|NCT03502707|468542972|FG011|Overall Study|Randomized but not vaccinated|1|||
130158609|NCT03502707|468542973|FG012|Overall Study|Randomized but not vaccinated|0|||
130158610|NCT03502707|468542974|FG013|Overall Study|Randomized but not vaccinated|0|||
130158611|NCT03502707|468542975|FG014|Overall Study|Randomized but not vaccinated|0|||
130158612|NCT03502707|468542976|FG015|Overall Study|Randomized but not vaccinated|0|||
130158613|NCT03502707|468542977|FG016|Overall Study|Randomized but not vaccinated|0|||
130158614|NCT03502707|468542978|FG017|Overall Study|Randomized but not vaccinated|1|||
130158615|NCT04908683|468542979|FG000|Overall Study|Failure to meet continuation criteria|34|||
130158616|NCT04908683|468542980|FG001|Overall Study|Failure to meet continuation criteria|22|||
130158617|NCT04908683|468542979|FG000|Overall Study|Initiated prohibited medication|3|||
130158618|NCT04908683|468542980|FG001|Overall Study|Initiated prohibited medication|0|||
130158619|NCT04908683|468542979|FG000|Overall Study|Randomized by mistake|1|||
130158620|NCT04908683|468542980|FG001|Overall Study|Randomized by mistake|0|||
130158621|NCT04908683|468542979|FG000|Overall Study|Lost to Follow-up|679|||
130158622|NCT04908683|468542980|FG001|Overall Study|Lost to Follow-up|341|||
130158623|NCT04908683|468542979|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
130158624|NCT04908683|468542980|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
130158625|NCT04908683|468542979|FG000|Overall Study|Physician Decision|44|||
130158626|NCT04908683|468542980|FG001|Overall Study|Physician Decision|35|||
130158627|NCT04908683|468542979|FG000|Overall Study|Technical problems|12|||
130158628|NCT04908683|468542980|FG001|Overall Study|Technical problems|9|||
130158629|NCT04908683|468542979|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
130158630|NCT04908683|468542980|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
130158631|NCT04908683|468542979|FG000|Overall Study|Protocol Violation|2|||
130158632|NCT04908683|468542980|FG001|Overall Study|Protocol Violation|0|||
130158633|NCT04908683|468542979|FG000|Overall Study|Withdrawal by Subject|1188|||
130158634|NCT04908683|468542980|FG001|Overall Study|Withdrawal by Subject|570|||
130158635|NCT04908683|468542979|FG000|Overall Study|Site Closure by Sponsor|6|||
130158636|NCT04908683|468542980|FG001|Overall Study|Site Closure by Sponsor|3|||
130158637|NCT04908683|468542979|FG000|Overall Study|Adverse Event|21|||
130158638|NCT04908683|468542980|FG001|Overall Study|Adverse Event|11|||
129980700|NCT00939822|467893311|FG000|Overall Study|Lost to Follow-up|1|||
130158639|NCT04908683|468542979|FG000|Overall Study|Death|101|||
129980701|NCT00939822|467893312|FG001|Overall Study|Lost to Follow-up|0|||
130158640|NCT04908683|468542980|FG001|Overall Study|Death|61|||
130158641|NCT04908683|468542979|FG000|Overall Study|Sponsor's decision|14398|||
130158642|NCT04908683|468542980|FG001|Overall Study|Sponsor's decision|7205|||
130158643|NCT04908683|468542979|FG000|Overall Study|Other|92|||
130158644|NCT04908683|468542980|FG001|Overall Study|Other|50|||
130158645|NCT04908683|468542979|FG000|Overall Study|Randomized not vaccinated|108|||
130158646|NCT04908683|468542980|FG001|Overall Study|Randomized not vaccinated|52|||
130158647|NCT02221037|468542982|FG000|Overall Study|Physician Decision|0|||
130158648|NCT02221037|468542983|FG001|Overall Study|Physician Decision|0|||
130158649|NCT02221037|468542984|FG002|Overall Study|Physician Decision|1|||
130158650|NCT02221037|468542985|FG003|Overall Study|Physician Decision|0|||
130158651|NCT01884311|468542986|FG000|Overall Study|Withdrawal by Subject|3|||
130158652|NCT01884311|468542986|FG000|Overall Study|withdrew consent due to AEs|1|||
130158653|NCT01884311|468542986|FG000|Overall Study|Precautionary measure|1|||
130158654|NCT02307266|468542987|FG000|Overall Study|Adverse Event|3|||
130158655|NCT02307266|468542988|FG001|Overall Study|Adverse Event|1|||
130158656|NCT02307266|468542989|FG002|Overall Study|Adverse Event|5|||
130158657|NCT02307266|468542987|FG000|Overall Study|Withdrawal by Subject|2|||
130158658|NCT02307266|468542988|FG001|Overall Study|Withdrawal by Subject|0|||
130158659|NCT02307266|468542989|FG002|Overall Study|Withdrawal by Subject|1|||
130158660|NCT02307266|468542987|FG000|Overall Study|Lost to Follow-up|3|||
130158661|NCT02307266|468542988|FG001|Overall Study|Lost to Follow-up|0|||
130158662|NCT02307266|468542989|FG002|Overall Study|Lost to Follow-up|0|||
130158663|NCT01293539|468543001|FG000|Overall Study|Physician Decision|1|||
130158664|NCT00866658|468543002|FG000|Overall Study|Adverse Event|5|||
130158665|NCT00866658|468543003|FG001|Overall Study|Adverse Event|14|||
130158666|NCT00866658|468543002|FG000|Overall Study|Lack of Efficacy|2|||
130158667|NCT00866658|468543003|FG001|Overall Study|Lack of Efficacy|1|||
130158668|NCT00866658|468543002|FG000|Overall Study|Withdrawal by Subject|1|||
130158669|NCT00866658|468543003|FG001|Overall Study|Withdrawal by Subject|0|||
130158670|NCT00866658|468543002|FG000|Overall Study|Protocol Violation|1|||
130158671|NCT00866658|468543003|FG001|Overall Study|Protocol Violation|1|||
130158672|NCT00866658|468543002|FG000|Overall Study|Familial and Personal Reasons|4|||
130158673|NCT00866658|468543003|FG001|Overall Study|Familial and Personal Reasons|5|||
130158674|NCT00609518|468543004|FG000|Overall Study|Death from Study Disease|32|||
130158675|NCT00609518|468543005|FG001|Overall Study|Death from Study Disease|32|||
130158676|NCT00609518|468543004|FG000|Overall Study|Withdrawal by Subject|5|||
130158677|NCT00609518|468543005|FG001|Overall Study|Withdrawal by Subject|3|||
130158678|NCT00609518|468543004|FG000|Overall Study|Lost to Follow-up|3|||
130158679|NCT00609518|468543005|FG001|Overall Study|Lost to Follow-up|0|||
130158680|NCT00609518|468543004|FG000|Overall Study|Physician Decision|1|||
130158681|NCT00609518|468543005|FG001|Overall Study|Physician Decision|3|||
130158682|NCT00609518|468543004|FG000|Overall Study|Death from Adverse Event|2|||
130158683|NCT00609518|468543005|FG001|Overall Study|Death from Adverse Event|2|||
130158684|NCT01687478|468543006|FG000|Overall Study|Adverse Event|3|||
130158685|NCT01687478|468543007|FG001|Overall Study|Adverse Event|10|||
130158686|NCT01687478|468543006|FG000|Overall Study|Lost to Follow-up|1|||
130158687|NCT01687478|468543007|FG001|Overall Study|Lost to Follow-up|3|||
130158688|NCT01687478|468543006|FG000|Overall Study|Protocol Violation|0|||
130158689|NCT01687478|468543007|FG001|Overall Study|Protocol Violation|2|||
130158690|NCT01687478|468543006|FG000|Overall Study|Withdrawal by Subject|21|||
130158691|NCT01687478|468543007|FG001|Overall Study|Withdrawal by Subject|19|||
130158692|NCT01687478|468543006|FG000|Overall Study|Physician Decision|1|||
130158693|NCT01687478|468543007|FG001|Overall Study|Physician Decision|3|||
130158694|NCT01687478|468543006|FG000|Overall Study|Entry Criteria Not Met|6|||
130158695|NCT01687478|468543007|FG001|Overall Study|Entry Criteria Not Met|2|||
130158696|NCT05855616|468543011|FG000|Overall Study|Lost to Follow-up|1|||
130158697|NCT05855616|468543012|FG001|Overall Study|Lost to Follow-up|2|||
130158698|NCT00059787|468543013|FG000|Overall Study|Adverse Event|13|||
130158699|NCT00059787|468543013|FG000|Overall Study|disease progression|2|||
130158700|NCT00059787|468543013|FG000|Overall Study|ineligible|1|||
130158701|NCT00059787|468543013|FG000|Overall Study|Other|4|||
130158702|NCT00292188|468543014|FG000|Single-Blind|Adverse Event|14|||
130158703|NCT00292188|468543015|FG001|Single-Blind|Adverse Event|0|||
130158704|NCT00292188|468543016|FG002|Single-Blind|Adverse Event|0|||
130158705|NCT00292188|468543014|FG000|Single-Blind|Lack of Efficacy|2|||
130158706|NCT00292188|468543015|FG001|Single-Blind|Lack of Efficacy|0|||
130158707|NCT00292188|468543016|FG002|Single-Blind|Lack of Efficacy|0|||
130158708|NCT00292188|468543014|FG000|Single-Blind|Laboratory Abnormality|5|||
130158709|NCT00292188|468543015|FG001|Single-Blind|Laboratory Abnormality|0|||
130158710|NCT00292188|468543016|FG002|Single-Blind|Laboratory Abnormality|0|||
130158711|NCT00292188|468543014|FG000|Single-Blind|Lost to Follow-up|3|||
130158712|NCT00292188|468543015|FG001|Single-Blind|Lost to Follow-up|0|||
130158713|NCT00292188|468543016|FG002|Single-Blind|Lost to Follow-up|0|||
130158714|NCT00292188|468543014|FG000|Single-Blind|Other|77|||
130158715|NCT00292188|468543015|FG001|Single-Blind|Other|0|||
130158716|NCT00292188|468543016|FG002|Single-Blind|Other|0|||
130158717|NCT00292188|468543014|FG000|Single-Blind|Withdrawal by Subject|12|||
130158718|NCT00292188|468543015|FG001|Single-Blind|Withdrawal by Subject|0|||
130158719|NCT00292188|468543016|FG002|Single-Blind|Withdrawal by Subject|0|||
130158720|NCT00292188|468543014|FG000|Single-Blind|Did not receive treatment|1|||
130158721|NCT00292188|468543015|FG001|Single-Blind|Did not receive treatment|0|||
129980702|NCT00939822|467893311|FG000|Overall Study|withdrew from study due to busy schedule|1|||
130158722|NCT00292188|468543016|FG002|Single-Blind|Did not receive treatment|0|||
130158723|NCT00292188|468543014|FG000|Double-Blind|Adverse Event|0|||
130158724|NCT00292188|468543015|FG001|Double-Blind|Adverse Event|25|||
130158725|NCT00292188|468543016|FG002|Double-Blind|Adverse Event|9|||
130158726|NCT00292188|468543014|FG000|Double-Blind|Lack of Efficacy|0|||
130158727|NCT00292188|468543015|FG001|Double-Blind|Lack of Efficacy|2|||
130158728|NCT00292188|468543016|FG002|Double-Blind|Lack of Efficacy|12|||
130158729|NCT00292188|468543014|FG000|Double-Blind|Lost to Follow-up|0|||
130158730|NCT00292188|468543015|FG001|Double-Blind|Lost to Follow-up|1|||
130158731|NCT00292188|468543016|FG002|Double-Blind|Lost to Follow-up|0|||
130158732|NCT00292188|468543014|FG000|Double-Blind|Other|0|||
130158733|NCT00292188|468543015|FG001|Double-Blind|Other|3|||
130158734|NCT00292188|468543016|FG002|Double-Blind|Other|4|||
130158735|NCT00292188|468543014|FG000|Double-Blind|Withdrawal by Subject|0|||
130158736|NCT00292188|468543015|FG001|Double-Blind|Withdrawal by Subject|0|||
130158737|NCT00292188|468543016|FG002|Double-Blind|Withdrawal by Subject|3|||
130158738|NCT00292188|468543014|FG000|Double-Blind|Laboratory Abnormality|0|||
130158739|NCT00292188|468543015|FG001|Double-Blind|Laboratory Abnormality|0|||
130158740|NCT00292188|468543016|FG002|Double-Blind|Laboratory Abnormality|1|||
130158741|NCT00824616|468543017|FG000|Overall Study|Adverse Event|2|||
130158742|NCT00824616|468543018|FG001|Overall Study|Adverse Event|1|||
130158743|NCT00824616|468543017|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
130158744|NCT00824616|468543018|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
130158745|NCT00824616|468543017|FG000|Overall Study|Hyperglycemia|1|||
130158746|NCT00824616|468543018|FG001|Overall Study|Hyperglycemia|1|||
130158747|NCT00824616|468543017|FG000|Overall Study|Lack of Efficacy|2|||
130158748|NCT00824616|468543018|FG001|Overall Study|Lack of Efficacy|1|||
130158749|NCT00824616|468543017|FG000|Overall Study|Lost to Follow-up|0|||
130158750|NCT00824616|468543018|FG001|Overall Study|Lost to Follow-up|1|||
130158751|NCT00824616|468543017|FG000|Overall Study|Withdrawal by Subject|1|||
130158752|NCT00824616|468543018|FG001|Overall Study|Withdrawal by Subject|1|||
130158753|NCT04322149|468543019|FG000|Overall Study|Adverse Event|1|||
130158754|NCT04322149|468543020|FG001|Overall Study|Adverse Event|1|||
130158755|NCT04322149|468543021|FG002|Overall Study|Adverse Event|0|||
130158756|NCT04322149|468543022|FG003|Overall Study|Adverse Event|0|||
130158757|NCT04322149|468543019|FG000|Overall Study|Withdrawal by Subject|0|||
130158758|NCT04322149|468543020|FG001|Overall Study|Withdrawal by Subject|0|||
130158759|NCT04322149|468543021|FG002|Overall Study|Withdrawal by Subject|0|||
130158760|NCT04322149|468543022|FG003|Overall Study|Withdrawal by Subject|2|||
130158761|NCT04322149|468543019|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130158762|NCT04322149|468543020|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
130158763|NCT04322149|468543021|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130158764|NCT04322149|468543022|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
130158765|NCT00103311|468543031|FG000|Overall Study|Lost to Follow-up|1|||
130158766|NCT00103311|468543032|FG001|Overall Study|Lost to Follow-up|0|||
130158767|NCT00103311|468543031|FG000|Overall Study|Withdrawal by Subject|2|||
130158768|NCT00103311|468543032|FG001|Overall Study|Withdrawal by Subject|1|||
130158769|NCT00103311|468543031|FG000|Overall Study|Adverse Event|1|||
130158770|NCT00103311|468543032|FG001|Overall Study|Adverse Event|0|||
130158771|NCT00974974|468543037|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
130158772|NCT00974974|468543038|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
130158773|NCT00974974|468543037|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
130158774|NCT00974974|468543038|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
130158775|NCT00974974|468543037|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
130158776|NCT00974974|468543038|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
130158777|NCT00974974|468543037|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
130158778|NCT00974974|468543038|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
130158779|NCT00974974|468543037|FG000|IR CD-LD Dose Adjustment|Various|0|||
130158780|NCT00974974|468543038|FG001|IR CD-LD Dose Adjustment|Various|9|||
130158781|NCT00974974|468543037|FG000|IPX066 Dose Conversion|Adverse Event|23|||
129980703|NCT00939822|467893312|FG001|Overall Study|withdrew from study due to busy schedule|1|||
129980704|NCT00939822|467893311|FG000|Overall Study|Mental health issues|0|||
129980705|NCT00939822|467893312|FG001|Overall Study|Mental health issues|2|||
130158782|NCT00974974|468543038|FG001|IPX066 Dose Conversion|Adverse Event|0|||
130158783|NCT00974974|468543037|FG000|IPX066 Dose Conversion|Death|2|||
130158784|NCT00974974|468543038|FG001|IPX066 Dose Conversion|Death|0|||
130158785|NCT00974974|468543037|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
130158786|NCT00974974|468543038|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
130158787|NCT00974974|468543037|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
130158788|NCT00974974|468543038|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
130158789|NCT00974974|468543037|FG000|IPX066 Dose Conversion|Various|3|||
130158790|NCT00974974|468543038|FG001|IPX066 Dose Conversion|Various|0|||
130158791|NCT00974974|468543037|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
130158792|NCT00974974|468543038|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
130158793|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
129980706|NCT03046121|467893315|FG000|Overall Study|Death|32|||
130158794|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
130158795|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
130158796|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
130158797|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
130158798|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
130158799|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
130158800|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
130158801|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
130158802|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
130158803|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
130158804|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
130158805|NCT00974974|468543037|FG000|Maintenance - Double Blind Treatment|Various|4|||
130158806|NCT00974974|468543038|FG001|Maintenance - Double Blind Treatment|Various|0|||
130158807|NCT03254602|468543039|FG000|Overall Study|Lost to Follow-up|4|||
130158808|NCT02836496|468543046|FG000|Overall Study|Adverse Event|2|||
130158809|NCT02836496|468543047|FG001|Overall Study|Adverse Event|1|||
130158810|NCT02836496|468543046|FG000|Overall Study|Withdrawal by Subject|0|||
130158811|NCT02836496|468543047|FG001|Overall Study|Withdrawal by Subject|1|||
130158812|NCT03822832|468543048|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
130158813|NCT03822832|468543049|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
130158814|NCT03822832|468543048|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
130158815|NCT03822832|468543049|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
130158816|NCT03822832|468543048|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
130158817|NCT03822832|468543049|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
130158818|NCT03822832|468543048|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
130158819|NCT03822832|468543049|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
130158820|NCT03822832|468543048|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
130158821|NCT03822832|468543049|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
130158822|NCT03822832|468543048|FG000|Re-allocation|Not re-allocated to open label period|2|||
130158823|NCT03822832|468543049|FG001|Re-allocation|Not re-allocated to open label period|6|||
130158824|NCT03822832|468543048|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
130158825|NCT03822832|468543049|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
130158826|NCT03822832|468543048|FG000|Period 2 - Open Label Period|Adverse Event|0|||
130158827|NCT03822832|468543049|FG001|Period 2 - Open Label Period|Adverse Event|3|||
130158828|NCT03914950|468543054|FG000|Overall Study|Physician Decision|54|||
130158829|NCT02575911|468543055|FG000|Overall Study|Lost to Follow-up|1|||
130158830|NCT01249365|468543056|FG000|Overall Study|Lost to Follow-up|1|||
130158831|NCT01460901|468543057|FG000|Overall Study|Withdrawal by Subject|2|||
130158832|NCT02566993|468543058|FG000|Overall Study|Randomized but not treated|5|||
130158833|NCT02566993|468543059|FG001|Overall Study|Randomized but not treated|16|||
130158834|NCT02566993|468543058|FG000|Overall Study|Progressive disease|213|||
130158835|NCT02566993|468543059|FG001|Overall Study|Progressive disease|152|||
130158836|NCT02566993|468543058|FG000|Overall Study|Withdrawal by Subject|12|||
130158837|NCT02566993|468543059|FG001|Overall Study|Withdrawal by Subject|28|||
130158838|NCT02566993|468543058|FG000|Overall Study|Death|17|||
130158839|NCT02566993|468543059|FG001|Overall Study|Death|23|||
130158840|NCT02566993|468543058|FG000|Overall Study|Physician Decision|10|||
130158841|NCT02566993|468543059|FG001|Overall Study|Physician Decision|17|||
130158842|NCT02566993|468543058|FG000|Overall Study|Study drug-related adverse event|20|||
130158843|NCT02566993|468543059|FG001|Overall Study|Study drug-related adverse event|41|||
130158844|NCT02566993|468543058|FG000|Overall Study|Non study drug-related adverse event|9|||
130158845|NCT02566993|468543059|FG001|Overall Study|Non study drug-related adverse event|9|||
130158846|NCT02566993|468543058|FG000|Overall Study|Symptomatic deterioration|9|||
130158847|NCT02566993|468543059|FG001|Overall Study|Symptomatic deterioration|16|||
130158848|NCT02566993|468543058|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
130158849|NCT02566993|468543059|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
130158850|NCT02566993|468543058|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
130158851|NCT02566993|468543059|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
130158852|NCT02566993|468543058|FG000|Overall Study|Screening failure|2|||
130158853|NCT02566993|468543059|FG001|Overall Study|Screening failure|0|||
130158854|NCT02566993|468543058|FG000|Overall Study|Lost to Follow-up|0|||
130158855|NCT02566993|468543059|FG001|Overall Study|Lost to Follow-up|1|||
130158856|NCT02566993|468543058|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
130158857|NCT02566993|468543059|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
130158858|NCT01169532|468543061|FG000|Overall Study|Withdrawal by Subject|1|||
130158859|NCT03127644|468543072|FG000|Overall Study|Study-specific withdrawal criteria|0|||
130158860|NCT03127644|468543073|FG001|Overall Study|Study-specific withdrawal criteria|0|||
130158861|NCT03127644|468543074|FG002|Overall Study|Study-specific withdrawal criteria|2|||
130158862|NCT01550744|468543075|FG000|Open-Label|Lost to Follow-up|7|||
130158863|NCT01550744|468543076|FG001|Open-Label|Lost to Follow-up|0|||
130158864|NCT01550744|468543077|FG002|Open-Label|Lost to Follow-up|0|||
130158865|NCT01550744|468543075|FG000|Open-Label|Withdrawal by Subject|13|||
129980707|NCT03046121|467893316|FG001|Overall Study|Death|60|||
129980708|NCT03046121|467893315|FG000|Overall Study|Withdrawal by Subject|14|||
129980709|NCT03046121|467893316|FG001|Overall Study|Withdrawal by Subject|12|||
129980710|NCT00910039|467893317|FG000|Overall Study|Physician Decision|1|||
129980711|NCT03547739|467893324|FG000|Overall Study|Death|0|||
129980712|NCT03547739|467893325|FG001|Overall Study|Death|1|||
129980713|NCT03547739|467893326|FG002|Overall Study|Death|5|||
129980714|NCT03547739|467893324|FG000|Overall Study|Adverse Event|24|||
129980715|NCT03547739|467893325|FG001|Overall Study|Adverse Event|11|||
129980716|NCT03547739|467893326|FG002|Overall Study|Adverse Event|13|||
129980717|NCT03547739|467893324|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
129980718|NCT03547739|467893325|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
129980719|NCT03547739|467893326|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
129980720|NCT03547739|467893324|FG000|Overall Study|Lost to Follow-up|80|||
129980721|NCT03547739|467893325|FG001|Overall Study|Lost to Follow-up|84|||
129980722|NCT03547739|467893326|FG002|Overall Study|Lost to Follow-up|116|||
129980723|NCT04035499|467893329|FG000|Overall Study|Death|2|||
129980724|NCT04035499|467893329|FG000|Overall Study|Withdrawal by Subject|1|||
129980725|NCT00416195|467893330|FG000|Overall Study|Adverse Event|1|||
129980726|NCT00416195|467893331|FG001|Overall Study|Adverse Event|2|||
129980727|NCT00416195|467893330|FG000|Overall Study|Protocol Violation|1|||
129980728|NCT00416195|467893331|FG001|Overall Study|Protocol Violation|1|||
129980729|NCT00416195|467893330|FG000|Overall Study|Other|0|||
129980730|NCT00416195|467893331|FG001|Overall Study|Other|1|||
129980731|NCT01305408|467893337|FG000|Overall Study|Adverse Event|10|||
129980732|NCT01305408|467893338|FG001|Overall Study|Adverse Event|7|||
129980733|NCT01305408|467893337|FG000|Overall Study|Lack of Efficacy|3|||
129980734|NCT01305408|467893338|FG001|Overall Study|Lack of Efficacy|4|||
129980735|NCT01305408|467893337|FG000|Overall Study|Withdrawal by Subject|9|||
129980736|NCT01305408|467893338|FG001|Overall Study|Withdrawal by Subject|9|||
129980737|NCT01305408|467893337|FG000|Overall Study|Protocol Violation|4|||
129980738|NCT01305408|467893338|FG001|Overall Study|Protocol Violation|6|||
129980739|NCT01305408|467893337|FG000|Overall Study|Lost to Follow-up|5|||
129980740|NCT01305408|467893338|FG001|Overall Study|Lost to Follow-up|3|||
129980741|NCT01305408|467893337|FG000|Overall Study|Noncompliance with study medication|0|||
129980742|NCT01305408|467893338|FG001|Overall Study|Noncompliance with study medication|1|||
129980743|NCT01305408|467893337|FG000|Overall Study|Noncompliance with study procedures|0|||
129980744|NCT01305408|467893338|FG001|Overall Study|Noncompliance with study procedures|1|||
129980745|NCT01305408|467893337|FG000|Overall Study|Other|1|||
129980746|NCT01305408|467893338|FG001|Overall Study|Other|0|||
129980747|NCT02530970|467893339|FG000|Overall Study|Adverse Event|8|||
129980748|NCT02530970|467893339|FG000|Overall Study|Lost to Follow-up|88|||
129980749|NCT02530970|467893339|FG000|Overall Study|Physician Decision|5|||
129980750|NCT02530970|467893339|FG000|Overall Study|Withdrawal by Subject|14|||
129980751|NCT02530970|467893339|FG000|Overall Study|Death|6|||
129980752|NCT02530970|467893339|FG000|Overall Study|Hospitalization|1|||
129980753|NCT02530970|467893339|FG000|Overall Study|Insurance|2|||
129980754|NCT02530970|467893339|FG000|Overall Study|Explant|2|||
129980755|NCT02530970|467893339|FG000|Overall Study|Change in Provider|5|||
129980756|NCT02530970|467893339|FG000|Overall Study|Relocation|3|||
129980757|NCT02770612|467893341|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
129980758|NCT00958841|467893346|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129980759|NCT00958841|467893346|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129980760|NCT00958841|467893346|FG000|Overall Study|Administrative problems|1|||
129980761|NCT00958841|467893346|FG000|Overall Study|Adverse Event|8|||
129980762|NCT00958841|467893346|FG000|Overall Study|New cancer therapy|5|||
129980763|NCT00958841|467893346|FG000|Overall Study|Withdrawal by Subject|1|||
129980764|NCT00958841|467893346|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
129980765|NCT00958841|467893346|FG000|Overall Study|Completed M6/did not enter extension|27|||
129980766|NCT00958841|467893346|FG000|Overall Study|Discontinued prior to M*|28|||
129980767|NCT03014011|467893354|FG000|First Intervention|Withdrawal by Subject|1|||
129980768|NCT03014011|467893355|FG001|First Intervention|Withdrawal by Subject|0|||
129980769|NCT03014011|467893354|FG000|Washout|Withdrawal by Subject|1|||
129980770|NCT03014011|467893355|FG001|Washout|Withdrawal by Subject|0|||
129980771|NCT02416453|467893357|FG000|Overall Study|Adverse Event|0|||
129980772|NCT02416453|467893358|FG001|Overall Study|Adverse Event|0|||
129980773|NCT02416453|467893359|FG002|Overall Study|Adverse Event|0|||
129980774|NCT02416453|467893360|FG003|Overall Study|Adverse Event|2|||
129980775|NCT02416453|467893361|FG004|Overall Study|Adverse Event|0|||
129980776|NCT02416453|467893362|FG005|Overall Study|Adverse Event|1|||
129980777|NCT02416453|467893363|FG006|Overall Study|Adverse Event|0|||
129980778|NCT02416453|467893364|FG007|Overall Study|Adverse Event|0|||
129980779|NCT02416453|467893365|FG008|Overall Study|Adverse Event|0|||
129980780|NCT02416453|467893366|FG009|Overall Study|Adverse Event|0|||
129980781|NCT02416453|467893367|FG010|Overall Study|Adverse Event|0|||
129980782|NCT02416453|467893357|FG000|Overall Study|Lost to Follow-up|1|||
129980783|NCT02416453|467893358|FG001|Overall Study|Lost to Follow-up|3|||
129980784|NCT02416453|467893359|FG002|Overall Study|Lost to Follow-up|0|||
130158866|NCT01550744|468543076|FG001|Open-Label|Withdrawal by Subject|0|||
130158867|NCT01550744|468543077|FG002|Open-Label|Withdrawal by Subject|0|||
130158868|NCT01550744|468543075|FG000|Open-Label|Adverse Event|11|||
130158869|NCT01550744|468543076|FG001|Open-Label|Adverse Event|0|||
130158870|NCT01550744|468543077|FG002|Open-Label|Adverse Event|0|||
130158871|NCT01550744|468543075|FG000|Open-Label|Lack of Efficacy|4|||
130158872|NCT01550744|468543076|FG001|Open-Label|Lack of Efficacy|0|||
130158873|NCT01550744|468543077|FG002|Open-Label|Lack of Efficacy|0|||
130158874|NCT01550744|468543075|FG000|Open-Label|Protocol Violation|4|||
130158875|NCT01550744|468543076|FG001|Open-Label|Protocol Violation|0|||
130158876|NCT01550744|468543077|FG002|Open-Label|Protocol Violation|0|||
130158877|NCT01550744|468543075|FG000|Open-Label|Not all 3 study drug injections received|2|||
130158878|NCT01550744|468543076|FG001|Open-Label|Not all 3 study drug injections received|0|||
130158879|NCT01550744|468543077|FG002|Open-Label|Not all 3 study drug injections received|0|||
130158880|NCT01550744|468543075|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
130158881|NCT01550744|468543076|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
130158882|NCT01550744|468543077|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
130158883|NCT01550744|468543075|FG000|Open-Label|Other|1|||
130158884|NCT01550744|468543076|FG001|Open-Label|Other|0|||
130158885|NCT01550744|468543077|FG002|Open-Label|Other|0|||
130158886|NCT01550744|468543075|FG000|Double-Blind|Lost to Follow-up|0|||
130158887|NCT01550744|468543076|FG001|Double-Blind|Lost to Follow-up|6|||
130158888|NCT01550744|468543077|FG002|Double-Blind|Lost to Follow-up|12|||
130158889|NCT01550744|468543075|FG000|Double-Blind|Withdrawal by Subject|0|||
130158890|NCT01550744|468543076|FG001|Double-Blind|Withdrawal by Subject|2|||
130158891|NCT01550744|468543077|FG002|Double-Blind|Withdrawal by Subject|15|||
130158892|NCT01550744|468543075|FG000|Double-Blind|Adverse Event|0|||
130158893|NCT01550744|468543076|FG001|Double-Blind|Adverse Event|4|||
130158894|NCT01550744|468543077|FG002|Double-Blind|Adverse Event|15|||
130158895|NCT01550744|468543075|FG000|Double-Blind|Death|0|||
130158896|NCT01550744|468543076|FG001|Double-Blind|Death|1|||
130158897|NCT01550744|468543077|FG002|Double-Blind|Death|0|||
130158898|NCT01550744|468543075|FG000|Double-Blind|Lack of Efficacy|0|||
130158899|NCT01550744|468543076|FG001|Double-Blind|Lack of Efficacy|2|||
130158900|NCT01550744|468543077|FG002|Double-Blind|Lack of Efficacy|8|||
130158901|NCT01550744|468543075|FG000|Double-Blind|Protocol Violation|0|||
130158902|NCT01550744|468543076|FG001|Double-Blind|Protocol Violation|0|||
130158903|NCT01550744|468543077|FG002|Double-Blind|Protocol Violation|4|||
130158904|NCT01550744|468543075|FG000|Double-Blind|Pregnancy|0|||
130158905|NCT01550744|468543076|FG001|Double-Blind|Pregnancy|0|||
130158906|NCT01550744|468543077|FG002|Double-Blind|Pregnancy|3|||
130158907|NCT01550744|468543075|FG000|Double-Blind|Other|0|||
130158908|NCT01550744|468543076|FG001|Double-Blind|Other|2|||
130158909|NCT01550744|468543077|FG002|Double-Blind|Other|10|||
130158910|NCT00311311|468543078|FG000|Overall Study|Adverse Event|3|||
130158911|NCT00311311|468543079|FG001|Overall Study|Adverse Event|2|||
130158912|NCT00311311|468543078|FG000|Overall Study|Withdrawal by Subject|1|||
130158913|NCT00311311|468543079|FG001|Overall Study|Withdrawal by Subject|1|||
130158914|NCT00311311|468543078|FG000|Overall Study|Noncompliance|0|||
130158915|NCT00311311|468543079|FG001|Overall Study|Noncompliance|1|||
130158916|NCT00311311|468543078|FG000|Overall Study|Study Termination by Sponsor|3|||
130158917|NCT00311311|468543079|FG001|Overall Study|Study Termination by Sponsor|4|||
130158918|NCT00311311|468543078|FG000|Overall Study|Death|1|||
130158919|NCT00311311|468543079|FG001|Overall Study|Death|0|||
130158920|NCT00311311|468543078|FG000|Overall Study|Lack of ancillary assistance|0|||
130158921|NCT00311311|468543079|FG001|Overall Study|Lack of ancillary assistance|1|||
130158922|NCT00988065|468543081|FG000|Overall Study|Adverse Event|4|||
130158923|NCT00988065|468543082|FG001|Overall Study|Adverse Event|10|||
130158924|NCT00988065|468543083|FG002|Overall Study|Adverse Event|2|||
130158925|NCT00988065|468543081|FG000|Overall Study|Lost to Follow-up|1|||
130158926|NCT00988065|468543082|FG001|Overall Study|Lost to Follow-up|2|||
130158927|NCT00988065|468543083|FG002|Overall Study|Lost to Follow-up|2|||
130158928|NCT00988065|468543081|FG000|Overall Study|Subject withdrew consent|3|||
130158929|NCT00988065|468543082|FG001|Overall Study|Subject withdrew consent|5|||
130158930|NCT00988065|468543083|FG002|Overall Study|Subject withdrew consent|2|||
130158931|NCT00988065|468543081|FG000|Overall Study|Noncompliance with protocol|5|||
130158932|NCT00988065|468543082|FG001|Overall Study|Noncompliance with protocol|6|||
130158933|NCT00988065|468543083|FG002|Overall Study|Noncompliance with protocol|9|||
130158934|NCT02685202|468543084|FG000|Overall Study|Lost to Follow-up|9|||
130158935|NCT01229735|468543085|FG000|Overall Study|Lack of Efficacy|8|||
130158936|NCT01229735|468543086|FG001|Overall Study|Lack of Efficacy|8|||
130158937|NCT01229735|468543085|FG000|Overall Study|Protocol Violation|13|||
130158938|NCT01229735|468543086|FG001|Overall Study|Protocol Violation|8|||
130158939|NCT01229735|468543085|FG000|Overall Study|Lost to Follow-up|0|||
130158940|NCT01229735|468543086|FG001|Overall Study|Lost to Follow-up|2|||
130158941|NCT01229735|468543085|FG000|Overall Study|Withdrawal by Subject|18|||
130158942|NCT01229735|468543086|FG001|Overall Study|Withdrawal by Subject|17|||
130158943|NCT01229735|468543085|FG000|Overall Study|Other Reason|13|||
130158944|NCT01229735|468543086|FG001|Overall Study|Other Reason|10|||
130158945|NCT01229735|468543085|FG000|Overall Study|SAE, non-fatal|0|||
130158946|NCT01229735|468543086|FG001|Overall Study|SAE, non-fatal|4|||
130158947|NCT01229735|468543085|FG000|Overall Study|AE, non-serious non-fatal|13|||
130158948|NCT01229735|468543086|FG001|Overall Study|AE, non-serious non-fatal|17|||
130158949|NCT01229735|468543085|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
130158950|NCT01229735|468543086|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
130158951|NCT02787408|468543087|FG000|Overall Study|Death|16|||
130158952|NCT02787408|468543087|FG000|Overall Study|Withdrawal by Subject|1|||
130158953|NCT02787408|468543087|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
130158954|NCT00985712|468543088|FG000|Overall Study|Adverse Event|0|||
130158955|NCT00985712|468543089|FG001|Overall Study|Adverse Event|1|||
130158956|NCT00985712|468543088|FG000|Overall Study|Lost to Follow-up|2|||
130158957|NCT00985712|468543089|FG001|Overall Study|Lost to Follow-up|2|||
130158958|NCT00985712|468543088|FG000|Overall Study|Protocol Violation|0|||
130158959|NCT00985712|468543089|FG001|Overall Study|Protocol Violation|1|||
130158960|NCT00985712|468543088|FG000|Overall Study|Withdrawal by Subject|4|||
130158961|NCT00985712|468543089|FG001|Overall Study|Withdrawal by Subject|1|||
130158962|NCT00985712|468543088|FG000|Overall Study|Sponsor decision|0|||
130158963|NCT00985712|468543089|FG001|Overall Study|Sponsor decision|2|||
130158964|NCT01000493|468543092|FG000|Overall Study|Adverse Event|3|||
130158965|NCT01000493|468543093|FG001|Overall Study|Adverse Event|6|||
130158966|NCT01000493|468543092|FG000|Overall Study|Lack of Efficacy|1|||
130158967|NCT01000493|468543093|FG001|Overall Study|Lack of Efficacy|1|||
130158968|NCT01000493|468543092|FG000|Overall Study|Protocol Violation|1|||
130158969|NCT01000493|468543093|FG001|Overall Study|Protocol Violation|8|||
130158970|NCT01000493|468543092|FG000|Overall Study|Study closed/terminated|25|||
130158971|NCT01000493|468543093|FG001|Overall Study|Study closed/terminated|23|||
130158972|NCT01000493|468543092|FG000|Overall Study|Lost to Follow-up|5|||
130158973|NCT01000493|468543093|FG001|Overall Study|Lost to Follow-up|9|||
130158974|NCT01000493|468543092|FG000|Overall Study|Physician Decision|1|||
130158975|NCT01000493|468543093|FG001|Overall Study|Physician Decision|1|||
130158976|NCT01000493|468543092|FG000|Overall Study|Withdrawal by Subject|3|||
130158977|NCT01000493|468543093|FG001|Overall Study|Withdrawal by Subject|7|||
130158978|NCT01346774|468543094|FG000|Overall Study|Did not take a single dose|6|||
130158979|NCT01346774|468543095|FG001|Overall Study|Did not take a single dose|4|||
130158980|NCT01346774|468543094|FG000|Overall Study|Lost to Follow-up|3|||
130158981|NCT01346774|468543095|FG001|Overall Study|Lost to Follow-up|4|||
130158982|NCT01346774|468543094|FG000|Overall Study|Withdrawal by Subject|1|||
130158983|NCT01346774|468543095|FG001|Overall Study|Withdrawal by Subject|4|||
130158984|NCT01346774|468543094|FG000|Overall Study|Protocol Violation|2|||
130158985|NCT01346774|468543095|FG001|Overall Study|Protocol Violation|3|||
130158986|NCT01346774|468543094|FG000|Overall Study|Adverse Event|1|||
130158987|NCT01346774|468543095|FG001|Overall Study|Adverse Event|2|||
130158988|NCT00321737|468543098|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
130158989|NCT00321737|468543099|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
130158990|NCT00321737|468543100|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
130158991|NCT00321737|468543098|FG000|Overall Study|Adverse Event|11|||
130158992|NCT00321737|468543099|FG001|Overall Study|Adverse Event|3|||
130158993|NCT00321737|468543100|FG002|Overall Study|Adverse Event|6|||
130158994|NCT00321737|468543098|FG000|Overall Study|Lost to Follow-up|5|||
130158995|NCT00321737|468543099|FG001|Overall Study|Lost to Follow-up|5|||
130158996|NCT00321737|468543100|FG002|Overall Study|Lost to Follow-up|6|||
130158997|NCT00321737|468543098|FG000|Overall Study|Withdrawal by Subject|19|||
130158998|NCT00321737|468543099|FG001|Overall Study|Withdrawal by Subject|12|||
130158999|NCT00321737|468543100|FG002|Overall Study|Withdrawal by Subject|17|||
130159000|NCT00321737|468543098|FG000|Overall Study|Protocol Violation|0|||
130159001|NCT00321737|468543099|FG001|Overall Study|Protocol Violation|0|||
130159002|NCT00321737|468543100|FG002|Overall Study|Protocol Violation|1|||
130159003|NCT00321737|468543098|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
130159004|NCT00321737|468543099|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130159005|NCT00321737|468543100|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
130159006|NCT00321737|468543098|FG000|Overall Study|Possible Barrett's Esophagus|2|||
130159007|NCT00321737|468543099|FG001|Overall Study|Possible Barrett's Esophagus|1|||
130159008|NCT00321737|468543100|FG002|Overall Study|Possible Barrett's Esophagus|1|||
130159009|NCT00321737|468543098|FG000|Overall Study|Therapeutic Failure|6|||
130159010|NCT00321737|468543099|FG001|Overall Study|Therapeutic Failure|0|||
130159011|NCT00321737|468543100|FG002|Overall Study|Therapeutic Failure|2|||
130159012|NCT00321737|468543098|FG000|Overall Study|Pregnancy|0|||
130159013|NCT00321737|468543099|FG001|Overall Study|Pregnancy|2|||
130159014|NCT00321737|468543100|FG002|Overall Study|Pregnancy|0|||
130159015|NCT00321737|468543098|FG000|Overall Study|Noncompliance|2|||
130159016|NCT00321737|468543099|FG001|Overall Study|Noncompliance|0|||
130159017|NCT00321737|468543100|FG002|Overall Study|Noncompliance|0|||
130159018|NCT00321737|468543098|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
130159019|NCT00321737|468543099|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
130159020|NCT00321737|468543100|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
130159021|NCT01769339|468543101|FG000|Overall Study|Lost to Follow-up|42|||
130159022|NCT01769339|468543101|FG000|Overall Study|Adverse Event|1|||
130159023|NCT00290251|468543102|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130159024|NCT00290251|468543103|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130159025|NCT00290251|468543104|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130159026|NCT00290251|468543105|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130159027|NCT00290251|468543106|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
130159028|NCT00290251|468543107|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
130159029|NCT00290251|468543102|FG000|Treatment 1 (Months 2-4)|headache|0|||
130159030|NCT00290251|468543103|FG001|Treatment 1 (Months 2-4)|headache|0|||
130159031|NCT00290251|468543104|FG002|Treatment 1 (Months 2-4)|headache|0|||
130159032|NCT00290251|468543105|FG003|Treatment 1 (Months 2-4)|headache|0|||
130159033|NCT00290251|468543106|FG004|Treatment 1 (Months 2-4)|headache|1|||
130159034|NCT00290251|468543107|FG005|Treatment 1 (Months 2-4)|headache|0|||
130159035|NCT00290251|468543102|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
130159036|NCT00290251|468543103|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
130159037|NCT00290251|468543104|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
130159038|NCT00290251|468543105|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
130159039|NCT00290251|468543106|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
130159040|NCT00290251|468543107|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
130159041|NCT04062448|468545483|FG000|Overall Study|Lost to Follow-up|1|||
130159042|NCT04062448|468545483|FG000|Overall Study|Withdrawal by Subject|2|||
130159043|NCT05101486|468545484|FG000|Overall Study|Death|1|||
130159044|NCT05101486|468545485|FG001|Overall Study|Death|0|||
130159045|NCT05101486|468545486|FG002|Overall Study|Death|1|||
130159046|NCT05101486|468545484|FG000|Overall Study|Lost to Follow-up|12|||
130159047|NCT05101486|468545485|FG001|Overall Study|Lost to Follow-up|8|||
130159048|NCT05101486|468545486|FG002|Overall Study|Lost to Follow-up|17|||
130159049|NCT05101486|468545484|FG000|Overall Study|Physician Decision|1|||
130159050|NCT05101486|468545485|FG001|Overall Study|Physician Decision|0|||
130159051|NCT05101486|468545486|FG002|Overall Study|Physician Decision|0|||
130159052|NCT05101486|468545484|FG000|Overall Study|Protocol Violation|0|||
130159053|NCT05101486|468545485|FG001|Overall Study|Protocol Violation|0|||
130159054|NCT05101486|468545486|FG002|Overall Study|Protocol Violation|1|||
130159055|NCT05101486|468545484|FG000|Overall Study|Withdrawal by Subject|5|||
130159056|NCT05101486|468545485|FG001|Overall Study|Withdrawal by Subject|2|||
130159057|NCT05101486|468545486|FG002|Overall Study|Withdrawal by Subject|4|||
130159058|NCT05101486|468545484|FG000|Overall Study|Randomized but not vaccinated|1|||
130159059|NCT05101486|468545485|FG001|Overall Study|Randomized but not vaccinated|1|||
130159060|NCT05101486|468545486|FG002|Overall Study|Randomized but not vaccinated|1|||
130159061|NCT02788045|468545487|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
130159062|NCT02788045|468545488|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
130159063|NCT02788045|468545489|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
130159064|NCT02788045|468545487|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
130159065|NCT02788045|468545488|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
130159066|NCT02788045|468545489|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
130159067|NCT02788045|468545487|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
130159068|NCT02788045|468545488|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
130159069|NCT02788045|468545489|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
130159070|NCT02788045|468545487|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
130159071|NCT02788045|468545488|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
130159072|NCT02788045|468545489|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
130159073|NCT02788045|468545487|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
130159074|NCT02788045|468545488|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
130159075|NCT02788045|468545489|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
130159076|NCT02788045|468545487|FG000|Main Study (Up to Week 72)|Other|3|||
130159077|NCT02788045|468545488|FG001|Main Study (Up to Week 72)|Other|0|||
129980785|NCT02416453|467893360|FG003|Overall Study|Lost to Follow-up|8|||
129980786|NCT02416453|467893361|FG004|Overall Study|Lost to Follow-up|0|||
129980787|NCT02416453|467893362|FG005|Overall Study|Lost to Follow-up|5|||
129980788|NCT02416453|467893363|FG006|Overall Study|Lost to Follow-up|1|||
129980789|NCT02416453|467893364|FG007|Overall Study|Lost to Follow-up|3|||
129980790|NCT02416453|467893365|FG008|Overall Study|Lost to Follow-up|1|||
129980791|NCT02416453|467893366|FG009|Overall Study|Lost to Follow-up|0|||
129980792|NCT02416453|467893367|FG010|Overall Study|Lost to Follow-up|0|||
130159078|NCT02788045|468545489|FG002|Main Study (Up to Week 72)|Other|0|||
130159079|NCT02788045|468545487|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
130159080|NCT02788045|468545488|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
129980793|NCT02416453|467893357|FG000|Overall Study|Physician Decision|0|||
130159081|NCT02788045|468545489|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
130159082|NCT02788045|468545487|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
130159083|NCT02788045|468545488|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
130159084|NCT02788045|468545489|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
130159085|NCT02788045|468545487|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
130159086|NCT02788045|468545488|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
129980794|NCT02416453|467893358|FG001|Overall Study|Physician Decision|0|||
129980795|NCT02416453|467893359|FG002|Overall Study|Physician Decision|0|||
130159087|NCT02788045|468545489|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
130159088|NCT01183221|468545490|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
130159089|NCT01183221|468545491|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
130159090|NCT00858143|468545497|FG000|Overall Study|Adverse Event|16|||
130159091|NCT00858143|468545497|FG000|Overall Study|Lack of Efficacy|4|||
130159092|NCT00858143|468545497|FG000|Overall Study|Death|7|||
130159093|NCT00858143|468545497|FG000|Overall Study|Other|23|||
130159094|NCT00852969|468545498|FG000|Overall Study|Adverse Event|0|||
130159095|NCT00852969|468545499|FG001|Overall Study|Adverse Event|1|||
130159096|NCT00852969|468545498|FG000|Overall Study|Lost to Follow-up|0|||
130159097|NCT00852969|468545499|FG001|Overall Study|Lost to Follow-up|1|||
130159098|NCT03853148|468545500|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
130159099|NCT03853148|468545501|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
130159100|NCT03853148|468545502|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
130159101|NCT03853148|468545503|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
130159102|NCT00658658|468545506|FG000|Overall Study|Withdrawal by Subject|0|||
130159103|NCT00658658|468545507|FG001|Overall Study|Withdrawal by Subject|1|||
130159104|NCT00658658|468545508|FG002|Overall Study|Withdrawal by Subject|0|||
130159105|NCT00658658|468545509|FG003|Overall Study|Withdrawal by Subject|0|||
130159106|NCT00658658|468545510|FG004|Overall Study|Withdrawal by Subject|0|||
130159107|NCT00658658|468545506|FG000|Overall Study|Death|4|||
130159108|NCT00658658|468545507|FG001|Overall Study|Death|0|||
130159109|NCT00658658|468545508|FG002|Overall Study|Death|0|||
130159110|NCT00658658|468545509|FG003|Overall Study|Death|1|||
130159111|NCT00658658|468545510|FG004|Overall Study|Death|1|||
130159112|NCT00658658|468545506|FG000|Overall Study|Disease Progression|0|||
130159113|NCT00658658|468545507|FG001|Overall Study|Disease Progression|1|||
130159114|NCT00658658|468545508|FG002|Overall Study|Disease Progression|0|||
130159115|NCT00658658|468545509|FG003|Overall Study|Disease Progression|1|||
130159116|NCT00658658|468545510|FG004|Overall Study|Disease Progression|3|||
130159117|NCT00658658|468545506|FG000|Overall Study|Protocol-specified Criteria|1|||
130159118|NCT00658658|468545507|FG001|Overall Study|Protocol-specified Criteria|0|||
130159119|NCT00658658|468545508|FG002|Overall Study|Protocol-specified Criteria|0|||
130159120|NCT00658658|468545509|FG003|Overall Study|Protocol-specified Criteria|0|||
130159121|NCT00658658|468545510|FG004|Overall Study|Protocol-specified Criteria|0|||
130159122|NCT00658658|468545506|FG000|Overall Study|Other|0|||
130159123|NCT00658658|468545507|FG001|Overall Study|Other|0|||
130159124|NCT00658658|468545508|FG002|Overall Study|Other|0|||
130159125|NCT00658658|468545509|FG003|Overall Study|Other|0|||
130159126|NCT00658658|468545510|FG004|Overall Study|Other|1|||
130159127|NCT00678041|468545511|FG000|Overall Study|Physician Decision|5|||
130159128|NCT00678041|468545512|FG001|Overall Study|Physician Decision|5|||
130159129|NCT02358343|468545513|FG000|Screening Intervention|Death|0|||
130159130|NCT02358343|468545514|FG001|Screening Intervention|Death|2|||
130159131|NCT02358343|468545515|FG002|Screening Intervention|Death|0|||
130159132|NCT02358343|468545516|FG003|Screening Intervention|Death|0|||
130159133|NCT02358343|468545517|FG004|Screening Intervention|Death|0|||
130159134|NCT02358343|468545513|FG000|Screening Intervention|Withdrawal by Subject|1|||
130159135|NCT02358343|468545514|FG001|Screening Intervention|Withdrawal by Subject|0|||
130159136|NCT02358343|468545515|FG002|Screening Intervention|Withdrawal by Subject|0|||
130159137|NCT02358343|468545516|FG003|Screening Intervention|Withdrawal by Subject|0|||
130159138|NCT02358343|468545517|FG004|Screening Intervention|Withdrawal by Subject|0|||
130159139|NCT02358343|468545513|FG000|Screening Intervention|Determined Ineligible|5|||
130159140|NCT02358343|468545514|FG001|Screening Intervention|Determined Ineligible|6|||
130159141|NCT02358343|468545515|FG002|Screening Intervention|Determined Ineligible|0|||
130159142|NCT02358343|468545516|FG003|Screening Intervention|Determined Ineligible|0|||
130159143|NCT02358343|468545517|FG004|Screening Intervention|Determined Ineligible|0|||
130159144|NCT02358343|468545513|FG000|Comparative Efficacy Trial / Observation|Death|0|||
130159145|NCT02358343|468545514|FG001|Comparative Efficacy Trial / Observation|Death|0|||
130159146|NCT02358343|468545515|FG002|Comparative Efficacy Trial / Observation|Death|2|||
130159147|NCT02358343|468545516|FG003|Comparative Efficacy Trial / Observation|Death|0|||
130159148|NCT02358343|468545517|FG004|Comparative Efficacy Trial / Observation|Death|0|||
129980796|NCT02416453|467893360|FG003|Overall Study|Physician Decision|0|||
130159149|NCT02358343|468545513|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
130159150|NCT02358343|468545514|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
130159151|NCT02358343|468545515|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130159152|NCT02358343|468545516|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130159153|NCT02358343|468545517|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
130159154|NCT02358343|468545513|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130159155|NCT02358343|468545514|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130159156|NCT02358343|468545515|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
130159157|NCT02358343|468545516|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130159158|NCT02358343|468545517|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
130159159|NCT00090610|468545520|FG000|Overall Study|Withdrawal by Subject|1|||
130159160|NCT00090610|468545521|FG001|Overall Study|Withdrawal by Subject|1|||
130159161|NCT00807248|468545522|FG000|Overall Study|Adverse Event|1|||
130159162|NCT00807248|468545523|FG001|Overall Study|Adverse Event|2|||
130159163|NCT00807248|468545524|FG002|Overall Study|Adverse Event|2|||
130159164|NCT00807248|468545525|FG003|Overall Study|Adverse Event|6|||
130159165|NCT00807248|468545522|FG000|Overall Study|Lack of Efficacy|14|||
130159166|NCT00807248|468545523|FG001|Overall Study|Lack of Efficacy|4|||
130159167|NCT00807248|468545524|FG002|Overall Study|Lack of Efficacy|8|||
130159168|NCT00807248|468545525|FG003|Overall Study|Lack of Efficacy|3|||
130159169|NCT00807248|468545522|FG000|Overall Study|Protocol Violation|0|||
130159170|NCT00807248|468545523|FG001|Overall Study|Protocol Violation|1|||
130159171|NCT00807248|468545524|FG002|Overall Study|Protocol Violation|1|||
130159172|NCT00807248|468545525|FG003|Overall Study|Protocol Violation|0|||
130159173|NCT00807248|468545522|FG000|Overall Study|Withdrawal of Consent|5|||
130159174|NCT00807248|468545523|FG001|Overall Study|Withdrawal of Consent|5|||
130159175|NCT00807248|468545524|FG002|Overall Study|Withdrawal of Consent|5|||
130159176|NCT00807248|468545525|FG003|Overall Study|Withdrawal of Consent|5|||
130159177|NCT00807248|468545522|FG000|Overall Study|Lost to Follow-up|1|||
130159178|NCT00807248|468545523|FG001|Overall Study|Lost to Follow-up|0|||
130159179|NCT00807248|468545524|FG002|Overall Study|Lost to Follow-up|0|||
130159180|NCT00807248|468545525|FG003|Overall Study|Lost to Follow-up|0|||
130159181|NCT00807248|468545522|FG000|Overall Study|Other Reason|0|||
130159182|NCT00807248|468545523|FG001|Overall Study|Other Reason|0|||
130159183|NCT00807248|468545524|FG002|Overall Study|Other Reason|2|||
130159184|NCT00807248|468545525|FG003|Overall Study|Other Reason|0|||
130159185|NCT02504671|468545526|FG000|Overall Study|Withdrawal by Subject|1|||
130159186|NCT02504671|468545527|FG001|Overall Study|Withdrawal by Subject|5|||
130159187|NCT02504671|468545528|FG002|Overall Study|Withdrawal by Subject|4|||
130159188|NCT02504671|468545529|FG003|Overall Study|Withdrawal by Subject|4|||
130159189|NCT02504671|468545530|FG004|Overall Study|Withdrawal by Subject|5|||
130159190|NCT02504671|468545531|FG005|Overall Study|Withdrawal by Subject|3|||
130159191|NCT02504671|468545526|FG000|Overall Study|Lack of Efficacy|1|||
130159192|NCT02504671|468545527|FG001|Overall Study|Lack of Efficacy|3|||
130159193|NCT02504671|468545528|FG002|Overall Study|Lack of Efficacy|1|||
130159194|NCT02504671|468545529|FG003|Overall Study|Lack of Efficacy|0|||
130159195|NCT02504671|468545530|FG004|Overall Study|Lack of Efficacy|4|||
130159196|NCT02504671|468545531|FG005|Overall Study|Lack of Efficacy|4|||
130159197|NCT02504671|468545526|FG000|Overall Study|Adverse Event|1|||
130159198|NCT02504671|468545527|FG001|Overall Study|Adverse Event|1|||
130159199|NCT02504671|468545528|FG002|Overall Study|Adverse Event|0|||
130159200|NCT02504671|468545529|FG003|Overall Study|Adverse Event|1|||
130159201|NCT02504671|468545530|FG004|Overall Study|Adverse Event|0|||
130159202|NCT02504671|468545531|FG005|Overall Study|Adverse Event|2|||
130159203|NCT02504671|468545526|FG000|Overall Study|Protocol Violation|2|||
130159204|NCT02504671|468545527|FG001|Overall Study|Protocol Violation|1|||
130159205|NCT02504671|468545528|FG002|Overall Study|Protocol Violation|0|||
130159206|NCT02504671|468545529|FG003|Overall Study|Protocol Violation|0|||
130159207|NCT02504671|468545530|FG004|Overall Study|Protocol Violation|0|||
130159208|NCT02504671|468545531|FG005|Overall Study|Protocol Violation|1|||
130159209|NCT02504671|468545526|FG000|Overall Study|Lost to Follow-up|0|||
130159210|NCT02504671|468545527|FG001|Overall Study|Lost to Follow-up|0|||
130159211|NCT02504671|468545528|FG002|Overall Study|Lost to Follow-up|2|||
130159212|NCT02504671|468545529|FG003|Overall Study|Lost to Follow-up|0|||
130159213|NCT02504671|468545530|FG004|Overall Study|Lost to Follow-up|0|||
130159214|NCT02504671|468545531|FG005|Overall Study|Lost to Follow-up|1|||
130159215|NCT02504671|468545526|FG000|Overall Study|Protocol defined stopping criteria|7|||
130159216|NCT02504671|468545527|FG001|Overall Study|Protocol defined stopping criteria|4|||
130159217|NCT02504671|468545528|FG002|Overall Study|Protocol defined stopping criteria|3|||
130159218|NCT02504671|468545529|FG003|Overall Study|Protocol defined stopping criteria|5|||
130159219|NCT02504671|468545530|FG004|Overall Study|Protocol defined stopping criteria|3|||
130159220|NCT02504671|468545531|FG005|Overall Study|Protocol defined stopping criteria|3|||
130159221|NCT00210249|468545532|FG000|Overall Study|Lost to Follow-up|5|||
130159222|NCT00210249|468545532|FG000|Overall Study|Protocol Violation|11|||
130159223|NCT02518919|468545533|FG000|Overall Study|Protocol Violation|1|||
130159224|NCT02518919|468545534|FG001|Overall Study|Protocol Violation|1|||
130159225|NCT02518919|468545535|FG002|Overall Study|Protocol Violation|2|||
130159226|NCT01700049|468545539|FG000|Overall Study|Withdrawal by Subject|1|||
130159227|NCT01248013|468545540|FG000|Overall Study|Withdrawal by Subject|14|||
130159228|NCT01859130|468545541|FG000|Overall Study|Death|4|||
130159229|NCT01859130|468545541|FG000|Overall Study|Lost to Follow-up|16|||
130159230|NCT01859130|468545541|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
130159231|NCT01859130|468545541|FG000|Overall Study|Physician Decision|6|||
130159232|NCT01859130|468545541|FG000|Overall Study|Withdrawal by Subject|17|||
130159233|NCT01859130|468545541|FG000|Overall Study|Adverse Event|11|||
130159234|NCT00307034|468545542|FG000|Overall Study|Adverse Event|1|||
130159235|NCT00307034|468545543|FG001|Overall Study|Adverse Event|2|||
130159236|NCT00307034|468545542|FG000|Overall Study|Withdrawal by Subject|1|||
130159237|NCT00307034|468545543|FG001|Overall Study|Withdrawal by Subject|2|||
130159238|NCT00307034|468545542|FG000|Overall Study|Lost to Follow-up|0|||
130159239|NCT00307034|468545543|FG001|Overall Study|Lost to Follow-up|3|||
130159240|NCT04442490|468545548|FG000|Overall Study|Withdrawal by Subject|18|||
130159241|NCT04442490|468545549|FG001|Overall Study|Withdrawal by Subject|10|||
130159242|NCT04442490|468545548|FG000|Overall Study|Lost to Follow-up|7|||
130159243|NCT04442490|468545549|FG001|Overall Study|Lost to Follow-up|7|||
130159244|NCT04442490|468545548|FG000|Overall Study|Adverse Event|2|||
130159245|NCT04442490|468545549|FG001|Overall Study|Adverse Event|6|||
130159246|NCT04442490|468545548|FG000|Overall Study|Noncompliance|3|||
130159247|NCT04442490|468545549|FG001|Overall Study|Noncompliance|1|||
130159248|NCT04442490|468545548|FG000|Overall Study|Physician Decision|2|||
130159249|NCT04442490|468545549|FG001|Overall Study|Physician Decision|1|||
130159250|NCT04442490|468545548|FG000|Overall Study|Reason not Specified|2|||
130159251|NCT04442490|468545549|FG001|Overall Study|Reason not Specified|1|||
130159252|NCT04442490|468545548|FG000|Overall Study|Randomized but not Treated|3|||
130159253|NCT04442490|468545549|FG001|Overall Study|Randomized but not Treated|3|||
130159254|NCT02227147|468545550|FG000|Controlled Treatment Period|Adverse Event|4|||
130159255|NCT02227147|468545551|FG001|Controlled Treatment Period|Adverse Event|3|||
130159256|NCT02227147|468545550|FG000|Controlled Treatment Period|Other|2|||
130159257|NCT02227147|468545551|FG001|Controlled Treatment Period|Other|0|||
130159258|NCT02227147|468545550|FG000|Follow-up Period|Other|3|||
130159259|NCT02227147|468545551|FG001|Follow-up Period|Other|5|||
130159260|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
130159261|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
130159262|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
130159263|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
130159264|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
130159265|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
130159266|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
130159267|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
130159268|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
130159269|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
130159270|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
130159271|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
130159272|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
130159273|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
130159274|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
130159275|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
130159276|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
130159277|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
130159278|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
130159279|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
130159280|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
130159281|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130159282|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130159283|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
130159284|NCT03514641|468545552|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130159285|NCT03514641|468545553|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
130159286|NCT03514641|468545554|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130159287|NCT03514641|468545555|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
130159288|NCT03514641|468545552|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
130159289|NCT03514641|468545553|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
130159290|NCT03514641|468545554|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
130159291|NCT03514641|468545555|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
130159292|NCT03514641|468545552|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
130159293|NCT03514641|468545553|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
130159294|NCT03514641|468545554|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
129980797|NCT02416453|467893361|FG004|Overall Study|Physician Decision|0|||
130159295|NCT03514641|468545555|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
130159296|NCT03514641|468545552|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
130159297|NCT03514641|468545553|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
130159298|NCT03514641|468545554|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
130159299|NCT03514641|468545555|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
130159300|NCT03514641|468545552|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
130159301|NCT03514641|468545553|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
130159302|NCT03514641|468545554|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
130159303|NCT03514641|468545555|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
130159304|NCT03514641|468545552|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
129980798|NCT02416453|467893362|FG005|Overall Study|Physician Decision|1|||
129980799|NCT02416453|467893363|FG006|Overall Study|Physician Decision|1|||
130159305|NCT03514641|468545553|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
130159306|NCT03514641|468545554|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
130159307|NCT03514641|468545555|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
130159308|NCT01449279|468545556|FG000|Overall Study|Lack of Efficacy|5|||
130159309|NCT01449279|468545556|FG000|Overall Study|Toxicity|2|||
130159310|NCT04234984|468545557|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
130159311|NCT04234984|468545557|FG000|Follow-up at the Second Time Point|Death|1|||
130159312|NCT04234984|468545557|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
130159313|NCT01055132|468545558|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
130159314|NCT01055132|468545559|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
130159315|NCT01055132|468545558|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
130159316|NCT01055132|468545559|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
130159317|NCT02038907|468545560|FG000|Overall Study|Protocol Violation|0|||
130159318|NCT02038907|468545561|FG001|Overall Study|Protocol Violation|0|||
130159319|NCT02038907|468545562|FG002|Overall Study|Protocol Violation|0|||
130159320|NCT02038907|468545563|FG003|Overall Study|Protocol Violation|0|||
130159321|NCT02038907|468545564|FG004|Overall Study|Protocol Violation|0|||
130159322|NCT02038907|468545565|FG005|Overall Study|Protocol Violation|0|||
130159323|NCT02038907|468545566|FG006|Overall Study|Protocol Violation|0|||
130159324|NCT02038907|468545567|FG007|Overall Study|Protocol Violation|0|||
130159325|NCT02038907|468545568|FG008|Overall Study|Protocol Violation|0|||
130159326|NCT02038907|468545569|FG009|Overall Study|Protocol Violation|0|||
130159327|NCT02038907|468545570|FG010|Overall Study|Protocol Violation|1|||
130159328|NCT02038907|468545571|FG011|Overall Study|Protocol Violation|0|||
130159329|NCT02038907|468545572|FG012|Overall Study|Protocol Violation|0|||
130159330|NCT02038907|468545573|FG013|Overall Study|Protocol Violation|0|||
130159331|NCT02038907|468545560|FG000|Overall Study|Withdrawal by Subject|0|||
130159332|NCT02038907|468545561|FG001|Overall Study|Withdrawal by Subject|0|||
130159333|NCT02038907|468545562|FG002|Overall Study|Withdrawal by Subject|0|||
130159334|NCT02038907|468545563|FG003|Overall Study|Withdrawal by Subject|0|||
130159335|NCT02038907|468545564|FG004|Overall Study|Withdrawal by Subject|0|||
130159336|NCT02038907|468545565|FG005|Overall Study|Withdrawal by Subject|0|||
130159337|NCT02038907|468545566|FG006|Overall Study|Withdrawal by Subject|0|||
130159338|NCT02038907|468545567|FG007|Overall Study|Withdrawal by Subject|0|||
130159339|NCT02038907|468545568|FG008|Overall Study|Withdrawal by Subject|0|||
130159340|NCT02038907|468545569|FG009|Overall Study|Withdrawal by Subject|0|||
130159341|NCT02038907|468545570|FG010|Overall Study|Withdrawal by Subject|1|||
130159342|NCT02038907|468545571|FG011|Overall Study|Withdrawal by Subject|0|||
130159343|NCT02038907|468545572|FG012|Overall Study|Withdrawal by Subject|0|||
130159344|NCT02038907|468545573|FG013|Overall Study|Withdrawal by Subject|0|||
130159345|NCT01156142|468545577|FG000|Overall Study|Withdrawal by Subject|8|||
130159346|NCT01156142|468545578|FG001|Overall Study|Withdrawal by Subject|6|||
130159347|NCT01156142|468545577|FG000|Overall Study|Ineligible|0|||
130159348|NCT01156142|468545578|FG001|Overall Study|Ineligible|1|||
130159349|NCT00893737|468545579|FG000|Overall Study|Adverse Event|4|||
130159350|NCT00893737|468545579|FG000|Overall Study|Withdrawal by Subject|2|||
130159351|NCT00893737|468545579|FG000|Overall Study|Lost to Follow-up|6|||
130159352|NCT02140411|468545580|FG000|Overall Study|Adverse Event|1|||
130159353|NCT03981419|468545583|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
130159354|NCT03981419|468545584|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
130159355|NCT01330459|468545589|FG000|Overall Study|Physician Decision|0|||
130159356|NCT01330459|468545590|FG001|Overall Study|Physician Decision|2|||
130159357|NCT01359644|468545604|FG000|Treatment Period|Lack of Efficacy|0|||
130159358|NCT01359644|468545605|FG001|Treatment Period|Lack of Efficacy|1|||
130159359|NCT01359644|468545606|FG002|Treatment Period|Lack of Efficacy|0|||
130159360|NCT01359644|468545607|FG003|Treatment Period|Lack of Efficacy|0|||
130159361|NCT01359644|468545608|FG004|Treatment Period|Lack of Efficacy|0|||
130159362|NCT01359644|468545609|FG005|Treatment Period|Lack of Efficacy|0|||
130159363|NCT01359644|468545610|FG006|Treatment Period|Lack of Efficacy|0|||
129980800|NCT02416453|467893364|FG007|Overall Study|Physician Decision|1|||
129980801|NCT02416453|467893365|FG008|Overall Study|Physician Decision|0|||
130159364|NCT01359644|468545611|FG007|Treatment Period|Lack of Efficacy|0|||
129980802|NCT02416453|467893366|FG009|Overall Study|Physician Decision|0|||
129980803|NCT02416453|467893367|FG010|Overall Study|Physician Decision|0|||
129980804|NCT02416453|467893357|FG000|Overall Study|Withdrawal by Subject|2|||
130159365|NCT01359644|468545612|FG008|Treatment Period|Lack of Efficacy|0|||
130159366|NCT01359644|468545613|FG009|Treatment Period|Lack of Efficacy|0|||
130159367|NCT01359644|468545604|FG000|Treatment Period|Adverse Event|0|||
130159368|NCT01359644|468545605|FG001|Treatment Period|Adverse Event|0|||
130159369|NCT01359644|468545606|FG002|Treatment Period|Adverse Event|1|||
130159370|NCT01359644|468545607|FG003|Treatment Period|Adverse Event|0|||
130159371|NCT01359644|468545608|FG004|Treatment Period|Adverse Event|0|||
130159372|NCT01359644|468545609|FG005|Treatment Period|Adverse Event|1|||
130159373|NCT01359644|468545610|FG006|Treatment Period|Adverse Event|0|||
130159374|NCT01359644|468545611|FG007|Treatment Period|Adverse Event|0|||
130159375|NCT01359644|468545612|FG008|Treatment Period|Adverse Event|0|||
130159376|NCT01359644|468545613|FG009|Treatment Period|Adverse Event|0|||
130159377|NCT01359644|468545604|FG000|Treatment Period|Lost to Follow-up|0|||
130159378|NCT01359644|468545605|FG001|Treatment Period|Lost to Follow-up|0|||
130159379|NCT01359644|468545606|FG002|Treatment Period|Lost to Follow-up|0|||
130159380|NCT01359644|468545607|FG003|Treatment Period|Lost to Follow-up|0|||
130159381|NCT01359644|468545608|FG004|Treatment Period|Lost to Follow-up|0|||
130159382|NCT01359644|468545609|FG005|Treatment Period|Lost to Follow-up|1|||
130159383|NCT01359644|468545610|FG006|Treatment Period|Lost to Follow-up|0|||
130159384|NCT01359644|468545611|FG007|Treatment Period|Lost to Follow-up|0|||
130159385|NCT01359644|468545612|FG008|Treatment Period|Lost to Follow-up|0|||
130159386|NCT01359644|468545613|FG009|Treatment Period|Lost to Follow-up|0|||
130159387|NCT01359644|468545604|FG000|Follow-up Period|Withdrawal by Subject|0|||
130159388|NCT01359644|468545605|FG001|Follow-up Period|Withdrawal by Subject|0|||
130159389|NCT01359644|468545606|FG002|Follow-up Period|Withdrawal by Subject|0|||
130159390|NCT01359644|468545607|FG003|Follow-up Period|Withdrawal by Subject|0|||
130159391|NCT01359644|468545608|FG004|Follow-up Period|Withdrawal by Subject|0|||
130159392|NCT01359644|468545609|FG005|Follow-up Period|Withdrawal by Subject|1|||
130159393|NCT01359644|468545610|FG006|Follow-up Period|Withdrawal by Subject|0|||
130159394|NCT01359644|468545611|FG007|Follow-up Period|Withdrawal by Subject|0|||
130159395|NCT01359644|468545612|FG008|Follow-up Period|Withdrawal by Subject|0|||
130159396|NCT01359644|468545613|FG009|Follow-up Period|Withdrawal by Subject|0|||
130159397|NCT01359644|468545604|FG000|Follow-up Period|Lost to Follow-up|0|||
130159398|NCT01359644|468545605|FG001|Follow-up Period|Lost to Follow-up|0|||
130159399|NCT01359644|468545606|FG002|Follow-up Period|Lost to Follow-up|0|||
130159400|NCT01359644|468545607|FG003|Follow-up Period|Lost to Follow-up|0|||
130159401|NCT01359644|468545608|FG004|Follow-up Period|Lost to Follow-up|0|||
130159402|NCT01359644|468545609|FG005|Follow-up Period|Lost to Follow-up|0|||
130159403|NCT01359644|468545610|FG006|Follow-up Period|Lost to Follow-up|1|||
130159404|NCT01359644|468545611|FG007|Follow-up Period|Lost to Follow-up|2|||
130159405|NCT01359644|468545612|FG008|Follow-up Period|Lost to Follow-up|0|||
130159406|NCT01359644|468545613|FG009|Follow-up Period|Lost to Follow-up|0|||
130159407|NCT02130882|468545615|FG000|Overall Study|Withdrawal by Subject|0|||
130159408|NCT02130882|468545616|FG001|Overall Study|Withdrawal by Subject|1|||
130159409|NCT01355159|468545627|FG000|Overall Study|Withdrew consent|39|||
130159410|NCT01355159|468545628|FG001|Overall Study|Withdrew consent|47|||
130159411|NCT01355159|468545627|FG000|Overall Study|No primary outcome data|17|||
130159412|NCT01355159|468545628|FG001|Overall Study|No primary outcome data|11|||
130159413|NCT01355159|468545627|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
130159414|NCT01355159|468545628|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
130159415|NCT01355159|468545627|FG000|Overall Study|Early intrauterine fetal death|6|||
130159416|NCT01355159|468545628|FG001|Overall Study|Early intrauterine fetal death|6|||
130159417|NCT01194973|468545629|FG000|Screening Period|Screen Failure|3|||
130159418|NCT01194973|468545629|FG000|26 Week Treatment Period|Adverse Event|1|||
130159419|NCT01194973|468545629|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
130159420|NCT01194973|468545629|FG000|26 Week Treatment Period|Pregnancy|1|||
130159421|NCT00359632|468545632|FG000|Overall Study|Death|2|||
130159422|NCT00359632|468545633|FG001|Overall Study|Death|0|||
130159423|NCT00359632|468545632|FG000|Overall Study|Adverse Event|1|||
130159424|NCT00359632|468545633|FG001|Overall Study|Adverse Event|0|||
130159425|NCT00359632|468545632|FG000|Overall Study|Non-compliance with visit schedule|1|||
130159426|NCT00359632|468545633|FG001|Overall Study|Non-compliance with visit schedule|0|||
130159427|NCT04700280|468545634|FG000|Overall Study|Adverse Event|4|||
130159428|NCT04700280|468545635|FG001|Overall Study|Adverse Event|0|||
130159429|NCT04700280|468545634|FG000|Overall Study|Lack of Efficacy|1|||
130159430|NCT04700280|468545635|FG001|Overall Study|Lack of Efficacy|0|||
130159431|NCT04700280|468545634|FG000|Overall Study|Study terminated by sponsor|5|||
130159432|NCT04700280|468545635|FG001|Overall Study|Study terminated by sponsor|3|||
130159433|NCT04700280|468545634|FG000|Overall Study|Other than specified|1|||
129980805|NCT02416453|467893358|FG001|Overall Study|Withdrawal by Subject|0|||
129980806|NCT02416453|467893359|FG002|Overall Study|Withdrawal by Subject|0|||
129980807|NCT02416453|467893360|FG003|Overall Study|Withdrawal by Subject|5|||
130159434|NCT04700280|468545635|FG001|Overall Study|Other than specified|0|||
130159435|NCT02615171|468545636|FG000|Overall Study|Lost to Follow-up|2|||
130159436|NCT02615171|468545637|FG001|Overall Study|Lost to Follow-up|1|||
130159437|NCT00502801|468545643|FG000|Treatment Period|Withdrawal by Subject|3|||
129980808|NCT02416453|467893361|FG004|Overall Study|Withdrawal by Subject|1|||
130159438|NCT00502801|468545643|FG000|Treatment Period|Adverse Event|7|||
130159439|NCT00502801|468545643|FG000|Treatment Period|Death|14|||
130159440|NCT00502801|468545643|FG000|Treatment Period|OTHER|30|||
130159441|NCT00502801|468545643|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
130159442|NCT00502801|468545643|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
130159443|NCT00502801|468545643|FG000|End of Therapy to Test of Cure|Death|3|||
130159444|NCT00502801|468545643|FG000|End of Therapy to Test of Cure|OTHER|2|||
130159445|NCT00444457|468545649|FG000|Infant Series|Other|0|||
130159446|NCT00444457|468545650|FG001|Infant Series|Other|1|||
130159447|NCT00444457|468545651|FG002|Infant Series|Other|0|||
130159448|NCT00444457|468545652|FG003|Infant Series|Other|0|||
130159449|NCT00444457|468545649|FG000|Infant Series|Parent or legal guardian request|18|||
130159450|NCT00444457|468545650|FG001|Infant Series|Parent or legal guardian request|29|||
130159451|NCT00444457|468545651|FG002|Infant Series|Parent or legal guardian request|34|||
130159452|NCT00444457|468545652|FG003|Infant Series|Parent or legal guardian request|14|||
130159453|NCT00444457|468545649|FG000|Infant Series|Lost to Follow-up|10|||
130159454|NCT00444457|468545650|FG001|Infant Series|Lost to Follow-up|11|||
130159455|NCT00444457|468545651|FG002|Infant Series|Lost to Follow-up|7|||
130159456|NCT00444457|468545652|FG003|Infant Series|Lost to Follow-up|6|||
130159457|NCT00444457|468545649|FG000|Infant Series|Protocol Violation|16|||
130159458|NCT00444457|468545650|FG001|Infant Series|Protocol Violation|8|||
130159459|NCT00444457|468545651|FG002|Infant Series|Protocol Violation|6|||
130159460|NCT00444457|468545652|FG003|Infant Series|Protocol Violation|3|||
130159461|NCT00444457|468545649|FG000|Infant Series|Failed to return|5|||
130159462|NCT00444457|468545650|FG001|Infant Series|Failed to return|4|||
130159463|NCT00444457|468545651|FG002|Infant Series|Failed to return|4|||
130159464|NCT00444457|468545652|FG003|Infant Series|Failed to return|2|||
130159465|NCT00444457|468545649|FG000|Infant Series|Investigator request|4|||
130159466|NCT00444457|468545650|FG001|Infant Series|Investigator request|3|||
130159467|NCT00444457|468545651|FG002|Infant Series|Investigator request|3|||
130159468|NCT00444457|468545652|FG003|Infant Series|Investigator request|2|||
130159469|NCT00444457|468545649|FG000|Infant Series|Other|0|||
130159470|NCT00444457|468545650|FG001|Infant Series|Other|2|||
130159471|NCT00444457|468545651|FG002|Infant Series|Other|4|||
130159472|NCT00444457|468545652|FG003|Infant Series|Other|0|||
130159473|NCT00444457|468545649|FG000|Infant Series|Adverse Event|1|||
130159474|NCT00444457|468545650|FG001|Infant Series|Adverse Event|2|||
130159475|NCT00444457|468545651|FG002|Infant Series|Adverse Event|2|||
130159476|NCT00444457|468545652|FG003|Infant Series|Adverse Event|0|||
130159477|NCT00444457|468545649|FG000|Infant Series|Death|0|||
130159478|NCT00444457|468545650|FG001|Infant Series|Death|1|||
130159479|NCT00444457|468545651|FG002|Infant Series|Death|1|||
130159480|NCT00444457|468545652|FG003|Infant Series|Death|1|||
130159481|NCT00444457|468545649|FG000|After Infant Series|Other|0|||
130159482|NCT00444457|468545650|FG001|After Infant Series|Other|1|||
130159483|NCT00444457|468545651|FG002|After Infant Series|Other|1|||
130159484|NCT00444457|468545652|FG003|After Infant Series|Other|1|||
130159485|NCT00444457|468545649|FG000|After Infant Series|Parent or legal guardian request|4|||
130159486|NCT00444457|468545650|FG001|After Infant Series|Parent or legal guardian request|11|||
130159487|NCT00444457|468545651|FG002|After Infant Series|Parent or legal guardian request|6|||
130159488|NCT00444457|468545652|FG003|After Infant Series|Parent or legal guardian request|3|||
130159489|NCT00444457|468545649|FG000|After Infant Series|Failed to return|7|||
130159490|NCT00444457|468545650|FG001|After Infant Series|Failed to return|6|||
130159491|NCT00444457|468545651|FG002|After Infant Series|Failed to return|5|||
130159492|NCT00444457|468545652|FG003|After Infant Series|Failed to return|1|||
130159493|NCT00444457|468545649|FG000|After Infant Series|Lost to Follow-up|5|||
130159494|NCT00444457|468545650|FG001|After Infant Series|Lost to Follow-up|5|||
130159495|NCT00444457|468545651|FG002|After Infant Series|Lost to Follow-up|5|||
130159496|NCT00444457|468545652|FG003|After Infant Series|Lost to Follow-up|2|||
130159497|NCT00444457|468545649|FG000|After Infant Series|Protocol Violation|2|||
130159498|NCT00444457|468545650|FG001|After Infant Series|Protocol Violation|4|||
130159499|NCT00444457|468545651|FG002|After Infant Series|Protocol Violation|2|||
130159500|NCT00444457|468545652|FG003|After Infant Series|Protocol Violation|2|||
130159501|NCT00444457|468545649|FG000|After Infant Series|Adverse Event|2|||
130159502|NCT00444457|468545650|FG001|After Infant Series|Adverse Event|2|||
130159503|NCT00444457|468545651|FG002|After Infant Series|Adverse Event|0|||
130159504|NCT00444457|468545652|FG003|After Infant Series|Adverse Event|0|||
130159505|NCT00444457|468545649|FG000|After Infant Series|Investigator request|0|||
130159506|NCT00444457|468545650|FG001|After Infant Series|Investigator request|0|||
130159507|NCT00444457|468545651|FG002|After Infant Series|Investigator request|0|||
130159508|NCT00444457|468545652|FG003|After Infant Series|Investigator request|1|||
130159509|NCT00444457|468545649|FG000|After Infant Series|Other|0|||
130159510|NCT00444457|468545650|FG001|After Infant Series|Other|1|||
130159511|NCT00444457|468545651|FG002|After Infant Series|Other|0|||
130159512|NCT00444457|468545652|FG003|After Infant Series|Other|0|||
130159513|NCT00444457|468545649|FG000|Toddler Dose|Lost to Follow-up|4|||
130159514|NCT00444457|468545650|FG001|Toddler Dose|Lost to Follow-up|1|||
130159515|NCT00444457|468545651|FG002|Toddler Dose|Lost to Follow-up|1|||
130159516|NCT00444457|468545652|FG003|Toddler Dose|Lost to Follow-up|3|||
130159517|NCT00444457|468545649|FG000|Toddler Dose|Failed to return|2|||
130159518|NCT00444457|468545650|FG001|Toddler Dose|Failed to return|2|||
130159519|NCT00444457|468545651|FG002|Toddler Dose|Failed to return|1|||
130159520|NCT00444457|468545652|FG003|Toddler Dose|Failed to return|3|||
130159521|NCT00444457|468545649|FG000|Toddler Dose|Parent or legal guardian request|0|||
130159522|NCT00444457|468545650|FG001|Toddler Dose|Parent or legal guardian request|3|||
130159523|NCT00444457|468545651|FG002|Toddler Dose|Parent or legal guardian request|2|||
130159524|NCT00444457|468545652|FG003|Toddler Dose|Parent or legal guardian request|1|||
130159525|NCT00444457|468545649|FG000|Toddler Dose|Protocol Violation|1|||
130159526|NCT00444457|468545650|FG001|Toddler Dose|Protocol Violation|0|||
130159527|NCT00444457|468545651|FG002|Toddler Dose|Protocol Violation|0|||
130159528|NCT00444457|468545652|FG003|Toddler Dose|Protocol Violation|1|||
130159529|NCT01121666|468545655|FG000|Overall Study|Protocol Violation|29|||
130159530|NCT01121666|468545656|FG001|Overall Study|Protocol Violation|10|||
130159531|NCT03176459|468545659|FG000|Overall Study|Lost to Follow-up|5|||
130159532|NCT03176459|468545660|FG001|Overall Study|Lost to Follow-up|7|||
130159533|NCT01602965|468545661|FG000|Overall Study|Lost to Follow-up|4|||
130159534|NCT01602965|468545662|FG001|Overall Study|Lost to Follow-up|2|||
130159535|NCT02283294|468545663|FG000|Overall Study|Lost to Follow-up|1|||
130159536|NCT02283294|468545664|FG001|Overall Study|Lost to Follow-up|1|||
130159537|NCT02283294|468545663|FG000|Overall Study|Withdrawal by Subject|1|||
130159538|NCT02283294|468545664|FG001|Overall Study|Withdrawal by Subject|6|||
130159539|NCT02283294|468545663|FG000|Overall Study|Protocol Violation|1|||
130159540|NCT02283294|468545664|FG001|Overall Study|Protocol Violation|0|||
130159541|NCT02283294|468545663|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
130159542|NCT02283294|468545664|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
130159543|NCT03047473|468548313|FG000|Overall Study|Lost to Follow-up|2|||
130159544|NCT02935686|468548314|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
130159545|NCT02935686|468548315|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130159546|NCT02935686|468548316|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130159547|NCT02935686|468548317|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130159548|NCT02935686|468548318|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
130159549|NCT02935686|468548314|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
130159550|NCT02935686|468548315|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
130159551|NCT02935686|468548316|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
130159552|NCT02935686|468548317|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
130159553|NCT02935686|468548318|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
130159554|NCT02935686|468548314|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130159555|NCT02935686|468548315|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
130159556|NCT02935686|468548316|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130159557|NCT02935686|468548317|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130159558|NCT02935686|468548318|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
130159559|NCT02935686|468548314|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
130159560|NCT02935686|468548315|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
130159561|NCT02935686|468548316|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130159562|NCT02935686|468548317|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130159563|NCT02935686|468548318|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
130159564|NCT02935686|468548314|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
130159565|NCT02935686|468548315|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
130159566|NCT02935686|468548316|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
130159567|NCT02935686|468548317|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
130159568|NCT02935686|468548318|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
129980809|NCT02416453|467893362|FG005|Overall Study|Withdrawal by Subject|8|||
129980810|NCT02416453|467893363|FG006|Overall Study|Withdrawal by Subject|0|||
129980811|NCT02416453|467893364|FG007|Overall Study|Withdrawal by Subject|8|||
129980812|NCT02416453|467893365|FG008|Overall Study|Withdrawal by Subject|4|||
129980813|NCT02416453|467893366|FG009|Overall Study|Withdrawal by Subject|0|||
129980814|NCT02416453|467893367|FG010|Overall Study|Withdrawal by Subject|0|||
129980815|NCT02416453|467893357|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980816|NCT02416453|467893358|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980817|NCT02416453|467893359|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
129980818|NCT02416453|467893360|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980819|NCT02416453|467893361|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980820|NCT02416453|467893362|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980821|NCT02416453|467893363|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980822|NCT02416453|467893364|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980823|NCT02416453|467893365|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980824|NCT02416453|467893366|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980825|NCT02416453|467893367|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980826|NCT02416453|467893357|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980827|NCT02416453|467893358|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130159569|NCT02935686|468548314|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130159570|NCT02935686|468548315|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
130159571|NCT02935686|468548316|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130159572|NCT02935686|468548317|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130159573|NCT02935686|468548318|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
130159574|NCT02935686|468548314|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
130159575|NCT02935686|468548315|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
130159576|NCT02935686|468548316|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129980828|NCT02416453|467893359|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130159577|NCT02935686|468548317|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130159578|NCT02935686|468548318|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
130159579|NCT02935686|468548314|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130159580|NCT02935686|468548315|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
130159581|NCT02935686|468548316|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130159582|NCT02935686|468548317|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130159583|NCT02935686|468548318|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
130159584|NCT02935686|468548314|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130159585|NCT02935686|468548315|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
130159586|NCT02935686|468548316|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130159587|NCT02935686|468548317|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130159588|NCT02935686|468548318|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
130159589|NCT02935686|468548314|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130159590|NCT02935686|468548315|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130159591|NCT02935686|468548316|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130159592|NCT02935686|468548317|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
130159593|NCT02935686|468548318|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
130159594|NCT02935686|468548314|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130159595|NCT02935686|468548315|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130159596|NCT02935686|468548316|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
130159597|NCT02935686|468548317|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
130159598|NCT02935686|468548318|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
130159599|NCT00541970|468548324|FG000|Month 7|Protocol Violation|9|||
130159600|NCT00541970|468548325|FG001|Month 7|Protocol Violation|13|||
130159601|NCT00541970|468548326|FG002|Month 7|Protocol Violation|11|||
130159602|NCT00541970|468548327|FG003|Month 7|Protocol Violation|5|||
130159603|NCT00541970|468548324|FG000|Month 12|Adverse Event|0|||
130159604|NCT00541970|468548325|FG001|Month 12|Adverse Event|1|||
130159605|NCT00541970|468548326|FG002|Month 12|Adverse Event|1|||
130159606|NCT00541970|468548327|FG003|Month 12|Adverse Event|1|||
130159607|NCT00541970|468548324|FG000|Month 12|Protocol Violation|12|||
130159608|NCT00541970|468548325|FG001|Month 12|Protocol Violation|21|||
130159609|NCT00541970|468548326|FG002|Month 12|Protocol Violation|20|||
130159610|NCT00541970|468548327|FG003|Month 12|Protocol Violation|15|||
130159611|NCT00541970|468548324|FG000|Month 18|Adverse Event|0|||
130159612|NCT00541970|468548325|FG001|Month 18|Adverse Event|1|||
130159613|NCT00541970|468548326|FG002|Month 18|Adverse Event|1|||
130159614|NCT00541970|468548327|FG003|Month 18|Adverse Event|1|||
130159615|NCT00541970|468548324|FG000|Month 18|Protocol Violation|14|||
130159616|NCT00541970|468548325|FG001|Month 18|Protocol Violation|23|||
130159617|NCT00541970|468548326|FG002|Month 18|Protocol Violation|24|||
130159618|NCT00541970|468548327|FG003|Month 18|Protocol Violation|16|||
130159619|NCT00541970|468548324|FG000|Month 24|Adverse Event|0|||
130159620|NCT00541970|468548325|FG001|Month 24|Adverse Event|1|||
130159621|NCT00541970|468548326|FG002|Month 24|Adverse Event|1|||
130159622|NCT00541970|468548327|FG003|Month 24|Adverse Event|1|||
130159623|NCT00541970|468548324|FG000|Month 24|Protocol Violation|29|||
130159624|NCT00541970|468548325|FG001|Month 24|Protocol Violation|31|||
130159625|NCT00541970|468548326|FG002|Month 24|Protocol Violation|31|||
130159626|NCT00541970|468548327|FG003|Month 24|Protocol Violation|21|||
130159627|NCT00541970|468548324|FG000|Month 36|Protocol Violation|61|||
130159628|NCT00541970|468548325|FG001|Month 36|Protocol Violation|66|||
130159629|NCT00541970|468548326|FG002|Month 36|Protocol Violation|66|||
130159630|NCT00541970|468548327|FG003|Month 36|Protocol Violation|60|||
130159631|NCT00541970|468548324|FG000|Month 48|Withdrawal by Subject|2|||
130159632|NCT00541970|468548325|FG001|Month 48|Withdrawal by Subject|4|||
130159633|NCT00541970|468548326|FG002|Month 48|Withdrawal by Subject|4|||
130159634|NCT00541970|468548327|FG003|Month 48|Withdrawal by Subject|2|||
130159635|NCT00541970|468548324|FG000|Month 48|Other|3|||
130159636|NCT00541970|468548325|FG001|Month 48|Other|1|||
130159637|NCT00541970|468548326|FG002|Month 48|Other|1|||
130159638|NCT00541970|468548327|FG003|Month 48|Other|0|||
130159639|NCT00541970|468548324|FG000|Month 48|Lost to Follow-up|66|||
130159640|NCT00541970|468548325|FG001|Month 48|Lost to Follow-up|68|||
130159641|NCT00541970|468548326|FG002|Month 48|Lost to Follow-up|68|||
130159642|NCT00541970|468548327|FG003|Month 48|Lost to Follow-up|73|||
130159643|NCT00541970|468548324|FG000|Month 60|Protocol Violation|78|||
130159644|NCT00541970|468548325|FG001|Month 60|Protocol Violation|77|||
130159645|NCT00541970|468548326|FG002|Month 60|Protocol Violation|82|||
130159646|NCT00541970|468548327|FG003|Month 60|Protocol Violation|72|||
130159647|NCT00321828|468548328|FG000|Overall Study|Ineligible|3|||
130159648|NCT00321828|468548328|FG000|Overall Study|No follow up data|1|||
130159649|NCT00062010|468548331|FG000|Overall Study|Ineligible|3|||
130159650|NCT02856880|468548332|FG000|Overall Study|Withdrawal of consent|1|||
130159651|NCT00573157|468548333|FG000|Overall Study|Adverse Event|3|||
130159652|NCT00573157|468548334|FG001|Overall Study|Adverse Event|1|||
130159653|NCT00573157|468548333|FG000|Overall Study|Other|1|||
130159654|NCT00573157|468548334|FG001|Overall Study|Other|1|||
130159655|NCT02944383|468548335|FG000|Overall Study|Lost to Follow-up|0|||
130159656|NCT02944383|468548336|FG001|Overall Study|Lost to Follow-up|0|||
130159657|NCT02944383|468548337|FG002|Overall Study|Lost to Follow-up|1|||
130159658|NCT02944383|468548335|FG000|Overall Study|Withdrawal by Subject|1|||
130159659|NCT02944383|468548336|FG001|Overall Study|Withdrawal by Subject|0|||
130159660|NCT02944383|468548337|FG002|Overall Study|Withdrawal by Subject|0|||
130159661|NCT02444793|468548340|FG000|Overall Study|Lost to Follow-up|2|||
130159662|NCT02444793|468548341|FG001|Overall Study|Lost to Follow-up|2|||
129980829|NCT02416453|467893360|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980830|NCT02416453|467893361|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980831|NCT02416453|467893362|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
129980832|NCT02416453|467893363|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980833|NCT02416453|467893364|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980834|NCT02416453|467893365|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980835|NCT02416453|467893366|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980836|NCT02416453|467893367|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
130159663|NCT02444793|468548342|FG002|Overall Study|Lost to Follow-up|0|||
130159664|NCT02444793|468548343|FG003|Overall Study|Lost to Follow-up|0|||
130159665|NCT02444793|468548340|FG000|Overall Study|Death|0|||
130159666|NCT02444793|468548341|FG001|Overall Study|Death|3|||
130159667|NCT02444793|468548342|FG002|Overall Study|Death|0|||
130159668|NCT02444793|468548343|FG003|Overall Study|Death|0|||
130159669|NCT02444793|468548340|FG000|Overall Study|Other|0|||
130159670|NCT02444793|468548341|FG001|Overall Study|Other|0|||
130159671|NCT02444793|468548342|FG002|Overall Study|Other|2|||
130159672|NCT02444793|468548343|FG003|Overall Study|Other|0|||
130159673|NCT02444793|468548340|FG000|Overall Study|Objective progression or relapse|9|||
130159674|NCT02444793|468548341|FG001|Overall Study|Objective progression or relapse|1|||
129980837|NCT01152814|467893369|FG000|Overall Study|Lost to Follow-up|2|||
129980838|NCT01877239|467893377|FG000|Overall Study|Adverse Event|4|||
130159675|NCT02444793|468548342|FG002|Overall Study|Objective progression or relapse|2|||
130159676|NCT02444793|468548343|FG003|Overall Study|Objective progression or relapse|3|||
130159677|NCT00599521|468548345|FG000|Overall Study|Lack of Efficacy|4|||
130159678|NCT00599521|468548346|FG001|Overall Study|Lack of Efficacy|8|||
130159679|NCT00599521|468548345|FG000|Overall Study|Adverse Event|4|||
130159680|NCT00599521|468548346|FG001|Overall Study|Adverse Event|1|||
130159681|NCT00599521|468548345|FG000|Overall Study|Withdrawal by Subject|28|||
130159682|NCT00599521|468548346|FG001|Overall Study|Withdrawal by Subject|34|||
130159683|NCT00599521|468548345|FG000|Overall Study|Protocol Violation|1|||
130159684|NCT00599521|468548346|FG001|Overall Study|Protocol Violation|1|||
130159685|NCT00599521|468548345|FG000|Overall Study|Lost to Follow-up|23|||
130159686|NCT00599521|468548346|FG001|Overall Study|Lost to Follow-up|23|||
130159687|NCT00599521|468548345|FG000|Overall Study|Pregnancy|0|||
130159688|NCT00599521|468548346|FG001|Overall Study|Pregnancy|2|||
130159689|NCT04498403|468548347|FG000|Overall Study|Adverse Event|1|||
130159690|NCT04498403|468548348|FG001|Overall Study|Adverse Event|0|||
130159691|NCT04498403|468548347|FG000|Overall Study|Study Terminated By Sponsor|29|||
130159692|NCT04498403|468548348|FG001|Overall Study|Study Terminated By Sponsor|10|||
130159693|NCT01951885|468548350|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
130159694|NCT01951885|468548351|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
130159695|NCT01951885|468548350|FG000|Overall Study|Adverse Event|1|||
130159696|NCT01951885|468548351|FG001|Overall Study|Adverse Event|0|||
130159697|NCT01951885|468548350|FG000|Overall Study|Withdrawal by Subject|0|||
130159698|NCT01951885|468548351|FG001|Overall Study|Withdrawal by Subject|1|||
130159699|NCT01951885|468548350|FG000|Overall Study|ineligible due to a change in donor|0|||
130159700|NCT01951885|468548351|FG001|Overall Study|ineligible due to a change in donor|1|||
130159701|NCT01951885|468548350|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
130159702|NCT01951885|468548351|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
130159703|NCT01206101|468548352|FG000|Overall Study|Adverse Event|1|||
130159704|NCT01206101|468548353|FG001|Overall Study|Adverse Event|0|||
130159705|NCT01206101|468548352|FG000|Overall Study|Physician Decision|0|||
130159706|NCT01206101|468548353|FG001|Overall Study|Physician Decision|1|||
130159707|NCT01206101|468548352|FG000|Overall Study|Unclassified|1|||
130159708|NCT01206101|468548353|FG001|Overall Study|Unclassified|0|||
129980839|NCT01877239|467893377|FG000|Overall Study|Disease Remission|1|||
130159709|NCT04710979|468548354|FG000|Overall Study|Lost to Follow-up|2|||
130159710|NCT04710979|468548355|FG001|Overall Study|Lost to Follow-up|4|||
130159711|NCT04710979|468548354|FG000|Overall Study|Withdrawal by Subject|1|||
130159712|NCT04710979|468548355|FG001|Overall Study|Withdrawal by Subject|0|||
130159713|NCT01462318|468548359|FG000|Main Study / TP-DI Study|Other|2|||
130159714|NCT01462318|468548360|FG001|Main Study / TP-DI Study|Other|0|||
130159715|NCT01462318|468548361|FG002|Main Study / TP-DI Study|Other|0|||
130159716|NCT01462318|468548359|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
130159717|NCT01462318|468548360|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
130159718|NCT01462318|468548361|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
130159719|NCT01462318|468548359|FG000|Main Study / TP-DI Study|Adverse Event|4|||
130159720|NCT01462318|468548360|FG001|Main Study / TP-DI Study|Adverse Event|0|||
130159721|NCT01462318|468548361|FG002|Main Study / TP-DI Study|Adverse Event|0|||
130159722|NCT01462318|468548359|FG000|Extension Phase|Lost to Follow-up|0|||
130159723|NCT01462318|468548360|FG001|Extension Phase|Lost to Follow-up|0|||
130159724|NCT01462318|468548361|FG002|Extension Phase|Lost to Follow-up|1|||
130159725|NCT01462318|468548359|FG000|Extension Phase|Other|0|||
130159726|NCT01462318|468548360|FG001|Extension Phase|Other|0|||
130159727|NCT01462318|468548361|FG002|Extension Phase|Other|1|||
130159728|NCT01462318|468548359|FG000|Extension Phase|Disease Progression|0|||
130159729|NCT01462318|468548360|FG001|Extension Phase|Disease Progression|0|||
130159730|NCT01462318|468548361|FG002|Extension Phase|Disease Progression|1|||
130159731|NCT01462318|468548359|FG000|Extension Phase|Withdrawal by Subject|0|||
130159732|NCT01462318|468548360|FG001|Extension Phase|Withdrawal by Subject|0|||
130159733|NCT01462318|468548361|FG002|Extension Phase|Withdrawal by Subject|15|||
130159734|NCT01462318|468548359|FG000|Extension Phase|Investigator Decision|0|||
130159735|NCT01462318|468548360|FG001|Extension Phase|Investigator Decision|0|||
130159736|NCT01462318|468548361|FG002|Extension Phase|Investigator Decision|5|||
130159737|NCT01462318|468548359|FG000|Extension Phase|Adverse Event|0|||
130159738|NCT01462318|468548360|FG001|Extension Phase|Adverse Event|0|||
130159739|NCT01462318|468548361|FG002|Extension Phase|Adverse Event|22|||
130159740|NCT00891371|468548362|FG000|Pre-assignment|Inclusion/exclusion|5|||
130159741|NCT00891371|468548362|FG000|Pre-assignment|Consent withdrawal|1|||
130159742|NCT00891371|468548362|FG000|Treatment|Lack of Efficacy|5|||
130159743|NCT00891371|468548362|FG000|Treatment|Adverse Event|2|||
130159744|NCT00891371|468548362|FG000|Treatment|Death|1|||
130159745|NCT00891371|468548362|FG000|Treatment|Lost to Follow-up|1|||
130159746|NCT02746471|468548363|FG000|Overall Study|Death|43|||
130159747|NCT02746471|468548363|FG000|Overall Study|Exited before 36 months|1119|||
130159748|NCT04594707|468548367|FG000|Overall Study|Adverse Event|0|||
130159749|NCT04594707|468548368|FG001|Overall Study|Adverse Event|0|||
130159750|NCT04594707|468548369|FG002|Overall Study|Adverse Event|1|||
130159751|NCT04594707|468548367|FG000|Overall Study|Death|0|||
130159752|NCT04594707|468548368|FG001|Overall Study|Death|2|||
130159753|NCT04594707|468548369|FG002|Overall Study|Death|2|||
130159754|NCT04594707|468548367|FG000|Overall Study|Lung Transplant|0|||
130159755|NCT04594707|468548368|FG001|Overall Study|Lung Transplant|0|||
130159756|NCT04594707|468548369|FG002|Overall Study|Lung Transplant|1|||
130159757|NCT04594707|468548367|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
130159758|NCT04594707|468548368|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
130159759|NCT04594707|468548369|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
130159760|NCT04594707|468548367|FG000|Overall Study|Study Terminated By Sponsor|19|||
130159761|NCT04594707|468548368|FG001|Overall Study|Study Terminated By Sponsor|47|||
130159762|NCT04594707|468548369|FG002|Overall Study|Study Terminated By Sponsor|41|||
130159763|NCT04594707|468548367|FG000|Overall Study|Withdrawal by Subject|1|||
130159764|NCT04594707|468548368|FG001|Overall Study|Withdrawal by Subject|0|||
130159765|NCT04594707|468548369|FG002|Overall Study|Withdrawal by Subject|2|||
130159766|NCT01593696|468548370|FG000|Dose Escalation|Progressive Disease|2|||
130159767|NCT01593696|468548371|FG001|Dose Escalation|Progressive Disease|0|||
130159768|NCT01593696|468548372|FG002|Dose Escalation|Progressive Disease|0|||
130159769|NCT01593696|468548373|FG003|Dose Escalation|Progressive Disease|0|||
130159770|NCT01593696|468548370|FG000|Dose Expansion|Fungal infection|0|||
130159771|NCT01593696|468548371|FG001|Dose Expansion|Fungal infection|0|||
130159772|NCT01593696|468548372|FG002|Dose Expansion|Fungal infection|1|||
130159773|NCT01593696|468548373|FG003|Dose Expansion|Fungal infection|0|||
130159774|NCT01936623|468548374|FG000|Overall Study|Lost to Follow-up|0|||
130159775|NCT01936623|468548375|FG001|Overall Study|Lost to Follow-up|5|||
130159776|NCT01340768|468548376|FG000|Overall Study|Lost to Follow-up|10|||
130159777|NCT01340768|468548377|FG001|Overall Study|Lost to Follow-up|4|||
130159778|NCT01340768|468548376|FG000|Overall Study|Withdrawal by Subject|5|||
130159779|NCT01340768|468548377|FG001|Overall Study|Withdrawal by Subject|1|||
130159780|NCT01340768|468548376|FG000|Overall Study|Other|2|||
130159781|NCT01340768|468548377|FG001|Overall Study|Other|0|||
130159782|NCT03052959|468548382|FG000|Overall Study|Lost to Follow-up|4|||
130159783|NCT03052959|468548383|FG001|Overall Study|Lost to Follow-up|5|||
130159784|NCT00950963|468548384|FG000|Overall Study|Lost to Follow-up|29|||
130159785|NCT00950963|468548385|FG001|Overall Study|Lost to Follow-up|24|||
130159786|NCT00655876|468548386|FG000|Overall Study|Protocol Violation|9|||
130159787|NCT00655876|468548387|FG001|Overall Study|Protocol Violation|7|||
130159788|NCT01831765|468548388|FG000|Overall Study|Lack of Efficacy|1|||
130159789|NCT01831765|468548389|FG001|Overall Study|Lack of Efficacy|0|||
130159790|NCT01831765|468548390|FG002|Overall Study|Lack of Efficacy|0|||
130159791|NCT01831765|468548388|FG000|Overall Study|Other, sponsor withdrew subject|0|||
130159792|NCT01831765|468548389|FG001|Overall Study|Other, sponsor withdrew subject|1|||
130159793|NCT01831765|468548390|FG002|Overall Study|Other, sponsor withdrew subject|0|||
130159794|NCT01831765|468548388|FG000|Overall Study|Pregnancy|1|||
130159795|NCT01831765|468548389|FG001|Overall Study|Pregnancy|1|||
130159796|NCT01831765|468548390|FG002|Overall Study|Pregnancy|2|||
130159797|NCT01831765|468548388|FG000|Overall Study|Death|0|||
130159798|NCT01831765|468548389|FG001|Overall Study|Death|1|||
130159799|NCT01831765|468548390|FG002|Overall Study|Death|1|||
130159800|NCT01831765|468548388|FG000|Overall Study|Other, site closed|1|||
130159801|NCT01831765|468548389|FG001|Overall Study|Other, site closed|1|||
130159802|NCT01831765|468548390|FG002|Overall Study|Other, site closed|0|||
130159803|NCT01831765|468548388|FG000|Overall Study|Adverse Event|5|||
130159804|NCT01831765|468548389|FG001|Overall Study|Adverse Event|3|||
130159805|NCT01831765|468548390|FG002|Overall Study|Adverse Event|3|||
130159806|NCT01831765|468548388|FG000|Overall Study|Withdrawal by Subject|22|||
130159807|NCT01831765|468548389|FG001|Overall Study|Withdrawal by Subject|7|||
130159808|NCT01831765|468548390|FG002|Overall Study|Withdrawal by Subject|17|||
130159809|NCT01831765|468548388|FG000|Overall Study|Withdrawal criteria|12|||
130159810|NCT01831765|468548389|FG001|Overall Study|Withdrawal criteria|10|||
130159811|NCT01831765|468548390|FG002|Overall Study|Withdrawal criteria|16|||
130159812|NCT01831765|468548388|FG000|Overall Study|Lost to Follow-up|2|||
130159813|NCT01831765|468548389|FG001|Overall Study|Lost to Follow-up|3|||
130159814|NCT01831765|468548390|FG002|Overall Study|Lost to Follow-up|3|||
130159815|NCT00859586|468548391|FG000|Overall Study|Donors|4|||
130159816|NCT00080938|468548392|FG000|Overall Study|Adverse Event|3|||
130159817|NCT00080938|468548392|FG000|Overall Study|Withdrawal by Subject|6|||
130159818|NCT00080938|468548392|FG000|Overall Study|Death|2|||
130159819|NCT00080938|468548392|FG000|Overall Study|Lack of Efficacy|7|||
130159820|NCT00080938|468548392|FG000|Overall Study|other disease|1|||
130159821|NCT00080938|468548392|FG000|Overall Study|Not started protocol therapy|1|||
130159822|NCT00080938|468548392|FG000|Overall Study|Ineligible|4|||
130159823|NCT00706511|468548395|FG000|Overall Study|Withdrawal by Subject|1|||
130159824|NCT00706511|468548396|FG001|Overall Study|Withdrawal by Subject|0|||
130159825|NCT00706511|468548397|FG002|Overall Study|Withdrawal by Subject|0|||
130159826|NCT00706511|468548398|FG003|Overall Study|Withdrawal by Subject|0|||
130159827|NCT01732484|468548402|FG000|Overall Study|Death|7|||
130159828|NCT01732484|468548402|FG000|Overall Study|Lost to Follow-up|14|||
130159829|NCT01732484|468548402|FG000|Overall Study|chronical illness|5|||
130159830|NCT05297578|468548403|FG000|Overall Study|Lost to Follow-up|1|||
130159831|NCT05297578|468548404|FG001|Overall Study|Lost to Follow-up|1|||
130159832|NCT05297578|468548405|FG002|Overall Study|Lost to Follow-up|2|||
130159833|NCT05297578|468548406|FG003|Overall Study|Lost to Follow-up|1|||
130159834|NCT05297578|468548403|FG000|Overall Study|Death|0|||
130159835|NCT05297578|468548404|FG001|Overall Study|Death|1|||
130159836|NCT05297578|468548405|FG002|Overall Study|Death|0|||
130159837|NCT05297578|468548406|FG003|Overall Study|Death|0|||
130159838|NCT05297578|468548403|FG000|Overall Study|Withdrawal by Subject|0|||
130159839|NCT05297578|468548404|FG001|Overall Study|Withdrawal by Subject|0|||
130159840|NCT05297578|468548405|FG002|Overall Study|Withdrawal by Subject|1|||
130159841|NCT05297578|468548406|FG003|Overall Study|Withdrawal by Subject|0|||
130159842|NCT01087489|468548407|FG000|Overall Study|enrolled in another VA study|0|||
130159843|NCT01087489|468548408|FG001|Overall Study|enrolled in another VA study|1|||
130159844|NCT01087489|468548407|FG000|Overall Study|Death|0|||
130159845|NCT01087489|468548408|FG001|Overall Study|Death|1|||
130159846|NCT01087489|468548407|FG000|Overall Study|unable to survey by telephone|0|||
130159847|NCT01087489|468548408|FG001|Overall Study|unable to survey by telephone|1|||
130159848|NCT00928707|468548409|FG000|Overall Study|Protocol Violation|1|||
130159849|NCT00928707|468548410|FG001|Overall Study|Protocol Violation|0|||
130159850|NCT00132028|468548411|FG000|Overall Study|Adverse Event|7|||
130159851|NCT00132028|468548411|FG000|Overall Study|Death|2|||
130159852|NCT00132028|468548411|FG000|Overall Study|Lack of Efficacy|11|||
130159853|NCT00132028|468548411|FG000|Overall Study|Withdrawal by Subject|2|||
130159854|NCT00132028|468548411|FG000|Overall Study|not eligible|2|||
130159855|NCT00132028|468548411|FG000|Overall Study|Physician Decision|3|||
130159856|NCT02731326|468548412|FG000|Overall Study|Withdrawal by Subject|4|||
130159857|NCT02731326|468548413|FG001|Overall Study|Withdrawal by Subject|1|||
130159858|NCT02731326|468548412|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
130159859|NCT02731326|468548413|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
130159860|NCT02731326|468548412|FG000|Overall Study|Discharged without AliveCor|10|||
130159861|NCT02731326|468548413|FG001|Overall Study|Discharged without AliveCor|0|||
130159862|NCT02731326|468548412|FG000|Overall Study|Duplicate Participant|1|||
129980840|NCT01877239|467893377|FG000|Overall Study|Withdrawal by Subject|4|||
129980841|NCT01877239|467893377|FG000|Overall Study|Other|2|||
129980842|NCT01877239|467893377|FG000|Overall Study|Lack of Efficacy|4|||
130159863|NCT02731326|468548413|FG001|Overall Study|Duplicate Participant|1|||
130159864|NCT02272634|468548415|FG000|Overall Study|Adverse Event|1|||
130159865|NCT02272634|468548416|FG001|Overall Study|Adverse Event|0|||
130159866|NCT02272634|468548417|FG002|Overall Study|Adverse Event|0|||
130159867|NCT02272634|468548415|FG000|Overall Study|Protocol Violation|0|||
130159868|NCT02272634|468548416|FG001|Overall Study|Protocol Violation|0|||
130159869|NCT02272634|468548417|FG002|Overall Study|Protocol Violation|1|||
130159870|NCT02272634|468548415|FG000|Overall Study|Withdrawal by Subject|0|||
130159871|NCT02272634|468548416|FG001|Overall Study|Withdrawal by Subject|1|||
130159872|NCT02272634|468548417|FG002|Overall Study|Withdrawal by Subject|0|||
130159873|NCT04647721|468548418|FG000|Overall Study|Withdrawal by Subject|0|||
130159874|NCT04647721|468548419|FG001|Overall Study|Withdrawal by Subject|2|||
130159875|NCT04647721|468548418|FG000|Overall Study|Lost to Follow-up|2|||
130159876|NCT04647721|468548419|FG001|Overall Study|Lost to Follow-up|0|||
130159877|NCT05070546|468548420|FG000|Overall Study|Death|0|||
130159878|NCT05070546|468548421|FG001|Overall Study|Death|0|||
130159879|NCT05070546|468548422|FG002|Overall Study|Death|0|||
130159880|NCT05070546|468548423|FG003|Overall Study|Death|0|||
130159881|NCT05070546|468548424|FG004|Overall Study|Death|0|||
130159882|NCT05070546|468548425|FG005|Overall Study|Death|1|||
130159883|NCT05070546|468548420|FG000|Overall Study|Lost to Follow-up|8|||
130159884|NCT05070546|468548421|FG001|Overall Study|Lost to Follow-up|2|||
130159885|NCT05070546|468548422|FG002|Overall Study|Lost to Follow-up|7|||
130159886|NCT05070546|468548423|FG003|Overall Study|Lost to Follow-up|1|||
130159887|NCT05070546|468548424|FG004|Overall Study|Lost to Follow-up|2|||
130159888|NCT05070546|468548425|FG005|Overall Study|Lost to Follow-up|0|||
130159889|NCT05070546|468548420|FG000|Overall Study|Withdrawal by Subject|1|||
130159890|NCT05070546|468548421|FG001|Overall Study|Withdrawal by Subject|1|||
130159891|NCT05070546|468548422|FG002|Overall Study|Withdrawal by Subject|3|||
130159892|NCT05070546|468548423|FG003|Overall Study|Withdrawal by Subject|0|||
130159893|NCT05070546|468548424|FG004|Overall Study|Withdrawal by Subject|0|||
130159894|NCT05070546|468548425|FG005|Overall Study|Withdrawal by Subject|0|||
130159895|NCT05070546|468548420|FG000|Overall Study|Other|0|||
130159896|NCT05070546|468548421|FG001|Overall Study|Other|0|||
130159897|NCT05070546|468548422|FG002|Overall Study|Other|0|||
130159898|NCT05070546|468548423|FG003|Overall Study|Other|0|||
130159899|NCT05070546|468548424|FG004|Overall Study|Other|3|||
130159900|NCT05070546|468548425|FG005|Overall Study|Other|0|||
130159901|NCT05070546|468548420|FG000|Overall Study|Randomized but not vaccinated|1|||
130159902|NCT05070546|468548421|FG001|Overall Study|Randomized but not vaccinated|0|||
130159903|NCT05070546|468548422|FG002|Overall Study|Randomized but not vaccinated|1|||
130159904|NCT05070546|468548423|FG003|Overall Study|Randomized but not vaccinated|1|||
130159905|NCT05070546|468548424|FG004|Overall Study|Randomized but not vaccinated|3|||
130159906|NCT05070546|468548425|FG005|Overall Study|Randomized but not vaccinated|0|||
130159907|NCT00302081|468548426|FG000|Overall Study|Adverse Event|6|||
130159908|NCT00302081|468548427|FG001|Overall Study|Adverse Event|5|||
130159909|NCT00302081|468548428|FG002|Overall Study|Adverse Event|4|||
130159910|NCT00302081|468548426|FG000|Overall Study|Lost to Follow-up|21|||
130159911|NCT00302081|468548427|FG001|Overall Study|Lost to Follow-up|18|||
130159912|NCT00302081|468548428|FG002|Overall Study|Lost to Follow-up|28|||
130159913|NCT00302081|468548426|FG000|Overall Study|Withdrawal by Subject|8|||
130159914|NCT00302081|468548427|FG001|Overall Study|Withdrawal by Subject|12|||
130159915|NCT00302081|468548428|FG002|Overall Study|Withdrawal by Subject|8|||
130159916|NCT00302081|468548426|FG000|Overall Study|Protocol Violation|5|||
130159917|NCT00302081|468548427|FG001|Overall Study|Protocol Violation|1|||
130159918|NCT00302081|468548428|FG002|Overall Study|Protocol Violation|2|||
130159919|NCT00302081|468548426|FG000|Overall Study|Lack of Efficacy|1|||
130159920|NCT00302081|468548427|FG001|Overall Study|Lack of Efficacy|0|||
130159921|NCT00302081|468548428|FG002|Overall Study|Lack of Efficacy|5|||
130159922|NCT00302081|468548426|FG000|Overall Study|Death|2|||
130159923|NCT00302081|468548427|FG001|Overall Study|Death|1|||
130159924|NCT00302081|468548428|FG002|Overall Study|Death|0|||
130159925|NCT00302081|468548426|FG000|Overall Study|Other|13|||
130159926|NCT00302081|468548427|FG001|Overall Study|Other|6|||
130159927|NCT00302081|468548428|FG002|Overall Study|Other|5|||
130159928|NCT04771403|468548429|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
130159929|NCT04771403|468548430|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
130159930|NCT04771403|468548429|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
130159931|NCT04771403|468548430|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
130159932|NCT04771403|468548429|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
130159933|NCT04771403|468548430|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
130159934|NCT04771403|468548429|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
130159935|NCT04771403|468548430|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
130159936|NCT04771403|468548429|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
130159937|NCT04771403|468548430|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
129980843|NCT01877239|467893377|FG000|Overall Study|Data not available|35|||
129980844|NCT01669577|467893378|FG000|Overall Study|Death|22|||
129980845|NCT01669577|467893378|FG000|Overall Study|Lost to Follow-up|78|||
129980846|NCT01669577|467893378|FG000|Overall Study|Physician Decision|34|||
129980847|NCT00132873|467893384|FG000|Overall Study|Adverse Event|3|||
129980848|NCT00132873|467893384|FG000|Overall Study|Lost to Follow-up|1|||
129980849|NCT00132873|467893384|FG000|Overall Study|Lack of Efficacy|1|||
129980850|NCT00132873|467893384|FG000|Overall Study|Withdrawal by Subject|3|||
129980851|NCT00132873|467893384|FG000|Overall Study|Planned Pregnancy|1|||
129980852|NCT02045875|467893385|FG000|Overall Study|Lost to Follow-up|3|||
129980853|NCT02045875|467893386|FG001|Overall Study|Lost to Follow-up|0|||
130159938|NCT04771403|468548429|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
130159939|NCT04771403|468548430|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
130159940|NCT04771403|468548429|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
130159941|NCT04771403|468548430|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
130159942|NCT04771403|468548429|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
130159943|NCT04771403|468548430|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
130159944|NCT00816361|468548431|FG000|Overall Study|Withdrawal by Subject|0|||
130159945|NCT00816361|468548432|FG001|Overall Study|Withdrawal by Subject|0|||
130159946|NCT00816361|468548433|FG002|Overall Study|Withdrawal by Subject|0|||
130159947|NCT00816361|468548434|FG003|Overall Study|Withdrawal by Subject|0|||
130159948|NCT00816361|468548435|FG004|Overall Study|Withdrawal by Subject|1|||
130159949|NCT00816361|468548436|FG005|Overall Study|Withdrawal by Subject|2|||
130159950|NCT00816361|468548437|FG006|Overall Study|Withdrawal by Subject|0|||
130159951|NCT00816361|468548438|FG007|Overall Study|Withdrawal by Subject|2|||
130159952|NCT00816361|468548439|FG008|Overall Study|Withdrawal by Subject|1|||
130159953|NCT00816361|468548431|FG000|Overall Study|Death|4|||
130159954|NCT00816361|468548432|FG001|Overall Study|Death|3|||
130159955|NCT00816361|468548433|FG002|Overall Study|Death|3|||
130159956|NCT00816361|468548434|FG003|Overall Study|Death|3|||
130159957|NCT00816361|468548435|FG004|Overall Study|Death|1|||
130159958|NCT00816361|468548436|FG005|Overall Study|Death|1|||
130159959|NCT00816361|468548437|FG006|Overall Study|Death|3|||
130159960|NCT00816361|468548438|FG007|Overall Study|Death|7|||
130159961|NCT00816361|468548439|FG008|Overall Study|Death|8|||
130159962|NCT00816361|468548431|FG000|Overall Study|Other|0|||
130159963|NCT00816361|468548432|FG001|Overall Study|Other|0|||
130159964|NCT00816361|468548433|FG002|Overall Study|Other|0|||
130159965|NCT00816361|468548434|FG003|Overall Study|Other|0|||
130159966|NCT00816361|468548435|FG004|Overall Study|Other|0|||
130159967|NCT00816361|468548436|FG005|Overall Study|Other|0|||
130159968|NCT00816361|468548437|FG006|Overall Study|Other|0|||
130159969|NCT00816361|468548438|FG007|Overall Study|Other|0|||
130159970|NCT00816361|468548439|FG008|Overall Study|Other|1|||
130159971|NCT00546572|468548440|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
130159972|NCT00546572|468548441|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
130159973|NCT00546572|468548440|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
130159974|NCT00546572|468548441|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
130159975|NCT00546572|468548440|FG000|Vax 1 / Year 0|Protocol Violation|3|||
130159976|NCT00546572|468548441|FG001|Vax 1 / Year 0|Protocol Violation|4|||
130159977|NCT00546572|468548440|FG000|Vax 1 / Year 0|Death|2|||
130159978|NCT00546572|468548441|FG001|Vax 1 / Year 0|Death|2|||
130159979|NCT00546572|468548440|FG000|Vax 1 / Year 0|Adverse Event|0|||
130159980|NCT00546572|468548441|FG001|Vax 1 / Year 0|Adverse Event|1|||
130159981|NCT00546572|468548440|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
130159982|NCT00546572|468548441|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
130159983|NCT00546572|468548440|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
130159984|NCT00546572|468548441|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
130159985|NCT00546572|468548440|FG000|Vax 2 / Year 1|Other|1|||
130159986|NCT00546572|468548441|FG001|Vax 2 / Year 1|Other|1|||
130159987|NCT00546572|468548440|FG000|Vax 2 / Year 1|Adverse Event|1|||
130159988|NCT00546572|468548441|FG001|Vax 2 / Year 1|Adverse Event|0|||
130159989|NCT00546572|468548440|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
130159990|NCT00546572|468548441|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
130159991|NCT00741936|468548446|FG000|Overall Study|Lost to Follow-up|1|||
130159992|NCT00741936|468548447|FG001|Overall Study|Lost to Follow-up|1|||
130159993|NCT00741936|468548446|FG000|Overall Study|Adverse Event|3|||
130159994|NCT00741936|468548447|FG001|Overall Study|Adverse Event|4|||
130159995|NCT00741936|468548446|FG000|Overall Study|Pregnancy|0|||
130159996|NCT00741936|468548447|FG001|Overall Study|Pregnancy|1|||
130159997|NCT00741936|468548446|FG000|Overall Study|Protocol Violation|2|||
130159998|NCT00741936|468548447|FG001|Overall Study|Protocol Violation|0|||
130159999|NCT00741936|468548446|FG000|Overall Study|Lack of Efficacy|0|||
130160000|NCT00741936|468548447|FG001|Overall Study|Lack of Efficacy|2|||
130160001|NCT00741936|468548446|FG000|Overall Study|Low compliance|3|||
130160002|NCT00741936|468548447|FG001|Overall Study|Low compliance|0|||
130160003|NCT01408628|468548448|FG000|Consented|Withdrawal by Subject|12|||
130160004|NCT01408628|468548448|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
130160005|NCT01408628|468548448|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
130160006|NCT01408628|468548448|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
130160007|NCT01941940|468548449|FG000|Overall Study|Adverse Event|11|||
130160008|NCT01941940|468548449|FG000|Overall Study|Lost to Follow-up|2|||
130160009|NCT01941940|468548449|FG000|Overall Study|Physician Decision|2|||
130160010|NCT01941940|468548449|FG000|Overall Study|Withdrawal by Subject|15|||
130160011|NCT01941940|468548449|FG000|Overall Study|Death|1|||
130160012|NCT01941940|468548449|FG000|Overall Study|Other|1|||
130160013|NCT01941940|468548449|FG000|Overall Study|Other|1|||
130160014|NCT00750308|468548450|FG000|First Treatment|Adverse Event|0|||
130160015|NCT00750308|468548451|FG001|First Treatment|Adverse Event|1|||
130160016|NCT00750308|468548452|FG002|First Treatment|Adverse Event|0|||
130160017|NCT00750308|468548453|FG003|First Treatment|Adverse Event|0|||
130160018|NCT00750308|468548454|FG004|First Treatment|Adverse Event|0|||
130160019|NCT00750308|468548455|FG005|First Treatment|Adverse Event|0|||
130160020|NCT00750308|468548456|FG006|First Treatment|Adverse Event|0|||
130160021|NCT00750308|468548457|FG007|First Treatment|Adverse Event|0|||
130160022|NCT00750308|468548458|FG008|First Treatment|Adverse Event|0|||
130160023|NCT00750308|468548459|FG009|First Treatment|Adverse Event|0|||
130160024|NCT00750308|468548460|FG010|First Treatment|Adverse Event|1|||
130160025|NCT00750308|468548461|FG011|First Treatment|Adverse Event|1|||
130160026|NCT00750308|468548450|FG000|First Treatment|Withdrawal by Subject|0|||
130160027|NCT00750308|468548451|FG001|First Treatment|Withdrawal by Subject|0|||
130160028|NCT00750308|468548452|FG002|First Treatment|Withdrawal by Subject|0|||
130160029|NCT00750308|468548453|FG003|First Treatment|Withdrawal by Subject|1|||
130160030|NCT00750308|468548454|FG004|First Treatment|Withdrawal by Subject|0|||
130160031|NCT00750308|468548455|FG005|First Treatment|Withdrawal by Subject|0|||
130160032|NCT00750308|468548456|FG006|First Treatment|Withdrawal by Subject|0|||
130160033|NCT00750308|468548457|FG007|First Treatment|Withdrawal by Subject|1|||
130160034|NCT00750308|468548458|FG008|First Treatment|Withdrawal by Subject|0|||
130160035|NCT00750308|468548459|FG009|First Treatment|Withdrawal by Subject|0|||
130160036|NCT00750308|468548460|FG010|First Treatment|Withdrawal by Subject|0|||
130160037|NCT00750308|468548461|FG011|First Treatment|Withdrawal by Subject|0|||
130160038|NCT00750308|468548450|FG000|Second Treatment|Adverse Event|0|||
130160039|NCT00750308|468548451|FG001|Second Treatment|Adverse Event|0|||
130160040|NCT00750308|468548452|FG002|Second Treatment|Adverse Event|0|||
130160041|NCT00750308|468548453|FG003|Second Treatment|Adverse Event|0|||
130160042|NCT00750308|468548454|FG004|Second Treatment|Adverse Event|0|||
130160043|NCT00750308|468548455|FG005|Second Treatment|Adverse Event|1|||
130160044|NCT00750308|468548456|FG006|Second Treatment|Adverse Event|0|||
130160045|NCT00750308|468548457|FG007|Second Treatment|Adverse Event|0|||
130160046|NCT00750308|468548458|FG008|Second Treatment|Adverse Event|1|||
130160047|NCT00750308|468548459|FG009|Second Treatment|Adverse Event|0|||
130160048|NCT00750308|468548460|FG010|Second Treatment|Adverse Event|0|||
130160049|NCT00750308|468548461|FG011|Second Treatment|Adverse Event|0|||
130160050|NCT00750308|468548450|FG000|Second Treatment|Withdrawal by Subject|0|||
130160051|NCT00750308|468548451|FG001|Second Treatment|Withdrawal by Subject|0|||
130160052|NCT00750308|468548452|FG002|Second Treatment|Withdrawal by Subject|0|||
130160053|NCT00750308|468548453|FG003|Second Treatment|Withdrawal by Subject|0|||
130160054|NCT00750308|468548454|FG004|Second Treatment|Withdrawal by Subject|1|||
130160055|NCT00750308|468548455|FG005|Second Treatment|Withdrawal by Subject|0|||
130160056|NCT00750308|468548456|FG006|Second Treatment|Withdrawal by Subject|0|||
130160057|NCT00750308|468548457|FG007|Second Treatment|Withdrawal by Subject|0|||
130160058|NCT00750308|468548458|FG008|Second Treatment|Withdrawal by Subject|0|||
130160059|NCT00750308|468548459|FG009|Second Treatment|Withdrawal by Subject|0|||
130160060|NCT00750308|468548460|FG010|Second Treatment|Withdrawal by Subject|0|||
130160061|NCT00750308|468548461|FG011|Second Treatment|Withdrawal by Subject|0|||
130160062|NCT00750308|468548450|FG000|Third Treatment|Withdrawal by Subject|0|||
130160063|NCT00750308|468548451|FG001|Third Treatment|Withdrawal by Subject|1|||
130160064|NCT00750308|468548452|FG002|Third Treatment|Withdrawal by Subject|0|||
130160065|NCT00750308|468548453|FG003|Third Treatment|Withdrawal by Subject|0|||
130160066|NCT00750308|468548454|FG004|Third Treatment|Withdrawal by Subject|0|||
130160067|NCT00750308|468548455|FG005|Third Treatment|Withdrawal by Subject|0|||
130160068|NCT00750308|468548456|FG006|Third Treatment|Withdrawal by Subject|0|||
130160069|NCT00750308|468548457|FG007|Third Treatment|Withdrawal by Subject|0|||
130160070|NCT00750308|468548458|FG008|Third Treatment|Withdrawal by Subject|0|||
130160071|NCT00750308|468548459|FG009|Third Treatment|Withdrawal by Subject|0|||
130160072|NCT00750308|468548460|FG010|Third Treatment|Withdrawal by Subject|0|||
130160073|NCT00750308|468548461|FG011|Third Treatment|Withdrawal by Subject|0|||
130160074|NCT00513682|468548462|FG000|Washout Phase|Adverse Event|2|||
130160075|NCT02450526|468548463|FG000|DB Period (Cycle 1)|Adverse Event|0|||
130160076|NCT02450526|468548464|FG001|DB Period (Cycle 1)|Adverse Event|0|||
130160077|NCT02450526|468548465|FG002|DB Period (Cycle 1)|Adverse Event|2|||
130160078|NCT02450526|468548466|FG003|DB Period (Cycle 1)|Adverse Event|0|||
130160079|NCT02450526|468548467|FG004|DB Period (Cycle 1)|Adverse Event|0|||
130160080|NCT02450526|468548463|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
130160081|NCT02450526|468548464|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
130160082|NCT02450526|468548465|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
130160083|NCT02450526|468548466|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
130160084|NCT02450526|468548467|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
130160085|NCT02450526|468548463|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
130160086|NCT02450526|468548464|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
130160087|NCT02450526|468548465|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
130160088|NCT02450526|468548466|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
130160089|NCT02450526|468548467|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
130160090|NCT02450526|468548463|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
130160091|NCT02450526|468548464|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
129980854|NCT02045875|467893385|FG000|Overall Study|Withdrawal by Subject|4|||
130160092|NCT02450526|468548465|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
130160093|NCT02450526|468548466|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
130160094|NCT02450526|468548467|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
130160095|NCT02450526|468548463|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
130160096|NCT02450526|468548464|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
130160097|NCT02450526|468548465|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
130160098|NCT02450526|468548466|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
130160099|NCT02450526|468548467|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
130160100|NCT02450526|468548463|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130160101|NCT02450526|468548464|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130160102|NCT02450526|468548465|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130160103|NCT02450526|468548466|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
130160104|NCT02450526|468548467|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
130160105|NCT02450526|468548463|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130160106|NCT02450526|468548464|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130160107|NCT02450526|468548465|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130160108|NCT02450526|468548466|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
130160109|NCT02450526|468548467|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
130160110|NCT02450526|468548463|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
130160111|NCT02450526|468548464|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
130160112|NCT02450526|468548465|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
130160113|NCT02450526|468548466|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
130160114|NCT02450526|468548467|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
130160115|NCT03212521|468548468|FG000|Overall Study|Adverse Event|1|||
130160116|NCT03212521|468548468|FG000|Overall Study|Lost to Follow-up|4|||
130160117|NCT03212521|468548468|FG000|Overall Study|Withdrawal by Subject|1|||
130160118|NCT03212521|468548468|FG000|Overall Study|Other|1|||
130160119|NCT02435836|468548469|FG000|Overall Study|Lost to Follow-up|21|||
130160120|NCT02435836|468548469|FG000|Overall Study|Lack of Efficacy|1|||
130160121|NCT02435836|468548469|FG000|Overall Study|Withdrawal by Subject|236|||
130160122|NCT02435836|468548469|FG000|Overall Study|Insufficient Clinical Response|26|||
130160123|NCT02435836|468548469|FG000|Overall Study|Adverse Event|44|||
130160124|NCT02435836|468548469|FG000|Overall Study|Sponsor discontinued trial|167|||
130160125|NCT02435836|468548469|FG000|Overall Study|Noncompliance|27|||
130160126|NCT02435836|468548469|FG000|Overall Study|Protocol Violation|6|||
130160127|NCT02435836|468548469|FG000|Overall Study|Met Withdrawal Criteria|7|||
130160128|NCT02435836|468548469|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
130160129|NCT01970865|468548470|FG000|Overall Study|Death|3|||
130160130|NCT01970865|468548471|FG001|Overall Study|Death|2|||
130160131|NCT01970865|468548472|FG002|Overall Study|Death|3|||
130160132|NCT01970865|468548473|FG003|Overall Study|Death|6|||
130160133|NCT01970865|468548474|FG004|Overall Study|Death|9|||
130160134|NCT01970865|468548475|FG005|Overall Study|Death|3|||
130160135|NCT01970865|468548476|FG006|Overall Study|Death|2|||
130160136|NCT01970865|468548477|FG007|Overall Study|Death|3|||
130160137|NCT01970865|468548478|FG008|Overall Study|Death|2|||
130160138|NCT01970865|468548479|FG009|Overall Study|Death|2|||
130160139|NCT01970865|468548480|FG010|Overall Study|Death|8|||
130160140|NCT01970865|468548481|FG011|Overall Study|Death|13|||
130160141|NCT01970865|468548482|FG012|Overall Study|Death|25|||
130160142|NCT01970865|468548483|FG013|Overall Study|Death|46|||
130160143|NCT01970865|468548484|FG014|Overall Study|Death|37|||
130160144|NCT01970865|468548485|FG015|Overall Study|Death|22|||
130160145|NCT01970865|468548486|FG016|Overall Study|Death|1|||
130160146|NCT01970865|468548487|FG017|Overall Study|Death|17|||
130160147|NCT01970865|468548470|FG000|Overall Study|Lost to Follow-up|0|||
130160148|NCT01970865|468548471|FG001|Overall Study|Lost to Follow-up|0|||
130160149|NCT01970865|468548472|FG002|Overall Study|Lost to Follow-up|0|||
130160150|NCT01970865|468548473|FG003|Overall Study|Lost to Follow-up|1|||
130160151|NCT01970865|468548474|FG004|Overall Study|Lost to Follow-up|1|||
130160152|NCT01970865|468548475|FG005|Overall Study|Lost to Follow-up|0|||
130160153|NCT01970865|468548476|FG006|Overall Study|Lost to Follow-up|0|||
130160154|NCT01970865|468548477|FG007|Overall Study|Lost to Follow-up|0|||
130160155|NCT01970865|468548478|FG008|Overall Study|Lost to Follow-up|0|||
130160156|NCT01970865|468548479|FG009|Overall Study|Lost to Follow-up|0|||
130160157|NCT01970865|468548480|FG010|Overall Study|Lost to Follow-up|1|||
130160158|NCT01970865|468548481|FG011|Overall Study|Lost to Follow-up|0|||
130160159|NCT01970865|468548482|FG012|Overall Study|Lost to Follow-up|2|||
130160160|NCT01970865|468548483|FG013|Overall Study|Lost to Follow-up|0|||
130160161|NCT01970865|468548484|FG014|Overall Study|Lost to Follow-up|1|||
130160162|NCT01970865|468548485|FG015|Overall Study|Lost to Follow-up|4|||
130160163|NCT01970865|468548486|FG016|Overall Study|Lost to Follow-up|0|||
130160164|NCT01970865|468548487|FG017|Overall Study|Lost to Follow-up|1|||
130160165|NCT01970865|468548470|FG000|Overall Study|Other|0|||
130160166|NCT01970865|468548471|FG001|Overall Study|Other|1|||
130160167|NCT01970865|468548472|FG002|Overall Study|Other|0|||
130160168|NCT01970865|468548473|FG003|Overall Study|Other|1|||
130160169|NCT01970865|468548474|FG004|Overall Study|Other|1|||
130160170|NCT01970865|468548475|FG005|Overall Study|Other|0|||
130160171|NCT01970865|468548476|FG006|Overall Study|Other|1|||
130160172|NCT01970865|468548477|FG007|Overall Study|Other|0|||
130160173|NCT01970865|468548478|FG008|Overall Study|Other|0|||
130160174|NCT01970865|468548479|FG009|Overall Study|Other|0|||
130160175|NCT01970865|468548480|FG010|Overall Study|Other|2|||
130160176|NCT01970865|468548481|FG011|Overall Study|Other|3|||
130160177|NCT01970865|468548482|FG012|Overall Study|Other|8|||
130160178|NCT01970865|468548483|FG013|Overall Study|Other|3|||
130160179|NCT01970865|468548484|FG014|Overall Study|Other|2|||
130160180|NCT01970865|468548485|FG015|Overall Study|Other|3|||
130160181|NCT01970865|468548486|FG016|Overall Study|Other|0|||
130160182|NCT01970865|468548487|FG017|Overall Study|Other|2|||
130160183|NCT01970865|468548470|FG000|Overall Study|Participant refused further follow-up|0|||
130160184|NCT01970865|468548471|FG001|Overall Study|Participant refused further follow-up|0|||
130160185|NCT01970865|468548472|FG002|Overall Study|Participant refused further follow-up|0|||
130160186|NCT01970865|468548473|FG003|Overall Study|Participant refused further follow-up|2|||
130160187|NCT01970865|468548474|FG004|Overall Study|Participant refused further follow-up|3|||
130160188|NCT01970865|468548475|FG005|Overall Study|Participant refused further follow-up|0|||
130160189|NCT01970865|468548476|FG006|Overall Study|Participant refused further follow-up|0|||
130160190|NCT01970865|468548477|FG007|Overall Study|Participant refused further follow-up|0|||
130160191|NCT01970865|468548478|FG008|Overall Study|Participant refused further follow-up|0|||
130160192|NCT01970865|468548479|FG009|Overall Study|Participant refused further follow-up|0|||
130160193|NCT01970865|468548480|FG010|Overall Study|Participant refused further follow-up|1|||
130160194|NCT01970865|468548481|FG011|Overall Study|Participant refused further follow-up|4|||
130160195|NCT01970865|468548482|FG012|Overall Study|Participant refused further follow-up|7|||
130160196|NCT01970865|468548483|FG013|Overall Study|Participant refused further follow-up|8|||
130160197|NCT01970865|468548484|FG014|Overall Study|Participant refused further follow-up|3|||
130160198|NCT01970865|468548485|FG015|Overall Study|Participant refused further follow-up|11|||
130160199|NCT01970865|468548486|FG016|Overall Study|Participant refused further follow-up|0|||
130160200|NCT01970865|468548487|FG017|Overall Study|Participant refused further follow-up|6|||
130160201|NCT02041091|468548490|FG000|Treatment|Adverse Event|3|||
130160202|NCT02041091|468548491|FG001|Treatment|Adverse Event|3|||
130160203|NCT02041091|468548490|FG000|Treatment|Withdrawal by Subject|2|||
130160204|NCT02041091|468548491|FG001|Treatment|Withdrawal by Subject|4|||
130160205|NCT02041091|468548490|FG000|Treatment|Physician Decision|1|||
130160206|NCT02041091|468548491|FG001|Treatment|Physician Decision|0|||
130160207|NCT02041091|468548490|FG000|Treatment|Sponsor Decision|15|||
130160208|NCT02041091|468548491|FG001|Treatment|Sponsor Decision|16|||
130160209|NCT02041091|468548490|FG000|Treatment|Lost to Follow-up|1|||
130160210|NCT02041091|468548491|FG001|Treatment|Lost to Follow-up|0|||
130160211|NCT02041091|468548490|FG000|Optional Safety Extension Period|Adverse Event|4|||
130160212|NCT02041091|468548491|FG001|Optional Safety Extension Period|Adverse Event|2|||
130160213|NCT02041091|468548490|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
130160214|NCT02041091|468548491|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
130160215|NCT02041091|468548490|FG000|Optional Safety Extension Period|Protocol Violation|2|||
130160216|NCT02041091|468548491|FG001|Optional Safety Extension Period|Protocol Violation|0|||
130160217|NCT02041091|468548490|FG000|Optional Safety Extension Period|Physician Decision|2|||
130160218|NCT02041091|468548491|FG001|Optional Safety Extension Period|Physician Decision|1|||
130160219|NCT02041091|468548490|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
130160220|NCT02041091|468548491|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
130160221|NCT02041091|468548490|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
130160222|NCT02041091|468548491|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
130160223|NCT01855074|468548492|FG000|Overall Study|Adverse Event|1|||
130160224|NCT01855074|468548492|FG000|Overall Study|Lost to Follow-up|4|||
130160225|NCT01855074|468548492|FG000|Overall Study|Withdrawal by Subject|8|||
130160226|NCT01855074|468548492|FG000|Overall Study|Started but not treated|1|||
130160227|NCT01150890|468548493|FG000|Overall Study|Other|0|||
130160228|NCT01150890|468548494|FG001|Overall Study|Other|1|||
130160229|NCT01150890|468548495|FG002|Overall Study|Other|0|||
130160230|NCT01150890|468548496|FG003|Overall Study|Other|2|||
130160231|NCT01150890|468548493|FG000|Overall Study|Pregnancy|0|||
130160232|NCT01150890|468548494|FG001|Overall Study|Pregnancy|0|||
130160233|NCT01150890|468548495|FG002|Overall Study|Pregnancy|0|||
130160234|NCT01150890|468548496|FG003|Overall Study|Pregnancy|1|||
130160235|NCT01150890|468548493|FG000|Overall Study|Administrative Decision|4|||
130160236|NCT01150890|468548494|FG001|Overall Study|Administrative Decision|4|||
130160237|NCT01150890|468548495|FG002|Overall Study|Administrative Decision|5|||
130160238|NCT01150890|468548496|FG003|Overall Study|Administrative Decision|6|||
130160239|NCT01150890|468548493|FG000|Overall Study|Ineligibility determined|0|||
130160240|NCT01150890|468548494|FG001|Overall Study|Ineligibility determined|1|||
130160241|NCT01150890|468548495|FG002|Overall Study|Ineligibility determined|0|||
130160242|NCT01150890|468548496|FG003|Overall Study|Ineligibility determined|0|||
130160243|NCT01150890|468548493|FG000|Overall Study|Adverse Event|0|||
130160244|NCT01150890|468548494|FG001|Overall Study|Adverse Event|0|||
130160245|NCT01150890|468548495|FG002|Overall Study|Adverse Event|2|||
130160246|NCT01150890|468548496|FG003|Overall Study|Adverse Event|0|||
130160247|NCT01150890|468548493|FG000|Overall Study|Withdrawal by Subject|0|||
130160248|NCT01150890|468548494|FG001|Overall Study|Withdrawal by Subject|0|||
130160249|NCT01150890|468548495|FG002|Overall Study|Withdrawal by Subject|2|||
130160250|NCT01150890|468548496|FG003|Overall Study|Withdrawal by Subject|1|||
130160251|NCT01150890|468548493|FG000|Overall Study|Disease progression|0|||
130160252|NCT01150890|468548494|FG001|Overall Study|Disease progression|7|||
130160253|NCT01150890|468548495|FG002|Overall Study|Disease progression|3|||
130160254|NCT01150890|468548496|FG003|Overall Study|Disease progression|7|||
130160255|NCT00922987|468548497|FG000|Overall Study|Insufficient clinical response|1|||
130160256|NCT00922987|468548497|FG000|Overall Study|Protocol Violation|2|||
130160257|NCT00922987|468548497|FG000|Overall Study|Adverse Event|1|||
130160258|NCT00446199|468548498|FG000|Overall Study|Adverse Event|7|||
130160259|NCT00446199|468548499|FG001|Overall Study|Adverse Event|4|||
130160260|NCT00446199|468548500|FG002|Overall Study|Adverse Event|6|||
130160261|NCT00446199|468548501|FG003|Overall Study|Adverse Event|4|||
130160262|NCT00446199|468548498|FG000|Overall Study|Lost to Follow-up|4|||
130160263|NCT00446199|468548499|FG001|Overall Study|Lost to Follow-up|5|||
130160264|NCT00446199|468548500|FG002|Overall Study|Lost to Follow-up|2|||
130160265|NCT00446199|468548501|FG003|Overall Study|Lost to Follow-up|6|||
130160266|NCT00446199|468548498|FG000|Overall Study|Protocol Violation|1|||
130160267|NCT00446199|468548499|FG001|Overall Study|Protocol Violation|2|||
130160268|NCT00446199|468548500|FG002|Overall Study|Protocol Violation|1|||
130160269|NCT00446199|468548501|FG003|Overall Study|Protocol Violation|3|||
130160270|NCT00446199|468548498|FG000|Overall Study|Withdrawal by Subject|2|||
130160271|NCT00446199|468548499|FG001|Overall Study|Withdrawal by Subject|5|||
130160272|NCT00446199|468548500|FG002|Overall Study|Withdrawal by Subject|9|||
130160273|NCT00446199|468548501|FG003|Overall Study|Withdrawal by Subject|10|||
130160274|NCT00446199|468548498|FG000|Overall Study|Site termination|2|||
130160275|NCT00446199|468548499|FG001|Overall Study|Site termination|0|||
130160276|NCT00446199|468548500|FG002|Overall Study|Site termination|0|||
130160277|NCT00446199|468548501|FG003|Overall Study|Site termination|1|||
130160278|NCT00446199|468548498|FG000|Overall Study|Randomization in Error|2|||
130160279|NCT00446199|468548499|FG001|Overall Study|Randomization in Error|0|||
130160280|NCT00446199|468548500|FG002|Overall Study|Randomization in Error|1|||
130160281|NCT00446199|468548501|FG003|Overall Study|Randomization in Error|1|||
130160282|NCT00446199|468548498|FG000|Overall Study|Lack of Efficacy|1|||
130160283|NCT00446199|468548499|FG001|Overall Study|Lack of Efficacy|0|||
130160284|NCT00446199|468548500|FG002|Overall Study|Lack of Efficacy|0|||
130160285|NCT00446199|468548501|FG003|Overall Study|Lack of Efficacy|1|||
130160286|NCT00446199|468548498|FG000|Overall Study|Non-compliant with study drug|1|||
130160287|NCT00446199|468548499|FG001|Overall Study|Non-compliant with study drug|0|||
130160288|NCT00446199|468548500|FG002|Overall Study|Non-compliant with study drug|5|||
130160289|NCT00446199|468548501|FG003|Overall Study|Non-compliant with study drug|0|||
130160290|NCT00446199|468548498|FG000|Overall Study|Non-compliant with visit schedule|1|||
130160291|NCT00446199|468548499|FG001|Overall Study|Non-compliant with visit schedule|1|||
130160292|NCT00446199|468548500|FG002|Overall Study|Non-compliant with visit schedule|1|||
130160293|NCT00446199|468548501|FG003|Overall Study|Non-compliant with visit schedule|2|||
130160294|NCT00446199|468548498|FG000|Overall Study|Hormone fear|0|||
130160295|NCT00446199|468548499|FG001|Overall Study|Hormone fear|0|||
130160296|NCT00446199|468548500|FG002|Overall Study|Hormone fear|0|||
130160297|NCT00446199|468548501|FG003|Overall Study|Hormone fear|1|||
130160298|NCT00446199|468548498|FG000|Overall Study|Lost interest in study participation|0|||
130160299|NCT00446199|468548499|FG001|Overall Study|Lost interest in study participation|1|||
130160300|NCT00446199|468548500|FG002|Overall Study|Lost interest in study participation|0|||
130160301|NCT00446199|468548501|FG003|Overall Study|Lost interest in study participation|0|||
130160302|NCT00446199|468548498|FG000|Overall Study|In-/Exclusion criterion violated|2|||
130160303|NCT00446199|468548499|FG001|Overall Study|In-/Exclusion criterion violated|1|||
130160304|NCT00446199|468548500|FG002|Overall Study|In-/Exclusion criterion violated|2|||
130160305|NCT00446199|468548501|FG003|Overall Study|In-/Exclusion criterion violated|1|||
130160306|NCT00446199|468548498|FG000|Overall Study|Move|0|||
130160307|NCT00446199|468548499|FG001|Overall Study|Move|1|||
130160308|NCT00446199|468548500|FG002|Overall Study|Move|0|||
130160309|NCT00446199|468548501|FG003|Overall Study|Move|0|||
130160310|NCT03071094|468548505|FG000|Overall Study|Death|1|||
130160311|NCT03071094|468548506|FG001|Overall Study|Death|1|||
130160312|NCT03071094|468548505|FG000|Overall Study|Adverse Event|1|||
130160313|NCT03071094|468548506|FG001|Overall Study|Adverse Event|0|||
130160314|NCT02312063|468548507|FG000|Overall Study|Withdrawal by Subject|0|||
130160315|NCT02312063|468548508|FG001|Overall Study|Withdrawal by Subject|1|||
130160316|NCT01079832|468548509|FG000|Overall Study|Withdrawal by Subject|1|||
130160317|NCT00577395|468550350|FG000|Overall Study|Study was terminated early by Sponsor|7|||
130160318|NCT00577395|468550351|FG001|Overall Study|Study was terminated early by Sponsor|6|||
130160319|NCT04709835|468550356|FG000|Overall Study|Withdrawal by Subject|0|||
130160320|NCT04709835|468550357|FG001|Overall Study|Withdrawal by Subject|1|||
130160321|NCT04709835|468550358|FG002|Overall Study|Withdrawal by Subject|0|||
130160322|NCT04325204|468550359|FG000|Overall Study|Death|0|||
130160323|NCT04325204|468550360|FG001|Overall Study|Death|1|||
130160324|NCT04325204|468550359|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
130160325|NCT04325204|468550360|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
130160326|NCT04325204|468550359|FG000|Overall Study|Lost to Follow-up|8|||
130160327|NCT04325204|468550360|FG001|Overall Study|Lost to Follow-up|8|||
130160328|NCT04325204|468550359|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
130160329|NCT04325204|468550360|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
130160330|NCT04711902|468550362|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
130160331|NCT04711902|468550363|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
130160332|NCT04711902|468550364|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
130160333|NCT04711902|468550365|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
130160334|NCT04711902|468550366|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
130160335|NCT04711902|468550367|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
130160336|NCT03827564|468550370|FG000|Overall Study|Discontinued due to Study Termination|1|||
130160337|NCT03827564|468550371|FG001|Overall Study|Discontinued due to Study Termination|0|||
130160338|NCT02238626|468550372|FG000|Overall Study|Adverse Event|3|||
130160339|NCT02238626|468550373|FG001|Overall Study|Adverse Event|5|||
130160340|NCT02238626|468550374|FG002|Overall Study|Adverse Event|0|||
130160341|NCT02238626|468550375|FG003|Overall Study|Adverse Event|3|||
130160342|NCT02238626|468550372|FG000|Overall Study|Lost to Follow-up|2|||
130160343|NCT02238626|468550373|FG001|Overall Study|Lost to Follow-up|4|||
130160344|NCT02238626|468550374|FG002|Overall Study|Lost to Follow-up|2|||
130160345|NCT02238626|468550375|FG003|Overall Study|Lost to Follow-up|2|||
130160346|NCT02238626|468550372|FG000|Overall Study|Withdrawal by Subject|0|||
130160347|NCT02238626|468550373|FG001|Overall Study|Withdrawal by Subject|3|||
130160348|NCT02238626|468550374|FG002|Overall Study|Withdrawal by Subject|0|||
129980855|NCT02045875|467893386|FG001|Overall Study|Withdrawal by Subject|3|||
129980856|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
129980857|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
129980858|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
129980859|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
129980860|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
129980861|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
129980862|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
129980863|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
129980864|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
129980865|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
129980866|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Adverse Event|0|||
129980867|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Adverse Event|0|||
129980868|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Adverse Event|3|||
129980869|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Adverse Event|2|||
129980870|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Adverse Event|13|||
129980871|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
129980872|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
129980873|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
129980874|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
129980875|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
129980876|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Patient's wish|0|||
129980877|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Patient's wish|0|||
129980878|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Patient's wish|19|||
129980879|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Patient's wish|9|||
129980880|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Patient's wish|20|||
129980881|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
129980882|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
129980883|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
129980884|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
129980885|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
129980886|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
129980887|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
129980888|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
129980889|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
129980890|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
129980891|NCT00743431|467893395|FG000|Overall Study|Toxicity|6|||
129980892|NCT00743431|467893395|FG000|Overall Study|Tumor progression|56|||
130160349|NCT02238626|468550375|FG003|Overall Study|Withdrawal by Subject|1|||
130160350|NCT02238626|468550372|FG000|Overall Study|Death|0|||
129980893|NCT00743431|467893395|FG000|Overall Study|Withdrawal by Subject|13|||
129980894|NCT00743431|467893395|FG000|Overall Study|Death|9|||
129980895|NCT00743431|467893395|FG000|Overall Study|Reason for discontinuation not specified|29|||
130160351|NCT02238626|468550373|FG001|Overall Study|Death|0|||
130160352|NCT02238626|468550374|FG002|Overall Study|Death|1|||
130160353|NCT02238626|468550375|FG003|Overall Study|Death|1|||
130160354|NCT02238626|468550372|FG000|Overall Study|Other|0|||
130160355|NCT02238626|468550373|FG001|Overall Study|Other|2|||
130160356|NCT02238626|468550374|FG002|Overall Study|Other|0|||
130160357|NCT02238626|468550375|FG003|Overall Study|Other|0|||
130160358|NCT02622113|468550378|FG000|Overall Study|Adverse Event|4|||
130160359|NCT02622113|468550379|FG001|Overall Study|Adverse Event|4|||
130160360|NCT02622113|468550378|FG000|Overall Study|Physician Decision|0|||
130160361|NCT02622113|468550379|FG001|Overall Study|Physician Decision|1|||
130160362|NCT02622113|468550378|FG000|Overall Study|Withdrawal by Subject|0|||
130160363|NCT02622113|468550379|FG001|Overall Study|Withdrawal by Subject|2|||
130160364|NCT02622113|468550378|FG000|Overall Study|Stopping Criteria|1|||
130160365|NCT02622113|468550379|FG001|Overall Study|Stopping Criteria|3|||
130160366|NCT00667810|468550380|FG000|Overall Study|Adverse Event|13|||
130160367|NCT00667810|468550381|FG001|Overall Study|Adverse Event|14|||
130160368|NCT00667810|468550382|FG002|Overall Study|Adverse Event|19|||
130160369|NCT00667810|468550383|FG003|Overall Study|Adverse Event|1|||
130160370|NCT00667810|468550380|FG000|Overall Study|Death|1|||
130160371|NCT00667810|468550381|FG001|Overall Study|Death|1|||
130160372|NCT00667810|468550382|FG002|Overall Study|Death|3|||
130160373|NCT00667810|468550383|FG003|Overall Study|Death|0|||
130160374|NCT00667810|468550380|FG000|Overall Study|Lack of Efficacy|1|||
130160375|NCT00667810|468550381|FG001|Overall Study|Lack of Efficacy|0|||
130160376|NCT00667810|468550382|FG002|Overall Study|Lack of Efficacy|2|||
130160377|NCT00667810|468550383|FG003|Overall Study|Lack of Efficacy|0|||
130160378|NCT00667810|468550380|FG000|Overall Study|Lost to Follow-up|1|||
130160379|NCT00667810|468550381|FG001|Overall Study|Lost to Follow-up|4|||
130160380|NCT00667810|468550382|FG002|Overall Study|Lost to Follow-up|2|||
130160381|NCT00667810|468550383|FG003|Overall Study|Lost to Follow-up|0|||
130160382|NCT00667810|468550380|FG000|Overall Study|Physician Decision|1|||
130160383|NCT00667810|468550381|FG001|Overall Study|Physician Decision|1|||
130160384|NCT00667810|468550382|FG002|Overall Study|Physician Decision|2|||
130160385|NCT00667810|468550383|FG003|Overall Study|Physician Decision|0|||
130160386|NCT00667810|468550380|FG000|Overall Study|Protocol Violation|0|||
130160387|NCT00667810|468550381|FG001|Overall Study|Protocol Violation|2|||
130160388|NCT00667810|468550382|FG002|Overall Study|Protocol Violation|0|||
130160389|NCT00667810|468550383|FG003|Overall Study|Protocol Violation|0|||
130160390|NCT00667810|468550380|FG000|Overall Study|Withdrawal by Subject|14|||
130160391|NCT00667810|468550381|FG001|Overall Study|Withdrawal by Subject|20|||
130160392|NCT00667810|468550382|FG002|Overall Study|Withdrawal by Subject|29|||
130160393|NCT00667810|468550383|FG003|Overall Study|Withdrawal by Subject|1|||
130160394|NCT00667810|468550380|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
130160395|NCT00667810|468550381|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
130160396|NCT00667810|468550382|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
130160397|NCT00667810|468550383|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130160398|NCT00667810|468550380|FG000|Overall Study|Failed to Return|0|||
130160399|NCT00667810|468550381|FG001|Overall Study|Failed to Return|0|||
130160400|NCT00667810|468550382|FG002|Overall Study|Failed to Return|2|||
130160401|NCT00667810|468550383|FG003|Overall Study|Failed to Return|0|||
130160402|NCT00667810|468550380|FG000|Overall Study|Loss of Caregiver|0|||
130160403|NCT00667810|468550381|FG001|Overall Study|Loss of Caregiver|1|||
130160404|NCT00667810|468550382|FG002|Overall Study|Loss of Caregiver|3|||
130160405|NCT00667810|468550383|FG003|Overall Study|Loss of Caregiver|0|||
130160406|NCT00667810|468550380|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
130160407|NCT00667810|468550381|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
130160408|NCT00667810|468550382|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
130160409|NCT00667810|468550383|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
130160410|NCT00667810|468550380|FG000|Overall Study|Other|6|||
130160411|NCT00667810|468550381|FG001|Overall Study|Other|6|||
130160412|NCT00667810|468550382|FG002|Overall Study|Other|5|||
130160413|NCT00667810|468550383|FG003|Overall Study|Other|0|||
130160414|NCT00505375|468550386|FG000|Overall Study|Death|1|||
130160415|NCT00505375|468550387|FG001|Overall Study|Death|0|||
130160416|NCT00505375|468550386|FG000|Overall Study|Withdrawal by Subject|2|||
130160417|NCT00505375|468550387|FG001|Overall Study|Withdrawal by Subject|2|||
130160418|NCT00505375|468550386|FG000|Overall Study|Lost to Follow-up|0|||
130160419|NCT00505375|468550387|FG001|Overall Study|Lost to Follow-up|2|||
130160420|NCT00505375|468550386|FG000|Overall Study|Pregnancy|1|||
130160421|NCT00505375|468550387|FG001|Overall Study|Pregnancy|0|||
130160422|NCT00505375|468550386|FG000|Overall Study|Travel issues|0|||
130160423|NCT00505375|468550387|FG001|Overall Study|Travel issues|1|||
130160424|NCT01561430|468550390|FG000|Overall Study|Adverse Event|0|||
130160425|NCT01561430|468550391|FG001|Overall Study|Adverse Event|0|||
130160426|NCT01561430|468550392|FG002|Overall Study|Adverse Event|3|||
130160427|NCT01561430|468550393|FG003|Overall Study|Adverse Event|1|||
130160428|NCT01561430|468550390|FG000|Overall Study|Withdrawal by Subject|0|||
130160429|NCT01561430|468550391|FG001|Overall Study|Withdrawal by Subject|0|||
130160430|NCT01561430|468550392|FG002|Overall Study|Withdrawal by Subject|1|||
130160431|NCT01561430|468550393|FG003|Overall Study|Withdrawal by Subject|0|||
130160432|NCT01561430|468550390|FG000|Overall Study|Physician Decision|0|||
130160433|NCT01561430|468550391|FG001|Overall Study|Physician Decision|1|||
130160434|NCT01561430|468550392|FG002|Overall Study|Physician Decision|0|||
130160435|NCT01561430|468550393|FG003|Overall Study|Physician Decision|0|||
130160436|NCT01561430|468550390|FG000|Overall Study|Sponsor Decision|1|||
130160437|NCT01561430|468550391|FG001|Overall Study|Sponsor Decision|14|||
130160438|NCT01561430|468550392|FG002|Overall Study|Sponsor Decision|13|||
130160439|NCT01561430|468550393|FG003|Overall Study|Sponsor Decision|12|||
130160440|NCT03709823|468550394|FG000|Overall Study|Adverse Event|0|||
130160441|NCT03709823|468550395|FG001|Overall Study|Adverse Event|0|||
130160442|NCT03709823|468550396|FG002|Overall Study|Adverse Event|1|||
130160443|NCT03709823|468550397|FG003|Overall Study|Adverse Event|0|||
130160444|NCT03709823|468550398|FG004|Overall Study|Adverse Event|0|||
130160445|NCT03709823|468550399|FG005|Overall Study|Adverse Event|0|||
130160446|NCT03709823|468550394|FG000|Overall Study|Lost to Follow-up|2|||
130160447|NCT03709823|468550395|FG001|Overall Study|Lost to Follow-up|2|||
130160448|NCT03709823|468550396|FG002|Overall Study|Lost to Follow-up|2|||
130160449|NCT03709823|468550397|FG003|Overall Study|Lost to Follow-up|1|||
130160450|NCT03709823|468550398|FG004|Overall Study|Lost to Follow-up|1|||
130160451|NCT03709823|468550399|FG005|Overall Study|Lost to Follow-up|0|||
130160452|NCT03709823|468550394|FG000|Overall Study|Withdrawal by Subject|1|||
130160453|NCT03709823|468550395|FG001|Overall Study|Withdrawal by Subject|3|||
130160454|NCT03709823|468550396|FG002|Overall Study|Withdrawal by Subject|0|||
130160455|NCT03709823|468550397|FG003|Overall Study|Withdrawal by Subject|0|||
130160456|NCT03709823|468550398|FG004|Overall Study|Withdrawal by Subject|0|||
130160457|NCT03709823|468550399|FG005|Overall Study|Withdrawal by Subject|0|||
130160458|NCT03709823|468550394|FG000|Overall Study|Other, Not Specified|0|||
130160459|NCT03709823|468550395|FG001|Overall Study|Other, Not Specified|0|||
130160460|NCT03709823|468550396|FG002|Overall Study|Other, Not Specified|0|||
130160461|NCT03709823|468550397|FG003|Overall Study|Other, Not Specified|1|||
130160462|NCT03709823|468550398|FG004|Overall Study|Other, Not Specified|0|||
130160463|NCT03709823|468550399|FG005|Overall Study|Other, Not Specified|0|||
130160464|NCT03201250|468550402|FG000|Overall Study|screen failures|3|||
130160465|NCT03201250|468550403|FG001|Overall Study|screen failures|0|||
130160466|NCT03201250|468550404|FG002|Overall Study|screen failures|0|||
130160467|NCT03167723|468550405|FG000|Overall Study|Protocol Violation|4|||
130160468|NCT03167723|468550406|FG001|Overall Study|Protocol Violation|6|||
130160469|NCT01175811|468550407|FG000|Overall Study|Adverse Event|1|||
130160470|NCT01175811|468550408|FG001|Overall Study|Adverse Event|1|||
130160471|NCT01175811|468550407|FG000|Overall Study|Entry criteria not met|3|||
130160472|NCT01175811|468550408|FG001|Overall Study|Entry criteria not met|1|||
130160473|NCT01175811|468550407|FG000|Overall Study|Lack of Efficacy|1|||
130160474|NCT01175811|468550408|FG001|Overall Study|Lack of Efficacy|0|||
130160475|NCT01175811|468550407|FG000|Overall Study|Lost to Follow-up|3|||
130160476|NCT01175811|468550408|FG001|Overall Study|Lost to Follow-up|2|||
130160477|NCT01175811|468550407|FG000|Overall Study|Physician Decision|1|||
130160478|NCT01175811|468550408|FG001|Overall Study|Physician Decision|1|||
130160479|NCT01175811|468550407|FG000|Overall Study|Protocol Violation|1|||
130160480|NCT01175811|468550408|FG001|Overall Study|Protocol Violation|2|||
130160481|NCT01175811|468550407|FG000|Overall Study|Withdrawal by Subject|6|||
130160482|NCT01175811|468550408|FG001|Overall Study|Withdrawal by Subject|7|||
130160483|NCT03579966|468550409|FG000|Overall Study|Adverse Event|6|||
130160484|NCT03579966|468550409|FG000|Overall Study|Lost to Follow-up|4|||
130160485|NCT03579966|468550409|FG000|Overall Study|Physician Decision|10|||
130160486|NCT03579966|468550409|FG000|Overall Study|Pregnancy|1|||
130160487|NCT03579966|468550409|FG000|Overall Study|Withdrawal by Subject|16|||
130160488|NCT03579966|468550409|FG000|Overall Study|Study terminated by Sponsor|22|||
130160489|NCT03579966|468550409|FG000|Overall Study|Protocol Violation|1|||
130160490|NCT00415194|468550410|FG000|Overall Study|Adverse Event|37|||
130160491|NCT00415194|468550411|FG001|Overall Study|Adverse Event|32|||
130160492|NCT00415194|468550410|FG000|Overall Study|Entry Criteria Not Met|4|||
130160493|NCT00415194|468550411|FG001|Overall Study|Entry Criteria Not Met|8|||
130160494|NCT00415194|468550410|FG000|Overall Study|Lost to Follow-up|1|||
130160495|NCT00415194|468550411|FG001|Overall Study|Lost to Follow-up|0|||
130160496|NCT00415194|468550410|FG000|Overall Study|Physician Decision|10|||
130160497|NCT00415194|468550411|FG001|Overall Study|Physician Decision|16|||
130160498|NCT00415194|468550410|FG000|Overall Study|Progressive Disease|180|||
130160499|NCT00415194|468550411|FG001|Overall Study|Progressive Disease|217|||
130160500|NCT00415194|468550410|FG000|Overall Study|Protocol Violation|4|||
130160501|NCT00415194|468550411|FG001|Overall Study|Protocol Violation|2|||
130160502|NCT00415194|468550410|FG000|Overall Study|Withdrawal by Subject|28|||
130160503|NCT00415194|468550411|FG001|Overall Study|Withdrawal by Subject|21|||
130160504|NCT00415194|468550410|FG000|Overall Study|Death Due to Study Disease|26|||
130160505|NCT00415194|468550411|FG001|Overall Study|Death Due to Study Disease|29|||
130160506|NCT00415194|468550410|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
130160507|NCT00415194|468550411|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
130160508|NCT00415194|468550410|FG000|Overall Study|Death Due to Procedural Related AE|0|||
130160509|NCT00415194|468550411|FG001|Overall Study|Death Due to Procedural Related AE|1|||
130160510|NCT00415194|468550410|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
130160511|NCT00415194|468550411|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
130160512|NCT01297465|468550412|FG000|Overall Study|Lack of Ovarian Response|1|||
130160513|NCT01297465|468550413|FG001|Overall Study|Lack of Ovarian Response|1|||
130160514|NCT01297465|468550412|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
130160515|NCT01297465|468550413|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
130160516|NCT01297465|468550412|FG000|Overall Study|No Oocytes Retrieved|1|||
130160517|NCT01297465|468550413|FG001|Overall Study|No Oocytes Retrieved|1|||
130160518|NCT01297465|468550412|FG000|Overall Study|Poor oocyte quality|0|||
130160519|NCT01297465|468550413|FG001|Overall Study|Poor oocyte quality|1|||
130160520|NCT01297465|468550412|FG000|Overall Study|No Fertilization|6|||
130160521|NCT01297465|468550413|FG001|Overall Study|No Fertilization|4|||
130160522|NCT01297465|468550412|FG000|Overall Study|All Embryos Discarded|0|||
130160523|NCT01297465|468550413|FG001|Overall Study|All Embryos Discarded|1|||
130160524|NCT01297465|468550412|FG000|Overall Study|Intention to Freeze all Embryos|0|||
130160525|NCT01297465|468550413|FG001|Overall Study|Intention to Freeze all Embryos|1|||
130160526|NCT00369655|468550414|FG000|Overall Study|Refusal of further treatment|2|||
130160527|NCT04049617|468550415|FG000|Overall Study|Adverse Event|0|||
130160528|NCT04049617|468550416|FG001|Overall Study|Adverse Event|0|||
130160529|NCT04049617|468550417|FG002|Overall Study|Adverse Event|0|||
130160530|NCT04049617|468550418|FG003|Overall Study|Adverse Event|1|||
130160531|NCT04049617|468550419|FG004|Overall Study|Adverse Event|0|||
130160532|NCT04049617|468550420|FG005|Overall Study|Adverse Event|0|||
129980896|NCT00743431|467893395|FG000|Overall Study|No documentation available|13|||
129980897|NCT03291288|467893396|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
129980898|NCT03291288|467893397|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
129980899|NCT03291288|467893396|FG000|Drug-drug Interaction Phase|Disease progression|1|||
129980900|NCT03291288|467893397|FG001|Drug-drug Interaction Phase|Disease progression|0|||
129980901|NCT03291288|467893396|FG000|Drug-drug Interaction Phase|Other|3|||
129980902|NCT03291288|467893397|FG001|Drug-drug Interaction Phase|Other|0|||
129980903|NCT03291288|467893396|FG000|Pexidartinib Only|Ongoing|0|||
129980904|NCT03291288|467893397|FG001|Pexidartinib Only|Ongoing|2|||
129980905|NCT04276415|467893398|FG000|Overall Study|Adverse Event|0|||
129980906|NCT04276415|467893399|FG001|Overall Study|Adverse Event|0|||
129980907|NCT04276415|467893400|FG002|Overall Study|Adverse Event|0|||
129980908|NCT04276415|467893401|FG003|Overall Study|Adverse Event|3|||
129980909|NCT04276415|467893402|FG004|Overall Study|Adverse Event|0|||
129980910|NCT04276415|467893403|FG005|Overall Study|Adverse Event|0|||
129980911|NCT04276415|467893398|FG000|Overall Study|Clinical progression|1|||
129980912|NCT04276415|467893399|FG001|Overall Study|Clinical progression|1|||
129980913|NCT04276415|467893400|FG002|Overall Study|Clinical progression|0|||
129980914|NCT04276415|467893401|FG003|Overall Study|Clinical progression|0|||
129980915|NCT04276415|467893402|FG004|Overall Study|Clinical progression|1|||
129980916|NCT04276415|467893403|FG005|Overall Study|Clinical progression|0|||
129980917|NCT04276415|467893398|FG000|Overall Study|Other|0|||
129980918|NCT04276415|467893399|FG001|Overall Study|Other|0|||
129980919|NCT04276415|467893400|FG002|Overall Study|Other|0|||
129980920|NCT04276415|467893401|FG003|Overall Study|Other|1|||
129980921|NCT04276415|467893402|FG004|Overall Study|Other|0|||
129980922|NCT04276415|467893403|FG005|Overall Study|Other|0|||
129980923|NCT04276415|467893398|FG000|Overall Study|Physician Decision|0|||
129980924|NCT04276415|467893399|FG001|Overall Study|Physician Decision|0|||
129980925|NCT04276415|467893400|FG002|Overall Study|Physician Decision|1|||
129980926|NCT04276415|467893401|FG003|Overall Study|Physician Decision|3|||
129980927|NCT04276415|467893402|FG004|Overall Study|Physician Decision|2|||
129980928|NCT04276415|467893403|FG005|Overall Study|Physician Decision|0|||
129980929|NCT04276415|467893398|FG000|Overall Study|Progressive disease|3|||
129980930|NCT04276415|467893399|FG001|Overall Study|Progressive disease|3|||
129980931|NCT04276415|467893400|FG002|Overall Study|Progressive disease|4|||
129980932|NCT04276415|467893401|FG003|Overall Study|Progressive disease|5|||
129980933|NCT04276415|467893402|FG004|Overall Study|Progressive disease|1|||
129980934|NCT04276415|467893403|FG005|Overall Study|Progressive disease|2|||
130160533|NCT04049617|468550415|FG000|Overall Study|Death|0|||
129980935|NCT04276415|467893398|FG000|Overall Study|Withdrawal by patient|0|||
129980936|NCT04276415|467893399|FG001|Overall Study|Withdrawal by patient|0|||
129980937|NCT04276415|467893400|FG002|Overall Study|Withdrawal by patient|0|||
129980938|NCT04276415|467893401|FG003|Overall Study|Withdrawal by patient|1|||
129980939|NCT04276415|467893402|FG004|Overall Study|Withdrawal by patient|2|||
130160534|NCT04049617|468550416|FG001|Overall Study|Death|0|||
129980940|NCT04276415|467893403|FG005|Overall Study|Withdrawal by patient|0|||
129980941|NCT03309813|467893404|FG000|Main Randomized Study|Withdrawal by Subject|1|||
130160535|NCT04049617|468550417|FG002|Overall Study|Death|0|||
130160536|NCT04049617|468550418|FG003|Overall Study|Death|0|||
130160537|NCT04049617|468550419|FG004|Overall Study|Death|0|||
130160538|NCT04049617|468550420|FG005|Overall Study|Death|1|||
129980942|NCT03309813|467893405|FG001|Main Randomized Study|Withdrawal by Subject|0|||
129980943|NCT01989169|467893408|FG000|Period 2|Adverse Event|0|||
130160539|NCT04049617|468550415|FG000|Overall Study|Lost to Follow-up|0|||
130160540|NCT04049617|468550416|FG001|Overall Study|Lost to Follow-up|0|||
129980944|NCT01989169|467893409|FG001|Period 2|Adverse Event|1|||
130160541|NCT04049617|468550417|FG002|Overall Study|Lost to Follow-up|0|||
130160542|NCT04049617|468550418|FG003|Overall Study|Lost to Follow-up|1|||
130160543|NCT04049617|468550419|FG004|Overall Study|Lost to Follow-up|0|||
130160544|NCT04049617|468550420|FG005|Overall Study|Lost to Follow-up|0|||
130160545|NCT04049617|468550415|FG000|Overall Study|Withdrew consent|0|||
130160546|NCT04049617|468550416|FG001|Overall Study|Withdrew consent|0|||
130160547|NCT04049617|468550417|FG002|Overall Study|Withdrew consent|1|||
130160548|NCT04049617|468550418|FG003|Overall Study|Withdrew consent|0|||
130160549|NCT04049617|468550419|FG004|Overall Study|Withdrew consent|0|||
130160550|NCT04049617|468550420|FG005|Overall Study|Withdrew consent|0|||
130160551|NCT03551496|468550421|FG000|Overall Study|Death|11|||
130160552|NCT03551496|468550422|FG001|Overall Study|Death|7|||
130160553|NCT03551496|468550421|FG000|Overall Study|Withdrawal by Subject|4|||
130160554|NCT03551496|468550422|FG001|Overall Study|Withdrawal by Subject|3|||
130160555|NCT03551496|468550421|FG000|Overall Study|Other Reasons|1|||
130160556|NCT03551496|468550422|FG001|Overall Study|Other Reasons|0|||
130160557|NCT00140426|468550423|FG000|Overall Study|Withdrawal by Subject|0|||
130160558|NCT00140426|468550424|FG001|Overall Study|Withdrawal by Subject|3|||
130160559|NCT02149108|468550425|FG000|Overall Study|Not treated|1|||
130160560|NCT02149108|468550426|FG001|Overall Study|Not treated|2|||
130160561|NCT02149108|468550425|FG000|Overall Study|Progressive Disease (PD)|324|||
130160562|NCT02149108|468550426|FG001|Overall Study|Progressive Disease (PD)|318|||
130160563|NCT02149108|468550425|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
129980945|NCT02406677|467893410|FG000|Overall Study|Death|16|||
129980946|NCT02406677|467893411|FG001|Overall Study|Death|8|||
129980947|NCT02406677|467893410|FG000|Overall Study|Discharged without P2Y12|1|||
129980948|NCT02406677|467893411|FG001|Overall Study|Discharged without P2Y12|3|||
129980949|NCT02406677|467893410|FG000|Overall Study|Discharged on prasugrel|283|||
129980950|NCT02406677|467893411|FG001|Overall Study|Discharged on prasugrel|587|||
129980951|NCT02406677|467893410|FG000|Overall Study|Withdrawal by Subject|1|||
129980952|NCT02406677|467893411|FG001|Overall Study|Withdrawal by Subject|0|||
129980953|NCT04531904|467893412|FG000|Overall Study|Lost to Follow-up|1|||
129980954|NCT04531904|467893412|FG000|Overall Study|Death|14|||
129980955|NCT00283244|467893413|FG000|Overall Study|Adverse Event|0|||
129980956|NCT00283244|467893414|FG001|Overall Study|Adverse Event|8|||
129980957|NCT00283244|467893415|FG002|Overall Study|Adverse Event|11|||
129980958|NCT00283244|467893413|FG000|Overall Study|Death|4|||
129980959|NCT00283244|467893414|FG001|Overall Study|Death|3|||
129980960|NCT00283244|467893415|FG002|Overall Study|Death|2|||
129980961|NCT00283244|467893413|FG000|Overall Study|Lack of Efficacy|8|||
129980962|NCT00283244|467893414|FG001|Overall Study|Lack of Efficacy|32|||
129980963|NCT00283244|467893415|FG002|Overall Study|Lack of Efficacy|26|||
129980964|NCT00283244|467893413|FG000|Overall Study|Withdrawal by Subject|1|||
129980965|NCT00283244|467893414|FG001|Overall Study|Withdrawal by Subject|2|||
129980966|NCT00283244|467893415|FG002|Overall Study|Withdrawal by Subject|2|||
129980967|NCT00283244|467893413|FG000|Overall Study|Physician Decision|0|||
129980968|NCT00283244|467893414|FG001|Overall Study|Physician Decision|0|||
129980969|NCT00283244|467893415|FG002|Overall Study|Physician Decision|1|||
129980970|NCT00283244|467893413|FG000|Overall Study|Medical illness (other complicating dz)|4|||
129980971|NCT00283244|467893414|FG001|Overall Study|Medical illness (other complicating dz)|3|||
129980972|NCT00283244|467893415|FG002|Overall Study|Medical illness (other complicating dz)|6|||
129980973|NCT00283244|467893413|FG000|Overall Study|Clinical deterioration|1|||
129980974|NCT00283244|467893414|FG001|Overall Study|Clinical deterioration|3|||
129980975|NCT00283244|467893415|FG002|Overall Study|Clinical deterioration|3|||
129980976|NCT00586612|467893416|FG000|Primary Phase|Protocol Violation|1|||
129980977|NCT00586612|467893417|FG001|Primary Phase|Protocol Violation|0|||
129980978|NCT00586612|467893416|FG000|Primary Phase|Lost to Follow-up|0|||
129980979|NCT00586612|467893417|FG001|Primary Phase|Lost to Follow-up|1|||
129980980|NCT00586612|467893416|FG000|Primary Phase|Withdrawal by Subject|0|||
129980981|NCT00586612|467893417|FG001|Primary Phase|Withdrawal by Subject|2|||
129980982|NCT00586612|467893416|FG000|Booster Phase|Lost to Follow-up|3|||
129980983|NCT00586612|467893417|FG001|Booster Phase|Lost to Follow-up|1|||
129980984|NCT01609062|467893418|FG000|Extension Phase|Terminated by Sponsor|14|||
129980985|NCT01609062|467893419|FG001|Extension Phase|Terminated by Sponsor|9|||
129980986|NCT01609062|467893418|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
129980987|NCT01609062|467893419|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
129980988|NCT01609062|467893418|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
129980989|NCT01609062|467893419|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
129980990|NCT02738853|467893420|FG000|Enrollment|Inclusion/Exclusion not met|21|||
129980991|NCT02738853|467893420|FG000|Enrollment|Withdrawal by Subject|3|||
129980992|NCT02738853|467893420|FG000|Enrollment|Subject treated with commercially available device|6|||
129980993|NCT02738853|467893420|FG000|Enrollment|Study Enrollment Closed|3|||
130160564|NCT02149108|468550426|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
130160565|NCT02149108|468550425|FG000|Overall Study|Other Adverse Event (AE)|8|||
130160566|NCT02149108|468550426|FG001|Overall Study|Other Adverse Event (AE)|18|||
130160567|NCT02149108|468550425|FG000|Overall Study|Other not defined above|0|||
130160568|NCT02149108|468550426|FG001|Overall Study|Other not defined above|2|||
130160569|NCT02149108|468550425|FG000|Overall Study|Refusal to continue trial medication|15|||
130160570|NCT02149108|468550426|FG001|Overall Study|Refusal to continue trial medication|11|||
129980994|NCT02738853|467893420|FG000|Procedure|Death|1|||
129980995|NCT02738853|467893420|FG000|1 Month|Death|2|||
129980996|NCT02738853|467893420|FG000|6 Month|Death|4|||
129980997|NCT02738853|467893420|FG000|6 Month|Withdrawal by Subject|2|||
130160571|NCT02149108|468550425|FG000|Overall Study|Lost to Follow-up|1|||
130160572|NCT02149108|468550426|FG001|Overall Study|Lost to Follow-up|0|||
130160573|NCT04765384|468550427|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
130160574|NCT04765384|468550428|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
130160575|NCT04765384|468550429|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
130160576|NCT04765384|468550430|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
130160577|NCT04765384|468550431|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
130160578|NCT04765384|468550432|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
130160579|NCT04765384|468550427|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
130160580|NCT04765384|468550428|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
130160581|NCT04765384|468550429|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
130160582|NCT04765384|468550430|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
130160583|NCT04765384|468550431|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
130160584|NCT04765384|468550432|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
130160585|NCT04765384|468550427|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130160586|NCT04765384|468550428|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130160587|NCT04765384|468550429|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130160588|NCT04765384|468550430|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130160589|NCT04765384|468550431|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
130160590|NCT04765384|468550432|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
130160591|NCT04765384|468550427|FG000|Post-natal: Neonates and Infants|Death|0|||
130160592|NCT04765384|468550428|FG001|Post-natal: Neonates and Infants|Death|0|||
130160593|NCT04765384|468550429|FG002|Post-natal: Neonates and Infants|Death|0|||
130160594|NCT04765384|468550430|FG003|Post-natal: Neonates and Infants|Death|1|||
130160595|NCT04765384|468550431|FG004|Post-natal: Neonates and Infants|Death|0|||
130160596|NCT04765384|468550432|FG005|Post-natal: Neonates and Infants|Death|0|||
130160597|NCT04765384|468550427|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130160598|NCT04765384|468550428|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130160599|NCT04765384|468550429|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130160600|NCT04765384|468550430|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130160601|NCT04765384|468550431|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
130160602|NCT04765384|468550432|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
130160603|NCT01971970|468550433|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
130160604|NCT01971970|468550434|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
130160605|NCT01971970|468550433|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
130160606|NCT01971970|468550434|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
130160607|NCT01971970|468550433|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
130160608|NCT01971970|468550434|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
130160609|NCT01971970|468550433|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
130160610|NCT01971970|468550434|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
130160611|NCT01971970|468550433|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
130160612|NCT01971970|468550434|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
130160613|NCT01971970|468550433|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
130160614|NCT01971970|468550434|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
130160615|NCT01971970|468550433|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
130160616|NCT01971970|468550434|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
130160617|NCT00848107|468550435|FG000|Overall Study|Lost to Follow-up|2|||
130160618|NCT00848107|468550435|FG000|Overall Study|Withdrawal by Subject|8|||
130160619|NCT00848107|468550435|FG000|Overall Study|Adverse Event|9|||
130160620|NCT00848107|468550435|FG000|Overall Study|Death|1|||
130160621|NCT00848107|468550435|FG000|Overall Study|Pregnancy|1|||
130160622|NCT02335983|468550436|FG000|Overall Study|Sponsor Decision|0|||
130160623|NCT02335983|468550437|FG001|Overall Study|Sponsor Decision|0|||
130160624|NCT02335983|468550438|FG002|Overall Study|Sponsor Decision|1|||
130160625|NCT02335983|468550439|FG003|Overall Study|Sponsor Decision|1|||
130160626|NCT02335983|468550440|FG004|Overall Study|Sponsor Decision|0|||
130160627|NCT02335983|468550441|FG005|Overall Study|Sponsor Decision|1|||
130160628|NCT02335983|468550436|FG000|Overall Study|Withdrawal by Subject|3|||
130160629|NCT02335983|468550437|FG001|Overall Study|Withdrawal by Subject|2|||
129980998|NCT02738853|467893420|FG000|1 Year|Death|6|||
129980999|NCT02738853|467893420|FG000|1 Year|Withdrawal by Subject|1|||
130160630|NCT02335983|468550438|FG002|Overall Study|Withdrawal by Subject|2|||
130160631|NCT02335983|468550439|FG003|Overall Study|Withdrawal by Subject|1|||
130160632|NCT02335983|468550440|FG004|Overall Study|Withdrawal by Subject|3|||
129981000|NCT02738853|467893420|FG000|2 Year|Death|2|||
130160633|NCT02335983|468550441|FG005|Overall Study|Withdrawal by Subject|9|||
130160634|NCT02335983|468550436|FG000|Overall Study|Death|0|||
130160635|NCT02335983|468550437|FG001|Overall Study|Death|0|||
130160636|NCT02335983|468550438|FG002|Overall Study|Death|2|||
130160637|NCT02335983|468550439|FG003|Overall Study|Death|0|||
130160638|NCT02335983|468550440|FG004|Overall Study|Death|0|||
130160639|NCT02335983|468550441|FG005|Overall Study|Death|0|||
130160640|NCT02335983|468550436|FG000|Overall Study|Lost to Follow-up|0|||
130160641|NCT02335983|468550437|FG001|Overall Study|Lost to Follow-up|0|||
130160642|NCT02335983|468550438|FG002|Overall Study|Lost to Follow-up|0|||
130160643|NCT02335983|468550439|FG003|Overall Study|Lost to Follow-up|0|||
130160644|NCT02335983|468550440|FG004|Overall Study|Lost to Follow-up|0|||
130160645|NCT02335983|468550441|FG005|Overall Study|Lost to Follow-up|1|||
130160646|NCT02335983|468550436|FG000|Overall Study|Protocol Specified Criteria|5|||
130160647|NCT02335983|468550437|FG001|Overall Study|Protocol Specified Criteria|7|||
130160648|NCT02335983|468550438|FG002|Overall Study|Protocol Specified Criteria|27|||
130160649|NCT02335983|468550439|FG003|Overall Study|Protocol Specified Criteria|7|||
130160650|NCT02335983|468550440|FG004|Overall Study|Protocol Specified Criteria|5|||
130160651|NCT02335983|468550441|FG005|Overall Study|Protocol Specified Criteria|21|||
130160652|NCT00987389|468550442|FG000|Overall Study|Ineligible|0|||
130160653|NCT00987389|468550443|FG001|Overall Study|Ineligible|3|||
130160654|NCT00987389|468550444|FG002|Overall Study|Ineligible|0|||
130160655|NCT00987389|468550445|FG003|Overall Study|Ineligible|0|||
130160656|NCT00987389|468550442|FG000|Overall Study|Lost to Follow-up|4|||
130160657|NCT00987389|468550443|FG001|Overall Study|Lost to Follow-up|1|||
130160658|NCT00987389|468550444|FG002|Overall Study|Lost to Follow-up|3|||
130160659|NCT00987389|468550445|FG003|Overall Study|Lost to Follow-up|1|||
130160660|NCT00987389|468550442|FG000|Overall Study|Withdrawal by Subject|4|||
130160661|NCT00987389|468550443|FG001|Overall Study|Withdrawal by Subject|3|||
130160662|NCT00987389|468550444|FG002|Overall Study|Withdrawal by Subject|2|||
130160663|NCT00987389|468550445|FG003|Overall Study|Withdrawal by Subject|1|||
130160664|NCT00987389|468550442|FG000|Overall Study|Withdrawn from Treatment|0|||
130160665|NCT00987389|468550443|FG001|Overall Study|Withdrawn from Treatment|1|||
130160666|NCT00987389|468550444|FG002|Overall Study|Withdrawn from Treatment|0|||
130160667|NCT00987389|468550445|FG003|Overall Study|Withdrawn from Treatment|0|||
130160668|NCT00987389|468550442|FG000|Overall Study|Multiple different reasons|1|||
130160669|NCT00987389|468550443|FG001|Overall Study|Multiple different reasons|0|||
130160670|NCT00987389|468550444|FG002|Overall Study|Multiple different reasons|3|||
130160671|NCT00987389|468550445|FG003|Overall Study|Multiple different reasons|1|||
130160672|NCT00326963|468550446|FG000|Overall Study|Adverse Event|2|||
130160673|NCT00326963|468550446|FG000|Overall Study|Injection site reaction|1|||
130160674|NCT00326963|468550446|FG000|Overall Study|Death|1|||
130160675|NCT00326963|468550446|FG000|Overall Study|Failure to return|10|||
130160676|NCT00326963|468550446|FG000|Overall Study|Withdrawal by Subject|10|||
130160677|NCT00326963|468550446|FG000|Overall Study|Refused treatment / did not cooperate|5|||
130160678|NCT00326963|468550446|FG000|Overall Study|Violation of selection criteria at entry|2|||
130160679|NCT00326963|468550446|FG000|Overall Study|Other protocol violation|1|||
130160680|NCT00326963|468550446|FG000|Overall Study|Administrative / other|1|||
130160681|NCT02524730|468550447|FG000|Overall Study|Lost to Follow-up|5|||
130160682|NCT02524730|468550447|FG000|Overall Study|Withdrawal by Subject|18|||
130160683|NCT02524730|468550447|FG000|Overall Study|Death|10|||
130160684|NCT02524730|468550447|FG000|Overall Study|Adverse Event|8|||
130160685|NCT02524730|468550447|FG000|Overall Study|Protocol Violation|1|||
130160686|NCT02524730|468550447|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
130160687|NCT00507130|468550448|FG000|Overall Study|Lost to Follow-up|0|||
130160688|NCT00507130|468550449|FG001|Overall Study|Lost to Follow-up|0|||
130160689|NCT00507130|468550450|FG002|Overall Study|Lost to Follow-up|1|||
130160690|NCT00507130|468550451|FG003|Overall Study|Lost to Follow-up|1|||
130160691|NCT00507130|468550448|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
130160692|NCT00507130|468550449|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130160693|NCT00507130|468550450|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130160694|NCT00507130|468550451|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
130160695|NCT00977379|468550456|FG000|Overall Study|Withdrawal by Subject|1|||
130160696|NCT00977379|468550457|FG001|Overall Study|Withdrawal by Subject|1|||
130160697|NCT00977379|468550456|FG000|Overall Study|Death|7|||
130160698|NCT00977379|468550457|FG001|Overall Study|Death|9|||
130160699|NCT00977379|468550456|FG000|Overall Study|Premature Study Termination|4|||
130160700|NCT00977379|468550457|FG001|Overall Study|Premature Study Termination|0|||
130160701|NCT00977379|468550456|FG000|Overall Study|Participant Moving House|0|||
130160702|NCT00977379|468550457|FG001|Overall Study|Participant Moving House|1|||
130160703|NCT00977379|468550456|FG000|Overall Study|Randomization Error|0|||
130160704|NCT00977379|468550457|FG001|Overall Study|Randomization Error|1|||
130160705|NCT02992418|468550463|FG000|Overall Study|Withdrawal by Subject|11|||
130160706|NCT02992418|468550464|FG001|Overall Study|Withdrawal by Subject|12|||
130160707|NCT02992418|468550463|FG000|Overall Study|Non-compliance with the protocol|308|||
130160708|NCT02992418|468550464|FG001|Overall Study|Non-compliance with the protocol|308|||
130160709|NCT02992418|468550463|FG000|Overall Study|Lost to Follow-up|27|||
130160710|NCT02992418|468550464|FG001|Overall Study|Lost to Follow-up|22|||
130160711|NCT03246126|468550469|FG000|Overall Study|Withdrawal by Subject|0|||
130160712|NCT03246126|468550470|FG001|Overall Study|Withdrawal by Subject|1|||
130160713|NCT01006135|468550475|FG000|Overall Study|Adverse Event|22|||
130160714|NCT01006135|468550475|FG000|Overall Study|Protocol Violation|14|||
130160715|NCT01006135|468550475|FG000|Overall Study|Lost to Follow-up|32|||
130160716|NCT01006135|468550475|FG000|Overall Study|Other|72|||
130160717|NCT02266134|468550480|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
130160718|NCT02266134|468550481|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
130160719|NCT02266134|468550482|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
130160720|NCT02266134|468550483|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
130160721|NCT02266134|468550480|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
130160722|NCT02266134|468550481|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
130160723|NCT02266134|468550482|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
130160724|NCT02266134|468550483|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
130160725|NCT02266134|468550480|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
130160726|NCT02266134|468550481|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
130160727|NCT02266134|468550482|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
130160728|NCT02266134|468550483|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
130160729|NCT02266134|468550480|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
130160730|NCT02266134|468550481|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130160731|NCT02266134|468550482|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130160732|NCT02266134|468550483|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
130160733|NCT02266134|468550480|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
130160734|NCT02266134|468550481|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
130160735|NCT02266134|468550482|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
130160736|NCT02266134|468550483|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
130160737|NCT02266134|468550480|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
130160738|NCT02266134|468550481|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130160739|NCT02266134|468550482|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130160740|NCT02266134|468550483|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
130160741|NCT01437943|468550487|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
130160742|NCT01437943|468550488|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
130160743|NCT01437943|468550487|FG000|Overall Study|Subject expressed pregnancy plans|1|||
130160744|NCT01437943|468550488|FG001|Overall Study|Subject expressed pregnancy plans|0|||
130160745|NCT01437943|468550487|FG000|Overall Study|Adverse Event|2|||
130160746|NCT01437943|468550488|FG001|Overall Study|Adverse Event|0|||
130160747|NCT05442866|468550490|FG000|Overall Study|Death|1|||
130160748|NCT05442866|468550490|FG000|Overall Study|Lost to Follow-up|9|||
130160749|NCT05442866|468550490|FG000|Overall Study|Protocol Violation|1|||
130160750|NCT03819049|468550491|FG000|Overall Study|Lost to Follow-up|1|||
130160751|NCT03819049|468550492|FG001|Overall Study|Lost to Follow-up|2|||
130160752|NCT03819049|468550493|FG002|Overall Study|Lost to Follow-up|9|||
130160753|NCT03819049|468550494|FG003|Overall Study|Lost to Follow-up|0|||
130160754|NCT03819049|468550495|FG004|Overall Study|Lost to Follow-up|3|||
130160755|NCT03819049|468550496|FG005|Overall Study|Lost to Follow-up|1|||
130160756|NCT03819049|468550497|FG006|Overall Study|Lost to Follow-up|0|||
130160757|NCT03819049|468550491|FG000|Overall Study|Withdrawal by Subject|0|||
130160758|NCT03819049|468550492|FG001|Overall Study|Withdrawal by Subject|0|||
130160759|NCT03819049|468550493|FG002|Overall Study|Withdrawal by Subject|18|||
130160760|NCT03819049|468550494|FG003|Overall Study|Withdrawal by Subject|0|||
130160761|NCT03819049|468550495|FG004|Overall Study|Withdrawal by Subject|10|||
130160762|NCT03819049|468550496|FG005|Overall Study|Withdrawal by Subject|9|||
130160763|NCT03819049|468550497|FG006|Overall Study|Withdrawal by Subject|1|||
130160764|NCT03819049|468550491|FG000|Overall Study|Ongoing|0|||
130160765|NCT03819049|468550492|FG001|Overall Study|Ongoing|0|||
130160766|NCT03819049|468550493|FG002|Overall Study|Ongoing|75|||
130160767|NCT03819049|468550494|FG003|Overall Study|Ongoing|0|||
130160768|NCT03819049|468550495|FG004|Overall Study|Ongoing|41|||
130160769|NCT03819049|468550496|FG005|Overall Study|Ongoing|0|||
130160770|NCT03819049|468550497|FG006|Overall Study|Ongoing|0|||
130160771|NCT03819049|468550491|FG000|Overall Study|Other|0|||
130160772|NCT03819049|468550492|FG001|Overall Study|Other|0|||
130160773|NCT03819049|468550493|FG002|Overall Study|Other|2|||
130160774|NCT03819049|468550494|FG003|Overall Study|Other|0|||
130160775|NCT03819049|468550495|FG004|Overall Study|Other|0|||
130160776|NCT03819049|468550496|FG005|Overall Study|Other|0|||
130160777|NCT03819049|468550497|FG006|Overall Study|Other|0|||
130160778|NCT03819049|468550491|FG000|Overall Study|Randomized but not vaccinated|0|||
130160779|NCT03819049|468550492|FG001|Overall Study|Randomized but not vaccinated|0|||
130160780|NCT03819049|468550493|FG002|Overall Study|Randomized but not vaccinated|0|||
130160781|NCT03819049|468550494|FG003|Overall Study|Randomized but not vaccinated|1|||
130160782|NCT03819049|468550495|FG004|Overall Study|Randomized but not vaccinated|0|||
130160783|NCT03819049|468550496|FG005|Overall Study|Randomized but not vaccinated|2|||
130160784|NCT03819049|468550497|FG006|Overall Study|Randomized but not vaccinated|1|||
130160785|NCT03819049|468550491|FG000|Overall Study|Physician Decision|0|||
130160786|NCT03819049|468550492|FG001|Overall Study|Physician Decision|0|||
130160787|NCT03819049|468550493|FG002|Overall Study|Physician Decision|0|||
130160788|NCT03819049|468550494|FG003|Overall Study|Physician Decision|0|||
130160789|NCT03819049|468550495|FG004|Overall Study|Physician Decision|0|||
130160790|NCT03819049|468550496|FG005|Overall Study|Physician Decision|0|||
130160791|NCT03819049|468550497|FG006|Overall Study|Physician Decision|1|||
130160792|NCT01986010|468550498|FG000|Overall Study|Adverse Event|0|||
130160793|NCT01986010|468550499|FG001|Overall Study|Adverse Event|1|||
130160794|NCT01986010|468550500|FG002|Overall Study|Adverse Event|0|||
130160795|NCT01986010|468550501|FG003|Overall Study|Adverse Event|0|||
130160796|NCT01986010|468550502|FG004|Overall Study|Adverse Event|0|||
130160797|NCT01986010|468550503|FG005|Overall Study|Adverse Event|0|||
130160798|NCT01986010|468550504|FG006|Overall Study|Adverse Event|0|||
130160799|NCT01986010|468550505|FG007|Overall Study|Adverse Event|0|||
130160800|NCT01986010|468550506|FG008|Overall Study|Adverse Event|0|||
130160801|NCT01986010|468550507|FG009|Overall Study|Adverse Event|0|||
130160802|NCT01986010|468550508|FG010|Overall Study|Adverse Event|0|||
130160803|NCT01986010|468550509|FG011|Overall Study|Adverse Event|0|||
130160804|NCT01986010|468550510|FG012|Overall Study|Adverse Event|0|||
130160805|NCT01986010|468550511|FG013|Overall Study|Adverse Event|0|||
130160806|NCT01986010|468550512|FG014|Overall Study|Adverse Event|0|||
130160807|NCT01986010|468550513|FG015|Overall Study|Adverse Event|1|||
130160808|NCT01986010|468550514|FG016|Overall Study|Adverse Event|0|||
130160809|NCT01986010|468550498|FG000|Overall Study|Lost to Follow-up|2|||
130160810|NCT01986010|468550499|FG001|Overall Study|Lost to Follow-up|1|||
130160811|NCT01986010|468550500|FG002|Overall Study|Lost to Follow-up|2|||
130160812|NCT01986010|468550501|FG003|Overall Study|Lost to Follow-up|2|||
130160813|NCT01986010|468550502|FG004|Overall Study|Lost to Follow-up|2|||
130160814|NCT01986010|468550503|FG005|Overall Study|Lost to Follow-up|2|||
130160815|NCT01986010|468550504|FG006|Overall Study|Lost to Follow-up|0|||
130160816|NCT01986010|468550505|FG007|Overall Study|Lost to Follow-up|0|||
130160817|NCT01986010|468550506|FG008|Overall Study|Lost to Follow-up|4|||
130160818|NCT01986010|468550507|FG009|Overall Study|Lost to Follow-up|2|||
130160819|NCT01986010|468550508|FG010|Overall Study|Lost to Follow-up|0|||
130160820|NCT01986010|468550509|FG011|Overall Study|Lost to Follow-up|1|||
130160821|NCT01986010|468550510|FG012|Overall Study|Lost to Follow-up|1|||
130160822|NCT01986010|468550511|FG013|Overall Study|Lost to Follow-up|1|||
130160823|NCT01986010|468550512|FG014|Overall Study|Lost to Follow-up|2|||
130160824|NCT01986010|468550513|FG015|Overall Study|Lost to Follow-up|0|||
130160825|NCT01986010|468550514|FG016|Overall Study|Lost to Follow-up|0|||
130160826|NCT01986010|468550498|FG000|Overall Study|Physician Decision|0|||
130160827|NCT01986010|468550499|FG001|Overall Study|Physician Decision|0|||
130160828|NCT01986010|468550500|FG002|Overall Study|Physician Decision|0|||
130160829|NCT01986010|468550501|FG003|Overall Study|Physician Decision|0|||
130160830|NCT01986010|468550502|FG004|Overall Study|Physician Decision|0|||
130160831|NCT01986010|468550503|FG005|Overall Study|Physician Decision|0|||
130160832|NCT01986010|468550504|FG006|Overall Study|Physician Decision|0|||
130160833|NCT01986010|468550505|FG007|Overall Study|Physician Decision|0|||
130160834|NCT01986010|468550506|FG008|Overall Study|Physician Decision|0|||
130160835|NCT01986010|468550507|FG009|Overall Study|Physician Decision|0|||
130160836|NCT01986010|468550508|FG010|Overall Study|Physician Decision|0|||
130160837|NCT01986010|468550509|FG011|Overall Study|Physician Decision|0|||
130160838|NCT01986010|468550510|FG012|Overall Study|Physician Decision|0|||
130160839|NCT01986010|468550511|FG013|Overall Study|Physician Decision|0|||
130160840|NCT01986010|468550512|FG014|Overall Study|Physician Decision|1|||
130160841|NCT01986010|468550513|FG015|Overall Study|Physician Decision|0|||
130160842|NCT01986010|468550514|FG016|Overall Study|Physician Decision|0|||
130160843|NCT01986010|468550498|FG000|Overall Study|Withdrawal by Subject|2|||
130160844|NCT01986010|468550499|FG001|Overall Study|Withdrawal by Subject|2|||
130160845|NCT01986010|468550500|FG002|Overall Study|Withdrawal by Subject|3|||
130160846|NCT01986010|468550501|FG003|Overall Study|Withdrawal by Subject|0|||
130160847|NCT01986010|468550502|FG004|Overall Study|Withdrawal by Subject|2|||
130160848|NCT01986010|468550503|FG005|Overall Study|Withdrawal by Subject|4|||
130160849|NCT01986010|468550504|FG006|Overall Study|Withdrawal by Subject|0|||
130160850|NCT01986010|468550505|FG007|Overall Study|Withdrawal by Subject|0|||
130160851|NCT01986010|468550506|FG008|Overall Study|Withdrawal by Subject|0|||
130160852|NCT01986010|468550507|FG009|Overall Study|Withdrawal by Subject|0|||
130160853|NCT01986010|468550508|FG010|Overall Study|Withdrawal by Subject|0|||
130160854|NCT01986010|468550509|FG011|Overall Study|Withdrawal by Subject|2|||
130160855|NCT01986010|468550510|FG012|Overall Study|Withdrawal by Subject|0|||
130160856|NCT01986010|468550511|FG013|Overall Study|Withdrawal by Subject|1|||
130160857|NCT01986010|468550512|FG014|Overall Study|Withdrawal by Subject|2|||
130160858|NCT01986010|468550513|FG015|Overall Study|Withdrawal by Subject|0|||
130160859|NCT01986010|468550514|FG016|Overall Study|Withdrawal by Subject|0|||
130160860|NCT01986010|468550498|FG000|Overall Study|Status Not Recorded|2|||
130160861|NCT01986010|468550499|FG001|Overall Study|Status Not Recorded|4|||
130160862|NCT01986010|468550500|FG002|Overall Study|Status Not Recorded|2|||
130160863|NCT01986010|468550501|FG003|Overall Study|Status Not Recorded|0|||
130160864|NCT01986010|468550502|FG004|Overall Study|Status Not Recorded|1|||
130160865|NCT01986010|468550503|FG005|Overall Study|Status Not Recorded|2|||
130160866|NCT01986010|468550504|FG006|Overall Study|Status Not Recorded|0|||
130160867|NCT01986010|468550505|FG007|Overall Study|Status Not Recorded|0|||
130160868|NCT01986010|468550506|FG008|Overall Study|Status Not Recorded|2|||
130160869|NCT01986010|468550507|FG009|Overall Study|Status Not Recorded|1|||
130160870|NCT01986010|468550508|FG010|Overall Study|Status Not Recorded|7|||
130160871|NCT01986010|468550509|FG011|Overall Study|Status Not Recorded|7|||
130160872|NCT01986010|468550510|FG012|Overall Study|Status Not Recorded|9|||
130160873|NCT01986010|468550511|FG013|Overall Study|Status Not Recorded|9|||
130160874|NCT01986010|468550512|FG014|Overall Study|Status Not Recorded|5|||
130160875|NCT01986010|468550513|FG015|Overall Study|Status Not Recorded|10|||
130160876|NCT01986010|468550514|FG016|Overall Study|Status Not Recorded|4|||
130160877|NCT01335997|468550515|FG000|Period I and II|Adverse Event|63|||
130160878|NCT01335997|468550516|FG001|Period I and II|Adverse Event|43|||
130160879|NCT01335997|468550515|FG000|Period I and II|Noncompliance with Study Drug|1|||
130160880|NCT01335997|468550516|FG001|Period I and II|Noncompliance with Study Drug|1|||
130160881|NCT01335997|468550515|FG000|Period I and II|Lost to Follow-up|3|||
130160882|NCT01335997|468550516|FG001|Period I and II|Lost to Follow-up|5|||
130160883|NCT01335997|468550515|FG000|Period I and II|Withdrawal by Subject|9|||
130160884|NCT01335997|468550516|FG001|Period I and II|Withdrawal by Subject|4|||
130160885|NCT01335997|468550515|FG000|Period I and II|Study Terminated by Sponsor|406|||
130160886|NCT01335997|468550516|FG001|Period I and II|Study Terminated by Sponsor|415|||
130160887|NCT01335997|468550515|FG000|Period I and II|Protocol Violation|9|||
130160888|NCT01335997|468550516|FG001|Period I and II|Protocol Violation|10|||
130160889|NCT01335997|468550515|FG000|Period I and II|Physician Decision|2|||
130160890|NCT01335997|468550516|FG001|Period I and II|Physician Decision|1|||
130160891|NCT01335997|468550515|FG000|Period III|Adverse Event|0|||
130160892|NCT01335997|468550516|FG001|Period III|Adverse Event|2|||
130160893|NCT01335997|468550515|FG000|Period III|Study Terminated by Sponsor|77|||
130160894|NCT01335997|468550516|FG001|Period III|Study Terminated by Sponsor|76|||
130160895|NCT01335997|468550515|FG000|Period III|Protocol Violation|0|||
130160896|NCT01335997|468550516|FG001|Period III|Protocol Violation|1|||
130160897|NCT01335997|468550515|FG000|Period III|Lost to Follow-up|1|||
130160898|NCT01335997|468550516|FG001|Period III|Lost to Follow-up|0|||
130160899|NCT04740814|468550517|FG000|Overall Study|Adverse Event|3|||
130160900|NCT04740814|468550517|FG000|Overall Study|Protocol Violation|2|||
130160901|NCT04740814|468550517|FG000|Overall Study|Lost to Follow-up|2|||
130160902|NCT04740814|468550517|FG000|Overall Study|Withdrawal by Subject|3|||
130160903|NCT02500641|468550520|FG000|Overall Study|Adverse Event|0|||
130160904|NCT02500641|468550521|FG001|Overall Study|Adverse Event|2|||
130160905|NCT02500641|468550520|FG000|Overall Study|Withdrawal by Subject|4|||
130160906|NCT02500641|468550521|FG001|Overall Study|Withdrawal by Subject|5|||
130160907|NCT02500641|468550520|FG000|Overall Study|Unable to follow study procedures|3|||
130160908|NCT02500641|468550521|FG001|Overall Study|Unable to follow study procedures|2|||
130160909|NCT02500641|468550520|FG000|Overall Study|Protocol Violation|1|||
130160910|NCT02500641|468550521|FG001|Overall Study|Protocol Violation|2|||
130160911|NCT02500641|468550520|FG000|Overall Study|Lost to Follow-up|1|||
130160912|NCT02500641|468550521|FG001|Overall Study|Lost to Follow-up|0|||
130160913|NCT02500641|468550520|FG000|Overall Study|Sponsor decision|1|||
130160914|NCT02500641|468550521|FG001|Overall Study|Sponsor decision|0|||
130160915|NCT02500641|468550520|FG000|Overall Study|Non compliance to study drug|0|||
130160916|NCT02500641|468550521|FG001|Overall Study|Non compliance to study drug|1|||
130160917|NCT02331368|468550522|FG000|Overall Study|Withdrawal by Subject|3|||
130160918|NCT01763684|468550531|FG000|Overall Study|Study terminated early due to low enrollment|126|||
130160919|NCT01763684|468550532|FG001|Overall Study|Study terminated early due to low enrollment|127|||
130160920|NCT01763684|468550531|FG000|Overall Study|Study surgery not performed|7|||
130160921|NCT01763684|468550532|FG001|Overall Study|Study surgery not performed|6|||
130160922|NCT00643565|468550533|FG000|Overall Study|Death|12|||
130160923|NCT00643565|468550534|FG001|Overall Study|Death|11|||
130160924|NCT00643565|468550533|FG000|Overall Study|Withdrawal by Subject|4|||
130160925|NCT00643565|468550534|FG001|Overall Study|Withdrawal by Subject|1|||
130160926|NCT00643565|468550533|FG000|Overall Study|Lost to Follow-up|0|||
130160927|NCT00643565|468550534|FG001|Overall Study|Lost to Follow-up|6|||
130160928|NCT00643565|468550533|FG000|Overall Study|Other|7|||
130160929|NCT00643565|468550534|FG001|Overall Study|Other|8|||
130160930|NCT00643565|468550533|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
130160931|NCT00643565|468550534|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
130160932|NCT00643565|468550533|FG000|Overall Study|Recurrence of Disease|2|||
130160933|NCT00643565|468550534|FG001|Overall Study|Recurrence of Disease|1|||
130160934|NCT00643565|468550533|FG000|Overall Study|Progression of Disease|18|||
130160935|NCT00643565|468550534|FG001|Overall Study|Progression of Disease|14|||
130160936|NCT00643565|468550533|FG000|Overall Study|Protocol Violation|3|||
130160937|NCT00643565|468550534|FG001|Overall Study|Protocol Violation|0|||
130160938|NCT00643565|468550533|FG000|Overall Study|Did Not Cooperate|0|||
130160939|NCT00643565|468550534|FG001|Overall Study|Did Not Cooperate|1|||
130160940|NCT00643565|468550533|FG000|Overall Study|Administrative|22|||
130160941|NCT00643565|468550534|FG001|Overall Study|Administrative|16|||
130160942|NCT00643565|468550533|FG000|Overall Study|Adverse Event|5|||
130160943|NCT00643565|468550534|FG001|Overall Study|Adverse Event|8|||
130160944|NCT02317614|468550535|FG000|Overall Study|Lost to Follow-up|1|||
130160945|NCT02317614|468550536|FG001|Overall Study|Lost to Follow-up|1|||
130160946|NCT02317614|468550535|FG000|Overall Study|Withdrawal by Subject|1|||
130160947|NCT02317614|468550536|FG001|Overall Study|Withdrawal by Subject|0|||
130160948|NCT02317614|468550535|FG000|Overall Study|Death|1|||
130160949|NCT02317614|468550536|FG001|Overall Study|Death|1|||
130160950|NCT00669071|468550541|FG000|Overall Study|Lost to Follow-up|3|||
130160951|NCT00669071|468550541|FG000|Overall Study|Final visit 40 days out of window|1|||
130160952|NCT02980874|468550549|FG000|Overall Study|Adverse Event|2|||
130160953|NCT02980874|468550550|FG001|Overall Study|Adverse Event|7|||
130160954|NCT02980874|468550549|FG000|Overall Study|Withdrawal by Subject|7|||
130160955|NCT02980874|468550550|FG001|Overall Study|Withdrawal by Subject|2|||
130160956|NCT02980874|468550549|FG000|Overall Study|Lost to Follow-up|5|||
130160957|NCT02980874|468550550|FG001|Overall Study|Lost to Follow-up|5|||
130160958|NCT02980874|468550549|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
130160959|NCT02980874|468550550|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
130160960|NCT02980874|468550549|FG000|Overall Study|Unknown study completion status|1|||
130160961|NCT02980874|468550550|FG001|Overall Study|Unknown study completion status|0|||
130160962|NCT06077487|468552502|FG000|Overall Study|Withdrawal by Subject|0|||
130160963|NCT06077487|468552503|FG001|Overall Study|Withdrawal by Subject|1|||
130160964|NCT00759902|468552505|FG000|Overall Study|Adverse Event|0|||
130160965|NCT00759902|468552506|FG001|Overall Study|Adverse Event|1|||
130160966|NCT02128217|468552509|FG000|Overall Study|Lost to Follow-up|0|||
130160967|NCT02128217|468552510|FG001|Overall Study|Lost to Follow-up|1|||
130160968|NCT05071313|468552511|FG000|Overall Study|Lost to Follow-up|17|||
130160969|NCT05071313|468552512|FG001|Overall Study|Lost to Follow-up|10|||
130160970|NCT05071313|468552511|FG000|Overall Study|Physician Decision|1|||
130160971|NCT05071313|468552512|FG001|Overall Study|Physician Decision|6|||
130160972|NCT05071313|468552511|FG000|Overall Study|Death|1|||
130160973|NCT05071313|468552512|FG001|Overall Study|Death|0|||
130160974|NCT05071313|468552511|FG000|Overall Study|Withdrawal by Subject|10|||
130160975|NCT05071313|468552512|FG001|Overall Study|Withdrawal by Subject|15|||
130160976|NCT05071313|468552511|FG000|Overall Study|Other|1|||
130160977|NCT05071313|468552512|FG001|Overall Study|Other|0|||
130160978|NCT05071313|468552511|FG000|Overall Study|Randomized but not vaccinated|4|||
130160979|NCT05071313|468552512|FG001|Overall Study|Randomized but not vaccinated|2|||
130160980|NCT03107026|468552513|FG000|Overall Study|Adverse Event|2|||
130160981|NCT03107026|468552514|FG001|Overall Study|Adverse Event|14|||
130160982|NCT03107026|468552515|FG002|Overall Study|Adverse Event|23|||
130160983|NCT03107026|468552513|FG000|Overall Study|Lost to Follow-up|12|||
130160984|NCT03107026|468552514|FG001|Overall Study|Lost to Follow-up|12|||
130160985|NCT03107026|468552515|FG002|Overall Study|Lost to Follow-up|13|||
130160986|NCT03107026|468552513|FG000|Overall Study|Protocol Violation|1|||
130160987|NCT03107026|468552514|FG001|Overall Study|Protocol Violation|2|||
130160988|NCT03107026|468552515|FG002|Overall Study|Protocol Violation|0|||
130160989|NCT03107026|468552513|FG000|Overall Study|Pregnancy|1|||
130160990|NCT03107026|468552514|FG001|Overall Study|Pregnancy|0|||
130160991|NCT03107026|468552515|FG002|Overall Study|Pregnancy|0|||
130160992|NCT03107026|468552513|FG000|Overall Study|Withdrawal by Subject|13|||
130160993|NCT03107026|468552514|FG001|Overall Study|Withdrawal by Subject|5|||
130160994|NCT03107026|468552515|FG002|Overall Study|Withdrawal by Subject|17|||
130160995|NCT03107026|468552513|FG000|Overall Study|non compliance with study visits|1|||
130160996|NCT03107026|468552514|FG001|Overall Study|non compliance with study visits|2|||
130160997|NCT03107026|468552515|FG002|Overall Study|non compliance with study visits|0|||
130160998|NCT03107026|468552513|FG000|Overall Study|non-compliance with study drug|2|||
130160999|NCT03107026|468552514|FG001|Overall Study|non-compliance with study drug|2|||
129981001|NCT02738853|467893420|FG000|2 Year|Lost to Follow-up|1|||
129981002|NCT02738853|467893420|FG000|3 Year|Death|2|||
129981003|NCT02738853|467893420|FG000|3 Year|Withdrawal by Subject|1|||
129981004|NCT02738853|467893420|FG000|4 Year|Death|9|||
129981005|NCT02738853|467893420|FG000|5 Year|Lost to Follow-up|4|||
129981006|NCT01803282|467893421|FG000|Overall Study|Progressive Disease|4|||
129981007|NCT01803282|467893422|FG001|Overall Study|Progressive Disease|3|||
130161000|NCT03107026|468552515|FG002|Overall Study|non-compliance with study drug|3|||
130161001|NCT03107026|468552513|FG000|Overall Study|Physician Decision|0|||
130161002|NCT03107026|468552514|FG001|Overall Study|Physician Decision|1|||
130161003|NCT03107026|468552515|FG002|Overall Study|Physician Decision|0|||
129981008|NCT01803282|467893423|FG002|Overall Study|Progressive Disease|6|||
129981009|NCT01803282|467893424|FG003|Overall Study|Progressive Disease|22|||
130161004|NCT02049450|468552516|FG000|Overall Study|Adverse Event|2|||
130161005|NCT02049450|468552516|FG000|Overall Study|Withdrawal by Subject|1|||
130161006|NCT02049450|468552516|FG000|Overall Study|Patients/guardian decision|1|||
130161007|NCT03347422|468552520|FG000|Part A (26 Weeks)|Adverse Event|3|||
130161008|NCT03347422|468552521|FG001|Part A (26 Weeks)|Adverse Event|0|||
130161009|NCT03347422|468552520|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
129981010|NCT01803282|467893425|FG004|Overall Study|Progressive Disease|5|||
130161010|NCT03347422|468552521|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
130161011|NCT03347422|468552520|FG000|Part B (149 Weeks)|Adverse Event|0|||
130161012|NCT03347422|468552521|FG001|Part B (149 Weeks)|Adverse Event|1|||
130161013|NCT03347422|468552520|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
130161014|NCT03347422|468552521|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
130161015|NCT03347422|468552520|FG000|Part B (149 Weeks)|Other|1|||
130161016|NCT03347422|468552521|FG001|Part B (149 Weeks)|Other|0|||
130161017|NCT05183217|468552522|FG000|Overall Study|Withdrawal by Subject|1|||
130161018|NCT05183217|468552523|FG001|Overall Study|Withdrawal by Subject|1|||
130161019|NCT00969540|468552526|FG000|Overall Study|Lost to Follow-up|1|||
130161020|NCT00969540|468552527|FG001|Overall Study|Lost to Follow-up|1|||
130161021|NCT02397408|468552528|FG000|Overall Study|Physician Decision|4|||
130161022|NCT02397408|468552528|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
130161023|NCT01646138|468552529|FG000|Overall Study|Lost to Follow-up|0|||
130161024|NCT01646138|468552530|FG001|Overall Study|Lost to Follow-up|0|||
130161025|NCT01646138|468552531|FG002|Overall Study|Lost to Follow-up|0|||
130161026|NCT01646138|468552532|FG003|Overall Study|Lost to Follow-up|0|||
130161027|NCT01646138|468552533|FG004|Overall Study|Lost to Follow-up|2|||
130161028|NCT01683838|468552534|FG000|Overall Study|Adverse Event|12|||
130161029|NCT01683838|468552535|FG001|Overall Study|Adverse Event|2|||
130161030|NCT01683838|468552534|FG000|Overall Study|Protocol Violation|3|||
130161031|NCT01683838|468552535|FG001|Overall Study|Protocol Violation|1|||
130161032|NCT01683838|468552534|FG000|Overall Study|Withdrawal by Subject|6|||
130161033|NCT01683838|468552535|FG001|Overall Study|Withdrawal by Subject|5|||
130161034|NCT01683838|468552534|FG000|Overall Study|Lost to Follow-up|1|||
130161035|NCT01683838|468552535|FG001|Overall Study|Lost to Follow-up|1|||
130161036|NCT01683838|468552534|FG000|Overall Study|Other|4|||
130161037|NCT01683838|468552535|FG001|Overall Study|Other|3|||
130161038|NCT01524679|468552536|FG000|Overall Study|Lost to Follow-up|1|||
130161039|NCT01524679|468552537|FG001|Overall Study|Lost to Follow-up|4|||
130161040|NCT01524679|468552536|FG000|Overall Study|Withdrawal by Subject|4|||
130161041|NCT01524679|468552537|FG001|Overall Study|Withdrawal by Subject|4|||
130161042|NCT01524679|468552536|FG000|Overall Study|Adverse Event|9|||
130161043|NCT01524679|468552537|FG001|Overall Study|Adverse Event|0|||
130161044|NCT01524679|468552536|FG000|Overall Study|Protocol Violation|1|||
130161045|NCT01524679|468552537|FG001|Overall Study|Protocol Violation|0|||
130161046|NCT01524679|468552536|FG000|Overall Study|Lack of Efficacy|2|||
130161047|NCT01524679|468552537|FG001|Overall Study|Lack of Efficacy|0|||
130161048|NCT01524679|468552536|FG000|Overall Study|e.g.wish for children, relocation|6|||
130161049|NCT01524679|468552537|FG001|Overall Study|e.g.wish for children, relocation|1|||
130161050|NCT00801099|468552538|FG000|Overall Study|Lost to Follow-up|101|||
130161051|NCT03321630|468552546|FG000|Overall Study|Adverse Event|1|||
130161052|NCT03321630|468552546|FG000|Overall Study|Investigator Discretion|2|||
130161053|NCT03321630|468552546|FG000|Overall Study|Withdrawal by Subject|1|||
130161054|NCT02455050|468552547|FG000|Treatment Period 1|Lost to Follow-up|1|||
130161055|NCT02455050|468552548|FG001|Treatment Period 1|Lost to Follow-up|1|||
130161056|NCT02455050|468552549|FG002|Treatment Period 1|Lost to Follow-up|1|||
130161057|NCT02455050|468552550|FG003|Treatment Period 1|Lost to Follow-up|2|||
130161058|NCT02455050|468552547|FG000|Treatment Period 2|Lost to Follow-up|1|||
130161059|NCT02455050|468552548|FG001|Treatment Period 2|Lost to Follow-up|0|||
130161060|NCT02455050|468552549|FG002|Treatment Period 2|Lost to Follow-up|2|||
130161061|NCT02455050|468552550|FG003|Treatment Period 2|Lost to Follow-up|1|||
130161062|NCT02981303|468552551|FG000|Overall Study|Progressive Disease|17|||
130161063|NCT02981303|468552552|FG001|Overall Study|Progressive Disease|37|||
130161064|NCT02981303|468552551|FG000|Overall Study|Adverse Event|1|||
130161065|NCT02981303|468552552|FG001|Overall Study|Adverse Event|4|||
130161066|NCT02981303|468552551|FG000|Overall Study|Withdrawal by Subject|0|||
130161067|NCT02981303|468552552|FG001|Overall Study|Withdrawal by Subject|1|||
130161068|NCT02325518|468552553|FG000|Overall Study|Adverse Event|4|||
130161069|NCT02325518|468552554|FG001|Overall Study|Adverse Event|1|||
130161070|NCT02325518|468552553|FG000|Overall Study|Physician Decision|0|||
130161071|NCT02325518|468552554|FG001|Overall Study|Physician Decision|1|||
130161072|NCT02325518|468552553|FG000|Overall Study|Withdrawal by Subject|0|||
130161073|NCT02325518|468552554|FG001|Overall Study|Withdrawal by Subject|1|||
130161074|NCT03393806|468552557|FG000|Overall Study|Physician Decision|1|||
130161075|NCT03393806|468552558|FG001|Overall Study|Physician Decision|0|||
130161076|NCT00886288|468552559|FG000|Overall Study|no respect of the 12 weeks period|657|||
130161077|NCT00886288|468552560|FG001|Overall Study|no respect of the 12 weeks period|227|||
130161078|NCT00886288|468552559|FG000|Overall Study|Lost to Follow-up|86|||
130161079|NCT00886288|468552560|FG001|Overall Study|Lost to Follow-up|0|||
130161080|NCT01259115|468552561|FG000|Period 1|Adverse Event|1|||
130161081|NCT01259115|468552562|FG001|Period 1|Adverse Event|0|||
130161082|NCT01259115|468552561|FG000|Period 1|Protocol Violation|2|||
130161083|NCT01259115|468552562|FG001|Period 1|Protocol Violation|0|||
130161084|NCT01259115|468552561|FG000|Period 1|Lost to Follow-up|0|||
130161085|NCT01259115|468552562|FG001|Period 1|Lost to Follow-up|1|||
130161086|NCT01259115|468552561|FG000|Period 2|Adverse Event|1|||
130161087|NCT01259115|468552562|FG001|Period 2|Adverse Event|0|||
130161088|NCT01675661|468552563|FG000|Overall Study|Lost to Follow-up|22|||
130161089|NCT01675661|468552564|FG001|Overall Study|Lost to Follow-up|23|||
130161090|NCT01675661|468552563|FG000|Overall Study|Practical problems|9|||
130161091|NCT01675661|468552564|FG001|Overall Study|Practical problems|5|||
130161092|NCT01675661|468552563|FG000|Overall Study|Moved away|5|||
130161093|NCT01675661|468552564|FG001|Overall Study|Moved away|6|||
130161094|NCT01675661|468552563|FG000|Overall Study|Withdrawal by Subject|3|||
130161095|NCT01675661|468552564|FG001|Overall Study|Withdrawal by Subject|7|||
130161096|NCT01675661|468552563|FG000|Overall Study|Physician Decision|0|||
130161097|NCT01675661|468552564|FG001|Overall Study|Physician Decision|2|||
130161098|NCT01675661|468552563|FG000|Overall Study|Death|0|||
130161099|NCT01675661|468552564|FG001|Overall Study|Death|1|||
130161100|NCT01675661|468552563|FG000|Overall Study|Other reason|1|||
130161101|NCT01675661|468552564|FG001|Overall Study|Other reason|2|||
130161102|NCT02393248|468552565|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161103|NCT02393248|468552566|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130161104|NCT02393248|468552567|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161105|NCT02393248|468552568|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161106|NCT02393248|468552569|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161107|NCT02393248|468552570|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130161108|NCT02393248|468552571|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
130161109|NCT02393248|468552572|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161110|NCT02393248|468552573|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161111|NCT02393248|468552574|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161112|NCT02393248|468552575|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161113|NCT02393248|468552576|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161114|NCT02393248|468552577|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161115|NCT02393248|468552578|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161116|NCT02393248|468552579|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161117|NCT02393248|468552580|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161118|NCT02393248|468552581|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161119|NCT02393248|468552582|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161120|NCT02393248|468552583|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161121|NCT02393248|468552584|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161122|NCT02393248|468552585|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161123|NCT02393248|468552586|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161124|NCT02393248|468552587|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161125|NCT02393248|468552588|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161126|NCT02393248|468552589|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
130161127|NCT02393248|468552565|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161128|NCT02393248|468552566|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
130161129|NCT02393248|468552567|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161130|NCT02393248|468552568|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161131|NCT02393248|468552569|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161132|NCT02393248|468552570|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161133|NCT02393248|468552571|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161134|NCT02393248|468552572|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161135|NCT02393248|468552573|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161136|NCT02393248|468552574|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161137|NCT02393248|468552575|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161138|NCT02393248|468552576|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161139|NCT02393248|468552577|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161140|NCT02393248|468552578|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161141|NCT02393248|468552579|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161142|NCT02393248|468552580|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161143|NCT02393248|468552581|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161144|NCT02393248|468552582|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161145|NCT02393248|468552583|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161146|NCT02393248|468552584|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161147|NCT02393248|468552585|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161148|NCT02393248|468552586|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161149|NCT02393248|468552587|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161150|NCT02393248|468552588|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161151|NCT02393248|468552589|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
130161152|NCT02393248|468552565|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
130161153|NCT02393248|468552566|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
130161154|NCT02393248|468552567|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
130161155|NCT02393248|468552568|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
130161156|NCT02393248|468552569|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
130161157|NCT02393248|468552570|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
130161158|NCT02393248|468552571|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
130161159|NCT02393248|468552572|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
130161160|NCT02393248|468552573|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
130161161|NCT02393248|468552574|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
130161162|NCT02393248|468552575|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
130161163|NCT02393248|468552576|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
130161164|NCT02393248|468552577|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
130161165|NCT02393248|468552578|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
130161166|NCT02393248|468552579|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
130161167|NCT02393248|468552580|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
130161168|NCT02393248|468552581|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
130161169|NCT02393248|468552582|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
130161170|NCT02393248|468552583|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
130161171|NCT02393248|468552584|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
130161172|NCT02393248|468552585|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
130161173|NCT02393248|468552586|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
130161174|NCT02393248|468552587|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
130161175|NCT02393248|468552588|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
130161176|NCT02393248|468552589|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
130161177|NCT02393248|468552565|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
130161178|NCT02393248|468552566|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161179|NCT02393248|468552567|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161180|NCT02393248|468552568|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161181|NCT02393248|468552569|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161182|NCT02393248|468552570|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161183|NCT02393248|468552571|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161184|NCT02393248|468552572|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161185|NCT02393248|468552573|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161186|NCT02393248|468552574|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161187|NCT02393248|468552575|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161188|NCT02393248|468552576|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161189|NCT02393248|468552577|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161190|NCT02393248|468552578|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161191|NCT02393248|468552579|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161192|NCT02393248|468552580|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161193|NCT02393248|468552581|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161194|NCT02393248|468552582|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161195|NCT02393248|468552583|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161196|NCT02393248|468552584|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161197|NCT02393248|468552585|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161198|NCT02393248|468552586|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161199|NCT02393248|468552587|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161200|NCT02393248|468552588|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161201|NCT02393248|468552589|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
130161202|NCT02393248|468552565|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161203|NCT02393248|468552566|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161204|NCT02393248|468552567|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161205|NCT02393248|468552568|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161206|NCT02393248|468552569|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161207|NCT02393248|468552570|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
130161208|NCT02393248|468552571|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
130161209|NCT02393248|468552572|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161210|NCT02393248|468552573|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161211|NCT02393248|468552574|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
130161212|NCT02393248|468552575|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161213|NCT02393248|468552576|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161214|NCT02393248|468552577|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161215|NCT02393248|468552578|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161216|NCT02393248|468552579|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161217|NCT02393248|468552580|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161218|NCT02393248|468552581|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161219|NCT02393248|468552582|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161220|NCT02393248|468552583|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161221|NCT02393248|468552584|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161222|NCT02393248|468552585|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161223|NCT02393248|468552586|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161224|NCT02393248|468552587|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161225|NCT02393248|468552588|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161226|NCT02393248|468552589|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
130161227|NCT02393248|468552565|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161228|NCT02393248|468552566|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161229|NCT02393248|468552567|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161230|NCT02393248|468552568|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161231|NCT02393248|468552569|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161232|NCT02393248|468552570|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161233|NCT02393248|468552571|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
130161234|NCT02393248|468552572|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161235|NCT02393248|468552573|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161236|NCT02393248|468552574|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161237|NCT02393248|468552575|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161238|NCT02393248|468552576|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161239|NCT02393248|468552577|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161240|NCT02393248|468552578|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161241|NCT02393248|468552579|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161242|NCT02393248|468552580|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161243|NCT02393248|468552581|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161244|NCT02393248|468552582|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161245|NCT02393248|468552583|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161246|NCT02393248|468552584|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161247|NCT02393248|468552585|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161248|NCT02393248|468552586|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161249|NCT02393248|468552587|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161250|NCT02393248|468552588|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161251|NCT02393248|468552589|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
130161252|NCT02393248|468552565|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161253|NCT02393248|468552566|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161254|NCT02393248|468552567|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161255|NCT02393248|468552568|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161256|NCT02393248|468552569|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161257|NCT02393248|468552570|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161258|NCT02393248|468552571|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161259|NCT02393248|468552572|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161260|NCT02393248|468552573|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161261|NCT02393248|468552574|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161262|NCT02393248|468552575|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161263|NCT02393248|468552576|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
130161264|NCT02393248|468552577|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
130161265|NCT02393248|468552578|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
130161266|NCT02393248|468552579|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
130161267|NCT02393248|468552580|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161268|NCT02393248|468552581|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161269|NCT02393248|468552582|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161270|NCT02393248|468552583|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161271|NCT02393248|468552584|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161272|NCT02393248|468552585|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161273|NCT02393248|468552586|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161274|NCT02393248|468552587|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161275|NCT02393248|468552588|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161276|NCT02393248|468552589|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
130161277|NCT02393248|468552565|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161278|NCT02393248|468552566|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161279|NCT02393248|468552567|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161280|NCT02393248|468552568|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161281|NCT02393248|468552569|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161282|NCT02393248|468552570|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161283|NCT02393248|468552571|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161284|NCT02393248|468552572|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161285|NCT02393248|468552573|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161286|NCT02393248|468552574|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161287|NCT02393248|468552575|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
130161288|NCT02393248|468552576|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
130161289|NCT02393248|468552577|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161290|NCT02393248|468552578|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161291|NCT02393248|468552579|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161292|NCT02393248|468552580|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161293|NCT02393248|468552581|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161294|NCT02393248|468552582|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161295|NCT02393248|468552583|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161296|NCT02393248|468552584|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161297|NCT02393248|468552585|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161298|NCT02393248|468552586|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161299|NCT02393248|468552587|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161300|NCT02393248|468552588|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161301|NCT02393248|468552589|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
130161302|NCT02393248|468552565|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
130161303|NCT02393248|468552566|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
130161304|NCT02393248|468552567|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
130161305|NCT02393248|468552568|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
130161306|NCT02393248|468552569|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
130161307|NCT02393248|468552570|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
130161308|NCT02393248|468552571|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
130161309|NCT02393248|468552572|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
130161310|NCT02393248|468552573|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
130161311|NCT02393248|468552574|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
130161312|NCT02393248|468552575|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
130161313|NCT02393248|468552576|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
130161314|NCT02393248|468552577|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
130161315|NCT02393248|468552578|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
130161316|NCT02393248|468552579|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
130161317|NCT02393248|468552580|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
130161318|NCT02393248|468552581|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
130161319|NCT02393248|468552582|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
130161320|NCT02393248|468552583|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
130161321|NCT02393248|468552584|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
130161322|NCT02393248|468552585|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
130161323|NCT02393248|468552586|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
130161324|NCT02393248|468552587|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
130161325|NCT02393248|468552588|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
130161326|NCT02393248|468552589|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
130161327|NCT02393248|468552565|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161328|NCT02393248|468552566|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161329|NCT02393248|468552567|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161330|NCT02393248|468552568|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161331|NCT02393248|468552569|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161332|NCT02393248|468552570|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161333|NCT02393248|468552571|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161334|NCT02393248|468552572|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161335|NCT02393248|468552573|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161336|NCT02393248|468552574|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161337|NCT02393248|468552575|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161338|NCT02393248|468552576|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
130161339|NCT02393248|468552577|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161340|NCT02393248|468552578|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
130161341|NCT02393248|468552579|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161342|NCT02393248|468552580|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161343|NCT02393248|468552581|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161344|NCT02393248|468552582|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161345|NCT02393248|468552583|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161346|NCT02393248|468552584|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161347|NCT02393248|468552585|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161348|NCT02393248|468552586|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161349|NCT02393248|468552587|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161350|NCT02393248|468552588|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161351|NCT02393248|468552589|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
130161352|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161353|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161354|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161355|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161356|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161357|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161358|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161359|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161360|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161361|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161362|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161363|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161364|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161365|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161366|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161367|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161368|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161369|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161370|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130161371|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161372|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
130161373|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130161374|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161375|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
130161376|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
130161377|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Death|0|||
130161378|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Death|0|||
130161379|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Death|0|||
130161380|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Death|0|||
130161381|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Death|0|||
130161382|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Death|0|||
130161383|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Death|0|||
130161384|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Death|0|||
130161385|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Death|0|||
130161386|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Death|0|||
130161387|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Death|0|||
130161388|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Death|0|||
130161389|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Death|0|||
130161390|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Death|0|||
130161391|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Death|0|||
130161392|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Death|1|||
130161393|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Death|7|||
130161394|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Death|5|||
130161395|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Death|5|||
130161396|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Death|3|||
130161397|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Death|7|||
130161398|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Death|5|||
130161399|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Death|6|||
130161400|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Death|3|||
130161401|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Death|0|||
130161402|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161403|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161404|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161405|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161406|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161407|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161408|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161409|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129981011|NCT01803282|467893426|FG005|Overall Study|Progressive Disease|8|||
129981012|NCT01803282|467893427|FG006|Overall Study|Progressive Disease|23|||
129981013|NCT01803282|467893428|FG007|Overall Study|Progressive Disease|24|||
129981014|NCT01803282|467893429|FG008|Overall Study|Progressive Disease|3|||
130161410|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161411|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129981015|NCT01803282|467893430|FG009|Overall Study|Progressive Disease|29|||
130161412|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161413|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161414|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161415|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161416|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161417|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161418|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129981016|NCT01803282|467893431|FG010|Overall Study|Progressive Disease|6|||
130161419|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130161420|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130161421|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
130161422|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130161423|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130161424|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130161425|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
130161426|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
130161427|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Disease Progression|0|||
130161428|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Disease Progression|0|||
130161429|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Disease Progression|0|||
130161430|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Disease Progression|0|||
130161431|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Disease Progression|0|||
130161432|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Disease Progression|0|||
130161433|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Disease Progression|0|||
130161434|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Disease Progression|0|||
130161435|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Disease Progression|0|||
130161436|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Disease Progression|0|||
130161437|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Disease Progression|0|||
130161438|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Disease Progression|0|||
130161439|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Disease Progression|0|||
130161440|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Disease Progression|0|||
130161441|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Disease Progression|0|||
130161442|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Disease Progression|0|||
130161443|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Disease Progression|0|||
130161444|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Disease Progression|0|||
130161445|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Disease Progression|0|||
130161446|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Disease Progression|0|||
130161447|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Disease Progression|2|||
130161448|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Disease Progression|1|||
130161449|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Disease Progression|0|||
130161450|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Disease Progression|0|||
130161451|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Disease Progression|0|||
130161452|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161453|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161454|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161455|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161456|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161457|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161458|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161459|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161460|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
129981017|NCT01803282|467893432|FG011|Overall Study|Progressive Disease|11|||
129981018|NCT01803282|467893421|FG000|Overall Study|Death|0|||
129981019|NCT01803282|467893422|FG001|Overall Study|Death|0|||
129981020|NCT01803282|467893423|FG002|Overall Study|Death|0|||
129981021|NCT01803282|467893424|FG003|Overall Study|Death|0|||
129981022|NCT01803282|467893425|FG004|Overall Study|Death|2|||
129981023|NCT01803282|467893426|FG005|Overall Study|Death|1|||
129981024|NCT01803282|467893427|FG006|Overall Study|Death|1|||
129981025|NCT01803282|467893428|FG007|Overall Study|Death|5|||
129981026|NCT01803282|467893429|FG008|Overall Study|Death|1|||
129981027|NCT01803282|467893430|FG009|Overall Study|Death|1|||
129981028|NCT01803282|467893431|FG010|Overall Study|Death|0|||
129981029|NCT01803282|467893432|FG011|Overall Study|Death|0|||
129981030|NCT01803282|467893421|FG000|Overall Study|Withdrew Consent|0|||
129981031|NCT01803282|467893422|FG001|Overall Study|Withdrew Consent|0|||
129981032|NCT01803282|467893423|FG002|Overall Study|Withdrew Consent|0|||
129981033|NCT01803282|467893424|FG003|Overall Study|Withdrew Consent|6|||
129981034|NCT01803282|467893425|FG004|Overall Study|Withdrew Consent|1|||
129981035|NCT01803282|467893426|FG005|Overall Study|Withdrew Consent|0|||
129981036|NCT01803282|467893427|FG006|Overall Study|Withdrew Consent|8|||
129981037|NCT01803282|467893428|FG007|Overall Study|Withdrew Consent|3|||
129981038|NCT01803282|467893429|FG008|Overall Study|Withdrew Consent|1|||
130161461|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161462|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161463|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161464|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161465|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161466|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
129981039|NCT01803282|467893430|FG009|Overall Study|Withdrew Consent|5|||
129981040|NCT01803282|467893431|FG010|Overall Study|Withdrew Consent|0|||
129981041|NCT01803282|467893432|FG011|Overall Study|Withdrew Consent|1|||
130161467|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161468|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161469|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161470|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161471|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161472|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
130161473|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
130161474|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161475|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161476|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
130161477|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161478|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161479|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161480|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161481|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161482|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161483|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161484|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161485|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161486|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161487|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161488|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161489|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161490|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161491|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161492|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161493|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161494|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161495|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161496|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161497|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
130161498|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161499|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161500|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161501|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
130161502|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Adverse Event|0|||
130161503|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Adverse Event|0|||
130161504|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Adverse Event|0|||
130161505|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Adverse Event|0|||
130161506|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Adverse Event|0|||
130161507|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Adverse Event|0|||
130161508|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Adverse Event|0|||
130161509|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Adverse Event|0|||
130161510|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Adverse Event|0|||
130161511|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Adverse Event|0|||
130161512|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Adverse Event|0|||
130161513|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Adverse Event|0|||
130161514|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Adverse Event|0|||
130161515|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Adverse Event|0|||
130161516|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Adverse Event|0|||
130161517|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Adverse Event|0|||
130161518|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Adverse Event|0|||
130161519|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Adverse Event|0|||
130161520|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Adverse Event|0|||
130161521|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Adverse Event|0|||
130161522|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Adverse Event|0|||
130161523|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Adverse Event|0|||
130161524|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Adverse Event|0|||
130161525|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Adverse Event|1|||
130161526|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Adverse Event|0|||
130161527|NCT02393248|468552565|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161528|NCT02393248|468552566|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161529|NCT02393248|468552567|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161530|NCT02393248|468552568|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161531|NCT02393248|468552569|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161532|NCT02393248|468552570|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161533|NCT02393248|468552571|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161534|NCT02393248|468552572|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161535|NCT02393248|468552573|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161536|NCT02393248|468552574|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161537|NCT02393248|468552575|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161538|NCT02393248|468552576|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161539|NCT02393248|468552577|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161540|NCT02393248|468552578|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161541|NCT02393248|468552579|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161542|NCT02393248|468552580|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161543|NCT02393248|468552581|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161544|NCT02393248|468552582|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161545|NCT02393248|468552583|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161546|NCT02393248|468552584|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161547|NCT02393248|468552585|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161548|NCT02393248|468552586|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161549|NCT02393248|468552587|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161550|NCT02393248|468552588|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
130161551|NCT02393248|468552589|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
130161552|NCT00117325|468552590|FG000|Overall Study|Adverse Event|3|||
130161553|NCT00117325|468552591|FG001|Overall Study|Adverse Event|3|||
130161554|NCT00117325|468552590|FG000|Overall Study|Lost to Follow-up|1|||
130161555|NCT00117325|468552591|FG001|Overall Study|Lost to Follow-up|1|||
130161556|NCT00117325|468552590|FG000|Overall Study|Protocol Violation|2|||
130161557|NCT00117325|468552591|FG001|Overall Study|Protocol Violation|3|||
130161558|NCT00117325|468552590|FG000|Overall Study|Withdrawal by Subject|3|||
130161559|NCT00117325|468552591|FG001|Overall Study|Withdrawal by Subject|2|||
130161560|NCT00117325|468552590|FG000|Overall Study|Lack of Efficacy|1|||
130161561|NCT00117325|468552591|FG001|Overall Study|Lack of Efficacy|0|||
130161562|NCT00117325|468552590|FG000|Overall Study|Use of prohibited medicine|1|||
130161563|NCT00117325|468552591|FG001|Overall Study|Use of prohibited medicine|2|||
130161564|NCT00117325|468552590|FG000|Overall Study|Early termination|1|||
130161565|NCT00117325|468552591|FG001|Overall Study|Early termination|1|||
130161566|NCT00117325|468552590|FG000|Overall Study|Admisnitrative|1|||
130161567|NCT00117325|468552591|FG001|Overall Study|Admisnitrative|0|||
130161568|NCT00338455|468552599|FG000|Overall Study|Death|2|||
130161569|NCT00338455|468552600|FG001|Overall Study|Death|1|||
130161570|NCT00338455|468552599|FG000|Overall Study|Physician Decision|1|||
130161571|NCT00338455|468552600|FG001|Overall Study|Physician Decision|0|||
130161572|NCT05084963|468552601|FG000|Overall Study|Withdrawal by Subject|0|||
130161573|NCT05084963|468552602|FG001|Overall Study|Withdrawal by Subject|0|||
130161574|NCT05084963|468552603|FG002|Overall Study|Withdrawal by Subject|1|||
130161575|NCT01568320|468552604|FG000|Overall Study|Death|20|||
130161576|NCT01568320|468552604|FG000|Overall Study|Lost to Follow-up|9|||
130161577|NCT01568320|468552604|FG000|Overall Study|Withdrawal by Subject|10|||
130161578|NCT01568320|468552604|FG000|Overall Study|Conversion to open repair|1|||
130161579|NCT01568320|468552604|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
130161580|NCT01616953|468552605|FG000|Overall Study|Lost to Follow-up|1|||
130161581|NCT01616953|468552606|FG001|Overall Study|Lost to Follow-up|0|||
130161582|NCT01616953|468552605|FG000|Overall Study|lack of bone and soft tissue|1|||
130161583|NCT01616953|468552606|FG001|Overall Study|lack of bone and soft tissue|0|||
130161584|NCT01394952|468552607|FG000|Overall Study|Lost to Follow-up|0|||
130161585|NCT01394952|468552608|FG001|Overall Study|Lost to Follow-up|5|||
130161586|NCT01394952|468552607|FG000|Overall Study|Withdrawal by Subject|10|||
130161587|NCT01394952|468552608|FG001|Overall Study|Withdrawal by Subject|5|||
130161588|NCT01394952|468552607|FG000|Overall Study|Physician Decision|2|||
130161589|NCT01394952|468552608|FG001|Overall Study|Physician Decision|0|||
130161590|NCT01394952|468552607|FG000|Overall Study|Sponsor Decision|5|||
130161591|NCT01394952|468552608|FG001|Overall Study|Sponsor Decision|7|||
130161592|NCT01103466|468552611|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
130161593|NCT01103466|468552612|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
130161594|NCT01103466|468552613|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
130161595|NCT01103466|468552611|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
130161596|NCT01103466|468552612|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
130161597|NCT01103466|468552613|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
130161598|NCT01103466|468552611|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130161599|NCT01103466|468552612|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130161600|NCT01103466|468552613|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130161601|NCT01103466|468552611|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
130161602|NCT01103466|468552612|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
130161603|NCT01103466|468552613|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
130161604|NCT01103466|468552611|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
130161605|NCT01103466|468552612|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130161606|NCT01103466|468552613|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
130161607|NCT01103466|468552611|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
129981042|NCT01803282|467893421|FG000|Overall Study|Investigator's Discretion|0|||
129981043|NCT01803282|467893422|FG001|Overall Study|Investigator's Discretion|0|||
129981044|NCT01803282|467893423|FG002|Overall Study|Investigator's Discretion|0|||
129981045|NCT01803282|467893424|FG003|Overall Study|Investigator's Discretion|7|||
129981046|NCT01803282|467893425|FG004|Overall Study|Investigator's Discretion|2|||
129981047|NCT01803282|467893426|FG005|Overall Study|Investigator's Discretion|1|||
129981048|NCT01803282|467893427|FG006|Overall Study|Investigator's Discretion|7|||
129981049|NCT01803282|467893428|FG007|Overall Study|Investigator's Discretion|10|||
129981050|NCT01803282|467893429|FG008|Overall Study|Investigator's Discretion|6|||
129981051|NCT01803282|467893430|FG009|Overall Study|Investigator's Discretion|7|||
129981052|NCT01803282|467893431|FG010|Overall Study|Investigator's Discretion|1|||
129981053|NCT01803282|467893432|FG011|Overall Study|Investigator's Discretion|0|||
129981054|NCT01803282|467893421|FG000|Overall Study|Adverse Event|0|||
129981055|NCT01803282|467893422|FG001|Overall Study|Adverse Event|0|||
129981056|NCT01803282|467893423|FG002|Overall Study|Adverse Event|0|||
129981057|NCT01803282|467893424|FG003|Overall Study|Adverse Event|0|||
129981058|NCT01803282|467893425|FG004|Overall Study|Adverse Event|0|||
129981059|NCT01803282|467893426|FG005|Overall Study|Adverse Event|0|||
129981060|NCT01803282|467893427|FG006|Overall Study|Adverse Event|1|||
129981061|NCT01803282|467893428|FG007|Overall Study|Adverse Event|2|||
129981062|NCT01803282|467893429|FG008|Overall Study|Adverse Event|0|||
129981063|NCT01803282|467893430|FG009|Overall Study|Adverse Event|1|||
129981064|NCT01803282|467893431|FG010|Overall Study|Adverse Event|0|||
129981065|NCT01803282|467893432|FG011|Overall Study|Adverse Event|3|||
129981066|NCT01803282|467893421|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129981067|NCT01803282|467893422|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129981068|NCT01803282|467893423|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129981069|NCT01803282|467893424|FG003|Overall Study|Non-Compliance with Study Drug|1|||
129981070|NCT01803282|467893425|FG004|Overall Study|Non-Compliance with Study Drug|0|||
129981071|NCT01803282|467893426|FG005|Overall Study|Non-Compliance with Study Drug|0|||
129981072|NCT01803282|467893427|FG006|Overall Study|Non-Compliance with Study Drug|0|||
129981073|NCT01803282|467893428|FG007|Overall Study|Non-Compliance with Study Drug|0|||
129981074|NCT01803282|467893429|FG008|Overall Study|Non-Compliance with Study Drug|0|||
129981075|NCT01803282|467893430|FG009|Overall Study|Non-Compliance with Study Drug|0|||
129981076|NCT01803282|467893431|FG010|Overall Study|Non-Compliance with Study Drug|0|||
129981077|NCT01803282|467893432|FG011|Overall Study|Non-Compliance with Study Drug|0|||
129981078|NCT01803282|467893421|FG000|Overall Study|Unknown Reason|0|||
129981079|NCT01803282|467893422|FG001|Overall Study|Unknown Reason|0|||
129981080|NCT01803282|467893423|FG002|Overall Study|Unknown Reason|0|||
129981081|NCT01803282|467893424|FG003|Overall Study|Unknown Reason|0|||
129981082|NCT01803282|467893425|FG004|Overall Study|Unknown Reason|0|||
129981083|NCT01803282|467893426|FG005|Overall Study|Unknown Reason|0|||
129981084|NCT01803282|467893427|FG006|Overall Study|Unknown Reason|0|||
129981085|NCT01803282|467893428|FG007|Overall Study|Unknown Reason|1|||
129981086|NCT01803282|467893429|FG008|Overall Study|Unknown Reason|0|||
129981087|NCT01803282|467893430|FG009|Overall Study|Unknown Reason|0|||
129981088|NCT01803282|467893431|FG010|Overall Study|Unknown Reason|0|||
129981089|NCT01803282|467893432|FG011|Overall Study|Unknown Reason|0|||
129981090|NCT01803282|467893421|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
129981091|NCT01803282|467893422|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
129981092|NCT01803282|467893423|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
129981093|NCT01803282|467893424|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
129981094|NCT01803282|467893425|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
129981095|NCT01803282|467893426|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
130161608|NCT01103466|468552612|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
130161609|NCT01103466|468552613|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
129981096|NCT01803282|467893427|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
129981097|NCT01803282|467893428|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
129981098|NCT01803282|467893429|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
130161610|NCT02283983|468552625|FG000|Overall Study|Inclusion criteria not met|0|||
129981099|NCT01803282|467893430|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
129981100|NCT01803282|467893431|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
129981101|NCT01803282|467893432|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
130161611|NCT02283983|468552626|FG001|Overall Study|Inclusion criteria not met|1|||
130161612|NCT02283983|468552625|FG000|Overall Study|Withdrawal by Subject|4|||
130161613|NCT02283983|468552626|FG001|Overall Study|Withdrawal by Subject|2|||
130161614|NCT02283983|468552625|FG000|Overall Study|Protocol Violation|0|||
130161615|NCT02283983|468552626|FG001|Overall Study|Protocol Violation|4|||
130161616|NCT02283983|468552625|FG000|Overall Study|Physician Decision|2|||
130161617|NCT02283983|468552626|FG001|Overall Study|Physician Decision|4|||
130161618|NCT02283983|468552625|FG000|Overall Study|Death|1|||
130161619|NCT02283983|468552626|FG001|Overall Study|Death|0|||
130161620|NCT02283983|468552625|FG000|Overall Study|Adverse Event|1|||
130161621|NCT02283983|468552626|FG001|Overall Study|Adverse Event|0|||
130161622|NCT02283983|468552625|FG000|Overall Study|Lost to Follow-up|9|||
130161623|NCT02283983|468552626|FG001|Overall Study|Lost to Follow-up|8|||
130161624|NCT02283983|468552625|FG000|Overall Study|Relapse|1|||
130161625|NCT02283983|468552626|FG001|Overall Study|Relapse|0|||
130161626|NCT04453202|468552632|FG000|Overall Study|Adverse Event|0|||
130161627|NCT04453202|468552633|FG001|Overall Study|Adverse Event|0|||
130161628|NCT04453202|468552634|FG002|Overall Study|Adverse Event|0|||
130161629|NCT04453202|468552635|FG003|Overall Study|Adverse Event|0|||
130161630|NCT04453202|468552636|FG004|Overall Study|Adverse Event|0|||
130161631|NCT04453202|468552637|FG005|Overall Study|Adverse Event|0|||
130161632|NCT04453202|468552638|FG006|Overall Study|Adverse Event|1|||
130161633|NCT04453202|468552639|FG007|Overall Study|Adverse Event|0|||
130161634|NCT04453202|468552640|FG008|Overall Study|Adverse Event|0|||
130161635|NCT04453202|468552641|FG009|Overall Study|Adverse Event|0|||
130161636|NCT04453202|468552642|FG010|Overall Study|Adverse Event|0|||
130161637|NCT04453202|468552632|FG000|Overall Study|Death|0|||
130161638|NCT04453202|468552633|FG001|Overall Study|Death|0|||
130161639|NCT04453202|468552634|FG002|Overall Study|Death|0|||
130161640|NCT04453202|468552635|FG003|Overall Study|Death|0|||
130161641|NCT04453202|468552636|FG004|Overall Study|Death|0|||
130161642|NCT04453202|468552637|FG005|Overall Study|Death|0|||
130161643|NCT04453202|468552638|FG006|Overall Study|Death|0|||
130161644|NCT04453202|468552639|FG007|Overall Study|Death|0|||
130161645|NCT04453202|468552640|FG008|Overall Study|Death|0|||
130161646|NCT04453202|468552641|FG009|Overall Study|Death|1|||
130161647|NCT04453202|468552642|FG010|Overall Study|Death|0|||
130161648|NCT04453202|468552632|FG000|Overall Study|Lost to Follow-up|0|||
130161649|NCT04453202|468552633|FG001|Overall Study|Lost to Follow-up|1|||
130161650|NCT04453202|468552634|FG002|Overall Study|Lost to Follow-up|0|||
130161651|NCT04453202|468552635|FG003|Overall Study|Lost to Follow-up|1|||
130161652|NCT04453202|468552636|FG004|Overall Study|Lost to Follow-up|0|||
130161653|NCT04453202|468552637|FG005|Overall Study|Lost to Follow-up|0|||
130161654|NCT04453202|468552638|FG006|Overall Study|Lost to Follow-up|0|||
130161655|NCT04453202|468552639|FG007|Overall Study|Lost to Follow-up|0|||
130161656|NCT04453202|468552640|FG008|Overall Study|Lost to Follow-up|0|||
130161657|NCT04453202|468552641|FG009|Overall Study|Lost to Follow-up|1|||
130161658|NCT04453202|468552642|FG010|Overall Study|Lost to Follow-up|1|||
130161659|NCT04453202|468552632|FG000|Overall Study|Withdrawal by Subject|1|||
130161660|NCT04453202|468552633|FG001|Overall Study|Withdrawal by Subject|2|||
130161661|NCT04453202|468552634|FG002|Overall Study|Withdrawal by Subject|1|||
130161662|NCT04453202|468552635|FG003|Overall Study|Withdrawal by Subject|2|||
130161663|NCT04453202|468552636|FG004|Overall Study|Withdrawal by Subject|1|||
130161664|NCT04453202|468552637|FG005|Overall Study|Withdrawal by Subject|1|||
130161665|NCT04453202|468552638|FG006|Overall Study|Withdrawal by Subject|0|||
130161666|NCT04453202|468552639|FG007|Overall Study|Withdrawal by Subject|0|||
130161667|NCT04453202|468552640|FG008|Overall Study|Withdrawal by Subject|0|||
130161668|NCT04453202|468552641|FG009|Overall Study|Withdrawal by Subject|1|||
130161669|NCT04453202|468552642|FG010|Overall Study|Withdrawal by Subject|0|||
130161670|NCT04453202|468552632|FG000|Overall Study|Adverse Event|0|||
129981102|NCT01803282|467893421|FG000|Overall Study|Enrolled but Never Treated|0|||
130161671|NCT04453202|468552633|FG001|Overall Study|Adverse Event|0|||
130161672|NCT04453202|468552634|FG002|Overall Study|Adverse Event|0|||
130161673|NCT04453202|468552635|FG003|Overall Study|Adverse Event|0|||
130161674|NCT04453202|468552636|FG004|Overall Study|Adverse Event|0|||
130161675|NCT04453202|468552637|FG005|Overall Study|Adverse Event|1|||
130161676|NCT04453202|468552638|FG006|Overall Study|Adverse Event|0|||
130161677|NCT04453202|468552639|FG007|Overall Study|Adverse Event|0|||
130161678|NCT04453202|468552640|FG008|Overall Study|Adverse Event|0|||
130161679|NCT04453202|468552641|FG009|Overall Study|Adverse Event|0|||
130161680|NCT04453202|468552642|FG010|Overall Study|Adverse Event|0|||
130161681|NCT01157897|468552643|FG000|Overall Study|Lost to Follow-up|2|||
130161682|NCT01157897|468552644|FG001|Overall Study|Lost to Follow-up|0|||
130161683|NCT01157897|468552645|FG002|Overall Study|Lost to Follow-up|0|||
130161684|NCT01157897|468552646|FG003|Overall Study|Lost to Follow-up|1|||
130161685|NCT01157897|468552643|FG000|Overall Study|Relocated|0|||
130161686|NCT01157897|468552644|FG001|Overall Study|Relocated|2|||
130161687|NCT01157897|468552645|FG002|Overall Study|Relocated|0|||
130161688|NCT01157897|468552646|FG003|Overall Study|Relocated|0|||
130161689|NCT03276221|468552647|FG000|Overall Study|Lost to Follow-up|6|||
130161690|NCT03276221|468552648|FG001|Overall Study|Lost to Follow-up|2|||
130161691|NCT03276221|468552649|FG002|Overall Study|Lost to Follow-up|0|||
130161692|NCT03276221|468552647|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
130161693|NCT03276221|468552648|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
130161694|NCT03276221|468552649|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
130161695|NCT00424775|468552650|FG000|Overall Study|Adverse Event|2|||
130161696|NCT00424775|468552651|FG001|Overall Study|Adverse Event|0|||
130161697|NCT00424775|468552650|FG000|Overall Study|Lack of Efficacy|1|||
130161698|NCT00424775|468552651|FG001|Overall Study|Lack of Efficacy|0|||
130161699|NCT02912650|468552652|FG000|Overall Study|Withdrawal by Subject|1|||
130161700|NCT02912650|468552653|FG001|Overall Study|Withdrawal by Subject|0|||
130161701|NCT02912650|468552654|FG002|Overall Study|Withdrawal by Subject|1|||
130161702|NCT02912650|468552655|FG003|Overall Study|Withdrawal by Subject|5|||
130161703|NCT02912650|468552652|FG000|Overall Study|Adverse Event|0|||
130161704|NCT02912650|468552653|FG001|Overall Study|Adverse Event|0|||
130161705|NCT02912650|468552654|FG002|Overall Study|Adverse Event|1|||
130161706|NCT02912650|468552655|FG003|Overall Study|Adverse Event|0|||
130161707|NCT02562482|468552657|FG000|Overall Study|Enrolled, but did not receive product|4|||
130161708|NCT02562482|468552658|FG001|Overall Study|Enrolled, but did not receive product|0|||
130161709|NCT02562482|468552657|FG000|Overall Study|Lost to Follow-up|9|||
130161710|NCT02562482|468552658|FG001|Overall Study|Lost to Follow-up|6|||
130161711|NCT02562482|468552657|FG000|Overall Study|Moved from area|2|||
130161712|NCT02562482|468552658|FG001|Overall Study|Moved from area|3|||
130161713|NCT02562482|468552657|FG000|Overall Study|Withdrawal by Subject|5|||
130161714|NCT02562482|468552658|FG001|Overall Study|Withdrawal by Subject|3|||
130161715|NCT02562482|468552657|FG000|Overall Study|Physician Decision|1|||
130161716|NCT02562482|468552658|FG001|Overall Study|Physician Decision|3|||
130161717|NCT02562482|468552657|FG000|Overall Study|Illness/Injury unrelated to product|0|||
130161718|NCT02562482|468552658|FG001|Overall Study|Illness/Injury unrelated to product|1|||
130161719|NCT00975286|468552659|FG000|Overall Study|Adverse Event|9|||
130161720|NCT00975286|468552660|FG001|Overall Study|Adverse Event|19|||
130161721|NCT00975286|468552659|FG000|Overall Study|Protocol Violation|1|||
130161722|NCT00975286|468552660|FG001|Overall Study|Protocol Violation|2|||
130161723|NCT00975286|468552659|FG000|Overall Study|Withdrawal by Subject|0|||
130161724|NCT00975286|468552660|FG001|Overall Study|Withdrawal by Subject|2|||
130161725|NCT00975286|468552659|FG000|Overall Study|Familial and Personal Reasons|2|||
130161726|NCT00975286|468552660|FG001|Overall Study|Familial and Personal Reasons|2|||
130161727|NCT00975286|468552659|FG000|Overall Study|Poor Compliance to Protocol|0|||
130161728|NCT00975286|468552660|FG001|Overall Study|Poor Compliance to Protocol|2|||
130161729|NCT00975286|468552659|FG000|Overall Study|Sponsor Decision|0|||
130161730|NCT00975286|468552660|FG001|Overall Study|Sponsor Decision|2|||
130161731|NCT01674647|468552661|FG000|Treatment Period|Death|4|||
130161732|NCT01674647|468552662|FG001|Treatment Period|Death|1|||
130161733|NCT01674647|468552661|FG000|Treatment Period|Efficacy outcome reached|0|||
130161734|NCT01674647|468552662|FG001|Treatment Period|Efficacy outcome reached|1|||
130161735|NCT01674647|468552661|FG000|Treatment Period|Physician Decision|3|||
130161736|NCT01674647|468552662|FG001|Treatment Period|Physician Decision|1|||
130161737|NCT01674647|468552661|FG000|Treatment Period|Adverse Event|60|||
130161738|NCT01674647|468552662|FG001|Treatment Period|Adverse Event|22|||
130161739|NCT01674647|468552661|FG000|Treatment Period|Non-compliance with study drug|3|||
130161740|NCT01674647|468552662|FG001|Treatment Period|Non-compliance with study drug|0|||
130161741|NCT01674647|468552661|FG000|Treatment Period|Lost to Follow-up|1|||
130161742|NCT01674647|468552662|FG001|Treatment Period|Lost to Follow-up|1|||
130161743|NCT01674647|468552661|FG000|Treatment Period|Withdrawal by Subject|19|||
130161744|NCT01674647|468552662|FG001|Treatment Period|Withdrawal by Subject|16|||
130161745|NCT01674647|468552661|FG000|Treatment Period|Switching to other therapy|5|||
130161746|NCT01674647|468552662|FG001|Treatment Period|Switching to other therapy|2|||
130161747|NCT01674647|468552661|FG000|Treatment Period|Logistical difficulties|5|||
130161748|NCT01674647|468552662|FG001|Treatment Period|Logistical difficulties|8|||
130161749|NCT01674647|468552661|FG000|Treatment Period|Treatment failure|0|||
130161750|NCT01674647|468552662|FG001|Treatment Period|Treatment failure|14|||
130161751|NCT01674647|468552661|FG000|Treatment Period|Protocol Violation|56|||
130161752|NCT01674647|468552662|FG001|Treatment Period|Protocol Violation|36|||
130161753|NCT01674647|468552661|FG000|30-day Safety Follow-up Period|Death|3|||
129981103|NCT01803282|467893422|FG001|Overall Study|Enrolled but Never Treated|0|||
129981104|NCT01803282|467893423|FG002|Overall Study|Enrolled but Never Treated|0|||
130161754|NCT01674647|468552662|FG001|30-day Safety Follow-up Period|Death|2|||
130161755|NCT01674647|468552661|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
130161756|NCT01674647|468552662|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
130161757|NCT01674647|468552661|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
130161758|NCT01674647|468552662|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
130161759|NCT01674647|468552661|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
130161760|NCT01674647|468552662|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
130161761|NCT01674647|468552661|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
129981105|NCT01803282|467893424|FG003|Overall Study|Enrolled but Never Treated|0|||
130161762|NCT01674647|468552662|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
130161763|NCT01674647|468552661|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
130161764|NCT01674647|468552662|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
130161765|NCT01490866|468552663|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
130161766|NCT01490866|468552663|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
130161767|NCT01490866|468552663|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
130161768|NCT01490866|468552663|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
130161769|NCT01490866|468552663|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
130161770|NCT01490866|468552663|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
130161771|NCT01490866|468552663|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
130161772|NCT01490866|468552663|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
130161773|NCT01490866|468552663|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
130161774|NCT01490866|468552663|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
130161775|NCT01490866|468552663|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
130161776|NCT02722148|468552664|FG000|Overall Study|Lost to Follow-up|2|||
130161777|NCT02722148|468552664|FG000|Overall Study|Non compliant with treatment regimen|3|||
130161778|NCT00914459|468552666|FG000|Overall Study|Protocol Violation|0|||
130161779|NCT00914459|468552667|FG001|Overall Study|Protocol Violation|1|||
130161780|NCT00914459|468552666|FG000|Overall Study|Parent/Legal guardian request|1|||
130161781|NCT00914459|468552667|FG001|Overall Study|Parent/Legal guardian request|0|||
130161782|NCT01661179|468552671|FG000|Overall Study|Death|1|||
130161783|NCT01661179|468552671|FG000|Overall Study|Withdrawal by Subject|1|||
130161784|NCT01661179|468552671|FG000|Overall Study|Other Eligibility criteria|4|||
130161785|NCT01946191|468552672|FG000|Allocation|Did not complete orientation|1|||
130161786|NCT01946191|468552673|FG001|Allocation|Did not complete orientation|1|||
130161787|NCT01946191|468552672|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
130161788|NCT01946191|468552673|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
130161789|NCT01946191|468552672|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
130161790|NCT01946191|468552673|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
130161791|NCT01946191|468552672|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
130161792|NCT01946191|468552673|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
130161793|NCT04188301|468552674|FG000|Month 3|Lost to Follow-up|0|||
130161794|NCT04188301|468552675|FG001|Month 3|Lost to Follow-up|0|||
130161795|NCT04188301|468552676|FG002|Month 3|Lost to Follow-up|1|||
130161796|NCT04188301|468552674|FG000|Month 12|Lost to Follow-up|0|||
130161797|NCT04188301|468552675|FG001|Month 12|Lost to Follow-up|0|||
130161798|NCT04188301|468552676|FG002|Month 12|Lost to Follow-up|2|||
130161799|NCT04188301|468552674|FG000|Month 12|Death|1|||
130161800|NCT04188301|468552675|FG001|Month 12|Death|1|||
130161801|NCT04188301|468552676|FG002|Month 12|Death|0|||
130161802|NCT04188301|468552674|FG000|Month 18|Lost to Follow-up|6|||
130161803|NCT04188301|468552675|FG001|Month 18|Lost to Follow-up|0|||
130161804|NCT04188301|468552676|FG002|Month 18|Lost to Follow-up|0|||
130161805|NCT01104779|468552679|FG000|Overall Study|Protocol Violation|1|||
130161806|NCT01104779|468552680|FG001|Overall Study|Protocol Violation|2|||
130161807|NCT01104779|468552681|FG002|Overall Study|Protocol Violation|2|||
130161808|NCT01104779|468552679|FG000|Overall Study|Lack of Efficacy|26|||
130161809|NCT01104779|468552680|FG001|Overall Study|Lack of Efficacy|12|||
130161810|NCT01104779|468552681|FG002|Overall Study|Lack of Efficacy|13|||
130161811|NCT01104779|468552679|FG000|Overall Study|Adverse Event|13|||
130161812|NCT01104779|468552680|FG001|Overall Study|Adverse Event|14|||
130161813|NCT01104779|468552681|FG002|Overall Study|Adverse Event|13|||
130161814|NCT01104779|468552679|FG000|Overall Study|Did not meet inc/exc criteria|1|||
130161815|NCT01104779|468552680|FG001|Overall Study|Did not meet inc/exc criteria|1|||
130161816|NCT01104779|468552681|FG002|Overall Study|Did not meet inc/exc criteria|1|||
130161817|NCT01104779|468552679|FG000|Overall Study|Other reasons|0|||
130161818|NCT01104779|468552680|FG001|Overall Study|Other reasons|1|||
130161819|NCT01104779|468552681|FG002|Overall Study|Other reasons|0|||
129981106|NCT01803282|467893425|FG004|Overall Study|Enrolled but Never Treated|1|||
129981107|NCT01803282|467893426|FG005|Overall Study|Enrolled but Never Treated|0|||
129981108|NCT01803282|467893427|FG006|Overall Study|Enrolled but Never Treated|1|||
129981109|NCT01803282|467893428|FG007|Overall Study|Enrolled but Never Treated|1|||
130161820|NCT01104779|468552679|FG000|Overall Study|Lost to Follow-up|2|||
130161821|NCT01104779|468552680|FG001|Overall Study|Lost to Follow-up|0|||
130161822|NCT01104779|468552681|FG002|Overall Study|Lost to Follow-up|1|||
130161823|NCT01104779|468552679|FG000|Overall Study|Withdrawal by Subject|16|||
130161824|NCT01104779|468552680|FG001|Overall Study|Withdrawal by Subject|25|||
130161825|NCT01104779|468552681|FG002|Overall Study|Withdrawal by Subject|32|||
130161826|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
130161827|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
130161828|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161829|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161830|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161831|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161832|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161833|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161834|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161835|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161836|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161837|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161838|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161839|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
130161840|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
130161841|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
130161842|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161843|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161844|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161845|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161846|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161847|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161848|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161849|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161850|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161851|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161852|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161853|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
130161854|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
130161855|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
130161856|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161857|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161858|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161859|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161860|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161861|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161862|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161863|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161864|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161865|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161866|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161867|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
130161868|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
130161869|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
130161870|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161871|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161872|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161873|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161874|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161875|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161876|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161877|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161878|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161879|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161880|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161881|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
130161882|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
130161883|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
130161884|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161885|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161886|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161887|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161888|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161889|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161890|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161891|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161892|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161893|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161894|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161895|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
130161896|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
130161897|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
130161898|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161899|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161900|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161901|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161902|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161903|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161904|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161905|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129981110|NCT01803282|467893429|FG008|Overall Study|Enrolled but Never Treated|0|||
129981111|NCT01803282|467893430|FG009|Overall Study|Enrolled but Never Treated|1|||
129981112|NCT01803282|467893431|FG010|Overall Study|Enrolled but Never Treated|0|||
129981113|NCT01803282|467893432|FG011|Overall Study|Enrolled but Never Treated|0|||
129981114|NCT01743989|467893433|FG000|Treatment Phase|Unstable MR4.0|0|||
129981115|NCT01743989|467893434|FG001|Treatment Phase|Unstable MR4.0|6|||
129981116|NCT01743989|467893435|FG002|Treatment Phase|Unstable MR4.0|263|||
129981117|NCT01743989|467893433|FG000|Treatment Phase|Adverse Event|0|||
129981118|NCT01743989|467893434|FG001|Treatment Phase|Adverse Event|4|||
129981119|NCT01743989|467893435|FG002|Treatment Phase|Adverse Event|67|||
129981120|NCT01743989|467893433|FG000|Treatment Phase|Withdrawal by Subject|1|||
129981121|NCT01743989|467893434|FG001|Treatment Phase|Withdrawal by Subject|3|||
129981122|NCT01743989|467893435|FG002|Treatment Phase|Withdrawal by Subject|28|||
129981123|NCT01743989|467893433|FG000|Treatment Phase|Death|0|||
129981124|NCT01743989|467893434|FG001|Treatment Phase|Death|1|||
129981125|NCT01743989|467893435|FG002|Treatment Phase|Death|3|||
129981126|NCT01743989|467893433|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
129981127|NCT01743989|467893434|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
129981128|NCT01743989|467893435|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
129981129|NCT01743989|467893433|FG000|Treatment Phase|Protocol deviation|0|||
129981130|NCT01743989|467893434|FG001|Treatment Phase|Protocol deviation|0|||
129981131|NCT01743989|467893435|FG002|Treatment Phase|Protocol deviation|3|||
129981132|NCT01743989|467893433|FG000|Treatment Phase|Pregnancy|0|||
129981133|NCT01743989|467893434|FG001|Treatment Phase|Pregnancy|0|||
129981134|NCT01743989|467893435|FG002|Treatment Phase|Pregnancy|2|||
129981135|NCT01743989|467893433|FG000|Treatment Phase|Lost to Follow-up|0|||
129981136|NCT01743989|467893434|FG001|Treatment Phase|Lost to Follow-up|0|||
129981137|NCT01743989|467893435|FG002|Treatment Phase|Lost to Follow-up|2|||
129981138|NCT01743989|467893433|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
129981139|NCT01743989|467893434|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
129981140|NCT01743989|467893435|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
129981141|NCT01743989|467893433|FG000|Treatment Phase|Administrative problems|0|||
129981142|NCT01743989|467893434|FG001|Treatment Phase|Administrative problems|0|||
129981143|NCT01743989|467893435|FG002|Treatment Phase|Administrative problems|1|||
129981144|NCT01743989|467893433|FG000|Treatment Phase|New cancer (CML) therapy|0|||
129981145|NCT01743989|467893434|FG001|Treatment Phase|New cancer (CML) therapy|1|||
129981146|NCT01743989|467893435|FG002|Treatment Phase|New cancer (CML) therapy|0|||
129981147|NCT01743989|467893433|FG000|Treatment Phase|Physician Decision|0|||
129981148|NCT01743989|467893434|FG001|Treatment Phase|Physician Decision|0|||
129981149|NCT01743989|467893435|FG002|Treatment Phase|Physician Decision|3|||
129981150|NCT01743989|467893433|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
129981151|NCT01743989|467893434|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
129981152|NCT01743989|467893435|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
129981153|NCT01743989|467893433|FG000|Treatment Phase|Not randomized by mistake|0|||
129981154|NCT01743989|467893434|FG001|Treatment Phase|Not randomized by mistake|0|||
129981155|NCT01743989|467893435|FG002|Treatment Phase|Not randomized by mistake|1|||
129981156|NCT01743989|467893433|FG000|Treatment Phase|Included by mistake|0|||
129981157|NCT01743989|467893434|FG001|Treatment Phase|Included by mistake|0|||
129981158|NCT01743989|467893435|FG002|Treatment Phase|Included by mistake|1|||
129981159|NCT01743989|467893433|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
130161906|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161907|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161908|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161909|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
130161910|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
130161911|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
130161912|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129981160|NCT01743989|467893434|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
129981161|NCT01743989|467893435|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
129981162|NCT01743989|467893433|FG000|TFR Phase|Adverse Event|0|||
129981163|NCT01743989|467893434|FG001|TFR Phase|Adverse Event|1|||
129981164|NCT01743989|467893435|FG002|TFR Phase|Adverse Event|0|||
129981165|NCT01743989|467893433|FG000|TFR Phase|Lost to Follow-up|0|||
129981166|NCT01743989|467893434|FG001|TFR Phase|Lost to Follow-up|2|||
129981167|NCT01743989|467893435|FG002|TFR Phase|Lost to Follow-up|0|||
129981168|NCT01743989|467893433|FG000|TFR Phase|Physician Decision|0|||
129981169|NCT01743989|467893434|FG001|TFR Phase|Physician Decision|1|||
129981170|NCT01743989|467893435|FG002|TFR Phase|Physician Decision|0|||
129981171|NCT01743989|467893433|FG000|TFR Phase|Logistical problems|0|||
129981172|NCT01743989|467893434|FG001|TFR Phase|Logistical problems|2|||
130161913|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161914|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161915|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161916|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161917|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161918|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161919|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161920|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161921|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161922|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161923|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
130161924|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
130161925|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
130161926|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161927|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161928|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161929|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161930|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161931|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161932|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161933|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161934|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161935|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129981173|NCT01743989|467893435|FG002|TFR Phase|Logistical problems|0|||
129981174|NCT01743989|467893433|FG000|TFR Phase|Protocol deviation|0|||
129981175|NCT01743989|467893434|FG001|TFR Phase|Protocol deviation|1|||
129981176|NCT01743989|467893435|FG002|TFR Phase|Protocol deviation|0|||
129981177|NCT01743989|467893433|FG000|TFR Phase|Withdrawal by Subject|0|||
129981178|NCT01743989|467893434|FG001|TFR Phase|Withdrawal by Subject|2|||
129981179|NCT01743989|467893435|FG002|TFR Phase|Withdrawal by Subject|0|||
129981180|NCT01743989|467893433|FG000|Re-treatment Phase|Adverse Event|8|||
129981181|NCT01743989|467893434|FG001|Re-treatment Phase|Adverse Event|4|||
129981182|NCT01743989|467893435|FG002|Re-treatment Phase|Adverse Event|0|||
129981183|NCT01743989|467893433|FG000|Re-treatment Phase|Death|1|||
129981184|NCT01743989|467893434|FG001|Re-treatment Phase|Death|1|||
129981185|NCT01743989|467893435|FG002|Re-treatment Phase|Death|0|||
129981186|NCT01743989|467893433|FG000|Re-treatment Phase|Administrative problems|1|||
129981187|NCT01743989|467893434|FG001|Re-treatment Phase|Administrative problems|1|||
129981188|NCT01743989|467893435|FG002|Re-treatment Phase|Administrative problems|0|||
129981189|NCT01743989|467893433|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
129981190|NCT01743989|467893434|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
129981191|NCT01743989|467893435|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
129981192|NCT01743989|467893433|FG000|Re-treatment Phase|Unstable MR|1|||
129981193|NCT01743989|467893434|FG001|Re-treatment Phase|Unstable MR|0|||
129981194|NCT01743989|467893435|FG002|Re-treatment Phase|Unstable MR|0|||
129981195|NCT01743989|467893433|FG000|Re-treatment Phase|Physician Decision|0|||
129981196|NCT01743989|467893434|FG001|Re-treatment Phase|Physician Decision|1|||
129981197|NCT01743989|467893435|FG002|Re-treatment Phase|Physician Decision|0|||
129981198|NCT01743989|467893433|FG000|Re-treatment Phase|Lost to Follow-up|0|||
129981199|NCT01743989|467893434|FG001|Re-treatment Phase|Lost to Follow-up|1|||
129981200|NCT01743989|467893435|FG002|Re-treatment Phase|Lost to Follow-up|0|||
129981201|NCT02235311|467893440|FG000|Overall Study|Lost to Follow-up|0|||
129981202|NCT02235311|467893441|FG001|Overall Study|Lost to Follow-up|1|||
129981203|NCT02235311|467893440|FG000|Overall Study|Protocol Violation|0|||
129981204|NCT02235311|467893441|FG001|Overall Study|Protocol Violation|1|||
130161936|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161937|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
130161938|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
130161939|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
130161940|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161941|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161942|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161943|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129981205|NCT00658788|467893442|FG000|Overall Study|Adverse Event|11|||
129981206|NCT00658788|467893442|FG000|Overall Study|Withdrawal by Subject|13|||
129981207|NCT00658788|467893442|FG000|Overall Study|Lost to Follow-up|18|||
129981208|NCT00658788|467893442|FG000|Overall Study|Treatment Discontinuation|32|||
129981209|NCT00653523|467893443|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
129981210|NCT00653523|467893443|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
129981211|NCT00653523|467893443|FG000|Overall Study|Adverse Event|7|||
129981212|NCT00653523|467893443|FG000|Overall Study|Withdrawal by Subject|6|||
130161944|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161945|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161946|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161947|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161948|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161949|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161950|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161951|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
130161952|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
130161953|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
130161954|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161955|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161956|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161957|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161958|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161959|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161960|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161961|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161962|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161963|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161964|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161965|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
130161966|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
130161967|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
130161968|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161969|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161970|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161971|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161972|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161973|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129981213|NCT00653523|467893443|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
129981214|NCT00653523|467893443|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
129981215|NCT02425904|467893444|FG000|Overall Study|Lost to Follow-up|1|||
129981216|NCT02425904|467893445|FG001|Overall Study|Lost to Follow-up|0|||
129981217|NCT02425904|467893444|FG000|Overall Study|Withdrawal by Subject|2|||
129981218|NCT02425904|467893445|FG001|Overall Study|Withdrawal by Subject|0|||
129981219|NCT02425904|467893444|FG000|Overall Study|Death|0|||
129981220|NCT02425904|467893445|FG001|Overall Study|Death|3|||
129981221|NCT05384938|467893447|FG000|Overall Study|Withdrawal by Subject|8|||
129981222|NCT05384938|467893447|FG000|Overall Study|Lost to Follow-up|6|||
129981223|NCT05384938|467893447|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
129981224|NCT02626455|467893448|FG000|Overall Study|Other|1|||
129981225|NCT02626455|467893449|FG001|Overall Study|Other|1|||
129981226|NCT02626455|467893450|FG002|Overall Study|Other|0|||
129981227|NCT02626455|467893451|FG003|Overall Study|Other|0|||
129981228|NCT02626455|467893452|FG004|Overall Study|Other|0|||
129981229|NCT02626455|467893453|FG005|Overall Study|Other|17|||
129981230|NCT02626455|467893454|FG006|Overall Study|Other|23|||
129981231|NCT02626455|467893448|FG000|Overall Study|Withdrawal by Subject|1|||
129981232|NCT02626455|467893449|FG001|Overall Study|Withdrawal by Subject|0|||
129981233|NCT02626455|467893450|FG002|Overall Study|Withdrawal by Subject|0|||
129981234|NCT02626455|467893451|FG003|Overall Study|Withdrawal by Subject|0|||
129981235|NCT02626455|467893452|FG004|Overall Study|Withdrawal by Subject|0|||
129981236|NCT02626455|467893453|FG005|Overall Study|Withdrawal by Subject|10|||
129981237|NCT02626455|467893454|FG006|Overall Study|Withdrawal by Subject|6|||
129981238|NCT02626455|467893448|FG000|Overall Study|Physician Decision|0|||
129981239|NCT02626455|467893449|FG001|Overall Study|Physician Decision|2|||
129981240|NCT02626455|467893450|FG002|Overall Study|Physician Decision|2|||
129981241|NCT02626455|467893451|FG003|Overall Study|Physician Decision|2|||
129981242|NCT02626455|467893452|FG004|Overall Study|Physician Decision|1|||
129981243|NCT02626455|467893453|FG005|Overall Study|Physician Decision|10|||
129981244|NCT02626455|467893454|FG006|Overall Study|Physician Decision|3|||
129981245|NCT02626455|467893448|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130161974|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129981246|NCT02626455|467893449|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130161975|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161976|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161977|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129981247|NCT02626455|467893450|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129981248|NCT02626455|467893451|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129981249|NCT02626455|467893452|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
130161978|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161979|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
130161980|NCT03982199|468552682|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
130161981|NCT03982199|468552683|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
130161982|NCT03982199|468552684|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161983|NCT03982199|468552685|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161984|NCT03982199|468552686|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161985|NCT03982199|468552687|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161986|NCT03982199|468552688|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161987|NCT03982199|468552689|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161988|NCT03982199|468552690|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161989|NCT03982199|468552691|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161990|NCT03982199|468552692|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161991|NCT03982199|468552693|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161992|NCT03982199|468552694|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161993|NCT03982199|468552695|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
130161994|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130161995|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130161996|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130161997|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
130161998|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130161999|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162000|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162001|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162002|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162003|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162004|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162005|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162006|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162007|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
130162008|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162009|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162010|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
130162011|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162012|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162013|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162014|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162015|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162016|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162017|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162018|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162019|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162020|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162021|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
130162022|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162023|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162024|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
130162025|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162026|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162027|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162028|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162029|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162030|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162031|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162032|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162033|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162034|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
130162035|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129981250|NCT02626455|467893453|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129981251|NCT02626455|467893454|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
129981252|NCT02626455|467893448|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981253|NCT02626455|467893449|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981254|NCT02626455|467893450|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130162036|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162037|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162038|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
130162039|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
130162040|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162041|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162042|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162043|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162044|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162045|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162046|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162047|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162048|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162049|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
130162050|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162051|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162052|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162053|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
130162054|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162055|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162056|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162057|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162058|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162059|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162060|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162061|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162062|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162063|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
130162064|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162065|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162066|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
130162067|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
130162068|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162069|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162070|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162071|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162072|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162073|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162074|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162075|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162076|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162077|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
130162078|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162079|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162080|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162081|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162082|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162083|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162084|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162085|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162086|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
130162087|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162088|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162089|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162090|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162091|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
130162092|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129981255|NCT02626455|467893451|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981256|NCT02626455|467893452|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981257|NCT02626455|467893453|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
130162093|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129981258|NCT02626455|467893454|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
129981259|NCT02626455|467893448|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981260|NCT02626455|467893449|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
130162094|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162095|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162096|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162097|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162098|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162099|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162100|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
130162101|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162102|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162103|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162104|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162105|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
130162106|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162107|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162108|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162109|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162110|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162111|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162112|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162113|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162114|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
130162115|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162116|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162117|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162118|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
130162119|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129981261|NCT02626455|467893450|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981262|NCT02626455|467893451|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981263|NCT02626455|467893452|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981264|NCT02626455|467893453|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
129981265|NCT02626455|467893454|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
129981266|NCT02626455|467893448|FG000|Overall Study|Patient decision|0|||
129981267|NCT02626455|467893449|FG001|Overall Study|Patient decision|1|||
129981268|NCT02626455|467893450|FG002|Overall Study|Patient decision|0|||
129981269|NCT02626455|467893451|FG003|Overall Study|Patient decision|0|||
129981270|NCT02626455|467893452|FG004|Overall Study|Patient decision|1|||
129981271|NCT02626455|467893453|FG005|Overall Study|Patient decision|36|||
129981272|NCT02626455|467893454|FG006|Overall Study|Patient decision|22|||
129981273|NCT02626455|467893448|FG000|Overall Study|Protocol Violation|0|||
129981274|NCT02626455|467893449|FG001|Overall Study|Protocol Violation|0|||
129981275|NCT02626455|467893450|FG002|Overall Study|Protocol Violation|0|||
129981276|NCT02626455|467893451|FG003|Overall Study|Protocol Violation|0|||
129981277|NCT02626455|467893452|FG004|Overall Study|Protocol Violation|0|||
129981278|NCT02626455|467893453|FG005|Overall Study|Protocol Violation|0|||
129981279|NCT02626455|467893454|FG006|Overall Study|Protocol Violation|1|||
129981280|NCT02626455|467893448|FG000|Overall Study|Progressive disease - radiological progression|0|||
129981281|NCT02626455|467893449|FG001|Overall Study|Progressive disease - radiological progression|0|||
129981282|NCT02626455|467893450|FG002|Overall Study|Progressive disease - radiological progression|0|||
129981283|NCT02626455|467893451|FG003|Overall Study|Progressive disease - radiological progression|0|||
129981284|NCT02626455|467893452|FG004|Overall Study|Progressive disease - radiological progression|0|||
129981285|NCT02626455|467893453|FG005|Overall Study|Progressive disease - radiological progression|11|||
129981286|NCT02626455|467893454|FG006|Overall Study|Progressive disease - radiological progression|22|||
129981287|NCT02626455|467893448|FG000|Overall Study|Progressive disease - clinical progression|0|||
129981288|NCT02626455|467893449|FG001|Overall Study|Progressive disease - clinical progression|0|||
129981289|NCT02626455|467893450|FG002|Overall Study|Progressive disease - clinical progression|0|||
129981290|NCT02626455|467893451|FG003|Overall Study|Progressive disease - clinical progression|0|||
129981291|NCT02626455|467893452|FG004|Overall Study|Progressive disease - clinical progression|0|||
129981292|NCT02626455|467893453|FG005|Overall Study|Progressive disease - clinical progression|1|||
129981293|NCT02626455|467893454|FG006|Overall Study|Progressive disease - clinical progression|2|||
129981294|NCT02626455|467893448|FG000|Overall Study|Lost to Follow-up|0|||
130162120|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129981295|NCT02626455|467893449|FG001|Overall Study|Lost to Follow-up|0|||
129981296|NCT02626455|467893450|FG002|Overall Study|Lost to Follow-up|0|||
129981297|NCT02626455|467893451|FG003|Overall Study|Lost to Follow-up|0|||
129981298|NCT02626455|467893452|FG004|Overall Study|Lost to Follow-up|0|||
130162121|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162122|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162123|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162124|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162125|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162126|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162127|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162128|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
130162129|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162130|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162131|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162132|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162133|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
130162134|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162135|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162136|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162137|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162138|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162139|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162140|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162141|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162142|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
130162143|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162144|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162145|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162146|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162147|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
130162148|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162149|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162150|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162151|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162152|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162153|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
130162154|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162155|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
130162156|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
130162157|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162158|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162159|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162160|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162161|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
130162162|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162163|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162164|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162165|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162166|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162167|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162168|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162169|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162170|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
130162171|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162172|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162173|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162174|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162175|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
130162176|NCT03982199|468552682|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162177|NCT03982199|468552683|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162178|NCT03982199|468552684|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162179|NCT03982199|468552685|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162180|NCT03982199|468552686|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162181|NCT03982199|468552687|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
130162182|NCT03982199|468552688|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162183|NCT03982199|468552689|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
130162184|NCT03982199|468552690|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
130162185|NCT03982199|468552691|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162186|NCT03982199|468552692|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162187|NCT03982199|468552693|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162188|NCT03982199|468552694|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162189|NCT03982199|468552695|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
130162190|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162191|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162192|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162193|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162194|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162195|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162196|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162197|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162198|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
130162199|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
130162200|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
130162201|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
130162202|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
130162203|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
130162204|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162205|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162206|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162207|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162208|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162209|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162210|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162211|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162212|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162213|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
130162214|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162215|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162216|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162217|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
130162218|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162219|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162220|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162221|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162222|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162223|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162224|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162225|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162226|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162227|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162228|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162229|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162230|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
130162231|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
130162232|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162233|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162234|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162235|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162236|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162237|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162238|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162239|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162240|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162241|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162242|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
130162243|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
130162244|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
130162245|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
130162246|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162247|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162248|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162249|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162250|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162251|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162252|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162253|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162254|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162255|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162256|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162257|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162258|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
130162259|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
130162260|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162261|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162262|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162263|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162264|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162265|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162266|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162267|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162268|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162269|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162270|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162271|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
130162272|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
130162273|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
130162274|NCT03982199|468552682|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162275|NCT03982199|468552683|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162276|NCT03982199|468552684|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162277|NCT03982199|468552685|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162278|NCT03982199|468552686|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162279|NCT03982199|468552687|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162280|NCT03982199|468552688|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162281|NCT03982199|468552689|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162282|NCT03982199|468552690|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162283|NCT03982199|468552691|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162284|NCT03982199|468552692|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162285|NCT03982199|468552693|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162286|NCT03982199|468552694|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
130162287|NCT03982199|468552695|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
130162288|NCT00594646|468552696|FG000|Overall Study|Withdrawal by Subject|1|||
130162289|NCT00594646|468552696|FG000|Overall Study|Lost to Follow-up|15|||
130162290|NCT03907462|468552699|FG000|Overall Study|Physician Decision|1|||
130162291|NCT03907462|468552700|FG001|Overall Study|Physician Decision|3|||
130162292|NCT03907462|468552701|FG002|Overall Study|Physician Decision|1|||
130162293|NCT03907462|468552699|FG000|Overall Study|Withdrawal by Subject|6|||
130162294|NCT03907462|468552700|FG001|Overall Study|Withdrawal by Subject|3|||
130162295|NCT03907462|468552701|FG002|Overall Study|Withdrawal by Subject|3|||
130162296|NCT03907462|468552699|FG000|Overall Study|Pregnancy|4|||
130162297|NCT03907462|468552700|FG001|Overall Study|Pregnancy|2|||
130162298|NCT03907462|468552701|FG002|Overall Study|Pregnancy|6|||
130162299|NCT03907462|468552699|FG000|Overall Study|Lost to Follow-up|16|||
130162300|NCT03907462|468552700|FG001|Overall Study|Lost to Follow-up|18|||
130162301|NCT03907462|468552701|FG002|Overall Study|Lost to Follow-up|22|||
130162302|NCT03548064|468554850|FG000|Overall Study|Withdrawal by Subject|0|||
130162303|NCT03548064|468554851|FG001|Overall Study|Withdrawal by Subject|0|||
130162304|NCT03548064|468554852|FG002|Overall Study|Withdrawal by Subject|0|||
130162305|NCT03548064|468554853|FG003|Overall Study|Withdrawal by Subject|1|||
130162306|NCT03548064|468554854|FG004|Overall Study|Withdrawal by Subject|0|||
129981299|NCT02626455|467893453|FG005|Overall Study|Lost to Follow-up|1|||
130162307|NCT03548064|468554855|FG005|Overall Study|Withdrawal by Subject|0|||
129981300|NCT02626455|467893454|FG006|Overall Study|Lost to Follow-up|0|||
129981301|NCT02626455|467893448|FG000|Overall Study|AE not associated with clinical disease progression|1|||
129981302|NCT02626455|467893449|FG001|Overall Study|AE not associated with clinical disease progression|1|||
129981303|NCT02626455|467893450|FG002|Overall Study|AE not associated with clinical disease progression|0|||
129981304|NCT02626455|467893451|FG003|Overall Study|AE not associated with clinical disease progression|2|||
130162308|NCT03548064|468554856|FG006|Overall Study|Withdrawal by Subject|0|||
130162309|NCT03548064|468554857|FG007|Overall Study|Withdrawal by Subject|0|||
130162310|NCT03548064|468554850|FG000|Overall Study|Lost to Follow-up|0|||
130162311|NCT03548064|468554851|FG001|Overall Study|Lost to Follow-up|0|||
130162312|NCT03548064|468554852|FG002|Overall Study|Lost to Follow-up|0|||
130162313|NCT03548064|468554853|FG003|Overall Study|Lost to Follow-up|0|||
130162314|NCT03548064|468554854|FG004|Overall Study|Lost to Follow-up|2|||
130162315|NCT03548064|468554855|FG005|Overall Study|Lost to Follow-up|0|||
130162316|NCT03548064|468554856|FG006|Overall Study|Lost to Follow-up|0|||
130162317|NCT03548064|468554857|FG007|Overall Study|Lost to Follow-up|0|||
130162318|NCT03548064|468554850|FG000|Overall Study|Covid-19 Pandemic|0|||
130162319|NCT03548064|468554851|FG001|Overall Study|Covid-19 Pandemic|0|||
130162320|NCT03548064|468554852|FG002|Overall Study|Covid-19 Pandemic|0|||
130162321|NCT03548064|468554853|FG003|Overall Study|Covid-19 Pandemic|0|||
130162322|NCT03548064|468554854|FG004|Overall Study|Covid-19 Pandemic|10|||
130162323|NCT03548064|468554855|FG005|Overall Study|Covid-19 Pandemic|3|||
130162324|NCT03548064|468554856|FG006|Overall Study|Covid-19 Pandemic|0|||
130162325|NCT03548064|468554857|FG007|Overall Study|Covid-19 Pandemic|0|||
130162326|NCT05011123|468554858|FG000|Overall Study|Withdrawal by Subject|4|||
130162327|NCT05011123|468554859|FG001|Overall Study|Withdrawal by Subject|2|||
130162328|NCT05011123|468554858|FG000|Overall Study|Lost to Follow-up|7|||
130162329|NCT05011123|468554859|FG001|Overall Study|Lost to Follow-up|6|||
130162330|NCT05011123|468554858|FG000|Overall Study|Ongoing at the time of DBL date|36|||
130162331|NCT05011123|468554859|FG001|Overall Study|Ongoing at the time of DBL date|10|||
130162332|NCT05011123|468554858|FG000|Overall Study|Randomized but did not receive vaccination|1|||
130162333|NCT05011123|468554859|FG001|Overall Study|Randomized but did not receive vaccination|0|||
130162334|NCT04221789|468554860|FG000|Overall Study|deviation from protoco|22|||
130162335|NCT04221789|468554861|FG001|Overall Study|deviation from protoco|8|||
130162336|NCT04732221|468554862|FG000|Base Period|Death|2|||
130162337|NCT04732221|468554863|FG001|Base Period|Death|0|||
130162338|NCT04732221|468554864|FG002|Base Period|Death|0|||
130162339|NCT04732221|468554865|FG003|Base Period|Death|0|||
130162340|NCT04732221|468554866|FG004|Base Period|Death|0|||
130162341|NCT04732221|468554867|FG005|Base Period|Death|0|||
130162342|NCT04732221|468554868|FG006|Base Period|Death|0|||
130162343|NCT04732221|468554862|FG000|Base Period|Withdrawal by Subject|0|||
130162344|NCT04732221|468554863|FG001|Base Period|Withdrawal by Subject|1|||
130162345|NCT04732221|468554864|FG002|Base Period|Withdrawal by Subject|1|||
130162346|NCT04732221|468554865|FG003|Base Period|Withdrawal by Subject|0|||
130162347|NCT04732221|468554866|FG004|Base Period|Withdrawal by Subject|0|||
130162348|NCT04732221|468554867|FG005|Base Period|Withdrawal by Subject|0|||
130162349|NCT04732221|468554868|FG006|Base Period|Withdrawal by Subject|0|||
130162350|NCT04732221|468554862|FG000|Extension Period|Adverse Event|0|||
130162351|NCT04732221|468554863|FG001|Extension Period|Adverse Event|0|||
130162352|NCT04732221|468554864|FG002|Extension Period|Adverse Event|0|||
130162353|NCT04732221|468554865|FG003|Extension Period|Adverse Event|0|||
130162354|NCT04732221|468554866|FG004|Extension Period|Adverse Event|0|||
130162355|NCT04732221|468554867|FG005|Extension Period|Adverse Event|1|||
130162356|NCT04732221|468554868|FG006|Extension Period|Adverse Event|0|||
130162357|NCT04732221|468554862|FG000|Extension Period|Death|0|||
130162358|NCT04732221|468554863|FG001|Extension Period|Death|0|||
130162359|NCT04732221|468554864|FG002|Extension Period|Death|0|||
130162360|NCT04732221|468554865|FG003|Extension Period|Death|0|||
130162361|NCT04732221|468554866|FG004|Extension Period|Death|1|||
130162362|NCT04732221|468554867|FG005|Extension Period|Death|0|||
130162363|NCT04732221|468554868|FG006|Extension Period|Death|2|||
130162364|NCT04732221|468554862|FG000|Extension Period|Pregnancy|0|||
130162365|NCT04732221|468554863|FG001|Extension Period|Pregnancy|0|||
130162366|NCT04732221|468554864|FG002|Extension Period|Pregnancy|0|||
130162367|NCT04732221|468554865|FG003|Extension Period|Pregnancy|0|||
130162368|NCT04732221|468554866|FG004|Extension Period|Pregnancy|1|||
130162369|NCT04732221|468554867|FG005|Extension Period|Pregnancy|0|||
130162370|NCT04732221|468554868|FG006|Extension Period|Pregnancy|0|||
130162371|NCT04732221|468554862|FG000|Extension Period|Sponsors Decision|0|||
130162372|NCT04732221|468554863|FG001|Extension Period|Sponsors Decision|0|||
130162373|NCT04732221|468554864|FG002|Extension Period|Sponsors Decision|0|||
130162374|NCT04732221|468554865|FG003|Extension Period|Sponsors Decision|0|||
130162375|NCT04732221|468554866|FG004|Extension Period|Sponsors Decision|41|||
130162376|NCT04732221|468554867|FG005|Extension Period|Sponsors Decision|40|||
130162377|NCT04732221|468554868|FG006|Extension Period|Sponsors Decision|40|||
130162378|NCT04732221|468554862|FG000|Extension Period|Withdrawal by Subject|0|||
130162379|NCT04732221|468554863|FG001|Extension Period|Withdrawal by Subject|0|||
130162380|NCT04732221|468554864|FG002|Extension Period|Withdrawal by Subject|0|||
130162381|NCT04732221|468554865|FG003|Extension Period|Withdrawal by Subject|0|||
130162382|NCT04732221|468554866|FG004|Extension Period|Withdrawal by Subject|1|||
130162383|NCT04732221|468554867|FG005|Extension Period|Withdrawal by Subject|5|||
130162384|NCT04732221|468554868|FG006|Extension Period|Withdrawal by Subject|2|||
130162385|NCT03747601|468554869|FG000|Overall Study|COVID halt to visits|4|||
130162386|NCT03303625|468554870|FG000|Overall Study|Withdrawal by Subject|2|||
130162387|NCT03303625|468554871|FG001|Overall Study|Withdrawal by Subject|0|||
130162388|NCT03303625|468554872|FG002|Overall Study|Withdrawal by Subject|0|||
130162389|NCT03303625|468554873|FG003|Overall Study|Withdrawal by Subject|0|||
130162390|NCT05327816|468554874|FG000|Overall Study|Lost to Follow-up|1|||
130162391|NCT05327816|468554875|FG001|Overall Study|Lost to Follow-up|0|||
130162392|NCT05327816|468554876|FG002|Overall Study|Lost to Follow-up|0|||
130162393|NCT05327816|468554877|FG003|Overall Study|Lost to Follow-up|0|||
130162394|NCT05327816|468554878|FG004|Overall Study|Lost to Follow-up|0|||
130162395|NCT05327816|468554879|FG005|Overall Study|Lost to Follow-up|0|||
130162396|NCT05327816|468554880|FG006|Overall Study|Lost to Follow-up|0|||
130162397|NCT05327816|468554881|FG007|Overall Study|Lost to Follow-up|0|||
130162398|NCT05327816|468554882|FG008|Overall Study|Lost to Follow-up|0|||
130162399|NCT05327816|468554883|FG009|Overall Study|Lost to Follow-up|1|||
130162400|NCT05327816|468554884|FG010|Overall Study|Lost to Follow-up|0|||
130162401|NCT05327816|468554874|FG000|Overall Study|Withdrawal by Subject|0|||
130162402|NCT05327816|468554875|FG001|Overall Study|Withdrawal by Subject|0|||
130162403|NCT05327816|468554876|FG002|Overall Study|Withdrawal by Subject|0|||
130162404|NCT05327816|468554877|FG003|Overall Study|Withdrawal by Subject|0|||
130162405|NCT05327816|468554878|FG004|Overall Study|Withdrawal by Subject|1|||
130162406|NCT05327816|468554879|FG005|Overall Study|Withdrawal by Subject|1|||
130162407|NCT05327816|468554880|FG006|Overall Study|Withdrawal by Subject|0|||
130162408|NCT05327816|468554881|FG007|Overall Study|Withdrawal by Subject|0|||
130162409|NCT05327816|468554882|FG008|Overall Study|Withdrawal by Subject|0|||
130162410|NCT05327816|468554883|FG009|Overall Study|Withdrawal by Subject|0|||
130162411|NCT05327816|468554884|FG010|Overall Study|Withdrawal by Subject|0|||
130162412|NCT05327816|468554874|FG000|Overall Study|Study Terminated by Sponsor|11|||
130162413|NCT05327816|468554875|FG001|Overall Study|Study Terminated by Sponsor|12|||
130162414|NCT05327816|468554876|FG002|Overall Study|Study Terminated by Sponsor|12|||
130162415|NCT05327816|468554877|FG003|Overall Study|Study Terminated by Sponsor|12|||
130162416|NCT05327816|468554878|FG004|Overall Study|Study Terminated by Sponsor|11|||
130162417|NCT05327816|468554879|FG005|Overall Study|Study Terminated by Sponsor|11|||
130162418|NCT05327816|468554880|FG006|Overall Study|Study Terminated by Sponsor|11|||
130162419|NCT05327816|468554881|FG007|Overall Study|Study Terminated by Sponsor|11|||
130162420|NCT05327816|468554882|FG008|Overall Study|Study Terminated by Sponsor|11|||
130162421|NCT05327816|468554883|FG009|Overall Study|Study Terminated by Sponsor|11|||
130162422|NCT05327816|468554884|FG010|Overall Study|Study Terminated by Sponsor|12|||
130162423|NCT05327816|468554874|FG000|Overall Study|Randomized but not treated|0|||
130162424|NCT05327816|468554875|FG001|Overall Study|Randomized but not treated|0|||
130162425|NCT05327816|468554876|FG002|Overall Study|Randomized but not treated|0|||
130162426|NCT05327816|468554877|FG003|Overall Study|Randomized but not treated|0|||
130162427|NCT05327816|468554878|FG004|Overall Study|Randomized but not treated|0|||
130162428|NCT05327816|468554879|FG005|Overall Study|Randomized but not treated|0|||
130162429|NCT05327816|468554880|FG006|Overall Study|Randomized but not treated|1|||
130162430|NCT05327816|468554881|FG007|Overall Study|Randomized but not treated|1|||
130162431|NCT05327816|468554882|FG008|Overall Study|Randomized but not treated|1|||
130162432|NCT05327816|468554883|FG009|Overall Study|Randomized but not treated|0|||
130162433|NCT05327816|468554884|FG010|Overall Study|Randomized but not treated|0|||
130162434|NCT04305587|468554885|FG000|Overall Study|Withdrawal by Subject|0|||
130162435|NCT04305587|468554886|FG001|Overall Study|Withdrawal by Subject|0|||
130162436|NCT04305587|468554887|FG002|Overall Study|Withdrawal by Subject|0|||
130162437|NCT04305587|468554888|FG003|Overall Study|Withdrawal by Subject|1|||
130162438|NCT04305587|468554889|FG004|Overall Study|Withdrawal by Subject|0|||
130162439|NCT04305587|468554890|FG005|Overall Study|Withdrawal by Subject|0|||
130162440|NCT04305587|468554891|FG006|Overall Study|Withdrawal by Subject|0|||
130162441|NCT04305587|468554892|FG007|Overall Study|Withdrawal by Subject|0|||
130162442|NCT04305587|468554893|FG008|Overall Study|Withdrawal by Subject|0|||
130162443|NCT01367665|468554894|FG000|Overall Study|Death|102|||
130162444|NCT01367665|468554895|FG001|Overall Study|Death|19|||
130162445|NCT01367665|468554894|FG000|Overall Study|Lost to Follow-up|222|||
129981305|NCT02626455|467893452|FG004|Overall Study|AE not associated with clinical disease progression|1|||
129981306|NCT02626455|467893453|FG005|Overall Study|AE not associated with clinical disease progression|65|||
129981307|NCT02626455|467893454|FG006|Overall Study|AE not associated with clinical disease progression|21|||
129981308|NCT02626455|467893448|FG000|Overall Study|AE associated with clinical disease progression|0|||
129981309|NCT02626455|467893449|FG001|Overall Study|AE associated with clinical disease progression|0|||
129981310|NCT02626455|467893450|FG002|Overall Study|AE associated with clinical disease progression|0|||
129981311|NCT02626455|467893451|FG003|Overall Study|AE associated with clinical disease progression|0|||
129981312|NCT02626455|467893452|FG004|Overall Study|AE associated with clinical disease progression|0|||
130162446|NCT01367665|468554895|FG001|Overall Study|Lost to Follow-up|22|||
130162447|NCT01367665|468554894|FG000|Overall Study|Not Done|118|||
130162448|NCT01367665|468554895|FG001|Overall Study|Not Done|14|||
130162449|NCT02752906|468554896|FG000|Overall Study|Protocol Violation|2|||
130162450|NCT02752906|468554897|FG001|Overall Study|Protocol Violation|1|||
130162451|NCT02752906|468554896|FG000|Overall Study|Withdrawal by Subject|2|||
130162452|NCT02752906|468554897|FG001|Overall Study|Withdrawal by Subject|2|||
130162453|NCT02752906|468554896|FG000|Overall Study|Lost to Follow-up|3|||
130162454|NCT02752906|468554897|FG001|Overall Study|Lost to Follow-up|2|||
129981313|NCT02626455|467893453|FG005|Overall Study|AE associated with clinical disease progression|1|||
129981314|NCT02626455|467893454|FG006|Overall Study|AE associated with clinical disease progression|2|||
129981315|NCT02626455|467893448|FG000|Overall Study|Study intervention never administered|0|||
129981316|NCT02626455|467893449|FG001|Overall Study|Study intervention never administered|0|||
129981317|NCT02626455|467893450|FG002|Overall Study|Study intervention never administered|0|||
129981318|NCT02626455|467893451|FG003|Overall Study|Study intervention never administered|0|||
129981319|NCT02626455|467893452|FG004|Overall Study|Study intervention never administered|0|||
129981320|NCT02626455|467893453|FG005|Overall Study|Study intervention never administered|1|||
129981321|NCT02626455|467893454|FG006|Overall Study|Study intervention never administered|3|||
129981322|NCT03843554|467894942|FG000|Overall Study|Physician Decision|0|||
129981323|NCT03843554|467894943|FG001|Overall Study|Physician Decision|2|||
129981324|NCT04396366|467894948|FG000|Overall Study|Adverse Event|1|||
129981325|NCT04396366|467894949|FG001|Overall Study|Adverse Event|0|||
129981326|NCT00166712|467894951|FG000|Overall Study|Death|0|||
129981327|NCT00166712|467894952|FG001|Overall Study|Death|1|||
129981328|NCT00166712|467894951|FG000|Overall Study|Adverse Event|1|||
129981329|NCT00166712|467894952|FG001|Overall Study|Adverse Event|0|||
129981330|NCT00166712|467894951|FG000|Overall Study|Withdrawal by Subject|1|||
129981331|NCT00166712|467894952|FG001|Overall Study|Withdrawal by Subject|2|||
129981332|NCT00166712|467894951|FG000|Overall Study|Physician Decision|0|||
129981333|NCT00166712|467894952|FG001|Overall Study|Physician Decision|2|||
129981334|NCT03986944|467894953|FG000|Overall Study|Adverse Event|1|||
129981335|NCT03986944|467894954|FG001|Overall Study|Adverse Event|2|||
129981336|NCT03986944|467894955|FG002|Overall Study|Adverse Event|3|||
129981337|NCT03986944|467894953|FG000|Overall Study|Protocol Violation|0|||
129981338|NCT03986944|467894954|FG001|Overall Study|Protocol Violation|1|||
129981339|NCT03986944|467894955|FG002|Overall Study|Protocol Violation|1|||
129981340|NCT03986944|467894953|FG000|Overall Study|Withdrawal by Subject|3|||
129981341|NCT03986944|467894954|FG001|Overall Study|Withdrawal by Subject|5|||
129981342|NCT03986944|467894955|FG002|Overall Study|Withdrawal by Subject|5|||
129981343|NCT03986944|467894953|FG000|Overall Study|Study termination|10|||
129981344|NCT03986944|467894954|FG001|Overall Study|Study termination|10|||
129981345|NCT03986944|467894955|FG002|Overall Study|Study termination|10|||
129981346|NCT03986944|467894953|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
129981347|NCT03986944|467894954|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
129981348|NCT03986944|467894955|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
129981349|NCT03986944|467894953|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
129981350|NCT03986944|467894954|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
130162455|NCT02771795|468554899|FG000|Overall Study|Withdrawal by Subject|47|||
130162456|NCT02771795|468554900|FG001|Overall Study|Withdrawal by Subject|37|||
130162457|NCT02771795|468554899|FG000|Overall Study|Termination by premature discontinuation of study|168|||
130162458|NCT02771795|468554900|FG001|Overall Study|Termination by premature discontinuation of study|185|||
130162459|NCT04112173|468554901|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
130162460|NCT02906930|468554902|FG000|Overall Study|Withdrawal by Subject|0|||
130162461|NCT02906930|468554903|FG001|Overall Study|Withdrawal by Subject|5|||
130162462|NCT02906930|468554904|FG002|Overall Study|Withdrawal by Subject|5|||
130162463|NCT02906930|468554905|FG003|Overall Study|Withdrawal by Subject|4|||
130162464|NCT02906930|468554902|FG000|Overall Study|Lost to Follow-up|5|||
130162465|NCT02906930|468554903|FG001|Overall Study|Lost to Follow-up|7|||
130162466|NCT02906930|468554904|FG002|Overall Study|Lost to Follow-up|5|||
130162467|NCT02906930|468554905|FG003|Overall Study|Lost to Follow-up|2|||
130162468|NCT02906930|468554902|FG000|Overall Study|Death|0|||
130162469|NCT02906930|468554903|FG001|Overall Study|Death|0|||
130162470|NCT02906930|468554904|FG002|Overall Study|Death|1|||
130162471|NCT02906930|468554905|FG003|Overall Study|Death|0|||
130162472|NCT02906930|468554902|FG000|Overall Study|Other|1|||
130162473|NCT02906930|468554903|FG001|Overall Study|Other|2|||
130162474|NCT02906930|468554904|FG002|Overall Study|Other|1|||
130162475|NCT02906930|468554905|FG003|Overall Study|Other|2|||
130162476|NCT02570113|468554908|FG000|Overall Study|Withdrawal by Subject|3|||
130162477|NCT02564211|468554909|FG000|Overall Study|Adverse Event|4|||
130162478|NCT00910091|468554910|FG000|Pre-assignment|Withdrawal by Subject|0|||
130162479|NCT00910091|468554911|FG001|Pre-assignment|Withdrawal by Subject|2|||
130162480|NCT00910091|468554910|FG000|Treatment and Survival|Withdrawal by Subject|3|||
130162481|NCT00910091|468554911|FG001|Treatment and Survival|Withdrawal by Subject|4|||
130162482|NCT00910091|468554910|FG000|Treatment and Survival|Adverse Event|1|||
130162483|NCT00910091|468554911|FG001|Treatment and Survival|Adverse Event|0|||
130162484|NCT00622466|468554912|FG000|Overall Study|Death|1|||
130162485|NCT00622466|468554912|FG000|Overall Study|Adverse Event|1|||
130162486|NCT00622466|468554912|FG000|Overall Study|Withdrawal by Subject|2|||
130162487|NCT01908816|468554913|FG000|Overall Study|Subject's no longer requires study drug|0|||
130162488|NCT01908816|468554914|FG001|Overall Study|Subject's no longer requires study drug|0|||
130162489|NCT01908816|468554915|FG002|Overall Study|Subject's no longer requires study drug|0|||
130162490|NCT01908816|468554916|FG003|Overall Study|Subject's no longer requires study drug|1|||
130162491|NCT01908816|468554913|FG000|Overall Study|Protocol deviation|1|||
130162492|NCT01908816|468554914|FG001|Overall Study|Protocol deviation|2|||
130162493|NCT01908816|468554915|FG002|Overall Study|Protocol deviation|1|||
130162494|NCT01908816|468554916|FG003|Overall Study|Protocol deviation|1|||
130162495|NCT01908816|468554913|FG000|Overall Study|Withdrawal by Subject|0|||
130162496|NCT01908816|468554914|FG001|Overall Study|Withdrawal by Subject|4|||
130162497|NCT01908816|468554915|FG002|Overall Study|Withdrawal by Subject|2|||
130162498|NCT01908816|468554916|FG003|Overall Study|Withdrawal by Subject|2|||
130162499|NCT01908816|468554913|FG000|Overall Study|Lost to Follow-up|3|||
130162500|NCT01908816|468554914|FG001|Overall Study|Lost to Follow-up|5|||
130162501|NCT01908816|468554915|FG002|Overall Study|Lost to Follow-up|4|||
130162502|NCT01908816|468554916|FG003|Overall Study|Lost to Follow-up|2|||
130162503|NCT01908816|468554913|FG000|Overall Study|Death|1|||
130162504|NCT01908816|468554914|FG001|Overall Study|Death|0|||
130162505|NCT01908816|468554915|FG002|Overall Study|Death|7|||
130162506|NCT01908816|468554916|FG003|Overall Study|Death|1|||
130162507|NCT01908816|468554913|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
130162508|NCT01908816|468554914|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
130162509|NCT01908816|468554915|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
130162510|NCT01908816|468554916|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
130162511|NCT01908816|468554913|FG000|Overall Study|Early termination|87|||
130162512|NCT01908816|468554914|FG001|Overall Study|Early termination|60|||
130162513|NCT01908816|468554915|FG002|Overall Study|Early termination|43|||
130162514|NCT01908816|468554916|FG003|Overall Study|Early termination|28|||
130162515|NCT01155024|468554917|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
130162516|NCT01155024|468554918|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
130162517|NCT01155024|468554917|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
130162518|NCT01155024|468554918|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
130162519|NCT01155024|468554917|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
130162520|NCT01155024|468554918|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
130162521|NCT04585789|468554919|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
130162522|NCT04585789|468554920|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
130162523|NCT04585789|468554921|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
130162524|NCT04585789|468554919|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
130162525|NCT04585789|468554920|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
130162526|NCT04585789|468554921|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
130162527|NCT01383135|468554928|FG000|Overall Study|Not Scanned / Imaged|1|||
130162528|NCT01383135|468554929|FG001|Overall Study|Not Scanned / Imaged|0|||
130162529|NCT01383135|468554930|FG002|Overall Study|Not Scanned / Imaged|1|||
130162530|NCT01383135|468554931|FG003|Overall Study|Not Scanned / Imaged|0|||
130162531|NCT01154816|468554933|FG000|Overall Study|Withdrawal by Subject|1|||
130162532|NCT01154816|468554934|FG001|Overall Study|Withdrawal by Subject|0|||
130162533|NCT01154816|468554935|FG002|Overall Study|Withdrawal by Subject|0|||
130162534|NCT01154816|468554936|FG003|Overall Study|Withdrawal by Subject|1|||
130162535|NCT01154816|468554937|FG004|Overall Study|Withdrawal by Subject|0|||
130162536|NCT01154816|468554938|FG005|Overall Study|Withdrawal by Subject|0|||
130162537|NCT01154816|468554939|FG006|Overall Study|Withdrawal by Subject|0|||
130162538|NCT01154816|468554940|FG007|Overall Study|Withdrawal by Subject|0|||
130162539|NCT01154816|468554941|FG008|Overall Study|Withdrawal by Subject|1|||
130162540|NCT01154816|468554942|FG009|Overall Study|Withdrawal by Subject|3|||
130162541|NCT01154816|468554943|FG010|Overall Study|Withdrawal by Subject|0|||
130162542|NCT01154816|468554944|FG011|Overall Study|Withdrawal by Subject|0|||
130162543|NCT01154816|468554933|FG000|Overall Study|Progressive Disease|13|||
130162544|NCT01154816|468554934|FG001|Overall Study|Progressive Disease|8|||
130162545|NCT01154816|468554935|FG002|Overall Study|Progressive Disease|9|||
130162546|NCT01154816|468554936|FG003|Overall Study|Progressive Disease|9|||
130162547|NCT01154816|468554937|FG004|Overall Study|Progressive Disease|8|||
130162548|NCT01154816|468554938|FG005|Overall Study|Progressive Disease|8|||
130162549|NCT01154816|468554939|FG006|Overall Study|Progressive Disease|5|||
130162550|NCT01154816|468554940|FG007|Overall Study|Progressive Disease|6|||
130162551|NCT01154816|468554941|FG008|Overall Study|Progressive Disease|8|||
130162552|NCT01154816|468554942|FG009|Overall Study|Progressive Disease|6|||
130162553|NCT01154816|468554943|FG010|Overall Study|Progressive Disease|10|||
130162554|NCT01154816|468554944|FG011|Overall Study|Progressive Disease|3|||
130162555|NCT01154816|468554933|FG000|Overall Study|Physician Decision|1|||
130162556|NCT01154816|468554934|FG001|Overall Study|Physician Decision|0|||
130162557|NCT01154816|468554935|FG002|Overall Study|Physician Decision|1|||
130162558|NCT01154816|468554936|FG003|Overall Study|Physician Decision|0|||
130162559|NCT01154816|468554937|FG004|Overall Study|Physician Decision|2|||
130162560|NCT01154816|468554938|FG005|Overall Study|Physician Decision|0|||
130162561|NCT01154816|468554939|FG006|Overall Study|Physician Decision|0|||
130162562|NCT01154816|468554940|FG007|Overall Study|Physician Decision|0|||
130162563|NCT01154816|468554941|FG008|Overall Study|Physician Decision|0|||
130162564|NCT01154816|468554942|FG009|Overall Study|Physician Decision|1|||
130162565|NCT01154816|468554943|FG010|Overall Study|Physician Decision|1|||
130162566|NCT01154816|468554944|FG011|Overall Study|Physician Decision|1|||
130162567|NCT01154816|468554933|FG000|Overall Study|Adverse Event|5|||
130162568|NCT01154816|468554934|FG001|Overall Study|Adverse Event|2|||
130162569|NCT01154816|468554935|FG002|Overall Study|Adverse Event|0|||
130162570|NCT01154816|468554936|FG003|Overall Study|Adverse Event|0|||
130162571|NCT01154816|468554937|FG004|Overall Study|Adverse Event|0|||
130162572|NCT01154816|468554938|FG005|Overall Study|Adverse Event|0|||
130162573|NCT01154816|468554939|FG006|Overall Study|Adverse Event|1|||
130162574|NCT01154816|468554940|FG007|Overall Study|Adverse Event|1|||
130162575|NCT01154816|468554941|FG008|Overall Study|Adverse Event|0|||
130162576|NCT01154816|468554942|FG009|Overall Study|Adverse Event|0|||
130162577|NCT01154816|468554943|FG010|Overall Study|Adverse Event|0|||
130162578|NCT01154816|468554944|FG011|Overall Study|Adverse Event|0|||
130162579|NCT03397771|468554945|FG000|Overall Study|2 erroneously randomized, never treated|3|||
130162580|NCT03397771|468554946|FG001|Overall Study|2 erroneously randomized, never treated|1|||
130162581|NCT03397771|468554945|FG000|Overall Study|Withdrawal by Subject|1|||
130162582|NCT03397771|468554946|FG001|Overall Study|Withdrawal by Subject|3|||
130162583|NCT03397771|468554945|FG000|Overall Study|Protocol Violation|2|||
130162584|NCT03397771|468554946|FG001|Overall Study|Protocol Violation|2|||
130162585|NCT03397771|468554945|FG000|Overall Study|Adverse Event|2|||
130162586|NCT03397771|468554946|FG001|Overall Study|Adverse Event|1|||
130162587|NCT04078126|468554947|FG000|Washout|Study put on hold due to COVID-19|0|||
130162588|NCT04078126|468554948|FG001|Washout|Study put on hold due to COVID-19|2|||
130162589|NCT04078126|468554947|FG000|Period 2|Study put on hold due to COVID-19|1|||
130162590|NCT04078126|468554948|FG001|Period 2|Study put on hold due to COVID-19|1|||
130162591|NCT02669758|468554951|FG000|Overall Study|Withdrawal by Subject|43|||
130162592|NCT02669758|468554951|FG000|Overall Study|Lost to Follow-up|19|||
130162593|NCT02669758|468554951|FG000|Overall Study|Adverse Event|16|||
130162594|NCT02669758|468554951|FG000|Overall Study|Non-Compliance with Study Drug|8|||
130162595|NCT02669758|468554951|FG000|Overall Study|Lack of Efficacy|5|||
130162596|NCT02669758|468554951|FG000|Overall Study|Pregnancy|1|||
130162597|NCT02669758|468554951|FG000|Overall Study|Study noncompliance|1|||
130162598|NCT02669758|468554951|FG000|Overall Study|Protocol Violation|1|||
130162599|NCT02605993|468554954|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130162600|NCT02605993|468554955|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130162601|NCT02605993|468554956|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
130162602|NCT02605993|468554957|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
130162603|NCT02603393|468554958|FG000|Overall Study|Patient/guardian decision|32|||
130162604|NCT02603393|468554959|FG001|Overall Study|Patient/guardian decision|18|||
130162605|NCT02603393|468554958|FG000|Overall Study|Adverse Event|17|||
130162606|NCT02603393|468554959|FG001|Overall Study|Adverse Event|15|||
130162607|NCT02603393|468554958|FG000|Overall Study|Technical problems|4|||
130162608|NCT02603393|468554959|FG001|Overall Study|Technical problems|7|||
130162609|NCT02603393|468554958|FG000|Overall Study|Lack of Efficacy|7|||
130162610|NCT02603393|468554959|FG001|Overall Study|Lack of Efficacy|2|||
130162611|NCT02603393|468554958|FG000|Overall Study|Death|3|||
130162612|NCT02603393|468554959|FG001|Overall Study|Death|4|||
130162613|NCT02603393|468554958|FG000|Overall Study|Physician Decision|3|||
130162614|NCT02603393|468554959|FG001|Overall Study|Physician Decision|3|||
130162615|NCT02603393|468554958|FG000|Overall Study|Protocol deviation|2|||
130162616|NCT02603393|468554959|FG001|Overall Study|Protocol deviation|3|||
130162617|NCT02603393|468554958|FG000|Overall Study|Lost to Follow-up|1|||
130162618|NCT02603393|468554959|FG001|Overall Study|Lost to Follow-up|2|||
130162619|NCT02603393|468554958|FG000|Overall Study|Non-compliance with study treatment|1|||
130162620|NCT02603393|468554959|FG001|Overall Study|Non-compliance with study treatment|0|||
129981351|NCT03986944|467894955|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
129981352|NCT01015560|467894957|FG000|Overall Study|Adverse Event|1|||
129981353|NCT01015560|467894957|FG000|Overall Study|Not protocol specified|1|||
129981354|NCT01015560|467894957|FG000|Overall Study|Withdrawal by Subject|1|||
129981355|NCT00640133|467894958|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
130162621|NCT02603393|468554958|FG000|Overall Study|Sponsor decision|1|||
130162622|NCT02603393|468554959|FG001|Overall Study|Sponsor decision|0|||
130162623|NCT01868893|468554962|FG000|Overall Study|Adverse Event|2|||
130162624|NCT01868893|468554962|FG000|Overall Study|Commercial availability of study drug|17|||
130162625|NCT01868893|468554962|FG000|Overall Study|Neutropenia|1|||
130162626|NCT01783548|468554963|FG000|Overall Study|Adverse Event|8|||
130162627|NCT01783548|468554964|FG001|Overall Study|Adverse Event|4|||
130162628|NCT01783548|468554963|FG000|Overall Study|Withdrawal by Subject|11|||
130162629|NCT01783548|468554964|FG001|Overall Study|Withdrawal by Subject|8|||
130162630|NCT01783548|468554963|FG000|Overall Study|Non-compliance|4|||
130162631|NCT01783548|468554964|FG001|Overall Study|Non-compliance|0|||
130162632|NCT01783548|468554963|FG000|Overall Study|Protocol Violation|2|||
130162633|NCT01783548|468554964|FG001|Overall Study|Protocol Violation|2|||
130162634|NCT01783548|468554963|FG000|Overall Study|Lost to Follow-up|8|||
130162635|NCT01783548|468554964|FG001|Overall Study|Lost to Follow-up|3|||
130162636|NCT01783548|468554963|FG000|Overall Study|Lack of Efficacy|1|||
130162637|NCT01783548|468554964|FG001|Overall Study|Lack of Efficacy|1|||
130162638|NCT00988442|468554965|FG000|Overall Study|Death|1|||
130162639|NCT00988442|468554966|FG001|Overall Study|Death|2|||
130162640|NCT00988442|468554965|FG000|Overall Study|Lost to Follow-up|0|||
130162641|NCT00988442|468554966|FG001|Overall Study|Lost to Follow-up|1|||
130162642|NCT00988442|468554965|FG000|Overall Study|Early Study Closure|29|||
130162643|NCT00988442|468554966|FG001|Overall Study|Early Study Closure|25|||
130162644|NCT01212588|468554970|FG000|Overall Study|Physician Decision|0|||
130162645|NCT01212588|468554971|FG001|Overall Study|Physician Decision|1|||
130162646|NCT01212588|468554970|FG000|Overall Study|Protocol Violation|1|||
130162647|NCT01212588|468554971|FG001|Overall Study|Protocol Violation|1|||
130162648|NCT01735955|468554972|FG000|Overall Study|Administrative problems|1|||
130162649|NCT01735955|468554972|FG000|Overall Study|Patient/guardian decision|1|||
130162650|NCT01735955|468554972|FG000|Overall Study|Patient withdrew consent|2|||
130162651|NCT01735955|468554972|FG000|Overall Study|Physician Decision|4|||
130162652|NCT01735955|468554972|FG000|Overall Study|Disease progression|24|||
130162653|NCT01735955|468554972|FG000|Overall Study|Adverse Event|5|||
130162654|NCT03317834|468554975|FG000|Overall Study|Death|2|||
130162655|NCT03317834|468554975|FG000|Overall Study|Device Revision|5|||
130162656|NCT03317834|468554975|FG000|Overall Study|Withdrawal by Subject|13|||
130162657|NCT03317834|468554975|FG000|Overall Study|Lost to Follow-up|13|||
130162658|NCT00123474|468554981|FG000|Randomized to Treatment|Randomized, never treated|1|||
130162659|NCT00123474|468554982|FG001|Randomized to Treatment|Randomized, never treated|4|||
130162660|NCT00123474|468554983|FG002|Randomized to Treatment|Randomized, never treated|2|||
130162661|NCT00123474|468554984|FG003|Randomized to Treatment|Randomized, never treated|1|||
130162662|NCT00123474|468554981|FG000|As Treated at Study Closure|not reported when site closed|1|||
130162663|NCT00123474|468554982|FG001|As Treated at Study Closure|not reported when site closed|0|||
130162664|NCT00123474|468554983|FG002|As Treated at Study Closure|not reported when site closed|1|||
130162665|NCT00123474|468554984|FG003|As Treated at Study Closure|not reported when site closed|0|||
130162666|NCT00123474|468554981|FG000|As Treated at Study Closure|Adverse Event|10|||
130162667|NCT00123474|468554982|FG001|As Treated at Study Closure|Adverse Event|4|||
130162668|NCT00123474|468554983|FG002|As Treated at Study Closure|Adverse Event|10|||
130162669|NCT00123474|468554984|FG003|As Treated at Study Closure|Adverse Event|8|||
130162670|NCT00123474|468554981|FG000|As Treated at Study Closure|Disease Progression|35|||
130162671|NCT00123474|468554982|FG001|As Treated at Study Closure|Disease Progression|42|||
130162672|NCT00123474|468554983|FG002|As Treated at Study Closure|Disease Progression|29|||
130162673|NCT00123474|468554984|FG003|As Treated at Study Closure|Disease Progression|27|||
130162674|NCT00123474|468554981|FG000|As Treated at Study Closure|Investigator Request|12|||
130162675|NCT00123474|468554982|FG001|As Treated at Study Closure|Investigator Request|6|||
130162676|NCT00123474|468554983|FG002|As Treated at Study Closure|Investigator Request|7|||
130162677|NCT00123474|468554984|FG003|As Treated at Study Closure|Investigator Request|5|||
130162678|NCT00123474|468554981|FG000|As Treated at Study Closure|non-specified|54|||
130162679|NCT00123474|468554982|FG001|As Treated at Study Closure|non-specified|47|||
130162680|NCT00123474|468554983|FG002|As Treated at Study Closure|non-specified|57|||
130162681|NCT00123474|468554984|FG003|As Treated at Study Closure|non-specified|60|||
130162682|NCT00123474|468554981|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
130162683|NCT00123474|468554982|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
130162684|NCT00123474|468554983|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
130162685|NCT00123474|468554984|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
130162686|NCT00123474|468554981|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
130162687|NCT00123474|468554982|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
130162688|NCT00123474|468554983|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
130162689|NCT00123474|468554984|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
130162690|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
130162691|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
130162692|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
130162693|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
130162694|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
129981356|NCT00640133|467894959|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
129981357|NCT00640133|467894958|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
129981358|NCT00640133|467894959|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
129981359|NCT00640133|467894958|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
130162695|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
130162696|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
130162697|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
130162698|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
129981360|NCT00640133|467894959|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
130162699|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162700|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
130162701|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162702|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162703|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162704|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162705|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162706|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162707|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
130162708|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162709|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
130162710|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162711|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
130162712|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129981361|NCT00128102|467894962|FG000|Overall Study|Site Discontinued|3|||
129981362|NCT00128102|467894963|FG001|Overall Study|Site Discontinued|6|||
129981363|NCT00128102|467894962|FG000|Overall Study|Other|0|||
129981364|NCT00128102|467894963|FG001|Overall Study|Other|1|||
129981365|NCT00128102|467894962|FG000|Overall Study|Progressive Disease|255|||
129981366|NCT00128102|467894963|FG001|Overall Study|Progressive Disease|285|||
129981367|NCT00128102|467894962|FG000|Overall Study|Adverse Event|34|||
129981368|NCT00128102|467894963|FG001|Overall Study|Adverse Event|11|||
129981369|NCT00128102|467894962|FG000|Overall Study|Death|12|||
129981370|NCT00128102|467894963|FG001|Overall Study|Death|13|||
129981371|NCT00128102|467894962|FG000|Overall Study|Physician Decision|3|||
129981372|NCT00128102|467894963|FG001|Overall Study|Physician Decision|3|||
129981373|NCT00128102|467894962|FG000|Overall Study|Withdrawal by Subject|19|||
129981374|NCT00128102|467894963|FG001|Overall Study|Withdrawal by Subject|11|||
129981375|NCT00128102|467894962|FG000|Overall Study|Protocol Violation|2|||
129981376|NCT00128102|467894963|FG001|Overall Study|Protocol Violation|2|||
129981377|NCT01202903|467894965|FG000|Overall Study|Administrative Probelms|1|||
129981378|NCT01202903|467894966|FG001|Overall Study|Administrative Probelms|4|||
129981379|NCT01202903|467894965|FG000|Overall Study|Protocol Violation|0|||
129981380|NCT01202903|467894966|FG001|Overall Study|Protocol Violation|1|||
129981381|NCT01202903|467894965|FG000|Overall Study|Death|1|||
129981382|NCT01202903|467894966|FG001|Overall Study|Death|0|||
129981383|NCT01202903|467894965|FG000|Overall Study|Lost to Follow-up|1|||
129981384|NCT01202903|467894966|FG001|Overall Study|Lost to Follow-up|1|||
129981385|NCT01202903|467894965|FG000|Overall Study|Lack of Efficacy|1|||
129981386|NCT01202903|467894966|FG001|Overall Study|Lack of Efficacy|3|||
129981387|NCT01202903|467894965|FG000|Overall Study|Adverse Event|3|||
129981388|NCT01202903|467894966|FG001|Overall Study|Adverse Event|3|||
129981389|NCT01202903|467894965|FG000|Overall Study|Withdrawal by Subject|4|||
129981390|NCT01202903|467894966|FG001|Overall Study|Withdrawal by Subject|4|||
129981391|NCT01302080|467894967|FG000|Overall Study|Withdrew Consent|92|||
129981392|NCT01302080|467894968|FG001|Overall Study|Withdrew Consent|39|||
129981393|NCT01302080|467894967|FG000|Overall Study|Patient/Family Moved|28|||
129981394|NCT01302080|467894968|FG001|Overall Study|Patient/Family Moved|3|||
129981395|NCT01302080|467894967|FG000|Overall Study|Lost to Follow-up|192|||
129981396|NCT01302080|467894968|FG001|Overall Study|Lost to Follow-up|93|||
129981397|NCT01302080|467894967|FG000|Overall Study|Death|1|||
129981398|NCT01302080|467894968|FG001|Overall Study|Death|0|||
129981399|NCT01302080|467894967|FG000|Overall Study|Other|52|||
129981400|NCT01302080|467894968|FG001|Overall Study|Other|8|||
129981401|NCT01302080|467894967|FG000|Overall Study|Reason Missing For Discontinuation|1|||
129981402|NCT01302080|467894968|FG001|Overall Study|Reason Missing For Discontinuation|0|||
129981403|NCT03339245|467894971|FG000|Overall Study|Adverse Event|1|||
129981404|NCT03339245|467894972|FG001|Overall Study|Adverse Event|1|||
129981405|NCT03339245|467894971|FG000|Overall Study|Withdrawal by Subject|1|||
129981406|NCT03339245|467894972|FG001|Overall Study|Withdrawal by Subject|0|||
129981407|NCT00837694|467894973|FG000|Overall Study|Lost to Follow-up|2|||
129981408|NCT00837694|467894974|FG001|Overall Study|Lost to Follow-up|0|||
129981409|NCT00837694|467894975|FG002|Overall Study|Lost to Follow-up|2|||
129981410|NCT00837694|467894976|FG003|Overall Study|Lost to Follow-up|1|||
129981411|NCT00837694|467894977|FG004|Overall Study|Lost to Follow-up|1|||
129981412|NCT00837694|467894978|FG005|Overall Study|Lost to Follow-up|1|||
129981413|NCT00306670|467894985|FG000|Overall Study|patients recruited; Genentech, the st|0|||
129981414|NCT00306670|467894986|FG001|Overall Study|patients recruited; Genentech, the st|2|||
129981415|NCT00503139|467894987|FG000|Overall Study|Case Report Forms were not collected|4|||
129981416|NCT00503139|467894987|FG000|Overall Study|Protocol Violation|4|||
129981417|NCT02735577|467894991|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
129981418|NCT02735577|467894991|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
129981419|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981420|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981421|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
129981422|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
129981423|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981424|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981425|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
130162713|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162714|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162715|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162716|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162717|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162718|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
130162719|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162720|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
130162721|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162722|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162723|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162724|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162725|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
130162726|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
130162727|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
130162728|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
130162729|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162730|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
130162731|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162732|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162733|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162734|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162735|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162736|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
130162737|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162738|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162739|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162740|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162741|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162742|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162743|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
130162744|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162745|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162746|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162747|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
130162748|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162749|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162750|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162751|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162752|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162753|NCT03893565|468554989|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130162754|NCT03893565|468554990|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
130162755|NCT03893565|468554991|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
130162756|NCT03893565|468554992|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
130162757|NCT03893565|468554993|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130162758|NCT03893565|468554994|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130162759|NCT03893565|468554995|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130162760|NCT03893565|468554996|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130162761|NCT03893565|468554997|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
130162762|NCT03893565|468554989|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
130162763|NCT03893565|468554990|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
130162764|NCT03893565|468554991|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
130162765|NCT03893565|468554992|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
130162766|NCT03893565|468554993|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
130162767|NCT03893565|468554994|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
130162768|NCT03893565|468554995|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
130162769|NCT03893565|468554996|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
130162770|NCT03893565|468554997|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
130162771|NCT03893565|468554989|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162772|NCT03893565|468554990|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162773|NCT03893565|468554991|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129981426|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
130162774|NCT03893565|468554992|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162775|NCT03893565|468554993|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162776|NCT03893565|468554994|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162777|NCT03893565|468554995|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
130162778|NCT03893565|468554996|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162779|NCT03893565|468554997|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
130162780|NCT03893565|468554989|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162781|NCT03893565|468554990|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162782|NCT03893565|468554991|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162783|NCT03893565|468554992|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162784|NCT03893565|468554993|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162785|NCT03893565|468554994|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
130162786|NCT03893565|468554995|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
130162787|NCT03893565|468554996|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162788|NCT03893565|468554997|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
130162789|NCT03893565|468554989|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
130162790|NCT03893565|468554990|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
130162791|NCT03893565|468554991|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
130162792|NCT03893565|468554992|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
130162793|NCT03893565|468554993|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
130162794|NCT03893565|468554994|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
130162795|NCT03893565|468554995|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
130162796|NCT03893565|468554996|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
130162797|NCT03893565|468554997|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
130162798|NCT03893565|468554989|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162799|NCT03893565|468554990|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162800|NCT03893565|468554991|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162801|NCT03893565|468554992|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162802|NCT03893565|468554993|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162803|NCT03893565|468554994|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162804|NCT03893565|468554995|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162805|NCT03893565|468554996|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
130162806|NCT03893565|468554997|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
130162807|NCT03893565|468554989|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162808|NCT03893565|468554990|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162809|NCT03893565|468554991|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162810|NCT03893565|468554992|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162811|NCT03893565|468554993|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162812|NCT03893565|468554994|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162813|NCT03893565|468554995|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162814|NCT03893565|468554996|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
130162815|NCT03893565|468554997|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
130162816|NCT03893565|468554989|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162817|NCT03893565|468554990|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162818|NCT03893565|468554991|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162819|NCT03893565|468554992|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162820|NCT03893565|468554993|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162821|NCT03893565|468554994|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162822|NCT03893565|468554995|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162823|NCT03893565|468554996|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
130162824|NCT03893565|468554997|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
130162825|NCT03893565|468554989|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162826|NCT03893565|468554990|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162827|NCT03893565|468554991|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162828|NCT03893565|468554992|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162829|NCT03893565|468554993|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162830|NCT03893565|468554994|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162831|NCT03893565|468554995|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162832|NCT03893565|468554996|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
130162833|NCT03893565|468554997|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
130162834|NCT02387983|468555001|FG000|Overall Study|Adverse Event|4|||
130162835|NCT02387983|468555001|FG000|Overall Study|Protocol Violation|1|||
130162836|NCT02387983|468555001|FG000|Overall Study|Withdrawal by Subject|2|||
130162837|NCT02440568|468555002|FG000|Overall Study|Death|1|||
130162838|NCT02440568|468555003|FG001|Overall Study|Death|3|||
130162839|NCT02440568|468555004|FG002|Overall Study|Death|4|||
130162840|NCT02440568|468555005|FG003|Overall Study|Death|2|||
130162841|NCT02440568|468555002|FG000|Overall Study|Lack of Efficacy|2|||
130162842|NCT02440568|468555003|FG001|Overall Study|Lack of Efficacy|0|||
130162843|NCT02440568|468555004|FG002|Overall Study|Lack of Efficacy|1|||
130162844|NCT02440568|468555005|FG003|Overall Study|Lack of Efficacy|0|||
130162845|NCT02440568|468555002|FG000|Overall Study|Lost to Follow-up|1|||
130162846|NCT02440568|468555003|FG001|Overall Study|Lost to Follow-up|0|||
130162847|NCT02440568|468555004|FG002|Overall Study|Lost to Follow-up|0|||
130162848|NCT02440568|468555005|FG003|Overall Study|Lost to Follow-up|0|||
130162849|NCT02302859|468555008|FG000|Overall Study|Lost Phone|1|||
130162850|NCT02302859|468555009|FG001|Overall Study|Lost Phone|1|||
130162851|NCT02302859|468555008|FG000|Overall Study|Withdrawal by Subject|0|||
130162852|NCT02302859|468555009|FG001|Overall Study|Withdrawal by Subject|1|||
130162853|NCT03285308|468555010|FG000|Overall Study|Adverse Event|3|||
130162854|NCT03285308|468555011|FG001|Overall Study|Adverse Event|7|||
130162855|NCT03285308|468555010|FG000|Overall Study|Withdrawal by Subject|8|||
130162856|NCT03285308|468555011|FG001|Overall Study|Withdrawal by Subject|9|||
130162857|NCT03285308|468555010|FG000|Overall Study|Lost to Follow-up|3|||
130162858|NCT03285308|468555011|FG001|Overall Study|Lost to Follow-up|1|||
130162859|NCT03285308|468555010|FG000|Overall Study|Protocol Deviation|6|||
130162860|NCT03285308|468555011|FG001|Overall Study|Protocol Deviation|5|||
130162861|NCT03285308|468555010|FG000|Overall Study|Reason not Specified|0|||
130162862|NCT03285308|468555011|FG001|Overall Study|Reason not Specified|1|||
130162863|NCT03734666|468555015|FG000|Overall Study|Other|7|||
130162864|NCT03734666|468555016|FG001|Overall Study|Other|4|||
130162865|NCT03734666|468555015|FG000|Overall Study|Lost to Follow-up|12|||
130162866|NCT03734666|468555016|FG001|Overall Study|Lost to Follow-up|12|||
130162867|NCT00681590|468555017|FG000|Overall Study|Withdrawal by Subject|2|||
130162868|NCT00681590|468555018|FG001|Overall Study|Withdrawal by Subject|12|||
130162869|NCT01791153|468555019|FG000|Part 1: Blinded Period|Adverse Event|7|||
130162870|NCT01791153|468555020|FG001|Part 1: Blinded Period|Adverse Event|3|||
130162871|NCT01791153|468555021|FG002|Part 1: Blinded Period|Adverse Event|2|||
130162872|NCT01791153|468555022|FG003|Part 1: Blinded Period|Adverse Event|0|||
130162873|NCT01791153|468555023|FG004|Part 1: Blinded Period|Adverse Event|0|||
130162874|NCT01791153|468555024|FG005|Part 1: Blinded Period|Adverse Event|0|||
130162875|NCT01791153|468555025|FG006|Part 1: Blinded Period|Adverse Event|0|||
130162876|NCT01791153|468555026|FG007|Part 1: Blinded Period|Adverse Event|0|||
130162877|NCT01791153|468555019|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
130162878|NCT01791153|468555020|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
130162879|NCT01791153|468555021|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
130162880|NCT01791153|468555022|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
130162881|NCT01791153|468555023|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
130162882|NCT01791153|468555024|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
130162883|NCT01791153|468555025|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
130162884|NCT01791153|468555026|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
130162885|NCT01791153|468555019|FG000|Part 1: Blinded Period|Non-Compliance|1|||
130162886|NCT01791153|468555020|FG001|Part 1: Blinded Period|Non-Compliance|0|||
130162887|NCT01791153|468555021|FG002|Part 1: Blinded Period|Non-Compliance|0|||
130162888|NCT01791153|468555022|FG003|Part 1: Blinded Period|Non-Compliance|0|||
130162889|NCT01791153|468555023|FG004|Part 1: Blinded Period|Non-Compliance|0|||
130162890|NCT01791153|468555024|FG005|Part 1: Blinded Period|Non-Compliance|0|||
130162891|NCT01791153|468555025|FG006|Part 1: Blinded Period|Non-Compliance|0|||
130162892|NCT01791153|468555026|FG007|Part 1: Blinded Period|Non-Compliance|0|||
130162893|NCT01791153|468555019|FG000|Part 1: Blinded Period|Physician Decision|0|||
130162894|NCT01791153|468555020|FG001|Part 1: Blinded Period|Physician Decision|0|||
130162895|NCT01791153|468555021|FG002|Part 1: Blinded Period|Physician Decision|0|||
130162896|NCT01791153|468555022|FG003|Part 1: Blinded Period|Physician Decision|1|||
130162897|NCT01791153|468555023|FG004|Part 1: Blinded Period|Physician Decision|0|||
130162898|NCT01791153|468555024|FG005|Part 1: Blinded Period|Physician Decision|0|||
130162899|NCT01791153|468555025|FG006|Part 1: Blinded Period|Physician Decision|0|||
130162900|NCT01791153|468555026|FG007|Part 1: Blinded Period|Physician Decision|0|||
130162901|NCT01791153|468555019|FG000|Part 1: Blinded Period|Protocol Violation|0|||
130162902|NCT01791153|468555020|FG001|Part 1: Blinded Period|Protocol Violation|0|||
130162903|NCT01791153|468555021|FG002|Part 1: Blinded Period|Protocol Violation|0|||
130162904|NCT01791153|468555022|FG003|Part 1: Blinded Period|Protocol Violation|1|||
130162905|NCT01791153|468555023|FG004|Part 1: Blinded Period|Protocol Violation|0|||
130162906|NCT01791153|468555024|FG005|Part 1: Blinded Period|Protocol Violation|0|||
130162907|NCT01791153|468555025|FG006|Part 1: Blinded Period|Protocol Violation|0|||
130162908|NCT01791153|468555026|FG007|Part 1: Blinded Period|Protocol Violation|0|||
130162909|NCT01791153|468555019|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
130162910|NCT01791153|468555020|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
130162911|NCT01791153|468555021|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
130162912|NCT01791153|468555022|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
130162913|NCT01791153|468555023|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
130162914|NCT01791153|468555024|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
130162915|NCT01791153|468555025|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
130162916|NCT01791153|468555026|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
130162917|NCT01791153|468555019|FG000|Part 2: Open-label Period|Adverse Event|0|||
130162918|NCT01791153|468555020|FG001|Part 2: Open-label Period|Adverse Event|0|||
130162919|NCT01791153|468555021|FG002|Part 2: Open-label Period|Adverse Event|0|||
130162920|NCT01791153|468555022|FG003|Part 2: Open-label Period|Adverse Event|0|||
130162921|NCT01791153|468555023|FG004|Part 2: Open-label Period|Adverse Event|0|||
130162922|NCT01791153|468555024|FG005|Part 2: Open-label Period|Adverse Event|1|||
130162923|NCT01791153|468555025|FG006|Part 2: Open-label Period|Adverse Event|1|||
130162924|NCT01791153|468555026|FG007|Part 2: Open-label Period|Adverse Event|2|||
130162925|NCT01791153|468555019|FG000|Part 2: Open-label Period|Death|0|||
130162926|NCT01791153|468555020|FG001|Part 2: Open-label Period|Death|0|||
130162927|NCT01791153|468555021|FG002|Part 2: Open-label Period|Death|0|||
130162928|NCT01791153|468555022|FG003|Part 2: Open-label Period|Death|0|||
130162929|NCT01791153|468555023|FG004|Part 2: Open-label Period|Death|0|||
130162930|NCT01791153|468555024|FG005|Part 2: Open-label Period|Death|1|||
130162931|NCT01791153|468555025|FG006|Part 2: Open-label Period|Death|1|||
130162932|NCT01791153|468555026|FG007|Part 2: Open-label Period|Death|1|||
130162933|NCT01791153|468555019|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
130162934|NCT01791153|468555020|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
130162935|NCT01791153|468555021|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
130162936|NCT01791153|468555022|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
130162937|NCT01791153|468555023|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
130162938|NCT01791153|468555024|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
130162939|NCT01791153|468555025|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
130162940|NCT01791153|468555026|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
130162941|NCT01791153|468555019|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
130162942|NCT01791153|468555020|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
130162943|NCT01791153|468555021|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
130162944|NCT01791153|468555022|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
130162945|NCT01791153|468555023|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
130162946|NCT01791153|468555024|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
130162947|NCT01791153|468555025|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
130162948|NCT01791153|468555026|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
130162949|NCT01791153|468555019|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
130162950|NCT01791153|468555020|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
130162951|NCT01791153|468555021|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
130162952|NCT01791153|468555022|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
130162953|NCT01791153|468555023|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
130162954|NCT01791153|468555024|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
130162955|NCT01791153|468555025|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
130162956|NCT01791153|468555026|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
130162957|NCT01791153|468555019|FG000|Part 2: Open-label Period|Physician Decision|0|||
130162958|NCT01791153|468555020|FG001|Part 2: Open-label Period|Physician Decision|0|||
130162959|NCT01791153|468555021|FG002|Part 2: Open-label Period|Physician Decision|0|||
130162960|NCT01791153|468555022|FG003|Part 2: Open-label Period|Physician Decision|0|||
130162961|NCT01791153|468555023|FG004|Part 2: Open-label Period|Physician Decision|1|||
130162962|NCT01791153|468555024|FG005|Part 2: Open-label Period|Physician Decision|1|||
130162963|NCT01791153|468555025|FG006|Part 2: Open-label Period|Physician Decision|0|||
130162964|NCT01791153|468555026|FG007|Part 2: Open-label Period|Physician Decision|0|||
130162965|NCT02357342|468555027|FG000|First 6 Months|Death|2|||
130162966|NCT02357342|468555028|FG001|First 6 Months|Death|0|||
130162967|NCT04156620|468555030|FG000|Overall Study|Adverse event - TP 1|5|||
130162968|NCT04156620|468555031|FG001|Overall Study|Adverse event - TP 1|2|||
130162969|NCT04156620|468555030|FG000|Overall Study|Lost to follow-up TP 1|1|||
130162970|NCT04156620|468555031|FG001|Overall Study|Lost to follow-up TP 1|1|||
129981427|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
130162971|NCT04156620|468555030|FG000|Overall Study|Progressive disease - TP 1|0|||
130162972|NCT04156620|468555031|FG001|Overall Study|Progressive disease - TP 1|1|||
130162973|NCT04156620|468555030|FG000|Overall Study|Subject decision - TP 1|3|||
130162974|NCT04156620|468555031|FG001|Overall Study|Subject decision - TP 1|5|||
130162975|NCT04156620|468555030|FG000|Overall Study|Adverse event - TP 2|5|||
130162976|NCT04156620|468555031|FG001|Overall Study|Adverse event - TP 2|6|||
130162977|NCT04156620|468555030|FG000|Overall Study|Death - TP 2|1|||
130162978|NCT04156620|468555031|FG001|Overall Study|Death - TP 2|0|||
129981428|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
129981429|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
130162979|NCT04156620|468555030|FG000|Overall Study|Lost to follow-up - TP 2|5|||
130162980|NCT04156620|468555031|FG001|Overall Study|Lost to follow-up - TP 2|2|||
130162981|NCT04156620|468555030|FG000|Overall Study|Physician decision - TP 2|4|||
130162982|NCT04156620|468555031|FG001|Overall Study|Physician decision - TP 2|2|||
130162983|NCT04156620|468555030|FG000|Overall Study|Pregnancy - TP 2|1|||
130162984|NCT04156620|468555031|FG001|Overall Study|Pregnancy - TP 2|1|||
130162985|NCT04156620|468555030|FG000|Overall Study|Subject decision - TP 2|11|||
130162986|NCT04156620|468555031|FG001|Overall Study|Subject decision - TP 2|9|||
130162987|NCT04156620|468555030|FG000|Overall Study|New therapy for study indication - TP 2|1|||
130162988|NCT04156620|468555031|FG001|Overall Study|New therapy for study indication - TP 2|0|||
130162989|NCT01753336|468555032|FG000|Overall Study|Patient decision|12|||
130162990|NCT01753336|468555032|FG000|Overall Study|Lost to Follow-up|3|||
130162991|NCT01753336|468555032|FG000|Overall Study|Physician Decision|2|||
130162992|NCT01753336|468555032|FG000|Overall Study|Sponsor's decision|2|||
130162993|NCT01753336|468555032|FG000|Overall Study|Withdrawal by Subject|1|||
130162994|NCT01629966|468555033|FG000|Overall Study|Pregnancy|0|||
130162995|NCT01629966|468555034|FG001|Overall Study|Pregnancy|1|||
130162996|NCT01629966|468555035|FG002|Overall Study|Pregnancy|0|||
130162997|NCT01629966|468555033|FG000|Overall Study|Lost to Follow-up|10|||
130162998|NCT01629966|468555034|FG001|Overall Study|Lost to Follow-up|13|||
130162999|NCT01629966|468555035|FG002|Overall Study|Lost to Follow-up|9|||
130163000|NCT01629966|468555033|FG000|Overall Study|Withdrawal by Subject|8|||
130163001|NCT01629966|468555034|FG001|Overall Study|Withdrawal by Subject|9|||
130163002|NCT01629966|468555035|FG002|Overall Study|Withdrawal by Subject|16|||
130163003|NCT01629966|468555033|FG000|Overall Study|Protocol Violation|7|||
130163004|NCT01629966|468555034|FG001|Overall Study|Protocol Violation|9|||
130163005|NCT01629966|468555035|FG002|Overall Study|Protocol Violation|7|||
130163006|NCT01629966|468555033|FG000|Overall Study|Lack of Efficacy|5|||
130163007|NCT01629966|468555034|FG001|Overall Study|Lack of Efficacy|2|||
130163008|NCT01629966|468555035|FG002|Overall Study|Lack of Efficacy|4|||
130163009|NCT01629966|468555033|FG000|Overall Study|Adverse Event|11|||
130163010|NCT01629966|468555034|FG001|Overall Study|Adverse Event|18|||
130163011|NCT01629966|468555035|FG002|Overall Study|Adverse Event|30|||
130163012|NCT04568031|468555036|FG000|Overall Study|Lost to Follow-up|1|||
130163013|NCT04568031|468555037|FG001|Overall Study|Lost to Follow-up|0|||
130163014|NCT04568031|468555038|FG002|Overall Study|Lost to Follow-up|0|||
130163015|NCT04568031|468555039|FG003|Overall Study|Lost to Follow-up|0|||
130163016|NCT04568031|468555036|FG000|Overall Study|Physician Decision|1|||
130163017|NCT04568031|468555037|FG001|Overall Study|Physician Decision|0|||
130163018|NCT04568031|468555038|FG002|Overall Study|Physician Decision|1|||
130163019|NCT04568031|468555039|FG003|Overall Study|Physician Decision|0|||
130163020|NCT04568031|468555036|FG000|Overall Study|Withdrawal by Subject|1|||
130163021|NCT04568031|468555037|FG001|Overall Study|Withdrawal by Subject|0|||
130163022|NCT04568031|468555038|FG002|Overall Study|Withdrawal by Subject|4|||
130163023|NCT04568031|468555039|FG003|Overall Study|Withdrawal by Subject|1|||
130163024|NCT03753763|468555056|FG000|Overall Study|Adverse Event|2|||
130163025|NCT03753763|468555057|FG001|Overall Study|Adverse Event|0|||
130163026|NCT03753763|468555056|FG000|Overall Study|Withdrawal by Subject|3|||
130163027|NCT03753763|468555057|FG001|Overall Study|Withdrawal by Subject|1|||
130163028|NCT03753763|468555056|FG000|Overall Study|clinical deterioration|1|||
130163029|NCT03753763|468555057|FG001|Overall Study|clinical deterioration|0|||
130163030|NCT00389831|468555058|FG000|Overall Study|Lack of Efficacy|0|||
130163031|NCT00389831|468555059|FG001|Overall Study|Lack of Efficacy|2|||
130163032|NCT00389831|468555058|FG000|Overall Study|Did not receive treatment.|0|||
130163033|NCT00389831|468555059|FG001|Overall Study|Did not receive treatment.|2|||
130163034|NCT00389831|468555058|FG000|Overall Study|Other reasons|0|||
130163035|NCT00389831|468555059|FG001|Overall Study|Other reasons|2|||
130163036|NCT00389831|468555058|FG000|Overall Study|Lost to Follow-up|0|||
130163037|NCT00389831|468555059|FG001|Overall Study|Lost to Follow-up|1|||
130163038|NCT00006721|468558799|FG000|Overall Study|Adverse Event|0|||
130163039|NCT00006721|468558800|FG001|Overall Study|Adverse Event|4|||
130163040|NCT00006721|468558801|FG002|Overall Study|Adverse Event|4|||
130163041|NCT00006721|468558799|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130163042|NCT00006721|468558800|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
130163043|NCT00006721|468558801|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
130163044|NCT00006721|468558799|FG000|Overall Study|Progression/Relapse|0|||
130163045|NCT00006721|468558800|FG001|Overall Study|Progression/Relapse|1|||
130163046|NCT00006721|468558801|FG002|Overall Study|Progression/Relapse|2|||
130163047|NCT00006721|468558799|FG000|Overall Study|Death|0|||
130163048|NCT00006721|468558800|FG001|Overall Study|Death|1|||
130163049|NCT00006721|468558801|FG002|Overall Study|Death|2|||
130163050|NCT00006721|468558799|FG000|Overall Study|Other - Not Protocol Specified|0|||
130163051|NCT00006721|468558800|FG001|Overall Study|Other - Not Protocol Specified|7|||
130163052|NCT00006721|468558801|FG002|Overall Study|Other - Not Protocol Specified|7|||
130163053|NCT00006721|468558799|FG000|Overall Study|Ineligible|2|||
130163054|NCT00006721|468558800|FG001|Overall Study|Ineligible|12|||
130163055|NCT00006721|468558801|FG002|Overall Study|Ineligible|10|||
130163056|NCT00006721|468558799|FG000|Overall Study|Eligible but no Treatment Received|1|||
130163057|NCT00006721|468558800|FG001|Overall Study|Eligible but no Treatment Received|0|||
130163058|NCT00006721|468558801|FG002|Overall Study|Eligible but no Treatment Received|0|||
130163059|NCT05091307|468558802|FG000|Overall Study|Death|0|||
130163060|NCT05091307|468558803|FG001|Overall Study|Death|0|||
130163061|NCT05091307|468558804|FG002|Overall Study|Death|1|||
130163062|NCT05091307|468558805|FG003|Overall Study|Death|0|||
130163063|NCT05091307|468558802|FG000|Overall Study|Lost to Follow-up|33|||
130163064|NCT05091307|468558803|FG001|Overall Study|Lost to Follow-up|33|||
130163065|NCT05091307|468558804|FG002|Overall Study|Lost to Follow-up|2|||
130163066|NCT05091307|468558805|FG003|Overall Study|Lost to Follow-up|0|||
130163067|NCT05091307|468558802|FG000|Overall Study|Physician Decision|1|||
130163068|NCT05091307|468558803|FG001|Overall Study|Physician Decision|0|||
130163069|NCT05091307|468558804|FG002|Overall Study|Physician Decision|0|||
130163070|NCT05091307|468558805|FG003|Overall Study|Physician Decision|0|||
130163071|NCT05091307|468558802|FG000|Overall Study|Protocol Violation|1|||
130163072|NCT05091307|468558803|FG001|Overall Study|Protocol Violation|0|||
130163073|NCT05091307|468558804|FG002|Overall Study|Protocol Violation|0|||
130163074|NCT05091307|468558805|FG003|Overall Study|Protocol Violation|0|||
130163075|NCT05091307|468558802|FG000|Overall Study|Withdrawal by Subject|16|||
130163076|NCT05091307|468558803|FG001|Overall Study|Withdrawal by Subject|16|||
130163077|NCT05091307|468558804|FG002|Overall Study|Withdrawal by Subject|0|||
130163078|NCT05091307|468558805|FG003|Overall Study|Withdrawal by Subject|1|||
130163079|NCT05091307|468558802|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
130163080|NCT05091307|468558803|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
130163081|NCT05091307|468558804|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
130163082|NCT05091307|468558805|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
130163083|NCT05091307|468558802|FG000|Overall Study|Initiated Prohibited Medication|1|||
130163084|NCT05091307|468558803|FG001|Overall Study|Initiated Prohibited Medication|0|||
130163085|NCT05091307|468558804|FG002|Overall Study|Initiated Prohibited Medication|0|||
130163086|NCT05091307|468558805|FG003|Overall Study|Initiated Prohibited Medication|0|||
130163087|NCT05091307|468558802|FG000|Overall Study|Other|4|||
130163088|NCT05091307|468558803|FG001|Overall Study|Other|4|||
130163089|NCT05091307|468558804|FG002|Overall Study|Other|0|||
130163090|NCT05091307|468558805|FG003|Overall Study|Other|0|||
130163091|NCT05091307|468558802|FG000|Overall Study|Randomized but not vaccinated|0|||
130163092|NCT05091307|468558803|FG001|Overall Study|Randomized but not vaccinated|2|||
130163093|NCT05091307|468558804|FG002|Overall Study|Randomized but not vaccinated|0|||
130163094|NCT05091307|468558805|FG003|Overall Study|Randomized but not vaccinated|0|||
130163095|NCT04347122|468558806|FG000|Overall Study|Physician Decision|0|||
130163096|NCT04347122|468558807|FG001|Overall Study|Physician Decision|3|||
130163097|NCT04347122|468558808|FG002|Overall Study|Physician Decision|3|||
130163098|NCT04347122|468558809|FG003|Overall Study|Physician Decision|6|||
130163099|NCT00112866|468558810|FG000|Overall Study|Protocol Violation|1|||
130163100|NCT00112866|468558811|FG001|Overall Study|Protocol Violation|0|||
130163101|NCT00112866|468558810|FG000|Overall Study|did not start treatment post-op|1|||
130163102|NCT00112866|468558811|FG001|Overall Study|did not start treatment post-op|2|||
130163103|NCT01167257|468558813|FG000|Overall Study|Lost to Follow-up|2|||
130163104|NCT01167257|468558814|FG001|Overall Study|Lost to Follow-up|2|||
130163105|NCT01167257|468558813|FG000|Overall Study|Withdrew consent|1|||
130163106|NCT01167257|468558814|FG001|Overall Study|Withdrew consent|1|||
130163107|NCT02492880|468558815|FG000|Overall Study|Lost to Follow-up|1|||
130163108|NCT02492880|468558815|FG000|Overall Study|Protocol Violation|1|||
130163109|NCT00554190|468558816|FG000|Overall Study|Termination forms not completed|10|||
130163110|NCT04241315|468558823|FG000|Overall Study|Withdrawal by Subject|0|||
130163111|NCT04241315|468558824|FG001|Overall Study|Withdrawal by Subject|1|||
130163112|NCT00699283|468558825|FG000|Overall Study|Lack of Efficacy|15|||
130163113|NCT00699283|468558826|FG001|Overall Study|Lack of Efficacy|5|||
130163114|NCT00699283|468558825|FG000|Overall Study|Lost to Follow-up|2|||
130163115|NCT00699283|468558826|FG001|Overall Study|Lost to Follow-up|0|||
130163116|NCT00699283|468558825|FG000|Overall Study|Withdrawal by Subject|1|||
130163117|NCT00699283|468558826|FG001|Overall Study|Withdrawal by Subject|0|||
130163118|NCT00699283|468558825|FG000|Overall Study|Other Reason|5|||
129981430|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981431|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
129981432|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
129981433|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
129981434|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
129981435|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
130163119|NCT00699283|468558826|FG001|Overall Study|Other Reason|1|||
130163120|NCT00699283|468558825|FG000|Overall Study|SAE, non-fatal|1|||
130163121|NCT00699283|468558826|FG001|Overall Study|SAE, non-fatal|1|||
130163122|NCT00699283|468558825|FG000|Overall Study|AE, non-serious non-fatal|8|||
130163123|NCT00699283|468558826|FG001|Overall Study|AE, non-serious non-fatal|1|||
129981436|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
130163124|NCT00699283|468558825|FG000|Overall Study|AE of unknown type|1|||
130163125|NCT00699283|468558826|FG001|Overall Study|AE of unknown type|0|||
130163126|NCT00394524|468558827|FG000|Overall Study|Protocol Violation|2|||
130163127|NCT00394524|468558828|FG001|Overall Study|Protocol Violation|3|||
130163128|NCT00394524|468558827|FG000|Overall Study|Death|1|||
130163129|NCT00394524|468558828|FG001|Overall Study|Death|0|||
130163130|NCT00394524|468558827|FG000|Overall Study|Withdrawal by Subject|0|||
130163131|NCT00394524|468558828|FG001|Overall Study|Withdrawal by Subject|1|||
130163132|NCT01398514|468558829|FG000|Overall Study|Adverse Event|1|||
130163133|NCT01398514|468558830|FG001|Overall Study|Adverse Event|0|||
130163134|NCT01398514|468558829|FG000|Overall Study|Non-compliance with study procedures|2|||
130163135|NCT01398514|468558830|FG001|Overall Study|Non-compliance with study procedures|0|||
130163136|NCT01398514|468558829|FG000|Overall Study|Physiologic non-responsiveness|1|||
130163137|NCT01398514|468558830|FG001|Overall Study|Physiologic non-responsiveness|3|||
130163138|NCT01398514|468558829|FG000|Overall Study|Failure to show a conditioned response|4|||
130163139|NCT01398514|468558830|FG001|Overall Study|Failure to show a conditioned response|3|||
130163140|NCT01345175|468558835|FG000|Overall Study|Physician Decision|0|||
130163141|NCT01345175|468558836|FG001|Overall Study|Physician Decision|1|||
130163142|NCT01345175|468558835|FG000|Overall Study|Withdrawal by Subject|1|||
130163143|NCT01345175|468558836|FG001|Overall Study|Withdrawal by Subject|1|||
130163144|NCT01345175|468558835|FG000|Overall Study|Failed to complete BFI|3|||
130163145|NCT01345175|468558836|FG001|Overall Study|Failed to complete BFI|2|||
130163146|NCT01345175|468558835|FG000|Overall Study|Stopped taking medication|2|||
130163147|NCT01345175|468558836|FG001|Overall Study|Stopped taking medication|2|||
130163148|NCT03537599|468558847|FG000|Overall Study|Disease Progression|2|||
130163149|NCT03537599|468558848|FG001|Overall Study|Disease Progression|1|||
130163150|NCT03537599|468558847|FG000|Overall Study|Death|0|||
130163151|NCT03537599|468558848|FG001|Overall Study|Death|1|||
130163152|NCT01007942|468558851|FG000|Overall Study|Adverse Event|29|||
130163153|NCT01007942|468558852|FG001|Overall Study|Adverse Event|14|||
130163154|NCT01007942|468558851|FG000|Overall Study|Abnormal test procedure|0|||
130163155|NCT01007942|468558852|FG001|Overall Study|Abnormal test procedure|1|||
130163156|NCT01007942|468558851|FG000|Overall Study|Disease progression|217|||
130163157|NCT01007942|468558852|FG001|Overall Study|Disease progression|242|||
130163158|NCT01007942|468558851|FG000|Overall Study|New cancer therapy|5|||
130163159|NCT01007942|468558852|FG001|Overall Study|New cancer therapy|1|||
130163160|NCT01007942|468558851|FG000|Overall Study|Protocol Violation|1|||
130163161|NCT01007942|468558852|FG001|Overall Study|Protocol Violation|1|||
130163162|NCT01007942|468558851|FG000|Overall Study|Withdrawal by Subject|19|||
130163163|NCT01007942|468558852|FG001|Overall Study|Withdrawal by Subject|14|||
130163164|NCT01007942|468558851|FG000|Overall Study|Lost to Follow-up|1|||
130163165|NCT01007942|468558852|FG001|Overall Study|Lost to Follow-up|0|||
130163166|NCT01007942|468558851|FG000|Overall Study|Administrative problems|2|||
130163167|NCT01007942|468558852|FG001|Overall Study|Administrative problems|0|||
130163168|NCT01007942|468558851|FG000|Overall Study|Death|3|||
130163169|NCT01007942|468558852|FG001|Overall Study|Death|2|||
130163170|NCT01007942|468558851|FG000|Overall Study|Patients untreated|4|||
130163171|NCT01007942|468558852|FG001|Overall Study|Patients untreated|3|||
130163172|NCT05083585|468558853|FG000|Overall Study|Death|1|||
130163173|NCT05083585|468558854|FG001|Overall Study|Death|1|||
130163174|NCT05083585|468558853|FG000|Overall Study|Lost to Follow-up|1|||
130163175|NCT05083585|468558854|FG001|Overall Study|Lost to Follow-up|1|||
130163176|NCT05083585|468558853|FG000|Overall Study|Withdrawal by Subject|2|||
130163177|NCT05083585|468558854|FG001|Overall Study|Withdrawal by Subject|0|||
130163178|NCT05083585|468558853|FG000|Overall Study|Randomized but not vaccinated|2|||
130163179|NCT05083585|468558854|FG001|Overall Study|Randomized but not vaccinated|0|||
130163180|NCT00114166|468558855|FG000|Overall Study|Wrong primary|0|||
130163181|NCT00114166|468558856|FG001|Overall Study|Wrong primary|1|||
130163182|NCT03469336|468558857|FG000|Overall Study|Adverse Event|1|||
130163183|NCT02628743|468558859|FG000|Overall Study|Other|3|||
130163184|NCT02628743|468558859|FG000|Overall Study|Withdrawal by Subject|50|||
130163185|NCT02628743|468558859|FG000|Overall Study|Study Terminated by Sponsor|76|||
130163186|NCT02628743|468558859|FG000|Overall Study|Physician Decision|2|||
130163187|NCT02534844|468558860|FG000|Part B|Withdrawal by Subject|0|||
130163188|NCT02534844|468558861|FG001|Part B|Withdrawal by Subject|0|||
130163189|NCT02534844|468558862|FG002|Part B|Withdrawal by Subject|0|||
130163190|NCT02534844|468558863|FG003|Part B|Withdrawal by Subject|0|||
130163191|NCT02534844|468558864|FG004|Part B|Withdrawal by Subject|2|||
130163192|NCT02534844|468558865|FG005|Part B|Withdrawal by Subject|1|||
130163193|NCT03560986|468558866|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
130163194|NCT03560986|468558867|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
130163195|NCT03560986|468558866|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130163196|NCT03560986|468558867|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
130163197|NCT03560986|468558866|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
130163198|NCT03560986|468558867|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
130163199|NCT03560986|468558866|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
130163200|NCT03560986|468558867|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
130163201|NCT03560986|468558866|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
130163202|NCT03560986|468558867|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
130163203|NCT03560986|468558866|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
130163204|NCT03560986|468558867|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
130163205|NCT03560986|468558866|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
130163206|NCT03560986|468558867|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
130163207|NCT00593736|468558879|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
130163208|NCT00593736|468558880|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
130163209|NCT00593736|468558881|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
130163210|NCT00593736|468558882|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
130163211|NCT00593736|468558879|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130163212|NCT00593736|468558880|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130163213|NCT00593736|468558881|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
130163214|NCT00593736|468558882|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
130163215|NCT00593736|468558879|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130163216|NCT00593736|468558880|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130163217|NCT00593736|468558881|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
130163218|NCT00593736|468558882|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
130163219|NCT00593736|468558879|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
130163220|NCT00593736|468558880|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
130163221|NCT00593736|468558881|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
130163222|NCT00593736|468558882|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
130163223|NCT00593736|468558879|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130163224|NCT00593736|468558880|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130163225|NCT00593736|468558881|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
130163226|NCT00593736|468558882|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
130163227|NCT00593736|468558879|FG000|Screening Period and Placebo Run-in|Various|0|||
130163228|NCT00593736|468558880|FG001|Screening Period and Placebo Run-in|Various|0|||
130163229|NCT00593736|468558881|FG002|Screening Period and Placebo Run-in|Various|0|||
130163230|NCT00593736|468558882|FG003|Screening Period and Placebo Run-in|Various|25|||
130163231|NCT00593736|468558879|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
130163232|NCT00593736|468558880|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
130163233|NCT00593736|468558881|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
130163234|NCT00593736|468558882|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
130163235|NCT00593736|468558879|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
130163236|NCT00593736|468558880|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
130163237|NCT00593736|468558881|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
130163238|NCT00593736|468558882|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
130163239|NCT00593736|468558879|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
130163240|NCT00593736|468558880|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
130163241|NCT00593736|468558881|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
130163242|NCT00593736|468558882|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
130163243|NCT00593736|468558879|FG000|Treatment Period and Placebo Run-out|Various|1|||
130163244|NCT00593736|468558880|FG001|Treatment Period and Placebo Run-out|Various|1|||
130163245|NCT00593736|468558881|FG002|Treatment Period and Placebo Run-out|Various|1|||
130163246|NCT00593736|468558882|FG003|Treatment Period and Placebo Run-out|Various|0|||
130163247|NCT01857271|468558883|FG000|Overall Study|Lost to Follow-up|1|||
130163248|NCT03493386|468558884|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130163249|NCT03493386|468558885|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
130163250|NCT03493386|468558886|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130163251|NCT03493386|468558887|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
130163252|NCT04645966|468558888|FG000|Vaccination Phase|Adverse Event|1|||
130163253|NCT04645966|468558889|FG001|Vaccination Phase|Adverse Event|0|||
130163254|NCT04645966|468558890|FG002|Vaccination Phase|Adverse Event|0|||
130163255|NCT04645966|468558891|FG003|Vaccination Phase|Adverse Event|0|||
130163256|NCT04645966|468558892|FG004|Vaccination Phase|Adverse Event|0|||
130163257|NCT04645966|468558893|FG005|Vaccination Phase|Adverse Event|0|||
130163258|NCT04645966|468558894|FG006|Vaccination Phase|Adverse Event|1|||
130163259|NCT04645966|468558895|FG007|Vaccination Phase|Adverse Event|0|||
130163260|NCT04645966|468558896|FG008|Vaccination Phase|Adverse Event|0|||
130163261|NCT04645966|468558888|FG000|Vaccination Phase|Death|0|||
130163262|NCT04645966|468558889|FG001|Vaccination Phase|Death|0|||
130163263|NCT04645966|468558890|FG002|Vaccination Phase|Death|0|||
130163264|NCT04645966|468558891|FG003|Vaccination Phase|Death|0|||
130163265|NCT04645966|468558892|FG004|Vaccination Phase|Death|0|||
130163266|NCT04645966|468558893|FG005|Vaccination Phase|Death|1|||
130163267|NCT04645966|468558894|FG006|Vaccination Phase|Death|0|||
130163268|NCT04645966|468558895|FG007|Vaccination Phase|Death|0|||
130163269|NCT04645966|468558896|FG008|Vaccination Phase|Death|0|||
130163270|NCT04645966|468558888|FG000|Vaccination Phase|Protocol Violation|0|||
130163271|NCT04645966|468558889|FG001|Vaccination Phase|Protocol Violation|0|||
129981437|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
129981438|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
129981439|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
129981440|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
129981441|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
129981442|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
130163272|NCT04645966|468558890|FG002|Vaccination Phase|Protocol Violation|0|||
130163273|NCT04645966|468558891|FG003|Vaccination Phase|Protocol Violation|0|||
130163274|NCT04645966|468558892|FG004|Vaccination Phase|Protocol Violation|1|||
130163275|NCT04645966|468558893|FG005|Vaccination Phase|Protocol Violation|0|||
130163276|NCT04645966|468558894|FG006|Vaccination Phase|Protocol Violation|0|||
130163277|NCT04645966|468558895|FG007|Vaccination Phase|Protocol Violation|0|||
130163278|NCT04645966|468558896|FG008|Vaccination Phase|Protocol Violation|0|||
130163279|NCT04645966|468558888|FG000|Vaccination Phase|Study terminated by sponsor|0|||
130163280|NCT04645966|468558889|FG001|Vaccination Phase|Study terminated by sponsor|0|||
130163281|NCT04645966|468558890|FG002|Vaccination Phase|Study terminated by sponsor|14|||
130163282|NCT04645966|468558891|FG003|Vaccination Phase|Study terminated by sponsor|15|||
130163283|NCT04645966|468558892|FG004|Vaccination Phase|Study terminated by sponsor|47|||
130163284|NCT04645966|468558893|FG005|Vaccination Phase|Study terminated by sponsor|43|||
130163285|NCT04645966|468558894|FG006|Vaccination Phase|Study terminated by sponsor|29|||
130163286|NCT04645966|468558895|FG007|Vaccination Phase|Study terminated by sponsor|29|||
130163287|NCT04645966|468558896|FG008|Vaccination Phase|Study terminated by sponsor|12|||
130163288|NCT04645966|468558888|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
130163289|NCT04645966|468558889|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
130163290|NCT04645966|468558890|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
130163291|NCT04645966|468558891|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
130163292|NCT04645966|468558892|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
130163293|NCT04645966|468558893|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
130163294|NCT04645966|468558894|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
130163295|NCT04645966|468558895|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
130163296|NCT04645966|468558896|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
130163297|NCT04645966|468558888|FG000|Vaccination Phase|Other|0|||
130163298|NCT04645966|468558889|FG001|Vaccination Phase|Other|0|||
130163299|NCT04645966|468558890|FG002|Vaccination Phase|Other|0|||
130163300|NCT04645966|468558891|FG003|Vaccination Phase|Other|0|||
130163301|NCT04645966|468558892|FG004|Vaccination Phase|Other|0|||
130163302|NCT04645966|468558893|FG005|Vaccination Phase|Other|2|||
130163303|NCT04645966|468558894|FG006|Vaccination Phase|Other|0|||
130163304|NCT04645966|468558895|FG007|Vaccination Phase|Other|0|||
130163305|NCT04645966|468558896|FG008|Vaccination Phase|Other|0|||
130163306|NCT04645966|468558888|FG000|Vaccination Phase|Lost to Follow-up|0|||
130163307|NCT04645966|468558889|FG001|Vaccination Phase|Lost to Follow-up|0|||
130163308|NCT04645966|468558890|FG002|Vaccination Phase|Lost to Follow-up|0|||
130163309|NCT04645966|468558891|FG003|Vaccination Phase|Lost to Follow-up|0|||
130163310|NCT04645966|468558892|FG004|Vaccination Phase|Lost to Follow-up|0|||
130163311|NCT04645966|468558893|FG005|Vaccination Phase|Lost to Follow-up|0|||
130163312|NCT04645966|468558894|FG006|Vaccination Phase|Lost to Follow-up|0|||
130163313|NCT04645966|468558895|FG007|Vaccination Phase|Lost to Follow-up|1|||
130163314|NCT04645966|468558896|FG008|Vaccination Phase|Lost to Follow-up|0|||
130163315|NCT04645966|468558888|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
130163316|NCT04645966|468558889|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
130163317|NCT04645966|468558890|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
130163318|NCT04645966|468558891|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
130163319|NCT04645966|468558892|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
130163320|NCT04645966|468558893|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
130163321|NCT04645966|468558894|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
130163322|NCT04645966|468558895|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
130163323|NCT04645966|468558896|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
130163324|NCT04645966|468558888|FG000|Follow-up Phase|Lost to Follow-up|0|||
130163325|NCT04645966|468558889|FG001|Follow-up Phase|Lost to Follow-up|0|||
130163326|NCT04645966|468558890|FG002|Follow-up Phase|Lost to Follow-up|0|||
130163327|NCT04645966|468558891|FG003|Follow-up Phase|Lost to Follow-up|0|||
130163328|NCT04645966|468558892|FG004|Follow-up Phase|Lost to Follow-up|0|||
130163329|NCT04645966|468558893|FG005|Follow-up Phase|Lost to Follow-up|0|||
130163330|NCT04645966|468558894|FG006|Follow-up Phase|Lost to Follow-up|0|||
130163331|NCT04645966|468558895|FG007|Follow-up Phase|Lost to Follow-up|1|||
130163332|NCT04645966|468558896|FG008|Follow-up Phase|Lost to Follow-up|0|||
130163333|NCT02116608|468558898|FG000|Overall Study|Lost to Follow-up|0|||
130163334|NCT02116608|468558899|FG001|Overall Study|Lost to Follow-up|0|||
130163335|NCT02116608|468558900|FG002|Overall Study|Lost to Follow-up|1|||
130163336|NCT02116608|468558898|FG000|Overall Study|Physician Decision|0|||
129981443|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
130163337|NCT02116608|468558899|FG001|Overall Study|Physician Decision|1|||
130163338|NCT02116608|468558900|FG002|Overall Study|Physician Decision|0|||
130163339|NCT02116608|468558898|FG000|Overall Study|Death|0|||
130163340|NCT02116608|468558899|FG001|Overall Study|Death|1|||
130163341|NCT02116608|468558900|FG002|Overall Study|Death|0|||
130163342|NCT01468818|468558904|FG000|Overall Study|Death during treatment|2|||
130163343|NCT02338193|468558906|FG000|Overall Study|Withdrawal by Subject|0|||
130163344|NCT02338193|468558907|FG001|Overall Study|Withdrawal by Subject|0|||
130163345|NCT02338193|468558908|FG002|Overall Study|Withdrawal by Subject|2|||
130163346|NCT02338193|468558906|FG000|Overall Study|Pregnancy|0|||
130163347|NCT02338193|468558907|FG001|Overall Study|Pregnancy|1|||
130163348|NCT02338193|468558908|FG002|Overall Study|Pregnancy|1|||
130163349|NCT02338193|468558906|FG000|Overall Study|Noncompliant with visits|2|||
130163350|NCT02338193|468558907|FG001|Overall Study|Noncompliant with visits|2|||
130163351|NCT02338193|468558908|FG002|Overall Study|Noncompliant with visits|7|||
130163352|NCT02338193|468558906|FG000|Overall Study|moved out of state|0|||
130163353|NCT02338193|468558907|FG001|Overall Study|moved out of state|1|||
130163354|NCT02338193|468558908|FG002|Overall Study|moved out of state|0|||
130163355|NCT02338193|468558906|FG000|Overall Study|intolerant of side effects|1|||
130163356|NCT02338193|468558907|FG001|Overall Study|intolerant of side effects|0|||
130163357|NCT02338193|468558908|FG002|Overall Study|intolerant of side effects|0|||
130163358|NCT01059344|468558909|FG000|Overall Study|Adverse Event|12|||
130163359|NCT01059344|468558910|FG001|Overall Study|Adverse Event|30|||
130163360|NCT01059344|468558909|FG000|Overall Study|Withdrawal by Subject|6|||
130163361|NCT01059344|468558910|FG001|Overall Study|Withdrawal by Subject|9|||
130163362|NCT01059344|468558909|FG000|Overall Study|Lost to Follow-up|1|||
130163363|NCT01059344|468558910|FG001|Overall Study|Lost to Follow-up|1|||
130163364|NCT01059344|468558909|FG000|Overall Study|Other|3|||
130163365|NCT01059344|468558910|FG001|Overall Study|Other|6|||
130163366|NCT01739348|468558911|FG000|Part I (Base Study)|Adverse Event|41|||
130163367|NCT01739348|468558912|FG001|Part I (Base Study)|Adverse Event|52|||
130163368|NCT01739348|468558913|FG002|Part I (Base Study)|Adverse Event|8|||
130163369|NCT01739348|468558914|FG003|Part I (Base Study)|Adverse Event|33|||
130163370|NCT01739348|468558911|FG000|Part I (Base Study)|Death|10|||
130163371|NCT01739348|468558912|FG001|Part I (Base Study)|Death|7|||
130163372|NCT01739348|468558913|FG002|Part I (Base Study)|Death|2|||
130163373|NCT01739348|468558914|FG003|Part I (Base Study)|Death|8|||
130163374|NCT01739348|468558911|FG000|Part I (Base Study)|Lack of Efficacy|3|||
130163375|NCT01739348|468558912|FG001|Part I (Base Study)|Lack of Efficacy|8|||
130163376|NCT01739348|468558913|FG002|Part I (Base Study)|Lack of Efficacy|0|||
130163377|NCT01739348|468558914|FG003|Part I (Base Study)|Lack of Efficacy|7|||
130163378|NCT01739348|468558911|FG000|Part I (Base Study)|Lost to Follow-up|4|||
130163379|NCT01739348|468558912|FG001|Part I (Base Study)|Lost to Follow-up|2|||
130163380|NCT01739348|468558913|FG002|Part I (Base Study)|Lost to Follow-up|4|||
130163381|NCT01739348|468558914|FG003|Part I (Base Study)|Lost to Follow-up|4|||
130163382|NCT01739348|468558911|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
130163383|NCT01739348|468558912|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
130163384|NCT01739348|468558913|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
130163385|NCT01739348|468558914|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
130163386|NCT01739348|468558911|FG000|Part I (Base Study)|Physician Decision|10|||
130163387|NCT01739348|468558912|FG001|Part I (Base Study)|Physician Decision|7|||
130163388|NCT01739348|468558913|FG002|Part I (Base Study)|Physician Decision|1|||
130163389|NCT01739348|468558914|FG003|Part I (Base Study)|Physician Decision|4|||
130163390|NCT01739348|468558911|FG000|Part I (Base Study)|Protocol Violation|2|||
130163391|NCT01739348|468558912|FG001|Part I (Base Study)|Protocol Violation|0|||
130163392|NCT01739348|468558913|FG002|Part I (Base Study)|Protocol Violation|1|||
130163393|NCT01739348|468558914|FG003|Part I (Base Study)|Protocol Violation|2|||
130163394|NCT01739348|468558911|FG000|Part I (Base Study)|Screen Failure|2|||
130163395|NCT01739348|468558912|FG001|Part I (Base Study)|Screen Failure|0|||
130163396|NCT01739348|468558913|FG002|Part I (Base Study)|Screen Failure|0|||
130163397|NCT01739348|468558914|FG003|Part I (Base Study)|Screen Failure|0|||
130163398|NCT01739348|468558911|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
130163399|NCT01739348|468558912|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
130163400|NCT01739348|468558913|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
130163401|NCT01739348|468558914|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
130163402|NCT01739348|468558911|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
130163403|NCT01739348|468558912|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
130163404|NCT01739348|468558913|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
130163405|NCT01739348|468558914|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
130163406|NCT01739348|468558911|FG000|Part I (Base Study)|Participant Moved|4|||
130163407|NCT01739348|468558912|FG001|Part I (Base Study)|Participant Moved|3|||
130163408|NCT01739348|468558913|FG002|Part I (Base Study)|Participant Moved|1|||
130163409|NCT01739348|468558914|FG003|Part I (Base Study)|Participant Moved|7|||
130163410|NCT01739348|468558911|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
130163411|NCT01739348|468558912|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
130163412|NCT01739348|468558913|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
130163413|NCT01739348|468558914|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
130163414|NCT01739348|468558911|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
130163415|NCT01739348|468558912|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
130163416|NCT01739348|468558913|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
130163417|NCT01739348|468558914|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
130163418|NCT01739348|468558911|FG000|Part II (Extension Study)|Adverse Event|10|||
130163419|NCT01739348|468558912|FG001|Part II (Extension Study)|Adverse Event|11|||
130163420|NCT01739348|468558913|FG002|Part II (Extension Study)|Adverse Event|7|||
130163421|NCT01739348|468558914|FG003|Part II (Extension Study)|Adverse Event|26|||
130163422|NCT01739348|468558911|FG000|Part II (Extension Study)|Death|3|||
130163423|NCT01739348|468558912|FG001|Part II (Extension Study)|Death|3|||
130163424|NCT01739348|468558913|FG002|Part II (Extension Study)|Death|2|||
130163425|NCT01739348|468558914|FG003|Part II (Extension Study)|Death|6|||
130163426|NCT01739348|468558911|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
130163427|NCT01739348|468558912|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
130163428|NCT01739348|468558913|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
130163429|NCT01739348|468558914|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
130163430|NCT01739348|468558911|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
130163431|NCT01739348|468558912|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
130163432|NCT01739348|468558913|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
130163433|NCT01739348|468558914|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
130163434|NCT01739348|468558911|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130163435|NCT01739348|468558912|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130163436|NCT01739348|468558913|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
130163437|NCT01739348|468558914|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
130163438|NCT01739348|468558911|FG000|Part II (Extension Study)|Physician Decision|7|||
130163439|NCT01739348|468558912|FG001|Part II (Extension Study)|Physician Decision|11|||
130163440|NCT01739348|468558913|FG002|Part II (Extension Study)|Physician Decision|6|||
130163441|NCT01739348|468558914|FG003|Part II (Extension Study)|Physician Decision|12|||
130163442|NCT01739348|468558911|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
130163443|NCT01739348|468558912|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
130163444|NCT01739348|468558913|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
130163445|NCT01739348|468558914|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
130163446|NCT01739348|468558911|FG000|Part II (Extension Study)|Participant Moved|3|||
130163447|NCT01739348|468558912|FG001|Part II (Extension Study)|Participant Moved|3|||
130163448|NCT01739348|468558913|FG002|Part II (Extension Study)|Participant Moved|0|||
130163449|NCT01739348|468558914|FG003|Part II (Extension Study)|Participant Moved|3|||
130163450|NCT01739348|468558911|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
130163451|NCT01739348|468558912|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
130163452|NCT01739348|468558913|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
130163453|NCT01739348|468558914|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
130163454|NCT01739348|468558911|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
130163455|NCT01739348|468558912|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
130163456|NCT01739348|468558913|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
130163457|NCT01739348|468558914|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
130163458|NCT01447420|468558918|FG000|Overall Study|Adverse Event|2|||
130163459|NCT01447420|468558919|FG001|Overall Study|Adverse Event|4|||
130163460|NCT01447420|468558920|FG002|Overall Study|Adverse Event|2|||
130163461|NCT01447420|468558918|FG000|Overall Study|Protocol Violation|3|||
130163462|NCT01447420|468558919|FG001|Overall Study|Protocol Violation|3|||
130163463|NCT01447420|468558920|FG002|Overall Study|Protocol Violation|0|||
130163464|NCT01447420|468558918|FG000|Overall Study|Withdrawal by Subject|4|||
130163465|NCT01447420|468558919|FG001|Overall Study|Withdrawal by Subject|1|||
130163466|NCT01447420|468558920|FG002|Overall Study|Withdrawal by Subject|0|||
130163467|NCT01447420|468558918|FG000|Overall Study|Lack of Efficacy|1|||
130163468|NCT01447420|468558919|FG001|Overall Study|Lack of Efficacy|19|||
130163469|NCT01447420|468558920|FG002|Overall Study|Lack of Efficacy|8|||
130163470|NCT05788289|468558927|FG000|Overall Study|Death|3|||
130163471|NCT01974440|468558928|FG000|Overall Study|Lost to Follow-up|7|||
130163472|NCT01974440|468558929|FG001|Overall Study|Lost to Follow-up|7|||
130163473|NCT01974440|468558928|FG000|Overall Study|Withdrawal by Subject|24|||
130163474|NCT01974440|468558929|FG001|Overall Study|Withdrawal by Subject|20|||
130163475|NCT01974440|468558928|FG000|Overall Study|Sponsor decision|109|||
130163476|NCT01974440|468558929|FG001|Overall Study|Sponsor decision|110|||
130163477|NCT00762437|468558930|FG000|Overall Study|Lost to Follow-up|7|||
130163478|NCT00762437|468558930|FG000|Overall Study|Missed final study visit|11|||
130163479|NCT00762437|468558930|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
130163480|NCT03569228|468558931|FG000|Overall Study|Withdrawal by PI|0|||
130163481|NCT03569228|468558932|FG001|Overall Study|Withdrawal by PI|0|||
130163482|NCT03569228|468558933|FG002|Overall Study|Withdrawal by PI|2|||
130163483|NCT03569228|468558934|FG003|Overall Study|Withdrawal by PI|2|||
130163484|NCT03569228|468558935|FG004|Overall Study|Withdrawal by PI|1|||
130163485|NCT03569228|468558936|FG005|Overall Study|Withdrawal by PI|0|||
130163486|NCT03569228|468558937|FG006|Overall Study|Withdrawal by PI|0|||
130163487|NCT03569228|468558938|FG007|Overall Study|Withdrawal by PI|0|||
129981444|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130163488|NCT03569228|468558939|FG008|Overall Study|Withdrawal by PI|0|||
130163489|NCT03569228|468558931|FG000|Overall Study|Lost to Follow-up|0|||
130163490|NCT03569228|468558932|FG001|Overall Study|Lost to Follow-up|0|||
130163491|NCT03569228|468558933|FG002|Overall Study|Lost to Follow-up|0|||
130163492|NCT03569228|468558934|FG003|Overall Study|Lost to Follow-up|0|||
130163493|NCT03569228|468558935|FG004|Overall Study|Lost to Follow-up|0|||
130163494|NCT03569228|468558936|FG005|Overall Study|Lost to Follow-up|0|||
130163495|NCT03569228|468558937|FG006|Overall Study|Lost to Follow-up|0|||
130163496|NCT03569228|468558938|FG007|Overall Study|Lost to Follow-up|0|||
130163497|NCT03569228|468558939|FG008|Overall Study|Lost to Follow-up|1|||
130163498|NCT03569228|468558931|FG000|Overall Study|Screen Fail|2|||
130163499|NCT03569228|468558932|FG001|Overall Study|Screen Fail|2|||
130163500|NCT03569228|468558933|FG002|Overall Study|Screen Fail|1|||
130163501|NCT03569228|468558934|FG003|Overall Study|Screen Fail|1|||
130163502|NCT03569228|468558935|FG004|Overall Study|Screen Fail|1|||
130163503|NCT03569228|468558936|FG005|Overall Study|Screen Fail|3|||
130163504|NCT03569228|468558937|FG006|Overall Study|Screen Fail|1|||
130163505|NCT03569228|468558938|FG007|Overall Study|Screen Fail|5|||
130163506|NCT03569228|468558939|FG008|Overall Study|Screen Fail|2|||
130163507|NCT06354998|468558940|FG000|Overall Study|Withdrawal by Subject|3|||
130163508|NCT06354998|468558941|FG001|Overall Study|Withdrawal by Subject|0|||
130163509|NCT00085423|468558946|FG000|Overall Study|Withdrawal by Subject|1|||
130163510|NCT00085423|468558946|FG000|Overall Study|screen failure|1|||
130163511|NCT00536263|468558954|FG000|Overall Study|Adverse Event|5|||
130163512|NCT00536263|468558955|FG001|Overall Study|Adverse Event|5|||
130163513|NCT00536263|468558956|FG002|Overall Study|Adverse Event|7|||
130163514|NCT00536263|468558954|FG000|Overall Study|Lost to Follow-up|3|||
130163515|NCT00536263|468558955|FG001|Overall Study|Lost to Follow-up|4|||
130163516|NCT00536263|468558956|FG002|Overall Study|Lost to Follow-up|4|||
130163517|NCT00536263|468558954|FG000|Overall Study|Subject withdrew - not treatment related|2|||
130163518|NCT00536263|468558955|FG001|Overall Study|Subject withdrew - not treatment related|0|||
130163519|NCT00536263|468558956|FG002|Overall Study|Subject withdrew - not treatment related|5|||
130163520|NCT00536263|468558954|FG000|Overall Study|Subject withdrew - treatment related|0|||
130163521|NCT00536263|468558955|FG001|Overall Study|Subject withdrew - treatment related|3|||
130163522|NCT00536263|468558956|FG002|Overall Study|Subject withdrew - treatment related|2|||
130163523|NCT00536263|468558954|FG000|Overall Study|Noncompliance with protocol|0|||
130163524|NCT00536263|468558955|FG001|Overall Study|Noncompliance with protocol|0|||
130163525|NCT00536263|468558956|FG002|Overall Study|Noncompliance with protocol|1|||
130163526|NCT00536263|468558954|FG000|Overall Study|Did not meet protocol eligibility|1|||
130163527|NCT00536263|468558955|FG001|Overall Study|Did not meet protocol eligibility|2|||
130163528|NCT00536263|468558956|FG002|Overall Study|Did not meet protocol eligibility|2|||
130163529|NCT01181271|468558959|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
130163530|NCT01181271|468558959|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
130163531|NCT01181271|468558959|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
130163532|NCT01181271|468558959|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
130163533|NCT04135196|468558960|FG000|Overall Study|Lost to Follow-up|8|||
130163534|NCT04135196|468558961|FG001|Overall Study|Lost to Follow-up|7|||
130163535|NCT04135196|468558962|FG002|Overall Study|Lost to Follow-up|8|||
130163536|NCT04135196|468558963|FG003|Overall Study|Lost to Follow-up|9|||
130163537|NCT04135196|468558964|FG004|Overall Study|Lost to Follow-up|1|||
130163538|NCT04135196|468558960|FG000|Overall Study|Pregnancy|0|||
130163539|NCT04135196|468558961|FG001|Overall Study|Pregnancy|0|||
130163540|NCT04135196|468558962|FG002|Overall Study|Pregnancy|1|||
130163541|NCT04135196|468558963|FG003|Overall Study|Pregnancy|0|||
130163542|NCT04135196|468558964|FG004|Overall Study|Pregnancy|0|||
130163543|NCT04135196|468558960|FG000|Overall Study|Withdrawal by Subject|0|||
130163544|NCT04135196|468558961|FG001|Overall Study|Withdrawal by Subject|0|||
130163545|NCT04135196|468558962|FG002|Overall Study|Withdrawal by Subject|0|||
130163546|NCT04135196|468558963|FG003|Overall Study|Withdrawal by Subject|0|||
130163547|NCT04135196|468558964|FG004|Overall Study|Withdrawal by Subject|1|||
130163548|NCT00809159|468558965|FG000|Part 1|Adverse Event|1|||
130163549|NCT00809159|468558966|FG001|Part 1|Adverse Event|1|||
130163550|NCT00809159|468558967|FG002|Part 1|Adverse Event|0|||
130163551|NCT00809159|468558968|FG003|Part 1|Adverse Event|0|||
130163552|NCT00809159|468558969|FG004|Part 1|Adverse Event|0|||
130163553|NCT00809159|468558970|FG005|Part 1|Adverse Event|0|||
130163554|NCT00809159|468558965|FG000|Part 1|Lost to Follow-up|1|||
130163555|NCT00809159|468558966|FG001|Part 1|Lost to Follow-up|0|||
130163556|NCT00809159|468558967|FG002|Part 1|Lost to Follow-up|0|||
130163557|NCT00809159|468558968|FG003|Part 1|Lost to Follow-up|0|||
130163558|NCT00809159|468558969|FG004|Part 1|Lost to Follow-up|0|||
130163559|NCT00809159|468558970|FG005|Part 1|Lost to Follow-up|0|||
130163560|NCT00809159|468558965|FG000|Part 1|Withdrawal by Subject|3|||
130163561|NCT00809159|468558966|FG001|Part 1|Withdrawal by Subject|1|||
130163562|NCT00809159|468558967|FG002|Part 1|Withdrawal by Subject|0|||
130163563|NCT00809159|468558968|FG003|Part 1|Withdrawal by Subject|0|||
130163564|NCT00809159|468558969|FG004|Part 1|Withdrawal by Subject|0|||
130163565|NCT00809159|468558970|FG005|Part 1|Withdrawal by Subject|0|||
130163566|NCT00809159|468558965|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
130163567|NCT00809159|468558966|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
130163568|NCT00809159|468558967|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
130163569|NCT00809159|468558968|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
130163570|NCT00809159|468558969|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
130163571|NCT00809159|468558970|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
130163572|NCT00809159|468558965|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
130163573|NCT00809159|468558966|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
130163574|NCT00809159|468558967|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
130163575|NCT00809159|468558968|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
130163576|NCT00809159|468558969|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
130163577|NCT00809159|468558970|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
130163578|NCT00809159|468558965|FG000|Part 1 and 2|Administrative problems|0|||
130163579|NCT00809159|468558966|FG001|Part 1 and 2|Administrative problems|0|||
130163580|NCT00809159|468558967|FG002|Part 1 and 2|Administrative problems|0|||
130163581|NCT00809159|468558968|FG003|Part 1 and 2|Administrative problems|1|||
130163582|NCT00809159|468558969|FG004|Part 1 and 2|Administrative problems|0|||
130163583|NCT00809159|468558970|FG005|Part 1 and 2|Administrative problems|0|||
130163584|NCT00809159|468558965|FG000|Part 1 and 2|Adverse Event|0|||
129981445|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
129981446|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981447|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981448|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981449|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
130163585|NCT00809159|468558966|FG001|Part 1 and 2|Adverse Event|0|||
130163586|NCT00809159|468558967|FG002|Part 1 and 2|Adverse Event|1|||
130163587|NCT00809159|468558968|FG003|Part 1 and 2|Adverse Event|0|||
130163588|NCT00809159|468558969|FG004|Part 1 and 2|Adverse Event|1|||
130163589|NCT00809159|468558970|FG005|Part 1 and 2|Adverse Event|1|||
130163590|NCT00809159|468558965|FG000|Part 1 and 2|Lost to Follow-up|0|||
130163591|NCT00809159|468558966|FG001|Part 1 and 2|Lost to Follow-up|0|||
130163592|NCT00809159|468558967|FG002|Part 1 and 2|Lost to Follow-up|1|||
130163593|NCT00809159|468558968|FG003|Part 1 and 2|Lost to Follow-up|1|||
130163594|NCT00809159|468558969|FG004|Part 1 and 2|Lost to Follow-up|0|||
130163595|NCT00809159|468558970|FG005|Part 1 and 2|Lost to Follow-up|0|||
130163596|NCT00809159|468558965|FG000|Part 1 and 2|Withdrawal by Subject|0|||
130163597|NCT00809159|468558966|FG001|Part 1 and 2|Withdrawal by Subject|0|||
130163598|NCT00809159|468558967|FG002|Part 1 and 2|Withdrawal by Subject|4|||
130163599|NCT00809159|468558968|FG003|Part 1 and 2|Withdrawal by Subject|0|||
130163600|NCT00809159|468558969|FG004|Part 1 and 2|Withdrawal by Subject|0|||
130163601|NCT00809159|468558970|FG005|Part 1 and 2|Withdrawal by Subject|1|||
130163602|NCT03201211|468558971|FG000|Overall Study|Adverse Event|1|||
130163603|NCT03201211|468558972|FG001|Overall Study|Adverse Event|0|||
130163604|NCT03201211|468558973|FG002|Overall Study|Adverse Event|0|||
130163605|NCT03201211|468558971|FG000|Overall Study|Protocol Violation|1|||
130163606|NCT03201211|468558972|FG001|Overall Study|Protocol Violation|0|||
130163607|NCT03201211|468558973|FG002|Overall Study|Protocol Violation|0|||
130163608|NCT03201211|468558971|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130163609|NCT03201211|468558972|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
130163610|NCT03201211|468558973|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
130163611|NCT03201211|468558971|FG000|Overall Study|OTHER unknown reasons|0|||
130163612|NCT03201211|468558972|FG001|Overall Study|OTHER unknown reasons|1|||
130163613|NCT03201211|468558973|FG002|Overall Study|OTHER unknown reasons|0|||
130163614|NCT01083810|468558974|FG000|Overall Study|Lost to Follow-up|23|||
130163615|NCT01083810|468558975|FG001|Overall Study|Lost to Follow-up|11|||
130163616|NCT01083810|468558976|FG002|Overall Study|Lost to Follow-up|4|||
130163617|NCT01083810|468558974|FG000|Overall Study|Adverse Event|15|||
130163618|NCT01083810|468558975|FG001|Overall Study|Adverse Event|11|||
130163619|NCT01083810|468558976|FG002|Overall Study|Adverse Event|4|||
130163620|NCT01083810|468558974|FG000|Overall Study|Withdrawal by Subject|7|||
130163621|NCT01083810|468558975|FG001|Overall Study|Withdrawal by Subject|2|||
130163622|NCT01083810|468558976|FG002|Overall Study|Withdrawal by Subject|4|||
130163623|NCT01083810|468558974|FG000|Overall Study|Reason not reported|6|||
130163624|NCT01083810|468558975|FG001|Overall Study|Reason not reported|1|||
130163625|NCT01083810|468558976|FG002|Overall Study|Reason not reported|1|||
130163626|NCT01083810|468558974|FG000|Overall Study|Non-compliance|4|||
130163627|NCT01083810|468558975|FG001|Overall Study|Non-compliance|7|||
130163628|NCT01083810|468558976|FG002|Overall Study|Non-compliance|2|||
130163629|NCT01083810|468558974|FG000|Overall Study|Simplification|4|||
130163630|NCT01083810|468558975|FG001|Overall Study|Simplification|1|||
130163631|NCT01083810|468558976|FG002|Overall Study|Simplification|0|||
130163632|NCT01083810|468558974|FG000|Overall Study|Death|2|||
130163633|NCT01083810|468558975|FG001|Overall Study|Death|2|||
130163634|NCT01083810|468558976|FG002|Overall Study|Death|3|||
130163635|NCT01083810|468558974|FG000|Overall Study|Co-morbidities|1|||
130163636|NCT01083810|468558975|FG001|Overall Study|Co-morbidities|0|||
130163637|NCT01083810|468558976|FG002|Overall Study|Co-morbidities|0|||
130163638|NCT01083810|468558974|FG000|Overall Study|Participation in study|1|||
130163639|NCT01083810|468558975|FG001|Overall Study|Participation in study|0|||
130163640|NCT01083810|468558976|FG002|Overall Study|Participation in study|0|||
130163641|NCT01083810|468558974|FG000|Overall Study|Therapy break|1|||
130163642|NCT01083810|468558975|FG001|Overall Study|Therapy break|2|||
130163643|NCT01083810|468558976|FG002|Overall Study|Therapy break|2|||
130163644|NCT01083810|468558974|FG000|Overall Study|Virologic failure|1|||
130163645|NCT01083810|468558975|FG001|Overall Study|Virologic failure|8|||
130163646|NCT01083810|468558976|FG002|Overall Study|Virologic failure|0|||
130163647|NCT02991430|468558979|FG000|Treatment Period 1|Adverse Event|1|||
130163648|NCT02991430|468558980|FG001|Treatment Period 1|Adverse Event|0|||
130163649|NCT02991430|468558981|FG002|Treatment Period 1|Adverse Event|2|||
130163650|NCT02991430|468558979|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130163651|NCT02991430|468558980|FG001|Treatment Period 1|Withdrawal by Subject|4|||
130163652|NCT02991430|468558981|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130163653|NCT02991430|468558979|FG000|Treatment Period 2|Study Termination|6|||
130163654|NCT02991430|468558980|FG001|Treatment Period 2|Study Termination|3|||
130163655|NCT02991430|468558981|FG002|Treatment Period 2|Study Termination|3|||
130163656|NCT02991430|468558979|FG000|Treatment Period 2|Lost to Follow-up|0|||
130163657|NCT02991430|468558980|FG001|Treatment Period 2|Lost to Follow-up|0|||
130163658|NCT02991430|468558981|FG002|Treatment Period 2|Lost to Follow-up|1|||
130163659|NCT02991430|468558979|FG000|Post-treatment Observation Period|Study Termination|3|||
130163660|NCT02991430|468558980|FG001|Post-treatment Observation Period|Study Termination|6|||
130163661|NCT02991430|468558981|FG002|Post-treatment Observation Period|Study Termination|5|||
130163662|NCT03118570|468558982|FG000|Overall Study|Adverse Event|2|||
130163663|NCT03118570|468558983|FG001|Overall Study|Adverse Event|0|||
130163664|NCT03118570|468558984|FG002|Overall Study|Adverse Event|0|||
130163665|NCT03118570|468558985|FG003|Overall Study|Adverse Event|0|||
130163666|NCT03118570|468558986|FG004|Overall Study|Adverse Event|3|||
130163667|NCT03118570|468558982|FG000|Overall Study|Withdrawal by Subject|0|||
130163668|NCT03118570|468558983|FG001|Overall Study|Withdrawal by Subject|1|||
130163669|NCT03118570|468558984|FG002|Overall Study|Withdrawal by Subject|4|||
130163670|NCT03118570|468558985|FG003|Overall Study|Withdrawal by Subject|0|||
130163671|NCT03118570|468558986|FG004|Overall Study|Withdrawal by Subject|1|||
130163672|NCT03118570|468558982|FG000|Overall Study|Lost to Follow-up|2|||
130163673|NCT03118570|468558983|FG001|Overall Study|Lost to Follow-up|3|||
130163674|NCT03118570|468558984|FG002|Overall Study|Lost to Follow-up|1|||
130163675|NCT03118570|468558985|FG003|Overall Study|Lost to Follow-up|0|||
130163676|NCT03118570|468558986|FG004|Overall Study|Lost to Follow-up|1|||
130163677|NCT03118570|468558982|FG000|Overall Study|Other, Not Specified|1|||
130163678|NCT03118570|468558983|FG001|Overall Study|Other, Not Specified|3|||
130163679|NCT03118570|468558984|FG002|Overall Study|Other, Not Specified|0|||
130163680|NCT03118570|468558985|FG003|Overall Study|Other, Not Specified|0|||
130163681|NCT03118570|468558986|FG004|Overall Study|Other, Not Specified|0|||
130163682|NCT03970837|468558987|FG000|Overall Study|Adverse Event|23|||
130163683|NCT03970837|468558988|FG001|Overall Study|Adverse Event|20|||
130163684|NCT03970837|468558989|FG002|Overall Study|Adverse Event|16|||
130163685|NCT03970837|468558990|FG003|Overall Study|Adverse Event|6|||
130163686|NCT03970837|468558991|FG004|Overall Study|Adverse Event|4|||
130163687|NCT03970837|468558992|FG005|Overall Study|Adverse Event|5|||
130163688|NCT03970837|468558993|FG006|Overall Study|Adverse Event|1|||
130163689|NCT03970837|468558994|FG007|Overall Study|Adverse Event|5|||
130163690|NCT03970837|468558995|FG008|Overall Study|Adverse Event|0|||
130163691|NCT03970837|468558996|FG009|Overall Study|Adverse Event|0|||
130163692|NCT03970837|468558997|FG010|Overall Study|Adverse Event|1|||
130163693|NCT03970837|468558998|FG011|Overall Study|Adverse Event|1|||
130163694|NCT03970837|468558987|FG000|Overall Study|Lack of Efficacy|14|||
130163695|NCT03970837|468558988|FG001|Overall Study|Lack of Efficacy|12|||
130163696|NCT03970837|468558989|FG002|Overall Study|Lack of Efficacy|1|||
130163697|NCT03970837|468558990|FG003|Overall Study|Lack of Efficacy|2|||
130163698|NCT03970837|468558991|FG004|Overall Study|Lack of Efficacy|3|||
130163699|NCT03970837|468558992|FG005|Overall Study|Lack of Efficacy|4|||
130163700|NCT03970837|468558993|FG006|Overall Study|Lack of Efficacy|6|||
130163701|NCT03970837|468558994|FG007|Overall Study|Lack of Efficacy|1|||
130163702|NCT03970837|468558995|FG008|Overall Study|Lack of Efficacy|1|||
130163703|NCT03970837|468558996|FG009|Overall Study|Lack of Efficacy|0|||
130163704|NCT03970837|468558997|FG010|Overall Study|Lack of Efficacy|0|||
130163705|NCT03970837|468558998|FG011|Overall Study|Lack of Efficacy|0|||
130163706|NCT03970837|468558987|FG000|Overall Study|Lost to Follow-up|6|||
129981450|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
129981451|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
130163707|NCT03970837|468558988|FG001|Overall Study|Lost to Follow-up|5|||
129981452|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
130163708|NCT03970837|468558989|FG002|Overall Study|Lost to Follow-up|5|||
130163709|NCT03970837|468558990|FG003|Overall Study|Lost to Follow-up|1|||
130163710|NCT03970837|468558991|FG004|Overall Study|Lost to Follow-up|0|||
130163711|NCT03970837|468558992|FG005|Overall Study|Lost to Follow-up|2|||
130163712|NCT03970837|468558993|FG006|Overall Study|Lost to Follow-up|0|||
130163713|NCT03970837|468558994|FG007|Overall Study|Lost to Follow-up|0|||
130163714|NCT03970837|468558995|FG008|Overall Study|Lost to Follow-up|0|||
130163715|NCT03970837|468558996|FG009|Overall Study|Lost to Follow-up|0|||
130163716|NCT03970837|468558997|FG010|Overall Study|Lost to Follow-up|0|||
130163717|NCT03970837|468558998|FG011|Overall Study|Lost to Follow-up|0|||
130163718|NCT03970837|468558987|FG000|Overall Study|Protocol Violation|1|||
130163719|NCT03970837|468558988|FG001|Overall Study|Protocol Violation|0|||
130163720|NCT03970837|468558989|FG002|Overall Study|Protocol Violation|0|||
130163721|NCT03970837|468558990|FG003|Overall Study|Protocol Violation|0|||
130163722|NCT03970837|468558991|FG004|Overall Study|Protocol Violation|0|||
130163723|NCT03970837|468558992|FG005|Overall Study|Protocol Violation|0|||
130163724|NCT03970837|468558993|FG006|Overall Study|Protocol Violation|0|||
130163725|NCT03970837|468558994|FG007|Overall Study|Protocol Violation|0|||
130163726|NCT03970837|468558995|FG008|Overall Study|Protocol Violation|0|||
130163727|NCT03970837|468558996|FG009|Overall Study|Protocol Violation|0|||
130163728|NCT03970837|468558997|FG010|Overall Study|Protocol Violation|0|||
130163729|NCT03970837|468558998|FG011|Overall Study|Protocol Violation|0|||
130163730|NCT03970837|468558987|FG000|Overall Study|Physician Decision|5|||
130163731|NCT03970837|468558988|FG001|Overall Study|Physician Decision|8|||
130163732|NCT03970837|468558989|FG002|Overall Study|Physician Decision|4|||
130163733|NCT03970837|468558990|FG003|Overall Study|Physician Decision|1|||
130163734|NCT03970837|468558991|FG004|Overall Study|Physician Decision|5|||
130163735|NCT03970837|468558992|FG005|Overall Study|Physician Decision|2|||
130163736|NCT03970837|468558993|FG006|Overall Study|Physician Decision|4|||
130163737|NCT03970837|468558994|FG007|Overall Study|Physician Decision|5|||
130163738|NCT03970837|468558995|FG008|Overall Study|Physician Decision|0|||
130163739|NCT03970837|468558996|FG009|Overall Study|Physician Decision|1|||
130163740|NCT03970837|468558997|FG010|Overall Study|Physician Decision|0|||
130163741|NCT03970837|468558998|FG011|Overall Study|Physician Decision|0|||
130163742|NCT03970837|468558987|FG000|Overall Study|Withdrawal by Subject|32|||
130163743|NCT03970837|468558988|FG001|Overall Study|Withdrawal by Subject|35|||
130163744|NCT03970837|468558989|FG002|Overall Study|Withdrawal by Subject|12|||
130163745|NCT03970837|468558990|FG003|Overall Study|Withdrawal by Subject|8|||
130163746|NCT03970837|468558991|FG004|Overall Study|Withdrawal by Subject|6|||
130163747|NCT03970837|468558992|FG005|Overall Study|Withdrawal by Subject|8|||
130163748|NCT03970837|468558993|FG006|Overall Study|Withdrawal by Subject|2|||
130163749|NCT03970837|468558994|FG007|Overall Study|Withdrawal by Subject|3|||
130163750|NCT03970837|468558995|FG008|Overall Study|Withdrawal by Subject|0|||
130163751|NCT03970837|468558996|FG009|Overall Study|Withdrawal by Subject|0|||
130163752|NCT03970837|468558997|FG010|Overall Study|Withdrawal by Subject|0|||
130163753|NCT03970837|468558998|FG011|Overall Study|Withdrawal by Subject|1|||
130163754|NCT03970837|468558987|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
130163755|NCT03970837|468558988|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
130163756|NCT03970837|468558989|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
130163757|NCT03970837|468558990|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130163758|NCT03970837|468558991|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
130163759|NCT03970837|468558992|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130163760|NCT03970837|468558993|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130163761|NCT03970837|468558994|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130163762|NCT03970837|468558995|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
130163763|NCT03970837|468558996|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130163764|NCT03970837|468558997|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130163765|NCT03970837|468558998|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
130163766|NCT03970837|468558987|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130163767|NCT03970837|468558988|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130163768|NCT03970837|468558989|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130163769|NCT03970837|468558990|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130163770|NCT03970837|468558991|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130163771|NCT03970837|468558992|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130163772|NCT03970837|468558993|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
130163773|NCT03970837|468558994|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
130163774|NCT03970837|468558995|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
130163775|NCT03970837|468558996|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
130163776|NCT03970837|468558997|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
130163777|NCT03970837|468558998|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
130163778|NCT02132754|468558999|FG000|Overall Study|Adverse Event|0|||
130163779|NCT02132754|468559000|FG001|Overall Study|Adverse Event|0|||
130163780|NCT02132754|468559001|FG002|Overall Study|Adverse Event|0|||
130163781|NCT02132754|468559002|FG003|Overall Study|Adverse Event|0|||
130163782|NCT02132754|468559003|FG004|Overall Study|Adverse Event|0|||
130163783|NCT02132754|468559004|FG005|Overall Study|Adverse Event|0|||
129981453|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
130163784|NCT02132754|468559005|FG006|Overall Study|Adverse Event|0|||
130163785|NCT02132754|468559006|FG007|Overall Study|Adverse Event|0|||
130163786|NCT02132754|468559007|FG008|Overall Study|Adverse Event|0|||
130163787|NCT02132754|468559008|FG009|Overall Study|Adverse Event|0|||
130163788|NCT02132754|468559009|FG010|Overall Study|Adverse Event|0|||
130163789|NCT02132754|468559010|FG011|Overall Study|Adverse Event|0|||
130163790|NCT02132754|468559011|FG012|Overall Study|Adverse Event|0|||
130163791|NCT02132754|468559012|FG013|Overall Study|Adverse Event|0|||
130163792|NCT02132754|468559013|FG014|Overall Study|Adverse Event|0|||
129981454|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
129981455|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
130163793|NCT02132754|468559014|FG015|Overall Study|Adverse Event|0|||
130163794|NCT02132754|468559015|FG016|Overall Study|Adverse Event|0|||
130163795|NCT02132754|468559016|FG017|Overall Study|Adverse Event|1|||
130163796|NCT02132754|468559017|FG018|Overall Study|Adverse Event|0|||
130163797|NCT02132754|468559018|FG019|Overall Study|Adverse Event|0|||
130163798|NCT02132754|468559019|FG020|Overall Study|Adverse Event|0|||
130163799|NCT02132754|468559020|FG021|Overall Study|Adverse Event|0|||
130163800|NCT02132754|468559021|FG022|Overall Study|Adverse Event|0|||
130163801|NCT02132754|468559022|FG023|Overall Study|Adverse Event|0|||
130163802|NCT02132754|468559023|FG024|Overall Study|Adverse Event|0|||
130163803|NCT02132754|468559024|FG025|Overall Study|Adverse Event|1|||
130163804|NCT02132754|468559025|FG026|Overall Study|Adverse Event|1|||
130163805|NCT02132754|468559026|FG027|Overall Study|Adverse Event|0|||
130163806|NCT02132754|468559027|FG028|Overall Study|Adverse Event|0|||
130163807|NCT02132754|468559028|FG029|Overall Study|Adverse Event|0|||
130163808|NCT02132754|468559029|FG030|Overall Study|Adverse Event|1|||
130163809|NCT02132754|468559030|FG031|Overall Study|Adverse Event|0|||
130163810|NCT02132754|468559031|FG032|Overall Study|Adverse Event|1|||
130163811|NCT02132754|468559032|FG033|Overall Study|Adverse Event|1|||
130163812|NCT02132754|468558999|FG000|Overall Study|Clinical Progression|0|||
130163813|NCT02132754|468559000|FG001|Overall Study|Clinical Progression|0|||
130163814|NCT02132754|468559001|FG002|Overall Study|Clinical Progression|0|||
130163815|NCT02132754|468559002|FG003|Overall Study|Clinical Progression|0|||
130163816|NCT02132754|468559003|FG004|Overall Study|Clinical Progression|0|||
130163817|NCT02132754|468559004|FG005|Overall Study|Clinical Progression|0|||
130163818|NCT02132754|468559005|FG006|Overall Study|Clinical Progression|0|||
130163819|NCT02132754|468559006|FG007|Overall Study|Clinical Progression|0|||
130163820|NCT02132754|468559007|FG008|Overall Study|Clinical Progression|0|||
130163821|NCT02132754|468559008|FG009|Overall Study|Clinical Progression|1|||
130163822|NCT02132754|468559009|FG010|Overall Study|Clinical Progression|0|||
130163823|NCT02132754|468559010|FG011|Overall Study|Clinical Progression|0|||
130163824|NCT02132754|468559011|FG012|Overall Study|Clinical Progression|0|||
130163825|NCT02132754|468559012|FG013|Overall Study|Clinical Progression|0|||
130163826|NCT02132754|468559013|FG014|Overall Study|Clinical Progression|0|||
130163827|NCT02132754|468559014|FG015|Overall Study|Clinical Progression|0|||
130163828|NCT02132754|468559015|FG016|Overall Study|Clinical Progression|1|||
130163829|NCT02132754|468559016|FG017|Overall Study|Clinical Progression|1|||
130163830|NCT02132754|468559017|FG018|Overall Study|Clinical Progression|0|||
130163831|NCT02132754|468559018|FG019|Overall Study|Clinical Progression|1|||
130163832|NCT02132754|468559019|FG020|Overall Study|Clinical Progression|0|||
130163833|NCT02132754|468559020|FG021|Overall Study|Clinical Progression|0|||
130163834|NCT02132754|468559021|FG022|Overall Study|Clinical Progression|1|||
130163835|NCT02132754|468559022|FG023|Overall Study|Clinical Progression|0|||
130163836|NCT02132754|468559023|FG024|Overall Study|Clinical Progression|1|||
130163837|NCT02132754|468559024|FG025|Overall Study|Clinical Progression|1|||
130163838|NCT02132754|468559025|FG026|Overall Study|Clinical Progression|0|||
130163839|NCT02132754|468559026|FG027|Overall Study|Clinical Progression|1|||
130163840|NCT02132754|468559027|FG028|Overall Study|Clinical Progression|1|||
130163841|NCT02132754|468559028|FG029|Overall Study|Clinical Progression|0|||
130163842|NCT02132754|468559029|FG030|Overall Study|Clinical Progression|1|||
130163843|NCT02132754|468559030|FG031|Overall Study|Clinical Progression|0|||
130163844|NCT02132754|468559031|FG032|Overall Study|Clinical Progression|0|||
130163845|NCT02132754|468559032|FG033|Overall Study|Clinical Progression|2|||
130163846|NCT02132754|468558999|FG000|Overall Study|Death|0|||
130163847|NCT02132754|468559000|FG001|Overall Study|Death|0|||
130163848|NCT02132754|468559001|FG002|Overall Study|Death|0|||
130163849|NCT02132754|468559002|FG003|Overall Study|Death|0|||
130163850|NCT02132754|468559003|FG004|Overall Study|Death|0|||
130163851|NCT02132754|468559004|FG005|Overall Study|Death|0|||
130163852|NCT02132754|468559005|FG006|Overall Study|Death|0|||
130163853|NCT02132754|468559006|FG007|Overall Study|Death|0|||
130163854|NCT02132754|468559007|FG008|Overall Study|Death|0|||
130163855|NCT02132754|468559008|FG009|Overall Study|Death|0|||
130163856|NCT02132754|468559009|FG010|Overall Study|Death|0|||
130163857|NCT02132754|468559010|FG011|Overall Study|Death|0|||
130163858|NCT02132754|468559011|FG012|Overall Study|Death|0|||
130163859|NCT02132754|468559012|FG013|Overall Study|Death|0|||
130163860|NCT02132754|468559013|FG014|Overall Study|Death|0|||
130163861|NCT02132754|468559014|FG015|Overall Study|Death|1|||
130163862|NCT02132754|468559015|FG016|Overall Study|Death|0|||
130163863|NCT02132754|468559016|FG017|Overall Study|Death|0|||
130163864|NCT02132754|468559017|FG018|Overall Study|Death|0|||
130163865|NCT02132754|468559018|FG019|Overall Study|Death|1|||
130163866|NCT02132754|468559019|FG020|Overall Study|Death|0|||
130163867|NCT02132754|468559020|FG021|Overall Study|Death|1|||
130163868|NCT02132754|468559021|FG022|Overall Study|Death|0|||
130163869|NCT02132754|468559022|FG023|Overall Study|Death|0|||
130163870|NCT02132754|468559023|FG024|Overall Study|Death|0|||
130163871|NCT02132754|468559024|FG025|Overall Study|Death|0|||
130163872|NCT02132754|468559025|FG026|Overall Study|Death|1|||
130163873|NCT02132754|468559026|FG027|Overall Study|Death|0|||
130163874|NCT02132754|468559027|FG028|Overall Study|Death|0|||
130163875|NCT02132754|468559028|FG029|Overall Study|Death|0|||
130163876|NCT02132754|468559029|FG030|Overall Study|Death|0|||
130163877|NCT02132754|468559030|FG031|Overall Study|Death|0|||
130163878|NCT02132754|468559031|FG032|Overall Study|Death|0|||
130163879|NCT02132754|468559032|FG033|Overall Study|Death|2|||
130163880|NCT02132754|468558999|FG000|Overall Study|Excluded Medication|0|||
130163881|NCT02132754|468559000|FG001|Overall Study|Excluded Medication|0|||
130163882|NCT02132754|468559001|FG002|Overall Study|Excluded Medication|0|||
130163883|NCT02132754|468559002|FG003|Overall Study|Excluded Medication|0|||
130163884|NCT02132754|468559003|FG004|Overall Study|Excluded Medication|0|||
130163885|NCT02132754|468559004|FG005|Overall Study|Excluded Medication|0|||
130163886|NCT02132754|468559005|FG006|Overall Study|Excluded Medication|0|||
130163887|NCT02132754|468559006|FG007|Overall Study|Excluded Medication|0|||
130163888|NCT02132754|468559007|FG008|Overall Study|Excluded Medication|0|||
130163889|NCT02132754|468559008|FG009|Overall Study|Excluded Medication|0|||
130163890|NCT02132754|468559009|FG010|Overall Study|Excluded Medication|0|||
130163891|NCT02132754|468559010|FG011|Overall Study|Excluded Medication|0|||
130163892|NCT02132754|468559011|FG012|Overall Study|Excluded Medication|0|||
130163893|NCT02132754|468559012|FG013|Overall Study|Excluded Medication|0|||
130163894|NCT02132754|468559013|FG014|Overall Study|Excluded Medication|0|||
130163895|NCT02132754|468559014|FG015|Overall Study|Excluded Medication|0|||
130163896|NCT02132754|468559015|FG016|Overall Study|Excluded Medication|0|||
130163897|NCT02132754|468559016|FG017|Overall Study|Excluded Medication|0|||
130163898|NCT02132754|468559017|FG018|Overall Study|Excluded Medication|0|||
130163899|NCT02132754|468559018|FG019|Overall Study|Excluded Medication|0|||
130163900|NCT02132754|468559019|FG020|Overall Study|Excluded Medication|1|||
130163901|NCT02132754|468559020|FG021|Overall Study|Excluded Medication|0|||
130163902|NCT02132754|468559021|FG022|Overall Study|Excluded Medication|0|||
130163903|NCT02132754|468559022|FG023|Overall Study|Excluded Medication|0|||
130163904|NCT02132754|468559023|FG024|Overall Study|Excluded Medication|0|||
130163905|NCT02132754|468559024|FG025|Overall Study|Excluded Medication|0|||
130163906|NCT02132754|468559025|FG026|Overall Study|Excluded Medication|0|||
130163907|NCT02132754|468559026|FG027|Overall Study|Excluded Medication|0|||
130163908|NCT02132754|468559027|FG028|Overall Study|Excluded Medication|0|||
130163909|NCT02132754|468559028|FG029|Overall Study|Excluded Medication|0|||
130163910|NCT02132754|468559029|FG030|Overall Study|Excluded Medication|0|||
130163911|NCT02132754|468559030|FG031|Overall Study|Excluded Medication|0|||
130163912|NCT02132754|468559031|FG032|Overall Study|Excluded Medication|0|||
130163913|NCT02132754|468559032|FG033|Overall Study|Excluded Medication|1|||
130163914|NCT02132754|468558999|FG000|Overall Study|Physician Decision|0|||
130163915|NCT02132754|468559000|FG001|Overall Study|Physician Decision|0|||
130163916|NCT02132754|468559001|FG002|Overall Study|Physician Decision|0|||
130163917|NCT02132754|468559002|FG003|Overall Study|Physician Decision|0|||
130163918|NCT02132754|468559003|FG004|Overall Study|Physician Decision|0|||
130163919|NCT02132754|468559004|FG005|Overall Study|Physician Decision|0|||
130163920|NCT02132754|468559005|FG006|Overall Study|Physician Decision|0|||
130163921|NCT02132754|468559006|FG007|Overall Study|Physician Decision|0|||
130163922|NCT02132754|468559007|FG008|Overall Study|Physician Decision|0|||
130163923|NCT02132754|468559008|FG009|Overall Study|Physician Decision|1|||
130163924|NCT02132754|468559009|FG010|Overall Study|Physician Decision|0|||
130163925|NCT02132754|468559010|FG011|Overall Study|Physician Decision|1|||
130163926|NCT02132754|468559011|FG012|Overall Study|Physician Decision|1|||
130163927|NCT02132754|468559012|FG013|Overall Study|Physician Decision|0|||
130163928|NCT02132754|468559013|FG014|Overall Study|Physician Decision|0|||
130163929|NCT02132754|468559014|FG015|Overall Study|Physician Decision|1|||
130163930|NCT02132754|468559015|FG016|Overall Study|Physician Decision|0|||
130163931|NCT02132754|468559016|FG017|Overall Study|Physician Decision|0|||
130163932|NCT02132754|468559017|FG018|Overall Study|Physician Decision|0|||
130163933|NCT02132754|468559018|FG019|Overall Study|Physician Decision|0|||
129981456|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129981457|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129981458|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129981459|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
130163934|NCT02132754|468559019|FG020|Overall Study|Physician Decision|0|||
130163935|NCT02132754|468559020|FG021|Overall Study|Physician Decision|0|||
130163936|NCT02132754|468559021|FG022|Overall Study|Physician Decision|0|||
130163937|NCT02132754|468559022|FG023|Overall Study|Physician Decision|0|||
130163938|NCT02132754|468559023|FG024|Overall Study|Physician Decision|1|||
130163939|NCT02132754|468559024|FG025|Overall Study|Physician Decision|0|||
130163940|NCT02132754|468559025|FG026|Overall Study|Physician Decision|0|||
130163941|NCT02132754|468559026|FG027|Overall Study|Physician Decision|0|||
130163942|NCT02132754|468559027|FG028|Overall Study|Physician Decision|0|||
130163943|NCT02132754|468559028|FG029|Overall Study|Physician Decision|0|||
130163944|NCT02132754|468559029|FG030|Overall Study|Physician Decision|0|||
130163945|NCT02132754|468559030|FG031|Overall Study|Physician Decision|1|||
130163946|NCT02132754|468559031|FG032|Overall Study|Physician Decision|0|||
130163947|NCT02132754|468559032|FG033|Overall Study|Physician Decision|3|||
130163948|NCT02132754|468558999|FG000|Overall Study|Progressive Disease|1|||
130163949|NCT02132754|468559000|FG001|Overall Study|Progressive Disease|1|||
130163950|NCT02132754|468559001|FG002|Overall Study|Progressive Disease|1|||
130163951|NCT02132754|468559002|FG003|Overall Study|Progressive Disease|1|||
130163952|NCT02132754|468559003|FG004|Overall Study|Progressive Disease|1|||
130163953|NCT02132754|468559004|FG005|Overall Study|Progressive Disease|1|||
130163954|NCT02132754|468559005|FG006|Overall Study|Progressive Disease|1|||
130163955|NCT02132754|468559006|FG007|Overall Study|Progressive Disease|1|||
130163956|NCT02132754|468559007|FG008|Overall Study|Progressive Disease|1|||
130163957|NCT02132754|468559008|FG009|Overall Study|Progressive Disease|3|||
130163958|NCT02132754|468559009|FG010|Overall Study|Progressive Disease|3|||
130163959|NCT02132754|468559010|FG011|Overall Study|Progressive Disease|2|||
130163960|NCT02132754|468559011|FG012|Overall Study|Progressive Disease|2|||
130163961|NCT02132754|468559012|FG013|Overall Study|Progressive Disease|3|||
130163962|NCT02132754|468559013|FG014|Overall Study|Progressive Disease|2|||
130163963|NCT02132754|468559014|FG015|Overall Study|Progressive Disease|1|||
130163964|NCT02132754|468559015|FG016|Overall Study|Progressive Disease|2|||
130163965|NCT02132754|468559016|FG017|Overall Study|Progressive Disease|1|||
130163966|NCT02132754|468559017|FG018|Overall Study|Progressive Disease|3|||
130163967|NCT02132754|468559018|FG019|Overall Study|Progressive Disease|1|||
130163968|NCT02132754|468559019|FG020|Overall Study|Progressive Disease|1|||
130163969|NCT02132754|468559020|FG021|Overall Study|Progressive Disease|3|||
130163970|NCT02132754|468559021|FG022|Overall Study|Progressive Disease|2|||
130163971|NCT02132754|468559022|FG023|Overall Study|Progressive Disease|3|||
130163972|NCT02132754|468559023|FG024|Overall Study|Progressive Disease|0|||
130163973|NCT02132754|468559024|FG025|Overall Study|Progressive Disease|1|||
130163974|NCT02132754|468559025|FG026|Overall Study|Progressive Disease|2|||
130163975|NCT02132754|468559026|FG027|Overall Study|Progressive Disease|1|||
130163976|NCT02132754|468559027|FG028|Overall Study|Progressive Disease|2|||
130163977|NCT02132754|468559028|FG029|Overall Study|Progressive Disease|3|||
130163978|NCT02132754|468559029|FG030|Overall Study|Progressive Disease|1|||
130163979|NCT02132754|468559030|FG031|Overall Study|Progressive Disease|1|||
130163980|NCT02132754|468559031|FG032|Overall Study|Progressive Disease|3|||
130163981|NCT02132754|468559032|FG033|Overall Study|Progressive Disease|6|||
130163982|NCT02132754|468558999|FG000|Overall Study|Screen Failure|0|||
130163983|NCT02132754|468559000|FG001|Overall Study|Screen Failure|0|||
130163984|NCT02132754|468559001|FG002|Overall Study|Screen Failure|0|||
130163985|NCT02132754|468559002|FG003|Overall Study|Screen Failure|0|||
130163986|NCT02132754|468559003|FG004|Overall Study|Screen Failure|0|||
130163987|NCT02132754|468559004|FG005|Overall Study|Screen Failure|0|||
130163988|NCT02132754|468559005|FG006|Overall Study|Screen Failure|0|||
130163989|NCT02132754|468559006|FG007|Overall Study|Screen Failure|0|||
130163990|NCT02132754|468559007|FG008|Overall Study|Screen Failure|0|||
130163991|NCT02132754|468559008|FG009|Overall Study|Screen Failure|0|||
130163992|NCT02132754|468559009|FG010|Overall Study|Screen Failure|0|||
130163993|NCT02132754|468559010|FG011|Overall Study|Screen Failure|0|||
130163994|NCT02132754|468559011|FG012|Overall Study|Screen Failure|0|||
130163995|NCT02132754|468559012|FG013|Overall Study|Screen Failure|0|||
130163996|NCT02132754|468559013|FG014|Overall Study|Screen Failure|0|||
130163997|NCT02132754|468559014|FG015|Overall Study|Screen Failure|0|||
130163998|NCT02132754|468559015|FG016|Overall Study|Screen Failure|0|||
130163999|NCT02132754|468559016|FG017|Overall Study|Screen Failure|0|||
130164000|NCT02132754|468559017|FG018|Overall Study|Screen Failure|0|||
130164001|NCT02132754|468559018|FG019|Overall Study|Screen Failure|1|||
130164002|NCT02132754|468559019|FG020|Overall Study|Screen Failure|0|||
130164003|NCT02132754|468559020|FG021|Overall Study|Screen Failure|1|||
130164004|NCT02132754|468559021|FG022|Overall Study|Screen Failure|0|||
130164005|NCT02132754|468559022|FG023|Overall Study|Screen Failure|0|||
130164006|NCT02132754|468559023|FG024|Overall Study|Screen Failure|0|||
130164007|NCT02132754|468559024|FG025|Overall Study|Screen Failure|0|||
129981460|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
129981461|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129981462|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129981463|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129981464|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
130164008|NCT02132754|468559025|FG026|Overall Study|Screen Failure|0|||
130164009|NCT02132754|468559026|FG027|Overall Study|Screen Failure|0|||
130164010|NCT02132754|468559027|FG028|Overall Study|Screen Failure|0|||
130164011|NCT02132754|468559028|FG029|Overall Study|Screen Failure|0|||
130164012|NCT02132754|468559029|FG030|Overall Study|Screen Failure|0|||
130164013|NCT02132754|468559030|FG031|Overall Study|Screen Failure|0|||
130164014|NCT02132754|468559031|FG032|Overall Study|Screen Failure|0|||
130164015|NCT02132754|468559032|FG033|Overall Study|Screen Failure|0|||
130164016|NCT02132754|468558999|FG000|Overall Study|Transferred to Extension Study|0|||
130164017|NCT02132754|468559000|FG001|Overall Study|Transferred to Extension Study|0|||
130164018|NCT02132754|468559001|FG002|Overall Study|Transferred to Extension Study|0|||
129981465|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
130164019|NCT02132754|468559002|FG003|Overall Study|Transferred to Extension Study|0|||
130164020|NCT02132754|468559003|FG004|Overall Study|Transferred to Extension Study|0|||
130164021|NCT02132754|468559004|FG005|Overall Study|Transferred to Extension Study|0|||
130164022|NCT02132754|468559005|FG006|Overall Study|Transferred to Extension Study|0|||
130164023|NCT02132754|468559006|FG007|Overall Study|Transferred to Extension Study|0|||
130164024|NCT02132754|468559007|FG008|Overall Study|Transferred to Extension Study|0|||
130164025|NCT02132754|468559008|FG009|Overall Study|Transferred to Extension Study|0|||
130164026|NCT02132754|468559009|FG010|Overall Study|Transferred to Extension Study|0|||
130164027|NCT02132754|468559010|FG011|Overall Study|Transferred to Extension Study|0|||
130164028|NCT02132754|468559011|FG012|Overall Study|Transferred to Extension Study|0|||
130164029|NCT02132754|468559012|FG013|Overall Study|Transferred to Extension Study|0|||
130164030|NCT02132754|468559013|FG014|Overall Study|Transferred to Extension Study|0|||
130164031|NCT02132754|468559014|FG015|Overall Study|Transferred to Extension Study|0|||
130164032|NCT02132754|468559015|FG016|Overall Study|Transferred to Extension Study|0|||
130164033|NCT02132754|468559016|FG017|Overall Study|Transferred to Extension Study|0|||
130164034|NCT02132754|468559017|FG018|Overall Study|Transferred to Extension Study|0|||
130164035|NCT02132754|468559018|FG019|Overall Study|Transferred to Extension Study|0|||
130164036|NCT02132754|468559019|FG020|Overall Study|Transferred to Extension Study|0|||
130164037|NCT02132754|468559020|FG021|Overall Study|Transferred to Extension Study|0|||
130164038|NCT02132754|468559021|FG022|Overall Study|Transferred to Extension Study|0|||
130164039|NCT02132754|468559022|FG023|Overall Study|Transferred to Extension Study|0|||
130164040|NCT02132754|468559023|FG024|Overall Study|Transferred to Extension Study|0|||
130164041|NCT02132754|468559024|FG025|Overall Study|Transferred to Extension Study|0|||
130164042|NCT02132754|468559025|FG026|Overall Study|Transferred to Extension Study|0|||
130164043|NCT02132754|468559026|FG027|Overall Study|Transferred to Extension Study|0|||
130164044|NCT02132754|468559027|FG028|Overall Study|Transferred to Extension Study|0|||
130164045|NCT02132754|468559028|FG029|Overall Study|Transferred to Extension Study|0|||
130164046|NCT02132754|468559029|FG030|Overall Study|Transferred to Extension Study|0|||
130164047|NCT02132754|468559030|FG031|Overall Study|Transferred to Extension Study|0|||
130164048|NCT02132754|468559031|FG032|Overall Study|Transferred to Extension Study|0|||
130164049|NCT02132754|468559032|FG033|Overall Study|Transferred to Extension Study|6|||
130164050|NCT02132754|468558999|FG000|Overall Study|Withdrawal by Subject|0|||
130164051|NCT02132754|468559000|FG001|Overall Study|Withdrawal by Subject|0|||
130164052|NCT02132754|468559001|FG002|Overall Study|Withdrawal by Subject|0|||
130164053|NCT02132754|468559002|FG003|Overall Study|Withdrawal by Subject|0|||
130164054|NCT02132754|468559003|FG004|Overall Study|Withdrawal by Subject|0|||
130164055|NCT02132754|468559004|FG005|Overall Study|Withdrawal by Subject|0|||
130164056|NCT02132754|468559005|FG006|Overall Study|Withdrawal by Subject|0|||
130164057|NCT02132754|468559006|FG007|Overall Study|Withdrawal by Subject|0|||
130164058|NCT02132754|468559007|FG008|Overall Study|Withdrawal by Subject|0|||
130164059|NCT02132754|468559008|FG009|Overall Study|Withdrawal by Subject|1|||
130164060|NCT02132754|468559009|FG010|Overall Study|Withdrawal by Subject|0|||
130164061|NCT02132754|468559010|FG011|Overall Study|Withdrawal by Subject|0|||
130164062|NCT02132754|468559011|FG012|Overall Study|Withdrawal by Subject|1|||
130164063|NCT02132754|468559012|FG013|Overall Study|Withdrawal by Subject|0|||
130164064|NCT02132754|468559013|FG014|Overall Study|Withdrawal by Subject|1|||
130164065|NCT02132754|468559014|FG015|Overall Study|Withdrawal by Subject|2|||
130164066|NCT02132754|468559015|FG016|Overall Study|Withdrawal by Subject|1|||
130164067|NCT02132754|468559016|FG017|Overall Study|Withdrawal by Subject|0|||
130164068|NCT02132754|468559017|FG018|Overall Study|Withdrawal by Subject|0|||
130164069|NCT02132754|468559018|FG019|Overall Study|Withdrawal by Subject|0|||
130164070|NCT02132754|468559019|FG020|Overall Study|Withdrawal by Subject|1|||
130164071|NCT02132754|468559020|FG021|Overall Study|Withdrawal by Subject|0|||
130164072|NCT02132754|468559021|FG022|Overall Study|Withdrawal by Subject|0|||
130164073|NCT02132754|468559022|FG023|Overall Study|Withdrawal by Subject|0|||
130164074|NCT02132754|468559023|FG024|Overall Study|Withdrawal by Subject|1|||
130164075|NCT02132754|468559024|FG025|Overall Study|Withdrawal by Subject|0|||
130164076|NCT02132754|468559025|FG026|Overall Study|Withdrawal by Subject|0|||
130164077|NCT02132754|468559026|FG027|Overall Study|Withdrawal by Subject|1|||
130164078|NCT02132754|468559027|FG028|Overall Study|Withdrawal by Subject|0|||
130164079|NCT02132754|468559028|FG029|Overall Study|Withdrawal by Subject|0|||
130164080|NCT02132754|468559029|FG030|Overall Study|Withdrawal by Subject|0|||
129981466|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
129981467|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
129981468|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
130164081|NCT02132754|468559030|FG031|Overall Study|Withdrawal by Subject|1|||
130164082|NCT02132754|468559031|FG032|Overall Study|Withdrawal by Subject|0|||
130164083|NCT02132754|468559032|FG033|Overall Study|Withdrawal by Subject|2|||
130164084|NCT00477295|468559037|FG000|Overall Study|Adverse Event|31|||
130164085|NCT00477295|468559038|FG001|Overall Study|Adverse Event|35|||
130164086|NCT00477295|468559037|FG000|Overall Study|Withdrawal by Subject|35|||
130164087|NCT00477295|468559038|FG001|Overall Study|Withdrawal by Subject|24|||
130164088|NCT00477295|468559037|FG000|Overall Study|Lack of Efficacy|23|||
130164089|NCT00477295|468559038|FG001|Overall Study|Lack of Efficacy|23|||
130164090|NCT00477295|468559037|FG000|Overall Study|Protocol Violation|3|||
129981469|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
130164091|NCT00477295|468559038|FG001|Overall Study|Protocol Violation|8|||
130164092|NCT00477295|468559037|FG000|Overall Study|Physician Decision|4|||
130164093|NCT00477295|468559038|FG001|Overall Study|Physician Decision|5|||
130164094|NCT00477295|468559037|FG000|Overall Study|Lost to Follow-up|21|||
130164095|NCT00477295|468559038|FG001|Overall Study|Lost to Follow-up|11|||
130164096|NCT00477295|468559037|FG000|Overall Study|Other|4|||
130164097|NCT00477295|468559038|FG001|Overall Study|Other|3|||
130164098|NCT00228423|468559041|FG000|Overall Study|Adverse Event|2|||
130164099|NCT00228423|468559042|FG001|Overall Study|Adverse Event|5|||
130164100|NCT00228423|468559041|FG000|Overall Study|Withdrawal by Subject|7|||
130164101|NCT00228423|468559042|FG001|Overall Study|Withdrawal by Subject|3|||
130164102|NCT00228423|468559041|FG000|Overall Study|Protocol Violation|1|||
130164103|NCT00228423|468559042|FG001|Overall Study|Protocol Violation|3|||
130164104|NCT00228423|468559041|FG000|Overall Study|Physician Decision|0|||
130164105|NCT00228423|468559042|FG001|Overall Study|Physician Decision|1|||
130164106|NCT01709838|468559056|FG000|Overall Study|Withdrawal by Subject|21|||
130164107|NCT01709838|468559056|FG000|Overall Study|Lost to Follow-up|16|||
130164108|NCT01709838|468559056|FG000|Overall Study|Pregnancy|10|||
130164109|NCT01709838|468559056|FG000|Overall Study|Subject/guardian decision|8|||
130164110|NCT01709838|468559056|FG000|Overall Study|Adverse Event|4|||
130164111|NCT01709838|468559056|FG000|Overall Study|Physician Decision|4|||
130164112|NCT01709838|468559056|FG000|Overall Study|Death|3|||
130164113|NCT01709838|468559056|FG000|Overall Study|Protocol Violation|1|||
130164114|NCT03433755|468559061|FG000|Overall Study|Lost to Follow-up|1|||
130164115|NCT03433755|468559062|FG001|Overall Study|Lost to Follow-up|0|||
130164116|NCT03433755|468559063|FG002|Overall Study|Lost to Follow-up|0|||
130164117|NCT03433755|468559064|FG003|Overall Study|Lost to Follow-up|0|||
130164118|NCT03433755|468559061|FG000|Overall Study|Decision by Sponsor|1|||
130164119|NCT03433755|468559062|FG001|Overall Study|Decision by Sponsor|0|||
130164120|NCT03433755|468559063|FG002|Overall Study|Decision by Sponsor|0|||
130164121|NCT03433755|468559064|FG003|Overall Study|Decision by Sponsor|0|||
130164122|NCT03190330|468560975|FG000|Overall Study|Adverse Event|2|||
130164123|NCT03190330|468560975|FG000|Overall Study|Death|10|||
130164124|NCT03190330|468560975|FG000|Overall Study|Lost to Follow-up|1|||
130164125|NCT03190330|468560975|FG000|Overall Study|Withdrawal by Subject|6|||
130164126|NCT03190330|468560975|FG000|Overall Study|Progressive Disease|1|||
130164127|NCT03845296|468560984|FG000|Overall Study|On Treatment|2|||
130164128|NCT03845296|468560985|FG001|Overall Study|On Treatment|1|||
130164129|NCT03845296|468560984|FG000|Overall Study|Adverse Event|4|||
130164130|NCT03845296|468560985|FG001|Overall Study|Adverse Event|11|||
130164131|NCT03845296|468560984|FG000|Overall Study|Refusal unrelated to adverse event|0|||
130164132|NCT03845296|468560985|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130164133|NCT03845296|468560984|FG000|Overall Study|Progression/relapse|14|||
130164134|NCT03845296|468560985|FG001|Overall Study|Progression/relapse|18|||
130164135|NCT03845296|468560984|FG000|Overall Study|Death|4|||
130164136|NCT03845296|468560985|FG001|Overall Study|Death|0|||
130164137|NCT03845296|468560984|FG000|Overall Study|Other - not protocol specified|1|||
130164138|NCT03845296|468560985|FG001|Overall Study|Other - not protocol specified|3|||
130164139|NCT03611543|468560988|FG000|Overall Study|Withdrawal by Subject|4|||
130164140|NCT03611543|468560989|FG001|Overall Study|Withdrawal by Subject|4|||
130164141|NCT03611543|468560988|FG000|Overall Study|Physician Decision|1|||
130164142|NCT03611543|468560989|FG001|Overall Study|Physician Decision|1|||
130164143|NCT03611543|468560988|FG000|Overall Study|Protocol Violation|2|||
130164144|NCT03611543|468560989|FG001|Overall Study|Protocol Violation|2|||
130164145|NCT03611543|468560988|FG000|Overall Study|Device failure|2|||
130164146|NCT03611543|468560989|FG001|Overall Study|Device failure|2|||
130164147|NCT03611543|468560988|FG000|Overall Study|Missing information|5|||
130164148|NCT03611543|468560989|FG001|Overall Study|Missing information|5|||
130164149|NCT02081209|468560990|FG000|Overall Study|Withdrawal by Subject|1|||
130164150|NCT02799095|468560998|FG000|Part A|Adverse Event|1|||
130164151|NCT02799095|468560999|FG001|Part A|Adverse Event|0|||
130164152|NCT02799095|468561000|FG002|Part A|Adverse Event|1|||
129981470|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
129981471|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
129981472|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
129981473|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981474|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
130164153|NCT02799095|468561001|FG003|Part A|Adverse Event|4|||
130164154|NCT02799095|468561002|FG004|Part A|Adverse Event|1|||
130164155|NCT02799095|468561003|FG005|Part A|Adverse Event|0|||
130164156|NCT02799095|468561004|FG006|Part A|Adverse Event|0|||
130164157|NCT02799095|468561005|FG007|Part A|Adverse Event|0|||
130164158|NCT02799095|468561006|FG008|Part A|Adverse Event|0|||
130164159|NCT02799095|468561007|FG009|Part A|Adverse Event|0|||
130164160|NCT02799095|468561008|FG010|Part A|Adverse Event|0|||
130164161|NCT02799095|468561009|FG011|Part A|Adverse Event|0|||
130164162|NCT02799095|468561010|FG012|Part A|Adverse Event|0|||
130164163|NCT02799095|468561011|FG013|Part A|Adverse Event|0|||
130164164|NCT02799095|468561012|FG014|Part A|Adverse Event|0|||
130164165|NCT02799095|468561013|FG015|Part A|Adverse Event|0|||
130164166|NCT02799095|468561014|FG016|Part A|Adverse Event|0|||
130164167|NCT02799095|468560998|FG000|Part A|Death|0|||
130164168|NCT02799095|468560999|FG001|Part A|Death|0|||
130164169|NCT02799095|468561000|FG002|Part A|Death|0|||
130164170|NCT02799095|468561001|FG003|Part A|Death|0|||
130164171|NCT02799095|468561002|FG004|Part A|Death|0|||
130164172|NCT02799095|468561003|FG005|Part A|Death|0|||
130164173|NCT02799095|468561004|FG006|Part A|Death|3|||
130164174|NCT02799095|468561005|FG007|Part A|Death|0|||
130164175|NCT02799095|468561006|FG008|Part A|Death|0|||
130164176|NCT02799095|468561007|FG009|Part A|Death|0|||
130164177|NCT02799095|468561008|FG010|Part A|Death|0|||
130164178|NCT02799095|468561009|FG011|Part A|Death|0|||
130164179|NCT02799095|468561010|FG012|Part A|Death|0|||
130164180|NCT02799095|468561011|FG013|Part A|Death|0|||
130164181|NCT02799095|468561012|FG014|Part A|Death|0|||
130164182|NCT02799095|468561013|FG015|Part A|Death|0|||
130164183|NCT02799095|468561014|FG016|Part A|Death|0|||
130164184|NCT02799095|468560998|FG000|Part A|Lost to Follow-up|0|||
130164185|NCT02799095|468560999|FG001|Part A|Lost to Follow-up|1|||
130164186|NCT02799095|468561000|FG002|Part A|Lost to Follow-up|0|||
130164187|NCT02799095|468561001|FG003|Part A|Lost to Follow-up|0|||
130164188|NCT02799095|468561002|FG004|Part A|Lost to Follow-up|0|||
130164189|NCT02799095|468561003|FG005|Part A|Lost to Follow-up|0|||
130164190|NCT02799095|468561004|FG006|Part A|Lost to Follow-up|1|||
130164191|NCT02799095|468561005|FG007|Part A|Lost to Follow-up|0|||
130164192|NCT02799095|468561006|FG008|Part A|Lost to Follow-up|0|||
130164193|NCT02799095|468561007|FG009|Part A|Lost to Follow-up|0|||
130164194|NCT02799095|468561008|FG010|Part A|Lost to Follow-up|0|||
130164195|NCT02799095|468561009|FG011|Part A|Lost to Follow-up|0|||
130164196|NCT02799095|468561010|FG012|Part A|Lost to Follow-up|0|||
130164197|NCT02799095|468561011|FG013|Part A|Lost to Follow-up|0|||
130164198|NCT02799095|468561012|FG014|Part A|Lost to Follow-up|0|||
130164199|NCT02799095|468561013|FG015|Part A|Lost to Follow-up|0|||
130164200|NCT02799095|468561014|FG016|Part A|Lost to Follow-up|0|||
130164201|NCT02799095|468560998|FG000|Part A|Progressive Disease|3|||
130164202|NCT02799095|468560999|FG001|Part A|Progressive Disease|3|||
130164203|NCT02799095|468561000|FG002|Part A|Progressive Disease|3|||
130164204|NCT02799095|468561001|FG003|Part A|Progressive Disease|2|||
130164205|NCT02799095|468561002|FG004|Part A|Progressive Disease|2|||
130164206|NCT02799095|468561003|FG005|Part A|Progressive Disease|0|||
130164207|NCT02799095|468561004|FG006|Part A|Progressive Disease|0|||
130164208|NCT02799095|468561005|FG007|Part A|Progressive Disease|0|||
130164209|NCT02799095|468561006|FG008|Part A|Progressive Disease|0|||
130164210|NCT02799095|468561007|FG009|Part A|Progressive Disease|0|||
130164211|NCT02799095|468561008|FG010|Part A|Progressive Disease|0|||
130164212|NCT02799095|468561009|FG011|Part A|Progressive Disease|0|||
130164213|NCT02799095|468561010|FG012|Part A|Progressive Disease|0|||
130164214|NCT02799095|468561011|FG013|Part A|Progressive Disease|0|||
130164215|NCT02799095|468561012|FG014|Part A|Progressive Disease|0|||
130164216|NCT02799095|468561013|FG015|Part A|Progressive Disease|0|||
130164217|NCT02799095|468561014|FG016|Part A|Progressive Disease|0|||
130164218|NCT02799095|468560998|FG000|Part A|Clinical Progression|1|||
130164219|NCT02799095|468560999|FG001|Part A|Clinical Progression|0|||
130164220|NCT02799095|468561000|FG002|Part A|Clinical Progression|2|||
130164221|NCT02799095|468561001|FG003|Part A|Clinical Progression|1|||
130164222|NCT02799095|468561002|FG004|Part A|Clinical Progression|5|||
130164223|NCT02799095|468561003|FG005|Part A|Clinical Progression|0|||
130164224|NCT02799095|468561004|FG006|Part A|Clinical Progression|0|||
130164225|NCT02799095|468561005|FG007|Part A|Clinical Progression|0|||
130164226|NCT02799095|468561006|FG008|Part A|Clinical Progression|0|||
130164227|NCT02799095|468561007|FG009|Part A|Clinical Progression|0|||
130164228|NCT02799095|468561008|FG010|Part A|Clinical Progression|0|||
130164229|NCT02799095|468561009|FG011|Part A|Clinical Progression|0|||
130164230|NCT02799095|468561010|FG012|Part A|Clinical Progression|0|||
130164231|NCT02799095|468561011|FG013|Part A|Clinical Progression|0|||
130164232|NCT02799095|468561012|FG014|Part A|Clinical Progression|0|||
130164233|NCT02799095|468561013|FG015|Part A|Clinical Progression|0|||
130164234|NCT02799095|468561014|FG016|Part A|Clinical Progression|0|||
130164235|NCT02799095|468560998|FG000|Part A|Protocol Deviation|0|||
130164236|NCT02799095|468560999|FG001|Part A|Protocol Deviation|0|||
130164237|NCT02799095|468561000|FG002|Part A|Protocol Deviation|1|||
130164238|NCT02799095|468561001|FG003|Part A|Protocol Deviation|0|||
130164239|NCT02799095|468561002|FG004|Part A|Protocol Deviation|0|||
130164240|NCT02799095|468561003|FG005|Part A|Protocol Deviation|0|||
130164241|NCT02799095|468561004|FG006|Part A|Protocol Deviation|0|||
130164242|NCT02799095|468561005|FG007|Part A|Protocol Deviation|0|||
130164243|NCT02799095|468561006|FG008|Part A|Protocol Deviation|0|||
130164244|NCT02799095|468561007|FG009|Part A|Protocol Deviation|0|||
130164245|NCT02799095|468561008|FG010|Part A|Protocol Deviation|0|||
130164246|NCT02799095|468561009|FG011|Part A|Protocol Deviation|0|||
130164247|NCT02799095|468561010|FG012|Part A|Protocol Deviation|0|||
130164248|NCT02799095|468561011|FG013|Part A|Protocol Deviation|0|||
130164249|NCT02799095|468561012|FG014|Part A|Protocol Deviation|0|||
130164250|NCT02799095|468561013|FG015|Part A|Protocol Deviation|0|||
130164251|NCT02799095|468561014|FG016|Part A|Protocol Deviation|0|||
130164252|NCT02799095|468560998|FG000|Part A|Withdrawal by Subject|0|||
130164253|NCT02799095|468560999|FG001|Part A|Withdrawal by Subject|0|||
130164254|NCT02799095|468561000|FG002|Part A|Withdrawal by Subject|0|||
130164255|NCT02799095|468561001|FG003|Part A|Withdrawal by Subject|1|||
130164256|NCT02799095|468561002|FG004|Part A|Withdrawal by Subject|3|||
130164257|NCT02799095|468561003|FG005|Part A|Withdrawal by Subject|1|||
130164258|NCT02799095|468561004|FG006|Part A|Withdrawal by Subject|1|||
130164259|NCT02799095|468561005|FG007|Part A|Withdrawal by Subject|0|||
130164260|NCT02799095|468561006|FG008|Part A|Withdrawal by Subject|0|||
130164261|NCT02799095|468561007|FG009|Part A|Withdrawal by Subject|0|||
130164262|NCT02799095|468561008|FG010|Part A|Withdrawal by Subject|0|||
130164263|NCT02799095|468561009|FG011|Part A|Withdrawal by Subject|0|||
130164264|NCT02799095|468561010|FG012|Part A|Withdrawal by Subject|0|||
130164265|NCT02799095|468561011|FG013|Part A|Withdrawal by Subject|0|||
130164266|NCT02799095|468561012|FG014|Part A|Withdrawal by Subject|0|||
130164267|NCT02799095|468561013|FG015|Part A|Withdrawal by Subject|0|||
130164268|NCT02799095|468561014|FG016|Part A|Withdrawal by Subject|0|||
130164269|NCT02799095|468560998|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
130164270|NCT02799095|468560999|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
130164271|NCT02799095|468561000|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
130164272|NCT02799095|468561001|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
130164273|NCT02799095|468561002|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
130164274|NCT02799095|468561003|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
130164275|NCT02799095|468561004|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
130164276|NCT02799095|468561005|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
130164277|NCT02799095|468561006|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
130164278|NCT02799095|468561007|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
130164279|NCT02799095|468561008|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
130164280|NCT02799095|468561009|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
130164281|NCT02799095|468561010|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
130164282|NCT02799095|468561011|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
130164283|NCT02799095|468561012|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
130164284|NCT02799095|468561013|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
130164285|NCT02799095|468561014|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
130164286|NCT02799095|468560998|FG000|Part B|Death|0|||
130164287|NCT02799095|468560999|FG001|Part B|Death|0|||
130164288|NCT02799095|468561000|FG002|Part B|Death|0|||
130164289|NCT02799095|468561001|FG003|Part B|Death|0|||
130164290|NCT02799095|468561002|FG004|Part B|Death|0|||
130164291|NCT02799095|468561003|FG005|Part B|Death|0|||
130164292|NCT02799095|468561004|FG006|Part B|Death|0|||
130164293|NCT02799095|468561005|FG007|Part B|Death|7|||
130164294|NCT02799095|468561006|FG008|Part B|Death|7|||
130164295|NCT02799095|468561007|FG009|Part B|Death|0|||
130164296|NCT02799095|468561008|FG010|Part B|Death|0|||
130164297|NCT02799095|468561009|FG011|Part B|Death|0|||
130164298|NCT02799095|468561010|FG012|Part B|Death|0|||
130164299|NCT02799095|468561011|FG013|Part B|Death|0|||
130164300|NCT02799095|468561012|FG014|Part B|Death|0|||
130164301|NCT02799095|468561013|FG015|Part B|Death|0|||
130164302|NCT02799095|468561014|FG016|Part B|Death|0|||
130164303|NCT02799095|468560998|FG000|Part B|Progressive Disease|0|||
130164304|NCT02799095|468560999|FG001|Part B|Progressive Disease|0|||
130164305|NCT02799095|468561000|FG002|Part B|Progressive Disease|0|||
130164306|NCT02799095|468561001|FG003|Part B|Progressive Disease|0|||
130164307|NCT02799095|468561002|FG004|Part B|Progressive Disease|0|||
130164308|NCT02799095|468561003|FG005|Part B|Progressive Disease|0|||
130164309|NCT02799095|468561004|FG006|Part B|Progressive Disease|0|||
130164310|NCT02799095|468561005|FG007|Part B|Progressive Disease|1|||
130164311|NCT02799095|468561006|FG008|Part B|Progressive Disease|0|||
130164312|NCT02799095|468561007|FG009|Part B|Progressive Disease|0|||
130164313|NCT02799095|468561008|FG010|Part B|Progressive Disease|0|||
130164314|NCT02799095|468561009|FG011|Part B|Progressive Disease|0|||
130164315|NCT02799095|468561010|FG012|Part B|Progressive Disease|0|||
130164316|NCT02799095|468561011|FG013|Part B|Progressive Disease|0|||
130164317|NCT02799095|468561012|FG014|Part B|Progressive Disease|0|||
130164318|NCT02799095|468561013|FG015|Part B|Progressive Disease|0|||
130164319|NCT02799095|468561014|FG016|Part B|Progressive Disease|0|||
130164320|NCT02799095|468560998|FG000|Part B|Withdrawal by Subject|0|||
130164321|NCT02799095|468560999|FG001|Part B|Withdrawal by Subject|0|||
130164322|NCT02799095|468561000|FG002|Part B|Withdrawal by Subject|0|||
130164323|NCT02799095|468561001|FG003|Part B|Withdrawal by Subject|0|||
130164324|NCT02799095|468561002|FG004|Part B|Withdrawal by Subject|0|||
130164325|NCT02799095|468561003|FG005|Part B|Withdrawal by Subject|0|||
130164326|NCT02799095|468561004|FG006|Part B|Withdrawal by Subject|0|||
130164327|NCT02799095|468561005|FG007|Part B|Withdrawal by Subject|10|||
130164328|NCT02799095|468561006|FG008|Part B|Withdrawal by Subject|7|||
130164329|NCT02799095|468561007|FG009|Part B|Withdrawal by Subject|0|||
130164330|NCT02799095|468561008|FG010|Part B|Withdrawal by Subject|0|||
130164331|NCT02799095|468561009|FG011|Part B|Withdrawal by Subject|0|||
130164332|NCT02799095|468561010|FG012|Part B|Withdrawal by Subject|0|||
130164333|NCT02799095|468561011|FG013|Part B|Withdrawal by Subject|0|||
130164334|NCT02799095|468561012|FG014|Part B|Withdrawal by Subject|0|||
130164335|NCT02799095|468561013|FG015|Part B|Withdrawal by Subject|0|||
130164336|NCT02799095|468561014|FG016|Part B|Withdrawal by Subject|0|||
130164337|NCT02799095|468560998|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
130164338|NCT02799095|468560999|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
130164339|NCT02799095|468561000|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
130164340|NCT02799095|468561001|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
130164341|NCT02799095|468561002|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
130164342|NCT02799095|468561003|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
130164343|NCT02799095|468561004|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
130164344|NCT02799095|468561005|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
130164345|NCT02799095|468561006|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
130164346|NCT02799095|468561007|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
130164347|NCT02799095|468561008|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
130164348|NCT02799095|468561009|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
130164349|NCT02799095|468561010|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
130164350|NCT02799095|468561011|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
130164351|NCT02799095|468561012|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
130164352|NCT02799095|468561013|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
130164353|NCT02799095|468561014|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
130164354|NCT02799095|468560998|FG000|Part C|Adverse Event|0|||
130164355|NCT02799095|468560999|FG001|Part C|Adverse Event|0|||
130164356|NCT02799095|468561000|FG002|Part C|Adverse Event|0|||
130164357|NCT02799095|468561001|FG003|Part C|Adverse Event|0|||
130164358|NCT02799095|468561002|FG004|Part C|Adverse Event|0|||
130164359|NCT02799095|468561003|FG005|Part C|Adverse Event|0|||
130164360|NCT02799095|468561004|FG006|Part C|Adverse Event|0|||
130164361|NCT02799095|468561005|FG007|Part C|Adverse Event|0|||
130164362|NCT02799095|468561006|FG008|Part C|Adverse Event|0|||
130164363|NCT02799095|468561007|FG009|Part C|Adverse Event|0|||
130164364|NCT02799095|468561008|FG010|Part C|Adverse Event|3|||
130164365|NCT02799095|468561009|FG011|Part C|Adverse Event|1|||
130164366|NCT02799095|468561010|FG012|Part C|Adverse Event|0|||
130164367|NCT02799095|468561011|FG013|Part C|Adverse Event|1|||
130164368|NCT02799095|468561012|FG014|Part C|Adverse Event|0|||
130164369|NCT02799095|468561013|FG015|Part C|Adverse Event|0|||
130164370|NCT02799095|468561014|FG016|Part C|Adverse Event|0|||
130164371|NCT02799095|468560998|FG000|Part C|Death|0|||
130164372|NCT02799095|468560999|FG001|Part C|Death|0|||
130164373|NCT02799095|468561000|FG002|Part C|Death|0|||
130164374|NCT02799095|468561001|FG003|Part C|Death|0|||
130164375|NCT02799095|468561002|FG004|Part C|Death|0|||
130164376|NCT02799095|468561003|FG005|Part C|Death|0|||
130164377|NCT02799095|468561004|FG006|Part C|Death|0|||
130164378|NCT02799095|468561005|FG007|Part C|Death|0|||
130164379|NCT02799095|468561006|FG008|Part C|Death|0|||
130164380|NCT02799095|468561007|FG009|Part C|Death|0|||
130164381|NCT02799095|468561008|FG010|Part C|Death|7|||
130164382|NCT02799095|468561009|FG011|Part C|Death|5|||
130164383|NCT02799095|468561010|FG012|Part C|Death|6|||
130164384|NCT02799095|468561011|FG013|Part C|Death|8|||
130164385|NCT02799095|468561012|FG014|Part C|Death|1|||
130164386|NCT02799095|468561013|FG015|Part C|Death|8|||
130164387|NCT02799095|468561014|FG016|Part C|Death|1|||
130164388|NCT02799095|468560998|FG000|Part C|Lost to Follow-up|0|||
130164389|NCT02799095|468560999|FG001|Part C|Lost to Follow-up|0|||
130164390|NCT02799095|468561000|FG002|Part C|Lost to Follow-up|0|||
130164391|NCT02799095|468561001|FG003|Part C|Lost to Follow-up|0|||
130164392|NCT02799095|468561002|FG004|Part C|Lost to Follow-up|0|||
130164393|NCT02799095|468561003|FG005|Part C|Lost to Follow-up|0|||
130164394|NCT02799095|468561004|FG006|Part C|Lost to Follow-up|0|||
130164395|NCT02799095|468561005|FG007|Part C|Lost to Follow-up|0|||
130164396|NCT02799095|468561006|FG008|Part C|Lost to Follow-up|0|||
130164397|NCT02799095|468561007|FG009|Part C|Lost to Follow-up|0|||
130164398|NCT02799095|468561008|FG010|Part C|Lost to Follow-up|1|||
130164399|NCT02799095|468561009|FG011|Part C|Lost to Follow-up|1|||
130164400|NCT02799095|468561010|FG012|Part C|Lost to Follow-up|1|||
130164401|NCT02799095|468561011|FG013|Part C|Lost to Follow-up|3|||
130164402|NCT02799095|468561012|FG014|Part C|Lost to Follow-up|0|||
130164403|NCT02799095|468561013|FG015|Part C|Lost to Follow-up|0|||
130164404|NCT02799095|468561014|FG016|Part C|Lost to Follow-up|0|||
130164405|NCT02799095|468560998|FG000|Part C|Progressive Disease|0|||
130164406|NCT02799095|468560999|FG001|Part C|Progressive Disease|0|||
130164407|NCT02799095|468561000|FG002|Part C|Progressive Disease|0|||
130164408|NCT02799095|468561001|FG003|Part C|Progressive Disease|0|||
130164409|NCT02799095|468561002|FG004|Part C|Progressive Disease|0|||
130164410|NCT02799095|468561003|FG005|Part C|Progressive Disease|0|||
130164411|NCT02799095|468561004|FG006|Part C|Progressive Disease|0|||
130164412|NCT02799095|468561005|FG007|Part C|Progressive Disease|0|||
130164413|NCT02799095|468561006|FG008|Part C|Progressive Disease|0|||
130164414|NCT02799095|468561007|FG009|Part C|Progressive Disease|2|||
130164415|NCT02799095|468561008|FG010|Part C|Progressive Disease|13|||
130164416|NCT02799095|468561009|FG011|Part C|Progressive Disease|2|||
130164417|NCT02799095|468561010|FG012|Part C|Progressive Disease|0|||
130164418|NCT02799095|468561011|FG013|Part C|Progressive Disease|1|||
130164419|NCT02799095|468561012|FG014|Part C|Progressive Disease|0|||
130164420|NCT02799095|468561013|FG015|Part C|Progressive Disease|0|||
130164421|NCT02799095|468561014|FG016|Part C|Progressive Disease|0|||
130164422|NCT02799095|468560998|FG000|Part C|Clinical Progression|0|||
130164423|NCT02799095|468560999|FG001|Part C|Clinical Progression|0|||
130164424|NCT02799095|468561000|FG002|Part C|Clinical Progression|0|||
130164425|NCT02799095|468561001|FG003|Part C|Clinical Progression|0|||
130164426|NCT02799095|468561002|FG004|Part C|Clinical Progression|0|||
130164427|NCT02799095|468561003|FG005|Part C|Clinical Progression|0|||
130164428|NCT02799095|468561004|FG006|Part C|Clinical Progression|0|||
130164429|NCT02799095|468561005|FG007|Part C|Clinical Progression|0|||
130164430|NCT02799095|468561006|FG008|Part C|Clinical Progression|0|||
130164431|NCT02799095|468561007|FG009|Part C|Clinical Progression|1|||
130164432|NCT02799095|468561008|FG010|Part C|Clinical Progression|3|||
130164433|NCT02799095|468561009|FG011|Part C|Clinical Progression|0|||
130164434|NCT02799095|468561010|FG012|Part C|Clinical Progression|0|||
130164435|NCT02799095|468561011|FG013|Part C|Clinical Progression|1|||
130164436|NCT02799095|468561012|FG014|Part C|Clinical Progression|0|||
130164437|NCT02799095|468561013|FG015|Part C|Clinical Progression|0|||
130164438|NCT02799095|468561014|FG016|Part C|Clinical Progression|0|||
130164439|NCT02799095|468560998|FG000|Part C|Withdrawal by Subject|0|||
130164440|NCT02799095|468560999|FG001|Part C|Withdrawal by Subject|0|||
130164441|NCT02799095|468561000|FG002|Part C|Withdrawal by Subject|0|||
130164442|NCT02799095|468561001|FG003|Part C|Withdrawal by Subject|0|||
130164443|NCT02799095|468561002|FG004|Part C|Withdrawal by Subject|0|||
130164444|NCT02799095|468561003|FG005|Part C|Withdrawal by Subject|0|||
130164445|NCT02799095|468561004|FG006|Part C|Withdrawal by Subject|0|||
130164446|NCT02799095|468561005|FG007|Part C|Withdrawal by Subject|0|||
130164447|NCT02799095|468561006|FG008|Part C|Withdrawal by Subject|0|||
130164448|NCT02799095|468561007|FG009|Part C|Withdrawal by Subject|0|||
130164449|NCT02799095|468561008|FG010|Part C|Withdrawal by Subject|13|||
130164450|NCT02799095|468561009|FG011|Part C|Withdrawal by Subject|15|||
130164451|NCT02799095|468561010|FG012|Part C|Withdrawal by Subject|13|||
130164452|NCT02799095|468561011|FG013|Part C|Withdrawal by Subject|21|||
130164453|NCT02799095|468561012|FG014|Part C|Withdrawal by Subject|0|||
130164454|NCT02799095|468561013|FG015|Part C|Withdrawal by Subject|12|||
130164455|NCT02799095|468561014|FG016|Part C|Withdrawal by Subject|1|||
130164456|NCT02799095|468560998|FG000|Part C|Physician Decision|0|||
130164457|NCT02799095|468560999|FG001|Part C|Physician Decision|0|||
130164458|NCT02799095|468561000|FG002|Part C|Physician Decision|0|||
130164459|NCT02799095|468561001|FG003|Part C|Physician Decision|0|||
130164460|NCT02799095|468561002|FG004|Part C|Physician Decision|0|||
130164461|NCT02799095|468561003|FG005|Part C|Physician Decision|0|||
130164462|NCT02799095|468561004|FG006|Part C|Physician Decision|0|||
130164463|NCT02799095|468561005|FG007|Part C|Physician Decision|0|||
130164464|NCT02799095|468561006|FG008|Part C|Physician Decision|0|||
130164465|NCT02799095|468561007|FG009|Part C|Physician Decision|0|||
130164466|NCT02799095|468561008|FG010|Part C|Physician Decision|1|||
130164467|NCT02799095|468561009|FG011|Part C|Physician Decision|0|||
130164468|NCT02799095|468561010|FG012|Part C|Physician Decision|0|||
130164469|NCT02799095|468561011|FG013|Part C|Physician Decision|0|||
130164470|NCT02799095|468561012|FG014|Part C|Physician Decision|0|||
130164471|NCT02799095|468561013|FG015|Part C|Physician Decision|0|||
130164472|NCT02799095|468561014|FG016|Part C|Physician Decision|0|||
130164473|NCT02799095|468560998|FG000|Part C|Other|0|||
130164474|NCT02799095|468560999|FG001|Part C|Other|0|||
130164475|NCT02799095|468561000|FG002|Part C|Other|0|||
130164476|NCT02799095|468561001|FG003|Part C|Other|0|||
130164477|NCT02799095|468561002|FG004|Part C|Other|0|||
130164478|NCT02799095|468561003|FG005|Part C|Other|0|||
130164479|NCT02799095|468561004|FG006|Part C|Other|0|||
130164480|NCT02799095|468561005|FG007|Part C|Other|0|||
130164481|NCT02799095|468561006|FG008|Part C|Other|0|||
130164482|NCT02799095|468561007|FG009|Part C|Other|0|||
130164483|NCT02799095|468561008|FG010|Part C|Other|0|||
130164484|NCT02799095|468561009|FG011|Part C|Other|2|||
130164485|NCT02799095|468561010|FG012|Part C|Other|2|||
130164486|NCT02799095|468561011|FG013|Part C|Other|0|||
130164487|NCT02799095|468561012|FG014|Part C|Other|0|||
130164488|NCT02799095|468561013|FG015|Part C|Other|0|||
130164489|NCT02799095|468561014|FG016|Part C|Other|0|||
130164490|NCT04994483|468561018|FG000|Overall Study|Adverse Event|26|||
130164491|NCT04994483|468561019|FG001|Overall Study|Adverse Event|17|||
130164492|NCT04994483|468561018|FG000|Overall Study|Lost to Follow-up|6|||
130164493|NCT04994483|468561019|FG001|Overall Study|Lost to Follow-up|10|||
130164494|NCT04994483|468561018|FG000|Overall Study|Noncompliance with study drug|8|||
130164495|NCT04994483|468561019|FG001|Overall Study|Noncompliance with study drug|5|||
130164496|NCT04994483|468561018|FG000|Overall Study|Physician Decision|5|||
130164497|NCT04994483|468561019|FG001|Overall Study|Physician Decision|0|||
130164498|NCT04994483|468561018|FG000|Overall Study|Withdrawal by Subject|41|||
130164499|NCT04994483|468561019|FG001|Overall Study|Withdrawal by Subject|38|||
130164500|NCT04994483|468561018|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
130164501|NCT04994483|468561019|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
130164502|NCT04994483|468561018|FG000|Overall Study|Met stopping criteria|1|||
130164503|NCT04994483|468561019|FG001|Overall Study|Met stopping criteria|0|||
130164504|NCT04994483|468561018|FG000|Overall Study|Randomized in error, not treated|4|||
130164505|NCT04994483|468561019|FG001|Overall Study|Randomized in error, not treated|3|||
130164506|NCT04994483|468561018|FG000|Overall Study|Lack of a reliable study partner|0|||
130164507|NCT04994483|468561019|FG001|Overall Study|Lack of a reliable study partner|1|||
130164508|NCT04994483|468561018|FG000|Overall Study|Met MRI exclusion criteria|0|||
130164509|NCT04994483|468561019|FG001|Overall Study|Met MRI exclusion criteria|1|||
130164510|NCT03589768|468561024|FG000|Overall Study|Death|1|||
130164511|NCT03589768|468561025|FG001|Overall Study|Death|0|||
130164512|NCT03589768|468561026|FG002|Overall Study|Death|8|||
130164513|NCT03589768|468561027|FG003|Overall Study|Death|3|||
130164514|NCT03589768|468561024|FG000|Overall Study|Withdrawal by Subject|2|||
130164515|NCT03589768|468561025|FG001|Overall Study|Withdrawal by Subject|0|||
130164516|NCT03589768|468561026|FG002|Overall Study|Withdrawal by Subject|0|||
130164517|NCT03589768|468561027|FG003|Overall Study|Withdrawal by Subject|0|||
130164518|NCT03589768|468561024|FG000|Overall Study|Protocol Violation|1|||
130164519|NCT03589768|468561025|FG001|Overall Study|Protocol Violation|0|||
130164520|NCT03589768|468561026|FG002|Overall Study|Protocol Violation|0|||
130164521|NCT03589768|468561027|FG003|Overall Study|Protocol Violation|0|||
130164522|NCT01200992|468561030|FG000|Overall Study|Study terminated early|35|||
130164523|NCT01200992|468561031|FG001|Overall Study|Study terminated early|41|||
130164524|NCT01200992|468561030|FG000|Overall Study|Randomized but not treated|2|||
130164525|NCT01200992|468561031|FG001|Overall Study|Randomized but not treated|0|||
130164526|NCT02213510|468561040|FG000|Overall Study|Death|0|||
130164527|NCT02213510|468561041|FG001|Overall Study|Death|1|||
130164528|NCT02213510|468561040|FG000|Overall Study|Lost to Follow-up|1|||
130164529|NCT02213510|468561041|FG001|Overall Study|Lost to Follow-up|0|||
130164530|NCT02903030|468561045|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
130164531|NCT02903030|468561046|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
130164532|NCT01502410|468561047|FG000|Overall Study|Adverse Event|1|||
130164533|NCT01502410|468561048|FG001|Overall Study|Adverse Event|2|||
130164534|NCT01502410|468561049|FG002|Overall Study|Adverse Event|0|||
130164535|NCT01502410|468561050|FG003|Overall Study|Adverse Event|0|||
130164536|NCT01502410|468561047|FG000|Overall Study|Lack of Efficacy|7|||
130164537|NCT01502410|468561048|FG001|Overall Study|Lack of Efficacy|7|||
130164538|NCT01502410|468561049|FG002|Overall Study|Lack of Efficacy|0|||
130164539|NCT01502410|468561050|FG003|Overall Study|Lack of Efficacy|0|||
130164540|NCT01502410|468561047|FG000|Overall Study|Physician Decision|0|||
130164541|NCT01502410|468561048|FG001|Overall Study|Physician Decision|1|||
130164542|NCT01502410|468561049|FG002|Overall Study|Physician Decision|0|||
130164543|NCT01502410|468561050|FG003|Overall Study|Physician Decision|0|||
130164544|NCT01502410|468561047|FG000|Overall Study|Withdrawal by Subject|2|||
130164545|NCT01502410|468561048|FG001|Overall Study|Withdrawal by Subject|0|||
130164546|NCT01502410|468561049|FG002|Overall Study|Withdrawal by Subject|0|||
130164547|NCT01502410|468561050|FG003|Overall Study|Withdrawal by Subject|0|||
130164548|NCT03786718|468561054|FG000|Overall Study|Lost to Follow-up|3|||
130164549|NCT03786718|468561054|FG000|Overall Study|Withdrawal by Subject|1|||
130164550|NCT03786718|468561054|FG000|Overall Study|Did not use the intervention|2|||
130164551|NCT03786718|468561054|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
130164552|NCT00754650|468561068|FG000|Overall Study|Disease Progression|2|||
130164553|NCT00805675|468561069|FG000|Overall Study|Adverse Event|0|||
130164554|NCT00805675|468561070|FG001|Overall Study|Adverse Event|0|||
130164555|NCT00805675|468561071|FG002|Overall Study|Adverse Event|1|||
130164556|NCT03929757|468561072|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
130164557|NCT03929757|468561073|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
130164558|NCT03929757|468561074|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
130164559|NCT03929757|468561072|FG000|Main Study: Up to Day 365|Other|1|||
130164560|NCT03929757|468561073|FG001|Main Study: Up to Day 365|Other|0|||
130164561|NCT03929757|468561074|FG002|Main Study: Up to Day 365|Other|0|||
130164562|NCT03929757|468561072|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
130164563|NCT03929757|468561073|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
130164564|NCT03929757|468561074|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
130164565|NCT00806286|468561075|FG000|Overall Study|Adverse Event|5|||
130164566|NCT00806286|468561076|FG001|Overall Study|Adverse Event|2|||
130164567|NCT00806286|468561077|FG002|Overall Study|Adverse Event|0|||
130164568|NCT00806286|468561075|FG000|Overall Study|Disease progression|31|||
129981475|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981476|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981477|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
130164569|NCT00806286|468561076|FG001|Overall Study|Disease progression|38|||
130164570|NCT00806286|468561077|FG002|Overall Study|Disease progression|1|||
130164571|NCT00806286|468561075|FG000|Overall Study|Death|1|||
130164572|NCT00806286|468561076|FG001|Overall Study|Death|6|||
130164573|NCT00806286|468561077|FG002|Overall Study|Death|0|||
130164574|NCT00806286|468561075|FG000|Overall Study|Lost to Follow-up|0|||
130164575|NCT00806286|468561076|FG001|Overall Study|Lost to Follow-up|1|||
130164576|NCT00806286|468561077|FG002|Overall Study|Lost to Follow-up|0|||
130164577|NCT00806286|468561075|FG000|Overall Study|Withdrawal by Subject|8|||
130164578|NCT00806286|468561076|FG001|Overall Study|Withdrawal by Subject|3|||
130164579|NCT00806286|468561077|FG002|Overall Study|Withdrawal by Subject|1|||
130164580|NCT00806286|468561075|FG000|Overall Study|Physician Decision|2|||
130164581|NCT00806286|468561076|FG001|Overall Study|Physician Decision|2|||
130164582|NCT00806286|468561077|FG002|Overall Study|Physician Decision|0|||
130164583|NCT00806286|468561075|FG000|Overall Study|Due to a variety of reasons|7|||
130164584|NCT00806286|468561076|FG001|Overall Study|Due to a variety of reasons|2|||
130164585|NCT00806286|468561077|FG002|Overall Study|Due to a variety of reasons|1|||
129981478|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
129981479|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981480|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981481|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981482|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981483|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
129981484|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
129981485|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
129981486|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
129981487|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
129981488|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
129981489|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
129981490|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
129981491|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981492|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981493|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981494|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981495|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981496|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
129981497|NCT01994837|467894998|FG000|Overall Study|Progressive disease per protocol|23|||
129981498|NCT01994837|467894998|FG000|Overall Study|Adv event related to progressive disease|3|||
129981499|NCT01994837|467894998|FG000|Overall Study|Fatal progressive disease|2|||
129981500|NCT01994837|467894998|FG000|Overall Study|Adverse event not related to progression|1|||
129981501|NCT01994837|467894998|FG000|Overall Study|Chose palliative care|1|||
129981502|NCT01994837|467894998|FG000|Overall Study|Proceeded to transplant|1|||
129981503|NCT01994837|467894998|FG000|Overall Study|Removed from study due to no response|1|||
129981504|NCT01127893|467894999|FG000|Overall Study|Study Termination by the Sponsor|1|||
129981505|NCT00574873|467895000|FG000|Overall Study|Withdrawal by Subject|18|||
129981506|NCT00574873|467895001|FG001|Overall Study|Withdrawal by Subject|19|||
129981507|NCT00574873|467895000|FG000|Overall Study|Investigator request|18|||
129981508|NCT00574873|467895001|FG001|Overall Study|Investigator request|8|||
129981509|NCT00574873|467895000|FG000|Overall Study|Death|15|||
129981510|NCT00574873|467895001|FG001|Overall Study|Death|14|||
129981511|NCT00574873|467895000|FG000|Overall Study|Lost to Follow-up|14|||
129981512|NCT00574873|467895001|FG001|Overall Study|Lost to Follow-up|5|||
129981513|NCT00574873|467895000|FG000|Overall Study|Other|40|||
129981514|NCT00574873|467895001|FG001|Overall Study|Other|4|||
129981515|NCT00574873|467895000|FG000|Overall Study|Discontinuation of study by sponsor|5|||
129981516|NCT00574873|467895001|FG001|Overall Study|Discontinuation of study by sponsor|199|||
129981517|NCT00574873|467895000|FG000|Overall Study|Blank, site closed per local regulations|2|||
129981518|NCT00574873|467895001|FG001|Overall Study|Blank, site closed per local regulations|2|||
129981519|NCT00574873|467895000|FG000|Overall Study|Extension Study|126|||
129981520|NCT00574873|467895001|FG001|Overall Study|Extension Study|0|||
129981521|NCT03568318|467895007|FG000|Overall Study|Adverse Event|3|||
129981522|NCT03568318|467895008|FG001|Overall Study|Adverse Event|1|||
129981523|NCT03568318|467895009|FG002|Overall Study|Adverse Event|1|||
129981524|NCT03568318|467895010|FG003|Overall Study|Adverse Event|0|||
129981525|NCT03568318|467895011|FG004|Overall Study|Adverse Event|1|||
129981526|NCT03568318|467895012|FG005|Overall Study|Adverse Event|0|||
129981527|NCT03568318|467895007|FG000|Overall Study|Withdrawal by Subject|6|||
129981528|NCT03568318|467895008|FG001|Overall Study|Withdrawal by Subject|5|||
129981529|NCT03568318|467895009|FG002|Overall Study|Withdrawal by Subject|2|||
130164586|NCT03402750|468561078|FG000|Overall Study|Lost to Follow-up|2|||
130164587|NCT03402750|468561079|FG001|Overall Study|Lost to Follow-up|1|||
130164588|NCT03825341|468561080|FG000|Overall Study|Withdrawal by Subject|0|||
130164589|NCT03825341|468561081|FG001|Overall Study|Withdrawal by Subject|1|||
130164590|NCT00289536|468561083|FG000|Period 3|Lost to Follow-up|0|||
130164591|NCT00289536|468561084|FG001|Period 3|Lost to Follow-up|0|||
130164592|NCT00289536|468561085|FG002|Period 3|Lost to Follow-up|1|||
130164593|NCT04283500|468561089|FG000|Overall Study|Lost to Follow-up|8|||
130164594|NCT04283500|468561089|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
130164595|NCT02006693|468561092|FG000|Overall Study|No Reason Specified|6|||
130164596|NCT02006693|468561093|FG001|Overall Study|No Reason Specified|8|||
129981530|NCT03568318|467895010|FG003|Overall Study|Withdrawal by Subject|1|||
129981531|NCT03568318|467895011|FG004|Overall Study|Withdrawal by Subject|0|||
129981532|NCT03568318|467895012|FG005|Overall Study|Withdrawal by Subject|0|||
129981533|NCT03568318|467895007|FG000|Overall Study|Lost to Follow-up|3|||
129981534|NCT03568318|467895008|FG001|Overall Study|Lost to Follow-up|2|||
129981535|NCT03568318|467895009|FG002|Overall Study|Lost to Follow-up|2|||
129981536|NCT03568318|467895010|FG003|Overall Study|Lost to Follow-up|2|||
130164597|NCT02006693|468561092|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
130164598|NCT02006693|468561093|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
130164599|NCT02006693|468561092|FG000|Overall Study|XEN Implant Explantation|0|||
130164600|NCT02006693|468561093|FG001|Overall Study|XEN Implant Explantation|1|||
130164601|NCT02006693|468561092|FG000|Overall Study|Death|2|||
130164602|NCT02006693|468561093|FG001|Overall Study|Death|2|||
130164603|NCT02006693|468561092|FG000|Overall Study|Lost to Follow-up|4|||
130164604|NCT02006693|468561093|FG001|Overall Study|Lost to Follow-up|1|||
130164605|NCT02006693|468561092|FG000|Overall Study|Patient Decision|4|||
130164606|NCT02006693|468561093|FG001|Overall Study|Patient Decision|0|||
130164607|NCT01119508|468561096|FG000|Overall Study|Adverse Event|56|||
130164608|NCT01119508|468561096|FG000|Overall Study|Withdrawal by Subject|2|||
130164609|NCT01119508|468561096|FG000|Overall Study|Died before tumor response evaluation|1|||
130164610|NCT00265395|468561097|FG000|Overall Study|Adverse Event|3|||
130164611|NCT00265395|468561098|FG001|Overall Study|Adverse Event|6|||
130164612|NCT00265395|468561097|FG000|Overall Study|Lost to Follow-up|2|||
130164613|NCT00265395|468561098|FG001|Overall Study|Lost to Follow-up|1|||
130164614|NCT00265395|468561097|FG000|Overall Study|Withdrawal by Subject|1|||
130164615|NCT00265395|468561098|FG001|Overall Study|Withdrawal by Subject|6|||
130164616|NCT00265395|468561097|FG000|Overall Study|Protocol Violation|2|||
130164617|NCT00265395|468561098|FG001|Overall Study|Protocol Violation|2|||
130164618|NCT00265395|468561097|FG000|Overall Study|Lack of Efficacy|0|||
130164619|NCT00265395|468561098|FG001|Overall Study|Lack of Efficacy|1|||
130164620|NCT00265395|468561097|FG000|Overall Study|Administrative|0|||
130164621|NCT00265395|468561098|FG001|Overall Study|Administrative|1|||
130164622|NCT00552578|468561104|FG000|Overall Study|Lost to Follow-up|1|||
130164623|NCT00552578|468561105|FG001|Overall Study|Lost to Follow-up|1|||
130164624|NCT04053465|468561106|FG000|Overall Study|Withdrawal by Subject|4|||
130164625|NCT04053465|468561107|FG001|Overall Study|Withdrawal by Subject|4|||
130164626|NCT00742924|468561108|FG000|Overall Study|Adverse Event|0|||
130164627|NCT00742924|468561109|FG001|Overall Study|Adverse Event|0|||
130164628|NCT00742924|468561110|FG002|Overall Study|Adverse Event|1|||
130164629|NCT00742924|468561111|FG003|Overall Study|Adverse Event|1|||
130164630|NCT00742924|468561108|FG000|Overall Study|Lack of Efficacy|5|||
130164631|NCT00742924|468561109|FG001|Overall Study|Lack of Efficacy|1|||
130164632|NCT00742924|468561110|FG002|Overall Study|Lack of Efficacy|2|||
130164633|NCT00742924|468561111|FG003|Overall Study|Lack of Efficacy|4|||
130164634|NCT00742924|468561108|FG000|Overall Study|Physician Decision|0|||
130164635|NCT00742924|468561109|FG001|Overall Study|Physician Decision|0|||
130164636|NCT00742924|468561110|FG002|Overall Study|Physician Decision|0|||
130164637|NCT00742924|468561111|FG003|Overall Study|Physician Decision|1|||
130164638|NCT00742924|468561108|FG000|Overall Study|Withdrawal by Subject|0|||
130164639|NCT00742924|468561109|FG001|Overall Study|Withdrawal by Subject|1|||
130164640|NCT00742924|468561110|FG002|Overall Study|Withdrawal by Subject|1|||
130164641|NCT00742924|468561111|FG003|Overall Study|Withdrawal by Subject|0|||
130164642|NCT00660400|468561112|FG000|Overall Study|Lack of insurance approval|1|||
130164643|NCT00660400|468561112|FG000|Overall Study|Suboptimal organ function|1|||
130164644|NCT00660400|468561112|FG000|Overall Study|Intracranial hemorrhage|1|||
130164645|NCT00660400|468561112|FG000|Overall Study|Withdrawal by Subject|1|||
130164646|NCT02643355|468561113|FG000|Overall Study|Withdrawal by Subject|1|||
130164647|NCT02643355|468561114|FG001|Overall Study|Withdrawal by Subject|3|||
130164648|NCT02643355|468561113|FG000|Overall Study|Protocol Violation|0|||
130164649|NCT02643355|468561114|FG001|Overall Study|Protocol Violation|2|||
130164650|NCT04524364|468561115|FG000|Overall Study|Physician Decision|3|||
130164651|NCT04524364|468561116|FG001|Overall Study|Physician Decision|6|||
130164652|NCT04524364|468561115|FG000|Overall Study|Adverse Event|0|||
130164653|NCT04524364|468561116|FG001|Overall Study|Adverse Event|1|||
130164654|NCT04524364|468561115|FG000|Overall Study|Investigational device deficiency|0|||
130164655|NCT04524364|468561116|FG001|Overall Study|Investigational device deficiency|1|||
130164656|NCT04524364|468561115|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
129981537|NCT03568318|467895011|FG004|Overall Study|Lost to Follow-up|1|||
130164657|NCT04524364|468561116|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
130164658|NCT04524364|468561115|FG000|Overall Study|Device unavailability|0|||
130164659|NCT04524364|468561116|FG001|Overall Study|Device unavailability|2|||
130164660|NCT04524364|468561115|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
130164661|NCT04524364|468561116|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
130164662|NCT04524364|468561115|FG000|Overall Study|Low International normalized ratio (INR)|1|||
130164663|NCT04524364|468561116|FG001|Overall Study|Low International normalized ratio (INR)|0|||
130164664|NCT00826449|468561117|FG000|Overall Study|Disease Progression|4|||
130164665|NCT00826449|468561117|FG000|Overall Study|Withdrawal by Subject|1|||
130164666|NCT02994940|468561118|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
130164667|NCT02994940|468561119|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
130164668|NCT02994940|468561118|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
129981538|NCT03568318|467895012|FG005|Overall Study|Lost to Follow-up|0|||
130164669|NCT02994940|468561119|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
130164670|NCT02994940|468561118|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
130164671|NCT02994940|468561119|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
130164672|NCT03233230|468561120|FG000|Overall Study|Adverse Event|6|||
130164673|NCT03233230|468561121|FG001|Overall Study|Adverse Event|3|||
130164674|NCT03233230|468561122|FG002|Overall Study|Adverse Event|6|||
130164675|NCT03233230|468561123|FG003|Overall Study|Adverse Event|3|||
130164676|NCT03233230|468561120|FG000|Overall Study|Protocol Violation|1|||
130164677|NCT03233230|468561121|FG001|Overall Study|Protocol Violation|2|||
130164678|NCT03233230|468561122|FG002|Overall Study|Protocol Violation|1|||
130164679|NCT03233230|468561123|FG003|Overall Study|Protocol Violation|1|||
130164680|NCT03233230|468561120|FG000|Overall Study|Lack of Efficacy|1|||
130164681|NCT03233230|468561121|FG001|Overall Study|Lack of Efficacy|0|||
130164682|NCT03233230|468561122|FG002|Overall Study|Lack of Efficacy|0|||
130164683|NCT03233230|468561123|FG003|Overall Study|Lack of Efficacy|0|||
130164684|NCT03233230|468561120|FG000|Overall Study|Other|5|||
130164685|NCT03233230|468561121|FG001|Overall Study|Other|5|||
130164686|NCT03233230|468561122|FG002|Overall Study|Other|5|||
130164687|NCT03233230|468561123|FG003|Overall Study|Other|3|||
130164688|NCT03233230|468561120|FG000|Overall Study|Withdrawal by Subject|2|||
130164689|NCT03233230|468561121|FG001|Overall Study|Withdrawal by Subject|2|||
130164690|NCT03233230|468561122|FG002|Overall Study|Withdrawal by Subject|0|||
130164691|NCT03233230|468561123|FG003|Overall Study|Withdrawal by Subject|1|||
130164692|NCT03233230|468561120|FG000|Overall Study|Lost to Follow-up|0|||
130164693|NCT03233230|468561121|FG001|Overall Study|Lost to Follow-up|3|||
130164694|NCT03233230|468561122|FG002|Overall Study|Lost to Follow-up|0|||
130164695|NCT03233230|468561123|FG003|Overall Study|Lost to Follow-up|0|||
130164696|NCT02987959|468561124|FG000|Overall Study|Grantor stopped supply of drugs|6|||
130164697|NCT02853370|468561125|FG000|Overall Study|Physician Decision|1|||
130164698|NCT02853370|468561125|FG000|Overall Study|Lack of Efficacy|2|||
130164699|NCT02853370|468561125|FG000|Overall Study|Death|1|||
130164700|NCT02853370|468561125|FG000|Overall Study|Adverse Event|4|||
130164701|NCT02853370|468561125|FG000|Overall Study|Withdrawal by Subject|3|||
130164702|NCT01898650|468561130|FG000|Overall Study|the subject would not lie still for imaging|1|||
130164703|NCT00911807|468561132|FG000|Overall Study|Adverse Event|2|||
130164704|NCT00911807|468561133|FG001|Overall Study|Adverse Event|1|||
130164705|NCT00911807|468561134|FG002|Overall Study|Adverse Event|5|||
130164706|NCT00911807|468561132|FG000|Overall Study|Death|0|||
130164707|NCT00911807|468561133|FG001|Overall Study|Death|0|||
130164708|NCT00911807|468561134|FG002|Overall Study|Death|1|||
130164709|NCT00911807|468561132|FG000|Overall Study|Protocol Violation|6|||
130164710|NCT00911807|468561133|FG001|Overall Study|Protocol Violation|4|||
130164711|NCT00911807|468561134|FG002|Overall Study|Protocol Violation|9|||
130164712|NCT00911807|468561132|FG000|Overall Study|Withdrawal by Subject|8|||
130164713|NCT00911807|468561133|FG001|Overall Study|Withdrawal by Subject|10|||
130164714|NCT00911807|468561134|FG002|Overall Study|Withdrawal by Subject|7|||
130164715|NCT00911807|468561132|FG000|Overall Study|Organizational reasons|1|||
130164716|NCT00911807|468561133|FG001|Overall Study|Organizational reasons|3|||
130164717|NCT00911807|468561134|FG002|Overall Study|Organizational reasons|1|||
130164718|NCT04430855|468561137|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
130164719|NCT04430855|468561138|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
130164720|NCT04430855|468561137|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
130164721|NCT04430855|468561138|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
130164722|NCT04430855|468561137|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
130164723|NCT04430855|468561138|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
130164724|NCT04430855|468561137|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
130164725|NCT04430855|468561138|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
130164726|NCT04430855|468561137|FG000|Period 1 (Weeks 1-12)|Other|0|||
130164727|NCT04430855|468561138|FG001|Period 1 (Weeks 1-12)|Other|1|||
130164728|NCT04430855|468561137|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
130164729|NCT04430855|468561138|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
130164730|NCT04430855|468561137|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
130164731|NCT04430855|468561138|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
130164732|NCT04430855|468561137|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
130164733|NCT04430855|468561138|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
130164734|NCT01425723|468561139|FG000|Overall Study|Lack of Efficacy|0|||
130164735|NCT01425723|468561140|FG001|Overall Study|Lack of Efficacy|1|||
130164736|NCT01425723|468561139|FG000|Overall Study|Withdrawal by Subject|1|||
130164737|NCT01425723|468561140|FG001|Overall Study|Withdrawal by Subject|4|||
130164738|NCT01425723|468561139|FG000|Overall Study|Lost to Follow-up|0|||
130164739|NCT01425723|468561140|FG001|Overall Study|Lost to Follow-up|3|||
130164740|NCT01425723|468561139|FG000|Overall Study|Physician Decision|2|||
130164741|NCT01425723|468561140|FG001|Overall Study|Physician Decision|0|||
130164742|NCT01425723|468561139|FG000|Overall Study|Other|1|||
130164743|NCT01425723|468561140|FG001|Overall Study|Other|10|||
130164744|NCT00186043|468561141|FG000|Overall Study|Lack of Efficacy|1|||
130164745|NCT00186043|468561142|FG001|Overall Study|Lack of Efficacy|3|||
130164746|NCT00186043|468561141|FG000|Overall Study|Lost to Follow-up|4|||
130164747|NCT00186043|468561142|FG001|Overall Study|Lost to Follow-up|6|||
130164748|NCT00186043|468561141|FG000|Overall Study|Withdrawal by Subject|1|||
130164749|NCT00186043|468561142|FG001|Overall Study|Withdrawal by Subject|0|||
130164750|NCT00186043|468561141|FG000|Overall Study|Adverse Event|7|||
130164751|NCT00186043|468561142|FG001|Overall Study|Adverse Event|3|||
130164752|NCT00186043|468561141|FG000|Overall Study|Protocol Violation|2|||
130164753|NCT00186043|468561142|FG001|Overall Study|Protocol Violation|1|||
130164754|NCT04874636|468561143|FG000|Overall Study|Adverse Event|17|||
130164755|NCT04874636|468561144|FG001|Overall Study|Adverse Event|7|||
130164756|NCT04874636|468561143|FG000|Overall Study|Lost to Follow-up|1|||
130164757|NCT04874636|468561144|FG001|Overall Study|Lost to Follow-up|0|||
130164758|NCT04874636|468561143|FG000|Overall Study|Non-Compliance with Study Drug|2|||
130164759|NCT04874636|468561144|FG001|Overall Study|Non-Compliance with Study Drug|0|||
130164760|NCT04874636|468561143|FG000|Overall Study|Physician Decision|1|||
130164761|NCT04874636|468561144|FG001|Overall Study|Physician Decision|0|||
130164762|NCT04874636|468561143|FG000|Overall Study|Withdrawal by Subject|6|||
130164763|NCT04874636|468561144|FG001|Overall Study|Withdrawal by Subject|5|||
130164764|NCT01770392|468561145|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
130164765|NCT04639713|468561146|FG000|Overall Study|Protocol Noncompliance|2|||
130164766|NCT04639713|468561146|FG000|Overall Study|Withdrawal by Subject|1|||
130164767|NCT00390221|468561149|FG000|Overall Study|Lost to Follow-up|0|||
130164768|NCT00390221|468561150|FG001|Overall Study|Lost to Follow-up|3|||
130164769|NCT00390221|468561151|FG002|Overall Study|Lost to Follow-up|0|||
130164770|NCT00390221|468561149|FG000|Overall Study|Adverse Event|1|||
130164771|NCT00390221|468561150|FG001|Overall Study|Adverse Event|4|||
130164772|NCT00390221|468561151|FG002|Overall Study|Adverse Event|3|||
130164773|NCT00390221|468561149|FG000|Overall Study|Investigator Decision|0|||
130164774|NCT00390221|468561150|FG001|Overall Study|Investigator Decision|0|||
130164775|NCT00390221|468561151|FG002|Overall Study|Investigator Decision|1|||
130164776|NCT00390221|468561149|FG000|Overall Study|Withdrawal by Subject|13|||
130164777|NCT00390221|468561150|FG001|Overall Study|Withdrawal by Subject|9|||
130164778|NCT00390221|468561151|FG002|Overall Study|Withdrawal by Subject|7|||
130164779|NCT00390221|468561149|FG000|Overall Study|Subject Non-compliance|1|||
130164780|NCT00390221|468561150|FG001|Overall Study|Subject Non-compliance|0|||
130164781|NCT00390221|468561151|FG002|Overall Study|Subject Non-compliance|2|||
130164782|NCT00390221|468561149|FG000|Overall Study|Other|3|||
130164783|NCT00390221|468561150|FG001|Overall Study|Other|4|||
130164784|NCT00390221|468561151|FG002|Overall Study|Other|2|||
130164785|NCT02533375|468561152|FG000|Overall Study|Lack of Efficacy|3|||
130164786|NCT02533375|468561152|FG000|Overall Study|Adverse Event|2|||
130164787|NCT03870477|468561161|FG000|Overall Study|Early Study Termination|1|||
130164788|NCT03258853|468561162|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
130164789|NCT03258853|468561163|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
130164790|NCT00871741|468561170|FG000|Overall Study|Premature study termination|9|||
130164791|NCT00871741|468561171|FG001|Overall Study|Premature study termination|7|||
130164792|NCT01565850|468561172|FG000|Overall Study|Adverse Event|0|||
130164793|NCT01565850|468561173|FG001|Overall Study|Adverse Event|1|||
130164794|NCT01565850|468561172|FG000|Overall Study|Lost to Follow-up|12|||
130164795|NCT01565850|468561173|FG001|Overall Study|Lost to Follow-up|4|||
130164796|NCT01565850|468561172|FG000|Overall Study|Investigator's Discretion|2|||
130164797|NCT01565850|468561173|FG001|Overall Study|Investigator's Discretion|1|||
130164798|NCT01565850|468561172|FG000|Overall Study|Participant noncompliance|2|||
130164799|NCT01565850|468561173|FG001|Overall Study|Participant noncompliance|0|||
130164800|NCT01565850|468561172|FG000|Overall Study|Withdrew Consent|4|||
130164801|NCT01565850|468561173|FG001|Overall Study|Withdrew Consent|2|||
130164802|NCT04941729|468562933|FG000|Overall Study|Death|0|||
130164803|NCT04941729|468562934|FG001|Overall Study|Death|1|||
130164804|NCT04941729|468562933|FG000|Overall Study|Study terminated by sponsor|11|||
130164805|NCT04941729|468562934|FG001|Overall Study|Study terminated by sponsor|10|||
130164806|NCT00191113|468562935|FG000|Core Study|Withdrawal by Subject|25|||
130164807|NCT00191113|468562936|FG001|Core Study|Withdrawal by Subject|9|||
130164808|NCT00191113|468562935|FG000|Core Study|Protocol Violation|6|||
130164809|NCT00191113|468562936|FG001|Core Study|Protocol Violation|2|||
130164810|NCT00191113|468562935|FG000|Core Study|Lost to Follow-up|3|||
130164811|NCT00191113|468562936|FG001|Core Study|Lost to Follow-up|0|||
130164812|NCT00191113|468562935|FG000|Core Study|Adverse Event|0|||
130164813|NCT00191113|468562936|FG001|Core Study|Adverse Event|2|||
130164814|NCT00191113|468562935|FG000|Core Study|Lack of Efficacy|0|||
130164815|NCT00191113|468562936|FG001|Core Study|Lack of Efficacy|2|||
130164816|NCT00191113|468562935|FG000|Core Study|Death|1|||
130164817|NCT00191113|468562936|FG001|Core Study|Death|0|||
130164818|NCT00368979|468562941|FG000|Overall Study|Adverse Event|9|||
129981539|NCT03568318|467895007|FG000|Overall Study|Other|3|||
130164819|NCT00368979|468562942|FG001|Overall Study|Adverse Event|16|||
130164820|NCT00368979|468562941|FG000|Overall Study|Lack of Efficacy|5|||
130164821|NCT00368979|468562942|FG001|Overall Study|Lack of Efficacy|3|||
130164822|NCT00368979|468562941|FG000|Overall Study|Other|3|||
129981540|NCT03568318|467895008|FG001|Overall Study|Other|1|||
130164823|NCT00368979|468562942|FG001|Overall Study|Other|1|||
130164824|NCT00368979|468562941|FG000|Overall Study|Lost to Follow-up|1|||
130164825|NCT00368979|468562942|FG001|Overall Study|Lost to Follow-up|0|||
130164826|NCT00368979|468562941|FG000|Overall Study|Protocol Violation|2|||
130164827|NCT00368979|468562942|FG001|Overall Study|Protocol Violation|1|||
130164828|NCT00368979|468562941|FG000|Overall Study|Withdrawal by Subject|5|||
130164829|NCT00368979|468562942|FG001|Overall Study|Withdrawal by Subject|9|||
130164830|NCT00631657|468562945|FG000|6-Month Treatment Period|Adverse Event|47|||
130164831|NCT00631657|468562946|FG001|6-Month Treatment Period|Adverse Event|0|||
130164832|NCT00631657|468562947|FG002|6-Month Treatment Period|Adverse Event|7|||
130164833|NCT00631657|468562945|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
130164834|NCT00631657|468562946|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
130164835|NCT00631657|468562947|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
130164836|NCT00631657|468562945|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
130164837|NCT00631657|468562946|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
130164838|NCT00631657|468562947|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
130164839|NCT00631657|468562945|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
130164840|NCT00631657|468562946|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
130164841|NCT00631657|468562947|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
129981541|NCT03568318|467895009|FG002|Overall Study|Other|3|||
129981542|NCT03568318|467895010|FG003|Overall Study|Other|0|||
129981543|NCT03568318|467895011|FG004|Overall Study|Other|0|||
129981544|NCT03568318|467895012|FG005|Overall Study|Other|0|||
129981545|NCT03568318|467895007|FG000|Overall Study|Ongoing at Time of Analysis|5|||
129981546|NCT03568318|467895008|FG001|Overall Study|Ongoing at Time of Analysis|3|||
129981547|NCT03568318|467895009|FG002|Overall Study|Ongoing at Time of Analysis|2|||
129981548|NCT03568318|467895010|FG003|Overall Study|Ongoing at Time of Analysis|1|||
129981549|NCT03568318|467895011|FG004|Overall Study|Ongoing at Time of Analysis|0|||
129981550|NCT03568318|467895012|FG005|Overall Study|Ongoing at Time of Analysis|0|||
129981551|NCT01638429|467895015|FG000|Overall Study|Withdrawal by Subject|1|||
129981552|NCT03207451|467895016|FG000|Overall Study|scheduling conflict|1|||
129981553|NCT03207451|467895017|FG001|Overall Study|scheduling conflict|0|||
129981554|NCT03207451|467895018|FG002|Overall Study|scheduling conflict|2|||
129981555|NCT03207451|467895019|FG003|Overall Study|scheduling conflict|2|||
129981556|NCT03207451|467895016|FG000|Overall Study|Adverse Event|0|||
129981557|NCT03207451|467895017|FG001|Overall Study|Adverse Event|0|||
129981558|NCT03207451|467895018|FG002|Overall Study|Adverse Event|0|||
129981559|NCT03207451|467895019|FG003|Overall Study|Adverse Event|1|||
129981560|NCT02040584|467895021|FG000|Overall Study|Adverse Event|13|||
129981561|NCT02040584|467895022|FG001|Overall Study|Adverse Event|6|||
129981562|NCT02040584|467895021|FG000|Overall Study|Protocol Violation|9|||
129981563|NCT02040584|467895022|FG001|Overall Study|Protocol Violation|11|||
129981564|NCT02040584|467895021|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129981565|NCT02040584|467895022|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129981566|NCT02040584|467895021|FG000|Overall Study|Death|6|||
129981567|NCT02040584|467895022|FG001|Overall Study|Death|3|||
129981568|NCT02040584|467895021|FG000|Overall Study|Transplant rejection/retransplant|0|||
129981569|NCT02040584|467895022|FG001|Overall Study|Transplant rejection/retransplant|1|||
129981570|NCT02040584|467895021|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
129981571|NCT02040584|467895022|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
129981572|NCT01802567|467895023|FG000|Overall Study|Withdrawal by Subject|2|||
129981573|NCT01802567|467895023|FG000|Overall Study|Physician Decision|1|||
129981574|NCT01802567|467895023|FG000|Overall Study|Lack of Efficacy|7|||
129981575|NCT01802567|467895023|FG000|Overall Study|Consented but did not start therapy|7|||
129981576|NCT01802567|467895023|FG000|Overall Study|Protocol Violation|1|||
129981577|NCT03167359|467895026|FG000|Overall Study|Physician Decision|1|||
129981578|NCT03167359|467895026|FG000|Overall Study|Lost to Follow-up|1|||
129981579|NCT03339583|467895027|FG000|First Intervention (14 Days)|Adverse Event|1|||
129981580|NCT03339583|467895028|FG001|First Intervention (14 Days)|Adverse Event|0|||
129981581|NCT03339583|467895027|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
129981582|NCT03339583|467895028|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
129981583|NCT03339583|467895027|FG000|Second Intervention (14 Days)|Adverse Event|0|||
129981584|NCT03339583|467895028|FG001|Second Intervention (14 Days)|Adverse Event|1|||
130164842|NCT00631657|468562945|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
130164843|NCT00631657|468562946|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
130164844|NCT00631657|468562947|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
130164845|NCT00631657|468562945|FG000|6-Month Treatment Period|Other|16|||
130164846|NCT00631657|468562946|FG001|6-Month Treatment Period|Other|0|||
129981585|NCT03339583|467895027|FG000|Follow-up (14 Days)|Physician Decision|6|||
129981586|NCT03339583|467895028|FG001|Follow-up (14 Days)|Physician Decision|3|||
129981587|NCT01896557|467895029|FG000|Clopidogrel Alone|Adverse Event|1|||
129981588|NCT01896557|467895030|FG001|Clopidogrel Alone|Adverse Event|0|||
129981589|NCT01896557|467895029|FG000|Clopidogrel + GI Protector|low adherence|1|||
129981590|NCT01896557|467895030|FG001|Clopidogrel + GI Protector|low adherence|1|||
129981591|NCT01896557|467895029|FG000|Clopidogrel + GI Protector|Reading error|1|||
129981592|NCT01896557|467895030|FG001|Clopidogrel + GI Protector|Reading error|3|||
129981593|NCT00734591|467895031|FG000|Screening for Prospective Period|Site did not participate|1604|||
130164847|NCT00631657|468562947|FG002|6-Month Treatment Period|Other|4|||
130164848|NCT00631657|468562945|FG000|6-Month Treatment Period|Not Treated|2|||
130164849|NCT00631657|468562946|FG001|6-Month Treatment Period|Not Treated|0|||
130164850|NCT00631657|468562947|FG002|6-Month Treatment Period|Not Treated|1|||
130164851|NCT00631657|468562945|FG000|7-Day Discontinuation Period|Not Treated|1|||
130164852|NCT00631657|468562946|FG001|7-Day Discontinuation Period|Not Treated|1|||
130164853|NCT00631657|468562947|FG002|7-Day Discontinuation Period|Not Treated|1|||
130164854|NCT00631657|468562945|FG000|7-Day Discontinuation Period|Other|1|||
130164855|NCT00631657|468562946|FG001|7-Day Discontinuation Period|Other|0|||
130164856|NCT00631657|468562947|FG002|7-Day Discontinuation Period|Other|0|||
130164857|NCT00325195|468562948|FG000|Randomized|Not dosed|5|||
130164858|NCT00325195|468562949|FG001|Randomized|Not dosed|5|||
130164859|NCT00325195|468562950|FG002|Randomized|Not dosed|3|||
130164860|NCT00325195|468562948|FG000|Received Intervention: ITT Population|Adverse Event|15|||
130164861|NCT00325195|468562949|FG001|Received Intervention: ITT Population|Adverse Event|17|||
130164862|NCT00325195|468562950|FG002|Received Intervention: ITT Population|Adverse Event|1|||
130164863|NCT00325195|468562948|FG000|Received Intervention: ITT Population|Death|3|||
130164864|NCT00325195|468562949|FG001|Received Intervention: ITT Population|Death|1|||
130164865|NCT00325195|468562950|FG002|Received Intervention: ITT Population|Death|0|||
130164866|NCT00325195|468562948|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
130164867|NCT00325195|468562949|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
130164868|NCT00325195|468562950|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
130164869|NCT00325195|468562948|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
130164870|NCT00325195|468562949|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
130164871|NCT00325195|468562950|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
130164872|NCT00325195|468562948|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
130164873|NCT00325195|468562949|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
130164874|NCT00325195|468562950|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
130164875|NCT01716715|468562951|FG000|Overall Study|Never Treated|2|||
130164876|NCT01716715|468562952|FG001|Overall Study|Never Treated|4|||
130164877|NCT04228783|468562953|FG000|Overall Study|Adverse Event|1|||
130164878|NCT04228783|468562954|FG001|Overall Study|Adverse Event|0|||
130164879|NCT04228783|468562955|FG002|Overall Study|Adverse Event|2|||
130164880|NCT04228783|468562956|FG003|Overall Study|Adverse Event|0|||
130164881|NCT04228783|468562957|FG004|Overall Study|Adverse Event|0|||
130164882|NCT04228783|468562958|FG005|Overall Study|Adverse Event|1|||
130164883|NCT04228783|468562953|FG000|Overall Study|Death|0|||
130164884|NCT04228783|468562954|FG001|Overall Study|Death|0|||
130164885|NCT04228783|468562955|FG002|Overall Study|Death|0|||
130164886|NCT04228783|468562956|FG003|Overall Study|Death|0|||
130164887|NCT04228783|468562957|FG004|Overall Study|Death|1|||
130164888|NCT04228783|468562958|FG005|Overall Study|Death|0|||
130164889|NCT04228783|468562953|FG000|Overall Study|Lost to Follow-up|36|||
130164890|NCT04228783|468562954|FG001|Overall Study|Lost to Follow-up|36|||
130164891|NCT04228783|468562955|FG002|Overall Study|Lost to Follow-up|28|||
130164892|NCT04228783|468562956|FG003|Overall Study|Lost to Follow-up|6|||
130164893|NCT04228783|468562957|FG004|Overall Study|Lost to Follow-up|14|||
130164894|NCT04228783|468562958|FG005|Overall Study|Lost to Follow-up|3|||
130164895|NCT04228783|468562953|FG000|Overall Study|Physician Decision|1|||
130164896|NCT04228783|468562954|FG001|Overall Study|Physician Decision|2|||
130164897|NCT04228783|468562955|FG002|Overall Study|Physician Decision|0|||
130164898|NCT04228783|468562956|FG003|Overall Study|Physician Decision|0|||
130164899|NCT04228783|468562957|FG004|Overall Study|Physician Decision|0|||
130164900|NCT04228783|468562958|FG005|Overall Study|Physician Decision|0|||
130164901|NCT04228783|468562953|FG000|Overall Study|Protocol Violation|0|||
130164902|NCT04228783|468562954|FG001|Overall Study|Protocol Violation|0|||
130164903|NCT04228783|468562955|FG002|Overall Study|Protocol Violation|0|||
130164904|NCT04228783|468562956|FG003|Overall Study|Protocol Violation|1|||
130164905|NCT04228783|468562957|FG004|Overall Study|Protocol Violation|0|||
130164906|NCT04228783|468562958|FG005|Overall Study|Protocol Violation|0|||
130164907|NCT04228783|468562953|FG000|Overall Study|Withdrawal by Subject|6|||
130164908|NCT04228783|468562954|FG001|Overall Study|Withdrawal by Subject|10|||
130164909|NCT04228783|468562955|FG002|Overall Study|Withdrawal by Subject|19|||
130164910|NCT04228783|468562956|FG003|Overall Study|Withdrawal by Subject|1|||
130164911|NCT04228783|468562957|FG004|Overall Study|Withdrawal by Subject|2|||
130164912|NCT04228783|468562958|FG005|Overall Study|Withdrawal by Subject|0|||
130164913|NCT04228783|468562953|FG000|Overall Study|Other|4|||
130164914|NCT04228783|468562954|FG001|Overall Study|Other|3|||
130164915|NCT04228783|468562955|FG002|Overall Study|Other|2|||
130164916|NCT04228783|468562956|FG003|Overall Study|Other|1|||
130164917|NCT04228783|468562957|FG004|Overall Study|Other|0|||
130164918|NCT04228783|468562958|FG005|Overall Study|Other|0|||
130164919|NCT00626392|468562959|FG000|Run-in Period|Adverse Event|0|||
130164920|NCT00626392|468562960|FG001|Run-in Period|Adverse Event|0|||
130164921|NCT00626392|468562961|FG002|Run-in Period|Adverse Event|1|||
130164922|NCT00626392|468562962|FG003|Run-in Period|Adverse Event|0|||
130164923|NCT00626392|468562963|FG004|Run-in Period|Adverse Event|1|||
130164924|NCT00626392|468562964|FG005|Run-in Period|Adverse Event|0|||
130164925|NCT00626392|468562959|FG000|Run-in Period|Withdrawal by Subject|0|||
130164926|NCT00626392|468562960|FG001|Run-in Period|Withdrawal by Subject|1|||
130164927|NCT00626392|468562961|FG002|Run-in Period|Withdrawal by Subject|1|||
130164928|NCT00626392|468562962|FG003|Run-in Period|Withdrawal by Subject|1|||
130164929|NCT00626392|468562963|FG004|Run-in Period|Withdrawal by Subject|3|||
130164930|NCT00626392|468562964|FG005|Run-in Period|Withdrawal by Subject|1|||
130164931|NCT00626392|468562959|FG000|Run-in Period|Noncompliance|1|||
130164932|NCT00626392|468562960|FG001|Run-in Period|Noncompliance|0|||
130164933|NCT00626392|468562961|FG002|Run-in Period|Noncompliance|1|||
130164934|NCT00626392|468562962|FG003|Run-in Period|Noncompliance|0|||
130164935|NCT00626392|468562963|FG004|Run-in Period|Noncompliance|0|||
130164936|NCT00626392|468562964|FG005|Run-in Period|Noncompliance|0|||
130164937|NCT00626392|468562959|FG000|Coadministration Period|Adverse Event|3|||
130164938|NCT00626392|468562960|FG001|Coadministration Period|Adverse Event|1|||
130164939|NCT00626392|468562961|FG002|Coadministration Period|Adverse Event|7|||
130164940|NCT00626392|468562962|FG003|Coadministration Period|Adverse Event|4|||
130164941|NCT00626392|468562963|FG004|Coadministration Period|Adverse Event|3|||
130164942|NCT00626392|468562964|FG005|Coadministration Period|Adverse Event|4|||
130164943|NCT00626392|468562959|FG000|Coadministration Period|Withdrawal by Subject|1|||
130164944|NCT00626392|468562960|FG001|Coadministration Period|Withdrawal by Subject|1|||
130164945|NCT00626392|468562961|FG002|Coadministration Period|Withdrawal by Subject|0|||
130164946|NCT00626392|468562962|FG003|Coadministration Period|Withdrawal by Subject|1|||
130164947|NCT00626392|468562963|FG004|Coadministration Period|Withdrawal by Subject|0|||
130164948|NCT00626392|468562964|FG005|Coadministration Period|Withdrawal by Subject|1|||
130164949|NCT00626392|468562959|FG000|Coadministration Period|Protocol Violation|0|||
130164950|NCT00626392|468562960|FG001|Coadministration Period|Protocol Violation|1|||
130164951|NCT00626392|468562961|FG002|Coadministration Period|Protocol Violation|0|||
130164952|NCT00626392|468562962|FG003|Coadministration Period|Protocol Violation|1|||
130164953|NCT00626392|468562963|FG004|Coadministration Period|Protocol Violation|1|||
130164954|NCT00626392|468562964|FG005|Coadministration Period|Protocol Violation|0|||
130164955|NCT00626392|468562959|FG000|Coadministration Period|Other|0|||
129981594|NCT00734591|467895032|FG001|Screening for Prospective Period|Site did not participate|1488|||
129981595|NCT00734591|467895031|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
129981596|NCT00734591|467895032|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
129981597|NCT00734591|467895031|FG000|Prospective Period|Withdrawal by Subject|11|||
129981598|NCT00734591|467895032|FG001|Prospective Period|Withdrawal by Subject|9|||
129981599|NCT00734591|467895031|FG000|Prospective Period|Lost to Follow-up|37|||
129981600|NCT00734591|467895032|FG001|Prospective Period|Lost to Follow-up|33|||
129981601|NCT00734591|467895031|FG000|Prospective Period|Study Terminated|1|||
129981602|NCT00734591|467895032|FG001|Prospective Period|Study Terminated|0|||
129981603|NCT00734591|467895031|FG000|Prospective Period|Other|2|||
129981604|NCT00734591|467895032|FG001|Prospective Period|Other|2|||
129981605|NCT02236988|467895033|FG000|Overall Study|Lost to Follow-up|0|||
129981606|NCT02236988|467895034|FG001|Overall Study|Lost to Follow-up|0|||
129981607|NCT02236988|467895035|FG002|Overall Study|Lost to Follow-up|0|||
129981608|NCT02236988|467895036|FG003|Overall Study|Lost to Follow-up|1|||
129981609|NCT02236988|467895033|FG000|Overall Study|Unable to Comply with Study Visits|0|||
129981610|NCT02236988|467895034|FG001|Overall Study|Unable to Comply with Study Visits|0|||
129981611|NCT02236988|467895035|FG002|Overall Study|Unable to Comply with Study Visits|0|||
129981612|NCT02236988|467895036|FG003|Overall Study|Unable to Comply with Study Visits|2|||
129981613|NCT04032613|467895037|FG000|Overall Study|Did not complete post-program assessment|5|||
129981614|NCT04032613|467895038|FG001|Overall Study|Did not complete post-program assessment|2|||
129981615|NCT01659853|467895039|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
129981616|NCT01659853|467895040|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
129981617|NCT01659853|467895039|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
129981618|NCT01659853|467895040|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
129981619|NCT03053518|467895043|FG000|Overall Study|Withdrawal by Subject|3|||
129981620|NCT03053518|467895043|FG000|Overall Study|Lost to Follow-up|2|||
129981621|NCT03053518|467895043|FG000|Overall Study|Ineligible|5|||
130164956|NCT00626392|468562960|FG001|Coadministration Period|Other|2|||
130164957|NCT00626392|468562961|FG002|Coadministration Period|Other|3|||
130164958|NCT00626392|468562962|FG003|Coadministration Period|Other|1|||
130164959|NCT00626392|468562963|FG004|Coadministration Period|Other|1|||
130164960|NCT00626392|468562964|FG005|Coadministration Period|Other|1|||
130164961|NCT03327792|468562965|FG000|Overall Study|Adverse Event|4|||
130164962|NCT03327792|468562966|FG001|Overall Study|Adverse Event|0|||
130164963|NCT03327792|468562965|FG000|Overall Study|Family/Personal issues|3|||
130164964|NCT03327792|468562966|FG001|Overall Study|Family/Personal issues|2|||
130164965|NCT03327792|468562965|FG000|Overall Study|Lost to Follow-up|0|||
130164966|NCT03327792|468562966|FG001|Overall Study|Lost to Follow-up|1|||
130164967|NCT01085734|468562971|FG000|Overall Study|Adverse Event|0|||
129981622|NCT02071290|467895044|FG000|Overall Study|Death|1|||
129981623|NCT02071290|467895045|FG001|Overall Study|Death|0|||
129981624|NCT02071290|467895044|FG000|Overall Study|Withdrawal by Subject|0|||
130164968|NCT01085734|468562972|FG001|Overall Study|Adverse Event|2|||
130164969|NCT01085734|468562971|FG000|Overall Study|Death|1|||
130164970|NCT01085734|468562972|FG001|Overall Study|Death|0|||
130164971|NCT01085734|468562971|FG000|Overall Study|Lost to Follow-up|0|||
130164972|NCT01085734|468562972|FG001|Overall Study|Lost to Follow-up|1|||
130164973|NCT01085734|468562971|FG000|Overall Study|Withdrawal by Subject|0|||
130164974|NCT01085734|468562972|FG001|Overall Study|Withdrawal by Subject|1|||
130164975|NCT01715571|468562973|FG000|Overall Study|Lost to Follow-up|8|||
130164976|NCT04480710|468562980|FG000|Overall Study|Adverse Event|0|||
130164977|NCT04480710|468562981|FG001|Overall Study|Adverse Event|2|||
130164978|NCT04480710|468562982|FG002|Overall Study|Adverse Event|0|||
130164979|NCT04480710|468562983|FG003|Overall Study|Adverse Event|0|||
130164980|NCT04480710|468562980|FG000|Overall Study|Withdrawal by Subject|0|||
130164981|NCT04480710|468562981|FG001|Overall Study|Withdrawal by Subject|1|||
130164982|NCT04480710|468562982|FG002|Overall Study|Withdrawal by Subject|0|||
130164983|NCT04480710|468562983|FG003|Overall Study|Withdrawal by Subject|0|||
130164984|NCT04480710|468562980|FG000|Overall Study|Physician Decision|0|||
130164985|NCT04480710|468562981|FG001|Overall Study|Physician Decision|0|||
130164986|NCT04480710|468562982|FG002|Overall Study|Physician Decision|1|||
130164987|NCT04480710|468562983|FG003|Overall Study|Physician Decision|0|||
130164988|NCT04126213|468562985|FG000|Overall Study|Lost to Follow-up|9|||
130164989|NCT04126213|468562986|FG001|Overall Study|Lost to Follow-up|1|||
130164990|NCT04126213|468562987|FG002|Overall Study|Lost to Follow-up|5|||
130164991|NCT04126213|468562988|FG003|Overall Study|Lost to Follow-up|10|||
130164992|NCT04126213|468562989|FG004|Overall Study|Lost to Follow-up|4|||
130164993|NCT04126213|468562990|FG005|Overall Study|Lost to Follow-up|7|||
130164994|NCT04126213|468562985|FG000|Overall Study|Withdrawal by Subject|3|||
130164995|NCT04126213|468562986|FG001|Overall Study|Withdrawal by Subject|2|||
130164996|NCT04126213|468562987|FG002|Overall Study|Withdrawal by Subject|1|||
130164997|NCT04126213|468562988|FG003|Overall Study|Withdrawal by Subject|1|||
130164998|NCT04126213|468562989|FG004|Overall Study|Withdrawal by Subject|1|||
130164999|NCT04126213|468562990|FG005|Overall Study|Withdrawal by Subject|1|||
130165000|NCT04126213|468562985|FG000|Overall Study|Other|0|||
130165001|NCT04126213|468562986|FG001|Overall Study|Other|0|||
130165002|NCT04126213|468562987|FG002|Overall Study|Other|2|||
130165003|NCT04126213|468562988|FG003|Overall Study|Other|2|||
130165004|NCT04126213|468562989|FG004|Overall Study|Other|0|||
130165005|NCT04126213|468562990|FG005|Overall Study|Other|1|||
130165006|NCT04126213|468562985|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130165007|NCT04126213|468562986|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130165008|NCT04126213|468562987|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130165009|NCT04126213|468562988|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130165010|NCT04126213|468562989|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
130165011|NCT04126213|468562990|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130165012|NCT02196701|468562993|FG000|Overall Study|Adverse Event|1|||
130165013|NCT02196701|468562993|FG000|Overall Study|Lost to Follow-up|1|||
130165014|NCT02196701|468562993|FG000|Overall Study|Non-adherence to Protocol|1|||
130165015|NCT04159935|468562994|FG000|Overall Study|Study terminated due to COVID-19|1|||
130165016|NCT04159935|468562995|FG001|Overall Study|Study terminated due to COVID-19|3|||
130165017|NCT03275064|468562996|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130165018|NCT03275064|468562997|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130165019|NCT03275064|468562998|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130165020|NCT03275064|468562999|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
130165021|NCT03275064|468563000|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
130165022|NCT03275064|468562996|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
130165023|NCT03275064|468562997|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130165024|NCT03275064|468562998|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130165025|NCT03275064|468562999|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130165026|NCT03275064|468563000|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
130165027|NCT03275064|468562996|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
129981625|NCT02071290|467895045|FG001|Overall Study|Withdrawal by Subject|1|||
129981626|NCT02071290|467895044|FG000|Overall Study|Protocol Violation|3|||
130165028|NCT03275064|468562997|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
130165029|NCT03275064|468562998|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
130165030|NCT03275064|468562999|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
130165031|NCT03275064|468563000|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
130165032|NCT03275064|468562996|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130165033|NCT03275064|468562997|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130165034|NCT03275064|468562998|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130165035|NCT03275064|468562999|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
130165036|NCT03275064|468563000|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
130165037|NCT03275064|468562996|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
130165038|NCT03275064|468562997|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130165039|NCT03275064|468562998|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
130165040|NCT03275064|468562999|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130165041|NCT03275064|468563000|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
130165042|NCT01341782|468563001|FG000|Overall Study|Adverse Event|1|||
130165043|NCT01341782|468563002|FG001|Overall Study|Adverse Event|1|||
130165044|NCT01341782|468563001|FG000|Overall Study|Withdrawal by Subject|6|||
130165045|NCT01341782|468563002|FG001|Overall Study|Withdrawal by Subject|5|||
130165046|NCT01341782|468563001|FG000|Overall Study|Missed 3 consecutive doses|0|||
130165047|NCT01341782|468563002|FG001|Overall Study|Missed 3 consecutive doses|4|||
130165048|NCT01341782|468563001|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
130165049|NCT01341782|468563002|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
130165050|NCT01341782|468563001|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
130165051|NCT01341782|468563002|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
130165052|NCT01341782|468563001|FG000|Overall Study|Other|5|||
130165053|NCT01341782|468563002|FG001|Overall Study|Other|0|||
130165054|NCT00620555|468563003|FG000|Overall Study|Adverse Event|4|||
130165055|NCT00620555|468563003|FG000|Overall Study|Protocol Violation|2|||
130165056|NCT00620555|468563003|FG000|Overall Study|Lack of Efficacy|12|||
130165057|NCT00620555|468563003|FG000|Overall Study|Withdrawal by Subject|1|||
130165058|NCT00620555|468563003|FG000|Overall Study|Choice of other treatment|1|||
130165059|NCT00620555|468563003|FG000|Overall Study|Visit failure against planned|1|||
130165060|NCT01140503|468563004|FG000|Overall Study|Withdrawal by Subject|1|||
130165061|NCT00724048|468563005|FG000|Overall Study|Adverse Event|1|||
130165062|NCT00724048|468563006|FG001|Overall Study|Adverse Event|1|||
130165063|NCT00724048|468563007|FG002|Overall Study|Adverse Event|1|||
130165064|NCT00724048|468563008|FG003|Overall Study|Adverse Event|0|||
130165065|NCT00724048|468563005|FG000|Overall Study|Lost to Follow-up|0|||
130165066|NCT00724048|468563006|FG001|Overall Study|Lost to Follow-up|1|||
130165067|NCT00724048|468563007|FG002|Overall Study|Lost to Follow-up|0|||
130165068|NCT00724048|468563008|FG003|Overall Study|Lost to Follow-up|0|||
130165069|NCT00724048|468563005|FG000|Overall Study|Withdrawal by Subject|1|||
130165070|NCT00724048|468563006|FG001|Overall Study|Withdrawal by Subject|2|||
130165071|NCT00724048|468563007|FG002|Overall Study|Withdrawal by Subject|1|||
130165072|NCT00724048|468563008|FG003|Overall Study|Withdrawal by Subject|2|||
130165073|NCT00724048|468563005|FG000|Overall Study|Investigator decision|0|||
130165074|NCT00724048|468563006|FG001|Overall Study|Investigator decision|0|||
130165075|NCT00724048|468563007|FG002|Overall Study|Investigator decision|1|||
130165076|NCT00724048|468563008|FG003|Overall Study|Investigator decision|0|||
130165077|NCT00724048|468563005|FG000|Overall Study|Did not tolerate study drug|0|||
130165078|NCT00724048|468563006|FG001|Overall Study|Did not tolerate study drug|0|||
130165079|NCT00724048|468563007|FG002|Overall Study|Did not tolerate study drug|0|||
130165080|NCT00724048|468563008|FG003|Overall Study|Did not tolerate study drug|1|||
130165081|NCT00724048|468563005|FG000|Overall Study|Other than specified|1|||
130165082|NCT00724048|468563006|FG001|Overall Study|Other than specified|1|||
130165083|NCT00724048|468563007|FG002|Overall Study|Other than specified|0|||
130165084|NCT00724048|468563008|FG003|Overall Study|Other than specified|0|||
130165085|NCT03923530|468563009|FG000|Overall Study|Withdrawal by Subject|1|||
130165086|NCT03923530|468563009|FG000|Overall Study|screen failure|3|||
130165087|NCT00407758|468563010|FG000|Overall Study|ineligible -improper prior treatment|1|||
130165088|NCT01822275|468563018|FG000|Overall Study|Withdrawal by Subject|3|||
130165089|NCT01822275|468563018|FG000|Overall Study|Adverse Event|3|||
130165090|NCT01822275|468563018|FG000|Overall Study|Progression|14|||
130165091|NCT01822275|468563018|FG000|Overall Study|Physician Decision|2|||
130165092|NCT01458106|468563020|FG000|Overall Study|Withdrawal by Subject|2|||
130165093|NCT01458106|468563021|FG001|Overall Study|Withdrawal by Subject|0|||
130165094|NCT01458106|468563020|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
130165095|NCT01458106|468563021|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
130165096|NCT01458106|468563020|FG000|Overall Study|Withdrawn Per Protocol|0|||
130165097|NCT01458106|468563021|FG001|Overall Study|Withdrawn Per Protocol|1|||
130165098|NCT00073021|468563022|FG000|Overall Study|Protocol Violation|2|||
130165099|NCT00073021|468563023|FG001|Overall Study|Protocol Violation|1|||
130165100|NCT00073021|468563022|FG000|Overall Study|Adverse Event|4|||
130165101|NCT00073021|468563023|FG001|Overall Study|Adverse Event|4|||
130165102|NCT00073021|468563022|FG000|Overall Study|Withdrawal by Subject|6|||
130165103|NCT00073021|468563023|FG001|Overall Study|Withdrawal by Subject|5|||
130165104|NCT00073021|468563022|FG000|Overall Study|Physician Decision|3|||
130165105|NCT00073021|468563023|FG001|Overall Study|Physician Decision|1|||
130165106|NCT00073021|468563022|FG000|Overall Study|Lack of Efficacy|11|||
130165107|NCT00073021|468563023|FG001|Overall Study|Lack of Efficacy|5|||
130165108|NCT00855803|468563024|FG000|Overall Study|Death|2|||
130165109|NCT00855803|468563024|FG000|Overall Study|Lost to Follow-up|2|||
130165110|NCT00855803|468563024|FG000|Overall Study|Technical inability to undergo procedure|2|||
130165111|NCT00855803|468563024|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
130165112|NCT00855803|468563024|FG000|Overall Study|Withdrawal by Subject|3|||
130165113|NCT00855803|468563024|FG000|Overall Study|Physician Decision|3|||
130165114|NCT01672970|468563028|FG000|Overall Study|Lack of Efficacy|12|||
130165115|NCT01672970|468563028|FG000|Overall Study|Adverse Event|18|||
130165116|NCT01672970|468563028|FG000|Overall Study|Withdrawal by Subject|2|||
130165117|NCT01672970|468563028|FG000|Overall Study|Lost to Follow-up|5|||
130165118|NCT01672970|468563028|FG000|Overall Study|Other|9|||
130165119|NCT01672970|468563028|FG000|Overall Study|Enrolled but not treated|1|||
130165120|NCT03050060|468563031|FG000|Overall Study|Adverse Event|7|||
130165121|NCT03050060|468563031|FG000|Overall Study|Withdrawal by Subject|1|||
130165122|NCT03050060|468563031|FG000|Overall Study|Progression|7|||
130165123|NCT03276780|468563032|FG000|Overall Study|Withdrawal by Subject|5|||
130165124|NCT03276780|468563033|FG001|Overall Study|Withdrawal by Subject|3|||
130165125|NCT03276780|468563032|FG000|Overall Study|Lost to Follow-up|3|||
130165126|NCT03276780|468563033|FG001|Overall Study|Lost to Follow-up|5|||
130165127|NCT03276780|468563032|FG000|Overall Study|Moved out of state|1|||
130165128|NCT03276780|468563033|FG001|Overall Study|Moved out of state|1|||
130165129|NCT03276780|468563032|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
130165130|NCT03276780|468563033|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
130165131|NCT03276780|468563032|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
130165132|NCT03276780|468563033|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
130165133|NCT03835221|468563034|FG000|Methafilcon A|Withdrawal by Subject|1|||
130165134|NCT02582866|468563037|FG000|Overall Study|Death|1|||
130165135|NCT02582866|468563037|FG000|Overall Study|Lack of Efficacy|2|||
130165136|NCT02582866|468563037|FG000|Overall Study|Lost to Follow-up|2|||
130165137|NCT02582866|468563037|FG000|Overall Study|Withdrawal by Subject|7|||
130165138|NCT02582866|468563037|FG000|Overall Study|Investigator decision|5|||
130165139|NCT02582866|468563037|FG000|Overall Study|Participant wants to get pregnant|1|||
130165140|NCT02582866|468563037|FG000|Overall Study|Pregnancy|2|||
130165141|NCT02582866|468563037|FG000|Overall Study|Sponsor decision|1|||
130165142|NCT02582866|468563037|FG000|Overall Study|Withdrawal due to personal reasons|1|||
130165143|NCT02823652|468563038|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
130165144|NCT02823652|468563039|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
130165145|NCT02823652|468563040|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
130165146|NCT02823652|468563038|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
130165147|NCT02823652|468563039|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
130165148|NCT02823652|468563040|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
130165149|NCT02823652|468563038|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
130165150|NCT02823652|468563039|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
130165151|NCT02823652|468563040|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
130165152|NCT02823652|468563038|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
130165153|NCT02823652|468563039|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
130165154|NCT02823652|468563040|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
130165155|NCT03567382|468563047|FG000|Overall Study|Lost to Follow-up|1|||
130165156|NCT03567382|468563048|FG001|Overall Study|Lost to Follow-up|21|||
130165157|NCT03567382|468563049|FG002|Overall Study|Lost to Follow-up|1|||
130165158|NCT03567382|468563050|FG003|Overall Study|Lost to Follow-up|21|||
130165159|NCT03567382|468563047|FG000|Overall Study|Withdrawal by Subject|2|||
130165160|NCT03567382|468563048|FG001|Overall Study|Withdrawal by Subject|14|||
130165161|NCT03567382|468563049|FG002|Overall Study|Withdrawal by Subject|1|||
130165162|NCT03567382|468563050|FG003|Overall Study|Withdrawal by Subject|12|||
130165163|NCT00620659|468563051|FG000|Treatment Period 1|Adverse Event|1|||
130165164|NCT00620659|468563052|FG001|Treatment Period 1|Adverse Event|0|||
130165165|NCT00620659|468563053|FG002|Treatment Period 1|Adverse Event|0|||
130165166|NCT00620659|468563054|FG003|Treatment Period 1|Adverse Event|3|||
130165167|NCT00620659|468563055|FG004|Treatment Period 1|Adverse Event|0|||
130165168|NCT00620659|468563056|FG005|Treatment Period 1|Adverse Event|0|||
130165169|NCT00620659|468563051|FG000|Treatment Period 1|Protocol Violation|1|||
130165170|NCT00620659|468563052|FG001|Treatment Period 1|Protocol Violation|0|||
130165171|NCT00620659|468563053|FG002|Treatment Period 1|Protocol Violation|0|||
130165172|NCT00620659|468563054|FG003|Treatment Period 1|Protocol Violation|0|||
130165173|NCT00620659|468563055|FG004|Treatment Period 1|Protocol Violation|0|||
130165174|NCT00620659|468563056|FG005|Treatment Period 1|Protocol Violation|0|||
130165175|NCT00620659|468563051|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130165176|NCT00620659|468563052|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130165177|NCT00620659|468563053|FG002|Treatment Period 1|Withdrawal by Subject|1|||
130165178|NCT00620659|468563054|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130165179|NCT00620659|468563055|FG004|Treatment Period 1|Withdrawal by Subject|1|||
130165180|NCT00620659|468563056|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130165181|NCT00620659|468563051|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
130165182|NCT00620659|468563052|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
130165183|NCT00620659|468563053|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
130165184|NCT00620659|468563054|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
130165185|NCT00620659|468563055|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
130165186|NCT00620659|468563056|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
130165187|NCT00620659|468563051|FG000|Treatment Period 2|Adverse Event|0|||
130165188|NCT00620659|468563052|FG001|Treatment Period 2|Adverse Event|3|||
130165189|NCT00620659|468563053|FG002|Treatment Period 2|Adverse Event|0|||
130165190|NCT00620659|468563054|FG003|Treatment Period 2|Adverse Event|0|||
130165191|NCT00620659|468563055|FG004|Treatment Period 2|Adverse Event|2|||
130165192|NCT00620659|468563056|FG005|Treatment Period 2|Adverse Event|0|||
130165193|NCT00620659|468563051|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130165194|NCT00620659|468563052|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130165195|NCT00620659|468563053|FG002|Treatment Period 2|Withdrawal by Subject|1|||
130165196|NCT00620659|468563054|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130165197|NCT00620659|468563055|FG004|Treatment Period 2|Withdrawal by Subject|3|||
130165198|NCT00620659|468563056|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130165199|NCT00620659|468563051|FG000|Placebo Washout Period 2|Adverse Event|2|||
130165200|NCT00620659|468563052|FG001|Placebo Washout Period 2|Adverse Event|0|||
130165201|NCT00620659|468563053|FG002|Placebo Washout Period 2|Adverse Event|0|||
130165202|NCT00620659|468563054|FG003|Placebo Washout Period 2|Adverse Event|0|||
130165203|NCT00620659|468563055|FG004|Placebo Washout Period 2|Adverse Event|0|||
130165204|NCT00620659|468563056|FG005|Placebo Washout Period 2|Adverse Event|0|||
130165205|NCT00620659|468563051|FG000|Treatment Period 3|Adverse Event|0|||
130165206|NCT00620659|468563052|FG001|Treatment Period 3|Adverse Event|2|||
130165207|NCT00620659|468563053|FG002|Treatment Period 3|Adverse Event|0|||
130165208|NCT00620659|468563054|FG003|Treatment Period 3|Adverse Event|0|||
130165209|NCT00620659|468563055|FG004|Treatment Period 3|Adverse Event|0|||
130165210|NCT00620659|468563056|FG005|Treatment Period 3|Adverse Event|0|||
130165211|NCT00620659|468563051|FG000|Treatment Period 3|Withdrawal by Subject|0|||
130165212|NCT00620659|468563052|FG001|Treatment Period 3|Withdrawal by Subject|0|||
130165213|NCT00620659|468563053|FG002|Treatment Period 3|Withdrawal by Subject|0|||
130165214|NCT00620659|468563054|FG003|Treatment Period 3|Withdrawal by Subject|1|||
130165215|NCT00620659|468563055|FG004|Treatment Period 3|Withdrawal by Subject|0|||
130165216|NCT00620659|468563056|FG005|Treatment Period 3|Withdrawal by Subject|0|||
130165217|NCT01193127|468563057|FG000|Randomized|Surgery Cancelled|0|||
130165218|NCT01193127|468563058|FG001|Randomized|Surgery Cancelled|0|||
130165219|NCT01193127|468563059|FG002|Randomized|Surgery Cancelled|0|||
130165220|NCT01193127|468563060|FG003|Randomized|Surgery Cancelled|1|||
130165221|NCT01193127|468563057|FG000|Treated|Withdrawal by Subject|0|||
130165222|NCT01193127|468563058|FG001|Treated|Withdrawal by Subject|0|||
130165223|NCT01193127|468563059|FG002|Treated|Withdrawal by Subject|0|||
130165224|NCT01193127|468563060|FG003|Treated|Withdrawal by Subject|1|||
130165225|NCT03246646|468563063|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
130165226|NCT03246646|468563064|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
130165227|NCT03246646|468563063|FG000|Overall Study|Withdrawal by Subject|3|||
130165228|NCT03246646|468563064|FG001|Overall Study|Withdrawal by Subject|0|||
130165229|NCT03246646|468563063|FG000|Overall Study|Lost to Follow-up|7|||
130165230|NCT03246646|468563064|FG001|Overall Study|Lost to Follow-up|0|||
130165231|NCT02352779|468563065|FG000|Overall Study|Personal Issues|1|||
130165232|NCT02352779|468563066|FG001|Overall Study|Personal Issues|1|||
130165233|NCT02352779|468563067|FG002|Overall Study|Personal Issues|0|||
130165234|NCT02352779|468563065|FG000|Overall Study|Too Many Forms|2|||
130165235|NCT02352779|468563066|FG001|Overall Study|Too Many Forms|0|||
130165236|NCT02352779|468563067|FG002|Overall Study|Too Many Forms|0|||
130165237|NCT02352779|468563065|FG000|Overall Study|Feeling Overwhelmed|1|||
130165238|NCT02352779|468563066|FG001|Overall Study|Feeling Overwhelmed|0|||
130165239|NCT02352779|468563067|FG002|Overall Study|Feeling Overwhelmed|0|||
130165240|NCT02352779|468563065|FG000|Overall Study|Disliked Intervention|1|||
130165241|NCT02352779|468563066|FG001|Overall Study|Disliked Intervention|0|||
130165242|NCT02352779|468563067|FG002|Overall Study|Disliked Intervention|0|||
130165243|NCT02352779|468563065|FG000|Overall Study|Changed Mind|1|||
130165244|NCT02352779|468563066|FG001|Overall Study|Changed Mind|0|||
130165245|NCT02352779|468563067|FG002|Overall Study|Changed Mind|0|||
129981627|NCT02071290|467895045|FG001|Overall Study|Protocol Violation|5|||
129981628|NCT02071290|467895044|FG000|Overall Study|Physician Decision|0|||
129981629|NCT02071290|467895045|FG001|Overall Study|Physician Decision|1|||
129981630|NCT05560243|467895047|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
130165246|NCT02352779|468563065|FG000|Overall Study|Study Related Symptoms|1|||
129981631|NCT01072630|467895048|FG000|Overall Study|Adverse Event|11|||
130165247|NCT02352779|468563066|FG001|Overall Study|Study Related Symptoms|0|||
130165248|NCT02352779|468563067|FG002|Overall Study|Study Related Symptoms|0|||
130165249|NCT02352779|468563065|FG000|Overall Study|Absence of Symptoms|1|||
130165250|NCT02352779|468563066|FG001|Overall Study|Absence of Symptoms|0|||
129981632|NCT01072630|467895049|FG001|Overall Study|Adverse Event|19|||
130165251|NCT02352779|468563067|FG002|Overall Study|Absence of Symptoms|0|||
130165252|NCT02352779|468563065|FG000|Overall Study|Other Medical Reason|0|||
130165253|NCT02352779|468563066|FG001|Overall Study|Other Medical Reason|0|||
130165254|NCT02352779|468563067|FG002|Overall Study|Other Medical Reason|1|||
130165255|NCT02352779|468563065|FG000|Overall Study|No Reason|0|||
130165256|NCT02352779|468563066|FG001|Overall Study|No Reason|0|||
130165257|NCT02352779|468563067|FG002|Overall Study|No Reason|1|||
130165258|NCT04555720|468563070|FG000|Overall Study|Lost to Follow-up|2|||
130165259|NCT04555720|468563071|FG001|Overall Study|Lost to Follow-up|0|||
130165260|NCT04555720|468563072|FG002|Overall Study|Lost to Follow-up|0|||
130165261|NCT04555720|468563073|FG003|Overall Study|Lost to Follow-up|0|||
130165262|NCT04555720|468563070|FG000|Overall Study|Withdrawal by Subject|4|||
130165263|NCT04555720|468563071|FG001|Overall Study|Withdrawal by Subject|6|||
130165264|NCT04555720|468563072|FG002|Overall Study|Withdrawal by Subject|0|||
130165265|NCT04555720|468563073|FG003|Overall Study|Withdrawal by Subject|0|||
130165266|NCT00968799|468563074|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
130165267|NCT00719849|468563075|FG000|Overall Study|Death|0|||
130165268|NCT00719849|468563076|FG001|Overall Study|Death|1|||
130165269|NCT01372774|468563079|FG000|Overall Study|Withdrawal prior to treatment|4|||
130165270|NCT01372774|468563080|FG001|Overall Study|Withdrawal prior to treatment|5|||
130165271|NCT02201290|468563081|FG000|Overall Study|Withdrawal by Subject|2|||
130165272|NCT02201290|468563081|FG000|Overall Study|Lack of Efficacy|2|||
130165273|NCT02201290|468563081|FG000|Overall Study|Adverse Event|1|||
130165274|NCT00461253|468565762|FG000|Overall Study|Death|985|||
130165275|NCT00461253|468565763|FG001|Overall Study|Death|0|||
130165276|NCT00461253|468565762|FG000|Overall Study|Protocol Violation|613|||
130165277|NCT00461253|468565763|FG001|Overall Study|Protocol Violation|236|||
130165278|NCT00461253|468565762|FG000|Overall Study|no response|2609|||
130165279|NCT00461253|468565763|FG001|Overall Study|no response|11789|||
130165280|NCT00461253|468565762|FG000|Overall Study|administrative|773|||
130165281|NCT00461253|468565763|FG001|Overall Study|administrative|7773|||
130165282|NCT04240392|468565764|FG000|Overall Study|Withdrawal by Subject|13|||
130165283|NCT04240392|468565765|FG001|Overall Study|Withdrawal by Subject|4|||
130165284|NCT04240392|468565764|FG000|Overall Study|Lost to Follow-up|11|||
130165285|NCT04240392|468565765|FG001|Overall Study|Lost to Follow-up|12|||
130165286|NCT03283319|468565766|FG000|Overall Study|Lost to Follow-up|5|||
130165287|NCT03283319|468565767|FG001|Overall Study|Lost to Follow-up|4|||
130165288|NCT03283319|468565768|FG002|Overall Study|Lost to Follow-up|5|||
130165289|NCT03283319|468565769|FG003|Overall Study|Lost to Follow-up|5|||
130165290|NCT03283319|468565770|FG004|Overall Study|Lost to Follow-up|4|||
130165291|NCT03283319|468565771|FG005|Overall Study|Lost to Follow-up|3|||
130165292|NCT03283319|468565766|FG000|Overall Study|Withdrawal by Subject|2|||
130165293|NCT03283319|468565767|FG001|Overall Study|Withdrawal by Subject|2|||
130165294|NCT03283319|468565768|FG002|Overall Study|Withdrawal by Subject|2|||
130165295|NCT03283319|468565769|FG003|Overall Study|Withdrawal by Subject|1|||
130165296|NCT03283319|468565770|FG004|Overall Study|Withdrawal by Subject|0|||
130165297|NCT03283319|468565771|FG005|Overall Study|Withdrawal by Subject|1|||
130165298|NCT03283319|468565766|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
130165299|NCT03283319|468565767|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
130165300|NCT03283319|468565768|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
130165301|NCT03283319|468565769|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
130165302|NCT03283319|468565770|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
130165303|NCT03283319|468565771|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
130165304|NCT00721630|468565772|FG000|Overall Study|Participant found to be ineligible|1|||
130165305|NCT00792935|468565773|FG000|Overall Study|Adverse Event|2|||
130165306|NCT00792935|468565774|FG001|Overall Study|Adverse Event|1|||
130165307|NCT00792935|468565773|FG000|Overall Study|Lost to Follow-up|0|||
130165308|NCT00792935|468565774|FG001|Overall Study|Lost to Follow-up|1|||
130165309|NCT00792935|468565773|FG000|Overall Study|Protocol Violation|2|||
130165310|NCT00792935|468565774|FG001|Overall Study|Protocol Violation|0|||
130165311|NCT00792935|468565773|FG000|Overall Study|Withdrawal by Subject|0|||
130165312|NCT00792935|468565774|FG001|Overall Study|Withdrawal by Subject|1|||
130165313|NCT03186781|468565775|FG000|Overall Study|Lost to Follow-up|0|||
130165314|NCT03186781|468565776|FG001|Overall Study|Lost to Follow-up|0|||
130165315|NCT03186781|468565777|FG002|Overall Study|Lost to Follow-up|1|||
130165316|NCT03186781|468565778|FG003|Overall Study|Lost to Follow-up|0|||
130165317|NCT03186781|468565779|FG004|Overall Study|Lost to Follow-up|1|||
130165318|NCT03186781|468565780|FG005|Overall Study|Lost to Follow-up|0|||
130165319|NCT03186781|468565775|FG000|Overall Study|Moved from Area|0|||
130165320|NCT03186781|468565776|FG001|Overall Study|Moved from Area|0|||
130165321|NCT03186781|468565777|FG002|Overall Study|Moved from Area|0|||
130165322|NCT03186781|468565778|FG003|Overall Study|Moved from Area|0|||
130165323|NCT03186781|468565779|FG004|Overall Study|Moved from Area|1|||
130165324|NCT03186781|468565780|FG005|Overall Study|Moved from Area|0|||
130165325|NCT03186781|468565775|FG000|Overall Study|Withdrawal by Subject|0|||
130165326|NCT03186781|468565776|FG001|Overall Study|Withdrawal by Subject|0|||
130165327|NCT03186781|468565777|FG002|Overall Study|Withdrawal by Subject|0|||
130165328|NCT03186781|468565778|FG003|Overall Study|Withdrawal by Subject|0|||
129981633|NCT01072630|467895050|FG002|Overall Study|Adverse Event|2|||
130165329|NCT03186781|468565779|FG004|Overall Study|Withdrawal by Subject|1|||
130165330|NCT03186781|468565780|FG005|Overall Study|Withdrawal by Subject|0|||
130165331|NCT04663295|468565781|FG000|Run-in Period|Withdrawal by Subject|3|||
130165332|NCT04663295|468565781|FG000|Overall Study Period|Pregnancy|1|||
130165333|NCT04663295|468565781|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
130165334|NCT03665441|468565782|FG000|Overall Study|survival follow up ongoing|23|||
130165335|NCT03665441|468565783|FG001|Overall Study|survival follow up ongoing|0|||
130165336|NCT03665441|468565782|FG000|Overall Study|Patients ongoing on treatment|9|||
130165337|NCT03665441|468565783|FG001|Overall Study|Patients ongoing on treatment|6|||
130165338|NCT03665441|468565782|FG000|Overall Study|Randomized but not treated|7|||
130165339|NCT03665441|468565783|FG001|Overall Study|Randomized but not treated|11|||
130165340|NCT03954834|468565784|FG000|Overall Study|Adverse Event|1|||
130165341|NCT03954834|468565785|FG001|Overall Study|Adverse Event|3|||
130165342|NCT03954834|468565786|FG002|Overall Study|Adverse Event|1|||
130165343|NCT03954834|468565787|FG003|Overall Study|Adverse Event|1|||
130165344|NCT03954834|468565784|FG000|Overall Study|Death|0|||
130165345|NCT03954834|468565785|FG001|Overall Study|Death|0|||
130165346|NCT03954834|468565786|FG002|Overall Study|Death|0|||
130165347|NCT03954834|468565787|FG003|Overall Study|Death|1|||
130165348|NCT03954834|468565784|FG000|Overall Study|Physician Decision|0|||
130165349|NCT03954834|468565785|FG001|Overall Study|Physician Decision|1|||
130165350|NCT03954834|468565786|FG002|Overall Study|Physician Decision|0|||
130165351|NCT03954834|468565787|FG003|Overall Study|Physician Decision|2|||
130165352|NCT03954834|468565784|FG000|Overall Study|Protocol Violation|1|||
130165353|NCT03954834|468565785|FG001|Overall Study|Protocol Violation|0|||
130165354|NCT03954834|468565786|FG002|Overall Study|Protocol Violation|0|||
130165355|NCT03954834|468565787|FG003|Overall Study|Protocol Violation|1|||
130165356|NCT03954834|468565784|FG000|Overall Study|Withdrawal by Subject|2|||
130165357|NCT03954834|468565785|FG001|Overall Study|Withdrawal by Subject|3|||
130165358|NCT03954834|468565786|FG002|Overall Study|Withdrawal by Subject|13|||
130165359|NCT03954834|468565787|FG003|Overall Study|Withdrawal by Subject|6|||
130165360|NCT03954834|468565784|FG000|Overall Study|Participant left the country|0|||
130165361|NCT03954834|468565785|FG001|Overall Study|Participant left the country|0|||
130165362|NCT03954834|468565786|FG002|Overall Study|Participant left the country|1|||
130165363|NCT03954834|468565787|FG003|Overall Study|Participant left the country|0|||
130165364|NCT03954834|468565784|FG000|Overall Study|Lost to Follow-up|3|||
130165365|NCT03954834|468565785|FG001|Overall Study|Lost to Follow-up|2|||
130165366|NCT03954834|468565786|FG002|Overall Study|Lost to Follow-up|3|||
130165367|NCT03954834|468565787|FG003|Overall Study|Lost to Follow-up|5|||
130165368|NCT03047330|468565791|FG000|Sleep Block 1|Withdrawal by Subject|3|||
130165369|NCT00663026|468565792|FG000|Overall Study|Lost to Follow-up|1|||
130165370|NCT00663026|468565793|FG001|Overall Study|Lost to Follow-up|0|||
130165371|NCT00663026|468565794|FG002|Overall Study|Lost to Follow-up|0|||
130165372|NCT00663026|468565792|FG000|Overall Study|Other|1|||
130165373|NCT00663026|468565793|FG001|Overall Study|Other|2|||
130165374|NCT00663026|468565794|FG002|Overall Study|Other|0|||
130165375|NCT00663026|468565792|FG000|Overall Study|Adverse Event|0|||
130165376|NCT00663026|468565793|FG001|Overall Study|Adverse Event|2|||
130165377|NCT00663026|468565794|FG002|Overall Study|Adverse Event|3|||
130165378|NCT00663026|468565792|FG000|Overall Study|Caregiver Request|0|||
130165379|NCT00663026|468565793|FG001|Overall Study|Caregiver Request|2|||
130165380|NCT00663026|468565794|FG002|Overall Study|Caregiver Request|0|||
130165381|NCT00663026|468565792|FG000|Overall Study|Withdrawal by Subject|0|||
130165382|NCT00663026|468565793|FG001|Overall Study|Withdrawal by Subject|0|||
130165383|NCT00663026|468565794|FG002|Overall Study|Withdrawal by Subject|1|||
130165384|NCT01570686|468565795|FG000|Overall Study|Abnormal test procedure result(s)|1|||
130165385|NCT01570686|468565796|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130165386|NCT01570686|468565795|FG000|Overall Study|Administrative problems|0|||
130165387|NCT01570686|468565796|FG001|Overall Study|Administrative problems|1|||
130165388|NCT01570686|468565795|FG000|Overall Study|Adverse Event|8|||
130165389|NCT01570686|468565796|FG001|Overall Study|Adverse Event|6|||
129981634|NCT01072630|467895048|FG000|Overall Study|Lack of Efficacy|10|||
130165390|NCT01570686|468565795|FG000|Overall Study|Lost to Follow-up|4|||
130165391|NCT01570686|468565796|FG001|Overall Study|Lost to Follow-up|3|||
130165392|NCT01570686|468565795|FG000|Overall Study|Protocol Deviation|3|||
130165393|NCT01570686|468565796|FG001|Overall Study|Protocol Deviation|0|||
130165394|NCT01570686|468565795|FG000|Overall Study|Withdrawal by Subject|4|||
130165395|NCT01570686|468565796|FG001|Overall Study|Withdrawal by Subject|4|||
130165396|NCT01570686|468565795|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
130165397|NCT01570686|468565796|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130165398|NCT00686075|468565798|FG000|Overall Study|Withdrawal by Subject|4|||
130165399|NCT00686075|468565799|FG001|Overall Study|Withdrawal by Subject|3|||
130165400|NCT00686075|468565800|FG002|Overall Study|Withdrawal by Subject|3|||
130165401|NCT00686075|468565801|FG003|Overall Study|Withdrawal by Subject|7|||
130165402|NCT00686075|468565802|FG004|Overall Study|Withdrawal by Subject|1|||
130165403|NCT00686075|468565803|FG005|Overall Study|Withdrawal by Subject|0|||
130165404|NCT00686075|468565804|FG006|Overall Study|Withdrawal by Subject|0|||
130165405|NCT00686075|468565805|FG007|Overall Study|Withdrawal by Subject|2|||
130165406|NCT00686075|468565806|FG008|Overall Study|Withdrawal by Subject|4|||
130165407|NCT00686075|468565807|FG009|Overall Study|Withdrawal by Subject|6|||
130165408|NCT00686075|468565798|FG000|Overall Study|Lost to Follow-up|3|||
130165409|NCT00686075|468565799|FG001|Overall Study|Lost to Follow-up|6|||
130165410|NCT00686075|468565800|FG002|Overall Study|Lost to Follow-up|3|||
130165411|NCT00686075|468565801|FG003|Overall Study|Lost to Follow-up|2|||
130165412|NCT00686075|468565802|FG004|Overall Study|Lost to Follow-up|3|||
130165413|NCT00686075|468565803|FG005|Overall Study|Lost to Follow-up|3|||
130165414|NCT00686075|468565804|FG006|Overall Study|Lost to Follow-up|0|||
129981635|NCT01072630|467895049|FG001|Overall Study|Lack of Efficacy|10|||
129981636|NCT01072630|467895050|FG002|Overall Study|Lack of Efficacy|1|||
129981637|NCT01072630|467895048|FG000|Overall Study|Withdrawal by Subject|8|||
129981638|NCT01072630|467895049|FG001|Overall Study|Withdrawal by Subject|7|||
129981639|NCT01072630|467895050|FG002|Overall Study|Withdrawal by Subject|2|||
129981640|NCT01072630|467895048|FG000|Overall Study|Protocol Violation|10|||
129981641|NCT01072630|467895049|FG001|Overall Study|Protocol Violation|8|||
129981642|NCT01072630|467895050|FG002|Overall Study|Protocol Violation|4|||
129981643|NCT01072630|467895048|FG000|Overall Study|Lost to Follow-up|11|||
129981644|NCT01072630|467895049|FG001|Overall Study|Lost to Follow-up|11|||
129981645|NCT01072630|467895050|FG002|Overall Study|Lost to Follow-up|1|||
129981646|NCT01072630|467895048|FG000|Overall Study|Noncompliance with study medication|1|||
129981647|NCT01072630|467895049|FG001|Overall Study|Noncompliance with study medication|1|||
129981648|NCT01072630|467895050|FG002|Overall Study|Noncompliance with study medication|1|||
129981649|NCT01072630|467895048|FG000|Overall Study|Noncompliance with study procedures|1|||
129981650|NCT01072630|467895049|FG001|Overall Study|Noncompliance with study procedures|2|||
129981651|NCT01072630|467895050|FG002|Overall Study|Noncompliance with study procedures|1|||
129981652|NCT01072630|467895048|FG000|Overall Study|Other|3|||
129981653|NCT01072630|467895049|FG001|Overall Study|Other|2|||
129981654|NCT01072630|467895050|FG002|Overall Study|Other|1|||
129981655|NCT01232738|467895051|FG000|Overall Study|Death|3|||
129981656|NCT01232738|467895051|FG000|Overall Study|Physician Decision|2|||
129981657|NCT01232738|467895051|FG000|Overall Study|Lost to Follow-up|1|||
129981658|NCT01232738|467895051|FG000|Overall Study|Withdrawal by Subject|2|||
129981659|NCT01232738|467895051|FG000|Overall Study|Adverse Event|5|||
129981660|NCT00338962|467895052|FG000|Overall Study|Lost to Follow-up|3|||
129981661|NCT00338962|467895053|FG001|Overall Study|Lost to Follow-up|3|||
129981662|NCT00338962|467895054|FG002|Overall Study|Lost to Follow-up|2|||
129981663|NCT00338962|467895055|FG003|Overall Study|Lost to Follow-up|3|||
129981664|NCT00338962|467895052|FG000|Overall Study|Withdrawal by Subject|1|||
129981665|NCT00338962|467895053|FG001|Overall Study|Withdrawal by Subject|0|||
129981666|NCT00338962|467895054|FG002|Overall Study|Withdrawal by Subject|0|||
129981667|NCT00338962|467895055|FG003|Overall Study|Withdrawal by Subject|0|||
129981668|NCT00338962|467895052|FG000|Overall Study|No Transportation|2|||
129981669|NCT00338962|467895053|FG001|Overall Study|No Transportation|0|||
129981670|NCT00338962|467895054|FG002|Overall Study|No Transportation|0|||
129981671|NCT00338962|467895055|FG003|Overall Study|No Transportation|0|||
129981672|NCT00338962|467895052|FG000|Overall Study|Time Constraint|2|||
129981673|NCT00338962|467895053|FG001|Overall Study|Time Constraint|0|||
129981674|NCT00338962|467895054|FG002|Overall Study|Time Constraint|0|||
129981675|NCT00338962|467895055|FG003|Overall Study|Time Constraint|0|||
129981676|NCT00338962|467895052|FG000|Overall Study|Moved|0|||
129981677|NCT00338962|467895053|FG001|Overall Study|Moved|1|||
129981678|NCT00338962|467895054|FG002|Overall Study|Moved|0|||
129981679|NCT00338962|467895055|FG003|Overall Study|Moved|0|||
129981680|NCT00338962|467895052|FG000|Overall Study|Adverse Event|0|||
129981681|NCT00338962|467895053|FG001|Overall Study|Adverse Event|0|||
129981682|NCT00338962|467895054|FG002|Overall Study|Adverse Event|2|||
129981683|NCT00338962|467895055|FG003|Overall Study|Adverse Event|0|||
129981684|NCT00338962|467895052|FG000|Overall Study|Poor Compliance|0|||
129981685|NCT00338962|467895053|FG001|Overall Study|Poor Compliance|0|||
129981686|NCT00338962|467895054|FG002|Overall Study|Poor Compliance|2|||
129981687|NCT00338962|467895055|FG003|Overall Study|Poor Compliance|0|||
129981688|NCT03214640|467895056|FG000|Overall Study|Protocol Violation|1|||
129981689|NCT03214640|467895057|FG001|Overall Study|Protocol Violation|2|||
129981690|NCT03214640|467895058|FG002|Overall Study|Protocol Violation|1|||
129981691|NCT03214640|467895059|FG003|Overall Study|Protocol Violation|4|||
129981692|NCT02731690|467896695|FG000|Overall Study|Adverse Event|1|||
129981693|NCT02731690|467896695|FG000|Overall Study|Withdrawal by Subject|3|||
129981694|NCT02731690|467896695|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
130165415|NCT00686075|468565805|FG007|Overall Study|Lost to Follow-up|0|||
129981695|NCT01262677|467896696|FG000|Overall Study|Does not meet entrance criteria|0|||
129981696|NCT01262677|467896697|FG001|Overall Study|Does not meet entrance criteria|2|||
130165416|NCT00686075|468565806|FG008|Overall Study|Lost to Follow-up|2|||
129981697|NCT01262677|467896698|FG002|Overall Study|Does not meet entrance criteria|0|||
129981698|NCT01262677|467896696|FG000|Overall Study|Insufficient clinical response|0|||
129981699|NCT01262677|467896697|FG001|Overall Study|Insufficient clinical response|0|||
129981700|NCT01262677|467896698|FG002|Overall Study|Insufficient clinical response|1|||
129981701|NCT01262677|467896696|FG000|Overall Study|Lost to Follow-up|1|||
129981702|NCT01262677|467896697|FG001|Overall Study|Lost to Follow-up|0|||
129981703|NCT01262677|467896698|FG002|Overall Study|Lost to Follow-up|2|||
129981704|NCT01262677|467896696|FG000|Overall Study|No longer willing to participate|3|||
129981705|NCT01262677|467896697|FG001|Overall Study|No longer willing to participate|3|||
129981706|NCT01262677|467896698|FG002|Overall Study|No longer willing to participate|2|||
130165417|NCT00686075|468565807|FG009|Overall Study|Lost to Follow-up|3|||
130165418|NCT00686075|468565798|FG000|Overall Study|Other|1|||
130165419|NCT00686075|468565799|FG001|Overall Study|Other|1|||
130165420|NCT00686075|468565800|FG002|Overall Study|Other|0|||
130165421|NCT00686075|468565801|FG003|Overall Study|Other|0|||
130165422|NCT00686075|468565802|FG004|Overall Study|Other|0|||
130165423|NCT00686075|468565803|FG005|Overall Study|Other|0|||
130165424|NCT00686075|468565804|FG006|Overall Study|Other|0|||
130165425|NCT00686075|468565805|FG007|Overall Study|Other|0|||
130165426|NCT00686075|468565806|FG008|Overall Study|Other|0|||
130165427|NCT00686075|468565807|FG009|Overall Study|Other|1|||
130165428|NCT04715932|468565808|FG000|Overall Study|Lost to Follow-up|1|||
130165429|NCT04715932|468565809|FG001|Overall Study|Lost to Follow-up|0|||
130165430|NCT02740699|468565820|FG000|Overall Study|Lost to Follow-up|5|||
130165431|NCT02740699|468565820|FG000|Overall Study|Withdrawal by Subject|14|||
130165432|NCT02740699|468565820|FG000|Overall Study|Physician Decision|5|||
130165433|NCT03783039|468565823|FG000|Overall Study|Death|2|||
130165434|NCT03783039|468565824|FG001|Overall Study|Death|1|||
130165435|NCT01682863|468565825|FG000|Overall Study|Subject/guardian decision|19|||
130165436|NCT01682863|468565826|FG001|Overall Study|Subject/guardian decision|12|||
130165437|NCT01682863|468565827|FG002|Overall Study|Subject/guardian decision|10|||
130165438|NCT01682863|468565825|FG000|Overall Study|Lost to Follow-up|5|||
130165439|NCT01682863|468565826|FG001|Overall Study|Lost to Follow-up|1|||
130165440|NCT01682863|468565827|FG002|Overall Study|Lost to Follow-up|6|||
130165441|NCT01682863|468565825|FG000|Overall Study|Death|1|||
130165442|NCT01682863|468565826|FG001|Overall Study|Death|3|||
130165443|NCT01682863|468565827|FG002|Overall Study|Death|4|||
130165444|NCT01682863|468565825|FG000|Overall Study|Protocol deviation|1|||
130165445|NCT01682863|468565826|FG001|Overall Study|Protocol deviation|0|||
130165446|NCT01682863|468565827|FG002|Overall Study|Protocol deviation|1|||
130165447|NCT01682863|468565825|FG000|Overall Study|Technical problems|1|||
130165448|NCT01682863|468565826|FG001|Overall Study|Technical problems|0|||
130165449|NCT01682863|468565827|FG002|Overall Study|Technical problems|0|||
130165450|NCT01682863|468565825|FG000|Overall Study|Adverse Event|0|||
130165451|NCT01682863|468565826|FG001|Overall Study|Adverse Event|1|||
130165452|NCT01682863|468565827|FG002|Overall Study|Adverse Event|2|||
130165453|NCT01682863|468565825|FG000|Overall Study|Physician Decision|0|||
130165454|NCT01682863|468565826|FG001|Overall Study|Physician Decision|0|||
130165455|NCT01682863|468565827|FG002|Overall Study|Physician Decision|1|||
130165456|NCT00918138|468565829|FG000|Overall Study|Subject withdrew consent|1|||
130165457|NCT00918138|468565830|FG001|Overall Study|Subject withdrew consent|1|||
130165458|NCT00918138|468565829|FG000|Overall Study|Death|1|||
130165459|NCT00918138|468565830|FG001|Overall Study|Death|0|||
130165460|NCT00699374|468565831|FG000|Overall Study|Death|93|||
130165461|NCT00699374|468565832|FG001|Overall Study|Death|83|||
130165462|NCT00699374|468565831|FG000|Overall Study|Adverse Event|70|||
130165463|NCT00699374|468565832|FG001|Overall Study|Adverse Event|67|||
130165464|NCT00699374|468565831|FG000|Overall Study|Global deterioration of health status|7|||
130165465|NCT00699374|468565832|FG001|Overall Study|Global deterioration of health status|8|||
130165466|NCT00699374|468565831|FG000|Overall Study|Lost to Follow-up|3|||
130165467|NCT00699374|468565832|FG001|Overall Study|Lost to Follow-up|5|||
130165468|NCT00699374|468565831|FG000|Overall Study|Withdrawal by Subject|34|||
130165469|NCT00699374|468565832|FG001|Overall Study|Withdrawal by Subject|44|||
130165470|NCT00699374|468565831|FG000|Overall Study|Objective progression or relapse|281|||
130165471|NCT00699374|468565832|FG001|Overall Study|Objective progression or relapse|277|||
130165472|NCT00699374|468565831|FG000|Overall Study|Other|18|||
130165473|NCT00699374|468565832|FG001|Overall Study|Other|15|||
130165474|NCT00699374|468565831|FG000|Overall Study|Protocol Violation|2|||
130165475|NCT00699374|468565832|FG001|Overall Study|Protocol Violation|6|||
130165476|NCT00699374|468565831|FG000|Overall Study|Study terminated by sponsor|13|||
130165477|NCT00699374|468565832|FG001|Overall Study|Study terminated by sponsor|28|||
130165478|NCT00699374|468565831|FG000|Overall Study|Randomized but not treated|4|||
130165479|NCT00699374|468565832|FG001|Overall Study|Randomized but not treated|2|||
130165480|NCT00699374|468565831|FG000|Overall Study|Died 28 days after last dose|5|||
130165481|NCT00699374|468565832|FG001|Overall Study|Died 28 days after last dose|9|||
130165482|NCT01136967|468565836|FG000|Overall Study|Adverse Event|9|||
130165483|NCT01136967|468565837|FG001|Overall Study|Adverse Event|12|||
129981707|NCT01262677|467896696|FG000|Overall Study|Reason not provided|2|||
129981708|NCT01262677|467896697|FG001|Overall Study|Reason not provided|1|||
130165484|NCT01136967|468565836|FG000|Overall Study|Participant Choice|8|||
130165485|NCT01136967|468565837|FG001|Overall Study|Participant Choice|3|||
130165486|NCT01136967|468565836|FG000|Overall Study|Lost to Follow-up|0|||
130165487|NCT01136967|468565837|FG001|Overall Study|Lost to Follow-up|1|||
129981709|NCT01262677|467896698|FG002|Overall Study|Reason not provided|3|||
129981710|NCT01262677|467896696|FG000|Overall Study|Protocol Violation|0|||
130165488|NCT01136967|468565836|FG000|Overall Study|Withdrawal by Subject|1|||
130165489|NCT01136967|468565837|FG001|Overall Study|Withdrawal by Subject|2|||
130165490|NCT01136967|468565836|FG000|Overall Study|Clinical Progression|3|||
130165491|NCT01136967|468565837|FG001|Overall Study|Clinical Progression|5|||
130165492|NCT01136967|468565836|FG000|Overall Study|Radiation|1|||
130165493|NCT01136967|468565837|FG001|Overall Study|Radiation|0|||
130165494|NCT01136967|468565836|FG000|Overall Study|Non-compliance|1|||
130165495|NCT01136967|468565837|FG001|Overall Study|Non-compliance|0|||
130165496|NCT01136967|468565836|FG000|Overall Study|Investigator's Choice|1|||
130165497|NCT01136967|468565837|FG001|Overall Study|Investigator's Choice|1|||
130165498|NCT01136967|468565836|FG000|Overall Study|Increase in Lesion Size|0|||
130165499|NCT01136967|468565837|FG001|Overall Study|Increase in Lesion Size|2|||
130165500|NCT01136967|468565836|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
130165501|NCT01136967|468565837|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
130165502|NCT02885181|468565838|FG000|Overall Study|Investigator's Discretion|0|||
130165503|NCT02885181|468565839|FG001|Overall Study|Investigator's Discretion|1|||
130165504|NCT02885181|468565840|FG002|Overall Study|Investigator's Discretion|0|||
130165505|NCT02885181|468565841|FG003|Overall Study|Investigator's Discretion|1|||
130165506|NCT02885181|468565838|FG000|Overall Study|Adverse Event|0|||
130165507|NCT02885181|468565839|FG001|Overall Study|Adverse Event|0|||
130165508|NCT02885181|468565840|FG002|Overall Study|Adverse Event|0|||
130165509|NCT02885181|468565841|FG003|Overall Study|Adverse Event|1|||
130165510|NCT02885181|468565838|FG000|Overall Study|Withdrawal by Subject|0|||
130165511|NCT02885181|468565839|FG001|Overall Study|Withdrawal by Subject|0|||
130165512|NCT02885181|468565840|FG002|Overall Study|Withdrawal by Subject|0|||
130165513|NCT02885181|468565841|FG003|Overall Study|Withdrawal by Subject|1|||
130165514|NCT03839823|468565842|FG000|Overall Study|Adverse Event|8|||
130165515|NCT03839823|468565843|FG001|Overall Study|Adverse Event|4|||
130165516|NCT03839823|468565842|FG000|Overall Study|Death|1|||
130165517|NCT03839823|468565843|FG001|Overall Study|Death|0|||
130165518|NCT03839823|468565842|FG000|Overall Study|Physician Decision|1|||
130165519|NCT03839823|468565843|FG001|Overall Study|Physician Decision|5|||
130165520|NCT03839823|468565842|FG000|Overall Study|Progressive Disease (PD)|65|||
130165521|NCT03839823|468565843|FG001|Overall Study|Progressive Disease (PD)|65|||
130165522|NCT03839823|468565842|FG000|Overall Study|Subject Decision|2|||
130165523|NCT03839823|468565843|FG001|Overall Study|Subject Decision|9|||
130165524|NCT03839823|468565842|FG000|Overall Study|Not Treated|0|||
130165525|NCT03839823|468565843|FG001|Overall Study|Not Treated|10|||
130165526|NCT03151811|468565846|FG000|Overall Study|Randomized But Not Treated|18|||
130165527|NCT03151811|468565847|FG001|Overall Study|Randomized But Not Treated|3|||
130165528|NCT03151811|468565846|FG000|Overall Study|Progressive Disease|130|||
130165529|NCT03151811|468565847|FG001|Overall Study|Progressive Disease|170|||
130165530|NCT03151811|468565846|FG000|Overall Study|Adverse Event|49|||
130165531|NCT03151811|468565847|FG001|Overall Study|Adverse Event|40|||
130165532|NCT03151811|468565846|FG000|Overall Study|Lack of Efficacy|6|||
130165533|NCT03151811|468565847|FG001|Overall Study|Lack of Efficacy|8|||
130165534|NCT03151811|468565846|FG000|Overall Study|Physician Decision|21|||
130165535|NCT03151811|468565847|FG001|Overall Study|Physician Decision|9|||
130165536|NCT03151811|468565846|FG000|Overall Study|Withdrawal by Subject|17|||
130165537|NCT03151811|468565847|FG001|Overall Study|Withdrawal by Subject|7|||
130165538|NCT03151811|468565846|FG000|Overall Study|Lost to Follow-up|0|||
130165539|NCT03151811|468565847|FG001|Overall Study|Lost to Follow-up|1|||
130165540|NCT03151811|468565846|FG000|Overall Study|Study Terminated by Sponsor|5|||
130165541|NCT03151811|468565847|FG001|Overall Study|Study Terminated by Sponsor|11|||
130165542|NCT01517373|468565850|FG000|Run-in Period|Death|1|||
130165543|NCT01517373|468565851|FG001|Run-in Period|Death|0|||
130165544|NCT01517373|468565852|FG002|Run-in Period|Death|0|||
130165545|NCT01517373|468565853|FG003|Run-in Period|Death|0|||
130165546|NCT01517373|468565854|FG004|Run-in Period|Death|0|||
130165547|NCT01517373|468565855|FG005|Run-in Period|Death|0|||
130165548|NCT01517373|468565850|FG000|Run-in Period|Adverse Event|5|||
130165549|NCT01517373|468565851|FG001|Run-in Period|Adverse Event|0|||
130165550|NCT01517373|468565852|FG002|Run-in Period|Adverse Event|0|||
130165551|NCT01517373|468565853|FG003|Run-in Period|Adverse Event|0|||
130165552|NCT01517373|468565854|FG004|Run-in Period|Adverse Event|0|||
130165553|NCT01517373|468565855|FG005|Run-in Period|Adverse Event|0|||
130165554|NCT01517373|468565850|FG000|Run-in Period|Did not meet eligibility criteria|34|||
130165555|NCT01517373|468565851|FG001|Run-in Period|Did not meet eligibility criteria|0|||
130165556|NCT01517373|468565852|FG002|Run-in Period|Did not meet eligibility criteria|0|||
130165557|NCT01517373|468565853|FG003|Run-in Period|Did not meet eligibility criteria|0|||
130165558|NCT01517373|468565854|FG004|Run-in Period|Did not meet eligibility criteria|0|||
130165559|NCT01517373|468565855|FG005|Run-in Period|Did not meet eligibility criteria|0|||
130165560|NCT01517373|468565850|FG000|Run-in Period|Lost to Follow-up|1|||
130165561|NCT01517373|468565851|FG001|Run-in Period|Lost to Follow-up|0|||
130165562|NCT01517373|468565852|FG002|Run-in Period|Lost to Follow-up|0|||
130165563|NCT01517373|468565853|FG003|Run-in Period|Lost to Follow-up|0|||
130165564|NCT01517373|468565854|FG004|Run-in Period|Lost to Follow-up|0|||
130165565|NCT01517373|468565855|FG005|Run-in Period|Lost to Follow-up|0|||
130165566|NCT01517373|468565850|FG000|Run-in Period|Withdrawal by Subject|12|||
130165567|NCT01517373|468565851|FG001|Run-in Period|Withdrawal by Subject|0|||
130165568|NCT01517373|468565852|FG002|Run-in Period|Withdrawal by Subject|0|||
130165569|NCT01517373|468565853|FG003|Run-in Period|Withdrawal by Subject|0|||
130165570|NCT01517373|468565854|FG004|Run-in Period|Withdrawal by Subject|0|||
130165571|NCT01517373|468565855|FG005|Run-in Period|Withdrawal by Subject|0|||
130165572|NCT01517373|468565850|FG000|Run-in Period|Sponsor Decision|3|||
130165573|NCT01517373|468565851|FG001|Run-in Period|Sponsor Decision|0|||
130165574|NCT01517373|468565852|FG002|Run-in Period|Sponsor Decision|0|||
130165575|NCT01517373|468565853|FG003|Run-in Period|Sponsor Decision|0|||
130165576|NCT01517373|468565854|FG004|Run-in Period|Sponsor Decision|0|||
130165577|NCT01517373|468565855|FG005|Run-in Period|Sponsor Decision|0|||
130165578|NCT01517373|468565850|FG000|Run-in Period|Other|1|||
130165579|NCT01517373|468565851|FG001|Run-in Period|Other|0|||
130165580|NCT01517373|468565852|FG002|Run-in Period|Other|0|||
130165581|NCT01517373|468565853|FG003|Run-in Period|Other|0|||
130165582|NCT01517373|468565854|FG004|Run-in Period|Other|0|||
130165583|NCT01517373|468565855|FG005|Run-in Period|Other|0|||
130165584|NCT01517373|468565850|FG000|Treatment Period|Adverse Event|0|||
130165585|NCT01517373|468565851|FG001|Treatment Period|Adverse Event|0|||
130165586|NCT01517373|468565852|FG002|Treatment Period|Adverse Event|0|||
130165587|NCT01517373|468565853|FG003|Treatment Period|Adverse Event|0|||
130165588|NCT01517373|468565854|FG004|Treatment Period|Adverse Event|0|||
130165589|NCT01517373|468565855|FG005|Treatment Period|Adverse Event|2|||
130165590|NCT01517373|468565850|FG000|Treatment Period|Lost to Follow-up|0|||
130165591|NCT01517373|468565851|FG001|Treatment Period|Lost to Follow-up|0|||
130165592|NCT01517373|468565852|FG002|Treatment Period|Lost to Follow-up|1|||
130165593|NCT01517373|468565853|FG003|Treatment Period|Lost to Follow-up|1|||
130165594|NCT01517373|468565854|FG004|Treatment Period|Lost to Follow-up|0|||
130165595|NCT01517373|468565855|FG005|Treatment Period|Lost to Follow-up|0|||
130165596|NCT01517373|468565850|FG000|Treatment Period|Withdrawal by Subject|0|||
130165597|NCT01517373|468565851|FG001|Treatment Period|Withdrawal by Subject|3|||
130165598|NCT01517373|468565852|FG002|Treatment Period|Withdrawal by Subject|2|||
130165599|NCT01517373|468565853|FG003|Treatment Period|Withdrawal by Subject|2|||
130165600|NCT01517373|468565854|FG004|Treatment Period|Withdrawal by Subject|2|||
130165601|NCT01517373|468565855|FG005|Treatment Period|Withdrawal by Subject|3|||
130165602|NCT01517373|468565850|FG000|Treatment Period|Other|0|||
130165603|NCT01517373|468565851|FG001|Treatment Period|Other|0|||
130165604|NCT01517373|468565852|FG002|Treatment Period|Other|0|||
130165605|NCT01517373|468565853|FG003|Treatment Period|Other|0|||
130165606|NCT01517373|468565854|FG004|Treatment Period|Other|1|||
130165607|NCT01517373|468565855|FG005|Treatment Period|Other|0|||
130165608|NCT01517373|468565850|FG000|Treatment Period|Protocol Violation|0|||
130165609|NCT01517373|468565851|FG001|Treatment Period|Protocol Violation|0|||
130165610|NCT01517373|468565852|FG002|Treatment Period|Protocol Violation|0|||
130165611|NCT01517373|468565853|FG003|Treatment Period|Protocol Violation|0|||
130165612|NCT01517373|468565854|FG004|Treatment Period|Protocol Violation|1|||
130165613|NCT01517373|468565855|FG005|Treatment Period|Protocol Violation|0|||
130165614|NCT01517373|468565850|FG000|Treatment Period|Lack of Efficacy|0|||
130165615|NCT01517373|468565851|FG001|Treatment Period|Lack of Efficacy|1|||
130165616|NCT01517373|468565852|FG002|Treatment Period|Lack of Efficacy|1|||
130165617|NCT01517373|468565853|FG003|Treatment Period|Lack of Efficacy|3|||
130165618|NCT01517373|468565854|FG004|Treatment Period|Lack of Efficacy|2|||
130165619|NCT01517373|468565855|FG005|Treatment Period|Lack of Efficacy|0|||
130165620|NCT01517373|468565850|FG000|Treatment Period|Medication error without AEs|0|||
130165621|NCT01517373|468565851|FG001|Treatment Period|Medication error without AEs|0|||
130165622|NCT01517373|468565852|FG002|Treatment Period|Medication error without AEs|2|||
130165623|NCT01517373|468565853|FG003|Treatment Period|Medication error without AEs|1|||
130165624|NCT01517373|468565854|FG004|Treatment Period|Medication error without AEs|0|||
130165625|NCT01517373|468565855|FG005|Treatment Period|Medication error without AEs|2|||
130165626|NCT04562155|468565859|FG000|Overall Study|COVID-19 pandemic|0|||
130165627|NCT04562155|468565860|FG001|Overall Study|COVID-19 pandemic|0|||
130165628|NCT04562155|468565861|FG002|Overall Study|COVID-19 pandemic|0|||
130165629|NCT04562155|468565862|FG003|Overall Study|COVID-19 pandemic|1|||
130165630|NCT04562155|468565859|FG000|Overall Study|Adverse Event|7|||
130165631|NCT04562155|468565860|FG001|Overall Study|Adverse Event|3|||
130165632|NCT04562155|468565861|FG002|Overall Study|Adverse Event|8|||
129981711|NCT01262677|467896697|FG001|Overall Study|Protocol Violation|1|||
129981712|NCT01262677|467896698|FG002|Overall Study|Protocol Violation|1|||
129981713|NCT01262677|467896696|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
129981714|NCT01262677|467896697|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
129981715|NCT01262677|467896698|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
130165633|NCT04562155|468565862|FG003|Overall Study|Adverse Event|1|||
130165634|NCT04562155|468565859|FG000|Overall Study|Withdrawal by Subject|3|||
130165635|NCT04562155|468565860|FG001|Overall Study|Withdrawal by Subject|6|||
130165636|NCT04562155|468565861|FG002|Overall Study|Withdrawal by Subject|3|||
130165637|NCT04562155|468565862|FG003|Overall Study|Withdrawal by Subject|3|||
130165638|NCT04562155|468565859|FG000|Overall Study|Participant personal reason|1|||
130165639|NCT04562155|468565860|FG001|Overall Study|Participant personal reason|0|||
130165640|NCT04562155|468565861|FG002|Overall Study|Participant personal reason|2|||
130165641|NCT04562155|468565862|FG003|Overall Study|Participant personal reason|1|||
130165642|NCT01085201|468565865|FG000|Overall Study|Scheduling conflict|1|||
130165643|NCT01085201|468565866|FG001|Overall Study|Scheduling conflict|0|||
130165644|NCT01085201|468565867|FG002|Overall Study|Scheduling conflict|1|||
130165645|NCT01085201|468565868|FG003|Overall Study|Scheduling conflict|0|||
130165646|NCT01085201|468565869|FG004|Overall Study|Scheduling conflict|0|||
130165647|NCT01085201|468565865|FG000|Overall Study|Unknown- no study drug|2|||
130165648|NCT01085201|468565866|FG001|Overall Study|Unknown- no study drug|0|||
130165649|NCT01085201|468565867|FG002|Overall Study|Unknown- no study drug|0|||
130165650|NCT01085201|468565868|FG003|Overall Study|Unknown- no study drug|0|||
130165651|NCT01085201|468565869|FG004|Overall Study|Unknown- no study drug|0|||
130165652|NCT01085201|468565865|FG000|Overall Study|Fond ineligible after consent|0|||
130165653|NCT01085201|468565866|FG001|Overall Study|Fond ineligible after consent|1|||
130165654|NCT01085201|468565867|FG002|Overall Study|Fond ineligible after consent|1|||
130165655|NCT01085201|468565868|FG003|Overall Study|Fond ineligible after consent|0|||
130165656|NCT01085201|468565869|FG004|Overall Study|Fond ineligible after consent|0|||
130165657|NCT04516759|468565872|FG000|Overall Study|Withdrawal by Subject|1|||
130165658|NCT04516759|468565873|FG001|Overall Study|Withdrawal by Subject|1|||
130165659|NCT04516759|468565872|FG000|Overall Study|Other|0|||
130165660|NCT04516759|468565873|FG001|Overall Study|Other|1|||
130165661|NCT00528411|468565874|FG000|Overall Study|Adverse Event|4|||
130165662|NCT00528411|468565875|FG001|Overall Study|Adverse Event|0|||
130165663|NCT00528411|468565876|FG002|Overall Study|Adverse Event|1|||
130165664|NCT00528411|468565874|FG000|Overall Study|Incorrect Enrolment|1|||
130165665|NCT00528411|468565875|FG001|Overall Study|Incorrect Enrolment|1|||
130165666|NCT00528411|468565876|FG002|Overall Study|Incorrect Enrolment|0|||
130165667|NCT00528411|468565874|FG000|Overall Study|Severe non-compliance to protocol|0|||
130165668|NCT00528411|468565875|FG001|Overall Study|Severe non-compliance to protocol|1|||
130165669|NCT00528411|468565876|FG002|Overall Study|Severe non-compliance to protocol|0|||
130165670|NCT00528411|468565874|FG000|Overall Study|Prior commitment medication|0|||
130165671|NCT00528411|468565875|FG001|Overall Study|Prior commitment medication|1|||
130165672|NCT00528411|468565876|FG002|Overall Study|Prior commitment medication|0|||
130165673|NCT01221363|468565880|FG000|Overall Study|Pregnancy|1|||
130165674|NCT01221363|468565881|FG001|Overall Study|Pregnancy|0|||
130165675|NCT01221363|468565880|FG000|Overall Study|Withdrawal by Subject|11|||
130165676|NCT01221363|468565881|FG001|Overall Study|Withdrawal by Subject|5|||
130165677|NCT02695537|468565886|FG000|Overall Study|Adverse Event|3|||
130165678|NCT02695537|468565886|FG000|Overall Study|Lack of Efficacy|28|||
130165679|NCT02695537|468565886|FG000|Overall Study|Withdrawal by Subject|4|||
130165680|NCT02695537|468565886|FG000|Overall Study|Protocol Violation|3|||
130165681|NCT03597529|468565887|FG000|Overall Study|Lost to Follow-up|10|||
130165682|NCT03597529|468565888|FG001|Overall Study|Lost to Follow-up|12|||
130165683|NCT03597529|468565887|FG000|Overall Study|Physician Decision|3|||
130165684|NCT03597529|468565888|FG001|Overall Study|Physician Decision|1|||
130165685|NCT03597529|468565887|FG000|Overall Study|Withdrawal by Subject|6|||
130165686|NCT03597529|468565888|FG001|Overall Study|Withdrawal by Subject|3|||
130165687|NCT03597529|468565887|FG000|Overall Study|Non-compliant with study activities|1|||
130165688|NCT03597529|468565888|FG001|Overall Study|Non-compliant with study activities|2|||
130165689|NCT00998309|468565895|FG000|Overall Study|Protocol Violation|4|||
130165690|NCT02865460|468565896|FG000|Overall Study|Adverse Event|1|||
130165691|NCT02865460|468565897|FG001|Overall Study|Adverse Event|0|||
130165692|NCT02865460|468565896|FG000|Overall Study|Withdrawal by Subject|1|||
130165693|NCT02865460|468565897|FG001|Overall Study|Withdrawal by Subject|1|||
130165694|NCT02865460|468565896|FG000|Overall Study|Lost to Follow-up|7|||
130165695|NCT02865460|468565897|FG001|Overall Study|Lost to Follow-up|4|||
130165696|NCT02865460|468565896|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
130165697|NCT02865460|468565897|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
130165698|NCT02238795|468565904|FG000|Overall Study|Patient without purpura fulminans|1|||
130165699|NCT01292226|468565908|FG000|Overall Study|Adverse Event|5|||
130165700|NCT01292226|468565908|FG000|Overall Study|Death|1|||
130165701|NCT01292226|468565908|FG000|Overall Study|Graft loss|1|||
130165702|NCT01292226|468565908|FG000|Overall Study|Protocol Violation|3|||
130165703|NCT01292226|468565908|FG000|Overall Study|Withdrawal by Subject|1|||
130165704|NCT01292226|468565908|FG000|Overall Study|Other|2|||
130165705|NCT01584843|468565909|FG000|First Treatment Period|Adverse Event|0|||
130165706|NCT01584843|468565910|FG001|First Treatment Period|Adverse Event|0|||
130165707|NCT01584843|468565911|FG002|First Treatment Period|Adverse Event|1|||
130165708|NCT01584843|468565912|FG003|First Treatment Period|Adverse Event|0|||
130165709|NCT01584843|468565913|FG004|First Treatment Period|Adverse Event|0|||
130165710|NCT01584843|468565914|FG005|First Treatment Period|Adverse Event|0|||
130165711|NCT01584843|468565909|FG000|First Treatment Period|Protocol Violation|0|||
130165712|NCT01584843|468565910|FG001|First Treatment Period|Protocol Violation|0|||
130165713|NCT01584843|468565911|FG002|First Treatment Period|Protocol Violation|0|||
130165714|NCT01584843|468565912|FG003|First Treatment Period|Protocol Violation|0|||
130165715|NCT01584843|468565913|FG004|First Treatment Period|Protocol Violation|0|||
130165716|NCT01584843|468565914|FG005|First Treatment Period|Protocol Violation|1|||
130165717|NCT01584843|468565909|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130165718|NCT01584843|468565910|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129981716|NCT00201643|467896704|FG000|Overall Study|Withdrawal by Subject|5|||
130165719|NCT01584843|468565911|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130165720|NCT01584843|468565912|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130165721|NCT01584843|468565913|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
130165722|NCT01584843|468565914|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
130165723|NCT01584843|468565909|FG000|Second Treatment Period|Withdrawal by Subject|0|||
130165724|NCT01584843|468565910|FG001|Second Treatment Period|Withdrawal by Subject|0|||
130165725|NCT01584843|468565911|FG002|Second Treatment Period|Withdrawal by Subject|0|||
130165726|NCT01584843|468565912|FG003|Second Treatment Period|Withdrawal by Subject|0|||
130165727|NCT01584843|468565913|FG004|Second Treatment Period|Withdrawal by Subject|0|||
130165728|NCT01584843|468565914|FG005|Second Treatment Period|Withdrawal by Subject|1|||
130165729|NCT00311402|468565915|FG000|Overall Study|Adverse Event|118|||
130165730|NCT00311402|468565916|FG001|Overall Study|Adverse Event|105|||
130165731|NCT00311402|468565915|FG000|Overall Study|Lost to Follow-up|0|||
130165732|NCT00311402|468565916|FG001|Overall Study|Lost to Follow-up|3|||
130165733|NCT00311402|468565915|FG000|Overall Study|Withdrawal by Subject|17|||
130165734|NCT00311402|468565916|FG001|Overall Study|Withdrawal by Subject|18|||
130165735|NCT00311402|468565915|FG000|Overall Study|Lack of Efficacy|58|||
130165736|NCT00311402|468565916|FG001|Overall Study|Lack of Efficacy|42|||
130165737|NCT00311402|468565915|FG000|Overall Study|Protocol Violation|7|||
130165738|NCT00311402|468565916|FG001|Overall Study|Protocol Violation|6|||
130165739|NCT00311402|468565915|FG000|Overall Study|IRB's rejection etc.|10|||
130165740|NCT00311402|468565916|FG001|Overall Study|IRB's rejection etc.|3|||
130165741|NCT02640053|468565917|FG000|Overall Study|Withdrawal by Subject|2|||
130165742|NCT02640053|468565918|FG001|Overall Study|Withdrawal by Subject|1|||
130165743|NCT02640053|468565917|FG000|Overall Study|Adverse Event|1|||
130165744|NCT02640053|468565918|FG001|Overall Study|Adverse Event|1|||
130165745|NCT02640053|468565917|FG000|Overall Study|Alternative Therapy|1|||
130165746|NCT02640053|468565918|FG001|Overall Study|Alternative Therapy|1|||
130165747|NCT02640053|468565917|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
130165748|NCT02640053|468565918|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
130165749|NCT03283761|468565919|FG000|Study Treatment|Patient Non-Compliance|1|||
130165750|NCT03283761|468565919|FG000|Study Treatment|Alternative Cancer Therapy|7|||
130165751|NCT03283761|468565919|FG000|Study Treatment|Disease progression|21|||
130165752|NCT03283761|468565919|FG000|Study Treatment|Adverse Event|3|||
130165753|NCT03283761|468565919|FG000|Study Treatment|Withdrawal by Subject|4|||
130165754|NCT03283761|468565919|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
130165755|NCT03283761|468565919|FG000|Study Treatment|Symptomatic Deterioration|1|||
130165756|NCT03283761|468565919|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
130165757|NCT03283761|468565919|FG000|Follow up|Lost to Follow-up|1|||
130165758|NCT03283761|468565919|FG000|Follow up|Symptomatic Deterioration|1|||
130165759|NCT03283761|468565919|FG000|Follow up|Death|29|||
130165760|NCT03283761|468565919|FG000|Follow up|study terminated|4|||
130165761|NCT03283761|468565919|FG000|Follow up|Primary Investigator Withdrawal|1|||
130165762|NCT03283761|468565919|FG000|Follow up|Switched to alternative therapy|1|||
130165763|NCT03283761|468565919|FG000|Follow up|Subject is now in Hospice|1|||
130165764|NCT02036775|468565920|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130165765|NCT02036775|468565921|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130165766|NCT02036775|468565922|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130165767|NCT02036775|468565923|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130165768|NCT02036775|468565924|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
130165769|NCT02036775|468565925|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
130165770|NCT02288182|468565926|FG000|Overall Study|Adverse Event|0|||
130165771|NCT02288182|468565927|FG001|Overall Study|Adverse Event|1|||
130165772|NCT02288182|468565926|FG000|Overall Study|Lost to Follow-up|0|||
130165773|NCT02288182|468565927|FG001|Overall Study|Lost to Follow-up|1|||
130165774|NCT01214915|468565931|FG000|Overall Study|Adverse Event|8|||
130165775|NCT01214915|468565931|FG000|Overall Study|Lack of Efficacy|3|||
130165776|NCT02056392|468565932|FG000|Overall Study|Lost to Follow-up|0|||
130165777|NCT02056392|468565933|FG001|Overall Study|Lost to Follow-up|1|||
130165778|NCT02056392|468565934|FG002|Overall Study|Lost to Follow-up|2|||
130165779|NCT02056392|468565935|FG003|Overall Study|Lost to Follow-up|0|||
130165780|NCT02056392|468565936|FG004|Overall Study|Lost to Follow-up|0|||
130165781|NCT02056392|468565937|FG005|Overall Study|Lost to Follow-up|0|||
130165782|NCT02056392|468565932|FG000|Overall Study|Protocol Violation|1|||
130165783|NCT02056392|468565933|FG001|Overall Study|Protocol Violation|0|||
130165784|NCT02056392|468565934|FG002|Overall Study|Protocol Violation|1|||
130165785|NCT02056392|468565935|FG003|Overall Study|Protocol Violation|0|||
130165786|NCT02056392|468565936|FG004|Overall Study|Protocol Violation|0|||
130165787|NCT02056392|468565937|FG005|Overall Study|Protocol Violation|0|||
130165788|NCT02056392|468565932|FG000|Overall Study|Withdrawal by Subject|1|||
130165789|NCT02056392|468565933|FG001|Overall Study|Withdrawal by Subject|0|||
130165790|NCT02056392|468565934|FG002|Overall Study|Withdrawal by Subject|0|||
130165791|NCT02056392|468565935|FG003|Overall Study|Withdrawal by Subject|0|||
130165792|NCT02056392|468565936|FG004|Overall Study|Withdrawal by Subject|1|||
130165793|NCT02056392|468565937|FG005|Overall Study|Withdrawal by Subject|0|||
130165794|NCT02022748|468567768|FG000|Overall Study|Adverse Event|1|||
130165795|NCT02022748|468567769|FG001|Overall Study|Adverse Event|1|||
130165796|NCT02022748|468567770|FG002|Overall Study|Adverse Event|0|||
130165797|NCT02022748|468567768|FG000|Overall Study|Withdrawal by Subject|0|||
130165798|NCT02022748|468567769|FG001|Overall Study|Withdrawal by Subject|1|||
130165799|NCT02022748|468567770|FG002|Overall Study|Withdrawal by Subject|0|||
130165800|NCT00633243|468567771|FG000|Overall Study|Withdrawal by Subject|0|||
130165801|NCT00633243|468567772|FG001|Overall Study|Withdrawal by Subject|1|||
130165802|NCT00633243|468567771|FG000|Overall Study|incarceration|0|||
130165803|NCT00633243|468567772|FG001|Overall Study|incarceration|2|||
130165804|NCT00633243|468567771|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
130165805|NCT00633243|468567772|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
130165806|NCT00633243|468567771|FG000|Overall Study|Not comfortable with self-injecting|0|||
130165807|NCT00633243|468567772|FG001|Overall Study|Not comfortable with self-injecting|1|||
130165808|NCT00633243|468567771|FG000|Overall Study|Mental Health--Depression|0|||
130165809|NCT00633243|468567772|FG001|Overall Study|Mental Health--Depression|1|||
130165810|NCT00633243|468567771|FG000|Overall Study|Couldn't tolerate side-effects|1|||
130165811|NCT00633243|468567772|FG001|Overall Study|Couldn't tolerate side-effects|1|||
130165812|NCT01523457|468567773|FG000|Overall Study|Withdrawal by Subject|7|||
130165813|NCT01523457|468567774|FG001|Overall Study|Withdrawal by Subject|2|||
130165814|NCT03700385|468567777|FG000|Overall Study|Lost to Follow-up|1|||
130165815|NCT01555671|468567781|FG000|Overall Study|Physician Decision|20|||
130165816|NCT01555671|468567782|FG001|Overall Study|Physician Decision|25|||
130165817|NCT00372411|468567783|FG000|Overall Study|Withdrawal by Subject|3|||
130165818|NCT00372411|468567784|FG001|Overall Study|Withdrawal by Subject|4|||
130165819|NCT00372411|468567785|FG002|Overall Study|Withdrawal by Subject|1|||
130165820|NCT00372411|468567783|FG000|Overall Study|Death|0|||
130165821|NCT00372411|468567784|FG001|Overall Study|Death|2|||
130165822|NCT00372411|468567785|FG002|Overall Study|Death|1|||
130165823|NCT00372411|468567783|FG000|Overall Study|Lost to Follow-up|1|||
130165824|NCT00372411|468567784|FG001|Overall Study|Lost to Follow-up|1|||
130165825|NCT00372411|468567785|FG002|Overall Study|Lost to Follow-up|1|||
130165826|NCT00372411|468567783|FG000|Overall Study|Adverse Event|1|||
130165827|NCT00372411|468567784|FG001|Overall Study|Adverse Event|1|||
130165828|NCT00372411|468567785|FG002|Overall Study|Adverse Event|0|||
130165829|NCT04590040|468567786|FG000|Treatment Period|Lost to Follow-up|2|||
130165830|NCT04590040|468567787|FG001|Treatment Period|Lost to Follow-up|5|||
130165831|NCT04590040|468567788|FG002|Treatment Period|Lost to Follow-up|0|||
130165832|NCT04590040|468567786|FG000|Treatment Period|Physician Decision|0|||
130165833|NCT04590040|468567787|FG001|Treatment Period|Physician Decision|0|||
130165834|NCT04590040|468567788|FG002|Treatment Period|Physician Decision|2|||
130165835|NCT01284361|468567791|FG000|Overall Study|Withdrawal by Subject|1|||
130165836|NCT01284361|468567791|FG000|Overall Study|Protocol Violation|5|||
130165837|NCT01284361|468567791|FG000|Overall Study|Adverse Event|1|||
130165838|NCT01284361|468567791|FG000|Overall Study|Lost to Follow-up|2|||
130165839|NCT04003896|468567792|FG000|Overall Study|Withdrawal by Subject|3|||
130165840|NCT04003896|468567792|FG000|Overall Study|Physician Decision|1|||
130165841|NCT01957397|468567795|FG000|Test Period 1|sudden leakage/small bag|1|||
130165842|NCT01957397|468567796|FG001|Test Period 1|sudden leakage/small bag|1|||
130165843|NCT01957397|468567795|FG000|Test Period 1|Withdrawal by Subject|1|||
130165844|NCT01957397|468567796|FG001|Test Period 1|Withdrawal by Subject|0|||
130165845|NCT01957397|468567795|FG000|Test Period 2|Adverse Event|0|||
130165846|NCT01957397|468567796|FG001|Test Period 2|Adverse Event|1|||
130165847|NCT01957397|468567795|FG000|Test Period 3|Adverse Event|1|||
130165848|NCT01957397|468567796|FG001|Test Period 3|Adverse Event|2|||
130165849|NCT01957397|468567795|FG000|Test Period 3|the adhesive did not work|1|||
130165850|NCT01957397|468567796|FG001|Test Period 3|the adhesive did not work|0|||
130165851|NCT00324649|468567797|FG000|Overall Study|Adverse Event|1|||
130165852|NCT00324649|468567798|FG001|Overall Study|Adverse Event|4|||
130165853|NCT00324649|468567797|FG000|Overall Study|Withdrawal by Subject|0|||
130165854|NCT00324649|468567798|FG001|Overall Study|Withdrawal by Subject|1|||
129981717|NCT00201643|467896705|FG001|Overall Study|Withdrawal by Subject|4|||
129981718|NCT03446781|467896714|FG000|Overall Study|Lost to Follow-up|11|||
130165855|NCT00324649|468567797|FG000|Overall Study|Noncompliance|1|||
130165856|NCT00324649|468567798|FG001|Overall Study|Noncompliance|0|||
129981719|NCT03446781|467896715|FG001|Overall Study|Lost to Follow-up|5|||
130165857|NCT00540293|468567799|FG000|Overall Study|Adverse event related to study drug|10|||
130165858|NCT00540293|468567799|FG000|Overall Study|Adverse event not related to study drug|7|||
130165859|NCT00540293|468567799|FG000|Overall Study|Withdrawal by Subject|6|||
130165860|NCT00540293|468567799|FG000|Overall Study|Protocol violation, & subject schedule|12|||
130165861|NCT04713553|468567802|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
130165862|NCT04713553|468567803|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
130165863|NCT04713553|468567804|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
130165864|NCT04713553|468567805|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
130165865|NCT04713553|468567806|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
130165866|NCT04713553|468567807|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
130165867|NCT04713553|468567808|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
130165868|NCT04713553|468567802|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130165869|NCT04713553|468567803|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130165870|NCT04713553|468567804|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130165871|NCT04713553|468567805|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
130165872|NCT04713553|468567806|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130165873|NCT04713553|468567807|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130165874|NCT04713553|468567808|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
130165875|NCT04713553|468567802|FG000|Primary Study (2 Months)|Other|1|||
130165876|NCT04713553|468567803|FG001|Primary Study (2 Months)|Other|2|||
130165877|NCT04713553|468567804|FG002|Primary Study (2 Months)|Other|0|||
130165878|NCT04713553|468567805|FG003|Primary Study (2 Months)|Other|0|||
130165879|NCT04713553|468567806|FG004|Primary Study (2 Months)|Other|1|||
130165880|NCT04713553|468567807|FG005|Primary Study (2 Months)|Other|0|||
130165881|NCT04713553|468567808|FG006|Primary Study (2 Months)|Other|0|||
130165882|NCT04713553|468567802|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
130165883|NCT04713553|468567803|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
130165884|NCT04713553|468567804|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
130165885|NCT04713553|468567805|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
130165886|NCT04713553|468567806|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
130165887|NCT04713553|468567807|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
130165888|NCT04713553|468567808|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
130165889|NCT04713553|468567802|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
130165890|NCT04713553|468567803|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
130165891|NCT04713553|468567804|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
130165892|NCT04713553|468567805|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
130165893|NCT04713553|468567806|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
130165894|NCT04713553|468567807|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
130165895|NCT04713553|468567808|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
130165896|NCT02315196|468567815|FG000|Overall Study|Withdrew consent|9|||
130165897|NCT04729309|468567816|FG000|Period 1|Subject unable to return for Period 2|3|||
130165898|NCT04729309|468567817|FG001|Period 1|Subject unable to return for Period 2|0|||
130165899|NCT04729309|468567816|FG000|Period 1|Lost to Follow-up|1|||
130165900|NCT04729309|468567817|FG001|Period 1|Lost to Follow-up|0|||
130165901|NCT00537303|468567818|FG000|Overall Study|Adverse Event|1|||
130165902|NCT00537303|468567819|FG001|Overall Study|Adverse Event|4|||
130165903|NCT00537303|468567818|FG000|Overall Study|Lack of Efficacy|6|||
130165904|NCT00537303|468567819|FG001|Overall Study|Lack of Efficacy|7|||
130165905|NCT00537303|468567818|FG000|Overall Study|Protocol Violation|8|||
130165906|NCT00537303|468567819|FG001|Overall Study|Protocol Violation|4|||
130165907|NCT00537303|468567818|FG000|Overall Study|Withdrawal criteria|3|||
130165908|NCT00537303|468567819|FG001|Overall Study|Withdrawal criteria|3|||
130165909|NCT00537303|468567818|FG000|Overall Study|Unclassified|8|||
130165910|NCT00537303|468567819|FG001|Overall Study|Unclassified|7|||
130165911|NCT02085135|468567820|FG000|Overall Study|Adverse Event|4|||
130165912|NCT02085135|468567821|FG001|Overall Study|Adverse Event|7|||
130165913|NCT02085135|468567820|FG000|Overall Study|Lost to Follow-up|2|||
130165914|NCT02085135|468567821|FG001|Overall Study|Lost to Follow-up|2|||
130165915|NCT02085135|468567820|FG000|Overall Study|Withdrawal by Subject|3|||
130165916|NCT02085135|468567821|FG001|Overall Study|Withdrawal by Subject|0|||
130165917|NCT02085135|468567820|FG000|Overall Study|Lack of Efficacy|2|||
130165918|NCT02085135|468567821|FG001|Overall Study|Lack of Efficacy|0|||
130165919|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
130165920|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
130165921|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
130165922|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
130165923|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
130165924|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
130165925|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
130165926|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
130165927|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
130165928|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
130165929|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Death|1|||
130165930|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Death|0|||
129981720|NCT03446781|467896714|FG000|Overall Study|Withdrawal by Subject|9|||
130165931|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Death|0|||
130165932|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Death|0|||
130165933|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Death|0|||
130165934|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129981721|NCT03446781|467896715|FG001|Overall Study|Withdrawal by Subject|7|||
130165935|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
130165936|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
129981722|NCT03446781|467896714|FG000|Overall Study|Adverse Event|8|||
130165937|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
129981723|NCT03446781|467896715|FG001|Overall Study|Adverse Event|2|||
130165938|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
130165939|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
130165940|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
130165941|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130165942|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
130165943|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
130165944|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
130165945|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130165946|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
130165947|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130165948|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
130165949|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
130165950|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
130165951|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
130165952|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
130165953|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130165954|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
130165955|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130165956|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130165957|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130165958|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
130165959|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Other|4|||
130165960|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Other|4|||
130165961|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Other|3|||
130165962|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Other|1|||
130165963|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Other|0|||
130165964|NCT01081834|468567828|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
130165965|NCT01081834|468567829|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
130165966|NCT01081834|468567830|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130165967|NCT01081834|468567831|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130165968|NCT01081834|468567832|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
130165969|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130165970|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130165971|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130165972|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130165973|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
130165974|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Death|1|||
130165975|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Death|0|||
130165976|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130165977|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Death|0|||
130165978|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Death|0|||
130165979|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
130165980|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
130165981|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130165982|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130165983|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130165984|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130165985|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130165986|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130165987|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130165988|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130165989|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130165990|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
130165991|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130165992|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130165993|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
130165994|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130165995|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130165996|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130165997|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130165998|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130165999|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
130166000|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
130166001|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129981724|NCT03446781|467896714|FG000|Overall Study|Protocol Violation|0|||
129981725|NCT03446781|467896715|FG001|Overall Study|Protocol Violation|3|||
129981726|NCT00996476|467896719|FG000|Overall Study|Withdrawal by Subject|1|||
129981727|NCT00996476|467896720|FG001|Overall Study|Withdrawal by Subject|2|||
129981728|NCT00996476|467896721|FG002|Overall Study|Withdrawal by Subject|1|||
129981729|NCT00996476|467896722|FG003|Overall Study|Withdrawal by Subject|0|||
129981730|NCT00996476|467896723|FG004|Overall Study|Withdrawal by Subject|1|||
129981731|NCT00996476|467896719|FG000|Overall Study|Adverse Event|0|||
129981732|NCT00996476|467896720|FG001|Overall Study|Adverse Event|1|||
129981733|NCT00996476|467896721|FG002|Overall Study|Adverse Event|0|||
129981734|NCT00996476|467896722|FG003|Overall Study|Adverse Event|0|||
129981735|NCT00996476|467896723|FG004|Overall Study|Adverse Event|1|||
129981736|NCT05540717|467896724|FG000|Overall Study|Lost to Follow-up|2|||
129981737|NCT05540717|467896725|FG001|Overall Study|Lost to Follow-up|5|||
129981738|NCT05540717|467896724|FG000|Overall Study|Withdrawal by Subject|6|||
129981739|NCT05540717|467896725|FG001|Overall Study|Withdrawal by Subject|6|||
129981740|NCT05540717|467896724|FG000|Overall Study|Sponsor request|1|||
129981741|NCT05540717|467896725|FG001|Overall Study|Sponsor request|0|||
129981742|NCT05540717|467896724|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
129981743|NCT05540717|467896725|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
129981744|NCT05540717|467896724|FG000|Overall Study|Other|0|||
129981745|NCT05540717|467896725|FG001|Overall Study|Other|1|||
129981746|NCT00473265|467896726|FG000|Overall Study|Unrelated adverse event|5|||
129981747|NCT00473265|467896726|FG000|Overall Study|Off treatment early|15|||
129981748|NCT01940939|467896731|FG000|Overall Study|Withdrawal by Subject|2|||
129981749|NCT01940939|467896732|FG001|Overall Study|Withdrawal by Subject|8|||
129981750|NCT01470001|467896733|FG000|Overall Study|Lost to Follow-up|1|||
129981751|NCT01470001|467896734|FG001|Overall Study|Lost to Follow-up|1|||
129981752|NCT01470001|467896733|FG000|Overall Study|Physician Decision|2|||
129981753|NCT01470001|467896734|FG001|Overall Study|Physician Decision|0|||
129981754|NCT01470001|467896733|FG000|Overall Study|Withdrawal by Subject|2|||
129981755|NCT01470001|467896734|FG001|Overall Study|Withdrawal by Subject|1|||
129981756|NCT01895101|467896735|FG000|Overall Study|OPCAB procedure|1|||
129981757|NCT01895101|467896736|FG001|Overall Study|OPCAB procedure|1|||
129981758|NCT01895101|467896737|FG002|Overall Study|OPCAB procedure|3|||
129981759|NCT01895101|467896735|FG000|Overall Study|Withdrawal by Subject|0|||
129981760|NCT01895101|467896736|FG001|Overall Study|Withdrawal by Subject|1|||
129981761|NCT01895101|467896737|FG002|Overall Study|Withdrawal by Subject|2|||
129981762|NCT01895101|467896735|FG000|Overall Study|another study, enrolled in other study|0|||
129981763|NCT01895101|467896736|FG001|Overall Study|another study, enrolled in other study|1|||
129981764|NCT01895101|467896737|FG002|Overall Study|another study, enrolled in other study|0|||
129981765|NCT01895101|467896735|FG000|Overall Study|Death|0|||
129981766|NCT01895101|467896736|FG001|Overall Study|Death|1|||
129981767|NCT01895101|467896737|FG002|Overall Study|Death|0|||
129981768|NCT01895101|467896735|FG000|Overall Study|coagulation disorder|0|||
129981769|NCT01895101|467896736|FG001|Overall Study|coagulation disorder|1|||
129981770|NCT01895101|467896737|FG002|Overall Study|coagulation disorder|0|||
129981771|NCT00370682|467896738|FG000|Overall Study|Moved from area|0|||
129981772|NCT00370682|467896739|FG001|Overall Study|Moved from area|2|||
129981773|NCT00370682|467896740|FG002|Overall Study|Moved from area|0|||
129981774|NCT00370682|467896738|FG000|Overall Study|Lost to Follow-up|0|||
129981775|NCT00370682|467896739|FG001|Overall Study|Lost to Follow-up|1|||
129981776|NCT00370682|467896740|FG002|Overall Study|Lost to Follow-up|1|||
129981777|NCT00127205|467896741|FG000|Overall Study|Adverse Event|228|||
129981778|NCT00127205|467896742|FG001|Overall Study|Adverse Event|387|||
129981779|NCT00127205|467896743|FG002|Overall Study|Adverse Event|273|||
129981780|NCT00127205|467896741|FG000|Overall Study|Death|8|||
129981781|NCT00127205|467896742|FG001|Overall Study|Death|6|||
129981782|NCT00127205|467896743|FG002|Overall Study|Death|5|||
129981783|NCT00127205|467896741|FG000|Overall Study|Withdrawal by Subject|318|||
129981784|NCT00127205|467896742|FG001|Overall Study|Withdrawal by Subject|310|||
129981785|NCT00127205|467896743|FG002|Overall Study|Withdrawal by Subject|172|||
129981786|NCT00127205|467896741|FG000|Overall Study|Other-non protocol specified|142|||
129981787|NCT00127205|467896742|FG001|Overall Study|Other-non protocol specified|129|||
129981788|NCT00127205|467896743|FG002|Overall Study|Other-non protocol specified|77|||
129981789|NCT00127205|467896741|FG000|Overall Study|Data not reported|6|||
129981790|NCT00127205|467896742|FG001|Overall Study|Data not reported|10|||
129981791|NCT00127205|467896743|FG002|Overall Study|Data not reported|1|||
129981792|NCT00127205|467896741|FG000|Overall Study|Progression|127|||
129981793|NCT00127205|467896742|FG001|Overall Study|Progression|131|||
129981794|NCT00127205|467896743|FG002|Overall Study|Progression|84|||
129981795|NCT01280357|467896748|FG000|Overall Study|Excluded no internal monitoring|14|||
129981796|NCT01280357|467896748|FG000|Overall Study|IInsufficient data/No data supplied|12|||
129981797|NCT01259089|467896749|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981798|NCT01259089|467896750|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981799|NCT01259089|467896751|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
130166002|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130166003|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
130166004|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Other|4|||
130166005|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130166006|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Other|4|||
130166007|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Other|0|||
130166008|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Other|0|||
130166009|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
130166010|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
130166011|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130166012|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130166013|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
130166014|NCT01081834|468567828|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130166015|NCT01081834|468567829|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
130166016|NCT01081834|468567830|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129981800|NCT01259089|467896752|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981801|NCT01259089|467896753|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981802|NCT01259089|467896754|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
129981803|NCT01259089|467896749|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
129981804|NCT01259089|467896750|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
129981805|NCT01259089|467896751|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
129981806|NCT01259089|467896752|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
129981807|NCT01259089|467896753|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
129981808|NCT01259089|467896754|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
129981809|NCT01259089|467896749|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981810|NCT01259089|467896750|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981811|NCT01259089|467896751|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981812|NCT01259089|467896752|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981813|NCT01259089|467896753|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981814|NCT01259089|467896754|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
129981815|NCT01259089|467896749|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981816|NCT01259089|467896750|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981817|NCT01259089|467896751|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981818|NCT01259089|467896752|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981819|NCT01259089|467896753|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
129981820|NCT01259089|467896754|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
129981821|NCT01259089|467896749|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
129981822|NCT01259089|467896750|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
129981823|NCT01259089|467896751|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
129981824|NCT01259089|467896752|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
129981825|NCT01259089|467896753|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
129981826|NCT01259089|467896754|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
129981827|NCT01259089|467896749|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
129981828|NCT01259089|467896750|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981829|NCT01259089|467896751|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981830|NCT01259089|467896752|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981831|NCT01259089|467896753|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981832|NCT01259089|467896754|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981833|NCT01259089|467896749|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981834|NCT01259089|467896750|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981835|NCT01259089|467896751|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981836|NCT01259089|467896752|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981837|NCT01259089|467896753|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
129981838|NCT01259089|467896754|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
129981839|NCT01259089|467896749|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981840|NCT01259089|467896750|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981841|NCT01259089|467896751|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981842|NCT01259089|467896752|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981843|NCT01259089|467896753|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
129981844|NCT01259089|467896754|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
129981845|NCT01259089|467896749|FG000|Survival Follow up for Two Years|Death|3|||
129981846|NCT01259089|467896750|FG001|Survival Follow up for Two Years|Death|2|||
129981847|NCT01259089|467896751|FG002|Survival Follow up for Two Years|Death|2|||
129981848|NCT01259089|467896752|FG003|Survival Follow up for Two Years|Death|3|||
129981849|NCT01259089|467896753|FG004|Survival Follow up for Two Years|Death|6|||
129981850|NCT01259089|467896754|FG005|Survival Follow up for Two Years|Death|13|||
129981851|NCT01259089|467896749|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
130166017|NCT01081834|468567831|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130166018|NCT01081834|468567832|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
130166019|NCT01475097|468567839|FG000|Overall Study|Protocol Violation|1|||
130166020|NCT01475097|468567840|FG001|Overall Study|Protocol Violation|1|||
130166021|NCT00851318|468567851|FG000|Overall Study|Withdrawal by Subject|7|||
130166022|NCT00851318|468567852|FG001|Overall Study|Withdrawal by Subject|1|||
130166023|NCT00851318|468567853|FG002|Overall Study|Withdrawal by Subject|5|||
130166024|NCT00851318|468567854|FG003|Overall Study|Withdrawal by Subject|3|||
130166025|NCT00851318|468567851|FG000|Overall Study|Adverse Event|13|||
130166026|NCT00851318|468567852|FG001|Overall Study|Adverse Event|2|||
130166027|NCT00851318|468567853|FG002|Overall Study|Adverse Event|9|||
130166028|NCT00851318|468567854|FG003|Overall Study|Adverse Event|12|||
130166029|NCT00851318|468567851|FG000|Overall Study|Pregnancy|0|||
130166030|NCT00851318|468567852|FG001|Overall Study|Pregnancy|0|||
130166031|NCT00851318|468567853|FG002|Overall Study|Pregnancy|1|||
130166032|NCT00851318|468567854|FG003|Overall Study|Pregnancy|1|||
130166033|NCT00851318|468567851|FG000|Overall Study|Lack of Efficacy|8|||
130166034|NCT00851318|468567852|FG001|Overall Study|Lack of Efficacy|2|||
130166035|NCT00851318|468567853|FG002|Overall Study|Lack of Efficacy|4|||
130166036|NCT00851318|468567854|FG003|Overall Study|Lack of Efficacy|2|||
130166037|NCT00851318|468567851|FG000|Overall Study|Non-compliance with Study Procedures|2|||
130166038|NCT00851318|468567852|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130166039|NCT00851318|468567853|FG002|Overall Study|Non-compliance with Study Procedures|1|||
130166040|NCT00851318|468567854|FG003|Overall Study|Non-compliance with Study Procedures|0|||
130166041|NCT00851318|468567851|FG000|Overall Study|Physician Decision|0|||
130166042|NCT00851318|468567852|FG001|Overall Study|Physician Decision|0|||
130166043|NCT00851318|468567853|FG002|Overall Study|Physician Decision|1|||
130166044|NCT00851318|468567854|FG003|Overall Study|Physician Decision|1|||
130166045|NCT01001988|468567861|FG000|Overall Study|Protocol Violation|84|||
130166046|NCT01001988|468567861|FG000|Overall Study|Withdrawal by Subject|18|||
130166047|NCT01001988|468567861|FG000|Overall Study|Lost to Follow-up|15|||
130166048|NCT01844856|468567862|FG000|Overall Study|Lost to Follow-up|15|||
130166049|NCT01844856|468567863|FG001|Overall Study|Lost to Follow-up|3|||
130166050|NCT01844856|468567862|FG000|Overall Study|Adverse Event|3|||
130166051|NCT01844856|468567863|FG001|Overall Study|Adverse Event|6|||
130166052|NCT01844856|468567862|FG000|Overall Study|Withdrawal by Subject|3|||
130166053|NCT01844856|468567863|FG001|Overall Study|Withdrawal by Subject|2|||
130166054|NCT01844856|468567862|FG000|Overall Study|Noncompliance|2|||
130166055|NCT01844856|468567863|FG001|Overall Study|Noncompliance|3|||
130166056|NCT01844856|468567862|FG000|Overall Study|Enterococcus Resistant|0|||
130166057|NCT01844856|468567863|FG001|Overall Study|Enterococcus Resistant|1|||
130166058|NCT01844856|468567862|FG000|Overall Study|Inadvertently Not Scheduled|1|||
130166059|NCT01844856|468567863|FG001|Overall Study|Inadvertently Not Scheduled|0|||
130166060|NCT01844856|468567862|FG000|Overall Study|Randomized but was a Screen Failure|0|||
130166061|NCT01844856|468567863|FG001|Overall Study|Randomized but was a Screen Failure|1|||
130166062|NCT01442688|468567864|FG000|First Intervention|Withdrawal by Subject|1|||
130166063|NCT01442688|468567865|FG001|First Intervention|Withdrawal by Subject|0|||
130166064|NCT01442688|468567864|FG000|First Intervention|subject incarcerated|1|||
130166065|NCT01442688|468567865|FG001|First Intervention|subject incarcerated|0|||
130166066|NCT01442688|468567864|FG000|Second Intervention|Adverse Event|1|||
130166067|NCT01442688|468567865|FG001|Second Intervention|Adverse Event|0|||
130166068|NCT00927394|468567868|FG000|Overall Study|Adverse Event|14|||
130166069|NCT00927394|468567869|FG001|Overall Study|Adverse Event|9|||
130166070|NCT00927394|468567868|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
130166071|NCT00927394|468567869|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
130166072|NCT00927394|468567868|FG000|Overall Study|Withdrawal by Subject|20|||
130166073|NCT00927394|468567869|FG001|Overall Study|Withdrawal by Subject|24|||
130166074|NCT00927394|468567868|FG000|Overall Study|Lost to Follow-up|8|||
130166075|NCT00927394|468567869|FG001|Overall Study|Lost to Follow-up|14|||
130166076|NCT00927394|468567868|FG000|Overall Study|Administrative Problem|1|||
130166077|NCT00927394|468567869|FG001|Overall Study|Administrative Problem|0|||
130166078|NCT00927394|468567868|FG000|Overall Study|Death|1|||
130166079|NCT00927394|468567869|FG001|Overall Study|Death|1|||
130166080|NCT00927394|468567868|FG000|Overall Study|Protocol deviation|16|||
130166081|NCT00927394|468567869|FG001|Overall Study|Protocol deviation|13|||
130166082|NCT00927394|468567868|FG000|Overall Study|Randomized in error|0|||
130166083|NCT00927394|468567869|FG001|Overall Study|Randomized in error|1|||
130166084|NCT01329549|468567872|FG000|Overall Study|Withdrawal by Subject|1|||
130166085|NCT01329549|468567872|FG000|Overall Study|Adverse Event|1|||
130166086|NCT02792699|468567882|FG000|Overall Study|Adverse Event|1|||
130166087|NCT02792699|468567883|FG001|Overall Study|Adverse Event|2|||
130166088|NCT02792699|468567884|FG002|Overall Study|Adverse Event|4|||
130166089|NCT02792699|468567882|FG000|Overall Study|Withdrawal by Subject|4|||
130166090|NCT02792699|468567883|FG001|Overall Study|Withdrawal by Subject|4|||
130166091|NCT02792699|468567884|FG002|Overall Study|Withdrawal by Subject|3|||
130166092|NCT02792699|468567882|FG000|Overall Study|Lost to Follow-up|0|||
130166093|NCT02792699|468567883|FG001|Overall Study|Lost to Follow-up|1|||
130166094|NCT02792699|468567884|FG002|Overall Study|Lost to Follow-up|2|||
130166095|NCT02792699|468567882|FG000|Overall Study|Physician Decision|2|||
130166096|NCT02792699|468567883|FG001|Overall Study|Physician Decision|0|||
130166097|NCT02792699|468567884|FG002|Overall Study|Physician Decision|0|||
130166098|NCT02792699|468567882|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
130166099|NCT02792699|468567883|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
130166100|NCT02792699|468567884|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
130166101|NCT02792699|468567882|FG000|Overall Study|Other|1|||
130166102|NCT02792699|468567883|FG001|Overall Study|Other|0|||
130166103|NCT02792699|468567884|FG002|Overall Study|Other|0|||
130166104|NCT01755767|468567885|FG000|Overall Study|Progressive Disease|8|||
130166105|NCT01755767|468567886|FG001|Overall Study|Progressive Disease|7|||
130166106|NCT01755767|468567887|FG002|Overall Study|Progressive Disease|91|||
130166107|NCT01755767|468567888|FG003|Overall Study|Progressive Disease|43|||
130166108|NCT01755767|468567885|FG000|Overall Study|Clinical Disease Progression|4|||
130166109|NCT01755767|468567886|FG001|Overall Study|Clinical Disease Progression|2|||
130166110|NCT01755767|468567887|FG002|Overall Study|Clinical Disease Progression|29|||
130166111|NCT01755767|468567888|FG003|Overall Study|Clinical Disease Progression|20|||
130166112|NCT01755767|468567885|FG000|Overall Study|Radiographic Disease Progression|9|||
130166113|NCT01755767|468567886|FG001|Overall Study|Radiographic Disease Progression|4|||
130166114|NCT01755767|468567887|FG002|Overall Study|Radiographic Disease Progression|44|||
130166115|NCT01755767|468567888|FG003|Overall Study|Radiographic Disease Progression|27|||
130166116|NCT01755767|468567885|FG000|Overall Study|Adverse Event|6|||
130166117|NCT01755767|468567886|FG001|Overall Study|Adverse Event|0|||
130166118|NCT01755767|468567887|FG002|Overall Study|Adverse Event|28|||
130166119|NCT01755767|468567888|FG003|Overall Study|Adverse Event|11|||
130166120|NCT01755767|468567885|FG000|Overall Study|Death|1|||
130166121|NCT01755767|468567886|FG001|Overall Study|Death|2|||
130166122|NCT01755767|468567887|FG002|Overall Study|Death|15|||
130166123|NCT01755767|468567888|FG003|Overall Study|Death|4|||
130166124|NCT01755767|468567885|FG000|Overall Study|Subject Decision|0|||
130166125|NCT01755767|468567886|FG001|Overall Study|Subject Decision|0|||
130166126|NCT01755767|468567887|FG002|Overall Study|Subject Decision|10|||
130166127|NCT01755767|468567888|FG003|Overall Study|Subject Decision|3|||
130166128|NCT01755767|468567885|FG000|Overall Study|Withdrawal by Subject|0|||
130166129|NCT01755767|468567886|FG001|Overall Study|Withdrawal by Subject|0|||
130166130|NCT01755767|468567887|FG002|Overall Study|Withdrawal by Subject|2|||
130166131|NCT01755767|468567888|FG003|Overall Study|Withdrawal by Subject|1|||
130166132|NCT01755767|468567885|FG000|Overall Study|Other|0|||
130166133|NCT01755767|468567886|FG001|Overall Study|Other|0|||
130166134|NCT01755767|468567887|FG002|Overall Study|Other|2|||
130166135|NCT01755767|468567888|FG003|Overall Study|Other|3|||
130166136|NCT01755767|468567885|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
130166137|NCT01755767|468567886|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
130166138|NCT01755767|468567887|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
130166139|NCT01755767|468567888|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
130166140|NCT03464630|468567889|FG000|Overall Study|Lost to Follow-up|62|||
130166141|NCT03464630|468567890|FG001|Overall Study|Lost to Follow-up|52|||
130166142|NCT03464630|468567889|FG000|Overall Study|Withdrawal by Subject|16|||
130166143|NCT03464630|468567890|FG001|Overall Study|Withdrawal by Subject|10|||
130166144|NCT03464630|468567889|FG000|Overall Study|Passive Disengagement|8|||
130166145|NCT03464630|468567890|FG001|Overall Study|Passive Disengagement|4|||
130166146|NCT00191165|468567891|FG000|Overall Study|Adverse Event|2|||
130166147|NCT00191165|468567892|FG001|Overall Study|Adverse Event|0|||
130166148|NCT00191165|468567891|FG000|Overall Study|Protocol Violation|0|||
130166149|NCT00191165|468567892|FG001|Overall Study|Protocol Violation|1|||
130166150|NCT00191165|468567891|FG000|Overall Study|Participant Moved Away|0|||
130166151|NCT00191165|468567892|FG001|Overall Study|Participant Moved Away|1|||
130166152|NCT03196635|468567893|FG000|Overall Study|Withdrawal by Subject|1|||
130166153|NCT00380744|468567898|FG000|Overall Study|Death|0|||
130166154|NCT00380744|468567899|FG001|Overall Study|Death|0|||
130166155|NCT00380744|468567900|FG002|Overall Study|Death|0|||
130166156|NCT00380744|468567901|FG003|Overall Study|Death|0|||
130166157|NCT00380744|468567902|FG004|Overall Study|Death|0|||
130166158|NCT00380744|468567903|FG005|Overall Study|Death|0|||
130166159|NCT00380744|468567904|FG006|Overall Study|Death|1|||
130166160|NCT00380744|468567898|FG000|Overall Study|Withdrawal by Subject|1|||
130166161|NCT00380744|468567899|FG001|Overall Study|Withdrawal by Subject|0|||
130166162|NCT00380744|468567900|FG002|Overall Study|Withdrawal by Subject|0|||
130166163|NCT00380744|468567901|FG003|Overall Study|Withdrawal by Subject|0|||
130166164|NCT00380744|468567902|FG004|Overall Study|Withdrawal by Subject|0|||
130166165|NCT00380744|468567903|FG005|Overall Study|Withdrawal by Subject|0|||
130166166|NCT00380744|468567904|FG006|Overall Study|Withdrawal by Subject|0|||
130166167|NCT01338870|468567905|FG000|Overall Study|Lost to Follow-up|0|||
130166168|NCT01338870|468567906|FG001|Overall Study|Lost to Follow-up|0|||
130166169|NCT01338870|468567907|FG002|Overall Study|Lost to Follow-up|1|||
130166170|NCT01338870|468567908|FG003|Overall Study|Lost to Follow-up|0|||
130166171|NCT01338870|468567909|FG004|Overall Study|Lost to Follow-up|1|||
130166172|NCT01338870|468567910|FG005|Overall Study|Lost to Follow-up|0|||
130166173|NCT01338870|468567905|FG000|Overall Study|Withdrawal by Subject|2|||
130166174|NCT01338870|468567906|FG001|Overall Study|Withdrawal by Subject|3|||
130166175|NCT01338870|468567907|FG002|Overall Study|Withdrawal by Subject|4|||
130166176|NCT01338870|468567908|FG003|Overall Study|Withdrawal by Subject|0|||
130166177|NCT01338870|468567909|FG004|Overall Study|Withdrawal by Subject|0|||
130166178|NCT01338870|468567910|FG005|Overall Study|Withdrawal by Subject|2|||
130166179|NCT01338870|468567905|FG000|Overall Study|Other|3|||
130166180|NCT01338870|468567906|FG001|Overall Study|Other|3|||
130166181|NCT01338870|468567907|FG002|Overall Study|Other|3|||
130166182|NCT01338870|468567908|FG003|Overall Study|Other|2|||
130166183|NCT01338870|468567909|FG004|Overall Study|Other|0|||
130166184|NCT01338870|468567910|FG005|Overall Study|Other|2|||
130166185|NCT01338870|468567905|FG000|Overall Study|Protocol Violation|0|||
130166186|NCT01338870|468567906|FG001|Overall Study|Protocol Violation|2|||
130166187|NCT01338870|468567907|FG002|Overall Study|Protocol Violation|2|||
130166188|NCT01338870|468567908|FG003|Overall Study|Protocol Violation|2|||
130166189|NCT01338870|468567909|FG004|Overall Study|Protocol Violation|1|||
130166190|NCT01338870|468567910|FG005|Overall Study|Protocol Violation|1|||
130166191|NCT01338870|468567905|FG000|Overall Study|Adverse Event|4|||
130166192|NCT01338870|468567906|FG001|Overall Study|Adverse Event|4|||
130166193|NCT01338870|468567907|FG002|Overall Study|Adverse Event|1|||
130166194|NCT01338870|468567908|FG003|Overall Study|Adverse Event|5|||
130166195|NCT01338870|468567909|FG004|Overall Study|Adverse Event|4|||
130166196|NCT01338870|468567910|FG005|Overall Study|Adverse Event|1|||
130166197|NCT04480021|468567915|FG000|Overall Study|Lost to Follow-up|3|||
130166198|NCT04480021|468567916|FG001|Overall Study|Lost to Follow-up|4|||
130166199|NCT01844505|468567919|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
130166200|NCT01844505|468567920|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
130166201|NCT01844505|468567921|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
130166202|NCT01844505|468567919|FG000|Treatment Period|Other Reasons|120|||
130166203|NCT01844505|468567920|FG001|Treatment Period|Other Reasons|136|||
130166204|NCT01844505|468567921|FG002|Treatment Period|Other Reasons|58|||
130166205|NCT01844505|468567919|FG000|Treatment Period|Lost to Follow-up|9|||
130166206|NCT01844505|468567920|FG001|Treatment Period|Lost to Follow-up|11|||
130166207|NCT01844505|468567921|FG002|Treatment Period|Lost to Follow-up|6|||
130166208|NCT01844505|468567919|FG000|Treatment Period|Death|175|||
130166209|NCT01844505|468567920|FG001|Treatment Period|Death|154|||
130166210|NCT01844505|468567921|FG002|Treatment Period|Death|228|||
130166211|NCT03384654|468567922|FG000|Overall Study|Withdrawal by Subject|0|||
130166212|NCT03384654|468567923|FG001|Overall Study|Withdrawal by Subject|0|||
130166213|NCT03384654|468567924|FG002|Overall Study|Withdrawal by Subject|1|||
130166214|NCT03384654|468567925|FG003|Overall Study|Withdrawal by Subject|0|||
130166215|NCT00423319|468567926|FG000|Overall Study|Death|2|||
130166216|NCT00423319|468567927|FG001|Overall Study|Death|0|||
130166217|NCT00423319|468567926|FG000|Overall Study|Adverse Event|93|||
130166218|NCT00423319|468567927|FG001|Overall Study|Adverse Event|112|||
130166219|NCT00423319|468567926|FG000|Overall Study|Withdrawal by Subject|86|||
130166220|NCT00423319|468567927|FG001|Overall Study|Withdrawal by Subject|99|||
130166221|NCT00423319|468567926|FG000|Overall Study|Lost to Follow-up|4|||
130166222|NCT00423319|468567927|FG001|Overall Study|Lost to Follow-up|3|||
130166223|NCT00423319|468567926|FG000|Overall Study|Poor compliance or noncompliance|1|||
130166224|NCT00423319|468567927|FG001|Overall Study|Poor compliance or noncompliance|1|||
130166225|NCT00423319|468567926|FG000|Overall Study|No longer meets study criteria|15|||
130166226|NCT00423319|468567927|FG001|Overall Study|No longer meets study criteria|15|||
130166227|NCT00423319|468567926|FG000|Overall Study|Other|23|||
130166228|NCT00423319|468567927|FG001|Overall Study|Other|22|||
130166229|NCT01268501|468567928|FG000|Overall Study|Lost to Follow-up|1|||
130166230|NCT01268501|468567928|FG000|Overall Study|Withdrawal by Subject|3|||
130166231|NCT01268501|468567928|FG000|Overall Study|Unacceptable Subjective Vision|3|||
130166232|NCT01268501|468567928|FG000|Overall Study|Handling Difficulties|2|||
130166233|NCT00678886|468567929|FG000|Overall Study|Withdrawal by Subject|0|||
130166234|NCT00678886|468567930|FG001|Overall Study|Withdrawal by Subject|0|||
130166235|NCT00678886|468567931|FG002|Overall Study|Withdrawal by Subject|4|||
130166236|NCT00678886|468567932|FG003|Overall Study|Withdrawal by Subject|6|||
130166237|NCT00678886|468567929|FG000|Overall Study|Physician Decision|0|||
130166238|NCT00678886|468567930|FG001|Overall Study|Physician Decision|0|||
130166239|NCT00678886|468567931|FG002|Overall Study|Physician Decision|1|||
130166240|NCT00678886|468567932|FG003|Overall Study|Physician Decision|1|||
130166241|NCT00678886|468567929|FG000|Overall Study|Lost to Follow-up|0|||
130166242|NCT00678886|468567930|FG001|Overall Study|Lost to Follow-up|0|||
130166243|NCT00678886|468567931|FG002|Overall Study|Lost to Follow-up|3|||
130166244|NCT00678886|468567932|FG003|Overall Study|Lost to Follow-up|2|||
130166245|NCT00678886|468567929|FG000|Overall Study|Other|0|||
130166246|NCT00678886|468567930|FG001|Overall Study|Other|0|||
130166247|NCT00678886|468567931|FG002|Overall Study|Other|1|||
130166248|NCT00678886|468567932|FG003|Overall Study|Other|0|||
130166249|NCT00206323|468567933|FG000|Overall Study|Lack of Efficacy|4|||
130166250|NCT00206323|468567934|FG001|Overall Study|Lack of Efficacy|1|||
130166251|NCT00206323|468567933|FG000|Overall Study|Adverse Event|1|||
130166252|NCT00206323|468567934|FG001|Overall Study|Adverse Event|1|||
130166253|NCT00206323|468567933|FG000|Overall Study|Lost to Follow-up|1|||
130166254|NCT00206323|468567934|FG001|Overall Study|Lost to Follow-up|1|||
130166255|NCT00827632|468567937|FG000|Overall Study|Lost to Follow-up|8|||
130166256|NCT00827632|468567938|FG001|Overall Study|Lost to Follow-up|12|||
130166257|NCT00827632|468567937|FG000|Overall Study|Early withdrawal|14|||
130166258|NCT00827632|468567938|FG001|Overall Study|Early withdrawal|11|||
130166259|NCT01910389|468567942|FG000|Overall Study|Withdrawal by Subject|2|||
130166260|NCT01910389|468567943|FG001|Overall Study|Withdrawal by Subject|0|||
130166261|NCT01910389|468567942|FG000|Overall Study|Study Closed|13|||
130166262|NCT01910389|468567943|FG001|Overall Study|Study Closed|8|||
130166263|NCT04669691|468567947|FG000|Overall Study|Death|0|||
130166264|NCT04669691|468567948|FG001|Overall Study|Death|1|||
130166265|NCT04669691|468567949|FG002|Overall Study|Death|0|||
130166266|NCT04669691|468567950|FG003|Overall Study|Death|0|||
130166267|NCT04669691|468567951|FG004|Overall Study|Death|0|||
130166268|NCT04669691|468567952|FG005|Overall Study|Death|0|||
130166269|NCT02304458|468567953|FG000|Overall Study|Adverse Event|0|||
130166270|NCT02304458|468567954|FG001|Overall Study|Adverse Event|0|||
130166271|NCT02304458|468567955|FG002|Overall Study|Adverse Event|7|||
130166272|NCT02304458|468567956|FG003|Overall Study|Adverse Event|0|||
130166273|NCT02304458|468567957|FG004|Overall Study|Adverse Event|0|||
130166274|NCT02304458|468567958|FG005|Overall Study|Adverse Event|0|||
130166275|NCT02304458|468567959|FG006|Overall Study|Adverse Event|3|||
130166276|NCT02304458|468567960|FG007|Overall Study|Adverse Event|4|||
130166277|NCT02304458|468567953|FG000|Overall Study|Death|0|||
130166278|NCT02304458|468567954|FG001|Overall Study|Death|0|||
130166279|NCT02304458|468567955|FG002|Overall Study|Death|2|||
130166280|NCT02304458|468567956|FG003|Overall Study|Death|0|||
130166281|NCT02304458|468567957|FG004|Overall Study|Death|0|||
130166282|NCT02304458|468567958|FG005|Overall Study|Death|0|||
130166283|NCT02304458|468567959|FG006|Overall Study|Death|1|||
130166284|NCT02304458|468567960|FG007|Overall Study|Death|0|||
130166285|NCT02304458|468567953|FG000|Overall Study|Lack of Efficacy|4|||
130166286|NCT02304458|468567954|FG001|Overall Study|Lack of Efficacy|6|||
130166287|NCT02304458|468567955|FG002|Overall Study|Lack of Efficacy|38|||
130166288|NCT02304458|468567956|FG003|Overall Study|Lack of Efficacy|5|||
130166289|NCT02304458|468567957|FG004|Overall Study|Lack of Efficacy|6|||
130166290|NCT02304458|468567958|FG005|Overall Study|Lack of Efficacy|6|||
130166291|NCT02304458|468567959|FG006|Overall Study|Lack of Efficacy|21|||
130166292|NCT02304458|468567960|FG007|Overall Study|Lack of Efficacy|4|||
130166293|NCT02304458|468567953|FG000|Overall Study|Physician Decision|2|||
130166294|NCT02304458|468567954|FG001|Overall Study|Physician Decision|0|||
130166295|NCT02304458|468567955|FG002|Overall Study|Physician Decision|16|||
130166296|NCT02304458|468567956|FG003|Overall Study|Physician Decision|1|||
130166297|NCT02304458|468567957|FG004|Overall Study|Physician Decision|0|||
130166298|NCT02304458|468567958|FG005|Overall Study|Physician Decision|0|||
130166299|NCT02304458|468567959|FG006|Overall Study|Physician Decision|3|||
130166300|NCT02304458|468567960|FG007|Overall Study|Physician Decision|0|||
130166301|NCT02304458|468567953|FG000|Overall Study|Protocol Violation|0|||
130166302|NCT02304458|468567954|FG001|Overall Study|Protocol Violation|0|||
130166303|NCT02304458|468567955|FG002|Overall Study|Protocol Violation|1|||
130166304|NCT02304458|468567956|FG003|Overall Study|Protocol Violation|0|||
130166305|NCT02304458|468567957|FG004|Overall Study|Protocol Violation|0|||
130166306|NCT02304458|468567958|FG005|Overall Study|Protocol Violation|0|||
130166307|NCT02304458|468567959|FG006|Overall Study|Protocol Violation|0|||
130166308|NCT02304458|468567960|FG007|Overall Study|Protocol Violation|0|||
130166309|NCT02304458|468567953|FG000|Overall Study|Withdrawal by Subject|1|||
130166310|NCT02304458|468567954|FG001|Overall Study|Withdrawal by Subject|0|||
130166311|NCT02304458|468567955|FG002|Overall Study|Withdrawal by Subject|7|||
130166312|NCT02304458|468567956|FG003|Overall Study|Withdrawal by Subject|0|||
130166313|NCT02304458|468567957|FG004|Overall Study|Withdrawal by Subject|0|||
130166314|NCT02304458|468567958|FG005|Overall Study|Withdrawal by Subject|0|||
130166315|NCT02304458|468567959|FG006|Overall Study|Withdrawal by Subject|1|||
130166316|NCT02304458|468567960|FG007|Overall Study|Withdrawal by Subject|0|||
130166317|NCT03401450|468567961|FG000|Overall Study|Lost to Follow-up|4|||
130166318|NCT03401450|468567962|FG001|Overall Study|Lost to Follow-up|6|||
130166319|NCT03401450|468567961|FG000|Overall Study|Anesthesia plan changed|2|||
130166320|NCT03401450|468567962|FG001|Overall Study|Anesthesia plan changed|2|||
130166321|NCT03401450|468567961|FG000|Overall Study|Did not complete medication diary|4|||
130166322|NCT03401450|468567962|FG001|Overall Study|Did not complete medication diary|2|||
130166323|NCT03401450|468567961|FG000|Overall Study|post surgery medication change|2|||
130166324|NCT03401450|468567962|FG001|Overall Study|post surgery medication change|1|||
130166325|NCT03401450|468567961|FG000|Overall Study|Cancelled surgery|0|||
130166326|NCT03401450|468567962|FG001|Overall Study|Cancelled surgery|2|||
130166327|NCT03155945|468567963|FG000|Overall Study|Lost to Follow-up|0|||
130166328|NCT03155945|468567964|FG001|Overall Study|Lost to Follow-up|1|||
130166329|NCT03155945|468567963|FG000|Overall Study|Withdrawal by Subject|0|||
130166330|NCT03155945|468567964|FG001|Overall Study|Withdrawal by Subject|1|||
130166331|NCT03155945|468567963|FG000|Overall Study|Other Reason|0|||
130166332|NCT03155945|468567964|FG001|Overall Study|Other Reason|1|||
130166333|NCT03395405|468569484|FG000|Overall Study|Death|0|||
130166334|NCT03395405|468569485|FG001|Overall Study|Death|2|||
130166335|NCT03395405|468569484|FG000|Overall Study|Lost to Follow-up|0|||
130166336|NCT03395405|468569485|FG001|Overall Study|Lost to Follow-up|1|||
130166337|NCT03395405|468569484|FG000|Overall Study|Protocol Violation|0|||
130166338|NCT03395405|468569485|FG001|Overall Study|Protocol Violation|1|||
130166339|NCT03395405|468569484|FG000|Overall Study|Withdrawal by Subject|3|||
130166340|NCT03395405|468569485|FG001|Overall Study|Withdrawal by Subject|1|||
130166341|NCT03395405|468569484|FG000|Overall Study|COVID-19 Pandemic|1|||
130166342|NCT03395405|468569485|FG001|Overall Study|COVID-19 Pandemic|0|||
130166343|NCT04345601|468569486|FG000|Overall Study|Death|0|||
130166344|NCT04345601|468569487|FG001|Overall Study|Death|3|||
130166345|NCT04345601|468569488|FG002|Overall Study|Death|2|||
130166346|NCT04345601|468569486|FG000|Overall Study|Lost to Follow-up|0|||
130166347|NCT04345601|468569487|FG001|Overall Study|Lost to Follow-up|0|||
130166348|NCT04345601|468569488|FG002|Overall Study|Lost to Follow-up|2|||
130166349|NCT00000378|468569489|FG000|Overall Study|Lack of Efficacy|16|||
130166350|NCT00000378|468569490|FG001|Overall Study|Lack of Efficacy|14|||
130166351|NCT02585934|468569495|FG000|Overall Study|Lost to Follow-up|2|||
130166352|NCT02585934|468569496|FG001|Overall Study|Lost to Follow-up|2|||
130166353|NCT02585934|468569495|FG000|Overall Study|Protocol Violation|14|||
130166354|NCT02585934|468569496|FG001|Overall Study|Protocol Violation|11|||
130166355|NCT02585934|468569495|FG000|Overall Study|Adverse Event|21|||
130166356|NCT02585934|468569496|FG001|Overall Study|Adverse Event|22|||
130166357|NCT02585934|468569495|FG000|Overall Study|Physician Decision|3|||
130166358|NCT02585934|468569496|FG001|Overall Study|Physician Decision|2|||
130166359|NCT02585934|468569495|FG000|Overall Study|Withdrawal by Subject|7|||
130166360|NCT02585934|468569496|FG001|Overall Study|Withdrawal by Subject|21|||
130166361|NCT02585934|468569495|FG000|Overall Study|Lack of Efficacy|2|||
130166362|NCT02585934|468569496|FG001|Overall Study|Lack of Efficacy|1|||
130166363|NCT02585934|468569495|FG000|Overall Study|Death|2|||
130166364|NCT02585934|468569496|FG001|Overall Study|Death|0|||
130166365|NCT02585934|468569495|FG000|Overall Study|Caregiver Withdrew Consent|7|||
130166366|NCT02585934|468569496|FG001|Overall Study|Caregiver Withdrew Consent|7|||
130166367|NCT02585934|468569495|FG000|Overall Study|Sponsor Termination|1|||
130166368|NCT02585934|468569496|FG001|Overall Study|Sponsor Termination|2|||
130166369|NCT02585934|468569495|FG000|Overall Study|Another Reason|10|||
130166370|NCT02585934|468569496|FG001|Overall Study|Another Reason|5|||
130166371|NCT02448706|468569497|FG000|Overall Study|Withdrawal by Subject|4|||
130166372|NCT02448706|468569498|FG001|Overall Study|Withdrawal by Subject|3|||
130166373|NCT02448706|468569497|FG000|Overall Study|Protocol Violation|1|||
130166374|NCT02448706|468569498|FG001|Overall Study|Protocol Violation|1|||
130166375|NCT01359969|468569499|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
130166376|NCT00470067|468569507|FG000|Overall Study|Death|1|||
130166377|NCT00470067|468569507|FG000|Overall Study|Disease Progression|6|||
130166378|NCT03400943|468569508|FG000|Treatment Period 1|Adverse Event|0|||
130166379|NCT03400943|468569509|FG001|Treatment Period 1|Adverse Event|0|||
130166380|NCT03400943|468569510|FG002|Treatment Period 1|Adverse Event|0|||
130166381|NCT03400943|468569511|FG003|Treatment Period 1|Adverse Event|1|||
130166382|NCT03400943|468569508|FG000|Treatment Period 1|Lost to Follow-up|1|||
130166383|NCT03400943|468569509|FG001|Treatment Period 1|Lost to Follow-up|0|||
130166384|NCT03400943|468569510|FG002|Treatment Period 1|Lost to Follow-up|0|||
130166385|NCT03400943|468569511|FG003|Treatment Period 1|Lost to Follow-up|0|||
130166386|NCT03400943|468569508|FG000|Treatment Period 1|Protocol Violation|0|||
130166387|NCT03400943|468569509|FG001|Treatment Period 1|Protocol Violation|1|||
130166388|NCT03400943|468569510|FG002|Treatment Period 1|Protocol Violation|1|||
130166389|NCT03400943|468569511|FG003|Treatment Period 1|Protocol Violation|0|||
130166390|NCT03400943|468569508|FG000|Treatment Period 1|Study terminated by sponsor|2|||
130166391|NCT03400943|468569509|FG001|Treatment Period 1|Study terminated by sponsor|0|||
130166392|NCT03400943|468569510|FG002|Treatment Period 1|Study terminated by sponsor|0|||
130166393|NCT03400943|468569511|FG003|Treatment Period 1|Study terminated by sponsor|1|||
130166394|NCT03400943|468569508|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130166395|NCT03400943|468569509|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130166396|NCT03400943|468569510|FG002|Treatment Period 1|Withdrawal by Subject|3|||
130166397|NCT03400943|468569511|FG003|Treatment Period 1|Withdrawal by Subject|1|||
130166398|NCT03400943|468569508|FG000|Treatment Period 1|Other|2|||
130166399|NCT03400943|468569509|FG001|Treatment Period 1|Other|1|||
130166400|NCT03400943|468569510|FG002|Treatment Period 1|Other|2|||
130166401|NCT03400943|468569511|FG003|Treatment Period 1|Other|2|||
130166402|NCT03400943|468569508|FG000|Post-treatment Period 1|Adverse Event|2|||
130166403|NCT03400943|468569509|FG001|Post-treatment Period 1|Adverse Event|0|||
130166404|NCT03400943|468569510|FG002|Post-treatment Period 1|Adverse Event|0|||
130166405|NCT03400943|468569511|FG003|Post-treatment Period 1|Adverse Event|0|||
130166406|NCT03400943|468569508|FG000|Post-treatment Period 1|Protocol Violation|1|||
130166407|NCT03400943|468569509|FG001|Post-treatment Period 1|Protocol Violation|0|||
130166408|NCT03400943|468569510|FG002|Post-treatment Period 1|Protocol Violation|0|||
130166409|NCT03400943|468569511|FG003|Post-treatment Period 1|Protocol Violation|0|||
130166410|NCT03400943|468569508|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
130166411|NCT03400943|468569509|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
130166412|NCT03400943|468569510|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
130166413|NCT03400943|468569511|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
130166414|NCT03400943|468569508|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
130166415|NCT03400943|468569509|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
130166416|NCT03400943|468569510|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
130166417|NCT03400943|468569511|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
130166418|NCT03400943|468569508|FG000|Post-treatment Period 1|Other|2|||
130166419|NCT03400943|468569509|FG001|Post-treatment Period 1|Other|0|||
130166420|NCT03400943|468569510|FG002|Post-treatment Period 1|Other|4|||
130166421|NCT03400943|468569511|FG003|Post-treatment Period 1|Other|5|||
130166422|NCT03400943|468569508|FG000|Treatment Period 2|Study terminated by sponsor|0|||
130166423|NCT03400943|468569509|FG001|Treatment Period 2|Study terminated by sponsor|1|||
130166424|NCT03400943|468569510|FG002|Treatment Period 2|Study terminated by sponsor|0|||
130166425|NCT03400943|468569511|FG003|Treatment Period 2|Study terminated by sponsor|0|||
130166426|NCT03400943|468569508|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130166427|NCT03400943|468569509|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130166428|NCT03400943|468569510|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130166429|NCT03400943|468569511|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130166430|NCT03400943|468569508|FG000|Treatment Period 2|Other|1|||
130166431|NCT03400943|468569509|FG001|Treatment Period 2|Other|6|||
130166432|NCT03400943|468569510|FG002|Treatment Period 2|Other|0|||
130166433|NCT03400943|468569511|FG003|Treatment Period 2|Other|0|||
130166434|NCT03400943|468569508|FG000|Follow-up Period|Withdrawal by Subject|1|||
130166435|NCT03400943|468569509|FG001|Follow-up Period|Withdrawal by Subject|0|||
130166436|NCT03400943|468569510|FG002|Follow-up Period|Withdrawal by Subject|0|||
130166437|NCT03400943|468569511|FG003|Follow-up Period|Withdrawal by Subject|0|||
130166438|NCT02563106|468569512|FG000|Overall Study|Withdrawal by Subject|7|||
130166439|NCT02563106|468569513|FG001|Overall Study|Withdrawal by Subject|8|||
130166440|NCT02563106|468569512|FG000|Overall Study|Adverse Event|17|||
130166441|NCT02563106|468569513|FG001|Overall Study|Adverse Event|15|||
130166442|NCT02563106|468569512|FG000|Overall Study|Protocol Violation|1|||
130166443|NCT02563106|468569513|FG001|Overall Study|Protocol Violation|0|||
130166444|NCT02563106|468569512|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
130166445|NCT02563106|468569513|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
130166446|NCT02563106|468569512|FG000|Overall Study|Lost to Follow-up|3|||
130166447|NCT02563106|468569513|FG001|Overall Study|Lost to Follow-up|2|||
130166448|NCT02563106|468569512|FG000|Overall Study|Physician Decision|3|||
130166449|NCT02563106|468569513|FG001|Overall Study|Physician Decision|1|||
130166450|NCT02563106|468569512|FG000|Overall Study|Other reason - not specified|2|||
130166451|NCT02563106|468569513|FG001|Overall Study|Other reason - not specified|1|||
130166452|NCT01059539|468569514|FG000|Overall Study|Adverse Event|66|||
130166453|NCT01059539|468569514|FG000|Overall Study|Insufficient Therapeutic Response|26|||
130166454|NCT01059539|468569514|FG000|Overall Study|Protocol Violation|55|||
130166455|NCT01059539|468569514|FG000|Overall Study|Withdrawal of Consent|80|||
130166456|NCT01059539|468569514|FG000|Overall Study|Lost to Follow-up|42|||
130166457|NCT01059539|468569514|FG000|Overall Study|Reason Not Specified|2|||
130166458|NCT04091659|468569515|FG000|Overall Study|Protocol Violation|3|||
130166459|NCT04091659|468569516|FG001|Overall Study|Protocol Violation|0|||
130166460|NCT04091659|468569515|FG000|Overall Study|Lost to Follow-up|0|||
130166461|NCT04091659|468569516|FG001|Overall Study|Lost to Follow-up|1|||
130166462|NCT03678285|468569521|FG000|Overall Study|Adverse Event|2|||
130166463|NCT03678285|468569521|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
130166464|NCT03678285|468569521|FG000|Overall Study|Dehydrated prior to start of workout|1|||
130166465|NCT00616629|468569522|FG000|Overall Study|Protocol Violation|1|||
130166466|NCT00616629|468569523|FG001|Overall Study|Protocol Violation|2|||
130166467|NCT00616629|468569524|FG002|Overall Study|Protocol Violation|1|||
130166468|NCT00616629|468569525|FG003|Overall Study|Protocol Violation|0|||
130166469|NCT00616629|468569526|FG004|Overall Study|Protocol Violation|0|||
130166470|NCT00616629|468569522|FG000|Overall Study|AV-block|1|||
130166471|NCT00616629|468569523|FG001|Overall Study|AV-block|0|||
130166472|NCT00616629|468569524|FG002|Overall Study|AV-block|0|||
130166473|NCT00616629|468569525|FG003|Overall Study|AV-block|0|||
130166474|NCT00616629|468569526|FG004|Overall Study|AV-block|0|||
130166475|NCT01777620|468569527|FG000|Overall Study|Subject Withdrawal|1|||
130166476|NCT01777620|468569528|FG001|Overall Study|Subject Withdrawal|0|||
130166477|NCT04005352|468569530|FG000|Overall Study|Adverse Event|4|||
130166478|NCT04005352|468569531|FG001|Overall Study|Adverse Event|5|||
130166479|NCT04005352|468569530|FG000|Overall Study|Death|4|||
130166480|NCT04005352|468569531|FG001|Overall Study|Death|2|||
130166481|NCT04005352|468569530|FG000|Overall Study|Lost to Follow-up|6|||
130166482|NCT04005352|468569531|FG001|Overall Study|Lost to Follow-up|2|||
130166483|NCT04005352|468569530|FG000|Overall Study|Physician Decision|7|||
130166484|NCT04005352|468569531|FG001|Overall Study|Physician Decision|13|||
130166485|NCT04005352|468569530|FG000|Overall Study|Protocol Violation|0|||
130166486|NCT04005352|468569531|FG001|Overall Study|Protocol Violation|1|||
130166487|NCT04005352|468569530|FG000|Overall Study|Withdrawal by Subject|28|||
130166488|NCT04005352|468569531|FG001|Overall Study|Withdrawal by Subject|38|||
130166489|NCT00936897|468569534|FG000|Overall Study|Withdrawal by Subject|9|||
130166490|NCT00936897|468569535|FG001|Overall Study|Withdrawal by Subject|19|||
130166491|NCT00936897|468569534|FG000|Overall Study|Adverse Event|4|||
130166492|NCT00936897|468569535|FG001|Overall Study|Adverse Event|13|||
130166493|NCT00936897|468569534|FG000|Overall Study|Other|3|||
130166494|NCT00936897|468569535|FG001|Overall Study|Other|9|||
130166495|NCT00936897|468569534|FG000|Overall Study|Lost to Follow-up|1|||
130166496|NCT00936897|468569535|FG001|Overall Study|Lost to Follow-up|10|||
130166497|NCT00936897|468569534|FG000|Overall Study|Administrative Decision|1|||
130166498|NCT00936897|468569535|FG001|Overall Study|Administrative Decision|2|||
130166499|NCT00936897|468569534|FG000|Overall Study|Protocol Violation|1|||
130166500|NCT00936897|468569535|FG001|Overall Study|Protocol Violation|1|||
130166501|NCT00936897|468569534|FG000|Overall Study|Ineligibility Determined|0|||
130166502|NCT00936897|468569535|FG001|Overall Study|Ineligibility Determined|3|||
130166503|NCT00936897|468569534|FG000|Overall Study|Noncompliance|0|||
130166504|NCT00936897|468569535|FG001|Overall Study|Noncompliance|2|||
130166505|NCT00936897|468569534|FG000|Overall Study|Death|0|||
130166506|NCT00936897|468569535|FG001|Overall Study|Death|1|||
130166507|NCT00417170|468569536|FG000|Overall Study|Adverse Event|1|||
130166508|NCT00417170|468569537|FG001|Overall Study|Adverse Event|1|||
130166509|NCT00417170|468569536|FG000|Overall Study|Withdrawal by Subject|1|||
130166510|NCT00417170|468569537|FG001|Overall Study|Withdrawal by Subject|1|||
130166511|NCT00417170|468569536|FG000|Overall Study|Lost to Follow-up|0|||
130166512|NCT00417170|468569537|FG001|Overall Study|Lost to Follow-up|1|||
130166513|NCT04058067|468569538|FG000|Overall Study|Adverse Event|2|||
130166514|NCT04058067|468569539|FG001|Overall Study|Adverse Event|0|||
130166515|NCT04058067|468569538|FG000|Overall Study|Death|0|||
130166516|NCT04058067|468569539|FG001|Overall Study|Death|1|||
130166517|NCT04058067|468569538|FG000|Overall Study|Physician Decision|3|||
130166518|NCT04058067|468569539|FG001|Overall Study|Physician Decision|1|||
130166519|NCT04058067|468569538|FG000|Overall Study|Protocol Violation|0|||
130166520|NCT04058067|468569539|FG001|Overall Study|Protocol Violation|1|||
130166521|NCT04058067|468569538|FG000|Overall Study|Withdrawal by Subject|7|||
130166522|NCT04058067|468569539|FG001|Overall Study|Withdrawal by Subject|8|||
130166523|NCT05005312|468569540|FG000|Overall Study|Enrolled, but not treated|0|||
130166524|NCT05005312|468569541|FG001|Overall Study|Enrolled, but not treated|1|||
130166525|NCT01283035|468569542|FG000|Overall Study|Subject later found ineligible|1|||
130166526|NCT00867503|468569544|FG000|Overall Study|Withdrawal by Subject|1|||
130166527|NCT02704403|468569545|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
130166528|NCT02704403|468569546|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
130166529|NCT02704403|468569545|FG000|Overall Study|Administrative reasons by sponsor|1251|||
130166530|NCT02704403|468569546|FG001|Overall Study|Administrative reasons by sponsor|616|||
130166531|NCT02704403|468569545|FG000|Overall Study|Death|4|||
130166532|NCT02704403|468569546|FG001|Overall Study|Death|3|||
130166533|NCT02704403|468569545|FG000|Overall Study|Endpoint event|52|||
130166534|NCT02704403|468569546|FG001|Overall Study|Endpoint event|24|||
130166535|NCT02704403|468569545|FG000|Overall Study|Lost to Follow-up|22|||
130166536|NCT02704403|468569546|FG001|Overall Study|Lost to Follow-up|11|||
130166537|NCT02704403|468569545|FG000|Overall Study|Protocol Violation|15|||
130166538|NCT02704403|468569546|FG001|Overall Study|Protocol Violation|15|||
130166539|NCT02704403|468569545|FG000|Overall Study|Adverse Event|2|||
130166540|NCT02704403|468569546|FG001|Overall Study|Adverse Event|0|||
130166541|NCT02704403|468569545|FG000|Overall Study|Withdrawal by Subject|85|||
130166542|NCT02704403|468569546|FG001|Overall Study|Withdrawal by Subject|45|||
130166543|NCT02704403|468569545|FG000|Overall Study|Investigator decision|1|||
130166544|NCT02704403|468569546|FG001|Overall Study|Investigator decision|1|||
129981852|NCT01259089|467896750|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981853|NCT01259089|467896751|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981854|NCT01259089|467896752|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981855|NCT01259089|467896753|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981856|NCT01259089|467896754|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
129981857|NCT01259089|467896749|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981858|NCT01259089|467896750|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981859|NCT01259089|467896751|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981860|NCT01259089|467896752|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981861|NCT01259089|467896753|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
130166545|NCT02704403|468569545|FG000|Overall Study|Follow-up not possible|1|||
130166546|NCT02704403|468569546|FG001|Overall Study|Follow-up not possible|2|||
130166547|NCT00077857|468569547|FG000|Overall Study|Adverse Event|30|||
130166548|NCT00077857|468569548|FG001|Overall Study|Adverse Event|32|||
130166549|NCT00077857|468569547|FG000|Overall Study|Death|7|||
130166550|NCT00077857|468569548|FG001|Overall Study|Death|3|||
130166551|NCT00077857|468569547|FG000|Overall Study|Insufficient therapeutic response|112|||
130166552|NCT00077857|468569548|FG001|Overall Study|Insufficient therapeutic response|128|||
130166553|NCT00077857|468569547|FG000|Overall Study|Violation of selection criteria at entry|3|||
130166554|NCT00077857|468569548|FG001|Overall Study|Violation of selection criteria at entry|1|||
130166555|NCT00077857|468569547|FG000|Overall Study|Other protocol violation|0|||
130166556|NCT00077857|468569548|FG001|Overall Study|Other protocol violation|1|||
130166557|NCT00077857|468569547|FG000|Overall Study|Refused treatment|29|||
130166558|NCT00077857|468569548|FG001|Overall Study|Refused treatment|21|||
130166559|NCT00077857|468569547|FG000|Overall Study|Failure to return|5|||
130166560|NCT00077857|468569548|FG001|Overall Study|Failure to return|5|||
130166561|NCT00077857|468569547|FG000|Overall Study|Other|15|||
130166562|NCT00077857|468569548|FG001|Overall Study|Other|13|||
130166563|NCT02348723|468569550|FG000|Overall Study|No ablation|21|||
130166564|NCT02348723|468569551|FG001|Overall Study|No ablation|20|||
130166565|NCT02348723|468569550|FG000|Overall Study|Non-compliant with Protocol|1|||
130166566|NCT02348723|468569551|FG001|Overall Study|Non-compliant with Protocol|0|||
130166567|NCT02348723|468569550|FG000|Overall Study|Lost to Follow-up|1|||
130166568|NCT02348723|468569551|FG001|Overall Study|Lost to Follow-up|1|||
130166569|NCT02348723|468569550|FG000|Overall Study|Consent withdrawn|1|||
130166570|NCT02348723|468569551|FG001|Overall Study|Consent withdrawn|3|||
130166571|NCT02348723|468569550|FG000|Overall Study|Reason other than specified|1|||
130166572|NCT02348723|468569551|FG001|Overall Study|Reason other than specified|1|||
130166573|NCT02348723|468569550|FG000|Overall Study|Adverse Event|3|||
130166574|NCT02348723|468569551|FG001|Overall Study|Adverse Event|1|||
130166575|NCT04874155|468569553|FG000|Overall Study|Lost to Follow-up|1|||
130166576|NCT04874155|468569554|FG001|Overall Study|Lost to Follow-up|1|||
130166577|NCT04874155|468569553|FG000|Overall Study|Withdrawal by Subject|2|||
130166578|NCT04874155|468569554|FG001|Overall Study|Withdrawal by Subject|2|||
130166579|NCT02329847|468569557|FG000|Overall Study|Death|4|||
130166580|NCT02329847|468569558|FG001|Overall Study|Death|4|||
130166581|NCT02329847|468569559|FG002|Overall Study|Death|22|||
130166582|NCT02329847|468569560|FG003|Overall Study|Death|12|||
130166583|NCT02329847|468569561|FG004|Overall Study|Death|20|||
130166584|NCT02329847|468569562|FG005|Overall Study|Death|13|||
130166585|NCT02329847|468569557|FG000|Overall Study|Lost to Follow-up|0|||
130166586|NCT02329847|468569558|FG001|Overall Study|Lost to Follow-up|0|||
130166587|NCT02329847|468569559|FG002|Overall Study|Lost to Follow-up|2|||
130166588|NCT02329847|468569560|FG003|Overall Study|Lost to Follow-up|3|||
130166589|NCT02329847|468569561|FG004|Overall Study|Lost to Follow-up|0|||
130166590|NCT02329847|468569562|FG005|Overall Study|Lost to Follow-up|1|||
130166591|NCT02329847|468569557|FG000|Overall Study|Physician Decision|0|||
130166592|NCT02329847|468569558|FG001|Overall Study|Physician Decision|0|||
130166593|NCT02329847|468569559|FG002|Overall Study|Physician Decision|0|||
130166594|NCT02329847|468569560|FG003|Overall Study|Physician Decision|0|||
130166595|NCT02329847|468569561|FG004|Overall Study|Physician Decision|1|||
130166596|NCT02329847|468569562|FG005|Overall Study|Physician Decision|0|||
130166597|NCT02329847|468569557|FG000|Overall Study|Withdrawal by Subject|2|||
130166598|NCT02329847|468569558|FG001|Overall Study|Withdrawal by Subject|1|||
130166599|NCT02329847|468569559|FG002|Overall Study|Withdrawal by Subject|5|||
130166600|NCT02329847|468569560|FG003|Overall Study|Withdrawal by Subject|7|||
130166601|NCT02329847|468569561|FG004|Overall Study|Withdrawal by Subject|8|||
130166602|NCT02329847|468569562|FG005|Overall Study|Withdrawal by Subject|3|||
130166603|NCT02329847|468569557|FG000|Overall Study|Other|1|||
130166604|NCT02329847|468569558|FG001|Overall Study|Other|2|||
130166605|NCT02329847|468569559|FG002|Overall Study|Other|6|||
130166606|NCT02329847|468569560|FG003|Overall Study|Other|13|||
130166607|NCT02329847|468569561|FG004|Overall Study|Other|10|||
130166608|NCT02329847|468569562|FG005|Overall Study|Other|3|||
130166609|NCT05293639|468569563|FG000|Overall Study|Withdrawal by Subject|1|||
130166610|NCT05293639|468569564|FG001|Overall Study|Withdrawal by Subject|1|||
130166611|NCT05293639|468569565|FG002|Overall Study|Withdrawal by Subject|2|||
130166612|NCT05293639|468569563|FG000|Overall Study|Death|0|||
130166613|NCT05293639|468569564|FG001|Overall Study|Death|1|||
130166614|NCT05293639|468569565|FG002|Overall Study|Death|0|||
130166615|NCT05293639|468569563|FG000|Overall Study|Lost to Follow-up|0|||
130166616|NCT05293639|468569564|FG001|Overall Study|Lost to Follow-up|0|||
130166617|NCT05293639|468569565|FG002|Overall Study|Lost to Follow-up|5|||
130166618|NCT05293639|468569563|FG000|Overall Study|Other|0|||
130166619|NCT05293639|468569564|FG001|Overall Study|Other|0|||
130166620|NCT05293639|468569565|FG002|Overall Study|Other|1|||
130166621|NCT03918109|468569578|FG000|Overall Study|Withdrawal by Subject|0|||
130166622|NCT03918109|468569579|FG001|Overall Study|Withdrawal by Subject|0|||
130166623|NCT03918109|468569580|FG002|Overall Study|Withdrawal by Subject|2|||
130166624|NCT03918109|468569581|FG003|Overall Study|Withdrawal by Subject|1|||
130166625|NCT03918109|468569578|FG000|Overall Study|Lost to Follow-up|0|||
130166626|NCT03918109|468569579|FG001|Overall Study|Lost to Follow-up|0|||
130166627|NCT03918109|468569580|FG002|Overall Study|Lost to Follow-up|0|||
130166628|NCT03918109|468569581|FG003|Overall Study|Lost to Follow-up|1|||
130166629|NCT00758680|468569582|FG000|Overall Study|Adverse Event|0|||
130166630|NCT00758680|468569583|FG001|Overall Study|Adverse Event|0|||
130166631|NCT00758680|468569584|FG002|Overall Study|Adverse Event|0|||
130166632|NCT00758680|468569585|FG003|Overall Study|Adverse Event|0|||
130166633|NCT00758680|468569586|FG004|Overall Study|Adverse Event|0|||
130166634|NCT00758680|468569587|FG005|Overall Study|Adverse Event|0|||
130166635|NCT00758680|468569588|FG006|Overall Study|Adverse Event|0|||
130166636|NCT00758680|468569589|FG007|Overall Study|Adverse Event|1|||
130166637|NCT00758680|468569590|FG008|Overall Study|Adverse Event|0|||
130166638|NCT00758680|468569591|FG009|Overall Study|Adverse Event|1|||
130166639|NCT00758680|468569582|FG000|Overall Study|Laboratory Adverse Event|0|||
130166640|NCT00758680|468569583|FG001|Overall Study|Laboratory Adverse Event|0|||
130166641|NCT00758680|468569584|FG002|Overall Study|Laboratory Adverse Event|0|||
130166642|NCT00758680|468569585|FG003|Overall Study|Laboratory Adverse Event|0|||
130166643|NCT00758680|468569586|FG004|Overall Study|Laboratory Adverse Event|0|||
130166644|NCT00758680|468569587|FG005|Overall Study|Laboratory Adverse Event|0|||
130166645|NCT00758680|468569588|FG006|Overall Study|Laboratory Adverse Event|0|||
130166646|NCT00758680|468569589|FG007|Overall Study|Laboratory Adverse Event|0|||
130166647|NCT00758680|468569590|FG008|Overall Study|Laboratory Adverse Event|1|||
130166648|NCT00758680|468569591|FG009|Overall Study|Laboratory Adverse Event|0|||
130166649|NCT00758680|468569582|FG000|Overall Study|Withdrawal by Subject|0|||
130166650|NCT00758680|468569583|FG001|Overall Study|Withdrawal by Subject|0|||
130166651|NCT00758680|468569584|FG002|Overall Study|Withdrawal by Subject|0|||
130166652|NCT00758680|468569585|FG003|Overall Study|Withdrawal by Subject|0|||
130166653|NCT00758680|468569586|FG004|Overall Study|Withdrawal by Subject|0|||
130166654|NCT00758680|468569587|FG005|Overall Study|Withdrawal by Subject|0|||
130166655|NCT00758680|468569588|FG006|Overall Study|Withdrawal by Subject|1|||
130166656|NCT00758680|468569589|FG007|Overall Study|Withdrawal by Subject|0|||
130166657|NCT00758680|468569590|FG008|Overall Study|Withdrawal by Subject|1|||
130166658|NCT00758680|468569591|FG009|Overall Study|Withdrawal by Subject|0|||
130166659|NCT00761865|468569592|FG000|Overall Study|Lost to Follow-up|8|||
130166660|NCT00761865|468569593|FG001|Overall Study|Lost to Follow-up|7|||
130166661|NCT00319982|468569594|FG000|Overall Study|Withdrawal by Subject|1|||
130166662|NCT00319982|468569595|FG001|Overall Study|Withdrawal by Subject|0|||
130166663|NCT01094886|468569598|FG000|Overall Study|Adverse Event|2|||
130166664|NCT01094886|468569598|FG000|Overall Study|Withdrawal by Subject|5|||
130166665|NCT03866902|468569600|FG000|Overall Study|Lost to Follow-up|98|||
130166666|NCT03866902|468569601|FG001|Overall Study|Lost to Follow-up|82|||
130166667|NCT03866902|468569600|FG000|Overall Study|Pregnancy|18|||
130166668|NCT03866902|468569601|FG001|Overall Study|Pregnancy|24|||
130166669|NCT04730349|468569604|FG000|Overall Study|Participant withdrew consent|1|||
130166670|NCT04730349|468569605|FG001|Overall Study|Participant withdrew consent|0|||
130166671|NCT04730349|468569604|FG000|Overall Study|Disease progression|6|||
130166672|NCT04730349|468569605|FG001|Overall Study|Disease progression|4|||
130166673|NCT04730349|468569604|FG000|Overall Study|Study drug toxicity|0|||
130166674|NCT04730349|468569605|FG001|Overall Study|Study drug toxicity|1|||
130166675|NCT00638027|468569606|FG000|Overall Study|Adverse Event|0|||
130166676|NCT00638027|468569607|FG001|Overall Study|Adverse Event|2|||
130166677|NCT00371397|468569609|FG000|Session 1|Withdrawal by Subject|1|||
130166678|NCT00371397|468569610|FG001|Session 1|Withdrawal by Subject|0|||
130166679|NCT00371397|468569611|FG002|Session 1|Withdrawal by Subject|0|||
130166680|NCT00371397|468569612|FG003|Session 1|Withdrawal by Subject|0|||
130166681|NCT00371397|468569613|FG004|Session 1|Withdrawal by Subject|0|||
130166682|NCT00371397|468569614|FG005|Session 1|Withdrawal by Subject|0|||
130166683|NCT00371397|468569615|FG006|Session 1|Withdrawal by Subject|0|||
130166684|NCT00371397|468569616|FG007|Session 1|Withdrawal by Subject|1|||
130166685|NCT00371397|468569617|FG008|Session 1|Withdrawal by Subject|0|||
130166686|NCT00371397|468569618|FG009|Session 1|Withdrawal by Subject|0|||
130166687|NCT00371397|468569619|FG010|Session 1|Withdrawal by Subject|0|||
130166688|NCT00371397|468569620|FG011|Session 1|Withdrawal by Subject|0|||
130166689|NCT03014180|468569621|FG000|Overall Study|Protocol Violation|2|||
130166690|NCT01284621|468569622|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130166691|NCT01284621|468569623|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130166692|NCT01284621|468569624|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130166693|NCT01284621|468569625|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130166694|NCT01284621|468569626|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
130166695|NCT01284621|468569627|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
130166696|NCT02802631|468569630|FG000|Overall Study|Withdrawal by Subject|1|||
130166697|NCT02802631|468569631|FG001|Overall Study|Withdrawal by Subject|0|||
130166698|NCT02802631|468569632|FG002|Overall Study|Withdrawal by Subject|0|||
130166699|NCT02802631|468569633|FG003|Overall Study|Withdrawal by Subject|0|||
130166700|NCT02802631|468569634|FG004|Overall Study|Withdrawal by Subject|0|||
130166701|NCT02802631|468569635|FG005|Overall Study|Withdrawal by Subject|0|||
130166702|NCT02802631|468569636|FG006|Overall Study|Withdrawal by Subject|0|||
130166703|NCT02802631|468569637|FG007|Overall Study|Withdrawal by Subject|0|||
130166704|NCT02802631|468569630|FG000|Overall Study|Physician Decision|1|||
130166705|NCT02802631|468569631|FG001|Overall Study|Physician Decision|0|||
130166706|NCT02802631|468569632|FG002|Overall Study|Physician Decision|0|||
130166707|NCT02802631|468569633|FG003|Overall Study|Physician Decision|0|||
130166708|NCT02802631|468569634|FG004|Overall Study|Physician Decision|0|||
130166709|NCT02802631|468569635|FG005|Overall Study|Physician Decision|0|||
130166710|NCT02802631|468569636|FG006|Overall Study|Physician Decision|1|||
130166711|NCT02802631|468569637|FG007|Overall Study|Physician Decision|0|||
130166712|NCT02802631|468569630|FG000|Overall Study|Adverse Event|0|||
130166713|NCT02802631|468569631|FG001|Overall Study|Adverse Event|2|||
130166714|NCT02802631|468569632|FG002|Overall Study|Adverse Event|0|||
130166715|NCT02802631|468569633|FG003|Overall Study|Adverse Event|1|||
130166716|NCT02802631|468569634|FG004|Overall Study|Adverse Event|6|||
130166717|NCT02802631|468569635|FG005|Overall Study|Adverse Event|1|||
130166718|NCT02802631|468569636|FG006|Overall Study|Adverse Event|4|||
130166719|NCT02802631|468569637|FG007|Overall Study|Adverse Event|0|||
130166720|NCT02802631|468569630|FG000|Overall Study|Sponsor Decision|0|||
130166721|NCT02802631|468569631|FG001|Overall Study|Sponsor Decision|0|||
130166722|NCT02802631|468569632|FG002|Overall Study|Sponsor Decision|6|||
130166723|NCT02802631|468569633|FG003|Overall Study|Sponsor Decision|0|||
130166724|NCT02802631|468569634|FG004|Overall Study|Sponsor Decision|2|||
130166725|NCT02802631|468569635|FG005|Overall Study|Sponsor Decision|0|||
130166726|NCT02802631|468569636|FG006|Overall Study|Sponsor Decision|0|||
130166727|NCT02802631|468569637|FG007|Overall Study|Sponsor Decision|4|||
130166728|NCT02377427|468569638|FG000|Part A (Up to Week 20)|Physician Decision|1|||
130166729|NCT02377427|468569639|FG001|Part A (Up to Week 20)|Physician Decision|0|||
130166730|NCT02377427|468569640|FG002|Part A (Up to Week 20)|Physician Decision|0|||
130166731|NCT02377427|468569641|FG003|Part A (Up to Week 20)|Physician Decision|0|||
130166732|NCT02377427|468569642|FG004|Part A (Up to Week 20)|Physician Decision|0|||
130166733|NCT02377427|468569638|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
130166734|NCT02377427|468569639|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130166735|NCT02377427|468569640|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130166736|NCT02377427|468569641|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130166737|NCT02377427|468569642|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
130166738|NCT02377427|468569638|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
130166739|NCT02377427|468569639|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130166740|NCT02377427|468569640|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130166741|NCT02377427|468569641|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130166742|NCT02377427|468569642|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
130166743|NCT02377427|468569638|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130166744|NCT02377427|468569639|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130166745|NCT02377427|468569640|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
130166746|NCT02377427|468569641|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130166747|NCT02377427|468569642|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
130166748|NCT02342639|468569643|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
130166749|NCT02342639|468569644|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
130166750|NCT02342639|468569643|FG000|Overall Study|Protocol Violation|0|||
130166751|NCT02342639|468569644|FG001|Overall Study|Protocol Violation|2|||
130166752|NCT02212379|468569645|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
130166753|NCT02212379|468569645|FG000|From Baseline to Week 48|Adverse Event|7|||
130166754|NCT02212379|468569645|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
130166755|NCT02212379|468569645|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
130166756|NCT02212379|468569645|FG000|From Week 48 to Week 96|Adverse Event|1|||
130166757|NCT02212379|468569645|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
130166758|NCT02105974|468569646|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
130166759|NCT02105974|468569647|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
130166760|NCT02105974|468569648|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
130166761|NCT02105974|468569646|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
130166762|NCT02105974|468569647|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
130166763|NCT02105974|468569648|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
130166764|NCT02105974|468569646|FG000|2 Week Run-in Period|Adverse Event|6|||
130166765|NCT02105974|468569647|FG001|2 Week Run-in Period|Adverse Event|0|||
130166766|NCT02105974|468569648|FG002|2 Week Run-in Period|Adverse Event|0|||
130166767|NCT02105974|468569646|FG000|2 Week Run-in Period|Study closed/terminated|1|||
130166768|NCT02105974|468569647|FG001|2 Week Run-in Period|Study closed/terminated|0|||
130166769|NCT02105974|468569648|FG002|2 Week Run-in Period|Study closed/terminated|0|||
130166770|NCT02105974|468569646|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
130166771|NCT02105974|468569647|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
130166772|NCT02105974|468569648|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
130166773|NCT02105974|468569646|FG000|2 Week Run-in Period|Withdrew consent|23|||
130166774|NCT02105974|468569647|FG001|2 Week Run-in Period|Withdrew consent|0|||
130166775|NCT02105974|468569648|FG002|2 Week Run-in Period|Withdrew consent|0|||
130166776|NCT02105974|468569646|FG000|2 Week Run-in Period|Investigator discretion|8|||
130166777|NCT02105974|468569647|FG001|2 Week Run-in Period|Investigator discretion|0|||
130166778|NCT02105974|468569648|FG002|2 Week Run-in Period|Investigator discretion|0|||
130166779|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
130166780|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
130166781|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
130166782|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
130166783|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
130166784|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
130166785|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
130166786|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
130166787|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
130166788|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
130166789|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
130166790|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
130166791|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
130166792|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
130166793|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
130166794|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
130166795|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
130166796|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
130166797|NCT02105974|468569646|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
130166798|NCT02105974|468569647|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
130166799|NCT02105974|468569648|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
130166800|NCT01177059|468569650|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
130166801|NCT01177059|468569650|FG000|Overall Study|Withdrew consent|2|||
130166802|NCT01177059|468569650|FG000|Overall Study|Lost to Follow-up|18|||
130166803|NCT02886624|468571077|FG000|12-week Post Treatment Follow-up|Death|1|||
130166804|NCT02886624|468571077|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
130166805|NCT03972163|468571078|FG000|Overall Study|Death|0|||
130166806|NCT03972163|468571079|FG001|Overall Study|Death|1|||
130166807|NCT01161407|468571082|FG000|Overall Study|Protocol Violation|3|||
130166808|NCT01161407|468571083|FG001|Overall Study|Protocol Violation|1|||
130166809|NCT00849186|468571091|FG000|Overall Study|Adverse Event|2|||
130166810|NCT00849186|468571091|FG000|Overall Study|Withdrawal by Subject|1|||
130166811|NCT00849186|468571091|FG000|Overall Study|not treated|6|||
130166812|NCT00849186|468571091|FG000|Overall Study|Other|1|||
130166813|NCT00492024|468571094|FG000|Treatment|Adverse Event|3|||
130166814|NCT00492024|468571095|FG001|Treatment|Adverse Event|1|||
130166815|NCT00492024|468571094|FG000|Treatment|Lack of Efficacy|21|||
130166816|NCT00492024|468571095|FG001|Treatment|Lack of Efficacy|20|||
130166817|NCT00492024|468571094|FG000|Treatment|Lost to Follow-up|3|||
130166818|NCT00492024|468571095|FG001|Treatment|Lost to Follow-up|1|||
130166819|NCT00492024|468571094|FG000|Treatment|Withdrawal by Subject|2|||
130166820|NCT00492024|468571095|FG001|Treatment|Withdrawal by Subject|0|||
130166821|NCT00492024|468571094|FG000|Follow up|Lack of Efficacy|0|||
130166822|NCT00492024|468571095|FG001|Follow up|Lack of Efficacy|1|||
130166823|NCT00492024|468571094|FG000|Follow up|Lost to Follow-up|1|||
130166824|NCT00492024|468571095|FG001|Follow up|Lost to Follow-up|1|||
130166825|NCT03247816|468571098|FG000|Overall Study|Adverse Event|12|||
130166826|NCT03247816|468571098|FG000|Overall Study|Physician Decision|3|||
130166827|NCT03247816|468571098|FG000|Overall Study|Lack of Efficacy|1|||
130166828|NCT03247816|468571098|FG000|Overall Study|Lost to Follow-up|10|||
130166829|NCT03247816|468571098|FG000|Overall Study|Missing Feraccru stop date|3|||
130166830|NCT03257865|468571099|FG000|Overall Study|Adverse Event|4|||
130166831|NCT03257865|468571100|FG001|Overall Study|Adverse Event|8|||
130166832|NCT03257865|468571099|FG000|Overall Study|Lack of Efficacy|1|||
130166833|NCT03257865|468571100|FG001|Overall Study|Lack of Efficacy|2|||
130166834|NCT03257865|468571099|FG000|Overall Study|Non-compliance with Study Drug|0|||
130166835|NCT03257865|468571100|FG001|Overall Study|Non-compliance with Study Drug|2|||
130166836|NCT03257865|468571099|FG000|Overall Study|Withdrawal by Subject|23|||
130166837|NCT03257865|468571100|FG001|Overall Study|Withdrawal by Subject|17|||
130166838|NCT03257865|468571099|FG000|Overall Study|Physician Decision|3|||
130166839|NCT03257865|468571100|FG001|Overall Study|Physician Decision|1|||
130166840|NCT03257865|468571099|FG000|Overall Study|Other|0|||
130166841|NCT03257865|468571100|FG001|Overall Study|Other|1|||
130166842|NCT03257865|468571099|FG000|Overall Study|Lost to Follow-up|4|||
130166843|NCT03257865|468571100|FG001|Overall Study|Lost to Follow-up|4|||
130166844|NCT04015908|468571101|FG000|Overall Study|Lost to Follow-up|0|||
130166845|NCT04015908|468571102|FG001|Overall Study|Lost to Follow-up|1|||
130166846|NCT04623086|468571103|FG000|Overall Study|Withdrawal by Subject|0|||
130166847|NCT04623086|468571104|FG001|Overall Study|Withdrawal by Subject|0|||
130166848|NCT04623086|468571105|FG002|Overall Study|Withdrawal by Subject|10|||
130166849|NCT02538965|468571106|FG000|Treatment Period|Other = Death due to disease progression|1|||
130166850|NCT02538965|468571106|FG000|Treatment Period|Adverse Event|2|||
130166851|NCT02538965|468571106|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
130166852|NCT02538965|468571106|FG000|Treatment Period|Treatment Failure|9|||
130166853|NCT02538965|468571106|FG000|Treatment Period|Disease Progression|1|||
130166854|NCT02538965|468571106|FG000|Treatment Period|Physician Decision|2|||
130166855|NCT02538965|468571106|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
130166856|NCT02538965|468571106|FG000|Follow-Up Period|Withdrawal by Parent|4|||
130166857|NCT04546724|468571115|FG000|Overall Study|Withdrawal by Subject|145|||
130166858|NCT04546724|468571116|FG001|Overall Study|Withdrawal by Subject|41|||
130166859|NCT04546724|468571115|FG000|Overall Study|Adverse Event|1|||
130166860|NCT04546724|468571116|FG001|Overall Study|Adverse Event|1|||
130166861|NCT04546724|468571115|FG000|Overall Study|Lost to Follow-up|186|||
130166862|NCT04546724|468571116|FG001|Overall Study|Lost to Follow-up|63|||
130166863|NCT04546724|468571115|FG000|Overall Study|Physician Decision|8|||
130166864|NCT04546724|468571116|FG001|Overall Study|Physician Decision|2|||
130166865|NCT04546724|468571115|FG000|Overall Study|Death|2|||
130166866|NCT04546724|468571116|FG001|Overall Study|Death|1|||
130166867|NCT04546724|468571115|FG000|Overall Study|subject has been out of town|1|||
130166868|NCT04546724|468571116|FG001|Overall Study|subject has been out of town|0|||
130166869|NCT04546724|468571115|FG000|Overall Study|subject is incarcerated|2|||
130166870|NCT04546724|468571116|FG001|Overall Study|subject is incarcerated|0|||
130166871|NCT04546724|468571115|FG000|Overall Study|subject is relocating|12|||
130166872|NCT04546724|468571116|FG001|Overall Study|subject is relocating|4|||
130166873|NCT04546724|468571115|FG000|Overall Study|Subject in another study|1|||
130166874|NCT04546724|468571116|FG001|Overall Study|Subject in another study|1|||
130166875|NCT01147107|468571122|FG000|Overall Study|Lack of Efficacy|5|||
130166876|NCT01147107|468571123|FG001|Overall Study|Lack of Efficacy|0|||
130166877|NCT01147107|468571122|FG000|Overall Study|Withdrawal by Subject|1|||
130166878|NCT01147107|468571123|FG001|Overall Study|Withdrawal by Subject|1|||
130166879|NCT03201965|468571126|FG000|Overall Study|Death|5|||
130166880|NCT03201965|468571127|FG001|Overall Study|Death|27|||
130166881|NCT03201965|468571128|FG002|Overall Study|Death|27|||
130166882|NCT03201965|468571126|FG000|Overall Study|Lost to Follow-up|0|||
130166883|NCT03201965|468571127|FG001|Overall Study|Lost to Follow-up|1|||
130166884|NCT03201965|468571128|FG002|Overall Study|Lost to Follow-up|0|||
130166885|NCT03201965|468571126|FG000|Overall Study|Withdrawal by Subject|3|||
130166886|NCT03201965|468571127|FG001|Overall Study|Withdrawal by Subject|13|||
130166887|NCT03201965|468571128|FG002|Overall Study|Withdrawal by Subject|4|||
130166888|NCT03201965|468571126|FG000|Overall Study|Ongoing|20|||
130166889|NCT03201965|468571127|FG001|Overall Study|Ongoing|152|||
130166890|NCT03201965|468571128|FG002|Overall Study|Ongoing|164|||
130166891|NCT02365558|468571129|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
130166892|NCT02365558|468571130|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
130166893|NCT02365558|468571129|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
130166894|NCT02365558|468571130|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
130166895|NCT00369317|468571131|FG000|Overall Study|Adverse Event|3|||
130166896|NCT00369317|468571131|FG000|Overall Study|Death|1|||
130166897|NCT00369317|468571131|FG000|Overall Study|Lack of Efficacy|5|||
130166898|NCT00369317|468571131|FG000|Overall Study|Physician Decision|2|||
130166899|NCT00369317|468571131|FG000|Overall Study|Withdrawal by Subject|8|||
130166900|NCT00369317|468571131|FG000|Overall Study|Ineligible|1|||
130166901|NCT02828241|468571140|FG000|Overall Study|Adverse Event|7|||
130166902|NCT02828241|468571141|FG001|Overall Study|Adverse Event|2|||
130166903|NCT02828241|468571140|FG000|Overall Study|Protocol Violation|1|||
130166904|NCT02828241|468571141|FG001|Overall Study|Protocol Violation|0|||
130166905|NCT03185013|468571146|FG000|Overall Study|Withdrawal by Subject|5|||
130166906|NCT03185013|468571147|FG001|Overall Study|Withdrawal by Subject|3|||
130166907|NCT03185013|468571146|FG000|Overall Study|Adverse Event|1|||
130166908|NCT03185013|468571147|FG001|Overall Study|Adverse Event|0|||
130166909|NCT03185013|468571146|FG000|Overall Study|Progressive Disease|1|||
130166910|NCT03185013|468571147|FG001|Overall Study|Progressive Disease|0|||
130166911|NCT03185013|468571146|FG000|Overall Study|Lost to Follow-up|8|||
130166912|NCT03185013|468571147|FG001|Overall Study|Lost to Follow-up|2|||
130166913|NCT03185013|468571146|FG000|Overall Study|Physician Decision|1|||
130166914|NCT03185013|468571147|FG001|Overall Study|Physician Decision|0|||
130166915|NCT03185013|468571146|FG000|Overall Study|Protocol Deviation|2|||
130166916|NCT03185013|468571147|FG001|Overall Study|Protocol Deviation|0|||
130166917|NCT03185013|468571146|FG000|Overall Study|Reason not Specified|3|||
130166918|NCT03185013|468571147|FG001|Overall Study|Reason not Specified|2|||
130166919|NCT03185013|468571146|FG000|Overall Study|Death|1|||
130166920|NCT03185013|468571147|FG001|Overall Study|Death|0|||
130166921|NCT00510289|468571151|FG000|Overall Study|Withdrawal by Subject|7|||
130166922|NCT00510289|468571151|FG000|Overall Study|Refused bone marrow biopsy|2|||
130166923|NCT00510289|468571151|FG000|Overall Study|Lost to Follow-up|1|||
130166924|NCT00510289|468571151|FG000|Overall Study|Progressed prior to starting drug|2|||
130166925|NCT00673387|468571154|FG000|Overall Study|Withdrawal by Subject|15|||
130166926|NCT00673387|468571155|FG001|Overall Study|Withdrawal by Subject|16|||
130166927|NCT00673387|468571156|FG002|Overall Study|Withdrawal by Subject|20|||
130166928|NCT00673387|468571157|FG003|Overall Study|Withdrawal by Subject|16|||
130166929|NCT00673387|468571158|FG004|Overall Study|Withdrawal by Subject|18|||
130166930|NCT00673387|468571159|FG005|Overall Study|Withdrawal by Subject|21|||
130166931|NCT00673387|468571160|FG006|Overall Study|Withdrawal by Subject|15|||
130166932|NCT00673387|468571161|FG007|Overall Study|Withdrawal by Subject|21|||
130166933|NCT00673387|468571154|FG000|Overall Study|Adverse Event|3|||
130166934|NCT00673387|468571155|FG001|Overall Study|Adverse Event|1|||
130166935|NCT00673387|468571156|FG002|Overall Study|Adverse Event|5|||
130166936|NCT00673387|468571157|FG003|Overall Study|Adverse Event|2|||
130166937|NCT00673387|468571158|FG004|Overall Study|Adverse Event|6|||
130166938|NCT00673387|468571159|FG005|Overall Study|Adverse Event|2|||
130166939|NCT00673387|468571160|FG006|Overall Study|Adverse Event|5|||
130166940|NCT00673387|468571161|FG007|Overall Study|Adverse Event|5|||
130166941|NCT00673387|468571154|FG000|Overall Study|Physician Decision|0|||
130166942|NCT00673387|468571155|FG001|Overall Study|Physician Decision|0|||
130166943|NCT00673387|468571156|FG002|Overall Study|Physician Decision|0|||
130166944|NCT00673387|468571157|FG003|Overall Study|Physician Decision|0|||
130166945|NCT00673387|468571158|FG004|Overall Study|Physician Decision|0|||
130166946|NCT00673387|468571159|FG005|Overall Study|Physician Decision|5|||
130166947|NCT00673387|468571160|FG006|Overall Study|Physician Decision|1|||
130166948|NCT00673387|468571161|FG007|Overall Study|Physician Decision|1|||
130166949|NCT00673387|468571154|FG000|Overall Study|Protocol Violation|3|||
130166950|NCT00673387|468571155|FG001|Overall Study|Protocol Violation|0|||
130166951|NCT00673387|468571156|FG002|Overall Study|Protocol Violation|1|||
130166952|NCT00673387|468571157|FG003|Overall Study|Protocol Violation|2|||
130166953|NCT00673387|468571158|FG004|Overall Study|Protocol Violation|0|||
130166954|NCT00673387|468571159|FG005|Overall Study|Protocol Violation|1|||
130166955|NCT00673387|468571160|FG006|Overall Study|Protocol Violation|1|||
130166956|NCT00673387|468571161|FG007|Overall Study|Protocol Violation|3|||
130166957|NCT00673387|468571154|FG000|Overall Study|Lost to Follow-up|8|||
130166958|NCT00673387|468571155|FG001|Overall Study|Lost to Follow-up|6|||
130166959|NCT00673387|468571156|FG002|Overall Study|Lost to Follow-up|5|||
130166960|NCT00673387|468571157|FG003|Overall Study|Lost to Follow-up|6|||
130166961|NCT00673387|468571158|FG004|Overall Study|Lost to Follow-up|6|||
130166962|NCT00673387|468571159|FG005|Overall Study|Lost to Follow-up|5|||
130166963|NCT00673387|468571160|FG006|Overall Study|Lost to Follow-up|8|||
130166964|NCT00673387|468571161|FG007|Overall Study|Lost to Follow-up|5|||
130166965|NCT00960115|468571164|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
130166966|NCT00960115|468571165|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
130166967|NCT00861198|468571166|FG000|Overall Study|SpyGlass Failed|5|||
130166968|NCT02011386|468571167|FG000|Overall Study|Non-compliance|2|||
130166969|NCT02011386|468571167|FG000|Overall Study|Lack of Efficacy|3|||
130166970|NCT01197755|468571168|FG000|Overall Study|Adverse Event|8|||
130166971|NCT01197755|468571169|FG001|Overall Study|Adverse Event|10|||
130166972|NCT01197755|468571170|FG002|Overall Study|Adverse Event|10|||
130166973|NCT01197755|468571168|FG000|Overall Study|Study-specific discontinuation criteria|2|||
130166974|NCT01197755|468571169|FG001|Overall Study|Study-specific discontinuation criteria|1|||
130166975|NCT01197755|468571170|FG002|Overall Study|Study-specific discontinuation criteria|0|||
130166976|NCT01197755|468571168|FG000|Overall Study|Entered the long-term extension study|18|||
130166977|NCT01197755|468571169|FG001|Overall Study|Entered the long-term extension study|21|||
130166978|NCT01197755|468571170|FG002|Overall Study|Entered the long-term extension study|35|||
130166979|NCT01197755|468571168|FG000|Overall Study|Lack of therapeutic response|0|||
130166980|NCT01197755|468571169|FG001|Overall Study|Lack of therapeutic response|7|||
130166981|NCT01197755|468571170|FG002|Overall Study|Lack of therapeutic response|4|||
130166982|NCT01197755|468571168|FG000|Overall Study|Severe non-compliance to the protocol|2|||
130166983|NCT01197755|468571169|FG001|Overall Study|Severe non-compliance to the protocol|1|||
130166984|NCT01197755|468571170|FG002|Overall Study|Severe non-compliance to the protocol|2|||
130166985|NCT01197755|468571168|FG000|Overall Study|Withdrawal by Subject|1|||
130166986|NCT01197755|468571169|FG001|Overall Study|Withdrawal by Subject|0|||
130166987|NCT01197755|468571170|FG002|Overall Study|Withdrawal by Subject|0|||
130166988|NCT01197755|468571168|FG000|Overall Study|Lost to Follow-up|0|||
130166989|NCT01197755|468571169|FG001|Overall Study|Lost to Follow-up|0|||
130166990|NCT01197755|468571170|FG002|Overall Study|Lost to Follow-up|1|||
130166991|NCT01197755|468571168|FG000|Overall Study|eg, change in circumstances|7|||
130166992|NCT01197755|468571169|FG001|Overall Study|eg, change in circumstances|3|||
130166993|NCT01197755|468571170|FG002|Overall Study|eg, change in circumstances|2|||
130166994|NCT03255655|468571171|FG000|Overall Study|Lost to Follow-up|7|||
130166995|NCT03255655|468571172|FG001|Overall Study|Lost to Follow-up|4|||
130166996|NCT04428333|468571175|FG000|Overall Study|Physician Decision|5|||
130166997|NCT04428333|468571176|FG001|Overall Study|Physician Decision|6|||
130166998|NCT04428333|468571175|FG000|Overall Study|Withdrawal by Subject|1|||
130166999|NCT04428333|468571176|FG001|Overall Study|Withdrawal by Subject|3|||
129981862|NCT01259089|467896754|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
129981863|NCT00886795|467896759|FG000|Overall Study|Lack of Efficacy|1|||
130167000|NCT04428333|468571175|FG000|Overall Study|Study Terminated By Sponsor|14|||
130167001|NCT04428333|468571176|FG001|Overall Study|Study Terminated By Sponsor|16|||
130167002|NCT03365011|468571177|FG000|Overall Study|Withdrawal by Subject|1|||
130167003|NCT03365011|468571178|FG001|Overall Study|Withdrawal by Subject|2|||
130167004|NCT04853992|468571179|FG000|Treatment Period A|Adverse Event|0|||
130167005|NCT04853992|468571180|FG001|Treatment Period A|Adverse Event|1|||
130167006|NCT04853992|468571179|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
130167007|NCT04853992|468571180|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
130167008|NCT03582826|468571181|FG000|Overall Study|Lost to Follow-up|39|||
130167009|NCT03582826|468571182|FG001|Overall Study|Lost to Follow-up|0|||
130167010|NCT03582826|468571181|FG000|Overall Study|Withdrawal by Subject|2|||
130167011|NCT03582826|468571182|FG001|Overall Study|Withdrawal by Subject|0|||
130167012|NCT00499174|468571183|FG000|Overall Study|Physician Decision|78|||
130167013|NCT00499174|468571184|FG001|Overall Study|Physician Decision|9|||
130167014|NCT02269163|468571185|FG000|Overall Study|Lost to Follow-up|1|||
130167015|NCT02269163|468571186|FG001|Overall Study|Lost to Follow-up|0|||
130167016|NCT02269163|468571185|FG000|Overall Study|Major protocol violation|0|||
130167017|NCT02269163|468571186|FG001|Overall Study|Major protocol violation|1|||
130167018|NCT02269163|468571185|FG000|Overall Study|Other|2|||
130167019|NCT02269163|468571186|FG001|Overall Study|Other|2|||
130167020|NCT02269163|468571185|FG000|Overall Study|Withdrawal by Subject|0|||
130167021|NCT02269163|468571186|FG001|Overall Study|Withdrawal by Subject|3|||
130167022|NCT02269163|468571185|FG000|Overall Study|Physician Decision|0|||
130167023|NCT02269163|468571186|FG001|Overall Study|Physician Decision|1|||
130167024|NCT02351960|468571189|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
130167025|NCT02351960|468571190|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
130167026|NCT02351960|468571189|FG000|Overall Study|Voluntary Withdrawal|5|||
130167027|NCT02351960|468571190|FG001|Overall Study|Voluntary Withdrawal|4|||
130167028|NCT02351960|468571189|FG000|Overall Study|Significant Protocol Deviation|0|||
130167029|NCT02351960|468571190|FG001|Overall Study|Significant Protocol Deviation|5|||
130167030|NCT03480386|468571191|FG000|Overall Study|Did not complete measures at 3-months|17|||
130167031|NCT03480386|468571192|FG001|Overall Study|Did not complete measures at 3-months|14|||
130167032|NCT03480386|468571191|FG000|Overall Study|No baseline measures|11|||
130167033|NCT03480386|468571192|FG001|Overall Study|No baseline measures|14|||
130167034|NCT03480386|468571191|FG000|Overall Study|Death|0|||
130167035|NCT03480386|468571192|FG001|Overall Study|Death|5|||
130167036|NCT03480386|468571191|FG000|Overall Study|Withdrawal by Subject|12|||
130167037|NCT03480386|468571192|FG001|Overall Study|Withdrawal by Subject|8|||
130167038|NCT03480386|468571191|FG000|Overall Study|Lost to Follow-up|2|||
130167039|NCT03480386|468571192|FG001|Overall Study|Lost to Follow-up|1|||
130167040|NCT03480386|468571191|FG000|Overall Study|Complicating disease|0|||
130167041|NCT03480386|468571192|FG001|Overall Study|Complicating disease|1|||
130167042|NCT03480386|468571191|FG000|Overall Study|Disease progression|3|||
130167043|NCT03480386|468571192|FG001|Overall Study|Disease progression|0|||
130167044|NCT03480386|468571191|FG000|Overall Study|Became ineligible|0|||
130167045|NCT03480386|468571192|FG001|Overall Study|Became ineligible|2|||
130167046|NCT02968849|468571198|FG000|Overall Study|Death|8|||
130167047|NCT02968849|468571199|FG001|Overall Study|Death|10|||
130167048|NCT02968849|468571198|FG000|Overall Study|Lost to Follow-up|31|||
130167049|NCT02968849|468571199|FG001|Overall Study|Lost to Follow-up|29|||
130167050|NCT02968849|468571198|FG000|Overall Study|Withdrawal by Subject|73|||
130167051|NCT02968849|468571199|FG001|Overall Study|Withdrawal by Subject|64|||
130167052|NCT02968849|468571198|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
130167053|NCT02968849|468571199|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
130167054|NCT02968849|468571198|FG000|Overall Study|Physician Decision|6|||
130167055|NCT02968849|468571199|FG001|Overall Study|Physician Decision|9|||
130167056|NCT02968849|468571198|FG000|Overall Study|Other|16|||
130167057|NCT02968849|468571199|FG001|Overall Study|Other|10|||
130167058|NCT02013674|468571202|FG000|Overall Study|Death|0|||
130167059|NCT02013674|468571203|FG001|Overall Study|Death|1|||
130167060|NCT02013674|468571202|FG000|Overall Study|Lost to Follow-up|1|||
130167061|NCT02013674|468571203|FG001|Overall Study|Lost to Follow-up|0|||
130167062|NCT00416884|468571204|FG000|Overall Study|Study terminated due to low accrual|1|||
130167063|NCT02203331|468571205|FG000|Overall Study|Pregnancy|1|||
130167064|NCT02203331|468571206|FG001|Overall Study|Pregnancy|0|||
130167065|NCT02203331|468571207|FG002|Overall Study|Pregnancy|0|||
130167066|NCT02203331|468571208|FG003|Overall Study|Pregnancy|0|||
130167067|NCT02203331|468571209|FG004|Overall Study|Pregnancy|2|||
130167068|NCT02203331|468571210|FG005|Overall Study|Pregnancy|0|||
130167069|NCT02203331|468571205|FG000|Overall Study|Withdrawal by Subject|1|||
130167070|NCT02203331|468571206|FG001|Overall Study|Withdrawal by Subject|0|||
130167071|NCT02203331|468571207|FG002|Overall Study|Withdrawal by Subject|1|||
130167072|NCT02203331|468571208|FG003|Overall Study|Withdrawal by Subject|0|||
130167073|NCT02203331|468571209|FG004|Overall Study|Withdrawal by Subject|0|||
130167074|NCT02203331|468571210|FG005|Overall Study|Withdrawal by Subject|3|||
130167075|NCT02203331|468571205|FG000|Overall Study|Adverse Event|4|||
130167076|NCT02203331|468571206|FG001|Overall Study|Adverse Event|8|||
130167077|NCT02203331|468571207|FG002|Overall Study|Adverse Event|3|||
130167078|NCT02203331|468571208|FG003|Overall Study|Adverse Event|4|||
130167079|NCT02203331|468571209|FG004|Overall Study|Adverse Event|3|||
129981864|NCT02310100|467896760|FG000|Overall Study|Physician Decision|3|||
130167080|NCT02203331|468571210|FG005|Overall Study|Adverse Event|3|||
130167081|NCT02203331|468571205|FG000|Overall Study|Other Reasons|1|||
130167082|NCT02203331|468571206|FG001|Overall Study|Other Reasons|2|||
130167083|NCT02203331|468571207|FG002|Overall Study|Other Reasons|0|||
130167084|NCT02203331|468571208|FG003|Overall Study|Other Reasons|2|||
130167085|NCT02203331|468571209|FG004|Overall Study|Other Reasons|0|||
130167086|NCT02203331|468571210|FG005|Overall Study|Other Reasons|0|||
129981865|NCT02310100|467896760|FG000|Overall Study|Withdrawal by Subject|10|||
130167087|NCT02203331|468571205|FG000|Overall Study|Lack of Efficacy|0|||
130167088|NCT02203331|468571206|FG001|Overall Study|Lack of Efficacy|2|||
130167089|NCT02203331|468571207|FG002|Overall Study|Lack of Efficacy|1|||
130167090|NCT02203331|468571208|FG003|Overall Study|Lack of Efficacy|0|||
130167091|NCT02203331|468571209|FG004|Overall Study|Lack of Efficacy|0|||
130167092|NCT02203331|468571210|FG005|Overall Study|Lack of Efficacy|1|||
130167093|NCT02203331|468571205|FG000|Overall Study|Protocol Violation|0|||
130167094|NCT02203331|468571206|FG001|Overall Study|Protocol Violation|2|||
130167095|NCT02203331|468571207|FG002|Overall Study|Protocol Violation|0|||
130167096|NCT02203331|468571208|FG003|Overall Study|Protocol Violation|1|||
130167097|NCT02203331|468571209|FG004|Overall Study|Protocol Violation|1|||
130167098|NCT02203331|468571210|FG005|Overall Study|Protocol Violation|0|||
130167099|NCT02203331|468571205|FG000|Overall Study|Lost to Follow-up|0|||
130167100|NCT02203331|468571206|FG001|Overall Study|Lost to Follow-up|0|||
130167101|NCT02203331|468571207|FG002|Overall Study|Lost to Follow-up|0|||
130167102|NCT02203331|468571208|FG003|Overall Study|Lost to Follow-up|0|||
130167103|NCT02203331|468571209|FG004|Overall Study|Lost to Follow-up|1|||
130167104|NCT02203331|468571210|FG005|Overall Study|Lost to Follow-up|0|||
130167105|NCT00704730|468571217|FG000|Overall Study|Adverse Event|35|||
130167106|NCT00704730|468571218|FG001|Overall Study|Adverse Event|9|||
130167107|NCT00704730|468571217|FG000|Overall Study|Death|11|||
130167108|NCT00704730|468571218|FG001|Overall Study|Death|5|||
130167109|NCT00704730|468571217|FG000|Overall Study|Physician Decision|2|||
130167110|NCT00704730|468571218|FG001|Overall Study|Physician Decision|0|||
130167111|NCT00704730|468571217|FG000|Overall Study|Did not receive drug|5|||
130167112|NCT00704730|468571218|FG001|Overall Study|Did not receive drug|2|||
130167113|NCT00704730|468571217|FG000|Overall Study|Disease progression per PI|58|||
130167114|NCT00704730|468571218|FG001|Overall Study|Disease progression per PI|67|||
130167115|NCT00704730|468571217|FG000|Overall Study|data unavailable|1|||
130167116|NCT00704730|468571218|FG001|Overall Study|data unavailable|0|||
130167117|NCT00704730|468571217|FG000|Overall Study|Withdrawal by Subject|9|||
130167118|NCT00704730|468571218|FG001|Overall Study|Withdrawal by Subject|13|||
130167119|NCT05065567|468571220|FG000|Overall Study|Lost to Follow-up|10|||
130167120|NCT05065567|468571221|FG001|Overall Study|Lost to Follow-up|9|||
130167121|NCT05065567|468571222|FG002|Overall Study|Lost to Follow-up|6|||
130167122|NCT02551666|468571223|FG000|Overall Study|Withdrawal by Subject|1|||
130167123|NCT02551666|468571224|FG001|Overall Study|Withdrawal by Subject|3|||
130167124|NCT04051619|468571225|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
130167125|NCT04051619|468571226|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
130167126|NCT04051619|468571225|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
130167127|NCT04051619|468571226|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
130167128|NCT03510598|468572603|FG000|Overall Study|Withdrawal by Subject|1|||
130167129|NCT05307510|468572607|FG000|Overall Study|Lost to Follow-up|3|||
130167130|NCT05307510|468572608|FG001|Overall Study|Lost to Follow-up|6|||
130167131|NCT05307510|468572607|FG000|Overall Study|Withdrawal by Subject|0|||
130167132|NCT05307510|468572608|FG001|Overall Study|Withdrawal by Subject|1|||
130167133|NCT03610516|468572611|FG000|Treatment Epoch|Adverse Event|3|||
130167134|NCT03610516|468572612|FG001|Treatment Epoch|Adverse Event|1|||
130167135|NCT03610516|468572611|FG000|Treatment Epoch|Death|1|||
130167136|NCT03610516|468572612|FG001|Treatment Epoch|Death|0|||
130167137|NCT03610516|468572611|FG000|Treatment Epoch|Lack of Efficacy|0|||
130167138|NCT03610516|468572612|FG001|Treatment Epoch|Lack of Efficacy|1|||
130167139|NCT03610516|468572611|FG000|Treatment Epoch|No longer requires treatment|1|||
130167140|NCT03610516|468572612|FG001|Treatment Epoch|No longer requires treatment|0|||
130167141|NCT03610516|468572611|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
130167142|NCT03610516|468572612|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
130167143|NCT03610516|468572611|FG000|Treatment Epoch|Physician Decision|8|||
130167144|NCT03610516|468572612|FG001|Treatment Epoch|Physician Decision|5|||
130167145|NCT03610516|468572611|FG000|Treatment Epoch|Protocol Deviation|1|||
130167146|NCT03610516|468572612|FG001|Treatment Epoch|Protocol Deviation|0|||
130167147|NCT03610516|468572611|FG000|Treatment Epoch|Withdrawal by Subject|3|||
130167148|NCT03610516|468572612|FG001|Treatment Epoch|Withdrawal by Subject|1|||
130167149|NCT03610516|468572611|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
130167150|NCT03610516|468572612|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
130167151|NCT03610516|468572611|FG000|Post-Treatment Follow-up|Death|1|||
130167152|NCT03610516|468572612|FG001|Post-Treatment Follow-up|Death|0|||
130167153|NCT01664130|468572617|FG000|Overall Study|competing secondary disease|2|||
130167154|NCT00554606|468572618|FG000|Overall Study|Adverse Event|3|||
130167155|NCT00554606|468572618|FG000|Overall Study|Abnormal laboratory values|1|||
130167156|NCT00554606|468572618|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
130167157|NCT00554606|468572618|FG000|Overall Study|Subject withdrew consent|2|||
130167158|NCT00554606|468572618|FG000|Overall Study|Lost to Follow-up|2|||
130167159|NCT00554606|468572618|FG000|Overall Study|Administrative problems|60|||
130167160|NCT00554606|468572618|FG000|Overall Study|Death|1|||
130167161|NCT00554606|468572618|FG000|Overall Study|Protocol deviation|2|||
130167162|NCT03323437|468572619|FG000|Overall Study|Withdrawal by Subject|0|||
130167163|NCT03323437|468572620|FG001|Overall Study|Withdrawal by Subject|4|||
130167164|NCT01305044|468572621|FG000|Overall Study|Withdrawal by Subject|3|||
130167165|NCT01305044|468572622|FG001|Overall Study|Withdrawal by Subject|6|||
130167166|NCT02677714|468572629|FG000|Overall Study|Withdrawal by Subject|2|||
130167167|NCT02677714|468572630|FG001|Overall Study|Withdrawal by Subject|0|||
130167168|NCT04628793|468572631|FG000|Overall Study|Study terminated by sponsor|0|||
130167169|NCT04628793|468572632|FG001|Overall Study|Study terminated by sponsor|0|||
130167170|NCT04628793|468572633|FG002|Overall Study|Study terminated by sponsor|8|||
130167171|NCT04628793|468572631|FG000|Overall Study|Withdrawal by Subject|2|||
130167172|NCT04628793|468572632|FG001|Overall Study|Withdrawal by Subject|3|||
130167173|NCT04628793|468572633|FG002|Overall Study|Withdrawal by Subject|0|||
130167174|NCT04628793|468572631|FG000|Overall Study|Lost to Follow-up|0|||
130167175|NCT04628793|468572632|FG001|Overall Study|Lost to Follow-up|1|||
130167176|NCT04628793|468572633|FG002|Overall Study|Lost to Follow-up|0|||
130167177|NCT01422187|468572636|FG000|Overall Study|Personal reason|1|||
130167178|NCT01422187|468572637|FG001|Overall Study|Personal reason|0|||
130167179|NCT01422187|468572638|FG002|Overall Study|Personal reason|0|||
130167180|NCT01422187|468572636|FG000|Overall Study|Lost to Follow-up|0|||
130167181|NCT01422187|468572637|FG001|Overall Study|Lost to Follow-up|1|||
130167182|NCT01422187|468572638|FG002|Overall Study|Lost to Follow-up|0|||
130167183|NCT02227446|468572639|FG000|Overall Study|not eligible post randomization|18|||
130167184|NCT02227446|468572640|FG001|Overall Study|not eligible post randomization|29|||
130167185|NCT02227446|468572639|FG000|Overall Study|Withdrawal by Subject|4|||
130167186|NCT02227446|468572640|FG001|Overall Study|Withdrawal by Subject|5|||
130167187|NCT00875797|468572641|FG000|Overall Study|Protocol Violation|6|||
130167188|NCT00875797|468572642|FG001|Overall Study|Protocol Violation|3|||
130167189|NCT00715624|468572643|FG000|Overall Study|Adverse Event|12|||
130167190|NCT00715624|468572644|FG001|Overall Study|Adverse Event|37|||
130167191|NCT00715624|468572643|FG000|Overall Study|Lack of Efficacy|11|||
130167192|NCT00715624|468572644|FG001|Overall Study|Lack of Efficacy|11|||
130167193|NCT00715624|468572643|FG000|Overall Study|Lost to Follow-up|1|||
130167194|NCT00715624|468572644|FG001|Overall Study|Lost to Follow-up|2|||
130167195|NCT00715624|468572643|FG000|Overall Study|Protocol Violation|1|||
130167196|NCT00715624|468572644|FG001|Overall Study|Protocol Violation|0|||
130167197|NCT00715624|468572643|FG000|Overall Study|Withdrawal by Subject|11|||
130167198|NCT00715624|468572644|FG001|Overall Study|Withdrawal by Subject|25|||
130167199|NCT00715624|468572643|FG000|Overall Study|Familial and personal reasons|10|||
130167200|NCT00715624|468572644|FG001|Overall Study|Familial and personal reasons|22|||
130167201|NCT00715624|468572643|FG000|Overall Study|Poor compliance|6|||
130167202|NCT00715624|468572644|FG001|Overall Study|Poor compliance|13|||
130167203|NCT00715624|468572643|FG000|Overall Study|Sponsor decision|0|||
130167204|NCT00715624|468572644|FG001|Overall Study|Sponsor decision|4|||
130167205|NCT00715624|468572643|FG000|Overall Study|Incorrect randomization (not treated)|0|||
130167206|NCT00715624|468572644|FG001|Overall Study|Incorrect randomization (not treated)|1|||
130167207|NCT00715624|468572643|FG000|Overall Study|Other|0|||
130167208|NCT00715624|468572644|FG001|Overall Study|Other|1|||
130167209|NCT03200912|468572645|FG000|Overall Study|Adverse Event|3|||
130167210|NCT03200912|468572646|FG001|Overall Study|Adverse Event|0|||
130167211|NCT03200912|468572647|FG002|Overall Study|Adverse Event|0|||
130167212|NCT03200912|468572645|FG000|Overall Study|Withdrawal by Subject|1|||
130167213|NCT03200912|468572646|FG001|Overall Study|Withdrawal by Subject|2|||
130167214|NCT03200912|468572647|FG002|Overall Study|Withdrawal by Subject|4|||
130167215|NCT03200912|468572645|FG000|Overall Study|Non-compliance with study drug|0|||
130167216|NCT03200912|468572646|FG001|Overall Study|Non-compliance with study drug|1|||
130167217|NCT03200912|468572647|FG002|Overall Study|Non-compliance with study drug|0|||
130167218|NCT02309138|468572648|FG000|Overall Study|Withdrawal by Subject|44|||
130167219|NCT02309138|468572649|FG001|Overall Study|Withdrawal by Subject|15|||
130167220|NCT02309138|468572648|FG000|Overall Study|Protocol Violation|4|||
130167221|NCT02309138|468572649|FG001|Overall Study|Protocol Violation|2|||
130167222|NCT02309138|468572648|FG000|Overall Study|delivered before visit 2|0|||
129981866|NCT02310100|467896760|FG000|Overall Study|Enrollment closure|1|||
129981867|NCT02310100|467896760|FG000|Overall Study|Unapproved ablation operator|1|||
129981868|NCT02310100|467896760|FG000|Overall Study|Visit compliance|1|||
129981869|NCT02310100|467896760|FG000|Overall Study|Lost to Follow-up|2|||
129981870|NCT00688870|467896763|FG000|Infant Series|Parent or legal guardian request|4|||
129981871|NCT00688870|467896764|FG001|Infant Series|Parent or legal guardian request|0|||
129981872|NCT01253018|467896775|FG000|Overall Study|Lost to Follow-up|1|||
130167223|NCT02309138|468572649|FG001|Overall Study|delivered before visit 2|1|||
130167224|NCT03421730|468572658|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167225|NCT03421730|468572659|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
130167226|NCT03421730|468572660|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167227|NCT03421730|468572661|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167228|NCT03421730|468572662|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167229|NCT03421730|468572663|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167230|NCT03421730|468572664|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167231|NCT03421730|468572665|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167232|NCT03421730|468572666|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167233|NCT03421730|468572667|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167234|NCT03421730|468572668|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167235|NCT03421730|468572669|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
130167236|NCT03421730|468572658|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167237|NCT03421730|468572659|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167238|NCT03421730|468572660|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167239|NCT03421730|468572661|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167240|NCT03421730|468572662|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
130167241|NCT03421730|468572663|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167242|NCT03421730|468572664|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167243|NCT03421730|468572665|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167244|NCT03421730|468572666|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167245|NCT03421730|468572667|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167246|NCT03421730|468572668|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167247|NCT03421730|468572669|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
130167248|NCT02901548|468572674|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
130167249|NCT01955083|468572675|FG000|Overall Study|Lost to Follow-up|1|||
130167250|NCT01955083|468572676|FG001|Overall Study|Lost to Follow-up|1|||
130167251|NCT02871492|468572677|FG000|Overall Study|Lost to Follow-up|6|||
130167252|NCT02871492|468572678|FG001|Overall Study|Lost to Follow-up|3|||
130167253|NCT02871492|468572679|FG002|Overall Study|Lost to Follow-up|5|||
130167254|NCT02871492|468572677|FG000|Overall Study|Withdrawal by Subject|0|||
130167255|NCT02871492|468572678|FG001|Overall Study|Withdrawal by Subject|0|||
130167256|NCT02871492|468572679|FG002|Overall Study|Withdrawal by Subject|1|||
130167257|NCT02256436|468572680|FG000|Overall Study|Adverse Event|9|||
130167258|NCT02256436|468572681|FG001|Overall Study|Adverse Event|14|||
130167259|NCT02256436|468572680|FG000|Overall Study|Death|216|||
130167260|NCT02256436|468572681|FG001|Overall Study|Death|208|||
130167261|NCT02256436|468572680|FG000|Overall Study|Lost to Follow-up|1|||
130167262|NCT02256436|468572681|FG001|Overall Study|Lost to Follow-up|2|||
130167263|NCT02256436|468572680|FG000|Overall Study|Physician Decision|1|||
130167264|NCT02256436|468572681|FG001|Overall Study|Physician Decision|0|||
130167265|NCT02256436|468572680|FG000|Overall Study|Protocol Violation|0|||
130167266|NCT02256436|468572681|FG001|Overall Study|Protocol Violation|1|||
130167267|NCT02256436|468572680|FG000|Overall Study|Withdrawal by Subject|26|||
130167268|NCT02256436|468572681|FG001|Overall Study|Withdrawal by Subject|10|||
130167269|NCT02256436|468572680|FG000|Overall Study|Transferred to Extension Study|11|||
130167270|NCT02256436|468572681|FG001|Overall Study|Transferred to Extension Study|23|||
130167271|NCT02256436|468572680|FG000|Overall Study|Did Not Continue on Extension Study|8|||
130167272|NCT02256436|468572681|FG001|Overall Study|Did Not Continue on Extension Study|12|||
130167273|NCT03583086|468572682|FG000|Overall Study|Death|2|||
130167274|NCT03583086|468572683|FG001|Overall Study|Death|6|||
130167275|NCT03583086|468572684|FG002|Overall Study|Death|12|||
130167276|NCT03583086|468572685|FG003|Overall Study|Death|10|||
130167277|NCT03583086|468572686|FG004|Overall Study|Death|14|||
130167278|NCT03583086|468572687|FG005|Overall Study|Death|14|||
130167279|NCT03583086|468572688|FG006|Overall Study|Death|4|||
130167280|NCT03583086|468572682|FG000|Overall Study|Withdrawal by Subject|0|||
130167281|NCT03583086|468572683|FG001|Overall Study|Withdrawal by Subject|0|||
130167282|NCT03583086|468572684|FG002|Overall Study|Withdrawal by Subject|1|||
130167283|NCT03583086|468572685|FG003|Overall Study|Withdrawal by Subject|0|||
130167284|NCT03583086|468572686|FG004|Overall Study|Withdrawal by Subject|0|||
130167285|NCT03583086|468572687|FG005|Overall Study|Withdrawal by Subject|0|||
130167286|NCT03583086|468572688|FG006|Overall Study|Withdrawal by Subject|1|||
130167287|NCT03583086|468572682|FG000|Overall Study|Refused follow-up|0|||
129981873|NCT01253018|467896776|FG001|Overall Study|Lost to Follow-up|1|||
129981874|NCT01253018|467896775|FG000|Overall Study|Robot Repair Issues|2|||
129981875|NCT01253018|467896776|FG001|Overall Study|Robot Repair Issues|0|||
129981876|NCT01253018|467896775|FG000|Overall Study|Withdrawal by Subject|1|||
129981877|NCT01253018|467896776|FG001|Overall Study|Withdrawal by Subject|1|||
129981878|NCT03449901|467896777|FG000|Overall Study|Progression|57|||
129981879|NCT03449901|467896778|FG001|Overall Study|Progression|12|||
129981880|NCT03449901|467896777|FG000|Overall Study|Adverse Event|3|||
130167288|NCT03583086|468572683|FG001|Overall Study|Refused follow-up|0|||
130167289|NCT03583086|468572684|FG002|Overall Study|Refused follow-up|1|||
130167290|NCT03583086|468572685|FG003|Overall Study|Refused follow-up|0|||
130167291|NCT03583086|468572686|FG004|Overall Study|Refused follow-up|1|||
130167292|NCT03583086|468572687|FG005|Overall Study|Refused follow-up|0|||
130167293|NCT03583086|468572688|FG006|Overall Study|Refused follow-up|0|||
130167294|NCT03583086|468572682|FG000|Overall Study|Declining Performance Status|0|||
130167295|NCT03583086|468572683|FG001|Overall Study|Declining Performance Status|0|||
129981881|NCT03449901|467896778|FG001|Overall Study|Adverse Event|0|||
130167296|NCT03583086|468572684|FG002|Overall Study|Declining Performance Status|1|||
129981882|NCT03449901|467896777|FG000|Overall Study|Death|6|||
130167297|NCT03583086|468572685|FG003|Overall Study|Declining Performance Status|0|||
130167298|NCT03583086|468572686|FG004|Overall Study|Declining Performance Status|0|||
130167299|NCT03583086|468572687|FG005|Overall Study|Declining Performance Status|0|||
130167300|NCT03583086|468572688|FG006|Overall Study|Declining Performance Status|0|||
130167301|NCT03583086|468572682|FG000|Overall Study|Still on study|0|||
130167302|NCT03583086|468572683|FG001|Overall Study|Still on study|0|||
130167303|NCT03583086|468572684|FG002|Overall Study|Still on study|0|||
130167304|NCT03583086|468572685|FG003|Overall Study|Still on study|1|||
130167305|NCT03583086|468572686|FG004|Overall Study|Still on study|0|||
130167306|NCT03583086|468572687|FG005|Overall Study|Still on study|0|||
130167307|NCT03583086|468572688|FG006|Overall Study|Still on study|1|||
130167308|NCT03583086|468572682|FG000|Overall Study|Disease progression|0|||
130167309|NCT03583086|468572683|FG001|Overall Study|Disease progression|0|||
130167310|NCT03583086|468572684|FG002|Overall Study|Disease progression|0|||
130167311|NCT03583086|468572685|FG003|Overall Study|Disease progression|0|||
130167312|NCT03583086|468572686|FG004|Overall Study|Disease progression|0|||
130167313|NCT03583086|468572687|FG005|Overall Study|Disease progression|0|||
130167314|NCT03583086|468572688|FG006|Overall Study|Disease progression|1|||
130167315|NCT03583086|468572682|FG000|Overall Study|Undergoing radiation therapy|0|||
130167316|NCT03583086|468572683|FG001|Overall Study|Undergoing radiation therapy|0|||
130167317|NCT03583086|468572684|FG002|Overall Study|Undergoing radiation therapy|0|||
130167318|NCT03583086|468572685|FG003|Overall Study|Undergoing radiation therapy|0|||
130167319|NCT03583086|468572686|FG004|Overall Study|Undergoing radiation therapy|0|||
130167320|NCT03583086|468572687|FG005|Overall Study|Undergoing radiation therapy|0|||
130167321|NCT03583086|468572688|FG006|Overall Study|Undergoing radiation therapy|1|||
130167322|NCT03583086|468572682|FG000|Overall Study|Lost to Follow-up|0|||
130167323|NCT03583086|468572683|FG001|Overall Study|Lost to Follow-up|0|||
130167324|NCT03583086|468572684|FG002|Overall Study|Lost to Follow-up|0|||
130167325|NCT03583086|468572685|FG003|Overall Study|Lost to Follow-up|0|||
130167326|NCT03583086|468572686|FG004|Overall Study|Lost to Follow-up|0|||
130167327|NCT03583086|468572687|FG005|Overall Study|Lost to Follow-up|1|||
130167328|NCT03583086|468572688|FG006|Overall Study|Lost to Follow-up|0|||
130167329|NCT03583086|468572682|FG000|Overall Study|Adverse Event|0|||
130167330|NCT03583086|468572683|FG001|Overall Study|Adverse Event|0|||
130167331|NCT03583086|468572684|FG002|Overall Study|Adverse Event|0|||
130167332|NCT03583086|468572685|FG003|Overall Study|Adverse Event|0|||
130167333|NCT03583086|468572686|FG004|Overall Study|Adverse Event|0|||
130167334|NCT03583086|468572687|FG005|Overall Study|Adverse Event|1|||
130167335|NCT03583086|468572688|FG006|Overall Study|Adverse Event|0|||
130167336|NCT01696279|468572689|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
130167337|NCT01696279|468572690|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130167338|NCT01696279|468572691|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130167339|NCT01696279|468572692|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
130167340|NCT01696279|468572689|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
130167341|NCT01696279|468572690|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
130167342|NCT01696279|468572691|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
130167343|NCT01696279|468572692|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
130167344|NCT01696279|468572689|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130167345|NCT01696279|468572690|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
130167346|NCT01696279|468572691|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130167347|NCT01696279|468572692|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
130167348|NCT01696279|468572689|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130167349|NCT01696279|468572690|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
130167350|NCT01696279|468572691|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130167351|NCT01696279|468572692|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
130167352|NCT01696279|468572689|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130167353|NCT01696279|468572690|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
130167354|NCT01696279|468572691|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
130167355|NCT01696279|468572692|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129981883|NCT03449901|467896778|FG001|Overall Study|Death|2|||
129981884|NCT03449901|467896777|FG000|Overall Study|Withdrawal by Subject|12|||
130167356|NCT01696279|468572689|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130167357|NCT01696279|468572690|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
130167358|NCT01696279|468572691|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130167359|NCT01696279|468572692|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
130167360|NCT01696279|468572689|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130167361|NCT01696279|468572690|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
130167362|NCT01696279|468572691|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130167363|NCT01696279|468572692|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
130167364|NCT01696279|468572689|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130167365|NCT01696279|468572690|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130167366|NCT01696279|468572691|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
130167367|NCT01696279|468572692|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
130167368|NCT01696279|468572689|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130167369|NCT01696279|468572690|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130167370|NCT01696279|468572691|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
130167371|NCT01696279|468572692|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
130167372|NCT01696279|468572689|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130167373|NCT01696279|468572690|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130167374|NCT01696279|468572691|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
130167375|NCT01696279|468572692|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
130167376|NCT01696279|468572689|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130167377|NCT01696279|468572690|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130167378|NCT01696279|468572691|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
130167379|NCT01696279|468572692|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
130167380|NCT01441947|468572695|FG000|Overall Study|Withdrawal by Subject|3|||
130167381|NCT01441947|468572696|FG001|Overall Study|Withdrawal by Subject|0|||
130167382|NCT04106661|468572700|FG000|Overall Study|Protocol Violation|3|||
130167383|NCT04106661|468572701|FG001|Overall Study|Protocol Violation|0|||
130167384|NCT04106661|468572700|FG000|Overall Study|Scheduling difficulties|1|||
130167385|NCT04106661|468572701|FG001|Overall Study|Scheduling difficulties|1|||
130167386|NCT00468650|468572703|FG000|Overall Study|Lost to Follow-up|4|||
130167387|NCT00468650|468572703|FG000|Overall Study|Withdrawal by Subject|2|||
130167388|NCT00468650|468572703|FG000|Overall Study|Protocol Violation|1|||
130167389|NCT02639052|468572704|FG000|Overall Study|Lost to Follow-up|1|||
130167390|NCT02730351|468572706|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
130167391|NCT02730351|468572707|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
130167392|NCT02730351|468572706|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
130167393|NCT02730351|468572707|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
130167394|NCT02730351|468572706|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
130167395|NCT02730351|468572707|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
130167396|NCT02730351|468572706|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
130167397|NCT02730351|468572707|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
130167398|NCT02730351|468572706|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
130167399|NCT02730351|468572707|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
130167400|NCT00128830|468572708|FG000|Overall Study|Adverse Event|10|||
130167401|NCT00128830|468572708|FG000|Overall Study|Withdrawal by Subject|14|||
130167402|NCT00128830|468572708|FG000|Overall Study|Lost to Follow-up|4|||
130167403|NCT00128830|468572708|FG000|Overall Study|Reached a virologic endpoint|29|||
130167404|NCT00128830|468572708|FG000|Overall Study|Non-compliant|4|||
130167405|NCT00128830|468572708|FG000|Overall Study|Discontinued or ineligible for study|2|||
130167406|NCT00128830|468572708|FG000|Overall Study|Other|9|||
130167407|NCT00838435|468572709|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
130167408|NCT00838435|468572709|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
130167409|NCT00838435|468572709|FG000|Part 2 (7 Years)|Adverse Event|2|||
130167410|NCT00838435|468572709|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
130167411|NCT00838435|468572709|FG000|Part 2 (7 Years)|Physician Decision|1|||
130167412|NCT00838435|468572709|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
130167413|NCT00838435|468572709|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
130167414|NCT03796039|468572711|FG000|Overall Study|Death|2|||
130167415|NCT03796039|468572712|FG001|Overall Study|Death|1|||
130167416|NCT03796039|468572711|FG000|Overall Study|Withdrawal by Subject|7|||
130167417|NCT03796039|468572712|FG001|Overall Study|Withdrawal by Subject|4|||
130167418|NCT02927366|468572713|FG000|Overall Study|Adverse Event|1|||
130167419|NCT02927366|468572714|FG001|Overall Study|Adverse Event|0|||
130167420|NCT02927366|468572713|FG000|Overall Study|Patient schedule|1|||
130167421|NCT02927366|468572714|FG001|Overall Study|Patient schedule|0|||
130167422|NCT00587990|468572719|FG000|Overall Study|Death|0|||
130167423|NCT00587990|468572720|FG001|Overall Study|Death|0|||
130167424|NCT00587990|468572721|FG002|Overall Study|Death|1|||
130167425|NCT02754856|468572722|FG000|Overall Study|Withdrawal by Subject|1|||
130167426|NCT00530218|468572723|FG000|Overall Study|CMV Not Detected|13|||
130167427|NCT00530218|468572723|FG000|Overall Study|Death|12|||
130167428|NCT03477903|468572724|FG000|Overall Study|Study Terminated by Sponsor|1|||
130167429|NCT00426361|468572725|FG000|Overall Study|Lost to Follow-up|3|||
130167430|NCT00426361|468572726|FG001|Overall Study|Lost to Follow-up|2|||
130167431|NCT00426361|468572727|FG002|Overall Study|Lost to Follow-up|5|||
130167432|NCT00426361|468572725|FG000|Overall Study|Withdrawal by Subject|1|||
130167433|NCT00426361|468572726|FG001|Overall Study|Withdrawal by Subject|3|||
130167434|NCT00426361|468572727|FG002|Overall Study|Withdrawal by Subject|0|||
130167435|NCT02478320|468572728|FG000|Overall Study|Adverse Event|2|||
130167436|NCT02478320|468572729|FG001|Overall Study|Adverse Event|0|||
130167437|NCT02478320|468572728|FG000|Overall Study|Death|1|||
130167438|NCT02478320|468572729|FG001|Overall Study|Death|0|||
130167439|NCT02478320|468572728|FG000|Overall Study|Lack of Efficacy|4|||
130167440|NCT02478320|468572729|FG001|Overall Study|Lack of Efficacy|0|||
130167441|NCT02478320|468572728|FG000|Overall Study|Withdrawal by Subject|2|||
130167442|NCT02478320|468572729|FG001|Overall Study|Withdrawal by Subject|0|||
130167443|NCT02478320|468572728|FG000|Overall Study|Screen Failure|3|||
130167444|NCT02478320|468572729|FG001|Overall Study|Screen Failure|0|||
130167445|NCT00574912|468572730|FG000|Overall Study|Could not place IV lines.|3|||
130167446|NCT00574912|468572730|FG000|Overall Study|scheduling conflicts|3|||
130167447|NCT00574912|468572730|FG000|Overall Study|Physician Decision|2|||
130167448|NCT02099682|468572733|FG000|Overall Study|Data Not Available|51|||
130167449|NCT02099682|468572733|FG000|Overall Study|Lost to Follow-up|31|||
130167450|NCT02099682|468572733|FG000|Overall Study|Other|29|||
130167451|NCT00805467|468574971|FG000|Overall Study|Lack of Efficacy|0|||
130167452|NCT00805467|468574972|FG001|Overall Study|Lack of Efficacy|8|||
130167453|NCT00805467|468574973|FG002|Overall Study|Lack of Efficacy|13|||
130167454|NCT00805467|468574974|FG003|Overall Study|Lack of Efficacy|86|||
130167455|NCT00805467|468574971|FG000|Overall Study|Lost to Follow-up|0|||
130167456|NCT00805467|468574972|FG001|Overall Study|Lost to Follow-up|1|||
130167457|NCT00805467|468574973|FG002|Overall Study|Lost to Follow-up|7|||
130167458|NCT00805467|468574974|FG003|Overall Study|Lost to Follow-up|21|||
130167459|NCT00805467|468574971|FG000|Overall Study|Withdrawal by Subject|0|||
130167460|NCT00805467|468574972|FG001|Overall Study|Withdrawal by Subject|6|||
130167461|NCT00805467|468574973|FG002|Overall Study|Withdrawal by Subject|45|||
130167462|NCT00805467|468574974|FG003|Overall Study|Withdrawal by Subject|50|||
130167463|NCT00805467|468574971|FG000|Overall Study|Protocol Violation|0|||
130167464|NCT00805467|468574972|FG001|Overall Study|Protocol Violation|3|||
130167465|NCT00805467|468574973|FG002|Overall Study|Protocol Violation|0|||
130167466|NCT00805467|468574974|FG003|Overall Study|Protocol Violation|5|||
130167467|NCT00805467|468574971|FG000|Overall Study|Adverse Event|0|||
130167468|NCT00805467|468574972|FG001|Overall Study|Adverse Event|13|||
130167469|NCT00805467|468574973|FG002|Overall Study|Adverse Event|26|||
130167470|NCT00805467|468574974|FG003|Overall Study|Adverse Event|57|||
130167471|NCT00805467|468574971|FG000|Overall Study|Death|0|||
130167472|NCT00805467|468574972|FG001|Overall Study|Death|2|||
130167473|NCT00805467|468574973|FG002|Overall Study|Death|7|||
130167474|NCT00805467|468574974|FG003|Overall Study|Death|5|||
130167475|NCT00805467|468574971|FG000|Overall Study|Physician Decision|0|||
130167476|NCT00805467|468574972|FG001|Overall Study|Physician Decision|1|||
130167477|NCT00805467|468574973|FG002|Overall Study|Physician Decision|2|||
130167478|NCT00805467|468574974|FG003|Overall Study|Physician Decision|6|||
130167479|NCT00805467|468574971|FG000|Overall Study|Not reported|0|||
130167480|NCT00805467|468574972|FG001|Overall Study|Not reported|0|||
130167481|NCT00805467|468574973|FG002|Overall Study|Not reported|3|||
130167482|NCT00805467|468574974|FG003|Overall Study|Not reported|7|||
130167483|NCT00213135|468574975|FG000|Overall Study|Adverse Event|9|||
130167484|NCT00213135|468574976|FG001|Overall Study|Adverse Event|5|||
130167485|NCT00213135|468574977|FG002|Overall Study|Adverse Event|5|||
130167486|NCT00213135|468574975|FG000|Overall Study|Lost to Follow-up|11|||
130167487|NCT00213135|468574976|FG001|Overall Study|Lost to Follow-up|8|||
130167488|NCT00213135|468574977|FG002|Overall Study|Lost to Follow-up|4|||
130167489|NCT00213135|468574975|FG000|Overall Study|Protocol Violation|4|||
130167490|NCT00213135|468574976|FG001|Overall Study|Protocol Violation|4|||
130167491|NCT00213135|468574977|FG002|Overall Study|Protocol Violation|10|||
130167492|NCT00213135|468574975|FG000|Overall Study|Death|1|||
130167493|NCT00213135|468574976|FG001|Overall Study|Death|1|||
130167494|NCT00213135|468574977|FG002|Overall Study|Death|2|||
130167495|NCT00213135|468574975|FG000|Overall Study|Disease progression|4|||
130167496|NCT00213135|468574976|FG001|Overall Study|Disease progression|5|||
130167497|NCT00213135|468574977|FG002|Overall Study|Disease progression|21|||
130167498|NCT00213135|468574975|FG000|Overall Study|Other|21|||
130167499|NCT00213135|468574976|FG001|Overall Study|Other|12|||
130167500|NCT00213135|468574977|FG002|Overall Study|Other|15|||
130167501|NCT00660907|468574981|FG000|Overall Study|Incorrect Enrollment|1|||
130167502|NCT00660907|468574982|FG001|Overall Study|Incorrect Enrollment|1|||
130167503|NCT00660907|468574981|FG000|Overall Study|Adverse Event|33|||
130167504|NCT00660907|468574982|FG001|Overall Study|Adverse Event|19|||
130167505|NCT00660907|468574981|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
130167506|NCT00660907|468574982|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
130167507|NCT00660907|468574981|FG000|Overall Study|Withdrawal by Subject|23|||
130167508|NCT00660907|468574982|FG001|Overall Study|Withdrawal by Subject|32|||
130167509|NCT00660907|468574981|FG000|Overall Study|Lost to Follow-up|3|||
130167510|NCT00660907|468574982|FG001|Overall Study|Lost to Follow-up|3|||
130167511|NCT00660907|468574981|FG000|Overall Study|Poor/Non-Compliance|5|||
130167512|NCT00660907|468574982|FG001|Overall Study|Poor/Non-Compliance|1|||
130167513|NCT00660907|468574981|FG000|Overall Study|Safety|1|||
130167514|NCT00660907|468574982|FG001|Overall Study|Safety|0|||
130167515|NCT00660907|468574981|FG000|Overall Study|Death|1|||
130167516|NCT00660907|468574982|FG001|Overall Study|Death|3|||
130167517|NCT00660907|468574981|FG000|Overall Study|Various|11|||
130167518|NCT00660907|468574982|FG001|Overall Study|Various|8|||
130167519|NCT04975191|468574985|FG000|Overall Study|Protocol Violation|1|||
130167520|NCT04975191|468574986|FG001|Overall Study|Protocol Violation|2|||
130167521|NCT04975191|468574987|FG002|Overall Study|Protocol Violation|2|||
130167522|NCT04975191|468574988|FG003|Overall Study|Protocol Violation|2|||
130167523|NCT04975191|468574985|FG000|Overall Study|Lost to Follow-up|13|||
130167524|NCT04975191|468574986|FG001|Overall Study|Lost to Follow-up|3|||
130167525|NCT04975191|468574987|FG002|Overall Study|Lost to Follow-up|8|||
130167526|NCT04975191|468574988|FG003|Overall Study|Lost to Follow-up|8|||
130167527|NCT01056289|468575007|FG000|Open-label Phase|Adverse Event|29|||
130167528|NCT01056289|468575008|FG001|Open-label Phase|Adverse Event|0|||
130167529|NCT01056289|468575009|FG002|Open-label Phase|Adverse Event|0|||
130167530|NCT01056289|468575010|FG003|Open-label Phase|Adverse Event|0|||
130167531|NCT01056289|468575007|FG000|Open-label Phase|Lost to Follow-up|30|||
130167532|NCT01056289|468575008|FG001|Open-label Phase|Lost to Follow-up|0|||
130167533|NCT01056289|468575009|FG002|Open-label Phase|Lost to Follow-up|0|||
130167534|NCT01056289|468575010|FG003|Open-label Phase|Lost to Follow-up|0|||
130167535|NCT01056289|468575007|FG000|Open-label Phase|Other|9|||
130167536|NCT01056289|468575008|FG001|Open-label Phase|Other|0|||
129981885|NCT03449901|467896778|FG001|Overall Study|Withdrawal by Subject|1|||
129981886|NCT03449901|467896777|FG000|Overall Study|Physician Decision|1|||
129981887|NCT03449901|467896778|FG001|Overall Study|Physician Decision|0|||
129981888|NCT03449901|467896777|FG000|Overall Study|Patient elected for surgical intervention|1|||
129981889|NCT03449901|467896778|FG001|Overall Study|Patient elected for surgical intervention|0|||
129981890|NCT03449901|467896777|FG000|Overall Study|Patient off for other complicating disease|1|||
129981891|NCT03449901|467896778|FG001|Overall Study|Patient off for other complicating disease|0|||
129981892|NCT03466073|467896779|FG000|Overall Study|Death|1|||
129981893|NCT03466073|467896780|FG001|Overall Study|Death|0|||
129981894|NCT03466073|467896781|FG002|Overall Study|Death|0|||
129981895|NCT03466073|467896782|FG003|Overall Study|Death|0|||
129981896|NCT03466073|467896783|FG004|Overall Study|Death|0|||
129981897|NCT03466073|467896784|FG005|Overall Study|Death|1|||
129981898|NCT00744757|467896785|FG000|Overall Study|Objective disease progression|7|||
129981899|NCT00744757|467896785|FG000|Overall Study|Physician Decision|5|||
129981900|NCT00744757|467896785|FG000|Overall Study|Withdrawal by Subject|1|||
129981901|NCT00744757|467896785|FG000|Overall Study|Death|6|||
129981902|NCT00744757|467896785|FG000|Overall Study|Adverse Event|2|||
129981903|NCT03682302|467896786|FG000|Overall Study|Lost to Follow-up|1|||
129981904|NCT03682302|467896787|FG001|Overall Study|Lost to Follow-up|2|||
129981905|NCT03682302|467896788|FG002|Overall Study|Lost to Follow-up|0|||
130167537|NCT01056289|468575009|FG002|Open-label Phase|Other|0|||
130167538|NCT01056289|468575010|FG003|Open-label Phase|Other|0|||
130167539|NCT01056289|468575007|FG000|Open-label Phase|Protocol Violation|6|||
130167540|NCT01056289|468575008|FG001|Open-label Phase|Protocol Violation|0|||
130167541|NCT01056289|468575009|FG002|Open-label Phase|Protocol Violation|0|||
130167542|NCT01056289|468575010|FG003|Open-label Phase|Protocol Violation|0|||
130167543|NCT01056289|468575007|FG000|Open-label Phase|Withdrawal by Subject|26|||
130167544|NCT01056289|468575008|FG001|Open-label Phase|Withdrawal by Subject|0|||
130167545|NCT01056289|468575009|FG002|Open-label Phase|Withdrawal by Subject|0|||
130167546|NCT01056289|468575010|FG003|Open-label Phase|Withdrawal by Subject|0|||
130167547|NCT01056289|468575007|FG000|Open-label Phase|Lack of Efficacy|18|||
130167548|NCT01056289|468575008|FG001|Open-label Phase|Lack of Efficacy|0|||
130167549|NCT01056289|468575009|FG002|Open-label Phase|Lack of Efficacy|0|||
130167550|NCT01056289|468575010|FG003|Open-label Phase|Lack of Efficacy|0|||
130167551|NCT01056289|468575007|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
130167552|NCT01056289|468575008|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
130167553|NCT01056289|468575009|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
130167554|NCT01056289|468575010|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
130167555|NCT01056289|468575007|FG000|Double-blind Phase|Adverse Event|0|||
130167556|NCT01056289|468575008|FG001|Double-blind Phase|Adverse Event|1|||
130167557|NCT01056289|468575009|FG002|Double-blind Phase|Adverse Event|2|||
130167558|NCT01056289|468575010|FG003|Double-blind Phase|Adverse Event|1|||
130167559|NCT01056289|468575007|FG000|Double-blind Phase|Lost to Follow-up|0|||
130167560|NCT01056289|468575008|FG001|Double-blind Phase|Lost to Follow-up|2|||
130167561|NCT01056289|468575009|FG002|Double-blind Phase|Lost to Follow-up|2|||
130167562|NCT01056289|468575010|FG003|Double-blind Phase|Lost to Follow-up|2|||
130167563|NCT01056289|468575007|FG000|Double-blind Phase|Other|0|||
130167564|NCT01056289|468575008|FG001|Double-blind Phase|Other|0|||
130167565|NCT01056289|468575009|FG002|Double-blind Phase|Other|1|||
130167566|NCT01056289|468575010|FG003|Double-blind Phase|Other|2|||
129981906|NCT03682302|467896789|FG003|Overall Study|Lost to Follow-up|1|||
129981907|NCT03682302|467896786|FG000|Overall Study|Study drug was not administered|0|||
129981908|NCT03682302|467896787|FG001|Overall Study|Study drug was not administered|0|||
129981909|NCT03682302|467896788|FG002|Overall Study|Study drug was not administered|1|||
130167567|NCT01056289|468575007|FG000|Double-blind Phase|Protocol Violation|0|||
130167568|NCT01056289|468575008|FG001|Double-blind Phase|Protocol Violation|0|||
130167569|NCT01056289|468575009|FG002|Double-blind Phase|Protocol Violation|1|||
130167570|NCT01056289|468575010|FG003|Double-blind Phase|Protocol Violation|1|||
130167571|NCT01056289|468575007|FG000|Double-blind Phase|Withdrawal by Subject|0|||
130167572|NCT01056289|468575008|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130167573|NCT01056289|468575009|FG002|Double-blind Phase|Withdrawal by Subject|4|||
130167574|NCT01056289|468575010|FG003|Double-blind Phase|Withdrawal by Subject|2|||
130167575|NCT01056289|468575007|FG000|Double-blind Phase|Discontinuation symptom|0|||
130167576|NCT01056289|468575008|FG001|Double-blind Phase|Discontinuation symptom|1|||
130167577|NCT01056289|468575009|FG002|Double-blind Phase|Discontinuation symptom|2|||
130167578|NCT01056289|468575010|FG003|Double-blind Phase|Discontinuation symptom|2|||
130167579|NCT01056289|468575007|FG000|Double-blind Phase|Physician Decision|0|||
130167580|NCT01056289|468575008|FG001|Double-blind Phase|Physician Decision|0|||
130167581|NCT01056289|468575009|FG002|Double-blind Phase|Physician Decision|1|||
130167582|NCT01056289|468575010|FG003|Double-blind Phase|Physician Decision|0|||
130167583|NCT05776862|468575013|FG000|Overall Study|Adverse Event|0|||
130167584|NCT05776862|468575014|FG001|Overall Study|Adverse Event|1|||
130167585|NCT05776862|468575013|FG000|Overall Study|non-compliance|1|||
130167586|NCT05776862|468575014|FG001|Overall Study|non-compliance|0|||
130167587|NCT01199471|468575015|FG000|Overall Study|Protocol Violation|4|||
130167588|NCT01199471|468575015|FG000|Overall Study|Withdrawal by Subject|1|||
130167589|NCT01199471|468575015|FG000|Overall Study|Physician Decision|1|||
130167590|NCT02065700|468575016|FG000|Overall Study|Adverse Event|165|||
130167591|NCT02065700|468575017|FG001|Overall Study|Adverse Event|101|||
130167592|NCT02065700|468575016|FG000|Overall Study|Withdrawal by Subject|90|||
130167593|NCT02065700|468575017|FG001|Overall Study|Withdrawal by Subject|29|||
130167594|NCT02065700|468575016|FG000|Overall Study|Lost to Follow-up|12|||
130167595|NCT02065700|468575017|FG001|Overall Study|Lost to Follow-up|9|||
130167596|NCT02065700|468575016|FG000|Overall Study|Physician Decision|2|||
130167597|NCT02065700|468575017|FG001|Overall Study|Physician Decision|0|||
130167598|NCT02065700|468575016|FG000|Overall Study|Sponsor Request|38|||
130167599|NCT02065700|468575017|FG001|Overall Study|Sponsor Request|15|||
130167600|NCT02065700|468575016|FG000|Overall Study|Treatment Failure|3|||
130167601|NCT02065700|468575017|FG001|Overall Study|Treatment Failure|2|||
130167602|NCT02065700|468575016|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
130167603|NCT02065700|468575017|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
130167604|NCT02065700|468575016|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
130167605|NCT02065700|468575017|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
130167606|NCT02065700|468575016|FG000|Overall Study|Non-compliance with Study Procedures|2|||
130167607|NCT02065700|468575017|FG001|Overall Study|Non-compliance with Study Procedures|0|||
130167608|NCT02065700|468575016|FG000|Overall Study|Not Defined|21|||
130167609|NCT02065700|468575017|FG001|Overall Study|Not Defined|3|||
130167610|NCT03511326|468575025|FG000|Overall Study|Withdrawal by Subject|1|||
130167611|NCT04746794|468575030|FG000|Overall Study|Did not complete any study assessment|50303|||
130167612|NCT04746794|468575031|FG001|Overall Study|Did not complete any study assessment|44997|||
130167613|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
130167614|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
130167615|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
130167616|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
130167617|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
130167618|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
130167619|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
130167620|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
130167621|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
130167622|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
130167623|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
130167624|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
130167625|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
130167626|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
130167627|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
130167628|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
129981910|NCT03682302|467896789|FG003|Overall Study|Study drug was not administered|1|||
129981911|NCT01585155|467896790|FG000|Overall Study|Adverse Event|1|||
129981912|NCT01585155|467896790|FG000|Overall Study|Lack of Efficacy|2|||
129981913|NCT01585155|467896790|FG000|Overall Study|Worsening ulcerative colitis|2|||
129981914|NCT03772587|467896795|FG000|Overall Study|COVID-19|0|||
129981915|NCT03772587|467896796|FG001|Overall Study|COVID-19|0|||
129981916|NCT03772587|467896797|FG002|Overall Study|COVID-19|1|||
129981917|NCT03772587|467896798|FG003|Overall Study|COVID-19|1|||
129981918|NCT03772587|467896799|FG004|Overall Study|COVID-19|0|||
129981919|NCT03772587|467896795|FG000|Overall Study|Withdrawal by Subject|1|||
129981920|NCT03772587|467896796|FG001|Overall Study|Withdrawal by Subject|0|||
130167629|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
130167630|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
130167631|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
130167632|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
130167633|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
130167634|NCT04040192|468575032|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
130167635|NCT04040192|468575033|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
130167636|NCT04040192|468575034|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
130167637|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
130167638|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
130167639|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
130167640|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
130167641|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
130167642|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
130167643|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
130167644|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
130167645|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
130167646|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
130167647|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
130167648|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
130167649|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130167650|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
130167651|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
130167652|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
130167653|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
130167654|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
130167655|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
130167656|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
130167657|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
130167658|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
130167659|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
130167660|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
130167661|NCT04040192|468575032|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
130167662|NCT04040192|468575033|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
130167663|NCT04040192|468575034|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
130167664|NCT03207243|468575035|FG000|Overall Study|Adverse Event|2|||
130167665|NCT03207243|468575036|FG001|Overall Study|Adverse Event|2|||
130167666|NCT03207243|468575035|FG000|Overall Study|Loss of Asthma Control|47|||
130167667|NCT03207243|468575036|FG001|Overall Study|Loss of Asthma Control|31|||
130167668|NCT03207243|468575035|FG000|Overall Study|Withdrawal by Subject|2|||
130167669|NCT03207243|468575036|FG001|Overall Study|Withdrawal by Subject|4|||
130167670|NCT03207243|468575035|FG000|Overall Study|Physician Decision|1|||
130167671|NCT03207243|468575036|FG001|Overall Study|Physician Decision|1|||
130167672|NCT03207243|468575035|FG000|Overall Study|Lost to Follow-up|0|||
130167673|NCT03207243|468575036|FG001|Overall Study|Lost to Follow-up|1|||
130167674|NCT03207243|468575035|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
130167675|NCT03207243|468575036|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
130167676|NCT03207243|468575035|FG000|Overall Study|Protocol Violation|0|||
130167677|NCT03207243|468575036|FG001|Overall Study|Protocol Violation|3|||
130167678|NCT00229723|468575041|FG000|Concomitant Phase|Adverse Event|4|||
130167679|NCT00229723|468575042|FG001|Concomitant Phase|Adverse Event|2|||
130167680|NCT00229723|468575043|FG002|Concomitant Phase|Adverse Event|5|||
130167681|NCT00229723|468575044|FG003|Concomitant Phase|Adverse Event|2|||
130167682|NCT00229723|468575045|FG004|Concomitant Phase|Adverse Event|0|||
130167683|NCT00229723|468575046|FG005|Concomitant Phase|Adverse Event|1|||
130167684|NCT00229723|468575047|FG006|Concomitant Phase|Adverse Event|2|||
130167685|NCT00229723|468575041|FG000|Concomitant Phase|Objective disease progression|0|||
130167686|NCT00229723|468575042|FG001|Concomitant Phase|Objective disease progression|0|||
130167687|NCT00229723|468575043|FG002|Concomitant Phase|Objective disease progression|0|||
130167688|NCT00229723|468575044|FG003|Concomitant Phase|Objective disease progression|0|||
130167689|NCT00229723|468575045|FG004|Concomitant Phase|Objective disease progression|0|||
130167690|NCT00229723|468575046|FG005|Concomitant Phase|Objective disease progression|0|||
130167691|NCT00229723|468575047|FG006|Concomitant Phase|Objective disease progression|0|||
130167692|NCT00229723|468575041|FG000|Concomitant Phase|Clinical progression|0|||
130167693|NCT00229723|468575042|FG001|Concomitant Phase|Clinical progression|0|||
130167694|NCT00229723|468575043|FG002|Concomitant Phase|Clinical progression|0|||
130167695|NCT00229723|468575044|FG003|Concomitant Phase|Clinical progression|0|||
130167696|NCT00229723|468575045|FG004|Concomitant Phase|Clinical progression|0|||
130167697|NCT00229723|468575046|FG005|Concomitant Phase|Clinical progression|0|||
130167698|NCT00229723|468575047|FG006|Concomitant Phase|Clinical progression|1|||
130167699|NCT00229723|468575041|FG000|Concomitant Phase|Lost to Follow-up|0|||
130167700|NCT00229723|468575042|FG001|Concomitant Phase|Lost to Follow-up|0|||
130167701|NCT00229723|468575043|FG002|Concomitant Phase|Lost to Follow-up|0|||
130167702|NCT00229723|468575044|FG003|Concomitant Phase|Lost to Follow-up|0|||
130167703|NCT00229723|468575045|FG004|Concomitant Phase|Lost to Follow-up|1|||
130167704|NCT00229723|468575046|FG005|Concomitant Phase|Lost to Follow-up|0|||
130167705|NCT00229723|468575047|FG006|Concomitant Phase|Lost to Follow-up|0|||
130167706|NCT00229723|468575041|FG000|Concomitant Phase|Informed consent withdrawn|3|||
130167707|NCT00229723|468575042|FG001|Concomitant Phase|Informed consent withdrawn|2|||
130167708|NCT00229723|468575043|FG002|Concomitant Phase|Informed consent withdrawn|0|||
130167709|NCT00229723|468575044|FG003|Concomitant Phase|Informed consent withdrawn|2|||
130167710|NCT00229723|468575045|FG004|Concomitant Phase|Informed consent withdrawn|0|||
130167711|NCT00229723|468575046|FG005|Concomitant Phase|Informed consent withdrawn|0|||
130167712|NCT00229723|468575047|FG006|Concomitant Phase|Informed consent withdrawn|0|||
130167713|NCT00229723|468575041|FG000|Concomitant Phase|Severe non-compliance|0|||
130167714|NCT00229723|468575042|FG001|Concomitant Phase|Severe non-compliance|1|||
130167715|NCT00229723|468575043|FG002|Concomitant Phase|Severe non-compliance|0|||
130167716|NCT00229723|468575044|FG003|Concomitant Phase|Severe non-compliance|0|||
130167717|NCT00229723|468575045|FG004|Concomitant Phase|Severe non-compliance|1|||
130167718|NCT00229723|468575046|FG005|Concomitant Phase|Severe non-compliance|0|||
130167719|NCT00229723|468575047|FG006|Concomitant Phase|Severe non-compliance|0|||
130167720|NCT00229723|468575041|FG000|Concomitant Phase|Other|3|||
130167721|NCT00229723|468575042|FG001|Concomitant Phase|Other|0|||
130167722|NCT00229723|468575043|FG002|Concomitant Phase|Other|1|||
130167723|NCT00229723|468575044|FG003|Concomitant Phase|Other|1|||
130167724|NCT00229723|468575045|FG004|Concomitant Phase|Other|0|||
130167725|NCT00229723|468575046|FG005|Concomitant Phase|Other|2|||
130167726|NCT00229723|468575047|FG006|Concomitant Phase|Other|0|||
130167727|NCT00229723|468575041|FG000|Maintenance Phase|Adverse Event|7|||
130167728|NCT00229723|468575042|FG001|Maintenance Phase|Adverse Event|2|||
130167729|NCT00229723|468575043|FG002|Maintenance Phase|Adverse Event|1|||
130167730|NCT00229723|468575044|FG003|Maintenance Phase|Adverse Event|4|||
130167731|NCT00229723|468575045|FG004|Maintenance Phase|Adverse Event|7|||
130167732|NCT00229723|468575046|FG005|Maintenance Phase|Adverse Event|5|||
130167733|NCT00229723|468575047|FG006|Maintenance Phase|Adverse Event|2|||
130167734|NCT00229723|468575041|FG000|Maintenance Phase|Objective disease progression|5|||
130167735|NCT00229723|468575042|FG001|Maintenance Phase|Objective disease progression|5|||
130167736|NCT00229723|468575043|FG002|Maintenance Phase|Objective disease progression|3|||
130167737|NCT00229723|468575044|FG003|Maintenance Phase|Objective disease progression|6|||
130167738|NCT00229723|468575045|FG004|Maintenance Phase|Objective disease progression|2|||
130167739|NCT00229723|468575046|FG005|Maintenance Phase|Objective disease progression|9|||
130167740|NCT00229723|468575047|FG006|Maintenance Phase|Objective disease progression|5|||
130167741|NCT00229723|468575041|FG000|Maintenance Phase|Clinical progression|4|||
130167742|NCT00229723|468575042|FG001|Maintenance Phase|Clinical progression|1|||
130167743|NCT00229723|468575043|FG002|Maintenance Phase|Clinical progression|2|||
130167744|NCT00229723|468575044|FG003|Maintenance Phase|Clinical progression|2|||
130167745|NCT00229723|468575045|FG004|Maintenance Phase|Clinical progression|1|||
130167746|NCT00229723|468575046|FG005|Maintenance Phase|Clinical progression|1|||
130167747|NCT00229723|468575047|FG006|Maintenance Phase|Clinical progression|1|||
130167748|NCT00229723|468575041|FG000|Maintenance Phase|Lost to Follow-up|0|||
130167749|NCT00229723|468575042|FG001|Maintenance Phase|Lost to Follow-up|1|||
130167750|NCT00229723|468575043|FG002|Maintenance Phase|Lost to Follow-up|2|||
130167751|NCT00229723|468575044|FG003|Maintenance Phase|Lost to Follow-up|2|||
130167752|NCT00229723|468575045|FG004|Maintenance Phase|Lost to Follow-up|0|||
130167753|NCT00229723|468575046|FG005|Maintenance Phase|Lost to Follow-up|0|||
130167754|NCT00229723|468575047|FG006|Maintenance Phase|Lost to Follow-up|1|||
130167755|NCT00229723|468575041|FG000|Maintenance Phase|Informed consent withdrawn|1|||
130167756|NCT00229723|468575042|FG001|Maintenance Phase|Informed consent withdrawn|0|||
130167757|NCT00229723|468575043|FG002|Maintenance Phase|Informed consent withdrawn|0|||
130167758|NCT00229723|468575044|FG003|Maintenance Phase|Informed consent withdrawn|1|||
130167759|NCT00229723|468575045|FG004|Maintenance Phase|Informed consent withdrawn|1|||
130167760|NCT00229723|468575046|FG005|Maintenance Phase|Informed consent withdrawn|1|||
130167761|NCT00229723|468575047|FG006|Maintenance Phase|Informed consent withdrawn|0|||
130167762|NCT00229723|468575041|FG000|Maintenance Phase|Severe non-compliance|3|||
130167763|NCT00229723|468575042|FG001|Maintenance Phase|Severe non-compliance|1|||
130167764|NCT00229723|468575043|FG002|Maintenance Phase|Severe non-compliance|0|||
130167765|NCT00229723|468575044|FG003|Maintenance Phase|Severe non-compliance|0|||
130167766|NCT00229723|468575045|FG004|Maintenance Phase|Severe non-compliance|1|||
130167767|NCT00229723|468575046|FG005|Maintenance Phase|Severe non-compliance|0|||
130167768|NCT00229723|468575047|FG006|Maintenance Phase|Severe non-compliance|0|||
130167769|NCT00229723|468575041|FG000|Maintenance Phase|Other|5|||
130167770|NCT00229723|468575042|FG001|Maintenance Phase|Other|4|||
130167771|NCT00229723|468575043|FG002|Maintenance Phase|Other|1|||
130167772|NCT00229723|468575044|FG003|Maintenance Phase|Other|2|||
130167773|NCT00229723|468575045|FG004|Maintenance Phase|Other|3|||
130167774|NCT00229723|468575046|FG005|Maintenance Phase|Other|3|||
130167775|NCT00229723|468575047|FG006|Maintenance Phase|Other|1|||
130167776|NCT00735397|468575050|FG000|Overall Study|Adverse Event|194|||
130167777|NCT00735397|468575050|FG000|Overall Study|Lost to Follow-up|33|||
130167778|NCT00735397|468575050|FG000|Overall Study|Participant choice|252|||
130167779|NCT00735397|468575050|FG000|Overall Study|Inadequate therapeutic effect|202|||
130167780|NCT00735397|468575050|FG000|Overall Study|Administrative/Other|502|||
130167781|NCT03016975|468575055|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
130167782|NCT03016975|468575056|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
130167783|NCT03016975|468575057|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
130167784|NCT03016975|468575055|FG000|At 6 Months Follow-up|Death|2|||
130167785|NCT03016975|468575056|FG001|At 6 Months Follow-up|Death|0|||
130167786|NCT03016975|468575057|FG002|At 6 Months Follow-up|Death|0|||
130167787|NCT03016975|468575055|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
130167788|NCT03016975|468575056|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
130167789|NCT03016975|468575057|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
130167790|NCT03016975|468575055|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
130167791|NCT03016975|468575056|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
130167792|NCT03016975|468575057|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
130167793|NCT03016975|468575055|FG000|At 6 Months Follow-up|Aborted implant|1|||
130167794|NCT03016975|468575056|FG001|At 6 Months Follow-up|Aborted implant|0|||
130167795|NCT03016975|468575057|FG002|At 6 Months Follow-up|Aborted implant|0|||
130167796|NCT03016975|468575055|FG000|At 2 Year Follow-up|Death|1|||
130167797|NCT03016975|468575056|FG001|At 2 Year Follow-up|Death|0|||
130167798|NCT03016975|468575057|FG002|At 2 Year Follow-up|Death|0|||
130167799|NCT03016975|468575055|FG000|At 3 Year Follow-up|Death|1|||
130167800|NCT03016975|468575056|FG001|At 3 Year Follow-up|Death|0|||
130167801|NCT03016975|468575057|FG002|At 3 Year Follow-up|Death|0|||
130167802|NCT03016975|468575055|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
130167803|NCT03016975|468575056|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
130167804|NCT03016975|468575057|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
130167805|NCT03016975|468575055|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
130167806|NCT03016975|468575056|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
130167807|NCT03016975|468575057|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
130167808|NCT01590797|468575060|FG000|Overall Study|Adverse Event|4|||
130167809|NCT01590797|468575061|FG001|Overall Study|Adverse Event|3|||
130167810|NCT01590797|468575060|FG000|Overall Study|Lack of Efficacy|0|||
130167811|NCT01590797|468575061|FG001|Overall Study|Lack of Efficacy|2|||
130167812|NCT01590797|468575060|FG000|Overall Study|Lost to Follow-up|0|||
130167813|NCT01590797|468575061|FG001|Overall Study|Lost to Follow-up|1|||
130167814|NCT01590797|468575060|FG000|Overall Study|Protocol Violation|4|||
130167815|NCT01590797|468575061|FG001|Overall Study|Protocol Violation|1|||
130167816|NCT01590797|468575060|FG000|Overall Study|Withdrawal by Subject|7|||
130167817|NCT01590797|468575061|FG001|Overall Study|Withdrawal by Subject|5|||
130167818|NCT01590797|468575060|FG000|Overall Study|Other Protocol Specified Criteria|2|||
130167819|NCT01590797|468575061|FG001|Overall Study|Other Protocol Specified Criteria|4|||
130167820|NCT00901576|468575067|FG000|Second Intervention|Withdrawal by Subject|0|||
130167821|NCT00901576|468575068|FG001|Second Intervention|Withdrawal by Subject|0|||
130167822|NCT00901576|468575069|FG002|Second Intervention|Withdrawal by Subject|0|||
130167823|NCT00901576|468575070|FG003|Second Intervention|Withdrawal by Subject|1|||
130167824|NCT00901576|468575071|FG004|Second Intervention|Withdrawal by Subject|0|||
130167825|NCT00901576|468575072|FG005|Second Intervention|Withdrawal by Subject|1|||
130167826|NCT00901576|468575067|FG000|Second Intervention|Physician Decision|1|||
130167827|NCT00901576|468575068|FG001|Second Intervention|Physician Decision|0|||
130167828|NCT00901576|468575069|FG002|Second Intervention|Physician Decision|0|||
130167829|NCT00901576|468575070|FG003|Second Intervention|Physician Decision|0|||
130167830|NCT00901576|468575071|FG004|Second Intervention|Physician Decision|0|||
130167831|NCT00901576|468575072|FG005|Second Intervention|Physician Decision|0|||
130167832|NCT01559389|468575073|FG000|Overall Study|Withdrawal by Subject|20|||
130167833|NCT01559389|468575074|FG001|Overall Study|Withdrawal by Subject|20|||
130167834|NCT03201445|468575075|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
130167835|NCT03201445|468575076|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
130167836|NCT03201445|468575075|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
130167837|NCT03201445|468575076|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
130167838|NCT03201445|468575075|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
130167839|NCT03201445|468575076|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
130167840|NCT03201445|468575075|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
130167841|NCT03201445|468575076|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
130167842|NCT03201445|468575075|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
130167843|NCT03201445|468575076|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
130167844|NCT03201445|468575075|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
130167845|NCT03201445|468575076|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
130167846|NCT03201445|468575075|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
130167847|NCT03201445|468575076|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
130167848|NCT03201445|468575075|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
130167849|NCT03201445|468575076|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
130167850|NCT03201445|468575075|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
130167851|NCT03201445|468575076|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
130167852|NCT03201445|468575075|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
130167853|NCT03201445|468575076|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
130167854|NCT03201445|468575075|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
130167855|NCT03201445|468575076|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
130167856|NCT03201445|468575075|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
130167857|NCT03201445|468575076|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
130167858|NCT03201445|468575075|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
130167859|NCT03201445|468575076|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
130167860|NCT03201445|468575075|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
130167861|NCT03201445|468575076|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
130167862|NCT03201445|468575075|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
130167863|NCT03201445|468575076|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
130167864|NCT03201445|468575075|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
130167865|NCT03201445|468575076|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
130167866|NCT03201445|468575075|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
130167867|NCT03201445|468575076|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
130167868|NCT03201445|468575075|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
130167869|NCT03201445|468575076|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
130167870|NCT03201445|468575075|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
130167871|NCT03201445|468575076|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
130167872|NCT03201445|468575075|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
130167873|NCT03201445|468575076|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
130167874|NCT03201445|468575075|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
130167875|NCT03201445|468575076|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
130167876|NCT01228019|468575077|FG000|Overall Study|Dose Violation|70|||
130167877|NCT01228019|468575077|FG000|Overall Study|Duplicate enrollment|1|||
130167878|NCT01228019|468575077|FG000|Overall Study|Missing pre-treatment data|72|||
130167879|NCT01228019|468575077|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
130167880|NCT01228019|468575077|FG000|Overall Study|Violation of Entry Criterion|9|||
130167881|NCT01346293|468575080|FG000|Overall Study|Protocol Violation|30|||
130167882|NCT01346293|468575081|FG001|Overall Study|Protocol Violation|9|||
130167883|NCT01346293|468575080|FG000|Overall Study|Lost to Follow-up|21|||
130167884|NCT01346293|468575081|FG001|Overall Study|Lost to Follow-up|8|||
130167885|NCT01346293|468575080|FG000|Overall Study|Withdrawal by Subject|15|||
130167886|NCT01346293|468575081|FG001|Overall Study|Withdrawal by Subject|4|||
130167887|NCT01346293|468575080|FG000|Overall Study|Other|1|||
130167888|NCT01346293|468575081|FG001|Overall Study|Other|0|||
130167889|NCT03503864|468575082|FG000|Overall Study|Protocol Violation|6|||
130167890|NCT03503864|468575082|FG000|Overall Study|Withdrawal by Subject|7|||
130167891|NCT02910063|468575083|FG000|Phase 2|Withdrawal by Subject|3|||
130167892|NCT02910063|468575084|FG001|Phase 2|Withdrawal by Subject|0|||
130167893|NCT02910063|468575085|FG002|Phase 2|Withdrawal by Subject|0|||
130167894|NCT02910063|468575083|FG000|Phase 2|Lost to Follow-up|1|||
130167895|NCT02910063|468575084|FG001|Phase 2|Lost to Follow-up|0|||
130167896|NCT02910063|468575085|FG002|Phase 2|Lost to Follow-up|0|||
130167897|NCT02910063|468575083|FG000|Phase 2|Death|24|||
130167898|NCT02910063|468575084|FG001|Phase 2|Death|0|||
130167899|NCT02910063|468575085|FG002|Phase 2|Death|0|||
130167900|NCT04693416|468575086|FG000|Overall Study|Lost to Follow-up|13|||
130167901|NCT04693416|468575087|FG001|Overall Study|Lost to Follow-up|0|||
130167902|NCT00474266|468575088|FG000|Overall Study|Withdrawal by Subject|7|||
130167903|NCT00474266|468575089|FG001|Overall Study|Withdrawal by Subject|20|||
130167904|NCT00474266|468575090|FG002|Overall Study|Withdrawal by Subject|4|||
130167905|NCT00474266|468575091|FG003|Overall Study|Withdrawal by Subject|7|||
130167906|NCT02774642|468575092|FG000|Overall Study|Lost to Follow-up|9|||
130167907|NCT02774642|468575093|FG001|Overall Study|Lost to Follow-up|7|||
130167908|NCT04642365|468575103|FG000|Overall Study|Death|3|||
130167909|NCT04642365|468575104|FG001|Overall Study|Death|2|||
130167910|NCT04642365|468575105|FG002|Overall Study|Death|4|||
130167911|NCT04642365|468575106|FG003|Overall Study|Death|5|||
130167912|NCT04642365|468575107|FG004|Overall Study|Death|5|||
130167913|NCT04642365|468575108|FG005|Overall Study|Death|3|||
130167914|NCT04642365|468575109|FG006|Overall Study|Death|2|||
129981921|NCT03772587|467896797|FG002|Overall Study|Withdrawal by Subject|0|||
129981922|NCT03772587|467896798|FG003|Overall Study|Withdrawal by Subject|0|||
130167915|NCT04642365|468575110|FG007|Overall Study|Death|1|||
129981923|NCT03772587|467896799|FG004|Overall Study|Withdrawal by Subject|0|||
130167916|NCT04642365|468575103|FG000|Overall Study|Physician Decision|1|||
130167917|NCT04642365|468575104|FG001|Overall Study|Physician Decision|0|||
130167918|NCT04642365|468575105|FG002|Overall Study|Physician Decision|0|||
130167919|NCT04642365|468575106|FG003|Overall Study|Physician Decision|0|||
130167920|NCT04642365|468575107|FG004|Overall Study|Physician Decision|0|||
130167921|NCT04642365|468575108|FG005|Overall Study|Physician Decision|0|||
130167922|NCT04642365|468575109|FG006|Overall Study|Physician Decision|0|||
130167923|NCT04642365|468575110|FG007|Overall Study|Physician Decision|0|||
130167924|NCT04642365|468575103|FG000|Overall Study|Progressive Disease|1|||
130167925|NCT04642365|468575104|FG001|Overall Study|Progressive Disease|1|||
130167926|NCT04642365|468575105|FG002|Overall Study|Progressive Disease|1|||
130167927|NCT04642365|468575106|FG003|Overall Study|Progressive Disease|0|||
130167928|NCT04642365|468575107|FG004|Overall Study|Progressive Disease|0|||
130167929|NCT04642365|468575108|FG005|Overall Study|Progressive Disease|0|||
130167930|NCT04642365|468575109|FG006|Overall Study|Progressive Disease|1|||
130167931|NCT04642365|468575110|FG007|Overall Study|Progressive Disease|0|||
130167932|NCT04642365|468575103|FG000|Overall Study|Study Terminated By Sponsor|0|||
130167933|NCT04642365|468575104|FG001|Overall Study|Study Terminated By Sponsor|2|||
130167934|NCT04642365|468575105|FG002|Overall Study|Study Terminated By Sponsor|1|||
130167935|NCT04642365|468575106|FG003|Overall Study|Study Terminated By Sponsor|1|||
130167936|NCT04642365|468575107|FG004|Overall Study|Study Terminated By Sponsor|1|||
130167937|NCT04642365|468575108|FG005|Overall Study|Study Terminated By Sponsor|2|||
130167938|NCT04642365|468575109|FG006|Overall Study|Study Terminated By Sponsor|2|||
130167939|NCT04642365|468575110|FG007|Overall Study|Study Terminated By Sponsor|1|||
130167940|NCT04642365|468575103|FG000|Overall Study|Symptomatic Deterioration|1|||
130167941|NCT04642365|468575104|FG001|Overall Study|Symptomatic Deterioration|1|||
130167942|NCT04642365|468575105|FG002|Overall Study|Symptomatic Deterioration|0|||
130167943|NCT04642365|468575106|FG003|Overall Study|Symptomatic Deterioration|0|||
130167944|NCT04642365|468575107|FG004|Overall Study|Symptomatic Deterioration|0|||
130167945|NCT04642365|468575108|FG005|Overall Study|Symptomatic Deterioration|1|||
130167946|NCT04642365|468575109|FG006|Overall Study|Symptomatic Deterioration|0|||
130167947|NCT04642365|468575110|FG007|Overall Study|Symptomatic Deterioration|0|||
130167948|NCT04642365|468575103|FG000|Overall Study|Withdrawal by Subject|0|||
130167949|NCT04642365|468575104|FG001|Overall Study|Withdrawal by Subject|0|||
130167950|NCT04642365|468575105|FG002|Overall Study|Withdrawal by Subject|1|||
130167951|NCT04642365|468575106|FG003|Overall Study|Withdrawal by Subject|1|||
130167952|NCT04642365|468575107|FG004|Overall Study|Withdrawal by Subject|0|||
130167953|NCT04642365|468575108|FG005|Overall Study|Withdrawal by Subject|0|||
130167954|NCT04642365|468575109|FG006|Overall Study|Withdrawal by Subject|2|||
130167955|NCT04642365|468575110|FG007|Overall Study|Withdrawal by Subject|0|||
130167956|NCT04642365|468575103|FG000|Overall Study|Adverse Event|0|||
130167957|NCT04642365|468575104|FG001|Overall Study|Adverse Event|0|||
130167958|NCT04642365|468575105|FG002|Overall Study|Adverse Event|0|||
130167959|NCT04642365|468575106|FG003|Overall Study|Adverse Event|0|||
130167960|NCT04642365|468575107|FG004|Overall Study|Adverse Event|0|||
130167961|NCT04642365|468575108|FG005|Overall Study|Adverse Event|0|||
130167962|NCT04642365|468575109|FG006|Overall Study|Adverse Event|0|||
130167963|NCT04642365|468575110|FG007|Overall Study|Adverse Event|1|||
130167964|NCT01144715|468575111|FG000|Overall Study|Lost to Follow-up|2|||
130167965|NCT01144715|468575112|FG001|Overall Study|Lost to Follow-up|1|||
130167966|NCT01144715|468575111|FG000|Overall Study|Withdrawal by Subject|2|||
130167967|NCT01144715|468575112|FG001|Overall Study|Withdrawal by Subject|1|||
130167968|NCT01144715|468575111|FG000|Overall Study|Adverse Event|0|||
130167969|NCT01144715|468575112|FG001|Overall Study|Adverse Event|1|||
130167970|NCT06281171|468575113|FG000|Timepoint 2|Lost to Follow-up|6|||
130167971|NCT06281171|468575114|FG001|Timepoint 2|Lost to Follow-up|4|||
130167972|NCT06281171|468575113|FG000|Timepoint 3|Lost to Follow-up|0|||
130167973|NCT06281171|468575114|FG001|Timepoint 3|Lost to Follow-up|5|||
130167974|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
130167975|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
130167976|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
130167977|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
130167978|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
130167979|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
130167980|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
130167981|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
130167982|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
130167983|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
130167984|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
130167985|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
130167986|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
130167987|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
130167988|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
130167989|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
130167990|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
130167991|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
130167992|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
130167993|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
130167994|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
130167995|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
130167996|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
130167997|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
130167998|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
130167999|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
130168000|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
130168001|NCT02552212|468575115|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
130168002|NCT02552212|468575116|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
130168003|NCT02552212|468575117|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
130168004|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
130168005|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
130168006|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
130168007|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
130168008|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
130168009|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
130168010|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
130168011|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
130168012|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
130168013|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
130168014|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
130168015|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
130168016|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
130168017|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
130168018|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
130168019|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
130168020|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
130168021|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
130168022|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
130168023|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
130168024|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
130168025|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
130168026|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
130168027|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
130168028|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
130168029|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
130168030|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
130168031|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
130168032|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
130168033|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
130168034|NCT02552212|468575115|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
130168035|NCT02552212|468575116|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
130168036|NCT02552212|468575117|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
130168037|NCT00205803|468575119|FG000|Infant Series|Lost to Follow-up|10|||
130168038|NCT00205803|468575120|FG001|Infant Series|Lost to Follow-up|4|||
130168039|NCT00205803|468575119|FG000|Infant Series|Withdrawal by Subject|2|||
130168040|NCT00205803|468575120|FG001|Infant Series|Withdrawal by Subject|5|||
130168041|NCT00205803|468575119|FG000|Infant Series|Physician Decision|3|||
130168042|NCT00205803|468575120|FG001|Infant Series|Physician Decision|1|||
130168043|NCT00205803|468575119|FG000|Infant Series|Protocol Violation|1|||
130168044|NCT00205803|468575120|FG001|Infant Series|Protocol Violation|0|||
130168045|NCT00205803|468575119|FG000|Infant Series|Lost Kaiser coverage|0|||
130168046|NCT00205803|468575120|FG001|Infant Series|Lost Kaiser coverage|1|||
130168047|NCT00205803|468575119|FG000|Infant Series|Non-compliant|1|||
130168048|NCT00205803|468575120|FG001|Infant Series|Non-compliant|0|||
130168049|NCT00205803|468575119|FG000|Infant Series|Sponsor request|1|||
130168050|NCT00205803|468575120|FG001|Infant Series|Sponsor request|0|||
130168051|NCT00205803|468575119|FG000|After Infant Series|Adverse Event|1|||
130168052|NCT00205803|468575120|FG001|After Infant Series|Adverse Event|1|||
130168053|NCT00205803|468575119|FG000|After Infant Series|Protocol Violation|1|||
130168054|NCT00205803|468575120|FG001|After Infant Series|Protocol Violation|1|||
130168055|NCT00205803|468575119|FG000|After Infant Series|Lost to Follow-up|2|||
130168056|NCT00205803|468575120|FG001|After Infant Series|Lost to Follow-up|1|||
130168057|NCT00205803|468575119|FG000|After Infant Series|Physician Decision|3|||
130168058|NCT00205803|468575120|FG001|After Infant Series|Physician Decision|2|||
130168059|NCT00205803|468575119|FG000|After Infant Series|Withdrawal by Subject|1|||
130168060|NCT00205803|468575120|FG001|After Infant Series|Withdrawal by Subject|4|||
130168061|NCT00205803|468575119|FG000|After Infant Series|Other|10|||
130168062|NCT00205803|468575120|FG001|After Infant Series|Other|4|||
130168063|NCT00205803|468575119|FG000|Toddler Dose|Lost to Follow-up|2|||
130168064|NCT00205803|468575120|FG001|Toddler Dose|Lost to Follow-up|3|||
130168065|NCT02369458|468575130|FG000|Overall Study|Determined to be not eligible|1|||
130168066|NCT02369458|468575131|FG001|Overall Study|Determined to be not eligible|0|||
130168067|NCT04572893|468575132|FG000|Part A|Adverse Event|1|||
130168068|NCT04572893|468575133|FG001|Part A|Adverse Event|0|||
130168069|NCT04572893|468575134|FG002|Part A|Adverse Event|0|||
130168070|NCT04572893|468575135|FG003|Part A|Adverse Event|0|||
130168071|NCT04572893|468575136|FG004|Part A|Adverse Event|0|||
130168072|NCT04572893|468575137|FG005|Part A|Adverse Event|0|||
130168073|NCT04572893|468575138|FG006|Part A|Adverse Event|0|||
130168074|NCT04572893|468575132|FG000|Part B|Withdrawal by Subject|0|||
130168075|NCT04572893|468575133|FG001|Part B|Withdrawal by Subject|0|||
130168076|NCT04572893|468575134|FG002|Part B|Withdrawal by Subject|0|||
130168077|NCT04572893|468575135|FG003|Part B|Withdrawal by Subject|0|||
130168078|NCT04572893|468575136|FG004|Part B|Withdrawal by Subject|0|||
130168079|NCT04572893|468575137|FG005|Part B|Withdrawal by Subject|1|||
130168080|NCT04572893|468575138|FG006|Part B|Withdrawal by Subject|0|||
130168081|NCT04572893|468575132|FG000|Part B|Study terminated by sponsor|0|||
130168082|NCT04572893|468575133|FG001|Part B|Study terminated by sponsor|0|||
130168083|NCT04572893|468575134|FG002|Part B|Study terminated by sponsor|0|||
130168084|NCT04572893|468575135|FG003|Part B|Study terminated by sponsor|0|||
130168085|NCT04572893|468575136|FG004|Part B|Study terminated by sponsor|7|||
130168086|NCT04572893|468575137|FG005|Part B|Study terminated by sponsor|5|||
130168087|NCT04572893|468575138|FG006|Part B|Study terminated by sponsor|3|||
130168088|NCT04572893|468575132|FG000|Part B|Lost to Follow-up|0|||
130168089|NCT04572893|468575133|FG001|Part B|Lost to Follow-up|0|||
130168090|NCT04572893|468575134|FG002|Part B|Lost to Follow-up|0|||
130168091|NCT04572893|468575135|FG003|Part B|Lost to Follow-up|0|||
130168092|NCT04572893|468575136|FG004|Part B|Lost to Follow-up|0|||
130168093|NCT04572893|468575137|FG005|Part B|Lost to Follow-up|0|||
130168094|NCT04572893|468575138|FG006|Part B|Lost to Follow-up|1|||
130168095|NCT04572893|468575132|FG000|Part B|Adverse Event|0|||
130168096|NCT04572893|468575133|FG001|Part B|Adverse Event|0|||
130168097|NCT04572893|468575134|FG002|Part B|Adverse Event|0|||
130168098|NCT04572893|468575135|FG003|Part B|Adverse Event|0|||
130168099|NCT04572893|468575136|FG004|Part B|Adverse Event|1|||
130168100|NCT04572893|468575137|FG005|Part B|Adverse Event|1|||
130168101|NCT04572893|468575138|FG006|Part B|Adverse Event|0|||
130168102|NCT00121134|468575139|FG000|Overall Study|Progression of Disease|5|||
130168103|NCT00121134|468575140|FG001|Overall Study|Progression of Disease|3|||
130168104|NCT00121134|468575141|FG002|Overall Study|Progression of Disease|4|||
130168105|NCT00121134|468575142|FG003|Overall Study|Progression of Disease|2|||
130168106|NCT00121134|468575139|FG000|Overall Study|Toxicity|4|||
130168107|NCT00121134|468575140|FG001|Overall Study|Toxicity|7|||
130168108|NCT00121134|468575141|FG002|Overall Study|Toxicity|13|||
130168109|NCT00121134|468575142|FG003|Overall Study|Toxicity|5|||
130168110|NCT00121134|468575139|FG000|Overall Study|Physician Decision|6|||
130168111|NCT00121134|468575140|FG001|Overall Study|Physician Decision|4|||
130168112|NCT00121134|468575141|FG002|Overall Study|Physician Decision|4|||
130168113|NCT00121134|468575142|FG003|Overall Study|Physician Decision|1|||
130168114|NCT00121134|468575139|FG000|Overall Study|Treatment Delay|1|||
130168115|NCT00121134|468575140|FG001|Overall Study|Treatment Delay|0|||
130168116|NCT00121134|468575141|FG002|Overall Study|Treatment Delay|0|||
130168117|NCT00121134|468575142|FG003|Overall Study|Treatment Delay|0|||
130168118|NCT00121134|468575139|FG000|Overall Study|Intercurrent Illness|0|||
130168119|NCT00121134|468575140|FG001|Overall Study|Intercurrent Illness|0|||
130168120|NCT00121134|468575141|FG002|Overall Study|Intercurrent Illness|0|||
130168121|NCT00121134|468575142|FG003|Overall Study|Intercurrent Illness|1|||
130168122|NCT00121134|468575139|FG000|Overall Study|Patient Personal Reasons|0|||
130168123|NCT00121134|468575140|FG001|Overall Study|Patient Personal Reasons|1|||
130168124|NCT00121134|468575141|FG002|Overall Study|Patient Personal Reasons|0|||
130168125|NCT00121134|468575142|FG003|Overall Study|Patient Personal Reasons|0|||
130168126|NCT01102374|468575156|FG000|Overall Study|Death|9|||
130168127|NCT01102374|468575157|FG001|Overall Study|Death|13|||
130168128|NCT01102374|468575156|FG000|Overall Study|Lost to Follow-up|7|||
130168129|NCT01102374|468575157|FG001|Overall Study|Lost to Follow-up|6|||
130168130|NCT00418821|468575158|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
130168131|NCT02071849|468575159|FG000|6-month Primary Endpoint|Did not receive device|4|||
130168132|NCT02071849|468575159|FG000|6-month Primary Endpoint|Adverse Event|1|||
130168133|NCT02071849|468575159|FG000|2-year Extended Follow-up|Adverse Event|1|||
130168134|NCT04619992|468575160|FG000|Overall Study|Withdrawal by Subject|1|||
130168135|NCT04619992|468575161|FG001|Overall Study|Withdrawal by Subject|0|||
130168136|NCT02618759|468576835|FG000|Overall Study|Lost to Follow-up|0|||
130168137|NCT02618759|468576836|FG001|Overall Study|Lost to Follow-up|1|||
130168138|NCT02618759|468576835|FG000|Overall Study|Withdrawal by Subject|1|||
130168139|NCT02618759|468576836|FG001|Overall Study|Withdrawal by Subject|0|||
130168140|NCT02618759|468576835|FG000|Overall Study|Other Reasons|1|||
130168141|NCT02618759|468576836|FG001|Overall Study|Other Reasons|4|||
130168142|NCT02500043|468576839|FG000|Overall Study|Randomized, but not Treated|2|||
130168143|NCT02500043|468576840|FG001|Overall Study|Randomized, but not Treated|2|||
130168144|NCT02500043|468576839|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
130168145|NCT02500043|468576840|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
130168146|NCT02500043|468576839|FG000|Overall Study|Adverse Event|33|||
130168147|NCT02500043|468576840|FG001|Overall Study|Adverse Event|11|||
130168148|NCT02500043|468576839|FG000|Overall Study|Clinical Progression|54|||
130168149|NCT02500043|468576840|FG001|Overall Study|Clinical Progression|35|||
130168150|NCT02500043|468576839|FG000|Overall Study|Radiological Progression|192|||
130168151|NCT02500043|468576840|FG001|Overall Study|Radiological Progression|110|||
130168152|NCT02500043|468576839|FG000|Overall Study|Physician's Decision|11|||
130168153|NCT02500043|468576840|FG001|Overall Study|Physician's Decision|3|||
130168154|NCT02500043|468576839|FG000|Overall Study|Withdrawal by Subject|14|||
130168155|NCT02500043|468576840|FG001|Overall Study|Withdrawal by Subject|4|||
130168156|NCT02500043|468576839|FG000|Overall Study|Death|11|||
130168157|NCT02500043|468576840|FG001|Overall Study|Death|2|||
130168158|NCT02500043|468576839|FG000|Overall Study|Protocol Deviation|1|||
130168159|NCT02500043|468576840|FG001|Overall Study|Protocol Deviation|0|||
130168160|NCT02856555|468576841|FG000|Overall Study|Adverse Event|1|||
130168161|NCT02856555|468576842|FG001|Overall Study|Adverse Event|0|||
130168162|NCT02856555|468576843|FG002|Overall Study|Adverse Event|0|||
130168163|NCT02856555|468576841|FG000|Overall Study|Lost to Follow-up|1|||
130168164|NCT02856555|468576842|FG001|Overall Study|Lost to Follow-up|3|||
130168165|NCT02856555|468576843|FG002|Overall Study|Lost to Follow-up|0|||
130168166|NCT02856555|468576841|FG000|Overall Study|Withdrawal by Subject|3|||
130168167|NCT02856555|468576842|FG001|Overall Study|Withdrawal by Subject|0|||
130168168|NCT02856555|468576843|FG002|Overall Study|Withdrawal by Subject|0|||
130168169|NCT02856555|468576841|FG000|Overall Study|Randomized but Never Treated|0|||
130168170|NCT02856555|468576842|FG001|Overall Study|Randomized but Never Treated|1|||
130168171|NCT02856555|468576843|FG002|Overall Study|Randomized but Never Treated|0|||
130168172|NCT03333941|468576844|FG000|Overall Study|Lost to Follow-up|10|||
130168173|NCT03333941|468576844|FG000|Overall Study|Death|2|||
130168174|NCT03333941|468576844|FG000|Overall Study|Adverse Event|1|||
130168175|NCT02932306|468576845|FG000|Overall Study|Withdrawal by Subject|16|||
130168176|NCT02932306|468576846|FG001|Overall Study|Withdrawal by Subject|25|||
130168177|NCT02932306|468576845|FG000|Overall Study|Adverse Event|3|||
130168178|NCT02932306|468576846|FG001|Overall Study|Adverse Event|0|||
130168179|NCT02932306|468576845|FG000|Overall Study|Pregnancy|2|||
130168180|NCT02932306|468576846|FG001|Overall Study|Pregnancy|0|||
130168181|NCT02932306|468576845|FG000|Overall Study|Protocol Violation|1|||
130168182|NCT02932306|468576846|FG001|Overall Study|Protocol Violation|1|||
130168183|NCT02932306|468576845|FG000|Overall Study|Noncompliance with Study Drug|1|||
130168184|NCT02932306|468576846|FG001|Overall Study|Noncompliance with Study Drug|1|||
130168185|NCT02932306|468576845|FG000|Overall Study|Lost to Follow-up|36|||
130168186|NCT02932306|468576846|FG001|Overall Study|Lost to Follow-up|40|||
130168187|NCT02932306|468576845|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
130168188|NCT02932306|468576846|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
130168189|NCT02932306|468576845|FG000|Overall Study|Lack of Efficacy|0|||
130168190|NCT02932306|468576846|FG001|Overall Study|Lack of Efficacy|2|||
130168191|NCT02932306|468576845|FG000|Overall Study|Worsening condition|2|||
130168192|NCT02932306|468576846|FG001|Overall Study|Worsening condition|0|||
130168193|NCT02932306|468576845|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
130168194|NCT02932306|468576846|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
130168195|NCT00605540|468576851|FG000|Overall Study|Death|15|||
130168196|NCT00605540|468576851|FG000|Overall Study|Lost to Follow-up|23|||
130168197|NCT01544179|468576854|FG000|Overall Study|Death|50|||
130168198|NCT01544179|468576855|FG001|Overall Study|Death|37|||
130168199|NCT01544179|468576854|FG000|Overall Study|Lost to Follow-up|0|||
130168200|NCT01544179|468576855|FG001|Overall Study|Lost to Follow-up|1|||
130168201|NCT01544179|468576854|FG000|Overall Study|Adverse Event|0|||
130168202|NCT01544179|468576855|FG001|Overall Study|Adverse Event|1|||
130168203|NCT01544179|468576854|FG000|Overall Study|Withdrawal by Subject|12|||
130168204|NCT01544179|468576855|FG001|Overall Study|Withdrawal by Subject|7|||
130168205|NCT01544179|468576854|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
130168206|NCT01544179|468576855|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130168207|NCT00049530|468576856|FG000|Overall Study|Lack of Efficacy|25|||
130168208|NCT00049530|468576856|FG000|Overall Study|Adverse Event|2|||
130168209|NCT00049530|468576856|FG000|Overall Study|Death|1|||
130168210|NCT00049530|468576856|FG000|Overall Study|symptomatic deterioration|1|||
130168211|NCT00049530|468576856|FG000|Overall Study|ineligible|3|||
130168212|NCT01635283|468576857|FG000|Overall Study|Tumor Progression|3|||
129981924|NCT05051462|467896801|FG000|Overall Study|Lost to Follow-up|1|||
130168213|NCT01635283|468576857|FG000|Overall Study|Lost to Follow-up|1|||
130168214|NCT01438996|468576858|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
130168215|NCT01438996|468576859|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
130168216|NCT01438996|468576860|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
130168217|NCT01433549|468576861|FG000|Phase 2: Second Study Product|Adverse Event|0|||
130168218|NCT01433549|468576862|FG001|Phase 2: Second Study Product|Adverse Event|1|||
130168219|NCT01696058|468576866|FG000|Overall Study|Adverse Event|21|||
130168220|NCT01696058|468576867|FG001|Overall Study|Adverse Event|11|||
130168221|NCT01696058|468576866|FG000|Overall Study|Lack of Efficacy|2|||
130168222|NCT01696058|468576867|FG001|Overall Study|Lack of Efficacy|3|||
130168223|NCT01696058|468576866|FG000|Overall Study|Protocol Violation|9|||
130168224|NCT01696058|468576867|FG001|Overall Study|Protocol Violation|3|||
129981925|NCT05051462|467896802|FG001|Overall Study|Lost to Follow-up|8|||
130168225|NCT01696058|468576866|FG000|Overall Study|Lost to Follow-up|2|||
130168226|NCT01696058|468576867|FG001|Overall Study|Lost to Follow-up|5|||
130168227|NCT01696058|468576866|FG000|Overall Study|Withdrawal by Subject|4|||
130168228|NCT01696058|468576867|FG001|Overall Study|Withdrawal by Subject|6|||
130168229|NCT01696058|468576866|FG000|Overall Study|Other reason prematurely discontinued|5|||
130168230|NCT01696058|468576867|FG001|Overall Study|Other reason prematurely discontinued|3|||
130168231|NCT02278055|468576868|FG000|Overall Study|Adverse Event|1|||
130168232|NCT02278055|468576868|FG000|Overall Study|Lost to Follow-up|1|||
130168233|NCT02278055|468576868|FG000|Overall Study|Withdrawal by Subject|2|||
130168234|NCT02278055|468576868|FG000|Overall Study|Progressive Disease|4|||
130168235|NCT01934335|468576869|FG000|Overall Study|Withdrawal by Subject|1|||
130168236|NCT01934335|468576870|FG001|Overall Study|Withdrawal by Subject|1|||
130168237|NCT05384171|468576871|FG000|Overall Study|Lost to Follow-up|9|||
130168238|NCT05384171|468576872|FG001|Overall Study|Lost to Follow-up|9|||
130168239|NCT05384171|468576871|FG000|Overall Study|Withdrawal by Subject|3|||
130168240|NCT05384171|468576872|FG001|Overall Study|Withdrawal by Subject|0|||
130168241|NCT01421511|468576873|FG000|Overall Study|Lost to Follow-up|11|||
130168242|NCT01421511|468576874|FG001|Overall Study|Lost to Follow-up|14|||
130168243|NCT01421511|468576873|FG000|Overall Study|Randomized but didn't receive study drug|1|||
130168244|NCT01421511|468576874|FG001|Overall Study|Randomized but didn't receive study drug|7|||
130168245|NCT01421511|468576873|FG000|Overall Study|Physician Decision|0|||
130168246|NCT01421511|468576874|FG001|Overall Study|Physician Decision|1|||
130168247|NCT01421511|468576873|FG000|Overall Study|Withdrawal by Subject|6|||
130168248|NCT01421511|468576874|FG001|Overall Study|Withdrawal by Subject|5|||
130168249|NCT01421511|468576873|FG000|Overall Study|Death|1|||
130168250|NCT01421511|468576874|FG001|Overall Study|Death|1|||
130168251|NCT00749892|468576875|FG000|Overall Study|Withdrawal by Subject|3|||
130168252|NCT01756079|468576876|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
130168253|NCT01756079|468576876|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
130168254|NCT01756079|468576876|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
130168255|NCT01756079|468576876|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
130168256|NCT01756079|468576876|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
130168257|NCT00106964|468576877|FG000|Overall Study|Lost to Follow-up|8|||
130168258|NCT00106964|468576878|FG001|Overall Study|Lost to Follow-up|6|||
130168259|NCT00106964|468576879|FG002|Overall Study|Lost to Follow-up|2|||
130168260|NCT00106964|468576877|FG000|Overall Study|Pregnancy|2|||
130168261|NCT00106964|468576878|FG001|Overall Study|Pregnancy|3|||
130168262|NCT00106964|468576879|FG002|Overall Study|Pregnancy|2|||
130168263|NCT00106964|468576877|FG000|Overall Study|Death|1|||
130168264|NCT00106964|468576878|FG001|Overall Study|Death|1|||
130168265|NCT00106964|468576879|FG002|Overall Study|Death|0|||
130168266|NCT00106964|468576877|FG000|Overall Study|Incarceration|0|||
130168267|NCT00106964|468576878|FG001|Overall Study|Incarceration|1|||
130168268|NCT00106964|468576879|FG002|Overall Study|Incarceration|0|||
130168269|NCT00106964|468576877|FG000|Overall Study|Site Funding Terminated|0|||
130168270|NCT00106964|468576878|FG001|Overall Study|Site Funding Terminated|1|||
130168271|NCT00106964|468576879|FG002|Overall Study|Site Funding Terminated|1|||
130168272|NCT00106964|468576877|FG000|Overall Study|Failure to adhere|2|||
130168273|NCT00106964|468576878|FG001|Overall Study|Failure to adhere|0|||
130168274|NCT00106964|468576879|FG002|Overall Study|Failure to adhere|0|||
130168275|NCT00106964|468576877|FG000|Overall Study|Did not meet eligibility criteria|0|||
130168276|NCT00106964|468576878|FG001|Overall Study|Did not meet eligibility criteria|2|||
130168277|NCT00106964|468576879|FG002|Overall Study|Did not meet eligibility criteria|2|||
130168278|NCT00106964|468576877|FG000|Overall Study|Required disallowed medication|0|||
130168279|NCT00106964|468576878|FG001|Overall Study|Required disallowed medication|1|||
130168280|NCT00106964|468576879|FG002|Overall Study|Required disallowed medication|0|||
130168281|NCT00168818|468576880|FG000|Overall Study|Adverse Event|23|||
130168282|NCT00168818|468576881|FG001|Overall Study|Adverse Event|29|||
130168283|NCT00168818|468576882|FG002|Overall Study|Adverse Event|31|||
130168284|NCT00168818|468576880|FG000|Overall Study|Protocol Violation|16|||
130168285|NCT00168818|468576881|FG001|Overall Study|Protocol Violation|11|||
130168286|NCT00168818|468576882|FG002|Overall Study|Protocol Violation|11|||
130168287|NCT00168818|468576880|FG000|Overall Study|Lost to Follow-up|13|||
130168288|NCT00168818|468576881|FG001|Overall Study|Lost to Follow-up|4|||
130168289|NCT00168818|468576882|FG002|Overall Study|Lost to Follow-up|15|||
130168290|NCT00168818|468576880|FG000|Overall Study|Withdrawal by Subject|43|||
130168291|NCT00168818|468576881|FG001|Overall Study|Withdrawal by Subject|41|||
130168292|NCT00168818|468576882|FG002|Overall Study|Withdrawal by Subject|37|||
130168293|NCT00168818|468576880|FG000|Overall Study|Other|22|||
130168294|NCT00168818|468576881|FG001|Overall Study|Other|24|||
130168295|NCT00168818|468576882|FG002|Overall Study|Other|30|||
130168296|NCT00168818|468576880|FG000|Treatment|Adverse Event|77|||
130168297|NCT00168818|468576881|FG001|Treatment|Adverse Event|89|||
130168298|NCT00168818|468576882|FG002|Treatment|Adverse Event|68|||
130168299|NCT00168818|468576880|FG000|Treatment|Protocol Violation|8|||
130168300|NCT00168818|468576881|FG001|Treatment|Protocol Violation|11|||
130168301|NCT00168818|468576882|FG002|Treatment|Protocol Violation|11|||
130168302|NCT00168818|468576880|FG000|Treatment|Lost to Follow-up|0|||
130168303|NCT00168818|468576881|FG001|Treatment|Lost to Follow-up|2|||
130168304|NCT00168818|468576882|FG002|Treatment|Lost to Follow-up|1|||
130168305|NCT00168818|468576880|FG000|Treatment|Withdrawal by Subject|25|||
130168306|NCT00168818|468576881|FG001|Treatment|Withdrawal by Subject|20|||
130168307|NCT00168818|468576882|FG002|Treatment|Withdrawal by Subject|22|||
130168308|NCT00168818|468576880|FG000|Treatment|Other|23|||
130168309|NCT00168818|468576881|FG001|Treatment|Other|29|||
130168310|NCT00168818|468576882|FG002|Treatment|Other|31|||
130168311|NCT00469144|468576885|FG000|Overall Study|Death|0|||
130168312|NCT00469144|468576886|FG001|Overall Study|Death|1|||
130168313|NCT00469144|468576885|FG000|Overall Study|No Response|5|||
130168314|NCT00469144|468576886|FG001|Overall Study|No Response|5|||
130168315|NCT00469144|468576885|FG000|Overall Study|Progressive Disease|1|||
130168316|NCT00469144|468576886|FG001|Overall Study|Progressive Disease|0|||
130168317|NCT04602546|468576887|FG000|Overall Study|Training|2|||
130168318|NCT04602546|468576888|FG001|Overall Study|Training|2|||
130168319|NCT04602546|468576889|FG002|Overall Study|Training|1|||
130168320|NCT04602546|468576890|FG003|Overall Study|Training|2|||
130168321|NCT04602546|468576891|FG004|Overall Study|Training|0|||
130168322|NCT04602546|468576887|FG000|Overall Study|Randomized with disqualified data|2|||
130168323|NCT04602546|468576888|FG001|Overall Study|Randomized with disqualified data|0|||
130168324|NCT04602546|468576889|FG002|Overall Study|Randomized with disqualified data|2|||
130168325|NCT04602546|468576890|FG003|Overall Study|Randomized with disqualified data|5|||
130168326|NCT04602546|468576891|FG004|Overall Study|Randomized with disqualified data|3|||
130168327|NCT02794246|468576892|FG000|Overall Study|Withdrawal by Subject|2|||
130168328|NCT02794246|468576892|FG000|Overall Study|Physician Decision|4|||
130168329|NCT01994291|468576893|FG000|Overall Study|Adverse Event|4|||
130168330|NCT01994291|468576894|FG001|Overall Study|Adverse Event|1|||
130168331|NCT01994291|468576895|FG002|Overall Study|Adverse Event|3|||
130168332|NCT01994291|468576893|FG000|Overall Study|Lost to Follow-up|1|||
130168333|NCT01994291|468576894|FG001|Overall Study|Lost to Follow-up|1|||
130168334|NCT01994291|468576895|FG002|Overall Study|Lost to Follow-up|0|||
130168335|NCT01994291|468576893|FG000|Overall Study|Does not meet entrance criteria|1|||
130168336|NCT01994291|468576894|FG001|Overall Study|Does not meet entrance criteria|0|||
130168337|NCT01994291|468576895|FG002|Overall Study|Does not meet entrance criteria|0|||
130168338|NCT01994291|468576893|FG000|Overall Study|Medication error without associated AE|1|||
130168339|NCT01994291|468576894|FG001|Overall Study|Medication error without associated AE|0|||
130168340|NCT01994291|468576895|FG002|Overall Study|Medication error without associated AE|1|||
130168341|NCT01994291|468576893|FG000|Overall Study|Protocol Violation|1|||
130168342|NCT01994291|468576894|FG001|Overall Study|Protocol Violation|0|||
130168343|NCT01994291|468576895|FG002|Overall Study|Protocol Violation|0|||
130168344|NCT01994291|468576893|FG000|Overall Study|Withdrawal by Subject|6|||
130168345|NCT01994291|468576894|FG001|Overall Study|Withdrawal by Subject|3|||
130168346|NCT01994291|468576895|FG002|Overall Study|Withdrawal by Subject|5|||
130168347|NCT01994291|468576893|FG000|Overall Study|Other|1|||
130168348|NCT01994291|468576894|FG001|Overall Study|Other|2|||
130168349|NCT01994291|468576895|FG002|Overall Study|Other|0|||
130168350|NCT01775189|468576896|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130168351|NCT01775189|468576897|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
130168352|NCT01775189|468576898|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130168353|NCT01775189|468576899|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130168354|NCT01775189|468576900|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130168355|NCT01775189|468576901|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130168356|NCT01775189|468576902|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
130168357|NCT01775189|468576896|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130168358|NCT01775189|468576897|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
130168359|NCT01775189|468576898|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130168360|NCT01775189|468576899|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130168361|NCT01775189|468576900|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130168362|NCT01775189|468576901|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130168363|NCT01775189|468576902|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
130168364|NCT01775189|468576896|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130168365|NCT01775189|468576897|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
130168366|NCT01775189|468576898|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
130168367|NCT01775189|468576899|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130168368|NCT01775189|468576900|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130168369|NCT01775189|468576901|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
130168370|NCT01775189|468576902|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129981926|NCT05051462|467896801|FG000|Overall Study|Withdrawal by Subject|1|||
130168371|NCT01775189|468576896|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129981927|NCT05051462|467896802|FG001|Overall Study|Withdrawal by Subject|0|||
130168372|NCT01775189|468576897|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130168373|NCT01775189|468576898|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130168374|NCT01775189|468576899|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130168375|NCT01775189|468576900|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129981928|NCT05051462|467896801|FG000|Overall Study|Protocol Violation|0|||
130168376|NCT01775189|468576901|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
130168377|NCT01775189|468576902|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
130168378|NCT01775189|468576896|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130168379|NCT01775189|468576897|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130168380|NCT01775189|468576898|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130168381|NCT01775189|468576899|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
130168382|NCT01775189|468576900|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130168383|NCT01775189|468576901|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130168384|NCT01775189|468576902|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
130168385|NCT01775189|468576896|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130168386|NCT01775189|468576897|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130168387|NCT01775189|468576898|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130168388|NCT01775189|468576899|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
130168389|NCT01775189|468576900|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130168390|NCT01775189|468576901|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
130168391|NCT01775189|468576902|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
130168392|NCT00856375|468576903|FG000|Overall Study|Other|0|||
130168393|NCT00856375|468576904|FG001|Overall Study|Other|1|||
130168394|NCT00856375|468576903|FG000|Overall Study|Death|32|||
130168395|NCT00856375|468576904|FG001|Overall Study|Death|30|||
130168396|NCT00856375|468576903|FG000|Overall Study|Sponsor Terminated Study|7|||
130168397|NCT00856375|468576904|FG001|Overall Study|Sponsor Terminated Study|7|||
130168398|NCT00856375|468576903|FG000|Overall Study|Withdrawal by Subject|2|||
130168399|NCT00856375|468576904|FG001|Overall Study|Withdrawal by Subject|1|||
130168400|NCT00856375|468576903|FG000|Overall Study|Lost to Follow-up|1|||
130168401|NCT00856375|468576904|FG001|Overall Study|Lost to Follow-up|2|||
130168402|NCT02121392|468576907|FG000|Prior to Intervention|Protocol Violation|40|||
130168403|NCT02121392|468576908|FG001|Prior to Intervention|Protocol Violation|35|||
130168404|NCT02121392|468576907|FG000|Prior to Intervention|Withdrawal by Subject|8|||
130168405|NCT02121392|468576908|FG001|Prior to Intervention|Withdrawal by Subject|6|||
130168406|NCT02121392|468576907|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
130168407|NCT02121392|468576908|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
130168408|NCT02121392|468576907|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
130168409|NCT02121392|468576908|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
130168410|NCT01352416|468576909|FG000|Overall Study|Physician Decision|1|||
130168411|NCT01352416|468576910|FG001|Overall Study|Physician Decision|2|||
130168412|NCT01352416|468576911|FG002|Overall Study|Physician Decision|2|||
130168413|NCT01352416|468576912|FG003|Overall Study|Physician Decision|1|||
130168414|NCT00811928|468576923|FG000|Overall Study|AEs and SAEs Including Death|7|||
130168415|NCT00811928|468576924|FG001|Overall Study|AEs and SAEs Including Death|11|||
130168416|NCT00811928|468576923|FG000|Overall Study|Withdrawal by Subject|18|||
130168417|NCT00811928|468576924|FG001|Overall Study|Withdrawal by Subject|12|||
130168418|NCT00811928|468576923|FG000|Overall Study|Did Not Take Study Drug|3|||
130168419|NCT00811928|468576924|FG001|Overall Study|Did Not Take Study Drug|0|||
130168420|NCT00811928|468576923|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
130168421|NCT00811928|468576924|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
130168422|NCT00811928|468576923|FG000|Overall Study|Investigator Decision|2|||
130168423|NCT00811928|468576924|FG001|Overall Study|Investigator Decision|1|||
130168424|NCT00811928|468576923|FG000|Overall Study|Poor Compliance|2|||
130168425|NCT00811928|468576924|FG001|Overall Study|Poor Compliance|5|||
130168426|NCT00171951|468576925|FG000|Overall Study|Adverse Event|1|||
130168427|NCT00171951|468576925|FG000|Overall Study|Abnormal Laboratory Values|2|||
130168428|NCT00171951|468576925|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130168429|NCT00171951|468576925|FG000|Overall Study|Participants Withdrew Consent|3|||
130168430|NCT00171951|468576925|FG000|Overall Study|New Cancer Therapy|5|||
130168431|NCT00171951|468576925|FG000|Overall Study|Reason not Specified|2|||
130168432|NCT00396812|468576926|FG000|Overall Study|Physician Decision|1|||
130168433|NCT00843635|468576935|FG000|Overall Study|Adverse Event|2|||
130168434|NCT00843635|468576936|FG001|Overall Study|Adverse Event|2|||
130168435|NCT00843635|468576937|FG002|Overall Study|Adverse Event|0|||
130168436|NCT03496610|468576938|FG000|Overall Study|Lost to Follow-up|3|||
130168437|NCT03496610|468576939|FG001|Overall Study|Lost to Follow-up|2|||
130168438|NCT03496610|468576938|FG000|Overall Study|Physician Decision|1|||
129981929|NCT05051462|467896802|FG001|Overall Study|Protocol Violation|2|||
130168439|NCT03496610|468576939|FG001|Overall Study|Physician Decision|0|||
130168440|NCT03496610|468576938|FG000|Overall Study|Withdrawal by Subject|1|||
130168441|NCT03496610|468576939|FG001|Overall Study|Withdrawal by Subject|0|||
130168442|NCT02714426|468576943|FG000|Overall Study|Withdrawal by Subject|2|||
130168443|NCT02714426|468576944|FG001|Overall Study|Withdrawal by Subject|2|||
129981930|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
130168444|NCT04435184|468576945|FG000|Overall Study|follow-up blood draws missing|3|||
130168445|NCT04435184|468576946|FG001|Overall Study|follow-up blood draws missing|5|||
129981931|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
130168446|NCT00813800|468576950|FG000|Overall Study|Screen Failure after Consent|2|||
130168447|NCT00813800|468576950|FG000|Overall Study|Adverse Event|1|||
130168448|NCT00813800|468576950|FG000|Overall Study|Worsening of depression|2|||
130168449|NCT00813800|468576950|FG000|Overall Study|Physician Decision|1|||
130168450|NCT03456453|468576951|FG000|Overall Study|Withdrawal by Subject|2|||
130168451|NCT03456453|468576952|FG001|Overall Study|Withdrawal by Subject|0|||
130168452|NCT03456453|468576951|FG000|Overall Study|Not released to community|1|||
130168453|NCT03456453|468576952|FG001|Overall Study|Not released to community|5|||
130168454|NCT03456453|468576951|FG000|Overall Study|Lost to Follow-up|0|||
130168455|NCT03456453|468576952|FG001|Overall Study|Lost to Follow-up|2|||
130168456|NCT04762277|468576953|FG000|Overall Study|Withdrawal by Subject|0|||
130168457|NCT04762277|468576954|FG001|Overall Study|Withdrawal by Subject|2|||
130168458|NCT04762277|468576953|FG000|Overall Study|Protocol Violation|0|||
130168459|NCT04762277|468576954|FG001|Overall Study|Protocol Violation|1|||
130168460|NCT04762277|468576953|FG000|Overall Study|Adverse Event|1|||
130168461|NCT04762277|468576954|FG001|Overall Study|Adverse Event|0|||
130168462|NCT01860677|468576955|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
130168463|NCT01860677|468576956|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
130168464|NCT00896480|468576957|FG000|Overall Study|Disease progression/recurrence|21|||
130168465|NCT00642278|468576958|FG000|Overall Study|Adverse Event|2|||
130168466|NCT00642278|468576959|FG001|Overall Study|Adverse Event|1|||
130168467|NCT00642278|468576960|FG002|Overall Study|Adverse Event|3|||
130168468|NCT00642278|468576961|FG003|Overall Study|Adverse Event|1|||
130168469|NCT00642278|468576962|FG004|Overall Study|Adverse Event|2|||
130168470|NCT00642278|468576963|FG005|Overall Study|Adverse Event|2|||
130168471|NCT00642278|468576964|FG006|Overall Study|Adverse Event|0|||
130168472|NCT00642278|468576958|FG000|Overall Study|Lack of Efficacy|0|||
130168473|NCT00642278|468576959|FG001|Overall Study|Lack of Efficacy|1|||
130168474|NCT00642278|468576960|FG002|Overall Study|Lack of Efficacy|0|||
130168475|NCT00642278|468576961|FG003|Overall Study|Lack of Efficacy|0|||
130168476|NCT00642278|468576962|FG004|Overall Study|Lack of Efficacy|0|||
130168477|NCT00642278|468576963|FG005|Overall Study|Lack of Efficacy|0|||
130168478|NCT00642278|468576964|FG006|Overall Study|Lack of Efficacy|0|||
130168479|NCT00642278|468576958|FG000|Overall Study|Lost to Follow-up|5|||
130168480|NCT00642278|468576959|FG001|Overall Study|Lost to Follow-up|1|||
130168481|NCT00642278|468576960|FG002|Overall Study|Lost to Follow-up|0|||
130168482|NCT00642278|468576961|FG003|Overall Study|Lost to Follow-up|1|||
130168483|NCT00642278|468576962|FG004|Overall Study|Lost to Follow-up|0|||
130168484|NCT00642278|468576963|FG005|Overall Study|Lost to Follow-up|1|||
130168485|NCT00642278|468576964|FG006|Overall Study|Lost to Follow-up|1|||
130168486|NCT00642278|468576958|FG000|Overall Study|Physician Decision|0|||
130168487|NCT00642278|468576959|FG001|Overall Study|Physician Decision|0|||
130168488|NCT00642278|468576960|FG002|Overall Study|Physician Decision|0|||
130168489|NCT00642278|468576961|FG003|Overall Study|Physician Decision|1|||
130168490|NCT00642278|468576962|FG004|Overall Study|Physician Decision|0|||
130168491|NCT00642278|468576963|FG005|Overall Study|Physician Decision|0|||
130168492|NCT00642278|468576964|FG006|Overall Study|Physician Decision|0|||
130168493|NCT00642278|468576958|FG000|Overall Study|Protocol Violation|0|||
130168494|NCT00642278|468576959|FG001|Overall Study|Protocol Violation|0|||
130168495|NCT00642278|468576960|FG002|Overall Study|Protocol Violation|1|||
130168496|NCT00642278|468576961|FG003|Overall Study|Protocol Violation|1|||
130168497|NCT00642278|468576962|FG004|Overall Study|Protocol Violation|0|||
130168498|NCT00642278|468576963|FG005|Overall Study|Protocol Violation|1|||
130168499|NCT00642278|468576964|FG006|Overall Study|Protocol Violation|2|||
130168500|NCT00642278|468576958|FG000|Overall Study|Withdrawal by Subject|1|||
130168501|NCT00642278|468576959|FG001|Overall Study|Withdrawal by Subject|1|||
130168502|NCT00642278|468576960|FG002|Overall Study|Withdrawal by Subject|1|||
130168503|NCT00642278|468576961|FG003|Overall Study|Withdrawal by Subject|3|||
130168504|NCT00642278|468576962|FG004|Overall Study|Withdrawal by Subject|6|||
130168505|NCT00642278|468576963|FG005|Overall Study|Withdrawal by Subject|2|||
130168506|NCT00642278|468576964|FG006|Overall Study|Withdrawal by Subject|2|||
130168507|NCT00642278|468576958|FG000|Overall Study|Noncompliance with study drug regimen|0|||
130168508|NCT00642278|468576959|FG001|Overall Study|Noncompliance with study drug regimen|0|||
130168509|NCT00642278|468576960|FG002|Overall Study|Noncompliance with study drug regimen|0|||
130168510|NCT00642278|468576961|FG003|Overall Study|Noncompliance with study drug regimen|1|||
130168511|NCT00642278|468576962|FG004|Overall Study|Noncompliance with study drug regimen|0|||
130168512|NCT00642278|468576963|FG005|Overall Study|Noncompliance with study drug regimen|0|||
130168513|NCT00642278|468576964|FG006|Overall Study|Noncompliance with study drug regimen|0|||
130168514|NCT00642278|468576958|FG000|Overall Study|Other|2|||
130168515|NCT00642278|468576959|FG001|Overall Study|Other|1|||
130168516|NCT00642278|468576960|FG002|Overall Study|Other|0|||
130168517|NCT00642278|468576961|FG003|Overall Study|Other|1|||
130168518|NCT00642278|468576962|FG004|Overall Study|Other|0|||
130168519|NCT00642278|468576963|FG005|Overall Study|Other|1|||
130168520|NCT00642278|468576964|FG006|Overall Study|Other|0|||
130168521|NCT00090363|468576965|FG000|Overall Study|Lost to Follow-up|1|||
130168522|NCT00090363|468576966|FG001|Overall Study|Lost to Follow-up|2|||
130168523|NCT00090363|468576967|FG002|Overall Study|Lost to Follow-up|1|||
130168524|NCT00090363|468576965|FG000|Overall Study|Withdrawal by Subject|7|||
130168525|NCT00090363|468576966|FG001|Overall Study|Withdrawal by Subject|7|||
130168526|NCT00090363|468576967|FG002|Overall Study|Withdrawal by Subject|6|||
130168527|NCT00090363|468576965|FG000|Overall Study|Study-specific discontinuation criteria|75|||
130168528|NCT00090363|468576966|FG001|Overall Study|Study-specific discontinuation criteria|74|||
130168529|NCT00090363|468576967|FG002|Overall Study|Study-specific discontinuation criteria|62|||
130168530|NCT00090363|468576965|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130168531|NCT00090363|468576966|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
130168532|NCT00090363|468576967|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130168533|NCT00090363|468576965|FG000|Overall Study|Consent expired|7|||
130168534|NCT00090363|468576966|FG001|Overall Study|Consent expired|10|||
130168535|NCT00090363|468576967|FG002|Overall Study|Consent expired|9|||
129981932|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
129981933|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
129981934|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
129981935|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
130168536|NCT00090363|468576965|FG000|Overall Study|Reasons not specified|2|||
130168537|NCT00090363|468576966|FG001|Overall Study|Reasons not specified|1|||
130168538|NCT00090363|468576967|FG002|Overall Study|Reasons not specified|1|||
130168539|NCT00090363|468576965|FG000|Overall Study|Continuing on study off treatment|14|||
130168540|NCT00090363|468576966|FG001|Overall Study|Continuing on study off treatment|13|||
130168541|NCT00090363|468576967|FG002|Overall Study|Continuing on study off treatment|16|||
130168542|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130168543|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130168544|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
130168545|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130168546|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130168547|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
130168548|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130168549|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130168550|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130168551|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130168552|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130168553|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130168554|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
130168555|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
130168556|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
130168557|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130168558|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130168559|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130168560|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130168561|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130168562|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
130168563|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
130168564|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
130168565|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130168566|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130168567|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130168568|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130168569|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
130168570|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130168571|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
130168572|NCT03713619|468576968|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
130168573|NCT03713619|468576969|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
130168574|NCT03713619|468576970|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130168575|NCT03713619|468576971|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130168576|NCT03713619|468576972|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
130168577|NCT03713619|468576968|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
130168578|NCT03713619|468576969|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
130168579|NCT03713619|468576970|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
130168580|NCT03713619|468576971|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
130168581|NCT03713619|468576972|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
130168582|NCT03713619|468576968|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130168583|NCT03713619|468576969|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130168584|NCT03713619|468576970|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130168585|NCT03713619|468576971|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130168586|NCT03713619|468576972|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130168587|NCT03713619|468576968|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
130168588|NCT03713619|468576969|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
130168589|NCT03713619|468576970|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
130168590|NCT03713619|468576971|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
130168591|NCT03713619|468576972|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
130168592|NCT03713619|468576968|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
130168593|NCT03713619|468576969|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
130168594|NCT03713619|468576970|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
130168595|NCT03713619|468576971|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
130168596|NCT03713619|468576972|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
130168597|NCT03713619|468576968|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
130168598|NCT03713619|468576969|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
130168599|NCT03713619|468576970|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130168600|NCT03713619|468576971|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
130168601|NCT03713619|468576972|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
130168602|NCT03713619|468576968|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130168603|NCT03713619|468576969|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130168604|NCT03713619|468576970|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130168605|NCT03713619|468576971|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130168606|NCT03713619|468576972|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130168607|NCT00197496|468576978|FG000|Baseline to Discharge|not interested|1|||
130168608|NCT00197496|468576979|FG001|Baseline to Discharge|not interested|0|||
130168609|NCT00197496|468576978|FG000|Baseline to Discharge|MRSA|1|||
130168610|NCT00197496|468576979|FG001|Baseline to Discharge|MRSA|0|||
130168611|NCT00197496|468576978|FG000|Baseline to Discharge|Physician Decision|0|||
130168612|NCT00197496|468576979|FG001|Baseline to Discharge|Physician Decision|1|||
130168613|NCT00197496|468576978|FG000|Baseline to Discharge|Protocol Violation|0|||
130168614|NCT00197496|468576979|FG001|Baseline to Discharge|Protocol Violation|1|||
130168615|NCT00197496|468576978|FG000|Follow-up|Lost to Follow-up|2|||
130168616|NCT00197496|468576979|FG001|Follow-up|Lost to Follow-up|1|||
130168617|NCT00857584|468576980|FG000|Overall Study|Lack of Efficacy|1|||
130168618|NCT00857584|468576981|FG001|Overall Study|Lack of Efficacy|2|||
130168619|NCT00857584|468576980|FG000|Overall Study|Adverse Event|2|||
130168620|NCT00857584|468576981|FG001|Overall Study|Adverse Event|2|||
130168621|NCT00857584|468576980|FG000|Overall Study|Physician Decision|1|||
130168622|NCT00857584|468576981|FG001|Overall Study|Physician Decision|1|||
130168623|NCT00259272|468576982|FG000|Overall Study|Adverse Event|2|||
130168624|NCT00259272|468576983|FG001|Overall Study|Adverse Event|1|||
130168625|NCT00259272|468576984|FG002|Overall Study|Adverse Event|0|||
130168626|NCT00259272|468576985|FG003|Overall Study|Adverse Event|3|||
130168627|NCT00259272|468576982|FG000|Overall Study|Lack of Efficacy|5|||
130168628|NCT00259272|468576983|FG001|Overall Study|Lack of Efficacy|1|||
130168629|NCT00259272|468576984|FG002|Overall Study|Lack of Efficacy|2|||
130168630|NCT00259272|468576985|FG003|Overall Study|Lack of Efficacy|6|||
130168631|NCT00259272|468576982|FG000|Overall Study|Physician Decision|1|||
130168632|NCT00259272|468576983|FG001|Overall Study|Physician Decision|2|||
130168633|NCT00259272|468576984|FG002|Overall Study|Physician Decision|1|||
130168634|NCT00259272|468576985|FG003|Overall Study|Physician Decision|3|||
130168635|NCT00259272|468576982|FG000|Overall Study|Protocol Violation|2|||
130168636|NCT00259272|468576983|FG001|Overall Study|Protocol Violation|0|||
130168637|NCT00259272|468576984|FG002|Overall Study|Protocol Violation|0|||
130168638|NCT00259272|468576985|FG003|Overall Study|Protocol Violation|1|||
130168639|NCT00259272|468576982|FG000|Overall Study|Sponsor Decision|0|||
130168640|NCT00259272|468576983|FG001|Overall Study|Sponsor Decision|1|||
130168641|NCT00259272|468576984|FG002|Overall Study|Sponsor Decision|0|||
130168642|NCT00259272|468576985|FG003|Overall Study|Sponsor Decision|0|||
130168643|NCT00259272|468576982|FG000|Overall Study|Withdrawal by Subject|4|||
130168644|NCT00259272|468576983|FG001|Overall Study|Withdrawal by Subject|2|||
130168645|NCT00259272|468576984|FG002|Overall Study|Withdrawal by Subject|2|||
130168646|NCT00259272|468576985|FG003|Overall Study|Withdrawal by Subject|7|||
130168647|NCT00259272|468576982|FG000|Overall Study|Lost to Follow-up|1|||
130168648|NCT00259272|468576983|FG001|Overall Study|Lost to Follow-up|0|||
130168649|NCT00259272|468576984|FG002|Overall Study|Lost to Follow-up|0|||
130168650|NCT00259272|468576985|FG003|Overall Study|Lost to Follow-up|1|||
130168651|NCT01908907|468578282|FG000|Overall Study|Physician Decision|1|||
130168652|NCT01908907|468578283|FG001|Overall Study|Physician Decision|0|||
130168653|NCT01908907|468578282|FG000|Overall Study|Protocol Violation|1|||
130168654|NCT01908907|468578283|FG001|Overall Study|Protocol Violation|0|||
130168655|NCT00761657|468578284|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
130168656|NCT00761657|468578285|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
130168657|NCT00761657|468578286|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
130168658|NCT00761657|468578287|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
130168659|NCT00761657|468578288|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
130168660|NCT00761657|468578289|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
130168661|NCT00761657|468578290|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
130168662|NCT00761657|468578291|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
130168663|NCT00761657|468578292|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
130168664|NCT00761657|468578284|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168665|NCT00761657|468578285|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168666|NCT00761657|468578286|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
130168667|NCT00761657|468578287|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
130168668|NCT00761657|468578288|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168669|NCT00761657|468578289|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168670|NCT00761657|468578290|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168671|NCT00761657|468578291|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168672|NCT00761657|468578292|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
130168673|NCT00761657|468578284|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
130168674|NCT00761657|468578285|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
130168675|NCT00761657|468578286|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
130168676|NCT00761657|468578287|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
130168677|NCT00761657|468578288|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
130168678|NCT00761657|468578289|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
130168679|NCT00761657|468578290|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
130168680|NCT00761657|468578291|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
130168681|NCT00761657|468578292|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
130168682|NCT00761657|468578284|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
130168683|NCT00761657|468578285|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
130168684|NCT00761657|468578286|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
130168685|NCT00761657|468578287|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
130168686|NCT00761657|468578288|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
130168687|NCT00761657|468578289|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
130168688|NCT00761657|468578290|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
130168689|NCT00761657|468578291|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
130168690|NCT00761657|468578292|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
130168691|NCT00359801|468578293|FG000|Overall Study|Lost to Follow-up|72|||
130168692|NCT00359801|468578294|FG001|Overall Study|Lost to Follow-up|58|||
130168693|NCT00359801|468578293|FG000|Overall Study|Withdrawal by Subject|143|||
130168694|NCT00359801|468578294|FG001|Overall Study|Withdrawal by Subject|96|||
130168695|NCT00359801|468578293|FG000|Overall Study|Other|66|||
130168696|NCT00359801|468578294|FG001|Overall Study|Other|46|||
130168697|NCT00359801|468578293|FG000|Overall Study|Final Status Unknown: missing data|7|||
130168698|NCT00359801|468578294|FG001|Overall Study|Final Status Unknown: missing data|4|||
130168699|NCT00359801|468578293|FG000|Overall Study|Sponsor Decision|17|||
130168700|NCT00359801|468578294|FG001|Overall Study|Sponsor Decision|16|||
130168701|NCT03151408|468578299|FG000|Overall Study|Adverse Event|24|||
130168702|NCT03151408|468578300|FG001|Overall Study|Adverse Event|23|||
130168703|NCT03151408|468578299|FG000|Overall Study|Death|46|||
130168704|NCT03151408|468578300|FG001|Overall Study|Death|26|||
130168705|NCT03151408|468578299|FG000|Overall Study|Physician Decision|13|||
130168706|NCT03151408|468578300|FG001|Overall Study|Physician Decision|19|||
130168707|NCT03151408|468578299|FG000|Overall Study|Withdrawal by Subject|16|||
130168708|NCT03151408|468578300|FG001|Overall Study|Withdrawal by Subject|20|||
130168709|NCT03151408|468578299|FG000|Overall Study|Progressive disease|45|||
130168710|NCT03151408|468578300|FG001|Overall Study|Progressive disease|61|||
130168711|NCT03151408|468578299|FG000|Overall Study|non-compliance by patient|1|||
130168712|NCT03151408|468578300|FG001|Overall Study|non-compliance by patient|0|||
130168713|NCT03151408|468578299|FG000|Overall Study|other reasons|56|||
130168714|NCT03151408|468578300|FG001|Overall Study|other reasons|52|||
130168715|NCT03151408|468578299|FG000|Overall Study|randomized and not treated|2|||
130168716|NCT03151408|468578300|FG001|Overall Study|randomized and not treated|2|||
130168717|NCT01473524|468578303|FG000|DB Phase|Adverse Event|4|||
130168718|NCT01473524|468578304|FG001|DB Phase|Adverse Event|8|||
130168719|NCT01473524|468578305|FG002|DB Phase|Adverse Event|2|||
130168720|NCT01473524|468578306|FG003|DB Phase|Adverse Event|0|||
130168721|NCT01473524|468578307|FG004|DB Phase|Adverse Event|0|||
129981936|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
129981937|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
129981938|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
130168722|NCT01473524|468578308|FG005|DB Phase|Adverse Event|0|||
130168723|NCT01473524|468578303|FG000|DB Phase|Death|1|||
130168724|NCT01473524|468578304|FG001|DB Phase|Death|0|||
130168725|NCT01473524|468578305|FG002|DB Phase|Death|0|||
130168726|NCT01473524|468578306|FG003|DB Phase|Death|0|||
130168727|NCT01473524|468578307|FG004|DB Phase|Death|0|||
130168728|NCT01473524|468578308|FG005|DB Phase|Death|0|||
130168729|NCT01473524|468578303|FG000|DB Phase|Withdrawal by Subject|2|||
130168730|NCT01473524|468578304|FG001|DB Phase|Withdrawal by Subject|1|||
130168731|NCT01473524|468578305|FG002|DB Phase|Withdrawal by Subject|1|||
130168732|NCT01473524|468578306|FG003|DB Phase|Withdrawal by Subject|0|||
130168733|NCT01473524|468578307|FG004|DB Phase|Withdrawal by Subject|0|||
130168734|NCT01473524|468578308|FG005|DB Phase|Withdrawal by Subject|0|||
130168735|NCT01473524|468578303|FG000|LTSE Phase|Withdrawal by Subject|0|||
130168736|NCT01473524|468578304|FG001|LTSE Phase|Withdrawal by Subject|0|||
130168737|NCT01473524|468578305|FG002|LTSE Phase|Withdrawal by Subject|0|||
130168738|NCT01473524|468578306|FG003|LTSE Phase|Withdrawal by Subject|3|||
130168739|NCT01473524|468578307|FG004|LTSE Phase|Withdrawal by Subject|3|||
130168740|NCT01473524|468578308|FG005|LTSE Phase|Withdrawal by Subject|6|||
130168741|NCT01473524|468578303|FG000|LTSE Phase|Death|0|||
130168742|NCT01473524|468578304|FG001|LTSE Phase|Death|0|||
130168743|NCT01473524|468578305|FG002|LTSE Phase|Death|0|||
130168744|NCT01473524|468578306|FG003|LTSE Phase|Death|0|||
130168745|NCT01473524|468578307|FG004|LTSE Phase|Death|1|||
130168746|NCT01473524|468578308|FG005|LTSE Phase|Death|0|||
130168747|NCT01473524|468578303|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
130168748|NCT01473524|468578304|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
130168749|NCT01473524|468578305|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
130168750|NCT01473524|468578306|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
130168751|NCT01473524|468578307|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
130168752|NCT01473524|468578308|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
130168753|NCT01473524|468578303|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130168754|NCT01473524|468578304|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130168755|NCT01473524|468578305|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
130168756|NCT01473524|468578306|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
130168757|NCT01473524|468578307|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
130168758|NCT01473524|468578308|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
130168759|NCT01473524|468578303|FG000|LTSE Phase|Lost to Follow-up|0|||
130168760|NCT01473524|468578304|FG001|LTSE Phase|Lost to Follow-up|0|||
130168761|NCT01473524|468578305|FG002|LTSE Phase|Lost to Follow-up|0|||
130168762|NCT01473524|468578306|FG003|LTSE Phase|Lost to Follow-up|1|||
130168763|NCT01473524|468578307|FG004|LTSE Phase|Lost to Follow-up|3|||
130168764|NCT01473524|468578308|FG005|LTSE Phase|Lost to Follow-up|2|||
130168765|NCT01473524|468578303|FG000|LTSE Phase|Principal Investigator Decision|0|||
130168766|NCT01473524|468578304|FG001|LTSE Phase|Principal Investigator Decision|0|||
130168767|NCT01473524|468578305|FG002|LTSE Phase|Principal Investigator Decision|0|||
130168768|NCT01473524|468578306|FG003|LTSE Phase|Principal Investigator Decision|1|||
130168769|NCT01473524|468578307|FG004|LTSE Phase|Principal Investigator Decision|1|||
130168770|NCT01473524|468578308|FG005|LTSE Phase|Principal Investigator Decision|3|||
130168771|NCT01473524|468578303|FG000|LTSE Phase|Liver Transplantation|0|||
130168772|NCT01473524|468578304|FG001|LTSE Phase|Liver Transplantation|0|||
130168773|NCT01473524|468578305|FG002|LTSE Phase|Liver Transplantation|0|||
130168774|NCT01473524|468578306|FG003|LTSE Phase|Liver Transplantation|0|||
130168775|NCT01473524|468578307|FG004|LTSE Phase|Liver Transplantation|0|||
130168776|NCT01473524|468578308|FG005|LTSE Phase|Liver Transplantation|1|||
130168777|NCT01473524|468578303|FG000|LTSE Phase|Pregnancy|0|||
130168778|NCT01473524|468578304|FG001|LTSE Phase|Pregnancy|0|||
130168779|NCT01473524|468578305|FG002|LTSE Phase|Pregnancy|0|||
130168780|NCT01473524|468578306|FG003|LTSE Phase|Pregnancy|1|||
130168781|NCT01473524|468578307|FG004|LTSE Phase|Pregnancy|0|||
130168782|NCT01473524|468578308|FG005|LTSE Phase|Pregnancy|0|||
130168783|NCT01473524|468578303|FG000|LTSE Phase|Protocol Violation|0|||
130168784|NCT01473524|468578304|FG001|LTSE Phase|Protocol Violation|0|||
130168785|NCT01473524|468578305|FG002|LTSE Phase|Protocol Violation|0|||
130168786|NCT01473524|468578306|FG003|LTSE Phase|Protocol Violation|0|||
130168787|NCT01473524|468578307|FG004|LTSE Phase|Protocol Violation|0|||
130168788|NCT01473524|468578308|FG005|LTSE Phase|Protocol Violation|1|||
130168789|NCT02383810|468578309|FG000|Overall Study|Physician Decision|1|||
130168790|NCT02383810|468578310|FG001|Overall Study|Physician Decision|1|||
130168791|NCT02383810|468578311|FG002|Overall Study|Physician Decision|0|||
130168792|NCT02383810|468578312|FG003|Overall Study|Physician Decision|0|||
130168793|NCT02383810|468578313|FG004|Overall Study|Physician Decision|0|||
130168794|NCT02383810|468578314|FG005|Overall Study|Physician Decision|0|||
130168795|NCT02383810|468578315|FG006|Overall Study|Physician Decision|0|||
130168796|NCT02383810|468578316|FG007|Overall Study|Physician Decision|0|||
130168797|NCT02383810|468578309|FG000|Overall Study|Withdrawal by Subject|2|||
130168798|NCT02383810|468578310|FG001|Overall Study|Withdrawal by Subject|3|||
130168799|NCT02383810|468578311|FG002|Overall Study|Withdrawal by Subject|3|||
130168800|NCT02383810|468578312|FG003|Overall Study|Withdrawal by Subject|3|||
130168801|NCT02383810|468578313|FG004|Overall Study|Withdrawal by Subject|0|||
130168802|NCT02383810|468578314|FG005|Overall Study|Withdrawal by Subject|0|||
130168803|NCT02383810|468578315|FG006|Overall Study|Withdrawal by Subject|0|||
130168804|NCT02383810|468578316|FG007|Overall Study|Withdrawal by Subject|0|||
130168805|NCT02383810|468578309|FG000|Overall Study|Adverse Event|0|||
130168806|NCT02383810|468578310|FG001|Overall Study|Adverse Event|2|||
130168807|NCT02383810|468578311|FG002|Overall Study|Adverse Event|4|||
130168808|NCT02383810|468578312|FG003|Overall Study|Adverse Event|5|||
130168809|NCT02383810|468578313|FG004|Overall Study|Adverse Event|0|||
130168810|NCT02383810|468578314|FG005|Overall Study|Adverse Event|1|||
130168811|NCT02383810|468578315|FG006|Overall Study|Adverse Event|1|||
130168812|NCT02383810|468578316|FG007|Overall Study|Adverse Event|0|||
130168813|NCT02383810|468578309|FG000|Overall Study|Lost to Follow-up|0|||
130168814|NCT02383810|468578310|FG001|Overall Study|Lost to Follow-up|1|||
130168815|NCT02383810|468578311|FG002|Overall Study|Lost to Follow-up|0|||
130168816|NCT02383810|468578312|FG003|Overall Study|Lost to Follow-up|1|||
130168817|NCT02383810|468578313|FG004|Overall Study|Lost to Follow-up|0|||
130168818|NCT02383810|468578314|FG005|Overall Study|Lost to Follow-up|0|||
130168819|NCT02383810|468578315|FG006|Overall Study|Lost to Follow-up|0|||
130168820|NCT02383810|468578316|FG007|Overall Study|Lost to Follow-up|0|||
130168821|NCT02383810|468578309|FG000|Overall Study|other|0|||
130168822|NCT02383810|468578310|FG001|Overall Study|other|0|||
130168823|NCT02383810|468578311|FG002|Overall Study|other|0|||
130168824|NCT02383810|468578312|FG003|Overall Study|other|2|||
130168825|NCT02383810|468578313|FG004|Overall Study|other|0|||
130168826|NCT02383810|468578314|FG005|Overall Study|other|0|||
130168827|NCT02383810|468578315|FG006|Overall Study|other|0|||
130168828|NCT02383810|468578316|FG007|Overall Study|other|0|||
130168829|NCT02383810|468578309|FG000|Overall Study|subject did not receive study treatment|0|||
130168830|NCT02383810|468578310|FG001|Overall Study|subject did not receive study treatment|1|||
130168831|NCT02383810|468578311|FG002|Overall Study|subject did not receive study treatment|0|||
130168832|NCT02383810|468578312|FG003|Overall Study|subject did not receive study treatment|0|||
130168833|NCT02383810|468578313|FG004|Overall Study|subject did not receive study treatment|0|||
130168834|NCT02383810|468578314|FG005|Overall Study|subject did not receive study treatment|0|||
130168835|NCT02383810|468578315|FG006|Overall Study|subject did not receive study treatment|0|||
130168836|NCT02383810|468578316|FG007|Overall Study|subject did not receive study treatment|0|||
130168837|NCT00282919|468578317|FG000|Overall Study|Lack of Efficacy|4|||
130168838|NCT00282919|468578317|FG000|Overall Study|Withdrawal by Subject|1|||
130168839|NCT00282919|468578317|FG000|Overall Study|Asymptomatic Parasitemia|2|||
130168840|NCT02540850|468578320|FG000|Overall Study|Lost to Follow-up|69|||
130168841|NCT02540850|468578321|FG001|Overall Study|Lost to Follow-up|66|||
130168842|NCT02540850|468578322|FG002|Overall Study|Lost to Follow-up|34|||
130168843|NCT02861014|468578323|FG000|Primary Analysis|Adverse Event|7|||
130168844|NCT02861014|468578323|FG000|Primary Analysis|Death|1|||
130168845|NCT02861014|468578323|FG000|Primary Analysis|Lack of Efficacy|3|||
130168846|NCT02861014|468578323|FG000|Primary Analysis|Physician Decision|2|||
130168847|NCT02861014|468578323|FG000|Primary Analysis|Pregnancy|4|||
130168848|NCT02861014|468578323|FG000|Primary Analysis|Protocol Violation|2|||
130168849|NCT02861014|468578323|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
130168850|NCT02861014|468578323|FG000|Primary Analysis|Withdrawal by Subject|14|||
130168851|NCT02861014|468578323|FG000|Primary Analysis|Commercial ocrelizumab|3|||
130168852|NCT02861014|468578323|FG000|Safety Follow-up|Adverse Event|1|||
130168853|NCT02861014|468578323|FG000|Safety Follow-up|Pregnancy|1|||
130168854|NCT02861014|468578323|FG000|Safety Follow-up|Withdrawal by Subject|9|||
130168855|NCT02861014|468578323|FG000|Safety Follow-up|Study terminated by sponsor|1|||
130168856|NCT02861014|468578323|FG000|Safety Follow-up|Physician Decision|1|||
130168857|NCT02861014|468578323|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
130168858|NCT02861014|468578323|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
130168859|NCT00926783|468578324|FG000|Overall Study|Incomplete CFAE Procedures|3|||
130168860|NCT00926783|468578325|FG001|Overall Study|Incomplete CFAE Procedures|3|||
130168861|NCT02549027|468578327|FG000|Washout After Period 4|Withdrawal by Subject|0|||
130168862|NCT02549027|468578328|FG001|Washout After Period 4|Withdrawal by Subject|1|||
130168863|NCT02549027|468578329|FG002|Washout After Period 4|Withdrawal by Subject|1|||
130168864|NCT02549027|468578330|FG003|Washout After Period 4|Withdrawal by Subject|1|||
130168865|NCT02549027|468578331|FG004|Washout After Period 4|Withdrawal by Subject|0|||
130168866|NCT02549027|468578332|FG005|Washout After Period 4|Withdrawal by Subject|0|||
130168867|NCT02549027|468578327|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130168868|NCT02549027|468578328|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130168869|NCT02549027|468578329|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130168870|NCT02549027|468578330|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130168871|NCT02549027|468578331|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
130168872|NCT02549027|468578332|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
130168873|NCT02186834|468578333|FG000|Dose Escalation|Death|0|||
130168874|NCT02186834|468578334|FG001|Dose Escalation|Death|0|||
130168875|NCT02186834|468578335|FG002|Dose Escalation|Death|0|||
130168876|NCT02186834|468578336|FG003|Dose Escalation|Death|1|||
130168877|NCT02186834|468578337|FG004|Dose Escalation|Death|0|||
130168878|NCT02186834|468578338|FG005|Dose Escalation|Death|0|||
130168879|NCT02186834|468578333|FG000|Treatment at RP2D|Died prior to treatment|0|||
130168880|NCT02186834|468578334|FG001|Treatment at RP2D|Died prior to treatment|0|||
130168881|NCT02186834|468578335|FG002|Treatment at RP2D|Died prior to treatment|0|||
130168882|NCT02186834|468578336|FG003|Treatment at RP2D|Died prior to treatment|0|||
130168883|NCT02186834|468578337|FG004|Treatment at RP2D|Died prior to treatment|0|||
130168884|NCT02186834|468578338|FG005|Treatment at RP2D|Died prior to treatment|1|||
130168885|NCT04581369|468578344|FG000|Overall Study|Death|7|||
130168886|NCT04581369|468578345|FG001|Overall Study|Death|6|||
130168887|NCT04581369|468578346|FG002|Overall Study|Death|0|||
130168888|NCT04581369|468578344|FG000|Overall Study|Lost to Follow-up|7|||
130168889|NCT04581369|468578345|FG001|Overall Study|Lost to Follow-up|3|||
130168890|NCT04581369|468578346|FG002|Overall Study|Lost to Follow-up|0|||
130168891|NCT04581369|468578344|FG000|Overall Study|liver transplant|2|||
130168892|NCT04581369|468578345|FG001|Overall Study|liver transplant|2|||
130168893|NCT04581369|468578346|FG002|Overall Study|liver transplant|0|||
130168894|NCT04581369|468578344|FG000|Overall Study|transitioned to hospice care|0|||
130168895|NCT04581369|468578345|FG001|Overall Study|transitioned to hospice care|5|||
130168896|NCT04581369|468578346|FG002|Overall Study|transitioned to hospice care|0|||
130168897|NCT00780910|468578347|FG000|Overall Study|Adverse Event|2|||
130168898|NCT01111825|468578350|FG000|Overall Study|Withdrawal by Subject|0|||
130168899|NCT01111825|468578351|FG001|Overall Study|Withdrawal by Subject|0|||
130168900|NCT01111825|468578352|FG002|Overall Study|Withdrawal by Subject|1|||
130168901|NCT01111825|468578353|FG003|Overall Study|Withdrawal by Subject|0|||
130168902|NCT01111825|468578350|FG000|Overall Study|Lost to Follow-up|0|||
130168903|NCT01111825|468578351|FG001|Overall Study|Lost to Follow-up|0|||
130168904|NCT01111825|468578352|FG002|Overall Study|Lost to Follow-up|3|||
130168905|NCT01111825|468578353|FG003|Overall Study|Lost to Follow-up|1|||
130168906|NCT01111825|468578350|FG000|Overall Study|Adverse Event|2|||
130168907|NCT01111825|468578351|FG001|Overall Study|Adverse Event|1|||
130168908|NCT01111825|468578352|FG002|Overall Study|Adverse Event|4|||
130168909|NCT01111825|468578353|FG003|Overall Study|Adverse Event|0|||
130168910|NCT01111825|468578350|FG000|Overall Study|Disease Progression|1|||
130168911|NCT01111825|468578351|FG001|Overall Study|Disease Progression|0|||
130168912|NCT01111825|468578352|FG002|Overall Study|Disease Progression|0|||
130168913|NCT01111825|468578353|FG003|Overall Study|Disease Progression|0|||
130168914|NCT01111825|468578350|FG000|Overall Study|Discontinuation by Sponsor|0|||
130168915|NCT01111825|468578351|FG001|Overall Study|Discontinuation by Sponsor|0|||
130168916|NCT01111825|468578352|FG002|Overall Study|Discontinuation by Sponsor|0|||
130168917|NCT01111825|468578353|FG003|Overall Study|Discontinuation by Sponsor|20|||
130168918|NCT00741286|468578360|FG000|Overall Study|Lost to Follow-up|15|||
130168919|NCT00741286|468578361|FG001|Overall Study|Lost to Follow-up|10|||
130168920|NCT00741286|468578360|FG000|Overall Study|Adverse Event|1|||
130168921|NCT00741286|468578361|FG001|Overall Study|Adverse Event|6|||
130168922|NCT00741286|468578360|FG000|Overall Study|Protocol Violation|3|||
130168923|NCT00741286|468578361|FG001|Overall Study|Protocol Violation|2|||
130168924|NCT00741286|468578360|FG000|Overall Study|Primary Outcome|1|||
130168925|NCT00741286|468578361|FG001|Overall Study|Primary Outcome|1|||
130168926|NCT01831258|468578362|FG000|Overall Study|Withdrawal by Subject|2|||
130168927|NCT01831258|468578363|FG001|Overall Study|Withdrawal by Subject|1|||
130168928|NCT01831258|468578362|FG000|Overall Study|Lost to Follow-up|3|||
130168929|NCT01831258|468578363|FG001|Overall Study|Lost to Follow-up|2|||
130168930|NCT02564887|468578364|FG000|Overall Study|Lost to Follow-up|6|||
130168931|NCT02564887|468578365|FG001|Overall Study|Lost to Follow-up|0|||
130168932|NCT01851330|468578366|FG000|Overall Study|Lack of Efficacy|10|||
130168933|NCT01851330|468578367|FG001|Overall Study|Lack of Efficacy|9|||
130168934|NCT01851330|468578368|FG002|Overall Study|Lack of Efficacy|2|||
130168935|NCT01851330|468578366|FG000|Overall Study|Lost to Follow-up|1|||
130168936|NCT01851330|468578367|FG001|Overall Study|Lost to Follow-up|6|||
130168937|NCT01851330|468578368|FG002|Overall Study|Lost to Follow-up|9|||
130168938|NCT01851330|468578366|FG000|Overall Study|Withdrew Consent|2|||
130168939|NCT01851330|468578367|FG001|Overall Study|Withdrew Consent|1|||
130168940|NCT01851330|468578368|FG002|Overall Study|Withdrew Consent|0|||
130168941|NCT01851330|468578366|FG000|Overall Study|Investigator's Discretion|0|||
130168942|NCT01851330|468578367|FG001|Overall Study|Investigator's Discretion|0|||
130168943|NCT01851330|468578368|FG002|Overall Study|Investigator's Discretion|1|||
130168944|NCT00314951|468578371|FG000|Treatment|Didn't meet criteria for mITT population|16|||
130168945|NCT00314951|468578372|FG001|Treatment|Didn't meet criteria for mITT population|11|||
130168946|NCT00314951|468578371|FG000|Follow-up|mITT failure|44|||
130168947|NCT00314951|468578372|FG001|Follow-up|mITT failure|34|||
130168948|NCT00233402|468578373|FG000|Overall Study|No pathology data|12|||
130168949|NCT00233402|468578374|FG001|Overall Study|No pathology data|9|||
130168950|NCT00233402|468578373|FG000|Overall Study|No Ta/T1|89|||
130168951|NCT00233402|468578374|FG001|Overall Study|No Ta/T1|94|||
130168952|NCT00233402|468578373|FG000|Overall Study|Lost to follow up etc|3|||
130168953|NCT00233402|468578374|FG001|Overall Study|Lost to follow up etc|21|||
130168954|NCT02087189|468578377|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
130168955|NCT01189487|468578378|FG000|Overall Study|Lack of Efficacy|2|||
130168956|NCT01189487|468578378|FG000|Overall Study|Adverse Event|1|||
130168957|NCT04630158|468578379|FG000|Overall Study|Adverse Event|1|||
130168958|NCT04630158|468578380|FG001|Overall Study|Adverse Event|1|||
130168959|NCT04630158|468578381|FG002|Overall Study|Adverse Event|1|||
130168960|NCT04630158|468578379|FG000|Overall Study|Physician Decision|0|||
130168961|NCT04630158|468578380|FG001|Overall Study|Physician Decision|2|||
130168962|NCT04630158|468578381|FG002|Overall Study|Physician Decision|0|||
130168963|NCT04630158|468578379|FG000|Overall Study|Protocol Violation|1|||
129981939|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
130168964|NCT04630158|468578380|FG001|Overall Study|Protocol Violation|0|||
130168965|NCT04630158|468578381|FG002|Overall Study|Protocol Violation|1|||
130168966|NCT04630158|468578379|FG000|Overall Study|Withdrawal by Subject|2|||
130168967|NCT04630158|468578380|FG001|Overall Study|Withdrawal by Subject|1|||
130168968|NCT04630158|468578381|FG002|Overall Study|Withdrawal by Subject|2|||
130168969|NCT03136965|468578386|FG000|Overall Study|Lost to Follow-up|0|||
130168970|NCT03136965|468578387|FG001|Overall Study|Lost to Follow-up|1|||
130168971|NCT03136965|468578388|FG002|Overall Study|Lost to Follow-up|0|||
130168972|NCT04868968|468578392|FG000|Overall Study|Lost to Follow-up|1|||
130168973|NCT03553576|468578393|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
130168974|NCT03553576|468578394|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
130168975|NCT03553576|468578393|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
130168976|NCT03553576|468578394|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
130168977|NCT03553576|468578393|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
130168978|NCT03553576|468578394|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
130168979|NCT03553576|468578393|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
130168980|NCT03553576|468578394|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
130168981|NCT03553576|468578393|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
130168982|NCT03553576|468578394|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
130168983|NCT03553576|468578393|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
130168984|NCT03553576|468578394|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
130168985|NCT03553576|468578393|FG000|Overall Study|Physician Decision|2|||
130168986|NCT03553576|468578394|FG001|Overall Study|Physician Decision|5|||
130168987|NCT05038800|468578396|FG000|Overall Study|Death|1|||
130168988|NCT05038800|468578397|FG001|Overall Study|Death|1|||
130168989|NCT05038800|468578398|FG002|Overall Study|Death|5|||
130168990|NCT05038800|468578399|FG003|Overall Study|Death|3|||
130168991|NCT05038800|468578400|FG004|Overall Study|Death|1|||
130168992|NCT05038800|468578396|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130168993|NCT05038800|468578397|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130168994|NCT05038800|468578398|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130168995|NCT05038800|468578399|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
130168996|NCT05038800|468578400|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
130168997|NCT05038800|468578396|FG000|Overall Study|Lack of Efficacy|0|||
130168998|NCT05038800|468578397|FG001|Overall Study|Lack of Efficacy|0|||
130168999|NCT05038800|468578398|FG002|Overall Study|Lack of Efficacy|0|||
130169000|NCT05038800|468578399|FG003|Overall Study|Lack of Efficacy|0|||
130169001|NCT05038800|468578400|FG004|Overall Study|Lack of Efficacy|1|||
130169002|NCT01104792|468578401|FG000|Overall Study|Adverse Event|77|||
130169003|NCT01104792|468578401|FG000|Overall Study|Insufficient Therapeutic Response|22|||
130169004|NCT01104792|468578401|FG000|Overall Study|Protocol Violation|45|||
130169005|NCT01104792|468578401|FG000|Overall Study|Withdrawal of Consent|179|||
130169006|NCT01104792|468578401|FG000|Overall Study|Lost to Follow-up|43|||
130169007|NCT01104792|468578401|FG000|Overall Study|Reasons Not Specified|27|||
130169008|NCT01104792|468578401|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
130169009|NCT00658021|468578404|FG000|28-Week Treatment Period|Adverse Event|3|||
130169010|NCT00658021|468578405|FG001|28-Week Treatment Period|Adverse Event|1|||
130169011|NCT00658021|468578406|FG002|28-Week Treatment Period|Adverse Event|0|||
130169012|NCT00658021|468578404|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
130169013|NCT00658021|468578405|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
130169014|NCT00658021|468578406|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
130169015|NCT00658021|468578404|FG000|28-Week Treatment Period|Protocol Violation|0|||
130169016|NCT00658021|468578405|FG001|28-Week Treatment Period|Protocol Violation|2|||
130169017|NCT00658021|468578406|FG002|28-Week Treatment Period|Protocol Violation|1|||
130169018|NCT00658021|468578404|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
130169019|NCT00658021|468578405|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
130169020|NCT00658021|468578406|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
130169021|NCT00658021|468578404|FG000|28-Week Treatment Period|Physician Decision|1|||
130169022|NCT00658021|468578405|FG001|28-Week Treatment Period|Physician Decision|2|||
130169023|NCT00658021|468578406|FG002|28-Week Treatment Period|Physician Decision|1|||
130169024|NCT00658021|468578404|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130169025|NCT00658021|468578405|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130169026|NCT00658021|468578406|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
130169027|NCT00658021|468578404|FG000|28-Week Treatment Period|Loss of glucose control|1|||
130169028|NCT00658021|468578405|FG001|28-Week Treatment Period|Loss of glucose control|1|||
130169029|NCT00658021|468578406|FG002|28-Week Treatment Period|Loss of glucose control|10|||
130169030|NCT00658021|468578404|FG000|28-Week Treatment Period|Other|2|||
130169031|NCT00658021|468578405|FG001|28-Week Treatment Period|Other|3|||
130169032|NCT00658021|468578406|FG002|28-Week Treatment Period|Other|1|||
130169033|NCT00658021|468578404|FG000|28-Week Treatment Period|Did not receive treatment|2|||
130169034|NCT00658021|468578405|FG001|28-Week Treatment Period|Did not receive treatment|0|||
130169035|NCT00658021|468578406|FG002|28-Week Treatment Period|Did not receive treatment|0|||
129981940|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
129981941|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
129981942|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
129981943|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
129981944|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
129981945|NCT03842358|467896810|FG000|Overall Study|Poor DOT probe contact with breast|2|||
129981946|NCT03842358|467896810|FG000|Overall Study|DOT system problem|1|||
129981947|NCT03842358|467896810|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
129981948|NCT03842358|467896810|FG000|Overall Study|No biopsy after physician review|4|||
129981949|NCT03842358|467896810|FG000|Overall Study|Patient withdrew|2|||
129981950|NCT01525238|467896811|FG000|Overall Study|Withdrawal by Subject|1|||
129981951|NCT01525238|467896812|FG001|Overall Study|Withdrawal by Subject|0|||
129981952|NCT01525238|467896813|FG002|Overall Study|Withdrawal by Subject|0|||
129981953|NCT04625413|467896814|FG000|Overall Study|Hospice|2|||
129981954|NCT04625413|467896814|FG000|Overall Study|Distress|1|||
129981955|NCT04625413|467896814|FG000|Overall Study|Not feeling well|1|||
129981956|NCT04679935|467896815|FG000|Overall Study|Death|0|||
129981957|NCT04679935|467896816|FG001|Overall Study|Death|1|||
129981958|NCT02993146|467896817|FG000|Overall Study|Withdrawal by Subject|0|||
129981959|NCT02993146|467896818|FG001|Overall Study|Withdrawal by Subject|0|||
129981960|NCT02993146|467896819|FG002|Overall Study|Withdrawal by Subject|1|||
129981961|NCT02993146|467896820|FG003|Overall Study|Withdrawal by Subject|1|||
129981962|NCT04362189|467896821|FG000|Overall Study|Lost to Follow-up|0|||
129981963|NCT04362189|467896822|FG001|Overall Study|Lost to Follow-up|1|||
129981964|NCT04362189|467896821|FG000|Overall Study|Withdrawal by Subject|1|||
129981965|NCT04362189|467896822|FG001|Overall Study|Withdrawal by Subject|0|||
129981966|NCT04362189|467896821|FG000|Overall Study|FDA Clinical Hold|7|||
129981967|NCT04362189|467896822|FG001|Overall Study|FDA Clinical Hold|2|||
129981968|NCT04362189|467896821|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
129981969|NCT04362189|467896822|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
129981970|NCT04362189|467896821|FG000|Overall Study|Adverse Event|0|||
129981971|NCT04362189|467896822|FG001|Overall Study|Adverse Event|2|||
129981972|NCT04362189|467896821|FG000|Overall Study|Death|4|||
129981973|NCT04362189|467896822|FG001|Overall Study|Death|1|||
129981974|NCT02111681|467896823|FG000|Overall Study|Death|5|||
129981975|NCT02111681|467896823|FG000|Overall Study|Lack of Efficacy|2|||
129981976|NCT02111681|467896823|FG000|Overall Study|Progression of disease|4|||
129981977|NCT01077271|467898740|FG000|Overall Study|Parental desire|8|||
129981978|NCT01077271|467898740|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
129981979|NCT01077271|467898740|FG000|Overall Study|Noncompliance|2|||
129981980|NCT01077271|467898740|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
129981981|NCT01077271|467898740|FG000|Overall Study|Changed doctors|2|||
129981982|NCT01077271|467898740|FG000|Overall Study|Parents thought too many injections|2|||
129981983|NCT01077271|467898740|FG000|Overall Study|End of RSV season nearly reached|1|||
129981984|NCT01077271|467898740|FG000|Overall Study|Mother unconvinced of the necessity|1|||
129981985|NCT03333876|467898741|FG000|Screening Period|Screen Failure|4|||
129981986|NCT03333876|467898741|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
129981987|NCT03333876|467898741|FG000|Mandibular Advancement|Adverse Event|2|||
129981988|NCT03333876|467898741|FG000|Mandibular Advancement|Product Damage|2|||
129981989|NCT00095498|467898742|FG000|Overall Study|Physician Decision|9|||
129981990|NCT00095498|467898743|FG001|Overall Study|Physician Decision|10|||
129981991|NCT00095498|467898744|FG002|Overall Study|Physician Decision|8|||
129981992|NCT00095498|467898742|FG000|Overall Study|Adverse Event|1|||
129981993|NCT00095498|467898743|FG001|Overall Study|Adverse Event|0|||
129981994|NCT00095498|467898744|FG002|Overall Study|Adverse Event|1|||
129981995|NCT00095498|467898742|FG000|Overall Study|Withdrawal by Subject|15|||
130169036|NCT00658021|468578404|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
130169037|NCT00658021|468578405|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
129981996|NCT00095498|467898743|FG001|Overall Study|Withdrawal by Subject|16|||
129981997|NCT00095498|467898744|FG002|Overall Study|Withdrawal by Subject|15|||
129981998|NCT00095498|467898742|FG000|Overall Study|Disease progression|0|||
129981999|NCT00095498|467898743|FG001|Overall Study|Disease progression|1|||
129982000|NCT00095498|467898744|FG002|Overall Study|Disease progression|1|||
129982001|NCT00095498|467898742|FG000|Overall Study|Ineligibility determined|3|||
129982002|NCT00095498|467898743|FG001|Overall Study|Ineligibility determined|0|||
129982003|NCT00095498|467898744|FG002|Overall Study|Ineligibility determined|2|||
129982004|NCT00095498|467898742|FG000|Overall Study|Lost to Follow-up|1|||
129982005|NCT00095498|467898743|FG001|Overall Study|Lost to Follow-up|1|||
129982006|NCT00095498|467898744|FG002|Overall Study|Lost to Follow-up|2|||
129982007|NCT00095498|467898742|FG000|Overall Study|Noncompliance|1|||
129982008|NCT00095498|467898743|FG001|Overall Study|Noncompliance|0|||
129982009|NCT00095498|467898744|FG002|Overall Study|Noncompliance|1|||
129982010|NCT00095498|467898742|FG000|Overall Study|Other|6|||
129982011|NCT00095498|467898743|FG001|Overall Study|Other|7|||
129982012|NCT00095498|467898744|FG002|Overall Study|Other|6|||
129982013|NCT00095498|467898742|FG000|Overall Study|Protocol Violation|0|||
129982014|NCT00095498|467898743|FG001|Overall Study|Protocol Violation|0|||
129982015|NCT00095498|467898744|FG002|Overall Study|Protocol Violation|1|||
129982016|NCT00095498|467898742|FG000|Overall Study|Requirement for alternative therapy|1|||
129982017|NCT00095498|467898743|FG001|Overall Study|Requirement for alternative therapy|0|||
129982018|NCT00095498|467898744|FG002|Overall Study|Requirement for alternative therapy|2|||
129982019|NCT05020327|467898745|FG000|Overall Study|Physician Decision|3|||
129982020|NCT05020327|467898746|FG001|Overall Study|Physician Decision|0|||
129982021|NCT05020327|467898747|FG002|Overall Study|Physician Decision|0|||
129982022|NCT05020327|467898745|FG000|Overall Study|Withdrawal by Subject|1|||
129982023|NCT05020327|467898746|FG001|Overall Study|Withdrawal by Subject|1|||
129982024|NCT05020327|467898747|FG002|Overall Study|Withdrawal by Subject|0|||
129982025|NCT05020327|467898745|FG000|Overall Study|personal/cultural, ineligible|12|||
129982026|NCT05020327|467898746|FG001|Overall Study|personal/cultural, ineligible|0|||
129982027|NCT05020327|467898747|FG002|Overall Study|personal/cultural, ineligible|0|||
129982028|NCT04684394|467898748|FG000|Overall Study|Death|1|||
129982029|NCT04684394|467898749|FG001|Overall Study|Death|2|||
129982030|NCT04684394|467898748|FG000|Overall Study|Lost to Follow-up|1|||
129982031|NCT04684394|467898749|FG001|Overall Study|Lost to Follow-up|0|||
129982032|NCT04684394|467898748|FG000|Overall Study|Withdrawal by Subject|2|||
129982033|NCT04684394|467898749|FG001|Overall Study|Withdrawal by Subject|0|||
129982034|NCT04684394|467898748|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
129982035|NCT04684394|467898749|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
129982036|NCT00591370|467898751|FG000|Overall Study|Not Treated|2|||
129982037|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
129982038|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
129982039|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
129982040|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
129982041|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
129982042|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
129982043|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
129982044|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982045|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982046|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982047|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982048|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982049|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Death|1|||
129982050|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Death|2|||
129982051|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Death|2|||
129982052|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Death|0|||
130169038|NCT00658021|468578406|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
130169039|NCT00658021|468578404|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
130169040|NCT00658021|468578405|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
130169041|NCT00658021|468578406|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
130169042|NCT02952898|468578412|FG000|Overall Study|Withdrawal by Subject|10|||
130169043|NCT02952898|468578413|FG001|Overall Study|Withdrawal by Subject|8|||
130169044|NCT02952898|468578414|FG002|Overall Study|Withdrawal by Subject|8|||
130169045|NCT02952898|468578412|FG000|Overall Study|Adverse Event|8|||
130169046|NCT02952898|468578413|FG001|Overall Study|Adverse Event|8|||
130169047|NCT02952898|468578414|FG002|Overall Study|Adverse Event|3|||
130169048|NCT02952898|468578412|FG000|Overall Study|Lost to Follow-up|3|||
130169049|NCT02952898|468578413|FG001|Overall Study|Lost to Follow-up|2|||
130169050|NCT02952898|468578414|FG002|Overall Study|Lost to Follow-up|2|||
130169051|NCT02952898|468578412|FG000|Overall Study|Non-compliance with study drug|1|||
130169052|NCT02952898|468578413|FG001|Overall Study|Non-compliance with study drug|1|||
130169053|NCT02952898|468578414|FG002|Overall Study|Non-compliance with study drug|2|||
130169054|NCT04123561|468578425|FG000|Overall Study|Lost to Follow-up|20|||
130169055|NCT04123561|468578426|FG001|Overall Study|Lost to Follow-up|12|||
130169056|NCT04123561|468578427|FG002|Overall Study|Lost to Follow-up|5|||
130169057|NCT04123561|468578425|FG000|Overall Study|Withdrawal by Subject|9|||
130169058|NCT04123561|468578426|FG001|Overall Study|Withdrawal by Subject|7|||
130169059|NCT04123561|468578427|FG002|Overall Study|Withdrawal by Subject|9|||
130169060|NCT04123561|468578425|FG000|Overall Study|Lack of Efficacy|7|||
130169061|NCT04123561|468578426|FG001|Overall Study|Lack of Efficacy|8|||
130169062|NCT04123561|468578427|FG002|Overall Study|Lack of Efficacy|6|||
129982053|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Death|0|||
129982054|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Death|0|||
130169063|NCT04123561|468578425|FG000|Overall Study|Adverse Event|5|||
130169064|NCT04123561|468578426|FG001|Overall Study|Adverse Event|2|||
130169065|NCT04123561|468578427|FG002|Overall Study|Adverse Event|3|||
130169066|NCT04123561|468578425|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
130169067|NCT04123561|468578426|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
129982055|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129982056|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
129982057|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
129982058|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
130169068|NCT04123561|468578427|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
130169069|NCT04123561|468578425|FG000|Overall Study|Death|0|||
130169070|NCT04123561|468578426|FG001|Overall Study|Death|0|||
130169071|NCT04123561|468578427|FG002|Overall Study|Death|1|||
130169072|NCT04123561|468578425|FG000|Overall Study|Protocol Violation|0|||
130169073|NCT04123561|468578426|FG001|Overall Study|Protocol Violation|1|||
130169074|NCT04123561|468578427|FG002|Overall Study|Protocol Violation|0|||
130169075|NCT00278889|468578438|FG000|Overall Study|Withdrawal by Subject|0|||
130169076|NCT00278889|468578439|FG001|Overall Study|Withdrawal by Subject|5|||
130169077|NCT00278889|468578440|FG002|Overall Study|Withdrawal by Subject|3|||
130169078|NCT00278889|468578438|FG000|Overall Study|Lost to Follow-up|1|||
130169079|NCT00278889|468578439|FG001|Overall Study|Lost to Follow-up|1|||
130169080|NCT00278889|468578440|FG002|Overall Study|Lost to Follow-up|0|||
130169081|NCT00278889|468578438|FG000|Overall Study|Death|24|||
130169082|NCT00278889|468578439|FG001|Overall Study|Death|21|||
130169083|NCT00278889|468578440|FG002|Overall Study|Death|17|||
130169084|NCT03462459|468578441|FG000|Overall Study|Death|1|||
130169085|NCT03462459|468578442|FG001|Overall Study|Death|0|||
130169086|NCT03462459|468578441|FG000|Overall Study|Lack of Efficacy|2|||
130169087|NCT03462459|468578442|FG001|Overall Study|Lack of Efficacy|4|||
130169088|NCT03462459|468578441|FG000|Overall Study|Lost to Follow-up|1|||
130169089|NCT03462459|468578442|FG001|Overall Study|Lost to Follow-up|3|||
130169090|NCT03462459|468578441|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
130169091|NCT03462459|468578442|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
130169092|NCT03462459|468578441|FG000|Overall Study|Withdrawal by Subject|3|||
130169093|NCT03462459|468578442|FG001|Overall Study|Withdrawal by Subject|2|||
130169094|NCT03462459|468578441|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
130169095|NCT03462459|468578442|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
130169096|NCT04042376|468578444|FG000|Overall Study|Withdrawal by Subject|1|||
130169097|NCT04042376|468578444|FG000|Overall Study|Death|3|||
130169098|NCT03132155|468580483|FG000|Overall Study|Lack of Efficacy|6|||
130169099|NCT03132155|468580483|FG000|Overall Study|Lost to Follow-up|1|||
130169100|NCT03132155|468580483|FG000|Overall Study|Withdrawal by Subject|1|||
130169101|NCT00270855|468580485|FG000|Overall Study|Withdrawal by Subject|8|||
130169102|NCT00270855|468580486|FG001|Overall Study|Withdrawal by Subject|8|||
130169103|NCT01396512|468580491|FG000|Overall Study|Withdrawal by Subject|0|||
130169104|NCT01396512|468580492|FG001|Overall Study|Withdrawal by Subject|1|||
130169105|NCT02755649|468580493|FG000|Overall Study|Transitioned into OLE study|99|||
130169106|NCT02755649|468580494|FG001|Overall Study|Transitioned into OLE study|98|||
130169107|NCT02755649|468580495|FG002|Overall Study|Transitioned into OLE study|100|||
130169108|NCT02755649|468580493|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
130169109|NCT02755649|468580494|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
130169110|NCT02755649|468580495|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
130169111|NCT02755649|468580493|FG000|Overall Study|Physician Decision|0|||
130169112|NCT02755649|468580494|FG001|Overall Study|Physician Decision|0|||
130169113|NCT02755649|468580495|FG002|Overall Study|Physician Decision|2|||
130169114|NCT02755649|468580493|FG000|Overall Study|Withdrawal by Subject|0|||
130169115|NCT02755649|468580494|FG001|Overall Study|Withdrawal by Subject|1|||
130169116|NCT02755649|468580495|FG002|Overall Study|Withdrawal by Subject|0|||
130169117|NCT02755649|468580493|FG000|Overall Study|Undecided|1|||
130169118|NCT02755649|468580494|FG001|Overall Study|Undecided|0|||
130169119|NCT02755649|468580495|FG002|Overall Study|Undecided|0|||
130169120|NCT02152605|468580496|FG000|Overall Study|Adverse Event|6|||
130169121|NCT02152605|468580497|FG001|Overall Study|Adverse Event|8|||
130169122|NCT02152605|468580496|FG000|Overall Study|Lack of Efficacy|7|||
130169123|NCT02152605|468580497|FG001|Overall Study|Lack of Efficacy|4|||
130169124|NCT02152605|468580496|FG000|Overall Study|Protocol deviation|1|||
130169125|NCT02152605|468580497|FG001|Overall Study|Protocol deviation|4|||
130169126|NCT02152605|468580496|FG000|Overall Study|Lost to Follow-up|1|||
130169127|NCT02152605|468580497|FG001|Overall Study|Lost to Follow-up|0|||
130169128|NCT02152605|468580496|FG000|Overall Study|Withdrew consent|4|||
130169129|NCT02152605|468580497|FG001|Overall Study|Withdrew consent|2|||
130169130|NCT03301649|468580498|FG000|Overall Study|Need alternate therapy due to live lice|17|||
130169131|NCT03301649|468580499|FG001|Overall Study|Need alternate therapy due to live lice|25|||
130169132|NCT03301649|468580500|FG002|Overall Study|Need alternate therapy due to live lice|81|||
130169133|NCT03301649|468580498|FG000|Overall Study|Lost to Follow-up|11|||
130169134|NCT03301649|468580499|FG001|Overall Study|Lost to Follow-up|11|||
130169135|NCT03301649|468580500|FG002|Overall Study|Lost to Follow-up|3|||
130169136|NCT03301649|468580498|FG000|Overall Study|Protocol Violation|0|||
130169137|NCT03301649|468580499|FG001|Overall Study|Protocol Violation|1|||
130169138|NCT03301649|468580500|FG002|Overall Study|Protocol Violation|1|||
130169139|NCT03301649|468580498|FG000|Overall Study|Withdrawal by Subject|10|||
130169140|NCT03301649|468580499|FG001|Overall Study|Withdrawal by Subject|4|||
129982059|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129982060|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129982061|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
129982062|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129982063|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130169141|NCT03301649|468580500|FG002|Overall Study|Withdrawal by Subject|0|||
130169142|NCT03301649|468580498|FG000|Overall Study|Other than specified|5|||
130169143|NCT03301649|468580499|FG001|Overall Study|Other than specified|3|||
130169144|NCT03301649|468580500|FG002|Overall Study|Other than specified|0|||
130169145|NCT01564537|468580501|FG000|Overall Study|Site Terminated by Sponsor|1|||
130169146|NCT01564537|468580502|FG001|Overall Study|Site Terminated by Sponsor|0|||
130169147|NCT01564537|468580501|FG000|Overall Study|Withdrawal by Subject|12|||
130169148|NCT01564537|468580502|FG001|Overall Study|Withdrawal by Subject|14|||
130169149|NCT01564537|468580501|FG000|Overall Study|Lost to Follow-up|7|||
130169150|NCT01564537|468580502|FG001|Overall Study|Lost to Follow-up|3|||
130169151|NCT01564537|468580501|FG000|Overall Study|Reason not specified|81|||
130169152|NCT01564537|468580502|FG001|Overall Study|Reason not specified|82|||
130169153|NCT00837473|468580503|FG000|Overall Study|Lost to Follow-up|1|||
130169154|NCT00837473|468580503|FG000|Overall Study|Withdrawal by Subject|2|||
130169155|NCT01635218|468580504|FG000|Overall Study|Lost to Follow-up|3|||
130169156|NCT01635218|468580505|FG001|Overall Study|Lost to Follow-up|7|||
130169157|NCT01635218|468580506|FG002|Overall Study|Lost to Follow-up|6|||
130169158|NCT03559400|468580507|FG000|Overall Study|Lost to Follow-up|9|||
130169159|NCT03559400|468580508|FG001|Overall Study|Lost to Follow-up|7|||
130169160|NCT03559400|468580507|FG000|Overall Study|Death|0|||
130169161|NCT03559400|468580508|FG001|Overall Study|Death|2|||
130169162|NCT03262038|468580509|FG000|Overall Study|Withdrawal by Subject|0|||
130169163|NCT03262038|468580510|FG001|Overall Study|Withdrawal by Subject|1|||
130169164|NCT04933968|468580511|FG000|Overall Study|Adverse Event|0|||
130169165|NCT04933968|468580512|FG001|Overall Study|Adverse Event|0|||
130169166|NCT04933968|468580513|FG002|Overall Study|Adverse Event|1|||
130169167|NCT04933968|468580514|FG003|Overall Study|Adverse Event|1|||
130169168|NCT04933968|468580515|FG004|Overall Study|Adverse Event|0|||
130169169|NCT04933968|468580516|FG005|Overall Study|Adverse Event|0|||
130169170|NCT04933968|468580511|FG000|Overall Study|Lost to Follow-up|1|||
130169171|NCT04933968|468580512|FG001|Overall Study|Lost to Follow-up|0|||
130169172|NCT04933968|468580513|FG002|Overall Study|Lost to Follow-up|1|||
130169173|NCT04933968|468580514|FG003|Overall Study|Lost to Follow-up|0|||
130169174|NCT04933968|468580515|FG004|Overall Study|Lost to Follow-up|0|||
130169175|NCT04933968|468580516|FG005|Overall Study|Lost to Follow-up|0|||
130169176|NCT04933968|468580511|FG000|Overall Study|Randomized not treated|1|||
130169177|NCT04933968|468580512|FG001|Overall Study|Randomized not treated|0|||
130169178|NCT04933968|468580513|FG002|Overall Study|Randomized not treated|0|||
130169179|NCT04933968|468580514|FG003|Overall Study|Randomized not treated|0|||
130169180|NCT04933968|468580515|FG004|Overall Study|Randomized not treated|0|||
130169181|NCT04933968|468580516|FG005|Overall Study|Randomized not treated|0|||
130169182|NCT04933968|468580511|FG000|Overall Study|Sponsor terminated study|0|||
130169183|NCT04933968|468580512|FG001|Overall Study|Sponsor terminated study|0|||
130169184|NCT04933968|468580513|FG002|Overall Study|Sponsor terminated study|0|||
130169185|NCT04933968|468580514|FG003|Overall Study|Sponsor terminated study|1|||
130169186|NCT04933968|468580515|FG004|Overall Study|Sponsor terminated study|2|||
130169187|NCT04933968|468580516|FG005|Overall Study|Sponsor terminated study|0|||
130169188|NCT04933968|468580511|FG000|Overall Study|Other|0|||
130169189|NCT04933968|468580512|FG001|Overall Study|Other|0|||
130169190|NCT04933968|468580513|FG002|Overall Study|Other|0|||
130169191|NCT04933968|468580514|FG003|Overall Study|Other|1|||
130169192|NCT04933968|468580515|FG004|Overall Study|Other|0|||
130169193|NCT04933968|468580516|FG005|Overall Study|Other|0|||
130169194|NCT04933968|468580511|FG000|Overall Study|Missing|1|||
130169195|NCT04933968|468580512|FG001|Overall Study|Missing|3|||
130169196|NCT04933968|468580513|FG002|Overall Study|Missing|2|||
130169197|NCT04933968|468580514|FG003|Overall Study|Missing|1|||
130169198|NCT04933968|468580515|FG004|Overall Study|Missing|1|||
130169199|NCT04933968|468580516|FG005|Overall Study|Missing|0|||
130169200|NCT01724489|468580517|FG000|Overall Study|Adverse Event|8|||
130169201|NCT01724489|468580518|FG001|Overall Study|Adverse Event|3|||
129982064|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129982065|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130169202|NCT01724489|468580517|FG000|Overall Study|Surgery, medication|1|||
130169203|NCT01724489|468580518|FG001|Overall Study|Surgery, medication|1|||
130169204|NCT01724489|468580517|FG000|Overall Study|Lost to Follow-up|1|||
130169205|NCT01724489|468580518|FG001|Overall Study|Lost to Follow-up|2|||
130169206|NCT01724489|468580517|FG000|Overall Study|Withdrawal by Subject|6|||
130169207|NCT01724489|468580518|FG001|Overall Study|Withdrawal by Subject|6|||
130169208|NCT04576923|468580519|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
130169209|NCT02679235|468580522|FG000|Overall Study|Withdrawal by Subject|3|||
130169210|NCT02679235|468580522|FG000|Overall Study|Adverse Event|1|||
130169211|NCT00923273|468580523|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130169212|NCT00923273|468580524|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130169213|NCT00923273|468580525|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130169214|NCT00923273|468580526|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
130169215|NCT00923273|468580527|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
130169216|NCT00923273|468580523|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130169217|NCT00923273|468580524|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130169218|NCT00923273|468580525|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130169219|NCT00923273|468580526|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
130169220|NCT00923273|468580527|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
130169221|NCT00094861|468580528|FG000|Overall Study|Adverse Event|5|||
130169222|NCT00094861|468580529|FG001|Overall Study|Adverse Event|2|||
130169223|NCT00094861|468580528|FG000|Overall Study|Withdrawal by Subject|5|||
130169224|NCT00094861|468580529|FG001|Overall Study|Withdrawal by Subject|3|||
130169225|NCT00094861|468580528|FG000|Overall Study|Physician Decision|1|||
130169226|NCT00094861|468580529|FG001|Overall Study|Physician Decision|1|||
130169227|NCT00094861|468580528|FG000|Overall Study|Lost to Follow-up|0|||
130169228|NCT00094861|468580529|FG001|Overall Study|Lost to Follow-up|1|||
130169229|NCT00094861|468580528|FG000|Overall Study|Death|4|||
130169230|NCT00094861|468580529|FG001|Overall Study|Death|2|||
130169231|NCT00094861|468580528|FG000|Overall Study|Other|3|||
130169232|NCT00094861|468580529|FG001|Overall Study|Other|0|||
130169233|NCT00509366|468580530|FG000|Overall Study|Not Treated (Screen Failure)|1|||
130169234|NCT00509366|468580531|FG001|Overall Study|Not Treated (Screen Failure)|1|||
130169235|NCT00509366|468580532|FG002|Overall Study|Not Treated (Screen Failure)|1|||
130169236|NCT00509366|468580533|FG003|Overall Study|Not Treated (Screen Failure)|0|||
130169237|NCT00509366|468580534|FG004|Overall Study|Not Treated (Screen Failure)|0|||
130169238|NCT01377987|468580539|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
130169239|NCT01377987|468580540|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130169240|NCT02552303|468580543|FG000|Allocation|Withdrawal by Subject|2|||
130169241|NCT02552303|468580544|FG001|Allocation|Withdrawal by Subject|1|||
130169242|NCT02552303|468580545|FG002|Allocation|Withdrawal by Subject|1|||
130169243|NCT02552303|468580546|FG003|Allocation|Withdrawal by Subject|1|||
130169244|NCT02552303|468580543|FG000|Allocation|ineligible|1|||
130169245|NCT02552303|468580544|FG001|Allocation|ineligible|1|||
130169246|NCT02552303|468580545|FG002|Allocation|ineligible|0|||
130169247|NCT02552303|468580546|FG003|Allocation|ineligible|0|||
130169248|NCT02552303|468580543|FG000|Follow-Up|Lost to Follow-up|0|||
130169249|NCT02552303|468580544|FG001|Follow-Up|Lost to Follow-up|0|||
130169250|NCT02552303|468580545|FG002|Follow-Up|Lost to Follow-up|1|||
130169251|NCT02552303|468580546|FG003|Follow-Up|Lost to Follow-up|0|||
130169252|NCT02552303|468580543|FG000|Follow-Up|ineligible|0|||
130169253|NCT02552303|468580544|FG001|Follow-Up|ineligible|2|||
130169254|NCT02552303|468580545|FG002|Follow-Up|ineligible|0|||
130169255|NCT02552303|468580546|FG003|Follow-Up|ineligible|0|||
130169256|NCT00253448|468580555|FG000|Overall Study|Withdrawal by Subject|1|||
130169257|NCT01199016|468580556|FG000|Overall Study|No longer meets eligibility criteria|4|||
130169258|NCT01199016|468580556|FG000|Overall Study|Entrance criteria|5|||
130169259|NCT01199016|468580556|FG000|Overall Study|Protocol Violation|9|||
130169260|NCT01199016|468580556|FG000|Overall Study|Other|13|||
130169261|NCT01199016|468580556|FG000|Overall Study|Withdrawal by Subject|21|||
130169262|NCT01199016|468580556|FG000|Overall Study|Lost to Follow-up|25|||
130169263|NCT02368314|468580567|FG000|Overall Study|Withdrawal by Subject|2|||
130169264|NCT02368314|468580568|FG001|Overall Study|Withdrawal by Subject|1|||
130169265|NCT02368314|468580567|FG000|Overall Study|Adverse Event|1|||
130169266|NCT02368314|468580568|FG001|Overall Study|Adverse Event|2|||
130169267|NCT02842073|468580573|FG000|Overall Study|Withdrawal by Subject|1|||
130169268|NCT00195338|468580574|FG000|Overall Study|Lost to Follow-up|2|||
130169269|NCT00195338|468580574|FG000|Overall Study|Adverse Event|5|||
130169270|NCT00195338|468580574|FG000|Overall Study|Lack of Efficacy|1|||
130169271|NCT00195338|468580574|FG000|Overall Study|Early closure of the site|4|||
130169272|NCT05320887|468580583|FG000|Overall Study|Lost to Follow-up|0|||
130169273|NCT05320887|468580584|FG001|Overall Study|Lost to Follow-up|3|||
130169274|NCT05320887|468580585|FG002|Overall Study|Lost to Follow-up|0|||
130169275|NCT05320887|468580586|FG003|Overall Study|Lost to Follow-up|0|||
130169276|NCT02289456|468580587|FG000|Induction Period|Death|2|||
130169277|NCT02289456|468580587|FG000|Induction Period|Adverse Event|11|||
130169278|NCT02289456|468580587|FG000|Induction Period|Progressive Disease (PD)|4|||
130169279|NCT02289456|468580587|FG000|Induction Period|Symptomatic Deterioration|4|||
130169280|NCT02289456|468580587|FG000|Induction Period|Withdrawal by Subject|2|||
130169281|NCT02289456|468580587|FG000|Induction Period|Miscellaneous|1|||
130169282|NCT02289456|468580587|FG000|Monotherapy Period|Death|1|||
130169283|NCT02289456|468580587|FG000|Monotherapy Period|Adverse Event|1|||
130169284|NCT02289456|468580587|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
130169285|NCT02289456|468580587|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
130169286|NCT02289456|468580587|FG000|Monotherapy Period|Withdrawal by Subject|2|||
130169287|NCT02289456|468580587|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
130169288|NCT02289456|468580587|FG000|Monotherapy Period|Miscellaneous|1|||
130169289|NCT01661062|468580590|FG000|Overall Study|Completed Treatment Off Study|3|||
130169290|NCT01661062|468580590|FG000|Overall Study|Withdrawal by Subject|2|||
130169291|NCT02015065|468580595|FG000|Overall Study|Death on study|1|||
130169292|NCT02015065|468580596|FG001|Overall Study|Death on study|2|||
130169293|NCT02015065|468580597|FG002|Overall Study|Death on study|1|||
130169294|NCT03485365|468580630|FG000|Overall Study|Protocol Violation|0|||
130169295|NCT03485365|468580631|FG001|Overall Study|Protocol Violation|0|||
130169296|NCT03485365|468580632|FG002|Overall Study|Protocol Violation|0|||
130169297|NCT03485365|468580633|FG003|Overall Study|Protocol Violation|1|||
130169298|NCT03485365|468580634|FG004|Overall Study|Protocol Violation|0|||
130169299|NCT03485365|468580635|FG005|Overall Study|Protocol Violation|0|||
130169300|NCT03485365|468580636|FG006|Overall Study|Protocol Violation|1|||
130169301|NCT03485365|468580637|FG007|Overall Study|Protocol Violation|0|||
130169302|NCT03485365|468580638|FG008|Overall Study|Protocol Violation|0|||
130169303|NCT01547130|468580641|FG000|Overall Study|Lost to Follow-up|9|||
130169304|NCT01547130|468580642|FG001|Overall Study|Lost to Follow-up|5|||
130169305|NCT00103610|468580645|FG000|Overall Study|Entered Rescue Procedure|10|||
130169306|NCT00103610|468580646|FG001|Overall Study|Entered Rescue Procedure|52|||
130169307|NCT00103610|468580645|FG000|Overall Study|Death|16|||
130169308|NCT00103610|468580646|FG001|Overall Study|Death|12|||
130169309|NCT00103610|468580645|FG000|Overall Study|Elective Withdrawal|4|||
130169310|NCT00103610|468580646|FG001|Overall Study|Elective Withdrawal|0|||
130169311|NCT00103610|468580645|FG000|Overall Study|Lost to Follow-up|3|||
130169312|NCT00103610|468580646|FG001|Overall Study|Lost to Follow-up|1|||
130169313|NCT00103610|468580645|FG000|Overall Study|Adverse Event|2|||
130169314|NCT00103610|468580646|FG001|Overall Study|Adverse Event|2|||
130169315|NCT00103610|468580645|FG000|Overall Study|Other|2|||
130169316|NCT00103610|468580646|FG001|Overall Study|Other|7|||
130169317|NCT00103610|468580645|FG000|Overall Study|Failed mobilization|1|||
130169318|NCT00103610|468580646|FG001|Overall Study|Failed mobilization|5|||
130169319|NCT00103610|468580645|FG000|Overall Study|Noncompliance|0|||
130169320|NCT00103610|468580646|FG001|Overall Study|Noncompliance|1|||
130169321|NCT03301623|468580647|FG000|Overall Study|Death|3|||
130169322|NCT03301623|468580648|FG001|Overall Study|Death|1|||
130169323|NCT03301623|468580647|FG000|Overall Study|Withdrawal by Subject|11|||
130169324|NCT03301623|468580648|FG001|Overall Study|Withdrawal by Subject|13|||
130169325|NCT03301623|468580647|FG000|Overall Study|Lost to Follow-up|3|||
130169326|NCT03301623|468580648|FG001|Overall Study|Lost to Follow-up|1|||
130169327|NCT02092467|468580649|FG000|Overall Study|Death|49|||
130169328|NCT02092467|468580650|FG001|Overall Study|Death|66|||
130169329|NCT02092467|468580651|FG002|Overall Study|Death|38|||
130169330|NCT02092467|468580649|FG000|Overall Study|Lost to Follow-up|38|||
130169331|NCT02092467|468580650|FG001|Overall Study|Lost to Follow-up|35|||
130169332|NCT02092467|468580651|FG002|Overall Study|Lost to Follow-up|40|||
130169333|NCT02092467|468580649|FG000|Overall Study|Global Deterioration of Health Status|1|||
130169334|NCT02092467|468580650|FG001|Overall Study|Global Deterioration of Health Status|0|||
130169335|NCT02092467|468580651|FG002|Overall Study|Global Deterioration of Health Status|0|||
130169336|NCT02092467|468580649|FG000|Overall Study|Other|32|||
130169337|NCT02092467|468580650|FG001|Overall Study|Other|30|||
130169338|NCT02092467|468580651|FG002|Overall Study|Other|24|||
130169339|NCT02092467|468580649|FG000|Overall Study|Withdrawal by Subject|282|||
130169340|NCT02092467|468580650|FG001|Overall Study|Withdrawal by Subject|327|||
130169341|NCT02092467|468580651|FG002|Overall Study|Withdrawal by Subject|289|||
130169342|NCT02092467|468580649|FG000|Overall Study|Randomized but not treated|2|||
130169343|NCT02092467|468580650|FG001|Overall Study|Randomized but not treated|1|||
130169344|NCT02092467|468580651|FG002|Overall Study|Randomized but not treated|7|||
130169345|NCT04844762|468580654|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169346|NCT04844762|468580655|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169347|NCT04844762|468580656|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
130169348|NCT04844762|468580657|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169349|NCT04844762|468580658|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169350|NCT04844762|468580659|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169351|NCT04844762|468580654|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130169352|NCT04844762|468580655|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130169353|NCT04844762|468580656|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130169354|NCT04844762|468580657|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130169355|NCT04844762|468580658|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
130169356|NCT04844762|468580659|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
130169357|NCT04844762|468580654|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169358|NCT04844762|468580655|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169359|NCT04844762|468580656|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130169360|NCT04844762|468580657|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
130169361|NCT04844762|468580658|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169362|NCT04844762|468580659|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129982066|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
130169363|NCT04844762|468580654|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169364|NCT04844762|468580655|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169365|NCT04844762|468580656|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130169366|NCT04844762|468580657|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130169367|NCT04844762|468580658|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
130169368|NCT04844762|468580659|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169369|NCT04844762|468580654|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
130169370|NCT04844762|468580655|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
130169371|NCT04844762|468580656|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169372|NCT04844762|468580657|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169373|NCT04844762|468580658|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169374|NCT04844762|468580659|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169375|NCT04844762|468580654|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130169376|NCT04844762|468580655|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169377|NCT04844762|468580656|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169378|NCT04844762|468580657|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169379|NCT04844762|468580658|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169380|NCT04844762|468580659|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169381|NCT04844762|468580654|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169382|NCT04844762|468580655|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169383|NCT04844762|468580656|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169384|NCT04844762|468580657|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169385|NCT04844762|468580658|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
130169386|NCT04844762|468580659|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
130169387|NCT04844762|468580654|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
130169388|NCT04844762|468580655|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169389|NCT04844762|468580656|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169390|NCT04844762|468580657|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169391|NCT04844762|468580658|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169392|NCT04844762|468580659|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
130169393|NCT04844762|468580654|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130169394|NCT04844762|468580655|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169395|NCT04844762|468580656|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169396|NCT04844762|468580657|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169397|NCT04844762|468580658|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
130169398|NCT04844762|468580659|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
130169399|NCT04844762|468580654|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130169400|NCT04844762|468580655|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
130169401|NCT04844762|468580656|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130169402|NCT04844762|468580657|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130169403|NCT04844762|468580658|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130169404|NCT04844762|468580659|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
130169405|NCT04844762|468580654|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130169406|NCT04844762|468580655|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130169407|NCT04844762|468580656|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130169408|NCT04844762|468580657|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
130169409|NCT04844762|468580658|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130169410|NCT04844762|468580659|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
130169411|NCT04400682|468580662|FG000|Period 1|Withdrawal by Subject|1|||
130169412|NCT04400682|468580663|FG001|Period 1|Withdrawal by Subject|4|||
130169413|NCT02293863|468580664|FG000|Overall Study|Death|4|||
130169414|NCT02293863|468580665|FG001|Overall Study|Death|6|||
130169415|NCT02293863|468580666|FG002|Overall Study|Death|4|||
130169416|NCT02293863|468580664|FG000|Overall Study|Lost to Follow-up|2|||
130169417|NCT02293863|468580665|FG001|Overall Study|Lost to Follow-up|2|||
130169418|NCT02293863|468580666|FG002|Overall Study|Lost to Follow-up|2|||
130169419|NCT02293863|468580664|FG000|Overall Study|Withdrawal by Subject|3|||
130169420|NCT02293863|468580665|FG001|Overall Study|Withdrawal by Subject|3|||
130169421|NCT02293863|468580666|FG002|Overall Study|Withdrawal by Subject|1|||
130169422|NCT02293863|468580664|FG000|Overall Study|Reason Not Specified|0|||
130169423|NCT02293863|468580665|FG001|Overall Study|Reason Not Specified|2|||
130169424|NCT02293863|468580666|FG002|Overall Study|Reason Not Specified|2|||
130169425|NCT00477633|468580667|FG000|Overall Study|Did not receive treatment|23|||
130169426|NCT00477633|468580667|FG000|Overall Study|Adverse Event|143|||
130169427|NCT00477633|468580667|FG000|Overall Study|Pregnancy|23|||
130169428|NCT00477633|468580667|FG000|Overall Study|Lost to Follow-up|271|||
130169429|NCT00477633|468580667|FG000|Overall Study|Withdrawal by Subject|149|||
130169430|NCT00477633|468580667|FG000|Overall Study|Protocol Violation|25|||
130169431|NCT00477633|468580667|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
130169432|NCT01374269|468580673|FG000|Overall Study|Withdrawal by Subject|4|||
130169433|NCT01374269|468580674|FG001|Overall Study|Withdrawal by Subject|0|||
130169434|NCT01374269|468580673|FG000|Overall Study|Lost to Follow-up|1|||
130169435|NCT01374269|468580674|FG001|Overall Study|Lost to Follow-up|3|||
130169436|NCT01374269|468580673|FG000|Overall Study|closed research|1|||
130169437|NCT01374269|468580674|FG001|Overall Study|closed research|2|||
130169438|NCT00996892|468580675|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
130169439|NCT00996892|468580676|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
130169440|NCT00996892|468580677|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
130169441|NCT00996892|468580678|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
130169442|NCT00996892|468580679|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
130169443|NCT00996892|468580680|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
130169444|NCT00996892|468580681|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
130169445|NCT00996892|468580682|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
130169446|NCT00996892|468580683|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
130169447|NCT00996892|468580684|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
130169448|NCT00996892|468580685|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
130169449|NCT00996892|468580686|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
130169450|NCT00996892|468580687|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
130169451|NCT00996892|468580688|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
130169452|NCT00996892|468580689|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
130169453|NCT00996892|468580690|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
130169454|NCT00996892|468580691|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
130169455|NCT00996892|468580692|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
130169456|NCT00996892|468580693|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
130169457|NCT00996892|468580694|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
130169458|NCT00996892|468580675|FG000|Dose-Escalation Stage 1|Death|1|||
130169459|NCT00996892|468580676|FG001|Dose-Escalation Stage 1|Death|0|||
130169460|NCT00996892|468580677|FG002|Dose-Escalation Stage 1|Death|0|||
130169461|NCT00996892|468580678|FG003|Dose-Escalation Stage 1|Death|0|||
130169462|NCT00996892|468580679|FG004|Dose-Escalation Stage 1|Death|0|||
130169463|NCT00996892|468580680|FG005|Dose-Escalation Stage 1|Death|1|||
130169464|NCT00996892|468580681|FG006|Dose-Escalation Stage 1|Death|0|||
130169465|NCT00996892|468580682|FG007|Dose-Escalation Stage 1|Death|0|||
130169466|NCT00996892|468580683|FG008|Dose-Escalation Stage 1|Death|0|||
130169467|NCT00996892|468580684|FG009|Dose-Escalation Stage 1|Death|0|||
130169468|NCT00996892|468580685|FG010|Dose-Escalation Stage 1|Death|0|||
130169469|NCT00996892|468580686|FG011|Dose-Escalation Stage 1|Death|0|||
130169470|NCT00996892|468580687|FG012|Dose-Escalation Stage 1|Death|0|||
130169471|NCT00996892|468580688|FG013|Dose-Escalation Stage 1|Death|0|||
130169472|NCT00996892|468580689|FG014|Dose-Escalation Stage 1|Death|0|||
130169473|NCT00996892|468580690|FG015|Dose-Escalation Stage 1|Death|0|||
130169474|NCT00996892|468580691|FG016|Dose-Escalation Stage 1|Death|0|||
130169475|NCT00996892|468580692|FG017|Dose-Escalation Stage 1|Death|0|||
130169476|NCT00996892|468580693|FG018|Dose-Escalation Stage 1|Death|0|||
130169477|NCT00996892|468580694|FG019|Dose-Escalation Stage 1|Death|0|||
130169478|NCT00996892|468580675|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
130169479|NCT00996892|468580676|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
130169480|NCT00996892|468580677|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
130169481|NCT00996892|468580678|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
130169482|NCT00996892|468580679|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
130169483|NCT00996892|468580680|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
130169484|NCT00996892|468580681|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
130169485|NCT00996892|468580682|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
130169486|NCT00996892|468580683|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
130169487|NCT00996892|468580684|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
130169488|NCT00996892|468580685|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
130169489|NCT00996892|468580686|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
130169490|NCT00996892|468580687|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
130169491|NCT00996892|468580688|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
130169492|NCT00996892|468580689|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
130169493|NCT00996892|468580690|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
130169494|NCT00996892|468580691|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
130169495|NCT00996892|468580692|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
129982067|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
130169496|NCT00996892|468580693|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
130169497|NCT00996892|468580694|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
130169498|NCT00996892|468580675|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169499|NCT00996892|468580676|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130169500|NCT00996892|468580677|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169501|NCT00996892|468580678|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
130169502|NCT00996892|468580679|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130169503|NCT00996892|468580680|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130169504|NCT00996892|468580681|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
130169505|NCT00996892|468580682|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169506|NCT00996892|468580683|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169507|NCT00996892|468580684|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169508|NCT00996892|468580685|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169509|NCT00996892|468580686|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169510|NCT00996892|468580687|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169511|NCT00996892|468580688|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169512|NCT00996892|468580689|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169513|NCT00996892|468580690|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169514|NCT00996892|468580691|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169515|NCT00996892|468580692|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169516|NCT00996892|468580693|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169517|NCT00996892|468580694|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
130169518|NCT00996892|468580675|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
130169519|NCT00996892|468580676|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
130169520|NCT00996892|468580677|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
130169521|NCT00996892|468580678|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
130169522|NCT00996892|468580679|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
130169523|NCT00996892|468580680|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
130169524|NCT00996892|468580681|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
130169525|NCT00996892|468580682|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
130169526|NCT00996892|468580683|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
130169527|NCT00996892|468580684|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
130169528|NCT00996892|468580685|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
130169529|NCT00996892|468580686|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
130169530|NCT00996892|468580687|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
130169531|NCT00996892|468580688|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
130169532|NCT00996892|468580689|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
130169533|NCT00996892|468580690|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
130169534|NCT00996892|468580691|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
130169535|NCT00996892|468580692|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
130169536|NCT00996892|468580693|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
130169537|NCT00996892|468580694|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
130169538|NCT00996892|468580675|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
130169539|NCT00996892|468580676|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
130169540|NCT00996892|468580677|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
130169541|NCT00996892|468580678|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
130169542|NCT00996892|468580679|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
130169543|NCT00996892|468580680|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
130169544|NCT00996892|468580681|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
130169545|NCT00996892|468580682|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
130169546|NCT00996892|468580683|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
130169547|NCT00996892|468580684|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
130169548|NCT00996892|468580685|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
130169549|NCT00996892|468580686|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
130169550|NCT00996892|468580687|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
130169551|NCT00996892|468580688|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
130169552|NCT00996892|468580689|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
130169553|NCT00996892|468580690|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
130169554|NCT00996892|468580691|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
130169555|NCT00996892|468580692|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
130169556|NCT00996892|468580693|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
130169557|NCT00996892|468580694|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
130169558|NCT00996892|468580675|FG000|Dose-Escalation Stage 1A|Death|0|||
130169559|NCT00996892|468580676|FG001|Dose-Escalation Stage 1A|Death|0|||
130169560|NCT00996892|468580677|FG002|Dose-Escalation Stage 1A|Death|0|||
130169561|NCT00996892|468580678|FG003|Dose-Escalation Stage 1A|Death|0|||
130169562|NCT00996892|468580679|FG004|Dose-Escalation Stage 1A|Death|0|||
130169563|NCT00996892|468580680|FG005|Dose-Escalation Stage 1A|Death|0|||
130169564|NCT00996892|468580681|FG006|Dose-Escalation Stage 1A|Death|0|||
130169565|NCT00996892|468580682|FG007|Dose-Escalation Stage 1A|Death|0|||
130169566|NCT00996892|468580683|FG008|Dose-Escalation Stage 1A|Death|0|||
130169567|NCT00996892|468580684|FG009|Dose-Escalation Stage 1A|Death|2|||
130169568|NCT00996892|468580685|FG010|Dose-Escalation Stage 1A|Death|0|||
130169569|NCT00996892|468580686|FG011|Dose-Escalation Stage 1A|Death|1|||
130169570|NCT00996892|468580687|FG012|Dose-Escalation Stage 1A|Death|1|||
130169571|NCT00996892|468580688|FG013|Dose-Escalation Stage 1A|Death|0|||
130169572|NCT00996892|468580689|FG014|Dose-Escalation Stage 1A|Death|0|||
130169573|NCT00996892|468580690|FG015|Dose-Escalation Stage 1A|Death|0|||
130169574|NCT00996892|468580691|FG016|Dose-Escalation Stage 1A|Death|0|||
130169575|NCT00996892|468580692|FG017|Dose-Escalation Stage 1A|Death|0|||
130169576|NCT00996892|468580693|FG018|Dose-Escalation Stage 1A|Death|0|||
130169577|NCT00996892|468580694|FG019|Dose-Escalation Stage 1A|Death|0|||
130169578|NCT00996892|468580675|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
130169579|NCT00996892|468580676|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
130169580|NCT00996892|468580677|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
130169581|NCT00996892|468580678|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
130169582|NCT00996892|468580679|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
130169583|NCT00996892|468580680|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
130169584|NCT00996892|468580681|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
130169585|NCT00996892|468580682|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
130169586|NCT00996892|468580683|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
130169587|NCT00996892|468580684|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
130169588|NCT00996892|468580685|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
130169589|NCT00996892|468580686|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
130169590|NCT00996892|468580687|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
130169591|NCT00996892|468580688|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
130169592|NCT00996892|468580689|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
130169593|NCT00996892|468580690|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
130169594|NCT00996892|468580691|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
130169595|NCT00996892|468580692|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
130169596|NCT00996892|468580693|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
130169597|NCT00996892|468580694|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
130169598|NCT00996892|468580675|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169599|NCT00996892|468580676|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169600|NCT00996892|468580677|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169601|NCT00996892|468580678|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169602|NCT00996892|468580679|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169603|NCT00996892|468580680|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169604|NCT00996892|468580681|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169605|NCT00996892|468580682|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169606|NCT00996892|468580683|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169607|NCT00996892|468580684|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130169608|NCT00996892|468580685|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130169609|NCT00996892|468580686|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130169610|NCT00996892|468580687|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
130169611|NCT00996892|468580688|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169612|NCT00996892|468580689|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169613|NCT00996892|468580690|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169614|NCT00996892|468580691|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169615|NCT00996892|468580692|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169616|NCT00996892|468580693|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169617|NCT00996892|468580694|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
130169618|NCT00996892|468580675|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
130169619|NCT00996892|468580676|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
130169620|NCT00996892|468580677|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
130169621|NCT00996892|468580678|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
130169622|NCT00996892|468580679|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
130169623|NCT00996892|468580680|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
130169624|NCT00996892|468580681|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
130169625|NCT00996892|468580682|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
130169626|NCT00996892|468580683|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
130169627|NCT00996892|468580684|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
130169628|NCT00996892|468580685|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
130169629|NCT00996892|468580686|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
130169630|NCT00996892|468580687|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
130169631|NCT00996892|468580688|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
130169632|NCT00996892|468580689|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
130169633|NCT00996892|468580690|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
130169634|NCT00996892|468580691|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
130169635|NCT00996892|468580692|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
130169636|NCT00996892|468580693|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
130169637|NCT00996892|468580694|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
130169638|NCT00996892|468580675|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
130169639|NCT00996892|468580676|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
130169640|NCT00996892|468580677|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
130169641|NCT00996892|468580678|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
130169642|NCT00996892|468580679|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
130169643|NCT00996892|468580680|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
130169644|NCT00996892|468580681|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
130169645|NCT00996892|468580682|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
129982068|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129982069|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129982070|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130169646|NCT00996892|468580683|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
130169647|NCT00996892|468580684|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
129982071|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130169648|NCT00996892|468580685|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
130169649|NCT00996892|468580686|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
130169650|NCT00996892|468580687|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
130169651|NCT00996892|468580688|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
130169652|NCT00996892|468580689|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
130169653|NCT00996892|468580690|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
130169654|NCT00996892|468580691|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
130169655|NCT00996892|468580692|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
130169656|NCT00996892|468580693|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
130169657|NCT00996892|468580694|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
130169658|NCT00996892|468580675|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
130169659|NCT00996892|468580676|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
130169660|NCT00996892|468580677|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
130169661|NCT00996892|468580678|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
130169662|NCT00996892|468580679|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
130169663|NCT00996892|468580680|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
130169664|NCT00996892|468580681|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
130169665|NCT00996892|468580682|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
130169666|NCT00996892|468580683|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
130169667|NCT00996892|468580684|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
130169668|NCT00996892|468580685|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
130169669|NCT00996892|468580686|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
130169670|NCT00996892|468580687|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
130169671|NCT00996892|468580688|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
130169672|NCT00996892|468580689|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
130169673|NCT00996892|468580690|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
130169674|NCT00996892|468580691|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
130169675|NCT00996892|468580692|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
130169676|NCT00996892|468580693|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
130169677|NCT00996892|468580694|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
130169678|NCT00996892|468580675|FG000|Expansion Stage 2|Adverse Event|0|||
130169679|NCT00996892|468580676|FG001|Expansion Stage 2|Adverse Event|0|||
130169680|NCT00996892|468580677|FG002|Expansion Stage 2|Adverse Event|0|||
130169681|NCT00996892|468580678|FG003|Expansion Stage 2|Adverse Event|0|||
130169682|NCT00996892|468580679|FG004|Expansion Stage 2|Adverse Event|0|||
130169683|NCT00996892|468580680|FG005|Expansion Stage 2|Adverse Event|0|||
130169684|NCT00996892|468580681|FG006|Expansion Stage 2|Adverse Event|0|||
130169685|NCT00996892|468580682|FG007|Expansion Stage 2|Adverse Event|0|||
130169686|NCT00996892|468580683|FG008|Expansion Stage 2|Adverse Event|0|||
130169687|NCT00996892|468580684|FG009|Expansion Stage 2|Adverse Event|0|||
130169688|NCT00996892|468580685|FG010|Expansion Stage 2|Adverse Event|0|||
130169689|NCT00996892|468580686|FG011|Expansion Stage 2|Adverse Event|0|||
130169690|NCT00996892|468580687|FG012|Expansion Stage 2|Adverse Event|0|||
130169691|NCT00996892|468580688|FG013|Expansion Stage 2|Adverse Event|0|||
130169692|NCT00996892|468580689|FG014|Expansion Stage 2|Adverse Event|0|||
130169693|NCT00996892|468580690|FG015|Expansion Stage 2|Adverse Event|0|||
130169694|NCT00996892|468580691|FG016|Expansion Stage 2|Adverse Event|0|||
130169695|NCT00996892|468580692|FG017|Expansion Stage 2|Adverse Event|0|||
130169696|NCT00996892|468580693|FG018|Expansion Stage 2|Adverse Event|3|||
130169697|NCT00996892|468580694|FG019|Expansion Stage 2|Adverse Event|0|||
130169698|NCT00996892|468580675|FG000|Expansion Stage 2|Death|0|||
130169699|NCT00996892|468580676|FG001|Expansion Stage 2|Death|0|||
130169700|NCT00996892|468580677|FG002|Expansion Stage 2|Death|0|||
130169701|NCT00996892|468580678|FG003|Expansion Stage 2|Death|0|||
130169702|NCT00996892|468580679|FG004|Expansion Stage 2|Death|0|||
130169703|NCT00996892|468580680|FG005|Expansion Stage 2|Death|0|||
130169704|NCT00996892|468580681|FG006|Expansion Stage 2|Death|0|||
130169705|NCT00996892|468580682|FG007|Expansion Stage 2|Death|0|||
130169706|NCT00996892|468580683|FG008|Expansion Stage 2|Death|0|||
130169707|NCT00996892|468580684|FG009|Expansion Stage 2|Death|0|||
130169708|NCT00996892|468580685|FG010|Expansion Stage 2|Death|0|||
129982072|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
130169709|NCT00996892|468580686|FG011|Expansion Stage 2|Death|0|||
130169710|NCT00996892|468580687|FG012|Expansion Stage 2|Death|0|||
130169711|NCT00996892|468580688|FG013|Expansion Stage 2|Death|0|||
130169712|NCT00996892|468580689|FG014|Expansion Stage 2|Death|0|||
130169713|NCT00996892|468580690|FG015|Expansion Stage 2|Death|0|||
130169714|NCT00996892|468580691|FG016|Expansion Stage 2|Death|0|||
130169715|NCT00996892|468580692|FG017|Expansion Stage 2|Death|0|||
130169716|NCT00996892|468580693|FG018|Expansion Stage 2|Death|2|||
130169717|NCT00996892|468580694|FG019|Expansion Stage 2|Death|0|||
130169718|NCT00996892|468580675|FG000|Expansion Stage 2|Physician Decision|0|||
130169719|NCT00996892|468580676|FG001|Expansion Stage 2|Physician Decision|0|||
130169720|NCT00996892|468580677|FG002|Expansion Stage 2|Physician Decision|0|||
130169721|NCT00996892|468580678|FG003|Expansion Stage 2|Physician Decision|0|||
130169722|NCT00996892|468580679|FG004|Expansion Stage 2|Physician Decision|0|||
130169723|NCT00996892|468580680|FG005|Expansion Stage 2|Physician Decision|0|||
130169724|NCT00996892|468580681|FG006|Expansion Stage 2|Physician Decision|0|||
130169725|NCT00996892|468580682|FG007|Expansion Stage 2|Physician Decision|0|||
130169726|NCT00996892|468580683|FG008|Expansion Stage 2|Physician Decision|0|||
130169727|NCT00996892|468580684|FG009|Expansion Stage 2|Physician Decision|0|||
130169728|NCT00996892|468580685|FG010|Expansion Stage 2|Physician Decision|0|||
130169729|NCT00996892|468580686|FG011|Expansion Stage 2|Physician Decision|0|||
130169730|NCT00996892|468580687|FG012|Expansion Stage 2|Physician Decision|0|||
130169731|NCT00996892|468580688|FG013|Expansion Stage 2|Physician Decision|0|||
130169732|NCT00996892|468580689|FG014|Expansion Stage 2|Physician Decision|0|||
130169733|NCT00996892|468580690|FG015|Expansion Stage 2|Physician Decision|0|||
130169734|NCT00996892|468580691|FG016|Expansion Stage 2|Physician Decision|0|||
130169735|NCT00996892|468580692|FG017|Expansion Stage 2|Physician Decision|0|||
130169736|NCT00996892|468580693|FG018|Expansion Stage 2|Physician Decision|1|||
130169737|NCT00996892|468580694|FG019|Expansion Stage 2|Physician Decision|0|||
130169738|NCT00996892|468580675|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
130169739|NCT00996892|468580676|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
130169740|NCT00996892|468580677|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
130169741|NCT00996892|468580678|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
130169742|NCT00996892|468580679|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
130169743|NCT00996892|468580680|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
130169744|NCT00996892|468580681|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
130169745|NCT00996892|468580682|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
130169746|NCT00996892|468580683|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
130169747|NCT00996892|468580684|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
130169748|NCT00996892|468580685|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
130169749|NCT00996892|468580686|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
130169750|NCT00996892|468580687|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
130169751|NCT00996892|468580688|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
130169752|NCT00996892|468580689|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
130169753|NCT00996892|468580690|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
130169754|NCT00996892|468580691|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
130169755|NCT00996892|468580692|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
130169756|NCT00996892|468580693|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
130169757|NCT00996892|468580694|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
130169758|NCT00996892|468580675|FG000|Expansion Stage 2|Disease Progression|0|||
130169759|NCT00996892|468580676|FG001|Expansion Stage 2|Disease Progression|0|||
130169760|NCT00996892|468580677|FG002|Expansion Stage 2|Disease Progression|0|||
130169761|NCT00996892|468580678|FG003|Expansion Stage 2|Disease Progression|0|||
130169762|NCT00996892|468580679|FG004|Expansion Stage 2|Disease Progression|0|||
130169763|NCT00996892|468580680|FG005|Expansion Stage 2|Disease Progression|0|||
130169764|NCT00996892|468580681|FG006|Expansion Stage 2|Disease Progression|0|||
130169765|NCT00996892|468580682|FG007|Expansion Stage 2|Disease Progression|0|||
130169766|NCT00996892|468580683|FG008|Expansion Stage 2|Disease Progression|0|||
130169767|NCT00996892|468580684|FG009|Expansion Stage 2|Disease Progression|0|||
130169768|NCT00996892|468580685|FG010|Expansion Stage 2|Disease Progression|0|||
130169769|NCT00996892|468580686|FG011|Expansion Stage 2|Disease Progression|0|||
130169770|NCT00996892|468580687|FG012|Expansion Stage 2|Disease Progression|0|||
130169771|NCT00996892|468580688|FG013|Expansion Stage 2|Disease Progression|0|||
130169772|NCT00996892|468580689|FG014|Expansion Stage 2|Disease Progression|0|||
130169773|NCT00996892|468580690|FG015|Expansion Stage 2|Disease Progression|0|||
130169774|NCT00996892|468580691|FG016|Expansion Stage 2|Disease Progression|0|||
130169775|NCT00996892|468580692|FG017|Expansion Stage 2|Disease Progression|0|||
130169776|NCT00996892|468580693|FG018|Expansion Stage 2|Disease Progression|28|||
130169777|NCT00996892|468580694|FG019|Expansion Stage 2|Disease Progression|0|||
130169778|NCT00996892|468580675|FG000|Expansion Stage 2A|Adverse Event|0|||
130169779|NCT00996892|468580676|FG001|Expansion Stage 2A|Adverse Event|0|||
130169780|NCT00996892|468580677|FG002|Expansion Stage 2A|Adverse Event|0|||
130169781|NCT00996892|468580678|FG003|Expansion Stage 2A|Adverse Event|0|||
130169782|NCT00996892|468580679|FG004|Expansion Stage 2A|Adverse Event|0|||
130169783|NCT00996892|468580680|FG005|Expansion Stage 2A|Adverse Event|0|||
130169784|NCT00996892|468580681|FG006|Expansion Stage 2A|Adverse Event|0|||
130169785|NCT00996892|468580682|FG007|Expansion Stage 2A|Adverse Event|0|||
130169786|NCT00996892|468580683|FG008|Expansion Stage 2A|Adverse Event|0|||
130169787|NCT00996892|468580684|FG009|Expansion Stage 2A|Adverse Event|0|||
130169788|NCT00996892|468580685|FG010|Expansion Stage 2A|Adverse Event|0|||
130169789|NCT00996892|468580686|FG011|Expansion Stage 2A|Adverse Event|0|||
130169790|NCT00996892|468580687|FG012|Expansion Stage 2A|Adverse Event|0|||
130169791|NCT00996892|468580688|FG013|Expansion Stage 2A|Adverse Event|0|||
130169792|NCT00996892|468580689|FG014|Expansion Stage 2A|Adverse Event|0|||
130169793|NCT00996892|468580690|FG015|Expansion Stage 2A|Adverse Event|0|||
130169794|NCT00996892|468580691|FG016|Expansion Stage 2A|Adverse Event|0|||
130169795|NCT00996892|468580692|FG017|Expansion Stage 2A|Adverse Event|0|||
130169796|NCT00996892|468580693|FG018|Expansion Stage 2A|Adverse Event|0|||
130169797|NCT00996892|468580694|FG019|Expansion Stage 2A|Adverse Event|8|||
130169798|NCT00996892|468580675|FG000|Expansion Stage 2A|Physician Decision|0|||
130169799|NCT00996892|468580676|FG001|Expansion Stage 2A|Physician Decision|0|||
130169800|NCT00996892|468580677|FG002|Expansion Stage 2A|Physician Decision|0|||
130169801|NCT00996892|468580678|FG003|Expansion Stage 2A|Physician Decision|0|||
130169802|NCT00996892|468580679|FG004|Expansion Stage 2A|Physician Decision|0|||
130169803|NCT00996892|468580680|FG005|Expansion Stage 2A|Physician Decision|0|||
130169804|NCT00996892|468580681|FG006|Expansion Stage 2A|Physician Decision|0|||
130169805|NCT00996892|468580682|FG007|Expansion Stage 2A|Physician Decision|0|||
130169806|NCT00996892|468580683|FG008|Expansion Stage 2A|Physician Decision|0|||
130169807|NCT00996892|468580684|FG009|Expansion Stage 2A|Physician Decision|0|||
130169808|NCT00996892|468580685|FG010|Expansion Stage 2A|Physician Decision|0|||
130169809|NCT00996892|468580686|FG011|Expansion Stage 2A|Physician Decision|0|||
130169810|NCT00996892|468580687|FG012|Expansion Stage 2A|Physician Decision|0|||
130169811|NCT00996892|468580688|FG013|Expansion Stage 2A|Physician Decision|0|||
130169812|NCT00996892|468580689|FG014|Expansion Stage 2A|Physician Decision|0|||
130169813|NCT00996892|468580690|FG015|Expansion Stage 2A|Physician Decision|0|||
130169814|NCT00996892|468580691|FG016|Expansion Stage 2A|Physician Decision|0|||
130169815|NCT00996892|468580692|FG017|Expansion Stage 2A|Physician Decision|0|||
130169816|NCT00996892|468580693|FG018|Expansion Stage 2A|Physician Decision|0|||
130169817|NCT00996892|468580694|FG019|Expansion Stage 2A|Physician Decision|2|||
130169818|NCT00996892|468580675|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
130169819|NCT00996892|468580676|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
130169820|NCT00996892|468580677|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
130169821|NCT00996892|468580678|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
130169822|NCT00996892|468580679|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
130169823|NCT00996892|468580680|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
130169824|NCT00996892|468580681|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
130169825|NCT00996892|468580682|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
130169826|NCT00996892|468580683|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
130169827|NCT00996892|468580684|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
130169828|NCT00996892|468580685|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
130169829|NCT00996892|468580686|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
130169830|NCT00996892|468580687|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
130169831|NCT00996892|468580688|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
130169832|NCT00996892|468580689|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
130169833|NCT00996892|468580690|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
130169834|NCT00996892|468580691|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
130169835|NCT00996892|468580692|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
130169836|NCT00996892|468580693|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
130169837|NCT00996892|468580694|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
130169838|NCT00996892|468580675|FG000|Expansion Stage 2A|Disease Progression|0|||
130169839|NCT00996892|468580676|FG001|Expansion Stage 2A|Disease Progression|0|||
130169840|NCT00996892|468580677|FG002|Expansion Stage 2A|Disease Progression|0|||
130169841|NCT00996892|468580678|FG003|Expansion Stage 2A|Disease Progression|0|||
130169842|NCT00996892|468580679|FG004|Expansion Stage 2A|Disease Progression|0|||
130169843|NCT00996892|468580680|FG005|Expansion Stage 2A|Disease Progression|0|||
130169844|NCT00996892|468580681|FG006|Expansion Stage 2A|Disease Progression|0|||
130169845|NCT00996892|468580682|FG007|Expansion Stage 2A|Disease Progression|0|||
130169846|NCT00996892|468580683|FG008|Expansion Stage 2A|Disease Progression|0|||
130169847|NCT00996892|468580684|FG009|Expansion Stage 2A|Disease Progression|0|||
130169848|NCT00996892|468580685|FG010|Expansion Stage 2A|Disease Progression|0|||
130169849|NCT00996892|468580686|FG011|Expansion Stage 2A|Disease Progression|0|||
130169850|NCT00996892|468580687|FG012|Expansion Stage 2A|Disease Progression|0|||
130169851|NCT00996892|468580688|FG013|Expansion Stage 2A|Disease Progression|0|||
130169852|NCT00996892|468580689|FG014|Expansion Stage 2A|Disease Progression|0|||
130169853|NCT00996892|468580690|FG015|Expansion Stage 2A|Disease Progression|0|||
130169854|NCT00996892|468580691|FG016|Expansion Stage 2A|Disease Progression|0|||
130169855|NCT00996892|468580692|FG017|Expansion Stage 2A|Disease Progression|0|||
130169856|NCT00996892|468580693|FG018|Expansion Stage 2A|Disease Progression|0|||
130169857|NCT00996892|468580694|FG019|Expansion Stage 2A|Disease Progression|31|||
130169858|NCT01987479|468580695|FG000|Overall Study|Protocol Violation|1|||
130169859|NCT01987479|468580695|FG000|Overall Study|Physician Decision|2|||
130169860|NCT01987479|468580695|FG000|Overall Study|Participant/legal guardian decision|1|||
130169861|NCT01987479|468580695|FG000|Overall Study|Other|5|||
130169862|NCT01987479|468580695|FG000|Overall Study|Lost to Follow-up|1|||
130169863|NCT01987479|468580695|FG000|Overall Study|Adverse Event|7|||
130169864|NCT00602641|468582659|FG000|Overall Study|Never started protocol therapy|6|||
130169865|NCT00602641|468582660|FG001|Overall Study|Never started protocol therapy|2|||
130169866|NCT00602641|468582659|FG000|Overall Study|Still on treatment at time of analysis|8|||
130169867|NCT00602641|468582660|FG001|Overall Study|Still on treatment at time of analysis|15|||
130169868|NCT00602641|468582659|FG000|Overall Study|Adverse Event|62|||
130169869|NCT00602641|468582660|FG001|Overall Study|Adverse Event|53|||
130169870|NCT00602641|468582659|FG000|Overall Study|Disease progression|38|||
130169871|NCT00602641|468582660|FG001|Overall Study|Disease progression|55|||
130169872|NCT00602641|468582659|FG000|Overall Study|Death|6|||
130169873|NCT00602641|468582660|FG001|Overall Study|Death|5|||
130169874|NCT00602641|468582659|FG000|Overall Study|Withdrawal by Subject|15|||
130169875|NCT00602641|468582660|FG001|Overall Study|Withdrawal by Subject|12|||
130169876|NCT00602641|468582659|FG000|Overall Study|Alternative therapy|5|||
130169877|NCT00602641|468582660|FG001|Overall Study|Alternative therapy|2|||
130169878|NCT00602641|468582659|FG000|Overall Study|Other Complicating Disease|5|||
130169879|NCT00602641|468582660|FG001|Overall Study|Other Complicating Disease|2|||
130169880|NCT00602641|468582659|FG000|Overall Study|Physician Decision|5|||
130169881|NCT00602641|468582660|FG001|Overall Study|Physician Decision|4|||
130169882|NCT00602641|468582659|FG000|Overall Study|Administrative Closure|1|||
130169883|NCT00602641|468582660|FG001|Overall Study|Administrative Closure|1|||
130169884|NCT00602641|468582659|FG000|Overall Study|Other|3|||
130169885|NCT00602641|468582660|FG001|Overall Study|Other|1|||
130169886|NCT00478244|468582663|FG000|Overall Study|Did not receive transplant|1|||
130169887|NCT02929056|468582666|FG000|Overall Study|Lost to Follow-up|0|||
130169888|NCT02929056|468582667|FG001|Overall Study|Lost to Follow-up|1|||
130169889|NCT02925403|468582673|FG000|Overall Study|Lost to Follow-up|0|||
130169890|NCT02925403|468582674|FG001|Overall Study|Lost to Follow-up|1|||
130169891|NCT00459043|468582675|FG000|Overall Study|Withdrawal by Subject|1|||
130169892|NCT00459043|468582676|FG001|Overall Study|Withdrawal by Subject|0|||
130169893|NCT02899195|468582679|FG000|Concurrent Durvalumab|Adverse Event|4|||
130169894|NCT02899195|468582679|FG000|Concurrent Durvalumab|Physician Decision|1|||
130169895|NCT02899195|468582679|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
130169896|NCT02899195|468582679|FG000|Concurrent Durvalumab|Progressive Disease|5|||
130169897|NCT02899195|468582679|FG000|Maintenance Durvalumab|Adverse Event|1|||
130169898|NCT02899195|468582679|FG000|Maintenance Durvalumab|Physician Decision|1|||
130169899|NCT02899195|468582679|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
130169900|NCT02899195|468582679|FG000|Maintenance Durvalumab|Progressive Disease|31|||
130169901|NCT03156504|468582681|FG000|Overall Study|Withdrawal by Subject|1|||
130169902|NCT00450801|468582682|FG000|Overall Study|Death|1|||
130169903|NCT03452137|468582683|FG000|Overall Study|Death|67|||
130169904|NCT03452137|468582684|FG001|Overall Study|Death|70|||
130169905|NCT03452137|468582683|FG000|Overall Study|Lost to Follow-up|4|||
130169906|NCT03452137|468582684|FG001|Overall Study|Lost to Follow-up|2|||
130169907|NCT03452137|468582683|FG000|Overall Study|Physician Decision|0|||
130169908|NCT03452137|468582684|FG001|Overall Study|Physician Decision|1|||
130169909|NCT03452137|468582683|FG000|Overall Study|Study Terminated by Sponsor|120|||
130169910|NCT03452137|468582684|FG001|Overall Study|Study Terminated by Sponsor|121|||
130169911|NCT03452137|468582683|FG000|Overall Study|Withdrawal by Subject|12|||
130169912|NCT03452137|468582684|FG001|Overall Study|Withdrawal by Subject|9|||
130169913|NCT00587860|468582685|FG000|Overall Study|Lost to Follow-up|2|||
130169914|NCT00587860|468582686|FG001|Overall Study|Lost to Follow-up|2|||
130169915|NCT00587860|468582685|FG000|Overall Study|Withdrawal by Subject|3|||
130169916|NCT00587860|468582686|FG001|Overall Study|Withdrawal by Subject|3|||
130169917|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
130169918|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
130169919|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
130169920|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
130169921|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
130169922|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
130169923|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
130169924|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
130169925|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
130169926|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
130169927|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
130169928|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
130169929|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
130169930|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
130169931|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
130169932|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
130169933|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
130169934|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
130169935|NCT00261443|468582687|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
130169936|NCT00261443|468582688|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
130169937|NCT00261443|468582689|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
130169938|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
130169939|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
130169940|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
130169941|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
130169942|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
130169943|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
130169944|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
130169945|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
130169946|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
130169947|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
130169948|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
130169949|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
130169950|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
130169951|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
130169952|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
130169953|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
130169954|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
130169955|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
130169956|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
130169957|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
130169958|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
130169959|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
130169960|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
130169961|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
130169962|NCT00261443|468582687|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
130169963|NCT00261443|468582688|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
130169964|NCT00261443|468582689|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
130169965|NCT00261443|468582687|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
130169966|NCT00261443|468582688|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
130169967|NCT00261443|468582689|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
130169968|NCT00261443|468582687|FG000|3: Assessment of Relapse|Adverse Event|0|||
130169969|NCT00261443|468582688|FG001|3: Assessment of Relapse|Adverse Event|15|||
130169970|NCT00261443|468582689|FG002|3: Assessment of Relapse|Adverse Event|19|||
130169971|NCT00261443|468582687|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
130169972|NCT00261443|468582688|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
130169973|NCT00261443|468582689|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
130169974|NCT00261443|468582687|FG000|3: Assessment of Relapse|Death|0|||
130169975|NCT00261443|468582688|FG001|3: Assessment of Relapse|Death|0|||
130169976|NCT00261443|468582689|FG002|3: Assessment of Relapse|Death|1|||
130169977|NCT00261443|468582687|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
130169978|NCT00261443|468582688|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
130169979|NCT00261443|468582689|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
130169980|NCT00261443|468582687|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
130169981|NCT00261443|468582688|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
130169982|NCT00261443|468582689|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
130169983|NCT00261443|468582687|FG000|3: Assessment of Relapse|Pregnancy|0|||
130169984|NCT00261443|468582688|FG001|3: Assessment of Relapse|Pregnancy|2|||
130169985|NCT00261443|468582689|FG002|3: Assessment of Relapse|Pregnancy|1|||
130169986|NCT00261443|468582687|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
130169987|NCT00261443|468582688|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
130169988|NCT00261443|468582689|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
130169989|NCT00261443|468582687|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
130169990|NCT00261443|468582688|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
130169991|NCT00261443|468582689|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
130169992|NCT00261443|468582687|FG000|3: Assessment of Relapse|Other Reasons|0|||
130169993|NCT00261443|468582688|FG001|3: Assessment of Relapse|Other Reasons|4|||
130169994|NCT00261443|468582689|FG002|3: Assessment of Relapse|Other Reasons|3|||
130169995|NCT00261443|468582687|FG000|4: Extension Phase|Adverse Event|0|||
130169996|NCT00261443|468582688|FG001|4: Extension Phase|Adverse Event|1|||
130169997|NCT00261443|468582689|FG002|4: Extension Phase|Adverse Event|0|||
130169998|NCT00261443|468582687|FG000|4: Extension Phase|Withdrawal by Subject|0|||
130169999|NCT00261443|468582688|FG001|4: Extension Phase|Withdrawal by Subject|1|||
130170000|NCT00261443|468582689|FG002|4: Extension Phase|Withdrawal by Subject|2|||
130170001|NCT00261443|468582687|FG000|4: Extension Phase|Lost to Follow-up|0|||
130170002|NCT00261443|468582688|FG001|4: Extension Phase|Lost to Follow-up|1|||
130170003|NCT00261443|468582689|FG002|4: Extension Phase|Lost to Follow-up|0|||
130170004|NCT01286753|468582692|FG000|Overall Study|Adverse Event|7|||
130170005|NCT01286753|468582693|FG001|Overall Study|Adverse Event|6|||
130170006|NCT01286753|468582692|FG000|Overall Study|Progression|11|||
130170007|NCT01286753|468582693|FG001|Overall Study|Progression|13|||
130170008|NCT01286753|468582692|FG000|Overall Study|Refused Treatment|1|||
130170009|NCT01286753|468582693|FG001|Overall Study|Refused Treatment|0|||
130170010|NCT01286753|468582692|FG000|Overall Study|Withdrawal of Consent|0|||
130170011|NCT01286753|468582693|FG001|Overall Study|Withdrawal of Consent|2|||
130170012|NCT01286753|468582692|FG000|Overall Study|Discontinued to Join Extension Study|6|||
130170013|NCT01286753|468582693|FG001|Overall Study|Discontinued to Join Extension Study|4|||
130170014|NCT01286753|468582692|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
130170015|NCT01286753|468582693|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
130170016|NCT02094417|468582701|FG000|Overall Study|Adverse Event|0|||
130170017|NCT02094417|468582702|FG001|Overall Study|Adverse Event|0|||
130170018|NCT02094417|468582703|FG002|Overall Study|Adverse Event|0|||
130170019|NCT02094417|468582704|FG003|Overall Study|Adverse Event|1|||
130170020|NCT02094417|468582701|FG000|Overall Study|Eligibility criteria|0|||
130170021|NCT02094417|468582702|FG001|Overall Study|Eligibility criteria|1|||
130170022|NCT02094417|468582703|FG002|Overall Study|Eligibility criteria|0|||
130170023|NCT02094417|468582704|FG003|Overall Study|Eligibility criteria|0|||
130170024|NCT02094417|468582701|FG000|Overall Study|No responder|4|||
130170025|NCT02094417|468582702|FG001|Overall Study|No responder|4|||
130170026|NCT02094417|468582703|FG002|Overall Study|No responder|4|||
130170027|NCT02094417|468582704|FG003|Overall Study|No responder|3|||
130170028|NCT02094417|468582701|FG000|Overall Study|Unable to conduct observations or assess|0|||
130170029|NCT02094417|468582702|FG001|Overall Study|Unable to conduct observations or assess|1|||
130170030|NCT02094417|468582703|FG002|Overall Study|Unable to conduct observations or assess|0|||
130170031|NCT02094417|468582704|FG003|Overall Study|Unable to conduct observations or assess|0|||
130170032|NCT02094417|468582701|FG000|Overall Study|Withdrawal by Subject|1|||
130170033|NCT02094417|468582702|FG001|Overall Study|Withdrawal by Subject|2|||
130170034|NCT02094417|468582703|FG002|Overall Study|Withdrawal by Subject|1|||
130170035|NCT02094417|468582704|FG003|Overall Study|Withdrawal by Subject|3|||
130170036|NCT02119819|468582707|FG000|Overall Study|Adverse Event|3|||
130170037|NCT02119819|468582708|FG001|Overall Study|Adverse Event|1|||
130170038|NCT02119819|468582709|FG002|Overall Study|Adverse Event|2|||
130170039|NCT02119819|468582710|FG003|Overall Study|Adverse Event|3|||
130170040|NCT02119819|468582711|FG004|Overall Study|Adverse Event|0|||
130170041|NCT02119819|468582712|FG005|Overall Study|Adverse Event|1|||
130170042|NCT02119819|468582707|FG000|Overall Study|Lack of Efficacy|0|||
130170043|NCT02119819|468582708|FG001|Overall Study|Lack of Efficacy|0|||
130170044|NCT02119819|468582709|FG002|Overall Study|Lack of Efficacy|0|||
130170045|NCT02119819|468582710|FG003|Overall Study|Lack of Efficacy|0|||
130170046|NCT02119819|468582711|FG004|Overall Study|Lack of Efficacy|0|||
130170047|NCT02119819|468582712|FG005|Overall Study|Lack of Efficacy|1|||
130170048|NCT02119819|468582707|FG000|Overall Study|Lost to Follow-up|0|||
130170049|NCT02119819|468582708|FG001|Overall Study|Lost to Follow-up|0|||
130170050|NCT02119819|468582709|FG002|Overall Study|Lost to Follow-up|1|||
130170051|NCT02119819|468582710|FG003|Overall Study|Lost to Follow-up|2|||
130170052|NCT02119819|468582711|FG004|Overall Study|Lost to Follow-up|1|||
130170053|NCT02119819|468582712|FG005|Overall Study|Lost to Follow-up|2|||
130170054|NCT02119819|468582707|FG000|Overall Study|Physician Decision|1|||
130170055|NCT02119819|468582708|FG001|Overall Study|Physician Decision|1|||
130170056|NCT02119819|468582709|FG002|Overall Study|Physician Decision|0|||
130170057|NCT02119819|468582710|FG003|Overall Study|Physician Decision|0|||
130170058|NCT02119819|468582711|FG004|Overall Study|Physician Decision|0|||
130170059|NCT02119819|468582712|FG005|Overall Study|Physician Decision|1|||
130170060|NCT02119819|468582707|FG000|Overall Study|Withdrawal by Subject|5|||
130170061|NCT02119819|468582708|FG001|Overall Study|Withdrawal by Subject|3|||
130170062|NCT02119819|468582709|FG002|Overall Study|Withdrawal by Subject|0|||
130170063|NCT02119819|468582710|FG003|Overall Study|Withdrawal by Subject|0|||
130170064|NCT02119819|468582711|FG004|Overall Study|Withdrawal by Subject|6|||
130170065|NCT02119819|468582712|FG005|Overall Study|Withdrawal by Subject|10|||
130170066|NCT02119819|468582707|FG000|Overall Study|Jury Duty|0|||
130170067|NCT02119819|468582708|FG001|Overall Study|Jury Duty|0|||
130170068|NCT02119819|468582709|FG002|Overall Study|Jury Duty|1|||
130170069|NCT02119819|468582710|FG003|Overall Study|Jury Duty|0|||
130170070|NCT02119819|468582711|FG004|Overall Study|Jury Duty|0|||
130170071|NCT02119819|468582712|FG005|Overall Study|Jury Duty|0|||
130170072|NCT02119819|468582707|FG000|Overall Study|Protocol Violation|0|||
130170073|NCT02119819|468582708|FG001|Overall Study|Protocol Violation|0|||
130170074|NCT02119819|468582709|FG002|Overall Study|Protocol Violation|0|||
130170075|NCT02119819|468582710|FG003|Overall Study|Protocol Violation|1|||
130170076|NCT02119819|468582711|FG004|Overall Study|Protocol Violation|0|||
130170077|NCT02119819|468582712|FG005|Overall Study|Protocol Violation|0|||
130170078|NCT02119819|468582707|FG000|Overall Study|Left the city to get a job|0|||
130170079|NCT02119819|468582708|FG001|Overall Study|Left the city to get a job|0|||
130170080|NCT02119819|468582709|FG002|Overall Study|Left the city to get a job|0|||
130170081|NCT02119819|468582710|FG003|Overall Study|Left the city to get a job|1|||
130170082|NCT02119819|468582711|FG004|Overall Study|Left the city to get a job|0|||
130170083|NCT02119819|468582712|FG005|Overall Study|Left the city to get a job|0|||
130170084|NCT02699684|468582713|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
130170085|NCT02699684|468582714|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
130170086|NCT04839692|468582715|FG000|Overall Study|Withdrawal by Subject|0|||
130170087|NCT04839692|468582716|FG001|Overall Study|Withdrawal by Subject|3|||
130170088|NCT04839692|468582715|FG000|Overall Study|Physician Decision|1|||
130170089|NCT04839692|468582716|FG001|Overall Study|Physician Decision|0|||
130170090|NCT03146962|468582717|FG000|Overall Study|Lost to Follow-up|1|||
130170091|NCT03146962|468582718|FG001|Overall Study|Lost to Follow-up|1|||
130170092|NCT03146962|468582719|FG002|Overall Study|Lost to Follow-up|0|||
130170093|NCT03146962|468582720|FG003|Overall Study|Lost to Follow-up|0|||
130170094|NCT03146962|468582721|FG004|Overall Study|Lost to Follow-up|0|||
130170095|NCT03146962|468582722|FG005|Overall Study|Lost to Follow-up|0|||
130170096|NCT03146962|468582723|FG006|Overall Study|Lost to Follow-up|0|||
130170097|NCT03146962|468582724|FG007|Overall Study|Lost to Follow-up|0|||
130170098|NCT03146962|468582725|FG008|Overall Study|Lost to Follow-up|0|||
130170099|NCT03146962|468582726|FG009|Overall Study|Lost to Follow-up|0|||
130170100|NCT03146962|468582717|FG000|Overall Study|Adverse Event|0|||
130170101|NCT03146962|468582718|FG001|Overall Study|Adverse Event|3|||
130170102|NCT03146962|468582719|FG002|Overall Study|Adverse Event|0|||
130170103|NCT03146962|468582720|FG003|Overall Study|Adverse Event|0|||
130170104|NCT03146962|468582721|FG004|Overall Study|Adverse Event|0|||
130170105|NCT03146962|468582722|FG005|Overall Study|Adverse Event|0|||
130170106|NCT03146962|468582723|FG006|Overall Study|Adverse Event|0|||
130170107|NCT03146962|468582724|FG007|Overall Study|Adverse Event|1|||
130170108|NCT03146962|468582725|FG008|Overall Study|Adverse Event|0|||
130170109|NCT03146962|468582726|FG009|Overall Study|Adverse Event|0|||
130170110|NCT03146962|468582717|FG000|Overall Study|Withdrawal by Subject|0|||
130170111|NCT03146962|468582718|FG001|Overall Study|Withdrawal by Subject|0|||
130170112|NCT03146962|468582719|FG002|Overall Study|Withdrawal by Subject|0|||
130170113|NCT03146962|468582720|FG003|Overall Study|Withdrawal by Subject|0|||
130170114|NCT03146962|468582721|FG004|Overall Study|Withdrawal by Subject|1|||
130170115|NCT03146962|468582722|FG005|Overall Study|Withdrawal by Subject|0|||
130170116|NCT03146962|468582723|FG006|Overall Study|Withdrawal by Subject|0|||
130170117|NCT03146962|468582724|FG007|Overall Study|Withdrawal by Subject|0|||
130170118|NCT03146962|468582725|FG008|Overall Study|Withdrawal by Subject|0|||
130170119|NCT03146962|468582726|FG009|Overall Study|Withdrawal by Subject|0|||
130170120|NCT03146962|468582717|FG000|Overall Study|Death|0|||
130170121|NCT03146962|468582718|FG001|Overall Study|Death|1|||
130170122|NCT03146962|468582719|FG002|Overall Study|Death|0|||
130170123|NCT03146962|468582720|FG003|Overall Study|Death|0|||
130170124|NCT03146962|468582721|FG004|Overall Study|Death|0|||
130170125|NCT03146962|468582722|FG005|Overall Study|Death|0|||
130170126|NCT03146962|468582723|FG006|Overall Study|Death|0|||
130170127|NCT03146962|468582724|FG007|Overall Study|Death|0|||
130170128|NCT03146962|468582725|FG008|Overall Study|Death|0|||
130170129|NCT03146962|468582726|FG009|Overall Study|Death|0|||
130170130|NCT03146962|468582717|FG000|Overall Study|COVID Precautions|1|||
130170131|NCT03146962|468582718|FG001|Overall Study|COVID Precautions|0|||
130170132|NCT03146962|468582719|FG002|Overall Study|COVID Precautions|0|||
130170133|NCT03146962|468582720|FG003|Overall Study|COVID Precautions|0|||
130170134|NCT03146962|468582721|FG004|Overall Study|COVID Precautions|0|||
130170135|NCT03146962|468582722|FG005|Overall Study|COVID Precautions|0|||
130170136|NCT03146962|468582723|FG006|Overall Study|COVID Precautions|0|||
130170137|NCT03146962|468582724|FG007|Overall Study|COVID Precautions|0|||
130170138|NCT03146962|468582725|FG008|Overall Study|COVID Precautions|0|||
130170139|NCT03146962|468582726|FG009|Overall Study|COVID Precautions|0|||
130170140|NCT03146962|468582717|FG000|Overall Study|Physician Decision|0|||
130170141|NCT03146962|468582718|FG001|Overall Study|Physician Decision|0|||
130170142|NCT03146962|468582719|FG002|Overall Study|Physician Decision|0|||
130170143|NCT03146962|468582720|FG003|Overall Study|Physician Decision|0|||
130170144|NCT03146962|468582721|FG004|Overall Study|Physician Decision|0|||
130170145|NCT03146962|468582722|FG005|Overall Study|Physician Decision|0|||
130170146|NCT03146962|468582723|FG006|Overall Study|Physician Decision|0|||
130170147|NCT03146962|468582724|FG007|Overall Study|Physician Decision|0|||
130170148|NCT03146962|468582725|FG008|Overall Study|Physician Decision|0|||
130170149|NCT03146962|468582726|FG009|Overall Study|Physician Decision|1|||
130170150|NCT03146962|468582717|FG000|Overall Study|Started New Treatment|0|||
130170151|NCT03146962|468582718|FG001|Overall Study|Started New Treatment|1|||
130170152|NCT03146962|468582719|FG002|Overall Study|Started New Treatment|0|||
130170153|NCT03146962|468582720|FG003|Overall Study|Started New Treatment|0|||
130170154|NCT03146962|468582721|FG004|Overall Study|Started New Treatment|0|||
130170155|NCT03146962|468582722|FG005|Overall Study|Started New Treatment|0|||
130170156|NCT03146962|468582723|FG006|Overall Study|Started New Treatment|0|||
130170157|NCT03146962|468582724|FG007|Overall Study|Started New Treatment|0|||
130170158|NCT03146962|468582725|FG008|Overall Study|Started New Treatment|0|||
130170159|NCT03146962|468582726|FG009|Overall Study|Started New Treatment|0|||
130170160|NCT00264550|468582727|FG000|Overall Study|Death|0|||
130170161|NCT00264550|468582728|FG001|Overall Study|Death|3|||
130170162|NCT00264550|468582729|FG002|Overall Study|Death|0|||
130170163|NCT00264550|468582730|FG003|Overall Study|Death|0|||
130170164|NCT00264550|468582727|FG000|Overall Study|Lost to Follow-up|3|||
130170165|NCT00264550|468582728|FG001|Overall Study|Lost to Follow-up|1|||
130170166|NCT00264550|468582729|FG002|Overall Study|Lost to Follow-up|1|||
130170167|NCT00264550|468582730|FG003|Overall Study|Lost to Follow-up|1|||
130170168|NCT00264550|468582727|FG000|Overall Study|Adverse Event|23|||
130170169|NCT00264550|468582728|FG001|Overall Study|Adverse Event|18|||
130170170|NCT00264550|468582729|FG002|Overall Study|Adverse Event|9|||
130170171|NCT00264550|468582730|FG003|Overall Study|Adverse Event|14|||
130170172|NCT00264550|468582727|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
130170173|NCT00264550|468582728|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
130170174|NCT00264550|468582729|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
130170175|NCT00264550|468582730|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
130170176|NCT00264550|468582727|FG000|Overall Study|Discontinued oral study agent|0|||
130170177|NCT00264550|468582728|FG001|Overall Study|Discontinued oral study agent|1|||
130170178|NCT00264550|468582729|FG002|Overall Study|Discontinued oral study agent|0|||
130170179|NCT00264550|468582730|FG003|Overall Study|Discontinued oral study agent|0|||
130170180|NCT00264550|468582727|FG000|Overall Study|Other|13|||
130170181|NCT00264550|468582728|FG001|Overall Study|Other|7|||
130170182|NCT00264550|468582729|FG002|Overall Study|Other|3|||
130170183|NCT00264550|468582730|FG003|Overall Study|Other|9|||
130170184|NCT02246114|468582731|FG000|Overall Study|miscarriage|1|||
130170185|NCT02246114|468582732|FG001|Overall Study|miscarriage|0|||
130170186|NCT01439009|468582738|FG000|Overall Study|Physician Decision|5|||
130170187|NCT01439009|468582739|FG001|Overall Study|Physician Decision|3|||
130170188|NCT01439009|468582738|FG000|Overall Study|Protocol Violation|2|||
130170189|NCT01439009|468582739|FG001|Overall Study|Protocol Violation|0|||
130170190|NCT01439009|468582738|FG000|Overall Study|Deviation of exclusion criteria|1|||
130170191|NCT01439009|468582739|FG001|Overall Study|Deviation of exclusion criteria|0|||
130170192|NCT00696787|468582741|FG000|Overall Study|Adverse Event|1|||
130170193|NCT00696787|468582742|FG001|Overall Study|Adverse Event|0|||
130170194|NCT00696787|468582743|FG002|Overall Study|Adverse Event|6|||
130170195|NCT00696787|468582741|FG000|Overall Study|Discontinuation by Sponsor|9|||
130170196|NCT00696787|468582742|FG001|Overall Study|Discontinuation by Sponsor|13|||
130170197|NCT00696787|468582743|FG002|Overall Study|Discontinuation by Sponsor|14|||
130170198|NCT00696787|468582741|FG000|Overall Study|Lack of Efficacy|0|||
130170199|NCT00696787|468582742|FG001|Overall Study|Lack of Efficacy|1|||
130170200|NCT00696787|468582743|FG002|Overall Study|Lack of Efficacy|0|||
130170201|NCT00696787|468582741|FG000|Overall Study|Lost to Follow-up|4|||
130170202|NCT00696787|468582742|FG001|Overall Study|Lost to Follow-up|0|||
130170203|NCT00696787|468582743|FG002|Overall Study|Lost to Follow-up|3|||
130170204|NCT00696787|468582741|FG000|Overall Study|Withdrawal by Subject|0|||
130170205|NCT00696787|468582742|FG001|Overall Study|Withdrawal by Subject|3|||
130170206|NCT00696787|468582743|FG002|Overall Study|Withdrawal by Subject|2|||
130170207|NCT00696787|468582741|FG000|Overall Study|Failed to return|1|||
130170208|NCT00696787|468582742|FG001|Overall Study|Failed to return|3|||
130170209|NCT00696787|468582743|FG002|Overall Study|Failed to return|1|||
130170210|NCT03760185|468582748|FG000|Overall Study|Lost to Follow-up|1|||
130170211|NCT03760185|468582749|FG001|Overall Study|Lost to Follow-up|1|||
130170212|NCT01191944|468582750|FG000|Overall Study|Adverse Event|11|||
130170213|NCT01191944|468582751|FG001|Overall Study|Adverse Event|12|||
130170214|NCT01191944|468582750|FG000|Overall Study|Protocol Violation|1|||
130170215|NCT01191944|468582751|FG001|Overall Study|Protocol Violation|2|||
130170216|NCT01191944|468582750|FG000|Overall Study|Withdrawal by Subject|4|||
130170217|NCT01191944|468582751|FG001|Overall Study|Withdrawal by Subject|2|||
130170218|NCT01191944|468582750|FG000|Overall Study|Other|1|||
130170219|NCT01191944|468582751|FG001|Overall Study|Other|3|||
130170220|NCT00603837|468582752|FG000|Overall Study|Physician Decision|3|||
130170221|NCT00603837|468582753|FG001|Overall Study|Physician Decision|0|||
130170222|NCT04611529|468582754|FG000|2-day Follow up|Lost to Follow-up|5|||
130170223|NCT04611529|468582755|FG001|2-day Follow up|Lost to Follow-up|6|||
130170224|NCT04611529|468582756|FG002|2-day Follow up|Lost to Follow-up|3|||
130170225|NCT02052011|468582757|FG000|Overall Study|Lost to Follow-up|3|||
130170226|NCT02052011|468582758|FG001|Overall Study|Lost to Follow-up|0|||
130170227|NCT02052011|468582757|FG000|Overall Study|Withdrawal by Subject|1|||
130170228|NCT02052011|468582758|FG001|Overall Study|Withdrawal by Subject|2|||
129982073|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
129982074|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982075|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982076|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982077|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982078|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982079|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982080|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
129982081|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982082|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982083|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982084|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982085|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982086|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
130170229|NCT00000620|468582759|FG000|Overall Study|Death|86|||
130170230|NCT00000620|468582760|FG001|Overall Study|Death|67|||
130170231|NCT00000620|468582761|FG002|Overall Study|Death|112|||
130170232|NCT00000620|468582762|FG003|Overall Study|Death|126|||
130170233|NCT00000620|468582763|FG004|Overall Study|Death|64|||
130170234|NCT00000620|468582764|FG005|Overall Study|Death|77|||
130170235|NCT00000620|468582765|FG006|Overall Study|Death|91|||
130170236|NCT00000620|468582766|FG007|Overall Study|Death|95|||
129982087|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
129982088|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982089|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982090|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982091|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982092|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982093|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
129982094|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982095|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982096|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982097|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Site closure|0|||
129982098|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Site closure|0|||
129982099|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Site closure|1|||
129982100|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Site closure|0|||
129982101|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Site closure|0|||
129982102|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Site closure|0|||
129982103|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
129982104|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
129982105|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
129982106|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
129982107|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
129982108|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
129982109|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
129982110|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982111|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982112|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982113|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982114|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982115|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
129982116|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
129982117|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
129982118|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
129982119|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
129982120|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
129982121|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
129982122|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
129982123|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
129982124|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
129982125|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
129982126|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
129982127|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982128|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982129|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982130|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
129982131|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982132|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
129982133|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982134|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982135|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982136|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982137|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982138|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
129982139|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982140|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982141|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982142|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982143|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
129982144|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982145|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982146|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982147|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982148|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982149|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
129982150|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982151|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982152|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982153|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982154|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982155|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982156|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
129982157|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982158|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982159|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982160|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
129982161|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982162|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982163|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129982164|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129982165|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129982166|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
129982167|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
130170237|NCT00000620|468582759|FG000|Overall Study|Lost to Follow-up|14|||
130170238|NCT00000620|468582760|FG001|Overall Study|Lost to Follow-up|14|||
130170239|NCT00000620|468582761|FG002|Overall Study|Lost to Follow-up|14|||
130170240|NCT00000620|468582762|FG003|Overall Study|Lost to Follow-up|14|||
130170241|NCT00000620|468582763|FG004|Overall Study|Lost to Follow-up|15|||
130170242|NCT00000620|468582764|FG005|Overall Study|Lost to Follow-up|15|||
130170243|NCT00000620|468582765|FG006|Overall Study|Lost to Follow-up|13|||
130170244|NCT00000620|468582766|FG007|Overall Study|Lost to Follow-up|14|||
130170245|NCT00000620|468582759|FG000|Overall Study|Withdrawal by Subject|40|||
130170246|NCT00000620|468582760|FG001|Overall Study|Withdrawal by Subject|27|||
130170247|NCT00000620|468582761|FG002|Overall Study|Withdrawal by Subject|28|||
130170248|NCT00000620|468582762|FG003|Overall Study|Withdrawal by Subject|27|||
130170249|NCT00000620|468582763|FG004|Overall Study|Withdrawal by Subject|30|||
130170250|NCT00000620|468582764|FG005|Overall Study|Withdrawal by Subject|32|||
130170251|NCT00000620|468582765|FG006|Overall Study|Withdrawal by Subject|32|||
130170252|NCT00000620|468582766|FG007|Overall Study|Withdrawal by Subject|21|||
130170253|NCT00000620|468582759|FG000|Overall Study|missed closeout visit|22|||
130170254|NCT00000620|468582760|FG001|Overall Study|missed closeout visit|28|||
130170255|NCT00000620|468582761|FG002|Overall Study|missed closeout visit|16|||
130170256|NCT00000620|468582762|FG003|Overall Study|missed closeout visit|11|||
130170257|NCT00000620|468582763|FG004|Overall Study|missed closeout visit|26|||
130170258|NCT00000620|468582764|FG005|Overall Study|missed closeout visit|28|||
130170259|NCT00000620|468582765|FG006|Overall Study|missed closeout visit|13|||
130170260|NCT00000620|468582766|FG007|Overall Study|missed closeout visit|16|||
130170261|NCT02648932|468582767|FG000|Overall Study|No transplant|3|||
130170262|NCT02648932|468582768|FG001|Overall Study|No transplant|1|||
130170263|NCT02960490|468582769|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
130170264|NCT02960490|468582770|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
130170265|NCT02960490|468582771|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170266|NCT02960490|468582772|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170267|NCT02960490|468582773|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170268|NCT02960490|468582774|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170269|NCT02960490|468582775|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170270|NCT02960490|468582776|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170271|NCT02960490|468582777|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170272|NCT02960490|468582778|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
130170273|NCT02960490|468582769|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170274|NCT02960490|468582770|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
130170275|NCT02960490|468582771|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170276|NCT02960490|468582772|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170277|NCT02960490|468582773|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129982168|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
130170278|NCT02960490|468582774|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170279|NCT02960490|468582775|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170280|NCT02960490|468582776|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170281|NCT02960490|468582777|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170282|NCT02960490|468582778|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
130170283|NCT02960490|468582769|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
130170284|NCT02960490|468582770|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
130170285|NCT02960490|468582771|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170286|NCT02960490|468582772|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170287|NCT02960490|468582773|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170288|NCT02960490|468582774|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170289|NCT02960490|468582775|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170290|NCT02960490|468582776|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170291|NCT02960490|468582777|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170292|NCT02960490|468582778|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
130170293|NCT02960490|468582769|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
130170294|NCT02960490|468582770|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
130170295|NCT02960490|468582771|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170296|NCT02960490|468582772|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170297|NCT02960490|468582773|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170298|NCT02960490|468582774|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170299|NCT02960490|468582775|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170300|NCT02960490|468582776|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170301|NCT02960490|468582777|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170302|NCT02960490|468582778|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
130170303|NCT02960490|468582769|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170304|NCT02960490|468582770|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170305|NCT02960490|468582771|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
130170306|NCT02960490|468582772|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
130170307|NCT02960490|468582773|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170308|NCT02960490|468582774|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
130170309|NCT02960490|468582775|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170310|NCT02960490|468582776|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170311|NCT02960490|468582777|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170312|NCT02960490|468582778|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
130170313|NCT02960490|468582769|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170314|NCT02960490|468582770|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170315|NCT02960490|468582771|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
130170316|NCT02960490|468582772|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170317|NCT02960490|468582773|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
130170318|NCT02960490|468582774|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170319|NCT02960490|468582775|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170320|NCT02960490|468582776|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170321|NCT02960490|468582777|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170322|NCT02960490|468582778|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
130170323|NCT02960490|468582769|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
130170324|NCT02960490|468582770|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
130170325|NCT02960490|468582771|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
130170326|NCT02960490|468582772|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
130170327|NCT02960490|468582773|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
130170328|NCT02960490|468582774|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
130170329|NCT02960490|468582775|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
130170330|NCT02960490|468582776|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
130170331|NCT02960490|468582777|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
130170332|NCT02960490|468582778|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
130170333|NCT02960490|468582769|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170334|NCT02960490|468582770|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170335|NCT02960490|468582771|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170336|NCT02960490|468582772|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170337|NCT02960490|468582773|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170338|NCT02960490|468582774|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170339|NCT02960490|468582775|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
130170340|NCT02960490|468582776|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
130170341|NCT02960490|468582777|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
130170342|NCT02960490|468582778|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
130170343|NCT02960490|468582769|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170344|NCT02960490|468582770|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170345|NCT02960490|468582771|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129982169|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
130170346|NCT02960490|468582772|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170347|NCT02960490|468582773|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170348|NCT02960490|468582774|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170349|NCT02960490|468582775|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170350|NCT02960490|468582776|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
130170351|NCT02960490|468582777|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170352|NCT02960490|468582778|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
130170353|NCT02960490|468582769|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130170354|NCT02960490|468582770|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130170355|NCT02960490|468582771|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130170356|NCT02960490|468582772|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130170357|NCT02960490|468582773|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130170358|NCT02960490|468582774|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
130170359|NCT02960490|468582775|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
130170360|NCT02960490|468582776|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
130170361|NCT02960490|468582777|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
130170362|NCT02960490|468582778|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
130170363|NCT02960490|468582769|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170364|NCT02960490|468582770|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170365|NCT02960490|468582771|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170366|NCT02960490|468582772|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170367|NCT02960490|468582773|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170368|NCT02960490|468582774|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170369|NCT02960490|468582775|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
130170370|NCT02960490|468582776|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170371|NCT02960490|468582777|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170372|NCT02960490|468582778|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
130170373|NCT02960490|468582769|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170374|NCT02960490|468582770|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170375|NCT02960490|468582771|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170376|NCT02960490|468582772|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170377|NCT02960490|468582773|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170378|NCT02960490|468582774|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170379|NCT02960490|468582775|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170380|NCT02960490|468582776|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
130170381|NCT02960490|468582777|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170382|NCT02960490|468582778|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
130170383|NCT01307111|468582781|FG000|IUD Insertion|Lost to Follow-up|2|||
130170384|NCT01307111|468582782|FG001|IUD Insertion|Lost to Follow-up|0|||
130170385|NCT01307111|468582781|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
130170386|NCT01307111|468582782|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
130170387|NCT01333397|468582783|FG000|Overall Study|Lost to Follow-up|1|||
130170388|NCT01333397|468582784|FG001|Overall Study|Lost to Follow-up|0|||
130170389|NCT01333397|468582785|FG002|Overall Study|Lost to Follow-up|0|||
130170390|NCT01333397|468582786|FG003|Overall Study|Lost to Follow-up|1|||
130170391|NCT01333397|468582787|FG004|Overall Study|Lost to Follow-up|0|||
130170392|NCT01085357|468582788|FG000|Overall Study|Adverse Event|1|||
130170393|NCT01085357|468582789|FG001|Overall Study|Adverse Event|1|||
130170394|NCT01085357|468582788|FG000|Overall Study|Subject Decision|4|||
130170395|NCT01085357|468582789|FG001|Overall Study|Subject Decision|3|||
130170396|NCT01085357|468582788|FG000|Overall Study|Investigator Decision|1|||
130170397|NCT01085357|468582789|FG001|Overall Study|Investigator Decision|1|||
130170398|NCT01085357|468582788|FG000|Overall Study|Death|11|||
130170399|NCT01085357|468582789|FG001|Overall Study|Death|1|||
130170400|NCT01085357|468582788|FG000|Overall Study|Lost to Follow-up|2|||
130170401|NCT01085357|468582789|FG001|Overall Study|Lost to Follow-up|0|||
130170402|NCT00920790|468582792|FG000|Overall Study|aggravation of general condition|14|||
130170403|NCT02892149|468582793|FG000|Overall Study|Death|262|||
130170404|NCT02892149|468582794|FG001|Overall Study|Death|278|||
130170405|NCT02892149|468582793|FG000|Overall Study|Withdrawal by Subject|53|||
130170406|NCT02892149|468582794|FG001|Overall Study|Withdrawal by Subject|47|||
130170407|NCT02892149|468582793|FG000|Overall Study|Lost to Follow-up|37|||
130170408|NCT02892149|468582794|FG001|Overall Study|Lost to Follow-up|31|||
130170409|NCT00895414|468582799|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
129982170|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
129982171|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
130170410|NCT00895414|468582800|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
130170411|NCT00895414|468582799|FG000|First Intervention (14 Days)|Physician Decision|0|||
130170412|NCT00895414|468582800|FG001|First Intervention (14 Days)|Physician Decision|1|||
130170413|NCT00252239|468582801|FG000|Overall Study|Withdrawal by Subject|1|||
130170414|NCT00252239|468582802|FG001|Overall Study|Withdrawal by Subject|0|||
130170415|NCT00252239|468582803|FG002|Overall Study|Withdrawal by Subject|0|||
130170416|NCT00252239|468582804|FG003|Overall Study|Withdrawal by Subject|1|||
130170417|NCT00252239|468582801|FG000|Overall Study|Lost to Follow-up|0|||
129982172|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
130170418|NCT00252239|468582802|FG001|Overall Study|Lost to Follow-up|0|||
130170419|NCT00252239|468582803|FG002|Overall Study|Lost to Follow-up|2|||
130170420|NCT00252239|468582804|FG003|Overall Study|Lost to Follow-up|0|||
130170421|NCT00478426|468582805|FG000|Overall Study|Withdrawal by Subject|1|||
130170422|NCT00384930|468582810|FG000|Overall Study|Adverse Event|5|||
130170423|NCT00384930|468582811|FG001|Overall Study|Adverse Event|4|||
130170424|NCT00384930|468582812|FG002|Overall Study|Adverse Event|12|||
130170425|NCT00384930|468582813|FG003|Overall Study|Adverse Event|11|||
130170426|NCT00384930|468582814|FG004|Overall Study|Adverse Event|14|||
130170427|NCT00384930|468582810|FG000|Overall Study|Entry Criteria Not Met|2|||
130170428|NCT00384930|468582811|FG001|Overall Study|Entry Criteria Not Met|6|||
130170429|NCT00384930|468582812|FG002|Overall Study|Entry Criteria Not Met|7|||
130170430|NCT00384930|468582813|FG003|Overall Study|Entry Criteria Not Met|8|||
130170431|NCT00384930|468582814|FG004|Overall Study|Entry Criteria Not Met|4|||
130170432|NCT00384930|468582810|FG000|Overall Study|Lack of Efficacy|1|||
130170433|NCT00384930|468582811|FG001|Overall Study|Lack of Efficacy|1|||
130170434|NCT00384930|468582812|FG002|Overall Study|Lack of Efficacy|2|||
130170435|NCT00384930|468582813|FG003|Overall Study|Lack of Efficacy|1|||
130170436|NCT00384930|468582814|FG004|Overall Study|Lack of Efficacy|2|||
130170437|NCT00384930|468582810|FG000|Overall Study|Lost to Follow-up|5|||
130170438|NCT00384930|468582811|FG001|Overall Study|Lost to Follow-up|3|||
130170439|NCT00384930|468582812|FG002|Overall Study|Lost to Follow-up|0|||
130170440|NCT00384930|468582813|FG003|Overall Study|Lost to Follow-up|4|||
130170441|NCT00384930|468582814|FG004|Overall Study|Lost to Follow-up|6|||
130170442|NCT00384930|468582810|FG000|Overall Study|Physician Decision|0|||
130170443|NCT00384930|468582811|FG001|Overall Study|Physician Decision|1|||
130170444|NCT00384930|468582812|FG002|Overall Study|Physician Decision|1|||
130170445|NCT00384930|468582813|FG003|Overall Study|Physician Decision|0|||
130170446|NCT00384930|468582814|FG004|Overall Study|Physician Decision|1|||
130170447|NCT00384930|468582810|FG000|Overall Study|Protocol Violation|1|||
130170448|NCT00384930|468582811|FG001|Overall Study|Protocol Violation|0|||
130170449|NCT00384930|468582812|FG002|Overall Study|Protocol Violation|1|||
130170450|NCT00384930|468582813|FG003|Overall Study|Protocol Violation|6|||
130170451|NCT00384930|468582814|FG004|Overall Study|Protocol Violation|4|||
130170452|NCT00384930|468582810|FG000|Overall Study|Sponsor Decision|3|||
130170453|NCT00384930|468582811|FG001|Overall Study|Sponsor Decision|4|||
130170454|NCT00384930|468582812|FG002|Overall Study|Sponsor Decision|0|||
130170455|NCT00384930|468582813|FG003|Overall Study|Sponsor Decision|5|||
130170456|NCT00384930|468582814|FG004|Overall Study|Sponsor Decision|0|||
130170457|NCT00384930|468582810|FG000|Overall Study|Withdrawal by Subject|9|||
130170458|NCT00384930|468582811|FG001|Overall Study|Withdrawal by Subject|7|||
130170459|NCT00384930|468582812|FG002|Overall Study|Withdrawal by Subject|7|||
130170460|NCT00384930|468582813|FG003|Overall Study|Withdrawal by Subject|6|||
130170461|NCT00384930|468582814|FG004|Overall Study|Withdrawal by Subject|16|||
130170462|NCT00384930|468582810|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
130170463|NCT00384930|468582811|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
130170464|NCT00384930|468582812|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130170465|NCT00384930|468582813|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130170466|NCT00384930|468582814|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
130170467|NCT02752087|468582815|FG000|Washout|Physician Decision|1|||
130170468|NCT02752087|468582816|FG001|Washout|Physician Decision|0|||
130170469|NCT00863772|468582817|FG000|Overall Study|Adverse Event|1|||
130170470|NCT00863772|468582818|FG001|Overall Study|Adverse Event|4|||
130170471|NCT00863772|468582819|FG002|Overall Study|Adverse Event|0|||
130170472|NCT00863772|468582817|FG000|Overall Study|Lack of Efficacy|4|||
130170473|NCT00863772|468582818|FG001|Overall Study|Lack of Efficacy|2|||
130170474|NCT00863772|468582819|FG002|Overall Study|Lack of Efficacy|4|||
130170475|NCT00863772|468582817|FG000|Overall Study|Lost to Follow-up|5|||
130170476|NCT00863772|468582818|FG001|Overall Study|Lost to Follow-up|1|||
130170477|NCT00863772|468582819|FG002|Overall Study|Lost to Follow-up|1|||
130170478|NCT00863772|468582817|FG000|Overall Study|Protocol Violation|2|||
130170479|NCT00863772|468582818|FG001|Overall Study|Protocol Violation|0|||
130170480|NCT00863772|468582819|FG002|Overall Study|Protocol Violation|2|||
129982173|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
130170481|NCT00863772|468582817|FG000|Overall Study|Withdrawal by Subject|4|||
130170482|NCT00863772|468582818|FG001|Overall Study|Withdrawal by Subject|7|||
130170483|NCT00863772|468582819|FG002|Overall Study|Withdrawal by Subject|5|||
130170484|NCT00863772|468582817|FG000|Overall Study|Study terminated by sponsor|44|||
130170485|NCT00863772|468582818|FG001|Overall Study|Study terminated by sponsor|45|||
130170486|NCT00863772|468582819|FG002|Overall Study|Study terminated by sponsor|36|||
130170487|NCT00863772|468582817|FG000|Overall Study|Entered extension study|6|||
130170488|NCT00863772|468582818|FG001|Overall Study|Entered extension study|4|||
129982174|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
130170489|NCT00863772|468582819|FG002|Overall Study|Entered extension study|9|||
130170490|NCT00863772|468582817|FG000|Overall Study|Other|1|||
130170491|NCT00863772|468582818|FG001|Overall Study|Other|2|||
130170492|NCT00863772|468582819|FG002|Overall Study|Other|4|||
130170493|NCT00863772|468582817|FG000|Overall Study|Randomized but not Treated|1|||
130170494|NCT00863772|468582818|FG001|Overall Study|Randomized but not Treated|0|||
130170495|NCT00863772|468582819|FG002|Overall Study|Randomized but not Treated|0|||
130170496|NCT02785952|468582820|FG000|Overall Study|Adverse Event|31|||
130170497|NCT02785952|468582821|FG001|Overall Study|Adverse Event|19|||
130170498|NCT02785952|468582820|FG000|Overall Study|Refusal unrelated to adverse events|10|||
130170499|NCT02785952|468582821|FG001|Overall Study|Refusal unrelated to adverse events|5|||
130170500|NCT02785952|468582820|FG000|Overall Study|Disease progression/relapse|61|||
130170501|NCT02785952|468582821|FG001|Overall Study|Disease progression/relapse|89|||
130170502|NCT02785952|468582820|FG000|Overall Study|Death|11|||
130170503|NCT02785952|468582821|FG001|Overall Study|Death|7|||
130170504|NCT02785952|468582820|FG000|Overall Study|Other- not protocol specified|6|||
130170505|NCT02785952|468582821|FG001|Overall Study|Other- not protocol specified|4|||
130170506|NCT02785952|468582820|FG000|Overall Study|On protocol treatment|6|||
130170507|NCT02785952|468582821|FG001|Overall Study|On protocol treatment|3|||
130170508|NCT01671332|468582822|FG000|Overall Study|Withdrawal by Subject|1|||
130170509|NCT01671332|468582823|FG001|Overall Study|Withdrawal by Subject|1|||
130170510|NCT02728843|468582824|FG000|Overall Study|Adverse Event|0|||
130170511|NCT02728843|468582825|FG001|Overall Study|Adverse Event|2|||
130170512|NCT02728843|468582826|FG002|Overall Study|Adverse Event|3|||
130170513|NCT02728843|468582827|FG003|Overall Study|Adverse Event|1|||
130170514|NCT02728843|468582828|FG004|Overall Study|Adverse Event|2|||
130170515|NCT02728843|468582824|FG000|Overall Study|Lack of Efficacy|0|||
130170516|NCT02728843|468582825|FG001|Overall Study|Lack of Efficacy|1|||
130170517|NCT02728843|468582826|FG002|Overall Study|Lack of Efficacy|1|||
130170518|NCT02728843|468582827|FG003|Overall Study|Lack of Efficacy|0|||
130170519|NCT02728843|468582828|FG004|Overall Study|Lack of Efficacy|0|||
130170520|NCT02728843|468582824|FG000|Overall Study|Protocol Violation|2|||
130170521|NCT02728843|468582825|FG001|Overall Study|Protocol Violation|0|||
130170522|NCT02728843|468582826|FG002|Overall Study|Protocol Violation|4|||
130170523|NCT02728843|468582827|FG003|Overall Study|Protocol Violation|2|||
130170524|NCT02728843|468582828|FG004|Overall Study|Protocol Violation|2|||
130170525|NCT02728843|468582824|FG000|Overall Study|Withdrawal by Subject|1|||
130170526|NCT02728843|468582825|FG001|Overall Study|Withdrawal by Subject|0|||
130170527|NCT02728843|468582826|FG002|Overall Study|Withdrawal by Subject|0|||
130170528|NCT02728843|468582827|FG003|Overall Study|Withdrawal by Subject|1|||
130170529|NCT02728843|468582828|FG004|Overall Study|Withdrawal by Subject|0|||
130170530|NCT02728843|468582824|FG000|Overall Study|Use of rescue medication|0|||
130170531|NCT02728843|468582825|FG001|Overall Study|Use of rescue medication|2|||
130170532|NCT02728843|468582826|FG002|Overall Study|Use of rescue medication|0|||
130170533|NCT02728843|468582827|FG003|Overall Study|Use of rescue medication|2|||
130170534|NCT02728843|468582828|FG004|Overall Study|Use of rescue medication|1|||
130170535|NCT00351533|468582829|FG000|Overall Study|Extubated before first BAL|1|||
130170536|NCT00351533|468582830|FG001|Overall Study|Extubated before first BAL|0|||
130170537|NCT00351533|468582829|FG000|Overall Study|Lost to Follow-up|1|||
130170538|NCT00351533|468582830|FG001|Overall Study|Lost to Follow-up|3|||
130170539|NCT00351533|468582829|FG000|Overall Study|Physician Decision|0|||
130170540|NCT00351533|468582830|FG001|Overall Study|Physician Decision|1|||
130170541|NCT00351533|468582829|FG000|Overall Study|Withdrawal by Subject|0|||
130170542|NCT00351533|468582830|FG001|Overall Study|Withdrawal by Subject|1|||
130170543|NCT01806506|468582831|FG000|Overall Study|Lost to Follow-up|2|||
130170544|NCT01806506|468582832|FG001|Overall Study|Lost to Follow-up|1|||
130170545|NCT01653912|468582838|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130170546|NCT01653912|468582839|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
130170547|NCT01653912|468582840|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130170548|NCT01653912|468582841|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130170549|NCT01653912|468582842|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130170550|NCT01653912|468582843|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
130170551|NCT01653912|468582838|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130170552|NCT01653912|468582839|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130170553|NCT01653912|468582840|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
130170554|NCT01653912|468582841|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130170555|NCT01653912|468582842|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130170556|NCT01653912|468582843|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
130170557|NCT01653912|468582838|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130170558|NCT01653912|468582839|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130170559|NCT01653912|468582840|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130170560|NCT01653912|468582841|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
130170561|NCT01653912|468582842|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129982175|NCT02075476|467898759|FG000|Overall Study|Death|2|||
129982176|NCT02075476|467898760|FG001|Overall Study|Death|2|||
130170562|NCT01653912|468582843|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
130170563|NCT01653912|468582838|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170564|NCT01653912|468582839|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170565|NCT01653912|468582840|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170566|NCT01653912|468582841|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
130170567|NCT01653912|468582842|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170568|NCT01653912|468582843|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170569|NCT01653912|468582838|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130170570|NCT01653912|468582839|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130170571|NCT01653912|468582840|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130170572|NCT01653912|468582841|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130170573|NCT01653912|468582842|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
130170574|NCT01653912|468582843|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
130170575|NCT01653912|468582838|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130170576|NCT01653912|468582839|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130170577|NCT01653912|468582840|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130170578|NCT01653912|468582841|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130170579|NCT01653912|468582842|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
130170580|NCT01653912|468582843|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
130170581|NCT01653912|468582838|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170582|NCT01653912|468582839|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170583|NCT01653912|468582840|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170584|NCT01653912|468582841|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170585|NCT01653912|468582842|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
130170586|NCT01653912|468582843|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
130170587|NCT03408639|468584542|FG000|Overall Study|Death|5|||
130170588|NCT03408639|468584543|FG001|Overall Study|Death|5|||
130170589|NCT03408639|468584542|FG000|Overall Study|Lost to Follow-up|1|||
130170590|NCT03408639|468584543|FG001|Overall Study|Lost to Follow-up|4|||
130170591|NCT03408639|468584542|FG000|Overall Study|Withdrawal by Subject|2|||
130170592|NCT03408639|468584543|FG001|Overall Study|Withdrawal by Subject|7|||
130170593|NCT03408639|468584542|FG000|Overall Study|Physician Decision|3|||
130170594|NCT03408639|468584543|FG001|Overall Study|Physician Decision|6|||
130170595|NCT00070499|468584544|FG000|Overall Study|Adverse Event|6|||
130170596|NCT00070499|468584545|FG001|Overall Study|Adverse Event|6|||
130170597|NCT00070499|468584546|FG002|Overall Study|Adverse Event|19|||
130170598|NCT00070499|468584547|FG003|Overall Study|Adverse Event|15|||
130170599|NCT00070499|468584544|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
129982177|NCT02075476|467898759|FG000|Overall Study|Lost to Follow-up|1|||
129982178|NCT02075476|467898760|FG001|Overall Study|Lost to Follow-up|3|||
129982179|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
129982180|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
129982181|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
129982182|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
129982183|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Death|1|||
129982184|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Death|0|||
129982185|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
129982186|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
129982187|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
129982188|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
129982189|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
129982190|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
130170600|NCT00070499|468584545|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
130170601|NCT00070499|468584546|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
130170602|NCT00070499|468584547|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
130170603|NCT00070499|468584544|FG000|Overall Study|Progression/relapse|4|||
130170604|NCT00070499|468584545|FG001|Overall Study|Progression/relapse|2|||
130170605|NCT00070499|468584546|FG002|Overall Study|Progression/relapse|1|||
129982191|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
130170606|NCT00070499|468584547|FG003|Overall Study|Progression/relapse|4|||
130170607|NCT00070499|468584544|FG000|Overall Study|Death|1|||
130170608|NCT00070499|468584545|FG001|Overall Study|Death|1|||
130170609|NCT00070499|468584546|FG002|Overall Study|Death|1|||
130170610|NCT00070499|468584547|FG003|Overall Study|Death|2|||
130170611|NCT00070499|468584544|FG000|Overall Study|Other - not protocol specified|7|||
129982192|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
129982193|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
129982194|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
129982195|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Death|3|||
129982196|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Death|1|||
129982197|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
129982198|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
129982199|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
129982200|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
129982201|NCT00923260|467898768|FG000|Overall Study|Lost to Follow-up|1|||
130170612|NCT00070499|468584545|FG001|Overall Study|Other - not protocol specified|3|||
130170613|NCT00070499|468584546|FG002|Overall Study|Other - not protocol specified|12|||
130170614|NCT00070499|468584547|FG003|Overall Study|Other - not protocol specified|20|||
130170615|NCT00070499|468584544|FG000|Overall Study|Still on protocol treatment|10|||
130170616|NCT00070499|468584545|FG001|Overall Study|Still on protocol treatment|4|||
130170617|NCT00070499|468584546|FG002|Overall Study|Still on protocol treatment|79|||
130170618|NCT00070499|468584547|FG003|Overall Study|Still on protocol treatment|57|||
130170619|NCT00070499|468584544|FG000|Overall Study|Did not start treatment|1|||
130170620|NCT00070499|468584545|FG001|Overall Study|Did not start treatment|0|||
130170621|NCT00070499|468584546|FG002|Overall Study|Did not start treatment|0|||
130170622|NCT00070499|468584547|FG003|Overall Study|Did not start treatment|2|||
130170623|NCT00070499|468584544|FG000|Overall Study|Not eligible|2|||
130170624|NCT00070499|468584545|FG001|Overall Study|Not eligible|5|||
130170625|NCT00070499|468584546|FG002|Overall Study|Not eligible|3|||
130170626|NCT00070499|468584547|FG003|Overall Study|Not eligible|2|||
130170627|NCT02883049|468584548|FG000|Induction|Adverse Event|52|||
130170628|NCT02883049|468584549|FG001|Induction|Adverse Event|2|||
130170629|NCT02883049|468584550|FG002|Induction|Adverse Event|0|||
130170630|NCT02883049|468584551|FG003|Induction|Adverse Event|0|||
130170631|NCT02883049|468584552|FG004|Induction|Adverse Event|0|||
130170632|NCT02883049|468584553|FG005|Induction|Adverse Event|0|||
130170633|NCT02883049|468584554|FG006|Induction|Adverse Event|0|||
130170634|NCT02883049|468584555|FG007|Induction|Adverse Event|0|||
130170635|NCT02883049|468584556|FG008|Induction|Adverse Event|0|||
130170636|NCT02883049|468584557|FG009|Induction|Adverse Event|0|||
130170637|NCT02883049|468584558|FG010|Induction|Adverse Event|0|||
130170638|NCT02883049|468584559|FG011|Induction|Adverse Event|0|||
130170639|NCT02883049|468584560|FG012|Induction|Adverse Event|0|||
130170640|NCT02883049|468584561|FG013|Induction|Adverse Event|0|||
130170641|NCT02883049|468584562|FG014|Induction|Adverse Event|0|||
130170642|NCT02883049|468584563|FG015|Induction|Adverse Event|0|||
130170643|NCT02883049|468584548|FG000|Induction|Death|76|||
130170644|NCT02883049|468584549|FG001|Induction|Death|8|||
130170645|NCT02883049|468584550|FG002|Induction|Death|0|||
130170646|NCT02883049|468584551|FG003|Induction|Death|0|||
130170647|NCT02883049|468584552|FG004|Induction|Death|0|||
130170648|NCT02883049|468584553|FG005|Induction|Death|0|||
130170649|NCT02883049|468584554|FG006|Induction|Death|0|||
130170650|NCT02883049|468584555|FG007|Induction|Death|0|||
130170651|NCT02883049|468584556|FG008|Induction|Death|0|||
130170652|NCT02883049|468584557|FG009|Induction|Death|0|||
130170653|NCT02883049|468584558|FG010|Induction|Death|0|||
130170654|NCT02883049|468584559|FG011|Induction|Death|0|||
130170655|NCT02883049|468584560|FG012|Induction|Death|0|||
130170656|NCT02883049|468584561|FG013|Induction|Death|0|||
130170657|NCT02883049|468584562|FG014|Induction|Death|0|||
130170658|NCT02883049|468584563|FG015|Induction|Death|0|||
130170659|NCT02883049|468584548|FG000|Induction|Lost to Follow-up|2|||
130170660|NCT02883049|468584549|FG001|Induction|Lost to Follow-up|0|||
130170661|NCT02883049|468584550|FG002|Induction|Lost to Follow-up|0|||
130170662|NCT02883049|468584551|FG003|Induction|Lost to Follow-up|0|||
130170663|NCT02883049|468584552|FG004|Induction|Lost to Follow-up|0|||
130170664|NCT02883049|468584553|FG005|Induction|Lost to Follow-up|0|||
130170665|NCT02883049|468584554|FG006|Induction|Lost to Follow-up|0|||
130170666|NCT02883049|468584555|FG007|Induction|Lost to Follow-up|0|||
130170667|NCT02883049|468584556|FG008|Induction|Lost to Follow-up|0|||
130170668|NCT02883049|468584557|FG009|Induction|Lost to Follow-up|0|||
130170669|NCT02883049|468584558|FG010|Induction|Lost to Follow-up|0|||
130170670|NCT02883049|468584559|FG011|Induction|Lost to Follow-up|0|||
130170671|NCT02883049|468584560|FG012|Induction|Lost to Follow-up|0|||
130170672|NCT02883049|468584561|FG013|Induction|Lost to Follow-up|0|||
130170673|NCT02883049|468584562|FG014|Induction|Lost to Follow-up|0|||
130170674|NCT02883049|468584563|FG015|Induction|Lost to Follow-up|0|||
130170675|NCT02883049|468584548|FG000|Induction|Physician Decision|1407|||
130170676|NCT02883049|468584549|FG001|Induction|Physician Decision|8|||
129982202|NCT00923260|467898769|FG001|Overall Study|Lost to Follow-up|1|||
130170677|NCT02883049|468584550|FG002|Induction|Physician Decision|0|||
130170678|NCT02883049|468584551|FG003|Induction|Physician Decision|0|||
130170679|NCT02883049|468584552|FG004|Induction|Physician Decision|0|||
130170680|NCT02883049|468584553|FG005|Induction|Physician Decision|0|||
130170681|NCT02883049|468584554|FG006|Induction|Physician Decision|0|||
130170682|NCT02883049|468584555|FG007|Induction|Physician Decision|0|||
130170683|NCT02883049|468584556|FG008|Induction|Physician Decision|0|||
130170684|NCT02883049|468584557|FG009|Induction|Physician Decision|0|||
130170685|NCT02883049|468584558|FG010|Induction|Physician Decision|0|||
130170686|NCT02883049|468584559|FG011|Induction|Physician Decision|0|||
130170687|NCT02883049|468584560|FG012|Induction|Physician Decision|0|||
130170688|NCT02883049|468584561|FG013|Induction|Physician Decision|0|||
130170689|NCT02883049|468584562|FG014|Induction|Physician Decision|0|||
130170690|NCT02883049|468584563|FG015|Induction|Physician Decision|0|||
130170691|NCT02883049|468584548|FG000|Induction|Protocol Violation|6|||
130170692|NCT02883049|468584549|FG001|Induction|Protocol Violation|0|||
130170693|NCT02883049|468584550|FG002|Induction|Protocol Violation|0|||
130170694|NCT02883049|468584551|FG003|Induction|Protocol Violation|0|||
130170695|NCT02883049|468584552|FG004|Induction|Protocol Violation|0|||
130170696|NCT02883049|468584553|FG005|Induction|Protocol Violation|0|||
130170697|NCT02883049|468584554|FG006|Induction|Protocol Violation|0|||
130170698|NCT02883049|468584555|FG007|Induction|Protocol Violation|0|||
130170699|NCT02883049|468584556|FG008|Induction|Protocol Violation|0|||
130170700|NCT02883049|468584557|FG009|Induction|Protocol Violation|0|||
130170701|NCT02883049|468584558|FG010|Induction|Protocol Violation|0|||
130170702|NCT02883049|468584559|FG011|Induction|Protocol Violation|0|||
130170703|NCT02883049|468584560|FG012|Induction|Protocol Violation|0|||
130170704|NCT02883049|468584561|FG013|Induction|Protocol Violation|0|||
130170705|NCT02883049|468584562|FG014|Induction|Protocol Violation|0|||
130170706|NCT02883049|468584563|FG015|Induction|Protocol Violation|0|||
130170707|NCT02883049|468584548|FG000|Induction|Withdrawal by Subject|6|||
130170708|NCT02883049|468584549|FG001|Induction|Withdrawal by Subject|0|||
130170709|NCT02883049|468584550|FG002|Induction|Withdrawal by Subject|0|||
130170710|NCT02883049|468584551|FG003|Induction|Withdrawal by Subject|0|||
130170711|NCT02883049|468584552|FG004|Induction|Withdrawal by Subject|0|||
130170712|NCT02883049|468584553|FG005|Induction|Withdrawal by Subject|0|||
130170713|NCT02883049|468584554|FG006|Induction|Withdrawal by Subject|0|||
130170714|NCT02883049|468584555|FG007|Induction|Withdrawal by Subject|0|||
130170715|NCT02883049|468584556|FG008|Induction|Withdrawal by Subject|0|||
130170716|NCT02883049|468584557|FG009|Induction|Withdrawal by Subject|0|||
130170717|NCT02883049|468584558|FG010|Induction|Withdrawal by Subject|0|||
130170718|NCT02883049|468584559|FG011|Induction|Withdrawal by Subject|0|||
130170719|NCT02883049|468584560|FG012|Induction|Withdrawal by Subject|0|||
130170720|NCT02883049|468584561|FG013|Induction|Withdrawal by Subject|0|||
130170721|NCT02883049|468584562|FG014|Induction|Withdrawal by Subject|0|||
130170722|NCT02883049|468584563|FG015|Induction|Withdrawal by Subject|0|||
130170723|NCT02883049|468584548|FG000|Induction|Ineligible|35|||
130170724|NCT02883049|468584549|FG001|Induction|Ineligible|1|||
130170725|NCT02883049|468584550|FG002|Induction|Ineligible|0|||
130170726|NCT02883049|468584551|FG003|Induction|Ineligible|0|||
130170727|NCT02883049|468584552|FG004|Induction|Ineligible|0|||
130170728|NCT02883049|468584553|FG005|Induction|Ineligible|0|||
130170729|NCT02883049|468584554|FG006|Induction|Ineligible|0|||
130170730|NCT02883049|468584555|FG007|Induction|Ineligible|0|||
130170731|NCT02883049|468584556|FG008|Induction|Ineligible|0|||
130170732|NCT02883049|468584557|FG009|Induction|Ineligible|0|||
130170733|NCT02883049|468584558|FG010|Induction|Ineligible|0|||
130170734|NCT02883049|468584559|FG011|Induction|Ineligible|0|||
130170735|NCT02883049|468584560|FG012|Induction|Ineligible|0|||
130170736|NCT02883049|468584561|FG013|Induction|Ineligible|0|||
130170737|NCT02883049|468584562|FG014|Induction|Ineligible|0|||
130170738|NCT02883049|468584563|FG015|Induction|Ineligible|0|||
130170739|NCT02883049|468584548|FG000|Induction|Refusal of further protocol therapy|466|||
130170740|NCT02883049|468584549|FG001|Induction|Refusal of further protocol therapy|2|||
130170741|NCT02883049|468584550|FG002|Induction|Refusal of further protocol therapy|0|||
130170742|NCT02883049|468584551|FG003|Induction|Refusal of further protocol therapy|0|||
130170743|NCT02883049|468584552|FG004|Induction|Refusal of further protocol therapy|0|||
130170744|NCT02883049|468584553|FG005|Induction|Refusal of further protocol therapy|0|||
130170745|NCT02883049|468584554|FG006|Induction|Refusal of further protocol therapy|0|||
130170746|NCT02883049|468584555|FG007|Induction|Refusal of further protocol therapy|0|||
130170747|NCT02883049|468584556|FG008|Induction|Refusal of further protocol therapy|0|||
130170748|NCT02883049|468584557|FG009|Induction|Refusal of further protocol therapy|0|||
130170749|NCT02883049|468584558|FG010|Induction|Refusal of further protocol therapy|0|||
130170750|NCT02883049|468584559|FG011|Induction|Refusal of further protocol therapy|0|||
130170751|NCT02883049|468584560|FG012|Induction|Refusal of further protocol therapy|0|||
130170752|NCT02883049|468584561|FG013|Induction|Refusal of further protocol therapy|0|||
130170753|NCT02883049|468584562|FG014|Induction|Refusal of further protocol therapy|0|||
130170754|NCT02883049|468584563|FG015|Induction|Refusal of further protocol therapy|0|||
130170755|NCT02883049|468584548|FG000|Induction|Identified as Ph+ patients|279|||
130170756|NCT02883049|468584549|FG001|Induction|Identified as Ph+ patients|1|||
130170757|NCT02883049|468584550|FG002|Induction|Identified as Ph+ patients|0|||
130170758|NCT02883049|468584551|FG003|Induction|Identified as Ph+ patients|0|||
130170759|NCT02883049|468584552|FG004|Induction|Identified as Ph+ patients|0|||
130170760|NCT02883049|468584553|FG005|Induction|Identified as Ph+ patients|0|||
130170761|NCT02883049|468584554|FG006|Induction|Identified as Ph+ patients|0|||
130170762|NCT02883049|468584555|FG007|Induction|Identified as Ph+ patients|0|||
130170763|NCT02883049|468584556|FG008|Induction|Identified as Ph+ patients|0|||
130170764|NCT02883049|468584557|FG009|Induction|Identified as Ph+ patients|0|||
129982203|NCT04410523|467898771|FG000|Overall Study|Study terminated by sponsor|1|||
130170765|NCT02883049|468584558|FG010|Induction|Identified as Ph+ patients|0|||
130170766|NCT02883049|468584559|FG011|Induction|Identified as Ph+ patients|0|||
130170767|NCT02883049|468584560|FG012|Induction|Identified as Ph+ patients|0|||
130170768|NCT02883049|468584561|FG013|Induction|Identified as Ph+ patients|0|||
130170769|NCT02883049|468584562|FG014|Induction|Identified as Ph+ patients|0|||
130170770|NCT02883049|468584563|FG015|Induction|Identified as Ph+ patients|0|||
130170771|NCT02883049|468584548|FG000|Induction|M3 Marrow at Day29|8|||
130170772|NCT02883049|468584549|FG001|Induction|M3 Marrow at Day29|1|||
130170773|NCT02883049|468584550|FG002|Induction|M3 Marrow at Day29|0|||
130170774|NCT02883049|468584551|FG003|Induction|M3 Marrow at Day29|0|||
130170775|NCT02883049|468584552|FG004|Induction|M3 Marrow at Day29|0|||
130170776|NCT02883049|468584553|FG005|Induction|M3 Marrow at Day29|0|||
130170777|NCT02883049|468584554|FG006|Induction|M3 Marrow at Day29|0|||
130170778|NCT02883049|468584555|FG007|Induction|M3 Marrow at Day29|0|||
130170779|NCT02883049|468584556|FG008|Induction|M3 Marrow at Day29|0|||
130170780|NCT02883049|468584557|FG009|Induction|M3 Marrow at Day29|0|||
130170781|NCT02883049|468584558|FG010|Induction|M3 Marrow at Day29|0|||
130170782|NCT02883049|468584559|FG011|Induction|M3 Marrow at Day29|0|||
130170783|NCT02883049|468584560|FG012|Induction|M3 Marrow at Day29|0|||
130170784|NCT02883049|468584561|FG013|Induction|M3 Marrow at Day29|0|||
130170785|NCT02883049|468584562|FG014|Induction|M3 Marrow at Day29|0|||
130170786|NCT02883049|468584563|FG015|Induction|M3 Marrow at Day29|0|||
130170787|NCT02883049|468584548|FG000|Induction|Inevaluable|33|||
130170788|NCT02883049|468584549|FG001|Induction|Inevaluable|1|||
130170789|NCT02883049|468584550|FG002|Induction|Inevaluable|0|||
130170790|NCT02883049|468584551|FG003|Induction|Inevaluable|0|||
130170791|NCT02883049|468584552|FG004|Induction|Inevaluable|0|||
130170792|NCT02883049|468584553|FG005|Induction|Inevaluable|0|||
130170793|NCT02883049|468584554|FG006|Induction|Inevaluable|0|||
130170794|NCT02883049|468584555|FG007|Induction|Inevaluable|0|||
130170795|NCT02883049|468584556|FG008|Induction|Inevaluable|0|||
130170796|NCT02883049|468584557|FG009|Induction|Inevaluable|0|||
130170797|NCT02883049|468584558|FG010|Induction|Inevaluable|0|||
130170798|NCT02883049|468584559|FG011|Induction|Inevaluable|0|||
130170799|NCT02883049|468584560|FG012|Induction|Inevaluable|0|||
130170800|NCT02883049|468584561|FG013|Induction|Inevaluable|0|||
130170801|NCT02883049|468584562|FG014|Induction|Inevaluable|0|||
130170802|NCT02883049|468584563|FG015|Induction|Inevaluable|0|||
130170803|NCT02883049|468584548|FG000|Induction|Identified as VHR at end of Induction|244|||
130170804|NCT02883049|468584549|FG001|Induction|Identified as VHR at end of Induction|0|||
130170805|NCT02883049|468584550|FG002|Induction|Identified as VHR at end of Induction|0|||
130170806|NCT02883049|468584551|FG003|Induction|Identified as VHR at end of Induction|0|||
130170807|NCT02883049|468584552|FG004|Induction|Identified as VHR at end of Induction|0|||
130170808|NCT02883049|468584553|FG005|Induction|Identified as VHR at end of Induction|0|||
130170809|NCT02883049|468584554|FG006|Induction|Identified as VHR at end of Induction|0|||
130170810|NCT02883049|468584555|FG007|Induction|Identified as VHR at end of Induction|0|||
130170811|NCT02883049|468584556|FG008|Induction|Identified as VHR at end of Induction|0|||
130170812|NCT02883049|468584557|FG009|Induction|Identified as VHR at end of Induction|0|||
130170813|NCT02883049|468584558|FG010|Induction|Identified as VHR at end of Induction|0|||
130170814|NCT02883049|468584559|FG011|Induction|Identified as VHR at end of Induction|0|||
130170815|NCT02883049|468584560|FG012|Induction|Identified as VHR at end of Induction|0|||
130170816|NCT02883049|468584561|FG013|Induction|Identified as VHR at end of Induction|0|||
130170817|NCT02883049|468584562|FG014|Induction|Identified as VHR at end of Induction|0|||
130170818|NCT02883049|468584563|FG015|Induction|Identified as VHR at end of Induction|0|||
130170819|NCT02883049|468584548|FG000|Induction|Moved to another non-COG institution|3|||
130170820|NCT02883049|468584549|FG001|Induction|Moved to another non-COG institution|0|||
130170821|NCT02883049|468584550|FG002|Induction|Moved to another non-COG institution|0|||
130170822|NCT02883049|468584551|FG003|Induction|Moved to another non-COG institution|0|||
130170823|NCT02883049|468584552|FG004|Induction|Moved to another non-COG institution|0|||
130170824|NCT02883049|468584553|FG005|Induction|Moved to another non-COG institution|0|||
130170825|NCT02883049|468584554|FG006|Induction|Moved to another non-COG institution|0|||
130170826|NCT02883049|468584555|FG007|Induction|Moved to another non-COG institution|0|||
130170827|NCT02883049|468584556|FG008|Induction|Moved to another non-COG institution|0|||
130170828|NCT02883049|468584557|FG009|Induction|Moved to another non-COG institution|0|||
130170829|NCT02883049|468584558|FG010|Induction|Moved to another non-COG institution|0|||
130170830|NCT02883049|468584559|FG011|Induction|Moved to another non-COG institution|0|||
130170831|NCT02883049|468584560|FG012|Induction|Moved to another non-COG institution|0|||
130170832|NCT02883049|468584561|FG013|Induction|Moved to another non-COG institution|0|||
130170833|NCT02883049|468584562|FG014|Induction|Moved to another non-COG institution|0|||
130170834|NCT02883049|468584563|FG015|Induction|Moved to another non-COG institution|0|||
130170835|NCT02883049|468584548|FG000|Induction|Randomization closed|41|||
130170836|NCT02883049|468584549|FG001|Induction|Randomization closed|0|||
130170837|NCT02883049|468584550|FG002|Induction|Randomization closed|0|||
130170838|NCT02883049|468584551|FG003|Induction|Randomization closed|0|||
130170839|NCT02883049|468584552|FG004|Induction|Randomization closed|0|||
130170840|NCT02883049|468584553|FG005|Induction|Randomization closed|0|||
130170841|NCT02883049|468584554|FG006|Induction|Randomization closed|0|||
130170842|NCT02883049|468584555|FG007|Induction|Randomization closed|0|||
130170843|NCT02883049|468584556|FG008|Induction|Randomization closed|0|||
130170844|NCT02883049|468584557|FG009|Induction|Randomization closed|0|||
130170845|NCT02883049|468584558|FG010|Induction|Randomization closed|0|||
130170846|NCT02883049|468584559|FG011|Induction|Randomization closed|0|||
130170847|NCT02883049|468584560|FG012|Induction|Randomization closed|0|||
130170848|NCT02883049|468584561|FG013|Induction|Randomization closed|0|||
130170849|NCT02883049|468584562|FG014|Induction|Randomization closed|0|||
130170850|NCT02883049|468584563|FG015|Induction|Randomization closed|0|||
130170851|NCT02883049|468584548|FG000|Induction|MRD negative|36|||
130170852|NCT02883049|468584549|FG001|Induction|MRD negative|0|||
130170853|NCT02883049|468584550|FG002|Induction|MRD negative|0|||
130170854|NCT02883049|468584551|FG003|Induction|MRD negative|0|||
130170855|NCT02883049|468584552|FG004|Induction|MRD negative|0|||
130170856|NCT02883049|468584553|FG005|Induction|MRD negative|0|||
130170857|NCT02883049|468584554|FG006|Induction|MRD negative|0|||
130170858|NCT02883049|468584555|FG007|Induction|MRD negative|0|||
130170859|NCT02883049|468584556|FG008|Induction|MRD negative|0|||
130170860|NCT02883049|468584557|FG009|Induction|MRD negative|0|||
130170861|NCT02883049|468584558|FG010|Induction|MRD negative|0|||
130170862|NCT02883049|468584559|FG011|Induction|MRD negative|0|||
130170863|NCT02883049|468584560|FG012|Induction|MRD negative|0|||
130170864|NCT02883049|468584561|FG013|Induction|MRD negative|0|||
130170865|NCT02883049|468584562|FG014|Induction|MRD negative|0|||
130170866|NCT02883049|468584563|FG015|Induction|MRD negative|0|||
130170867|NCT02883049|468584548|FG000|Induction|Identified as HR patients|165|||
130170868|NCT02883049|468584549|FG001|Induction|Identified as HR patients|0|||
130170869|NCT02883049|468584550|FG002|Induction|Identified as HR patients|0|||
130170870|NCT02883049|468584551|FG003|Induction|Identified as HR patients|0|||
130170871|NCT02883049|468584552|FG004|Induction|Identified as HR patients|0|||
130170872|NCT02883049|468584553|FG005|Induction|Identified as HR patients|0|||
130170873|NCT02883049|468584554|FG006|Induction|Identified as HR patients|0|||
130170874|NCT02883049|468584555|FG007|Induction|Identified as HR patients|0|||
130170875|NCT02883049|468584556|FG008|Induction|Identified as HR patients|0|||
130170876|NCT02883049|468584557|FG009|Induction|Identified as HR patients|0|||
130170877|NCT02883049|468584558|FG010|Induction|Identified as HR patients|0|||
130170878|NCT02883049|468584559|FG011|Induction|Identified as HR patients|0|||
130170879|NCT02883049|468584560|FG012|Induction|Identified as HR patients|0|||
130170880|NCT02883049|468584561|FG013|Induction|Identified as HR patients|0|||
130170881|NCT02883049|468584562|FG014|Induction|Identified as HR patients|0|||
130170882|NCT02883049|468584563|FG015|Induction|Identified as HR patients|0|||
130170883|NCT02883049|468584548|FG000|Induction|Developed SMN|0|||
130170884|NCT02883049|468584549|FG001|Induction|Developed SMN|1|||
130170885|NCT02883049|468584550|FG002|Induction|Developed SMN|0|||
130170886|NCT02883049|468584551|FG003|Induction|Developed SMN|0|||
130170887|NCT02883049|468584552|FG004|Induction|Developed SMN|0|||
130170888|NCT02883049|468584553|FG005|Induction|Developed SMN|0|||
130170889|NCT02883049|468584554|FG006|Induction|Developed SMN|0|||
130170890|NCT02883049|468584555|FG007|Induction|Developed SMN|0|||
130170891|NCT02883049|468584556|FG008|Induction|Developed SMN|0|||
130170892|NCT02883049|468584557|FG009|Induction|Developed SMN|0|||
130170893|NCT02883049|468584558|FG010|Induction|Developed SMN|0|||
130170894|NCT02883049|468584559|FG011|Induction|Developed SMN|0|||
130170895|NCT02883049|468584560|FG012|Induction|Developed SMN|0|||
130170896|NCT02883049|468584561|FG013|Induction|Developed SMN|0|||
130170897|NCT02883049|468584562|FG014|Induction|Developed SMN|0|||
130170898|NCT02883049|468584563|FG015|Induction|Developed SMN|0|||
130170899|NCT02883049|468584548|FG000|Induction|Enrolled onto another COG study|72|||
130170900|NCT02883049|468584549|FG001|Induction|Enrolled onto another COG study|0|||
130170901|NCT02883049|468584550|FG002|Induction|Enrolled onto another COG study|0|||
130170902|NCT02883049|468584551|FG003|Induction|Enrolled onto another COG study|0|||
130170903|NCT02883049|468584552|FG004|Induction|Enrolled onto another COG study|0|||
130170904|NCT02883049|468584553|FG005|Induction|Enrolled onto another COG study|0|||
130170905|NCT02883049|468584554|FG006|Induction|Enrolled onto another COG study|0|||
130170906|NCT02883049|468584555|FG007|Induction|Enrolled onto another COG study|0|||
130170907|NCT02883049|468584556|FG008|Induction|Enrolled onto another COG study|0|||
130170908|NCT02883049|468584557|FG009|Induction|Enrolled onto another COG study|0|||
130170909|NCT02883049|468584558|FG010|Induction|Enrolled onto another COG study|0|||
130170910|NCT02883049|468584559|FG011|Induction|Enrolled onto another COG study|0|||
130170911|NCT02883049|468584560|FG012|Induction|Enrolled onto another COG study|0|||
130170912|NCT02883049|468584561|FG013|Induction|Enrolled onto another COG study|0|||
130170913|NCT02883049|468584562|FG014|Induction|Enrolled onto another COG study|0|||
130170914|NCT02883049|468584563|FG015|Induction|Enrolled onto another COG study|0|||
130170915|NCT02883049|468584548|FG000|Induction|Incomplete induction data|17|||
130170916|NCT02883049|468584549|FG001|Induction|Incomplete induction data|0|||
130170917|NCT02883049|468584550|FG002|Induction|Incomplete induction data|0|||
130170918|NCT02883049|468584551|FG003|Induction|Incomplete induction data|0|||
130170919|NCT02883049|468584552|FG004|Induction|Incomplete induction data|0|||
130170920|NCT02883049|468584553|FG005|Induction|Incomplete induction data|0|||
130170921|NCT02883049|468584554|FG006|Induction|Incomplete induction data|0|||
130170922|NCT02883049|468584555|FG007|Induction|Incomplete induction data|0|||
130170923|NCT02883049|468584556|FG008|Induction|Incomplete induction data|0|||
130170924|NCT02883049|468584557|FG009|Induction|Incomplete induction data|0|||
130170925|NCT02883049|468584558|FG010|Induction|Incomplete induction data|0|||
130170926|NCT02883049|468584559|FG011|Induction|Incomplete induction data|0|||
130170927|NCT02883049|468584560|FG012|Induction|Incomplete induction data|0|||
130170928|NCT02883049|468584561|FG013|Induction|Incomplete induction data|0|||
130170929|NCT02883049|468584562|FG014|Induction|Incomplete induction data|0|||
130170930|NCT02883049|468584563|FG015|Induction|Incomplete induction data|0|||
130170931|NCT02883049|468584548|FG000|Post Induction|Adverse Event|0|||
130170932|NCT02883049|468584549|FG001|Post Induction|Adverse Event|0|||
130170933|NCT02883049|468584550|FG002|Post Induction|Adverse Event|0|||
130170934|NCT02883049|468584551|FG003|Post Induction|Adverse Event|7|||
130170935|NCT02883049|468584552|FG004|Post Induction|Adverse Event|8|||
130170936|NCT02883049|468584553|FG005|Post Induction|Adverse Event|3|||
130170937|NCT02883049|468584554|FG006|Post Induction|Adverse Event|4|||
130170938|NCT02883049|468584555|FG007|Post Induction|Adverse Event|5|||
130170939|NCT02883049|468584556|FG008|Post Induction|Adverse Event|6|||
130170940|NCT02883049|468584557|FG009|Post Induction|Adverse Event|7|||
130170941|NCT02883049|468584558|FG010|Post Induction|Adverse Event|2|||
130170942|NCT02883049|468584559|FG011|Post Induction|Adverse Event|2|||
130170943|NCT02883049|468584560|FG012|Post Induction|Adverse Event|0|||
130170944|NCT02883049|468584561|FG013|Post Induction|Adverse Event|0|||
130170945|NCT02883049|468584562|FG014|Post Induction|Adverse Event|5|||
130170946|NCT02883049|468584563|FG015|Post Induction|Adverse Event|2|||
130170947|NCT02883049|468584548|FG000|Post Induction|Death|0|||
130170948|NCT02883049|468584549|FG001|Post Induction|Death|0|||
130170949|NCT02883049|468584550|FG002|Post Induction|Death|0|||
130170950|NCT02883049|468584551|FG003|Post Induction|Death|9|||
130170951|NCT02883049|468584552|FG004|Post Induction|Death|9|||
130170952|NCT02883049|468584553|FG005|Post Induction|Death|0|||
130170953|NCT02883049|468584554|FG006|Post Induction|Death|1|||
130170954|NCT02883049|468584555|FG007|Post Induction|Death|6|||
130170955|NCT02883049|468584556|FG008|Post Induction|Death|5|||
130170956|NCT02883049|468584557|FG009|Post Induction|Death|3|||
130170957|NCT02883049|468584558|FG010|Post Induction|Death|1|||
130170958|NCT02883049|468584559|FG011|Post Induction|Death|0|||
130170959|NCT02883049|468584560|FG012|Post Induction|Death|1|||
130170960|NCT02883049|468584561|FG013|Post Induction|Death|1|||
130170961|NCT02883049|468584562|FG014|Post Induction|Death|10|||
130170962|NCT02883049|468584563|FG015|Post Induction|Death|2|||
130170963|NCT02883049|468584548|FG000|Post Induction|Lost to Follow-up|0|||
130170964|NCT02883049|468584549|FG001|Post Induction|Lost to Follow-up|0|||
130170965|NCT02883049|468584550|FG002|Post Induction|Lost to Follow-up|0|||
130170966|NCT02883049|468584551|FG003|Post Induction|Lost to Follow-up|0|||
130170967|NCT02883049|468584552|FG004|Post Induction|Lost to Follow-up|1|||
130170968|NCT02883049|468584553|FG005|Post Induction|Lost to Follow-up|1|||
130170969|NCT02883049|468584554|FG006|Post Induction|Lost to Follow-up|0|||
130170970|NCT02883049|468584555|FG007|Post Induction|Lost to Follow-up|0|||
130170971|NCT02883049|468584556|FG008|Post Induction|Lost to Follow-up|3|||
130170972|NCT02883049|468584557|FG009|Post Induction|Lost to Follow-up|0|||
130170973|NCT02883049|468584558|FG010|Post Induction|Lost to Follow-up|1|||
130170974|NCT02883049|468584559|FG011|Post Induction|Lost to Follow-up|0|||
130170975|NCT02883049|468584560|FG012|Post Induction|Lost to Follow-up|0|||
130170976|NCT02883049|468584561|FG013|Post Induction|Lost to Follow-up|0|||
130170977|NCT02883049|468584562|FG014|Post Induction|Lost to Follow-up|0|||
130170978|NCT02883049|468584563|FG015|Post Induction|Lost to Follow-up|0|||
130170979|NCT02883049|468584548|FG000|Post Induction|Physician Decision|0|||
130170980|NCT02883049|468584549|FG001|Post Induction|Physician Decision|0|||
130170981|NCT02883049|468584550|FG002|Post Induction|Physician Decision|0|||
130170982|NCT02883049|468584551|FG003|Post Induction|Physician Decision|27|||
130170983|NCT02883049|468584552|FG004|Post Induction|Physician Decision|27|||
130170984|NCT02883049|468584553|FG005|Post Induction|Physician Decision|23|||
130170985|NCT02883049|468584554|FG006|Post Induction|Physician Decision|30|||
130170986|NCT02883049|468584555|FG007|Post Induction|Physician Decision|56|||
130170987|NCT02883049|468584556|FG008|Post Induction|Physician Decision|85|||
130170988|NCT02883049|468584557|FG009|Post Induction|Physician Decision|12|||
130170989|NCT02883049|468584558|FG010|Post Induction|Physician Decision|5|||
130170990|NCT02883049|468584559|FG011|Post Induction|Physician Decision|14|||
130170991|NCT02883049|468584560|FG012|Post Induction|Physician Decision|1|||
130170992|NCT02883049|468584561|FG013|Post Induction|Physician Decision|11|||
130170993|NCT02883049|468584562|FG014|Post Induction|Physician Decision|19|||
130170994|NCT02883049|468584563|FG015|Post Induction|Physician Decision|5|||
130170995|NCT02883049|468584548|FG000|Post Induction|Protocol Violation|0|||
130170996|NCT02883049|468584549|FG001|Post Induction|Protocol Violation|0|||
130170997|NCT02883049|468584550|FG002|Post Induction|Protocol Violation|0|||
130170998|NCT02883049|468584551|FG003|Post Induction|Protocol Violation|0|||
130170999|NCT02883049|468584552|FG004|Post Induction|Protocol Violation|0|||
130171000|NCT02883049|468584553|FG005|Post Induction|Protocol Violation|0|||
130171001|NCT02883049|468584554|FG006|Post Induction|Protocol Violation|0|||
130171002|NCT02883049|468584555|FG007|Post Induction|Protocol Violation|1|||
130171003|NCT02883049|468584556|FG008|Post Induction|Protocol Violation|0|||
130171004|NCT02883049|468584557|FG009|Post Induction|Protocol Violation|0|||
130171005|NCT02883049|468584558|FG010|Post Induction|Protocol Violation|0|||
130171006|NCT02883049|468584559|FG011|Post Induction|Protocol Violation|0|||
130171007|NCT02883049|468584560|FG012|Post Induction|Protocol Violation|0|||
130171008|NCT02883049|468584561|FG013|Post Induction|Protocol Violation|0|||
130171009|NCT02883049|468584562|FG014|Post Induction|Protocol Violation|0|||
130171010|NCT02883049|468584563|FG015|Post Induction|Protocol Violation|0|||
130171011|NCT02883049|468584548|FG000|Post Induction|Withdrawal by Subject|0|||
130171012|NCT02883049|468584549|FG001|Post Induction|Withdrawal by Subject|0|||
130171013|NCT02883049|468584550|FG002|Post Induction|Withdrawal by Subject|0|||
130171014|NCT02883049|468584551|FG003|Post Induction|Withdrawal by Subject|5|||
130171015|NCT02883049|468584552|FG004|Post Induction|Withdrawal by Subject|2|||
130171016|NCT02883049|468584553|FG005|Post Induction|Withdrawal by Subject|1|||
130171017|NCT02883049|468584554|FG006|Post Induction|Withdrawal by Subject|0|||
130171018|NCT02883049|468584555|FG007|Post Induction|Withdrawal by Subject|0|||
130171019|NCT02883049|468584556|FG008|Post Induction|Withdrawal by Subject|2|||
130171020|NCT02883049|468584557|FG009|Post Induction|Withdrawal by Subject|0|||
130171021|NCT02883049|468584558|FG010|Post Induction|Withdrawal by Subject|1|||
130171022|NCT02883049|468584559|FG011|Post Induction|Withdrawal by Subject|1|||
130171023|NCT02883049|468584560|FG012|Post Induction|Withdrawal by Subject|0|||
130171024|NCT02883049|468584561|FG013|Post Induction|Withdrawal by Subject|0|||
130171025|NCT02883049|468584562|FG014|Post Induction|Withdrawal by Subject|1|||
130171026|NCT02883049|468584563|FG015|Post Induction|Withdrawal by Subject|0|||
130171027|NCT02883049|468584548|FG000|Post Induction|Ineligible|0|||
130171028|NCT02883049|468584549|FG001|Post Induction|Ineligible|0|||
130171029|NCT02883049|468584550|FG002|Post Induction|Ineligible|2|||
130171030|NCT02883049|468584551|FG003|Post Induction|Ineligible|0|||
130171031|NCT02883049|468584552|FG004|Post Induction|Ineligible|0|||
130171032|NCT02883049|468584553|FG005|Post Induction|Ineligible|0|||
130171033|NCT02883049|468584554|FG006|Post Induction|Ineligible|1|||
130171034|NCT02883049|468584555|FG007|Post Induction|Ineligible|0|||
130171035|NCT02883049|468584556|FG008|Post Induction|Ineligible|0|||
130171036|NCT02883049|468584557|FG009|Post Induction|Ineligible|0|||
130171037|NCT02883049|468584558|FG010|Post Induction|Ineligible|1|||
130171038|NCT02883049|468584559|FG011|Post Induction|Ineligible|0|||
130171039|NCT02883049|468584560|FG012|Post Induction|Ineligible|0|||
130171040|NCT02883049|468584561|FG013|Post Induction|Ineligible|0|||
130171041|NCT02883049|468584562|FG014|Post Induction|Ineligible|0|||
130171042|NCT02883049|468584563|FG015|Post Induction|Ineligible|1|||
130171043|NCT02883049|468584548|FG000|Post Induction|Refusal of further protocol therapy|0|||
130171044|NCT02883049|468584549|FG001|Post Induction|Refusal of further protocol therapy|0|||
130171045|NCT02883049|468584550|FG002|Post Induction|Refusal of further protocol therapy|0|||
130171046|NCT02883049|468584551|FG003|Post Induction|Refusal of further protocol therapy|11|||
130171047|NCT02883049|468584552|FG004|Post Induction|Refusal of further protocol therapy|15|||
130171048|NCT02883049|468584553|FG005|Post Induction|Refusal of further protocol therapy|9|||
130171049|NCT02883049|468584554|FG006|Post Induction|Refusal of further protocol therapy|13|||
130171050|NCT02883049|468584555|FG007|Post Induction|Refusal of further protocol therapy|5|||
130171051|NCT02883049|468584556|FG008|Post Induction|Refusal of further protocol therapy|21|||
130171052|NCT02883049|468584557|FG009|Post Induction|Refusal of further protocol therapy|7|||
130171053|NCT02883049|468584558|FG010|Post Induction|Refusal of further protocol therapy|0|||
130171054|NCT02883049|468584559|FG011|Post Induction|Refusal of further protocol therapy|7|||
130171055|NCT02883049|468584560|FG012|Post Induction|Refusal of further protocol therapy|3|||
130171056|NCT02883049|468584561|FG013|Post Induction|Refusal of further protocol therapy|0|||
130171057|NCT02883049|468584562|FG014|Post Induction|Refusal of further protocol therapy|4|||
130171058|NCT02883049|468584563|FG015|Post Induction|Refusal of further protocol therapy|1|||
130171059|NCT02883049|468584548|FG000|Post Induction|Inevaluable|0|||
130171060|NCT02883049|468584549|FG001|Post Induction|Inevaluable|0|||
130171061|NCT02883049|468584550|FG002|Post Induction|Inevaluable|0|||
130171062|NCT02883049|468584551|FG003|Post Induction|Inevaluable|1|||
130171063|NCT02883049|468584552|FG004|Post Induction|Inevaluable|1|||
130171064|NCT02883049|468584553|FG005|Post Induction|Inevaluable|2|||
130171065|NCT02883049|468584554|FG006|Post Induction|Inevaluable|7|||
130171066|NCT02883049|468584555|FG007|Post Induction|Inevaluable|6|||
130171067|NCT02883049|468584556|FG008|Post Induction|Inevaluable|4|||
130171068|NCT02883049|468584557|FG009|Post Induction|Inevaluable|4|||
130171069|NCT02883049|468584558|FG010|Post Induction|Inevaluable|1|||
130171070|NCT02883049|468584559|FG011|Post Induction|Inevaluable|1|||
130171071|NCT02883049|468584560|FG012|Post Induction|Inevaluable|2|||
130171072|NCT02883049|468584561|FG013|Post Induction|Inevaluable|0|||
130171073|NCT02883049|468584562|FG014|Post Induction|Inevaluable|0|||
130171074|NCT02883049|468584563|FG015|Post Induction|Inevaluable|1|||
130171075|NCT02883049|468584548|FG000|Post Induction|Moved to another non-COG institution|0|||
130171076|NCT02883049|468584549|FG001|Post Induction|Moved to another non-COG institution|0|||
130171077|NCT02883049|468584550|FG002|Post Induction|Moved to another non-COG institution|0|||
130171078|NCT02883049|468584551|FG003|Post Induction|Moved to another non-COG institution|0|||
130171079|NCT02883049|468584552|FG004|Post Induction|Moved to another non-COG institution|0|||
130171080|NCT02883049|468584553|FG005|Post Induction|Moved to another non-COG institution|0|||
130171081|NCT02883049|468584554|FG006|Post Induction|Moved to another non-COG institution|0|||
130171082|NCT02883049|468584555|FG007|Post Induction|Moved to another non-COG institution|2|||
130171083|NCT02883049|468584556|FG008|Post Induction|Moved to another non-COG institution|2|||
130171084|NCT02883049|468584557|FG009|Post Induction|Moved to another non-COG institution|0|||
130171085|NCT02883049|468584558|FG010|Post Induction|Moved to another non-COG institution|0|||
130171086|NCT02883049|468584559|FG011|Post Induction|Moved to another non-COG institution|1|||
130171087|NCT02883049|468584560|FG012|Post Induction|Moved to another non-COG institution|0|||
130171088|NCT02883049|468584561|FG013|Post Induction|Moved to another non-COG institution|0|||
130171089|NCT02883049|468584562|FG014|Post Induction|Moved to another non-COG institution|0|||
130171090|NCT02883049|468584563|FG015|Post Induction|Moved to another non-COG institution|0|||
130171091|NCT02883049|468584548|FG000|Post Induction|Randomization closed|0|||
130171092|NCT02883049|468584549|FG001|Post Induction|Randomization closed|0|||
130171093|NCT02883049|468584550|FG002|Post Induction|Randomization closed|0|||
130171094|NCT02883049|468584551|FG003|Post Induction|Randomization closed|0|||
130171095|NCT02883049|468584552|FG004|Post Induction|Randomization closed|0|||
130171096|NCT02883049|468584553|FG005|Post Induction|Randomization closed|0|||
130171097|NCT02883049|468584554|FG006|Post Induction|Randomization closed|0|||
130171098|NCT02883049|468584555|FG007|Post Induction|Randomization closed|20|||
130171099|NCT02883049|468584556|FG008|Post Induction|Randomization closed|0|||
130171100|NCT02883049|468584557|FG009|Post Induction|Randomization closed|0|||
130171101|NCT02883049|468584558|FG010|Post Induction|Randomization closed|0|||
130171102|NCT02883049|468584559|FG011|Post Induction|Randomization closed|0|||
130171103|NCT02883049|468584560|FG012|Post Induction|Randomization closed|0|||
130171104|NCT02883049|468584561|FG013|Post Induction|Randomization closed|0|||
130171105|NCT02883049|468584562|FG014|Post Induction|Randomization closed|0|||
130171106|NCT02883049|468584563|FG015|Post Induction|Randomization closed|0|||
130171107|NCT02883049|468584548|FG000|Post Induction|MRD negative|0|||
130171108|NCT02883049|468584549|FG001|Post Induction|MRD negative|0|||
130171109|NCT02883049|468584550|FG002|Post Induction|MRD negative|0|||
130171110|NCT02883049|468584551|FG003|Post Induction|MRD negative|0|||
130171111|NCT02883049|468584552|FG004|Post Induction|MRD negative|0|||
130171112|NCT02883049|468584553|FG005|Post Induction|MRD negative|0|||
130171113|NCT02883049|468584554|FG006|Post Induction|MRD negative|0|||
130171114|NCT02883049|468584555|FG007|Post Induction|MRD negative|11|||
130171115|NCT02883049|468584556|FG008|Post Induction|MRD negative|0|||
130171116|NCT02883049|468584557|FG009|Post Induction|MRD negative|0|||
130171117|NCT02883049|468584558|FG010|Post Induction|MRD negative|0|||
130171118|NCT02883049|468584559|FG011|Post Induction|MRD negative|0|||
130171119|NCT02883049|468584560|FG012|Post Induction|MRD negative|0|||
130171120|NCT02883049|468584561|FG013|Post Induction|MRD negative|0|||
130171121|NCT02883049|468584562|FG014|Post Induction|MRD negative|0|||
130171122|NCT02883049|468584563|FG015|Post Induction|MRD negative|0|||
130171123|NCT02883049|468584548|FG000|Post Induction|Developed SMN|0|||
130171124|NCT02883049|468584549|FG001|Post Induction|Developed SMN|0|||
130171125|NCT02883049|468584550|FG002|Post Induction|Developed SMN|0|||
130171126|NCT02883049|468584551|FG003|Post Induction|Developed SMN|0|||
130171127|NCT02883049|468584552|FG004|Post Induction|Developed SMN|1|||
130171128|NCT02883049|468584553|FG005|Post Induction|Developed SMN|0|||
130171129|NCT02883049|468584554|FG006|Post Induction|Developed SMN|1|||
130171130|NCT02883049|468584555|FG007|Post Induction|Developed SMN|0|||
130171131|NCT02883049|468584556|FG008|Post Induction|Developed SMN|0|||
130171132|NCT02883049|468584557|FG009|Post Induction|Developed SMN|0|||
130171133|NCT02883049|468584558|FG010|Post Induction|Developed SMN|1|||
130171134|NCT02883049|468584559|FG011|Post Induction|Developed SMN|1|||
130171135|NCT02883049|468584560|FG012|Post Induction|Developed SMN|0|||
130171136|NCT02883049|468584561|FG013|Post Induction|Developed SMN|0|||
130171137|NCT02883049|468584562|FG014|Post Induction|Developed SMN|1|||
130171138|NCT02883049|468584563|FG015|Post Induction|Developed SMN|0|||
130171139|NCT02883049|468584548|FG000|Post Induction|Enrolled onto another COG study|0|||
130171140|NCT02883049|468584549|FG001|Post Induction|Enrolled onto another COG study|0|||
130171141|NCT02883049|468584550|FG002|Post Induction|Enrolled onto another COG study|0|||
130171142|NCT02883049|468584551|FG003|Post Induction|Enrolled onto another COG study|1|||
130171143|NCT02883049|468584552|FG004|Post Induction|Enrolled onto another COG study|1|||
130171144|NCT02883049|468584553|FG005|Post Induction|Enrolled onto another COG study|0|||
130171145|NCT02883049|468584554|FG006|Post Induction|Enrolled onto another COG study|0|||
130171146|NCT02883049|468584555|FG007|Post Induction|Enrolled onto another COG study|4|||
130171147|NCT02883049|468584556|FG008|Post Induction|Enrolled onto another COG study|0|||
130171148|NCT02883049|468584557|FG009|Post Induction|Enrolled onto another COG study|0|||
130171149|NCT02883049|468584558|FG010|Post Induction|Enrolled onto another COG study|0|||
130171150|NCT02883049|468584559|FG011|Post Induction|Enrolled onto another COG study|2|||
130171151|NCT02883049|468584560|FG012|Post Induction|Enrolled onto another COG study|0|||
130171152|NCT02883049|468584561|FG013|Post Induction|Enrolled onto another COG study|1|||
130171153|NCT02883049|468584562|FG014|Post Induction|Enrolled onto another COG study|0|||
130171154|NCT02883049|468584563|FG015|Post Induction|Enrolled onto another COG study|0|||
130171155|NCT02883049|468584548|FG000|Post Induction|Recurrent leukemia|0|||
130171156|NCT02883049|468584549|FG001|Post Induction|Recurrent leukemia|0|||
130171157|NCT02883049|468584550|FG002|Post Induction|Recurrent leukemia|0|||
130171158|NCT02883049|468584551|FG003|Post Induction|Recurrent leukemia|17|||
130171159|NCT02883049|468584552|FG004|Post Induction|Recurrent leukemia|12|||
130171160|NCT02883049|468584553|FG005|Post Induction|Recurrent leukemia|4|||
130171161|NCT02883049|468584554|FG006|Post Induction|Recurrent leukemia|1|||
130171162|NCT02883049|468584555|FG007|Post Induction|Recurrent leukemia|13|||
130171163|NCT02883049|468584556|FG008|Post Induction|Recurrent leukemia|27|||
130171164|NCT02883049|468584557|FG009|Post Induction|Recurrent leukemia|5|||
130171165|NCT02883049|468584558|FG010|Post Induction|Recurrent leukemia|3|||
130171166|NCT02883049|468584559|FG011|Post Induction|Recurrent leukemia|12|||
130171167|NCT02883049|468584560|FG012|Post Induction|Recurrent leukemia|1|||
130171168|NCT02883049|468584561|FG013|Post Induction|Recurrent leukemia|1|||
130171169|NCT02883049|468584562|FG014|Post Induction|Recurrent leukemia|9|||
130171170|NCT02883049|468584563|FG015|Post Induction|Recurrent leukemia|3|||
130171171|NCT02883049|468584548|FG000|Post Induction|Induction Failure|0|||
130171172|NCT02883049|468584549|FG001|Post Induction|Induction Failure|0|||
130171173|NCT02883049|468584550|FG002|Post Induction|Induction Failure|0|||
130171174|NCT02883049|468584551|FG003|Post Induction|Induction Failure|0|||
130171175|NCT02883049|468584552|FG004|Post Induction|Induction Failure|0|||
130171176|NCT02883049|468584553|FG005|Post Induction|Induction Failure|0|||
130171177|NCT02883049|468584554|FG006|Post Induction|Induction Failure|0|||
130171178|NCT02883049|468584555|FG007|Post Induction|Induction Failure|2|||
130171179|NCT02883049|468584556|FG008|Post Induction|Induction Failure|2|||
130171180|NCT02883049|468584557|FG009|Post Induction|Induction Failure|0|||
130171181|NCT02883049|468584558|FG010|Post Induction|Induction Failure|0|||
130171182|NCT02883049|468584559|FG011|Post Induction|Induction Failure|0|||
130171183|NCT02883049|468584560|FG012|Post Induction|Induction Failure|0|||
130171184|NCT02883049|468584561|FG013|Post Induction|Induction Failure|2|||
130171185|NCT02883049|468584562|FG014|Post Induction|Induction Failure|0|||
130171186|NCT02883049|468584563|FG015|Post Induction|Induction Failure|0|||
130171187|NCT02245412|468584568|FG000|Treatment Period|Death|1|||
130171188|NCT02245412|468584569|FG001|Treatment Period|Death|1|||
130171189|NCT02245412|468584570|FG002|Treatment Period|Death|0|||
130171190|NCT02245412|468584568|FG000|Treatment Period|Physician Decision|1|||
130171191|NCT02245412|468584569|FG001|Treatment Period|Physician Decision|1|||
130171192|NCT02245412|468584570|FG002|Treatment Period|Physician Decision|0|||
130171193|NCT02245412|468584568|FG000|Treatment Period|Withdrawal by Subject|2|||
130171194|NCT02245412|468584569|FG001|Treatment Period|Withdrawal by Subject|1|||
130171195|NCT02245412|468584570|FG002|Treatment Period|Withdrawal by Subject|0|||
130171196|NCT02245412|468584568|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
130171197|NCT02245412|468584569|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
130171198|NCT02245412|468584570|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
130171199|NCT02245412|468584568|FG000|Follow-Up Period|Death|4|||
130171200|NCT02245412|468584569|FG001|Follow-Up Period|Death|2|||
130171201|NCT02245412|468584570|FG002|Follow-Up Period|Death|1|||
130171202|NCT02245412|468584568|FG000|Follow-Up Period|Physician Decision|1|||
130171203|NCT02245412|468584569|FG001|Follow-Up Period|Physician Decision|0|||
130171204|NCT02245412|468584570|FG002|Follow-Up Period|Physician Decision|0|||
130171205|NCT02245412|468584568|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
130171206|NCT02245412|468584569|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
130171207|NCT02245412|468584570|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
130171208|NCT01371747|468584571|FG000|Overall Study|Adverse Event|4|||
130171209|NCT01371747|468584572|FG001|Overall Study|Adverse Event|2|||
130171210|NCT01371747|468584573|FG002|Overall Study|Adverse Event|7|||
130171211|NCT01371747|468584574|FG003|Overall Study|Adverse Event|2|||
130171212|NCT01371747|468584575|FG004|Overall Study|Adverse Event|2|||
130171213|NCT01371747|468584576|FG005|Overall Study|Adverse Event|2|||
130171214|NCT01371747|468584571|FG000|Overall Study|Death|1|||
130171215|NCT01371747|468584572|FG001|Overall Study|Death|0|||
130171216|NCT01371747|468584573|FG002|Overall Study|Death|4|||
130171217|NCT01371747|468584574|FG003|Overall Study|Death|1|||
130171218|NCT01371747|468584575|FG004|Overall Study|Death|2|||
130171219|NCT01371747|468584576|FG005|Overall Study|Death|0|||
130171220|NCT01371747|468584571|FG000|Overall Study|Abnormal Renal Function|0|||
130171221|NCT01371747|468584572|FG001|Overall Study|Abnormal Renal Function|2|||
130171222|NCT01371747|468584573|FG002|Overall Study|Abnormal Renal Function|0|||
130171223|NCT01371747|468584574|FG003|Overall Study|Abnormal Renal Function|1|||
130171224|NCT01371747|468584575|FG004|Overall Study|Abnormal Renal Function|0|||
130171225|NCT01371747|468584576|FG005|Overall Study|Abnormal Renal Function|1|||
130171226|NCT01371747|468584571|FG000|Overall Study|High Serum Potassium Results|1|||
130171227|NCT01371747|468584572|FG001|Overall Study|High Serum Potassium Results|1|||
130171228|NCT01371747|468584573|FG002|Overall Study|High Serum Potassium Results|1|||
130171229|NCT01371747|468584574|FG003|Overall Study|High Serum Potassium Results|2|||
130171230|NCT01371747|468584575|FG004|Overall Study|High Serum Potassium Results|0|||
130171231|NCT01371747|468584576|FG005|Overall Study|High Serum Potassium Results|2|||
130171232|NCT01371747|468584571|FG000|Overall Study|Low Serum Potassium Results|1|||
130171233|NCT01371747|468584572|FG001|Overall Study|Low Serum Potassium Results|1|||
130171234|NCT01371747|468584573|FG002|Overall Study|Low Serum Potassium Results|1|||
130171235|NCT01371747|468584574|FG003|Overall Study|Low Serum Potassium Results|1|||
130171236|NCT01371747|468584575|FG004|Overall Study|Low Serum Potassium Results|0|||
130171237|NCT01371747|468584576|FG005|Overall Study|Low Serum Potassium Results|3|||
130171238|NCT01371747|468584571|FG000|Overall Study|Protocol Violation|0|||
130171239|NCT01371747|468584572|FG001|Overall Study|Protocol Violation|0|||
130171240|NCT01371747|468584573|FG002|Overall Study|Protocol Violation|1|||
130171241|NCT01371747|468584574|FG003|Overall Study|Protocol Violation|0|||
130171242|NCT01371747|468584575|FG004|Overall Study|Protocol Violation|0|||
130171243|NCT01371747|468584576|FG005|Overall Study|Protocol Violation|0|||
130171244|NCT01371747|468584571|FG000|Overall Study|Non-Compliance|3|||
130171245|NCT01371747|468584572|FG001|Overall Study|Non-Compliance|4|||
130171246|NCT01371747|468584573|FG002|Overall Study|Non-Compliance|3|||
130171247|NCT01371747|468584574|FG003|Overall Study|Non-Compliance|0|||
130171248|NCT01371747|468584575|FG004|Overall Study|Non-Compliance|0|||
130171249|NCT01371747|468584576|FG005|Overall Study|Non-Compliance|1|||
130171250|NCT01371747|468584571|FG000|Overall Study|Physician Decision|0|||
130171251|NCT01371747|468584572|FG001|Overall Study|Physician Decision|0|||
130171252|NCT01371747|468584573|FG002|Overall Study|Physician Decision|0|||
130171253|NCT01371747|468584574|FG003|Overall Study|Physician Decision|0|||
130171254|NCT01371747|468584575|FG004|Overall Study|Physician Decision|1|||
130171255|NCT01371747|468584576|FG005|Overall Study|Physician Decision|0|||
130171256|NCT01371747|468584571|FG000|Overall Study|Withdrawal by Subject|6|||
130171257|NCT01371747|468584572|FG001|Overall Study|Withdrawal by Subject|12|||
130171258|NCT01371747|468584573|FG002|Overall Study|Withdrawal by Subject|5|||
130171259|NCT01371747|468584574|FG003|Overall Study|Withdrawal by Subject|2|||
130171260|NCT01371747|468584575|FG004|Overall Study|Withdrawal by Subject|2|||
130171261|NCT01371747|468584576|FG005|Overall Study|Withdrawal by Subject|4|||
130171262|NCT01371747|468584571|FG000|Overall Study|Other Reasons|2|||
130171263|NCT01371747|468584572|FG001|Overall Study|Other Reasons|1|||
130171264|NCT01371747|468584573|FG002|Overall Study|Other Reasons|2|||
130171265|NCT01371747|468584574|FG003|Overall Study|Other Reasons|0|||
130171266|NCT01371747|468584575|FG004|Overall Study|Other Reasons|0|||
130171267|NCT01371747|468584576|FG005|Overall Study|Other Reasons|1|||
130171268|NCT00580788|468584580|FG000|Overall Study|Adverse Event|0|||
130171269|NCT00580788|468584581|FG001|Overall Study|Adverse Event|0|||
130171270|NCT00580788|468584582|FG002|Overall Study|Adverse Event|0|||
130171271|NCT00580788|468584583|FG003|Overall Study|Adverse Event|1|||
130171272|NCT04971187|468584584|FG000|Overall Study|Screen failures|2|||
130171273|NCT01443728|468584585|FG000|Overall Study|Lost to Follow-up|2|||
130171274|NCT01443728|468584586|FG001|Overall Study|Lost to Follow-up|0|||
130171275|NCT01443728|468584585|FG000|Overall Study|Withdrawal by Subject|1|||
130171276|NCT01443728|468584586|FG001|Overall Study|Withdrawal by Subject|1|||
130171277|NCT01443728|468584585|FG000|Overall Study|Adverse Event|0|||
130171278|NCT01443728|468584586|FG001|Overall Study|Adverse Event|2|||
130171279|NCT01403051|468584587|FG000|Overall Study|Protocol Violation|2|||
130171280|NCT01403051|468584588|FG001|Overall Study|Protocol Violation|0|||
130171281|NCT01403051|468584587|FG000|Overall Study|Death|1|||
130171282|NCT01403051|468584588|FG001|Overall Study|Death|0|||
130171283|NCT01403051|468584587|FG000|Overall Study|Withdrawal by Subject|2|||
130171284|NCT01403051|468584588|FG001|Overall Study|Withdrawal by Subject|1|||
130171285|NCT01403051|468584587|FG000|Overall Study|Lost to Follow-up|5|||
130171286|NCT01403051|468584588|FG001|Overall Study|Lost to Follow-up|5|||
130171287|NCT02135614|468584594|FG000|Overall Study|Randomized but Not Treated|2|||
130171288|NCT02135614|468584595|FG001|Overall Study|Randomized but Not Treated|1|||
130171289|NCT02135614|468584594|FG000|Overall Study|Adverse Event|0|||
130171290|NCT02135614|468584595|FG001|Overall Study|Adverse Event|1|||
130171291|NCT02135614|468584594|FG000|Overall Study|Death|1|||
130171292|NCT02135614|468584595|FG001|Overall Study|Death|0|||
130171293|NCT02135614|468584594|FG000|Overall Study|Investigator's Discretion|0|||
130171294|NCT02135614|468584595|FG001|Overall Study|Investigator's Discretion|1|||
130171295|NCT02135614|468584594|FG000|Overall Study|Withdrew Consent|2|||
130171296|NCT02135614|468584595|FG001|Overall Study|Withdrew Consent|2|||
130171297|NCT02135614|468584594|FG000|Overall Study|Lost to Follow-up|3|||
130171298|NCT02135614|468584595|FG001|Overall Study|Lost to Follow-up|0|||
130171299|NCT02906358|468584599|FG000|Overall Study|Withdrawal by Subject|10|||
130171300|NCT02906358|468584600|FG001|Overall Study|Withdrawal by Subject|7|||
130171301|NCT02906358|468584599|FG000|Overall Study|Lost to Follow-up|12|||
130171302|NCT02906358|468584600|FG001|Overall Study|Lost to Follow-up|15|||
130171303|NCT01145508|468584602|FG000|Overall Study|Adverse Event|1|||
130171304|NCT01145508|468584603|FG001|Overall Study|Adverse Event|0|||
130171305|NCT01145508|468584602|FG000|Overall Study|Death|1|||
130171306|NCT01145508|468584603|FG001|Overall Study|Death|0|||
130171307|NCT01145508|468584602|FG000|Overall Study|Physician Decision|2|||
130171308|NCT01145508|468584603|FG001|Overall Study|Physician Decision|1|||
130171309|NCT01145508|468584602|FG000|Overall Study|Never started treatment|1|||
130171310|NCT01145508|468584603|FG001|Overall Study|Never started treatment|1|||
130171311|NCT02045147|468584604|FG000|Overall Study|Withdrawal by Subject|2|||
130171312|NCT02045147|468584605|FG001|Overall Study|Withdrawal by Subject|0|||
130171313|NCT02045147|468584606|FG002|Overall Study|Withdrawal by Subject|0|||
130171314|NCT02045147|468584607|FG003|Overall Study|Withdrawal by Subject|0|||
130171315|NCT02045147|468584608|FG004|Overall Study|Withdrawal by Subject|0|||
130171316|NCT02045147|468584609|FG005|Overall Study|Withdrawal by Subject|0|||
130171317|NCT02045147|468584610|FG006|Overall Study|Withdrawal by Subject|0|||
130171318|NCT02045147|468584611|FG007|Overall Study|Withdrawal by Subject|1|||
130171319|NCT02045147|468584604|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
130171320|NCT02045147|468584605|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
130171321|NCT02045147|468584606|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
130171322|NCT02045147|468584607|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
130171323|NCT02045147|468584608|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
130171324|NCT02045147|468584609|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
130171325|NCT02045147|468584610|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
130171326|NCT02045147|468584611|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
130171327|NCT04497948|468584614|FG000|Overall Study|Death|2|||
130171328|NCT00129389|468584615|FG000|Overall Study|Adverse Event|19|||
130171329|NCT00129389|468584616|FG001|Overall Study|Adverse Event|87|||
130171330|NCT00129389|468584615|FG000|Overall Study|Death|0|||
130171331|NCT00129389|468584616|FG001|Overall Study|Death|1|||
130171332|NCT00129389|468584615|FG000|Overall Study|Lost to Follow-up|2|||
130171333|NCT00129389|468584616|FG001|Overall Study|Lost to Follow-up|1|||
130171334|NCT00129389|468584615|FG000|Overall Study|Physician Decision|0|||
130171335|NCT00129389|468584616|FG001|Overall Study|Physician Decision|4|||
130171336|NCT00129389|468584615|FG000|Overall Study|Protocol Violation|0|||
130171337|NCT00129389|468584616|FG001|Overall Study|Protocol Violation|6|||
130171338|NCT00129389|468584615|FG000|Overall Study|Withdrawal by Subject|9|||
130171339|NCT00129389|468584616|FG001|Overall Study|Withdrawal by Subject|23|||
130171340|NCT00129389|468584615|FG000|Overall Study|Relapse|1|||
130171341|NCT00129389|468584616|FG001|Overall Study|Relapse|0|||
130171342|NCT00129389|468584615|FG000|Overall Study|Not eligible|1|||
130171343|NCT00129389|468584616|FG001|Overall Study|Not eligible|2|||
130171344|NCT00129389|468584615|FG000|Overall Study|Crossed to the other arm|1|||
130171345|NCT00129389|468584616|FG001|Overall Study|Crossed to the other arm|16|||
130171346|NCT00425373|468584682|FG000|Overall Study|Adverse Event|2|||
130171347|NCT00425373|468584683|FG001|Overall Study|Adverse Event|2|||
130171348|NCT00425373|468584684|FG002|Overall Study|Adverse Event|0|||
130171349|NCT00425373|468584685|FG003|Overall Study|Adverse Event|1|||
130171350|NCT00425373|468584686|FG004|Overall Study|Adverse Event|4|||
130171351|NCT00425373|468584687|FG005|Overall Study|Adverse Event|6|||
130171352|NCT00425373|468584688|FG006|Overall Study|Adverse Event|2|||
130171353|NCT00425373|468584689|FG007|Overall Study|Adverse Event|3|||
130171354|NCT00425373|468584690|FG008|Overall Study|Adverse Event|8|||
130171355|NCT00425373|468584682|FG000|Overall Study|Lost to Follow-up|0|||
130171356|NCT00425373|468584683|FG001|Overall Study|Lost to Follow-up|1|||
130171357|NCT00425373|468584684|FG002|Overall Study|Lost to Follow-up|0|||
130171358|NCT00425373|468584685|FG003|Overall Study|Lost to Follow-up|0|||
130171359|NCT00425373|468584686|FG004|Overall Study|Lost to Follow-up|1|||
130171360|NCT00425373|468584687|FG005|Overall Study|Lost to Follow-up|0|||
130171361|NCT00425373|468584688|FG006|Overall Study|Lost to Follow-up|0|||
130171362|NCT00425373|468584689|FG007|Overall Study|Lost to Follow-up|0|||
130171363|NCT00425373|468584690|FG008|Overall Study|Lost to Follow-up|0|||
130171364|NCT00425373|468584682|FG000|Overall Study|Protocol Violation|1|||
130171365|NCT00425373|468584683|FG001|Overall Study|Protocol Violation|0|||
130171366|NCT00425373|468584684|FG002|Overall Study|Protocol Violation|1|||
130171367|NCT00425373|468584685|FG003|Overall Study|Protocol Violation|0|||
130171368|NCT00425373|468584686|FG004|Overall Study|Protocol Violation|0|||
130171369|NCT00425373|468584687|FG005|Overall Study|Protocol Violation|0|||
130171370|NCT00425373|468584688|FG006|Overall Study|Protocol Violation|0|||
130171371|NCT00425373|468584689|FG007|Overall Study|Protocol Violation|5|||
130171372|NCT00425373|468584690|FG008|Overall Study|Protocol Violation|3|||
130171373|NCT00425373|468584682|FG000|Overall Study|Withdrawal by Subject|2|||
130171374|NCT00425373|468584683|FG001|Overall Study|Withdrawal by Subject|0|||
130171375|NCT00425373|468584684|FG002|Overall Study|Withdrawal by Subject|2|||
130171376|NCT00425373|468584685|FG003|Overall Study|Withdrawal by Subject|1|||
130171377|NCT00425373|468584686|FG004|Overall Study|Withdrawal by Subject|4|||
130171378|NCT00425373|468584687|FG005|Overall Study|Withdrawal by Subject|0|||
130171379|NCT00425373|468584688|FG006|Overall Study|Withdrawal by Subject|2|||
130171380|NCT00425373|468584689|FG007|Overall Study|Withdrawal by Subject|2|||
130171381|NCT00425373|468584690|FG008|Overall Study|Withdrawal by Subject|2|||
130171382|NCT00425373|468584682|FG000|Overall Study|Lack of Efficacy|0|||
130171383|NCT00425373|468584683|FG001|Overall Study|Lack of Efficacy|0|||
130171384|NCT00425373|468584684|FG002|Overall Study|Lack of Efficacy|0|||
130171385|NCT00425373|468584685|FG003|Overall Study|Lack of Efficacy|0|||
130171386|NCT00425373|468584686|FG004|Overall Study|Lack of Efficacy|1|||
130171387|NCT00425373|468584687|FG005|Overall Study|Lack of Efficacy|3|||
130171388|NCT00425373|468584688|FG006|Overall Study|Lack of Efficacy|3|||
130171389|NCT00425373|468584689|FG007|Overall Study|Lack of Efficacy|0|||
130171390|NCT00425373|468584690|FG008|Overall Study|Lack of Efficacy|5|||
130171391|NCT01275729|468584698|FG000|Overall Study|Death|3|||
130171392|NCT01275729|468584698|FG000|Overall Study|Withdrawal by Subject|1|||
130171393|NCT02252406|468584699|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
130171394|NCT02252406|468584700|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
130171395|NCT02252406|468584699|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
130171396|NCT02252406|468584700|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
130171397|NCT02252406|468584699|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
130171398|NCT02252406|468584700|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
130171399|NCT02252406|468584699|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
130171400|NCT02252406|468584700|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
130171401|NCT02252406|468584699|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
130171402|NCT02252406|468584700|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
130171403|NCT02952586|468584708|FG000|Lead-In Phase (7 Days)|Death|0|||
130171404|NCT02952586|468584709|FG001|Lead-In Phase (7 Days)|Death|1|||
130171405|NCT02952586|468584708|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
130171406|NCT02952586|468584709|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
130171407|NCT02952586|468584708|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
130171408|NCT02952586|468584709|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
129982204|NCT04410523|467898772|FG001|Overall Study|Study terminated by sponsor|3|||
129982205|NCT04410523|467898773|FG002|Overall Study|Study terminated by sponsor|2|||
129982206|NCT04410523|467898774|FG003|Overall Study|Study terminated by sponsor|6|||
129982207|NCT04410523|467898775|FG004|Overall Study|Study terminated by sponsor|3|||
129982208|NCT04410523|467898776|FG005|Overall Study|Study terminated by sponsor|4|||
129982209|NCT04410523|467898771|FG000|Overall Study|Adverse Event|1|||
129982210|NCT04410523|467898772|FG001|Overall Study|Adverse Event|0|||
129982211|NCT04410523|467898773|FG002|Overall Study|Adverse Event|0|||
129982212|NCT04410523|467898774|FG003|Overall Study|Adverse Event|0|||
129982213|NCT04410523|467898775|FG004|Overall Study|Adverse Event|0|||
129982214|NCT04410523|467898776|FG005|Overall Study|Adverse Event|2|||
129982215|NCT04410523|467898771|FG000|Overall Study|Lost to Follow-up|0|||
129982216|NCT04410523|467898772|FG001|Overall Study|Lost to Follow-up|1|||
129982217|NCT04410523|467898773|FG002|Overall Study|Lost to Follow-up|0|||
129982218|NCT04410523|467898774|FG003|Overall Study|Lost to Follow-up|0|||
129982219|NCT04410523|467898775|FG004|Overall Study|Lost to Follow-up|0|||
129982220|NCT04410523|467898776|FG005|Overall Study|Lost to Follow-up|0|||
129982221|NCT04410523|467898771|FG000|Overall Study|Physician Decision|0|||
129982222|NCT04410523|467898772|FG001|Overall Study|Physician Decision|1|||
129982223|NCT04410523|467898773|FG002|Overall Study|Physician Decision|0|||
129982224|NCT04410523|467898774|FG003|Overall Study|Physician Decision|0|||
129982225|NCT04410523|467898775|FG004|Overall Study|Physician Decision|0|||
129982226|NCT04410523|467898776|FG005|Overall Study|Physician Decision|0|||
129982227|NCT04410523|467898771|FG000|Overall Study|Pregnancy|0|||
129982228|NCT04410523|467898772|FG001|Overall Study|Pregnancy|0|||
129982229|NCT04410523|467898773|FG002|Overall Study|Pregnancy|0|||
129982230|NCT04410523|467898774|FG003|Overall Study|Pregnancy|0|||
129982231|NCT04410523|467898775|FG004|Overall Study|Pregnancy|0|||
129982232|NCT04410523|467898776|FG005|Overall Study|Pregnancy|1|||
129982233|NCT04410523|467898771|FG000|Overall Study|Protocol deviation|0|||
129982234|NCT04410523|467898772|FG001|Overall Study|Protocol deviation|0|||
129982235|NCT04410523|467898773|FG002|Overall Study|Protocol deviation|0|||
129982236|NCT04410523|467898774|FG003|Overall Study|Protocol deviation|0|||
129982237|NCT04410523|467898775|FG004|Overall Study|Protocol deviation|0|||
129982238|NCT04410523|467898776|FG005|Overall Study|Protocol deviation|2|||
129982239|NCT04410523|467898771|FG000|Overall Study|Subject decision|2|||
129982240|NCT04410523|467898772|FG001|Overall Study|Subject decision|0|||
129982241|NCT04410523|467898773|FG002|Overall Study|Subject decision|0|||
129982242|NCT04410523|467898774|FG003|Overall Study|Subject decision|1|||
129982243|NCT04410523|467898775|FG004|Overall Study|Subject decision|0|||
129982244|NCT04410523|467898776|FG005|Overall Study|Subject decision|1|||
129982245|NCT00490490|467898777|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
129982246|NCT00490490|467898777|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
129982247|NCT03651622|467898778|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
129982248|NCT03651622|467898779|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
129982249|NCT03651622|467898780|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
129982250|NCT03651622|467898778|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
129982251|NCT03651622|467898779|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
129982252|NCT03651622|467898780|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
129982253|NCT03651622|467898778|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
129982254|NCT03651622|467898779|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
129982255|NCT03651622|467898780|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
129982256|NCT03651622|467898778|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
129982257|NCT03651622|467898779|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
129982258|NCT03651622|467898780|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
129982259|NCT03651622|467898778|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
129982260|NCT03651622|467898779|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
129982261|NCT03651622|467898780|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
129982262|NCT01519089|467898781|FG000|Overall Study|Adverse Event|4|||
129982263|NCT01519089|467898782|FG001|Overall Study|Adverse Event|4|||
129982264|NCT01519089|467898781|FG000|Overall Study|Lack of Efficacy|0|||
129982265|NCT01519089|467898782|FG001|Overall Study|Lack of Efficacy|2|||
129982266|NCT01519089|467898781|FG000|Overall Study|Lost to Follow-up|1|||
129982267|NCT01519089|467898782|FG001|Overall Study|Lost to Follow-up|0|||
129982268|NCT01519089|467898781|FG000|Overall Study|Withdrawal by Subject|0|||
130171409|NCT02952586|468584708|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
130171410|NCT02952586|468584709|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
129982269|NCT01519089|467898782|FG001|Overall Study|Withdrawal by Subject|2|||
130171411|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
130171412|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
130171413|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
130171414|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
130171415|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
130171416|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
130171417|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
130171418|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
130171419|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
130171420|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
130171421|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
130171422|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
130171423|NCT02952586|468584708|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
130171424|NCT02952586|468584709|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
130171425|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Death|3|||
130171426|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Death|8|||
130171427|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
130171428|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
130171429|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
130171430|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
130171431|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
130171432|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
130171433|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
130171434|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
130171435|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
130171436|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
130171437|NCT02952586|468584708|FG000|CRT for Cisplatin (63 Days)|Other|1|||
130171438|NCT02952586|468584709|FG001|CRT for Cisplatin (63 Days)|Other|1|||
130171439|NCT02952586|468584708|FG000|CRT for IMRT (63 Days)|Death|5|||
130171440|NCT02952586|468584709|FG001|CRT for IMRT (63 Days)|Death|8|||
130171441|NCT02952586|468584708|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
130171442|NCT02952586|468584709|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
130171443|NCT02952586|468584708|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
130171444|NCT02952586|468584709|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
130171445|NCT02952586|468584708|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
130171446|NCT02952586|468584709|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
130171447|NCT02952586|468584708|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
130171448|NCT02952586|468584709|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
130171449|NCT02952586|468584708|FG000|CRT for IMRT (63 Days)|Other|1|||
130171450|NCT02952586|468584709|FG001|CRT for IMRT (63 Days)|Other|0|||
130171451|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Death|17|||
130171452|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Death|11|||
130171453|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
130171454|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
130171455|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
130171456|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
130171457|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
130171458|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
130171459|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
130171460|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
130171461|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
130171462|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
130171463|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
130171464|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
130171465|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
130171466|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
130171467|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Other|2|||
130171468|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Other|1|||
130171469|NCT02952586|468584708|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
130171470|NCT02952586|468584709|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
130171471|NCT02952586|468584708|FG000|Follow-Up Phase (90 Days)|Death|12|||
130171472|NCT02952586|468584709|FG001|Follow-Up Phase (90 Days)|Death|10|||
130171473|NCT02952586|468584708|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
130171474|NCT02952586|468584709|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
130171475|NCT02952586|468584708|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
130171476|NCT02952586|468584709|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
130171477|NCT02952586|468584708|FG000|Follow-Up Phase (90 Days)|Other|7|||
130171478|NCT02952586|468584709|FG001|Follow-Up Phase (90 Days)|Other|5|||
130171479|NCT02952586|468584708|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
129982270|NCT01519089|467898781|FG000|Overall Study|Other|2|||
130171480|NCT02952586|468584709|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
130171481|NCT02952586|468584708|FG000|LT Follow-up (up to 45 Months)|Death|51|||
130171482|NCT02952586|468584709|FG001|LT Follow-up (up to 45 Months)|Death|31|||
130171483|NCT02952586|468584708|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
130171484|NCT02952586|468584709|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
130171485|NCT02952586|468584708|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
130171486|NCT02952586|468584709|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
130171487|NCT02952586|468584708|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
130171488|NCT02952586|468584709|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
130171489|NCT03717012|468584710|FG000|Overall Study|Due to trial termination|1|||
130171490|NCT03717012|468584711|FG001|Overall Study|Due to trial termination|2|||
130171491|NCT03717012|468584710|FG000|Overall Study|Protocol Violation|0|||
130171492|NCT03717012|468584711|FG001|Overall Study|Protocol Violation|2|||
130171493|NCT03717012|468584710|FG000|Overall Study|Adverse Event|0|||
130171494|NCT03717012|468584711|FG001|Overall Study|Adverse Event|1|||
130171495|NCT03717012|468584710|FG000|Overall Study|Lung transplant|0|||
130171496|NCT03717012|468584711|FG001|Overall Study|Lung transplant|1|||
130171497|NCT00789035|468584712|FG000|Overall Study|Adverse Event|0|||
130171498|NCT00789035|468584713|FG001|Overall Study|Adverse Event|2|||
130171499|NCT00789035|468584714|FG002|Overall Study|Adverse Event|0|||
130171500|NCT00789035|468584715|FG003|Overall Study|Adverse Event|1|||
130171501|NCT00789035|468584716|FG004|Overall Study|Adverse Event|3|||
130171502|NCT00789035|468584712|FG000|Overall Study|Lack of Efficacy|3|||
130171503|NCT00789035|468584713|FG001|Overall Study|Lack of Efficacy|0|||
130171504|NCT00789035|468584714|FG002|Overall Study|Lack of Efficacy|0|||
130171505|NCT00789035|468584715|FG003|Overall Study|Lack of Efficacy|0|||
130171506|NCT00789035|468584716|FG004|Overall Study|Lack of Efficacy|2|||
130171507|NCT00789035|468584712|FG000|Overall Study|Protocol Violation|1|||
130171508|NCT00789035|468584713|FG001|Overall Study|Protocol Violation|0|||
130171509|NCT00789035|468584714|FG002|Overall Study|Protocol Violation|0|||
130171510|NCT00789035|468584715|FG003|Overall Study|Protocol Violation|0|||
130171511|NCT00789035|468584716|FG004|Overall Study|Protocol Violation|0|||
130171512|NCT00789035|468584712|FG000|Overall Study|Withdrawal by Subject|0|||
130171513|NCT00789035|468584713|FG001|Overall Study|Withdrawal by Subject|2|||
130171514|NCT00789035|468584714|FG002|Overall Study|Withdrawal by Subject|0|||
130171515|NCT00789035|468584715|FG003|Overall Study|Withdrawal by Subject|0|||
130171516|NCT00789035|468584716|FG004|Overall Study|Withdrawal by Subject|0|||
130171517|NCT00789035|468584712|FG000|Overall Study|Other reason not defined above|2|||
130171518|NCT00789035|468584713|FG001|Overall Study|Other reason not defined above|3|||
130171519|NCT00789035|468584714|FG002|Overall Study|Other reason not defined above|1|||
130171520|NCT00789035|468584715|FG003|Overall Study|Other reason not defined above|0|||
130171521|NCT00789035|468584716|FG004|Overall Study|Other reason not defined above|1|||
130171522|NCT02640690|468584717|FG000|Overall Study|Lost to Follow-up|7|||
130171523|NCT02640690|468584718|FG001|Overall Study|Lost to Follow-up|7|||
130171524|NCT02640690|468584717|FG000|Overall Study|Withdrawal by Subject|16|||
130171525|NCT02640690|468584718|FG001|Overall Study|Withdrawal by Subject|20|||
130171526|NCT02640690|468584717|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
130171527|NCT02640690|468584718|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
130171528|NCT01118975|468584719|FG000|Overall Study|Adverse Event|0|||
130171529|NCT01118975|468584720|FG001|Overall Study|Adverse Event|1|||
130171530|NCT01520870|468584721|FG000|Overall Study|Withdrawal by Subject|2|||
130171531|NCT02463357|468584722|FG000|Overall Study|Withdrawal by Subject|1|||
130171532|NCT02463357|468584723|FG001|Overall Study|Withdrawal by Subject|0|||
130171533|NCT02463357|468584724|FG002|Overall Study|Withdrawal by Subject|0|||
130171534|NCT02463357|468584725|FG003|Overall Study|Withdrawal by Subject|0|||
130171535|NCT02463357|468584726|FG004|Overall Study|Withdrawal by Subject|0|||
130171536|NCT02463357|468584722|FG000|Overall Study|Withdrawal by Subject|0|||
130171537|NCT02463357|468584723|FG001|Overall Study|Withdrawal by Subject|0|||
130171538|NCT02463357|468584724|FG002|Overall Study|Withdrawal by Subject|0|||
130171539|NCT02463357|468584725|FG003|Overall Study|Withdrawal by Subject|0|||
130171540|NCT02463357|468584726|FG004|Overall Study|Withdrawal by Subject|1|||
130171541|NCT01399658|468584727|FG000|Overall Study|Ineligible|1|||
130171542|NCT01399658|468584727|FG000|Overall Study|Machine Technical Issue|3|||
130171543|NCT01399658|468584727|FG000|Overall Study|Alternative therapy|1|||
130171544|NCT01399658|468584727|FG000|Overall Study|No reason given|1|||
130171545|NCT02460679|468584728|FG000|Overall Study|Investigator Decision|1|||
130171546|NCT02460679|468584728|FG000|Overall Study|Withdrawal by Subject|4|||
130171547|NCT02620579|468584729|FG000|Overall Study|Physician Decision|0|||
130171548|NCT02620579|468584730|FG001|Overall Study|Physician Decision|0|||
130171549|NCT02620579|468584731|FG002|Overall Study|Physician Decision|0|||
130171550|NCT02620579|468584732|FG003|Overall Study|Physician Decision|1|||
130171551|NCT02620579|468584729|FG000|Overall Study|Withdrawal by Subject|0|||
130171552|NCT02620579|468584730|FG001|Overall Study|Withdrawal by Subject|1|||
130171553|NCT02620579|468584731|FG002|Overall Study|Withdrawal by Subject|1|||
130171554|NCT02620579|468584732|FG003|Overall Study|Withdrawal by Subject|0|||
130171555|NCT00796107|468584738|FG000|Overall Study|Lack of Efficacy|1|||
130171556|NCT00796107|468584738|FG000|Overall Study|Progressive Disease|5|||
130171557|NCT04411914|468584739|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
130171558|NCT04411914|468584740|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
130171559|NCT01721317|468584742|FG000|Overall Study|Study Closed / Terminated|2|||
130171560|NCT01721317|468584743|FG001|Overall Study|Study Closed / Terminated|2|||
130171561|NCT01721317|468584742|FG000|Overall Study|Physician Decision|0|||
130171562|NCT01721317|468584743|FG001|Overall Study|Physician Decision|1|||
130171563|NCT01721317|468584742|FG000|Overall Study|Withdrawal by Subject|0|||
130171564|NCT01721317|468584743|FG001|Overall Study|Withdrawal by Subject|1|||
130171565|NCT02806024|468584762|FG000|Overall Study|Night Delivery|1|||
130171566|NCT02806024|468584763|FG001|Overall Study|Night Delivery|1|||
130171567|NCT02806024|468584762|FG000|Overall Study|DVT during antepartum admission|0|||
130171568|NCT02806024|468584763|FG001|Overall Study|DVT during antepartum admission|1|||
130171569|NCT01994850|468584764|FG000|Overall Study|Physician Decision|1|||
130171570|NCT01994850|468584764|FG000|Overall Study|Withdrawal by Subject|1|||
130171571|NCT00789737|468584767|FG000|Overall Study|Withdrawal by Subject|13|||
130171572|NCT00789737|468584768|FG001|Overall Study|Withdrawal by Subject|22|||
130171573|NCT00789737|468584767|FG000|Overall Study|Lost to Follow-up|10|||
130171574|NCT00789737|468584768|FG001|Overall Study|Lost to Follow-up|14|||
130171575|NCT00789737|468584767|FG000|Overall Study|Adverse Event|8|||
130171576|NCT00789737|468584768|FG001|Overall Study|Adverse Event|8|||
130171577|NCT00789737|468584767|FG000|Overall Study|Protocol Violation|3|||
130171578|NCT00789737|468584768|FG001|Overall Study|Protocol Violation|0|||
130171579|NCT00789737|468584767|FG000|Overall Study|Lack of Efficacy|3|||
130171580|NCT00789737|468584768|FG001|Overall Study|Lack of Efficacy|0|||
130171581|NCT00789737|468584767|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
130171582|NCT00789737|468584768|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
130171583|NCT00789737|468584767|FG000|Overall Study|Other|11|||
130171584|NCT00789737|468584768|FG001|Overall Study|Other|7|||
130171585|NCT03489109|468584771|FG000|Overall Study|Lost to Follow-up|1|||
130171586|NCT03489109|468584772|FG001|Overall Study|Lost to Follow-up|2|||
130171587|NCT02181790|468584773|FG000|Overall Study|study terminated|2|||
130171588|NCT02181790|468584774|FG001|Overall Study|study terminated|0|||
130171589|NCT02458287|468584775|FG000|Overall Study|Adverse Event|0|||
130171590|NCT02458287|468584776|FG001|Overall Study|Adverse Event|0|||
130171591|NCT02458287|468584777|FG002|Overall Study|Adverse Event|0|||
130171592|NCT02458287|468584778|FG003|Overall Study|Adverse Event|1|||
130171593|NCT02458287|468584775|FG000|Overall Study|Lost to Follow-up|0|||
130171594|NCT02458287|468584776|FG001|Overall Study|Lost to Follow-up|1|||
130171595|NCT02458287|468584777|FG002|Overall Study|Lost to Follow-up|1|||
130171596|NCT02458287|468584778|FG003|Overall Study|Lost to Follow-up|0|||
130171597|NCT02458287|468584775|FG000|Overall Study|Protocol Violation|0|||
130171598|NCT02458287|468584776|FG001|Overall Study|Protocol Violation|1|||
130171599|NCT02458287|468584777|FG002|Overall Study|Protocol Violation|0|||
130171600|NCT02458287|468584778|FG003|Overall Study|Protocol Violation|0|||
130171601|NCT02458287|468584775|FG000|Overall Study|Withdrawal by Subject|0|||
130171602|NCT02458287|468584776|FG001|Overall Study|Withdrawal by Subject|2|||
130171603|NCT02458287|468584777|FG002|Overall Study|Withdrawal by Subject|2|||
130171604|NCT02458287|468584778|FG003|Overall Study|Withdrawal by Subject|1|||
130171605|NCT02458287|468584775|FG000|Overall Study|Relocated Out of State|0|||
130171606|NCT02458287|468584776|FG001|Overall Study|Relocated Out of State|0|||
130171607|NCT02458287|468584777|FG002|Overall Study|Relocated Out of State|0|||
130171608|NCT02458287|468584778|FG003|Overall Study|Relocated Out of State|1|||
130171609|NCT02613182|468584779|FG000|Overall Study|Death|6|||
130171610|NCT02613182|468584779|FG000|Overall Study|Physician Decision|1|||
130171611|NCT02613182|468584779|FG000|Overall Study|Study Terminated by Sponsor|21|||
130171612|NCT02613182|468584779|FG000|Overall Study|Withdrawal by Subject|6|||
130171613|NCT03968978|468584780|FG000|Overall Study|Adverse Event|1|||
130171614|NCT03968978|468584781|FG001|Overall Study|Adverse Event|0|||
130171615|NCT00908310|468584785|FG000|Overall Study|Death|37|||
130171616|NCT00908310|468584785|FG000|Overall Study|Withdrawal by Subject|7|||
130171617|NCT00908310|468584785|FG000|Overall Study|Lost to Follow-up|7|||
130171618|NCT00908310|468584785|FG000|Overall Study|Screening failure|5|||
130171619|NCT00908310|468584785|FG000|Overall Study|Other reasons|4|||
130171620|NCT04614246|468584788|FG000|Overall Study|Adverse Event|0|||
130171621|NCT04614246|468584789|FG001|Overall Study|Adverse Event|1|||
130171622|NCT04614246|468584790|FG002|Overall Study|Adverse Event|1|||
130171623|NCT04614246|468584791|FG003|Overall Study|Adverse Event|2|||
130171624|NCT04614246|468584792|FG004|Overall Study|Adverse Event|1|||
130171625|NCT04614246|468584788|FG000|Overall Study|Lost to Follow-up|0|||
130171626|NCT04614246|468584789|FG001|Overall Study|Lost to Follow-up|1|||
130171627|NCT04614246|468584790|FG002|Overall Study|Lost to Follow-up|0|||
130171628|NCT04614246|468584791|FG003|Overall Study|Lost to Follow-up|1|||
130171629|NCT04614246|468584792|FG004|Overall Study|Lost to Follow-up|3|||
130171630|NCT04614246|468584788|FG000|Overall Study|Other reason|0|||
130171631|NCT04614246|468584789|FG001|Overall Study|Other reason|1|||
130171632|NCT04614246|468584790|FG002|Overall Study|Other reason|2|||
130171633|NCT04614246|468584791|FG003|Overall Study|Other reason|0|||
130171634|NCT04614246|468584792|FG004|Overall Study|Other reason|0|||
130171635|NCT04614246|468584788|FG000|Overall Study|Withdrawal by Subject|4|||
130171636|NCT04614246|468584789|FG001|Overall Study|Withdrawal by Subject|2|||
130171637|NCT04614246|468584790|FG002|Overall Study|Withdrawal by Subject|4|||
130171638|NCT04614246|468584791|FG003|Overall Study|Withdrawal by Subject|3|||
130171639|NCT04614246|468584792|FG004|Overall Study|Withdrawal by Subject|4|||
130171640|NCT04614246|468584788|FG000|Overall Study|Physician Decision|0|||
130171641|NCT04614246|468584789|FG001|Overall Study|Physician Decision|2|||
130171642|NCT04614246|468584790|FG002|Overall Study|Physician Decision|1|||
130171643|NCT04614246|468584791|FG003|Overall Study|Physician Decision|0|||
130171644|NCT04614246|468584792|FG004|Overall Study|Physician Decision|0|||
130171645|NCT04614246|468584788|FG000|Overall Study|Study terminated by sponsor|10|||
130171646|NCT04614246|468584789|FG001|Overall Study|Study terminated by sponsor|15|||
130171647|NCT04614246|468584790|FG002|Overall Study|Study terminated by sponsor|12|||
130171648|NCT04614246|468584791|FG003|Overall Study|Study terminated by sponsor|13|||
130171649|NCT04614246|468584792|FG004|Overall Study|Study terminated by sponsor|9|||
130171650|NCT04614246|468584788|FG000|Overall Study|Pregnancy|2|||
130171651|NCT04614246|468584789|FG001|Overall Study|Pregnancy|0|||
130171652|NCT04614246|468584790|FG002|Overall Study|Pregnancy|1|||
130171653|NCT04614246|468584791|FG003|Overall Study|Pregnancy|0|||
130171654|NCT04614246|468584792|FG004|Overall Study|Pregnancy|0|||
130171655|NCT01680497|468584793|FG000|Overall Study|Lost to Follow-up|2|||
130171656|NCT00725205|468584794|FG000|Overall Study|Adverse Event|22|||
130171657|NCT00725205|468584794|FG000|Overall Study|Investigator Discontinued|1|||
130171658|NCT00725205|468584794|FG000|Overall Study|Non-compliance With Protocol|14|||
130171659|NCT00725205|468584794|FG000|Overall Study|Other|8|||
130171660|NCT00725205|468584794|FG000|Overall Study|Protocol Defined Clinical Event|1|||
130171661|NCT00725205|468584794|FG000|Overall Study|Treatment Failure|41|||
130171662|NCT01200069|468586769|FG000|Overall Study|Withdrawal by Subject|0|||
130171663|NCT01200069|468586770|FG001|Overall Study|Withdrawal by Subject|1|||
130171664|NCT04998851|468586771|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
130171665|NCT04998851|468586772|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
130171666|NCT04998851|468586771|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
130171667|NCT04998851|468586772|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
130171668|NCT01924754|468586774|FG000|Overall Study|Lost to Follow-up|1|||
130171669|NCT01924754|468586775|FG001|Overall Study|Lost to Follow-up|2|||
130171670|NCT01924754|468586776|FG002|Overall Study|Lost to Follow-up|1|||
130171671|NCT01924754|468586774|FG000|Overall Study|Pregnancy|0|||
130171672|NCT01924754|468586775|FG001|Overall Study|Pregnancy|1|||
130171673|NCT01924754|468586776|FG002|Overall Study|Pregnancy|2|||
130171674|NCT00369486|468586777|FG000|4-Week Visit|Missed visit|2|||
130171675|NCT00369486|468586778|FG001|4-Week Visit|Missed visit|2|||
130171676|NCT00369486|468586779|FG002|4-Week Visit|Missed visit|0|||
130171677|NCT00369486|468586780|FG003|4-Week Visit|Missed visit|2|||
130171678|NCT00369486|468586781|FG004|4-Week Visit|Missed visit|1|||
130171679|NCT00369486|468586777|FG000|4-Week Visit|Dropped|0|||
130171680|NCT00369486|468586778|FG001|4-Week Visit|Dropped|0|||
130171681|NCT00369486|468586779|FG002|4-Week Visit|Dropped|1|||
130171682|NCT00369486|468586780|FG003|4-Week Visit|Dropped|0|||
130171683|NCT00369486|468586781|FG004|4-Week Visit|Dropped|0|||
130171684|NCT00369486|468586777|FG000|8-Week Visit|Missed visit|0|||
130171685|NCT00369486|468586778|FG001|8-Week Visit|Missed visit|1|||
130171686|NCT00369486|468586779|FG002|8-Week Visit|Missed visit|0|||
130171687|NCT00369486|468586780|FG003|8-Week Visit|Missed visit|0|||
130171688|NCT00369486|468586781|FG004|8-Week Visit|Missed visit|1|||
130171689|NCT00369486|468586777|FG000|8-Week Visit|Dropped|0|||
130171690|NCT00369486|468586778|FG001|8-Week Visit|Dropped|0|||
130171691|NCT00369486|468586779|FG002|8-Week Visit|Dropped|0|||
130171692|NCT00369486|468586780|FG003|8-Week Visit|Dropped|1|||
130171693|NCT00369486|468586781|FG004|8-Week Visit|Dropped|0|||
130171694|NCT00369486|468586777|FG000|17-Week Visit|Missed visit|0|||
130171695|NCT00369486|468586778|FG001|17-Week Visit|Missed visit|0|||
130171696|NCT00369486|468586779|FG002|17-Week Visit|Missed visit|1|||
130171697|NCT00369486|468586780|FG003|17-Week Visit|Missed visit|1|||
130171698|NCT00369486|468586781|FG004|17-Week Visit|Missed visit|1|||
130171699|NCT00369486|468586777|FG000|34-Week Visit|Dropped|0|||
130171700|NCT00369486|468586778|FG001|34-Week Visit|Dropped|1|||
130171701|NCT00369486|468586779|FG002|34-Week Visit|Dropped|1|||
130171702|NCT00369486|468586780|FG003|34-Week Visit|Dropped|3|||
129982271|NCT01519089|467898782|FG001|Overall Study|Other|6|||
129982272|NCT01519089|467898781|FG000|Overall Study|Not received study drug|0|||
130171703|NCT00369486|468586781|FG004|34-Week Visit|Dropped|3|||
130171704|NCT01392963|468586782|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
130171705|NCT01392963|468586783|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
130171706|NCT01392963|468586782|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
130171707|NCT01392963|468586783|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
130171708|NCT01392963|468586782|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
130171709|NCT01392963|468586783|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
130171710|NCT00402116|468586784|FG000|Overall Study|Jaw infection after surgery-other|1|||
130171711|NCT00402116|468586785|FG001|Overall Study|Jaw infection after surgery-other|0|||
130171712|NCT00402116|468586786|FG002|Overall Study|Jaw infection after surgery-other|0|||
130171713|NCT00402116|468586784|FG000|Overall Study|Withdrawal by Subject|1|||
130171714|NCT00402116|468586785|FG001|Overall Study|Withdrawal by Subject|0|||
130171715|NCT00402116|468586786|FG002|Overall Study|Withdrawal by Subject|5|||
130171716|NCT00402116|468586784|FG000|Overall Study|Treatment completed per protocol|1|||
130171717|NCT00402116|468586785|FG001|Overall Study|Treatment completed per protocol|1|||
130171718|NCT00402116|468586786|FG002|Overall Study|Treatment completed per protocol|2|||
130171719|NCT00402116|468586784|FG000|Overall Study|other complicating disease|0|||
130171720|NCT00402116|468586785|FG001|Overall Study|other complicating disease|0|||
130171721|NCT00402116|468586786|FG002|Overall Study|other complicating disease|2|||
130171722|NCT00402116|468586784|FG000|Overall Study|Disease Progression|0|||
130171723|NCT00402116|468586785|FG001|Overall Study|Disease Progression|4|||
130171724|NCT00402116|468586786|FG002|Overall Study|Disease Progression|38|||
130171725|NCT00402116|468586784|FG000|Overall Study|mistaken thrombocytopenia|0|||
130171726|NCT00402116|468586785|FG001|Overall Study|mistaken thrombocytopenia|0|||
130171727|NCT00402116|468586786|FG002|Overall Study|mistaken thrombocytopenia|1|||
130171728|NCT00402116|468586784|FG000|Overall Study|decline related hyponatremia/tumor|0|||
130171729|NCT00402116|468586785|FG001|Overall Study|decline related hyponatremia/tumor|0|||
130171730|NCT00402116|468586786|FG002|Overall Study|decline related hyponatremia/tumor|1|||
130171731|NCT00402116|468586784|FG000|Overall Study|Adverse Event|0|||
130171732|NCT00402116|468586785|FG001|Overall Study|Adverse Event|1|||
130171733|NCT00402116|468586786|FG002|Overall Study|Adverse Event|6|||
130171734|NCT04778904|468586787|FG000|Overall Study|Protocol Violation|1|||
130171735|NCT04778904|468586788|FG001|Overall Study|Protocol Violation|0|||
130171736|NCT04778904|468586789|FG002|Overall Study|Protocol Violation|0|||
130171737|NCT04778904|468586790|FG003|Overall Study|Protocol Violation|0|||
130171738|NCT04778904|468586787|FG000|Overall Study|Withdrawal by Subject|0|||
130171739|NCT04778904|468586788|FG001|Overall Study|Withdrawal by Subject|0|||
130171740|NCT04778904|468586789|FG002|Overall Study|Withdrawal by Subject|1|||
130171741|NCT04778904|468586790|FG003|Overall Study|Withdrawal by Subject|0|||
130171742|NCT05048329|468586797|FG000|Overall Study|Withdrawal by Subject|1|||
130171743|NCT05048329|468586797|FG000|Overall Study|Screenfail|1|||
130171744|NCT03772717|468586798|FG000|Overall Study|Withdrawal by Subject|2|||
130171745|NCT04138043|468586799|FG000|Overall Study|Withdrawal by Subject|0|||
130171746|NCT04138043|468586800|FG001|Overall Study|Withdrawal by Subject|1|||
130171747|NCT02856802|468586801|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
130171748|NCT02856802|468586802|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
130171749|NCT02856802|468586801|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
130171750|NCT02856802|468586802|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
130171751|NCT02856802|468586801|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
130171752|NCT02856802|468586802|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
130171753|NCT02856802|468586801|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
130171754|NCT02856802|468586802|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
130171755|NCT02856802|468586801|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
130171756|NCT02856802|468586802|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
130171757|NCT02856802|468586801|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
130171758|NCT02856802|468586802|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
130171759|NCT03092219|468586803|FG000|Overall Study|Protocol Violation|7|||
130171760|NCT03092219|468586804|FG001|Overall Study|Protocol Violation|4|||
130171761|NCT00459355|468586813|FG000|Overall Study|Subject no longer met inc criteria|20|||
130171762|NCT00459355|468586814|FG001|Overall Study|Subject no longer met inc criteria|18|||
130171763|NCT00287586|468586815|FG000|Overall Study|Withdrew Consent|19|||
130171764|NCT00287586|468586816|FG001|Overall Study|Withdrew Consent|30|||
130171765|NCT00287586|468586815|FG000|Overall Study|Lost to Follow-up|5|||
130171766|NCT00287586|468586816|FG001|Overall Study|Lost to Follow-up|4|||
130171767|NCT00287586|468586815|FG000|Overall Study|Death|2|||
130171768|NCT00287586|468586816|FG001|Overall Study|Death|3|||
130171769|NCT00287586|468586815|FG000|Overall Study|Elevated Hematocrit|3|||
130171770|NCT00287586|468586816|FG001|Overall Study|Elevated Hematocrit|0|||
130171771|NCT00287586|468586815|FG000|Overall Study|Rash|3|||
130171772|NCT00287586|468586816|FG001|Overall Study|Rash|0|||
130171773|NCT00287586|468586815|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
130171774|NCT00287586|468586816|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
130171775|NCT00287586|468586815|FG000|Overall Study|Stroke|2|||
130171776|NCT00287586|468586816|FG001|Overall Study|Stroke|0|||
130171777|NCT00287586|468586815|FG000|Overall Study|Myocardial Infarction|1|||
130171778|NCT00287586|468586816|FG001|Overall Study|Myocardial Infarction|0|||
130171779|NCT00287586|468586815|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
130171780|NCT00287586|468586816|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
130171781|NCT00287586|468586815|FG000|Overall Study|Cognitive Impairment|1|||
130171782|NCT00287586|468586816|FG001|Overall Study|Cognitive Impairment|0|||
130171783|NCT00287586|468586815|FG000|Overall Study|Pancreatic Cancer|1|||
130171784|NCT00287586|468586816|FG001|Overall Study|Pancreatic Cancer|3|||
130171785|NCT00287586|468586815|FG000|Overall Study|Sleep Apnea|1|||
130171786|NCT00287586|468586816|FG001|Overall Study|Sleep Apnea|0|||
130171787|NCT00287586|468586815|FG000|Overall Study|Shoulder Pain|1|||
130171788|NCT00287586|468586816|FG001|Overall Study|Shoulder Pain|0|||
130171789|NCT00287586|468586815|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
130171790|NCT00287586|468586816|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
130171791|NCT00287586|468586815|FG000|Overall Study|Nonadherence|1|||
130171792|NCT00287586|468586816|FG001|Overall Study|Nonadherence|1|||
130171793|NCT00287586|468586815|FG000|Overall Study|Enrolled in Another Study|1|||
130171794|NCT00287586|468586816|FG001|Overall Study|Enrolled in Another Study|0|||
130171795|NCT00287586|468586815|FG000|Overall Study|Major Depression|0|||
130171796|NCT00287586|468586816|FG001|Overall Study|Major Depression|2|||
130171797|NCT00287586|468586815|FG000|Overall Study|Lung Cancer|0|||
130171798|NCT00287586|468586816|FG001|Overall Study|Lung Cancer|2|||
130171799|NCT00287586|468586815|FG000|Overall Study|Elevated IPSS Score|0|||
130171800|NCT00287586|468586816|FG001|Overall Study|Elevated IPSS Score|1|||
130171801|NCT00287586|468586815|FG000|Overall Study|Retroperitoneal Cancer|0|||
130171802|NCT00287586|468586816|FG001|Overall Study|Retroperitoneal Cancer|1|||
130171803|NCT00287586|468586815|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
130171804|NCT00287586|468586816|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
130171805|NCT00287586|468586815|FG000|Overall Study|Mood Swings and Irritability|0|||
130171806|NCT00287586|468586816|FG001|Overall Study|Mood Swings and Irritability|1|||
130171807|NCT00287586|468586815|FG000|Overall Study|Bradycardia|0|||
130171808|NCT00287586|468586816|FG001|Overall Study|Bradycardia|1|||
130171809|NCT00287586|468586815|FG000|Overall Study|Itchy Swollen Eyes|0|||
130171810|NCT00287586|468586816|FG001|Overall Study|Itchy Swollen Eyes|1|||
130171811|NCT00287586|468586815|FG000|Overall Study|Recurrent Melanoma|0|||
130171812|NCT00287586|468586816|FG001|Overall Study|Recurrent Melanoma|1|||
130171813|NCT03743415|468586818|FG000|Overall Study|Death|5|||
130171814|NCT03743415|468586819|FG001|Overall Study|Death|3|||
130171815|NCT03743415|468586820|FG002|Overall Study|Death|1|||
130171816|NCT03743415|468586821|FG003|Overall Study|Death|4|||
130171817|NCT03743415|468586822|FG004|Overall Study|Death|0|||
130171818|NCT03743415|468586823|FG005|Overall Study|Death|0|||
130171819|NCT03743415|468586824|FG006|Overall Study|Death|0|||
130171820|NCT03743415|468586825|FG007|Overall Study|Death|0|||
130171821|NCT03743415|468586826|FG008|Overall Study|Death|1|||
130171822|NCT03743415|468586827|FG009|Overall Study|Death|0|||
130171823|NCT03743415|468586818|FG000|Overall Study|Withdrawal by Subject|1|||
130171824|NCT03743415|468586819|FG001|Overall Study|Withdrawal by Subject|0|||
130171825|NCT03743415|468586820|FG002|Overall Study|Withdrawal by Subject|4|||
130171826|NCT03743415|468586821|FG003|Overall Study|Withdrawal by Subject|5|||
130171827|NCT03743415|468586822|FG004|Overall Study|Withdrawal by Subject|5|||
130171828|NCT03743415|468586823|FG005|Overall Study|Withdrawal by Subject|2|||
130171829|NCT03743415|468586824|FG006|Overall Study|Withdrawal by Subject|2|||
130171830|NCT03743415|468586825|FG007|Overall Study|Withdrawal by Subject|5|||
130171831|NCT03743415|468586826|FG008|Overall Study|Withdrawal by Subject|9|||
130171832|NCT03743415|468586827|FG009|Overall Study|Withdrawal by Subject|10|||
130171833|NCT03743415|468586818|FG000|Overall Study|Lost to Follow-up|2|||
130171834|NCT03743415|468586819|FG001|Overall Study|Lost to Follow-up|0|||
130171835|NCT03743415|468586820|FG002|Overall Study|Lost to Follow-up|2|||
130171836|NCT03743415|468586821|FG003|Overall Study|Lost to Follow-up|1|||
130171837|NCT03743415|468586822|FG004|Overall Study|Lost to Follow-up|1|||
130171838|NCT03743415|468586823|FG005|Overall Study|Lost to Follow-up|0|||
130171839|NCT03743415|468586824|FG006|Overall Study|Lost to Follow-up|1|||
130171840|NCT03743415|468586825|FG007|Overall Study|Lost to Follow-up|4|||
130171841|NCT03743415|468586826|FG008|Overall Study|Lost to Follow-up|13|||
130171842|NCT03743415|468586827|FG009|Overall Study|Lost to Follow-up|13|||
130171843|NCT02242045|468586828|FG000|Overall Study|Investigator's Discretion|1|||
130171844|NCT02242045|468586828|FG000|Overall Study|Progressive Disease|2|||
130171845|NCT02242045|468586828|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
130171846|NCT02242045|468586828|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
130171847|NCT02473523|468586829|FG000|Overall Study|Death|1|||
130171848|NCT02473523|468586829|FG000|Overall Study|Lost to Follow-up|1|||
130171849|NCT00976911|468586835|FG000|Overall Study|Withdrawal by Subject|4|||
130171850|NCT00976911|468586836|FG001|Overall Study|Withdrawal by Subject|6|||
130171851|NCT00976911|468586835|FG000|Overall Study|Death|138|||
130171852|NCT00976911|468586836|FG001|Overall Study|Death|126|||
130171853|NCT00976911|468586835|FG000|Overall Study|Adverse Event|0|||
129982273|NCT01519089|467898782|FG001|Overall Study|Not received study drug|1|||
130171854|NCT00976911|468586836|FG001|Overall Study|Adverse Event|1|||
130171855|NCT00976911|468586835|FG000|Overall Study|Protocol Violation|2|||
130171856|NCT00976911|468586836|FG001|Overall Study|Protocol Violation|0|||
129982274|NCT03582943|467898785|FG000|Allocated to Groups|Withdrawal by Subject|1|||
130171857|NCT00976911|468586835|FG000|Overall Study|Other|8|||
130171858|NCT00976911|468586836|FG001|Overall Study|Other|9|||
130171859|NCT00976911|468586835|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
130171860|NCT00976911|468586836|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
130171861|NCT02954991|468586837|FG000|Overall Study|Death|92|||
130171862|NCT02954991|468586838|FG001|Overall Study|Death|11|||
130171863|NCT02954991|468586839|FG002|Overall Study|Death|2|||
130171864|NCT02954991|468586837|FG000|Overall Study|Lost to Follow-up|3|||
130171865|NCT02954991|468586838|FG001|Overall Study|Lost to Follow-up|2|||
130171866|NCT02954991|468586839|FG002|Overall Study|Lost to Follow-up|0|||
130171867|NCT02954991|468586837|FG000|Overall Study|Withdrawal by Subject|9|||
130171868|NCT02954991|468586838|FG001|Overall Study|Withdrawal by Subject|8|||
130171869|NCT02954991|468586839|FG002|Overall Study|Withdrawal by Subject|1|||
130171870|NCT02954991|468586837|FG000|Overall Study|Study Terminated by Sponsor|18|||
130171871|NCT02954991|468586838|FG001|Overall Study|Study Terminated by Sponsor|10|||
130171872|NCT02954991|468586839|FG002|Overall Study|Study Terminated by Sponsor|1|||
130171873|NCT02954991|468586837|FG000|Overall Study|Miscellaneous|2|||
130171874|NCT02954991|468586838|FG001|Overall Study|Miscellaneous|1|||
130171875|NCT02954991|468586839|FG002|Overall Study|Miscellaneous|1|||
130171876|NCT00576316|468586840|FG000|Overall Study|Adverse Event|9|||
130171877|NCT00576316|468586840|FG000|Overall Study|Withdrawal by Subject|2|||
130171878|NCT00576316|468586840|FG000|Overall Study|Protocol Violation|9|||
130171879|NCT01266031|468586842|FG000|Overall Study|Not treated|0|||
130171880|NCT01266031|468586843|FG001|Overall Study|Not treated|3|||
130171881|NCT01266031|468586844|FG002|Overall Study|Not treated|2|||
130171882|NCT01434810|468586845|FG000|Overall Study|Did not receive treatment|11|||
130171883|NCT01434810|468586846|FG001|Overall Study|Did not receive treatment|3|||
130171884|NCT01434810|468586845|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
130171885|NCT01434810|468586846|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
130171886|NCT04893018|468586848|FG000|Overall Study|Lost to Follow-up|1|||
130171887|NCT04893018|468586849|FG001|Overall Study|Lost to Follow-up|0|||
130171888|NCT04893018|468586848|FG000|Overall Study|Withdrawal by Subject|2|||
130171889|NCT04893018|468586849|FG001|Overall Study|Withdrawal by Subject|0|||
130171890|NCT04893018|468586848|FG000|Overall Study|Study Terminated|1|||
130171891|NCT04893018|468586849|FG001|Overall Study|Study Terminated|2|||
130171892|NCT00447876|468586852|FG000|Overall Study|Withdrawal by Subject|1|||
130171893|NCT00447876|468586853|FG001|Overall Study|Withdrawal by Subject|4|||
130171894|NCT00447876|468586852|FG000|Overall Study|Lost to Follow-up|1|||
130171895|NCT00447876|468586853|FG001|Overall Study|Lost to Follow-up|0|||
130171896|NCT00447876|468586852|FG000|Overall Study|Deterioration of symptomology|1|||
130171897|NCT00447876|468586853|FG001|Overall Study|Deterioration of symptomology|0|||
130171898|NCT02533180|468586854|FG000|Overall Study|Death|0|||
130171899|NCT02533180|468586855|FG001|Overall Study|Death|2|||
130171900|NCT02533180|468586854|FG000|Overall Study|Lost to Follow-up|0|||
130171901|NCT02533180|468586855|FG001|Overall Study|Lost to Follow-up|1|||
130171902|NCT02533180|468586854|FG000|Overall Study|Physician Decision|0|||
130171903|NCT02533180|468586855|FG001|Overall Study|Physician Decision|1|||
130171904|NCT02533180|468586854|FG000|Overall Study|Withdrawal by Subject|2|||
130171905|NCT02533180|468586855|FG001|Overall Study|Withdrawal by Subject|5|||
130171906|NCT02533180|468586854|FG000|Overall Study|Screen Failure|37|||
130171907|NCT02533180|468586855|FG001|Overall Study|Screen Failure|0|||
130171908|NCT02533180|468586854|FG000|Overall Study|Protocol Deviation|0|||
130171909|NCT02533180|468586855|FG001|Overall Study|Protocol Deviation|1|||
130171910|NCT02533180|468586854|FG000|Overall Study|Non-compliance|0|||
130171911|NCT02533180|468586855|FG001|Overall Study|Non-compliance|1|||
130171912|NCT00005957|468586858|FG000|Overall Study|No treated|3|||
130171913|NCT00005957|468586859|FG001|Overall Study|No treated|9|||
130171914|NCT00005957|468586858|FG000|Overall Study|Crossover to the other arm|5|||
130171915|NCT00005957|468586859|FG001|Overall Study|Crossover to the other arm|19|||
130171916|NCT01609023|468586860|FG000|Overall Study|Lack of Efficacy|3|||
130171917|NCT01609023|468586860|FG000|Overall Study|Withdrawal by Subject|4|||
130171918|NCT01609023|468586860|FG000|Overall Study|Lost to Follow-up|8|||
130171919|NCT01609023|468586860|FG000|Overall Study|Toxicity|3|||
130171920|NCT01609023|468586860|FG000|Overall Study|Disease progression|10|||
130171921|NCT01609023|468586860|FG000|Overall Study|Physician Decision|2|||
130171922|NCT01609023|468586860|FG000|Overall Study|Death|2|||
129982275|NCT03582943|467898786|FG001|Allocated to Groups|Withdrawal by Subject|1|||
129982276|NCT03582943|467898785|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
129982277|NCT03582943|467898786|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
129982278|NCT03582943|467898785|FG000|Analyzed|Protocol Violation|4|||
129982279|NCT03582943|467898786|FG001|Analyzed|Protocol Violation|1|||
129982280|NCT05032872|467898789|FG000|Overall Study|Adverse Event|1|||
129982281|NCT05032872|467898790|FG001|Overall Study|Adverse Event|0|||
129982282|NCT05032872|467898789|FG000|Overall Study|Lost to Follow-up|2|||
129982283|NCT05032872|467898790|FG001|Overall Study|Lost to Follow-up|4|||
129982284|NCT05032872|467898789|FG000|Overall Study|Withdrawal by Subject|4|||
129982285|NCT05032872|467898790|FG001|Overall Study|Withdrawal by Subject|3|||
129982286|NCT05870228|467898791|FG000|Overall Study|Lost to Follow-up|2|||
130171923|NCT01609023|468586860|FG000|Overall Study|Personal reasons|1|||
130171924|NCT02047734|468586862|FG000|Overall Study|Adverse Event|18|||
130171925|NCT02047734|468586863|FG001|Overall Study|Adverse Event|13|||
130171926|NCT02047734|468586864|FG002|Overall Study|Adverse Event|13|||
130171927|NCT02047734|468586862|FG000|Overall Study|Lack of Efficacy|4|||
129982287|NCT05870228|467898792|FG001|Overall Study|Lost to Follow-up|0|||
130171928|NCT02047734|468586863|FG001|Overall Study|Lack of Efficacy|5|||
130171929|NCT02047734|468586864|FG002|Overall Study|Lack of Efficacy|1|||
130171930|NCT02047734|468586862|FG000|Overall Study|Protocol Violation|3|||
130171931|NCT02047734|468586863|FG001|Overall Study|Protocol Violation|1|||
130171932|NCT02047734|468586864|FG002|Overall Study|Protocol Violation|1|||
130171933|NCT02047734|468586862|FG000|Overall Study|Lost to Follow-up|1|||
130171934|NCT02047734|468586863|FG001|Overall Study|Lost to Follow-up|4|||
130171935|NCT02047734|468586864|FG002|Overall Study|Lost to Follow-up|0|||
130171936|NCT02047734|468586862|FG000|Overall Study|Death|0|||
130171937|NCT02047734|468586863|FG001|Overall Study|Death|1|||
130171938|NCT02047734|468586864|FG002|Overall Study|Death|0|||
130171939|NCT02047734|468586862|FG000|Overall Study|Withdrawal by Subject|30|||
130171940|NCT02047734|468586863|FG001|Overall Study|Withdrawal by Subject|31|||
130171941|NCT02047734|468586864|FG002|Overall Study|Withdrawal by Subject|19|||
130171942|NCT02047734|468586862|FG000|Overall Study|Physician Decision|7|||
130171943|NCT02047734|468586863|FG001|Overall Study|Physician Decision|6|||
130171944|NCT02047734|468586864|FG002|Overall Study|Physician Decision|5|||
130171945|NCT02047734|468586862|FG000|Overall Study|Miscellaneous|2|||
130171946|NCT02047734|468586863|FG001|Overall Study|Miscellaneous|4|||
130171947|NCT02047734|468586864|FG002|Overall Study|Miscellaneous|6|||
130171948|NCT02047734|468586862|FG000|Overall Study|Did Not Receive Study Drug|2|||
130171949|NCT02047734|468586863|FG001|Overall Study|Did Not Receive Study Drug|4|||
130171950|NCT02047734|468586864|FG002|Overall Study|Did Not Receive Study Drug|1|||
130171951|NCT00799825|468586867|FG000|Overall Study|Adverse Event|1|||
130171952|NCT00799825|468586867|FG000|Overall Study|Withdrawal by Subject|6|||
130171953|NCT00799825|468586867|FG000|Overall Study|Lost to Follow-up|38|||
130171954|NCT00799825|468586867|FG000|Overall Study|Pregnancy|3|||
130171955|NCT02439970|468586868|FG000|Overall Study|Study Terminated|2|||
130171956|NCT02439970|468586869|FG001|Overall Study|Study Terminated|3|||
130171957|NCT00492778|468586870|FG000|Overall Study|Ineligible by Pathology Review|8|||
130171958|NCT00492778|468586871|FG001|Overall Study|Ineligible by Pathology Review|1|||
130171959|NCT02910011|468586874|FG000|Overall Study|Physician Decision|2|||
130171960|NCT03280381|468586875|FG000|Overall Study|Physician Decision|0|||
130171961|NCT03280381|468586876|FG001|Overall Study|Physician Decision|2|||
130171962|NCT01822366|468586877|FG000|Overall Study|Lost to Follow-up|5|||
130171963|NCT01822366|468586878|FG001|Overall Study|Lost to Follow-up|1|||
130171964|NCT01822366|468586879|FG002|Overall Study|Lost to Follow-up|5|||
130171965|NCT01822366|468586880|FG003|Overall Study|Lost to Follow-up|1|||
130171966|NCT01822366|468586877|FG000|Overall Study|Withdrawal by Subject|0|||
130171967|NCT01822366|468586878|FG001|Overall Study|Withdrawal by Subject|6|||
130171968|NCT01822366|468586879|FG002|Overall Study|Withdrawal by Subject|0|||
130171969|NCT01822366|468586880|FG003|Overall Study|Withdrawal by Subject|6|||
130171970|NCT01822366|468586877|FG000|Overall Study|Partial Intervention Completion|0|||
130171971|NCT01822366|468586878|FG001|Overall Study|Partial Intervention Completion|15|||
130171972|NCT01822366|468586879|FG002|Overall Study|Partial Intervention Completion|0|||
130171973|NCT01822366|468586880|FG003|Overall Study|Partial Intervention Completion|15|||
130171974|NCT00025259|468586881|FG000|Overall Study|Death|1|||
130171975|NCT00025259|468586882|FG001|Overall Study|Death|3|||
130171976|NCT00025259|468586883|FG002|Overall Study|Death|0|||
130171977|NCT00025259|468586884|FG003|Overall Study|Death|3|||
130171978|NCT00025259|468586885|FG004|Overall Study|Death|0|||
130171979|NCT00025259|468586886|FG005|Overall Study|Death|1|||
130171980|NCT00025259|468586887|FG006|Overall Study|Death|2|||
130171981|NCT00025259|468586881|FG000|Overall Study|Lack of Efficacy|2|||
130171982|NCT00025259|468586882|FG001|Overall Study|Lack of Efficacy|46|||
130171983|NCT00025259|468586883|FG002|Overall Study|Lack of Efficacy|60|||
130171984|NCT00025259|468586884|FG003|Overall Study|Lack of Efficacy|78|||
130171985|NCT00025259|468586885|FG004|Overall Study|Lack of Efficacy|11|||
130171986|NCT00025259|468586886|FG005|Overall Study|Lack of Efficacy|30|||
130171987|NCT00025259|468586887|FG006|Overall Study|Lack of Efficacy|38|||
130171988|NCT00025259|468586881|FG000|Overall Study|Lost to Follow-up|2|||
130171989|NCT00025259|468586882|FG001|Overall Study|Lost to Follow-up|9|||
130171990|NCT00025259|468586883|FG002|Overall Study|Lost to Follow-up|13|||
130171991|NCT00025259|468586884|FG003|Overall Study|Lost to Follow-up|13|||
130171992|NCT00025259|468586885|FG004|Overall Study|Lost to Follow-up|1|||
130171993|NCT00025259|468586886|FG005|Overall Study|Lost to Follow-up|3|||
130171994|NCT00025259|468586887|FG006|Overall Study|Lost to Follow-up|1|||
130171995|NCT00025259|468586881|FG000|Overall Study|Physician Decision|12|||
130171996|NCT00025259|468586882|FG001|Overall Study|Physician Decision|1|||
130171997|NCT00025259|468586883|FG002|Overall Study|Physician Decision|0|||
130171998|NCT00025259|468586884|FG003|Overall Study|Physician Decision|5|||
130171999|NCT00025259|468586885|FG004|Overall Study|Physician Decision|4|||
130172000|NCT00025259|468586886|FG005|Overall Study|Physician Decision|2|||
130172001|NCT00025259|468586887|FG006|Overall Study|Physician Decision|1|||
130172002|NCT00025259|468586881|FG000|Overall Study|Protocol Violation|3|||
130172003|NCT00025259|468586882|FG001|Overall Study|Protocol Violation|2|||
130172004|NCT00025259|468586883|FG002|Overall Study|Protocol Violation|2|||
130172005|NCT00025259|468586884|FG003|Overall Study|Protocol Violation|1|||
130172006|NCT00025259|468586885|FG004|Overall Study|Protocol Violation|2|||
130172007|NCT00025259|468586886|FG005|Overall Study|Protocol Violation|1|||
129982288|NCT05870228|467898791|FG000|Overall Study|Withdrawal by Subject|1|||
130172008|NCT00025259|468586887|FG006|Overall Study|Protocol Violation|3|||
130172009|NCT00025259|468586881|FG000|Overall Study|Withdrawal by Subject|9|||
130172010|NCT00025259|468586882|FG001|Overall Study|Withdrawal by Subject|27|||
130172011|NCT00025259|468586883|FG002|Overall Study|Withdrawal by Subject|6|||
130172012|NCT00025259|468586884|FG003|Overall Study|Withdrawal by Subject|14|||
130172013|NCT00025259|468586885|FG004|Overall Study|Withdrawal by Subject|11|||
130172014|NCT00025259|468586886|FG005|Overall Study|Withdrawal by Subject|8|||
130172015|NCT00025259|468586887|FG006|Overall Study|Withdrawal by Subject|3|||
130172016|NCT00025259|468586881|FG000|Overall Study|Ineligible|14|||
130172017|NCT00025259|468586882|FG001|Overall Study|Ineligible|1|||
130172018|NCT00025259|468586883|FG002|Overall Study|Ineligible|0|||
130172019|NCT00025259|468586884|FG003|Overall Study|Ineligible|0|||
130172020|NCT00025259|468586885|FG004|Overall Study|Ineligible|6|||
130172021|NCT00025259|468586886|FG005|Overall Study|Ineligible|0|||
130172022|NCT00025259|468586887|FG006|Overall Study|Ineligible|1|||
130172023|NCT00025259|468586881|FG000|Overall Study|Randomization error|1|||
130172024|NCT00025259|468586882|FG001|Overall Study|Randomization error|0|||
130172025|NCT00025259|468586883|FG002|Overall Study|Randomization error|0|||
130172026|NCT00025259|468586884|FG003|Overall Study|Randomization error|0|||
130172027|NCT00025259|468586885|FG004|Overall Study|Randomization error|1|||
130172028|NCT00025259|468586886|FG005|Overall Study|Randomization error|7|||
130172029|NCT00025259|468586887|FG006|Overall Study|Randomization error|2|||
130172030|NCT00025259|468586881|FG000|Overall Study|Adverse Event|1|||
130172031|NCT00025259|468586882|FG001|Overall Study|Adverse Event|0|||
130172032|NCT00025259|468586883|FG002|Overall Study|Adverse Event|0|||
130172033|NCT00025259|468586884|FG003|Overall Study|Adverse Event|0|||
130172034|NCT00025259|468586885|FG004|Overall Study|Adverse Event|0|||
130172035|NCT00025259|468586886|FG005|Overall Study|Adverse Event|0|||
130172036|NCT00025259|468586887|FG006|Overall Study|Adverse Event|0|||
130172037|NCT01449370|468586888|FG000|Overall Study|Disease Progression|5|||
130172038|NCT01449370|468586889|FG001|Overall Study|Disease Progression|4|||
130172039|NCT01449370|468586890|FG002|Overall Study|Disease Progression|8|||
130172040|NCT01449370|468586891|FG003|Overall Study|Disease Progression|3|||
130172041|NCT01449370|468586892|FG004|Overall Study|Disease Progression|3|||
130172042|NCT01449370|468586893|FG005|Overall Study|Disease Progression|3|||
130172043|NCT01449370|468586894|FG006|Overall Study|Disease Progression|3|||
130172044|NCT01449370|468586895|FG007|Overall Study|Disease Progression|2|||
130172045|NCT01449370|468586896|FG008|Overall Study|Disease Progression|9|||
130172046|NCT01449370|468586897|FG009|Overall Study|Disease Progression|1|||
130172047|NCT01449370|468586898|FG010|Overall Study|Disease Progression|3|||
130172048|NCT01449370|468586899|FG011|Overall Study|Disease Progression|3|||
130172049|NCT01449370|468586900|FG012|Overall Study|Disease Progression|2|||
130172050|NCT01449370|468586901|FG013|Overall Study|Disease Progression|8|||
130172051|NCT01449370|468586902|FG014|Overall Study|Disease Progression|3|||
130172052|NCT01449370|468586903|FG015|Overall Study|Disease Progression|1|||
130172053|NCT01449370|468586904|FG016|Overall Study|Disease Progression|4|||
130172054|NCT01449370|468586905|FG017|Overall Study|Disease Progression|3|||
130172055|NCT01449370|468586906|FG018|Overall Study|Disease Progression|1|||
130172056|NCT01449370|468586907|FG019|Overall Study|Disease Progression|2|||
130172057|NCT01449370|468586908|FG020|Overall Study|Disease Progression|5|||
130172058|NCT01449370|468586909|FG021|Overall Study|Disease Progression|2|||
130172059|NCT01449370|468586910|FG022|Overall Study|Disease Progression|3|||
130172060|NCT01449370|468586911|FG023|Overall Study|Disease Progression|7|||
130172061|NCT01449370|468586912|FG024|Overall Study|Disease Progression|3|||
130172062|NCT01449370|468586888|FG000|Overall Study|Adverse Event|1|||
130172063|NCT01449370|468586889|FG001|Overall Study|Adverse Event|2|||
130172064|NCT01449370|468586890|FG002|Overall Study|Adverse Event|0|||
130172065|NCT01449370|468586891|FG003|Overall Study|Adverse Event|1|||
130172066|NCT01449370|468586892|FG004|Overall Study|Adverse Event|0|||
130172067|NCT01449370|468586893|FG005|Overall Study|Adverse Event|0|||
130172068|NCT01449370|468586894|FG006|Overall Study|Adverse Event|0|||
130172069|NCT01449370|468586895|FG007|Overall Study|Adverse Event|0|||
130172070|NCT01449370|468586896|FG008|Overall Study|Adverse Event|1|||
130172071|NCT01449370|468586897|FG009|Overall Study|Adverse Event|1|||
130172072|NCT01449370|468586898|FG010|Overall Study|Adverse Event|0|||
130172073|NCT01449370|468586899|FG011|Overall Study|Adverse Event|0|||
129982289|NCT05870228|467898792|FG001|Overall Study|Withdrawal by Subject|0|||
130172074|NCT01449370|468586900|FG012|Overall Study|Adverse Event|0|||
130172075|NCT01449370|468586901|FG013|Overall Study|Adverse Event|2|||
130172076|NCT01449370|468586902|FG014|Overall Study|Adverse Event|0|||
130172077|NCT01449370|468586903|FG015|Overall Study|Adverse Event|1|||
129982290|NCT00488475|467898793|FG000|Overall Study|Other|1754|||
130172078|NCT01449370|468586904|FG016|Overall Study|Adverse Event|0|||
130172079|NCT01449370|468586905|FG017|Overall Study|Adverse Event|0|||
130172080|NCT01449370|468586906|FG018|Overall Study|Adverse Event|1|||
130172081|NCT01449370|468586907|FG019|Overall Study|Adverse Event|1|||
130172082|NCT01449370|468586908|FG020|Overall Study|Adverse Event|0|||
130172083|NCT01449370|468586909|FG021|Overall Study|Adverse Event|1|||
130172084|NCT01449370|468586910|FG022|Overall Study|Adverse Event|0|||
130172085|NCT01449370|468586911|FG023|Overall Study|Adverse Event|1|||
129982291|NCT00798590|467898812|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
130172086|NCT01449370|468586912|FG024|Overall Study|Adverse Event|3|||
130172087|NCT01449370|468586888|FG000|Overall Study|Participant Decision|0|||
130172088|NCT01449370|468586889|FG001|Overall Study|Participant Decision|0|||
130172089|NCT01449370|468586890|FG002|Overall Study|Participant Decision|0|||
130172090|NCT01449370|468586891|FG003|Overall Study|Participant Decision|0|||
130172091|NCT01449370|468586892|FG004|Overall Study|Participant Decision|0|||
130172092|NCT01449370|468586893|FG005|Overall Study|Participant Decision|0|||
130172093|NCT01449370|468586894|FG006|Overall Study|Participant Decision|0|||
130172094|NCT01449370|468586895|FG007|Overall Study|Participant Decision|1|||
130172095|NCT01449370|468586896|FG008|Overall Study|Participant Decision|1|||
130172096|NCT01449370|468586897|FG009|Overall Study|Participant Decision|0|||
130172097|NCT01449370|468586898|FG010|Overall Study|Participant Decision|0|||
130172098|NCT01449370|468586899|FG011|Overall Study|Participant Decision|0|||
130172099|NCT01449370|468586900|FG012|Overall Study|Participant Decision|1|||
130172100|NCT01449370|468586901|FG013|Overall Study|Participant Decision|1|||
130172101|NCT01449370|468586902|FG014|Overall Study|Participant Decision|0|||
130172102|NCT01449370|468586903|FG015|Overall Study|Participant Decision|1|||
130172103|NCT01449370|468586904|FG016|Overall Study|Participant Decision|3|||
130172104|NCT01449370|468586905|FG017|Overall Study|Participant Decision|0|||
130172105|NCT01449370|468586906|FG018|Overall Study|Participant Decision|1|||
130172106|NCT01449370|468586907|FG019|Overall Study|Participant Decision|0|||
130172107|NCT01449370|468586908|FG020|Overall Study|Participant Decision|0|||
130172108|NCT01449370|468586909|FG021|Overall Study|Participant Decision|1|||
130172109|NCT01449370|468586910|FG022|Overall Study|Participant Decision|0|||
130172110|NCT01449370|468586911|FG023|Overall Study|Participant Decision|0|||
130172111|NCT01449370|468586912|FG024|Overall Study|Participant Decision|1|||
130172112|NCT01449370|468586888|FG000|Overall Study|Lost to Follow-up|0|||
130172113|NCT01449370|468586889|FG001|Overall Study|Lost to Follow-up|0|||
130172114|NCT01449370|468586890|FG002|Overall Study|Lost to Follow-up|0|||
130172115|NCT01449370|468586891|FG003|Overall Study|Lost to Follow-up|0|||
130172116|NCT01449370|468586892|FG004|Overall Study|Lost to Follow-up|0|||
130172117|NCT01449370|468586893|FG005|Overall Study|Lost to Follow-up|0|||
130172118|NCT01449370|468586894|FG006|Overall Study|Lost to Follow-up|0|||
130172119|NCT01449370|468586895|FG007|Overall Study|Lost to Follow-up|0|||
130172120|NCT01449370|468586896|FG008|Overall Study|Lost to Follow-up|0|||
130172121|NCT01449370|468586897|FG009|Overall Study|Lost to Follow-up|0|||
130172122|NCT01449370|468586898|FG010|Overall Study|Lost to Follow-up|0|||
130172123|NCT01449370|468586899|FG011|Overall Study|Lost to Follow-up|0|||
130172124|NCT01449370|468586900|FG012|Overall Study|Lost to Follow-up|0|||
130172125|NCT01449370|468586901|FG013|Overall Study|Lost to Follow-up|0|||
130172126|NCT01449370|468586902|FG014|Overall Study|Lost to Follow-up|0|||
130172127|NCT01449370|468586903|FG015|Overall Study|Lost to Follow-up|0|||
130172128|NCT01449370|468586904|FG016|Overall Study|Lost to Follow-up|0|||
130172129|NCT01449370|468586905|FG017|Overall Study|Lost to Follow-up|0|||
130172130|NCT01449370|468586906|FG018|Overall Study|Lost to Follow-up|0|||
130172131|NCT01449370|468586907|FG019|Overall Study|Lost to Follow-up|0|||
130172132|NCT01449370|468586908|FG020|Overall Study|Lost to Follow-up|1|||
130172133|NCT01449370|468586909|FG021|Overall Study|Lost to Follow-up|0|||
130172134|NCT01449370|468586910|FG022|Overall Study|Lost to Follow-up|0|||
130172135|NCT01449370|468586911|FG023|Overall Study|Lost to Follow-up|0|||
130172136|NCT01449370|468586912|FG024|Overall Study|Lost to Follow-up|0|||
130172137|NCT01449370|468586888|FG000|Overall Study|Other|0|||
130172138|NCT01449370|468586889|FG001|Overall Study|Other|0|||
130172139|NCT01449370|468586890|FG002|Overall Study|Other|0|||
130172140|NCT01449370|468586891|FG003|Overall Study|Other|0|||
130172141|NCT01449370|468586892|FG004|Overall Study|Other|0|||
130172142|NCT01449370|468586893|FG005|Overall Study|Other|0|||
130172143|NCT01449370|468586894|FG006|Overall Study|Other|0|||
130172144|NCT01449370|468586895|FG007|Overall Study|Other|0|||
130172145|NCT01449370|468586896|FG008|Overall Study|Other|1|||
130172146|NCT01449370|468586897|FG009|Overall Study|Other|1|||
130172147|NCT01449370|468586898|FG010|Overall Study|Other|0|||
130172148|NCT01449370|468586899|FG011|Overall Study|Other|0|||
130172149|NCT01449370|468586900|FG012|Overall Study|Other|0|||
130172150|NCT01449370|468586901|FG013|Overall Study|Other|0|||
130172151|NCT01449370|468586902|FG014|Overall Study|Other|0|||
130172152|NCT01449370|468586903|FG015|Overall Study|Other|0|||
130172153|NCT01449370|468586904|FG016|Overall Study|Other|0|||
130172154|NCT01449370|468586905|FG017|Overall Study|Other|0|||
130172155|NCT01449370|468586906|FG018|Overall Study|Other|0|||
130172156|NCT01449370|468586907|FG019|Overall Study|Other|0|||
130172157|NCT01449370|468586908|FG020|Overall Study|Other|0|||
130172158|NCT01449370|468586909|FG021|Overall Study|Other|0|||
130172159|NCT01449370|468586910|FG022|Overall Study|Other|1|||
130172160|NCT01449370|468586911|FG023|Overall Study|Other|1|||
130172161|NCT01449370|468586912|FG024|Overall Study|Other|0|||
130172162|NCT01449370|468586888|FG000|Overall Study|Medication Prohibited by Protocol|0|||
130172163|NCT01449370|468586889|FG001|Overall Study|Medication Prohibited by Protocol|0|||
130172164|NCT01449370|468586890|FG002|Overall Study|Medication Prohibited by Protocol|0|||
130172165|NCT01449370|468586891|FG003|Overall Study|Medication Prohibited by Protocol|0|||
130172166|NCT01449370|468586892|FG004|Overall Study|Medication Prohibited by Protocol|0|||
130172167|NCT01449370|468586893|FG005|Overall Study|Medication Prohibited by Protocol|0|||
130172168|NCT01449370|468586894|FG006|Overall Study|Medication Prohibited by Protocol|0|||
130172169|NCT01449370|468586895|FG007|Overall Study|Medication Prohibited by Protocol|0|||
129982292|NCT00798590|467898813|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
129982293|NCT01769326|467898818|FG000|Overall Study|Lost to Follow-up|1|||
130172170|NCT01449370|468586896|FG008|Overall Study|Medication Prohibited by Protocol|0|||
130172171|NCT01449370|468586897|FG009|Overall Study|Medication Prohibited by Protocol|0|||
130172172|NCT01449370|468586898|FG010|Overall Study|Medication Prohibited by Protocol|0|||
130172173|NCT01449370|468586899|FG011|Overall Study|Medication Prohibited by Protocol|0|||
130172174|NCT01449370|468586900|FG012|Overall Study|Medication Prohibited by Protocol|0|||
130172175|NCT01449370|468586901|FG013|Overall Study|Medication Prohibited by Protocol|0|||
130172176|NCT01449370|468586902|FG014|Overall Study|Medication Prohibited by Protocol|0|||
130172177|NCT01449370|468586903|FG015|Overall Study|Medication Prohibited by Protocol|0|||
130172178|NCT01449370|468586904|FG016|Overall Study|Medication Prohibited by Protocol|0|||
130172179|NCT01449370|468586905|FG017|Overall Study|Medication Prohibited by Protocol|0|||
130172180|NCT01449370|468586906|FG018|Overall Study|Medication Prohibited by Protocol|0|||
130172181|NCT01449370|468586907|FG019|Overall Study|Medication Prohibited by Protocol|0|||
130172182|NCT01449370|468586908|FG020|Overall Study|Medication Prohibited by Protocol|0|||
130172183|NCT01449370|468586909|FG021|Overall Study|Medication Prohibited by Protocol|0|||
130172184|NCT01449370|468586910|FG022|Overall Study|Medication Prohibited by Protocol|0|||
130172185|NCT01449370|468586911|FG023|Overall Study|Medication Prohibited by Protocol|1|||
130172186|NCT01449370|468586912|FG024|Overall Study|Medication Prohibited by Protocol|0|||
130172187|NCT01449370|468586888|FG000|Overall Study|Death|0|||
130172188|NCT01449370|468586889|FG001|Overall Study|Death|0|||
130172189|NCT01449370|468586890|FG002|Overall Study|Death|0|||
130172190|NCT01449370|468586891|FG003|Overall Study|Death|0|||
130172191|NCT01449370|468586892|FG004|Overall Study|Death|0|||
130172192|NCT01449370|468586893|FG005|Overall Study|Death|0|||
130172193|NCT01449370|468586894|FG006|Overall Study|Death|0|||
130172194|NCT01449370|468586895|FG007|Overall Study|Death|0|||
130172195|NCT01449370|468586896|FG008|Overall Study|Death|0|||
130172196|NCT01449370|468586897|FG009|Overall Study|Death|0|||
130172197|NCT01449370|468586898|FG010|Overall Study|Death|0|||
130172198|NCT01449370|468586899|FG011|Overall Study|Death|0|||
130172199|NCT01449370|468586900|FG012|Overall Study|Death|0|||
130172200|NCT01449370|468586901|FG013|Overall Study|Death|0|||
130172201|NCT01449370|468586902|FG014|Overall Study|Death|0|||
130172202|NCT01449370|468586903|FG015|Overall Study|Death|0|||
130172203|NCT01449370|468586904|FG016|Overall Study|Death|0|||
130172204|NCT01449370|468586905|FG017|Overall Study|Death|0|||
130172205|NCT01449370|468586906|FG018|Overall Study|Death|0|||
130172206|NCT01449370|468586907|FG019|Overall Study|Death|0|||
130172207|NCT01449370|468586908|FG020|Overall Study|Death|0|||
130172208|NCT01449370|468586909|FG021|Overall Study|Death|0|||
130172209|NCT01449370|468586910|FG022|Overall Study|Death|0|||
130172210|NCT01449370|468586911|FG023|Overall Study|Death|0|||
130172211|NCT01449370|468586912|FG024|Overall Study|Death|1|||
130172212|NCT02290223|468586913|FG000|6 Months|Lost to Follow-up|9|||
130172213|NCT02290223|468586914|FG001|6 Months|Lost to Follow-up|6|||
130172214|NCT02290223|468586913|FG000|6 Months|Withdrawal by Subject|5|||
130172215|NCT02290223|468586914|FG001|6 Months|Withdrawal by Subject|0|||
130172216|NCT02290223|468586913|FG000|6 Months|deceased (not related to study)|2|||
130172217|NCT02290223|468586914|FG001|6 Months|deceased (not related to study)|0|||
130172218|NCT02290223|468586913|FG000|12 Months|Lost to Follow-up|16|||
130172219|NCT02290223|468586914|FG001|12 Months|Lost to Follow-up|10|||
130172220|NCT02290223|468586913|FG000|12 Months|Refusal|0|||
130172221|NCT02290223|468586914|FG001|12 Months|Refusal|1|||
130172222|NCT00534404|468586915|FG000|Overall Study|Death|0|||
130172223|NCT00534404|468586916|FG001|Overall Study|Death|0|||
130172224|NCT00534404|468586917|FG002|Overall Study|Death|2|||
130172225|NCT00534404|468586915|FG000|Overall Study|Withdrawal by Subject|8|||
130172226|NCT00534404|468586916|FG001|Overall Study|Withdrawal by Subject|2|||
130172227|NCT00534404|468586917|FG002|Overall Study|Withdrawal by Subject|38|||
130172228|NCT00534404|468586915|FG000|Overall Study|Removed by study staff|2|||
130172229|NCT00534404|468586916|FG001|Overall Study|Removed by study staff|3|||
130172230|NCT00534404|468586917|FG002|Overall Study|Removed by study staff|1|||
130172231|NCT00534404|468586915|FG000|Overall Study|Lost to Follow-up|170|||
130172232|NCT00534404|468586916|FG001|Overall Study|Lost to Follow-up|138|||
130172233|NCT00534404|468586917|FG002|Overall Study|Lost to Follow-up|201|||
130172234|NCT03371459|468586922|FG000|Washout|Lost to Follow-up|0|||
129982294|NCT01769326|467898819|FG001|Overall Study|Lost to Follow-up|2|||
130172235|NCT03371459|468586923|FG001|Washout|Lost to Follow-up|1|||
130172236|NCT00315731|468586925|FG000|Overall Study|Lost to Follow-up|1|||
130172237|NCT00315731|468586925|FG000|Overall Study|Death|5|||
130172238|NCT02185053|468586926|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
130172239|NCT02185053|468586927|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
130172240|NCT02185053|468586928|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
130172241|NCT02185053|468586926|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
130172242|NCT02185053|468586927|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130172243|NCT02185053|468586928|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130172244|NCT02185053|468586926|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
129982295|NCT01769326|467898820|FG002|Overall Study|Lost to Follow-up|0|||
129982296|NCT01769326|467898821|FG003|Overall Study|Lost to Follow-up|0|||
129982297|NCT01769326|467898818|FG000|Overall Study|unrelated injry|1|||
129982298|NCT01769326|467898819|FG001|Overall Study|unrelated injry|1|||
129982299|NCT01769326|467898820|FG002|Overall Study|unrelated injry|0|||
129982300|NCT01769326|467898821|FG003|Overall Study|unrelated injry|0|||
130172245|NCT02185053|468586927|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
130172246|NCT02185053|468586928|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
130172247|NCT02185053|468586926|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
130172248|NCT02185053|468586927|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
130172249|NCT02185053|468586928|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
130172250|NCT02185053|468586926|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130172251|NCT02185053|468586927|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
130172252|NCT02185053|468586928|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
130172253|NCT02185053|468586926|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
130172254|NCT02185053|468586927|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
130172255|NCT02185053|468586928|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
130172256|NCT02185053|468586926|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
130172257|NCT02185053|468586927|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
130172258|NCT02185053|468586928|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
130172259|NCT02185053|468586926|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
130172260|NCT02185053|468586927|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
130172261|NCT02185053|468586928|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
130172262|NCT03597464|468586931|FG000|Overall Study|Withdrawal by Subject|4|||
130172263|NCT03597464|468586932|FG001|Overall Study|Withdrawal by Subject|5|||
130172264|NCT03597464|468586931|FG000|Overall Study|Lost to Follow-up|3|||
130172265|NCT03597464|468586932|FG001|Overall Study|Lost to Follow-up|1|||
130172266|NCT03597464|468586931|FG000|Overall Study|Pregnancy|3|||
130172267|NCT03597464|468586932|FG001|Overall Study|Pregnancy|1|||
130172268|NCT03597464|468586931|FG000|Overall Study|Lack of Efficacy|2|||
130172269|NCT03597464|468586932|FG001|Overall Study|Lack of Efficacy|0|||
130172270|NCT03597464|468586931|FG000|Overall Study|Physician Decision|2|||
130172271|NCT03597464|468586932|FG001|Overall Study|Physician Decision|2|||
130172272|NCT03597464|468586931|FG000|Overall Study|Protocol Violation|1|||
130172273|NCT03597464|468586932|FG001|Overall Study|Protocol Violation|1|||
130172274|NCT03597464|468586931|FG000|Overall Study|Adverse Event|0|||
130172275|NCT03597464|468586932|FG001|Overall Study|Adverse Event|2|||
130172276|NCT03597464|468586931|FG000|Overall Study|Death|0|||
130172277|NCT03597464|468586932|FG001|Overall Study|Death|3|||
130172278|NCT02542605|468586935|FG000|Part B: Challenge Phase|Sponsor decision|1|||
130172279|NCT02542605|468586936|FG001|Part B: Challenge Phase|Sponsor decision|0|||
130172280|NCT02542605|468586937|FG002|Part B: Challenge Phase|Sponsor decision|0|||
130172281|NCT02542605|468586935|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
130172282|NCT02542605|468586936|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
130172283|NCT02542605|468586937|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
130172284|NCT02682927|468586938|FG000|Overall Study|Adverse Event|0|||
130172285|NCT02682927|468586939|FG001|Overall Study|Adverse Event|0|||
130172286|NCT02682927|468586940|FG002|Overall Study|Adverse Event|5|||
130172287|NCT02682927|468586941|FG003|Overall Study|Adverse Event|1|||
130172288|NCT02682927|468586942|FG004|Overall Study|Adverse Event|0|||
130172289|NCT02682927|468586943|FG005|Overall Study|Adverse Event|2|||
130172290|NCT02682927|468586938|FG000|Overall Study|Death|0|||
130172291|NCT02682927|468586939|FG001|Overall Study|Death|0|||
130172292|NCT02682927|468586940|FG002|Overall Study|Death|0|||
130172293|NCT02682927|468586941|FG003|Overall Study|Death|1|||
130172294|NCT02682927|468586942|FG004|Overall Study|Death|0|||
130172295|NCT02682927|468586943|FG005|Overall Study|Death|0|||
130172296|NCT02682927|468586938|FG000|Overall Study|Lack of Efficacy|1|||
130172297|NCT02682927|468586939|FG001|Overall Study|Lack of Efficacy|0|||
130172298|NCT02682927|468586940|FG002|Overall Study|Lack of Efficacy|0|||
130172299|NCT02682927|468586941|FG003|Overall Study|Lack of Efficacy|1|||
130172300|NCT02682927|468586942|FG004|Overall Study|Lack of Efficacy|0|||
130172301|NCT02682927|468586943|FG005|Overall Study|Lack of Efficacy|0|||
130172302|NCT02682927|468586938|FG000|Overall Study|Other|0|||
130172303|NCT02682927|468586939|FG001|Overall Study|Other|0|||
130172304|NCT02682927|468586940|FG002|Overall Study|Other|0|||
130172305|NCT02682927|468586941|FG003|Overall Study|Other|2|||
130172306|NCT02682927|468586942|FG004|Overall Study|Other|0|||
130172307|NCT02682927|468586943|FG005|Overall Study|Other|0|||
130172308|NCT02682927|468586938|FG000|Overall Study|Withdrawal by Subject|2|||
130172309|NCT02682927|468586939|FG001|Overall Study|Withdrawal by Subject|0|||
130172310|NCT02682927|468586940|FG002|Overall Study|Withdrawal by Subject|1|||
129982301|NCT01769326|467898818|FG000|Overall Study|got a job|0|||
130172311|NCT02682927|468586941|FG003|Overall Study|Withdrawal by Subject|0|||
130172312|NCT02682927|468586942|FG004|Overall Study|Withdrawal by Subject|1|||
130172313|NCT02682927|468586943|FG005|Overall Study|Withdrawal by Subject|1|||
129982302|NCT01769326|467898819|FG001|Overall Study|got a job|1|||
130172314|NCT05314816|468586945|FG000|Overall Study|Lost to Follow-up|5|||
130172315|NCT05314816|468586946|FG001|Overall Study|Lost to Follow-up|0|||
130172316|NCT05314816|468586947|FG002|Overall Study|Lost to Follow-up|1|||
130172317|NCT05314816|468586945|FG000|Overall Study|Protocol Violation|13|||
130172318|NCT05314816|468586946|FG001|Overall Study|Protocol Violation|8|||
130172319|NCT05314816|468586947|FG002|Overall Study|Protocol Violation|0|||
130172320|NCT01810302|468588851|FG000|Overall Study|Death|1|||
130172321|NCT01810302|468588852|FG001|Overall Study|Death|0|||
130172322|NCT01810302|468588851|FG000|Overall Study|Physician Decision|0|||
130172323|NCT01810302|468588852|FG001|Overall Study|Physician Decision|1|||
130172324|NCT04981717|468588856|FG000|Overall Study|Protocol Violation|0|||
130172325|NCT04981717|468588857|FG001|Overall Study|Protocol Violation|3|||
130172326|NCT04981717|468588856|FG000|Overall Study|Adverse Event|1|||
130172327|NCT04981717|468588857|FG001|Overall Study|Adverse Event|3|||
130172328|NCT04981717|468588856|FG000|Overall Study|Pregnancy|1|||
130172329|NCT04981717|468588857|FG001|Overall Study|Pregnancy|0|||
130172330|NCT04981717|468588856|FG000|Overall Study|Physician Decision|1|||
130172331|NCT04981717|468588857|FG001|Overall Study|Physician Decision|0|||
130172332|NCT04981717|468588856|FG000|Overall Study|Sponsor Request|157|||
130172333|NCT04981717|468588857|FG001|Overall Study|Sponsor Request|172|||
130172334|NCT04981717|468588856|FG000|Overall Study|Lost to Follow-up|4|||
130172335|NCT04981717|468588857|FG001|Overall Study|Lost to Follow-up|5|||
130172336|NCT04981717|468588856|FG000|Overall Study|Withdrawal by Subject|50|||
130172337|NCT04981717|468588857|FG001|Overall Study|Withdrawal by Subject|37|||
130172338|NCT02207634|468588858|FG000|Overall Study|Withdrawal by Subject|21|||
130172339|NCT02207634|468588859|FG001|Overall Study|Withdrawal by Subject|31|||
130172340|NCT02207634|468588858|FG000|Overall Study|Lost to Follow-up|1|||
130172341|NCT02207634|468588859|FG001|Overall Study|Lost to Follow-up|0|||
130172342|NCT00887289|468588860|FG000|Overall Study|Lack of Efficacy|14|||
130172343|NCT00887289|468588860|FG000|Overall Study|Adverse Event|27|||
130172344|NCT00887289|468588860|FG000|Overall Study|Withdrawal by Subject|26|||
130172345|NCT00887289|468588860|FG000|Overall Study|Lost to Follow-up|8|||
130172346|NCT00887289|468588860|FG000|Overall Study|Other|20|||
130172347|NCT00591773|468588861|FG000|Overall Study|Adverse Event|9|||
130172348|NCT00591773|468588862|FG001|Overall Study|Adverse Event|9|||
130172349|NCT00591773|468588863|FG002|Overall Study|Adverse Event|6|||
130172350|NCT00591773|468588861|FG000|Overall Study|Protocol Violation|2|||
130172351|NCT00591773|468588862|FG001|Overall Study|Protocol Violation|3|||
130172352|NCT00591773|468588863|FG002|Overall Study|Protocol Violation|0|||
130172353|NCT00591773|468588861|FG000|Overall Study|Lost to Follow-up|1|||
130172354|NCT00591773|468588862|FG001|Overall Study|Lost to Follow-up|4|||
130172355|NCT00591773|468588863|FG002|Overall Study|Lost to Follow-up|1|||
130172356|NCT00591773|468588861|FG000|Overall Study|Withdrawal by Subject|2|||
130172357|NCT00591773|468588862|FG001|Overall Study|Withdrawal by Subject|5|||
130172358|NCT00591773|468588863|FG002|Overall Study|Withdrawal by Subject|3|||
130172359|NCT00591773|468588861|FG000|Overall Study|Lack of Efficacy|1|||
130172360|NCT00591773|468588862|FG001|Overall Study|Lack of Efficacy|2|||
130172361|NCT00591773|468588863|FG002|Overall Study|Lack of Efficacy|2|||
130172362|NCT00591773|468588861|FG000|Overall Study|Other|1|||
130172363|NCT00591773|468588862|FG001|Overall Study|Other|1|||
130172364|NCT00591773|468588863|FG002|Overall Study|Other|4|||
130172365|NCT01371539|468588864|FG000|Period One: One Week|Lost to Follow-up|0|||
130172366|NCT01371539|468588865|FG001|Period One: One Week|Lost to Follow-up|1|||
130172367|NCT01371539|468588864|FG000|Period Two: One Week|Lost to Follow-up|0|||
130172368|NCT01371539|468588865|FG001|Period Two: One Week|Lost to Follow-up|1|||
130172369|NCT01371539|468588864|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
130172370|NCT01371539|468588865|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
130172371|NCT01371539|468588864|FG000|Period Two: One Week|Time/job conflict|0|||
130172372|NCT01371539|468588865|FG001|Period Two: One Week|Time/job conflict|1|||
130172373|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
130172374|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
130172375|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
130172376|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130172377|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
130172378|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
130172379|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130172380|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
130172381|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130172382|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
130172383|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130172384|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130172385|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
130172386|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130172387|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
130172388|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
130172389|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130172390|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
130172391|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130172392|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
130172393|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130172394|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130172395|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
130172396|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130172397|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
130172398|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130172399|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130172400|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
130172401|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130172402|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
130172403|NCT03713632|468588866|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
130172404|NCT03713632|468588867|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130172405|NCT03713632|468588868|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130172406|NCT03713632|468588869|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130172407|NCT03713632|468588870|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
130172408|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
130172409|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
130172410|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
130172411|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
130172412|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
130172413|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
130172414|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
130172415|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
130172416|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
130172417|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
130172418|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
130172419|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
130172420|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
130172421|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
130172422|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
130172423|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
130172424|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
130172425|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130172426|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
130172427|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
130172428|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
130172429|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130172430|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130172431|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
130172432|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
130172433|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
130172434|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130172435|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130172436|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130172437|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
130172438|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Death|0|||
130172439|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Death|1|||
130172440|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Death|0|||
130172441|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Death|0|||
130172442|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Death|0|||
130172443|NCT03713632|468588866|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130172444|NCT03713632|468588867|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
130172445|NCT03713632|468588868|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129982303|NCT01769326|467898820|FG002|Overall Study|got a job|0|||
130172446|NCT03713632|468588869|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130172447|NCT03713632|468588870|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
130172448|NCT01098474|468588871|FG000|Active Phase|Other|0|||
129982304|NCT01769326|467898821|FG003|Overall Study|got a job|0|||
129982305|NCT01769326|467898818|FG000|Overall Study|Got sick and could not complete study|0|||
129982306|NCT01769326|467898819|FG001|Overall Study|Got sick and could not complete study|0|||
129982307|NCT01769326|467898820|FG002|Overall Study|Got sick and could not complete study|1|||
129982308|NCT01769326|467898821|FG003|Overall Study|Got sick and could not complete study|0|||
129982309|NCT01278173|467898822|FG000|Overall Study|Lack of Efficacy|13|||
129982310|NCT01278173|467898822|FG000|Overall Study|Adverse Event|8|||
129982311|NCT01278173|467898822|FG000|Overall Study|Administrative or other reason|4|||
130172449|NCT01098474|468588872|FG001|Active Phase|Other|0|||
130172450|NCT01098474|468588873|FG002|Active Phase|Other|3|||
130172451|NCT01098474|468588874|FG003|Active Phase|Other|0|||
130172452|NCT01098474|468588875|FG004|Active Phase|Other|0|||
130172453|NCT01098474|468588876|FG005|Active Phase|Other|0|||
130172454|NCT01098474|468588871|FG000|Active Phase|Withdrawal by Subject|1|||
130172455|NCT01098474|468588872|FG001|Active Phase|Withdrawal by Subject|1|||
130172456|NCT01098474|468588873|FG002|Active Phase|Withdrawal by Subject|2|||
130172457|NCT01098474|468588874|FG003|Active Phase|Withdrawal by Subject|0|||
130172458|NCT01098474|468588875|FG004|Active Phase|Withdrawal by Subject|0|||
130172459|NCT01098474|468588876|FG005|Active Phase|Withdrawal by Subject|0|||
130172460|NCT01098474|468588871|FG000|Active Phase|Lost to Follow-up|1|||
130172461|NCT01098474|468588872|FG001|Active Phase|Lost to Follow-up|0|||
130172462|NCT01098474|468588873|FG002|Active Phase|Lost to Follow-up|0|||
130172463|NCT01098474|468588874|FG003|Active Phase|Lost to Follow-up|0|||
130172464|NCT01098474|468588875|FG004|Active Phase|Lost to Follow-up|0|||
130172465|NCT01098474|468588876|FG005|Active Phase|Lost to Follow-up|0|||
130172466|NCT01098474|468588871|FG000|Follow Up Phase|Travelled out of study area|0|||
130172467|NCT01098474|468588872|FG001|Follow Up Phase|Travelled out of study area|0|||
130172468|NCT01098474|468588873|FG002|Follow Up Phase|Travelled out of study area|0|||
130172469|NCT01098474|468588874|FG003|Follow Up Phase|Travelled out of study area|0|||
130172470|NCT01098474|468588875|FG004|Follow Up Phase|Travelled out of study area|1|||
130172471|NCT01098474|468588876|FG005|Follow Up Phase|Travelled out of study area|0|||
130172472|NCT01098474|468588871|FG000|Follow Up Phase|Other|0|||
130172473|NCT01098474|468588872|FG001|Follow Up Phase|Other|0|||
130172474|NCT01098474|468588873|FG002|Follow Up Phase|Other|0|||
130172475|NCT01098474|468588874|FG003|Follow Up Phase|Other|0|||
130172476|NCT01098474|468588875|FG004|Follow Up Phase|Other|0|||
130172477|NCT01098474|468588876|FG005|Follow Up Phase|Other|4|||
130172478|NCT01098474|468588871|FG000|Follow Up Phase|Withdrawal by Subject|0|||
130172479|NCT01098474|468588872|FG001|Follow Up Phase|Withdrawal by Subject|0|||
130172480|NCT01098474|468588873|FG002|Follow Up Phase|Withdrawal by Subject|0|||
130172481|NCT01098474|468588874|FG003|Follow Up Phase|Withdrawal by Subject|2|||
130172482|NCT01098474|468588875|FG004|Follow Up Phase|Withdrawal by Subject|0|||
130172483|NCT01098474|468588876|FG005|Follow Up Phase|Withdrawal by Subject|1|||
130172484|NCT01098474|468588871|FG000|Follow Up Phase|Lost to Follow-up|0|||
130172485|NCT01098474|468588872|FG001|Follow Up Phase|Lost to Follow-up|0|||
130172486|NCT01098474|468588873|FG002|Follow Up Phase|Lost to Follow-up|0|||
130172487|NCT01098474|468588874|FG003|Follow Up Phase|Lost to Follow-up|0|||
130172488|NCT01098474|468588875|FG004|Follow Up Phase|Lost to Follow-up|1|||
130172489|NCT01098474|468588876|FG005|Follow Up Phase|Lost to Follow-up|0|||
130172490|NCT02165735|468588879|FG000|Overall Study|Lost to Follow-up|12|||
130172491|NCT02165735|468588880|FG001|Overall Study|Lost to Follow-up|10|||
130172492|NCT02165735|468588879|FG000|Overall Study|Withdrawal by Subject|3|||
130172493|NCT02165735|468588880|FG001|Overall Study|Withdrawal by Subject|0|||
130172494|NCT02165735|468588879|FG000|Overall Study|Participant indicated lack of time|1|||
130172495|NCT02165735|468588880|FG001|Overall Study|Participant indicated lack of time|3|||
130172496|NCT02165735|468588879|FG000|Overall Study|Protocol Violation|0|||
130172497|NCT02165735|468588880|FG001|Overall Study|Protocol Violation|1|||
130172498|NCT02784795|468588881|FG000|Overall Study|Progressive Disease|2|||
130172499|NCT02784795|468588882|FG001|Overall Study|Progressive Disease|1|||
130172500|NCT02784795|468588883|FG002|Overall Study|Progressive Disease|1|||
130172501|NCT02784795|468588884|FG003|Overall Study|Progressive Disease|0|||
130172502|NCT02784795|468588885|FG004|Overall Study|Progressive Disease|2|||
130172503|NCT02784795|468588886|FG005|Overall Study|Progressive Disease|0|||
130172504|NCT02784795|468588887|FG006|Overall Study|Progressive Disease|2|||
130172505|NCT02784795|468588888|FG007|Overall Study|Progressive Disease|0|||
130172506|NCT02784795|468588889|FG008|Overall Study|Progressive Disease|0|||
130172507|NCT02784795|468588890|FG009|Overall Study|Progressive Disease|0|||
130172508|NCT02784795|468588891|FG010|Overall Study|Progressive Disease|1|||
130172509|NCT02784795|468588892|FG011|Overall Study|Progressive Disease|0|||
130172510|NCT02784795|468588881|FG000|Overall Study|Adverse Event|1|||
130172511|NCT02784795|468588882|FG001|Overall Study|Adverse Event|0|||
130172512|NCT02784795|468588883|FG002|Overall Study|Adverse Event|0|||
130172513|NCT02784795|468588884|FG003|Overall Study|Adverse Event|1|||
130172514|NCT02784795|468588885|FG004|Overall Study|Adverse Event|0|||
130172515|NCT02784795|468588886|FG005|Overall Study|Adverse Event|0|||
130172516|NCT02784795|468588887|FG006|Overall Study|Adverse Event|1|||
130172517|NCT02784795|468588888|FG007|Overall Study|Adverse Event|0|||
130172518|NCT02784795|468588889|FG008|Overall Study|Adverse Event|0|||
130172519|NCT02784795|468588890|FG009|Overall Study|Adverse Event|0|||
130172520|NCT02784795|468588891|FG010|Overall Study|Adverse Event|0|||
130172521|NCT02784795|468588892|FG011|Overall Study|Adverse Event|2|||
130172522|NCT02784795|468588881|FG000|Overall Study|Withdrawal by Subject|1|||
130172523|NCT02784795|468588882|FG001|Overall Study|Withdrawal by Subject|0|||
130172524|NCT02784795|468588883|FG002|Overall Study|Withdrawal by Subject|2|||
130172525|NCT02784795|468588884|FG003|Overall Study|Withdrawal by Subject|1|||
130172526|NCT02784795|468588885|FG004|Overall Study|Withdrawal by Subject|3|||
130172527|NCT02784795|468588886|FG005|Overall Study|Withdrawal by Subject|0|||
130172528|NCT02784795|468588887|FG006|Overall Study|Withdrawal by Subject|0|||
130172529|NCT02784795|468588888|FG007|Overall Study|Withdrawal by Subject|1|||
130172530|NCT02784795|468588889|FG008|Overall Study|Withdrawal by Subject|0|||
130172531|NCT02784795|468588890|FG009|Overall Study|Withdrawal by Subject|0|||
130172532|NCT02784795|468588891|FG010|Overall Study|Withdrawal by Subject|0|||
130172533|NCT02784795|468588892|FG011|Overall Study|Withdrawal by Subject|2|||
130172534|NCT02784795|468588881|FG000|Overall Study|Death|0|||
130172535|NCT02784795|468588882|FG001|Overall Study|Death|0|||
130172536|NCT02784795|468588883|FG002|Overall Study|Death|0|||
130172537|NCT02784795|468588884|FG003|Overall Study|Death|0|||
130172538|NCT02784795|468588885|FG004|Overall Study|Death|1|||
130172539|NCT02784795|468588886|FG005|Overall Study|Death|0|||
130172540|NCT02784795|468588887|FG006|Overall Study|Death|0|||
130172541|NCT02784795|468588888|FG007|Overall Study|Death|0|||
130172542|NCT02784795|468588889|FG008|Overall Study|Death|0|||
130172543|NCT02784795|468588890|FG009|Overall Study|Death|0|||
130172544|NCT02784795|468588891|FG010|Overall Study|Death|0|||
130172545|NCT02784795|468588892|FG011|Overall Study|Death|0|||
130172546|NCT02784795|468588881|FG000|Overall Study|Physician Decision|0|||
130172547|NCT02784795|468588882|FG001|Overall Study|Physician Decision|0|||
130172548|NCT02784795|468588883|FG002|Overall Study|Physician Decision|0|||
130172549|NCT02784795|468588884|FG003|Overall Study|Physician Decision|0|||
130172550|NCT02784795|468588885|FG004|Overall Study|Physician Decision|0|||
130172551|NCT02784795|468588886|FG005|Overall Study|Physician Decision|0|||
130172552|NCT02784795|468588887|FG006|Overall Study|Physician Decision|1|||
130172553|NCT02784795|468588888|FG007|Overall Study|Physician Decision|0|||
130172554|NCT02784795|468588889|FG008|Overall Study|Physician Decision|0|||
130172555|NCT02784795|468588890|FG009|Overall Study|Physician Decision|0|||
130172556|NCT02784795|468588891|FG010|Overall Study|Physician Decision|0|||
130172557|NCT02784795|468588892|FG011|Overall Study|Physician Decision|0|||
130172558|NCT00626561|468588893|FG000|Overall Study|Withdrawal by Subject|2|||
130172559|NCT00626561|468588893|FG000|Overall Study|Disease Progression|2|||
130172560|NCT00101283|468588896|FG000|Overall Study|Withdrawal by Subject|0|||
130172561|NCT00101283|468588897|FG001|Overall Study|Withdrawal by Subject|1|||
130172562|NCT00101283|468588896|FG000|Overall Study|Insurance Refusal|0|||
130172563|NCT00101283|468588897|FG001|Overall Study|Insurance Refusal|1|||
130172564|NCT00101283|468588896|FG000|Overall Study|Prostate Cancer Recurrence|0|||
130172565|NCT00101283|468588897|FG001|Overall Study|Prostate Cancer Recurrence|1|||
130172566|NCT00595309|468588898|FG000|Overall Study|Lost to Follow-up|1|||
130172567|NCT00595309|468588898|FG000|Overall Study|planned vaccination against yellow fever|1|||
130172568|NCT00595309|468588898|FG000|Overall Study|acute infection after V0|1|||
130172569|NCT00595309|468588898|FG000|Overall Study|personal reason|1|||
130172570|NCT00398866|468588905|FG000|Overall Study|Adverse Event|1|||
130172571|NCT00398866|468588906|FG001|Overall Study|Adverse Event|0|||
130172572|NCT00398866|468588907|FG002|Overall Study|Adverse Event|0|||
130172573|NCT00398866|468588905|FG000|Overall Study|Lack of Efficacy|0|||
130172574|NCT00398866|468588906|FG001|Overall Study|Lack of Efficacy|0|||
130172575|NCT00398866|468588907|FG002|Overall Study|Lack of Efficacy|1|||
130172576|NCT00398866|468588905|FG000|Overall Study|Lost to Follow-up|7|||
130172577|NCT00398866|468588906|FG001|Overall Study|Lost to Follow-up|6|||
130172578|NCT00398866|468588907|FG002|Overall Study|Lost to Follow-up|4|||
130172579|NCT00398866|468588905|FG000|Overall Study|Withdrawal by Subject|5|||
130172580|NCT00398866|468588906|FG001|Overall Study|Withdrawal by Subject|1|||
130172581|NCT00398866|468588907|FG002|Overall Study|Withdrawal by Subject|2|||
130172582|NCT00398866|468588905|FG000|Overall Study|Unable to complete requirements of study|1|||
130172583|NCT00398866|468588906|FG001|Overall Study|Unable to complete requirements of study|1|||
130172584|NCT00398866|468588907|FG002|Overall Study|Unable to complete requirements of study|1|||
130172585|NCT00442962|468588911|FG000|Overall Study|Pregnancy|1|||
130172586|NCT00442962|468588911|FG000|Overall Study|Lost to Follow-up|7|||
130172587|NCT03633825|468588912|FG000|Enrollment|Did not post on network|5066|||
130172588|NCT03633825|468588913|FG001|Enrollment|Did not post on network|5080|||
130172589|NCT03633825|468588912|FG000|Enrollment|Post not classified as crisis|13967|||
130172590|NCT03633825|468588913|FG001|Enrollment|Post not classified as crisis|13757|||
130172591|NCT03633825|468588912|FG000|Follow up|Lost to Follow-up|478|||
130172592|NCT03633825|468588913|FG001|Follow up|Lost to Follow-up|450|||
130172593|NCT04841577|468588915|FG000|Overall Study|Adverse Event|5|||
130172594|NCT04841577|468588916|FG001|Overall Study|Adverse Event|10|||
130172595|NCT04841577|468588915|FG000|Overall Study|Lost to Follow-up|8|||
130172596|NCT04841577|468588916|FG001|Overall Study|Lost to Follow-up|7|||
130172597|NCT04841577|468588915|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130172598|NCT04841577|468588916|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
130172599|NCT04841577|468588915|FG000|Overall Study|Other|0|||
130172600|NCT04841577|468588916|FG001|Overall Study|Other|1|||
130172601|NCT00182325|468588917|FG000|Overall Study|Lost to Follow-up|7|||
130172602|NCT00182325|468588918|FG001|Overall Study|Lost to Follow-up|7|||
130172603|NCT00182325|468588917|FG000|Overall Study|Miscarriage|5|||
130172604|NCT00182325|468588918|FG001|Overall Study|Miscarriage|3|||
130172605|NCT00182325|468588917|FG000|Overall Study|Did not complete survey|22|||
130172606|NCT00182325|468588918|FG001|Overall Study|Did not complete survey|43|||
130172607|NCT01420965|468588923|FG000|Overall Study|Withdrawal by Subject|1|||
130172608|NCT01420965|468588924|FG001|Overall Study|Withdrawal by Subject|0|||
130172609|NCT01420965|468588925|FG002|Overall Study|Withdrawal by Subject|0|||
130172610|NCT01420965|468588923|FG000|Overall Study|Adverse Event|0|||
130172611|NCT01420965|468588924|FG001|Overall Study|Adverse Event|1|||
130172612|NCT01420965|468588925|FG002|Overall Study|Adverse Event|0|||
130172613|NCT00339144|468588930|FG000|Overall Study|Disease progression|5|||
130172614|NCT00339144|468588931|FG001|Overall Study|Disease progression|2|||
130172615|NCT00339144|468588932|FG002|Overall Study|Disease progression|2|||
130172616|NCT00339144|468588930|FG000|Overall Study|Study drug toxicity|3|||
130172617|NCT00339144|468588931|FG001|Overall Study|Study drug toxicity|1|||
130172618|NCT00339144|468588932|FG002|Overall Study|Study drug toxicity|1|||
130172619|NCT00339144|468588930|FG000|Overall Study|Participant's request to discontinuation|1|||
130172620|NCT00339144|468588931|FG001|Overall Study|Participant's request to discontinuation|0|||
130172621|NCT00339144|468588932|FG002|Overall Study|Participant's request to discontinuation|1|||
130172622|NCT01890434|468588933|FG000|Overall Study|Adverse Event|8|||
130172623|NCT01890434|468588933|FG000|Overall Study|PCI at external hospital|1|||
130172624|NCT01890434|468588933|FG000|Overall Study|Assessment discrepancy|1|||
130172625|NCT01890434|468588933|FG000|Overall Study|CRC didn't contact participant for FU|1|||
130172626|NCT01890434|468588933|FG000|Overall Study|Could not get whole set of images|1|||
130172627|NCT01890434|468588933|FG000|Overall Study|Decline to return for GSPECT|1|||
130172628|NCT01890434|468588933|FG000|Overall Study|GSPECT at rest was not done|1|||
130172629|NCT01890434|468588933|FG000|Overall Study|Participant didn't complete MRI|1|||
130172630|NCT01890434|468588933|FG000|Overall Study|Uncontactable by phone|1|||
130172631|NCT01890434|468588933|FG000|Overall Study|Moved out of position|1|||
130172632|NCT01890434|468588933|FG000|Overall Study|Unable to contact|1|||
130172633|NCT01890434|468588933|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
130172634|NCT01141205|468588934|FG000|Overall Study|Physician Decision|1|||
130172635|NCT01141205|468588935|FG001|Overall Study|Physician Decision|1|||
130172636|NCT01141205|468588934|FG000|Overall Study|Lost to Follow-up|1|||
130172637|NCT01141205|468588935|FG001|Overall Study|Lost to Follow-up|0|||
130172638|NCT01141205|468588934|FG000|Overall Study|Withdrawal by Subject|1|||
130172639|NCT01141205|468588935|FG001|Overall Study|Withdrawal by Subject|1|||
130172640|NCT02257385|468588937|FG000|Overall Study|Adverse Event|12|||
130172641|NCT02257385|468588938|FG001|Overall Study|Adverse Event|8|||
130172642|NCT02257385|468588937|FG000|Overall Study|Lack of Efficacy|1|||
130172643|NCT02257385|468588938|FG001|Overall Study|Lack of Efficacy|2|||
130172644|NCT02257385|468588937|FG000|Overall Study|Protocol Violation|5|||
130172645|NCT02257385|468588938|FG001|Overall Study|Protocol Violation|7|||
130172646|NCT02257385|468588937|FG000|Overall Study|Lost to Follow-up|0|||
130172647|NCT02257385|468588938|FG001|Overall Study|Lost to Follow-up|1|||
130172648|NCT02257385|468588937|FG000|Overall Study|Withdrawal by Subject|4|||
130172649|NCT02257385|468588938|FG001|Overall Study|Withdrawal by Subject|4|||
130172650|NCT05199090|468588939|FG000|Overall Study|Adverse Event|1|||
130172651|NCT05199090|468588940|FG001|Overall Study|Adverse Event|4|||
130172652|NCT05199090|468588941|FG002|Overall Study|Adverse Event|0|||
130172653|NCT05199090|468588942|FG003|Overall Study|Adverse Event|0|||
130172654|NCT05199090|468588943|FG004|Overall Study|Adverse Event|0|||
130172655|NCT05199090|468588944|FG005|Overall Study|Adverse Event|0|||
130172656|NCT05199090|468588939|FG000|Overall Study|Lost to Follow-up|1|||
130172657|NCT05199090|468588940|FG001|Overall Study|Lost to Follow-up|0|||
130172658|NCT05199090|468588941|FG002|Overall Study|Lost to Follow-up|1|||
130172659|NCT05199090|468588942|FG003|Overall Study|Lost to Follow-up|4|||
130172660|NCT05199090|468588943|FG004|Overall Study|Lost to Follow-up|0|||
130172661|NCT05199090|468588944|FG005|Overall Study|Lost to Follow-up|5|||
130172662|NCT05199090|468588939|FG000|Overall Study|Physician Decision|0|||
130172663|NCT05199090|468588940|FG001|Overall Study|Physician Decision|0|||
130172664|NCT05199090|468588941|FG002|Overall Study|Physician Decision|0|||
130172665|NCT05199090|468588942|FG003|Overall Study|Physician Decision|0|||
130172666|NCT05199090|468588943|FG004|Overall Study|Physician Decision|0|||
130172667|NCT05199090|468588944|FG005|Overall Study|Physician Decision|1|||
130172668|NCT05199090|468588939|FG000|Overall Study|Study terminated by sponsor|0|||
130172669|NCT05199090|468588940|FG001|Overall Study|Study terminated by sponsor|6|||
130172670|NCT05199090|468588941|FG002|Overall Study|Study terminated by sponsor|0|||
130172671|NCT05199090|468588942|FG003|Overall Study|Study terminated by sponsor|0|||
130172672|NCT05199090|468588943|FG004|Overall Study|Study terminated by sponsor|0|||
130172673|NCT05199090|468588944|FG005|Overall Study|Study terminated by sponsor|5|||
130172674|NCT05199090|468588939|FG000|Overall Study|Subject decision|0|||
130172675|NCT05199090|468588940|FG001|Overall Study|Subject decision|4|||
129982312|NCT01278173|467898822|FG000|Overall Study|Protocol Violation|1|||
130172676|NCT05199090|468588941|FG002|Overall Study|Subject decision|0|||
130172677|NCT05199090|468588942|FG003|Overall Study|Subject decision|2|||
130172678|NCT05199090|468588943|FG004|Overall Study|Subject decision|5|||
130172679|NCT05199090|468588944|FG005|Overall Study|Subject decision|2|||
130172680|NCT03276078|468588945|FG000|Overall Study|Adverse Event|1|||
130172681|NCT02552732|468588947|FG000|Overall Study|Lost to Follow-up|2|||
130172682|NCT02552732|468588947|FG000|Overall Study|Physician Decision|1|||
130172683|NCT02552732|468588947|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
130172684|NCT02552732|468588947|FG000|Overall Study|Withdrawal by Subject|6|||
130172685|NCT04988087|468588950|FG000|Overall Study|Adverse Event|4|||
130172686|NCT04988087|468588951|FG001|Overall Study|Adverse Event|0|||
130172687|NCT04988087|468588952|FG002|Overall Study|Adverse Event|0|||
130172688|NCT04988087|468588953|FG003|Overall Study|Adverse Event|0|||
130172689|NCT04988087|468588950|FG000|Overall Study|Withdrawal by Subject|1|||
130172690|NCT04988087|468588951|FG001|Overall Study|Withdrawal by Subject|1|||
130172691|NCT04988087|468588952|FG002|Overall Study|Withdrawal by Subject|0|||
130172692|NCT04988087|468588953|FG003|Overall Study|Withdrawal by Subject|0|||
130172693|NCT04988087|468588950|FG000|Overall Study|Technical problems|7|||
130172694|NCT04988087|468588951|FG001|Overall Study|Technical problems|9|||
130172695|NCT04988087|468588952|FG002|Overall Study|Technical problems|1|||
130172696|NCT04988087|468588953|FG003|Overall Study|Technical problems|2|||
130172697|NCT02800642|468588957|FG000|Overall Study|Death|3|||
130172698|NCT02800642|468588957|FG000|Overall Study|Other|10|||
130172699|NCT02800642|468588957|FG000|Overall Study|Physician Decision|2|||
130172700|NCT02800642|468588957|FG000|Overall Study|Adverse Event|6|||
130172701|NCT02800642|468588957|FG000|Overall Study|Withdrawal by Subject|3|||
130172702|NCT02800642|468588957|FG000|Overall Study|Lost to Follow-up|1|||
130172703|NCT01004003|468588958|FG000|Overall Study|Progressive disease|2|||
130172704|NCT01004003|468588959|FG001|Overall Study|Progressive disease|1|||
130172705|NCT01004003|468588960|FG002|Overall Study|Progressive disease|1|||
130172706|NCT01004003|468588961|FG003|Overall Study|Progressive disease|0|||
130172707|NCT01004003|468588962|FG004|Overall Study|Progressive disease|2|||
130172708|NCT01004003|468588963|FG005|Overall Study|Progressive disease|1|||
130172709|NCT01004003|468588964|FG006|Overall Study|Progressive disease|1|||
130172710|NCT01004003|468588965|FG007|Overall Study|Progressive disease|39|||
130172711|NCT01004003|468588966|FG008|Overall Study|Progressive disease|22|||
130172712|NCT01004003|468588958|FG000|Overall Study|Adverse Event|4|||
130172713|NCT01004003|468588959|FG001|Overall Study|Adverse Event|2|||
130172714|NCT01004003|468588960|FG002|Overall Study|Adverse Event|3|||
130172715|NCT01004003|468588961|FG003|Overall Study|Adverse Event|3|||
130172716|NCT01004003|468588962|FG004|Overall Study|Adverse Event|2|||
130172717|NCT01004003|468588963|FG005|Overall Study|Adverse Event|2|||
130172718|NCT01004003|468588964|FG006|Overall Study|Adverse Event|7|||
130172719|NCT01004003|468588965|FG007|Overall Study|Adverse Event|21|||
130172720|NCT01004003|468588966|FG008|Overall Study|Adverse Event|6|||
130172721|NCT01004003|468588958|FG000|Overall Study|Refused to continue taking trial med.|0|||
130172722|NCT01004003|468588959|FG001|Overall Study|Refused to continue taking trial med.|0|||
130172723|NCT01004003|468588960|FG002|Overall Study|Refused to continue taking trial med.|0|||
130172724|NCT01004003|468588961|FG003|Overall Study|Refused to continue taking trial med.|0|||
130172725|NCT01004003|468588962|FG004|Overall Study|Refused to continue taking trial med.|0|||
130172726|NCT01004003|468588963|FG005|Overall Study|Refused to continue taking trial med.|0|||
130172727|NCT01004003|468588964|FG006|Overall Study|Refused to continue taking trial med.|0|||
130172728|NCT01004003|468588965|FG007|Overall Study|Refused to continue taking trial med.|0|||
130172729|NCT01004003|468588966|FG008|Overall Study|Refused to continue taking trial med.|2|||
130172730|NCT01004003|468588958|FG000|Overall Study|Other|0|||
130172731|NCT01004003|468588959|FG001|Overall Study|Other|0|||
130172732|NCT01004003|468588960|FG002|Overall Study|Other|0|||
130172733|NCT01004003|468588961|FG003|Overall Study|Other|0|||
130172734|NCT01004003|468588962|FG004|Overall Study|Other|0|||
130172735|NCT01004003|468588963|FG005|Overall Study|Other|1|||
130172736|NCT01004003|468588964|FG006|Overall Study|Other|0|||
130172737|NCT01004003|468588965|FG007|Overall Study|Other|0|||
130172738|NCT01004003|468588966|FG008|Overall Study|Other|0|||
130172739|NCT01130597|468588973|FG000|Overall Study|Protocol-specified (High K+)|1|||
130172740|NCT01130597|468588973|FG000|Overall Study|Adverse Event|4|||
130172741|NCT01130597|468588973|FG000|Overall Study|Death|1|||
130172742|NCT01130597|468588973|FG000|Overall Study|Protocol Violation|1|||
130172743|NCT05794503|468588974|FG000|Overall Study|Operation Cancelled|2|||
130172744|NCT05794503|468588975|FG001|Overall Study|Operation Cancelled|0|||
130172745|NCT05794503|468588974|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
130172746|NCT05794503|468588975|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
130172747|NCT05794503|468588974|FG000|Overall Study|Protocol Violation|1|||
130172748|NCT05794503|468588975|FG001|Overall Study|Protocol Violation|0|||
130172749|NCT01589497|468588976|FG000|Overall Study|Withdrawal by Subject|0|||
129982313|NCT01278173|467898822|FG000|Overall Study|Withdrawal by Subject|1|||
129982314|NCT04662931|467898824|FG000|Overall Study|Withdrawal by Subject|17|||
130172750|NCT01589497|468588977|FG001|Overall Study|Withdrawal by Subject|1|||
130172751|NCT01589497|468588978|FG002|Overall Study|Withdrawal by Subject|0|||
130172752|NCT01589497|468588979|FG003|Overall Study|Withdrawal by Subject|1|||
130172753|NCT01589497|468588976|FG000|Overall Study|Death|1|||
130172754|NCT01589497|468588977|FG001|Overall Study|Death|0|||
130172755|NCT01589497|468588978|FG002|Overall Study|Death|0|||
130172756|NCT01589497|468588979|FG003|Overall Study|Death|0|||
130172757|NCT01589497|468588976|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130172758|NCT01589497|468588977|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130172759|NCT01589497|468588978|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
130172760|NCT01589497|468588979|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
130172761|NCT05819203|468588986|FG000|Overall Study|Protocol Violation|1|||
130172762|NCT05819203|468588987|FG001|Overall Study|Protocol Violation|2|||
130172763|NCT05819203|468588986|FG000|Overall Study|Withdrawal by Subject|1|||
130172764|NCT05819203|468588987|FG001|Overall Study|Withdrawal by Subject|0|||
130172765|NCT04784533|468588988|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
130172766|NCT04784533|468588989|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
130172767|NCT04784533|468588990|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172768|NCT04784533|468588991|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172769|NCT04784533|468588992|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172770|NCT04784533|468588993|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172771|NCT04784533|468588994|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172772|NCT04784533|468588995|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172773|NCT04784533|468588996|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172774|NCT04784533|468588997|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
130172775|NCT04784533|468588988|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
130172776|NCT04784533|468588989|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
130172777|NCT04784533|468588990|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172778|NCT04784533|468588991|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172779|NCT04784533|468588992|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172780|NCT04784533|468588993|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172781|NCT04784533|468588994|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172782|NCT04784533|468588995|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172783|NCT04784533|468588996|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172784|NCT04784533|468588997|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
130172785|NCT04784533|468588988|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172786|NCT04784533|468588989|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
130172787|NCT04784533|468588990|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172788|NCT04784533|468588991|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172789|NCT04784533|468588992|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172790|NCT04784533|468588993|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172791|NCT04784533|468588994|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172792|NCT04784533|468588995|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172793|NCT04784533|468588996|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
130172794|NCT04784533|468588997|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129982315|NCT04662931|467898824|FG000|Overall Study|Death|3|||
129982316|NCT04662931|467898824|FG000|Overall Study|Lost to Follow-up|3|||
129982317|NCT04662931|467898824|FG000|Overall Study|Guardian Decision|1|||
129982318|NCT00680992|467898828|FG000|Overall Study|Complete Resection (as per protocol)|25|||
129982319|NCT00680992|467898829|FG001|Overall Study|Complete Resection (as per protocol)|121|||
129982320|NCT00680992|467898830|FG002|Overall Study|Complete Resection (as per protocol)|0|||
129982321|NCT00680992|467898828|FG000|Overall Study|Administrative Decision|83|||
129982322|NCT00680992|467898829|FG001|Overall Study|Administrative Decision|42|||
129982323|NCT00680992|467898830|FG002|Overall Study|Administrative Decision|5|||
129982324|NCT00680992|467898828|FG000|Overall Study|End of Trial|32|||
129982325|NCT00680992|467898829|FG001|Overall Study|End of Trial|12|||
129982326|NCT00680992|467898830|FG002|Overall Study|End of Trial|3|||
129982327|NCT00680992|467898828|FG000|Overall Study|Withdrawal by Subject|33|||
129982328|NCT00680992|467898829|FG001|Overall Study|Withdrawal by Subject|11|||
129982329|NCT00680992|467898830|FG002|Overall Study|Withdrawal by Subject|1|||
129982330|NCT00680992|467898828|FG000|Overall Study|Adverse Event|21|||
129982331|NCT00680992|467898829|FG001|Overall Study|Adverse Event|19|||
129982332|NCT00680992|467898830|FG002|Overall Study|Adverse Event|1|||
129982333|NCT00680992|467898828|FG000|Overall Study|Other|19|||
129982334|NCT00680992|467898829|FG001|Overall Study|Other|14|||
129982335|NCT00680992|467898830|FG002|Overall Study|Other|1|||
129982336|NCT00680992|467898828|FG000|Overall Study|Disease Progression|21|||
129982337|NCT00680992|467898829|FG001|Overall Study|Disease Progression|9|||
129982338|NCT00680992|467898830|FG002|Overall Study|Disease Progression|0|||
129982339|NCT00680992|467898828|FG000|Overall Study|Lost to Follow-up|12|||
129982340|NCT00680992|467898829|FG001|Overall Study|Lost to Follow-up|14|||
129982341|NCT00680992|467898830|FG002|Overall Study|Lost to Follow-up|0|||
129982342|NCT00680992|467898828|FG000|Overall Study|Noncompliance|4|||
129982343|NCT00680992|467898829|FG001|Overall Study|Noncompliance|6|||
129982344|NCT00680992|467898830|FG002|Overall Study|Noncompliance|0|||
129982345|NCT00680992|467898828|FG000|Overall Study|Requirement for Alternative Therapy|8|||
129982346|NCT00680992|467898829|FG001|Overall Study|Requirement for Alternative Therapy|2|||
129982347|NCT00680992|467898830|FG002|Overall Study|Requirement for Alternative Therapy|0|||
130172795|NCT04784533|468588988|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
130172796|NCT04784533|468588989|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172797|NCT04784533|468588990|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172798|NCT04784533|468588991|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172799|NCT04784533|468588992|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172800|NCT04784533|468588993|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172801|NCT04784533|468588994|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172802|NCT04784533|468588995|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172803|NCT04784533|468588996|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172804|NCT04784533|468588997|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
130172805|NCT04784533|468588988|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
130172806|NCT04784533|468588989|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
130172807|NCT04784533|468588990|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172808|NCT04784533|468588991|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172809|NCT04784533|468588992|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172810|NCT04784533|468588993|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172811|NCT04784533|468588994|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172812|NCT04784533|468588995|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172813|NCT04784533|468588996|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172814|NCT04784533|468588997|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
130172815|NCT04784533|468588988|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
130172816|NCT04784533|468588989|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
130172817|NCT04784533|468588990|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172818|NCT04784533|468588991|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172819|NCT04784533|468588992|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172820|NCT04784533|468588993|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172821|NCT04784533|468588994|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172822|NCT04784533|468588995|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172823|NCT04784533|468588996|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172824|NCT04784533|468588997|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
130172825|NCT04784533|468588988|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172826|NCT04784533|468588989|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172827|NCT04784533|468588990|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
130172828|NCT04784533|468588991|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172829|NCT04784533|468588992|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172830|NCT04784533|468588993|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172831|NCT04784533|468588994|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172832|NCT04784533|468588995|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172833|NCT04784533|468588996|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172834|NCT04784533|468588997|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
130172835|NCT04784533|468588988|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172836|NCT04784533|468588989|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172837|NCT04784533|468588990|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172838|NCT04784533|468588991|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172839|NCT04784533|468588992|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172840|NCT04784533|468588993|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172841|NCT04784533|468588994|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172842|NCT04784533|468588995|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172843|NCT04784533|468588996|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
130172844|NCT04784533|468588997|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
130172845|NCT04784533|468588988|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172846|NCT04784533|468588989|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172847|NCT04784533|468588990|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172848|NCT04784533|468588991|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172849|NCT04784533|468588992|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172850|NCT04784533|468588993|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172851|NCT04784533|468588994|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172852|NCT04784533|468588995|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
130172853|NCT04784533|468588996|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
130172854|NCT04784533|468588997|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
130172855|NCT02521376|468588998|FG000|Overall Study|Enrolled, But Not Treated|1|||
130172856|NCT02521376|468588999|FG001|Overall Study|Enrolled, But Not Treated|0|||
130172857|NCT02521376|468589000|FG002|Overall Study|Enrolled, But Not Treated|0|||
130172858|NCT02521376|468589001|FG003|Overall Study|Enrolled, But Not Treated|0|||
130172859|NCT00340678|468589011|FG000|Overall Study|Lost to Follow-up|1|||
130172860|NCT00340678|468589012|FG001|Overall Study|Lost to Follow-up|0|||
130172861|NCT00340678|468589013|FG002|Overall Study|Lost to Follow-up|0|||
130172862|NCT00340678|468589014|FG003|Overall Study|Lost to Follow-up|0|||
130172863|NCT03316547|468589018|FG000|Overall Study|Death|3|||
130172864|NCT03316547|468589019|FG001|Overall Study|Death|1|||
130172865|NCT03316547|468589018|FG000|Overall Study|Lost to Follow-up|6|||
130172866|NCT03316547|468589019|FG001|Overall Study|Lost to Follow-up|6|||
130172867|NCT03316547|468589018|FG000|Overall Study|Withdrawal by Subject|3|||
130172868|NCT03316547|468589019|FG001|Overall Study|Withdrawal by Subject|2|||
130172869|NCT03316547|468589018|FG000|Overall Study|Transfer to another hospital|6|||
130172870|NCT03316547|468589019|FG001|Overall Study|Transfer to another hospital|4|||
130172871|NCT00708227|468589020|FG000|Overall Study|Physician Decision|0|||
130172872|NCT00708227|468589021|FG001|Overall Study|Physician Decision|3|||
130172873|NCT00708227|468589022|FG002|Overall Study|Physician Decision|1|||
130172874|NCT00708227|468589023|FG003|Overall Study|Physician Decision|2|||
130172875|NCT00708227|468589020|FG000|Overall Study|Withdrawal by Subject|1|||
130172876|NCT00708227|468589021|FG001|Overall Study|Withdrawal by Subject|2|||
130172877|NCT00708227|468589022|FG002|Overall Study|Withdrawal by Subject|0|||
130172878|NCT00708227|468589023|FG003|Overall Study|Withdrawal by Subject|1|||
130172879|NCT04007991|468589024|FG000|Overall Study|Withdrawal by Subject|1|||
130172880|NCT04007991|468589025|FG001|Overall Study|Withdrawal by Subject|1|||
130172881|NCT04007991|468589024|FG000|Overall Study|Physician Decision|1|||
130172882|NCT04007991|468589025|FG001|Overall Study|Physician Decision|1|||
130172883|NCT04007991|468589024|FG000|Overall Study|Non-compliance with Study Drug|0|||
130172884|NCT04007991|468589025|FG001|Overall Study|Non-compliance with Study Drug|1|||
130172885|NCT04007991|468589024|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
130172886|NCT04007991|468589025|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
130172887|NCT04007991|468589024|FG000|Overall Study|Adverse event, non-fatal|5|||
130172888|NCT04007991|468589025|FG001|Overall Study|Adverse event, non-fatal|0|||
130172889|NCT04007991|468589024|FG000|Overall Study|Lost to Follow-up|2|||
130172890|NCT04007991|468589025|FG001|Overall Study|Lost to Follow-up|1|||
130172891|NCT06390826|468590001|FG000|Overall Study|Never Start Protocol Therapy|1|||
130172892|NCT06390826|468590001|FG000|Overall Study|Adverse Event|1|||
130172893|NCT06390826|468590001|FG000|Overall Study|Disease Progression|8|||
130172894|NCT02126826|468590002|FG000|Overall Study|Withdrawal by Subject|0|||
130172895|NCT02126826|468590003|FG001|Overall Study|Withdrawal by Subject|0|||
130172896|NCT02126826|468590004|FG002|Overall Study|Withdrawal by Subject|0|||
130172897|NCT02126826|468590005|FG003|Overall Study|Withdrawal by Subject|1|||
130172898|NCT02126826|468590006|FG004|Overall Study|Withdrawal by Subject|0|||
130172899|NCT02126826|468590007|FG005|Overall Study|Withdrawal by Subject|0|||
130172900|NCT02126826|468590008|FG006|Overall Study|Withdrawal by Subject|0|||
130172901|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #1|24|||
130172902|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #1|0|||
130172903|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
130172904|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
130172905|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172906|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172907|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
130172908|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
130172909|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
130172910|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
130172911|NCT03888066|468590009|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172912|NCT03888066|468590010|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172913|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172914|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172915|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
130172916|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
130172917|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172918|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172919|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
130172920|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172921|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #2|5|||
130172922|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #2|0|||
130172923|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
130172924|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
130172925|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
130172926|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
130172927|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
130172928|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
130172929|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #3|11|||
130172930|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #3|0|||
130172931|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
130172932|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
130172933|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
130172934|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130172935|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172936|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172937|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #4|3|||
130172938|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #4|0|||
130172939|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
130172940|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
130172941|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
130172942|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
130172943|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
130172944|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130172945|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
130172946|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
130172947|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
130172948|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172949|NCT03888066|468590009|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
130172950|NCT03888066|468590010|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130172951|NCT03888066|468590009|FG000|Run-in Phase|AE (Adverse Event)|17|||
130172952|NCT03888066|468590010|FG001|Run-in Phase|AE (Adverse Event)|0|||
130172953|NCT03888066|468590009|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
130172954|NCT03888066|468590010|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
130172955|NCT03888066|468590009|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172956|NCT03888066|468590010|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172957|NCT03888066|468590009|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
130172958|NCT03888066|468590010|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172959|NCT03888066|468590009|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
130172960|NCT03888066|468590010|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130172961|NCT03888066|468590009|FG000|Run-in Phase|Withdrawal by Subject|43|||
130172962|NCT03888066|468590010|FG001|Run-in Phase|Withdrawal by Subject|0|||
130172963|NCT03888066|468590009|FG000|Run-in Phase|AE; Physician Decision|1|||
130172964|NCT03888066|468590010|FG001|Run-in Phase|AE; Physician Decision|0|||
130172965|NCT03888066|468590009|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
130172966|NCT03888066|468590010|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
130172967|NCT03888066|468590009|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
130172968|NCT03888066|468590010|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
130172969|NCT03888066|468590009|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
130172970|NCT03888066|468590010|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
130172971|NCT03888066|468590009|FG000|Run-in Phase|Death|1|||
130172972|NCT03888066|468590010|FG001|Run-in Phase|Death|0|||
130172973|NCT03888066|468590009|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
130172974|NCT03888066|468590010|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
130172975|NCT03888066|468590009|FG000|Run-in Phase|Physician Decision|1|||
130172976|NCT03888066|468590010|FG001|Run-in Phase|Physician Decision|0|||
130172977|NCT03888066|468590009|FG000|Run-in Phase|Protocol Violation|13|||
130172978|NCT03888066|468590010|FG001|Run-in Phase|Protocol Violation|0|||
130172979|NCT03888066|468590009|FG000|Run-in Phase|Sponsor Request|34|||
130172980|NCT03888066|468590010|FG001|Run-in Phase|Sponsor Request|0|||
130172981|NCT03888066|468590009|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
130172982|NCT03888066|468590010|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
130172983|NCT03888066|468590009|FG000|Run-in Phase|Withdrawal Of Consent|1|||
130172984|NCT03888066|468590010|FG001|Run-in Phase|Withdrawal Of Consent|0|||
130172985|NCT03888066|468590009|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
130172986|NCT03888066|468590010|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
130172987|NCT03888066|468590009|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
130172988|NCT03888066|468590010|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
130172989|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
130172990|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
130172991|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
130172992|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
130172993|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
130172994|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
130172995|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
130172996|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
130172997|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
130172998|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
130172999|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
130173000|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
130173001|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
130173002|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
130173003|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
130173004|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
130173005|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
130173006|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
130173007|NCT03888066|468590009|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
130173008|NCT03888066|468590010|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
130173009|NCT03278626|468590011|FG000|Overall Study|Death|2|||
130173010|NCT03278626|468590011|FG000|Overall Study|Toxicity|1|||
130173011|NCT03278626|468590011|FG000|Overall Study|Disease Progression|2|||
130173012|NCT05013008|468590013|FG000|Overall Study|Exclusion from mBFAS|5|||
130173013|NCT05013008|468590014|FG001|Overall Study|Exclusion from mBFAS|25|||
130173014|NCT02111603|468590034|FG000|Overall Study|Withdrawal by Subject|1|||
130173015|NCT03106987|468590035|FG000|Overall Study|Death|37|||
130173016|NCT03106987|468590036|FG001|Overall Study|Death|22|||
130173017|NCT03106987|468590037|FG002|Overall Study|Death|12|||
130173018|NCT03106987|468590038|FG003|Overall Study|Death|8|||
130173019|NCT03106987|468590035|FG000|Overall Study|Lost to Follow-up|2|||
130173020|NCT03106987|468590036|FG001|Overall Study|Lost to Follow-up|0|||
130173021|NCT03106987|468590037|FG002|Overall Study|Lost to Follow-up|2|||
130173022|NCT03106987|468590038|FG003|Overall Study|Lost to Follow-up|2|||
130173023|NCT03106987|468590035|FG000|Overall Study|Withdrawal by Subject|5|||
130173024|NCT03106987|468590036|FG001|Overall Study|Withdrawal by Subject|1|||
130173025|NCT03106987|468590037|FG002|Overall Study|Withdrawal by Subject|4|||
130173026|NCT03106987|468590038|FG003|Overall Study|Withdrawal by Subject|1|||
130173027|NCT02114385|468590040|FG000|Overall Study|Withdrawal by Subject|3|||
130173028|NCT02114385|468590041|FG001|Overall Study|Withdrawal by Subject|2|||
130173029|NCT02114385|468590040|FG000|Overall Study|Lost to Follow-up|0|||
130173030|NCT02114385|468590041|FG001|Overall Study|Lost to Follow-up|6|||
130173031|NCT01174043|468590045|FG000|Overall Study|Disease progression|5|||
130173032|NCT01174043|468590045|FG000|Overall Study|Adverse Event|3|||
130173033|NCT01174043|468590045|FG000|Overall Study|Death|1|||
130173034|NCT01174043|468590045|FG000|Overall Study|Withdrawal by Subject|2|||
130173035|NCT00582010|468590050|FG000|Overall Study|Death|0|||
130173036|NCT00582010|468590051|FG001|Overall Study|Death|1|||
130173037|NCT02681510|468590059|FG000|Overall Study|Withdrawal by Subject|1|||
130173038|NCT02681510|468590059|FG000|Overall Study|Lost to Follow-up|9|||
130173039|NCT00741338|468590063|FG000|Overall Study|Adverse Event|0|||
130173040|NCT00741338|468590064|FG001|Overall Study|Adverse Event|1|||
130173041|NCT03066258|468590067|FG000|Overall Study|Death|1|||
130173042|NCT03066258|468590068|FG001|Overall Study|Death|0|||
130173043|NCT03066258|468590069|FG002|Overall Study|Death|0|||
130173044|NCT03066258|468590070|FG003|Overall Study|Death|0|||
130173045|NCT03066258|468590071|FG004|Overall Study|Death|1|||
130173046|NCT00704132|468590076|FG000|Overall Study|Clinical Adverse Experience|1|||
130173047|NCT00704132|468590077|FG001|Overall Study|Clinical Adverse Experience|0|||
130173048|NCT00704132|468590076|FG000|Overall Study|Lack of Efficacy|0|||
130173049|NCT00704132|468590077|FG001|Overall Study|Lack of Efficacy|1|||
130173050|NCT00704132|468590076|FG000|Overall Study|Withdrawal by Subject|0|||
130173051|NCT00704132|468590077|FG001|Overall Study|Withdrawal by Subject|1|||
130173052|NCT00214383|468590078|FG000|Overall Study|Lost to Follow-up|16|||
130173053|NCT00214383|468590079|FG001|Overall Study|Lost to Follow-up|26|||
130173054|NCT00879411|468590080|FG000|Overall Study|lost to follow-up (non-AE)|162|||
130173055|NCT02655666|468590083|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
130173056|NCT01267994|468590084|FG000|Overall Study|Adverse Event|2|||
130173057|NCT03837743|468590085|FG000|Overall Study|Adverse Event|1|||
130173058|NCT03837743|468590085|FG000|Overall Study|Withdrawal by Subject|2|||
130173059|NCT01210612|468590089|FG000|Overall Study|Withdrawal by Subject|0|||
130173060|NCT01210612|468590090|FG001|Overall Study|Withdrawal by Subject|2|||
130173061|NCT00086281|468590093|FG000|Phase 1|Adverse Event|0|||
130173062|NCT00086281|468590094|FG001|Phase 1|Adverse Event|0|||
130173063|NCT00086281|468590095|FG002|Phase 1|Adverse Event|0|||
130173064|NCT00086281|468590096|FG003|Phase 1|Adverse Event|0|||
130173065|NCT00086281|468590097|FG004|Phase 1|Adverse Event|0|||
130173066|NCT00086281|468590098|FG005|Phase 1|Adverse Event|0|||
130173067|NCT00086281|468590099|FG006|Phase 1|Adverse Event|0|||
130173068|NCT00086281|468590100|FG007|Phase 1|Adverse Event|0|||
130173069|NCT00086281|468590101|FG008|Phase 1|Adverse Event|0|||
130173070|NCT00086281|468590102|FG009|Phase 1|Adverse Event|1|||
130173071|NCT00086281|468590103|FG010|Phase 1|Adverse Event|2|||
130173072|NCT00086281|468590104|FG011|Phase 1|Adverse Event|1|||
130173073|NCT00086281|468590105|FG012|Phase 1|Adverse Event|1|||
130173074|NCT00086281|468590106|FG013|Phase 1|Adverse Event|1|||
130173075|NCT00086281|468590107|FG014|Phase 1|Adverse Event|2|||
130173076|NCT00086281|468590093|FG000|Phase 1|Protocol Violation|0|||
130173077|NCT00086281|468590094|FG001|Phase 1|Protocol Violation|0|||
130173078|NCT00086281|468590095|FG002|Phase 1|Protocol Violation|0|||
130173079|NCT00086281|468590096|FG003|Phase 1|Protocol Violation|0|||
130173080|NCT00086281|468590097|FG004|Phase 1|Protocol Violation|0|||
130173081|NCT00086281|468590098|FG005|Phase 1|Protocol Violation|0|||
130173082|NCT00086281|468590099|FG006|Phase 1|Protocol Violation|0|||
130173083|NCT00086281|468590100|FG007|Phase 1|Protocol Violation|0|||
130173084|NCT00086281|468590101|FG008|Phase 1|Protocol Violation|0|||
130173085|NCT00086281|468590102|FG009|Phase 1|Protocol Violation|0|||
130173086|NCT00086281|468590103|FG010|Phase 1|Protocol Violation|1|||
130173087|NCT00086281|468590104|FG011|Phase 1|Protocol Violation|0|||
130173088|NCT00086281|468590105|FG012|Phase 1|Protocol Violation|0|||
130173089|NCT00086281|468590106|FG013|Phase 1|Protocol Violation|0|||
130173090|NCT00086281|468590107|FG014|Phase 1|Protocol Violation|0|||
130173091|NCT00086281|468590093|FG000|Phase 1|Serious Adverse Event|0|||
130173092|NCT00086281|468590094|FG001|Phase 1|Serious Adverse Event|0|||
130173093|NCT00086281|468590095|FG002|Phase 1|Serious Adverse Event|0|||
130173094|NCT00086281|468590096|FG003|Phase 1|Serious Adverse Event|0|||
130173095|NCT00086281|468590097|FG004|Phase 1|Serious Adverse Event|0|||
130173096|NCT00086281|468590098|FG005|Phase 1|Serious Adverse Event|0|||
130173097|NCT00086281|468590099|FG006|Phase 1|Serious Adverse Event|0|||
130173098|NCT00086281|468590100|FG007|Phase 1|Serious Adverse Event|0|||
130173099|NCT00086281|468590101|FG008|Phase 1|Serious Adverse Event|0|||
130173100|NCT00086281|468590102|FG009|Phase 1|Serious Adverse Event|0|||
130173101|NCT00086281|468590103|FG010|Phase 1|Serious Adverse Event|0|||
130173102|NCT00086281|468590104|FG011|Phase 1|Serious Adverse Event|0|||
130173103|NCT00086281|468590105|FG012|Phase 1|Serious Adverse Event|0|||
130173104|NCT00086281|468590106|FG013|Phase 1|Serious Adverse Event|0|||
130173105|NCT00086281|468590107|FG014|Phase 1|Serious Adverse Event|1|||
130173106|NCT00086281|468590093|FG000|Phase 2|Adverse Event|0|||
130173107|NCT00086281|468590094|FG001|Phase 2|Adverse Event|0|||
130173108|NCT00086281|468590095|FG002|Phase 2|Adverse Event|0|||
130173109|NCT00086281|468590096|FG003|Phase 2|Adverse Event|0|||
130173110|NCT00086281|468590097|FG004|Phase 2|Adverse Event|0|||
130173111|NCT00086281|468590098|FG005|Phase 2|Adverse Event|0|||
130173112|NCT00086281|468590099|FG006|Phase 2|Adverse Event|0|||
130173113|NCT00086281|468590100|FG007|Phase 2|Adverse Event|0|||
130173114|NCT00086281|468590101|FG008|Phase 2|Adverse Event|0|||
130173115|NCT00086281|468590102|FG009|Phase 2|Adverse Event|0|||
130173116|NCT00086281|468590103|FG010|Phase 2|Adverse Event|0|||
130173117|NCT00086281|468590104|FG011|Phase 2|Adverse Event|0|||
130173118|NCT00086281|468590105|FG012|Phase 2|Adverse Event|1|||
130173119|NCT00086281|468590106|FG013|Phase 2|Adverse Event|1|||
130173120|NCT00086281|468590107|FG014|Phase 2|Adverse Event|0|||
130173121|NCT04759768|468590108|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
130173122|NCT04759768|468590109|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
130173123|NCT04759768|468590108|FG000|Washout (7 Days)|Physician Decision|0|||
130173124|NCT04759768|468590109|FG001|Washout (7 Days)|Physician Decision|1|||
130173125|NCT02996487|468590110|FG000|Overall Study|Lost to Follow-up|1|||
130173126|NCT02996487|468590111|FG001|Overall Study|Lost to Follow-up|1|||
130173127|NCT02996487|468590112|FG002|Overall Study|Lost to Follow-up|0|||
130173128|NCT02996487|468590110|FG000|Overall Study|Death|0|||
130173129|NCT02996487|468590111|FG001|Overall Study|Death|1|||
130173130|NCT02996487|468590112|FG002|Overall Study|Death|0|||
130173131|NCT02996487|468590110|FG000|Overall Study|Withdrawal by Subject|2|||
130173132|NCT02996487|468590111|FG001|Overall Study|Withdrawal by Subject|3|||
130173133|NCT02996487|468590112|FG002|Overall Study|Withdrawal by Subject|0|||
130173134|NCT02027428|468590113|FG000|Induction|Never treated|7|||
130173135|NCT02027428|468590114|FG001|Induction|Never treated|0|||
130173136|NCT02027428|468590115|FG002|Induction|Never treated|0|||
130173137|NCT02027428|468590113|FG000|Induction|Progressive disease|77|||
130173138|NCT02027428|468590114|FG001|Induction|Progressive disease|0|||
130173139|NCT02027428|468590115|FG002|Induction|Progressive disease|0|||
130173140|NCT02027428|468590113|FG000|Induction|Adverse Event|51|||
130173141|NCT02027428|468590114|FG001|Induction|Adverse Event|0|||
130173142|NCT02027428|468590115|FG002|Induction|Adverse Event|0|||
130173143|NCT02027428|468590113|FG000|Induction|Withdrawal by Subject|22|||
130173144|NCT02027428|468590114|FG001|Induction|Withdrawal by Subject|0|||
130173145|NCT02027428|468590115|FG002|Induction|Withdrawal by Subject|0|||
130173146|NCT02027428|468590113|FG000|Induction|Death|21|||
130173147|NCT02027428|468590114|FG001|Induction|Death|0|||
130173148|NCT02027428|468590115|FG002|Induction|Death|0|||
130173149|NCT02027428|468590113|FG000|Induction|Symptomatic deterioration|16|||
130173150|NCT02027428|468590114|FG001|Induction|Symptomatic deterioration|0|||
130173151|NCT02027428|468590115|FG002|Induction|Symptomatic deterioration|0|||
130173152|NCT02027428|468590113|FG000|Induction|Study terminated by sponsor|12|||
130173153|NCT02027428|468590114|FG001|Induction|Study terminated by sponsor|0|||
130173154|NCT02027428|468590115|FG002|Induction|Study terminated by sponsor|0|||
130173155|NCT02027428|468590113|FG000|Induction|Protocol Violation|1|||
130173156|NCT02027428|468590114|FG001|Induction|Protocol Violation|0|||
130173157|NCT02027428|468590115|FG002|Induction|Protocol Violation|0|||
130173158|NCT02027428|468590113|FG000|Induction|Miscellaneous|14|||
130173159|NCT02027428|468590114|FG001|Induction|Miscellaneous|0|||
130173160|NCT02027428|468590115|FG002|Induction|Miscellaneous|0|||
130173161|NCT02027428|468590113|FG000|Induction|Induction Treatment Ongoing|4|||
130173162|NCT02027428|468590114|FG001|Induction|Induction Treatment Ongoing|0|||
130173163|NCT02027428|468590115|FG002|Induction|Induction Treatment Ongoing|0|||
130173164|NCT02027428|468590113|FG000|Maintenance|Death|0|||
130173165|NCT02027428|468590114|FG001|Maintenance|Death|3|||
130173166|NCT02027428|468590115|FG002|Maintenance|Death|2|||
130173167|NCT02027428|468590113|FG000|Maintenance|Adverse Event|0|||
130173168|NCT02027428|468590114|FG001|Maintenance|Adverse Event|21|||
130173169|NCT02027428|468590115|FG002|Maintenance|Adverse Event|1|||
130173170|NCT02027428|468590113|FG000|Maintenance|Progressive disease|0|||
130173171|NCT02027428|468590114|FG001|Maintenance|Progressive disease|84|||
130173172|NCT02027428|468590115|FG002|Maintenance|Progressive disease|47|||
130173173|NCT02027428|468590113|FG000|Maintenance|Symptomatic deterioration|0|||
130173174|NCT02027428|468590114|FG001|Maintenance|Symptomatic deterioration|4|||
130173175|NCT02027428|468590115|FG002|Maintenance|Symptomatic deterioration|1|||
130173176|NCT02027428|468590113|FG000|Maintenance|Withdrawal by Subject|0|||
130173177|NCT02027428|468590114|FG001|Maintenance|Withdrawal by Subject|6|||
130173178|NCT02027428|468590115|FG002|Maintenance|Withdrawal by Subject|5|||
130173179|NCT02027428|468590113|FG000|Maintenance|Protocol Violation|0|||
130173180|NCT02027428|468590114|FG001|Maintenance|Protocol Violation|0|||
130173181|NCT02027428|468590115|FG002|Maintenance|Protocol Violation|1|||
130173182|NCT02027428|468590113|FG000|Maintenance|Other|0|||
130173183|NCT02027428|468590114|FG001|Maintenance|Other|6|||
130173184|NCT02027428|468590115|FG002|Maintenance|Other|3|||
130173185|NCT02027428|468590113|FG000|Survival Follow-up|Death|0|||
130173186|NCT02027428|468590114|FG001|Survival Follow-up|Death|78|||
130173187|NCT02027428|468590115|FG002|Survival Follow-up|Death|45|||
130173188|NCT02027428|468590113|FG000|Survival Follow-up|Lost to Follow-up|0|||
130173189|NCT02027428|468590114|FG001|Survival Follow-up|Lost to Follow-up|1|||
130173190|NCT02027428|468590115|FG002|Survival Follow-up|Lost to Follow-up|1|||
130173191|NCT04873934|468590116|FG000|Overall Study|Adverse Event|0|||
130173192|NCT04873934|468590117|FG001|Overall Study|Adverse Event|1|||
130173193|NCT04873934|468590116|FG000|Overall Study|Death|0|||
130173194|NCT04873934|468590117|FG001|Overall Study|Death|2|||
130173195|NCT04873934|468590116|FG000|Overall Study|Lost to Follow-up|13|||
130173196|NCT04873934|468590117|FG001|Overall Study|Lost to Follow-up|9|||
130173197|NCT04873934|468590116|FG000|Overall Study|Physician Decision|1|||
130173198|NCT04873934|468590117|FG001|Overall Study|Physician Decision|1|||
130173199|NCT04873934|468590116|FG000|Overall Study|Protocol deviation|2|||
130173200|NCT04873934|468590117|FG001|Overall Study|Protocol deviation|1|||
130173201|NCT04873934|468590116|FG000|Overall Study|Subject decision|1|||
130173202|NCT04873934|468590117|FG001|Overall Study|Subject decision|8|||
130173203|NCT04873934|468590116|FG000|Overall Study|Withdrew consent|0|||
130173204|NCT04873934|468590117|FG001|Overall Study|Withdrew consent|4|||
130173205|NCT04873934|468590116|FG000|Overall Study|Missing|1|||
130173206|NCT04873934|468590117|FG001|Overall Study|Missing|0|||
130173207|NCT00307437|468590120|FG000|Controlled Period|Adverse Event|7|||
130173208|NCT00307437|468590121|FG001|Controlled Period|Adverse Event|2|||
130173209|NCT00307437|468590122|FG002|Controlled Period|Adverse Event|5|||
130173210|NCT00307437|468590123|FG003|Controlled Period|Adverse Event|0|||
130173211|NCT00307437|468590124|FG004|Controlled Period|Adverse Event|0|||
130173212|NCT00307437|468590125|FG005|Controlled Period|Adverse Event|0|||
130173213|NCT00307437|468590126|FG006|Controlled Period|Adverse Event|0|||
130173214|NCT00307437|468590120|FG000|Controlled Period|Death|0|||
130173215|NCT00307437|468590121|FG001|Controlled Period|Death|0|||
130173216|NCT00307437|468590122|FG002|Controlled Period|Death|1|||
130173217|NCT00307437|468590123|FG003|Controlled Period|Death|0|||
130173218|NCT00307437|468590124|FG004|Controlled Period|Death|0|||
130173219|NCT00307437|468590125|FG005|Controlled Period|Death|0|||
130173220|NCT00307437|468590126|FG006|Controlled Period|Death|0|||
130173221|NCT00307437|468590120|FG000|Controlled Period|Lack of Efficacy|2|||
130173222|NCT00307437|468590121|FG001|Controlled Period|Lack of Efficacy|0|||
130173223|NCT00307437|468590122|FG002|Controlled Period|Lack of Efficacy|0|||
130173224|NCT00307437|468590123|FG003|Controlled Period|Lack of Efficacy|0|||
129982348|NCT00680992|467898828|FG000|Overall Study|Pregnancy|5|||
129982349|NCT00680992|467898829|FG001|Overall Study|Pregnancy|0|||
129982350|NCT00680992|467898830|FG002|Overall Study|Pregnancy|1|||
129982351|NCT00680992|467898828|FG000|Overall Study|Death|5|||
129982352|NCT00680992|467898829|FG001|Overall Study|Death|1|||
129982353|NCT00680992|467898830|FG002|Overall Study|Death|0|||
129982354|NCT00680992|467898828|FG000|Overall Study|Ineligibility Determined|0|||
129982355|NCT00680992|467898829|FG001|Overall Study|Ineligibility Determined|1|||
129982356|NCT00680992|467898830|FG002|Overall Study|Ineligibility Determined|0|||
129982357|NCT01397422|467898831|FG000|Overall Study|Adverse Event|0|||
129982358|NCT01397422|467898832|FG001|Overall Study|Adverse Event|3|||
130173225|NCT00307437|468590124|FG004|Controlled Period|Lack of Efficacy|0|||
130173226|NCT00307437|468590125|FG005|Controlled Period|Lack of Efficacy|0|||
130173227|NCT00307437|468590126|FG006|Controlled Period|Lack of Efficacy|0|||
130173228|NCT00307437|468590120|FG000|Controlled Period|Lost to Follow-up|2|||
130173229|NCT00307437|468590121|FG001|Controlled Period|Lost to Follow-up|3|||
130173230|NCT00307437|468590122|FG002|Controlled Period|Lost to Follow-up|0|||
130173231|NCT00307437|468590123|FG003|Controlled Period|Lost to Follow-up|0|||
130173232|NCT00307437|468590124|FG004|Controlled Period|Lost to Follow-up|0|||
130173233|NCT00307437|468590125|FG005|Controlled Period|Lost to Follow-up|0|||
130173234|NCT00307437|468590126|FG006|Controlled Period|Lost to Follow-up|0|||
130173235|NCT00307437|468590120|FG000|Controlled Period|Other|5|||
130173236|NCT00307437|468590121|FG001|Controlled Period|Other|1|||
130173237|NCT00307437|468590122|FG002|Controlled Period|Other|3|||
130173238|NCT00307437|468590123|FG003|Controlled Period|Other|0|||
130173239|NCT00307437|468590124|FG004|Controlled Period|Other|0|||
130173240|NCT00307437|468590125|FG005|Controlled Period|Other|0|||
130173241|NCT00307437|468590126|FG006|Controlled Period|Other|0|||
130173242|NCT00307437|468590120|FG000|After Controlled Period|Adverse Event|0|||
130173243|NCT00307437|468590121|FG001|After Controlled Period|Adverse Event|0|||
130173244|NCT00307437|468590122|FG002|After Controlled Period|Adverse Event|0|||
130173245|NCT00307437|468590123|FG003|After Controlled Period|Adverse Event|18|||
130173246|NCT00307437|468590124|FG004|After Controlled Period|Adverse Event|16|||
130173247|NCT00307437|468590125|FG005|After Controlled Period|Adverse Event|31|||
130173248|NCT00307437|468590126|FG006|After Controlled Period|Adverse Event|40|||
130173249|NCT00307437|468590120|FG000|After Controlled Period|Death|0|||
130173250|NCT00307437|468590121|FG001|After Controlled Period|Death|0|||
130173251|NCT00307437|468590122|FG002|After Controlled Period|Death|0|||
130173252|NCT00307437|468590123|FG003|After Controlled Period|Death|3|||
130173253|NCT00307437|468590124|FG004|After Controlled Period|Death|1|||
130173254|NCT00307437|468590125|FG005|After Controlled Period|Death|1|||
130173255|NCT00307437|468590126|FG006|After Controlled Period|Death|3|||
130173256|NCT00307437|468590120|FG000|After Controlled Period|Lack of Efficacy|0|||
130173257|NCT00307437|468590121|FG001|After Controlled Period|Lack of Efficacy|0|||
130173258|NCT00307437|468590122|FG002|After Controlled Period|Lack of Efficacy|0|||
130173259|NCT00307437|468590123|FG003|After Controlled Period|Lack of Efficacy|15|||
130173260|NCT00307437|468590124|FG004|After Controlled Period|Lack of Efficacy|17|||
130173261|NCT00307437|468590125|FG005|After Controlled Period|Lack of Efficacy|37|||
130173262|NCT00307437|468590126|FG006|After Controlled Period|Lack of Efficacy|24|||
130173263|NCT00307437|468590120|FG000|After Controlled Period|Lost to Follow-up|0|||
130173264|NCT00307437|468590121|FG001|After Controlled Period|Lost to Follow-up|0|||
130173265|NCT00307437|468590122|FG002|After Controlled Period|Lost to Follow-up|0|||
130173266|NCT00307437|468590123|FG003|After Controlled Period|Lost to Follow-up|7|||
130173267|NCT00307437|468590124|FG004|After Controlled Period|Lost to Follow-up|12|||
130173268|NCT00307437|468590125|FG005|After Controlled Period|Lost to Follow-up|13|||
130173269|NCT00307437|468590126|FG006|After Controlled Period|Lost to Follow-up|18|||
130173270|NCT00307437|468590120|FG000|After Controlled Period|Other|0|||
130173271|NCT00307437|468590121|FG001|After Controlled Period|Other|0|||
130173272|NCT00307437|468590122|FG002|After Controlled Period|Other|0|||
130173273|NCT00307437|468590123|FG003|After Controlled Period|Other|15|||
130173274|NCT00307437|468590124|FG004|After Controlled Period|Other|9|||
130173275|NCT00307437|468590125|FG005|After Controlled Period|Other|40|||
130173276|NCT00307437|468590126|FG006|After Controlled Period|Other|28|||
130173277|NCT00338728|468590133|FG000|Overall Study|Screen Failure|14|||
130173278|NCT00143247|468590137|FG000|Overall Study|Death|8|||
130173279|NCT00143247|468590137|FG000|Overall Study|Adverse Event|19|||
130173280|NCT00143247|468590137|FG000|Overall Study|Lack of Efficacy|3|||
130173281|NCT00143247|468590137|FG000|Overall Study|Withdrawal by Subject|55|||
130173282|NCT00143247|468590137|FG000|Overall Study|Study terminated by sponsor|31|||
130173283|NCT00143247|468590137|FG000|Overall Study|Protocol Violation|15|||
130173284|NCT00143247|468590137|FG000|Overall Study|Lost to Follow-up|12|||
130173285|NCT00143247|468590137|FG000|Overall Study|following inaccurate lab adverse event|1|||
130173286|NCT00143247|468590137|FG000|Overall Study|Other|12|||
130173287|NCT02766283|468590138|FG000|Overall Study|Lost to Follow-up|27|||
130173288|NCT04803305|468590139|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
130173289|NCT04803305|468590140|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
130173290|NCT04803305|468590139|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
130173291|NCT04803305|468590140|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
130173292|NCT04803305|468590139|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
130173293|NCT04803305|468590140|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
130173294|NCT04803305|468590139|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
130173295|NCT04803305|468590140|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
130173296|NCT04803305|468590139|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
130173297|NCT04803305|468590140|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
130173298|NCT04803305|468590139|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
130173299|NCT04803305|468590140|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
130173300|NCT04803305|468590139|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
130173301|NCT04803305|468590140|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
130173302|NCT04803305|468590139|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
130173303|NCT04803305|468590140|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
130173304|NCT00721227|468590141|FG000|Overall Study|Lost to Follow-up|3|||
130173305|NCT00721227|468590142|FG001|Overall Study|Lost to Follow-up|0|||
130173306|NCT00721227|468590141|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
130173307|NCT00721227|468590142|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
130173308|NCT03654599|468590148|FG000|Overall Study|Lost to Follow-up|14|||
130173309|NCT03654599|468590149|FG001|Overall Study|Lost to Follow-up|12|||
130173310|NCT03654599|468590148|FG000|Overall Study|Death|8|||
130173311|NCT03654599|468590149|FG001|Overall Study|Death|6|||
130173312|NCT03654599|468590148|FG000|Overall Study|Withdrawal by Subject|6|||
130173313|NCT03654599|468590149|FG001|Overall Study|Withdrawal by Subject|4|||
130173314|NCT01243775|468590150|FG000|Overall Study|Withdrawal by Subject|2|||
130173315|NCT01659125|468592343|FG000|Overall Study|Withdrawal by Subject|2|||
130173316|NCT01659125|468592343|FG000|Overall Study|Lost to Follow-up|7|||
130173317|NCT01659125|468592343|FG000|Overall Study|Technical Problem|1|||
130173318|NCT01659125|468592343|FG000|Overall Study|Time Constraints|2|||
130173319|NCT01659125|468592343|FG000|Overall Study|Failed to Start Treatment|2|||
130173320|NCT02077140|468592344|FG000|Overall Study|Lost to Follow-up|4|||
130173321|NCT02077140|468592345|FG001|Overall Study|Lost to Follow-up|1|||
130173322|NCT02077140|468592346|FG002|Overall Study|Lost to Follow-up|2|||
130173323|NCT02077140|468592347|FG003|Overall Study|Lost to Follow-up|2|||
130173324|NCT02077140|468592348|FG004|Overall Study|Lost to Follow-up|3|||
130173325|NCT02077140|468592344|FG000|Overall Study|Withdrawal by Subject|0|||
130173326|NCT02077140|468592345|FG001|Overall Study|Withdrawal by Subject|1|||
130173327|NCT02077140|468592346|FG002|Overall Study|Withdrawal by Subject|0|||
130173328|NCT02077140|468592347|FG003|Overall Study|Withdrawal by Subject|2|||
130173329|NCT02077140|468592348|FG004|Overall Study|Withdrawal by Subject|2|||
130173330|NCT01762800|468592351|FG000|Overall Study|Adverse Event|8|||
130173331|NCT01762800|468592352|FG001|Overall Study|Adverse Event|13|||
130173332|NCT01762800|468592351|FG000|Overall Study|Lack of Efficacy|3|||
130173333|NCT01762800|468592352|FG001|Overall Study|Lack of Efficacy|2|||
130173334|NCT01762800|468592351|FG000|Overall Study|Study Closed/Terminated|0|||
130173335|NCT01762800|468592352|FG001|Overall Study|Study Closed/Terminated|1|||
130173336|NCT01762800|468592351|FG000|Overall Study|Physician Decision|1|||
130173337|NCT01762800|468592352|FG001|Overall Study|Physician Decision|1|||
130173338|NCT01762800|468592351|FG000|Overall Study|Withdrawal by Subject|7|||
130173339|NCT01762800|468592352|FG001|Overall Study|Withdrawal by Subject|4|||
130173340|NCT02640482|468592353|FG000|Overall Study|Lost to Follow-up|3|||
130173341|NCT02640482|468592354|FG001|Overall Study|Lost to Follow-up|0|||
130173342|NCT00113763|468592356|FG000|Overall Study|Adverse Event|5|||
130173343|NCT00113763|468592357|FG001|Overall Study|Adverse Event|2|||
130173344|NCT00113763|468592356|FG000|Overall Study|Disease Progression|28|||
130173345|NCT00113763|468592357|FG001|Overall Study|Disease Progression|14|||
130173346|NCT00113763|468592356|FG000|Overall Study|Lost to Follow-up|10|||
130173347|NCT00113763|468592357|FG001|Overall Study|Lost to Follow-up|0|||
130173348|NCT00113763|468592356|FG000|Overall Study|Withdrawal by Subject|1|||
130173349|NCT00113763|468592357|FG001|Overall Study|Withdrawal by Subject|4|||
129982359|NCT01397422|467898833|FG002|Overall Study|Adverse Event|3|||
129982360|NCT01397422|467898834|FG003|Overall Study|Adverse Event|8|||
129982361|NCT01397422|467898831|FG000|Overall Study|Withdrawal by Subject|1|||
129982362|NCT01397422|467898832|FG001|Overall Study|Withdrawal by Subject|0|||
129982363|NCT01397422|467898833|FG002|Overall Study|Withdrawal by Subject|0|||
129982364|NCT01397422|467898834|FG003|Overall Study|Withdrawal by Subject|0|||
129982365|NCT01397422|467898831|FG000|Overall Study|Increased bradykinesia related to PD|1|||
129982366|NCT01397422|467898832|FG001|Overall Study|Increased bradykinesia related to PD|0|||
129982367|NCT01397422|467898833|FG002|Overall Study|Increased bradykinesia related to PD|0|||
129982368|NCT01397422|467898834|FG003|Overall Study|Increased bradykinesia related to PD|0|||
129982369|NCT06665919|467898835|FG000|Overall Study|Withdrawal by Subject|4|||
129982370|NCT06665919|467898836|FG001|Overall Study|Withdrawal by Subject|4|||
129982371|NCT06665919|467898837|FG002|Overall Study|Withdrawal by Subject|4|||
129982372|NCT06665919|467898835|FG000|Overall Study|Non-compliance to Treatment|4|||
129982373|NCT06665919|467898836|FG001|Overall Study|Non-compliance to Treatment|1|||
129982374|NCT06665919|467898837|FG002|Overall Study|Non-compliance to Treatment|6|||
129982375|NCT06665919|467898835|FG000|Overall Study|Lost to Follow-up|3|||
130173350|NCT00113763|468592356|FG000|Overall Study|Other|27|||
130173351|NCT00113763|468592357|FG001|Overall Study|Other|6|||
130173352|NCT00113763|468592356|FG000|Overall Study|Non-compliance|1|||
130173353|NCT00113763|468592357|FG001|Overall Study|Non-compliance|0|||
130173354|NCT00113763|468592356|FG000|Overall Study|Ongoing|1|||
130173355|NCT00113763|468592357|FG001|Overall Study|Ongoing|0|||
129982376|NCT06665919|467898836|FG001|Overall Study|Lost to Follow-up|0|||
129982377|NCT06665919|467898837|FG002|Overall Study|Lost to Follow-up|2|||
129982378|NCT06665919|467898835|FG000|Overall Study|Physician Decision|4|||
129982379|NCT06665919|467898836|FG001|Overall Study|Physician Decision|0|||
130173356|NCT00517881|468592358|FG000|Overall Study|Protocol Violation|2|||
129982380|NCT06665919|467898837|FG002|Overall Study|Physician Decision|1|||
129982381|NCT05148962|467898838|FG000|Overall Study|Withdrawal by Subject|1|||
130173357|NCT00517881|468592358|FG000|Overall Study|Adverse Event|1|||
130173358|NCT00517881|468592358|FG000|Overall Study|Renal transplantation|2|||
130173359|NCT01383707|468592363|FG000|Overall Study|Consent withdrawal|6|||
130173360|NCT01383707|468592363|FG000|Overall Study|Death|19|||
130173361|NCT01383707|468592363|FG000|Overall Study|Other|8|||
130173362|NCT01383707|468592363|FG000|Overall Study|Sponsor's decision|2|||
130173363|NCT01383707|468592363|FG000|Overall Study|Adverse Event|14|||
130173364|NCT01383707|468592363|FG000|Overall Study|Progressive disease|23|||
130173365|NCT02013817|468592364|FG000|Overall Study|Adverse Event|12|||
130173366|NCT02013817|468592364|FG000|Overall Study|Withdrawal by Subject|4|||
130173367|NCT02013817|468592364|FG000|Overall Study|Death|2|||
130173368|NCT02013817|468592364|FG000|Overall Study|Other|9|||
130173369|NCT03336528|468592365|FG000|Overall Study|Protocol Violation|1|||
130173370|NCT03336528|468592366|FG001|Overall Study|Protocol Violation|1|||
130173371|NCT03336528|468592365|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
130173372|NCT03336528|468592366|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
130173373|NCT03336528|468592365|FG000|Overall Study|Did not receive study medication|1|||
130173374|NCT03336528|468592366|FG001|Overall Study|Did not receive study medication|2|||
130173375|NCT00230178|468592371|FG000|Overall Study|Adverse Event|1|||
130173376|NCT00230178|468592372|FG001|Overall Study|Adverse Event|5|||
130173377|NCT00230178|468592373|FG002|Overall Study|Adverse Event|2|||
130173378|NCT00230178|468592371|FG000|Overall Study|Withdrawal by Subject|0|||
130173379|NCT00230178|468592372|FG001|Overall Study|Withdrawal by Subject|0|||
130173380|NCT00230178|468592373|FG002|Overall Study|Withdrawal by Subject|1|||
130173381|NCT00230178|468592371|FG000|Overall Study|Various other reasons|3|||
130173382|NCT00230178|468592372|FG001|Overall Study|Various other reasons|2|||
130173383|NCT00230178|468592373|FG002|Overall Study|Various other reasons|4|||
130173384|NCT01753297|468592374|FG000|Overall Study|Lost to Follow-up|7|||
130173385|NCT01753297|468592375|FG001|Overall Study|Lost to Follow-up|2|||
130173386|NCT01753297|468592374|FG000|Overall Study|Withdrawal by Subject|26|||
130173387|NCT01753297|468592375|FG001|Overall Study|Withdrawal by Subject|23|||
130173388|NCT01753297|468592374|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
130173389|NCT01753297|468592375|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
129982382|NCT05148962|467898839|FG001|Overall Study|Withdrawal by Subject|1|||
129982383|NCT05148962|467898840|FG002|Overall Study|Withdrawal by Subject|0|||
129982384|NCT05148962|467898841|FG003|Overall Study|Withdrawal by Subject|1|||
129982385|NCT05148962|467898842|FG004|Overall Study|Withdrawal by Subject|0|||
129982386|NCT05148962|467898838|FG000|Overall Study|Participant was early terminated per protocol|0|||
129982387|NCT05148962|467898839|FG001|Overall Study|Participant was early terminated per protocol|0|||
129982388|NCT05148962|467898840|FG002|Overall Study|Participant was early terminated per protocol|3|||
129982389|NCT05148962|467898841|FG003|Overall Study|Participant was early terminated per protocol|5|||
129982390|NCT05148962|467898842|FG004|Overall Study|Participant was early terminated per protocol|2|||
129982391|NCT05148962|467898838|FG000|Overall Study|Miscellaneous|0|||
129982392|NCT05148962|467898839|FG001|Overall Study|Miscellaneous|0|||
129982393|NCT05148962|467898840|FG002|Overall Study|Miscellaneous|0|||
129982394|NCT05148962|467898841|FG003|Overall Study|Miscellaneous|1|||
129982395|NCT05148962|467898842|FG004|Overall Study|Miscellaneous|0|||
129982396|NCT01200290|467898843|FG000|Treatment Period|Adverse Event|1|||
129982397|NCT01200290|467898843|FG000|Post-Treatment Follow-Up Period|Death|2|||
129982398|NCT01144377|467898844|FG000|52 Week Treatment Period|Adverse Event|0|||
129982399|NCT01144377|467898845|FG001|52 Week Treatment Period|Adverse Event|0|||
129982400|NCT01144377|467898846|FG002|52 Week Treatment Period|Adverse Event|3|||
129982401|NCT01144377|467898847|FG003|52 Week Treatment Period|Adverse Event|2|||
129982402|NCT01144377|467898848|FG004|52 Week Treatment Period|Adverse Event|1|||
129982403|NCT01144377|467898844|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
129982404|NCT01144377|467898845|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
129982405|NCT01144377|467898846|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
129982406|NCT01144377|467898847|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
129982407|NCT01144377|467898848|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
129982408|NCT01144377|467898844|FG000|52 Week Treatment Period|Protocol Violation|0|||
129982409|NCT01144377|467898845|FG001|52 Week Treatment Period|Protocol Violation|0|||
129982410|NCT01144377|467898846|FG002|52 Week Treatment Period|Protocol Violation|0|||
129982411|NCT01144377|467898847|FG003|52 Week Treatment Period|Protocol Violation|0|||
129982412|NCT01144377|467898848|FG004|52 Week Treatment Period|Protocol Violation|1|||
129982413|NCT01144377|467898844|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
130173390|NCT01753297|468592374|FG000|Overall Study|Death|0|||
130173391|NCT01753297|468592375|FG001|Overall Study|Death|2|||
130173392|NCT01753297|468592374|FG000|Overall Study|Did not attend end of study visit|7|||
130173393|NCT01753297|468592375|FG001|Overall Study|Did not attend end of study visit|8|||
129982414|NCT01144377|467898845|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
129982415|NCT01144377|467898846|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
129982416|NCT01144377|467898847|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
130173394|NCT04974749|468592382|FG000|Overall Study|Withdrawal by Subject|2|||
130173395|NCT04974749|468592382|FG000|Overall Study|Gestation|1|||
130173396|NCT01645787|468592383|FG000|Washout (2 Weeks)|Adverse Event|1|||
130173397|NCT01645787|468592384|FG001|Washout (2 Weeks)|Adverse Event|0|||
130173398|NCT04315506|468592386|FG000|Overall Study|Lost to Follow-up|74|||
129982417|NCT01144377|467898848|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
129982418|NCT01144377|467898844|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
129982419|NCT01144377|467898845|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
129982420|NCT01144377|467898846|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
129982421|NCT01144377|467898847|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
129982422|NCT01144377|467898848|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
129982423|NCT01144377|467898844|FG000|52 Week Treatment Period|Sponsor Decision|0|||
129982424|NCT01144377|467898845|FG001|52 Week Treatment Period|Sponsor Decision|0|||
129982425|NCT01144377|467898846|FG002|52 Week Treatment Period|Sponsor Decision|0|||
129982426|NCT01144377|467898847|FG003|52 Week Treatment Period|Sponsor Decision|0|||
129982427|NCT01144377|467898848|FG004|52 Week Treatment Period|Sponsor Decision|1|||
129982428|NCT01144377|467898844|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
129982429|NCT01144377|467898845|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
129982430|NCT01144377|467898846|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
129982431|NCT01144377|467898847|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
129982432|NCT01144377|467898848|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
129982433|NCT01144377|467898844|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982434|NCT01144377|467898845|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982435|NCT01144377|467898846|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982436|NCT01144377|467898847|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982437|NCT01144377|467898848|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
129982438|NCT01144377|467898844|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
129982439|NCT01144377|467898845|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982440|NCT01144377|467898846|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982441|NCT01144377|467898847|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982442|NCT01144377|467898848|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982443|NCT00151281|467898849|FG000|Overall Study|Not evaluable|3|||
129982444|NCT01133418|467898850|FG000|Overall Study|Lost to Follow-up|5|||
129982445|NCT01133418|467898851|FG001|Overall Study|Lost to Follow-up|6|||
129982446|NCT04150068|467898852|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
129982447|NCT04150068|467898853|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
129982448|NCT04150068|467898854|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
129982449|NCT04150068|467898852|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
129982450|NCT04150068|467898853|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
129982451|NCT04150068|467898854|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
129982452|NCT05316701|467898855|FG000|Overall Study|Adverse Event|0|||
129982453|NCT05316701|467898856|FG001|Overall Study|Adverse Event|1|||
129982454|NCT05316701|467898855|FG000|Overall Study|Death|3|||
129982455|NCT05316701|467898856|FG001|Overall Study|Death|9|||
129982456|NCT05316701|467898855|FG000|Overall Study|Lost to Follow-up|1|||
129982457|NCT05316701|467898856|FG001|Overall Study|Lost to Follow-up|0|||
129982458|NCT05316701|467898855|FG000|Overall Study|Physician Decision|1|||
129982459|NCT05316701|467898856|FG001|Overall Study|Physician Decision|4|||
129982460|NCT05316701|467898855|FG000|Overall Study|Withdrawal by Subject|3|||
129982461|NCT05316701|467898856|FG001|Overall Study|Withdrawal by Subject|5|||
129982462|NCT05316701|467898855|FG000|Overall Study|Progression/Relapse|14|||
129982463|NCT05316701|467898856|FG001|Overall Study|Progression/Relapse|9|||
129982464|NCT05316701|467898855|FG000|Overall Study|Received Standard of Care|1|||
129982465|NCT05316701|467898856|FG001|Overall Study|Received Standard of Care|0|||
129982466|NCT05316701|467898855|FG000|Overall Study|Ongoing|70|||
129982467|NCT05316701|467898856|FG001|Overall Study|Ongoing|64|||
129982468|NCT04696653|467898857|FG000|Overall Study|left organization|18|||
129982469|NCT04696653|467898857|FG000|Overall Study|Lost to Follow-up|3|||
129982470|NCT04349631|467898858|FG000|Overall Study|Lost to Follow-up|3|||
129982471|NCT04349631|467898858|FG000|Overall Study|Withdrawal by Subject|7|||
129982472|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
129982473|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
129982474|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
129982475|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
129982476|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
129982477|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
129982478|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
129982479|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
129982480|NCT00836745|467900578|FG000|Overall Study|Death|2|||
129982481|NCT00836745|467900578|FG000|Overall Study|Lost to Follow-up|10|||
129982482|NCT00836745|467900578|FG000|Overall Study|Adverse Event|3|||
129982483|NCT00836745|467900578|FG000|Overall Study|Objective progression or relapse|4|||
129982484|NCT00836745|467900578|FG000|Overall Study|Other|2|||
129982485|NCT02898077|467900580|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
129982486|NCT02898077|467900581|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
129982487|NCT02898077|467900580|FG000|Overall Study|Lost to Follow-up|4|||
129982488|NCT02898077|467900581|FG001|Overall Study|Lost to Follow-up|3|||
129982489|NCT02898077|467900580|FG000|Overall Study|Physician Decision|0|||
129982490|NCT02898077|467900581|FG001|Overall Study|Physician Decision|2|||
129982491|NCT02898077|467900580|FG000|Overall Study|Sponsor Decision|32|||
129982492|NCT02898077|467900581|FG001|Overall Study|Sponsor Decision|13|||
129982493|NCT02898077|467900580|FG000|Overall Study|Withdrawal by Subject|6|||
129982494|NCT02898077|467900581|FG001|Overall Study|Withdrawal by Subject|3|||
129982495|NCT02898077|467900580|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
129982496|NCT02898077|467900581|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
129982497|NCT02898077|467900580|FG000|Overall Study|Ended extension period|3|||
129982498|NCT02898077|467900581|FG001|Overall Study|Ended extension period|0|||
129982499|NCT00621777|467900582|FG000|Open Phase|Adverse Event|20|||
129982500|NCT00621777|467900583|FG001|Open Phase|Adverse Event|0|||
129982501|NCT00621777|467900582|FG000|Open Phase|Did not abstain during open phase|56|||
129982502|NCT00621777|467900583|FG001|Open Phase|Did not abstain during open phase|0|||
129982503|NCT00621777|467900582|FG000|Open Phase|Withdrawal by Subject|17|||
129982504|NCT00621777|467900583|FG001|Open Phase|Withdrawal by Subject|0|||
129982505|NCT00621777|467900582|FG000|Open Phase|administrative|13|||
129982506|NCT00621777|467900583|FG001|Open Phase|administrative|0|||
129982507|NCT00621777|467900582|FG000|Open Phase|Lost to Follow-up|10|||
129982508|NCT00621777|467900583|FG001|Open Phase|Lost to Follow-up|0|||
129982509|NCT00621777|467900582|FG000|Randomized Phase|Adverse Event|3|||
129982510|NCT00621777|467900583|FG001|Randomized Phase|Adverse Event|3|||
129982511|NCT00621777|467900582|FG000|Randomized Phase|Lost to Follow-up|3|||
129982512|NCT00621777|467900583|FG001|Randomized Phase|Lost to Follow-up|3|||
129982513|NCT00621777|467900582|FG000|Randomized Phase|Withdrawal by Subject|1|||
129982514|NCT00621777|467900583|FG001|Randomized Phase|Withdrawal by Subject|9|||
129982515|NCT00621777|467900582|FG000|Randomized Phase|administrative|0|||
129982516|NCT00621777|467900583|FG001|Randomized Phase|administrative|3|||
129982517|NCT00621777|467900582|FG000|Randomized Phase|Death|0|||
129982518|NCT00621777|467900583|FG001|Randomized Phase|Death|1|||
129982519|NCT01239043|467900584|FG000|Overall Study|Protocol Violation|2|||
129982520|NCT01239043|467900585|FG001|Overall Study|Protocol Violation|1|||
129982521|NCT02121301|467900588|FG000|Overall Study|Protocol Violation|1|||
129982522|NCT02121301|467900589|FG001|Overall Study|Protocol Violation|4|||
129982523|NCT02121301|467900590|FG002|Overall Study|Protocol Violation|1|||
129982524|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Death|0|||
129982525|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Death|0|||
129982526|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Death|1|||
129982527|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Death|0|||
129982528|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Death|0|||
129982529|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Death|0|||
129982530|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Death|0|||
129982531|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Death|0|||
129982532|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Death|0|||
129982533|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Death|0|||
129982534|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Death|0|||
129982535|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Death|0|||
129982536|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Death|0|||
129982537|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Death|0|||
129982538|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130173399|NCT04315506|468592387|FG001|Overall Study|Lost to Follow-up|82|||
130173400|NCT04315506|468592386|FG000|Overall Study|Withdrawal by Subject|8|||
130173401|NCT04315506|468592387|FG001|Overall Study|Withdrawal by Subject|8|||
130173402|NCT04315506|468592386|FG000|Overall Study|Physician Decision|0|||
130173403|NCT04315506|468592387|FG001|Overall Study|Physician Decision|1|||
130173404|NCT00958893|468592394|FG000|Overall Study|Study prematurely terminated|4|||
130173405|NCT03593395|468592401|FG000|Overall Study|Lost to Follow-up|48|||
130173406|NCT03593395|468592402|FG001|Overall Study|Lost to Follow-up|3|||
129982539|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982540|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
129982541|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982542|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982543|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982544|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982545|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130173407|NCT03593395|468592401|FG000|Overall Study|Withdrawal by Subject|5|||
129982546|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130173408|NCT03593395|468592402|FG001|Overall Study|Withdrawal by Subject|24|||
130173409|NCT03593395|468592401|FG000|Overall Study|Death|2|||
130173410|NCT03593395|468592402|FG001|Overall Study|Death|3|||
130173411|NCT03593395|468592401|FG000|Overall Study|Physician Decision|0|||
130173412|NCT03593395|468592402|FG001|Overall Study|Physician Decision|6|||
130173413|NCT03593395|468592401|FG000|Overall Study|Participant Relocated|19|||
130173414|NCT03593395|468592402|FG001|Overall Study|Participant Relocated|3|||
129982547|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982548|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
130173415|NCT03593395|468592401|FG000|Overall Study|No Information|1|||
130173416|NCT03593395|468592402|FG001|Overall Study|No Information|7|||
130173417|NCT01524978|468592403|FG000|Overall Study|Other|16|||
130173418|NCT01524978|468592404|FG001|Overall Study|Other|2|||
130173419|NCT01524978|468592405|FG002|Overall Study|Other|1|||
130173420|NCT01524978|468592406|FG003|Overall Study|Other|2|||
130173421|NCT01524978|468592407|FG004|Overall Study|Other|1|||
130173422|NCT01524978|468592408|FG005|Overall Study|Other|3|||
130173423|NCT01524978|468592409|FG006|Overall Study|Other|17|||
130173424|NCT01524978|468592410|FG007|Overall Study|Other|1|||
130173425|NCT01524978|468592411|FG008|Overall Study|Other|2|||
130173426|NCT01524978|468592412|FG009|Overall Study|Other|2|||
130173427|NCT01524978|468592413|FG010|Overall Study|Other|5|||
130173428|NCT01524978|468592403|FG000|Overall Study|Withdrawal by Subject|12|||
130173429|NCT01524978|468592404|FG001|Overall Study|Withdrawal by Subject|0|||
130173430|NCT01524978|468592405|FG002|Overall Study|Withdrawal by Subject|1|||
130173431|NCT01524978|468592406|FG003|Overall Study|Withdrawal by Subject|1|||
130173432|NCT01524978|468592407|FG004|Overall Study|Withdrawal by Subject|3|||
130173433|NCT01524978|468592408|FG005|Overall Study|Withdrawal by Subject|1|||
130173434|NCT01524978|468592409|FG006|Overall Study|Withdrawal by Subject|6|||
130173435|NCT01524978|468592410|FG007|Overall Study|Withdrawal by Subject|2|||
130173436|NCT01524978|468592411|FG008|Overall Study|Withdrawal by Subject|4|||
130173437|NCT01524978|468592412|FG009|Overall Study|Withdrawal by Subject|0|||
130173438|NCT01524978|468592413|FG010|Overall Study|Withdrawal by Subject|5|||
130173439|NCT01524978|468592403|FG000|Overall Study|Lost to Follow-up|0|||
130173440|NCT01524978|468592404|FG001|Overall Study|Lost to Follow-up|0|||
130173441|NCT01524978|468592405|FG002|Overall Study|Lost to Follow-up|3|||
130173442|NCT01524978|468592406|FG003|Overall Study|Lost to Follow-up|0|||
130173443|NCT01524978|468592407|FG004|Overall Study|Lost to Follow-up|1|||
130173444|NCT01524978|468592408|FG005|Overall Study|Lost to Follow-up|1|||
130173445|NCT01524978|468592409|FG006|Overall Study|Lost to Follow-up|2|||
130173446|NCT01524978|468592410|FG007|Overall Study|Lost to Follow-up|0|||
130173447|NCT01524978|468592411|FG008|Overall Study|Lost to Follow-up|1|||
130173448|NCT01524978|468592412|FG009|Overall Study|Lost to Follow-up|1|||
130173449|NCT01524978|468592413|FG010|Overall Study|Lost to Follow-up|1|||
130173450|NCT01524978|468592403|FG000|Overall Study|Death|34|||
130173451|NCT01524978|468592404|FG001|Overall Study|Death|2|||
130173452|NCT01524978|468592405|FG002|Overall Study|Death|5|||
130173453|NCT01524978|468592406|FG003|Overall Study|Death|24|||
130173454|NCT01524978|468592407|FG004|Overall Study|Death|4|||
130173455|NCT01524978|468592408|FG005|Overall Study|Death|4|||
130173456|NCT01524978|468592409|FG006|Overall Study|Death|1|||
130173457|NCT01524978|468592410|FG007|Overall Study|Death|9|||
130173458|NCT01524978|468592411|FG008|Overall Study|Death|5|||
130173459|NCT01524978|468592412|FG009|Overall Study|Death|6|||
130173460|NCT01524978|468592413|FG010|Overall Study|Death|17|||
130173461|NCT00606632|468592416|FG000|Overall Study|Withdrawal by Subject|13|||
130173462|NCT00606632|468592416|FG000|Overall Study|Miscellaneous reasons|9|||
130173463|NCT02481869|468592417|FG000|Overall Study|Lost to Follow-up|3|||
130173464|NCT02481869|468592418|FG001|Overall Study|Lost to Follow-up|4|||
130173465|NCT02481869|468592417|FG000|Overall Study|Withdrawal by Subject|2|||
130173466|NCT02481869|468592418|FG001|Overall Study|Withdrawal by Subject|0|||
130173467|NCT00711880|468592419|FG000|Overall Study|Adverse Event|11|||
130173468|NCT00711880|468592420|FG001|Overall Study|Adverse Event|2|||
130173469|NCT00711880|468592419|FG000|Overall Study|Patient non-compliance|1|||
130173470|NCT00711880|468592420|FG001|Overall Study|Patient non-compliance|0|||
130173471|NCT00711880|468592419|FG000|Overall Study|Lack of Efficacy|1|||
130173472|NCT00711880|468592420|FG001|Overall Study|Lack of Efficacy|5|||
130173473|NCT04238650|468592423|FG000|Overall Study|Withdrawal by Subject|0|||
130173474|NCT04238650|468592424|FG001|Overall Study|Withdrawal by Subject|1|||
130173475|NCT02756208|468592428|FG000|Overall Study|Withdrawal by Subject|1|||
130173476|NCT02756208|468592429|FG001|Overall Study|Withdrawal by Subject|0|||
130173477|NCT02756208|468592430|FG002|Overall Study|Withdrawal by Subject|1|||
130173478|NCT02756208|468592431|FG003|Overall Study|Withdrawal by Subject|3|||
130173479|NCT02756208|468592428|FG000|Overall Study|Lost to Follow-up|3|||
130173480|NCT02756208|468592429|FG001|Overall Study|Lost to Follow-up|1|||
130173481|NCT02756208|468592430|FG002|Overall Study|Lost to Follow-up|1|||
130173482|NCT02756208|468592431|FG003|Overall Study|Lost to Follow-up|1|||
130173483|NCT02756208|468592428|FG000|Overall Study|Physician Decision|1|||
130173484|NCT02756208|468592429|FG001|Overall Study|Physician Decision|0|||
130173485|NCT02756208|468592430|FG002|Overall Study|Physician Decision|0|||
130173486|NCT02756208|468592431|FG003|Overall Study|Physician Decision|0|||
130173487|NCT02756208|468592428|FG000|Overall Study|Protocol Violation|0|||
130173488|NCT02756208|468592429|FG001|Overall Study|Protocol Violation|1|||
130173489|NCT02756208|468592430|FG002|Overall Study|Protocol Violation|0|||
130173490|NCT02756208|468592431|FG003|Overall Study|Protocol Violation|0|||
130173491|NCT02370238|468592432|FG000|Overall Study|Death|42|||
130173492|NCT02370238|468592433|FG001|Overall Study|Death|35|||
130173493|NCT02370238|468592432|FG000|Overall Study|Lost to Follow-up|1|||
130173494|NCT02370238|468592433|FG001|Overall Study|Lost to Follow-up|3|||
130173495|NCT02370238|468592432|FG000|Overall Study|Withdrawal by Subject|2|||
130173496|NCT02370238|468592433|FG001|Overall Study|Withdrawal by Subject|6|||
130173497|NCT02370238|468592432|FG000|Overall Study|Other|2|||
130173498|NCT02370238|468592433|FG001|Overall Study|Other|1|||
130173499|NCT01295320|468592438|FG000|Overall Study|Adverse Event|2|||
130173500|NCT01295320|468592438|FG000|Overall Study|Lost to Follow-up|4|||
130173501|NCT01295320|468592438|FG000|Overall Study|Withdrawal by Subject|2|||
130173502|NCT01295320|468592438|FG000|Overall Study|Subject was bedridden|1|||
130173503|NCT01295320|468592438|FG000|Overall Study|Unable to travel|1|||
130173504|NCT00652340|468592439|FG000|Overall Study|Had not progressed.|4|||
130173505|NCT00652340|468592440|FG001|Overall Study|Had not progressed.|3|||
130173506|NCT03682107|468592441|FG000|Overall Study|Withdrawal by Subject|0|||
130173507|NCT03682107|468592442|FG001|Overall Study|Withdrawal by Subject|1|||
130173508|NCT03682107|468592443|FG002|Overall Study|Withdrawal by Subject|0|||
130173509|NCT03682107|468592444|FG003|Overall Study|Withdrawal by Subject|0|||
130173510|NCT03682107|468592445|FG004|Overall Study|Withdrawal by Subject|0|||
130173511|NCT04342819|468592446|FG000|Overall Study|Declined|4|||
130173512|NCT04342819|468592446|FG000|Overall Study|Not meeeting selection criteria|1|||
130173513|NCT01569295|468592447|FG000|Overall Study|Progressive Disease|75|||
130173514|NCT01569295|468592448|FG001|Overall Study|Progressive Disease|139|||
130173515|NCT01569295|468592447|FG000|Overall Study|Adverse Event|39|||
130173516|NCT01569295|468592448|FG001|Overall Study|Adverse Event|14|||
130173517|NCT01569295|468592447|FG000|Overall Study|Withdrawal by Subject|25|||
130173518|NCT01569295|468592448|FG001|Overall Study|Withdrawal by Subject|12|||
130173519|NCT01569295|468592447|FG000|Overall Study|Death|19|||
130173520|NCT01569295|468592448|FG001|Overall Study|Death|15|||
130173521|NCT01569295|468592447|FG000|Overall Study|Physician Decision|13|||
130173522|NCT01569295|468592448|FG001|Overall Study|Physician Decision|18|||
130173523|NCT01569295|468592447|FG000|Overall Study|Study Terminated by Sponsor|24|||
130173524|NCT01569295|468592448|FG001|Overall Study|Study Terminated by Sponsor|2|||
130173525|NCT01569295|468592447|FG000|Overall Study|Other Reason not Specified|3|||
130173526|NCT01569295|468592448|FG001|Overall Study|Other Reason not Specified|5|||
130173527|NCT01569295|468592447|FG000|Overall Study|Non-Compliance with Study Drug|6|||
130173528|NCT01569295|468592448|FG001|Overall Study|Non-Compliance with Study Drug|1|||
130173529|NCT01569295|468592447|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
130173530|NCT01569295|468592448|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
130173531|NCT01569295|468592447|FG000|Overall Study|Lost to Follow-up|1|||
130173532|NCT01569295|468592448|FG001|Overall Study|Lost to Follow-up|1|||
130173533|NCT03607487|468592449|FG000|Overall Study|Withdrawal by Subject|2|||
130173534|NCT03607487|468592450|FG001|Overall Study|Withdrawal by Subject|0|||
130173535|NCT03607487|468592451|FG002|Overall Study|Withdrawal by Subject|0|||
130173536|NCT03607487|468592452|FG003|Overall Study|Withdrawal by Subject|1|||
130173537|NCT01884337|468592453|FG000|Treatment|Adverse Event|2|||
130173538|NCT01884337|468592454|FG001|Treatment|Adverse Event|2|||
130173539|NCT01884337|468592453|FG000|Treatment|Subj. request to discont. treatment|2|||
130173540|NCT01884337|468592454|FG001|Treatment|Subj. request to discont. treatment|0|||
130173541|NCT01884337|468592453|FG000|Follow-up Period|Lost to Follow-up|1|||
130173542|NCT01884337|468592454|FG001|Follow-up Period|Lost to Follow-up|1|||
130173543|NCT02455518|468592455|FG000|Overall Study|Protocol Violation|0|||
130173544|NCT02455518|468592456|FG001|Overall Study|Protocol Violation|1|||
130173545|NCT02455518|468592457|FG002|Overall Study|Protocol Violation|1|||
130173546|NCT02455518|468592458|FG003|Overall Study|Protocol Violation|3|||
130173547|NCT01038297|468592459|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
130173548|NCT01038297|468592460|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
130173549|NCT01038297|468592461|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
130173550|NCT01973595|468592464|FG000|Washout|Withdrawal by Subject|1|||
130173551|NCT01973595|468592465|FG001|Washout|Withdrawal by Subject|0|||
130173552|NCT01973595|468592466|FG002|Washout|Withdrawal by Subject|1|||
130173553|NCT01973595|468592467|FG003|Washout|Withdrawal by Subject|0|||
130173554|NCT02508935|468592468|FG000|Overall Study|Withdrawal by Subject|1|||
130173555|NCT02508935|468592468|FG000|Overall Study|Withdrawal by Caregiver|8|||
130173556|NCT02508935|468592468|FG000|Overall Study|Pain Score <4|1|||
130173557|NCT02508935|468592468|FG000|Overall Study|Emesis|3|||
130173558|NCT02508935|468592468|FG000|Overall Study|Adverse Event|3|||
129982549|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982550|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982551|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982552|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
129982553|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
129982554|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
129982555|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
130173559|NCT02508935|468592468|FG000|Overall Study|Protocol Violation|1|||
130173560|NCT02508935|468592468|FG000|Overall Study|Physician Decision|1|||
130173561|NCT02508935|468592468|FG000|Overall Study|Trial terminated by sponsor|5|||
130173562|NCT01275430|468592474|FG000|Overall Study|Adverse Event|1|||
130173563|NCT01275430|468592474|FG000|Overall Study|No Contrast Injection|6|||
129982556|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
130173564|NCT01275430|468592474|FG000|Overall Study|Device Malfunction|1|||
130173565|NCT01275430|468592474|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
130173566|NCT00710866|468592475|FG000|Overall Study|Protocol Violation|5|||
130173567|NCT00710866|468592476|FG001|Overall Study|Protocol Violation|4|||
130173568|NCT00710866|468592475|FG000|Overall Study|Withdrawal by Subject|2|||
130173569|NCT00710866|468592476|FG001|Overall Study|Withdrawal by Subject|1|||
130173570|NCT00710866|468592475|FG000|Overall Study|Lost to Follow-up|1|||
130173571|NCT00710866|468592476|FG001|Overall Study|Lost to Follow-up|0|||
130173572|NCT00710866|468592475|FG000|Overall Study|Failed to meet eligibility|1|||
130173573|NCT00710866|468592476|FG001|Overall Study|Failed to meet eligibility|1|||
130173574|NCT04036110|468592477|FG000|Overall Study|Lost to Follow-up|3|||
130173575|NCT04036110|468592478|FG001|Overall Study|Lost to Follow-up|2|||
130173576|NCT04036110|468592479|FG002|Overall Study|Lost to Follow-up|1|||
130173577|NCT04036110|468592477|FG000|Overall Study|Study Suspended|4|||
130173578|NCT04036110|468592478|FG001|Overall Study|Study Suspended|5|||
130173579|NCT04036110|468592479|FG002|Overall Study|Study Suspended|1|||
130173580|NCT00396565|468592484|FG000|Overall Study|Physician Decision|3|||
130173581|NCT00396565|468592485|FG001|Overall Study|Physician Decision|1|||
130173582|NCT00396565|468592486|FG002|Overall Study|Physician Decision|2|||
130173583|NCT00396565|468592484|FG000|Overall Study|Adverse Event|5|||
130173584|NCT00396565|468592485|FG001|Overall Study|Adverse Event|13|||
130173585|NCT00396565|468592486|FG002|Overall Study|Adverse Event|3|||
129982557|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982558|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982559|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982560|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982561|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982562|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982563|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982564|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982565|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982566|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
129982567|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982568|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
129982569|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
129982570|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982571|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982572|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982573|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982574|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982575|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982576|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982577|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982578|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982579|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982580|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Other|0|||
129982581|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Other|0|||
129982582|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Other|2|||
129982583|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Other|0|||
129982584|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Other|0|||
129982585|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Other|0|||
129982586|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Other|0|||
129982587|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Other|0|||
129982588|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Other|0|||
129982589|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Other|0|||
129982590|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Other|0|||
129982591|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Other|0|||
129982592|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Other|0|||
129982593|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Other|0|||
129982594|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982595|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982596|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982597|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982598|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
129982599|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982600|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
129982601|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
129982602|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982603|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982604|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982605|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982606|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982607|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
130173586|NCT00396565|468592484|FG000|Overall Study|Withdrawal by Subject|8|||
130173587|NCT00396565|468592485|FG001|Overall Study|Withdrawal by Subject|13|||
130173588|NCT00396565|468592486|FG002|Overall Study|Withdrawal by Subject|1|||
130173589|NCT00396565|468592484|FG000|Overall Study|Lack of Efficacy|32|||
130173590|NCT00396565|468592485|FG001|Overall Study|Lack of Efficacy|64|||
130173591|NCT00396565|468592486|FG002|Overall Study|Lack of Efficacy|11|||
130173592|NCT04324021|468592489|FG000|Overall Study|Adverse Event|1|||
130173593|NCT04324021|468592490|FG001|Overall Study|Adverse Event|0|||
130173594|NCT04324021|468592491|FG002|Overall Study|Adverse Event|0|||
130173595|NCT04324021|468592489|FG000|Overall Study|Lack of Efficacy|0|||
130173596|NCT04324021|468592490|FG001|Overall Study|Lack of Efficacy|0|||
130173597|NCT04324021|468592491|FG002|Overall Study|Lack of Efficacy|1|||
130173598|NCT04324021|468592489|FG000|Overall Study|Death|1|||
130173599|NCT04324021|468592490|FG001|Overall Study|Death|1|||
130173600|NCT04324021|468592491|FG002|Overall Study|Death|0|||
130173601|NCT03097991|468592492|FG000|Overall Study|Didn't meet study criteria|8|||
130173602|NCT03097991|468592493|FG001|Overall Study|Didn't meet study criteria|0|||
130173603|NCT03097991|468592492|FG000|Overall Study|Withdrawal by Subject|12|||
130173604|NCT03097991|468592493|FG001|Overall Study|Withdrawal by Subject|6|||
130173605|NCT03097991|468592492|FG000|Overall Study|Death of Baby|3|||
130173606|NCT03097991|468592493|FG001|Overall Study|Death of Baby|1|||
130173607|NCT03097991|468592492|FG000|Overall Study|Lost to Follow-up|24|||
130173608|NCT03097991|468592493|FG001|Overall Study|Lost to Follow-up|38|||
130173609|NCT03097991|468592492|FG000|Overall Study|Adverse Event|3|||
130173610|NCT03097991|468592493|FG001|Overall Study|Adverse Event|5|||
130173611|NCT00246324|468592494|FG000|Overall Study|Withdrawal by Subject|1|||
130173612|NCT02006732|468592495|FG000|Overall Study|Adverse Event|10|||
130173613|NCT02006732|468592496|FG001|Overall Study|Adverse Event|7|||
130173614|NCT02006732|468592497|FG002|Overall Study|Adverse Event|4|||
130173615|NCT02006732|468592498|FG003|Overall Study|Adverse Event|2|||
130173616|NCT02006732|468592495|FG000|Overall Study|Lack of Efficacy|6|||
130173617|NCT02006732|468592496|FG001|Overall Study|Lack of Efficacy|3|||
130173618|NCT02006732|468592497|FG002|Overall Study|Lack of Efficacy|1|||
130173619|NCT02006732|468592498|FG003|Overall Study|Lack of Efficacy|1|||
130173620|NCT02006732|468592495|FG000|Overall Study|Protocol Violation|1|||
130173621|NCT02006732|468592496|FG001|Overall Study|Protocol Violation|1|||
130173622|NCT02006732|468592497|FG002|Overall Study|Protocol Violation|0|||
130173623|NCT02006732|468592498|FG003|Overall Study|Protocol Violation|0|||
130173624|NCT02006732|468592495|FG000|Overall Study|Lost to Follow-up|0|||
130173625|NCT02006732|468592496|FG001|Overall Study|Lost to Follow-up|1|||
130173626|NCT02006732|468592497|FG002|Overall Study|Lost to Follow-up|0|||
130173627|NCT02006732|468592498|FG003|Overall Study|Lost to Follow-up|0|||
130173628|NCT02006732|468592495|FG000|Overall Study|Withdrawal by Subject|3|||
130173629|NCT02006732|468592496|FG001|Overall Study|Withdrawal by Subject|0|||
130173630|NCT02006732|468592497|FG002|Overall Study|Withdrawal by Subject|4|||
130173631|NCT02006732|468592498|FG003|Overall Study|Withdrawal by Subject|1|||
130173632|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
130173633|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
130173634|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
130173635|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Death|1|||
130173636|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Death|3|||
130173637|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Death|1|||
130173638|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
129982608|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982609|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982610|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982611|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982612|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
129982613|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982614|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
129982615|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
129982616|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982617|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982618|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982619|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982620|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982621|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982622|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982623|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982624|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130173639|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
130173640|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
130173641|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
130173642|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
130173643|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
130173644|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
130173645|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
130173646|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
130173647|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
130173648|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
130173649|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
130173650|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
130173651|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
130173652|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
130173653|NCT00299130|468592499|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
130173654|NCT00299130|468592500|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
130173655|NCT00299130|468592501|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
130173656|NCT00299130|468592499|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
130173657|NCT00299130|468592500|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
130173658|NCT00299130|468592501|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
130173659|NCT00299130|468592499|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
130173660|NCT00299130|468592500|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
130173661|NCT00299130|468592501|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
130173662|NCT00299130|468592499|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
130173663|NCT00299130|468592500|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
130173664|NCT00299130|468592501|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
130173665|NCT00299130|468592499|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
130173666|NCT00299130|468592500|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
130173667|NCT00299130|468592501|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
130173668|NCT00299130|468592499|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
130173669|NCT00299130|468592500|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
130173670|NCT00299130|468592501|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
130173671|NCT00299130|468592499|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
130173672|NCT00299130|468592500|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
130173673|NCT00299130|468592501|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
130173674|NCT00299130|468592499|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
130173675|NCT00299130|468592500|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
130173676|NCT00299130|468592501|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
130173677|NCT00299130|468592499|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
130173678|NCT00299130|468592500|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
130173679|NCT00299130|468592501|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
130173680|NCT00299130|468592499|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
130173681|NCT00299130|468592500|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
130173682|NCT00299130|468592501|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
130173683|NCT02516553|468592502|FG000|Overall Study|Progressive disease|2|||
130173684|NCT02516553|468592503|FG001|Overall Study|Progressive disease|2|||
130173685|NCT02516553|468592504|FG002|Overall Study|Progressive disease|3|||
130173686|NCT02516553|468592505|FG003|Overall Study|Progressive disease|5|||
130173687|NCT02516553|468592506|FG004|Overall Study|Progressive disease|3|||
130173688|NCT02516553|468592507|FG005|Overall Study|Progressive disease|0|||
130173689|NCT02516553|468592508|FG006|Overall Study|Progressive disease|5|||
130173690|NCT02516553|468592509|FG007|Overall Study|Progressive disease|5|||
130173691|NCT02516553|468592510|FG008|Overall Study|Progressive disease|11|||
130173692|NCT02516553|468592511|FG009|Overall Study|Progressive disease|3|||
130173693|NCT02516553|468592512|FG010|Overall Study|Progressive disease|10|||
130173694|NCT02516553|468592513|FG011|Overall Study|Progressive disease|8|||
130173695|NCT02516553|468592514|FG012|Overall Study|Progressive disease|8|||
130173696|NCT02516553|468592515|FG013|Overall Study|Progressive disease|2|||
130173697|NCT02516553|468592516|FG014|Overall Study|Progressive disease|2|||
130173698|NCT02516553|468592517|FG015|Overall Study|Progressive disease|2|||
130173699|NCT02516553|468592518|FG016|Overall Study|Progressive disease|1|||
130173700|NCT02516553|468592519|FG017|Overall Study|Progressive disease|9|||
130173701|NCT02516553|468592520|FG018|Overall Study|Progressive disease|12|||
130173702|NCT02516553|468592521|FG019|Overall Study|Progressive disease|7|||
130173703|NCT02516553|468592522|FG020|Overall Study|Progressive disease|16|||
130173704|NCT02516553|468592523|FG021|Overall Study|Progressive disease|18|||
130173705|NCT02516553|468592502|FG000|Overall Study|Dose limiting toxicity|0|||
130173706|NCT02516553|468592503|FG001|Overall Study|Dose limiting toxicity|0|||
130173707|NCT02516553|468592504|FG002|Overall Study|Dose limiting toxicity|0|||
130173708|NCT02516553|468592505|FG003|Overall Study|Dose limiting toxicity|0|||
130173709|NCT02516553|468592506|FG004|Overall Study|Dose limiting toxicity|3|||
129982625|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982626|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
130173710|NCT02516553|468592507|FG005|Overall Study|Dose limiting toxicity|1|||
130173711|NCT02516553|468592508|FG006|Overall Study|Dose limiting toxicity|1|||
130173712|NCT02516553|468592509|FG007|Overall Study|Dose limiting toxicity|0|||
130173713|NCT02516553|468592510|FG008|Overall Study|Dose limiting toxicity|1|||
129982627|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982628|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130173714|NCT02516553|468592511|FG009|Overall Study|Dose limiting toxicity|0|||
130173715|NCT02516553|468592512|FG010|Overall Study|Dose limiting toxicity|0|||
130173716|NCT02516553|468592513|FG011|Overall Study|Dose limiting toxicity|1|||
130173717|NCT02516553|468592514|FG012|Overall Study|Dose limiting toxicity|0|||
130173718|NCT02516553|468592515|FG013|Overall Study|Dose limiting toxicity|1|||
130173719|NCT02516553|468592516|FG014|Overall Study|Dose limiting toxicity|0|||
130173720|NCT02516553|468592517|FG015|Overall Study|Dose limiting toxicity|0|||
130173721|NCT02516553|468592518|FG016|Overall Study|Dose limiting toxicity|1|||
130173722|NCT02516553|468592519|FG017|Overall Study|Dose limiting toxicity|1|||
130173723|NCT02516553|468592520|FG018|Overall Study|Dose limiting toxicity|0|||
130173724|NCT02516553|468592521|FG019|Overall Study|Dose limiting toxicity|2|||
130173725|NCT02516553|468592522|FG020|Overall Study|Dose limiting toxicity|0|||
130173726|NCT02516553|468592523|FG021|Overall Study|Dose limiting toxicity|0|||
130173727|NCT02516553|468592502|FG000|Overall Study|Other Adverse Events|0|||
130173728|NCT02516553|468592503|FG001|Overall Study|Other Adverse Events|0|||
130173729|NCT02516553|468592504|FG002|Overall Study|Other Adverse Events|0|||
130173730|NCT02516553|468592505|FG003|Overall Study|Other Adverse Events|1|||
130173731|NCT02516553|468592506|FG004|Overall Study|Other Adverse Events|0|||
130173732|NCT02516553|468592507|FG005|Overall Study|Other Adverse Events|1|||
130173733|NCT02516553|468592508|FG006|Overall Study|Other Adverse Events|0|||
130173734|NCT02516553|468592509|FG007|Overall Study|Other Adverse Events|0|||
130173735|NCT02516553|468592510|FG008|Overall Study|Other Adverse Events|0|||
130173736|NCT02516553|468592511|FG009|Overall Study|Other Adverse Events|1|||
130173737|NCT02516553|468592512|FG010|Overall Study|Other Adverse Events|3|||
130173738|NCT02516553|468592513|FG011|Overall Study|Other Adverse Events|2|||
130173739|NCT02516553|468592514|FG012|Overall Study|Other Adverse Events|0|||
130173740|NCT02516553|468592515|FG013|Overall Study|Other Adverse Events|1|||
130173741|NCT02516553|468592516|FG014|Overall Study|Other Adverse Events|0|||
130173742|NCT02516553|468592517|FG015|Overall Study|Other Adverse Events|0|||
130173743|NCT02516553|468592518|FG016|Overall Study|Other Adverse Events|0|||
130173744|NCT02516553|468592519|FG017|Overall Study|Other Adverse Events|2|||
130173745|NCT02516553|468592520|FG018|Overall Study|Other Adverse Events|1|||
130173746|NCT02516553|468592521|FG019|Overall Study|Other Adverse Events|2|||
130173747|NCT02516553|468592522|FG020|Overall Study|Other Adverse Events|2|||
130173748|NCT02516553|468592523|FG021|Overall Study|Other Adverse Events|1|||
130173749|NCT02516553|468592502|FG000|Overall Study|Refused to continue trial medication|0|||
130173750|NCT02516553|468592503|FG001|Overall Study|Refused to continue trial medication|0|||
130173751|NCT02516553|468592504|FG002|Overall Study|Refused to continue trial medication|0|||
130173752|NCT02516553|468592505|FG003|Overall Study|Refused to continue trial medication|0|||
130173753|NCT02516553|468592506|FG004|Overall Study|Refused to continue trial medication|0|||
130173754|NCT02516553|468592507|FG005|Overall Study|Refused to continue trial medication|0|||
130173755|NCT02516553|468592508|FG006|Overall Study|Refused to continue trial medication|0|||
130173756|NCT02516553|468592509|FG007|Overall Study|Refused to continue trial medication|0|||
130173757|NCT02516553|468592510|FG008|Overall Study|Refused to continue trial medication|0|||
130173758|NCT02516553|468592511|FG009|Overall Study|Refused to continue trial medication|0|||
130173759|NCT02516553|468592512|FG010|Overall Study|Refused to continue trial medication|1|||
130173760|NCT02516553|468592513|FG011|Overall Study|Refused to continue trial medication|0|||
130173761|NCT02516553|468592514|FG012|Overall Study|Refused to continue trial medication|0|||
130173762|NCT02516553|468592515|FG013|Overall Study|Refused to continue trial medication|0|||
130173763|NCT02516553|468592516|FG014|Overall Study|Refused to continue trial medication|0|||
130173764|NCT02516553|468592517|FG015|Overall Study|Refused to continue trial medication|0|||
130173765|NCT02516553|468592518|FG016|Overall Study|Refused to continue trial medication|0|||
130173766|NCT02516553|468592519|FG017|Overall Study|Refused to continue trial medication|0|||
130173767|NCT02516553|468592520|FG018|Overall Study|Refused to continue trial medication|1|||
130173768|NCT02516553|468592521|FG019|Overall Study|Refused to continue trial medication|0|||
130173769|NCT02516553|468592522|FG020|Overall Study|Refused to continue trial medication|0|||
130173770|NCT02516553|468592523|FG021|Overall Study|Refused to continue trial medication|1|||
130173771|NCT02516553|468592502|FG000|Overall Study|other reasons than listed|0|||
130173772|NCT02516553|468592503|FG001|Overall Study|other reasons than listed|0|||
130173773|NCT02516553|468592504|FG002|Overall Study|other reasons than listed|0|||
130173774|NCT02516553|468592505|FG003|Overall Study|other reasons than listed|0|||
130173775|NCT02516553|468592506|FG004|Overall Study|other reasons than listed|0|||
130173776|NCT02516553|468592507|FG005|Overall Study|other reasons than listed|0|||
130173777|NCT02516553|468592508|FG006|Overall Study|other reasons than listed|0|||
130173778|NCT02516553|468592509|FG007|Overall Study|other reasons than listed|1|||
130173779|NCT02516553|468592510|FG008|Overall Study|other reasons than listed|1|||
130173780|NCT02516553|468592511|FG009|Overall Study|other reasons than listed|0|||
130173781|NCT02516553|468592512|FG010|Overall Study|other reasons than listed|1|||
130173782|NCT02516553|468592513|FG011|Overall Study|other reasons than listed|1|||
130173783|NCT02516553|468592514|FG012|Overall Study|other reasons than listed|0|||
130173784|NCT02516553|468592515|FG013|Overall Study|other reasons than listed|0|||
130173785|NCT02516553|468592516|FG014|Overall Study|other reasons than listed|0|||
130173786|NCT02516553|468592517|FG015|Overall Study|other reasons than listed|0|||
130173787|NCT02516553|468592518|FG016|Overall Study|other reasons than listed|0|||
130173788|NCT02516553|468592519|FG017|Overall Study|other reasons than listed|0|||
130173789|NCT02516553|468592520|FG018|Overall Study|other reasons than listed|0|||
130173790|NCT02516553|468592521|FG019|Overall Study|other reasons than listed|0|||
130173791|NCT02516553|468592522|FG020|Overall Study|other reasons than listed|2|||
130173792|NCT02516553|468592523|FG021|Overall Study|other reasons than listed|2|||
130173793|NCT03052127|468592524|FG000|Overall Study|Withdrawal by Subject|0|||
130173794|NCT03052127|468592525|FG001|Overall Study|Withdrawal by Subject|0|||
130173795|NCT03052127|468592526|FG002|Overall Study|Withdrawal by Subject|0|||
130173796|NCT03052127|468592527|FG003|Overall Study|Withdrawal by Subject|0|||
130173797|NCT03052127|468592528|FG004|Overall Study|Withdrawal by Subject|0|||
130173798|NCT03052127|468592529|FG005|Overall Study|Withdrawal by Subject|0|||
130173799|NCT03052127|468592530|FG006|Overall Study|Withdrawal by Subject|0|||
130173800|NCT03052127|468592531|FG007|Overall Study|Withdrawal by Subject|1|||
130173801|NCT03052127|468592532|FG008|Overall Study|Withdrawal by Subject|1|||
130173802|NCT03052127|468592533|FG009|Overall Study|Withdrawal by Subject|1|||
130173803|NCT03052127|468592534|FG010|Overall Study|Withdrawal by Subject|0|||
130173804|NCT03052127|468592535|FG011|Overall Study|Withdrawal by Subject|0|||
130173805|NCT03052127|468592524|FG000|Overall Study|Discontinuation by Sponsor|0|||
130173806|NCT03052127|468592525|FG001|Overall Study|Discontinuation by Sponsor|0|||
130173807|NCT03052127|468592526|FG002|Overall Study|Discontinuation by Sponsor|0|||
130173808|NCT03052127|468592527|FG003|Overall Study|Discontinuation by Sponsor|0|||
130173809|NCT03052127|468592528|FG004|Overall Study|Discontinuation by Sponsor|0|||
130173810|NCT03052127|468592529|FG005|Overall Study|Discontinuation by Sponsor|0|||
130173811|NCT03052127|468592530|FG006|Overall Study|Discontinuation by Sponsor|0|||
130173812|NCT03052127|468592531|FG007|Overall Study|Discontinuation by Sponsor|0|||
130173813|NCT03052127|468592532|FG008|Overall Study|Discontinuation by Sponsor|4|||
130173814|NCT03052127|468592533|FG009|Overall Study|Discontinuation by Sponsor|2|||
130173815|NCT03052127|468592534|FG010|Overall Study|Discontinuation by Sponsor|5|||
130173816|NCT03052127|468592535|FG011|Overall Study|Discontinuation by Sponsor|13|||
130173817|NCT03052127|468592524|FG000|Overall Study|Inability to comply with trial requirements|0|||
130173818|NCT03052127|468592525|FG001|Overall Study|Inability to comply with trial requirements|0|||
130173819|NCT03052127|468592526|FG002|Overall Study|Inability to comply with trial requirements|1|||
130173820|NCT03052127|468592527|FG003|Overall Study|Inability to comply with trial requirements|0|||
130173821|NCT03052127|468592528|FG004|Overall Study|Inability to comply with trial requirements|0|||
130173822|NCT03052127|468592529|FG005|Overall Study|Inability to comply with trial requirements|0|||
130173823|NCT03052127|468592530|FG006|Overall Study|Inability to comply with trial requirements|0|||
130173824|NCT03052127|468592531|FG007|Overall Study|Inability to comply with trial requirements|0|||
130173825|NCT03052127|468592532|FG008|Overall Study|Inability to comply with trial requirements|0|||
130173826|NCT03052127|468592533|FG009|Overall Study|Inability to comply with trial requirements|0|||
130173827|NCT03052127|468592534|FG010|Overall Study|Inability to comply with trial requirements|0|||
130173828|NCT03052127|468592535|FG011|Overall Study|Inability to comply with trial requirements|0|||
130173829|NCT03052127|468592524|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130173830|NCT03052127|468592525|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173831|NCT03052127|468592526|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173832|NCT03052127|468592527|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173833|NCT03052127|468592528|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130173834|NCT03052127|468592529|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130173835|NCT03052127|468592530|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
130173836|NCT03052127|468592531|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173837|NCT03052127|468592532|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173838|NCT03052127|468592533|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173839|NCT03052127|468592534|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173840|NCT03052127|468592535|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
130173841|NCT03694327|468592536|FG000|Overall Study|Lost to Follow-up|13|||
130173842|NCT03694327|468592537|FG001|Overall Study|Lost to Follow-up|23|||
130173843|NCT01464931|468592540|FG000|Overall Study|Withdrawal by Subject|1|||
130173844|NCT01464931|468592541|FG001|Overall Study|Withdrawal by Subject|0|||
130173845|NCT01982812|468592542|FG000|Overall Study|Death|1|||
130173846|NCT01982812|468592543|FG001|Overall Study|Death|5|||
130173847|NCT01982812|468592542|FG000|Overall Study|Adverse Event|0|||
130173848|NCT01982812|468592543|FG001|Overall Study|Adverse Event|5|||
130173849|NCT02933255|468592546|FG000|Overall Study|Discontinued due to study closure.|1|||
129982629|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130173850|NCT02933255|468592547|FG001|Overall Study|Discontinued due to study closure.|0|||
130173851|NCT05833139|468595095|FG000|Study Period 2|Adverse Event|1|||
130173852|NCT03922529|468595096|FG000|Overall Study|Withdrawal by Subject|13|||
130173853|NCT03922529|468595097|FG001|Overall Study|Withdrawal by Subject|12|||
130173854|NCT03922529|468595096|FG000|Overall Study|Death|7|||
130173855|NCT03922529|468595097|FG001|Overall Study|Death|12|||
130173856|NCT03922529|468595096|FG000|Overall Study|Lost to Follow-up|12|||
130173857|NCT03922529|468595097|FG001|Overall Study|Lost to Follow-up|19|||
130173858|NCT03922529|468595096|FG000|Overall Study|Adverse Event|1|||
130173859|NCT03922529|468595097|FG001|Overall Study|Adverse Event|0|||
130173860|NCT03922529|468595096|FG000|Overall Study|Death after withdrawal|1|||
130173861|NCT03922529|468595097|FG001|Overall Study|Death after withdrawal|0|||
130173862|NCT03922529|468595096|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
130173863|NCT03922529|468595097|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
130173864|NCT03922529|468595096|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
130173865|NCT03922529|468595097|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
130173866|NCT02506153|468595098|FG000|Overall Study|Adverse Event|359|||
130173867|NCT02506153|468595099|FG001|Overall Study|Adverse Event|114|||
130173868|NCT02506153|468595098|FG000|Overall Study|Refused unrelated to adverse event|127|||
130173869|NCT02506153|468595099|FG001|Overall Study|Refused unrelated to adverse event|18|||
130173870|NCT02506153|468595098|FG000|Overall Study|Progression/relapse|91|||
130173871|NCT02506153|468595099|FG001|Overall Study|Progression/relapse|136|||
130173872|NCT02506153|468595098|FG000|Overall Study|Death|2|||
130173873|NCT02506153|468595099|FG001|Overall Study|Death|1|||
130173874|NCT02506153|468595098|FG000|Overall Study|Other - not protocol specified|23|||
130173875|NCT02506153|468595099|FG001|Overall Study|Other - not protocol specified|12|||
130173876|NCT02017015|468595100|FG000|Overall Study|Adverse Event|9|||
130173877|NCT02017015|468595100|FG000|Overall Study|Withdrawal by Subject|21|||
130173878|NCT02017015|468595100|FG000|Overall Study|Death|4|||
130173879|NCT02017015|468595100|FG000|Overall Study|Progressive Disease|31|||
130173880|NCT02017015|468595100|FG000|Overall Study|Non-compliance with study drug|2|||
130173881|NCT02017015|468595100|FG000|Overall Study|Physician Decision|2|||
130173882|NCT04158245|468595101|FG000|Overall Study|Lost to Follow-up|1|||
130173883|NCT02567435|468595104|FG000|Overall Study|Death|1|||
130173884|NCT02567435|468595105|FG001|Overall Study|Death|1|||
130173885|NCT02567435|468595106|FG002|Overall Study|Death|0|||
130173886|NCT02567435|468595107|FG003|Overall Study|Death|0|||
130173887|NCT02567435|468595104|FG000|Overall Study|Ineligible|1|||
130173888|NCT02567435|468595105|FG001|Overall Study|Ineligible|3|||
130173889|NCT02567435|468595106|FG002|Overall Study|Ineligible|0|||
130173890|NCT02567435|468595107|FG003|Overall Study|Ineligible|0|||
130173891|NCT02567435|468595104|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
130173892|NCT02567435|468595105|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
130173893|NCT02567435|468595106|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
130173894|NCT02567435|468595107|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
130173895|NCT03765788|468595108|FG000|Overall Study|Subject decision|2|||
130173896|NCT03765788|468595109|FG001|Overall Study|Subject decision|3|||
130173897|NCT03765788|468595108|FG000|Overall Study|Physician Decision|2|||
130173898|NCT03765788|468595109|FG001|Overall Study|Physician Decision|4|||
130173899|NCT03765788|468595108|FG000|Overall Study|Death|0|||
130173900|NCT03765788|468595109|FG001|Overall Study|Death|1|||
130173901|NCT03765788|468595108|FG000|Overall Study|Lost to Follow-up|1|||
130173902|NCT03765788|468595109|FG001|Overall Study|Lost to Follow-up|0|||
130173903|NCT04856930|468595110|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
130173904|NCT04856930|468595111|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
130173905|NCT04856930|468595112|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
130173906|NCT04856930|468595110|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
130173907|NCT04856930|468595111|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
130173908|NCT04856930|468595112|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
130173909|NCT04856930|468595110|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
130173910|NCT04856930|468595111|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
130173911|NCT04856930|468595112|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
130173912|NCT04856930|468595110|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
130173913|NCT04856930|468595111|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
130173914|NCT04856930|468595112|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
130173915|NCT04856930|468595110|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
130173916|NCT04856930|468595111|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
130173917|NCT04856930|468595112|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
130173918|NCT04856930|468595110|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130173919|NCT04856930|468595111|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
130173920|NCT04856930|468595112|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130173921|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
130173922|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
130173923|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
130173924|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
130173925|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
130173926|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
130173927|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
130173928|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
130173929|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
130173930|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
130173931|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
130173932|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
130173933|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
130173934|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130173935|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
130173936|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
130173937|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
130173938|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
130173939|NCT04856930|468595110|FG000|Extension Period (16 Weeks)|Other than specified|0|||
130173940|NCT04856930|468595111|FG001|Extension Period (16 Weeks)|Other than specified|0|||
130173941|NCT04856930|468595112|FG002|Extension Period (16 Weeks)|Other than specified|1|||
130173942|NCT04856930|468595110|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130173943|NCT04856930|468595111|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
130173944|NCT04856930|468595112|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
130173945|NCT04856930|468595110|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
130173946|NCT04856930|468595111|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
130173947|NCT04856930|468595112|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
130173948|NCT04856930|468595110|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
130173949|NCT04856930|468595111|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130173950|NCT04856930|468595112|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
130173951|NCT04856930|468595110|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
130173952|NCT04856930|468595111|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
130173953|NCT04856930|468595112|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
130173954|NCT00678210|468595113|FG000|Overall Study|Adverse Event|1|||
130173955|NCT00678210|468595114|FG001|Overall Study|Adverse Event|2|||
130173956|NCT00678210|468595115|FG002|Overall Study|Adverse Event|3|||
130173957|NCT00678210|468595116|FG003|Overall Study|Adverse Event|3|||
130173958|NCT00678210|468595113|FG000|Overall Study|Lack of Efficacy|2|||
130173959|NCT00678210|468595114|FG001|Overall Study|Lack of Efficacy|3|||
130173960|NCT00678210|468595115|FG002|Overall Study|Lack of Efficacy|1|||
130173961|NCT00678210|468595116|FG003|Overall Study|Lack of Efficacy|9|||
130173962|NCT00678210|468595113|FG000|Overall Study|Lost to Follow-up|4|||
130173963|NCT00678210|468595114|FG001|Overall Study|Lost to Follow-up|2|||
130173964|NCT00678210|468595115|FG002|Overall Study|Lost to Follow-up|0|||
130173965|NCT00678210|468595116|FG003|Overall Study|Lost to Follow-up|1|||
130173966|NCT00678210|468595113|FG000|Overall Study|Withdrawal by Subject|3|||
130173967|NCT00678210|468595114|FG001|Overall Study|Withdrawal by Subject|4|||
130173968|NCT00678210|468595115|FG002|Overall Study|Withdrawal by Subject|1|||
130173969|NCT00678210|468595116|FG003|Overall Study|Withdrawal by Subject|7|||
130173970|NCT00678210|468595113|FG000|Overall Study|Other|1|||
130173971|NCT00678210|468595114|FG001|Overall Study|Other|0|||
130173972|NCT00678210|468595115|FG002|Overall Study|Other|1|||
130173973|NCT00678210|468595116|FG003|Overall Study|Other|0|||
130173974|NCT04825912|468595117|FG000|Overall Study|Death|3|||
130173975|NCT04825912|468595117|FG000|Overall Study|Withdrawal by Subject|1|||
130173976|NCT00974922|468595118|FG000|Overall Study|study terminated|24|||
130173977|NCT03965689|468595119|FG000|Overall Study|Too sick to get study intervention|2|||
130173978|NCT03022084|468595120|FG000|Overall Study|Lost to Follow-up|2|||
130173979|NCT03022084|468595121|FG001|Overall Study|Lost to Follow-up|3|||
130173980|NCT01173120|468595122|FG000|Overall Study|Lack of Efficacy|2|||
130173981|NCT01173120|468595122|FG000|Overall Study|Lost to Follow-up|1|||
130173982|NCT01173120|468595122|FG000|Overall Study|Participant Decision|2|||
130173983|NCT01173120|468595122|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
130173984|NCT01173120|468595122|FG000|Overall Study|Switch-Participant Decision|12|||
130173985|NCT01173120|468595122|FG000|Overall Study|Switch-Difficulty With Device|12|||
130173986|NCT01207583|468595123|FG000|Overall Study|Withdrawal by Subject|0|||
130173987|NCT01207583|468595124|FG001|Overall Study|Withdrawal by Subject|3|||
130173988|NCT01207583|468595125|FG002|Overall Study|Withdrawal by Subject|1|||
130173989|NCT01207583|468595123|FG000|Overall Study|Participant failed to return|1|||
130173990|NCT01207583|468595124|FG001|Overall Study|Participant failed to return|0|||
130173991|NCT01207583|468595125|FG002|Overall Study|Participant failed to return|0|||
130173992|NCT01207583|468595123|FG000|Overall Study|Lost to Follow-up|0|||
130173993|NCT01207583|468595124|FG001|Overall Study|Lost to Follow-up|2|||
130173994|NCT01207583|468595125|FG002|Overall Study|Lost to Follow-up|0|||
130173995|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
130173996|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
130173997|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
130173998|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
130173999|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
130174000|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
130174001|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
130174002|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
130174003|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
130174004|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
130174005|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
130174006|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
130174007|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
130174008|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
130174009|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
130174010|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130174011|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130174012|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130174013|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130174014|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
130174015|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
130174016|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
130174017|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
130174018|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
130174019|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
130174020|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130174021|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130174022|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130174023|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130174024|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
130174025|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
130174026|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
130174027|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
130174028|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
130174029|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
130174030|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130174031|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130174032|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130174033|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130174034|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
130174035|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174036|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174037|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174038|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
130174039|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174040|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174041|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174042|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174043|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174044|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
130174045|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
130174046|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
130174047|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
130174048|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
130174049|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
130174050|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
130174051|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
130174052|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
130174053|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
130174054|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
130174055|NCT03104400|468595126|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174056|NCT03104400|468595127|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174057|NCT03104400|468595128|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174058|NCT03104400|468595129|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
130174059|NCT03104400|468595130|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174060|NCT03104400|468595131|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129982630|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130174061|NCT03104400|468595132|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174062|NCT03104400|468595133|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174063|NCT03104400|468595134|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174064|NCT03104400|468595135|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
130174065|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
130174066|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
130174067|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
130174068|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
130174069|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
130174070|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
130174071|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
130174072|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
130174073|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
130174074|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
130174075|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130174076|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130174077|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130174078|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130174079|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
130174080|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
130174081|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
130174082|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
130174083|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
130174084|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
130174085|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130174086|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130174087|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130174088|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130174089|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
130174090|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
130174091|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
130174092|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
130174093|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
130174094|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
130174095|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130174096|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130174097|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130174098|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130174099|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
130174100|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
130174101|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
130174102|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
130174103|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
130174104|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
130174105|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174106|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174107|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174108|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174109|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174110|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174111|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
130174112|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
130174113|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
130174114|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
130174115|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174116|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174117|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174118|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174119|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174120|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174121|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174122|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
130174123|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
130174124|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
130174125|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
130174126|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
130174127|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
130174128|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
130174129|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
130174130|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
130174131|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
129982631|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130174132|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
130174133|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
129982632|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982633|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130174134|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
130174135|NCT03104400|468595126|FG000|Period 2 Week 56 - 260)|Other|0|||
130174136|NCT03104400|468595127|FG001|Period 2 Week 56 - 260)|Other|0|||
130174137|NCT03104400|468595128|FG002|Period 2 Week 56 - 260)|Other|0|||
130174138|NCT03104400|468595129|FG003|Period 2 Week 56 - 260)|Other|0|||
130174139|NCT03104400|468595130|FG004|Period 2 Week 56 - 260)|Other|0|||
130174140|NCT03104400|468595131|FG005|Period 2 Week 56 - 260)|Other|0|||
130174141|NCT03104400|468595132|FG006|Period 2 Week 56 - 260)|Other|0|||
130174142|NCT03104400|468595133|FG007|Period 2 Week 56 - 260)|Other|0|||
130174143|NCT03104400|468595134|FG008|Period 2 Week 56 - 260)|Other|1|||
130174144|NCT03104400|468595135|FG009|Period 2 Week 56 - 260)|Other|1|||
130174145|NCT04948333|468595136|FG000|Overall Study|Adverse Event|6|||
130174146|NCT04948333|468595137|FG001|Overall Study|Adverse Event|4|||
130174147|NCT04948333|468595138|FG002|Overall Study|Adverse Event|0|||
130174148|NCT04948333|468595139|FG003|Overall Study|Adverse Event|2|||
130174149|NCT04948333|468595136|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130174150|NCT04948333|468595137|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130174151|NCT04948333|468595138|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130174152|NCT04948333|468595139|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
130174153|NCT04948333|468595136|FG000|Overall Study|Progressive Disease|1|||
130174154|NCT04948333|468595137|FG001|Overall Study|Progressive Disease|5|||
130174155|NCT04948333|468595138|FG002|Overall Study|Progressive Disease|0|||
130174156|NCT04948333|468595139|FG003|Overall Study|Progressive Disease|0|||
130174157|NCT04948333|468595136|FG000|Overall Study|Physician Decision|2|||
130174158|NCT04948333|468595137|FG001|Overall Study|Physician Decision|2|||
130174159|NCT04948333|468595138|FG002|Overall Study|Physician Decision|0|||
130174160|NCT04948333|468595139|FG003|Overall Study|Physician Decision|0|||
130174161|NCT04948333|468595136|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
130174162|NCT04948333|468595137|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
130174163|NCT04948333|468595138|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
130174164|NCT04948333|468595139|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
130174165|NCT04948333|468595136|FG000|Overall Study|Withdrawal by Subject|2|||
130174166|NCT04948333|468595137|FG001|Overall Study|Withdrawal by Subject|0|||
130174167|NCT04948333|468595138|FG002|Overall Study|Withdrawal by Subject|0|||
130174168|NCT04948333|468595139|FG003|Overall Study|Withdrawal by Subject|1|||
130174169|NCT04948333|468595136|FG000|Overall Study|Protocol Violation|0|||
130174170|NCT04948333|468595137|FG001|Overall Study|Protocol Violation|1|||
130174171|NCT04948333|468595138|FG002|Overall Study|Protocol Violation|0|||
130174172|NCT04948333|468595139|FG003|Overall Study|Protocol Violation|0|||
130174173|NCT04948333|468595136|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
130174174|NCT04948333|468595137|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
130174175|NCT04948333|468595138|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
130174176|NCT04948333|468595139|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
130174177|NCT02129608|468595140|FG000|Overall Study|Lost to Follow-up|0|||
130174178|NCT02129608|468595141|FG001|Overall Study|Lost to Follow-up|1|||
130174179|NCT02129608|468595142|FG002|Overall Study|Lost to Follow-up|1|||
130174180|NCT02129608|468595140|FG000|Overall Study|Withdrawal by Subject|0|||
130174181|NCT02129608|468595141|FG001|Overall Study|Withdrawal by Subject|0|||
130174182|NCT02129608|468595142|FG002|Overall Study|Withdrawal by Subject|2|||
130174183|NCT03055624|468595143|FG000|Overall Study|Study closed|9|||
130174184|NCT02794870|468595147|FG000|Overall Study|Withdrawal by Subject|2|||
130174185|NCT02794870|468595148|FG001|Overall Study|Withdrawal by Subject|0|||
130174186|NCT02437903|468595149|FG000|Overall Study|Adverse Event|1|||
130174187|NCT02437903|468595149|FG000|Overall Study|Withdrawal by Subject|1|||
130174188|NCT02437903|468595149|FG000|Overall Study|Lost to Follow-up|3|||
130174189|NCT04414618|468595153|FG000|Overall Study|Death|3|||
130174190|NCT04414618|468595154|FG001|Overall Study|Death|3|||
130174191|NCT04414618|468595153|FG000|Overall Study|Withdrawal by Subject|2|||
130174192|NCT04414618|468595154|FG001|Overall Study|Withdrawal by Subject|1|||
130174193|NCT04414618|468595153|FG000|Overall Study|Lost to Follow-up|2|||
130174194|NCT04414618|468595154|FG001|Overall Study|Lost to Follow-up|3|||
130174195|NCT04414618|468595153|FG000|Overall Study|Physician Decision|1|||
130174196|NCT04414618|468595154|FG001|Overall Study|Physician Decision|0|||
130174197|NCT00658879|468595155|FG000|Overall Study|Protocol Violation|1|||
130174198|NCT00616421|468595156|FG000|Overall Study|Withdrawal by Subject|9|||
130174199|NCT00616421|468595157|FG001|Overall Study|Withdrawal by Subject|11|||
130174200|NCT00616421|468595158|FG002|Overall Study|Withdrawal by Subject|8|||
130174201|NCT00616421|468595156|FG000|Overall Study|Lost to Follow-up|12|||
130174202|NCT00616421|468595157|FG001|Overall Study|Lost to Follow-up|26|||
130174203|NCT00616421|468595158|FG002|Overall Study|Lost to Follow-up|30|||
130174204|NCT00616421|468595156|FG000|Overall Study|Inappropriate enrollment|3|||
130174205|NCT00616421|468595157|FG001|Overall Study|Inappropriate enrollment|0|||
130174206|NCT00616421|468595158|FG002|Overall Study|Inappropriate enrollment|1|||
130174207|NCT00616421|468595156|FG000|Overall Study|Administrative reason|1|||
130174208|NCT00616421|468595157|FG001|Overall Study|Administrative reason|0|||
130174209|NCT00616421|468595158|FG002|Overall Study|Administrative reason|0|||
130174210|NCT00616421|468595156|FG000|Overall Study|Protocol Violation|0|||
130174211|NCT00616421|468595157|FG001|Overall Study|Protocol Violation|1|||
130174212|NCT00616421|468595158|FG002|Overall Study|Protocol Violation|2|||
130174213|NCT00616421|468595156|FG000|Overall Study|Unable to classify|1|||
130174214|NCT00616421|468595157|FG001|Overall Study|Unable to classify|0|||
130174215|NCT00616421|468595158|FG002|Overall Study|Unable to classify|0|||
130174216|NCT02661217|468595159|FG000|Overall Study|Physician Decision|12|||
130174217|NCT02661217|468595160|FG001|Overall Study|Physician Decision|15|||
130174218|NCT02661217|468595159|FG000|Overall Study|Lost to Follow-up|1|||
130174219|NCT02661217|468595160|FG001|Overall Study|Lost to Follow-up|4|||
130174220|NCT02661217|468595159|FG000|Overall Study|Protocol Deviation|0|||
130174221|NCT02661217|468595160|FG001|Overall Study|Protocol Deviation|4|||
130174222|NCT02661217|468595159|FG000|Overall Study|Non-compliance with study treatment|5|||
130174223|NCT02661217|468595160|FG001|Overall Study|Non-compliance with study treatment|5|||
130174224|NCT02661217|468595159|FG000|Overall Study|Death|21|||
130174225|NCT02661217|468595160|FG001|Overall Study|Death|15|||
129982634|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
130174226|NCT02661217|468595159|FG000|Overall Study|Adverse Event|10|||
130174227|NCT02661217|468595160|FG001|Overall Study|Adverse Event|8|||
130174228|NCT02661217|468595159|FG000|Overall Study|Withdrawal by Subject|15|||
130174229|NCT02661217|468595160|FG001|Overall Study|Withdrawal by Subject|19|||
130174230|NCT02661217|468595159|FG000|Overall Study|Did not enter follow-up epoch|7|||
130174231|NCT02661217|468595160|FG001|Overall Study|Did not enter follow-up epoch|10|||
130174232|NCT02661217|468595159|FG000|Overall Study|Death - no study drug received|1|||
130174233|NCT02661217|468595160|FG001|Overall Study|Death - no study drug received|2|||
130174234|NCT02661217|468595159|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
130174235|NCT02661217|468595160|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
130174236|NCT02604407|468595163|FG000|Overall Study|Adverse Event|0|||
130174237|NCT02604407|468595164|FG001|Overall Study|Adverse Event|7|||
130174238|NCT02604407|468595165|FG002|Overall Study|Adverse Event|5|||
130174239|NCT02604407|468595163|FG000|Overall Study|Protocol Violation|2|||
130174240|NCT02604407|468595164|FG001|Overall Study|Protocol Violation|0|||
130174241|NCT02604407|468595165|FG002|Overall Study|Protocol Violation|0|||
130174242|NCT02604407|468595163|FG000|Overall Study|Withdrawal by Subject|3|||
130174243|NCT02604407|468595164|FG001|Overall Study|Withdrawal by Subject|3|||
130174244|NCT02604407|468595165|FG002|Overall Study|Withdrawal by Subject|5|||
130174245|NCT02604407|468595163|FG000|Overall Study|Lost to Follow-up|2|||
130174246|NCT02604407|468595164|FG001|Overall Study|Lost to Follow-up|1|||
130174247|NCT02604407|468595165|FG002|Overall Study|Lost to Follow-up|2|||
130174248|NCT02604407|468595163|FG000|Overall Study|Lack of Efficacy|1|||
130174249|NCT02604407|468595164|FG001|Overall Study|Lack of Efficacy|0|||
130174250|NCT02604407|468595165|FG002|Overall Study|Lack of Efficacy|0|||
130174251|NCT02604407|468595163|FG000|Overall Study|Other|3|||
130174252|NCT02604407|468595164|FG001|Overall Study|Other|1|||
130174253|NCT02604407|468595165|FG002|Overall Study|Other|4|||
130174254|NCT00185588|468595166|FG000|Overall Study|Adverse Event|3|||
130174255|NCT00185588|468595167|FG001|Overall Study|Adverse Event|1|||
130174256|NCT00185588|468595168|FG002|Overall Study|Adverse Event|4|||
130174257|NCT00185588|468595169|FG003|Overall Study|Adverse Event|2|||
130174258|NCT00185588|468595166|FG000|Overall Study|Lost to Follow-up|0|||
130174259|NCT00185588|468595167|FG001|Overall Study|Lost to Follow-up|0|||
130174260|NCT00185588|468595168|FG002|Overall Study|Lost to Follow-up|1|||
130174261|NCT00185588|468595169|FG003|Overall Study|Lost to Follow-up|2|||
130174262|NCT00185588|468595166|FG000|Overall Study|Withdrawal by Subject|0|||
130174263|NCT00185588|468595167|FG001|Overall Study|Withdrawal by Subject|1|||
130174264|NCT00185588|468595168|FG002|Overall Study|Withdrawal by Subject|0|||
130174265|NCT00185588|468595169|FG003|Overall Study|Withdrawal by Subject|0|||
130174266|NCT00185588|468595166|FG000|Overall Study|Physician Decision|0|||
130174267|NCT00185588|468595167|FG001|Overall Study|Physician Decision|0|||
130174268|NCT00185588|468595168|FG002|Overall Study|Physician Decision|1|||
130174269|NCT00185588|468595169|FG003|Overall Study|Physician Decision|0|||
130174270|NCT03908437|468595170|FG000|Overall Study|Death|0|||
130174271|NCT03908437|468595171|FG001|Overall Study|Death|1|||
130174272|NCT03908437|468595170|FG000|Overall Study|Lost to Follow-up|31|||
130174273|NCT03908437|468595171|FG001|Overall Study|Lost to Follow-up|24|||
130174274|NCT05445492|468595172|FG000|Overall Study|Physician Decision|1|||
130174275|NCT00191191|468595173|FG000|Overall Study|Entry Criteria Exclusion|2|||
130174276|NCT00191191|468595174|FG001|Overall Study|Entry Criteria Exclusion|0|||
130174277|NCT00191191|468595173|FG000|Overall Study|Treated with Another Systemic Agent|1|||
130174278|NCT00191191|468595174|FG001|Overall Study|Treated with Another Systemic Agent|1|||
130174279|NCT00191191|468595173|FG000|Overall Study|Adverse Event|11|||
130174280|NCT00191191|468595174|FG001|Overall Study|Adverse Event|21|||
130174281|NCT00191191|468595173|FG000|Overall Study|Progressive Disease|84|||
130174282|NCT00191191|468595174|FG001|Overall Study|Progressive Disease|72|||
130174283|NCT00191191|468595173|FG000|Overall Study|Toxicity After Dose Reduction|7|||
130174284|NCT00191191|468595174|FG001|Overall Study|Toxicity After Dose Reduction|8|||
130174285|NCT00191191|468595173|FG000|Overall Study|Family/Caregiver Decision|5|||
130174286|NCT00191191|468595174|FG001|Overall Study|Family/Caregiver Decision|7|||
130174287|NCT00191191|468595173|FG000|Overall Study|Lost to Follow-up|1|||
130174288|NCT00191191|468595174|FG001|Overall Study|Lost to Follow-up|0|||
130174289|NCT00191191|468595173|FG000|Overall Study|Physician Decision|3|||
130174290|NCT00191191|468595174|FG001|Overall Study|Physician Decision|2|||
130174291|NCT00191191|468595173|FG000|Overall Study|Good Clinical Practice Violation|0|||
130174292|NCT00191191|468595174|FG001|Overall Study|Good Clinical Practice Violation|1|||
130174293|NCT04289363|468595175|FG000|Overall Study|Lost to Follow-up|14|||
130174294|NCT04289363|468595176|FG001|Overall Study|Lost to Follow-up|0|||
130174295|NCT03348163|468595177|FG000|Overall Study|Withdrawal by Subject|2|||
130174296|NCT03348163|468595178|FG001|Overall Study|Withdrawal by Subject|0|||
130174297|NCT02585778|468595179|FG000|Overall Study|Adverse Event|17|||
130174298|NCT02585778|468595180|FG001|Overall Study|Adverse Event|4|||
130174299|NCT02585778|468595179|FG000|Overall Study|Participant did not wish to continue|9|||
130174300|NCT02585778|468595180|FG001|Overall Study|Participant did not wish to continue|4|||
130174301|NCT02585778|468595179|FG000|Overall Study|Poor compliance to study protocol|0|||
130174302|NCT02585778|468595180|FG001|Overall Study|Poor compliance to study protocol|2|||
130174303|NCT02585778|468595179|FG000|Overall Study|Death|0|||
130174304|NCT02585778|468595180|FG001|Overall Study|Death|1|||
130174305|NCT02585778|468595179|FG000|Overall Study|Randomized but not treated|1|||
130174306|NCT02585778|468595180|FG001|Overall Study|Randomized but not treated|2|||
130174307|NCT02585778|468595179|FG000|Overall Study|Other than specified above|6|||
130174308|NCT02585778|468595180|FG001|Overall Study|Other than specified above|2|||
130174309|NCT02789137|468595182|FG000|Overall Study|Dropped out/Died|58|||
130174310|NCT01482312|468595185|FG000|Period 1, 90 Minutes of Wear|Other|1|||
130174311|NCT01482312|468595186|FG001|Period 1, 90 Minutes of Wear|Other|0|||
130174312|NCT01482312|468595187|FG002|Period 1, 90 Minutes of Wear|Other|0|||
130174313|NCT01482312|468595185|FG000|Period 2, 90 Minutes of Wear|Other|1|||
130174314|NCT01482312|468595186|FG001|Period 2, 90 Minutes of Wear|Other|0|||
130174315|NCT01482312|468595187|FG002|Period 2, 90 Minutes of Wear|Other|0|||
130174316|NCT03597295|468595189|FG000|Overall Study|Death|70|||
130174317|NCT03597295|468595189|FG000|Overall Study|Lost to Follow-up|7|||
130174318|NCT00428116|468595190|FG000|Overall Study|Death|1|||
130174319|NCT00428116|468595191|FG001|Overall Study|Death|0|||
130174320|NCT00428116|468595190|FG000|Overall Study|Withdrawal by Subject|1|||
130174321|NCT00428116|468595191|FG001|Overall Study|Withdrawal by Subject|0|||
130174322|NCT00428116|468595190|FG000|Overall Study|Lost to Follow-up|1|||
130174323|NCT00428116|468595191|FG001|Overall Study|Lost to Follow-up|0|||
130174324|NCT02125877|468595192|FG000|Overall Study|Physician Decision|1|||
130174325|NCT02125877|468595193|FG001|Overall Study|Physician Decision|0|||
130174326|NCT02125877|468595192|FG000|Overall Study|Death|0|||
130174327|NCT02125877|468595193|FG001|Overall Study|Death|1|||
130174328|NCT02125877|468595192|FG000|Overall Study|Administrative problems|0|||
130174329|NCT02125877|468595193|FG001|Overall Study|Administrative problems|1|||
130174330|NCT02125877|468595192|FG000|Overall Study|Participant/guardian decision|0|||
130174331|NCT02125877|468595193|FG001|Overall Study|Participant/guardian decision|2|||
130174332|NCT02125877|468595192|FG000|Overall Study|Withdrawal by Subject|2|||
130174333|NCT02125877|468595193|FG001|Overall Study|Withdrawal by Subject|1|||
130174334|NCT02125877|468595192|FG000|Overall Study|Protocol deviation|4|||
130174335|NCT02125877|468595193|FG001|Overall Study|Protocol deviation|1|||
130174336|NCT02125877|468595192|FG000|Overall Study|Adverse Event|6|||
130174337|NCT02125877|468595193|FG001|Overall Study|Adverse Event|4|||
130174338|NCT01685840|468595194|FG000|Overall Study|Death|77|||
130174339|NCT01685840|468595195|FG001|Overall Study|Death|66|||
130174340|NCT01685840|468595194|FG000|Overall Study|Lost to Follow-up|27|||
130174341|NCT01685840|468595195|FG001|Overall Study|Lost to Follow-up|25|||
130174342|NCT01685840|468595194|FG000|Overall Study|Physician Decision|3|||
130174343|NCT01685840|468595195|FG001|Overall Study|Physician Decision|7|||
130174344|NCT01685840|468595194|FG000|Overall Study|Withdrawal by Subject|14|||
130174345|NCT01685840|468595195|FG001|Overall Study|Withdrawal by Subject|17|||
130174346|NCT01685840|468595194|FG000|Overall Study|Futility|197|||
130174347|NCT01685840|468595195|FG001|Overall Study|Futility|200|||
130174348|NCT01685840|468595194|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
130174349|NCT01685840|468595195|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
130174350|NCT01128543|468595196|FG000|Overall Study|Withdrawal by Subject|3|||
130174351|NCT01128543|468595196|FG000|Overall Study|Protocol Violation|1|||
130174352|NCT01198132|468595200|FG000|Overall Study|Withdrawal by Subject|4|||
130174353|NCT01198132|468595201|FG001|Overall Study|Withdrawal by Subject|5|||
130174354|NCT01198132|468595200|FG000|Overall Study|Physician Decision|5|||
130174355|NCT01198132|468595201|FG001|Overall Study|Physician Decision|4|||
130174356|NCT01198132|468595200|FG000|Overall Study|Other Unspecified|3|||
130174357|NCT01198132|468595201|FG001|Overall Study|Other Unspecified|6|||
130174358|NCT01198132|468595200|FG000|Overall Study|Lack of Efficacy|2|||
130174359|NCT01198132|468595201|FG001|Overall Study|Lack of Efficacy|3|||
130174360|NCT01198132|468595200|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
130174361|NCT01198132|468595201|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
130174362|NCT01198132|468595200|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
130174363|NCT01198132|468595201|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
130174364|NCT01198132|468595200|FG000|Overall Study|Adverse Event|0|||
130174365|NCT01198132|468595201|FG001|Overall Study|Adverse Event|1|||
130174366|NCT01198132|468595200|FG000|Overall Study|Protocol Violation|1|||
130174367|NCT01198132|468595201|FG001|Overall Study|Protocol Violation|0|||
130174368|NCT03516513|468595204|FG000|Overall Study|Withdrawal by Subject|2|||
130174369|NCT03516513|468595205|FG001|Overall Study|Withdrawal by Subject|2|||
130174370|NCT03516513|468595206|FG002|Overall Study|Withdrawal by Subject|0|||
130174371|NCT03516513|468595207|FG003|Overall Study|Withdrawal by Subject|0|||
130174372|NCT01098487|468595209|FG000|Overall Study|Adverse Event|22|||
130174373|NCT01098487|468595209|FG000|Overall Study|Lack of Efficacy|11|||
130174374|NCT01098487|468595209|FG000|Overall Study|Withdrawal by Subject|7|||
130174375|NCT01098487|468595209|FG000|Overall Study|Lost to Follow-up|3|||
130174376|NCT01098487|468595209|FG000|Overall Study|Physician Decision|1|||
130174377|NCT00345631|468595210|FG000|Overall Study|Withdrawal by Subject|1|||
130174378|NCT00345631|468595211|FG001|Overall Study|Withdrawal by Subject|0|||
130174379|NCT00345631|468595212|FG002|Overall Study|Withdrawal by Subject|1|||
130174380|NCT00345631|468595210|FG000|Overall Study|Adverse Event|0|||
130174381|NCT00345631|468595211|FG001|Overall Study|Adverse Event|1|||
130174382|NCT00345631|468595212|FG002|Overall Study|Adverse Event|0|||
130174383|NCT00345631|468595210|FG000|Overall Study|Lost to Follow-up|3|||
130174384|NCT00345631|468595211|FG001|Overall Study|Lost to Follow-up|7|||
130174385|NCT00345631|468595212|FG002|Overall Study|Lost to Follow-up|4|||
129982635|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982636|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982637|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982638|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982639|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982640|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
129982641|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
129982642|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
129982643|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
129982644|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982645|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982646|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982647|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982648|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982649|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982650|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982651|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982652|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982653|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982654|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
129982655|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982656|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
129982657|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982658|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982659|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982660|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982661|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982662|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982663|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982664|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982665|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982666|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982667|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982668|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982669|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982670|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
129982671|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982672|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982673|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982674|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982675|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982676|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982677|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982678|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
129982679|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
129982680|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
129982681|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
129982682|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
129982683|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
129982684|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
130174386|NCT00345631|468595210|FG000|Overall Study|Other reasons|0|||
130174387|NCT00345631|468595211|FG001|Overall Study|Other reasons|0|||
130174388|NCT00345631|468595212|FG002|Overall Study|Other reasons|1|||
130174389|NCT01301729|468595213|FG000|Overall Study|Withdrawal by Subject|2|||
130174390|NCT01301729|468595213|FG000|Overall Study|Participant did not Return for Treatment|1|||
130174391|NCT01301729|468595213|FG000|Overall Study|Violated Selection Criteria|1|||
130174392|NCT03071276|468595214|FG000|Overall Study|Adverse Event|1|||
130174393|NCT03071276|468595214|FG000|Overall Study|Lack of Efficacy|14|||
130174394|NCT01885195|468595215|FG000|Overall Study|Adverse Event|29|||
130174395|NCT01885195|468595215|FG000|Overall Study|Death|1|||
130174396|NCT01885195|468595215|FG000|Overall Study|Disease Progression|67|||
130174397|NCT01885195|468595215|FG000|Overall Study|Protocol Deviation|2|||
130174398|NCT01885195|468595215|FG000|Overall Study|Physician Decision|3|||
130174399|NCT01885195|468595215|FG000|Overall Study|Patient/guardian decision|8|||
130174400|NCT03390426|468595216|FG000|Overall Study|Protocol Violation|0|||
130174401|NCT03390426|468595217|FG001|Overall Study|Protocol Violation|1|||
130174402|NCT00548093|468595222|FG000|Overall Study|Death|33|||
130174403|NCT00548093|468595223|FG001|Overall Study|Death|13|||
130174404|NCT00548093|468595222|FG000|Overall Study|Lost to Follow-up|3|||
130174405|NCT00548093|468595223|FG001|Overall Study|Lost to Follow-up|1|||
130174406|NCT00548093|468595222|FG000|Overall Study|Objective progression or relapse|1|||
130174407|NCT00548093|468595223|FG001|Overall Study|Objective progression or relapse|1|||
130174408|NCT00548093|468595222|FG000|Overall Study|Other|11|||
130174409|NCT00548093|468595223|FG001|Overall Study|Other|1|||
130174410|NCT00548093|468595222|FG000|Overall Study|Withdrawal by Subject|1|||
130174411|NCT00548093|468595223|FG001|Overall Study|Withdrawal by Subject|0|||
130174412|NCT00548093|468595222|FG000|Overall Study|Completed post-treatment follow-up|1|||
130174413|NCT00548093|468595223|FG001|Overall Study|Completed post-treatment follow-up|0|||
130174414|NCT02924727|468595226|FG000|Overall Study|Withdrawal by Subject|2|||
130174415|NCT02924727|468595227|FG001|Overall Study|Withdrawal by Subject|4|||
130174416|NCT02924727|468595226|FG000|Overall Study|Lost to Follow-up|2|||
130174417|NCT02924727|468595227|FG001|Overall Study|Lost to Follow-up|5|||
130174418|NCT02924727|468595226|FG000|Overall Study|Death|221|||
130174419|NCT02924727|468595227|FG001|Overall Study|Death|247|||
130174420|NCT02924727|468595226|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
130174421|NCT02924727|468595227|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
130174422|NCT00509795|468595232|FG000|Overall Study|Adverse Event|4|||
130174423|NCT00509795|468595233|FG001|Overall Study|Adverse Event|3|||
130174424|NCT00509795|468595234|FG002|Overall Study|Adverse Event|5|||
130174425|NCT00509795|468595235|FG003|Overall Study|Adverse Event|4|||
130174426|NCT00509795|468595232|FG000|Overall Study|Death|3|||
130174427|NCT00509795|468595233|FG001|Overall Study|Death|1|||
130174428|NCT00509795|468595234|FG002|Overall Study|Death|2|||
130174429|NCT00509795|468595235|FG003|Overall Study|Death|7|||
130174430|NCT00509795|468595232|FG000|Overall Study|Lack of Efficacy|0|||
130174431|NCT00509795|468595233|FG001|Overall Study|Lack of Efficacy|0|||
130174432|NCT00509795|468595234|FG002|Overall Study|Lack of Efficacy|2|||
130174433|NCT00509795|468595235|FG003|Overall Study|Lack of Efficacy|2|||
130174434|NCT00509795|468595232|FG000|Overall Study|Lost to Follow-up|1|||
130174435|NCT00509795|468595233|FG001|Overall Study|Lost to Follow-up|2|||
130174436|NCT00509795|468595234|FG002|Overall Study|Lost to Follow-up|4|||
130174437|NCT00509795|468595235|FG003|Overall Study|Lost to Follow-up|4|||
130174438|NCT00509795|468595232|FG000|Overall Study|OTHER|1|||
130174439|NCT00509795|468595233|FG001|Overall Study|OTHER|0|||
130174440|NCT00509795|468595234|FG002|Overall Study|OTHER|4|||
130174441|NCT00509795|468595235|FG003|Overall Study|OTHER|1|||
130174442|NCT00509795|468595232|FG000|Overall Study|Protocol Violation|3|||
130174443|NCT00509795|468595233|FG001|Overall Study|Protocol Violation|0|||
130174444|NCT00509795|468595234|FG002|Overall Study|Protocol Violation|3|||
130174445|NCT00509795|468595235|FG003|Overall Study|Protocol Violation|1|||
130174446|NCT00509795|468595232|FG000|Overall Study|Withdrawal by Subject|10|||
130174447|NCT00509795|468595233|FG001|Overall Study|Withdrawal by Subject|5|||
130174448|NCT00509795|468595234|FG002|Overall Study|Withdrawal by Subject|7|||
130174449|NCT00509795|468595235|FG003|Overall Study|Withdrawal by Subject|8|||
130174450|NCT04386616|468595241|FG000|Overall Study|Death|22|||
130174451|NCT04386616|468595242|FG001|Overall Study|Death|22|||
130174452|NCT04386616|468595243|FG002|Overall Study|Death|21|||
130174453|NCT04386616|468595241|FG000|Overall Study|Lost to Follow-up|5|||
130174454|NCT04386616|468595242|FG001|Overall Study|Lost to Follow-up|8|||
130174455|NCT04386616|468595243|FG002|Overall Study|Lost to Follow-up|6|||
130174456|NCT04386616|468595241|FG000|Overall Study|Withdrawal by Subject|2|||
130174457|NCT04386616|468595242|FG001|Overall Study|Withdrawal by Subject|4|||
130174458|NCT04386616|468595243|FG002|Overall Study|Withdrawal by Subject|1|||
130174459|NCT04386616|468595241|FG000|Overall Study|Adverse Event|1|||
130174460|NCT04386616|468595242|FG001|Overall Study|Adverse Event|1|||
130174461|NCT04386616|468595243|FG002|Overall Study|Adverse Event|0|||
130174462|NCT02759692|468595244|FG000|Period 1|Test article no longer available|1|||
130174463|NCT02759692|468595245|FG001|Period 1|Test article no longer available|1|||
130174464|NCT02759692|468595244|FG000|Period 1|No longer meets eligibility criteria.|1|||
130174465|NCT02759692|468595245|FG001|Period 1|No longer meets eligibility criteria.|0|||
130174466|NCT02759692|468595244|FG000|Period 1|Miss-Randomized|1|||
130174467|NCT02759692|468595245|FG001|Period 1|Miss-Randomized|1|||
130174468|NCT02759692|468595244|FG000|Period 2|Lost to Follow-up|1|||
130174469|NCT02759692|468595245|FG001|Period 2|Lost to Follow-up|0|||
130174470|NCT02759692|468595244|FG000|Period 2|Test article no longer available|0|||
130174471|NCT02759692|468595245|FG001|Period 2|Test article no longer available|1|||
130174472|NCT00451178|468595246|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
129982685|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
129982686|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
129982687|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
129982688|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
129982689|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
129982690|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
129982691|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
129982692|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982693|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982694|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982695|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982696|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982697|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982698|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982699|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982700|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982701|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982702|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982703|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982704|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
129982705|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982706|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982707|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982708|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982709|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982710|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982711|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982712|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982713|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982714|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982715|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982716|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982717|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
129982718|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982719|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982720|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982721|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982722|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982723|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982724|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982725|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982726|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982727|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982728|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982729|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
129982730|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982731|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
129982732|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
129982733|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
129982734|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
129982735|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
129982736|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
129982737|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
129982738|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
129982739|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
129982740|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
129982741|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
129982742|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
129982743|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
129982744|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
129982745|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
129982746|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
129982747|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
130174473|NCT00451178|468595247|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
130174474|NCT00451178|468595246|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
130174475|NCT00451178|468595247|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
130174476|NCT00451178|468595246|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
130174477|NCT00451178|468595247|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
130174478|NCT00451178|468595246|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
130174479|NCT00451178|468595247|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
130174480|NCT00451178|468595246|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
130174481|NCT00451178|468595247|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
130174482|NCT00451178|468595246|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
130174483|NCT00451178|468595247|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
130174484|NCT00451178|468595246|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
130174485|NCT00451178|468595247|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
130174486|NCT00451178|468595246|FG000|Prior to Maintenance Therapy|PD|2|||
130174487|NCT00451178|468595247|FG001|Prior to Maintenance Therapy|PD|0|||
130174488|NCT00451178|468595246|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
130174489|NCT00451178|468595247|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
130174490|NCT00451178|468595246|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
130174491|NCT00451178|468595247|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
130174492|NCT00451178|468595246|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
130174493|NCT00451178|468595247|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
130174494|NCT00451178|468595246|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
130174495|NCT00451178|468595247|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
130174496|NCT00451178|468595246|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
130174497|NCT00451178|468595247|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
130174498|NCT00451178|468595246|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
130174499|NCT00451178|468595247|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
130174500|NCT00451178|468595246|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
130174501|NCT00451178|468595247|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
130174502|NCT03207867|468595250|FG000|Overall Study|Adverse Event|1|||
130174503|NCT03207867|468595251|FG001|Overall Study|Adverse Event|0|||
130174504|NCT03207867|468595252|FG002|Overall Study|Adverse Event|1|||
130174505|NCT03207867|468595253|FG003|Overall Study|Adverse Event|0|||
130174506|NCT03207867|468595254|FG004|Overall Study|Adverse Event|0|||
130174507|NCT03207867|468595255|FG005|Overall Study|Adverse Event|2|||
130174508|NCT03207867|468595256|FG006|Overall Study|Adverse Event|1|||
130174509|NCT03207867|468595257|FG007|Overall Study|Adverse Event|1|||
130174510|NCT03207867|468595258|FG008|Overall Study|Adverse Event|2|||
130174511|NCT03207867|468595259|FG009|Overall Study|Adverse Event|2|||
130174512|NCT03207867|468595260|FG010|Overall Study|Adverse Event|0|||
130174513|NCT03207867|468595261|FG011|Overall Study|Adverse Event|0|||
130174514|NCT03207867|468595262|FG012|Overall Study|Adverse Event|0|||
130174515|NCT03207867|468595263|FG013|Overall Study|Adverse Event|0|||
130174516|NCT03207867|468595264|FG014|Overall Study|Adverse Event|0|||
130174517|NCT03207867|468595265|FG015|Overall Study|Adverse Event|0|||
130174518|NCT03207867|468595266|FG016|Overall Study|Adverse Event|3|||
130174519|NCT03207867|468595267|FG017|Overall Study|Adverse Event|1|||
130174520|NCT03207867|468595268|FG018|Overall Study|Adverse Event|2|||
130174521|NCT03207867|468595269|FG019|Overall Study|Adverse Event|1|||
130174522|NCT03207867|468595270|FG020|Overall Study|Adverse Event|0|||
130174523|NCT03207867|468595271|FG021|Overall Study|Adverse Event|0|||
130174524|NCT03207867|468595272|FG022|Overall Study|Adverse Event|0|||
130174525|NCT03207867|468595273|FG023|Overall Study|Adverse Event|0|||
130174526|NCT03207867|468595250|FG000|Overall Study|Death|0|||
130174527|NCT03207867|468595251|FG001|Overall Study|Death|0|||
130174528|NCT03207867|468595252|FG002|Overall Study|Death|0|||
130174529|NCT03207867|468595253|FG003|Overall Study|Death|0|||
130174530|NCT03207867|468595254|FG004|Overall Study|Death|0|||
130174531|NCT03207867|468595255|FG005|Overall Study|Death|1|||
130174532|NCT03207867|468595256|FG006|Overall Study|Death|0|||
130174533|NCT03207867|468595257|FG007|Overall Study|Death|3|||
130174534|NCT03207867|468595258|FG008|Overall Study|Death|1|||
130174535|NCT03207867|468595259|FG009|Overall Study|Death|2|||
129982748|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130174536|NCT03207867|468595260|FG010|Overall Study|Death|0|||
130174537|NCT03207867|468595261|FG011|Overall Study|Death|1|||
130174538|NCT03207867|468595262|FG012|Overall Study|Death|0|||
130174539|NCT03207867|468595263|FG013|Overall Study|Death|1|||
130174540|NCT03207867|468595264|FG014|Overall Study|Death|0|||
130174541|NCT03207867|468595265|FG015|Overall Study|Death|0|||
130174542|NCT03207867|468595266|FG016|Overall Study|Death|0|||
130174543|NCT03207867|468595267|FG017|Overall Study|Death|2|||
130174544|NCT03207867|468595268|FG018|Overall Study|Death|0|||
130174545|NCT03207867|468595269|FG019|Overall Study|Death|1|||
130174546|NCT03207867|468595270|FG020|Overall Study|Death|0|||
130174547|NCT03207867|468595271|FG021|Overall Study|Death|0|||
130174548|NCT03207867|468595272|FG022|Overall Study|Death|0|||
130174549|NCT03207867|468595273|FG023|Overall Study|Death|0|||
130174550|NCT03207867|468595250|FG000|Overall Study|Physician Decision|3|||
130174551|NCT03207867|468595251|FG001|Overall Study|Physician Decision|5|||
130174552|NCT03207867|468595252|FG002|Overall Study|Physician Decision|0|||
130174553|NCT03207867|468595253|FG003|Overall Study|Physician Decision|3|||
130174554|NCT03207867|468595254|FG004|Overall Study|Physician Decision|2|||
130174555|NCT03207867|468595255|FG005|Overall Study|Physician Decision|0|||
130174556|NCT03207867|468595256|FG006|Overall Study|Physician Decision|0|||
130174557|NCT03207867|468595257|FG007|Overall Study|Physician Decision|0|||
130174558|NCT03207867|468595258|FG008|Overall Study|Physician Decision|4|||
130174559|NCT03207867|468595259|FG009|Overall Study|Physician Decision|2|||
130174560|NCT03207867|468595260|FG010|Overall Study|Physician Decision|0|||
130174561|NCT03207867|468595261|FG011|Overall Study|Physician Decision|4|||
130174562|NCT03207867|468595262|FG012|Overall Study|Physician Decision|0|||
130174563|NCT03207867|468595263|FG013|Overall Study|Physician Decision|0|||
130174564|NCT03207867|468595264|FG014|Overall Study|Physician Decision|2|||
130174565|NCT03207867|468595265|FG015|Overall Study|Physician Decision|1|||
130174566|NCT03207867|468595266|FG016|Overall Study|Physician Decision|1|||
130174567|NCT03207867|468595267|FG017|Overall Study|Physician Decision|2|||
130174568|NCT03207867|468595268|FG018|Overall Study|Physician Decision|1|||
130174569|NCT03207867|468595269|FG019|Overall Study|Physician Decision|3|||
130174570|NCT03207867|468595270|FG020|Overall Study|Physician Decision|0|||
130174571|NCT03207867|468595271|FG021|Overall Study|Physician Decision|0|||
130174572|NCT03207867|468595272|FG022|Overall Study|Physician Decision|0|||
130174573|NCT03207867|468595273|FG023|Overall Study|Physician Decision|0|||
130174574|NCT03207867|468595250|FG000|Overall Study|Progressive Disease|7|||
130174575|NCT03207867|468595251|FG001|Overall Study|Progressive Disease|7|||
130174576|NCT03207867|468595252|FG002|Overall Study|Progressive Disease|9|||
130174577|NCT03207867|468595253|FG003|Overall Study|Progressive Disease|10|||
130174578|NCT03207867|468595254|FG004|Overall Study|Progressive Disease|11|||
130174579|NCT03207867|468595255|FG005|Overall Study|Progressive Disease|10|||
130174580|NCT03207867|468595256|FG006|Overall Study|Progressive Disease|9|||
130174581|NCT03207867|468595257|FG007|Overall Study|Progressive Disease|8|||
130174582|NCT03207867|468595258|FG008|Overall Study|Progressive Disease|19|||
130174583|NCT03207867|468595259|FG009|Overall Study|Progressive Disease|23|||
130174584|NCT03207867|468595260|FG010|Overall Study|Progressive Disease|2|||
130174585|NCT03207867|468595261|FG011|Overall Study|Progressive Disease|24|||
130174586|NCT03207867|468595262|FG012|Overall Study|Progressive Disease|3|||
130174587|NCT03207867|468595263|FG013|Overall Study|Progressive Disease|11|||
130174588|NCT03207867|468595264|FG014|Overall Study|Progressive Disease|9|||
130174589|NCT03207867|468595265|FG015|Overall Study|Progressive Disease|5|||
130174590|NCT03207867|468595266|FG016|Overall Study|Progressive Disease|10|||
130174591|NCT03207867|468595267|FG017|Overall Study|Progressive Disease|14|||
130174592|NCT03207867|468595268|FG018|Overall Study|Progressive Disease|13|||
130174593|NCT03207867|468595269|FG019|Overall Study|Progressive Disease|14|||
130174594|NCT03207867|468595270|FG020|Overall Study|Progressive Disease|6|||
130174595|NCT03207867|468595271|FG021|Overall Study|Progressive Disease|3|||
130174596|NCT03207867|468595272|FG022|Overall Study|Progressive Disease|3|||
130174597|NCT03207867|468595273|FG023|Overall Study|Progressive Disease|3|||
130174598|NCT03207867|468595250|FG000|Overall Study|Patient/guardian Decision|0|||
130174599|NCT03207867|468595251|FG001|Overall Study|Patient/guardian Decision|0|||
130174600|NCT03207867|468595252|FG002|Overall Study|Patient/guardian Decision|1|||
129982749|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982750|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982751|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982752|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982753|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982754|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982755|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982756|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982757|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130174601|NCT03207867|468595253|FG003|Overall Study|Patient/guardian Decision|1|||
130174602|NCT03207867|468595254|FG004|Overall Study|Patient/guardian Decision|1|||
130174603|NCT03207867|468595255|FG005|Overall Study|Patient/guardian Decision|2|||
129982758|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
130174604|NCT03207867|468595256|FG006|Overall Study|Patient/guardian Decision|1|||
130174605|NCT03207867|468595257|FG007|Overall Study|Patient/guardian Decision|0|||
130174606|NCT03207867|468595258|FG008|Overall Study|Patient/guardian Decision|1|||
130174607|NCT03207867|468595259|FG009|Overall Study|Patient/guardian Decision|0|||
130174608|NCT03207867|468595260|FG010|Overall Study|Patient/guardian Decision|0|||
130174609|NCT03207867|468595261|FG011|Overall Study|Patient/guardian Decision|1|||
130174610|NCT03207867|468595262|FG012|Overall Study|Patient/guardian Decision|0|||
130174611|NCT03207867|468595263|FG013|Overall Study|Patient/guardian Decision|1|||
130174612|NCT03207867|468595264|FG014|Overall Study|Patient/guardian Decision|2|||
130174613|NCT03207867|468595265|FG015|Overall Study|Patient/guardian Decision|0|||
130174614|NCT03207867|468595266|FG016|Overall Study|Patient/guardian Decision|1|||
130174615|NCT03207867|468595267|FG017|Overall Study|Patient/guardian Decision|3|||
130174616|NCT03207867|468595268|FG018|Overall Study|Patient/guardian Decision|4|||
130174617|NCT03207867|468595269|FG019|Overall Study|Patient/guardian Decision|1|||
130174618|NCT03207867|468595270|FG020|Overall Study|Patient/guardian Decision|0|||
130174619|NCT03207867|468595271|FG021|Overall Study|Patient/guardian Decision|0|||
130174620|NCT03207867|468595272|FG022|Overall Study|Patient/guardian Decision|0|||
130174621|NCT03207867|468595273|FG023|Overall Study|Patient/guardian Decision|0|||
130174622|NCT00912912|468595274|FG000|Overall Study|Withdrawal by Subject|1|||
130174623|NCT00912912|468595274|FG000|Overall Study|Disease Progression|3|||
130174624|NCT02447744|468595275|FG000|Overall Study|Withdrawal by Subject|3|||
130174625|NCT02447744|468595276|FG001|Overall Study|Withdrawal by Subject|1|||
130174626|NCT02447744|468595275|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
130174627|NCT02447744|468595276|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
130174628|NCT00306995|468595277|FG000|Study Part I|Withdrawal by Subject|0|||
130174629|NCT00306995|468595278|FG001|Study Part I|Withdrawal by Subject|0|||
130174630|NCT00306995|468595279|FG002|Study Part I|Withdrawal by Subject|0|||
130174631|NCT00306995|468595280|FG003|Study Part I|Withdrawal by Subject|0|||
130174632|NCT00306995|468595281|FG004|Study Part I|Withdrawal by Subject|0|||
130174633|NCT00306995|468595282|FG005|Study Part I|Withdrawal by Subject|0|||
130174634|NCT00306995|468595283|FG006|Study Part I|Withdrawal by Subject|1|||
130174635|NCT00306995|468595277|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
130174636|NCT00306995|468595278|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
130174637|NCT00306995|468595279|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
130174638|NCT00306995|468595280|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
130174639|NCT00306995|468595281|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
130174640|NCT00306995|468595282|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
130174641|NCT00306995|468595283|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
130174642|NCT05422625|468595284|FG000|Overall Study|Withdrawal by Subject|1|||
130174643|NCT05422625|468595285|FG001|Overall Study|Withdrawal by Subject|0|||
130174644|NCT04324073|468597028|FG000|Overall Study|withdrew consent|0|||
130174645|NCT04324073|468597029|FG001|Overall Study|withdrew consent|4|||
130174646|NCT04324073|468597030|FG002|Overall Study|withdrew consent|2|||
130174647|NCT04324073|468597031|FG003|Overall Study|withdrew consent|8|||
130174648|NCT06400238|468597036|FG000|Overall Study|Started Protocol Therapy|2|||
130174649|NCT06400238|468597036|FG000|Overall Study|Adverse Event|1|||
130174650|NCT06400238|468597036|FG000|Overall Study|Death|1|||
130174651|NCT06400238|468597036|FG000|Overall Study|Disease Progression|27|||
130174652|NCT06400238|468597036|FG000|Overall Study|Withdrawal by Subject|2|||
130174653|NCT06400238|468597036|FG000|Overall Study|Physician Decision|2|||
130174654|NCT01277601|468597039|FG000|Overall Study|Adverse Event|5|||
130174655|NCT01277601|468597040|FG001|Overall Study|Adverse Event|3|||
130174656|NCT01277601|468597041|FG002|Overall Study|Adverse Event|0|||
130174657|NCT01277601|468597042|FG003|Overall Study|Adverse Event|7|||
130174658|NCT01277601|468597039|FG000|Overall Study|Withdrawal by Subject|18|||
130174659|NCT01277601|468597040|FG001|Overall Study|Withdrawal by Subject|21|||
130174660|NCT01277601|468597041|FG002|Overall Study|Withdrawal by Subject|8|||
130174661|NCT01277601|468597042|FG003|Overall Study|Withdrawal by Subject|17|||
130174662|NCT01277601|468597039|FG000|Overall Study|Lost to Follow-up|7|||
130174663|NCT01277601|468597040|FG001|Overall Study|Lost to Follow-up|9|||
130174664|NCT01277601|468597041|FG002|Overall Study|Lost to Follow-up|4|||
130174665|NCT01277601|468597042|FG003|Overall Study|Lost to Follow-up|2|||
130174666|NCT01277601|468597039|FG000|Overall Study|Physician Decision|3|||
130174667|NCT01277601|468597040|FG001|Overall Study|Physician Decision|5|||
130174668|NCT01277601|468597041|FG002|Overall Study|Physician Decision|1|||
130174669|NCT01277601|468597042|FG003|Overall Study|Physician Decision|6|||
130174670|NCT01277601|468597039|FG000|Overall Study|Pregnancy|2|||
130174671|NCT01277601|468597040|FG001|Overall Study|Pregnancy|2|||
130174672|NCT01277601|468597041|FG002|Overall Study|Pregnancy|4|||
130174673|NCT01277601|468597042|FG003|Overall Study|Pregnancy|1|||
129982759|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982760|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
129982761|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982762|NCT03896152|467900613|FG000|Overall Study|Patient/guardian decision|1|||
130174674|NCT01277601|468597039|FG000|Overall Study|Noncompliance with Study Drug|1|||
130174675|NCT01277601|468597040|FG001|Overall Study|Noncompliance with Study Drug|3|||
130174676|NCT01277601|468597041|FG002|Overall Study|Noncompliance with Study Drug|2|||
130174677|NCT01277601|468597042|FG003|Overall Study|Noncompliance with Study Drug|0|||
130174678|NCT01277601|468597039|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
130174679|NCT01277601|468597040|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
130174680|NCT01277601|468597041|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
130174681|NCT01277601|468597042|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
130174682|NCT01277601|468597039|FG000|Overall Study|Protocol Violation|0|||
130174683|NCT01277601|468597040|FG001|Overall Study|Protocol Violation|2|||
130174684|NCT01277601|468597041|FG002|Overall Study|Protocol Violation|5|||
130174685|NCT01277601|468597042|FG003|Overall Study|Protocol Violation|0|||
130174686|NCT01277601|468597039|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
129982763|NCT03896152|467900614|FG001|Overall Study|Patient/guardian decision|1|||
130174687|NCT01277601|468597040|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
130174688|NCT01277601|468597041|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
130174689|NCT01277601|468597042|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
130174690|NCT04034927|468597043|FG000|Overall Study|Adverse Event|4|||
130174691|NCT04034927|468597044|FG001|Overall Study|Adverse Event|9|||
130174692|NCT04034927|468597043|FG000|Overall Study|Death|0|||
130174693|NCT04034927|468597044|FG001|Overall Study|Death|1|||
130174694|NCT04034927|468597043|FG000|Overall Study|Withdrawal by Subject|0|||
130174695|NCT04034927|468597044|FG001|Overall Study|Withdrawal by Subject|3|||
130174696|NCT04034927|468597043|FG000|Overall Study|Still on Treatment|2|||
130174697|NCT04034927|468597044|FG001|Overall Study|Still on Treatment|1|||
130174698|NCT04034927|468597043|FG000|Overall Study|Other|1|||
130174699|NCT04034927|468597044|FG001|Overall Study|Other|1|||
130174700|NCT03996447|468597045|FG000|First MRI Examination|Adverse Event|2|||
130174701|NCT03996447|468597046|FG001|First MRI Examination|Adverse Event|0|||
130174702|NCT03996447|468597045|FG000|First MRI Examination|Withdrawal by Subject|1|||
130174703|NCT03996447|468597046|FG001|First MRI Examination|Withdrawal by Subject|2|||
130174704|NCT03996447|468597045|FG000|First MRI Examination|Protocol Violation|0|||
130174705|NCT03996447|468597046|FG001|First MRI Examination|Protocol Violation|1|||
130174706|NCT03996447|468597045|FG000|Washout|Adverse Event|2|||
130174707|NCT03996447|468597046|FG001|Washout|Adverse Event|0|||
130174708|NCT03996447|468597045|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
130174709|NCT03996447|468597046|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
130174710|NCT03996447|468597045|FG000|Washout|Withdrawal by Subject|0|||
130174711|NCT03996447|468597046|FG001|Washout|Withdrawal by Subject|1|||
130174712|NCT03996447|468597045|FG000|Washout|Other reason|1|||
130174713|NCT03996447|468597046|FG001|Washout|Other reason|1|||
130174742|NCT02291510|468597054|FG000|Overall Study|Adverse Event|0|||
130174743|NCT02291510|468597055|FG001|Overall Study|Adverse Event|0|||
130174744|NCT02291510|468597056|FG002|Overall Study|Adverse Event|0|||
130174745|NCT02291510|468597057|FG003|Overall Study|Adverse Event|1|||
129982764|NCT03896152|467900613|FG000|Overall Study|Adverse Event|0|||
130174746|NCT06390839|468597059|FG000|Overall Study|Ineligible|2|||
130174747|NCT06390839|468597059|FG000|Overall Study|Never start protocol therapy|3|||
130174748|NCT06390839|468597059|FG000|Overall Study|Adverse Event|1|||
130174749|NCT06390839|468597059|FG000|Overall Study|Alternative therapy|2|||
130174750|NCT06390839|468597059|FG000|Overall Study|Death|3|||
130174751|NCT06390839|468597059|FG000|Overall Study|Disease progression|28|||
130174752|NCT06390839|468597059|FG000|Overall Study|Withdrawal by Subject|2|||
130174753|NCT06390839|468597059|FG000|Overall Study|Complicating disease|1|||
130174754|NCT06390839|468597059|FG000|Overall Study|Noncompliance|1|||
130174755|NCT04458922|468597060|FG000|Overall Study|Withdrawal by Subject|1|||
129982765|NCT03896152|467900614|FG001|Overall Study|Adverse Event|1|||
130174756|NCT04458922|468597061|FG001|Overall Study|Withdrawal by Subject|0|||
130174757|NCT04458922|468597062|FG002|Overall Study|Withdrawal by Subject|2|||
130174758|NCT04458922|468597060|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
130174759|NCT04458922|468597061|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
130174760|NCT04458922|468597062|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
130174761|NCT04458922|468597060|FG000|Overall Study|Adverse Event|1|||
130174762|NCT04458922|468597061|FG001|Overall Study|Adverse Event|0|||
130174763|NCT04458922|468597062|FG002|Overall Study|Adverse Event|0|||
130174764|NCT04458922|468597060|FG000|Overall Study|Started new study|0|||
130174765|NCT04458922|468597061|FG001|Overall Study|Started new study|0|||
130174766|NCT04458922|468597062|FG002|Overall Study|Started new study|1|||
130174767|NCT04458922|468597060|FG000|Overall Study|Progressive disease|6|||
130174768|NCT04458922|468597061|FG001|Overall Study|Progressive disease|8|||
130174769|NCT04458922|468597062|FG002|Overall Study|Progressive disease|2|||
130174770|NCT04458922|468597060|FG000|Overall Study|Death|1|||
130174771|NCT04458922|468597061|FG001|Overall Study|Death|0|||
130174772|NCT04458922|468597062|FG002|Overall Study|Death|2|||
130174773|NCT04458922|468597060|FG000|Overall Study|Participant started chemotherapy|0|||
130174774|NCT04458922|468597061|FG001|Overall Study|Participant started chemotherapy|1|||
130174775|NCT04458922|468597062|FG002|Overall Study|Participant started chemotherapy|0|||
130174776|NCT06351371|468597064|FG000|Overall Study|Mutation Status Not Confirmed|9|||
130174777|NCT06351371|468597064|FG000|Overall Study|Ineligible|1|||
130174778|NCT06351371|468597064|FG000|Overall Study|Adverse Event|4|||
130174779|NCT06351371|468597064|FG000|Overall Study|Death|1|||
130174780|NCT06351371|468597064|FG000|Overall Study|Disease progression|14|||
130174781|NCT06351371|468597064|FG000|Overall Study|Withdrawal by Subject|3|||
130174782|NCT06351371|468597064|FG000|Overall Study|Physician Decision|3|||
130174783|NCT03203850|468597066|FG000|Overall Study|Subject/guardian decision|4|||
130174784|NCT03203850|468597067|FG001|Overall Study|Subject/guardian decision|3|||
130174785|NCT03203850|468597066|FG000|Overall Study|Adverse Event|3|||
130174786|NCT03203850|468597067|FG001|Overall Study|Adverse Event|0|||
130174787|NCT03203850|468597066|FG000|Overall Study|Death|1|||
130174788|NCT03203850|468597067|FG001|Overall Study|Death|0|||
130174789|NCT01272037|468597068|FG000|Overall Study|Death|25|||
130174790|NCT01272037|468597069|FG001|Overall Study|Death|28|||
130174791|NCT01272037|468597068|FG000|Overall Study|Adverse Event|12|||
130174792|NCT01272037|468597069|FG001|Overall Study|Adverse Event|7|||
130174793|NCT01272037|468597068|FG000|Overall Study|Withdrawal by Subject|175|||
130174794|NCT01272037|468597069|FG001|Overall Study|Withdrawal by Subject|93|||
130174795|NCT01272037|468597068|FG000|Overall Study|Disease progression|70|||
130174796|NCT01272037|468597069|FG001|Overall Study|Disease progression|111|||
130174797|NCT01272037|468597068|FG000|Overall Study|Other reason|42|||
130174798|NCT01272037|468597069|FG001|Overall Study|Other reason|41|||
130174799|NCT01272037|468597068|FG000|Overall Study|Delinquent data|24|||
130174800|NCT01272037|468597069|FG001|Overall Study|Delinquent data|19|||
130174801|NCT01272037|468597068|FG000|Overall Study|Reason under review|33|||
130174802|NCT01272037|468597069|FG001|Overall Study|Reason under review|29|||
130174803|NCT01272037|468597068|FG000|Overall Study|On treatment|626|||
130174804|NCT01272037|468597069|FG001|Overall Study|On treatment|632|||
130174805|NCT01009814|468597071|FG000|Overall Study|No longer met study criteria|1|||
130174806|NCT01009814|468597072|FG001|Overall Study|No longer met study criteria|1|||
130174807|NCT01009814|468597073|FG002|Overall Study|No longer met study criteria|0|||
130174808|NCT01009814|468597074|FG003|Overall Study|No longer met study criteria|0|||
130174809|NCT01009814|468597075|FG004|Overall Study|No longer met study criteria|0|||
130174810|NCT00618371|468597076|FG000|Overall Study|Withdrawal by Subject|2|||
130174811|NCT03348631|468597079|FG000|Overall Study|Not Eligible, No treatment|0|||
130174812|NCT03348631|468597080|FG001|Overall Study|Not Eligible, No treatment|1|||
130174813|NCT03348631|468597079|FG000|Overall Study|Not Eligible, Treated|2|||
130174814|NCT03348631|468597080|FG001|Overall Study|Not Eligible, Treated|0|||
130174815|NCT03348631|468597079|FG000|Overall Study|Eligible, No Treatment|1|||
130174816|NCT03348631|468597080|FG001|Overall Study|Eligible, No Treatment|0|||
130174817|NCT00451204|468597081|FG000|Overall Study|Adverse Event|4|||
130174818|NCT00451204|468597082|FG001|Overall Study|Adverse Event|6|||
130174819|NCT00451204|468597081|FG000|Overall Study|Lack of Efficacy|4|||
130174820|NCT00451204|468597082|FG001|Overall Study|Lack of Efficacy|4|||
130174821|NCT00451204|468597081|FG000|Overall Study|Lost to Follow-up|4|||
129982766|NCT03896152|467900613|FG000|Overall Study|Physician Decision|1|||
130174822|NCT00451204|468597082|FG001|Overall Study|Lost to Follow-up|4|||
130174823|NCT00451204|468597081|FG000|Overall Study|Protocol Violation|1|||
130174824|NCT00451204|468597082|FG001|Overall Study|Protocol Violation|0|||
130174825|NCT00451204|468597081|FG000|Overall Study|Patient refusal|8|||
130174826|NCT00451204|468597082|FG001|Overall Study|Patient refusal|4|||
129982767|NCT03896152|467900614|FG001|Overall Study|Physician Decision|0|||
129982768|NCT03896152|467900613|FG000|Overall Study|Technical problems|1|||
130174827|NCT00451204|468597081|FG000|Overall Study|Other|1|||
130174828|NCT00451204|468597082|FG001|Overall Study|Other|2|||
130174829|NCT01582152|468597083|FG000|Overall Study|Disease Progression|4|||
130174830|NCT01582152|468597084|FG001|Overall Study|Disease Progression|5|||
130174831|NCT01582152|468597083|FG000|Overall Study|Adverse Event|2|||
130174832|NCT01582152|468597084|FG001|Overall Study|Adverse Event|1|||
130174833|NCT04172597|468597087|FG000|Overall Study|Disease Progression|0|||
129982769|NCT03896152|467900614|FG001|Overall Study|Technical problems|0|||
129982770|NCT00436852|467900615|FG000|Overall Study|Death|23|||
130174834|NCT04172597|468597088|FG001|Overall Study|Disease Progression|0|||
130174835|NCT04172597|468597089|FG002|Overall Study|Disease Progression|0|||
130174836|NCT04172597|468597090|FG003|Overall Study|Disease Progression|0|||
130174837|NCT04172597|468597091|FG004|Overall Study|Disease Progression|1|||
130174838|NCT00794339|468597092|FG000|Overall Study|Withdrawal by Subject|3|||
130174839|NCT00794339|468597092|FG000|Overall Study|Ineligible|4|||
130174840|NCT00794339|468597092|FG000|Overall Study|Tx prior to ATSM|3|||
130174841|NCT00794339|468597092|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
130174842|NCT00794339|468597092|FG000|Overall Study|Tx not per protocol|1|||
130174843|NCT01611857|468597093|FG000|Overall Study|Withdrawal by Subject|0|||
130174844|NCT01611857|468597094|FG001|Overall Study|Withdrawal by Subject|2|||
130174845|NCT00362336|468597111|FG000|Overall Study|Serious Adverse Event|1|||
130174846|NCT00362336|468597112|FG001|Overall Study|Serious Adverse Event|0|||
130174847|NCT00362336|468597113|FG002|Overall Study|Serious Adverse Event|1|||
130174848|NCT00362336|468597111|FG000|Overall Study|Protocol Violation|0|||
130174849|NCT00362336|468597112|FG001|Overall Study|Protocol Violation|0|||
130174850|NCT00362336|468597113|FG002|Overall Study|Protocol Violation|1|||
130174851|NCT00362336|468597111|FG000|Overall Study|Lost to Follow-up|6|||
130174852|NCT00362336|468597112|FG001|Overall Study|Lost to Follow-up|4|||
130174853|NCT00362336|468597113|FG002|Overall Study|Lost to Follow-up|0|||
130174854|NCT00362336|468597111|FG000|Overall Study|Withdrawal by Subject|3|||
130174855|NCT00362336|468597112|FG001|Overall Study|Withdrawal by Subject|3|||
130174856|NCT00362336|468597113|FG002|Overall Study|Withdrawal by Subject|1|||
130174857|NCT01121562|468597116|FG000|Overall Study|Objective progression or relapse|8|||
130174858|NCT01121562|468597116|FG000|Overall Study|Withdrawal by Subject|1|||
130174859|NCT01121562|468597116|FG000|Overall Study|Adverse Event|1|||
130174860|NCT01121562|468597116|FG000|Overall Study|Sponsor Decision|1|||
130174861|NCT01121562|468597116|FG000|Overall Study|Met study discontinuation criteria|1|||
130174862|NCT01495702|468597117|FG000|Randomized Phase|Randomized But Not Treated|1|||
130174863|NCT01495702|468597118|FG001|Randomized Phase|Randomized But Not Treated|4|||
130174864|NCT01495702|468597117|FG000|Randomized Phase|Adverse Event|2|||
130174865|NCT01495702|468597118|FG001|Randomized Phase|Adverse Event|2|||
130174866|NCT01495702|468597117|FG000|Randomized Phase|Death|1|||
130174867|NCT01495702|468597118|FG001|Randomized Phase|Death|0|||
130174868|NCT01495702|468597117|FG000|Randomized Phase|Lack of Efficacy|2|||
130174869|NCT01495702|468597118|FG001|Randomized Phase|Lack of Efficacy|0|||
130174870|NCT01495702|468597117|FG000|Randomized Phase|Investigators Discretion|2|||
130174871|NCT01495702|468597118|FG001|Randomized Phase|Investigators Discretion|0|||
130174872|NCT01495702|468597117|FG000|Randomized Phase|Withdrew Consent|10|||
130174873|NCT01495702|468597118|FG001|Randomized Phase|Withdrew Consent|18|||
130174874|NCT01495702|468597117|FG000|Randomized Phase|Lost to Follow-up|4|||
130174875|NCT01495702|468597118|FG001|Randomized Phase|Lost to Follow-up|3|||
130174876|NCT01495702|468597117|FG000|Randomized Phase|Participant Noncompliance|1|||
130174877|NCT01495702|468597118|FG001|Randomized Phase|Participant Noncompliance|0|||
130174878|NCT01495702|468597117|FG000|Randomized Phase|Protocol Violation|3|||
130174879|NCT01495702|468597118|FG001|Randomized Phase|Protocol Violation|1|||
130174880|NCT04152863|468597119|FG000|Overall Study|Death|13|||
130174881|NCT04152863|468597120|FG001|Overall Study|Death|12|||
130174882|NCT04152863|468597121|FG002|Overall Study|Death|7|||
130174883|NCT04152863|468597119|FG000|Overall Study|Physician Decision|1|||
130174884|NCT04152863|468597120|FG001|Overall Study|Physician Decision|1|||
130174885|NCT04152863|468597121|FG002|Overall Study|Physician Decision|1|||
130174886|NCT04152863|468597119|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
130174887|NCT04152863|468597120|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
130174888|NCT04152863|468597121|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
130174889|NCT04152863|468597119|FG000|Overall Study|Withdrawal by Subject|2|||
130174890|NCT04152863|468597120|FG001|Overall Study|Withdrawal by Subject|1|||
130174891|NCT04152863|468597121|FG002|Overall Study|Withdrawal by Subject|3|||
130174892|NCT02075515|468597122|FG000|Overall Study|Serious Adverse Event|1|||
130174893|NCT02075515|468597123|FG001|Overall Study|Serious Adverse Event|1|||
130174894|NCT02075515|468597124|FG002|Overall Study|Serious Adverse Event|1|||
130174895|NCT02075515|468597122|FG000|Overall Study|Non-Serious Adverse Event|0|||
129982771|NCT00436852|467900616|FG001|Overall Study|Death|34|||
129982772|NCT00436852|467900615|FG000|Overall Study|Lack of Efficacy|9|||
129982773|NCT00436852|467900616|FG001|Overall Study|Lack of Efficacy|7|||
129982774|NCT00436852|467900615|FG000|Overall Study|Withdrawal by Subject|2|||
129982775|NCT00436852|467900616|FG001|Overall Study|Withdrawal by Subject|4|||
129982776|NCT00436852|467900615|FG000|Overall Study|Ineligible|1|||
129982777|NCT00436852|467900616|FG001|Overall Study|Ineligible|0|||
129982778|NCT00943852|467900617|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982779|NCT00943852|467900618|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982780|NCT00943852|467900619|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
130174896|NCT02075515|468597123|FG001|Overall Study|Non-Serious Adverse Event|1|||
130174897|NCT02075515|468597124|FG002|Overall Study|Non-Serious Adverse Event|0|||
130174898|NCT02075515|468597122|FG000|Overall Study|Withdrawal by Subject|2|||
130174899|NCT02075515|468597123|FG001|Overall Study|Withdrawal by Subject|0|||
130174900|NCT02075515|468597124|FG002|Overall Study|Withdrawal by Subject|1|||
130174901|NCT02075515|468597122|FG000|Overall Study|Lost to Follow-up|1|||
130174902|NCT02075515|468597123|FG001|Overall Study|Lost to Follow-up|3|||
130174903|NCT02075515|468597124|FG002|Overall Study|Lost to Follow-up|6|||
130174904|NCT00378573|468597127|FG000|Treatment Period|Adverse Event|9|||
130174905|NCT00378573|468597127|FG000|Treatment Period|Physician Decision|1|||
130174906|NCT00378573|468597127|FG000|Treatment Period|Withdrawal by Subject|2|||
130174907|NCT00378573|468597127|FG000|Treatment Period|Disease Progression|4|||
130174908|NCT00378573|468597127|FG000|Treatment Period|Sponsor decision to close study|1|||
130174909|NCT00378573|468597127|FG000|Follow-up|Death|12|||
130174910|NCT00378573|468597127|FG000|Follow-up|Lost to Follow-up|1|||
130174911|NCT00378573|468597127|FG000|Follow-up|Withdrawal by Subject|1|||
130174912|NCT00196326|468597128|FG000|Overall Study|Did not meet protocol requirements|64|||
130174913|NCT00196326|468597128|FG000|Overall Study|Non-compliance with the protocol|81|||
130174914|NCT00196326|468597128|FG000|Overall Study|Physician Decision|3|||
130174915|NCT00196326|468597128|FG000|Overall Study|Withdrawal by Subject|225|||
130174916|NCT00196326|468597128|FG000|Overall Study|Adverse Event|253|||
130174917|NCT00196326|468597128|FG000|Overall Study|Pregnancy|34|||
130174918|NCT00196326|468597128|FG000|Overall Study|Lost to Follow-up|304|||
130174919|NCT00196326|468597128|FG000|Overall Study|Other|22|||
130174920|NCT02797171|468597129|FG000|Overall Study|Lost to Follow-up|2|||
130174921|NCT02797171|468597130|FG001|Overall Study|Lost to Follow-up|0|||
130174922|NCT02797171|468597131|FG002|Overall Study|Lost to Follow-up|2|||
130174923|NCT02797171|468597132|FG003|Overall Study|Lost to Follow-up|1|||
130174924|NCT02797171|468597133|FG004|Overall Study|Lost to Follow-up|2|||
130174925|NCT02797171|468597134|FG005|Overall Study|Lost to Follow-up|0|||
130174926|NCT02797171|468597129|FG000|Overall Study|Withdrawal by Subject|1|||
130174927|NCT02797171|468597130|FG001|Overall Study|Withdrawal by Subject|1|||
130174928|NCT02797171|468597131|FG002|Overall Study|Withdrawal by Subject|0|||
130174929|NCT02797171|468597132|FG003|Overall Study|Withdrawal by Subject|0|||
130174930|NCT02797171|468597133|FG004|Overall Study|Withdrawal by Subject|0|||
130174931|NCT02797171|468597134|FG005|Overall Study|Withdrawal by Subject|0|||
130174932|NCT02797171|468597129|FG000|Overall Study|Protocol Violation|1|||
130174933|NCT02797171|468597130|FG001|Overall Study|Protocol Violation|0|||
130174934|NCT02797171|468597131|FG002|Overall Study|Protocol Violation|0|||
130174935|NCT02797171|468597132|FG003|Overall Study|Protocol Violation|0|||
130174936|NCT02797171|468597133|FG004|Overall Study|Protocol Violation|0|||
130174937|NCT02797171|468597134|FG005|Overall Study|Protocol Violation|0|||
130174938|NCT02797171|468597129|FG000|Overall Study|Participant unable to adhere|0|||
130174939|NCT02797171|468597130|FG001|Overall Study|Participant unable to adhere|1|||
130174940|NCT02797171|468597131|FG002|Overall Study|Participant unable to adhere|0|||
130174941|NCT02797171|468597132|FG003|Overall Study|Participant unable to adhere|0|||
130174942|NCT02797171|468597133|FG004|Overall Study|Participant unable to adhere|0|||
130174943|NCT02797171|468597134|FG005|Overall Study|Participant unable to adhere|0|||
130174944|NCT02797171|468597129|FG000|Overall Study|Not Randomized|0|||
130174945|NCT02797171|468597130|FG001|Overall Study|Not Randomized|0|||
130174946|NCT02797171|468597131|FG002|Overall Study|Not Randomized|0|||
130174947|NCT02797171|468597132|FG003|Overall Study|Not Randomized|0|||
130174948|NCT02797171|468597133|FG004|Overall Study|Not Randomized|0|||
130174949|NCT02797171|468597134|FG005|Overall Study|Not Randomized|1|||
130174950|NCT02540083|468597135|FG000|Overall Study|Withdrawal by Subject|16|||
130174951|NCT01372748|468597136|FG000|Overall Study|Lost to Follow-up|16|||
130174952|NCT01372748|468597137|FG001|Overall Study|Lost to Follow-up|34|||
130174953|NCT01372748|468597136|FG000|Overall Study|Withdrawal by Subject|7|||
130174954|NCT01372748|468597137|FG001|Overall Study|Withdrawal by Subject|5|||
130174955|NCT00134901|468597138|FG000|Overall Study|Lost to Follow-up|5|||
130174956|NCT00134901|468597139|FG001|Overall Study|Lost to Follow-up|5|||
130174957|NCT00134901|468597138|FG000|Overall Study|discontinued intervention|12|||
130174958|NCT00134901|468597139|FG001|Overall Study|discontinued intervention|10|||
130174959|NCT00445432|468597142|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
130174960|NCT00445432|468597143|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
130174961|NCT00445432|468597144|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
130174962|NCT00445432|468597145|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
130174963|NCT00445432|468597142|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130174964|NCT00445432|468597143|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130174965|NCT00445432|468597144|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
130174966|NCT00445432|468597145|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
130174967|NCT00445432|468597142|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
130174968|NCT00445432|468597143|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
130174969|NCT00445432|468597144|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
130174970|NCT00445432|468597145|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
130174971|NCT00445432|468597142|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
130174972|NCT00445432|468597143|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
130174973|NCT00445432|468597144|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
130174974|NCT00445432|468597145|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
130174975|NCT00445432|468597142|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130174976|NCT00445432|468597143|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130174977|NCT00445432|468597144|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
130174978|NCT00445432|468597145|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
130174979|NCT00445432|468597142|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130174980|NCT00445432|468597143|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130174981|NCT00445432|468597144|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
130174982|NCT00445432|468597145|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
130174983|NCT00445432|468597142|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
130174984|NCT00445432|468597143|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
130174985|NCT00445432|468597144|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
130174986|NCT00445432|468597145|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
130174987|NCT01699815|468597146|FG000|Overall Study|Protocol Violation|4|||
130174988|NCT01699815|468597147|FG001|Overall Study|Protocol Violation|7|||
130174989|NCT01699815|468597146|FG000|Overall Study|record could not be located|1|||
130174990|NCT01699815|468597147|FG001|Overall Study|record could not be located|0|||
130174991|NCT01699815|468597146|FG000|Overall Study|Adverse Event|0|||
130174992|NCT01699815|468597147|FG001|Overall Study|Adverse Event|1|||
130174993|NCT00356525|468597148|FG000|Overall Study|Progressive Disease|8|||
130174994|NCT00356525|468597149|FG001|Overall Study|Progressive Disease|5|||
130174995|NCT00356525|468597150|FG002|Overall Study|Progressive Disease|4|||
130174996|NCT00356525|468597151|FG003|Overall Study|Progressive Disease|2|||
130174997|NCT00356525|468597148|FG000|Overall Study|Adverse Event|1|||
130174998|NCT00356525|468597149|FG001|Overall Study|Adverse Event|3|||
130174999|NCT00356525|468597150|FG002|Overall Study|Adverse Event|1|||
130175000|NCT00356525|468597151|FG003|Overall Study|Adverse Event|1|||
130175001|NCT00356525|468597148|FG000|Overall Study|Lost to Follow-up|1|||
130175002|NCT00356525|468597149|FG001|Overall Study|Lost to Follow-up|0|||
130175003|NCT00356525|468597150|FG002|Overall Study|Lost to Follow-up|0|||
130175004|NCT00356525|468597151|FG003|Overall Study|Lost to Follow-up|0|||
130175005|NCT00356525|468597148|FG000|Overall Study|Physician Decision|2|||
130175006|NCT00356525|468597149|FG001|Overall Study|Physician Decision|2|||
130175007|NCT00356525|468597150|FG002|Overall Study|Physician Decision|2|||
130175008|NCT00356525|468597151|FG003|Overall Study|Physician Decision|1|||
130175009|NCT00356525|468597148|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
130175010|NCT00356525|468597149|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
130175011|NCT00356525|468597150|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
130175012|NCT00356525|468597151|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
130175013|NCT00356525|468597148|FG000|Overall Study|Withdrawal by Subject|1|||
130175014|NCT00356525|468597149|FG001|Overall Study|Withdrawal by Subject|1|||
130175015|NCT00356525|468597150|FG002|Overall Study|Withdrawal by Subject|0|||
130175016|NCT00356525|468597151|FG003|Overall Study|Withdrawal by Subject|3|||
130175017|NCT00356525|468597148|FG000|Overall Study|Death|0|||
130175018|NCT00356525|468597149|FG001|Overall Study|Death|0|||
130175019|NCT00356525|468597150|FG002|Overall Study|Death|0|||
130175020|NCT00356525|468597151|FG003|Overall Study|Death|1|||
130175021|NCT00356525|468597148|FG000|Overall Study|Sponsor Decision|0|||
130175022|NCT00356525|468597149|FG001|Overall Study|Sponsor Decision|0|||
130175023|NCT00356525|468597150|FG002|Overall Study|Sponsor Decision|0|||
130175024|NCT00356525|468597151|FG003|Overall Study|Sponsor Decision|1|||
130175025|NCT04487067|468597174|FG000|Overall Study|Adverse Event|3|||
130175026|NCT04487067|468597174|FG000|Overall Study|Death Other Than Progressive Disease|60|||
130175027|NCT04487067|468597174|FG000|Overall Study|Death Due To Progressive Disease|40|||
130175028|NCT04487067|468597174|FG000|Overall Study|Lost to Follow-up|3|||
130175029|NCT04487067|468597174|FG000|Overall Study|Progressive Disease|1|||
130175030|NCT04487067|468597174|FG000|Overall Study|Protocol Violation|3|||
130175031|NCT04487067|468597174|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
130175032|NCT04487067|468597174|FG000|Overall Study|Withdrawal by Subject|15|||
130175033|NCT02211417|468597175|FG000|Overall Study|Withdrawal by Subject|11|||
130175034|NCT02211417|468597176|FG001|Overall Study|Withdrawal by Subject|8|||
130175035|NCT02211417|468597175|FG000|Overall Study|Protocol Violation|1|||
130175036|NCT02211417|468597176|FG001|Overall Study|Protocol Violation|0|||
130175037|NCT02211417|468597175|FG000|Overall Study|Pregnancy|0|||
130175038|NCT02211417|468597176|FG001|Overall Study|Pregnancy|1|||
130175039|NCT02211417|468597175|FG000|Overall Study|Lost to Follow-up|2|||
130175040|NCT02211417|468597176|FG001|Overall Study|Lost to Follow-up|3|||
130175041|NCT02211417|468597175|FG000|Overall Study|Adverse Event|1|||
130175042|NCT02211417|468597176|FG001|Overall Study|Adverse Event|4|||
130175043|NCT01755091|468597177|FG000|Overall Study|Withdrawal by Subject|6|||
130175044|NCT01755091|468597178|FG001|Overall Study|Withdrawal by Subject|1|||
130175045|NCT01755091|468597179|FG002|Overall Study|Withdrawal by Subject|3|||
130175046|NCT01755091|468597177|FG000|Overall Study|Adverse Event|1|||
130175047|NCT01755091|468597178|FG001|Overall Study|Adverse Event|1|||
130175048|NCT01755091|468597179|FG002|Overall Study|Adverse Event|1|||
130175049|NCT01755091|468597177|FG000|Overall Study|Lost to Follow-up|1|||
130175050|NCT01755091|468597178|FG001|Overall Study|Lost to Follow-up|0|||
130175051|NCT01755091|468597179|FG002|Overall Study|Lost to Follow-up|1|||
130175052|NCT01755091|468597177|FG000|Overall Study|Physician Decision|1|||
130175053|NCT01755091|468597178|FG001|Overall Study|Physician Decision|1|||
130175054|NCT01755091|468597179|FG002|Overall Study|Physician Decision|2|||
130175055|NCT00490841|468597180|FG000|Overall Study|Death|5|||
130175056|NCT00490841|468597180|FG000|Overall Study|Withdrawal by Subject|4|||
130175057|NCT00490841|468597180|FG000|Overall Study|Lost to Follow-up|1|||
130175058|NCT00490841|468597180|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
130175059|NCT06385483|468597181|FG000|Overall Study|Withdrawal by Subject|2|||
130175060|NCT06385483|468597181|FG000|Overall Study|Never start protocol therapy|2|||
130175061|NCT06385483|468597181|FG000|Overall Study|Disease progression|15|||
130175062|NCT04700137|468597186|FG000|Overall Study|Lost to Follow-up|1|||
130175063|NCT04700137|468597187|FG001|Overall Study|Lost to Follow-up|6|||
130175064|NCT04700137|468597188|FG002|Overall Study|Lost to Follow-up|1|||
130175065|NCT04700137|468597189|FG003|Overall Study|Lost to Follow-up|1|||
130175066|NCT04700137|468597186|FG000|Overall Study|Withdrawal by Subject|0|||
130175067|NCT04700137|468597187|FG001|Overall Study|Withdrawal by Subject|0|||
130175068|NCT04700137|468597188|FG002|Overall Study|Withdrawal by Subject|1|||
130175069|NCT04700137|468597189|FG003|Overall Study|Withdrawal by Subject|0|||
130175070|NCT04700137|468597186|FG000|Overall Study|Death|0|||
130175071|NCT04700137|468597187|FG001|Overall Study|Death|0|||
130175072|NCT04700137|468597188|FG002|Overall Study|Death|1|||
130175073|NCT04700137|468597189|FG003|Overall Study|Death|0|||
130175074|NCT01320150|468597191|FG000|Overall Study|Protocol Violation|15|||
130175075|NCT01320150|468597191|FG000|Overall Study|Withdrawal by Subject|5|||
130175076|NCT01320150|468597191|FG000|Overall Study|Death|2|||
130175077|NCT01320150|468597191|FG000|Overall Study|Lost to Follow-up|44|||
130175078|NCT00919854|468597192|FG000|Overall Study|Adverse Event|1|||
130175079|NCT00985491|468597195|FG000|Overall Study|Adverse Event|8|||
130175080|NCT00985491|468597195|FG000|Overall Study|device migration|7|||
130175081|NCT00985491|468597195|FG000|Overall Study|Withdrawal by Subject|1|||
130175082|NCT00985491|468597195|FG000|Overall Study|implant failure|3|||
130175083|NCT01862484|468597200|FG000|Overall Study|Lack of Efficacy|1|||
130175084|NCT01862484|468597201|FG001|Overall Study|Lack of Efficacy|1|||
130175085|NCT01862484|468597200|FG000|Overall Study|Lost to Follow-up|1|||
130175086|NCT01862484|468597201|FG001|Overall Study|Lost to Follow-up|2|||
130175087|NCT01862484|468597200|FG000|Overall Study|Protocol Violation|0|||
130175088|NCT01862484|468597201|FG001|Overall Study|Protocol Violation|2|||
130175089|NCT01862484|468597200|FG000|Overall Study|Withdrawal by Subject|0|||
130175090|NCT01862484|468597201|FG001|Overall Study|Withdrawal by Subject|3|||
130175091|NCT01632280|468597202|FG000|Overall Study|Withdrawal by Subject|1|||
130175092|NCT01632280|468597203|FG001|Overall Study|Withdrawal by Subject|0|||
130175093|NCT00993421|468597204|FG000|Overall Study|Adverse Event|2|||
130175094|NCT00993421|468597205|FG001|Overall Study|Adverse Event|7|||
130175095|NCT00993421|468597206|FG002|Overall Study|Adverse Event|6|||
130175096|NCT00993421|468597207|FG003|Overall Study|Adverse Event|9|||
130175097|NCT00993421|468597208|FG004|Overall Study|Adverse Event|5|||
130175098|NCT00993421|468597209|FG005|Overall Study|Adverse Event|7|||
130175099|NCT00993421|468597210|FG006|Overall Study|Adverse Event|1|||
130175100|NCT00993421|468597204|FG000|Overall Study|Sponsor Decision|36|||
130175101|NCT00993421|468597205|FG001|Overall Study|Sponsor Decision|31|||
130175102|NCT00993421|468597206|FG002|Overall Study|Sponsor Decision|28|||
130175103|NCT00993421|468597207|FG003|Overall Study|Sponsor Decision|30|||
130175104|NCT00993421|468597208|FG004|Overall Study|Sponsor Decision|38|||
130175105|NCT00993421|468597209|FG005|Overall Study|Sponsor Decision|30|||
130175106|NCT00993421|468597210|FG006|Overall Study|Sponsor Decision|29|||
130175107|NCT00993421|468597204|FG000|Overall Study|Lost to Follow-up|3|||
130175108|NCT00993421|468597205|FG001|Overall Study|Lost to Follow-up|5|||
130175109|NCT00993421|468597206|FG002|Overall Study|Lost to Follow-up|5|||
130175110|NCT00993421|468597207|FG003|Overall Study|Lost to Follow-up|0|||
130175111|NCT00993421|468597208|FG004|Overall Study|Lost to Follow-up|0|||
130175112|NCT00993421|468597209|FG005|Overall Study|Lost to Follow-up|0|||
130175113|NCT00993421|468597210|FG006|Overall Study|Lost to Follow-up|6|||
130175114|NCT00993421|468597204|FG000|Overall Study|Withdrawal by Subject|3|||
130175115|NCT00993421|468597205|FG001|Overall Study|Withdrawal by Subject|2|||
130175116|NCT00993421|468597206|FG002|Overall Study|Withdrawal by Subject|3|||
130175117|NCT00993421|468597207|FG003|Overall Study|Withdrawal by Subject|3|||
130175118|NCT00993421|468597208|FG004|Overall Study|Withdrawal by Subject|3|||
130175119|NCT00993421|468597209|FG005|Overall Study|Withdrawal by Subject|5|||
130175120|NCT00993421|468597210|FG006|Overall Study|Withdrawal by Subject|3|||
130175121|NCT00993421|468597204|FG000|Overall Study|Death|0|||
130175122|NCT00993421|468597205|FG001|Overall Study|Death|0|||
130175123|NCT00993421|468597206|FG002|Overall Study|Death|0|||
130175124|NCT00993421|468597207|FG003|Overall Study|Death|0|||
130175125|NCT00993421|468597208|FG004|Overall Study|Death|0|||
130175126|NCT00993421|468597209|FG005|Overall Study|Death|0|||
130175127|NCT00993421|468597210|FG006|Overall Study|Death|1|||
130175128|NCT00993421|468597204|FG000|Overall Study|Entry Criteria Exclusion|0|||
130175129|NCT00993421|468597205|FG001|Overall Study|Entry Criteria Exclusion|0|||
130175130|NCT00993421|468597206|FG002|Overall Study|Entry Criteria Exclusion|1|||
130175131|NCT00993421|468597207|FG003|Overall Study|Entry Criteria Exclusion|3|||
130175132|NCT00993421|468597208|FG004|Overall Study|Entry Criteria Exclusion|0|||
130175133|NCT00993421|468597209|FG005|Overall Study|Entry Criteria Exclusion|1|||
130175134|NCT00993421|468597210|FG006|Overall Study|Entry Criteria Exclusion|0|||
130175135|NCT00993421|468597204|FG000|Overall Study|Physician Decision|0|||
130175136|NCT00993421|468597205|FG001|Overall Study|Physician Decision|0|||
130175137|NCT00993421|468597206|FG002|Overall Study|Physician Decision|0|||
130175138|NCT00993421|468597207|FG003|Overall Study|Physician Decision|0|||
130175139|NCT00993421|468597208|FG004|Overall Study|Physician Decision|0|||
130175140|NCT00993421|468597209|FG005|Overall Study|Physician Decision|1|||
130175141|NCT00993421|468597210|FG006|Overall Study|Physician Decision|1|||
130175142|NCT00993421|468597204|FG000|Overall Study|Protocol Violation|0|||
130175143|NCT00993421|468597205|FG001|Overall Study|Protocol Violation|0|||
130175144|NCT00993421|468597206|FG002|Overall Study|Protocol Violation|0|||
130175145|NCT00993421|468597207|FG003|Overall Study|Protocol Violation|0|||
130175146|NCT00993421|468597208|FG004|Overall Study|Protocol Violation|0|||
130175147|NCT00993421|468597209|FG005|Overall Study|Protocol Violation|2|||
130175148|NCT00993421|468597210|FG006|Overall Study|Protocol Violation|1|||
130175149|NCT02215967|468597211|FG000|Overall Study|Patient became ineligible for treatment|0|||
130175150|NCT02215967|468597212|FG001|Overall Study|Patient became ineligible for treatment|0|||
130175151|NCT02215967|468597213|FG002|Overall Study|Patient became ineligible for treatment|0|||
130175152|NCT02215967|468597214|FG003|Overall Study|Patient became ineligible for treatment|3|||
130175153|NCT02215967|468597211|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
130175154|NCT02215967|468597212|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
130175155|NCT02215967|468597213|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
130175156|NCT02215967|468597214|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
130175157|NCT00352417|468597218|FG000|Overall Study|Adverse Event|1|||
130175158|NCT00352417|468597219|FG001|Overall Study|Adverse Event|0|||
130175159|NCT00352417|468597218|FG000|Overall Study|Protocol Violation|0|||
130175160|NCT00352417|468597219|FG001|Overall Study|Protocol Violation|2|||
130175161|NCT00352417|468597218|FG000|Overall Study|Withdrawal by Subject|1|||
130175162|NCT00352417|468597219|FG001|Overall Study|Withdrawal by Subject|2|||
130175163|NCT00352417|468597218|FG000|Overall Study|Lost to Follow-up|1|||
130175164|NCT00352417|468597219|FG001|Overall Study|Lost to Follow-up|0|||
130175165|NCT00352417|468597218|FG000|Overall Study|Schedule Change|2|||
130175166|NCT00352417|468597219|FG001|Overall Study|Schedule Change|1|||
130175167|NCT01496976|468598756|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
130175168|NCT05292183|468598768|FG000|Overall Study|Adverse Event|1|||
130175169|NCT00371033|468598769|FG000|Overall Study|Lost to Follow-up|3|||
130175170|NCT00371033|468598770|FG001|Overall Study|Lost to Follow-up|2|||
130175171|NCT00371033|468598769|FG000|Overall Study|No longer interested|2|||
130175172|NCT00371033|468598770|FG001|Overall Study|No longer interested|0|||
130175173|NCT00371033|468598769|FG000|Overall Study|Uknown|3|||
130175174|NCT00371033|468598770|FG001|Overall Study|Uknown|1|||
130175175|NCT03631199|468598771|FG000|Overall Study|Progressive disease|9|||
130175176|NCT03631199|468598772|FG001|Overall Study|Progressive disease|5|||
130175177|NCT03631199|468598773|FG002|Overall Study|Progressive disease|5|||
130175178|NCT03631199|468598774|FG003|Overall Study|Progressive disease|149|||
130175179|NCT03631199|468598775|FG004|Overall Study|Progressive disease|148|||
130175180|NCT03631199|468598771|FG000|Overall Study|Physician Decision|0|||
130175181|NCT03631199|468598772|FG001|Overall Study|Physician Decision|2|||
130175182|NCT03631199|468598773|FG002|Overall Study|Physician Decision|3|||
130175183|NCT03631199|468598774|FG003|Overall Study|Physician Decision|19|||
130175184|NCT03631199|468598775|FG004|Overall Study|Physician Decision|13|||
130175185|NCT03631199|468598771|FG000|Overall Study|Adverse Event|1|||
130175186|NCT03631199|468598772|FG001|Overall Study|Adverse Event|1|||
130175187|NCT03631199|468598773|FG002|Overall Study|Adverse Event|0|||
130175188|NCT03631199|468598774|FG003|Overall Study|Adverse Event|28|||
130175189|NCT03631199|468598775|FG004|Overall Study|Adverse Event|29|||
130175190|NCT03631199|468598771|FG000|Overall Study|Death|0|||
130175191|NCT03631199|468598772|FG001|Overall Study|Death|1|||
130175192|NCT03631199|468598773|FG002|Overall Study|Death|0|||
130175193|NCT03631199|468598774|FG003|Overall Study|Death|35|||
130175194|NCT03631199|468598775|FG004|Overall Study|Death|48|||
130175195|NCT03631199|468598771|FG000|Overall Study|Subject decision|0|||
130175196|NCT03631199|468598772|FG001|Overall Study|Subject decision|1|||
130175197|NCT03631199|468598773|FG002|Overall Study|Subject decision|0|||
130175198|NCT03631199|468598774|FG003|Overall Study|Subject decision|12|||
130175199|NCT03631199|468598775|FG004|Overall Study|Subject decision|12|||
130175200|NCT03631199|468598771|FG000|Overall Study|No treated|0|||
130175201|NCT03631199|468598772|FG001|Overall Study|No treated|0|||
130175202|NCT03631199|468598773|FG002|Overall Study|No treated|0|||
130175203|NCT03631199|468598774|FG003|Overall Study|No treated|0|||
130175204|NCT03631199|468598775|FG004|Overall Study|No treated|1|||
130175205|NCT03631199|468598771|FG000|Overall Study|Treatment ongoing|0|||
130175206|NCT03631199|468598772|FG001|Overall Study|Treatment ongoing|1|||
130175207|NCT03631199|468598773|FG002|Overall Study|Treatment ongoing|1|||
130175208|NCT03631199|468598774|FG003|Overall Study|Treatment ongoing|76|||
130175209|NCT03631199|468598775|FG004|Overall Study|Treatment ongoing|71|||
130175210|NCT03631199|468598771|FG000|Overall Study|Guardian decision|0|||
129982781|NCT00943852|467900620|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
130175211|NCT03631199|468598772|FG001|Overall Study|Guardian decision|0|||
130175212|NCT03631199|468598773|FG002|Overall Study|Guardian decision|0|||
130175213|NCT03631199|468598774|FG003|Overall Study|Guardian decision|1|||
130175214|NCT03631199|468598775|FG004|Overall Study|Guardian decision|1|||
130175217|NCT02847260|468598778|FG000|Overall Study|Adverse Event|3|||
130175218|NCT02847260|468598778|FG000|Overall Study|Withdrawal by Subject|2|||
130175219|NCT02847260|468598778|FG000|Overall Study|Clinical Deterioration|1|||
130175220|NCT02847260|468598778|FG000|Overall Study|Physician Decision|1|||
130175221|NCT03698019|468598779|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
130175222|NCT03698019|468598780|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
130175223|NCT03698019|468598779|FG000|Step 1: Registration|Withdrawal by Subject|7|||
130175224|NCT03698019|468598780|FG001|Step 1: Registration|Withdrawal by Subject|2|||
130175225|NCT03698019|468598779|FG000|Step 1: Registration|Toxicity|0|||
130175226|NCT03698019|468598780|FG001|Step 1: Registration|Toxicity|1|||
130175227|NCT03698019|468598779|FG000|Step 1: Registration|Disease Progression|0|||
130175228|NCT03698019|468598780|FG001|Step 1: Registration|Disease Progression|12|||
130175229|NCT03698019|468598779|FG000|Step 1: Registration|Co-morbidities|0|||
130175230|NCT03698019|468598780|FG001|Step 1: Registration|Co-morbidities|1|||
130175231|NCT03698019|468598779|FG000|Step 1: Registration|Scheduling Issues|1|||
130175232|NCT03698019|468598780|FG001|Step 1: Registration|Scheduling Issues|0|||
130175233|NCT03698019|468598779|FG000|Step 1: Registration|Participant Refusal|0|||
130175234|NCT03698019|468598780|FG001|Step 1: Registration|Participant Refusal|1|||
130175235|NCT03698019|468598779|FG000|Step 2: Surgery|Participant Refusal|2|||
130175236|NCT03698019|468598780|FG001|Step 2: Surgery|Participant Refusal|1|||
130175237|NCT03698019|468598779|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
130175238|NCT03698019|468598780|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
130175239|NCT03698019|468598779|FG000|Step 2: Surgery|Metastatic Disease|16|||
130175240|NCT03698019|468598780|FG001|Step 2: Surgery|Metastatic Disease|9|||
130175241|NCT03698019|468598779|FG000|Step 2: Surgery|Residual Disease|2|||
130175242|NCT03698019|468598780|FG001|Step 2: Surgery|Residual Disease|1|||
130175243|NCT03698019|468598779|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
130175244|NCT03698019|468598780|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
130175245|NCT03698019|468598779|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
130175246|NCT03698019|468598780|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
130175247|NCT03698019|468598779|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
130175248|NCT03698019|468598780|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
130175249|NCT03698019|468598779|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
130175250|NCT03698019|468598780|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
130175251|NCT03698019|468598779|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
130175252|NCT03698019|468598780|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
130175253|NCT03698019|468598779|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
130175254|NCT03698019|468598780|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
130175255|NCT03698019|468598779|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
130175256|NCT03698019|468598780|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
130175257|NCT03698019|468598779|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
130175258|NCT03698019|468598780|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
130175259|NCT00588770|468598781|FG000|Overall Study|Disease progression|85|||
130175260|NCT00588770|468598782|FG001|Overall Study|Disease progression|68|||
130175261|NCT00588770|468598781|FG000|Overall Study|Adverse Event|29|||
130175262|NCT00588770|468598782|FG001|Overall Study|Adverse Event|58|||
130175263|NCT00588770|468598781|FG000|Overall Study|Death|13|||
129982782|NCT00943852|467900621|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982783|NCT00943852|467900622|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982784|NCT00943852|467900623|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982785|NCT00943852|467900624|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982786|NCT00943852|467900625|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982787|NCT00943852|467900626|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982788|NCT00943852|467900617|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982789|NCT00943852|467900618|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982790|NCT00943852|467900619|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
130175264|NCT00588770|468598782|FG001|Overall Study|Death|22|||
130175265|NCT00588770|468598781|FG000|Overall Study|Withdrawal by Subject|15|||
130175266|NCT00588770|468598782|FG001|Overall Study|Withdrawal by Subject|25|||
130175267|NCT00588770|468598781|FG000|Overall Study|Alternative therapy|2|||
130175268|NCT00588770|468598782|FG001|Overall Study|Alternative therapy|4|||
130175269|NCT00588770|468598781|FG000|Overall Study|Other complicating disease|3|||
130175270|NCT00588770|468598782|FG001|Overall Study|Other complicating disease|2|||
130175271|NCT00588770|468598781|FG000|Overall Study|Not start protocol therapy|0|||
130175272|NCT00588770|468598782|FG001|Overall Study|Not start protocol therapy|9|||
130175273|NCT00588770|468598781|FG000|Overall Study|Lack of Efficacy|8|||
130175274|NCT00588770|468598782|FG001|Overall Study|Lack of Efficacy|10|||
130175275|NCT00588770|468598781|FG000|Overall Study|Physician discretion|2|||
130175276|NCT00588770|468598782|FG001|Overall Study|Physician discretion|0|||
129982791|NCT00943852|467900620|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982792|NCT00943852|467900621|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982793|NCT00943852|467900622|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
129982794|NCT00943852|467900623|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982795|NCT00943852|467900624|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982796|NCT00943852|467900625|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982797|NCT00943852|467900626|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982798|NCT00943852|467900617|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982799|NCT00943852|467900618|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982800|NCT00943852|467900619|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982801|NCT00943852|467900620|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982802|NCT00943852|467900621|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130175277|NCT00588770|468598781|FG000|Overall Study|Patient non-compliance|2|||
130175278|NCT00588770|468598782|FG001|Overall Study|Patient non-compliance|2|||
130175279|NCT01856192|468598783|FG000|Overall Study|Adverse Event|12|||
130175280|NCT01856192|468598784|FG001|Overall Study|Adverse Event|4|||
130175281|NCT01856192|468598783|FG000|Overall Study|Alternative therapy|0|||
130175282|NCT01856192|468598784|FG001|Overall Study|Alternative therapy|3|||
130175283|NCT01856192|468598783|FG000|Overall Study|Death|3|||
130175284|NCT01856192|468598784|FG001|Overall Study|Death|5|||
130175285|NCT01856192|468598783|FG000|Overall Study|Lack of Efficacy|0|||
130175286|NCT01856192|468598784|FG001|Overall Study|Lack of Efficacy|5|||
130175287|NCT01856192|468598783|FG000|Overall Study|Withdrawal by Subject|1|||
130175288|NCT01856192|468598784|FG001|Overall Study|Withdrawal by Subject|1|||
130175289|NCT01856192|468598783|FG000|Overall Study|Other diseases|1|||
130175290|NCT01856192|468598784|FG001|Overall Study|Other diseases|0|||
130175291|NCT01856192|468598783|FG000|Overall Study|Never started treatment|7|||
130175292|NCT01856192|468598784|FG001|Overall Study|Never started treatment|5|||
130175293|NCT01856192|468598783|FG000|Overall Study|Path ineligible|20|||
130175294|NCT01856192|468598784|FG001|Overall Study|Path ineligible|34|||
130175295|NCT01856192|468598783|FG000|Overall Study|Non-path ineligible|2|||
130175296|NCT01856192|468598784|FG001|Overall Study|Non-path ineligible|2|||
130175297|NCT01856192|468598783|FG000|Overall Study|Physician Decision|1|||
130175298|NCT01856192|468598784|FG001|Overall Study|Physician Decision|1|||
130175299|NCT01856192|468598783|FG000|Overall Study|Suspicion of progressive disease|1|||
130175300|NCT01856192|468598784|FG001|Overall Study|Suspicion of progressive disease|0|||
130175301|NCT01856192|468598783|FG000|Overall Study|Non-compliance|1|||
130175302|NCT01856192|468598784|FG001|Overall Study|Non-compliance|0|||
130175303|NCT02642042|468598785|FG000|Overall Study|Adverse Event|22|||
130175304|NCT02642042|468598785|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
130175305|NCT02642042|468598785|FG000|Overall Study|Progression/Relapse|28|||
130175306|NCT02642042|468598785|FG000|Overall Study|Death|1|||
130175307|NCT02642042|468598785|FG000|Overall Study|Not Protocol Specified|2|||
130175308|NCT04976621|468598786|FG000|Overall Study|Lost to Follow-up|2|||
130175309|NCT04976621|468598787|FG001|Overall Study|Lost to Follow-up|1|||
130175310|NCT04976621|468598786|FG000|Overall Study|Withdrawal by Subject|1|||
130175311|NCT04976621|468598787|FG001|Overall Study|Withdrawal by Subject|0|||
130175312|NCT01625988|468598797|FG000|Overall Study|Lost to Follow-up|5|||
130175313|NCT01625988|468598798|FG001|Overall Study|Lost to Follow-up|6|||
130175314|NCT01625988|468598797|FG000|Overall Study|Withdrawal by Subject|8|||
130175315|NCT01625988|468598798|FG001|Overall Study|Withdrawal by Subject|3|||
130175316|NCT01625988|468598797|FG000|Overall Study|Adverse Event|0|||
130175317|NCT01625988|468598798|FG001|Overall Study|Adverse Event|1|||
130175318|NCT01625988|468598797|FG000|Overall Study|Lack of Efficacy|0|||
130175319|NCT01625988|468598798|FG001|Overall Study|Lack of Efficacy|1|||
130175320|NCT01625988|468598797|FG000|Overall Study|Randomized Inappropriately|1|||
130175321|NCT01625988|468598798|FG001|Overall Study|Randomized Inappropriately|0|||
130175322|NCT01625988|468598797|FG000|Overall Study|Protocol Violation|0|||
130175323|NCT01625988|468598798|FG001|Overall Study|Protocol Violation|2|||
130175324|NCT01644617|468598799|FG000|Overall Study|Withdrawal by Subject|3|||
130175325|NCT01644617|468598800|FG001|Overall Study|Withdrawal by Subject|4|||
130175326|NCT01644617|468598801|FG002|Overall Study|Withdrawal by Subject|1|||
130175327|NCT01644617|468598799|FG000|Overall Study|Lost to Follow-up|0|||
130175328|NCT01644617|468598800|FG001|Overall Study|Lost to Follow-up|1|||
130175329|NCT01644617|468598801|FG002|Overall Study|Lost to Follow-up|0|||
130175330|NCT01644617|468598799|FG000|Overall Study|Adverse Event|3|||
130175331|NCT01644617|468598800|FG001|Overall Study|Adverse Event|0|||
130175332|NCT01644617|468598801|FG002|Overall Study|Adverse Event|6|||
130175333|NCT03993379|468598805|FG000|Overall Study|The study was terminated early due to business decision.|0|||
130175334|NCT03993379|468598806|FG001|Overall Study|The study was terminated early due to business decision.|2|||
130175335|NCT03993379|468598807|FG002|Overall Study|The study was terminated early due to business decision.|0|||
130175336|NCT03993379|468598808|FG003|Overall Study|The study was terminated early due to business decision.|0|||
130175337|NCT03993379|468598805|FG000|Overall Study|Withdrawal by Subject|0|||
130175338|NCT03993379|468598806|FG001|Overall Study|Withdrawal by Subject|1|||
130175339|NCT03993379|468598807|FG002|Overall Study|Withdrawal by Subject|0|||
130175340|NCT03993379|468598808|FG003|Overall Study|Withdrawal by Subject|0|||
130175341|NCT01427608|468598809|FG000|Overall Study|Death|1|||
130175342|NCT01427608|468598810|FG001|Overall Study|Death|0|||
130175343|NCT01427608|468598809|FG000|Overall Study|Withdrawal by Subject|7|||
130175344|NCT01427608|468598810|FG001|Overall Study|Withdrawal by Subject|3|||
130175345|NCT01427608|468598809|FG000|Overall Study|Relapsed-all cause|13|||
130175346|NCT01427608|468598810|FG001|Overall Study|Relapsed-all cause|34|||
130175347|NCT01427608|468598809|FG000|Overall Study|Events not attributed to study meds|0|||
130175348|NCT01427608|468598810|FG001|Overall Study|Events not attributed to study meds|1|||
130175349|NCT05223920|468598811|FG000|Overall Study|Adverse Event|6|||
130175350|NCT05223920|468598812|FG001|Overall Study|Adverse Event|3|||
130175351|NCT05223920|468598811|FG000|Overall Study|Death|2|||
130175352|NCT05223920|468598812|FG001|Overall Study|Death|0|||
130175353|NCT05223920|468598811|FG000|Overall Study|Disease Progression|1|||
130175354|NCT05223920|468598812|FG001|Overall Study|Disease Progression|2|||
130175355|NCT05223920|468598811|FG000|Overall Study|Physician Decision|1|||
130175356|NCT05223920|468598812|FG001|Overall Study|Physician Decision|2|||
130175357|NCT05223920|468598811|FG000|Overall Study|Sponsor decision|11|||
130175358|NCT05223920|468598812|FG001|Overall Study|Sponsor decision|9|||
130175359|NCT05223920|468598811|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
130175360|NCT05223920|468598812|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
130175361|NCT05223920|468598811|FG000|Overall Study|Subject decision|1|||
130175362|NCT05223920|468598812|FG001|Overall Study|Subject decision|0|||
130175363|NCT05223920|468598811|FG000|Overall Study|Withdrawal by Subject|1|||
130175364|NCT05223920|468598812|FG001|Overall Study|Withdrawal by Subject|6|||
130175365|NCT03790657|468598813|FG000|Overall Study|Adverse Event|1|||
130175366|NCT03790657|468598814|FG001|Overall Study|Adverse Event|1|||
130175367|NCT03790657|468598813|FG000|Overall Study|Withdrawal by Subject|1|||
130175368|NCT03790657|468598814|FG001|Overall Study|Withdrawal by Subject|1|||
130175369|NCT01807065|468598815|FG000|Overall Study|Receive no sip-T due to IV access|1|||
130175370|NCT01807065|468598816|FG001|Overall Study|Receive no sip-T due to IV access|1|||
130175371|NCT05246670|468598821|FG000|Overall Study|Withdrawal by Subject|2|||
130175372|NCT05246670|468598822|FG001|Overall Study|Withdrawal by Subject|3|||
130175373|NCT05246670|468598823|FG002|Overall Study|Withdrawal by Subject|0|||
130175374|NCT05246670|468598824|FG003|Overall Study|Withdrawal by Subject|1|||
130175375|NCT05246670|468598821|FG000|Overall Study|Adverse Event|0|||
130175376|NCT05246670|468598822|FG001|Overall Study|Adverse Event|0|||
130175377|NCT05246670|468598823|FG002|Overall Study|Adverse Event|1|||
130175378|NCT05246670|468598824|FG003|Overall Study|Adverse Event|0|||
130175379|NCT05246670|468598821|FG000|Overall Study|Physician Decision|1|||
130175380|NCT05246670|468598822|FG001|Overall Study|Physician Decision|0|||
130175381|NCT05246670|468598823|FG002|Overall Study|Physician Decision|0|||
130175382|NCT05246670|468598824|FG003|Overall Study|Physician Decision|0|||
130175383|NCT05246670|468598821|FG000|Overall Study|Protocol Violation|1|||
130175384|NCT05246670|468598822|FG001|Overall Study|Protocol Violation|0|||
130175385|NCT05246670|468598823|FG002|Overall Study|Protocol Violation|0|||
130175386|NCT05246670|468598824|FG003|Overall Study|Protocol Violation|0|||
130175387|NCT03154125|468598830|FG000|Overall Study|Lost to Follow-up|11|||
130175388|NCT03154125|468598831|FG001|Overall Study|Lost to Follow-up|11|||
130175389|NCT03154125|468598832|FG002|Overall Study|Lost to Follow-up|0|||
130175390|NCT03154125|468598830|FG000|Overall Study|Withdrawal by Subject|49|||
130175391|NCT03154125|468598831|FG001|Overall Study|Withdrawal by Subject|55|||
130175392|NCT03154125|468598832|FG002|Overall Study|Withdrawal by Subject|8|||
130175393|NCT03154125|468598830|FG000|Overall Study|Physician Decision|13|||
130175394|NCT03154125|468598831|FG001|Overall Study|Physician Decision|6|||
130175395|NCT03154125|468598832|FG002|Overall Study|Physician Decision|0|||
130175396|NCT03154125|468598830|FG000|Overall Study|Protocol Violation|3|||
130175397|NCT03154125|468598831|FG001|Overall Study|Protocol Violation|5|||
130175398|NCT03154125|468598832|FG002|Overall Study|Protocol Violation|0|||
130175399|NCT00799058|468598833|FG000|Overall Study|Withdrawal by Subject|2|||
130175400|NCT00799058|468598834|FG001|Overall Study|Withdrawal by Subject|2|||
130175401|NCT00799058|468598835|FG002|Overall Study|Withdrawal by Subject|2|||
130175402|NCT00799058|468598833|FG000|Overall Study|Lost to Follow-up|1|||
130175403|NCT00799058|468598834|FG001|Overall Study|Lost to Follow-up|2|||
130175404|NCT00799058|468598835|FG002|Overall Study|Lost to Follow-up|1|||
130175405|NCT00799058|468598833|FG000|Overall Study|Adverse Event|0|||
130175406|NCT00799058|468598834|FG001|Overall Study|Adverse Event|2|||
130175407|NCT00799058|468598835|FG002|Overall Study|Adverse Event|0|||
130175408|NCT00799058|468598833|FG000|Overall Study|Pregnancy|1|||
130175409|NCT00799058|468598834|FG001|Overall Study|Pregnancy|0|||
130175410|NCT00799058|468598835|FG002|Overall Study|Pregnancy|0|||
130175411|NCT00799058|468598833|FG000|Overall Study|Not adherent|3|||
130175412|NCT00799058|468598834|FG001|Overall Study|Not adherent|2|||
130175413|NCT00799058|468598835|FG002|Overall Study|Not adherent|1|||
130175414|NCT00799058|468598833|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
130175415|NCT00799058|468598834|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
130175416|NCT00799058|468598835|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
130175417|NCT00799058|468598833|FG000|Overall Study|IP dispensing error|1|||
130175418|NCT00799058|468598834|FG001|Overall Study|IP dispensing error|0|||
130175419|NCT00799058|468598835|FG002|Overall Study|IP dispensing error|0|||
130175420|NCT00799058|468598833|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
130175421|NCT00799058|468598834|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
130175422|NCT00799058|468598835|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
130175423|NCT00799058|468598833|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
130175424|NCT00799058|468598834|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
130175425|NCT00799058|468598835|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
130175426|NCT00799058|468598833|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
130175427|NCT00799058|468598834|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
130175428|NCT00799058|468598835|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
130175429|NCT00799058|468598833|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
130175430|NCT00799058|468598834|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
130175431|NCT00799058|468598835|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
130175432|NCT03639779|468598836|FG000|Overall Study|Lost to Follow-up|1|||
130175433|NCT00810511|468598837|FG000|Overall Study|Protocol Violation|0|||
130175434|NCT00810511|468598838|FG001|Overall Study|Protocol Violation|1|||
130175435|NCT00810511|468598837|FG000|Overall Study|Lack of Efficacy|9|||
130175436|NCT00810511|468598838|FG001|Overall Study|Lack of Efficacy|1|||
130175437|NCT00810511|468598837|FG000|Overall Study|death in the family|0|||
130175438|NCT00810511|468598838|FG001|Overall Study|death in the family|1|||
130175439|NCT00810511|468598837|FG000|Overall Study|Lost to Follow-up|1|||
130175440|NCT00810511|468598838|FG001|Overall Study|Lost to Follow-up|0|||
130175441|NCT00810511|468598837|FG000|Overall Study|deposits on contact lens|0|||
130175442|NCT00810511|468598838|FG001|Overall Study|deposits on contact lens|1|||
130175443|NCT02088697|468598839|FG000|Period I|Physician Decision|1|||
130175444|NCT02088697|468598840|FG001|Period I|Physician Decision|4|||
130175445|NCT02088697|468598839|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
130175446|NCT02088697|468598840|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
130175447|NCT00462904|468598841|FG000|Overall Study|Lost to Follow-up|1|||
130175448|NCT05219448|468598842|FG000|Overall Study|Lost to Follow-up|9|||
130175449|NCT05219448|468598843|FG001|Overall Study|Lost to Follow-up|0|||
130175450|NCT00911300|468598847|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
130175451|NCT00911300|468598848|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
130175452|NCT00911300|468598847|FG000|Overall Study|Death|1|||
130175453|NCT00911300|468598848|FG001|Overall Study|Death|0|||
130175454|NCT00911300|468598847|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
130175455|NCT00911300|468598848|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
130175456|NCT00911300|468598847|FG000|Overall Study|Adverse Event|14|||
130175457|NCT00911300|468598848|FG001|Overall Study|Adverse Event|6|||
130175458|NCT00911300|468598847|FG000|Overall Study|Protocol Violation|3|||
130175459|NCT00911300|468598848|FG001|Overall Study|Protocol Violation|2|||
130175460|NCT00911300|468598847|FG000|Overall Study|Consent Withdrawn|4|||
130175461|NCT00911300|468598848|FG001|Overall Study|Consent Withdrawn|12|||
130175462|NCT00911300|468598847|FG000|Overall Study|Coronary Angiography Performed|1|||
130175463|NCT00911300|468598848|FG001|Overall Study|Coronary Angiography Performed|0|||
130175464|NCT00911300|468598847|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
130175465|NCT00911300|468598848|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
130175466|NCT00911300|468598847|FG000|Overall Study|Received Commercial Treatment|1|||
130175467|NCT00911300|468598848|FG001|Overall Study|Received Commercial Treatment|0|||
130175468|NCT00911300|468598847|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
130175469|NCT00911300|468598848|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
130175470|NCT00911300|468598847|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
130175471|NCT00911300|468598848|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
130175472|NCT00911300|468598847|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
130175473|NCT00911300|468598848|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
130175474|NCT00911300|468598847|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
130175475|NCT00911300|468598848|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
130175476|NCT00911300|468598847|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
130175477|NCT00911300|468598848|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
130175478|NCT00911300|468598847|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
130175479|NCT00911300|468598848|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
130175480|NCT00911300|468598847|FG000|Overall Study|International Normalized Ratio Too High|0|||
129982803|NCT00943852|467900622|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130175481|NCT00911300|468598848|FG001|Overall Study|International Normalized Ratio Too High|1|||
130175482|NCT00911300|468598847|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
130175483|NCT00911300|468598848|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
129982804|NCT00943852|467900623|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
130175484|NCT00911300|468598847|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
130175485|NCT00911300|468598848|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
130175486|NCT00911300|468598847|FG000|Overall Study|Physician Decision|0|||
130175487|NCT00911300|468598848|FG001|Overall Study|Physician Decision|1|||
130175488|NCT00911300|468598847|FG000|Overall Study|Treatment Stopped by Mistake|0|||
130175489|NCT00911300|468598848|FG001|Overall Study|Treatment Stopped by Mistake|1|||
130175490|NCT00911300|468598847|FG000|Overall Study|Randomized; No Study Medication Received|0|||
130175491|NCT00911300|468598848|FG001|Overall Study|Randomized; No Study Medication Received|2|||
130175492|NCT02287922|468598849|FG000|Overall Study|Adverse Event|1|||
130175493|NCT02287922|468598850|FG001|Overall Study|Adverse Event|1|||
130175494|NCT02287922|468598851|FG002|Overall Study|Adverse Event|3|||
130175495|NCT02287922|468598852|FG003|Overall Study|Adverse Event|4|||
130175496|NCT02287922|468598849|FG000|Overall Study|Withdrawal by Subject|1|||
130175497|NCT02287922|468598850|FG001|Overall Study|Withdrawal by Subject|1|||
130175498|NCT02287922|468598851|FG002|Overall Study|Withdrawal by Subject|1|||
130175499|NCT02287922|468598852|FG003|Overall Study|Withdrawal by Subject|2|||
130175500|NCT02287922|468598849|FG000|Overall Study|Lost to Follow-up|0|||
130175501|NCT02287922|468598850|FG001|Overall Study|Lost to Follow-up|0|||
130175502|NCT02287922|468598851|FG002|Overall Study|Lost to Follow-up|1|||
130175503|NCT02287922|468598852|FG003|Overall Study|Lost to Follow-up|0|||
130175504|NCT02287922|468598849|FG000|Overall Study|Sponsor's decision|0|||
130175505|NCT02287922|468598850|FG001|Overall Study|Sponsor's decision|0|||
130175506|NCT02287922|468598851|FG002|Overall Study|Sponsor's decision|0|||
130175507|NCT02287922|468598852|FG003|Overall Study|Sponsor's decision|1|||
130175508|NCT02287922|468598849|FG000|Overall Study|Other|1|||
130175509|NCT02287922|468598850|FG001|Overall Study|Other|0|||
130175510|NCT02287922|468598851|FG002|Overall Study|Other|2|||
130175511|NCT02287922|468598852|FG003|Overall Study|Other|0|||
130175512|NCT04152291|468598853|FG000|Overall Study|Covid-19 restrictions|27|||
130175513|NCT04152291|468598853|FG000|Overall Study|Withdrawal by Subject|3|||
130175514|NCT05124691|468598854|FG000|Phase II|Eligibility criteria|0|||
130175515|NCT05124691|468598855|FG001|Phase II|Eligibility criteria|1|||
130175516|NCT05124691|468598856|FG002|Phase II|Eligibility criteria|0|||
130175517|NCT05124691|468598854|FG000|Phase II|Withdrawal by Subject|6|||
130175518|NCT05124691|468598855|FG001|Phase II|Withdrawal by Subject|2|||
130175519|NCT05124691|468598856|FG002|Phase II|Withdrawal by Subject|3|||
130175520|NCT05124691|468598854|FG000|Phase III|Withdrawal by Subject|6|||
130175521|NCT05124691|468598855|FG001|Phase III|Withdrawal by Subject|4|||
130175522|NCT05124691|468598856|FG002|Phase III|Withdrawal by Subject|4|||
130175523|NCT05124691|468598854|FG000|Phase III|Lost to Follow-up|1|||
130175524|NCT05124691|468598855|FG001|Phase III|Lost to Follow-up|0|||
130175525|NCT05124691|468598856|FG002|Phase III|Lost to Follow-up|0|||
130175526|NCT04223752|468598859|FG000|Overall Study|Participant enrolled in error|0|||
130175527|NCT04223752|468598860|FG001|Overall Study|Participant enrolled in error|0|||
130175528|NCT04223752|468598861|FG002|Overall Study|Participant enrolled in error|0|||
130175529|NCT04223752|468598862|FG003|Overall Study|Participant enrolled in error|0|||
130175530|NCT04223752|468598863|FG004|Overall Study|Participant enrolled in error|1|||
130175531|NCT04223752|468598859|FG000|Overall Study|Death|0|||
130175532|NCT04223752|468598860|FG001|Overall Study|Death|0|||
130175533|NCT04223752|468598861|FG002|Overall Study|Death|0|||
130175534|NCT04223752|468598862|FG003|Overall Study|Death|2|||
130175535|NCT04223752|468598863|FG004|Overall Study|Death|1|||
130175536|NCT04739800|468598864|FG000|Overall Study|Adverse Event|2|||
130175537|NCT04739800|468598865|FG001|Overall Study|Adverse Event|1|||
130175538|NCT04739800|468598866|FG002|Overall Study|Adverse Event|4|||
130175539|NCT04739800|468598867|FG003|Overall Study|Adverse Event|5|||
130175540|NCT04739800|468598864|FG000|Overall Study|Never Treated|2|||
130175541|NCT04739800|468598865|FG001|Overall Study|Never Treated|0|||
130175542|NCT04739800|468598866|FG002|Overall Study|Never Treated|1|||
129982805|NCT00943852|467900624|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982806|NCT00943852|467900625|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982807|NCT00943852|467900626|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
130175543|NCT04739800|468598867|FG003|Overall Study|Never Treated|1|||
130175544|NCT04739800|468598864|FG000|Overall Study|On Treatment|5|||
130175545|NCT04739800|468598865|FG001|Overall Study|On Treatment|9|||
130175546|NCT04739800|468598866|FG002|Overall Study|On Treatment|9|||
130175547|NCT04739800|468598867|FG003|Overall Study|On Treatment|9|||
130175548|NCT04739800|468598864|FG000|Overall Study|Symptomatic Deterioration|1|||
130175549|NCT04739800|468598865|FG001|Overall Study|Symptomatic Deterioration|1|||
130175550|NCT04739800|468598866|FG002|Overall Study|Symptomatic Deterioration|3|||
130175551|NCT04739800|468598867|FG003|Overall Study|Symptomatic Deterioration|0|||
130175552|NCT04739800|468598864|FG000|Overall Study|Withdrawal by Subject|1|||
130175553|NCT04739800|468598865|FG001|Overall Study|Withdrawal by Subject|2|||
130175554|NCT04739800|468598866|FG002|Overall Study|Withdrawal by Subject|1|||
130175555|NCT04739800|468598867|FG003|Overall Study|Withdrawal by Subject|3|||
130175556|NCT04739800|468598864|FG000|Overall Study|Other Reason|1|||
130175557|NCT04739800|468598865|FG001|Overall Study|Other Reason|3|||
130175558|NCT04739800|468598866|FG002|Overall Study|Other Reason|5|||
130175559|NCT04739800|468598867|FG003|Overall Study|Other Reason|4|||
130175560|NCT02779855|468598868|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
130175561|NCT02779855|468598869|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
130175562|NCT02779855|468598870|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
130175563|NCT00447993|468598873|FG000|Overall Study|Lost to Follow-up|0|||
130175564|NCT00447993|468598874|FG001|Overall Study|Lost to Follow-up|0|||
130175565|NCT00447993|468598875|FG002|Overall Study|Lost to Follow-up|2|||
130175566|NCT00447993|468598876|FG003|Overall Study|Lost to Follow-up|2|||
130175567|NCT00447993|468598873|FG000|Overall Study|Withdrawal by Subject|0|||
130175568|NCT00447993|468598874|FG001|Overall Study|Withdrawal by Subject|0|||
130175569|NCT00447993|468598875|FG002|Overall Study|Withdrawal by Subject|2|||
130175570|NCT00447993|468598876|FG003|Overall Study|Withdrawal by Subject|2|||
130175571|NCT02503787|468598877|FG000|Enrollment|Withdrawal by Subject|6|||
130175572|NCT02503787|468598877|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
130175573|NCT02503787|468598877|FG000|Enrollment|Physician Decision|2|||
130175574|NCT02503787|468598877|FG000|Enrollment|Insurance issue|2|||
130175575|NCT02503787|468598877|FG000|Enrollment|Lost to Follow-up|1|||
130175576|NCT02503787|468598877|FG000|Enrollment|Study closure|1|||
130175577|NCT02503787|468598877|FG000|Enrollment|Adverse Event|1|||
130175578|NCT02503787|468598877|FG000|Enrollment|Protocol Violation|1|||
130175579|NCT02503787|468598877|FG000|Enrollment|Inability to implant system|1|||
130175580|NCT02503787|468598877|FG000|Enrollment|Unable to be programmed|1|||
130175581|NCT02503787|468598877|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
130175582|NCT02503787|468598877|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
130175583|NCT02503787|468598877|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
130175584|NCT02503787|468598877|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
130175585|NCT02503787|468598877|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
130175586|NCT02503787|468598877|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
130175587|NCT04787627|468598878|FG000|Overall Study|Withdrawal by Subject|3|||
130175588|NCT04787627|468598879|FG001|Overall Study|Withdrawal by Subject|0|||
130175589|NCT04787627|468598878|FG000|Overall Study|Physician Decision|2|||
130175590|NCT04787627|468598879|FG001|Overall Study|Physician Decision|0|||
130175591|NCT04787627|468598878|FG000|Overall Study|Excluded|0|||
130175592|NCT04787627|468598879|FG001|Overall Study|Excluded|1|||
130175593|NCT00174954|468598881|FG000|Overall Study|Adverse Event|2|||
130175594|NCT00174954|468598881|FG000|Overall Study|No tophi found in MRI|1|||
130175595|NCT00174954|468598881|FG000|Overall Study|Physician Decision|1|||
130175596|NCT00839254|468598882|FG000|Overall Study|Protocol Violation|0|||
130175597|NCT00839254|468598883|FG001|Overall Study|Protocol Violation|1|||
130175598|NCT00839254|468598884|FG002|Overall Study|Protocol Violation|1|||
130175599|NCT00839254|468598885|FG003|Overall Study|Protocol Violation|1|||
130175600|NCT00839254|468598886|FG004|Overall Study|Protocol Violation|0|||
130175601|NCT00839254|468598887|FG005|Overall Study|Protocol Violation|0|||
130175602|NCT00839254|468598888|FG006|Overall Study|Protocol Violation|1|||
130175603|NCT00839254|468598889|FG007|Overall Study|Protocol Violation|2|||
130175604|NCT00839254|468598882|FG000|Overall Study|Physician Decision|0|||
130175605|NCT00839254|468598883|FG001|Overall Study|Physician Decision|1|||
130175606|NCT00839254|468598884|FG002|Overall Study|Physician Decision|0|||
130175607|NCT00839254|468598885|FG003|Overall Study|Physician Decision|0|||
130175608|NCT00839254|468598886|FG004|Overall Study|Physician Decision|0|||
130175609|NCT00839254|468598887|FG005|Overall Study|Physician Decision|0|||
130175610|NCT00839254|468598888|FG006|Overall Study|Physician Decision|0|||
130175611|NCT00839254|468598889|FG007|Overall Study|Physician Decision|1|||
130175612|NCT00839254|468598882|FG000|Overall Study|Wrong treatment number allocation|0|||
130175613|NCT00839254|468598883|FG001|Overall Study|Wrong treatment number allocation|1|||
130175614|NCT00839254|468598884|FG002|Overall Study|Wrong treatment number allocation|0|||
130175615|NCT00839254|468598885|FG003|Overall Study|Wrong treatment number allocation|0|||
130175616|NCT00839254|468598886|FG004|Overall Study|Wrong treatment number allocation|0|||
130175617|NCT00839254|468598887|FG005|Overall Study|Wrong treatment number allocation|1|||
130175618|NCT00839254|468598888|FG006|Overall Study|Wrong treatment number allocation|0|||
130175619|NCT00839254|468598889|FG007|Overall Study|Wrong treatment number allocation|0|||
130175620|NCT00839254|468598882|FG000|Overall Study|Adverse Event|12|||
130175621|NCT00839254|468598883|FG001|Overall Study|Adverse Event|6|||
130175622|NCT00839254|468598884|FG002|Overall Study|Adverse Event|3|||
129982808|NCT00943852|467900617|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982809|NCT00943852|467900618|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130175623|NCT00839254|468598885|FG003|Overall Study|Adverse Event|5|||
130175624|NCT00839254|468598886|FG004|Overall Study|Adverse Event|2|||
130175625|NCT00839254|468598887|FG005|Overall Study|Adverse Event|1|||
130175626|NCT00839254|468598888|FG006|Overall Study|Adverse Event|0|||
130175627|NCT00839254|468598889|FG007|Overall Study|Adverse Event|1|||
130175628|NCT00839254|468598882|FG000|Overall Study|Withdrawal by Subject|87|||
130175629|NCT00839254|468598883|FG001|Overall Study|Withdrawal by Subject|53|||
130175630|NCT00839254|468598884|FG002|Overall Study|Withdrawal by Subject|54|||
130175631|NCT00839254|468598885|FG003|Overall Study|Withdrawal by Subject|32|||
130175632|NCT00839254|468598886|FG004|Overall Study|Withdrawal by Subject|27|||
130175633|NCT00839254|468598887|FG005|Overall Study|Withdrawal by Subject|15|||
130175634|NCT00839254|468598888|FG006|Overall Study|Withdrawal by Subject|22|||
130175635|NCT00839254|468598889|FG007|Overall Study|Withdrawal by Subject|9|||
130175636|NCT00839254|468598882|FG000|Overall Study|Wrong group allocation|0|||
130175637|NCT00839254|468598883|FG001|Overall Study|Wrong group allocation|0|||
130175638|NCT00839254|468598884|FG002|Overall Study|Wrong group allocation|0|||
130175639|NCT00839254|468598885|FG003|Overall Study|Wrong group allocation|0|||
130175640|NCT00839254|468598886|FG004|Overall Study|Wrong group allocation|0|||
130175641|NCT00839254|468598887|FG005|Overall Study|Wrong group allocation|0|||
130175642|NCT00839254|468598888|FG006|Overall Study|Wrong group allocation|1|||
130175643|NCT00839254|468598889|FG007|Overall Study|Wrong group allocation|0|||
130175644|NCT00839254|468598882|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
130175645|NCT00839254|468598883|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
130175646|NCT00839254|468598884|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
130175647|NCT00839254|468598885|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
130175648|NCT00839254|468598886|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
130175649|NCT00839254|468598887|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
130175650|NCT00839254|468598888|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
130175651|NCT00839254|468598889|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
130175652|NCT00839254|468598882|FG000|Overall Study|Withdrawn due to non-compliance|2|||
130175653|NCT00839254|468598883|FG001|Overall Study|Withdrawn due to non-compliance|0|||
130175654|NCT00839254|468598884|FG002|Overall Study|Withdrawn due to non-compliance|0|||
130175655|NCT00839254|468598885|FG003|Overall Study|Withdrawn due to non-compliance|0|||
130175656|NCT00839254|468598886|FG004|Overall Study|Withdrawn due to non-compliance|0|||
130175657|NCT00839254|468598887|FG005|Overall Study|Withdrawn due to non-compliance|0|||
130175658|NCT00839254|468598888|FG006|Overall Study|Withdrawn due to non-compliance|0|||
130175659|NCT00839254|468598889|FG007|Overall Study|Withdrawn due to non-compliance|0|||
130175660|NCT00839254|468598882|FG000|Overall Study|Lost to Follow-up|51|||
130175661|NCT00839254|468598883|FG001|Overall Study|Lost to Follow-up|30|||
130175662|NCT00839254|468598884|FG002|Overall Study|Lost to Follow-up|32|||
130175663|NCT00839254|468598885|FG003|Overall Study|Lost to Follow-up|24|||
130175664|NCT00839254|468598886|FG004|Overall Study|Lost to Follow-up|8|||
130175665|NCT00839254|468598887|FG005|Overall Study|Lost to Follow-up|8|||
130175666|NCT00839254|468598888|FG006|Overall Study|Lost to Follow-up|4|||
130175667|NCT00839254|468598889|FG007|Overall Study|Lost to Follow-up|2|||
130175668|NCT00489827|468598892|FG000|Overall Study|Intraoperative exclusion criteria|1|||
130175669|NCT00489827|468598893|FG001|Overall Study|Intraoperative exclusion criteria|1|||
130175670|NCT00489827|468598892|FG000|Overall Study|Intraoperative exclusion criteria|1|||
130175671|NCT00489827|468598893|FG001|Overall Study|Intraoperative exclusion criteria|1|||
130175672|NCT02296931|468598894|FG000|Overall Study|Protocol Violation|0|||
130175673|NCT02296931|468598895|FG001|Overall Study|Protocol Violation|2|||
130175674|NCT01590277|468598896|FG000|Overall Study|Withdrawal by Subject|3|||
130175675|NCT01590277|468598896|FG000|Overall Study|Withdrawal by Subject|2|||
130175676|NCT01590277|468598896|FG000|Overall Study|Withdrawal by Subject|1|||
130175677|NCT01590277|468598896|FG000|Overall Study|Withdrawal by Subject|1|||
130175678|NCT01377012|468598897|FG000|Core Study|Study terminated by Sponsor|47|||
130175679|NCT01377012|468598898|FG001|Core Study|Study terminated by Sponsor|54|||
130175680|NCT01377012|468598899|FG002|Core Study|Study terminated by Sponsor|46|||
130175681|NCT01377012|468598897|FG000|Core Study|Technical problems|1|||
130175682|NCT01377012|468598898|FG001|Core Study|Technical problems|0|||
130175683|NCT01377012|468598899|FG002|Core Study|Technical problems|0|||
130175684|NCT01377012|468598897|FG000|Core Study|Withdrawal by Subject|15|||
130175685|NCT01377012|468598898|FG001|Core Study|Withdrawal by Subject|23|||
130175686|NCT01377012|468598899|FG002|Core Study|Withdrawal by Subject|18|||
130175687|NCT01377012|468598897|FG000|Core Study|Protocol Violation|7|||
130175688|NCT01377012|468598898|FG001|Core Study|Protocol Violation|3|||
130175689|NCT01377012|468598899|FG002|Core Study|Protocol Violation|2|||
130175690|NCT01377012|468598897|FG000|Core Study|Pregnancy|0|||
130175691|NCT01377012|468598898|FG001|Core Study|Pregnancy|0|||
130175692|NCT01377012|468598899|FG002|Core Study|Pregnancy|1|||
130175693|NCT01377012|468598897|FG000|Core Study|Physician Decision|5|||
130175694|NCT01377012|468598898|FG001|Core Study|Physician Decision|4|||
130175695|NCT01377012|468598899|FG002|Core Study|Physician Decision|10|||
130175696|NCT01377012|468598897|FG000|Core Study|Non-Compliant with study treatment|0|||
130175697|NCT01377012|468598898|FG001|Core Study|Non-Compliant with study treatment|0|||
130175698|NCT01377012|468598899|FG002|Core Study|Non-Compliant with study treatment|1|||
130175699|NCT01377012|468598897|FG000|Core Study|No Longer require treatment|0|||
130175700|NCT01377012|468598898|FG001|Core Study|No Longer require treatment|0|||
130175701|NCT01377012|468598899|FG002|Core Study|No Longer require treatment|1|||
130175702|NCT01377012|468598897|FG000|Core Study|Lost to Follow-up|7|||
130175703|NCT01377012|468598898|FG001|Core Study|Lost to Follow-up|5|||
130175704|NCT01377012|468598899|FG002|Core Study|Lost to Follow-up|4|||
130175705|NCT01377012|468598897|FG000|Core Study|Lack of Efficacy|41|||
130175706|NCT01377012|468598898|FG001|Core Study|Lack of Efficacy|28|||
130175707|NCT01377012|468598899|FG002|Core Study|Lack of Efficacy|37|||
130175708|NCT01377012|468598897|FG000|Core Study|Death|1|||
130175709|NCT01377012|468598898|FG001|Core Study|Death|1|||
130175710|NCT01377012|468598899|FG002|Core Study|Death|1|||
130175711|NCT01377012|468598897|FG000|Core Study|Adverse Event|10|||
130175712|NCT01377012|468598898|FG001|Core Study|Adverse Event|14|||
130175713|NCT01377012|468598899|FG002|Core Study|Adverse Event|13|||
130175714|NCT01377012|468598897|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
130175715|NCT01377012|468598898|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
130175716|NCT01377012|468598899|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
130175717|NCT01377012|468598897|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
130175718|NCT01377012|468598898|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
130175719|NCT01377012|468598899|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
130175720|NCT01377012|468598897|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
130175721|NCT01377012|468598898|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
130175722|NCT01377012|468598899|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
130175723|NCT01377012|468598897|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
130175724|NCT01377012|468598898|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
130175725|NCT01377012|468598899|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
130175726|NCT01377012|468598897|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
130175727|NCT01377012|468598898|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
130175728|NCT01377012|468598899|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
130175729|NCT01377012|468598897|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
130175730|NCT01377012|468598898|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
130175731|NCT01377012|468598899|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
130175732|NCT04380961|468598902|FG000|Overall Study|Lost to Follow-up|17|||
130175733|NCT04380961|468598903|FG001|Overall Study|Lost to Follow-up|11|||
130175734|NCT04380961|468598902|FG000|Overall Study|Withdrawal by Subject|3|||
130175735|NCT04380961|468598903|FG001|Overall Study|Withdrawal by Subject|0|||
130175736|NCT04380961|468598902|FG000|Overall Study|Death|22|||
130175737|NCT04380961|468598903|FG001|Overall Study|Death|16|||
130175738|NCT04380961|468598902|FG000|Overall Study|Other|1|||
130175739|NCT04380961|468598903|FG001|Overall Study|Other|0|||
130175740|NCT04380961|468598902|FG000|Overall Study|Randomized but Not Treated|1|||
130175741|NCT04380961|468598903|FG001|Overall Study|Randomized but Not Treated|2|||
130175742|NCT00805961|468598904|FG000|Modality Therapy|Withdrawal by Subject|1|||
130175743|NCT00805961|468598904|FG000|Modality Therapy|Adverse Event|1|||
130175744|NCT00805961|468598904|FG000|Modality Therapy|Disease Progression|2|||
130175745|NCT00805961|468598904|FG000|Treatment-Free Interval|Adverse Event|3|||
130175746|NCT00805961|468598904|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
130175747|NCT00805961|468598904|FG000|Treatment-Free Interval|Physician Decision|1|||
130175748|NCT00805961|468598904|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
130175749|NCT00805961|468598904|FG000|Maintenance Treatment|Lack of Efficacy|13|||
130175750|NCT00805961|468598904|FG000|Maintenance Treatment|Intercurrent Illness|7|||
130175751|NCT00805961|468598904|FG000|Maintenance Treatment|Adverse Event|6|||
130175752|NCT00805961|468598904|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
130175753|NCT00805961|468598904|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
130175754|NCT00805961|468598904|FG000|Maintenance Treatment|Withdrawn Consent|1|||
130175755|NCT03736031|468598906|FG000|Overall Study|Death|2|||
130175756|NCT03736031|468598907|FG001|Overall Study|Death|4|||
130175757|NCT03736031|468598906|FG000|Overall Study|Lost to Follow-up|21|||
130175758|NCT03736031|468598907|FG001|Overall Study|Lost to Follow-up|2|||
130175759|NCT03736031|468598906|FG000|Overall Study|Withdrawal by Subject|9|||
130175760|NCT03736031|468598907|FG001|Overall Study|Withdrawal by Subject|0|||
130175761|NCT01954745|468598908|FG000|Overall Study|Radiological Progression|11|||
130175762|NCT01954745|468598908|FG000|Overall Study|Clinical Progression|5|||
130175763|NCT01954745|468598908|FG000|Overall Study|Adverse Event|2|||
130175764|NCT01954745|468598908|FG000|Overall Study|Death|1|||
130175765|NCT03514017|468598909|FG000|Overall Study|Death|1|||
130175766|NCT03514017|468598909|FG000|Overall Study|Adverse Event|1|||
130175767|NCT05938621|468599959|FG000|Overall Study|Lost to Follow-up|1|||
130175768|NCT05938621|468599960|FG001|Overall Study|Lost to Follow-up|5|||
130175769|NCT05938621|468599961|FG002|Overall Study|Lost to Follow-up|2|||
130175770|NCT05938621|468599962|FG003|Overall Study|Lost to Follow-up|2|||
130175771|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
130175772|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
130175773|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
130175774|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130175775|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130175776|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
130175777|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
130175778|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
130175779|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
130175780|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
130175781|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
130175782|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
130175783|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175784|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175785|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175786|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
130175787|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175788|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
130175789|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
130175790|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
130175791|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
130175792|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175793|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175794|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175795|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175796|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175797|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
130175798|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
130175799|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
130175800|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
130175801|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175802|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175803|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175804|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175805|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175806|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
130175807|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
130175808|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
130175809|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
130175810|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175811|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175812|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175813|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
130175814|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175815|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
130175816|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
130175817|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175818|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175819|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175820|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175821|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175822|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175823|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175824|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
130175825|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175826|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
130175827|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175828|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175829|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175830|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175831|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175832|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175833|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175834|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175835|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175836|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
130175837|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175838|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175839|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175840|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175841|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175842|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
130175843|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
130175844|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175845|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129982810|NCT00943852|467900619|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130175846|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175847|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175848|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175849|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175850|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175851|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
130175852|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
130175853|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175854|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175855|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175856|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175857|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175858|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175859|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175860|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
130175861|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
130175862|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175863|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175864|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175865|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175866|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175867|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175868|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175869|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
130175870|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175871|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
130175872|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
130175873|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175874|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175875|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175876|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175877|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175878|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
130175879|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
130175880|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
130175881|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175882|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175883|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175884|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175885|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175886|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175887|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
130175888|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175889|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
130175890|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175891|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175892|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175893|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175894|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175895|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175896|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
130175897|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175898|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
130175899|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175900|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175901|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175902|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175903|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175904|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
130175905|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129982811|NCT00943852|467900620|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
130175906|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175907|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175908|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
130175909|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175910|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175911|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175912|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175913|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175914|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
130175915|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175916|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175917|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
130175918|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175919|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175920|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175921|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175922|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175923|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
130175924|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175925|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175926|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
130175927|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175928|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175929|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175930|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175931|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175932|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
130175933|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175934|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175935|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175936|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175937|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175938|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175939|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
130175940|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175941|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
130175942|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
130175943|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
130175944|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175945|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175946|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175947|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175948|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175949|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175950|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
130175951|NCT03598790|468599963|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175952|NCT03598790|468599964|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175953|NCT03598790|468599965|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
130175954|NCT03598790|468599966|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175955|NCT03598790|468599967|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175956|NCT03598790|468599968|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175957|NCT03598790|468599969|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175958|NCT03598790|468599970|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175959|NCT03598790|468599971|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
130175960|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175961|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175962|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175963|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130175964|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
130175965|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
130175966|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175967|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175968|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
130175969|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175970|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175971|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175972|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
130175973|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175974|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175975|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175976|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175977|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
130175978|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175979|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175980|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175981|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
130175982|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175983|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175984|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175985|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175986|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
130175987|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175988|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175989|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175990|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
130175991|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
130175992|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175993|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175994|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175995|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
130175996|NCT03598790|468599963|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130175997|NCT03598790|468599964|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130175998|NCT03598790|468599965|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130175999|NCT03598790|468599966|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
130176000|NCT03598790|468599967|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176001|NCT03598790|468599968|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176002|NCT03598790|468599969|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176003|NCT03598790|468599970|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176004|NCT03598790|468599971|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
130176005|NCT05929651|468599975|FG000|Overall Study|Protocol Deviation|1|||
130176006|NCT05929651|468599975|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
130176007|NCT02260570|468599976|FG000|Overall Study|Withdrawal by Subject|2|||
130176008|NCT02260570|468599977|FG001|Overall Study|Withdrawal by Subject|1|||
130176009|NCT02260570|468599976|FG000|Overall Study|Physician Decision|1|||
130176010|NCT02260570|468599977|FG001|Overall Study|Physician Decision|1|||
130176011|NCT05026177|468599978|FG000|Overall Study|Adverse Event|33|||
130176012|NCT05026177|468599979|FG001|Overall Study|Adverse Event|33|||
130176013|NCT05026177|468599980|FG002|Overall Study|Adverse Event|17|||
130176014|NCT05026177|468599978|FG000|Overall Study|Lost to Follow-up|7|||
130176015|NCT05026177|468599979|FG001|Overall Study|Lost to Follow-up|6|||
130176016|NCT05026177|468599980|FG002|Overall Study|Lost to Follow-up|8|||
130176017|NCT05026177|468599978|FG000|Overall Study|Noncompliance with study drug|6|||
130176018|NCT05026177|468599979|FG001|Overall Study|Noncompliance with study drug|2|||
130176019|NCT05026177|468599980|FG002|Overall Study|Noncompliance with study drug|1|||
130176020|NCT05026177|468599978|FG000|Overall Study|Physician Decision|4|||
130176021|NCT05026177|468599979|FG001|Overall Study|Physician Decision|1|||
130176022|NCT05026177|468599980|FG002|Overall Study|Physician Decision|0|||
130176023|NCT05026177|468599978|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
130176024|NCT05026177|468599979|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
130176025|NCT05026177|468599980|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
130176026|NCT05026177|468599978|FG000|Overall Study|Withdrawal by Subject|53|||
130176027|NCT05026177|468599979|FG001|Overall Study|Withdrawal by Subject|51|||
130176028|NCT05026177|468599980|FG002|Overall Study|Withdrawal by Subject|55|||
130176029|NCT05026177|468599978|FG000|Overall Study|Protocol Violation|0|||
130176030|NCT05026177|468599979|FG001|Overall Study|Protocol Violation|1|||
130176031|NCT05026177|468599980|FG002|Overall Study|Protocol Violation|0|||
130176032|NCT05026177|468599978|FG000|Overall Study|Study terminated by sponsor|70|||
130176033|NCT05026177|468599979|FG001|Overall Study|Study terminated by sponsor|74|||
130176034|NCT05026177|468599980|FG002|Overall Study|Study terminated by sponsor|67|||
130176035|NCT05026177|468599978|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
130176036|NCT05026177|468599979|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
130176037|NCT05026177|468599980|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
130176038|NCT05026177|468599978|FG000|Overall Study|Starting alternative treatment|0|||
130176039|NCT05026177|468599979|FG001|Overall Study|Starting alternative treatment|1|||
130176040|NCT05026177|468599980|FG002|Overall Study|Starting alternative treatment|1|||
130176041|NCT05026177|468599978|FG000|Overall Study|Noncompliance with study procedures|0|||
130176042|NCT05026177|468599979|FG001|Overall Study|Noncompliance with study procedures|1|||
130176043|NCT05026177|468599980|FG002|Overall Study|Noncompliance with study procedures|1|||
130176044|NCT05026177|468599978|FG000|Overall Study|Met stopping criteria|0|||
130176045|NCT05026177|468599979|FG001|Overall Study|Met stopping criteria|0|||
130176046|NCT05026177|468599980|FG002|Overall Study|Met stopping criteria|1|||
130176047|NCT05026177|468599978|FG000|Overall Study|Health issues preventing continuation|0|||
130176048|NCT05026177|468599979|FG001|Overall Study|Health issues preventing continuation|0|||
130176049|NCT05026177|468599980|FG002|Overall Study|Health issues preventing continuation|1|||
130176050|NCT05026177|468599978|FG000|Overall Study|Randomized in error, not treated|0|||
130176051|NCT05026177|468599979|FG001|Overall Study|Randomized in error, not treated|0|||
130176052|NCT05026177|468599980|FG002|Overall Study|Randomized in error, not treated|2|||
130176053|NCT04856917|468599981|FG000|Overall Study|Withdrawal by Subject|4|||
130176054|NCT04856917|468599982|FG001|Overall Study|Withdrawal by Subject|3|||
130176055|NCT04856917|468599983|FG002|Overall Study|Withdrawal by Subject|1|||
130176056|NCT04856917|468599981|FG000|Overall Study|Lost to Follow-up|3|||
130176057|NCT04856917|468599982|FG001|Overall Study|Lost to Follow-up|1|||
130176058|NCT04856917|468599983|FG002|Overall Study|Lost to Follow-up|1|||
130176059|NCT04856917|468599981|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
130176060|NCT04856917|468599982|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
130176061|NCT04856917|468599983|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
130176062|NCT04856917|468599981|FG000|Overall Study|Other|1|||
130176063|NCT04856917|468599982|FG001|Overall Study|Other|1|||
130176064|NCT04856917|468599983|FG002|Overall Study|Other|0|||
130176065|NCT01169337|468599984|FG000|Overall Study|Lack of Efficacy|5|||
130176066|NCT01169337|468599985|FG001|Overall Study|Lack of Efficacy|7|||
130176067|NCT01169337|468599986|FG002|Overall Study|Lack of Efficacy|0|||
130176068|NCT01169337|468599984|FG000|Overall Study|Adverse Event|12|||
130176069|NCT01169337|468599985|FG001|Overall Study|Adverse Event|18|||
130176070|NCT01169337|468599986|FG002|Overall Study|Adverse Event|0|||
130176071|NCT01169337|468599984|FG000|Overall Study|Death|2|||
130176072|NCT01169337|468599985|FG001|Overall Study|Death|0|||
130176073|NCT01169337|468599986|FG002|Overall Study|Death|0|||
130176074|NCT01169337|468599984|FG000|Overall Study|Withdrawal by Subject|11|||
130176075|NCT01169337|468599985|FG001|Overall Study|Withdrawal by Subject|11|||
130176076|NCT01169337|468599986|FG002|Overall Study|Withdrawal by Subject|6|||
130176077|NCT01169337|468599984|FG000|Overall Study|Noncompliance|2|||
130176078|NCT01169337|468599985|FG001|Overall Study|Noncompliance|0|||
130176079|NCT01169337|468599986|FG002|Overall Study|Noncompliance|0|||
130176080|NCT01169337|468599984|FG000|Overall Study|Other complicating disease|1|||
130176081|NCT01169337|468599985|FG001|Overall Study|Other complicating disease|1|||
130176082|NCT01169337|468599986|FG002|Overall Study|Other complicating disease|0|||
130176083|NCT01169337|468599984|FG000|Overall Study|Physician Decision|1|||
130176084|NCT01169337|468599985|FG001|Overall Study|Physician Decision|5|||
130176085|NCT01169337|468599986|FG002|Overall Study|Physician Decision|0|||
130176086|NCT01169337|468599984|FG000|Overall Study|Alternative therapy|0|||
130176087|NCT01169337|468599985|FG001|Overall Study|Alternative therapy|2|||
130176088|NCT01169337|468599986|FG002|Overall Study|Alternative therapy|0|||
130176089|NCT01169337|468599984|FG000|Overall Study|Changed hospital|0|||
130176090|NCT01169337|468599985|FG001|Overall Study|Changed hospital|1|||
130176091|NCT01169337|468599986|FG002|Overall Study|Changed hospital|0|||
130176092|NCT01169337|468599984|FG000|Overall Study|Never started treatment|0|||
130176093|NCT01169337|468599985|FG001|Overall Study|Never started treatment|2|||
130176094|NCT01169337|468599986|FG002|Overall Study|Never started treatment|0|||
130176095|NCT01169337|468599984|FG000|Overall Study|Reason not reported|1|||
130176096|NCT01169337|468599985|FG001|Overall Study|Reason not reported|0|||
130176097|NCT01169337|468599986|FG002|Overall Study|Reason not reported|0|||
130176098|NCT01169337|468599984|FG000|Overall Study|Continuing lenalidomide|9|||
130176099|NCT01169337|468599985|FG001|Overall Study|Continuing lenalidomide|43|||
130176100|NCT01169337|468599986|FG002|Overall Study|Continuing lenalidomide|0|||
130176101|NCT03560037|468599987|FG000|Overall Study|Protocol Violation|1|||
130176102|NCT03560037|468599988|FG001|Overall Study|Protocol Violation|0|||
130176103|NCT03560037|468599987|FG000|Overall Study|Physician Decision|0|||
130176104|NCT03560037|468599988|FG001|Overall Study|Physician Decision|1|||
130176105|NCT03816878|468599991|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
130176106|NCT03816878|468599992|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
130176107|NCT03816878|468599991|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
130176108|NCT03816878|468599992|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
130176109|NCT03355469|468599993|FG000|Overall Study|COVID-19|3|||
130176110|NCT03355469|468599994|FG001|Overall Study|COVID-19|2|||
130176111|NCT03355469|468599995|FG002|Overall Study|COVID-19|3|||
130176112|NCT03355469|468599996|FG003|Overall Study|COVID-19|3|||
130176113|NCT03355469|468599993|FG000|Overall Study|Lost to Follow-up|1|||
130176114|NCT03355469|468599994|FG001|Overall Study|Lost to Follow-up|0|||
130176115|NCT03355469|468599995|FG002|Overall Study|Lost to Follow-up|1|||
130176116|NCT03355469|468599996|FG003|Overall Study|Lost to Follow-up|0|||
130176117|NCT03355469|468599993|FG000|Overall Study|Withdrawal by Subject|2|||
130176118|NCT03355469|468599994|FG001|Overall Study|Withdrawal by Subject|1|||
130176119|NCT03355469|468599995|FG002|Overall Study|Withdrawal by Subject|0|||
130176120|NCT03355469|468599996|FG003|Overall Study|Withdrawal by Subject|3|||
130176121|NCT01708941|468599997|FG000|Overall Study|Adverse Event|4|||
130176122|NCT01708941|468599998|FG001|Overall Study|Adverse Event|6|||
130176123|NCT01708941|468599999|FG002|Overall Study|Adverse Event|1|||
130176124|NCT01708941|468600000|FG003|Overall Study|Adverse Event|0|||
130176125|NCT01708941|468599997|FG000|Overall Study|Death|1|||
130176126|NCT01708941|468599998|FG001|Overall Study|Death|1|||
130176127|NCT01708941|468599999|FG002|Overall Study|Death|2|||
130176128|NCT01708941|468600000|FG003|Overall Study|Death|14|||
130176129|NCT01708941|468599997|FG000|Overall Study|Withdrawal by Subject|1|||
130176130|NCT01708941|468599998|FG001|Overall Study|Withdrawal by Subject|0|||
130176131|NCT01708941|468599999|FG002|Overall Study|Withdrawal by Subject|3|||
130176132|NCT01708941|468600000|FG003|Overall Study|Withdrawal by Subject|4|||
130176133|NCT01708941|468599997|FG000|Overall Study|Disease progression|9|||
130176134|NCT01708941|468599998|FG001|Overall Study|Disease progression|10|||
130176135|NCT01708941|468599999|FG002|Overall Study|Disease progression|8|||
130176136|NCT01708941|468600000|FG003|Overall Study|Disease progression|0|||
130176137|NCT01708941|468599997|FG000|Overall Study|Alternative therapy|0|||
130176138|NCT01708941|468599998|FG001|Overall Study|Alternative therapy|0|||
130176139|NCT01708941|468599999|FG002|Overall Study|Alternative therapy|2|||
130176140|NCT01708941|468600000|FG003|Overall Study|Alternative therapy|0|||
130176141|NCT01708941|468599997|FG000|Overall Study|Ineligible and never started treatment|1|||
130176142|NCT01708941|468599998|FG001|Overall Study|Ineligible and never started treatment|0|||
130176143|NCT01708941|468599999|FG002|Overall Study|Ineligible and never started treatment|1|||
130176144|NCT01708941|468600000|FG003|Overall Study|Ineligible and never started treatment|0|||
130176145|NCT01708941|468599997|FG000|Overall Study|Never started treatment|2|||
130176146|NCT01708941|468599998|FG001|Overall Study|Never started treatment|1|||
130176147|NCT01708941|468599999|FG002|Overall Study|Never started treatment|0|||
130176148|NCT01708941|468600000|FG003|Overall Study|Never started treatment|0|||
130176149|NCT01708941|468599997|FG000|Overall Study|Ineligible|0|||
130176150|NCT01708941|468599998|FG001|Overall Study|Ineligible|0|||
130176151|NCT01708941|468599999|FG002|Overall Study|Ineligible|2|||
130176152|NCT01708941|468600000|FG003|Overall Study|Ineligible|0|||
130176153|NCT01575548|468600001|FG000|Overall Study|Adverse Event|15|||
130176154|NCT01575548|468600002|FG001|Overall Study|Adverse Event|2|||
130176155|NCT01575548|468600001|FG000|Overall Study|Disease progression|12|||
130176156|NCT01575548|468600002|FG001|Overall Study|Disease progression|25|||
130176157|NCT01575548|468600001|FG000|Overall Study|Death|1|||
130176158|NCT01575548|468600002|FG001|Overall Study|Death|0|||
130176159|NCT01575548|468600001|FG000|Overall Study|Other complicating disease|1|||
130176160|NCT01575548|468600002|FG001|Overall Study|Other complicating disease|0|||
130176161|NCT01575548|468600001|FG000|Overall Study|Withdrawal by Subject|7|||
130176162|NCT01575548|468600002|FG001|Overall Study|Withdrawal by Subject|3|||
130176163|NCT01575548|468600001|FG000|Overall Study|Noncompliance|1|||
130176164|NCT01575548|468600002|FG001|Overall Study|Noncompliance|0|||
130176165|NCT01575548|468600001|FG000|Overall Study|Anticipated surgery|0|||
130176166|NCT01575548|468600002|FG001|Overall Study|Anticipated surgery|1|||
130176167|NCT01575548|468600001|FG000|Overall Study|Never started protocol therapy|3|||
130176168|NCT01575548|468600002|FG001|Overall Study|Never started protocol therapy|2|||
130176169|NCT04175912|468600003|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
130176170|NCT04175912|468600004|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
130176171|NCT04175912|468600003|FG000|Overall Study|Adverse Event|0|||
130176172|NCT04175912|468600004|FG001|Overall Study|Adverse Event|3|||
130176173|NCT04175912|468600003|FG000|Overall Study|Never started treatment|3|||
130176174|NCT04175912|468600004|FG001|Overall Study|Never started treatment|3|||
130176175|NCT04175912|468600003|FG000|Overall Study|Death|0|||
130176176|NCT04175912|468600004|FG001|Overall Study|Death|1|||
130176177|NCT02048813|468600005|FG000|Overall Study|Still on treatment|279|||
130176178|NCT02048813|468600006|FG001|Overall Study|Still on treatment|0|||
130176179|NCT02048813|468600005|FG000|Overall Study|Adverse Event|40|||
130176180|NCT02048813|468600006|FG001|Overall Study|Adverse Event|38|||
130176181|NCT02048813|468600005|FG000|Overall Study|Disease progression|13|||
130176182|NCT02048813|468600006|FG001|Overall Study|Disease progression|3|||
130176183|NCT02048813|468600005|FG000|Overall Study|Withdrawal by Subject|7|||
130176184|NCT02048813|468600006|FG001|Overall Study|Withdrawal by Subject|8|||
130176185|NCT02048813|468600005|FG000|Overall Study|Death|2|||
130176186|NCT02048813|468600006|FG001|Overall Study|Death|1|||
130176187|NCT02048813|468600005|FG000|Overall Study|Complication|2|||
130176188|NCT02048813|468600006|FG001|Overall Study|Complication|2|||
130176189|NCT02048813|468600005|FG000|Overall Study|Non-protocol therapy|0|||
130176190|NCT02048813|468600006|FG001|Overall Study|Non-protocol therapy|1|||
130176191|NCT02048813|468600005|FG000|Overall Study|Second primary cancer|2|||
130176192|NCT02048813|468600006|FG001|Overall Study|Second primary cancer|0|||
130176193|NCT02048813|468600005|FG000|Overall Study|Insurance|2|||
130176194|NCT02048813|468600006|FG001|Overall Study|Insurance|0|||
130176195|NCT02048813|468600005|FG000|Overall Study|Wound infection/healing|2|||
130176196|NCT02048813|468600006|FG001|Overall Study|Wound infection/healing|0|||
130176197|NCT02048813|468600005|FG000|Overall Study|Missed appointment|3|||
130176198|NCT02048813|468600006|FG001|Overall Study|Missed appointment|0|||
130176199|NCT02048813|468600005|FG000|Overall Study|Never started treatment|2|||
130176200|NCT02048813|468600006|FG001|Overall Study|Never started treatment|17|||
130176201|NCT01708954|468600007|FG000|Step 1|Disease progression|26|||
130176202|NCT01708954|468600008|FG001|Step 1|Disease progression|17|||
130176203|NCT01708954|468600009|FG002|Step 1|Disease progression|14|||
130176204|NCT01708954|468600007|FG000|Step 1|Adverse Event|3|||
130176205|NCT01708954|468600008|FG001|Step 1|Adverse Event|11|||
130176206|NCT01708954|468600009|FG002|Step 1|Adverse Event|13|||
130176207|NCT01708954|468600007|FG000|Step 1|Death|3|||
130176208|NCT01708954|468600008|FG001|Step 1|Death|2|||
130176209|NCT01708954|468600009|FG002|Step 1|Death|3|||
130176210|NCT01708954|468600007|FG000|Step 1|Withdrawal by Subject|2|||
130176211|NCT01708954|468600008|FG001|Step 1|Withdrawal by Subject|5|||
130176212|NCT01708954|468600009|FG002|Step 1|Withdrawal by Subject|3|||
130176213|NCT01708954|468600007|FG000|Step 1|Other complicating disease|0|||
130176214|NCT01708954|468600008|FG001|Step 1|Other complicating disease|2|||
130176215|NCT01708954|468600009|FG002|Step 1|Other complicating disease|0|||
130176216|NCT01708954|468600007|FG000|Step 1|Crossed over to Step 2|2|||
130176217|NCT01708954|468600008|FG001|Step 1|Crossed over to Step 2|0|||
130176218|NCT01708954|468600009|FG002|Step 1|Crossed over to Step 2|0|||
130176219|NCT01708954|468600007|FG000|Step 1|Symptomatic deterioration|1|||
130176220|NCT01708954|468600008|FG001|Step 1|Symptomatic deterioration|0|||
130176221|NCT01708954|468600009|FG002|Step 1|Symptomatic deterioration|1|||
130176222|NCT01708954|468600007|FG000|Step 1|Off-treatment reason not submitted|1|||
130176223|NCT01708954|468600008|FG001|Step 1|Off-treatment reason not submitted|1|||
130176224|NCT01708954|468600009|FG002|Step 1|Off-treatment reason not submitted|1|||
130176225|NCT01708954|468600007|FG000|Step 1|Ineligible or never received treatment|4|||
130176226|NCT01708954|468600008|FG001|Step 1|Ineligible or never received treatment|2|||
130176227|NCT01708954|468600009|FG002|Step 1|Ineligible or never received treatment|8|||
130176228|NCT01708954|468600007|FG000|Step 2|Disease progression|9|||
130176229|NCT01708954|468600008|FG001|Step 2|Disease progression|4|||
130176230|NCT01708954|468600009|FG002|Step 2|Disease progression|0|||
130176231|NCT01708954|468600007|FG000|Step 2|Adverse Event|3|||
130176232|NCT01708954|468600008|FG001|Step 2|Adverse Event|2|||
130176233|NCT01708954|468600009|FG002|Step 2|Adverse Event|0|||
130176234|NCT01708954|468600007|FG000|Step 2|Withdrawal by Subject|1|||
130176235|NCT01708954|468600008|FG001|Step 2|Withdrawal by Subject|1|||
130176236|NCT01708954|468600009|FG002|Step 2|Withdrawal by Subject|0|||
130176237|NCT06400251|468600010|FG000|Overall Study|Never Start Protocol Therapy|1|||
130176238|NCT06400251|468600010|FG000|Overall Study|Ineligible|2|||
130176239|NCT06400251|468600010|FG000|Overall Study|Mutation Status Not Confirmed|3|||
129982812|NCT00943852|467900621|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982813|NCT00943852|467900622|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982814|NCT00943852|467900623|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982815|NCT00943852|467900624|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
130176240|NCT06400251|468600010|FG000|Overall Study|Disease Progression|25|||
130176241|NCT06400251|468600010|FG000|Overall Study|Adverse Event|1|||
130176242|NCT06400251|468600010|FG000|Overall Study|Complicating Disease|1|||
130176243|NCT06400251|468600010|FG000|Overall Study|Physician Decision|2|||
130176244|NCT04759703|468600018|FG000|Overall Study|Withdrawal by Subject|4|||
130176245|NCT04759703|468600019|FG001|Overall Study|Withdrawal by Subject|9|||
130176246|NCT04759703|468600018|FG000|Overall Study|Adverse Event|1|||
130176247|NCT04759703|468600019|FG001|Overall Study|Adverse Event|0|||
130176248|NCT04759703|468600018|FG000|Overall Study|Lost to Follow-up|2|||
130176249|NCT04759703|468600019|FG001|Overall Study|Lost to Follow-up|0|||
130176250|NCT04186845|468600020|FG000|Overall Study|Death|2|||
130176251|NCT04186845|468600020|FG000|Overall Study|Lost to Follow-up|1|||
130176252|NCT04186845|468600020|FG000|Overall Study|Physician Decision|1|||
130176253|NCT04186845|468600020|FG000|Overall Study|Protocol Violation|1|||
130176254|NCT04186845|468600020|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
130176255|NCT04186845|468600020|FG000|Overall Study|Biopsy ordered but not done|1|||
130176256|NCT04186845|468600020|FG000|Overall Study|It was previously confirmed|1|||
130176257|NCT04186845|468600020|FG000|Overall Study|Patient cancelled scheduled scans|2|||
130176258|NCT04186845|468600020|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
130176259|NCT04186845|468600020|FG000|Overall Study|Subject refused confirmatory imaging|1|||
130176260|NCT04186845|468600020|FG000|Overall Study|Too small to biopsy|1|||
130176261|NCT01814553|468600023|FG000|Overall Study|PD per clinical progression|6|||
130176262|NCT01814553|468600024|FG001|Overall Study|PD per clinical progression|8|||
130176263|NCT01814553|468600023|FG000|Overall Study|Other Adverse Event|4|||
130176264|NCT01814553|468600024|FG001|Overall Study|Other Adverse Event|5|||
130176265|NCT01814553|468600023|FG000|Overall Study|Withdrawal by Subject|1|||
130176266|NCT01814553|468600024|FG001|Overall Study|Withdrawal by Subject|1|||
130176267|NCT01814553|468600023|FG000|Overall Study|Other than stated|7|||
130176268|NCT01814553|468600024|FG001|Overall Study|Other than stated|8|||
130176269|NCT04138823|468600025|FG000|Overall Study|Clinical disease progression|0|||
130176270|NCT04138823|468600026|FG001|Overall Study|Clinical disease progression|0|||
130176271|NCT04138823|468600027|FG002|Overall Study|Clinical disease progression|1|||
130176272|NCT04138823|468600025|FG000|Overall Study|Objective disease progression|3|||
130176273|NCT04138823|468600026|FG001|Overall Study|Objective disease progression|2|||
130176274|NCT04138823|468600027|FG002|Overall Study|Objective disease progression|5|||
130176275|NCT02859142|468600028|FG000|Overall Study|Adverse Event|1|||
130176276|NCT02859142|468600029|FG001|Overall Study|Adverse Event|2|||
130176277|NCT02859142|468600028|FG000|Overall Study|Lost to Follow-up|1|||
130176278|NCT02859142|468600029|FG001|Overall Study|Lost to Follow-up|4|||
130176279|NCT02859142|468600028|FG000|Overall Study|Withdrawal by Subject|2|||
130176280|NCT02859142|468600029|FG001|Overall Study|Withdrawal by Subject|0|||
130176281|NCT02859142|468600028|FG000|Overall Study|Scheduling difficulties|0|||
130176282|NCT02859142|468600029|FG001|Overall Study|Scheduling difficulties|3|||
130176283|NCT03290079|468600030|FG000|Overall Study|Death|2|||
130176284|NCT02676765|468600031|FG000|Overall Study|Lost to Follow-up|0|||
130176285|NCT02676765|468600032|FG001|Overall Study|Lost to Follow-up|1|||
130176286|NCT01941498|468600035|FG000|Overall Study|Relocated out of state|1|||
130176287|NCT04877457|468600036|FG000|Overall Study|Early termination of study due to low enrollment|2|||
130176288|NCT04877457|468600037|FG001|Overall Study|Early termination of study due to low enrollment|1|||
130176289|NCT04697069|468600039|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
130176290|NCT04697069|468600040|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
130176291|NCT04697069|468600039|FG000|Overall Study|Study termination|2|||
130176292|NCT04697069|468600040|FG001|Overall Study|Study termination|1|||
130176293|NCT04597632|468600041|FG000|Overall Study|Withdrawal by Subject|10|||
130176294|NCT04597632|468600041|FG000|Overall Study|Lost to Follow-up|1|||
130176295|NCT04597632|468600041|FG000|Overall Study|Death|1|||
130176296|NCT04597632|468600041|FG000|Overall Study|Adverse Event|5|||
130176297|NCT01893346|468600042|FG000|Overall Study|Lost to Follow-up|0|||
130176298|NCT01893346|468600043|FG001|Overall Study|Lost to Follow-up|1|||
130176299|NCT01893346|468600044|FG002|Overall Study|Lost to Follow-up|0|||
130176300|NCT01893346|468600045|FG003|Overall Study|Lost to Follow-up|0|||
130176301|NCT01893346|468600042|FG000|Overall Study|Protocol Violation|1|||
130176302|NCT01893346|468600043|FG001|Overall Study|Protocol Violation|0|||
130176303|NCT01893346|468600044|FG002|Overall Study|Protocol Violation|0|||
130176304|NCT01893346|468600045|FG003|Overall Study|Protocol Violation|0|||
130176305|NCT01893346|468600042|FG000|Overall Study|Withdrawal by Subject|2|||
130176306|NCT01893346|468600043|FG001|Overall Study|Withdrawal by Subject|0|||
130176307|NCT01893346|468600044|FG002|Overall Study|Withdrawal by Subject|0|||
130176308|NCT01893346|468600045|FG003|Overall Study|Withdrawal by Subject|0|||
130176309|NCT01449812|468600046|FG000|Overall Study|Migrated/moved from study area|1|||
130176310|NCT01449812|468600047|FG001|Overall Study|Migrated/moved from study area|0|||
130176311|NCT01449812|468600048|FG002|Overall Study|Migrated/moved from study area|0|||
130176312|NCT01449812|468600046|FG000|Overall Study|Withdrawal by Subject|0|||
130176313|NCT01449812|468600047|FG001|Overall Study|Withdrawal by Subject|0|||
130176314|NCT01449812|468600048|FG002|Overall Study|Withdrawal by Subject|1|||
130176315|NCT01449812|468600046|FG000|Overall Study|Lost to Follow-up|1|||
130176316|NCT01449812|468600047|FG001|Overall Study|Lost to Follow-up|0|||
130176317|NCT01449812|468600048|FG002|Overall Study|Lost to Follow-up|0|||
130176318|NCT04239027|468600051|FG000|Overall Study|Adverse Event|4|||
130176319|NCT04239027|468600051|FG000|Overall Study|Withdrawal by Subject|9|||
130176320|NCT04239027|468600051|FG000|Overall Study|Death|1|||
130176321|NCT04239027|468600051|FG000|Overall Study|Physician Decision|9|||
130176322|NCT04239027|468600051|FG000|Overall Study|Lost to Follow-up|2|||
130176323|NCT04239027|468600051|FG000|Overall Study|Lack of Efficacy|1|||
130176324|NCT02839707|468600054|FG000|Phase I|Not eligible for analysis|9|||
130176325|NCT02839707|468600055|FG001|Phase I|Not eligible for analysis|0|||
130176326|NCT02839707|468600056|FG002|Phase I|Not eligible for analysis|0|||
130176327|NCT02839707|468600054|FG000|Phase II|Not treated according to protocol|4|||
130176328|NCT02839707|468600055|FG001|Phase II|Not treated according to protocol|0|||
130176329|NCT02839707|468600056|FG002|Phase II|Not treated according to protocol|2|||
130176330|NCT02839707|468600054|FG000|Phase III|Not treated according to protocol|0|||
130176331|NCT02839707|468600055|FG001|Phase III|Not treated according to protocol|0|||
130176332|NCT02839707|468600056|FG002|Phase III|Not treated according to protocol|4|||
130176333|NCT01290302|468602212|FG000|Overall Study|Adverse Event|2|||
130176334|NCT01290302|468602213|FG001|Overall Study|Adverse Event|0|||
130176335|NCT01290302|468602212|FG000|Overall Study|Withdrawal by Subject|1|||
130176336|NCT01290302|468602213|FG001|Overall Study|Withdrawal by Subject|0|||
130176337|NCT01290302|468602212|FG000|Overall Study|Physician Decision|0|||
130176338|NCT01290302|468602213|FG001|Overall Study|Physician Decision|2|||
130176339|NCT01290302|468602212|FG000|Overall Study|Expiration of time for screening window|1|||
130176340|NCT01290302|468602213|FG001|Overall Study|Expiration of time for screening window|0|||
130176341|NCT06419907|468602216|FG000|Overall Study|Protocol Violation|0|||
130176342|NCT06419907|468602217|FG001|Overall Study|Protocol Violation|3|||
130176343|NCT06419907|468602218|FG002|Overall Study|Protocol Violation|0|||
130176344|NCT06419907|468602219|FG003|Overall Study|Protocol Violation|1|||
130176345|NCT06419907|468602216|FG000|Overall Study|Lost to Follow-up|0|||
130176346|NCT06419907|468602217|FG001|Overall Study|Lost to Follow-up|0|||
130176347|NCT06419907|468602218|FG002|Overall Study|Lost to Follow-up|2|||
130176348|NCT06419907|468602219|FG003|Overall Study|Lost to Follow-up|1|||
130176349|NCT02586688|468602222|FG000|Overall Study|Lost to Follow-up|2|||
130176350|NCT02586688|468602223|FG001|Overall Study|Lost to Follow-up|1|||
130176351|NCT02586688|468602222|FG000|Overall Study|Withdrawal by Subject|1|||
130176352|NCT02586688|468602223|FG001|Overall Study|Withdrawal by Subject|1|||
130176353|NCT02586688|468602222|FG000|Overall Study|Adverse Event|3|||
130176354|NCT02586688|468602223|FG001|Overall Study|Adverse Event|1|||
130176355|NCT02454608|468602224|FG000|Double-Blind Period|Lack of Efficacy|0|||
130176356|NCT02454608|468602225|FG001|Double-Blind Period|Lack of Efficacy|2|||
130176357|NCT02454608|468602226|FG002|Double-Blind Period|Lack of Efficacy|0|||
130176358|NCT02454608|468602224|FG000|Open Label Period|Lost to Follow-up|0|||
130176359|NCT02454608|468602225|FG001|Open Label Period|Lost to Follow-up|0|||
130176360|NCT02454608|468602226|FG002|Open Label Period|Lost to Follow-up|11|||
130176361|NCT02454608|468602224|FG000|Open Label Period|Withdrawal by Subject|0|||
130176362|NCT02454608|468602225|FG001|Open Label Period|Withdrawal by Subject|0|||
130176363|NCT02454608|468602226|FG002|Open Label Period|Withdrawal by Subject|8|||
130176364|NCT03573830|468602227|FG000|Overall Study|Dropped without completing treatment|0|||
130176365|NCT03573830|468602228|FG001|Overall Study|Dropped without completing treatment|7|||
130176366|NCT03573830|468602227|FG000|Overall Study|Lost to Follow-up|4|||
130176367|NCT03573830|468602228|FG001|Overall Study|Lost to Follow-up|0|||
130176368|NCT01769456|468602229|FG000|Overall Study|Lost to Follow-up|19|||
130176369|NCT01769456|468602229|FG000|Overall Study|Withdrawal by Subject|3|||
130176370|NCT01769456|468602229|FG000|Overall Study|Did not receive PCC intervention|6|||
130176371|NCT01769456|468602229|FG000|Overall Study|Moved out of the area|3|||
130176372|NCT01769456|468602229|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
130176373|NCT01769456|468602229|FG000|Overall Study|Parental request to youth to withdraw|1|||
130176374|NCT02465398|468602236|FG000|Overall Study|Death|7|||
130176375|NCT02465398|468602236|FG000|Overall Study|Revision|7|||
130176376|NCT02465398|468602236|FG000|Overall Study|did not receive study device|1|||
130176377|NCT02465398|468602236|FG000|Overall Study|Withdrawal by Subject|1|||
130176378|NCT02465398|468602236|FG000|Overall Study|Lost to Follow-up|14|||
130176379|NCT05244122|468602241|FG000|Overall Study|Withdrawal by Subject|318|||
130176380|NCT00064987|468602246|FG000|Overall Study|Physician Decision|3|||
130176381|NCT00064987|468602247|FG001|Overall Study|Physician Decision|0|||
130176382|NCT02969382|468602248|FG000|Overall Study|Adverse Event|8|||
130176383|NCT02969382|468602249|FG001|Overall Study|Adverse Event|10|||
130176384|NCT02969382|468602248|FG000|Overall Study|Lack of Efficacy|4|||
130176385|NCT02969382|468602249|FG001|Overall Study|Lack of Efficacy|5|||
130176386|NCT02969382|468602248|FG000|Overall Study|Death|0|||
130176387|NCT02969382|468602249|FG001|Overall Study|Death|1|||
130176388|NCT02969382|468602248|FG000|Overall Study|PROTOCOL DEVIATION|0|||
130176389|NCT02969382|468602249|FG001|Overall Study|PROTOCOL DEVIATION|1|||
130176390|NCT02969382|468602248|FG000|Overall Study|Withdrawal by Subject|14|||
130176391|NCT02969382|468602249|FG001|Overall Study|Withdrawal by Subject|9|||
130176392|NCT00764881|468602250|FG000|Overall Study|Adverse Event|5|||
130176393|NCT00764881|468602251|FG001|Overall Study|Adverse Event|1|||
130176394|NCT00764881|468602250|FG000|Overall Study|Withdrawal by Subject|1|||
130176395|NCT00764881|468602251|FG001|Overall Study|Withdrawal by Subject|3|||
130176396|NCT00764881|468602250|FG000|Overall Study|Protocol Violation|2|||
130176397|NCT00764881|468602251|FG001|Overall Study|Protocol Violation|2|||
130176398|NCT00764881|468602250|FG000|Overall Study|Lost to Follow-up|2|||
130176399|NCT00764881|468602251|FG001|Overall Study|Lost to Follow-up|0|||
130176400|NCT00764881|468602250|FG000|Overall Study|Noncompliant|1|||
130176401|NCT00764881|468602251|FG001|Overall Study|Noncompliant|0|||
130176402|NCT00764881|468602250|FG000|Overall Study|Accidentally discontinued study drug|1|||
130176403|NCT00764881|468602251|FG001|Overall Study|Accidentally discontinued study drug|0|||
130176404|NCT00764881|468602250|FG000|Overall Study|Wished to become pregnant|1|||
130176405|NCT00764881|468602251|FG001|Overall Study|Wished to become pregnant|0|||
130176406|NCT00764881|468602250|FG000|Overall Study|Carcinoma detected|1|||
130176407|NCT00764881|468602251|FG001|Overall Study|Carcinoma detected|0|||
130176408|NCT00764881|468602250|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
130176409|NCT00764881|468602251|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
130176410|NCT00764881|468602250|FG000|Overall Study|no treatment or no observation|2|||
130176411|NCT00764881|468602251|FG001|Overall Study|no treatment or no observation|2|||
130176412|NCT01567462|468602252|FG000|Overall Study|Withdrawal by Subject|4|||
130176413|NCT01567462|468602253|FG001|Overall Study|Withdrawal by Subject|7|||
130176414|NCT01977417|468602261|FG000|Overall Study|Adverse Event|1|||
130176415|NCT01977417|468602262|FG001|Overall Study|Adverse Event|0|||
130176416|NCT01977417|468602261|FG000|Overall Study|Withdrawal by Subject|2|||
130176417|NCT01977417|468602262|FG001|Overall Study|Withdrawal by Subject|4|||
130176418|NCT01977417|468602261|FG000|Overall Study|Female enrollment goal met|0|||
130176419|NCT01977417|468602262|FG001|Overall Study|Female enrollment goal met|2|||
130176420|NCT01692626|468602263|FG000|Overall Study|Death|0|||
130176421|NCT01692626|468602264|FG001|Overall Study|Death|1|||
130176422|NCT01692626|468602263|FG000|Overall Study|Adverse Event|2|||
130176423|NCT01692626|468602264|FG001|Overall Study|Adverse Event|3|||
130176424|NCT01692626|468602263|FG000|Overall Study|Protocol Violation|1|||
130176425|NCT01692626|468602264|FG001|Overall Study|Protocol Violation|2|||
130176426|NCT01692626|468602263|FG000|Overall Study|Withdrawal by Subject|1|||
130176427|NCT01692626|468602264|FG001|Overall Study|Withdrawal by Subject|0|||
130176428|NCT00855894|468602267|FG000|Overall Study|Death|31|||
130176429|NCT00855894|468602267|FG000|Overall Study|Patient's decision|1|||
130176430|NCT00855894|468602267|FG000|Overall Study|Disease progression|1|||
130176431|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
130176432|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
130176433|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
130176434|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
130176435|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
130176436|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
130176437|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130176438|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
130176439|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
130176440|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
130176441|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
130176442|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
130176443|NCT02422797|468602268|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
130176444|NCT02422797|468602269|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
130176445|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
130176446|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
130176447|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
130176448|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
130176449|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
130176450|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
130176451|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
130176452|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
130176453|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
130176454|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
130176455|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
129982816|NCT00943852|467900625|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982817|NCT00943852|467900626|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982818|NCT00943852|467900617|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982819|NCT00943852|467900618|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982820|NCT00943852|467900619|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982821|NCT00943852|467900620|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982822|NCT00943852|467900621|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130176456|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
130176457|NCT02422797|468602268|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
130176458|NCT02422797|468602269|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
130176459|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
130176460|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
130176461|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
130176462|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
130176463|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
130176464|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
130176465|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
130176466|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
130176467|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
130176468|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
130176469|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
130176470|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
130176471|NCT02422797|468602268|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
130176472|NCT02422797|468602269|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
130176473|NCT04071405|468602270|FG000|Overall Study|Protocol Violation|3|||
130176474|NCT00369941|468602271|FG000|Overall Study|Never Treated|1|||
130176475|NCT00369941|468602272|FG001|Overall Study|Never Treated|2|||
130176476|NCT00369941|468602271|FG000|Overall Study|Adverse Event|14|||
130176477|NCT00369941|468602272|FG001|Overall Study|Adverse Event|28|||
130176478|NCT00369941|468602271|FG000|Overall Study|Lack of Efficacy|6|||
130176479|NCT00369941|468602272|FG001|Overall Study|Lack of Efficacy|10|||
130176480|NCT00369941|468602271|FG000|Overall Study|Lost to Follow-up|12|||
130176481|NCT00369941|468602272|FG001|Overall Study|Lost to Follow-up|22|||
130176482|NCT00369941|468602271|FG000|Overall Study|Protocol Violation|5|||
130176483|NCT00369941|468602272|FG001|Overall Study|Protocol Violation|3|||
130176484|NCT00369941|468602271|FG000|Overall Study|Withdrawal by Subject|5|||
130176485|NCT00369941|468602272|FG001|Overall Study|Withdrawal by Subject|18|||
130176486|NCT00369941|468602271|FG000|Overall Study|Pregnancy|4|||
130176487|NCT00369941|468602272|FG001|Overall Study|Pregnancy|2|||
130176488|NCT00369941|468602271|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
130176489|NCT00369941|468602272|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
130176490|NCT00369941|468602271|FG000|Overall Study|Moved|11|||
130176491|NCT00369941|468602272|FG001|Overall Study|Moved|5|||
130176492|NCT00369941|468602271|FG000|Overall Study|Treatment with Prohibited Medication|3|||
130176493|NCT00369941|468602272|FG001|Overall Study|Treatment with Prohibited Medication|1|||
130176494|NCT00369941|468602271|FG000|Overall Study|Employment Interfered with Study Visits|1|||
130176495|NCT00369941|468602272|FG001|Overall Study|Employment Interfered with Study Visits|0|||
130176496|NCT00369941|468602271|FG000|Overall Study|Study Site Terminated|2|||
130176497|NCT00369941|468602272|FG001|Overall Study|Study Site Terminated|0|||
130176498|NCT00369941|468602271|FG000|Overall Study|Miscellaneous|3|||
130176499|NCT00369941|468602272|FG001|Overall Study|Miscellaneous|3|||
130176500|NCT00403585|468602273|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
130176501|NCT00403585|468602273|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
130176502|NCT00403585|468602273|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
130176503|NCT02276807|468602274|FG000|Overall Study|Withdrawal by Subject|8|||
130176504|NCT02276807|468602275|FG001|Overall Study|Withdrawal by Subject|7|||
130176505|NCT02276807|468602274|FG000|Overall Study|Lost to Follow-up|10|||
130176506|NCT02276807|468602275|FG001|Overall Study|Lost to Follow-up|10|||
130176507|NCT03971474|468602276|FG000|Overall Study|Adverse Event|11|||
130176508|NCT03971474|468602277|FG001|Overall Study|Adverse Event|7|||
130176509|NCT03971474|468602276|FG000|Overall Study|Refusal unrelated to adverse event|5|||
130176510|NCT03971474|468602277|FG001|Overall Study|Refusal unrelated to adverse event|1|||
130176511|NCT03971474|468602276|FG000|Overall Study|Progression/relapse|40|||
130176512|NCT03971474|468602277|FG001|Overall Study|Progression/relapse|47|||
130176513|NCT03971474|468602276|FG000|Overall Study|Death|6|||
130176514|NCT03971474|468602277|FG001|Overall Study|Death|3|||
130176515|NCT03971474|468602276|FG000|Overall Study|Other - not protocol specified|5|||
130176516|NCT03971474|468602277|FG001|Overall Study|Other - not protocol specified|4|||
130176517|NCT03971474|468602276|FG000|Overall Study|On treatment|0|||
130176518|NCT03971474|468602277|FG001|Overall Study|On treatment|7|||
130176519|NCT00261950|468602278|FG000|Overall Study|Lost to Follow-up|2|||
130176520|NCT00261950|468602278|FG000|Overall Study|Death|6|||
130176521|NCT00261950|468602278|FG000|Overall Study|Withdrawal by Subject|5|||
130176522|NCT00261950|468602278|FG000|Overall Study|Other|1|||
130176523|NCT00261950|468602278|FG000|Overall Study|Physician Decision|1|||
130176524|NCT00261950|468602278|FG000|Overall Study|Protocol specified Criteria|11|||
130176525|NCT01937871|468602285|FG000|Overall Study|Adverse Event|6|||
130176526|NCT01937871|468602286|FG001|Overall Study|Adverse Event|6|||
130176527|NCT01937871|468602287|FG002|Overall Study|Adverse Event|2|||
130176528|NCT01937871|468602285|FG000|Overall Study|Lost to Follow-up|8|||
130176529|NCT01937871|468602286|FG001|Overall Study|Lost to Follow-up|2|||
130176530|NCT01937871|468602287|FG002|Overall Study|Lost to Follow-up|4|||
130176531|NCT01937871|468602285|FG000|Overall Study|Withdrawal by Subject|9|||
130176532|NCT01937871|468602286|FG001|Overall Study|Withdrawal by Subject|6|||
130176533|NCT01937871|468602287|FG002|Overall Study|Withdrawal by Subject|4|||
130176534|NCT01937871|468602285|FG000|Overall Study|Physician Decision|0|||
130176535|NCT01937871|468602286|FG001|Overall Study|Physician Decision|1|||
130176536|NCT01937871|468602287|FG002|Overall Study|Physician Decision|0|||
130176537|NCT01937871|468602285|FG000|Overall Study|Entry Criteria Not Met|1|||
130176538|NCT01937871|468602286|FG001|Overall Study|Entry Criteria Not Met|2|||
130176539|NCT01937871|468602287|FG002|Overall Study|Entry Criteria Not Met|1|||
130176540|NCT00577863|468602294|FG000|Overall Study|Adverse Event|4|||
130176541|NCT00577863|468602295|FG001|Overall Study|Adverse Event|2|||
130176542|NCT00577863|468602294|FG000|Overall Study|Death|1|||
130176543|NCT00577863|468602295|FG001|Overall Study|Death|0|||
130176544|NCT00577863|468602294|FG000|Overall Study|Lost to Follow-up|2|||
130176545|NCT00577863|468602295|FG001|Overall Study|Lost to Follow-up|2|||
130176546|NCT00577863|468602294|FG000|Overall Study|Entry Criteria Exclusion|1|||
130176547|NCT00577863|468602295|FG001|Overall Study|Entry Criteria Exclusion|0|||
130176548|NCT00577863|468602294|FG000|Overall Study|Withdrawal by Subject|0|||
130176549|NCT00577863|468602295|FG001|Overall Study|Withdrawal by Subject|2|||
130176550|NCT00577863|468602294|FG000|Overall Study|Sponsor Decision|2|||
130176551|NCT00577863|468602295|FG001|Overall Study|Sponsor Decision|7|||
130176552|NCT00577863|468602294|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
130176553|NCT00577863|468602295|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
130176554|NCT00668317|468602300|FG000|Overall Study|Adverse Event|2|||
130176555|NCT05211726|468602309|FG000|Overall Study|Withdrawal by Subject|2|||
130176556|NCT05211726|468602310|FG001|Overall Study|Withdrawal by Subject|3|||
130176557|NCT05211726|468602309|FG000|Overall Study|Protocol Violation|0|||
130176558|NCT05211726|468602310|FG001|Overall Study|Protocol Violation|1|||
130176559|NCT03509467|468602311|FG000|Overall Study|Withdrawal by Subject|5|||
130176560|NCT03509467|468602312|FG001|Overall Study|Withdrawal by Subject|1|||
130176561|NCT03509467|468602313|FG002|Overall Study|Withdrawal by Subject|6|||
130176562|NCT03509467|468602314|FG003|Overall Study|Withdrawal by Subject|7|||
130176563|NCT03509467|468602315|FG004|Overall Study|Withdrawal by Subject|10|||
130176564|NCT03509467|468602316|FG005|Overall Study|Withdrawal by Subject|10|||
130176565|NCT03509467|468602317|FG006|Overall Study|Withdrawal by Subject|10|||
130176566|NCT03509467|468602318|FG007|Overall Study|Withdrawal by Subject|10|||
130176567|NCT03509467|468602311|FG000|Overall Study|Death|0|||
130176568|NCT03509467|468602312|FG001|Overall Study|Death|0|||
130176569|NCT03509467|468602313|FG002|Overall Study|Death|2|||
130176570|NCT03509467|468602314|FG003|Overall Study|Death|2|||
130176571|NCT03509467|468602315|FG004|Overall Study|Death|1|||
130176572|NCT03509467|468602316|FG005|Overall Study|Death|0|||
130176573|NCT03509467|468602317|FG006|Overall Study|Death|1|||
130176574|NCT03509467|468602318|FG007|Overall Study|Death|0|||
130176575|NCT03509467|468602311|FG000|Overall Study|Proxy Withdrawal|0|||
130176576|NCT03509467|468602312|FG001|Overall Study|Proxy Withdrawal|0|||
130176577|NCT03509467|468602313|FG002|Overall Study|Proxy Withdrawal|0|||
130176578|NCT03509467|468602314|FG003|Overall Study|Proxy Withdrawal|0|||
130176579|NCT03509467|468602315|FG004|Overall Study|Proxy Withdrawal|0|||
130176580|NCT03509467|468602316|FG005|Overall Study|Proxy Withdrawal|0|||
130176581|NCT03509467|468602317|FG006|Overall Study|Proxy Withdrawal|0|||
130176582|NCT03509467|468602318|FG007|Overall Study|Proxy Withdrawal|1|||
130176583|NCT02829918|468602320|FG000|Overall Study|Death|2|||
130176584|NCT02829918|468602320|FG000|Overall Study|Withdrawal by Subject|4|||
130176585|NCT02829918|468602320|FG000|Overall Study|Adverse Event|1|||
130176586|NCT02829918|468602320|FG000|Overall Study|Progression|1|||
130176587|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Death|8|||
130176588|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Death|5|||
130176589|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Death|5|||
130176590|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Death|7|||
130176591|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
130176592|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
130176593|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
130176594|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
130176595|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
130176596|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
130176597|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
130176598|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
130176599|NCT03340974|468602327|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
130176600|NCT03340974|468602328|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
130176601|NCT03340974|468602329|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
129982823|NCT00943852|467900622|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
130176602|NCT03340974|468602330|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
130176603|NCT02466685|468602331|FG000|Overall Study|Adverse Event|5|||
130176604|NCT02466685|468602332|FG001|Overall Study|Adverse Event|2|||
130176605|NCT02466685|468602331|FG000|Overall Study|Lost to Follow-up|1|||
130176606|NCT02466685|468602332|FG001|Overall Study|Lost to Follow-up|1|||
130176607|NCT02466685|468602331|FG000|Overall Study|Withdrawal by Subject|1|||
130176608|NCT02466685|468602332|FG001|Overall Study|Withdrawal by Subject|0|||
130176609|NCT02466685|468602331|FG000|Overall Study|Physician Decision|1|||
130176610|NCT02466685|468602332|FG001|Overall Study|Physician Decision|1|||
130176611|NCT02374346|468602333|FG000|Overall Study|operated or discharged during weekend|48|||
130176612|NCT05299528|468602336|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176613|NCT05299528|468602337|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
130176614|NCT05299528|468602338|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176615|NCT05299528|468602339|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176616|NCT05299528|468602340|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176617|NCT05299528|468602341|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176618|NCT05299528|468602342|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
130176619|NCT05299528|468602336|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176620|NCT05299528|468602337|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176621|NCT05299528|468602338|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176622|NCT05299528|468602339|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176623|NCT05299528|468602340|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176624|NCT05299528|468602341|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
130176625|NCT05299528|468602342|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
130176626|NCT05299528|468602336|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
130176627|NCT05299528|468602337|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
130176628|NCT05299528|468602338|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
130176629|NCT05299528|468602339|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
130176630|NCT05299528|468602340|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
130176631|NCT05299528|468602341|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
130176632|NCT05299528|468602342|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
130176633|NCT05180227|468602346|FG000|Overall Study|Hypertension at screening|1|||
130176634|NCT05180227|468602346|FG000|Overall Study|Lost to Follow-up|1|||
130176635|NCT03548337|468602347|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
130176636|NCT03548337|468602348|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
130176637|NCT03548337|468602347|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
130176638|NCT03548337|468602348|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
130176639|NCT03548337|468602347|FG000|Infant Series|Lost to Follow-up|2|||
130176640|NCT03548337|468602348|FG001|Infant Series|Lost to Follow-up|1|||
130176641|NCT03548337|468602347|FG000|Infant Series|Adverse Event|0|||
130176642|NCT03548337|468602348|FG001|Infant Series|Adverse Event|2|||
130176643|NCT03548337|468602347|FG000|Infant Series|Randomized but Not Vaccinated|1|||
130176644|NCT03548337|468602348|FG001|Infant Series|Randomized but Not Vaccinated|0|||
130176645|NCT03548337|468602347|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
130176646|NCT03548337|468602348|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
130176647|NCT01911273|468602351|FG000|Overall Study|Progression of Disease|1|||
130176648|NCT01911273|468602352|FG001|Overall Study|Progression of Disease|0|||
130176649|NCT01911273|468602351|FG000|Overall Study|Withdrawal by Subject|0|||
130176650|NCT01911273|468602352|FG001|Overall Study|Withdrawal by Subject|2|||
130176651|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
130176652|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Off-label use|283|||
130176653|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
130176654|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
130176655|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
130176656|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
130176657|NCT01070953|468602353|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
130176658|NCT01070953|468602353|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
130176659|NCT01070953|468602353|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
130176660|NCT01070953|468602353|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
130176661|NCT02445963|468602354|FG000|Overall Study|Lost to Follow-up|1|||
130176662|NCT02445963|468602355|FG001|Overall Study|Lost to Follow-up|0|||
130176663|NCT02445963|468602356|FG002|Overall Study|Lost to Follow-up|0|||
130176664|NCT02445963|468602357|FG003|Overall Study|Lost to Follow-up|0|||
130176665|NCT02445963|468602354|FG000|Overall Study|Change in employment|1|||
130176666|NCT02445963|468602355|FG001|Overall Study|Change in employment|0|||
130176667|NCT02445963|468602356|FG002|Overall Study|Change in employment|0|||
130176668|NCT02445963|468602357|FG003|Overall Study|Change in employment|0|||
130176669|NCT02445963|468602354|FG000|Overall Study|Symptoms post-vaccination|0|||
130176670|NCT02445963|468602355|FG001|Overall Study|Symptoms post-vaccination|0|||
130176671|NCT02445963|468602356|FG002|Overall Study|Symptoms post-vaccination|1|||
130176672|NCT02445963|468602357|FG003|Overall Study|Symptoms post-vaccination|0|||
130176673|NCT01957176|468602361|FG000|Overall Study|Adverse Event|2|||
130176674|NCT01957176|468602362|FG001|Overall Study|Adverse Event|0|||
130176675|NCT01957176|468602361|FG000|Overall Study|Physician Decision|2|||
130176676|NCT01957176|468602362|FG001|Overall Study|Physician Decision|1|||
130176677|NCT01957176|468602361|FG000|Overall Study|Withdrawal by Subject|1|||
130176678|NCT01957176|468602362|FG001|Overall Study|Withdrawal by Subject|0|||
130176679|NCT02359994|468602363|FG000|Overall Population Study|Adverse Event|1|||
130176680|NCT02359994|468602364|FG001|Overall Population Study|Adverse Event|1|||
130176681|NCT02359994|468602363|FG000|Overall Population Study|Death|1|||
130176682|NCT02359994|468602364|FG001|Overall Population Study|Death|5|||
130176683|NCT02359994|468602363|FG000|Overall Population Study|Lost to Follow-up|1|||
130176684|NCT02359994|468602364|FG001|Overall Population Study|Lost to Follow-up|1|||
130176685|NCT02359994|468602363|FG000|Overall Population Study|Withdrawal by Subject|1|||
130176686|NCT02359994|468602364|FG001|Overall Population Study|Withdrawal by Subject|0|||
130176687|NCT02359994|468602363|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
130176688|NCT02359994|468602364|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
130176689|NCT02359994|468602363|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
130176690|NCT02359994|468602364|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
130176691|NCT02359994|468602363|FG000|Extended Oncology 24-Month Survival|Death|19|||
130176692|NCT02359994|468602364|FG001|Extended Oncology 24-Month Survival|Death|21|||
130176693|NCT02359994|468602363|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
130176694|NCT02359994|468602364|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
130176695|NCT01823835|468602367|FG000|Overall Study|Adverse Event|0|||
130176696|NCT01823835|468602368|FG001|Overall Study|Adverse Event|0|||
130176697|NCT01823835|468602369|FG002|Overall Study|Adverse Event|0|||
130176698|NCT01823835|468602370|FG003|Overall Study|Adverse Event|0|||
129982824|NCT00943852|467900623|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982825|NCT00943852|467900624|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982826|NCT00943852|467900625|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982827|NCT00943852|467900626|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982828|NCT02141620|467900627|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
129982829|NCT02141620|467900628|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
129982830|NCT03377699|467900632|FG000|Overall Study|Withdrawal by Subject|2|||
129982831|NCT03377699|467900633|FG001|Overall Study|Withdrawal by Subject|9|||
130176699|NCT01823835|468602371|FG004|Overall Study|Adverse Event|1|||
130176700|NCT01823835|468602372|FG005|Overall Study|Adverse Event|0|||
130176701|NCT01823835|468602373|FG006|Overall Study|Adverse Event|1|||
130176702|NCT01823835|468602374|FG007|Overall Study|Adverse Event|0|||
130176703|NCT01823835|468602375|FG008|Overall Study|Adverse Event|0|||
130176704|NCT01823835|468602376|FG009|Overall Study|Adverse Event|0|||
130176705|NCT01823835|468602377|FG010|Overall Study|Adverse Event|1|||
130176706|NCT01823835|468602378|FG011|Overall Study|Adverse Event|2|||
130176707|NCT01823835|468602379|FG012|Overall Study|Adverse Event|0|||
130176708|NCT01823835|468602380|FG013|Overall Study|Adverse Event|0|||
130176709|NCT01823835|468602381|FG014|Overall Study|Adverse Event|0|||
130176710|NCT01823835|468602367|FG000|Overall Study|Physician Decision|0|||
130176711|NCT01823835|468602368|FG001|Overall Study|Physician Decision|0|||
130176712|NCT01823835|468602369|FG002|Overall Study|Physician Decision|0|||
130176713|NCT01823835|468602370|FG003|Overall Study|Physician Decision|0|||
130176714|NCT01823835|468602371|FG004|Overall Study|Physician Decision|0|||
130176715|NCT01823835|468602372|FG005|Overall Study|Physician Decision|0|||
130176716|NCT01823835|468602373|FG006|Overall Study|Physician Decision|0|||
130176717|NCT01823835|468602374|FG007|Overall Study|Physician Decision|0|||
130176718|NCT01823835|468602375|FG008|Overall Study|Physician Decision|0|||
130176719|NCT01823835|468602376|FG009|Overall Study|Physician Decision|0|||
130176720|NCT01823835|468602377|FG010|Overall Study|Physician Decision|0|||
130176721|NCT01823835|468602378|FG011|Overall Study|Physician Decision|2|||
130176722|NCT01823835|468602379|FG012|Overall Study|Physician Decision|0|||
130176723|NCT01823835|468602380|FG013|Overall Study|Physician Decision|0|||
130176724|NCT01823835|468602381|FG014|Overall Study|Physician Decision|0|||
130176725|NCT01823835|468602367|FG000|Overall Study|Progressive Disease|3|||
130176726|NCT01823835|468602368|FG001|Overall Study|Progressive Disease|4|||
130176727|NCT01823835|468602369|FG002|Overall Study|Progressive Disease|3|||
130176728|NCT01823835|468602370|FG003|Overall Study|Progressive Disease|6|||
130176729|NCT01823835|468602371|FG004|Overall Study|Progressive Disease|4|||
130176730|NCT01823835|468602372|FG005|Overall Study|Progressive Disease|6|||
130176731|NCT01823835|468602373|FG006|Overall Study|Progressive Disease|5|||
130176732|NCT01823835|468602374|FG007|Overall Study|Progressive Disease|3|||
130176733|NCT01823835|468602375|FG008|Overall Study|Progressive Disease|3|||
130176734|NCT01823835|468602376|FG009|Overall Study|Progressive Disease|18|||
130176735|NCT01823835|468602377|FG010|Overall Study|Progressive Disease|8|||
130176736|NCT01823835|468602378|FG011|Overall Study|Progressive Disease|46|||
129982832|NCT03377699|467900632|FG000|Overall Study|Lost to Follow-up|1|||
130176737|NCT01823835|468602379|FG012|Overall Study|Progressive Disease|18|||
130176738|NCT01823835|468602380|FG013|Overall Study|Progressive Disease|4|||
130176739|NCT01823835|468602381|FG014|Overall Study|Progressive Disease|6|||
130176740|NCT01823835|468602367|FG000|Overall Study|Study Termination|0|||
130176741|NCT01823835|468602368|FG001|Overall Study|Study Termination|0|||
130176742|NCT01823835|468602369|FG002|Overall Study|Study Termination|0|||
129982833|NCT03377699|467900633|FG001|Overall Study|Lost to Follow-up|1|||
130176743|NCT01823835|468602370|FG003|Overall Study|Study Termination|0|||
130176744|NCT01823835|468602371|FG004|Overall Study|Study Termination|1|||
130176745|NCT01823835|468602372|FG005|Overall Study|Study Termination|0|||
130176746|NCT01823835|468602373|FG006|Overall Study|Study Termination|0|||
130176747|NCT01823835|468602374|FG007|Overall Study|Study Termination|0|||
130176748|NCT01823835|468602375|FG008|Overall Study|Study Termination|0|||
130176749|NCT01823835|468602376|FG009|Overall Study|Study Termination|0|||
130176750|NCT01823835|468602377|FG010|Overall Study|Study Termination|0|||
130176751|NCT01823835|468602378|FG011|Overall Study|Study Termination|1|||
130176752|NCT01823835|468602379|FG012|Overall Study|Study Termination|0|||
130176753|NCT01823835|468602380|FG013|Overall Study|Study Termination|0|||
130176754|NCT01823835|468602381|FG014|Overall Study|Study Termination|0|||
130176755|NCT01823835|468602367|FG000|Overall Study|Withdrawal by Subject|0|||
130176756|NCT01823835|468602368|FG001|Overall Study|Withdrawal by Subject|0|||
130176757|NCT01823835|468602369|FG002|Overall Study|Withdrawal by Subject|1|||
130176758|NCT01823835|468602370|FG003|Overall Study|Withdrawal by Subject|0|||
130176759|NCT01823835|468602371|FG004|Overall Study|Withdrawal by Subject|0|||
130176760|NCT01823835|468602372|FG005|Overall Study|Withdrawal by Subject|0|||
130176761|NCT01823835|468602373|FG006|Overall Study|Withdrawal by Subject|0|||
130176762|NCT01823835|468602374|FG007|Overall Study|Withdrawal by Subject|0|||
130176763|NCT01823835|468602375|FG008|Overall Study|Withdrawal by Subject|0|||
130176764|NCT01823835|468602376|FG009|Overall Study|Withdrawal by Subject|1|||
130176765|NCT01823835|468602377|FG010|Overall Study|Withdrawal by Subject|1|||
130176766|NCT01823835|468602378|FG011|Overall Study|Withdrawal by Subject|2|||
130176767|NCT01823835|468602379|FG012|Overall Study|Withdrawal by Subject|1|||
130176768|NCT01823835|468602380|FG013|Overall Study|Withdrawal by Subject|0|||
130176769|NCT01823835|468602381|FG014|Overall Study|Withdrawal by Subject|0|||
130176770|NCT03017612|468602382|FG000|Overall Study|Adverse Event|2|||
130176771|NCT04895982|468602383|FG000|Overall Study|Withdrawal by Subject|0|||
130176772|NCT04895982|468602384|FG001|Overall Study|Withdrawal by Subject|0|||
130176773|NCT04895982|468602385|FG002|Overall Study|Withdrawal by Subject|0|||
130176774|NCT04895982|468602386|FG003|Overall Study|Withdrawal by Subject|0|||
130176775|NCT04895982|468602387|FG004|Overall Study|Withdrawal by Subject|0|||
130176776|NCT04895982|468602388|FG005|Overall Study|Withdrawal by Subject|1|||
130176777|NCT04895982|468602389|FG006|Overall Study|Withdrawal by Subject|1|||
130176778|NCT04895982|468602390|FG007|Overall Study|Withdrawal by Subject|0|||
130176779|NCT04895982|468602391|FG008|Overall Study|Withdrawal by Subject|0|||
130176780|NCT04895982|468602392|FG009|Overall Study|Withdrawal by Subject|1|||
130176781|NCT04895982|468602393|FG010|Overall Study|Withdrawal by Subject|0|||
130176782|NCT04895982|468602394|FG011|Overall Study|Withdrawal by Subject|1|||
130176783|NCT04895982|468602383|FG000|Overall Study|Withdrawal by parent/guardian|2|||
130176784|NCT04895982|468602384|FG001|Overall Study|Withdrawal by parent/guardian|3|||
130176785|NCT04895982|468602385|FG002|Overall Study|Withdrawal by parent/guardian|3|||
130176786|NCT04895982|468602386|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130176787|NCT04895982|468602387|FG004|Overall Study|Withdrawal by parent/guardian|3|||
130176788|NCT04895982|468602388|FG005|Overall Study|Withdrawal by parent/guardian|2|||
130176789|NCT04895982|468602389|FG006|Overall Study|Withdrawal by parent/guardian|1|||
130176790|NCT04895982|468602390|FG007|Overall Study|Withdrawal by parent/guardian|0|||
130176791|NCT04895982|468602391|FG008|Overall Study|Withdrawal by parent/guardian|3|||
130176792|NCT04895982|468602392|FG009|Overall Study|Withdrawal by parent/guardian|0|||
130176793|NCT04895982|468602393|FG010|Overall Study|Withdrawal by parent/guardian|0|||
130176794|NCT04895982|468602394|FG011|Overall Study|Withdrawal by parent/guardian|0|||
130176795|NCT04895982|468602383|FG000|Overall Study|Other|0|||
130176796|NCT04895982|468602384|FG001|Overall Study|Other|0|||
130176797|NCT04895982|468602385|FG002|Overall Study|Other|1|||
130176798|NCT04895982|468602386|FG003|Overall Study|Other|1|||
130176799|NCT04895982|468602387|FG004|Overall Study|Other|0|||
130176800|NCT04895982|468602388|FG005|Overall Study|Other|0|||
130176801|NCT04895982|468602389|FG006|Overall Study|Other|0|||
130176802|NCT04895982|468602390|FG007|Overall Study|Other|0|||
130176803|NCT04895982|468602391|FG008|Overall Study|Other|0|||
130176804|NCT04895982|468602392|FG009|Overall Study|Other|1|||
130176805|NCT04895982|468602393|FG010|Overall Study|Other|0|||
130176806|NCT04895982|468602394|FG011|Overall Study|Other|0|||
130176807|NCT04895982|468602383|FG000|Overall Study|Protocol Violation|0|||
130176808|NCT04895982|468602384|FG001|Overall Study|Protocol Violation|0|||
130176809|NCT04895982|468602385|FG002|Overall Study|Protocol Violation|1|||
130176810|NCT04895982|468602386|FG003|Overall Study|Protocol Violation|1|||
130176811|NCT04895982|468602387|FG004|Overall Study|Protocol Violation|1|||
130176812|NCT04895982|468602388|FG005|Overall Study|Protocol Violation|0|||
130176813|NCT04895982|468602389|FG006|Overall Study|Protocol Violation|0|||
130176814|NCT04895982|468602390|FG007|Overall Study|Protocol Violation|1|||
130176815|NCT04895982|468602391|FG008|Overall Study|Protocol Violation|0|||
130176816|NCT04895982|468602392|FG009|Overall Study|Protocol Violation|0|||
130176817|NCT04895982|468602393|FG010|Overall Study|Protocol Violation|0|||
130176818|NCT04895982|468602394|FG011|Overall Study|Protocol Violation|0|||
130176819|NCT04895982|468602383|FG000|Overall Study|Lost to Follow-up|0|||
130176820|NCT04895982|468602384|FG001|Overall Study|Lost to Follow-up|0|||
130176821|NCT04895982|468602385|FG002|Overall Study|Lost to Follow-up|1|||
130176822|NCT04895982|468602386|FG003|Overall Study|Lost to Follow-up|0|||
130176823|NCT04895982|468602387|FG004|Overall Study|Lost to Follow-up|0|||
130176824|NCT04895982|468602388|FG005|Overall Study|Lost to Follow-up|1|||
130176825|NCT04895982|468602389|FG006|Overall Study|Lost to Follow-up|0|||
130176826|NCT04895982|468602390|FG007|Overall Study|Lost to Follow-up|0|||
130176827|NCT04895982|468602391|FG008|Overall Study|Lost to Follow-up|1|||
130176828|NCT04895982|468602392|FG009|Overall Study|Lost to Follow-up|0|||
130176829|NCT04895982|468602393|FG010|Overall Study|Lost to Follow-up|0|||
130176830|NCT04895982|468602394|FG011|Overall Study|Lost to Follow-up|0|||
130176831|NCT04895982|468602383|FG000|Overall Study|Refused further study procedures|0|||
130176832|NCT04895982|468602384|FG001|Overall Study|Refused further study procedures|0|||
130176833|NCT04895982|468602385|FG002|Overall Study|Refused further study procedures|1|||
130176834|NCT04895982|468602386|FG003|Overall Study|Refused further study procedures|0|||
130176835|NCT04895982|468602387|FG004|Overall Study|Refused further study procedures|0|||
130176836|NCT04895982|468602388|FG005|Overall Study|Refused further study procedures|0|||
130176837|NCT04895982|468602389|FG006|Overall Study|Refused further study procedures|0|||
130176838|NCT04895982|468602390|FG007|Overall Study|Refused further study procedures|0|||
130176839|NCT04895982|468602391|FG008|Overall Study|Refused further study procedures|0|||
130176840|NCT04895982|468602392|FG009|Overall Study|Refused further study procedures|0|||
130176841|NCT04895982|468602393|FG010|Overall Study|Refused further study procedures|0|||
130176842|NCT04895982|468602394|FG011|Overall Study|Refused further study procedures|0|||
130176843|NCT01059786|468604022|FG000|Overall Study|Did not receive 6 cycles.|0|||
130176844|NCT01059786|468604023|FG001|Overall Study|Did not receive 6 cycles.|0|||
130176845|NCT01059786|468604024|FG002|Overall Study|Did not receive 6 cycles.|4|||
130176846|NCT01059786|468604025|FG003|Overall Study|Did not receive 6 cycles.|1|||
130176847|NCT01059786|468604026|FG004|Overall Study|Did not receive 6 cycles.|0|||
130176848|NCT04460885|468604027|FG000|Overall Study|Withdrawal by Subject|6|||
130176849|NCT04460885|468604028|FG001|Overall Study|Withdrawal by Subject|8|||
130176850|NCT04460885|468604027|FG000|Overall Study|Site closure|1|||
130176851|NCT04460885|468604028|FG001|Overall Study|Site closure|0|||
130176852|NCT04460885|468604027|FG000|Overall Study|Death|5|||
130176853|NCT04460885|468604028|FG001|Overall Study|Death|4|||
130176854|NCT04460885|468604027|FG000|Overall Study|Physician Decision|2|||
130176855|NCT04460885|468604028|FG001|Overall Study|Physician Decision|1|||
130176856|NCT04460885|468604027|FG000|Overall Study|Lost to Follow-up|4|||
130176857|NCT04460885|468604028|FG001|Overall Study|Lost to Follow-up|4|||
130176858|NCT04559347|468604029|FG000|Overall Study|Death|1|||
130176859|NCT04559347|468604030|FG001|Overall Study|Death|0|||
130176860|NCT04559347|468604029|FG000|Overall Study|Thoracotomy conversion|1|||
130176861|NCT04559347|468604030|FG001|Overall Study|Thoracotomy conversion|1|||
130176862|NCT04559347|468604029|FG000|Overall Study|Provider unavailable|2|||
130176863|NCT04559347|468604030|FG001|Overall Study|Provider unavailable|1|||
130176864|NCT04559347|468604029|FG000|Overall Study|Other|2|||
130176865|NCT04559347|468604030|FG001|Overall Study|Other|1|||
130176866|NCT02717455|468604032|FG000|Overall Study|Adverse Event|1|||
130176867|NCT02717455|468604033|FG001|Overall Study|Adverse Event|0|||
130176868|NCT02717455|468604034|FG002|Overall Study|Adverse Event|0|||
130176869|NCT02717455|468604035|FG003|Overall Study|Adverse Event|2|||
130176870|NCT02717455|468604036|FG004|Overall Study|Adverse Event|2|||
130176871|NCT02717455|468604037|FG005|Overall Study|Adverse Event|2|||
130176872|NCT02717455|468604032|FG000|Overall Study|Withdrawal by Subject|1|||
130176873|NCT02717455|468604033|FG001|Overall Study|Withdrawal by Subject|1|||
130176874|NCT02717455|468604034|FG002|Overall Study|Withdrawal by Subject|0|||
130176875|NCT02717455|468604035|FG003|Overall Study|Withdrawal by Subject|2|||
130176876|NCT02717455|468604036|FG004|Overall Study|Withdrawal by Subject|2|||
130176877|NCT02717455|468604037|FG005|Overall Study|Withdrawal by Subject|1|||
130176878|NCT02717455|468604032|FG000|Overall Study|Death|1|||
130176879|NCT02717455|468604033|FG001|Overall Study|Death|0|||
130176880|NCT02717455|468604034|FG002|Overall Study|Death|0|||
130176881|NCT02717455|468604035|FG003|Overall Study|Death|0|||
130176882|NCT02717455|468604036|FG004|Overall Study|Death|1|||
130176883|NCT02717455|468604037|FG005|Overall Study|Death|0|||
130176884|NCT02717455|468604032|FG000|Overall Study|Did not receive study drug|0|||
130176885|NCT02717455|468604033|FG001|Overall Study|Did not receive study drug|0|||
130176886|NCT02717455|468604034|FG002|Overall Study|Did not receive study drug|0|||
130176887|NCT02717455|468604035|FG003|Overall Study|Did not receive study drug|1|||
130176888|NCT02717455|468604036|FG004|Overall Study|Did not receive study drug|0|||
130176889|NCT02717455|468604037|FG005|Overall Study|Did not receive study drug|1|||
130176890|NCT02717455|468604032|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176891|NCT02717455|468604033|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176892|NCT02717455|468604034|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176893|NCT02717455|468604035|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176894|NCT02717455|468604036|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
130176895|NCT02717455|468604037|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
130176896|NCT02717455|468604032|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
130176897|NCT02717455|468604033|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
130176898|NCT02717455|468604034|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
130176899|NCT02717455|468604035|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
130176900|NCT02717455|468604036|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
130176901|NCT02717455|468604037|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
130176902|NCT01433055|468604038|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
130176903|NCT01433055|468604039|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
130176904|NCT01433055|468604038|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
130176905|NCT01433055|468604039|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
130176906|NCT00233948|468604043|FG000|Overall Study|Adverse Event|1|||
130176907|NCT00233948|468604044|FG001|Overall Study|Adverse Event|0|||
130176908|NCT00233948|468604045|FG002|Overall Study|Adverse Event|0|||
130176909|NCT00233948|468604046|FG003|Overall Study|Adverse Event|0|||
130176910|NCT00233948|468604047|FG004|Overall Study|Adverse Event|0|||
130176911|NCT00233948|468604048|FG005|Overall Study|Adverse Event|0|||
130176912|NCT01214655|468604056|FG000|Part A|Progressive Disease|7|||
130176913|NCT01214655|468604057|FG001|Part A|Progressive Disease|0|||
130176914|NCT01214655|468604058|FG002|Part A|Progressive Disease|0|||
130176915|NCT01214655|468604056|FG000|Part A|Physician Decision|1|||
130176916|NCT01214655|468604057|FG001|Part A|Physician Decision|0|||
130176917|NCT01214655|468604058|FG002|Part A|Physician Decision|0|||
130176918|NCT01214655|468604056|FG000|Part B|Progressive disease|0|||
130176919|NCT01214655|468604057|FG001|Part B|Progressive disease|10|||
130176920|NCT01214655|468604058|FG002|Part B|Progressive disease|0|||
130176921|NCT01214655|468604056|FG000|Part B|Death|0|||
130176922|NCT01214655|468604057|FG001|Part B|Death|1|||
130176923|NCT01214655|468604058|FG002|Part B|Death|0|||
130176924|NCT01214655|468604056|FG000|Part B|Withdrawal by Subject|0|||
130176925|NCT01214655|468604057|FG001|Part B|Withdrawal by Subject|2|||
130176926|NCT01214655|468604058|FG002|Part B|Withdrawal by Subject|0|||
130176927|NCT01214655|468604056|FG000|Part C|Progressive Disease|0|||
130176928|NCT01214655|468604057|FG001|Part C|Progressive Disease|0|||
130176929|NCT01214655|468604058|FG002|Part C|Progressive Disease|5|||
130176930|NCT01214655|468604056|FG000|Part C|Death|0|||
130176931|NCT01214655|468604057|FG001|Part C|Death|0|||
130176932|NCT01214655|468604058|FG002|Part C|Death|1|||
130176933|NCT01214655|468604056|FG000|Part C|Physician Decision|0|||
130176934|NCT01214655|468604057|FG001|Part C|Physician Decision|0|||
130176935|NCT01214655|468604058|FG002|Part C|Physician Decision|1|||
130176936|NCT05256134|468604059|FG000|Overall Study|Study Terminated by Sponsor|11|||
130176937|NCT05256134|468604060|FG001|Overall Study|Study Terminated by Sponsor|10|||
130176938|NCT05256134|468604059|FG000|Overall Study|Withdrawal by Subject|1|||
130176939|NCT05256134|468604060|FG001|Overall Study|Withdrawal by Subject|3|||
130176940|NCT00886015|468604063|FG000|Overall Study|Death|0|||
130176941|NCT00886015|468604064|FG001|Overall Study|Death|2|||
130176942|NCT05490771|468604070|FG000|Overall Study|Disease progression|18|||
130176943|NCT05490771|468604070|FG000|Overall Study|Adverse Event|3|||
130176944|NCT05490771|468604070|FG000|Overall Study|Other complicating disease|1|||
130176945|NCT05490771|468604070|FG000|Overall Study|Withdrawal by Subject|3|||
130176946|NCT05490771|468604070|FG000|Overall Study|Physician Decision|1|||
130176947|NCT05490771|468604070|FG000|Overall Study|Still on treatment|2|||
130176948|NCT05490771|468604070|FG000|Overall Study|Never start protocol therapy|5|||
130176949|NCT05490771|468604070|FG000|Overall Study|Ineligible|2|||
130176950|NCT01720225|468604071|FG000|Overall Study|Withdrawal by Subject|0|||
130176951|NCT01720225|468604072|FG001|Overall Study|Withdrawal by Subject|1|||
130176952|NCT01720225|468604071|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
130176953|NCT01720225|468604072|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
130176954|NCT00661193|468604076|FG000|Overall Study|Adverse Event|2|||
130176955|NCT00661193|468604077|FG001|Overall Study|Adverse Event|1|||
130176956|NCT00661193|468604076|FG000|Overall Study|Withdrawal by Subject|3|||
130176957|NCT00661193|468604077|FG001|Overall Study|Withdrawal by Subject|1|||
130176958|NCT00661193|468604076|FG000|Overall Study|Progression|27|||
130176959|NCT00661193|468604077|FG001|Overall Study|Progression|24|||
130176960|NCT00661193|468604076|FG000|Overall Study|Not protocol specified|1|||
130176961|NCT00661193|468604077|FG001|Overall Study|Not protocol specified|0|||
130176962|NCT02964312|468604078|FG000|Overall Study|Lost to Follow-up|28|||
130176963|NCT02964312|468604078|FG000|Overall Study|Withdrawal by Subject|11|||
130176964|NCT02964312|468604078|FG000|Overall Study|Lack of Efficacy|10|||
130176965|NCT02964312|468604078|FG000|Overall Study|Did not consent to long-term FU|14|||
130176966|NCT02964312|468604078|FG000|Overall Study|Death|1|||
130176967|NCT02862730|468604087|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176968|NCT02862730|468604088|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176969|NCT02862730|468604089|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
130176970|NCT02862730|468604090|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176971|NCT02862730|468604091|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176972|NCT02862730|468604092|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176973|NCT02862730|468604093|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
130176974|NCT02862730|468604087|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
130176975|NCT02862730|468604088|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176976|NCT02862730|468604089|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176977|NCT02862730|468604090|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176978|NCT02862730|468604091|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176979|NCT02862730|468604092|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176980|NCT02862730|468604093|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
130176981|NCT02862730|468604087|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176982|NCT02862730|468604088|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176983|NCT02862730|468604089|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
130176984|NCT02862730|468604090|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176985|NCT02862730|468604091|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
130176986|NCT02862730|468604092|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176987|NCT02862730|468604093|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
130176988|NCT02862730|468604087|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176989|NCT02862730|468604088|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176990|NCT02862730|468604089|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176991|NCT02862730|468604090|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
130176992|NCT02862730|468604091|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176993|NCT02862730|468604092|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176994|NCT02862730|468604093|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
130176995|NCT03685344|468604094|FG000|Overall Study|Withdrawal by Subject|1|||
130176996|NCT03685344|468604095|FG001|Overall Study|Withdrawal by Subject|1|||
130176997|NCT03685344|468604096|FG002|Overall Study|Withdrawal by Subject|2|||
130176998|NCT03685344|468604097|FG003|Overall Study|Withdrawal by Subject|0|||
130176999|NCT03685344|468604094|FG000|Overall Study|Physician Decision|1|||
130177000|NCT03685344|468604095|FG001|Overall Study|Physician Decision|1|||
130177001|NCT03685344|468604096|FG002|Overall Study|Physician Decision|5|||
130177002|NCT03685344|468604097|FG003|Overall Study|Physician Decision|0|||
130177003|NCT03685344|468604094|FG000|Overall Study|Death|1|||
130177004|NCT03685344|468604095|FG001|Overall Study|Death|1|||
130177005|NCT03685344|468604096|FG002|Overall Study|Death|0|||
130177006|NCT03685344|468604097|FG003|Overall Study|Death|0|||
130177007|NCT03126435|468604099|FG000|Overall Study|Death|90|||
130177008|NCT03126435|468604100|FG001|Overall Study|Death|84|||
130177009|NCT03126435|468604099|FG000|Overall Study|Lost to Follow-up|4|||
130177010|NCT03126435|468604100|FG001|Overall Study|Lost to Follow-up|3|||
130177011|NCT03126435|468604099|FG000|Overall Study|Physician Decision|0|||
130177012|NCT03126435|468604100|FG001|Overall Study|Physician Decision|1|||
130177013|NCT03126435|468604099|FG000|Overall Study|Withdrawal by Subject|6|||
130177014|NCT03126435|468604100|FG001|Overall Study|Withdrawal by Subject|12|||
130177015|NCT03126435|468604099|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
130177016|NCT03126435|468604100|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
130177017|NCT01023035|468604102|FG000|Treatment Period|Adverse Event|27|||
130177018|NCT01023035|468604103|FG001|Treatment Period|Adverse Event|32|||
130177019|NCT01023035|468604104|FG002|Treatment Period|Adverse Event|50|||
130177020|NCT01023035|468604102|FG000|Treatment Period|Non-Medical Reasons|19|||
130177021|NCT01023035|468604103|FG001|Treatment Period|Non-Medical Reasons|22|||
130177022|NCT01023035|468604104|FG002|Treatment Period|Non-Medical Reasons|44|||
130177023|NCT01023035|468604102|FG000|Treatment Period|Treatment Failure|26|||
130177024|NCT01023035|468604103|FG001|Treatment Period|Treatment Failure|31|||
130177025|NCT01023035|468604104|FG002|Treatment Period|Treatment Failure|24|||
130177026|NCT01023035|468604102|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
130177027|NCT01023035|468604103|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
130177028|NCT01023035|468604104|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
130177029|NCT01023035|468604102|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
130177030|NCT01023035|468604103|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
130177031|NCT01023035|468604104|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
130177032|NCT00524420|468604108|FG000|Overall Study|Lack of Efficacy|1|||
130177033|NCT00524420|468604109|FG001|Overall Study|Lack of Efficacy|0|||
129982834|NCT03377699|467900632|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
129982835|NCT03377699|467900633|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
129982836|NCT03377699|467900632|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
129982837|NCT03377699|467900633|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
129982838|NCT03377699|467900632|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
129982839|NCT03377699|467900633|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
130177034|NCT01090414|468604110|FG000|Study 101-99|Progressive Disease|28|||
130177035|NCT01090414|468604111|FG001|Study 101-99|Progressive Disease|48|||
130177036|NCT01090414|468604112|FG002|Study 101-99|Progressive Disease|10|||
130177037|NCT01090414|468604113|FG003|Study 101-99|Progressive Disease|4|||
130177038|NCT01090414|468604110|FG000|Study 101-99|Adverse Event|10|||
130177039|NCT01090414|468604111|FG001|Study 101-99|Adverse Event|28|||
130177040|NCT01090414|468604112|FG002|Study 101-99|Adverse Event|18|||
130177041|NCT01090414|468604113|FG003|Study 101-99|Adverse Event|0|||
130177042|NCT01090414|468604110|FG000|Study 101-99|Investigator Request|1|||
130177043|NCT01090414|468604111|FG001|Study 101-99|Investigator Request|11|||
130177044|NCT01090414|468604112|FG002|Study 101-99|Investigator Request|4|||
130177045|NCT01090414|468604113|FG003|Study 101-99|Investigator Request|0|||
130177046|NCT01090414|468604110|FG000|Study 101-99|Death|3|||
130177047|NCT01090414|468604111|FG001|Study 101-99|Death|8|||
130177048|NCT01090414|468604112|FG002|Study 101-99|Death|1|||
130177049|NCT01090414|468604113|FG003|Study 101-99|Death|0|||
130177050|NCT01090414|468604110|FG000|Study 101-99|Sponsor Discontinued Study|0|||
130177051|NCT01090414|468604111|FG001|Study 101-99|Sponsor Discontinued Study|7|||
130177052|NCT01090414|468604112|FG002|Study 101-99|Sponsor Discontinued Study|5|||
130177053|NCT01090414|468604113|FG003|Study 101-99|Sponsor Discontinued Study|0|||
130177054|NCT01090414|468604110|FG000|Study 101-99|Other (Unknown Reasons)|3|||
130177055|NCT01090414|468604111|FG001|Study 101-99|Other (Unknown Reasons)|3|||
130177056|NCT01090414|468604112|FG002|Study 101-99|Other (Unknown Reasons)|0|||
130177057|NCT01090414|468604113|FG003|Study 101-99|Other (Unknown Reasons)|0|||
130177058|NCT01090414|468604110|FG000|Study 101-99|Withdrew Consent|0|||
130177059|NCT01090414|468604111|FG001|Study 101-99|Withdrew Consent|2|||
130177060|NCT01090414|468604112|FG002|Study 101-99|Withdrew Consent|3|||
130177061|NCT01090414|468604113|FG003|Study 101-99|Withdrew Consent|1|||
130177062|NCT01090414|468604110|FG000|Study 101-99|Participant Request|3|||
130177063|NCT01090414|468604111|FG001|Study 101-99|Participant Request|1|||
130177064|NCT01090414|468604112|FG002|Study 101-99|Participant Request|0|||
130177065|NCT01090414|468604113|FG003|Study 101-99|Participant Request|0|||
130177066|NCT02413229|468604119|FG000|Overall Study|Adverse Event|0|||
130177067|NCT02413229|468604120|FG001|Overall Study|Adverse Event|0|||
130177068|NCT02413229|468604121|FG002|Overall Study|Adverse Event|0|||
130177069|NCT02413229|468604122|FG003|Overall Study|Adverse Event|1|||
130177070|NCT02413229|468604123|FG004|Overall Study|Adverse Event|0|||
130177071|NCT02413229|468604124|FG005|Overall Study|Adverse Event|0|||
130177072|NCT02413229|468604125|FG006|Overall Study|Adverse Event|0|||
130177073|NCT02413229|468604126|FG007|Overall Study|Adverse Event|1|||
130177074|NCT02413229|468604119|FG000|Overall Study|Lost to Follow-up|0|||
130177075|NCT02413229|468604120|FG001|Overall Study|Lost to Follow-up|0|||
130177076|NCT02413229|468604121|FG002|Overall Study|Lost to Follow-up|1|||
130177077|NCT02413229|468604122|FG003|Overall Study|Lost to Follow-up|0|||
130177078|NCT02413229|468604123|FG004|Overall Study|Lost to Follow-up|2|||
130177079|NCT02413229|468604124|FG005|Overall Study|Lost to Follow-up|0|||
130177080|NCT02413229|468604125|FG006|Overall Study|Lost to Follow-up|0|||
130177081|NCT02413229|468604126|FG007|Overall Study|Lost to Follow-up|0|||
130177082|NCT02413229|468604119|FG000|Overall Study|Withdrawal by Subject|1|||
130177083|NCT02413229|468604120|FG001|Overall Study|Withdrawal by Subject|1|||
130177084|NCT02413229|468604121|FG002|Overall Study|Withdrawal by Subject|0|||
130177085|NCT02413229|468604122|FG003|Overall Study|Withdrawal by Subject|0|||
130177086|NCT02413229|468604123|FG004|Overall Study|Withdrawal by Subject|1|||
130177087|NCT02413229|468604124|FG005|Overall Study|Withdrawal by Subject|0|||
130177088|NCT02413229|468604125|FG006|Overall Study|Withdrawal by Subject|0|||
130177089|NCT02413229|468604126|FG007|Overall Study|Withdrawal by Subject|2|||
130177090|NCT02413229|468604119|FG000|Overall Study|Progressive Disease|0|||
130177091|NCT02413229|468604120|FG001|Overall Study|Progressive Disease|0|||
130177092|NCT02413229|468604121|FG002|Overall Study|Progressive Disease|0|||
130177093|NCT02413229|468604122|FG003|Overall Study|Progressive Disease|0|||
130177094|NCT02413229|468604123|FG004|Overall Study|Progressive Disease|0|||
130177095|NCT02413229|468604124|FG005|Overall Study|Progressive Disease|0|||
130177096|NCT02413229|468604125|FG006|Overall Study|Progressive Disease|0|||
130177097|NCT02413229|468604126|FG007|Overall Study|Progressive Disease|1|||
130177098|NCT03594071|468604127|FG000|Overall Study|Re-operation|3|||
130177099|NCT03594071|468604127|FG000|Overall Study|Missed visit|2|||
130177100|NCT03022370|468604128|FG000|Overall Study|Death|6|||
130177101|NCT03022370|468604129|FG001|Overall Study|Death|12|||
130177102|NCT03022370|468604128|FG000|Overall Study|Lost to Follow-up|174|||
130177103|NCT03022370|468604129|FG001|Overall Study|Lost to Follow-up|109|||
130177104|NCT00699816|468604130|FG000|Overall Study|Protocol Violation|1|||
130177105|NCT00699816|468604131|FG001|Overall Study|Protocol Violation|3|||
130177106|NCT02454933|468604136|FG000|Overall Study|Progressive disease|10|||
130177107|NCT02454933|468604137|FG001|Overall Study|Progressive disease|7|||
130177108|NCT02454933|468604136|FG000|Overall Study|Adverse Event|1|||
130177109|NCT02454933|468604137|FG001|Overall Study|Adverse Event|1|||
130177110|NCT02454933|468604136|FG000|Overall Study|Withdrawal by Subject|0|||
130177111|NCT02454933|468604137|FG001|Overall Study|Withdrawal by Subject|3|||
130177112|NCT02454933|468604136|FG000|Overall Study|Lost to Follow-up|1|||
130177113|NCT02454933|468604137|FG001|Overall Study|Lost to Follow-up|0|||
130177114|NCT03668808|468604138|FG000|First Intervention|Withdrawal by Subject|2|||
130177115|NCT03668808|468604139|FG001|First Intervention|Withdrawal by Subject|2|||
130177116|NCT01526655|468604140|FG000|Overall Study|Withdrawal by Subject|0|||
130177117|NCT01526655|468604141|FG001|Overall Study|Withdrawal by Subject|1|||
130177118|NCT02288325|468604145|FG000|Run-in Period|Adverse Event|48|||
130177119|NCT02288325|468604146|FG001|Run-in Period|Adverse Event|0|||
130177120|NCT02288325|468604147|FG002|Run-in Period|Adverse Event|0|||
130177121|NCT02288325|468604145|FG000|Run-in Period|Lack of Efficacy|16|||
130177122|NCT02288325|468604146|FG001|Run-in Period|Lack of Efficacy|0|||
130177123|NCT02288325|468604147|FG002|Run-in Period|Lack of Efficacy|0|||
130177124|NCT02288325|468604145|FG000|Run-in Period|Withdrawal of Consent|28|||
130177125|NCT02288325|468604146|FG001|Run-in Period|Withdrawal of Consent|0|||
130177126|NCT02288325|468604147|FG002|Run-in Period|Withdrawal of Consent|0|||
130177127|NCT02288325|468604145|FG000|Run-in Period|Lost to Follow-up|25|||
130177128|NCT02288325|468604146|FG001|Run-in Period|Lost to Follow-up|0|||
130177129|NCT02288325|468604147|FG002|Run-in Period|Lost to Follow-up|0|||
130177130|NCT02288325|468604145|FG000|Run-in Period|Protocol Violation|17|||
130177131|NCT02288325|468604146|FG001|Run-in Period|Protocol Violation|0|||
130177132|NCT02288325|468604147|FG002|Run-in Period|Protocol Violation|0|||
130177133|NCT02288325|468604145|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
130177134|NCT02288325|468604146|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
130177135|NCT02288325|468604147|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
130177136|NCT02288325|468604145|FG000|Run-in Period|Reason not Specified|8|||
130177137|NCT02288325|468604146|FG001|Run-in Period|Reason not Specified|0|||
130177138|NCT02288325|468604147|FG002|Run-in Period|Reason not Specified|0|||
130177139|NCT02288325|468604145|FG000|Stabilization Period|Adverse Event|13|||
130177140|NCT02288325|468604146|FG001|Stabilization Period|Adverse Event|0|||
130177141|NCT02288325|468604147|FG002|Stabilization Period|Adverse Event|0|||
130177142|NCT02288325|468604145|FG000|Stabilization Period|Lack of Efficacy|22|||
130177143|NCT02288325|468604146|FG001|Stabilization Period|Lack of Efficacy|0|||
130177144|NCT02288325|468604147|FG002|Stabilization Period|Lack of Efficacy|0|||
130177145|NCT02288325|468604145|FG000|Stabilization Period|Withdrawal of Consent|23|||
130177146|NCT02288325|468604146|FG001|Stabilization Period|Withdrawal of Consent|0|||
130177147|NCT02288325|468604147|FG002|Stabilization Period|Withdrawal of Consent|0|||
130177148|NCT02288325|468604145|FG000|Stabilization Period|Lost to Follow-up|12|||
130177149|NCT02288325|468604146|FG001|Stabilization Period|Lost to Follow-up|0|||
130177150|NCT02288325|468604147|FG002|Stabilization Period|Lost to Follow-up|0|||
130177151|NCT02288325|468604145|FG000|Stabilization Period|Protocol Violation|8|||
130177152|NCT02288325|468604146|FG001|Stabilization Period|Protocol Violation|0|||
130177153|NCT02288325|468604147|FG002|Stabilization Period|Protocol Violation|0|||
130177154|NCT02288325|468604145|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
130177155|NCT02288325|468604146|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
130177156|NCT02288325|468604147|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
130177157|NCT02288325|468604145|FG000|Stabilization Period|Reason not Specified|15|||
130177158|NCT02288325|468604146|FG001|Stabilization Period|Reason not Specified|0|||
130177159|NCT02288325|468604147|FG002|Stabilization Period|Reason not Specified|0|||
130177160|NCT02288325|468604145|FG000|Double-blind Treatment Period|Adverse Event|0|||
130177161|NCT02288325|468604146|FG001|Double-blind Treatment Period|Adverse Event|2|||
130177162|NCT02288325|468604147|FG002|Double-blind Treatment Period|Adverse Event|5|||
130177163|NCT02288325|468604145|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
130177164|NCT02288325|468604146|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
130177165|NCT02288325|468604147|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
130177166|NCT02288325|468604145|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130177167|NCT02288325|468604146|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
130177168|NCT02288325|468604147|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130177169|NCT02288325|468604145|FG000|Double-blind Treatment Period|Protocol Violation|0|||
130177170|NCT02288325|468604146|FG001|Double-blind Treatment Period|Protocol Violation|1|||
130177171|NCT02288325|468604147|FG002|Double-blind Treatment Period|Protocol Violation|2|||
130177172|NCT02288325|468604145|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
130177173|NCT02288325|468604146|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
130177174|NCT02288325|468604147|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
130177175|NCT02288325|468604145|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
130177176|NCT02288325|468604146|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
130177177|NCT02288325|468604147|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
130177178|NCT05061420|468604160|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
130177179|NCT05061420|468604161|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130177180|NCT05061420|468604162|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
130177181|NCT05061420|468604160|FG000|Overall Study|Progressive disease|11|||
130177182|NCT05061420|468604161|FG001|Overall Study|Progressive disease|15|||
130177183|NCT05061420|468604162|FG002|Overall Study|Progressive disease|14|||
130177184|NCT05061420|468604160|FG000|Overall Study|Withdrawal by Subject|2|||
130177185|NCT05061420|468604161|FG001|Overall Study|Withdrawal by Subject|0|||
130177186|NCT05061420|468604162|FG002|Overall Study|Withdrawal by Subject|1|||
130177187|NCT05061420|468604160|FG000|Overall Study|Not related to COVID-19|2|||
130177188|NCT05061420|468604161|FG001|Overall Study|Not related to COVID-19|0|||
130177189|NCT05061420|468604162|FG002|Overall Study|Not related to COVID-19|0|||
130177190|NCT04868500|468604163|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
130177191|NCT04868500|468604164|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
130177192|NCT04868500|468604163|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
130177193|NCT04868500|468604164|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
130177194|NCT04807400|468604166|FG000|Overall Study|Adverse Event|2|||
130177195|NCT04807400|468604167|FG001|Overall Study|Adverse Event|3|||
130177196|NCT04807400|468604168|FG002|Overall Study|Adverse Event|3|||
130177197|NCT04807400|468604166|FG000|Overall Study|Death|2|||
130177198|NCT04807400|468604167|FG001|Overall Study|Death|0|||
130177199|NCT04807400|468604168|FG002|Overall Study|Death|0|||
130177200|NCT04807400|468604166|FG000|Overall Study|Lost to Follow-up|8|||
130177201|NCT04807400|468604167|FG001|Overall Study|Lost to Follow-up|6|||
130177202|NCT04807400|468604168|FG002|Overall Study|Lost to Follow-up|6|||
130177203|NCT04807400|468604166|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130177204|NCT04807400|468604167|FG001|Overall Study|Non-Compliance With Study Drug|4|||
130177205|NCT04807400|468604168|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130177206|NCT04807400|468604166|FG000|Overall Study|Participant Decision|20|||
130177207|NCT04807400|468604167|FG001|Overall Study|Participant Decision|19|||
130177208|NCT04807400|468604168|FG002|Overall Study|Participant Decision|26|||
130177209|NCT04807400|468604166|FG000|Overall Study|Physician Decision|0|||
130177210|NCT04807400|468604167|FG001|Overall Study|Physician Decision|1|||
130177211|NCT04807400|468604168|FG002|Overall Study|Physician Decision|0|||
130177212|NCT04807400|468604166|FG000|Overall Study|Protocol Violation|4|||
130177213|NCT04807400|468604167|FG001|Overall Study|Protocol Violation|3|||
130177214|NCT04807400|468604168|FG002|Overall Study|Protocol Violation|7|||
130177215|NCT04807400|468604166|FG000|Overall Study|Withdrawal by Subject|13|||
130177216|NCT04807400|468604167|FG001|Overall Study|Withdrawal by Subject|9|||
130177217|NCT04807400|468604168|FG002|Overall Study|Withdrawal by Subject|20|||
130177218|NCT04807400|468604166|FG000|Overall Study|Mis-randomized|1|||
130177219|NCT04807400|468604167|FG001|Overall Study|Mis-randomized|0|||
130177220|NCT04807400|468604168|FG002|Overall Study|Mis-randomized|0|||
130177221|NCT01332292|468604173|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
130177222|NCT01332292|468604174|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
130177223|NCT01332292|468604173|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130177224|NCT01332292|468604174|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
130177225|NCT01332292|468604173|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
130177226|NCT01332292|468604174|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
130177227|NCT04650204|468604175|FG000|Overall Study|Study was Terminated|2|||
130177228|NCT04650204|468604176|FG001|Overall Study|Study was Terminated|1|||
130177229|NCT01330303|468604177|FG000|Period 1|Adverse Event|1|||
130177230|NCT01330303|468604178|FG001|Period 1|Adverse Event|0|||
130177231|NCT01330303|468604177|FG000|Period 1|Protocol Violation|0|||
130177232|NCT01330303|468604178|FG001|Period 1|Protocol Violation|1|||
130177233|NCT01330303|468604177|FG000|Period 1|Withdrawal by Subject|0|||
130177234|NCT01330303|468604178|FG001|Period 1|Withdrawal by Subject|1|||
130177235|NCT01107197|468604179|FG000|Overall Study|Death|12|||
130177236|NCT01107197|468604180|FG001|Overall Study|Death|10|||
130177237|NCT01107197|468604179|FG000|Overall Study|Lost to Follow-up|5|||
130177238|NCT01107197|468604180|FG001|Overall Study|Lost to Follow-up|8|||
130177239|NCT01107197|468604179|FG000|Overall Study|Withdrawal by Subject|3|||
130177240|NCT01107197|468604180|FG001|Overall Study|Withdrawal by Subject|5|||
130177241|NCT03999996|468605838|FG000|Prior to Booster|Adverse Event|2|||
130177242|NCT03999996|468605839|FG001|Prior to Booster|Adverse Event|0|||
130177243|NCT03999996|468605840|FG002|Prior to Booster|Adverse Event|0|||
130177244|NCT03999996|468605841|FG003|Prior to Booster|Adverse Event|0|||
130177245|NCT03999996|468605838|FG000|Prior to Booster|Lost to Follow-up|17|||
130177246|NCT03999996|468605839|FG001|Prior to Booster|Lost to Follow-up|22|||
130177247|NCT03999996|468605840|FG002|Prior to Booster|Lost to Follow-up|0|||
130177248|NCT03999996|468605841|FG003|Prior to Booster|Lost to Follow-up|0|||
130177249|NCT03999996|468605838|FG000|Prior to Booster|Withdrawal of Consent|51|||
130177250|NCT03999996|468605839|FG001|Prior to Booster|Withdrawal of Consent|8|||
130177251|NCT03999996|468605840|FG002|Prior to Booster|Withdrawal of Consent|0|||
130177252|NCT03999996|468605841|FG003|Prior to Booster|Withdrawal of Consent|0|||
130177253|NCT03999996|468605838|FG000|Prior to Booster|Death|0|||
130177254|NCT03999996|468605839|FG001|Prior to Booster|Death|1|||
130177255|NCT03999996|468605840|FG002|Prior to Booster|Death|0|||
130177256|NCT03999996|468605841|FG003|Prior to Booster|Death|0|||
130177257|NCT03999996|468605838|FG000|Prior to Booster|Reason Not Specified|27|||
130177258|NCT03999996|468605839|FG001|Prior to Booster|Reason Not Specified|4|||
130177259|NCT03999996|468605840|FG002|Prior to Booster|Reason Not Specified|0|||
130177260|NCT03999996|468605841|FG003|Prior to Booster|Reason Not Specified|0|||
130177261|NCT03999996|468605838|FG000|Booster Phase|Lost to Follow-up|0|||
130177262|NCT03999996|468605839|FG001|Booster Phase|Lost to Follow-up|0|||
130177263|NCT03999996|468605840|FG002|Booster Phase|Lost to Follow-up|3|||
130177264|NCT03999996|468605841|FG003|Booster Phase|Lost to Follow-up|3|||
130177265|NCT03999996|468605838|FG000|Booster Phase|Withdrawal of Consent|0|||
130177266|NCT03999996|468605839|FG001|Booster Phase|Withdrawal of Consent|0|||
130177267|NCT03999996|468605840|FG002|Booster Phase|Withdrawal of Consent|0|||
130177268|NCT03999996|468605841|FG003|Booster Phase|Withdrawal of Consent|1|||
130177269|NCT03999996|468605838|FG000|Booster Phase|Reason Not Specified|0|||
130177270|NCT03999996|468605839|FG001|Booster Phase|Reason Not Specified|0|||
130177271|NCT03999996|468605840|FG002|Booster Phase|Reason Not Specified|0|||
130177272|NCT03999996|468605841|FG003|Booster Phase|Reason Not Specified|1|||
130177273|NCT00733005|468605844|FG000|Overall Study|Adverse Event|0|||
130177274|NCT00733005|468605845|FG001|Overall Study|Adverse Event|1|||
130177275|NCT00733005|468605844|FG000|Overall Study|Treatment Failure|0|||
130177276|NCT00733005|468605845|FG001|Overall Study|Treatment Failure|1|||
130177277|NCT00733005|468605844|FG000|Overall Study|Withdrawal by Subject|0|||
130177278|NCT00733005|468605845|FG001|Overall Study|Withdrawal by Subject|1|||
130177279|NCT00733005|468605844|FG000|Overall Study|Protocol Violation|2|||
130177280|NCT00733005|468605845|FG001|Overall Study|Protocol Violation|0|||
130177281|NCT00266630|468605846|FG000|Overall Study|Adverse Event|8|||
130177282|NCT00266630|468605847|FG001|Overall Study|Adverse Event|6|||
130177283|NCT00266630|468605846|FG000|Overall Study|Lack of Efficacy|1|||
130177284|NCT00266630|468605847|FG001|Overall Study|Lack of Efficacy|4|||
130177285|NCT00266630|468605846|FG000|Overall Study|Entry Criteria not met|1|||
130177286|NCT00266630|468605847|FG001|Overall Study|Entry Criteria not met|0|||
130177287|NCT00266630|468605846|FG000|Overall Study|Protocol Violation|1|||
130177288|NCT00266630|468605847|FG001|Overall Study|Protocol Violation|3|||
130177289|NCT00266630|468605846|FG000|Overall Study|Physician Decision|1|||
130177290|NCT00266630|468605847|FG001|Overall Study|Physician Decision|2|||
130177291|NCT00266630|468605846|FG000|Overall Study|Withdrawal by Subject|10|||
130177292|NCT00266630|468605847|FG001|Overall Study|Withdrawal by Subject|2|||
130177293|NCT00266630|468605846|FG000|Overall Study|Lost to Follow-up|1|||
130177294|NCT00266630|468605847|FG001|Overall Study|Lost to Follow-up|0|||
130177295|NCT00266630|468605846|FG000|Overall Study|Other|19|||
130177296|NCT00266630|468605847|FG001|Overall Study|Other|11|||
130177297|NCT03410056|468605848|FG000|Overall Study|Decision by Sponsor|0|||
130177298|NCT03410056|468605849|FG001|Overall Study|Decision by Sponsor|0|||
130177299|NCT03410056|468605850|FG002|Overall Study|Decision by Sponsor|3|||
130177300|NCT03410056|468605851|FG003|Overall Study|Decision by Sponsor|0|||
130177301|NCT03410056|468605852|FG004|Overall Study|Decision by Sponsor|0|||
130177302|NCT03410056|468605853|FG005|Overall Study|Decision by Sponsor|0|||
130177303|NCT03410056|468605854|FG006|Overall Study|Decision by Sponsor|0|||
130177304|NCT03410056|468605848|FG000|Overall Study|Withdrawal by Subject|0|||
130177305|NCT03410056|468605849|FG001|Overall Study|Withdrawal by Subject|2|||
130177306|NCT03410056|468605850|FG002|Overall Study|Withdrawal by Subject|5|||
130177307|NCT03410056|468605851|FG003|Overall Study|Withdrawal by Subject|5|||
130177308|NCT03410056|468605852|FG004|Overall Study|Withdrawal by Subject|0|||
130177309|NCT03410056|468605853|FG005|Overall Study|Withdrawal by Subject|0|||
130177310|NCT03410056|468605854|FG006|Overall Study|Withdrawal by Subject|0|||
130177311|NCT02548156|468605860|FG000|Washout Period 1|Lost to Follow-up|0|||
130177312|NCT02548156|468605861|FG001|Washout Period 1|Lost to Follow-up|0|||
130177313|NCT02548156|468605862|FG002|Washout Period 1|Lost to Follow-up|0|||
130177314|NCT02548156|468605863|FG003|Washout Period 1|Lost to Follow-up|0|||
130177315|NCT02548156|468605864|FG004|Washout Period 1|Lost to Follow-up|1|||
130177316|NCT02548156|468605865|FG005|Washout Period 1|Lost to Follow-up|0|||
130177317|NCT01068262|468605870|FG000|Overall Study|Adverse Event|2|||
130177318|NCT01068262|468605871|FG001|Overall Study|Adverse Event|0|||
130177319|NCT01068262|468605872|FG002|Overall Study|Adverse Event|1|||
130177320|NCT01068262|468605873|FG003|Overall Study|Adverse Event|0|||
130177321|NCT01068262|468605870|FG000|Overall Study|Protocol Violation|1|||
130177322|NCT01068262|468605871|FG001|Overall Study|Protocol Violation|0|||
130177323|NCT01068262|468605872|FG002|Overall Study|Protocol Violation|0|||
130177324|NCT01068262|468605873|FG003|Overall Study|Protocol Violation|0|||
130177325|NCT01068262|468605870|FG000|Overall Study|Withdrawal by Subject|0|||
130177326|NCT01068262|468605871|FG001|Overall Study|Withdrawal by Subject|1|||
130177327|NCT01068262|468605872|FG002|Overall Study|Withdrawal by Subject|0|||
130177328|NCT01068262|468605873|FG003|Overall Study|Withdrawal by Subject|0|||
130177329|NCT00444587|468605876|FG000|Overall Study|Death|2|||
130177330|NCT00444587|468605877|FG001|Overall Study|Death|1|||
130177331|NCT00444587|468605876|FG000|Overall Study|Progression of the disease|73|||
130177332|NCT00444587|468605877|FG001|Overall Study|Progression of the disease|8|||
130177333|NCT00444587|468605876|FG000|Overall Study|Refused treatment/did not cooperate|4|||
130177334|NCT00444587|468605877|FG001|Overall Study|Refused treatment/did not cooperate|1|||
130177335|NCT00444587|468605876|FG000|Overall Study|Investigator decision|3|||
130177336|NCT00444587|468605877|FG001|Overall Study|Investigator decision|0|||
130177337|NCT00444587|468605876|FG000|Overall Study|Protocol Violation|1|||
130177338|NCT00444587|468605877|FG001|Overall Study|Protocol Violation|0|||
130177339|NCT00444587|468605876|FG000|Overall Study|Missing|0|||
130177340|NCT00444587|468605877|FG001|Overall Study|Missing|5|||
130177341|NCT01473407|468605886|FG000|Overall Study|Physician Decision|1|||
130177342|NCT01473407|468605887|FG001|Overall Study|Physician Decision|4|||
130177343|NCT01473407|468605886|FG000|Overall Study|Lost to Follow-up|10|||
130177344|NCT01473407|468605887|FG001|Overall Study|Lost to Follow-up|4|||
129982840|NCT03377699|467900632|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
130177345|NCT01473407|468605886|FG000|Overall Study|Adverse Event|8|||
130177346|NCT01473407|468605887|FG001|Overall Study|Adverse Event|8|||
130177347|NCT01473407|468605886|FG000|Overall Study|Randomization Error|3|||
130177348|NCT01473407|468605887|FG001|Overall Study|Randomization Error|1|||
130177349|NCT01473407|468605886|FG000|Overall Study|Withdrawal by Subject|4|||
130177350|NCT01473407|468605887|FG001|Overall Study|Withdrawal by Subject|7|||
130177351|NCT01473407|468605886|FG000|Overall Study|Kidney Transplant|7|||
130177352|NCT01473407|468605887|FG001|Overall Study|Kidney Transplant|6|||
130177353|NCT01473407|468605886|FG000|Overall Study|Vacation/Travel|1|||
130177354|NCT01473407|468605887|FG001|Overall Study|Vacation/Travel|1|||
130177355|NCT01473407|468605886|FG000|Overall Study|Elevated Hemoglobin|1|||
130177356|NCT01473407|468605887|FG001|Overall Study|Elevated Hemoglobin|0|||
130177357|NCT01473407|468605886|FG000|Overall Study|Patient Received Aranesp|1|||
130177358|NCT01473407|468605887|FG001|Overall Study|Patient Received Aranesp|0|||
130177359|NCT01473407|468605886|FG000|Overall Study|Patient Lost Green Card Status|1|||
130177360|NCT01473407|468605887|FG001|Overall Study|Patient Lost Green Card Status|0|||
130177361|NCT01473407|468605886|FG000|Overall Study|Temperature Excursion|2|||
130177362|NCT01473407|468605887|FG001|Overall Study|Temperature Excursion|3|||
130177363|NCT01473407|468605886|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
130177364|NCT01473407|468605887|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
130177365|NCT01473407|468605886|FG000|Overall Study|Sponsor's Decision|10|||
130177366|NCT01473407|468605887|FG001|Overall Study|Sponsor's Decision|10|||
130177367|NCT01473407|468605886|FG000|Overall Study|Site Closure|1|||
130177368|NCT01473407|468605887|FG001|Overall Study|Site Closure|0|||
130177369|NCT01027702|468605890|FG000|Overall Study|Received subsequent therapy|1|||
129982841|NCT03377699|467900633|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
129982842|NCT00307684|467900634|FG000|Open Label Phase|Lack of Efficacy|0|||
129982843|NCT00307684|467900635|FG001|Open Label Phase|Lack of Efficacy|0|||
129982844|NCT00307684|467900636|FG002|Open Label Phase|Lack of Efficacy|3|||
129982845|NCT00307684|467900634|FG000|Open Label Phase|Adverse Event|0|||
129982846|NCT00307684|467900635|FG001|Open Label Phase|Adverse Event|0|||
130177370|NCT01027702|468605891|FG001|Overall Study|Received subsequent therapy|2|||
130177371|NCT01027702|468605892|FG002|Overall Study|Received subsequent therapy|0|||
130177372|NCT01027702|468605893|FG003|Overall Study|Received subsequent therapy|4|||
130177373|NCT01027702|468605894|FG004|Overall Study|Received subsequent therapy|1|||
130177374|NCT01027702|468605895|FG005|Overall Study|Received subsequent therapy|0|||
130177375|NCT01027702|468605896|FG006|Overall Study|Received subsequent therapy|1|||
130177376|NCT01027702|468605890|FG000|Overall Study|Death|0|||
130177377|NCT01027702|468605891|FG001|Overall Study|Death|0|||
130177378|NCT01027702|468605892|FG002|Overall Study|Death|1|||
130177379|NCT01027702|468605893|FG003|Overall Study|Death|0|||
130177380|NCT01027702|468605894|FG004|Overall Study|Death|0|||
130177381|NCT01027702|468605895|FG005|Overall Study|Death|0|||
130177382|NCT01027702|468605896|FG006|Overall Study|Death|0|||
130177383|NCT02301390|468605897|FG000|Overall Study|Withdrawal by Subject|3|||
130177384|NCT02301390|468605898|FG001|Overall Study|Withdrawal by Subject|5|||
130177385|NCT02301390|468605897|FG000|Overall Study|Protocol Violation|1|||
130177386|NCT02301390|468605898|FG001|Overall Study|Protocol Violation|0|||
130177387|NCT02301390|468605897|FG000|Overall Study|Physician Decision|1|||
130177388|NCT02301390|468605898|FG001|Overall Study|Physician Decision|0|||
130177389|NCT02301390|468605897|FG000|Overall Study|Lost to Follow-up|0|||
130177390|NCT02301390|468605898|FG001|Overall Study|Lost to Follow-up|1|||
130177391|NCT02301390|468605897|FG000|Overall Study|Death|2|||
130177392|NCT02301390|468605898|FG001|Overall Study|Death|2|||
130177393|NCT02301390|468605897|FG000|Overall Study|Procedure not completed|0|||
130177394|NCT02301390|468605898|FG001|Overall Study|Procedure not completed|4|||
130177395|NCT02301390|468605897|FG000|Overall Study|Missed multiple visits|1|||
130177396|NCT02301390|468605898|FG001|Overall Study|Missed multiple visits|1|||
130177397|NCT02301390|468605897|FG000|Overall Study|study terminated|2|||
130177398|NCT02301390|468605898|FG001|Overall Study|study terminated|0|||
130177399|NCT02121652|468605901|FG000|Overall Study|Lost to Follow-up|2|||
130177400|NCT02121652|468605902|FG001|Overall Study|Lost to Follow-up|1|||
130177401|NCT02121652|468605901|FG000|Overall Study|Death|1|||
130177402|NCT02121652|468605902|FG001|Overall Study|Death|0|||
130177403|NCT02121652|468605901|FG000|Overall Study|Withdrawal by Subject|3|||
130177404|NCT02121652|468605902|FG001|Overall Study|Withdrawal by Subject|3|||
130177405|NCT01153425|468605903|FG000|Overall Study|Withdrawal by Subject|3|||
130177406|NCT01153425|468605904|FG001|Overall Study|Withdrawal by Subject|3|||
130177407|NCT02932462|468605905|FG000|Overall Study|Adverse Event|1|||
130177408|NCT02932462|468605906|FG001|Overall Study|Adverse Event|2|||
130177409|NCT02932462|468605905|FG000|Overall Study|Lost to Follow-up|4|||
130177410|NCT02932462|468605906|FG001|Overall Study|Lost to Follow-up|1|||
130177411|NCT02932462|468605905|FG000|Overall Study|Protocol Violation|0|||
130177412|NCT02932462|468605906|FG001|Overall Study|Protocol Violation|5|||
130177413|NCT02932462|468605905|FG000|Overall Study|Withdrawal by Subject|1|||
130177414|NCT02932462|468605906|FG001|Overall Study|Withdrawal by Subject|4|||
130177415|NCT02932462|468605905|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130177416|NCT02932462|468605906|FG001|Overall Study|Non-Compliance With Study Drug|1|||
130177417|NCT02932462|468605905|FG000|Overall Study|Progressive Disease|1|||
130177418|NCT02932462|468605906|FG001|Overall Study|Progressive Disease|0|||
130177419|NCT02652949|468605907|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
130177420|NCT02652949|468605907|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
130177421|NCT02652949|468605907|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
130177422|NCT02652949|468605907|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130177423|NCT02652949|468605907|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130177424|NCT02652949|468605907|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
130177425|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
130177426|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
130177427|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
130177428|NCT02652949|468605907|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
130177429|NCT02652949|468605907|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
130177430|NCT02652949|468605907|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
130177431|NCT02652949|468605907|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
130177432|NCT02652949|468605907|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
130177433|NCT02652949|468605907|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130177434|NCT02652949|468605907|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
130177435|NCT02652949|468605907|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
130177436|NCT00280735|468605917|FG000|Overall Study|Adverse Event|5|||
130177437|NCT00280735|468605917|FG000|Overall Study|Lack of Efficacy|3|||
130177438|NCT00280735|468605917|FG000|Overall Study|Withdrawal by Subject|8|||
130177439|NCT00280735|468605917|FG000|Overall Study|Intercurrent Illness|2|||
130177440|NCT04753216|468605918|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
130177441|NCT04753216|468605918|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
130177442|NCT04753216|468605918|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
130177443|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
130177444|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Death|1|||
130177445|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
130177446|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
130177447|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
130177448|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
130177449|NCT02001987|468605920|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
130177450|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
130177451|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
130177452|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
130177453|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
130177454|NCT02001987|468605920|FG000|LTE Period (52 Weeks)|Other|3|||
130177455|NCT01895777|468605921|FG000|Overall Study|Adverse Event|1|||
130177456|NCT01895777|468605922|FG001|Overall Study|Adverse Event|2|||
130177457|NCT01895777|468605921|FG000|Overall Study|Lost to Follow-up|2|||
130177458|NCT01895777|468605922|FG001|Overall Study|Lost to Follow-up|0|||
130177459|NCT01895777|468605921|FG000|Overall Study|Not treated|1|||
130177460|NCT01895777|468605922|FG001|Overall Study|Not treated|0|||
130177461|NCT01895777|468605921|FG000|Overall Study|Other reasons|3|||
130177462|NCT01895777|468605922|FG001|Overall Study|Other reasons|2|||
130177463|NCT01895777|468605921|FG000|Overall Study|Non-compliance with the CTP|2|||
130177464|NCT01895777|468605922|FG001|Overall Study|Non-compliance with the CTP|1|||
130177465|NCT01965860|468605923|FG000|Overall Study|Pregnancy|1|||
130177466|NCT01965860|468605924|FG001|Overall Study|Pregnancy|0|||
130177467|NCT01965860|468605925|FG002|Overall Study|Pregnancy|1|||
130177468|NCT01965860|468605923|FG000|Overall Study|Logistics|1|||
130177469|NCT01965860|468605924|FG001|Overall Study|Logistics|0|||
130177470|NCT01965860|468605925|FG002|Overall Study|Logistics|0|||
130177471|NCT03735121|468605929|FG000|Overall Study|Death|3|||
130177472|NCT03735121|468605930|FG001|Overall Study|Death|6|||
130177473|NCT03735121|468605931|FG002|Overall Study|Death|8|||
130177474|NCT03735121|468605932|FG003|Overall Study|Death|37|||
130177475|NCT03735121|468605933|FG004|Overall Study|Death|86|||
130177476|NCT03735121|468605929|FG000|Overall Study|Withdrawal by Subject|1|||
130177477|NCT03735121|468605930|FG001|Overall Study|Withdrawal by Subject|1|||
130177478|NCT03735121|468605931|FG002|Overall Study|Withdrawal by Subject|3|||
130177479|NCT03735121|468605932|FG003|Overall Study|Withdrawal by Subject|4|||
130177480|NCT03735121|468605933|FG004|Overall Study|Withdrawal by Subject|2|||
130177481|NCT03735121|468605929|FG000|Overall Study|Progressive Disease|0|||
130177482|NCT03735121|468605930|FG001|Overall Study|Progressive Disease|0|||
130177483|NCT03735121|468605931|FG002|Overall Study|Progressive Disease|1|||
130177484|NCT03735121|468605932|FG003|Overall Study|Progressive Disease|0|||
130177485|NCT03735121|468605933|FG004|Overall Study|Progressive Disease|0|||
130177486|NCT03735121|468605929|FG000|Overall Study|Lost to Follow-up|0|||
130177487|NCT03735121|468605930|FG001|Overall Study|Lost to Follow-up|0|||
130177488|NCT03735121|468605931|FG002|Overall Study|Lost to Follow-up|0|||
130177489|NCT03735121|468605932|FG003|Overall Study|Lost to Follow-up|0|||
130177490|NCT03735121|468605933|FG004|Overall Study|Lost to Follow-up|1|||
130177491|NCT03735121|468605929|FG000|Overall Study|Ongoing|3|||
130177492|NCT03735121|468605930|FG001|Overall Study|Ongoing|3|||
130177493|NCT03735121|468605931|FG002|Overall Study|Ongoing|26|||
130177494|NCT03735121|468605932|FG003|Overall Study|Ongoing|83|||
130177495|NCT03735121|468605933|FG004|Overall Study|Ongoing|158|||
130177496|NCT00344448|468605934|FG000|Screening|Withdrawal by Subject|0|||
130177497|NCT00344448|468605935|FG001|Screening|Withdrawal by Subject|1|||
130177498|NCT00344448|468605934|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
130177499|NCT00344448|468605935|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
130177500|NCT00344448|468605934|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
130177501|NCT00344448|468605935|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
130177502|NCT00344448|468605934|FG000|Open Label|Withdrawal by Subject|1|||
130177503|NCT00344448|468605935|FG001|Open Label|Withdrawal by Subject|1|||
130177504|NCT00344448|468605934|FG000|Open Label|Study terminated|1|||
130177505|NCT00344448|468605935|FG001|Open Label|Study terminated|0|||
130177506|NCT03138655|468605937|FG000|Overall Study|Adverse Event|2|||
130177507|NCT03138655|468605938|FG001|Overall Study|Adverse Event|1|||
130177508|NCT03138655|468605939|FG002|Overall Study|Adverse Event|2|||
130177509|NCT03138655|468605940|FG003|Overall Study|Adverse Event|1|||
130177510|NCT03138655|468605941|FG004|Overall Study|Adverse Event|1|||
130177511|NCT03138655|468605942|FG005|Overall Study|Adverse Event|4|||
130177512|NCT03138655|468605943|FG006|Overall Study|Adverse Event|2|||
130177513|NCT03138655|468605944|FG007|Overall Study|Adverse Event|2|||
130177514|NCT03138655|468605937|FG000|Overall Study|Withdrawal by Subject|0|||
130177515|NCT03138655|468605938|FG001|Overall Study|Withdrawal by Subject|1|||
130177516|NCT03138655|468605939|FG002|Overall Study|Withdrawal by Subject|0|||
130177517|NCT03138655|468605940|FG003|Overall Study|Withdrawal by Subject|0|||
130177518|NCT03138655|468605941|FG004|Overall Study|Withdrawal by Subject|0|||
130177519|NCT03138655|468605942|FG005|Overall Study|Withdrawal by Subject|0|||
130177520|NCT03138655|468605943|FG006|Overall Study|Withdrawal by Subject|1|||
130177521|NCT03138655|468605944|FG007|Overall Study|Withdrawal by Subject|0|||
130177522|NCT03138655|468605937|FG000|Overall Study|Reason not Specified|1|||
130177523|NCT03138655|468605938|FG001|Overall Study|Reason not Specified|0|||
130177524|NCT03138655|468605939|FG002|Overall Study|Reason not Specified|0|||
130177525|NCT03138655|468605940|FG003|Overall Study|Reason not Specified|2|||
130177526|NCT03138655|468605941|FG004|Overall Study|Reason not Specified|1|||
130177527|NCT03138655|468605942|FG005|Overall Study|Reason not Specified|1|||
130177528|NCT03138655|468605943|FG006|Overall Study|Reason not Specified|0|||
130177529|NCT03138655|468605944|FG007|Overall Study|Reason not Specified|0|||
130177530|NCT02565511|468605945|FG000|Overall Study|Study terminated by Sponsor|35|||
130177531|NCT02565511|468605946|FG001|Overall Study|Study terminated by Sponsor|22|||
130177532|NCT02565511|468605947|FG002|Overall Study|Study terminated by Sponsor|235|||
130177533|NCT02565511|468605948|FG003|Overall Study|Study terminated by Sponsor|156|||
130177534|NCT02565511|468605945|FG000|Overall Study|Withdrawal by Subject|3|||
130177535|NCT02565511|468605946|FG001|Overall Study|Withdrawal by Subject|0|||
130177536|NCT02565511|468605947|FG002|Overall Study|Withdrawal by Subject|12|||
130177537|NCT02565511|468605948|FG003|Overall Study|Withdrawal by Subject|5|||
130177538|NCT02565511|468605945|FG000|Overall Study|Adverse Event|0|||
130177539|NCT02565511|468605946|FG001|Overall Study|Adverse Event|0|||
130177540|NCT02565511|468605947|FG002|Overall Study|Adverse Event|1|||
130177541|NCT02565511|468605948|FG003|Overall Study|Adverse Event|1|||
130177542|NCT02565511|468605945|FG000|Overall Study|Lost to Follow-up|4|||
130177543|NCT02565511|468605946|FG001|Overall Study|Lost to Follow-up|1|||
130177544|NCT02565511|468605947|FG002|Overall Study|Lost to Follow-up|0|||
130177545|NCT02565511|468605948|FG003|Overall Study|Lost to Follow-up|1|||
130177546|NCT02565511|468605945|FG000|Overall Study|Physician Decision|0|||
130177547|NCT02565511|468605946|FG001|Overall Study|Physician Decision|0|||
130177548|NCT02565511|468605947|FG002|Overall Study|Physician Decision|0|||
130177549|NCT02565511|468605948|FG003|Overall Study|Physician Decision|1|||
130177550|NCT02565511|468605945|FG000|Overall Study|Protocol deviation|0|||
130177551|NCT02565511|468605946|FG001|Overall Study|Protocol deviation|0|||
130177552|NCT02565511|468605947|FG002|Overall Study|Protocol deviation|3|||
130177553|NCT02565511|468605948|FG003|Overall Study|Protocol deviation|0|||
130177554|NCT03656744|468605951|FG000|Overall Study|Adverse Event|1|||
130177555|NCT03656744|468605952|FG001|Overall Study|Adverse Event|4|||
130177556|NCT03656744|468605953|FG002|Overall Study|Adverse Event|1|||
130177557|NCT03656744|468605951|FG000|Overall Study|Protocol Violation|1|||
130177558|NCT03656744|468605952|FG001|Overall Study|Protocol Violation|0|||
130177559|NCT03656744|468605953|FG002|Overall Study|Protocol Violation|0|||
130177560|NCT03656744|468605951|FG000|Overall Study|Lost to Follow-up|2|||
130177561|NCT03656744|468605952|FG001|Overall Study|Lost to Follow-up|2|||
130177562|NCT03656744|468605953|FG002|Overall Study|Lost to Follow-up|0|||
130177563|NCT03656744|468605951|FG000|Overall Study|Withdrawal by Subject|0|||
130177564|NCT03656744|468605952|FG001|Overall Study|Withdrawal by Subject|1|||
130177565|NCT03656744|468605953|FG002|Overall Study|Withdrawal by Subject|0|||
130177566|NCT03656744|468605951|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
130177567|NCT03656744|468605952|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
130177568|NCT03656744|468605953|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
130177569|NCT00098774|468605957|FG000|Overall Study|Adverse Event|2|||
130177570|NCT00098774|468605957|FG000|Overall Study|Disease Progression|9|||
130177571|NCT00098774|468605957|FG000|Overall Study|Withdrawal by Subject|1|||
130177572|NCT00098774|468605957|FG000|Overall Study|Failed (to respond) during induction|4|||
130177573|NCT00098774|468605957|FG000|Overall Study|Physician Decision|2|||
130177574|NCT03910673|468605958|FG000|Overall Study|Adverse Event|0|||
130177575|NCT03910673|468605959|FG001|Overall Study|Adverse Event|0|||
130177576|NCT03910673|468605960|FG002|Overall Study|Adverse Event|0|||
130177577|NCT03910673|468605961|FG003|Overall Study|Adverse Event|2|||
130177578|NCT03910673|468605962|FG004|Overall Study|Adverse Event|0|||
130177579|NCT00796757|468605963|FG000|Overall Study|Withdrawal by Subject|14|||
130177580|NCT00796757|468605963|FG000|Overall Study|Death|61|||
130177581|NCT00796757|468605963|FG000|Overall Study|Protocol Violation|1|||
130177582|NCT00796757|468605963|FG000|Overall Study|Participant noncompliance|1|||
130177583|NCT00796757|468605963|FG000|Overall Study|Investigator's decision|2|||
130177584|NCT00796757|468605963|FG000|Overall Study|Other|7|||
130177585|NCT01277211|468605964|FG000|Overall Study|Adverse Event|60|||
130177586|NCT01277211|468605965|FG001|Overall Study|Adverse Event|22|||
130177587|NCT01277211|468605964|FG000|Overall Study|Pregnancy|9|||
130177588|NCT01277211|468605965|FG001|Overall Study|Pregnancy|4|||
130177589|NCT01277211|468605964|FG000|Overall Study|Lost to Follow-up|14|||
130177590|NCT01277211|468605965|FG001|Overall Study|Lost to Follow-up|9|||
130177591|NCT01277211|468605964|FG000|Overall Study|Did not wish to continue|17|||
130177592|NCT01277211|468605965|FG001|Overall Study|Did not wish to continue|0|||
130177593|NCT01277211|468605964|FG000|Overall Study|Withdrew Consent|9|||
130177594|NCT01277211|468605965|FG001|Overall Study|Withdrew Consent|9|||
130177595|NCT01277211|468605964|FG000|Overall Study|Non-compliance with protocol|13|||
130177596|NCT01277211|468605965|FG001|Overall Study|Non-compliance with protocol|4|||
130177597|NCT01277211|468605964|FG000|Overall Study|Did not meet protocol eligibility|1|||
130177598|NCT01277211|468605965|FG001|Overall Study|Did not meet protocol eligibility|0|||
130177599|NCT01277211|468605964|FG000|Overall Study|Administrative|3|||
130177600|NCT01277211|468605965|FG001|Overall Study|Administrative|0|||
130177601|NCT01277211|468605964|FG000|Overall Study|Pregnancy wish|0|||
130177602|NCT01277211|468605965|FG001|Overall Study|Pregnancy wish|2|||
130177603|NCT01277211|468605964|FG000|Overall Study|Discontinued prior to treatment|24|||
130177604|NCT01277211|468605965|FG001|Overall Study|Discontinued prior to treatment|13|||
130177605|NCT00879086|468605966|FG000|Overall Study|Adverse Event|3|||
130177606|NCT00879086|468605967|FG001|Overall Study|Adverse Event|15|||
130177607|NCT00879086|468605966|FG000|Overall Study|Participant choice|2|||
130177608|NCT00879086|468605967|FG001|Overall Study|Participant choice|2|||
130177609|NCT00879086|468605966|FG000|Overall Study|Progression of disease|40|||
130177610|NCT00879086|468605967|FG001|Overall Study|Progression of disease|26|||
130177611|NCT00879086|468605966|FG000|Overall Study|Withdrawal of consent|2|||
130177612|NCT00879086|468605967|FG001|Overall Study|Withdrawal of consent|1|||
130177613|NCT00879086|468605966|FG000|Overall Study|Other|4|||
130177614|NCT00879086|468605967|FG001|Overall Study|Other|6|||
130177615|NCT00879086|468605966|FG000|Overall Study|Death|1|||
130177616|NCT00879086|468605967|FG001|Overall Study|Death|2|||
130177617|NCT01487525|468605968|FG000|Overall Study|Withdrawal by Subject|0|||
130177618|NCT01487525|468605969|FG001|Overall Study|Withdrawal by Subject|1|||
130177619|NCT01855828|468605970|FG000|Overall Study|Adverse Event|1|||
130177620|NCT01855828|468605970|FG000|Overall Study|Withdrawal by Subject|1|||
130177621|NCT01866098|468605971|FG000|Overall Study|Lost to Follow-up|11|||
130177622|NCT01866098|468605972|FG001|Overall Study|Lost to Follow-up|18|||
130177623|NCT01866098|468605973|FG002|Overall Study|Lost to Follow-up|13|||
130177624|NCT01866098|468605971|FG000|Overall Study|Physician Decision|0|||
130177625|NCT01866098|468605972|FG001|Overall Study|Physician Decision|1|||
130177626|NCT01866098|468605973|FG002|Overall Study|Physician Decision|2|||
130177627|NCT01866098|468605971|FG000|Overall Study|Adverse Event|1|||
130177628|NCT01866098|468605972|FG001|Overall Study|Adverse Event|5|||
130177629|NCT01866098|468605973|FG002|Overall Study|Adverse Event|4|||
130177630|NCT01866098|468605971|FG000|Overall Study|Protocol Violation|1|||
130177631|NCT01866098|468605972|FG001|Overall Study|Protocol Violation|0|||
130177632|NCT01866098|468605973|FG002|Overall Study|Protocol Violation|0|||
130177633|NCT01866098|468605971|FG000|Overall Study|Withdrawal by Subject|1|||
130177634|NCT01866098|468605972|FG001|Overall Study|Withdrawal by Subject|2|||
130177635|NCT01866098|468605973|FG002|Overall Study|Withdrawal by Subject|0|||
130177636|NCT01866098|468605971|FG000|Overall Study|Unrelated Hospitalization|2|||
130177637|NCT01866098|468605972|FG001|Overall Study|Unrelated Hospitalization|0|||
130177638|NCT01866098|468605973|FG002|Overall Study|Unrelated Hospitalization|1|||
130177639|NCT01866098|468605971|FG000|Overall Study|Non-compliance|1|||
130177640|NCT01866098|468605972|FG001|Overall Study|Non-compliance|0|||
130177641|NCT01866098|468605973|FG002|Overall Study|Non-compliance|1|||
130177642|NCT01866098|468605971|FG000|Overall Study|Pregnancy|2|||
130177643|NCT01866098|468605972|FG001|Overall Study|Pregnancy|0|||
130177644|NCT01866098|468605973|FG002|Overall Study|Pregnancy|0|||
130177645|NCT01866098|468605971|FG000|Overall Study|Death|0|||
130177646|NCT01866098|468605972|FG001|Overall Study|Death|1|||
130177647|NCT01866098|468605973|FG002|Overall Study|Death|0|||
130177648|NCT03449446|468605984|FG000|Overall Study|Randomized but Never Treated|0|||
130177649|NCT03449446|468605985|FG001|Overall Study|Randomized but Never Treated|0|||
130177650|NCT03449446|468605986|FG002|Overall Study|Randomized but Never Treated|1|||
130177651|NCT03449446|468605987|FG003|Overall Study|Randomized but Never Treated|1|||
130177652|NCT03449446|468605988|FG004|Overall Study|Randomized but Never Treated|1|||
130177653|NCT03449446|468605989|FG005|Overall Study|Randomized but Never Treated|0|||
130177654|NCT03449446|468605990|FG006|Overall Study|Randomized but Never Treated|0|||
130177655|NCT03449446|468605984|FG000|Overall Study|Unknown Reason|33|||
130177656|NCT03449446|468605985|FG001|Overall Study|Unknown Reason|1|||
130177657|NCT03449446|468605986|FG002|Overall Study|Unknown Reason|1|||
130177658|NCT03449446|468605987|FG003|Overall Study|Unknown Reason|1|||
130177659|NCT03449446|468605988|FG004|Overall Study|Unknown Reason|2|||
130177660|NCT03449446|468605989|FG005|Overall Study|Unknown Reason|2|||
130177661|NCT03449446|468605990|FG006|Overall Study|Unknown Reason|0|||
130177662|NCT03449446|468605984|FG000|Overall Study|Withdrew Consent|1|||
130177663|NCT03449446|468605985|FG001|Overall Study|Withdrew Consent|3|||
130177664|NCT03449446|468605986|FG002|Overall Study|Withdrew Consent|1|||
130177665|NCT03449446|468605987|FG003|Overall Study|Withdrew Consent|4|||
130177666|NCT03449446|468605988|FG004|Overall Study|Withdrew Consent|4|||
130177667|NCT03449446|468605989|FG005|Overall Study|Withdrew Consent|4|||
130177668|NCT03449446|468605990|FG006|Overall Study|Withdrew Consent|1|||
130177669|NCT03449446|468605984|FG000|Overall Study|Adverse Event|1|||
130177670|NCT03449446|468605985|FG001|Overall Study|Adverse Event|2|||
130177671|NCT03449446|468605986|FG002|Overall Study|Adverse Event|1|||
130177672|NCT03449446|468605987|FG003|Overall Study|Adverse Event|0|||
130177673|NCT03449446|468605988|FG004|Overall Study|Adverse Event|0|||
130177674|NCT03449446|468605989|FG005|Overall Study|Adverse Event|2|||
130177675|NCT03449446|468605990|FG006|Overall Study|Adverse Event|0|||
130177676|NCT03449446|468605984|FG000|Overall Study|Lost to Follow-up|0|||
130177677|NCT03449446|468605985|FG001|Overall Study|Lost to Follow-up|0|||
130177678|NCT03449446|468605986|FG002|Overall Study|Lost to Follow-up|2|||
130177679|NCT03449446|468605987|FG003|Overall Study|Lost to Follow-up|1|||
130177680|NCT03449446|468605988|FG004|Overall Study|Lost to Follow-up|3|||
130177681|NCT03449446|468605989|FG005|Overall Study|Lost to Follow-up|0|||
130177682|NCT03449446|468605990|FG006|Overall Study|Lost to Follow-up|0|||
130177683|NCT03449446|468605984|FG000|Overall Study|Investigator's Discretion|0|||
130177684|NCT03449446|468605985|FG001|Overall Study|Investigator's Discretion|1|||
130177685|NCT03449446|468605986|FG002|Overall Study|Investigator's Discretion|1|||
130177686|NCT03449446|468605987|FG003|Overall Study|Investigator's Discretion|2|||
130177687|NCT03449446|468605988|FG004|Overall Study|Investigator's Discretion|0|||
130177688|NCT03449446|468605989|FG005|Overall Study|Investigator's Discretion|0|||
130177689|NCT03449446|468605990|FG006|Overall Study|Investigator's Discretion|0|||
130177690|NCT03449446|468605984|FG000|Overall Study|Non Compliance with Study Drug|1|||
130177691|NCT03449446|468605985|FG001|Overall Study|Non Compliance with Study Drug|0|||
129982847|NCT00307684|467900636|FG002|Open Label Phase|Adverse Event|16|||
129982848|NCT00307684|467900634|FG000|Open Label Phase|Withdrawal by Subject|0|||
129982849|NCT00307684|467900635|FG001|Open Label Phase|Withdrawal by Subject|0|||
129982850|NCT00307684|467900636|FG002|Open Label Phase|Withdrawal by Subject|15|||
129982851|NCT00307684|467900634|FG000|Open Label Phase|Lost to Follow-up|0|||
129982852|NCT00307684|467900635|FG001|Open Label Phase|Lost to Follow-up|0|||
129982853|NCT00307684|467900636|FG002|Open Label Phase|Lost to Follow-up|11|||
129982854|NCT00307684|467900634|FG000|Open Label Phase|non compliance|0|||
129982855|NCT00307684|467900635|FG001|Open Label Phase|non compliance|0|||
129982856|NCT00307684|467900636|FG002|Open Label Phase|non compliance|5|||
129982857|NCT00307684|467900634|FG000|Open Label Phase|other|0|||
129982858|NCT00307684|467900635|FG001|Open Label Phase|other|0|||
129982859|NCT00307684|467900636|FG002|Open Label Phase|other|6|||
129982860|NCT00307684|467900634|FG000|Double Blind Phase|Lack of Efficacy|2|||
129982861|NCT00307684|467900635|FG001|Double Blind Phase|Lack of Efficacy|5|||
129982862|NCT00307684|467900636|FG002|Double Blind Phase|Lack of Efficacy|0|||
129982863|NCT02580305|467900637|FG000|Overall Study|Adverse Event|15|||
129982864|NCT02580305|467900638|FG001|Overall Study|Adverse Event|19|||
129982865|NCT02580305|467900639|FG002|Overall Study|Adverse Event|10|||
129982866|NCT02580305|467900637|FG000|Overall Study|Lack of Efficacy|5|||
129982867|NCT02580305|467900638|FG001|Overall Study|Lack of Efficacy|0|||
129982868|NCT02580305|467900639|FG002|Overall Study|Lack of Efficacy|2|||
129982869|NCT02580305|467900637|FG000|Overall Study|Protocol Violation|4|||
129982870|NCT02580305|467900638|FG001|Overall Study|Protocol Violation|9|||
129982871|NCT02580305|467900639|FG002|Overall Study|Protocol Violation|6|||
129982872|NCT02580305|467900637|FG000|Overall Study|Lost to Follow-up|4|||
129982873|NCT02580305|467900638|FG001|Overall Study|Lost to Follow-up|4|||
130177692|NCT03449446|468605986|FG002|Overall Study|Non Compliance with Study Drug|0|||
129982874|NCT02580305|467900639|FG002|Overall Study|Lost to Follow-up|2|||
129982875|NCT02580305|467900637|FG000|Overall Study|Withdrawal by Subject|11|||
129982876|NCT02580305|467900638|FG001|Overall Study|Withdrawal by Subject|9|||
129982877|NCT02580305|467900639|FG002|Overall Study|Withdrawal by Subject|7|||
129982878|NCT02580305|467900637|FG000|Overall Study|Randomized in error and never treated|4|||
129982879|NCT02580305|467900638|FG001|Overall Study|Randomized in error and never treated|8|||
129982880|NCT02580305|467900639|FG002|Overall Study|Randomized in error and never treated|5|||
130177693|NCT03449446|468605987|FG003|Overall Study|Non Compliance with Study Drug|0|||
130177694|NCT03449446|468605988|FG004|Overall Study|Non Compliance with Study Drug|0|||
130177695|NCT03449446|468605989|FG005|Overall Study|Non Compliance with Study Drug|0|||
130177696|NCT03449446|468605990|FG006|Overall Study|Non Compliance with Study Drug|0|||
130177697|NCT03449446|468605984|FG000|Overall Study|Protocol Violation|0|||
130177698|NCT03449446|468605985|FG001|Overall Study|Protocol Violation|0|||
130177699|NCT03449446|468605986|FG002|Overall Study|Protocol Violation|0|||
130177700|NCT03449446|468605987|FG003|Overall Study|Protocol Violation|0|||
130177701|NCT03449446|468605988|FG004|Overall Study|Protocol Violation|1|||
130177702|NCT03449446|468605989|FG005|Overall Study|Protocol Violation|1|||
130177703|NCT03449446|468605990|FG006|Overall Study|Protocol Violation|0|||
130177704|NCT03449446|468605984|FG000|Overall Study|Death|0|||
130177705|NCT03449446|468605985|FG001|Overall Study|Death|0|||
130177706|NCT03449446|468605986|FG002|Overall Study|Death|0|||
130177707|NCT03449446|468605987|FG003|Overall Study|Death|0|||
130177708|NCT03449446|468605988|FG004|Overall Study|Death|1|||
130177709|NCT03449446|468605989|FG005|Overall Study|Death|0|||
130177710|NCT03449446|468605990|FG006|Overall Study|Death|0|||
130177711|NCT01450683|468606011|FG000|Overall Study|Adverse Event|2|||
130177712|NCT02108912|468606013|FG000|Overall Study|Lost to Follow-up|1|||
130177713|NCT02108912|468606014|FG001|Overall Study|Lost to Follow-up|1|||
130177714|NCT02108912|468606013|FG000|Overall Study|lack of transportation|1|||
130177715|NCT02108912|468606014|FG001|Overall Study|lack of transportation|0|||
130177716|NCT02108912|468606013|FG000|Overall Study|high blood pressure|1|||
130177717|NCT02108912|468606014|FG001|Overall Study|high blood pressure|0|||
130177718|NCT01950390|468606020|FG000|Overall Study|Never started treatment|3|||
130177719|NCT01950390|468606021|FG001|Overall Study|Never started treatment|2|||
130177720|NCT01950390|468606020|FG000|Overall Study|Disease progression|45|||
130177721|NCT01950390|468606021|FG001|Overall Study|Disease progression|52|||
130177722|NCT01950390|468606020|FG000|Overall Study|Adverse Event|22|||
130177723|NCT01950390|468606021|FG001|Overall Study|Adverse Event|16|||
130177724|NCT01950390|468606020|FG000|Overall Study|Death|5|||
130177725|NCT01950390|468606021|FG001|Overall Study|Death|3|||
130177726|NCT01950390|468606020|FG000|Overall Study|Withdrawal by Subject|5|||
130177727|NCT01950390|468606021|FG001|Overall Study|Withdrawal by Subject|1|||
130177728|NCT01950390|468606020|FG000|Overall Study|Alternative therapy|0|||
130177729|NCT01950390|468606021|FG001|Overall Study|Alternative therapy|3|||
130177730|NCT01950390|468606020|FG000|Overall Study|Complicating disease|1|||
130177731|NCT01950390|468606021|FG001|Overall Study|Complicating disease|0|||
130177732|NCT01950390|468606020|FG000|Overall Study|On treatment|1|||
130177733|NCT01950390|468606021|FG001|Overall Study|On treatment|0|||
130177734|NCT01950390|468606020|FG000|Overall Study|Symptomatic deterioration|2|||
130177735|NCT01950390|468606021|FG001|Overall Study|Symptomatic deterioration|1|||
130177736|NCT01950390|468606020|FG000|Overall Study|Physician Decision|0|||
130177737|NCT01950390|468606021|FG001|Overall Study|Physician Decision|4|||
130177738|NCT01950390|468606020|FG000|Overall Study|Lack of clinical benefit|0|||
130177739|NCT01950390|468606021|FG001|Overall Study|Lack of clinical benefit|1|||
130177740|NCT01950390|468606020|FG000|Overall Study|Maintained PR and moved to observation only|0|||
130177741|NCT01950390|468606021|FG001|Overall Study|Maintained PR and moved to observation only|1|||
130177742|NCT01682811|468606022|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177743|NCT01682811|468606023|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177744|NCT01682811|468606024|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177745|NCT01682811|468606025|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177746|NCT01682811|468606026|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
130177747|NCT01682811|468606027|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177748|NCT01682811|468606028|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
130177749|NCT01682811|468606022|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
130177750|NCT01682811|468606023|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
130177751|NCT01682811|468606024|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
130177752|NCT01682811|468606025|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
130177753|NCT01682811|468606026|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
130177754|NCT01682811|468606027|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
130177755|NCT01682811|468606028|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
130177756|NCT01682811|468606022|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177757|NCT01682811|468606023|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177758|NCT01682811|468606024|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177759|NCT01682811|468606025|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177760|NCT01682811|468606026|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
130177761|NCT01682811|468606027|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177762|NCT01682811|468606028|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
130177763|NCT01682811|468606022|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177764|NCT01682811|468606023|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177765|NCT01682811|468606024|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177766|NCT01682811|468606025|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177767|NCT01682811|468606026|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177768|NCT01682811|468606027|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
130177769|NCT01682811|468606028|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
130177770|NCT01128179|468606029|FG000|Overall Study|Death|1|||
130177771|NCT01128179|468606030|FG001|Overall Study|Death|0|||
130177772|NCT01128179|468606029|FG000|Overall Study|Protocol Violation|1|||
130177773|NCT01128179|468606030|FG001|Overall Study|Protocol Violation|0|||
130177774|NCT05192889|468606031|FG000|Block 1: All Eligible Patients|Death|2|||
130177775|NCT05192889|468606032|FG001|Block 1: All Eligible Patients|Death|0|||
130177776|NCT05192889|468606033|FG002|Block 1: All Eligible Patients|Death|0|||
130177777|NCT05192889|468606031|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
130177778|NCT05192889|468606032|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
130177779|NCT05192889|468606033|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
130177780|NCT05192889|468606031|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
130177781|NCT05192889|468606032|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
130177782|NCT05192889|468606033|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
130177783|NCT02731638|468608156|FG000|Overall Study|Lost to Follow-up|6|||
130177784|NCT02731638|468608157|FG001|Overall Study|Lost to Follow-up|9|||
130177785|NCT03284723|468608158|FG000|Overall Study|Death|0|||
130177786|NCT03284723|468608159|FG001|Overall Study|Death|0|||
130177787|NCT03284723|468608160|FG002|Overall Study|Death|0|||
130177788|NCT03284723|468608161|FG003|Overall Study|Death|1|||
130177789|NCT03284723|468608162|FG004|Overall Study|Death|0|||
130177790|NCT03284723|468608163|FG005|Overall Study|Death|0|||
130177791|NCT03284723|468608164|FG006|Overall Study|Death|1|||
130177792|NCT03284723|468608165|FG007|Overall Study|Death|0|||
130177793|NCT03284723|468608166|FG008|Overall Study|Death|0|||
130177794|NCT03284723|468608167|FG009|Overall Study|Death|2|||
130177795|NCT03284723|468608168|FG010|Overall Study|Death|1|||
130177796|NCT03284723|468608169|FG011|Overall Study|Death|0|||
130177797|NCT03284723|468608158|FG000|Overall Study|Lost to Follow-up|0|||
130177798|NCT03284723|468608159|FG001|Overall Study|Lost to Follow-up|0|||
130177799|NCT03284723|468608160|FG002|Overall Study|Lost to Follow-up|0|||
130177800|NCT03284723|468608161|FG003|Overall Study|Lost to Follow-up|0|||
130177801|NCT03284723|468608162|FG004|Overall Study|Lost to Follow-up|0|||
130177802|NCT03284723|468608163|FG005|Overall Study|Lost to Follow-up|2|||
130177803|NCT03284723|468608164|FG006|Overall Study|Lost to Follow-up|1|||
130177804|NCT03284723|468608165|FG007|Overall Study|Lost to Follow-up|0|||
130177805|NCT03284723|468608166|FG008|Overall Study|Lost to Follow-up|0|||
130177806|NCT03284723|468608167|FG009|Overall Study|Lost to Follow-up|2|||
130177807|NCT03284723|468608168|FG010|Overall Study|Lost to Follow-up|0|||
130177808|NCT03284723|468608169|FG011|Overall Study|Lost to Follow-up|0|||
130177809|NCT03284723|468608158|FG000|Overall Study|Study Terminated By Sponsor|0|||
130177810|NCT03284723|468608159|FG001|Overall Study|Study Terminated By Sponsor|0|||
130177811|NCT03284723|468608160|FG002|Overall Study|Study Terminated By Sponsor|0|||
130177812|NCT03284723|468608161|FG003|Overall Study|Study Terminated By Sponsor|0|||
130177813|NCT03284723|468608162|FG004|Overall Study|Study Terminated By Sponsor|1|||
130177814|NCT03284723|468608163|FG005|Overall Study|Study Terminated By Sponsor|0|||
130177815|NCT03284723|468608164|FG006|Overall Study|Study Terminated By Sponsor|0|||
130177816|NCT03284723|468608165|FG007|Overall Study|Study Terminated By Sponsor|0|||
130177817|NCT03284723|468608166|FG008|Overall Study|Study Terminated By Sponsor|1|||
130177818|NCT03284723|468608167|FG009|Overall Study|Study Terminated By Sponsor|1|||
130177819|NCT03284723|468608168|FG010|Overall Study|Study Terminated By Sponsor|1|||
130177820|NCT03284723|468608169|FG011|Overall Study|Study Terminated By Sponsor|1|||
130177821|NCT03284723|468608158|FG000|Overall Study|Withdrawal by Subject|0|||
130177822|NCT03284723|468608159|FG001|Overall Study|Withdrawal by Subject|0|||
130177823|NCT03284723|468608160|FG002|Overall Study|Withdrawal by Subject|0|||
130177824|NCT03284723|468608161|FG003|Overall Study|Withdrawal by Subject|0|||
130177825|NCT03284723|468608162|FG004|Overall Study|Withdrawal by Subject|5|||
130177826|NCT03284723|468608163|FG005|Overall Study|Withdrawal by Subject|3|||
130177827|NCT03284723|468608164|FG006|Overall Study|Withdrawal by Subject|1|||
130177828|NCT03284723|468608165|FG007|Overall Study|Withdrawal by Subject|0|||
130177829|NCT03284723|468608166|FG008|Overall Study|Withdrawal by Subject|6|||
130177830|NCT03284723|468608167|FG009|Overall Study|Withdrawal by Subject|0|||
130177831|NCT03284723|468608168|FG010|Overall Study|Withdrawal by Subject|3|||
130177832|NCT03284723|468608169|FG011|Overall Study|Withdrawal by Subject|1|||
130177833|NCT03284723|468608158|FG000|Overall Study|Other|1|||
130177834|NCT03284723|468608159|FG001|Overall Study|Other|0|||
129982881|NCT00224887|467900640|FG000|Overall Study|Pregnancy|6|||
130177835|NCT03284723|468608160|FG002|Overall Study|Other|1|||
130177836|NCT03284723|468608161|FG003|Overall Study|Other|0|||
130177837|NCT03284723|468608162|FG004|Overall Study|Other|1|||
130177838|NCT03284723|468608163|FG005|Overall Study|Other|0|||
130177839|NCT03284723|468608164|FG006|Overall Study|Other|0|||
130177840|NCT03284723|468608165|FG007|Overall Study|Other|0|||
130177841|NCT03284723|468608166|FG008|Overall Study|Other|0|||
130177842|NCT03284723|468608167|FG009|Overall Study|Other|0|||
130177843|NCT03284723|468608168|FG010|Overall Study|Other|1|||
130177844|NCT03284723|468608169|FG011|Overall Study|Other|0|||
130177845|NCT03284723|468608158|FG000|Overall Study|Adverse Event|0|||
130177846|NCT03284723|468608159|FG001|Overall Study|Adverse Event|0|||
130177847|NCT03284723|468608160|FG002|Overall Study|Adverse Event|0|||
130177848|NCT03284723|468608161|FG003|Overall Study|Adverse Event|0|||
130177849|NCT03284723|468608162|FG004|Overall Study|Adverse Event|0|||
130177850|NCT03284723|468608163|FG005|Overall Study|Adverse Event|0|||
130177851|NCT03284723|468608164|FG006|Overall Study|Adverse Event|0|||
130177852|NCT03284723|468608165|FG007|Overall Study|Adverse Event|0|||
130177853|NCT03284723|468608166|FG008|Overall Study|Adverse Event|1|||
130177854|NCT03284723|468608167|FG009|Overall Study|Adverse Event|0|||
130177855|NCT03284723|468608168|FG010|Overall Study|Adverse Event|0|||
130177856|NCT03284723|468608169|FG011|Overall Study|Adverse Event|0|||
130177857|NCT00615199|468608170|FG000|Overall Study|Adverse Event|3|||
130177858|NCT00615199|468608171|FG001|Overall Study|Adverse Event|1|||
130177859|NCT00615199|468608172|FG002|Overall Study|Adverse Event|1|||
130177860|NCT00615199|468608173|FG003|Overall Study|Adverse Event|0|||
130177861|NCT00615199|468608170|FG000|Overall Study|Lack of Efficacy|2|||
130177862|NCT00615199|468608171|FG001|Overall Study|Lack of Efficacy|0|||
130177863|NCT00615199|468608172|FG002|Overall Study|Lack of Efficacy|0|||
130177864|NCT00615199|468608173|FG003|Overall Study|Lack of Efficacy|1|||
130177865|NCT00615199|468608170|FG000|Overall Study|Lost to Follow-up|1|||
130177866|NCT00615199|468608171|FG001|Overall Study|Lost to Follow-up|0|||
130177867|NCT00615199|468608172|FG002|Overall Study|Lost to Follow-up|0|||
130177868|NCT00615199|468608173|FG003|Overall Study|Lost to Follow-up|0|||
130177869|NCT00615199|468608170|FG000|Overall Study|Other|0|||
130177870|NCT00615199|468608171|FG001|Overall Study|Other|0|||
130177871|NCT00615199|468608172|FG002|Overall Study|Other|0|||
130177872|NCT00615199|468608173|FG003|Overall Study|Other|1|||
130177873|NCT00615199|468608170|FG000|Overall Study|Withdrawal by Subject|2|||
130177874|NCT00615199|468608171|FG001|Overall Study|Withdrawal by Subject|1|||
130177875|NCT00615199|468608172|FG002|Overall Study|Withdrawal by Subject|0|||
130177876|NCT00615199|468608173|FG003|Overall Study|Withdrawal by Subject|0|||
130177877|NCT01499095|468608174|FG000|Overall Study|Randomized But Not Treated|1|||
130177878|NCT01499095|468608175|FG001|Overall Study|Randomized But Not Treated|1|||
130177879|NCT01499095|468608174|FG000|Overall Study|Adverse Event|12|||
130177880|NCT01499095|468608175|FG001|Overall Study|Adverse Event|7|||
130177881|NCT01499095|468608174|FG000|Overall Study|Lack of Efficacy|2|||
130177882|NCT01499095|468608175|FG001|Overall Study|Lack of Efficacy|1|||
130177883|NCT01499095|468608174|FG000|Overall Study|Protocol Violation|6|||
130177884|NCT01499095|468608175|FG001|Overall Study|Protocol Violation|7|||
130177885|NCT01499095|468608174|FG000|Overall Study|Received Rescue Therapy|32|||
130177886|NCT01499095|468608175|FG001|Overall Study|Received Rescue Therapy|40|||
130177887|NCT01499095|468608174|FG000|Overall Study|Diverse Reasons|22|||
130177888|NCT01499095|468608175|FG001|Overall Study|Diverse Reasons|25|||
130177889|NCT01499095|468608174|FG000|Overall Study|Lost to Follow-up|6|||
130177890|NCT01499095|468608175|FG001|Overall Study|Lost to Follow-up|4|||
130177891|NCT01499095|468608174|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
130177892|NCT01499095|468608175|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
130177893|NCT01499095|468608174|FG000|Overall Study|Hypoglycemia|3|||
130177894|NCT01499095|468608175|FG001|Overall Study|Hypoglycemia|1|||
130177895|NCT01499095|468608174|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
130177896|NCT01499095|468608175|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
130177897|NCT01499095|468608174|FG000|Overall Study|Change in Injection Schedule|2|||
130177898|NCT01499095|468608175|FG001|Overall Study|Change in Injection Schedule|0|||
130177899|NCT01499095|468608174|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130177900|NCT01499095|468608175|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130177901|NCT01811472|468608181|FG000|Overall Study|Adverse Event|1|||
130177902|NCT01811472|468608182|FG001|Overall Study|Adverse Event|0|||
130177903|NCT01811472|468608183|FG002|Overall Study|Adverse Event|4|||
130177904|NCT01811472|468608181|FG000|Overall Study|Lost to Follow-up|0|||
130177905|NCT01811472|468608182|FG001|Overall Study|Lost to Follow-up|0|||
130177906|NCT01811472|468608183|FG002|Overall Study|Lost to Follow-up|1|||
130177907|NCT01811472|468608181|FG000|Overall Study|Subject/guardian decision|1|||
130177908|NCT01811472|468608182|FG001|Overall Study|Subject/guardian decision|0|||
130177909|NCT01811472|468608183|FG002|Overall Study|Subject/guardian decision|0|||
130177910|NCT03280264|468608184|FG000|Overall Study|Adverse Event|1|||
130177911|NCT03280264|468608184|FG000|Overall Study|Physician Decision|1|||
130177912|NCT03280264|468608184|FG000|Overall Study|Withdrawal by Subject|1|||
130177913|NCT02738138|468608185|FG000|Overall Study|Adverse Event|0|||
130177914|NCT02738138|468608186|FG001|Overall Study|Adverse Event|1|||
130177915|NCT02738138|468608185|FG000|Overall Study|Lost to Follow-up|2|||
130177916|NCT02738138|468608186|FG001|Overall Study|Lost to Follow-up|0|||
130177917|NCT02738138|468608185|FG000|Overall Study|Other - not further specified|1|||
130177918|NCT02738138|468608186|FG001|Overall Study|Other - not further specified|0|||
130177919|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Other|34|||
130177920|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Other|0|||
130177921|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Other|0|||
130177922|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Other|0|||
130177923|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Death|14|||
130177924|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Death|0|||
130177925|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Death|0|||
130177926|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Death|0|||
130177927|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
130177928|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
130177929|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
130177930|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
130177931|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
130177932|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130177933|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130177934|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
130177935|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
130177936|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
130177937|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
130177938|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
130177939|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
130177940|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130177941|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130177942|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
130177943|NCT01995513|468608192|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
130177944|NCT01995513|468608193|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130177945|NCT01995513|468608194|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130177946|NCT01995513|468608195|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
130177947|NCT01995513|468608192|FG000|Period 1: Second Open Label Treatment|Other|0|||
130177948|NCT01995513|468608193|FG001|Period 1: Second Open Label Treatment|Other|2|||
130177949|NCT01995513|468608194|FG002|Period 1: Second Open Label Treatment|Other|0|||
130177950|NCT01995513|468608195|FG003|Period 1: Second Open Label Treatment|Other|0|||
130177951|NCT01995513|468608192|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
130177952|NCT01995513|468608193|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
130177953|NCT01995513|468608194|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
130177954|NCT01995513|468608195|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
130177955|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Death|0|||
130177956|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Death|0|||
130177957|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Death|0|||
130177958|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Death|1|||
130177959|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Other|0|||
130177960|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Other|0|||
130177961|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Other|3|||
130177962|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Other|3|||
130177963|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
130177964|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
130177965|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
130177966|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
130177967|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
130177968|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
130177969|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
130177970|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
130177971|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
130177972|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
130177973|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
130177974|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
130177975|NCT01995513|468608192|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130177976|NCT01995513|468608193|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130177977|NCT01995513|468608194|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
130177978|NCT01995513|468608195|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
130177979|NCT01232452|468608196|FG000|Overall Study|Adverse Event|17|||
130177980|NCT01232452|468608197|FG001|Overall Study|Adverse Event|15|||
130177981|NCT01232452|468608196|FG000|Overall Study|Withdrawal by Subject|11|||
130177982|NCT01232452|468608197|FG001|Overall Study|Withdrawal by Subject|8|||
130177983|NCT01232452|468608196|FG000|Overall Study|Physician Decision|8|||
130177984|NCT01232452|468608197|FG001|Overall Study|Physician Decision|12|||
129982882|NCT00224887|467900641|FG001|Overall Study|Pregnancy|6|||
129982883|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
129982884|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129982885|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
130177985|NCT01232452|468608196|FG000|Overall Study|Protocol entry criterion not met|0|||
130177986|NCT01232452|468608197|FG001|Overall Study|Protocol entry criterion not met|2|||
130177987|NCT01232452|468608196|FG000|Overall Study|Sponsor Decision|3|||
130177988|NCT01232452|468608197|FG001|Overall Study|Sponsor Decision|1|||
130177989|NCT01232452|468608196|FG000|Overall Study|Protocol Violation|0|||
130177990|NCT01232452|468608197|FG001|Overall Study|Protocol Violation|1|||
130177991|NCT04108299|468608199|FG000|Overall Study|Not interested in participating|2|||
130177992|NCT04108299|468608200|FG001|Overall Study|Not interested in participating|1|||
130177993|NCT04108299|468608201|FG002|Overall Study|Not interested in participating|2|||
130177994|NCT04108299|468608202|FG003|Overall Study|Not interested in participating|1|||
130177995|NCT00247676|468608203|FG000|Overall Study|Death|5|||
130177996|NCT00247676|468608203|FG000|Overall Study|Adverse Event|11|||
130177997|NCT00247676|468608203|FG000|Overall Study|Lack of Efficacy|15|||
129982886|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129982887|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129982888|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
129982889|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982890|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982891|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982892|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982893|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
129982894|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982895|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982896|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982897|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982898|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
129982899|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982900|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982901|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982902|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982903|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
129982904|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982905|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982906|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982907|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982908|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
129982909|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982910|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982911|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982912|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982913|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
129982914|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982915|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982916|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982917|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982918|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
129982919|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982920|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982921|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982922|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982923|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
129982924|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982925|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982926|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982927|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982928|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982929|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
129982930|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982931|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982932|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982933|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982934|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
129982935|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982936|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982937|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982938|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129982939|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
129982940|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129982941|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129982942|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
130177998|NCT00247676|468608203|FG000|Overall Study|Other|3|||
130177999|NCT00247676|468608203|FG000|Overall Study|Withdrawal by Subject|2|||
130178000|NCT05024747|468608204|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
130178001|NCT05024747|468608205|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
130178002|NCT05024747|468608204|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
130178003|NCT05024747|468608205|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
130178004|NCT05024747|468608204|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
130178005|NCT05024747|468608205|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
130178006|NCT00662649|468608206|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
130178007|NCT00662649|468608207|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
130178008|NCT00662649|468608208|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
130178009|NCT00662649|468608209|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
130178010|NCT00662649|468608210|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
130178011|NCT00662649|468608206|FG000|Core Study (24 Months)|Adverse Event|22|||
130178012|NCT00662649|468608207|FG001|Core Study (24 Months)|Adverse Event|13|||
130178013|NCT00662649|468608208|FG002|Core Study (24 Months)|Adverse Event|18|||
130178014|NCT00662649|468608209|FG003|Core Study (24 Months)|Adverse Event|0|||
130178015|NCT00662649|468608210|FG004|Core Study (24 Months)|Adverse Event|0|||
130178016|NCT00662649|468608206|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
130178017|NCT00662649|468608207|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
130178018|NCT00662649|468608208|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
130178019|NCT00662649|468608209|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
130178020|NCT00662649|468608210|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
130178021|NCT00662649|468608206|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
130178022|NCT00662649|468608207|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
130178023|NCT00662649|468608208|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
130178024|NCT00662649|468608209|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
130178025|NCT00662649|468608210|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
130178026|NCT00662649|468608206|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
130178027|NCT00662649|468608207|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
130178028|NCT00662649|468608208|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
130178029|NCT00662649|468608209|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
130178030|NCT00662649|468608210|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
130178031|NCT00662649|468608206|FG000|Core Study (24 Months)|Protocol Violation|5|||
130178032|NCT00662649|468608207|FG001|Core Study (24 Months)|Protocol Violation|5|||
130178033|NCT00662649|468608208|FG002|Core Study (24 Months)|Protocol Violation|4|||
130178034|NCT00662649|468608209|FG003|Core Study (24 Months)|Protocol Violation|0|||
130178035|NCT00662649|468608210|FG004|Core Study (24 Months)|Protocol Violation|0|||
130178036|NCT00662649|468608206|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
130178037|NCT00662649|468608207|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
130178038|NCT00662649|468608208|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
130178039|NCT00662649|468608209|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
130178040|NCT00662649|468608210|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
130178041|NCT00662649|468608206|FG000|Core Study (24 Months)|Death|1|||
130178042|NCT00662649|468608207|FG001|Core Study (24 Months)|Death|0|||
130178043|NCT00662649|468608208|FG002|Core Study (24 Months)|Death|2|||
130178044|NCT00662649|468608209|FG003|Core Study (24 Months)|Death|0|||
130178045|NCT00662649|468608210|FG004|Core Study (24 Months)|Death|0|||
130178046|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
130178047|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
130178048|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
130178049|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
130178050|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
130178051|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
130178052|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
130178053|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
130178054|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
130178055|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
130178056|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178057|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178058|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178059|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
130178060|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
130178061|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
130178062|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
130178063|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
130178064|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
130178065|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
130178066|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
130178067|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
130178068|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
130178069|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
130178070|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
130178071|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
130178072|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
130178073|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130178074|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130178075|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
130178076|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
130178077|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
130178078|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
130178079|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
130178080|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
130178081|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178082|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
130178083|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178084|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178085|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
130178086|NCT00662649|468608206|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
130178087|NCT00662649|468608207|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
130178088|NCT00662649|468608208|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
130178089|NCT00662649|468608209|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
130178090|NCT00662649|468608210|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
130178091|NCT02009722|468608217|FG000|Overall Study|Protocol Violation|1|||
130178092|NCT02009722|468608218|FG001|Overall Study|Protocol Violation|2|||
130178093|NCT02009722|468608217|FG000|Overall Study|Did not receive intervention|0|||
130178094|NCT02009722|468608218|FG001|Overall Study|Did not receive intervention|1|||
130178095|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
130178096|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
130178097|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
130178098|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
130178099|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
130178100|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
130178101|NCT02955212|468608219|FG000|Period 1: Double-blind Treatment Period|Other|3|||
130178102|NCT02955212|468608220|FG001|Period 1: Double-blind Treatment Period|Other|2|||
130178103|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Adverse Event|11|||
130178104|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Adverse Event|7|||
130178105|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
130178106|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
130178107|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
130178108|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
130178109|NCT02955212|468608219|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
130178110|NCT02955212|468608220|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
130178111|NCT02955212|468608219|FG000|Period 2: Open-label Extension|Other|2|||
130178112|NCT02955212|468608220|FG001|Period 2: Open-label Extension|Other|4|||
130178113|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Physician Decision|3|||
130178114|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
130178115|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Disease Progression|1|||
130178116|NCT00545714|468608221|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
130178117|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
130178118|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
130178119|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
130178120|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
130178121|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
130178122|NCT00545714|468608221|FG000|Maintenance Phase (36 Months)|Death|2|||
130178123|NCT04428034|468608226|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
130178124|NCT00560391|468608231|FG000|Overall Study|Still on treatment|0|||
130178125|NCT00560391|468608232|FG001|Overall Study|Still on treatment|0|||
130178126|NCT00560391|468608233|FG002|Overall Study|Still on treatment|0|||
130178127|NCT00560391|468608234|FG003|Overall Study|Still on treatment|1|||
130178128|NCT00560391|468608235|FG004|Overall Study|Still on treatment|2|||
130178129|NCT02556801|468608236|FG000|Overall Study|Lost to Follow-up|1|||
130178130|NCT02556801|468608237|FG001|Overall Study|Lost to Follow-up|0|||
130178131|NCT02556801|468608238|FG002|Overall Study|Lost to Follow-up|2|||
130178132|NCT02556801|468608239|FG003|Overall Study|Lost to Follow-up|0|||
130178133|NCT02556801|468608236|FG000|Overall Study|Withdrawal by Subject|1|||
130178134|NCT02556801|468608237|FG001|Overall Study|Withdrawal by Subject|1|||
130178135|NCT02556801|468608238|FG002|Overall Study|Withdrawal by Subject|1|||
130178136|NCT02556801|468608239|FG003|Overall Study|Withdrawal by Subject|0|||
130178137|NCT02556801|468608236|FG000|Overall Study|Protocol Violation|0|||
130178138|NCT02556801|468608237|FG001|Overall Study|Protocol Violation|3|||
130178139|NCT02556801|468608238|FG002|Overall Study|Protocol Violation|1|||
130178140|NCT02556801|468608239|FG003|Overall Study|Protocol Violation|1|||
130178141|NCT02556801|468608236|FG000|Overall Study|Adverse Event|0|||
130178142|NCT02556801|468608237|FG001|Overall Study|Adverse Event|2|||
130178143|NCT02556801|468608238|FG002|Overall Study|Adverse Event|0|||
130178144|NCT02556801|468608239|FG003|Overall Study|Adverse Event|3|||
130178145|NCT02556801|468608236|FG000|Overall Study|Pregnancy|0|||
130178146|NCT02556801|468608237|FG001|Overall Study|Pregnancy|1|||
130178147|NCT02556801|468608238|FG002|Overall Study|Pregnancy|0|||
130178148|NCT02556801|468608239|FG003|Overall Study|Pregnancy|0|||
130178149|NCT02556801|468608236|FG000|Overall Study|Personal reasons patient|0|||
130178150|NCT02556801|468608237|FG001|Overall Study|Personal reasons patient|0|||
130178151|NCT02556801|468608238|FG002|Overall Study|Personal reasons patient|0|||
130178152|NCT02556801|468608239|FG003|Overall Study|Personal reasons patient|1|||
130178153|NCT02071225|468608240|FG000|Overall Study|Withdrawal of Consent|2|||
130178154|NCT02071225|468608240|FG000|Overall Study|Protocol Deviation|1|||
130178155|NCT02071225|468608240|FG000|Overall Study|Lost to Follow-up|2|||
130178156|NCT02071225|468608240|FG000|Overall Study|Death|25|||
130178157|NCT02064296|468608241|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
130178158|NCT02064296|468608242|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
130178159|NCT02064296|468608243|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
130178160|NCT02064296|468608241|FG000|Intervention|Withdrawal by Subject|0|||
130178161|NCT02064296|468608242|FG001|Intervention|Withdrawal by Subject|1|||
130178162|NCT02064296|468608243|FG002|Intervention|Withdrawal by Subject|2|||
130178163|NCT03519087|468608248|FG000|Clinic Evaluation|Physician Decision|15|||
130178164|NCT03519087|468608249|FG001|Clinic Evaluation|Physician Decision|18|||
130178165|NCT03519087|468608250|FG002|Clinic Evaluation|Physician Decision|0|||
130178166|NCT03519087|468608251|FG003|Clinic Evaluation|Physician Decision|0|||
130178167|NCT03519087|468608252|FG004|Clinic Evaluation|Physician Decision|0|||
130178168|NCT03519087|468608248|FG000|Clinic Evaluation|Protocol Violation|1|||
130178169|NCT03519087|468608249|FG001|Clinic Evaluation|Protocol Violation|0|||
130178170|NCT03519087|468608250|FG002|Clinic Evaluation|Protocol Violation|0|||
130178171|NCT03519087|468608251|FG003|Clinic Evaluation|Protocol Violation|0|||
130178172|NCT03519087|468608252|FG004|Clinic Evaluation|Protocol Violation|0|||
130178173|NCT03519087|468608248|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
130178174|NCT03519087|468608249|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
130178175|NCT03519087|468608250|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
130178176|NCT03519087|468608251|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
130178177|NCT03519087|468608252|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
130178178|NCT03519087|468608248|FG000|Re-randomization for Treatment|Not appropriate|2|||
130178179|NCT03519087|468608249|FG001|Re-randomization for Treatment|Not appropriate|3|||
130178180|NCT03519087|468608250|FG002|Re-randomization for Treatment|Not appropriate|0|||
130178181|NCT03519087|468608251|FG003|Re-randomization for Treatment|Not appropriate|0|||
130178182|NCT03519087|468608252|FG004|Re-randomization for Treatment|Not appropriate|0|||
130178183|NCT03519087|468608248|FG000|Laboratory Testing|Lost to Follow-up|0|||
130178184|NCT03519087|468608249|FG001|Laboratory Testing|Lost to Follow-up|0|||
130178185|NCT03519087|468608250|FG002|Laboratory Testing|Lost to Follow-up|2|||
130178186|NCT03519087|468608251|FG003|Laboratory Testing|Lost to Follow-up|3|||
130178187|NCT03519087|468608252|FG004|Laboratory Testing|Lost to Follow-up|6|||
130178188|NCT03519087|468608248|FG000|Laboratory Testing|Protocol Violation|0|||
130178189|NCT03519087|468608249|FG001|Laboratory Testing|Protocol Violation|0|||
130178190|NCT03519087|468608250|FG002|Laboratory Testing|Protocol Violation|0|||
130178191|NCT03519087|468608251|FG003|Laboratory Testing|Protocol Violation|1|||
130178192|NCT03519087|468608252|FG004|Laboratory Testing|Protocol Violation|0|||
130178193|NCT01137071|468608253|FG000|Overall Study|Disease Progression|11|||
130178194|NCT01137071|468608253|FG000|Overall Study|Withdrawal by Subject|2|||
130178195|NCT01137071|468608253|FG000|Overall Study|Wrongly Included|1|||
130178196|NCT02324582|468608254|FG000|Overall Study|Screen Failures|0|||
130178197|NCT02324582|468608255|FG001|Overall Study|Screen Failures|5|||
130178198|NCT04388553|468608258|FG000|Overall Study|Protocol Violation|1|||
130178199|NCT04388553|468608259|FG001|Overall Study|Protocol Violation|0|||
130178200|NCT02123446|468608260|FG000|Washout Period (1 Day)|Physician Decision|1|||
130178201|NCT02123446|468608261|FG001|Washout Period (1 Day)|Physician Decision|0|||
130178202|NCT04604795|468608262|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
130178203|NCT04604795|468608263|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
130178204|NCT04604795|468608264|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178205|NCT04604795|468608265|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178206|NCT04604795|468608266|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178207|NCT04604795|468608267|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178208|NCT04604795|468608268|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178209|NCT04604795|468608269|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178210|NCT04604795|468608270|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178211|NCT04604795|468608271|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
130178212|NCT04604795|468608262|FG000|Part B: Up to Day 14|Adverse Event|0|||
130178213|NCT04604795|468608263|FG001|Part B: Up to Day 14|Adverse Event|0|||
130178214|NCT04604795|468608264|FG002|Part B: Up to Day 14|Adverse Event|0|||
130178215|NCT04604795|468608265|FG003|Part B: Up to Day 14|Adverse Event|0|||
130178216|NCT04604795|468608266|FG004|Part B: Up to Day 14|Adverse Event|2|||
130178217|NCT04604795|468608267|FG005|Part B: Up to Day 14|Adverse Event|1|||
130178218|NCT04604795|468608268|FG006|Part B: Up to Day 14|Adverse Event|0|||
130178219|NCT04604795|468608269|FG007|Part B: Up to Day 14|Adverse Event|0|||
130178220|NCT04604795|468608270|FG008|Part B: Up to Day 14|Adverse Event|0|||
130178221|NCT04604795|468608271|FG009|Part B: Up to Day 14|Adverse Event|0|||
130178222|NCT04604795|468608262|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178223|NCT04604795|468608263|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178224|NCT04604795|468608264|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178225|NCT04604795|468608265|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178226|NCT04604795|468608266|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178227|NCT04604795|468608267|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178228|NCT04604795|468608268|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178229|NCT04604795|468608269|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178230|NCT04604795|468608270|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
130178231|NCT04604795|468608271|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
130178232|NCT04604795|468608262|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178233|NCT04604795|468608263|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178234|NCT04604795|468608264|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178235|NCT04604795|468608265|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178236|NCT04604795|468608266|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178237|NCT04604795|468608267|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178238|NCT04604795|468608268|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178239|NCT04604795|468608269|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178240|NCT04604795|468608270|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
130178241|NCT04604795|468608271|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
130178242|NCT04604795|468608262|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178243|NCT04604795|468608263|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178244|NCT04604795|468608264|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178245|NCT04604795|468608265|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178246|NCT04604795|468608266|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178247|NCT04604795|468608267|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178248|NCT04604795|468608268|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178249|NCT04604795|468608269|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178250|NCT04604795|468608270|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
130178251|NCT04604795|468608271|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
130178252|NCT04604795|468608262|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178253|NCT04604795|468608263|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178254|NCT04604795|468608264|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178255|NCT04604795|468608265|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178256|NCT04604795|468608266|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178257|NCT04604795|468608267|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178258|NCT04604795|468608268|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178259|NCT04604795|468608269|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178260|NCT04604795|468608270|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
130178261|NCT04604795|468608271|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
130178262|NCT04502212|468608277|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
130178263|NCT04502212|468608277|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
130178264|NCT00111241|468608282|FG000|Overall Study|Lost to Follow-up|1|||
130178265|NCT00111241|468608283|FG001|Overall Study|Lost to Follow-up|0|||
130178266|NCT00111241|468608282|FG000|Overall Study|Withdrawal by Subject|4|||
130178267|NCT00111241|468608283|FG001|Overall Study|Withdrawal by Subject|0|||
130178268|NCT00111241|468608282|FG000|Overall Study|Protocol Violation|9|||
130178269|NCT00111241|468608283|FG001|Overall Study|Protocol Violation|8|||
130178270|NCT00111241|468608282|FG000|Overall Study|Adverse Event|1|||
130178271|NCT00111241|468608283|FG001|Overall Study|Adverse Event|0|||
130178272|NCT02096744|468608284|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
130178273|NCT02096744|468608285|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
130178274|NCT02096744|468608284|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
130178275|NCT02096744|468608285|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
130178276|NCT02096744|468608284|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
130178277|NCT02096744|468608285|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
130178278|NCT00952731|468608291|FG000|Overall Study|Drug supply expired|1|||
130178279|NCT00952731|468608292|FG001|Overall Study|Drug supply expired|0|||
130178280|NCT02517463|468608294|FG000|Overall Study|Lost to Follow-up|5|||
130178281|NCT02517463|468608295|FG001|Overall Study|Lost to Follow-up|2|||
130178282|NCT03172494|468608300|FG000|Overall Study|Adverse Event|5|||
130178283|NCT03172494|468608301|FG001|Overall Study|Adverse Event|1|||
130178284|NCT03172494|468608302|FG002|Overall Study|Adverse Event|15|||
130178285|NCT03172494|468608300|FG000|Overall Study|Protocol Violation|3|||
130178286|NCT03172494|468608301|FG001|Overall Study|Protocol Violation|2|||
130178287|NCT03172494|468608302|FG002|Overall Study|Protocol Violation|1|||
130178288|NCT03172494|468608300|FG000|Overall Study|Lack of Efficacy|0|||
130178289|NCT03172494|468608301|FG001|Overall Study|Lack of Efficacy|0|||
130178290|NCT03172494|468608302|FG002|Overall Study|Lack of Efficacy|4|||
130178291|NCT03172494|468608300|FG000|Overall Study|Pregnancy|0|||
130178292|NCT03172494|468608301|FG001|Overall Study|Pregnancy|1|||
130178293|NCT03172494|468608302|FG002|Overall Study|Pregnancy|0|||
130178294|NCT03172494|468608300|FG000|Overall Study|Withdrawal by Subject|10|||
130178295|NCT03172494|468608301|FG001|Overall Study|Withdrawal by Subject|8|||
130178296|NCT03172494|468608302|FG002|Overall Study|Withdrawal by Subject|8|||
130178297|NCT03172494|468608300|FG000|Overall Study|Severe hypoglycaemic episode|0|||
130178298|NCT03172494|468608301|FG001|Overall Study|Severe hypoglycaemic episode|0|||
130178299|NCT03172494|468608302|FG002|Overall Study|Severe hypoglycaemic episode|1|||
130178300|NCT03172494|468608300|FG000|Overall Study|Non-compliance towards treatment|2|||
130178301|NCT03172494|468608301|FG001|Overall Study|Non-compliance towards treatment|0|||
130178302|NCT03172494|468608302|FG002|Overall Study|Non-compliance towards treatment|0|||
130178303|NCT02764151|468608303|FG000|Overall Study|Subject refused further follow-up|0|||
130178304|NCT02764151|468608304|FG001|Overall Study|Subject refused further follow-up|0|||
130178305|NCT02764151|468608305|FG002|Overall Study|Subject refused further follow-up|0|||
130178306|NCT02764151|468608306|FG003|Overall Study|Subject refused further follow-up|1|||
130178307|NCT02764151|468608303|FG000|Overall Study|Other|0|||
130178308|NCT02764151|468608304|FG001|Overall Study|Other|0|||
130178309|NCT02764151|468608305|FG002|Overall Study|Other|0|||
130178310|NCT02764151|468608306|FG003|Overall Study|Other|2|||
130178311|NCT00852202|468608307|FG000|Overall Study|Adverse Event|2|||
130178312|NCT00852202|468608308|FG001|Overall Study|Adverse Event|3|||
130178313|NCT00852202|468608309|FG002|Overall Study|Adverse Event|7|||
130178314|NCT00852202|468608307|FG000|Overall Study|Lack of Efficacy|4|||
130178315|NCT00852202|468608308|FG001|Overall Study|Lack of Efficacy|1|||
130178316|NCT00852202|468608309|FG002|Overall Study|Lack of Efficacy|2|||
130178317|NCT00852202|468608307|FG000|Overall Study|Protocol Violation|2|||
130178318|NCT00852202|468608308|FG001|Overall Study|Protocol Violation|2|||
130178319|NCT00852202|468608309|FG002|Overall Study|Protocol Violation|7|||
130178320|NCT00852202|468608307|FG000|Overall Study|Withdrawal by Subject|3|||
130178321|NCT00852202|468608308|FG001|Overall Study|Withdrawal by Subject|1|||
130178322|NCT00852202|468608309|FG002|Overall Study|Withdrawal by Subject|2|||
130178323|NCT00852202|468608307|FG000|Overall Study|Lost to Follow-up|5|||
130178324|NCT00852202|468608308|FG001|Overall Study|Lost to Follow-up|5|||
130178325|NCT00852202|468608309|FG002|Overall Study|Lost to Follow-up|6|||
130178326|NCT00852202|468608307|FG000|Overall Study|pregnancy,moving away and surgery|1|||
130178327|NCT00852202|468608308|FG001|Overall Study|pregnancy,moving away and surgery|0|||
130178328|NCT00852202|468608309|FG002|Overall Study|pregnancy,moving away and surgery|2|||
130178329|NCT05022212|468608312|FG000|Overall Study|Lost to Follow-up|0|||
130178330|NCT05022212|468608313|FG001|Overall Study|Lost to Follow-up|2|||
130178331|NCT02890355|468608314|FG000|Overall Study|Adverse Event|5|||
130178332|NCT02890355|468608315|FG001|Overall Study|Adverse Event|5|||
130178333|NCT02890355|468608314|FG000|Overall Study|Refusal unrelated to adverse event|5|||
130178334|NCT02890355|468608315|FG001|Overall Study|Refusal unrelated to adverse event|10|||
130178335|NCT02890355|468608314|FG000|Overall Study|Progression/relapse|46|||
130178336|NCT02890355|468608315|FG001|Overall Study|Progression/relapse|39|||
130178337|NCT02890355|468608314|FG000|Overall Study|Not protocol specified|3|||
130178338|NCT02890355|468608315|FG001|Overall Study|Not protocol specified|4|||
130178339|NCT02694328|468608316|FG000|Overall Study|Adverse Event|27|||
130178340|NCT02694328|468608317|FG001|Overall Study|Adverse Event|33|||
130178341|NCT02694328|468608316|FG000|Overall Study|Withdrawal by Subject|27|||
130178342|NCT02694328|468608317|FG001|Overall Study|Withdrawal by Subject|23|||
130178343|NCT02694328|468608316|FG000|Overall Study|Lost to Follow-up|26|||
130178344|NCT02694328|468608317|FG001|Overall Study|Lost to Follow-up|22|||
130178345|NCT02694328|468608316|FG000|Overall Study|Noncompliant with study drug|11|||
130178346|NCT02694328|468608317|FG001|Overall Study|Noncompliant with study drug|8|||
130178347|NCT02694328|468608316|FG000|Overall Study|Incarceration|1|||
130178348|NCT02694328|468608317|FG001|Overall Study|Incarceration|1|||
130178349|NCT02694328|468608316|FG000|Overall Study|Lack of Efficacy|1|||
130178350|NCT02694328|468608317|FG001|Overall Study|Lack of Efficacy|2|||
130178351|NCT02694328|468608316|FG000|Overall Study|Pregnancy|1|||
130178352|NCT02694328|468608317|FG001|Overall Study|Pregnancy|1|||
130178353|NCT02694328|468608316|FG000|Overall Study|Protocol Violation|6|||
130178354|NCT02694328|468608317|FG001|Overall Study|Protocol Violation|5|||
130178355|NCT02694328|468608316|FG000|Overall Study|Abnormal Laboratory Value|0|||
130178356|NCT02694328|468608317|FG001|Overall Study|Abnormal Laboratory Value|3|||
130178357|NCT01260701|468608318|FG000|Overall Study|Adverse Event|9|||
130178358|NCT01260701|468608318|FG000|Overall Study|Withdrawal by Subject|2|||
130178359|NCT01260701|468608318|FG000|Overall Study|Progression|53|||
130178360|NCT01260701|468608318|FG000|Overall Study|Death|2|||
130178361|NCT01260701|468608318|FG000|Overall Study|Not protocol specified|3|||
130178362|NCT01260701|468608318|FG000|Overall Study|Under review|1|||
130178363|NCT01260701|468608318|FG000|Overall Study|Ineligible|4|||
130178364|NCT01260701|468608318|FG000|Overall Study|Did not begin protocol therapy|1|||
130178365|NCT00720382|468608320|FG000|Overall Study|Adverse Event|54|||
130178366|NCT00720382|468608321|FG001|Overall Study|Adverse Event|17|||
130178367|NCT00720382|468608320|FG000|Overall Study|Lack of Efficacy|18|||
130178368|NCT00720382|468608321|FG001|Overall Study|Lack of Efficacy|7|||
130178369|NCT00720382|468608320|FG000|Overall Study|Non-Compliance|15|||
130178370|NCT00720382|468608321|FG001|Overall Study|Non-Compliance|5|||
130178371|NCT00720382|468608320|FG000|Overall Study|Withdrawal by Subject|47|||
130178372|NCT00720382|468608321|FG001|Overall Study|Withdrawal by Subject|11|||
130178373|NCT00720382|468608320|FG000|Overall Study|Lost to Follow-up|28|||
130178374|NCT00720382|468608321|FG001|Overall Study|Lost to Follow-up|14|||
130178375|NCT00720382|468608320|FG000|Overall Study|administrative|14|||
130178376|NCT00720382|468608321|FG001|Overall Study|administrative|5|||
130178377|NCT04205812|468609976|FG000|Randomized Treatment Period|Ongoing|28|||
130178378|NCT04205812|468609977|FG001|Randomized Treatment Period|Ongoing|138|||
130178379|NCT04205812|468609976|FG000|Randomized Treatment Period|Death|94|||
130178380|NCT04205812|468609977|FG001|Randomized Treatment Period|Death|226|||
130178381|NCT04205812|468609976|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
130178382|NCT04205812|468609977|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
130178383|NCT04205812|468609976|FG000|Randomized Treatment Period|Physician Decision|1|||
130178384|NCT04205812|468609977|FG001|Randomized Treatment Period|Physician Decision|4|||
130178385|NCT04205812|468609976|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
130178386|NCT04205812|468609977|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
130178387|NCT04205812|468609976|FG000|Randomized Treatment Period|Progressive Disease|0|||
130178388|NCT04205812|468609977|FG001|Randomized Treatment Period|Progressive Disease|1|||
130178389|NCT04205812|468609976|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
130178390|NCT04205812|468609977|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
130178391|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Ongoing|17|||
130178392|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Ongoing|0|||
130178393|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Death|39|||
130178394|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Death|0|||
130178395|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
130178396|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
130178397|NCT04205812|468609976|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
130178398|NCT04205812|468609977|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
130178399|NCT05221320|468609978|FG000|Overall Study|Lack of Efficacy|3|||
130178400|NCT05221320|468609979|FG001|Overall Study|Lack of Efficacy|7|||
130178401|NCT05221320|468609980|FG002|Overall Study|Lack of Efficacy|10|||
130178402|NCT05221320|468609981|FG003|Overall Study|Lack of Efficacy|1|||
130178403|NCT05221320|468609982|FG004|Overall Study|Lack of Efficacy|0|||
130178404|NCT05221320|468609983|FG005|Overall Study|Lack of Efficacy|0|||
130178405|NCT05221320|468609978|FG000|Overall Study|Physician Decision|1|||
130178406|NCT05221320|468609979|FG001|Overall Study|Physician Decision|0|||
130178407|NCT05221320|468609980|FG002|Overall Study|Physician Decision|3|||
130178408|NCT05221320|468609981|FG003|Overall Study|Physician Decision|1|||
130178409|NCT05221320|468609982|FG004|Overall Study|Physician Decision|0|||
130178410|NCT05221320|468609983|FG005|Overall Study|Physician Decision|0|||
129982943|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
130178411|NCT05221320|468609978|FG000|Overall Study|Withdrawal by Subject|0|||
130178412|NCT05221320|468609979|FG001|Overall Study|Withdrawal by Subject|3|||
130178413|NCT05221320|468609980|FG002|Overall Study|Withdrawal by Subject|1|||
130178414|NCT05221320|468609981|FG003|Overall Study|Withdrawal by Subject|0|||
130178415|NCT05221320|468609982|FG004|Overall Study|Withdrawal by Subject|0|||
130178416|NCT05221320|468609983|FG005|Overall Study|Withdrawal by Subject|0|||
130178417|NCT05221320|468609978|FG000|Overall Study|Death|0|||
130178418|NCT05221320|468609979|FG001|Overall Study|Death|5|||
130178419|NCT05221320|468609980|FG002|Overall Study|Death|6|||
130178420|NCT05221320|468609981|FG003|Overall Study|Death|0|||
130178421|NCT05221320|468609982|FG004|Overall Study|Death|1|||
130178422|NCT05221320|468609983|FG005|Overall Study|Death|0|||
130178423|NCT06473519|468609984|FG000|Overall Study|Lost to Follow-up|2|||
130178424|NCT06473519|468609985|FG001|Overall Study|Lost to Follow-up|5|||
130178425|NCT06473519|468609984|FG000|Overall Study|Withdrawal by Subject|1|||
130178426|NCT06473519|468609985|FG001|Overall Study|Withdrawal by Subject|4|||
130178427|NCT06473519|468609984|FG000|Overall Study|Randomized but not vaccinated|1|||
130178428|NCT06473519|468609985|FG001|Overall Study|Randomized but not vaccinated|2|||
130178429|NCT02514447|468609987|FG000|Overall Study|Withdrawal by Subject|3|||
130178430|NCT02514447|468609988|FG001|Overall Study|Withdrawal by Subject|1|||
130178431|NCT02514447|468609989|FG002|Overall Study|Withdrawal by Subject|1|||
130178432|NCT02514447|468609990|FG003|Overall Study|Withdrawal by Subject|0|||
130178433|NCT02514447|468609991|FG004|Overall Study|Withdrawal by Subject|0|||
130178434|NCT02514447|468609992|FG005|Overall Study|Withdrawal by Subject|0|||
130178435|NCT02514447|468609993|FG006|Overall Study|Withdrawal by Subject|0|||
130178436|NCT02514447|468609994|FG007|Overall Study|Withdrawal by Subject|1|||
130178437|NCT02514447|468609995|FG008|Overall Study|Withdrawal by Subject|1|||
130178438|NCT02514447|468609987|FG000|Overall Study|Death|24|||
130178439|NCT02514447|468609988|FG001|Overall Study|Death|28|||
130178440|NCT02514447|468609989|FG002|Overall Study|Death|29|||
130178441|NCT02514447|468609990|FG003|Overall Study|Death|0|||
130178442|NCT02514447|468609991|FG004|Overall Study|Death|3|||
130178443|NCT02514447|468609992|FG005|Overall Study|Death|4|||
130178444|NCT02514447|468609993|FG006|Overall Study|Death|8|||
130178445|NCT02514447|468609994|FG007|Overall Study|Death|6|||
130178446|NCT02514447|468609995|FG008|Overall Study|Death|5|||
130178447|NCT02514447|468609987|FG000|Overall Study|Lost to Follow-up|1|||
130178448|NCT02514447|468609988|FG001|Overall Study|Lost to Follow-up|0|||
130178449|NCT02514447|468609989|FG002|Overall Study|Lost to Follow-up|0|||
130178450|NCT02514447|468609990|FG003|Overall Study|Lost to Follow-up|0|||
130178451|NCT02514447|468609991|FG004|Overall Study|Lost to Follow-up|0|||
130178452|NCT02514447|468609992|FG005|Overall Study|Lost to Follow-up|0|||
130178453|NCT02514447|468609993|FG006|Overall Study|Lost to Follow-up|0|||
130178454|NCT02514447|468609994|FG007|Overall Study|Lost to Follow-up|0|||
130178455|NCT02514447|468609995|FG008|Overall Study|Lost to Follow-up|1|||
130178456|NCT02514447|468609987|FG000|Overall Study|Sponsor Termination of Study|0|||
130178457|NCT02514447|468609988|FG001|Overall Study|Sponsor Termination of Study|1|||
130178458|NCT02514447|468609989|FG002|Overall Study|Sponsor Termination of Study|1|||
130178459|NCT02514447|468609990|FG003|Overall Study|Sponsor Termination of Study|0|||
130178460|NCT02514447|468609991|FG004|Overall Study|Sponsor Termination of Study|0|||
130178461|NCT02514447|468609992|FG005|Overall Study|Sponsor Termination of Study|0|||
130178462|NCT02514447|468609993|FG006|Overall Study|Sponsor Termination of Study|0|||
130178463|NCT02514447|468609994|FG007|Overall Study|Sponsor Termination of Study|0|||
130178464|NCT02514447|468609995|FG008|Overall Study|Sponsor Termination of Study|0|||
130178465|NCT02514447|468609987|FG000|Overall Study|Study completion per Investigator|1|||
130178466|NCT02514447|468609988|FG001|Overall Study|Study completion per Investigator|0|||
130178467|NCT02514447|468609989|FG002|Overall Study|Study completion per Investigator|1|||
130178468|NCT02514447|468609990|FG003|Overall Study|Study completion per Investigator|2|||
130178469|NCT02514447|468609991|FG004|Overall Study|Study completion per Investigator|0|||
130178470|NCT02514447|468609992|FG005|Overall Study|Study completion per Investigator|0|||
130178471|NCT02514447|468609993|FG006|Overall Study|Study completion per Investigator|0|||
130178472|NCT02514447|468609994|FG007|Overall Study|Study completion per Investigator|0|||
130178473|NCT02514447|468609995|FG008|Overall Study|Study completion per Investigator|1|||
130178474|NCT05626231|468609996|FG000|Provider Enrollment|Worked part-time|4|||
130178475|NCT05626231|468609996|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
130178476|NCT05626231|468609996|FG000|Provider Enrollment|Non-clinical employee|1|||
130178477|NCT05626231|468609996|FG000|Provider Enrollment|Provider does not see clients|3|||
130178478|NCT05626231|468609996|FG000|Provider Enrollment|Other|5|||
130178479|NCT02653625|468609997|FG000|Overall Study|Adverse Event|1|||
130178480|NCT02653625|468609997|FG000|Overall Study|Non-compliance with Study Drug|1|||
130178481|NCT02653625|468609997|FG000|Overall Study|Protocol Violation|1|||
130178482|NCT02653625|468609997|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
130178483|NCT05377749|468610000|FG000|3 Weeks|Lost to Follow-up|2|||
130178484|NCT05377749|468610001|FG001|3 Weeks|Lost to Follow-up|4|||
130178485|NCT05377749|468610000|FG000|3 Weeks|Withdrawal by Subject|1|||
130178486|NCT05377749|468610001|FG001|3 Weeks|Withdrawal by Subject|1|||
130178487|NCT02762929|468610002|FG000|Overall Study|Adverse Event|0|||
130178488|NCT02762929|468610003|FG001|Overall Study|Adverse Event|0|||
130178489|NCT02762929|468610004|FG002|Overall Study|Adverse Event|0|||
130178490|NCT02762929|468610005|FG003|Overall Study|Adverse Event|1|||
130178491|NCT02762929|468610006|FG004|Overall Study|Adverse Event|0|||
130178492|NCT02762929|468610007|FG005|Overall Study|Adverse Event|0|||
130178493|NCT02762929|468610002|FG000|Overall Study|Lost to Follow-up|1|||
130178494|NCT02762929|468610003|FG001|Overall Study|Lost to Follow-up|2|||
130178495|NCT02762929|468610004|FG002|Overall Study|Lost to Follow-up|0|||
130178496|NCT02762929|468610005|FG003|Overall Study|Lost to Follow-up|1|||
130178497|NCT02762929|468610006|FG004|Overall Study|Lost to Follow-up|0|||
130178498|NCT02762929|468610007|FG005|Overall Study|Lost to Follow-up|0|||
130178499|NCT02762929|468610002|FG000|Overall Study|Withdrawal by Subject|0|||
130178500|NCT02762929|468610003|FG001|Overall Study|Withdrawal by Subject|1|||
130178501|NCT02762929|468610004|FG002|Overall Study|Withdrawal by Subject|0|||
130178502|NCT02762929|468610005|FG003|Overall Study|Withdrawal by Subject|0|||
130178503|NCT02762929|468610006|FG004|Overall Study|Withdrawal by Subject|0|||
130178504|NCT02762929|468610007|FG005|Overall Study|Withdrawal by Subject|0|||
130178505|NCT02762929|468610002|FG000|Overall Study|exclusionary medication disclosed late|0|||
130178506|NCT02762929|468610003|FG001|Overall Study|exclusionary medication disclosed late|0|||
130178507|NCT02762929|468610004|FG002|Overall Study|exclusionary medication disclosed late|0|||
130178508|NCT02762929|468610005|FG003|Overall Study|exclusionary medication disclosed late|1|||
130178509|NCT02762929|468610006|FG004|Overall Study|exclusionary medication disclosed late|0|||
130178510|NCT02762929|468610007|FG005|Overall Study|exclusionary medication disclosed late|0|||
130178511|NCT04123405|468610013|FG000|Overall Study|Adverse Event|1|||
130178512|NCT04123405|468610014|FG001|Overall Study|Adverse Event|2|||
130178513|NCT04123405|468610015|FG002|Overall Study|Adverse Event|3|||
130178514|NCT04123405|468610016|FG003|Overall Study|Adverse Event|3|||
130178515|NCT04123405|468610013|FG000|Overall Study|Exclusion criteria met|1|||
130178516|NCT04123405|468610014|FG001|Overall Study|Exclusion criteria met|2|||
130178517|NCT04123405|468610015|FG002|Overall Study|Exclusion criteria met|0|||
130178518|NCT04123405|468610016|FG003|Overall Study|Exclusion criteria met|2|||
130178519|NCT04123405|468610013|FG000|Overall Study|Withdrawal by Subject|1|||
130178520|NCT04123405|468610014|FG001|Overall Study|Withdrawal by Subject|3|||
130178521|NCT04123405|468610015|FG002|Overall Study|Withdrawal by Subject|0|||
130178522|NCT04123405|468610016|FG003|Overall Study|Withdrawal by Subject|2|||
130178523|NCT04123405|468610013|FG000|Overall Study|Contact to subject lost|0|||
130178524|NCT04123405|468610014|FG001|Overall Study|Contact to subject lost|0|||
130178525|NCT04123405|468610015|FG002|Overall Study|Contact to subject lost|0|||
130178526|NCT04123405|468610016|FG003|Overall Study|Contact to subject lost|1|||
130178527|NCT04123405|468610013|FG000|Overall Study|screening failure|1|||
130178528|NCT04123405|468610014|FG001|Overall Study|screening failure|0|||
130178529|NCT04123405|468610015|FG002|Overall Study|screening failure|0|||
130178530|NCT04123405|468610016|FG003|Overall Study|screening failure|0|||
130178531|NCT01026194|468610017|FG000|Period 1：Double Blind Period|Adverse Event|2|||
130178532|NCT01026194|468610018|FG001|Period 1：Double Blind Period|Adverse Event|1|||
130178533|NCT01026194|468610017|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
130178534|NCT01026194|468610018|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
130178535|NCT01026194|468610017|FG000|Period 1：Double Blind Period|Physician Decision|0|||
130178536|NCT01026194|468610018|FG001|Period 1：Double Blind Period|Physician Decision|4|||
130178537|NCT01026194|468610017|FG000|Period 2：Open-label Period|Adverse Event|4|||
130178538|NCT01026194|468610018|FG001|Period 2：Open-label Period|Adverse Event|5|||
130178539|NCT01026194|468610017|FG000|Period 2：Open-label Period|Physician Decision|3|||
130178540|NCT01026194|468610018|FG001|Period 2：Open-label Period|Physician Decision|1|||
130178541|NCT01026194|468610017|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
130178542|NCT01026194|468610018|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
130178543|NCT01750190|468610019|FG000|Overall Study|Adverse Event|47|||
130178544|NCT01750190|468610020|FG001|Overall Study|Adverse Event|19|||
130178545|NCT01750190|468610019|FG000|Overall Study|Death|38|||
130178546|NCT01750190|468610020|FG001|Overall Study|Death|11|||
130178547|NCT01750190|468610019|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
130178548|NCT01750190|468610020|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
130178549|NCT01750190|468610019|FG000|Overall Study|Lost to Follow-up|28|||
130178550|NCT01750190|468610020|FG001|Overall Study|Lost to Follow-up|7|||
130178551|NCT01750190|468610019|FG000|Overall Study|Physician Decision|16|||
130178552|NCT01750190|468610020|FG001|Overall Study|Physician Decision|17|||
130178553|NCT01750190|468610019|FG000|Overall Study|Protocol Violation|6|||
130178554|NCT01750190|468610020|FG001|Overall Study|Protocol Violation|5|||
130178555|NCT01750190|468610019|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
130178556|NCT01750190|468610020|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
130178557|NCT01750190|468610019|FG000|Overall Study|Withdrawal by Subject|83|||
130178558|NCT01750190|468610020|FG001|Overall Study|Withdrawal by Subject|89|||
130178559|NCT01750190|468610019|FG000|Overall Study|Kidney Transplant|8|||
130178560|NCT01750190|468610020|FG001|Overall Study|Kidney Transplant|4|||
130178561|NCT01750190|468610019|FG000|Overall Study|Dialysis|22|||
130178562|NCT01750190|468610020|FG001|Overall Study|Dialysis|8|||
130178563|NCT01750190|468610019|FG000|Overall Study|Other than Specified|13|||
130178564|NCT01750190|468610020|FG001|Overall Study|Other than Specified|4|||
130178565|NCT03934541|468610032|FG000|Overall Study|Study Terminated by Sponsor|0|||
130178566|NCT03934541|468610033|FG001|Overall Study|Study Terminated by Sponsor|1|||
130178567|NCT03934541|468610034|FG002|Overall Study|Study Terminated by Sponsor|0|||
130178568|NCT03934541|468610035|FG003|Overall Study|Study Terminated by Sponsor|0|||
130178569|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
130178570|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
130178571|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
130178572|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
130178573|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
130178574|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
130178575|NCT02673775|468610036|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
130178576|NCT02673775|468610037|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
130178577|NCT02441686|468610038|FG000|Induction|Adverse Event|4|||
130178578|NCT02441686|468610038|FG000|Induction|Complicating disease|1|||
130178579|NCT02441686|468610038|FG000|Induction|Physician Decision|1|||
130178580|NCT02441686|468610038|FG000|Induction|Withdrawal by Subject|1|||
130178581|NCT02441686|468610038|FG000|Induction|Did not receive treatment|1|||
130178582|NCT02441686|468610038|FG000|Maintenance|Remaining on Treatment|23|||
130178583|NCT02441686|468610038|FG000|Maintenance|Physician Decision|1|||
130178584|NCT02441686|468610038|FG000|Maintenance|Adverse Event|3|||
130178585|NCT02441686|468610038|FG000|Maintenance|Progressive Disease|10|||
130178586|NCT02441686|468610038|FG000|Maintenance|Withdrawal by Subject|1|||
130178587|NCT03151304|468610039|FG000|Overall Study|Termination of study by Sponsor|23|||
130178588|NCT03151304|468610039|FG000|Overall Study|missing|3|||
130178589|NCT03151304|468610039|FG000|Overall Study|Withdrawal by Subject|8|||
130178590|NCT03151304|468610039|FG000|Overall Study|multiple reasons|30|||
130178591|NCT04194645|468610042|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178592|NCT04194645|468610043|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178593|NCT04194645|468610044|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178594|NCT04194645|468610045|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178595|NCT04194645|468610046|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178596|NCT04194645|468610047|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178597|NCT04194645|468610048|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178598|NCT04194645|468610049|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178599|NCT04194645|468610050|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178600|NCT04194645|468610051|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
130178601|NCT04194645|468610052|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178602|NCT04194645|468610053|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178603|NCT04194645|468610054|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178604|NCT04194645|468610055|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178605|NCT04194645|468610056|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
130178606|NCT03076775|468610057|FG000|Overall Study|Lost to Follow-up|1|||
130178607|NCT03076775|468610058|FG001|Overall Study|Lost to Follow-up|0|||
130178608|NCT01783886|468610059|FG000|Overall Study|Lost to Follow-up|0|||
130178609|NCT01783886|468610060|FG001|Overall Study|Lost to Follow-up|3|||
130178610|NCT01783886|468610061|FG002|Overall Study|Lost to Follow-up|0|||
130178611|NCT01783886|468610059|FG000|Overall Study|Protocol deviation|0|||
130178612|NCT01783886|468610060|FG001|Overall Study|Protocol deviation|0|||
130178613|NCT01783886|468610061|FG002|Overall Study|Protocol deviation|2|||
130178614|NCT01783886|468610059|FG000|Overall Study|Withdrawal of consent by participant|1|||
130178615|NCT01783886|468610060|FG001|Overall Study|Withdrawal of consent by participant|3|||
130178616|NCT01783886|468610061|FG002|Overall Study|Withdrawal of consent by participant|4|||
130178617|NCT01783886|468610059|FG000|Overall Study|Adverse Event|4|||
130178618|NCT01783886|468610060|FG001|Overall Study|Adverse Event|5|||
130178619|NCT01783886|468610061|FG002|Overall Study|Adverse Event|4|||
130178620|NCT04542057|468610062|FG000|Overall Study|Death|3|||
130178621|NCT04542057|468610063|FG001|Overall Study|Death|1|||
130178622|NCT04542057|468610062|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
130178623|NCT04542057|468610063|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
130178624|NCT04542057|468610062|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
130178625|NCT04542057|468610063|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
130178626|NCT04542057|468610062|FG000|Overall Study|Adverse Event|15|||
130178627|NCT04542057|468610063|FG001|Overall Study|Adverse Event|6|||
130178628|NCT04542057|468610062|FG000|Overall Study|COVID-19 adverse event|6|||
130178629|NCT04542057|468610063|FG001|Overall Study|COVID-19 adverse event|4|||
130178630|NCT04542057|468610062|FG000|Overall Study|Lack of Efficacy|2|||
130178631|NCT04542057|468610063|FG001|Overall Study|Lack of Efficacy|5|||
130178632|NCT04542057|468610062|FG000|Overall Study|Study terminated by sponsor|1|||
130178633|NCT04542057|468610063|FG001|Overall Study|Study terminated by sponsor|0|||
130178634|NCT04542057|468610062|FG000|Overall Study|Investigator discretion|2|||
130178635|NCT04542057|468610063|FG001|Overall Study|Investigator discretion|1|||
130178636|NCT04542057|468610062|FG000|Overall Study|Withdrawal by Subject|52|||
130178637|NCT04542057|468610063|FG001|Overall Study|Withdrawal by Subject|30|||
130178638|NCT04542057|468610062|FG000|Overall Study|Lost to Follow-up|8|||
130178639|NCT04542057|468610063|FG001|Overall Study|Lost to Follow-up|11|||
130178640|NCT04542057|468610062|FG000|Overall Study|Other|2|||
130178641|NCT04542057|468610063|FG001|Overall Study|Other|2|||
130178642|NCT00104572|468610064|FG000|Overall Study|Withdrawal by Subject|3|||
130178643|NCT00104572|468610065|FG001|Overall Study|Withdrawal by Subject|3|||
130178644|NCT00104572|468610066|FG002|Overall Study|Withdrawal by Subject|0|||
130178645|NCT00940316|468610069|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
130178646|NCT00940316|468610070|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
130178647|NCT00940316|468610071|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
130178648|NCT00940316|468610069|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
130178649|NCT00940316|468610070|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
130178650|NCT00940316|468610071|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
130178651|NCT00940316|468610069|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
130178652|NCT00940316|468610070|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
130178653|NCT00940316|468610071|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
130178654|NCT00940316|468610069|FG000|Treated After Cycle 5|Adverse Event|0|||
130178655|NCT00940316|468610070|FG001|Treated After Cycle 5|Adverse Event|0|||
130178656|NCT00940316|468610071|FG002|Treated After Cycle 5|Adverse Event|1|||
130178657|NCT00940316|468610069|FG000|Treated After Cycle 5|Progressive disease|0|||
130178658|NCT00940316|468610070|FG001|Treated After Cycle 5|Progressive disease|1|||
130178659|NCT00940316|468610071|FG002|Treated After Cycle 5|Progressive disease|0|||
130178660|NCT02290405|468610075|FG000|Overall Study|Withdrawal by Subject|1|||
130178661|NCT02290405|468610076|FG001|Overall Study|Withdrawal by Subject|0|||
130178662|NCT02016183|468610077|FG000|Overall Study|Case Report Forms Uncollected|13|||
130178663|NCT02016183|468610077|FG000|Overall Study|Protocol Violation|52|||
130178664|NCT00996489|468610078|FG000|Overall Study|Device failure|45|||
130178665|NCT00996489|468610078|FG000|Overall Study|Discontinued|116|||
130178666|NCT03142191|468610079|FG000|Placebo Controlled Period|Death|0|||
130178667|NCT03142191|468610080|FG001|Placebo Controlled Period|Death|1|||
130178668|NCT03142191|468610081|FG002|Placebo Controlled Period|Death|1|||
130178669|NCT03142191|468610082|FG003|Placebo Controlled Period|Death|0|||
130178670|NCT03142191|468610083|FG004|Placebo Controlled Period|Death|0|||
130178671|NCT03142191|468610079|FG000|Placebo Controlled Period|Adverse Event|4|||
130178672|NCT03142191|468610080|FG001|Placebo Controlled Period|Adverse Event|5|||
130178673|NCT03142191|468610081|FG002|Placebo Controlled Period|Adverse Event|1|||
130178674|NCT03142191|468610082|FG003|Placebo Controlled Period|Adverse Event|0|||
130178675|NCT03142191|468610083|FG004|Placebo Controlled Period|Adverse Event|0|||
130178676|NCT03142191|468610079|FG000|Placebo Controlled Period|Progressive Disease|1|||
130178677|NCT03142191|468610080|FG001|Placebo Controlled Period|Progressive Disease|0|||
130178678|NCT03142191|468610081|FG002|Placebo Controlled Period|Progressive Disease|1|||
130178679|NCT03142191|468610082|FG003|Placebo Controlled Period|Progressive Disease|0|||
130178680|NCT03142191|468610083|FG004|Placebo Controlled Period|Progressive Disease|0|||
130178681|NCT03142191|468610079|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
130178682|NCT03142191|468610080|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
130178683|NCT03142191|468610081|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
130178684|NCT03142191|468610082|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
130178685|NCT03142191|468610083|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
130178686|NCT03142191|468610079|FG000|Placebo Controlled Period|Other Reasons|1|||
130178687|NCT03142191|468610080|FG001|Placebo Controlled Period|Other Reasons|0|||
130178688|NCT03142191|468610081|FG002|Placebo Controlled Period|Other Reasons|0|||
130178689|NCT03142191|468610082|FG003|Placebo Controlled Period|Other Reasons|0|||
130178690|NCT03142191|468610083|FG004|Placebo Controlled Period|Other Reasons|0|||
130178691|NCT03142191|468610079|FG000|Active Treatment Extension Period|Death|2|||
130178692|NCT03142191|468610080|FG001|Active Treatment Extension Period|Death|1|||
130178693|NCT03142191|468610081|FG002|Active Treatment Extension Period|Death|1|||
130178694|NCT03142191|468610082|FG003|Active Treatment Extension Period|Death|1|||
130178695|NCT03142191|468610083|FG004|Active Treatment Extension Period|Death|0|||
130178696|NCT03142191|468610079|FG000|Active Treatment Extension Period|Adverse Event|6|||
130178697|NCT03142191|468610080|FG001|Active Treatment Extension Period|Adverse Event|5|||
130178698|NCT03142191|468610081|FG002|Active Treatment Extension Period|Adverse Event|4|||
130178699|NCT03142191|468610082|FG003|Active Treatment Extension Period|Adverse Event|1|||
130178700|NCT03142191|468610083|FG004|Active Treatment Extension Period|Adverse Event|0|||
130178701|NCT03142191|468610079|FG000|Active Treatment Extension Period|Progressive Disease|10|||
130178702|NCT03142191|468610080|FG001|Active Treatment Extension Period|Progressive Disease|5|||
130178703|NCT03142191|468610081|FG002|Active Treatment Extension Period|Progressive Disease|4|||
130178704|NCT03142191|468610082|FG003|Active Treatment Extension Period|Progressive Disease|1|||
130178705|NCT03142191|468610083|FG004|Active Treatment Extension Period|Progressive Disease|2|||
130178706|NCT03142191|468610079|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
130178707|NCT03142191|468610080|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
130178708|NCT03142191|468610081|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
130178709|NCT03142191|468610082|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
130178710|NCT03142191|468610083|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
130178711|NCT03142191|468610079|FG000|Active Treatment Extension Period|Physician Decision|2|||
130178712|NCT03142191|468610080|FG001|Active Treatment Extension Period|Physician Decision|0|||
130178713|NCT03142191|468610081|FG002|Active Treatment Extension Period|Physician Decision|0|||
130178714|NCT03142191|468610082|FG003|Active Treatment Extension Period|Physician Decision|0|||
130178715|NCT03142191|468610083|FG004|Active Treatment Extension Period|Physician Decision|0|||
130178716|NCT03142191|468610079|FG000|Active Treatment Extension Period|Other Reasons|3|||
130178717|NCT03142191|468610080|FG001|Active Treatment Extension Period|Other Reasons|3|||
130178718|NCT03142191|468610081|FG002|Active Treatment Extension Period|Other Reasons|3|||
130178719|NCT03142191|468610082|FG003|Active Treatment Extension Period|Other Reasons|8|||
130178720|NCT03142191|468610083|FG004|Active Treatment Extension Period|Other Reasons|3|||
130178721|NCT03142191|468610079|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
130178722|NCT03142191|468610080|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
130178723|NCT03142191|468610081|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
130178724|NCT03142191|468610082|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
130178725|NCT03142191|468610083|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
130178726|NCT00770328|468610086|FG000|Overall Study|Adverse Event|11|||
130178727|NCT00770328|468610087|FG001|Overall Study|Adverse Event|2|||
130178728|NCT00770328|468610086|FG000|Overall Study|Lost to Follow-up|2|||
130178729|NCT00770328|468610087|FG001|Overall Study|Lost to Follow-up|2|||
130178730|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
130178731|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
130178732|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
130178733|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
130178734|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
130178735|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
130178736|NCT03452943|468610088|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
130178737|NCT03452943|468610089|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
130178738|NCT03452943|468610088|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
130178739|NCT03452943|468610089|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
130178740|NCT03452943|468610088|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
130178741|NCT03452943|468610089|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
130178742|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
130178743|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
130178744|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
130178745|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
130178746|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
130178747|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
130178748|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
130178749|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
130178750|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
130178751|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
130178752|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
130178753|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
130178754|NCT01130493|468610090|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
130178755|NCT01130493|468610091|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
130178756|NCT01130493|468610092|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
130178757|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
130178758|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
130178759|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
130178760|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
130178761|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
130178762|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
130178763|NCT01130493|468610090|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
129982944|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
129982945|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129982946|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129982947|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129982948|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982949|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
129982950|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982951|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982952|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982953|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982954|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
129982955|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982956|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982957|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982958|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982959|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
129982960|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982961|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982962|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982963|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982964|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
129982965|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982966|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982967|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982968|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
129982969|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
129982970|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130178764|NCT01130493|468610091|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
130178765|NCT01130493|468610092|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
130178766|NCT01130493|468610090|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
130178767|NCT01130493|468610091|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
130178768|NCT01130493|468610092|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
130178769|NCT01130493|468610090|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
130178770|NCT01130493|468610091|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
130178771|NCT01130493|468610092|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
130178772|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
130178773|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
130178774|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
130178775|NCT01130493|468610090|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
130178776|NCT01130493|468610091|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
130178777|NCT01130493|468610092|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
130178778|NCT01130493|468610090|FG000|Part 2: OLE|Adverse Event|0|||
130178779|NCT01130493|468610091|FG001|Part 2: OLE|Adverse Event|2|||
130178780|NCT01130493|468610092|FG002|Part 2: OLE|Adverse Event|1|||
130178781|NCT01130493|468610090|FG000|Part 2: OLE|Withdrawal by Subject|0|||
130178782|NCT01130493|468610091|FG001|Part 2: OLE|Withdrawal by Subject|1|||
130178783|NCT01130493|468610092|FG002|Part 2: OLE|Withdrawal by Subject|4|||
130178784|NCT03541317|468610093|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
130178785|NCT03541317|468610094|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178786|NCT03541317|468610095|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178787|NCT03541317|468610096|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178788|NCT03541317|468610097|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178789|NCT03541317|468610098|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
130178790|NCT02286843|468610099|FG000|Overall Study|Not Treated|4|||
130178791|NCT02286843|468610099|FG000|Overall Study|Protocol Violation|1|||
130178792|NCT02286843|468610099|FG000|Overall Study|Withdrawal by Subject|1|||
130178793|NCT02536846|468610100|FG000|Overall Study|Withdrawal by Subject|1|||
130178794|NCT02593110|468610101|FG000|Overall Study|Withdrawal by Subject|0|||
130178795|NCT02593110|468610102|FG001|Overall Study|Withdrawal by Subject|3|||
130178796|NCT02593110|468610103|FG002|Overall Study|Withdrawal by Subject|3|||
130178797|NCT02593110|468610104|FG003|Overall Study|Withdrawal by Subject|2|||
130178798|NCT02593110|468610101|FG000|Overall Study|Death|0|||
130178799|NCT02593110|468610102|FG001|Overall Study|Death|0|||
130178800|NCT02593110|468610103|FG002|Overall Study|Death|1|||
130178801|NCT02593110|468610104|FG003|Overall Study|Death|0|||
130178802|NCT03086551|468610105|FG000|First Intervention|Failure to meet inclusion criterion|1|||
130178803|NCT03086551|468610106|FG001|First Intervention|Failure to meet inclusion criterion|0|||
130178804|NCT03086551|468610105|FG000|First Intervention|Lost to Follow-up|0|||
130178805|NCT03086551|468610106|FG001|First Intervention|Lost to Follow-up|1|||
130178806|NCT03086551|468610105|FG000|Washout|Lost to Follow-up|1|||
130178807|NCT03086551|468610106|FG001|Washout|Lost to Follow-up|2|||
130178808|NCT03086551|468610105|FG000|Washout|Withdrawal by Subject|2|||
130178809|NCT03086551|468610106|FG001|Washout|Withdrawal by Subject|1|||
130178810|NCT00625872|468610109|FG000|Overall Study|Withdrawal by Subject|1|||
130178811|NCT00625872|468610110|FG001|Overall Study|Withdrawal by Subject|0|||
130178812|NCT00625872|468610109|FG000|Overall Study|Does not meet inclusion criteria|1|||
130178813|NCT00625872|468610110|FG001|Overall Study|Does not meet inclusion criteria|0|||
130178814|NCT00625872|468610109|FG000|Overall Study|Terminated by sponsor|2|||
130178815|NCT00625872|468610110|FG001|Overall Study|Terminated by sponsor|5|||
130178816|NCT00625872|468610109|FG000|Overall Study|Randomized but not treated|0|||
130178817|NCT00625872|468610110|FG001|Overall Study|Randomized but not treated|1|||
130178818|NCT04208750|468610111|FG000|Overall Study|Lost to Follow-up|16|||
130178819|NCT04208750|468610112|FG001|Overall Study|Lost to Follow-up|15|||
130178820|NCT02201277|468610113|FG000|Overall Study|Death|3|||
130178821|NCT02201277|468610114|FG001|Overall Study|Death|4|||
130178822|NCT02201277|468610113|FG000|Overall Study|Lost to Follow-up|2|||
130178823|NCT02201277|468610114|FG001|Overall Study|Lost to Follow-up|1|||
130178824|NCT02201277|468610113|FG000|Overall Study|Failed retrieval|1|||
130178825|NCT02201277|468610114|FG001|Overall Study|Failed retrieval|0|||
130178826|NCT02201277|468610113|FG000|Overall Study|Physician Decision|1|||
130178827|NCT02201277|468610114|FG001|Overall Study|Physician Decision|0|||
130178828|NCT03485352|468610115|FG000|Overall Study|Lost to Follow-up|9|||
130178829|NCT01512160|468610116|FG000|Overall Study|Lost to Follow-up|1|||
130178830|NCT01512160|468610117|FG001|Overall Study|Lost to Follow-up|0|||
129982971|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130178831|NCT01512160|468610118|FG002|Overall Study|Lost to Follow-up|0|||
130178832|NCT01512160|468610119|FG003|Overall Study|Lost to Follow-up|0|||
130178833|NCT01512160|468610116|FG000|Overall Study|Withdrawal by Subject|1|||
130178834|NCT01512160|468610117|FG001|Overall Study|Withdrawal by Subject|0|||
130178835|NCT01512160|468610118|FG002|Overall Study|Withdrawal by Subject|0|||
130178836|NCT01512160|468610119|FG003|Overall Study|Withdrawal by Subject|1|||
130178837|NCT02163057|468610121|FG000|Overall Study|Participant Refusal to Continue|2|||
130178838|NCT02163057|468610122|FG001|Overall Study|Participant Refusal to Continue|2|||
130178839|NCT02163057|468610121|FG000|Overall Study|Participant Significant Noncompliance|0|||
130178840|NCT02163057|468610122|FG001|Overall Study|Participant Significant Noncompliance|1|||
130178841|NCT02163057|468610121|FG000|Overall Study|Progression of Disease|1|||
130178842|NCT02163057|468610122|FG001|Overall Study|Progression of Disease|2|||
130178843|NCT01959295|468610123|FG000|Overall Study|Adverse Event|2|||
130178844|NCT01959295|468610124|FG001|Overall Study|Adverse Event|0|||
130178845|NCT01959295|468610123|FG000|Overall Study|Lost to Follow-up|0|||
130178846|NCT01959295|468610124|FG001|Overall Study|Lost to Follow-up|2|||
130178847|NCT01959295|468610123|FG000|Overall Study|Physician Decision|2|||
130178848|NCT01959295|468610124|FG001|Overall Study|Physician Decision|3|||
130178849|NCT01959295|468610123|FG000|Overall Study|Protocol Violation|16|||
130178850|NCT01959295|468610124|FG001|Overall Study|Protocol Violation|5|||
130178851|NCT01959295|468610123|FG000|Overall Study|Withdrawal by Subject|3|||
130178852|NCT01959295|468610124|FG001|Overall Study|Withdrawal by Subject|1|||
130178853|NCT01959295|468610123|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
130178854|NCT01959295|468610124|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
130178855|NCT04903288|468611521|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
130178856|NCT04903288|468611521|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
130178857|NCT04903288|468611521|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
130178858|NCT04903288|468611521|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
130178859|NCT02498613|468611526|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
130178860|NCT02498613|468611527|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
130178861|NCT02498613|468611528|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
130178862|NCT02498613|468611529|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
130178863|NCT02498613|468611526|FG000|Overall Study|Withdrawal by Subject|3|||
130178864|NCT02498613|468611527|FG001|Overall Study|Withdrawal by Subject|1|||
130178865|NCT02498613|468611528|FG002|Overall Study|Withdrawal by Subject|0|||
130178866|NCT02498613|468611529|FG003|Overall Study|Withdrawal by Subject|0|||
130178867|NCT05168202|468611530|FG000|Overall Study|Progressive Disease|4|||
130178868|NCT05168202|468611531|FG001|Overall Study|Progressive Disease|4|||
130178869|NCT05168202|468611532|FG002|Overall Study|Progressive Disease|2|||
130178870|NCT05168202|468611533|FG003|Overall Study|Progressive Disease|3|||
130178871|NCT05168202|468611534|FG004|Overall Study|Progressive Disease|2|||
130178872|NCT05168202|468611535|FG005|Overall Study|Progressive Disease|3|||
130178873|NCT05168202|468611536|FG006|Overall Study|Progressive Disease|2|||
130178874|NCT05168202|468611530|FG000|Overall Study|Adverse Event|2|||
130178875|NCT05168202|468611531|FG001|Overall Study|Adverse Event|1|||
130178876|NCT05168202|468611532|FG002|Overall Study|Adverse Event|4|||
130178877|NCT05168202|468611533|FG003|Overall Study|Adverse Event|4|||
130178878|NCT05168202|468611534|FG004|Overall Study|Adverse Event|3|||
130178879|NCT05168202|468611535|FG005|Overall Study|Adverse Event|2|||
130178880|NCT05168202|468611536|FG006|Overall Study|Adverse Event|0|||
130178881|NCT05168202|468611530|FG000|Overall Study|Lack of Efficacy|0|||
130178882|NCT05168202|468611531|FG001|Overall Study|Lack of Efficacy|1|||
130178883|NCT05168202|468611532|FG002|Overall Study|Lack of Efficacy|1|||
130178884|NCT05168202|468611533|FG003|Overall Study|Lack of Efficacy|0|||
130178885|NCT05168202|468611534|FG004|Overall Study|Lack of Efficacy|1|||
130178886|NCT05168202|468611535|FG005|Overall Study|Lack of Efficacy|2|||
130178887|NCT05168202|468611536|FG006|Overall Study|Lack of Efficacy|2|||
130178888|NCT05168202|468611530|FG000|Overall Study|Withdrawal by Subject|0|||
130178889|NCT05168202|468611531|FG001|Overall Study|Withdrawal by Subject|0|||
130178890|NCT05168202|468611532|FG002|Overall Study|Withdrawal by Subject|1|||
130178891|NCT05168202|468611533|FG003|Overall Study|Withdrawal by Subject|1|||
130178892|NCT05168202|468611534|FG004|Overall Study|Withdrawal by Subject|1|||
130178893|NCT05168202|468611535|FG005|Overall Study|Withdrawal by Subject|1|||
130178894|NCT05168202|468611536|FG006|Overall Study|Withdrawal by Subject|0|||
130178895|NCT05168202|468611530|FG000|Overall Study|Disease Relapse|0|||
130178896|NCT05168202|468611531|FG001|Overall Study|Disease Relapse|1|||
130178897|NCT05168202|468611532|FG002|Overall Study|Disease Relapse|0|||
130178898|NCT05168202|468611533|FG003|Overall Study|Disease Relapse|1|||
130178899|NCT05168202|468611534|FG004|Overall Study|Disease Relapse|1|||
130178900|NCT05168202|468611535|FG005|Overall Study|Disease Relapse|0|||
130178901|NCT05168202|468611536|FG006|Overall Study|Disease Relapse|0|||
130178902|NCT05168202|468611530|FG000|Overall Study|Other Reasons|0|||
130178903|NCT05168202|468611531|FG001|Overall Study|Other Reasons|0|||
130178904|NCT05168202|468611532|FG002|Overall Study|Other Reasons|0|||
130178905|NCT05168202|468611533|FG003|Overall Study|Other Reasons|0|||
130178906|NCT05168202|468611534|FG004|Overall Study|Other Reasons|0|||
130178907|NCT05168202|468611535|FG005|Overall Study|Other Reasons|2|||
130178908|NCT05168202|468611536|FG006|Overall Study|Other Reasons|1|||
130178909|NCT05168202|468611530|FG000|Overall Study|Physician Decision|0|||
130178910|NCT05168202|468611531|FG001|Overall Study|Physician Decision|1|||
130178911|NCT05168202|468611532|FG002|Overall Study|Physician Decision|1|||
130178912|NCT05168202|468611533|FG003|Overall Study|Physician Decision|0|||
130178913|NCT05168202|468611534|FG004|Overall Study|Physician Decision|0|||
130178914|NCT05168202|468611535|FG005|Overall Study|Physician Decision|0|||
130178915|NCT05168202|468611536|FG006|Overall Study|Physician Decision|0|||
130178916|NCT05168202|468611530|FG000|Overall Study|Study Terminated by Sponsor|0|||
130178917|NCT05168202|468611531|FG001|Overall Study|Study Terminated by Sponsor|0|||
130178918|NCT05168202|468611532|FG002|Overall Study|Study Terminated by Sponsor|0|||
130178919|NCT05168202|468611533|FG003|Overall Study|Study Terminated by Sponsor|1|||
130178920|NCT05168202|468611534|FG004|Overall Study|Study Terminated by Sponsor|0|||
130178921|NCT05168202|468611535|FG005|Overall Study|Study Terminated by Sponsor|0|||
130178922|NCT05168202|468611536|FG006|Overall Study|Study Terminated by Sponsor|0|||
130178923|NCT05878093|468611537|FG000|Overall Study|Withdrawal by Subject|3|||
130178924|NCT05878093|468611538|FG001|Overall Study|Withdrawal by Subject|1|||
130178925|NCT03690388|468611541|FG000|Overall Study|Adverse Event|8|||
130178926|NCT03690388|468611542|FG001|Overall Study|Adverse Event|1|||
130178927|NCT03690388|468611541|FG000|Overall Study|Radiographic Progression|14|||
130178928|NCT03690388|468611542|FG001|Overall Study|Radiographic Progression|29|||
130178929|NCT03690388|468611541|FG000|Overall Study|Clinical deterioration|10|||
130178930|NCT03690388|468611542|FG001|Overall Study|Clinical deterioration|6|||
130178931|NCT03690388|468611541|FG000|Overall Study|Withdrawal by Subject|2|||
130178932|NCT03690388|468611542|FG001|Overall Study|Withdrawal by Subject|0|||
130178933|NCT03690388|468611541|FG000|Overall Study|Lack of Efficacy|1|||
130178934|NCT03690388|468611542|FG001|Overall Study|Lack of Efficacy|0|||
130178935|NCT03690388|468611541|FG000|Overall Study|Lost to Follow-up|1|||
130178936|NCT03690388|468611542|FG001|Overall Study|Lost to Follow-up|0|||
130178937|NCT04100018|468611544|FG000|Pre-Treatment Period|Not Reported|0|||
130178938|NCT04100018|468611545|FG001|Pre-Treatment Period|Not Reported|4|||
130178939|NCT04100018|468611544|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
130178940|NCT04100018|468611545|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
130178941|NCT04100018|468611544|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
130178942|NCT04100018|468611545|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
130178943|NCT04100018|468611544|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
130178944|NCT04100018|468611545|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
130178945|NCT04100018|468611544|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
130178946|NCT04100018|468611545|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
130178947|NCT04100018|468611544|FG000|Treatment Period|Ongoing Treatment|1|||
130178948|NCT04100018|468611545|FG001|Treatment Period|Ongoing Treatment|0|||
130178949|NCT04100018|468611544|FG000|Treatment Period|Other Reason|26|||
130178950|NCT04100018|468611545|FG001|Treatment Period|Other Reason|37|||
130178951|NCT04100018|468611544|FG000|Treatment Period|Completed treatment as per protocol|1|||
130178952|NCT04100018|468611545|FG001|Treatment Period|Completed treatment as per protocol|2|||
130178953|NCT04100018|468611544|FG000|Treatment Period|Maximum clinical benefit|3|||
130178954|NCT04100018|468611545|FG001|Treatment Period|Maximum clinical benefit|0|||
130178955|NCT04100018|468611544|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
130178956|NCT04100018|468611545|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
130178957|NCT04100018|468611544|FG000|Treatment Period|Study drug toxicity|67|||
130178958|NCT04100018|468611545|FG001|Treatment Period|Study drug toxicity|28|||
130178959|NCT04100018|468611544|FG000|Treatment Period|Disease Progression|284|||
130178960|NCT04100018|468611545|FG001|Treatment Period|Disease Progression|327|||
130178961|NCT04100018|468611544|FG000|Treatment Period|Administrative reasons by sponsor|16|||
130178962|NCT04100018|468611545|FG001|Treatment Period|Administrative reasons by sponsor|30|||
130178963|NCT04100018|468611544|FG000|Treatment Period|Poor/Non-Compliance|1|||
130178964|NCT04100018|468611545|FG001|Treatment Period|Poor/Non-Compliance|0|||
130178965|NCT04100018|468611544|FG000|Treatment Period|Lost to Follow-up|2|||
130178966|NCT04100018|468611545|FG001|Treatment Period|Lost to Follow-up|2|||
130178967|NCT04100018|468611544|FG000|Treatment Period|Death|16|||
130178968|NCT04100018|468611545|FG001|Treatment Period|Death|11|||
130178969|NCT04100018|468611544|FG000|Treatment Period|Participant withdrew consent|10|||
130178970|NCT04100018|468611545|FG001|Treatment Period|Participant withdrew consent|10|||
130178971|NCT04100018|468611544|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
130178972|NCT04100018|468611545|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
130178973|NCT04100018|468611544|FG000|Treatment Period|Adverse Event|14|||
130178974|NCT04100018|468611545|FG001|Treatment Period|Adverse Event|6|||
130178975|NCT04100018|468611544|FG000|Treatment Period|Lack of Efficacy|4|||
130178976|NCT04100018|468611545|FG001|Treatment Period|Lack of Efficacy|2|||
130178977|NCT02090725|468611550|FG000|Overall Study|Withdrawal by Subject|1|||
130178978|NCT02090725|468611550|FG000|Overall Study|participants moved from area|3|||
130178979|NCT04358081|468611551|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
130178980|NCT04358081|468611552|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
130178981|NCT04358081|468611553|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
130178982|NCT04358081|468611551|FG000|Treatment Phase of Study|Adverse Event|1|||
130178983|NCT04358081|468611552|FG001|Treatment Phase of Study|Adverse Event|0|||
130178984|NCT04358081|468611553|FG002|Treatment Phase of Study|Adverse Event|1|||
130178985|NCT04358081|468611551|FG000|Treatment Phase of Study|Physician Decision|2|||
130178986|NCT04358081|468611552|FG001|Treatment Phase of Study|Physician Decision|0|||
129982972|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
130178987|NCT04358081|468611553|FG002|Treatment Phase of Study|Physician Decision|1|||
130178988|NCT04358081|468611551|FG000|Treatment Phase of Study|Protocol Violation|1|||
130178989|NCT04358081|468611552|FG001|Treatment Phase of Study|Protocol Violation|0|||
130178990|NCT04358081|468611553|FG002|Treatment Phase of Study|Protocol Violation|0|||
130178991|NCT04358081|468611551|FG000|Study Completion Phase|Death|0|||
130178992|NCT04358081|468611552|FG001|Study Completion Phase|Death|0|||
130178993|NCT04358081|468611553|FG002|Study Completion Phase|Death|1|||
130178994|NCT04358081|468611551|FG000|Study Completion Phase|Lost to Follow-up|1|||
130178995|NCT04358081|468611552|FG001|Study Completion Phase|Lost to Follow-up|0|||
130178996|NCT04358081|468611553|FG002|Study Completion Phase|Lost to Follow-up|1|||
130178997|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
130178998|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
130178999|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
130179000|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
130179001|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
130179002|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
130179003|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
130179004|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
130179005|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
130179006|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
130179007|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
130179008|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
130179009|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
130179010|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
130179011|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
130179012|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
130179013|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
130179014|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
130179015|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
130179016|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
130179017|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
130179018|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
130179019|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
130179020|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
130179021|NCT01130532|468611554|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
130179022|NCT01130532|468611555|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
130179023|NCT01130532|468611556|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
130179024|NCT01130532|468611557|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
130179025|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
130179026|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
130179027|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
130179028|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
130179029|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130179030|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130179031|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
130179032|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
130179033|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130179034|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130179035|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
130179036|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
130179037|NCT01130532|468611554|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130179038|NCT01130532|468611555|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130179039|NCT01130532|468611556|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
130179040|NCT01130532|468611557|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
130179041|NCT02656303|468611558|FG000|Overall Study|Adverse Event|3|||
130179042|NCT02656303|468611559|FG001|Overall Study|Adverse Event|2|||
130179043|NCT02656303|468611560|FG002|Overall Study|Adverse Event|0|||
130179044|NCT02656303|468611558|FG000|Overall Study|Death|12|||
130179045|NCT02656303|468611559|FG001|Overall Study|Death|4|||
130179046|NCT02656303|468611560|FG002|Overall Study|Death|1|||
130179047|NCT02656303|468611558|FG000|Overall Study|Lack of Efficacy|1|||
130179048|NCT02656303|468611559|FG001|Overall Study|Lack of Efficacy|0|||
130179049|NCT02656303|468611560|FG002|Overall Study|Lack of Efficacy|0|||
130179050|NCT02656303|468611558|FG000|Overall Study|Non-Compliance with Study|1|||
130179051|NCT02656303|468611559|FG001|Overall Study|Non-Compliance with Study|1|||
130179052|NCT02656303|468611560|FG002|Overall Study|Non-Compliance with Study|0|||
130179053|NCT02656303|468611558|FG000|Overall Study|Investigator Decision|2|||
130179054|NCT02656303|468611559|FG001|Overall Study|Investigator Decision|1|||
130179055|NCT02656303|468611560|FG002|Overall Study|Investigator Decision|0|||
130179056|NCT02656303|468611558|FG000|Overall Study|Progressive Disease|25|||
130179057|NCT02656303|468611559|FG001|Overall Study|Progressive Disease|14|||
130179058|NCT02656303|468611560|FG002|Overall Study|Progressive Disease|10|||
130179059|NCT02656303|468611558|FG000|Overall Study|Study Terminated by Sponsor|20|||
130179060|NCT02656303|468611559|FG001|Overall Study|Study Terminated by Sponsor|7|||
130179061|NCT02656303|468611560|FG002|Overall Study|Study Terminated by Sponsor|5|||
130179062|NCT02656303|468611558|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
130179063|NCT02656303|468611559|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
130179064|NCT02656303|468611560|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
130179065|NCT02656303|468611558|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
130179066|NCT02656303|468611559|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
130179067|NCT02656303|468611560|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
130179068|NCT02656303|468611558|FG000|Overall Study|Reason not Specified|1|||
130179069|NCT02656303|468611559|FG001|Overall Study|Reason not Specified|1|||
130179070|NCT02656303|468611560|FG002|Overall Study|Reason not Specified|2|||
130179071|NCT03041311|468611561|FG000|Overall Study|Death|39|||
130179072|NCT03041311|468611562|FG001|Overall Study|Death|42|||
130179073|NCT03041311|468611561|FG000|Overall Study|Lost to Follow-up|0|||
130179074|NCT03041311|468611562|FG001|Overall Study|Lost to Follow-up|1|||
130179075|NCT03041311|468611561|FG000|Overall Study|Withdrawal by Subject|8|||
130179076|NCT03041311|468611562|FG001|Overall Study|Withdrawal by Subject|5|||
130179077|NCT03041311|468611561|FG000|Overall Study|Sponsor Terminated Study|2|||
130179078|NCT03041311|468611562|FG001|Overall Study|Sponsor Terminated Study|4|||
130179079|NCT03041311|468611561|FG000|Overall Study|Disease Progression|3|||
130179080|NCT03041311|468611562|FG001|Overall Study|Disease Progression|1|||
130179081|NCT03041311|468611561|FG000|Overall Study|Randomized in error, did not receive drug|2|||
130179082|NCT03041311|468611562|FG001|Overall Study|Randomized in error, did not receive drug|0|||
130179083|NCT01842438|468611563|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
130179084|NCT01842438|468611564|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
130179085|NCT01842438|468611563|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
130179086|NCT01842438|468611564|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
130179087|NCT01842438|468611563|FG000|T2: 6month Follow-up|Death|0|||
130179088|NCT01842438|468611564|FG001|T2: 6month Follow-up|Death|1|||
130179089|NCT00782626|468611568|FG000|Overall Study|Adverse Event|1|||
130179090|NCT00782626|468611568|FG000|Overall Study|Progressive Disease|5|||
130179091|NCT00782626|468611568|FG000|Overall Study|Other Complicating Disease|1|||
130179092|NCT04909853|468611569|FG000|Part 1|Assigned but not treated|0|||
130179093|NCT04909853|468611570|FG001|Part 1|Assigned but not treated|0|||
130179094|NCT04909853|468611571|FG002|Part 1|Assigned but not treated|1|||
130179095|NCT04909853|468611572|FG003|Part 1|Assigned but not treated|0|||
130179096|NCT04909853|468611569|FG000|Part 2|Adverse Event|0|||
130179097|NCT04909853|468611570|FG001|Part 2|Adverse Event|0|||
130179098|NCT04909853|468611571|FG002|Part 2|Adverse Event|0|||
130179099|NCT04909853|468611572|FG003|Part 2|Adverse Event|1|||
130179100|NCT04054765|468611573|FG000|Baseline|Withdrawal by Subject|5|||
130179101|NCT04054765|468611574|FG001|Baseline|Withdrawal by Subject|3|||
130179102|NCT04054765|468611573|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
130179103|NCT04054765|468611574|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
130179104|NCT04054765|468611573|FG000|3-month Follow up|Withdrawal by Subject|0|||
130179105|NCT04054765|468611574|FG001|3-month Follow up|Withdrawal by Subject|3|||
130179106|NCT04054765|468611573|FG000|6-month Follow up|Lost to Follow-up|32|||
130179107|NCT04054765|468611574|FG001|6-month Follow up|Lost to Follow-up|32|||
130179108|NCT00077207|468611576|FG000|Overall Study|Adverse Event|5|||
130179109|NCT00077207|468611576|FG000|Overall Study|Lack of Efficacy|12|||
130179110|NCT00077207|468611576|FG000|Overall Study|Physician Decision|6|||
130179111|NCT00077207|468611576|FG000|Overall Study|Withdrawal by Subject|6|||
130179112|NCT00077207|468611576|FG000|Overall Study|Ineligible|1|||
130179113|NCT04182490|468611577|FG000|Overall Study|Withdrawal by Subject|3|||
130179114|NCT04182490|468611578|FG001|Overall Study|Withdrawal by Subject|3|||
130179115|NCT04182490|468611577|FG000|Overall Study|Lost to Follow-up|0|||
130179116|NCT04182490|468611578|FG001|Overall Study|Lost to Follow-up|1|||
130179117|NCT04182490|468611577|FG000|Overall Study|Physician Decision|0|||
130179118|NCT04182490|468611578|FG001|Overall Study|Physician Decision|1|||
130179119|NCT00853099|468611579|FG000|Double-blind Period|Adverse Event|7|||
130179120|NCT00853099|468611580|FG001|Double-blind Period|Adverse Event|9|||
130179121|NCT00853099|468611581|FG002|Double-blind Period|Adverse Event|13|||
130179122|NCT00853099|468611582|FG003|Double-blind Period|Adverse Event|0|||
130179123|NCT00853099|468611579|FG000|Double-blind Period|Withdrawal by Subject|2|||
130179124|NCT00853099|468611580|FG001|Double-blind Period|Withdrawal by Subject|3|||
130179125|NCT00853099|468611581|FG002|Double-blind Period|Withdrawal by Subject|0|||
130179126|NCT00853099|468611582|FG003|Double-blind Period|Withdrawal by Subject|0|||
130179127|NCT00853099|468611579|FG000|Double-blind Period|Lack of Efficacy|14|||
130179128|NCT00853099|468611580|FG001|Double-blind Period|Lack of Efficacy|17|||
130179129|NCT00853099|468611581|FG002|Double-blind Period|Lack of Efficacy|16|||
130179130|NCT00853099|468611582|FG003|Double-blind Period|Lack of Efficacy|0|||
130179131|NCT00853099|468611579|FG000|Double-blind Period|Other|0|||
130179132|NCT00853099|468611580|FG001|Double-blind Period|Other|0|||
130179133|NCT00853099|468611581|FG002|Double-blind Period|Other|1|||
130179134|NCT00853099|468611582|FG003|Double-blind Period|Other|0|||
130179135|NCT00853099|468611579|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
130179136|NCT00853099|468611580|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
130179137|NCT00853099|468611581|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
130179138|NCT00853099|468611582|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
130179139|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130179140|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130179141|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
130179142|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
130179143|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
130179144|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
130179145|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
130179146|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
130179147|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130179148|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130179149|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
130179150|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
130179151|NCT00853099|468611579|FG000|Double-blind + Open-label Periods|Other|0|||
130179152|NCT00853099|468611580|FG001|Double-blind + Open-label Periods|Other|0|||
130179153|NCT00853099|468611581|FG002|Double-blind + Open-label Periods|Other|0|||
130179154|NCT00853099|468611582|FG003|Double-blind + Open-label Periods|Other|6|||
130179155|NCT01342081|468611591|FG000|Overall Study|Did not receive allocated intervention|0|||
130179156|NCT01342081|468611592|FG001|Overall Study|Did not receive allocated intervention|0|||
130179157|NCT01342081|468611593|FG002|Overall Study|Did not receive allocated intervention|1|||
130179158|NCT01342081|468611591|FG000|Overall Study|Adverse Event|1|||
130179159|NCT01342081|468611592|FG001|Overall Study|Adverse Event|0|||
130179160|NCT01342081|468611593|FG002|Overall Study|Adverse Event|0|||
130179161|NCT01342081|468611591|FG000|Overall Study|Physician Decision|0|||
130179162|NCT01342081|468611592|FG001|Overall Study|Physician Decision|1|||
130179163|NCT01342081|468611593|FG002|Overall Study|Physician Decision|0|||
130179164|NCT01342081|468611591|FG000|Overall Study|Withdrawal by Subject|1|||
130179165|NCT01342081|468611592|FG001|Overall Study|Withdrawal by Subject|1|||
130179166|NCT01342081|468611593|FG002|Overall Study|Withdrawal by Subject|0|||
130179167|NCT02790437|468611594|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
130179168|NCT02790437|468611595|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
130179169|NCT02790437|468611594|FG000|Overall Study|Adverse Event|1|||
130179170|NCT02790437|468611595|FG001|Overall Study|Adverse Event|0|||
130179171|NCT02790437|468611594|FG000|Overall Study|Withdrawal by Subject|1|||
130179172|NCT02790437|468611595|FG001|Overall Study|Withdrawal by Subject|0|||
130179173|NCT03908125|468611600|FG000|Overall Study|Withdrawal by Subject|92|||
130179174|NCT03908125|468611600|FG000|Overall Study|Lost to Follow-up|8|||
130179175|NCT01071915|468611601|FG000|Overall Study|Adverse Event|3|||
130179176|NCT01071915|468611601|FG000|Overall Study|Physician Decision|2|||
130179177|NCT01071915|468611601|FG000|Overall Study|Withdrawal by Subject|2|||
130179178|NCT01071915|468611601|FG000|Overall Study|Miscellaneous Reasons|2|||
130179179|NCT00114140|468611602|FG000|Overall Study|Protocol Violation|7|||
130179180|NCT00666328|468611606|FG000|Overall Study|Death|2|||
130179181|NCT00666328|468611606|FG000|Overall Study|Lost to Follow-up|2|||
130179182|NCT00666328|468611606|FG000|Overall Study|No longer met eligibility criteria|1|||
130179183|NCT03885661|468611609|FG000|Overall Study|Withdrawal by Subject|0|||
130179184|NCT03885661|468611610|FG001|Overall Study|Withdrawal by Subject|1|||
130179185|NCT03885661|468611609|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
130179186|NCT03885661|468611610|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
130179187|NCT05064397|468611611|FG000|Overall Study|Adverse Event|4|||
130179188|NCT05064397|468611611|FG000|Overall Study|Lack of Efficacy|12|||
130179189|NCT05064397|468611611|FG000|Overall Study|Withdrawal by Subject|3|||
130179190|NCT05064397|468611611|FG000|Overall Study|Lost to Follow-up|1|||
130179191|NCT05064397|468611611|FG000|Overall Study|Other reasons|3|||
130179192|NCT02232984|468611612|FG000|Overall Study|Withdrawal by Subject|5|||
130179193|NCT02232984|468611612|FG000|Overall Study|Death|1|||
129982973|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129982974|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
129982975|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129982976|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
130179194|NCT02232984|468611612|FG000|Overall Study|Investigator withdrawal|10|||
130179195|NCT02232984|468611612|FG000|Overall Study|Device implant unsuccessful|53|||
130179196|NCT02232984|468611612|FG000|Overall Study|not disclosed by site|7|||
130179197|NCT02232984|468611612|FG000|Overall Study|Protocol Violation|1|||
130179198|NCT00535405|468611617|FG000|Overall Study|Adverse Event|6|||
130179199|NCT00535405|468611618|FG001|Overall Study|Adverse Event|8|||
130179200|NCT00535405|468611619|FG002|Overall Study|Adverse Event|3|||
130179201|NCT00535405|468611620|FG003|Overall Study|Adverse Event|8|||
130179202|NCT00535405|468611621|FG004|Overall Study|Adverse Event|6|||
130179203|NCT00535405|468611617|FG000|Overall Study|Lost to Follow-up|1|||
130179204|NCT00535405|468611618|FG001|Overall Study|Lost to Follow-up|3|||
130179205|NCT00535405|468611619|FG002|Overall Study|Lost to Follow-up|3|||
130179206|NCT00535405|468611620|FG003|Overall Study|Lost to Follow-up|2|||
130179207|NCT00535405|468611621|FG004|Overall Study|Lost to Follow-up|1|||
130179208|NCT00535405|468611617|FG000|Overall Study|Physician Decision|3|||
130179209|NCT00535405|468611618|FG001|Overall Study|Physician Decision|2|||
130179210|NCT00535405|468611619|FG002|Overall Study|Physician Decision|0|||
130179211|NCT00535405|468611620|FG003|Overall Study|Physician Decision|1|||
130179212|NCT00535405|468611621|FG004|Overall Study|Physician Decision|1|||
130179213|NCT00535405|468611617|FG000|Overall Study|Protocol Violation|2|||
130179214|NCT00535405|468611618|FG001|Overall Study|Protocol Violation|2|||
130179215|NCT00535405|468611619|FG002|Overall Study|Protocol Violation|2|||
130179216|NCT00535405|468611620|FG003|Overall Study|Protocol Violation|1|||
130179217|NCT00535405|468611621|FG004|Overall Study|Protocol Violation|0|||
130179218|NCT00535405|468611617|FG000|Overall Study|Withdrawal by Subject|5|||
130179219|NCT00535405|468611618|FG001|Overall Study|Withdrawal by Subject|11|||
130179220|NCT00535405|468611619|FG002|Overall Study|Withdrawal by Subject|10|||
130179221|NCT00535405|468611620|FG003|Overall Study|Withdrawal by Subject|10|||
130179222|NCT00535405|468611621|FG004|Overall Study|Withdrawal by Subject|8|||
130179223|NCT02969044|468611624|FG000|Overall Study|Withdrawal by Subject|2|||
130179224|NCT02969044|468611625|FG001|Overall Study|Withdrawal by Subject|6|||
130179225|NCT02969044|468611624|FG000|Overall Study|Adverse Event|3|||
130179226|NCT02969044|468611625|FG001|Overall Study|Adverse Event|0|||
130179227|NCT04728802|468611626|FG000|Overall Study|Withdrawal by Subject|4|||
130179228|NCT04728802|468611627|FG001|Overall Study|Withdrawal by Subject|20|||
130179229|NCT04728802|468611626|FG000|Overall Study|Physician Decision|7|||
130179230|NCT04728802|468611627|FG001|Overall Study|Physician Decision|7|||
130179231|NCT04728802|468611626|FG000|Overall Study|Protocol Violation|10|||
130179232|NCT04728802|468611627|FG001|Overall Study|Protocol Violation|4|||
130179233|NCT04728802|468611626|FG000|Overall Study|Transfer|1|||
130179234|NCT04728802|468611627|FG001|Overall Study|Transfer|0|||
130179235|NCT04728802|468611626|FG000|Overall Study|Death|4|||
130179236|NCT04728802|468611627|FG001|Overall Study|Death|5|||
130179237|NCT04728802|468611626|FG000|Overall Study|Other|3|||
130179238|NCT04728802|468611627|FG001|Overall Study|Other|0|||
130179239|NCT01176513|468611628|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
130179240|NCT03164616|468611632|FG000|Overall Study|Death|250|||
130179241|NCT03164616|468611633|FG001|Overall Study|Death|264|||
130179242|NCT03164616|468611634|FG002|Overall Study|Death|279|||
130179243|NCT03164616|468611632|FG000|Overall Study|Lost to Follow-up|2|||
130179244|NCT03164616|468611633|FG001|Overall Study|Lost to Follow-up|2|||
130179245|NCT03164616|468611634|FG002|Overall Study|Lost to Follow-up|2|||
130179246|NCT03164616|468611632|FG000|Overall Study|Withdrawal by Subject|6|||
130179247|NCT03164616|468611633|FG001|Overall Study|Withdrawal by Subject|7|||
130179248|NCT03164616|468611634|FG002|Overall Study|Withdrawal by Subject|16|||
130179249|NCT00489255|468611646|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
130179250|NCT00489255|468611647|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
130179251|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
130179252|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
130179253|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
130179254|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
130179255|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
130179256|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
130179257|NCT00489255|468611646|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
130179258|NCT00489255|468611647|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
130179259|NCT00489255|468611646|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
130179260|NCT00489255|468611647|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
130179261|NCT00489255|468611646|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
130179262|NCT00489255|468611647|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
130179263|NCT00489255|468611646|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
130179264|NCT00489255|468611647|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
130179265|NCT00489255|468611646|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
130179266|NCT00489255|468611647|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
130179267|NCT00489255|468611646|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
130179268|NCT00489255|468611647|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
130179269|NCT01625091|468611648|FG000|Intervention|Death|1|||
130179270|NCT01625091|468611649|FG001|Intervention|Death|1|||
130179271|NCT01625091|468611648|FG000|Intervention|Withdrawal by Subject|4|||
130179272|NCT01625091|468611649|FG001|Intervention|Withdrawal by Subject|1|||
130179273|NCT01625091|468611648|FG000|Intervention|Adverse Event|0|||
130179274|NCT01625091|468611649|FG001|Intervention|Adverse Event|2|||
130179275|NCT01625091|468611648|FG000|Intervention|Lost to Follow-up|4|||
130179276|NCT01625091|468611649|FG001|Intervention|Lost to Follow-up|4|||
130179277|NCT01625091|468611648|FG000|Intervention|Study termination|2|||
130179278|NCT01625091|468611649|FG001|Intervention|Study termination|3|||
130179279|NCT01625091|468611648|FG000|Post-intervention|Death|0|||
130179280|NCT01625091|468611649|FG001|Post-intervention|Death|1|||
130179281|NCT01625091|468611648|FG000|Post-intervention|Lost to Follow-up|2|||
130179282|NCT01625091|468611649|FG001|Post-intervention|Lost to Follow-up|0|||
130179283|NCT01625091|468611648|FG000|Post-intervention|Study termination|2|||
130179284|NCT01625091|468611649|FG001|Post-intervention|Study termination|1|||
130179285|NCT03130777|468613530|FG000|Overall Study|Death|0|||
130179286|NCT03130777|468613531|FG001|Overall Study|Death|1|||
130179287|NCT03130777|468613530|FG000|Overall Study|Did not meet eligibility criteria|1|||
130179288|NCT03130777|468613531|FG001|Overall Study|Did not meet eligibility criteria|0|||
130179289|NCT05109611|468613532|FG000|Overall Study|Adverse Event|13|||
130179290|NCT05109611|468613533|FG001|Overall Study|Adverse Event|10|||
130179291|NCT05109611|468613532|FG000|Overall Study|Withdrawal by Subject|1|||
130179292|NCT05109611|468613533|FG001|Overall Study|Withdrawal by Subject|0|||
130179293|NCT05109611|468613532|FG000|Overall Study|Lost to Follow-up|1|||
130179294|NCT05109611|468613533|FG001|Overall Study|Lost to Follow-up|2|||
130179295|NCT05109611|468613532|FG000|Overall Study|Protocol Violation|0|||
130179296|NCT05109611|468613533|FG001|Overall Study|Protocol Violation|4|||
130179297|NCT05109611|468613532|FG000|Overall Study|Information unavailable|1|||
130179298|NCT05109611|468613533|FG001|Overall Study|Information unavailable|1|||
130179299|NCT06195930|468613536|FG000|Overall Study|Adverse Event|4|||
130179300|NCT04995029|468613537|FG000|Induction Phase|Did not meet eligibility criteria|5|||
130179301|NCT04995029|468613538|FG001|Induction Phase|Did not meet eligibility criteria|2|||
130179302|NCT04995029|468613539|FG002|Induction Phase|Did not meet eligibility criteria|0|||
130179303|NCT04995029|468613540|FG003|Induction Phase|Did not meet eligibility criteria|0|||
130179304|NCT04995029|468613537|FG000|Induction Phase|Withdrawal by Subject|85|||
130179305|NCT04995029|468613538|FG001|Induction Phase|Withdrawal by Subject|42|||
130179306|NCT04995029|468613539|FG002|Induction Phase|Withdrawal by Subject|0|||
130179307|NCT04995029|468613540|FG003|Induction Phase|Withdrawal by Subject|0|||
130179308|NCT04995029|468613537|FG000|Induction Phase|Lost to Follow-up|103|||
130179309|NCT04995029|468613538|FG001|Induction Phase|Lost to Follow-up|67|||
130179310|NCT04995029|468613539|FG002|Induction Phase|Lost to Follow-up|0|||
130179311|NCT04995029|468613540|FG003|Induction Phase|Lost to Follow-up|0|||
130179312|NCT04995029|468613537|FG000|Induction Phase|Adverse Event|5|||
130179313|NCT04995029|468613538|FG001|Induction Phase|Adverse Event|3|||
130179314|NCT04995029|468613539|FG002|Induction Phase|Adverse Event|0|||
130179315|NCT04995029|468613540|FG003|Induction Phase|Adverse Event|0|||
130179316|NCT04995029|468613537|FG000|Induction Phase|Physician Decision|11|||
130179317|NCT04995029|468613538|FG001|Induction Phase|Physician Decision|8|||
130179318|NCT04995029|468613539|FG002|Induction Phase|Physician Decision|0|||
130179319|NCT04995029|468613540|FG003|Induction Phase|Physician Decision|0|||
130179320|NCT04995029|468613537|FG000|Induction Phase|Incarceration|6|||
130179321|NCT04995029|468613538|FG001|Induction Phase|Incarceration|3|||
130179322|NCT04995029|468613539|FG002|Induction Phase|Incarceration|0|||
130179323|NCT04995029|468613540|FG003|Induction Phase|Incarceration|0|||
130179324|NCT04995029|468613537|FG000|Induction Phase|Not otherwise described|5|||
130179325|NCT04995029|468613538|FG001|Induction Phase|Not otherwise described|5|||
130179326|NCT04995029|468613539|FG002|Induction Phase|Not otherwise described|0|||
130179327|NCT04995029|468613540|FG003|Induction Phase|Not otherwise described|0|||
130179328|NCT04995029|468613537|FG000|Maintenance Phase|Lost to Follow-up|0|||
130179329|NCT04995029|468613538|FG001|Maintenance Phase|Lost to Follow-up|0|||
130179330|NCT04995029|468613539|FG002|Maintenance Phase|Lost to Follow-up|51|||
130179331|NCT04995029|468613540|FG003|Maintenance Phase|Lost to Follow-up|44|||
130179332|NCT04995029|468613537|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
130179333|NCT04995029|468613538|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
130179334|NCT04995029|468613539|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
130179335|NCT04995029|468613540|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
130179336|NCT04995029|468613537|FG000|Maintenance Phase|Adverse Event|0|||
130179337|NCT04995029|468613538|FG001|Maintenance Phase|Adverse Event|0|||
130179338|NCT04995029|468613539|FG002|Maintenance Phase|Adverse Event|0|||
130179339|NCT04995029|468613540|FG003|Maintenance Phase|Adverse Event|1|||
130179340|NCT04995029|468613537|FG000|Maintenance Phase|Physician Decision|0|||
130179341|NCT04995029|468613538|FG001|Maintenance Phase|Physician Decision|0|||
130179342|NCT04995029|468613539|FG002|Maintenance Phase|Physician Decision|8|||
130179343|NCT04995029|468613540|FG003|Maintenance Phase|Physician Decision|4|||
130179344|NCT04995029|468613537|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130179345|NCT04995029|468613538|FG001|Maintenance Phase|Withdrawal by Subject|0|||
130179346|NCT04995029|468613539|FG002|Maintenance Phase|Withdrawal by Subject|17|||
130179347|NCT04995029|468613540|FG003|Maintenance Phase|Withdrawal by Subject|31|||
130179348|NCT04995029|468613537|FG000|Maintenance Phase|Incarceration|0|||
130179349|NCT04995029|468613538|FG001|Maintenance Phase|Incarceration|0|||
130179350|NCT04995029|468613539|FG002|Maintenance Phase|Incarceration|4|||
130179351|NCT04995029|468613540|FG003|Maintenance Phase|Incarceration|3|||
130179352|NCT04995029|468613537|FG000|Maintenance Phase|Not otherwise described|0|||
130179353|NCT04995029|468613538|FG001|Maintenance Phase|Not otherwise described|0|||
130179354|NCT04995029|468613539|FG002|Maintenance Phase|Not otherwise described|2|||
130179355|NCT04995029|468613540|FG003|Maintenance Phase|Not otherwise described|3|||
130179356|NCT04995029|468613537|FG000|Maintenance Phase|Pregnancy|0|||
130179357|NCT04995029|468613538|FG001|Maintenance Phase|Pregnancy|0|||
130179358|NCT04995029|468613539|FG002|Maintenance Phase|Pregnancy|2|||
130179359|NCT04995029|468613540|FG003|Maintenance Phase|Pregnancy|2|||
130179360|NCT00970593|468613547|FG000|Overall Study|Adverse Event|1|||
130179361|NCT00970593|468613548|FG001|Overall Study|Adverse Event|1|||
130179362|NCT00970593|468613549|FG002|Overall Study|Adverse Event|0|||
130179363|NCT00970593|468613550|FG003|Overall Study|Adverse Event|0|||
130179364|NCT00970593|468613551|FG004|Overall Study|Adverse Event|0|||
130179365|NCT00970593|468613552|FG005|Overall Study|Adverse Event|0|||
130179366|NCT00970593|468613553|FG006|Overall Study|Adverse Event|0|||
130179367|NCT00970593|468613547|FG000|Overall Study|Discontinuation of study by sponsor|0|||
130179368|NCT00970593|468613548|FG001|Overall Study|Discontinuation of study by sponsor|0|||
130179369|NCT00970593|468613549|FG002|Overall Study|Discontinuation of study by sponsor|5|||
130179370|NCT00970593|468613550|FG003|Overall Study|Discontinuation of study by sponsor|0|||
130179371|NCT00970593|468613551|FG004|Overall Study|Discontinuation of study by sponsor|0|||
130179372|NCT00970593|468613552|FG005|Overall Study|Discontinuation of study by sponsor|0|||
130179373|NCT00970593|468613553|FG006|Overall Study|Discontinuation of study by sponsor|2|||
130179374|NCT00970593|468613547|FG000|Overall Study|Withdrawal by Subject|0|||
130179375|NCT00970593|468613548|FG001|Overall Study|Withdrawal by Subject|0|||
130179376|NCT00970593|468613549|FG002|Overall Study|Withdrawal by Subject|1|||
130179377|NCT00970593|468613550|FG003|Overall Study|Withdrawal by Subject|0|||
130179378|NCT00970593|468613551|FG004|Overall Study|Withdrawal by Subject|0|||
130179379|NCT00970593|468613552|FG005|Overall Study|Withdrawal by Subject|0|||
130179380|NCT00970593|468613553|FG006|Overall Study|Withdrawal by Subject|0|||
130179381|NCT03889886|468613561|FG000|Overall Study|Other|0|||
130179382|NCT03889886|468613562|FG001|Overall Study|Other|1|||
130179383|NCT03889886|468613563|FG002|Overall Study|Other|0|||
130179384|NCT03889886|468613564|FG003|Overall Study|Other|1|||
130179385|NCT03889886|468613561|FG000|Overall Study|Withdrawal by Subject|0|||
130179386|NCT03889886|468613562|FG001|Overall Study|Withdrawal by Subject|0|||
130179387|NCT03889886|468613563|FG002|Overall Study|Withdrawal by Subject|1|||
130179388|NCT03889886|468613564|FG003|Overall Study|Withdrawal by Subject|0|||
130179389|NCT03889886|468613561|FG000|Overall Study|Adverse Event|0|||
130179390|NCT03889886|468613562|FG001|Overall Study|Adverse Event|0|||
130179391|NCT03889886|468613563|FG002|Overall Study|Adverse Event|0|||
130179392|NCT03889886|468613564|FG003|Overall Study|Adverse Event|6|||
130179393|NCT04176250|468613565|FG000|Overall Study|Adverse Event|0|||
130179394|NCT04176250|468613566|FG001|Overall Study|Adverse Event|1|||
130179395|NCT04176250|468613567|FG002|Overall Study|Adverse Event|0|||
130179396|NCT04176250|468613568|FG003|Overall Study|Adverse Event|1|||
130179397|NCT04176250|468613569|FG004|Overall Study|Adverse Event|0|||
130179398|NCT04176250|468613570|FG005|Overall Study|Adverse Event|1|||
130179399|NCT04176250|468613565|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179400|NCT04176250|468613566|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179401|NCT04176250|468613567|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
130179402|NCT04176250|468613568|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
130179403|NCT04176250|468613569|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179404|NCT04176250|468613570|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
130179405|NCT04176250|468613565|FG000|Overall Study|Withdrawal by Subject|0|||
130179406|NCT04176250|468613566|FG001|Overall Study|Withdrawal by Subject|0|||
130179407|NCT04176250|468613567|FG002|Overall Study|Withdrawal by Subject|0|||
130179408|NCT04176250|468613568|FG003|Overall Study|Withdrawal by Subject|0|||
130179409|NCT04176250|468613569|FG004|Overall Study|Withdrawal by Subject|0|||
130179410|NCT04176250|468613570|FG005|Overall Study|Withdrawal by Subject|1|||
130179411|NCT04176250|468613565|FG000|Overall Study|Randomized in error|0|||
130179412|NCT04176250|468613566|FG001|Overall Study|Randomized in error|0|||
130179413|NCT04176250|468613567|FG002|Overall Study|Randomized in error|0|||
130179414|NCT04176250|468613568|FG003|Overall Study|Randomized in error|0|||
130179415|NCT04176250|468613569|FG004|Overall Study|Randomized in error|1|||
130179416|NCT04176250|468613570|FG005|Overall Study|Randomized in error|0|||
130179417|NCT04747470|468613586|FG000|Overall Study|Death|0|||
130179418|NCT04747470|468613587|FG001|Overall Study|Death|3|||
130179419|NCT04747470|468613588|FG002|Overall Study|Death|2|||
130179420|NCT04747470|468613589|FG003|Overall Study|Death|2|||
130179421|NCT04747470|468613590|FG004|Overall Study|Death|2|||
130179422|NCT04747470|468613591|FG005|Overall Study|Death|0|||
130179423|NCT04747470|468613592|FG006|Overall Study|Death|0|||
130179424|NCT04747470|468613593|FG007|Overall Study|Death|0|||
130179425|NCT04747470|468613594|FG008|Overall Study|Death|0|||
130179426|NCT04747470|468613595|FG009|Overall Study|Death|0|||
130179427|NCT04747470|468613596|FG010|Overall Study|Death|0|||
130179428|NCT04747470|468613586|FG000|Overall Study|Withdrew Consent|0|||
130179429|NCT04747470|468613587|FG001|Overall Study|Withdrew Consent|0|||
130179430|NCT04747470|468613588|FG002|Overall Study|Withdrew Consent|0|||
130179431|NCT04747470|468613589|FG003|Overall Study|Withdrew Consent|1|||
130179432|NCT04747470|468613590|FG004|Overall Study|Withdrew Consent|0|||
130179433|NCT04747470|468613591|FG005|Overall Study|Withdrew Consent|0|||
130179434|NCT04747470|468613592|FG006|Overall Study|Withdrew Consent|0|||
130179435|NCT04747470|468613593|FG007|Overall Study|Withdrew Consent|0|||
130179436|NCT04747470|468613594|FG008|Overall Study|Withdrew Consent|0|||
130179437|NCT04747470|468613595|FG009|Overall Study|Withdrew Consent|0|||
130179438|NCT04747470|468613596|FG010|Overall Study|Withdrew Consent|0|||
130179439|NCT04747470|468613586|FG000|Overall Study|Study Terminated by Sponsor|0|||
130179440|NCT04747470|468613587|FG001|Overall Study|Study Terminated by Sponsor|0|||
130179441|NCT04747470|468613588|FG002|Overall Study|Study Terminated by Sponsor|1|||
130179442|NCT04747470|468613589|FG003|Overall Study|Study Terminated by Sponsor|0|||
130179443|NCT04747470|468613590|FG004|Overall Study|Study Terminated by Sponsor|2|||
130179444|NCT04747470|468613591|FG005|Overall Study|Study Terminated by Sponsor|0|||
130179445|NCT04747470|468613592|FG006|Overall Study|Study Terminated by Sponsor|0|||
130179446|NCT04747470|468613593|FG007|Overall Study|Study Terminated by Sponsor|0|||
130179447|NCT04747470|468613594|FG008|Overall Study|Study Terminated by Sponsor|0|||
130179448|NCT04747470|468613595|FG009|Overall Study|Study Terminated by Sponsor|0|||
130179449|NCT04747470|468613596|FG010|Overall Study|Study Terminated by Sponsor|0|||
130179450|NCT01202175|468613597|FG000|Overall Study|Lost to Follow-up|2|||
130179451|NCT01202175|468613597|FG000|Overall Study|Withdrawal by Subject|1|||
130179452|NCT01202175|468613597|FG000|Overall Study|Adverse Event|2|||
130179453|NCT04688671|468613601|FG000|Overall Study|Adverse Event|3|||
130179454|NCT04688671|468613602|FG001|Overall Study|Adverse Event|1|||
130179455|NCT04688671|468613601|FG000|Overall Study|Withdrawal by Subject|3|||
130179456|NCT04688671|468613602|FG001|Overall Study|Withdrawal by Subject|1|||
130179457|NCT04688671|468613601|FG000|Overall Study|Lack of Efficacy|1|||
130179458|NCT04688671|468613602|FG001|Overall Study|Lack of Efficacy|1|||
130179459|NCT04688671|468613601|FG000|Overall Study|Protocol Violation|1|||
130179460|NCT04688671|468613602|FG001|Overall Study|Protocol Violation|0|||
130179461|NCT04688671|468613601|FG000|Overall Study|Lost to Follow-up|0|||
130179462|NCT04688671|468613602|FG001|Overall Study|Lost to Follow-up|1|||
130179463|NCT04720053|468613603|FG000|Overall Study|Lost to Follow-up|12|||
130179464|NCT01942993|468613604|FG000|Overall Study|Lost to Follow-up|1|||
130179465|NCT01942993|468613604|FG000|Overall Study|Physician Decision|1|||
130179466|NCT01350271|468613605|FG000|Overall Study|Lost to Follow-up|21|||
130179467|NCT01350271|468613606|FG001|Overall Study|Lost to Follow-up|17|||
130179468|NCT01350271|468613607|FG002|Overall Study|Lost to Follow-up|26|||
130179469|NCT02906670|468613611|FG000|Cohort 1, QW|Radiological Progression|1|||
130179470|NCT02906670|468613612|FG001|Cohort 1, QW|Radiological Progression|0|||
130179471|NCT02906670|468613613|FG002|Cohort 1, QW|Radiological Progression|0|||
130179472|NCT02906670|468613614|FG003|Cohort 1, QW|Radiological Progression|0|||
130179473|NCT02906670|468613615|FG004|Cohort 1, QW|Radiological Progression|0|||
130179474|NCT02906670|468613616|FG005|Cohort 1, QW|Radiological Progression|0|||
130179475|NCT02906670|468613617|FG006|Cohort 1, QW|Radiological Progression|0|||
130179476|NCT02906670|468613618|FG007|Cohort 1, QW|Radiological Progression|0|||
130179477|NCT02906670|468613619|FG008|Cohort 1, QW|Radiological Progression|0|||
130179478|NCT02906670|468613620|FG009|Cohort 1, QW|Radiological Progression|0|||
130179479|NCT02906670|468613611|FG000|Cohort 2, QW|Radiological Progression|0|||
130179480|NCT02906670|468613612|FG001|Cohort 2, QW|Radiological Progression|1|||
130179481|NCT02906670|468613613|FG002|Cohort 2, QW|Radiological Progression|0|||
130179482|NCT02906670|468613614|FG003|Cohort 2, QW|Radiological Progression|0|||
130179483|NCT02906670|468613615|FG004|Cohort 2, QW|Radiological Progression|0|||
130179484|NCT02906670|468613616|FG005|Cohort 2, QW|Radiological Progression|0|||
130179485|NCT02906670|468613617|FG006|Cohort 2, QW|Radiological Progression|0|||
130179486|NCT02906670|468613618|FG007|Cohort 2, QW|Radiological Progression|0|||
130179487|NCT02906670|468613619|FG008|Cohort 2, QW|Radiological Progression|0|||
130179488|NCT02906670|468613620|FG009|Cohort 2, QW|Radiological Progression|0|||
130179489|NCT02906670|468613611|FG000|Cohort 3, QW|Radiological Progression|0|||
130179490|NCT02906670|468613612|FG001|Cohort 3, QW|Radiological Progression|0|||
130179491|NCT02906670|468613613|FG002|Cohort 3, QW|Radiological Progression|2|||
130179492|NCT02906670|468613614|FG003|Cohort 3, QW|Radiological Progression|0|||
130179493|NCT02906670|468613615|FG004|Cohort 3, QW|Radiological Progression|0|||
130179494|NCT02906670|468613616|FG005|Cohort 3, QW|Radiological Progression|0|||
130179495|NCT02906670|468613617|FG006|Cohort 3, QW|Radiological Progression|0|||
130179496|NCT02906670|468613618|FG007|Cohort 3, QW|Radiological Progression|0|||
130179497|NCT02906670|468613619|FG008|Cohort 3, QW|Radiological Progression|0|||
130179498|NCT02906670|468613620|FG009|Cohort 3, QW|Radiological Progression|0|||
130179499|NCT02906670|468613611|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179500|NCT02906670|468613612|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179501|NCT02906670|468613613|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
130179502|NCT02906670|468613614|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179503|NCT02906670|468613615|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179504|NCT02906670|468613616|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179505|NCT02906670|468613617|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179506|NCT02906670|468613618|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179507|NCT02906670|468613619|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179508|NCT02906670|468613620|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
130179509|NCT02906670|468613611|FG000|Cohort 4, Q2W|Radiological Progression|0|||
130179510|NCT02906670|468613612|FG001|Cohort 4, Q2W|Radiological Progression|0|||
130179511|NCT02906670|468613613|FG002|Cohort 4, Q2W|Radiological Progression|0|||
130179512|NCT02906670|468613614|FG003|Cohort 4, Q2W|Radiological Progression|0|||
130179513|NCT02906670|468613615|FG004|Cohort 4, Q2W|Radiological Progression|0|||
130179514|NCT02906670|468613616|FG005|Cohort 4, Q2W|Radiological Progression|1|||
130179515|NCT02906670|468613617|FG006|Cohort 4, Q2W|Radiological Progression|0|||
130179516|NCT02906670|468613618|FG007|Cohort 4, Q2W|Radiological Progression|0|||
130179517|NCT02906670|468613619|FG008|Cohort 4, Q2W|Radiological Progression|0|||
130179518|NCT02906670|468613620|FG009|Cohort 4, Q2W|Radiological Progression|0|||
130179519|NCT02906670|468613611|FG000|Cohort 4, Q2W|Clinical Progression|0|||
130179520|NCT02906670|468613612|FG001|Cohort 4, Q2W|Clinical Progression|0|||
130179521|NCT02906670|468613613|FG002|Cohort 4, Q2W|Clinical Progression|0|||
130179522|NCT02906670|468613614|FG003|Cohort 4, Q2W|Clinical Progression|0|||
130179523|NCT02906670|468613615|FG004|Cohort 4, Q2W|Clinical Progression|0|||
130179524|NCT02906670|468613616|FG005|Cohort 4, Q2W|Clinical Progression|2|||
130179525|NCT02906670|468613617|FG006|Cohort 4, Q2W|Clinical Progression|0|||
130179526|NCT02906670|468613618|FG007|Cohort 4, Q2W|Clinical Progression|0|||
130179527|NCT02906670|468613619|FG008|Cohort 4, Q2W|Clinical Progression|0|||
130179528|NCT02906670|468613620|FG009|Cohort 4, Q2W|Clinical Progression|0|||
130179529|NCT02906670|468613611|FG000|Cohort 5, Q2W|Radiological Progression|0|||
130179530|NCT02906670|468613612|FG001|Cohort 5, Q2W|Radiological Progression|0|||
130179531|NCT02906670|468613613|FG002|Cohort 5, Q2W|Radiological Progression|0|||
130179532|NCT02906670|468613614|FG003|Cohort 5, Q2W|Radiological Progression|0|||
130179533|NCT02906670|468613615|FG004|Cohort 5, Q2W|Radiological Progression|0|||
130179534|NCT02906670|468613616|FG005|Cohort 5, Q2W|Radiological Progression|0|||
130179535|NCT02906670|468613617|FG006|Cohort 5, Q2W|Radiological Progression|4|||
130179536|NCT02906670|468613618|FG007|Cohort 5, Q2W|Radiological Progression|0|||
130179537|NCT02906670|468613619|FG008|Cohort 5, Q2W|Radiological Progression|0|||
130179538|NCT02906670|468613620|FG009|Cohort 5, Q2W|Radiological Progression|0|||
130179539|NCT02906670|468613611|FG000|Cohort 5, Q2W|Clinical Progression|0|||
130179540|NCT02906670|468613612|FG001|Cohort 5, Q2W|Clinical Progression|0|||
130179541|NCT02906670|468613613|FG002|Cohort 5, Q2W|Clinical Progression|0|||
130179542|NCT02906670|468613614|FG003|Cohort 5, Q2W|Clinical Progression|0|||
130179543|NCT02906670|468613615|FG004|Cohort 5, Q2W|Clinical Progression|0|||
130179544|NCT02906670|468613616|FG005|Cohort 5, Q2W|Clinical Progression|0|||
130179545|NCT02906670|468613617|FG006|Cohort 5, Q2W|Clinical Progression|1|||
130179546|NCT02906670|468613618|FG007|Cohort 5, Q2W|Clinical Progression|0|||
130179547|NCT02906670|468613619|FG008|Cohort 5, Q2W|Clinical Progression|0|||
130179548|NCT02906670|468613620|FG009|Cohort 5, Q2W|Clinical Progression|0|||
130179549|NCT02906670|468613611|FG000|Cohort 5, Q2W|Adverse Event|0|||
130179550|NCT02906670|468613612|FG001|Cohort 5, Q2W|Adverse Event|0|||
130179551|NCT02906670|468613613|FG002|Cohort 5, Q2W|Adverse Event|0|||
130179552|NCT02906670|468613614|FG003|Cohort 5, Q2W|Adverse Event|0|||
130179553|NCT02906670|468613615|FG004|Cohort 5, Q2W|Adverse Event|0|||
130179554|NCT02906670|468613616|FG005|Cohort 5, Q2W|Adverse Event|0|||
130179555|NCT02906670|468613617|FG006|Cohort 5, Q2W|Adverse Event|1|||
130179556|NCT02906670|468613618|FG007|Cohort 5, Q2W|Adverse Event|0|||
130179557|NCT02906670|468613619|FG008|Cohort 5, Q2W|Adverse Event|0|||
130179558|NCT02906670|468613620|FG009|Cohort 5, Q2W|Adverse Event|0|||
130179559|NCT02906670|468613611|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179560|NCT02906670|468613612|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179561|NCT02906670|468613613|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179562|NCT02906670|468613614|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179563|NCT02906670|468613615|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179564|NCT02906670|468613616|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179565|NCT02906670|468613617|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
130179566|NCT02906670|468613618|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179567|NCT02906670|468613619|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179568|NCT02906670|468613620|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
130179569|NCT02906670|468613611|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
130179570|NCT02906670|468613612|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
130179571|NCT02906670|468613613|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
130179572|NCT02906670|468613614|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
130179573|NCT02906670|468613615|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
130179574|NCT02906670|468613616|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
130179575|NCT02906670|468613617|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
130179576|NCT02906670|468613618|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
130179577|NCT02906670|468613619|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
130179578|NCT02906670|468613620|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
130179579|NCT02906670|468613611|FG000|Cohort 5P, Q2W|Adverse Event|0|||
130179580|NCT02906670|468613612|FG001|Cohort 5P, Q2W|Adverse Event|0|||
130179581|NCT02906670|468613613|FG002|Cohort 5P, Q2W|Adverse Event|0|||
130179582|NCT02906670|468613614|FG003|Cohort 5P, Q2W|Adverse Event|0|||
130179583|NCT02906670|468613615|FG004|Cohort 5P, Q2W|Adverse Event|0|||
130179584|NCT02906670|468613616|FG005|Cohort 5P, Q2W|Adverse Event|0|||
130179585|NCT02906670|468613617|FG006|Cohort 5P, Q2W|Adverse Event|0|||
130179586|NCT02906670|468613618|FG007|Cohort 5P, Q2W|Adverse Event|1|||
130179587|NCT02906670|468613619|FG008|Cohort 5P, Q2W|Adverse Event|0|||
130179588|NCT02906670|468613620|FG009|Cohort 5P, Q2W|Adverse Event|0|||
130179589|NCT02906670|468613611|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
130179590|NCT02906670|468613612|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
130179591|NCT02906670|468613613|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
130179592|NCT02906670|468613614|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
130179593|NCT02906670|468613615|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
130179594|NCT02906670|468613616|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
130179595|NCT02906670|468613617|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
130179596|NCT02906670|468613618|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
129982977|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129982978|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
129982979|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
129982980|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
129982981|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
129982982|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
129982983|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
129982984|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
129982985|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
129982986|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
129982987|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
129982988|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
129982989|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
129982990|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
129982991|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
129982992|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
129982993|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
129982994|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
129982995|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
129982996|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
129982997|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
129982998|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
129982999|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
129983000|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
129983001|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
129983002|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
129983003|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983004|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983005|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983006|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
129983007|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983008|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983009|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983010|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983011|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
129983012|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983013|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
129983014|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
129983015|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
129983016|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
129983017|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
129983018|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983019|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983020|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
129983021|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983022|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983023|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983024|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983025|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
129983026|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983027|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983028|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983029|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983030|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983031|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983032|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
129983033|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
130179597|NCT02906670|468613619|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
130179598|NCT02906670|468613620|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
130179599|NCT02906670|468613611|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
130179600|NCT02906670|468613612|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
130179601|NCT02906670|468613613|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
130179602|NCT02906670|468613614|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
130179603|NCT02906670|468613615|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
130179604|NCT02906670|468613616|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
130179605|NCT02906670|468613617|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
130179606|NCT02906670|468613618|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
130179607|NCT02906670|468613619|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
130179608|NCT02906670|468613620|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
130179609|NCT02906670|468613611|FG000|Cohort 4P, QW|Radiological Progression|0|||
130179610|NCT02906670|468613612|FG001|Cohort 4P, QW|Radiological Progression|0|||
130179611|NCT02906670|468613613|FG002|Cohort 4P, QW|Radiological Progression|0|||
130179612|NCT02906670|468613614|FG003|Cohort 4P, QW|Radiological Progression|3|||
130179613|NCT02906670|468613615|FG004|Cohort 4P, QW|Radiological Progression|0|||
130179614|NCT02906670|468613616|FG005|Cohort 4P, QW|Radiological Progression|0|||
130179615|NCT02906670|468613617|FG006|Cohort 4P, QW|Radiological Progression|0|||
130179616|NCT02906670|468613618|FG007|Cohort 4P, QW|Radiological Progression|0|||
130179617|NCT02906670|468613619|FG008|Cohort 4P, QW|Radiological Progression|0|||
130179618|NCT02906670|468613620|FG009|Cohort 4P, QW|Radiological Progression|0|||
130179619|NCT02906670|468613611|FG000|Cohort 7P, Q2W|Adverse Event|0|||
130179620|NCT02906670|468613612|FG001|Cohort 7P, Q2W|Adverse Event|0|||
130179621|NCT02906670|468613613|FG002|Cohort 7P, Q2W|Adverse Event|0|||
130179622|NCT02906670|468613614|FG003|Cohort 7P, Q2W|Adverse Event|0|||
130179623|NCT02906670|468613615|FG004|Cohort 7P, Q2W|Adverse Event|0|||
130179624|NCT02906670|468613616|FG005|Cohort 7P, Q2W|Adverse Event|0|||
129983034|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
129983035|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
129983036|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
129983037|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
129983038|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983039|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983040|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983041|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983042|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
129983043|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983044|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983045|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983046|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983047|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
129983048|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983049|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983050|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983051|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983052|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
129983053|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983054|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983055|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983056|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983057|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
129983058|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983059|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983060|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983061|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983062|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
129983063|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983064|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983065|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983066|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983067|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
129983068|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983069|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983070|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983071|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983072|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
129983073|NCT00941070|467900650|FG000|Overall Study|Patient non-compliant|1|||
129983074|NCT04075994|467900651|FG000|Overall Study|Withdrawal by Subject|8|||
129983075|NCT04075994|467900652|FG001|Overall Study|Withdrawal by Subject|9|||
130179625|NCT02906670|468613617|FG006|Cohort 7P, Q2W|Adverse Event|0|||
130179626|NCT02906670|468613618|FG007|Cohort 7P, Q2W|Adverse Event|0|||
130179627|NCT02906670|468613619|FG008|Cohort 7P, Q2W|Adverse Event|0|||
130179628|NCT02906670|468613620|FG009|Cohort 7P, Q2W|Adverse Event|1|||
130179629|NCT02906670|468613611|FG000|Cohort 7P, Q2W|Physician Decision|0|||
130179630|NCT02906670|468613612|FG001|Cohort 7P, Q2W|Physician Decision|0|||
130179631|NCT02906670|468613613|FG002|Cohort 7P, Q2W|Physician Decision|0|||
130179632|NCT02906670|468613614|FG003|Cohort 7P, Q2W|Physician Decision|0|||
130179633|NCT02906670|468613615|FG004|Cohort 7P, Q2W|Physician Decision|0|||
129983076|NCT04075994|467900651|FG000|Overall Study|Adverse Event|2|||
129983077|NCT04075994|467900652|FG001|Overall Study|Adverse Event|2|||
129983078|NCT04075994|467900651|FG000|Overall Study|Investigator withdrew|3|||
129983079|NCT04075994|467900652|FG001|Overall Study|Investigator withdrew|1|||
129983080|NCT01125514|467900662|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
129983081|NCT01125514|467900662|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
129983082|NCT01125514|467900662|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
129983083|NCT01125514|467900662|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
129983084|NCT01125514|467900662|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
129983085|NCT01125514|467900662|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
129983086|NCT00858364|467900665|FG000|Overall Study|Administrative Decision|3|||
129983087|NCT00858364|467900666|FG001|Overall Study|Administrative Decision|2|||
129983088|NCT00858364|467900665|FG000|Overall Study|Adverse Event|5|||
129983089|NCT00858364|467900666|FG001|Overall Study|Adverse Event|2|||
129983090|NCT00858364|467900665|FG000|Overall Study|Withdrawal by Subject|44|||
129983091|NCT00858364|467900666|FG001|Overall Study|Withdrawal by Subject|118|||
129983092|NCT00858364|467900665|FG000|Overall Study|Ineligibility Determined|1|||
129983093|NCT00858364|467900666|FG001|Overall Study|Ineligibility Determined|10|||
129983094|NCT00858364|467900665|FG000|Overall Study|Lost to Follow-up|24|||
129983095|NCT00858364|467900666|FG001|Overall Study|Lost to Follow-up|54|||
129983096|NCT00858364|467900665|FG000|Overall Study|Noncompliance|3|||
129983097|NCT00858364|467900666|FG001|Overall Study|Noncompliance|4|||
129983098|NCT00858364|467900665|FG000|Overall Study|Protocol Deviation|0|||
129983099|NCT00858364|467900666|FG001|Overall Study|Protocol Deviation|2|||
129983100|NCT00858364|467900665|FG000|Overall Study|Other|9|||
129983101|NCT00858364|467900666|FG001|Overall Study|Other|17|||
129983102|NCT00858364|467900665|FG000|Overall Study|Missing|1|||
129983103|NCT00858364|467900666|FG001|Overall Study|Missing|1|||
129983104|NCT00858364|467900665|FG000|Overall Study|Still on-study|114|||
129983105|NCT00858364|467900666|FG001|Overall Study|Still on-study|247|||
129983106|NCT02755818|467900667|FG000|Overall Study|Withdrawal by Subject|0|||
129983107|NCT02755818|467900668|FG001|Overall Study|Withdrawal by Subject|0|||
129983108|NCT02755818|467900669|FG002|Overall Study|Withdrawal by Subject|0|||
129983109|NCT02755818|467900670|FG003|Overall Study|Withdrawal by Subject|2|||
129983110|NCT02755818|467900667|FG000|Overall Study|withdrawal by PI|0|||
129983111|NCT02755818|467900668|FG001|Overall Study|withdrawal by PI|0|||
129983112|NCT02755818|467900669|FG002|Overall Study|withdrawal by PI|1|||
129983113|NCT02755818|467900670|FG003|Overall Study|withdrawal by PI|1|||
129983114|NCT01163292|467900676|FG000|Overall Study|Lack of Efficacy|9|||
129983115|NCT01163292|467900677|FG001|Overall Study|Lack of Efficacy|0|||
129983116|NCT01163292|467900676|FG000|Overall Study|Adverse Event|6|||
129983117|NCT01163292|467900677|FG001|Overall Study|Adverse Event|0|||
129983118|NCT01163292|467900676|FG000|Overall Study|Initiation of biological therapy|0|||
129983119|NCT01163292|467900677|FG001|Overall Study|Initiation of biological therapy|15|||
129983120|NCT01163292|467900676|FG000|Overall Study|Sufficient response to adalimumab|8|||
129983121|NCT01163292|467900677|FG001|Overall Study|Sufficient response to adalimumab|0|||
129983122|NCT01163292|467900676|FG000|Overall Study|Refusal to receive adalimumab|7|||
129983123|NCT01163292|467900677|FG001|Overall Study|Refusal to receive adalimumab|0|||
129983124|NCT01163292|467900676|FG000|Overall Study|Economic reasons|6|||
129983125|NCT01163292|467900677|FG001|Overall Study|Economic reasons|0|||
129983126|NCT01163292|467900676|FG000|Overall Study|No further visits|5|||
129983127|NCT01163292|467900677|FG001|Overall Study|No further visits|7|||
129983128|NCT02535091|467900678|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
129983129|NCT02535091|467900679|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
129983130|NCT02535091|467900680|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
129983131|NCT02535091|467900678|FG000|Overall Study|Withdrawal by Subject|14|||
129983132|NCT02535091|467900679|FG001|Overall Study|Withdrawal by Subject|5|||
129983133|NCT02535091|467900680|FG002|Overall Study|Withdrawal by Subject|121|||
129983134|NCT02535091|467900678|FG000|Overall Study|Adverse Event|9|||
129983135|NCT02535091|467900679|FG001|Overall Study|Adverse Event|4|||
129983136|NCT02535091|467900680|FG002|Overall Study|Adverse Event|170|||
129983137|NCT02535091|467900678|FG000|Overall Study|Other|4|||
129983138|NCT02535091|467900679|FG001|Overall Study|Other|3|||
129983139|NCT02535091|467900680|FG002|Overall Study|Other|81|||
129983140|NCT02535091|467900678|FG000|Overall Study|Lost to Follow-up|0|||
129983141|NCT02535091|467900679|FG001|Overall Study|Lost to Follow-up|1|||
129983142|NCT02535091|467900680|FG002|Overall Study|Lost to Follow-up|19|||
129983143|NCT02535091|467900678|FG000|Overall Study|Protocol Violation|0|||
130179634|NCT02906670|468613616|FG005|Cohort 7P, Q2W|Physician Decision|0|||
129983144|NCT02535091|467900679|FG001|Overall Study|Protocol Violation|1|||
129983145|NCT02535091|467900680|FG002|Overall Study|Protocol Violation|11|||
130179635|NCT02906670|468613617|FG006|Cohort 7P, Q2W|Physician Decision|0|||
130179636|NCT02906670|468613618|FG007|Cohort 7P, Q2W|Physician Decision|0|||
130179637|NCT02906670|468613619|FG008|Cohort 7P, Q2W|Physician Decision|0|||
130179638|NCT02906670|468613620|FG009|Cohort 7P, Q2W|Physician Decision|1|||
130179639|NCT02906670|468613611|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179640|NCT02906670|468613612|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179641|NCT02906670|468613613|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179642|NCT02906670|468613614|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179643|NCT02906670|468613615|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179644|NCT02906670|468613616|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179645|NCT02906670|468613617|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179646|NCT02906670|468613618|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179647|NCT02906670|468613619|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
130179648|NCT02906670|468613620|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
130179649|NCT02906670|468613611|FG000|Cohort 5P, QW|Radiological Progression|0|||
130179650|NCT02906670|468613612|FG001|Cohort 5P, QW|Radiological Progression|0|||
130179651|NCT02906670|468613613|FG002|Cohort 5P, QW|Radiological Progression|0|||
130179652|NCT02906670|468613614|FG003|Cohort 5P, QW|Radiological Progression|0|||
130179653|NCT02906670|468613615|FG004|Cohort 5P, QW|Radiological Progression|3|||
130179654|NCT02906670|468613616|FG005|Cohort 5P, QW|Radiological Progression|0|||
130179655|NCT02906670|468613617|FG006|Cohort 5P, QW|Radiological Progression|0|||
130179656|NCT02906670|468613618|FG007|Cohort 5P, QW|Radiological Progression|0|||
130179657|NCT02906670|468613619|FG008|Cohort 5P, QW|Radiological Progression|0|||
130179658|NCT02906670|468613620|FG009|Cohort 5P, QW|Radiological Progression|0|||
130179659|NCT01349192|468613621|FG000|Overall Study|Protocol Violation|0|||
130179660|NCT01349192|468613622|FG001|Overall Study|Protocol Violation|1|||
130179661|NCT01349192|468613621|FG000|Overall Study|Withdrawal by Subject|0|||
130179662|NCT01349192|468613622|FG001|Overall Study|Withdrawal by Subject|2|||
130179663|NCT01349192|468613621|FG000|Overall Study|Lost to Follow-up|1|||
130179664|NCT01349192|468613622|FG001|Overall Study|Lost to Follow-up|3|||
130179665|NCT01349192|468613621|FG000|Overall Study|Failure to adhere to Protocol|2|||
130179666|NCT01349192|468613622|FG001|Overall Study|Failure to adhere to Protocol|0|||
130179667|NCT03749330|468613623|FG000|Overall Study|Clinicians left work in the CICU|0|||
130179668|NCT03749330|468613624|FG001|Overall Study|Clinicians left work in the CICU|2|||
130179669|NCT03749330|468613625|FG002|Overall Study|Clinicians left work in the CICU|0|||
130179670|NCT03749330|468613626|FG003|Overall Study|Clinicians left work in the CICU|0|||
130179671|NCT03749330|468613627|FG004|Overall Study|Clinicians left work in the CICU|0|||
130179672|NCT03749330|468613628|FG005|Overall Study|Clinicians left work in the CICU|0|||
130179673|NCT01973439|468613629|FG000|Overall Study|Lost samples from one PK Day|2|||
130179674|NCT01973439|468613629|FG000|Overall Study|Vomiting after commencing once daily|1|||
130179675|NCT01973439|468613629|FG000|Overall Study|PK curve incomplete|2|||
130179676|NCT02262325|468613631|FG000|Overall Study|Death|16|||
130179677|NCT02262325|468613631|FG000|Overall Study|Lost to Follow-up|1|||
130179678|NCT02815995|468613632|FG000|Overall Study|Disease Progression|3|||
130179679|NCT02815995|468613633|FG001|Overall Study|Disease Progression|7|||
130179680|NCT02815995|468613634|FG002|Overall Study|Disease Progression|2|||
130179681|NCT02815995|468613635|FG003|Overall Study|Disease Progression|4|||
130179682|NCT02815995|468613636|FG004|Overall Study|Disease Progression|3|||
130179683|NCT02815995|468613637|FG005|Overall Study|Disease Progression|9|||
130179684|NCT02815995|468613638|FG006|Overall Study|Disease Progression|3|||
130179685|NCT02815995|468613639|FG007|Overall Study|Disease Progression|1|||
130179686|NCT02815995|468613632|FG000|Overall Study|Adverse Event|1|||
130179687|NCT02815995|468613633|FG001|Overall Study|Adverse Event|2|||
130179688|NCT02815995|468613634|FG002|Overall Study|Adverse Event|2|||
130179689|NCT02815995|468613635|FG003|Overall Study|Adverse Event|0|||
130179690|NCT02815995|468613636|FG004|Overall Study|Adverse Event|0|||
130179691|NCT02815995|468613637|FG005|Overall Study|Adverse Event|1|||
129983146|NCT02535091|467900678|FG000|Overall Study|Pregnancy|0|||
130179692|NCT02815995|468613638|FG006|Overall Study|Adverse Event|0|||
130179693|NCT02815995|468613639|FG007|Overall Study|Adverse Event|0|||
130179694|NCT02815995|468613632|FG000|Overall Study|Pregnancy|0|||
130179695|NCT02815995|468613633|FG001|Overall Study|Pregnancy|0|||
130179696|NCT02815995|468613634|FG002|Overall Study|Pregnancy|0|||
130179697|NCT02815995|468613635|FG003|Overall Study|Pregnancy|0|||
130179698|NCT02815995|468613636|FG004|Overall Study|Pregnancy|0|||
130179699|NCT02815995|468613637|FG005|Overall Study|Pregnancy|0|||
130179700|NCT02815995|468613638|FG006|Overall Study|Pregnancy|1|||
130179701|NCT02815995|468613639|FG007|Overall Study|Pregnancy|0|||
130179702|NCT03571828|468613644|FG000|Overall Study|Withdrawal by Subject|1|||
130179703|NCT03571828|468613645|FG001|Overall Study|Withdrawal by Subject|0|||
130179704|NCT03571828|468613644|FG000|Overall Study|Decision by sponsor|5|||
130179705|NCT03571828|468613645|FG001|Overall Study|Decision by sponsor|1|||
130179706|NCT03571828|468613644|FG000|Overall Study|Death|2|||
130179707|NCT03571828|468613645|FG001|Overall Study|Death|0|||
130179708|NCT00769379|468613646|FG000|Overall Study|No follow up data mapped to Other.|3|||
130179709|NCT00769379|468613647|FG001|Overall Study|No follow up data mapped to Other.|13|||
129983147|NCT02535091|467900679|FG001|Overall Study|Pregnancy|0|||
130179710|NCT03404674|468613648|FG000|Overall Study|Inability to Attend Future Visits|0|||
130179711|NCT03404674|468613649|FG001|Overall Study|Inability to Attend Future Visits|1|||
130179712|NCT03404674|468613650|FG002|Overall Study|Inability to Attend Future Visits|1|||
130179713|NCT03404674|468613651|FG003|Overall Study|Inability to Attend Future Visits|0|||
130179714|NCT03404674|468613652|FG004|Overall Study|Inability to Attend Future Visits|0|||
130179715|NCT03404674|468613653|FG005|Overall Study|Inability to Attend Future Visits|0|||
130179716|NCT03404674|468613648|FG000|Overall Study|Behavioral Problems|0|||
130179717|NCT03404674|468613649|FG001|Overall Study|Behavioral Problems|0|||
130179718|NCT03404674|468613650|FG002|Overall Study|Behavioral Problems|1|||
130179719|NCT03404674|468613651|FG003|Overall Study|Behavioral Problems|0|||
130179720|NCT03404674|468613652|FG004|Overall Study|Behavioral Problems|0|||
130179721|NCT03404674|468613653|FG005|Overall Study|Behavioral Problems|0|||
130179722|NCT03404674|468613648|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179723|NCT03404674|468613649|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179724|NCT03404674|468613650|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179725|NCT03404674|468613651|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
130179726|NCT03404674|468613652|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
130179727|NCT03404674|468613653|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
130179728|NCT00143390|468613662|FG000|Overall Study|Death|2|||
130179729|NCT00143390|468613663|FG001|Overall Study|Death|0|||
130179730|NCT00143390|468613662|FG000|Overall Study|Not meeting entry criteria|2|||
130179731|NCT00143390|468613663|FG001|Overall Study|Not meeting entry criteria|5|||
130179732|NCT00143390|468613662|FG000|Overall Study|Withdrawal by Subject|4|||
130179733|NCT00143390|468613663|FG001|Overall Study|Withdrawal by Subject|4|||
130179734|NCT00143390|468613662|FG000|Overall Study|Progressive disease|119|||
130179735|NCT00143390|468613663|FG001|Overall Study|Progressive disease|115|||
130179736|NCT00143390|468613662|FG000|Overall Study|Protocol Violation|2|||
130179737|NCT00143390|468613663|FG001|Overall Study|Protocol Violation|0|||
130179738|NCT00143390|468613662|FG000|Overall Study|Study termination|10|||
130179739|NCT00143390|468613663|FG001|Overall Study|Study termination|15|||
130179740|NCT00143390|468613662|FG000|Overall Study|Adverse Event|9|||
130179741|NCT00143390|468613663|FG001|Overall Study|Adverse Event|8|||
130179742|NCT00143390|468613662|FG000|Overall Study|Other|1|||
130179743|NCT00143390|468613663|FG001|Overall Study|Other|2|||
130179744|NCT00041132|468613664|FG000|Overall Study|Adverse Event|19|||
130179745|NCT00041132|468613664|FG000|Overall Study|Death|1|||
130179746|NCT00041132|468613664|FG000|Overall Study|Not Eligible|7|||
130179747|NCT00041132|468613664|FG000|Overall Study|Withdrawal by Subject|1|||
130179748|NCT00041132|468613664|FG000|Overall Study|Physician Decision|2|||
130179749|NCT03180645|468613667|FG000|Overall Study|Adverse Event|0|||
130179750|NCT03180645|468613668|FG001|Overall Study|Adverse Event|1|||
130179751|NCT03180645|468613669|FG002|Overall Study|Adverse Event|2|||
130179752|NCT02729909|468613671|FG000|Overall Study|Lost to Follow-up|0|||
130179753|NCT02729909|468613672|FG001|Overall Study|Lost to Follow-up|1|||
130179754|NCT02729909|468613671|FG000|Overall Study|Lack of Efficacy|0|||
130179755|NCT02729909|468613672|FG001|Overall Study|Lack of Efficacy|2|||
130179756|NCT02729909|468613671|FG000|Overall Study|Significant Protocol Deviation|0|||
130179757|NCT02729909|468613672|FG001|Overall Study|Significant Protocol Deviation|2|||
130179758|NCT02729909|468613671|FG000|Overall Study|Voluntary Withdrawal|1|||
130179759|NCT02729909|468613672|FG001|Overall Study|Voluntary Withdrawal|0|||
130179760|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
130179761|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
130179762|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
130179763|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
130179764|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
130179765|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130179766|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130179767|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
130179768|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
130179769|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130179770|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130179771|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
130179772|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
130179773|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
130179774|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
130179775|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
130179776|NCT00866359|468613673|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
130179777|NCT00866359|468613674|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
130179778|NCT00866359|468613675|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
130179779|NCT00866359|468613676|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
130179780|NCT00866359|468613673|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
130179781|NCT00866359|468613674|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
130179782|NCT00866359|468613675|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
130179783|NCT00866359|468613676|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
129983148|NCT02535091|467900680|FG002|Overall Study|Pregnancy|7|||
129983149|NCT03223662|467900681|FG000|Overall Study|Physician Decision|1|||
129983150|NCT03223662|467900681|FG000|Overall Study|Study closure|1|||
129983151|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
129983152|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
129983153|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
129983154|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
129983155|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
129983156|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
129983157|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
129983158|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
129983159|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
129983160|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
129983161|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
129983162|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
129983163|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
129983164|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
129983165|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
129983166|NCT02217475|467900682|FG000|Discontinued After Period 1|Adverse Event|1|||
129983167|NCT02217475|467900683|FG001|Discontinued After Period 1|Adverse Event|2|||
129983168|NCT02217475|467900684|FG002|Discontinued After Period 1|Adverse Event|0|||
129983169|NCT02217475|467900682|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
129983170|NCT02217475|467900683|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
129983171|NCT02217475|467900684|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
129983172|NCT02217475|467900682|FG000|Discontinued After Period 1|Physician Decision|0|||
129983173|NCT02217475|467900683|FG001|Discontinued After Period 1|Physician Decision|0|||
129983174|NCT02217475|467900684|FG002|Discontinued After Period 1|Physician Decision|1|||
129983175|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
129983176|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
129983177|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
129983178|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
129983179|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
129983180|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
129983181|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
129983182|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
129983183|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
129983184|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
129983185|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
129983186|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
129983187|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
129983188|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
129983189|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
129983190|NCT02643472|467900685|FG000|Overall Study|Death|2|||
129983191|NCT02643472|467900686|FG001|Overall Study|Death|5|||
129983192|NCT02643472|467900685|FG000|Overall Study|Withdrawal by Subject|3|||
129983193|NCT02643472|467900686|FG001|Overall Study|Withdrawal by Subject|2|||
129983194|NCT02643472|467900685|FG000|Overall Study|Protocol Violation|0|||
129983195|NCT02643472|467900686|FG001|Overall Study|Protocol Violation|1|||
129983196|NCT02643472|467900685|FG000|Overall Study|Lost to Follow-up|22|||
129983197|NCT02643472|467900686|FG001|Overall Study|Lost to Follow-up|26|||
129983198|NCT01215188|467900687|FG000|Overall Study|Lost to Follow-up|22|||
129983199|NCT01215188|467900688|FG001|Overall Study|Lost to Follow-up|22|||
129983200|NCT01215188|467900689|FG002|Overall Study|Lost to Follow-up|16|||
129983201|NCT01215188|467900687|FG000|Overall Study|Adverse Event|1|||
129983202|NCT01215188|467900688|FG001|Overall Study|Adverse Event|1|||
129983203|NCT01215188|467900689|FG002|Overall Study|Adverse Event|3|||
129983204|NCT01215188|467900687|FG000|Overall Study|Physician Decision|2|||
129983205|NCT01215188|467900688|FG001|Overall Study|Physician Decision|1|||
129983206|NCT01215188|467900689|FG002|Overall Study|Physician Decision|0|||
129983207|NCT01215188|467900687|FG000|Overall Study|Lack of Efficacy|0|||
129983208|NCT01215188|467900688|FG001|Overall Study|Lack of Efficacy|0|||
129983209|NCT01215188|467900689|FG002|Overall Study|Lack of Efficacy|1|||
129983210|NCT01215188|467900687|FG000|Overall Study|Protocol Violation|1|||
129983211|NCT01215188|467900688|FG001|Overall Study|Protocol Violation|1|||
129983212|NCT01215188|467900689|FG002|Overall Study|Protocol Violation|1|||
129983213|NCT01215188|467900687|FG000|Overall Study|Withdrawal by Subject|32|||
129983214|NCT01215188|467900688|FG001|Overall Study|Withdrawal by Subject|34|||
129983215|NCT01215188|467900689|FG002|Overall Study|Withdrawal by Subject|31|||
129983216|NCT01012414|467900690|FG000|Overall Study|Withdrawal by Subject|2|||
129983217|NCT01012414|467900690|FG000|Overall Study|Lost to Follow-up|1|||
129983218|NCT01012414|467900690|FG000|Overall Study|Trial was stopped before completed|7|||
129983219|NCT00506441|467900691|FG000|Period 1; Open-label Period|Adverse Event|21|||
129983220|NCT00506441|467900692|FG001|Period 1; Open-label Period|Adverse Event|0|||
130179784|NCT00768248|468613678|FG000|Overall Study|Research coordinator didn't collect data|1|||
130179785|NCT00768248|468613679|FG001|Overall Study|Research coordinator didn't collect data|1|||
130179786|NCT01547390|468613680|FG000|Overall Study|Withdrawal by Subject|10|||
130179787|NCT01547390|468613681|FG001|Overall Study|Withdrawal by Subject|7|||
130179788|NCT01547390|468613680|FG000|Overall Study|termination of pregnancy|0|||
130179789|NCT01547390|468613681|FG001|Overall Study|termination of pregnancy|1|||
130179790|NCT01547390|468613680|FG000|Overall Study|Lost to Follow-up|0|||
130179791|NCT01547390|468613681|FG001|Overall Study|Lost to Follow-up|2|||
130179792|NCT01547390|468613680|FG000|Overall Study|Adverse Event|3|||
130179793|NCT01547390|468613681|FG001|Overall Study|Adverse Event|0|||
130179794|NCT01459783|468613682|FG000|Baseline to 6 Months|Death|1|||
130179795|NCT01459783|468613683|FG001|Baseline to 6 Months|Death|0|||
130179796|NCT01459783|468613682|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
130179797|NCT01459783|468613683|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
130179798|NCT01459783|468613682|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
130179799|NCT01459783|468613683|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
130179800|NCT01459783|468613682|FG000|6 Months to 12 Months|Death|0|||
130179801|NCT01459783|468613683|FG001|6 Months to 12 Months|Death|1|||
130179802|NCT01459783|468613682|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
130179803|NCT01459783|468613683|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
130179804|NCT01459783|468613682|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
130179805|NCT01459783|468613683|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
130179806|NCT01459783|468613682|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
130179807|NCT01459783|468613683|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
130179808|NCT06018129|468613685|FG000|Overall Study|Death|1|||
130179809|NCT06018129|468613686|FG001|Overall Study|Death|1|||
130179810|NCT06018129|468613687|FG002|Overall Study|Death|2|||
130179811|NCT06018129|468613685|FG000|Overall Study|Sponsor Decision|2|||
130179812|NCT06018129|468613686|FG001|Overall Study|Sponsor Decision|2|||
130179813|NCT06018129|468613687|FG002|Overall Study|Sponsor Decision|1|||
130179814|NCT04917861|468613688|FG000|Main Study (196 Days)|Adverse Event|0|||
130179815|NCT04917861|468613689|FG001|Main Study (196 Days)|Adverse Event|1|||
130179816|NCT04917861|468613690|FG002|Main Study (196 Days)|Adverse Event|0|||
130179817|NCT04917861|468613691|FG003|Main Study (196 Days)|Adverse Event|0|||
130179818|NCT04917861|468613688|FG000|Main Study (196 Days)|Death|0|||
130179819|NCT04917861|468613689|FG001|Main Study (196 Days)|Death|0|||
130179820|NCT04917861|468613690|FG002|Main Study (196 Days)|Death|0|||
130179821|NCT04917861|468613691|FG003|Main Study (196 Days)|Death|1|||
130179822|NCT04917861|468613688|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
130179823|NCT04917861|468613689|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
130179824|NCT04917861|468613690|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
130179825|NCT04917861|468613691|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
130179826|NCT04917861|468613688|FG000|Main Study (196 Days)|Physician Decision|0|||
130179827|NCT04917861|468613689|FG001|Main Study (196 Days)|Physician Decision|0|||
130179828|NCT04917861|468613690|FG002|Main Study (196 Days)|Physician Decision|0|||
130179829|NCT04917861|468613691|FG003|Main Study (196 Days)|Physician Decision|1|||
130179830|NCT04917861|468613688|FG000|Main Study (196 Days)|Pregnancy|1|||
130179831|NCT04917861|468613689|FG001|Main Study (196 Days)|Pregnancy|1|||
130179832|NCT04917861|468613690|FG002|Main Study (196 Days)|Pregnancy|0|||
130179833|NCT04917861|468613691|FG003|Main Study (196 Days)|Pregnancy|0|||
130179834|NCT04917861|468613688|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
130179835|NCT04917861|468613689|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
130179836|NCT04917861|468613690|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
130179837|NCT04917861|468613691|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
130179838|NCT04917861|468613688|FG000|Main Study (196 Days)|Other Than Specified|1|||
130179839|NCT04917861|468613689|FG001|Main Study (196 Days)|Other Than Specified|0|||
130179840|NCT04917861|468613690|FG002|Main Study (196 Days)|Other Than Specified|1|||
130179841|NCT04917861|468613691|FG003|Main Study (196 Days)|Other Than Specified|2|||
130179842|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
130179843|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
130179844|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
130179845|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
130179846|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130179847|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
130179848|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130179849|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
130179850|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130179851|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
130179852|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130179853|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
130179854|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
130179855|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
130179856|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
130179857|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
130179858|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130179859|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
130179860|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130179861|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
130179862|NCT04917861|468613688|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
130179863|NCT04917861|468613689|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
130179864|NCT04917861|468613690|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
130179865|NCT04917861|468613691|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
130179866|NCT06389487|468613692|FG000|Overall Study|Lost to Follow-up|9|||
130179867|NCT06389487|468613693|FG001|Overall Study|Lost to Follow-up|5|||
130179868|NCT06389487|468613694|FG002|Overall Study|Lost to Follow-up|13|||
130179869|NCT06389487|468613692|FG000|Overall Study|Protocol Violation|0|||
130179870|NCT06389487|468613693|FG001|Overall Study|Protocol Violation|0|||
130179871|NCT06389487|468613694|FG002|Overall Study|Protocol Violation|2|||
130179872|NCT06389487|468613692|FG000|Overall Study|Withdrawal by Subject|2|||
130179873|NCT06389487|468613693|FG001|Overall Study|Withdrawal by Subject|2|||
130179874|NCT06389487|468613694|FG002|Overall Study|Withdrawal by Subject|1|||
130179875|NCT06389487|468613692|FG000|Overall Study|Other|1|||
130179876|NCT06389487|468613693|FG001|Overall Study|Other|0|||
130179877|NCT06389487|468613694|FG002|Overall Study|Other|1|||
130179878|NCT03493685|468615412|FG000|Overall Study|Death|4|||
130179879|NCT03493685|468615413|FG001|Overall Study|Death|3|||
130179880|NCT03493685|468615412|FG000|Overall Study|Lost to Follow-up|3|||
130179881|NCT03493685|468615413|FG001|Overall Study|Lost to Follow-up|2|||
130179882|NCT03493685|468615412|FG000|Overall Study|Physician Decision|2|||
130179883|NCT03493685|468615413|FG001|Overall Study|Physician Decision|0|||
130179884|NCT03493685|468615412|FG000|Overall Study|Withdrawal by Subject|7|||
130179885|NCT03493685|468615413|FG001|Overall Study|Withdrawal by Subject|11|||
130179886|NCT04452669|468615414|FG000|Overall Study|Death|1|||
130179887|NCT04452669|468615415|FG001|Overall Study|Death|4|||
130179888|NCT03300817|468615416|FG000|Overall Study|Withdrawal by Subject|1|||
130179889|NCT03300817|468615416|FG000|Overall Study|Adverse Event|1|||
130179890|NCT03300817|468615416|FG000|Overall Study|Subject Found to be Ineligible|2|||
130179891|NCT03729596|468615419|FG000|Overall Study|Death|3|||
130179892|NCT03729596|468615420|FG001|Overall Study|Death|5|||
130179893|NCT03729596|468615421|FG002|Overall Study|Death|4|||
130179894|NCT03729596|468615422|FG003|Overall Study|Death|1|||
130179895|NCT03729596|468615423|FG004|Overall Study|Death|0|||
130179896|NCT03729596|468615424|FG005|Overall Study|Death|34|||
130179897|NCT03729596|468615425|FG006|Overall Study|Death|18|||
130179898|NCT03729596|468615426|FG007|Overall Study|Death|14|||
130179899|NCT03729596|468615427|FG008|Overall Study|Death|19|||
130179900|NCT03729596|468615428|FG009|Overall Study|Death|9|||
130179901|NCT03729596|468615419|FG000|Overall Study|Lost to Follow-up|0|||
130179902|NCT03729596|468615420|FG001|Overall Study|Lost to Follow-up|0|||
130179903|NCT03729596|468615421|FG002|Overall Study|Lost to Follow-up|0|||
130179904|NCT03729596|468615422|FG003|Overall Study|Lost to Follow-up|0|||
130179905|NCT03729596|468615423|FG004|Overall Study|Lost to Follow-up|0|||
130179906|NCT03729596|468615424|FG005|Overall Study|Lost to Follow-up|0|||
130179907|NCT03729596|468615425|FG006|Overall Study|Lost to Follow-up|1|||
130179908|NCT03729596|468615426|FG007|Overall Study|Lost to Follow-up|0|||
130179909|NCT03729596|468615427|FG008|Overall Study|Lost to Follow-up|0|||
130179910|NCT03729596|468615428|FG009|Overall Study|Lost to Follow-up|1|||
130179911|NCT03729596|468615419|FG000|Overall Study|protocol amendment|0|||
130179912|NCT03729596|468615420|FG001|Overall Study|protocol amendment|1|||
130179913|NCT03729596|468615421|FG002|Overall Study|protocol amendment|3|||
130179914|NCT03729596|468615422|FG003|Overall Study|protocol amendment|6|||
130179915|NCT03729596|468615423|FG004|Overall Study|protocol amendment|5|||
130179916|NCT03729596|468615424|FG005|Overall Study|protocol amendment|0|||
130179917|NCT03729596|468615425|FG006|Overall Study|protocol amendment|0|||
130179918|NCT03729596|468615426|FG007|Overall Study|protocol amendment|0|||
130179919|NCT03729596|468615427|FG008|Overall Study|protocol amendment|0|||
130179920|NCT03729596|468615428|FG009|Overall Study|protocol amendment|0|||
130179921|NCT03729596|468615419|FG000|Overall Study|Withdrawal by Subject|0|||
130179922|NCT03729596|468615420|FG001|Overall Study|Withdrawal by Subject|0|||
130179923|NCT03729596|468615421|FG002|Overall Study|Withdrawal by Subject|0|||
130179924|NCT03729596|468615422|FG003|Overall Study|Withdrawal by Subject|0|||
130179925|NCT03729596|468615423|FG004|Overall Study|Withdrawal by Subject|0|||
130179926|NCT03729596|468615424|FG005|Overall Study|Withdrawal by Subject|4|||
130179927|NCT03729596|468615425|FG006|Overall Study|Withdrawal by Subject|2|||
130179928|NCT03729596|468615426|FG007|Overall Study|Withdrawal by Subject|3|||
130179929|NCT03729596|468615427|FG008|Overall Study|Withdrawal by Subject|2|||
130179930|NCT03729596|468615428|FG009|Overall Study|Withdrawal by Subject|3|||
130179931|NCT03729596|468615419|FG000|Overall Study|study terminated by sponsor|0|||
130179932|NCT03729596|468615420|FG001|Overall Study|study terminated by sponsor|0|||
130179933|NCT03729596|468615421|FG002|Overall Study|study terminated by sponsor|0|||
130179934|NCT03729596|468615422|FG003|Overall Study|study terminated by sponsor|0|||
130179935|NCT03729596|468615423|FG004|Overall Study|study terminated by sponsor|1|||
130179936|NCT03729596|468615424|FG005|Overall Study|study terminated by sponsor|3|||
130179937|NCT03729596|468615425|FG006|Overall Study|study terminated by sponsor|0|||
130179938|NCT03729596|468615426|FG007|Overall Study|study terminated by sponsor|1|||
130179939|NCT03729596|468615427|FG008|Overall Study|study terminated by sponsor|0|||
130179940|NCT03729596|468615428|FG009|Overall Study|study terminated by sponsor|0|||
130179941|NCT03713593|468615429|FG000|Overall Study|Sponsor Decision|73|||
130179942|NCT03713593|468615430|FG001|Overall Study|Sponsor Decision|41|||
130179943|NCT03713593|468615429|FG000|Overall Study|Lost to Follow-up|2|||
130179944|NCT03713593|468615430|FG001|Overall Study|Lost to Follow-up|1|||
130179945|NCT03713593|468615429|FG000|Overall Study|Death|314|||
130179946|NCT03713593|468615430|FG001|Overall Study|Death|349|||
130179947|NCT03713593|468615429|FG000|Overall Study|Withdrawal by Subject|6|||
130179948|NCT03713593|468615430|FG001|Overall Study|Withdrawal by Subject|8|||
130179949|NCT04653454|468615431|FG000|Overall Study|Withdrawal by Subject|1|||
130179950|NCT04653454|468615431|FG000|Overall Study|Physician Decision|40|||
130179951|NCT03620708|468615432|FG000|Overall Study|Lost to Follow-up|1|||
130179952|NCT03620708|468615433|FG001|Overall Study|Lost to Follow-up|1|||
130179953|NCT03620708|468615434|FG002|Overall Study|Lost to Follow-up|2|||
130179954|NCT03620708|468615432|FG000|Overall Study|Withdrawal by Subject|0|||
130179955|NCT03620708|468615433|FG001|Overall Study|Withdrawal by Subject|0|||
130179956|NCT03620708|468615434|FG002|Overall Study|Withdrawal by Subject|1|||
130179957|NCT05126693|468615435|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
130179958|NCT05126693|468615436|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
130179959|NCT05126693|468615435|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
130179960|NCT05126693|468615436|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
130179961|NCT05126693|468615435|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
130179962|NCT05126693|468615436|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
130179963|NCT04011722|468615440|FG000|30 Days|Death|5|||
130179964|NCT04011722|468615441|FG001|30 Days|Death|1|||
130179965|NCT04011722|468615440|FG000|1 Year|Death|13|||
130179966|NCT04011722|468615441|FG001|1 Year|Death|5|||
130179967|NCT04011722|468615440|FG000|1 Year|Withdrawal by Subject|8|||
130179968|NCT04011722|468615441|FG001|1 Year|Withdrawal by Subject|2|||
130179969|NCT04011722|468615440|FG000|1 Year|Missed Visit|6|||
130179970|NCT04011722|468615441|FG001|1 Year|Missed Visit|1|||
130179971|NCT04011722|468615440|FG000|1 Year|Pending Visit|0|||
130179972|NCT04011722|468615441|FG001|1 Year|Pending Visit|11|||
130179973|NCT04011722|468615440|FG000|1 Year|Not Yet Due|0|||
130179974|NCT04011722|468615441|FG001|1 Year|Not Yet Due|9|||
130179975|NCT04011722|468615440|FG000|2 Year|Death|16|||
130179976|NCT04011722|468615441|FG001|2 Year|Death|1|||
130179977|NCT04011722|468615440|FG000|2 Year|Withdrawal by Subject|10|||
130179978|NCT04011722|468615441|FG001|2 Year|Withdrawal by Subject|1|||
130179979|NCT04011722|468615440|FG000|2 Year|Missed Visit|9|||
130179980|NCT04011722|468615441|FG001|2 Year|Missed Visit|0|||
130179981|NCT04011722|468615440|FG000|2 Year|Visit Pending|1|||
130179982|NCT04011722|468615441|FG001|2 Year|Visit Pending|3|||
130179983|NCT04011722|468615440|FG000|2 Year|Not Yet Due|43|||
130179984|NCT04011722|468615441|FG001|2 Year|Not Yet Due|54|||
130179985|NCT04011722|468615440|FG000|3 Year|Death|10|||
130179986|NCT04011722|468615441|FG001|3 Year|Death|0|||
130179987|NCT04011722|468615440|FG000|3 Year|Withdrawal by Subject|2|||
130179988|NCT04011722|468615441|FG001|3 Year|Withdrawal by Subject|0|||
130179989|NCT04011722|468615440|FG000|3 Year|Missed Visit|2|||
130179990|NCT04011722|468615441|FG001|3 Year|Missed Visit|0|||
130179991|NCT04011722|468615440|FG000|3 Year|Pending Visit|34|||
130179992|NCT04011722|468615441|FG001|3 Year|Pending Visit|0|||
130179993|NCT04011722|468615440|FG000|3 Year|Not Yet Due|99|||
130179994|NCT04011722|468615441|FG001|3 Year|Not Yet Due|0|||
130179995|NCT05061134|468615442|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
130179996|NCT05061134|468615443|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
130179997|NCT05061134|468615444|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
130179998|NCT05061134|468615442|FG000|Overall Study|Subject not treated|0|||
130179999|NCT05061134|468615443|FG001|Overall Study|Subject not treated|0|||
130180000|NCT05061134|468615444|FG002|Overall Study|Subject not treated|2|||
130180001|NCT05061134|468615442|FG000|Overall Study|Other|0|||
130180002|NCT05061134|468615443|FG001|Overall Study|Other|0|||
130180003|NCT05061134|468615444|FG002|Overall Study|Other|9|||
130180004|NCT05061134|468615442|FG000|Overall Study|Withdrawal by Subject|9|||
130180005|NCT05061134|468615443|FG001|Overall Study|Withdrawal by Subject|8|||
130180006|NCT05061134|468615444|FG002|Overall Study|Withdrawal by Subject|5|||
130180007|NCT05061134|468615442|FG000|Overall Study|Study Terminated by Sponsor|22|||
129983221|NCT00506441|467900691|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
130180008|NCT05061134|468615443|FG001|Overall Study|Study Terminated by Sponsor|14|||
130180009|NCT05061134|468615444|FG002|Overall Study|Study Terminated by Sponsor|7|||
130180010|NCT05061134|468615442|FG000|Overall Study|Progressive Disease|1|||
130180011|NCT05061134|468615443|FG001|Overall Study|Progressive Disease|2|||
130180012|NCT05061134|468615444|FG002|Overall Study|Progressive Disease|0|||
130180013|NCT05061134|468615442|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
129983222|NCT00506441|467900692|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
129983223|NCT00506441|467900691|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
129983224|NCT00506441|467900692|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
129983225|NCT00506441|467900691|FG000|Period 1; Open-label Period|Physician Decision|5|||
129983226|NCT00506441|467900692|FG001|Period 1; Open-label Period|Physician Decision|0|||
129983227|NCT00506441|467900691|FG000|Period 1; Open-label Period|Protocol Violation|9|||
129983228|NCT00506441|467900692|FG001|Period 1; Open-label Period|Protocol Violation|0|||
129983229|NCT00506441|467900691|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
129983230|NCT00506441|467900692|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
129983231|NCT00506441|467900691|FG000|Period 1; Open-label Period|Other Reasons|13|||
129983232|NCT00506441|467900692|FG001|Period 1; Open-label Period|Other Reasons|0|||
129983233|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Adverse Event|0|||
129983234|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Adverse Event|1|||
129983235|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
129983236|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
129983237|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Physician Decision|1|||
129983238|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Physician Decision|1|||
129983239|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
129983240|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
129983241|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Other Reason|1|||
130180014|NCT05061134|468615443|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
130180015|NCT05061134|468615444|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
130180016|NCT05061134|468615442|FG000|Overall Study|Lost to Follow-up|1|||
130180017|NCT05061134|468615443|FG001|Overall Study|Lost to Follow-up|0|||
130180018|NCT05061134|468615444|FG002|Overall Study|Lost to Follow-up|0|||
130180019|NCT05061134|468615442|FG000|Overall Study|Physician Decision|1|||
130180020|NCT05061134|468615443|FG001|Overall Study|Physician Decision|1|||
130180021|NCT05061134|468615444|FG002|Overall Study|Physician Decision|0|||
130180022|NCT05061134|468615442|FG000|Overall Study|Disease progression|1|||
130180023|NCT05061134|468615443|FG001|Overall Study|Disease progression|0|||
130180024|NCT05061134|468615444|FG002|Overall Study|Disease progression|0|||
130180025|NCT05061134|468615442|FG000|Overall Study|Death|43|||
130180026|NCT05061134|468615443|FG001|Overall Study|Death|23|||
130180027|NCT05061134|468615444|FG002|Overall Study|Death|14|||
130180028|NCT05061134|468615442|FG000|Overall Study|Database lock|2|||
130180029|NCT05061134|468615443|FG001|Overall Study|Database lock|0|||
130180030|NCT05061134|468615444|FG002|Overall Study|Database lock|0|||
130180031|NCT00001521|468615450|FG000|Overall Study|Withdrawal by Subject|3|||
130180032|NCT00001521|468615451|FG001|Overall Study|Withdrawal by Subject|3|||
130180033|NCT00001521|468615450|FG000|Overall Study|Physician Decision|1|||
130180034|NCT00001521|468615451|FG001|Overall Study|Physician Decision|1|||
130180035|NCT00001521|468615450|FG000|Overall Study|Noncompliant|6|||
130180036|NCT00001521|468615451|FG001|Overall Study|Noncompliant|3|||
130180037|NCT02366689|468615456|FG000|Overall Study|Withdrawal by Subject|1|||
130180038|NCT02366689|468615457|FG001|Overall Study|Withdrawal by Subject|0|||
130180039|NCT02366689|468615458|FG002|Overall Study|Withdrawal by Subject|1|||
130180040|NCT02366689|468615456|FG000|Overall Study|Lost to Follow-up|3|||
130180041|NCT02366689|468615457|FG001|Overall Study|Lost to Follow-up|2|||
130180042|NCT02366689|468615458|FG002|Overall Study|Lost to Follow-up|0|||
130180043|NCT02366689|468615456|FG000|Overall Study|Pregnancy|0|||
130180044|NCT02366689|468615457|FG001|Overall Study|Pregnancy|1|||
130180045|NCT02366689|468615458|FG002|Overall Study|Pregnancy|1|||
130180046|NCT03283566|468615459|FG000|Overall Study|Lost to Follow-up|1|||
130180047|NCT03283566|468615460|FG001|Overall Study|Lost to Follow-up|2|||
130180048|NCT03288714|468615463|FG000|Overall Study|Lost to Follow-up|2|||
130180049|NCT03288714|468615464|FG001|Overall Study|Lost to Follow-up|1|||
130180050|NCT03288714|468615463|FG000|Overall Study|Non-compliance with study schedule|2|||
130180051|NCT03288714|468615464|FG001|Overall Study|Non-compliance with study schedule|0|||
130180052|NCT03288714|468615463|FG000|Overall Study|Withdrawal by Subject|3|||
130180053|NCT03288714|468615464|FG001|Overall Study|Withdrawal by Subject|1|||
130180054|NCT03288714|468615463|FG000|Overall Study|Clinical Worsening|2|||
130180055|NCT03288714|468615464|FG001|Overall Study|Clinical Worsening|1|||
130180056|NCT03288714|468615463|FG000|Overall Study|Adverse Event|1|||
130180057|NCT03288714|468615464|FG001|Overall Study|Adverse Event|0|||
130180058|NCT04882241|468615466|FG000|Overall Study|Ongoing in study|46|||
130180059|NCT04882241|468615467|FG001|Overall Study|Ongoing in study|48|||
130180060|NCT04882241|468615468|FG002|Overall Study|Ongoing in study|0|||
130180061|NCT04882241|468615469|FG003|Overall Study|Ongoing in study|0|||
130180062|NCT04882241|468615466|FG000|Overall Study|Death|13|||
130180063|NCT04882241|468615467|FG001|Overall Study|Death|13|||
129983242|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Other Reason|1|||
130180064|NCT04882241|468615468|FG002|Overall Study|Death|0|||
130180065|NCT04882241|468615469|FG003|Overall Study|Death|0|||
130180066|NCT00470535|468615482|FG000|Overall Study|Disease Progression|13|||
130180067|NCT00470535|468615482|FG000|Overall Study|Withdrawal by Subject|1|||
130180068|NCT00470535|468615482|FG000|Overall Study|Adverse Event|1|||
130180069|NCT00470535|468615482|FG000|Overall Study|Death|1|||
130180070|NCT00470535|468615482|FG000|Overall Study|Other|2|||
130180071|NCT02070965|468615487|FG000|Overall Study|Lost to Follow-up|0|||
130180072|NCT02070965|468615488|FG001|Overall Study|Lost to Follow-up|1|||
130180073|NCT02070965|468615489|FG002|Overall Study|Lost to Follow-up|0|||
130180074|NCT02070965|468615487|FG000|Overall Study|Withdrawal by Subject|1|||
129983243|NCT02601300|467900693|FG000|Induction Phase|Lack of Efficacy|2|||
129983244|NCT02601300|467900693|FG000|Induction Phase|Protocol Violation|1|||
129983245|NCT02601300|467900693|FG000|Extension Phase|Withdrawal by Subject|3|||
129983246|NCT02601300|467900693|FG000|Extension Phase|Adverse Event|4|||
129983247|NCT02601300|467900693|FG000|Extension Phase|Lack of Efficacy|10|||
129983248|NCT01127763|467900697|FG000|Overall Study|Adverse Event|2|||
129983249|NCT01127763|467900697|FG000|Overall Study|Withdrawal by Subject|1|||
129983250|NCT01127763|467900697|FG000|Overall Study|Physician Decision|2|||
129983251|NCT00528931|467900698|FG000|Overall Study|Lost to Follow-up|1|||
129983252|NCT00291642|467900701|FG000|Overall Study|Adverse Event|1|||
129983253|NCT00291642|467900702|FG001|Overall Study|Adverse Event|0|||
129983254|NCT00291642|467900703|FG002|Overall Study|Adverse Event|1|||
129983255|NCT00291642|467900704|FG003|Overall Study|Adverse Event|0|||
129983256|NCT00291642|467900705|FG004|Overall Study|Adverse Event|1|||
129983257|NCT00291642|467900701|FG000|Overall Study|Patient missed visit|0|||
129983258|NCT00291642|467900702|FG001|Overall Study|Patient missed visit|0|||
129983259|NCT00291642|467900703|FG002|Overall Study|Patient missed visit|1|||
129983260|NCT00291642|467900704|FG003|Overall Study|Patient missed visit|0|||
129983261|NCT00291642|467900705|FG004|Overall Study|Patient missed visit|0|||
129983262|NCT00291642|467900701|FG000|Overall Study|Intake of prohibited medication|1|||
129983263|NCT00291642|467900702|FG001|Overall Study|Intake of prohibited medication|0|||
130180075|NCT02070965|468615488|FG001|Overall Study|Withdrawal by Subject|1|||
130180076|NCT02070965|468615489|FG002|Overall Study|Withdrawal by Subject|1|||
130180077|NCT02070965|468615487|FG000|Overall Study|Subject moved|1|||
130180078|NCT02070965|468615488|FG001|Overall Study|Subject moved|0|||
130180079|NCT02070965|468615489|FG002|Overall Study|Subject moved|0|||
130180080|NCT02515331|468615490|FG000|Overall Study|Withdrawal by Subject|0|||
130180081|NCT02515331|468615491|FG001|Overall Study|Withdrawal by Subject|0|||
130180082|NCT02515331|468615492|FG002|Overall Study|Withdrawal by Subject|1|||
130180083|NCT02515331|468615490|FG000|Overall Study|Protocol deviation|0|||
130180084|NCT02515331|468615491|FG001|Overall Study|Protocol deviation|0|||
130180085|NCT02515331|468615492|FG002|Overall Study|Protocol deviation|3|||
130180086|NCT02515331|468615490|FG000|Overall Study|Adverse Event|2|||
130180087|NCT02515331|468615491|FG001|Overall Study|Adverse Event|0|||
130180088|NCT02515331|468615492|FG002|Overall Study|Adverse Event|0|||
130180089|NCT00124748|468615493|FG000|Overall Study|Adverse Event|8|||
130180090|NCT00124748|468615494|FG001|Overall Study|Adverse Event|39|||
129983264|NCT00291642|467900703|FG002|Overall Study|Intake of prohibited medication|0|||
129983265|NCT00291642|467900704|FG003|Overall Study|Intake of prohibited medication|0|||
129983266|NCT00291642|467900705|FG004|Overall Study|Intake of prohibited medication|0|||
129983267|NCT02576587|467900710|FG000|Baseline|Equipment failure|0|||
129983268|NCT02576587|467900711|FG001|Baseline|Equipment failure|1|||
129983269|NCT02576587|467900710|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
129983270|NCT02576587|467900711|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
129983271|NCT02576587|467900710|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
129983272|NCT02576587|467900711|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
129983273|NCT02576587|467900710|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
129983274|NCT02576587|467900711|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
129983275|NCT00532493|467900712|FG000|Overall Study|Death|1|||
129983276|NCT00532493|467900713|FG001|Overall Study|Death|1|||
129983277|NCT00532493|467900712|FG000|Overall Study|Lost to Follow-up|10|||
129983278|NCT00532493|467900713|FG001|Overall Study|Lost to Follow-up|7|||
129983279|NCT00532493|467900712|FG000|Overall Study|Withdrawal by Subject|7|||
129983280|NCT00532493|467900713|FG001|Overall Study|Withdrawal by Subject|9|||
129983281|NCT00532493|467900712|FG000|Overall Study|Physician Decision|1|||
129983282|NCT00532493|467900713|FG001|Overall Study|Physician Decision|6|||
129983283|NCT00532493|467900712|FG000|Overall Study|Adverse Event|6|||
129983284|NCT00532493|467900713|FG001|Overall Study|Adverse Event|5|||
129983285|NCT00532493|467900712|FG000|Overall Study|Protocol Deviation|1|||
129983286|NCT00532493|467900713|FG001|Overall Study|Protocol Deviation|0|||
129983287|NCT00532493|467900712|FG000|Overall Study|Subject Moved Away|3|||
129983288|NCT00532493|467900713|FG001|Overall Study|Subject Moved Away|1|||
129983289|NCT00532493|467900712|FG000|Overall Study|Contraindicative Medication|1|||
130180091|NCT00124748|468615493|FG000|Overall Study|Abnormal laboratory Value|2|||
129983290|NCT00532493|467900713|FG001|Overall Study|Contraindicative Medication|0|||
129983291|NCT00513305|467900714|FG000|Overall Study|Adverse Event|6|||
129983292|NCT00513305|467900715|FG001|Overall Study|Adverse Event|2|||
129983293|NCT00513305|467900714|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
129983294|NCT00513305|467900715|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
129983295|NCT00513305|467900714|FG000|Overall Study|Lack of Efficacy|8|||
129983296|NCT00513305|467900715|FG001|Overall Study|Lack of Efficacy|13|||
129983297|NCT00513305|467900714|FG000|Overall Study|Withdrawal by Subject|1|||
129983298|NCT00513305|467900715|FG001|Overall Study|Withdrawal by Subject|2|||
129983299|NCT00513305|467900714|FG000|Overall Study|Disease progression|8|||
129983300|NCT00513305|467900715|FG001|Overall Study|Disease progression|5|||
129983301|NCT00513305|467900714|FG000|Overall Study|Eligible for stem cell transplant|1|||
129983302|NCT00513305|467900715|FG001|Overall Study|Eligible for stem cell transplant|0|||
129983303|NCT00513305|467900714|FG000|Overall Study|Hematologic counts did not recover|1|||
129983304|NCT00513305|467900715|FG001|Overall Study|Hematologic counts did not recover|0|||
129983305|NCT00513305|467900714|FG000|Overall Study|Physician Decision|1|||
129983306|NCT00513305|467900715|FG001|Overall Study|Physician Decision|0|||
129983307|NCT00513305|467900714|FG000|Overall Study|Persistent hypocellularity|0|||
129983308|NCT00513305|467900715|FG001|Overall Study|Persistent hypocellularity|1|||
129983309|NCT00513305|467900714|FG000|Overall Study|Sponsor Decision|0|||
129983310|NCT00513305|467900715|FG001|Overall Study|Sponsor Decision|2|||
129983311|NCT02489968|467900722|FG000|Open-label Treatment Period|Adverse Event|14|||
129983312|NCT02489968|467900723|FG001|Open-label Treatment Period|Adverse Event|7|||
129983313|NCT02489968|467900724|FG002|Open-label Treatment Period|Adverse Event|0|||
129983314|NCT02489968|467900725|FG003|Open-label Treatment Period|Adverse Event|0|||
129983315|NCT02489968|467900726|FG004|Open-label Treatment Period|Adverse Event|0|||
129983316|NCT02489968|467900727|FG005|Open-label Treatment Period|Adverse Event|0|||
129983317|NCT02489968|467900722|FG000|Open-label Treatment Period|Protocol Violation|2|||
129983318|NCT02489968|467900723|FG001|Open-label Treatment Period|Protocol Violation|2|||
129983319|NCT02489968|467900724|FG002|Open-label Treatment Period|Protocol Violation|0|||
129983320|NCT02489968|467900725|FG003|Open-label Treatment Period|Protocol Violation|0|||
129983321|NCT02489968|467900726|FG004|Open-label Treatment Period|Protocol Violation|0|||
129983322|NCT02489968|467900727|FG005|Open-label Treatment Period|Protocol Violation|0|||
129983323|NCT02489968|467900722|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129983324|NCT02489968|467900723|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
129983325|NCT02489968|467900724|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129983326|NCT02489968|467900725|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
129983327|NCT02489968|467900726|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
129983328|NCT02489968|467900727|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
129983329|NCT02489968|467900722|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
129983330|NCT02489968|467900723|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
129983331|NCT02489968|467900724|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129983332|NCT02489968|467900725|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
129983333|NCT02489968|467900726|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
129983334|NCT02489968|467900727|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
129983335|NCT02489968|467900722|FG000|Open-label Treatment Period|Other than specified above|204|||
129983336|NCT02489968|467900723|FG001|Open-label Treatment Period|Other than specified above|189|||
129983337|NCT02489968|467900724|FG002|Open-label Treatment Period|Other than specified above|0|||
129983338|NCT02489968|467900725|FG003|Open-label Treatment Period|Other than specified above|0|||
129983339|NCT02489968|467900726|FG004|Open-label Treatment Period|Other than specified above|0|||
129983340|NCT02489968|467900727|FG005|Open-label Treatment Period|Other than specified above|0|||
129983341|NCT02489968|467900722|FG000|Double-blind Treatment Period|Adverse Event|0|||
129983342|NCT02489968|467900723|FG001|Double-blind Treatment Period|Adverse Event|0|||
129983343|NCT02489968|467900724|FG002|Double-blind Treatment Period|Adverse Event|2|||
129983344|NCT02489968|467900725|FG003|Double-blind Treatment Period|Adverse Event|6|||
129983345|NCT02489968|467900726|FG004|Double-blind Treatment Period|Adverse Event|4|||
129983346|NCT02489968|467900727|FG005|Double-blind Treatment Period|Adverse Event|5|||
129983347|NCT02489968|467900722|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129983348|NCT02489968|467900723|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129983349|NCT02489968|467900724|FG002|Double-blind Treatment Period|Protocol Violation|0|||
129983350|NCT02489968|467900725|FG003|Double-blind Treatment Period|Protocol Violation|0|||
129983351|NCT02489968|467900726|FG004|Double-blind Treatment Period|Protocol Violation|1|||
129983352|NCT02489968|467900727|FG005|Double-blind Treatment Period|Protocol Violation|1|||
129983353|NCT02489968|467900722|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983354|NCT02489968|467900723|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983355|NCT02489968|467900724|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983356|NCT02489968|467900725|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
129983357|NCT02489968|467900726|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983358|NCT02489968|467900727|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
129983359|NCT02489968|467900722|FG000|Double-blind Treatment Period|Other than specified above|0|||
129983360|NCT02489968|467900723|FG001|Double-blind Treatment Period|Other than specified above|0|||
129983361|NCT02489968|467900724|FG002|Double-blind Treatment Period|Other than specified above|0|||
129983362|NCT02489968|467900725|FG003|Double-blind Treatment Period|Other than specified above|0|||
129983363|NCT02489968|467900726|FG004|Double-blind Treatment Period|Other than specified above|1|||
129983364|NCT02489968|467900727|FG005|Double-blind Treatment Period|Other than specified above|0|||
129983365|NCT00607724|467900728|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
129983366|NCT00607724|467900729|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
129983367|NCT00607724|467900730|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
130180092|NCT00124748|468615494|FG001|Overall Study|Abnormal laboratory Value|2|||
130180093|NCT00124748|468615493|FG000|Overall Study|Abnormal Procedure|0|||
130180094|NCT00124748|468615494|FG001|Overall Study|Abnormal Procedure|1|||
130180095|NCT00124748|468615493|FG000|Overall Study|Lack of Efficacy|20|||
130180096|NCT00124748|468615494|FG001|Overall Study|Lack of Efficacy|41|||
130180097|NCT00124748|468615493|FG000|Overall Study|No longer requires study drug|1|||
130180098|NCT00124748|468615494|FG001|Overall Study|No longer requires study drug|1|||
130180099|NCT00124748|468615493|FG000|Overall Study|Protocol Violation|3|||
130180100|NCT00124748|468615494|FG001|Overall Study|Protocol Violation|1|||
130180101|NCT00124748|468615493|FG000|Overall Study|Withdrawal by Subject|5|||
130180102|NCT00124748|468615494|FG001|Overall Study|Withdrawal by Subject|15|||
130180103|NCT00124748|468615493|FG000|Overall Study|Lost to Follow-up|2|||
130180104|NCT00124748|468615494|FG001|Overall Study|Lost to Follow-up|7|||
130180105|NCT00124748|468615493|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
130180106|NCT00124748|468615494|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
130180107|NCT00124748|468615493|FG000|Overall Study|Death|1|||
130180108|NCT00124748|468615494|FG001|Overall Study|Death|3|||
130180109|NCT00322712|468615495|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
130180110|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
130180111|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
130180112|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
130180113|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180114|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
130180115|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
130180116|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180117|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180118|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180119|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180120|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180121|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180122|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180123|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180124|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180125|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180126|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
130180127|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130180128|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180129|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
130180130|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130180131|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
130180132|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
130180133|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180134|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180135|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180136|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180137|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180138|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180139|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180140|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180141|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180142|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180143|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
130180144|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
130180145|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130180146|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130180147|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
130180148|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
130180149|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
130180150|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180151|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180152|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180153|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180154|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180155|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180156|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180157|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180158|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180159|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180160|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
130180161|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180162|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
130180163|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
130180164|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180165|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
130180166|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
130180167|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180168|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180169|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180170|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180171|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180172|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180173|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180174|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180175|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180176|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180177|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
130180178|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180179|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180180|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
130180181|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
130180182|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180183|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180184|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180185|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180186|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180187|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180188|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180189|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180190|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180191|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180192|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180193|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180194|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
130180195|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180196|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180197|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180198|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180199|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
130180200|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180201|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180202|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180203|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180204|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180205|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180206|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180207|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180208|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180209|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180210|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180211|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
130180212|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180213|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
130180214|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180215|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180216|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180217|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180218|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180219|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180220|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180221|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180222|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180223|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180224|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180225|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129983368|NCT00607724|467900731|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
130180226|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180227|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180228|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
130180229|NCT00758524|468615496|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180230|NCT00758524|468615497|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
130180231|NCT00758524|468615498|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180232|NCT00758524|468615499|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180233|NCT00758524|468615500|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180234|NCT00758524|468615501|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180235|NCT00758524|468615502|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180236|NCT00758524|468615503|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180237|NCT00758524|468615504|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180238|NCT00758524|468615505|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180239|NCT00758524|468615506|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180240|NCT00758524|468615507|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180241|NCT00758524|468615508|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180242|NCT00758524|468615509|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180243|NCT00758524|468615510|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180244|NCT00758524|468615511|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180245|NCT00758524|468615512|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
130180246|NCT00758524|468615496|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180247|NCT00758524|468615497|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180248|NCT00758524|468615498|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180249|NCT00758524|468615499|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180250|NCT00758524|468615500|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180251|NCT00758524|468615501|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180252|NCT00758524|468615502|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180253|NCT00758524|468615503|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180254|NCT00758524|468615504|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
130180255|NCT00758524|468615505|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180256|NCT00758524|468615506|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180257|NCT00758524|468615507|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180258|NCT00758524|468615508|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180259|NCT00758524|468615509|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180260|NCT00758524|468615510|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180261|NCT00758524|468615511|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180262|NCT00758524|468615512|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
130180263|NCT00758524|468615496|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180264|NCT00758524|468615497|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180265|NCT00758524|468615498|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180266|NCT00758524|468615499|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180267|NCT00758524|468615500|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180268|NCT00758524|468615501|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180269|NCT00758524|468615502|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
130180270|NCT00758524|468615503|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180271|NCT00758524|468615504|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180272|NCT00758524|468615505|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180273|NCT00758524|468615506|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180274|NCT00758524|468615507|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180275|NCT00758524|468615508|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180276|NCT00758524|468615509|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180277|NCT00758524|468615510|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180278|NCT00758524|468615511|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180279|NCT00758524|468615512|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
130180280|NCT01269918|468615513|FG000|Overall Study|Did not receive study drug|0|||
130180281|NCT01269918|468615514|FG001|Overall Study|Did not receive study drug|3|||
130180282|NCT01928472|468615515|FG000|Overall Study|Death|0|||
130180283|NCT01928472|468615516|FG001|Overall Study|Death|0|||
130180284|NCT01928472|468615517|FG002|Overall Study|Death|1|||
130180285|NCT01928472|468615518|FG003|Overall Study|Death|0|||
130180286|NCT01928472|468615515|FG000|Overall Study|Withdrawal by Subject|4|||
130180287|NCT01928472|468615516|FG001|Overall Study|Withdrawal by Subject|4|||
130180288|NCT01928472|468615517|FG002|Overall Study|Withdrawal by Subject|1|||
130180289|NCT01928472|468615518|FG003|Overall Study|Withdrawal by Subject|2|||
130180290|NCT01928472|468615515|FG000|Overall Study|Lost to Follow-up|2|||
130180291|NCT01928472|468615516|FG001|Overall Study|Lost to Follow-up|3|||
130180292|NCT01928472|468615517|FG002|Overall Study|Lost to Follow-up|4|||
130180293|NCT01928472|468615518|FG003|Overall Study|Lost to Follow-up|0|||
130180294|NCT01928472|468615515|FG000|Overall Study|Administrative Reason|2|||
130180295|NCT01928472|468615516|FG001|Overall Study|Administrative Reason|1|||
130180296|NCT01928472|468615517|FG002|Overall Study|Administrative Reason|0|||
130180297|NCT01928472|468615518|FG003|Overall Study|Administrative Reason|0|||
130180298|NCT01928472|468615515|FG000|Overall Study|Unclassified|0|||
130180299|NCT01928472|468615516|FG001|Overall Study|Unclassified|0|||
130180300|NCT01928472|468615517|FG002|Overall Study|Unclassified|1|||
130180301|NCT01928472|468615518|FG003|Overall Study|Unclassified|0|||
130180302|NCT01308424|468615519|FG000|Baseline Eligibility|Screen Failures|71|||
130180303|NCT01308424|468615520|FG001|Baseline Eligibility|Screen Failures|0|||
130180304|NCT01308424|468615521|FG002|Baseline Eligibility|Screen Failures|0|||
130180305|NCT01308424|468615519|FG000|Randomization|Adverse Event|0|||
130180306|NCT01308424|468615520|FG001|Randomization|Adverse Event|1|||
130180307|NCT01308424|468615521|FG002|Randomization|Adverse Event|1|||
130180308|NCT01308424|468615519|FG000|Randomization|Lost to Follow-up|0|||
130180309|NCT01308424|468615520|FG001|Randomization|Lost to Follow-up|1|||
130180310|NCT01308424|468615521|FG002|Randomization|Lost to Follow-up|0|||
130180311|NCT01308424|468615519|FG000|Randomization|Physician Decision|0|||
130180312|NCT01308424|468615520|FG001|Randomization|Physician Decision|1|||
130180313|NCT01308424|468615521|FG002|Randomization|Physician Decision|1|||
130180314|NCT04471428|468615525|FG000|Overall Study|Withdrawal by Subject|29|||
130180315|NCT04471428|468615526|FG001|Overall Study|Withdrawal by Subject|1|||
130180316|NCT04471428|468615525|FG000|Overall Study|Physician Decision|0|||
130180317|NCT04471428|468615526|FG001|Overall Study|Physician Decision|1|||
130180318|NCT04471428|468615525|FG000|Overall Study|Reason Not Specified|0|||
130180319|NCT04471428|468615526|FG001|Overall Study|Reason Not Specified|2|||
130180320|NCT04471428|468615525|FG000|Overall Study|Death|106|||
130180321|NCT04471428|468615526|FG001|Overall Study|Death|114|||
130180322|NCT04471428|468615525|FG000|Overall Study|Ongoing in the study|45|||
130180323|NCT04471428|468615526|FG001|Overall Study|Ongoing in the study|68|||
130180324|NCT00129545|468615529|FG000|Overall Study|Death|5|||
130180325|NCT00129545|468615530|FG001|Overall Study|Death|60|||
130180326|NCT00129545|468615531|FG002|Overall Study|Death|44|||
130180327|NCT00129545|468615529|FG000|Overall Study|Withdrawal by Subject|3|||
130180328|NCT00129545|468615530|FG001|Overall Study|Withdrawal by Subject|18|||
130180329|NCT00129545|468615531|FG002|Overall Study|Withdrawal by Subject|44|||
130180330|NCT00129545|468615529|FG000|Overall Study|Lost to Follow-up|2|||
130180331|NCT00129545|468615530|FG001|Overall Study|Lost to Follow-up|22|||
130180332|NCT00129545|468615531|FG002|Overall Study|Lost to Follow-up|13|||
130180333|NCT00129545|468615529|FG000|Overall Study|Physician Decision|0|||
130180334|NCT00129545|468615530|FG001|Overall Study|Physician Decision|3|||
130180335|NCT00129545|468615531|FG002|Overall Study|Physician Decision|10|||
130180336|NCT00129545|468615529|FG000|Overall Study|Device not implanted|16|||
130180337|NCT00129545|468615530|FG001|Overall Study|Device not implanted|61|||
130180338|NCT00129545|468615531|FG002|Overall Study|Device not implanted|0|||
130180339|NCT01841593|468615532|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
130180340|NCT01841593|468615533|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
130180341|NCT01841593|468615532|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
130180342|NCT01841593|468615533|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
130180343|NCT00307086|468615534|FG000|Overall Study|ineligible|5|||
130180344|NCT01870778|468615538|FG000|Overall Study|Withdrawal by Subject|8|||
130180345|NCT01870778|468615539|FG001|Overall Study|Withdrawal by Subject|7|||
130180346|NCT01870778|468615538|FG000|Overall Study|Lost to Follow-up|0|||
130180347|NCT01870778|468615539|FG001|Overall Study|Lost to Follow-up|2|||
130180348|NCT00312338|468615540|FG000|Overall Study|Adverse Event|7|||
130180349|NCT00312338|468615541|FG001|Overall Study|Adverse Event|2|||
130180350|NCT00312338|468615540|FG000|Overall Study|Lost to Follow-up|9|||
130180351|NCT00312338|468615541|FG001|Overall Study|Lost to Follow-up|1|||
130180352|NCT00312338|468615540|FG000|Overall Study|Withdrawal by Subject|4|||
130180353|NCT00312338|468615541|FG001|Overall Study|Withdrawal by Subject|0|||
130180354|NCT00312338|468615540|FG000|Overall Study|Subsequent infection|2|||
130180355|NCT00312338|468615541|FG001|Overall Study|Subsequent infection|0|||
130180356|NCT00262028|468615542|FG000|Overall Study|Withdrawal by Subject|6|||
130180357|NCT00262028|468615543|FG001|Overall Study|Withdrawal by Subject|3|||
130180358|NCT00262028|468615544|FG002|Overall Study|Withdrawal by Subject|6|||
130180359|NCT00262028|468615545|FG003|Overall Study|Withdrawal by Subject|5|||
130180360|NCT00262028|468615546|FG004|Overall Study|Withdrawal by Subject|2|||
130180361|NCT00262028|468615547|FG005|Overall Study|Withdrawal by Subject|3|||
130180362|NCT00262028|468615548|FG006|Overall Study|Withdrawal by Subject|5|||
130180363|NCT00262028|468615549|FG007|Overall Study|Withdrawal by Subject|7|||
130180364|NCT00262028|468615550|FG008|Overall Study|Withdrawal by Subject|2|||
130180365|NCT00262028|468615542|FG000|Overall Study|Lost to Follow-up|7|||
130180366|NCT00262028|468615543|FG001|Overall Study|Lost to Follow-up|7|||
130180367|NCT00262028|468615544|FG002|Overall Study|Lost to Follow-up|5|||
130180368|NCT00262028|468615545|FG003|Overall Study|Lost to Follow-up|5|||
130180369|NCT00262028|468615546|FG004|Overall Study|Lost to Follow-up|4|||
130180370|NCT00262028|468615547|FG005|Overall Study|Lost to Follow-up|3|||
130180371|NCT00262028|468615548|FG006|Overall Study|Lost to Follow-up|3|||
130180372|NCT00262028|468615549|FG007|Overall Study|Lost to Follow-up|5|||
130180373|NCT00262028|468615550|FG008|Overall Study|Lost to Follow-up|6|||
130180374|NCT00262028|468615542|FG000|Overall Study|Administrative Reason|11|||
130180375|NCT00262028|468615543|FG001|Overall Study|Administrative Reason|14|||
130180376|NCT00262028|468615544|FG002|Overall Study|Administrative Reason|9|||
130180377|NCT00262028|468615545|FG003|Overall Study|Administrative Reason|12|||
130180378|NCT00262028|468615546|FG004|Overall Study|Administrative Reason|6|||
130180379|NCT00262028|468615547|FG005|Overall Study|Administrative Reason|7|||
130180380|NCT00262028|468615548|FG006|Overall Study|Administrative Reason|4|||
130180381|NCT00262028|468615549|FG007|Overall Study|Administrative Reason|6|||
130180382|NCT00262028|468615550|FG008|Overall Study|Administrative Reason|10|||
130180383|NCT00262028|468615542|FG000|Overall Study|Protocol Violation|0|||
130180384|NCT00262028|468615543|FG001|Overall Study|Protocol Violation|0|||
130180385|NCT00262028|468615544|FG002|Overall Study|Protocol Violation|0|||
130180386|NCT00262028|468615545|FG003|Overall Study|Protocol Violation|1|||
130180387|NCT00262028|468615546|FG004|Overall Study|Protocol Violation|0|||
130180388|NCT00262028|468615547|FG005|Overall Study|Protocol Violation|0|||
130180389|NCT00262028|468615548|FG006|Overall Study|Protocol Violation|0|||
130180390|NCT00262028|468615549|FG007|Overall Study|Protocol Violation|0|||
130180391|NCT00262028|468615550|FG008|Overall Study|Protocol Violation|0|||
130180392|NCT00262028|468615542|FG000|Overall Study|Unable to classify|0|||
130180393|NCT00262028|468615543|FG001|Overall Study|Unable to classify|3|||
130180394|NCT00262028|468615544|FG002|Overall Study|Unable to classify|0|||
130180395|NCT00262028|468615545|FG003|Overall Study|Unable to classify|0|||
130180396|NCT00262028|468615546|FG004|Overall Study|Unable to classify|0|||
130180397|NCT00262028|468615547|FG005|Overall Study|Unable to classify|0|||
130180398|NCT00262028|468615548|FG006|Overall Study|Unable to classify|0|||
130180399|NCT00262028|468615549|FG007|Overall Study|Unable to classify|0|||
130180400|NCT00262028|468615550|FG008|Overall Study|Unable to classify|1|||
130180401|NCT02308124|468615551|FG000|Overall Study|Lost to Follow-up|6|||
130180402|NCT02308124|468615552|FG001|Overall Study|Lost to Follow-up|6|||
130180403|NCT02308124|468615553|FG002|Overall Study|Lost to Follow-up|6|||
130180404|NCT02308124|468615551|FG000|Overall Study|Adverse Event|0|||
130180405|NCT02308124|468615552|FG001|Overall Study|Adverse Event|2|||
130180406|NCT02308124|468615553|FG002|Overall Study|Adverse Event|2|||
130180407|NCT02553772|468615555|FG000|Overall Study|Adverse Event|2|||
130180408|NCT02553772|468615556|FG001|Overall Study|Adverse Event|3|||
130180409|NCT02553772|468615555|FG000|Overall Study|Lost to Follow-up|2|||
130180410|NCT02553772|468615556|FG001|Overall Study|Lost to Follow-up|1|||
129983369|NCT00607724|467900732|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129983370|NCT00607724|467900733|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129983371|NCT00607724|467900734|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129983372|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
129983373|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
129983374|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
129983375|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
129983376|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
129983377|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
129983378|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
129983379|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
129983380|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
129983381|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
130180411|NCT02553772|468615555|FG000|Overall Study|Withdrawal of Consent|1|||
130180412|NCT02553772|468615556|FG001|Overall Study|Withdrawal of Consent|1|||
130180413|NCT02553772|468615555|FG000|Overall Study|Lack of Efficacy|1|||
130180414|NCT02553772|468615556|FG001|Overall Study|Lack of Efficacy|0|||
130180415|NCT02553772|468615555|FG000|Overall Study|Other Miscellaneous Reasons|0|||
130180416|NCT02553772|468615556|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130180417|NCT05724589|468615557|FG000|Overall Study|Lost to Follow-up|1|||
130180418|NCT00786409|468615558|FG000|Overall Study|Withdrawal by Subject|2|||
130180419|NCT00786409|468615558|FG000|Overall Study|Adverse Event|2|||
130180420|NCT00786409|468615558|FG000|Overall Study|Pregnancy|2|||
130180421|NCT00786409|468615558|FG000|Overall Study|Lost to Follow-up|1|||
130180422|NCT00610129|468615559|FG000|Overall Study|Not treated since patients ineligible|3|||
130180423|NCT02273388|468615562|FG000|Overall Study|Adverse Event|0|||
130180424|NCT02273388|468615563|FG001|Overall Study|Adverse Event|0|||
130180425|NCT02273388|468615564|FG002|Overall Study|Adverse Event|0|||
130180426|NCT02273388|468615565|FG003|Overall Study|Adverse Event|0|||
130180427|NCT02273388|468615566|FG004|Overall Study|Adverse Event|0|||
130180428|NCT02273388|468615567|FG005|Overall Study|Adverse Event|0|||
130180429|NCT02273388|468615568|FG006|Overall Study|Adverse Event|1|||
130180430|NCT02273388|468615569|FG007|Overall Study|Adverse Event|2|||
130180431|NCT02273388|468615570|FG008|Overall Study|Adverse Event|0|||
130180432|NCT02273388|468615571|FG009|Overall Study|Adverse Event|0|||
130180433|NCT02273388|468615572|FG010|Overall Study|Adverse Event|0|||
130180434|NCT02273388|468615573|FG011|Overall Study|Adverse Event|0|||
130180435|NCT02273388|468615562|FG000|Overall Study|Adverse Event study disease worse|4|||
130180436|NCT02273388|468615563|FG001|Overall Study|Adverse Event study disease worse|3|||
130180437|NCT02273388|468615564|FG002|Overall Study|Adverse Event study disease worse|3|||
130180438|NCT02273388|468615565|FG003|Overall Study|Adverse Event study disease worse|2|||
130180439|NCT02273388|468615566|FG004|Overall Study|Adverse Event study disease worse|4|||
130180440|NCT02273388|468615567|FG005|Overall Study|Adverse Event study disease worse|3|||
130180441|NCT02273388|468615568|FG006|Overall Study|Adverse Event study disease worse|14|||
130180442|NCT02273388|468615569|FG007|Overall Study|Adverse Event study disease worse|6|||
130180443|NCT02273388|468615570|FG008|Overall Study|Adverse Event study disease worse|6|||
130180444|NCT02273388|468615571|FG009|Overall Study|Adverse Event study disease worse|5|||
130180445|NCT02273388|468615572|FG010|Overall Study|Adverse Event study disease worse|10|||
130180446|NCT02273388|468615573|FG011|Overall Study|Adverse Event study disease worse|1|||
130180447|NCT02273388|468615562|FG000|Overall Study|Sponsor decision|0|||
130180448|NCT02273388|468615563|FG001|Overall Study|Sponsor decision|0|||
130180449|NCT02273388|468615564|FG002|Overall Study|Sponsor decision|0|||
130180450|NCT02273388|468615565|FG003|Overall Study|Sponsor decision|0|||
130180451|NCT02273388|468615566|FG004|Overall Study|Sponsor decision|0|||
130180452|NCT02273388|468615567|FG005|Overall Study|Sponsor decision|0|||
130180453|NCT02273388|468615568|FG006|Overall Study|Sponsor decision|0|||
130180454|NCT02273388|468615569|FG007|Overall Study|Sponsor decision|0|||
130180455|NCT02273388|468615570|FG008|Overall Study|Sponsor decision|0|||
130180456|NCT02273388|468615571|FG009|Overall Study|Sponsor decision|0|||
130180457|NCT02273388|468615572|FG010|Overall Study|Sponsor decision|0|||
130180458|NCT02273388|468615573|FG011|Overall Study|Sponsor decision|1|||
130180459|NCT01042093|468615574|FG000|Overall Study|Protocol Violation|2|||
130180460|NCT01042093|468615575|FG001|Overall Study|Protocol Violation|2|||
130180461|NCT01042093|468615576|FG002|Overall Study|Protocol Violation|2|||
130180462|NCT01042093|468615577|FG003|Overall Study|Protocol Violation|3|||
130180463|NCT01042093|468615574|FG000|Overall Study|Withdrawal by Subject|0|||
130180464|NCT01042093|468615575|FG001|Overall Study|Withdrawal by Subject|0|||
130180465|NCT01042093|468615576|FG002|Overall Study|Withdrawal by Subject|0|||
130180466|NCT01042093|468615577|FG003|Overall Study|Withdrawal by Subject|1|||
130180467|NCT04331808|468615578|FG000|Overall Study|Withdrew consent|1|||
130180468|NCT04331808|468615579|FG001|Overall Study|Withdrew consent|0|||
130180469|NCT04331808|468615580|FG002|Overall Study|Withdrew consent|2|||
129983382|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
129983383|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
129983384|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
129983385|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
129983386|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
129983387|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
129983388|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
129983389|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
129983390|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
129983391|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
129983392|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
129983393|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983394|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983395|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983396|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
129983397|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983398|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983399|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983400|NCT03738423|467900735|FG000|Overall Study|Withdrawal by Subject|9|||
129983401|NCT03738423|467900736|FG001|Overall Study|Withdrawal by Subject|12|||
129983402|NCT03738423|467900737|FG002|Overall Study|Withdrawal by Subject|9|||
129983403|NCT03738423|467900738|FG003|Overall Study|Withdrawal by Subject|12|||
129983404|NCT03738423|467900739|FG004|Overall Study|Withdrawal by Subject|10|||
129983405|NCT03738423|467900735|FG000|Overall Study|Lack of Efficacy|3|||
130180470|NCT04331808|468615581|FG003|Overall Study|Withdrew consent|3|||
130180471|NCT01184079|468615585|FG000|Overall Study|Lost to Follow-up|14|||
130180472|NCT01184079|468615586|FG001|Overall Study|Lost to Follow-up|2|||
130180473|NCT04233073|468615587|FG000|Overall Study|Death|5|||
130180474|NCT02198963|468615588|FG000|Overall Study|Adverse Event|1|||
130180475|NCT02198963|468615588|FG000|Overall Study|Withdrawal by Subject|6|||
130180476|NCT02905032|468615595|FG000|Overall Study|Withdrawal by Subject|2|||
130180477|NCT02905032|468615596|FG001|Overall Study|Withdrawal by Subject|0|||
130180478|NCT02905032|468615597|FG002|Overall Study|Withdrawal by Subject|0|||
130180479|NCT02905032|468615595|FG000|Overall Study|Protocol Violation|6|||
130180480|NCT02905032|468615596|FG001|Overall Study|Protocol Violation|12|||
130180481|NCT02905032|468615597|FG002|Overall Study|Protocol Violation|0|||
130180482|NCT02603146|468617300|FG000|Overall Study|Lost to Follow-up|5|||
130180483|NCT02603146|468617301|FG001|Overall Study|Lost to Follow-up|6|||
130180484|NCT02603146|468617300|FG000|Overall Study|Withdrawal by Subject|8|||
130180485|NCT02603146|468617301|FG001|Overall Study|Withdrawal by Subject|10|||
130180486|NCT02603146|468617300|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
130180487|NCT02603146|468617301|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
130180488|NCT02603146|468617300|FG000|Overall Study|Participant moved|2|||
130180489|NCT02603146|468617301|FG001|Overall Study|Participant moved|0|||
130180490|NCT02603146|468617300|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
130180491|NCT02603146|468617301|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
130180492|NCT00265759|468617302|FG000|Overall Study|Withdrawal by Subject|0|||
130180493|NCT00265759|468617303|FG001|Overall Study|Withdrawal by Subject|1|||
130180494|NCT00265759|468617304|FG002|Overall Study|Withdrawal by Subject|2|||
130180495|NCT00265759|468617305|FG003|Overall Study|Withdrawal by Subject|2|||
130180496|NCT00265759|468617302|FG000|Overall Study|Cancel|0|||
130180497|NCT00265759|468617303|FG001|Overall Study|Cancel|0|||
130180498|NCT00265759|468617304|FG002|Overall Study|Cancel|0|||
130180499|NCT00265759|468617305|FG003|Overall Study|Cancel|3|||
130180500|NCT00265759|468617302|FG000|Overall Study|Ineligible|0|||
130180501|NCT00265759|468617303|FG001|Overall Study|Ineligible|0|||
130180502|NCT00265759|468617304|FG002|Overall Study|Ineligible|0|||
130180503|NCT00265759|468617305|FG003|Overall Study|Ineligible|1|||
130180504|NCT00265759|468617302|FG000|Overall Study|Bilateral disease|0|||
130180505|NCT00265759|468617303|FG001|Overall Study|Bilateral disease|0|||
130180506|NCT00265759|468617304|FG002|Overall Study|Bilateral disease|0|||
130180507|NCT00265759|468617305|FG003|Overall Study|Bilateral disease|2|||
130180508|NCT00265759|468617302|FG000|Overall Study|Discontinued due to intolerability|0|||
130180509|NCT00265759|468617303|FG001|Overall Study|Discontinued due to intolerability|0|||
130180510|NCT00265759|468617304|FG002|Overall Study|Discontinued due to intolerability|0|||
130180511|NCT00265759|468617305|FG003|Overall Study|Discontinued due to intolerability|1|||
130180512|NCT04467840|468617306|FG000|Overall Study|Death|35|||
130180513|NCT04467840|468617307|FG001|Overall Study|Death|39|||
130180514|NCT04467840|468617306|FG000|Overall Study|Withdrawal by Subject|8|||
130180515|NCT04467840|468617307|FG001|Overall Study|Withdrawal by Subject|4|||
130180516|NCT04467840|468617306|FG000|Overall Study|Adverse Event|2|||
130180517|NCT04467840|468617307|FG001|Overall Study|Adverse Event|0|||
130180518|NCT04467840|468617306|FG000|Overall Study|Lost to Follow-up|1|||
130180519|NCT04467840|468617307|FG001|Overall Study|Lost to Follow-up|3|||
130180520|NCT04467840|468617306|FG000|Overall Study|Physician Decision|1|||
130180521|NCT04467840|468617307|FG001|Overall Study|Physician Decision|0|||
130180522|NCT04467840|468617306|FG000|Overall Study|Other|1|||
130180523|NCT04467840|468617307|FG001|Overall Study|Other|5|||
130180524|NCT04467840|468617306|FG000|Overall Study|Missing study completion status|3|||
130180525|NCT04467840|468617307|FG001|Overall Study|Missing study completion status|1|||
130180526|NCT05201794|468617310|FG000|Overall Study|Withdrawal by Subject|13|||
130180527|NCT05201794|468617311|FG001|Overall Study|Withdrawal by Subject|12|||
130180528|NCT05201794|468617312|FG002|Overall Study|Withdrawal by Subject|14|||
130180529|NCT05201794|468617313|FG003|Overall Study|Withdrawal by Subject|0|||
130180530|NCT05201794|468617310|FG000|Overall Study|Adverse Event|5|||
130180531|NCT05201794|468617311|FG001|Overall Study|Adverse Event|5|||
130180532|NCT05201794|468617312|FG002|Overall Study|Adverse Event|4|||
130180533|NCT05201794|468617313|FG003|Overall Study|Adverse Event|0|||
130180534|NCT05201794|468617310|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
130180535|NCT05201794|468617311|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
130180536|NCT05201794|468617312|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
129983406|NCT03738423|467900736|FG001|Overall Study|Lack of Efficacy|1|||
129983407|NCT03738423|467900737|FG002|Overall Study|Lack of Efficacy|1|||
129983408|NCT03738423|467900738|FG003|Overall Study|Lack of Efficacy|1|||
129983409|NCT03738423|467900739|FG004|Overall Study|Lack of Efficacy|2|||
129983410|NCT03738423|467900735|FG000|Overall Study|Lost to Follow-up|1|||
130180537|NCT05201794|468617313|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
130180538|NCT05201794|468617310|FG000|Overall Study|Non-Compliance With Study Drug|2|||
130180539|NCT05201794|468617311|FG001|Overall Study|Non-Compliance With Study Drug|3|||
130180540|NCT05201794|468617312|FG002|Overall Study|Non-Compliance With Study Drug|3|||
129983411|NCT03738423|467900736|FG001|Overall Study|Lost to Follow-up|0|||
129983412|NCT03738423|467900737|FG002|Overall Study|Lost to Follow-up|1|||
130180541|NCT05201794|468617313|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130180542|NCT05201794|468617310|FG000|Overall Study|Physician Decision|1|||
130180543|NCT05201794|468617311|FG001|Overall Study|Physician Decision|3|||
130180544|NCT05201794|468617312|FG002|Overall Study|Physician Decision|2|||
130180545|NCT05201794|468617313|FG003|Overall Study|Physician Decision|0|||
130180546|NCT05201794|468617310|FG000|Overall Study|Lost to Follow-up|2|||
130180547|NCT05201794|468617311|FG001|Overall Study|Lost to Follow-up|2|||
130180548|NCT05201794|468617312|FG002|Overall Study|Lost to Follow-up|0|||
130180549|NCT05201794|468617313|FG003|Overall Study|Lost to Follow-up|0|||
130180550|NCT05201794|468617310|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
130180551|NCT05201794|468617311|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
130180552|NCT05201794|468617312|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
130180553|NCT05201794|468617313|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
130180554|NCT05201794|468617310|FG000|Overall Study|Protocol Violation|2|||
130180555|NCT05201794|468617311|FG001|Overall Study|Protocol Violation|0|||
130180556|NCT05201794|468617312|FG002|Overall Study|Protocol Violation|1|||
130180557|NCT05201794|468617313|FG003|Overall Study|Protocol Violation|0|||
130180558|NCT05201794|468617310|FG000|Overall Study|Death|1|||
130180559|NCT05201794|468617311|FG001|Overall Study|Death|0|||
130180560|NCT05201794|468617312|FG002|Overall Study|Death|0|||
130180561|NCT05201794|468617313|FG003|Overall Study|Death|0|||
130180562|NCT05201794|468617310|FG000|Overall Study|Site Terminated By Sponsor|0|||
130180563|NCT05201794|468617311|FG001|Overall Study|Site Terminated By Sponsor|1|||
130180564|NCT05201794|468617312|FG002|Overall Study|Site Terminated By Sponsor|0|||
130180565|NCT05201794|468617313|FG003|Overall Study|Site Terminated By Sponsor|0|||
130180566|NCT05201794|468617310|FG000|Overall Study|Other|3|||
130180567|NCT05201794|468617311|FG001|Overall Study|Other|3|||
130180568|NCT05201794|468617312|FG002|Overall Study|Other|3|||
130180569|NCT05201794|468617313|FG003|Overall Study|Other|0|||
130180570|NCT05201794|468617310|FG000|Overall Study|Randomized But Not Treated|1|||
130180571|NCT05201794|468617311|FG001|Overall Study|Randomized But Not Treated|2|||
130180572|NCT05201794|468617312|FG002|Overall Study|Randomized But Not Treated|1|||
130180573|NCT05201794|468617313|FG003|Overall Study|Randomized But Not Treated|0|||
130180574|NCT06082843|468617319|FG000|Overall Study|Withdrawal by Subject|0|||
130180575|NCT06082843|468617320|FG001|Overall Study|Withdrawal by Subject|2|||
130180576|NCT06082843|468617319|FG000|Overall Study|Study terminated by sponsor|12|||
130180577|NCT06082843|468617320|FG001|Overall Study|Study terminated by sponsor|8|||
130180578|NCT04848480|468617324|FG000|Main Phase (26 Weeks)|Death|1|||
130180579|NCT04848480|468617325|FG001|Main Phase (26 Weeks)|Death|0|||
130180580|NCT04848480|468617324|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
130180581|NCT04848480|468617325|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
130180582|NCT04848480|468617324|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
130180583|NCT04848480|468617325|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
130180584|NCT04848480|468617324|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
130180585|NCT04848480|468617325|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
130180586|NCT04848480|468617324|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
130180587|NCT04848480|468617325|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
130180588|NCT04848480|468617324|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
130180589|NCT04848480|468617325|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
130180590|NCT03176134|468617326|FG000|Overall Study|Lost to Follow-up|0|||
130180591|NCT03176134|468617327|FG001|Overall Study|Lost to Follow-up|2|||
130180592|NCT03176134|468617328|FG002|Overall Study|Lost to Follow-up|0|||
130180593|NCT03176134|468617329|FG003|Overall Study|Lost to Follow-up|0|||
130180594|NCT03176134|468617330|FG004|Overall Study|Lost to Follow-up|0|||
130180595|NCT03176134|468617331|FG005|Overall Study|Lost to Follow-up|0|||
130180596|NCT03176134|468617332|FG006|Overall Study|Lost to Follow-up|0|||
130180597|NCT03176134|468617333|FG007|Overall Study|Lost to Follow-up|0|||
130180598|NCT03176134|468617326|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
130180599|NCT03176134|468617327|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
130180600|NCT03176134|468617328|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
130180601|NCT03176134|468617329|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
130180602|NCT03176134|468617330|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
130180603|NCT03176134|468617331|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
130180604|NCT03176134|468617332|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
130180605|NCT03176134|468617333|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
130180606|NCT01368497|468617334|FG000|Overall Study|Lost to Follow-up|2|||
130180607|NCT05989672|468617336|FG000|Overall Study|Adverse Event|3|||
130180608|NCT05989672|468617337|FG001|Overall Study|Adverse Event|0|||
130180609|NCT05989672|468617338|FG002|Overall Study|Adverse Event|0|||
130180610|NCT00443729|468617339|FG000|Overall Study|Never Treated|0|||
130180611|NCT00443729|468617340|FG001|Overall Study|Never Treated|1|||
130180612|NCT00443729|468617339|FG000|Overall Study|Lack of Efficacy|4|||
130180613|NCT00443729|468617340|FG001|Overall Study|Lack of Efficacy|2|||
130180614|NCT00443729|468617339|FG000|Overall Study|Lost to Follow-up|0|||
130180615|NCT00443729|468617340|FG001|Overall Study|Lost to Follow-up|1|||
130180616|NCT00443729|468617339|FG000|Overall Study|Physician Decision|2|||
130180617|NCT00443729|468617340|FG001|Overall Study|Physician Decision|1|||
130180618|NCT00443729|468617339|FG000|Overall Study|Protocol Violation|1|||
130180619|NCT00443729|468617340|FG001|Overall Study|Protocol Violation|1|||
130180620|NCT00443729|468617339|FG000|Overall Study|Withdrawal by Subject|3|||
130180621|NCT00443729|468617340|FG001|Overall Study|Withdrawal by Subject|1|||
130180622|NCT03718832|468617343|FG000|Analysis Sample|Withdrawal by Subject|18|||
130180623|NCT03718832|468617344|FG001|Analysis Sample|Withdrawal by Subject|15|||
130180624|NCT03718832|468617343|FG000|Analysis Sample|Legal hold on data|1|||
130180625|NCT03718832|468617344|FG001|Analysis Sample|Legal hold on data|0|||
130180626|NCT03718832|468617343|FG000|Analysis Sample|Participant from treated household|0|||
130180627|NCT03718832|468617344|FG001|Analysis Sample|Participant from treated household|1|||
130180628|NCT03718832|468617343|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
130180629|NCT03718832|468617344|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
130180630|NCT00276484|468617348|FG000|Overall Study|Adverse Event|4|||
130180631|NCT00276484|468617349|FG001|Overall Study|Adverse Event|7|||
130180632|NCT00276484|468617348|FG000|Overall Study|Lost to Follow-up|1|||
130180633|NCT00276484|468617349|FG001|Overall Study|Lost to Follow-up|1|||
130180634|NCT00276484|468617348|FG000|Overall Study|Protocol Violation|0|||
130180635|NCT00276484|468617349|FG001|Overall Study|Protocol Violation|1|||
130180636|NCT00276484|468617348|FG000|Overall Study|Withdrawal by Subject|4|||
130180637|NCT00276484|468617349|FG001|Overall Study|Withdrawal by Subject|3|||
130180638|NCT00276484|468617348|FG000|Overall Study|Could not take time off work|0|||
130180639|NCT00276484|468617349|FG001|Overall Study|Could not take time off work|1|||
130180640|NCT01626690|468617350|FG000|Overall Study|Protocol Violation|1|||
130180641|NCT01626690|468617351|FG001|Overall Study|Protocol Violation|0|||
130180642|NCT01626690|468617350|FG000|Overall Study|Adverse Event|1|||
130180643|NCT01626690|468617351|FG001|Overall Study|Adverse Event|0|||
130180644|NCT00110396|468617352|FG000|Overall Study|Adverse Event|15|||
130180645|NCT00110396|468617352|FG000|Overall Study|Lost to Follow-up|1|||
130180646|NCT00110396|468617352|FG000|Overall Study|Administration of plasmapheresis|1|||
130180647|NCT00110396|468617352|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
130180648|NCT00110396|468617352|FG000|Overall Study|Lack of Efficacy|1|||
130180649|NCT00110396|468617352|FG000|Overall Study|Decided not to continue treatment|1|||
130180650|NCT00110396|468617352|FG000|Overall Study|Patient non-compliance|1|||
130180651|NCT00110396|468617352|FG000|Overall Study|Patient refused to continue|1|||
130180652|NCT00110396|468617352|FG000|Overall Study|Patient refused to participate|1|||
130180653|NCT00110396|468617352|FG000|Overall Study|Patient will|1|||
130180654|NCT00110396|468617352|FG000|Overall Study|Patient's decision|1|||
130180655|NCT00110396|468617352|FG000|Overall Study|Participation in MS vaccine study|1|||
130180656|NCT00110396|468617352|FG000|Overall Study|Pregnancy|1|||
130180657|NCT00110396|468617352|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
130180658|NCT00110396|468617352|FG000|Overall Study|Protocol Violation|2|||
130180659|NCT00110396|468617352|FG000|Overall Study|Patient refused to come back|1|||
129983413|NCT03738423|467900738|FG003|Overall Study|Lost to Follow-up|1|||
129983414|NCT03738423|467900739|FG004|Overall Study|Lost to Follow-up|0|||
129983415|NCT03738423|467900735|FG000|Overall Study|Protocol Violation|1|||
129983416|NCT03738423|467900736|FG001|Overall Study|Protocol Violation|0|||
129983417|NCT03738423|467900737|FG002|Overall Study|Protocol Violation|0|||
129983418|NCT03738423|467900738|FG003|Overall Study|Protocol Violation|0|||
129983419|NCT03738423|467900739|FG004|Overall Study|Protocol Violation|1|||
129983420|NCT03738423|467900735|FG000|Overall Study|Physician Decision|0|||
129983421|NCT03738423|467900736|FG001|Overall Study|Physician Decision|0|||
129983422|NCT03738423|467900737|FG002|Overall Study|Physician Decision|1|||
129983423|NCT03738423|467900738|FG003|Overall Study|Physician Decision|0|||
129983424|NCT03738423|467900739|FG004|Overall Study|Physician Decision|1|||
129983425|NCT03738423|467900735|FG000|Overall Study|Death|0|||
129983426|NCT03738423|467900736|FG001|Overall Study|Death|0|||
129983427|NCT03738423|467900737|FG002|Overall Study|Death|0|||
129983428|NCT03738423|467900738|FG003|Overall Study|Death|0|||
129983429|NCT03738423|467900739|FG004|Overall Study|Death|1|||
129983430|NCT03738423|467900735|FG000|Overall Study|Randomized but never treated|0|||
129983431|NCT03738423|467900736|FG001|Overall Study|Randomized but never treated|0|||
129983432|NCT03738423|467900737|FG002|Overall Study|Randomized but never treated|1|||
129983433|NCT03738423|467900738|FG003|Overall Study|Randomized but never treated|1|||
129983434|NCT03738423|467900739|FG004|Overall Study|Randomized but never treated|0|||
129983435|NCT01198756|467902210|FG000|Overall Study|Adverse Event|0|||
129983436|NCT01198756|467902211|FG001|Overall Study|Adverse Event|0|||
129983437|NCT01198756|467902212|FG002|Overall Study|Adverse Event|0|||
129983438|NCT01198756|467902213|FG003|Overall Study|Adverse Event|1|||
129983439|NCT01198756|467902210|FG000|Overall Study|Protocol Violation|0|||
129983440|NCT01198756|467902211|FG001|Overall Study|Protocol Violation|0|||
129983441|NCT01198756|467902212|FG002|Overall Study|Protocol Violation|0|||
129983442|NCT01198756|467902213|FG003|Overall Study|Protocol Violation|2|||
129983443|NCT01198756|467902210|FG000|Overall Study|Withdrawal by Subject|9|||
129983444|NCT01198756|467902211|FG001|Overall Study|Withdrawal by Subject|4|||
129983445|NCT01198756|467902212|FG002|Overall Study|Withdrawal by Subject|7|||
129983446|NCT01198756|467902213|FG003|Overall Study|Withdrawal by Subject|5|||
129983447|NCT01198756|467902210|FG000|Overall Study|Lost to Follow-up|29|||
130180660|NCT00110396|468617352|FG000|Overall Study|The patient has refused|2|||
130180661|NCT00110396|468617352|FG000|Overall Study|The patient has refused to visit site|1|||
130180662|NCT00110396|468617352|FG000|Overall Study|Patient is to be administered copaxone|1|||
129983448|NCT01198756|467902211|FG001|Overall Study|Lost to Follow-up|36|||
129983449|NCT01198756|467902212|FG002|Overall Study|Lost to Follow-up|23|||
129983450|NCT01198756|467902213|FG003|Overall Study|Lost to Follow-up|18|||
129983451|NCT01290315|467902215|FG000|Overall Study|Adverse Event|0|||
129983452|NCT01290315|467902216|FG001|Overall Study|Adverse Event|0|||
129983453|NCT01290315|467902217|FG002|Overall Study|Adverse Event|0|||
130180663|NCT02414958|468617353|FG000|Overall Study|Adverse Event|6|||
130180664|NCT02414958|468617354|FG001|Overall Study|Adverse Event|6|||
130180665|NCT02414958|468617355|FG002|Overall Study|Adverse Event|3|||
130180666|NCT02414958|468617353|FG000|Overall Study|Protocol Violation|10|||
130180667|NCT02414958|468617354|FG001|Overall Study|Protocol Violation|3|||
129983454|NCT01290315|467902218|FG003|Overall Study|Adverse Event|3|||
129983455|NCT01290315|467902215|FG000|Overall Study|Selection criteria/compliance|2|||
129983456|NCT01290315|467902216|FG001|Overall Study|Selection criteria/compliance|1|||
129983457|NCT01290315|467902217|FG002|Overall Study|Selection criteria/compliance|0|||
129983458|NCT01290315|467902218|FG003|Overall Study|Selection criteria/compliance|2|||
129983459|NCT01290315|467902215|FG000|Overall Study|Lost to Follow-up|0|||
129983460|NCT01290315|467902216|FG001|Overall Study|Lost to Follow-up|1|||
129983461|NCT01290315|467902217|FG002|Overall Study|Lost to Follow-up|0|||
129983462|NCT01290315|467902218|FG003|Overall Study|Lost to Follow-up|0|||
129983463|NCT01290315|467902215|FG000|Overall Study|Withdrawal by Subject|1|||
129983464|NCT01290315|467902216|FG001|Overall Study|Withdrawal by Subject|1|||
129983465|NCT01290315|467902217|FG002|Overall Study|Withdrawal by Subject|0|||
129983466|NCT01290315|467902218|FG003|Overall Study|Withdrawal by Subject|0|||
129983467|NCT00591721|467902219|FG000|Overall Study|Withdrawal by Subject|10|||
129983468|NCT00591721|467902220|FG001|Overall Study|Withdrawal by Subject|10|||
129983469|NCT00591721|467902219|FG000|Overall Study|Lost to Follow-up|1|||
129983470|NCT00591721|467902220|FG001|Overall Study|Lost to Follow-up|4|||
129983471|NCT00591721|467902219|FG000|Overall Study|Intervention not received|10|||
129983472|NCT00591721|467902220|FG001|Overall Study|Intervention not received|8|||
129983473|NCT00901186|467902223|FG000|Overall Study|Lack of Efficacy|0|||
129983474|NCT00901186|467902224|FG001|Overall Study|Lack of Efficacy|1|||
129983475|NCT00901186|467902223|FG000|Overall Study|Abnormal laboratory values|0|||
129983476|NCT00901186|467902224|FG001|Overall Study|Abnormal laboratory values|1|||
129983477|NCT00901186|467902223|FG000|Overall Study|Lost to Follow-up|2|||
129983478|NCT00901186|467902224|FG001|Overall Study|Lost to Follow-up|0|||
129983479|NCT00901186|467902223|FG000|Overall Study|Adverse Event|2|||
129983480|NCT00901186|467902224|FG001|Overall Study|Adverse Event|4|||
129983481|NCT00901186|467902223|FG000|Overall Study|Administration problems|0|||
129983482|NCT00901186|467902224|FG001|Overall Study|Administration problems|1|||
129983483|NCT00901186|467902223|FG000|Overall Study|Protocol deviations|5|||
129983484|NCT00901186|467902224|FG001|Overall Study|Protocol deviations|4|||
129983485|NCT00581555|467902227|FG000|Overall Study|Adverse Event|4|||
129983486|NCT00581555|467902228|FG001|Overall Study|Adverse Event|3|||
129983487|NCT00581555|467902227|FG000|Overall Study|Physician Decision|3|||
129983488|NCT00581555|467902228|FG001|Overall Study|Physician Decision|2|||
129983489|NCT00581555|467902227|FG000|Overall Study|Withdrawal by Subject|18|||
129983490|NCT00581555|467902228|FG001|Overall Study|Withdrawal by Subject|9|||
129983491|NCT00581555|467902227|FG000|Overall Study|Lost to Follow-up|2|||
129983492|NCT00581555|467902228|FG001|Overall Study|Lost to Follow-up|2|||
129983493|NCT00581555|467902227|FG000|Overall Study|Other reasons|16|||
129983494|NCT00581555|467902228|FG001|Overall Study|Other reasons|4|||
129983495|NCT05816330|467902229|FG000|Overall Study|Withdrawal by Subject|4|||
129983496|NCT05816330|467902230|FG001|Overall Study|Withdrawal by Subject|1|||
129983497|NCT03900416|467902231|FG000|Six Week Follow-up|Lost to Follow-up|1|||
129983498|NCT03900416|467902232|FG001|Six Week Follow-up|Lost to Follow-up|0|||
129983499|NCT03900416|467902231|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
129983500|NCT03900416|467902232|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
129983501|NCT03900416|467902231|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
129983502|NCT03900416|467902232|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
129983503|NCT03900416|467902231|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
129983504|NCT03900416|467902232|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
129983505|NCT03900416|467902231|FG000|Twelve Week Follow-up|Adverse Event|1|||
129983506|NCT03900416|467902232|FG001|Twelve Week Follow-up|Adverse Event|1|||
129983507|NCT03900416|467902231|FG000|Six Month Follow-up|Lost to Follow-up|4|||
129983508|NCT03900416|467902232|FG001|Six Month Follow-up|Lost to Follow-up|3|||
129983509|NCT03900416|467902231|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
129983510|NCT03900416|467902232|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
129983511|NCT00772330|467902233|FG000|Overall Study|Lost to Follow-up|3|||
129983512|NCT01353859|467902234|FG000|Overall Study|Adverse Event|3|||
129983513|NCT01353859|467902234|FG000|Overall Study|Lack of Efficacy|1|||
129983514|NCT03231800|467902235|FG000|Overall Study|Lost to Follow-up|0|||
129983515|NCT03231800|467902236|FG001|Overall Study|Lost to Follow-up|2|||
129983516|NCT03231800|467902235|FG000|Overall Study|Protocol Violation|1|||
129983517|NCT03231800|467902236|FG001|Overall Study|Protocol Violation|1|||
129983518|NCT03231800|467902235|FG000|Overall Study|reason not provided|2|||
129983519|NCT03231800|467902236|FG001|Overall Study|reason not provided|0|||
129983520|NCT00859222|467902237|FG000|Overall Study|Adverse Event|2|||
129983521|NCT00859222|467902238|FG001|Overall Study|Adverse Event|3|||
129983522|NCT00859222|467902239|FG002|Overall Study|Adverse Event|6|||
129983523|NCT00859222|467902240|FG003|Overall Study|Adverse Event|24|||
129983524|NCT00859222|467902241|FG004|Overall Study|Adverse Event|15|||
129983525|NCT00859222|467902237|FG000|Overall Study|DLT|1|||
129983526|NCT00859222|467902238|FG001|Overall Study|DLT|0|||
129983527|NCT00859222|467902239|FG002|Overall Study|DLT|0|||
129983528|NCT00859222|467902240|FG003|Overall Study|DLT|0|||
129983529|NCT00859222|467902241|FG004|Overall Study|DLT|0|||
129983530|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
129983531|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
130180668|NCT02414958|468617355|FG002|Overall Study|Protocol Violation|1|||
130180669|NCT02414958|468617353|FG000|Overall Study|Lost to Follow-up|7|||
130180670|NCT02414958|468617354|FG001|Overall Study|Lost to Follow-up|4|||
130180671|NCT02414958|468617355|FG002|Overall Study|Lost to Follow-up|0|||
130180672|NCT02414958|468617353|FG000|Overall Study|Withdrawal by Subject|5|||
130180673|NCT02414958|468617354|FG001|Overall Study|Withdrawal by Subject|3|||
130180674|NCT02414958|468617355|FG002|Overall Study|Withdrawal by Subject|5|||
130180675|NCT02414958|468617353|FG000|Overall Study|Other than specified|4|||
130180676|NCT02414958|468617354|FG001|Overall Study|Other than specified|4|||
130180677|NCT02414958|468617355|FG002|Overall Study|Other than specified|5|||
130180678|NCT00476190|468617358|FG000|Overall Study|Ineligible|1|||
130180679|NCT00476190|468617359|FG001|Overall Study|Ineligible|1|||
130180680|NCT00476190|468617358|FG000|Overall Study|Induction Death|2|||
130180681|NCT00476190|468617359|FG001|Overall Study|Induction Death|0|||
130180682|NCT00476190|468617358|FG000|Overall Study|Induction Failure|2|||
130180683|NCT00476190|468617359|FG001|Overall Study|Induction Failure|4|||
130180684|NCT00476190|468617358|FG000|Overall Study|Lost to Follow-up|1|||
130180685|NCT00476190|468617359|FG001|Overall Study|Lost to Follow-up|0|||
130180686|NCT00476190|468617358|FG000|Overall Study|Relapse/Progression|5|||
130180687|NCT00476190|468617359|FG001|Overall Study|Relapse/Progression|2|||
130180688|NCT00476190|468617358|FG000|Overall Study|Remission Death|0|||
130180689|NCT00476190|468617359|FG001|Overall Study|Remission Death|1|||
130180690|NCT00476190|468617358|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
130180691|NCT00476190|468617359|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
130180692|NCT00476190|468617358|FG000|Overall Study|Withdrawal by Subject|6|||
130180693|NCT00476190|468617359|FG001|Overall Study|Withdrawal by Subject|2|||
130180694|NCT00476190|468617358|FG000|Overall Study|Other|9|||
130180695|NCT00476190|468617359|FG001|Overall Study|Other|10|||
130180696|NCT01329900|468617362|FG000|Overall Study|Elevated creatinine/renal function|1|||
130180697|NCT00995774|468617366|FG000|Training Period 2|Withdrawal by Subject|2|||
130180698|NCT00995774|468617367|FG001|Training Period 2|Withdrawal by Subject|0|||
130180699|NCT01808573|468617368|FG000|Overall Study|Death|212|||
130180700|NCT01808573|468617369|FG001|Overall Study|Death|240|||
130180701|NCT01808573|468617368|FG000|Overall Study|Withdrawal by Subject|12|||
130180702|NCT01808573|468617369|FG001|Overall Study|Withdrawal by Subject|10|||
130180703|NCT01808573|468617368|FG000|Overall Study|Lost to Follow-up|3|||
130180704|NCT01808573|468617369|FG001|Overall Study|Lost to Follow-up|0|||
130180705|NCT01808573|468617368|FG000|Overall Study|Discontinuation of study by sponsor|79|||
130180706|NCT01808573|468617369|FG001|Overall Study|Discontinuation of study by sponsor|64|||
130180707|NCT01808573|468617368|FG000|Overall Study|Randomized in Error|1|||
130180708|NCT01808573|468617369|FG001|Overall Study|Randomized in Error|0|||
130180709|NCT01523002|468617372|FG000|Period 1|Withdrawal by Subject|1|||
130180710|NCT01523002|468617373|FG001|Period 1|Withdrawal by Subject|3|||
130180711|NCT01523002|468617372|FG000|Period 1|Lost to Follow-up|1|||
130180712|NCT01523002|468617373|FG001|Period 1|Lost to Follow-up|0|||
130180713|NCT01523002|468617372|FG000|Period 1|Adverse Event|0|||
130180714|NCT01523002|468617373|FG001|Period 1|Adverse Event|8|||
130180715|NCT01523002|468617372|FG000|Period 2|Withdrawal by Subject|4|||
130180716|NCT01523002|468617373|FG001|Period 2|Withdrawal by Subject|1|||
130180717|NCT01523002|468617372|FG000|Period 2|Adverse Event|2|||
130180718|NCT01523002|468617373|FG001|Period 2|Adverse Event|5|||
130180719|NCT01523002|468617372|FG000|Period 3|Withdrawal by Subject|1|||
130180720|NCT01523002|468617373|FG001|Period 3|Withdrawal by Subject|0|||
130180721|NCT01523002|468617372|FG000|Period 3|Adverse Event|3|||
130180722|NCT01523002|468617373|FG001|Period 3|Adverse Event|0|||
130180723|NCT01256502|468617375|FG000|Overall Study|Had scaffold removed|4|||
130180724|NCT01256502|468617375|FG000|Overall Study|Personal reasons|5|||
130180725|NCT01256502|468617375|FG000|Overall Study|Protocol deviation|1|||
130180726|NCT03953612|468617376|FG000|Overall Study|Randomized but did not start|1|||
130180727|NCT03953612|468617377|FG001|Overall Study|Randomized but did not start|1|||
130180728|NCT03953612|468617378|FG002|Overall Study|Randomized but did not start|1|||
130180729|NCT03953612|468617376|FG000|Overall Study|Withdrawal by Subject|2|||
130180730|NCT03953612|468617377|FG001|Overall Study|Withdrawal by Subject|1|||
130180731|NCT03953612|468617378|FG002|Overall Study|Withdrawal by Subject|0|||
130180732|NCT03200717|468617394|FG000|Overall Study|Progressive disease|24|||
130180733|NCT03200717|468617395|FG001|Overall Study|Progressive disease|5|||
130180734|NCT03200717|468617394|FG000|Overall Study|Adverse Event|11|||
130180735|NCT03200717|468617395|FG001|Overall Study|Adverse Event|8|||
130180736|NCT03200717|468617394|FG000|Overall Study|Physician Decision|3|||
130180737|NCT03200717|468617395|FG001|Overall Study|Physician Decision|2|||
130180738|NCT03200717|468617394|FG000|Overall Study|Death|2|||
130180739|NCT03200717|468617395|FG001|Overall Study|Death|0|||
130180740|NCT03200717|468617394|FG000|Overall Study|Subject/Guardian Decision|1|||
130180741|NCT03200717|468617395|FG001|Overall Study|Subject/Guardian Decision|0|||
130180742|NCT01461538|468617396|FG000|Overall Study|Death|15|||
130180743|NCT01461538|468617397|FG001|Overall Study|Death|6|||
130180744|NCT01461538|468617398|FG002|Overall Study|Death|2|||
130180745|NCT01461538|468617396|FG000|Overall Study|Study Stopped by Sponsor|2|||
130180746|NCT01461538|468617397|FG001|Overall Study|Study Stopped by Sponsor|1|||
130180747|NCT01461538|468617398|FG002|Overall Study|Study Stopped by Sponsor|0|||
130180748|NCT01461538|468617396|FG000|Overall Study|Withdrawal by Subject|1|||
130180749|NCT01461538|468617397|FG001|Overall Study|Withdrawal by Subject|1|||
130180750|NCT01461538|468617398|FG002|Overall Study|Withdrawal by Subject|0|||
130180751|NCT00141778|468617399|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
130180752|NCT00141778|468617400|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
130180753|NCT00141778|468617401|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
130180754|NCT00141778|468617399|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
130180755|NCT00141778|468617400|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
130180756|NCT00141778|468617401|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
130180757|NCT00141778|468617399|FG000|Started Study Medication|Withdrawal by Subject|0|||
130180758|NCT00141778|468617400|FG001|Started Study Medication|Withdrawal by Subject|2|||
130180759|NCT00141778|468617401|FG002|Started Study Medication|Withdrawal by Subject|0|||
130180760|NCT00141778|468617399|FG000|Started Study Medication|Difficulty Swallowing|0|||
130180761|NCT00141778|468617400|FG001|Started Study Medication|Difficulty Swallowing|1|||
130180762|NCT00141778|468617401|FG002|Started Study Medication|Difficulty Swallowing|0|||
130180763|NCT00141778|468617399|FG000|Started Study Medication|Chest Discomfort|0|||
130180764|NCT00141778|468617400|FG001|Started Study Medication|Chest Discomfort|0|||
130180765|NCT00141778|468617401|FG002|Started Study Medication|Chest Discomfort|1|||
129983532|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
129983533|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
129983534|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
129983535|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
129983536|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
129983537|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
129983538|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
129983539|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
129983540|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
129983541|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
129983542|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
129983543|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
129983544|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
129983545|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
129983546|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
129983547|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
129983548|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
129983549|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
129983550|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
129983551|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
129983552|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
129983553|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
129983554|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
129983555|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
129983556|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
129983557|NCT01941719|467902245|FG000|Overall Study|Lost to Follow-up|20|||
129983558|NCT01941719|467902246|FG001|Overall Study|Lost to Follow-up|19|||
129983559|NCT00252577|467902247|FG000|Overall Study|Lost to Follow-up|20|||
129983560|NCT01744392|467902248|FG000|Overall Study|Physician Decision|1|||
129983561|NCT01416389|467902249|FG000|Overall Study|Lost to Follow-up|1|||
129983562|NCT01416389|467902250|FG001|Overall Study|Lost to Follow-up|0|||
129983563|NCT01416389|467902249|FG000|Overall Study|Started New Therapy|2|||
129983564|NCT01416389|467902250|FG001|Overall Study|Started New Therapy|0|||
129983565|NCT00992225|467902259|FG000|Overall Study|Entry Criteria Not Met|8|||
129983566|NCT00992225|467902259|FG000|Overall Study|Adverse Event|2|||
129983567|NCT01036438|467902260|FG000|Overall Study|Adverse Event|7|||
129983568|NCT01036438|467902261|FG001|Overall Study|Adverse Event|8|||
129983569|NCT01036438|467902260|FG000|Overall Study|Death|0|||
129983570|NCT01036438|467902261|FG001|Overall Study|Death|1|||
129983571|NCT01036438|467902260|FG000|Overall Study|No effect of study treatment|3|||
129983572|NCT01036438|467902261|FG001|Overall Study|No effect of study treatment|1|||
129983573|NCT00888927|467902262|FG000|Overall Study|Adverse Event|0|||
129983574|NCT00888927|467902263|FG001|Overall Study|Adverse Event|0|||
130180766|NCT01245283|468617406|FG000|Overall Study|Lost to Follow-up|14|||
130180767|NCT01245283|468617407|FG001|Overall Study|Lost to Follow-up|11|||
130180768|NCT01245283|468617408|FG002|Overall Study|Lost to Follow-up|11|||
129983575|NCT00888927|467902264|FG002|Overall Study|Adverse Event|0|||
129983576|NCT00888927|467902265|FG003|Overall Study|Adverse Event|1|||
129983577|NCT00888927|467902262|FG000|Overall Study|Withdrawal of consent|0|||
129983578|NCT00888927|467902263|FG001|Overall Study|Withdrawal of consent|0|||
130180769|NCT01610492|468617411|FG000|Overall Study|Adverse Event|1|||
130180770|NCT01610492|468617411|FG000|Overall Study|Lack of Efficacy|3|||
130180771|NCT01610492|468617411|FG000|Overall Study|Other: Reached stopping criteria|1|||
129983579|NCT00888927|467902264|FG002|Overall Study|Withdrawal of consent|0|||
130180772|NCT01610492|468617411|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
130180773|NCT01982955|468617412|FG000|Overall Study|Randomized but not treated|0|||
130180774|NCT01982955|468617413|FG001|Overall Study|Randomized but not treated|0|||
130180775|NCT01982955|468617414|FG002|Overall Study|Randomized but not treated|0|||
130180776|NCT01982955|468617415|FG003|Overall Study|Randomized but not treated|1|||
130180777|NCT01982955|468617416|FG004|Overall Study|Randomized but not treated|0|||
130180778|NCT04211831|468617419|FG000|Overall Study|Withdrawal by Subject|4|||
130180779|NCT04211831|468617420|FG001|Overall Study|Withdrawal by Subject|1|||
130180780|NCT04211831|468617421|FG002|Overall Study|Withdrawal by Subject|1|||
130180781|NCT04211831|468617419|FG000|Overall Study|Protocol Violation|0|||
130180782|NCT04211831|468617420|FG001|Overall Study|Protocol Violation|0|||
130180783|NCT04211831|468617421|FG002|Overall Study|Protocol Violation|1|||
130180784|NCT04211831|468617419|FG000|Overall Study|Adverse Event|0|||
130180785|NCT04211831|468617420|FG001|Overall Study|Adverse Event|1|||
130180786|NCT04211831|468617421|FG002|Overall Study|Adverse Event|0|||
130180787|NCT04211831|468617419|FG000|Overall Study|Lack of Efficacy|0|||
130180788|NCT04211831|468617420|FG001|Overall Study|Lack of Efficacy|0|||
130180789|NCT04211831|468617421|FG002|Overall Study|Lack of Efficacy|1|||
130180790|NCT04211831|468617419|FG000|Overall Study|Lost to Follow-up|0|||
130180791|NCT04211831|468617420|FG001|Overall Study|Lost to Follow-up|0|||
130180792|NCT04211831|468617421|FG002|Overall Study|Lost to Follow-up|2|||
130180793|NCT04211831|468617419|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
130180794|NCT04211831|468617420|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
130180795|NCT04211831|468617421|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
130180796|NCT04211831|468617419|FG000|Overall Study|Other|0|||
130180797|NCT04211831|468617420|FG001|Overall Study|Other|1|||
130180798|NCT04211831|468617421|FG002|Overall Study|Other|0|||
130180799|NCT01256879|468617422|FG000|Overall Study|Withdrawal by Subject|1|||
130180800|NCT00397514|468617423|FG000|Overall Study|Withdrawal by Subject|1|||
130180801|NCT00397514|468617423|FG000|Overall Study|Pacing wire malfunction|1|||
130180802|NCT00397514|468617423|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
130180803|NCT00397514|468617423|FG000|Overall Study|early extubation|2|||
130180804|NCT00397514|468617423|FG000|Overall Study|poor echocardiographic windows|1|||
130180805|NCT00640315|468617425|FG000|Overall Study|Withdrawal by Subject|0|||
130180806|NCT00640315|468617426|FG001|Overall Study|Withdrawal by Subject|1|||
130180807|NCT05525520|468619060|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
130180808|NCT05525520|468619061|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
130180809|NCT05525520|468619060|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
130180810|NCT05525520|468619061|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
130180811|NCT03657797|468619062|FG000|Overall Study|Lost to Follow-up|0|||
130180812|NCT03657797|468619063|FG001|Overall Study|Lost to Follow-up|1|||
130180813|NCT03657797|468619064|FG002|Overall Study|Lost to Follow-up|1|||
130180814|NCT03657797|468619065|FG003|Overall Study|Lost to Follow-up|0|||
130180815|NCT03657797|468619062|FG000|Overall Study|Physician Decision|0|||
130180816|NCT03657797|468619063|FG001|Overall Study|Physician Decision|1|||
130180817|NCT03657797|468619064|FG002|Overall Study|Physician Decision|0|||
130180818|NCT03657797|468619065|FG003|Overall Study|Physician Decision|0|||
130180819|NCT03657797|468619062|FG000|Overall Study|Withdrawal by Subject|0|||
130180820|NCT03657797|468619063|FG001|Overall Study|Withdrawal by Subject|1|||
130180821|NCT03657797|468619064|FG002|Overall Study|Withdrawal by Subject|2|||
130180822|NCT03657797|468619065|FG003|Overall Study|Withdrawal by Subject|0|||
130180823|NCT03657797|468619062|FG000|Overall Study|Adverse Event|0|||
130180824|NCT03657797|468619063|FG001|Overall Study|Adverse Event|0|||
129983580|NCT00888927|467902265|FG003|Overall Study|Withdrawal of consent|1|||
129983581|NCT03459443|467902266|FG000|Overall Study|Lack of Efficacy|3|||
129983582|NCT03459443|467902266|FG000|Overall Study|Adverse Event|1|||
129983583|NCT03459443|467902266|FG000|Overall Study|Sponsor's decision to close the study|18|||
129983584|NCT02153073|467902267|FG000|Overall Study|Case Report Forms Uncollected|230|||
129983585|NCT02153073|467902267|FG000|Overall Study|Protocol Deviation|68|||
129983586|NCT03702231|467902268|FG000|Overall Study|Withdrawal by Subject|1|||
129983587|NCT03702231|467902269|FG001|Overall Study|Withdrawal by Subject|0|||
129983588|NCT03702231|467902270|FG002|Overall Study|Withdrawal by Subject|0|||
129983589|NCT03702231|467902268|FG000|Overall Study|Protocol Violation|0|||
129983590|NCT03702231|467902269|FG001|Overall Study|Protocol Violation|0|||
129983591|NCT03702231|467902270|FG002|Overall Study|Protocol Violation|1|||
129983592|NCT03702231|467902268|FG000|Overall Study|Change in CLL Treatment|0|||
129983593|NCT03702231|467902269|FG001|Overall Study|Change in CLL Treatment|0|||
129983594|NCT03702231|467902270|FG002|Overall Study|Change in CLL Treatment|1|||
129983595|NCT03702231|467902268|FG000|Overall Study|COVID Pandemic|1|||
129983596|NCT03702231|467902269|FG001|Overall Study|COVID Pandemic|4|||
129983597|NCT03702231|467902270|FG002|Overall Study|COVID Pandemic|1|||
129983598|NCT03702231|467902268|FG000|Overall Study|Non-compliance|0|||
129983599|NCT03702231|467902269|FG001|Overall Study|Non-compliance|0|||
129983600|NCT03702231|467902270|FG002|Overall Study|Non-compliance|1|||
129983601|NCT03592745|467902271|FG000|Overall Study|Adverse Event|0|||
129983602|NCT03592745|467902272|FG001|Overall Study|Adverse Event|2|||
129983603|NCT03592745|467902271|FG000|Overall Study|Lost to Follow-up|2|||
129983604|NCT03592745|467902272|FG001|Overall Study|Lost to Follow-up|0|||
129983605|NCT03592745|467902271|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
129983606|NCT03592745|467902272|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
129983607|NCT03590366|467902273|FG000|Overall Study|Adverse Event|0|||
129983608|NCT03590366|467902274|FG001|Overall Study|Adverse Event|3|||
129983609|NCT03590366|467902273|FG000|Overall Study|Lost to Follow-up|3|||
129983610|NCT03590366|467902274|FG001|Overall Study|Lost to Follow-up|3|||
129983611|NCT03590366|467902273|FG000|Overall Study|Withdrawal by Subject|0|||
129983612|NCT03590366|467902274|FG001|Overall Study|Withdrawal by Subject|2|||
129983613|NCT00738894|467902275|FG000|Overall Study|Lost to Follow-up|23|||
129983614|NCT00738894|467902276|FG001|Overall Study|Lost to Follow-up|13|||
129983615|NCT00738894|467902275|FG000|Overall Study|Withdrawal by Subject|10|||
129983616|NCT00738894|467902276|FG001|Overall Study|Withdrawal by Subject|15|||
129983617|NCT00738894|467902275|FG000|Overall Study|Physician Decision|4|||
129983618|NCT00738894|467902276|FG001|Overall Study|Physician Decision|5|||
129983619|NCT00738894|467902275|FG000|Overall Study|Death|2|||
129983620|NCT00738894|467902276|FG001|Overall Study|Death|0|||
129983621|NCT01081665|467902277|FG000|Overall Study|Death|41|||
129983622|NCT01081665|467902277|FG000|Overall Study|Lost to Follow-up|18|||
129983623|NCT01081665|467902277|FG000|Overall Study|Withdrawal by Subject|17|||
129983624|NCT01081665|467902277|FG000|Overall Study|Change of dialysis unit|10|||
130180825|NCT03657797|468619064|FG002|Overall Study|Adverse Event|2|||
130180826|NCT03657797|468619065|FG003|Overall Study|Adverse Event|0|||
129983625|NCT01081665|467902277|FG000|Overall Study|Regulation of iPTH|5|||
129983626|NCT01081665|467902277|FG000|Overall Study|Change in renal replacement therapy|2|||
129983627|NCT01081665|467902277|FG000|Overall Study|Adverse Event|1|||
129983628|NCT01081665|467902277|FG000|Overall Study|Lack of Efficacy|1|||
129983629|NCT01413503|467902288|FG000|Overall Study|Lost to Follow-up|1|||
129983630|NCT02546921|467902289|FG000|Overall Study|Adverse Event|0|||
129983631|NCT02546921|467902290|FG001|Overall Study|Adverse Event|5|||
129983632|NCT02546921|467902291|FG002|Overall Study|Adverse Event|2|||
129983633|NCT02546921|467902292|FG003|Overall Study|Adverse Event|0|||
130180827|NCT00118157|468619066|FG000|Overall Study|Adverse Event|2|||
130180828|NCT00118157|468619066|FG000|Overall Study|Death|8|||
130180829|NCT00118157|468619066|FG000|Overall Study|Withdrawal by Subject|2|||
130180830|NCT00696423|468619067|FG000|Overall Study|Lost to Follow-up|0|||
130180831|NCT00696423|468619068|FG001|Overall Study|Lost to Follow-up|5|||
130180832|NCT03989102|468619069|FG000|Year 1|Withdrawal by Subject|6|||
130180833|NCT03989102|468619070|FG001|Year 1|Withdrawal by Subject|2|||
130180834|NCT03989102|468619071|FG002|Year 1|Withdrawal by Subject|7|||
130180835|NCT03989102|468619069|FG000|Year 1|Lost to Follow-up|5|||
130180836|NCT03989102|468619070|FG001|Year 1|Lost to Follow-up|2|||
130180837|NCT03989102|468619071|FG002|Year 1|Lost to Follow-up|5|||
130180838|NCT03989102|468619069|FG000|Year 1|Subject met withdrawal criteria|1|||
130180839|NCT03989102|468619070|FG001|Year 1|Subject met withdrawal criteria|0|||
130180840|NCT03989102|468619071|FG002|Year 1|Subject met withdrawal criteria|1|||
130180841|NCT03989102|468619069|FG000|Year 2|Lost to Follow-up|7|||
130180842|NCT03989102|468619070|FG001|Year 2|Lost to Follow-up|3|||
130180843|NCT03989102|468619071|FG002|Year 2|Lost to Follow-up|4|||
130180844|NCT03989102|468619069|FG000|Year 2|Withdrawal by Subject|3|||
130180845|NCT03989102|468619070|FG001|Year 2|Withdrawal by Subject|1|||
130180846|NCT03989102|468619071|FG002|Year 2|Withdrawal by Subject|2|||
129983634|NCT02546921|467902293|FG004|Overall Study|Adverse Event|0|||
129983635|NCT02546921|467902294|FG005|Overall Study|Adverse Event|0|||
129983636|NCT02546921|467902295|FG006|Overall Study|Adverse Event|0|||
129983637|NCT02546921|467902289|FG000|Overall Study|Evidence of Disease Progression|1|||
129983638|NCT02546921|467902290|FG001|Overall Study|Evidence of Disease Progression|0|||
129983639|NCT02546921|467902291|FG002|Overall Study|Evidence of Disease Progression|0|||
129983640|NCT02546921|467902292|FG003|Overall Study|Evidence of Disease Progression|0|||
129983641|NCT02546921|467902293|FG004|Overall Study|Evidence of Disease Progression|1|||
129983642|NCT02546921|467902294|FG005|Overall Study|Evidence of Disease Progression|0|||
129983643|NCT02546921|467902295|FG006|Overall Study|Evidence of Disease Progression|0|||
129983644|NCT02546921|467902289|FG000|Overall Study|Patient Choice|0|||
129983645|NCT02546921|467902290|FG001|Overall Study|Patient Choice|1|||
129983646|NCT02546921|467902291|FG002|Overall Study|Patient Choice|0|||
129983647|NCT02546921|467902292|FG003|Overall Study|Patient Choice|0|||
129983648|NCT02546921|467902293|FG004|Overall Study|Patient Choice|0|||
129983649|NCT02546921|467902294|FG005|Overall Study|Patient Choice|1|||
129983650|NCT02546921|467902295|FG006|Overall Study|Patient Choice|0|||
129983651|NCT03026075|467902299|FG000|Overall Study|Physician Decision|1|||
129983652|NCT03381339|467902300|FG000|Overall Study|Protocol Violation|4|||
129983653|NCT03381339|467902301|FG001|Overall Study|Protocol Violation|3|||
129983654|NCT03381339|467902300|FG000|Overall Study|Lost to Follow-up|0|||
129983655|NCT03381339|467902301|FG001|Overall Study|Lost to Follow-up|1|||
129983656|NCT04927247|467902303|FG000|Overall Study|Other|2|||
129983657|NCT04927247|467902304|FG001|Overall Study|Other|1|||
129983658|NCT04927247|467902303|FG000|Overall Study|Physician Decision|0|||
129983659|NCT04927247|467902304|FG001|Overall Study|Physician Decision|1|||
129983660|NCT04927247|467902303|FG000|Overall Study|Adverse Event|1|||
129983661|NCT04927247|467902304|FG001|Overall Study|Adverse Event|0|||
129983662|NCT00293059|467902305|FG000|Overall Study|Adverse Event|12|||
129983663|NCT00293059|467902306|FG001|Overall Study|Adverse Event|4|||
129983664|NCT00293059|467902305|FG000|Overall Study|Lack of Efficacy|2|||
129983665|NCT00293059|467902306|FG001|Overall Study|Lack of Efficacy|0|||
129983666|NCT00293059|467902305|FG000|Overall Study|Lost to Follow-up|2|||
129983667|NCT00293059|467902306|FG001|Overall Study|Lost to Follow-up|3|||
129983668|NCT00293059|467902305|FG000|Overall Study|Pregnancy|1|||
129983669|NCT00293059|467902306|FG001|Overall Study|Pregnancy|1|||
129983670|NCT00293059|467902305|FG000|Overall Study|Protocol Violation|2|||
129983671|NCT00293059|467902306|FG001|Overall Study|Protocol Violation|0|||
129983672|NCT00293059|467902305|FG000|Overall Study|Withdrawal by Subject|11|||
129983673|NCT00293059|467902306|FG001|Overall Study|Withdrawal by Subject|5|||
129983674|NCT00293059|467902305|FG000|Overall Study|Participant moved out of state|1|||
129983675|NCT00293059|467902306|FG001|Overall Study|Participant moved out of state|0|||
129983676|NCT00293059|467902305|FG000|Overall Study|Participant stopped study drug|1|||
129983677|NCT00293059|467902306|FG001|Overall Study|Participant stopped study drug|0|||
129983678|NCT00293059|467902305|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
129983679|NCT00293059|467902306|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
129983680|NCT00293059|467902305|FG000|Overall Study|missing|3|||
129983681|NCT00293059|467902306|FG001|Overall Study|missing|5|||
129983682|NCT02227199|467902321|FG000|Overall Study|Physician Decision|0|||
129983683|NCT02227199|467902322|FG001|Overall Study|Physician Decision|0|||
129983684|NCT02227199|467902323|FG002|Overall Study|Physician Decision|1|||
129983685|NCT02227199|467902321|FG000|Overall Study|Adverse Event|0|||
129983686|NCT02227199|467902322|FG001|Overall Study|Adverse Event|0|||
129983687|NCT02227199|467902323|FG002|Overall Study|Adverse Event|3|||
129983688|NCT05597787|467902324|FG000|Overall Study|Withdrawal by Subject|0|||
129983689|NCT05597787|467902325|FG001|Overall Study|Withdrawal by Subject|0|||
129983690|NCT05597787|467902326|FG002|Overall Study|Withdrawal by Subject|1|||
130180847|NCT03989102|468619069|FG000|Year 2|Subject non-compliant|3|||
130180848|NCT03989102|468619070|FG001|Year 2|Subject non-compliant|2|||
130180849|NCT03989102|468619071|FG002|Year 2|Subject non-compliant|0|||
130180850|NCT03989102|468619069|FG000|Year 2|Travel|1|||
130180851|NCT03989102|468619070|FG001|Year 2|Travel|0|||
130180852|NCT03989102|468619071|FG002|Year 2|Travel|1|||
130180853|NCT03989102|468619069|FG000|Year 2|P16 missing|4|||
130180854|NCT03989102|468619070|FG001|Year 2|P16 missing|2|||
130180855|NCT03989102|468619071|FG002|Year 2|P16 missing|1|||
130180856|NCT03989102|468619069|FG000|Year 2|P11 missing|1|||
129983691|NCT05453201|467902328|FG000|Overall Study|Withdrawal by Subject|1|||
130180857|NCT03989102|468619070|FG001|Year 2|P11 missing|3|||
130180858|NCT03989102|468619071|FG002|Year 2|P11 missing|7|||
130180859|NCT03989102|468619069|FG000|Year 2|Definitive displacement outside the study site|0|||
130180860|NCT03989102|468619070|FG001|Year 2|Definitive displacement outside the study site|1|||
129983692|NCT01934790|467902329|FG000|Treatment|Adverse Event|3|||
129983693|NCT01934790|467902329|FG000|Treatment|Clinical progression|6|||
129983694|NCT01934790|467902329|FG000|Treatment|Radiological progression|4|||
129983695|NCT01934790|467902329|FG000|Treatment|Withdrawal by Subject|2|||
129983696|NCT01934790|467902329|FG000|Treatment|Study drug never administered|1|||
129983697|NCT01934790|467902329|FG000|Active Follow up|Death|20|||
129983698|NCT01934790|467902329|FG000|Active Follow up|Physician Decision|2|||
129983699|NCT01934790|467902329|FG000|Active Follow up|Progressive disease|1|||
129983700|NCT01934790|467902329|FG000|Active Follow up|Other reason|1|||
129983701|NCT03798691|467902330|FG000|Overall Study|Lost to Follow-up|2|||
129983702|NCT03798691|467902331|FG001|Overall Study|Lost to Follow-up|2|||
129983703|NCT01241604|467902337|FG000|Screening Period|Screen Failure|3|||
129983704|NCT01241604|467902338|FG001|Screening Period|Screen Failure|0|||
129983705|NCT01241604|467902339|FG002|Screening Period|Screen Failure|0|||
129983706|NCT01865747|467902341|FG000|Overall Study (ITT)|Adverse Event|32|||
129983707|NCT01865747|467902342|FG001|Overall Study (ITT)|Adverse Event|31|||
129983708|NCT01865747|467902341|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
129983709|NCT01865747|467902342|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
129983710|NCT01865747|467902341|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
129983711|NCT01865747|467902342|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
129983712|NCT01865747|467902341|FG000|Overall Study (ITT)|Protocol Violation|1|||
129983713|NCT01865747|467902342|FG001|Overall Study (ITT)|Protocol Violation|1|||
129983714|NCT01865747|467902341|FG000|Overall Study (ITT)|Physician Decision|5|||
129983715|NCT01865747|467902342|FG001|Overall Study (ITT)|Physician Decision|2|||
129983716|NCT01865747|467902341|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
129983717|NCT01865747|467902342|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
129983718|NCT01865747|467902341|FG000|Overall Study (ITT)|Sponsor Decision|0|||
129983719|NCT01865747|467902342|FG001|Overall Study (ITT)|Sponsor Decision|1|||
129983720|NCT01865747|467902341|FG000|Overall Study (ITT)|Progressive Disease|122|||
129983721|NCT01865747|467902342|FG001|Overall Study (ITT)|Progressive Disease|158|||
129983722|NCT01865747|467902341|FG000|Overall Study (ITT)|Reason Not Provided|0|||
129983723|NCT01865747|467902342|FG001|Overall Study (ITT)|Reason Not Provided|1|||
129983724|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
129983725|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
129983726|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
129983727|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
129983728|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
129983729|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
129983730|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
129983731|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
129983732|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
129983733|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
129983734|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
129983735|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
129983736|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
129983737|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
129983738|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Other|0|||
129983739|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Other|1|||
129983740|NCT02592876|467902343|FG000|Overall Study|Withdrawal by Subject|3|||
129983741|NCT02592876|467902344|FG001|Overall Study|Withdrawal by Subject|3|||
129983742|NCT02592876|467902343|FG000|Overall Study|Study Termination by Sponsor|32|||
129983743|NCT02592876|467902344|FG001|Overall Study|Study Termination by Sponsor|27|||
129983744|NCT02592876|467902343|FG000|Overall Study|Lost to Follow-up|0|||
130180861|NCT03989102|468619071|FG002|Year 2|Definitive displacement outside the study site|0|||
130180862|NCT03989102|468619069|FG000|Year 2|Subject missed last study visit|0|||
130180863|NCT03989102|468619070|FG001|Year 2|Subject missed last study visit|1|||
130180864|NCT03989102|468619071|FG002|Year 2|Subject missed last study visit|0|||
130180865|NCT03989102|468619069|FG000|Year 2|Death|0|||
130180866|NCT03989102|468619070|FG001|Year 2|Death|1|||
130180867|NCT03989102|468619071|FG002|Year 2|Death|0|||
130180868|NCT03989102|468619069|FG000|Year 2|Subject not reachable|0|||
130180869|NCT03989102|468619070|FG001|Year 2|Subject not reachable|0|||
130180870|NCT03989102|468619071|FG002|Year 2|Subject not reachable|1|||
129983745|NCT02592876|467902344|FG001|Overall Study|Lost to Follow-up|1|||
129983746|NCT02592876|467902343|FG000|Overall Study|Death|6|||
129983747|NCT02592876|467902344|FG001|Overall Study|Death|9|||
130180871|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
130180872|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
130180873|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
130180874|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130180875|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130180876|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
130180877|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
130180878|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
130180879|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
130180880|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
130180881|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
130180882|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
130180883|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
130180884|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
130180885|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
130180886|NCT03989102|468619069|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
130180887|NCT03989102|468619070|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
130180888|NCT03989102|468619071|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
130180889|NCT03642262|468619072|FG000|Period 1|Withdrawal by Subject|1|||
130180890|NCT03642262|468619073|FG001|Period 1|Withdrawal by Subject|1|||
130180891|NCT03642262|468619072|FG000|Period 1|Adverse Event|0|||
130180892|NCT03642262|468619073|FG001|Period 1|Adverse Event|1|||
130180893|NCT02760004|468619078|FG000|Overall Study|Lost to Follow-up|13|||
130180894|NCT02760004|468619079|FG001|Overall Study|Lost to Follow-up|22|||
130180895|NCT02203357|468619082|FG000|Overall Study|Lost to Follow-up|58|||
130180896|NCT02203357|468619083|FG001|Overall Study|Lost to Follow-up|66|||
130180897|NCT02203357|468619084|FG002|Overall Study|Lost to Follow-up|70|||
130180898|NCT01431079|468619085|FG000|Overall Study|Lost to Follow-up|35|||
130180899|NCT01431079|468619086|FG001|Overall Study|Lost to Follow-up|39|||
130180900|NCT02038010|468619090|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130180901|NCT02038010|468619091|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
130180902|NCT02038010|468619092|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130180903|NCT02038010|468619093|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
130180904|NCT02038010|468619090|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
130180905|NCT02038010|468619091|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130180906|NCT02038010|468619092|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130180907|NCT02038010|468619093|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
130180908|NCT02038010|468619090|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130180909|NCT02038010|468619091|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
130180910|NCT02038010|468619092|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130180911|NCT02038010|468619093|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
130180912|NCT02038010|468619090|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
130180913|NCT02038010|468619091|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
130180914|NCT02038010|468619092|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
130180915|NCT02038010|468619093|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
130180916|NCT02038010|468619090|FG000|Follow Up|Death|4|||
130180917|NCT02038010|468619091|FG001|Follow Up|Death|3|||
130180918|NCT02038010|468619092|FG002|Follow Up|Death|0|||
130180919|NCT02038010|468619093|FG003|Follow Up|Death|0|||
130180920|NCT02038010|468619090|FG000|Follow Up|Other|3|||
130180921|NCT02038010|468619091|FG001|Follow Up|Other|0|||
130180922|NCT02038010|468619092|FG002|Follow Up|Other|0|||
130180923|NCT02038010|468619093|FG003|Follow Up|Other|0|||
130180924|NCT00245466|468619095|FG000|Overall Study|Adverse Event|2|||
130180925|NCT00245466|468619096|FG001|Overall Study|Adverse Event|8|||
130180926|NCT00245466|468619097|FG002|Overall Study|Adverse Event|4|||
130180927|NCT00245466|468619095|FG000|Overall Study|Low prostate specific antigen suppr|16|||
130180928|NCT00245466|468619096|FG001|Overall Study|Low prostate specific antigen suppr|14|||
130180929|NCT00245466|468619097|FG002|Overall Study|Low prostate specific antigen suppr|5|||
130180930|NCT00245466|468619095|FG000|Overall Study|Insufficient testosterone suppr|12|||
130180931|NCT00245466|468619096|FG001|Overall Study|Insufficient testosterone suppr|12|||
130180932|NCT00245466|468619097|FG002|Overall Study|Insufficient testosterone suppr|21|||
130180933|NCT00245466|468619095|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
130180934|NCT00245466|468619096|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
130180935|NCT00245466|468619097|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
130180936|NCT00245466|468619095|FG000|Overall Study|Withdrawal by Subject|2|||
130180937|NCT00245466|468619096|FG001|Overall Study|Withdrawal by Subject|2|||
130180938|NCT00245466|468619097|FG002|Overall Study|Withdrawal by Subject|1|||
130180939|NCT00245466|468619095|FG000|Overall Study|Lost to Follow-up|3|||
130180940|NCT00245466|468619096|FG001|Overall Study|Lost to Follow-up|0|||
130180941|NCT00245466|468619097|FG002|Overall Study|Lost to Follow-up|0|||
130180942|NCT00245466|468619095|FG000|Overall Study|Disease progression|0|||
130180943|NCT00245466|468619096|FG001|Overall Study|Disease progression|3|||
130180944|NCT00245466|468619097|FG002|Overall Study|Disease progression|1|||
130180945|NCT00245466|468619095|FG000|Overall Study|Protocol Violation|1|||
130180946|NCT00245466|468619096|FG001|Overall Study|Protocol Violation|2|||
130180947|NCT00245466|468619097|FG002|Overall Study|Protocol Violation|2|||
130180948|NCT00245466|468619095|FG000|Overall Study|Death|0|||
130180949|NCT00245466|468619096|FG001|Overall Study|Death|2|||
130180950|NCT00245466|468619097|FG002|Overall Study|Death|0|||
130180951|NCT00245466|468619095|FG000|Overall Study|Administrative reasons|0|||
130180952|NCT00245466|468619096|FG001|Overall Study|Administrative reasons|1|||
130180953|NCT00245466|468619097|FG002|Overall Study|Administrative reasons|0|||
130180954|NCT01958437|468619098|FG000|Overall Study|Incidental MRI findings|0|||
130180955|NCT01958437|468619099|FG001|Overall Study|Incidental MRI findings|0|||
130180956|NCT01958437|468619100|FG002|Overall Study|Incidental MRI findings|1|||
130180957|NCT01958437|468619101|FG003|Overall Study|Incidental MRI findings|1|||
130180958|NCT04886596|468619104|FG000|Overall Study|Adverse Event|442|||
130180959|NCT04886596|468619105|FG001|Overall Study|Adverse Event|441|||
130180960|NCT04886596|468619104|FG000|Overall Study|Lost to Follow-up|448|||
130180961|NCT04886596|468619105|FG001|Overall Study|Lost to Follow-up|465|||
130180962|NCT04886596|468619104|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
130180963|NCT04886596|468619105|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
130180964|NCT04886596|468619104|FG000|Overall Study|Migrated/moved from the study area|201|||
130180965|NCT04886596|468619105|FG001|Overall Study|Migrated/moved from the study area|184|||
130180966|NCT04886596|468619104|FG000|Overall Study|Other|298|||
130180967|NCT04886596|468619105|FG001|Overall Study|Other|326|||
130180968|NCT00948155|468619108|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
130180969|NCT00948155|468619109|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
130180970|NCT00948155|468619108|FG000|Washout 14 Days|Lost to Follow-up|1|||
130180971|NCT00948155|468619109|FG001|Washout 14 Days|Lost to Follow-up|2|||
130180972|NCT03473925|468619110|FG000|Overall Study|Death|48|||
130180973|NCT03473925|468619111|FG001|Overall Study|Death|44|||
130180974|NCT03473925|468619110|FG000|Overall Study|Sponsor Decision|2|||
130180975|NCT03473925|468619111|FG001|Overall Study|Sponsor Decision|7|||
130180976|NCT03473925|468619110|FG000|Overall Study|Withdrawal by Subject|1|||
130180977|NCT03473925|468619111|FG001|Overall Study|Withdrawal by Subject|3|||
130180978|NCT03473925|468619110|FG000|Overall Study|Not Treated|1|||
130180979|NCT03473925|468619111|FG001|Overall Study|Not Treated|1|||
130180980|NCT04661150|468619116|FG000|Overall Study|Ongoing in study|19|||
130180981|NCT04661150|468619117|FG001|Overall Study|Ongoing in study|20|||
130180982|NCT04661150|468619116|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
130180983|NCT04661150|468619117|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
130180984|NCT04661150|468619116|FG000|Overall Study|Death|2|||
130180985|NCT04661150|468619117|FG001|Overall Study|Death|0|||
130180986|NCT05767905|468619118|FG000|Overall Study|Adverse Event|0|||
130180987|NCT05767905|468619119|FG001|Overall Study|Adverse Event|0|||
130180988|NCT05767905|468619120|FG002|Overall Study|Adverse Event|1|||
130180989|NCT03762239|468619121|FG000|Overall Study|Appointment to the doctor|1|||
130180990|NCT03762239|468619122|FG001|Overall Study|Appointment to the doctor|1|||
130180991|NCT03645863|468619123|FG000|Overall Study|Withdrawal by Subject|1|||
130180992|NCT03645863|468619124|FG001|Overall Study|Withdrawal by Subject|0|||
130180993|NCT03645863|468619125|FG002|Overall Study|Withdrawal by Subject|0|||
130180994|NCT04660331|468619139|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
130180995|NCT04660331|468619140|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
130180996|NCT04660331|468619141|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
130180997|NCT03624192|468619142|FG000|Overall Study|Lost to Follow-up|1|||
130180998|NCT03624192|468619143|FG001|Overall Study|Lost to Follow-up|1|||
130180999|NCT02635984|468619144|FG000|Overall Study|Lost to Follow-up|2|||
130181000|NCT02635984|468619145|FG001|Overall Study|Lost to Follow-up|4|||
130181001|NCT02635984|468619144|FG000|Overall Study|Study Arm Closed|1|||
130181002|NCT02635984|468619145|FG001|Overall Study|Study Arm Closed|0|||
130181003|NCT01640249|468619147|FG000|Period 1|Withdrawal by Subject|1|||
130181004|NCT01640249|468619148|FG001|Period 1|Withdrawal by Subject|0|||
130181005|NCT01640249|468619149|FG002|Period 1|Withdrawal by Subject|0|||
130181006|NCT01640249|468619150|FG003|Period 1|Withdrawal by Subject|0|||
130181007|NCT01640249|468619151|FG004|Period 1|Withdrawal by Subject|0|||
130181008|NCT01640249|468619152|FG005|Period 1|Withdrawal by Subject|1|||
130181009|NCT01640249|468619153|FG006|Period 1|Withdrawal by Subject|0|||
130181010|NCT00065156|468619156|FG000|Overall Study|Adverse Event|37|||
130181011|NCT00065156|468619156|FG000|Overall Study|Lack of Efficacy|52|||
130181012|NCT00065156|468619156|FG000|Overall Study|Withdrawal by Subject|8|||
130181013|NCT00065156|468619156|FG000|Overall Study|Lost to Follow-up|1|||
130181014|NCT00065156|468619156|FG000|Overall Study|Death|11|||
130181015|NCT00065156|468619156|FG000|Overall Study|Study Closed by Sponsor|2|||
130181016|NCT00065156|468619156|FG000|Overall Study|Disease Progression|7|||
130181017|NCT00065156|468619156|FG000|Overall Study|Investigator Decision|2|||
130181018|NCT00065156|468619156|FG000|Overall Study|Non-Compliance|2|||
130181019|NCT00065156|468619156|FG000|Overall Study|Loss of Response|1|||
130181020|NCT00065156|468619156|FG000|Overall Study|Secondary Malign Disease|1|||
130181021|NCT03518008|468619157|FG000|Period 2, Second Week of Wear|Family emergency|0|||
130181022|NCT03518008|468619158|FG001|Period 2, Second Week of Wear|Family emergency|1|||
130181023|NCT01215136|468619159|FG000|Overall Study|Adverse Event|2|||
130181024|NCT01215136|468619160|FG001|Overall Study|Adverse Event|9|||
130181025|NCT01215136|468619159|FG000|Overall Study|Disease Progression|3|||
130181026|NCT01215136|468619160|FG001|Overall Study|Disease Progression|14|||
130181027|NCT01215136|468619159|FG000|Overall Study|Symptomatic Deterioration|1|||
130181028|NCT01215136|468619160|FG001|Overall Study|Symptomatic Deterioration|1|||
130181029|NCT01215136|468619159|FG000|Overall Study|Death|0|||
130181030|NCT01215136|468619160|FG001|Overall Study|Death|2|||
130181031|NCT01215136|468619159|FG000|Overall Study|Withdrawal by Subject|0|||
130181032|NCT01215136|468619160|FG001|Overall Study|Withdrawal by Subject|1|||
130181033|NCT00951496|468619165|FG000|Overall Study|Did not initiate study treatment|10|||
130181034|NCT00951496|468619166|FG001|Overall Study|Did not initiate study treatment|8|||
130181035|NCT00951496|468619167|FG002|Overall Study|Did not initiate study treatment|13|||
130181036|NCT01526057|468619169|FG000|Overall Study|Withdrawal by Subject|3|||
130181037|NCT01526057|468619170|FG001|Overall Study|Withdrawal by Subject|2|||
130181038|NCT01526057|468619171|FG002|Overall Study|Withdrawal by Subject|2|||
130181039|NCT01526057|468619169|FG000|Overall Study|Adverse Event|3|||
130181040|NCT01526057|468619170|FG001|Overall Study|Adverse Event|1|||
130181041|NCT01526057|468619171|FG002|Overall Study|Adverse Event|1|||
130181042|NCT01526057|468619169|FG000|Overall Study|Death|1|||
130181043|NCT01526057|468619170|FG001|Overall Study|Death|0|||
130181044|NCT01526057|468619171|FG002|Overall Study|Death|0|||
130181045|NCT01526057|468619169|FG000|Overall Study|Lost to Follow-up|1|||
130181046|NCT01526057|468619170|FG001|Overall Study|Lost to Follow-up|0|||
130181047|NCT01526057|468619171|FG002|Overall Study|Lost to Follow-up|1|||
130181048|NCT01526057|468619169|FG000|Overall Study|Other|1|||
130181049|NCT01526057|468619170|FG001|Overall Study|Other|0|||
130181050|NCT01526057|468619171|FG002|Overall Study|Other|1|||
130181051|NCT01526057|468619169|FG000|Overall Study|Protocol Violation|0|||
130181052|NCT01526057|468619170|FG001|Overall Study|Protocol Violation|0|||
130181053|NCT01526057|468619171|FG002|Overall Study|Protocol Violation|1|||
130181054|NCT02289729|468619182|FG000|Overall Study|Lack of Efficacy|3|||
130181055|NCT02289729|468619182|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
130181056|NCT02289729|468619182|FG000|Overall Study|Withdrawal by Subject|1|||
130181057|NCT02289729|468619182|FG000|Overall Study|Death|1|||
130181058|NCT04870710|468619186|FG000|Overall Study|Lost to Follow-up|3|||
130181059|NCT00281957|468619201|FG000|Overall Study|Adverse Event|7|||
130181060|NCT00281957|468619202|FG001|Overall Study|Adverse Event|2|||
130181061|NCT00281957|468619201|FG000|Overall Study|Death|1|||
130181062|NCT00281957|468619202|FG001|Overall Study|Death|0|||
130181063|NCT00281957|468619201|FG000|Overall Study|Progression/relapse|47|||
130181064|NCT00281957|468619202|FG001|Overall Study|Progression/relapse|35|||
130181065|NCT00281957|468619201|FG000|Overall Study|Not protocol specified|8|||
130181066|NCT00281957|468619202|FG001|Overall Study|Not protocol specified|1|||
130181067|NCT00281957|468619201|FG000|Overall Study|Not eligible|1|||
130181068|NCT00281957|468619202|FG001|Overall Study|Not eligible|2|||
130181069|NCT00281957|468619201|FG000|Overall Study|Did not start treatment|3|||
130181070|NCT00281957|468619202|FG001|Overall Study|Did not start treatment|1|||
130181071|NCT00281957|468619201|FG000|Overall Study|Refusal unrelated to adverse events|0|||
130181072|NCT00281957|468619202|FG001|Overall Study|Refusal unrelated to adverse events|1|||
130181073|NCT01876446|468619203|FG000|Overall Study|Death|0|||
130181074|NCT01876446|468619204|FG001|Overall Study|Death|1|||
130181075|NCT01876446|468619203|FG000|Overall Study|Withdrawal by Subject|1|||
130181076|NCT01876446|468619204|FG001|Overall Study|Withdrawal by Subject|2|||
130181077|NCT01876446|468619203|FG000|Overall Study|Physician Decision|1|||
130181078|NCT01876446|468619204|FG001|Overall Study|Physician Decision|3|||
130181079|NCT00822692|468619205|FG000|Overall Study|Lost to Follow-up|17|||
129983748|NCT00611975|467902349|FG000|Overall Study|Withdrawal by Subject|3|||
130181080|NCT00822692|468619206|FG001|Overall Study|Lost to Follow-up|25|||
130181081|NCT03629184|468619207|FG000|Overall Study|Withdrawal by Subject|2|||
130181082|NCT03629184|468619208|FG001|Overall Study|Withdrawal by Subject|1|||
129983749|NCT00611975|467902350|FG001|Overall Study|Withdrawal by Subject|7|||
129983750|NCT00611975|467902349|FG000|Overall Study|Pregnancy|2|||
130181083|NCT03629184|468619207|FG000|Overall Study|Physician Decision|1|||
130181084|NCT03629184|468619208|FG001|Overall Study|Physician Decision|0|||
130181085|NCT02548143|468619210|FG000|Overall Study|Adverse Event|1|||
130181086|NCT02548143|468619211|FG001|Overall Study|Adverse Event|0|||
130181087|NCT02548143|468619210|FG000|Overall Study|Withdrawal by Subject|0|||
130181088|NCT02548143|468619211|FG001|Overall Study|Withdrawal by Subject|1|||
130181089|NCT05620082|468619215|FG000|Overall Study|Discharged before study end|1|||
130181090|NCT05620082|468619216|FG001|Overall Study|Discharged before study end|4|||
130181091|NCT05620082|468619217|FG002|Overall Study|Discharged before study end|0|||
130181092|NCT05620082|468619215|FG000|Overall Study|Moved to a different ward|1|||
130181093|NCT05620082|468619216|FG001|Overall Study|Moved to a different ward|0|||
130181094|NCT05620082|468619217|FG002|Overall Study|Moved to a different ward|0|||
130181095|NCT05620082|468619215|FG000|Overall Study|Feeling too unwell|1|||
130181096|NCT05620082|468619216|FG001|Overall Study|Feeling too unwell|0|||
130181097|NCT05620082|468619217|FG002|Overall Study|Feeling too unwell|0|||
130181098|NCT02721732|468621156|FG000|Overall Study|Adverse Event|2|||
130181099|NCT02721732|468621157|FG001|Overall Study|Adverse Event|0|||
130181100|NCT02721732|468621158|FG002|Overall Study|Adverse Event|2|||
130181101|NCT02721732|468621159|FG003|Overall Study|Adverse Event|0|||
130181102|NCT02721732|468621160|FG004|Overall Study|Adverse Event|1|||
130181103|NCT02721732|468621161|FG005|Overall Study|Adverse Event|0|||
130181104|NCT02721732|468621162|FG006|Overall Study|Adverse Event|1|||
130181105|NCT02721732|468621163|FG007|Overall Study|Adverse Event|0|||
130181106|NCT02721732|468621164|FG008|Overall Study|Adverse Event|1|||
130181107|NCT02721732|468621165|FG009|Overall Study|Adverse Event|1|||
130181108|NCT02721732|468621156|FG000|Overall Study|Death|0|||
130181109|NCT02721732|468621157|FG001|Overall Study|Death|0|||
130181110|NCT02721732|468621158|FG002|Overall Study|Death|0|||
130181111|NCT02721732|468621159|FG003|Overall Study|Death|0|||
130181112|NCT02721732|468621160|FG004|Overall Study|Death|1|||
130181113|NCT02721732|468621161|FG005|Overall Study|Death|0|||
130181114|NCT02721732|468621162|FG006|Overall Study|Death|1|||
130181115|NCT02721732|468621163|FG007|Overall Study|Death|0|||
130181116|NCT02721732|468621164|FG008|Overall Study|Death|0|||
130181117|NCT02721732|468621165|FG009|Overall Study|Death|1|||
130181118|NCT02721732|468621156|FG000|Overall Study|Lack of Efficacy|12|||
130181119|NCT02721732|468621157|FG001|Overall Study|Lack of Efficacy|11|||
130181120|NCT02721732|468621158|FG002|Overall Study|Lack of Efficacy|18|||
130181121|NCT02721732|468621159|FG003|Overall Study|Lack of Efficacy|5|||
130181122|NCT02721732|468621160|FG004|Overall Study|Lack of Efficacy|21|||
130181123|NCT02721732|468621161|FG005|Overall Study|Lack of Efficacy|2|||
130181124|NCT02721732|468621162|FG006|Overall Study|Lack of Efficacy|8|||
130181125|NCT02721732|468621163|FG007|Overall Study|Lack of Efficacy|11|||
130181126|NCT02721732|468621164|FG008|Overall Study|Lack of Efficacy|10|||
130181127|NCT02721732|468621165|FG009|Overall Study|Lack of Efficacy|20|||
130181128|NCT02721732|468621156|FG000|Overall Study|Physician Decision|0|||
130181129|NCT02721732|468621157|FG001|Overall Study|Physician Decision|0|||
130181130|NCT02721732|468621158|FG002|Overall Study|Physician Decision|1|||
130181131|NCT02721732|468621159|FG003|Overall Study|Physician Decision|0|||
130181132|NCT02721732|468621160|FG004|Overall Study|Physician Decision|0|||
130181133|NCT02721732|468621161|FG005|Overall Study|Physician Decision|0|||
130181134|NCT02721732|468621162|FG006|Overall Study|Physician Decision|0|||
130181135|NCT02721732|468621163|FG007|Overall Study|Physician Decision|0|||
130181136|NCT02721732|468621164|FG008|Overall Study|Physician Decision|0|||
130181137|NCT02721732|468621165|FG009|Overall Study|Physician Decision|0|||
130181138|NCT02721732|468621156|FG000|Overall Study|Withdrawal by Subject|1|||
130181139|NCT02721732|468621157|FG001|Overall Study|Withdrawal by Subject|0|||
130181140|NCT02721732|468621158|FG002|Overall Study|Withdrawal by Subject|0|||
130181141|NCT02721732|468621159|FG003|Overall Study|Withdrawal by Subject|0|||
130181142|NCT02721732|468621160|FG004|Overall Study|Withdrawal by Subject|3|||
130181143|NCT02721732|468621161|FG005|Overall Study|Withdrawal by Subject|0|||
130181144|NCT02721732|468621162|FG006|Overall Study|Withdrawal by Subject|1|||
130181145|NCT02721732|468621163|FG007|Overall Study|Withdrawal by Subject|1|||
130181146|NCT02721732|468621164|FG008|Overall Study|Withdrawal by Subject|0|||
130181147|NCT02721732|468621165|FG009|Overall Study|Withdrawal by Subject|1|||
130181148|NCT02721732|468621156|FG000|Overall Study|Participant Choice|1|||
130181149|NCT02721732|468621157|FG001|Overall Study|Participant Choice|0|||
130181150|NCT02721732|468621158|FG002|Overall Study|Participant Choice|0|||
130181151|NCT02721732|468621159|FG003|Overall Study|Participant Choice|0|||
130181152|NCT02721732|468621160|FG004|Overall Study|Participant Choice|0|||
130181153|NCT02721732|468621161|FG005|Overall Study|Participant Choice|0|||
130181154|NCT02721732|468621162|FG006|Overall Study|Participant Choice|0|||
129983751|NCT00611975|467902350|FG001|Overall Study|Pregnancy|1|||
130181155|NCT02721732|468621163|FG007|Overall Study|Participant Choice|0|||
130181156|NCT02721732|468621164|FG008|Overall Study|Participant Choice|0|||
130181157|NCT02721732|468621165|FG009|Overall Study|Participant Choice|1|||
130181158|NCT02721732|468621156|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129983752|NCT03465904|467902351|FG000|Overall Study|Withdrawal by Subject|9|||
130181159|NCT02721732|468621157|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181160|NCT02721732|468621158|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
130181161|NCT02721732|468621159|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181162|NCT02721732|468621160|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181163|NCT02721732|468621161|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181164|NCT02721732|468621162|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181165|NCT02721732|468621163|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181166|NCT02721732|468621164|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129983753|NCT03465904|467902352|FG001|Overall Study|Withdrawal by Subject|5|||
129983754|NCT03465904|467902351|FG000|Overall Study|Lost to Follow-up|11|||
130181167|NCT02721732|468621165|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
130181168|NCT02721732|468621156|FG000|Overall Study|Progression and withdrew consent|1|||
130181169|NCT02721732|468621157|FG001|Overall Study|Progression and withdrew consent|1|||
130181170|NCT02721732|468621158|FG002|Overall Study|Progression and withdrew consent|0|||
130181171|NCT02721732|468621159|FG003|Overall Study|Progression and withdrew consent|0|||
130181172|NCT02721732|468621160|FG004|Overall Study|Progression and withdrew consent|0|||
130181173|NCT02721732|468621161|FG005|Overall Study|Progression and withdrew consent|0|||
130181174|NCT02721732|468621162|FG006|Overall Study|Progression and withdrew consent|0|||
130181175|NCT02721732|468621163|FG007|Overall Study|Progression and withdrew consent|0|||
130181176|NCT02721732|468621164|FG008|Overall Study|Progression and withdrew consent|0|||
130181177|NCT02721732|468621165|FG009|Overall Study|Progression and withdrew consent|1|||
130181178|NCT02721732|468621156|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
130181179|NCT02721732|468621157|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
130181180|NCT02721732|468621158|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
130181181|NCT02721732|468621159|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
130181182|NCT02721732|468621160|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
130181183|NCT02721732|468621161|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
130181184|NCT02721732|468621162|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
130181185|NCT02721732|468621163|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
130181186|NCT02721732|468621164|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
130181187|NCT02721732|468621165|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
130181188|NCT00725283|468621166|FG000|Overall Study|Missing Code|3|||
130181189|NCT00725283|468621166|FG000|Overall Study|Death|5|||
130181190|NCT00725283|468621166|FG000|Overall Study|Other|6|||
130181191|NCT00725283|468621166|FG000|Overall Study|Withdrawal by Subject|10|||
130181192|NCT01996241|468621167|FG000|Overall Study|Lost to Follow-up|252|||
130181193|NCT01996241|468621168|FG001|Overall Study|Lost to Follow-up|235|||
130181194|NCT04515147|468621170|FG000|Overall Study|Withdrawal by Subject|1|||
130181195|NCT04515147|468621171|FG001|Overall Study|Withdrawal by Subject|0|||
130181196|NCT04515147|468621172|FG002|Overall Study|Withdrawal by Subject|10|||
130181197|NCT04515147|468621173|FG003|Overall Study|Withdrawal by Subject|18|||
130181198|NCT04515147|468621174|FG004|Overall Study|Withdrawal by Subject|1|||
130181199|NCT04515147|468621175|FG005|Overall Study|Withdrawal by Subject|8|||
130181200|NCT04515147|468621170|FG000|Overall Study|Lost to Follow-up|0|||
130181201|NCT04515147|468621171|FG001|Overall Study|Lost to Follow-up|1|||
130181202|NCT04515147|468621172|FG002|Overall Study|Lost to Follow-up|5|||
130181203|NCT04515147|468621173|FG003|Overall Study|Lost to Follow-up|6|||
130181204|NCT04515147|468621174|FG004|Overall Study|Lost to Follow-up|2|||
130181205|NCT04515147|468621175|FG005|Overall Study|Lost to Follow-up|1|||
130181206|NCT04515147|468621170|FG000|Overall Study|Adverse Event|0|||
130181207|NCT04515147|468621171|FG001|Overall Study|Adverse Event|0|||
130181208|NCT04515147|468621172|FG002|Overall Study|Adverse Event|0|||
130181209|NCT04515147|468621173|FG003|Overall Study|Adverse Event|2|||
130181210|NCT04515147|468621174|FG004|Overall Study|Adverse Event|0|||
130181211|NCT04515147|468621175|FG005|Overall Study|Adverse Event|0|||
130181212|NCT04515147|468621170|FG000|Overall Study|Miscellaneous|0|||
130181213|NCT04515147|468621171|FG001|Overall Study|Miscellaneous|0|||
130181214|NCT04515147|468621172|FG002|Overall Study|Miscellaneous|0|||
130181215|NCT04515147|468621173|FG003|Overall Study|Miscellaneous|1|||
130181216|NCT04515147|468621174|FG004|Overall Study|Miscellaneous|0|||
130181217|NCT04515147|468621175|FG005|Overall Study|Miscellaneous|1|||
130181218|NCT03052751|468621176|FG000|Dosing Period 1|Adverse Event|0|||
130181219|NCT03052751|468621177|FG001|Dosing Period 1|Adverse Event|1|||
130181220|NCT03052751|468621178|FG002|Dosing Period 1|Adverse Event|0|||
130181221|NCT03052751|468621179|FG003|Dosing Period 1|Adverse Event|0|||
130181222|NCT03052751|468621180|FG004|Dosing Period 1|Adverse Event|0|||
130181223|NCT03052751|468621181|FG005|Dosing Period 1|Adverse Event|0|||
130181224|NCT03052751|468621176|FG000|Dosing Period 2|Adverse Event|0|||
130181225|NCT03052751|468621177|FG001|Dosing Period 2|Adverse Event|0|||
129983755|NCT03465904|467902352|FG001|Overall Study|Lost to Follow-up|9|||
129983756|NCT03465904|467902351|FG000|Overall Study|Protocol Violation|20|||
130181226|NCT03052751|468621178|FG002|Dosing Period 2|Adverse Event|3|||
130181227|NCT03052751|468621179|FG003|Dosing Period 2|Adverse Event|0|||
130181228|NCT03052751|468621180|FG004|Dosing Period 2|Adverse Event|0|||
130181229|NCT03052751|468621181|FG005|Dosing Period 2|Adverse Event|0|||
130181230|NCT03052751|468621176|FG000|Observation Period|Adverse Event|0|||
130181231|NCT03052751|468621177|FG001|Observation Period|Adverse Event|0|||
130181232|NCT03052751|468621178|FG002|Observation Period|Adverse Event|0|||
130181233|NCT03052751|468621179|FG003|Observation Period|Adverse Event|0|||
130181234|NCT03052751|468621180|FG004|Observation Period|Adverse Event|1|||
130181235|NCT03052751|468621181|FG005|Observation Period|Adverse Event|0|||
130181236|NCT02719184|468621182|FG000|Overall Study|Other than listed|1|||
129983757|NCT03465904|467902352|FG001|Overall Study|Protocol Violation|15|||
130181237|NCT02719184|468621183|FG001|Overall Study|Other than listed|12|||
130181238|NCT02719184|468621184|FG002|Overall Study|Other than listed|13|||
130181239|NCT02719184|468621185|FG003|Overall Study|Other than listed|22|||
130181240|NCT02719184|468621186|FG004|Overall Study|Other than listed|9|||
130181241|NCT02719184|468621182|FG000|Overall Study|Withdrawal by Subject|5|||
130181242|NCT02719184|468621183|FG001|Overall Study|Withdrawal by Subject|3|||
130181243|NCT02719184|468621184|FG002|Overall Study|Withdrawal by Subject|6|||
130181244|NCT02719184|468621185|FG003|Overall Study|Withdrawal by Subject|6|||
130181245|NCT02719184|468621186|FG004|Overall Study|Withdrawal by Subject|0|||
130181246|NCT02719184|468621182|FG000|Overall Study|Lost to Follow-up|0|||
130181247|NCT02719184|468621183|FG001|Overall Study|Lost to Follow-up|4|||
130181248|NCT02719184|468621184|FG002|Overall Study|Lost to Follow-up|1|||
130181249|NCT02719184|468621185|FG003|Overall Study|Lost to Follow-up|3|||
130181250|NCT02719184|468621186|FG004|Overall Study|Lost to Follow-up|0|||
130181251|NCT02719184|468621182|FG000|Overall Study|Protocol Violation|0|||
130181252|NCT02719184|468621183|FG001|Overall Study|Protocol Violation|3|||
130181253|NCT02719184|468621184|FG002|Overall Study|Protocol Violation|0|||
130181254|NCT02719184|468621185|FG003|Overall Study|Protocol Violation|2|||
130181255|NCT02719184|468621186|FG004|Overall Study|Protocol Violation|0|||
130181256|NCT02719184|468621182|FG000|Overall Study|Adverse Event|0|||
130181257|NCT02719184|468621183|FG001|Overall Study|Adverse Event|0|||
130181258|NCT02719184|468621184|FG002|Overall Study|Adverse Event|0|||
130181259|NCT02719184|468621185|FG003|Overall Study|Adverse Event|3|||
130181260|NCT02719184|468621186|FG004|Overall Study|Adverse Event|0|||
130181261|NCT02439216|468621187|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
130181262|NCT02439216|468621188|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181263|NCT02439216|468621189|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181264|NCT02439216|468621190|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181265|NCT02439216|468621191|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181266|NCT02439216|468621192|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181267|NCT02439216|468621193|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181268|NCT02439216|468621194|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181269|NCT02439216|468621195|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
130181270|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181271|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181272|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181273|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181274|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181275|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181276|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181277|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
130181278|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
130181279|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181280|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181281|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181282|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181283|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181284|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181285|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
130181286|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
130181287|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
130181288|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181289|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181290|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181291|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181292|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181293|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181294|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181295|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
130181296|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
130181297|NCT02439216|468621187|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181298|NCT02439216|468621188|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181299|NCT02439216|468621189|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181300|NCT02439216|468621190|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181301|NCT02439216|468621191|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181302|NCT02439216|468621192|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181303|NCT02439216|468621193|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
130181304|NCT02439216|468621194|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
130181305|NCT02439216|468621195|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
130181306|NCT02094300|468621196|FG000|Overall Study|Death|7|||
129983758|NCT01305200|467902354|FG000|Overall Study|Physician Decision|4|||
129983759|NCT01305200|467902355|FG001|Overall Study|Physician Decision|6|||
129983760|NCT01305200|467902356|FG002|Overall Study|Physician Decision|1|||
129983761|NCT01305200|467902354|FG000|Overall Study|Withdrawal by Subject|24|||
130181307|NCT02094300|468621196|FG000|Overall Study|Lost to Follow-up|10|||
130181308|NCT02094300|468621196|FG000|Overall Study|Still be eligible for follow-up|3|||
130181309|NCT01050530|468621200|FG000|Overall Study|Adverse Event|6|||
130181310|NCT01050530|468621201|FG001|Overall Study|Adverse Event|3|||
130181311|NCT01050530|468621200|FG000|Overall Study|Lack of Efficacy|1|||
130181312|NCT01050530|468621201|FG001|Overall Study|Lack of Efficacy|4|||
130181313|NCT01050530|468621200|FG000|Overall Study|Withdrawal by Subject|0|||
130181314|NCT01050530|468621201|FG001|Overall Study|Withdrawal by Subject|3|||
130181315|NCT01050530|468621200|FG000|Overall Study|Protocol Violation|1|||
130181316|NCT01050530|468621201|FG001|Overall Study|Protocol Violation|0|||
130181317|NCT02288312|468621204|FG000|Overall Study|Pregnancy|1|||
130181318|NCT02288312|468621205|FG001|Overall Study|Pregnancy|0|||
130181319|NCT02288312|468621206|FG002|Overall Study|Pregnancy|0|||
130181320|NCT01276041|468621207|FG000|Overall Study|Adverse Event|2|||
130181321|NCT01276041|468621207|FG000|Overall Study|Protocol Violation|1|||
130181322|NCT00485264|468621214|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
130181323|NCT00485264|468621215|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
130181324|NCT00485264|468621216|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
130181325|NCT00485264|468621217|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
130181326|NCT00485264|468621218|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
130181327|NCT00485264|468621219|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
130181328|NCT00485264|468621214|FG000|Overall Study|Death|1|||
130181329|NCT00485264|468621215|FG001|Overall Study|Death|0|||
130181330|NCT00485264|468621216|FG002|Overall Study|Death|0|||
130181331|NCT00485264|468621217|FG003|Overall Study|Death|0|||
130181332|NCT00485264|468621218|FG004|Overall Study|Death|1|||
130181333|NCT00485264|468621219|FG005|Overall Study|Death|0|||
130181334|NCT00485264|468621214|FG000|Overall Study|Adverse Event|1|||
130181335|NCT00485264|468621215|FG001|Overall Study|Adverse Event|0|||
130181336|NCT00485264|468621216|FG002|Overall Study|Adverse Event|2|||
130181337|NCT00485264|468621217|FG003|Overall Study|Adverse Event|3|||
130181338|NCT00485264|468621218|FG004|Overall Study|Adverse Event|1|||
130181339|NCT00485264|468621219|FG005|Overall Study|Adverse Event|3|||
130181340|NCT00485264|468621214|FG000|Overall Study|Pregnancy|4|||
130181341|NCT00485264|468621215|FG001|Overall Study|Pregnancy|0|||
130181342|NCT00485264|468621216|FG002|Overall Study|Pregnancy|0|||
130181343|NCT00485264|468621217|FG003|Overall Study|Pregnancy|0|||
130181344|NCT00485264|468621218|FG004|Overall Study|Pregnancy|0|||
130181345|NCT00485264|468621219|FG005|Overall Study|Pregnancy|0|||
129983762|NCT01305200|467902355|FG001|Overall Study|Withdrawal by Subject|21|||
129983763|NCT01305200|467902356|FG002|Overall Study|Withdrawal by Subject|1|||
129983764|NCT01305200|467902354|FG000|Overall Study|Ineligible|1|||
129983765|NCT01305200|467902355|FG001|Overall Study|Ineligible|2|||
129983766|NCT01305200|467902356|FG002|Overall Study|Ineligible|1|||
130181346|NCT00485264|468621214|FG000|Overall Study|Disallowed Medication|0|||
130181347|NCT00485264|468621215|FG001|Overall Study|Disallowed Medication|0|||
130181348|NCT00485264|468621216|FG002|Overall Study|Disallowed Medication|0|||
130181349|NCT00485264|468621217|FG003|Overall Study|Disallowed Medication|0|||
130181350|NCT00485264|468621218|FG004|Overall Study|Disallowed Medication|0|||
130181351|NCT00485264|468621219|FG005|Overall Study|Disallowed Medication|1|||
130181352|NCT00485264|468621214|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
130181353|NCT00485264|468621215|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
130181354|NCT00485264|468621216|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
130181355|NCT00485264|468621217|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
130181356|NCT00485264|468621218|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
130181357|NCT00485264|468621219|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
130181358|NCT00485264|468621214|FG000|Overall Study|Lack of Efficacy|0|||
130181359|NCT00485264|468621215|FG001|Overall Study|Lack of Efficacy|1|||
130181360|NCT00485264|468621216|FG002|Overall Study|Lack of Efficacy|0|||
130181361|NCT00485264|468621217|FG003|Overall Study|Lack of Efficacy|0|||
130181362|NCT00485264|468621218|FG004|Overall Study|Lack of Efficacy|0|||
130181363|NCT00485264|468621219|FG005|Overall Study|Lack of Efficacy|0|||
130181364|NCT00485264|468621214|FG000|Overall Study|Guardian Consent Withdrawn|1|||
130181365|NCT00485264|468621215|FG001|Overall Study|Guardian Consent Withdrawn|0|||
130181366|NCT00485264|468621216|FG002|Overall Study|Guardian Consent Withdrawn|0|||
130181367|NCT00485264|468621217|FG003|Overall Study|Guardian Consent Withdrawn|0|||
130181368|NCT00485264|468621218|FG004|Overall Study|Guardian Consent Withdrawn|1|||
130181369|NCT00485264|468621219|FG005|Overall Study|Guardian Consent Withdrawn|0|||
130181370|NCT00485264|468621214|FG000|Overall Study|Physician Decision|0|||
130181371|NCT00485264|468621215|FG001|Overall Study|Physician Decision|2|||
130181372|NCT00485264|468621216|FG002|Overall Study|Physician Decision|0|||
130181373|NCT00485264|468621217|FG003|Overall Study|Physician Decision|0|||
130181374|NCT00485264|468621218|FG004|Overall Study|Physician Decision|0|||
130181375|NCT00485264|468621219|FG005|Overall Study|Physician Decision|0|||
130181376|NCT00485264|468621214|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181377|NCT00485264|468621215|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181378|NCT00485264|468621216|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
130181379|NCT00485264|468621217|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181380|NCT00485264|468621218|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181381|NCT00485264|468621219|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
130181382|NCT00485264|468621214|FG000|Overall Study|Not Able to Attend Clinic|5|||
130181383|NCT00485264|468621215|FG001|Overall Study|Not Able to Attend Clinic|0|||
130181384|NCT00485264|468621216|FG002|Overall Study|Not Able to Attend Clinic|0|||
130181385|NCT00485264|468621217|FG003|Overall Study|Not Able to Attend Clinic|1|||
130181386|NCT00485264|468621218|FG004|Overall Study|Not Able to Attend Clinic|1|||
130181387|NCT00485264|468621219|FG005|Overall Study|Not Able to Attend Clinic|2|||
130181388|NCT00485264|468621214|FG000|Overall Study|Non-Compliant|17|||
130181389|NCT00485264|468621215|FG001|Overall Study|Non-Compliant|2|||
130181390|NCT00485264|468621216|FG002|Overall Study|Non-Compliant|1|||
130181391|NCT00485264|468621217|FG003|Overall Study|Non-Compliant|0|||
130181392|NCT00485264|468621218|FG004|Overall Study|Non-Compliant|1|||
130181393|NCT00485264|468621219|FG005|Overall Study|Non-Compliant|0|||
130181394|NCT00485264|468621214|FG000|Overall Study|Lost to Follow-up|2|||
130181395|NCT00485264|468621215|FG001|Overall Study|Lost to Follow-up|1|||
130181396|NCT00485264|468621216|FG002|Overall Study|Lost to Follow-up|1|||
130181397|NCT00485264|468621217|FG003|Overall Study|Lost to Follow-up|0|||
130181398|NCT00485264|468621218|FG004|Overall Study|Lost to Follow-up|0|||
130181399|NCT00485264|468621219|FG005|Overall Study|Lost to Follow-up|1|||
130181400|NCT00485264|468621214|FG000|Overall Study|Other Reason|3|||
130181401|NCT00485264|468621215|FG001|Overall Study|Other Reason|0|||
130181402|NCT00485264|468621216|FG002|Overall Study|Other Reason|0|||
130181403|NCT00485264|468621217|FG003|Overall Study|Other Reason|0|||
130181404|NCT00485264|468621218|FG004|Overall Study|Other Reason|0|||
130181405|NCT00485264|468621219|FG005|Overall Study|Other Reason|0|||
130181406|NCT00654095|468621221|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
130181407|NCT00654095|468621221|FG000|Overall Study|Elevated triglyceride level (2)|1|||
130181408|NCT00654095|468621221|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
130181409|NCT00654095|468621221|FG000|Overall Study|Adverse Event|11|||
130181410|NCT00654095|468621221|FG000|Overall Study|Withdrawal by Subject|5|||
130181411|NCT00654095|468621221|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
130181412|NCT00654095|468621221|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
130181413|NCT00654095|468621221|FG000|Overall Study|Did not meet inclusion criteria|1|||
130181414|NCT02440464|468621222|FG000|Overall Study|Withdrawal by Subject|3|||
130181415|NCT02440464|468621223|FG001|Overall Study|Withdrawal by Subject|2|||
130181416|NCT04620746|468621239|FG000|Overall Study|Adverse Event|2|||
130181417|NCT04620746|468621240|FG001|Overall Study|Adverse Event|0|||
130181418|NCT04620746|468621239|FG000|Overall Study|Uniterpretable skin test|1|||
130181419|NCT04620746|468621240|FG001|Overall Study|Uniterpretable skin test|0|||
130181420|NCT04620746|468621239|FG000|Overall Study|Withdrawal by Subject|0|||
130181421|NCT04620746|468621240|FG001|Overall Study|Withdrawal by Subject|1|||
130181422|NCT03411863|468621241|FG000|Overall Study|Withdrawal by Subject|3|||
130181423|NCT03411863|468621242|FG001|Overall Study|Withdrawal by Subject|1|||
130181424|NCT03411863|468621241|FG000|Overall Study|Physician Decision|0|||
130181425|NCT03411863|468621242|FG001|Overall Study|Physician Decision|1|||
130181426|NCT03535740|468621243|FG000|Overall Study|Death|44|||
130181427|NCT03535740|468621243|FG000|Overall Study|Lost to Follow-up|1|||
130181428|NCT03535740|468621243|FG000|Overall Study|Withdrawal by Subject|13|||
130181429|NCT03535740|468621243|FG000|Overall Study|Site terminated by Sponsor|45|||
130181430|NCT05198518|468621248|FG000|Screening Visit|Deemed unable to participate|58|||
130181431|NCT05198518|468621249|FG001|Screening Visit|Deemed unable to participate|0|||
130181432|NCT05198518|468621250|FG002|Screening Visit|Deemed unable to participate|0|||
130181433|NCT02756611|468621254|FG000|Overall Study|Death|70|||
130181434|NCT02756611|468621254|FG000|Overall Study|Withdrawal by Subject|2|||
130181435|NCT02756611|468621254|FG000|Overall Study|Lost to Follow-up|3|||
130181436|NCT02756611|468621254|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
130181437|NCT02756611|468621254|FG000|Overall Study|Other|10|||
130181438|NCT03125798|468621255|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
130181439|NCT03125798|468621256|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
130181440|NCT03125798|468621255|FG000|Overall Study|Conversion to thoracotomy|7|||
130181441|NCT03125798|468621256|FG001|Overall Study|Conversion to thoracotomy|7|||
130181442|NCT00100828|468621260|FG000|Overall Study|Physician Decision|6|||
130181443|NCT04583735|468621261|FG000|Double-masked Treatment Period|Adverse Event|0|||
130181444|NCT04583735|468621262|FG001|Double-masked Treatment Period|Adverse Event|1|||
130181445|NCT04583735|468621261|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
130181446|NCT04583735|468621262|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
130181447|NCT04583735|468621261|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
130181448|NCT04583735|468621262|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
130181449|NCT04583735|468621261|FG000|Open-label Treatment Period|Adverse Event|1|||
130181450|NCT04583735|468621262|FG001|Open-label Treatment Period|Adverse Event|1|||
130181451|NCT04583735|468621261|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
130181452|NCT04583735|468621262|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130181453|NCT04583735|468621261|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130181454|NCT04583735|468621262|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
130181455|NCT00124917|468621263|FG000|Overall Study|Physician Decision|3|||
130181456|NCT00613171|468621264|FG000|Overall Study|Adverse Event|7|||
130181457|NCT00613171|468621264|FG000|Overall Study|Withdrawal by Subject|3|||
130181458|NCT00613171|468621264|FG000|Overall Study|Reason not Specified|4|||
130181459|NCT01197911|468621265|FG000|Overall Study|Adverse Event|0|||
130181460|NCT01197911|468621266|FG001|Overall Study|Adverse Event|0|||
130181461|NCT01197911|468621267|FG002|Overall Study|Adverse Event|1|||
130181462|NCT01169350|468621268|FG000|Overall Study|Physician Decision|3|||
130181463|NCT01169350|468621268|FG000|Overall Study|Lost to Follow-up|2|||
130181464|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
130181465|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
130181466|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
130181467|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
130181468|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
130181469|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
130181470|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
130181471|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
130181472|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
130181473|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
130181474|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
130181475|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
130181476|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
130181477|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
130181478|NCT04338022|468621269|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
130181479|NCT04338022|468621270|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
130181480|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
130181481|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
130181482|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
130181483|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
130181484|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
130181485|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
130181486|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
130181487|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
130181488|NCT04338022|468621269|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
130181489|NCT04338022|468621270|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
130181490|NCT04338022|468621269|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
130181491|NCT04338022|468621270|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
130181492|NCT02860546|468621272|FG000|Overall Study|Clinical Progression|6|||
130181493|NCT02860546|468621272|FG000|Overall Study|Radiological Progression|12|||
130181494|NCT02466321|468621273|FG000|Overall Study|Death|26|||
130181495|NCT02466321|468621273|FG000|Overall Study|Revision|6|||
130181496|NCT02466321|468621273|FG000|Overall Study|Lost to Follow-up|60|||
130181497|NCT02466321|468621273|FG000|Overall Study|Did not receive study device|1|||
130181498|NCT06071754|468621274|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
130181499|NCT02189837|468621275|FG000|Overall Study|Withdrawal by Subject|2|||
130181500|NCT02189837|468621276|FG001|Overall Study|Withdrawal by Subject|1|||
130181501|NCT02189837|468621277|FG002|Overall Study|Withdrawal by Subject|3|||
130181502|NCT02189837|468621278|FG003|Overall Study|Withdrawal by Subject|1|||
130181503|NCT02189837|468621275|FG000|Overall Study|Sponsor Decision|0|||
130181504|NCT02189837|468621276|FG001|Overall Study|Sponsor Decision|0|||
130181505|NCT02189837|468621277|FG002|Overall Study|Sponsor Decision|0|||
130181506|NCT02189837|468621278|FG003|Overall Study|Sponsor Decision|1|||
130181507|NCT02443740|468621285|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181508|NCT02443740|468621286|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181509|NCT02443740|468621287|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181510|NCT02443740|468621288|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181511|NCT02443740|468621289|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181512|NCT02443740|468621290|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
130181513|NCT02443740|468621291|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181514|NCT02443740|468621292|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181515|NCT02443740|468621293|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181516|NCT02443740|468621294|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181517|NCT02443740|468621295|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
130181518|NCT02443740|468621285|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
130181519|NCT02443740|468621286|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181520|NCT02443740|468621287|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181521|NCT02443740|468621288|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181522|NCT02443740|468621289|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181523|NCT02443740|468621290|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181524|NCT02443740|468621291|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
130181525|NCT02443740|468621292|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181526|NCT02443740|468621293|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181527|NCT02443740|468621294|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181528|NCT02443740|468621295|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
130181529|NCT02443740|468621285|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181530|NCT02443740|468621286|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181531|NCT02443740|468621287|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181532|NCT02443740|468621288|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181533|NCT02443740|468621289|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181534|NCT02443740|468621290|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
130181535|NCT02443740|468621291|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181536|NCT02443740|468621292|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181537|NCT02443740|468621293|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181538|NCT02443740|468621294|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181539|NCT02443740|468621295|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
130181540|NCT00456300|468621296|FG000|Overall Study|Adverse Event|1|||
130181541|NCT00456300|468621297|FG001|Overall Study|Adverse Event|0|||
130181542|NCT01478373|468621298|FG000|Treatment Phase|Protocol Violation|1|||
130181543|NCT01478373|468621298|FG000|Survival Phase|Adverse Event|8|||
130181544|NCT01478373|468621298|FG000|Survival Phase|Protocol Violation|1|||
130181545|NCT01478373|468621298|FG000|Survival Phase|crossover to another study|2|||
130181546|NCT01478373|468621298|FG000|Survival Phase|Progressive Disease|27|||
130181547|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
130181548|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181549|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181550|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181551|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
130181552|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
130181553|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181554|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181555|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181556|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
130181557|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
130181558|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181559|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181560|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181561|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
130181562|NCT01074944|468621302|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
130181563|NCT01074944|468621303|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181564|NCT01074944|468621304|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181565|NCT01074944|468621305|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181566|NCT01074944|468621306|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
130181567|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130181568|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
130181569|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
130181570|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130181571|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
130181572|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130181573|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
130181574|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
130181575|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130181576|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
130181577|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130181578|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
130181579|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
130181580|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130181581|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
130181582|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181583|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
130181584|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181585|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181586|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
130181587|NCT01074944|468621302|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130181588|NCT01074944|468621303|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
130181589|NCT01074944|468621304|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
130181590|NCT01074944|468621305|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130181591|NCT01074944|468621306|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
130181592|NCT01074944|468621302|FG000|Long Term Treatment|Adverse Event|0|||
130181593|NCT01074944|468621303|FG001|Long Term Treatment|Adverse Event|0|||
130181594|NCT01074944|468621304|FG002|Long Term Treatment|Adverse Event|0|||
130181595|NCT01074944|468621305|FG003|Long Term Treatment|Adverse Event|3|||
130181596|NCT01074944|468621306|FG004|Long Term Treatment|Adverse Event|0|||
130181597|NCT01074944|468621302|FG000|Long Term Treatment|Lost to Follow-up|0|||
130181598|NCT01074944|468621303|FG001|Long Term Treatment|Lost to Follow-up|0|||
130181599|NCT01074944|468621304|FG002|Long Term Treatment|Lost to Follow-up|0|||
130181600|NCT01074944|468621305|FG003|Long Term Treatment|Lost to Follow-up|2|||
130181601|NCT01074944|468621306|FG004|Long Term Treatment|Lost to Follow-up|0|||
130181602|NCT01074944|468621302|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181603|NCT01074944|468621303|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181604|NCT01074944|468621304|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181605|NCT01074944|468621305|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
130181606|NCT01074944|468621306|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
130181607|NCT01074944|468621302|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181608|NCT01074944|468621303|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181609|NCT01074944|468621304|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181610|NCT01074944|468621305|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
130181611|NCT01074944|468621306|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
130181612|NCT01074944|468621302|FG000|Long Term Treatment|Withdrawal by Subject|0|||
130181613|NCT01074944|468621303|FG001|Long Term Treatment|Withdrawal by Subject|0|||
130181614|NCT01074944|468621304|FG002|Long Term Treatment|Withdrawal by Subject|0|||
130181615|NCT01074944|468621305|FG003|Long Term Treatment|Withdrawal by Subject|2|||
130181616|NCT01074944|468621306|FG004|Long Term Treatment|Withdrawal by Subject|0|||
130181617|NCT01074944|468621302|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181618|NCT01074944|468621303|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181619|NCT01074944|468621304|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181620|NCT01074944|468621305|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
130181621|NCT01074944|468621306|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
130181622|NCT01074944|468621302|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181623|NCT01074944|468621303|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181624|NCT01074944|468621304|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181625|NCT01074944|468621305|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
130181626|NCT01074944|468621306|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
130181627|NCT02348112|468621307|FG000|Overall Study|Withdrawal by Subject|32|||
130181628|NCT02348112|468621308|FG001|Overall Study|Withdrawal by Subject|29|||
130181629|NCT02348112|468621307|FG000|Overall Study|Lost to Follow-up|24|||
130181630|NCT02348112|468621308|FG001|Overall Study|Lost to Follow-up|20|||
130181631|NCT02348112|468621307|FG000|Overall Study|Physician Decision|17|||
130181632|NCT02348112|468621308|FG001|Overall Study|Physician Decision|15|||
130181633|NCT02348112|468621307|FG000|Overall Study|Site closed due to PI leaving|0|||
130181634|NCT02348112|468621308|FG001|Overall Study|Site closed due to PI leaving|30|||
130181635|NCT02348112|468621307|FG000|Overall Study|Sponsor withdrawal|0|||
130181636|NCT02348112|468621308|FG001|Overall Study|Sponsor withdrawal|7|||
130181637|NCT02348112|468621307|FG000|Overall Study|Death|0|||
130181638|NCT02348112|468621308|FG001|Overall Study|Death|1|||
130181639|NCT01998841|468621315|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
130181640|NCT01998841|468621316|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
130181641|NCT01998841|468621317|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
130181642|NCT01998841|468621318|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181643|NCT01998841|468621319|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181644|NCT01998841|468621315|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181645|NCT01998841|468621316|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181646|NCT01998841|468621317|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
130181647|NCT01998841|468621318|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
130181648|NCT01998841|468621319|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
130181649|NCT05101343|468621320|FG000|Overall Study|Withdrawal by Subject|2|||
130181650|NCT05101343|468621321|FG001|Overall Study|Withdrawal by Subject|1|||
130181651|NCT02046603|468621322|FG000|Overall Study|Other|11|||
130181652|NCT02046603|468621323|FG001|Overall Study|Other|66|||
130181653|NCT02046603|468621322|FG000|Overall Study|Protocol Violation|0|||
130181654|NCT02046603|468621323|FG001|Overall Study|Protocol Violation|1|||
130181655|NCT02046603|468621322|FG000|Overall Study|Participant/legal guardian decision|1|||
130181656|NCT02046603|468621323|FG001|Overall Study|Participant/legal guardian decision|3|||
130181657|NCT02046603|468621322|FG000|Overall Study|Physician Decision|2|||
130181658|NCT02046603|468621323|FG001|Overall Study|Physician Decision|1|||
130181659|NCT02046603|468621322|FG000|Overall Study|Lost to Follow-up|1|||
130181660|NCT02046603|468621323|FG001|Overall Study|Lost to Follow-up|2|||
130181661|NCT02046603|468621322|FG000|Overall Study|Death|0|||
130181662|NCT02046603|468621323|FG001|Overall Study|Death|1|||
130181663|NCT02046603|468621322|FG000|Overall Study|Adverse Event|0|||
130181664|NCT02046603|468621323|FG001|Overall Study|Adverse Event|1|||
130181665|NCT03447743|468621324|FG000|Overall Study|Withdrawal by Subject|2|||
130181666|NCT03447743|468621324|FG000|Overall Study|Lost to Follow-up|3|||
130181667|NCT03447743|468621324|FG000|Overall Study|Adverse Event|1|||
130181668|NCT03447743|468621324|FG000|Overall Study|Did not meet criteria to continue|1|||
130181669|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
130181670|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
130181671|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Physician Decision|2|||
130181672|NCT00193050|468621325|FG000|Neoadjuvant Treatment|Adverse Event|2|||
130181673|NCT00193050|468621325|FG000|Adjuvant|Physician Decision|5|||
130181674|NCT00193050|468621325|FG000|Adjuvant|Intercurrent Hospitalization|3|||
130181675|NCT00193050|468621325|FG000|Adjuvant|Lack of Efficacy|2|||
130181676|NCT00061932|468621326|FG000|Overall Study|Withdrawal by Subject|13|||
130181677|NCT00061932|468621327|FG001|Overall Study|Withdrawal by Subject|4|||
130181678|NCT03567980|468621328|FG000|Overall Study|Adverse Event|1|||
130181679|NCT03093259|468621330|FG000|Overall Study|Adverse Event|1|||
130181680|NCT03093259|468621331|FG001|Overall Study|Adverse Event|0|||
130181681|NCT03093259|468621330|FG000|Overall Study|Withdrawal by Subject|1|||
130181682|NCT03093259|468621331|FG001|Overall Study|Withdrawal by Subject|0|||
130181683|NCT02575833|468621332|FG000|Overall Study|Withdrawal by Subject|0|||
130181684|NCT02575833|468621333|FG001|Overall Study|Withdrawal by Subject|1|||
130181685|NCT02575833|468621332|FG000|Overall Study|Lost to Follow-up|1|||
130181686|NCT02575833|468621333|FG001|Overall Study|Lost to Follow-up|0|||
130181687|NCT00445146|468621334|FG000|Overall Study|Withdrew Consent|29|||
130181688|NCT00445146|468621334|FG000|Overall Study|Lack of Efficacy|28|||
130181689|NCT00445146|468621334|FG000|Overall Study|Investigator's Discretion|22|||
130181690|NCT00445146|468621334|FG000|Overall Study|Adverse Event|13|||
130181691|NCT00445146|468621334|FG000|Overall Study|Lost to Follow-up|13|||
130181692|NCT00445146|468621334|FG000|Overall Study|Death|9|||
130181693|NCT00445146|468621334|FG000|Overall Study|Protocol Violation|4|||
130181694|NCT00445146|468621334|FG000|Overall Study|Pregnancy|1|||
130181695|NCT00625820|468621335|FG000|Overall Study|Withdrawal by Subject|1|||
130181696|NCT00967330|468621336|FG000|Overall Study|Protocol Violation|3|||
130181697|NCT00967330|468621337|FG001|Overall Study|Protocol Violation|4|||
130181698|NCT00967330|468621336|FG000|Overall Study|Regular|10|||
130181699|NCT00967330|468621337|FG001|Overall Study|Regular|3|||
130181700|NCT00967330|468621336|FG000|Overall Study|Withdrawal by Subject|6|||
130181701|NCT00967330|468621337|FG001|Overall Study|Withdrawal by Subject|0|||
130181702|NCT00967330|468621336|FG000|Overall Study|Lost to Follow-up|1|||
130181703|NCT00967330|468621337|FG001|Overall Study|Lost to Follow-up|1|||
130181704|NCT00967330|468621336|FG000|Overall Study|Death|102|||
130181705|NCT00967330|468621337|FG001|Overall Study|Death|51|||
130181706|NCT00967330|468621336|FG000|Overall Study|Severe protocol deviation|0|||
130181707|NCT00967330|468621337|FG001|Overall Study|Severe protocol deviation|1|||
130181708|NCT03759392|468621338|FG000|Overall Study|Adverse Event|12|||
130181709|NCT03759392|468621339|FG001|Overall Study|Adverse Event|4|||
130181710|NCT03759392|468621338|FG000|Overall Study|Death|2|||
130181711|NCT03759392|468621339|FG001|Overall Study|Death|1|||
130181712|NCT03759392|468621338|FG000|Overall Study|Withdrawal by Subject|2|||
130181713|NCT03759392|468621339|FG001|Overall Study|Withdrawal by Subject|0|||
130181714|NCT03759392|468621338|FG000|Overall Study|Protocol Violation|2|||
130181715|NCT03759392|468621339|FG001|Overall Study|Protocol Violation|0|||
130181716|NCT03759392|468621338|FG000|Overall Study|Physician Decision|0|||
130181717|NCT03759392|468621339|FG001|Overall Study|Physician Decision|1|||
130181718|NCT03759392|468621338|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
130181719|NCT03759392|468621339|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
130181720|NCT03759392|468621338|FG000|Overall Study|No longer able to take medicines|1|||
130181721|NCT03759392|468621339|FG001|Overall Study|No longer able to take medicines|0|||
130181722|NCT03759392|468621338|FG000|Overall Study|Stopped taking study drug|1|||
130181723|NCT03759392|468621339|FG001|Overall Study|Stopped taking study drug|0|||
130181724|NCT02623725|468621340|FG000|Overall Study|Non compliance with protocol|9|||
130181725|NCT02623725|468621341|FG001|Overall Study|Non compliance with protocol|3|||
130181726|NCT02623725|468621340|FG000|Overall Study|Serious adverse event|0|||
129983767|NCT01305200|467902354|FG000|Overall Study|Death|0|||
130181727|NCT02623725|468621341|FG001|Overall Study|Serious adverse event|2|||
130181728|NCT02623725|468621340|FG000|Overall Study|Withdrawal by Subject|7|||
130181729|NCT02623725|468621341|FG001|Overall Study|Withdrawal by Subject|1|||
130181730|NCT02848001|468624039|FG000|Overall Study|other reasons|0|||
130181731|NCT02848001|468624040|FG001|Overall Study|other reasons|0|||
130181732|NCT02848001|468624041|FG002|Overall Study|other reasons|1|||
130181733|NCT02848001|468624042|FG003|Overall Study|other reasons|0|||
130181734|NCT02848001|468624043|FG004|Overall Study|other reasons|4|||
130181735|NCT02848001|468624044|FG005|Overall Study|other reasons|1|||
130181736|NCT02848001|468624045|FG006|Overall Study|other reasons|0|||
130181737|NCT02848001|468624046|FG007|Overall Study|other reasons|2|||
130181738|NCT02848001|468624047|FG008|Overall Study|other reasons|2|||
130181739|NCT02848001|468624048|FG009|Overall Study|other reasons|3|||
130181740|NCT02848001|468624049|FG010|Overall Study|other reasons|0|||
130181741|NCT02848001|468624050|FG011|Overall Study|other reasons|1|||
130181742|NCT02848001|468624051|FG012|Overall Study|other reasons|1|||
130181743|NCT02848001|468624052|FG013|Overall Study|other reasons|0|||
130181744|NCT02848001|468624053|FG014|Overall Study|other reasons|0|||
130181745|NCT02848001|468624054|FG015|Overall Study|other reasons|2|||
130181746|NCT02848001|468624055|FG016|Overall Study|other reasons|1|||
130181747|NCT02848001|468624039|FG000|Overall Study|Lack of Efficacy|0|||
130181748|NCT02848001|468624040|FG001|Overall Study|Lack of Efficacy|1|||
130181749|NCT02848001|468624041|FG002|Overall Study|Lack of Efficacy|1|||
130181750|NCT02848001|468624042|FG003|Overall Study|Lack of Efficacy|2|||
130181751|NCT02848001|468624043|FG004|Overall Study|Lack of Efficacy|3|||
130181752|NCT02848001|468624044|FG005|Overall Study|Lack of Efficacy|0|||
130181753|NCT02848001|468624045|FG006|Overall Study|Lack of Efficacy|1|||
130181754|NCT02848001|468624046|FG007|Overall Study|Lack of Efficacy|0|||
130181755|NCT02848001|468624047|FG008|Overall Study|Lack of Efficacy|0|||
130181756|NCT02848001|468624048|FG009|Overall Study|Lack of Efficacy|1|||
130181757|NCT02848001|468624049|FG010|Overall Study|Lack of Efficacy|0|||
130181758|NCT02848001|468624050|FG011|Overall Study|Lack of Efficacy|2|||
130181759|NCT02848001|468624051|FG012|Overall Study|Lack of Efficacy|0|||
130181760|NCT02848001|468624052|FG013|Overall Study|Lack of Efficacy|2|||
130181761|NCT02848001|468624053|FG014|Overall Study|Lack of Efficacy|2|||
130181762|NCT02848001|468624054|FG015|Overall Study|Lack of Efficacy|0|||
130181763|NCT02848001|468624055|FG016|Overall Study|Lack of Efficacy|0|||
130181764|NCT02848001|468624039|FG000|Overall Study|Progressive Disease|2|||
130181765|NCT02848001|468624040|FG001|Overall Study|Progressive Disease|1|||
130181766|NCT02848001|468624041|FG002|Overall Study|Progressive Disease|0|||
130181767|NCT02848001|468624042|FG003|Overall Study|Progressive Disease|4|||
130181768|NCT02848001|468624043|FG004|Overall Study|Progressive Disease|3|||
130181769|NCT02848001|468624044|FG005|Overall Study|Progressive Disease|0|||
130181770|NCT02848001|468624045|FG006|Overall Study|Progressive Disease|4|||
130181771|NCT02848001|468624046|FG007|Overall Study|Progressive Disease|1|||
130181772|NCT02848001|468624047|FG008|Overall Study|Progressive Disease|0|||
130181773|NCT02848001|468624048|FG009|Overall Study|Progressive Disease|2|||
130181774|NCT02848001|468624049|FG010|Overall Study|Progressive Disease|3|||
130181775|NCT02848001|468624050|FG011|Overall Study|Progressive Disease|2|||
130181776|NCT02848001|468624051|FG012|Overall Study|Progressive Disease|1|||
130181777|NCT02848001|468624052|FG013|Overall Study|Progressive Disease|0|||
130181778|NCT02848001|468624053|FG014|Overall Study|Progressive Disease|2|||
130181779|NCT02848001|468624054|FG015|Overall Study|Progressive Disease|4|||
130181780|NCT02848001|468624055|FG016|Overall Study|Progressive Disease|0|||
130181781|NCT02848001|468624039|FG000|Overall Study|Adverse Event|0|||
130181782|NCT02848001|468624040|FG001|Overall Study|Adverse Event|0|||
130181783|NCT02848001|468624041|FG002|Overall Study|Adverse Event|0|||
130181784|NCT02848001|468624042|FG003|Overall Study|Adverse Event|0|||
130181785|NCT02848001|468624043|FG004|Overall Study|Adverse Event|2|||
130181786|NCT02848001|468624044|FG005|Overall Study|Adverse Event|0|||
130181787|NCT02848001|468624045|FG006|Overall Study|Adverse Event|0|||
130181788|NCT02848001|468624046|FG007|Overall Study|Adverse Event|0|||
130181789|NCT02848001|468624047|FG008|Overall Study|Adverse Event|0|||
130181790|NCT02848001|468624048|FG009|Overall Study|Adverse Event|1|||
130181791|NCT02848001|468624049|FG010|Overall Study|Adverse Event|0|||
130181792|NCT02848001|468624050|FG011|Overall Study|Adverse Event|1|||
130181793|NCT02848001|468624051|FG012|Overall Study|Adverse Event|1|||
130181794|NCT02848001|468624052|FG013|Overall Study|Adverse Event|0|||
130181795|NCT02848001|468624053|FG014|Overall Study|Adverse Event|2|||
130181796|NCT02848001|468624054|FG015|Overall Study|Adverse Event|0|||
130181797|NCT02848001|468624055|FG016|Overall Study|Adverse Event|0|||
130181798|NCT02848001|468624039|FG000|Overall Study|Death|0|||
130181799|NCT02848001|468624040|FG001|Overall Study|Death|0|||
130181800|NCT02848001|468624041|FG002|Overall Study|Death|0|||
130181801|NCT02848001|468624042|FG003|Overall Study|Death|1|||
130181802|NCT02848001|468624043|FG004|Overall Study|Death|3|||
130181803|NCT02848001|468624044|FG005|Overall Study|Death|1|||
130181804|NCT02848001|468624045|FG006|Overall Study|Death|2|||
130181805|NCT02848001|468624046|FG007|Overall Study|Death|3|||
130181806|NCT02848001|468624047|FG008|Overall Study|Death|4|||
130181807|NCT02848001|468624048|FG009|Overall Study|Death|1|||
130181808|NCT02848001|468624049|FG010|Overall Study|Death|0|||
130181809|NCT02848001|468624050|FG011|Overall Study|Death|1|||
130181810|NCT02848001|468624051|FG012|Overall Study|Death|3|||
130181811|NCT02848001|468624052|FG013|Overall Study|Death|0|||
130181812|NCT02848001|468624053|FG014|Overall Study|Death|2|||
130181813|NCT02848001|468624054|FG015|Overall Study|Death|3|||
130181814|NCT02848001|468624055|FG016|Overall Study|Death|0|||
130181815|NCT02848001|468624039|FG000|Overall Study|Physician Decision|0|||
130181816|NCT02848001|468624040|FG001|Overall Study|Physician Decision|0|||
130181817|NCT02848001|468624041|FG002|Overall Study|Physician Decision|0|||
130181818|NCT02848001|468624042|FG003|Overall Study|Physician Decision|0|||
130181819|NCT02848001|468624043|FG004|Overall Study|Physician Decision|0|||
130181820|NCT02848001|468624044|FG005|Overall Study|Physician Decision|0|||
130181821|NCT02848001|468624045|FG006|Overall Study|Physician Decision|0|||
130181822|NCT02848001|468624046|FG007|Overall Study|Physician Decision|0|||
130181823|NCT02848001|468624047|FG008|Overall Study|Physician Decision|1|||
130181824|NCT02848001|468624048|FG009|Overall Study|Physician Decision|1|||
130181825|NCT02848001|468624049|FG010|Overall Study|Physician Decision|0|||
130181826|NCT02848001|468624050|FG011|Overall Study|Physician Decision|0|||
130181827|NCT02848001|468624051|FG012|Overall Study|Physician Decision|2|||
130181828|NCT02848001|468624052|FG013|Overall Study|Physician Decision|0|||
130181829|NCT02848001|468624053|FG014|Overall Study|Physician Decision|0|||
130181830|NCT02848001|468624054|FG015|Overall Study|Physician Decision|0|||
130181831|NCT02848001|468624055|FG016|Overall Study|Physician Decision|0|||
130181832|NCT02848001|468624039|FG000|Overall Study|Withdrawal by Subject|0|||
130181833|NCT02848001|468624040|FG001|Overall Study|Withdrawal by Subject|0|||
130181834|NCT02848001|468624041|FG002|Overall Study|Withdrawal by Subject|0|||
130181835|NCT02848001|468624042|FG003|Overall Study|Withdrawal by Subject|0|||
130181836|NCT02848001|468624043|FG004|Overall Study|Withdrawal by Subject|0|||
130181837|NCT02848001|468624044|FG005|Overall Study|Withdrawal by Subject|1|||
130181838|NCT02848001|468624045|FG006|Overall Study|Withdrawal by Subject|1|||
130181839|NCT02848001|468624046|FG007|Overall Study|Withdrawal by Subject|1|||
130181840|NCT02848001|468624047|FG008|Overall Study|Withdrawal by Subject|0|||
130181841|NCT02848001|468624048|FG009|Overall Study|Withdrawal by Subject|0|||
130181842|NCT02848001|468624049|FG010|Overall Study|Withdrawal by Subject|0|||
130181843|NCT02848001|468624050|FG011|Overall Study|Withdrawal by Subject|0|||
130181844|NCT02848001|468624051|FG012|Overall Study|Withdrawal by Subject|0|||
130181845|NCT02848001|468624052|FG013|Overall Study|Withdrawal by Subject|0|||
130181846|NCT02848001|468624053|FG014|Overall Study|Withdrawal by Subject|0|||
130181847|NCT02848001|468624054|FG015|Overall Study|Withdrawal by Subject|0|||
130181848|NCT02848001|468624055|FG016|Overall Study|Withdrawal by Subject|0|||
130181849|NCT00711243|468624061|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
130181850|NCT00711243|468624062|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
130181851|NCT00711243|468624063|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
130181852|NCT00711243|468624064|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
130181853|NCT00711243|468624065|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
130181854|NCT00711243|468624066|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
130181855|NCT00711243|468624061|FG000|Reached First Response/4 Cycles|Death|0|||
130181856|NCT00711243|468624062|FG001|Reached First Response/4 Cycles|Death|0|||
130181857|NCT00711243|468624063|FG002|Reached First Response/4 Cycles|Death|0|||
130181858|NCT00711243|468624064|FG003|Reached First Response/4 Cycles|Death|0|||
130181859|NCT00711243|468624065|FG004|Reached First Response/4 Cycles|Death|0|||
130181860|NCT00711243|468624066|FG005|Reached First Response/4 Cycles|Death|2|||
130181861|NCT00711243|468624061|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
130181862|NCT00711243|468624062|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
130181863|NCT00711243|468624063|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
130181864|NCT00711243|468624064|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
130181865|NCT00711243|468624065|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
130181866|NCT00711243|468624066|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
130181867|NCT00711243|468624061|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
130181868|NCT00711243|468624062|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
130181869|NCT00711243|468624063|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
130181870|NCT00711243|468624064|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
130181871|NCT00711243|468624065|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
130181872|NCT00711243|468624066|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
130181873|NCT00711243|468624061|FG000|Treated Cycle 5 After First Response|Death|0|||
130181874|NCT00711243|468624062|FG001|Treated Cycle 5 After First Response|Death|0|||
130181875|NCT00711243|468624063|FG002|Treated Cycle 5 After First Response|Death|0|||
130181876|NCT00711243|468624064|FG003|Treated Cycle 5 After First Response|Death|0|||
130181877|NCT00711243|468624065|FG004|Treated Cycle 5 After First Response|Death|0|||
130181878|NCT00711243|468624066|FG005|Treated Cycle 5 After First Response|Death|2|||
130181879|NCT00711243|468624061|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181880|NCT00711243|468624062|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181881|NCT00711243|468624063|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181882|NCT00711243|468624064|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181883|NCT00711243|468624065|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
130181884|NCT00711243|468624066|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
130181885|NCT00711243|468624061|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181886|NCT00711243|468624062|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181887|NCT00711243|468624063|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181888|NCT00711243|468624064|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181889|NCT00711243|468624065|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
130181890|NCT00711243|468624066|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
130181891|NCT01402570|468624069|FG000|Overall Study|Adverse Event|1|||
130181892|NCT01962103|468624073|FG000|Phase 1|Adverse Event|4|||
130181893|NCT01962103|468624074|FG001|Phase 1|Adverse Event|0|||
130181894|NCT01962103|468624075|FG002|Phase 1|Adverse Event|2|||
130181895|NCT01962103|468624076|FG003|Phase 1|Adverse Event|1|||
130181896|NCT01962103|468624077|FG004|Phase 1|Adverse Event|2|||
130181897|NCT01962103|468624078|FG005|Phase 1|Adverse Event|2|||
130181898|NCT01962103|468624079|FG006|Phase 1|Adverse Event|0|||
130181899|NCT01962103|468624080|FG007|Phase 1|Adverse Event|0|||
130181900|NCT01962103|468624081|FG008|Phase 1|Adverse Event|0|||
130181901|NCT01962103|468624073|FG000|Phase 1|Progressive Disease|8|||
130181902|NCT01962103|468624074|FG001|Phase 1|Progressive Disease|6|||
130181903|NCT01962103|468624075|FG002|Phase 1|Progressive Disease|8|||
130181904|NCT01962103|468624076|FG003|Phase 1|Progressive Disease|4|||
130181905|NCT01962103|468624077|FG004|Phase 1|Progressive Disease|5|||
130181906|NCT01962103|468624078|FG005|Phase 1|Progressive Disease|4|||
130181907|NCT01962103|468624079|FG006|Phase 1|Progressive Disease|0|||
130181908|NCT01962103|468624080|FG007|Phase 1|Progressive Disease|0|||
130181909|NCT01962103|468624081|FG008|Phase 1|Progressive Disease|0|||
130181910|NCT01962103|468624073|FG000|Phase 1|Withdrawal by Subject|0|||
130181911|NCT01962103|468624074|FG001|Phase 1|Withdrawal by Subject|0|||
130181912|NCT01962103|468624075|FG002|Phase 1|Withdrawal by Subject|0|||
130181913|NCT01962103|468624076|FG003|Phase 1|Withdrawal by Subject|2|||
130181914|NCT01962103|468624077|FG004|Phase 1|Withdrawal by Subject|0|||
130181915|NCT01962103|468624078|FG005|Phase 1|Withdrawal by Subject|0|||
130181916|NCT01962103|468624079|FG006|Phase 1|Withdrawal by Subject|0|||
130181917|NCT01962103|468624080|FG007|Phase 1|Withdrawal by Subject|0|||
130181918|NCT01962103|468624081|FG008|Phase 1|Withdrawal by Subject|0|||
130181919|NCT01962103|468624073|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
130181920|NCT01962103|468624074|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
130181921|NCT01962103|468624075|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
130181922|NCT01962103|468624076|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
130181923|NCT01962103|468624077|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
130181924|NCT01962103|468624078|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
130181925|NCT01962103|468624079|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
130181926|NCT01962103|468624080|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
130181927|NCT01962103|468624081|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
130181928|NCT01962103|468624073|FG000|Phase 1|Physician Decision|0|||
130181929|NCT01962103|468624074|FG001|Phase 1|Physician Decision|0|||
130181930|NCT01962103|468624075|FG002|Phase 1|Physician Decision|0|||
130181931|NCT01962103|468624076|FG003|Phase 1|Physician Decision|1|||
130181932|NCT01962103|468624077|FG004|Phase 1|Physician Decision|0|||
130181933|NCT01962103|468624078|FG005|Phase 1|Physician Decision|0|||
130181934|NCT01962103|468624079|FG006|Phase 1|Physician Decision|0|||
130181935|NCT01962103|468624080|FG007|Phase 1|Physician Decision|0|||
130181936|NCT01962103|468624081|FG008|Phase 1|Physician Decision|0|||
130181937|NCT01962103|468624073|FG000|Phase 1|Symptomatic Deterioration|3|||
130181938|NCT01962103|468624074|FG001|Phase 1|Symptomatic Deterioration|2|||
130181939|NCT01962103|468624075|FG002|Phase 1|Symptomatic Deterioration|2|||
130181940|NCT01962103|468624076|FG003|Phase 1|Symptomatic Deterioration|2|||
130181941|NCT01962103|468624077|FG004|Phase 1|Symptomatic Deterioration|1|||
130181942|NCT01962103|468624078|FG005|Phase 1|Symptomatic Deterioration|1|||
130181943|NCT01962103|468624079|FG006|Phase 1|Symptomatic Deterioration|0|||
129983768|NCT01305200|467902355|FG001|Overall Study|Death|2|||
129983769|NCT01305200|467902356|FG002|Overall Study|Death|0|||
130181944|NCT01962103|468624080|FG007|Phase 1|Symptomatic Deterioration|0|||
130181945|NCT01962103|468624081|FG008|Phase 1|Symptomatic Deterioration|0|||
130181946|NCT01962103|468624073|FG000|Phase 1|Miscellaneous|1|||
130181947|NCT01962103|468624074|FG001|Phase 1|Miscellaneous|0|||
130181948|NCT01962103|468624075|FG002|Phase 1|Miscellaneous|0|||
130181949|NCT01962103|468624076|FG003|Phase 1|Miscellaneous|0|||
130181950|NCT01962103|468624077|FG004|Phase 1|Miscellaneous|0|||
130181951|NCT01962103|468624078|FG005|Phase 1|Miscellaneous|0|||
130181952|NCT01962103|468624079|FG006|Phase 1|Miscellaneous|0|||
130181953|NCT01962103|468624080|FG007|Phase 1|Miscellaneous|0|||
130181954|NCT01962103|468624081|FG008|Phase 1|Miscellaneous|0|||
130181955|NCT01962103|468624073|FG000|Phase 2|Adverse Event|0|||
130181956|NCT01962103|468624074|FG001|Phase 2|Adverse Event|0|||
130181957|NCT01962103|468624075|FG002|Phase 2|Adverse Event|0|||
130181958|NCT01962103|468624076|FG003|Phase 2|Adverse Event|0|||
130181959|NCT01962103|468624077|FG004|Phase 2|Adverse Event|0|||
130181960|NCT01962103|468624078|FG005|Phase 2|Adverse Event|0|||
130181961|NCT01962103|468624079|FG006|Phase 2|Adverse Event|1|||
130181962|NCT01962103|468624080|FG007|Phase 2|Adverse Event|0|||
130181963|NCT01962103|468624081|FG008|Phase 2|Adverse Event|3|||
130181964|NCT01962103|468624073|FG000|Phase 2|Progressive Disease|0|||
130181965|NCT01962103|468624074|FG001|Phase 2|Progressive Disease|0|||
130181966|NCT01962103|468624075|FG002|Phase 2|Progressive Disease|0|||
130181967|NCT01962103|468624076|FG003|Phase 2|Progressive Disease|0|||
130181968|NCT01962103|468624077|FG004|Phase 2|Progressive Disease|0|||
130181969|NCT01962103|468624078|FG005|Phase 2|Progressive Disease|0|||
130181970|NCT01962103|468624079|FG006|Phase 2|Progressive Disease|11|||
130181971|NCT01962103|468624080|FG007|Phase 2|Progressive Disease|12|||
130181972|NCT01962103|468624081|FG008|Phase 2|Progressive Disease|11|||
130181973|NCT01962103|468624073|FG000|Phase 2|Symptomatic Deterioration|0|||
130181974|NCT01962103|468624074|FG001|Phase 2|Symptomatic Deterioration|0|||
130181975|NCT01962103|468624075|FG002|Phase 2|Symptomatic Deterioration|0|||
130181976|NCT01962103|468624076|FG003|Phase 2|Symptomatic Deterioration|0|||
130181977|NCT01962103|468624077|FG004|Phase 2|Symptomatic Deterioration|0|||
130181978|NCT01962103|468624078|FG005|Phase 2|Symptomatic Deterioration|0|||
130181979|NCT01962103|468624079|FG006|Phase 2|Symptomatic Deterioration|2|||
130181980|NCT01962103|468624080|FG007|Phase 2|Symptomatic Deterioration|2|||
130181981|NCT01962103|468624081|FG008|Phase 2|Symptomatic Deterioration|0|||
130181982|NCT01321749|468624082|FG000|Overall Study|Lost to Follow-up|4|||
130181983|NCT01321749|468624083|FG001|Overall Study|Lost to Follow-up|11|||
130181984|NCT01321749|468624082|FG000|Overall Study|Protocol Violation|4|||
130181985|NCT01321749|468624083|FG001|Overall Study|Protocol Violation|7|||
130181986|NCT01321749|468624082|FG000|Overall Study|Withdrawal by Subject|5|||
130181987|NCT01321749|468624083|FG001|Overall Study|Withdrawal by Subject|4|||
130181988|NCT04179838|468624087|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
130181989|NCT04179838|468624088|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
130181990|NCT04179838|468624087|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
130181991|NCT04179838|468624088|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
130181992|NCT01290068|468624093|FG000|Overall Study|Adverse Event|1|||
130181993|NCT01290068|468624094|FG001|Overall Study|Adverse Event|3|||
130181994|NCT01290068|468624093|FG000|Overall Study|Lost to Follow-up|3|||
130181995|NCT01290068|468624094|FG001|Overall Study|Lost to Follow-up|0|||
130181996|NCT01290068|468624093|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
130181997|NCT01290068|468624094|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
130181998|NCT01290068|468624093|FG000|Overall Study|Other|3|||
130181999|NCT01290068|468624094|FG001|Overall Study|Other|1|||
130182000|NCT00513695|468624095|FG000|Overall Study|Discontinued therapy|2|||
130182001|NCT00513695|468624095|FG000|Overall Study|Progression prior to surgery|3|||
130182002|NCT01417156|468624102|FG000|Overall Study|Adverse Event|12|||
130182003|NCT01417156|468624102|FG000|Overall Study|Protocol Violation|2|||
130182004|NCT00818766|468624105|FG000|Overall Study|Could not be Contacted on Day 28|11|||
130182005|NCT00818766|468624106|FG001|Overall Study|Could not be Contacted on Day 28|10|||
130182006|NCT00818766|468624105|FG000|Overall Study|Death|1|||
130182007|NCT00818766|468624106|FG001|Overall Study|Death|0|||
130182008|NCT00818766|468624105|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
130182009|NCT00818766|468624106|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
130182010|NCT00086684|468624107|FG000|Overall Study|Adverse Event|12|||
130182011|NCT00086684|468624108|FG001|Overall Study|Adverse Event|17|||
130182012|NCT00086684|468624109|FG002|Overall Study|Adverse Event|14|||
130182013|NCT00086684|468624107|FG000|Overall Study|Lack of Efficacy|6|||
130182014|NCT00086684|468624108|FG001|Overall Study|Lack of Efficacy|6|||
130182015|NCT00086684|468624109|FG002|Overall Study|Lack of Efficacy|5|||
130182016|NCT00086684|468624107|FG000|Overall Study|Lost to Follow-up|15|||
130182017|NCT00086684|468624108|FG001|Overall Study|Lost to Follow-up|8|||
130182018|NCT00086684|468624109|FG002|Overall Study|Lost to Follow-up|10|||
130182019|NCT00086684|468624107|FG000|Overall Study|Protocol Violation|8|||
130182020|NCT00086684|468624108|FG001|Overall Study|Protocol Violation|3|||
130182021|NCT00086684|468624109|FG002|Overall Study|Protocol Violation|0|||
130182022|NCT00086684|468624107|FG000|Overall Study|Withdrawal by Subject|0|||
130182023|NCT00086684|468624108|FG001|Overall Study|Withdrawal by Subject|4|||
130182024|NCT00086684|468624109|FG002|Overall Study|Withdrawal by Subject|10|||
130182025|NCT00086684|468624107|FG000|Overall Study|NONCOMPLIANCE|5|||
130182026|NCT00086684|468624108|FG001|Overall Study|NONCOMPLIANCE|7|||
130182027|NCT00086684|468624109|FG002|Overall Study|NONCOMPLIANCE|6|||
130182028|NCT00086684|468624107|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130182029|NCT00086684|468624108|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
130182030|NCT00086684|468624109|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
130182031|NCT00086684|468624107|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
130182032|NCT00086684|468624108|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
130182033|NCT00086684|468624109|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
130182034|NCT00086684|468624107|FG000|Overall Study|Other|4|||
130182035|NCT00086684|468624108|FG001|Overall Study|Other|2|||
130182036|NCT00086684|468624109|FG002|Overall Study|Other|3|||
130182037|NCT00725491|468624119|FG000|Overall Study|Adverse Event|3|||
130182038|NCT00725491|468624120|FG001|Overall Study|Adverse Event|2|||
130182039|NCT00725491|468624119|FG000|Overall Study|Pregnancy|0|||
130182040|NCT00725491|468624120|FG001|Overall Study|Pregnancy|3|||
130182041|NCT00725491|468624119|FG000|Overall Study|Risk for hyperstimulation|2|||
130182042|NCT00725491|468624120|FG001|Overall Study|Risk for hyperstimulation|9|||
130182043|NCT00725491|468624119|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
130182044|NCT00725491|468624120|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
130182045|NCT00725491|468624119|FG000|Overall Study|Fertilization failure|0|||
130182046|NCT00725491|468624120|FG001|Overall Study|Fertilization failure|1|||
130182047|NCT00725491|468624119|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
130182048|NCT00725491|468624120|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
130182049|NCT03359850|468624125|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
130182050|NCT03359850|468624126|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
130182051|NCT03359850|468624125|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
130182052|NCT03359850|468624126|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
130182053|NCT03359850|468624125|FG000|Extension Phase (Up to 28 Months)|Death|2|||
130182054|NCT03359850|468624126|FG001|Extension Phase (Up to 28 Months)|Death|4|||
130182055|NCT03359850|468624125|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
130182056|NCT03359850|468624126|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
130182057|NCT03359850|468624125|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
130182058|NCT03359850|468624126|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
130182059|NCT00942357|468624134|FG000|Overall Study|Ineligible|37|||
130182060|NCT00942357|468624135|FG001|Overall Study|Ineligible|40|||
130182061|NCT00882518|468624136|FG000|Overall Study|Adverse Event|9|||
130182062|NCT00882518|468624137|FG001|Overall Study|Adverse Event|18|||
130182063|NCT00882518|468624136|FG000|Overall Study|Withdrawal by Subject|9|||
130182064|NCT00882518|468624137|FG001|Overall Study|Withdrawal by Subject|13|||
130182065|NCT00882518|468624136|FG000|Overall Study|Lack of Efficacy|12|||
130182066|NCT00882518|468624137|FG001|Overall Study|Lack of Efficacy|9|||
130182067|NCT00882518|468624136|FG000|Overall Study|Severe non-compliance to protocol|3|||
130182068|NCT00882518|468624137|FG001|Overall Study|Severe non-compliance to protocol|1|||
130182069|NCT00882518|468624136|FG000|Overall Study|Incorrect enrolment|4|||
130182070|NCT00882518|468624137|FG001|Overall Study|Incorrect enrolment|2|||
130182071|NCT00882518|468624136|FG000|Overall Study|Central lab closure for National day|1|||
130182072|NCT00882518|468624137|FG001|Overall Study|Central lab closure for National day|0|||
130182073|NCT00882518|468624136|FG000|Overall Study|Allocating random number by mistake|0|||
130182074|NCT00882518|468624137|FG001|Overall Study|Allocating random number by mistake|1|||
130182075|NCT02137252|468624138|FG000|Overall Study|trial terminated early|2|||
130182076|NCT02137252|468624139|FG001|Overall Study|trial terminated early|1|||
130182077|NCT04421131|468624142|FG000|Overall Study|Lost to Follow-up|1|||
130182078|NCT04421131|468624142|FG000|Overall Study|Protocol Violation|2|||
130182079|NCT04421131|468624142|FG000|Overall Study|App crashed|5|||
130182080|NCT00729937|468624143|FG000|Overall Study|Lost to Follow-up|49|||
130182081|NCT00729937|468624144|FG001|Overall Study|Lost to Follow-up|58|||
130182082|NCT00729937|468624145|FG002|Overall Study|Lost to Follow-up|18|||
130182083|NCT00729937|468624146|FG003|Overall Study|Lost to Follow-up|33|||
130182084|NCT00729937|468624147|FG004|Overall Study|Lost to Follow-up|18|||
130182085|NCT00729937|468624148|FG005|Overall Study|Lost to Follow-up|23|||
130182086|NCT00729937|468624143|FG000|Overall Study|Physician Decision|7|||
130182087|NCT00729937|468624144|FG001|Overall Study|Physician Decision|16|||
130182088|NCT00729937|468624145|FG002|Overall Study|Physician Decision|2|||
130182089|NCT00729937|468624146|FG003|Overall Study|Physician Decision|0|||
130182090|NCT00729937|468624147|FG004|Overall Study|Physician Decision|5|||
130182091|NCT00729937|468624148|FG005|Overall Study|Physician Decision|8|||
130182092|NCT00729937|468624143|FG000|Overall Study|Death|1|||
130182093|NCT00729937|468624144|FG001|Overall Study|Death|0|||
130182094|NCT00729937|468624145|FG002|Overall Study|Death|1|||
130182095|NCT00729937|468624146|FG003|Overall Study|Death|0|||
130182096|NCT00729937|468624147|FG004|Overall Study|Death|0|||
130182097|NCT00729937|468624148|FG005|Overall Study|Death|1|||
130182098|NCT00729937|468624143|FG000|Overall Study|Withdrawal by Subject|3|||
130182099|NCT00729937|468624144|FG001|Overall Study|Withdrawal by Subject|5|||
130182100|NCT00729937|468624145|FG002|Overall Study|Withdrawal by Subject|6|||
130182101|NCT00729937|468624146|FG003|Overall Study|Withdrawal by Subject|0|||
130182102|NCT00729937|468624147|FG004|Overall Study|Withdrawal by Subject|4|||
130182103|NCT00729937|468624148|FG005|Overall Study|Withdrawal by Subject|2|||
130182104|NCT00729937|468624143|FG000|Overall Study|Randomized but not treated|12|||
130182105|NCT00729937|468624144|FG001|Overall Study|Randomized but not treated|6|||
130182106|NCT00729937|468624145|FG002|Overall Study|Randomized but not treated|1|||
130182107|NCT00729937|468624146|FG003|Overall Study|Randomized but not treated|0|||
130182108|NCT00729937|468624147|FG004|Overall Study|Randomized but not treated|1|||
130182109|NCT00729937|468624148|FG005|Overall Study|Randomized but not treated|3|||
130182110|NCT00729937|468624143|FG000|Overall Study|Did not meet eligibility criteria|2|||
130182111|NCT00729937|468624144|FG001|Overall Study|Did not meet eligibility criteria|1|||
130182112|NCT00729937|468624145|FG002|Overall Study|Did not meet eligibility criteria|0|||
130182113|NCT00729937|468624146|FG003|Overall Study|Did not meet eligibility criteria|0|||
130182114|NCT00729937|468624147|FG004|Overall Study|Did not meet eligibility criteria|0|||
130182115|NCT00729937|468624148|FG005|Overall Study|Did not meet eligibility criteria|0|||
130182116|NCT00729937|468624143|FG000|Overall Study|Incarcerated|0|||
130182117|NCT00729937|468624144|FG001|Overall Study|Incarcerated|2|||
130182118|NCT00729937|468624145|FG002|Overall Study|Incarcerated|1|||
130182119|NCT00729937|468624146|FG003|Overall Study|Incarcerated|1|||
130182120|NCT00729937|468624147|FG004|Overall Study|Incarcerated|0|||
130182121|NCT00729937|468624148|FG005|Overall Study|Incarcerated|0|||
130182122|NCT00243412|468624149|FG000|Overall Study|Death|0|||
130182123|NCT00243412|468624150|FG001|Overall Study|Death|1|||
130182124|NCT00243412|468624149|FG000|Overall Study|Adverse Event|4|||
130182125|NCT00243412|468624150|FG001|Overall Study|Adverse Event|2|||
130182126|NCT00243412|468624149|FG000|Overall Study|Lost to Follow-up|0|||
130182127|NCT00243412|468624150|FG001|Overall Study|Lost to Follow-up|1|||
130182128|NCT00243412|468624149|FG000|Overall Study|Physician Decision|1|||
130182129|NCT00243412|468624150|FG001|Overall Study|Physician Decision|1|||
130182130|NCT00243412|468624149|FG000|Overall Study|Withdrawal by Subject|4|||
130182131|NCT00243412|468624150|FG001|Overall Study|Withdrawal by Subject|5|||
130182132|NCT00243412|468624149|FG000|Overall Study|Other|1|||
130182133|NCT00243412|468624150|FG001|Overall Study|Other|1|||
130182134|NCT03281876|468624159|FG000|Overall Study|Adverse Event|4|||
130182135|NCT03281876|468624160|FG001|Overall Study|Adverse Event|15|||
130182136|NCT03281876|468624159|FG000|Overall Study|Lost to Follow-up|1|||
130182137|NCT03281876|468624160|FG001|Overall Study|Lost to Follow-up|4|||
130182138|NCT03281876|468624159|FG000|Overall Study|Withdrawal by Subject|11|||
130182139|NCT03281876|468624160|FG001|Overall Study|Withdrawal by Subject|15|||
130182140|NCT03281876|468624159|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
130182141|NCT03281876|468624160|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
130182142|NCT03281876|468624159|FG000|Overall Study|OTHER|5|||
130182143|NCT03281876|468624160|FG001|Overall Study|OTHER|5|||
130182144|NCT02208089|468624161|FG000|Overall Study|Withdrawal by Subject|1|||
130182145|NCT02208089|468624162|FG001|Overall Study|Withdrawal by Subject|0|||
130182146|NCT02208089|468624161|FG000|Overall Study|Lost to Follow-up|6|||
130182147|NCT02208089|468624162|FG001|Overall Study|Lost to Follow-up|0|||
130182148|NCT00683657|468624165|FG000|Overall Study|Adverse Event|0|||
130182149|NCT00683657|468624166|FG001|Overall Study|Adverse Event|1|||
130182150|NCT00683657|468624165|FG000|Overall Study|Subject Withdrew Consent|1|||
130182151|NCT00683657|468624166|FG001|Overall Study|Subject Withdrew Consent|0|||
130182152|NCT01408043|468624172|FG000|Overall Study|unable to collect cells|1|||
130182153|NCT00972595|468624173|FG000|Period 1|Adverse Event|1|||
130182154|NCT00972595|468624174|FG001|Period 1|Adverse Event|0|||
130182155|NCT02552121|468624175|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
130182156|NCT02552121|468624176|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182157|NCT02552121|468624177|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182158|NCT02552121|468624178|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182159|NCT02552121|468624179|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182160|NCT02552121|468624180|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182161|NCT02552121|468624181|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182162|NCT02552121|468624182|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
130182163|NCT02552121|468624175|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
130182164|NCT02552121|468624176|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182165|NCT02552121|468624177|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182166|NCT02552121|468624178|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182167|NCT02552121|468624179|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182168|NCT02552121|468624180|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182169|NCT02552121|468624181|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182170|NCT02552121|468624182|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
130182171|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182172|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
130182173|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182174|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182175|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182176|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182177|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182178|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
130182179|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182180|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
130182181|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182182|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182183|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182184|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182185|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182186|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
130182187|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182188|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
130182189|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182190|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182191|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182192|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182193|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182194|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
130182195|NCT02552121|468624175|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182196|NCT02552121|468624176|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
130182197|NCT02552121|468624177|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182198|NCT02552121|468624178|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182199|NCT02552121|468624179|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182200|NCT02552121|468624180|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182201|NCT02552121|468624181|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182202|NCT02552121|468624182|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
130182203|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
130182204|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
130182205|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
130182206|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
130182207|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
130182208|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
130182209|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
130182210|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
130182211|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
130182212|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
130182213|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
130182214|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
130182215|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
130182216|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
130182217|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
130182218|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
130182219|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
130182220|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
130182221|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
130182222|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
130182223|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
130182224|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
130182225|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
130182226|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
130182227|NCT02552121|468624175|FG000|Part 2: Cohort Expansion|Death|0|||
130182228|NCT02552121|468624176|FG001|Part 2: Cohort Expansion|Death|0|||
130182229|NCT02552121|468624177|FG002|Part 2: Cohort Expansion|Death|1|||
130182230|NCT02552121|468624178|FG003|Part 2: Cohort Expansion|Death|0|||
130182231|NCT02552121|468624179|FG004|Part 2: Cohort Expansion|Death|0|||
130182232|NCT02552121|468624180|FG005|Part 2: Cohort Expansion|Death|0|||
130182233|NCT02552121|468624181|FG006|Part 2: Cohort Expansion|Death|0|||
130182234|NCT02552121|468624182|FG007|Part 2: Cohort Expansion|Death|0|||
130182235|NCT02586155|468624183|FG000|Overall Study|Adverse Event|2|||
130182236|NCT02586155|468624184|FG001|Overall Study|Adverse Event|3|||
130182237|NCT02586155|468624183|FG000|Overall Study|Withdrawal by Subject|31|||
130182238|NCT02586155|468624184|FG001|Overall Study|Withdrawal by Subject|24|||
130182239|NCT02586155|468624183|FG000|Overall Study|Lost to Follow-up|7|||
130182240|NCT02586155|468624184|FG001|Overall Study|Lost to Follow-up|13|||
130182241|NCT02586155|468624183|FG000|Overall Study|Death|61|||
130182242|NCT02586155|468624184|FG001|Overall Study|Death|72|||
130182243|NCT02586155|468624183|FG000|Overall Study|Other reasons|26|||
130182244|NCT02586155|468624184|FG001|Overall Study|Other reasons|15|||
130182245|NCT00739063|468624187|FG000|Overall Study|Screen failures|8|||
130182246|NCT04779879|468624188|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182247|NCT04779879|468624189|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182248|NCT04779879|468624190|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182249|NCT04779879|468624191|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
130182250|NCT04779879|468624192|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182251|NCT04779879|468624193|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
130182252|NCT04779879|468624188|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182253|NCT04779879|468624189|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182254|NCT04779879|468624190|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182255|NCT04779879|468624191|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
130182256|NCT04779879|468624192|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182257|NCT04779879|468624193|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
130182258|NCT04779879|468624188|FG000|Part C: Up to Week 36|Death|0|||
130182259|NCT04779879|468624189|FG001|Part C: Up to Week 36|Death|0|||
130182260|NCT04779879|468624190|FG002|Part C: Up to Week 36|Death|0|||
130182261|NCT04779879|468624191|FG003|Part C: Up to Week 36|Death|0|||
130182262|NCT04779879|468624192|FG004|Part C: Up to Week 36|Death|0|||
130182263|NCT04779879|468624193|FG005|Part C: Up to Week 36|Death|1|||
130182264|NCT04779879|468624188|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182265|NCT04779879|468624189|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182266|NCT04779879|468624190|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182267|NCT04779879|468624191|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
130182268|NCT04779879|468624192|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
130182269|NCT04779879|468624193|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
130182270|NCT02461160|468624194|FG000|Overall Study|Lost to Follow-up|0|||
130182271|NCT02461160|468624195|FG001|Overall Study|Lost to Follow-up|0|||
130182272|NCT02461160|468624196|FG002|Overall Study|Lost to Follow-up|0|||
130182273|NCT02461160|468624197|FG003|Overall Study|Lost to Follow-up|0|||
130182274|NCT02461160|468624198|FG004|Overall Study|Lost to Follow-up|0|||
130182275|NCT02461160|468624199|FG005|Overall Study|Lost to Follow-up|0|||
130182276|NCT02461160|468624200|FG006|Overall Study|Lost to Follow-up|0|||
130182277|NCT02461160|468624201|FG007|Overall Study|Lost to Follow-up|1|||
130182278|NCT02461160|468624202|FG008|Overall Study|Lost to Follow-up|0|||
130182279|NCT02461160|468624203|FG009|Overall Study|Lost to Follow-up|0|||
130182280|NCT02461160|468624204|FG010|Overall Study|Lost to Follow-up|0|||
130182281|NCT02461160|468624205|FG011|Overall Study|Lost to Follow-up|0|||
130182282|NCT02461160|468624206|FG012|Overall Study|Lost to Follow-up|0|||
130182283|NCT02854527|468624207|FG000|Overall Study|Adverse Event|0|||
130182284|NCT02854527|468624208|FG001|Overall Study|Adverse Event|0|||
130182285|NCT02854527|468624209|FG002|Overall Study|Adverse Event|0|||
130182286|NCT02854527|468624210|FG003|Overall Study|Adverse Event|0|||
130182287|NCT02854527|468624211|FG004|Overall Study|Adverse Event|1|||
130182288|NCT02854527|468624212|FG005|Overall Study|Adverse Event|0|||
130182289|NCT02854527|468624213|FG006|Overall Study|Adverse Event|0|||
130182290|NCT02854527|468624214|FG007|Overall Study|Adverse Event|0|||
130182291|NCT02854527|468624215|FG008|Overall Study|Adverse Event|0|||
130182292|NCT02854527|468624216|FG009|Overall Study|Adverse Event|0|||
130182293|NCT02854527|468624207|FG000|Overall Study|Lost to Follow-up|0|||
130182294|NCT02854527|468624208|FG001|Overall Study|Lost to Follow-up|0|||
130182295|NCT02854527|468624209|FG002|Overall Study|Lost to Follow-up|0|||
130182296|NCT02854527|468624210|FG003|Overall Study|Lost to Follow-up|1|||
130182297|NCT02854527|468624211|FG004|Overall Study|Lost to Follow-up|0|||
130182298|NCT02854527|468624212|FG005|Overall Study|Lost to Follow-up|0|||
130182299|NCT02854527|468624213|FG006|Overall Study|Lost to Follow-up|0|||
130182300|NCT02854527|468624214|FG007|Overall Study|Lost to Follow-up|0|||
130182301|NCT02854527|468624215|FG008|Overall Study|Lost to Follow-up|0|||
130182302|NCT02854527|468624216|FG009|Overall Study|Lost to Follow-up|0|||
130182303|NCT02899962|468624217|FG000|Open-label Phase|Adverse Event|2|||
130182304|NCT02899962|468624218|FG001|Open-label Phase|Adverse Event|0|||
130182305|NCT02899962|468624219|FG002|Open-label Phase|Adverse Event|0|||
130182306|NCT02899962|468624217|FG000|Open-label Phase|Lost to Follow-up|9|||
130182307|NCT02899962|468624218|FG001|Open-label Phase|Lost to Follow-up|0|||
130182308|NCT02899962|468624219|FG002|Open-label Phase|Lost to Follow-up|0|||
130182309|NCT02899962|468624217|FG000|Open-label Phase|Other reasons|9|||
130182310|NCT02899962|468624218|FG001|Open-label Phase|Other reasons|0|||
130182311|NCT02899962|468624219|FG002|Open-label Phase|Other reasons|0|||
130182312|NCT02899962|468624217|FG000|Open-label Phase|Withdrawal by Subject|7|||
130182313|NCT02899962|468624218|FG001|Open-label Phase|Withdrawal by Subject|0|||
130182314|NCT02899962|468624219|FG002|Open-label Phase|Withdrawal by Subject|0|||
130182315|NCT02899962|468624217|FG000|Maintenance Phase|Adverse Event|0|||
130182316|NCT02899962|468624218|FG001|Maintenance Phase|Adverse Event|2|||
130182317|NCT02899962|468624219|FG002|Maintenance Phase|Adverse Event|1|||
130182318|NCT02899962|468624217|FG000|Maintenance Phase|Death|0|||
130182319|NCT02899962|468624218|FG001|Maintenance Phase|Death|0|||
130182320|NCT02899962|468624219|FG002|Maintenance Phase|Death|1|||
130182321|NCT02899962|468624217|FG000|Maintenance Phase|Lack of Efficacy|0|||
130182322|NCT02899962|468624218|FG001|Maintenance Phase|Lack of Efficacy|20|||
130182323|NCT02899962|468624219|FG002|Maintenance Phase|Lack of Efficacy|16|||
130182324|NCT02899962|468624217|FG000|Maintenance Phase|Lost to Follow-up|0|||
130182325|NCT02899962|468624218|FG001|Maintenance Phase|Lost to Follow-up|12|||
130182326|NCT02899962|468624219|FG002|Maintenance Phase|Lost to Follow-up|14|||
130182327|NCT02899962|468624217|FG000|Maintenance Phase|Other reasons|0|||
130182328|NCT02899962|468624218|FG001|Maintenance Phase|Other reasons|9|||
130182329|NCT02899962|468624219|FG002|Maintenance Phase|Other reasons|13|||
130182330|NCT02899962|468624217|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
130182331|NCT02899962|468624218|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
130182332|NCT02899962|468624219|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
130182333|NCT02899962|468624217|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
130182334|NCT02899962|468624218|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
130182335|NCT02899962|468624219|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
130182336|NCT02899962|468624217|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130182337|NCT02899962|468624218|FG001|Maintenance Phase|Withdrawal by Subject|30|||
130182338|NCT02899962|468624219|FG002|Maintenance Phase|Withdrawal by Subject|36|||
130182339|NCT01821807|468624226|FG000|Overall Study|Lost to Follow-up|3|||
130182340|NCT01821807|468624227|FG001|Overall Study|Lost to Follow-up|1|||
130182341|NCT02633787|468624229|FG000|Overall Study|Withdrawal by Subject|1|||
130182342|NCT00550459|468624230|FG000|Overall Study|Adverse Event|0|||
130182343|NCT00550459|468624231|FG001|Overall Study|Adverse Event|2|||
130182344|NCT00550459|468624230|FG000|Overall Study|Withdrawal by Subject|1|||
130182345|NCT00550459|468624231|FG001|Overall Study|Withdrawal by Subject|1|||
130182346|NCT01742897|468624232|FG000|Overall Study|Adverse Event|3|||
130182347|NCT01742897|468624232|FG000|Overall Study|Withdrawal by Subject|1|||
130182348|NCT01742897|468624232|FG000|Overall Study|Other|1|||
130182349|NCT02404805|468624233|FG000|Overall Study|Withdrawal by Subject|1|||
130182350|NCT02404805|468624234|FG001|Overall Study|Withdrawal by Subject|0|||
130182351|NCT02404805|468624235|FG002|Overall Study|Withdrawal by Subject|0|||
130182352|NCT02404805|468624236|FG003|Overall Study|Withdrawal by Subject|0|||
130182353|NCT02404805|468624237|FG004|Overall Study|Withdrawal by Subject|0|||
130182354|NCT02404805|468624238|FG005|Overall Study|Withdrawal by Subject|0|||
130182355|NCT02456740|468624240|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130182356|NCT02456740|468624241|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130182357|NCT02456740|468624242|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
130182358|NCT02456740|468624243|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182359|NCT02456740|468624244|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182360|NCT02456740|468624245|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182361|NCT02456740|468624246|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182362|NCT02456740|468624247|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182363|NCT02456740|468624248|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
130182364|NCT02456740|468624240|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
130182365|NCT02456740|468624241|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
130182366|NCT02456740|468624242|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
130182367|NCT02456740|468624243|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182368|NCT02456740|468624244|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182369|NCT02456740|468624245|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182370|NCT02456740|468624246|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182371|NCT02456740|468624247|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182372|NCT02456740|468624248|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
130182373|NCT02456740|468624240|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
130182374|NCT02456740|468624241|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
130182375|NCT02456740|468624242|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
130182376|NCT02456740|468624243|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182377|NCT02456740|468624244|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182378|NCT02456740|468624245|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182379|NCT02456740|468624246|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182380|NCT02456740|468624247|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182381|NCT02456740|468624248|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
130182382|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182383|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182384|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182385|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
130182386|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
130182387|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182388|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182389|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
130182390|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
130182391|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130182392|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130182393|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
130182394|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
130182395|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
130182396|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
130182397|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
130182398|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
130182399|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
130182400|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182401|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182402|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182403|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182404|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182405|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182406|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182407|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
130182408|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
130182409|NCT02456740|468624240|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130182410|NCT02456740|468624241|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130182411|NCT02456740|468624242|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
130182412|NCT02456740|468624243|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
130182413|NCT02456740|468624244|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
130182414|NCT02456740|468624245|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
130182415|NCT02456740|468624246|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
130182416|NCT02456740|468624247|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
130182417|NCT02456740|468624248|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
130182418|NCT04720105|468624249|FG000|Overall Study|Lack of Efficacy|1|||
130182419|NCT04720105|468624249|FG000|Overall Study|Lost to Follow-up|1|||
130182420|NCT04720105|468624249|FG000|Overall Study|Withdrawal by Subject|3|||
130182421|NCT04871776|468624253|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
130182422|NCT04871776|468624254|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
130182423|NCT04871776|468624255|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
130182424|NCT04871776|468624253|FG000|Overall Study|Did not meet eligibility criteria|1|||
130182425|NCT04871776|468624254|FG001|Overall Study|Did not meet eligibility criteria|1|||
130182426|NCT04871776|468624255|FG002|Overall Study|Did not meet eligibility criteria|1|||
130182427|NCT04075487|468625670|FG000|Overall Study|Withdrawal by Subject|1|||
130182428|NCT02750618|468625673|FG000|Overall Study|Withdrawal by Subject|1|||
130182429|NCT02572570|468625679|FG000|Overall Study|Study Terminated|27|||
130182430|NCT02763046|468625680|FG000|Overall Study|Adverse Event|5|||
130182431|NCT02763046|468625681|FG001|Overall Study|Adverse Event|4|||
130182432|NCT02763046|468625682|FG002|Overall Study|Adverse Event|0|||
130182433|NCT02763046|468625680|FG000|Overall Study|Lack of Efficacy|1|||
130182434|NCT02763046|468625681|FG001|Overall Study|Lack of Efficacy|1|||
130182435|NCT02763046|468625682|FG002|Overall Study|Lack of Efficacy|3|||
130182436|NCT02763046|468625680|FG000|Overall Study|Physician Decision|1|||
130182437|NCT02763046|468625681|FG001|Overall Study|Physician Decision|0|||
130182438|NCT02763046|468625682|FG002|Overall Study|Physician Decision|1|||
130182439|NCT02763046|468625680|FG000|Overall Study|Subject/guardian decision|2|||
130182440|NCT02763046|468625681|FG001|Overall Study|Subject/guardian decision|0|||
130182441|NCT02763046|468625682|FG002|Overall Study|Subject/guardian decision|4|||
130182442|NCT01067105|468625683|FG000|Overall Study|Adverse Event|14|||
130182443|NCT01067105|468625683|FG000|Overall Study|Protocol Violation|48|||
130182444|NCT01067105|468625683|FG000|Overall Study|Withdrawal by Subject|36|||
130182445|NCT01067105|468625683|FG000|Overall Study|Lost to Follow-up|6|||
130182446|NCT01067105|468625683|FG000|Overall Study|Physician Decision|6|||
130182447|NCT01067105|468625683|FG000|Overall Study|Other|31|||
130182448|NCT02302833|468625686|FG000|Overall Study|Lost to Follow-up|3|||
130182449|NCT04878432|468625687|FG000|Overall Study|Adverse Event|1|||
130182450|NCT04878432|468625687|FG000|Overall Study|Death|2|||
130182451|NCT04878432|468625687|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
130182452|NCT04878432|468625687|FG000|Overall Study|Withdrawal by Subject|6|||
130182453|NCT04878432|468625687|FG000|Overall Study|Progressive Disease|7|||
130182454|NCT04878432|468625687|FG000|Overall Study|New Therapy for Study Indication|7|||
130182455|NCT04878432|468625687|FG000|Overall Study|Physician Decision|11|||
130182456|NCT05017246|468625688|FG000|Overall Study|Withdrawal by Subject|5|||
130182457|NCT05017246|468625689|FG001|Overall Study|Withdrawal by Subject|3|||
130182458|NCT05017246|468625688|FG000|Overall Study|Determined to be ineligible|0|||
130182459|NCT05017246|468625689|FG001|Overall Study|Determined to be ineligible|1|||
130182460|NCT05017246|468625688|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
130182461|NCT05017246|468625689|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
130182462|NCT05017246|468625688|FG000|Overall Study|Technical failure|1|||
130182463|NCT05017246|468625689|FG001|Overall Study|Technical failure|3|||
130182464|NCT01495000|468625690|FG000|Overall Study|Lost to Follow-up|2|||
130182465|NCT01495000|468625691|FG001|Overall Study|Lost to Follow-up|2|||
130182466|NCT01495000|468625690|FG000|Overall Study|Protocol Violation|1|||
130182467|NCT01495000|468625691|FG001|Overall Study|Protocol Violation|0|||
130182468|NCT01495000|468625690|FG000|Overall Study|Withdrawal by Subject|10|||
130182469|NCT01495000|468625691|FG001|Overall Study|Withdrawal by Subject|10|||
130182470|NCT01514461|468625692|FG000|Overall Study|Adverse Event|2|||
130182471|NCT01514461|468625693|FG001|Overall Study|Adverse Event|1|||
130182472|NCT01514461|468625694|FG002|Overall Study|Adverse Event|3|||
130182473|NCT01514461|468625692|FG000|Overall Study|Physician Decision|1|||
130182474|NCT01514461|468625693|FG001|Overall Study|Physician Decision|1|||
130182475|NCT01514461|468625694|FG002|Overall Study|Physician Decision|0|||
130182476|NCT01514461|468625692|FG000|Overall Study|Patient/guardian decision|1|||
130182477|NCT01514461|468625693|FG001|Overall Study|Patient/guardian decision|1|||
130182478|NCT01514461|468625694|FG002|Overall Study|Patient/guardian decision|1|||
130182479|NCT01514461|468625692|FG000|Overall Study|Death|1|||
130182480|NCT01514461|468625693|FG001|Overall Study|Death|0|||
130182481|NCT01514461|468625694|FG002|Overall Study|Death|0|||
130182482|NCT03499067|468625695|FG000|First Intervention|Physician Decision|2|||
130182483|NCT03499067|468625696|FG001|First Intervention|Physician Decision|1|||
130182484|NCT03499067|468625695|FG000|First Intervention|Withdrawal by Subject|3|||
130182485|NCT03499067|468625696|FG001|First Intervention|Withdrawal by Subject|6|||
130182486|NCT02548832|468625697|FG000|Overall Study|Lost to Follow-up|2|||
130182487|NCT02548832|468625698|FG001|Overall Study|Lost to Follow-up|2|||
130182488|NCT02548832|468625699|FG002|Overall Study|Lost to Follow-up|2|||
130182489|NCT03565900|468625700|FG000|Overall Study|Disposition Unknown|4|||
130182490|NCT03565900|468625701|FG001|Overall Study|Disposition Unknown|1|||
130182491|NCT03565900|468625700|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130182492|NCT03565900|468625701|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
130182493|NCT03565900|468625700|FG000|Overall Study|Withdrawal by Subject|4|||
130182494|NCT03565900|468625701|FG001|Overall Study|Withdrawal by Subject|5|||
130182495|NCT03565900|468625700|FG000|Overall Study|Randomized By Mistake|0|||
130182496|NCT03565900|468625701|FG001|Overall Study|Randomized By Mistake|2|||
130182497|NCT03565900|468625700|FG000|Overall Study|Physician Decision|7|||
130182498|NCT03565900|468625701|FG001|Overall Study|Physician Decision|11|||
130182499|NCT03565900|468625700|FG000|Overall Study|Death|9|||
130182500|NCT03565900|468625701|FG001|Overall Study|Death|7|||
130182501|NCT01960257|468625707|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
130182502|NCT01960257|468625708|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
130182503|NCT01960257|468625709|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
130182504|NCT01960257|468625707|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
130182505|NCT01960257|468625708|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
130182506|NCT01960257|468625709|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
130182507|NCT01960257|468625707|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
130182508|NCT01960257|468625708|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
130182509|NCT01960257|468625709|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
130182510|NCT02002221|468625710|FG000|Overall Study|Adverse Event|2|||
130182511|NCT02002221|468625711|FG001|Overall Study|Adverse Event|1|||
130182512|NCT02002221|468625710|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
130182513|NCT02002221|468625711|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
130182514|NCT02002221|468625710|FG000|Overall Study|Patient withdrew consent|0|||
130182515|NCT02002221|468625711|FG001|Overall Study|Patient withdrew consent|1|||
130182516|NCT03347110|468625712|FG000|Overall Study|Other (Participant is incarcerated)|1|||
130182517|NCT03347110|468625712|FG000|Overall Study|Withdrawal by Subject|9|||
130182518|NCT03347110|468625712|FG000|Overall Study|Lost to Follow-up|1|||
130182519|NCT03347110|468625712|FG000|Overall Study|Lack of Efficacy|2|||
130182520|NCT03347110|468625712|FG000|Overall Study|Adverse Event, non-fatal|9|||
130182521|NCT02105467|468625715|FG000|Period 1|Lost to Follow-up|1|||
130182522|NCT02105467|468625716|FG001|Period 1|Lost to Follow-up|0|||
130182523|NCT02105467|468625715|FG000|Period 1|Death|1|||
130182524|NCT02105467|468625716|FG001|Period 1|Death|0|||
130182525|NCT02105467|468625715|FG000|Period 2|Lost to Follow-up|1|||
130182526|NCT02105467|468625716|FG001|Period 2|Lost to Follow-up|0|||
130182527|NCT02105467|468625715|FG000|Period 2|Death|1|||
130182528|NCT02105467|468625716|FG001|Period 2|Death|0|||
130182529|NCT02105467|468625715|FG000|Period 2|Withdrawal by Subject|0|||
130182530|NCT02105467|468625716|FG001|Period 2|Withdrawal by Subject|2|||
130182531|NCT02105467|468625715|FG000|Period 3|Lost to Follow-up|0|||
130182532|NCT02105467|468625716|FG001|Period 3|Lost to Follow-up|1|||
130182533|NCT01518322|468625718|FG000|Overall Study|FeNO measurement was missing|13|||
130182534|NCT02792517|468625723|FG000|Overall Study|Withdrawal by Subject|10|||
130182535|NCT02792517|468625723|FG000|Overall Study|Decision by Sponsor|7|||
130182536|NCT02792517|468625723|FG000|Overall Study|Lost to Follow-up|3|||
130182537|NCT00856193|468625726|FG000|Period 2|Abnormal test procedure results|0|||
130182538|NCT00856193|468625727|FG001|Period 2|Abnormal test procedure results|1|||
130182539|NCT00856193|468625726|FG000|Period 2|Lost to Follow-up|0|||
130182540|NCT00856193|468625727|FG001|Period 2|Lost to Follow-up|1|||
130182541|NCT02766335|468625729|FG000|Initial Registration|Adverse Event|6|||
130182542|NCT02766335|468625730|FG001|Initial Registration|Adverse Event|3|||
130182543|NCT02766335|468625731|FG002|Initial Registration|Adverse Event|0|||
130182544|NCT02766335|468625729|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
130182545|NCT02766335|468625730|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
130182546|NCT02766335|468625731|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
130182547|NCT02766335|468625729|FG000|Initial Registration|Progression/relapse|49|||
130182548|NCT02766335|468625730|FG001|Initial Registration|Progression/relapse|15|||
130182549|NCT02766335|468625731|FG002|Initial Registration|Progression/relapse|0|||
130182550|NCT02766335|468625729|FG000|Initial Registration|Death|1|||
130182551|NCT02766335|468625730|FG001|Initial Registration|Death|3|||
130182552|NCT02766335|468625731|FG002|Initial Registration|Death|0|||
130182553|NCT02766335|468625729|FG000|Initial Registration|not protocol specified|1|||
130182554|NCT02766335|468625730|FG001|Initial Registration|not protocol specified|9|||
130182555|NCT02766335|468625731|FG002|Initial Registration|not protocol specified|0|||
130182556|NCT02766335|468625729|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
130182557|NCT02766335|468625730|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
130182558|NCT02766335|468625731|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
130182559|NCT02766335|468625729|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
130182560|NCT02766335|468625730|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
130182561|NCT02766335|468625731|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
130182562|NCT03164551|468625745|FG000|Overall Study|Imaging discontinued prior completion|8|||
130182563|NCT03164551|468625746|FG001|Overall Study|Imaging discontinued prior completion|0|||
130182564|NCT03164551|468625745|FG000|Overall Study|Participant was non-compliant|1|||
130182565|NCT03164551|468625746|FG001|Overall Study|Participant was non-compliant|0|||
130182566|NCT03164551|468625745|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
130182567|NCT03164551|468625746|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
130182568|NCT03164551|468625745|FG000|Overall Study|Other|8|||
130182569|NCT03164551|468625746|FG001|Overall Study|Other|2|||
130182570|NCT01515423|468625747|FG000|Open Label Phase|Adverse Event|57|||
130182571|NCT01515423|468625748|FG001|Open Label Phase|Adverse Event|0|||
130182572|NCT01515423|468625749|FG002|Open Label Phase|Adverse Event|0|||
130182573|NCT01515423|468625747|FG000|Open Label Phase|Death|2|||
130182574|NCT01515423|468625748|FG001|Open Label Phase|Death|0|||
130182575|NCT01515423|468625749|FG002|Open Label Phase|Death|0|||
130182576|NCT01515423|468625747|FG000|Open Label Phase|Lack of Efficacy|117|||
130182577|NCT01515423|468625748|FG001|Open Label Phase|Lack of Efficacy|0|||
130182578|NCT01515423|468625749|FG002|Open Label Phase|Lack of Efficacy|0|||
130182579|NCT01515423|468625747|FG000|Open Label Phase|Lost to Follow-up|21|||
130182580|NCT01515423|468625748|FG001|Open Label Phase|Lost to Follow-up|0|||
130182581|NCT01515423|468625749|FG002|Open Label Phase|Lost to Follow-up|0|||
130182582|NCT01515423|468625747|FG000|Open Label Phase|Withdrawal by Subject|118|||
130182583|NCT01515423|468625748|FG001|Open Label Phase|Withdrawal by Subject|0|||
130182584|NCT01515423|468625749|FG002|Open Label Phase|Withdrawal by Subject|0|||
130182585|NCT01515423|468625747|FG000|Open Label Phase|excluded from DB Phase|70|||
130182586|NCT01515423|468625748|FG001|Open Label Phase|excluded from DB Phase|0|||
130182587|NCT01515423|468625749|FG002|Open Label Phase|excluded from DB Phase|0|||
130182588|NCT01515423|468625747|FG000|Open Label Phase|Other|28|||
130182589|NCT01515423|468625748|FG001|Open Label Phase|Other|0|||
130182590|NCT01515423|468625749|FG002|Open Label Phase|Other|0|||
130182591|NCT01515423|468625747|FG000|DOUBLE BLIND|Adverse Event|0|||
130182592|NCT01515423|468625748|FG001|DOUBLE BLIND|Adverse Event|15|||
130182593|NCT01515423|468625749|FG002|DOUBLE BLIND|Adverse Event|13|||
130182594|NCT01515423|468625747|FG000|DOUBLE BLIND|Death|0|||
130182595|NCT01515423|468625748|FG001|DOUBLE BLIND|Death|1|||
130182596|NCT01515423|468625749|FG002|DOUBLE BLIND|Death|2|||
130182597|NCT01515423|468625747|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
130182598|NCT01515423|468625748|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
130182599|NCT01515423|468625749|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
130182600|NCT01515423|468625747|FG000|DOUBLE BLIND|Pregnancy|0|||
130182601|NCT01515423|468625748|FG001|DOUBLE BLIND|Pregnancy|2|||
130182602|NCT01515423|468625749|FG002|DOUBLE BLIND|Pregnancy|0|||
130182603|NCT01515423|468625747|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
130182604|NCT01515423|468625748|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
130182605|NCT01515423|468625749|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
130182606|NCT01515423|468625747|FG000|DOUBLE BLIND|Other|0|||
130182607|NCT01515423|468625748|FG001|DOUBLE BLIND|Other|6|||
130182608|NCT01515423|468625749|FG002|DOUBLE BLIND|Other|12|||
130182609|NCT01515423|468625747|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
130182610|NCT01515423|468625748|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
130182611|NCT01515423|468625749|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
130182612|NCT01125917|468625754|FG000|Overall Study|Adverse Event|43|||
130182613|NCT01125917|468625754|FG000|Overall Study|Lost to Follow-up|23|||
130182614|NCT01125917|468625754|FG000|Overall Study|Withdrawal by Subject|31|||
130182615|NCT01125917|468625754|FG000|Overall Study|Administrative|223|||
130182616|NCT01125917|468625754|FG000|Overall Study|Lack of Efficacy|19|||
130182617|NCT02501928|468625756|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130182618|NCT02501928|468625757|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
130182619|NCT02501928|468625758|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
130182620|NCT02501928|468625759|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
130182621|NCT02501928|468625760|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
130182622|NCT02501928|468625761|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
130182623|NCT00838526|468625769|FG000|Overall Study|Adverse Event|3|||
130182624|NCT00838526|468625770|FG001|Overall Study|Adverse Event|12|||
130182625|NCT00838526|468625769|FG000|Overall Study|Lost to Follow-up|4|||
130182626|NCT00838526|468625770|FG001|Overall Study|Lost to Follow-up|12|||
130182627|NCT00838526|468625769|FG000|Overall Study|Withdrawal by Subject|4|||
130182628|NCT00838526|468625770|FG001|Overall Study|Withdrawal by Subject|5|||
130182629|NCT00838526|468625769|FG000|Overall Study|Lack of Efficacy|2|||
130182630|NCT00838526|468625770|FG001|Overall Study|Lack of Efficacy|3|||
130182631|NCT00838526|468625769|FG000|Overall Study|Other|11|||
130182632|NCT00838526|468625770|FG001|Overall Study|Other|7|||
130182633|NCT01320293|468625771|FG000|Overall Study|Lack of Efficacy|1|||
130182634|NCT01320293|468625771|FG000|Overall Study|Adverse Event|1|||
130182635|NCT00931411|468625772|FG000|First Intervention - 42 Days|Adverse Event|2|||
130182636|NCT00931411|468625773|FG001|First Intervention - 42 Days|Adverse Event|3|||
130182637|NCT00931411|468625772|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
130182638|NCT00931411|468625773|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
130182639|NCT00931411|468625772|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
130182640|NCT00931411|468625773|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
130182641|NCT03483012|468625776|FG000|Overall Study|Lack of Efficacy|6|||
130182642|NCT04782076|468625777|FG000|Overall Study|Family Emergency|1|||
130182643|NCT01949662|468625788|FG000|Overall Study|Death|9|||
130182644|NCT01949662|468625789|FG001|Overall Study|Death|7|||
130182645|NCT01949662|468625788|FG000|Overall Study|Discharged before an agitation event|8|||
130182646|NCT01949662|468625789|FG001|Overall Study|Discharged before an agitation event|3|||
130182647|NCT01949662|468625788|FG000|Overall Study|Dropped out|1|||
130182648|NCT01949662|468625789|FG001|Overall Study|Dropped out|3|||
130182649|NCT01949662|468625788|FG000|Overall Study|Ineligible|0|||
130182650|NCT01949662|468625789|FG001|Overall Study|Ineligible|1|||
130182651|NCT04135937|468625791|FG000|Overall Study|Lost to Follow-up|2|||
130182652|NCT04135937|468625791|FG000|Overall Study|Withdrawal by Subject|1|||
130182653|NCT00856492|468625794|FG000|Overall Study|Ineligible or withdrew consent|1|||
130182654|NCT00856492|468625795|FG001|Overall Study|Ineligible or withdrew consent|1|||
130182655|NCT00856492|468625796|FG002|Overall Study|Ineligible or withdrew consent|2|||
130182656|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
130182657|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
130182658|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
130182659|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
130182660|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
130182661|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
130182662|NCT00955617|468625799|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
130182663|NCT00955617|468625800|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
130182664|NCT00070564|468626874|FG000|Overall Study|Progression|2|||
130182665|NCT00070564|468626875|FG001|Overall Study|Progression|4|||
130182666|NCT00070564|468626876|FG002|Overall Study|Progression|7|||
130182667|NCT00070564|468626877|FG003|Overall Study|Progression|7|||
130182668|NCT00070564|468626878|FG004|Overall Study|Progression|1|||
130182669|NCT00070564|468626879|FG005|Overall Study|Progression|0|||
130182670|NCT00070564|468626874|FG000|Overall Study|Delinquent|1|||
130182671|NCT00070564|468626875|FG001|Overall Study|Delinquent|4|||
130182672|NCT00070564|468626876|FG002|Overall Study|Delinquent|2|||
130182673|NCT00070564|468626877|FG003|Overall Study|Delinquent|0|||
130182674|NCT00070564|468626878|FG004|Overall Study|Delinquent|0|||
130182675|NCT00070564|468626879|FG005|Overall Study|Delinquent|0|||
130182676|NCT00070564|468626874|FG000|Overall Study|Adverse Event|150|||
130182677|NCT00070564|468626875|FG001|Overall Study|Adverse Event|142|||
130182678|NCT00070564|468626876|FG002|Overall Study|Adverse Event|120|||
130182679|NCT00070564|468626877|FG003|Overall Study|Adverse Event|108|||
130182680|NCT00070564|468626878|FG004|Overall Study|Adverse Event|63|||
130182681|NCT00070564|468626879|FG005|Overall Study|Adverse Event|36|||
130182682|NCT00070564|468626874|FG000|Overall Study|Death|4|||
130182683|NCT00070564|468626875|FG001|Overall Study|Death|1|||
130182684|NCT00070564|468626876|FG002|Overall Study|Death|5|||
130182685|NCT00070564|468626877|FG003|Overall Study|Death|3|||
130182686|NCT00070564|468626878|FG004|Overall Study|Death|0|||
130182687|NCT00070564|468626879|FG005|Overall Study|Death|1|||
130182688|NCT00070564|468626874|FG000|Overall Study|Other, not protocol specified|17|||
130182689|NCT00070564|468626875|FG001|Overall Study|Other, not protocol specified|15|||
130182690|NCT00070564|468626876|FG002|Overall Study|Other, not protocol specified|14|||
130182691|NCT00070564|468626877|FG003|Overall Study|Other, not protocol specified|19|||
130182692|NCT00070564|468626878|FG004|Overall Study|Other, not protocol specified|6|||
130182693|NCT00070564|468626879|FG005|Overall Study|Other, not protocol specified|7|||
130182694|NCT00070564|468626874|FG000|Overall Study|Withdrawal by Subject|26|||
130182695|NCT00070564|468626875|FG001|Overall Study|Withdrawal by Subject|37|||
130182696|NCT00070564|468626876|FG002|Overall Study|Withdrawal by Subject|23|||
130182697|NCT00070564|468626877|FG003|Overall Study|Withdrawal by Subject|30|||
130182698|NCT00070564|468626878|FG004|Overall Study|Withdrawal by Subject|8|||
130182699|NCT00070564|468626879|FG005|Overall Study|Withdrawal by Subject|8|||
130182700|NCT00070564|468626874|FG000|Overall Study|Not reported|0|||
130182701|NCT00070564|468626875|FG001|Overall Study|Not reported|0|||
130182702|NCT00070564|468626876|FG002|Overall Study|Not reported|0|||
130182703|NCT00070564|468626877|FG003|Overall Study|Not reported|0|||
130182704|NCT00070564|468626878|FG004|Overall Study|Not reported|1|||
130182705|NCT00070564|468626879|FG005|Overall Study|Not reported|0|||
130182706|NCT00931528|468626880|FG000|Overall Study|Protocol Violation|9|||
130182707|NCT00931528|468626881|FG001|Overall Study|Protocol Violation|12|||
130182708|NCT00931528|468626880|FG000|Overall Study|Withdrawal by Subject|4|||
130182709|NCT00931528|468626881|FG001|Overall Study|Withdrawal by Subject|12|||
130182710|NCT00931528|468626880|FG000|Overall Study|Lost to Follow-up|6|||
130182711|NCT00931528|468626881|FG001|Overall Study|Lost to Follow-up|13|||
130182712|NCT00931528|468626880|FG000|Overall Study|Assessment outside of Time Frame|22|||
130182713|NCT00931528|468626881|FG001|Overall Study|Assessment outside of Time Frame|23|||
130182714|NCT02115269|468626882|FG000|Overall Study|Lost to Follow-up|43|||
130182715|NCT02115269|468626882|FG000|Overall Study|Did not complete patient diary|3|||
130182716|NCT02115269|468626882|FG000|Overall Study|Moved to another city|7|||
130182717|NCT02115269|468626882|FG000|Overall Study|Withdrawal by Subject|2|||
130182718|NCT02115269|468626882|FG000|Overall Study|Didn't take study drug|2|||
130182719|NCT01557504|468626883|FG000|Overall Study|Physician Decision|1|||
130182720|NCT01557504|468626884|FG001|Overall Study|Physician Decision|0|||
130182721|NCT02058069|468626885|FG000|Overall Study|Exclusion due to implant size|5|||
130182722|NCT02058069|468626885|FG000|Overall Study|Withdrawal by Subject|6|||
130182723|NCT02676882|468626889|FG000|Overall Study|Adverse Event|1|||
130182724|NCT02676882|468626890|FG001|Overall Study|Adverse Event|0|||
130182725|NCT02676882|468626889|FG000|Overall Study|Lost to Follow-up|1|||
130182726|NCT02676882|468626890|FG001|Overall Study|Lost to Follow-up|0|||
130182727|NCT02676882|468626889|FG000|Overall Study|Withdrawal by Subject|1|||
130182728|NCT02676882|468626890|FG001|Overall Study|Withdrawal by Subject|2|||
130182729|NCT02568072|468626891|FG000|Overall Study|Unavailable for appointment|23|||
130182730|NCT02568072|468626891|FG000|Overall Study|Unable to contact|3|||
130182731|NCT02568072|468626891|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
130182732|NCT02568072|468626891|FG000|Overall Study|Withdrawal by Subject|1|||
130182733|NCT02568072|468626891|FG000|Overall Study|Sustained injury, marathon not run|24|||
130182734|NCT00958828|468626893|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
130182735|NCT00958828|468626894|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
130182736|NCT00958828|468626893|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
130182737|NCT00958828|468626894|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
130182738|NCT02687451|468626895|FG000|Overall Study|Withdrawal by Subject|1|||
130182739|NCT02687451|468626896|FG001|Overall Study|Withdrawal by Subject|0|||
130182740|NCT02687451|468626897|FG002|Overall Study|Withdrawal by Subject|0|||
130182741|NCT02687451|468626898|FG003|Overall Study|Withdrawal by Subject|0|||
130182742|NCT02687451|468626899|FG004|Overall Study|Withdrawal by Subject|0|||
130182743|NCT02687451|468626900|FG005|Overall Study|Withdrawal by Subject|1|||
130182744|NCT00927589|468626907|FG000|Overall Study|Death|1|||
130182745|NCT00927589|468626907|FG000|Overall Study|Physician Decision|1|||
130182746|NCT00927589|468626907|FG000|Overall Study|Withdrawal by Subject|3|||
130182747|NCT00927589|468626907|FG000|Overall Study|Adverse Event|2|||
130182748|NCT00927589|468626907|FG000|Overall Study|Disease Progression|8|||
130182749|NCT00927589|468626907|FG000|Overall Study|Non-compliance|1|||
130182750|NCT01125189|468626908|FG000|Treatment Period|Lack of Efficacy|15|||
130182751|NCT01125189|468626909|FG001|Treatment Period|Lack of Efficacy|18|||
130182752|NCT01125189|468626910|FG002|Treatment Period|Lack of Efficacy|25|||
130182753|NCT01125189|468626908|FG000|Treatment Period|Adverse Event|7|||
130182754|NCT01125189|468626909|FG001|Treatment Period|Adverse Event|8|||
130182755|NCT01125189|468626910|FG002|Treatment Period|Adverse Event|8|||
130182756|NCT01125189|468626908|FG000|Treatment Period|Withdrawal by Subject|3|||
130182757|NCT01125189|468626909|FG001|Treatment Period|Withdrawal by Subject|1|||
130182758|NCT01125189|468626910|FG002|Treatment Period|Withdrawal by Subject|1|||
130182759|NCT01125189|468626908|FG000|Treatment Period|Death|1|||
130182760|NCT01125189|468626909|FG001|Treatment Period|Death|0|||
130182761|NCT01125189|468626910|FG002|Treatment Period|Death|0|||
130182762|NCT01125189|468626908|FG000|Treatment Period|Lost to Follow-up|1|||
130182763|NCT01125189|468626909|FG001|Treatment Period|Lost to Follow-up|2|||
130182764|NCT01125189|468626910|FG002|Treatment Period|Lost to Follow-up|1|||
130182765|NCT01125189|468626908|FG000|Treatment Period|Poor compliance/noncompliance|0|||
130182766|NCT01125189|468626909|FG001|Treatment Period|Poor compliance/noncompliance|1|||
130182767|NCT01125189|468626910|FG002|Treatment Period|Poor compliance/noncompliance|0|||
130182768|NCT01125189|468626908|FG000|Treatment Period|Participants requested to discontinue|1|||
130182769|NCT01125189|468626909|FG001|Treatment Period|Participants requested to discontinue|3|||
130182770|NCT01125189|468626910|FG002|Treatment Period|Participants requested to discontinue|4|||
130182771|NCT01125189|468626908|FG000|Treatment Period|Other reasons|1|||
130182772|NCT01125189|468626909|FG001|Treatment Period|Other reasons|1|||
130182773|NCT01125189|468626910|FG002|Treatment Period|Other reasons|0|||
130182774|NCT01125189|468626908|FG000|Treatment Period|Completed 24 week treatment period only|2|||
130182775|NCT01125189|468626909|FG001|Treatment Period|Completed 24 week treatment period only|1|||
130182776|NCT01125189|468626910|FG002|Treatment Period|Completed 24 week treatment period only|2|||
130182777|NCT01125189|468626908|FG000|Follow up Period|Withdrawal by Subject|3|||
130182778|NCT01125189|468626909|FG001|Follow up Period|Withdrawal by Subject|2|||
130182779|NCT01125189|468626910|FG002|Follow up Period|Withdrawal by Subject|5|||
130182780|NCT01125189|468626908|FG000|Follow up Period|Death|1|||
130182781|NCT01125189|468626909|FG001|Follow up Period|Death|0|||
130182782|NCT01125189|468626910|FG002|Follow up Period|Death|0|||
130182783|NCT01125189|468626908|FG000|Follow up Period|Lost to Follow-up|12|||
130182784|NCT01125189|468626909|FG001|Follow up Period|Lost to Follow-up|9|||
130182785|NCT01125189|468626910|FG002|Follow up Period|Lost to Follow-up|6|||
130182786|NCT01125189|468626908|FG000|Follow up Period|Other reasons|4|||
130182787|NCT01125189|468626909|FG001|Follow up Period|Other reasons|4|||
130182788|NCT01125189|468626910|FG002|Follow up Period|Other reasons|5|||
130182789|NCT00707239|468626911|FG000|Overall Study|Adverse Event|5|||
130182790|NCT00707239|468626912|FG001|Overall Study|Adverse Event|3|||
130182791|NCT00707239|468626913|FG002|Overall Study|Adverse Event|2|||
130182792|NCT00707239|468626911|FG000|Overall Study|Death|3|||
130182793|NCT00707239|468626912|FG001|Overall Study|Death|1|||
130182794|NCT00707239|468626913|FG002|Overall Study|Death|3|||
130182795|NCT00707239|468626911|FG000|Overall Study|Physician Decision|1|||
130182796|NCT00707239|468626912|FG001|Overall Study|Physician Decision|1|||
130182797|NCT00707239|468626913|FG002|Overall Study|Physician Decision|2|||
130182798|NCT00707239|468626911|FG000|Overall Study|Protocol Violation|0|||
130182799|NCT00707239|468626912|FG001|Overall Study|Protocol Violation|0|||
130182800|NCT00707239|468626913|FG002|Overall Study|Protocol Violation|1|||
130182801|NCT00707239|468626911|FG000|Overall Study|Lack of Efficacy|1|||
130182802|NCT00707239|468626912|FG001|Overall Study|Lack of Efficacy|2|||
130182803|NCT00707239|468626913|FG002|Overall Study|Lack of Efficacy|0|||
130182804|NCT00707239|468626911|FG000|Overall Study|Randomized, but not treated|1|||
130182805|NCT00707239|468626912|FG001|Overall Study|Randomized, but not treated|1|||
130182806|NCT00707239|468626913|FG002|Overall Study|Randomized, but not treated|1|||
130182807|NCT00707239|468626911|FG000|Overall Study|Other|8|||
130182808|NCT00707239|468626912|FG001|Overall Study|Other|3|||
130182809|NCT00707239|468626913|FG002|Overall Study|Other|5|||
130182810|NCT02088177|468626914|FG000|Overall Study|Lost to Follow-up|3|||
130182811|NCT01778530|468626915|FG000|Overall Study|Progression on study|1|||
130182812|NCT01778530|468626915|FG000|Overall Study|Adverse event/side effect|1|||
130182813|NCT03472014|468626916|FG000|Overall Study|Lost to Follow-up|4|||
130182814|NCT01894919|468626917|FG000|Overall Study|Withdrawal by Subject|1|||
130182815|NCT01894919|468626918|FG001|Overall Study|Withdrawal by Subject|0|||
130182816|NCT01894919|468626919|FG002|Overall Study|Withdrawal by Subject|0|||
130182817|NCT01894919|468626920|FG003|Overall Study|Withdrawal by Subject|0|||
130182818|NCT01894919|468626921|FG004|Overall Study|Withdrawal by Subject|1|||
130182819|NCT01894919|468626922|FG005|Overall Study|Withdrawal by Subject|0|||
130182820|NCT01894919|468626923|FG006|Overall Study|Withdrawal by Subject|0|||
130182821|NCT01894919|468626924|FG007|Overall Study|Withdrawal by Subject|0|||
130182822|NCT01894919|468626925|FG008|Overall Study|Withdrawal by Subject|0|||
130182823|NCT01894919|468626926|FG009|Overall Study|Withdrawal by Subject|1|||
130182824|NCT01894919|468626927|FG010|Overall Study|Withdrawal by Subject|1|||
130182825|NCT01894919|468626928|FG011|Overall Study|Withdrawal by Subject|0|||
130182826|NCT01894919|468626929|FG012|Overall Study|Withdrawal by Subject|0|||
130182827|NCT01894919|468626917|FG000|Overall Study|Adverse Event|0|||
130182828|NCT01894919|468626918|FG001|Overall Study|Adverse Event|0|||
130182829|NCT01894919|468626919|FG002|Overall Study|Adverse Event|0|||
130182830|NCT01894919|468626920|FG003|Overall Study|Adverse Event|0|||
130182831|NCT01894919|468626921|FG004|Overall Study|Adverse Event|0|||
130182832|NCT01894919|468626922|FG005|Overall Study|Adverse Event|0|||
130182833|NCT01894919|468626923|FG006|Overall Study|Adverse Event|0|||
130182834|NCT01894919|468626924|FG007|Overall Study|Adverse Event|0|||
130182835|NCT01894919|468626925|FG008|Overall Study|Adverse Event|0|||
130182836|NCT01894919|468626926|FG009|Overall Study|Adverse Event|0|||
130182837|NCT01894919|468626927|FG010|Overall Study|Adverse Event|1|||
130182838|NCT01894919|468626928|FG011|Overall Study|Adverse Event|0|||
130182839|NCT01894919|468626929|FG012|Overall Study|Adverse Event|0|||
130182840|NCT01894919|468626917|FG000|Overall Study|Other-Unspecified|1|||
130182841|NCT01894919|468626918|FG001|Overall Study|Other-Unspecified|0|||
130182842|NCT01894919|468626919|FG002|Overall Study|Other-Unspecified|0|||
130182843|NCT01894919|468626920|FG003|Overall Study|Other-Unspecified|0|||
130182844|NCT01894919|468626921|FG004|Overall Study|Other-Unspecified|0|||
130182845|NCT01894919|468626922|FG005|Overall Study|Other-Unspecified|0|||
130182846|NCT01894919|468626923|FG006|Overall Study|Other-Unspecified|0|||
130182847|NCT01894919|468626924|FG007|Overall Study|Other-Unspecified|0|||
130182848|NCT01894919|468626925|FG008|Overall Study|Other-Unspecified|0|||
130182849|NCT01894919|468626926|FG009|Overall Study|Other-Unspecified|0|||
130182850|NCT01894919|468626927|FG010|Overall Study|Other-Unspecified|0|||
130182851|NCT01894919|468626928|FG011|Overall Study|Other-Unspecified|0|||
130182852|NCT01894919|468626929|FG012|Overall Study|Other-Unspecified|0|||
130182853|NCT01894919|468626917|FG000|Overall Study|Lost to Follow-up|0|||
130182854|NCT01894919|468626918|FG001|Overall Study|Lost to Follow-up|0|||
130182855|NCT01894919|468626919|FG002|Overall Study|Lost to Follow-up|0|||
130182856|NCT01894919|468626920|FG003|Overall Study|Lost to Follow-up|0|||
130182857|NCT01894919|468626921|FG004|Overall Study|Lost to Follow-up|2|||
130182858|NCT01894919|468626922|FG005|Overall Study|Lost to Follow-up|0|||
130182859|NCT01894919|468626923|FG006|Overall Study|Lost to Follow-up|0|||
130182860|NCT01894919|468626924|FG007|Overall Study|Lost to Follow-up|0|||
130182861|NCT01894919|468626925|FG008|Overall Study|Lost to Follow-up|0|||
130182862|NCT01894919|468626926|FG009|Overall Study|Lost to Follow-up|0|||
130182863|NCT01894919|468626927|FG010|Overall Study|Lost to Follow-up|0|||
130182864|NCT01894919|468626928|FG011|Overall Study|Lost to Follow-up|0|||
130182865|NCT01894919|468626929|FG012|Overall Study|Lost to Follow-up|0|||
130182866|NCT01433471|468626930|FG000|Overall Study|Withdrawal by Subject|0|||
130182867|NCT01433471|468626931|FG001|Overall Study|Withdrawal by Subject|1|||
130182868|NCT03711188|468626932|FG000|Overall Study|Disease progression|11|||
130182869|NCT03711188|468626932|FG000|Overall Study|Adverse Event|1|||
130182870|NCT03743051|468626937|FG000|Overall Study|Adverse Event|5|||
130182871|NCT03743051|468626938|FG001|Overall Study|Adverse Event|9|||
130182872|NCT03743051|468626937|FG000|Overall Study|Death|27|||
130182873|NCT03743051|468626938|FG001|Overall Study|Death|26|||
130182874|NCT03743051|468626937|FG000|Overall Study|Lost to Follow-up|4|||
130182875|NCT03743051|468626938|FG001|Overall Study|Lost to Follow-up|8|||
130182876|NCT03743051|468626937|FG000|Overall Study|Withdrawal by Subject|32|||
130182877|NCT03743051|468626938|FG001|Overall Study|Withdrawal by Subject|19|||
130182878|NCT03743051|468626937|FG000|Overall Study|Physician Decision|10|||
130182879|NCT03743051|468626938|FG001|Overall Study|Physician Decision|15|||
130182880|NCT03743051|468626937|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
130182881|NCT03743051|468626938|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
130182882|NCT00711087|468626941|FG000|Overall Study|Lost to Follow-up|1|||
130182883|NCT00711087|468626942|FG001|Overall Study|Lost to Follow-up|0|||
130182884|NCT00811733|468626943|FG000|Overall Study|Investigator Discretion|10|||
130182885|NCT00811733|468626944|FG001|Overall Study|Investigator Discretion|8|||
130182886|NCT00811733|468626943|FG000|Overall Study|Withdrawal by Subject|1|||
130182887|NCT00811733|468626944|FG001|Overall Study|Withdrawal by Subject|2|||
130182888|NCT00793871|468626945|FG000|Overall Study|Death|50|||
130182889|NCT00793871|468626945|FG000|Overall Study|Lost to Follow-up|3|||
130182890|NCT00793871|468626945|FG000|Overall Study|Study terminated by the Sponsor|7|||
130182891|NCT02500589|468626946|FG000|Overall Study|Withdrawal by Subject|11|||
130182892|NCT02500589|468626947|FG001|Overall Study|Withdrawal by Subject|14|||
130182893|NCT02500589|468626946|FG000|Overall Study|Lost to Follow-up|10|||
130182894|NCT02500589|468626947|FG001|Overall Study|Lost to Follow-up|12|||
130182895|NCT02500589|468626946|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
130182896|NCT02500589|468626947|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
130182897|NCT02500589|468626946|FG000|Overall Study|Death|7|||
130182898|NCT02500589|468626947|FG001|Overall Study|Death|5|||
130182899|NCT01113892|468626954|FG000|Overall Study|Lost to Follow-up|2|||
130182900|NCT01113892|468626955|FG001|Overall Study|Lost to Follow-up|2|||
130182901|NCT01113892|468626954|FG000|Overall Study|Withdrawal by Subject|1|||
130182902|NCT01113892|468626955|FG001|Overall Study|Withdrawal by Subject|1|||
130182903|NCT01113892|468626954|FG000|Overall Study|Death|2|||
130182904|NCT01113892|468626955|FG001|Overall Study|Death|4|||
130182905|NCT01113892|468626954|FG000|Overall Study|Graft no longer evaluable|9|||
130182906|NCT01113892|468626955|FG001|Overall Study|Graft no longer evaluable|9|||
130182907|NCT02569801|468626956|FG000|Overall Study|Withdrawal by Subject|9|||
130182908|NCT02569801|468626957|FG001|Overall Study|Withdrawal by Subject|9|||
130182909|NCT02569801|468626956|FG000|Overall Study|Sponsor Decision|13|||
130182910|NCT02569801|468626957|FG001|Overall Study|Sponsor Decision|14|||
130182911|NCT02569801|468626956|FG000|Overall Study|Progressive Disease|2|||
130182912|NCT02569801|468626957|FG001|Overall Study|Progressive Disease|7|||
130182913|NCT02569801|468626956|FG000|Overall Study|Lost to Follow-up|0|||
130182914|NCT02569801|468626957|FG001|Overall Study|Lost to Follow-up|1|||
130182915|NCT02569801|468626956|FG000|Overall Study|Death|12|||
130182916|NCT02569801|468626957|FG001|Overall Study|Death|4|||
130182917|NCT00428246|468626958|FG000|Overall Study|Withdrawal by Subject|0|||
130182918|NCT00428246|468626959|FG001|Overall Study|Withdrawal by Subject|0|||
130182919|NCT00428246|468626960|FG002|Overall Study|Withdrawal by Subject|1|||
130182920|NCT00428246|468626958|FG000|Overall Study|Adverse Event|1|||
130182921|NCT00428246|468626959|FG001|Overall Study|Adverse Event|0|||
130182922|NCT00428246|468626960|FG002|Overall Study|Adverse Event|0|||
130182923|NCT03442751|468626962|FG000|Overall Study|Withdrawal by Subject|3|||
130182924|NCT03442751|468626963|FG001|Overall Study|Withdrawal by Subject|1|||
130182925|NCT03442751|468626962|FG000|Overall Study|Lost to Follow-up|3|||
130182926|NCT03442751|468626963|FG001|Overall Study|Lost to Follow-up|0|||
130182927|NCT02603887|468626964|FG000|Stage 1|Adverse Event|4|||
130182928|NCT02603887|468626964|FG000|Stage 1|Disease progression|1|||
130182929|NCT02603887|468626964|FG000|Stage 2|FDA guidance|1|||
130182930|NCT00470470|468626970|FG000|Overall Study|Adverse Event|2|||
130182931|NCT00470470|468626970|FG000|Overall Study|Death|2|||
130182932|NCT00470470|468626970|FG000|Overall Study|Not treated|1|||
130182933|NCT02452476|468626977|FG000|Overall Study|Death|4|||
130182934|NCT02452476|468626978|FG001|Overall Study|Death|7|||
130182935|NCT02452476|468626977|FG000|Overall Study|Lost to Follow-up|1|||
130182936|NCT02452476|468626978|FG001|Overall Study|Lost to Follow-up|1|||
130182937|NCT02452476|468626977|FG000|Overall Study|Physician Decision|1|||
130182938|NCT02452476|468626978|FG001|Overall Study|Physician Decision|1|||
130182939|NCT02452476|468626977|FG000|Overall Study|Not treated|5|||
130182940|NCT02452476|468626978|FG001|Overall Study|Not treated|1|||
130182941|NCT03552380|468626979|FG000|Study Treatment|Disease Progression|3|||
130182942|NCT03552380|468626980|FG001|Study Treatment|Disease Progression|4|||
130182943|NCT03552380|468626979|FG000|Study Treatment|Adverse Event|2|||
130182944|NCT03552380|468626980|FG001|Study Treatment|Adverse Event|2|||
130182945|NCT03552380|468626979|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
130182946|NCT03552380|468626980|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
130182947|NCT03552380|468626979|FG000|Follow up|Death|3|||
130182948|NCT03552380|468626980|FG001|Follow up|Death|4|||
130182949|NCT03552380|468626979|FG000|Follow up|Site IRB terminated|0|||
130182950|NCT03552380|468626980|FG001|Follow up|Site IRB terminated|1|||
130182951|NCT02072980|468626981|FG000|Period 2, Second Wear|Adverse Event|0|||
130182952|NCT02072980|468626982|FG001|Period 2, Second Wear|Adverse Event|1|||
130182953|NCT01757275|468626983|FG000|Overall Study|Lost to Follow-up|1|||
130182954|NCT01757275|468626984|FG001|Overall Study|Lost to Follow-up|2|||
130182955|NCT01757275|468626983|FG000|Overall Study|Adverse Event|3|||
130182956|NCT01757275|468626984|FG001|Overall Study|Adverse Event|3|||
130182957|NCT01757275|468626983|FG000|Overall Study|Withdrawal by Subject|2|||
130182958|NCT01757275|468626984|FG001|Overall Study|Withdrawal by Subject|4|||
130182959|NCT01757275|468626983|FG000|Overall Study|Not treated|3|||
130182960|NCT01757275|468626984|FG001|Overall Study|Not treated|4|||
130182961|NCT01401452|468626987|FG000|Overall Study|Adverse reaction|9|||
130182962|NCT01401452|468626987|FG000|Overall Study|Lost to Follow-up|12|||
130182963|NCT01401452|468626987|FG000|Overall Study|Lack of Efficacy|30|||
130182964|NCT01401452|468626987|FG000|Overall Study|Participant developed breast cancer|1|||
130182965|NCT01401452|468626987|FG000|Overall Study|Tx stopped due to financial reasons|1|||
130182966|NCT01401452|468626987|FG000|Overall Study|Tx stopped by psychiatrist|1|||
130182967|NCT01401452|468626987|FG000|Overall Study|No more visits within the 36 wk followup|4|||
130182968|NCT01401452|468626987|FG000|Overall Study|Subject did not come to follow up visits|2|||
130182969|NCT01401452|468626987|FG000|Overall Study|Subject didn't return for routine visits|1|||
130182970|NCT01401452|468626987|FG000|Overall Study|Subject moved to another city|1|||
130182971|NCT01401452|468626987|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
130182972|NCT01401452|468626987|FG000|Overall Study|Psoriatic arthritis|1|||
130182973|NCT01401452|468626987|FG000|Overall Study|Participant stopped Tx|2|||
130182974|NCT01401452|468626987|FG000|Overall Study|Discontinuation for personal reasons|1|||
130182975|NCT01401452|468626987|FG000|Overall Study|Treatment failure|1|||
130182976|NCT01401452|468626987|FG000|Overall Study|Unsatisfactory output|1|||
130182977|NCT01401452|468626987|FG000|Overall Study|Subject withdrew because of Tx success|1|||
130182978|NCT01401452|468626987|FG000|Overall Study|Subject chose to discontinue treatment|1|||
130182979|NCT01401452|468626987|FG000|Overall Study|Participant withdrew consent|1|||
130182980|NCT02601014|468626988|FG000|Overall Study|Adverse Event|3|||
130182981|NCT02601014|468626989|FG001|Overall Study|Adverse Event|3|||
130182982|NCT02601014|468626988|FG000|Overall Study|Death|3|||
130182983|NCT02601014|468626989|FG001|Overall Study|Death|1|||
130182984|NCT02601014|468626988|FG000|Overall Study|Disease progression|4|||
130182985|NCT02601014|468626989|FG001|Overall Study|Disease progression|8|||
130182986|NCT01168427|468626990|FG000|Overall Study|Patient exited prior to implant|1|||
130182987|NCT01133067|468626995|FG000|Overall Study|Death|136|||
130182988|NCT01133067|468626995|FG000|Overall Study|Lost to Follow-up|3|||
130182989|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
130182990|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
130182991|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
130182992|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
130182993|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
130182994|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
130182995|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130182996|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130182997|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
130182998|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Other|1|||
130182999|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Other|0|||
130183000|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Other|4|||
130183001|NCT02654054|468626997|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130183002|NCT02654054|468626998|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
130183003|NCT02654054|468626999|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
130183004|NCT00420420|468627000|FG000|Overall Study|Adverse Event|5|||
130183005|NCT00420420|468627001|FG001|Overall Study|Adverse Event|3|||
130183006|NCT00420420|468627000|FG000|Overall Study|Protocol Violation|1|||
130183007|NCT00420420|468627001|FG001|Overall Study|Protocol Violation|1|||
130183008|NCT00420420|468627000|FG000|Overall Study|Withdrawal by Subject|1|||
130183009|NCT00420420|468627001|FG001|Overall Study|Withdrawal by Subject|0|||
130183010|NCT00420420|468627000|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
130183011|NCT00420420|468627001|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
130183012|NCT00273182|468627002|FG000|Overall Study|Death|450|||
130183013|NCT00273182|468627002|FG000|Overall Study|Lost to Follow-up|88|||
130183014|NCT00273182|468627002|FG000|Overall Study|Withdrawal by Subject|257|||
130183015|NCT00273182|468627002|FG000|Overall Study|Device/System Explant|154|||
130183016|NCT00273182|468627002|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
130183017|NCT03641469|468627003|FG000|Overall Study|Ineligible|2|||
130183018|NCT03641469|468627003|FG000|Overall Study|Withdrawal by Subject|5|||
130183019|NCT03641469|468627003|FG000|Overall Study|Physician Decision|1|||
130183020|NCT03641469|468627003|FG000|Overall Study|Protocol Violation|1|||
130183021|NCT03641469|468627003|FG000|Overall Study|Lost to Follow-up|2|||
130183022|NCT00868530|468627004|FG000|Overall Study|Adverse Event|3|||
130183023|NCT00868530|468627004|FG000|Overall Study|Lost to Follow-up|1|||
130183024|NCT00858273|468627005|FG000|Overall Study|Protocol Violation|3|||
130183025|NCT00858273|468627006|FG001|Overall Study|Protocol Violation|5|||
130183026|NCT04199104|468628905|FG000|Overall Study|Death|148|||
130183027|NCT04199104|468628906|FG001|Overall Study|Death|134|||
130183028|NCT04199104|468628905|FG000|Overall Study|Lost to Follow-up|1|||
130183029|NCT04199104|468628906|FG001|Overall Study|Lost to Follow-up|1|||
130183030|NCT04199104|468628905|FG000|Overall Study|Withdrawal by Subject|4|||
130183031|NCT04199104|468628906|FG001|Overall Study|Withdrawal by Subject|4|||
130183032|NCT04199104|468628905|FG000|Overall Study|Participants Ongoing|103|||
130183033|NCT04199104|468628906|FG001|Overall Study|Participants Ongoing|116|||
130183034|NCT02562235|468628909|FG000|Overall Study|Adverse Event|3|||
130183035|NCT05655546|468628912|FG000|Overall Study|Withdrawal by Subject|2|||
130183036|NCT05655546|468628913|FG001|Overall Study|Withdrawal by Subject|4|||
130183037|NCT01168232|468628914|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
130183038|NCT01168232|468628914|FG000|Overall Study|Ineligible- Wrong cell type|6|||
130183039|NCT01168232|468628914|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
130183040|NCT04576507|468628918|FG000|Overall Study|Adverse Event|4|||
130183041|NCT04576507|468628918|FG000|Overall Study|Withdrawal by Subject|1|||
130183042|NCT05012098|468628923|FG000|Overall Study|Disease progression|5|||
130183043|NCT05012098|468628924|FG001|Overall Study|Disease progression|2|||
130183044|NCT05012098|468628923|FG000|Overall Study|Adverse Event|1|||
130183045|NCT05012098|468628924|FG001|Overall Study|Adverse Event|0|||
130183046|NCT05012098|468628923|FG000|Overall Study|Withdrawal by Subject|1|||
130183047|NCT05012098|468628924|FG001|Overall Study|Withdrawal by Subject|0|||
130183048|NCT05012098|468628923|FG000|Overall Study|Discontinuation per protocol|1|||
130183049|NCT05012098|468628924|FG001|Overall Study|Discontinuation per protocol|0|||
130183050|NCT01490086|468628925|FG000|Overall Study|Consent withdrawn|4|||
130183051|NCT01490086|468628926|FG001|Overall Study|Consent withdrawn|4|||
130183052|NCT01490086|468628927|FG002|Overall Study|Consent withdrawn|3|||
130183053|NCT01490086|468628928|FG003|Overall Study|Consent withdrawn|0|||
130183054|NCT01490086|468628929|FG004|Overall Study|Consent withdrawn|1|||
130183055|NCT01490086|468628925|FG000|Overall Study|Non-compliance|0|||
130183056|NCT01490086|468628926|FG001|Overall Study|Non-compliance|1|||
130183057|NCT01490086|468628927|FG002|Overall Study|Non-compliance|0|||
130183058|NCT01490086|468628928|FG003|Overall Study|Non-compliance|0|||
130183059|NCT01490086|468628929|FG004|Overall Study|Non-compliance|0|||
130183060|NCT01490086|468628925|FG000|Overall Study|Abnormal laboratory findings|1|||
130183061|NCT01490086|468628926|FG001|Overall Study|Abnormal laboratory findings|0|||
130183062|NCT01490086|468628927|FG002|Overall Study|Abnormal laboratory findings|0|||
130183063|NCT01490086|468628928|FG003|Overall Study|Abnormal laboratory findings|0|||
130183064|NCT01490086|468628929|FG004|Overall Study|Abnormal laboratory findings|0|||
130183065|NCT01490086|468628925|FG000|Overall Study|Lost to Follow-up|0|||
130183066|NCT01490086|468628926|FG001|Overall Study|Lost to Follow-up|0|||
130183067|NCT01490086|468628927|FG002|Overall Study|Lost to Follow-up|0|||
130183068|NCT01490086|468628928|FG003|Overall Study|Lost to Follow-up|0|||
130183069|NCT01490086|468628929|FG004|Overall Study|Lost to Follow-up|1|||
130183070|NCT01490086|468628925|FG000|Overall Study|Physician Decision|3|||
130183071|NCT01490086|468628926|FG001|Overall Study|Physician Decision|4|||
130183072|NCT01490086|468628927|FG002|Overall Study|Physician Decision|2|||
130183073|NCT01490086|468628928|FG003|Overall Study|Physician Decision|3|||
130183074|NCT01490086|468628929|FG004|Overall Study|Physician Decision|1|||
130183075|NCT01490086|468628925|FG000|Overall Study|Adverse Event|0|||
130183076|NCT01490086|468628926|FG001|Overall Study|Adverse Event|0|||
130183077|NCT01490086|468628927|FG002|Overall Study|Adverse Event|1|||
130183078|NCT01490086|468628928|FG003|Overall Study|Adverse Event|2|||
130183079|NCT01490086|468628929|FG004|Overall Study|Adverse Event|0|||
130183080|NCT01490086|468628925|FG000|Overall Study|Lack of Efficacy|0|||
130183081|NCT01490086|468628926|FG001|Overall Study|Lack of Efficacy|3|||
130183082|NCT01490086|468628927|FG002|Overall Study|Lack of Efficacy|1|||
130183083|NCT01490086|468628928|FG003|Overall Study|Lack of Efficacy|0|||
130183084|NCT01490086|468628929|FG004|Overall Study|Lack of Efficacy|8|||
130183085|NCT01490086|468628925|FG000|Overall Study|Worsening of symptoms|0|||
130183086|NCT01490086|468628926|FG001|Overall Study|Worsening of symptoms|1|||
130183087|NCT01490086|468628927|FG002|Overall Study|Worsening of symptoms|0|||
130183088|NCT01490086|468628928|FG003|Overall Study|Worsening of symptoms|1|||
130183089|NCT01490086|468628929|FG004|Overall Study|Worsening of symptoms|0|||
130183090|NCT01490086|468628925|FG000|Overall Study|Subject uncontrollable and abusive|0|||
130183091|NCT01490086|468628926|FG001|Overall Study|Subject uncontrollable and abusive|1|||
130183092|NCT01490086|468628927|FG002|Overall Study|Subject uncontrollable and abusive|0|||
130183093|NCT01490086|468628928|FG003|Overall Study|Subject uncontrollable and abusive|0|||
130183094|NCT01490086|468628929|FG004|Overall Study|Subject uncontrollable and abusive|0|||
130183095|NCT01490086|468628925|FG000|Overall Study|Subject left hospital|0|||
130183096|NCT01490086|468628926|FG001|Overall Study|Subject left hospital|1|||
130183097|NCT01490086|468628927|FG002|Overall Study|Subject left hospital|0|||
130183098|NCT01490086|468628928|FG003|Overall Study|Subject left hospital|1|||
130183099|NCT01490086|468628929|FG004|Overall Study|Subject left hospital|0|||
130183100|NCT05825404|468628930|FG000|First Intervention (Weeks 2-5)|Death|0|||
130183101|NCT05825404|468628931|FG001|First Intervention (Weeks 2-5)|Death|1|||
130183102|NCT05825404|468628930|FG000|Second Intervention (Weeks 8-11)|Death|0|||
130183103|NCT05825404|468628931|FG001|Second Intervention (Weeks 8-11)|Death|1|||
130183104|NCT02157935|468628932|FG000|Overall Study|Withdrawal by Subject|25|||
130183105|NCT02157935|468628933|FG001|Overall Study|Withdrawal by Subject|39|||
130183106|NCT02157935|468628932|FG000|Overall Study|Screen failure|1|||
130183107|NCT02157935|468628933|FG001|Overall Study|Screen failure|2|||
130183108|NCT02157935|468628932|FG000|Overall Study|Protocol Violation|1|||
130183109|NCT02157935|468628933|FG001|Overall Study|Protocol Violation|0|||
130183110|NCT02157935|468628932|FG000|Overall Study|Progressive disease|0|||
130183111|NCT02157935|468628933|FG001|Overall Study|Progressive disease|2|||
130183112|NCT02157935|468628932|FG000|Overall Study|Other|5|||
130183113|NCT02157935|468628933|FG001|Overall Study|Other|12|||
130183114|NCT02157935|468628932|FG000|Overall Study|Lack of Efficacy|0|||
130183115|NCT02157935|468628933|FG001|Overall Study|Lack of Efficacy|1|||
130183116|NCT02157935|468628932|FG000|Overall Study|Death|4|||
130183117|NCT02157935|468628933|FG001|Overall Study|Death|4|||
130183118|NCT02157935|468628932|FG000|Overall Study|Adverse Event|3|||
130183119|NCT02157935|468628933|FG001|Overall Study|Adverse Event|5|||
130183120|NCT01103180|468628942|FG000|Overall Study|Withdrawal by Subject|8|||
130183121|NCT01103180|468628943|FG001|Overall Study|Withdrawal by Subject|13|||
130183122|NCT01103180|468628942|FG000|Overall Study|Lost to Follow-up|13|||
130183123|NCT01103180|468628943|FG001|Overall Study|Lost to Follow-up|7|||
130183124|NCT01103180|468628942|FG000|Overall Study|Physician Decision|1|||
130183125|NCT01103180|468628943|FG001|Overall Study|Physician Decision|0|||
130183126|NCT01103180|468628942|FG000|Overall Study|Protocol Violation|0|||
130183127|NCT01103180|468628943|FG001|Overall Study|Protocol Violation|1|||
130183128|NCT02493660|468628944|FG000|Overall Study|Physician Decision|0|||
130183129|NCT02493660|468628945|FG001|Overall Study|Physician Decision|1|||
130183130|NCT02493660|468628944|FG000|Overall Study|Adverse Event|4|||
130183131|NCT02493660|468628945|FG001|Overall Study|Adverse Event|2|||
130183132|NCT02493660|468628944|FG000|Overall Study|Withdrawal by Subject|2|||
130183133|NCT02493660|468628945|FG001|Overall Study|Withdrawal by Subject|3|||
130183134|NCT02493660|468628944|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
130183135|NCT02493660|468628945|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
130183136|NCT02493660|468628944|FG000|Overall Study|Protocol Violation|0|||
130183137|NCT02493660|468628945|FG001|Overall Study|Protocol Violation|1|||
130183138|NCT02493660|468628944|FG000|Overall Study|Death|0|||
130183139|NCT02493660|468628945|FG001|Overall Study|Death|1|||
130183140|NCT02493660|468628944|FG000|Overall Study|Lost to Follow-up|2|||
130183141|NCT02493660|468628945|FG001|Overall Study|Lost to Follow-up|4|||
130183142|NCT02392481|468628949|FG000|Overall Study|Adverse Event|0|||
130183143|NCT02392481|468628950|FG001|Overall Study|Adverse Event|0|||
130183144|NCT02392481|468628951|FG002|Overall Study|Adverse Event|1|||
130183145|NCT02392481|468628952|FG003|Overall Study|Adverse Event|2|||
130183146|NCT02392481|468628949|FG000|Overall Study|Withdrawal by Subject|0|||
130183147|NCT02392481|468628950|FG001|Overall Study|Withdrawal by Subject|0|||
130183148|NCT02392481|468628951|FG002|Overall Study|Withdrawal by Subject|1|||
130183149|NCT02392481|468628952|FG003|Overall Study|Withdrawal by Subject|0|||
130183150|NCT02502149|468628954|FG000|Intermediate|Discontinued prematurely|1|||
130183151|NCT02502149|468628955|FG001|Intermediate|Discontinued prematurely|0|||
130183152|NCT02502149|468628956|FG002|Intermediate|Discontinued prematurely|0|||
130183153|NCT02502149|468628957|FG003|Intermediate|Discontinued prematurely|0|||
130183154|NCT02502149|468628958|FG004|Intermediate|Discontinued prematurely|0|||
130183155|NCT02968576|468628959|FG000|Overall Study|Pregnancy|0|||
130183156|NCT02968576|468628960|FG001|Overall Study|Pregnancy|1|||
130183157|NCT02222922|468628961|FG000|Overall Study|Death|0|||
130183158|NCT02222922|468628962|FG001|Overall Study|Death|0|||
130183159|NCT02222922|468628963|FG002|Overall Study|Death|0|||
130183160|NCT02222922|468628964|FG003|Overall Study|Death|0|||
130183161|NCT02222922|468628965|FG004|Overall Study|Death|13|||
130183162|NCT02222922|468628966|FG005|Overall Study|Death|0|||
130183163|NCT02222922|468628967|FG006|Overall Study|Death|0|||
130183164|NCT02222922|468628968|FG007|Overall Study|Death|0|||
130183165|NCT02222922|468628969|FG008|Overall Study|Death|2|||
130183166|NCT02222922|468628961|FG000|Overall Study|Lost to Follow-up|0|||
130183167|NCT02222922|468628962|FG001|Overall Study|Lost to Follow-up|0|||
130183168|NCT02222922|468628963|FG002|Overall Study|Lost to Follow-up|1|||
130183169|NCT02222922|468628964|FG003|Overall Study|Lost to Follow-up|0|||
130183170|NCT02222922|468628965|FG004|Overall Study|Lost to Follow-up|9|||
130183171|NCT02222922|468628966|FG005|Overall Study|Lost to Follow-up|1|||
130183172|NCT02222922|468628967|FG006|Overall Study|Lost to Follow-up|0|||
130183173|NCT02222922|468628968|FG007|Overall Study|Lost to Follow-up|0|||
130183174|NCT02222922|468628969|FG008|Overall Study|Lost to Follow-up|0|||
130183175|NCT02222922|468628961|FG000|Overall Study|Other|0|||
130183176|NCT02222922|468628962|FG001|Overall Study|Other|0|||
130183177|NCT02222922|468628963|FG002|Overall Study|Other|0|||
130183178|NCT02222922|468628964|FG003|Overall Study|Other|2|||
130183179|NCT02222922|468628965|FG004|Overall Study|Other|10|||
130183180|NCT02222922|468628966|FG005|Overall Study|Other|2|||
130183181|NCT02222922|468628967|FG006|Overall Study|Other|2|||
130183182|NCT02222922|468628968|FG007|Overall Study|Other|4|||
130183183|NCT02222922|468628969|FG008|Overall Study|Other|1|||
130183184|NCT02222922|468628961|FG000|Overall Study|Participant refused further follow-up|1|||
130183185|NCT02222922|468628962|FG001|Overall Study|Participant refused further follow-up|0|||
130183186|NCT02222922|468628963|FG002|Overall Study|Participant refused further follow-up|0|||
130183187|NCT02222922|468628964|FG003|Overall Study|Participant refused further follow-up|1|||
130183188|NCT02222922|468628965|FG004|Overall Study|Participant refused further follow-up|6|||
130183189|NCT02222922|468628966|FG005|Overall Study|Participant refused further follow-up|0|||
130183190|NCT02222922|468628967|FG006|Overall Study|Participant refused further follow-up|0|||
130183191|NCT02222922|468628968|FG007|Overall Study|Participant refused further follow-up|0|||
130183192|NCT02222922|468628969|FG008|Overall Study|Participant refused further follow-up|3|||
130183193|NCT01254643|468628970|FG000|Overall Study|Withdrawal by Subject|1|||
130183194|NCT00116779|468628976|FG000|Overall Study|Adverse Event|4|||
130183195|NCT00116779|468628977|FG001|Overall Study|Adverse Event|2|||
130183196|NCT00116779|468628976|FG000|Overall Study|Protocol Violation|1|||
130183197|NCT00116779|468628977|FG001|Overall Study|Protocol Violation|4|||
130183198|NCT00116779|468628976|FG000|Overall Study|Withdrawal by Subject|4|||
130183199|NCT00116779|468628977|FG001|Overall Study|Withdrawal by Subject|1|||
130183200|NCT00116779|468628976|FG000|Overall Study|Inadequate testosterone suppression|7|||
130183201|NCT00116779|468628977|FG001|Overall Study|Inadequate testosterone suppression|9|||
130183202|NCT00116779|468628976|FG000|Overall Study|Physician Decision|3|||
130183203|NCT00116779|468628977|FG001|Overall Study|Physician Decision|1|||
130183204|NCT00116779|468628976|FG000|Overall Study|Elevated PSA levels|2|||
130183205|NCT00116779|468628977|FG001|Overall Study|Elevated PSA levels|2|||
130183206|NCT01037218|468628982|FG000|Overall Study|Adverse Event|4|||
130183207|NCT01037218|468628983|FG001|Overall Study|Adverse Event|2|||
130183208|NCT01037218|468628984|FG002|Overall Study|Adverse Event|2|||
130183209|NCT01037218|468628985|FG003|Overall Study|Adverse Event|1|||
130183210|NCT01037218|468628982|FG000|Overall Study|Lack of Efficacy|0|||
130183211|NCT01037218|468628983|FG001|Overall Study|Lack of Efficacy|2|||
130183212|NCT01037218|468628984|FG002|Overall Study|Lack of Efficacy|1|||
130183213|NCT01037218|468628985|FG003|Overall Study|Lack of Efficacy|5|||
130183214|NCT01037218|468628982|FG000|Overall Study|Lost to Follow-up|3|||
130183215|NCT01037218|468628983|FG001|Overall Study|Lost to Follow-up|5|||
130183216|NCT01037218|468628984|FG002|Overall Study|Lost to Follow-up|4|||
130183217|NCT01037218|468628985|FG003|Overall Study|Lost to Follow-up|2|||
130183218|NCT01037218|468628982|FG000|Overall Study|Withdrawal by Subject|6|||
130183219|NCT01037218|468628983|FG001|Overall Study|Withdrawal by Subject|7|||
130183220|NCT01037218|468628984|FG002|Overall Study|Withdrawal by Subject|7|||
130183221|NCT01037218|468628985|FG003|Overall Study|Withdrawal by Subject|4|||
130183222|NCT01037218|468628982|FG000|Overall Study|Partner Withdrew Consent|0|||
130183223|NCT01037218|468628983|FG001|Overall Study|Partner Withdrew Consent|3|||
130183224|NCT01037218|468628984|FG002|Overall Study|Partner Withdrew Consent|2|||
130183225|NCT01037218|468628985|FG003|Overall Study|Partner Withdrew Consent|1|||
130183226|NCT01037218|468628982|FG000|Overall Study|Protocol Violation|0|||
130183227|NCT01037218|468628983|FG001|Overall Study|Protocol Violation|0|||
130183228|NCT01037218|468628984|FG002|Overall Study|Protocol Violation|2|||
130183229|NCT01037218|468628985|FG003|Overall Study|Protocol Violation|2|||
130183230|NCT01037218|468628982|FG000|Overall Study|Various|3|||
130183231|NCT01037218|468628983|FG001|Overall Study|Various|2|||
130183232|NCT01037218|468628984|FG002|Overall Study|Various|3|||
130183233|NCT01037218|468628985|FG003|Overall Study|Various|1|||
130183234|NCT01651117|468628989|FG000|Overall Study|Death|2|||
130183235|NCT01651117|468628990|FG001|Overall Study|Death|3|||
130183236|NCT01651117|468628991|FG002|Overall Study|Death|2|||
130183237|NCT01651117|468628992|FG003|Overall Study|Death|2|||
130183238|NCT02714218|468628995|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130183239|NCT02714218|468628996|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
130183240|NCT02714218|468628997|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
130183241|NCT02714218|468628995|FG000|Pre-Treatment Period|Other reasons|0|||
130183242|NCT02714218|468628996|FG001|Pre-Treatment Period|Other reasons|1|||
130183243|NCT02714218|468628997|FG002|Pre-Treatment Period|Other reasons|0|||
130183244|NCT02714218|468628995|FG000|Treatment Period|Disease Progression|55|||
130183245|NCT02714218|468628996|FG001|Treatment Period|Disease Progression|52|||
130183246|NCT02714218|468628997|FG002|Treatment Period|Disease Progression|14|||
130183247|NCT02714218|468628995|FG000|Treatment Period|Study drug toxicity|46|||
130183248|NCT02714218|468628996|FG001|Treatment Period|Study drug toxicity|70|||
130183249|NCT02714218|468628997|FG002|Treatment Period|Study drug toxicity|6|||
130183250|NCT02714218|468628995|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
130183251|NCT02714218|468628996|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
130183252|NCT02714218|468628997|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
130183253|NCT02714218|468628995|FG000|Treatment Period|Request to discontinue treatment|1|||
130183254|NCT02714218|468628996|FG001|Treatment Period|Request to discontinue treatment|4|||
130183255|NCT02714218|468628997|FG002|Treatment Period|Request to discontinue treatment|1|||
130183256|NCT02714218|468628995|FG000|Treatment Period|Participant withdrew consent|2|||
130183257|NCT02714218|468628996|FG001|Treatment Period|Participant withdrew consent|2|||
130183258|NCT02714218|468628997|FG002|Treatment Period|Participant withdrew consent|0|||
130183259|NCT02714218|468628995|FG000|Treatment Period|Maximum clinical benefit|4|||
130183260|NCT02714218|468628996|FG001|Treatment Period|Maximum clinical benefit|2|||
130183261|NCT02714218|468628997|FG002|Treatment Period|Maximum clinical benefit|0|||
130183262|NCT02714218|468628995|FG000|Treatment Period|Administrative reason by sponsor|2|||
130183263|NCT02714218|468628996|FG001|Treatment Period|Administrative reason by sponsor|1|||
130183264|NCT02714218|468628997|FG002|Treatment Period|Administrative reason by sponsor|0|||
130183265|NCT02714218|468628995|FG000|Treatment Period|Other reasons|6|||
130183266|NCT02714218|468628996|FG001|Treatment Period|Other reasons|6|||
130183267|NCT02714218|468628997|FG002|Treatment Period|Other reasons|0|||
130183268|NCT02714218|468628995|FG000|Treatment Period|Completed treatment as per protocol|36|||
130183269|NCT02714218|468628996|FG001|Treatment Period|Completed treatment as per protocol|27|||
130183270|NCT02714218|468628997|FG002|Treatment Period|Completed treatment as per protocol|3|||
130183271|NCT02714218|468628995|FG000|Treatment Period|Not reported|9|||
130183272|NCT02714218|468628996|FG001|Treatment Period|Not reported|6|||
130183273|NCT02714218|468628997|FG002|Treatment Period|Not reported|0|||
130183274|NCT01199939|468629001|FG000|Overall Study|Adverse Event|4|||
130183275|NCT01199939|468629001|FG000|Overall Study|Protocol Violation|3|||
130183276|NCT01199939|468629001|FG000|Overall Study|Lost to Follow-up|2|||
130183277|NCT01199939|468629001|FG000|Overall Study|Reached a virologic endpoint|4|||
130183278|NCT03238651|468629004|FG000|Overall Study|Other|0|||
130183279|NCT03238651|468629005|FG001|Overall Study|Other|0|||
130183280|NCT03238651|468629006|FG002|Overall Study|Other|0|||
130183281|NCT03238651|468629007|FG003|Overall Study|Other|0|||
130183282|NCT03238651|468629008|FG004|Overall Study|Other|1|||
130183283|NCT03238651|468629004|FG000|Overall Study|Progressive Disease|2|||
130183284|NCT03238651|468629005|FG001|Overall Study|Progressive Disease|2|||
130183285|NCT03238651|468629006|FG002|Overall Study|Progressive Disease|2|||
130183286|NCT03238651|468629007|FG003|Overall Study|Progressive Disease|2|||
130183287|NCT03238651|468629008|FG004|Overall Study|Progressive Disease|0|||
130183288|NCT03238651|468629004|FG000|Overall Study|Withdrawal by Subject|0|||
130183289|NCT03238651|468629005|FG001|Overall Study|Withdrawal by Subject|1|||
130183290|NCT03238651|468629006|FG002|Overall Study|Withdrawal by Subject|0|||
130183291|NCT03238651|468629007|FG003|Overall Study|Withdrawal by Subject|1|||
130183292|NCT03238651|468629008|FG004|Overall Study|Withdrawal by Subject|0|||
130183293|NCT03238651|468629004|FG000|Overall Study|Adverse Event|1|||
130183294|NCT03238651|468629005|FG001|Overall Study|Adverse Event|3|||
130183295|NCT03238651|468629006|FG002|Overall Study|Adverse Event|2|||
130183296|NCT03238651|468629007|FG003|Overall Study|Adverse Event|0|||
130183297|NCT03238651|468629008|FG004|Overall Study|Adverse Event|0|||
130183298|NCT03875508|468629009|FG000|Overall Study|Adverse Event|1|||
130183299|NCT03875508|468629009|FG000|Overall Study|Lost to Follow-up|8|||
130183300|NCT03875508|468629009|FG000|Overall Study|Lack of Efficacy|1|||
130183301|NCT03875508|468629009|FG000|Overall Study|Other, not specified|2|||
130183302|NCT03652051|468629011|FG000|Stage 1|Adverse Event|0|||
130183303|NCT03652051|468629012|FG001|Stage 1|Adverse Event|5|||
130183304|NCT03652051|468629013|FG002|Stage 1|Adverse Event|7|||
130183305|NCT03652051|468629014|FG003|Stage 1|Adverse Event|1|||
130183306|NCT03652051|468629011|FG000|Stage 1|Withdrawal by Subject|0|||
130183307|NCT03652051|468629012|FG001|Stage 1|Withdrawal by Subject|0|||
130183308|NCT03652051|468629013|FG002|Stage 1|Withdrawal by Subject|1|||
130183309|NCT03652051|468629014|FG003|Stage 1|Withdrawal by Subject|0|||
130183310|NCT03652051|468629011|FG000|Stage 2|Adverse Event|0|||
130183311|NCT03652051|468629012|FG001|Stage 2|Adverse Event|2|||
130183312|NCT03652051|468629013|FG002|Stage 2|Adverse Event|1|||
130183313|NCT03652051|468629014|FG003|Stage 2|Adverse Event|0|||
130183314|NCT03652051|468629011|FG000|Stage 2|Protocol Violation|0|||
130183315|NCT03652051|468629012|FG001|Stage 2|Protocol Violation|1|||
130183316|NCT03652051|468629013|FG002|Stage 2|Protocol Violation|6|||
130183317|NCT03652051|468629014|FG003|Stage 2|Protocol Violation|0|||
130183318|NCT03652051|468629011|FG000|Stage 2|Lost to Follow-up|0|||
130183319|NCT03652051|468629012|FG001|Stage 2|Lost to Follow-up|2|||
130183320|NCT03652051|468629013|FG002|Stage 2|Lost to Follow-up|0|||
130183321|NCT03652051|468629014|FG003|Stage 2|Lost to Follow-up|3|||
130183322|NCT03652051|468629011|FG000|Stage 2|Withdrawal by Subject|0|||
130183323|NCT03652051|468629012|FG001|Stage 2|Withdrawal by Subject|11|||
130183324|NCT03652051|468629013|FG002|Stage 2|Withdrawal by Subject|9|||
130183325|NCT03652051|468629014|FG003|Stage 2|Withdrawal by Subject|3|||
130183326|NCT02550561|468629015|FG000|Overall Study|Lost to Follow-up|5|||
130183327|NCT02550561|468629015|FG000|Overall Study|Withdrawal by Subject|1|||
130183328|NCT02394600|468629016|FG000|Overall Study|Adverse Event|3|||
130183329|NCT02394600|468629017|FG001|Overall Study|Adverse Event|0|||
130183330|NCT02394600|468629016|FG000|Overall Study|Lost to Follow-up|0|||
130183331|NCT02394600|468629017|FG001|Overall Study|Lost to Follow-up|1|||
130183332|NCT02394600|468629016|FG000|Overall Study|Withdrawal by Subject|0|||
130183333|NCT02394600|468629017|FG001|Overall Study|Withdrawal by Subject|1|||
130183334|NCT02394600|468629016|FG000|Overall Study|Protocol Violation|1|||
130183335|NCT02394600|468629017|FG001|Overall Study|Protocol Violation|0|||
130183336|NCT01686373|468629018|FG000|Overall Study|Lost to Follow-up|3|||
130183337|NCT01686373|468629019|FG001|Overall Study|Lost to Follow-up|0|||
130183338|NCT01686373|468629018|FG000|Overall Study|Withdrawal by Subject|0|||
130183339|NCT01686373|468629019|FG001|Overall Study|Withdrawal by Subject|1|||
130183340|NCT01686373|468629018|FG000|Overall Study|Adverse Event|0|||
130183341|NCT01686373|468629019|FG001|Overall Study|Adverse Event|1|||
130183342|NCT04052620|468629021|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
130183343|NCT04052620|468629022|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
130183344|NCT04052620|468629021|FG000|Overall Study|Withdrawal by Subject|1|||
130183345|NCT04052620|468629022|FG001|Overall Study|Withdrawal by Subject|0|||
130183346|NCT04052620|468629021|FG000|Overall Study|Lost to Follow-up|1|||
130183347|NCT04052620|468629022|FG001|Overall Study|Lost to Follow-up|1|||
130183348|NCT04052620|468629021|FG000|Overall Study|Adverse Event|1|||
130183349|NCT04052620|468629022|FG001|Overall Study|Adverse Event|0|||
130183350|NCT04052620|468629021|FG000|Overall Study|Subject did not meet study Criteria|0|||
130183351|NCT04052620|468629022|FG001|Overall Study|Subject did not meet study Criteria|1|||
130183352|NCT04052620|468629021|FG000|Overall Study|Screened failure, randomized by mistake|0|||
130183353|NCT04052620|468629022|FG001|Overall Study|Screened failure, randomized by mistake|1|||
130183354|NCT04052620|468629021|FG000|Overall Study|Personal reasons|2|||
130183355|NCT04052620|468629022|FG001|Overall Study|Personal reasons|4|||
130183356|NCT04052620|468629021|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
130183357|NCT04052620|468629022|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
130183358|NCT02201784|468629023|FG000|Overall Study|Failure to achieve adequate block|2|||
130183359|NCT02201784|468629024|FG001|Overall Study|Failure to achieve adequate block|0|||
130183360|NCT02431364|468629025|FG000|Overall Study|Adverse Event|0|||
130183361|NCT02431364|468629026|FG001|Overall Study|Adverse Event|1|||
130183362|NCT02431364|468629027|FG002|Overall Study|Adverse Event|0|||
130183363|NCT02431364|468629028|FG003|Overall Study|Adverse Event|0|||
130183364|NCT02431364|468629029|FG004|Overall Study|Adverse Event|0|||
130183365|NCT02431364|468629025|FG000|Overall Study|Randomized but never treated|0|||
130183366|NCT02431364|468629026|FG001|Overall Study|Randomized but never treated|0|||
130183367|NCT02431364|468629027|FG002|Overall Study|Randomized but never treated|0|||
130183368|NCT02431364|468629028|FG003|Overall Study|Randomized but never treated|1|||
130183369|NCT02431364|468629029|FG004|Overall Study|Randomized but never treated|0|||
130183370|NCT00916383|468629030|FG000|Overall Study|Adverse Event|1|||
130183371|NCT00916383|468629030|FG000|Overall Study|Death|1|||
130183372|NCT00916383|468629030|FG000|Overall Study|Protocol Violation|1|||
130183373|NCT00258960|468629031|FG000|Overall Study|Death|2|||
130183374|NCT00258960|468629031|FG000|Overall Study|Disease Progression|7|||
130183375|NCT00258960|468629031|FG000|Overall Study|Adverse Event|4|||
130183376|NCT00258960|468629031|FG000|Overall Study|Physician Decision|1|||
130183377|NCT00258960|468629031|FG000|Overall Study|Withdrawal by Subject|1|||
130183378|NCT00258960|468629031|FG000|Overall Study|Mistake|2|||
130183379|NCT01112059|468629032|FG000|Overall Study|Withdrawal by Subject|1|||
130183380|NCT01112059|468629033|FG001|Overall Study|Withdrawal by Subject|0|||
130183381|NCT02235454|468629036|FG000|Overall Study|Withdrawal by Subject|2|||
130183382|NCT03323398|468629037|FG000|Overall Study|Other than Specified|0|||
130183383|NCT03323398|468629038|FG001|Overall Study|Other than Specified|1|||
130183384|NCT03323398|468629039|FG002|Overall Study|Other than Specified|2|||
130183385|NCT03323398|468629040|FG003|Overall Study|Other than Specified|0|||
130183386|NCT03323398|468629041|FG004|Overall Study|Other than Specified|0|||
130183387|NCT03323398|468629042|FG005|Overall Study|Other than Specified|0|||
130183388|NCT03323398|468629043|FG006|Overall Study|Other than Specified|1|||
130183389|NCT03323398|468629044|FG007|Overall Study|Other than Specified|0|||
130183390|NCT03323398|468629045|FG008|Overall Study|Other than Specified|2|||
130183391|NCT03323398|468629037|FG000|Overall Study|Lost to Follow-up|1|||
130183392|NCT03323398|468629038|FG001|Overall Study|Lost to Follow-up|2|||
130183393|NCT03323398|468629039|FG002|Overall Study|Lost to Follow-up|1|||
130183394|NCT03323398|468629040|FG003|Overall Study|Lost to Follow-up|0|||
130183395|NCT03323398|468629041|FG004|Overall Study|Lost to Follow-up|0|||
130183396|NCT03323398|468629042|FG005|Overall Study|Lost to Follow-up|0|||
130183397|NCT03323398|468629043|FG006|Overall Study|Lost to Follow-up|0|||
130183398|NCT03323398|468629044|FG007|Overall Study|Lost to Follow-up|0|||
130183399|NCT03323398|468629045|FG008|Overall Study|Lost to Follow-up|0|||
130183400|NCT03323398|468629037|FG000|Overall Study|Death|4|||
130183401|NCT03323398|468629038|FG001|Overall Study|Death|6|||
130183402|NCT03323398|468629039|FG002|Overall Study|Death|2|||
130183403|NCT03323398|468629040|FG003|Overall Study|Death|2|||
130183404|NCT03323398|468629041|FG004|Overall Study|Death|1|||
130183405|NCT03323398|468629042|FG005|Overall Study|Death|2|||
130183406|NCT03323398|468629043|FG006|Overall Study|Death|0|||
130183407|NCT03323398|468629044|FG007|Overall Study|Death|0|||
130183408|NCT03323398|468629045|FG008|Overall Study|Death|6|||
130183409|NCT03323398|468629037|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
130183410|NCT03323398|468629038|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
130183411|NCT03323398|468629039|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
130183412|NCT03323398|468629040|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
130183413|NCT03323398|468629041|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
130183414|NCT03323398|468629042|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
130183415|NCT03323398|468629043|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
130183416|NCT03323398|468629044|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
130183417|NCT03323398|468629045|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
130183418|NCT03323398|468629037|FG000|Overall Study|Withdrawal by Subject|2|||
130183419|NCT03323398|468629038|FG001|Overall Study|Withdrawal by Subject|1|||
130183420|NCT03323398|468629039|FG002|Overall Study|Withdrawal by Subject|3|||
130183421|NCT03323398|468629040|FG003|Overall Study|Withdrawal by Subject|0|||
130183422|NCT03323398|468629041|FG004|Overall Study|Withdrawal by Subject|0|||
130183423|NCT03323398|468629042|FG005|Overall Study|Withdrawal by Subject|1|||
130183424|NCT03323398|468629043|FG006|Overall Study|Withdrawal by Subject|0|||
130183425|NCT03323398|468629044|FG007|Overall Study|Withdrawal by Subject|0|||
130183426|NCT03323398|468629045|FG008|Overall Study|Withdrawal by Subject|0|||
130183427|NCT03323398|468629037|FG000|Overall Study|Participant was Put on Hospice|0|||
130183428|NCT03323398|468629038|FG001|Overall Study|Participant was Put on Hospice|0|||
130183429|NCT03323398|468629039|FG002|Overall Study|Participant was Put on Hospice|0|||
130183430|NCT03323398|468629040|FG003|Overall Study|Participant was Put on Hospice|0|||
130183431|NCT03323398|468629041|FG004|Overall Study|Participant was Put on Hospice|0|||
130183432|NCT03323398|468629042|FG005|Overall Study|Participant was Put on Hospice|0|||
130183433|NCT03323398|468629043|FG006|Overall Study|Participant was Put on Hospice|1|||
130183434|NCT03323398|468629044|FG007|Overall Study|Participant was Put on Hospice|0|||
130183435|NCT03323398|468629045|FG008|Overall Study|Participant was Put on Hospice|0|||
130183436|NCT03323398|468629037|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
130183437|NCT03323398|468629038|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
130183438|NCT03323398|468629039|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
130183439|NCT03323398|468629040|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
130183440|NCT03323398|468629041|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
130183441|NCT03323398|468629042|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
130183442|NCT03323398|468629043|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
130183443|NCT03323398|468629044|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
130183444|NCT03323398|468629045|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
130183445|NCT06025721|468630353|FG000|Overall Study|Physician Decision|1|||
130183446|NCT06025721|468630353|FG000|Overall Study|Protocol Violation|1|||
130183447|NCT06025721|468630353|FG000|Overall Study|Incarceration|1|||
130183448|NCT04510090|468630354|FG000|FE-HS|Withdrawal by Subject|0|||
130183449|NCT04510090|468630355|FG001|FE-HS|Withdrawal by Subject|0|||
130183450|NCT04510090|468630356|FG002|FE-HS|Withdrawal by Subject|0|||
130183451|NCT04510090|468630357|FG003|FE-HS|Withdrawal by Subject|0|||
130183452|NCT04510090|468630358|FG004|FE-HS|Withdrawal by Subject|1|||
130183453|NCT04510090|468630359|FG005|FE-HS|Withdrawal by Subject|0|||
130183454|NCT04510090|468630360|FG006|FE-HS|Withdrawal by Subject|0|||
130183455|NCT04510090|468630361|FG007|FE-HS|Withdrawal by Subject|0|||
130183456|NCT01749826|468630362|FG000|Overall Study|Study Terminated|20|||
130183457|NCT01749826|468630363|FG001|Overall Study|Study Terminated|0|||
130183458|NCT05085834|468630364|FG000|Overall Study|Lost to Follow-up|9|||
130183459|NCT05085834|468630365|FG001|Overall Study|Lost to Follow-up|2|||
130183460|NCT05085834|468630364|FG000|Overall Study|Adverse Event|6|||
130183461|NCT05085834|468630365|FG001|Overall Study|Adverse Event|0|||
130183462|NCT05085834|468630364|FG000|Overall Study|Death|1|||
130183463|NCT05085834|468630365|FG001|Overall Study|Death|0|||
130183464|NCT05085834|468630364|FG000|Overall Study|Inability to swallow the pill|0|||
130183465|NCT05085834|468630365|FG001|Overall Study|Inability to swallow the pill|1|||
130183466|NCT05842967|468630366|FG000|Period 1: SSA|Adverse Event|1|||
130183467|NCT05842967|468630367|FG001|Period 1: SSA|Adverse Event|1|||
130183468|NCT05842967|468630368|FG002|Period 1: SSA|Adverse Event|0|||
130183469|NCT05842967|468630369|FG003|Period 1: SSA|Adverse Event|0|||
130183470|NCT05842967|468630366|FG000|Period 1: SSA|Death|1|||
130183471|NCT05842967|468630367|FG001|Period 1: SSA|Death|0|||
130183472|NCT05842967|468630368|FG002|Period 1: SSA|Death|0|||
130183473|NCT05842967|468630369|FG003|Period 1: SSA|Death|0|||
130183474|NCT05842967|468630366|FG000|Period 1: SSA|Lost to Follow-up|16|||
130183475|NCT05842967|468630367|FG001|Period 1: SSA|Lost to Follow-up|4|||
130183476|NCT05842967|468630368|FG002|Period 1: SSA|Lost to Follow-up|0|||
130183477|NCT05842967|468630369|FG003|Period 1: SSA|Lost to Follow-up|0|||
130183478|NCT05842967|468630366|FG000|Period 1: SSA|Physician Decision|1|||
130183479|NCT05842967|468630367|FG001|Period 1: SSA|Physician Decision|0|||
130183480|NCT05842967|468630368|FG002|Period 1: SSA|Physician Decision|0|||
130183481|NCT05842967|468630369|FG003|Period 1: SSA|Physician Decision|0|||
130183482|NCT05842967|468630366|FG000|Period 1: SSA|Withdrawal by Subject|2|||
130183483|NCT05842967|468630367|FG001|Period 1: SSA|Withdrawal by Subject|2|||
130183484|NCT05842967|468630368|FG002|Period 1: SSA|Withdrawal by Subject|0|||
130183485|NCT05842967|468630369|FG003|Period 1: SSA|Withdrawal by Subject|0|||
130183486|NCT05842967|468630366|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
130183487|NCT05842967|468630367|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
130183488|NCT05842967|468630368|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
130183489|NCT05842967|468630369|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
130183490|NCT05842967|468630366|FG000|Period 2: SSB|Adverse Event|0|||
130183491|NCT05842967|468630367|FG001|Period 2: SSB|Adverse Event|0|||
130183492|NCT05842967|468630368|FG002|Period 2: SSB|Adverse Event|2|||
130183493|NCT05842967|468630369|FG003|Period 2: SSB|Adverse Event|0|||
130183494|NCT05842967|468630366|FG000|Period 2: SSB|Lost to Follow-up|0|||
130183495|NCT05842967|468630367|FG001|Period 2: SSB|Lost to Follow-up|0|||
130183496|NCT05842967|468630368|FG002|Period 2: SSB|Lost to Follow-up|4|||
130183497|NCT05842967|468630369|FG003|Period 2: SSB|Lost to Follow-up|3|||
130183498|NCT05842967|468630366|FG000|Period 2: SSB|Withdrawal by Subject|0|||
130183499|NCT05842967|468630367|FG001|Period 2: SSB|Withdrawal by Subject|0|||
130183500|NCT05842967|468630368|FG002|Period 2: SSB|Withdrawal by Subject|1|||
130183501|NCT05842967|468630369|FG003|Period 2: SSB|Withdrawal by Subject|0|||
130183502|NCT05842967|468630366|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
130183503|NCT05842967|468630367|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
130183504|NCT05842967|468630368|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
130183505|NCT05842967|468630369|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
130183506|NCT05842967|468630366|FG000|Period 2: SSB|Protocol Violation|0|||
130183507|NCT05842967|468630367|FG001|Period 2: SSB|Protocol Violation|0|||
130183508|NCT05842967|468630368|FG002|Period 2: SSB|Protocol Violation|0|||
130183509|NCT05842967|468630369|FG003|Period 2: SSB|Protocol Violation|1|||
130183510|NCT01823328|468630371|FG000|Overall Study|Withdrawal by Subject|8|||
130183511|NCT01823328|468630372|FG001|Overall Study|Withdrawal by Subject|6|||
130183512|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
130183513|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
130183514|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
130183515|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
130183516|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
130183517|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
130183518|NCT02547428|468630373|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
130183519|NCT02547428|468630374|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
130183520|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
130183521|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
130183522|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
130183523|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
130183524|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
130183525|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
130183526|NCT02547428|468630373|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
130183527|NCT02547428|468630374|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
130183528|NCT01479465|468630375|FG000|Overall Study|Disease Progression|9|||
130183529|NCT01479465|468630376|FG001|Overall Study|Disease Progression|61|||
130183530|NCT01479465|468630377|FG002|Overall Study|Disease Progression|65|||
130183531|NCT01479465|468630378|FG003|Overall Study|Disease Progression|70|||
130183532|NCT01479465|468630375|FG000|Overall Study|Study Discontinued by Sponsor|0|||
130183533|NCT01479465|468630376|FG001|Overall Study|Study Discontinued by Sponsor|7|||
130183534|NCT01479465|468630377|FG002|Overall Study|Study Discontinued by Sponsor|5|||
130183535|NCT01479465|468630378|FG003|Overall Study|Study Discontinued by Sponsor|3|||
130183536|NCT01479465|468630375|FG000|Overall Study|Adverse Event|0|||
130183537|NCT01479465|468630376|FG001|Overall Study|Adverse Event|3|||
130183538|NCT01479465|468630377|FG002|Overall Study|Adverse Event|6|||
130183539|NCT01479465|468630378|FG003|Overall Study|Adverse Event|4|||
130183540|NCT01479465|468630375|FG000|Overall Study|Investigator Discretion|1|||
130183541|NCT01479465|468630376|FG001|Overall Study|Investigator Discretion|4|||
130183542|NCT01479465|468630377|FG002|Overall Study|Investigator Discretion|2|||
130183543|NCT01479465|468630378|FG003|Overall Study|Investigator Discretion|4|||
130183544|NCT01479465|468630375|FG000|Overall Study|Subject Request|1|||
130183545|NCT01479465|468630376|FG001|Overall Study|Subject Request|3|||
130183546|NCT01479465|468630377|FG002|Overall Study|Subject Request|4|||
130183547|NCT01479465|468630378|FG003|Overall Study|Subject Request|2|||
130183548|NCT01479465|468630375|FG000|Overall Study|Subject Withdrew Consent|0|||
130183549|NCT01479465|468630376|FG001|Overall Study|Subject Withdrew Consent|5|||
130183550|NCT01479465|468630377|FG002|Overall Study|Subject Withdrew Consent|2|||
130183551|NCT01479465|468630378|FG003|Overall Study|Subject Withdrew Consent|1|||
130183552|NCT01479465|468630375|FG000|Overall Study|Protocol Violation|0|||
130183553|NCT01479465|468630376|FG001|Overall Study|Protocol Violation|1|||
130183554|NCT01479465|468630377|FG002|Overall Study|Protocol Violation|1|||
130183555|NCT01479465|468630378|FG003|Overall Study|Protocol Violation|0|||
130183556|NCT01479465|468630375|FG000|Overall Study|Death|0|||
130183557|NCT01479465|468630376|FG001|Overall Study|Death|0|||
130183558|NCT01479465|468630377|FG002|Overall Study|Death|0|||
130183559|NCT01479465|468630378|FG003|Overall Study|Death|1|||
130183560|NCT01479465|468630375|FG000|Overall Study|Lost to Follow-up|0|||
130183561|NCT01479465|468630376|FG001|Overall Study|Lost to Follow-up|0|||
130183562|NCT01479465|468630377|FG002|Overall Study|Lost to Follow-up|1|||
130183563|NCT01479465|468630378|FG003|Overall Study|Lost to Follow-up|0|||
130183564|NCT01173523|468630379|FG000|Overall Study|Clinical Progression|1|||
130183565|NCT01173523|468630380|FG001|Overall Study|Clinical Progression|1|||
130183566|NCT01173523|468630379|FG000|Overall Study|Progressive Disease|10|||
130183567|NCT01173523|468630380|FG001|Overall Study|Progressive Disease|8|||
130183568|NCT01173523|468630379|FG000|Overall Study|Other|2|||
130183569|NCT01173523|468630380|FG001|Overall Study|Other|3|||
130183570|NCT02717507|468630385|FG000|Overall Study|Lost to Follow-up|5|||
130183571|NCT02717507|468630386|FG001|Overall Study|Lost to Follow-up|8|||
130183572|NCT02717507|468630385|FG000|Overall Study|Pregnancy|1|||
130183573|NCT02717507|468630386|FG001|Overall Study|Pregnancy|1|||
130183574|NCT02717507|468630385|FG000|Overall Study|Protocol Violation|2|||
130183575|NCT02717507|468630386|FG001|Overall Study|Protocol Violation|2|||
130183576|NCT02717507|468630385|FG000|Overall Study|Withdrawal by Subject|20|||
130183577|NCT02717507|468630386|FG001|Overall Study|Withdrawal by Subject|20|||
130183578|NCT02717507|468630385|FG000|Overall Study|Relapse|1|||
130183579|NCT02717507|468630386|FG001|Overall Study|Relapse|1|||
130183580|NCT02717507|468630385|FG000|Overall Study|Cardiac Event|2|||
130183581|NCT02717507|468630386|FG001|Overall Study|Cardiac Event|6|||
130183582|NCT01439802|468630387|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
130183583|NCT01439802|468630387|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
130183584|NCT01866826|468630388|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
130183585|NCT01866826|468630389|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
130183586|NCT01866826|468630388|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
130183587|NCT01866826|468630389|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
130183588|NCT01866826|468630388|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
130183589|NCT01866826|468630389|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
130183590|NCT00709995|468630390|FG000|Overall Study|Adverse Event|4|||
130183591|NCT00709995|468630391|FG001|Overall Study|Adverse Event|2|||
130183592|NCT00709995|468630390|FG000|Overall Study|Withdrawal by Subject|1|||
130183593|NCT00709995|468630391|FG001|Overall Study|Withdrawal by Subject|3|||
130183594|NCT00742209|468630396|FG000|Overall Study|Adverse Event|11|||
130183595|NCT00742209|468630397|FG001|Overall Study|Adverse Event|4|||
130183596|NCT00742209|468630398|FG002|Overall Study|Adverse Event|17|||
130183597|NCT00742209|468630399|FG003|Overall Study|Adverse Event|16|||
130183598|NCT00742209|468630400|FG004|Overall Study|Adverse Event|13|||
130183599|NCT00742209|468630396|FG000|Overall Study|Participant Withdrew Consent|8|||
130183600|NCT00742209|468630397|FG001|Overall Study|Participant Withdrew Consent|4|||
130183601|NCT00742209|468630398|FG002|Overall Study|Participant Withdrew Consent|14|||
130183602|NCT00742209|468630399|FG003|Overall Study|Participant Withdrew Consent|7|||
130183603|NCT00742209|468630400|FG004|Overall Study|Participant Withdrew Consent|4|||
130183604|NCT00742209|468630396|FG000|Overall Study|Protocol Violation|6|||
130183605|NCT00742209|468630397|FG001|Overall Study|Protocol Violation|5|||
130183606|NCT00742209|468630398|FG002|Overall Study|Protocol Violation|4|||
130183607|NCT00742209|468630399|FG003|Overall Study|Protocol Violation|5|||
130183608|NCT00742209|468630400|FG004|Overall Study|Protocol Violation|3|||
130183609|NCT00742209|468630396|FG000|Overall Study|Lost to Follow-up|3|||
130183610|NCT00742209|468630397|FG001|Overall Study|Lost to Follow-up|4|||
130183611|NCT00742209|468630398|FG002|Overall Study|Lost to Follow-up|5|||
130183612|NCT00742209|468630399|FG003|Overall Study|Lost to Follow-up|5|||
130183613|NCT00742209|468630400|FG004|Overall Study|Lost to Follow-up|3|||
130183614|NCT00742209|468630396|FG000|Overall Study|Lack of Efficacy|6|||
130183615|NCT00742209|468630397|FG001|Overall Study|Lack of Efficacy|1|||
130183616|NCT00742209|468630398|FG002|Overall Study|Lack of Efficacy|1|||
130183617|NCT00742209|468630399|FG003|Overall Study|Lack of Efficacy|3|||
130183618|NCT00742209|468630400|FG004|Overall Study|Lack of Efficacy|1|||
130183619|NCT00742209|468630396|FG000|Overall Study|Investigator Discretion|0|||
130183620|NCT00742209|468630397|FG001|Overall Study|Investigator Discretion|0|||
130183621|NCT00742209|468630398|FG002|Overall Study|Investigator Discretion|5|||
130183622|NCT00742209|468630399|FG003|Overall Study|Investigator Discretion|1|||
130183623|NCT00742209|468630400|FG004|Overall Study|Investigator Discretion|1|||
130183624|NCT00595621|468630404|FG000|Open Label Run in|Adverse Event|1|||
130183625|NCT00595621|468630405|FG001|Open Label Run in|Adverse Event|0|||
130183626|NCT00595621|468630404|FG000|Open Label Run in|Physician Decision|1|||
130183627|NCT00595621|468630405|FG001|Open Label Run in|Physician Decision|0|||
130183628|NCT00595621|468630404|FG000|Open Label Run in|Withdrawal by Subject|1|||
130183629|NCT00595621|468630405|FG001|Open Label Run in|Withdrawal by Subject|0|||
130183630|NCT00595621|468630404|FG000|Randomization and Study|Adverse Event|2|||
130183631|NCT00595621|468630405|FG001|Randomization and Study|Adverse Event|0|||
130183632|NCT00595621|468630404|FG000|Randomization and Study|Withdrawal by Subject|0|||
130183633|NCT00595621|468630405|FG001|Randomization and Study|Withdrawal by Subject|1|||
130183634|NCT00324987|468630406|FG000|Overall Study|Adverse Event|2|||
130183635|NCT00324987|468630407|FG001|Overall Study|Adverse Event|1|||
130183636|NCT00324987|468630406|FG000|Overall Study|Withdrawal by Subject|1|||
130183637|NCT00324987|468630407|FG001|Overall Study|Withdrawal by Subject|1|||
130183638|NCT00324987|468630406|FG000|Overall Study|Progression|1|||
130183639|NCT00324987|468630407|FG001|Overall Study|Progression|1|||
130183640|NCT00324987|468630406|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
130183641|NCT00324987|468630407|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
130183642|NCT03817125|468630408|FG000|Overall Study|Adverse Event|1|||
130183643|NCT03817125|468630409|FG001|Overall Study|Adverse Event|0|||
130183644|NCT03817125|468630408|FG000|Overall Study|Physician Decision|0|||
130183645|NCT03817125|468630409|FG001|Overall Study|Physician Decision|1|||
130183646|NCT03817125|468630408|FG000|Overall Study|Lack of Efficacy|1|||
130183647|NCT03817125|468630409|FG001|Overall Study|Lack of Efficacy|5|||
130183648|NCT00942084|468630410|FG000|Overall Study|Death|2|||
130183649|NCT01998919|468630411|FG000|Overall Study|Death|2|||
130183650|NCT01998919|468630412|FG001|Overall Study|Death|2|||
130183651|NCT01998919|468630411|FG000|Overall Study|Adverse Event|0|||
130183652|NCT01998919|468630412|FG001|Overall Study|Adverse Event|5|||
130183653|NCT01998919|468630411|FG000|Overall Study|Disease progression|31|||
130183654|NCT01998919|468630412|FG001|Overall Study|Disease progression|22|||
130183655|NCT01998919|468630411|FG000|Overall Study|Withdrawal by Subject|2|||
130183656|NCT01998919|468630412|FG001|Overall Study|Withdrawal by Subject|4|||
130183657|NCT01998919|468630411|FG000|Overall Study|Lost to Follow-up|2|||
130183658|NCT01998919|468630412|FG001|Overall Study|Lost to Follow-up|0|||
130183659|NCT01998919|468630411|FG000|Overall Study|Other|5|||
130183660|NCT01998919|468630412|FG001|Overall Study|Other|2|||
130183661|NCT00897715|468630416|FG000|Overall Study|Lost to Follow-up|0|||
130183662|NCT00897715|468630417|FG001|Overall Study|Lost to Follow-up|1|||
130183663|NCT00897715|468630416|FG000|Overall Study|Physician Decision|1|||
130183664|NCT00897715|468630417|FG001|Overall Study|Physician Decision|0|||
130183665|NCT00897715|468630416|FG000|Overall Study|increased risk of infection|1|||
130183666|NCT00897715|468630417|FG001|Overall Study|increased risk of infection|0|||
130183667|NCT00063934|468630418|FG000|Overall Study|Ineligible|1|||
130183668|NCT04341363|468630419|FG000|Overall Study|Adverse Event|1|||
130183669|NCT04341363|468630419|FG000|Overall Study|Withdrawal by Subject|1|||
130183670|NCT00840749|468630420|FG000|Overall Study|Death|1|||
130183671|NCT00840749|468630421|FG001|Overall Study|Death|2|||
130183672|NCT00840749|468630420|FG000|Overall Study|not treated on study arm|11|||
130183673|NCT00840749|468630421|FG001|Overall Study|not treated on study arm|11|||
130183674|NCT00840749|468630420|FG000|Overall Study|study closed|19|||
130183675|NCT00840749|468630421|FG001|Overall Study|study closed|14|||
130183676|NCT01960413|468630422|FG000|Overall Study|Withdrawal by Subject|1|||
130183677|NCT01960413|468630423|FG001|Overall Study|Withdrawal by Subject|1|||
130183678|NCT01960413|468630422|FG000|Overall Study|Physician Decision|1|||
130183679|NCT01960413|468630423|FG001|Overall Study|Physician Decision|0|||
130183680|NCT01960413|468630422|FG000|Overall Study|Lost to Follow-up|2|||
130183681|NCT01960413|468630423|FG001|Overall Study|Lost to Follow-up|0|||
130183682|NCT00791778|468630427|FG000|Double-blind Treatment|Adverse Event|49|||
130183683|NCT00791778|468630428|FG001|Double-blind Treatment|Adverse Event|9|||
130183684|NCT00791778|468630427|FG000|Double-blind Treatment|Physician Decision|6|||
130183685|NCT00791778|468630428|FG001|Double-blind Treatment|Physician Decision|26|||
130183686|NCT00791778|468630427|FG000|Double-blind Treatment|Protocol Violation|0|||
130183687|NCT00791778|468630428|FG001|Double-blind Treatment|Protocol Violation|4|||
130183688|NCT00791778|468630427|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
130183689|NCT00791778|468630428|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
130183690|NCT00791778|468630427|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
130183691|NCT00791778|468630428|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
130183692|NCT00791778|468630427|FG000|Follow-up|Withdrawal by Subject|3|||
130183693|NCT00791778|468630428|FG001|Follow-up|Withdrawal by Subject|0|||
130183694|NCT00791778|468630427|FG000|Follow-up|Lost to Follow-up|2|||
130183695|NCT00791778|468630428|FG001|Follow-up|Lost to Follow-up|1|||
130183696|NCT03335475|468630429|FG000|Overall Study|Did not wear accelerometer|4|||
130183697|NCT03335475|468630430|FG001|Overall Study|Did not wear accelerometer|0|||
130183698|NCT03335475|468630429|FG000|Overall Study|Withdrawal by Subject|0|||
130183699|NCT03335475|468630430|FG001|Overall Study|Withdrawal by Subject|1|||
130183700|NCT05921903|468630433|FG000|Overall Study|Unsolicited non-SAE|0|||
130183701|NCT05921903|468630434|FG001|Overall Study|Unsolicited non-SAE|1|||
130183702|NCT05921903|468630435|FG002|Overall Study|Unsolicited non-SAE|0|||
130183703|NCT05921903|468630433|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
130183704|NCT05921903|468630434|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
130183705|NCT05921903|468630435|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
130183706|NCT05921903|468630433|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
130183707|NCT05921903|468630434|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
130183708|NCT05921903|468630435|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
130183709|NCT05317312|468630438|FG000|Overall Study|Withdrawal by Subject|0|||
130183710|NCT05317312|468630439|FG001|Overall Study|Withdrawal by Subject|1|||
130183711|NCT05317312|468630440|FG002|Overall Study|Withdrawal by Subject|0|||
130183712|NCT05317312|468630441|FG003|Overall Study|Withdrawal by Subject|0|||
130183713|NCT05317312|468630438|FG000|Overall Study|Lost to Follow-up|0|||
130183714|NCT05317312|468630439|FG001|Overall Study|Lost to Follow-up|0|||
130183715|NCT05317312|468630440|FG002|Overall Study|Lost to Follow-up|0|||
130183716|NCT05317312|468630441|FG003|Overall Study|Lost to Follow-up|1|||
130183717|NCT05317312|468630438|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
130183718|NCT05317312|468630439|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
130183719|NCT05317312|468630440|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
130183720|NCT05317312|468630441|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
130183721|NCT00235755|468630442|FG000|4-Week Titration Phase|Adverse Event|6|||
130183722|NCT00235755|468630443|FG001|4-Week Titration Phase|Adverse Event|14|||
130183723|NCT00235755|468630444|FG002|4-Week Titration Phase|Adverse Event|20|||
130183724|NCT00235755|468630442|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
130183725|NCT00235755|468630443|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
130183726|NCT00235755|468630444|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
130183727|NCT00235755|468630442|FG000|4-Week Titration Phase|Protocol Violation|2|||
130183728|NCT00235755|468630443|FG001|4-Week Titration Phase|Protocol Violation|2|||
130183729|NCT00235755|468630444|FG002|4-Week Titration Phase|Protocol Violation|1|||
130183730|NCT00235755|468630442|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
130183731|NCT00235755|468630443|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
130183732|NCT00235755|468630444|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
130183733|NCT00235755|468630442|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130183734|NCT00235755|468630443|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
130183735|NCT00235755|468630444|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
130183736|NCT00235755|468630442|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
130183737|NCT00235755|468630443|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
130183738|NCT00235755|468630444|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
130183739|NCT00235755|468630442|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
130183740|NCT00235755|468630443|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
130183741|NCT00235755|468630444|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
130183742|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Adverse Event|8|||
130183743|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Adverse Event|12|||
130183744|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Adverse Event|26|||
130183745|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
130183746|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
130183747|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
130183748|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
130183749|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
130183750|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
130183751|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
130183752|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
130183753|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
130183754|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
130183755|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
130183756|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
130183757|NCT00235755|468630442|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
130183758|NCT00235755|468630443|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
130183759|NCT00235755|468630444|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
130183760|NCT02314026|468630445|FG000|Overall Study|Protocol Violation|28|||
130183761|NCT01532934|468630446|FG000|Overall Study|Lost to Follow-up|11|||
130183762|NCT01532934|468630447|FG001|Overall Study|Lost to Follow-up|11|||
130183763|NCT01532934|468630446|FG000|Overall Study|In controlled environment|3|||
130183764|NCT01532934|468630447|FG001|Overall Study|In controlled environment|2|||
130183765|NCT02291237|468630448|FG000|Overall Study|Study Terminated by Sponsor|72|||
130183766|NCT02291237|468630449|FG001|Overall Study|Study Terminated by Sponsor|67|||
130183767|NCT02291237|468630448|FG000|Overall Study|Adverse Event|1|||
130183768|NCT02291237|468630449|FG001|Overall Study|Adverse Event|3|||
130183769|NCT02291237|468630448|FG000|Overall Study|Investigator's Discretion|0|||
130183770|NCT02291237|468630449|FG001|Overall Study|Investigator's Discretion|3|||
130183771|NCT02291237|468630448|FG000|Overall Study|Withdrew Consent|11|||
130183772|NCT02291237|468630449|FG001|Overall Study|Withdrew Consent|11|||
130183773|NCT02291237|468630448|FG000|Overall Study|Lost to Follow-up|0|||
130183774|NCT02291237|468630449|FG001|Overall Study|Lost to Follow-up|2|||
130183775|NCT02291237|468630448|FG000|Overall Study|Subject Required Prohibited Medication|2|||
130183776|NCT02291237|468630449|FG001|Overall Study|Subject Required Prohibited Medication|0|||
130183777|NCT01149863|468630450|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
130183778|NCT01306305|468630451|FG000|Overall Study|Lost to Follow-up|1|||
130183779|NCT01306305|468630452|FG001|Overall Study|Lost to Follow-up|0|||
130183780|NCT01306305|468630451|FG000|Overall Study|Withdrew consent|1|||
130183781|NCT01306305|468630452|FG001|Overall Study|Withdrew consent|0|||
130183782|NCT03326193|468630453|FG000|Overall Study|Sponsor decision|35|||
130183783|NCT00699998|468630455|FG000|Overall Study|Withdrawal by Subject|194|||
130183784|NCT00699998|468630456|FG001|Overall Study|Withdrawal by Subject|83|||
130183785|NCT00699998|468630457|FG002|Overall Study|Withdrawal by Subject|202|||
130183786|NCT00699998|468630458|FG003|Overall Study|Withdrawal by Subject|80|||
130183787|NCT00699998|468630455|FG000|Overall Study|Physician Decision|3|||
130183788|NCT00699998|468630456|FG001|Overall Study|Physician Decision|2|||
130183789|NCT00699998|468630457|FG002|Overall Study|Physician Decision|1|||
130183790|NCT00699998|468630458|FG003|Overall Study|Physician Decision|1|||
130183791|NCT00699998|468630455|FG000|Overall Study|Lost to Follow-up|2|||
130183792|NCT00699998|468630456|FG001|Overall Study|Lost to Follow-up|1|||
130183793|NCT00699998|468630457|FG002|Overall Study|Lost to Follow-up|3|||
130183794|NCT00699998|468630458|FG003|Overall Study|Lost to Follow-up|1|||
130183795|NCT01406574|468630459|FG000|Overall Study|Adverse Event|0|||
130183796|NCT01406574|468630460|FG001|Overall Study|Adverse Event|0|||
130183797|NCT01406574|468630461|FG002|Overall Study|Adverse Event|1|||
130183798|NCT01406574|468630462|FG003|Overall Study|Adverse Event|3|||
130183799|NCT01406574|468630459|FG000|Overall Study|Physician Decision|0|||
130183800|NCT01406574|468630460|FG001|Overall Study|Physician Decision|0|||
130183801|NCT01406574|468630461|FG002|Overall Study|Physician Decision|0|||
130183802|NCT01406574|468630462|FG003|Overall Study|Physician Decision|1|||
130183803|NCT01406574|468630459|FG000|Overall Study|Withdrawal by Subject|0|||
130183804|NCT01406574|468630460|FG001|Overall Study|Withdrawal by Subject|1|||
130183805|NCT01406574|468630461|FG002|Overall Study|Withdrawal by Subject|0|||
130183806|NCT01406574|468630462|FG003|Overall Study|Withdrawal by Subject|0|||
130183807|NCT01406574|468630459|FG000|Overall Study|Definite progression of primary disease|1|||
130183808|NCT01406574|468630460|FG001|Overall Study|Definite progression of primary disease|0|||
130183809|NCT01406574|468630461|FG002|Overall Study|Definite progression of primary disease|0|||
130183810|NCT01406574|468630462|FG003|Overall Study|Definite progression of primary disease|0|||
130183811|NCT00473590|468630467|FG000|Overall Study|Adverse Event|3|||
130183812|NCT00473590|468630468|FG001|Overall Study|Adverse Event|3|||
130183813|NCT00473590|468630467|FG000|Overall Study|Death|4|||
130183814|NCT00473590|468630468|FG001|Overall Study|Death|2|||
130183815|NCT00473590|468630467|FG000|Overall Study|Progression not resulting in death|24|||
130183816|NCT00473590|468630468|FG001|Overall Study|Progression not resulting in death|20|||
130183817|NCT00473590|468630467|FG000|Overall Study|Non-protocol-specified therapy|7|||
130183818|NCT00473590|468630468|FG001|Overall Study|Non-protocol-specified therapy|5|||
130183819|NCT00473590|468630467|FG000|Overall Study|Physician Decision|2|||
130183820|NCT00473590|468630468|FG001|Overall Study|Physician Decision|4|||
130183821|NCT00473590|468630467|FG000|Overall Study|Withdrawal by Subject|5|||
130183822|NCT00473590|468630468|FG001|Overall Study|Withdrawal by Subject|3|||
130183823|NCT00473590|468630467|FG000|Overall Study|Other|0|||
130183824|NCT00473590|468630468|FG001|Overall Study|Other|1|||
130183825|NCT03367819|468630471|FG000|Overall Study|Adverse Event|4|||
130183826|NCT03367819|468630472|FG001|Overall Study|Adverse Event|4|||
130183827|NCT03367819|468630471|FG000|Overall Study|Progressive Disease|15|||
130183828|NCT03367819|468630472|FG001|Overall Study|Progressive Disease|13|||
130183829|NCT03367819|468630471|FG000|Overall Study|Withdrawal by Subject|1|||
130183830|NCT03367819|468630472|FG001|Overall Study|Withdrawal by Subject|0|||
130183831|NCT03367819|468630471|FG000|Overall Study|Other|4|||
130183832|NCT03367819|468630472|FG001|Overall Study|Other|2|||
130183833|NCT00584454|468630473|FG000|Overall Study|Adverse Event|1|||
130183834|NCT00584454|468630473|FG000|Overall Study|Relocation|1|||
130183835|NCT00584454|468630473|FG000|Overall Study|Clinical Hold|2|||
130183836|NCT00982657|468630474|FG000|Overall Study|Death|1|||
130183837|NCT00982657|468630475|FG001|Overall Study|Death|0|||
130183838|NCT00982657|468630476|FG002|Overall Study|Death|1|||
130183839|NCT00982657|468630477|FG003|Overall Study|Death|1|||
130183840|NCT00982657|468630474|FG000|Overall Study|Withdrawal by Subject|0|||
130183841|NCT00982657|468630475|FG001|Overall Study|Withdrawal by Subject|0|||
130183842|NCT00982657|468630476|FG002|Overall Study|Withdrawal by Subject|1|||
130183843|NCT00982657|468630477|FG003|Overall Study|Withdrawal by Subject|3|||
130183844|NCT00982657|468630474|FG000|Overall Study|Other|0|||
130183845|NCT00982657|468630475|FG001|Overall Study|Other|0|||
130183846|NCT00982657|468630476|FG002|Overall Study|Other|0|||
130183847|NCT00982657|468630477|FG003|Overall Study|Other|4|||
130183848|NCT00982657|468630474|FG000|Overall Study|On going at date of cut-off|0|||
130183849|NCT00982657|468630475|FG001|Overall Study|On going at date of cut-off|0|||
130183850|NCT00982657|468630476|FG002|Overall Study|On going at date of cut-off|0|||
130183851|NCT00982657|468630477|FG003|Overall Study|On going at date of cut-off|1|||
130183852|NCT00725920|468630478|FG000|Overall Study|Lack of Efficacy|3|||
130183853|NCT00725920|468630479|FG001|Overall Study|Lack of Efficacy|6|||
130183854|NCT05373108|468630480|FG000|Overall Study|Withdrawal by Subject|2|||
130183855|NCT02546986|468632418|FG000|Treatment Period|Progressive Disease|20|||
130183856|NCT02546986|468632419|FG001|Treatment Period|Progressive Disease|22|||
130183857|NCT02546986|468632418|FG000|Treatment Period|Adverse Event|14|||
130183858|NCT02546986|468632419|FG001|Treatment Period|Adverse Event|6|||
130183859|NCT02546986|468632418|FG000|Treatment Period|Symptomatic Deterioration|4|||
130183860|NCT02546986|468632419|FG001|Treatment Period|Symptomatic Deterioration|3|||
130183861|NCT02546986|468632418|FG000|Treatment Period|Death|3|||
130183862|NCT02546986|468632419|FG001|Treatment Period|Death|4|||
130183863|NCT02546986|468632418|FG000|Treatment Period|Physician Decision|1|||
130183864|NCT02546986|468632419|FG001|Treatment Period|Physician Decision|2|||
130183865|NCT02546986|468632418|FG000|Treatment Period|Protocol Violation|1|||
130183866|NCT02546986|468632419|FG001|Treatment Period|Protocol Violation|0|||
130183867|NCT02546986|468632418|FG000|Treatment Period|Withdrawal by Subject|1|||
130183868|NCT02546986|468632419|FG001|Treatment Period|Withdrawal by Subject|1|||
130183869|NCT02546986|468632418|FG000|Treatment Period|Non-compliance with Study Drug|0|||
130183870|NCT02546986|468632419|FG001|Treatment Period|Non-compliance with Study Drug|1|||
130183871|NCT02546986|468632418|FG000|Treatment Period|Study Terminated by Sponsor|0|||
130183872|NCT02546986|468632419|FG001|Treatment Period|Study Terminated by Sponsor|1|||
130183873|NCT02546986|468632418|FG000|Treatment Period|Miscellaneous|7|||
130183874|NCT02546986|468632419|FG001|Treatment Period|Miscellaneous|9|||
130183875|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Missing Status|3|||
130183876|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Missing Status|5|||
130183877|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Death|18|||
130183878|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Death|12|||
130183879|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Alive|13|||
130183880|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Alive|16|||
130183881|NCT02546986|468632418|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
130183882|NCT02546986|468632419|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
130183883|NCT05016960|468632420|FG000|Overall Study|Withdrawal by Subject|1|||
130183884|NCT05016960|468632421|FG001|Overall Study|Withdrawal by Subject|9|||
130183885|NCT04796961|468632422|FG000|Overall Study|Lost to Follow-up|10|||
130183886|NCT04796961|468632422|FG000|Overall Study|Withdrawal by Subject|3|||
130183887|NCT04796961|468632422|FG000|Overall Study|Left Organization|10|||
130183888|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
130183889|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130183890|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130183891|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
130183892|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
130183893|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130183894|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130183895|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
130183896|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
130183897|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130183898|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130183899|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
130183900|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
130183901|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130183902|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130183903|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
130183904|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
130183905|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130183906|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130183907|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
130183908|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
130183909|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130183910|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130183911|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
130183912|NCT02513160|468632424|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
130183913|NCT02513160|468632425|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130183914|NCT02513160|468632426|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130183915|NCT02513160|468632427|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
130183916|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
130183917|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
130183918|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
130183919|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
130183920|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
130183921|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130183922|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130183923|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
130183924|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
130183925|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130183926|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130183927|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
130183928|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
130183929|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130183930|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130183931|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
130183932|NCT02513160|468632424|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130183933|NCT02513160|468632425|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
130183934|NCT02513160|468632426|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130183935|NCT02513160|468632427|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
130183936|NCT03428958|468632430|FG000|Overall Study|Adverse Event|0|||
130183937|NCT03428958|468632431|FG001|Overall Study|Adverse Event|0|||
130183938|NCT03428958|468632432|FG002|Overall Study|Adverse Event|0|||
130183939|NCT03428958|468632433|FG003|Overall Study|Adverse Event|1|||
130183940|NCT03428958|468632434|FG004|Overall Study|Adverse Event|0|||
130183941|NCT03428958|468632435|FG005|Overall Study|Adverse Event|2|||
130183942|NCT03428958|468632436|FG006|Overall Study|Adverse Event|1|||
130183943|NCT03428958|468632437|FG007|Overall Study|Adverse Event|0|||
130183944|NCT03428958|468632438|FG008|Overall Study|Adverse Event|0|||
130183945|NCT03428958|468632439|FG009|Overall Study|Adverse Event|0|||
130183946|NCT03428958|468632440|FG010|Overall Study|Adverse Event|0|||
130183947|NCT03428958|468632441|FG011|Overall Study|Adverse Event|0|||
130183948|NCT03428958|468632442|FG012|Overall Study|Adverse Event|0|||
130183949|NCT03428958|468632443|FG013|Overall Study|Adverse Event|0|||
130183950|NCT03428958|468632444|FG014|Overall Study|Adverse Event|0|||
130183951|NCT03428958|468632445|FG015|Overall Study|Adverse Event|0|||
130183952|NCT03428958|468632446|FG016|Overall Study|Adverse Event|0|||
130183953|NCT03428958|468632430|FG000|Overall Study|Clinical Progression|2|||
130183954|NCT03428958|468632431|FG001|Overall Study|Clinical Progression|3|||
130183955|NCT03428958|468632432|FG002|Overall Study|Clinical Progression|2|||
130183956|NCT03428958|468632433|FG003|Overall Study|Clinical Progression|1|||
130183957|NCT03428958|468632434|FG004|Overall Study|Clinical Progression|0|||
130183958|NCT03428958|468632435|FG005|Overall Study|Clinical Progression|2|||
130183959|NCT03428958|468632436|FG006|Overall Study|Clinical Progression|0|||
130183960|NCT03428958|468632437|FG007|Overall Study|Clinical Progression|0|||
130183961|NCT03428958|468632438|FG008|Overall Study|Clinical Progression|0|||
130183962|NCT03428958|468632439|FG009|Overall Study|Clinical Progression|0|||
130183963|NCT03428958|468632440|FG010|Overall Study|Clinical Progression|0|||
130183964|NCT03428958|468632441|FG011|Overall Study|Clinical Progression|0|||
130183965|NCT03428958|468632442|FG012|Overall Study|Clinical Progression|0|||
130183966|NCT03428958|468632443|FG013|Overall Study|Clinical Progression|0|||
130183967|NCT03428958|468632444|FG014|Overall Study|Clinical Progression|0|||
130183968|NCT03428958|468632445|FG015|Overall Study|Clinical Progression|0|||
130183969|NCT03428958|468632446|FG016|Overall Study|Clinical Progression|0|||
130183970|NCT03428958|468632430|FG000|Overall Study|Progression per RECIST|6|||
130183971|NCT03428958|468632431|FG001|Overall Study|Progression per RECIST|6|||
130183972|NCT03428958|468632432|FG002|Overall Study|Progression per RECIST|7|||
130183973|NCT03428958|468632433|FG003|Overall Study|Progression per RECIST|4|||
130183974|NCT03428958|468632434|FG004|Overall Study|Progression per RECIST|0|||
130183975|NCT03428958|468632435|FG005|Overall Study|Progression per RECIST|7|||
130183976|NCT03428958|468632436|FG006|Overall Study|Progression per RECIST|8|||
130183977|NCT03428958|468632437|FG007|Overall Study|Progression per RECIST|0|||
130183978|NCT03428958|468632438|FG008|Overall Study|Progression per RECIST|0|||
130183979|NCT03428958|468632439|FG009|Overall Study|Progression per RECIST|0|||
130183980|NCT03428958|468632440|FG010|Overall Study|Progression per RECIST|0|||
130183981|NCT03428958|468632441|FG011|Overall Study|Progression per RECIST|0|||
130183982|NCT03428958|468632442|FG012|Overall Study|Progression per RECIST|1|||
130183983|NCT03428958|468632443|FG013|Overall Study|Progression per RECIST|0|||
130183984|NCT03428958|468632444|FG014|Overall Study|Progression per RECIST|0|||
130183985|NCT03428958|468632445|FG015|Overall Study|Progression per RECIST|0|||
130183986|NCT03428958|468632446|FG016|Overall Study|Progression per RECIST|0|||
130183987|NCT03428958|468632430|FG000|Overall Study|Death|2|||
130183988|NCT03428958|468632431|FG001|Overall Study|Death|2|||
130183989|NCT03428958|468632432|FG002|Overall Study|Death|0|||
130183990|NCT03428958|468632433|FG003|Overall Study|Death|0|||
130183991|NCT03428958|468632434|FG004|Overall Study|Death|0|||
130183992|NCT03428958|468632435|FG005|Overall Study|Death|7|||
130183993|NCT03428958|468632436|FG006|Overall Study|Death|9|||
130183994|NCT03428958|468632437|FG007|Overall Study|Death|6|||
130183995|NCT03428958|468632438|FG008|Overall Study|Death|0|||
130183996|NCT03428958|468632439|FG009|Overall Study|Death|0|||
130183997|NCT03428958|468632440|FG010|Overall Study|Death|3|||
130183998|NCT03428958|468632441|FG011|Overall Study|Death|0|||
130183999|NCT03428958|468632442|FG012|Overall Study|Death|4|||
130184000|NCT03428958|468632443|FG013|Overall Study|Death|0|||
130184001|NCT03428958|468632444|FG014|Overall Study|Death|0|||
130184002|NCT03428958|468632445|FG015|Overall Study|Death|0|||
130184003|NCT03428958|468632446|FG016|Overall Study|Death|0|||
130184004|NCT03428958|468632430|FG000|Overall Study|Lost to Follow-up|0|||
130184005|NCT03428958|468632431|FG001|Overall Study|Lost to Follow-up|0|||
130184006|NCT03428958|468632432|FG002|Overall Study|Lost to Follow-up|0|||
130184007|NCT03428958|468632433|FG003|Overall Study|Lost to Follow-up|0|||
130184008|NCT03428958|468632434|FG004|Overall Study|Lost to Follow-up|0|||
130184009|NCT03428958|468632435|FG005|Overall Study|Lost to Follow-up|1|||
130184010|NCT03428958|468632436|FG006|Overall Study|Lost to Follow-up|1|||
130184011|NCT03428958|468632437|FG007|Overall Study|Lost to Follow-up|0|||
130184012|NCT03428958|468632438|FG008|Overall Study|Lost to Follow-up|0|||
130184013|NCT03428958|468632439|FG009|Overall Study|Lost to Follow-up|0|||
130184014|NCT03428958|468632440|FG010|Overall Study|Lost to Follow-up|0|||
130184015|NCT03428958|468632441|FG011|Overall Study|Lost to Follow-up|0|||
130184016|NCT03428958|468632442|FG012|Overall Study|Lost to Follow-up|0|||
130184017|NCT03428958|468632443|FG013|Overall Study|Lost to Follow-up|0|||
130184018|NCT03428958|468632444|FG014|Overall Study|Lost to Follow-up|0|||
130184019|NCT03428958|468632445|FG015|Overall Study|Lost to Follow-up|0|||
130184020|NCT03428958|468632446|FG016|Overall Study|Lost to Follow-up|0|||
130184021|NCT03428958|468632430|FG000|Overall Study|Physician/Sponsor Decision|1|||
130184022|NCT03428958|468632431|FG001|Overall Study|Physician/Sponsor Decision|0|||
130184023|NCT03428958|468632432|FG002|Overall Study|Physician/Sponsor Decision|1|||
130184024|NCT03428958|468632433|FG003|Overall Study|Physician/Sponsor Decision|0|||
130184025|NCT03428958|468632434|FG004|Overall Study|Physician/Sponsor Decision|0|||
130184026|NCT03428958|468632435|FG005|Overall Study|Physician/Sponsor Decision|2|||
130184027|NCT03428958|468632436|FG006|Overall Study|Physician/Sponsor Decision|2|||
130184028|NCT03428958|468632437|FG007|Overall Study|Physician/Sponsor Decision|2|||
130184029|NCT03428958|468632438|FG008|Overall Study|Physician/Sponsor Decision|0|||
130184030|NCT03428958|468632439|FG009|Overall Study|Physician/Sponsor Decision|0|||
130184031|NCT03428958|468632440|FG010|Overall Study|Physician/Sponsor Decision|2|||
130184032|NCT03428958|468632441|FG011|Overall Study|Physician/Sponsor Decision|0|||
130184033|NCT03428958|468632442|FG012|Overall Study|Physician/Sponsor Decision|4|||
130184034|NCT03428958|468632443|FG013|Overall Study|Physician/Sponsor Decision|0|||
130184035|NCT03428958|468632444|FG014|Overall Study|Physician/Sponsor Decision|0|||
130184036|NCT03428958|468632445|FG015|Overall Study|Physician/Sponsor Decision|0|||
130184037|NCT03428958|468632446|FG016|Overall Study|Physician/Sponsor Decision|0|||
130184038|NCT03428958|468632430|FG000|Overall Study|Withdrawal by Subject|0|||
130184039|NCT03428958|468632431|FG001|Overall Study|Withdrawal by Subject|0|||
130184040|NCT03428958|468632432|FG002|Overall Study|Withdrawal by Subject|2|||
130184041|NCT03428958|468632433|FG003|Overall Study|Withdrawal by Subject|0|||
130184042|NCT03428958|468632434|FG004|Overall Study|Withdrawal by Subject|0|||
130184043|NCT03428958|468632435|FG005|Overall Study|Withdrawal by Subject|2|||
130184044|NCT03428958|468632436|FG006|Overall Study|Withdrawal by Subject|4|||
130184045|NCT03428958|468632437|FG007|Overall Study|Withdrawal by Subject|1|||
130184046|NCT03428958|468632438|FG008|Overall Study|Withdrawal by Subject|0|||
130184047|NCT03428958|468632439|FG009|Overall Study|Withdrawal by Subject|0|||
130184048|NCT03428958|468632440|FG010|Overall Study|Withdrawal by Subject|0|||
130184049|NCT03428958|468632441|FG011|Overall Study|Withdrawal by Subject|0|||
130184050|NCT03428958|468632442|FG012|Overall Study|Withdrawal by Subject|0|||
130184051|NCT03428958|468632443|FG013|Overall Study|Withdrawal by Subject|0|||
130184052|NCT03428958|468632444|FG014|Overall Study|Withdrawal by Subject|0|||
130184053|NCT03428958|468632445|FG015|Overall Study|Withdrawal by Subject|0|||
130184054|NCT03428958|468632446|FG016|Overall Study|Withdrawal by Subject|0|||
130184055|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
130184056|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
130184057|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
130184058|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
130184059|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
130184060|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
130184061|NCT03874117|468632447|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
130184062|NCT03874117|468632448|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
130184063|NCT03874117|468632447|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
130184064|NCT03874117|468632448|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
130184065|NCT05258773|468632449|FG000|Overall Study|Screen Failure|1|||
130184066|NCT05258773|468632450|FG001|Overall Study|Screen Failure|1|||
130184067|NCT05258773|468632449|FG000|Overall Study|Adverse Event|1|||
130184068|NCT05258773|468632450|FG001|Overall Study|Adverse Event|0|||
130184069|NCT05258773|468632449|FG000|Overall Study|Withdrawal by Subject|0|||
130184070|NCT05258773|468632450|FG001|Overall Study|Withdrawal by Subject|1|||
130184071|NCT03018288|468632453|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
130184072|NCT03018288|468632454|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
130184073|NCT03018288|468632455|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
130184074|NCT03018288|468632456|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
130184075|NCT03018288|468632453|FG000|Overall Study|Participant withdrew consent.|0|||
130184076|NCT03018288|468632454|FG001|Overall Study|Participant withdrew consent.|0|||
130184077|NCT03018288|468632455|FG002|Overall Study|Participant withdrew consent.|1|||
130184078|NCT03018288|468632456|FG003|Overall Study|Participant withdrew consent.|0|||
130184079|NCT03018288|468632453|FG000|Overall Study|Switched to alternative treatment.|0|||
130184080|NCT03018288|468632454|FG001|Overall Study|Switched to alternative treatment.|0|||
130184081|NCT03018288|468632455|FG002|Overall Study|Switched to alternative treatment.|1|||
130184082|NCT03018288|468632456|FG003|Overall Study|Switched to alternative treatment.|0|||
130184083|NCT03018288|468632453|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
130184084|NCT03018288|468632454|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
130184085|NCT03018288|468632455|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
130184086|NCT03018288|468632456|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
130184087|NCT03018288|468632453|FG000|Overall Study|Screen failures|0|||
130184088|NCT03018288|468632454|FG001|Overall Study|Screen failures|0|||
130184089|NCT03018288|468632455|FG002|Overall Study|Screen failures|0|||
130184090|NCT03018288|468632456|FG003|Overall Study|Screen failures|51|||
130184091|NCT03018288|468632453|FG000|Overall Study|Chose treatment outside of UNC|0|||
130184092|NCT03018288|468632454|FG001|Overall Study|Chose treatment outside of UNC|0|||
130184093|NCT03018288|468632455|FG002|Overall Study|Chose treatment outside of UNC|0|||
130184094|NCT03018288|468632456|FG003|Overall Study|Chose treatment outside of UNC|1|||
130184095|NCT03018288|468632453|FG000|Overall Study|Unable to comply with protocol requirements|1|||
130184096|NCT03018288|468632454|FG001|Overall Study|Unable to comply with protocol requirements|1|||
130184097|NCT03018288|468632455|FG002|Overall Study|Unable to comply with protocol requirements|0|||
130184098|NCT03018288|468632456|FG003|Overall Study|Unable to comply with protocol requirements|1|||
130184099|NCT03018288|468632453|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
130184100|NCT03018288|468632454|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
130184101|NCT03018288|468632455|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
130184102|NCT03018288|468632456|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
130184103|NCT03018288|468632453|FG000|Overall Study|Physician Decision|0|||
130184104|NCT03018288|468632454|FG001|Overall Study|Physician Decision|0|||
130184105|NCT03018288|468632455|FG002|Overall Study|Physician Decision|0|||
130184106|NCT03018288|468632456|FG003|Overall Study|Physician Decision|1|||
130184107|NCT01127256|468632459|FG000|Overall Study|Adverse Event|13|||
130184108|NCT01127256|468632460|FG001|Overall Study|Adverse Event|13|||
130184109|NCT01127256|468632459|FG000|Overall Study|Lack of Efficacy|4|||
130184110|NCT01127256|468632460|FG001|Overall Study|Lack of Efficacy|0|||
130184111|NCT01127256|468632459|FG000|Overall Study|Lost to Follow-up|16|||
130184112|NCT01127256|468632460|FG001|Overall Study|Lost to Follow-up|17|||
130184113|NCT01127256|468632459|FG000|Overall Study|Withdrawal by Subject|5|||
130184114|NCT01127256|468632460|FG001|Overall Study|Withdrawal by Subject|9|||
130184115|NCT01127256|468632459|FG000|Overall Study|Protocol Violation|1|||
130184116|NCT01127256|468632460|FG001|Overall Study|Protocol Violation|0|||
130184117|NCT01415518|468632461|FG000|Overall Study|Withdrawal by Subject|2|||
130184118|NCT01415518|468632462|FG001|Overall Study|Withdrawal by Subject|12|||
130184119|NCT01415518|468632461|FG000|Overall Study|Protocol Violation|6|||
130184120|NCT01415518|468632462|FG001|Overall Study|Protocol Violation|8|||
130184121|NCT01415518|468632461|FG000|Overall Study|Lost to Follow-up|3|||
130184122|NCT01415518|468632462|FG001|Overall Study|Lost to Follow-up|5|||
130184123|NCT01415518|468632461|FG000|Overall Study|Adverse Event|3|||
130184124|NCT01415518|468632462|FG001|Overall Study|Adverse Event|4|||
130184125|NCT01415518|468632461|FG000|Overall Study|Death|1|||
130184126|NCT01415518|468632462|FG001|Overall Study|Death|1|||
130184127|NCT01415518|468632461|FG000|Overall Study|Condition under Investigation Worsened|1|||
130184128|NCT01415518|468632462|FG001|Overall Study|Condition under Investigation Worsened|1|||
130184129|NCT00679211|468632463|FG000|Overall Study|Progressive disease|82|||
130184130|NCT00679211|468632463|FG000|Overall Study|Adverse Event|7|||
130184131|NCT00679211|468632463|FG000|Overall Study|Withdrawal by Subject|2|||
130184132|NCT00679211|468632463|FG000|Overall Study|Physician Decision|5|||
130184133|NCT00679211|468632463|FG000|Overall Study|Refused to undergo protocol procedures|1|||
130184134|NCT00679211|468632463|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
130184135|NCT00679211|468632463|FG000|Overall Study|Other|1|||
130184136|NCT01922037|468632464|FG000|Overall Study|Withdrawal by Subject|2|||
130184137|NCT01922037|468632465|FG001|Overall Study|Withdrawal by Subject|44|||
130184138|NCT01922037|468632464|FG000|Overall Study|Adverse Event|1|||
130184139|NCT01922037|468632465|FG001|Overall Study|Adverse Event|7|||
130184140|NCT01922037|468632464|FG000|Overall Study|Death|0|||
130184141|NCT01922037|468632465|FG001|Overall Study|Death|5|||
130184142|NCT01922037|468632464|FG000|Overall Study|Pregnancy|0|||
130184143|NCT01922037|468632465|FG001|Overall Study|Pregnancy|2|||
130184144|NCT01922037|468632464|FG000|Overall Study|Participant non-compliance|4|||
130184145|NCT01922037|468632465|FG001|Overall Study|Participant non-compliance|46|||
130184146|NCT01922037|468632464|FG000|Overall Study|Investigator/Sponsor decision|1|||
130184147|NCT01922037|468632465|FG001|Overall Study|Investigator/Sponsor decision|4|||
130184148|NCT01922037|468632464|FG000|Overall Study|Other unspecified|2|||
130184149|NCT01922037|468632465|FG001|Overall Study|Other unspecified|66|||
130184150|NCT01730053|468632467|FG000|Overall Study|Participant moved|0|||
130184151|NCT01730053|468632468|FG001|Overall Study|Participant moved|0|||
130184152|NCT01730053|468632469|FG002|Overall Study|Participant moved|1|||
130184153|NCT01730053|468632470|FG003|Overall Study|Participant moved|0|||
130184154|NCT01730053|468632471|FG004|Overall Study|Participant moved|0|||
130184155|NCT01730053|468632472|FG005|Overall Study|Participant moved|0|||
130184156|NCT01730053|468632467|FG000|Overall Study|Physician Decision|0|||
130184157|NCT01730053|468632468|FG001|Overall Study|Physician Decision|0|||
130184158|NCT01730053|468632469|FG002|Overall Study|Physician Decision|0|||
130184159|NCT01730053|468632470|FG003|Overall Study|Physician Decision|1|||
130184160|NCT01730053|468632471|FG004|Overall Study|Physician Decision|0|||
130184161|NCT01730053|468632472|FG005|Overall Study|Physician Decision|0|||
130184162|NCT01730053|468632467|FG000|Overall Study|Adverse Event|2|||
130184163|NCT01730053|468632468|FG001|Overall Study|Adverse Event|6|||
130184164|NCT01730053|468632469|FG002|Overall Study|Adverse Event|3|||
130184165|NCT01730053|468632470|FG003|Overall Study|Adverse Event|3|||
130184166|NCT01730053|468632471|FG004|Overall Study|Adverse Event|2|||
130184167|NCT01730053|468632472|FG005|Overall Study|Adverse Event|2|||
130184168|NCT01730053|468632467|FG000|Overall Study|Poor compliance to protocol|1|||
130184169|NCT01730053|468632468|FG001|Overall Study|Poor compliance to protocol|2|||
130184170|NCT01730053|468632469|FG002|Overall Study|Poor compliance to protocol|2|||
130184171|NCT01730053|468632470|FG003|Overall Study|Poor compliance to protocol|0|||
130184172|NCT01730053|468632471|FG004|Overall Study|Poor compliance to protocol|0|||
130184173|NCT01730053|468632472|FG005|Overall Study|Poor compliance to protocol|2|||
130184174|NCT01730053|468632467|FG000|Overall Study|Other than specified|2|||
130184175|NCT01730053|468632468|FG001|Overall Study|Other than specified|6|||
130184176|NCT01730053|468632469|FG002|Overall Study|Other than specified|5|||
130184177|NCT01730053|468632470|FG003|Overall Study|Other than specified|4|||
130184178|NCT01730053|468632471|FG004|Overall Study|Other than specified|7|||
130184179|NCT01730053|468632472|FG005|Overall Study|Other than specified|9|||
130184180|NCT01470248|468632473|FG000|Overall Study|Withdrawal by Subject|1|||
130184181|NCT02243605|468632476|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
130184182|NCT02243605|468632477|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
130184183|NCT02243605|468632476|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
130184184|NCT02243605|468632477|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
130184185|NCT02243605|468632476|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
130184186|NCT02243605|468632477|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
130184187|NCT02243605|468632476|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
130184188|NCT02243605|468632477|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
130184189|NCT02243605|468632476|FG000|Stage 2 - Final Analysis Population|Progression|0|||
130184190|NCT02243605|468632477|FG001|Stage 2 - Final Analysis Population|Progression|1|||
130184191|NCT02019472|468632478|FG000|Overall Study|Adverse Event|14|||
130184192|NCT02019472|468632479|FG001|Overall Study|Adverse Event|23|||
130184193|NCT02019472|468632480|FG002|Overall Study|Adverse Event|17|||
130184194|NCT02019472|468632478|FG000|Overall Study|Death|0|||
130184195|NCT02019472|468632479|FG001|Overall Study|Death|1|||
130184196|NCT02019472|468632480|FG002|Overall Study|Death|1|||
130184197|NCT02019472|468632478|FG000|Overall Study|Lack of Efficacy|7|||
130184198|NCT02019472|468632479|FG001|Overall Study|Lack of Efficacy|4|||
130184199|NCT02019472|468632480|FG002|Overall Study|Lack of Efficacy|4|||
130184200|NCT02019472|468632478|FG000|Overall Study|Lost to Follow-up|0|||
130184201|NCT02019472|468632479|FG001|Overall Study|Lost to Follow-up|2|||
130184202|NCT02019472|468632480|FG002|Overall Study|Lost to Follow-up|1|||
130184203|NCT02019472|468632478|FG000|Overall Study|Physician Decision|1|||
130184204|NCT02019472|468632479|FG001|Overall Study|Physician Decision|2|||
130184205|NCT02019472|468632480|FG002|Overall Study|Physician Decision|0|||
130184206|NCT02019472|468632478|FG000|Overall Study|Pregnancy|1|||
130184207|NCT02019472|468632479|FG001|Overall Study|Pregnancy|2|||
130184208|NCT02019472|468632480|FG002|Overall Study|Pregnancy|2|||
130184209|NCT02019472|468632478|FG000|Overall Study|Withdrawal by Subject|11|||
130184210|NCT02019472|468632479|FG001|Overall Study|Withdrawal by Subject|10|||
130184211|NCT02019472|468632480|FG002|Overall Study|Withdrawal by Subject|11|||
130184212|NCT02019472|468632478|FG000|Overall Study|Other|3|||
130184213|NCT02019472|468632479|FG001|Overall Study|Other|8|||
130184214|NCT02019472|468632480|FG002|Overall Study|Other|6|||
130184215|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
130184216|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
130184217|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184218|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184219|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184220|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
130184221|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
130184222|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
130184223|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
130184224|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
130184225|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
130184226|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
130184227|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
130184228|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
130184229|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
130184230|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130184231|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130184232|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
130184233|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
130184234|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
130184235|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
130184236|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130184237|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130184238|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
130184239|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
130184240|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
130184241|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
130184242|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130184243|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130184244|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
130184245|NCT04429503|468632485|FG000|Main Study (Up to Wk 96)|Death|9|||
130184246|NCT04429503|468632486|FG001|Main Study (Up to Wk 96)|Death|18|||
130184247|NCT04429503|468632487|FG002|Main Study (Up to Wk 96)|Death|5|||
130184248|NCT04429503|468632488|FG003|Main Study (Up to Wk 96)|Death|0|||
130184249|NCT04429503|468632489|FG004|Main Study (Up to Wk 96)|Death|0|||
130184250|NCT04429503|468632490|FG005|Main Study (Up to Wk 96)|Death|0|||
130184251|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184252|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184253|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184254|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
130184255|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184256|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
130184257|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130184258|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130184259|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
130184260|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130184261|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130184262|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
130184263|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184264|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184265|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184266|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
130184267|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
130184268|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
130184269|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130184270|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130184271|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
130184272|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
130184273|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
130184274|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
130184275|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130184276|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130184277|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
130184278|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
130184279|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
130184280|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
130184281|NCT04429503|468632485|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130184282|NCT04429503|468632486|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130184283|NCT04429503|468632487|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
130184284|NCT04429503|468632488|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
130184285|NCT04429503|468632489|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
130184286|NCT04429503|468632490|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
130184287|NCT05516108|468632491|FG000|Overall Study|Time Commitment|3|||
130184288|NCT05516108|468632492|FG001|Overall Study|Time Commitment|1|||
130184289|NCT05516108|468632491|FG000|Overall Study|Reason Unknown|2|||
130184290|NCT05516108|468632492|FG001|Overall Study|Reason Unknown|4|||
130184291|NCT02003209|468632493|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
130184292|NCT02003209|468632494|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
130184293|NCT00638508|468632495|FG000|Overall Study|Physician Decision|5|||
130184294|NCT00638508|468632496|FG001|Overall Study|Physician Decision|2|||
130184295|NCT00370552|468632497|FG000|Overall Study|Adverse Event|2|||
130184296|NCT00370552|468632498|FG001|Overall Study|Adverse Event|2|||
130184297|NCT00370552|468632499|FG002|Overall Study|Adverse Event|2|||
130184298|NCT00370552|468632497|FG000|Overall Study|Disease progression|23|||
130184299|NCT00370552|468632498|FG001|Overall Study|Disease progression|23|||
130184300|NCT00370552|468632499|FG002|Overall Study|Disease progression|15|||
130184301|NCT00370552|468632497|FG000|Overall Study|Maximum clinical benefit|3|||
130184302|NCT00370552|468632498|FG001|Overall Study|Maximum clinical benefit|5|||
130184303|NCT00370552|468632499|FG002|Overall Study|Maximum clinical benefit|5|||
130184304|NCT00370552|468632497|FG000|Overall Study|Poor or noncompliance|0|||
130184305|NCT00370552|468632498|FG001|Overall Study|Poor or noncompliance|0|||
130184306|NCT00370552|468632499|FG002|Overall Study|Poor or noncompliance|1|||
130184307|NCT00370552|468632497|FG000|Overall Study|Study drug toxicity|11|||
130184308|NCT00370552|468632498|FG001|Overall Study|Study drug toxicity|8|||
130184309|NCT00370552|468632499|FG002|Overall Study|Study drug toxicity|6|||
130184310|NCT00370552|468632497|FG000|Overall Study|Withdrawal by Subject|2|||
130184311|NCT00370552|468632498|FG001|Overall Study|Withdrawal by Subject|0|||
130184312|NCT00370552|468632499|FG002|Overall Study|Withdrawal by Subject|1|||
130184313|NCT00370552|468632497|FG000|Overall Study|Still on treatment|1|||
130184314|NCT00370552|468632498|FG001|Overall Study|Still on treatment|3|||
130184315|NCT00370552|468632499|FG002|Overall Study|Still on treatment|2|||
130184316|NCT00370552|468632497|FG000|Overall Study|Never treated|1|||
130184317|NCT00370552|468632498|FG001|Overall Study|Never treated|0|||
130184318|NCT00370552|468632499|FG002|Overall Study|Never treated|0|||
130184319|NCT00370552|468632497|FG000|Overall Study|Physician Decision|1|||
130184320|NCT00370552|468632498|FG001|Overall Study|Physician Decision|1|||
130184321|NCT00370552|468632499|FG002|Overall Study|Physician Decision|0|||
130184322|NCT00370552|468632497|FG000|Overall Study|Investigator decision|2|||
130184323|NCT00370552|468632498|FG001|Overall Study|Investigator decision|1|||
130184324|NCT00370552|468632499|FG002|Overall Study|Investigator decision|0|||
130184325|NCT00370552|468632497|FG000|Overall Study|High risk of allergic reaction|0|||
130184326|NCT00370552|468632498|FG001|Overall Study|High risk of allergic reaction|1|||
130184327|NCT00370552|468632499|FG002|Overall Study|High risk of allergic reaction|0|||
130184328|NCT00370552|468632497|FG000|Overall Study|Planned radiation for palliation|0|||
130184329|NCT00370552|468632498|FG001|Overall Study|Planned radiation for palliation|1|||
130184330|NCT00370552|468632499|FG002|Overall Study|Planned radiation for palliation|0|||
130184331|NCT03500198|468632500|FG000|Overall Study|Lost to Follow-up|0|||
130184332|NCT03500198|468632501|FG001|Overall Study|Lost to Follow-up|1|||
130184333|NCT01836471|468632513|FG000|Overall Study|Pregnancy|1|||
130184334|NCT01836471|468632514|FG001|Overall Study|Pregnancy|0|||
130184335|NCT01836471|468632515|FG002|Overall Study|Pregnancy|0|||
130184336|NCT01836471|468632516|FG003|Overall Study|Pregnancy|0|||
130184337|NCT01836471|468632517|FG004|Overall Study|Pregnancy|0|||
130184338|NCT01836471|468632513|FG000|Overall Study|Withdrawal by Subject|3|||
130184339|NCT01836471|468632514|FG001|Overall Study|Withdrawal by Subject|4|||
130184340|NCT01836471|468632515|FG002|Overall Study|Withdrawal by Subject|1|||
130184341|NCT01836471|468632516|FG003|Overall Study|Withdrawal by Subject|0|||
130184342|NCT01836471|468632517|FG004|Overall Study|Withdrawal by Subject|2|||
130184343|NCT01836471|468632513|FG000|Overall Study|Physician Decision|0|||
130184344|NCT01836471|468632514|FG001|Overall Study|Physician Decision|1|||
130184345|NCT01836471|468632515|FG002|Overall Study|Physician Decision|0|||
130184346|NCT01836471|468632516|FG003|Overall Study|Physician Decision|0|||
130184347|NCT01836471|468632517|FG004|Overall Study|Physician Decision|0|||
130184348|NCT01836471|468632513|FG000|Overall Study|Lost to Follow-up|0|||
130184349|NCT01836471|468632514|FG001|Overall Study|Lost to Follow-up|0|||
130184350|NCT01836471|468632515|FG002|Overall Study|Lost to Follow-up|0|||
130184351|NCT01836471|468632516|FG003|Overall Study|Lost to Follow-up|1|||
130184352|NCT01836471|468632517|FG004|Overall Study|Lost to Follow-up|1|||
130184353|NCT01836471|468632513|FG000|Overall Study|Adverse Event|6|||
130184354|NCT01836471|468632514|FG001|Overall Study|Adverse Event|3|||
130184355|NCT01836471|468632515|FG002|Overall Study|Adverse Event|1|||
130184356|NCT01836471|468632516|FG003|Overall Study|Adverse Event|1|||
130184357|NCT01836471|468632517|FG004|Overall Study|Adverse Event|2|||
130184358|NCT01836471|468632513|FG000|Overall Study|Non compliance with tx|1|||
130184359|NCT01836471|468632514|FG001|Overall Study|Non compliance with tx|1|||
130184360|NCT01836471|468632515|FG002|Overall Study|Non compliance with tx|0|||
130184361|NCT01836471|468632516|FG003|Overall Study|Non compliance with tx|0|||
130184362|NCT01836471|468632517|FG004|Overall Study|Non compliance with tx|0|||
130184363|NCT02285361|468632520|FG000|Overall Study|Protocol Violation|43|||
130184364|NCT02285361|468632520|FG000|Overall Study|Lost to Follow-up|5|||
130184365|NCT02285361|468632520|FG000|Overall Study|Not taken GIOTRIF|2|||
130184366|NCT02285361|468632520|FG000|Overall Study|Consented prior to the contract date|1|||
130184367|NCT03776357|468632524|FG000|Overall Study|Lost to Follow-up|3|||
130184368|NCT02755103|468632527|FG000|Overall Study|Lost to Follow-up|17|||
130184369|NCT02755103|468632528|FG001|Overall Study|Lost to Follow-up|15|||
130184370|NCT02755103|468632527|FG000|Overall Study|Death|0|||
130184371|NCT02755103|468632528|FG001|Overall Study|Death|1|||
130184372|NCT02755103|468632527|FG000|Overall Study|Physician Decision|0|||
130184373|NCT02755103|468632528|FG001|Overall Study|Physician Decision|1|||
130184374|NCT02755103|468632527|FG000|Overall Study|Pregnancy|0|||
130184375|NCT02755103|468632528|FG001|Overall Study|Pregnancy|1|||
130184376|NCT02755103|468632527|FG000|Overall Study|Withdrawal by Subject|3|||
130184377|NCT02755103|468632528|FG001|Overall Study|Withdrawal by Subject|0|||
130184378|NCT00658723|468632532|FG000|Overall Study|Lost to Follow-up|0|||
130184379|NCT00658723|468632533|FG001|Overall Study|Lost to Follow-up|2|||
130184380|NCT00658723|468632534|FG002|Overall Study|Lost to Follow-up|2|||
130184381|NCT00658723|468632532|FG000|Overall Study|Death|2|||
130184382|NCT00658723|468632533|FG001|Overall Study|Death|1|||
130184383|NCT00658723|468632534|FG002|Overall Study|Death|4|||
130184384|NCT00658723|468632532|FG000|Overall Study|Scheduling Issue|1|||
130184385|NCT00658723|468632533|FG001|Overall Study|Scheduling Issue|1|||
130184386|NCT00658723|468632534|FG002|Overall Study|Scheduling Issue|0|||
130184387|NCT00658723|468632532|FG000|Overall Study|Withdrawal by Subject|1|||
130184388|NCT00658723|468632533|FG001|Overall Study|Withdrawal by Subject|0|||
130184389|NCT00658723|468632534|FG002|Overall Study|Withdrawal by Subject|1|||
130184390|NCT02411656|468632535|FG000|Overall Study|Adverse Event|4|||
130184391|NCT02411656|468632535|FG000|Overall Study|Clinical Progression|33|||
130184392|NCT06481709|468632536|FG000|Overall Study|Withdrawal by Subject|0|||
130184393|NCT06481709|468632537|FG001|Overall Study|Withdrawal by Subject|0|||
130184394|NCT06481709|468632538|FG002|Overall Study|Withdrawal by Subject|2|||
130184395|NCT06481709|468632539|FG003|Overall Study|Withdrawal by Subject|0|||
130184396|NCT03305848|468632540|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
130184397|NCT03305848|468632540|FG000|Overall Study|Physician Decision|2|||
130184398|NCT05366010|468632544|FG000|Overall Study|Withdrawal by Subject|1|||
130184399|NCT05366010|468632544|FG000|Overall Study|Protocol Violation|1|||
130184400|NCT05366010|468632544|FG000|Overall Study|Lost to Follow-up|2|||
130184401|NCT05366010|468632544|FG000|Overall Study|Screen Failure|2|||
130184402|NCT00586703|468632545|FG000|Overall Study|Death|12|||
130184403|NCT01422213|468632546|FG000|Overall Study|Adverse Event|8|||
130184404|NCT01422213|468632547|FG001|Overall Study|Adverse Event|7|||
130184405|NCT01422213|468632548|FG002|Overall Study|Adverse Event|11|||
130184406|NCT01422213|468632546|FG000|Overall Study|Lack of Efficacy|10|||
130184407|NCT01422213|468632547|FG001|Overall Study|Lack of Efficacy|2|||
130184408|NCT01422213|468632548|FG002|Overall Study|Lack of Efficacy|2|||
130184409|NCT01422213|468632546|FG000|Overall Study|Non-compliance with study drug|0|||
130184410|NCT01422213|468632547|FG001|Overall Study|Non-compliance with study drug|1|||
130184411|NCT01422213|468632548|FG002|Overall Study|Non-compliance with study drug|0|||
130184412|NCT01422213|468632546|FG000|Overall Study|Protocol Violation|0|||
130184413|NCT01422213|468632547|FG001|Overall Study|Protocol Violation|2|||
130184414|NCT01422213|468632548|FG002|Overall Study|Protocol Violation|4|||
130184415|NCT01422213|468632546|FG000|Overall Study|Withdrawal of Consent|7|||
130184416|NCT01422213|468632547|FG001|Overall Study|Withdrawal of Consent|3|||
130184417|NCT01422213|468632548|FG002|Overall Study|Withdrawal of Consent|5|||
130184418|NCT01422213|468632546|FG000|Overall Study|Lost to Follow-up|3|||
130184419|NCT01422213|468632547|FG001|Overall Study|Lost to Follow-up|3|||
130184420|NCT01422213|468632548|FG002|Overall Study|Lost to Follow-up|5|||
130184421|NCT01422213|468632546|FG000|Overall Study|Administrative or Other Reason(s)|5|||
130184422|NCT01422213|468632547|FG001|Overall Study|Administrative or Other Reason(s)|4|||
130184423|NCT01422213|468632548|FG002|Overall Study|Administrative or Other Reason(s)|2|||
130184424|NCT05271175|468632549|FG000|One Week Follow up|Lost to Follow-up|10|||
130184425|NCT05271175|468632550|FG001|One Week Follow up|Lost to Follow-up|7|||
130184426|NCT05271175|468632551|FG002|One Week Follow up|Lost to Follow-up|5|||
130184427|NCT05271175|468632549|FG000|One Month Follow up|Lost to Follow-up|12|||
130184428|NCT05271175|468632550|FG001|One Month Follow up|Lost to Follow-up|7|||
130184429|NCT05271175|468632551|FG002|One Month Follow up|Lost to Follow-up|9|||
130184430|NCT05271175|468632549|FG000|Six Months Follow up|Lost to Follow-up|8|||
130184431|NCT05271175|468632550|FG001|Six Months Follow up|Lost to Follow-up|2|||
130184432|NCT05271175|468632551|FG002|Six Months Follow up|Lost to Follow-up|2|||
130184433|NCT00991887|468632552|FG000|Overall Study|Lost to Follow-up|2|||
130184434|NCT00991887|468632553|FG001|Overall Study|Lost to Follow-up|1|||
130184435|NCT01964976|468632554|FG000|Overall Study|Protocol Violation|31|||
130184436|NCT01891864|468632557|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
130184437|NCT01891864|468632558|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
130184438|NCT01891864|468632559|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184439|NCT01891864|468632560|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184440|NCT01891864|468632561|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184441|NCT01891864|468632562|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
130184442|NCT01891864|468632557|FG000|Treatment Period 1|Physician Decision|0|||
130184443|NCT01891864|468632558|FG001|Treatment Period 1|Physician Decision|1|||
130184444|NCT01891864|468632559|FG002|Treatment Period 1|Physician Decision|0|||
130184445|NCT01891864|468632560|FG003|Treatment Period 1|Physician Decision|0|||
130184446|NCT01891864|468632561|FG004|Treatment Period 1|Physician Decision|0|||
130184447|NCT01891864|468632562|FG005|Treatment Period 1|Physician Decision|0|||
130184448|NCT01891864|468632557|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184449|NCT01891864|468632558|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
130184450|NCT01891864|468632559|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184451|NCT01891864|468632560|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184452|NCT01891864|468632561|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184453|NCT01891864|468632562|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
130184454|NCT01891864|468632557|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
130184455|NCT01891864|468632558|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
130184456|NCT01891864|468632559|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184457|NCT01891864|468632560|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184458|NCT01891864|468632561|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184459|NCT01891864|468632562|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
130184460|NCT01891864|468632557|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130184461|NCT01891864|468632558|FG001|Treatment Period 1|Withdrawal by Subject|5|||
130184462|NCT01891864|468632559|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130184463|NCT01891864|468632560|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130184464|NCT01891864|468632561|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130184465|NCT01891864|468632562|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130184466|NCT01891864|468632557|FG000|Treatment Period 1|Lost to Follow-up|1|||
130184467|NCT01891864|468632558|FG001|Treatment Period 1|Lost to Follow-up|0|||
130184468|NCT01891864|468632559|FG002|Treatment Period 1|Lost to Follow-up|0|||
130184469|NCT01891864|468632560|FG003|Treatment Period 1|Lost to Follow-up|0|||
130184470|NCT01891864|468632561|FG004|Treatment Period 1|Lost to Follow-up|0|||
130184471|NCT01891864|468632562|FG005|Treatment Period 1|Lost to Follow-up|0|||
130184472|NCT01891864|468632557|FG000|Treatment Period 2|Protocol Violation|0|||
130184473|NCT01891864|468632558|FG001|Treatment Period 2|Protocol Violation|0|||
130184474|NCT01891864|468632559|FG002|Treatment Period 2|Protocol Violation|0|||
130184475|NCT01891864|468632560|FG003|Treatment Period 2|Protocol Violation|1|||
130184476|NCT01891864|468632561|FG004|Treatment Period 2|Protocol Violation|0|||
130184477|NCT01891864|468632562|FG005|Treatment Period 2|Protocol Violation|0|||
130184478|NCT01891864|468632557|FG000|Treatment Period 2|Physician Decision|0|||
130184479|NCT01891864|468632558|FG001|Treatment Period 2|Physician Decision|0|||
130184480|NCT01891864|468632559|FG002|Treatment Period 2|Physician Decision|1|||
130184481|NCT01891864|468632560|FG003|Treatment Period 2|Physician Decision|0|||
130184482|NCT01891864|468632561|FG004|Treatment Period 2|Physician Decision|0|||
130184483|NCT01891864|468632562|FG005|Treatment Period 2|Physician Decision|0|||
130184484|NCT01891864|468632557|FG000|Treatment Period 2|Site Termination|0|||
130184485|NCT01891864|468632558|FG001|Treatment Period 2|Site Termination|0|||
130184486|NCT01891864|468632559|FG002|Treatment Period 2|Site Termination|1|||
130184487|NCT01891864|468632560|FG003|Treatment Period 2|Site Termination|2|||
130184488|NCT01891864|468632561|FG004|Treatment Period 2|Site Termination|0|||
130184489|NCT01891864|468632562|FG005|Treatment Period 2|Site Termination|0|||
130184490|NCT01891864|468632557|FG000|Treatment Period 2|Lack of Efficacy|0|||
130184491|NCT01891864|468632558|FG001|Treatment Period 2|Lack of Efficacy|0|||
130184492|NCT01891864|468632559|FG002|Treatment Period 2|Lack of Efficacy|1|||
130184493|NCT01891864|468632560|FG003|Treatment Period 2|Lack of Efficacy|0|||
130184494|NCT01891864|468632561|FG004|Treatment Period 2|Lack of Efficacy|1|||
130184495|NCT01891864|468632562|FG005|Treatment Period 2|Lack of Efficacy|0|||
130184496|NCT01891864|468632557|FG000|Treatment Period 2|Adverse Event|0|||
130184497|NCT01891864|468632558|FG001|Treatment Period 2|Adverse Event|0|||
130184498|NCT01891864|468632559|FG002|Treatment Period 2|Adverse Event|1|||
130184499|NCT01891864|468632560|FG003|Treatment Period 2|Adverse Event|2|||
130184500|NCT01891864|468632561|FG004|Treatment Period 2|Adverse Event|0|||
130184501|NCT01891864|468632562|FG005|Treatment Period 2|Adverse Event|4|||
130184502|NCT01891864|468632557|FG000|Treatment Period 2|Termination of Site|0|||
130184503|NCT01891864|468632558|FG001|Treatment Period 2|Termination of Site|0|||
130184504|NCT01891864|468632559|FG002|Treatment Period 2|Termination of Site|0|||
130184505|NCT01891864|468632560|FG003|Treatment Period 2|Termination of Site|0|||
130184506|NCT01891864|468632561|FG004|Treatment Period 2|Termination of Site|2|||
130184507|NCT01891864|468632562|FG005|Treatment Period 2|Termination of Site|0|||
130184508|NCT01891864|468632557|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130184509|NCT01891864|468632558|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130184510|NCT01891864|468632559|FG002|Treatment Period 2|Withdrawal by Subject|3|||
130184511|NCT01891864|468632560|FG003|Treatment Period 2|Withdrawal by Subject|4|||
130184512|NCT01891864|468632561|FG004|Treatment Period 2|Withdrawal by Subject|1|||
130184513|NCT01891864|468632562|FG005|Treatment Period 2|Withdrawal by Subject|1|||
130184514|NCT01891864|468632557|FG000|Extension Period|Lack of Efficacy|0|||
130184515|NCT01891864|468632558|FG001|Extension Period|Lack of Efficacy|0|||
130184516|NCT01891864|468632559|FG002|Extension Period|Lack of Efficacy|0|||
130184517|NCT01891864|468632560|FG003|Extension Period|Lack of Efficacy|1|||
130184518|NCT01891864|468632561|FG004|Extension Period|Lack of Efficacy|1|||
130184519|NCT01891864|468632562|FG005|Extension Period|Lack of Efficacy|0|||
130184520|NCT01891864|468632557|FG000|Extension Period|Pregnancy|0|||
130184521|NCT01891864|468632558|FG001|Extension Period|Pregnancy|0|||
130184522|NCT01891864|468632559|FG002|Extension Period|Pregnancy|1|||
130184523|NCT01891864|468632560|FG003|Extension Period|Pregnancy|0|||
130184524|NCT01891864|468632561|FG004|Extension Period|Pregnancy|0|||
130184525|NCT01891864|468632562|FG005|Extension Period|Pregnancy|0|||
130184526|NCT01891864|468632557|FG000|Extension Period|Adverse Event|0|||
130184527|NCT01891864|468632558|FG001|Extension Period|Adverse Event|0|||
130184528|NCT01891864|468632559|FG002|Extension Period|Adverse Event|4|||
130184529|NCT01891864|468632560|FG003|Extension Period|Adverse Event|2|||
130184530|NCT01891864|468632561|FG004|Extension Period|Adverse Event|2|||
130184531|NCT01891864|468632562|FG005|Extension Period|Adverse Event|0|||
130184532|NCT01891864|468632557|FG000|Extension Period|Withdrawal by Subject|0|||
130184533|NCT01891864|468632558|FG001|Extension Period|Withdrawal by Subject|0|||
130184534|NCT01891864|468632559|FG002|Extension Period|Withdrawal by Subject|1|||
130184535|NCT01891864|468632560|FG003|Extension Period|Withdrawal by Subject|2|||
130184536|NCT01891864|468632561|FG004|Extension Period|Withdrawal by Subject|4|||
130184537|NCT01891864|468632562|FG005|Extension Period|Withdrawal by Subject|0|||
130184538|NCT01891864|468632557|FG000|Extension Period|Lost to Follow-up|0|||
130184539|NCT01891864|468632558|FG001|Extension Period|Lost to Follow-up|0|||
130184540|NCT01891864|468632559|FG002|Extension Period|Lost to Follow-up|2|||
130184541|NCT01891864|468632560|FG003|Extension Period|Lost to Follow-up|0|||
130184542|NCT01891864|468632561|FG004|Extension Period|Lost to Follow-up|0|||
130184543|NCT01891864|468632562|FG005|Extension Period|Lost to Follow-up|0|||
130184544|NCT02698163|468632563|FG000|Overall Study|Lost to Follow-up|0|||
130184545|NCT02698163|468632564|FG001|Overall Study|Lost to Follow-up|1|||
130184546|NCT02892331|468632565|FG000|Overall Study|Withdrawal by Subject|0|||
130184547|NCT02892331|468632566|FG001|Overall Study|Withdrawal by Subject|1|||
130184548|NCT02892331|468632567|FG002|Overall Study|Withdrawal by Subject|1|||
130184549|NCT02892331|468632565|FG000|Overall Study|Sick family member|0|||
130184550|NCT02892331|468632566|FG001|Overall Study|Sick family member|0|||
130184551|NCT02892331|468632567|FG002|Overall Study|Sick family member|1|||
130184552|NCT02892331|468632565|FG000|Overall Study|Corona virus pandemic|1|||
130184553|NCT02892331|468632566|FG001|Overall Study|Corona virus pandemic|0|||
130184554|NCT02892331|468632567|FG002|Overall Study|Corona virus pandemic|1|||
130184555|NCT02892331|468632565|FG000|Overall Study|Lost to Follow-up|1|||
130184556|NCT02892331|468632566|FG001|Overall Study|Lost to Follow-up|0|||
130184557|NCT02892331|468632567|FG002|Overall Study|Lost to Follow-up|1|||
130184558|NCT02892331|468632565|FG000|Overall Study|Blood pressure was too elevated|0|||
130184559|NCT02892331|468632566|FG001|Overall Study|Blood pressure was too elevated|1|||
130184560|NCT02892331|468632567|FG002|Overall Study|Blood pressure was too elevated|0|||
130184561|NCT02892331|468632565|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
130184562|NCT02892331|468632566|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
130184563|NCT02892331|468632567|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
130184564|NCT00752128|468632571|FG000|Overall Study|Withdrawal by Subject|4|||
130184565|NCT00349973|468632572|FG000|Overall Study|Adverse Event|3|||
130184566|NCT00349973|468632573|FG001|Overall Study|Adverse Event|3|||
130184567|NCT00349973|468632572|FG000|Overall Study|Withdrawal by Subject|1|||
130184568|NCT00349973|468632573|FG001|Overall Study|Withdrawal by Subject|0|||
130184569|NCT02286713|468632574|FG000|One Week Follow-Up|Death|1|||
130184570|NCT02286713|468632575|FG001|One Week Follow-Up|Death|0|||
130184571|NCT02286713|468632574|FG000|One Week Follow-Up|Lost to Follow-up|17|||
130184572|NCT02286713|468632575|FG001|One Week Follow-Up|Lost to Follow-up|21|||
130184573|NCT02286713|468632574|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
130184574|NCT02286713|468632575|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
130184575|NCT02286713|468632574|FG000|Three Month Follow-Up|Death|1|||
130184576|NCT02286713|468632575|FG001|Three Month Follow-Up|Death|1|||
130184577|NCT02286713|468632574|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
130184578|NCT02286713|468632575|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
130184579|NCT02286713|468632574|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
130184580|NCT02286713|468632575|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
130184581|NCT02286713|468632574|FG000|Six Month Follow-Up|Death|2|||
130184582|NCT02286713|468632575|FG001|Six Month Follow-Up|Death|0|||
130184583|NCT02286713|468632574|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
130184584|NCT02286713|468632575|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
130184585|NCT04314037|468632576|FG000|Treatment Period 2|Adverse Event|1|||
130184586|NCT04314037|468632577|FG001|Treatment Period 2|Adverse Event|0|||
130184587|NCT04314037|468632576|FG000|Treatment Period 3|Protocol Violation|1|||
130184588|NCT04314037|468632577|FG001|Treatment Period 3|Protocol Violation|0|||
130184589|NCT04314037|468632576|FG000|Treatment Period 3|Adverse Event|0|||
130184590|NCT04314037|468632577|FG001|Treatment Period 3|Adverse Event|1|||
130184591|NCT03832686|468632580|FG000|Overall Study|Lost to Follow-up|6|||
130184592|NCT03832686|468632581|FG001|Overall Study|Lost to Follow-up|9|||
130184593|NCT03832686|468632580|FG000|Overall Study|Discontinued Intervention|5|||
130184594|NCT03832686|468632581|FG001|Overall Study|Discontinued Intervention|4|||
130184595|NCT05479435|468632582|FG000|Overall Study|Withdrawal by Subject|1|||
130184596|NCT05479435|468632583|FG001|Overall Study|Withdrawal by Subject|0|||
130184597|NCT05479435|468632584|FG002|Overall Study|Withdrawal by Subject|0|||
130184598|NCT05479435|468632582|FG000|Overall Study|Covid 19|0|||
130184599|NCT05479435|468632583|FG001|Overall Study|Covid 19|0|||
130184600|NCT05479435|468632584|FG002|Overall Study|Covid 19|2|||
130184601|NCT02325973|468634804|FG000|Overall Study|Death|5|||
130184602|NCT02325973|468634804|FG000|Overall Study|Withdrawal by subject or investigator|16|||
130184603|NCT02068508|468634805|FG000|Overall Study|Case report forms uncollected|27|||
130184604|NCT02068508|468634805|FG000|Overall Study|Patient did not visit the study site|1|||
130184605|NCT02068508|468634805|FG000|Overall Study|Protocol Violation|4|||
130184606|NCT03511105|468634809|FG000|Overall Study|Adverse Event|1|||
130184607|NCT03511105|468634810|FG001|Overall Study|Adverse Event|0|||
130184608|NCT03511105|468634809|FG000|Overall Study|Withdrew consent|1|||
130184609|NCT03511105|468634810|FG001|Overall Study|Withdrew consent|0|||
130184610|NCT02810457|468634811|FG000|Overall Study|Randomised but no treatment received|2|||
130184611|NCT02810457|468634812|FG001|Overall Study|Randomised but no treatment received|1|||
130184612|NCT02810457|468634811|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
130184613|NCT02810457|468634812|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
130184614|NCT02810457|468634811|FG000|Overall Study|Adverse Event|37|||
130184615|NCT02810457|468634812|FG001|Overall Study|Adverse Event|43|||
130184616|NCT02810457|468634811|FG000|Overall Study|Patient decision|31|||
130184617|NCT02810457|468634812|FG001|Overall Study|Patient decision|35|||
130184618|NCT02810457|468634811|FG000|Overall Study|Patient lost to follow-up|2|||
130184619|NCT02810457|468634812|FG001|Overall Study|Patient lost to follow-up|2|||
130184620|NCT02810457|468634811|FG000|Overall Study|Death|39|||
130184621|NCT02810457|468634812|FG001|Overall Study|Death|28|||
130184622|NCT02810457|468634811|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
130184623|NCT02810457|468634812|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
130184624|NCT02810457|468634811|FG000|Overall Study|Clinical progression|15|||
130184625|NCT02810457|468634812|FG001|Overall Study|Clinical progression|16|||
130184626|NCT02810457|468634811|FG000|Overall Study|Investigator decision|3|||
130184627|NCT02810457|468634812|FG001|Overall Study|Investigator decision|2|||
130184628|NCT02810457|468634811|FG000|Overall Study|Patient ineligibility|3|||
130184629|NCT02810457|468634812|FG001|Overall Study|Patient ineligibility|0|||
130184630|NCT02810457|468634811|FG000|Overall Study|Miscalculated PD|1|||
130184631|NCT02810457|468634812|FG001|Overall Study|Miscalculated PD|0|||
130184632|NCT02810457|468634811|FG000|Overall Study|Physician Decision|0|||
130184633|NCT02810457|468634812|FG001|Overall Study|Physician Decision|1|||
130184634|NCT04173507|468634813|FG000|Overall Study|On Treatment|3|||
130184635|NCT04173507|468634813|FG000|Overall Study|Adverse Event|3|||
130184636|NCT04173507|468634813|FG000|Overall Study|Progression/Relapse|34|||
130184637|NCT04173507|468634813|FG000|Overall Study|Death|2|||
130184638|NCT01217112|468634816|FG000|Overall Study|Adverse Event|0|||
130184639|NCT01217112|468634817|FG001|Overall Study|Adverse Event|2|||
130184640|NCT01217112|468634818|FG002|Overall Study|Adverse Event|0|||
130184641|NCT01217112|468634819|FG003|Overall Study|Adverse Event|2|||
130184642|NCT01217112|468634820|FG004|Overall Study|Adverse Event|0|||
130184643|NCT01217112|468634816|FG000|Overall Study|Withdrawal by Subject|0|||
130184644|NCT01217112|468634817|FG001|Overall Study|Withdrawal by Subject|0|||
130184645|NCT01217112|468634818|FG002|Overall Study|Withdrawal by Subject|1|||
130184646|NCT01217112|468634819|FG003|Overall Study|Withdrawal by Subject|0|||
130184647|NCT01217112|468634820|FG004|Overall Study|Withdrawal by Subject|0|||
130184648|NCT01217112|468634816|FG000|Overall Study|Physician Decision|0|||
130184649|NCT01217112|468634817|FG001|Overall Study|Physician Decision|0|||
130184650|NCT01217112|468634818|FG002|Overall Study|Physician Decision|0|||
130184651|NCT01217112|468634819|FG003|Overall Study|Physician Decision|0|||
130184652|NCT01217112|468634820|FG004|Overall Study|Physician Decision|1|||
130184653|NCT03192488|468634821|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
130184654|NCT03192488|468634822|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
130184655|NCT03192488|468634823|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
130184656|NCT03192488|468634824|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
130184657|NCT03192488|468634825|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
130184658|NCT03192488|468634826|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
130184659|NCT03192488|468634821|FG000|Third Intervention (d1)|Adverse Event|0|||
130184660|NCT03192488|468634822|FG001|Third Intervention (d1)|Adverse Event|0|||
130184661|NCT03192488|468634823|FG002|Third Intervention (d1)|Adverse Event|0|||
130184662|NCT03192488|468634824|FG003|Third Intervention (d1)|Adverse Event|0|||
130184663|NCT03192488|468634825|FG004|Third Intervention (d1)|Adverse Event|1|||
130184664|NCT03192488|468634826|FG005|Third Intervention (d1)|Adverse Event|0|||
130184665|NCT01401361|468634827|FG000|Overall Study|Withdrawal by Subject|16|||
130184666|NCT01401361|468634827|FG000|Overall Study|Lack of Efficacy|6|||
130184667|NCT01401361|468634827|FG000|Overall Study|Physician Decision|1|||
130184668|NCT01401361|468634827|FG000|Overall Study|Lost to Follow-up|3|||
130184669|NCT01401361|468634827|FG000|Overall Study|Subject/family decision post procedure|2|||
130184670|NCT02512302|468634829|FG000|Period 1|Adverse Event|0|||
130184671|NCT02512302|468634830|FG001|Period 1|Adverse Event|1|||
130184672|NCT02512302|468634831|FG002|Period 1|Adverse Event|0|||
130184673|NCT02512302|468634832|FG003|Period 1|Adverse Event|0|||
130184674|NCT02512302|468634833|FG004|Period 1|Adverse Event|0|||
130184675|NCT02512302|468634834|FG005|Period 1|Adverse Event|0|||
130184676|NCT02512302|468634835|FG006|Period 1|Adverse Event|0|||
130184677|NCT02512302|468634836|FG007|Period 1|Adverse Event|0|||
130184678|NCT02512302|468634837|FG008|Period 1|Adverse Event|0|||
130184679|NCT02512302|468634838|FG009|Period 1|Adverse Event|0|||
130184680|NCT02512302|468634829|FG000|Period 2|Adverse Event|0|||
130184681|NCT02512302|468634830|FG001|Period 2|Adverse Event|0|||
130184682|NCT02512302|468634831|FG002|Period 2|Adverse Event|0|||
130184683|NCT02512302|468634832|FG003|Period 2|Adverse Event|0|||
130184684|NCT02512302|468634833|FG004|Period 2|Adverse Event|0|||
130184685|NCT02512302|468634834|FG005|Period 2|Adverse Event|0|||
130184686|NCT02512302|468634835|FG006|Period 2|Adverse Event|0|||
130184687|NCT02512302|468634836|FG007|Period 2|Adverse Event|0|||
130184688|NCT02512302|468634837|FG008|Period 2|Adverse Event|0|||
130184689|NCT02512302|468634838|FG009|Period 2|Adverse Event|1|||
130184690|NCT02512302|468634829|FG000|Period 3|Lost to Follow-up|0|||
130184691|NCT02512302|468634830|FG001|Period 3|Lost to Follow-up|0|||
130184692|NCT02512302|468634831|FG002|Period 3|Lost to Follow-up|1|||
130184693|NCT02512302|468634832|FG003|Period 3|Lost to Follow-up|0|||
130184694|NCT02512302|468634833|FG004|Period 3|Lost to Follow-up|0|||
130184695|NCT02512302|468634834|FG005|Period 3|Lost to Follow-up|0|||
130184696|NCT02512302|468634835|FG006|Period 3|Lost to Follow-up|0|||
130184697|NCT02512302|468634836|FG007|Period 3|Lost to Follow-up|0|||
130184698|NCT02512302|468634837|FG008|Period 3|Lost to Follow-up|0|||
130184699|NCT02512302|468634838|FG009|Period 3|Lost to Follow-up|0|||
130184700|NCT02512302|468634829|FG000|Period 4|Adverse Event|0|||
130184701|NCT02512302|468634830|FG001|Period 4|Adverse Event|0|||
130184702|NCT02512302|468634831|FG002|Period 4|Adverse Event|0|||
130184703|NCT02512302|468634832|FG003|Period 4|Adverse Event|0|||
130184704|NCT02512302|468634833|FG004|Period 4|Adverse Event|0|||
130184705|NCT02512302|468634834|FG005|Period 4|Adverse Event|0|||
130184706|NCT02512302|468634835|FG006|Period 4|Adverse Event|1|||
130184707|NCT02512302|468634836|FG007|Period 4|Adverse Event|0|||
130184708|NCT02512302|468634837|FG008|Period 4|Adverse Event|0|||
130184709|NCT02512302|468634838|FG009|Period 4|Adverse Event|0|||
130184710|NCT02764762|468634842|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
130184711|NCT02764762|468634842|FG000|Overall Study|Lost to Follow-up|4|||
130184712|NCT02764762|468634842|FG000|Overall Study|Voluntary Withdrawal|8|||
130184713|NCT02764762|468634842|FG000|Overall Study|Site Termination|1|||
130184714|NCT02764762|468634842|FG000|Overall Study|Lack of Efficacy|16|||
130184715|NCT02764762|468634842|FG000|Overall Study|Reason not Specified|1|||
130184716|NCT01002989|468634843|FG000|Overall Study|exclusion criteria, no consent|5|||
130184717|NCT01892501|468634844|FG000|Overall Study|Protocol Violation|2|||
130184718|NCT01892501|468634844|FG000|Overall Study|Puncture not carried out|9|||
130184719|NCT01892501|468634844|FG000|Overall Study|Radiological monitoring not carried out|5|||
130184720|NCT01892501|468634844|FG000|Overall Study|Non-contributory histological result|12|||
130184721|NCT01068860|468634846|FG000|Overall Study|Withdrawal by Subject|0|||
130184722|NCT01068860|468634847|FG001|Overall Study|Withdrawal by Subject|0|||
130184723|NCT01068860|468634848|FG002|Overall Study|Withdrawal by Subject|0|||
130184724|NCT01068860|468634849|FG003|Overall Study|Withdrawal by Subject|0|||
130184725|NCT01068860|468634850|FG004|Overall Study|Withdrawal by Subject|0|||
130184726|NCT01068860|468634851|FG005|Overall Study|Withdrawal by Subject|2|||
130184727|NCT01068860|468634852|FG006|Overall Study|Withdrawal by Subject|0|||
130184728|NCT01068860|468634853|FG007|Overall Study|Withdrawal by Subject|0|||
130184729|NCT01068860|468634854|FG008|Overall Study|Withdrawal by Subject|0|||
130184730|NCT01068860|468634855|FG009|Overall Study|Withdrawal by Subject|3|||
130184731|NCT01068860|468634846|FG000|Overall Study|Administrative problems; misrandomized|0|||
130184732|NCT01068860|468634847|FG001|Overall Study|Administrative problems; misrandomized|0|||
130184733|NCT01068860|468634848|FG002|Overall Study|Administrative problems; misrandomized|0|||
130184734|NCT01068860|468634849|FG003|Overall Study|Administrative problems; misrandomized|1|||
130184735|NCT01068860|468634850|FG004|Overall Study|Administrative problems; misrandomized|0|||
130184736|NCT01068860|468634851|FG005|Overall Study|Administrative problems; misrandomized|0|||
130184737|NCT01068860|468634852|FG006|Overall Study|Administrative problems; misrandomized|0|||
130184738|NCT01068860|468634853|FG007|Overall Study|Administrative problems; misrandomized|0|||
130184739|NCT01068860|468634854|FG008|Overall Study|Administrative problems; misrandomized|0|||
130184740|NCT01068860|468634855|FG009|Overall Study|Administrative problems; misrandomized|1|||
130184741|NCT01068860|468634846|FG000|Overall Study|Lost to Follow-up|0|||
130184742|NCT01068860|468634847|FG001|Overall Study|Lost to Follow-up|1|||
130184743|NCT01068860|468634848|FG002|Overall Study|Lost to Follow-up|0|||
130184744|NCT01068860|468634849|FG003|Overall Study|Lost to Follow-up|0|||
130184745|NCT01068860|468634850|FG004|Overall Study|Lost to Follow-up|0|||
130184746|NCT01068860|468634851|FG005|Overall Study|Lost to Follow-up|0|||
130184747|NCT01068860|468634852|FG006|Overall Study|Lost to Follow-up|0|||
130184748|NCT01068860|468634853|FG007|Overall Study|Lost to Follow-up|0|||
130184749|NCT01068860|468634854|FG008|Overall Study|Lost to Follow-up|0|||
130184750|NCT01068860|468634855|FG009|Overall Study|Lost to Follow-up|0|||
130184751|NCT01321879|468634856|FG000|Overall Study|Lack of Efficacy|5|||
130184752|NCT01321879|468634856|FG000|Overall Study|Adverse Event|5|||
130184753|NCT01321879|468634856|FG000|Overall Study|Death|3|||
130184754|NCT01321879|468634856|FG000|Overall Study|Withdrawal by Subject|1|||
130184755|NCT00513240|468634858|FG000|Overall Study|Did not have intended surgery|3|||
130184756|NCT00513240|468634859|FG001|Overall Study|Did not have intended surgery|0|||
130184757|NCT00513240|468634858|FG000|Overall Study|Death|3|||
130184758|NCT00513240|468634859|FG001|Overall Study|Death|3|||
130184759|NCT00513240|468634858|FG000|Overall Study|Withdrawal by Subject|7|||
130184760|NCT00513240|468634859|FG001|Overall Study|Withdrawal by Subject|4|||
130184761|NCT05263908|468634860|FG000|Overall Study|No informed consent for publication of study results|397|||
130184762|NCT05263908|468634860|FG000|Overall Study|CRF not collected|1|||
130184763|NCT01641640|468634861|FG000|Overall Study|Enrolled but not treated|1|||
130184764|NCT01641640|468634861|FG000|Overall Study|Efficacy failure|29|||
130184765|NCT01641640|468634861|FG000|Overall Study|Lost to Follow-up|3|||
130184766|NCT01641640|468634861|FG000|Overall Study|Withdrawal by Subject|2|||
130184767|NCT01641640|468634861|FG000|Overall Study|Adverse Event|1|||
130184768|NCT01234350|468634863|FG000|Overall Study|Adverse Event|277|||
130184769|NCT01234350|468634864|FG001|Overall Study|Adverse Event|92|||
130184770|NCT01234350|468634863|FG000|Overall Study|Withdrawal by Subject|61|||
130184771|NCT01234350|468634864|FG001|Overall Study|Withdrawal by Subject|36|||
130184772|NCT01234350|468634863|FG000|Overall Study|Lost to Follow-up|115|||
130184773|NCT01234350|468634864|FG001|Overall Study|Lost to Follow-up|47|||
130184774|NCT01234350|468634863|FG000|Overall Study|Covers a diverse set of reasons|234|||
130184775|NCT01234350|468634864|FG001|Overall Study|Covers a diverse set of reasons|92|||
130184776|NCT01930162|468634867|FG000|Overall Study|Abnormal test procedure result(s)|4|||
130184777|NCT01930162|468634867|FG000|Overall Study|Death|1|||
130184778|NCT01051960|468634868|FG000|Overall Study|Adverse Event|1|||
130184779|NCT02069015|468634878|FG000|Overall Study|Lost to Follow-up|39|||
130184780|NCT02069015|468634879|FG001|Overall Study|Lost to Follow-up|32|||
130184781|NCT02069015|468634878|FG000|Overall Study|Withdrawal by Subject|1|||
130184782|NCT02069015|468634879|FG001|Overall Study|Withdrawal by Subject|1|||
130184783|NCT01082328|468634880|FG000|Overall Study|Adverse Event|1|||
130184784|NCT00031590|468634881|FG000|Overall Study|Adverse Event|1|||
130184785|NCT00031590|468634881|FG000|Overall Study|Withdrawal by parents|2|||
130184786|NCT05506046|468634882|FG000|Overall Study|Lost to Follow-up|89|||
130184787|NCT05506046|468634883|FG001|Overall Study|Lost to Follow-up|101|||
130184788|NCT05506046|468634884|FG002|Overall Study|Lost to Follow-up|102|||
130184789|NCT05506046|468634885|FG003|Overall Study|Lost to Follow-up|99|||
130184790|NCT03051100|468634887|FG000|Overall Study|Withdrawal by Subject|1|||
130184791|NCT03051100|468634888|FG001|Overall Study|Withdrawal by Subject|0|||
130184792|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
130184793|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
130184794|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
130184795|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
130184796|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
130184797|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
130184798|NCT02059135|468634889|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
130184799|NCT02059135|468634890|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
130184800|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
130184801|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
130184802|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
130184803|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
130184804|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
130184805|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
130184806|NCT02059135|468634889|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
130184807|NCT02059135|468634890|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
130184808|NCT00789854|468634893|FG000|Overall Study|Adverse Event|28|||
130184809|NCT00789854|468634894|FG001|Overall Study|Adverse Event|23|||
130184810|NCT00789854|468634895|FG002|Overall Study|Adverse Event|18|||
130184811|NCT00789854|468634893|FG000|Overall Study|Lost to Follow-up|1|||
130184812|NCT00789854|468634894|FG001|Overall Study|Lost to Follow-up|1|||
130184813|NCT00789854|468634895|FG002|Overall Study|Lost to Follow-up|4|||
130184814|NCT00789854|468634893|FG000|Overall Study|Withdrawal by Subject|9|||
130184815|NCT00789854|468634894|FG001|Overall Study|Withdrawal by Subject|6|||
130184816|NCT00789854|468634895|FG002|Overall Study|Withdrawal by Subject|17|||
130184817|NCT00789854|468634893|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130184818|NCT00789854|468634894|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
130184819|NCT00789854|468634895|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
130184820|NCT00789854|468634893|FG000|Overall Study|Severe non-compliance to the protocol|3|||
130184821|NCT00789854|468634894|FG001|Overall Study|Severe non-compliance to the protocol|0|||
130184822|NCT00789854|468634895|FG002|Overall Study|Severe non-compliance to the protocol|0|||
130184823|NCT00789854|468634893|FG000|Overall Study|Safety reasons|0|||
130184824|NCT00789854|468634894|FG001|Overall Study|Safety reasons|0|||
130184825|NCT00789854|468634895|FG002|Overall Study|Safety reasons|2|||
130184826|NCT00789854|468634893|FG000|Overall Study|Other|6|||
130184827|NCT00789854|468634894|FG001|Overall Study|Other|0|||
130184828|NCT00789854|468634895|FG002|Overall Study|Other|5|||
130184829|NCT00923013|468634896|FG000|Overall Study|Refused further treatment|0|||
130184830|NCT00923013|468634897|FG001|Overall Study|Refused further treatment|1|||
130184831|NCT00923013|468634898|FG002|Overall Study|Refused further treatment|2|||
130184832|NCT00923013|468634899|FG003|Overall Study|Refused further treatment|0|||
130184833|NCT00923013|468634900|FG004|Overall Study|Refused further treatment|0|||
130184834|NCT00923013|468634901|FG005|Overall Study|Refused further treatment|0|||
130184835|NCT00923013|468634896|FG000|Overall Study|Switched to alternative treatment|0|||
130184836|NCT00923013|468634897|FG001|Overall Study|Switched to alternative treatment|1|||
130184837|NCT00923013|468634898|FG002|Overall Study|Switched to alternative treatment|0|||
130184838|NCT00923013|468634899|FG003|Overall Study|Switched to alternative treatment|0|||
130184839|NCT00923013|468634900|FG004|Overall Study|Switched to alternative treatment|0|||
130184840|NCT00923013|468634901|FG005|Overall Study|Switched to alternative treatment|0|||
130184841|NCT00923013|468634896|FG000|Overall Study|Death on study|2|||
130184842|NCT00923013|468634897|FG001|Overall Study|Death on study|2|||
130184843|NCT00923013|468634898|FG002|Overall Study|Death on study|0|||
130184844|NCT00923013|468634899|FG003|Overall Study|Death on study|1|||
130184845|NCT00923013|468634900|FG004|Overall Study|Death on study|0|||
130184846|NCT00923013|468634901|FG005|Overall Study|Death on study|0|||
130184847|NCT02224157|468634903|FG000|Overall Study|Severe non-compliance to protocol|2|||
130184848|NCT02224157|468634904|FG001|Overall Study|Severe non-compliance to protocol|2|||
130184849|NCT02224157|468634903|FG000|Overall Study|Other|13|||
130184850|NCT02224157|468634904|FG001|Overall Study|Other|10|||
130184851|NCT02224157|468634903|FG000|Overall Study|Subject decision|58|||
130184852|NCT02224157|468634904|FG001|Overall Study|Subject decision|50|||
130184853|NCT02224157|468634903|FG000|Overall Study|Prematurely closed site|4|||
130184854|NCT02224157|468634904|FG001|Overall Study|Prematurely closed site|2|||
130184855|NCT02224157|468634903|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
130184856|NCT02224157|468634904|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
130184857|NCT02224157|468634903|FG000|Overall Study|Lost to Follow-up|27|||
130184858|NCT02224157|468634904|FG001|Overall Study|Lost to Follow-up|35|||
130184859|NCT02224157|468634903|FG000|Overall Study|Death|1|||
130184860|NCT02224157|468634904|FG001|Overall Study|Death|1|||
130184861|NCT02224157|468634903|FG000|Overall Study|Adverse Event|1|||
130184862|NCT02224157|468634904|FG001|Overall Study|Adverse Event|3|||
130184863|NCT05906628|468634907|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
130184864|NCT05906628|468634908|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
130184865|NCT05906628|468634907|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
130184866|NCT05906628|468634908|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
130184867|NCT05906628|468634907|FG000|16-Week DBVC Period|Protocol Violation|4|||
130184868|NCT05906628|468634908|FG001|16-Week DBVC Period|Protocol Violation|2|||
130184869|NCT05906628|468634907|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
130184870|NCT05906628|468634908|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
130184871|NCT05906628|468634907|FG000|16-Week OLE Period|Death|1|||
130184872|NCT05906628|468634908|FG001|16-Week OLE Period|Death|0|||
130184873|NCT05906628|468634907|FG000|16-Week OLE Period|Lost to Follow-up|1|||
130184874|NCT05906628|468634908|FG001|16-Week OLE Period|Lost to Follow-up|1|||
130184875|NCT05906628|468634907|FG000|16-Week OLE Period|Protocol Violation|0|||
130184876|NCT05906628|468634908|FG001|16-Week OLE Period|Protocol Violation|1|||
130184877|NCT05906628|468634907|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
130184878|NCT05906628|468634908|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
130184879|NCT04578535|468634909|FG000|Overall Study|Lost to Follow-up|1|||
130184880|NCT04578535|468634910|FG001|Overall Study|Lost to Follow-up|0|||
130184881|NCT04578535|468634911|FG002|Overall Study|Lost to Follow-up|0|||
130184882|NCT04578535|468634912|FG003|Overall Study|Lost to Follow-up|1|||
130184883|NCT04578535|468634913|FG004|Overall Study|Lost to Follow-up|0|||
130184884|NCT04578535|468634914|FG005|Overall Study|Lost to Follow-up|2|||
130184885|NCT04578535|468634909|FG000|Overall Study|Pregnancy|1|||
130184886|NCT04578535|468634910|FG001|Overall Study|Pregnancy|0|||
130184887|NCT04578535|468634911|FG002|Overall Study|Pregnancy|0|||
130184888|NCT04578535|468634912|FG003|Overall Study|Pregnancy|0|||
130184889|NCT04578535|468634913|FG004|Overall Study|Pregnancy|0|||
130184890|NCT04578535|468634914|FG005|Overall Study|Pregnancy|0|||
130184891|NCT04578535|468634909|FG000|Overall Study|Withdrawal by Subject|0|||
130184892|NCT04578535|468634910|FG001|Overall Study|Withdrawal by Subject|0|||
130184893|NCT04578535|468634911|FG002|Overall Study|Withdrawal by Subject|0|||
130184894|NCT04578535|468634912|FG003|Overall Study|Withdrawal by Subject|1|||
130184895|NCT04578535|468634913|FG004|Overall Study|Withdrawal by Subject|1|||
130184896|NCT04578535|468634914|FG005|Overall Study|Withdrawal by Subject|5|||
130184897|NCT04578535|468634909|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
130184898|NCT04578535|468634910|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
130184899|NCT04578535|468634911|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
130184900|NCT04578535|468634912|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
130184901|NCT04578535|468634913|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
130184902|NCT04578535|468634914|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
130184903|NCT01060072|468634915|FG000|Overall Study|Adverse Event|1|||
130184904|NCT01060072|468634916|FG001|Overall Study|Adverse Event|1|||
130184905|NCT01060072|468634915|FG000|Overall Study|Physician Decision|0|||
130184906|NCT01060072|468634916|FG001|Overall Study|Physician Decision|2|||
130184907|NCT01060072|468634915|FG000|Overall Study|Protocol Violation|0|||
130184908|NCT01060072|468634916|FG001|Overall Study|Protocol Violation|1|||
130184909|NCT01060072|468634915|FG000|Overall Study|Acute cholecystitis|1|||
130184910|NCT01060072|468634916|FG001|Overall Study|Acute cholecystitis|0|||
130184911|NCT01060072|468634915|FG000|Overall Study|Excluded Medications|0|||
130184912|NCT01060072|468634916|FG001|Overall Study|Excluded Medications|1|||
130184913|NCT00837148|468634917|FG000|Overall Study|Adverse Event|1|||
130184914|NCT00837148|468634917|FG000|Overall Study|Death|1|||
130184915|NCT02301169|468634920|FG000|Overall Study|Adverse Event|1|||
130184916|NCT02301169|468634921|FG001|Overall Study|Adverse Event|0|||
130184917|NCT03839628|468634922|FG000|Overall Study|Withdrawal by Subject|1|||
130184918|NCT00380874|468634923|FG000|Overall Study|Adverse Event|7|||
130184919|NCT00380874|468634924|FG001|Overall Study|Adverse Event|7|||
130184920|NCT00380874|468634923|FG000|Overall Study|Death|1|||
130184921|NCT00380874|468634924|FG001|Overall Study|Death|0|||
130184922|NCT00380874|468634923|FG000|Overall Study|Withdrawal by Subject|2|||
130184923|NCT00380874|468634924|FG001|Overall Study|Withdrawal by Subject|1|||
130184924|NCT00380874|468634923|FG000|Overall Study|Not related to study drug|3|||
130184925|NCT00380874|468634924|FG001|Overall Study|Not related to study drug|2|||
130184926|NCT01707290|468634929|FG000|Overall Study|Adverse event (AE)|1|||
130184927|NCT01707290|468634930|FG001|Overall Study|Adverse event (AE)|0|||
130184928|NCT01707290|468634929|FG000|Overall Study|Physician Decision|1|||
130184929|NCT01707290|468634930|FG001|Overall Study|Physician Decision|0|||
130184930|NCT01707290|468634929|FG000|Overall Study|Lost to Follow-up|3|||
130184931|NCT01707290|468634930|FG001|Overall Study|Lost to Follow-up|0|||
130184932|NCT01707290|468634929|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
130184933|NCT01707290|468634930|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
130184934|NCT01707290|468634929|FG000|Overall Study|Commercial drug available|60|||
130184935|NCT01707290|468634930|FG001|Overall Study|Commercial drug available|1|||
130184936|NCT01707290|468634929|FG000|Overall Study|Other unspecified|17|||
130184937|NCT01707290|468634930|FG001|Overall Study|Other unspecified|0|||
130184938|NCT01198470|468634931|FG000|Overall Study|Adverse Event|2|||
130184939|NCT02949973|468634932|FG000|Overall Study|Physician Decision|1|||
130184940|NCT02857816|468634933|FG000|Overall Study|Screen Failure|33|||
130184941|NCT02857816|468634933|FG000|Overall Study|Withdrawal by Subject|4|||
130184942|NCT02857816|468634933|FG000|Overall Study|Lost to Follow-up|1|||
130184943|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
130184944|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184945|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184946|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184947|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184948|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
130184949|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
130184950|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
130184951|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
130184952|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
130184953|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
130184954|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
130184955|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
130184956|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
130184957|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184958|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
130184959|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184960|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184961|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184962|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
130184963|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
130184964|NCT01147068|468634936|FG000|Subjects That Received 2nd Dose|Other|0|||
130184965|NCT01147068|468634937|FG001|Subjects That Received 2nd Dose|Other|3|||
130184966|NCT01147068|468634938|FG002|Subjects That Received 2nd Dose|Other|3|||
130184967|NCT01147068|468634939|FG003|Subjects That Received 2nd Dose|Other|0|||
130184968|NCT01147068|468634940|FG004|Subjects That Received 2nd Dose|Other|1|||
130184969|NCT01147068|468634941|FG005|Subjects That Received 2nd Dose|Other|0|||
130184970|NCT01147068|468634942|FG006|Subjects That Received 2nd Dose|Other|0|||
130184971|NCT01147068|468634936|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130184972|NCT01147068|468634937|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184973|NCT01147068|468634938|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184974|NCT01147068|468634939|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184975|NCT01147068|468634940|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
130184976|NCT01147068|468634941|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130184977|NCT01147068|468634942|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
130184978|NCT01147068|468634936|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184979|NCT01147068|468634937|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184980|NCT01147068|468634938|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184981|NCT01147068|468634939|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
130184982|NCT01147068|468634940|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184983|NCT01147068|468634941|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184984|NCT01147068|468634942|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
130184985|NCT01147068|468634936|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184986|NCT01147068|468634937|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
130184987|NCT01147068|468634938|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184988|NCT01147068|468634939|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184989|NCT01147068|468634940|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184990|NCT01147068|468634941|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184991|NCT01147068|468634942|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
130184992|NCT03181633|468634943|FG000|Overall Study|Withdrawal by Subject|1|||
130184993|NCT03181633|468634943|FG000|Overall Study|Missing follow-up visit|1|||
130184994|NCT01597778|468634945|FG000|Overall Study|Death|7|||
130184995|NCT01597778|468634946|FG001|Overall Study|Death|10|||
130184996|NCT01597778|468634945|FG000|Overall Study|Withdrawal by Subject|3|||
130184997|NCT01597778|468634946|FG001|Overall Study|Withdrawal by Subject|4|||
130184998|NCT01597778|468634945|FG000|Overall Study|Adverse Event|1|||
130184999|NCT01597778|468634946|FG001|Overall Study|Adverse Event|1|||
130185000|NCT01597778|468634945|FG000|Overall Study|Protocol Violation|1|||
130185001|NCT01597778|468634946|FG001|Overall Study|Protocol Violation|11|||
130185002|NCT01597778|468634945|FG000|Overall Study|Transplanted off protocol|2|||
130185003|NCT01597778|468634946|FG001|Overall Study|Transplanted off protocol|3|||
130185004|NCT04837196|468634956|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130185005|NCT04837196|468634957|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
130185006|NCT04837196|468634958|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130185007|NCT04837196|468634959|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
130185008|NCT04837196|468634960|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
130185009|NCT04837196|468634956|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130185010|NCT04837196|468634957|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
130185011|NCT04837196|468634958|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
130185012|NCT04837196|468634959|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130185013|NCT04837196|468634960|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
130185014|NCT04837196|468634956|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185015|NCT04837196|468634957|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
130185016|NCT04837196|468634958|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185017|NCT04837196|468634959|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185018|NCT04837196|468634960|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
130185019|NCT04837196|468634956|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185020|NCT04837196|468634957|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185021|NCT04837196|468634958|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
130185022|NCT04837196|468634959|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185023|NCT04837196|468634960|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
130185024|NCT04837196|468634956|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185025|NCT04837196|468634957|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185026|NCT04837196|468634958|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
130185027|NCT04837196|468634959|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185028|NCT04837196|468634960|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
130185029|NCT01522456|468634961|FG000|Overall Study|Adverse Event|2|||
130185030|NCT01522456|468634961|FG000|Overall Study|Lost to Follow-up|2|||
130185031|NCT01522456|468634961|FG000|Overall Study|Withdrawal by Subject|2|||
130185032|NCT01522456|468634961|FG000|Overall Study|Pregnancy|1|||
130185033|NCT01522456|468634961|FG000|Overall Study|Tolerability Assessment|1|||
130185034|NCT01565889|468634965|FG000|Part A|Withdrawal by Subject|1|||
130185035|NCT01565889|468634966|FG001|Part A|Withdrawal by Subject|0|||
130185036|NCT01565889|468634967|FG002|Part A|Withdrawal by Subject|0|||
130185037|NCT01565889|468634968|FG003|Part A|Withdrawal by Subject|0|||
130185038|NCT01565889|468634969|FG004|Part A|Withdrawal by Subject|0|||
130185039|NCT01565889|468634970|FG005|Part A|Withdrawal by Subject|0|||
130185040|NCT01565889|468634965|FG000|Part B|Withdrawal by Subject|0|||
130185041|NCT01565889|468634966|FG001|Part B|Withdrawal by Subject|0|||
130185042|NCT01565889|468634967|FG002|Part B|Withdrawal by Subject|0|||
130185043|NCT01565889|468634968|FG003|Part B|Withdrawal by Subject|0|||
130185044|NCT01565889|468634969|FG004|Part B|Withdrawal by Subject|0|||
130185045|NCT01565889|468634970|FG005|Part B|Withdrawal by Subject|1|||
130185046|NCT01565889|468634965|FG000|Part B|Lack of Efficacy|0|||
130185047|NCT01565889|468634966|FG001|Part B|Lack of Efficacy|0|||
130185048|NCT01565889|468634967|FG002|Part B|Lack of Efficacy|0|||
130185049|NCT01565889|468634968|FG003|Part B|Lack of Efficacy|0|||
130185050|NCT01565889|468634969|FG004|Part B|Lack of Efficacy|0|||
130185051|NCT01565889|468634970|FG005|Part B|Lack of Efficacy|2|||
130185052|NCT01565889|468634965|FG000|Part B|Lost to Follow-up|0|||
130185053|NCT01565889|468634966|FG001|Part B|Lost to Follow-up|0|||
130185054|NCT01565889|468634967|FG002|Part B|Lost to Follow-up|0|||
130185055|NCT01565889|468634968|FG003|Part B|Lost to Follow-up|0|||
130185056|NCT01565889|468634969|FG004|Part B|Lost to Follow-up|0|||
130185057|NCT01565889|468634970|FG005|Part B|Lost to Follow-up|1|||
130185058|NCT02723344|468634971|FG000|Overall Study|Lost to Follow-up|0|||
130185059|NCT02723344|468634972|FG001|Overall Study|Lost to Follow-up|4|||
130185060|NCT01326845|468634975|FG000|Overall Study|Administrative Problems|5|||
130185061|NCT01326845|468634976|FG001|Overall Study|Administrative Problems|2|||
130185062|NCT01326845|468634975|FG000|Overall Study|Adverse Event|1|||
130185063|NCT01326845|468634976|FG001|Overall Study|Adverse Event|0|||
130185064|NCT01326845|468634975|FG000|Overall Study|Misisng|1|||
130185065|NCT01326845|468634976|FG001|Overall Study|Misisng|3|||
130185066|NCT02964247|468634977|FG000|Overall Study|Lost to Follow-up|2|||
130185067|NCT02964247|468634978|FG001|Overall Study|Lost to Follow-up|0|||
130185068|NCT02964247|468634977|FG000|Overall Study|Withdrawal by Subject|1|||
130185069|NCT02964247|468634978|FG001|Overall Study|Withdrawal by Subject|2|||
130185070|NCT03918629|468634979|FG000|Overall Study|Adverse Event|19|||
130185071|NCT03918629|468634980|FG001|Overall Study|Adverse Event|20|||
130185072|NCT03918629|468634979|FG000|Overall Study|Death|14|||
130185073|NCT03918629|468634980|FG001|Overall Study|Death|7|||
130185074|NCT03918629|468634979|FG000|Overall Study|Lost to Follow-up|36|||
130185075|NCT03918629|468634980|FG001|Overall Study|Lost to Follow-up|28|||
130185076|NCT03918629|468634979|FG000|Overall Study|Physician Decision|1|||
130185077|NCT03918629|468634980|FG001|Overall Study|Physician Decision|0|||
130185078|NCT03918629|468634979|FG000|Overall Study|Protocol Violation|7|||
130185079|NCT03918629|468634980|FG001|Overall Study|Protocol Violation|4|||
130185080|NCT03918629|468634979|FG000|Overall Study|Withdrawal by Subject|47|||
130185081|NCT03918629|468634980|FG001|Overall Study|Withdrawal by Subject|47|||
130185082|NCT03918629|468634979|FG000|Overall Study|Other|7|||
130185083|NCT03918629|468634980|FG001|Overall Study|Other|11|||
130185084|NCT03918629|468634979|FG000|Overall Study|Randomized but not vaccinated|2|||
130185085|NCT03918629|468634980|FG001|Overall Study|Randomized but not vaccinated|1|||
130185086|NCT01709500|468634984|FG000|Overall Study|Randomized but not treated|0|||
130185087|NCT01709500|468634985|FG001|Overall Study|Randomized but not treated|1|||
130185088|NCT01709500|468634984|FG000|Overall Study|Adverse Event|5|||
130185089|NCT01709500|468634985|FG001|Overall Study|Adverse Event|1|||
130185090|NCT01709500|468634984|FG000|Overall Study|Poor compliance to protocol|2|||
130185091|NCT01709500|468634985|FG001|Overall Study|Poor compliance to protocol|1|||
130185092|NCT01709500|468634984|FG000|Overall Study|Other|3|||
130185093|NCT01709500|468634985|FG001|Overall Study|Other|1|||
130185094|NCT01709500|468634984|FG000|Overall Study|Related to IMP administration|1|||
130185095|NCT01709500|468634985|FG001|Overall Study|Related to IMP administration|0|||
130185096|NCT01709500|468634984|FG000|Overall Study|Treatment ongoing|156|||
130185097|NCT01709500|468634985|FG001|Overall Study|Treatment ongoing|78|||
130185098|NCT00740636|468634987|FG000|Overall Study|Adverse Event|0|||
130185099|NCT00740636|468634988|FG001|Overall Study|Adverse Event|2|||
130185100|NCT00740636|468634987|FG000|Overall Study|Patient Ineligible|0|||
130185101|NCT00740636|468634988|FG001|Overall Study|Patient Ineligible|1|||
130185102|NCT00740636|468634987|FG000|Overall Study|Patient Not Treated|0|||
130185103|NCT00740636|468634988|FG001|Overall Study|Patient Not Treated|1|||
130185104|NCT00740636|468634987|FG000|Overall Study|Progressive Disease|1|||
130185105|NCT00740636|468634988|FG001|Overall Study|Progressive Disease|0|||
130185106|NCT00740636|468634987|FG000|Overall Study|Death|1|||
130185107|NCT00740636|468634988|FG001|Overall Study|Death|0|||
130185108|NCT02844543|468636637|FG000|Overall Study|Withdrawal by Subject|4|||
130185109|NCT02844543|468636637|FG000|Overall Study|Did not meet eligibility criteria|1|||
130185110|NCT04710576|468636643|FG000|Overall Study|Participants still in the study|73|||
130185111|NCT04710576|468636644|FG001|Overall Study|Participants still in the study|70|||
130185112|NCT04710576|468636645|FG002|Overall Study|Participants still in the study|60|||
130185113|NCT04710576|468636643|FG000|Overall Study|Death|2|||
130185114|NCT04710576|468636644|FG001|Overall Study|Death|7|||
130185115|NCT04710576|468636645|FG002|Overall Study|Death|12|||
130185116|NCT04710576|468636643|FG000|Overall Study|Withdrawal by Subject|4|||
130185117|NCT04710576|468636644|FG001|Overall Study|Withdrawal by Subject|3|||
130185118|NCT04710576|468636645|FG002|Overall Study|Withdrawal by Subject|7|||
130185119|NCT04710576|468636643|FG000|Overall Study|Sponsor decision|1|||
130185120|NCT04710576|468636644|FG001|Overall Study|Sponsor decision|0|||
130185121|NCT04710576|468636645|FG002|Overall Study|Sponsor decision|0|||
130185122|NCT04581824|468636646|FG000|Overall Study|Lost to Follow-up|1|||
130185123|NCT04581824|468636647|FG001|Overall Study|Lost to Follow-up|0|||
130185124|NCT04581824|468636646|FG000|Overall Study|Withdrawal by Subject|2|||
130185125|NCT04581824|468636647|FG001|Overall Study|Withdrawal by Subject|7|||
130185126|NCT04581824|468636646|FG000|Overall Study|Study terminated by sponsor|37|||
130185127|NCT04581824|468636647|FG001|Overall Study|Study terminated by sponsor|23|||
130185128|NCT04796909|468636648|FG000|Overall Study|Withdrawal by Subject|1|||
130185129|NCT04796909|468636649|FG001|Overall Study|Withdrawal by Subject|1|||
130185130|NCT03879135|468636650|FG000|Overall Study|Physician Decision|0|||
130185131|NCT03879135|468636651|FG001|Overall Study|Physician Decision|0|||
130185132|NCT03879135|468636652|FG002|Overall Study|Physician Decision|0|||
130185133|NCT03879135|468636653|FG003|Overall Study|Physician Decision|1|||
130185134|NCT03879135|468636654|FG004|Overall Study|Physician Decision|0|||
130185135|NCT03879135|468636655|FG005|Overall Study|Physician Decision|0|||
130185136|NCT03879135|468636650|FG000|Overall Study|Withdrawal by Subject|0|||
130185137|NCT03879135|468636651|FG001|Overall Study|Withdrawal by Subject|0|||
130185138|NCT03879135|468636652|FG002|Overall Study|Withdrawal by Subject|0|||
130185139|NCT03879135|468636653|FG003|Overall Study|Withdrawal by Subject|0|||
130185140|NCT03879135|468636654|FG004|Overall Study|Withdrawal by Subject|0|||
130185141|NCT03879135|468636655|FG005|Overall Study|Withdrawal by Subject|1|||
130185142|NCT03879135|468636650|FG000|Overall Study|Site Closed by Sponsor|0|||
130185143|NCT03879135|468636651|FG001|Overall Study|Site Closed by Sponsor|0|||
130185144|NCT03879135|468636652|FG002|Overall Study|Site Closed by Sponsor|0|||
130185145|NCT03879135|468636653|FG003|Overall Study|Site Closed by Sponsor|1|||
130185146|NCT03879135|468636654|FG004|Overall Study|Site Closed by Sponsor|1|||
130185147|NCT03879135|468636655|FG005|Overall Study|Site Closed by Sponsor|0|||
130185148|NCT04162847|468636656|FG000|Overall Study|Withdrawal by Subject|7|||
130185149|NCT04162847|468636657|FG001|Overall Study|Withdrawal by Subject|1|||
130185150|NCT00813150|468636658|FG000|Treatment Period|Adverse Event|16|||
130185151|NCT00813150|468636659|FG001|Treatment Period|Adverse Event|15|||
130185152|NCT00813150|468636658|FG000|Treatment Period|Death|2|||
130185153|NCT00813150|468636659|FG001|Treatment Period|Death|0|||
130185154|NCT00813150|468636658|FG000|Treatment Period|Progressive disease|1|||
130185155|NCT00813150|468636659|FG001|Treatment Period|Progressive disease|0|||
130185156|NCT00813150|468636658|FG000|Treatment Period|Complete response|0|||
130185157|NCT00813150|468636659|FG001|Treatment Period|Complete response|1|||
130185158|NCT00813150|468636658|FG000|Treatment Period|Stable disease|1|||
130185159|NCT00813150|468636659|FG001|Treatment Period|Stable disease|2|||
130185160|NCT00813150|468636658|FG000|Treatment Period|Protocol Violation|3|||
130185161|NCT00813150|468636659|FG001|Treatment Period|Protocol Violation|4|||
130185162|NCT00813150|468636658|FG000|Treatment Period|Withdrawal by Subject|5|||
130185163|NCT00813150|468636659|FG001|Treatment Period|Withdrawal by Subject|3|||
130185164|NCT00813150|468636658|FG000|Treatment Period|Non compliance|0|||
130185165|NCT00813150|468636659|FG001|Treatment Period|Non compliance|1|||
130185166|NCT00813150|468636658|FG000|Treatment Period|Reason not specified|3|||
130185167|NCT00813150|468636659|FG001|Treatment Period|Reason not specified|4|||
130185168|NCT00813150|468636658|FG000|Treatment Period|Data not available|1|||
130185169|NCT00813150|468636659|FG001|Treatment Period|Data not available|2|||
130185170|NCT00813150|468636658|FG000|Long Term Follow-up|Death|0|||
130185171|NCT00813150|468636659|FG001|Long Term Follow-up|Death|4|||
130185172|NCT00813150|468636658|FG000|Long Term Follow-up|Other|0|||
130185173|NCT00813150|468636659|FG001|Long Term Follow-up|Other|3|||
130185174|NCT00813150|468636658|FG000|Long Term Follow-up|Lost to Follow-up|2|||
130185175|NCT00813150|468636659|FG001|Long Term Follow-up|Lost to Follow-up|0|||
130185176|NCT00813150|468636658|FG000|Long Term Follow-up|Progression/Relapse|22|||
130185177|NCT00813150|468636659|FG001|Long Term Follow-up|Progression/Relapse|24|||
130185178|NCT05423093|468636660|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
130185179|NCT05423093|468636660|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
130185180|NCT05423093|468636660|FG000|Attended Intervention Session|Lost to Follow-up|3|||
130185181|NCT05423093|468636660|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
130185182|NCT05423093|468636660|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
130185183|NCT02832687|468636661|FG000|Overall Study|Adverse Event|0|||
130185184|NCT02832687|468636662|FG001|Overall Study|Adverse Event|2|||
130185185|NCT00471822|468636663|FG000|Overall Study|Protocol Violation|2|||
130185186|NCT03664232|468636664|FG000|Overall Study|Withdrawal by Subject|0|||
130185187|NCT03664232|468636665|FG001|Overall Study|Withdrawal by Subject|1|||
130185188|NCT03664232|468636666|FG002|Overall Study|Withdrawal by Subject|0|||
130185189|NCT03664232|468636667|FG003|Overall Study|Withdrawal by Subject|1|||
130185190|NCT03664232|468636664|FG000|Overall Study|Adverse Event|0|||
130185191|NCT03664232|468636665|FG001|Overall Study|Adverse Event|0|||
130185192|NCT03664232|468636666|FG002|Overall Study|Adverse Event|1|||
130185193|NCT03664232|468636667|FG003|Overall Study|Adverse Event|0|||
130185194|NCT03664232|468636664|FG000|Overall Study|Other-Non-compliance with study drug|0|||
130185195|NCT03664232|468636665|FG001|Overall Study|Other-Non-compliance with study drug|1|||
130185196|NCT03664232|468636666|FG002|Overall Study|Other-Non-compliance with study drug|0|||
130185197|NCT03664232|468636667|FG003|Overall Study|Other-Non-compliance with study drug|2|||
130185198|NCT03664232|468636664|FG000|Overall Study|Other-Unspecified|0|||
130185199|NCT03664232|468636665|FG001|Overall Study|Other-Unspecified|3|||
130185200|NCT03664232|468636666|FG002|Overall Study|Other-Unspecified|0|||
130185201|NCT03664232|468636667|FG003|Overall Study|Other-Unspecified|1|||
130185202|NCT03664232|468636664|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
130185203|NCT03664232|468636665|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
130185204|NCT03664232|468636666|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
130185205|NCT03664232|468636667|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
130185206|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
130185207|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
130185208|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
130185209|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
130185210|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
130185211|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185212|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185213|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185214|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185215|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185216|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185217|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185218|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185219|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185220|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
130185221|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
130185222|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
130185223|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
130185224|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
130185225|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
130185226|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185227|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185228|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185229|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185230|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185231|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185232|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185233|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185234|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185235|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
130185236|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
130185237|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
130185238|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
130185239|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
130185240|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
130185241|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185242|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185243|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185244|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185245|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185246|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185247|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185248|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185249|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185250|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
130185251|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
130185252|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
130185253|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
130185254|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
130185255|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
130185256|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185257|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185258|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185259|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185260|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185261|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185262|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185263|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185264|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185265|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
130185266|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
130185267|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185268|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
130185269|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
130185270|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
130185271|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185272|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185273|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185274|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185275|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185276|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185277|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185278|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185279|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185280|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
130185281|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185282|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185283|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185284|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
130185285|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185286|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185287|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185288|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185289|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185290|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185291|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185292|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185293|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185294|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185295|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
130185296|NCT03334435|468636668|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185297|NCT03334435|468636669|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
130185298|NCT03334435|468636670|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
130185299|NCT03334435|468636671|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
130185300|NCT03334435|468636672|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
130185301|NCT03334435|468636673|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185302|NCT03334435|468636674|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185303|NCT03334435|468636675|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185304|NCT03334435|468636676|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185305|NCT03334435|468636677|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185306|NCT03334435|468636678|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185307|NCT03334435|468636679|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185308|NCT03334435|468636680|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185309|NCT03334435|468636681|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185310|NCT03334435|468636682|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
130185311|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185312|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185313|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185314|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185315|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
130185316|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130185317|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
130185318|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130185319|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
130185320|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
130185321|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
130185322|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
130185323|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
130185324|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
130185325|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
130185326|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185327|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185328|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185329|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185330|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
130185331|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
130185332|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
130185333|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
130185334|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
130185335|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
130185336|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
130185337|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
130185338|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
130185339|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
130185340|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
130185341|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185342|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185343|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185344|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185345|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185346|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
130185347|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
130185348|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
130185349|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
130185350|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
130185351|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
130185352|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
130185353|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
130185354|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
130185355|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
130185356|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185357|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185358|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185359|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185360|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
130185361|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
130185362|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
130185363|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130185364|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130185365|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
130185366|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
130185367|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
130185368|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
130185369|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
130185370|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
130185371|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185372|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185373|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185374|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185375|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185376|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185377|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
130185378|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
130185379|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
130185380|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130185381|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130185382|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
130185383|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
130185384|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
130185385|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
130185386|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185387|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185388|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185389|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185390|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185391|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185392|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185393|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185394|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185395|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185396|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185397|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
130185398|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185399|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
130185400|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
130185401|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185402|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185403|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185404|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185405|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185406|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
130185407|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185408|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185409|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185410|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185411|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185412|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185413|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185414|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
130185415|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
130185416|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185417|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185418|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185419|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185420|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185421|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185422|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185423|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185424|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185425|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
130185426|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185427|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
130185428|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185429|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185430|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
130185431|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185432|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185433|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185434|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185435|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185436|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185437|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185438|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185439|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185440|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185441|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
130185442|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185443|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
130185444|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
130185445|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
130185446|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185447|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185448|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185449|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185450|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185451|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130185452|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185453|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185454|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185455|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185456|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130185457|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185458|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185459|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
130185460|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
130185461|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185462|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185463|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185464|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185465|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185466|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185467|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185468|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185469|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185470|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185471|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185472|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
130185473|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
130185474|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185475|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
130185476|NCT03334435|468636668|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185477|NCT03334435|468636669|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185478|NCT03334435|468636670|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185479|NCT03334435|468636671|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185480|NCT03334435|468636672|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185481|NCT03334435|468636673|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185482|NCT03334435|468636674|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185483|NCT03334435|468636675|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185484|NCT03334435|468636676|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185485|NCT03334435|468636677|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185486|NCT03334435|468636678|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185487|NCT03334435|468636679|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130185488|NCT03334435|468636680|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
130185489|NCT03334435|468636681|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130185490|NCT03334435|468636682|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
130185491|NCT03922321|468636683|FG000|Overall Study|Participant Moved|1|||
130185492|NCT03922321|468636683|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
130185493|NCT04067050|468636684|FG000|One Month|Lost to Follow-up|4|||
130185494|NCT04067050|468636685|FG001|One Month|Lost to Follow-up|0|||
130185495|NCT04067050|468636684|FG000|Two Month|Lost to Follow-up|1|||
130185496|NCT04067050|468636685|FG001|Two Month|Lost to Follow-up|0|||
130185497|NCT04067050|468636684|FG000|Two Month|Adverse Event|1|||
130185498|NCT04067050|468636685|FG001|Two Month|Adverse Event|0|||
130185499|NCT01062425|468636690|FG000|Overall Study|Protocol Violation|3|||
130185500|NCT01062425|468636691|FG001|Overall Study|Protocol Violation|6|||
130185501|NCT02342678|468636692|FG000|Overall Study|Lost to Follow-up|0|||
130185502|NCT02342678|468636693|FG001|Overall Study|Lost to Follow-up|1|||
130185503|NCT02342678|468636692|FG000|Overall Study|Too busy to complete study|0|||
130185504|NCT02342678|468636693|FG001|Overall Study|Too busy to complete study|2|||
130185505|NCT02342678|468636692|FG000|Overall Study|Family illness/emergency|0|||
130185506|NCT02342678|468636693|FG001|Overall Study|Family illness/emergency|1|||
130185507|NCT02342678|468636692|FG000|Overall Study|Illness/medical reason|1|||
130185508|NCT02342678|468636693|FG001|Overall Study|Illness/medical reason|1|||
130185509|NCT02383017|468636694|FG000|Overall Study|Injury Sustained Outside Study|1|||
130185510|NCT02383017|468636695|FG001|Overall Study|Injury Sustained Outside Study|0|||
130185511|NCT02383017|468636694|FG000|Overall Study|Compliance|3|||
130185512|NCT02383017|468636695|FG001|Overall Study|Compliance|2|||
130185513|NCT02383017|468636694|FG000|Overall Study|Found to be Hypogonadal|1|||
130185514|NCT02383017|468636695|FG001|Overall Study|Found to be Hypogonadal|0|||
130185515|NCT00460603|468636696|FG000|Phase 1|Death|1|||
130185516|NCT00460603|468636697|FG001|Phase 1|Death|0|||
130185517|NCT00460603|468636698|FG002|Phase 1|Death|0|||
130185518|NCT00460603|468636699|FG003|Phase 1|Death|2|||
130185519|NCT00460603|468636700|FG004|Phase 1|Death|0|||
130185520|NCT00460603|468636701|FG005|Phase 1|Death|0|||
130185521|NCT00460603|468636702|FG006|Phase 1|Death|0|||
130185522|NCT00460603|468636703|FG007|Phase 1|Death|0|||
130185523|NCT00460603|468636704|FG008|Phase 1|Death|1|||
130185524|NCT00460603|468636705|FG009|Phase 1|Death|0|||
130185525|NCT00460603|468636706|FG010|Phase 1|Death|0|||
130185526|NCT00460603|468636707|FG011|Phase 1|Death|0|||
130185527|NCT00460603|468636696|FG000|Phase 1|Adverse Event|3|||
130185528|NCT00460603|468636697|FG001|Phase 1|Adverse Event|1|||
130185529|NCT00460603|468636698|FG002|Phase 1|Adverse Event|1|||
130185530|NCT00460603|468636699|FG003|Phase 1|Adverse Event|2|||
130185531|NCT00460603|468636700|FG004|Phase 1|Adverse Event|0|||
130185532|NCT00460603|468636701|FG005|Phase 1|Adverse Event|0|||
130185533|NCT00460603|468636702|FG006|Phase 1|Adverse Event|3|||
130185534|NCT00460603|468636703|FG007|Phase 1|Adverse Event|0|||
130185535|NCT00460603|468636704|FG008|Phase 1|Adverse Event|4|||
130185536|NCT00460603|468636705|FG009|Phase 1|Adverse Event|0|||
130185537|NCT00460603|468636706|FG010|Phase 1|Adverse Event|0|||
130185538|NCT00460603|468636707|FG011|Phase 1|Adverse Event|0|||
130185539|NCT00460603|468636696|FG000|Phase 1|Lack of Efficacy|1|||
130185540|NCT00460603|468636697|FG001|Phase 1|Lack of Efficacy|0|||
130185541|NCT00460603|468636698|FG002|Phase 1|Lack of Efficacy|1|||
130185542|NCT00460603|468636699|FG003|Phase 1|Lack of Efficacy|2|||
130185543|NCT00460603|468636700|FG004|Phase 1|Lack of Efficacy|2|||
130185544|NCT00460603|468636701|FG005|Phase 1|Lack of Efficacy|2|||
130185545|NCT00460603|468636702|FG006|Phase 1|Lack of Efficacy|2|||
130185546|NCT00460603|468636703|FG007|Phase 1|Lack of Efficacy|2|||
130185547|NCT00460603|468636704|FG008|Phase 1|Lack of Efficacy|11|||
130185548|NCT00460603|468636705|FG009|Phase 1|Lack of Efficacy|0|||
130185549|NCT00460603|468636706|FG010|Phase 1|Lack of Efficacy|0|||
130185550|NCT00460603|468636707|FG011|Phase 1|Lack of Efficacy|0|||
130185551|NCT00460603|468636696|FG000|Phase 1|Withdrawal by Subject|1|||
130185552|NCT00460603|468636697|FG001|Phase 1|Withdrawal by Subject|2|||
130185553|NCT00460603|468636698|FG002|Phase 1|Withdrawal by Subject|1|||
130185554|NCT00460603|468636699|FG003|Phase 1|Withdrawal by Subject|1|||
130185555|NCT00460603|468636700|FG004|Phase 1|Withdrawal by Subject|3|||
130185556|NCT00460603|468636701|FG005|Phase 1|Withdrawal by Subject|0|||
130185557|NCT00460603|468636702|FG006|Phase 1|Withdrawal by Subject|1|||
130185558|NCT00460603|468636703|FG007|Phase 1|Withdrawal by Subject|0|||
130185559|NCT00460603|468636704|FG008|Phase 1|Withdrawal by Subject|2|||
130185560|NCT00460603|468636705|FG009|Phase 1|Withdrawal by Subject|0|||
130185561|NCT00460603|468636706|FG010|Phase 1|Withdrawal by Subject|0|||
130185562|NCT00460603|468636707|FG011|Phase 1|Withdrawal by Subject|0|||
130185563|NCT00460603|468636696|FG000|Phase 1|Other|0|||
130185564|NCT00460603|468636697|FG001|Phase 1|Other|3|||
130185565|NCT00460603|468636698|FG002|Phase 1|Other|1|||
130185566|NCT00460603|468636699|FG003|Phase 1|Other|1|||
130185567|NCT00460603|468636700|FG004|Phase 1|Other|1|||
130185568|NCT00460603|468636701|FG005|Phase 1|Other|2|||
130185569|NCT00460603|468636702|FG006|Phase 1|Other|0|||
130185570|NCT00460603|468636703|FG007|Phase 1|Other|1|||
130185571|NCT00460603|468636704|FG008|Phase 1|Other|0|||
130185572|NCT00460603|468636705|FG009|Phase 1|Other|0|||
130185573|NCT00460603|468636706|FG010|Phase 1|Other|0|||
130185574|NCT00460603|468636707|FG011|Phase 1|Other|0|||
130185575|NCT00460603|468636696|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185576|NCT00460603|468636697|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185577|NCT00460603|468636698|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185578|NCT00460603|468636699|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185579|NCT00460603|468636700|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185580|NCT00460603|468636701|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185581|NCT00460603|468636702|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185582|NCT00460603|468636703|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185583|NCT00460603|468636704|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185584|NCT00460603|468636705|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
130185585|NCT00460603|468636706|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185586|NCT00460603|468636707|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
130185587|NCT00460603|468636696|FG000|Phase 2|Adverse Event|0|||
130185588|NCT00460603|468636697|FG001|Phase 2|Adverse Event|0|||
130185589|NCT00460603|468636698|FG002|Phase 2|Adverse Event|0|||
130185590|NCT00460603|468636699|FG003|Phase 2|Adverse Event|0|||
130185591|NCT00460603|468636700|FG004|Phase 2|Adverse Event|0|||
130185592|NCT00460603|468636701|FG005|Phase 2|Adverse Event|0|||
130185593|NCT00460603|468636702|FG006|Phase 2|Adverse Event|0|||
130185594|NCT00460603|468636703|FG007|Phase 2|Adverse Event|0|||
130185595|NCT00460603|468636704|FG008|Phase 2|Adverse Event|0|||
130185596|NCT00460603|468636705|FG009|Phase 2|Adverse Event|12|||
130185597|NCT00460603|468636706|FG010|Phase 2|Adverse Event|9|||
130185598|NCT00460603|468636707|FG011|Phase 2|Adverse Event|10|||
130185599|NCT00460603|468636696|FG000|Phase 2|Death|0|||
130185600|NCT00460603|468636697|FG001|Phase 2|Death|0|||
130185601|NCT00460603|468636698|FG002|Phase 2|Death|0|||
130185602|NCT00460603|468636699|FG003|Phase 2|Death|0|||
130185603|NCT00460603|468636700|FG004|Phase 2|Death|0|||
130185604|NCT00460603|468636701|FG005|Phase 2|Death|0|||
130185605|NCT00460603|468636702|FG006|Phase 2|Death|0|||
130185606|NCT00460603|468636703|FG007|Phase 2|Death|0|||
130185607|NCT00460603|468636704|FG008|Phase 2|Death|0|||
130185608|NCT00460603|468636705|FG009|Phase 2|Death|4|||
130185609|NCT00460603|468636706|FG010|Phase 2|Death|2|||
130185610|NCT00460603|468636707|FG011|Phase 2|Death|2|||
130185611|NCT00460603|468636696|FG000|Phase 2|Protocol Violation|0|||
130185612|NCT00460603|468636697|FG001|Phase 2|Protocol Violation|0|||
130185613|NCT00460603|468636698|FG002|Phase 2|Protocol Violation|0|||
130185614|NCT00460603|468636699|FG003|Phase 2|Protocol Violation|0|||
130185615|NCT00460603|468636700|FG004|Phase 2|Protocol Violation|0|||
130185616|NCT00460603|468636701|FG005|Phase 2|Protocol Violation|0|||
130185617|NCT00460603|468636702|FG006|Phase 2|Protocol Violation|0|||
130185618|NCT00460603|468636703|FG007|Phase 2|Protocol Violation|0|||
130185619|NCT00460603|468636704|FG008|Phase 2|Protocol Violation|0|||
130185620|NCT00460603|468636705|FG009|Phase 2|Protocol Violation|1|||
130185621|NCT00460603|468636706|FG010|Phase 2|Protocol Violation|1|||
130185622|NCT00460603|468636707|FG011|Phase 2|Protocol Violation|0|||
130185623|NCT00460603|468636696|FG000|Phase 2|Lost to Follow-up|0|||
130185624|NCT00460603|468636697|FG001|Phase 2|Lost to Follow-up|0|||
130185625|NCT00460603|468636698|FG002|Phase 2|Lost to Follow-up|0|||
130185626|NCT00460603|468636699|FG003|Phase 2|Lost to Follow-up|0|||
130185627|NCT00460603|468636700|FG004|Phase 2|Lost to Follow-up|0|||
130185628|NCT00460603|468636701|FG005|Phase 2|Lost to Follow-up|0|||
130185629|NCT00460603|468636702|FG006|Phase 2|Lost to Follow-up|0|||
130185630|NCT00460603|468636703|FG007|Phase 2|Lost to Follow-up|0|||
130185631|NCT00460603|468636704|FG008|Phase 2|Lost to Follow-up|0|||
130185632|NCT00460603|468636705|FG009|Phase 2|Lost to Follow-up|1|||
130185633|NCT00460603|468636706|FG010|Phase 2|Lost to Follow-up|0|||
130185634|NCT00460603|468636707|FG011|Phase 2|Lost to Follow-up|0|||
130185635|NCT00460603|468636696|FG000|Phase 2|Other|0|||
130185636|NCT00460603|468636697|FG001|Phase 2|Other|0|||
130185637|NCT00460603|468636698|FG002|Phase 2|Other|0|||
130185638|NCT00460603|468636699|FG003|Phase 2|Other|0|||
130185639|NCT00460603|468636700|FG004|Phase 2|Other|0|||
130185640|NCT00460603|468636701|FG005|Phase 2|Other|0|||
130185641|NCT00460603|468636702|FG006|Phase 2|Other|0|||
130185642|NCT00460603|468636703|FG007|Phase 2|Other|0|||
130185643|NCT00460603|468636704|FG008|Phase 2|Other|0|||
130185644|NCT00460603|468636705|FG009|Phase 2|Other|6|||
130185645|NCT00460603|468636706|FG010|Phase 2|Other|16|||
130185646|NCT00460603|468636707|FG011|Phase 2|Other|7|||
130185647|NCT00460603|468636696|FG000|Phase 2|Objective Progression or Relapse|0|||
130185648|NCT00460603|468636697|FG001|Phase 2|Objective Progression or Relapse|0|||
130185649|NCT00460603|468636698|FG002|Phase 2|Objective Progression or Relapse|0|||
130185650|NCT00460603|468636699|FG003|Phase 2|Objective Progression or Relapse|0|||
130185651|NCT00460603|468636700|FG004|Phase 2|Objective Progression or Relapse|0|||
130185652|NCT00460603|468636701|FG005|Phase 2|Objective Progression or Relapse|0|||
130185653|NCT00460603|468636702|FG006|Phase 2|Objective Progression or Relapse|0|||
130185654|NCT00460603|468636703|FG007|Phase 2|Objective Progression or Relapse|0|||
130185655|NCT00460603|468636704|FG008|Phase 2|Objective Progression or Relapse|0|||
130185656|NCT00460603|468636705|FG009|Phase 2|Objective Progression or Relapse|9|||
130185657|NCT00460603|468636706|FG010|Phase 2|Objective Progression or Relapse|10|||
130185658|NCT00460603|468636707|FG011|Phase 2|Objective Progression or Relapse|17|||
130185659|NCT00460603|468636696|FG000|Phase 2|Global Deterioration of Health Status|0|||
130185660|NCT00460603|468636697|FG001|Phase 2|Global Deterioration of Health Status|0|||
130185661|NCT00460603|468636698|FG002|Phase 2|Global Deterioration of Health Status|0|||
130185662|NCT00460603|468636699|FG003|Phase 2|Global Deterioration of Health Status|0|||
130185663|NCT00460603|468636700|FG004|Phase 2|Global Deterioration of Health Status|0|||
130185664|NCT00460603|468636701|FG005|Phase 2|Global Deterioration of Health Status|0|||
130185665|NCT00460603|468636702|FG006|Phase 2|Global Deterioration of Health Status|0|||
130185666|NCT00460603|468636703|FG007|Phase 2|Global Deterioration of Health Status|0|||
130185667|NCT00460603|468636704|FG008|Phase 2|Global Deterioration of Health Status|0|||
130185668|NCT00460603|468636705|FG009|Phase 2|Global Deterioration of Health Status|0|||
130185669|NCT00460603|468636706|FG010|Phase 2|Global Deterioration of Health Status|1|||
130185670|NCT00460603|468636707|FG011|Phase 2|Global Deterioration of Health Status|0|||
130185671|NCT00460603|468636696|FG000|Phase 2|Withdrawal by Subject|0|||
130185672|NCT00460603|468636697|FG001|Phase 2|Withdrawal by Subject|0|||
130185673|NCT00460603|468636698|FG002|Phase 2|Withdrawal by Subject|0|||
130185674|NCT00460603|468636699|FG003|Phase 2|Withdrawal by Subject|0|||
130185675|NCT00460603|468636700|FG004|Phase 2|Withdrawal by Subject|0|||
130185676|NCT00460603|468636701|FG005|Phase 2|Withdrawal by Subject|0|||
130185677|NCT00460603|468636702|FG006|Phase 2|Withdrawal by Subject|0|||
130185678|NCT00460603|468636703|FG007|Phase 2|Withdrawal by Subject|0|||
130185679|NCT00460603|468636704|FG008|Phase 2|Withdrawal by Subject|0|||
130185680|NCT00460603|468636705|FG009|Phase 2|Withdrawal by Subject|5|||
130185681|NCT00460603|468636706|FG010|Phase 2|Withdrawal by Subject|4|||
130185682|NCT00460603|468636707|FG011|Phase 2|Withdrawal by Subject|5|||
130185683|NCT00460603|468636696|FG000|Phase 2|Randomized, but not treated|0|||
130185684|NCT00460603|468636697|FG001|Phase 2|Randomized, but not treated|0|||
130185685|NCT00460603|468636698|FG002|Phase 2|Randomized, but not treated|0|||
130185686|NCT00460603|468636699|FG003|Phase 2|Randomized, but not treated|0|||
130185687|NCT00460603|468636700|FG004|Phase 2|Randomized, but not treated|0|||
130185688|NCT00460603|468636701|FG005|Phase 2|Randomized, but not treated|0|||
130185689|NCT00460603|468636702|FG006|Phase 2|Randomized, but not treated|0|||
130185690|NCT00460603|468636703|FG007|Phase 2|Randomized, but not treated|0|||
130185691|NCT00460603|468636704|FG008|Phase 2|Randomized, but not treated|0|||
130185692|NCT00460603|468636705|FG009|Phase 2|Randomized, but not treated|3|||
130185693|NCT00460603|468636706|FG010|Phase 2|Randomized, but not treated|0|||
130185694|NCT00460603|468636707|FG011|Phase 2|Randomized, but not treated|0|||
130185695|NCT00289848|468636708|FG000|Overall Study|Adverse Event|6|||
130185696|NCT00289848|468636709|FG001|Overall Study|Adverse Event|4|||
130185697|NCT00289848|468636708|FG000|Overall Study|Death|1|||
130185698|NCT00289848|468636709|FG001|Overall Study|Death|0|||
130185699|NCT00289848|468636708|FG000|Overall Study|Lack of Efficacy|20|||
130185700|NCT00289848|468636709|FG001|Overall Study|Lack of Efficacy|24|||
130185701|NCT00289848|468636708|FG000|Overall Study|Lost to Follow-up|3|||
130185702|NCT00289848|468636709|FG001|Overall Study|Lost to Follow-up|1|||
130185703|NCT00289848|468636708|FG000|Overall Study|Protocol Violation|5|||
130185704|NCT00289848|468636709|FG001|Overall Study|Protocol Violation|2|||
130185705|NCT00289848|468636708|FG000|Overall Study|Withdrawal by Subject|5|||
130185706|NCT00289848|468636709|FG001|Overall Study|Withdrawal by Subject|11|||
130185707|NCT00289848|468636708|FG000|Overall Study|Patient Moved|6|||
130185708|NCT00289848|468636709|FG001|Overall Study|Patient Moved|2|||
130185709|NCT00289848|468636708|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
130185710|NCT00289848|468636709|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
130185711|NCT03871543|468636712|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
130185712|NCT03871543|468636712|FG000|Period 1|Investigator Error|1|||
130185713|NCT03871543|468636712|FG000|Period 1|Protocol Violation|2|||
130185714|NCT03871543|468636712|FG000|Period 1|COVID-19 Related|1|||
130185715|NCT03871543|468636712|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
130185716|NCT03871543|468636712|FG000|Period 1|Withdrawal by Subject|10|||
130185717|NCT03871543|468636712|FG000|Period 2|Adverse Event|1|||
130185718|NCT03871543|468636712|FG000|Period 2|Withdrawal by Subject|1|||
130185719|NCT03534687|468636717|FG000|Overall Study|Lost to Follow-up|7|||
130185720|NCT03534687|468636718|FG001|Overall Study|Lost to Follow-up|2|||
130185721|NCT00395629|468636719|FG000|Core Study|Adverse Event|0|||
130185722|NCT00395629|468636720|FG001|Core Study|Adverse Event|3|||
130185723|NCT00395629|468636721|FG002|Core Study|Adverse Event|4|||
130185724|NCT00395629|468636719|FG000|Core Study|Abnormal laboratory value(s)|0|||
130185725|NCT00395629|468636720|FG001|Core Study|Abnormal laboratory value(s)|0|||
130185726|NCT00395629|468636721|FG002|Core Study|Abnormal laboratory value(s)|1|||
130185727|NCT00395629|468636719|FG000|Core Study|Protocol Violation|1|||
130185728|NCT00395629|468636720|FG001|Core Study|Protocol Violation|0|||
130185729|NCT00395629|468636721|FG002|Core Study|Protocol Violation|0|||
130185730|NCT00395629|468636719|FG000|Core Study|Withdrawal by Subject|0|||
130185731|NCT00395629|468636720|FG001|Core Study|Withdrawal by Subject|1|||
130185732|NCT00395629|468636721|FG002|Core Study|Withdrawal by Subject|1|||
130185733|NCT00395629|468636719|FG000|Core Study|Lost to Follow-up|0|||
130185734|NCT00395629|468636720|FG001|Core Study|Lost to Follow-up|0|||
130185735|NCT00395629|468636721|FG002|Core Study|Lost to Follow-up|1|||
130185736|NCT00395629|468636719|FG000|Extension Study|Adverse Event|0|||
130185737|NCT00395629|468636720|FG001|Extension Study|Adverse Event|0|||
130185738|NCT00395629|468636721|FG002|Extension Study|Adverse Event|2|||
130185739|NCT00395629|468636719|FG000|Extension Study|Administrative problems|0|||
130185740|NCT00395629|468636720|FG001|Extension Study|Administrative problems|0|||
130185741|NCT00395629|468636721|FG002|Extension Study|Administrative problems|1|||
130185742|NCT02570308|468636722|FG000|Overall Study|Death|1|||
130185743|NCT02570308|468636723|FG001|Overall Study|Death|5|||
130185744|NCT02570308|468636724|FG002|Overall Study|Death|4|||
130185745|NCT02570308|468636725|FG003|Overall Study|Death|4|||
130185746|NCT02570308|468636726|FG004|Overall Study|Death|69|||
130185747|NCT02570308|468636722|FG000|Overall Study|Lost to Follow-up|0|||
130185748|NCT02570308|468636723|FG001|Overall Study|Lost to Follow-up|0|||
130185749|NCT02570308|468636724|FG002|Overall Study|Lost to Follow-up|0|||
130185750|NCT02570308|468636725|FG003|Overall Study|Lost to Follow-up|0|||
130185751|NCT02570308|468636726|FG004|Overall Study|Lost to Follow-up|2|||
130185752|NCT02570308|468636722|FG000|Overall Study|Withdrawal by Subject|0|||
130185753|NCT02570308|468636723|FG001|Overall Study|Withdrawal by Subject|0|||
130185754|NCT02570308|468636724|FG002|Overall Study|Withdrawal by Subject|0|||
130185755|NCT02570308|468636725|FG003|Overall Study|Withdrawal by Subject|0|||
130185756|NCT02570308|468636726|FG004|Overall Study|Withdrawal by Subject|1|||
130185757|NCT02570308|468636722|FG000|Overall Study|Other|0|||
130185758|NCT02570308|468636723|FG001|Overall Study|Other|0|||
130185759|NCT02570308|468636724|FG002|Overall Study|Other|0|||
130185760|NCT02570308|468636725|FG003|Overall Study|Other|0|||
130185761|NCT02570308|468636726|FG004|Overall Study|Other|2|||
130185762|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130185763|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130185764|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
130185765|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185766|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185767|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185768|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130185769|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185770|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185771|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
130185772|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185773|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185774|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185775|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
130185776|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
130185777|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185778|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
130185779|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185780|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185781|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185782|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130185783|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
130185784|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185785|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
130185786|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185787|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185788|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185789|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130185790|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
130185791|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
130185792|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
130185793|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185794|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185795|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185796|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130185797|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185798|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185799|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
130185800|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185801|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185802|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185803|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
130185804|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185805|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185806|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
130185807|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185808|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185809|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185810|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
130185811|NCT04242498|468636727|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185812|NCT04242498|468636728|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
130185813|NCT04242498|468636729|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
130185814|NCT04242498|468636730|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185815|NCT04242498|468636731|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185816|NCT04242498|468636732|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185817|NCT04242498|468636733|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130185818|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185819|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185820|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185821|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130185822|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
130185823|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
130185824|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
130185825|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185826|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185827|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185828|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130185829|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
130185830|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
130185831|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
130185832|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185833|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185834|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185835|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185836|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130185837|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130185838|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130185839|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130185840|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130185841|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130185842|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130185843|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130185844|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
130185845|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130185846|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130185847|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130185848|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130185849|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
130185850|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
130185851|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
130185852|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
130185853|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185854|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185855|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185856|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185857|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
130185858|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185859|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
130185860|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185861|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185862|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185863|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185864|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185865|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
130185866|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
130185867|NCT04242498|468636727|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185868|NCT04242498|468636728|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185869|NCT04242498|468636729|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185870|NCT04242498|468636730|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185871|NCT04242498|468636731|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
130185872|NCT04242498|468636732|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
130185873|NCT04242498|468636733|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
130185874|NCT00765102|468636734|FG000|Overall Study|Progressive disease|18|||
130185875|NCT00765102|468636734|FG000|Overall Study|Adverse Event|6|||
130185876|NCT00765102|468636734|FG000|Overall Study|Physician Decision|4|||
130185877|NCT00765102|468636734|FG000|Overall Study|Withdrawal by Subject|2|||
130185878|NCT00765102|468636734|FG000|Overall Study|Protocol Violation|1|||
130185879|NCT04129125|468636741|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
130185880|NCT04129125|468636741|FG000|Overall Study|Study device was not used|3|||
130185881|NCT04484142|468636742|FG000|Overall Study|Adverse Event|13|||
130185882|NCT04484142|468636742|FG000|Overall Study|Progressive Disease|87|||
130185883|NCT04484142|468636742|FG000|Overall Study|Clinical Progression|10|||
130185884|NCT04484142|468636742|FG000|Overall Study|Withdrawal by Subject|6|||
130185885|NCT04484142|468636742|FG000|Overall Study|Physician Decision|1|||
130185886|NCT02962648|468636745|FG000|Overall Study|Withdrawal by Subject|3|||
130185887|NCT02962648|468636745|FG000|Overall Study|Lost to Follow-up|3|||
130185888|NCT02962648|468636745|FG000|Overall Study|Physician Decision|1|||
130185889|NCT02962648|468636745|FG000|Overall Study|Subject had problems with transportation|2|||
130185890|NCT04383327|468636746|FG000|Overall Study|Lost to Follow-up|112|||
130185891|NCT04383327|468636747|FG001|Overall Study|Lost to Follow-up|14|||
130185892|NCT04383327|468636748|FG002|Overall Study|Lost to Follow-up|78|||
130185893|NCT04383327|468636749|FG003|Overall Study|Lost to Follow-up|13|||
130185894|NCT04383327|468636750|FG004|Overall Study|Lost to Follow-up|110|||
130185895|NCT04383327|468636751|FG005|Overall Study|Lost to Follow-up|13|||
130185896|NCT04383327|468636752|FG006|Overall Study|Lost to Follow-up|74|||
130185897|NCT04383327|468636753|FG007|Overall Study|Lost to Follow-up|13|||
130185898|NCT04383327|468636754|FG008|Overall Study|Lost to Follow-up|78|||
130185899|NCT04383327|468636755|FG009|Overall Study|Lost to Follow-up|10|||
130185900|NCT04383327|468636756|FG010|Overall Study|Lost to Follow-up|160|||
130185901|NCT04383327|468636757|FG011|Overall Study|Lost to Follow-up|13|||
130185902|NCT05303194|468636758|FG000|Overall Study|Lost to Follow-up|1|||
130185903|NCT05303194|468636759|FG001|Overall Study|Lost to Follow-up|1|||
130185904|NCT05303194|468636758|FG000|Overall Study|Withdrawal by Subject|0|||
130185905|NCT05303194|468636759|FG001|Overall Study|Withdrawal by Subject|1|||
130185906|NCT01289678|468636760|FG000|Overall Study|Physician Decision|6|||
130185907|NCT04030299|468636761|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
130185908|NCT04030299|468636761|FG000|Overall Study|Withdrawal by Subject|3|||
130185909|NCT01530464|468636766|FG000|Washout (24h)|Withdrawal by Subject|1|||
130185910|NCT01530464|468636767|FG001|Washout (24h)|Withdrawal by Subject|0|||
130185911|NCT01530464|468636766|FG000|Washout (24h)|Withdrawal by Subject|0|||
130185912|NCT01530464|468636767|FG001|Washout (24h)|Withdrawal by Subject|1|||
130185913|NCT00908544|468636768|FG000|Overall Study|Withdrawal by Subject|2|||
130185914|NCT00908544|468636769|FG001|Overall Study|Withdrawal by Subject|4|||
130185915|NCT00908544|468636768|FG000|Overall Study|Lack of Efficacy|0|||
130185916|NCT00908544|468636769|FG001|Overall Study|Lack of Efficacy|1|||
130185917|NCT00908544|468636768|FG000|Overall Study|Pregnancy|1|||
130185918|NCT00908544|468636769|FG001|Overall Study|Pregnancy|0|||
130185919|NCT00908544|468636768|FG000|Overall Study|Relocation abroad|1|||
130185920|NCT00908544|468636769|FG001|Overall Study|Relocation abroad|1|||
130185921|NCT00908544|468636768|FG000|Overall Study|Unable to visit sutdy center|1|||
130185922|NCT00908544|468636769|FG001|Overall Study|Unable to visit sutdy center|0|||
130185923|NCT03539302|468636775|FG000|Overall Study|Spontaneous cardio version|0|||
130185924|NCT03539302|468636776|FG001|Overall Study|Spontaneous cardio version|0|||
130185925|NCT03539302|468636777|FG002|Overall Study|Spontaneous cardio version|0|||
130185926|NCT03539302|468636778|FG003|Overall Study|Spontaneous cardio version|0|||
130185927|NCT03539302|468636779|FG004|Overall Study|Spontaneous cardio version|0|||
130185928|NCT03539302|468636780|FG005|Overall Study|Spontaneous cardio version|1|||
130185929|NCT03539302|468636781|FG006|Overall Study|Spontaneous cardio version|1|||
130185930|NCT02107131|468636783|FG000|Overall Study|Lost to Follow-up|4|||
130185931|NCT02107131|468636784|FG001|Overall Study|Lost to Follow-up|4|||
130185932|NCT02107131|468636783|FG000|Overall Study|Physician Decision|1|||
130185933|NCT02107131|468636784|FG001|Overall Study|Physician Decision|0|||
130185934|NCT02107131|468636783|FG000|Overall Study|Withdrawal by Subject|2|||
130185935|NCT02107131|468636784|FG001|Overall Study|Withdrawal by Subject|0|||
130185936|NCT02107131|468636783|FG000|Overall Study|mental instability|1|||
130185937|NCT02107131|468636784|FG001|Overall Study|mental instability|0|||
130185938|NCT02107131|468636783|FG000|Overall Study|Death|0|||
130185939|NCT02107131|468636784|FG001|Overall Study|Death|1|||
130185940|NCT02107131|468636783|FG000|Overall Study|Protocol Violation|0|||
130185941|NCT02107131|468636784|FG001|Overall Study|Protocol Violation|4|||
130185942|NCT01609790|468636789|FG000|Overall Study|Protocol Violation|1|||
130185943|NCT01609790|468636790|FG001|Overall Study|Protocol Violation|7|||
130185944|NCT01609790|468636791|FG002|Overall Study|Protocol Violation|8|||
130185945|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Adverse Event|7|||
130185946|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
130185947|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Non-compliance|3|||
130185948|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Other|17|||
130185949|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Physician Decision|2|||
130185950|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Pregnancy|1|||
130185951|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
130185952|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
130185953|NCT05207865|468638416|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
130185954|NCT05207865|468638416|FG000|Follow-up Phase|Lost to Follow-up|1|||
130185955|NCT05207865|468638416|FG000|Follow-up Phase|Non-compliance|1|||
130185956|NCT05207865|468638416|FG000|Follow-up Phase|Not reported|2|||
130185957|NCT05207865|468638416|FG000|Follow-up Phase|Not collected|11|||
130185958|NCT05364931|468638434|FG000|Overall Study|Adverse Event|0|||
130185959|NCT05364931|468638435|FG001|Overall Study|Adverse Event|2|||
130185960|NCT05364931|468638436|FG002|Overall Study|Adverse Event|1|||
130185961|NCT05364931|468638437|FG003|Overall Study|Adverse Event|0|||
130185962|NCT05364931|468638434|FG000|Overall Study|Lost to Follow-up|1|||
130185963|NCT05364931|468638435|FG001|Overall Study|Lost to Follow-up|0|||
130185964|NCT05364931|468638436|FG002|Overall Study|Lost to Follow-up|0|||
130185965|NCT05364931|468638437|FG003|Overall Study|Lost to Follow-up|0|||
130185966|NCT05364931|468638434|FG000|Overall Study|Withdrawal by Subject|1|||
130185967|NCT05364931|468638435|FG001|Overall Study|Withdrawal by Subject|1|||
130185968|NCT05364931|468638436|FG002|Overall Study|Withdrawal by Subject|3|||
130185969|NCT05364931|468638437|FG003|Overall Study|Withdrawal by Subject|2|||
130185970|NCT05364931|468638434|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130185971|NCT05364931|468638435|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
130185972|NCT05364931|468638436|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130185973|NCT05364931|468638437|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
130185974|NCT05364931|468638434|FG000|Overall Study|Discontinued|1|||
130185975|NCT05364931|468638435|FG001|Overall Study|Discontinued|0|||
130185976|NCT05364931|468638436|FG002|Overall Study|Discontinued|0|||
130185977|NCT05364931|468638437|FG003|Overall Study|Discontinued|0|||
130185978|NCT03593525|468638438|FG000|Overall Study|Withdrawal by Subject|1|||
130185979|NCT03593525|468638439|FG001|Overall Study|Withdrawal by Subject|0|||
130185980|NCT03593525|468638438|FG000|Overall Study|Lost to Follow-up|7|||
130185981|NCT03593525|468638439|FG001|Overall Study|Lost to Follow-up|5|||
130185982|NCT03103087|468638447|FG000|Overall Study|Did not receive any study drug|1|||
130185983|NCT03103087|468638448|FG001|Overall Study|Did not receive any study drug|0|||
130185984|NCT03103087|468638449|FG002|Overall Study|Did not receive any study drug|0|||
130185985|NCT03103087|468638447|FG000|Overall Study|Protocol Violation|1|||
130185986|NCT03103087|468638448|FG001|Overall Study|Protocol Violation|2|||
130185987|NCT03103087|468638449|FG002|Overall Study|Protocol Violation|1|||
130185988|NCT03103087|468638447|FG000|Overall Study|Lack of Efficacy|2|||
130185989|NCT03103087|468638448|FG001|Overall Study|Lack of Efficacy|1|||
130185990|NCT03103087|468638449|FG002|Overall Study|Lack of Efficacy|1|||
130185991|NCT03103087|468638447|FG000|Overall Study|Pregnancy|0|||
130185992|NCT03103087|468638448|FG001|Overall Study|Pregnancy|0|||
130185993|NCT03103087|468638449|FG002|Overall Study|Pregnancy|1|||
130185994|NCT03103087|468638447|FG000|Overall Study|Adverse Event|2|||
130185995|NCT03103087|468638448|FG001|Overall Study|Adverse Event|15|||
130185996|NCT03103087|468638449|FG002|Overall Study|Adverse Event|6|||
130185997|NCT03103087|468638447|FG000|Overall Study|Withdrawal by Subject|13|||
130185998|NCT03103087|468638448|FG001|Overall Study|Withdrawal by Subject|6|||
130185999|NCT03103087|468638449|FG002|Overall Study|Withdrawal by Subject|6|||
130186000|NCT03103087|468638447|FG000|Overall Study|Lost to Follow-up|4|||
130186001|NCT03103087|468638448|FG001|Overall Study|Lost to Follow-up|2|||
130186002|NCT03103087|468638449|FG002|Overall Study|Lost to Follow-up|7|||
130186003|NCT03103087|468638447|FG000|Overall Study|Other reason not reported|1|||
130186004|NCT03103087|468638448|FG001|Overall Study|Other reason not reported|3|||
130186005|NCT03103087|468638449|FG002|Overall Study|Other reason not reported|5|||
130186006|NCT03504397|468638450|FG000|Overall Study|Progressive Disease|151|||
130186007|NCT03504397|468638451|FG001|Overall Study|Progressive Disease|199|||
130186008|NCT03504397|468638450|FG000|Overall Study|Withdrawal by Subject|29|||
130186009|NCT03504397|468638451|FG001|Overall Study|Withdrawal by Subject|17|||
130186010|NCT03504397|468638450|FG000|Overall Study|Lost to Follow-up|1|||
130186011|NCT03504397|468638451|FG001|Overall Study|Lost to Follow-up|0|||
130186012|NCT03504397|468638450|FG000|Overall Study|Death|14|||
130186013|NCT03504397|468638451|FG001|Overall Study|Death|16|||
130186014|NCT03504397|468638450|FG000|Overall Study|Adverse Event|40|||
130186015|NCT03504397|468638451|FG001|Overall Study|Adverse Event|14|||
130186016|NCT03504397|468638450|FG000|Overall Study|miscellaneous|17|||
130186017|NCT03504397|468638451|FG001|Overall Study|miscellaneous|15|||
130186018|NCT03504397|468638450|FG000|Overall Study|Protocol deviation|1|||
130186019|NCT03504397|468638451|FG001|Overall Study|Protocol deviation|0|||
130186020|NCT03504397|468638450|FG000|Overall Study|Participants who did not take the study drug|4|||
130186021|NCT03504397|468638451|FG001|Overall Study|Participants who did not take the study drug|4|||
130186022|NCT00413699|468638452|FG000|Initial Period|Death|25|||
130186023|NCT00413699|468638453|FG001|Initial Period|Death|30|||
130186024|NCT00413699|468638454|FG002|Initial Period|Death|0|||
130186025|NCT00413699|468638452|FG000|Initial Period|Lack of Efficacy|59|||
130186026|NCT00413699|468638453|FG001|Initial Period|Lack of Efficacy|115|||
130186027|NCT00413699|468638454|FG002|Initial Period|Lack of Efficacy|0|||
130186028|NCT00413699|468638452|FG000|Initial Period|Lost to Follow-up|31|||
130186029|NCT00413699|468638453|FG001|Initial Period|Lost to Follow-up|101|||
130186030|NCT00413699|468638454|FG002|Initial Period|Lost to Follow-up|0|||
130186031|NCT00413699|468638452|FG000|Initial Period|Protocol Violation|38|||
130186032|NCT00413699|468638453|FG001|Initial Period|Protocol Violation|89|||
130186033|NCT00413699|468638454|FG002|Initial Period|Protocol Violation|0|||
130186034|NCT00413699|468638452|FG000|Initial Period|Pregnancy|10|||
130186035|NCT00413699|468638453|FG001|Initial Period|Pregnancy|8|||
130186036|NCT00413699|468638454|FG002|Initial Period|Pregnancy|0|||
130186037|NCT00413699|468638452|FG000|Initial Period|Did not meet entrance criteria|2|||
130186038|NCT00413699|468638453|FG001|Initial Period|Did not meet entrance criteria|2|||
130186039|NCT00413699|468638454|FG002|Initial Period|Did not meet entrance criteria|0|||
130186040|NCT00413699|468638452|FG000|Initial Period|Medication error without adverse event|0|||
130186041|NCT00413699|468638453|FG001|Initial Period|Medication error without adverse event|1|||
130186042|NCT00413699|468638454|FG002|Initial Period|Medication error without adverse event|0|||
130186043|NCT00413699|468638452|FG000|Initial Period|Study terminated by Sponsor|0|||
130186044|NCT00413699|468638453|FG001|Initial Period|Study terminated by Sponsor|1|||
130186045|NCT00413699|468638454|FG002|Initial Period|Study terminated by Sponsor|0|||
130186046|NCT00413699|468638452|FG000|Initial Period|Other|67|||
130186047|NCT00413699|468638453|FG001|Initial Period|Other|211|||
130186048|NCT00413699|468638454|FG002|Initial Period|Other|0|||
130186049|NCT00413699|468638452|FG000|Initial Period|Adverse event related to study drug|178|||
130186050|NCT00413699|468638453|FG001|Initial Period|Adverse event related to study drug|527|||
130186051|NCT00413699|468638454|FG002|Initial Period|Adverse event related to study drug|0|||
130186052|NCT00413699|468638452|FG000|Initial Period|Adverse event not related to study drug|113|||
130186053|NCT00413699|468638453|FG001|Initial Period|Adverse event not related to study drug|248|||
130186054|NCT00413699|468638454|FG002|Initial Period|Adverse event not related to study drug|0|||
130186055|NCT00413699|468638452|FG000|Initial Period|Missing end of study page|0|||
130186056|NCT00413699|468638453|FG001|Initial Period|Missing end of study page|4|||
130186057|NCT00413699|468638454|FG002|Initial Period|Missing end of study page|0|||
130186058|NCT00413699|468638452|FG000|Initial Period|No longer willing to participate|116|||
130186059|NCT00413699|468638453|FG001|Initial Period|No longer willing to participate|368|||
130186060|NCT00413699|468638454|FG002|Initial Period|No longer willing to participate|0|||
130186061|NCT00413699|468638452|FG000|Extension Period|No Longer Willing to Participate|0|||
130186062|NCT00413699|468638453|FG001|Extension Period|No Longer Willing to Participate|0|||
130186063|NCT00413699|468638454|FG002|Extension Period|No Longer Willing to Participate|2|||
130186064|NCT00413699|468638452|FG000|Extension Period|Protocol Violation|0|||
130186065|NCT00413699|468638453|FG001|Extension Period|Protocol Violation|0|||
130186066|NCT00413699|468638454|FG002|Extension Period|Protocol Violation|1|||
130186067|NCT00413699|468638452|FG000|Extension Period|Adverse Event|0|||
130186068|NCT00413699|468638453|FG001|Extension Period|Adverse Event|0|||
130186069|NCT00413699|468638454|FG002|Extension Period|Adverse Event|2|||
130186070|NCT00075816|468638455|FG000|Overall Study|Did not undergo transplantation|14|||
130186071|NCT00075816|468638456|FG001|Overall Study|Did not undergo transplantation|11|||
130186072|NCT04231825|468638457|FG000|Overall Study|Protocol Violation|3|||
130186073|NCT04231825|468638458|FG001|Overall Study|Protocol Violation|3|||
130186074|NCT04231825|468638457|FG000|Overall Study|Lost to Follow-up|0|||
130186075|NCT04231825|468638458|FG001|Overall Study|Lost to Follow-up|1|||
130186076|NCT01662635|468638459|FG000|Overall Study|scarce samples for evaluation|30|||
130186077|NCT02445248|468638460|FG000|Overall Study|Death|45|||
130186078|NCT02445248|468638461|FG001|Overall Study|Death|12|||
130186079|NCT02445248|468638460|FG000|Overall Study|Progressive disease|13|||
130186080|NCT02445248|468638461|FG001|Overall Study|Progressive disease|1|||
130186081|NCT02445248|468638460|FG000|Overall Study|Subject decision|8|||
130186082|NCT02445248|468638461|FG001|Overall Study|Subject decision|0|||
130186083|NCT02445248|468638460|FG000|Overall Study|Physician Decision|5|||
130186084|NCT02445248|468638461|FG001|Overall Study|Physician Decision|0|||
130186085|NCT02445248|468638460|FG000|Overall Study|Adverse Event|1|||
130186086|NCT02445248|468638461|FG001|Overall Study|Adverse Event|0|||
130186087|NCT02445248|468638460|FG000|Overall Study|Lost to Follow-up|1|||
130186088|NCT02445248|468638461|FG001|Overall Study|Lost to Follow-up|0|||
130186089|NCT02596971|468638462|FG000|Overall Study|Death|5|||
130186090|NCT02596971|468638463|FG001|Overall Study|Death|1|||
130186091|NCT02596971|468638464|FG002|Overall Study|Death|5|||
130186092|NCT02596971|468638462|FG000|Overall Study|Withdrawal by Subject|5|||
130186093|NCT02596971|468638463|FG001|Overall Study|Withdrawal by Subject|1|||
130186094|NCT02596971|468638464|FG002|Overall Study|Withdrawal by Subject|4|||
130186095|NCT00595920|468638467|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
130186096|NCT00351468|468638468|FG000|Overall Study|Adverse Event|42|||
130186097|NCT00351468|468638468|FG000|Overall Study|Withdrawal by Subject|39|||
130186098|NCT00351468|468638468|FG000|Overall Study|Various -follow up w clinical team|39|||
130186099|NCT00351468|468638468|FG000|Overall Study|Lack of Efficacy|32|||
130186100|NCT00351468|468638468|FG000|Overall Study|Non-compliance|8|||
130186101|NCT00351468|468638468|FG000|Overall Study|Lost to Follow-up|4|||
130186102|NCT00351468|468638468|FG000|Overall Study|Protocol Violation|3|||
130186103|NCT03588910|468638469|FG000|Overall Study|Withdrawal by Subject|1|||
130186104|NCT03588910|468638470|FG001|Overall Study|Withdrawal by Subject|0|||
130186105|NCT03588910|468638469|FG000|Overall Study|Allergy|2|||
130186106|NCT03588910|468638470|FG001|Overall Study|Allergy|0|||
130186107|NCT03588910|468638469|FG000|Overall Study|Protocol Violation|0|||
130186108|NCT03588910|468638470|FG001|Overall Study|Protocol Violation|3|||
130186109|NCT03588910|468638469|FG000|Overall Study|Did not complete Day 1 Survey|5|||
130186110|NCT03588910|468638470|FG001|Overall Study|Did not complete Day 1 Survey|10|||
130186111|NCT03588910|468638469|FG000|Overall Study|Did not complete Day 7 Survey|5|||
130186112|NCT03588910|468638470|FG001|Overall Study|Did not complete Day 7 Survey|2|||
130186113|NCT00611923|468638471|FG000|Overall Study|Withdrawal by Subject|2|||
130186114|NCT00611923|468638472|FG001|Overall Study|Withdrawal by Subject|2|||
130186115|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
130186116|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
130186117|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
130186118|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
130186119|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
130186120|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
130186121|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
130186122|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
130186123|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
130186124|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
130186125|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
130186126|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
130186127|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130186128|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130186129|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
130186130|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
130186131|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
130186132|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
130186133|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
130186134|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
130186135|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
130186136|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
130186137|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
130186138|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
130186139|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
130186140|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
130186141|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
130186142|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
130186143|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
130186144|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
130186145|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
130186146|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
130186147|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130186148|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
130186149|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130186150|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
130186151|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130186152|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130186153|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
130186154|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
130186155|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
130186156|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130186157|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130186158|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
130186159|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
130186160|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
130186161|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
130186162|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
130186163|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130186164|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130186165|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
130186166|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
130186167|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Site closed|0|||
130186168|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Site closed|0|||
130186169|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Site closed|1|||
130186170|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Site closed|0|||
130186171|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
130186172|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130186173|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130186174|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
130186175|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
130186176|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
130186177|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
130186178|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
130186179|NCT00838903|468638473|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
130186180|NCT00838903|468638474|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130186181|NCT00838903|468638475|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130186182|NCT00838903|468638476|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
130186183|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
130186184|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
130186185|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
130186186|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
130186187|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
130186188|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
130186189|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
130186190|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
130186191|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
130186192|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
130186193|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
130186194|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
130186195|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
130186196|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
130186197|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
130186198|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
130186199|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
130186200|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
130186201|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
130186202|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
130186203|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186204|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186205|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186206|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
130186207|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
130186208|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130186209|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
130186210|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
130186211|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130186212|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
130186213|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130186214|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
130186215|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130186216|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
130186217|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130186218|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
130186219|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130186220|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130186221|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
130186222|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
130186223|NCT00838903|468638473|FG000|Follow-up Period (8 Weeks)|Missing|1|||
130186224|NCT00838903|468638474|FG001|Follow-up Period (8 Weeks)|Missing|2|||
130186225|NCT00838903|468638475|FG002|Follow-up Period (8 Weeks)|Missing|1|||
130186226|NCT00838903|468638476|FG003|Follow-up Period (8 Weeks)|Missing|1|||
130186227|NCT04565145|468638477|FG000|Overall Study|Withdrawal by Subject|1|||
130186228|NCT04565145|468638478|FG001|Overall Study|Withdrawal by Subject|1|||
130186229|NCT00683618|468638479|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
130186230|NCT00683618|468638480|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
130186231|NCT00683618|468638481|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
130186232|NCT00683618|468638479|FG000|Randomised Treatment Period|Protocol Violation|0|||
130186233|NCT00683618|468638480|FG001|Randomised Treatment Period|Protocol Violation|1|||
130186234|NCT00683618|468638481|FG002|Randomised Treatment Period|Protocol Violation|0|||
130186235|NCT00683618|468638479|FG000|Randomised Treatment Period|Adverse Event|2|||
130186236|NCT00683618|468638480|FG001|Randomised Treatment Period|Adverse Event|0|||
130186237|NCT00683618|468638481|FG002|Randomised Treatment Period|Adverse Event|2|||
130186238|NCT00683618|468638479|FG000|Randomised Treatment Period|Reason not provided|0|||
130186239|NCT00683618|468638480|FG001|Randomised Treatment Period|Reason not provided|0|||
130186240|NCT00683618|468638481|FG002|Randomised Treatment Period|Reason not provided|2|||
130186241|NCT00683618|468638479|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
130186242|NCT00683618|468638480|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130186243|NCT00683618|468638481|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
130186244|NCT00683618|468638479|FG000|Extension Treatment Period|Adverse Event|1|||
130186245|NCT00683618|468638480|FG001|Extension Treatment Period|Adverse Event|0|||
130186246|NCT00683618|468638481|FG002|Extension Treatment Period|Adverse Event|0|||
130186247|NCT00683618|468638479|FG000|Extension Treatment Period|Protocol Violation|1|||
130186248|NCT00683618|468638480|FG001|Extension Treatment Period|Protocol Violation|0|||
130186249|NCT00683618|468638481|FG002|Extension Treatment Period|Protocol Violation|0|||
130186250|NCT04570670|468638482|FG000|Overall Study|Withdrawal by Subject|1|||
130186251|NCT04570670|468638483|FG001|Overall Study|Withdrawal by Subject|0|||
130186252|NCT02549859|468638484|FG000|Long-term 60 Hz DBS|Study Closed|1|||
130186253|NCT03003962|468638493|FG000|Overall Study|Withdrawal by Subject|5|||
130186254|NCT03003962|468638494|FG001|Overall Study|Withdrawal by Subject|17|||
130186255|NCT03003962|468638493|FG000|Overall Study|Death|274|||
130186256|NCT03003962|468638494|FG001|Overall Study|Death|277|||
130186257|NCT03003962|468638493|FG000|Overall Study|Participants ongoing at DCO|55|||
130186258|NCT03003962|468638494|FG001|Overall Study|Participants ongoing at DCO|40|||
130186259|NCT03802825|468638502|FG000|Overall Study|Lost to follow-up for intervention|12|||
130186260|NCT03802825|468638503|FG001|Overall Study|Lost to follow-up for intervention|3|||
130186261|NCT03802825|468638502|FG000|Overall Study|Received only 1 component of intervention|0|||
130186262|NCT03802825|468638503|FG001|Overall Study|Received only 1 component of intervention|13|||
130186263|NCT03428152|468638505|FG000|Overall Study|Physician Decision|4|||
130186264|NCT03428152|468638506|FG001|Overall Study|Physician Decision|2|||
130186265|NCT03428152|468638505|FG000|Overall Study|Protocol Violation|3|||
130186266|NCT03428152|468638506|FG001|Overall Study|Protocol Violation|5|||
130186267|NCT03428152|468638505|FG000|Overall Study|Lack of Efficacy|0|||
130186268|NCT03428152|468638506|FG001|Overall Study|Lack of Efficacy|4|||
130186269|NCT01293695|468638513|FG000|Overall Study|Withdrawal by Subject|7|||
130186270|NCT01293695|468638514|FG001|Overall Study|Withdrawal by Subject|1|||
130186271|NCT01293695|468638513|FG000|Overall Study|Lost to Follow-up|8|||
130186272|NCT01293695|468638514|FG001|Overall Study|Lost to Follow-up|6|||
130186273|NCT00468819|468638515|FG000|Overall Study|Withdrawal by Subject|4|||
130186274|NCT00468819|468638516|FG001|Overall Study|Withdrawal by Subject|0|||
130186275|NCT00468819|468638517|FG002|Overall Study|Withdrawal by Subject|1|||
130186276|NCT00468819|468638515|FG000|Overall Study|Lost to Follow-up|0|||
130186277|NCT00468819|468638516|FG001|Overall Study|Lost to Follow-up|0|||
130186278|NCT00468819|468638517|FG002|Overall Study|Lost to Follow-up|1|||
130186279|NCT00468819|468638515|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
130186280|NCT00468819|468638516|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
130186281|NCT00468819|468638517|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
130186282|NCT04616612|468638518|FG000|Overall Study|Lost to Follow-up|6|||
130186283|NCT04616612|468638519|FG001|Overall Study|Lost to Follow-up|3|||
130186284|NCT04740918|468638520|FG000|Overall Study|Study Terminated by Sponsor|41|||
130186285|NCT04740918|468638521|FG001|Overall Study|Study Terminated by Sponsor|32|||
130186286|NCT04740918|468638520|FG000|Overall Study|Death|3|||
130186287|NCT04740918|468638521|FG001|Overall Study|Death|6|||
130186288|NCT04740918|468638520|FG000|Overall Study|Withdrawal by Subject|5|||
130186289|NCT04740918|468638521|FG001|Overall Study|Withdrawal by Subject|4|||
130186290|NCT04740918|468638520|FG000|Overall Study|Lost to Follow-up|1|||
130186291|NCT04740918|468638521|FG001|Overall Study|Lost to Follow-up|3|||
130186292|NCT04740918|468638520|FG000|Overall Study|Progressive disease|0|||
130186293|NCT04740918|468638521|FG001|Overall Study|Progressive disease|1|||
130186294|NCT02524847|468638522|FG000|Overall Study|Adverse Event|4|||
130186295|NCT02524847|468638522|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
130186296|NCT02524847|468638522|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
130186297|NCT02524847|468638522|FG000|Overall Study|Death|1|||
130186298|NCT02524847|468638522|FG000|Overall Study|Reason not Specified|1|||
130186299|NCT04352101|468638523|FG000|Overall Study|Physician Decision|2|||
130186300|NCT04352101|468638524|FG001|Overall Study|Physician Decision|1|||
130186301|NCT01288079|468638530|FG000|Overall Study|Withdrawal by Subject|2|||
130186302|NCT01288079|468638531|FG001|Overall Study|Withdrawal by Subject|4|||
130186303|NCT01288079|468638532|FG002|Overall Study|Withdrawal by Subject|1|||
130186304|NCT01288079|468638533|FG003|Overall Study|Withdrawal by Subject|0|||
130186305|NCT01288079|468638530|FG000|Overall Study|Adverse Event|2|||
130186306|NCT01288079|468638531|FG001|Overall Study|Adverse Event|1|||
130186307|NCT01288079|468638532|FG002|Overall Study|Adverse Event|2|||
130186308|NCT01288079|468638533|FG003|Overall Study|Adverse Event|3|||
130186309|NCT01288079|468638530|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
130186310|NCT01288079|468638531|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
130186311|NCT01288079|468638532|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
130186312|NCT01288079|468638533|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
130186313|NCT01288079|468638530|FG000|Overall Study|Condition under Investigation Worsened|0|||
130186314|NCT01288079|468638531|FG001|Overall Study|Condition under Investigation Worsened|0|||
130186315|NCT01288079|468638532|FG002|Overall Study|Condition under Investigation Worsened|0|||
130186316|NCT01288079|468638533|FG003|Overall Study|Condition under Investigation Worsened|1|||
130186317|NCT01288079|468638530|FG000|Overall Study|Lack of Efficacy|2|||
130186318|NCT01288079|468638531|FG001|Overall Study|Lack of Efficacy|2|||
130186319|NCT01288079|468638532|FG002|Overall Study|Lack of Efficacy|0|||
130186320|NCT01288079|468638533|FG003|Overall Study|Lack of Efficacy|2|||
130186321|NCT01288079|468638530|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
130186322|NCT01288079|468638531|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
130186323|NCT01288079|468638532|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
130186324|NCT01288079|468638533|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
130186325|NCT01288079|468638530|FG000|Overall Study|Lost to Follow-up|1|||
130186326|NCT01288079|468638531|FG001|Overall Study|Lost to Follow-up|1|||
130186327|NCT01288079|468638532|FG002|Overall Study|Lost to Follow-up|1|||
130186328|NCT01288079|468638533|FG003|Overall Study|Lost to Follow-up|0|||
130186329|NCT01288079|468638530|FG000|Overall Study|Other or Study Termination|11|||
130186330|NCT01288079|468638531|FG001|Overall Study|Other or Study Termination|15|||
130186331|NCT01288079|468638532|FG002|Overall Study|Other or Study Termination|14|||
130186332|NCT01288079|468638533|FG003|Overall Study|Other or Study Termination|8|||
130186333|NCT03170544|468638534|FG000|Part 1|Lost to Follow-up|1|||
130186334|NCT03170544|468638535|FG001|Part 1|Lost to Follow-up|0|||
130186335|NCT03170544|468638536|FG002|Part 1|Lost to Follow-up|0|||
130186336|NCT03170544|468638537|FG003|Part 1|Lost to Follow-up|0|||
130186337|NCT03170544|468638538|FG004|Part 1|Lost to Follow-up|0|||
130186338|NCT03170544|468638539|FG005|Part 1|Lost to Follow-up|0|||
130186339|NCT03170544|468638540|FG006|Part 1|Lost to Follow-up|0|||
130186340|NCT03170544|468638541|FG007|Part 1|Lost to Follow-up|0|||
130186341|NCT03170544|468638542|FG008|Part 1|Lost to Follow-up|0|||
130186342|NCT03170544|468638543|FG009|Part 1|Lost to Follow-up|0|||
130186343|NCT03170544|468638544|FG010|Part 1|Lost to Follow-up|0|||
130186344|NCT03170544|468638545|FG011|Part 1|Lost to Follow-up|0|||
130186345|NCT03170544|468638534|FG000|Part 1|Not treated|0|||
130186346|NCT03170544|468638535|FG001|Part 1|Not treated|0|||
130186347|NCT03170544|468638536|FG002|Part 1|Not treated|0|||
130186348|NCT03170544|468638537|FG003|Part 1|Not treated|1|||
130186349|NCT03170544|468638538|FG004|Part 1|Not treated|0|||
130186350|NCT03170544|468638539|FG005|Part 1|Not treated|0|||
130186351|NCT03170544|468638540|FG006|Part 1|Not treated|0|||
130186352|NCT03170544|468638541|FG007|Part 1|Not treated|0|||
130186353|NCT03170544|468638542|FG008|Part 1|Not treated|0|||
130186354|NCT03170544|468638543|FG009|Part 1|Not treated|0|||
130186355|NCT03170544|468638544|FG010|Part 1|Not treated|0|||
130186356|NCT03170544|468638545|FG011|Part 1|Not treated|0|||
130186357|NCT02387840|468638546|FG000|Overall Study|Death|0|||
130186358|NCT02387840|468638547|FG001|Overall Study|Death|0|||
130186359|NCT02387840|468638548|FG002|Overall Study|Death|0|||
130186360|NCT02387840|468638549|FG003|Overall Study|Death|0|||
130186361|NCT02387840|468638550|FG004|Overall Study|Death|0|||
130186362|NCT02387840|468638551|FG005|Overall Study|Death|1|||
130186363|NCT02174627|468638554|FG000|Overall Study|Missing|0|||
130186364|NCT02174627|468638555|FG001|Overall Study|Missing|1|||
130186365|NCT02174627|468638554|FG000|Overall Study|Incorrect enrolment before randomization|0|||
130186366|NCT02174627|468638555|FG001|Overall Study|Incorrect enrolment before randomization|1|||
130186367|NCT02174627|468638554|FG000|Overall Study|Participant decision|84|||
130186368|NCT02174627|468638555|FG001|Overall Study|Participant decision|128|||
130186369|NCT04564092|468638556|FG000|Overall Study|Withdrawal by Subject|1|||
130186370|NCT00071110|468638557|FG000|Overall Study|Protocol Violation|0|||
130186371|NCT00071110|468638558|FG001|Overall Study|Protocol Violation|4|||
130186372|NCT02259010|468638562|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
130186373|NCT03578367|468638563|FG000|Overall Study|Adverse Event|0|||
130186374|NCT03578367|468638564|FG001|Overall Study|Adverse Event|3|||
130186375|NCT03578367|468638565|FG002|Overall Study|Adverse Event|0|||
130186376|NCT03578367|468638566|FG003|Overall Study|Adverse Event|5|||
130186377|NCT03578367|468638563|FG000|Overall Study|Withdrawal by Subject|2|||
130186378|NCT03578367|468638564|FG001|Overall Study|Withdrawal by Subject|2|||
130186379|NCT03578367|468638565|FG002|Overall Study|Withdrawal by Subject|1|||
130186380|NCT03578367|468638566|FG003|Overall Study|Withdrawal by Subject|3|||
130186381|NCT03578367|468638563|FG000|Overall Study|Physician Decision|0|||
130186382|NCT03578367|468638564|FG001|Overall Study|Physician Decision|0|||
130186383|NCT03578367|468638565|FG002|Overall Study|Physician Decision|14|||
130186384|NCT03578367|468638566|FG003|Overall Study|Physician Decision|0|||
130186385|NCT03578367|468638563|FG000|Overall Study|Death|1|||
130186386|NCT03578367|468638564|FG001|Overall Study|Death|0|||
130186387|NCT03578367|468638565|FG002|Overall Study|Death|0|||
130186388|NCT03578367|468638566|FG003|Overall Study|Death|0|||
130186389|NCT03578367|468638563|FG000|Overall Study|Not treated|0|||
130186390|NCT03578367|468638564|FG001|Overall Study|Not treated|0|||
130186391|NCT03578367|468638565|FG002|Overall Study|Not treated|1|||
130186392|NCT03578367|468638566|FG003|Overall Study|Not treated|0|||
130186393|NCT02729025|468638570|FG000|Overall Study|Sponsor Decision|0|||
130186394|NCT02729025|468638571|FG001|Overall Study|Sponsor Decision|1|||
130186395|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
130186396|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
130186397|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
130186398|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186399|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186400|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186401|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
130186402|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186403|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
130186404|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
130186405|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186406|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186407|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186408|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
130186409|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
130186410|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
130186411|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
130186412|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186413|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186414|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186415|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
130186416|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
130186417|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
130186418|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
130186419|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186420|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186421|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186422|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
130186423|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
130186424|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186425|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186426|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186427|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186428|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186429|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
130186430|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186431|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186432|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
130186433|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186434|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186435|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186436|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
130186437|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186438|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186439|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
130186440|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186441|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186442|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186443|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
130186444|NCT04242446|468640269|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186445|NCT04242446|468640270|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
130186446|NCT04242446|468640271|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
130186447|NCT04242446|468640272|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186448|NCT04242446|468640273|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186449|NCT04242446|468640274|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186450|NCT04242446|468640275|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
130186451|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130186452|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130186453|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
130186454|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
130186455|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
130186456|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
130186457|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
130186458|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130186459|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130186460|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
130186461|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
130186462|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
130186463|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
130186464|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
130186465|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130186466|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130186467|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
130186468|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130186469|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130186470|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
130186471|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
130186472|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130186473|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130186474|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
130186475|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
130186476|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
130186477|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130186478|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
130186479|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130186480|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130186481|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
130186482|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
130186483|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
130186484|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
130186485|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
130186486|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186487|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186488|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186489|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
130186490|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186491|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186492|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
130186493|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186494|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186495|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186496|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186497|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
130186498|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186499|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
130186500|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186501|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186502|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186503|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186504|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
130186505|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186506|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
130186507|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186508|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186509|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186510|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186511|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
130186512|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186513|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
130186514|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186515|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186516|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186517|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186518|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
130186519|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186520|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
130186521|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186522|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186523|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186524|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186525|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
130186526|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186527|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
130186528|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186529|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186530|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186531|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186532|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186533|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
130186534|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
130186535|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186536|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186537|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186538|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186539|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186540|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
130186541|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
130186542|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186543|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186544|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186545|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186546|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186547|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
130186548|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
130186549|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186550|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186551|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186552|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186553|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186554|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
130186555|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
130186556|NCT04242446|468640269|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186557|NCT04242446|468640270|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186558|NCT04242446|468640271|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186559|NCT04242446|468640272|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186560|NCT04242446|468640273|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186561|NCT04242446|468640274|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
130186562|NCT04242446|468640275|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
130186563|NCT00739882|468640281|FG000|Double-blind Period|Adverse Event|1|||
130186564|NCT00739882|468640282|FG001|Double-blind Period|Adverse Event|2|||
130186565|NCT00739882|468640281|FG000|Double-blind Period|Protocol Violation|1|||
130186566|NCT00739882|468640282|FG001|Double-blind Period|Protocol Violation|0|||
130186567|NCT00739882|468640281|FG000|Double-blind Period|Lack of Efficacy|1|||
130186568|NCT00739882|468640282|FG001|Double-blind Period|Lack of Efficacy|1|||
130186569|NCT00739882|468640281|FG000|Double-blind Period|Other|16|||
130186570|NCT00739882|468640282|FG001|Double-blind Period|Other|8|||
130186571|NCT00739882|468640281|FG000|Open-label Period|Adverse Event|1|||
130186572|NCT00739882|468640282|FG001|Open-label Period|Adverse Event|0|||
130186573|NCT00739882|468640281|FG000|Open-label Period|Other|9|||
130186574|NCT00739882|468640282|FG001|Open-label Period|Other|5|||
130186575|NCT04021914|468640283|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
130186576|NCT03349060|468640284|FG000|Overall Study|Adverse Event|9|||
130186577|NCT03349060|468640285|FG001|Overall Study|Adverse Event|9|||
130186578|NCT03349060|468640286|FG002|Overall Study|Adverse Event|7|||
130186579|NCT03349060|468640284|FG000|Overall Study|Lack of Efficacy|1|||
130186580|NCT03349060|468640285|FG001|Overall Study|Lack of Efficacy|0|||
130186581|NCT03349060|468640286|FG002|Overall Study|Lack of Efficacy|2|||
130186582|NCT03349060|468640284|FG000|Overall Study|Lost to Follow-up|2|||
130186583|NCT03349060|468640285|FG001|Overall Study|Lost to Follow-up|1|||
130186584|NCT03349060|468640286|FG002|Overall Study|Lost to Follow-up|1|||
130186585|NCT03349060|468640284|FG000|Overall Study|Protocol Violation|2|||
130186586|NCT03349060|468640285|FG001|Overall Study|Protocol Violation|2|||
130186587|NCT03349060|468640286|FG002|Overall Study|Protocol Violation|1|||
130186588|NCT03349060|468640284|FG000|Overall Study|Withdrawal by Subject|5|||
130186589|NCT03349060|468640285|FG001|Overall Study|Withdrawal by Subject|3|||
130186590|NCT03349060|468640286|FG002|Overall Study|Withdrawal by Subject|4|||
130186591|NCT03349060|468640284|FG000|Overall Study|Medication error,no linked adverse event|0|||
130186592|NCT03349060|468640285|FG001|Overall Study|Medication error,no linked adverse event|0|||
130186593|NCT03349060|468640286|FG002|Overall Study|Medication error,no linked adverse event|1|||
130186594|NCT03349060|468640284|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
130186595|NCT03349060|468640285|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
130186596|NCT03349060|468640286|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
130186597|NCT03349060|468640284|FG000|Overall Study|Other|2|||
130186598|NCT03349060|468640285|FG001|Overall Study|Other|1|||
130186599|NCT03349060|468640286|FG002|Overall Study|Other|0|||
130186600|NCT02861586|468640287|FG000|Overall Study|Withdrawal by Subject|1|||
130186601|NCT02861586|468640288|FG001|Overall Study|Withdrawal by Subject|2|||
130186602|NCT02861586|468640289|FG002|Overall Study|Withdrawal by Subject|0|||
130186603|NCT02861586|468640290|FG003|Overall Study|Withdrawal by Subject|0|||
130186604|NCT02861586|468640291|FG004|Overall Study|Withdrawal by Subject|0|||
130186605|NCT02861586|468640292|FG005|Overall Study|Withdrawal by Subject|1|||
130186606|NCT02861586|468640293|FG006|Overall Study|Withdrawal by Subject|1|||
130186607|NCT02861586|468640294|FG007|Overall Study|Withdrawal by Subject|0|||
130186608|NCT02861586|468640287|FG000|Overall Study|Lost to Follow-up|3|||
130186609|NCT02861586|468640288|FG001|Overall Study|Lost to Follow-up|1|||
130186610|NCT02861586|468640289|FG002|Overall Study|Lost to Follow-up|1|||
130186611|NCT02861586|468640290|FG003|Overall Study|Lost to Follow-up|0|||
130186612|NCT02861586|468640291|FG004|Overall Study|Lost to Follow-up|0|||
130186613|NCT02861586|468640292|FG005|Overall Study|Lost to Follow-up|3|||
130186614|NCT02861586|468640293|FG006|Overall Study|Lost to Follow-up|0|||
130186615|NCT02861586|468640294|FG007|Overall Study|Lost to Follow-up|0|||
130186616|NCT02861586|468640287|FG000|Overall Study|Adverse Event|0|||
130186617|NCT02861586|468640288|FG001|Overall Study|Adverse Event|0|||
130186618|NCT02861586|468640289|FG002|Overall Study|Adverse Event|0|||
130186619|NCT02861586|468640290|FG003|Overall Study|Adverse Event|0|||
130186620|NCT02861586|468640291|FG004|Overall Study|Adverse Event|0|||
130186621|NCT02861586|468640292|FG005|Overall Study|Adverse Event|1|||
130186622|NCT02861586|468640293|FG006|Overall Study|Adverse Event|0|||
130186623|NCT02861586|468640294|FG007|Overall Study|Adverse Event|0|||
130186624|NCT00485732|468640295|FG000|Overall Study|Protocol Violation|1|||
130186625|NCT00485732|468640296|FG001|Overall Study|Protocol Violation|3|||
130186626|NCT00485732|468640295|FG000|Overall Study|Withdrawal by Subject|5|||
130186627|NCT00485732|468640296|FG001|Overall Study|Withdrawal by Subject|4|||
130186628|NCT00485732|468640295|FG000|Overall Study|Lost to Follow-up|2|||
130186629|NCT00485732|468640296|FG001|Overall Study|Lost to Follow-up|2|||
130186630|NCT01880554|468640297|FG000|Overall Study|Protocol Violation|14|||
130186631|NCT01880554|468640297|FG000|Overall Study|Simon's design requirements|2|||
130186632|NCT03985800|468640298|FG000|Overall Study|Death|1|||
130186633|NCT03985800|468640299|FG001|Overall Study|Death|2|||
130186634|NCT03985800|468640298|FG000|Overall Study|Withdrawal by Subject|3|||
130186635|NCT03985800|468640299|FG001|Overall Study|Withdrawal by Subject|6|||
130186636|NCT03985800|468640298|FG000|Overall Study|Protocol Violation|2|||
130186637|NCT03985800|468640299|FG001|Overall Study|Protocol Violation|0|||
130186638|NCT04281485|468640300|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
130186639|NCT04281485|468640301|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
130186640|NCT04281485|468640300|FG000|Overall Study|Ongoing (Safety data collection)|10|||
130186641|NCT04281485|468640301|FG001|Overall Study|Ongoing (Safety data collection)|5|||
130186642|NCT03096314|468640304|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
130186643|NCT03096314|468640305|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
130186644|NCT00957801|468640308|FG000|Overall Study|Withdrawal by Subject|0|||
130186645|NCT00957801|468640309|FG001|Overall Study|Withdrawal by Subject|0|||
130186646|NCT00957801|468640310|FG002|Overall Study|Withdrawal by Subject|0|||
130186647|NCT00957801|468640311|FG003|Overall Study|Withdrawal by Subject|1|||
130186648|NCT01778855|468640312|FG000|Overall Study|Death|0|||
130186649|NCT01778855|468640313|FG001|Overall Study|Death|1|||
130186650|NCT00191477|468640314|FG000|Overall Study|Tumor Recurrence|49|||
130186651|NCT00191477|468640315|FG001|Overall Study|Tumor Recurrence|48|||
130186652|NCT00191477|468640314|FG000|Overall Study|Death, Study Disease|1|||
130186653|NCT00191477|468640315|FG001|Overall Study|Death, Study Disease|1|||
130186654|NCT00191477|468640314|FG000|Overall Study|Death, Other Cause|3|||
130186655|NCT00191477|468640315|FG001|Overall Study|Death, Other Cause|6|||
130186656|NCT00191477|468640314|FG000|Overall Study|Lost to Follow-up|23|||
130186657|NCT00191477|468640315|FG001|Overall Study|Lost to Follow-up|21|||
130186658|NCT00191477|468640314|FG000|Overall Study|Protocol Violation|1|||
130186659|NCT00191477|468640315|FG001|Overall Study|Protocol Violation|1|||
130186660|NCT00191477|468640314|FG000|Overall Study|Treatment Change|2|||
130186661|NCT00191477|468640315|FG001|Overall Study|Treatment Change|0|||
130186662|NCT00191477|468640314|FG000|Overall Study|Withdrawal by Subject|2|||
130186663|NCT00191477|468640315|FG001|Overall Study|Withdrawal by Subject|0|||
130186664|NCT00191477|468640314|FG000|Overall Study|Other|2|||
130186665|NCT00191477|468640315|FG001|Overall Study|Other|0|||
130186666|NCT00191477|468640314|FG000|Overall Study|Not Eligible|41|||
130186667|NCT00191477|468640315|FG001|Overall Study|Not Eligible|38|||
130186668|NCT00191477|468640314|FG000|Overall Study|Pathological Specimen Lost|1|||
130186669|NCT00191477|468640315|FG001|Overall Study|Pathological Specimen Lost|0|||
130186670|NCT00191477|468640314|FG000|Overall Study|Discontinued Prior to Instillation|13|||
130186671|NCT00191477|468640315|FG001|Overall Study|Discontinued Prior to Instillation|14|||
130186672|NCT01286467|468640320|FG000|Overall Study|Death|1|||
130186673|NCT01286467|468640321|FG001|Overall Study|Death|1|||
130186674|NCT01286467|468640322|FG002|Overall Study|Death|1|||
130186675|NCT01286467|468640323|FG003|Overall Study|Death|0|||
130186676|NCT01286467|468640320|FG000|Overall Study|Lost to Follow-up|0|||
130186677|NCT01286467|468640321|FG001|Overall Study|Lost to Follow-up|0|||
130186678|NCT01286467|468640322|FG002|Overall Study|Lost to Follow-up|0|||
130186679|NCT01286467|468640323|FG003|Overall Study|Lost to Follow-up|1|||
130186680|NCT01286467|468640320|FG000|Overall Study|Withdrawal by Subject|0|||
130186681|NCT01286467|468640321|FG001|Overall Study|Withdrawal by Subject|0|||
130186682|NCT01286467|468640322|FG002|Overall Study|Withdrawal by Subject|1|||
130186683|NCT01286467|468640323|FG003|Overall Study|Withdrawal by Subject|0|||
130186684|NCT01286467|468640320|FG000|Overall Study|Physician Decision|0|||
130186685|NCT01286467|468640321|FG001|Overall Study|Physician Decision|0|||
130186686|NCT01286467|468640322|FG002|Overall Study|Physician Decision|0|||
130186687|NCT01286467|468640323|FG003|Overall Study|Physician Decision|1|||
130186688|NCT01286467|468640320|FG000|Overall Study|Disease progression|3|||
130186689|NCT01286467|468640321|FG001|Overall Study|Disease progression|2|||
130186690|NCT01286467|468640322|FG002|Overall Study|Disease progression|2|||
130186691|NCT01286467|468640323|FG003|Overall Study|Disease progression|3|||
130186692|NCT01286467|468640320|FG000|Overall Study|Adverse Event|0|||
130186693|NCT01286467|468640321|FG001|Overall Study|Adverse Event|1|||
130186694|NCT01286467|468640322|FG002|Overall Study|Adverse Event|2|||
130186695|NCT01286467|468640323|FG003|Overall Study|Adverse Event|3|||
130186696|NCT01286467|468640320|FG000|Overall Study|Study drug stop longer than 14 days|0|||
130186697|NCT01286467|468640321|FG001|Overall Study|Study drug stop longer than 14 days|0|||
130186698|NCT01286467|468640322|FG002|Overall Study|Study drug stop longer than 14 days|1|||
130186699|NCT01286467|468640323|FG003|Overall Study|Study drug stop longer than 14 days|0|||
130186700|NCT01058642|468640324|FG000|Treatment Period 1|Adverse Event|0|||
130186701|NCT01058642|468640325|FG001|Treatment Period 1|Adverse Event|1|||
130186702|NCT01058642|468640326|FG002|Treatment Period 1|Adverse Event|1|||
130186703|NCT01058642|468640327|FG003|Treatment Period 1|Adverse Event|0|||
130186704|NCT01058642|468640324|FG000|Treatment Period 1|Physician Decision|0|||
130186705|NCT01058642|468640325|FG001|Treatment Period 1|Physician Decision|0|||
130186706|NCT01058642|468640326|FG002|Treatment Period 1|Physician Decision|1|||
130186707|NCT01058642|468640327|FG003|Treatment Period 1|Physician Decision|0|||
130186708|NCT01058642|468640324|FG000|Treatment Period 1|Withdrawal by Subject|1|||
130186709|NCT01058642|468640325|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130186710|NCT01058642|468640326|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130186711|NCT01058642|468640327|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130186712|NCT01058642|468640324|FG000|Treatment Period 1|Lack of Efficacy|0|||
130186713|NCT01058642|468640325|FG001|Treatment Period 1|Lack of Efficacy|0|||
130186714|NCT01058642|468640326|FG002|Treatment Period 1|Lack of Efficacy|0|||
130186715|NCT01058642|468640327|FG003|Treatment Period 1|Lack of Efficacy|1|||
130186716|NCT01058642|468640324|FG000|Treatment Period 1|Protocol Violation|0|||
130186717|NCT01058642|468640325|FG001|Treatment Period 1|Protocol Violation|0|||
130186718|NCT01058642|468640326|FG002|Treatment Period 1|Protocol Violation|0|||
130186719|NCT01058642|468640327|FG003|Treatment Period 1|Protocol Violation|1|||
130186720|NCT01058642|468640324|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
130186721|NCT01058642|468640325|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130186722|NCT01058642|468640326|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130186723|NCT01058642|468640327|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
130186724|NCT03876743|468640328|FG000|Overall Study|Lost to Follow-up|6|||
130186725|NCT03876743|468640329|FG001|Overall Study|Lost to Follow-up|4|||
130186726|NCT03876743|468640330|FG002|Overall Study|Lost to Follow-up|4|||
130186727|NCT03876743|468640331|FG003|Overall Study|Lost to Follow-up|7|||
130186728|NCT00092118|468640332|FG000|Overall Study|Adverse Event|35|||
130186729|NCT00092118|468640333|FG001|Overall Study|Adverse Event|32|||
130186730|NCT00092118|468640332|FG000|Overall Study|Lack of Efficacy|12|||
130186731|NCT00092118|468640333|FG001|Overall Study|Lack of Efficacy|14|||
130186732|NCT00092118|468640332|FG000|Overall Study|Lost to Follow-up|4|||
130186733|NCT00092118|468640333|FG001|Overall Study|Lost to Follow-up|3|||
130186734|NCT00092118|468640332|FG000|Overall Study|Protocol Violation|23|||
130186735|NCT00092118|468640333|FG001|Overall Study|Protocol Violation|25|||
130186736|NCT00092118|468640332|FG000|Overall Study|Withdrawal by Subject|4|||
130186737|NCT00092118|468640333|FG001|Overall Study|Withdrawal by Subject|10|||
130186738|NCT00092118|468640332|FG000|Overall Study|Other|6|||
130186739|NCT00092118|468640333|FG001|Overall Study|Other|5|||
130186740|NCT01139125|468640334|FG000|Overall Study|Withdrawal by Subject|1|||
130186741|NCT03751098|468640335|FG000|Overall Study|Withdrawal by Subject|0|||
130186742|NCT03751098|468640336|FG001|Overall Study|Withdrawal by Subject|1|||
130186743|NCT01108718|468640339|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
130186744|NCT01108718|468640340|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
130186745|NCT03380429|468640341|FG000|Overall Study|Physician Decision|0|||
130186746|NCT03380429|468640342|FG001|Overall Study|Physician Decision|1|||
130186747|NCT03380429|468640343|FG002|Overall Study|Physician Decision|0|||
130186748|NCT03380429|468640344|FG003|Overall Study|Physician Decision|1|||
130186749|NCT03380429|468640345|FG004|Overall Study|Physician Decision|1|||
130186750|NCT03380429|468640341|FG000|Overall Study|Withdrawal by Subject|3|||
130186751|NCT03380429|468640342|FG001|Overall Study|Withdrawal by Subject|3|||
130186752|NCT03380429|468640343|FG002|Overall Study|Withdrawal by Subject|5|||
130186753|NCT03380429|468640344|FG003|Overall Study|Withdrawal by Subject|2|||
130186754|NCT03380429|468640345|FG004|Overall Study|Withdrawal by Subject|1|||
130186755|NCT03380429|468640341|FG000|Overall Study|Lost to Follow-up|0|||
130186756|NCT03380429|468640342|FG001|Overall Study|Lost to Follow-up|2|||
130186757|NCT03380429|468640343|FG002|Overall Study|Lost to Follow-up|4|||
130186758|NCT03380429|468640344|FG003|Overall Study|Lost to Follow-up|3|||
130186759|NCT03380429|468640345|FG004|Overall Study|Lost to Follow-up|1|||
130186760|NCT03380429|468640341|FG000|Overall Study|Protocol Violation|1|||
130186761|NCT03380429|468640342|FG001|Overall Study|Protocol Violation|0|||
130186762|NCT03380429|468640343|FG002|Overall Study|Protocol Violation|1|||
130186763|NCT03380429|468640344|FG003|Overall Study|Protocol Violation|0|||
130186764|NCT03380429|468640345|FG004|Overall Study|Protocol Violation|1|||
130186765|NCT03380429|468640341|FG000|Overall Study|Lack of Efficacy|0|||
130186766|NCT03380429|468640342|FG001|Overall Study|Lack of Efficacy|0|||
130186767|NCT03380429|468640343|FG002|Overall Study|Lack of Efficacy|0|||
130186768|NCT03380429|468640344|FG003|Overall Study|Lack of Efficacy|2|||
130186769|NCT03380429|468640345|FG004|Overall Study|Lack of Efficacy|1|||
130186770|NCT03380429|468640341|FG000|Overall Study|Adverse Event|1|||
130186771|NCT03380429|468640342|FG001|Overall Study|Adverse Event|1|||
130186772|NCT03380429|468640343|FG002|Overall Study|Adverse Event|1|||
130186773|NCT03380429|468640344|FG003|Overall Study|Adverse Event|2|||
130186774|NCT03380429|468640345|FG004|Overall Study|Adverse Event|0|||
130186775|NCT04760626|468640348|FG000|Overall Study|Withdrawal by Subject|24|||
130186776|NCT04760626|468640349|FG001|Overall Study|Withdrawal by Subject|20|||
130186777|NCT04760626|468640348|FG000|Overall Study|Lost to Follow-up|14|||
130186778|NCT04760626|468640349|FG001|Overall Study|Lost to Follow-up|19|||
130186779|NCT04760626|468640348|FG000|Overall Study|Physician Decision|3|||
130186780|NCT04760626|468640349|FG001|Overall Study|Physician Decision|5|||
130186781|NCT04760626|468640348|FG000|Overall Study|Death|3|||
130186782|NCT04760626|468640349|FG001|Overall Study|Death|6|||
130186783|NCT04760626|468640348|FG000|Overall Study|Site closure|1|||
130186784|NCT04760626|468640349|FG001|Overall Study|Site closure|0|||
130186785|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
130186786|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
130186787|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
130186788|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
130186789|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
130186790|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
130186791|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
130186792|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
130186793|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
130186794|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
130186795|NCT03762265|468640352|FG000|BT Period: Weeks 1 to 37|Other|0|||
130186796|NCT03762265|468640353|FG001|BT Period: Weeks 1 to 37|Other|1|||
130186797|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
130186798|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
130186799|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
130186800|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
130186801|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
130186802|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
130186803|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
130186804|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
130186805|NCT03762265|468640352|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
130186806|NCT03762265|468640353|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
130186807|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
130186808|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
130186809|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
130186810|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
130186811|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
130186812|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
130186813|NCT03762265|468640352|FG000|LTE Period: Weeks 61 to 109|Other|1|||
130186814|NCT03762265|468640353|FG001|LTE Period: Weeks 61 to 109|Other|0|||
130186815|NCT00806403|468640356|FG000|Overall Study|Death|4|||
130186816|NCT00806403|468640357|FG001|Overall Study|Death|3|||
130186817|NCT01882985|468640358|FG000|Overall Study|Lost to Follow-up|1|||
130186818|NCT01882985|468640358|FG000|Overall Study|Withdrawal by Subject|1|||
130186819|NCT01383174|468640359|FG000|3 Month Assessment|Death|0|||
130186820|NCT01383174|468640360|FG001|3 Month Assessment|Death|1|||
130186821|NCT01383174|468640359|FG000|3 Month Assessment|Lost to Follow-up|2|||
130186822|NCT01383174|468640360|FG001|3 Month Assessment|Lost to Follow-up|0|||
130186823|NCT01383174|468640359|FG000|3 Month Assessment|Refused to complete|4|||
130186824|NCT01383174|468640360|FG001|3 Month Assessment|Refused to complete|0|||
130186825|NCT01383174|468640359|FG000|6 Month Assessment|Lost to Follow-up|1|||
130186826|NCT01383174|468640360|FG001|6 Month Assessment|Lost to Follow-up|1|||
130186827|NCT01383174|468640359|FG000|6 Month Assessment|Refused to complete|4|||
130186828|NCT01383174|468640360|FG001|6 Month Assessment|Refused to complete|0|||
130186829|NCT01787292|468640361|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
130186830|NCT01787292|468640362|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
130186831|NCT01787292|468640361|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
130186832|NCT01787292|468640362|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
130186833|NCT01827111|468640363|FG000|Overall Study|Disease Progression|1|||
130186834|NCT02169271|468640364|FG000|Overall Study|Protocol Violation|1|||
130186835|NCT02169271|468640365|FG001|Overall Study|Protocol Violation|2|||
130186836|NCT01924689|468640368|FG000|Overall Study|Death|0|||
130186837|NCT01924689|468640369|FG001|Overall Study|Death|1|||
130186838|NCT01924689|468640370|FG002|Overall Study|Death|0|||
130186839|NCT01924689|468640371|FG003|Overall Study|Death|1|||
130186840|NCT01924689|468640372|FG004|Overall Study|Death|0|||
130186841|NCT01924689|468640373|FG005|Overall Study|Death|0|||
130186842|NCT01924689|468640368|FG000|Overall Study|Disease progression|0|||
130186843|NCT01924689|468640369|FG001|Overall Study|Disease progression|0|||
130186844|NCT01924689|468640370|FG002|Overall Study|Disease progression|2|||
130186845|NCT01924689|468640371|FG003|Overall Study|Disease progression|0|||
130186846|NCT01924689|468640372|FG004|Overall Study|Disease progression|3|||
130186847|NCT01924689|468640373|FG005|Overall Study|Disease progression|2|||
130186848|NCT01924689|468640368|FG000|Overall Study|New therapy or study|3|||
130186849|NCT01924689|468640369|FG001|Overall Study|New therapy or study|2|||
130186850|NCT01924689|468640370|FG002|Overall Study|New therapy or study|1|||
130186851|NCT01924689|468640371|FG003|Overall Study|New therapy or study|4|||
130186852|NCT01924689|468640372|FG004|Overall Study|New therapy or study|2|||
130186853|NCT01924689|468640373|FG005|Overall Study|New therapy or study|0|||
130186854|NCT01924689|468640368|FG000|Overall Study|Withdrawal of consent|0|||
130186855|NCT01924689|468640369|FG001|Overall Study|Withdrawal of consent|0|||
130186856|NCT01924689|468640370|FG002|Overall Study|Withdrawal of consent|1|||
130186857|NCT01924689|468640371|FG003|Overall Study|Withdrawal of consent|1|||
130186858|NCT01924689|468640372|FG004|Overall Study|Withdrawal of consent|0|||
130186859|NCT01924689|468640373|FG005|Overall Study|Withdrawal of consent|0|||
130186860|NCT01924689|468640368|FG000|Overall Study|Other|0|||
130186861|NCT01924689|468640369|FG001|Overall Study|Other|0|||
130186862|NCT01924689|468640370|FG002|Overall Study|Other|0|||
130186863|NCT01924689|468640371|FG003|Overall Study|Other|0|||
130186864|NCT01924689|468640372|FG004|Overall Study|Other|1|||
130186865|NCT01924689|468640373|FG005|Overall Study|Other|0|||
130186866|NCT03267212|468640374|FG000|First Intervention|Lost to Follow-up|0|||
130186867|NCT03267212|468640375|FG001|First Intervention|Lost to Follow-up|2|||
130186868|NCT03267212|468640374|FG000|First Intervention|Withdrawal by Subject|1|||
130186869|NCT03267212|468640375|FG001|First Intervention|Withdrawal by Subject|1|||
130186870|NCT03267212|468640374|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
130186871|NCT03267212|468640375|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
130186872|NCT00226499|468640378|FG000|Overall Study|Adverse Event|10|||
130186873|NCT00226499|468640379|FG001|Overall Study|Adverse Event|6|||
130186874|NCT00226499|468640380|FG002|Overall Study|Adverse Event|3|||
130186875|NCT00226499|468640378|FG000|Overall Study|Others|1064|||
130186876|NCT00226499|468640379|FG001|Overall Study|Others|1066|||
130186877|NCT00226499|468640380|FG002|Overall Study|Others|356|||
130186878|NCT00946920|468640381|FG000|Overall Study|Withdrawal by Subject|28|||
130186879|NCT00946920|468640382|FG001|Overall Study|Withdrawal by Subject|15|||
130186880|NCT00946920|468640381|FG000|Overall Study|Lost to Follow-up|2|||
130186881|NCT00946920|468640382|FG001|Overall Study|Lost to Follow-up|2|||
130186882|NCT00946920|468640381|FG000|Overall Study|Physician Decision|5|||
130186883|NCT00946920|468640382|FG001|Overall Study|Physician Decision|2|||
130186884|NCT00946920|468640381|FG000|Overall Study|Adverse Event|41|||
130186885|NCT00946920|468640382|FG001|Overall Study|Adverse Event|14|||
130186886|NCT00946920|468640381|FG000|Overall Study|Protocol Violation|16|||
130186887|NCT00946920|468640382|FG001|Overall Study|Protocol Violation|8|||
130186888|NCT00946920|468640381|FG000|Overall Study|Miscellaneous reasons|18|||
130186889|NCT00946920|468640382|FG001|Overall Study|Miscellaneous reasons|3|||
130186890|NCT01597973|468640383|FG000|Overall Study|Found ineligible before study medication started|4|||
130186891|NCT01597973|468640384|FG001|Overall Study|Found ineligible before study medication started|2|||
130186892|NCT01597973|468640383|FG000|Overall Study|Eligible pathogen not confirmed|14|||
130186893|NCT01597973|468640384|FG001|Overall Study|Eligible pathogen not confirmed|15|||
130186894|NCT01597973|468640383|FG000|Overall Study|LAR not authorized to consent|0|||
130186895|NCT01597973|468640384|FG001|Overall Study|LAR not authorized to consent|1|||
130186896|NCT01597973|468640383|FG000|Overall Study|Ineligible due to early seizures|1|||
130186897|NCT01597973|468640384|FG001|Overall Study|Ineligible due to early seizures|0|||
130186898|NCT01597973|468640383|FG000|Overall Study|Ineligible due to non-target infection|1|||
130186899|NCT01597973|468640384|FG001|Overall Study|Ineligible due to non-target infection|1|||
130186900|NCT02389829|468640391|FG000|Overall Study|Lost to Follow-up|0|||
130186901|NCT02389829|468640392|FG001|Overall Study|Lost to Follow-up|1|||
130186902|NCT02362360|468640393|FG000|Period 1|Lack of Efficacy|1|||
130186903|NCT02362360|468640394|FG001|Period 1|Lack of Efficacy|0|||
130186904|NCT02362360|468640393|FG000|Period 1|Withdrawal by Subject|2|||
130186905|NCT02362360|468640394|FG001|Period 1|Withdrawal by Subject|1|||
130186906|NCT02208362|468640395|FG000|Overall Study|Participant did not complete treatment|0|||
130186907|NCT02208362|468640396|FG001|Overall Study|Participant did not complete treatment|1|||
130186908|NCT02208362|468640397|FG002|Overall Study|Participant did not complete treatment|0|||
130186909|NCT02208362|468640398|FG003|Overall Study|Participant did not complete treatment|0|||
130186910|NCT02208362|468640399|FG004|Overall Study|Participant did not complete treatment|0|||
130186911|NCT02208362|468640400|FG005|Overall Study|Participant did not complete treatment|0|||
130186912|NCT02208362|468640401|FG006|Overall Study|Participant did not complete treatment|1|||
130186913|NCT02208362|468640402|FG007|Overall Study|Participant did not complete treatment|1|||
130186914|NCT02208362|468640403|FG008|Overall Study|Participant did not complete treatment|2|||
130186915|NCT02208362|468640404|FG009|Overall Study|Participant did not complete treatment|0|||
130186916|NCT02208362|468640405|FG010|Overall Study|Participant did not complete treatment|1|||
130186917|NCT02208362|468640406|FG011|Overall Study|Participant did not complete treatment|0|||
130186918|NCT02208362|468640395|FG000|Overall Study|Participant received disallowed treatment|0|||
130186919|NCT02208362|468640396|FG001|Overall Study|Participant received disallowed treatment|0|||
130186920|NCT02208362|468640397|FG002|Overall Study|Participant received disallowed treatment|0|||
130186921|NCT02208362|468640398|FG003|Overall Study|Participant received disallowed treatment|0|||
130186922|NCT02208362|468640399|FG004|Overall Study|Participant received disallowed treatment|0|||
130186923|NCT02208362|468640400|FG005|Overall Study|Participant received disallowed treatment|0|||
130186924|NCT02208362|468640401|FG006|Overall Study|Participant received disallowed treatment|0|||
130186925|NCT02208362|468640402|FG007|Overall Study|Participant received disallowed treatment|0|||
130186926|NCT02208362|468640403|FG008|Overall Study|Participant received disallowed treatment|1|||
130186927|NCT02208362|468640404|FG009|Overall Study|Participant received disallowed treatment|0|||
130186928|NCT02208362|468640405|FG010|Overall Study|Participant received disallowed treatment|0|||
130186929|NCT02208362|468640406|FG011|Overall Study|Participant received disallowed treatment|0|||
130186930|NCT05966584|468640411|FG000|Overall Study|Lost to Follow-up|1|||
130186931|NCT00955409|468641630|FG000|Overall Study|Lack of Efficacy|1|||
130186932|NCT00955409|468641631|FG001|Overall Study|Lack of Efficacy|0|||
130186933|NCT00955409|468641632|FG002|Overall Study|Lack of Efficacy|0|||
130186934|NCT00955409|468641633|FG003|Overall Study|Lack of Efficacy|0|||
130186935|NCT00955409|468641634|FG004|Overall Study|Lack of Efficacy|0|||
130186936|NCT00955409|468641635|FG005|Overall Study|Lack of Efficacy|0|||
130186937|NCT00955409|468641636|FG006|Overall Study|Lack of Efficacy|0|||
130186938|NCT00955409|468641637|FG007|Overall Study|Lack of Efficacy|0|||
130186939|NCT00955409|468641638|FG008|Overall Study|Lack of Efficacy|0|||
130186940|NCT00955409|468641639|FG009|Overall Study|Lack of Efficacy|0|||
130186941|NCT00955409|468641630|FG000|Overall Study|Withdrawal by Subject|1|||
130186942|NCT00955409|468641631|FG001|Overall Study|Withdrawal by Subject|0|||
130186943|NCT00955409|468641632|FG002|Overall Study|Withdrawal by Subject|5|||
130186944|NCT00955409|468641633|FG003|Overall Study|Withdrawal by Subject|2|||
130186945|NCT00955409|468641634|FG004|Overall Study|Withdrawal by Subject|0|||
130186946|NCT00955409|468641635|FG005|Overall Study|Withdrawal by Subject|0|||
130186947|NCT00955409|468641636|FG006|Overall Study|Withdrawal by Subject|2|||
130186948|NCT00955409|468641637|FG007|Overall Study|Withdrawal by Subject|0|||
130186949|NCT00955409|468641638|FG008|Overall Study|Withdrawal by Subject|1|||
130186950|NCT00955409|468641639|FG009|Overall Study|Withdrawal by Subject|0|||
130186951|NCT00955409|468641630|FG000|Overall Study|Caregiver Request|2|||
130186952|NCT00955409|468641631|FG001|Overall Study|Caregiver Request|0|||
130186953|NCT00955409|468641632|FG002|Overall Study|Caregiver Request|6|||
130186954|NCT00955409|468641633|FG003|Overall Study|Caregiver Request|5|||
130186955|NCT00955409|468641634|FG004|Overall Study|Caregiver Request|0|||
130186956|NCT00955409|468641635|FG005|Overall Study|Caregiver Request|2|||
130186957|NCT00955409|468641636|FG006|Overall Study|Caregiver Request|3|||
130186958|NCT00955409|468641637|FG007|Overall Study|Caregiver Request|1|||
130186959|NCT00955409|468641638|FG008|Overall Study|Caregiver Request|3|||
130186960|NCT00955409|468641639|FG009|Overall Study|Caregiver Request|0|||
130186961|NCT00955409|468641630|FG000|Overall Study|Investigator Request|0|||
130186962|NCT00955409|468641631|FG001|Overall Study|Investigator Request|0|||
130186963|NCT00955409|468641632|FG002|Overall Study|Investigator Request|1|||
130186964|NCT00955409|468641633|FG003|Overall Study|Investigator Request|0|||
130186965|NCT00955409|468641634|FG004|Overall Study|Investigator Request|0|||
130186966|NCT00955409|468641635|FG005|Overall Study|Investigator Request|0|||
130186967|NCT00955409|468641636|FG006|Overall Study|Investigator Request|0|||
130186968|NCT00955409|468641637|FG007|Overall Study|Investigator Request|0|||
130186969|NCT00955409|468641638|FG008|Overall Study|Investigator Request|0|||
130186970|NCT00955409|468641639|FG009|Overall Study|Investigator Request|0|||
130186971|NCT00955409|468641630|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
130186972|NCT00955409|468641631|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130186973|NCT00955409|468641632|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
130186974|NCT00955409|468641633|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
130186975|NCT00955409|468641634|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
130186976|NCT00955409|468641635|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
130186977|NCT00955409|468641636|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
130186978|NCT00955409|468641637|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
130186979|NCT00955409|468641638|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
130186980|NCT00955409|468641639|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
130186981|NCT00955409|468641630|FG000|Overall Study|Lost to Follow-up|0|||
130186982|NCT00955409|468641631|FG001|Overall Study|Lost to Follow-up|0|||
130186983|NCT00955409|468641632|FG002|Overall Study|Lost to Follow-up|1|||
130186984|NCT00955409|468641633|FG003|Overall Study|Lost to Follow-up|0|||
130186985|NCT00955409|468641634|FG004|Overall Study|Lost to Follow-up|0|||
130186986|NCT00955409|468641635|FG005|Overall Study|Lost to Follow-up|0|||
130186987|NCT00955409|468641636|FG006|Overall Study|Lost to Follow-up|1|||
130186988|NCT00955409|468641637|FG007|Overall Study|Lost to Follow-up|0|||
130186989|NCT00955409|468641638|FG008|Overall Study|Lost to Follow-up|0|||
130186990|NCT00955409|468641639|FG009|Overall Study|Lost to Follow-up|0|||
130186991|NCT00955409|468641630|FG000|Overall Study|Failed to Return|2|||
130186992|NCT00955409|468641631|FG001|Overall Study|Failed to Return|0|||
130186993|NCT00955409|468641632|FG002|Overall Study|Failed to Return|0|||
130186994|NCT00955409|468641633|FG003|Overall Study|Failed to Return|0|||
130186995|NCT00955409|468641634|FG004|Overall Study|Failed to Return|0|||
130186996|NCT00955409|468641635|FG005|Overall Study|Failed to Return|0|||
130186997|NCT00955409|468641636|FG006|Overall Study|Failed to Return|0|||
130186998|NCT00955409|468641637|FG007|Overall Study|Failed to Return|2|||
130186999|NCT00955409|468641638|FG008|Overall Study|Failed to Return|0|||
130187000|NCT00955409|468641639|FG009|Overall Study|Failed to Return|0|||
130187001|NCT00955409|468641630|FG000|Overall Study|Adverse Event (AE)|2|||
130187002|NCT00955409|468641631|FG001|Overall Study|Adverse Event (AE)|0|||
130187003|NCT00955409|468641632|FG002|Overall Study|Adverse Event (AE)|0|||
130187004|NCT00955409|468641633|FG003|Overall Study|Adverse Event (AE)|0|||
130187005|NCT00955409|468641634|FG004|Overall Study|Adverse Event (AE)|0|||
130187006|NCT00955409|468641635|FG005|Overall Study|Adverse Event (AE)|1|||
130187007|NCT00955409|468641636|FG006|Overall Study|Adverse Event (AE)|2|||
130187008|NCT00955409|468641637|FG007|Overall Study|Adverse Event (AE)|0|||
130187009|NCT00955409|468641638|FG008|Overall Study|Adverse Event (AE)|2|||
130187010|NCT00955409|468641639|FG009|Overall Study|Adverse Event (AE)|0|||
130187011|NCT00955409|468641630|FG000|Overall Study|Reason not Specified|2|||
130187012|NCT00955409|468641631|FG001|Overall Study|Reason not Specified|1|||
130187013|NCT00955409|468641632|FG002|Overall Study|Reason not Specified|13|||
130187014|NCT00955409|468641633|FG003|Overall Study|Reason not Specified|1|||
130187015|NCT00955409|468641634|FG004|Overall Study|Reason not Specified|2|||
130187016|NCT00955409|468641635|FG005|Overall Study|Reason not Specified|0|||
130187017|NCT00955409|468641636|FG006|Overall Study|Reason not Specified|16|||
130187018|NCT00955409|468641637|FG007|Overall Study|Reason not Specified|0|||
130187019|NCT00955409|468641638|FG008|Overall Study|Reason not Specified|8|||
130187020|NCT00955409|468641639|FG009|Overall Study|Reason not Specified|1|||
130187021|NCT00803790|468641640|FG000|Period 1|Adverse Event|0|||
130187022|NCT00803790|468641641|FG001|Period 1|Adverse Event|1|||
130187023|NCT00803790|468641642|FG002|Period 1|Adverse Event|0|||
130187024|NCT00803790|468641643|FG003|Period 1|Adverse Event|0|||
130187025|NCT00803790|468641640|FG000|Period 1|Lost to Follow-up|1|||
130187026|NCT00803790|468641641|FG001|Period 1|Lost to Follow-up|2|||
130187027|NCT00803790|468641642|FG002|Period 1|Lost to Follow-up|0|||
130187028|NCT00803790|468641643|FG003|Period 1|Lost to Follow-up|0|||
130187029|NCT00803790|468641640|FG000|Period 1|Withdrawal by Subject|8|||
130187030|NCT00803790|468641641|FG001|Period 1|Withdrawal by Subject|6|||
130187031|NCT00803790|468641642|FG002|Period 1|Withdrawal by Subject|0|||
130187032|NCT00803790|468641643|FG003|Period 1|Withdrawal by Subject|0|||
130187033|NCT00803790|468641640|FG000|Period 1|positive drug screen or personal reasons|0|||
130187034|NCT00803790|468641641|FG001|Period 1|positive drug screen or personal reasons|3|||
130187035|NCT00803790|468641642|FG002|Period 1|positive drug screen or personal reasons|0|||
130187036|NCT00803790|468641643|FG003|Period 1|positive drug screen or personal reasons|4|||
130187037|NCT00803790|468641640|FG000|Period 1|Protocol Violation|0|||
130187038|NCT00803790|468641641|FG001|Period 1|Protocol Violation|0|||
130187039|NCT00803790|468641642|FG002|Period 1|Protocol Violation|1|||
130187040|NCT00803790|468641643|FG003|Period 1|Protocol Violation|0|||
130187041|NCT00803790|468641640|FG000|Period 2|Adverse Event|0|||
130187042|NCT00803790|468641641|FG001|Period 2|Adverse Event|0|||
130187043|NCT00803790|468641642|FG002|Period 2|Adverse Event|1|||
130187044|NCT00803790|468641643|FG003|Period 2|Adverse Event|1|||
130187045|NCT00803790|468641640|FG000|Period 2|Withdrawal by Subject|1|||
130187046|NCT00803790|468641641|FG001|Period 2|Withdrawal by Subject|0|||
130187047|NCT00803790|468641642|FG002|Period 2|Withdrawal by Subject|0|||
130187048|NCT00803790|468641643|FG003|Period 2|Withdrawal by Subject|0|||
130187049|NCT00803790|468641640|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
130187050|NCT00803790|468641641|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
130187051|NCT00803790|468641642|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
130187052|NCT00803790|468641643|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
130187053|NCT05161481|468641644|FG000|Overall Study|Withdrawal of consent|0|||
130187054|NCT05161481|468641645|FG001|Overall Study|Withdrawal of consent|1|||
130187055|NCT05161481|468641646|FG002|Overall Study|Withdrawal of consent|1|||
130187056|NCT05161481|468641644|FG000|Overall Study|Study terminated by sponsor|3|||
130187057|NCT05161481|468641645|FG001|Overall Study|Study terminated by sponsor|3|||
130187058|NCT05161481|468641646|FG002|Overall Study|Study terminated by sponsor|2|||
130187059|NCT05161481|468641644|FG000|Overall Study|Adverse Event|3|||
130187060|NCT05161481|468641645|FG001|Overall Study|Adverse Event|0|||
130187061|NCT05161481|468641646|FG002|Overall Study|Adverse Event|6|||
130187062|NCT05161481|468641644|FG000|Overall Study|Randomised in error and was not treated|1|||
130187063|NCT05161481|468641645|FG001|Overall Study|Randomised in error and was not treated|0|||
130187064|NCT05161481|468641646|FG002|Overall Study|Randomised in error and was not treated|0|||
130187065|NCT05161481|468641644|FG000|Overall Study|Subject decision|0|||
130187066|NCT05161481|468641645|FG001|Overall Study|Subject decision|0|||
130187067|NCT05161481|468641646|FG002|Overall Study|Subject decision|1|||
130187068|NCT04815083|468641647|FG000|Overall Study|Physician Decision|1|||
130187069|NCT04815083|468641647|FG000|Overall Study|Study pause|2|||
130187070|NCT04815083|468641647|FG000|Overall Study|Screening failure|4|||
130187071|NCT00471081|468641648|FG000|Active Phase|Protocol Violation|1|||
130187072|NCT00471081|468641649|FG001|Active Phase|Protocol Violation|1|||
130187073|NCT00471081|468641648|FG000|Active Phase|Withdrawal by Subject|0|||
130187074|NCT00471081|468641649|FG001|Active Phase|Withdrawal by Subject|3|||
130187075|NCT00471081|468641648|FG000|Active Phase|Lost to Follow-up|0|||
130187076|NCT00471081|468641649|FG001|Active Phase|Lost to Follow-up|1|||
130187077|NCT00471081|468641648|FG000|Active Phase|Lost health plan/insurance|1|||
130187078|NCT00471081|468641649|FG001|Active Phase|Lost health plan/insurance|8|||
130187079|NCT00471081|468641648|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
130187080|NCT00471081|468641649|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
130187081|NCT00471081|468641648|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
130187082|NCT00471081|468641649|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
130187083|NCT00471081|468641648|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
130187084|NCT00471081|468641649|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
130187085|NCT04335123|468641651|FG000|Overall Study|Withdrawal by Subject|2|||
130187086|NCT04335123|468641652|FG001|Overall Study|Withdrawal by Subject|0|||
130187087|NCT04335123|468641651|FG000|Overall Study|Physician Decision|2|||
130187088|NCT04335123|468641652|FG001|Overall Study|Physician Decision|0|||
130187089|NCT01283464|468641653|FG000|Overall Study|Lost to Follow-up|0|||
130187090|NCT01283464|468641654|FG001|Overall Study|Lost to Follow-up|1|||
130187091|NCT01283464|468641653|FG000|Overall Study|Withdrawal by Subject|1|||
130187092|NCT01283464|468641654|FG001|Overall Study|Withdrawal by Subject|0|||
130187093|NCT01283464|468641653|FG000|Overall Study|Physician Decision|1|||
130187094|NCT01283464|468641654|FG001|Overall Study|Physician Decision|0|||
130187095|NCT02626026|468641655|FG000|Overall Study|Randomized but Never Treated|0|||
130187096|NCT02626026|468641656|FG001|Overall Study|Randomized but Never Treated|0|||
130187097|NCT02626026|468641657|FG002|Overall Study|Randomized but Never Treated|0|||
130187098|NCT02626026|468641658|FG003|Overall Study|Randomized but Never Treated|0|||
130187099|NCT02626026|468641659|FG004|Overall Study|Randomized but Never Treated|1|||
130187100|NCT02626026|468641660|FG005|Overall Study|Randomized but Never Treated|0|||
130187101|NCT03922308|468641665|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
130187102|NCT03922308|468641666|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
130187103|NCT03922308|468641667|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
130187104|NCT03922308|468641665|FG000|Overall Study|Lost to Follow-up|1|||
130187105|NCT03922308|468641666|FG001|Overall Study|Lost to Follow-up|0|||
130187106|NCT03922308|468641667|FG002|Overall Study|Lost to Follow-up|0|||
130187107|NCT03922308|468641665|FG000|Overall Study|Reason not Specified|0|||
130187108|NCT03922308|468641666|FG001|Overall Study|Reason not Specified|2|||
130187109|NCT03922308|468641667|FG002|Overall Study|Reason not Specified|1|||
130187110|NCT03376789|468641668|FG000|Overall Study|Withdrawal by Subject|3|||
130187111|NCT03376789|468641669|FG001|Overall Study|Withdrawal by Subject|5|||
130187112|NCT03376789|468641668|FG000|Overall Study|Protocol Violation|0|||
130187113|NCT03376789|468641669|FG001|Overall Study|Protocol Violation|1|||
130187114|NCT03376789|468641668|FG000|Overall Study|Adverse Event|0|||
130187115|NCT03376789|468641669|FG001|Overall Study|Adverse Event|1|||
130187116|NCT03376789|468641668|FG000|Overall Study|Lost to Follow-up|1|||
130187117|NCT03376789|468641669|FG001|Overall Study|Lost to Follow-up|1|||
130187118|NCT03376789|468641668|FG000|Overall Study|Per sponsor due to noncompliance|1|||
130187119|NCT03376789|468641669|FG001|Overall Study|Per sponsor due to noncompliance|0|||
130187120|NCT03376789|468641668|FG000|Overall Study|Subject off study medication|0|||
130187121|NCT03376789|468641669|FG001|Overall Study|Subject off study medication|1|||
130187122|NCT04177095|468641672|FG000|Overall Study|Withdrawal by Subject|3|||
130187123|NCT04177095|468641672|FG000|Overall Study|Screen Failure|3|||
130187124|NCT04177095|468641672|FG000|Overall Study|Problems with the Trugraf assay|1|||
130187125|NCT00777296|468641673|FG000|Overall Study|Adverse Event|0|||
130187126|NCT00777296|468641674|FG001|Overall Study|Adverse Event|1|||
130187127|NCT00777296|468641675|FG002|Overall Study|Adverse Event|0|||
130187128|NCT00777296|468641676|FG003|Overall Study|Adverse Event|1|||
130187129|NCT00777296|468641673|FG000|Overall Study|Withdrawal by Subject|1|||
130187130|NCT00777296|468641674|FG001|Overall Study|Withdrawal by Subject|0|||
130187131|NCT00777296|468641675|FG002|Overall Study|Withdrawal by Subject|0|||
130187132|NCT00777296|468641676|FG003|Overall Study|Withdrawal by Subject|0|||
130187133|NCT00777296|468641673|FG000|Overall Study|CRF form not completed|0|||
130187134|NCT00777296|468641674|FG001|Overall Study|CRF form not completed|0|||
130187135|NCT00777296|468641675|FG002|Overall Study|CRF form not completed|2|||
130187136|NCT00777296|468641676|FG003|Overall Study|CRF form not completed|0|||
130187137|NCT01592786|468641677|FG000|Overall Study|Adverse Event|60|||
130187138|NCT01592786|468641677|FG000|Overall Study|Lack of Efficacy|19|||
130187139|NCT01592786|468641677|FG000|Overall Study|Protocol Violation|14|||
130187140|NCT01592786|468641677|FG000|Overall Study|Withdrawal by Subject|23|||
130187141|NCT01592786|468641677|FG000|Overall Study|Lost to Follow-up|19|||
130187142|NCT01592786|468641677|FG000|Overall Study|Other|3|||
130187143|NCT02172664|468641678|FG000|Overall Study|Lost to Follow-up|4|||
130187144|NCT02172664|468641679|FG001|Overall Study|Lost to Follow-up|4|||
130187145|NCT02172664|468641678|FG000|Overall Study|Death|1|||
130187146|NCT02172664|468641679|FG001|Overall Study|Death|1|||
130187147|NCT02172664|468641678|FG000|Overall Study|Moved out of area|1|||
130187148|NCT02172664|468641679|FG001|Overall Study|Moved out of area|1|||
130187149|NCT04426006|468641680|FG000|Inclusion|Protocol Violation|1|||
130187150|NCT04426006|468641680|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
130187151|NCT04426006|468641680|FG000|Inclusion|Blood sample at inclusion not done|1|||
130187152|NCT04426006|468641680|FG000|3 Months|Lost to Follow-up|17|||
130187153|NCT04426006|468641680|FG000|12 Months|Lost to Follow-up|38|||
130187154|NCT02946463|468641681|FG000|Primary Evaluation Period|Physician Decision|0|||
130187155|NCT02946463|468641682|FG001|Primary Evaluation Period|Physician Decision|1|||
130187156|NCT02946463|468641683|FG002|Primary Evaluation Period|Physician Decision|0|||
130187157|NCT02946463|468641684|FG003|Primary Evaluation Period|Physician Decision|0|||
130187158|NCT02946463|468641681|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
130187159|NCT02946463|468641682|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
130187160|NCT02946463|468641683|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
130187161|NCT02946463|468641684|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
130187162|NCT02946463|468641681|FG000|Extension Period|Death|4|||
130187163|NCT02946463|468641682|FG001|Extension Period|Death|4|||
130187164|NCT02946463|468641683|FG002|Extension Period|Death|0|||
130187165|NCT02946463|468641684|FG003|Extension Period|Death|0|||
130187166|NCT02946463|468641681|FG000|Extension Period|Withdrawal by Subject|4|||
130187167|NCT02946463|468641682|FG001|Extension Period|Withdrawal by Subject|3|||
130187168|NCT02946463|468641683|FG002|Extension Period|Withdrawal by Subject|0|||
130187169|NCT02946463|468641684|FG003|Extension Period|Withdrawal by Subject|0|||
130187170|NCT02946463|468641681|FG000|Extension Period|Other than specified|2|||
130187171|NCT02946463|468641682|FG001|Extension Period|Other than specified|3|||
130187172|NCT02946463|468641683|FG002|Extension Period|Other than specified|2|||
130187173|NCT02946463|468641684|FG003|Extension Period|Other than specified|0|||
130187174|NCT02946463|468641681|FG000|Extension Period|Physician Decision|1|||
130187175|NCT02946463|468641682|FG001|Extension Period|Physician Decision|4|||
130187176|NCT02946463|468641683|FG002|Extension Period|Physician Decision|0|||
130187177|NCT02946463|468641684|FG003|Extension Period|Physician Decision|0|||
130187178|NCT02946463|468641681|FG000|Extension Period|Pregnancy|3|||
130187179|NCT02946463|468641682|FG001|Extension Period|Pregnancy|1|||
130187180|NCT02946463|468641683|FG002|Extension Period|Pregnancy|0|||
130187181|NCT02946463|468641684|FG003|Extension Period|Pregnancy|0|||
130187182|NCT02946463|468641681|FG000|Extension Period|Adverse Event|1|||
130187183|NCT02946463|468641682|FG001|Extension Period|Adverse Event|2|||
130187184|NCT02946463|468641683|FG002|Extension Period|Adverse Event|0|||
130187185|NCT02946463|468641684|FG003|Extension Period|Adverse Event|0|||
130187186|NCT02946463|468641681|FG000|Extension Period|Lost to Follow-up|1|||
130187187|NCT02946463|468641682|FG001|Extension Period|Lost to Follow-up|0|||
130187188|NCT02946463|468641683|FG002|Extension Period|Lost to Follow-up|0|||
130187189|NCT02946463|468641684|FG003|Extension Period|Lost to Follow-up|0|||
130187190|NCT05691712|468641687|FG000|Overall Study|Adverse Event|0|||
130187191|NCT05691712|468641688|FG001|Overall Study|Adverse Event|1|||
130187192|NCT05691712|468641689|FG002|Overall Study|Adverse Event|2|||
130187193|NCT05691712|468641690|FG003|Overall Study|Adverse Event|1|||
130187194|NCT05691712|468641687|FG000|Overall Study|Withdrawal by Subject|2|||
130187195|NCT05691712|468641688|FG001|Overall Study|Withdrawal by Subject|3|||
130187196|NCT05691712|468641689|FG002|Overall Study|Withdrawal by Subject|3|||
130187197|NCT05691712|468641690|FG003|Overall Study|Withdrawal by Subject|1|||
130187198|NCT05691712|468641687|FG000|Overall Study|Death|1|||
130187199|NCT05691712|468641688|FG001|Overall Study|Death|0|||
130187200|NCT05691712|468641689|FG002|Overall Study|Death|0|||
130187201|NCT05691712|468641690|FG003|Overall Study|Death|0|||
130187202|NCT05691712|468641687|FG000|Overall Study|Pregnancy|0|||
130187203|NCT05691712|468641688|FG001|Overall Study|Pregnancy|1|||
130187204|NCT05691712|468641689|FG002|Overall Study|Pregnancy|0|||
130187205|NCT05691712|468641690|FG003|Overall Study|Pregnancy|0|||
130187206|NCT05691712|468641687|FG000|Overall Study|Assigned Treatment by Mistake|1|||
130187207|NCT05691712|468641688|FG001|Overall Study|Assigned Treatment by Mistake|0|||
130187208|NCT05691712|468641689|FG002|Overall Study|Assigned Treatment by Mistake|0|||
130187209|NCT05691712|468641690|FG003|Overall Study|Assigned Treatment by Mistake|1|||
130187210|NCT02166333|468641693|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
130187211|NCT02166333|468641694|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130187212|NCT02166333|468641695|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130187213|NCT02166333|468641696|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
130187214|NCT02166333|468641697|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
130187215|NCT02166333|468641698|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
130187216|NCT02166333|468641693|FG000|Stage 1|Death|4|||
130187217|NCT02166333|468641694|FG001|Stage 1|Death|0|||
130187218|NCT02166333|468641695|FG002|Stage 1|Death|2|||
130187219|NCT02166333|468641696|FG003|Stage 1|Death|0|||
130187220|NCT02166333|468641697|FG004|Stage 1|Death|3|||
130187221|NCT02166333|468641698|FG005|Stage 1|Death|2|||
130187222|NCT02166333|468641693|FG000|Stage 1|Lost to Follow-up|12|||
130187223|NCT02166333|468641694|FG001|Stage 1|Lost to Follow-up|0|||
130187224|NCT02166333|468641695|FG002|Stage 1|Lost to Follow-up|6|||
130187225|NCT02166333|468641696|FG003|Stage 1|Lost to Follow-up|0|||
130187226|NCT02166333|468641697|FG004|Stage 1|Lost to Follow-up|3|||
130187227|NCT02166333|468641698|FG005|Stage 1|Lost to Follow-up|3|||
130187228|NCT02166333|468641693|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
130187229|NCT02166333|468641694|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
130187230|NCT02166333|468641695|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
130187231|NCT02166333|468641696|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
130187232|NCT02166333|468641697|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
130187233|NCT02166333|468641698|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
130187234|NCT02166333|468641693|FG000|Stage 2|Death|4|||
130187235|NCT02166333|468641694|FG001|Stage 2|Death|2|||
130187236|NCT02166333|468641695|FG002|Stage 2|Death|1|||
130187237|NCT02166333|468641696|FG003|Stage 2|Death|0|||
130187238|NCT02166333|468641697|FG004|Stage 2|Death|0|||
130187239|NCT02166333|468641698|FG005|Stage 2|Death|1|||
130187240|NCT02166333|468641693|FG000|Stage 2|Lost to Follow-up|23|||
130187241|NCT02166333|468641694|FG001|Stage 2|Lost to Follow-up|4|||
130187242|NCT02166333|468641695|FG002|Stage 2|Lost to Follow-up|11|||
130187243|NCT02166333|468641696|FG003|Stage 2|Lost to Follow-up|9|||
130187244|NCT02166333|468641697|FG004|Stage 2|Lost to Follow-up|3|||
130187245|NCT02166333|468641698|FG005|Stage 2|Lost to Follow-up|6|||
130187246|NCT00682786|468641700|FG000|Overall Study|Withdrawal by Subject|2|||
130187247|NCT00682786|468641701|FG001|Overall Study|Withdrawal by Subject|2|||
130187248|NCT00682786|468641700|FG000|Overall Study|Did not receive irinotecan|0|||
130187249|NCT00682786|468641701|FG001|Overall Study|Did not receive irinotecan|1|||
130187250|NCT00359424|468641702|FG000|Overall Study|Death|99|||
130187251|NCT00359424|468641703|FG001|Overall Study|Death|58|||
130187252|NCT00359424|468641702|FG000|Overall Study|Lost to Follow-up|19|||
130187253|NCT00359424|468641703|FG001|Overall Study|Lost to Follow-up|7|||
130187254|NCT00359424|468641702|FG000|Overall Study|Withdrawal by Subject|10|||
130187255|NCT00359424|468641703|FG001|Overall Study|Withdrawal by Subject|2|||
130187256|NCT00359424|468641702|FG000|Overall Study|follow up not conducted|2|||
130187257|NCT00359424|468641703|FG001|Overall Study|follow up not conducted|0|||
130187258|NCT01831635|468641704|FG000|Overall Study|Withdrawal by Subject|0|||
130187259|NCT01831635|468641705|FG001|Overall Study|Withdrawal by Subject|2|||
130187260|NCT01831635|468641706|FG002|Overall Study|Withdrawal by Subject|0|||
130187261|NCT03830333|468641709|FG000|Overall Study|Death|0|||
130187262|NCT03830333|468641710|FG001|Overall Study|Death|1|||
130187263|NCT03830333|468641709|FG000|Overall Study|Withdrawal by Subject|5|||
130187264|NCT03830333|468641710|FG001|Overall Study|Withdrawal by Subject|1|||
130187265|NCT03830333|468641709|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
130187266|NCT03830333|468641710|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
130187267|NCT03805412|468641711|FG000|Overall Study|Lost to Follow-up|0|||
130187268|NCT03805412|468641712|FG001|Overall Study|Lost to Follow-up|1|||
130187269|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
130187270|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
130187271|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
130187272|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
130187273|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
130187274|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
130187275|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
130187276|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130187277|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130187278|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
130187279|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
130187280|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
130187281|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
130187282|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
130187283|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
130187284|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
130187285|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
130187286|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
130187287|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
130187288|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
130187289|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
130187290|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
130187291|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
130187292|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
130187293|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
130187294|NCT03525678|468641727|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
130187295|NCT03525678|468641728|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
130187296|NCT03525678|468641729|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130187297|NCT03525678|468641730|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130187298|NCT03525678|468641731|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
130187299|NCT02747108|468641732|FG000|Overall Study|Death|2|||
130187300|NCT02747108|468641733|FG001|Overall Study|Death|2|||
130187301|NCT02747108|468641732|FG000|Overall Study|Withdrawal by Subject|1|||
130187302|NCT02747108|468641733|FG001|Overall Study|Withdrawal by Subject|0|||
130187303|NCT02747108|468641732|FG000|Overall Study|Protocol Violation|2|||
130187304|NCT02747108|468641733|FG001|Overall Study|Protocol Violation|0|||
130187305|NCT04563754|468642569|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
130187306|NCT04563754|468642570|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
130187307|NCT04563754|468642571|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
130187308|NCT04563754|468642569|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
130187309|NCT04563754|468642570|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
130187310|NCT04563754|468642571|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
130187311|NCT04563754|468642569|FG000|Follow up|Lost to Follow-up|61|||
130187312|NCT04563754|468642570|FG001|Follow up|Lost to Follow-up|23|||
130187313|NCT04563754|468642571|FG002|Follow up|Lost to Follow-up|5|||
130187314|NCT04563754|468642569|FG000|Follow up|Death|0|||
130187315|NCT04563754|468642570|FG001|Follow up|Death|2|||
130187316|NCT04563754|468642571|FG002|Follow up|Death|0|||
130187317|NCT04563754|468642569|FG000|Follow up|Ongoing|0|||
130187318|NCT04563754|468642570|FG001|Follow up|Ongoing|28|||
130187319|NCT04563754|468642571|FG002|Follow up|Ongoing|0|||
130187320|NCT04023396|468642572|FG000|Overall Study|Adverse Event|16|||
130187321|NCT04023396|468642572|FG000|Overall Study|Death|1|||
130187322|NCT04023396|468642572|FG000|Overall Study|Lost to Follow-up|1|||
130187323|NCT04023396|468642572|FG000|Overall Study|Withdrawal by Subject|14|||
130187324|NCT04023396|468642572|FG000|Overall Study|Pregnancy|4|||
130187325|NCT04023396|468642572|FG000|Overall Study|Lack of Efficacy|3|||
130187326|NCT04023396|468642572|FG000|Overall Study|Physician Decision|4|||
130187327|NCT04023396|468642572|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
130187328|NCT04075825|468642573|FG000|Overall Study|Withdrawal by Subject|6|||
130187329|NCT04075825|468642574|FG001|Overall Study|Withdrawal by Subject|8|||
130187330|NCT04075825|468642573|FG000|Overall Study|Physician Decision|3|||
130187331|NCT04075825|468642574|FG001|Overall Study|Physician Decision|1|||
130187332|NCT04075825|468642573|FG000|Overall Study|Lost to Follow-up|5|||
130187333|NCT04075825|468642574|FG001|Overall Study|Lost to Follow-up|1|||
130187334|NCT04075825|468642573|FG000|Overall Study|Participation in New Clinical Trial|1|||
130187335|NCT04075825|468642574|FG001|Overall Study|Participation in New Clinical Trial|1|||
130187336|NCT04075825|468642573|FG000|Overall Study|Reason Not Specified|2|||
130187337|NCT04075825|468642574|FG001|Overall Study|Reason Not Specified|2|||
130187338|NCT04225715|468642575|FG000|Overall Study|Reason not Specified|1|||
130187339|NCT04225715|468642576|FG001|Overall Study|Reason not Specified|0|||
130187340|NCT04225715|468642577|FG002|Overall Study|Reason not Specified|0|||
130187341|NCT04225715|468642578|FG003|Overall Study|Reason not Specified|0|||
130187342|NCT04225715|468642579|FG004|Overall Study|Reason not Specified|0|||
130187343|NCT04225715|468642580|FG005|Overall Study|Reason not Specified|0|||
130187344|NCT04225715|468642581|FG006|Overall Study|Reason not Specified|0|||
130187345|NCT04225715|468642582|FG007|Overall Study|Reason not Specified|0|||
130187346|NCT04225715|468642583|FG008|Overall Study|Reason not Specified|0|||
130187347|NCT04225715|468642575|FG000|Overall Study|Protocol Violation|1|||
130187348|NCT04225715|468642576|FG001|Overall Study|Protocol Violation|0|||
130187349|NCT04225715|468642577|FG002|Overall Study|Protocol Violation|0|||
130187350|NCT04225715|468642578|FG003|Overall Study|Protocol Violation|0|||
130187351|NCT04225715|468642579|FG004|Overall Study|Protocol Violation|0|||
130187352|NCT04225715|468642580|FG005|Overall Study|Protocol Violation|9|||
130187353|NCT04225715|468642581|FG006|Overall Study|Protocol Violation|0|||
130187354|NCT04225715|468642582|FG007|Overall Study|Protocol Violation|0|||
130187355|NCT04225715|468642583|FG008|Overall Study|Protocol Violation|0|||
130187356|NCT04225715|468642575|FG000|Overall Study|Withdrawal by Subject|4|||
130187357|NCT04225715|468642576|FG001|Overall Study|Withdrawal by Subject|1|||
130187358|NCT04225715|468642577|FG002|Overall Study|Withdrawal by Subject|1|||
130187359|NCT04225715|468642578|FG003|Overall Study|Withdrawal by Subject|0|||
130187360|NCT04225715|468642579|FG004|Overall Study|Withdrawal by Subject|3|||
130187361|NCT04225715|468642580|FG005|Overall Study|Withdrawal by Subject|1|||
130187362|NCT04225715|468642581|FG006|Overall Study|Withdrawal by Subject|1|||
130187363|NCT04225715|468642582|FG007|Overall Study|Withdrawal by Subject|1|||
130187364|NCT04225715|468642583|FG008|Overall Study|Withdrawal by Subject|0|||
130187365|NCT04225715|468642575|FG000|Overall Study|Adverse Event|0|||
130187366|NCT04225715|468642576|FG001|Overall Study|Adverse Event|0|||
130187367|NCT04225715|468642577|FG002|Overall Study|Adverse Event|0|||
130187368|NCT04225715|468642578|FG003|Overall Study|Adverse Event|0|||
130187369|NCT04225715|468642579|FG004|Overall Study|Adverse Event|0|||
130187370|NCT04225715|468642580|FG005|Overall Study|Adverse Event|0|||
130187371|NCT04225715|468642581|FG006|Overall Study|Adverse Event|0|||
130187372|NCT04225715|468642582|FG007|Overall Study|Adverse Event|0|||
130187373|NCT04225715|468642583|FG008|Overall Study|Adverse Event|1|||
130187374|NCT04225715|468642575|FG000|Overall Study|Arm Terminated By Sponsor|0|||
130187375|NCT04225715|468642576|FG001|Overall Study|Arm Terminated By Sponsor|0|||
130187376|NCT04225715|468642577|FG002|Overall Study|Arm Terminated By Sponsor|0|||
130187377|NCT04225715|468642578|FG003|Overall Study|Arm Terminated By Sponsor|0|||
130187378|NCT04225715|468642579|FG004|Overall Study|Arm Terminated By Sponsor|0|||
130187379|NCT04225715|468642580|FG005|Overall Study|Arm Terminated By Sponsor|0|||
130187380|NCT04225715|468642581|FG006|Overall Study|Arm Terminated By Sponsor|0|||
130187381|NCT04225715|468642582|FG007|Overall Study|Arm Terminated By Sponsor|17|||
130187382|NCT04225715|468642583|FG008|Overall Study|Arm Terminated By Sponsor|18|||
130187383|NCT03318861|468642591|FG000|Overall Study|Death|2|||
130187384|NCT03318861|468642592|FG001|Overall Study|Death|3|||
130187385|NCT03318861|468642593|FG002|Overall Study|Death|3|||
130187386|NCT03318861|468642594|FG003|Overall Study|Death|2|||
130187387|NCT03318861|468642595|FG004|Overall Study|Death|2|||
130187388|NCT03318861|468642591|FG000|Overall Study|Enrolled But Never Treated|0|||
130187389|NCT03318861|468642592|FG001|Overall Study|Enrolled But Never Treated|1|||
130187390|NCT03318861|468642593|FG002|Overall Study|Enrolled But Never Treated|0|||
130187391|NCT03318861|468642594|FG003|Overall Study|Enrolled But Never Treated|1|||
130187392|NCT03318861|468642595|FG004|Overall Study|Enrolled But Never Treated|1|||
130187393|NCT03318861|468642591|FG000|Overall Study|Informed Consent Withdraw|0|||
130187394|NCT03318861|468642592|FG001|Overall Study|Informed Consent Withdraw|0|||
130187395|NCT03318861|468642593|FG002|Overall Study|Informed Consent Withdraw|0|||
130187396|NCT03318861|468642594|FG003|Overall Study|Informed Consent Withdraw|1|||
130187397|NCT03318861|468642595|FG004|Overall Study|Informed Consent Withdraw|0|||
130187398|NCT03318861|468642591|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
130187399|NCT03318861|468642592|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187400|NCT03318861|468642593|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187401|NCT03318861|468642594|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187402|NCT03318861|468642595|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
130187403|NCT00917852|468642596|FG000|Overall Study|Death|6|||
130187404|NCT02844933|468642597|FG000|Overall Study|Discontinued due to premature termination of study|3|||
130187405|NCT02844933|468642598|FG001|Overall Study|Discontinued due to premature termination of study|2|||
130187406|NCT04537078|468642599|FG000|Overall Study|Protocol Violation|3|||
130187407|NCT04537078|468642600|FG001|Overall Study|Protocol Violation|2|||
130187408|NCT04537078|468642599|FG000|Overall Study|Lost to Follow-up|1|||
130187409|NCT04537078|468642600|FG001|Overall Study|Lost to Follow-up|0|||
130187410|NCT04537078|468642599|FG000|Overall Study|Withdrawal by Subject|0|||
130187411|NCT04537078|468642600|FG001|Overall Study|Withdrawal by Subject|1|||
130187412|NCT01568892|468642602|FG000|Open-label Phase|Adverse Event|2|||
130187413|NCT01568892|468642603|FG001|Open-label Phase|Adverse Event|0|||
130187414|NCT01568892|468642602|FG000|Open-label Phase|Lack of Efficacy|4|||
130187415|NCT01568892|468642603|FG001|Open-label Phase|Lack of Efficacy|2|||
130187416|NCT01568892|468642602|FG000|Open-label Phase|Lost to Follow-up|0|||
130187417|NCT01568892|468642603|FG001|Open-label Phase|Lost to Follow-up|1|||
130187418|NCT01256450|468642606|FG000|Open-label Titration|Adverse Event|39|||
130187419|NCT01256450|468642607|FG001|Open-label Titration|Adverse Event|0|||
130187420|NCT01256450|468642608|FG002|Open-label Titration|Adverse Event|0|||
130187421|NCT01256450|468642606|FG000|Open-label Titration|Lost to Follow-up|7|||
130187422|NCT01256450|468642607|FG001|Open-label Titration|Lost to Follow-up|0|||
130187423|NCT01256450|468642608|FG002|Open-label Titration|Lost to Follow-up|0|||
130187424|NCT01256450|468642606|FG000|Open-label Titration|Lack of analgesic effect|30|||
130187425|NCT01256450|468642607|FG001|Open-label Titration|Lack of analgesic effect|0|||
130187426|NCT01256450|468642608|FG002|Open-label Titration|Lack of analgesic effect|0|||
130187427|NCT01256450|468642606|FG000|Open-label Titration|Non-compliance|9|||
130187428|NCT01256450|468642607|FG001|Open-label Titration|Non-compliance|0|||
130187429|NCT01256450|468642608|FG002|Open-label Titration|Non-compliance|0|||
130187430|NCT01256450|468642606|FG000|Open-label Titration|Screen failure|1|||
130187431|NCT01256450|468642607|FG001|Open-label Titration|Screen failure|0|||
130187432|NCT01256450|468642608|FG002|Open-label Titration|Screen failure|0|||
130187433|NCT01256450|468642606|FG000|Open-label Titration|Other|13|||
130187434|NCT01256450|468642607|FG001|Open-label Titration|Other|0|||
130187435|NCT01256450|468642608|FG002|Open-label Titration|Other|0|||
130187436|NCT01256450|468642606|FG000|Double-blind Treatment|Adverse Event|0|||
130187437|NCT01256450|468642607|FG001|Double-blind Treatment|Adverse Event|8|||
130187438|NCT01256450|468642608|FG002|Double-blind Treatment|Adverse Event|6|||
130187439|NCT01256450|468642606|FG000|Double-blind Treatment|Lost to Follow-up|0|||
130187440|NCT01256450|468642607|FG001|Double-blind Treatment|Lost to Follow-up|1|||
130187441|NCT01256450|468642608|FG002|Double-blind Treatment|Lost to Follow-up|7|||
130187442|NCT01256450|468642606|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
130187443|NCT01256450|468642607|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
130187444|NCT01256450|468642608|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
130187445|NCT01256450|468642606|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
130187446|NCT01256450|468642607|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
130187447|NCT01256450|468642608|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
130187448|NCT01256450|468642606|FG000|Double-blind Treatment|Non-compliance|0|||
130187449|NCT01256450|468642607|FG001|Double-blind Treatment|Non-compliance|5|||
130187450|NCT01256450|468642608|FG002|Double-blind Treatment|Non-compliance|4|||
130187451|NCT01256450|468642606|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
130187452|NCT01256450|468642607|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
130187453|NCT01256450|468642608|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
130187454|NCT01256450|468642606|FG000|Double-blind Treatment|Other|0|||
130187455|NCT01256450|468642607|FG001|Double-blind Treatment|Other|9|||
130187456|NCT01256450|468642608|FG002|Double-blind Treatment|Other|12|||
130187457|NCT03889418|468642616|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
130187458|NCT03889418|468642617|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187459|NCT03889418|468642618|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187460|NCT03889418|468642619|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187461|NCT03889418|468642620|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187462|NCT03889418|468642621|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187463|NCT03889418|468642622|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187464|NCT03889418|468642623|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187465|NCT03889418|468642624|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187466|NCT03889418|468642625|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
130187467|NCT03889418|468642616|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187468|NCT03889418|468642617|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
130187469|NCT03889418|468642618|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
130187470|NCT03889418|468642619|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187471|NCT03889418|468642620|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187472|NCT03889418|468642621|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187473|NCT03889418|468642622|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187474|NCT03889418|468642623|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187475|NCT03889418|468642624|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187476|NCT03889418|468642625|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
130187477|NCT03889418|468642616|FG000|October-December 2019 (Month 7-9)|Death|0|||
130187478|NCT03889418|468642617|FG001|October-December 2019 (Month 7-9)|Death|0|||
130187479|NCT03889418|468642618|FG002|October-December 2019 (Month 7-9)|Death|0|||
130187480|NCT03889418|468642619|FG003|October-December 2019 (Month 7-9)|Death|0|||
130187481|NCT03889418|468642620|FG004|October-December 2019 (Month 7-9)|Death|0|||
130187482|NCT03889418|468642621|FG005|October-December 2019 (Month 7-9)|Death|0|||
130187483|NCT03889418|468642622|FG006|October-December 2019 (Month 7-9)|Death|0|||
130187484|NCT03889418|468642623|FG007|October-December 2019 (Month 7-9)|Death|0|||
130187485|NCT03889418|468642624|FG008|October-December 2019 (Month 7-9)|Death|1|||
130187486|NCT03889418|468642625|FG009|October-December 2019 (Month 7-9)|Death|0|||
130187487|NCT03889418|468642616|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187488|NCT03889418|468642617|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187489|NCT03889418|468642618|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187490|NCT03889418|468642619|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
130187491|NCT03889418|468642620|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187492|NCT03889418|468642621|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187493|NCT03889418|468642622|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187494|NCT03889418|468642623|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
130187495|NCT03889418|468642624|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187496|NCT03889418|468642625|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
130187497|NCT03889418|468642616|FG000|April - June 2020 (Month 13-15)|Death|0|||
130187498|NCT03889418|468642617|FG001|April - June 2020 (Month 13-15)|Death|1|||
130187499|NCT03889418|468642618|FG002|April - June 2020 (Month 13-15)|Death|0|||
130187500|NCT03889418|468642619|FG003|April - June 2020 (Month 13-15)|Death|0|||
130187501|NCT03889418|468642620|FG004|April - June 2020 (Month 13-15)|Death|0|||
130187502|NCT03889418|468642621|FG005|April - June 2020 (Month 13-15)|Death|0|||
130187503|NCT03889418|468642622|FG006|April - June 2020 (Month 13-15)|Death|0|||
130187504|NCT03889418|468642623|FG007|April - June 2020 (Month 13-15)|Death|0|||
130187505|NCT03889418|468642624|FG008|April - June 2020 (Month 13-15)|Death|0|||
130187506|NCT03889418|468642625|FG009|April - June 2020 (Month 13-15)|Death|0|||
130187507|NCT03889418|468642616|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187508|NCT03889418|468642617|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187509|NCT03889418|468642618|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187510|NCT03889418|468642619|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
130187511|NCT03889418|468642620|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187512|NCT03889418|468642621|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187513|NCT03889418|468642622|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187514|NCT03889418|468642623|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187515|NCT03889418|468642624|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187516|NCT03889418|468642625|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
130187517|NCT03889418|468642616|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
130187518|NCT03889418|468642617|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187519|NCT03889418|468642618|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
130187520|NCT03889418|468642619|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
130187521|NCT03889418|468642620|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187522|NCT03889418|468642621|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187523|NCT03889418|468642622|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187524|NCT03889418|468642623|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
130187525|NCT03889418|468642624|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187526|NCT03889418|468642625|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
130187527|NCT03889418|468642616|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187528|NCT03889418|468642617|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
130187529|NCT03889418|468642618|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
130187530|NCT03889418|468642619|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
130187531|NCT03889418|468642620|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187532|NCT03889418|468642621|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187533|NCT03889418|468642622|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187534|NCT03889418|468642623|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
130187535|NCT03889418|468642624|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
130187536|NCT03889418|468642625|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
130187537|NCT01909934|468642632|FG000|Overall Study|Withdrawal by Subject|3|||
130187538|NCT01909934|468642632|FG000|Overall Study|Lost to Follow-up|1|||
130187539|NCT01909934|468642632|FG000|Overall Study|Death|25|||
130187540|NCT01909934|468642632|FG000|Overall Study|Withdrawal of Informed Consent|1|||
130187541|NCT01909934|468642632|FG000|Overall Study|Reason Not Specified|1|||
130187542|NCT03810092|468642633|FG000|Overall Study|no ground support|17|||
130187543|NCT03810092|468642633|FG000|Overall Study|ADL not done at J0|16|||
130187544|NCT03810092|468642633|FG000|Overall Study|No hemoglobin measure at J5|27|||
130187545|NCT01139775|468642639|FG000|Overall Study|Adverse Event|0|||
130187546|NCT01139775|468642640|FG001|Overall Study|Adverse Event|6|||
130187547|NCT01139775|468642641|FG002|Overall Study|Adverse Event|2|||
130187548|NCT01139775|468642639|FG000|Overall Study|Protocol Violation|0|||
130187549|NCT01139775|468642640|FG001|Overall Study|Protocol Violation|5|||
130187550|NCT01139775|468642641|FG002|Overall Study|Protocol Violation|0|||
130187551|NCT01139775|468642639|FG000|Overall Study|Withdrawal by Subject|1|||
130187552|NCT01139775|468642640|FG001|Overall Study|Withdrawal by Subject|0|||
130187553|NCT01139775|468642641|FG002|Overall Study|Withdrawal by Subject|2|||
130187554|NCT01139775|468642639|FG000|Overall Study|Physician Decision|0|||
130187555|NCT01139775|468642640|FG001|Overall Study|Physician Decision|2|||
130187556|NCT01139775|468642641|FG002|Overall Study|Physician Decision|2|||
130187557|NCT01753310|468642644|FG000|Overall Study|Entered into open label extension study|25|||
130187558|NCT01753310|468642645|FG001|Overall Study|Entered into open label extension study|22|||
130187559|NCT01753310|468642644|FG000|Overall Study|Adverse Event|1|||
130187560|NCT01753310|468642645|FG001|Overall Study|Adverse Event|0|||
130187561|NCT01753310|468642644|FG000|Overall Study|Lost to Follow-up|2|||
130187562|NCT01753310|468642645|FG001|Overall Study|Lost to Follow-up|0|||
130187563|NCT01753310|468642644|FG000|Overall Study|Subject decision|2|||
130187564|NCT01753310|468642645|FG001|Overall Study|Subject decision|2|||
130187565|NCT01753310|468642644|FG000|Overall Study|Sponsor decision|1|||
130187566|NCT01753310|468642645|FG001|Overall Study|Sponsor decision|0|||
130187567|NCT01753310|468642644|FG000|Overall Study|Withdrawal by Subject|1|||
130187568|NCT01753310|468642645|FG001|Overall Study|Withdrawal by Subject|0|||
130187569|NCT03193853|468642646|FG000|Overall Study|Death|6|||
130187570|NCT02022202|468642647|FG000|Overall Study|Withdrawal by Subject|2|||
130187571|NCT02022202|468642647|FG000|Overall Study|Disease Progression|3|||
130187572|NCT02022202|468642647|FG000|Overall Study|Desire go to immediately to surgery|3|||
130187573|NCT05581641|468642651|FG000|Overall Study|Withdrawal by Subject|0|||
130187574|NCT05581641|468642652|FG001|Overall Study|Withdrawal by Subject|1|||
130187575|NCT05581641|468642653|FG002|Overall Study|Withdrawal by Subject|3|||
130187576|NCT05581641|468642654|FG003|Overall Study|Withdrawal by Subject|1|||
130187577|NCT05581641|468642651|FG000|Overall Study|Lost to Follow-up|0|||
130187578|NCT05581641|468642652|FG001|Overall Study|Lost to Follow-up|1|||
130187579|NCT05581641|468642653|FG002|Overall Study|Lost to Follow-up|0|||
130187580|NCT05581641|468642654|FG003|Overall Study|Lost to Follow-up|1|||
130187581|NCT05581641|468642651|FG000|Overall Study|Protocol Violation|1|||
130187582|NCT05581641|468642652|FG001|Overall Study|Protocol Violation|0|||
130187583|NCT05581641|468642653|FG002|Overall Study|Protocol Violation|0|||
130187584|NCT05581641|468642654|FG003|Overall Study|Protocol Violation|0|||
130187585|NCT05581641|468642651|FG000|Overall Study|Other|1|||
130187586|NCT05581641|468642652|FG001|Overall Study|Other|0|||
130187587|NCT05581641|468642653|FG002|Overall Study|Other|2|||
130187588|NCT05581641|468642654|FG003|Overall Study|Other|1|||
130187589|NCT00503698|468642661|FG000|Overall Study|Protocol Violation|5|||
130187590|NCT00503698|468642662|FG001|Overall Study|Protocol Violation|6|||
130187591|NCT00503698|468642661|FG000|Overall Study|Adverse Event|52|||
130187592|NCT00503698|468642662|FG001|Overall Study|Adverse Event|41|||
130187593|NCT00503698|468642661|FG000|Overall Study|Death|1|||
130187594|NCT00503698|468642662|FG001|Overall Study|Death|0|||
130187595|NCT00503698|468642661|FG000|Overall Study|Lack of Efficacy|3|||
130187596|NCT00503698|468642662|FG001|Overall Study|Lack of Efficacy|4|||
130187597|NCT00503698|468642661|FG000|Overall Study|Trial terminated|216|||
130187598|NCT00503698|468642662|FG001|Overall Study|Trial terminated|253|||
130187599|NCT00503698|468642661|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
130187600|NCT00503698|468642662|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
130187601|NCT00503698|468642661|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
130187602|NCT00503698|468642662|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
130187603|NCT00503698|468642661|FG000|Overall Study|Any condition in exclusion criteria|4|||
130187604|NCT00503698|468642662|FG001|Overall Study|Any condition in exclusion criteria|6|||
130187605|NCT00503698|468642661|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
130187606|NCT00503698|468642662|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
130187607|NCT00503698|468642661|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
130187608|NCT00503698|468642662|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
130187609|NCT00503698|468642661|FG000|Overall Study|Critically ill|2|||
130187610|NCT00503698|468642662|FG001|Overall Study|Critically ill|0|||
130187611|NCT00503698|468642661|FG000|Overall Study|Unclassified|48|||
130187612|NCT00503698|468642662|FG001|Overall Study|Unclassified|32|||
130187613|NCT00503698|468642661|FG000|Overall Study|Not exposed to trial drug|11|||
130187614|NCT00503698|468642662|FG001|Overall Study|Not exposed to trial drug|6|||
130187615|NCT02462603|468642670|FG000|Overall Study|Investigator Decision|1|||
130187616|NCT02462603|468642670|FG000|Overall Study|Non-Compliance|1|||
130187617|NCT02462603|468642670|FG000|Overall Study|Withdrawal by Subject|2|||
130187618|NCT01591096|468642672|FG000|Overall Study|Adverse Event|1|||
130187619|NCT01445730|468642673|FG000|Overall Study|Adverse Event|1|||
130187620|NCT01445730|468642673|FG000|Overall Study|For the advice of a dentist|1|||
130187621|NCT01445730|468642673|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
130187622|NCT00734994|468642674|FG000|Overall Study|Withdrawal by Subject|1|||
130187623|NCT01546025|468642675|FG000|Overall Study|Lost to Follow-up|0|||
130187624|NCT01546025|468642676|FG001|Overall Study|Lost to Follow-up|1|||
130187625|NCT05514873|468642677|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
130187626|NCT05514873|468642677|FG000|Main Treatment Period|Adverse Event|2|||
130187627|NCT05514873|468642677|FG000|Extension Treatment Period|Lost to Follow-up|3|||
130187628|NCT05177484|468643890|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
130187629|NCT05177484|468643891|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
130187630|NCT05177484|468643890|FG000|Overall Study|Inadvertently withdrawn|3|||
130187631|NCT05177484|468643891|FG001|Overall Study|Inadvertently withdrawn|1|||
130187632|NCT05177484|468643890|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
130187633|NCT05177484|468643891|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
130187634|NCT02393950|468643896|FG000|Overall Study|Adverse Event|1|||
130187635|NCT02393950|468643897|FG001|Overall Study|Adverse Event|0|||
130187636|NCT02393950|468643896|FG000|Overall Study|Withdrawal by Subject|0|||
130187637|NCT02393950|468643897|FG001|Overall Study|Withdrawal by Subject|1|||
130187638|NCT05486091|468643898|FG000|Overall Study|Withdrawal by Subject|1|||
130187639|NCT05486091|468643898|FG000|Overall Study|Lost to Follow-up|2|||
130187640|NCT03971071|468643899|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187641|NCT03971071|468643900|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
130187642|NCT03971071|468643901|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187643|NCT03971071|468643902|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187644|NCT03971071|468643903|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
130187645|NCT03971071|468643899|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
130187646|NCT03971071|468643900|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
130187647|NCT03971071|468643901|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
130187648|NCT03971071|468643902|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130187649|NCT03971071|468643903|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
130187650|NCT03971071|468643899|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
130187651|NCT03971071|468643900|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
130187652|NCT03971071|468643901|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
130187653|NCT03971071|468643902|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
130187654|NCT03971071|468643903|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
130187655|NCT03971071|468643899|FG000|Open-label Treatment Period|Sponsor decision|0|||
130187656|NCT03971071|468643900|FG001|Open-label Treatment Period|Sponsor decision|0|||
130187657|NCT03971071|468643901|FG002|Open-label Treatment Period|Sponsor decision|0|||
130187658|NCT03971071|468643902|FG003|Open-label Treatment Period|Sponsor decision|0|||
130187659|NCT03971071|468643903|FG004|Open-label Treatment Period|Sponsor decision|1|||
130187660|NCT03971071|468643899|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
130187661|NCT03971071|468643900|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
130187662|NCT03971071|468643901|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
130187663|NCT03971071|468643902|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
130187664|NCT03971071|468643903|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
130187665|NCT03971071|468643899|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
130187666|NCT03971071|468643900|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
130187667|NCT03971071|468643901|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
130187668|NCT03971071|468643902|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
130187669|NCT03971071|468643903|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
130187670|NCT01697748|468643904|FG000|Overall Study|ineligible skin incision|1|||
130187671|NCT01697748|468643905|FG001|Overall Study|ineligible skin incision|2|||
130187672|NCT01697748|468643904|FG000|Overall Study|ineligible uterine incision|4|||
130187673|NCT01697748|468643905|FG001|Overall Study|ineligible uterine incision|1|||
130187674|NCT01697748|468643904|FG000|Overall Study|Lost to Follow-up|53|||
130187675|NCT01697748|468643905|FG001|Overall Study|Lost to Follow-up|65|||
130187676|NCT01704495|468643909|FG000|Subjects Randomized|Other Reason|3|||
130187677|NCT01704495|468643910|FG001|Subjects Randomized|Other Reason|2|||
130187678|NCT01704495|468643911|FG002|Subjects Randomized|Other Reason|3|||
130187679|NCT01704495|468643912|FG003|Subjects Randomized|Other Reason|2|||
130187680|NCT01704495|468643909|FG000|Subjects Randomized|Discontinuation criteria met|4|||
130187681|NCT01704495|468643910|FG001|Subjects Randomized|Discontinuation criteria met|2|||
130187682|NCT01704495|468643911|FG002|Subjects Randomized|Discontinuation criteria met|2|||
130187683|NCT01704495|468643912|FG003|Subjects Randomized|Discontinuation criteria met|0|||
130187684|NCT01704495|468643909|FG000|Subjects Randomized|Adverse Event|8|||
130187685|NCT01704495|468643910|FG001|Subjects Randomized|Adverse Event|2|||
130187686|NCT01704495|468643911|FG002|Subjects Randomized|Adverse Event|0|||
130187687|NCT01704495|468643912|FG003|Subjects Randomized|Adverse Event|7|||
130187688|NCT01704495|468643909|FG000|Subjects Randomized|Withdrawal by Subject|5|||
130187689|NCT01704495|468643910|FG001|Subjects Randomized|Withdrawal by Subject|5|||
130187690|NCT01704495|468643911|FG002|Subjects Randomized|Withdrawal by Subject|5|||
130187691|NCT01704495|468643912|FG003|Subjects Randomized|Withdrawal by Subject|5|||
130187692|NCT01704495|468643909|FG000|Subjects Randomized|Protocol Violation|1|||
130187693|NCT01704495|468643910|FG001|Subjects Randomized|Protocol Violation|1|||
130187694|NCT01704495|468643911|FG002|Subjects Randomized|Protocol Violation|2|||
130187695|NCT01704495|468643912|FG003|Subjects Randomized|Protocol Violation|0|||
130187696|NCT01704495|468643909|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
130187697|NCT01704495|468643910|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
130187698|NCT01704495|468643911|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
130187699|NCT01704495|468643912|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
130187700|NCT01704495|468643909|FG000|Optional Safety Extension|Adverse Event|0|||
130187701|NCT01704495|468643910|FG001|Optional Safety Extension|Adverse Event|4|||
130187702|NCT01704495|468643911|FG002|Optional Safety Extension|Adverse Event|0|||
130187703|NCT01704495|468643912|FG003|Optional Safety Extension|Adverse Event|1|||
130187704|NCT01704495|468643909|FG000|Optional Safety Extension|Other reason|27|||
130187705|NCT01704495|468643910|FG001|Optional Safety Extension|Other reason|29|||
130187706|NCT01704495|468643911|FG002|Optional Safety Extension|Other reason|30|||
130187707|NCT01704495|468643912|FG003|Optional Safety Extension|Other reason|28|||
130187708|NCT01704495|468643909|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
130187709|NCT01704495|468643910|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
130187710|NCT01704495|468643911|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
130187711|NCT01704495|468643912|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
130187712|NCT03866512|468643913|FG000|Overall Study|Lost to Follow-up|1|||
130187713|NCT03866512|468643914|FG001|Overall Study|Lost to Follow-up|2|||
130187714|NCT03866512|468643915|FG002|Overall Study|Lost to Follow-up|1|||
130187715|NCT03866512|468643913|FG000|Overall Study|Cannulation issues|0|||
130187716|NCT03866512|468643914|FG001|Overall Study|Cannulation issues|1|||
130187717|NCT03866512|468643915|FG002|Overall Study|Cannulation issues|2|||
130187718|NCT00997373|468643920|FG000|Overall Study|Withdrawal by Subject|5|||
130187719|NCT00997373|468643921|FG001|Overall Study|Withdrawal by Subject|0|||
130187720|NCT00997373|468643920|FG000|Overall Study|wrong tumor type|4|||
130187721|NCT00997373|468643921|FG001|Overall Study|wrong tumor type|0|||
130187722|NCT00997373|468643920|FG000|Overall Study|could not have hysterectomy|6|||
130187723|NCT00997373|468643921|FG001|Overall Study|could not have hysterectomy|0|||
130187724|NCT03210714|468643927|FG000|Overall Study|Adverse Event|6|||
130187725|NCT03210714|468643927|FG000|Overall Study|Physician Decision|1|||
130187726|NCT03210714|468643927|FG000|Overall Study|Progressive disease|11|||
130187727|NCT03210714|468643927|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
130187728|NCT01956773|468643928|FG000|Overall Study|Lost to Follow-up|628|||
130187729|NCT01956773|468643929|FG001|Overall Study|Lost to Follow-up|1|||
130187730|NCT00450437|468643930|FG000|Overall Study|Withdrawal by Subject|10|||
130187731|NCT00450437|468643931|FG001|Overall Study|Withdrawal by Subject|2|||
130187732|NCT00450437|468643932|FG002|Overall Study|Withdrawal by Subject|0|||
130187733|NCT00450437|468643933|FG003|Overall Study|Withdrawal by Subject|1|||
130187734|NCT00450437|468643930|FG000|Overall Study|Lost to Follow-up|31|||
130187735|NCT00450437|468643931|FG001|Overall Study|Lost to Follow-up|12|||
130187736|NCT00450437|468643932|FG002|Overall Study|Lost to Follow-up|19|||
130187737|NCT00450437|468643933|FG003|Overall Study|Lost to Follow-up|9|||
130187738|NCT00450437|468643930|FG000|Overall Study|Protocol Violation|0|||
130187739|NCT00450437|468643931|FG001|Overall Study|Protocol Violation|1|||
130187740|NCT00450437|468643932|FG002|Overall Study|Protocol Violation|0|||
130187741|NCT00450437|468643933|FG003|Overall Study|Protocol Violation|1|||
130187742|NCT00450437|468643930|FG000|Overall Study|Inappropriate enrollment|4|||
130187743|NCT00450437|468643931|FG001|Overall Study|Inappropriate enrollment|1|||
130187744|NCT00450437|468643932|FG002|Overall Study|Inappropriate enrollment|3|||
130187745|NCT00450437|468643933|FG003|Overall Study|Inappropriate enrollment|0|||
130187746|NCT00450437|468643930|FG000|Overall Study|Administrative reason|0|||
130187747|NCT00450437|468643931|FG001|Overall Study|Administrative reason|0|||
130187748|NCT00450437|468643932|FG002|Overall Study|Administrative reason|1|||
130187749|NCT00450437|468643933|FG003|Overall Study|Administrative reason|0|||
130187750|NCT00450437|468643930|FG000|Overall Study|Unable to Classify|1|||
130187751|NCT00450437|468643931|FG001|Overall Study|Unable to Classify|0|||
130187752|NCT00450437|468643932|FG002|Overall Study|Unable to Classify|1|||
130187753|NCT00450437|468643933|FG003|Overall Study|Unable to Classify|0|||
130187754|NCT02492867|468643934|FG000|Overall Study|Alternate therapy|1|||
130187755|NCT02492867|468643934|FG000|Overall Study|Withdrawal by Subject|2|||
130187756|NCT02492867|468643934|FG000|Overall Study|Disease progression after treatment started|1|||
130187757|NCT02492867|468643934|FG000|Overall Study|Death|1|||
130187758|NCT03296527|468643935|FG000|Overall Study|Adverse Event|15|||
130187759|NCT03296527|468643936|FG001|Overall Study|Adverse Event|33|||
130187760|NCT03296527|468643935|FG000|Overall Study|Protocol Deviation|4|||
130187761|NCT03296527|468643936|FG001|Overall Study|Protocol Deviation|0|||
130187762|NCT03296527|468643935|FG000|Overall Study|Participant withdrew consent|3|||
130187763|NCT03296527|468643936|FG001|Overall Study|Participant withdrew consent|1|||
130187764|NCT03296527|468643935|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
130187765|NCT03296527|468643936|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
130187766|NCT03296527|468643935|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
130187767|NCT03296527|468643936|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
130187768|NCT03296527|468643935|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
130187769|NCT03296527|468643936|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
130187770|NCT03296527|468643935|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
130187771|NCT03296527|468643936|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
130187772|NCT03296527|468643935|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
130187773|NCT03296527|468643936|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
130187774|NCT00122382|468643937|FG000|Double-Blind Study|Adverse Event|9|||
130187775|NCT00122382|468643938|FG001|Double-Blind Study|Adverse Event|11|||
130187776|NCT00122382|468643939|FG002|Double-Blind Study|Adverse Event|0|||
130187777|NCT00122382|468643937|FG000|Double-Blind Study|Death|2|||
130187778|NCT00122382|468643938|FG001|Double-Blind Study|Death|2|||
130187779|NCT00122382|468643939|FG002|Double-Blind Study|Death|0|||
130187780|NCT00122382|468643937|FG000|Double-Blind Study|Lack of Efficacy|0|||
130187781|NCT00122382|468643938|FG001|Double-Blind Study|Lack of Efficacy|8|||
130187782|NCT00122382|468643939|FG002|Double-Blind Study|Lack of Efficacy|0|||
130187783|NCT00122382|468643937|FG000|Double-Blind Study|Lost to Follow-up|2|||
130187784|NCT00122382|468643938|FG001|Double-Blind Study|Lost to Follow-up|1|||
130187785|NCT00122382|468643939|FG002|Double-Blind Study|Lost to Follow-up|0|||
130187786|NCT00122382|468643937|FG000|Double-Blind Study|Pregnancy|2|||
130187787|NCT00122382|468643938|FG001|Double-Blind Study|Pregnancy|0|||
130187788|NCT00122382|468643939|FG002|Double-Blind Study|Pregnancy|0|||
130187789|NCT00122382|468643937|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
130187790|NCT00122382|468643938|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
130187791|NCT00122382|468643939|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
130187792|NCT00122382|468643937|FG000|Double-Blind Study|Withdrawal of Consent|7|||
130187793|NCT00122382|468643938|FG001|Double-Blind Study|Withdrawal of Consent|3|||
130187794|NCT00122382|468643939|FG002|Double-Blind Study|Withdrawal of Consent|0|||
130187795|NCT00122382|468643937|FG000|Double-Blind Study|Protocol Violation|1|||
130187796|NCT00122382|468643938|FG001|Double-Blind Study|Protocol Violation|0|||
130187797|NCT00122382|468643939|FG002|Double-Blind Study|Protocol Violation|0|||
130187798|NCT00122382|468643937|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
130187799|NCT00122382|468643938|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
130187800|NCT00122382|468643939|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
130187801|NCT00122382|468643937|FG000|Double-Blind Study|Randomized but not treated|0|||
130187802|NCT00122382|468643938|FG001|Double-Blind Study|Randomized but not treated|2|||
130187803|NCT00122382|468643939|FG002|Double-Blind Study|Randomized but not treated|0|||
130187804|NCT00122382|468643937|FG000|Open-Label Study|Adverse Event|0|||
130187805|NCT00122382|468643938|FG001|Open-Label Study|Adverse Event|0|||
130187806|NCT00122382|468643939|FG002|Open-Label Study|Adverse Event|11|||
130187807|NCT00122382|468643937|FG000|Open-Label Study|Death|0|||
130187808|NCT00122382|468643938|FG001|Open-Label Study|Death|0|||
130187809|NCT00122382|468643939|FG002|Open-Label Study|Death|2|||
130187810|NCT00122382|468643937|FG000|Open-Label Study|Lack of Efficacy|0|||
130187811|NCT00122382|468643938|FG001|Open-Label Study|Lack of Efficacy|0|||
130187812|NCT00122382|468643939|FG002|Open-Label Study|Lack of Efficacy|3|||
130187813|NCT00122382|468643937|FG000|Open-Label Study|Lost to Follow-up|0|||
130187814|NCT00122382|468643938|FG001|Open-Label Study|Lost to Follow-up|0|||
130187815|NCT00122382|468643939|FG002|Open-Label Study|Lost to Follow-up|3|||
130187816|NCT00122382|468643937|FG000|Open-Label Study|Pregnancy|0|||
130187817|NCT00122382|468643938|FG001|Open-Label Study|Pregnancy|0|||
130187818|NCT00122382|468643939|FG002|Open-Label Study|Pregnancy|2|||
130187819|NCT00122382|468643937|FG000|Open-Label Study|Poor/Non-Compliance|0|||
130187820|NCT00122382|468643938|FG001|Open-Label Study|Poor/Non-Compliance|0|||
130187821|NCT00122382|468643939|FG002|Open-Label Study|Poor/Non-Compliance|1|||
130187822|NCT00122382|468643937|FG000|Open-Label Study|Withdrawal of Consent|0|||
130187823|NCT00122382|468643938|FG001|Open-Label Study|Withdrawal of Consent|0|||
130187824|NCT00122382|468643939|FG002|Open-Label Study|Withdrawal of Consent|4|||
130187825|NCT02040805|468643940|FG000|Overall Study|Lost to Follow-up|14|||
130187826|NCT02040805|468643941|FG001|Overall Study|Lost to Follow-up|9|||
130187827|NCT02040805|468643940|FG000|Overall Study|Withdrawal by Subject|28|||
130187828|NCT02040805|468643941|FG001|Overall Study|Withdrawal by Subject|41|||
130187829|NCT01213966|468643943|FG000|Overall Study|Protocol Violation|1|||
130187830|NCT01213966|468643944|FG001|Overall Study|Protocol Violation|0|||
130187831|NCT01213966|468643945|FG002|Overall Study|Protocol Violation|3|||
130187832|NCT01213966|468643946|FG003|Overall Study|Protocol Violation|1|||
130187833|NCT03591874|468643947|FG000|Overall Study|Adverse Event|4|||
130187834|NCT03591874|468643948|FG001|Overall Study|Adverse Event|0|||
130187835|NCT03591874|468643947|FG000|Overall Study|Withdrawal by Subject|2|||
130187836|NCT03591874|468643948|FG001|Overall Study|Withdrawal by Subject|1|||
130187837|NCT03591874|468643947|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
130187838|NCT03591874|468643948|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
130187839|NCT03591874|468643947|FG000|Overall Study|On Study at Time of Study Termination|12|||
130187840|NCT03591874|468643948|FG001|Overall Study|On Study at Time of Study Termination|6|||
130187841|NCT03644342|468643951|FG000|Overall Study|Adverse Event|2|||
130187842|NCT03644342|468643952|FG001|Overall Study|Adverse Event|0|||
130187843|NCT03644342|468643951|FG000|Overall Study|Protocol Violation|0|||
130187844|NCT03644342|468643952|FG001|Overall Study|Protocol Violation|1|||
130187845|NCT03655405|468643953|FG000|Overall Study|Death after initial data collection|4|||
130187846|NCT03655405|468643954|FG001|Overall Study|Death after initial data collection|2|||
130187847|NCT03655405|468643953|FG000|Overall Study|Died before initial data collection|1|||
130187848|NCT03655405|468643954|FG001|Overall Study|Died before initial data collection|2|||
130187849|NCT03655405|468643953|FG000|Overall Study|Protocol Violation|0|||
130187850|NCT03655405|468643954|FG001|Overall Study|Protocol Violation|1|||
130187851|NCT01991743|468643956|FG000|Overall Study|external cephalic version not performed|0|||
130187852|NCT01991743|468643957|FG001|Overall Study|external cephalic version not performed|0|||
130187853|NCT01991743|468643958|FG002|Overall Study|external cephalic version not performed|1|||
130187854|NCT01991743|468643959|FG003|Overall Study|external cephalic version not performed|0|||
130187855|NCT02859337|468643961|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
130187856|NCT02859337|468643962|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
130187857|NCT02859337|468643963|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
130187858|NCT02859337|468643961|FG000|Overall Study|Withdrawal by Subject|3|||
130187859|NCT02859337|468643962|FG001|Overall Study|Withdrawal by Subject|1|||
130187860|NCT02859337|468643963|FG002|Overall Study|Withdrawal by Subject|0|||
130187861|NCT02859337|468643961|FG000|Overall Study|Lost to Follow-up|1|||
130187862|NCT02859337|468643962|FG001|Overall Study|Lost to Follow-up|0|||
130187863|NCT02859337|468643963|FG002|Overall Study|Lost to Follow-up|0|||
130187864|NCT01167140|468643966|FG000|Overall Study|Withdrawal by Subject|1|||
130187865|NCT04390113|468643967|FG000|Overall Study|Not Treated|0|||
130187866|NCT04390113|468643968|FG001|Overall Study|Not Treated|1|||
130187867|NCT04390113|468643967|FG000|Overall Study|Adverse Event|1|||
130187868|NCT04390113|468643968|FG001|Overall Study|Adverse Event|0|||
130187869|NCT04390113|468643967|FG000|Overall Study|Death|2|||
130187870|NCT04390113|468643968|FG001|Overall Study|Death|1|||
130187871|NCT04390113|468643967|FG000|Overall Study|Physician Decision|1|||
130187872|NCT04390113|468643968|FG001|Overall Study|Physician Decision|3|||
130187873|NCT04390113|468643967|FG000|Overall Study|Study Terminated by Sponsor|5|||
130187874|NCT04390113|468643968|FG001|Overall Study|Study Terminated by Sponsor|3|||
130187875|NCT04390113|468643967|FG000|Overall Study|Withdrawal by Subject|10|||
130187876|NCT04390113|468643968|FG001|Overall Study|Withdrawal by Subject|5|||
130187877|NCT04390113|468643967|FG000|Overall Study|Other|1|||
130187878|NCT04390113|468643968|FG001|Overall Study|Other|0|||
130187879|NCT04390113|468643967|FG000|Overall Study|Missing|0|||
130187880|NCT04390113|468643968|FG001|Overall Study|Missing|1|||
130187881|NCT01611883|468643969|FG000|Overall Study|Adverse Event|1|||
130187882|NCT01611883|468643970|FG001|Overall Study|Adverse Event|1|||
130187883|NCT00030901|468643973|FG000|Initial Registration|Ineligible|167|||
130187884|NCT00030901|468643974|FG001|Initial Registration|Ineligible|0|||
130187885|NCT00030901|468643975|FG002|Initial Registration|Ineligible|0|||
130187886|NCT00030901|468643973|FG000|Randomization|Adverse Event|0|||
130187887|NCT00030901|468643974|FG001|Randomization|Adverse Event|11|||
130187888|NCT00030901|468643975|FG002|Randomization|Adverse Event|7|||
130187889|NCT00030901|468643973|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
130187890|NCT00030901|468643974|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
130187891|NCT00030901|468643975|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
130187892|NCT00030901|468643973|FG000|Randomization|Progression/Relapse|0|||
130187893|NCT00030901|468643974|FG001|Randomization|Progression/Relapse|22|||
130187894|NCT00030901|468643975|FG002|Randomization|Progression/Relapse|21|||
130187895|NCT00030901|468643973|FG000|Randomization|Death|0|||
130187896|NCT00030901|468643974|FG001|Randomization|Death|1|||
130187897|NCT00030901|468643975|FG002|Randomization|Death|3|||
130187898|NCT00030901|468643973|FG000|Randomization|Other|0|||
130187899|NCT00030901|468643974|FG001|Randomization|Other|36|||
130187900|NCT00030901|468643975|FG002|Randomization|Other|33|||
130187901|NCT00030901|468643973|FG000|Randomization|Ineligible|0|||
130187902|NCT00030901|468643974|FG001|Randomization|Ineligible|15|||
130187903|NCT00030901|468643975|FG002|Randomization|Ineligible|14|||
130187904|NCT02576847|468643976|FG000|Overall Study|Adverse Event|27|||
130187905|NCT02576847|468643976|FG000|Overall Study|Lost to Follow-up|22|||
130187906|NCT02576847|468643976|FG000|Overall Study|Physician Decision|1|||
130187907|NCT02576847|468643976|FG000|Overall Study|Pregnancy|1|||
130187908|NCT02576847|468643976|FG000|Overall Study|Protocol Violation|3|||
130187909|NCT02576847|468643976|FG000|Overall Study|Withdrawal by Subject|78|||
130187910|NCT02576847|468643976|FG000|Overall Study|Other|5|||
130187911|NCT01806051|468643977|FG000|Overall Study|Withdrawal by Subject|6|||
130187912|NCT01205776|468643978|FG000|Overall Study|Lost to Follow-up|53|||
130187913|NCT01205776|468643979|FG001|Overall Study|Lost to Follow-up|61|||
130187914|NCT01205776|468643978|FG000|Overall Study|Withdrawal by Subject|11|||
130187915|NCT01205776|468643979|FG001|Overall Study|Withdrawal by Subject|34|||
130187916|NCT05142722|468645161|FG000|Overall Study|Lost to Follow-up|16|||
130187917|NCT05142722|468645162|FG001|Overall Study|Lost to Follow-up|38|||
130187918|NCT05142722|468645161|FG000|Overall Study|Withdrawal by Subject|20|||
130187919|NCT05142722|468645162|FG001|Overall Study|Withdrawal by Subject|27|||
130187920|NCT05142722|468645161|FG000|Overall Study|Death|11|||
130187921|NCT05142722|468645162|FG001|Overall Study|Death|17|||
130187922|NCT05142722|468645161|FG000|Overall Study|Physician Decision|0|||
130187923|NCT05142722|468645162|FG001|Overall Study|Physician Decision|1|||
130187924|NCT05142722|468645161|FG000|Overall Study|Participant Moved Away|0|||
130187925|NCT05142722|468645162|FG001|Overall Study|Participant Moved Away|2|||
130187926|NCT05142722|468645161|FG000|Overall Study|Adverse Event|2|||
130187927|NCT05142722|468645162|FG001|Overall Study|Adverse Event|1|||
130187928|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130187929|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187930|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130187931|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187932|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
130187933|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187934|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187935|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
130187936|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187937|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187938|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
130187939|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187940|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187941|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
130187942|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187943|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
130187944|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187945|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187946|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130187947|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187948|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187949|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130187950|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
130187951|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
130187952|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187953|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187954|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187955|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187956|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187957|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
130187958|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187959|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
130187960|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187961|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187962|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
130187963|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187964|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187965|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187966|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
130187967|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130187968|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187969|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187970|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
130187971|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187972|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187973|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
130187974|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
130187975|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
130187976|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
130187977|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
130187978|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187979|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187980|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187981|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187982|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187983|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
130187984|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187985|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
130187986|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187987|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187988|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187989|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187990|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187991|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
130187992|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187993|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187994|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187995|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187996|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
130187997|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187998|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130187999|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
130188000|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188001|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188002|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188003|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188004|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188005|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
130188006|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188007|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
130188008|NCT03896503|468645163|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188009|NCT03896503|468645164|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188010|NCT03896503|468645165|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188011|NCT03896503|468645166|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188012|NCT03896503|468645167|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188013|NCT03896503|468645168|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
130188014|NCT03896503|468645169|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
130188015|NCT03896503|468645170|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
130188016|NCT05734157|468645171|FG000|Overall Study|Death|3|||
130188017|NCT05734157|468645171|FG000|Overall Study|Withdrawal by Subject|2|||
130188018|NCT05734157|468645171|FG000|Overall Study|Lost to Follow-up|1|||
130188019|NCT05734157|468645171|FG000|Overall Study|Telephone call|3|||
130188020|NCT01467713|468645173|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
130188021|NCT01467713|468645174|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
130188022|NCT01467713|468645175|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
130188023|NCT01467713|468645176|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
130188024|NCT01467713|468645173|FG000|Overall Study|Major Protocol Deviation|2|||
130188025|NCT01467713|468645174|FG001|Overall Study|Major Protocol Deviation|4|||
130188026|NCT01467713|468645175|FG002|Overall Study|Major Protocol Deviation|4|||
130188027|NCT01467713|468645176|FG003|Overall Study|Major Protocol Deviation|1|||
130188028|NCT01467713|468645173|FG000|Overall Study|Lost to Follow-up|9|||
130188029|NCT01467713|468645174|FG001|Overall Study|Lost to Follow-up|12|||
130188030|NCT01467713|468645175|FG002|Overall Study|Lost to Follow-up|6|||
130188031|NCT01467713|468645176|FG003|Overall Study|Lost to Follow-up|9|||
130188032|NCT01467713|468645173|FG000|Overall Study|Voluntary Withdrawal|18|||
130188033|NCT01467713|468645174|FG001|Overall Study|Voluntary Withdrawal|14|||
130188034|NCT01467713|468645175|FG002|Overall Study|Voluntary Withdrawal|21|||
130188035|NCT01467713|468645176|FG003|Overall Study|Voluntary Withdrawal|20|||
130188036|NCT01467713|468645173|FG000|Overall Study|Study Termination|23|||
130188037|NCT01467713|468645174|FG001|Overall Study|Study Termination|33|||
130188038|NCT01467713|468645175|FG002|Overall Study|Study Termination|28|||
130188039|NCT01467713|468645176|FG003|Overall Study|Study Termination|29|||
130188040|NCT01467713|468645173|FG000|Overall Study|Pregnancy|0|||
130188041|NCT01467713|468645174|FG001|Overall Study|Pregnancy|1|||
130188042|NCT01467713|468645175|FG002|Overall Study|Pregnancy|1|||
130188043|NCT01467713|468645176|FG003|Overall Study|Pregnancy|3|||
130188044|NCT01467713|468645173|FG000|Overall Study|Relapse|35|||
130188045|NCT01467713|468645174|FG001|Overall Study|Relapse|25|||
130188046|NCT01467713|468645175|FG002|Overall Study|Relapse|28|||
130188047|NCT01467713|468645176|FG003|Overall Study|Relapse|35|||
130188048|NCT01467713|468645173|FG000|Overall Study|Reason not Specified|6|||
130188049|NCT01467713|468645174|FG001|Overall Study|Reason not Specified|11|||
130188050|NCT01467713|468645175|FG002|Overall Study|Reason not Specified|8|||
130188051|NCT01467713|468645176|FG003|Overall Study|Reason not Specified|7|||
130188052|NCT00210210|468645177|FG000|Overall Study|Withdrawal by Subject|3|||
130188053|NCT00210210|468645178|FG001|Overall Study|Withdrawal by Subject|2|||
130188054|NCT00210210|468645177|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
130188055|NCT00210210|468645178|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
130188056|NCT01100086|468645180|FG000|Period 1|Withdrawal by Subject|1|||
130188057|NCT01100086|468645181|FG001|Period 1|Withdrawal by Subject|0|||
130188058|NCT01611935|468645184|FG000|Overall Study|Family Declined Participation|1|||
130188059|NCT01611935|468645185|FG001|Overall Study|Family Declined Participation|0|||
130188060|NCT01735916|468645186|FG000|Overall Study|Subject not eligible to be randomized|11|||
130188061|NCT01735916|468645187|FG001|Overall Study|Subject not eligible to be randomized|0|||
130188062|NCT01735916|468645188|FG002|Overall Study|Subject not eligible to be randomized|0|||
130188063|NCT01735916|468645186|FG000|Overall Study|Early termination of study by sponsor|4|||
130188064|NCT01735916|468645187|FG001|Overall Study|Early termination of study by sponsor|19|||
130188065|NCT01735916|468645188|FG002|Overall Study|Early termination of study by sponsor|7|||
130188066|NCT01735916|468645186|FG000|Overall Study|Withdrawal by Subject|3|||
130188067|NCT01735916|468645187|FG001|Overall Study|Withdrawal by Subject|0|||
130188068|NCT01735916|468645188|FG002|Overall Study|Withdrawal by Subject|0|||
130188069|NCT02275546|468645199|FG000|Treatment Period 2|Withdrawal by Subject|2|||
130188070|NCT02275546|468645200|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130188071|NCT02275546|468645199|FG000|Treatment Period 2|Protocol Violation|0|||
130188072|NCT02275546|468645200|FG001|Treatment Period 2|Protocol Violation|1|||
130188073|NCT02955355|468645201|FG000|Overall Study|Adverse Event|4|||
130188074|NCT02955355|468645201|FG000|Overall Study|Death|1|||
130188075|NCT02955355|468645201|FG000|Overall Study|Physician Decision|21|||
130188076|NCT02955355|468645201|FG000|Overall Study|Site Terminated by Sponsor|35|||
130188077|NCT02955355|468645201|FG000|Overall Study|Withdrawal by Subject|19|||
130188078|NCT02955355|468645201|FG000|Overall Study|Reason Not Specified|5|||
130188079|NCT02612623|468645202|FG000|Overall Study|Withdrawal by Subject|0|||
130188080|NCT02612623|468645203|FG001|Overall Study|Withdrawal by Subject|1|||
130188081|NCT02612623|468645204|FG002|Overall Study|Withdrawal by Subject|0|||
130188082|NCT02612623|468645205|FG003|Overall Study|Withdrawal by Subject|0|||
130188083|NCT02612623|468645202|FG000|Overall Study|Adverse Event|1|||
130188084|NCT02612623|468645203|FG001|Overall Study|Adverse Event|0|||
130188085|NCT02612623|468645204|FG002|Overall Study|Adverse Event|1|||
130188086|NCT02612623|468645205|FG003|Overall Study|Adverse Event|0|||
130188087|NCT05344560|468645212|FG000|Period 1|Subject out of visit window|1|||
130188088|NCT05344560|468645213|FG001|Period 1|Subject out of visit window|1|||
130188089|NCT05344560|468645212|FG000|Period 2|Covid-19 Related|1|||
130188090|NCT05344560|468645213|FG001|Period 2|Covid-19 Related|0|||
130188091|NCT05344560|468645212|FG000|Period 2|Adverse Event|1|||
130188092|NCT05344560|468645213|FG001|Period 2|Adverse Event|0|||
130188093|NCT05344560|468645212|FG000|Period 2|Subject out of visit window|1|||
130188094|NCT05344560|468645213|FG001|Period 2|Subject out of visit window|1|||
130188095|NCT05344560|468645212|FG000|Period 3|Subject out of visit window|1|||
130188096|NCT05344560|468645213|FG001|Period 3|Subject out of visit window|0|||
130188097|NCT00360282|468645214|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
130188098|NCT00360282|468645215|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
130188099|NCT00360282|468645216|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
130188100|NCT00360282|468645217|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
130188101|NCT00360282|468645214|FG000|Second Intervention|Adverse Event|0|||
130188102|NCT00360282|468645215|FG001|Second Intervention|Adverse Event|1|||
130188103|NCT00360282|468645216|FG002|Second Intervention|Adverse Event|0|||
130188104|NCT00360282|468645217|FG003|Second Intervention|Adverse Event|0|||
130188105|NCT03817853|468645218|FG000|Induction Phase|Adverse Event|5|||
130188106|NCT03817853|468645219|FG001|Induction Phase|Adverse Event|0|||
130188107|NCT03817853|468645220|FG002|Induction Phase|Adverse Event|0|||
130188108|NCT03817853|468645218|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
130188109|NCT03817853|468645219|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
130188110|NCT03817853|468645220|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
130188111|NCT03817853|468645218|FG000|Induction Phase|Physician Decision|2|||
130188112|NCT03817853|468645219|FG001|Induction Phase|Physician Decision|0|||
130188113|NCT03817853|468645220|FG002|Induction Phase|Physician Decision|0|||
130188114|NCT03817853|468645218|FG000|Induction Phase|Progressive Disease|6|||
130188115|NCT03817853|468645219|FG001|Induction Phase|Progressive Disease|0|||
130188116|NCT03817853|468645220|FG002|Induction Phase|Progressive Disease|0|||
130188117|NCT03817853|468645218|FG000|Induction Phase|Withdrawal by Subject|4|||
130188118|NCT03817853|468645219|FG001|Induction Phase|Withdrawal by Subject|0|||
130188119|NCT03817853|468645220|FG002|Induction Phase|Withdrawal by Subject|0|||
130188120|NCT03817853|468645218|FG000|Maintenance Phase|Adverse Event|0|||
130188121|NCT03817853|468645219|FG001|Maintenance Phase|Adverse Event|8|||
130188122|NCT03817853|468645220|FG002|Maintenance Phase|Adverse Event|0|||
130188123|NCT03817853|468645218|FG000|Maintenance Phase|Death|0|||
130188124|NCT03817853|468645219|FG001|Maintenance Phase|Death|5|||
130188125|NCT03817853|468645220|FG002|Maintenance Phase|Death|0|||
130188126|NCT03817853|468645218|FG000|Maintenance Phase|Progressive Disease|0|||
130188127|NCT03817853|468645219|FG001|Maintenance Phase|Progressive Disease|7|||
130188128|NCT03817853|468645220|FG002|Maintenance Phase|Progressive Disease|0|||
130188129|NCT03817853|468645218|FG000|Maintenance Phase|Withdrawal by Subject|0|||
130188130|NCT03817853|468645219|FG001|Maintenance Phase|Withdrawal by Subject|2|||
130188131|NCT03817853|468645220|FG002|Maintenance Phase|Withdrawal by Subject|0|||
130188132|NCT03817853|468645218|FG000|Maintenance Phase|Physician Decision|0|||
130188133|NCT03817853|468645219|FG001|Maintenance Phase|Physician Decision|1|||
130188134|NCT03817853|468645220|FG002|Maintenance Phase|Physician Decision|0|||
130188135|NCT03817853|468645218|FG000|Maintenance Phase|Various reasons|0|||
130188136|NCT03817853|468645219|FG001|Maintenance Phase|Various reasons|4|||
130188137|NCT03817853|468645220|FG002|Maintenance Phase|Various reasons|0|||
130188138|NCT03817853|468645218|FG000|Maintenance Phase|Protocol Deviation|0|||
130188139|NCT03817853|468645219|FG001|Maintenance Phase|Protocol Deviation|1|||
130188140|NCT03817853|468645220|FG002|Maintenance Phase|Protocol Deviation|0|||
130188141|NCT03817853|468645218|FG000|Follow-up Phase|Adverse Event|0|||
130188142|NCT03817853|468645219|FG001|Follow-up Phase|Adverse Event|0|||
130188143|NCT03817853|468645220|FG002|Follow-up Phase|Adverse Event|2|||
130188144|NCT03817853|468645218|FG000|Follow-up Phase|Death|0|||
130188145|NCT03817853|468645219|FG001|Follow-up Phase|Death|0|||
130188146|NCT03817853|468645220|FG002|Follow-up Phase|Death|1|||
130188147|NCT03817853|468645218|FG000|Follow-up Phase|Progressive Disease|0|||
130188148|NCT03817853|468645219|FG001|Follow-up Phase|Progressive Disease|0|||
130188149|NCT03817853|468645220|FG002|Follow-up Phase|Progressive Disease|3|||
130188150|NCT03817853|468645218|FG000|Follow-up Phase|Withdrawal by Subject|0|||
130188151|NCT03817853|468645219|FG001|Follow-up Phase|Withdrawal by Subject|0|||
130188152|NCT03817853|468645220|FG002|Follow-up Phase|Withdrawal by Subject|1|||
130188153|NCT00314340|468645221|FG000|Overall Study|lost interest|1|||
130188154|NCT01620138|468645224|FG000|Overall Study|Withdrawal by Subject|3|||
130188155|NCT01620138|468645225|FG001|Overall Study|Withdrawal by Subject|0|||
130188156|NCT01620138|468645224|FG000|Overall Study|Lack of Efficacy|1|||
130188157|NCT01620138|468645225|FG001|Overall Study|Lack of Efficacy|0|||
130188158|NCT01620138|468645224|FG000|Overall Study|Adverse Event|2|||
130188159|NCT01620138|468645225|FG001|Overall Study|Adverse Event|0|||
130188160|NCT00449865|468645228|FG000|Overall Study|Withdrawal by Subject|110|||
130188161|NCT00449865|468645229|FG001|Overall Study|Withdrawal by Subject|110|||
130188162|NCT00449865|468645228|FG000|Overall Study|Lost to Follow-up|36|||
130188163|NCT00449865|468645229|FG001|Overall Study|Lost to Follow-up|37|||
130188164|NCT00449865|468645228|FG000|Overall Study|Physician Decision|13|||
130188165|NCT00449865|468645229|FG001|Overall Study|Physician Decision|12|||
130188166|NCT00449865|468645228|FG000|Overall Study|Death|31|||
130188167|NCT00449865|468645229|FG001|Overall Study|Death|40|||
130188168|NCT00449865|468645228|FG000|Overall Study|Protocol Violation|8|||
130188169|NCT00449865|468645229|FG001|Overall Study|Protocol Violation|7|||
130188170|NCT00449865|468645228|FG000|Overall Study|Study was stopped|324|||
130188171|NCT00449865|468645229|FG001|Overall Study|Study was stopped|328|||
130188172|NCT03252535|468645230|FG000|Overall Study|Withdrawal by Subject|1|||
130188173|NCT03252535|468645231|FG001|Overall Study|Withdrawal by Subject|0|||
130188174|NCT03252535|468645232|FG002|Overall Study|Withdrawal by Subject|0|||
130188175|NCT03252535|468645230|FG000|Overall Study|Physician Decision|0|||
130188176|NCT03252535|468645231|FG001|Overall Study|Physician Decision|1|||
130188177|NCT03252535|468645232|FG002|Overall Study|Physician Decision|0|||
130188178|NCT03252535|468645230|FG000|Overall Study|Met discontinuation criteria|0|||
130188179|NCT03252535|468645231|FG001|Overall Study|Met discontinuation criteria|1|||
130188180|NCT03252535|468645232|FG002|Overall Study|Met discontinuation criteria|0|||
130188181|NCT01346059|468645233|FG000|Overall Study|Withdrawal by Subject|1|||
130188182|NCT01346059|468645234|FG001|Overall Study|Withdrawal by Subject|0|||
130188183|NCT05600283|468645238|FG000|Overall Study|Withdrawal by Subject|3|||
130188184|NCT05600283|468645239|FG001|Overall Study|Withdrawal by Subject|8|||
130188185|NCT05600283|468645238|FG000|Overall Study|invalid individual swab|1|||
130188186|NCT05600283|468645239|FG001|Overall Study|invalid individual swab|0|||
130188187|NCT05600283|468645238|FG000|Overall Study|missing clinician collection|3|||
130188188|NCT05600283|468645239|FG001|Overall Study|missing clinician collection|0|||
130188189|NCT05600283|468645238|FG000|Overall Study|screening failure|0|||
130188190|NCT05600283|468645239|FG001|Overall Study|screening failure|2|||
130188191|NCT03907488|468645244|FG000|Overall Study|Adverse Event|20|||
130188192|NCT03907488|468645245|FG001|Overall Study|Adverse Event|20|||
130188193|NCT03907488|468645244|FG000|Overall Study|Withdrawal by Subject|9|||
130188194|NCT03907488|468645245|FG001|Overall Study|Withdrawal by Subject|13|||
130188195|NCT03907488|468645244|FG000|Overall Study|Lack of Efficacy|0|||
130188196|NCT03907488|468645245|FG001|Overall Study|Lack of Efficacy|9|||
130188197|NCT03907488|468645244|FG000|Overall Study|Death|3|||
130188198|NCT03907488|468645245|FG001|Overall Study|Death|8|||
130188199|NCT03907488|468645244|FG000|Overall Study|not protocol specified|5|||
130188200|NCT03907488|468645245|FG001|Overall Study|not protocol specified|8|||
130188201|NCT03907488|468645244|FG000|Overall Study|Ineligible|9|||
130188202|NCT03907488|468645245|FG001|Overall Study|Ineligible|15|||
130188203|NCT02269098|468645246|FG000|Overall Study|Lost to Follow-up|14|||
130188204|NCT02269098|468645247|FG001|Overall Study|Lost to Follow-up|9|||
130188205|NCT03194542|468645250|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
130188206|NCT03194542|468645251|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130188207|NCT03194542|468645252|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130188208|NCT03194542|468645253|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
130188209|NCT03194542|468645250|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
130188210|NCT03194542|468645251|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
130188211|NCT03194542|468645252|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
130188212|NCT03194542|468645253|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
130188213|NCT03194542|468645250|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
130188214|NCT03194542|468645251|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
130188215|NCT03194542|468645252|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
130188216|NCT03194542|468645253|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
130188217|NCT03194542|468645250|FG000|Overall Study|Loss of Response|4|||
130188218|NCT03194542|468645251|FG001|Overall Study|Loss of Response|2|||
130188219|NCT03194542|468645252|FG002|Overall Study|Loss of Response|3|||
130188220|NCT03194542|468645253|FG003|Overall Study|Loss of Response|4|||
130188221|NCT03194542|468645250|FG000|Overall Study|Physician Decision|0|||
130188222|NCT03194542|468645251|FG001|Overall Study|Physician Decision|1|||
130188223|NCT03194542|468645252|FG002|Overall Study|Physician Decision|0|||
130188224|NCT03194542|468645253|FG003|Overall Study|Physician Decision|0|||
130188225|NCT03194542|468645250|FG000|Overall Study|Lack of Efficacy|2|||
130188226|NCT03194542|468645251|FG001|Overall Study|Lack of Efficacy|2|||
130188227|NCT03194542|468645252|FG002|Overall Study|Lack of Efficacy|2|||
130188228|NCT03194542|468645253|FG003|Overall Study|Lack of Efficacy|6|||
130188229|NCT03194542|468645250|FG000|Overall Study|Withdrawal by Subject|2|||
130188230|NCT03194542|468645251|FG001|Overall Study|Withdrawal by Subject|1|||
130188231|NCT03194542|468645252|FG002|Overall Study|Withdrawal by Subject|5|||
130188232|NCT03194542|468645253|FG003|Overall Study|Withdrawal by Subject|4|||
130188233|NCT03194542|468645250|FG000|Overall Study|Progressive Disease|1|||
130188234|NCT03194542|468645251|FG001|Overall Study|Progressive Disease|0|||
130188235|NCT03194542|468645252|FG002|Overall Study|Progressive Disease|1|||
130188236|NCT03194542|468645253|FG003|Overall Study|Progressive Disease|1|||
130188237|NCT03194542|468645250|FG000|Overall Study|Adverse Event|1|||
130188238|NCT03194542|468645251|FG001|Overall Study|Adverse Event|2|||
130188239|NCT03194542|468645252|FG002|Overall Study|Adverse Event|0|||
130188240|NCT03194542|468645253|FG003|Overall Study|Adverse Event|5|||
130188241|NCT03194542|468645250|FG000|Overall Study|Death|1|||
130188242|NCT03194542|468645251|FG001|Overall Study|Death|2|||
130188243|NCT03194542|468645252|FG002|Overall Study|Death|0|||
130188244|NCT03194542|468645253|FG003|Overall Study|Death|5|||
130188245|NCT03194542|468645250|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
130188246|NCT03194542|468645251|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
130188247|NCT03194542|468645252|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
130188248|NCT03194542|468645253|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
130188249|NCT04762160|468645254|FG000|Overall Study|Study terminated early due to business reasons|5|||
130188250|NCT00571727|468645261|FG000|Overall Study|Did not enter in this study|1|||
130188251|NCT00571727|468645261|FG000|Overall Study|Non-compliance|4|||
130188252|NCT00571727|468645261|FG000|Overall Study|Lost to Follow-up|30|||
130188253|NCT00571727|468645261|FG000|Overall Study|Poor growth|1|||
130188254|NCT00571727|468645261|FG000|Overall Study|Parent/patient decision|2|||
130188255|NCT00571727|468645261|FG000|Overall Study|Participant transferred to commercial drug|14|||
130188256|NCT00571727|468645261|FG000|Overall Study|Unable to provide study drug|6|||
130188257|NCT00571727|468645261|FG000|Overall Study|On-treatment at end of study|8|||
130188258|NCT03817190|468645262|FG000|Overall Study|Early Termination|13|||
130188259|NCT03817190|468645263|FG001|Overall Study|Early Termination|20|||
130188260|NCT03817190|468645262|FG000|Overall Study|Adverse Event|10|||
130188261|NCT03817190|468645263|FG001|Overall Study|Adverse Event|17|||
130188262|NCT03817190|468645262|FG000|Overall Study|Withdrawal by Subject|12|||
130188263|NCT03817190|468645263|FG001|Overall Study|Withdrawal by Subject|8|||
130188264|NCT03817190|468645262|FG000|Overall Study|Lost to Follow-up|11|||
130188265|NCT03817190|468645263|FG001|Overall Study|Lost to Follow-up|7|||
130188266|NCT03817190|468645262|FG000|Overall Study|Lack of Efficacy|7|||
130188267|NCT03817190|468645263|FG001|Overall Study|Lack of Efficacy|5|||
130188268|NCT03817190|468645262|FG000|Overall Study|Investigator Decision|5|||
130188269|NCT03817190|468645263|FG001|Overall Study|Investigator Decision|1|||
130188270|NCT03817190|468645262|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
130188271|NCT03817190|468645263|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
130188272|NCT03817190|468645262|FG000|Overall Study|Lack of Contact|1|||
130188273|NCT03817190|468645263|FG001|Overall Study|Lack of Contact|0|||
130188274|NCT03817190|468645262|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
130188275|NCT03817190|468645263|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
130188276|NCT01622673|468645264|FG000|Treatment Period 1|Withdrawal by Subject|0|||
130188277|NCT01622673|468645265|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130188278|NCT01622673|468645266|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130188279|NCT01622673|468645267|FG003|Treatment Period 1|Withdrawal by Subject|1|||
130188280|NCT01622673|468645268|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130188281|NCT01622673|468645269|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130188282|NCT01622673|468645264|FG000|Treatment Period 1|Protocol Violation|0|||
130188283|NCT01622673|468645265|FG001|Treatment Period 1|Protocol Violation|1|||
130188284|NCT01622673|468645266|FG002|Treatment Period 1|Protocol Violation|0|||
130188285|NCT01622673|468645267|FG003|Treatment Period 1|Protocol Violation|0|||
130188286|NCT01622673|468645268|FG004|Treatment Period 1|Protocol Violation|0|||
130188287|NCT01622673|468645269|FG005|Treatment Period 1|Protocol Violation|0|||
130188288|NCT01622673|468645264|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130188289|NCT01622673|468645265|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130188290|NCT01622673|468645266|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130188291|NCT01622673|468645267|FG003|Treatment Period 2|Withdrawal by Subject|1|||
130188292|NCT01622673|468645268|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130188293|NCT01622673|468645269|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130188294|NCT01622673|468645264|FG000|Treatment Period 3|Protocol Violation|0|||
130188295|NCT01622673|468645265|FG001|Treatment Period 3|Protocol Violation|1|||
130188296|NCT01622673|468645266|FG002|Treatment Period 3|Protocol Violation|0|||
130188297|NCT01622673|468645267|FG003|Treatment Period 3|Protocol Violation|0|||
130188298|NCT01622673|468645268|FG004|Treatment Period 3|Protocol Violation|0|||
130188299|NCT01622673|468645269|FG005|Treatment Period 3|Protocol Violation|0|||
130188300|NCT04146012|468645270|FG000|Overall Study|Study Terminated|30|||
130188301|NCT04146012|468645271|FG001|Overall Study|Study Terminated|15|||
130188302|NCT05731700|468646271|FG000|Overall Study|Death|1|||
130188303|NCT00437021|468646290|FG000|Overall Study|Adverse Event|0|||
130188304|NCT00437021|468646291|FG001|Overall Study|Adverse Event|0|||
130188305|NCT00437021|468646292|FG002|Overall Study|Adverse Event|0|||
130188306|NCT00437021|468646293|FG003|Overall Study|Adverse Event|0|||
130188307|NCT00437021|468646294|FG004|Overall Study|Adverse Event|0|||
130188308|NCT00437021|468646295|FG005|Overall Study|Adverse Event|0|||
130188309|NCT00437021|468646296|FG006|Overall Study|Adverse Event|1|||
130188310|NCT00437021|468646297|FG007|Overall Study|Adverse Event|0|||
130188311|NCT00437021|468646298|FG008|Overall Study|Adverse Event|0|||
130188312|NCT00437021|468646299|FG009|Overall Study|Adverse Event|0|||
130188313|NCT00437021|468646300|FG010|Overall Study|Adverse Event|0|||
130188314|NCT00437021|468646301|FG011|Overall Study|Adverse Event|0|||
130188315|NCT00437021|468646290|FG000|Overall Study|Lost to Follow-up|0|||
130188316|NCT00437021|468646291|FG001|Overall Study|Lost to Follow-up|3|||
130188317|NCT00437021|468646292|FG002|Overall Study|Lost to Follow-up|0|||
130188318|NCT00437021|468646293|FG003|Overall Study|Lost to Follow-up|0|||
130188319|NCT00437021|468646294|FG004|Overall Study|Lost to Follow-up|0|||
130188320|NCT00437021|468646295|FG005|Overall Study|Lost to Follow-up|2|||
130188321|NCT00437021|468646296|FG006|Overall Study|Lost to Follow-up|0|||
130188322|NCT00437021|468646297|FG007|Overall Study|Lost to Follow-up|1|||
130188323|NCT00437021|468646298|FG008|Overall Study|Lost to Follow-up|0|||
130188324|NCT00437021|468646299|FG009|Overall Study|Lost to Follow-up|0|||
130188325|NCT00437021|468646300|FG010|Overall Study|Lost to Follow-up|0|||
130188326|NCT00437021|468646301|FG011|Overall Study|Lost to Follow-up|0|||
130188327|NCT00437021|468646290|FG000|Overall Study|Withdrawal by Subject|2|||
130188328|NCT00437021|468646291|FG001|Overall Study|Withdrawal by Subject|1|||
130188329|NCT00437021|468646292|FG002|Overall Study|Withdrawal by Subject|0|||
130188330|NCT00437021|468646293|FG003|Overall Study|Withdrawal by Subject|0|||
130188331|NCT00437021|468646294|FG004|Overall Study|Withdrawal by Subject|0|||
130188332|NCT00437021|468646295|FG005|Overall Study|Withdrawal by Subject|0|||
130188333|NCT00437021|468646296|FG006|Overall Study|Withdrawal by Subject|0|||
130188334|NCT00437021|468646297|FG007|Overall Study|Withdrawal by Subject|0|||
130188335|NCT00437021|468646298|FG008|Overall Study|Withdrawal by Subject|0|||
130188336|NCT00437021|468646299|FG009|Overall Study|Withdrawal by Subject|0|||
130188337|NCT00437021|468646300|FG010|Overall Study|Withdrawal by Subject|0|||
130188338|NCT00437021|468646301|FG011|Overall Study|Withdrawal by Subject|0|||
130188339|NCT05468164|468646302|FG000|Treatment Period 4|Adverse Event|0|||
130188340|NCT05468164|468646303|FG001|Treatment Period 4|Adverse Event|0|||
130188341|NCT05468164|468646304|FG002|Treatment Period 4|Adverse Event|0|||
130188342|NCT05468164|468646305|FG003|Treatment Period 4|Adverse Event|1|||
130188343|NCT05573464|468646306|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
130188344|NCT05573464|468646307|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
130188345|NCT05573464|468646306|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
130188346|NCT05573464|468646307|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
130188347|NCT05573464|468646306|FG000|12-week Treatment Period|Protocol Violation|3|||
130188348|NCT05573464|468646307|FG001|12-week Treatment Period|Protocol Violation|1|||
130188349|NCT05573464|468646306|FG000|12-week Treatment Period|Physician Decision|1|||
130188350|NCT05573464|468646307|FG001|12-week Treatment Period|Physician Decision|2|||
130188351|NCT05573464|468646306|FG000|12-week Treatment Period|Lost to Follow-up|2|||
130188352|NCT05573464|468646307|FG001|12-week Treatment Period|Lost to Follow-up|0|||
130188353|NCT05573464|468646306|FG000|12-week Treatment Period|Adverse Event|20|||
130188354|NCT05573464|468646307|FG001|12-week Treatment Period|Adverse Event|9|||
130188355|NCT05573464|468646306|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
130188356|NCT05573464|468646307|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
130188357|NCT05573464|468646306|FG000|12-week Treatment Period|Randomised, not treated|0|||
130188358|NCT05573464|468646307|FG001|12-week Treatment Period|Randomised, not treated|1|||
130188359|NCT05573464|468646306|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
130188360|NCT05573464|468646307|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
130188361|NCT05573464|468646306|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
130188362|NCT05573464|468646307|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
130188363|NCT05573464|468646306|FG000|52-week Treatment Period|Protocol Violation|1|||
130188364|NCT05573464|468646307|FG001|52-week Treatment Period|Protocol Violation|1|||
130188365|NCT05573464|468646306|FG000|52-week Treatment Period|Physician Decision|2|||
130188366|NCT05573464|468646307|FG001|52-week Treatment Period|Physician Decision|2|||
130188367|NCT05573464|468646306|FG000|52-week Treatment Period|Lost to Follow-up|1|||
130188368|NCT05573464|468646307|FG001|52-week Treatment Period|Lost to Follow-up|1|||
130188369|NCT05573464|468646306|FG000|52-week Treatment Period|Adverse Event|11|||
130188370|NCT05573464|468646307|FG001|52-week Treatment Period|Adverse Event|8|||
130188371|NCT05573464|468646306|FG000|52-week Treatment Period|Death|1|||
130188372|NCT05573464|468646307|FG001|52-week Treatment Period|Death|1|||
130188373|NCT04846569|468646308|FG000|Overall Study|Withdrawal by Subject|3|||
130188374|NCT04846569|468646309|FG001|Overall Study|Withdrawal by Subject|1|||
130188375|NCT00536939|468646314|FG000|Overall Study|Withdrawal by Subject|1|||
130188376|NCT00536939|468646315|FG001|Overall Study|Withdrawal by Subject|0|||
130188377|NCT00536939|468646314|FG000|Overall Study|Other Complicating Disease|1|||
130188378|NCT00536939|468646315|FG001|Overall Study|Other Complicating Disease|0|||
130188379|NCT02954601|468646316|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
130188380|NCT02954601|468646317|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
130188381|NCT02954601|468646318|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
130188382|NCT02954601|468646319|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
130188383|NCT04227197|468646323|FG000|Randomization|Protocol Violation|1|||
130188384|NCT04227197|468646324|FG001|Randomization|Protocol Violation|0|||
130188385|NCT04227197|468646323|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
130188386|NCT04227197|468646324|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
130188387|NCT04227197|468646323|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
130188388|NCT04227197|468646324|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
130188389|NCT04227197|468646323|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
130188390|NCT04227197|468646324|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
130188391|NCT04227197|468646323|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
130188392|NCT04227197|468646324|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
130188393|NCT04227197|468646323|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
130188394|NCT04227197|468646324|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
130188395|NCT04227197|468646323|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
130188396|NCT04227197|468646324|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
130188397|NCT00333983|468646325|FG000|Overall Study|Lost to Follow-up|2|||
130188398|NCT00333983|468646326|FG001|Overall Study|Lost to Follow-up|1|||
130188399|NCT00333983|468646327|FG002|Overall Study|Lost to Follow-up|0|||
130188400|NCT00333983|468646325|FG000|Overall Study|Adverse Event|1|||
130188401|NCT00333983|468646326|FG001|Overall Study|Adverse Event|1|||
130188402|NCT00333983|468646327|FG002|Overall Study|Adverse Event|1|||
130188403|NCT00333983|468646325|FG000|Overall Study|Withdrawal by Subject|0|||
130188404|NCT00333983|468646326|FG001|Overall Study|Withdrawal by Subject|3|||
130188405|NCT00333983|468646327|FG002|Overall Study|Withdrawal by Subject|1|||
130188406|NCT00570141|468646328|FG000|Overall Study|Adverse Event|1|||
130188407|NCT00570141|468646328|FG000|Overall Study|Missed visits|1|||
130188408|NCT00570141|468646328|FG000|Overall Study|Lost to Follow-up|1|||
130188409|NCT01209949|468646338|FG000|Overall Study|Lost to Follow-up|3|||
130188410|NCT00729612|468646343|FG000|Overall Study|Non evaluable for response|10|||
130188411|NCT02075203|468646344|FG000|Overall Study|Withdrawal by Subject|1|||
130188412|NCT02075203|468646345|FG001|Overall Study|Withdrawal by Subject|0|||
130188413|NCT02075203|468646346|FG002|Overall Study|Withdrawal by Subject|1|||
130188414|NCT02075203|468646344|FG000|Overall Study|Adverse Event|1|||
130188415|NCT02075203|468646345|FG001|Overall Study|Adverse Event|0|||
130188416|NCT02075203|468646346|FG002|Overall Study|Adverse Event|0|||
130188417|NCT02075203|468646344|FG000|Overall Study|participant refused to use contraception|1|||
130188418|NCT02075203|468646345|FG001|Overall Study|participant refused to use contraception|0|||
130188419|NCT02075203|468646346|FG002|Overall Study|participant refused to use contraception|0|||
130188420|NCT05266053|468646347|FG000|Overall Study|Withdrawal by Subject|8|||
130188421|NCT05266053|468646348|FG001|Overall Study|Withdrawal by Subject|4|||
130188422|NCT02996968|468646349|FG000|Overall Study|Withdrawal by Subject|1|||
130188423|NCT02996968|468646350|FG001|Overall Study|Withdrawal by Subject|0|||
130188424|NCT00444535|468646353|FG000|Overall Study|Withdrawal by Subject|5|||
130188425|NCT00444535|468646353|FG000|Overall Study|Physician Decision|5|||
130188426|NCT00444535|468646353|FG000|Overall Study|progressive disease|1|||
130188427|NCT00444535|468646353|FG000|Overall Study|Adverse Event|2|||
130188428|NCT05005507|468646355|FG000|Overall Study|Premature termination of study|1|||
130188429|NCT02556775|468646359|FG000|Overall Study|Withdrawal by Subject|1|||
130188430|NCT02556775|468646360|FG001|Overall Study|Withdrawal by Subject|0|||
130188431|NCT02556775|468646361|FG002|Overall Study|Withdrawal by Subject|1|||
130188432|NCT02556775|468646362|FG003|Overall Study|Withdrawal by Subject|0|||
130188433|NCT02556775|468646359|FG000|Overall Study|Lost to Follow-up|1|||
130188434|NCT02556775|468646360|FG001|Overall Study|Lost to Follow-up|0|||
130188435|NCT02556775|468646361|FG002|Overall Study|Lost to Follow-up|0|||
130188436|NCT02556775|468646362|FG003|Overall Study|Lost to Follow-up|0|||
130188437|NCT00558467|468646363|FG000|Overall Study|Adverse Event|1|||
130188438|NCT00558467|468646364|FG001|Overall Study|Adverse Event|2|||
130188439|NCT00558467|468646363|FG000|Overall Study|Lack of Efficacy|0|||
130188440|NCT00558467|468646364|FG001|Overall Study|Lack of Efficacy|1|||
130188441|NCT00558467|468646363|FG000|Overall Study|Patient moving out of state|0|||
130188442|NCT00558467|468646364|FG001|Overall Study|Patient moving out of state|1|||
130188443|NCT02025725|468646371|FG000|Overall Study|Adverse Event|5|||
130188444|NCT02025725|468646372|FG001|Overall Study|Adverse Event|0|||
130188445|NCT02025725|468646371|FG000|Overall Study|Lost to Follow-up|2|||
130188446|NCT02025725|468646372|FG001|Overall Study|Lost to Follow-up|0|||
130188447|NCT02025725|468646371|FG000|Overall Study|Protocol Violation|1|||
130188448|NCT02025725|468646372|FG001|Overall Study|Protocol Violation|1|||
130188449|NCT02025725|468646371|FG000|Overall Study|Withdrawal by Subject|3|||
130188450|NCT02025725|468646372|FG001|Overall Study|Withdrawal by Subject|2|||
130188451|NCT02025725|468646371|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
130188452|NCT02025725|468646372|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
130188453|NCT05047211|468646374|FG000|Overall Study|Lost to Follow-up|8|||
130188454|NCT05047211|468646375|FG001|Overall Study|Lost to Follow-up|5|||
130188455|NCT02867592|468646376|FG000|Overall Study|Adverse Event|3|||
130188456|NCT02867592|468646377|FG001|Overall Study|Adverse Event|0|||
130188457|NCT02867592|468646378|FG002|Overall Study|Adverse Event|2|||
130188458|NCT02867592|468646379|FG003|Overall Study|Adverse Event|1|||
130188459|NCT02867592|468646380|FG004|Overall Study|Adverse Event|1|||
130188460|NCT02867592|468646381|FG005|Overall Study|Adverse Event|5|||
130188461|NCT02867592|468646376|FG000|Overall Study|Death|0|||
130188462|NCT02867592|468646377|FG001|Overall Study|Death|0|||
130188463|NCT02867592|468646378|FG002|Overall Study|Death|0|||
130188464|NCT02867592|468646379|FG003|Overall Study|Death|1|||
130188465|NCT02867592|468646380|FG004|Overall Study|Death|0|||
130188466|NCT02867592|468646381|FG005|Overall Study|Death|1|||
130188467|NCT02867592|468646376|FG000|Overall Study|Lack of Efficacy|8|||
130188468|NCT02867592|468646377|FG001|Overall Study|Lack of Efficacy|10|||
130188469|NCT02867592|468646378|FG002|Overall Study|Lack of Efficacy|8|||
130188470|NCT02867592|468646379|FG003|Overall Study|Lack of Efficacy|8|||
130188471|NCT02867592|468646380|FG004|Overall Study|Lack of Efficacy|12|||
130188472|NCT02867592|468646381|FG005|Overall Study|Lack of Efficacy|17|||
130188473|NCT02867592|468646376|FG000|Overall Study|Physician Decision|1|||
130188474|NCT02867592|468646377|FG001|Overall Study|Physician Decision|2|||
130188475|NCT02867592|468646378|FG002|Overall Study|Physician Decision|2|||
130188476|NCT02867592|468646379|FG003|Overall Study|Physician Decision|0|||
130188477|NCT02867592|468646380|FG004|Overall Study|Physician Decision|5|||
130188478|NCT02867592|468646381|FG005|Overall Study|Physician Decision|1|||
130188479|NCT02867592|468646376|FG000|Overall Study|Protocol Violation|0|||
130188480|NCT02867592|468646377|FG001|Overall Study|Protocol Violation|0|||
130188481|NCT02867592|468646378|FG002|Overall Study|Protocol Violation|0|||
130188482|NCT02867592|468646379|FG003|Overall Study|Protocol Violation|0|||
130188483|NCT02867592|468646380|FG004|Overall Study|Protocol Violation|1|||
130188484|NCT02867592|468646381|FG005|Overall Study|Protocol Violation|1|||
130188485|NCT02867592|468646376|FG000|Overall Study|Withdrawal by Subject|0|||
130188486|NCT02867592|468646377|FG001|Overall Study|Withdrawal by Subject|1|||
130188487|NCT02867592|468646378|FG002|Overall Study|Withdrawal by Subject|0|||
130188488|NCT02867592|468646379|FG003|Overall Study|Withdrawal by Subject|1|||
130188489|NCT02867592|468646380|FG004|Overall Study|Withdrawal by Subject|3|||
130188490|NCT02867592|468646381|FG005|Overall Study|Withdrawal by Subject|3|||
130188491|NCT02867592|468646376|FG000|Overall Study|Ineligible|1|||
130188492|NCT02867592|468646377|FG001|Overall Study|Ineligible|1|||
130188493|NCT02867592|468646378|FG002|Overall Study|Ineligible|0|||
130188494|NCT02867592|468646379|FG003|Overall Study|Ineligible|0|||
130188495|NCT02867592|468646380|FG004|Overall Study|Ineligible|2|||
130188496|NCT02867592|468646381|FG005|Overall Study|Ineligible|0|||
130188497|NCT02867592|468646376|FG000|Overall Study|No Treatment|1|||
130188498|NCT02867592|468646377|FG001|Overall Study|No Treatment|0|||
130188499|NCT02867592|468646378|FG002|Overall Study|No Treatment|0|||
130188500|NCT02867592|468646379|FG003|Overall Study|No Treatment|0|||
130188501|NCT02867592|468646380|FG004|Overall Study|No Treatment|0|||
130188502|NCT02867592|468646381|FG005|Overall Study|No Treatment|0|||
130188503|NCT02867592|468646376|FG000|Overall Study|Still on Therapy|0|||
130188504|NCT02867592|468646377|FG001|Overall Study|Still on Therapy|0|||
130188505|NCT02867592|468646378|FG002|Overall Study|Still on Therapy|0|||
130188506|NCT02867592|468646379|FG003|Overall Study|Still on Therapy|0|||
130188507|NCT02867592|468646380|FG004|Overall Study|Still on Therapy|1|||
130188508|NCT02867592|468646381|FG005|Overall Study|Still on Therapy|0|||
130188509|NCT02867592|468646376|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188510|NCT02867592|468646377|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188511|NCT02867592|468646378|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188512|NCT02867592|468646379|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188513|NCT02867592|468646380|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
130188514|NCT02867592|468646381|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
130188515|NCT02867592|468646376|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
130188516|NCT02867592|468646377|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130188517|NCT02867592|468646378|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
130188518|NCT02867592|468646379|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
130188519|NCT02867592|468646380|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130188520|NCT02867592|468646381|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
130188521|NCT00594165|468646382|FG000|Overall Study|Major protocol violation|1|||
130188522|NCT00594165|468646382|FG000|Overall Study|Lack of Efficacy|12|||
130188523|NCT00594165|468646382|FG000|Overall Study|Adverse Event|52|||
130188524|NCT00594165|468646382|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
130188525|NCT00594165|468646382|FG000|Overall Study|Subject withdrew consent|27|||
130188526|NCT00594165|468646382|FG000|Overall Study|Study ended per sponsor|102|||
130188527|NCT00594165|468646382|FG000|Overall Study|Lost to Follow-up|4|||
130188528|NCT00594165|468646382|FG000|Overall Study|Other: PI discretion|5|||
130188529|NCT00594165|468646382|FG000|Overall Study|Other: Subject moving|3|||
130188530|NCT00594165|468646382|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
130188531|NCT00594165|468646382|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
130188532|NCT00594165|468646382|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
130188533|NCT00594165|468646382|FG000|Overall Study|Other: Site terminated participation|2|||
130188534|NCT03581292|468646387|FG000|Overall Study|Physician Decision|9|||
130188535|NCT03581292|468646388|FG001|Overall Study|Physician Decision|5|||
130188536|NCT03581292|468646387|FG000|Overall Study|Withdrawal by Subject|3|||
130188537|NCT03581292|468646388|FG001|Overall Study|Withdrawal by Subject|0|||
130188538|NCT03581292|468646387|FG000|Overall Study|Withdrawal before Therapy Start|1|||
130188539|NCT03581292|468646388|FG001|Overall Study|Withdrawal before Therapy Start|0|||
130188540|NCT00824772|468647720|FG000|Overall Study|Withdrawal by Subject|8|||
130188541|NCT03214224|468647729|FG000|Overall Study|Protocol Violation|1|||
130188542|NCT03214224|468647729|FG000|Overall Study|Withdrawal by Subject|2|||
130188543|NCT03214224|468647729|FG000|Overall Study|Practice controls or therapists|6|||
130188544|NCT02712320|468647730|FG000|Overall Study|Lost to Follow-up|1|||
130188545|NCT02712320|468647730|FG000|Overall Study|Withdrawal by Subject|1|||
130188546|NCT02712320|468647730|FG000|Overall Study|Transferred to another facility|1|||
130188547|NCT02712320|468647730|FG000|Overall Study|Treating with the prohibited medications|2|||
130188548|NCT00568451|468647733|FG000|Overall Study|Disease Progression|0|||
130188549|NCT00568451|468647734|FG001|Overall Study|Disease Progression|0|||
130188550|NCT00568451|468647735|FG002|Overall Study|Disease Progression|2|||
130188551|NCT00568451|468647736|FG003|Overall Study|Disease Progression|7|||
130188552|NCT01343043|468647739|FG000|Overall Study|Disease progression before treatment|1|||
130188553|NCT01343043|468647740|FG001|Overall Study|Disease progression before treatment|0|||
130188554|NCT01343043|468647741|FG002|Overall Study|Disease progression before treatment|0|||
130188555|NCT01343043|468647742|FG003|Overall Study|Disease progression before treatment|0|||
130188556|NCT01343043|468647739|FG000|Overall Study|Withdrawal by Subject|1|||
130188557|NCT01343043|468647740|FG001|Overall Study|Withdrawal by Subject|0|||
130188558|NCT01343043|468647741|FG002|Overall Study|Withdrawal by Subject|0|||
130188559|NCT01343043|468647742|FG003|Overall Study|Withdrawal by Subject|0|||
130188560|NCT01343043|468647739|FG000|Overall Study|Death|1|||
130188561|NCT01343043|468647740|FG001|Overall Study|Death|1|||
130188562|NCT01343043|468647741|FG002|Overall Study|Death|0|||
130188563|NCT01343043|468647742|FG003|Overall Study|Death|1|||
130188564|NCT00925704|468647743|FG000|First Intervention|Withdrew consent|0|||
130188565|NCT00925704|468647744|FG001|First Intervention|Withdrew consent|0|||
130188566|NCT00925704|468647745|FG002|First Intervention|Withdrew consent|0|||
130188567|NCT00925704|468647746|FG003|First Intervention|Withdrew consent|1|||
130188568|NCT00925704|468647747|FG004|First Intervention|Withdrew consent|1|||
130188569|NCT00925704|468647748|FG005|First Intervention|Withdrew consent|0|||
130188570|NCT00925704|468647743|FG000|Second Intervention|Withdrawal by Subject|1|||
130188571|NCT00925704|468647744|FG001|Second Intervention|Withdrawal by Subject|0|||
130188572|NCT00925704|468647745|FG002|Second Intervention|Withdrawal by Subject|0|||
130188573|NCT00925704|468647746|FG003|Second Intervention|Withdrawal by Subject|0|||
130188574|NCT00925704|468647747|FG004|Second Intervention|Withdrawal by Subject|1|||
130188575|NCT00925704|468647748|FG005|Second Intervention|Withdrawal by Subject|0|||
130188576|NCT00925704|468647743|FG000|Third Intervention|Withdrew consent|0|||
130188577|NCT00925704|468647744|FG001|Third Intervention|Withdrew consent|0|||
130188578|NCT00925704|468647745|FG002|Third Intervention|Withdrew consent|0|||
130188579|NCT00925704|468647746|FG003|Third Intervention|Withdrew consent|0|||
130188580|NCT00925704|468647747|FG004|Third Intervention|Withdrew consent|0|||
130188581|NCT00925704|468647748|FG005|Third Intervention|Withdrew consent|1|||
130188582|NCT02044302|468647752|FG000|Overall Study|study terminated|2|||
130188583|NCT02044302|468647753|FG001|Overall Study|study terminated|0|||
130188584|NCT03207815|468647754|FG000|Overall Study|Protocol Violation|3|||
130188585|NCT03207815|468647755|FG001|Overall Study|Protocol Violation|1|||
130188586|NCT03207815|468647754|FG000|Overall Study|Adverse Event|1|||
130188587|NCT03207815|468647755|FG001|Overall Study|Adverse Event|2|||
130188588|NCT03207815|468647754|FG000|Overall Study|Lost to Follow-up|1|||
130188589|NCT03207815|468647755|FG001|Overall Study|Lost to Follow-up|2|||
130188590|NCT03207815|468647754|FG000|Overall Study|Investigator's Discretion|1|||
130188591|NCT03207815|468647755|FG001|Overall Study|Investigator's Discretion|1|||
130188592|NCT03207815|468647754|FG000|Overall Study|Lack of Efficacy|0|||
130188593|NCT03207815|468647755|FG001|Overall Study|Lack of Efficacy|1|||
130188594|NCT03207815|468647754|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
130188595|NCT03207815|468647755|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
130188596|NCT03207815|468647754|FG000|Overall Study|Withdrew Consent|1|||
130188597|NCT03207815|468647755|FG001|Overall Study|Withdrew Consent|0|||
130188598|NCT01671007|468647756|FG000|Overall Study|Other reasons than listed|166|||
130188599|NCT01671007|468647757|FG001|Overall Study|Other reasons than listed|373|||
130188600|NCT01671007|468647758|FG002|Overall Study|Other reasons than listed|197|||
130188601|NCT01671007|468647759|FG003|Overall Study|Other reasons than listed|228|||
130188602|NCT01671007|468647760|FG004|Overall Study|Other reasons than listed|14|||
130188603|NCT01671007|468647761|FG005|Overall Study|Other reasons than listed|71|||
130188604|NCT01671007|468647762|FG006|Overall Study|Other reasons than listed|17|||
130188605|NCT01671007|468647763|FG007|Overall Study|Other reasons than listed|66|||
130188606|NCT01671007|468647764|FG008|Overall Study|Other reasons than listed|0|||
130188607|NCT01671007|468647756|FG000|Overall Study|Withdrawal by Subject|36|||
130188608|NCT01671007|468647757|FG001|Overall Study|Withdrawal by Subject|59|||
130188609|NCT01671007|468647758|FG002|Overall Study|Withdrawal by Subject|53|||
130188610|NCT01671007|468647759|FG003|Overall Study|Withdrawal by Subject|58|||
130188611|NCT01671007|468647760|FG004|Overall Study|Withdrawal by Subject|4|||
130188612|NCT01671007|468647761|FG005|Overall Study|Withdrawal by Subject|15|||
130188613|NCT01671007|468647762|FG006|Overall Study|Withdrawal by Subject|1|||
130188614|NCT01671007|468647763|FG007|Overall Study|Withdrawal by Subject|19|||
130188615|NCT01671007|468647764|FG008|Overall Study|Withdrawal by Subject|0|||
130188616|NCT01671007|468647756|FG000|Overall Study|Lost to Follow-up|93|||
130188617|NCT01671007|468647757|FG001|Overall Study|Lost to Follow-up|142|||
130188618|NCT01671007|468647758|FG002|Overall Study|Lost to Follow-up|91|||
130188619|NCT01671007|468647759|FG003|Overall Study|Lost to Follow-up|63|||
130188620|NCT01671007|468647760|FG004|Overall Study|Lost to Follow-up|7|||
130188621|NCT01671007|468647761|FG005|Overall Study|Lost to Follow-up|20|||
130188622|NCT01671007|468647762|FG006|Overall Study|Lost to Follow-up|2|||
130188623|NCT01671007|468647763|FG007|Overall Study|Lost to Follow-up|28|||
130188624|NCT01671007|468647764|FG008|Overall Study|Lost to Follow-up|0|||
130188625|NCT01671007|468647756|FG000|Overall Study|No end of study case report form|3|||
130188626|NCT01671007|468647757|FG001|Overall Study|No end of study case report form|1|||
130188627|NCT01671007|468647758|FG002|Overall Study|No end of study case report form|0|||
130188628|NCT01671007|468647759|FG003|Overall Study|No end of study case report form|2|||
130188629|NCT01671007|468647760|FG004|Overall Study|No end of study case report form|0|||
130188630|NCT01671007|468647761|FG005|Overall Study|No end of study case report form|0|||
130188631|NCT01671007|468647762|FG006|Overall Study|No end of study case report form|0|||
130188632|NCT01671007|468647763|FG007|Overall Study|No end of study case report form|0|||
130188633|NCT01671007|468647764|FG008|Overall Study|No end of study case report form|0|||
130188634|NCT01671007|468647756|FG000|Overall Study|Not eligible|23|||
130188635|NCT01671007|468647757|FG001|Overall Study|Not eligible|76|||
130188636|NCT01671007|468647758|FG002|Overall Study|Not eligible|25|||
130188637|NCT01671007|468647759|FG003|Overall Study|Not eligible|17|||
130188638|NCT01671007|468647760|FG004|Overall Study|Not eligible|0|||
130188639|NCT01671007|468647761|FG005|Overall Study|Not eligible|6|||
130188640|NCT01671007|468647762|FG006|Overall Study|Not eligible|1|||
130188641|NCT01671007|468647763|FG007|Overall Study|Not eligible|19|||
130188642|NCT01671007|468647764|FG008|Overall Study|Not eligible|0|||
130188643|NCT00391768|468647765|FG000|Overall Study|Withdrawal by Subject|0|||
130188644|NCT00391768|468647766|FG001|Overall Study|Withdrawal by Subject|0|||
130188645|NCT00391768|468647767|FG002|Overall Study|Withdrawal by Subject|1|||
130188646|NCT00391768|468647768|FG003|Overall Study|Withdrawal by Subject|0|||
130188647|NCT00391768|468647769|FG004|Overall Study|Withdrawal by Subject|0|||
130188648|NCT00391768|468647770|FG005|Overall Study|Withdrawal by Subject|1|||
130188649|NCT00391768|468647771|FG006|Overall Study|Withdrawal by Subject|1|||
130188650|NCT00391768|468647765|FG000|Overall Study|Lost to Follow-up|0|||
130188651|NCT00391768|468647766|FG001|Overall Study|Lost to Follow-up|0|||
130188652|NCT00391768|468647767|FG002|Overall Study|Lost to Follow-up|0|||
130188653|NCT00391768|468647768|FG003|Overall Study|Lost to Follow-up|1|||
130188654|NCT00391768|468647769|FG004|Overall Study|Lost to Follow-up|2|||
130188655|NCT00391768|468647770|FG005|Overall Study|Lost to Follow-up|2|||
130188656|NCT00391768|468647771|FG006|Overall Study|Lost to Follow-up|3|||
130188657|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
130188658|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
130188659|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
130188660|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
130188661|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
130188662|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
130188663|NCT00406367|468647772|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
130188664|NCT00406367|468647773|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
130188665|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
130188666|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
130188667|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
130188668|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
130188669|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
130188670|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
130188671|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
130188672|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
130188673|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
130188674|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
130188675|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
130188676|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
130188677|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
130188678|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
130188679|NCT00406367|468647772|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
130188680|NCT00406367|468647773|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
130188681|NCT00171210|468647774|FG000|Overall Study|Adverse Event|16|||
130188682|NCT00171210|468647775|FG001|Overall Study|Adverse Event|27|||
130188683|NCT00171210|468647774|FG000|Overall Study|Abnormal laboratory value(s)|6|||
130188684|NCT00171210|468647775|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130188685|NCT00171210|468647774|FG000|Overall Study|Abnormal test procedure result(s)|0|||
130188686|NCT00171210|468647775|FG001|Overall Study|Abnormal test procedure result(s)|1|||
130188687|NCT00171210|468647774|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
130188688|NCT00171210|468647775|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
130188689|NCT00171210|468647774|FG000|Overall Study|Protocol Violation|0|||
130188690|NCT00171210|468647775|FG001|Overall Study|Protocol Violation|2|||
130188691|NCT00171210|468647774|FG000|Overall Study|Withdrawal by Subject|32|||
130188692|NCT00171210|468647775|FG001|Overall Study|Withdrawal by Subject|30|||
130188693|NCT00171210|468647774|FG000|Overall Study|Lost to Follow-up|1|||
130188694|NCT00171210|468647775|FG001|Overall Study|Lost to Follow-up|0|||
130188695|NCT00171210|468647774|FG000|Overall Study|Administrative problems|1|||
130188696|NCT00171210|468647775|FG001|Overall Study|Administrative problems|1|||
130188697|NCT00171210|468647774|FG000|Overall Study|Death|2|||
130188698|NCT00171210|468647775|FG001|Overall Study|Death|3|||
130188699|NCT00171210|468647774|FG000|Overall Study|Stopped at end of core|0|||
130188700|NCT00171210|468647775|FG001|Overall Study|Stopped at end of core|32|||
130188701|NCT00171210|468647774|FG000|Overall Study|Stopped at end of extension 1|0|||
130188702|NCT00171210|468647775|FG001|Overall Study|Stopped at end of extension 1|1|||
130188703|NCT03187301|468647778|FG000|Titration Period|Adverse Event|0|||
130188704|NCT03187301|468647779|FG001|Titration Period|Adverse Event|0|||
130188705|NCT03187301|468647780|FG002|Titration Period|Adverse Event|0|||
130188706|NCT03187301|468647781|FG003|Titration Period|Adverse Event|0|||
130188707|NCT03187301|468647782|FG004|Titration Period|Adverse Event|0|||
130188708|NCT03187301|468647783|FG005|Titration Period|Adverse Event|0|||
130188709|NCT03187301|468647784|FG006|Titration Period|Adverse Event|5|||
130188710|NCT03187301|468647778|FG000|Titration Period|Withdrawal by Subject|0|||
130188711|NCT03187301|468647779|FG001|Titration Period|Withdrawal by Subject|0|||
130188712|NCT03187301|468647780|FG002|Titration Period|Withdrawal by Subject|0|||
130188713|NCT03187301|468647781|FG003|Titration Period|Withdrawal by Subject|0|||
130188714|NCT03187301|468647782|FG004|Titration Period|Withdrawal by Subject|0|||
130188715|NCT03187301|468647783|FG005|Titration Period|Withdrawal by Subject|0|||
130188716|NCT03187301|468647784|FG006|Titration Period|Withdrawal by Subject|1|||
130188717|NCT03187301|468647778|FG000|Titration Period|Exclusion Criteria Met|0|||
130188718|NCT03187301|468647779|FG001|Titration Period|Exclusion Criteria Met|0|||
130188719|NCT03187301|468647780|FG002|Titration Period|Exclusion Criteria Met|0|||
130188720|NCT03187301|468647781|FG003|Titration Period|Exclusion Criteria Met|0|||
130188721|NCT03187301|468647782|FG004|Titration Period|Exclusion Criteria Met|0|||
130188722|NCT03187301|468647783|FG005|Titration Period|Exclusion Criteria Met|0|||
130188723|NCT03187301|468647784|FG006|Titration Period|Exclusion Criteria Met|1|||
130188724|NCT03187301|468647778|FG000|Pre-Intervention|Withdrawal by Subject|1|||
130188725|NCT03187301|468647779|FG001|Pre-Intervention|Withdrawal by Subject|0|||
130188726|NCT03187301|468647780|FG002|Pre-Intervention|Withdrawal by Subject|0|||
130188727|NCT03187301|468647781|FG003|Pre-Intervention|Withdrawal by Subject|0|||
130188728|NCT03187301|468647782|FG004|Pre-Intervention|Withdrawal by Subject|0|||
130188729|NCT03187301|468647783|FG005|Pre-Intervention|Withdrawal by Subject|0|||
130188730|NCT03187301|468647784|FG006|Pre-Intervention|Withdrawal by Subject|0|||
130188731|NCT02182843|468647791|FG000|Overall Study|Withdrawal by Subject|7|||
130188732|NCT02182843|468647791|FG000|Overall Study|Lost to Follow-up|2|||
130188733|NCT02182843|468647791|FG000|Overall Study|Adverse Event|1|||
130188734|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
130188735|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
130188736|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
130188737|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130188738|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130188739|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
130188740|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
130188741|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
130188742|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
130188743|NCT02375971|468647792|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
130188744|NCT02375971|468647793|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
130188745|NCT02375971|468647794|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
130188746|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
130188747|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
130188748|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
130188749|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
130188750|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
130188751|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
130188752|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
130188753|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
130188754|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
130188755|NCT02375971|468647792|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
130188756|NCT02375971|468647793|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
130188757|NCT02375971|468647794|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
130188758|NCT00832455|468647796|FG000|Overall Study|Adverse Event|13|||
130188759|NCT00832455|468647796|FG000|Overall Study|Lost to Follow-up|26|||
130188760|NCT00832455|468647796|FG000|Overall Study|Protocol Violation|4|||
130188761|NCT00832455|468647796|FG000|Overall Study|Withdrawal by Subject|17|||
130188762|NCT00832455|468647796|FG000|Overall Study|Screening Failure|2|||
130188763|NCT00832455|468647796|FG000|Overall Study|Stopped Medication|4|||
130188764|NCT00832455|468647796|FG000|Overall Study|Parent misunderstood study|1|||
130188765|NCT00832455|468647796|FG000|Overall Study|Parent dissatisfied|1|||
130188766|NCT00832455|468647796|FG000|Overall Study|No improvement|3|||
130188767|NCT00832455|468647796|FG000|Overall Study|Patient moved|1|||
130188768|NCT00561392|468647799|FG000|Overall Study|Adverse Event|38|||
130188769|NCT00561392|468647799|FG000|Overall Study|Lack of Efficacy|2|||
130188770|NCT00561392|468647799|FG000|Overall Study|Protocol Violation|1|||
130188771|NCT00561392|468647799|FG000|Overall Study|Withdrawal by Subject|8|||
130188772|NCT00561392|468647799|FG000|Overall Study|Administrative problems|4|||
130188773|NCT01741688|468647800|FG000|Overall Study|Lack of insurance coverage|2|||
130188774|NCT01741688|468647800|FG000|Overall Study|Withdrawal by Subject|1|||
130188775|NCT01262872|468647805|FG000|Step 2|Death|0|||
130188776|NCT01262872|468647806|FG001|Step 2|Death|0|||
130188777|NCT01262872|468647807|FG002|Step 2|Death|0|||
130188778|NCT01262872|468647808|FG003|Step 2|Death|1|||
130188779|NCT01262872|468647809|FG004|Step 2|Death|0|||
130188780|NCT01262872|468647810|FG005|Step 2|Death|2|||
130188781|NCT01262872|468647811|FG006|Step 2|Death|2|||
130188782|NCT01262872|468647812|FG007|Step 2|Death|1|||
130188783|NCT01262872|468647805|FG000|Step 2|Protocol Violation|0|||
130188784|NCT01262872|468647806|FG001|Step 2|Protocol Violation|0|||
130188785|NCT01262872|468647807|FG002|Step 2|Protocol Violation|1|||
130188786|NCT01262872|468647808|FG003|Step 2|Protocol Violation|0|||
130188787|NCT01262872|468647809|FG004|Step 2|Protocol Violation|0|||
130188788|NCT01262872|468647810|FG005|Step 2|Protocol Violation|0|||
130188789|NCT01262872|468647811|FG006|Step 2|Protocol Violation|3|||
130188790|NCT01262872|468647812|FG007|Step 2|Protocol Violation|1|||
130188791|NCT01262872|468647805|FG000|Step 2|Withdrawal by Subject|0|||
130188792|NCT01262872|468647806|FG001|Step 2|Withdrawal by Subject|0|||
130188793|NCT01262872|468647807|FG002|Step 2|Withdrawal by Subject|4|||
130188794|NCT01262872|468647808|FG003|Step 2|Withdrawal by Subject|6|||
130188795|NCT01262872|468647809|FG004|Step 2|Withdrawal by Subject|3|||
130188796|NCT01262872|468647810|FG005|Step 2|Withdrawal by Subject|1|||
130188797|NCT01262872|468647811|FG006|Step 2|Withdrawal by Subject|2|||
130188798|NCT01262872|468647812|FG007|Step 2|Withdrawal by Subject|1|||
130188799|NCT01262872|468647805|FG000|Step 2|Migrated/moved from study area|0|||
130188800|NCT01262872|468647806|FG001|Step 2|Migrated/moved from study area|0|||
130188801|NCT01262872|468647807|FG002|Step 2|Migrated/moved from study area|4|||
130188802|NCT01262872|468647808|FG003|Step 2|Migrated/moved from study area|3|||
130188803|NCT01262872|468647809|FG004|Step 2|Migrated/moved from study area|2|||
130188804|NCT01262872|468647810|FG005|Step 2|Migrated/moved from study area|6|||
130188805|NCT01262872|468647811|FG006|Step 2|Migrated/moved from study area|2|||
130188806|NCT01262872|468647812|FG007|Step 2|Migrated/moved from study area|3|||
130188807|NCT00365794|468647815|FG000|Overall Study|Withdrawal by Subject|2|||
130188808|NCT00745901|468647816|FG000|Overall Study|Adverse Event|3|||
130188809|NCT00745901|468647817|FG001|Overall Study|Adverse Event|4|||
130188810|NCT00745901|468647816|FG000|Overall Study|Protocol Violation|0|||
130188811|NCT00745901|468647817|FG001|Overall Study|Protocol Violation|1|||
130188812|NCT00745901|468647816|FG000|Overall Study|Withdrawal by Subject|1|||
130188813|NCT00745901|468647817|FG001|Overall Study|Withdrawal by Subject|0|||
130188814|NCT00745901|468647816|FG000|Overall Study|Lost to Follow-up|7|||
130188815|NCT00745901|468647817|FG001|Overall Study|Lost to Follow-up|4|||
130188816|NCT00745901|468647816|FG000|Overall Study|Pregnancy|2|||
130188817|NCT00745901|468647817|FG001|Overall Study|Pregnancy|4|||
130188818|NCT00745901|468647816|FG000|Overall Study|Lack of compliance|2|||
130188819|NCT00745901|468647817|FG001|Overall Study|Lack of compliance|2|||
130188820|NCT00745901|468647816|FG000|Overall Study|Patient's next menses did not start with|1|||
130188821|NCT00745901|468647817|FG001|Overall Study|Patient's next menses did not start with|0|||
130188822|NCT00745901|468647816|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
130188823|NCT00745901|468647817|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
130188824|NCT00745901|468647816|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
130188825|NCT00745901|468647817|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
130188826|NCT00745901|468647816|FG000|Overall Study|Patient didn't take any study medication|7|||
130188827|NCT00745901|468647817|FG001|Overall Study|Patient didn't take any study medication|3|||
130188828|NCT01804946|468647819|FG000|Overall Study|Protocol Violation|1|||
130188829|NCT01804946|468647820|FG001|Overall Study|Protocol Violation|0|||
130188830|NCT01804946|468647819|FG000|Overall Study|Adverse Event|0|||
130188831|NCT01804946|468647820|FG001|Overall Study|Adverse Event|1|||
130188832|NCT01804946|468647819|FG000|Overall Study|Insufficient data available|0|||
130188833|NCT01804946|468647820|FG001|Overall Study|Insufficient data available|1|||
130188834|NCT01804946|468647819|FG000|Overall Study|Do not meet inclusion criteria|1|||
130188835|NCT01804946|468647820|FG001|Overall Study|Do not meet inclusion criteria|2|||
130188836|NCT00722137|468647822|FG000|Overall Study|Overt Disease Progression|5|||
130188837|NCT00722137|468647823|FG001|Overall Study|Overt Disease Progression|4|||
130188838|NCT00722137|468647822|FG000|Overall Study|Adverse Event|17|||
130188839|NCT00722137|468647823|FG001|Overall Study|Adverse Event|21|||
130188840|NCT00722137|468647822|FG000|Overall Study|Death|12|||
130188841|NCT00722137|468647823|FG001|Overall Study|Death|7|||
130188842|NCT00722137|468647822|FG000|Overall Study|Withdrawal by Subject|6|||
130188843|NCT00722137|468647823|FG001|Overall Study|Withdrawal by Subject|9|||
130188844|NCT00722137|468647822|FG000|Overall Study|Other Reason Unknown|3|||
130188845|NCT00722137|468647823|FG001|Overall Study|Other Reason Unknown|4|||
130188846|NCT00722137|468647822|FG000|Overall Study|Randomized But Not Treated|2|||
130188847|NCT00722137|468647823|FG001|Overall Study|Randomized But Not Treated|3|||
130188848|NCT00848718|468647824|FG000|Overall Study|Adverse Event|2|||
130188849|NCT00848718|468647825|FG001|Overall Study|Adverse Event|2|||
130188850|NCT00848718|468647826|FG002|Overall Study|Adverse Event|1|||
130188851|NCT00848718|468647827|FG003|Overall Study|Adverse Event|1|||
130188852|NCT00848718|468647828|FG004|Overall Study|Adverse Event|1|||
130188853|NCT00848718|468647829|FG005|Overall Study|Adverse Event|0|||
130188854|NCT00848718|468647830|FG006|Overall Study|Adverse Event|0|||
130188855|NCT00848718|468647831|FG007|Overall Study|Adverse Event|1|||
130188856|NCT00848718|468647832|FG008|Overall Study|Adverse Event|1|||
130188857|NCT00848718|468647833|FG009|Overall Study|Adverse Event|0|||
130188858|NCT00848718|468647834|FG010|Overall Study|Adverse Event|0|||
130188859|NCT00848718|468647835|FG011|Overall Study|Adverse Event|0|||
130188860|NCT00848718|468647836|FG012|Overall Study|Adverse Event|2|||
130188861|NCT00848718|468647824|FG000|Overall Study|Lack of Efficacy|0|||
130188862|NCT00848718|468647825|FG001|Overall Study|Lack of Efficacy|0|||
130188863|NCT00848718|468647826|FG002|Overall Study|Lack of Efficacy|1|||
130188864|NCT00848718|468647827|FG003|Overall Study|Lack of Efficacy|0|||
130188865|NCT00848718|468647828|FG004|Overall Study|Lack of Efficacy|0|||
130188866|NCT00848718|468647829|FG005|Overall Study|Lack of Efficacy|0|||
130188867|NCT00848718|468647830|FG006|Overall Study|Lack of Efficacy|1|||
130188868|NCT00848718|468647831|FG007|Overall Study|Lack of Efficacy|0|||
130188869|NCT00848718|468647832|FG008|Overall Study|Lack of Efficacy|0|||
130188870|NCT00848718|468647833|FG009|Overall Study|Lack of Efficacy|0|||
130188871|NCT00848718|468647834|FG010|Overall Study|Lack of Efficacy|0|||
130188872|NCT00848718|468647835|FG011|Overall Study|Lack of Efficacy|0|||
130188873|NCT00848718|468647836|FG012|Overall Study|Lack of Efficacy|0|||
130188874|NCT00848718|468647824|FG000|Overall Study|Physician Decision|0|||
130188875|NCT00848718|468647825|FG001|Overall Study|Physician Decision|1|||
130188876|NCT00848718|468647826|FG002|Overall Study|Physician Decision|0|||
130188877|NCT00848718|468647827|FG003|Overall Study|Physician Decision|0|||
130188878|NCT00848718|468647828|FG004|Overall Study|Physician Decision|1|||
130188879|NCT00848718|468647829|FG005|Overall Study|Physician Decision|1|||
130188880|NCT00848718|468647830|FG006|Overall Study|Physician Decision|0|||
130188881|NCT00848718|468647831|FG007|Overall Study|Physician Decision|0|||
130188882|NCT00848718|468647832|FG008|Overall Study|Physician Decision|1|||
130188883|NCT00848718|468647833|FG009|Overall Study|Physician Decision|2|||
130188884|NCT00848718|468647834|FG010|Overall Study|Physician Decision|0|||
130188885|NCT00848718|468647835|FG011|Overall Study|Physician Decision|0|||
130188886|NCT00848718|468647836|FG012|Overall Study|Physician Decision|1|||
130188887|NCT00848718|468647824|FG000|Overall Study|Progressive disease before treatment|1|||
130188888|NCT00848718|468647825|FG001|Overall Study|Progressive disease before treatment|5|||
130188889|NCT00848718|468647826|FG002|Overall Study|Progressive disease before treatment|1|||
130188890|NCT00848718|468647827|FG003|Overall Study|Progressive disease before treatment|3|||
130188891|NCT00848718|468647828|FG004|Overall Study|Progressive disease before treatment|4|||
130188892|NCT00848718|468647829|FG005|Overall Study|Progressive disease before treatment|4|||
130188893|NCT00848718|468647830|FG006|Overall Study|Progressive disease before treatment|2|||
130188894|NCT00848718|468647831|FG007|Overall Study|Progressive disease before treatment|1|||
130188895|NCT00848718|468647832|FG008|Overall Study|Progressive disease before treatment|2|||
130188896|NCT00848718|468647833|FG009|Overall Study|Progressive disease before treatment|7|||
130188897|NCT00848718|468647834|FG010|Overall Study|Progressive disease before treatment|3|||
130188898|NCT00848718|468647835|FG011|Overall Study|Progressive disease before treatment|6|||
130188899|NCT00848718|468647836|FG012|Overall Study|Progressive disease before treatment|2|||
130188900|NCT00848718|468647824|FG000|Overall Study|Protocol Violation|0|||
130188901|NCT00848718|468647825|FG001|Overall Study|Protocol Violation|1|||
130188902|NCT00848718|468647826|FG002|Overall Study|Protocol Violation|0|||
130188903|NCT00848718|468647827|FG003|Overall Study|Protocol Violation|0|||
130188904|NCT00848718|468647828|FG004|Overall Study|Protocol Violation|0|||
130188905|NCT00848718|468647829|FG005|Overall Study|Protocol Violation|0|||
130188906|NCT00848718|468647830|FG006|Overall Study|Protocol Violation|0|||
130188907|NCT00848718|468647831|FG007|Overall Study|Protocol Violation|1|||
130188908|NCT00848718|468647832|FG008|Overall Study|Protocol Violation|0|||
130188909|NCT00848718|468647833|FG009|Overall Study|Protocol Violation|0|||
130188910|NCT00848718|468647834|FG010|Overall Study|Protocol Violation|0|||
130188911|NCT00848718|468647835|FG011|Overall Study|Protocol Violation|0|||
130188912|NCT00848718|468647836|FG012|Overall Study|Protocol Violation|1|||
130188913|NCT00848718|468647824|FG000|Overall Study|Withdrawal by Subject|1|||
130188914|NCT00848718|468647825|FG001|Overall Study|Withdrawal by Subject|0|||
130188915|NCT00848718|468647826|FG002|Overall Study|Withdrawal by Subject|0|||
130188916|NCT00848718|468647827|FG003|Overall Study|Withdrawal by Subject|1|||
130188917|NCT00848718|468647828|FG004|Overall Study|Withdrawal by Subject|0|||
130188918|NCT00848718|468647829|FG005|Overall Study|Withdrawal by Subject|0|||
130188919|NCT00848718|468647830|FG006|Overall Study|Withdrawal by Subject|0|||
130188920|NCT00848718|468647831|FG007|Overall Study|Withdrawal by Subject|0|||
130188921|NCT00848718|468647832|FG008|Overall Study|Withdrawal by Subject|0|||
130188922|NCT00848718|468647833|FG009|Overall Study|Withdrawal by Subject|0|||
130188923|NCT00848718|468647834|FG010|Overall Study|Withdrawal by Subject|1|||
130188924|NCT00848718|468647835|FG011|Overall Study|Withdrawal by Subject|0|||
130188925|NCT00848718|468647836|FG012|Overall Study|Withdrawal by Subject|0|||
130188926|NCT00848718|468647824|FG000|Overall Study|Progressive disease during treatment|3|||
130188927|NCT00848718|468647825|FG001|Overall Study|Progressive disease during treatment|0|||
130188928|NCT00848718|468647826|FG002|Overall Study|Progressive disease during treatment|3|||
130188929|NCT00848718|468647827|FG003|Overall Study|Progressive disease during treatment|0|||
130188930|NCT00848718|468647828|FG004|Overall Study|Progressive disease during treatment|0|||
130188931|NCT00848718|468647829|FG005|Overall Study|Progressive disease during treatment|0|||
130188932|NCT00848718|468647830|FG006|Overall Study|Progressive disease during treatment|0|||
130188933|NCT00848718|468647831|FG007|Overall Study|Progressive disease during treatment|2|||
130188934|NCT00848718|468647832|FG008|Overall Study|Progressive disease during treatment|0|||
130188935|NCT00848718|468647833|FG009|Overall Study|Progressive disease during treatment|0|||
130188936|NCT00848718|468647834|FG010|Overall Study|Progressive disease during treatment|0|||
130188937|NCT00848718|468647835|FG011|Overall Study|Progressive disease during treatment|0|||
130188938|NCT00848718|468647836|FG012|Overall Study|Progressive disease during treatment|2|||
130188939|NCT02431676|468647838|FG000|Overall Study|no lab obtained|0|||
130188940|NCT02431676|468647839|FG001|Overall Study|no lab obtained|1|||
130188941|NCT02431676|468647840|FG002|Overall Study|no lab obtained|2|||
130188942|NCT01120184|468650188|FG000|Overall Study|Adverse Event|0|||
130188943|NCT01120184|468650189|FG001|Overall Study|Adverse Event|1|||
130188944|NCT01120184|468650190|FG002|Overall Study|Adverse Event|0|||
130188945|NCT01120184|468650188|FG000|Overall Study|Lost to Follow-up|13|||
130188946|NCT01120184|468650189|FG001|Overall Study|Lost to Follow-up|13|||
130188947|NCT01120184|468650190|FG002|Overall Study|Lost to Follow-up|11|||
130188948|NCT01120184|468650188|FG000|Overall Study|Physician Decision|9|||
130188949|NCT01120184|468650189|FG001|Overall Study|Physician Decision|1|||
130188950|NCT01120184|468650190|FG002|Overall Study|Physician Decision|3|||
130188951|NCT01120184|468650188|FG000|Overall Study|Reason not Specified|8|||
130188952|NCT01120184|468650189|FG001|Overall Study|Reason not Specified|3|||
130188953|NCT01120184|468650190|FG002|Overall Study|Reason not Specified|12|||
130188954|NCT01120184|468650188|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
130188955|NCT01120184|468650189|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
130188956|NCT01120184|468650190|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
130188957|NCT01120184|468650188|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
130188958|NCT01120184|468650189|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
130188959|NCT01120184|468650190|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
130188960|NCT01120184|468650188|FG000|Overall Study|Death|170|||
130188961|NCT01120184|468650189|FG001|Overall Study|Death|176|||
130188962|NCT01120184|468650190|FG002|Overall Study|Death|169|||
130188963|NCT02525783|468650191|FG000|Overall Study|Lost to Follow-up|10|||
130188964|NCT00866281|468650192|FG000|Overall Study|Adverse Event|1|||
130188965|NCT00866281|468650193|FG001|Overall Study|Adverse Event|0|||
130188966|NCT00866281|468650192|FG000|Overall Study|Withdrawal by participants|3|||
130188967|NCT00866281|468650193|FG001|Overall Study|Withdrawal by participants|0|||
130188968|NCT00866281|468650192|FG000|Overall Study|Disease progression|3|||
130188969|NCT00866281|468650193|FG001|Overall Study|Disease progression|11|||
130188970|NCT00866281|468650192|FG000|Overall Study|New cancer therapy|0|||
130188971|NCT00866281|468650193|FG001|Overall Study|New cancer therapy|4|||
130188972|NCT01894841|468650194|FG000|Overall Study|Withdrawal by Subject|9|||
130188973|NCT01894841|468650195|FG001|Overall Study|Withdrawal by Subject|4|||
130188974|NCT01894841|468650194|FG000|Overall Study|Withdrawn by investigator|2|||
130188975|NCT01894841|468650195|FG001|Overall Study|Withdrawn by investigator|2|||
130188976|NCT01894841|468650194|FG000|Overall Study|Lost to Follow-up|7|||
130188977|NCT01894841|468650195|FG001|Overall Study|Lost to Follow-up|3|||
130188978|NCT00529087|468650203|FG000|Overall Study|Adverse Event|10|||
130188979|NCT00529087|468650204|FG001|Overall Study|Adverse Event|13|||
130188980|NCT00529087|468650205|FG002|Overall Study|Adverse Event|4|||
130188981|NCT00529087|468650203|FG000|Overall Study|Lost to Follow-up|6|||
130188982|NCT00529087|468650204|FG001|Overall Study|Lost to Follow-up|4|||
130188983|NCT00529087|468650205|FG002|Overall Study|Lost to Follow-up|1|||
130188984|NCT00529087|468650203|FG000|Overall Study|Protocol Violation|8|||
130188985|NCT00529087|468650204|FG001|Overall Study|Protocol Violation|7|||
130188986|NCT00529087|468650205|FG002|Overall Study|Protocol Violation|6|||
130188987|NCT00529087|468650203|FG000|Overall Study|Withdrawal by Subject|3|||
130188988|NCT00529087|468650204|FG001|Overall Study|Withdrawal by Subject|3|||
130188989|NCT00529087|468650205|FG002|Overall Study|Withdrawal by Subject|3|||
130188990|NCT00529087|468650203|FG000|Overall Study|Protocol deviation|1|||
130188991|NCT00529087|468650204|FG001|Overall Study|Protocol deviation|1|||
130188992|NCT00529087|468650205|FG002|Overall Study|Protocol deviation|2|||
130188993|NCT00318474|468650206|FG000|Overall Study|Adverse Event|1|||
130188994|NCT00318474|468650207|FG001|Overall Study|Adverse Event|1|||
130188995|NCT00318474|468650206|FG000|Overall Study|Lost to Follow-up|0|||
130188996|NCT00318474|468650207|FG001|Overall Study|Lost to Follow-up|1|||
130188997|NCT00318474|468650206|FG000|Overall Study|Pregnancy|0|||
130188998|NCT00318474|468650207|FG001|Overall Study|Pregnancy|2|||
130188999|NCT00318474|468650206|FG000|Overall Study|Protocol Violation|1|||
130189000|NCT00318474|468650207|FG001|Overall Study|Protocol Violation|0|||
130189001|NCT00318474|468650206|FG000|Overall Study|Withdrawal by Subject|3|||
130189002|NCT00318474|468650207|FG001|Overall Study|Withdrawal by Subject|2|||
130189003|NCT00318474|468650206|FG000|Overall Study|Fall in GFR|3|||
130189004|NCT00318474|468650207|FG001|Overall Study|Fall in GFR|3|||
130189005|NCT00318474|468650206|FG000|Overall Study|Post-therapy hyperflycemia|0|||
130189006|NCT00318474|468650207|FG001|Overall Study|Post-therapy hyperflycemia|1|||
130189007|NCT00318474|468650206|FG000|Overall Study|Trial terminated|10|||
130189008|NCT00318474|468650207|FG001|Overall Study|Trial terminated|7|||
130189009|NCT00833105|468650217|FG000|Overall Study|Withdrawal by Subject|1|||
130189010|NCT00833105|468650217|FG000|Overall Study|Adverse Event|2|||
130189011|NCT03656068|468650222|FG000|Overall Study|Withdrawal by Subject|4|||
130189012|NCT03656068|468650222|FG000|Overall Study|Adverse Event|1|||
130189013|NCT05326529|468650223|FG000|Overall Study|Lack of Efficacy|0|||
130189014|NCT05326529|468650224|FG001|Overall Study|Lack of Efficacy|1|||
130189015|NCT05326529|468650225|FG002|Overall Study|Lack of Efficacy|0|||
130189016|NCT05326529|468650223|FG000|Overall Study|Physician Decision|0|||
130189017|NCT05326529|468650224|FG001|Overall Study|Physician Decision|0|||
130189018|NCT05326529|468650225|FG002|Overall Study|Physician Decision|2|||
130189019|NCT01379768|468650226|FG000|Overall Study|Adverse Event|1|||
130189020|NCT01379768|468650227|FG001|Overall Study|Adverse Event|1|||
130189021|NCT01379768|468650228|FG002|Overall Study|Adverse Event|0|||
130189022|NCT01379768|468650226|FG000|Overall Study|Lost to Follow-up|2|||
130189023|NCT01379768|468650227|FG001|Overall Study|Lost to Follow-up|0|||
130189024|NCT01379768|468650228|FG002|Overall Study|Lost to Follow-up|0|||
130189025|NCT00708552|468650229|FG000|Overall Study|Adverse Event|10|||
130189026|NCT00708552|468650230|FG001|Overall Study|Adverse Event|3|||
130189027|NCT00708552|468650231|FG002|Overall Study|Adverse Event|4|||
130189028|NCT00708552|468650232|FG003|Overall Study|Adverse Event|6|||
130189029|NCT00708552|468650229|FG000|Overall Study|Lack of Efficacy|0|||
130189030|NCT00708552|468650230|FG001|Overall Study|Lack of Efficacy|4|||
130189031|NCT00708552|468650231|FG002|Overall Study|Lack of Efficacy|1|||
130189032|NCT00708552|468650232|FG003|Overall Study|Lack of Efficacy|0|||
130189033|NCT00708552|468650229|FG000|Overall Study|Protocol Violation|0|||
130189034|NCT00708552|468650230|FG001|Overall Study|Protocol Violation|0|||
130189035|NCT00708552|468650231|FG002|Overall Study|Protocol Violation|2|||
130189036|NCT00708552|468650232|FG003|Overall Study|Protocol Violation|4|||
130189037|NCT00708552|468650229|FG000|Overall Study|Lost to Follow-up|4|||
130189038|NCT00708552|468650230|FG001|Overall Study|Lost to Follow-up|2|||
130189039|NCT00708552|468650231|FG002|Overall Study|Lost to Follow-up|0|||
130189040|NCT00708552|468650232|FG003|Overall Study|Lost to Follow-up|1|||
130189041|NCT00708552|468650229|FG000|Overall Study|Physician Decision|1|||
130189042|NCT00708552|468650230|FG001|Overall Study|Physician Decision|2|||
130189043|NCT00708552|468650231|FG002|Overall Study|Physician Decision|0|||
130189044|NCT00708552|468650232|FG003|Overall Study|Physician Decision|0|||
130189045|NCT00708552|468650229|FG000|Overall Study|Withdrawal by Subject|12|||
130189046|NCT00708552|468650230|FG001|Overall Study|Withdrawal by Subject|7|||
130189047|NCT00708552|468650231|FG002|Overall Study|Withdrawal by Subject|8|||
130189048|NCT00708552|468650232|FG003|Overall Study|Withdrawal by Subject|10|||
130189049|NCT00455403|468650234|FG000|Overall Study|Lost to Follow-up|2|||
130189050|NCT00455403|468650235|FG001|Overall Study|Lost to Follow-up|1|||
130189051|NCT00455403|468650234|FG000|Overall Study|Withdrawal by Subject|1|||
130189052|NCT00455403|468650235|FG001|Overall Study|Withdrawal by Subject|3|||
130189053|NCT00455403|468650234|FG000|Overall Study|Protocol Violation|0|||
130189054|NCT00455403|468650235|FG001|Overall Study|Protocol Violation|2|||
130189055|NCT00350207|468650236|FG000|Overall Study|Adverse Event|5|||
130189056|NCT00350207|468650237|FG001|Overall Study|Adverse Event|2|||
130189057|NCT00350207|468650238|FG002|Overall Study|Adverse Event|2|||
130189058|NCT00350207|468650236|FG000|Overall Study|Lack of Efficacy|1|||
130189059|NCT00350207|468650237|FG001|Overall Study|Lack of Efficacy|0|||
130189060|NCT00350207|468650238|FG002|Overall Study|Lack of Efficacy|2|||
130189061|NCT00350207|468650236|FG000|Overall Study|Lost to Follow-up|1|||
130189062|NCT00350207|468650237|FG001|Overall Study|Lost to Follow-up|0|||
130189063|NCT00350207|468650238|FG002|Overall Study|Lost to Follow-up|1|||
130189064|NCT00350207|468650236|FG000|Overall Study|Withdrawal by Subject|0|||
130189065|NCT00350207|468650237|FG001|Overall Study|Withdrawal by Subject|1|||
130189066|NCT00350207|468650238|FG002|Overall Study|Withdrawal by Subject|1|||
130189067|NCT00350207|468650236|FG000|Overall Study|Other|1|||
130189068|NCT00350207|468650237|FG001|Overall Study|Other|3|||
130189069|NCT00350207|468650238|FG002|Overall Study|Other|1|||
130189070|NCT00495391|468650239|FG000|Overall Study|Lack of Efficacy|34|||
130189071|NCT00495391|468650240|FG001|Overall Study|Lack of Efficacy|18|||
130189072|NCT00495391|468650239|FG000|Overall Study|Withdrawal by Subject|2|||
130189073|NCT00495391|468650240|FG001|Overall Study|Withdrawal by Subject|3|||
130189074|NCT04509076|468650249|FG000|Overall Study|Withdrawal by Subject|1|||
130189075|NCT04509076|468650250|FG001|Overall Study|Withdrawal by Subject|2|||
130189076|NCT04509076|468650249|FG000|Overall Study|Lost to Follow-up|1|||
130189077|NCT04509076|468650250|FG001|Overall Study|Lost to Follow-up|2|||
130189078|NCT00502242|468650255|FG000|Overall Study|Lack of Efficacy|1|||
130189079|NCT00502242|468650256|FG001|Overall Study|Lack of Efficacy|11|||
130189080|NCT00502242|468650255|FG000|Overall Study|Adverse Event|31|||
130189081|NCT00502242|468650256|FG001|Overall Study|Adverse Event|20|||
130189082|NCT00502242|468650255|FG000|Overall Study|Physician Decision|2|||
130189083|NCT00502242|468650256|FG001|Overall Study|Physician Decision|3|||
130189084|NCT00502242|468650255|FG000|Overall Study|Other - Unspecified|8|||
130189085|NCT00502242|468650256|FG001|Overall Study|Other - Unspecified|14|||
130189086|NCT00502242|468650255|FG000|Overall Study|Protocol Violation|3|||
130189087|NCT00502242|468650256|FG001|Overall Study|Protocol Violation|1|||
130189088|NCT00502242|468650255|FG000|Overall Study|Withdrawal by Subject|6|||
130189089|NCT00502242|468650256|FG001|Overall Study|Withdrawal by Subject|7|||
130189090|NCT01812109|468650257|FG000|Overall Study|research personnel delay|16|||
130189091|NCT01812109|468650257|FG000|Overall Study|NIRS Unattainable|17|||
130189092|NCT03313180|468650258|FG000|Overall Study|Adverse Event|120|||
130189093|NCT03313180|468650258|FG000|Overall Study|Lost to Follow-up|3|||
130189094|NCT03313180|468650258|FG000|Overall Study|Withdrawal by Subject|39|||
130189095|NCT03313180|468650258|FG000|Overall Study|Other than listed above|15|||
130189096|NCT03313180|468650258|FG000|Overall Study|Covid-19 related|2|||
130189097|NCT01966120|468650259|FG000|Overall Study|Withdrawal by Subject|0|||
130189098|NCT01966120|468650260|FG001|Overall Study|Withdrawal by Subject|5|||
130189099|NCT01966120|468650259|FG000|Overall Study|Lost to Follow-up|1|||
130189100|NCT01966120|468650260|FG001|Overall Study|Lost to Follow-up|1|||
130189101|NCT00461630|468650261|FG000|Overall Study|Death|798|||
130189102|NCT00461630|468650262|FG001|Overall Study|Death|732|||
130189103|NCT00461630|468650261|FG000|Overall Study|Lost to Follow-up|108|||
130189104|NCT00461630|468650262|FG001|Overall Study|Lost to Follow-up|95|||
130189105|NCT04630002|468650263|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
130189106|NCT04630002|468650264|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189107|NCT04630002|468650265|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189108|NCT04630002|468650263|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
130189109|NCT04630002|468650264|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189110|NCT04630002|468650265|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189111|NCT04630002|468650263|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
130189112|NCT04630002|468650264|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189113|NCT04630002|468650265|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189114|NCT04630002|468650263|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189115|NCT04630002|468650264|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
130189116|NCT04630002|468650265|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
130189117|NCT04630002|468650263|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189118|NCT04630002|468650264|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
130189119|NCT04630002|468650265|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
130189120|NCT04630002|468650263|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189121|NCT04630002|468650264|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
130189122|NCT04630002|468650265|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
130189123|NCT04630002|468650263|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
130189124|NCT04630002|468650264|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
130189125|NCT04630002|468650265|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
130189126|NCT04630002|468650263|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
130189127|NCT04630002|468650264|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
130189128|NCT04630002|468650265|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
130189129|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
130189130|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
130189131|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Death|0|||
130189132|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Death|1|||
130189133|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
130189134|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
130189135|NCT00442897|468650267|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
130189136|NCT00442897|468650268|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
130189137|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
130189138|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
130189139|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
130189140|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
130189141|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
130189142|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
130189143|NCT00442897|468650267|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
130189144|NCT00442897|468650268|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
130189145|NCT04498182|468650269|FG000|Overall Study|Adverse Event|2|||
130189146|NCT04498182|468650270|FG001|Overall Study|Adverse Event|3|||
130189147|NCT04498182|468650271|FG002|Overall Study|Adverse Event|2|||
130189148|NCT04498182|468650269|FG000|Overall Study|Withdrawal of Consent|3|||
130189149|NCT04498182|468650270|FG001|Overall Study|Withdrawal of Consent|4|||
130189150|NCT04498182|468650271|FG002|Overall Study|Withdrawal of Consent|3|||
130189151|NCT04498182|468650269|FG000|Overall Study|Non-Compliant|1|||
130189152|NCT04498182|468650270|FG001|Overall Study|Non-Compliant|0|||
130189153|NCT04498182|468650271|FG002|Overall Study|Non-Compliant|1|||
130189154|NCT04498182|468650269|FG000|Overall Study|Lost to Follow-up|0|||
130189155|NCT04498182|468650270|FG001|Overall Study|Lost to Follow-up|0|||
130189156|NCT04498182|468650271|FG002|Overall Study|Lost to Follow-up|1|||
130189157|NCT04498182|468650269|FG000|Overall Study|Investigator Decision|0|||
130189158|NCT04498182|468650270|FG001|Overall Study|Investigator Decision|0|||
130189159|NCT04498182|468650271|FG002|Overall Study|Investigator Decision|1|||
130189160|NCT04498182|468650269|FG000|Overall Study|Protocol Violation|1|||
130189161|NCT04498182|468650270|FG001|Overall Study|Protocol Violation|0|||
130189162|NCT04498182|468650271|FG002|Overall Study|Protocol Violation|2|||
130189163|NCT00891020|468650276|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
130189164|NCT00891020|468650277|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
130189165|NCT00891020|468650278|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
130189166|NCT00891020|468650276|FG000|24 Week Treatment Period|Death|0|||
130189167|NCT00891020|468650277|FG001|24 Week Treatment Period|Death|2|||
130189168|NCT00891020|468650278|FG002|24 Week Treatment Period|Death|0|||
130189169|NCT00891020|468650276|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
130189170|NCT00891020|468650277|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
130189171|NCT00891020|468650278|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
130189172|NCT00891020|468650276|FG000|24 Week Treatment Period|Failure to return|4|||
130189173|NCT00891020|468650277|FG001|24 Week Treatment Period|Failure to return|5|||
130189174|NCT00891020|468650278|FG002|24 Week Treatment Period|Failure to return|5|||
130189175|NCT00891020|468650276|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
130189176|NCT00891020|468650277|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
130189177|NCT00891020|468650278|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
130189178|NCT00891020|468650276|FG000|24 Week Treatment Period|Other protocol violation|1|||
130189179|NCT00891020|468650277|FG001|24 Week Treatment Period|Other protocol violation|1|||
130189180|NCT00891020|468650278|FG002|24 Week Treatment Period|Other protocol violation|2|||
130189181|NCT00891020|468650276|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
130189182|NCT00891020|468650277|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
130189183|NCT00891020|468650278|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
130189184|NCT00891020|468650276|FG000|24 Week Treatment Period|Withdrew consent|6|||
130189185|NCT00891020|468650277|FG001|24 Week Treatment Period|Withdrew consent|3|||
130189186|NCT00891020|468650278|FG002|24 Week Treatment Period|Withdrew consent|15|||
130189187|NCT00891020|468650276|FG000|24 Week Treatment Period|Administrative/Other|5|||
130189188|NCT00891020|468650277|FG001|24 Week Treatment Period|Administrative/Other|6|||
130189189|NCT00891020|468650278|FG002|24 Week Treatment Period|Administrative/Other|1|||
130189190|NCT00891020|468650276|FG000|Long-term Extension Period|Adverse Event|1|||
130189191|NCT00891020|468650277|FG001|Long-term Extension Period|Adverse Event|11|||
130189192|NCT00891020|468650278|FG002|Long-term Extension Period|Adverse Event|10|||
130189193|NCT00891020|468650276|FG000|Long-term Extension Period|Death|0|||
130189194|NCT00891020|468650277|FG001|Long-term Extension Period|Death|0|||
130189195|NCT00891020|468650278|FG002|Long-term Extension Period|Death|1|||
130189196|NCT00891020|468650276|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
130189197|NCT00891020|468650277|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
130189198|NCT00891020|468650278|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
130189199|NCT00891020|468650276|FG000|Long-term Extension Period|Protocol Violation|0|||
130189200|NCT00891020|468650277|FG001|Long-term Extension Period|Protocol Violation|1|||
130189201|NCT00891020|468650278|FG002|Long-term Extension Period|Protocol Violation|1|||
130189202|NCT00891020|468650276|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
130189203|NCT00891020|468650277|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
130189204|NCT00891020|468650278|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
130189205|NCT00891020|468650276|FG000|Long-term Extension Period|Failure to return|0|||
130189206|NCT00891020|468650277|FG001|Long-term Extension Period|Failure to return|2|||
130189207|NCT00891020|468650278|FG002|Long-term Extension Period|Failure to return|3|||
130189208|NCT00891020|468650276|FG000|Long-term Extension Period|Administrative|1|||
130189209|NCT00891020|468650277|FG001|Long-term Extension Period|Administrative|2|||
130189210|NCT00891020|468650278|FG002|Long-term Extension Period|Administrative|2|||
130189211|NCT00320710|468650286|FG000|Overall Study|Disease progression|24|||
130189212|NCT00320710|468650287|FG001|Overall Study|Disease progression|19|||
130189213|NCT00320710|468650288|FG002|Overall Study|Disease progression|2|||
130189214|NCT00320710|468650286|FG000|Overall Study|Death|10|||
130189215|NCT00320710|468650287|FG001|Overall Study|Death|7|||
130189216|NCT00320710|468650288|FG002|Overall Study|Death|1|||
130189217|NCT00320710|468650286|FG000|Overall Study|Administrative problems|1|||
130189218|NCT00320710|468650287|FG001|Overall Study|Administrative problems|2|||
130189219|NCT00320710|468650288|FG002|Overall Study|Administrative problems|0|||
130189220|NCT00320710|468650286|FG000|Overall Study|Withdrawal by Subject|20|||
130189221|NCT00320710|468650287|FG001|Overall Study|Withdrawal by Subject|26|||
130189222|NCT00320710|468650288|FG002|Overall Study|Withdrawal by Subject|1|||
130189223|NCT00320710|468650286|FG000|Overall Study|Protocol Violation|6|||
130189224|NCT00320710|468650287|FG001|Overall Study|Protocol Violation|5|||
130189225|NCT00320710|468650288|FG002|Overall Study|Protocol Violation|0|||
130189226|NCT00320710|468650286|FG000|Overall Study|Abnormal test procedure result(s)|2|||
130189227|NCT00320710|468650287|FG001|Overall Study|Abnormal test procedure result(s)|0|||
130189228|NCT00320710|468650288|FG002|Overall Study|Abnormal test procedure result(s)|0|||
130189229|NCT00320710|468650286|FG000|Overall Study|Abnormal laboratory value(s)|12|||
130189230|NCT00320710|468650287|FG001|Overall Study|Abnormal laboratory value(s)|3|||
130189231|NCT00320710|468650288|FG002|Overall Study|Abnormal laboratory value(s)|0|||
130189232|NCT00320710|468650286|FG000|Overall Study|Adverse Event|18|||
130189233|NCT00320710|468650287|FG001|Overall Study|Adverse Event|14|||
130189234|NCT00320710|468650288|FG002|Overall Study|Adverse Event|1|||
130189235|NCT00320710|468650286|FG000|Overall Study|Lost to Follow-up|1|||
130189236|NCT00320710|468650287|FG001|Overall Study|Lost to Follow-up|0|||
130189237|NCT00320710|468650288|FG002|Overall Study|Lost to Follow-up|0|||
130189238|NCT03448419|468650289|FG000|Overall Study|Adverse Event|10|||
130189239|NCT03448419|468650290|FG001|Overall Study|Adverse Event|9|||
130189240|NCT03448419|468650289|FG000|Overall Study|Lost to Follow-up|0|||
130189241|NCT03448419|468650290|FG001|Overall Study|Lost to Follow-up|2|||
130189242|NCT03448419|468650289|FG000|Overall Study|Withdrawal by Subject|3|||
130189243|NCT03448419|468650290|FG001|Overall Study|Withdrawal by Subject|1|||
130189244|NCT03448419|468650289|FG000|Overall Study|Not treated|0|||
130189245|NCT03448419|468650290|FG001|Overall Study|Not treated|1|||
130189246|NCT03448419|468650289|FG000|Overall Study|Patient did not attend all visits|0|||
130189247|NCT03448419|468650290|FG001|Overall Study|Patient did not attend all visits|2|||
130189248|NCT03448419|468650289|FG000|Overall Study|Withdrawn by Sponsor|0|||
130189249|NCT03448419|468650290|FG001|Overall Study|Withdrawn by Sponsor|1|||
130189250|NCT02841995|468650291|FG000|Overall Study|Disease progression|5|||
130189251|NCT02841995|468650292|FG001|Overall Study|Disease progression|11|||
130189252|NCT02841995|468650293|FG002|Overall Study|Disease progression|8|||
130189253|NCT02841995|468650291|FG000|Overall Study|Withdrawal by Subject|2|||
130189254|NCT02841995|468650292|FG001|Overall Study|Withdrawal by Subject|4|||
130189255|NCT02841995|468650293|FG002|Overall Study|Withdrawal by Subject|4|||
130189256|NCT02841995|468650291|FG000|Overall Study|Adverse Event|2|||
130189257|NCT02841995|468650292|FG001|Overall Study|Adverse Event|0|||
130189258|NCT02841995|468650293|FG002|Overall Study|Adverse Event|1|||
130189259|NCT02841995|468650291|FG000|Overall Study|Investigator decision|2|||
130189260|NCT02841995|468650292|FG001|Overall Study|Investigator decision|0|||
130189261|NCT02841995|468650293|FG002|Overall Study|Investigator decision|1|||
130189262|NCT02841995|468650291|FG000|Overall Study|Death|0|||
130189263|NCT02841995|468650292|FG001|Overall Study|Death|0|||
130189264|NCT02841995|468650293|FG002|Overall Study|Death|2|||
130189265|NCT02841995|468650291|FG000|Overall Study|Noncompliance to protocol|1|||
130189266|NCT02841995|468650292|FG001|Overall Study|Noncompliance to protocol|0|||
130189267|NCT02841995|468650293|FG002|Overall Study|Noncompliance to protocol|0|||
130189268|NCT02841995|468650291|FG000|Overall Study|Sponsor decision|1|||
130189269|NCT02841995|468650292|FG001|Overall Study|Sponsor decision|0|||
130189270|NCT02841995|468650293|FG002|Overall Study|Sponsor decision|0|||
130189271|NCT02841995|468650291|FG000|Overall Study|Other|4|||
130189272|NCT02841995|468650292|FG001|Overall Study|Other|1|||
130189273|NCT02841995|468650293|FG002|Overall Study|Other|5|||
130189274|NCT01703260|468650294|FG000|Overall Study|Adverse Event|1|||
130189275|NCT01703260|468650295|FG001|Overall Study|Adverse Event|2|||
130189276|NCT01703260|468650296|FG002|Overall Study|Adverse Event|2|||
130189277|NCT01703260|468650294|FG000|Overall Study|Lost to Follow-up|1|||
130189278|NCT01703260|468650295|FG001|Overall Study|Lost to Follow-up|0|||
130189279|NCT01703260|468650296|FG002|Overall Study|Lost to Follow-up|0|||
130189280|NCT01703260|468650294|FG000|Overall Study|Withdrawal by Subject|0|||
130189281|NCT01703260|468650295|FG001|Overall Study|Withdrawal by Subject|0|||
130189282|NCT01703260|468650296|FG002|Overall Study|Withdrawal by Subject|1|||
130189283|NCT01703260|468650294|FG000|Overall Study|Study Termination|1|||
130189284|NCT01703260|468650295|FG001|Overall Study|Study Termination|2|||
130189285|NCT01703260|468650296|FG002|Overall Study|Study Termination|0|||
130189286|NCT04548193|468650300|FG000|Overall Study|Lost to Follow-up|0|||
130189287|NCT04548193|468650301|FG001|Overall Study|Lost to Follow-up|1|||
130189288|NCT04548193|468650300|FG000|Overall Study|Death|0|||
130189289|NCT04548193|468650301|FG001|Overall Study|Death|1|||
130189290|NCT04548193|468650300|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
130189291|NCT04548193|468650301|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
130189292|NCT04548193|468650300|FG000|Overall Study|Withdrawal by Subject|2|||
130189293|NCT04548193|468650301|FG001|Overall Study|Withdrawal by Subject|2|||
130189294|NCT00630825|468650302|FG000|Overall Study|Adverse Event|4|||
130189295|NCT00630825|468650303|FG001|Overall Study|Adverse Event|4|||
130189296|NCT00630825|468650304|FG002|Overall Study|Adverse Event|3|||
130189297|NCT00630825|468650305|FG003|Overall Study|Adverse Event|1|||
130189298|NCT00630825|468650302|FG000|Overall Study|Entry Criteria Not Met|1|||
130189299|NCT00630825|468650303|FG001|Overall Study|Entry Criteria Not Met|0|||
130189300|NCT00630825|468650304|FG002|Overall Study|Entry Criteria Not Met|2|||
130189301|NCT00630825|468650305|FG003|Overall Study|Entry Criteria Not Met|1|||
130189302|NCT00630825|468650302|FG000|Overall Study|Lost to Follow-up|1|||
130189303|NCT00630825|468650303|FG001|Overall Study|Lost to Follow-up|1|||
130189304|NCT00630825|468650304|FG002|Overall Study|Lost to Follow-up|1|||
130189305|NCT00630825|468650305|FG003|Overall Study|Lost to Follow-up|1|||
130189306|NCT00630825|468650302|FG000|Overall Study|Physician Decision|1|||
130189307|NCT00630825|468650303|FG001|Overall Study|Physician Decision|0|||
130189308|NCT00630825|468650304|FG002|Overall Study|Physician Decision|0|||
130189309|NCT00630825|468650305|FG003|Overall Study|Physician Decision|0|||
130189310|NCT00630825|468650302|FG000|Overall Study|Withdrawal by Subject|2|||
130189311|NCT00630825|468650303|FG001|Overall Study|Withdrawal by Subject|2|||
130189312|NCT00630825|468650304|FG002|Overall Study|Withdrawal by Subject|2|||
130189313|NCT00630825|468650305|FG003|Overall Study|Withdrawal by Subject|3|||
130189314|NCT02275819|468650306|FG000|Overall Study|Adverse Event|0|||
130189315|NCT02275819|468650307|FG001|Overall Study|Adverse Event|1|||
130189316|NCT02211209|468650311|FG000|Overall Study|Investigator judgment|0|||
130189317|NCT02211209|468650312|FG001|Overall Study|Investigator judgment|1|||
130189318|NCT02211209|468650311|FG000|Overall Study|Voluntary withdrawal|1|||
130189319|NCT02211209|468650312|FG001|Overall Study|Voluntary withdrawal|4|||
130189320|NCT02211209|468650311|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
130189321|NCT02211209|468650312|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
130189322|NCT02211209|468650311|FG000|Overall Study|Reason Not Specified|1|||
130189323|NCT02211209|468650312|FG001|Overall Study|Reason Not Specified|0|||
130189324|NCT02792062|468650315|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
130189325|NCT02792062|468650316|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189326|NCT02792062|468650317|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189327|NCT02792062|468650318|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189328|NCT02792062|468650319|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189329|NCT02792062|468650320|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
130189330|NCT00931255|468650323|FG000|Overall Study|Follow up biopsy not done|2|||
130189331|NCT00931255|468650324|FG001|Overall Study|Follow up biopsy not done|3|||
130189332|NCT01681212|468650330|FG000|Overall Study|No longer met study criteria|5|||
130189333|NCT01681212|468650330|FG000|Overall Study|Administrative reason by sponsor|1|||
130189334|NCT02220764|468650333|FG000|Overall Study|Lost to Follow-up|3|||
130189335|NCT02220764|468650334|FG001|Overall Study|Lost to Follow-up|1|||
130189336|NCT02220764|468650333|FG000|Overall Study|Death|1|||
130189337|NCT02220764|468650334|FG001|Overall Study|Death|0|||
130189338|NCT02198664|468650335|FG000|Overall Study|Adverse Event|2|||
130189339|NCT02198664|468650336|FG001|Overall Study|Adverse Event|0|||
130189340|NCT02198664|468650335|FG000|Overall Study|Withdrawal by Subject|11|||
130189341|NCT02198664|468650336|FG001|Overall Study|Withdrawal by Subject|8|||
130189342|NCT02198664|468650335|FG000|Overall Study|Failure to tolerate|2|||
130189343|NCT02198664|468650336|FG001|Overall Study|Failure to tolerate|0|||
130189344|NCT02198664|468650335|FG000|Overall Study|Not stated|1|||
130189345|NCT02198664|468650336|FG001|Overall Study|Not stated|0|||
130189346|NCT03859427|468650340|FG000|Overall Study|Withdrawal by Subject|4|||
130189347|NCT03859427|468650341|FG001|Overall Study|Withdrawal by Subject|7|||
130189348|NCT03859427|468650340|FG000|Overall Study|Decision by sponsor|0|||
130189349|NCT03859427|468650341|FG001|Overall Study|Decision by sponsor|3|||
130189350|NCT03859427|468650340|FG000|Overall Study|Lost to Follow-up|3|||
130189351|NCT03859427|468650341|FG001|Overall Study|Lost to Follow-up|2|||
130189352|NCT03859427|468650340|FG000|Overall Study|Death|22|||
130189353|NCT03859427|468650341|FG001|Overall Study|Death|25|||
130189354|NCT02503540|468650342|FG000|Overall Study|Death|2|||
130189355|NCT02503540|468650342|FG000|Overall Study|Withdrawal by Subject|1|||
130189356|NCT01662492|468650343|FG000|Overall Study|Other miscellaneous reasons.|1|||
130189357|NCT01662492|468650344|FG001|Overall Study|Other miscellaneous reasons.|0|||
130189358|NCT01662492|468650345|FG002|Overall Study|Other miscellaneous reasons.|1|||
130189359|NCT01662492|468650343|FG000|Overall Study|Withdrawal by Subject|0|||
130189360|NCT01662492|468650344|FG001|Overall Study|Withdrawal by Subject|0|||
130189361|NCT01662492|468650345|FG002|Overall Study|Withdrawal by Subject|1|||
130189362|NCT01662492|468650343|FG000|Overall Study|Protocol Violation|1|||
130189363|NCT01662492|468650344|FG001|Overall Study|Protocol Violation|0|||
130189364|NCT01662492|468650345|FG002|Overall Study|Protocol Violation|0|||
130189365|NCT01662492|468650343|FG000|Overall Study|Lost to Follow-up|0|||
130189366|NCT01662492|468650344|FG001|Overall Study|Lost to Follow-up|0|||
130189367|NCT01662492|468650345|FG002|Overall Study|Lost to Follow-up|2|||
130189368|NCT01662492|468650343|FG000|Overall Study|Lack of Efficacy|1|||
130189369|NCT01662492|468650344|FG001|Overall Study|Lack of Efficacy|1|||
130189370|NCT01662492|468650345|FG002|Overall Study|Lack of Efficacy|2|||
130189371|NCT02418182|468650350|FG000|Overall Study|Unable to re-consent|18|||
130189372|NCT02418182|468650351|FG001|Overall Study|Unable to re-consent|15|||
130189373|NCT02418182|468650350|FG000|Overall Study|Lost to Follow-up|0|||
130189374|NCT02418182|468650351|FG001|Overall Study|Lost to Follow-up|2|||
130189375|NCT00570687|468652060|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189376|NCT00570687|468652061|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189377|NCT00570687|468652062|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189378|NCT00570687|468652063|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189379|NCT00570687|468652064|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189380|NCT00570687|468652065|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189381|NCT00570687|468652066|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
130189382|NCT00570687|468652067|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189383|NCT00570687|468652068|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
130189384|NCT00570687|468652069|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
130189385|NCT00570687|468652060|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189386|NCT00570687|468652061|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189387|NCT00570687|468652062|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189388|NCT00570687|468652063|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189389|NCT00570687|468652064|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189390|NCT00570687|468652065|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189391|NCT00570687|468652066|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189392|NCT00570687|468652067|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189393|NCT00570687|468652068|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
130189394|NCT00570687|468652069|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189395|NCT00570687|468652060|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189396|NCT00570687|468652061|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189397|NCT00570687|468652062|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189398|NCT00570687|468652063|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189399|NCT00570687|468652064|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189400|NCT00570687|468652065|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189401|NCT00570687|468652066|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
130189402|NCT00570687|468652067|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189403|NCT00570687|468652068|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189404|NCT00570687|468652069|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
130189405|NCT01102257|468652077|FG000|Overall Study|Adverse Event|1|||
130189406|NCT01102257|468652078|FG001|Overall Study|Adverse Event|0|||
130189407|NCT01102257|468652077|FG000|Overall Study|Adverse Event|1|||
130189408|NCT01102257|468652078|FG001|Overall Study|Adverse Event|0|||
130189409|NCT04003636|468652079|FG000|Overall Study|Death|409|||
130189410|NCT04003636|468652080|FG001|Overall Study|Death|443|||
130189411|NCT04003636|468652079|FG000|Overall Study|Lost to Follow-up|0|||
130189412|NCT04003636|468652080|FG001|Overall Study|Lost to Follow-up|1|||
130189413|NCT04003636|468652079|FG000|Overall Study|Withdrawal by Subject|5|||
130189414|NCT04003636|468652080|FG001|Overall Study|Withdrawal by Subject|2|||
130189415|NCT04003636|468652079|FG000|Overall Study|Participant On-going|119|||
130189416|NCT04003636|468652080|FG001|Overall Study|Participant On-going|90|||
130189417|NCT03048747|468652081|FG000|Overall Study|Adverse Event|2|||
130189418|NCT03048747|468652081|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
130189419|NCT03048747|468652081|FG000|Overall Study|Physician Decision|1|||
130189420|NCT03270657|468652083|FG000|Overall Study|Withdrawal by Subject|1|||
130189421|NCT00162981|468652084|FG000|Overall Study|Adverse Event|2|||
130189422|NCT00162981|468652085|FG001|Overall Study|Adverse Event|5|||
130189423|NCT00162981|468652084|FG000|Overall Study|Withdrawal by Subject|1|||
130189424|NCT00162981|468652085|FG001|Overall Study|Withdrawal by Subject|1|||
130189425|NCT00162981|468652084|FG000|Overall Study|Physician Decision|1|||
130189426|NCT00162981|468652085|FG001|Overall Study|Physician Decision|0|||
130189427|NCT02588612|468652093|FG000|Overall Study|Physician Decision|1|||
130189428|NCT02588612|468652093|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
130189429|NCT02588612|468652093|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
130189430|NCT02588612|468652093|FG000|Overall Study|Death prior to T-cell infusion|1|||
130189431|NCT03809663|468652094|FG000|Overall Study|Decision by sponsor|24|||
130189432|NCT03809663|468652095|FG001|Overall Study|Decision by sponsor|18|||
130189433|NCT03809663|468652096|FG002|Overall Study|Decision by sponsor|20|||
130189434|NCT03809663|468652097|FG003|Overall Study|Decision by sponsor|20|||
130189435|NCT03809663|468652098|FG004|Overall Study|Decision by sponsor|0|||
130189436|NCT03809663|468652099|FG005|Overall Study|Decision by sponsor|0|||
130189437|NCT03809663|468652094|FG000|Overall Study|Withdrawal by Subject|26|||
130189438|NCT03809663|468652095|FG001|Overall Study|Withdrawal by Subject|22|||
130189439|NCT03809663|468652096|FG002|Overall Study|Withdrawal by Subject|27|||
130189440|NCT03809663|468652097|FG003|Overall Study|Withdrawal by Subject|26|||
130189441|NCT03809663|468652098|FG004|Overall Study|Withdrawal by Subject|0|||
130189442|NCT03809663|468652099|FG005|Overall Study|Withdrawal by Subject|0|||
130189443|NCT03809663|468652094|FG000|Overall Study|Lost to Follow-up|1|||
130189444|NCT03809663|468652095|FG001|Overall Study|Lost to Follow-up|4|||
130189445|NCT03809663|468652096|FG002|Overall Study|Lost to Follow-up|1|||
130189446|NCT03809663|468652097|FG003|Overall Study|Lost to Follow-up|1|||
130189447|NCT03809663|468652098|FG004|Overall Study|Lost to Follow-up|0|||
130189448|NCT03809663|468652099|FG005|Overall Study|Lost to Follow-up|0|||
130189449|NCT02042014|468652100|FG000|Overall Study|Adverse Event|1|||
130189450|NCT02042014|468652100|FG000|Overall Study|Physician Decision|7|||
130189451|NCT03309943|468652101|FG000|Overall Study|Withdrawal by Subject|0|||
130189452|NCT03309943|468652102|FG001|Overall Study|Withdrawal by Subject|1|||
130189453|NCT03309943|468652101|FG000|Overall Study|Inappropriate behavior towards staff|0|||
130189454|NCT03309943|468652102|FG001|Overall Study|Inappropriate behavior towards staff|1|||
130189455|NCT01372995|468652103|FG000|Overall Study|Spouse withdrew participant from study|0|||
130189456|NCT01372995|468652104|FG001|Overall Study|Spouse withdrew participant from study|1|||
130189457|NCT01372995|468652105|FG002|Overall Study|Spouse withdrew participant from study|0|||
130189458|NCT01372995|468652103|FG000|Overall Study|Physician Decision|0|||
130189459|NCT01372995|468652104|FG001|Overall Study|Physician Decision|0|||
130189460|NCT01372995|468652105|FG002|Overall Study|Physician Decision|1|||
130189461|NCT03123393|468652109|FG000|Overall Study|Study Terminated by Sponsor|6|||
130189462|NCT03123393|468652110|FG001|Overall Study|Study Terminated by Sponsor|9|||
130189463|NCT03123393|468652109|FG000|Overall Study|Withdrawal by Subject|2|||
130189464|NCT03123393|468652110|FG001|Overall Study|Withdrawal by Subject|1|||
130189465|NCT03123393|468652109|FG000|Overall Study|Reason not Specified|13|||
130189466|NCT03123393|468652110|FG001|Overall Study|Reason not Specified|13|||
130189467|NCT00558701|468652111|FG000|Overall Study|Protocol Deviations|1|||
130189468|NCT00558701|468652112|FG001|Overall Study|Protocol Deviations|4|||
130189469|NCT00427648|468652113|FG000|Overall Study|Protocol Violation|1|||
130189470|NCT00427648|468652114|FG001|Overall Study|Protocol Violation|2|||
130189471|NCT00427648|468652113|FG000|Overall Study|Adverse Event|0|||
130189472|NCT00427648|468652114|FG001|Overall Study|Adverse Event|1|||
130189473|NCT00105079|468652115|FG000|Overall Study|Adverse Event|5|||
130189474|NCT00105079|468652116|FG001|Overall Study|Adverse Event|12|||
130189475|NCT00105079|468652115|FG000|Overall Study|Death|3|||
130189476|NCT00105079|468652116|FG001|Overall Study|Death|1|||
130189477|NCT00105079|468652115|FG000|Overall Study|Lost to Follow-up|12|||
130189478|NCT00105079|468652116|FG001|Overall Study|Lost to Follow-up|12|||
130189479|NCT00105079|468652115|FG000|Overall Study|Lack of Efficacy|9|||
130189480|NCT00105079|468652116|FG001|Overall Study|Lack of Efficacy|3|||
130189481|NCT00105079|468652115|FG000|Overall Study|Refused treatment|6|||
130189482|NCT00105079|468652116|FG001|Overall Study|Refused treatment|4|||
130189483|NCT00105079|468652115|FG000|Overall Study|Violation of selection criteria at entry|0|||
130189484|NCT00105079|468652116|FG001|Overall Study|Violation of selection criteria at entry|2|||
130189485|NCT00105079|468652115|FG000|Overall Study|Protocol Violation|1|||
130189486|NCT00105079|468652116|FG001|Overall Study|Protocol Violation|0|||
130189487|NCT00105079|468652115|FG000|Overall Study|Other|3|||
130189488|NCT00105079|468652116|FG001|Overall Study|Other|1|||
130189489|NCT01609296|468652117|FG000|Overall Study|Death|253|||
130189490|NCT01609296|468652117|FG000|Overall Study|Withdrawal by Subject|151|||
130189491|NCT01609296|468652117|FG000|Overall Study|Lost to Follow-up|21|||
130189492|NCT01609296|468652117|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
130189493|NCT01609296|468652117|FG000|Overall Study|missed visit but known to be alive|28|||
130189494|NCT00386360|468652118|FG000|Overall Study|Adverse Event|4|||
130189495|NCT00386360|468652119|FG001|Overall Study|Adverse Event|2|||
130189496|NCT00386360|468652118|FG000|Overall Study|Physician Decision|2|||
130189497|NCT00386360|468652119|FG001|Overall Study|Physician Decision|2|||
130189498|NCT00386360|468652118|FG000|Overall Study|Lost to Follow-up|0|||
130189499|NCT00386360|468652119|FG001|Overall Study|Lost to Follow-up|2|||
130189500|NCT00386360|468652118|FG000|Overall Study|Protocol Violation|0|||
130189501|NCT00386360|468652119|FG001|Overall Study|Protocol Violation|3|||
130189502|NCT00386360|468652118|FG000|Overall Study|Withdrawal by Subject|3|||
130189503|NCT00386360|468652119|FG001|Overall Study|Withdrawal by Subject|6|||
130189504|NCT00386360|468652118|FG000|Overall Study|Did not take any study medication|0|||
130189505|NCT00386360|468652119|FG001|Overall Study|Did not take any study medication|2|||
130189506|NCT02230904|468652122|FG000|Overall Study|Safety follow up could not take place|0|||
130189507|NCT02230904|468652123|FG001|Overall Study|Safety follow up could not take place|1|||
130189508|NCT01464424|468652124|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
130189509|NCT01464424|468652125|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
130189510|NCT01464333|468652127|FG000|Overall Study|Adverse Event|34|||
130189511|NCT01464333|468652127|FG000|Overall Study|Lack of Efficacy|72|||
130189512|NCT01464333|468652127|FG000|Overall Study|Withdrawal by Subject|11|||
130189513|NCT01464333|468652127|FG000|Overall Study|Other|4|||
130189514|NCT01464333|468652127|FG000|Overall Study|No Hospital Visit|42|||
130189515|NCT02187198|468652130|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
130189516|NCT02187198|468652131|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
130189517|NCT02187198|468652130|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
130189518|NCT02187198|468652131|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
130189519|NCT01532518|468652132|FG000|Overall Study|Withdrawal by Subject|0|||
130189520|NCT01532518|468652133|FG001|Overall Study|Withdrawal by Subject|0|||
130189521|NCT01532518|468652134|FG002|Overall Study|Withdrawal by Subject|1|||
130189522|NCT01575834|468652135|FG000|Overall Study|Withdrawal by Subject|352|||
130189523|NCT01575834|468652136|FG001|Overall Study|Withdrawal by Subject|390|||
130189524|NCT01575834|468652135|FG000|Overall Study|Death|81|||
130189525|NCT01575834|468652136|FG001|Overall Study|Death|74|||
130189526|NCT01575834|468652135|FG000|Overall Study|Other|70|||
130189527|NCT01575834|468652136|FG001|Overall Study|Other|70|||
130189528|NCT01575834|468652135|FG000|Overall Study|Adverse Event|63|||
130189529|NCT01575834|468652136|FG001|Overall Study|Adverse Event|61|||
130189530|NCT01575834|468652135|FG000|Overall Study|Lost to Follow-up|55|||
130189531|NCT01575834|468652136|FG001|Overall Study|Lost to Follow-up|68|||
130189532|NCT01575834|468652135|FG000|Overall Study|Noncompliance|52|||
130189533|NCT01575834|468652136|FG001|Overall Study|Noncompliance|27|||
130189534|NCT01575834|468652135|FG000|Overall Study|Administrative decision|15|||
130189535|NCT01575834|468652136|FG001|Overall Study|Administrative decision|33|||
130189536|NCT01575834|468652135|FG000|Overall Study|Ineligibility Determined|5|||
130189537|NCT01575834|468652136|FG001|Overall Study|Ineligibility Determined|8|||
130189538|NCT01575834|468652135|FG000|Overall Study|Protocol Deviation|4|||
130189539|NCT01575834|468652136|FG001|Overall Study|Protocol Deviation|3|||
130189540|NCT01575834|468652135|FG000|Overall Study|Requirement for Alternative Therapy|2|||
130189541|NCT01575834|468652136|FG001|Overall Study|Requirement for Alternative Therapy|4|||
130189542|NCT02155283|468652138|FG000|Overall Study|Lost to Follow-up|3|||
130189543|NCT02155283|468652138|FG000|Overall Study|Withdrawal by Subject|1|||
130189544|NCT02155283|468652138|FG000|Overall Study|Protocol Violation|3|||
130189545|NCT02282813|468652140|FG000|Overall Study|Withdrawal by Subject|4|||
130189546|NCT02282813|468652141|FG001|Overall Study|Withdrawal by Subject|5|||
130189547|NCT02282813|468652142|FG002|Overall Study|Withdrawal by Subject|0|||
130189548|NCT02282813|468652140|FG000|Overall Study|Adverse Event|3|||
130189549|NCT02282813|468652141|FG001|Overall Study|Adverse Event|10|||
130189550|NCT02282813|468652142|FG002|Overall Study|Adverse Event|1|||
130189551|NCT02282813|468652140|FG000|Overall Study|Subject non-compliance|1|||
130189552|NCT02282813|468652141|FG001|Overall Study|Subject non-compliance|4|||
130189553|NCT02282813|468652142|FG002|Overall Study|Subject non-compliance|0|||
130189554|NCT02282813|468652140|FG000|Overall Study|Physician Decision|0|||
130189555|NCT02282813|468652141|FG001|Overall Study|Physician Decision|3|||
130189556|NCT02282813|468652142|FG002|Overall Study|Physician Decision|1|||
130189557|NCT02282813|468652140|FG000|Overall Study|Lost to Follow-up|2|||
130189558|NCT02282813|468652141|FG001|Overall Study|Lost to Follow-up|0|||
130189559|NCT02282813|468652142|FG002|Overall Study|Lost to Follow-up|1|||
130189560|NCT02282813|468652140|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
130189561|NCT02282813|468652141|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
130189562|NCT02282813|468652142|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
130189563|NCT02282813|468652140|FG000|Overall Study|Lack of Efficacy|1|||
130189564|NCT02282813|468652141|FG001|Overall Study|Lack of Efficacy|0|||
130189565|NCT02282813|468652142|FG002|Overall Study|Lack of Efficacy|0|||
130189566|NCT02282813|468652140|FG000|Overall Study|Administrative reasons|0|||
130189567|NCT02282813|468652141|FG001|Overall Study|Administrative reasons|1|||
130189568|NCT02282813|468652142|FG002|Overall Study|Administrative reasons|0|||
130189569|NCT05000164|468652147|FG000|Overall Study|Adverse Event|1|||
130189570|NCT05000164|468652147|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130189571|NCT05000164|468652147|FG000|Overall Study|Lens Discomfort|3|||
130189572|NCT05000164|468652147|FG000|Overall Study|Withdrew Consent during Study|2|||
130189573|NCT05000164|468652147|FG000|Overall Study|Subject Withdrawn by PI|2|||
130189574|NCT05000164|468652147|FG000|Overall Study|Other Fractured Test Article|1|||
130189575|NCT06509438|468652153|FG000|Overall Study|Adverse Event|1|||
130189576|NCT06509438|468652153|FG000|Overall Study|Lost to Follow-up|3|||
130189577|NCT03331796|468652154|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
130189578|NCT03331796|468652155|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
130189579|NCT03331796|468652156|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
130189580|NCT03331796|468652154|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
130189581|NCT03331796|468652155|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
130189582|NCT03331796|468652156|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
130189583|NCT03331796|468652154|FG000|Extended Follow-up|Adverse Event|1|||
130189584|NCT03331796|468652155|FG001|Extended Follow-up|Adverse Event|0|||
130189585|NCT03331796|468652156|FG002|Extended Follow-up|Adverse Event|1|||
130189586|NCT03331796|468652154|FG000|Extended Follow-up|Lost to Follow-up|0|||
130189587|NCT03331796|468652155|FG001|Extended Follow-up|Lost to Follow-up|0|||
130189588|NCT03331796|468652156|FG002|Extended Follow-up|Lost to Follow-up|1|||
130189589|NCT03331796|468652154|FG000|Extended Follow-up|Withdrawal by Subject|1|||
130189590|NCT03331796|468652155|FG001|Extended Follow-up|Withdrawal by Subject|0|||
130189591|NCT03331796|468652156|FG002|Extended Follow-up|Withdrawal by Subject|0|||
130189592|NCT03331796|468652154|FG000|Extended Follow-up|Termination of Funding|0|||
130189593|NCT03331796|468652155|FG001|Extended Follow-up|Termination of Funding|1|||
130189594|NCT03331796|468652156|FG002|Extended Follow-up|Termination of Funding|0|||
130189595|NCT01753570|468652157|FG000|Overall Study|Adverse Event|1|||
130189596|NCT01753570|468652158|FG001|Overall Study|Adverse Event|0|||
130189597|NCT01753570|468652159|FG002|Overall Study|Adverse Event|1|||
130189598|NCT01753570|468652157|FG000|Overall Study|Physician Decision|0|||
130189599|NCT01753570|468652158|FG001|Overall Study|Physician Decision|1|||
130189600|NCT01753570|468652159|FG002|Overall Study|Physician Decision|0|||
130189601|NCT01753570|468652157|FG000|Overall Study|Withdrawal by Subject|1|||
130189602|NCT01753570|468652158|FG001|Overall Study|Withdrawal by Subject|4|||
130189603|NCT01753570|468652159|FG002|Overall Study|Withdrawal by Subject|0|||
130189604|NCT01000155|468652160|FG000|Overall Study|Withdrawal by Subject|1|||
130189605|NCT01000155|468652160|FG000|Overall Study|Adverse Event|1|||
130189606|NCT00720213|468652163|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
130189607|NCT00720213|468652164|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
130189608|NCT00720213|468652165|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
130189609|NCT01808066|468652168|FG000|Overall Study|Withdrawal by Subject|15|||
130189610|NCT01252095|468652170|FG000|Overall Study|Disease progression|1|||
130189611|NCT01252095|468652171|FG001|Overall Study|Disease progression|0|||
130189612|NCT01420068|468652172|FG000|Overall Study|Administrative problems|1|||
130189613|NCT01420068|468652173|FG001|Overall Study|Administrative problems|3|||
130189614|NCT01420068|468652172|FG000|Overall Study|Withdrawal by Subject|1|||
130189615|NCT01420068|468652173|FG001|Overall Study|Withdrawal by Subject|2|||
130189616|NCT02554682|468652174|FG000|Overall Study|Lost to Follow-up|11|||
130189617|NCT02554682|468652175|FG001|Overall Study|Lost to Follow-up|9|||
130189618|NCT02554682|468652176|FG002|Overall Study|Lost to Follow-up|4|||
130189619|NCT02554682|468652177|FG003|Overall Study|Lost to Follow-up|3|||
130189620|NCT02554682|468652178|FG004|Overall Study|Lost to Follow-up|2|||
130189621|NCT02554682|468652179|FG005|Overall Study|Lost to Follow-up|1|||
130189622|NCT02554682|468652180|FG006|Overall Study|Lost to Follow-up|6|||
130189623|NCT02554682|468652181|FG007|Overall Study|Lost to Follow-up|6|||
130189624|NCT02554682|468652182|FG008|Overall Study|Lost to Follow-up|2|||
130189625|NCT02554682|468652183|FG009|Overall Study|Lost to Follow-up|2|||
130189626|NCT02554682|468652174|FG000|Overall Study|Withdrawal by Subject|2|||
130189627|NCT02554682|468652175|FG001|Overall Study|Withdrawal by Subject|1|||
130189628|NCT02554682|468652176|FG002|Overall Study|Withdrawal by Subject|0|||
130189629|NCT02554682|468652177|FG003|Overall Study|Withdrawal by Subject|0|||
130189630|NCT02554682|468652178|FG004|Overall Study|Withdrawal by Subject|0|||
130189631|NCT02554682|468652179|FG005|Overall Study|Withdrawal by Subject|0|||
130189632|NCT02554682|468652180|FG006|Overall Study|Withdrawal by Subject|0|||
130189633|NCT02554682|468652181|FG007|Overall Study|Withdrawal by Subject|0|||
130189634|NCT02554682|468652182|FG008|Overall Study|Withdrawal by Subject|0|||
130189635|NCT02554682|468652183|FG009|Overall Study|Withdrawal by Subject|0|||
130189636|NCT02554682|468652174|FG000|Overall Study|Physician Decision|2|||
130189637|NCT02554682|468652175|FG001|Overall Study|Physician Decision|2|||
130189638|NCT02554682|468652176|FG002|Overall Study|Physician Decision|0|||
130189639|NCT02554682|468652177|FG003|Overall Study|Physician Decision|0|||
130189640|NCT02554682|468652178|FG004|Overall Study|Physician Decision|0|||
130189641|NCT02554682|468652179|FG005|Overall Study|Physician Decision|0|||
130189642|NCT02554682|468652180|FG006|Overall Study|Physician Decision|0|||
130189643|NCT02554682|468652181|FG007|Overall Study|Physician Decision|0|||
130189644|NCT02554682|468652182|FG008|Overall Study|Physician Decision|0|||
130189645|NCT02554682|468652183|FG009|Overall Study|Physician Decision|0|||
130189646|NCT00884117|468652186|FG000|Overall Study|Adverse Event|2|||
130189647|NCT00884117|468652186|FG000|Overall Study|Withdrawal by Subject|89|||
130189648|NCT00884117|468652186|FG000|Overall Study|Death|3|||
130189649|NCT00884117|468652186|FG000|Overall Study|Lost to Follow-up|143|||
130189650|NCT00884117|468652186|FG000|Overall Study|Other|12|||
130189651|NCT04830969|468652189|FG000|Overall Study|Withdrawal by Subject|6|||
130189652|NCT04830969|468652190|FG001|Overall Study|Withdrawal by Subject|2|||
130189653|NCT04830969|468652189|FG000|Overall Study|Protocol Violation|3|||
130189654|NCT04830969|468652190|FG001|Overall Study|Protocol Violation|9|||
130189655|NCT04830969|468652189|FG000|Overall Study|Lost to Follow-up|4|||
130189656|NCT04830969|468652190|FG001|Overall Study|Lost to Follow-up|4|||
130189657|NCT01153815|468652195|FG000|Overall Study|Adverse Event|3|||
130189658|NCT01153815|468652196|FG001|Overall Study|Adverse Event|1|||
130189659|NCT01153815|468652195|FG000|Overall Study|Withdrawal by Subject|6|||
130189660|NCT01153815|468652196|FG001|Overall Study|Withdrawal by Subject|4|||
130189661|NCT01786993|468652197|FG000|Overall Study|Death|6|||
130189662|NCT01786993|468652198|FG001|Overall Study|Death|7|||
130189663|NCT01786993|468652197|FG000|Overall Study|Withdrawal by Subject|3|||
130189664|NCT01786993|468652198|FG001|Overall Study|Withdrawal by Subject|2|||
130189665|NCT01786993|468652197|FG000|Overall Study|Lost to Follow-up|0|||
130189666|NCT01786993|468652198|FG001|Overall Study|Lost to Follow-up|1|||
130189667|NCT01786993|468652197|FG000|Overall Study|Subject Non-Compliance|1|||
130189668|NCT01786993|468652198|FG001|Overall Study|Subject Non-Compliance|0|||
130189669|NCT01786993|468652197|FG000|Overall Study|System Explant|1|||
130189670|NCT01786993|468652198|FG001|Overall Study|System Explant|0|||
130189671|NCT01786993|468652197|FG000|Overall Study|Hospice Admission|1|||
130189672|NCT01786993|468652198|FG001|Overall Study|Hospice Admission|0|||
130189673|NCT01890122|468652199|FG000|Overall Study|Adverse Event|1|||
130189674|NCT01890122|468652200|FG001|Overall Study|Adverse Event|1|||
130189675|NCT01890122|468652201|FG002|Overall Study|Adverse Event|1|||
130189676|NCT01890122|468652202|FG003|Overall Study|Adverse Event|2|||
130189677|NCT01890122|468652199|FG000|Overall Study|Major Protocol Deviation|3|||
130189678|NCT01890122|468652200|FG001|Overall Study|Major Protocol Deviation|1|||
130189679|NCT01890122|468652201|FG002|Overall Study|Major Protocol Deviation|0|||
130189680|NCT01890122|468652202|FG003|Overall Study|Major Protocol Deviation|1|||
130189681|NCT01890122|468652199|FG000|Overall Study|Lost to Follow-up|0|||
130189682|NCT01890122|468652200|FG001|Overall Study|Lost to Follow-up|1|||
130189683|NCT01890122|468652201|FG002|Overall Study|Lost to Follow-up|2|||
130189684|NCT01890122|468652202|FG003|Overall Study|Lost to Follow-up|2|||
130189685|NCT01890122|468652199|FG000|Overall Study|Voluntary Withdrawal|8|||
130189686|NCT01890122|468652200|FG001|Overall Study|Voluntary Withdrawal|8|||
130189687|NCT01890122|468652201|FG002|Overall Study|Voluntary Withdrawal|2|||
130189688|NCT01890122|468652202|FG003|Overall Study|Voluntary Withdrawal|11|||
130189689|NCT01890122|468652199|FG000|Overall Study|Lack of Efficacy|14|||
130189690|NCT01890122|468652200|FG001|Overall Study|Lack of Efficacy|24|||
130189691|NCT01890122|468652201|FG002|Overall Study|Lack of Efficacy|7|||
130189692|NCT01890122|468652202|FG003|Overall Study|Lack of Efficacy|41|||
130189693|NCT01890122|468652199|FG000|Overall Study|Reason not Specified|0|||
130189694|NCT01890122|468652200|FG001|Overall Study|Reason not Specified|1|||
130189695|NCT01890122|468652201|FG002|Overall Study|Reason not Specified|1|||
130189696|NCT01890122|468652202|FG003|Overall Study|Reason not Specified|2|||
130189697|NCT01890122|468652199|FG000|Overall Study|Randomized but not Treated|1|||
130189698|NCT01890122|468652200|FG001|Overall Study|Randomized but not Treated|1|||
130189699|NCT01890122|468652201|FG002|Overall Study|Randomized but not Treated|0|||
130189700|NCT01890122|468652202|FG003|Overall Study|Randomized but not Treated|0|||
130189701|NCT02505217|468652206|FG000|Overall Study|Withdrawal by Subject|1|||
130189702|NCT02505217|468652207|FG001|Overall Study|Withdrawal by Subject|2|||
130189703|NCT00153179|468652217|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
130189704|NCT00153179|468652218|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
130189705|NCT00153179|468652219|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
130189706|NCT00153179|468652220|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
130189707|NCT04495829|468652221|FG000|Overall Study|Lost to Follow-up|2|||
130189708|NCT04495829|468652221|FG000|Overall Study|Inclusion criterion not met|3|||
130189709|NCT02712554|468652224|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
130189710|NCT02712554|468652225|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
130189711|NCT02712554|468652224|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
130189712|NCT02712554|468652225|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
130189713|NCT02712554|468652224|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
130189714|NCT02712554|468652225|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
130189715|NCT02712554|468652224|FG000|Part B: Qualification Phase|Adverse Event|0|||
130189716|NCT02712554|468652225|FG001|Part B: Qualification Phase|Adverse Event|1|||
130189717|NCT02712554|468652224|FG000|Part B: Treatment Phase|Adverse Event|0|||
130189718|NCT02712554|468652225|FG001|Part B: Treatment Phase|Adverse Event|1|||
130189719|NCT02712554|468652224|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
130189720|NCT02712554|468652225|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
130189721|NCT02712554|468652224|FG000|Part B: Treatment Phase|Other|0|||
130189722|NCT02712554|468652225|FG001|Part B: Treatment Phase|Other|1|||
130189723|NCT00979654|468652226|FG000|Overall Study|Lost to Follow-up|1|||
130189724|NCT00979654|468652226|FG000|Overall Study|Withdrawal by Subject|22|||
130189725|NCT00979654|468652226|FG000|Overall Study|Death|1|||
130189726|NCT00979654|468652226|FG000|Overall Study|Lack of Efficacy|6|||
130189727|NCT00979654|468652226|FG000|Overall Study|Adverse Event|1|||
130189728|NCT00979654|468652226|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
130189729|NCT00979654|468652226|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
130189730|NCT00979654|468652226|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
130189731|NCT00979654|468652226|FG000|Overall Study|Serious Adverse Event|1|||
130189732|NCT00979654|468652226|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
130189733|NCT01129557|468652227|FG000|Overall Study|Adverse Event|1|||
130189734|NCT01129557|468652228|FG001|Overall Study|Adverse Event|2|||
130189735|NCT01129557|468652229|FG002|Overall Study|Adverse Event|2|||
130189736|NCT01129557|468652227|FG000|Overall Study|Novartis terminated study early|3|||
130189737|NCT01129557|468652228|FG001|Overall Study|Novartis terminated study early|3|||
130189738|NCT01129557|468652229|FG002|Overall Study|Novartis terminated study early|2|||
130189739|NCT00669669|468652230|FG000|Overall Study|To late to start treatment|1|||
130189740|NCT01068678|468653741|FG000|Overall Study|Lack of Efficacy|3|||
130189741|NCT01068678|468653742|FG001|Overall Study|Lack of Efficacy|2|||
130189742|NCT01068678|468653741|FG000|Overall Study|Protocol Violation|5|||
130189743|NCT01068678|468653742|FG001|Overall Study|Protocol Violation|1|||
130189744|NCT01068678|468653741|FG000|Overall Study|Withdrawal criteria|12|||
130189745|NCT01068678|468653742|FG001|Overall Study|Withdrawal criteria|6|||
130189746|NCT01068678|468653741|FG000|Overall Study|Unclassified|18|||
130189747|NCT01068678|468653742|FG001|Overall Study|Unclassified|15|||
130189748|NCT03055338|468653745|FG000|Overall Study|Lost to Follow-up|9|||
130189749|NCT03055338|468653746|FG001|Overall Study|Lost to Follow-up|2|||
130189750|NCT03055338|468653747|FG002|Overall Study|Lost to Follow-up|3|||
130189751|NCT03055338|468653745|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
130189752|NCT03055338|468653746|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
130189753|NCT03055338|468653747|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
130189754|NCT03055338|468653745|FG000|Overall Study|Physician Decision|0|||
130189755|NCT03055338|468653746|FG001|Overall Study|Physician Decision|0|||
130189756|NCT03055338|468653747|FG002|Overall Study|Physician Decision|2|||
130189757|NCT03055338|468653745|FG000|Overall Study|Withdrawal by Subject|9|||
130189758|NCT03055338|468653746|FG001|Overall Study|Withdrawal by Subject|8|||
130189759|NCT03055338|468653747|FG002|Overall Study|Withdrawal by Subject|7|||
130189760|NCT00975611|468653748|FG000|Overall Study|Screen Fail|16|||
130189761|NCT00975611|468653748|FG000|Overall Study|Physician Decision|1|||
130189762|NCT03058705|468653749|FG000|Overall Study|Withdrawal by Subject|2|||
130189763|NCT03058705|468653749|FG000|Overall Study|Physician Decision|2|||
130189764|NCT01682226|468653750|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
130189765|NCT01682226|468653750|FG000|Overall Study|Participants did not receive treatment|2|||
130189766|NCT01682226|468653750|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
130189767|NCT02159053|468653751|FG000|Overall Study|Death|2|||
130189768|NCT02159053|468653752|FG001|Overall Study|Death|0|||
130189769|NCT02159053|468653753|FG002|Overall Study|Death|1|||
130189770|NCT02159053|468653751|FG000|Overall Study|Physician Decision|0|||
130189771|NCT02159053|468653752|FG001|Overall Study|Physician Decision|1|||
130189772|NCT02159053|468653753|FG002|Overall Study|Physician Decision|1|||
130189773|NCT02159053|468653751|FG000|Overall Study|Lack of Efficacy|3|||
130189774|NCT02159053|468653752|FG001|Overall Study|Lack of Efficacy|4|||
130189775|NCT02159053|468653753|FG002|Overall Study|Lack of Efficacy|7|||
130189776|NCT02159053|468653751|FG000|Overall Study|Adverse Event|7|||
130189777|NCT02159053|468653752|FG001|Overall Study|Adverse Event|6|||
130189778|NCT02159053|468653753|FG002|Overall Study|Adverse Event|5|||
130189779|NCT02159053|468653751|FG000|Overall Study|Participants/guardian decision|8|||
130189780|NCT02159053|468653752|FG001|Overall Study|Participants/guardian decision|10|||
130189781|NCT02159053|468653753|FG002|Overall Study|Participants/guardian decision|6|||
130189782|NCT00457002|468653758|FG000|Overall Study|Death|40|||
130189783|NCT00457002|468653759|FG001|Overall Study|Death|47|||
130189784|NCT00457002|468653758|FG000|Overall Study|Adverse Event|284|||
130189785|NCT00457002|468653759|FG001|Overall Study|Adverse Event|260|||
130189786|NCT00457002|468653758|FG000|Overall Study|Withdrawal by Subject|299|||
130189787|NCT00457002|468653759|FG001|Overall Study|Withdrawal by Subject|271|||
130189788|NCT00457002|468653758|FG000|Overall Study|Lost to Follow-up|72|||
130189789|NCT00457002|468653759|FG001|Overall Study|Lost to Follow-up|71|||
130189790|NCT00457002|468653758|FG000|Overall Study|Poor/Non-compliance|46|||
130189791|NCT00457002|468653759|FG001|Overall Study|Poor/Non-compliance|33|||
130189792|NCT00457002|468653758|FG000|Overall Study|No longer met criteria|41|||
130189793|NCT00457002|468653759|FG001|Overall Study|No longer met criteria|37|||
130189794|NCT00457002|468653758|FG000|Overall Study|Administrative reason by Sponsor|1|||
130189795|NCT00457002|468653759|FG001|Overall Study|Administrative reason by Sponsor|0|||
130189796|NCT00457002|468653758|FG000|Overall Study|non-specified|29|||
130189797|NCT00457002|468653759|FG001|Overall Study|non-specified|38|||
130189798|NCT00457002|468653758|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
130189799|NCT00457002|468653759|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
130189800|NCT02283268|468653760|FG000|Overall Study|Withdrawal by Subject|1|||
130189801|NCT00454246|468653761|FG000|Overall Study|Adverse Event|2|||
130189802|NCT00454246|468653762|FG001|Overall Study|Adverse Event|2|||
130189803|NCT00454246|468653763|FG002|Overall Study|Adverse Event|0|||
130189804|NCT00454246|468653761|FG000|Overall Study|Violation of selection criteria at entry|6|||
130189805|NCT00454246|468653762|FG001|Overall Study|Violation of selection criteria at entry|0|||
130189806|NCT00454246|468653763|FG002|Overall Study|Violation of selection criteria at entry|0|||
130189807|NCT00454246|468653761|FG000|Overall Study|Protocol Violation|1|||
130189808|NCT00454246|468653762|FG001|Overall Study|Protocol Violation|0|||
130189809|NCT00454246|468653763|FG002|Overall Study|Protocol Violation|0|||
130189810|NCT00454246|468653761|FG000|Overall Study|Refused Treatment|1|||
130189811|NCT00454246|468653762|FG001|Overall Study|Refused Treatment|1|||
130189812|NCT00454246|468653763|FG002|Overall Study|Refused Treatment|0|||
130189813|NCT00454246|468653761|FG000|Overall Study|Failure to return|1|||
130189814|NCT00454246|468653762|FG001|Overall Study|Failure to return|0|||
130189815|NCT00454246|468653763|FG002|Overall Study|Failure to return|0|||
130189816|NCT00454246|468653761|FG000|Overall Study|Early termination of study|62|||
130189817|NCT00454246|468653762|FG001|Overall Study|Early termination of study|26|||
130189818|NCT00454246|468653763|FG002|Overall Study|Early termination of study|9|||
130189819|NCT01085630|468653774|FG000|Overall Study|Insufficient data|1|||
130189820|NCT01085630|468653775|FG001|Overall Study|Insufficient data|0|||
130189821|NCT01085630|468653774|FG000|Overall Study|Ineligible|3|||
130189822|NCT01085630|468653775|FG001|Overall Study|Ineligible|0|||
130189823|NCT01017874|468653776|FG000|Overall Study|Withdrawal by Subject|23|||
130189824|NCT01017874|468653777|FG001|Overall Study|Withdrawal by Subject|20|||
130189825|NCT01017874|468653776|FG000|Overall Study|Sponsor decision|3|||
130189826|NCT01017874|468653777|FG001|Overall Study|Sponsor decision|1|||
130189827|NCT01017874|468653776|FG000|Overall Study|Lost to Follow-up|3|||
130189828|NCT01017874|468653777|FG001|Overall Study|Lost to Follow-up|2|||
130189829|NCT01017874|468653776|FG000|Overall Study|Physician Decision|1|||
130189830|NCT01017874|468653777|FG001|Overall Study|Physician Decision|3|||
130189831|NCT01346696|468653778|FG000|Overall Study|Death|1|||
130189832|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
130189833|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189834|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189835|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189836|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
130189837|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130189838|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130189839|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
130189840|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
130189841|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130189842|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130189843|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
130189844|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
130189845|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189846|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189847|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189848|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
130189849|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189850|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189851|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189852|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
130189853|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189854|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189855|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189856|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
130189857|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130189858|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130189859|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
130189860|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
130189861|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130189862|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130189863|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
130189864|NCT00506415|468653789|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
130189865|NCT00506415|468653790|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189866|NCT00506415|468653791|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189867|NCT00506415|468653792|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189868|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
130189869|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
130189870|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
130189871|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
130189872|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
130189873|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
130189874|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
130189875|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
130189876|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
130189877|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
130189878|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
130189879|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
130189880|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
130189881|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
130189882|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
130189883|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
130189884|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
130189885|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
130189886|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
130189887|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
130189888|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
130189889|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
130189890|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
130189891|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
130189892|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
130189893|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
130189894|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
130189895|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
130189896|NCT00506415|468653789|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130189897|NCT00506415|468653790|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130189898|NCT00506415|468653791|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
130189899|NCT00506415|468653792|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
130189900|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130189901|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130189902|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
130189903|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
130189904|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189905|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189906|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
130189907|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
130189908|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189909|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189910|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
130189911|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
130189912|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189913|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189914|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
130189915|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
130189916|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189917|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189918|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
130189919|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
130189920|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189921|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189922|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
130189923|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
130189924|NCT00506415|468653789|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130189925|NCT00506415|468653790|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130189926|NCT00506415|468653791|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
130189927|NCT00506415|468653792|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
130189928|NCT04578457|468653793|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
130189929|NCT04578457|468653793|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
130189930|NCT04578457|468653793|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
130189931|NCT04578457|468653793|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
130189932|NCT01297517|468653809|FG000|Overall Study|Adverse Event|21|||
130189933|NCT01297517|468653810|FG001|Overall Study|Adverse Event|7|||
130189934|NCT01297517|468653811|FG002|Overall Study|Adverse Event|16|||
130189935|NCT01297517|468653809|FG000|Overall Study|Lost to Follow-up|1|||
130189936|NCT01297517|468653810|FG001|Overall Study|Lost to Follow-up|0|||
130189937|NCT01297517|468653811|FG002|Overall Study|Lost to Follow-up|1|||
130189938|NCT01297517|468653809|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
130189939|NCT01297517|468653810|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
130189940|NCT01297517|468653811|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
130189941|NCT01297517|468653809|FG000|Overall Study|Noncompliance|1|||
130189942|NCT01297517|468653810|FG001|Overall Study|Noncompliance|0|||
130189943|NCT01297517|468653811|FG002|Overall Study|Noncompliance|0|||
130189944|NCT01297517|468653809|FG000|Overall Study|Protocol Violation|1|||
130189945|NCT01297517|468653810|FG001|Overall Study|Protocol Violation|1|||
130189946|NCT01297517|468653811|FG002|Overall Study|Protocol Violation|1|||
130189947|NCT01297517|468653809|FG000|Overall Study|Inadequate Control of IOP|1|||
130189948|NCT01297517|468653810|FG001|Overall Study|Inadequate Control of IOP|1|||
130189949|NCT01297517|468653811|FG002|Overall Study|Inadequate Control of IOP|2|||
130189950|NCT00628212|468653814|FG000|Overall Study|Adverse Event|2|||
130189951|NCT00628212|468653815|FG001|Overall Study|Adverse Event|0|||
130189952|NCT00628212|468653816|FG002|Overall Study|Adverse Event|1|||
130189953|NCT00628212|468653817|FG003|Overall Study|Adverse Event|2|||
130189954|NCT00628212|468653814|FG000|Overall Study|Physician Decision|1|||
130189955|NCT00628212|468653815|FG001|Overall Study|Physician Decision|1|||
130189956|NCT00628212|468653816|FG002|Overall Study|Physician Decision|2|||
130189957|NCT00628212|468653817|FG003|Overall Study|Physician Decision|3|||
130189958|NCT00789373|468653820|FG000|Induction|Adverse Event|64|||
130189959|NCT00789373|468653821|FG001|Induction|Adverse Event|0|||
130189960|NCT00789373|468653822|FG002|Induction|Adverse Event|0|||
130189961|NCT00789373|468653820|FG000|Induction|Death Due to study disease|24|||
130189962|NCT00789373|468653821|FG001|Induction|Death Due to study disease|0|||
130189963|NCT00789373|468653822|FG002|Induction|Death Due to study disease|0|||
130189964|NCT00789373|468653820|FG000|Induction|Death due to adverse event|19|||
130189965|NCT00789373|468653821|FG001|Induction|Death due to adverse event|0|||
130189966|NCT00789373|468653822|FG002|Induction|Death due to adverse event|0|||
130189967|NCT00789373|468653820|FG000|Induction|Death due to toxicity|11|||
130189968|NCT00789373|468653821|FG001|Induction|Death due to toxicity|0|||
130189969|NCT00789373|468653822|FG002|Induction|Death due to toxicity|0|||
130189970|NCT00789373|468653820|FG000|Induction|Death due to procedure|1|||
130189971|NCT00789373|468653821|FG001|Induction|Death due to procedure|0|||
130189972|NCT00789373|468653822|FG002|Induction|Death due to procedure|0|||
130189973|NCT00789373|468653820|FG000|Induction|Investigator decision|7|||
130189974|NCT00789373|468653821|FG001|Induction|Investigator decision|0|||
130189975|NCT00789373|468653822|FG002|Induction|Investigator decision|0|||
130189976|NCT00789373|468653820|FG000|Induction|Protocol entry criteria not met|9|||
130189977|NCT00789373|468653821|FG001|Induction|Protocol entry criteria not met|0|||
130189978|NCT00789373|468653822|FG002|Induction|Protocol entry criteria not met|0|||
130189979|NCT00789373|468653820|FG000|Induction|Lost to Follow-up|6|||
130189980|NCT00789373|468653821|FG001|Induction|Lost to Follow-up|0|||
130189981|NCT00789373|468653822|FG002|Induction|Lost to Follow-up|0|||
130189982|NCT00789373|468653820|FG000|Induction|Protocol Violation|1|||
130189983|NCT00789373|468653821|FG001|Induction|Protocol Violation|0|||
130189984|NCT00789373|468653822|FG002|Induction|Protocol Violation|0|||
130189985|NCT00789373|468653820|FG000|Induction|Progressive Disease|220|||
130189986|NCT00789373|468653821|FG001|Induction|Progressive Disease|0|||
130189987|NCT00789373|468653822|FG002|Induction|Progressive Disease|0|||
130189988|NCT00789373|468653820|FG000|Induction|Withdrawal by Subject|37|||
130189989|NCT00789373|468653821|FG001|Induction|Withdrawal by Subject|0|||
130189990|NCT00789373|468653822|FG002|Induction|Withdrawal by Subject|0|||
130189991|NCT00789373|468653820|FG000|Maintenance|Adverse Event|0|||
130189992|NCT00789373|468653821|FG001|Maintenance|Adverse Event|65|||
130189993|NCT00789373|468653822|FG002|Maintenance|Adverse Event|12|||
130189994|NCT00789373|468653820|FG000|Maintenance|Death due to study disease|0|||
130189995|NCT00789373|468653821|FG001|Maintenance|Death due to study disease|3|||
130189996|NCT00789373|468653822|FG002|Maintenance|Death due to study disease|1|||
130189997|NCT00789373|468653820|FG000|Maintenance|Death due to adverse event|0|||
130189998|NCT00789373|468653821|FG001|Maintenance|Death due to adverse event|4|||
130189999|NCT00789373|468653822|FG002|Maintenance|Death due to adverse event|1|||
130190000|NCT00789373|468653820|FG000|Maintenance|Death due to toxicity|0|||
130190001|NCT00789373|468653821|FG001|Maintenance|Death due to toxicity|1|||
130190002|NCT00789373|468653822|FG002|Maintenance|Death due to toxicity|2|||
130190003|NCT00789373|468653820|FG000|Maintenance|Investigator Decision|0|||
130190004|NCT00789373|468653821|FG001|Maintenance|Investigator Decision|4|||
130190005|NCT00789373|468653822|FG002|Maintenance|Investigator Decision|2|||
130190006|NCT00789373|468653820|FG000|Maintenance|Protocol entry criteria not met|0|||
130190007|NCT00789373|468653821|FG001|Maintenance|Protocol entry criteria not met|2|||
130190008|NCT00789373|468653822|FG002|Maintenance|Protocol entry criteria not met|0|||
130190009|NCT00789373|468653820|FG000|Maintenance|Lost to Follow-up|0|||
130190010|NCT00789373|468653821|FG001|Maintenance|Lost to Follow-up|2|||
130190011|NCT00789373|468653822|FG002|Maintenance|Lost to Follow-up|0|||
130190012|NCT00789373|468653820|FG000|Maintenance|Progressive Disease|0|||
130190013|NCT00789373|468653821|FG001|Maintenance|Progressive Disease|253|||
130190014|NCT00789373|468653822|FG002|Maintenance|Progressive Disease|152|||
130190015|NCT00789373|468653820|FG000|Maintenance|Withdrawal by Subject|0|||
130190016|NCT00789373|468653821|FG001|Maintenance|Withdrawal by Subject|21|||
130190017|NCT00789373|468653822|FG002|Maintenance|Withdrawal by Subject|8|||
130190018|NCT00789373|468653820|FG000|Maintenance|Sponsor Decision|0|||
130190019|NCT00789373|468653821|FG001|Maintenance|Sponsor Decision|0|||
130190020|NCT00789373|468653822|FG002|Maintenance|Sponsor Decision|2|||
130190021|NCT00789373|468653820|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
130190022|NCT00789373|468653821|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
130190023|NCT00789373|468653822|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
130190024|NCT00546377|468653823|FG000|Overall Study|Deemed ineligible|1|||
130190025|NCT00546377|468653823|FG000|Overall Study|Adverse Event|6|||
130190026|NCT03321968|468653824|FG000|Overall Study|Withdrawal by Subject|1|||
130190027|NCT03321968|468653825|FG001|Overall Study|Withdrawal by Subject|2|||
130190028|NCT03321968|468653826|FG002|Overall Study|Withdrawal by Subject|1|||
130190029|NCT03321968|468653824|FG000|Overall Study|Lost to Follow-up|2|||
130190030|NCT03321968|468653825|FG001|Overall Study|Lost to Follow-up|0|||
130190031|NCT03321968|468653826|FG002|Overall Study|Lost to Follow-up|1|||
130190032|NCT03321968|468653824|FG000|Overall Study|Other than specified|0|||
130190033|NCT03321968|468653825|FG001|Overall Study|Other than specified|0|||
130190034|NCT03321968|468653826|FG002|Overall Study|Other than specified|1|||
130190035|NCT00463047|468653832|FG000|Titration Period 1|Adverse Event|10|||
130190036|NCT00463047|468653833|FG001|Titration Period 1|Adverse Event|8|||
130190037|NCT00463047|468653832|FG000|Titration Period 1|Lack of Efficacy|10|||
130190038|NCT00463047|468653833|FG001|Titration Period 1|Lack of Efficacy|4|||
130190039|NCT00463047|468653832|FG000|Titration Period 1|Lost to Follow-up|2|||
130190040|NCT00463047|468653833|FG001|Titration Period 1|Lost to Follow-up|0|||
130190041|NCT00463047|468653832|FG000|Titration Period 1|Non-compliance with study medication|3|||
130190042|NCT00463047|468653833|FG001|Titration Period 1|Non-compliance with study medication|5|||
130190043|NCT00463047|468653832|FG000|Titration Period 1|Protocol Violation|5|||
130190044|NCT00463047|468653833|FG001|Titration Period 1|Protocol Violation|5|||
130190045|NCT00463047|468653832|FG000|Titration Period 1|Withdrawal by Subject|3|||
130190046|NCT00463047|468653833|FG001|Titration Period 1|Withdrawal by Subject|5|||
130190047|NCT00463047|468653832|FG000|Titration Period 1|Non-compliance procedures|4|||
130190048|NCT00463047|468653833|FG001|Titration Period 1|Non-compliance procedures|10|||
130190049|NCT00463047|468653832|FG000|Titration Period 1|Other|0|||
130190050|NCT00463047|468653833|FG001|Titration Period 1|Other|2|||
130190051|NCT00463047|468653832|FG000|Titration Period 2|Adverse Event|9|||
130190052|NCT00463047|468653833|FG001|Titration Period 2|Adverse Event|9|||
130190053|NCT00463047|468653832|FG000|Titration Period 2|Lack of Efficacy|6|||
130190054|NCT00463047|468653833|FG001|Titration Period 2|Lack of Efficacy|4|||
130190055|NCT00463047|468653832|FG000|Titration Period 2|Withdrawal by Subject|1|||
130190056|NCT00463047|468653833|FG001|Titration Period 2|Withdrawal by Subject|0|||
130190057|NCT00463047|468653832|FG000|Titration Period 2|Protocol Violation|2|||
130190058|NCT00463047|468653833|FG001|Titration Period 2|Protocol Violation|3|||
130190059|NCT00463047|468653832|FG000|Titration Period 2|Lost to Follow-up|1|||
130190060|NCT00463047|468653833|FG001|Titration Period 2|Lost to Follow-up|2|||
130190061|NCT00463047|468653832|FG000|Titration Period 2|Non-compliance study medication|4|||
130190062|NCT00463047|468653833|FG001|Titration Period 2|Non-compliance study medication|2|||
130190063|NCT00463047|468653832|FG000|Titration Period 2|Non-compliance procedures|4|||
130190064|NCT00463047|468653833|FG001|Titration Period 2|Non-compliance procedures|1|||
130190065|NCT00463047|468653832|FG000|Titration Period 2|Other|3|||
130190066|NCT00463047|468653833|FG001|Titration Period 2|Other|2|||
130190067|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
130190068|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
130190069|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
130190070|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
130190071|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
130190072|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
130190073|NCT00463047|468653832|FG000|Double-Blind Treatment Period 1|Other|1|||
130190074|NCT00463047|468653833|FG001|Double-Blind Treatment Period 1|Other|0|||
130190075|NCT00463047|468653832|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
130190076|NCT00463047|468653833|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
130190077|NCT00463047|468653832|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
130190078|NCT00463047|468653833|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
130190079|NCT00463047|468653832|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
130190080|NCT00463047|468653833|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
130190081|NCT02861807|468653837|FG000|Overall Study|Lost to Follow-up|7|||
130190082|NCT02861807|468653838|FG001|Overall Study|Lost to Follow-up|6|||
130190083|NCT02861807|468653837|FG000|Overall Study|Withdrawal by Subject|5|||
130190084|NCT02861807|468653838|FG001|Overall Study|Withdrawal by Subject|8|||
130190085|NCT03020992|468653839|FG000|Overall Study|Adverse Event|5|||
130190086|NCT03020992|468653839|FG000|Overall Study|Withdrawal by Subject|1|||
130190087|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
130190088|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
130190089|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
130190090|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
130190091|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Pregnancy|0|||
130190092|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Pregnancy|1|||
130190093|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
130190094|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
130190095|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
130190096|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
130190097|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
130190098|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
130190099|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Other|3|||
130190100|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Other|0|||
130190101|NCT01006122|468653840|FG000|First Double-blind Intervention Period|Adverse Event|0|||
130190102|NCT01006122|468653841|FG001|First Double-blind Intervention Period|Adverse Event|4|||
130190103|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
130190104|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
130190105|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
130190106|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
130190107|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
130190108|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
130190109|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
130190110|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
130190111|NCT01006122|468653840|FG000|Second Double-blind Intervention Period|Death|0|||
130190112|NCT01006122|468653841|FG001|Second Double-blind Intervention Period|Death|1|||
130190113|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
130190114|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
130190115|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
130190116|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
130190117|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
130190118|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
130190119|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
130190120|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
130190121|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
130190122|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
130190123|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
130190124|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
130190125|NCT03493854|468653844|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
130190126|NCT03493854|468653845|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
130190127|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
130190128|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
130190129|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
130190130|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
130190131|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
130190132|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
130190133|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
130190134|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
130190135|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
130190136|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
130190137|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
130190138|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
130190139|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
130190140|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
130190141|NCT03493854|468653844|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
130190142|NCT03493854|468653845|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
130190143|NCT03493854|468653844|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
130190144|NCT03493854|468653845|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
130190145|NCT03493854|468653844|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
130190146|NCT03493854|468653845|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
130190147|NCT03493854|468653844|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
130190148|NCT03493854|468653845|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
130190149|NCT00739661|468653848|FG000|Overall Study|Adverse Event|2|||
130190150|NCT00739661|468653849|FG001|Overall Study|Adverse Event|0|||
130190151|NCT00739661|468653848|FG000|Overall Study|Physician decision to withdraw patient|1|||
130190152|NCT00739661|468653849|FG001|Overall Study|Physician decision to withdraw patient|0|||
130190153|NCT00739661|468653848|FG000|Overall Study|Patient decision to withdraw|9|||
130190154|NCT00739661|468653849|FG001|Overall Study|Patient decision to withdraw|4|||
130190155|NCT00739661|468653848|FG000|Overall Study|Disease progression, radiographic|33|||
130190156|NCT00739661|468653849|FG001|Overall Study|Disease progression, radiographic|37|||
130190157|NCT00739661|468653848|FG000|Overall Study|Reason for discontinuation not available|1|||
130190158|NCT00739661|468653849|FG001|Overall Study|Reason for discontinuation not available|1|||
130190159|NCT00529308|468653850|FG000|Overall Study|Withdrawal by Subject|1|||
130190160|NCT00529308|468653851|FG001|Overall Study|Withdrawal by Subject|1|||
130190161|NCT05343364|468653858|FG000|Overall Study|Miscellaneous|0|||
130190162|NCT05343364|468653859|FG001|Overall Study|Miscellaneous|1|||
130190163|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
130190164|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190165|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190166|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190167|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190168|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
130190169|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
130190170|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
130190171|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190172|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190173|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190174|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
130190175|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
130190176|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
130190177|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190178|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190179|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190180|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190181|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130190182|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130190183|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190184|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190185|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190186|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190187|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
130190188|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
130190189|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190190|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190191|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190192|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
130190193|NCT02105987|468653860|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190194|NCT02105987|468653861|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
130190195|NCT02105987|468653862|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190196|NCT02105987|468653863|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190197|NCT02105987|468653864|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190198|NCT02105987|468653865|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
130190199|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190200|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190201|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
130190202|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
130190203|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190204|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
130190205|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190206|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190207|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
130190208|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
130190209|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190210|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
130190211|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190212|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190213|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
130190214|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
130190215|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190216|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
130190217|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190218|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190219|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
130190220|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
130190221|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190222|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
130190223|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190224|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190225|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
130190226|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190227|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190228|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
130190229|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190230|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190231|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190232|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
130190233|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190234|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
130190235|NCT02105987|468653860|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190236|NCT02105987|468653861|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190237|NCT02105987|468653862|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
130190238|NCT02105987|468653863|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190239|NCT02105987|468653864|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190240|NCT02105987|468653865|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
130190241|NCT02105987|468653860|FG000|Continuation Phase|Protocol Violation|0|||
130190242|NCT02105987|468653861|FG001|Continuation Phase|Protocol Violation|0|||
130190243|NCT02105987|468653862|FG002|Continuation Phase|Protocol Violation|0|||
130190244|NCT02105987|468653863|FG003|Continuation Phase|Protocol Violation|0|||
130190245|NCT02105987|468653864|FG004|Continuation Phase|Protocol Violation|1|||
130190246|NCT02105987|468653865|FG005|Continuation Phase|Protocol Violation|0|||
130190247|NCT02268916|468653870|FG000|Overall Study|Lost to Follow-up|1|||
130190248|NCT02268916|468653871|FG001|Overall Study|Lost to Follow-up|1|||
130190249|NCT02268916|468653870|FG000|Overall Study|Withdrawal by Subject|6|||
130190250|NCT02268916|468653871|FG001|Overall Study|Withdrawal by Subject|5|||
130190251|NCT02268916|468653870|FG000|Overall Study|Participant did not have diabetes|1|||
130190252|NCT02268916|468653871|FG001|Overall Study|Participant did not have diabetes|0|||
130190253|NCT02268916|468653870|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
130190254|NCT02268916|468653871|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
130190255|NCT02418949|468653872|FG000|Overall Study|Withdrawal by Subject|1|||
130190256|NCT02418949|468653873|FG001|Overall Study|Withdrawal by Subject|0|||
130190257|NCT02418949|468653874|FG002|Overall Study|Withdrawal by Subject|1|||
130190258|NCT02418949|468653875|FG003|Overall Study|Withdrawal by Subject|1|||
130190259|NCT02418949|468653872|FG000|Overall Study|Lost to Follow-up|1|||
130190260|NCT02418949|468653873|FG001|Overall Study|Lost to Follow-up|0|||
130190261|NCT02418949|468653874|FG002|Overall Study|Lost to Follow-up|1|||
130190262|NCT02418949|468653875|FG003|Overall Study|Lost to Follow-up|0|||
130190263|NCT02418949|468653872|FG000|Overall Study|Physician Decision|1|||
130190264|NCT02418949|468653873|FG001|Overall Study|Physician Decision|1|||
130190265|NCT02418949|468653874|FG002|Overall Study|Physician Decision|1|||
130190266|NCT02418949|468653875|FG003|Overall Study|Physician Decision|0|||
130190267|NCT03926117|468653876|FG000|Overall Study|Unclassified|1|||
130190268|NCT03926117|468653877|FG001|Overall Study|Unclassified|4|||
130190269|NCT03926117|468653878|FG002|Overall Study|Unclassified|1|||
130190270|NCT03926117|468653879|FG003|Overall Study|Unclassified|4|||
130190271|NCT03926117|468653876|FG000|Overall Study|Withdrawal by Subject|3|||
130190272|NCT03926117|468653877|FG001|Overall Study|Withdrawal by Subject|0|||
130190273|NCT03926117|468653878|FG002|Overall Study|Withdrawal by Subject|1|||
130190274|NCT03926117|468653879|FG003|Overall Study|Withdrawal by Subject|1|||
130190275|NCT03926117|468653876|FG000|Overall Study|Lost to Follow-up|0|||
130190276|NCT03926117|468653877|FG001|Overall Study|Lost to Follow-up|2|||
130190277|NCT03926117|468653878|FG002|Overall Study|Lost to Follow-up|1|||
130190278|NCT03926117|468653879|FG003|Overall Study|Lost to Follow-up|0|||
130190279|NCT03926117|468653876|FG000|Overall Study|Adverse Event|1|||
130190280|NCT03926117|468653877|FG001|Overall Study|Adverse Event|2|||
130190281|NCT03926117|468653878|FG002|Overall Study|Adverse Event|3|||
130190282|NCT03926117|468653879|FG003|Overall Study|Adverse Event|1|||
130190283|NCT03926117|468653876|FG000|Overall Study|Randomized but not treated|1|||
130190284|NCT03926117|468653877|FG001|Overall Study|Randomized but not treated|1|||
130190285|NCT03926117|468653878|FG002|Overall Study|Randomized but not treated|0|||
130190286|NCT03926117|468653879|FG003|Overall Study|Randomized but not treated|1|||
130190287|NCT04526288|468653882|FG000|Overall Study|Disease Progression|1|||
130190288|NCT04526288|468653883|FG001|Overall Study|Disease Progression|0|||
130190289|NCT02684097|468653886|FG000|Overall Study|Lack of Efficacy|13|||
130190290|NCT02684097|468653887|FG001|Overall Study|Lack of Efficacy|6|||
130190291|NCT00460811|468653888|FG000|Overall Study|Adverse Event|4|||
130190292|NCT00460811|468653889|FG001|Overall Study|Adverse Event|6|||
130190293|NCT00460811|468653890|FG002|Overall Study|Adverse Event|3|||
130190294|NCT00460811|468653891|FG003|Overall Study|Adverse Event|10|||
130190295|NCT00460811|468653892|FG004|Overall Study|Adverse Event|2|||
130190296|NCT00460811|468653888|FG000|Overall Study|Noncompliance|1|||
130190297|NCT00460811|468653889|FG001|Overall Study|Noncompliance|0|||
130190298|NCT00460811|468653890|FG002|Overall Study|Noncompliance|0|||
130190299|NCT00460811|468653891|FG003|Overall Study|Noncompliance|2|||
130190300|NCT00460811|468653892|FG004|Overall Study|Noncompliance|1|||
130190301|NCT00460811|468653888|FG000|Overall Study|Withdrawal by Subject|7|||
130190302|NCT00460811|468653889|FG001|Overall Study|Withdrawal by Subject|7|||
130190303|NCT00460811|468653890|FG002|Overall Study|Withdrawal by Subject|6|||
130190304|NCT00460811|468653891|FG003|Overall Study|Withdrawal by Subject|3|||
130190305|NCT00460811|468653892|FG004|Overall Study|Withdrawal by Subject|11|||
130190306|NCT00460811|468653888|FG000|Overall Study|Physician Decision|1|||
130190307|NCT00460811|468653889|FG001|Overall Study|Physician Decision|0|||
130190308|NCT00460811|468653890|FG002|Overall Study|Physician Decision|0|||
130190309|NCT00460811|468653891|FG003|Overall Study|Physician Decision|0|||
130190310|NCT00460811|468653892|FG004|Overall Study|Physician Decision|0|||
130190311|NCT00460811|468653888|FG000|Overall Study|Lost to Follow-up|3|||
130190312|NCT00460811|468653889|FG001|Overall Study|Lost to Follow-up|2|||
130190313|NCT00460811|468653890|FG002|Overall Study|Lost to Follow-up|5|||
130190314|NCT00460811|468653891|FG003|Overall Study|Lost to Follow-up|3|||
130190315|NCT00460811|468653892|FG004|Overall Study|Lost to Follow-up|6|||
130190316|NCT02748356|468653893|FG000|Overall Study|Withdrawal by Subject|1|||
130190317|NCT00237458|468653894|FG000|Overall Study|Lack of Efficacy|1|||
130190318|NCT00237458|468653894|FG000|Overall Study|Adverse Event|1|||
130190319|NCT00237458|468653894|FG000|Overall Study|Withdrawal by Subject|1|||
130190320|NCT00952068|468653895|FG000|Overall Study|Adverse Event|3|||
130190321|NCT00952068|468653895|FG000|Overall Study|Withdrawal by Subject|4|||
130190322|NCT05870371|468653896|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
130190323|NCT05870371|468653897|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
130190324|NCT02062450|468653901|FG000|Overall Study|No follow-up visit|124|||
130190325|NCT02907177|468653904|FG000|Overall Study|Death|0|||
130190326|NCT02907177|468653905|FG001|Overall Study|Death|1|||
130190327|NCT02907177|468653904|FG000|Overall Study|Physician Decision|3|||
130190328|NCT02907177|468653905|FG001|Overall Study|Physician Decision|3|||
130190329|NCT02907177|468653904|FG000|Overall Study|Withdrawal by Subject|15|||
130190330|NCT02907177|468653905|FG001|Overall Study|Withdrawal by Subject|7|||
130190331|NCT02907177|468653904|FG000|Overall Study|Sponsor's Decision|50|||
130190332|NCT02907177|468653905|FG001|Overall Study|Sponsor's Decision|57|||
130190333|NCT01537042|468653911|FG000|Overall Study|Adverse Event|0|||
130190334|NCT01537042|468653912|FG001|Overall Study|Adverse Event|2|||
130190335|NCT01537042|468653911|FG000|Overall Study|Lack of Efficacy|0|||
130190336|NCT01537042|468653912|FG001|Overall Study|Lack of Efficacy|1|||
130190337|NCT01537042|468653911|FG000|Overall Study|Protocol Violation|0|||
130190338|NCT01537042|468653912|FG001|Overall Study|Protocol Violation|1|||
130190339|NCT01537042|468653911|FG000|Overall Study|Other|0|||
130190340|NCT01537042|468653912|FG001|Overall Study|Other|1|||
130190341|NCT02151851|468655632|FG000|Overall Study|Lack of Efficacy|67|||
130190342|NCT02151851|468655633|FG001|Overall Study|Lack of Efficacy|94|||
130190343|NCT02151851|468655632|FG000|Overall Study|Protocol Violation|0|||
130190344|NCT02151851|468655633|FG001|Overall Study|Protocol Violation|1|||
130190345|NCT02151851|468655632|FG000|Overall Study|Withdrawal by Subject|2|||
130190346|NCT02151851|468655633|FG001|Overall Study|Withdrawal by Subject|5|||
130190347|NCT02151851|468655632|FG000|Overall Study|Medical impairment|1|||
130190348|NCT02151851|468655633|FG001|Overall Study|Medical impairment|0|||
130190349|NCT02151851|468655632|FG000|Overall Study|Low compliance to study visits|0|||
130190350|NCT02151851|468655633|FG001|Overall Study|Low compliance to study visits|1|||
130190351|NCT02151851|468655632|FG000|Overall Study|Subject entered into study in error|0|||
130190352|NCT02151851|468655633|FG001|Overall Study|Subject entered into study in error|1|||
130190353|NCT02151851|468655632|FG000|Overall Study|Adverse Event|6|||
130190354|NCT02151851|468655633|FG001|Overall Study|Adverse Event|28|||
130190355|NCT01540487|468655634|FG000|Overall Study|Protocol Violation|1|||
130190356|NCT01540487|468655635|FG001|Overall Study|Protocol Violation|0|||
130190357|NCT03503370|468655638|FG000|Overall Study|Death|3|||
130190358|NCT03503370|468655639|FG001|Overall Study|Death|1|||
130190359|NCT00298272|468655644|FG000|Double-blind Phase|Adverse Event|2|||
130190360|NCT00298272|468655645|FG001|Double-blind Phase|Adverse Event|0|||
130190361|NCT00298272|468655644|FG000|Double-blind Phase|Failure to Return|2|||
130190362|NCT00298272|468655645|FG001|Double-blind Phase|Failure to Return|0|||
130190363|NCT00298272|468655644|FG000|Double-blind Phase|Protocol Violation|2|||
130190364|NCT00298272|468655645|FG001|Double-blind Phase|Protocol Violation|0|||
130190365|NCT00298272|468655644|FG000|Double-blind Phase|Withdrawal by Subject|2|||
130190366|NCT00298272|468655645|FG001|Double-blind Phase|Withdrawal by Subject|0|||
130190367|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Adverse Event|1|||
130190368|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Adverse Event|2|||
130190369|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
130190370|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
130190371|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Failure to Return|1|||
130190372|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Failure to Return|0|||
130190373|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
130190374|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
130190375|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
130190376|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
130190377|NCT00298272|468655644|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
130190378|NCT00298272|468655645|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
130190379|NCT00298272|468655644|FG000|Safety Follow-up Phase|Failure to Return|1|||
130190380|NCT00298272|468655645|FG001|Safety Follow-up Phase|Failure to Return|1|||
130190381|NCT00298272|468655644|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
130190382|NCT00298272|468655645|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
130190383|NCT00298272|468655644|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
130190384|NCT00298272|468655645|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
130190385|NCT04168112|468655646|FG000|Overall Study|Lost to Follow-up|1|||
130190386|NCT04168112|468655647|FG001|Overall Study|Lost to Follow-up|0|||
130190387|NCT04168112|468655646|FG000|Overall Study|Withdrawal by Subject|1|||
130190388|NCT04168112|468655647|FG001|Overall Study|Withdrawal by Subject|0|||
130190389|NCT05253573|468655650|FG000|Overall Study|Death|1|||
130190390|NCT05253573|468655651|FG001|Overall Study|Death|0|||
130190391|NCT01436370|468655652|FG000|Overall Study|Lost to Follow-up|0|||
130190392|NCT01436370|468655653|FG001|Overall Study|Lost to Follow-up|0|||
130190393|NCT01436370|468655654|FG002|Overall Study|Lost to Follow-up|0|||
130190394|NCT01436370|468655655|FG003|Overall Study|Lost to Follow-up|0|||
130190395|NCT01436370|468655656|FG004|Overall Study|Lost to Follow-up|1|||
130190396|NCT01436370|468655657|FG005|Overall Study|Lost to Follow-up|0|||
130190397|NCT01436370|468655658|FG006|Overall Study|Lost to Follow-up|0|||
130190398|NCT01436370|468655659|FG007|Overall Study|Lost to Follow-up|0|||
130190399|NCT02395848|468655660|FG000|Overall Study|Lost to Follow-up|2|||
130190400|NCT01754129|468655661|FG000|Overall Study|Death|13|||
130190401|NCT01754129|468655661|FG000|Overall Study|Duodopa discontinuation|9|||
130190402|NCT01754129|468655661|FG000|Overall Study|Lost to Follow-up|7|||
130190403|NCT01754129|468655661|FG000|Overall Study|Withdrew consent|1|||
130190404|NCT01754129|468655661|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
130190405|NCT02276560|468655662|FG000|Overall Study|Adverse Event|1|||
130190406|NCT02276560|468655663|FG001|Overall Study|Adverse Event|0|||
130190407|NCT02276560|468655664|FG002|Overall Study|Adverse Event|0|||
130190408|NCT02126579|468655666|FG000|Overall Study|disease progression|0|||
130190409|NCT02126579|468655667|FG001|Overall Study|disease progression|0|||
130190410|NCT02126579|468655668|FG002|Overall Study|disease progression|0|||
130190411|NCT02126579|468655669|FG003|Overall Study|disease progression|1|||
130190412|NCT02126579|468655670|FG004|Overall Study|disease progression|0|||
130190413|NCT02126579|468655671|FG005|Overall Study|disease progression|0|||
130190414|NCT02126579|468655672|FG006|Overall Study|disease progression|1|||
130190415|NCT01780038|468655676|FG000|Overall Study|Lost to Follow-up|4|||
130190416|NCT01780038|468655677|FG001|Overall Study|Lost to Follow-up|1|||
130190417|NCT02609607|468655683|FG000|Overall Study|Lost to Follow-up|0|||
130190418|NCT02609607|468655684|FG001|Overall Study|Lost to Follow-up|1|||
130190419|NCT03168711|468655687|FG000|Overall Study|Adverse Event|2|||
130190420|NCT03168711|468655688|FG001|Overall Study|Adverse Event|0|||
130190421|NCT03168711|468655687|FG000|Overall Study|Withdrawal by Subject|0|||
130190422|NCT03168711|468655688|FG001|Overall Study|Withdrawal by Subject|1|||
130190423|NCT03168711|468655687|FG000|Overall Study|Death|0|||
130190424|NCT03168711|468655688|FG001|Overall Study|Death|1|||
130190425|NCT02877004|468655695|FG000|Overall Study|Pregnancy|0|||
130190426|NCT02877004|468655696|FG001|Overall Study|Pregnancy|0|||
130190427|NCT02877004|468655697|FG002|Overall Study|Pregnancy|1|||
130190428|NCT02633293|468655698|FG000|Overall Study|Death|56|||
130190429|NCT02633293|468655698|FG000|Overall Study|Progressive Disease|12|||
130190430|NCT02633293|468655698|FG000|Overall Study|Adverse Event|29|||
130190431|NCT02633293|468655698|FG000|Overall Study|Withdrawal by Subject|41|||
130190432|NCT02633293|468655698|FG000|Overall Study|Protocol Violation|1|||
130190433|NCT02633293|468655698|FG000|Overall Study|Lost to Follow-up|1|||
130190434|NCT02633293|468655698|FG000|Overall Study|Study Terminated by Sponsor|24|||
130190435|NCT02633293|468655698|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
130190436|NCT02633293|468655698|FG000|Overall Study|Lung Transplant|5|||
130190437|NCT02633293|468655698|FG000|Overall Study|Lack of Efficacy|2|||
130190438|NCT02633293|468655698|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
130190439|NCT00778817|468655699|FG000|Overall Study|Adverse Event|2|||
130190440|NCT00778817|468655699|FG000|Overall Study|Withdrawal by Subject|2|||
130190441|NCT02356588|468655700|FG000|Overall Study|Lack of Efficacy|4|||
130190442|NCT02356588|468655701|FG001|Overall Study|Lack of Efficacy|10|||
130190443|NCT02356588|468655700|FG000|Overall Study|Adverse Event|0|||
130190444|NCT02356588|468655701|FG001|Overall Study|Adverse Event|2|||
130190445|NCT02356588|468655700|FG000|Overall Study|Withdrawal by Subject|1|||
130190446|NCT02356588|468655701|FG001|Overall Study|Withdrawal by Subject|0|||
130190447|NCT02356588|468655700|FG000|Overall Study|Protocol Violation|0|||
130190448|NCT02356588|468655701|FG001|Overall Study|Protocol Violation|1|||
130190449|NCT01418378|468655702|FG000|Overall Study|Death|1|||
130190450|NCT01418378|468655703|FG001|Overall Study|Death|2|||
130190451|NCT01418378|468655702|FG000|Overall Study|Physician Decision|0|||
130190452|NCT01418378|468655703|FG001|Overall Study|Physician Decision|1|||
130190453|NCT01418378|468655702|FG000|Overall Study|ligament imbalance|0|||
130190454|NCT01418378|468655703|FG001|Overall Study|ligament imbalance|1|||
130190455|NCT01418378|468655702|FG000|Overall Study|developed chronic myopathy|0|||
130190456|NCT01418378|468655703|FG001|Overall Study|developed chronic myopathy|1|||
130190457|NCT01790984|468655704|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
130190458|NCT01790984|468655705|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
130190459|NCT01790984|468655706|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
130190460|NCT01790984|468655707|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
130190461|NCT01051791|468655710|FG000|Overall Study|Failed screening|3|||
130190462|NCT01051791|468655710|FG000|Overall Study|Withdrawal by Subject|1|||
130190463|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
130190464|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
130190465|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
130190466|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
130190467|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
130190468|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
130190469|NCT01081769|468655715|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
130190470|NCT01081769|468655716|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
130190471|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Adverse Event|14|||
130190472|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Adverse Event|11|||
130190473|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Death|1|||
130190474|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Death|1|||
130190475|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
130190476|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
130190477|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
130190478|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
130190479|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Pregnancy|1|||
130190480|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Pregnancy|0|||
130190481|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
130190482|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
130190483|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
130190484|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
130190485|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Other|0|||
130190486|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Other|1|||
130190487|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Ineligibility|3|||
130190488|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Ineligibility|4|||
130190489|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
130190490|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
130190491|NCT01081769|468655715|FG000|CORE Intent-To-Treat|Patient Moved|2|||
130190492|NCT01081769|468655716|FG001|CORE Intent-To-Treat|Patient Moved|2|||
130190493|NCT00507455|468655717|FG000|Overall Study|Adverse Event|3|||
130190494|NCT00507455|468655718|FG001|Overall Study|Adverse Event|3|||
130190495|NCT00507455|468655719|FG002|Overall Study|Adverse Event|6|||
130190496|NCT00507455|468655717|FG000|Overall Study|Withdrawal by Subject|2|||
130190497|NCT00507455|468655718|FG001|Overall Study|Withdrawal by Subject|1|||
130190498|NCT00507455|468655719|FG002|Overall Study|Withdrawal by Subject|2|||
130190499|NCT00507455|468655717|FG000|Overall Study|Protocol Violation|4|||
130190500|NCT00507455|468655718|FG001|Overall Study|Protocol Violation|1|||
130190501|NCT00507455|468655719|FG002|Overall Study|Protocol Violation|1|||
130190502|NCT00507455|468655717|FG000|Overall Study|Lost to Follow-up|2|||
130190503|NCT00507455|468655718|FG001|Overall Study|Lost to Follow-up|0|||
130190504|NCT00507455|468655719|FG002|Overall Study|Lost to Follow-up|2|||
130190505|NCT00507455|468655717|FG000|Overall Study|Lack of Efficacy|0|||
130190506|NCT00507455|468655718|FG001|Overall Study|Lack of Efficacy|1|||
130190507|NCT00507455|468655719|FG002|Overall Study|Lack of Efficacy|0|||
130190508|NCT00507455|468655717|FG000|Overall Study|Other - miscellaneous reason|1|||
130190509|NCT00507455|468655718|FG001|Overall Study|Other - miscellaneous reason|0|||
130190510|NCT00507455|468655719|FG002|Overall Study|Other - miscellaneous reason|1|||
130190511|NCT01737710|468655720|FG000|Overall Study|Lost to Follow-up|0|||
130190512|NCT01737710|468655721|FG001|Overall Study|Lost to Follow-up|2|||
130190513|NCT01737710|468655722|FG002|Overall Study|Lost to Follow-up|2|||
130190514|NCT01737710|468655723|FG003|Overall Study|Lost to Follow-up|0|||
130190515|NCT01737710|468655724|FG004|Overall Study|Lost to Follow-up|0|||
130190516|NCT01737710|468655720|FG000|Overall Study|Withdrawal by Subject|1|||
130190517|NCT01737710|468655721|FG001|Overall Study|Withdrawal by Subject|1|||
130190518|NCT01737710|468655722|FG002|Overall Study|Withdrawal by Subject|1|||
130190519|NCT01737710|468655723|FG003|Overall Study|Withdrawal by Subject|0|||
130190520|NCT01737710|468655724|FG004|Overall Study|Withdrawal by Subject|0|||
130190521|NCT01737710|468655720|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
130190522|NCT01737710|468655721|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
130190523|NCT01737710|468655722|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
130190524|NCT01737710|468655723|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
130190525|NCT01737710|468655724|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
130190526|NCT03363776|468655725|FG000|Overall Study|Progressive disease|2|||
130190527|NCT03363776|468655726|FG001|Overall Study|Progressive disease|3|||
130190528|NCT03363776|468655727|FG002|Overall Study|Progressive disease|1|||
130190529|NCT03363776|468655725|FG000|Overall Study|Study drug toxicity|0|||
130190530|NCT03363776|468655726|FG001|Overall Study|Study drug toxicity|0|||
130190531|NCT03363776|468655727|FG002|Overall Study|Study drug toxicity|1|||
130190532|NCT03363776|468655725|FG000|Overall Study|Death|1|||
130190533|NCT03363776|468655726|FG001|Overall Study|Death|0|||
130190534|NCT03363776|468655727|FG002|Overall Study|Death|0|||
130190535|NCT00410813|468655728|FG000|Overall Study|Adverse Event|6|||
130190536|NCT00410813|468655729|FG001|Overall Study|Adverse Event|11|||
130190537|NCT00410813|468655728|FG000|Overall Study|Progression|32|||
130190538|NCT00410813|468655729|FG001|Overall Study|Progression|21|||
130190539|NCT00410813|468655728|FG000|Overall Study|Not protocol specified|3|||
130190540|NCT00410813|468655729|FG001|Overall Study|Not protocol specified|4|||
130190541|NCT00410813|468655728|FG000|Overall Study|Ineligible|2|||
130190542|NCT00410813|468655729|FG001|Overall Study|Ineligible|4|||
130190543|NCT00410813|468655728|FG000|Overall Study|Death|0|||
130190544|NCT00410813|468655729|FG001|Overall Study|Death|2|||
130190545|NCT00812981|468655730|FG000|Overall Study|Other|0|||
130190546|NCT00812981|468655731|FG001|Overall Study|Other|1|||
130190547|NCT02199795|468655732|FG000|Overall Study|no longer met inclusion criteria|1|||
130190548|NCT02199795|468655733|FG001|Overall Study|no longer met inclusion criteria|0|||
130190549|NCT02199795|468655732|FG000|Overall Study|withdrew due to shoulder pain|1|||
130190550|NCT02199795|468655733|FG001|Overall Study|withdrew due to shoulder pain|0|||
130190551|NCT01791894|468655735|FG000|Overall Study|Adverse Event|1|||
130190552|NCT00996125|468655737|FG000|Overall Study|Adverse Event|0|||
130190553|NCT00996125|468655738|FG001|Overall Study|Adverse Event|2|||
130190554|NCT00996125|468655737|FG000|Overall Study|Lost to Follow-up|1|||
130190555|NCT00996125|468655738|FG001|Overall Study|Lost to Follow-up|6|||
130190556|NCT00996125|468655737|FG000|Overall Study|Withdrawal by Subject|4|||
130190557|NCT00996125|468655738|FG001|Overall Study|Withdrawal by Subject|3|||
130190558|NCT04331067|468655739|FG000|Overall Study|Adverse Event|1|||
130190559|NCT04331067|468655740|FG001|Overall Study|Adverse Event|3|||
130190560|NCT04331067|468655741|FG002|Overall Study|Adverse Event|1|||
130190561|NCT04331067|468655739|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
130190562|NCT04331067|468655740|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
130190563|NCT04331067|468655741|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
130190564|NCT02203721|468655742|FG000|Overall Study|Lost to Follow-up|1|||
130190565|NCT02203721|468655743|FG001|Overall Study|Lost to Follow-up|0|||
130190566|NCT02203721|468655742|FG000|Overall Study|Death|0|||
130190567|NCT02203721|468655743|FG001|Overall Study|Death|2|||
130190568|NCT02203721|468655742|FG000|Overall Study|Illness|0|||
130190569|NCT02203721|468655743|FG001|Overall Study|Illness|1|||
130190570|NCT00708461|468655746|FG000|Overall Study|Lost to Follow-up|18|||
130190571|NCT00708461|468655747|FG001|Overall Study|Lost to Follow-up|11|||
130190572|NCT00708461|468655746|FG000|Overall Study|Withdrawal by Subject|8|||
130190573|NCT00708461|468655747|FG001|Overall Study|Withdrawal by Subject|9|||
130190574|NCT00708461|468655746|FG000|Overall Study|left workforce|115|||
130190575|NCT00708461|468655747|FG001|Overall Study|left workforce|180|||
130190576|NCT01796392|468655750|FG000|Overall Study|Withdrawal by Subject|2|||
130190577|NCT01796392|468655751|FG001|Overall Study|Withdrawal by Subject|0|||
130190578|NCT01796392|468655750|FG000|Overall Study|Death|5|||
130190579|NCT01796392|468655751|FG001|Overall Study|Death|1|||
130190580|NCT01796392|468655750|FG000|Overall Study|Excluded for medical reasons|1|||
130190581|NCT01796392|468655751|FG001|Overall Study|Excluded for medical reasons|2|||
130190582|NCT01796392|468655750|FG000|Overall Study|Lost to Follow-up|1|||
130190583|NCT01796392|468655751|FG001|Overall Study|Lost to Follow-up|0|||
130190584|NCT03517540|468655754|FG000|Overall Study|Protocol Violation|2|||
130190585|NCT03517540|468655755|FG001|Overall Study|Protocol Violation|0|||
130190586|NCT03517540|468655756|FG002|Overall Study|Protocol Violation|0|||
130190587|NCT03517540|468655757|FG003|Overall Study|Protocol Violation|1|||
130190588|NCT03517540|468655754|FG000|Overall Study|Adverse Event|9|||
130190589|NCT03517540|468655755|FG001|Overall Study|Adverse Event|3|||
130190590|NCT03517540|468655756|FG002|Overall Study|Adverse Event|8|||
130190591|NCT03517540|468655757|FG003|Overall Study|Adverse Event|1|||
130190592|NCT03517540|468655754|FG000|Overall Study|Withdrawal by Subject|3|||
130190593|NCT03517540|468655755|FG001|Overall Study|Withdrawal by Subject|4|||
130190594|NCT03517540|468655756|FG002|Overall Study|Withdrawal by Subject|1|||
130190595|NCT03517540|468655757|FG003|Overall Study|Withdrawal by Subject|3|||
130190596|NCT01779440|468655760|FG000|Overall Study|Withdrawal by Subject|3|||
130190597|NCT01779440|468655761|FG001|Overall Study|Withdrawal by Subject|5|||
130190598|NCT01205269|468655762|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190599|NCT01205269|468655763|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190600|NCT01205269|468655764|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190601|NCT01205269|468655765|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
130190602|NCT01205269|468655766|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190603|NCT01205269|468655767|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
130190604|NCT01408303|468655768|FG000|Overall Study|Adverse Event|3|||
130190605|NCT01408303|468655769|FG001|Overall Study|Adverse Event|7|||
130190606|NCT01408303|468655770|FG002|Overall Study|Adverse Event|2|||
130190607|NCT01408303|468655768|FG000|Overall Study|Lost to Follow-up|0|||
130190608|NCT01408303|468655769|FG001|Overall Study|Lost to Follow-up|1|||
130190609|NCT01408303|468655770|FG002|Overall Study|Lost to Follow-up|2|||
130190610|NCT01408303|468655768|FG000|Overall Study|Withdrawal by Subject|2|||
130190611|NCT01408303|468655769|FG001|Overall Study|Withdrawal by Subject|3|||
130190612|NCT01408303|468655770|FG002|Overall Study|Withdrawal by Subject|1|||
130190613|NCT01408303|468655768|FG000|Overall Study|Protocol Violation|0|||
130190614|NCT01408303|468655769|FG001|Overall Study|Protocol Violation|1|||
130190615|NCT01408303|468655770|FG002|Overall Study|Protocol Violation|0|||
130190616|NCT01408303|468655768|FG000|Overall Study|Noncompliance|1|||
130190617|NCT01408303|468655769|FG001|Overall Study|Noncompliance|0|||
130190618|NCT01408303|468655770|FG002|Overall Study|Noncompliance|1|||
130190619|NCT01207687|468655771|FG000|Overall Study|Adverse Event|1|||
130190620|NCT01207687|468655771|FG000|Overall Study|Withdrawal by Subject|1|||
130190621|NCT01486446|468655772|FG000|Overall Study|Adverse Event|1|||
130190622|NCT01486446|468655773|FG001|Overall Study|Adverse Event|0|||
130190623|NCT00523848|468655774|FG000|Overall Study|Adverse Event|11|||
130190624|NCT00523848|468655774|FG000|Overall Study|Withdrawal by Subject|2|||
130190625|NCT00523848|468655774|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
130190626|NCT00523848|468655774|FG000|Overall Study|Disease Progression|5|||
130190627|NCT00523848|468655774|FG000|Overall Study|Other, unspecified|4|||
130190628|NCT01801865|468655775|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
130190629|NCT01801865|468655775|FG000|Overall Study|Physician Decision|7|||
130190630|NCT01367886|468655776|FG000|Overall Study|Lost to Follow-up|4|||
130190631|NCT01367886|468655776|FG000|Overall Study|Lack of Efficacy|2|||
130190632|NCT01367886|468655776|FG000|Overall Study|Death|1|||
130190633|NCT00985504|468655783|FG000|Acute Treatment Period|Adverse Event|3|||
130190634|NCT00985504|468655784|FG001|Acute Treatment Period|Adverse Event|4|||
130190635|NCT00985504|468655783|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
130190636|NCT00985504|468655784|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
130190637|NCT00985504|468655783|FG000|Acute Treatment Period|Protocol Violation|2|||
130190638|NCT00985504|468655784|FG001|Acute Treatment Period|Protocol Violation|0|||
130190639|NCT00985504|468655783|FG000|Acute Treatment Period|Sponsor Decision|0|||
130190640|NCT00985504|468655784|FG001|Acute Treatment Period|Sponsor Decision|1|||
130190641|NCT00985504|468655783|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
130190642|NCT00985504|468655784|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
130190643|NCT00985504|468655783|FG000|Optimization Period|Adverse Event|7|||
130190644|NCT00985504|468655784|FG001|Optimization Period|Adverse Event|9|||
130190645|NCT00985504|468655783|FG000|Optimization Period|Death|0|||
130190646|NCT00985504|468655784|FG001|Optimization Period|Death|1|||
130190647|NCT00985504|468655783|FG000|Optimization Period|Lack of Efficacy|5|||
130190648|NCT00985504|468655784|FG001|Optimization Period|Lack of Efficacy|3|||
130190649|NCT00985504|468655783|FG000|Optimization Period|Lost to Follow-up|0|||
130190650|NCT00985504|468655784|FG001|Optimization Period|Lost to Follow-up|1|||
130190651|NCT00985504|468655783|FG000|Optimization Period|Physician Decision|1|||
130190652|NCT00985504|468655784|FG001|Optimization Period|Physician Decision|0|||
130190653|NCT00985504|468655783|FG000|Optimization Period|Protocol Violation|3|||
130190654|NCT00985504|468655784|FG001|Optimization Period|Protocol Violation|1|||
130190655|NCT00985504|468655783|FG000|Optimization Period|Withdrawal by Subject|10|||
130190656|NCT00985504|468655784|FG001|Optimization Period|Withdrawal by Subject|8|||
130190657|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
130190658|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
130190659|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
130190660|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
130190661|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
130190662|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
130190663|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
130190664|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
130190665|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
130190666|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
130190667|NCT03711786|468655785|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
130190668|NCT03711786|468655786|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
130190669|NCT03379727|468655787|FG000|Overall Study|Lack of Efficacy|73|||
130190670|NCT03379727|468655787|FG000|Overall Study|Adverse Event|32|||
130190671|NCT03379727|468655787|FG000|Overall Study|Death|18|||
130190672|NCT03379727|468655787|FG000|Overall Study|Patient/guardian decision|17|||
130190673|NCT03379727|468655787|FG000|Overall Study|Physician Decision|104|||
130190674|NCT03379727|468655787|FG000|Overall Study|Protocol Violation|4|||
130190675|NCT03379727|468655787|FG000|Overall Study|Lost to Follow-up|1|||
130190676|NCT04031846|468655791|FG000|Overall Study|Lost to Follow-up|4|||
130190677|NCT04031846|468655792|FG001|Overall Study|Lost to Follow-up|4|||
130190678|NCT04031846|468655791|FG000|Overall Study|Physician Decision|0|||
130190679|NCT04031846|468655792|FG001|Overall Study|Physician Decision|1|||
130190680|NCT04031846|468655791|FG000|Overall Study|Protocol Violation|1|||
130190681|NCT04031846|468655792|FG001|Overall Study|Protocol Violation|1|||
130190682|NCT04031846|468655791|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
130190683|NCT04031846|468655792|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
130190684|NCT06868654|468655793|FG000|Overall Study|Death|4|||
130190685|NCT06868654|468655794|FG001|Overall Study|Death|14|||
130190686|NCT06868654|468655793|FG000|Overall Study|Lost to Follow-up|0|||
130190687|NCT06868654|468655794|FG001|Overall Study|Lost to Follow-up|1|||
130190688|NCT06868654|468655793|FG000|Overall Study|Withdrawal by Subject|5|||
130190689|NCT06868654|468655794|FG001|Overall Study|Withdrawal by Subject|3|||
130190690|NCT06868654|468655793|FG000|Overall Study|Physician Decision|0|||
130190691|NCT06868654|468655794|FG001|Overall Study|Physician Decision|1|||
130190692|NCT06868654|468655793|FG000|Overall Study|Ongoing|23|||
130190693|NCT06868654|468655794|FG001|Overall Study|Ongoing|21|||
130190694|NCT01777282|468655801|FG000|Overall Study|Persistent Hyperglycemia|0|||
130190695|NCT01777282|468655802|FG001|Overall Study|Persistent Hyperglycemia|0|||
130190696|NCT01777282|468655803|FG002|Overall Study|Persistent Hyperglycemia|1|||
130190697|NCT01777282|468655804|FG003|Overall Study|Persistent Hyperglycemia|0|||
130190698|NCT01777282|468655805|FG004|Overall Study|Persistent Hyperglycemia|0|||
130190699|NCT01777282|468655801|FG000|Overall Study|New Antidiabetic Medication|0|||
130190700|NCT01777282|468655802|FG001|Overall Study|New Antidiabetic Medication|0|||
130190701|NCT01777282|468655803|FG002|Overall Study|New Antidiabetic Medication|1|||
130190702|NCT01777282|468655804|FG003|Overall Study|New Antidiabetic Medication|0|||
130190703|NCT01777282|468655805|FG004|Overall Study|New Antidiabetic Medication|0|||
130190704|NCT01777282|468655801|FG000|Overall Study|Adverse Event|4|||
130190705|NCT01777282|468655802|FG001|Overall Study|Adverse Event|4|||
130190706|NCT01777282|468655803|FG002|Overall Study|Adverse Event|2|||
130190707|NCT01777282|468655804|FG003|Overall Study|Adverse Event|1|||
130190708|NCT01777282|468655805|FG004|Overall Study|Adverse Event|3|||
130190709|NCT01777282|468655801|FG000|Overall Study|Withdrawal by Subject|4|||
130190710|NCT01777282|468655802|FG001|Overall Study|Withdrawal by Subject|0|||
130190711|NCT01777282|468655803|FG002|Overall Study|Withdrawal by Subject|0|||
130190712|NCT01777282|468655804|FG003|Overall Study|Withdrawal by Subject|1|||
130190713|NCT01777282|468655805|FG004|Overall Study|Withdrawal by Subject|2|||
130190714|NCT01777282|468655801|FG000|Overall Study|Protocol Violation|2|||
130190715|NCT01777282|468655802|FG001|Overall Study|Protocol Violation|0|||
130190716|NCT01777282|468655803|FG002|Overall Study|Protocol Violation|1|||
130190717|NCT01777282|468655804|FG003|Overall Study|Protocol Violation|0|||
130190718|NCT01777282|468655805|FG004|Overall Study|Protocol Violation|2|||
130190719|NCT01777282|468655801|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
130190720|NCT01777282|468655802|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130190721|NCT01777282|468655803|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
130190722|NCT01777282|468655804|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130190723|NCT01777282|468655805|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
130190724|NCT01131455|468655806|FG000|Overall Study|Death of PI|6|||
130190725|NCT01131455|468655807|FG001|Overall Study|Death of PI|4|||
130190726|NCT01131455|468655808|FG002|Overall Study|Death of PI|0|||
130190727|NCT00764660|468655809|FG000|Overall Study|Adverse Event|6|||
130190728|NCT00764660|468655810|FG001|Overall Study|Adverse Event|3|||
130190729|NCT00764660|468655809|FG000|Overall Study|Lost to Follow-up|3|||
130190730|NCT00764660|468655810|FG001|Overall Study|Lost to Follow-up|4|||
130190731|NCT00764660|468655809|FG000|Overall Study|Withdrawal by Subject|7|||
130190732|NCT00764660|468655810|FG001|Overall Study|Withdrawal by Subject|3|||
130190733|NCT00764660|468655809|FG000|Overall Study|Noncompliance With Protocol|5|||
130190734|NCT00764660|468655810|FG001|Overall Study|Noncompliance With Protocol|1|||
130190735|NCT00764660|468655809|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
130190736|NCT00764660|468655810|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
130190737|NCT03103152|468655811|FG000|Overall Study|Physician Decision|5|||
130190738|NCT03103152|468655812|FG001|Overall Study|Physician Decision|2|||
130190739|NCT03103152|468655813|FG002|Overall Study|Physician Decision|6|||
130190740|NCT03103152|468655814|FG003|Overall Study|Physician Decision|3|||
130190741|NCT03103152|468655815|FG004|Overall Study|Physician Decision|3|||
130190742|NCT03103152|468655816|FG005|Overall Study|Physician Decision|1|||
130190743|NCT03103152|468655811|FG000|Overall Study|Protocol Violation|2|||
130190744|NCT03103152|468655812|FG001|Overall Study|Protocol Violation|2|||
130190745|NCT03103152|468655813|FG002|Overall Study|Protocol Violation|1|||
130190746|NCT03103152|468655814|FG003|Overall Study|Protocol Violation|2|||
130190747|NCT03103152|468655815|FG004|Overall Study|Protocol Violation|1|||
130190748|NCT03103152|468655816|FG005|Overall Study|Protocol Violation|1|||
130190749|NCT03103152|468655811|FG000|Overall Study|Inter-current illness|0|||
130190750|NCT03103152|468655812|FG001|Overall Study|Inter-current illness|0|||
130190751|NCT03103152|468655813|FG002|Overall Study|Inter-current illness|1|||
130190752|NCT03103152|468655814|FG003|Overall Study|Inter-current illness|0|||
130190753|NCT03103152|468655815|FG004|Overall Study|Inter-current illness|0|||
130190754|NCT03103152|468655816|FG005|Overall Study|Inter-current illness|0|||
130190755|NCT03103152|468655811|FG000|Overall Study|Death|0|||
130190756|NCT03103152|468655812|FG001|Overall Study|Death|1|||
130190757|NCT03103152|468655813|FG002|Overall Study|Death|0|||
130190758|NCT03103152|468655814|FG003|Overall Study|Death|0|||
130190759|NCT03103152|468655815|FG004|Overall Study|Death|0|||
130190760|NCT03103152|468655816|FG005|Overall Study|Death|0|||
130190761|NCT03103152|468655811|FG000|Overall Study|Adverse Event|0|||
130190762|NCT03103152|468655812|FG001|Overall Study|Adverse Event|0|||
130190763|NCT03103152|468655813|FG002|Overall Study|Adverse Event|1|||
130190764|NCT03103152|468655814|FG003|Overall Study|Adverse Event|0|||
130190765|NCT03103152|468655815|FG004|Overall Study|Adverse Event|0|||
130190766|NCT03103152|468655816|FG005|Overall Study|Adverse Event|1|||
130190767|NCT03103152|468655811|FG000|Overall Study|Withdrawal by Subject|1|||
130190768|NCT03103152|468655812|FG001|Overall Study|Withdrawal by Subject|0|||
130190769|NCT03103152|468655813|FG002|Overall Study|Withdrawal by Subject|1|||
130190770|NCT03103152|468655814|FG003|Overall Study|Withdrawal by Subject|1|||
130190771|NCT03103152|468655815|FG004|Overall Study|Withdrawal by Subject|1|||
130190772|NCT03103152|468655816|FG005|Overall Study|Withdrawal by Subject|1|||
130190773|NCT03103152|468655811|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
130190774|NCT03103152|468655812|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
130190775|NCT03103152|468655813|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
130190776|NCT03103152|468655814|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
130190777|NCT03103152|468655815|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
130190778|NCT03103152|468655816|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
130190779|NCT03103152|468655811|FG000|Overall Study|Unacceptable side effects|0|||
130190780|NCT03103152|468655812|FG001|Overall Study|Unacceptable side effects|0|||
130190781|NCT03103152|468655813|FG002|Overall Study|Unacceptable side effects|0|||
130190782|NCT03103152|468655814|FG003|Overall Study|Unacceptable side effects|0|||
130190783|NCT03103152|468655815|FG004|Overall Study|Unacceptable side effects|0|||
130190784|NCT03103152|468655816|FG005|Overall Study|Unacceptable side effects|1|||
130190785|NCT03103152|468655811|FG000|Overall Study|Lost to Follow-up|0|||
130190786|NCT03103152|468655812|FG001|Overall Study|Lost to Follow-up|1|||
130190787|NCT03103152|468655813|FG002|Overall Study|Lost to Follow-up|0|||
130190788|NCT03103152|468655814|FG003|Overall Study|Lost to Follow-up|1|||
130190789|NCT03103152|468655815|FG004|Overall Study|Lost to Follow-up|0|||
130190790|NCT03103152|468655816|FG005|Overall Study|Lost to Follow-up|1|||
130190791|NCT03103152|468655811|FG000|Overall Study|Testicular pain|0|||
130190792|NCT03103152|468655812|FG001|Overall Study|Testicular pain|0|||
130190793|NCT03103152|468655813|FG002|Overall Study|Testicular pain|0|||
130190794|NCT03103152|468655814|FG003|Overall Study|Testicular pain|1|||
130190795|NCT03103152|468655815|FG004|Overall Study|Testicular pain|0|||
130190796|NCT03103152|468655816|FG005|Overall Study|Testicular pain|0|||
130190797|NCT03668119|468657204|FG000|Pre-treatment|Disease Progression|1|||
130190798|NCT03668119|468657205|FG001|Pre-treatment|Disease Progression|0|||
130190799|NCT03668119|468657204|FG000|Treatment|Disease Progression|76|||
130190800|NCT03668119|468657205|FG001|Treatment|Disease Progression|57|||
130190801|NCT03668119|468657204|FG000|Treatment|Study drug toxicity|19|||
130190802|NCT03668119|468657205|FG001|Treatment|Study drug toxicity|1|||
130190803|NCT03668119|468657204|FG000|Treatment|Death|3|||
130190804|NCT03668119|468657205|FG001|Treatment|Death|0|||
130190805|NCT03668119|468657204|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
130190806|NCT03668119|468657205|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
130190807|NCT03668119|468657204|FG000|Treatment|Withdrawal by Subject|1|||
130190808|NCT03668119|468657205|FG001|Treatment|Withdrawal by Subject|1|||
130190809|NCT03668119|468657204|FG000|Treatment|Participant request to discontinue study treatment|3|||
130190810|NCT03668119|468657205|FG001|Treatment|Participant request to discontinue study treatment|1|||
130190811|NCT03668119|468657204|FG000|Treatment|Maximum Clinical Benefit|0|||
130190812|NCT03668119|468657205|FG001|Treatment|Maximum Clinical Benefit|1|||
130190813|NCT03668119|468657204|FG000|Treatment|Participants completed treatment|27|||
130190814|NCT03668119|468657205|FG001|Treatment|Participants completed treatment|11|||
130190815|NCT03668119|468657204|FG000|Treatment|Other reasons|2|||
130190816|NCT03668119|468657205|FG001|Treatment|Other reasons|1|||
130190817|NCT05336227|468657206|FG000|Overall Study|Adverse Event|1|||
130190818|NCT05336227|468657207|FG001|Overall Study|Adverse Event|0|||
130190819|NCT05336227|468657206|FG000|Overall Study|Lost to Follow-up|2|||
130190820|NCT05336227|468657207|FG001|Overall Study|Lost to Follow-up|0|||
130190821|NCT05336227|468657206|FG000|Overall Study|Withdrawal by Subject|1|||
130190822|NCT05336227|468657207|FG001|Overall Study|Withdrawal by Subject|0|||
130190823|NCT00684411|468657210|FG000|Overall Study|New Primary Cancer|1|||
130190824|NCT00684411|468657210|FG000|Overall Study|Disease Progression|10|||
130190825|NCT00684411|468657210|FG000|Overall Study|Adverse Event|1|||
130190826|NCT01344824|468657211|FG000|Overall Study|Adverse Event|15|||
130190827|NCT01344824|468657211|FG000|Overall Study|Withdrawal by Subject|6|||
130190828|NCT01344824|468657211|FG000|Overall Study|Other complicating disease|1|||
130190829|NCT01344824|468657211|FG000|Overall Study|Progression|15|||
130190830|NCT01295671|468657214|FG000|Overall Study|Lost to Follow-up|4|||
130190831|NCT01295671|468657215|FG001|Overall Study|Lost to Follow-up|6|||
130190832|NCT01295671|468657216|FG002|Overall Study|Lost to Follow-up|3|||
130190833|NCT01295671|468657214|FG000|Overall Study|Withdrawal by Subject|3|||
130190834|NCT01295671|468657215|FG001|Overall Study|Withdrawal by Subject|1|||
130190835|NCT01295671|468657216|FG002|Overall Study|Withdrawal by Subject|0|||
130190836|NCT02058537|468657217|FG000|Overall Study|Withdrawal by Subject|1|||
130190837|NCT02366637|468657218|FG000|First Intervention Period|Adverse Event|0|||
130190838|NCT02366637|468657219|FG001|First Intervention Period|Adverse Event|1|||
130190839|NCT02366637|468657218|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
130190840|NCT02366637|468657219|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
130190841|NCT02366637|468657218|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
130190842|NCT02366637|468657219|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
130190843|NCT00651261|468657220|FG000|Overall Study|Adverse Event|32|||
130190844|NCT00651261|468657221|FG001|Overall Study|Adverse Event|22|||
130190845|NCT00651261|468657220|FG000|Overall Study|Death|18|||
130190846|NCT00651261|468657221|FG001|Overall Study|Death|18|||
130190847|NCT00651261|468657220|FG000|Overall Study|Withdrawal by Subject|22|||
130190848|NCT00651261|468657221|FG001|Overall Study|Withdrawal by Subject|40|||
130190849|NCT00651261|468657220|FG000|Overall Study|Induction failure|24|||
130190850|NCT00651261|468657221|FG001|Overall Study|Induction failure|35|||
130190851|NCT00651261|468657220|FG000|Overall Study|Disease progression|58|||
130190852|NCT00651261|468657221|FG001|Overall Study|Disease progression|58|||
130190853|NCT00651261|468657220|FG000|Overall Study|Alternative therapy|109|||
130190854|NCT00651261|468657221|FG001|Overall Study|Alternative therapy|107|||
130190855|NCT00651261|468657220|FG000|Overall Study|Other disease or participant decisions|23|||
130190856|NCT00651261|468657221|FG001|Overall Study|Other disease or participant decisions|23|||
130190857|NCT00651261|468657220|FG000|Overall Study|Never treated|5|||
130190858|NCT00651261|468657221|FG001|Overall Study|Never treated|3|||
130190859|NCT01609010|468657222|FG000|Overall Study|Stable disease (SD)|22|||
130190860|NCT01609010|468657223|FG001|Overall Study|Stable disease (SD)|16|||
130190861|NCT01609010|468657222|FG000|Overall Study|Progressive disease (PD)|8|||
130190862|NCT01609010|468657223|FG001|Overall Study|Progressive disease (PD)|10|||
130190863|NCT01609010|468657222|FG000|Overall Study|Adverse Event|3|||
130190864|NCT01609010|468657223|FG001|Overall Study|Adverse Event|6|||
130190865|NCT01609010|468657222|FG000|Overall Study|Withdrawal by Subject|2|||
130190866|NCT01609010|468657223|FG001|Overall Study|Withdrawal by Subject|2|||
130190867|NCT01609010|468657222|FG000|Overall Study|Other|2|||
130190868|NCT01609010|468657223|FG001|Overall Study|Other|0|||
130190869|NCT01609010|468657222|FG000|Overall Study|Other malignancy|1|||
130190870|NCT01609010|468657223|FG001|Overall Study|Other malignancy|0|||
130190871|NCT01609010|468657222|FG000|Overall Study|Pathology review|2|||
130190872|NCT01609010|468657223|FG001|Overall Study|Pathology review|1|||
130190873|NCT01609010|468657222|FG000|Overall Study|Protocol Violation|1|||
130190874|NCT01609010|468657223|FG001|Overall Study|Protocol Violation|1|||
130190875|NCT01609010|468657222|FG000|Overall Study|New cancer|1|||
130190876|NCT01609010|468657223|FG001|Overall Study|New cancer|0|||
130190877|NCT01609010|468657222|FG000|Overall Study|Lost to Follow-up|1|||
130190878|NCT01609010|468657223|FG001|Overall Study|Lost to Follow-up|1|||
130190879|NCT00687271|468657224|FG000|Overall Study|Adverse Event|1|||
130190880|NCT00687271|468657225|FG001|Overall Study|Adverse Event|3|||
130190881|NCT00687271|468657226|FG002|Overall Study|Adverse Event|1|||
130190882|NCT00687271|468657227|FG003|Overall Study|Adverse Event|0|||
130190883|NCT00687271|468657224|FG000|Overall Study|Lost to Follow-up|0|||
130190884|NCT00687271|468657225|FG001|Overall Study|Lost to Follow-up|1|||
130190885|NCT00687271|468657226|FG002|Overall Study|Lost to Follow-up|0|||
130190886|NCT00687271|468657227|FG003|Overall Study|Lost to Follow-up|0|||
130190887|NCT00687271|468657224|FG000|Overall Study|Protocol Violation|2|||
130190888|NCT00687271|468657225|FG001|Overall Study|Protocol Violation|1|||
130190889|NCT00687271|468657226|FG002|Overall Study|Protocol Violation|1|||
130190890|NCT00687271|468657227|FG003|Overall Study|Protocol Violation|0|||
130190891|NCT00687271|468657224|FG000|Overall Study|Withdrawal by Subject|0|||
130190892|NCT00687271|468657225|FG001|Overall Study|Withdrawal by Subject|1|||
130190893|NCT00687271|468657226|FG002|Overall Study|Withdrawal by Subject|3|||
130190894|NCT00687271|468657227|FG003|Overall Study|Withdrawal by Subject|0|||
130190895|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
130190896|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
130190897|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
130190898|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
130190899|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
130190900|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
130190901|NCT01134107|468657228|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
130190902|NCT01134107|468657229|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
130190903|NCT01134107|468657228|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
130190904|NCT01134107|468657229|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
130190905|NCT01134107|468657228|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
130190906|NCT01134107|468657229|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
130190907|NCT01134107|468657228|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
130190908|NCT01134107|468657229|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
130190909|NCT05483686|468657236|FG000|Overall Study|Lost to Follow-up|5|||
130190910|NCT05483686|468657237|FG001|Overall Study|Lost to Follow-up|7|||
130190911|NCT03351608|468657241|FG000|Overall Study|Lost to Follow-up|0|||
130190912|NCT03351608|468657242|FG001|Overall Study|Lost to Follow-up|1|||
130190913|NCT03351608|468657243|FG002|Overall Study|Lost to Follow-up|1|||
130190914|NCT03351608|468657244|FG003|Overall Study|Lost to Follow-up|1|||
130190915|NCT03351608|468657245|FG004|Overall Study|Lost to Follow-up|1|||
130190916|NCT03351608|468657241|FG000|Overall Study|Physician Decision|1|||
130190917|NCT03351608|468657242|FG001|Overall Study|Physician Decision|0|||
130190918|NCT03351608|468657243|FG002|Overall Study|Physician Decision|0|||
130190919|NCT03351608|468657244|FG003|Overall Study|Physician Decision|2|||
130190920|NCT03351608|468657245|FG004|Overall Study|Physician Decision|1|||
130190921|NCT03351608|468657241|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
130190922|NCT03351608|468657242|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
130190923|NCT03351608|468657243|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
130190924|NCT03351608|468657244|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
130190925|NCT03351608|468657245|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
130190926|NCT03351608|468657241|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130190927|NCT03351608|468657242|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130190928|NCT03351608|468657243|FG002|Overall Study|Withdrawal by parent/guardian|1|||
130190929|NCT03351608|468657244|FG003|Overall Study|Withdrawal by parent/guardian|1|||
130190930|NCT03351608|468657245|FG004|Overall Study|Withdrawal by parent/guardian|0|||
130190931|NCT03351608|468657241|FG000|Overall Study|Other|0|||
130190932|NCT03351608|468657242|FG001|Overall Study|Other|1|||
130190933|NCT03351608|468657243|FG002|Overall Study|Other|1|||
130190934|NCT03351608|468657244|FG003|Overall Study|Other|3|||
130190935|NCT03351608|468657245|FG004|Overall Study|Other|0|||
130190936|NCT02727478|468657246|FG000|Overall Study|Withdrawal by Subject|8|||
130190937|NCT02727478|468657247|FG001|Overall Study|Withdrawal by Subject|10|||
130190938|NCT00808210|468657251|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
130190939|NCT00808210|468657252|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
130190940|NCT00808210|468657251|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
130190941|NCT00808210|468657252|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
130190942|NCT00808210|468657251|FG000|Double-Blind TX Period|Adverse Event|0|||
130190943|NCT00808210|468657252|FG001|Double-Blind TX Period|Adverse Event|1|||
130190944|NCT00808210|468657251|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
130190945|NCT00808210|468657252|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
130190946|NCT00808210|468657251|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
130190947|NCT00808210|468657252|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
130190948|NCT00808210|468657251|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
130190949|NCT00808210|468657252|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
130190950|NCT03877068|468657253|FG000|Overall Study|Physician Decision|9|||
130190951|NCT03877068|468657254|FG001|Overall Study|Physician Decision|3|||
130190952|NCT03150719|468657257|FG000|Overall Study|Adverse Event|0|||
130190953|NCT03150719|468657258|FG001|Overall Study|Adverse Event|1|||
130190954|NCT03150719|468657257|FG000|Overall Study|Death|0|||
130190955|NCT03150719|468657258|FG001|Overall Study|Death|1|||
130190956|NCT03150719|468657257|FG000|Overall Study|Other|1|||
130190957|NCT03150719|468657258|FG001|Overall Study|Other|0|||
130190958|NCT00288626|468657263|FG000|Overall Study|Death|3|||
130190959|NCT00288626|468657263|FG000|Overall Study|Withdrawal by Subject|4|||
130190960|NCT02019264|468657265|FG000|Overall Study|Not treated|6|||
130190961|NCT02019264|468657266|FG001|Overall Study|Not treated|4|||
130190962|NCT02019264|468657265|FG000|Overall Study|Lost to Follow-up|50|||
130190963|NCT02019264|468657266|FG001|Overall Study|Lost to Follow-up|47|||
130190964|NCT02019264|468657265|FG000|Overall Study|Withdrawal by Subject|142|||
130190965|NCT02019264|468657266|FG001|Overall Study|Withdrawal by Subject|117|||
130190966|NCT02019264|468657265|FG000|Overall Study|Administrative reason|36|||
130190967|NCT02019264|468657266|FG001|Overall Study|Administrative reason|28|||
130190968|NCT02019264|468657265|FG000|Overall Study|Missing|14|||
130190969|NCT02019264|468657266|FG001|Overall Study|Missing|11|||
130190970|NCT02914613|468657267|FG000|Overall Study|Withdrawal by Subject|1|||
130190971|NCT02914613|468657268|FG001|Overall Study|Withdrawal by Subject|2|||
130190972|NCT02914613|468657267|FG000|Overall Study|Adverse Event|1|||
130190973|NCT02914613|468657268|FG001|Overall Study|Adverse Event|0|||
130190974|NCT01964222|468657272|FG000|Overall Study|Lost to Follow-up|7|||
130190975|NCT01964222|468657273|FG001|Overall Study|Lost to Follow-up|5|||
130190976|NCT01964222|468657272|FG000|Overall Study|Withdrawal by Subject|6|||
130190977|NCT01964222|468657273|FG001|Overall Study|Withdrawal by Subject|6|||
130190978|NCT01964222|468657272|FG000|Overall Study|Screening Failure|2|||
130190979|NCT01964222|468657273|FG001|Overall Study|Screening Failure|0|||
130190980|NCT02677922|468657284|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
130190981|NCT02677922|468657285|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
130190982|NCT02677922|468657286|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
130190983|NCT02677922|468657287|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
130190984|NCT02677922|468657288|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
130190985|NCT02677922|468657289|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
130190986|NCT02677922|468657284|FG000|Treatment Period|Adverse Event|0|||
130190987|NCT02677922|468657285|FG001|Treatment Period|Adverse Event|0|||
130190988|NCT02677922|468657286|FG002|Treatment Period|Adverse Event|1|||
130190989|NCT02677922|468657287|FG003|Treatment Period|Adverse Event|3|||
130190990|NCT02677922|468657288|FG004|Treatment Period|Adverse Event|5|||
130190991|NCT02677922|468657289|FG005|Treatment Period|Adverse Event|2|||
130190992|NCT02677922|468657284|FG000|Treatment Period|Progressive Disease|1|||
130190993|NCT02677922|468657285|FG001|Treatment Period|Progressive Disease|1|||
130190994|NCT02677922|468657286|FG002|Treatment Period|Progressive Disease|0|||
130190995|NCT02677922|468657287|FG003|Treatment Period|Progressive Disease|0|||
130190996|NCT02677922|468657288|FG004|Treatment Period|Progressive Disease|8|||
130190997|NCT02677922|468657289|FG005|Treatment Period|Progressive Disease|7|||
130190998|NCT02677922|468657284|FG000|Treatment Period|Lack of Efficacy|0|||
130190999|NCT02677922|468657285|FG001|Treatment Period|Lack of Efficacy|0|||
130191000|NCT02677922|468657286|FG002|Treatment Period|Lack of Efficacy|0|||
130191001|NCT02677922|468657287|FG003|Treatment Period|Lack of Efficacy|1|||
130191002|NCT02677922|468657288|FG004|Treatment Period|Lack of Efficacy|1|||
130191003|NCT02677922|468657289|FG005|Treatment Period|Lack of Efficacy|6|||
130191004|NCT02677922|468657284|FG000|Treatment Period|Withdrawal by Subject|0|||
130191005|NCT02677922|468657285|FG001|Treatment Period|Withdrawal by Subject|0|||
130191006|NCT02677922|468657286|FG002|Treatment Period|Withdrawal by Subject|1|||
130191007|NCT02677922|468657287|FG003|Treatment Period|Withdrawal by Subject|3|||
130191008|NCT02677922|468657288|FG004|Treatment Period|Withdrawal by Subject|5|||
130191009|NCT02677922|468657289|FG005|Treatment Period|Withdrawal by Subject|5|||
130191010|NCT02677922|468657284|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
130191011|NCT02677922|468657285|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
130191012|NCT02677922|468657286|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
130191013|NCT02677922|468657287|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
130191014|NCT02677922|468657288|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
130191015|NCT02677922|468657289|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
130191016|NCT02677922|468657284|FG000|Treatment Period|Disease Relapse|0|||
130191017|NCT02677922|468657285|FG001|Treatment Period|Disease Relapse|0|||
130191018|NCT02677922|468657286|FG002|Treatment Period|Disease Relapse|0|||
130191019|NCT02677922|468657287|FG003|Treatment Period|Disease Relapse|3|||
130191020|NCT02677922|468657288|FG004|Treatment Period|Disease Relapse|6|||
130191021|NCT02677922|468657289|FG005|Treatment Period|Disease Relapse|1|||
130191022|NCT02677922|468657284|FG000|Treatment Period|Allogeneic HSCT|1|||
130191023|NCT02677922|468657285|FG001|Treatment Period|Allogeneic HSCT|0|||
130191024|NCT02677922|468657286|FG002|Treatment Period|Allogeneic HSCT|0|||
130191025|NCT02677922|468657287|FG003|Treatment Period|Allogeneic HSCT|1|||
130191026|NCT02677922|468657288|FG004|Treatment Period|Allogeneic HSCT|4|||
130191027|NCT02677922|468657289|FG005|Treatment Period|Allogeneic HSCT|1|||
130191028|NCT02677922|468657284|FG000|Treatment Period|Other Reasons|0|||
130191029|NCT02677922|468657285|FG001|Treatment Period|Other Reasons|0|||
130191030|NCT02677922|468657286|FG002|Treatment Period|Other Reasons|0|||
130191031|NCT02677922|468657287|FG003|Treatment Period|Other Reasons|1|||
130191032|NCT02677922|468657288|FG004|Treatment Period|Other Reasons|3|||
130191033|NCT02677922|468657289|FG005|Treatment Period|Other Reasons|5|||
130191034|NCT02677922|468657284|FG000|Treatment Period|Death|0|||
130191035|NCT02677922|468657285|FG001|Treatment Period|Death|0|||
130191036|NCT02677922|468657286|FG002|Treatment Period|Death|0|||
130191037|NCT02677922|468657287|FG003|Treatment Period|Death|0|||
130191038|NCT02677922|468657288|FG004|Treatment Period|Death|12|||
130191039|NCT02677922|468657289|FG005|Treatment Period|Death|1|||
130191040|NCT02677922|468657284|FG000|Treatment Period|Non-compliance with Study Drug|0|||
130191041|NCT02677922|468657285|FG001|Treatment Period|Non-compliance with Study Drug|0|||
130191042|NCT02677922|468657286|FG002|Treatment Period|Non-compliance with Study Drug|0|||
130191043|NCT02677922|468657287|FG003|Treatment Period|Non-compliance with Study Drug|0|||
130191044|NCT02677922|468657288|FG004|Treatment Period|Non-compliance with Study Drug|1|||
130191045|NCT02677922|468657289|FG005|Treatment Period|Non-compliance with Study Drug|0|||
130191046|NCT02677922|468657284|FG000|Treatment Period|Physician Decision|0|||
130191047|NCT02677922|468657285|FG001|Treatment Period|Physician Decision|0|||
130191048|NCT02677922|468657286|FG002|Treatment Period|Physician Decision|0|||
130191049|NCT02677922|468657287|FG003|Treatment Period|Physician Decision|0|||
130191050|NCT02677922|468657288|FG004|Treatment Period|Physician Decision|0|||
130191051|NCT02677922|468657289|FG005|Treatment Period|Physician Decision|1|||
130191052|NCT02677922|468657284|FG000|Treatment Period|Symptomatic Deterioration|0|||
130191053|NCT02677922|468657285|FG001|Treatment Period|Symptomatic Deterioration|0|||
130191054|NCT02677922|468657286|FG002|Treatment Period|Symptomatic Deterioration|0|||
130191055|NCT02677922|468657287|FG003|Treatment Period|Symptomatic Deterioration|0|||
130191056|NCT02677922|468657288|FG004|Treatment Period|Symptomatic Deterioration|1|||
130191057|NCT02677922|468657289|FG005|Treatment Period|Symptomatic Deterioration|0|||
130191058|NCT05310071|468657290|FG000|Overall Study|Death|0|||
130191059|NCT05310071|468657291|FG001|Overall Study|Death|3|||
130191060|NCT05310071|468657290|FG000|Overall Study|Adverse Event|4|||
130191061|NCT05310071|468657291|FG001|Overall Study|Adverse Event|31|||
130191062|NCT05310071|468657290|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
130191063|NCT05310071|468657291|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
130191064|NCT05310071|468657290|FG000|Overall Study|Protocol Deviation|2|||
130191065|NCT05310071|468657291|FG001|Overall Study|Protocol Deviation|0|||
130191066|NCT05310071|468657290|FG000|Overall Study|Randomized by Mistake|0|||
130191067|NCT05310071|468657291|FG001|Overall Study|Randomized by Mistake|1|||
130191068|NCT05310071|468657290|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
130191069|NCT05310071|468657291|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
130191070|NCT05310071|468657290|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
130191071|NCT05310071|468657291|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
130191072|NCT05310071|468657290|FG000|Overall Study|Site Terminated by Sponsor|0|||
130191073|NCT05310071|468657291|FG001|Overall Study|Site Terminated by Sponsor|2|||
130191074|NCT05310071|468657290|FG000|Overall Study|Study Terminated by Sponsor|282|||
130191075|NCT05310071|468657291|FG001|Overall Study|Study Terminated by Sponsor|559|||
130191076|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
130191077|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
130191078|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
130191079|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
130191080|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
130191081|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
130191082|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
130191083|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
130191084|NCT05310071|468657290|FG000|Overall Study|Withdrawal by Participant - Other|25|||
130191085|NCT05310071|468657291|FG001|Overall Study|Withdrawal by Participant - Other|30|||
130191086|NCT05310071|468657290|FG000|Overall Study|Lost to Follow-up|2|||
130191087|NCT05310071|468657291|FG001|Overall Study|Lost to Follow-up|4|||
130191088|NCT05310071|468657290|FG000|Overall Study|Reason Not Specified|1|||
130191089|NCT05310071|468657291|FG001|Overall Study|Reason Not Specified|3|||
130191090|NCT03515811|468657296|FG000|Overall Study|Lost to Follow-up|2|||
130191091|NCT03515811|468657297|FG001|Overall Study|Lost to Follow-up|1|||
130191092|NCT03515811|468657296|FG000|Overall Study|Protocol Violation|1|||
130191093|NCT03515811|468657297|FG001|Overall Study|Protocol Violation|1|||
130191094|NCT03515811|468657296|FG000|Overall Study|Death|1|||
130191095|NCT03515811|468657297|FG001|Overall Study|Death|1|||
130191096|NCT03515811|468657296|FG000|Overall Study|Withdrawal by Subject|0|||
130191097|NCT03515811|468657297|FG001|Overall Study|Withdrawal by Subject|2|||
130191098|NCT03515811|468657296|FG000|Overall Study|Technical Problems|1|||
130191099|NCT03515811|468657297|FG001|Overall Study|Technical Problems|0|||
130191100|NCT03515811|468657296|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
130191101|NCT03515811|468657297|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
130191102|NCT03515811|468657296|FG000|Overall Study|COVID-19|0|||
130191103|NCT03515811|468657297|FG001|Overall Study|COVID-19|1|||
130191104|NCT05107492|468657298|FG000|Overall Study|Lost to Follow-up|1|||
130191105|NCT05107492|468657299|FG001|Overall Study|Lost to Follow-up|0|||
130191106|NCT04339062|468657300|FG000|Overall Study|Death|0|||
130191107|NCT04339062|468657301|FG001|Overall Study|Death|1|||
130191108|NCT02589639|468657303|FG000|Overall Study|Lost to Follow-up|1|||
130191109|NCT02589639|468657304|FG001|Overall Study|Lost to Follow-up|0|||
130191110|NCT02589639|468657305|FG002|Overall Study|Lost to Follow-up|0|||
130191111|NCT02589639|468657303|FG000|Overall Study|Protocol Violation|1|||
130191112|NCT02589639|468657304|FG001|Overall Study|Protocol Violation|0|||
130191113|NCT02589639|468657305|FG002|Overall Study|Protocol Violation|0|||
130191114|NCT02589639|468657303|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
130191115|NCT02589639|468657304|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
130191116|NCT02589639|468657305|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
130191117|NCT02589639|468657303|FG000|Overall Study|Adverse Event|4|||
130191118|NCT02589639|468657304|FG001|Overall Study|Adverse Event|5|||
130191119|NCT02589639|468657305|FG002|Overall Study|Adverse Event|3|||
130191120|NCT02589639|468657303|FG000|Overall Study|Other reason than specified above|1|||
130191121|NCT02589639|468657304|FG001|Overall Study|Other reason than specified above|2|||
130191122|NCT02589639|468657305|FG002|Overall Study|Other reason than specified above|1|||
130191123|NCT02589639|468657303|FG000|Overall Study|Not Treated|0|||
130191124|NCT02589639|468657304|FG001|Overall Study|Not Treated|3|||
130191125|NCT02589639|468657305|FG002|Overall Study|Not Treated|0|||
130191126|NCT00703157|468657306|FG000|Overall Study|Lost to Follow-up|0|||
130191127|NCT00703157|468657307|FG001|Overall Study|Lost to Follow-up|1|||
130191128|NCT00703157|468657306|FG000|Overall Study|source data permanently lost/ other|4|||
130191129|NCT00703157|468657307|FG001|Overall Study|source data permanently lost/ other|1|||
130191130|NCT02968173|468657308|FG000|Overall Study|Withdrawal by Subject|1|||
130191131|NCT02670525|468657309|FG000|Overall Study|Death|94|||
130191132|NCT02670525|468657310|FG001|Overall Study|Death|14|||
130191133|NCT02670525|468657309|FG000|Overall Study|Lost to Follow-up|4|||
130191134|NCT02670525|468657310|FG001|Overall Study|Lost to Follow-up|1|||
130191135|NCT02670525|468657309|FG000|Overall Study|Subject withdrew consent|1|||
130191136|NCT02670525|468657310|FG001|Overall Study|Subject withdrew consent|0|||
130191137|NCT02670525|468657309|FG000|Overall Study|Unknown, data entry delayed|123|||
130191138|NCT02670525|468657310|FG001|Overall Study|Unknown, data entry delayed|78|||
130191139|NCT00591565|468657311|FG000|Overall Study|lost follow up, withdrawn|5|||
130191140|NCT03564119|468657315|FG000|Overall Study|Adverse Event|4|||
130191141|NCT03564119|468657316|FG001|Overall Study|Adverse Event|0|||
130191142|NCT03564119|468657315|FG000|Overall Study|Lost to Follow-up|1|||
130191143|NCT03564119|468657316|FG001|Overall Study|Lost to Follow-up|4|||
130191144|NCT03564119|468657315|FG000|Overall Study|Protocol Violation|1|||
130191145|NCT03564119|468657316|FG001|Overall Study|Protocol Violation|0|||
130191146|NCT03564119|468657315|FG000|Overall Study|Withdrawal by Subject|9|||
130191147|NCT03564119|468657316|FG001|Overall Study|Withdrawal by Subject|4|||
130191148|NCT03564119|468657315|FG000|Overall Study|Other Than Specified|0|||
130191149|NCT03564119|468657316|FG001|Overall Study|Other Than Specified|1|||
130191150|NCT00634036|468657317|FG000|Overall Study|Lost to Follow-up|1|||
130191151|NCT00634036|468657318|FG001|Overall Study|Lost to Follow-up|1|||
130191152|NCT00634036|468657317|FG000|Overall Study|Withdrawal by Subject|1|||
130191153|NCT00634036|468657318|FG001|Overall Study|Withdrawal by Subject|1|||
130191154|NCT03896022|468657324|FG000|Overall Study|Withdrawal by Subject|1|||
130191155|NCT03896022|468657325|FG001|Overall Study|Withdrawal by Subject|0|||
130191156|NCT03896022|468657326|FG002|Overall Study|Withdrawal by Subject|0|||
130191157|NCT03896022|468657324|FG000|Overall Study|Did not have procedure|3|||
130191158|NCT03896022|468657325|FG001|Overall Study|Did not have procedure|0|||
130191159|NCT03896022|468657326|FG002|Overall Study|Did not have procedure|0|||
130191160|NCT00564850|468657331|FG000|Overall Study|Protocol Violation|2|||
130191161|NCT00314327|468657332|FG000|Overall Study|Withdrawal by Subject|1|||
130191162|NCT02741076|468657333|FG000|Overall Study|Adverse Event|0|||
130191163|NCT02741076|468657334|FG001|Overall Study|Adverse Event|1|||
130191164|NCT02741076|468657335|FG002|Overall Study|Adverse Event|1|||
130191165|NCT02741076|468657336|FG003|Overall Study|Adverse Event|0|||
130191166|NCT02741076|468657333|FG000|Overall Study|Lack of Efficacy|1|||
130191167|NCT02741076|468657334|FG001|Overall Study|Lack of Efficacy|0|||
130191168|NCT02741076|468657335|FG002|Overall Study|Lack of Efficacy|0|||
130191169|NCT02741076|468657336|FG003|Overall Study|Lack of Efficacy|0|||
130191170|NCT02741076|468657333|FG000|Overall Study|Withdrawal by Subject|0|||
130191171|NCT02741076|468657334|FG001|Overall Study|Withdrawal by Subject|1|||
130191172|NCT02741076|468657335|FG002|Overall Study|Withdrawal by Subject|0|||
130191173|NCT02741076|468657336|FG003|Overall Study|Withdrawal by Subject|0|||
130191174|NCT02741076|468657333|FG000|Overall Study|Sponsor Request|2|||
130191175|NCT02741076|468657334|FG001|Overall Study|Sponsor Request|3|||
130191176|NCT02741076|468657335|FG002|Overall Study|Sponsor Request|0|||
130191177|NCT02741076|468657336|FG003|Overall Study|Sponsor Request|1|||
130191178|NCT02741076|468657333|FG000|Overall Study|No additional information available|0|||
130191179|NCT02741076|468657334|FG001|Overall Study|No additional information available|0|||
130191180|NCT02741076|468657335|FG002|Overall Study|No additional information available|1|||
130191181|NCT02741076|468657336|FG003|Overall Study|No additional information available|1|||
130191182|NCT01500382|468657339|FG000|Washout Period|Study site went out of business|0|||
130191183|NCT01500382|468657340|FG001|Washout Period|Study site went out of business|0|||
130191184|NCT01500382|468657341|FG002|Washout Period|Study site went out of business|1|||
130191185|NCT01500382|468657342|FG003|Washout Period|Study site went out of business|0|||
130191186|NCT02134015|468657343|FG000|Overall Study|Protocol Violation|0|||
130191187|NCT02134015|468657344|FG001|Overall Study|Protocol Violation|1|||
130191188|NCT02134015|468657343|FG000|Overall Study|Death|2|||
130191189|NCT02134015|468657344|FG001|Overall Study|Death|1|||
130191190|NCT02134015|468657343|FG000|Overall Study|Reason not provided|1|||
130191191|NCT02134015|468657344|FG001|Overall Study|Reason not provided|2|||
130191192|NCT02134015|468657343|FG000|Overall Study|Clinical progression|14|||
130191193|NCT02134015|468657344|FG001|Overall Study|Clinical progression|7|||
130191194|NCT02134015|468657343|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
130191195|NCT02134015|468657344|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
130191196|NCT02134015|468657343|FG000|Overall Study|Study terminated by sponsor|2|||
130191197|NCT02134015|468657344|FG001|Overall Study|Study terminated by sponsor|3|||
130191198|NCT02134015|468657343|FG000|Overall Study|Adverse Event|9|||
130191199|NCT02134015|468657344|FG001|Overall Study|Adverse Event|10|||
130191200|NCT02134015|468657343|FG000|Overall Study|Withdrawal by Subject|3|||
130191201|NCT02134015|468657344|FG001|Overall Study|Withdrawal by Subject|7|||
130191202|NCT00347958|468659087|FG000|Overall Study|Adverse Event|1|||
130191203|NCT00347958|468659087|FG000|Overall Study|Protocol Violation|2|||
130191204|NCT00347958|468659087|FG000|Overall Study|Withdrawal by Subject|1|||
130191205|NCT00754234|468659088|FG000|Overall Study|Withdrawal by Subject|3|||
130191206|NCT00915018|468659089|FG000|Overall Study|Death|75|||
130191207|NCT00915018|468659090|FG001|Overall Study|Death|70|||
130191208|NCT00915018|468659089|FG000|Overall Study|Lost to Follow-up|10|||
130191209|NCT00915018|468659090|FG001|Overall Study|Lost to Follow-up|5|||
130191210|NCT00915018|468659089|FG000|Overall Study|Withdrawal by Subject|38|||
130191211|NCT00915018|468659090|FG001|Overall Study|Withdrawal by Subject|27|||
130191212|NCT00915018|468659089|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
130191213|NCT00915018|468659090|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
130191214|NCT00326716|468659091|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
130191215|NCT00326716|468659092|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
130191216|NCT00326716|468659093|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
130191217|NCT00326716|468659094|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
130191218|NCT04134767|468659095|FG000|Overall Study|Death|0|||
130191219|NCT04134767|468659096|FG001|Overall Study|Death|1|||
130191220|NCT04134767|468659095|FG000|Overall Study|Removed for harassing staff|0|||
130191221|NCT04134767|468659096|FG001|Overall Study|Removed for harassing staff|1|||
130191222|NCT04134767|468659095|FG000|Overall Study|Lost to Follow-up|44|||
130191223|NCT04134767|468659096|FG001|Overall Study|Lost to Follow-up|40|||
130191224|NCT00300885|468659097|FG000|Treatment|Adverse Event|134|||
130191225|NCT00300885|468659098|FG001|Treatment|Adverse Event|82|||
130191226|NCT00300885|468659097|FG000|Treatment|Death|20|||
130191227|NCT00300885|468659098|FG001|Treatment|Death|7|||
130191228|NCT00300885|468659097|FG000|Treatment|Lack of Efficacy|1|||
130191229|NCT00300885|468659098|FG001|Treatment|Lack of Efficacy|1|||
130191230|NCT00300885|468659097|FG000|Treatment|Lost to Follow-up|3|||
130191231|NCT00300885|468659098|FG001|Treatment|Lost to Follow-up|2|||
130191232|NCT00300885|468659097|FG000|Treatment|Physician Decision|4|||
130191233|NCT00300885|468659098|FG001|Treatment|Physician Decision|5|||
130191234|NCT00300885|468659097|FG000|Treatment|Protocol Violation|11|||
130191235|NCT00300885|468659098|FG001|Treatment|Protocol Violation|11|||
130191236|NCT00300885|468659097|FG000|Treatment|Withdrawal by Subject|26|||
130191237|NCT00300885|468659098|FG001|Treatment|Withdrawal by Subject|23|||
130191238|NCT00300885|468659097|FG000|Treatment|Disease progression|171|||
130191239|NCT00300885|468659098|FG001|Treatment|Disease progression|238|||
130191240|NCT00300885|468659097|FG000|Treatment|Random code broken (subject died)|0|||
130191241|NCT00300885|468659098|FG001|Treatment|Random code broken (subject died)|1|||
130191242|NCT00300885|468659097|FG000|Treatment|Non-compliant with study medication|3|||
130191243|NCT00300885|468659098|FG001|Treatment|Non-compliant with study medication|4|||
130191244|NCT00300885|468659097|FG000|Follow-up|Death|141|||
130191245|NCT00300885|468659098|FG001|Follow-up|Death|163|||
130191246|NCT00300885|468659097|FG000|Follow-up|Lost to Follow-up|11|||
130191247|NCT00300885|468659098|FG001|Follow-up|Lost to Follow-up|7|||
130191248|NCT00300885|468659097|FG000|Follow-up|Withdrawal by Subject|26|||
130191249|NCT00300885|468659098|FG001|Follow-up|Withdrawal by Subject|25|||
130191250|NCT02309411|468659107|FG000|Overall Study|Physician Decision|1|||
130191251|NCT02309411|468659108|FG001|Overall Study|Physician Decision|0|||
130191252|NCT02309411|468659109|FG002|Overall Study|Physician Decision|0|||
130191253|NCT02309411|468659107|FG000|Overall Study|Withdrawal by Subject|1|||
130191254|NCT02309411|468659108|FG001|Overall Study|Withdrawal by Subject|1|||
130191255|NCT02309411|468659109|FG002|Overall Study|Withdrawal by Subject|0|||
130191256|NCT03656692|468659110|FG000|Overall Study|Worsening of disease activity|2|||
130191257|NCT03656692|468659110|FG000|Overall Study|Physician Decision|1|||
130191258|NCT02693106|468659111|FG000|Overall Study|No time|3|||
130191259|NCT00839800|468659112|FG000|Overall Study|Adverse Event|8|||
130191260|NCT00839800|468659113|FG001|Overall Study|Adverse Event|12|||
130191261|NCT00839800|468659112|FG000|Overall Study|Lost to Follow-up|31|||
130191262|NCT00839800|468659113|FG001|Overall Study|Lost to Follow-up|26|||
130191263|NCT00839800|468659112|FG000|Overall Study|Withdrawal by Subject|28|||
130191264|NCT00839800|468659113|FG001|Overall Study|Withdrawal by Subject|34|||
130191265|NCT00839800|468659112|FG000|Overall Study|Incorrect Enrolment|3|||
130191266|NCT00839800|468659113|FG001|Overall Study|Incorrect Enrolment|3|||
130191267|NCT00839800|468659112|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
130191268|NCT00839800|468659113|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
130191269|NCT00839800|468659112|FG000|Overall Study|Safety Reasons|2|||
130191270|NCT00839800|468659113|FG001|Overall Study|Safety Reasons|1|||
130191271|NCT00839800|468659112|FG000|Overall Study|Other|8|||
130191272|NCT00839800|468659113|FG001|Overall Study|Other|14|||
130191273|NCT00839800|468659112|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
130191274|NCT00839800|468659113|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
130191275|NCT01372618|468659117|FG000|Overall Study|PI Died. Study Terminated|9|||
130191276|NCT02801617|468659118|FG000|Overall Study|Protocol Violation|2|||
130191277|NCT02801617|468659119|FG001|Overall Study|Protocol Violation|6|||
130191278|NCT01954056|468659120|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
130191279|NCT01954056|468659121|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
130191280|NCT06110494|468659122|FG000|Overall Study|Protocol Violation|2|||
130191281|NCT06110494|468659123|FG001|Overall Study|Protocol Violation|0|||
130191282|NCT06110494|468659124|FG002|Overall Study|Protocol Violation|1|||
130191283|NCT06110494|468659122|FG000|Overall Study|Dixon's test for outlier analysis|1|||
130191284|NCT06110494|468659123|FG001|Overall Study|Dixon's test for outlier analysis|1|||
130191285|NCT06110494|468659124|FG002|Overall Study|Dixon's test for outlier analysis|0|||
130191286|NCT04938180|468659129|FG000|Overall Study|Adverse Event|1|||
130191287|NCT03850496|468659141|FG000|Overall Study|Withdrawal by Subject|1|||
130191288|NCT03850496|468659142|FG001|Overall Study|Withdrawal by Subject|0|||
130191289|NCT03850496|468659143|FG002|Overall Study|Withdrawal by Subject|0|||
130191290|NCT03850496|468659141|FG000|Overall Study|Lost to Follow-up|0|||
130191291|NCT03850496|468659142|FG001|Overall Study|Lost to Follow-up|1|||
130191292|NCT03850496|468659143|FG002|Overall Study|Lost to Follow-up|4|||
130191293|NCT03674112|468659144|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
130191294|NCT03674112|468659145|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
130191295|NCT03674112|468659144|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
130191296|NCT03674112|468659145|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
130191297|NCT03674112|468659144|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
130191298|NCT03674112|468659145|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
130191299|NCT03674112|468659144|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
130191300|NCT03674112|468659145|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
130191301|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
130191302|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
130191303|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
130191304|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
130191305|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Death|2|||
130191306|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Death|0|||
130191307|NCT03674112|468659144|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
130191308|NCT03674112|468659145|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
130191309|NCT02097238|468659149|FG000|Overall Study|Death|1|||
130191310|NCT02097238|468659149|FG000|Overall Study|Physician Decision|1|||
130191311|NCT02097238|468659149|FG000|Overall Study|Progressive Disease|17|||
130191312|NCT01106911|468659150|FG000|Overall Study|Physician Decision|2|||
130191313|NCT01106911|468659150|FG000|Overall Study|deemed ineligible after screening|3|||
130191314|NCT01814696|468659158|FG000|Overall Study|Withdrawal by Subject|1|||
130191315|NCT01814696|468659159|FG001|Overall Study|Withdrawal by Subject|0|||
130191316|NCT01814696|468659158|FG000|Overall Study|Randomized to wrong group|1|||
130191317|NCT01814696|468659159|FG001|Overall Study|Randomized to wrong group|0|||
130191318|NCT00954941|468659160|FG000|Overall Study|Received treatment at home|1|||
130191319|NCT00954941|468659161|FG001|Overall Study|Received treatment at home|0|||
130191320|NCT00954941|468659160|FG000|Overall Study|Withdrawal by Subject|1|||
130191321|NCT00954941|468659161|FG001|Overall Study|Withdrawal by Subject|0|||
130191322|NCT00954941|468659160|FG000|Overall Study|Insurance Denial|2|||
130191323|NCT00954941|468659161|FG001|Overall Study|Insurance Denial|2|||
130191324|NCT00954941|468659160|FG000|Overall Study|Physician Decision|2|||
130191325|NCT00954941|468659161|FG001|Overall Study|Physician Decision|2|||
130191326|NCT00954941|468659160|FG000|Overall Study|Ineligible|2|||
130191327|NCT00954941|468659161|FG001|Overall Study|Ineligible|2|||
130191328|NCT00954941|468659160|FG000|Overall Study|Adverse Event|0|||
130191329|NCT00954941|468659161|FG001|Overall Study|Adverse Event|1|||
130191330|NCT00984542|468659178|FG000|Overall Study|disease progression|19|||
130191331|NCT00984542|468659178|FG000|Overall Study|toxicity|7|||
130191332|NCT00984542|468659178|FG000|Overall Study|Death|7|||
130191333|NCT00984542|468659178|FG000|Overall Study|complicating disease|3|||
130191334|NCT00984542|468659178|FG000|Overall Study|Withdrawal by Subject|3|||
130191335|NCT00984542|468659178|FG000|Overall Study|clinical deterioration|2|||
130191336|NCT01422889|468659179|FG000|Overall Study|No Data Entered for Study Stent|9|||
130191337|NCT00488644|468659184|FG000|Overall Study|Not Eligible|1|||
130191338|NCT00488644|468659184|FG000|Overall Study|Not Evaluable|1|||
130191339|NCT02977572|468659185|FG000|Overall Study|Exclusion criterion|2|||
130191340|NCT02977572|468659186|FG001|Overall Study|Exclusion criterion|2|||
130191341|NCT01197534|468659188|FG000|Overall Study|Not reported|16|||
130191342|NCT01197534|468659189|FG001|Overall Study|Not reported|10|||
130191343|NCT01197534|468659190|FG002|Overall Study|Not reported|16|||
130191344|NCT01197534|468659188|FG000|Overall Study|Enrolment in long term extension|57|||
130191345|NCT01197534|468659189|FG001|Overall Study|Enrolment in long term extension|66|||
130191346|NCT01197534|468659190|FG002|Overall Study|Enrolment in long term extension|119|||
130191347|NCT01197534|468659188|FG000|Overall Study|Severe non-compliance to protocol|3|||
130191348|NCT01197534|468659189|FG001|Overall Study|Severe non-compliance to protocol|4|||
130191349|NCT01197534|468659190|FG002|Overall Study|Severe non-compliance to protocol|1|||
130191350|NCT01197534|468659188|FG000|Overall Study|Lack of therapeutic response|9|||
130191351|NCT01197534|468659189|FG001|Overall Study|Lack of therapeutic response|4|||
130191352|NCT01197534|468659190|FG002|Overall Study|Lack of therapeutic response|9|||
130191353|NCT01197534|468659188|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
130191354|NCT01197534|468659189|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
130191355|NCT01197534|468659190|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
130191356|NCT01197534|468659188|FG000|Overall Study|Lost to Follow-up|1|||
130191357|NCT01197534|468659189|FG001|Overall Study|Lost to Follow-up|4|||
130191358|NCT01197534|468659190|FG002|Overall Study|Lost to Follow-up|2|||
130191359|NCT01197534|468659188|FG000|Overall Study|Adverse Event|35|||
130191360|NCT01197534|468659189|FG001|Overall Study|Adverse Event|36|||
130191361|NCT01197534|468659190|FG002|Overall Study|Adverse Event|24|||
130191362|NCT02593097|468659203|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
130191363|NCT02593097|468659204|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
130191364|NCT02593097|468659203|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
130191365|NCT02593097|468659204|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
130191366|NCT02593097|468659203|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
130191367|NCT02593097|468659204|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
130191368|NCT02593097|468659203|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
130191369|NCT02593097|468659204|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
130191370|NCT02593097|468659203|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
130191371|NCT02593097|468659204|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
130191372|NCT02522884|468659205|FG000|Overall Study|Withdrawal by Subject|6|||
130191373|NCT02522884|468659205|FG000|Overall Study|Death|3|||
130191374|NCT02522884|468659205|FG000|Overall Study|Missed 12-month Follow-up|9|||
130191375|NCT02630251|468659206|FG000|Overall Study|Physician Decision|0|||
130191376|NCT02630251|468659207|FG001|Overall Study|Physician Decision|0|||
130191377|NCT02630251|468659208|FG002|Overall Study|Physician Decision|1|||
130191378|NCT02630251|468659209|FG003|Overall Study|Physician Decision|0|||
130191379|NCT01863667|468659210|FG000|Overall Study|Adverse Event|1|||
130191380|NCT01863667|468659211|FG001|Overall Study|Adverse Event|0|||
130191381|NCT01863667|468659210|FG000|Overall Study|Study terminated by Sponsor|30|||
130191382|NCT01863667|468659211|FG001|Overall Study|Study terminated by Sponsor|30|||
130191383|NCT01863667|468659210|FG000|Overall Study|Withdrawal by Subject|2|||
130191384|NCT01863667|468659211|FG001|Overall Study|Withdrawal by Subject|2|||
130191385|NCT03627546|468659212|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
130191386|NCT03627546|468659213|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
130191387|NCT03627546|468659214|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
130191388|NCT03627546|468659212|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
130191389|NCT03627546|468659213|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
130191390|NCT03627546|468659214|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
130191391|NCT00615550|468659217|FG000|Overall Study|Lost to Follow-up|6|||
130191392|NCT00615550|468659218|FG001|Overall Study|Lost to Follow-up|1|||
130191393|NCT02640664|468659219|FG000|Epoch 1|Withdrawal of informed consent|1|||
130191394|NCT02640664|468659220|FG001|Epoch 1|Withdrawal of informed consent|0|||
130191395|NCT02640664|468659221|FG002|Epoch 1|Withdrawal of informed consent|0|||
130191396|NCT02640664|468659219|FG000|Epoch 1|Death|0|||
130191397|NCT02640664|468659220|FG001|Epoch 1|Death|0|||
130191398|NCT02640664|468659221|FG002|Epoch 1|Death|1|||
130191399|NCT02640664|468659219|FG000|Epoch 2|Withdrawal of informed consent|3|||
130191400|NCT02640664|468659220|FG001|Epoch 2|Withdrawal of informed consent|4|||
130191401|NCT02640664|468659221|FG002|Epoch 2|Withdrawal of informed consent|2|||
130191402|NCT02640664|468659219|FG000|Epoch 2|Subject/guardian decision|0|||
130191403|NCT02640664|468659220|FG001|Epoch 2|Subject/guardian decision|2|||
130191404|NCT02640664|468659221|FG002|Epoch 2|Subject/guardian decision|2|||
130191405|NCT02640664|468659219|FG000|Epoch 2|Lost to Follow-up|3|||
130191406|NCT02640664|468659220|FG001|Epoch 2|Lost to Follow-up|4|||
130191407|NCT02640664|468659221|FG002|Epoch 2|Lost to Follow-up|1|||
130191408|NCT02640664|468659219|FG000|Epoch 2|Death|0|||
130191409|NCT02640664|468659220|FG001|Epoch 2|Death|0|||
130191410|NCT02640664|468659221|FG002|Epoch 2|Death|1|||
130191411|NCT02965573|468659223|FG000|Overall Study|Lack of Efficacy|1|||
130191412|NCT02965573|468659224|FG001|Overall Study|Lack of Efficacy|0|||
130191413|NCT00315458|468659225|FG000|Overall Study|Administrative|0|||
130191414|NCT00315458|468659226|FG001|Overall Study|Administrative|3|||
130191415|NCT00315458|468659227|FG002|Overall Study|Administrative|8|||
130191416|NCT00315458|468659228|FG003|Overall Study|Administrative|21|||
130191417|NCT00315458|468659225|FG000|Overall Study|Adverse Event|2|||
130191418|NCT00315458|468659226|FG001|Overall Study|Adverse Event|4|||
130191419|NCT00315458|468659227|FG002|Overall Study|Adverse Event|23|||
130191420|NCT00315458|468659228|FG003|Overall Study|Adverse Event|3|||
130191421|NCT00315458|468659225|FG000|Overall Study|Lost to Follow-up|1|||
130191422|NCT00315458|468659226|FG001|Overall Study|Lost to Follow-up|2|||
130191423|NCT00315458|468659227|FG002|Overall Study|Lost to Follow-up|0|||
130191424|NCT00315458|468659228|FG003|Overall Study|Lost to Follow-up|2|||
130191425|NCT00315458|468659225|FG000|Overall Study|Withdrawal by Subject|0|||
130191426|NCT00315458|468659226|FG001|Overall Study|Withdrawal by Subject|3|||
130191427|NCT00315458|468659227|FG002|Overall Study|Withdrawal by Subject|0|||
130191428|NCT00315458|468659228|FG003|Overall Study|Withdrawal by Subject|2|||
130191429|NCT00315458|468659225|FG000|Overall Study|Lack of Efficacy|0|||
130191430|NCT00315458|468659226|FG001|Overall Study|Lack of Efficacy|0|||
130191431|NCT00315458|468659227|FG002|Overall Study|Lack of Efficacy|20|||
130191432|NCT00315458|468659228|FG003|Overall Study|Lack of Efficacy|1|||
130191433|NCT00315458|468659225|FG000|Overall Study|Did not qualify|0|||
130191434|NCT00315458|468659226|FG001|Overall Study|Did not qualify|0|||
130191435|NCT00315458|468659227|FG002|Overall Study|Did not qualify|1|||
130191436|NCT00315458|468659228|FG003|Overall Study|Did not qualify|0|||
130191437|NCT00987337|468659229|FG000|Overall Study|Adverse Event|10|||
130191438|NCT00987337|468659230|FG001|Overall Study|Adverse Event|9|||
130191439|NCT00987337|468659231|FG002|Overall Study|Adverse Event|8|||
130191440|NCT00987337|468659229|FG000|Overall Study|Insufficient Virologic Response|10|||
130191441|NCT00987337|468659230|FG001|Overall Study|Insufficient Virologic Response|7|||
130191442|NCT00987337|468659231|FG002|Overall Study|Insufficient Virologic Response|12|||
130191443|NCT00987337|468659229|FG000|Overall Study|Virologic Breakthrough|2|||
130191444|NCT00987337|468659230|FG001|Overall Study|Virologic Breakthrough|2|||
130191445|NCT00987337|468659231|FG002|Overall Study|Virologic Breakthrough|8|||
130191446|NCT00987337|468659229|FG000|Overall Study|Lost to Follow-up|10|||
130191447|NCT00987337|468659230|FG001|Overall Study|Lost to Follow-up|6|||
130191448|NCT00987337|468659231|FG002|Overall Study|Lost to Follow-up|2|||
130191449|NCT00987337|468659229|FG000|Overall Study|Withdrawal by Subject|6|||
130191450|NCT00987337|468659230|FG001|Overall Study|Withdrawal by Subject|9|||
130191451|NCT00987337|468659231|FG002|Overall Study|Withdrawal by Subject|9|||
130191452|NCT00987337|468659229|FG000|Overall Study|Other|0|||
130191453|NCT00987337|468659230|FG001|Overall Study|Other|2|||
130191454|NCT00987337|468659231|FG002|Overall Study|Other|5|||
130191455|NCT00987337|468659229|FG000|Overall Study|Protocol Violation|1|||
130191456|NCT00987337|468659230|FG001|Overall Study|Protocol Violation|0|||
130191457|NCT00987337|468659231|FG002|Overall Study|Protocol Violation|2|||
130191458|NCT00987337|468659229|FG000|Overall Study|Participant Relapsed|18|||
130191459|NCT00987337|468659230|FG001|Overall Study|Participant Relapsed|20|||
130191460|NCT00987337|468659231|FG002|Overall Study|Participant Relapsed|5|||
130191461|NCT00086619|468659234|FG000|Overall Study|Withdrawal by Subject|6|||
130191462|NCT00086619|468659235|FG001|Overall Study|Withdrawal by Subject|6|||
130191463|NCT00086619|468659234|FG000|Overall Study|Adverse Event|8|||
130191464|NCT00086619|468659235|FG001|Overall Study|Adverse Event|10|||
130191465|NCT00086619|468659234|FG000|Overall Study|Protocol Violation|1|||
130191466|NCT00086619|468659235|FG001|Overall Study|Protocol Violation|1|||
130191467|NCT00489918|468659236|FG000|Overall Study|Withdrawal by Subject|2|||
130191468|NCT00489918|468659237|FG001|Overall Study|Withdrawal by Subject|1|||
130191469|NCT00489918|468659238|FG002|Overall Study|Withdrawal by Subject|1|||
130191470|NCT00489918|468659239|FG003|Overall Study|Withdrawal by Subject|0|||
130191471|NCT00489918|468659240|FG004|Overall Study|Withdrawal by Subject|1|||
130191472|NCT00489918|468659236|FG000|Overall Study|Adverse Event|0|||
130191473|NCT00489918|468659237|FG001|Overall Study|Adverse Event|1|||
130191474|NCT00489918|468659238|FG002|Overall Study|Adverse Event|1|||
130191475|NCT00489918|468659239|FG003|Overall Study|Adverse Event|0|||
130191476|NCT00489918|468659240|FG004|Overall Study|Adverse Event|0|||
130191477|NCT00489918|468659236|FG000|Overall Study|Lost to Follow-up|0|||
130191478|NCT00489918|468659237|FG001|Overall Study|Lost to Follow-up|0|||
130191479|NCT00489918|468659238|FG002|Overall Study|Lost to Follow-up|1|||
130191480|NCT00489918|468659239|FG003|Overall Study|Lost to Follow-up|1|||
130191481|NCT00489918|468659240|FG004|Overall Study|Lost to Follow-up|0|||
130191482|NCT00489918|468659236|FG000|Overall Study|Physician Decision|0|||
130191483|NCT00489918|468659237|FG001|Overall Study|Physician Decision|0|||
130191484|NCT00489918|468659238|FG002|Overall Study|Physician Decision|1|||
130191485|NCT00489918|468659239|FG003|Overall Study|Physician Decision|0|||
130191486|NCT00489918|468659240|FG004|Overall Study|Physician Decision|0|||
130191487|NCT02748213|468659241|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
130191488|NCT02748213|468659242|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
130191489|NCT02748213|468659241|FG000|Overall Study|Abnormal Laboratory Test|1|||
130191490|NCT02748213|468659242|FG001|Overall Study|Abnormal Laboratory Test|0|||
130191491|NCT02748213|468659241|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
130191492|NCT02748213|468659242|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
130191493|NCT02748213|468659241|FG000|Overall Study|Death|5|||
130191494|NCT02748213|468659242|FG001|Overall Study|Death|3|||
130191495|NCT02748213|468659241|FG000|Overall Study|Insufficient Therapeutic Response|56|||
130191496|NCT02748213|468659242|FG001|Overall Study|Insufficient Therapeutic Response|57|||
130191497|NCT02748213|468659241|FG000|Overall Study|Violation of Selection Criteria|2|||
130191498|NCT02748213|468659242|FG001|Overall Study|Violation of Selection Criteria|0|||
130191499|NCT02748213|468659241|FG000|Overall Study|Protocol Violation|6|||
130191500|NCT02748213|468659242|FG001|Overall Study|Protocol Violation|4|||
130191501|NCT02748213|468659241|FG000|Overall Study|Refused Treatment*|6|||
130191502|NCT02748213|468659242|FG001|Overall Study|Refused Treatment*|6|||
130191503|NCT02748213|468659241|FG000|Overall Study|Failure to Return|1|||
130191504|NCT02748213|468659242|FG001|Overall Study|Failure to Return|0|||
130191505|NCT02748213|468659241|FG000|Overall Study|Other|30|||
130191506|NCT02748213|468659242|FG001|Overall Study|Other|29|||
130191507|NCT01209520|468659244|FG000|Overall Study|Withdrawal by Subject|3|||
130191508|NCT00961350|468659245|FG000|Overall Study|Adverse Event|18|||
130191509|NCT00961350|468659246|FG001|Overall Study|Adverse Event|33|||
130191510|NCT00961350|468659245|FG000|Overall Study|Withdrawal by Subject|10|||
130191511|NCT00961350|468659246|FG001|Overall Study|Withdrawal by Subject|10|||
130191512|NCT00961350|468659245|FG000|Overall Study|Lost to Follow-up|3|||
130191513|NCT00961350|468659246|FG001|Overall Study|Lost to Follow-up|3|||
130191514|NCT00961350|468659245|FG000|Overall Study|Misc|16|||
130191515|NCT00961350|468659246|FG001|Overall Study|Misc|21|||
130191516|NCT00550745|468659247|FG000|Overall Study|Death|20|||
130191517|NCT00550745|468659248|FG001|Overall Study|Death|16|||
130191518|NCT00550745|468659247|FG000|Overall Study|Lost to Follow-up|45|||
130191519|NCT00550745|468659248|FG001|Overall Study|Lost to Follow-up|30|||
130191520|NCT00550745|468659247|FG000|Overall Study|Physician Decision|0|||
130191521|NCT00550745|468659248|FG001|Overall Study|Physician Decision|2|||
130191522|NCT00550745|468659247|FG000|Overall Study|Protocol Violation|4|||
130191523|NCT00550745|468659248|FG001|Overall Study|Protocol Violation|2|||
130191524|NCT00550745|468659247|FG000|Overall Study|Withdrawal by Subject|17|||
130191525|NCT00550745|468659248|FG001|Overall Study|Withdrawal by Subject|10|||
130191526|NCT00550745|468659247|FG000|Overall Study|Screen failure|1|||
130191527|NCT00550745|468659248|FG001|Overall Study|Screen failure|0|||
130191528|NCT00617890|468661269|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
130191529|NCT00617890|468661270|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
130191530|NCT00617890|468661271|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
130191531|NCT00617890|468661272|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
130191532|NCT00617890|468661269|FG000|Overall Study|Lack of Efficacy|23|||
130191533|NCT00617890|468661270|FG001|Overall Study|Lack of Efficacy|26|||
130191534|NCT00617890|468661271|FG002|Overall Study|Lack of Efficacy|30|||
130191535|NCT00617890|468661272|FG003|Overall Study|Lack of Efficacy|97|||
130191536|NCT00617890|468661269|FG000|Overall Study|Lost to Follow-up|0|||
130191537|NCT00617890|468661270|FG001|Overall Study|Lost to Follow-up|0|||
130191538|NCT00617890|468661271|FG002|Overall Study|Lost to Follow-up|1|||
130191539|NCT00617890|468661272|FG003|Overall Study|Lost to Follow-up|2|||
130191540|NCT00617890|468661269|FG000|Overall Study|Withdrawal by Subject|4|||
130191541|NCT00617890|468661270|FG001|Overall Study|Withdrawal by Subject|1|||
130191542|NCT00617890|468661271|FG002|Overall Study|Withdrawal by Subject|0|||
130191543|NCT00617890|468661272|FG003|Overall Study|Withdrawal by Subject|2|||
130191544|NCT00617890|468661269|FG000|Overall Study|Protocol Violation|2|||
130191545|NCT00617890|468661270|FG001|Overall Study|Protocol Violation|1|||
130191546|NCT00617890|468661271|FG002|Overall Study|Protocol Violation|0|||
130191547|NCT00617890|468661272|FG003|Overall Study|Protocol Violation|0|||
130191548|NCT00617890|468661269|FG000|Overall Study|Adverse Event|1|||
130191549|NCT00617890|468661270|FG001|Overall Study|Adverse Event|0|||
130191550|NCT00617890|468661271|FG002|Overall Study|Adverse Event|3|||
130191551|NCT00617890|468661272|FG003|Overall Study|Adverse Event|8|||
130191552|NCT00617890|468661269|FG000|Overall Study|Not treated|1|||
130191553|NCT00617890|468661270|FG001|Overall Study|Not treated|0|||
130191554|NCT00617890|468661271|FG002|Overall Study|Not treated|1|||
130191555|NCT00617890|468661272|FG003|Overall Study|Not treated|1|||
130191556|NCT02640950|468661274|FG000|Overall Study|Adverse Event|1|||
130191557|NCT02640950|468661274|FG000|Overall Study|Withdrawal by Subject|1|||
130191558|NCT00154284|468661275|FG000|Overall Study|Adverse Event|6|||
130191559|NCT00154284|468661276|FG001|Overall Study|Adverse Event|9|||
130191560|NCT00154284|468661275|FG000|Overall Study|Abnormal laboratory value(s)|0|||
130191561|NCT00154284|468661276|FG001|Overall Study|Abnormal laboratory value(s)|1|||
130191562|NCT00154284|468661275|FG000|Overall Study|Lack of Efficacy|1|||
130191563|NCT00154284|468661276|FG001|Overall Study|Lack of Efficacy|2|||
130191564|NCT00154284|468661275|FG000|Overall Study|Protocol Violation|0|||
130191565|NCT00154284|468661276|FG001|Overall Study|Protocol Violation|1|||
130191566|NCT00566020|468661277|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
130191567|NCT00566020|468661278|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
130191568|NCT00566020|468661277|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
130191569|NCT00566020|468661278|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
130191570|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
130191571|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
130191572|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
130191573|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
130191574|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
130191575|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
130191576|NCT00566020|468661277|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
130191577|NCT00566020|468661278|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
130191578|NCT02582242|468661279|FG000|Overall Study|Adverse Event|4|||
130191579|NCT02582242|468661280|FG001|Overall Study|Adverse Event|3|||
130191580|NCT02582242|468661279|FG000|Overall Study|Protocol Violation|3|||
130191581|NCT02582242|468661280|FG001|Overall Study|Protocol Violation|1|||
130191582|NCT02582242|468661279|FG000|Overall Study|Lost to Follow-up|0|||
130191583|NCT02582242|468661280|FG001|Overall Study|Lost to Follow-up|1|||
130191584|NCT02582242|468661279|FG000|Overall Study|Withdrawal by Subject|11|||
130191585|NCT02582242|468661280|FG001|Overall Study|Withdrawal by Subject|11|||
130191586|NCT02582242|468661279|FG000|Overall Study|Unclassified|2|||
130191587|NCT02582242|468661280|FG001|Overall Study|Unclassified|1|||
130191588|NCT02101736|468661281|FG000|Overall Study|Protocol Violation|3|||
130191589|NCT02101736|468661282|FG001|Overall Study|Protocol Violation|0|||
130191590|NCT02101736|468661281|FG000|Overall Study|Withdrawal by Subject|1|||
130191591|NCT02101736|468661282|FG001|Overall Study|Withdrawal by Subject|1|||
130191592|NCT00459290|468661283|FG000|Overall Study|Adverse Event|3|||
130191593|NCT00459290|468661283|FG000|Overall Study|Ineligible|2|||
130191594|NCT02176655|468661291|FG000|Overall Study|Subjects did not treat|6|||
130191595|NCT01464593|468661296|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
130191596|NCT02476578|468661301|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
130191597|NCT02476578|468661302|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
130191598|NCT02476578|468661301|FG000|Overall Study|Lost to Follow-up|6|||
130191599|NCT02476578|468661302|FG001|Overall Study|Lost to Follow-up|13|||
130191600|NCT01019694|468661303|FG000|Overall Study|Adverse Event|12|||
130191601|NCT01019694|468661304|FG001|Overall Study|Adverse Event|16|||
130191602|NCT01019694|468661305|FG002|Overall Study|Adverse Event|19|||
130191603|NCT01019694|468661303|FG000|Overall Study|Protocol Violation|2|||
130191604|NCT01019694|468661304|FG001|Overall Study|Protocol Violation|6|||
130191605|NCT01019694|468661305|FG002|Overall Study|Protocol Violation|4|||
130191606|NCT01019694|468661303|FG000|Overall Study|Lost to Follow-up|5|||
130191607|NCT01019694|468661304|FG001|Overall Study|Lost to Follow-up|3|||
130191608|NCT01019694|468661305|FG002|Overall Study|Lost to Follow-up|3|||
130191609|NCT01019694|468661303|FG000|Overall Study|Withdrawal by Subject|4|||
130191610|NCT01019694|468661304|FG001|Overall Study|Withdrawal by Subject|6|||
130191611|NCT01019694|468661305|FG002|Overall Study|Withdrawal by Subject|12|||
130191612|NCT01019694|468661303|FG000|Overall Study|Not treated|0|||
130191613|NCT01019694|468661304|FG001|Overall Study|Not treated|2|||
130191614|NCT01019694|468661305|FG002|Overall Study|Not treated|3|||
130191615|NCT01019694|468661303|FG000|Overall Study|Other reason (not specified)|1|||
130191616|NCT01019694|468661304|FG001|Overall Study|Other reason (not specified)|5|||
130191617|NCT01019694|468661305|FG002|Overall Study|Other reason (not specified)|6|||
130191618|NCT00026494|468661312|FG000|Overall Study|Withdrawal by Subject|1|||
130191619|NCT00026494|468661313|FG001|Overall Study|Withdrawal by Subject|0|||
130191620|NCT00026494|468661314|FG002|Overall Study|Withdrawal by Subject|1|||
130191621|NCT00026494|468661315|FG003|Overall Study|Withdrawal by Subject|0|||
130191622|NCT00026494|468661312|FG000|Overall Study|Patient non-compliance|1|||
130191623|NCT00026494|468661313|FG001|Overall Study|Patient non-compliance|0|||
130191624|NCT00026494|468661314|FG002|Overall Study|Patient non-compliance|0|||
130191625|NCT00026494|468661315|FG003|Overall Study|Patient non-compliance|0|||
130191626|NCT00026494|468661312|FG000|Overall Study|Patient not treated|0|||
130191627|NCT00026494|468661313|FG001|Overall Study|Patient not treated|0|||
130191628|NCT00026494|468661314|FG002|Overall Study|Patient not treated|2|||
130191629|NCT00026494|468661315|FG003|Overall Study|Patient not treated|0|||
130191630|NCT00026494|468661312|FG000|Overall Study|Clinical progression|0|||
130191631|NCT00026494|468661313|FG001|Overall Study|Clinical progression|0|||
130191632|NCT00026494|468661314|FG002|Overall Study|Clinical progression|3|||
130191633|NCT00026494|468661315|FG003|Overall Study|Clinical progression|0|||
130191634|NCT01684423|468661316|FG000|Overall Study|Withdrawal by Subject|0|||
130191635|NCT01684423|468661317|FG001|Overall Study|Withdrawal by Subject|0|||
130191636|NCT01684423|468661318|FG002|Overall Study|Withdrawal by Subject|1|||
130191637|NCT01684423|468661319|FG003|Overall Study|Withdrawal by Subject|0|||
130191638|NCT01684423|468661320|FG004|Overall Study|Withdrawal by Subject|0|||
130191639|NCT01455597|468661321|FG000|Overall Study|Adverse Event|7|||
130191640|NCT01455597|468661322|FG001|Overall Study|Adverse Event|0|||
130191641|NCT01455597|468661323|FG002|Overall Study|Adverse Event|5|||
130191642|NCT01455597|468661324|FG003|Overall Study|Adverse Event|1|||
130191643|NCT01455597|468661321|FG000|Overall Study|Lack of Efficacy|0|||
130191644|NCT01455597|468661322|FG001|Overall Study|Lack of Efficacy|1|||
130191645|NCT01455597|468661323|FG002|Overall Study|Lack of Efficacy|2|||
130191646|NCT01455597|468661324|FG003|Overall Study|Lack of Efficacy|0|||
130191647|NCT01455597|468661321|FG000|Overall Study|Lost to Follow-up|3|||
130191648|NCT01455597|468661322|FG001|Overall Study|Lost to Follow-up|0|||
130191649|NCT01455597|468661323|FG002|Overall Study|Lost to Follow-up|2|||
130191650|NCT01455597|468661324|FG003|Overall Study|Lost to Follow-up|1|||
130191651|NCT01455597|468661321|FG000|Overall Study|Withdrew Consent|6|||
130191652|NCT01455597|468661322|FG001|Overall Study|Withdrew Consent|5|||
130191653|NCT01455597|468661323|FG002|Overall Study|Withdrew Consent|8|||
130191654|NCT01455597|468661324|FG003|Overall Study|Withdrew Consent|5|||
130191655|NCT01455597|468661321|FG000|Overall Study|Reason not Specified|1|||
130191656|NCT01455597|468661322|FG001|Overall Study|Reason not Specified|2|||
130191657|NCT01455597|468661323|FG002|Overall Study|Reason not Specified|3|||
130191658|NCT01455597|468661324|FG003|Overall Study|Reason not Specified|3|||
130191659|NCT00441129|468661325|FG000|Overall Study|Withdrawal by Subject|6|||
130191660|NCT00441129|468661326|FG001|Overall Study|Withdrawal by Subject|14|||
130191661|NCT03412734|468661329|FG000|Overall Study|Incorrect labeling of samples|2|||
130191662|NCT03412734|468661330|FG001|Overall Study|Incorrect labeling of samples|0|||
130191663|NCT03412734|468661329|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
130191664|NCT03412734|468661330|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
130191665|NCT04747886|468661331|FG000|Overall Study|Withdrawal by Subject|1|||
130191666|NCT04747886|468661332|FG001|Overall Study|Withdrawal by Subject|4|||
130191667|NCT03777436|468661336|FG000|Placebo-controlled Phase|Adverse Event|8|||
130191668|NCT03777436|468661337|FG001|Placebo-controlled Phase|Adverse Event|10|||
130191669|NCT03777436|468661338|FG002|Placebo-controlled Phase|Adverse Event|0|||
130191670|NCT03777436|468661336|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
130191671|NCT03777436|468661337|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
130191672|NCT03777436|468661338|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
130191673|NCT03777436|468661336|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
130191674|NCT03777436|468661337|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
130191675|NCT03777436|468661338|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
130191676|NCT03777436|468661336|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
130191677|NCT03777436|468661337|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
130191678|NCT03777436|468661338|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
130191679|NCT03777436|468661336|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
130191680|NCT03777436|468661337|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
130191681|NCT03777436|468661338|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
130191682|NCT03777436|468661336|FG000|Placebo-controlled Phase|Physician Decision|0|||
130191683|NCT03777436|468661337|FG001|Placebo-controlled Phase|Physician Decision|1|||
130191684|NCT03777436|468661338|FG002|Placebo-controlled Phase|Physician Decision|0|||
130191685|NCT03777436|468661336|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
130191686|NCT03777436|468661337|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
130191687|NCT03777436|468661338|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
130191688|NCT03777436|468661336|FG000|Apremilast Extension Phase|Adverse Event|0|||
130191689|NCT03777436|468661337|FG001|Apremilast Extension Phase|Adverse Event|0|||
130191690|NCT03777436|468661338|FG002|Apremilast Extension Phase|Adverse Event|6|||
130191691|NCT03777436|468661336|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
130191692|NCT03777436|468661337|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
130191693|NCT03777436|468661338|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
130191694|NCT03777436|468661336|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
130191695|NCT03777436|468661337|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
130191696|NCT03777436|468661338|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
130191697|NCT03777436|468661336|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
130191698|NCT03777436|468661337|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
130191699|NCT03777436|468661338|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
130191700|NCT03777436|468661336|FG000|Apremilast Extension Phase|Miscellaneous|0|||
130191701|NCT03777436|468661337|FG001|Apremilast Extension Phase|Miscellaneous|0|||
130191702|NCT03777436|468661338|FG002|Apremilast Extension Phase|Miscellaneous|1|||
130191703|NCT00869999|468661344|FG000|Overall Study|Withdrawal by Subject|1|||
130191704|NCT00869999|468661344|FG000|Overall Study|removed prior to starting therapy|1|||
130191705|NCT04478695|468661345|FG000|Overall Study|Death|1|||
130191706|NCT04478695|468661346|FG001|Overall Study|Death|0|||
130191707|NCT00644917|468661347|FG000|Overall Study|Withdrawal by Subject|2|||
130191708|NCT01136356|468661348|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
130191709|NCT01136356|468661349|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
130191710|NCT01136356|468661348|FG000|First 18-day Withdrawal|Physician Decision|1|||
130191711|NCT01136356|468661349|FG001|First 18-day Withdrawal|Physician Decision|0|||
130191712|NCT01136356|468661348|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
130191713|NCT01136356|468661349|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
130191714|NCT00758485|468661350|FG000|Overall Study|Lost to Follow-up|0|||
130191715|NCT00758485|468661351|FG001|Overall Study|Lost to Follow-up|1|||
130191716|NCT00758485|468661350|FG000|Overall Study|Not Treated|1|||
130191717|NCT00758485|468661351|FG001|Overall Study|Not Treated|2|||
130191718|NCT00402688|468661352|FG000|Overall Study|Adverse Event|12|||
130191719|NCT00402688|468661353|FG001|Overall Study|Adverse Event|9|||
130191720|NCT00402688|468661354|FG002|Overall Study|Adverse Event|3|||
130191721|NCT00402688|468661352|FG000|Overall Study|Withdrawal by Subject|3|||
130191722|NCT00402688|468661353|FG001|Overall Study|Withdrawal by Subject|1|||
130191723|NCT00402688|468661354|FG002|Overall Study|Withdrawal by Subject|1|||
130191724|NCT00402688|468661352|FG000|Overall Study|Physician Decision|0|||
130191725|NCT00402688|468661353|FG001|Overall Study|Physician Decision|0|||
130191726|NCT00402688|468661354|FG002|Overall Study|Physician Decision|1|||
130191727|NCT00402688|468661352|FG000|Overall Study|Lack of Efficacy|4|||
130191728|NCT00402688|468661353|FG001|Overall Study|Lack of Efficacy|4|||
130191729|NCT00402688|468661354|FG002|Overall Study|Lack of Efficacy|5|||
130191730|NCT00402688|468661352|FG000|Overall Study|Protocol Violation|1|||
130191731|NCT00402688|468661353|FG001|Overall Study|Protocol Violation|1|||
130191732|NCT00402688|468661354|FG002|Overall Study|Protocol Violation|1|||
130191733|NCT00402688|468661352|FG000|Overall Study|Lost to Follow-up|1|||
130191734|NCT00402688|468661353|FG001|Overall Study|Lost to Follow-up|0|||
130191735|NCT00402688|468661354|FG002|Overall Study|Lost to Follow-up|2|||
130191736|NCT00402688|468661352|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
130191737|NCT00402688|468661353|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
130191738|NCT00402688|468661354|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
130191739|NCT00402688|468661352|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
130191740|NCT00402688|468661353|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
130191741|NCT00402688|468661354|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
130191742|NCT00402688|468661352|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
130191743|NCT00402688|468661353|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
130191744|NCT00402688|468661354|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
130191745|NCT02347774|468661355|FG000|Study Participation|Lost to Follow-up|3|||
130191746|NCT02347774|468661356|FG001|Study Participation|Lost to Follow-up|6|||
130191747|NCT02347774|468661357|FG002|Study Participation|Lost to Follow-up|2|||
130191748|NCT02347774|468661355|FG000|Study Participation|Withdrawal by Subject|8|||
130191749|NCT02347774|468661356|FG001|Study Participation|Withdrawal by Subject|9|||
130191750|NCT02347774|468661357|FG002|Study Participation|Withdrawal by Subject|15|||
130191751|NCT02347774|468661355|FG000|Study Participation|Adverse Event|1|||
130191752|NCT02347774|468661356|FG001|Study Participation|Adverse Event|4|||
130191753|NCT02347774|468661357|FG002|Study Participation|Adverse Event|6|||
130191754|NCT02347774|468661355|FG000|Study Participation|withdrew consent|1|||
130191755|NCT02347774|468661356|FG001|Study Participation|withdrew consent|1|||
130191756|NCT02347774|468661357|FG002|Study Participation|withdrew consent|1|||
130191757|NCT02347774|468661355|FG000|Study Participation|Met Prolonged QT criteria|1|||
130191758|NCT02347774|468661356|FG001|Study Participation|Met Prolonged QT criteria|0|||
130191759|NCT02347774|468661357|FG002|Study Participation|Met Prolonged QT criteria|0|||
130191760|NCT02347774|468661355|FG000|Study Participation|non-compliance with study drug|0|||
130191761|NCT02347774|468661356|FG001|Study Participation|non-compliance with study drug|1|||
130191762|NCT02347774|468661357|FG002|Study Participation|non-compliance with study drug|0|||
130191763|NCT02347774|468661355|FG000|Study Participation|incarceration|1|||
130191764|NCT02347774|468661356|FG001|Study Participation|incarceration|0|||
130191765|NCT02347774|468661357|FG002|Study Participation|incarceration|0|||
130191766|NCT02347774|468661355|FG000|Study Participation|randomized in error|0|||
130191767|NCT02347774|468661356|FG001|Study Participation|randomized in error|0|||
130191768|NCT02347774|468661357|FG002|Study Participation|randomized in error|1|||
130191769|NCT02347774|468661355|FG000|On Study Treatment|Adverse Event|9|||
130191770|NCT02347774|468661356|FG001|On Study Treatment|Adverse Event|15|||
130191771|NCT02347774|468661357|FG002|On Study Treatment|Adverse Event|19|||
130191772|NCT02347774|468661355|FG000|On Study Treatment|Lack of Efficacy|3|||
130191773|NCT02347774|468661356|FG001|On Study Treatment|Lack of Efficacy|0|||
130191774|NCT02347774|468661357|FG002|On Study Treatment|Lack of Efficacy|2|||
130191775|NCT02347774|468661355|FG000|On Study Treatment|non-complicance with study medication|0|||
130191776|NCT02347774|468661356|FG001|On Study Treatment|non-complicance with study medication|2|||
130191777|NCT02347774|468661357|FG002|On Study Treatment|non-complicance with study medication|0|||
130191778|NCT02347774|468661355|FG000|On Study Treatment|Protocol Violation|0|||
130191779|NCT02347774|468661356|FG001|On Study Treatment|Protocol Violation|0|||
130191780|NCT02347774|468661357|FG002|On Study Treatment|Protocol Violation|1|||
130191781|NCT02347774|468661355|FG000|On Study Treatment|withdrew consent|9|||
130191782|NCT02347774|468661356|FG001|On Study Treatment|withdrew consent|8|||
130191783|NCT02347774|468661357|FG002|On Study Treatment|withdrew consent|12|||
130191784|NCT02347774|468661355|FG000|On Study Treatment|Lost to Follow-up|2|||
130191785|NCT02347774|468661356|FG001|On Study Treatment|Lost to Follow-up|6|||
130191786|NCT02347774|468661357|FG002|On Study Treatment|Lost to Follow-up|1|||
130191787|NCT02347774|468661355|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
130191788|NCT02347774|468661356|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
130191789|NCT02347774|468661357|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
130191790|NCT02347774|468661355|FG000|On Study Treatment|ranomized in error|0|||
130191791|NCT02347774|468661356|FG001|On Study Treatment|ranomized in error|0|||
130191792|NCT02347774|468661357|FG002|On Study Treatment|ranomized in error|1|||
130191793|NCT00921557|468661358|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
130191794|NCT00921557|468661359|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
130191795|NCT00921557|468661360|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
130191796|NCT00921557|468661358|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
130191797|NCT00921557|468661359|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
130191798|NCT00921557|468661360|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
130191799|NCT00921557|468661358|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
130191800|NCT00921557|468661359|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
130191801|NCT00921557|468661360|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
130191802|NCT00921557|468661358|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
130191803|NCT00921557|468661359|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
130191804|NCT00921557|468661360|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
130191805|NCT00921557|468661358|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
130191806|NCT00921557|468661359|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
130191807|NCT00921557|468661360|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
130191808|NCT00656292|468661361|FG000|Overall Study|Withdrawal by Subject|2|||
130191809|NCT00656292|468661362|FG001|Overall Study|Withdrawal by Subject|3|||
130191810|NCT00656292|468661361|FG000|Overall Study|Screen failure|1|||
130191811|NCT00656292|468661362|FG001|Overall Study|Screen failure|2|||
130191812|NCT03259425|468661363|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
130191813|NCT04112043|468661364|FG000|Overall Study|Withdrawal by Subject|1|||
130191814|NCT04112043|468661365|FG001|Overall Study|Withdrawal by Subject|1|||
130191815|NCT04112043|468661366|FG002|Overall Study|Withdrawal by Subject|1|||
130191816|NCT04112043|468661364|FG000|Overall Study|Taking NR supplement|1|||
130191817|NCT04112043|468661365|FG001|Overall Study|Taking NR supplement|0|||
130191818|NCT04112043|468661366|FG002|Overall Study|Taking NR supplement|0|||
130191819|NCT04112043|468661364|FG000|Overall Study|Adverse Event|0|||
130191820|NCT04112043|468661365|FG001|Overall Study|Adverse Event|1|||
130191821|NCT04112043|468661366|FG002|Overall Study|Adverse Event|0|||
130191822|NCT04157296|468661367|FG000|Overall Study|Withdrawal by Subject|0|||
130191823|NCT04157296|468661368|FG001|Overall Study|Withdrawal by Subject|1|||
130191824|NCT04157296|468661367|FG000|Overall Study|Did not obtain second fMRI.|0|||
130191825|NCT04157296|468661368|FG001|Overall Study|Did not obtain second fMRI.|1|||
130191826|NCT04157296|468661367|FG000|Overall Study|MRI failed/no second fMRI|0|||
130191827|NCT04157296|468661368|FG001|Overall Study|MRI failed/no second fMRI|1|||
130191828|NCT00356148|468661371|FG000|Overall Study|Reoperation within 30 days|2|||
130191829|NCT00356148|468661372|FG001|Overall Study|Reoperation within 30 days|1|||
130191830|NCT02484456|468661373|FG000|Washout Period|Withdrawal by Subject|0|||
130191831|NCT02484456|468661374|FG001|Washout Period|Withdrawal by Subject|1|||
130191832|NCT02484456|468661373|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
130191833|NCT02484456|468661374|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
130191834|NCT02484456|468661373|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
130191835|NCT02484456|468661374|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
130191836|NCT02484456|468661373|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
130191837|NCT02484456|468661374|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
130191838|NCT01996254|468661375|FG000|Overall Study|Change in Eligibility|0|||
130191839|NCT01996254|468661376|FG001|Overall Study|Change in Eligibility|2|||
130191840|NCT01996254|468661377|FG002|Overall Study|Change in Eligibility|0|||
130191841|NCT01996254|468661375|FG000|Overall Study|Withdrawal by Subject|0|||
130191842|NCT01996254|468661376|FG001|Overall Study|Withdrawal by Subject|3|||
130191843|NCT01996254|468661377|FG002|Overall Study|Withdrawal by Subject|4|||
130191844|NCT01996254|468661375|FG000|Overall Study|Lost to Follow-up|1|||
130191845|NCT01996254|468661376|FG001|Overall Study|Lost to Follow-up|0|||
130191846|NCT01996254|468661377|FG002|Overall Study|Lost to Follow-up|4|||
130191847|NCT03348930|468661380|FG000|Washout (1 Week)|Lost to Follow-up|1|||
130191848|NCT03348930|468661381|FG001|Washout (1 Week)|Lost to Follow-up|1|||
130191849|NCT02091089|468661383|FG000|Overall Study|Lost to Follow-up|2|||
130191850|NCT01580670|468661384|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
130191851|NCT01580670|468661384|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
130191852|NCT02097745|468661385|FG000|Overall Study|Adverse Event|25|||
130191853|NCT02097745|468661385|FG000|Overall Study|Death|16|||
130191854|NCT02097745|468661385|FG000|Overall Study|Failure to Return|14|||
130191855|NCT02097745|468661385|FG000|Overall Study|Administrative/Other|27|||
130191856|NCT02097745|468661385|FG000|Overall Study|Reason Not Specified|96|||
130191857|NCT00425750|468661386|FG000|Overall Study|Death|1|||
130191858|NCT00425750|468661386|FG000|Overall Study|Withdrawal by Subject|3|||
130191859|NCT00425750|468661386|FG000|Overall Study|Adverse Event|3|||
130191860|NCT00425750|468661386|FG000|Overall Study|Progression of disease|18|||
130191861|NCT01757184|468661387|FG000|Double-blind Period|Adverse Event|1|||
130191862|NCT01757184|468661388|FG001|Double-blind Period|Adverse Event|0|||
130191863|NCT01757184|468661389|FG002|Double-blind Period|Adverse Event|0|||
130191864|NCT01757184|468661390|FG003|Double-blind Period|Adverse Event|0|||
130191865|NCT01757184|468661387|FG000|Open-label Period|Lost to Follow-up|0|||
130191866|NCT01757184|468661388|FG001|Open-label Period|Lost to Follow-up|0|||
130191867|NCT01757184|468661389|FG002|Open-label Period|Lost to Follow-up|2|||
130191868|NCT01757184|468661390|FG003|Open-label Period|Lost to Follow-up|0|||
130191869|NCT01757184|468661387|FG000|Open-label Period|Withdrawal by Subject|0|||
130191870|NCT01757184|468661388|FG001|Open-label Period|Withdrawal by Subject|0|||
130191871|NCT01757184|468661389|FG002|Open-label Period|Withdrawal by Subject|1|||
130191872|NCT01757184|468661390|FG003|Open-label Period|Withdrawal by Subject|1|||
130191873|NCT01757184|468661387|FG000|Open-label Period|Discontinued by Sponsor|0|||
130191874|NCT01757184|468661388|FG001|Open-label Period|Discontinued by Sponsor|0|||
130191875|NCT01757184|468661389|FG002|Open-label Period|Discontinued by Sponsor|1|||
130191876|NCT01757184|468661390|FG003|Open-label Period|Discontinued by Sponsor|2|||
130191877|NCT00554515|468661391|FG000|Overall Study|Withdrawal by Subject|3|||
130191878|NCT00554515|468661391|FG000|Overall Study|Disease progression|52|||
130191879|NCT00554515|468661391|FG000|Overall Study|Physician Decision|18|||
130191880|NCT00554515|468661391|FG000|Overall Study|Withdrawal by Subject|11|||
130191881|NCT00554515|468661391|FG000|Overall Study|Adverse Event|9|||
130191882|NCT00554515|468661391|FG000|Overall Study|Death|2|||
130191883|NCT00554515|468661391|FG000|Overall Study|Achieved Stable Disease|7|||
130191884|NCT00554515|468661391|FG000|Overall Study|Other|1|||
130191885|NCT00554515|468661391|FG000|Overall Study|Misc|15|||
130191886|NCT01276756|468661394|FG000|Overall Study|Lost to Follow-up|2|||
130191887|NCT01276756|468661395|FG001|Overall Study|Lost to Follow-up|0|||
130191888|NCT01276756|468661394|FG000|Overall Study|Adverse Event|3|||
130191889|NCT01276756|468661395|FG001|Overall Study|Adverse Event|2|||
130191890|NCT01554527|468661403|FG000|Overall Study|Withdrawal by Subject|1|||
130191891|NCT01554527|468661404|FG001|Overall Study|Withdrawal by Subject|0|||
130191892|NCT01554527|468661405|FG002|Overall Study|Withdrawal by Subject|3|||
130191893|NCT01554527|468661403|FG000|Overall Study|Lost to Follow-up|0|||
130191894|NCT01554527|468661404|FG001|Overall Study|Lost to Follow-up|0|||
130191895|NCT01554527|468661405|FG002|Overall Study|Lost to Follow-up|4|||
130191896|NCT01554527|468661403|FG000|Overall Study|Physician Decision|0|||
130191897|NCT01554527|468661404|FG001|Overall Study|Physician Decision|0|||
130191898|NCT01554527|468661405|FG002|Overall Study|Physician Decision|1|||
130191899|NCT01052480|468661406|FG000|Overall Study|Lost to Follow-up|3|||
130191900|NCT01052480|468661407|FG001|Overall Study|Lost to Follow-up|3|||
130191901|NCT01052480|468661406|FG000|Overall Study|Protocol Violation|1|||
130191902|NCT01052480|468661407|FG001|Overall Study|Protocol Violation|0|||
130191903|NCT01052480|468661406|FG000|Overall Study|Withdrawal by Subject|3|||
130191904|NCT01052480|468661407|FG001|Overall Study|Withdrawal by Subject|7|||
130191905|NCT01052480|468661406|FG000|Overall Study|Physician Decision|0|||
130191906|NCT01052480|468661407|FG001|Overall Study|Physician Decision|2|||
130191907|NCT01052480|468661406|FG000|Overall Study|Death|1|||
130191908|NCT01052480|468661407|FG001|Overall Study|Death|5|||
130191909|NCT00529373|468661408|FG000|Base Study|Adverse Event|525|||
130191910|NCT00529373|468661409|FG001|Base Study|Adverse Event|470|||
130191911|NCT00529373|468661408|FG000|Base Study|Lack of Efficacy|16|||
130191912|NCT00529373|468661409|FG001|Base Study|Lack of Efficacy|75|||
130191913|NCT00529373|468661408|FG000|Base Study|Lost to Follow-up|221|||
130191914|NCT00529373|468661409|FG001|Base Study|Lost to Follow-up|208|||
130191915|NCT00529373|468661408|FG000|Base Study|Other Protocol Specified Criteria|19|||
130191916|NCT00529373|468661409|FG001|Base Study|Other Protocol Specified Criteria|20|||
130191917|NCT00529373|468661408|FG000|Base Study|Physician Decision|60|||
130191918|NCT00529373|468661409|FG001|Base Study|Physician Decision|52|||
130191919|NCT00529373|468661408|FG000|Base Study|Protocol Violation|48|||
130191920|NCT00529373|468661409|FG001|Base Study|Protocol Violation|38|||
130191921|NCT00529373|468661408|FG000|Base Study|Withdrawal by Subject|1062|||
130191922|NCT00529373|468661409|FG001|Base Study|Withdrawal by Subject|967|||
130191923|NCT00529373|468661408|FG000|Base Study|Did not continue into Extension|1795|||
130191924|NCT00529373|468661409|FG001|Base Study|Did not continue into Extension|2238|||
130191925|NCT00529373|468661408|FG000|First Extension Study|Adverse Event|162|||
130191926|NCT00529373|468661409|FG001|First Extension Study|Adverse Event|142|||
130191927|NCT00529373|468661408|FG000|First Extension Study|Lack of Efficacy|65|||
130191928|NCT00529373|468661409|FG001|First Extension Study|Lack of Efficacy|427|||
130191929|NCT00529373|468661408|FG000|First Extension Study|Lost to Follow-up|41|||
130191930|NCT00529373|468661409|FG001|First Extension Study|Lost to Follow-up|37|||
130191931|NCT00529373|468661408|FG000|First Extension Study|Other|27|||
130191932|NCT00529373|468661409|FG001|First Extension Study|Other|47|||
130191933|NCT00529373|468661408|FG000|First Extension Study|Physician Decision|50|||
130191934|NCT00529373|468661409|FG001|First Extension Study|Physician Decision|45|||
130191935|NCT00529373|468661408|FG000|First Extension Study|Protocol Violation|16|||
130191936|NCT00529373|468661409|FG001|First Extension Study|Protocol Violation|13|||
130191937|NCT00529373|468661408|FG000|First Extension Study|Withdrawal by Subject|296|||
130191938|NCT00529373|468661409|FG001|First Extension Study|Withdrawal by Subject|287|||
130191939|NCT00529373|468661408|FG000|First Extension Study|Disposition record non-existing|0|||
130191940|NCT00529373|468661409|FG001|First Extension Study|Disposition record non-existing|1|||
130191941|NCT00529373|468661408|FG000|First Extension Study|Discontinued after 5 years completion|208|||
130191942|NCT00529373|468661409|FG001|First Extension Study|Discontinued after 5 years completion|346|||
130191943|NCT00529373|468661408|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
130191944|NCT00529373|468661409|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
130191945|NCT00529373|468661408|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
130191946|NCT00529373|468661409|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
130191947|NCT00529373|468661408|FG000|Second Extension Study|Adverse Event|101|||
130191948|NCT00529373|468661409|FG001|Second Extension Study|Adverse Event|51|||
130191949|NCT00529373|468661408|FG000|Second Extension Study|Lack of Efficacy|7|||
130191950|NCT00529373|468661409|FG001|Second Extension Study|Lack of Efficacy|15|||
130191951|NCT00529373|468661408|FG000|Second Extension Study|Lost to Follow-up|18|||
130191952|NCT00529373|468661409|FG001|Second Extension Study|Lost to Follow-up|12|||
130191953|NCT00529373|468661408|FG000|Second Extension Study|Other|7|||
130191954|NCT00529373|468661409|FG001|Second Extension Study|Other|12|||
130191955|NCT00529373|468661408|FG000|Second Extension Study|Physician Decision|63|||
130191956|NCT00529373|468661409|FG001|Second Extension Study|Physician Decision|26|||
130191957|NCT00529373|468661408|FG000|Second Extension Study|Protocol Violation|2|||
130191958|NCT00529373|468661409|FG001|Second Extension Study|Protocol Violation|1|||
130191959|NCT00529373|468661408|FG000|Second Extension Study|Withdrawal by Subject|97|||
130191960|NCT00529373|468661409|FG001|Second Extension Study|Withdrawal by Subject|75|||
130191961|NCT00529373|468661408|FG000|Second Extension Study|Status Missing|5|||
130191962|NCT00529373|468661409|FG001|Second Extension Study|Status Missing|5|||
130191963|NCT00757042|468661418|FG000|Overall Study|Lost to Follow-up|0|||
130191964|NCT00757042|468661419|FG001|Overall Study|Lost to Follow-up|0|||
130191965|NCT00757042|468661420|FG002|Overall Study|Lost to Follow-up|0|||
130191966|NCT00757042|468661421|FG003|Overall Study|Lost to Follow-up|0|||
130191967|NCT00757042|468661422|FG004|Overall Study|Lost to Follow-up|0|||
130191968|NCT00757042|468661423|FG005|Overall Study|Lost to Follow-up|0|||
130191969|NCT00757042|468661424|FG006|Overall Study|Lost to Follow-up|0|||
130191970|NCT00757042|468661425|FG007|Overall Study|Lost to Follow-up|0|||
130191971|NCT00757042|468661426|FG008|Overall Study|Lost to Follow-up|1|||
130191972|NCT00757042|468661427|FG009|Overall Study|Lost to Follow-up|0|||
130191973|NCT00757042|468661428|FG010|Overall Study|Lost to Follow-up|0|||
130191974|NCT00757042|468661418|FG000|Overall Study|Ineligibility Determined|0|||
130191975|NCT00757042|468661419|FG001|Overall Study|Ineligibility Determined|0|||
130191976|NCT00757042|468661420|FG002|Overall Study|Ineligibility Determined|0|||
130191977|NCT00757042|468661421|FG003|Overall Study|Ineligibility Determined|0|||
130191978|NCT00757042|468661422|FG004|Overall Study|Ineligibility Determined|0|||
130191979|NCT00757042|468661423|FG005|Overall Study|Ineligibility Determined|0|||
130191980|NCT00757042|468661424|FG006|Overall Study|Ineligibility Determined|0|||
130191981|NCT00757042|468661425|FG007|Overall Study|Ineligibility Determined|0|||
130191982|NCT00757042|468661426|FG008|Overall Study|Ineligibility Determined|0|||
130191983|NCT00757042|468661427|FG009|Overall Study|Ineligibility Determined|0|||
130191984|NCT00757042|468661428|FG010|Overall Study|Ineligibility Determined|1|||
130191985|NCT00757042|468661418|FG000|Overall Study|Withdrawal by Subject|0|||
130191986|NCT00757042|468661419|FG001|Overall Study|Withdrawal by Subject|0|||
130191987|NCT00757042|468661420|FG002|Overall Study|Withdrawal by Subject|0|||
130191988|NCT00757042|468661421|FG003|Overall Study|Withdrawal by Subject|0|||
130191989|NCT00757042|468661422|FG004|Overall Study|Withdrawal by Subject|0|||
130191990|NCT00757042|468661423|FG005|Overall Study|Withdrawal by Subject|0|||
130191991|NCT00757042|468661424|FG006|Overall Study|Withdrawal by Subject|0|||
130191992|NCT00757042|468661425|FG007|Overall Study|Withdrawal by Subject|0|||
130191993|NCT00757042|468661426|FG008|Overall Study|Withdrawal by Subject|0|||
130191994|NCT00757042|468661427|FG009|Overall Study|Withdrawal by Subject|1|||
130191995|NCT00757042|468661428|FG010|Overall Study|Withdrawal by Subject|0|||
130191996|NCT01870973|468661432|FG000|Overall Study|Lost to Follow-up|10|||
130191997|NCT01870973|468661433|FG001|Overall Study|Lost to Follow-up|3|||
130191998|NCT01266291|468661435|FG000|Overall Study|Adverse Event|1|||
130191999|NCT03291431|468661436|FG000|Overall Study|Protocol Violation|2|||
130192000|NCT03291431|468661437|FG001|Overall Study|Protocol Violation|1|||
130192001|NCT03291431|468661436|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
130192002|NCT03291431|468661437|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
130192003|NCT03291431|468661436|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
130192004|NCT03291431|468661437|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
130192005|NCT03850483|468661442|FG000|Treatment for Stage 1|Adverse Event|1|||
130192006|NCT03850483|468661443|FG001|Treatment for Stage 1|Adverse Event|1|||
130192007|NCT03850483|468661444|FG002|Treatment for Stage 1|Adverse Event|3|||
130192008|NCT03850483|468661445|FG003|Treatment for Stage 1|Adverse Event|0|||
130192009|NCT03850483|468661446|FG004|Treatment for Stage 1|Adverse Event|2|||
130192010|NCT03850483|468661447|FG005|Treatment for Stage 1|Adverse Event|0|||
130192011|NCT03850483|468661448|FG006|Treatment for Stage 1|Adverse Event|2|||
130192012|NCT03850483|468661449|FG007|Treatment for Stage 1|Adverse Event|2|||
130192013|NCT03850483|468661450|FG008|Treatment for Stage 1|Adverse Event|0|||
130192014|NCT03850483|468661451|FG009|Treatment for Stage 1|Adverse Event|0|||
130192015|NCT03850483|468661442|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
130192016|NCT03850483|468661443|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
130192017|NCT03850483|468661444|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
130192018|NCT03850483|468661445|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
130192019|NCT03850483|468661446|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
130192020|NCT03850483|468661447|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
130192021|NCT03850483|468661448|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
130192022|NCT03850483|468661449|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
130192023|NCT03850483|468661450|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
130192024|NCT03850483|468661451|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
130192025|NCT03850483|468661442|FG000|Treatment for Stage 1|Protocol Violation|1|||
130192026|NCT03850483|468661443|FG001|Treatment for Stage 1|Protocol Violation|0|||
130192027|NCT03850483|468661444|FG002|Treatment for Stage 1|Protocol Violation|0|||
130192028|NCT03850483|468661445|FG003|Treatment for Stage 1|Protocol Violation|0|||
130192029|NCT03850483|468661446|FG004|Treatment for Stage 1|Protocol Violation|0|||
130192030|NCT03850483|468661447|FG005|Treatment for Stage 1|Protocol Violation|0|||
130192031|NCT03850483|468661448|FG006|Treatment for Stage 1|Protocol Violation|1|||
130192032|NCT03850483|468661449|FG007|Treatment for Stage 1|Protocol Violation|0|||
130192033|NCT03850483|468661450|FG008|Treatment for Stage 1|Protocol Violation|0|||
130192034|NCT03850483|468661451|FG009|Treatment for Stage 1|Protocol Violation|0|||
130192035|NCT03850483|468661442|FG000|Treatment for Stage 1|Physician Decision|0|||
130192036|NCT03850483|468661443|FG001|Treatment for Stage 1|Physician Decision|0|||
130192037|NCT03850483|468661444|FG002|Treatment for Stage 1|Physician Decision|0|||
130192038|NCT03850483|468661445|FG003|Treatment for Stage 1|Physician Decision|0|||
130192039|NCT03850483|468661446|FG004|Treatment for Stage 1|Physician Decision|0|||
130192040|NCT03850483|468661447|FG005|Treatment for Stage 1|Physician Decision|1|||
130192041|NCT03850483|468661448|FG006|Treatment for Stage 1|Physician Decision|0|||
130192042|NCT03850483|468661449|FG007|Treatment for Stage 1|Physician Decision|0|||
130192043|NCT03850483|468661450|FG008|Treatment for Stage 1|Physician Decision|0|||
130192044|NCT03850483|468661451|FG009|Treatment for Stage 1|Physician Decision|0|||
130192045|NCT03850483|468661442|FG000|Treatment for Stage 1|Other|0|||
130192046|NCT03850483|468661443|FG001|Treatment for Stage 1|Other|0|||
130192047|NCT03850483|468661444|FG002|Treatment for Stage 1|Other|0|||
130192048|NCT03850483|468661445|FG003|Treatment for Stage 1|Other|0|||
130192049|NCT03850483|468661446|FG004|Treatment for Stage 1|Other|2|||
130192050|NCT03850483|468661447|FG005|Treatment for Stage 1|Other|1|||
130192051|NCT03850483|468661448|FG006|Treatment for Stage 1|Other|0|||
130192052|NCT03850483|468661449|FG007|Treatment for Stage 1|Other|0|||
130192053|NCT03850483|468661450|FG008|Treatment for Stage 1|Other|0|||
130192054|NCT03850483|468661451|FG009|Treatment for Stage 1|Other|0|||
130192055|NCT03850483|468661442|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192056|NCT03850483|468661443|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192057|NCT03850483|468661444|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
130192058|NCT03850483|468661445|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192059|NCT03850483|468661446|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192060|NCT03850483|468661447|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192061|NCT03850483|468661448|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192062|NCT03850483|468661449|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192063|NCT03850483|468661450|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192064|NCT03850483|468661451|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
130192065|NCT03850483|468661442|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192066|NCT03850483|468661443|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192067|NCT03850483|468661444|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192068|NCT03850483|468661445|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192069|NCT03850483|468661446|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192070|NCT03850483|468661447|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
130192071|NCT03850483|468661448|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192072|NCT03850483|468661449|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192073|NCT03850483|468661450|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192074|NCT03850483|468661451|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
130192075|NCT03850483|468661442|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
130192076|NCT03850483|468661443|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
130192077|NCT03850483|468661444|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
130192078|NCT03850483|468661445|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
130192079|NCT03850483|468661446|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
130192080|NCT03850483|468661447|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
130192081|NCT03850483|468661448|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
130192082|NCT03850483|468661449|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
130192083|NCT03850483|468661450|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
130192084|NCT03850483|468661451|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
130192085|NCT03850483|468661442|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
130192086|NCT03850483|468661443|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
130192087|NCT03850483|468661444|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
130192088|NCT03850483|468661445|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
130192089|NCT03850483|468661446|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
130192090|NCT03850483|468661447|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
130192091|NCT03850483|468661448|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
130192092|NCT03850483|468661449|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
130192093|NCT03850483|468661450|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
130192094|NCT03850483|468661451|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
130192095|NCT03850483|468661442|FG000|Treatment for Stage 1|Death|0|||
130192096|NCT03850483|468661443|FG001|Treatment for Stage 1|Death|0|||
130192097|NCT03850483|468661444|FG002|Treatment for Stage 1|Death|0|||
130192098|NCT03850483|468661445|FG003|Treatment for Stage 1|Death|0|||
130192099|NCT03850483|468661446|FG004|Treatment for Stage 1|Death|0|||
130192100|NCT03850483|468661447|FG005|Treatment for Stage 1|Death|1|||
130192101|NCT03850483|468661448|FG006|Treatment for Stage 1|Death|0|||
130192102|NCT03850483|468661449|FG007|Treatment for Stage 1|Death|0|||
130192103|NCT03850483|468661450|FG008|Treatment for Stage 1|Death|0|||
130192104|NCT03850483|468661451|FG009|Treatment for Stage 1|Death|0|||
130192105|NCT03850483|468661442|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
130192106|NCT03850483|468661443|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
130192107|NCT03850483|468661444|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
130192108|NCT03850483|468661445|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
130192109|NCT03850483|468661446|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
130192110|NCT03850483|468661447|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
130192111|NCT03850483|468661448|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
130192112|NCT03850483|468661449|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
130192113|NCT03850483|468661450|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
130192114|NCT03850483|468661451|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
130192115|NCT03850483|468661442|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
130192116|NCT03850483|468661443|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
130192117|NCT03850483|468661444|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
130192118|NCT03850483|468661445|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
130192119|NCT03850483|468661446|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
130192120|NCT03850483|468661447|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
130192121|NCT03850483|468661448|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
130192122|NCT03850483|468661449|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
130192123|NCT03850483|468661450|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
130192124|NCT03850483|468661451|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
130192125|NCT03850483|468661442|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192126|NCT03850483|468661443|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192127|NCT03850483|468661444|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192128|NCT03850483|468661445|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192129|NCT03850483|468661446|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192130|NCT03850483|468661447|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192131|NCT03850483|468661448|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
130192132|NCT03850483|468661449|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
130192133|NCT03850483|468661450|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192134|NCT03850483|468661451|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
130192135|NCT03850483|468661442|FG000|Follow-up for Stage 1|Physician Decision|0|||
130192136|NCT03850483|468661443|FG001|Follow-up for Stage 1|Physician Decision|0|||
130192137|NCT03850483|468661444|FG002|Follow-up for Stage 1|Physician Decision|0|||
130192138|NCT03850483|468661445|FG003|Follow-up for Stage 1|Physician Decision|0|||
130192139|NCT03850483|468661446|FG004|Follow-up for Stage 1|Physician Decision|1|||
130192140|NCT03850483|468661447|FG005|Follow-up for Stage 1|Physician Decision|0|||
130192141|NCT03850483|468661448|FG006|Follow-up for Stage 1|Physician Decision|1|||
130192142|NCT03850483|468661449|FG007|Follow-up for Stage 1|Physician Decision|0|||
130192143|NCT03850483|468661450|FG008|Follow-up for Stage 1|Physician Decision|0|||
130192144|NCT03850483|468661451|FG009|Follow-up for Stage 1|Physician Decision|0|||
130192145|NCT03850483|468661442|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
130192146|NCT03850483|468661443|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
130192147|NCT03850483|468661444|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
130192148|NCT03850483|468661445|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
130192149|NCT03850483|468661446|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
130192150|NCT03850483|468661447|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
130192151|NCT03850483|468661448|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
130192152|NCT03850483|468661449|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
130192153|NCT03850483|468661450|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
130192154|NCT03850483|468661451|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
130192155|NCT03850483|468661442|FG000|Follow-up for Stage 1|Adverse Event|0|||
130192156|NCT03850483|468661443|FG001|Follow-up for Stage 1|Adverse Event|0|||
130192157|NCT03850483|468661444|FG002|Follow-up for Stage 1|Adverse Event|1|||
130192158|NCT03850483|468661445|FG003|Follow-up for Stage 1|Adverse Event|0|||
130192159|NCT03850483|468661446|FG004|Follow-up for Stage 1|Adverse Event|0|||
130192160|NCT03850483|468661447|FG005|Follow-up for Stage 1|Adverse Event|1|||
130192161|NCT03850483|468661448|FG006|Follow-up for Stage 1|Adverse Event|0|||
130192162|NCT03850483|468661449|FG007|Follow-up for Stage 1|Adverse Event|0|||
130192163|NCT03850483|468661450|FG008|Follow-up for Stage 1|Adverse Event|0|||
130192164|NCT03850483|468661451|FG009|Follow-up for Stage 1|Adverse Event|0|||
130192165|NCT03850483|468661442|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192166|NCT03850483|468661443|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
130192167|NCT03850483|468661444|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192168|NCT03850483|468661445|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192169|NCT03850483|468661446|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
130192170|NCT03850483|468661447|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
130192171|NCT03850483|468661448|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192172|NCT03850483|468661449|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192173|NCT03850483|468661450|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192174|NCT03850483|468661451|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
130192175|NCT03850483|468661442|FG000|Follow-up for Stage 1|Other|0|||
130192176|NCT03850483|468661443|FG001|Follow-up for Stage 1|Other|2|||
130192177|NCT03850483|468661444|FG002|Follow-up for Stage 1|Other|0|||
130192178|NCT03850483|468661445|FG003|Follow-up for Stage 1|Other|2|||
130192179|NCT03850483|468661446|FG004|Follow-up for Stage 1|Other|0|||
130192180|NCT03850483|468661447|FG005|Follow-up for Stage 1|Other|1|||
130192181|NCT03850483|468661448|FG006|Follow-up for Stage 1|Other|0|||
130192182|NCT03850483|468661449|FG007|Follow-up for Stage 1|Other|0|||
130192183|NCT03850483|468661450|FG008|Follow-up for Stage 1|Other|0|||
130192184|NCT03850483|468661451|FG009|Follow-up for Stage 1|Other|0|||
130192185|NCT03850483|468661442|FG000|Treatment for Stage 2|Adverse Event|0|||
130192186|NCT03850483|468661443|FG001|Treatment for Stage 2|Adverse Event|0|||
130192187|NCT03850483|468661444|FG002|Treatment for Stage 2|Adverse Event|0|||
130192188|NCT03850483|468661445|FG003|Treatment for Stage 2|Adverse Event|0|||
130192189|NCT03850483|468661446|FG004|Treatment for Stage 2|Adverse Event|0|||
130192190|NCT03850483|468661447|FG005|Treatment for Stage 2|Adverse Event|0|||
130192191|NCT03850483|468661448|FG006|Treatment for Stage 2|Adverse Event|0|||
130192192|NCT03850483|468661449|FG007|Treatment for Stage 2|Adverse Event|0|||
130192193|NCT03850483|468661450|FG008|Treatment for Stage 2|Adverse Event|0|||
130192194|NCT03850483|468661451|FG009|Treatment for Stage 2|Adverse Event|1|||
130192195|NCT03850483|468661442|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
130192196|NCT03850483|468661443|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
130192197|NCT03850483|468661444|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
130192198|NCT03850483|468661445|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
130192199|NCT03850483|468661446|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
130192200|NCT03850483|468661447|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
130192201|NCT03850483|468661448|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
130192202|NCT03850483|468661449|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
130192203|NCT03850483|468661450|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
130192204|NCT03850483|468661451|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
130192205|NCT03850483|468661442|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
130192206|NCT03850483|468661443|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
130192207|NCT03850483|468661444|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
130192208|NCT03850483|468661445|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
130192209|NCT03850483|468661446|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
130192210|NCT03850483|468661447|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
130192211|NCT03850483|468661448|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
130192212|NCT03850483|468661449|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
130192213|NCT03850483|468661450|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
130192214|NCT03850483|468661451|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
130192215|NCT03850483|468661442|FG000|Treatment for Stage 2|Physician Decision|0|||
130192216|NCT03850483|468661443|FG001|Treatment for Stage 2|Physician Decision|0|||
130192217|NCT03850483|468661444|FG002|Treatment for Stage 2|Physician Decision|0|||
130192218|NCT03850483|468661445|FG003|Treatment for Stage 2|Physician Decision|0|||
130192219|NCT03850483|468661446|FG004|Treatment for Stage 2|Physician Decision|0|||
130192220|NCT03850483|468661447|FG005|Treatment for Stage 2|Physician Decision|0|||
130192221|NCT03850483|468661448|FG006|Treatment for Stage 2|Physician Decision|0|||
130192222|NCT03850483|468661449|FG007|Treatment for Stage 2|Physician Decision|0|||
130192223|NCT03850483|468661450|FG008|Treatment for Stage 2|Physician Decision|0|||
130192224|NCT03850483|468661451|FG009|Treatment for Stage 2|Physician Decision|1|||
130192225|NCT03850483|468661442|FG000|Treatment for Stage 2|Protocol Violation|0|||
130192226|NCT03850483|468661443|FG001|Treatment for Stage 2|Protocol Violation|0|||
130192227|NCT03850483|468661444|FG002|Treatment for Stage 2|Protocol Violation|0|||
130192228|NCT03850483|468661445|FG003|Treatment for Stage 2|Protocol Violation|0|||
130192229|NCT03850483|468661446|FG004|Treatment for Stage 2|Protocol Violation|0|||
130192230|NCT03850483|468661447|FG005|Treatment for Stage 2|Protocol Violation|0|||
130192231|NCT03850483|468661448|FG006|Treatment for Stage 2|Protocol Violation|0|||
130192232|NCT03850483|468661449|FG007|Treatment for Stage 2|Protocol Violation|0|||
130192233|NCT03850483|468661450|FG008|Treatment for Stage 2|Protocol Violation|1|||
130192234|NCT03850483|468661451|FG009|Treatment for Stage 2|Protocol Violation|0|||
130192235|NCT03850483|468661442|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
130192236|NCT03850483|468661443|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
130192237|NCT03850483|468661444|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
130192238|NCT03850483|468661445|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
130192239|NCT03850483|468661446|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
130192240|NCT03850483|468661447|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
130192241|NCT03850483|468661448|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
130192242|NCT03850483|468661449|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
130192243|NCT03850483|468661450|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
130192244|NCT03850483|468661451|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
130192245|NCT03850483|468661442|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192246|NCT03850483|468661443|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192247|NCT03850483|468661444|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192248|NCT03850483|468661445|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192249|NCT03850483|468661446|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192250|NCT03850483|468661447|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192251|NCT03850483|468661448|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192252|NCT03850483|468661449|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192253|NCT03850483|468661450|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
130192254|NCT03850483|468661451|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
130192255|NCT03850483|468661442|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
130192256|NCT03850483|468661443|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
130192257|NCT03850483|468661444|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
130192258|NCT03850483|468661445|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
130192259|NCT03850483|468661446|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
130192260|NCT03850483|468661447|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
130192261|NCT03850483|468661448|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
130192262|NCT03850483|468661449|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
130192263|NCT03850483|468661450|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
130192264|NCT03850483|468661451|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
130192265|NCT03850483|468661442|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
130192266|NCT03850483|468661443|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
130192267|NCT03850483|468661444|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
130192268|NCT03850483|468661445|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
130192269|NCT03850483|468661446|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
130192270|NCT03850483|468661447|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
130192271|NCT03850483|468661448|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
130192272|NCT03850483|468661449|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
130192273|NCT03850483|468661450|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
130192274|NCT03850483|468661451|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
130192275|NCT03850483|468661442|FG000|Follow-up For Stage 2|Other|0|||
130192276|NCT03850483|468661443|FG001|Follow-up For Stage 2|Other|0|||
130192277|NCT03850483|468661444|FG002|Follow-up For Stage 2|Other|0|||
130192278|NCT03850483|468661445|FG003|Follow-up For Stage 2|Other|0|||
130192279|NCT03850483|468661446|FG004|Follow-up For Stage 2|Other|0|||
130192280|NCT03850483|468661447|FG005|Follow-up For Stage 2|Other|0|||
130192281|NCT03850483|468661448|FG006|Follow-up For Stage 2|Other|0|||
130192282|NCT03850483|468661449|FG007|Follow-up For Stage 2|Other|0|||
130192283|NCT03850483|468661450|FG008|Follow-up For Stage 2|Other|0|||
130192284|NCT03850483|468661451|FG009|Follow-up For Stage 2|Other|1|||
130192285|NCT04432831|468663211|FG000|Overall Study|Withdrawal by Subject|24|||
130192286|NCT04432831|468663212|FG001|Overall Study|Withdrawal by Subject|28|||
130192287|NCT04432831|468663213|FG002|Overall Study|Withdrawal by Subject|21|||
130192288|NCT04432831|468663211|FG000|Overall Study|Death|23|||
130192289|NCT04432831|468663212|FG001|Overall Study|Death|23|||
130192290|NCT04432831|468663213|FG002|Overall Study|Death|17|||
130192291|NCT04432831|468663211|FG000|Overall Study|Lost to Follow-up|15|||
130192292|NCT04432831|468663212|FG001|Overall Study|Lost to Follow-up|15|||
130192293|NCT04432831|468663213|FG002|Overall Study|Lost to Follow-up|12|||
130192294|NCT04432831|468663211|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
130192295|NCT04432831|468663212|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
130192296|NCT04432831|468663213|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
130192297|NCT04432831|468663211|FG000|Overall Study|Reason Not Specified|7|||
130192298|NCT04432831|468663212|FG001|Overall Study|Reason Not Specified|11|||
130192299|NCT04432831|468663213|FG002|Overall Study|Reason Not Specified|9|||
130192300|NCT04432831|468663211|FG000|Overall Study|Adverse Event|7|||
130192301|NCT04432831|468663212|FG001|Overall Study|Adverse Event|7|||
130192302|NCT04432831|468663213|FG002|Overall Study|Adverse Event|7|||
130192303|NCT04432831|468663211|FG000|Overall Study|Physician Decision|1|||
130192304|NCT04432831|468663212|FG001|Overall Study|Physician Decision|3|||
130192305|NCT04432831|468663213|FG002|Overall Study|Physician Decision|6|||
130192306|NCT04432831|468663211|FG000|Overall Study|Protocol Violation|1|||
130192307|NCT04432831|468663212|FG001|Overall Study|Protocol Violation|0|||
130192308|NCT04432831|468663213|FG002|Overall Study|Protocol Violation|2|||
130192309|NCT04432831|468663211|FG000|Overall Study|Pregnancy|0|||
130192310|NCT04432831|468663212|FG001|Overall Study|Pregnancy|1|||
130192311|NCT04432831|468663213|FG002|Overall Study|Pregnancy|0|||
130192312|NCT04432831|468663211|FG000|Overall Study|Lack of Efficacy|0|||
130192313|NCT04432831|468663212|FG001|Overall Study|Lack of Efficacy|0|||
130192314|NCT04432831|468663213|FG002|Overall Study|Lack of Efficacy|2|||
130192315|NCT00652626|468663216|FG000|Initial Treatment Phase|Adverse Event|0|||
130192316|NCT00652626|468663217|FG001|Initial Treatment Phase|Adverse Event|0|||
130192317|NCT00652626|468663218|FG002|Initial Treatment Phase|Adverse Event|0|||
130192318|NCT00652626|468663219|FG003|Initial Treatment Phase|Adverse Event|0|||
130192319|NCT00652626|468663220|FG004|Initial Treatment Phase|Adverse Event|1|||
130192320|NCT00652626|468663221|FG005|Initial Treatment Phase|Adverse Event|0|||
130192321|NCT00652626|468663222|FG006|Initial Treatment Phase|Adverse Event|0|||
130192322|NCT00652626|468663216|FG000|Initial Treatment Phase|Protocol Violation|0|||
130192323|NCT00652626|468663217|FG001|Initial Treatment Phase|Protocol Violation|0|||
130192324|NCT00652626|468663218|FG002|Initial Treatment Phase|Protocol Violation|0|||
130192325|NCT00652626|468663219|FG003|Initial Treatment Phase|Protocol Violation|1|||
130192326|NCT00652626|468663220|FG004|Initial Treatment Phase|Protocol Violation|0|||
130192327|NCT00652626|468663221|FG005|Initial Treatment Phase|Protocol Violation|0|||
130192328|NCT00652626|468663222|FG006|Initial Treatment Phase|Protocol Violation|0|||
130192329|NCT00652626|468663216|FG000|Initial Treatment Phase|Physician Decision|0|||
130192330|NCT00652626|468663217|FG001|Initial Treatment Phase|Physician Decision|0|||
130192331|NCT00652626|468663218|FG002|Initial Treatment Phase|Physician Decision|0|||
130192332|NCT00652626|468663219|FG003|Initial Treatment Phase|Physician Decision|0|||
130192333|NCT00652626|468663220|FG004|Initial Treatment Phase|Physician Decision|1|||
130192334|NCT00652626|468663221|FG005|Initial Treatment Phase|Physician Decision|0|||
130192335|NCT00652626|468663222|FG006|Initial Treatment Phase|Physician Decision|0|||
130192336|NCT00652626|468663216|FG000|Initial Treatment Phase|Sponsor Request|0|||
130192337|NCT00652626|468663217|FG001|Initial Treatment Phase|Sponsor Request|0|||
130192338|NCT00652626|468663218|FG002|Initial Treatment Phase|Sponsor Request|1|||
130192339|NCT00652626|468663219|FG003|Initial Treatment Phase|Sponsor Request|0|||
130192340|NCT00652626|468663220|FG004|Initial Treatment Phase|Sponsor Request|0|||
130192341|NCT00652626|468663221|FG005|Initial Treatment Phase|Sponsor Request|0|||
130192342|NCT00652626|468663222|FG006|Initial Treatment Phase|Sponsor Request|0|||
130192343|NCT00652626|468663216|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
130192344|NCT00652626|468663217|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
130192345|NCT00652626|468663218|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
130192346|NCT00652626|468663219|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
130192347|NCT00652626|468663220|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
130192348|NCT00652626|468663221|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
130192349|NCT00652626|468663222|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
130192350|NCT00652626|468663216|FG000|Extension Phase|Withdrawal by Subject|0|||
130192351|NCT00652626|468663217|FG001|Extension Phase|Withdrawal by Subject|0|||
130192352|NCT00652626|468663218|FG002|Extension Phase|Withdrawal by Subject|0|||
130192353|NCT00652626|468663219|FG003|Extension Phase|Withdrawal by Subject|0|||
130192354|NCT00652626|468663220|FG004|Extension Phase|Withdrawal by Subject|0|||
130192355|NCT00652626|468663221|FG005|Extension Phase|Withdrawal by Subject|2|||
130192356|NCT00652626|468663222|FG006|Extension Phase|Withdrawal by Subject|0|||
130192357|NCT00652626|468663216|FG000|Extension Phase|Adverse Event|0|||
130192358|NCT00652626|468663217|FG001|Extension Phase|Adverse Event|0|||
130192359|NCT00652626|468663218|FG002|Extension Phase|Adverse Event|0|||
130192360|NCT00652626|468663219|FG003|Extension Phase|Adverse Event|0|||
130192361|NCT00652626|468663220|FG004|Extension Phase|Adverse Event|0|||
130192362|NCT00652626|468663221|FG005|Extension Phase|Adverse Event|2|||
130192363|NCT00652626|468663222|FG006|Extension Phase|Adverse Event|1|||
130192364|NCT00652626|468663216|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192365|NCT00652626|468663217|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192366|NCT00652626|468663218|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192367|NCT00652626|468663219|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192368|NCT00652626|468663220|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192369|NCT00652626|468663221|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
130192370|NCT00652626|468663222|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
130192371|NCT00652626|468663216|FG000|Extension Phase|Physician Decision|0|||
130192372|NCT00652626|468663217|FG001|Extension Phase|Physician Decision|0|||
130192373|NCT00652626|468663218|FG002|Extension Phase|Physician Decision|0|||
130192374|NCT00652626|468663219|FG003|Extension Phase|Physician Decision|0|||
130192375|NCT00652626|468663220|FG004|Extension Phase|Physician Decision|0|||
130192376|NCT00652626|468663221|FG005|Extension Phase|Physician Decision|1|||
130192377|NCT00652626|468663222|FG006|Extension Phase|Physician Decision|1|||
130192378|NCT00652626|468663216|FG000|Extension Phase|Death|0|||
130192379|NCT00652626|468663217|FG001|Extension Phase|Death|0|||
130192380|NCT00652626|468663218|FG002|Extension Phase|Death|0|||
130192381|NCT00652626|468663219|FG003|Extension Phase|Death|0|||
130192382|NCT00652626|468663220|FG004|Extension Phase|Death|0|||
130192383|NCT00652626|468663221|FG005|Extension Phase|Death|1|||
130192384|NCT00652626|468663222|FG006|Extension Phase|Death|1|||
130192385|NCT01623310|468663223|FG000|Overall Study|Adverse Event|21|||
130192386|NCT01623310|468663223|FG000|Overall Study|Lost to Follow-up|18|||
130192387|NCT01623310|468663223|FG000|Overall Study|Lack of Efficacy|6|||
130192388|NCT01623310|468663223|FG000|Overall Study|Protocol Violation|6|||
130192389|NCT01623310|468663223|FG000|Overall Study|Withdrawal by Subject|25|||
130192390|NCT01623310|468663223|FG000|Overall Study|Became potentially child-bearing|1|||
130192391|NCT01623310|468663223|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
130192392|NCT01623310|468663223|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
130192393|NCT02898597|468663224|FG000|Overall Study|Protocol Violation|4|||
130192394|NCT02898597|468663225|FG001|Overall Study|Protocol Violation|2|||
130192395|NCT02898597|468663224|FG000|Overall Study|Lost to Follow-up|0|||
130192396|NCT02898597|468663225|FG001|Overall Study|Lost to Follow-up|9|||
130192397|NCT02898597|468663224|FG000|Overall Study|Death|0|||
130192398|NCT02898597|468663225|FG001|Overall Study|Death|1|||
130192399|NCT02530125|468663226|FG000|Completed Treatment|Early termination of study|1|||
130192400|NCT02530125|468663226|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
130192401|NCT01568034|468663227|FG000|Overall Study|Withdrawal by Subject|1|||
130192402|NCT01568034|468663228|FG001|Overall Study|Withdrawal by Subject|0|||
130192403|NCT01568034|468663229|FG002|Overall Study|Withdrawal by Subject|0|||
130192404|NCT01568034|468663230|FG003|Overall Study|Withdrawal by Subject|0|||
130192405|NCT06098339|468663231|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
130192406|NCT06098339|468663232|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
130192407|NCT06098339|468663231|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
130192408|NCT06098339|468663232|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
130192409|NCT02492984|468663233|FG000|Overall Study|Adverse Event|1|||
130192410|NCT02492984|468663234|FG001|Overall Study|Adverse Event|0|||
130192411|NCT02492984|468663233|FG000|Overall Study|Protocol Violation|1|||
130192412|NCT02492984|468663234|FG001|Overall Study|Protocol Violation|0|||
130192413|NCT02492984|468663233|FG000|Overall Study|Withdrawal by Subject|1|||
130192414|NCT02492984|468663234|FG001|Overall Study|Withdrawal by Subject|0|||
130192415|NCT02498444|468663235|FG000|Overall Study|Withdrawal by Subject|3|||
130192416|NCT02498444|468663236|FG001|Overall Study|Withdrawal by Subject|0|||
130192417|NCT02498444|468663235|FG000|Overall Study|Physician Decision|1|||
130192418|NCT02498444|468663236|FG001|Overall Study|Physician Decision|0|||
130192419|NCT02027545|468663237|FG000|Overall Study|Failed to sign HIPAA|0|||
130192420|NCT02027545|468663238|FG001|Overall Study|Failed to sign HIPAA|2|||
130192421|NCT02027545|468663237|FG000|Overall Study|Failed to attend study visit|2|||
130192422|NCT02027545|468663238|FG001|Overall Study|Failed to attend study visit|0|||
130192423|NCT02027545|468663237|FG000|Overall Study|Protocol Violation|1|||
130192424|NCT02027545|468663238|FG001|Overall Study|Protocol Violation|0|||
130192425|NCT02453334|468663239|FG000|Overall Study|Death|15|||
130192426|NCT02453334|468663240|FG001|Overall Study|Death|13|||
130192427|NCT02453334|468663239|FG000|Overall Study|Adverse Event|2|||
130192428|NCT02453334|468663240|FG001|Overall Study|Adverse Event|1|||
130192429|NCT02453334|468663239|FG000|Overall Study|Lost to Follow-up|5|||
130192430|NCT02453334|468663240|FG001|Overall Study|Lost to Follow-up|9|||
130192431|NCT02453334|468663239|FG000|Overall Study|Physician Decision|1|||
130192432|NCT02453334|468663240|FG001|Overall Study|Physician Decision|0|||
130192433|NCT02453334|468663239|FG000|Overall Study|Withdrawal by Subject|17|||
130192434|NCT02453334|468663240|FG001|Overall Study|Withdrawal by Subject|13|||
130192435|NCT02453334|468663239|FG000|Overall Study|Other reason|1|||
130192436|NCT02453334|468663240|FG001|Overall Study|Other reason|4|||
130192437|NCT04090060|468663243|FG000|Overall Study|Lost to Follow-up|76|||
130192438|NCT04090060|468663244|FG001|Overall Study|Lost to Follow-up|77|||
130192439|NCT03337113|468663251|FG000|Overall Study|Adverse Event|1|||
130192440|NCT03337113|468663252|FG001|Overall Study|Adverse Event|1|||
130192441|NCT03337113|468663253|FG002|Overall Study|Adverse Event|0|||
130192442|NCT03337113|468663254|FG003|Overall Study|Adverse Event|1|||
130192443|NCT03337113|468663251|FG000|Overall Study|Physician Decision|0|||
130192444|NCT03337113|468663252|FG001|Overall Study|Physician Decision|2|||
130192445|NCT03337113|468663253|FG002|Overall Study|Physician Decision|0|||
130192446|NCT03337113|468663254|FG003|Overall Study|Physician Decision|1|||
130192447|NCT03337113|468663251|FG000|Overall Study|Withdrawal by Subject|0|||
130192448|NCT03337113|468663252|FG001|Overall Study|Withdrawal by Subject|0|||
130192449|NCT03337113|468663253|FG002|Overall Study|Withdrawal by Subject|1|||
130192450|NCT03337113|468663254|FG003|Overall Study|Withdrawal by Subject|0|||
130192451|NCT01164579|468663255|FG000|Overall Study|Lack of Efficacy|0|||
130192452|NCT01164579|468663256|FG001|Overall Study|Lack of Efficacy|0|||
130192453|NCT01164579|468663257|FG002|Overall Study|Lack of Efficacy|6|||
130192454|NCT01164579|468663255|FG000|Overall Study|Lost to Follow-up|1|||
130192455|NCT01164579|468663256|FG001|Overall Study|Lost to Follow-up|1|||
130192456|NCT01164579|468663257|FG002|Overall Study|Lost to Follow-up|0|||
130192457|NCT01164579|468663255|FG000|Overall Study|Withdrawal by Subject|2|||
130192458|NCT01164579|468663256|FG001|Overall Study|Withdrawal by Subject|5|||
130192459|NCT01164579|468663257|FG002|Overall Study|Withdrawal by Subject|3|||
130192460|NCT01164579|468663255|FG000|Overall Study|Protocol Violation|0|||
130192461|NCT01164579|468663256|FG001|Overall Study|Protocol Violation|1|||
130192462|NCT01164579|468663257|FG002|Overall Study|Protocol Violation|2|||
130192463|NCT01164579|468663255|FG000|Overall Study|Adverse Event|4|||
130192464|NCT01164579|468663256|FG001|Overall Study|Adverse Event|2|||
130192465|NCT01164579|468663257|FG002|Overall Study|Adverse Event|5|||
130192466|NCT01164579|468663255|FG000|Overall Study|Reason not specified|1|||
130192467|NCT01164579|468663256|FG001|Overall Study|Reason not specified|0|||
130192468|NCT01164579|468663257|FG002|Overall Study|Reason not specified|0|||
130192469|NCT00302328|468663258|FG000|Overall Study|Physician Decision|0|||
130192470|NCT00302328|468663259|FG001|Overall Study|Physician Decision|1|||
130192471|NCT00302328|468663260|FG002|Overall Study|Physician Decision|0|||
130192472|NCT03491462|468663265|FG000|Overall Study|Lost to Follow-up|2|||
130192473|NCT03491462|468663266|FG001|Overall Study|Lost to Follow-up|0|||
130192474|NCT03491462|468663265|FG000|Overall Study|Adverse Event|11|||
130192475|NCT03491462|468663266|FG001|Overall Study|Adverse Event|1|||
130192476|NCT03491462|468663265|FG000|Overall Study|Physician Decision|3|||
130192477|NCT03491462|468663266|FG001|Overall Study|Physician Decision|0|||
130192478|NCT03491462|468663265|FG000|Overall Study|Withdrawal by Subject|22|||
130192479|NCT03491462|468663266|FG001|Overall Study|Withdrawal by Subject|15|||
130192480|NCT00423332|468663270|FG000|Overall Study|Adverse Event|6|||
130192481|NCT00423332|468663271|FG001|Overall Study|Adverse Event|2|||
130192482|NCT00423332|468663270|FG000|Overall Study|Withdrawal by Subject|1|||
130192483|NCT00423332|468663271|FG001|Overall Study|Withdrawal by Subject|0|||
130192484|NCT00423332|468663270|FG000|Overall Study|Condition under investigation worsened|1|||
130192485|NCT00423332|468663271|FG001|Overall Study|Condition under investigation worsened|1|||
130192486|NCT00423332|468663270|FG000|Overall Study|Progressive at Week 6|0|||
130192487|NCT00423332|468663271|FG001|Overall Study|Progressive at Week 6|1|||
130192488|NCT00423332|468663270|FG000|Overall Study|Unblinded before 12 weeks|1|||
130192489|NCT00423332|468663271|FG001|Overall Study|Unblinded before 12 weeks|3|||
130192490|NCT00685399|468663282|FG000|Treatment Period 1|Withdrawal by Subject|2|||
130192491|NCT00685399|468663283|FG001|Treatment Period 1|Withdrawal by Subject|0|||
130192492|NCT00685399|468663284|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130192493|NCT00685399|468663285|FG003|Treatment Period 1|Withdrawal by Subject|0|||
130192494|NCT00685399|468663286|FG004|Treatment Period 1|Withdrawal by Subject|0|||
130192495|NCT00685399|468663287|FG005|Treatment Period 1|Withdrawal by Subject|0|||
130192496|NCT00685399|468663288|FG006|Treatment Period 1|Withdrawal by Subject|0|||
130192497|NCT00685399|468663289|FG007|Treatment Period 1|Withdrawal by Subject|0|||
130192498|NCT00685399|468663282|FG000|Treatment Period 1|Protocol Violation|1|||
130192499|NCT00685399|468663283|FG001|Treatment Period 1|Protocol Violation|0|||
130192500|NCT00685399|468663284|FG002|Treatment Period 1|Protocol Violation|0|||
130192501|NCT00685399|468663285|FG003|Treatment Period 1|Protocol Violation|0|||
130192502|NCT00685399|468663286|FG004|Treatment Period 1|Protocol Violation|0|||
130192503|NCT00685399|468663287|FG005|Treatment Period 1|Protocol Violation|0|||
130192504|NCT00685399|468663288|FG006|Treatment Period 1|Protocol Violation|0|||
130192505|NCT00685399|468663289|FG007|Treatment Period 1|Protocol Violation|0|||
130192506|NCT00685399|468663282|FG000|Treatment Period 1|Administrative|2|||
130192507|NCT00685399|468663283|FG001|Treatment Period 1|Administrative|0|||
130192508|NCT00685399|468663284|FG002|Treatment Period 1|Administrative|0|||
130192509|NCT00685399|468663285|FG003|Treatment Period 1|Administrative|0|||
130192510|NCT00685399|468663286|FG004|Treatment Period 1|Administrative|0|||
130192511|NCT00685399|468663287|FG005|Treatment Period 1|Administrative|0|||
130192512|NCT00685399|468663288|FG006|Treatment Period 1|Administrative|0|||
130192513|NCT00685399|468663289|FG007|Treatment Period 1|Administrative|0|||
130192514|NCT00685399|468663282|FG000|Treatment Period 1|Lack of Efficacy|1|||
130192515|NCT00685399|468663283|FG001|Treatment Period 1|Lack of Efficacy|0|||
130192516|NCT00685399|468663284|FG002|Treatment Period 1|Lack of Efficacy|0|||
130192517|NCT00685399|468663285|FG003|Treatment Period 1|Lack of Efficacy|0|||
130192518|NCT00685399|468663286|FG004|Treatment Period 1|Lack of Efficacy|0|||
130192519|NCT00685399|468663287|FG005|Treatment Period 1|Lack of Efficacy|0|||
130192520|NCT00685399|468663288|FG006|Treatment Period 1|Lack of Efficacy|0|||
130192521|NCT00685399|468663289|FG007|Treatment Period 1|Lack of Efficacy|0|||
130192522|NCT00685399|468663282|FG000|Treatment Period 2|Administrative Problems|0|||
130192523|NCT00685399|468663283|FG001|Treatment Period 2|Administrative Problems|2|||
130192524|NCT00685399|468663284|FG002|Treatment Period 2|Administrative Problems|1|||
130192525|NCT00685399|468663285|FG003|Treatment Period 2|Administrative Problems|0|||
130192526|NCT00685399|468663286|FG004|Treatment Period 2|Administrative Problems|0|||
130192527|NCT00685399|468663287|FG005|Treatment Period 2|Administrative Problems|0|||
130192528|NCT00685399|468663288|FG006|Treatment Period 2|Administrative Problems|0|||
130192529|NCT00685399|468663289|FG007|Treatment Period 2|Administrative Problems|0|||
130192530|NCT00685399|468663282|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130192531|NCT00685399|468663283|FG001|Treatment Period 2|Withdrawal by Subject|0|||
130192532|NCT00685399|468663284|FG002|Treatment Period 2|Withdrawal by Subject|0|||
130192533|NCT00685399|468663285|FG003|Treatment Period 2|Withdrawal by Subject|0|||
130192534|NCT00685399|468663286|FG004|Treatment Period 2|Withdrawal by Subject|0|||
130192535|NCT00685399|468663287|FG005|Treatment Period 2|Withdrawal by Subject|0|||
130192536|NCT00685399|468663288|FG006|Treatment Period 2|Withdrawal by Subject|0|||
130192537|NCT00685399|468663289|FG007|Treatment Period 2|Withdrawal by Subject|2|||
130192538|NCT00685399|468663282|FG000|Treatment Period 2|Adverse Event|0|||
130192539|NCT00685399|468663283|FG001|Treatment Period 2|Adverse Event|0|||
130192540|NCT00685399|468663284|FG002|Treatment Period 2|Adverse Event|0|||
130192541|NCT00685399|468663285|FG003|Treatment Period 2|Adverse Event|0|||
130192542|NCT00685399|468663286|FG004|Treatment Period 2|Adverse Event|0|||
130192543|NCT00685399|468663287|FG005|Treatment Period 2|Adverse Event|1|||
130192544|NCT00685399|468663288|FG006|Treatment Period 2|Adverse Event|0|||
130192545|NCT00685399|468663289|FG007|Treatment Period 2|Adverse Event|0|||
130192546|NCT00685399|468663282|FG000|Treatment Period 2|Lack of Efficacy|0|||
130192547|NCT00685399|468663283|FG001|Treatment Period 2|Lack of Efficacy|10|||
130192548|NCT00685399|468663284|FG002|Treatment Period 2|Lack of Efficacy|2|||
130192549|NCT00685399|468663285|FG003|Treatment Period 2|Lack of Efficacy|0|||
130192550|NCT00685399|468663286|FG004|Treatment Period 2|Lack of Efficacy|0|||
130192551|NCT00685399|468663287|FG005|Treatment Period 2|Lack of Efficacy|1|||
130192552|NCT00685399|468663288|FG006|Treatment Period 2|Lack of Efficacy|0|||
130192553|NCT00685399|468663289|FG007|Treatment Period 2|Lack of Efficacy|0|||
130192554|NCT00685399|468663282|FG000|Extension|Administrative Issues|0|||
130192555|NCT00685399|468663283|FG001|Extension|Administrative Issues|0|||
130192556|NCT00685399|468663284|FG002|Extension|Administrative Issues|0|||
130192557|NCT00685399|468663285|FG003|Extension|Administrative Issues|1|||
130192558|NCT00685399|468663286|FG004|Extension|Administrative Issues|0|||
130192559|NCT00685399|468663287|FG005|Extension|Administrative Issues|0|||
130192560|NCT00685399|468663288|FG006|Extension|Administrative Issues|0|||
130192561|NCT00685399|468663289|FG007|Extension|Administrative Issues|0|||
130192562|NCT00685399|468663282|FG000|Extension|Withdrawal by Subject|0|||
130192563|NCT00685399|468663283|FG001|Extension|Withdrawal by Subject|0|||
130192564|NCT00685399|468663284|FG002|Extension|Withdrawal by Subject|0|||
130192565|NCT00685399|468663285|FG003|Extension|Withdrawal by Subject|1|||
130192566|NCT00685399|468663286|FG004|Extension|Withdrawal by Subject|0|||
130192567|NCT00685399|468663287|FG005|Extension|Withdrawal by Subject|0|||
130192568|NCT00685399|468663288|FG006|Extension|Withdrawal by Subject|0|||
130192569|NCT00685399|468663289|FG007|Extension|Withdrawal by Subject|0|||
130192570|NCT00685399|468663282|FG000|Extension|Protocol Violation|0|||
130192571|NCT00685399|468663283|FG001|Extension|Protocol Violation|0|||
130192572|NCT00685399|468663284|FG002|Extension|Protocol Violation|0|||
130192573|NCT00685399|468663285|FG003|Extension|Protocol Violation|1|||
130192574|NCT00685399|468663286|FG004|Extension|Protocol Violation|0|||
130192575|NCT00685399|468663287|FG005|Extension|Protocol Violation|0|||
130192576|NCT00685399|468663288|FG006|Extension|Protocol Violation|0|||
130192577|NCT00685399|468663289|FG007|Extension|Protocol Violation|0|||
130192578|NCT00685399|468663282|FG000|Extension|Lack of Efficacy|0|||
130192579|NCT00685399|468663283|FG001|Extension|Lack of Efficacy|0|||
130192580|NCT00685399|468663284|FG002|Extension|Lack of Efficacy|0|||
130192581|NCT00685399|468663285|FG003|Extension|Lack of Efficacy|2|||
130192582|NCT00685399|468663286|FG004|Extension|Lack of Efficacy|0|||
130192583|NCT00685399|468663287|FG005|Extension|Lack of Efficacy|0|||
130192584|NCT00685399|468663288|FG006|Extension|Lack of Efficacy|0|||
130192585|NCT00685399|468663289|FG007|Extension|Lack of Efficacy|0|||
130192586|NCT00685399|468663282|FG000|Extension|Adverse Event|0|||
130192587|NCT00685399|468663283|FG001|Extension|Adverse Event|0|||
130192588|NCT00685399|468663284|FG002|Extension|Adverse Event|0|||
130192589|NCT00685399|468663285|FG003|Extension|Adverse Event|2|||
130192590|NCT00685399|468663286|FG004|Extension|Adverse Event|0|||
130192591|NCT00685399|468663287|FG005|Extension|Adverse Event|0|||
130192592|NCT00685399|468663288|FG006|Extension|Adverse Event|0|||
130192593|NCT00685399|468663289|FG007|Extension|Adverse Event|0|||
130192594|NCT00927862|468663290|FG000|Overall Study|Missing data needed for endpt analyses|27|||
130192595|NCT00927862|468663291|FG001|Overall Study|Missing data needed for endpt analyses|45|||
130192596|NCT00820248|468663292|FG000|Overall Study|No treated|4|||
130192597|NCT00820248|468663293|FG001|Overall Study|No treated|1|||
130192598|NCT02237196|468663295|FG000|Overall Study|Adverse Event|0|||
130192599|NCT02237196|468663296|FG001|Overall Study|Adverse Event|1|||
130192600|NCT02237196|468663297|FG002|Overall Study|Adverse Event|1|||
130192601|NCT02237196|468663298|FG003|Overall Study|Adverse Event|0|||
130192602|NCT02237196|468663295|FG000|Overall Study|Lost to Follow-up|4|||
130192603|NCT02237196|468663296|FG001|Overall Study|Lost to Follow-up|2|||
130192604|NCT02237196|468663297|FG002|Overall Study|Lost to Follow-up|4|||
130192605|NCT02237196|468663298|FG003|Overall Study|Lost to Follow-up|6|||
130192606|NCT02237196|468663295|FG000|Overall Study|Physician Decision|2|||
130192607|NCT02237196|468663296|FG001|Overall Study|Physician Decision|0|||
130192608|NCT02237196|468663297|FG002|Overall Study|Physician Decision|0|||
130192609|NCT02237196|468663298|FG003|Overall Study|Physician Decision|1|||
130192610|NCT02237196|468663295|FG000|Overall Study|Pregnancy|0|||
130192611|NCT02237196|468663296|FG001|Overall Study|Pregnancy|0|||
130192612|NCT02237196|468663297|FG002|Overall Study|Pregnancy|1|||
130192613|NCT02237196|468663298|FG003|Overall Study|Pregnancy|1|||
130192614|NCT02237196|468663295|FG000|Overall Study|Withdrawal by Subject|1|||
130192615|NCT02237196|468663296|FG001|Overall Study|Withdrawal by Subject|1|||
130192616|NCT02237196|468663297|FG002|Overall Study|Withdrawal by Subject|4|||
130192617|NCT02237196|468663298|FG003|Overall Study|Withdrawal by Subject|1|||
130192618|NCT02237196|468663295|FG000|Overall Study|Site Error|1|||
130192619|NCT02237196|468663296|FG001|Overall Study|Site Error|2|||
130192620|NCT02237196|468663297|FG002|Overall Study|Site Error|0|||
130192621|NCT02237196|468663298|FG003|Overall Study|Site Error|2|||
130192622|NCT01750697|468663301|FG000|Overall Study|Transferred Back to Local Hospital|1|||
130192623|NCT01750697|468663301|FG000|Overall Study|Physician and Family Decision|1|||
130192624|NCT01750697|468663301|FG000|Overall Study|Transferred to Adult Services|5|||
130192625|NCT01750697|468663301|FG000|Overall Study|Physician Decision|1|||
130192626|NCT01750697|468663301|FG000|Overall Study|Withdrawal by Subject|1|||
130192627|NCT01562782|468663311|FG000|Overall Study|Withdrawal by Subject|3|||
130192628|NCT01562782|468663312|FG001|Overall Study|Withdrawal by Subject|3|||
130192629|NCT01562782|468663311|FG000|Overall Study|screen failure|1|||
130192630|NCT01562782|468663312|FG001|Overall Study|screen failure|2|||
130192631|NCT01421225|468663315|FG000|Overall Study|Withdrawal by Subject|0|||
130192632|NCT01421225|468663316|FG001|Overall Study|Withdrawal by Subject|1|||
130192633|NCT02049814|468663319|FG000|Overall Study|Reason not Specified|4|||
130192634|NCT02049814|468663320|FG001|Overall Study|Reason not Specified|3|||
130192635|NCT02049814|468663319|FG000|Overall Study|Pregnancy|1|||
130192636|NCT02049814|468663320|FG001|Overall Study|Pregnancy|0|||
130192637|NCT02049814|468663319|FG000|Overall Study|Lost to Follow-up|2|||
130192638|NCT02049814|468663320|FG001|Overall Study|Lost to Follow-up|3|||
130192639|NCT02049814|468663319|FG000|Overall Study|Serious Protocol Violation|5|||
130192640|NCT02049814|468663320|FG001|Overall Study|Serious Protocol Violation|7|||
130192641|NCT02049814|468663319|FG000|Overall Study|Study Termination|0|||
130192642|NCT02049814|468663320|FG001|Overall Study|Study Termination|1|||
130192643|NCT02049814|468663319|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
130192644|NCT02049814|468663320|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
130192645|NCT02049814|468663319|FG000|Overall Study|Voluntary withdrawal|9|||
130192646|NCT02049814|468663320|FG001|Overall Study|Voluntary withdrawal|8|||
130192647|NCT01282372|468663321|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
130192648|NCT01282372|468663321|FG000|Overall Study|Lost to Follow-up|23|||
130192649|NCT01282372|468663321|FG000|Overall Study|Withdrawal by Subject|11|||
130192650|NCT01282372|468663321|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
130192651|NCT01282372|468663321|FG000|Overall Study|Death|1|||
130192652|NCT01282372|468663321|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
130192653|NCT01282372|468663321|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
130192654|NCT01282372|468663321|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
130192655|NCT01282372|468663321|FG000|Overall Study|Adverse Event|12|||
130192656|NCT02993250|468663323|FG000|Overall Study|Lost to Follow-up|0|||
130192657|NCT02993250|468663324|FG001|Overall Study|Lost to Follow-up|1|||
130192658|NCT02527434|468663325|FG000|Overall Study|Lost to Follow-up|2|||
130192659|NCT02527434|468663326|FG001|Overall Study|Lost to Follow-up|2|||
130192660|NCT02527434|468663327|FG002|Overall Study|Lost to Follow-up|0|||
130192661|NCT02527434|468663325|FG000|Overall Study|Death|19|||
130192662|NCT02527434|468663326|FG001|Overall Study|Death|6|||
130192663|NCT02527434|468663327|FG002|Overall Study|Death|17|||
130192664|NCT02527434|468663325|FG000|Overall Study|Withdrawal by Subject|5|||
130192665|NCT02527434|468663326|FG001|Overall Study|Withdrawal by Subject|3|||
130192666|NCT02527434|468663327|FG002|Overall Study|Withdrawal by Subject|3|||
130192667|NCT02527434|468663325|FG000|Overall Study|Reason Not Specified|1|||
130192668|NCT02527434|468663326|FG001|Overall Study|Reason Not Specified|0|||
130192669|NCT02527434|468663327|FG002|Overall Study|Reason Not Specified|0|||
130192670|NCT02527434|468663325|FG000|Overall Study|Site closure|1|||
130192671|NCT02527434|468663326|FG001|Overall Study|Site closure|0|||
130192672|NCT02527434|468663327|FG002|Overall Study|Site closure|0|||
130192673|NCT00713258|468663328|FG000|Overall Study|Adverse Event|2|||
130192674|NCT00713258|468663329|FG001|Overall Study|Adverse Event|4|||
130192675|NCT00713258|468663328|FG000|Overall Study|Non-Compliance|2|||
130192676|NCT00713258|468663329|FG001|Overall Study|Non-Compliance|1|||
130192677|NCT00713258|468663328|FG000|Overall Study|Other|1|||
130192678|NCT00713258|468663329|FG001|Overall Study|Other|1|||
130192679|NCT01322490|468663330|FG000|Treatment Period|Adverse Event|12|||
130192680|NCT01322490|468663331|FG001|Treatment Period|Adverse Event|18|||
130192681|NCT01322490|468663332|FG002|Treatment Period|Adverse Event|15|||
130192682|NCT01322490|468663330|FG000|Treatment Period|Death|5|||
130192683|NCT01322490|468663331|FG001|Treatment Period|Death|7|||
130192684|NCT01322490|468663332|FG002|Treatment Period|Death|3|||
130192685|NCT01322490|468663330|FG000|Treatment Period|Lack of Efficacy|89|||
130192686|NCT01322490|468663331|FG001|Treatment Period|Lack of Efficacy|100|||
130192687|NCT01322490|468663332|FG002|Treatment Period|Lack of Efficacy|112|||
130192688|NCT01322490|468663330|FG000|Treatment Period|Physician Decision|0|||
130192689|NCT01322490|468663331|FG001|Treatment Period|Physician Decision|2|||
130192690|NCT01322490|468663332|FG002|Treatment Period|Physician Decision|1|||
130192691|NCT01322490|468663330|FG000|Treatment Period|Protocol Violation|7|||
130192692|NCT01322490|468663331|FG001|Treatment Period|Protocol Violation|5|||
130192693|NCT01322490|468663332|FG002|Treatment Period|Protocol Violation|4|||
130192694|NCT01322490|468663330|FG000|Treatment Period|Withdrawal by Subject|14|||
130192695|NCT01322490|468663331|FG001|Treatment Period|Withdrawal by Subject|16|||
130192696|NCT01322490|468663332|FG002|Treatment Period|Withdrawal by Subject|11|||
130192697|NCT01322490|468663330|FG000|Treatment Period|Non-compliance with study drug|0|||
130192698|NCT01322490|468663331|FG001|Treatment Period|Non-compliance with study drug|0|||
130192699|NCT01322490|468663332|FG002|Treatment Period|Non-compliance with study drug|1|||
130192700|NCT01322490|468663330|FG000|Treatment Period|Other per report|2|||
130192701|NCT01322490|468663331|FG001|Treatment Period|Other per report|2|||
130192702|NCT01322490|468663332|FG002|Treatment Period|Other per report|1|||
130192703|NCT01322490|468663330|FG000|Treatment Period|Randomized but Not Treated|3|||
130192704|NCT01322490|468663331|FG001|Treatment Period|Randomized but Not Treated|3|||
130192705|NCT01322490|468663332|FG002|Treatment Period|Randomized but Not Treated|5|||
130192706|NCT01322490|468663330|FG000|Long Term Follow-up Period|Death|235|||
130192707|NCT01322490|468663331|FG001|Long Term Follow-up Period|Death|239|||
130192708|NCT01322490|468663332|FG002|Long Term Follow-up Period|Death|236|||
130192709|NCT01322490|468663330|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
130192710|NCT01322490|468663331|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
130192711|NCT01322490|468663332|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
130192712|NCT01322490|468663330|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
130192713|NCT01322490|468663331|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
130192714|NCT01322490|468663332|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
130192715|NCT01322490|468663330|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
130192716|NCT01322490|468663331|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
130192717|NCT01322490|468663332|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
130192718|NCT01322490|468663330|FG000|Long Term Follow-up Period|Other per report|3|||
130192719|NCT01322490|468663331|FG001|Long Term Follow-up Period|Other per report|2|||
130192720|NCT01322490|468663332|FG002|Long Term Follow-up Period|Other per report|2|||
130192721|NCT01322490|468663330|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
130192722|NCT01322490|468663331|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
130192723|NCT01322490|468663332|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
130192724|NCT01431716|468663333|FG000|Overall Study|Withdrawal of consent|1|||
130192725|NCT00568061|468663334|FG000|Overall Study|Inclusion / exclusion criteria|5|||
130192726|NCT00568061|468663335|FG001|Overall Study|Inclusion / exclusion criteria|1|||
130192727|NCT00568061|468663334|FG000|Overall Study|Adverse Event|0|||
130192728|NCT00568061|468663335|FG001|Overall Study|Adverse Event|1|||
130192729|NCT05027451|468663336|FG000|Overall Study|Lost to Follow-up|1|||
130192730|NCT05027451|468663337|FG001|Overall Study|Lost to Follow-up|1|||
130192731|NCT01896128|468663338|FG000|Overall Study|Withdrawal by Subject|3|||
130192732|NCT01896128|468663339|FG001|Overall Study|Withdrawal by Subject|3|||
130192733|NCT02693002|468663342|FG000|Overall Study|Withdrawal by Subject|1|||
130192734|NCT02693002|468663343|FG001|Overall Study|Withdrawal by Subject|0|||
130192735|NCT00708214|468663346|FG000|Overall Study|Other Adverse Event|3|||
130192736|NCT00708214|468663347|FG001|Overall Study|Other Adverse Event|6|||
130192737|NCT00708214|468663348|FG002|Overall Study|Other Adverse Event|2|||
130192738|NCT00708214|468663346|FG000|Overall Study|Other|0|||
130192739|NCT00708214|468663347|FG001|Overall Study|Other|1|||
130192740|NCT00708214|468663348|FG002|Overall Study|Other|1|||
130192741|NCT00708214|468663346|FG000|Overall Study|Progressive Disease|4|||
130192742|NCT00708214|468663347|FG001|Overall Study|Progressive Disease|6|||
130192743|NCT00708214|468663348|FG002|Overall Study|Progressive Disease|5|||
130192744|NCT02929589|468663383|FG000|Overall Study|Withdrawal by Subject|1|||
130192745|NCT02929589|468663384|FG001|Overall Study|Withdrawal by Subject|0|||
130192746|NCT02929589|468663385|FG002|Overall Study|Withdrawal by Subject|0|||
130192747|NCT02929589|468663386|FG003|Overall Study|Withdrawal by Subject|0|||
130192748|NCT02929589|468663383|FG000|Overall Study|Physician Decision|2|||
130192749|NCT02929589|468663384|FG001|Overall Study|Physician Decision|0|||
130192750|NCT02929589|468663385|FG002|Overall Study|Physician Decision|0|||
130192751|NCT02929589|468663386|FG003|Overall Study|Physician Decision|0|||
130192752|NCT02343939|468663387|FG000|Overall Study|Death|0|||
130192753|NCT02343939|468663388|FG001|Overall Study|Death|15|||
130192754|NCT02343939|468663389|FG002|Overall Study|Death|4|||
130192755|NCT02343939|468663390|FG003|Overall Study|Death|2|||
130192756|NCT02343939|468663391|FG004|Overall Study|Death|5|||
130192757|NCT02343939|468663392|FG005|Overall Study|Death|11|||
130192758|NCT02343939|468663393|FG006|Overall Study|Death|8|||
130192759|NCT02343939|468663394|FG007|Overall Study|Death|22|||
130192760|NCT02343939|468663395|FG008|Overall Study|Death|1|||
130192761|NCT02343939|468663387|FG000|Overall Study|Study terminated by sponsor|0|||
130192762|NCT02343939|468663388|FG001|Overall Study|Study terminated by sponsor|27|||
130192763|NCT02343939|468663389|FG002|Overall Study|Study terminated by sponsor|0|||
130192764|NCT02343939|468663390|FG003|Overall Study|Study terminated by sponsor|1|||
130192765|NCT02343939|468663391|FG004|Overall Study|Study terminated by sponsor|1|||
130192766|NCT02343939|468663392|FG005|Overall Study|Study terminated by sponsor|5|||
130192767|NCT02343939|468663393|FG006|Overall Study|Study terminated by sponsor|3|||
130192768|NCT02343939|468663394|FG007|Overall Study|Study terminated by sponsor|4|||
130192769|NCT02343939|468663395|FG008|Overall Study|Study terminated by sponsor|0|||
130192770|NCT02343939|468663387|FG000|Overall Study|Withdrew consent|3|||
130192771|NCT02343939|468663388|FG001|Overall Study|Withdrew consent|6|||
130192772|NCT02343939|468663389|FG002|Overall Study|Withdrew consent|1|||
130192773|NCT02343939|468663390|FG003|Overall Study|Withdrew consent|2|||
130192774|NCT02343939|468663391|FG004|Overall Study|Withdrew consent|2|||
130192775|NCT02343939|468663392|FG005|Overall Study|Withdrew consent|0|||
130192776|NCT02343939|468663393|FG006|Overall Study|Withdrew consent|0|||
130192777|NCT02343939|468663394|FG007|Overall Study|Withdrew consent|8|||
130192778|NCT02343939|468663395|FG008|Overall Study|Withdrew consent|6|||
130192779|NCT02343939|468663387|FG000|Overall Study|Treatment failure|0|||
130192780|NCT02343939|468663388|FG001|Overall Study|Treatment failure|0|||
130192781|NCT02343939|468663389|FG002|Overall Study|Treatment failure|0|||
130192782|NCT02343939|468663390|FG003|Overall Study|Treatment failure|0|||
130192783|NCT02343939|468663391|FG004|Overall Study|Treatment failure|0|||
130192784|NCT02343939|468663392|FG005|Overall Study|Treatment failure|0|||
130192785|NCT02343939|468663393|FG006|Overall Study|Treatment failure|2|||
130192786|NCT02343939|468663394|FG007|Overall Study|Treatment failure|1|||
130192787|NCT02343939|468663395|FG008|Overall Study|Treatment failure|0|||
130192788|NCT02343939|468663387|FG000|Overall Study|Investigator's discretion|0|||
130192789|NCT02343939|468663388|FG001|Overall Study|Investigator's discretion|0|||
130192790|NCT02343939|468663389|FG002|Overall Study|Investigator's discretion|0|||
130192791|NCT02343939|468663390|FG003|Overall Study|Investigator's discretion|1|||
130192792|NCT02343939|468663391|FG004|Overall Study|Investigator's discretion|0|||
130192793|NCT02343939|468663392|FG005|Overall Study|Investigator's discretion|0|||
130192794|NCT02343939|468663393|FG006|Overall Study|Investigator's discretion|1|||
130192795|NCT02343939|468663394|FG007|Overall Study|Investigator's discretion|0|||
130192796|NCT02343939|468663395|FG008|Overall Study|Investigator's discretion|0|||
130192797|NCT02343939|468663387|FG000|Overall Study|Adverse Event|0|||
130192798|NCT02343939|468663388|FG001|Overall Study|Adverse Event|0|||
130192799|NCT02343939|468663389|FG002|Overall Study|Adverse Event|0|||
130192800|NCT02343939|468663390|FG003|Overall Study|Adverse Event|0|||
130192801|NCT02343939|468663391|FG004|Overall Study|Adverse Event|0|||
130192802|NCT02343939|468663392|FG005|Overall Study|Adverse Event|1|||
130192803|NCT02343939|468663393|FG006|Overall Study|Adverse Event|0|||
130192804|NCT02343939|468663394|FG007|Overall Study|Adverse Event|0|||
130192805|NCT02343939|468663395|FG008|Overall Study|Adverse Event|0|||
130192806|NCT02343939|468663387|FG000|Overall Study|Never Treated With ENTO|0|||
130192807|NCT02343939|468663388|FG001|Overall Study|Never Treated With ENTO|0|||
130192808|NCT02343939|468663389|FG002|Overall Study|Never Treated With ENTO|0|||
130192809|NCT02343939|468663390|FG003|Overall Study|Never Treated With ENTO|0|||
130192810|NCT02343939|468663391|FG004|Overall Study|Never Treated With ENTO|0|||
130192811|NCT02343939|468663392|FG005|Overall Study|Never Treated With ENTO|0|||
130192812|NCT02343939|468663393|FG006|Overall Study|Never Treated With ENTO|1|||
130192813|NCT02343939|468663394|FG007|Overall Study|Never Treated With ENTO|2|||
130192814|NCT02343939|468663395|FG008|Overall Study|Never Treated With ENTO|0|||
130192815|NCT01303172|468663402|FG000|Overall Study|Physician Decision|9|||
130192816|NCT01303172|468663403|FG001|Overall Study|Physician Decision|6|||
130192817|NCT01303172|468663402|FG000|Overall Study|Adverse Event|5|||
130192818|NCT01303172|468663403|FG001|Overall Study|Adverse Event|2|||
130192819|NCT01303172|468663402|FG000|Overall Study|Withdrawal by Subject|4|||
130192820|NCT01303172|468663403|FG001|Overall Study|Withdrawal by Subject|2|||
130192821|NCT01303172|468663402|FG000|Overall Study|Death|20|||
130192822|NCT01303172|468663403|FG001|Overall Study|Death|7|||
130192823|NCT01303172|468663402|FG000|Overall Study|Lack of Efficacy|25|||
130192824|NCT01303172|468663403|FG001|Overall Study|Lack of Efficacy|17|||
130192825|NCT00462709|468663406|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
130192826|NCT00462709|468663406|FG000|Overall Study|Lost to Follow-up|10|||
130192827|NCT00462709|468663406|FG000|Overall Study|Withdrawal by Subject|8|||
130192828|NCT00462709|468663406|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
130192829|NCT00462709|468663406|FG000|Overall Study|Death|2|||
130192830|NCT00462709|468663406|FG000|Overall Study|Logistical reasons|2|||
130192831|NCT00462709|468663406|FG000|Overall Study|Physician Decision|1|||
130192832|NCT00462709|468663406|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
130192833|NCT04468347|468663407|FG000|Overall Study|Withdrawal by Subject|0|||
130192834|NCT04468347|468663408|FG001|Overall Study|Withdrawal by Subject|1|||
130192835|NCT04468347|468663409|FG002|Overall Study|Withdrawal by Subject|3|||
130192836|NCT04468347|468663410|FG003|Overall Study|Withdrawal by Subject|3|||
130192837|NCT04468347|468663407|FG000|Overall Study|Lost to Follow-up|0|||
130192838|NCT04468347|468663408|FG001|Overall Study|Lost to Follow-up|0|||
130192839|NCT04468347|468663409|FG002|Overall Study|Lost to Follow-up|1|||
130192840|NCT04468347|468663410|FG003|Overall Study|Lost to Follow-up|1|||
130192841|NCT04468347|468663407|FG000|Overall Study|Physician Decision|1|||
130192842|NCT04468347|468663408|FG001|Overall Study|Physician Decision|0|||
130192843|NCT04468347|468663409|FG002|Overall Study|Physician Decision|2|||
130192844|NCT04468347|468663410|FG003|Overall Study|Physician Decision|0|||
130192845|NCT04468347|468663407|FG000|Overall Study|Protocol Violation|1|||
130192846|NCT04468347|468663408|FG001|Overall Study|Protocol Violation|0|||
130192847|NCT04468347|468663409|FG002|Overall Study|Protocol Violation|0|||
130192848|NCT04468347|468663410|FG003|Overall Study|Protocol Violation|0|||
130192849|NCT00665431|468663411|FG000|Overall Study|Adverse Event|16|||
130192850|NCT00665431|468663412|FG001|Overall Study|Adverse Event|22|||
130192851|NCT00665431|468663413|FG002|Overall Study|Adverse Event|6|||
130192852|NCT00665431|468663411|FG000|Overall Study|Withdrawal by Subject|17|||
130192853|NCT00665431|468663412|FG001|Overall Study|Withdrawal by Subject|25|||
130192854|NCT00665431|468663413|FG002|Overall Study|Withdrawal by Subject|15|||
130192855|NCT00665431|468663411|FG000|Overall Study|Lost to Follow-up|3|||
130192856|NCT00665431|468663412|FG001|Overall Study|Lost to Follow-up|3|||
130192857|NCT00665431|468663413|FG002|Overall Study|Lost to Follow-up|1|||
130192858|NCT00665431|468663411|FG000|Overall Study|Other|4|||
130192859|NCT00665431|468663412|FG001|Overall Study|Other|7|||
130192860|NCT00665431|468663413|FG002|Overall Study|Other|2|||
130192861|NCT03483961|468665421|FG000|Overall Study|Lost to Follow-up|7|||
130192862|NCT03483961|468665422|FG001|Overall Study|Lost to Follow-up|6|||
130192863|NCT03483961|468665423|FG002|Overall Study|Lost to Follow-up|6|||
130192864|NCT03483961|468665424|FG003|Overall Study|Lost to Follow-up|6|||
130192865|NCT03483961|468665425|FG004|Overall Study|Lost to Follow-up|6|||
130192866|NCT03483961|468665426|FG005|Overall Study|Lost to Follow-up|4|||
130192867|NCT03483961|468665427|FG006|Overall Study|Lost to Follow-up|4|||
130192868|NCT03483961|468665428|FG007|Overall Study|Lost to Follow-up|11|||
130192869|NCT03483961|468665429|FG008|Overall Study|Lost to Follow-up|1|||
130192870|NCT03483961|468665430|FG009|Overall Study|Lost to Follow-up|0|||
130192871|NCT03483961|468665421|FG000|Overall Study|Withdrawal by Subject|3|||
130192872|NCT03483961|468665422|FG001|Overall Study|Withdrawal by Subject|4|||
130192873|NCT03483961|468665423|FG002|Overall Study|Withdrawal by Subject|5|||
130192874|NCT03483961|468665424|FG003|Overall Study|Withdrawal by Subject|3|||
130192875|NCT03483961|468665425|FG004|Overall Study|Withdrawal by Subject|4|||
130192876|NCT03483961|468665426|FG005|Overall Study|Withdrawal by Subject|2|||
130192877|NCT03483961|468665427|FG006|Overall Study|Withdrawal by Subject|1|||
130192878|NCT03483961|468665428|FG007|Overall Study|Withdrawal by Subject|2|||
130192879|NCT03483961|468665429|FG008|Overall Study|Withdrawal by Subject|1|||
130192880|NCT03483961|468665430|FG009|Overall Study|Withdrawal by Subject|0|||
130192881|NCT03483961|468665421|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
130192882|NCT03483961|468665422|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192883|NCT03483961|468665423|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192884|NCT03483961|468665424|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192885|NCT03483961|468665425|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192886|NCT03483961|468665426|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192887|NCT03483961|468665427|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192888|NCT03483961|468665428|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192889|NCT03483961|468665429|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192890|NCT03483961|468665430|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
130192891|NCT03483961|468665421|FG000|Overall Study|Adverse Event|0|||
130192892|NCT03483961|468665422|FG001|Overall Study|Adverse Event|0|||
130192893|NCT03483961|468665423|FG002|Overall Study|Adverse Event|1|||
130192894|NCT03483961|468665424|FG003|Overall Study|Adverse Event|0|||
130192895|NCT03483961|468665425|FG004|Overall Study|Adverse Event|0|||
130192896|NCT03483961|468665426|FG005|Overall Study|Adverse Event|0|||
130192897|NCT03483961|468665427|FG006|Overall Study|Adverse Event|0|||
130192898|NCT03483961|468665428|FG007|Overall Study|Adverse Event|0|||
130192899|NCT03483961|468665429|FG008|Overall Study|Adverse Event|0|||
130192900|NCT03483961|468665430|FG009|Overall Study|Adverse Event|0|||
130192901|NCT00356603|468665431|FG000|Overall Study|Other|6|||
130192902|NCT00356603|468665432|FG001|Overall Study|Other|3|||
130192903|NCT00728468|468665434|FG000|Overall Study|Enrolled but not treated|1|||
130192904|NCT00728468|468665434|FG000|Overall Study|Death|1|||
130192905|NCT00728468|468665434|FG000|Overall Study|Protocol Violation|4|||
130192906|NCT00728468|468665434|FG000|Overall Study|Objective progression or relapse|9|||
130192907|NCT00728468|468665434|FG000|Overall Study|Study terminated by sponsor|1|||
130192908|NCT01262287|468665435|FG000|Overall Study|Lost to Follow-up|2|||
130192909|NCT01262287|468665436|FG001|Overall Study|Lost to Follow-up|1|||
130192910|NCT00932373|468665437|FG000|Overall Study|Progressive disease|3|||
130192911|NCT00932373|468665438|FG001|Overall Study|Progressive disease|1|||
130192912|NCT00932373|468665439|FG002|Overall Study|Progressive disease|0|||
130192913|NCT00932373|468665440|FG003|Overall Study|Progressive disease|0|||
130192914|NCT00932373|468665441|FG004|Overall Study|Progressive disease|10|||
130192915|NCT00932373|468665442|FG005|Overall Study|Progressive disease|1|||
130192916|NCT00932373|468665443|FG006|Overall Study|Progressive disease|0|||
130192917|NCT00932373|468665444|FG007|Overall Study|Progressive disease|2|||
130192918|NCT00932373|468665445|FG008|Overall Study|Progressive disease|1|||
130192919|NCT00932373|468665446|FG009|Overall Study|Progressive disease|9|||
130192920|NCT00932373|468665447|FG010|Overall Study|Progressive disease|2|||
130192921|NCT00932373|468665437|FG000|Overall Study|Adverse Event|0|||
130192922|NCT00932373|468665438|FG001|Overall Study|Adverse Event|0|||
130192923|NCT00932373|468665439|FG002|Overall Study|Adverse Event|0|||
130192924|NCT00932373|468665440|FG003|Overall Study|Adverse Event|0|||
130192925|NCT00932373|468665441|FG004|Overall Study|Adverse Event|2|||
130192926|NCT00932373|468665442|FG005|Overall Study|Adverse Event|1|||
130192927|NCT00932373|468665443|FG006|Overall Study|Adverse Event|0|||
130192928|NCT00932373|468665444|FG007|Overall Study|Adverse Event|1|||
130192929|NCT00932373|468665445|FG008|Overall Study|Adverse Event|0|||
130192930|NCT00932373|468665446|FG009|Overall Study|Adverse Event|2|||
130192931|NCT00932373|468665447|FG010|Overall Study|Adverse Event|1|||
130192932|NCT00932373|468665437|FG000|Overall Study|Physician Decision|0|||
130192933|NCT00932373|468665438|FG001|Overall Study|Physician Decision|0|||
130192934|NCT00932373|468665439|FG002|Overall Study|Physician Decision|1|||
130192935|NCT00932373|468665440|FG003|Overall Study|Physician Decision|0|||
130192936|NCT00932373|468665441|FG004|Overall Study|Physician Decision|2|||
130192937|NCT00932373|468665442|FG005|Overall Study|Physician Decision|0|||
130192938|NCT00932373|468665443|FG006|Overall Study|Physician Decision|0|||
130192939|NCT00932373|468665444|FG007|Overall Study|Physician Decision|0|||
130192940|NCT00932373|468665445|FG008|Overall Study|Physician Decision|0|||
130192941|NCT00932373|468665446|FG009|Overall Study|Physician Decision|1|||
130192942|NCT00932373|468665447|FG010|Overall Study|Physician Decision|0|||
130192943|NCT00932373|468665437|FG000|Overall Study|Dose limiting toxicity|0|||
130192944|NCT00932373|468665438|FG001|Overall Study|Dose limiting toxicity|0|||
130192945|NCT00932373|468665439|FG002|Overall Study|Dose limiting toxicity|0|||
130192946|NCT00932373|468665440|FG003|Overall Study|Dose limiting toxicity|0|||
130192947|NCT00932373|468665441|FG004|Overall Study|Dose limiting toxicity|0|||
130192948|NCT00932373|468665442|FG005|Overall Study|Dose limiting toxicity|1|||
130192949|NCT00932373|468665443|FG006|Overall Study|Dose limiting toxicity|0|||
130192950|NCT00932373|468665444|FG007|Overall Study|Dose limiting toxicity|0|||
130192951|NCT00932373|468665445|FG008|Overall Study|Dose limiting toxicity|0|||
130192952|NCT00932373|468665446|FG009|Overall Study|Dose limiting toxicity|0|||
130192953|NCT00932373|468665447|FG010|Overall Study|Dose limiting toxicity|0|||
130192954|NCT00932373|468665437|FG000|Overall Study|Withdrawal by Subject|0|||
130192955|NCT00932373|468665438|FG001|Overall Study|Withdrawal by Subject|0|||
130192956|NCT00932373|468665439|FG002|Overall Study|Withdrawal by Subject|0|||
130192957|NCT00932373|468665440|FG003|Overall Study|Withdrawal by Subject|0|||
130192958|NCT00932373|468665441|FG004|Overall Study|Withdrawal by Subject|0|||
130192959|NCT00932373|468665442|FG005|Overall Study|Withdrawal by Subject|0|||
130192960|NCT00932373|468665443|FG006|Overall Study|Withdrawal by Subject|0|||
130192961|NCT00932373|468665444|FG007|Overall Study|Withdrawal by Subject|0|||
130192962|NCT00932373|468665445|FG008|Overall Study|Withdrawal by Subject|1|||
130192963|NCT00932373|468665446|FG009|Overall Study|Withdrawal by Subject|0|||
130192964|NCT00932373|468665447|FG010|Overall Study|Withdrawal by Subject|0|||
130192965|NCT00932373|468665437|FG000|Overall Study|Clinical progression|0|||
130192966|NCT00932373|468665438|FG001|Overall Study|Clinical progression|0|||
130192967|NCT00932373|468665439|FG002|Overall Study|Clinical progression|0|||
130192968|NCT00932373|468665440|FG003|Overall Study|Clinical progression|0|||
130192969|NCT00932373|468665441|FG004|Overall Study|Clinical progression|0|||
130192970|NCT00932373|468665442|FG005|Overall Study|Clinical progression|0|||
130192971|NCT00932373|468665443|FG006|Overall Study|Clinical progression|1|||
130192972|NCT00932373|468665444|FG007|Overall Study|Clinical progression|0|||
130192973|NCT00932373|468665445|FG008|Overall Study|Clinical progression|0|||
130192974|NCT00932373|468665446|FG009|Overall Study|Clinical progression|0|||
130192975|NCT00932373|468665447|FG010|Overall Study|Clinical progression|0|||
130192976|NCT00932373|468665437|FG000|Overall Study|Lack of Efficacy|0|||
130192977|NCT00932373|468665438|FG001|Overall Study|Lack of Efficacy|0|||
130192978|NCT00932373|468665439|FG002|Overall Study|Lack of Efficacy|0|||
130192979|NCT00932373|468665440|FG003|Overall Study|Lack of Efficacy|0|||
130192980|NCT00932373|468665441|FG004|Overall Study|Lack of Efficacy|0|||
130192981|NCT00932373|468665442|FG005|Overall Study|Lack of Efficacy|0|||
130192982|NCT00932373|468665443|FG006|Overall Study|Lack of Efficacy|0|||
130192983|NCT00932373|468665444|FG007|Overall Study|Lack of Efficacy|0|||
130192984|NCT00932373|468665445|FG008|Overall Study|Lack of Efficacy|0|||
130192985|NCT00932373|468665446|FG009|Overall Study|Lack of Efficacy|1|||
130192986|NCT00932373|468665447|FG010|Overall Study|Lack of Efficacy|0|||
130192987|NCT01637922|468665448|FG000|Overall Study|Adverse Event|0|||
130192988|NCT01637922|468665449|FG001|Overall Study|Adverse Event|1|||
130192989|NCT01637922|468665448|FG000|Overall Study|Protocol Violation|0|||
130192990|NCT01637922|468665449|FG001|Overall Study|Protocol Violation|1|||
130192991|NCT01637922|468665448|FG000|Overall Study|Withdrawal by Subject|0|||
130192992|NCT01637922|468665449|FG001|Overall Study|Withdrawal by Subject|3|||
130192993|NCT01637922|468665448|FG000|Overall Study|Lost to Follow-up|2|||
130192994|NCT01637922|468665449|FG001|Overall Study|Lost to Follow-up|0|||
130192995|NCT00638404|468665450|FG000|Overall Study|Physician Decision|8|||
130192996|NCT00638404|468665451|FG001|Overall Study|Physician Decision|0|||
130192997|NCT02509507|468665452|FG000|Overall Study|Death|21|||
130192998|NCT02509507|468665453|FG001|Overall Study|Death|3|||
130192999|NCT02509507|468665454|FG002|Overall Study|Death|22|||
130193000|NCT02509507|468665455|FG003|Overall Study|Death|14|||
130193001|NCT02509507|468665456|FG004|Overall Study|Death|8|||
130193002|NCT02509507|468665457|FG005|Overall Study|Death|12|||
130193003|NCT02509507|468665458|FG006|Overall Study|Death|5|||
130193004|NCT02509507|468665459|FG007|Overall Study|Death|4|||
130193005|NCT02509507|468665460|FG008|Overall Study|Death|8|||
130193006|NCT02509507|468665452|FG000|Overall Study|Lost to Follow-up|0|||
130193007|NCT02509507|468665453|FG001|Overall Study|Lost to Follow-up|1|||
130193008|NCT02509507|468665454|FG002|Overall Study|Lost to Follow-up|0|||
130193009|NCT02509507|468665455|FG003|Overall Study|Lost to Follow-up|0|||
130193010|NCT02509507|468665456|FG004|Overall Study|Lost to Follow-up|0|||
130193011|NCT02509507|468665457|FG005|Overall Study|Lost to Follow-up|2|||
130193012|NCT02509507|468665458|FG006|Overall Study|Lost to Follow-up|0|||
130193013|NCT02509507|468665459|FG007|Overall Study|Lost to Follow-up|0|||
130193014|NCT02509507|468665460|FG008|Overall Study|Lost to Follow-up|0|||
130193015|NCT02509507|468665452|FG000|Overall Study|Withdrawal by Subject|2|||
130193016|NCT02509507|468665453|FG001|Overall Study|Withdrawal by Subject|0|||
130193017|NCT02509507|468665454|FG002|Overall Study|Withdrawal by Subject|1|||
130193018|NCT02509507|468665455|FG003|Overall Study|Withdrawal by Subject|4|||
130193019|NCT02509507|468665456|FG004|Overall Study|Withdrawal by Subject|1|||
130193020|NCT02509507|468665457|FG005|Overall Study|Withdrawal by Subject|3|||
130193021|NCT02509507|468665458|FG006|Overall Study|Withdrawal by Subject|4|||
130193022|NCT02509507|468665459|FG007|Overall Study|Withdrawal by Subject|0|||
130193023|NCT02509507|468665460|FG008|Overall Study|Withdrawal by Subject|1|||
130193024|NCT02510664|468665464|FG000|Overall Study|Transferred Care|9|||
130193025|NCT02510664|468665465|FG001|Overall Study|Transferred Care|9|||
130193026|NCT02510664|468665466|FG002|Overall Study|Transferred Care|0|||
130193027|NCT02510664|468665464|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
130193028|NCT02510664|468665465|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
130193029|NCT02510664|468665466|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
130193030|NCT02510664|468665464|FG000|Overall Study|Time Constraints|1|||
130193031|NCT02510664|468665465|FG001|Overall Study|Time Constraints|1|||
130193032|NCT02510664|468665466|FG002|Overall Study|Time Constraints|0|||
130193033|NCT00912743|468665479|FG000|Overall Study|Adverse Event|3|||
130193034|NCT00912743|468665480|FG001|Overall Study|Adverse Event|1|||
130193035|NCT00912743|468665479|FG000|Overall Study|Lack of Efficacy|9|||
130193036|NCT00912743|468665480|FG001|Overall Study|Lack of Efficacy|18|||
130193037|NCT00912743|468665479|FG000|Overall Study|Toxicity|0|||
130193038|NCT00912743|468665480|FG001|Overall Study|Toxicity|1|||
130193039|NCT00912743|468665479|FG000|Overall Study|End of treatment form was not collected|1|||
130193040|NCT00912743|468665480|FG001|Overall Study|End of treatment form was not collected|0|||
130193041|NCT00862823|468665482|FG000|First Intervention|Withdrawal by Subject|1|||
130193042|NCT00862823|468665483|FG001|First Intervention|Withdrawal by Subject|1|||
130193043|NCT02714595|468665487|FG000|Overall Study|Lost to Follow-up|1|||
130193044|NCT02714595|468665488|FG001|Overall Study|Lost to Follow-up|0|||
130193045|NCT02714595|468665487|FG000|Overall Study|Withdrawal by Subject|1|||
130193046|NCT02714595|468665488|FG001|Overall Study|Withdrawal by Subject|2|||
130193047|NCT02714595|468665487|FG000|Overall Study|Lack of Efficacy|0|||
130193048|NCT02714595|468665488|FG001|Overall Study|Lack of Efficacy|1|||
130193049|NCT02714595|468665487|FG000|Overall Study|Death|30|||
130193050|NCT02714595|468665488|FG001|Overall Study|Death|9|||
130193051|NCT02714595|468665487|FG000|Overall Study|Other-Miscellaneous|0|||
130193052|NCT02714595|468665488|FG001|Overall Study|Other-Miscellaneous|1|||
130193053|NCT02411396|468665489|FG000|Overall Study|Lost to Follow-up|31|||
130193054|NCT02411396|468665489|FG000|Overall Study|Death|10|||
130193055|NCT02423343|468665490|FG000|Overall Study|Withdrawal by Subject|0|||
130193056|NCT02423343|468665491|FG001|Overall Study|Withdrawal by Subject|1|||
130193057|NCT02423343|468665492|FG002|Overall Study|Withdrawal by Subject|0|||
130193058|NCT02423343|468665493|FG003|Overall Study|Withdrawal by Subject|0|||
130193059|NCT02423343|468665494|FG004|Overall Study|Withdrawal by Subject|0|||
130193060|NCT02423343|468665495|FG005|Overall Study|Withdrawal by Subject|0|||
130193061|NCT02423343|468665490|FG000|Overall Study|Progressive Disease|0|||
130193062|NCT02423343|468665491|FG001|Overall Study|Progressive Disease|0|||
130193063|NCT02423343|468665492|FG002|Overall Study|Progressive Disease|0|||
130193064|NCT02423343|468665493|FG003|Overall Study|Progressive Disease|0|||
130193065|NCT02423343|468665494|FG004|Overall Study|Progressive Disease|2|||
130193066|NCT02423343|468665495|FG005|Overall Study|Progressive Disease|0|||
130193067|NCT02423343|468665490|FG000|Overall Study|Adverse Event|0|||
130193068|NCT02423343|468665491|FG001|Overall Study|Adverse Event|0|||
130193069|NCT02423343|468665492|FG002|Overall Study|Adverse Event|0|||
130193070|NCT02423343|468665493|FG003|Overall Study|Adverse Event|0|||
130193071|NCT02423343|468665494|FG004|Overall Study|Adverse Event|2|||
130193072|NCT02423343|468665495|FG005|Overall Study|Adverse Event|0|||
130193073|NCT02423343|468665490|FG000|Overall Study|Death|0|||
130193074|NCT02423343|468665491|FG001|Overall Study|Death|0|||
130193075|NCT02423343|468665492|FG002|Overall Study|Death|0|||
130193076|NCT02423343|468665493|FG003|Overall Study|Death|0|||
130193077|NCT02423343|468665494|FG004|Overall Study|Death|1|||
130193078|NCT02423343|468665495|FG005|Overall Study|Death|0|||
130193079|NCT02865499|468665496|FG000|Baseline|Adverse Event|1|||
130193080|NCT02865499|468665496|FG000|Baseline|Withdrawal by Subject|1|||
130193081|NCT01860040|468665502|FG000|Overall Study|Withdrawal by Subject|1|||
130193082|NCT01860040|468665503|FG001|Overall Study|Withdrawal by Subject|0|||
130193083|NCT01931995|468665504|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
130193084|NCT01931995|468665505|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
130193085|NCT01931995|468665504|FG000|First Intervention (1 Day)|Physician Decision|1|||
130193086|NCT01931995|468665505|FG001|First Intervention (1 Day)|Physician Decision|1|||
130193087|NCT01931995|468665504|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
130193088|NCT01931995|468665505|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
130193089|NCT00014495|468665506|FG000|Overall Study|Death|0|||
130193090|NCT00014495|468665507|FG001|Overall Study|Death|0|||
130193091|NCT00014495|468665508|FG002|Overall Study|Death|1|||
130193092|NCT00014495|468665509|FG003|Overall Study|Death|0|||
130193093|NCT00014495|468665506|FG000|Overall Study|Clinical deterioration|0|||
130193094|NCT00014495|468665507|FG001|Overall Study|Clinical deterioration|0|||
130193095|NCT00014495|468665508|FG002|Overall Study|Clinical deterioration|0|||
130193096|NCT00014495|468665509|FG003|Overall Study|Clinical deterioration|1|||
130193097|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
130193098|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
130193099|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
130193100|NCT00403481|468665511|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
130193101|NCT00403481|468665511|FG000|Olm 40 mg|Adverse Event|2|||
130193102|NCT00403481|468665511|FG000|Olm 40 mg|Protocol Violation|1|||
130193103|NCT00403481|468665511|FG000|Olm 40 mg|Withdrawal by Subject|1|||
130193104|NCT00403481|468665511|FG000|Olm 40 mg|Other|1|||
130193105|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
130193106|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
130193107|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
130193108|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
130193109|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
130193110|NCT00403481|468665511|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
130193111|NCT02099110|468665519|FG000|Overall Study|Protocol Violation|2|||
130193112|NCT02099110|468665520|FG001|Overall Study|Protocol Violation|1|||
130193113|NCT02099110|468665521|FG002|Overall Study|Protocol Violation|0|||
130193114|NCT02099110|468665522|FG003|Overall Study|Protocol Violation|3|||
130193115|NCT02099110|468665523|FG004|Overall Study|Protocol Violation|1|||
130193116|NCT02099110|468665519|FG000|Overall Study|Participant moved|1|||
130193117|NCT02099110|468665520|FG001|Overall Study|Participant moved|1|||
130193118|NCT02099110|468665521|FG002|Overall Study|Participant moved|1|||
130193119|NCT02099110|468665522|FG003|Overall Study|Participant moved|0|||
130193120|NCT02099110|468665523|FG004|Overall Study|Participant moved|2|||
130193121|NCT02099110|468665519|FG000|Overall Study|Withdrawal by Subject|7|||
130193122|NCT02099110|468665520|FG001|Overall Study|Withdrawal by Subject|11|||
130193123|NCT02099110|468665521|FG002|Overall Study|Withdrawal by Subject|13|||
130193124|NCT02099110|468665522|FG003|Overall Study|Withdrawal by Subject|9|||
130193125|NCT02099110|468665523|FG004|Overall Study|Withdrawal by Subject|13|||
130193126|NCT02099110|468665519|FG000|Overall Study|Adverse Event|3|||
130193127|NCT02099110|468665520|FG001|Overall Study|Adverse Event|5|||
130193128|NCT02099110|468665521|FG002|Overall Study|Adverse Event|2|||
130193129|NCT02099110|468665522|FG003|Overall Study|Adverse Event|3|||
130193130|NCT02099110|468665523|FG004|Overall Study|Adverse Event|2|||
130193131|NCT02099110|468665519|FG000|Overall Study|Lost to Follow-up|6|||
130193132|NCT02099110|468665520|FG001|Overall Study|Lost to Follow-up|12|||
130193133|NCT02099110|468665521|FG002|Overall Study|Lost to Follow-up|11|||
130193134|NCT02099110|468665522|FG003|Overall Study|Lost to Follow-up|5|||
130193135|NCT02099110|468665523|FG004|Overall Study|Lost to Follow-up|6|||
130193136|NCT02099110|468665519|FG000|Overall Study|Death|0|||
130193137|NCT02099110|468665520|FG001|Overall Study|Death|1|||
130193138|NCT02099110|468665521|FG002|Overall Study|Death|0|||
130193139|NCT02099110|468665522|FG003|Overall Study|Death|0|||
130193140|NCT02099110|468665523|FG004|Overall Study|Death|0|||
130193141|NCT02099110|468665519|FG000|Overall Study|Screen failure|0|||
130193142|NCT02099110|468665520|FG001|Overall Study|Screen failure|0|||
130193143|NCT02099110|468665521|FG002|Overall Study|Screen failure|0|||
130193144|NCT02099110|468665522|FG003|Overall Study|Screen failure|0|||
130193145|NCT02099110|468665523|FG004|Overall Study|Screen failure|1|||
130193146|NCT02099110|468665519|FG000|Overall Study|Non-compliance with study drug|2|||
130193147|NCT02099110|468665520|FG001|Overall Study|Non-compliance with study drug|0|||
130193148|NCT02099110|468665521|FG002|Overall Study|Non-compliance with study drug|0|||
130193149|NCT02099110|468665522|FG003|Overall Study|Non-compliance with study drug|0|||
130193150|NCT02099110|468665523|FG004|Overall Study|Non-compliance with study drug|1|||
130193151|NCT02099110|468665519|FG000|Overall Study|Physician Decision|3|||
130193152|NCT02099110|468665520|FG001|Overall Study|Physician Decision|0|||
130193153|NCT02099110|468665521|FG002|Overall Study|Physician Decision|1|||
130193154|NCT02099110|468665522|FG003|Overall Study|Physician Decision|2|||
130193155|NCT02099110|468665523|FG004|Overall Study|Physician Decision|1|||
130193156|NCT02064816|468665524|FG000|Overall Study|Adverse Event|3|||
130193157|NCT02064816|468665525|FG001|Overall Study|Adverse Event|2|||
130193158|NCT02064816|468665524|FG000|Overall Study|Withdrawal by Subject|2|||
130193159|NCT02064816|468665525|FG001|Overall Study|Withdrawal by Subject|1|||
130193160|NCT02064816|468665524|FG000|Overall Study|Lost to Follow-up|2|||
130193161|NCT02064816|468665525|FG001|Overall Study|Lost to Follow-up|1|||
130193162|NCT02064816|468665524|FG000|Overall Study|Therapeutic failure|0|||
130193163|NCT02064816|468665525|FG001|Overall Study|Therapeutic failure|1|||
130193164|NCT02064816|468665524|FG000|Overall Study|Other|1|||
130193165|NCT02064816|468665525|FG001|Overall Study|Other|3|||
130193166|NCT01732458|468665530|FG000|Overall Study|Lost to Follow-up|0|||
130193167|NCT01732458|468665531|FG001|Overall Study|Lost to Follow-up|2|||
130193168|NCT01732458|468665532|FG002|Overall Study|Lost to Follow-up|0|||
130193169|NCT01732458|468665533|FG003|Overall Study|Lost to Follow-up|0|||
130193170|NCT01732458|468665530|FG000|Overall Study|Non-Compliance With Study Drug|0|||
130193171|NCT01732458|468665531|FG001|Overall Study|Non-Compliance With Study Drug|0|||
130193172|NCT01732458|468665532|FG002|Overall Study|Non-Compliance With Study Drug|1|||
130193173|NCT01732458|468665533|FG003|Overall Study|Non-Compliance With Study Drug|0|||
130193174|NCT01732458|468665530|FG000|Overall Study|Physician Decision|1|||
130193175|NCT01732458|468665531|FG001|Overall Study|Physician Decision|2|||
130193176|NCT01732458|468665532|FG002|Overall Study|Physician Decision|2|||
130193177|NCT01732458|468665533|FG003|Overall Study|Physician Decision|0|||
130193178|NCT01732458|468665530|FG000|Overall Study|Protocol Violation|2|||
130193179|NCT01732458|468665531|FG001|Overall Study|Protocol Violation|0|||
130193180|NCT01732458|468665532|FG002|Overall Study|Protocol Violation|0|||
130193181|NCT01732458|468665533|FG003|Overall Study|Protocol Violation|2|||
130193182|NCT01732458|468665530|FG000|Overall Study|Screen Failure|0|||
130193183|NCT01732458|468665531|FG001|Overall Study|Screen Failure|1|||
130193184|NCT01732458|468665532|FG002|Overall Study|Screen Failure|0|||
130193185|NCT01732458|468665533|FG003|Overall Study|Screen Failure|0|||
130193186|NCT00994461|468665534|FG000|Overall Study|Adverse Event|2|||
130193187|NCT00994461|468665535|FG001|Overall Study|Adverse Event|1|||
130193188|NCT00994461|468665536|FG002|Overall Study|Adverse Event|0|||
130193189|NCT02887248|468665542|FG000|Overall Study|Withdrawal by Subject|1|||
130193190|NCT02887248|468665542|FG000|Overall Study|Adverse Event|1|||
130193191|NCT02887248|468665542|FG000|Overall Study|Progressive Disease|1|||
130193192|NCT03759587|468665543|FG000|Overall Study|Adverse Event|5|||
130193193|NCT03759587|468665543|FG000|Overall Study|Progressive Disease|10|||
130193194|NCT03759587|468665543|FG000|Overall Study|Site Terminated by Sponsor|3|||
130193195|NCT03759587|468665543|FG000|Overall Study|Withdrawal by Subject|1|||
130193196|NCT00454363|468665546|FG000|Overall Study|Adverse Event|1|||
130193197|NCT00454363|468665547|FG001|Overall Study|Adverse Event|2|||
130193198|NCT00454363|468665546|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
130193199|NCT00454363|468665547|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
130193200|NCT00570063|468665548|FG000|Overall Study|Adverse Event|4|||
130193201|NCT00570063|468665549|FG001|Overall Study|Adverse Event|1|||
130193202|NCT00570063|468665548|FG000|Overall Study|Lack of Efficacy|0|||
130193203|NCT00570063|468665549|FG001|Overall Study|Lack of Efficacy|1|||
130193204|NCT00570063|468665548|FG000|Overall Study|Withdrawal by Subject|4|||
130193205|NCT00570063|468665549|FG001|Overall Study|Withdrawal by Subject|3|||
130193206|NCT00570063|468665548|FG000|Overall Study|Sponsor's Decision|7|||
130193207|NCT00570063|468665549|FG001|Overall Study|Sponsor's Decision|3|||
130193208|NCT00697463|468665550|FG000|Overall Study|Withdrawal by Subject|1|||
130193209|NCT03307252|468665551|FG000|Part 2, Period 1|Treatment not received|0|||
130193210|NCT03307252|468665552|FG001|Part 2, Period 1|Treatment not received|0|||
130193211|NCT03307252|468665553|FG002|Part 2, Period 1|Treatment not received|0|||
130193212|NCT03307252|468665554|FG003|Part 2, Period 1|Treatment not received|0|||
130193213|NCT03307252|468665555|FG004|Part 2, Period 1|Treatment not received|0|||
130193214|NCT03307252|468665556|FG005|Part 2, Period 1|Treatment not received|1|||
130193215|NCT03307252|468665557|FG006|Part 2, Period 1|Treatment not received|0|||
130193216|NCT03307252|468665558|FG007|Part 2, Period 1|Treatment not received|0|||
130193217|NCT03307252|468665559|FG008|Part 2, Period 1|Treatment not received|0|||
130193218|NCT03307252|468665560|FG009|Part 2, Period 1|Treatment not received|0|||
130193219|NCT03307252|468665561|FG010|Part 2, Period 1|Treatment not received|0|||
130193220|NCT03307252|468665551|FG000|Part 2, Period 3|Other than listed|0|||
130193221|NCT03307252|468665552|FG001|Part 2, Period 3|Other than listed|0|||
130193222|NCT03307252|468665553|FG002|Part 2, Period 3|Other than listed|0|||
130193223|NCT03307252|468665554|FG003|Part 2, Period 3|Other than listed|0|||
130193224|NCT03307252|468665555|FG004|Part 2, Period 3|Other than listed|1|||
130193225|NCT03307252|468665556|FG005|Part 2, Period 3|Other than listed|0|||
130193226|NCT03307252|468665557|FG006|Part 2, Period 3|Other than listed|0|||
130193227|NCT03307252|468665558|FG007|Part 2, Period 3|Other than listed|0|||
130193228|NCT03307252|468665559|FG008|Part 2, Period 3|Other than listed|0|||
130193229|NCT03307252|468665560|FG009|Part 2, Period 3|Other than listed|0|||
130193230|NCT03307252|468665561|FG010|Part 2, Period 3|Other than listed|0|||
130193231|NCT03307252|468665551|FG000|Part 2, Period 4|Other than listed|0|||
130193232|NCT03307252|468665552|FG001|Part 2, Period 4|Other than listed|0|||
130193233|NCT03307252|468665553|FG002|Part 2, Period 4|Other than listed|0|||
130193234|NCT03307252|468665554|FG003|Part 2, Period 4|Other than listed|0|||
130193235|NCT03307252|468665555|FG004|Part 2, Period 4|Other than listed|0|||
130193236|NCT03307252|468665556|FG005|Part 2, Period 4|Other than listed|0|||
130193237|NCT03307252|468665557|FG006|Part 2, Period 4|Other than listed|1|||
130193238|NCT03307252|468665558|FG007|Part 2, Period 4|Other than listed|0|||
130193239|NCT03307252|468665559|FG008|Part 2, Period 4|Other than listed|0|||
130193240|NCT03307252|468665560|FG009|Part 2, Period 4|Other than listed|0|||
130193241|NCT03307252|468665561|FG010|Part 2, Period 4|Other than listed|0|||
130193242|NCT03307252|468665551|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193243|NCT03307252|468665552|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193244|NCT03307252|468665553|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193245|NCT03307252|468665554|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193246|NCT03307252|468665555|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193247|NCT03307252|468665556|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193248|NCT03307252|468665557|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193249|NCT03307252|468665558|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193250|NCT03307252|468665559|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193251|NCT03307252|468665560|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
130193252|NCT03307252|468665561|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
130193253|NCT03482453|468665562|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193254|NCT03482453|468665563|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193255|NCT03482453|468665564|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193256|NCT03482453|468665565|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193257|NCT03482453|468665566|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193258|NCT03482453|468665567|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193259|NCT03482453|468665568|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193260|NCT03482453|468665569|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193261|NCT03482453|468665570|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193262|NCT03482453|468665571|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193263|NCT03482453|468665572|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
130193264|NCT03482453|468665573|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
130193265|NCT02568189|468665574|FG000|Overall Study|Protocol Violation|0|||
130193266|NCT02568189|468665575|FG001|Overall Study|Protocol Violation|0|||
130193267|NCT02568189|468665576|FG002|Overall Study|Protocol Violation|19|||
130193268|NCT02568189|468665577|FG003|Overall Study|Protocol Violation|18|||
130193269|NCT02157376|468665578|FG000|Overall Study|Death|10|||
130193270|NCT02157376|468665579|FG001|Overall Study|Death|4|||
130193271|NCT02157376|468665578|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130193272|NCT02157376|468665579|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
130193273|NCT02157376|468665578|FG000|Overall Study|Withdrawal by Subject|3|||
130193274|NCT02157376|468665579|FG001|Overall Study|Withdrawal by Subject|8|||
130193275|NCT02157376|468665578|FG000|Overall Study|Not treated|8|||
130193276|NCT02157376|468665579|FG001|Overall Study|Not treated|3|||
130193277|NCT02157376|468665578|FG000|Overall Study|Investigator's misjudgement|1|||
130193278|NCT02157376|468665579|FG001|Overall Study|Investigator's misjudgement|2|||
130193279|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
130193280|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
130193281|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
130193282|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
130193283|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
130193284|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
130193285|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
130193286|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
130193287|NCT01074268|468665580|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
130193288|NCT01074268|468665581|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
130193289|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
130193290|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
130193291|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
130193292|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
130193293|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
130193294|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
130193295|NCT01074268|468665580|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
130193296|NCT01074268|468665581|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
130193297|NCT01578239|468665584|FG000|Treatment Period|Progressive Disease|19|||
130193298|NCT01578239|468665585|FG001|Treatment Period|Progressive Disease|64|||
130193299|NCT01578239|468665584|FG000|Treatment Period|Physician Decision|17|||
130193300|NCT01578239|468665585|FG001|Treatment Period|Physician Decision|17|||
130193301|NCT01578239|468665584|FG000|Treatment Period|Adverse Event|13|||
130193302|NCT01578239|468665585|FG001|Treatment Period|Adverse Event|10|||
130193303|NCT01578239|468665584|FG000|Treatment Period|Non-compliance|2|||
130193304|NCT01578239|468665585|FG001|Treatment Period|Non-compliance|0|||
130193305|NCT01578239|468665584|FG000|Treatment Period|Withdrawal by Subject|10|||
130193306|NCT01578239|468665585|FG001|Treatment Period|Withdrawal by Subject|9|||
130193307|NCT01578239|468665584|FG000|Treatment Period|Other|6|||
130193308|NCT01578239|468665585|FG001|Treatment Period|Other|1|||
130193309|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Death|69|||
130193310|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Death|64|||
130193311|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
130193312|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
130193313|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
130193314|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
130193315|NCT01578239|468665584|FG000|Long-term Follow-Up Period|Other|2|||
130193316|NCT01578239|468665585|FG001|Long-term Follow-Up Period|Other|2|||
130193317|NCT02347813|468665589|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
130193318|NCT02347813|468665590|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
130193319|NCT02347813|468665589|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
130193320|NCT02347813|468665590|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
130193321|NCT02837731|468665595|FG000|Allocation|Admitted to General Floor|3|||
130193322|NCT02837731|468665596|FG001|Allocation|Admitted to General Floor|4|||
130193323|NCT02837731|468665595|FG000|Allocation|Immediate surgery/withdrew|2|||
130193324|NCT02837731|468665596|FG001|Allocation|Immediate surgery/withdrew|0|||
130193325|NCT02837731|468665595|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
130193326|NCT02837731|468665596|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
130193327|NCT02837731|468665595|FG000|Allocation|Withdrawal by Subject|2|||
130193328|NCT02837731|468665596|FG001|Allocation|Withdrawal by Subject|0|||
130193329|NCT02837731|468665595|FG000|Allocation|Device not available|1|||
130193330|NCT02837731|468665596|FG001|Allocation|Device not available|0|||
130193331|NCT02837731|468665595|FG000|Allocation|Protocol not implemented|7|||
130193332|NCT02837731|468665596|FG001|Allocation|Protocol not implemented|0|||
130193333|NCT02837731|468665595|FG000|Allocation|Moribund/Do not resuscitate|2|||
130193334|NCT02837731|468665596|FG001|Allocation|Moribund/Do not resuscitate|0|||
130193335|NCT02837731|468665595|FG000|Allocation|Did not meet sepsis criteria|1|||
130193336|NCT02837731|468665596|FG001|Allocation|Did not meet sepsis criteria|2|||
130193337|NCT02837731|468665595|FG000|Allocation|Known aortic abnormalities|0|||
130193338|NCT02837731|468665596|FG001|Allocation|Known aortic abnormalities|1|||
130193339|NCT01119859|468665597|FG000|Overall Study|Adverse Event|9|||
130193340|NCT01119859|468665598|FG001|Overall Study|Adverse Event|10|||
130193341|NCT01119859|468665597|FG000|Overall Study|Death|2|||
130193342|NCT01119859|468665598|FG001|Overall Study|Death|0|||
130193343|NCT01119859|468665597|FG000|Overall Study|Insufficient therapeutic response|7|||
130193344|NCT01119859|468665598|FG001|Overall Study|Insufficient therapeutic response|14|||
130193345|NCT01119859|468665597|FG000|Overall Study|Refused treatment|3|||
130193346|NCT01119859|468665598|FG001|Overall Study|Refused treatment|6|||
130193347|NCT01119859|468665597|FG000|Overall Study|Failure to return|3|||
130193348|NCT01119859|468665598|FG001|Overall Study|Failure to return|0|||
130193349|NCT04200651|468665599|FG000|Overall Study|Moved to another country during follow-up|2|||
130193350|NCT04200651|468665600|FG001|Overall Study|Moved to another country during follow-up|2|||
130193351|NCT04200651|468665599|FG000|Overall Study|Lost to Follow-up|1|||
130193352|NCT04200651|468665600|FG001|Overall Study|Lost to Follow-up|3|||
130193353|NCT03225105|468665601|FG000|Overall Study|Withdrawal by Subject|1|||
130193354|NCT03225105|468665602|FG001|Overall Study|Withdrawal by Subject|0|||
130193355|NCT03225105|468665603|FG002|Overall Study|Withdrawal by Subject|0|||
130193356|NCT03225105|468665604|FG003|Overall Study|Withdrawal by Subject|0|||
130193357|NCT03225105|468665601|FG000|Overall Study|Death|0|||
130193358|NCT03225105|468665602|FG001|Overall Study|Death|4|||
130193359|NCT03225105|468665603|FG002|Overall Study|Death|2|||
130193360|NCT03225105|468665604|FG003|Overall Study|Death|0|||
130193361|NCT03225105|468665601|FG000|Overall Study|Study termination per Sponsor Decision|2|||
130193362|NCT03225105|468665602|FG001|Overall Study|Study termination per Sponsor Decision|0|||
130193363|NCT03225105|468665603|FG002|Overall Study|Study termination per Sponsor Decision|3|||
130193364|NCT03225105|468665604|FG003|Overall Study|Study termination per Sponsor Decision|3|||
130193365|NCT02887183|468665606|FG000|Overall Study|Adverse Event|44|||
130193366|NCT02887183|468665606|FG000|Overall Study|Death|30|||
130193367|NCT02887183|468665606|FG000|Overall Study|Pregnancy|1|||
130193368|NCT02887183|468665606|FG000|Overall Study|Protocol Violation|6|||
130193369|NCT02887183|468665606|FG000|Overall Study|Technical Problems|2|||
130193370|NCT02887183|468665606|FG000|Overall Study|Lost to Follow-up|13|||
130193371|NCT02887183|468665606|FG000|Overall Study|Physician Decision|10|||
130193372|NCT02887183|468665606|FG000|Overall Study|Withdrawal by Subject|35|||
130193373|NCT01031680|468665607|FG000|Overall Study|Adverse Event|8|||
130193374|NCT01031680|468665608|FG001|Overall Study|Adverse Event|3|||
130193375|NCT01031680|468665607|FG000|Overall Study|Lost to Follow-up|2|||
130193376|NCT01031680|468665608|FG001|Overall Study|Lost to Follow-up|10|||
130193377|NCT01031680|468665607|FG000|Overall Study|Withdrawal by Subject|12|||
130193378|NCT01031680|468665608|FG001|Overall Study|Withdrawal by Subject|16|||
130193379|NCT01031680|468665607|FG000|Overall Study|Death|2|||
130193380|NCT01031680|468665608|FG001|Overall Study|Death|1|||
130193381|NCT01031680|468665607|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
130193382|NCT01031680|468665608|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
130193383|NCT01031680|468665607|FG000|Overall Study|Poor/Non-compliance|5|||
130193384|NCT01031680|468665608|FG001|Overall Study|Poor/Non-compliance|6|||
130193385|NCT01031680|468665607|FG000|Overall Study|Safety|1|||
130193386|NCT01031680|468665608|FG001|Overall Study|Safety|0|||
130193387|NCT01031680|468665607|FG000|Overall Study|Incorrect Enrolment|1|||
130193388|NCT01031680|468665608|FG001|Overall Study|Incorrect Enrolment|2|||
130193389|NCT01031680|468665607|FG000|Overall Study|Administrative Reason by Sponsor|0|||
130193390|NCT01031680|468665608|FG001|Overall Study|Administrative Reason by Sponsor|1|||
130193391|NCT01031680|468665607|FG000|Overall Study|Various|0|||
130193392|NCT01031680|468665608|FG001|Overall Study|Various|2|||
130193393|NCT02654977|468665615|FG000|Overall Study|Death|1|||
130193394|NCT02654977|468665615|FG000|Overall Study|Lost to Follow-up|1|||
130193395|NCT02654977|468665615|FG000|Overall Study|Adverse Event|1|||
130193396|NCT02654977|468665615|FG000|Overall Study|Withdrawal by Subject|1|||
130193397|NCT02654977|468665615|FG000|Overall Study|Lack of Efficacy|3|||
130193398|NCT01921101|468665616|FG000|Overall Study|Death|16|||
130193399|NCT01921101|468665617|FG001|Overall Study|Death|6|||
130193400|NCT01483027|468665618|FG000|Overall Study|Administrative Reasons|2|||
130193401|NCT01483027|468665619|FG001|Overall Study|Administrative Reasons|1|||
130193402|NCT01483027|468665618|FG000|Overall Study|Withdrawal by Subject|21|||
130193403|NCT01483027|468665619|FG001|Overall Study|Withdrawal by Subject|32|||
130193404|NCT01483027|468665618|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
130193405|NCT01483027|468665619|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
130193406|NCT01483027|468665618|FG000|Overall Study|Lost to Follow-up|1|||
130193407|NCT01483027|468665619|FG001|Overall Study|Lost to Follow-up|1|||
130193408|NCT01483027|468665618|FG000|Overall Study|Adverse Event|0|||
130193409|NCT01483027|468665619|FG001|Overall Study|Adverse Event|1|||
130193410|NCT01483027|468665618|FG000|Overall Study|Withdrawal by Subject|0|||
130193411|NCT01483027|468665619|FG001|Overall Study|Withdrawal by Subject|1|||
130193412|NCT03691207|468666838|FG000|Overall Study|Death|41|||
130193413|NCT03691207|468666839|FG001|Overall Study|Death|26|||
130193414|NCT03691207|468666838|FG000|Overall Study|Lost to Follow-up|1|||
130193415|NCT03691207|468666839|FG001|Overall Study|Lost to Follow-up|1|||
130193416|NCT03691207|468666838|FG000|Overall Study|Withdrawal by Subject|2|||
130193417|NCT03691207|468666839|FG001|Overall Study|Withdrawal by Subject|8|||
130193418|NCT03691207|468666838|FG000|Overall Study|Sponsor decision|1|||
130193419|NCT03691207|468666839|FG001|Overall Study|Sponsor decision|7|||
130193420|NCT01288937|468666842|FG000|Overall Study|Adverse Event|1|||
130193421|NCT01288937|468666843|FG001|Overall Study|Adverse Event|0|||
130193422|NCT02490371|468666844|FG000|Overall Study|Lost to Follow-up|1|||
130193423|NCT02490371|468666845|FG001|Overall Study|Lost to Follow-up|1|||
130193424|NCT00610155|468666846|FG000|Period 1|Withdrawal by Subject|0|||
130193425|NCT00610155|468666847|FG001|Period 1|Withdrawal by Subject|0|||
130193426|NCT00610155|468666848|FG002|Period 1|Withdrawal by Subject|1|||
130193427|NCT00610155|468666849|FG003|Period 1|Withdrawal by Subject|0|||
130193428|NCT00610155|468666850|FG004|Period 1|Withdrawal by Subject|0|||
130193429|NCT00610155|468666851|FG005|Period 1|Withdrawal by Subject|0|||
130193430|NCT00610155|468666846|FG000|Period 3|Adverse Event|1|||
130193431|NCT00610155|468666847|FG001|Period 3|Adverse Event|0|||
130193432|NCT00610155|468666848|FG002|Period 3|Adverse Event|0|||
130193433|NCT00610155|468666849|FG003|Period 3|Adverse Event|0|||
130193434|NCT00610155|468666850|FG004|Period 3|Adverse Event|0|||
130193435|NCT00610155|468666851|FG005|Period 3|Adverse Event|0|||
130193436|NCT01718535|468666852|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
130193437|NCT01718535|468666853|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
130193438|NCT01718535|468666854|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
130193439|NCT01718535|468666855|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
130193440|NCT01718535|468666856|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
130193441|NCT01718535|468666857|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
130193442|NCT01718535|468666858|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
130193443|NCT01718535|468666859|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
130193444|NCT01718535|468666860|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
130193445|NCT01718535|468666861|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
130193446|NCT03018080|468666867|FG000|Overall Study|Death|12|||
130193447|NCT03018080|468666868|FG001|Overall Study|Death|19|||
130193448|NCT00740792|468666869|FG000|Overall Study|Adverse Event|3|||
130193449|NCT00740792|468666870|FG001|Overall Study|Adverse Event|1|||
130193450|NCT00740792|468666871|FG002|Overall Study|Adverse Event|1|||
130193451|NCT00740792|468666872|FG003|Overall Study|Adverse Event|3|||
130193452|NCT00740792|468666869|FG000|Overall Study|Lack of Efficacy|1|||
130193453|NCT00740792|468666870|FG001|Overall Study|Lack of Efficacy|1|||
130193454|NCT00740792|468666871|FG002|Overall Study|Lack of Efficacy|0|||
130193455|NCT00740792|468666872|FG003|Overall Study|Lack of Efficacy|3|||
130193456|NCT00740792|468666869|FG000|Overall Study|Lost to Follow-up|2|||
130193457|NCT00740792|468666870|FG001|Overall Study|Lost to Follow-up|1|||
130193458|NCT00740792|468666871|FG002|Overall Study|Lost to Follow-up|0|||
130193459|NCT00740792|468666872|FG003|Overall Study|Lost to Follow-up|0|||
130193460|NCT00740792|468666869|FG000|Overall Study|Protocol Violation|0|||
130193461|NCT00740792|468666870|FG001|Overall Study|Protocol Violation|1|||
130193462|NCT00740792|468666871|FG002|Overall Study|Protocol Violation|0|||
130193463|NCT00740792|468666872|FG003|Overall Study|Protocol Violation|2|||
130193464|NCT00740792|468666869|FG000|Overall Study|Withdrawal by Subject|1|||
130193465|NCT00740792|468666870|FG001|Overall Study|Withdrawal by Subject|1|||
130193466|NCT00740792|468666871|FG002|Overall Study|Withdrawal by Subject|0|||
130193467|NCT00740792|468666872|FG003|Overall Study|Withdrawal by Subject|0|||
130193468|NCT00740792|468666869|FG000|Overall Study|administrative|3|||
130193469|NCT00740792|468666870|FG001|Overall Study|administrative|3|||
130193470|NCT00740792|468666871|FG002|Overall Study|administrative|8|||
130193471|NCT00740792|468666872|FG003|Overall Study|administrative|2|||
130193472|NCT00179660|468666873|FG000|Overall Study|Adverse Event|7|||
130193473|NCT00179660|468666873|FG000|Overall Study|Lack of therapeutic effect|28|||
130193474|NCT00179660|468666873|FG000|Overall Study|Withdrawal by Subject|2|||
130193475|NCT00179660|468666873|FG000|Overall Study|Lost to Follow-up|1|||
130193476|NCT00179660|468666873|FG000|Overall Study|Death|3|||
130193477|NCT00179660|468666873|FG000|Overall Study|Other - Unspecified|9|||
130193478|NCT02035202|468666876|FG000|Overall Study|Lost to Follow-up|8|||
130193479|NCT02035202|468666877|FG001|Overall Study|Lost to Follow-up|16|||
130193480|NCT02035202|468666878|FG002|Overall Study|Lost to Follow-up|2|||
130193481|NCT00178685|468666879|FG000|Overall Study|Death|3|||
130193482|NCT00178685|468666880|FG001|Overall Study|Death|3|||
130193483|NCT00178685|468666881|FG002|Overall Study|Death|6|||
130193484|NCT00178685|468666879|FG000|Overall Study|Lost to Follow-up|100|||
130193485|NCT00178685|468666880|FG001|Overall Study|Lost to Follow-up|187|||
130193486|NCT00178685|468666881|FG002|Overall Study|Lost to Follow-up|183|||
130193487|NCT00178685|468666879|FG000|Overall Study|Withdrawal by Subject|8|||
130193488|NCT00178685|468666880|FG001|Overall Study|Withdrawal by Subject|14|||
130193489|NCT00178685|468666881|FG002|Overall Study|Withdrawal by Subject|7|||
130193490|NCT00267969|468666893|FG000|Controlled Period|Adverse Event|6|||
130193491|NCT00267969|468666894|FG001|Controlled Period|Adverse Event|0|||
130193492|NCT00267969|468666895|FG002|Controlled Period|Adverse Event|2|||
130193493|NCT00267969|468666896|FG003|Controlled Period|Adverse Event|0|||
130193494|NCT00267969|468666897|FG004|Controlled Period|Adverse Event|0|||
130193495|NCT00267969|468666898|FG005|Controlled Period|Adverse Event|0|||
130193496|NCT00267969|468666899|FG006|Controlled Period|Adverse Event|0|||
130193497|NCT00267969|468666893|FG000|Controlled Period|Lack of Efficacy|3|||
130193498|NCT00267969|468666894|FG001|Controlled Period|Lack of Efficacy|0|||
130193499|NCT00267969|468666895|FG002|Controlled Period|Lack of Efficacy|1|||
130193500|NCT00267969|468666896|FG003|Controlled Period|Lack of Efficacy|0|||
130193501|NCT00267969|468666897|FG004|Controlled Period|Lack of Efficacy|0|||
130193502|NCT00267969|468666898|FG005|Controlled Period|Lack of Efficacy|0|||
130193503|NCT00267969|468666899|FG006|Controlled Period|Lack of Efficacy|0|||
130193504|NCT00267969|468666893|FG000|Controlled Period|Lost to Follow-up|1|||
130193505|NCT00267969|468666894|FG001|Controlled Period|Lost to Follow-up|0|||
130193506|NCT00267969|468666895|FG002|Controlled Period|Lost to Follow-up|1|||
130193507|NCT00267969|468666896|FG003|Controlled Period|Lost to Follow-up|0|||
130193508|NCT00267969|468666897|FG004|Controlled Period|Lost to Follow-up|0|||
130193509|NCT00267969|468666898|FG005|Controlled Period|Lost to Follow-up|0|||
130193510|NCT00267969|468666899|FG006|Controlled Period|Lost to Follow-up|0|||
130193511|NCT00267969|468666893|FG000|Controlled Period|Randomized but not treated|0|||
130193512|NCT00267969|468666894|FG001|Controlled Period|Randomized but not treated|0|||
130193513|NCT00267969|468666895|FG002|Controlled Period|Randomized but not treated|1|||
130193514|NCT00267969|468666896|FG003|Controlled Period|Randomized but not treated|0|||
130193515|NCT00267969|468666897|FG004|Controlled Period|Randomized but not treated|0|||
130193516|NCT00267969|468666898|FG005|Controlled Period|Randomized but not treated|0|||
130193517|NCT00267969|468666899|FG006|Controlled Period|Randomized but not treated|0|||
130193518|NCT00267969|468666893|FG000|Controlled Period|Other|2|||
130193519|NCT00267969|468666894|FG001|Controlled Period|Other|1|||
130193520|NCT00267969|468666895|FG002|Controlled Period|Other|6|||
130193521|NCT00267969|468666896|FG003|Controlled Period|Other|0|||
130193522|NCT00267969|468666897|FG004|Controlled Period|Other|0|||
130193523|NCT00267969|468666898|FG005|Controlled Period|Other|0|||
130193524|NCT00267969|468666899|FG006|Controlled Period|Other|0|||
130193525|NCT00267969|468666893|FG000|After Controlled Period|Adverse Event|0|||
130193526|NCT00267969|468666894|FG001|After Controlled Period|Adverse Event|0|||
130193527|NCT00267969|468666895|FG002|After Controlled Period|Adverse Event|0|||
130193528|NCT00267969|468666896|FG003|After Controlled Period|Adverse Event|7|||
130193529|NCT00267969|468666897|FG004|After Controlled Period|Adverse Event|8|||
130193530|NCT00267969|468666898|FG005|After Controlled Period|Adverse Event|23|||
130193531|NCT00267969|468666899|FG006|After Controlled Period|Adverse Event|21|||
130193532|NCT00267969|468666893|FG000|After Controlled Period|Death|0|||
130193533|NCT00267969|468666894|FG001|After Controlled Period|Death|0|||
130193534|NCT00267969|468666895|FG002|After Controlled Period|Death|0|||
130193535|NCT00267969|468666896|FG003|After Controlled Period|Death|1|||
130193536|NCT00267969|468666897|FG004|After Controlled Period|Death|2|||
130193537|NCT00267969|468666898|FG005|After Controlled Period|Death|0|||
130193538|NCT00267969|468666899|FG006|After Controlled Period|Death|1|||
130193539|NCT00267969|468666893|FG000|After Controlled Period|Lack of Efficacy|0|||
130193540|NCT00267969|468666894|FG001|After Controlled Period|Lack of Efficacy|0|||
130193541|NCT00267969|468666895|FG002|After Controlled Period|Lack of Efficacy|0|||
130193542|NCT00267969|468666896|FG003|After Controlled Period|Lack of Efficacy|10|||
130193543|NCT00267969|468666897|FG004|After Controlled Period|Lack of Efficacy|6|||
130193544|NCT00267969|468666898|FG005|After Controlled Period|Lack of Efficacy|28|||
130193545|NCT00267969|468666899|FG006|After Controlled Period|Lack of Efficacy|15|||
130193546|NCT00267969|468666893|FG000|After Controlled Period|Lost to Follow-up|0|||
130193547|NCT00267969|468666894|FG001|After Controlled Period|Lost to Follow-up|0|||
130193548|NCT00267969|468666895|FG002|After Controlled Period|Lost to Follow-up|0|||
130193549|NCT00267969|468666896|FG003|After Controlled Period|Lost to Follow-up|5|||
130193550|NCT00267969|468666897|FG004|After Controlled Period|Lost to Follow-up|8|||
130193551|NCT00267969|468666898|FG005|After Controlled Period|Lost to Follow-up|9|||
130193552|NCT00267969|468666899|FG006|After Controlled Period|Lost to Follow-up|10|||
130193553|NCT00267969|468666893|FG000|After Controlled Period|Other|0|||
130193554|NCT00267969|468666894|FG001|After Controlled Period|Other|0|||
130193555|NCT00267969|468666895|FG002|After Controlled Period|Other|0|||
130193556|NCT00267969|468666896|FG003|After Controlled Period|Other|13|||
130193557|NCT00267969|468666897|FG004|After Controlled Period|Other|11|||
130193558|NCT00267969|468666898|FG005|After Controlled Period|Other|22|||
130193559|NCT00267969|468666899|FG006|After Controlled Period|Other|25|||
130193560|NCT01053663|468666903|FG000|Overall Study|Death|2|||
130193561|NCT01053663|468666903|FG000|Overall Study|Lost to Follow-up|1|||
130193562|NCT01053663|468666903|FG000|Overall Study|Poor IV Access|1|||
130193563|NCT01053663|468666903|FG000|Overall Study|Transferred to Another Hospital|1|||
130193564|NCT01053663|468666903|FG000|Overall Study|Negative Influenza Diagnosis|1|||
130193565|NCT03533114|468666904|FG000|Overall|Adverse Event|16|||
130193566|NCT03533114|468666905|FG001|Overall|Adverse Event|11|||
130193567|NCT03533114|468666904|FG000|Overall|Consent Withdrawal by Participant|7|||
130193568|NCT03533114|468666905|FG001|Overall|Consent Withdrawal by Participant|6|||
130193569|NCT03533114|468666904|FG000|Overall|Lack of Efficacy|5|||
130193570|NCT03533114|468666905|FG001|Overall|Lack of Efficacy|3|||
130193571|NCT03533114|468666904|FG000|Overall|Lost to Follow-up|1|||
130193572|NCT03533114|468666905|FG001|Overall|Lost to Follow-up|1|||
130193573|NCT03533114|468666904|FG000|Overall|Physician Decision|0|||
130193574|NCT03533114|468666905|FG001|Overall|Physician Decision|2|||
130193575|NCT03533114|468666904|FG000|Overall|Protocol deviation|1|||
130193576|NCT03533114|468666905|FG001|Overall|Protocol deviation|1|||
130193577|NCT03533114|468666904|FG000|Overall|Failure to meet randomization criteria|1|||
130193578|NCT03533114|468666905|FG001|Overall|Failure to meet randomization criteria|2|||
130193579|NCT03533114|468666904|FG000|Overall|Non-Compliance with study drug|0|||
130193580|NCT03533114|468666905|FG001|Overall|Non-Compliance with study drug|1|||
130193581|NCT03533114|468666904|FG000|Overall|Other|0|||
130193582|NCT03533114|468666905|FG001|Overall|Other|1|||
130193583|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Adverse Event|11|||
130193584|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Adverse Event|8|||
130193585|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
130193586|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
130193587|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
130193588|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
130193589|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
130193590|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
130193591|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
130193592|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
130193593|NCT03533114|468666904|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
130193594|NCT03533114|468666905|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
130193595|NCT03533114|468666904|FG000|Stable Dose|Adverse Event|0|||
130193596|NCT03533114|468666905|FG001|Stable Dose|Adverse Event|2|||
130193597|NCT03533114|468666904|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
130193598|NCT03533114|468666905|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
130193599|NCT03533114|468666904|FG000|Stable Dose|Lack of Efficacy|1|||
130193600|NCT03533114|468666905|FG001|Stable Dose|Lack of Efficacy|0|||
130193601|NCT03533114|468666904|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
130193602|NCT03533114|468666905|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
130193603|NCT03533114|468666904|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
130193604|NCT03533114|468666905|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
130193605|NCT03533114|468666904|FG000|Open-Label Safety Extension|Adverse Event|3|||
130193606|NCT03533114|468666905|FG001|Open-Label Safety Extension|Adverse Event|0|||
130193607|NCT03533114|468666904|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
130193608|NCT03533114|468666905|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
130193609|NCT03533114|468666904|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
130193610|NCT03533114|468666905|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
130193611|NCT03533114|468666904|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
130193612|NCT03533114|468666905|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
130193613|NCT03533114|468666904|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
130193614|NCT03533114|468666905|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
130193615|NCT01862250|468666906|FG000|Overall Study|Adverse Event|4|||
130193616|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
130193617|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
130193618|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
130193619|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
130193620|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
130193621|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
130193622|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
130193623|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
130193624|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
130193625|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
130193626|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
130193627|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
130193628|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
130193629|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
130193630|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193631|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193632|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193633|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
130193634|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
130193635|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
130193636|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
130193637|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
130193638|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
130193639|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
130193640|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
130193641|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
130193642|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
130193643|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
130193644|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
130193645|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
130193646|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
130193647|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
130193648|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193649|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193650|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193651|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
130193652|NCT02016105|468666907|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
130193653|NCT02016105|468666908|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
130193654|NCT02016105|468666909|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193655|NCT02016105|468666910|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193656|NCT02016105|468666911|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193657|NCT02016105|468666912|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
130193658|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193659|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193660|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193661|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193662|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
130193663|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
130193664|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
130193665|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
130193666|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
130193667|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
130193668|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
130193669|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
130193670|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
130193671|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
130193672|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
130193673|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
130193674|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
130193675|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
130193676|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Death|0|||
130193677|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Death|0|||
130193678|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Death|0|||
130193679|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Death|0|||
130193680|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Death|0|||
130193681|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Death|1|||
130193682|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
130193683|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
130193684|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
130193685|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
130193686|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
130193687|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
130193688|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
130193689|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
130193690|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
130193691|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
130193692|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
130193693|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
130193694|NCT02016105|468666907|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193695|NCT02016105|468666908|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193696|NCT02016105|468666909|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
130193697|NCT02016105|468666910|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193698|NCT02016105|468666911|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
130193699|NCT02016105|468666912|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
130193700|NCT02016105|468666907|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
130193701|NCT02016105|468666908|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
130193702|NCT02016105|468666909|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
130193703|NCT02016105|468666910|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
130193704|NCT02016105|468666911|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
130193705|NCT02016105|468666912|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
130193706|NCT02016105|468666907|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
130193707|NCT02016105|468666908|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
130193708|NCT02016105|468666909|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
130193709|NCT02016105|468666910|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
130193710|NCT02016105|468666911|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
130193711|NCT02016105|468666912|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
130193712|NCT02016105|468666907|FG000|EXTENSION PERIOD|Adverse Event|0|||
130193713|NCT02016105|468666908|FG001|EXTENSION PERIOD|Adverse Event|0|||
130193714|NCT02016105|468666909|FG002|EXTENSION PERIOD|Adverse Event|2|||
130193715|NCT02016105|468666910|FG003|EXTENSION PERIOD|Adverse Event|0|||
130193716|NCT02016105|468666911|FG004|EXTENSION PERIOD|Adverse Event|1|||
130193717|NCT02016105|468666912|FG005|EXTENSION PERIOD|Adverse Event|0|||
130193718|NCT02016105|468666907|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
130193719|NCT02016105|468666908|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
130193720|NCT02016105|468666909|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193721|NCT02016105|468666910|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193722|NCT02016105|468666911|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193723|NCT02016105|468666912|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
130193724|NCT02016105|468666907|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193725|NCT02016105|468666908|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193726|NCT02016105|468666909|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193727|NCT02016105|468666910|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193728|NCT02016105|468666911|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
130193729|NCT02016105|468666912|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
130193730|NCT02016105|468666907|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
130193731|NCT02016105|468666908|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
130193732|NCT02016105|468666909|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
130193733|NCT02016105|468666910|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
130193734|NCT02016105|468666911|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
130193735|NCT02016105|468666912|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
130193736|NCT00900159|468666917|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
130193737|NCT00900159|468666918|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
130193738|NCT01377922|468666925|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
130193739|NCT01377922|468666926|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
130193740|NCT03170362|468666927|FG000|Overall Study|Death|2|||
130193741|NCT03170362|468666928|FG001|Overall Study|Death|2|||
130193742|NCT03170362|468666927|FG000|Overall Study|Withdrawal by Subject|23|||
130193743|NCT03170362|468666928|FG001|Overall Study|Withdrawal by Subject|22|||
130193744|NCT03170362|468666927|FG000|Overall Study|Lost to Follow-up|187|||
130193745|NCT03170362|468666928|FG001|Overall Study|Lost to Follow-up|167|||
130193746|NCT04615403|468666929|FG000|Overall Study|Death|1|||
130193747|NCT03340454|468666930|FG000|Overall Study|Lost to Follow-up|0|||
130193748|NCT03340454|468666931|FG001|Overall Study|Lost to Follow-up|4|||
130193749|NCT03682848|468666932|FG000|Overall Study|Withdrawal by Subject|2|||
130193750|NCT03682848|468666932|FG000|Overall Study|Site closed|5|||
130193751|NCT03682848|468666932|FG000|Overall Study|Protocol Deviation|1|||
130193752|NCT03682848|468666932|FG000|Overall Study|Adverse Event|1|||
130193753|NCT01464164|468666933|FG000|Overall Study|Screen failure|0|||
130193754|NCT01464164|468666934|FG001|Overall Study|Screen failure|1|||
130193755|NCT01464164|468666935|FG002|Overall Study|Screen failure|2|||
130193756|NCT01464164|468666936|FG003|Overall Study|Screen failure|0|||
130193757|NCT01464164|468666937|FG004|Overall Study|Screen failure|0|||
130193758|NCT01464164|468666938|FG005|Overall Study|Screen failure|0|||
130193759|NCT01464164|468666939|FG006|Overall Study|Screen failure|0|||
130193760|NCT01464164|468666933|FG000|Overall Study|Physician Decision|0|||
130193761|NCT01464164|468666934|FG001|Overall Study|Physician Decision|1|||
130193762|NCT01464164|468666935|FG002|Overall Study|Physician Decision|0|||
130193763|NCT01464164|468666936|FG003|Overall Study|Physician Decision|0|||
130193764|NCT01464164|468666937|FG004|Overall Study|Physician Decision|0|||
130193765|NCT01464164|468666938|FG005|Overall Study|Physician Decision|0|||
130193766|NCT01464164|468666939|FG006|Overall Study|Physician Decision|2|||
130193767|NCT00603473|468666940|FG000|Overall Study|Adverse Event|4|||
130193768|NCT00603473|468666940|FG000|Overall Study|Lack of Efficacy|4|||
130193769|NCT00603473|468666940|FG000|Overall Study|Protocol Violation|1|||
130193770|NCT02644668|468666941|FG000|Overall Study|Adverse Event|2|||
130193771|NCT02644668|468666942|FG001|Overall Study|Adverse Event|0|||
130193772|NCT02644668|468666943|FG002|Overall Study|Adverse Event|1|||
130193773|NCT02644668|468666941|FG000|Overall Study|Protocol Violation|0|||
130193774|NCT02644668|468666942|FG001|Overall Study|Protocol Violation|0|||
130193775|NCT02644668|468666943|FG002|Overall Study|Protocol Violation|1|||
130193776|NCT02644668|468666941|FG000|Overall Study|Withdrawal by Subject|0|||
130193777|NCT02644668|468666942|FG001|Overall Study|Withdrawal by Subject|0|||
130193778|NCT02644668|468666943|FG002|Overall Study|Withdrawal by Subject|1|||
130193779|NCT01134939|468666947|FG000|Overall Study|Adverse Event|9|||
130193780|NCT01134939|468666948|FG001|Overall Study|Adverse Event|3|||
130193781|NCT01134939|468666949|FG002|Overall Study|Adverse Event|4|||
130193782|NCT01134939|468666950|FG003|Overall Study|Adverse Event|5|||
130193783|NCT01134939|468666951|FG004|Overall Study|Adverse Event|5|||
130193784|NCT01134939|468666952|FG005|Overall Study|Adverse Event|5|||
130193785|NCT01134939|468666953|FG006|Overall Study|Adverse Event|1|||
130193786|NCT01134939|468666954|FG007|Overall Study|Adverse Event|0|||
130193787|NCT01134939|468666947|FG000|Overall Study|Lack of Efficacy|2|||
130193788|NCT01134939|468666948|FG001|Overall Study|Lack of Efficacy|5|||
130193789|NCT01134939|468666949|FG002|Overall Study|Lack of Efficacy|1|||
130193790|NCT01134939|468666950|FG003|Overall Study|Lack of Efficacy|0|||
130193791|NCT01134939|468666951|FG004|Overall Study|Lack of Efficacy|3|||
130193792|NCT01134939|468666952|FG005|Overall Study|Lack of Efficacy|0|||
130193793|NCT01134939|468666953|FG006|Overall Study|Lack of Efficacy|1|||
130193794|NCT01134939|468666954|FG007|Overall Study|Lack of Efficacy|0|||
130193795|NCT01134939|468666947|FG000|Overall Study|Lost to Follow-up|2|||
130193796|NCT01134939|468666948|FG001|Overall Study|Lost to Follow-up|3|||
130193797|NCT01134939|468666949|FG002|Overall Study|Lost to Follow-up|0|||
130193798|NCT01134939|468666950|FG003|Overall Study|Lost to Follow-up|1|||
130193799|NCT01134939|468666951|FG004|Overall Study|Lost to Follow-up|2|||
130193800|NCT01134939|468666952|FG005|Overall Study|Lost to Follow-up|1|||
130193801|NCT01134939|468666953|FG006|Overall Study|Lost to Follow-up|0|||
130193802|NCT01134939|468666954|FG007|Overall Study|Lost to Follow-up|0|||
130193803|NCT01134939|468666947|FG000|Overall Study|Death|0|||
130193804|NCT01134939|468666948|FG001|Overall Study|Death|1|||
130193805|NCT01134939|468666949|FG002|Overall Study|Death|0|||
130193806|NCT01134939|468666950|FG003|Overall Study|Death|0|||
130193807|NCT01134939|468666951|FG004|Overall Study|Death|0|||
130193808|NCT01134939|468666952|FG005|Overall Study|Death|0|||
130193809|NCT01134939|468666953|FG006|Overall Study|Death|0|||
130193810|NCT01134939|468666954|FG007|Overall Study|Death|0|||
130193811|NCT01134939|468666947|FG000|Overall Study|Termination page not available|4|||
130193812|NCT01134939|468666948|FG001|Overall Study|Termination page not available|6|||
130193813|NCT01134939|468666949|FG002|Overall Study|Termination page not available|5|||
130193814|NCT01134939|468666950|FG003|Overall Study|Termination page not available|8|||
130193815|NCT01134939|468666951|FG004|Overall Study|Termination page not available|0|||
130193816|NCT01134939|468666952|FG005|Overall Study|Termination page not available|3|||
130193817|NCT01134939|468666953|FG006|Overall Study|Termination page not available|7|||
130193818|NCT01134939|468666954|FG007|Overall Study|Termination page not available|0|||
130193819|NCT00733421|468666955|FG000|Overall Study|Withdrawal by Subject|1|||
130193820|NCT00733421|468666956|FG001|Overall Study|Withdrawal by Subject|1|||
130193821|NCT02547220|468666961|FG000|Overall Study|Withdrawal by Subject|1|||
130193822|NCT02547220|468666962|FG001|Overall Study|Withdrawal by Subject|0|||
130193823|NCT02547220|468666961|FG000|Overall Study|Study terminated by sponsor|18|||
130193824|NCT02547220|468666962|FG001|Overall Study|Study terminated by sponsor|20|||
130193825|NCT00550043|468666966|FG000|Overall Study|Adverse Event|0|||
130193826|NCT00550043|468666967|FG001|Overall Study|Adverse Event|0|||
130193827|NCT00550043|468666968|FG002|Overall Study|Adverse Event|0|||
130193828|NCT00550043|468666969|FG003|Overall Study|Adverse Event|1|||
130193829|NCT00550043|468666970|FG004|Overall Study|Adverse Event|1|||
130193830|NCT00550043|468666966|FG000|Overall Study|Subject Withdrew Consent|0|||
130193831|NCT00550043|468666967|FG001|Overall Study|Subject Withdrew Consent|2|||
130193832|NCT00550043|468666968|FG002|Overall Study|Subject Withdrew Consent|1|||
130193833|NCT00550043|468666969|FG003|Overall Study|Subject Withdrew Consent|0|||
130193834|NCT00550043|468666970|FG004|Overall Study|Subject Withdrew Consent|0|||
130193835|NCT00550043|468666966|FG000|Overall Study|Other Reasons- Unspecified|0|||
130193836|NCT00550043|468666967|FG001|Overall Study|Other Reasons- Unspecified|1|||
130193837|NCT00550043|468666968|FG002|Overall Study|Other Reasons- Unspecified|0|||
130193838|NCT00550043|468666969|FG003|Overall Study|Other Reasons- Unspecified|1|||
130193839|NCT00550043|468666970|FG004|Overall Study|Other Reasons- Unspecified|0|||
130193840|NCT04185220|468666971|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
130193841|NCT04185220|468666972|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
130193842|NCT04185220|468666971|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
130193843|NCT04185220|468666972|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
130193844|NCT03478644|468666974|FG000|Phase 2|Withdrawal by Subject|2|||
130193845|NCT03478644|468666975|FG001|Phase 2|Withdrawal by Subject|1|||
130193846|NCT03478644|468666974|FG000|Phase 2|Lost to Follow-up|1|||
130193847|NCT03478644|468666975|FG001|Phase 2|Lost to Follow-up|0|||
130193848|NCT01029782|468666976|FG000|Overall Study|Lost to Follow-up|2|||
130193849|NCT01029782|468666977|FG001|Overall Study|Lost to Follow-up|2|||
130193850|NCT01029782|468666976|FG000|Overall Study|Diagnosis changed|1|||
130193851|NCT01029782|468666977|FG001|Overall Study|Diagnosis changed|1|||
130193852|NCT01029782|468666976|FG000|Overall Study|Adverse Event|0|||
130193853|NCT01029782|468666977|FG001|Overall Study|Adverse Event|1|||
130193854|NCT01029782|468666976|FG000|Overall Study|Physician Decision|0|||
130193855|NCT01029782|468666977|FG001|Overall Study|Physician Decision|1|||
130193856|NCT01029782|468666976|FG000|Overall Study|Protocol Violation|0|||
130193857|NCT01029782|468666977|FG001|Overall Study|Protocol Violation|2|||
130193858|NCT01029782|468666976|FG000|Overall Study|Withdrawal by Subject|0|||
130193859|NCT01029782|468666977|FG001|Overall Study|Withdrawal by Subject|1|||
130193860|NCT02195869|468666979|FG000|Overall Study|cGVHD Progression|5|||
130193861|NCT02195869|468666979|FG000|Overall Study|Malignancy Progression/relapse|2|||
130193862|NCT02195869|468666979|FG000|Overall Study|Adverse Event|15|||
130193863|NCT02195869|468666979|FG000|Overall Study|Withdrawal by Subject|7|||
130193864|NCT02195869|468666979|FG000|Overall Study|Physician Decision|4|||
130193865|NCT02195869|468666979|FG000|Overall Study|Study Terminated by Sponsor|7|||
130193866|NCT02195869|468666979|FG000|Overall Study|Noncompliance with study drug|2|||
130193867|NCT00789698|468666980|FG000|Overall Study|Lack of Efficacy|10|||
130193868|NCT00789698|468666981|FG001|Overall Study|Lack of Efficacy|4|||
130193869|NCT00789698|468666982|FG002|Overall Study|Lack of Efficacy|5|||
130193870|NCT00789698|468666983|FG003|Overall Study|Lack of Efficacy|18|||
130193871|NCT00789698|468666980|FG000|Overall Study|Adverse Event|5|||
130193872|NCT00789698|468666981|FG001|Overall Study|Adverse Event|5|||
130193873|NCT00789698|468666982|FG002|Overall Study|Adverse Event|3|||
130193874|NCT00789698|468666983|FG003|Overall Study|Adverse Event|4|||
130193875|NCT00789698|468666980|FG000|Overall Study|Lost to Follow-up|5|||
130193876|NCT00789698|468666981|FG001|Overall Study|Lost to Follow-up|5|||
130193877|NCT00789698|468666982|FG002|Overall Study|Lost to Follow-up|2|||
130193878|NCT00789698|468666983|FG003|Overall Study|Lost to Follow-up|9|||
130193879|NCT00789698|468666980|FG000|Overall Study|Protocol Violation|6|||
130193880|NCT00789698|468666981|FG001|Overall Study|Protocol Violation|1|||
130193881|NCT00789698|468666982|FG002|Overall Study|Protocol Violation|2|||
130193882|NCT00789698|468666983|FG003|Overall Study|Protocol Violation|1|||
130193883|NCT00789698|468666980|FG000|Overall Study|Withdrawal by Subject|14|||
130193884|NCT00789698|468666981|FG001|Overall Study|Withdrawal by Subject|15|||
130193885|NCT00789698|468666982|FG002|Overall Study|Withdrawal by Subject|12|||
130193886|NCT00789698|468666983|FG003|Overall Study|Withdrawal by Subject|19|||
130193887|NCT00789698|468666980|FG000|Overall Study|Administrative|0|||
130193888|NCT00789698|468666981|FG001|Overall Study|Administrative|3|||
130193889|NCT00789698|468666982|FG002|Overall Study|Administrative|3|||
130193890|NCT00789698|468666983|FG003|Overall Study|Administrative|1|||
130193891|NCT03300505|468668847|FG000|Overall Study|Death|0|||
130193892|NCT03300505|468668848|FG001|Overall Study|Death|1|||
130193893|NCT03300505|468668849|FG002|Overall Study|Death|0|||
130193894|NCT03300505|468668847|FG000|Overall Study|Withdrawal by Subject|0|||
130193895|NCT03300505|468668848|FG001|Overall Study|Withdrawal by Subject|1|||
130193896|NCT03300505|468668849|FG002|Overall Study|Withdrawal by Subject|1|||
130193897|NCT03300505|468668847|FG000|Overall Study|Sponsor Termination|0|||
130193898|NCT03300505|468668848|FG001|Overall Study|Sponsor Termination|1|||
130193899|NCT03300505|468668849|FG002|Overall Study|Sponsor Termination|0|||
130193900|NCT03300505|468668847|FG000|Overall Study|Adverse Event|0|||
130193901|NCT03300505|468668848|FG001|Overall Study|Adverse Event|0|||
130193902|NCT03300505|468668849|FG002|Overall Study|Adverse Event|2|||
130193903|NCT05119595|468668850|FG000|Overall Study|Death|1|||
130193904|NCT05119595|468668850|FG000|Overall Study|Lost to Follow-up|7|||
130193905|NCT03056638|468668853|FG000|Overall Study|Death|1|||
130193906|NCT03056638|468668854|FG001|Overall Study|Death|0|||
130193907|NCT00468481|468668855|FG000|Overall Study|Adverse Event|13|||
130193908|NCT00468481|468668856|FG001|Overall Study|Adverse Event|3|||
130193909|NCT00468481|468668855|FG000|Overall Study|Lost to Follow-up|25|||
130193910|NCT00468481|468668856|FG001|Overall Study|Lost to Follow-up|8|||
130193911|NCT00468481|468668855|FG000|Overall Study|Pregnancy|2|||
130193912|NCT00468481|468668856|FG001|Overall Study|Pregnancy|0|||
130193913|NCT00468481|468668855|FG000|Overall Study|Protocol Violation|18|||
130193914|NCT00468481|468668856|FG001|Overall Study|Protocol Violation|8|||
130193915|NCT00468481|468668855|FG000|Overall Study|Withdrawal by Subject|12|||
130193916|NCT00468481|468668856|FG001|Overall Study|Withdrawal by Subject|3|||
130193917|NCT00468481|468668855|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
130193918|NCT00468481|468668856|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
130193919|NCT00468481|468668855|FG000|Overall Study|Prohibited Medication|1|||
130193920|NCT00468481|468668856|FG001|Overall Study|Prohibited Medication|1|||
130193921|NCT00468481|468668855|FG000|Overall Study|Egg Donor|1|||
130193922|NCT00468481|468668856|FG001|Overall Study|Egg Donor|0|||
130193923|NCT00468481|468668855|FG000|Overall Study|Moved out of area|4|||
130193924|NCT00468481|468668856|FG001|Overall Study|Moved out of area|1|||
130193925|NCT00468481|468668855|FG000|Overall Study|Non-Compliance|5|||
130193926|NCT00468481|468668856|FG001|Overall Study|Non-Compliance|0|||
130193927|NCT00468481|468668855|FG000|Overall Study|Other|6|||
130193928|NCT00468481|468668856|FG001|Overall Study|Other|0|||
130193929|NCT00734162|468668857|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
130193930|NCT00734162|468668858|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
130193931|NCT00734162|468668859|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
130193932|NCT00734162|468668860|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
130193933|NCT00734162|468668857|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130193934|NCT00734162|468668858|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130193935|NCT00734162|468668859|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
130193936|NCT00734162|468668860|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
130193937|NCT00734162|468668857|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
130193938|NCT00734162|468668858|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130193939|NCT00734162|468668859|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130193940|NCT00734162|468668860|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
130193941|NCT00734162|468668857|FG000|Open-Label Phase|Withdrew Consent|1|||
130193942|NCT00734162|468668858|FG001|Open-Label Phase|Withdrew Consent|0|||
130193943|NCT00734162|468668859|FG002|Open-Label Phase|Withdrew Consent|1|||
130193944|NCT00734162|468668860|FG003|Open-Label Phase|Withdrew Consent|1|||
130193945|NCT00734162|468668857|FG000|Open-Label Phase|Lost to Follow-up|1|||
130193946|NCT00734162|468668858|FG001|Open-Label Phase|Lost to Follow-up|2|||
130193947|NCT00734162|468668859|FG002|Open-Label Phase|Lost to Follow-up|0|||
130193948|NCT00734162|468668860|FG003|Open-Label Phase|Lost to Follow-up|1|||
130193949|NCT00734162|468668857|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130193950|NCT00734162|468668858|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130193951|NCT00734162|468668859|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
130193952|NCT00734162|468668860|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
130193953|NCT03831113|468668861|FG000|Overall Study|Withdrawal by Subject|0|||
130193954|NCT03831113|468668862|FG001|Overall Study|Withdrawal by Subject|2|||
130193955|NCT03831113|468668861|FG000|Overall Study|Protocol Violation|0|||
130193956|NCT03831113|468668862|FG001|Overall Study|Protocol Violation|9|||
130193957|NCT03508726|468668863|FG000|Overall Study|Withdrawal by Subject|0|||
130193958|NCT03508726|468668864|FG001|Overall Study|Withdrawal by Subject|1|||
130193959|NCT01515865|468668866|FG000|Part A (Open-label)|Other|3|||
130193960|NCT01515865|468668867|FG001|Part A (Open-label)|Other|0|||
130193961|NCT01515865|468668868|FG002|Part A (Open-label)|Other|0|||
130193962|NCT01515865|468668866|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
130193963|NCT01515865|468668867|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
130193964|NCT01515865|468668868|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
130193965|NCT01515865|468668866|FG000|Part B (Open-label)|Other|1|||
130193966|NCT01515865|468668867|FG001|Part B (Open-label)|Other|0|||
130193967|NCT01515865|468668868|FG002|Part B (Open-label)|Other|0|||
130193968|NCT01073605|468668869|FG000|Overall Study|Ongoing at Cutoff Date|1|||
130193969|NCT01073605|468668870|FG001|Overall Study|Ongoing at Cutoff Date|1|||
130193970|NCT01073605|468668871|FG002|Overall Study|Ongoing at Cutoff Date|0|||
130193971|NCT01073605|468668869|FG000|Overall Study|Adverse Event|2|||
130193972|NCT01073605|468668870|FG001|Overall Study|Adverse Event|1|||
130193973|NCT01073605|468668871|FG002|Overall Study|Adverse Event|0|||
130193974|NCT01073605|468668869|FG000|Overall Study|Lost to Follow-up|3|||
130193975|NCT01073605|468668870|FG001|Overall Study|Lost to Follow-up|4|||
130193976|NCT01073605|468668871|FG002|Overall Study|Lost to Follow-up|9|||
130193977|NCT01073605|468668869|FG000|Overall Study|Other|25|||
130193978|NCT01073605|468668870|FG001|Overall Study|Other|21|||
130193979|NCT01073605|468668871|FG002|Overall Study|Other|29|||
130193980|NCT01073605|468668869|FG000|Overall Study|Withdrawal by Subject|31|||
130193981|NCT01073605|468668870|FG001|Overall Study|Withdrawal by Subject|39|||
130193982|NCT01073605|468668871|FG002|Overall Study|Withdrawal by Subject|22|||
130193983|NCT01073605|468668869|FG000|Overall Study|Randomized But Not Treated|0|||
130193984|NCT01073605|468668870|FG001|Overall Study|Randomized But Not Treated|1|||
130193985|NCT01073605|468668871|FG002|Overall Study|Randomized But Not Treated|1|||
130193986|NCT02875613|468668874|FG000|Overall Study|Withdrawal by Subject|1|||
130193987|NCT02875613|468668874|FG000|Overall Study|Screen Failure|1|||
130193988|NCT02308540|468668876|FG000|Overall Study|Lost to Follow-up|0|||
130193989|NCT02308540|468668877|FG001|Overall Study|Lost to Follow-up|0|||
130193990|NCT02308540|468668878|FG002|Overall Study|Lost to Follow-up|0|||
130193991|NCT02308540|468668879|FG003|Overall Study|Lost to Follow-up|0|||
130193992|NCT02308540|468668880|FG004|Overall Study|Lost to Follow-up|0|||
130193993|NCT02308540|468668881|FG005|Overall Study|Lost to Follow-up|1|||
130193994|NCT02285166|468668882|FG000|Overall Study|Case Report Forms Uncollected|564|||
130193995|NCT02285166|468668882|FG000|Overall Study|Protocol Deviation|402|||
130193996|NCT00443079|468668883|FG000|Overall Study|Lost to Follow-up|0|||
130193997|NCT00443079|468668884|FG001|Overall Study|Lost to Follow-up|1|||
130193998|NCT02649439|468668885|FG000|Overall Study|Switched to alternative treatment|6|||
130193999|NCT02649439|468668886|FG001|Overall Study|Switched to alternative treatment|4|||
130194000|NCT02649439|468668885|FG000|Overall Study|Patient decision|1|||
130194001|NCT02649439|468668886|FG001|Overall Study|Patient decision|0|||
130194002|NCT02649439|468668885|FG000|Overall Study|Patient going out of country|1|||
130194003|NCT02649439|468668886|FG001|Overall Study|Patient going out of country|0|||
130194004|NCT02649439|468668885|FG000|Overall Study|To start finasteride|1|||
130194005|NCT02649439|468668886|FG001|Overall Study|To start finasteride|0|||
130194006|NCT02649439|468668885|FG000|Overall Study|Physician Decision|1|||
130194007|NCT02649439|468668886|FG001|Overall Study|Physician Decision|0|||
130194008|NCT02649439|468668885|FG000|Overall Study|Disease progression on study|12|||
130194009|NCT02649439|468668886|FG001|Overall Study|Disease progression on study|13|||
130194010|NCT02649439|468668885|FG000|Overall Study|Refused further treatment|1|||
130194011|NCT02649439|468668886|FG001|Overall Study|Refused further treatment|0|||
130194012|NCT02649439|468668885|FG000|Overall Study|Refused further follow up|2|||
130194013|NCT02649439|468668886|FG001|Overall Study|Refused further follow up|7|||
130194014|NCT02649439|468668885|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
130194015|NCT02649439|468668886|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
130194016|NCT02649439|468668885|FG000|Overall Study|No treatment, per protocol|1|||
130194017|NCT02649439|468668886|FG001|Overall Study|No treatment, per protocol|0|||
130194018|NCT02649439|468668885|FG000|Overall Study|PSA DT makes ineligible|0|||
130194019|NCT02649439|468668886|FG001|Overall Study|PSA DT makes ineligible|1|||
130194020|NCT02649439|468668885|FG000|Overall Study|Rising PSA No Mets|0|||
130194021|NCT02649439|468668886|FG001|Overall Study|Rising PSA No Mets|1|||
130194022|NCT02649439|468668885|FG000|Overall Study|Rising PSA|0|||
130194023|NCT02649439|468668886|FG001|Overall Study|Rising PSA|1|||
130194024|NCT02649439|468668885|FG000|Overall Study|Signed follow up protocol|0|||
130194025|NCT02649439|468668886|FG001|Overall Study|Signed follow up protocol|1|||
130194026|NCT00090493|468668889|FG000|Overall Study|Physician Decision|2|||
130194027|NCT02071706|468668890|FG000|Overall Study|Adverse Event|1|||
130194028|NCT02071706|468668890|FG000|Overall Study|Withdrawal by Subject|2|||
130194029|NCT01908829|468668896|FG000|Overall Study|Adverse Event|13|||
130194030|NCT01908829|468668897|FG001|Overall Study|Adverse Event|11|||
130194031|NCT01908829|468668898|FG002|Overall Study|Adverse Event|13|||
130194032|NCT01908829|468668896|FG000|Overall Study|Lost to Follow-up|4|||
130194033|NCT01908829|468668897|FG001|Overall Study|Lost to Follow-up|2|||
130194034|NCT01908829|468668898|FG002|Overall Study|Lost to Follow-up|1|||
130194035|NCT01908829|468668896|FG000|Overall Study|Randomized no double-blind drug received|1|||
130194036|NCT01908829|468668897|FG001|Overall Study|Randomized no double-blind drug received|0|||
130194037|NCT01908829|468668898|FG002|Overall Study|Randomized no double-blind drug received|1|||
130194038|NCT01908829|468668896|FG000|Overall Study|Discontinued (no EoT page)|2|||
130194039|NCT01908829|468668897|FG001|Overall Study|Discontinued (no EoT page)|0|||
130194040|NCT01908829|468668898|FG002|Overall Study|Discontinued (no EoT page)|0|||
130194041|NCT01908829|468668896|FG000|Overall Study|Miscellaneous|0|||
130194042|NCT01908829|468668897|FG001|Overall Study|Miscellaneous|2|||
130194043|NCT01908829|468668898|FG002|Overall Study|Miscellaneous|0|||
130194044|NCT01908829|468668896|FG000|Overall Study|Protocol Violation|2|||
130194045|NCT01908829|468668897|FG001|Overall Study|Protocol Violation|2|||
130194046|NCT01908829|468668898|FG002|Overall Study|Protocol Violation|0|||
130194047|NCT01908829|468668896|FG000|Overall Study|Lack of Efficacy|1|||
130194048|NCT01908829|468668897|FG001|Overall Study|Lack of Efficacy|3|||
130194049|NCT01908829|468668898|FG002|Overall Study|Lack of Efficacy|2|||
130194050|NCT01908829|468668896|FG000|Overall Study|Withdrawal by Subject|26|||
130194051|NCT01908829|468668897|FG001|Overall Study|Withdrawal by Subject|29|||
130194052|NCT01908829|468668898|FG002|Overall Study|Withdrawal by Subject|22|||
130194053|NCT02792192|468668899|FG000|Overall Study|Death|1|||
130194054|NCT02792192|468668900|FG001|Overall Study|Death|0|||
130194055|NCT02792192|468668901|FG002|Overall Study|Death|0|||
130194056|NCT02792192|468668902|FG003|Overall Study|Death|0|||
130194057|NCT02792192|468668899|FG000|Overall Study|Informed Consent Withdrawn|4|||
130194058|NCT02792192|468668900|FG001|Overall Study|Informed Consent Withdrawn|0|||
130194059|NCT02792192|468668901|FG002|Overall Study|Informed Consent Withdrawn|0|||
130194060|NCT02792192|468668902|FG003|Overall Study|Informed Consent Withdrawn|0|||
130194061|NCT02792192|468668899|FG000|Overall Study|Physician Decision|1|||
130194062|NCT02792192|468668900|FG001|Overall Study|Physician Decision|0|||
130194063|NCT02792192|468668901|FG002|Overall Study|Physician Decision|0|||
130194064|NCT02792192|468668902|FG003|Overall Study|Physician Decision|0|||
130194065|NCT02792192|468668899|FG000|Overall Study|Progressive Disease|0|||
130194066|NCT02792192|468668900|FG001|Overall Study|Progressive Disease|1|||
130194067|NCT02792192|468668901|FG002|Overall Study|Progressive Disease|0|||
130194068|NCT02792192|468668902|FG003|Overall Study|Progressive Disease|0|||
130194069|NCT02792192|468668899|FG000|Overall Study|Study Terminated By Sponsor|6|||
130194070|NCT02792192|468668900|FG001|Overall Study|Study Terminated By Sponsor|10|||
130194071|NCT02792192|468668901|FG002|Overall Study|Study Terminated By Sponsor|0|||
130194072|NCT02792192|468668902|FG003|Overall Study|Study Terminated By Sponsor|0|||
130194073|NCT02247440|468668903|FG000|Overall Study|Withdrawal by Subject|1|||
130194074|NCT02247440|468668903|FG000|Overall Study|Lack of Efficacy|3|||
130194075|NCT02320058|468668904|FG000|Overall Study|Death|25|||
130194076|NCT02320058|468668905|FG001|Overall Study|Death|10|||
130194077|NCT02320058|468668904|FG000|Overall Study|Lost to Follow-up|4|||
130194078|NCT02320058|468668905|FG001|Overall Study|Lost to Follow-up|0|||
130194079|NCT02320058|468668904|FG000|Overall Study|Other reasons|4|||
130194080|NCT02320058|468668905|FG001|Overall Study|Other reasons|1|||
130194081|NCT02320058|468668904|FG000|Overall Study|Withdrawal by Subject|8|||
130194082|NCT02320058|468668905|FG001|Overall Study|Withdrawal by Subject|2|||
130194083|NCT02320058|468668904|FG000|Overall Study|Not reported|1|||
130194084|NCT02320058|468668905|FG001|Overall Study|Not reported|0|||
130194085|NCT01339923|468668906|FG000|Overall Study|Adverse Event|1|||
130194086|NCT01339923|468668907|FG001|Overall Study|Adverse Event|1|||
130194087|NCT01339923|468668908|FG002|Overall Study|Adverse Event|1|||
130194088|NCT01339923|468668909|FG003|Overall Study|Adverse Event|0|||
130194089|NCT01339923|468668910|FG004|Overall Study|Adverse Event|0|||
130194090|NCT01339923|468668911|FG005|Overall Study|Adverse Event|0|||
130194091|NCT01339923|468668912|FG006|Overall Study|Adverse Event|1|||
130194092|NCT01339923|468668906|FG000|Overall Study|Inappropriate Enrollment|1|||
130194093|NCT01339923|468668907|FG001|Overall Study|Inappropriate Enrollment|0|||
130194094|NCT01339923|468668908|FG002|Overall Study|Inappropriate Enrollment|0|||
130194095|NCT01339923|468668909|FG003|Overall Study|Inappropriate Enrollment|0|||
130194096|NCT01339923|468668910|FG004|Overall Study|Inappropriate Enrollment|0|||
130194097|NCT01339923|468668911|FG005|Overall Study|Inappropriate Enrollment|1|||
130194098|NCT01339923|468668912|FG006|Overall Study|Inappropriate Enrollment|0|||
130194099|NCT01339923|468668906|FG000|Overall Study|Lost to Follow-up|4|||
130194100|NCT01339923|468668907|FG001|Overall Study|Lost to Follow-up|4|||
130194101|NCT01339923|468668908|FG002|Overall Study|Lost to Follow-up|0|||
130194102|NCT01339923|468668909|FG003|Overall Study|Lost to Follow-up|3|||
130194103|NCT01339923|468668910|FG004|Overall Study|Lost to Follow-up|1|||
130194104|NCT01339923|468668911|FG005|Overall Study|Lost to Follow-up|1|||
130194105|NCT01339923|468668912|FG006|Overall Study|Lost to Follow-up|5|||
130194106|NCT01339923|468668906|FG000|Overall Study|Protocol Violation|0|||
130194107|NCT01339923|468668907|FG001|Overall Study|Protocol Violation|0|||
130194108|NCT01339923|468668908|FG002|Overall Study|Protocol Violation|0|||
130194109|NCT01339923|468668909|FG003|Overall Study|Protocol Violation|0|||
130194110|NCT01339923|468668910|FG004|Overall Study|Protocol Violation|0|||
130194111|NCT01339923|468668911|FG005|Overall Study|Protocol Violation|3|||
130194112|NCT01339923|468668912|FG006|Overall Study|Protocol Violation|1|||
130194113|NCT01339923|468668906|FG000|Overall Study|Unable to Classify|1|||
130194114|NCT01339923|468668907|FG001|Overall Study|Unable to Classify|0|||
130194115|NCT01339923|468668908|FG002|Overall Study|Unable to Classify|1|||
130194116|NCT01339923|468668909|FG003|Overall Study|Unable to Classify|0|||
130194117|NCT01339923|468668910|FG004|Overall Study|Unable to Classify|0|||
130194118|NCT01339923|468668911|FG005|Overall Study|Unable to Classify|1|||
130194119|NCT01339923|468668912|FG006|Overall Study|Unable to Classify|5|||
130194120|NCT01339923|468668906|FG000|Overall Study|Withdrawal by Subject|7|||
130194121|NCT01339923|468668907|FG001|Overall Study|Withdrawal by Subject|11|||
130194122|NCT01339923|468668908|FG002|Overall Study|Withdrawal by Subject|6|||
130194123|NCT01339923|468668909|FG003|Overall Study|Withdrawal by Subject|1|||
130194124|NCT01339923|468668910|FG004|Overall Study|Withdrawal by Subject|4|||
130194125|NCT01339923|468668911|FG005|Overall Study|Withdrawal by Subject|3|||
130194126|NCT01339923|468668912|FG006|Overall Study|Withdrawal by Subject|2|||
130194127|NCT00729157|468668913|FG000|Overall Study|Withdrawal by Subject|1|||
130194128|NCT01430403|468668919|FG000|Overall Study|Lost to Follow-up|5|||
130194129|NCT01430403|468668920|FG001|Overall Study|Lost to Follow-up|5|||
130194130|NCT01430403|468668921|FG002|Overall Study|Lost to Follow-up|3|||
130194131|NCT01430403|468668919|FG000|Overall Study|Physician Decision|1|||
130194132|NCT01430403|468668920|FG001|Overall Study|Physician Decision|0|||
130194133|NCT01430403|468668921|FG002|Overall Study|Physician Decision|0|||
130194134|NCT01430403|468668919|FG000|Overall Study|Protocol Violation|2|||
130194135|NCT01430403|468668920|FG001|Overall Study|Protocol Violation|3|||
130194136|NCT01430403|468668921|FG002|Overall Study|Protocol Violation|2|||
130194137|NCT01430403|468668919|FG000|Overall Study|Withdrawal by Subject|9|||
130194138|NCT01430403|468668920|FG001|Overall Study|Withdrawal by Subject|1|||
130194139|NCT01430403|468668921|FG002|Overall Study|Withdrawal by Subject|3|||
130194140|NCT04481789|468668922|FG000|Period 1|Withdrawal by Subject|1|||
130194141|NCT04481789|468668923|FG001|Period 1|Withdrawal by Subject|0|||
130194142|NCT04481789|468668924|FG002|Period 1|Withdrawal by Subject|0|||
130194143|NCT04481789|468668925|FG003|Period 1|Withdrawal by Subject|0|||
130194144|NCT04481789|468668926|FG004|Period 1|Withdrawal by Subject|0|||
130194145|NCT04481789|468668927|FG005|Period 1|Withdrawal by Subject|0|||
130194146|NCT03124407|468668934|FG000|Overall Study|Lost to Follow-up|1|||
130194147|NCT03124407|468668935|FG001|Overall Study|Lost to Follow-up|0|||
130194148|NCT03124407|468668936|FG002|Overall Study|Lost to Follow-up|0|||
130194149|NCT03124407|468668937|FG003|Overall Study|Lost to Follow-up|0|||
130194150|NCT03124407|468668934|FG000|Overall Study|Adverse Event|0|||
130194151|NCT03124407|468668935|FG001|Overall Study|Adverse Event|0|||
130194152|NCT03124407|468668936|FG002|Overall Study|Adverse Event|1|||
130194153|NCT03124407|468668937|FG003|Overall Study|Adverse Event|0|||
130194154|NCT00396656|468668938|FG000|First Treatment Period|Withdrawal by Subject|0|||
130194155|NCT00396656|468668939|FG001|First Treatment Period|Withdrawal by Subject|2|||
130194156|NCT00396656|468668938|FG000|Second Treatment Period|Adverse Event|0|||
130194157|NCT00396656|468668939|FG001|Second Treatment Period|Adverse Event|1|||
130194158|NCT02821754|468668940|FG000|Overall Study|Procedure not required prior to amendment change|13|||
130194159|NCT02821754|468668941|FG001|Overall Study|Procedure not required prior to amendment change|11|||
130194160|NCT02821754|468668942|FG002|Overall Study|Procedure not required prior to amendment change|0|||
130194161|NCT02821754|468668940|FG000|Overall Study|Participant's Clinical status|2|||
130194162|NCT02821754|468668941|FG001|Overall Study|Participant's Clinical status|0|||
130194163|NCT02821754|468668942|FG002|Overall Study|Participant's Clinical status|0|||
130194164|NCT02821754|468668940|FG000|Overall Study|Participant removed for noncompliance|1|||
130194165|NCT02821754|468668941|FG001|Overall Study|Participant removed for noncompliance|0|||
130194166|NCT02821754|468668942|FG002|Overall Study|Participant removed for noncompliance|0|||
130194167|NCT02821754|468668940|FG000|Overall Study|Drug not available.|0|||
130194168|NCT02821754|468668941|FG001|Overall Study|Drug not available.|0|||
130194169|NCT02821754|468668942|FG002|Overall Study|Drug not available.|1|||
130194170|NCT02821754|468668940|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
130194171|NCT02821754|468668941|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
130194172|NCT02821754|468668942|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
130194173|NCT02477332|468668952|FG000|Overall Study|Adverse Event|0|||
130194174|NCT02477332|468668953|FG001|Overall Study|Adverse Event|1|||
130194175|NCT02477332|468668954|FG002|Overall Study|Adverse Event|1|||
130194176|NCT02477332|468668955|FG003|Overall Study|Adverse Event|2|||
130194177|NCT02477332|468668956|FG004|Overall Study|Adverse Event|1|||
130194178|NCT02477332|468668957|FG005|Overall Study|Adverse Event|2|||
130194179|NCT02477332|468668952|FG000|Overall Study|Lack of Efficacy|1|||
130194180|NCT02477332|468668953|FG001|Overall Study|Lack of Efficacy|2|||
130194181|NCT02477332|468668954|FG002|Overall Study|Lack of Efficacy|1|||
130194182|NCT02477332|468668955|FG003|Overall Study|Lack of Efficacy|2|||
130194183|NCT02477332|468668956|FG004|Overall Study|Lack of Efficacy|1|||
130194184|NCT02477332|468668957|FG005|Overall Study|Lack of Efficacy|1|||
130194185|NCT02477332|468668952|FG000|Overall Study|Non-compliance with study treatment|0|||
130194186|NCT02477332|468668953|FG001|Overall Study|Non-compliance with study treatment|1|||
130194187|NCT02477332|468668954|FG002|Overall Study|Non-compliance with study treatment|2|||
130194188|NCT02477332|468668955|FG003|Overall Study|Non-compliance with study treatment|0|||
130194189|NCT02477332|468668956|FG004|Overall Study|Non-compliance with study treatment|0|||
130194190|NCT02477332|468668957|FG005|Overall Study|Non-compliance with study treatment|0|||
130194191|NCT02477332|468668952|FG000|Overall Study|Pregnancy|0|||
130194192|NCT02477332|468668953|FG001|Overall Study|Pregnancy|0|||
130194193|NCT02477332|468668954|FG002|Overall Study|Pregnancy|0|||
130194194|NCT02477332|468668955|FG003|Overall Study|Pregnancy|1|||
130194195|NCT02477332|468668956|FG004|Overall Study|Pregnancy|0|||
130194196|NCT02477332|468668957|FG005|Overall Study|Pregnancy|0|||
130194197|NCT02477332|468668952|FG000|Overall Study|Protocol Violation|2|||
130194198|NCT02477332|468668953|FG001|Overall Study|Protocol Violation|0|||
130194199|NCT02477332|468668954|FG002|Overall Study|Protocol Violation|3|||
130194200|NCT02477332|468668955|FG003|Overall Study|Protocol Violation|3|||
130194201|NCT02477332|468668956|FG004|Overall Study|Protocol Violation|1|||
130194202|NCT02477332|468668957|FG005|Overall Study|Protocol Violation|1|||
130194203|NCT02477332|468668952|FG000|Overall Study|Technical problems|0|||
130194204|NCT02477332|468668953|FG001|Overall Study|Technical problems|0|||
130194205|NCT02477332|468668954|FG002|Overall Study|Technical problems|1|||
130194206|NCT02477332|468668955|FG003|Overall Study|Technical problems|0|||
130194207|NCT02477332|468668956|FG004|Overall Study|Technical problems|0|||
130194208|NCT02477332|468668957|FG005|Overall Study|Technical problems|0|||
130194209|NCT02477332|468668952|FG000|Overall Study|Lost to Follow-up|0|||
130194210|NCT02477332|468668953|FG001|Overall Study|Lost to Follow-up|0|||
130194211|NCT02477332|468668954|FG002|Overall Study|Lost to Follow-up|2|||
130194212|NCT02477332|468668955|FG003|Overall Study|Lost to Follow-up|0|||
130194213|NCT02477332|468668956|FG004|Overall Study|Lost to Follow-up|0|||
130194214|NCT02477332|468668957|FG005|Overall Study|Lost to Follow-up|0|||
130194215|NCT02477332|468668952|FG000|Overall Study|Physician Decision|0|||
130194216|NCT02477332|468668953|FG001|Overall Study|Physician Decision|0|||
130194217|NCT02477332|468668954|FG002|Overall Study|Physician Decision|1|||
130194218|NCT02477332|468668955|FG003|Overall Study|Physician Decision|3|||
130194219|NCT02477332|468668956|FG004|Overall Study|Physician Decision|0|||
130194220|NCT02477332|468668957|FG005|Overall Study|Physician Decision|1|||
130194221|NCT02477332|468668952|FG000|Overall Study|Withdrawal by Subject|0|||
130194222|NCT02477332|468668953|FG001|Overall Study|Withdrawal by Subject|3|||
130194223|NCT02477332|468668954|FG002|Overall Study|Withdrawal by Subject|1|||
130194224|NCT02477332|468668955|FG003|Overall Study|Withdrawal by Subject|2|||
130194225|NCT02477332|468668956|FG004|Overall Study|Withdrawal by Subject|1|||
130194226|NCT02477332|468668957|FG005|Overall Study|Withdrawal by Subject|0|||
130194227|NCT02549287|468668958|FG000|Overall Study|Lost to Follow-up|65|||
130194228|NCT02549287|468668959|FG001|Overall Study|Lost to Follow-up|26|||
130194229|NCT02549287|468668958|FG000|Overall Study|Withdrawal by Subject|15|||
130194230|NCT02549287|468668959|FG001|Overall Study|Withdrawal by Subject|6|||
130194231|NCT03793842|468668960|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
130194232|NCT03793842|468668961|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
130194233|NCT03793842|468668960|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
130194234|NCT03793842|468668961|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
130194235|NCT00427921|468668962|FG000|Overall Study|Adverse Event|26|||
130194236|NCT00427921|468668962|FG000|Overall Study|Withdrawal by Subject|4|||
130194237|NCT00427921|468668962|FG000|Overall Study|Lost to Follow-up|2|||
130194238|NCT00427921|468668962|FG000|Overall Study|Other reason not specified|10|||
130194239|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Hospitalization|1|||
130194240|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
130194241|NCT00427921|468668962|FG000|Overall Study|Adverse Event + No Response|1|||
130194242|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
130194243|NCT00427921|468668962|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
130194244|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Lost Response|1|||
130194245|NCT00427921|468668962|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
130194246|NCT00427921|468668962|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
130194247|NCT01166438|468668963|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
130194248|NCT01166438|468668964|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
130194249|NCT01166438|468668963|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
130194250|NCT01166438|468668964|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
130194251|NCT01166438|468668963|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
130194252|NCT01166438|468668964|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
130194253|NCT01166438|468668963|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
130194254|NCT01166438|468668964|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
130194255|NCT01166438|468668963|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
130194256|NCT01166438|468668964|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
130194257|NCT01166438|468668963|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
130194258|NCT01166438|468668964|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
130194259|NCT00347009|468668965|FG000|Overall Study|Death|1|||
130194260|NCT00347009|468668965|FG000|Overall Study|Adverse Event|6|||
130194261|NCT00347009|468668965|FG000|Overall Study|Withdrawal by Subject|3|||
130194262|NCT00347009|468668965|FG000|Overall Study|Physician Decision|5|||
130194263|NCT00347009|468668965|FG000|Overall Study|Lost to Follow-up|4|||
130194264|NCT00347009|468668965|FG000|Overall Study|Protocol Violation|2|||
130194265|NCT00347009|468668965|FG000|Overall Study|Adverse Laboratory Experience|1|||
130194266|NCT00347009|468668965|FG000|Overall Study|Insufficient Viral Suppression|3|||
130194267|NCT00347009|468668965|FG000|Overall Study|Increased ALT/HBV DNA|1|||
130194268|NCT00347009|468668965|FG000|Overall Study|Serious Adverse Event|1|||
130194269|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Death|1|||
130194270|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Death|0|||
130194271|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
130194272|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
130194273|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
130194274|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
130194275|NCT01972438|468668967|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
130194276|NCT01972438|468668968|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
130194277|NCT01972438|468668967|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
130194278|NCT01972438|468668968|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
130194279|NCT01972438|468668967|FG000|Months 6-12 Study Period|Death|1|||
130194280|NCT01972438|468668968|FG001|Months 6-12 Study Period|Death|0|||
130194281|NCT01972438|468668967|FG000|Months 6-12 Study Period|Early Study Closure|2|||
130194282|NCT01972438|468668968|FG001|Months 6-12 Study Period|Early Study Closure|2|||
130194283|NCT01972438|468668967|FG000|Post Month 12 Study Period|Early Study Closure|3|||
130194284|NCT01972438|468668968|FG001|Post Month 12 Study Period|Early Study Closure|4|||
130194285|NCT01186692|468668971|FG000|Overall Study|Not Catheterized|11|||
130194286|NCT01186692|468668971|FG000|Overall Study|Futher testing contraindicated implant|19|||
130194287|NCT01186692|468668971|FG000|Overall Study|Adverse Event|2|||
130194288|NCT00596817|468668972|FG000|Open-label Period|Adverse Event|0|||
130194289|NCT00596817|468668973|FG001|Open-label Period|Adverse Event|49|||
130194290|NCT00596817|468668972|FG000|Open-label Period|Lack of Efficacy|0|||
130194291|NCT00596817|468668973|FG001|Open-label Period|Lack of Efficacy|33|||
130194292|NCT00596817|468668972|FG000|Open-label Period|Other Reasons|0|||
130194293|NCT00596817|468668973|FG001|Open-label Period|Other Reasons|65|||
130194294|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
130194295|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
130194296|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
130194297|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
130194298|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
130194299|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
130194300|NCT00596817|468668972|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
130194301|NCT00596817|468668973|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
130194302|NCT00596817|468668972|FG000|Double-blind Period|Adverse Event|5|||
130194303|NCT00596817|468668973|FG001|Double-blind Period|Adverse Event|16|||
130194304|NCT00596817|468668972|FG000|Double-blind Period|Lack of Efficacy|52|||
130194305|NCT00596817|468668973|FG001|Double-blind Period|Lack of Efficacy|28|||
130194306|NCT00596817|468668972|FG000|Double-blind Period|Non-compliance With Study Product|3|||
130194307|NCT00596817|468668973|FG001|Double-blind Period|Non-compliance With Study Product|4|||
130194308|NCT00596817|468668972|FG000|Double-blind Period|Protocol Violation|11|||
130194309|NCT00596817|468668973|FG001|Double-blind Period|Protocol Violation|8|||
130194310|NCT00596817|468668972|FG000|Double-blind Period|Withdrawal of Consent|7|||
130194311|NCT00596817|468668973|FG001|Double-blind Period|Withdrawal of Consent|3|||
130194312|NCT00596817|468668972|FG000|Double-blind Period|Lost to Follow-up|0|||
130194313|NCT00596817|468668973|FG001|Double-blind Period|Lost to Follow-up|2|||
130194314|NCT00596817|468668972|FG000|Double-blind Period|Other Reasons|10|||
130194315|NCT00596817|468668973|FG001|Double-blind Period|Other Reasons|18|||
130194316|NCT00679029|468670195|FG000|Overall Study|Adverse Event|3|||
130194317|NCT00679029|468670195|FG000|Overall Study|Withdrawal by Subject|1|||
130194318|NCT00679029|468670195|FG000|Overall Study|Lost to Follow-up|1|||
130194319|NCT01108341|468670196|FG000|Overall Study|Death|2|||
130194320|NCT01108341|468670196|FG000|Overall Study|Withdrawal by Subject|1|||
130194321|NCT01108341|468670196|FG000|Overall Study|Lost to Follow-up|1|||
130194322|NCT01108341|468670196|FG000|Overall Study|Other|1|||
130194323|NCT04402138|468670197|FG000|Overall Study|Progressive Disease|2|||
130194324|NCT04402138|468670197|FG000|Overall Study|Adverse Event|1|||
130194325|NCT00596687|468670200|FG000|Overall Study|< 24 hours of insulin treatment|8|||
130194326|NCT00596687|468670201|FG001|Overall Study|< 24 hours of insulin treatment|6|||
130194327|NCT00596687|468670200|FG000|Overall Study|continuous insulin infusion during TPN|2|||
130194328|NCT00596687|468670201|FG001|Overall Study|continuous insulin infusion during TPN|1|||
130194329|NCT00596687|468670200|FG000|Overall Study|Withdrawal by Subject|3|||
130194330|NCT00596687|468670201|FG001|Overall Study|Withdrawal by Subject|1|||
130194331|NCT00596687|468670200|FG000|Overall Study|cancelled surgery|1|||
130194332|NCT00596687|468670201|FG001|Overall Study|cancelled surgery|1|||
130194333|NCT01284348|468670204|FG000|Overall Study|Death|1|||
130194334|NCT01284348|468670205|FG001|Overall Study|Death|1|||
130194335|NCT01284348|468670204|FG000|Overall Study|Withdrew consent|0|||
130194336|NCT01284348|468670205|FG001|Overall Study|Withdrew consent|1|||
130194337|NCT01284348|468670204|FG000|Overall Study|Status not recorded|9|||
130194338|NCT01284348|468670205|FG001|Overall Study|Status not recorded|10|||
130194339|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
130194340|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
130194341|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
130194342|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
130194343|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
130194344|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
130194345|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
130194346|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
130194347|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130194348|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130194349|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
130194350|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
130194351|NCT03645395|468670212|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
130194352|NCT03645395|468670213|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
130194353|NCT03645395|468670214|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
130194354|NCT03645395|468670215|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
130194355|NCT01057810|468670216|FG000|Overall Study|Disease progression|156|||
130194356|NCT01057810|468670217|FG001|Overall Study|Disease progression|197|||
130194357|NCT01057810|468670216|FG000|Overall Study|Study drug toxicity|5|||
130194358|NCT01057810|468670217|FG001|Overall Study|Study drug toxicity|114|||
130194359|NCT01057810|468670216|FG000|Overall Study|Adverse event unrelated to study drug|13|||
130194360|NCT01057810|468670217|FG001|Overall Study|Adverse event unrelated to study drug|29|||
130194361|NCT01057810|468670216|FG000|Overall Study|Withdrawal by Subject|10|||
130194362|NCT01057810|468670217|FG001|Overall Study|Withdrawal by Subject|25|||
130194363|NCT01057810|468670216|FG000|Overall Study|Death|2|||
130194364|NCT01057810|468670217|FG001|Overall Study|Death|12|||
130194365|NCT01057810|468670216|FG000|Overall Study|Maximum clinical benefit|5|||
130194366|NCT01057810|468670217|FG001|Overall Study|Maximum clinical benefit|5|||
130194367|NCT01057810|468670216|FG000|Overall Study|Poor/non-compliance|0|||
130194368|NCT01057810|468670217|FG001|Overall Study|Poor/non-compliance|1|||
130194369|NCT01057810|468670216|FG000|Overall Study|No longer met study criteria|0|||
130194370|NCT01057810|468670217|FG001|Overall Study|No longer met study criteria|1|||
130194371|NCT01057810|468670216|FG000|Overall Study|Other|7|||
130194372|NCT01057810|468670217|FG001|Overall Study|Other|14|||
130194373|NCT02088905|468670218|FG000|Overall Study|Withdrawal by Subject|5|||
130194374|NCT02088905|468670219|FG001|Overall Study|Withdrawal by Subject|1|||
130194375|NCT01091662|468670220|FG000|Overall Study|Adverse Event|1|||
130194376|NCT01091662|468670221|FG001|Overall Study|Adverse Event|9|||
130194377|NCT01091662|468670220|FG000|Overall Study|Physician Decision|1|||
130194378|NCT01091662|468670221|FG001|Overall Study|Physician Decision|1|||
130194379|NCT01091662|468670220|FG000|Overall Study|Withdrawal by Subject|7|||
130194380|NCT01091662|468670221|FG001|Overall Study|Withdrawal by Subject|6|||
130194381|NCT01091662|468670220|FG000|Overall Study|met exit criteria|7|||
130194382|NCT01091662|468670221|FG001|Overall Study|met exit criteria|13|||
130194383|NCT01091662|468670220|FG000|Overall Study|met exclusion criteria|1|||
130194384|NCT01091662|468670221|FG001|Overall Study|met exclusion criteria|0|||
130194385|NCT01091662|468670220|FG000|Overall Study|Lost to Follow-up|0|||
130194386|NCT01091662|468670221|FG001|Overall Study|Lost to Follow-up|1|||
130194387|NCT01091662|468670220|FG000|Overall Study|Pregnancy|0|||
130194388|NCT01091662|468670221|FG001|Overall Study|Pregnancy|1|||
130194389|NCT01091662|468670220|FG000|Overall Study|Protocol Violation|0|||
130194390|NCT01091662|468670221|FG001|Overall Study|Protocol Violation|2|||
130194391|NCT01091662|468670220|FG000|Overall Study|unable to swallow capsule|0|||
130194392|NCT01091662|468670221|FG001|Overall Study|unable to swallow capsule|1|||
130194393|NCT01222520|468670222|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
130194394|NCT01222520|468670223|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
130194395|NCT01222520|468670222|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
130194396|NCT01222520|468670223|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
130194397|NCT01222520|468670222|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
130194398|NCT01222520|468670223|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
130194399|NCT01222520|468670222|FG000|Double-blind Period|Adverse Event|0|||
130194400|NCT01222520|468670223|FG001|Double-blind Period|Adverse Event|1|||
130194401|NCT01222520|468670222|FG000|Double-blind Period|Lack of Efficacy|0|||
130194402|NCT01222520|468670223|FG001|Double-blind Period|Lack of Efficacy|1|||
130194403|NCT01222520|468670222|FG000|Double-blind Period|Study medication stolen|1|||
130194404|NCT01222520|468670223|FG001|Double-blind Period|Study medication stolen|0|||
130194405|NCT04109391|468670224|FG000|Overall Study|Adverse Event|2|||
130194406|NCT04109391|468670225|FG001|Overall Study|Adverse Event|2|||
130194407|NCT04109391|468670226|FG002|Overall Study|Adverse Event|0|||
130194408|NCT04109391|468670224|FG000|Overall Study|Withdrawal by Subject|2|||
130194409|NCT04109391|468670225|FG001|Overall Study|Withdrawal by Subject|0|||
130194410|NCT04109391|468670226|FG002|Overall Study|Withdrawal by Subject|0|||
130194411|NCT04109391|468670224|FG000|Overall Study|Pregnancy|1|||
130194412|NCT04109391|468670225|FG001|Overall Study|Pregnancy|0|||
130194413|NCT04109391|468670226|FG002|Overall Study|Pregnancy|0|||
130194414|NCT04109391|468670224|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
130194415|NCT04109391|468670225|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
130194416|NCT04109391|468670226|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
130194417|NCT04109391|468670224|FG000|Overall Study|Lost to Follow-up|0|||
130194418|NCT04109391|468670225|FG001|Overall Study|Lost to Follow-up|0|||
130194419|NCT04109391|468670226|FG002|Overall Study|Lost to Follow-up|1|||
130194420|NCT04109391|468670224|FG000|Overall Study|Lack of Efficacy|2|||
130194421|NCT04109391|468670225|FG001|Overall Study|Lack of Efficacy|2|||
130194422|NCT04109391|468670226|FG002|Overall Study|Lack of Efficacy|3|||
130194423|NCT01089608|468670229|FG000|Overall Study|Adverse Event|0|||
130194424|NCT01089608|468670230|FG001|Overall Study|Adverse Event|4|||
130194425|NCT01089608|468670229|FG000|Overall Study|Lost to Follow-up|0|||
130194426|NCT01089608|468670230|FG001|Overall Study|Lost to Follow-up|2|||
130194427|NCT00384839|468670233|FG000|Overall Study|Adverse Event|4|||
130194428|NCT00384839|468670233|FG000|Overall Study|Investigator Request|1|||
130194429|NCT00384839|468670233|FG000|Overall Study|Patient Request|1|||
130194430|NCT00384839|468670233|FG000|Overall Study|Ineligible|2|||
130194431|NCT00280397|468670234|FG000|Overall Study|Adverse Event|1|||
130194432|NCT02257489|468670235|FG000|Overall Study|Withdrawal by Subject|0|||
130194433|NCT02257489|468670236|FG001|Overall Study|Withdrawal by Subject|0|||
130194434|NCT02257489|468670237|FG002|Overall Study|Withdrawal by Subject|0|||
130194435|NCT02257489|468670238|FG003|Overall Study|Withdrawal by Subject|1|||
130194436|NCT02257489|468670239|FG004|Overall Study|Withdrawal by Subject|0|||
130194437|NCT02257489|468670240|FG005|Overall Study|Withdrawal by Subject|0|||
130194438|NCT02257489|468670241|FG006|Overall Study|Withdrawal by Subject|0|||
130194439|NCT02257489|468670242|FG007|Overall Study|Withdrawal by Subject|0|||
130194440|NCT02257489|468670243|FG008|Overall Study|Withdrawal by Subject|0|||
130194441|NCT04606394|468670244|FG000|Overall Study|Withdrawal by Subject|3|||
130194442|NCT04606394|468670244|FG000|Overall Study|Exclusion criteria screen failure|12|||
130194443|NCT00955955|468670245|FG000|Overall Study|Lost to Follow-up|2|||
130194444|NCT00955955|468670246|FG001|Overall Study|Lost to Follow-up|0|||
130194445|NCT00955955|468670247|FG002|Overall Study|Lost to Follow-up|0|||
130194446|NCT03423173|468670248|FG000|Overall Study|Randomized but not vaccinated|1|||
130194447|NCT03423173|468670249|FG001|Overall Study|Randomized but not vaccinated|0|||
130194448|NCT03423173|468670250|FG002|Overall Study|Randomized but not vaccinated|2|||
130194449|NCT03423173|468670251|FG003|Overall Study|Randomized but not vaccinated|1|||
130194450|NCT03423173|468670248|FG000|Overall Study|Adverse Event|1|||
130194451|NCT03423173|468670249|FG001|Overall Study|Adverse Event|1|||
130194452|NCT03423173|468670250|FG002|Overall Study|Adverse Event|1|||
130194453|NCT03423173|468670251|FG003|Overall Study|Adverse Event|1|||
130194454|NCT03423173|468670248|FG000|Overall Study|Lost to Follow-up|10|||
130194455|NCT03423173|468670249|FG001|Overall Study|Lost to Follow-up|19|||
130194456|NCT03423173|468670250|FG002|Overall Study|Lost to Follow-up|17|||
130194457|NCT03423173|468670251|FG003|Overall Study|Lost to Follow-up|22|||
130194458|NCT03423173|468670248|FG000|Overall Study|Withdrawal of consent|4|||
130194459|NCT03423173|468670249|FG001|Overall Study|Withdrawal of consent|10|||
130194460|NCT03423173|468670250|FG002|Overall Study|Withdrawal of consent|4|||
130194461|NCT03423173|468670251|FG003|Overall Study|Withdrawal of consent|5|||
130194462|NCT03423173|468670248|FG000|Overall Study|Death|1|||
130194463|NCT03423173|468670249|FG001|Overall Study|Death|0|||
130194464|NCT03423173|468670250|FG002|Overall Study|Death|0|||
130194465|NCT03423173|468670251|FG003|Overall Study|Death|0|||
130194466|NCT03423173|468670248|FG000|Overall Study|Reason not Specified|2|||
130194467|NCT03423173|468670249|FG001|Overall Study|Reason not Specified|5|||
130194468|NCT03423173|468670250|FG002|Overall Study|Reason not Specified|3|||
130194469|NCT03423173|468670251|FG003|Overall Study|Reason not Specified|1|||
130194470|NCT03852264|468670252|FG000|Third Research Visit|Lost to Follow-up|1|||
130194471|NCT03852264|468670253|FG001|Third Research Visit|Lost to Follow-up|0|||
130194472|NCT02217410|468670259|FG000|Overall Study|Graft Loss|0|||
130194473|NCT02217410|468670260|FG001|Overall Study|Graft Loss|0|||
130194474|NCT02217410|468670261|FG002|Overall Study|Graft Loss|2|||
130194475|NCT02217410|468670259|FG000|Overall Study|Withdrawal by Subject|0|||
130194476|NCT02217410|468670260|FG001|Overall Study|Withdrawal by Subject|0|||
130194477|NCT02217410|468670261|FG002|Overall Study|Withdrawal by Subject|2|||
130194478|NCT02217410|468670259|FG000|Overall Study|Lost to Follow-up|0|||
130194479|NCT02217410|468670260|FG001|Overall Study|Lost to Follow-up|0|||
130194480|NCT02217410|468670261|FG002|Overall Study|Lost to Follow-up|1|||
130194481|NCT02217410|468670259|FG000|Overall Study|Lack of Efficacy|0|||
130194482|NCT02217410|468670260|FG001|Overall Study|Lack of Efficacy|1|||
130194483|NCT02217410|468670261|FG002|Overall Study|Lack of Efficacy|0|||
130194484|NCT02217410|468670259|FG000|Overall Study|Physician Decision|1|||
130194485|NCT02217410|468670260|FG001|Overall Study|Physician Decision|3|||
130194486|NCT02217410|468670261|FG002|Overall Study|Physician Decision|0|||
130194487|NCT00661609|468670263|FG000|Overall Study|Adverse Event|4|||
130194488|NCT00661609|468670263|FG000|Overall Study|Death|20|||
130194489|NCT00661609|468670263|FG000|Overall Study|Withdrawal by Subject|2|||
130194490|NCT00661609|468670263|FG000|Overall Study|PI Decision|1|||
130194491|NCT00661609|468670263|FG000|Overall Study|Survival follow up stage discontinued|11|||
130194492|NCT00661609|468670263|FG000|Overall Study|Disease progression|3|||
130194493|NCT00637000|468670264|FG000|Overall Study|Withdrawal by Subject|4|||
130194494|NCT00637000|468670265|FG001|Overall Study|Withdrawal by Subject|3|||
130194495|NCT02751450|468670268|FG000|Overall Study|Adverse Event|1|||
130194496|NCT02751450|468670269|FG001|Overall Study|Adverse Event|0|||
130194497|NCT01290679|468670270|FG000|Overall Study|Adverse Event|2|||
130194498|NCT01290679|468670271|FG001|Overall Study|Adverse Event|0|||
130194499|NCT01290679|468670270|FG000|Overall Study|Lost to Follow-up|8|||
130194500|NCT01290679|468670271|FG001|Overall Study|Lost to Follow-up|10|||
130194501|NCT01290679|468670270|FG000|Overall Study|Protocol Violation|0|||
130194502|NCT01290679|468670271|FG001|Overall Study|Protocol Violation|1|||
130194503|NCT01290679|468670270|FG000|Overall Study|Withdrawal by Subject|6|||
130194504|NCT01290679|468670271|FG001|Overall Study|Withdrawal by Subject|5|||
130194505|NCT01290679|468670270|FG000|Overall Study|Subject Entered Another Trial|0|||
130194506|NCT01290679|468670271|FG001|Overall Study|Subject Entered Another Trial|5|||
130194507|NCT00562302|468670272|FG000|Overall Study|Lost to Follow-up|3|||
130194508|NCT00562302|468670273|FG001|Overall Study|Lost to Follow-up|3|||
130194509|NCT00562302|468670272|FG000|Overall Study|Adverse Event|0|||
130194510|NCT00562302|468670273|FG001|Overall Study|Adverse Event|6|||
130194511|NCT00562302|468670272|FG000|Overall Study|Non-compliance|1|||
130194512|NCT00562302|468670273|FG001|Overall Study|Non-compliance|2|||
130194513|NCT00562302|468670272|FG000|Overall Study|Withdrawal by Subject|7|||
130194514|NCT00562302|468670273|FG001|Overall Study|Withdrawal by Subject|8|||
130194515|NCT00562302|468670272|FG000|Overall Study|Death|1|||
130194516|NCT00562302|468670273|FG001|Overall Study|Death|2|||
130194517|NCT00562302|468670272|FG000|Overall Study|Lung resection prior to study completion|7|||
130194518|NCT00562302|468670273|FG001|Overall Study|Lung resection prior to study completion|7|||
130194519|NCT00562302|468670272|FG000|Overall Study|Not stated|1|||
130194520|NCT00562302|468670273|FG001|Overall Study|Not stated|4|||
130194521|NCT01855243|468670274|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
130194522|NCT01855243|468670275|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
130194523|NCT01855243|468670276|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
130194524|NCT03315286|468670277|FG000|Overall Study|Lost to Follow-up|0|||
130194525|NCT03315286|468670278|FG001|Overall Study|Lost to Follow-up|3|||
130194526|NCT03315286|468670277|FG000|Overall Study|Withdrawal by Subject|1|||
130194527|NCT03315286|468670278|FG001|Overall Study|Withdrawal by Subject|0|||
130194528|NCT03315286|468670277|FG000|Overall Study|Protocol Violation|0|||
130194529|NCT03315286|468670278|FG001|Overall Study|Protocol Violation|1|||
130194530|NCT03075891|468670279|FG000|Overall Study|Withdrawal by Subject|3|||
130194531|NCT03075891|468670280|FG001|Overall Study|Withdrawal by Subject|6|||
130194532|NCT03075891|468670279|FG000|Overall Study|Lost to Follow-up|1|||
130194533|NCT03075891|468670280|FG001|Overall Study|Lost to Follow-up|0|||
130194534|NCT03075891|468670279|FG000|Overall Study|Pregnancy|3|||
130194535|NCT03075891|468670280|FG001|Overall Study|Pregnancy|1|||
130194536|NCT03075891|468670279|FG000|Overall Study|visits not performed (no time)|1|||
130194537|NCT03075891|468670280|FG001|Overall Study|visits not performed (no time)|0|||
130194538|NCT03075891|468670279|FG000|Overall Study|Drug abuse relapse issue|0|||
130194539|NCT03075891|468670280|FG001|Overall Study|Drug abuse relapse issue|1|||
130194540|NCT03075891|468670279|FG000|Overall Study|Participant requiring study withdrawal|0|||
130194541|NCT03075891|468670280|FG001|Overall Study|Participant requiring study withdrawal|1|||
130194542|NCT03075891|468670279|FG000|Overall Study|Adverse event, non-fatal|1|||
130194543|NCT03075891|468670280|FG001|Overall Study|Adverse event, non-fatal|4|||
130194544|NCT00828568|468670283|FG000|Randomized|Withdrawal by Subject|1|||
130194545|NCT00828568|468670284|FG001|Randomized|Withdrawal by Subject|0|||
130194546|NCT00828568|468670285|FG002|Randomized|Withdrawal by Subject|2|||
130194547|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
130194548|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
130194549|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
130194550|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
130194551|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
130194552|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
130194553|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
130194554|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
130194555|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
130194556|NCT00828568|468670283|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
130194557|NCT00828568|468670284|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
130194558|NCT00828568|468670285|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
130194559|NCT03474731|468670286|FG000|Overall Study|Withdrawal by Subject|36|||
130194560|NCT03474731|468670287|FG001|Overall Study|Withdrawal by Subject|29|||
130194561|NCT03474731|468670288|FG002|Overall Study|Withdrawal by Subject|11|||
130194562|NCT03474731|468670289|FG003|Overall Study|Withdrawal by Subject|27|||
130194563|NCT03474731|468670286|FG000|Overall Study|COVID|0|||
130194564|NCT03474731|468670287|FG001|Overall Study|COVID|23|||
130194565|NCT03474731|468670288|FG002|Overall Study|COVID|0|||
130194566|NCT03474731|468670289|FG003|Overall Study|COVID|0|||
130194567|NCT03474731|468670286|FG000|Overall Study|Participant moved from area|1|||
130194568|NCT03474731|468670287|FG001|Overall Study|Participant moved from area|0|||
130194569|NCT03474731|468670288|FG002|Overall Study|Participant moved from area|0|||
130194570|NCT03474731|468670289|FG003|Overall Study|Participant moved from area|0|||
130194571|NCT03474731|468670286|FG000|Overall Study|Lost to Follow-up|11|||
130194572|NCT03474731|468670287|FG001|Overall Study|Lost to Follow-up|3|||
130194573|NCT03474731|468670288|FG002|Overall Study|Lost to Follow-up|18|||
130194574|NCT03474731|468670289|FG003|Overall Study|Lost to Follow-up|17|||
130194575|NCT03474731|468670286|FG000|Overall Study|Death|0|||
130194576|NCT03474731|468670287|FG001|Overall Study|Death|1|||
130194577|NCT03474731|468670288|FG002|Overall Study|Death|0|||
130194578|NCT03474731|468670289|FG003|Overall Study|Death|0|||
130194579|NCT03474731|468670286|FG000|Overall Study|Participant Removed|0|||
130194580|NCT03474731|468670287|FG001|Overall Study|Participant Removed|0|||
130194581|NCT03474731|468670288|FG002|Overall Study|Participant Removed|0|||
130194582|NCT03474731|468670289|FG003|Overall Study|Participant Removed|1|||
130194583|NCT00766636|468670290|FG000|Overall Study|Withdrawal by Subject|1|||
130194584|NCT00766636|468670291|FG001|Overall Study|Withdrawal by Subject|1|||
130194585|NCT00766636|468670290|FG000|Overall Study|Incomplete Treatment|0|||
130194586|NCT00766636|468670291|FG001|Overall Study|Incomplete Treatment|1|||
130194587|NCT00766636|468670290|FG000|Overall Study|Adverse Event|1|||
130194588|NCT00766636|468670291|FG001|Overall Study|Adverse Event|0|||
130194589|NCT00766636|468670290|FG000|Overall Study|Disease Progression|1|||
130194590|NCT00766636|468670291|FG001|Overall Study|Disease Progression|0|||
130194591|NCT04657198|468670292|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
130194592|NCT04657198|468670293|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130194593|NCT04657198|468670294|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
130194594|NCT01075256|468670297|FG000|Overall Study|Withdrawal by Subject|1|||
130194595|NCT01075256|468670298|FG001|Overall Study|Withdrawal by Subject|0|||
130194596|NCT01075256|468670299|FG002|Overall Study|Withdrawal by Subject|0|||
130194597|NCT00765336|468670300|FG000|Overall Study|Protocol Violation|4|||
130194598|NCT00765336|468670301|FG001|Overall Study|Protocol Violation|2|||
130194599|NCT00765336|468670300|FG000|Overall Study|Withdrawal by Subject|6|||
130194600|NCT00765336|468670301|FG001|Overall Study|Withdrawal by Subject|4|||
130194601|NCT00765336|468670300|FG000|Overall Study|Lost to Follow-up|7|||
130194602|NCT00765336|468670301|FG001|Overall Study|Lost to Follow-up|9|||
130194603|NCT00765336|468670300|FG000|Overall Study|Adverse Event|2|||
130194604|NCT00765336|468670301|FG001|Overall Study|Adverse Event|1|||
130194605|NCT02858583|468670302|FG000|Overall Study|Declined consent|1|||
130194606|NCT02858583|468670303|FG001|Overall Study|Declined consent|1|||
130194607|NCT01218087|468670304|FG000|Overall Study|Death|2|||
130194608|NCT01218087|468670305|FG001|Overall Study|Death|1|||
130194609|NCT01218087|468670304|FG000|Overall Study|Withdrawal by Subject|5|||
130194610|NCT01218087|468670305|FG001|Overall Study|Withdrawal by Subject|0|||
130194611|NCT01218087|468670304|FG000|Overall Study|Transferred|8|||
130194612|NCT01218087|468670305|FG001|Overall Study|Transferred|5|||
130194613|NCT01314872|468670311|FG000|Treatment Period 1|Protocol Violation|2|||
130194614|NCT01314872|468670312|FG001|Treatment Period 1|Protocol Violation|1|||
130194615|NCT01314872|468670313|FG002|Treatment Period 1|Protocol Violation|1|||
130194616|NCT01314872|468670314|FG003|Treatment Period 1|Protocol Violation|0|||
130194617|NCT01314872|468670315|FG004|Treatment Period 1|Protocol Violation|1|||
130194618|NCT01314872|468670316|FG005|Treatment Period 1|Protocol Violation|0|||
130194619|NCT01314872|468670317|FG006|Treatment Period 1|Protocol Violation|0|||
130194620|NCT01314872|468670318|FG007|Treatment Period 1|Protocol Violation|0|||
130194621|NCT01314872|468670319|FG008|Treatment Period 1|Protocol Violation|0|||
130194622|NCT01314872|468670320|FG009|Treatment Period 1|Protocol Violation|1|||
130194623|NCT01314872|468670321|FG010|Treatment Period 1|Protocol Violation|1|||
130194624|NCT01314872|468670322|FG011|Treatment Period 1|Protocol Violation|0|||
130194625|NCT01314872|468670323|FG012|Treatment Period 1|Protocol Violation|0|||
130194626|NCT01314872|468670324|FG013|Treatment Period 1|Protocol Violation|0|||
130194627|NCT01314872|468670325|FG014|Treatment Period 1|Protocol Violation|0|||
130194628|NCT01314872|468670311|FG000|Treatment Period 1|Physician Decision|0|||
130194629|NCT01314872|468670312|FG001|Treatment Period 1|Physician Decision|1|||
130194630|NCT01314872|468670313|FG002|Treatment Period 1|Physician Decision|0|||
130194631|NCT01314872|468670314|FG003|Treatment Period 1|Physician Decision|1|||
130194632|NCT01314872|468670315|FG004|Treatment Period 1|Physician Decision|0|||
130194633|NCT01314872|468670316|FG005|Treatment Period 1|Physician Decision|0|||
130194634|NCT01314872|468670317|FG006|Treatment Period 1|Physician Decision|0|||
130194635|NCT01314872|468670318|FG007|Treatment Period 1|Physician Decision|0|||
130194636|NCT01314872|468670319|FG008|Treatment Period 1|Physician Decision|0|||
130194637|NCT01314872|468670320|FG009|Treatment Period 1|Physician Decision|1|||
130194638|NCT01314872|468670321|FG010|Treatment Period 1|Physician Decision|0|||
130194639|NCT01314872|468670322|FG011|Treatment Period 1|Physician Decision|0|||
130194640|NCT01314872|468670323|FG012|Treatment Period 1|Physician Decision|0|||
130194641|NCT01314872|468670324|FG013|Treatment Period 1|Physician Decision|0|||
130194642|NCT01314872|468670325|FG014|Treatment Period 1|Physician Decision|0|||
130194643|NCT01314872|468670311|FG000|Treatment Period 1|Lack of Efficacy|1|||
130194644|NCT01314872|468670312|FG001|Treatment Period 1|Lack of Efficacy|0|||
130194645|NCT01314872|468670313|FG002|Treatment Period 1|Lack of Efficacy|0|||
130194646|NCT01314872|468670314|FG003|Treatment Period 1|Lack of Efficacy|0|||
130194647|NCT01314872|468670315|FG004|Treatment Period 1|Lack of Efficacy|0|||
130194648|NCT01314872|468670316|FG005|Treatment Period 1|Lack of Efficacy|1|||
130194649|NCT01314872|468670317|FG006|Treatment Period 1|Lack of Efficacy|0|||
130194650|NCT01314872|468670318|FG007|Treatment Period 1|Lack of Efficacy|2|||
130194651|NCT01314872|468670319|FG008|Treatment Period 1|Lack of Efficacy|0|||
130194652|NCT01314872|468670320|FG009|Treatment Period 1|Lack of Efficacy|0|||
130194653|NCT01314872|468670321|FG010|Treatment Period 1|Lack of Efficacy|0|||
130194654|NCT01314872|468670322|FG011|Treatment Period 1|Lack of Efficacy|0|||
130194655|NCT01314872|468670323|FG012|Treatment Period 1|Lack of Efficacy|0|||
130194656|NCT01314872|468670324|FG013|Treatment Period 1|Lack of Efficacy|0|||
130194657|NCT01314872|468670325|FG014|Treatment Period 1|Lack of Efficacy|0|||
130194658|NCT01314872|468670311|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
130194659|NCT01314872|468670312|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
130194660|NCT01314872|468670313|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
130194661|NCT01314872|468670314|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
130194662|NCT01314872|468670315|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
130194663|NCT01314872|468670316|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
130194664|NCT01314872|468670317|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
130194665|NCT01314872|468670318|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
130194666|NCT01314872|468670319|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
130194667|NCT01314872|468670320|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
130194668|NCT01314872|468670321|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
130194669|NCT01314872|468670322|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
130194670|NCT01314872|468670323|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
130194671|NCT01314872|468670324|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
130194672|NCT01314872|468670325|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
130194673|NCT01314872|468670311|FG000|Treatment Period 1|Withdrawal by Subject|3|||
130194674|NCT01314872|468670312|FG001|Treatment Period 1|Withdrawal by Subject|1|||
130194675|NCT01314872|468670313|FG002|Treatment Period 1|Withdrawal by Subject|0|||
130194676|NCT01314872|468670314|FG003|Treatment Period 1|Withdrawal by Subject|2|||
130194677|NCT01314872|468670315|FG004|Treatment Period 1|Withdrawal by Subject|3|||
130194678|NCT01314872|468670316|FG005|Treatment Period 1|Withdrawal by Subject|1|||
130194679|NCT01314872|468670317|FG006|Treatment Period 1|Withdrawal by Subject|3|||
130194680|NCT01314872|468670318|FG007|Treatment Period 1|Withdrawal by Subject|2|||
130194681|NCT01314872|468670319|FG008|Treatment Period 1|Withdrawal by Subject|2|||
130194682|NCT01314872|468670320|FG009|Treatment Period 1|Withdrawal by Subject|2|||
130194683|NCT01314872|468670321|FG010|Treatment Period 1|Withdrawal by Subject|1|||
130194684|NCT01314872|468670322|FG011|Treatment Period 1|Withdrawal by Subject|0|||
130194685|NCT01314872|468670323|FG012|Treatment Period 1|Withdrawal by Subject|0|||
130194686|NCT01314872|468670324|FG013|Treatment Period 1|Withdrawal by Subject|0|||
130194687|NCT01314872|468670325|FG014|Treatment Period 1|Withdrawal by Subject|0|||
130194688|NCT01314872|468670311|FG000|Treatment Period 1|Lost to Follow-up|0|||
130194689|NCT01314872|468670312|FG001|Treatment Period 1|Lost to Follow-up|1|||
130194690|NCT01314872|468670313|FG002|Treatment Period 1|Lost to Follow-up|2|||
130194691|NCT01314872|468670314|FG003|Treatment Period 1|Lost to Follow-up|2|||
130194692|NCT01314872|468670315|FG004|Treatment Period 1|Lost to Follow-up|1|||
130194693|NCT01314872|468670316|FG005|Treatment Period 1|Lost to Follow-up|1|||
130194694|NCT01314872|468670317|FG006|Treatment Period 1|Lost to Follow-up|1|||
130194695|NCT01314872|468670318|FG007|Treatment Period 1|Lost to Follow-up|1|||
130194696|NCT01314872|468670319|FG008|Treatment Period 1|Lost to Follow-up|1|||
130194697|NCT01314872|468670320|FG009|Treatment Period 1|Lost to Follow-up|0|||
130194698|NCT01314872|468670321|FG010|Treatment Period 1|Lost to Follow-up|0|||
130194699|NCT01314872|468670322|FG011|Treatment Period 1|Lost to Follow-up|0|||
130194700|NCT01314872|468670323|FG012|Treatment Period 1|Lost to Follow-up|0|||
130194701|NCT01314872|468670324|FG013|Treatment Period 1|Lost to Follow-up|0|||
130194702|NCT01314872|468670325|FG014|Treatment Period 1|Lost to Follow-up|0|||
130194703|NCT01314872|468670311|FG000|Period 2|Protocol Violation|0|||
130194704|NCT01314872|468670312|FG001|Period 2|Protocol Violation|0|||
130194705|NCT01314872|468670313|FG002|Period 2|Protocol Violation|0|||
130194706|NCT01314872|468670314|FG003|Period 2|Protocol Violation|0|||
130194707|NCT01314872|468670315|FG004|Period 2|Protocol Violation|0|||
130194708|NCT01314872|468670316|FG005|Period 2|Protocol Violation|0|||
130194709|NCT01314872|468670317|FG006|Period 2|Protocol Violation|0|||
130194710|NCT01314872|468670318|FG007|Period 2|Protocol Violation|0|||
130194711|NCT01314872|468670319|FG008|Period 2|Protocol Violation|0|||
130194712|NCT01314872|468670320|FG009|Period 2|Protocol Violation|0|||
130194713|NCT01314872|468670321|FG010|Period 2|Protocol Violation|0|||
130194714|NCT01314872|468670322|FG011|Period 2|Protocol Violation|3|||
130194715|NCT01314872|468670323|FG012|Period 2|Protocol Violation|3|||
130194716|NCT01314872|468670324|FG013|Period 2|Protocol Violation|2|||
130194717|NCT01314872|468670325|FG014|Period 2|Protocol Violation|0|||
130194718|NCT01314872|468670311|FG000|Period 2|Non-compliance with study drug|0|||
130194719|NCT01314872|468670312|FG001|Period 2|Non-compliance with study drug|0|||
130194720|NCT01314872|468670313|FG002|Period 2|Non-compliance with study drug|0|||
130194721|NCT01314872|468670314|FG003|Period 2|Non-compliance with study drug|0|||
130194722|NCT01314872|468670315|FG004|Period 2|Non-compliance with study drug|0|||
130194723|NCT01314872|468670316|FG005|Period 2|Non-compliance with study drug|0|||
130194724|NCT01314872|468670317|FG006|Period 2|Non-compliance with study drug|0|||
130194725|NCT01314872|468670318|FG007|Period 2|Non-compliance with study drug|0|||
130194726|NCT01314872|468670319|FG008|Period 2|Non-compliance with study drug|0|||
130194727|NCT01314872|468670320|FG009|Period 2|Non-compliance with study drug|0|||
130194728|NCT01314872|468670321|FG010|Period 2|Non-compliance with study drug|0|||
130194729|NCT01314872|468670322|FG011|Period 2|Non-compliance with study drug|3|||
130194730|NCT01314872|468670323|FG012|Period 2|Non-compliance with study drug|3|||
130194731|NCT01314872|468670324|FG013|Period 2|Non-compliance with study drug|1|||
130194732|NCT01314872|468670325|FG014|Period 2|Non-compliance with study drug|2|||
130194733|NCT01314872|468670311|FG000|Period 2|Lack of Efficacy|0|||
130194734|NCT01314872|468670312|FG001|Period 2|Lack of Efficacy|0|||
130194735|NCT01314872|468670313|FG002|Period 2|Lack of Efficacy|0|||
130194736|NCT01314872|468670314|FG003|Period 2|Lack of Efficacy|0|||
130194737|NCT01314872|468670315|FG004|Period 2|Lack of Efficacy|0|||
130194738|NCT01314872|468670316|FG005|Period 2|Lack of Efficacy|0|||
130194739|NCT01314872|468670317|FG006|Period 2|Lack of Efficacy|0|||
130194740|NCT01314872|468670318|FG007|Period 2|Lack of Efficacy|0|||
130194741|NCT01314872|468670319|FG008|Period 2|Lack of Efficacy|0|||
130194742|NCT01314872|468670320|FG009|Period 2|Lack of Efficacy|0|||
130194743|NCT01314872|468670321|FG010|Period 2|Lack of Efficacy|0|||
130194744|NCT01314872|468670322|FG011|Period 2|Lack of Efficacy|7|||
130194745|NCT01314872|468670323|FG012|Period 2|Lack of Efficacy|12|||
130194746|NCT01314872|468670324|FG013|Period 2|Lack of Efficacy|9|||
130194747|NCT01314872|468670325|FG014|Period 2|Lack of Efficacy|2|||
130194748|NCT01314872|468670311|FG000|Period 2|Pregnancy|0|||
130194749|NCT01314872|468670312|FG001|Period 2|Pregnancy|0|||
130194750|NCT01314872|468670313|FG002|Period 2|Pregnancy|0|||
130194751|NCT01314872|468670314|FG003|Period 2|Pregnancy|0|||
130194752|NCT01314872|468670315|FG004|Period 2|Pregnancy|0|||
130194753|NCT01314872|468670316|FG005|Period 2|Pregnancy|0|||
130194754|NCT01314872|468670317|FG006|Period 2|Pregnancy|0|||
130194755|NCT01314872|468670318|FG007|Period 2|Pregnancy|0|||
130194756|NCT01314872|468670319|FG008|Period 2|Pregnancy|0|||
130194757|NCT01314872|468670320|FG009|Period 2|Pregnancy|0|||
130194758|NCT01314872|468670321|FG010|Period 2|Pregnancy|0|||
130194759|NCT01314872|468670322|FG011|Period 2|Pregnancy|0|||
130194760|NCT01314872|468670323|FG012|Period 2|Pregnancy|0|||
130194761|NCT01314872|468670324|FG013|Period 2|Pregnancy|0|||
130194762|NCT01314872|468670325|FG014|Period 2|Pregnancy|1|||
130194763|NCT01314872|468670311|FG000|Period 2|Study terminated by Sponsor|0|||
130194764|NCT01314872|468670312|FG001|Period 2|Study terminated by Sponsor|0|||
130194765|NCT01314872|468670313|FG002|Period 2|Study terminated by Sponsor|0|||
130194766|NCT01314872|468670314|FG003|Period 2|Study terminated by Sponsor|0|||
130194767|NCT01314872|468670315|FG004|Period 2|Study terminated by Sponsor|0|||
130194768|NCT01314872|468670316|FG005|Period 2|Study terminated by Sponsor|0|||
130194769|NCT01314872|468670317|FG006|Period 2|Study terminated by Sponsor|0|||
130194770|NCT01314872|468670318|FG007|Period 2|Study terminated by Sponsor|0|||
130194771|NCT01314872|468670319|FG008|Period 2|Study terminated by Sponsor|0|||
130194772|NCT01314872|468670320|FG009|Period 2|Study terminated by Sponsor|0|||
130194773|NCT01314872|468670321|FG010|Period 2|Study terminated by Sponsor|0|||
130194774|NCT01314872|468670322|FG011|Period 2|Study terminated by Sponsor|2|||
130194775|NCT01314872|468670323|FG012|Period 2|Study terminated by Sponsor|2|||
130194776|NCT01314872|468670324|FG013|Period 2|Study terminated by Sponsor|3|||
130194777|NCT01314872|468670325|FG014|Period 2|Study terminated by Sponsor|0|||
130194778|NCT01314872|468670311|FG000|Period 2|Adverse event, non-fatal|0|||
130194779|NCT01314872|468670312|FG001|Period 2|Adverse event, non-fatal|0|||
130194780|NCT01314872|468670313|FG002|Period 2|Adverse event, non-fatal|0|||
130194781|NCT01314872|468670314|FG003|Period 2|Adverse event, non-fatal|0|||
130194782|NCT01314872|468670315|FG004|Period 2|Adverse event, non-fatal|0|||
130194783|NCT01314872|468670316|FG005|Period 2|Adverse event, non-fatal|0|||
130194784|NCT01314872|468670317|FG006|Period 2|Adverse event, non-fatal|0|||
130194785|NCT01314872|468670318|FG007|Period 2|Adverse event, non-fatal|0|||
130194786|NCT01314872|468670319|FG008|Period 2|Adverse event, non-fatal|0|||
130194787|NCT01314872|468670320|FG009|Period 2|Adverse event, non-fatal|0|||
130194788|NCT01314872|468670321|FG010|Period 2|Adverse event, non-fatal|0|||
130194789|NCT01314872|468670322|FG011|Period 2|Adverse event, non-fatal|13|||
130194790|NCT01314872|468670323|FG012|Period 2|Adverse event, non-fatal|16|||
130194791|NCT01314872|468670324|FG013|Period 2|Adverse event, non-fatal|24|||
130194792|NCT01314872|468670325|FG014|Period 2|Adverse event, non-fatal|9|||
130194793|NCT01314872|468670311|FG000|Period 2|Withdrawal by Subject|0|||
130194794|NCT01314872|468670312|FG001|Period 2|Withdrawal by Subject|0|||
130194795|NCT01314872|468670313|FG002|Period 2|Withdrawal by Subject|0|||
130194796|NCT01314872|468670314|FG003|Period 2|Withdrawal by Subject|0|||
130194797|NCT01314872|468670315|FG004|Period 2|Withdrawal by Subject|0|||
130194798|NCT01314872|468670316|FG005|Period 2|Withdrawal by Subject|0|||
130194799|NCT01314872|468670317|FG006|Period 2|Withdrawal by Subject|0|||
130194800|NCT01314872|468670318|FG007|Period 2|Withdrawal by Subject|0|||
130194801|NCT01314872|468670319|FG008|Period 2|Withdrawal by Subject|0|||
130194802|NCT01314872|468670320|FG009|Period 2|Withdrawal by Subject|0|||
130194803|NCT01314872|468670321|FG010|Period 2|Withdrawal by Subject|0|||
130194804|NCT01314872|468670322|FG011|Period 2|Withdrawal by Subject|14|||
130194805|NCT01314872|468670323|FG012|Period 2|Withdrawal by Subject|17|||
130194806|NCT01314872|468670324|FG013|Period 2|Withdrawal by Subject|12|||
130194807|NCT01314872|468670325|FG014|Period 2|Withdrawal by Subject|4|||
130194808|NCT01314872|468670311|FG000|Period 2|Lost to Follow-up|0|||
130194809|NCT01314872|468670312|FG001|Period 2|Lost to Follow-up|0|||
130194810|NCT01314872|468670313|FG002|Period 2|Lost to Follow-up|0|||
130194811|NCT01314872|468670314|FG003|Period 2|Lost to Follow-up|0|||
130194812|NCT01314872|468670315|FG004|Period 2|Lost to Follow-up|0|||
130194813|NCT01314872|468670316|FG005|Period 2|Lost to Follow-up|0|||
130194814|NCT01314872|468670317|FG006|Period 2|Lost to Follow-up|0|||
130194815|NCT01314872|468670318|FG007|Period 2|Lost to Follow-up|0|||
130194816|NCT01314872|468670319|FG008|Period 2|Lost to Follow-up|0|||
130194817|NCT01314872|468670320|FG009|Period 2|Lost to Follow-up|0|||
130194818|NCT01314872|468670321|FG010|Period 2|Lost to Follow-up|0|||
130194819|NCT01314872|468670322|FG011|Period 2|Lost to Follow-up|6|||
130194820|NCT01314872|468670323|FG012|Period 2|Lost to Follow-up|7|||
130194821|NCT01314872|468670324|FG013|Period 2|Lost to Follow-up|2|||
130194822|NCT01314872|468670325|FG014|Period 2|Lost to Follow-up|6|||
130194823|NCT03232931|468671737|FG000|Overall Study|Physician Decision|1|||
130194824|NCT03232931|468671738|FG001|Overall Study|Physician Decision|1|||
130194825|NCT03232931|468671737|FG000|Overall Study|Withdrawal by Subject|6|||
130194826|NCT03232931|468671738|FG001|Overall Study|Withdrawal by Subject|0|||
130194827|NCT03232931|468671737|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
130194828|NCT03232931|468671738|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
130194829|NCT03232931|468671737|FG000|Overall Study|Parent did not record voice|1|||
130194830|NCT03232931|468671738|FG001|Overall Study|Parent did not record voice|2|||
130194831|NCT03232931|468671737|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
130194832|NCT03232931|468671738|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
130194833|NCT04925557|468671739|FG000|Overall Study|Study closed|5|||
130194834|NCT04925557|468671740|FG001|Overall Study|Study closed|3|||
130194835|NCT05488470|468671741|FG000|Overall Study|Physician Decision|2|||
130194836|NCT05488470|468671741|FG000|Overall Study|Withdrawal by Subject|1|||
130194837|NCT05488470|468671741|FG000|Overall Study|Death|1|||
130194838|NCT04390503|468671748|FG000|Overall Study|Physician Decision|2|||
130194839|NCT04390503|468671749|FG001|Overall Study|Physician Decision|1|||
130194840|NCT04390503|468671748|FG000|Overall Study|Adverse Event|1|||
130194841|NCT04390503|468671749|FG001|Overall Study|Adverse Event|0|||
130194842|NCT01068730|468671751|FG000|Period 3|Personal reason|1|||
130194843|NCT01068730|468671752|FG001|Period 3|Personal reason|0|||
130194844|NCT01068730|468671753|FG002|Period 3|Personal reason|0|||
130194845|NCT01068730|468671754|FG003|Period 3|Personal reason|0|||
130194846|NCT01068730|468671751|FG000|Period 4|Family emergency|0|||
130194847|NCT01068730|468671752|FG001|Period 4|Family emergency|1|||
130194848|NCT01068730|468671753|FG002|Period 4|Family emergency|0|||
130194849|NCT01068730|468671754|FG003|Period 4|Family emergency|0|||
130194850|NCT00594100|468671758|FG000|Procedure|Technical Failure|9|||
130194851|NCT00594100|468671758|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
130194852|NCT00594100|468671758|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
130194853|NCT00594100|468671758|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
130194854|NCT01270464|468671759|FG000|Overall Study|Protocol Violation|4|||
130194855|NCT01270464|468671760|FG001|Overall Study|Protocol Violation|3|||
130194856|NCT01270464|468671761|FG002|Overall Study|Protocol Violation|2|||
130194857|NCT01270464|468671759|FG000|Overall Study|Lack of Efficacy|2|||
130194858|NCT01270464|468671760|FG001|Overall Study|Lack of Efficacy|3|||
130194859|NCT01270464|468671761|FG002|Overall Study|Lack of Efficacy|1|||
130194860|NCT01270464|468671759|FG000|Overall Study|Adverse Event|9|||
130194861|NCT01270464|468671760|FG001|Overall Study|Adverse Event|1|||
130194862|NCT01270464|468671761|FG002|Overall Study|Adverse Event|7|||
130194863|NCT01270464|468671759|FG000|Overall Study|Withdrawal by Subject|2|||
130194864|NCT01270464|468671760|FG001|Overall Study|Withdrawal by Subject|1|||
130194865|NCT01270464|468671761|FG002|Overall Study|Withdrawal by Subject|4|||
130194866|NCT01270464|468671759|FG000|Overall Study|Lost to Follow-up|2|||
130194867|NCT01270464|468671760|FG001|Overall Study|Lost to Follow-up|3|||
130194868|NCT01270464|468671761|FG002|Overall Study|Lost to Follow-up|1|||
130194869|NCT01270464|468671759|FG000|Overall Study|Other|1|||
130194870|NCT01270464|468671760|FG001|Overall Study|Other|1|||
130194871|NCT01270464|468671761|FG002|Overall Study|Other|3|||
130194872|NCT02448537|468671762|FG000|Overall Study|Withdrawal by Subject|1|||
130194873|NCT02448537|468671763|FG001|Overall Study|Withdrawal by Subject|1|||
130194874|NCT02448537|468671764|FG002|Overall Study|Withdrawal by Subject|1|||
130194875|NCT03981900|468671765|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
130194876|NCT03981900|468671765|FG000|Overall Study|Adverse Event|5|||
130194877|NCT03981900|468671765|FG000|Overall Study|Protocol Violation|1|||
130194878|NCT03981900|468671765|FG000|Overall Study|Withdrawal by Subject|7|||
130194879|NCT03981900|468671765|FG000|Overall Study|Lost to Follow-up|46|||
130194880|NCT03981900|468671765|FG000|Overall Study|Decision of the researcher|3|||
130194881|NCT03981900|468671765|FG000|Overall Study|Death|3|||
130194882|NCT03981900|468671765|FG000|Overall Study|Other|5|||
130194883|NCT04725812|468671770|FG000|Overall Study|Withdrawal by Subject|1|||
130194884|NCT04696055|468671775|FG000|Overall Study|Adverse Event|10|||
130194885|NCT04696055|468671776|FG001|Overall Study|Adverse Event|2|||
130194886|NCT04696055|468671775|FG000|Overall Study|Death|4|||
130194887|NCT04696055|468671776|FG001|Overall Study|Death|0|||
130194888|NCT04696055|468671775|FG000|Overall Study|Other|7|||
130194889|NCT04696055|468671776|FG001|Overall Study|Other|2|||
130194890|NCT04696055|468671775|FG000|Overall Study|Physician Decision|3|||
130194891|NCT04696055|468671776|FG001|Overall Study|Physician Decision|0|||
130194892|NCT04696055|468671775|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
130194893|NCT04696055|468671776|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
130194894|NCT04696055|468671775|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
130194895|NCT04696055|468671776|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
130194896|NCT04696055|468671775|FG000|Overall Study|Subject Decision|1|||
130194897|NCT04696055|468671776|FG001|Overall Study|Subject Decision|2|||
130194898|NCT03969901|468671777|FG000|Overall Study|Withdrawal by parent/guardian|0|||
130194899|NCT03969901|468671778|FG001|Overall Study|Withdrawal by parent/guardian|0|||
130194900|NCT03969901|468671779|FG002|Overall Study|Withdrawal by parent/guardian|0|||
130194901|NCT03969901|468671780|FG003|Overall Study|Withdrawal by parent/guardian|0|||
130194902|NCT03969901|468671781|FG004|Overall Study|Withdrawal by parent/guardian|1|||
130194903|NCT03969901|468671782|FG005|Overall Study|Withdrawal by parent/guardian|0|||
130194904|NCT03969901|468671783|FG006|Overall Study|Withdrawal by parent/guardian|0|||
130194905|NCT03969901|468671784|FG007|Overall Study|Withdrawal by parent/guardian|1|||
130194906|NCT03969901|468671785|FG008|Overall Study|Withdrawal by parent/guardian|1|||
130194907|NCT03969901|468671786|FG009|Overall Study|Withdrawal by parent/guardian|0|||
130194908|NCT04411810|468671787|FG000|Overall Study|Screen failure|1|||
130194909|NCT04411810|468671787|FG000|Overall Study|Withdrawal by Subject|1|||
130194910|NCT01920958|468671788|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
130194911|NCT01560234|468671789|FG000|Overall Study|Lost to Follow-up|3|||
130194912|NCT01560234|468671790|FG001|Overall Study|Lost to Follow-up|0|||
130194913|NCT01560234|468671791|FG002|Overall Study|Lost to Follow-up|1|||
130194914|NCT01560234|468671792|FG003|Overall Study|Lost to Follow-up|0|||
130194915|NCT01560234|468671793|FG004|Overall Study|Lost to Follow-up|0|||
130194916|NCT01560234|468671794|FG005|Overall Study|Lost to Follow-up|2|||
130194917|NCT01560234|468671795|FG006|Overall Study|Lost to Follow-up|0|||
130194918|NCT01560234|468671796|FG007|Overall Study|Lost to Follow-up|2|||
130194919|NCT00083759|468671801|FG000|Overall Study|Adverse Event|5|||
130194920|NCT00083759|468671802|FG001|Overall Study|Adverse Event|3|||
130194921|NCT00083759|468671801|FG000|Overall Study|Lost to Follow-up|1|||
130194922|NCT00083759|468671802|FG001|Overall Study|Lost to Follow-up|0|||
130194923|NCT00083759|468671801|FG000|Overall Study|Death|1|||
130194924|NCT00083759|468671802|FG001|Overall Study|Death|1|||
130194925|NCT00083759|468671801|FG000|Overall Study|Inadequate Therapeutic Response|32|||
130194926|NCT00083759|468671802|FG001|Overall Study|Inadequate Therapeutic Response|35|||
130194927|NCT00083759|468671801|FG000|Overall Study|Subject Withdrew Consent|2|||
130194928|NCT00083759|468671802|FG001|Overall Study|Subject Withdrew Consent|2|||
130194929|NCT00083759|468671801|FG000|Overall Study|Non-Compliance|1|||
130194930|NCT00083759|468671802|FG001|Overall Study|Non-Compliance|0|||
130194931|NCT00083759|468671801|FG000|Overall Study|Sponsor's Discretion|28|||
130194932|NCT00083759|468671802|FG001|Overall Study|Sponsor's Discretion|29|||
130194933|NCT00083759|468671801|FG000|Overall Study|Other|14|||
130194934|NCT00083759|468671802|FG001|Overall Study|Other|13|||
130194935|NCT00887315|468671805|FG000|Overall Study|Study termination|7|||
130194936|NCT00887315|468671806|FG001|Overall Study|Study termination|4|||
130194937|NCT00379080|468671807|FG000|Overall Study|Withdrawal by Subject|0|||
130194938|NCT00379080|468671808|FG001|Overall Study|Withdrawal by Subject|4|||
130194939|NCT00379080|468671809|FG002|Overall Study|Withdrawal by Subject|0|||
130194940|NCT00619892|468671810|FG000|Overall Study|Adverse Event|3|||
130194941|NCT00619892|468671811|FG001|Overall Study|Adverse Event|0|||
130194942|NCT00619892|468671810|FG000|Overall Study|Lost to Follow-up|0|||
130194943|NCT00619892|468671811|FG001|Overall Study|Lost to Follow-up|1|||
130194944|NCT00619892|468671810|FG000|Overall Study|Intercurrent illness|0|||
130194945|NCT00619892|468671811|FG001|Overall Study|Intercurrent illness|1|||
130194946|NCT00857896|468671817|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
130194947|NCT02920008|468671822|FG000|Overall Study|Death|117|||
130194948|NCT02920008|468671823|FG001|Overall Study|Death|127|||
130194949|NCT02920008|468671822|FG000|Overall Study|Withdrawal by Subject|3|||
130194950|NCT02920008|468671823|FG001|Overall Study|Withdrawal by Subject|6|||
130194951|NCT02920008|468671822|FG000|Overall Study|Lost to Follow-up|0|||
130194952|NCT02920008|468671823|FG001|Overall Study|Lost to Follow-up|1|||
130194953|NCT02737930|468671824|FG000|Overall Study|Withdrawal by Subject|0|||
130194954|NCT02737930|468671825|FG001|Overall Study|Withdrawal by Subject|1|||
130194955|NCT03169881|468671826|FG000|Overall Study|Incomplete Follow-up|10|||
130194956|NCT03169881|468671827|FG001|Overall Study|Incomplete Follow-up|15|||
130194957|NCT03169881|468671826|FG000|Overall Study|Lost to Follow-up|18|||
130194958|NCT03169881|468671827|FG001|Overall Study|Lost to Follow-up|20|||
130194959|NCT03169881|468671826|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
130194960|NCT03169881|468671827|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
130194961|NCT01028014|468671828|FG000|Overall Study|Lost to Follow-up|1|||
130194962|NCT01028014|468671829|FG001|Overall Study|Lost to Follow-up|2|||
130194963|NCT01028014|468671830|FG002|Overall Study|Lost to Follow-up|0|||
130194964|NCT01028014|468671831|FG003|Overall Study|Lost to Follow-up|1|||
130194965|NCT01028014|468671832|FG004|Overall Study|Lost to Follow-up|1|||
130194966|NCT01028014|468671833|FG005|Overall Study|Lost to Follow-up|2|||
130194967|NCT01127451|468671843|FG000|Overall Study|Other|2|||
130194968|NCT01127451|468671844|FG001|Overall Study|Other|1|||
130194969|NCT01127451|468671843|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
130194970|NCT01127451|468671844|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
130194971|NCT01127451|468671843|FG000|Overall Study|Death|22|||
130194972|NCT01127451|468671844|FG001|Overall Study|Death|17|||
130194973|NCT01127451|468671843|FG000|Overall Study|Lost to Follow-up|3|||
130194974|NCT01127451|468671844|FG001|Overall Study|Lost to Follow-up|0|||
130194975|NCT01127451|468671843|FG000|Overall Study|Administrative Reason by Sponsor|2|||
130194976|NCT01127451|468671844|FG001|Overall Study|Administrative Reason by Sponsor|2|||
130194977|NCT00930774|468671845|FG000|Overall Study|Withdrawal by Subject|1|||
130194978|NCT00930774|468671846|FG001|Overall Study|Withdrawal by Subject|9|||
130194979|NCT00930774|468671847|FG002|Overall Study|Withdrawal by Subject|2|||
130194980|NCT00930774|468671848|FG003|Overall Study|Withdrawal by Subject|0|||
130194981|NCT03200704|468671849|FG000|Overall Study|Withdrawal by Subject|1|||
130194982|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
130194983|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
130194984|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
130194985|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
130194986|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
130194987|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
130194988|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
130194989|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
130194990|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
130194991|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
130194992|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
130194993|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
130194994|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
130194995|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
130194996|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
130194997|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
130194998|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
130194999|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
130195000|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
130195001|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
130195002|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
130195003|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
130195004|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
130195005|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
130195006|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
130195007|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
130195008|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
130195009|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
130195010|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130195011|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
130195012|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
130195013|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
130195014|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
130195015|NCT00839527|468671851|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
130195016|NCT00839527|468671852|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
130195017|NCT00839527|468671853|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
130195018|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130195019|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
130195020|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
130195021|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
130195022|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
130195023|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
130195024|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
130195025|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
130195026|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
130195027|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
130195028|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
130195029|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
130195030|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
130195031|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
130195032|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
130195033|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
130195034|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
130195035|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
130195036|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
130195037|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
130195038|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
130195039|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
130195040|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
130195041|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
130195042|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
130195043|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
130195044|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
130195045|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
130195046|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
130195047|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
130195048|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
130195049|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
130195050|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
130195051|NCT00839527|468671851|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
130195052|NCT00839527|468671852|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
130195053|NCT00839527|468671853|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
130195054|NCT01704651|468671856|FG000|Overall Study|Pre-op withdrawal by subject|1|||
130195055|NCT01704651|468671857|FG001|Overall Study|Pre-op withdrawal by subject|1|||
130195056|NCT01704651|468671856|FG000|Overall Study|Pre-op change in treatment plan|1|||
130195057|NCT01704651|468671857|FG001|Overall Study|Pre-op change in treatment plan|4|||
130195058|NCT01704651|468671856|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
130195059|NCT01704651|468671857|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
130195060|NCT01704651|468671856|FG000|Overall Study|Post-op did not have laparotomy|2|||
130195061|NCT01704651|468671857|FG001|Overall Study|Post-op did not have laparotomy|1|||
130195062|NCT00634803|468671859|FG000|Overall Study|Lost to Follow-up|6|||
130195063|NCT00634803|468671860|FG001|Overall Study|Lost to Follow-up|7|||
130195064|NCT00634803|468671861|FG002|Overall Study|Lost to Follow-up|7|||
130195065|NCT00364923|468671863|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
130195066|NCT00364923|468671863|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
130195067|NCT04087720|468671867|FG000|Overall Study|Withdrawal by Subject|2|||
130195068|NCT04087720|468671867|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
130195069|NCT03706430|468671870|FG000|Overall Study|No A-Line placed|5|||
130195070|NCT03706430|468671870|FG000|Overall Study|Subject had gel nail polish|1|||
130195071|NCT03706430|468671870|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
130195072|NCT03706430|468671870|FG000|Overall Study|Cancelled Case|6|||
130195073|NCT03706430|468671870|FG000|Overall Study|Physician Decision|2|||
130195074|NCT00520533|468671871|FG000|Overall Study|Death|1|||
130195075|NCT00520533|468671871|FG000|Overall Study|Suspension of the study for safety reasons|1|||
130195076|NCT00520533|468671871|FG000|Overall Study|Withdrawal by Subject|1|||
130195077|NCT00520533|468671871|FG000|Overall Study|Physician Decision|1|||
130195078|NCT00478777|468671872|FG000|Overall Study|Adverse Event|29|||
130195079|NCT00478777|468671872|FG000|Overall Study|Lack of Efficacy|23|||
130195080|NCT00478777|468671872|FG000|Overall Study|Withdrawal by Subject|4|||
130195081|NCT00478777|468671872|FG000|Overall Study|Death|3|||
130195082|NCT00478777|468671872|FG000|Overall Study|Protocol Violation|3|||
130195083|NCT00478777|468671872|FG000|Overall Study|Lost to Follow-up|3|||
130195084|NCT00478777|468671872|FG000|Overall Study|Physician Decision|1|||
130195085|NCT00478777|468671872|FG000|Overall Study|Intolerance of therapy|1|||
130195086|NCT00478777|468671872|FG000|Overall Study|Lack of compliance|1|||
130195087|NCT00478777|468671872|FG000|Overall Study|Lymphocytes infusion|1|||
130195088|NCT00478777|468671872|FG000|Overall Study|End of therapy|2|||
130195089|NCT00478777|468671872|FG000|Overall Study|Not treated with lenalidomide|6|||
130195090|NCT00552396|468671873|FG000|Overall Study|protocol withdrawal criteria|3|||
130195091|NCT00552396|468671874|FG001|Overall Study|protocol withdrawal criteria|3|||
130195092|NCT00552396|468671875|FG002|Overall Study|protocol withdrawal criteria|3|||
130195093|NCT00552396|468671876|FG003|Overall Study|protocol withdrawal criteria|6|||
130195094|NCT00552396|468671877|FG004|Overall Study|protocol withdrawal criteria|3|||
130195095|NCT00552396|468671878|FG005|Overall Study|protocol withdrawal criteria|3|||
130195096|NCT00552396|468671879|FG006|Overall Study|protocol withdrawal criteria|9|||
130195097|NCT02553499|468671880|FG000|Overall Study|Adverse Event|0|||
130195098|NCT02553499|468671881|FG001|Overall Study|Adverse Event|0|||
130195099|NCT02553499|468671882|FG002|Overall Study|Adverse Event|0|||
130195100|NCT02553499|468671883|FG003|Overall Study|Adverse Event|0|||
130195101|NCT02553499|468671884|FG004|Overall Study|Adverse Event|0|||
130195102|NCT02553499|468671885|FG005|Overall Study|Adverse Event|0|||
130195103|NCT02553499|468671886|FG006|Overall Study|Adverse Event|1|||
130195104|NCT02553499|468671887|FG007|Overall Study|Adverse Event|1|||
130195105|NCT02553499|468671888|FG008|Overall Study|Adverse Event|0|||
130195106|NCT02553499|468671889|FG009|Overall Study|Adverse Event|0|||
130195107|NCT02553499|468671890|FG010|Overall Study|Adverse Event|0|||
130195108|NCT02553499|468671891|FG011|Overall Study|Adverse Event|0|||
130195109|NCT02553499|468671892|FG012|Overall Study|Adverse Event|0|||
130195110|NCT02553499|468671893|FG013|Overall Study|Adverse Event|1|||
130195111|NCT02553499|468671880|FG000|Overall Study|Death|0|||
130195112|NCT02553499|468671881|FG001|Overall Study|Death|1|||
130195113|NCT02553499|468671882|FG002|Overall Study|Death|1|||
130195114|NCT02553499|468671883|FG003|Overall Study|Death|0|||
130195115|NCT02553499|468671884|FG004|Overall Study|Death|1|||
130195116|NCT02553499|468671885|FG005|Overall Study|Death|2|||
130195117|NCT02553499|468671886|FG006|Overall Study|Death|0|||
130195118|NCT02553499|468671887|FG007|Overall Study|Death|0|||
130195119|NCT02553499|468671888|FG008|Overall Study|Death|0|||
130195120|NCT02553499|468671889|FG009|Overall Study|Death|0|||
130195121|NCT02553499|468671890|FG010|Overall Study|Death|1|||
130195122|NCT02553499|468671891|FG011|Overall Study|Death|0|||
130195123|NCT02553499|468671892|FG012|Overall Study|Death|0|||
130195124|NCT02553499|468671893|FG013|Overall Study|Death|0|||
130195125|NCT02553499|468671880|FG000|Overall Study|Lost to Follow-up|0|||
130195126|NCT02553499|468671881|FG001|Overall Study|Lost to Follow-up|0|||
130195127|NCT02553499|468671882|FG002|Overall Study|Lost to Follow-up|0|||
130195128|NCT02553499|468671883|FG003|Overall Study|Lost to Follow-up|0|||
130195129|NCT02553499|468671884|FG004|Overall Study|Lost to Follow-up|0|||
130195130|NCT02553499|468671885|FG005|Overall Study|Lost to Follow-up|0|||
130195131|NCT02553499|468671886|FG006|Overall Study|Lost to Follow-up|1|||
130195132|NCT02553499|468671887|FG007|Overall Study|Lost to Follow-up|0|||
130195133|NCT02553499|468671888|FG008|Overall Study|Lost to Follow-up|0|||
130195134|NCT02553499|468671889|FG009|Overall Study|Lost to Follow-up|0|||
130195135|NCT02553499|468671890|FG010|Overall Study|Lost to Follow-up|0|||
130195136|NCT02553499|468671891|FG011|Overall Study|Lost to Follow-up|0|||
130195137|NCT02553499|468671892|FG012|Overall Study|Lost to Follow-up|0|||
130195138|NCT02553499|468671893|FG013|Overall Study|Lost to Follow-up|0|||
130195139|NCT02553499|468671880|FG000|Overall Study|Physician Decision|0|||
130195140|NCT02553499|468671881|FG001|Overall Study|Physician Decision|1|||
130195141|NCT02553499|468671882|FG002|Overall Study|Physician Decision|1|||
130195142|NCT02553499|468671883|FG003|Overall Study|Physician Decision|0|||
130195143|NCT02553499|468671884|FG004|Overall Study|Physician Decision|1|||
130195144|NCT02553499|468671885|FG005|Overall Study|Physician Decision|0|||
130195145|NCT02553499|468671886|FG006|Overall Study|Physician Decision|0|||
130195146|NCT02553499|468671887|FG007|Overall Study|Physician Decision|1|||
130195147|NCT02553499|468671888|FG008|Overall Study|Physician Decision|1|||
130195148|NCT02553499|468671889|FG009|Overall Study|Physician Decision|2|||
130195149|NCT02553499|468671890|FG010|Overall Study|Physician Decision|1|||
130195150|NCT02553499|468671891|FG011|Overall Study|Physician Decision|3|||
130195151|NCT02553499|468671892|FG012|Overall Study|Physician Decision|1|||
130195152|NCT02553499|468671893|FG013|Overall Study|Physician Decision|0|||
130195153|NCT02553499|468671880|FG000|Overall Study|Progressive Disease|0|||
130195154|NCT02553499|468671881|FG001|Overall Study|Progressive Disease|0|||
130195155|NCT02553499|468671882|FG002|Overall Study|Progressive Disease|0|||
130195156|NCT02553499|468671883|FG003|Overall Study|Progressive Disease|2|||
130195157|NCT02553499|468671884|FG004|Overall Study|Progressive Disease|1|||
130195158|NCT02553499|468671885|FG005|Overall Study|Progressive Disease|1|||
130195159|NCT02553499|468671886|FG006|Overall Study|Progressive Disease|1|||
130195160|NCT02553499|468671887|FG007|Overall Study|Progressive Disease|0|||
130195161|NCT02553499|468671888|FG008|Overall Study|Progressive Disease|0|||
130195162|NCT02553499|468671889|FG009|Overall Study|Progressive Disease|1|||
130195163|NCT02553499|468671890|FG010|Overall Study|Progressive Disease|0|||
130195164|NCT02553499|468671891|FG011|Overall Study|Progressive Disease|0|||
130195165|NCT02553499|468671892|FG012|Overall Study|Progressive Disease|2|||
130195166|NCT02553499|468671893|FG013|Overall Study|Progressive Disease|1|||
130195167|NCT02553499|468671880|FG000|Overall Study|Study Terminated by Sponsor|0|||
130195168|NCT02553499|468671881|FG001|Overall Study|Study Terminated by Sponsor|0|||
130195169|NCT02553499|468671882|FG002|Overall Study|Study Terminated by Sponsor|0|||
130195170|NCT02553499|468671883|FG003|Overall Study|Study Terminated by Sponsor|0|||
130195171|NCT02553499|468671884|FG004|Overall Study|Study Terminated by Sponsor|0|||
130195172|NCT02553499|468671885|FG005|Overall Study|Study Terminated by Sponsor|0|||
130195173|NCT02553499|468671886|FG006|Overall Study|Study Terminated by Sponsor|0|||
130195174|NCT02553499|468671887|FG007|Overall Study|Study Terminated by Sponsor|0|||
130195175|NCT02553499|468671888|FG008|Overall Study|Study Terminated by Sponsor|1|||
130195176|NCT02553499|468671889|FG009|Overall Study|Study Terminated by Sponsor|0|||
130195177|NCT02553499|468671890|FG010|Overall Study|Study Terminated by Sponsor|0|||
130195178|NCT02553499|468671891|FG011|Overall Study|Study Terminated by Sponsor|0|||
130195179|NCT02553499|468671892|FG012|Overall Study|Study Terminated by Sponsor|0|||
130195180|NCT02553499|468671893|FG013|Overall Study|Study Terminated by Sponsor|0|||
130195181|NCT02553499|468671880|FG000|Overall Study|Withdrawal by Subject|2|||
130195182|NCT02553499|468671881|FG001|Overall Study|Withdrawal by Subject|0|||
130195183|NCT02553499|468671882|FG002|Overall Study|Withdrawal by Subject|0|||
130195184|NCT02553499|468671883|FG003|Overall Study|Withdrawal by Subject|0|||
130195185|NCT02553499|468671884|FG004|Overall Study|Withdrawal by Subject|0|||
130195186|NCT02553499|468671885|FG005|Overall Study|Withdrawal by Subject|0|||
130195187|NCT02553499|468671886|FG006|Overall Study|Withdrawal by Subject|0|||
130195188|NCT02553499|468671887|FG007|Overall Study|Withdrawal by Subject|1|||
130195189|NCT02553499|468671888|FG008|Overall Study|Withdrawal by Subject|1|||
130195190|NCT02553499|468671889|FG009|Overall Study|Withdrawal by Subject|0|||
130195191|NCT02553499|468671890|FG010|Overall Study|Withdrawal by Subject|1|||
130195192|NCT02553499|468671891|FG011|Overall Study|Withdrawal by Subject|0|||
130195193|NCT02553499|468671892|FG012|Overall Study|Withdrawal by Subject|0|||
130195194|NCT02553499|468671893|FG013|Overall Study|Withdrawal by Subject|0|||
130195195|NCT03319732|468671899|FG000|Overall Study|Adverse Event|40|||
130195196|NCT03319732|468671899|FG000|Overall Study|Withdrawal by Subject|50|||
130195197|NCT03319732|468671899|FG000|Overall Study|MS relapse|10|||
130195198|NCT03319732|468671899|FG000|Overall Study|reason not specified|5|||
130195199|NCT00767455|468671900|FG000|Overall Study|Investigator error|19|||
130195200|NCT03386994|468671901|FG000|Overall Study|Lung transplant|1|||
130195201|NCT03386994|468671901|FG000|Overall Study|Adverse Event|14|||
130195202|NCT03386994|468671901|FG000|Overall Study|Lost to Follow-up|4|||
130195203|NCT03386994|468671901|FG000|Overall Study|Withdrawal by Subject|3|||
130195204|NCT03386994|468671901|FG000|Overall Study|Death|16|||
130195211|NCT00068393|468673502|FG000|Overall Study|Adverse Event|2|||
130195212|NCT00068393|468673502|FG000|Overall Study|Death|3|||
130195213|NCT00068393|468673502|FG000|Overall Study|Withdrawal by Subject|3|||
130195214|NCT00068393|468673502|FG000|Overall Study|Alternative treatment|1|||
130195215|NCT00068393|468673502|FG000|Overall Study|Quality of life worsening|1|||
130195216|NCT04981470|468673506|FG000|Overall Study|Device failure in all 4 patients|4|||
130195217|NCT00593684|468673507|FG000|Overall Study|Death|2|||
130195218|NCT00593684|468673508|FG001|Overall Study|Death|1|||
130195219|NCT00078767|468673509|FG000|Overall Study|Withdrawal by Subject|1|||
130195220|NCT00078767|468673510|FG001|Overall Study|Withdrawal by Subject|1|||
130195221|NCT02282631|468673515|FG000|Overall Study|Lost to Follow-up|2|||
130195222|NCT02282631|468673516|FG001|Overall Study|Lost to Follow-up|0|||
130195223|NCT01736397|468673517|FG000|Overall Study|Lack of Efficacy|1|||
130195224|NCT01736397|468673518|FG001|Overall Study|Lack of Efficacy|11|||
130195225|NCT01736397|468673517|FG000|Overall Study|Withdrawal by Subject|6|||
130195226|NCT01736397|468673518|FG001|Overall Study|Withdrawal by Subject|5|||
130195227|NCT01736397|468673517|FG000|Overall Study|Lost to Follow-up|0|||
130195228|NCT01736397|468673518|FG001|Overall Study|Lost to Follow-up|1|||
130195229|NCT01736397|468673517|FG000|Overall Study|Adverse Event|6|||
130195230|NCT01736397|468673518|FG001|Overall Study|Adverse Event|3|||
130195231|NCT01736397|468673517|FG000|Overall Study|Not stated|1|||
130195232|NCT01736397|468673518|FG001|Overall Study|Not stated|4|||
130195233|NCT05088603|468673519|FG000|Overall Study|Protocol Violation|6|||
130195234|NCT05088603|468673520|FG001|Overall Study|Protocol Violation|1|||
130195235|NCT01841762|468673522|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
130195236|NCT01841762|468673522|FG000|Treatment Period|Adverse Event|16|||
130195237|NCT01841762|468673522|FG000|Treatment Period|Death|1|||
130195238|NCT01841762|468673522|FG000|Treatment Period|Withdrawal by Subject|7|||
130195239|NCT01841762|468673522|FG000|Treatment Period|Lost to Follow-up|1|||
130195240|NCT01841762|468673522|FG000|Treatment Period|Physician Decision|2|||
130195241|NCT01841762|468673522|FG000|Treatment Period|Other, including non-compliance|5|||
130195242|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
130195243|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
130195244|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
130195245|NCT01841762|468673522|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
130195246|NCT03260244|468673523|FG000|Overall Study|Death|19|||
130195247|NCT03260244|468673523|FG000|Overall Study|Lost to Follow-up|60|||
130195248|NCT03260244|468673523|FG000|Overall Study|Withdrawal by Subject|48|||
130195249|NCT03260244|468673523|FG000|Overall Study|Procedure Not Performed|21|||
130195250|NCT03260244|468673523|FG000|Overall Study|Enrollment Criteria Not Met|31|||
130195251|NCT03260244|468673523|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
130195252|NCT03260244|468673523|FG000|Overall Study|Subject Noncompliance|6|||
130195253|NCT03260244|468673523|FG000|Overall Study|No inducible Arrhythmia|2|||
130195254|NCT03260244|468673523|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
130195255|NCT03260244|468673523|FG000|Overall Study|Screen Failure|2|||
130195256|NCT03260244|468673523|FG000|Overall Study|Treated Off Label|69|||
130195257|NCT03260244|468673523|FG000|Overall Study|No Radiofrequency Ablation|14|||
130195258|NCT03528369|468673528|FG000|Overall Study|Withdrawal by Subject|2|||
130195259|NCT03528369|468673529|FG001|Overall Study|Withdrawal by Subject|0|||
130195260|NCT03528369|468673530|FG002|Overall Study|Withdrawal by Subject|0|||
130195261|NCT03528369|468673528|FG000|Overall Study|Lost to Follow-up|1|||
130195262|NCT03528369|468673529|FG001|Overall Study|Lost to Follow-up|0|||
130195263|NCT03528369|468673530|FG002|Overall Study|Lost to Follow-up|0|||
130195264|NCT03528369|468673528|FG000|Overall Study|Adverse Event|0|||
130195265|NCT03528369|468673529|FG001|Overall Study|Adverse Event|1|||
130195266|NCT03528369|468673530|FG002|Overall Study|Adverse Event|0|||
130195267|NCT02162719|468673531|FG000|Overall Study|Death|41|||
130195268|NCT02162719|468673532|FG001|Overall Study|Death|46|||
130195269|NCT02162719|468673531|FG000|Overall Study|Lost to Follow-up|1|||
130195270|NCT02162719|468673532|FG001|Overall Study|Lost to Follow-up|3|||
130195271|NCT02162719|468673531|FG000|Overall Study|Disease Progression|2|||
130195272|NCT02162719|468673532|FG001|Overall Study|Disease Progression|1|||
130195273|NCT02162719|468673531|FG000|Overall Study|Withdrawal by Subject|8|||
130195274|NCT02162719|468673532|FG001|Overall Study|Withdrawal by Subject|2|||
130195275|NCT02162719|468673531|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
130195276|NCT02162719|468673532|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
130195277|NCT03555565|468673533|FG000|Overall Study|Case Report Forms Uncollected|2|||
130195278|NCT03555565|468673533|FG000|Overall Study|Protocol Deviation|13|||
130195279|NCT01163851|468673539|FG000|Overall Study|Site Closure|0|||
130195280|NCT01163851|468673540|FG001|Overall Study|Site Closure|1|||
130195281|NCT01163851|468673539|FG000|Overall Study|Enrolled but not treated|1|||
130195282|NCT01163851|468673540|FG001|Overall Study|Enrolled but not treated|0|||
130195283|NCT03192306|468673543|FG000|Overall Study|Did not treat cold sore during study|149|||
130195284|NCT03192306|468673544|FG001|Overall Study|Did not treat cold sore during study|143|||
130195285|NCT03192306|468673543|FG000|Overall Study|Withdrawal by Subject|1|||
130195286|NCT03192306|468673544|FG001|Overall Study|Withdrawal by Subject|1|||
130195287|NCT03192306|468673543|FG000|Overall Study|Lost to Follow-up|1|||
130195288|NCT03192306|468673544|FG001|Overall Study|Lost to Follow-up|0|||
130195289|NCT03192306|468673543|FG000|Overall Study|Protocol Violation|1|||
130195290|NCT03192306|468673544|FG001|Overall Study|Protocol Violation|1|||
130195291|NCT02589626|468673549|FG000|Overall Study|Other than the reason specified|1|||
130195292|NCT02589626|468673550|FG001|Overall Study|Other than the reason specified|0|||
130195293|NCT02589626|468673549|FG000|Overall Study|Withdrawal by Subject|1|||
130195294|NCT02589626|468673550|FG001|Overall Study|Withdrawal by Subject|1|||
130195295|NCT02589626|468673549|FG000|Overall Study|Adverse Event|1|||
130195296|NCT02589626|468673550|FG001|Overall Study|Adverse Event|1|||
130195297|NCT02564900|468673551|FG000|Dose Escalation|Progressive disease per RECIST|2|||
130195298|NCT02564900|468673552|FG001|Dose Escalation|Progressive disease per RECIST|3|||
130195299|NCT02564900|468673553|FG002|Dose Escalation|Progressive disease per RECIST|3|||
130195300|NCT02564900|468673554|FG003|Dose Escalation|Progressive disease per RECIST|3|||
130195301|NCT02564900|468673555|FG004|Dose Escalation|Progressive disease per RECIST|3|||
130195302|NCT02564900|468673556|FG005|Dose Escalation|Progressive disease per RECIST|1|||
130195303|NCT02564900|468673557|FG006|Dose Escalation|Progressive disease per RECIST|0|||
130195304|NCT02564900|468673558|FG007|Dose Escalation|Progressive disease per RECIST|0|||
130195305|NCT02564900|468673559|FG008|Dose Escalation|Progressive disease per RECIST|0|||
130195306|NCT02564900|468673560|FG009|Dose Escalation|Progressive disease per RECIST|0|||
130195307|NCT02564900|468673561|FG010|Dose Escalation|Progressive disease per RECIST|0|||
130195308|NCT02564900|468673562|FG011|Dose Escalation|Progressive disease per RECIST|0|||
130195309|NCT02564900|468673563|FG012|Dose Escalation|Progressive disease per RECIST|0|||
130195310|NCT02564900|468673564|FG013|Dose Escalation|Progressive disease per RECIST|0|||
130195311|NCT02564900|468673565|FG014|Dose Escalation|Progressive disease per RECIST|0|||
130195312|NCT02564900|468673551|FG000|Dose Escalation|Ongoing|1|||
130195313|NCT02564900|468673552|FG001|Dose Escalation|Ongoing|0|||
130195314|NCT02564900|468673553|FG002|Dose Escalation|Ongoing|0|||
130195315|NCT02564900|468673554|FG003|Dose Escalation|Ongoing|2|||
130195316|NCT02564900|468673555|FG004|Dose Escalation|Ongoing|2|||
130195317|NCT02564900|468673556|FG005|Dose Escalation|Ongoing|2|||
130195318|NCT02564900|468673557|FG006|Dose Escalation|Ongoing|0|||
130195319|NCT02564900|468673558|FG007|Dose Escalation|Ongoing|0|||
130195320|NCT02564900|468673559|FG008|Dose Escalation|Ongoing|0|||
130195321|NCT02564900|468673560|FG009|Dose Escalation|Ongoing|0|||
130195322|NCT02564900|468673561|FG010|Dose Escalation|Ongoing|0|||
130195323|NCT02564900|468673562|FG011|Dose Escalation|Ongoing|0|||
130195324|NCT02564900|468673563|FG012|Dose Escalation|Ongoing|0|||
130195325|NCT02564900|468673564|FG013|Dose Escalation|Ongoing|0|||
130195326|NCT02564900|468673565|FG014|Dose Escalation|Ongoing|0|||
130195327|NCT02564900|468673551|FG000|Dose Escalation|Adverse Event|0|||
130195328|NCT02564900|468673552|FG001|Dose Escalation|Adverse Event|0|||
130195329|NCT02564900|468673553|FG002|Dose Escalation|Adverse Event|0|||
130195330|NCT02564900|468673554|FG003|Dose Escalation|Adverse Event|1|||
130195331|NCT02564900|468673555|FG004|Dose Escalation|Adverse Event|1|||
130195332|NCT02564900|468673556|FG005|Dose Escalation|Adverse Event|3|||
130195333|NCT02564900|468673557|FG006|Dose Escalation|Adverse Event|0|||
130195334|NCT02564900|468673558|FG007|Dose Escalation|Adverse Event|0|||
130195335|NCT02564900|468673559|FG008|Dose Escalation|Adverse Event|0|||
130195336|NCT02564900|468673560|FG009|Dose Escalation|Adverse Event|0|||
130195337|NCT02564900|468673561|FG010|Dose Escalation|Adverse Event|0|||
130195338|NCT02564900|468673562|FG011|Dose Escalation|Adverse Event|0|||
130195339|NCT02564900|468673563|FG012|Dose Escalation|Adverse Event|0|||
130195340|NCT02564900|468673564|FG013|Dose Escalation|Adverse Event|0|||
130195341|NCT02564900|468673565|FG014|Dose Escalation|Adverse Event|0|||
130195342|NCT02564900|468673551|FG000|Dose Expansion|Progressive disease per RECIST|0|||
130195343|NCT02564900|468673552|FG001|Dose Expansion|Progressive disease per RECIST|0|||
130195344|NCT02564900|468673553|FG002|Dose Expansion|Progressive disease per RECIST|0|||
130195345|NCT02564900|468673554|FG003|Dose Expansion|Progressive disease per RECIST|0|||
130195346|NCT02564900|468673555|FG004|Dose Expansion|Progressive disease per RECIST|0|||
130195347|NCT02564900|468673556|FG005|Dose Expansion|Progressive disease per RECIST|0|||
130195348|NCT02564900|468673557|FG006|Dose Expansion|Progressive disease per RECIST|19|||
130195349|NCT02564900|468673558|FG007|Dose Expansion|Progressive disease per RECIST|17|||
130195350|NCT02564900|468673559|FG008|Dose Expansion|Progressive disease per RECIST|8|||
130195351|NCT02564900|468673560|FG009|Dose Expansion|Progressive disease per RECIST|16|||
130195352|NCT02564900|468673561|FG010|Dose Expansion|Progressive disease per RECIST|13|||
130195353|NCT02564900|468673562|FG011|Dose Expansion|Progressive disease per RECIST|19|||
130195354|NCT02564900|468673563|FG012|Dose Expansion|Progressive disease per RECIST|10|||
130195355|NCT02564900|468673564|FG013|Dose Expansion|Progressive disease per RECIST|13|||
130195356|NCT02564900|468673565|FG014|Dose Expansion|Progressive disease per RECIST|11|||
130195357|NCT02564900|468673551|FG000|Dose Expansion|Clinical progression|0|||
130195358|NCT02564900|468673552|FG001|Dose Expansion|Clinical progression|0|||
130195359|NCT02564900|468673553|FG002|Dose Expansion|Clinical progression|0|||
130195360|NCT02564900|468673554|FG003|Dose Expansion|Clinical progression|0|||
130195361|NCT02564900|468673555|FG004|Dose Expansion|Clinical progression|0|||
130195362|NCT02564900|468673556|FG005|Dose Expansion|Clinical progression|0|||
130195363|NCT02564900|468673557|FG006|Dose Expansion|Clinical progression|5|||
130195364|NCT02564900|468673558|FG007|Dose Expansion|Clinical progression|12|||
130195365|NCT02564900|468673559|FG008|Dose Expansion|Clinical progression|0|||
130195366|NCT02564900|468673560|FG009|Dose Expansion|Clinical progression|3|||
130195367|NCT02564900|468673561|FG010|Dose Expansion|Clinical progression|2|||
130195368|NCT02564900|468673562|FG011|Dose Expansion|Clinical progression|0|||
130195369|NCT02564900|468673563|FG012|Dose Expansion|Clinical progression|1|||
130195370|NCT02564900|468673564|FG013|Dose Expansion|Clinical progression|3|||
130195371|NCT02564900|468673565|FG014|Dose Expansion|Clinical progression|1|||
130195372|NCT02564900|468673551|FG000|Dose Expansion|Adverse Event|0|||
130195373|NCT02564900|468673552|FG001|Dose Expansion|Adverse Event|0|||
130195374|NCT02564900|468673553|FG002|Dose Expansion|Adverse Event|0|||
130195375|NCT02564900|468673554|FG003|Dose Expansion|Adverse Event|0|||
130195376|NCT02564900|468673555|FG004|Dose Expansion|Adverse Event|0|||
130195377|NCT02564900|468673556|FG005|Dose Expansion|Adverse Event|0|||
130195378|NCT02564900|468673557|FG006|Dose Expansion|Adverse Event|9|||
130195379|NCT02564900|468673558|FG007|Dose Expansion|Adverse Event|22|||
130195380|NCT02564900|468673559|FG008|Dose Expansion|Adverse Event|0|||
130195381|NCT02564900|468673560|FG009|Dose Expansion|Adverse Event|11|||
130195382|NCT02564900|468673561|FG010|Dose Expansion|Adverse Event|0|||
130195383|NCT02564900|468673562|FG011|Dose Expansion|Adverse Event|5|||
130195384|NCT02564900|468673563|FG012|Dose Expansion|Adverse Event|2|||
130195385|NCT02564900|468673564|FG013|Dose Expansion|Adverse Event|2|||
130195386|NCT02564900|468673565|FG014|Dose Expansion|Adverse Event|1|||
130195387|NCT02564900|468673551|FG000|Dose Expansion|Ongoing|0|||
130195388|NCT02564900|468673552|FG001|Dose Expansion|Ongoing|0|||
130195389|NCT02564900|468673553|FG002|Dose Expansion|Ongoing|0|||
130195390|NCT02564900|468673554|FG003|Dose Expansion|Ongoing|0|||
130195391|NCT02564900|468673555|FG004|Dose Expansion|Ongoing|0|||
130195392|NCT02564900|468673556|FG005|Dose Expansion|Ongoing|0|||
130195393|NCT02564900|468673557|FG006|Dose Expansion|Ongoing|9|||
130195394|NCT02564900|468673558|FG007|Dose Expansion|Ongoing|10|||
130195395|NCT02564900|468673559|FG008|Dose Expansion|Ongoing|11|||
130195396|NCT02564900|468673560|FG009|Dose Expansion|Ongoing|3|||
130195397|NCT02564900|468673561|FG010|Dose Expansion|Ongoing|0|||
130195398|NCT02564900|468673562|FG011|Dose Expansion|Ongoing|0|||
130195399|NCT02564900|468673563|FG012|Dose Expansion|Ongoing|4|||
130195400|NCT02564900|468673564|FG013|Dose Expansion|Ongoing|0|||
130195401|NCT02564900|468673565|FG014|Dose Expansion|Ongoing|6|||
130195402|NCT02564900|468673551|FG000|Dose Expansion|Death|0|||
130195403|NCT02564900|468673552|FG001|Dose Expansion|Death|0|||
130195404|NCT02564900|468673553|FG002|Dose Expansion|Death|0|||
130195405|NCT02564900|468673554|FG003|Dose Expansion|Death|0|||
130195406|NCT02564900|468673555|FG004|Dose Expansion|Death|0|||
130195407|NCT02564900|468673556|FG005|Dose Expansion|Death|0|||
130195408|NCT02564900|468673557|FG006|Dose Expansion|Death|1|||
130195409|NCT02564900|468673558|FG007|Dose Expansion|Death|0|||
130195410|NCT02564900|468673559|FG008|Dose Expansion|Death|0|||
130195411|NCT02564900|468673560|FG009|Dose Expansion|Death|0|||
130195412|NCT02564900|468673561|FG010|Dose Expansion|Death|1|||
130195413|NCT02564900|468673562|FG011|Dose Expansion|Death|0|||
130195414|NCT02564900|468673563|FG012|Dose Expansion|Death|1|||
130195415|NCT02564900|468673564|FG013|Dose Expansion|Death|1|||
130195416|NCT02564900|468673565|FG014|Dose Expansion|Death|0|||
130195417|NCT02564900|468673551|FG000|Dose Expansion|Withdrawal by Subject|0|||
130195418|NCT02564900|468673552|FG001|Dose Expansion|Withdrawal by Subject|0|||
130195419|NCT02564900|468673553|FG002|Dose Expansion|Withdrawal by Subject|0|||
130195420|NCT02564900|468673554|FG003|Dose Expansion|Withdrawal by Subject|0|||
130195421|NCT02564900|468673555|FG004|Dose Expansion|Withdrawal by Subject|0|||
130195422|NCT02564900|468673556|FG005|Dose Expansion|Withdrawal by Subject|0|||
130195423|NCT02564900|468673557|FG006|Dose Expansion|Withdrawal by Subject|4|||
130195424|NCT02564900|468673558|FG007|Dose Expansion|Withdrawal by Subject|0|||
130195425|NCT02564900|468673559|FG008|Dose Expansion|Withdrawal by Subject|0|||
130195426|NCT02564900|468673560|FG009|Dose Expansion|Withdrawal by Subject|0|||
130195427|NCT02564900|468673561|FG010|Dose Expansion|Withdrawal by Subject|1|||
130195428|NCT02564900|468673562|FG011|Dose Expansion|Withdrawal by Subject|0|||
130195429|NCT02564900|468673563|FG012|Dose Expansion|Withdrawal by Subject|0|||
130195430|NCT02564900|468673564|FG013|Dose Expansion|Withdrawal by Subject|1|||
130195431|NCT02564900|468673565|FG014|Dose Expansion|Withdrawal by Subject|1|||
130195432|NCT02564900|468673551|FG000|Dose Expansion|Other|0|||
130195433|NCT02564900|468673552|FG001|Dose Expansion|Other|0|||
130195434|NCT02564900|468673553|FG002|Dose Expansion|Other|0|||
130195435|NCT02564900|468673554|FG003|Dose Expansion|Other|0|||
130195436|NCT02564900|468673555|FG004|Dose Expansion|Other|0|||
130195437|NCT02564900|468673556|FG005|Dose Expansion|Other|0|||
130195438|NCT02564900|468673557|FG006|Dose Expansion|Other|1|||
130195439|NCT02564900|468673558|FG007|Dose Expansion|Other|0|||
130195440|NCT02564900|468673559|FG008|Dose Expansion|Other|1|||
130195441|NCT02564900|468673560|FG009|Dose Expansion|Other|0|||
130195442|NCT02564900|468673561|FG010|Dose Expansion|Other|0|||
130195443|NCT02564900|468673562|FG011|Dose Expansion|Other|0|||
130195444|NCT02564900|468673563|FG012|Dose Expansion|Other|0|||
130195445|NCT02564900|468673564|FG013|Dose Expansion|Other|0|||
130195446|NCT02564900|468673565|FG014|Dose Expansion|Other|1|||
130195447|NCT02564900|468673551|FG000|Dose Expansion|Did not receive treatment|0|||
130195448|NCT02564900|468673552|FG001|Dose Expansion|Did not receive treatment|0|||
130195449|NCT02564900|468673553|FG002|Dose Expansion|Did not receive treatment|0|||
130195450|NCT02564900|468673554|FG003|Dose Expansion|Did not receive treatment|0|||
130195451|NCT02564900|468673555|FG004|Dose Expansion|Did not receive treatment|0|||
130195452|NCT02564900|468673556|FG005|Dose Expansion|Did not receive treatment|0|||
130195453|NCT02564900|468673557|FG006|Dose Expansion|Did not receive treatment|1|||
130195454|NCT02564900|468673558|FG007|Dose Expansion|Did not receive treatment|1|||
130195455|NCT02564900|468673559|FG008|Dose Expansion|Did not receive treatment|0|||
130195456|NCT02564900|468673560|FG009|Dose Expansion|Did not receive treatment|0|||
130195457|NCT02564900|468673561|FG010|Dose Expansion|Did not receive treatment|0|||
130195458|NCT02564900|468673562|FG011|Dose Expansion|Did not receive treatment|0|||
130195459|NCT02564900|468673563|FG012|Dose Expansion|Did not receive treatment|0|||
130195460|NCT02564900|468673564|FG013|Dose Expansion|Did not receive treatment|0|||
130195461|NCT02564900|468673565|FG014|Dose Expansion|Did not receive treatment|1|||
130195462|NCT00892151|468673566|FG000|Overall Study|Protocol Violation|1|||
130195463|NCT04075682|468673569|FG000|Overall Study|Lost to Follow-up|5|||
130195464|NCT04075682|468673570|FG001|Overall Study|Lost to Follow-up|5|||
130195465|NCT04075682|468673571|FG002|Overall Study|Lost to Follow-up|2|||
130195466|NCT04075682|468673572|FG003|Overall Study|Lost to Follow-up|2|||
130195467|NCT04075682|468673569|FG000|Overall Study|Withdrawal by Subject|1|||
130195468|NCT04075682|468673570|FG001|Overall Study|Withdrawal by Subject|0|||
130195469|NCT04075682|468673571|FG002|Overall Study|Withdrawal by Subject|1|||
130195470|NCT04075682|468673572|FG003|Overall Study|Withdrawal by Subject|0|||
130195471|NCT04075682|468673569|FG000|Overall Study|Protocol Violation|0|||
130195472|NCT04075682|468673570|FG001|Overall Study|Protocol Violation|1|||
130195473|NCT04075682|468673571|FG002|Overall Study|Protocol Violation|1|||
130195474|NCT04075682|468673572|FG003|Overall Study|Protocol Violation|0|||
130195475|NCT04075682|468673569|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
130195476|NCT04075682|468673570|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
130195477|NCT04075682|468673571|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
130195478|NCT04075682|468673572|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
130195479|NCT04075682|468673569|FG000|Overall Study|Lost study phone the first day of study participation|0|||
130195480|NCT04075682|468673570|FG001|Overall Study|Lost study phone the first day of study participation|1|||
130195481|NCT04075682|468673571|FG002|Overall Study|Lost study phone the first day of study participation|0|||
130195482|NCT04075682|468673572|FG003|Overall Study|Lost study phone the first day of study participation|0|||
130195483|NCT01289639|468673577|FG000|Overall Study|Lost to Follow-up|1|||
130195484|NCT01289639|468673578|FG001|Overall Study|Lost to Follow-up|0|||
130195485|NCT01289639|468673579|FG002|Overall Study|Lost to Follow-up|0|||
130195486|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
130195487|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
130195488|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
130195489|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
130195490|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
130195491|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
130195492|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
130195493|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
130195494|NCT01931475|468673582|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
130195495|NCT01931475|468673583|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
130195496|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
130195497|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
130195498|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
130195499|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
130195500|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
130195501|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
130195502|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
130195503|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
130195504|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
130195505|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
130195506|NCT01931475|468673582|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
130195507|NCT01931475|468673583|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
130195508|NCT04292912|468673584|FG000|Overall Study|Physician Decision|1|||
130195509|NCT04292912|468673584|FG000|Overall Study|Protocol Violation|6|||
130195510|NCT02475265|468673594|FG000|Overall Study|Physician Decision|1|||
130195511|NCT02475265|468673594|FG000|Overall Study|Withdrawal by Subject|2|||
130195512|NCT01323387|468673598|FG000|Overall Study|Withdrawal by Subject|41|||
130195513|NCT01323387|468673598|FG000|Overall Study|Radiographic Data Unavailable|1|||
130195514|NCT01323387|468673598|FG000|Overall Study|Revision|14|||
130195515|NCT01323387|468673598|FG000|Overall Study|Protocol Violation|12|||
130195516|NCT01323387|468673598|FG000|Overall Study|Randomized but Never Treated|16|||
130195517|NCT01726270|468673599|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
130195518|NCT01726270|468673599|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
130195519|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
130195520|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
130195521|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
130195522|NCT01726270|468673599|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
130195523|NCT00582608|468673600|FG000|Overall Study|Not Treated|7|||
130195524|NCT00582608|468673600|FG000|Overall Study|Patient Ineligible|1|||
130195525|NCT00582608|468673600|FG000|Overall Study|Lack of accrual|4|||
130195526|NCT02073929|468673616|FG000|Overall Study|Lost to Follow-up|2|||
130195527|NCT02073929|468673617|FG001|Overall Study|Lost to Follow-up|1|||
130195528|NCT02073929|468673616|FG000|Overall Study|Adverse Event|2|||
130195529|NCT02073929|468673617|FG001|Overall Study|Adverse Event|1|||
130195530|NCT02073929|468673616|FG000|Overall Study|Withdrawal by Subject|0|||
130195531|NCT02073929|468673617|FG001|Overall Study|Withdrawal by Subject|1|||
130195532|NCT00430573|468673618|FG000|Overall Study|Withdrawal by Subject|5|||
130195533|NCT04463251|468673619|FG000|Overall Study|Death|1|||
130195534|NCT04463251|468673620|FG001|Overall Study|Death|0|||
130195535|NCT04463251|468673621|FG002|Overall Study|Death|1|||
130195536|NCT04463251|468673619|FG000|Overall Study|Adverse Event|0|||
130195537|NCT04463251|468673620|FG001|Overall Study|Adverse Event|1|||
130195538|NCT04463251|468673621|FG002|Overall Study|Adverse Event|0|||
130195539|NCT04463251|468673619|FG000|Overall Study|Lost to Follow-up|0|||
130195540|NCT04463251|468673620|FG001|Overall Study|Lost to Follow-up|1|||
130195541|NCT04463251|468673621|FG002|Overall Study|Lost to Follow-up|0|||
130195542|NCT04463251|468673619|FG000|Overall Study|Withdrawal by Subject|0|||
130195543|NCT04463251|468673620|FG001|Overall Study|Withdrawal by Subject|2|||
130195544|NCT04463251|468673621|FG002|Overall Study|Withdrawal by Subject|2|||
130195545|NCT05020665|468673622|FG000|Overall Study|Study terminated by Sponsor|5|||
130195546|NCT05020665|468673623|FG001|Overall Study|Study terminated by Sponsor|4|||
130195547|NCT05020665|468673622|FG000|Overall Study|Death|2|||
130195548|NCT05020665|468673623|FG001|Overall Study|Death|1|||
130195549|NCT05020665|468673622|FG000|Overall Study|Physician Decision|0|||
130195550|NCT05020665|468673623|FG001|Overall Study|Physician Decision|1|||
130195551|NCT05020665|468673622|FG000|Overall Study|Withdrawal by Subject|0|||
130195552|NCT05020665|468673623|FG001|Overall Study|Withdrawal by Subject|1|||
130195553|NCT05020665|468673622|FG000|Overall Study|Reason not specified|1|||
130195554|NCT05020665|468673623|FG001|Overall Study|Reason not specified|0|||
130195555|NCT01732640|468673624|FG000|Overall Study|Adverse Event|0|||
130195556|NCT01732640|468673625|FG001|Overall Study|Adverse Event|1|||
130195557|NCT01732640|468673624|FG000|Overall Study|Death|0|||
130195558|NCT01732640|468673625|FG001|Overall Study|Death|1|||
130195559|NCT03070002|468673626|FG000|Follow up for 2 Years|Death|1|||
130195560|NCT02147158|468673627|FG000|Treatment Course 1|Adverse Event|1|||
130195561|NCT02147158|468673628|FG001|Treatment Course 1|Adverse Event|4|||
130195562|NCT02147158|468673629|FG002|Treatment Course 1|Adverse Event|3|||
130195563|NCT02147158|468673630|FG003|Treatment Course 1|Adverse Event|4|||
130195564|NCT02147158|468673631|FG004|Treatment Course 1|Adverse Event|1|||
130195565|NCT02147158|468673632|FG005|Treatment Course 1|Adverse Event|2|||
130195566|NCT02147158|468673627|FG000|Treatment Course 1|Lost to Follow-up|2|||
130195567|NCT02147158|468673628|FG001|Treatment Course 1|Lost to Follow-up|4|||
130195568|NCT02147158|468673629|FG002|Treatment Course 1|Lost to Follow-up|3|||
130195569|NCT02147158|468673630|FG003|Treatment Course 1|Lost to Follow-up|3|||
130195570|NCT02147158|468673631|FG004|Treatment Course 1|Lost to Follow-up|2|||
130195571|NCT02147158|468673632|FG005|Treatment Course 1|Lost to Follow-up|4|||
130195572|NCT02147158|468673627|FG000|Treatment Course 1|Protocol Violation|0|||
130195573|NCT02147158|468673628|FG001|Treatment Course 1|Protocol Violation|0|||
130195574|NCT02147158|468673629|FG002|Treatment Course 1|Protocol Violation|1|||
130195575|NCT02147158|468673630|FG003|Treatment Course 1|Protocol Violation|1|||
130195576|NCT02147158|468673631|FG004|Treatment Course 1|Protocol Violation|0|||
130195577|NCT02147158|468673632|FG005|Treatment Course 1|Protocol Violation|0|||
130195578|NCT02147158|468673627|FG000|Treatment Course 1|Withdrawal of Consent|1|||
130195579|NCT02147158|468673628|FG001|Treatment Course 1|Withdrawal of Consent|1|||
130195580|NCT02147158|468673629|FG002|Treatment Course 1|Withdrawal of Consent|1|||
130195581|NCT02147158|468673630|FG003|Treatment Course 1|Withdrawal of Consent|5|||
130195582|NCT02147158|468673631|FG004|Treatment Course 1|Withdrawal of Consent|3|||
130195583|NCT02147158|468673632|FG005|Treatment Course 1|Withdrawal of Consent|2|||
130195584|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Adverse Event|1|||
130195585|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Adverse Event|0|||
130195586|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Adverse Event|0|||
130195587|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Adverse Event|1|||
130195588|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Adverse Event|0|||
130195589|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Adverse Event|0|||
130195590|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
130195591|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
130195592|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
130195593|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
130195594|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
130195595|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
130195596|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
130195597|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
130195598|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
130195599|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
130195600|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
130195601|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
130195602|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
130195603|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
130195604|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
130195605|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
130195606|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
130195607|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
130195608|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195609|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195610|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
130195611|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195612|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
130195613|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
130195614|NCT02147158|468673627|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
130195615|NCT02147158|468673628|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130195616|NCT02147158|468673629|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
130195617|NCT02147158|468673630|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
130195618|NCT02147158|468673631|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130195619|NCT02147158|468673632|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
130195620|NCT02147158|468673627|FG000|Treatment Course 2|Adverse Event|0|||
130195621|NCT02147158|468673628|FG001|Treatment Course 2|Adverse Event|4|||
130195622|NCT02147158|468673629|FG002|Treatment Course 2|Adverse Event|2|||
130195623|NCT02147158|468673630|FG003|Treatment Course 2|Adverse Event|1|||
130195624|NCT02147158|468673631|FG004|Treatment Course 2|Adverse Event|0|||
130195625|NCT02147158|468673632|FG005|Treatment Course 2|Adverse Event|1|||
130195626|NCT02147158|468673627|FG000|Treatment Course 2|Withdrawal of Consent|0|||
130195627|NCT02147158|468673628|FG001|Treatment Course 2|Withdrawal of Consent|1|||
130195628|NCT02147158|468673629|FG002|Treatment Course 2|Withdrawal of Consent|2|||
130195629|NCT02147158|468673630|FG003|Treatment Course 2|Withdrawal of Consent|3|||
130195630|NCT02147158|468673631|FG004|Treatment Course 2|Withdrawal of Consent|0|||
130195631|NCT02147158|468673632|FG005|Treatment Course 2|Withdrawal of Consent|0|||
130195632|NCT02147158|468673627|FG000|Treatment Course 2|Lost to Follow-up|1|||
130195633|NCT02147158|468673628|FG001|Treatment Course 2|Lost to Follow-up|0|||
130195634|NCT02147158|468673629|FG002|Treatment Course 2|Lost to Follow-up|1|||
130195635|NCT02147158|468673630|FG003|Treatment Course 2|Lost to Follow-up|1|||
130195636|NCT02147158|468673631|FG004|Treatment Course 2|Lost to Follow-up|0|||
130195637|NCT02147158|468673632|FG005|Treatment Course 2|Lost to Follow-up|1|||
130195638|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195639|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
130195640|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
130195641|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195642|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195643|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
130195644|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
130195645|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
130195646|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
130195647|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
130195648|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
130195649|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
130195650|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
130195651|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
130195652|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
130195653|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
130195654|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
130195655|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
130195656|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
130195657|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
130195658|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
130195659|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
130195660|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
130195661|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
130195662|NCT02147158|468673627|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
130195663|NCT02147158|468673628|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
130195664|NCT02147158|468673629|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
130195665|NCT02147158|468673630|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
130195666|NCT02147158|468673631|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
130195667|NCT02147158|468673632|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
130195668|NCT03425396|468673633|FG000|Overall Study|Lost to Follow-up|2|||
130195669|NCT03425396|468673634|FG001|Overall Study|Lost to Follow-up|5|||
130195670|NCT03425396|468673635|FG002|Overall Study|Lost to Follow-up|2|||
130195671|NCT03425396|468673636|FG003|Overall Study|Lost to Follow-up|0|||
130195672|NCT03425396|468673637|FG004|Overall Study|Lost to Follow-up|0|||
130195673|NCT03425396|468673633|FG000|Overall Study|Withdrawal by Subject|0|||
130195674|NCT03425396|468673634|FG001|Overall Study|Withdrawal by Subject|1|||
130195675|NCT03425396|468673635|FG002|Overall Study|Withdrawal by Subject|0|||
130195676|NCT03425396|468673636|FG003|Overall Study|Withdrawal by Subject|1|||
130195677|NCT03425396|468673637|FG004|Overall Study|Withdrawal by Subject|0|||
130195678|NCT03425396|468673633|FG000|Overall Study|Other|0|||
130195679|NCT03425396|468673634|FG001|Overall Study|Other|1|||
130195680|NCT03425396|468673635|FG002|Overall Study|Other|1|||
130195681|NCT03425396|468673636|FG003|Overall Study|Other|0|||
130195682|NCT03425396|468673637|FG004|Overall Study|Other|1|||
130195683|NCT01441765|468673639|FG000|Overall Study|Death|1|||
130195684|NCT01441765|468673640|FG001|Overall Study|Death|0|||
130195685|NCT04520997|468673641|FG000|Overall Study|Lost to Follow-up|1|||
130195686|NCT04520997|468673642|FG001|Overall Study|Lost to Follow-up|1|||
130195687|NCT04520997|468673641|FG000|Overall Study|Withdrawal by Subject|1|||
130195688|NCT04520997|468673642|FG001|Overall Study|Withdrawal by Subject|0|||
130195689|NCT04520997|468673641|FG000|Overall Study|Not Treated|0|||
130195690|NCT04520997|468673642|FG001|Overall Study|Not Treated|1|||
130195691|NCT02981082|468673645|FG000|Overall Study|Withdrawal by Subject|2|||
130195692|NCT02981082|468673646|FG001|Overall Study|Withdrawal by Subject|0|||
130195693|NCT02981082|468673645|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
130195694|NCT02981082|468673646|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
130195695|NCT02981082|468673645|FG000|Overall Study|Adverse Event|0|||
130195696|NCT02981082|468673646|FG001|Overall Study|Adverse Event|1|||
130195697|NCT03689374|468673647|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
130195698|NCT03689374|468673648|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
130195699|NCT03689374|468673649|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
130195700|NCT03689374|468673647|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
130195701|NCT03689374|468673648|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
130195702|NCT03689374|468673649|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
130195703|NCT03689374|468673647|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
130195704|NCT03689374|468673648|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
130195705|NCT03689374|468673649|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
130195706|NCT03689374|468673647|FG000|Treatment Period (Week 0 to 52)|Death|0|||
130195707|NCT03689374|468673648|FG001|Treatment Period (Week 0 to 52)|Death|11|||
130195708|NCT03689374|468673649|FG002|Treatment Period (Week 0 to 52)|Death|1|||
130195709|NCT05367973|468673650|FG000|Overall Study|Adverse Event|0|||
130195710|NCT05367973|468673651|FG001|Overall Study|Adverse Event|2|||
130195711|NCT02805660|468673652|FG000|Overall Study|Death|5|||
130195712|NCT02805660|468673653|FG001|Overall Study|Death|2|||
130195713|NCT02805660|468673654|FG002|Overall Study|Death|9|||
130195714|NCT02805660|468673655|FG003|Overall Study|Death|5|||
130195715|NCT02805660|468673656|FG004|Overall Study|Death|0|||
130195716|NCT02805660|468673657|FG005|Overall Study|Death|14|||
130195717|NCT02805660|468673658|FG006|Overall Study|Death|12|||
130195718|NCT02805660|468673652|FG000|Overall Study|Lost to Follow-up|0|||
130195719|NCT02805660|468673653|FG001|Overall Study|Lost to Follow-up|1|||
130195720|NCT02805660|468673654|FG002|Overall Study|Lost to Follow-up|1|||
130195721|NCT02805660|468673655|FG003|Overall Study|Lost to Follow-up|2|||
130195722|NCT02805660|468673656|FG004|Overall Study|Lost to Follow-up|0|||
130195723|NCT02805660|468673657|FG005|Overall Study|Lost to Follow-up|0|||
130195724|NCT02805660|468673658|FG006|Overall Study|Lost to Follow-up|0|||
130195725|NCT02805660|468673652|FG000|Overall Study|Withdrawal by Subject|0|||
130195726|NCT02805660|468673653|FG001|Overall Study|Withdrawal by Subject|0|||
130195727|NCT02805660|468673654|FG002|Overall Study|Withdrawal by Subject|0|||
130195728|NCT02805660|468673655|FG003|Overall Study|Withdrawal by Subject|3|||
130195729|NCT02805660|468673656|FG004|Overall Study|Withdrawal by Subject|1|||
130195730|NCT02805660|468673657|FG005|Overall Study|Withdrawal by Subject|0|||
130195731|NCT02805660|468673658|FG006|Overall Study|Withdrawal by Subject|2|||
130195732|NCT02805660|468673652|FG000|Overall Study|Study terminated by Sponsor|0|||
130195733|NCT02805660|468673653|FG001|Overall Study|Study terminated by Sponsor|0|||
130195734|NCT02805660|468673654|FG002|Overall Study|Study terminated by Sponsor|1|||
130195735|NCT02805660|468673655|FG003|Overall Study|Study terminated by Sponsor|4|||
130195736|NCT02805660|468673656|FG004|Overall Study|Study terminated by Sponsor|2|||
130195737|NCT02805660|468673657|FG005|Overall Study|Study terminated by Sponsor|3|||
130195738|NCT02805660|468673658|FG006|Overall Study|Study terminated by Sponsor|1|||
130195739|NCT02805660|468673652|FG000|Overall Study|Miscellaneous|0|||
130195740|NCT02805660|468673653|FG001|Overall Study|Miscellaneous|1|||
130195741|NCT02805660|468673654|FG002|Overall Study|Miscellaneous|0|||
130195742|NCT02805660|468673655|FG003|Overall Study|Miscellaneous|4|||
130195743|NCT02805660|468673656|FG004|Overall Study|Miscellaneous|0|||
130195744|NCT02805660|468673657|FG005|Overall Study|Miscellaneous|6|||
130195745|NCT02805660|468673658|FG006|Overall Study|Miscellaneous|4|||
130195746|NCT00809471|468674789|FG000|Overall Study|Protocol non-compliance|15|||
130195747|NCT00809471|468674790|FG001|Overall Study|Protocol non-compliance|15|||
130195748|NCT00809471|468674791|FG002|Overall Study|Protocol non-compliance|6|||
130195749|NCT00809471|468674789|FG000|Overall Study|Lost to Follow-up|4|||
130195750|NCT00809471|468674790|FG001|Overall Study|Lost to Follow-up|2|||
130195751|NCT00809471|468674791|FG002|Overall Study|Lost to Follow-up|9|||
130195752|NCT00809471|468674789|FG000|Overall Study|Adverse Event|0|||
130195753|NCT00809471|468674790|FG001|Overall Study|Adverse Event|2|||
130195754|NCT00809471|468674791|FG002|Overall Study|Adverse Event|2|||
130195755|NCT00809471|468674789|FG000|Overall Study|Requirement for restricted medication|1|||
130195756|NCT00809471|468674790|FG001|Overall Study|Requirement for restricted medication|1|||
130195757|NCT00809471|468674791|FG002|Overall Study|Requirement for restricted medication|0|||
130195758|NCT00831311|468674792|FG000|Overall Study|Definitive Contraindication|3|||
130195759|NCT00831311|468674793|FG001|Overall Study|Definitive Contraindication|3|||
130195760|NCT00831311|468674792|FG000|Overall Study|Lost to Follow-up|3|||
130195761|NCT00831311|468674793|FG001|Overall Study|Lost to Follow-up|0|||
130195762|NCT00831311|468674792|FG000|Overall Study|Physician Decision|0|||
130195763|NCT00831311|468674793|FG001|Overall Study|Physician Decision|1|||
130195764|NCT00831311|468674792|FG000|Overall Study|Withdrawal by Subject|6|||
130195765|NCT00831311|468674793|FG001|Overall Study|Withdrawal by Subject|4|||
130195766|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
130195767|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
130195768|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
130195769|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
130195770|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
130195771|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
130195772|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
130195773|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
130195774|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Death|0|||
130195775|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Death|1|||
130195776|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
130195777|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
130195778|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
130195779|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
130195780|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
130195781|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
130195782|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
130195783|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
130195784|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
130195785|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
130195786|NCT00394836|468674796|FG000|Teatment or Follow-up Phase|Non compliance|0|||
130195787|NCT00394836|468674797|FG001|Teatment or Follow-up Phase|Non compliance|1|||
130195788|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
130195789|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
130195790|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
130195791|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
130195792|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
130195793|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
130195794|NCT00394836|468674796|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
130195795|NCT00394836|468674797|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
130195796|NCT02028767|468674798|FG000|Treatment Period 2|Non compliant with protocol|1|||
130195797|NCT02028767|468674799|FG001|Treatment Period 2|Non compliant with protocol|0|||
130195798|NCT02028767|468674798|FG000|Treatment Period 2|Reason other than those specified above|1|||
130195799|NCT02028767|468674799|FG001|Treatment Period 2|Reason other than those specified above|0|||
130195800|NCT02780713|468674800|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195801|NCT02780713|468674801|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195802|NCT02780713|468674802|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
130195803|NCT02780713|468674803|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195804|NCT02780713|468674804|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
130195805|NCT05338502|468674807|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
130195806|NCT05338502|468674808|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
130195807|NCT05338502|468674809|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
130195808|NCT05338502|468674807|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
130195809|NCT05338502|468674808|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
130195810|NCT05338502|468674809|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
130195811|NCT03575793|468674810|FG000|Overall Study|Withdrawal by Subject|0|||
130195812|NCT03575793|468674811|FG001|Overall Study|Withdrawal by Subject|1|||
130195813|NCT03575793|468674810|FG000|Overall Study|Never Treated|0|||
130195814|NCT03575793|468674811|FG001|Overall Study|Never Treated|2|||
130195815|NCT01250873|468674812|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
130195816|NCT01250873|468674812|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
130195817|NCT02278939|468674813|FG000|Overall Study|lack of time|1|||
130195818|NCT02278939|468674814|FG001|Overall Study|lack of time|0|||
130195819|NCT02278939|468674813|FG000|Overall Study|Lost to Follow-up|1|||
130195820|NCT02278939|468674814|FG001|Overall Study|Lost to Follow-up|1|||
130195821|NCT02278939|468674813|FG000|Overall Study|death in family|1|||
130195822|NCT02278939|468674814|FG001|Overall Study|death in family|0|||
130195823|NCT02278939|468674813|FG000|Overall Study|family emergency unable to commit|2|||
130195824|NCT02278939|468674814|FG001|Overall Study|family emergency unable to commit|0|||
130195825|NCT03436693|468674817|FG000|Overall Study|Adverse Event|22|||
130195826|NCT03436693|468674818|FG001|Overall Study|Adverse Event|10|||
130195827|NCT03436693|468674817|FG000|Overall Study|Physician Decision|3|||
130195828|NCT03436693|468674818|FG001|Overall Study|Physician Decision|3|||
130195829|NCT03436693|468674817|FG000|Overall Study|Withdrawal by Subject|4|||
130195830|NCT03436693|468674818|FG001|Overall Study|Withdrawal by Subject|13|||
130195831|NCT03436693|468674817|FG000|Overall Study|Progressive Disease|1|||
130195832|NCT03436693|468674818|FG001|Overall Study|Progressive Disease|1|||
130195833|NCT01680861|468674819|FG000|Early Post-transplant Period|Protocol Violation|1|||
130195834|NCT01680861|468674820|FG001|Early Post-transplant Period|Protocol Violation|1|||
130195835|NCT02111577|468674821|FG000|Overall Study|Protocol Violation|2|||
130195836|NCT02111577|468674822|FG001|Overall Study|Protocol Violation|0|||
130195837|NCT02111577|468674821|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
130195838|NCT02111577|468674822|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
130195839|NCT02111577|468674821|FG000|Overall Study|Failure to produce study treatment|6|||
130195840|NCT02111577|468674822|FG001|Overall Study|Failure to produce study treatment|0|||
130195841|NCT02111577|468674821|FG000|Overall Study|Death|518|||
130195842|NCT02111577|468674822|FG001|Overall Study|Death|254|||
130195843|NCT02111577|468674821|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
130195844|NCT02111577|468674822|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
130195845|NCT02111577|468674821|FG000|Overall Study|Adverse Event|1|||
130195846|NCT02111577|468674822|FG001|Overall Study|Adverse Event|1|||
130195847|NCT02111577|468674821|FG000|Overall Study|Withdrawal by Subject|51|||
130195848|NCT02111577|468674822|FG001|Overall Study|Withdrawal by Subject|23|||
130195849|NCT02111577|468674821|FG000|Overall Study|Disease progression|0|||
130195850|NCT02111577|468674822|FG001|Overall Study|Disease progression|1|||
130195851|NCT02111577|468674821|FG000|Overall Study|Lost to Follow-up|19|||
130195852|NCT02111577|468674822|FG001|Overall Study|Lost to Follow-up|10|||
130195853|NCT00654875|468674823|FG000|Overall Study|Adverse Event|5|||
130195854|NCT00654875|468674824|FG001|Overall Study|Adverse Event|5|||
130195855|NCT00654875|468674823|FG000|Overall Study|Withdrawal by Subject|4|||
130195856|NCT00654875|468674824|FG001|Overall Study|Withdrawal by Subject|4|||
130195857|NCT00654875|468674823|FG000|Overall Study|Protocol Violation|3|||
130195858|NCT00654875|468674824|FG001|Overall Study|Protocol Violation|3|||
130195859|NCT00654875|468674823|FG000|Overall Study|Lack of Efficacy|2|||
130195860|NCT00654875|468674824|FG001|Overall Study|Lack of Efficacy|2|||
130195861|NCT00654875|468674823|FG000|Overall Study|Lost to Follow-up|1|||
130195862|NCT00654875|468674824|FG001|Overall Study|Lost to Follow-up|3|||
130195863|NCT00654875|468674823|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
130195864|NCT00654875|468674824|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
130195865|NCT00654875|468674823|FG000|Overall Study|Administrative Problems|1|||
130195866|NCT00654875|468674824|FG001|Overall Study|Administrative Problems|0|||
130195867|NCT04967885|468674825|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
130195868|NCT04967885|468674826|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
130195869|NCT04967885|468674825|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
130195870|NCT04967885|468674826|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
130195871|NCT04967885|468674825|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
130195872|NCT04967885|468674826|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
130195873|NCT04967885|468674825|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
130195874|NCT04967885|468674826|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
130195875|NCT04967885|468674825|FG000|EMI-II Intervention|Lost to Follow-up|14|||
130195876|NCT04967885|468674826|FG001|EMI-II Intervention|Lost to Follow-up|10|||
130195877|NCT02042950|468674829|FG000|Overall Study|Progressive Disease|4|||
130195878|NCT00886743|468674832|FG000|Overall Study|Adverse Event|3|||
130195879|NCT00886743|468674832|FG000|Overall Study|Other|1|||
130195880|NCT01940887|468674833|FG000|Year 1|Protocol Violation|0|||
130195881|NCT01940887|468674834|FG001|Year 1|Protocol Violation|1|||
130195882|NCT01940887|468674833|FG000|Year 1|Physician Decision|7|||
130195883|NCT01940887|468674834|FG001|Year 1|Physician Decision|3|||
130195884|NCT01940887|468674833|FG000|Year 1|Death|5|||
130195885|NCT01940887|468674834|FG001|Year 1|Death|3|||
130195886|NCT01940887|468674833|FG000|Year 1|Adverse Event|7|||
130195887|NCT01940887|468674834|FG001|Year 1|Adverse Event|6|||
130195888|NCT01940887|468674833|FG000|Year 1|Withdrawal by Subject|18|||
130195889|NCT01940887|468674834|FG001|Year 1|Withdrawal by Subject|9|||
130195890|NCT01940887|468674833|FG000|Year 1|Lost to Follow-up|2|||
130195891|NCT01940887|468674834|FG001|Year 1|Lost to Follow-up|1|||
130195892|NCT01940887|468674833|FG000|Year 2|Physician Decision|8|||
130195893|NCT01940887|468674834|FG001|Year 2|Physician Decision|1|||
130195894|NCT01940887|468674833|FG000|Year 2|Death|0|||
130195895|NCT01940887|468674834|FG001|Year 2|Death|2|||
130195896|NCT01940887|468674833|FG000|Year 2|Sponsor Decision, early termination|192|||
130195897|NCT01940887|468674834|FG001|Year 2|Sponsor Decision, early termination|203|||
130195898|NCT01940887|468674833|FG000|Year 2|Adverse Event|8|||
130195899|NCT01940887|468674834|FG001|Year 2|Adverse Event|2|||
130195900|NCT01940887|468674833|FG000|Year 2|Withdrawal by Subject|8|||
130195901|NCT01940887|468674834|FG001|Year 2|Withdrawal by Subject|8|||
130195902|NCT01940887|468674833|FG000|Year 2|Lost to Follow-up|1|||
130195903|NCT01940887|468674834|FG001|Year 2|Lost to Follow-up|6|||
130195904|NCT02429778|468674836|FG000|Overall Study|Lost to Follow-up|2|||
130195905|NCT02429778|468674837|FG001|Overall Study|Lost to Follow-up|0|||
130195906|NCT02429778|468674836|FG000|Overall Study|Withdrawal by Subject|5|||
130195907|NCT02429778|468674837|FG001|Overall Study|Withdrawal by Subject|0|||
130195908|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
130195909|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
130195910|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
130195911|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
130195912|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195913|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195914|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195915|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195916|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195917|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195918|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
130195919|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
130195920|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195921|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
130195922|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
130195923|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195924|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195925|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195926|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195927|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195928|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195929|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
130195930|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
130195931|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
130195932|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
130195933|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
130195934|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195935|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195936|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195937|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195938|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195939|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195940|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
130195941|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
130195942|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
130195943|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
130195944|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
130195945|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195946|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195947|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195948|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195949|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195950|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195951|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
130195952|NCT04791319|468674841|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195953|NCT04791319|468674842|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195954|NCT04791319|468674843|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195955|NCT04791319|468674844|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
130195956|NCT04791319|468674845|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195957|NCT04791319|468674846|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195958|NCT04791319|468674847|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195959|NCT04791319|468674848|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195960|NCT04791319|468674849|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195961|NCT04791319|468674850|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195962|NCT04791319|468674851|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
130195963|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195964|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195965|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195966|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195967|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
130195968|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
130195969|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
130195970|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195971|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195972|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
130195973|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
130195974|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195975|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195976|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195977|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195978|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195979|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195980|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195981|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195982|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195983|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
130195984|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
130195985|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195986|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195987|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195988|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195989|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
130195990|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
130195991|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
130195992|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
130195993|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
130195994|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
130195995|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
130195996|NCT04791319|468674841|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130195997|NCT04791319|468674842|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130195998|NCT04791319|468674843|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130195999|NCT04791319|468674844|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
130196000|NCT04791319|468674845|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
130196001|NCT04791319|468674846|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
130196002|NCT04791319|468674847|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
130196003|NCT04791319|468674848|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
130196004|NCT04791319|468674849|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
130196005|NCT04791319|468674850|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
130196006|NCT04791319|468674851|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
130196007|NCT00355147|468674856|FG000|Overall Study|Lost to Follow-up|10|||
130196008|NCT00355147|468674857|FG001|Overall Study|Lost to Follow-up|8|||
130196009|NCT00355147|468674856|FG000|Overall Study|Withdrawal by Subject|8|||
130196010|NCT00355147|468674857|FG001|Overall Study|Withdrawal by Subject|12|||
130196011|NCT00072280|468674866|FG000|Treatment|Found ineligible|1|||
130196012|NCT00072280|468674867|FG001|Treatment|Found ineligible|2|||
130196013|NCT00072280|468674866|FG000|Follow-up|Early termination of study|2|||
130196014|NCT00072280|468674867|FG001|Follow-up|Early termination of study|2|||
130196015|NCT00022698|468674873|FG000|Overall Study|Adverse Event|5|||
130196016|NCT00022698|468674874|FG001|Overall Study|Adverse Event|9|||
130196017|NCT00022698|468674873|FG000|Overall Study|Death|0|||
130196018|NCT00022698|468674874|FG001|Overall Study|Death|2|||
130196019|NCT00022698|468674873|FG000|Overall Study|Failure to return|0|||
130196020|NCT00022698|468674874|FG001|Overall Study|Failure to return|1|||
130196021|NCT00022698|468674873|FG000|Overall Study|Refused treatment|0|||
130196022|NCT00022698|468674874|FG001|Overall Study|Refused treatment|2|||
130196023|NCT00022698|468674873|FG000|Overall Study|Insufficient therapeutic response|2|||
130196024|NCT00022698|468674874|FG001|Overall Study|Insufficient therapeutic response|14|||
130196025|NCT00022698|468674873|FG000|Overall Study|Administrative /other|1|||
130196026|NCT00022698|468674874|FG001|Overall Study|Administrative /other|7|||
130196027|NCT02504827|468674875|FG000|Overall Study|Could not produce sputum|1|||
130196028|NCT00877487|468674884|FG000|Open-label Treatment Phase|Adverse Event|1|||
130196029|NCT00877487|468674885|FG001|Open-label Treatment Phase|Adverse Event|0|||
130196030|NCT00877487|468674884|FG000|Open-label Treatment Phase|Protocol Violation|3|||
130196031|NCT00877487|468674885|FG001|Open-label Treatment Phase|Protocol Violation|0|||
130196032|NCT00877487|468674884|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
130196033|NCT00877487|468674885|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
130196034|NCT00877487|468674884|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
130196035|NCT00877487|468674885|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
130196036|NCT00877487|468674884|FG000|Open-label Treatment Phase|Out of country for business|1|||
130196037|NCT00877487|468674885|FG001|Open-label Treatment Phase|Out of country for business|0|||
130196038|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
130196039|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
130196040|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
130196041|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
130196042|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
130196043|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
130196044|NCT00877487|468674884|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
130196045|NCT00877487|468674885|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
130196046|NCT00712543|468674888|FG000|Day 8-14|Lost to Follow-up|0|||
130196047|NCT00712543|468674889|FG001|Day 8-14|Lost to Follow-up|2|||
130196048|NCT02729051|468674892|FG000|Overall Study|Adverse Event|21|||
130196049|NCT02729051|468674893|FG001|Overall Study|Adverse Event|11|||
130196050|NCT02729051|468674892|FG000|Overall Study|Lack of Efficacy|1|||
130196051|NCT02729051|468674893|FG001|Overall Study|Lack of Efficacy|1|||
130196052|NCT02729051|468674892|FG000|Overall Study|Lost to Follow-up|1|||
130196053|NCT02729051|468674893|FG001|Overall Study|Lost to Follow-up|2|||
130196054|NCT02729051|468674892|FG000|Overall Study|Physician Decision|1|||
130196055|NCT02729051|468674893|FG001|Overall Study|Physician Decision|1|||
130196056|NCT02729051|468674892|FG000|Overall Study|Withdrawal by Subject|6|||
130196057|NCT02729051|468674893|FG001|Overall Study|Withdrawal by Subject|17|||
130196058|NCT02702388|468674894|FG000|Overall Study|Disease Progression|18|||
130196059|NCT02702388|468674895|FG001|Overall Study|Disease Progression|25|||
130196060|NCT02702388|468674894|FG000|Overall Study|Withdrawal by Subject|9|||
130196061|NCT02702388|468674895|FG001|Overall Study|Withdrawal by Subject|7|||
130196062|NCT02702388|468674894|FG000|Overall Study|Adverse Event|11|||
130196063|NCT02702388|468674895|FG001|Overall Study|Adverse Event|15|||
130196064|NCT02702388|468674894|FG000|Overall Study|Other|2|||
130196065|NCT02702388|468674895|FG001|Overall Study|Other|4|||
130196066|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
130196067|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
130196068|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
130196069|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
130196070|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
130196071|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
130196072|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
130196073|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
130196074|NCT04740827|468674907|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
130196075|NCT04740827|468674908|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
130196076|NCT04740827|468674907|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
130196077|NCT04740827|468674908|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
130196078|NCT01190410|468676886|FG000|Overall Study|Adverse Event|0|||
130196079|NCT01190410|468676887|FG001|Overall Study|Adverse Event|3|||
130196080|NCT01190410|468676886|FG000|Overall Study|Lack of Efficacy|0|||
130196081|NCT01190410|468676887|FG001|Overall Study|Lack of Efficacy|2|||
130196082|NCT01190410|468676886|FG000|Overall Study|Withdrawal by Subject|0|||
130196083|NCT01190410|468676887|FG001|Overall Study|Withdrawal by Subject|2|||
130196084|NCT01190410|468676886|FG000|Overall Study|Administrative decision|1|||
130196085|NCT01190410|468676887|FG001|Overall Study|Administrative decision|0|||
130196086|NCT01190410|468676886|FG000|Overall Study|PI discretion|0|||
130196087|NCT01190410|468676887|FG001|Overall Study|PI discretion|2|||
130196088|NCT03652636|468676888|FG000|Overall Study|Withdrawal by Subject|7|||
130196089|NCT00504725|468676897|FG000|Overall Study|Protocol Violation|1|||
130196090|NCT00504725|468676898|FG001|Overall Study|Protocol Violation|0|||
130196091|NCT01435018|468676899|FG000|Overall Study|Death|37|||
130196092|NCT01435018|468676900|FG001|Overall Study|Death|18|||
130196093|NCT01435018|468676901|FG002|Overall Study|Death|25|||
130196094|NCT01435018|468676899|FG000|Overall Study|Site is closing|4|||
130196095|NCT01435018|468676900|FG001|Overall Study|Site is closing|9|||
130196096|NCT01435018|468676901|FG002|Overall Study|Site is closing|7|||
130196097|NCT01435018|468676899|FG000|Overall Study|Withdrew consent|0|||
130196098|NCT01435018|468676900|FG001|Overall Study|Withdrew consent|3|||
130196099|NCT01435018|468676901|FG002|Overall Study|Withdrew consent|1|||
130196100|NCT01435018|468676899|FG000|Overall Study|Not willing to adhere to requirements|0|||
130196101|NCT01435018|468676900|FG001|Overall Study|Not willing to adhere to requirements|2|||
130196102|NCT01435018|468676901|FG002|Overall Study|Not willing to adhere to requirements|3|||
130196103|NCT01435018|468676899|FG000|Overall Study|Not able to get to clinic|2|||
130196104|NCT01435018|468676900|FG001|Overall Study|Not able to get to clinic|0|||
130196105|NCT01435018|468676901|FG002|Overall Study|Not able to get to clinic|2|||
130196106|NCT01435018|468676899|FG000|Overall Study|Severe debilitation, unable to continue|0|||
130196107|NCT01435018|468676900|FG001|Overall Study|Severe debilitation, unable to continue|0|||
130196108|NCT01435018|468676901|FG002|Overall Study|Severe debilitation, unable to continue|1|||
130196109|NCT01435018|468676899|FG000|Overall Study|Unable to contact participant/parent|1|||
130196110|NCT01435018|468676900|FG001|Overall Study|Unable to contact participant/parent|1|||
130196111|NCT01435018|468676901|FG002|Overall Study|Unable to contact participant/parent|1|||
130196112|NCT01435018|468676899|FG000|Overall Study|Enrollment Violation|0|||
130196113|NCT01435018|468676900|FG001|Overall Study|Enrollment Violation|1|||
130196114|NCT01435018|468676901|FG002|Overall Study|Enrollment Violation|0|||
130196115|NCT01435018|468676899|FG000|Overall Study|Never started chemotherapy|3|||
130196116|NCT01435018|468676900|FG001|Overall Study|Never started chemotherapy|0|||
130196117|NCT01435018|468676901|FG002|Overall Study|Never started chemotherapy|1|||
130196118|NCT00769067|468676903|FG000|Overall Study|Death|89|||
130196119|NCT00769067|468676904|FG001|Overall Study|Death|86|||
130196120|NCT00769067|468676903|FG000|Overall Study|Lost to Follow-up|3|||
130196121|NCT00769067|468676904|FG001|Overall Study|Lost to Follow-up|1|||
130196122|NCT00769067|468676903|FG000|Overall Study|Study terminated by sponsor|1|||
130196123|NCT00769067|468676904|FG001|Overall Study|Study terminated by sponsor|3|||
130196124|NCT00769067|468676903|FG000|Overall Study|Other|1|||
130196125|NCT00769067|468676904|FG001|Overall Study|Other|3|||
130196126|NCT00769067|468676903|FG000|Overall Study|Withdrawal by Subject|0|||
130196127|NCT00769067|468676904|FG001|Overall Study|Withdrawal by Subject|1|||
130196128|NCT03806933|468676905|FG000|Main Period|Physician Decision|0|||
130196129|NCT03806933|468676906|FG001|Main Period|Physician Decision|0|||
130196130|NCT03806933|468676907|FG002|Main Period|Physician Decision|0|||
130196131|NCT03806933|468676908|FG003|Main Period|Physician Decision|1|||
130196132|NCT03806933|468676905|FG000|Main Period|Pregnancy|0|||
130196133|NCT03806933|468676906|FG001|Main Period|Pregnancy|0|||
130196134|NCT03806933|468676907|FG002|Main Period|Pregnancy|1|||
130196135|NCT03806933|468676908|FG003|Main Period|Pregnancy|0|||
130196136|NCT03806933|468676905|FG000|Main Period|Withdrawal by Subject|2|||
130196137|NCT03806933|468676906|FG001|Main Period|Withdrawal by Subject|1|||
130196138|NCT03806933|468676907|FG002|Main Period|Withdrawal by Subject|1|||
130196139|NCT03806933|468676908|FG003|Main Period|Withdrawal by Subject|2|||
130196140|NCT03806933|468676905|FG000|Main Period|Lost to Follow-up|2|||
130196141|NCT03806933|468676906|FG001|Main Period|Lost to Follow-up|2|||
130196142|NCT03806933|468676907|FG002|Main Period|Lost to Follow-up|0|||
130196143|NCT03806933|468676908|FG003|Main Period|Lost to Follow-up|0|||
130196144|NCT03806933|468676905|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130196145|NCT03806933|468676906|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130196146|NCT03806933|468676907|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
130196147|NCT03806933|468676908|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
130196148|NCT03625466|468676909|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
130196149|NCT03625466|468676910|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
130196150|NCT03625466|468676911|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
130196151|NCT03625466|468676909|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196152|NCT03625466|468676910|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130196153|NCT03625466|468676911|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196154|NCT03625466|468676909|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196155|NCT03625466|468676910|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
130196156|NCT03625466|468676911|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
130196157|NCT01868438|468676914|FG000|First Intervention|Withdrawal by Subject|5|||
130196158|NCT01868438|468676915|FG001|First Intervention|Withdrawal by Subject|1|||
130196159|NCT01868438|468676914|FG000|First Intervention|Lost to Follow-up|2|||
130196160|NCT01868438|468676915|FG001|First Intervention|Lost to Follow-up|3|||
130196161|NCT01868438|468676914|FG000|First Intervention|Meeting the non-redosing criteria|0|||
130196162|NCT01868438|468676915|FG001|First Intervention|Meeting the non-redosing criteria|1|||
130196163|NCT01868438|468676914|FG000|Second Intervention|Adverse Event|3|||
130196164|NCT01868438|468676915|FG001|Second Intervention|Adverse Event|3|||
130196165|NCT00956592|468676919|FG000|Overall Study|Protocol Violation|1|||
130196166|NCT00956592|468676920|FG001|Overall Study|Protocol Violation|3|||
130196167|NCT00076752|468676921|FG000|Overall Study|Death|2|||
130196168|NCT00076752|468676921|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
130196169|NCT02632409|468676924|FG000|Randomized|AE unrelated to study Drug|0|||
130196170|NCT02632409|468676925|FG001|Randomized|AE unrelated to study Drug|1|||
130196171|NCT02632409|468676924|FG000|Randomized|Participant withdrew consent|2|||
130196172|NCT02632409|468676925|FG001|Randomized|Participant withdrew consent|1|||
130196173|NCT02632409|468676924|FG000|Randomized|No Longer meets study criteria|5|||
130196174|NCT02632409|468676925|FG001|Randomized|No Longer meets study criteria|0|||
130196175|NCT02632409|468676924|FG000|Randomized|other reasons|1|||
130196176|NCT02632409|468676925|FG001|Randomized|other reasons|0|||
130196177|NCT02632409|468676924|FG000|Treatment Period|Ongoing Treatment|20|||
130196178|NCT02632409|468676925|FG001|Treatment Period|Ongoing Treatment|21|||
130196179|NCT02632409|468676924|FG000|Treatment Period|Disease Recurrence|147|||
130196180|NCT02632409|468676925|FG001|Treatment Period|Disease Recurrence|90|||
130196181|NCT02632409|468676924|FG000|Treatment Period|Study Drug Toxicity|8|||
130196182|NCT02632409|468676925|FG001|Treatment Period|Study Drug Toxicity|49|||
130196183|NCT02632409|468676924|FG000|Treatment Period|Death|1|||
130196184|NCT02632409|468676925|FG001|Treatment Period|Death|0|||
130196185|NCT02632409|468676924|FG000|Treatment Period|AE unrelated to study drug|15|||
130196186|NCT02632409|468676925|FG001|Treatment Period|AE unrelated to study drug|16|||
130196187|NCT02632409|468676924|FG000|Treatment Period|Request to discontinue treatment|4|||
130196188|NCT02632409|468676925|FG001|Treatment Period|Request to discontinue treatment|19|||
130196189|NCT02632409|468676924|FG000|Treatment Period|Participant withdrew consent|7|||
130196190|NCT02632409|468676925|FG001|Treatment Period|Participant withdrew consent|5|||
130196191|NCT02632409|468676924|FG000|Treatment Period|Lost to Follow-up|0|||
130196192|NCT02632409|468676925|FG001|Treatment Period|Lost to Follow-up|1|||
130196193|NCT02632409|468676924|FG000|Treatment Period|Maximum clinical benefit|1|||
130196194|NCT02632409|468676925|FG001|Treatment Period|Maximum clinical benefit|0|||
130196195|NCT02632409|468676924|FG000|Treatment Period|No longer meets study criteria|3|||
130196196|NCT02632409|468676925|FG001|Treatment Period|No longer meets study criteria|0|||
130196197|NCT02632409|468676924|FG000|Treatment Period|Administrative Reason by sponsor|0|||
130196198|NCT02632409|468676925|FG001|Treatment Period|Administrative Reason by sponsor|1|||
130196199|NCT02632409|468676924|FG000|Treatment Period|Other Reasons|10|||
130196200|NCT02632409|468676925|FG001|Treatment Period|Other Reasons|6|||
130196201|NCT01867710|468676926|FG000|Overall Study|Death|25|||
130196202|NCT01867710|468676927|FG001|Overall Study|Death|15|||
130196203|NCT01867710|468676928|FG002|Overall Study|Death|27|||
130196204|NCT01867710|468676929|FG003|Overall Study|Death|20|||
130196205|NCT01867710|468676926|FG000|Overall Study|Lost to Follow-up|3|||
130196206|NCT01867710|468676927|FG001|Overall Study|Lost to Follow-up|4|||
130196207|NCT01867710|468676928|FG002|Overall Study|Lost to Follow-up|3|||
130196208|NCT01867710|468676929|FG003|Overall Study|Lost to Follow-up|2|||
130196209|NCT01867710|468676926|FG000|Overall Study|Withdrawal of consent|2|||
130196210|NCT01867710|468676927|FG001|Overall Study|Withdrawal of consent|5|||
130196211|NCT01867710|468676928|FG002|Overall Study|Withdrawal of consent|1|||
130196212|NCT01867710|468676929|FG003|Overall Study|Withdrawal of consent|2|||
130196213|NCT01867710|468676926|FG000|Overall Study|Study Terminated by Sponsor|9|||
130196214|NCT01867710|468676927|FG001|Overall Study|Study Terminated by Sponsor|13|||
130196215|NCT01867710|468676928|FG002|Overall Study|Study Terminated by Sponsor|8|||
130196216|NCT01867710|468676929|FG003|Overall Study|Study Terminated by Sponsor|16|||
130196217|NCT01867710|468676926|FG000|Overall Study|Biochemical progression|0|||
130196218|NCT01867710|468676927|FG001|Overall Study|Biochemical progression|1|||
130196219|NCT01867710|468676928|FG002|Overall Study|Biochemical progression|0|||
130196220|NCT01867710|468676929|FG003|Overall Study|Biochemical progression|0|||
130196221|NCT01867710|468676926|FG000|Overall Study|Clinical progression|0|||
130196222|NCT01867710|468676927|FG001|Overall Study|Clinical progression|0|||
130196223|NCT01867710|468676928|FG002|Overall Study|Clinical progression|1|||
130196224|NCT01867710|468676929|FG003|Overall Study|Clinical progression|0|||
130196225|NCT01867710|468676926|FG000|Overall Study|Disease progression|1|||
130196226|NCT01867710|468676927|FG001|Overall Study|Disease progression|0|||
130196227|NCT01867710|468676928|FG002|Overall Study|Disease progression|0|||
130196228|NCT01867710|468676929|FG003|Overall Study|Disease progression|0|||
130196229|NCT01867710|468676926|FG000|Overall Study|Patient decision|0|||
130196230|NCT01867710|468676927|FG001|Overall Study|Patient decision|0|||
130196231|NCT01867710|468676928|FG002|Overall Study|Patient decision|0|||
130196232|NCT01867710|468676929|FG003|Overall Study|Patient decision|1|||
130196233|NCT01867710|468676926|FG000|Overall Study|Patient to follow subsequent treatment|0|||
130196234|NCT01867710|468676927|FG001|Overall Study|Patient to follow subsequent treatment|1|||
130196235|NCT01867710|468676928|FG002|Overall Study|Patient to follow subsequent treatment|0|||
130196236|NCT01867710|468676929|FG003|Overall Study|Patient to follow subsequent treatment|0|||
130196237|NCT01867710|468676926|FG000|Overall Study|Progressive disease|1|||
130196238|NCT01867710|468676927|FG001|Overall Study|Progressive disease|0|||
130196239|NCT01867710|468676928|FG002|Overall Study|Progressive disease|0|||
130196240|NCT01867710|468676929|FG003|Overall Study|Progressive disease|0|||
130196241|NCT01867710|468676926|FG000|Overall Study|Protocol Violation|0|||
130196242|NCT01867710|468676927|FG001|Overall Study|Protocol Violation|0|||
130196243|NCT01867710|468676928|FG002|Overall Study|Protocol Violation|0|||
130196244|NCT01867710|468676929|FG003|Overall Study|Protocol Violation|1|||
130196245|NCT01867710|468676926|FG000|Overall Study|PSA-progression|0|||
130196246|NCT01867710|468676927|FG001|Overall Study|PSA-progression|1|||
130196247|NCT01867710|468676928|FG002|Overall Study|PSA-progression|0|||
130196248|NCT01867710|468676929|FG003|Overall Study|PSA-progression|0|||
130196249|NCT01867710|468676926|FG000|Overall Study|Study medication no longer effective|0|||
130196250|NCT01867710|468676927|FG001|Overall Study|Study medication no longer effective|1|||
130196251|NCT01867710|468676928|FG002|Overall Study|Study medication no longer effective|0|||
130196252|NCT01867710|468676929|FG003|Overall Study|Study medication no longer effective|0|||
130196253|NCT03521115|468676930|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
130196254|NCT03521115|468676931|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
130196255|NCT03521115|468676930|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
130196256|NCT03521115|468676931|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
130196257|NCT01981954|468676936|FG000|Titration Period|Protocol Deviation|1|||
130196258|NCT01981954|468676936|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
130196259|NCT03655470|468676937|FG000|Overall Study|Lost to Follow-up|6|||
130196260|NCT03655470|468676938|FG001|Overall Study|Lost to Follow-up|7|||
130196261|NCT03063086|468676941|FG000|Overall Study|technical problems|1|||
130196262|NCT03063086|468676942|FG001|Overall Study|technical problems|0|||
130196263|NCT03063086|468676943|FG002|Overall Study|technical problems|0|||
130196264|NCT03063086|468676944|FG003|Overall Study|technical problems|0|||
130196265|NCT03063086|468676945|FG004|Overall Study|technical problems|0|||
130196266|NCT03063086|468676946|FG005|Overall Study|technical problems|0|||
130196267|NCT03063086|468676941|FG000|Overall Study|Adverse Event|1|||
130196268|NCT03063086|468676942|FG001|Overall Study|Adverse Event|1|||
130196269|NCT03063086|468676943|FG002|Overall Study|Adverse Event|1|||
130196270|NCT03063086|468676944|FG003|Overall Study|Adverse Event|1|||
130196271|NCT03063086|468676945|FG004|Overall Study|Adverse Event|0|||
130196272|NCT03063086|468676946|FG005|Overall Study|Adverse Event|0|||
130196273|NCT03063086|468676941|FG000|Overall Study|subject/guardian decision|1|||
130196274|NCT03063086|468676942|FG001|Overall Study|subject/guardian decision|0|||
130196275|NCT03063086|468676943|FG002|Overall Study|subject/guardian decision|0|||
130196276|NCT03063086|468676944|FG003|Overall Study|subject/guardian decision|0|||
130196277|NCT03063086|468676945|FG004|Overall Study|subject/guardian decision|0|||
130196278|NCT03063086|468676946|FG005|Overall Study|subject/guardian decision|0|||
130196279|NCT03063086|468676941|FG000|Overall Study|Non-compliance with study treatment|0|||
130196280|NCT03063086|468676942|FG001|Overall Study|Non-compliance with study treatment|0|||
130196281|NCT03063086|468676943|FG002|Overall Study|Non-compliance with study treatment|0|||
130196282|NCT03063086|468676944|FG003|Overall Study|Non-compliance with study treatment|1|||
130196283|NCT03063086|468676945|FG004|Overall Study|Non-compliance with study treatment|0|||
130196284|NCT03063086|468676946|FG005|Overall Study|Non-compliance with study treatment|1|||
130196285|NCT03063086|468676941|FG000|Overall Study|Physician Decision|0|||
130196286|NCT03063086|468676942|FG001|Overall Study|Physician Decision|0|||
130196287|NCT03063086|468676943|FG002|Overall Study|Physician Decision|0|||
130196288|NCT03063086|468676944|FG003|Overall Study|Physician Decision|1|||
130196289|NCT03063086|468676945|FG004|Overall Study|Physician Decision|0|||
130196290|NCT03063086|468676946|FG005|Overall Study|Physician Decision|0|||
130196291|NCT04590586|468676948|FG000|Overall Study|Death|7|||
130196292|NCT04590586|468676949|FG001|Overall Study|Death|1|||
130196293|NCT04590586|468676950|FG002|Overall Study|Death|37|||
130196294|NCT04590586|468676951|FG003|Overall Study|Death|34|||
130196295|NCT04590586|468676952|FG004|Overall Study|Death|19|||
130196296|NCT04590586|468676953|FG005|Overall Study|Death|3|||
130196297|NCT04590586|468676948|FG000|Overall Study|Lost to Follow-up|3|||
130196298|NCT04590586|468676949|FG001|Overall Study|Lost to Follow-up|0|||
130196299|NCT04590586|468676950|FG002|Overall Study|Lost to Follow-up|11|||
130196300|NCT04590586|468676951|FG003|Overall Study|Lost to Follow-up|11|||
130196301|NCT04590586|468676952|FG004|Overall Study|Lost to Follow-up|6|||
130196302|NCT04590586|468676953|FG005|Overall Study|Lost to Follow-up|0|||
130196303|NCT04590586|468676948|FG000|Overall Study|Withdrawal by Subject|0|||
130196304|NCT04590586|468676949|FG001|Overall Study|Withdrawal by Subject|0|||
130196305|NCT04590586|468676950|FG002|Overall Study|Withdrawal by Subject|6|||
130196306|NCT04590586|468676951|FG003|Overall Study|Withdrawal by Subject|0|||
130196307|NCT04590586|468676952|FG004|Overall Study|Withdrawal by Subject|3|||
130196308|NCT04590586|468676953|FG005|Overall Study|Withdrawal by Subject|0|||
130196309|NCT04590586|468676948|FG000|Overall Study|Other|3|||
130196310|NCT04590586|468676949|FG001|Overall Study|Other|0|||
130196311|NCT04590586|468676950|FG002|Overall Study|Other|1|||
130196312|NCT04590586|468676951|FG003|Overall Study|Other|1|||
130196313|NCT04590586|468676952|FG004|Overall Study|Other|2|||
130196314|NCT04590586|468676953|FG005|Overall Study|Other|1|||
130196315|NCT01893281|468676954|FG000|Overall Study|Adverse Event|1|||
130196316|NCT01893281|468676954|FG000|Overall Study|Protocol Violation|1|||
130196317|NCT01893281|468676954|FG000|Overall Study|Withdrawal by Subject|1|||
130196318|NCT02218736|468676955|FG000|Overall Study|Withdrawal by Subject|10|||
130196319|NCT02218736|468676956|FG001|Overall Study|Withdrawal by Subject|9|||
130196320|NCT02218736|468676955|FG000|Overall Study|Protocol Violation|2|||
130196321|NCT02218736|468676956|FG001|Overall Study|Protocol Violation|0|||
130196322|NCT05481125|468676959|FG000|Overall Study|Adverse Event|1|||
130196323|NCT05481125|468676960|FG001|Overall Study|Adverse Event|0|||
130196324|NCT05481125|468676959|FG000|Overall Study|Lost to Follow-up|0|||
130196325|NCT05481125|468676960|FG001|Overall Study|Lost to Follow-up|1|||
130196326|NCT05481125|468676959|FG000|Overall Study|Withdrawal by Subject|0|||
130196327|NCT05481125|468676960|FG001|Overall Study|Withdrawal by Subject|1|||
130196328|NCT02244463|468676961|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
130196329|NCT02244463|468676962|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196330|NCT02244463|468676963|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196331|NCT02244463|468676964|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196332|NCT02244463|468676965|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196333|NCT02244463|468676966|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
130196334|NCT02244463|468676961|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
130196335|NCT02244463|468676962|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
130196336|NCT02244463|468676963|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
130196337|NCT02244463|468676964|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
130196338|NCT02244463|468676965|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
130196339|NCT02244463|468676966|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
130196340|NCT02244463|468676961|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196341|NCT02244463|468676962|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
130196342|NCT02244463|468676963|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196343|NCT02244463|468676964|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196344|NCT02244463|468676965|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196345|NCT02244463|468676966|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
130196346|NCT02244463|468676961|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196347|NCT02244463|468676962|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196348|NCT02244463|468676963|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
130196349|NCT02244463|468676964|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196350|NCT02244463|468676965|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196351|NCT02244463|468676966|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
130196352|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196353|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196354|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196355|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
130196356|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196357|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
130196358|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196359|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196360|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196361|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
130196362|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196363|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
130196364|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196365|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196366|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196367|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
130196368|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196369|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
130196370|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196371|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196372|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196373|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
130196374|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196375|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
130196376|NCT02244463|468676961|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196377|NCT02244463|468676962|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196378|NCT02244463|468676963|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196379|NCT02244463|468676964|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
130196380|NCT02244463|468676965|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196381|NCT02244463|468676966|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
130196382|NCT02244463|468676961|FG000|Period 5: Phase II|Disease Progression|0|||
130196383|NCT02244463|468676962|FG001|Period 5: Phase II|Disease Progression|0|||
130196384|NCT02244463|468676963|FG002|Period 5: Phase II|Disease Progression|0|||
130196385|NCT02244463|468676964|FG003|Period 5: Phase II|Disease Progression|0|||
130196386|NCT02244463|468676965|FG004|Period 5: Phase II|Disease Progression|10|||
130196387|NCT02244463|468676966|FG005|Period 5: Phase II|Disease Progression|11|||
130196388|NCT02244463|468676961|FG000|Period 5: Phase II|Physician Decision|0|||
130196389|NCT02244463|468676962|FG001|Period 5: Phase II|Physician Decision|0|||
130196390|NCT02244463|468676963|FG002|Period 5: Phase II|Physician Decision|0|||
130196391|NCT02244463|468676964|FG003|Period 5: Phase II|Physician Decision|0|||
130196392|NCT02244463|468676965|FG004|Period 5: Phase II|Physician Decision|3|||
130196393|NCT02244463|468676966|FG005|Period 5: Phase II|Physician Decision|2|||
130196394|NCT02244463|468676961|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
130196395|NCT02244463|468676962|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
130196396|NCT02244463|468676963|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
130196397|NCT02244463|468676964|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
130196398|NCT02244463|468676965|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
130196399|NCT02244463|468676966|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
130196400|NCT02244463|468676961|FG000|Period 5: Phase II|Intercurrent Illness|0|||
130196401|NCT02244463|468676962|FG001|Period 5: Phase II|Intercurrent Illness|0|||
130196402|NCT02244463|468676963|FG002|Period 5: Phase II|Intercurrent Illness|0|||
130196403|NCT02244463|468676964|FG003|Period 5: Phase II|Intercurrent Illness|0|||
130196404|NCT02244463|468676965|FG004|Period 5: Phase II|Intercurrent Illness|2|||
130196405|NCT02244463|468676966|FG005|Period 5: Phase II|Intercurrent Illness|0|||
130196406|NCT02244463|468676961|FG000|Period 5: Phase II|Adverse Event|0|||
130196407|NCT02244463|468676962|FG001|Period 5: Phase II|Adverse Event|0|||
130196408|NCT02244463|468676963|FG002|Period 5: Phase II|Adverse Event|0|||
130196409|NCT02244463|468676964|FG003|Period 5: Phase II|Adverse Event|0|||
130196410|NCT02244463|468676965|FG004|Period 5: Phase II|Adverse Event|0|||
130196411|NCT02244463|468676966|FG005|Period 5: Phase II|Adverse Event|2|||
130196412|NCT02244463|468676961|FG000|Period 5: Phase II|Still On treatment|0|||
130196413|NCT02244463|468676962|FG001|Period 5: Phase II|Still On treatment|0|||
130196414|NCT02244463|468676963|FG002|Period 5: Phase II|Still On treatment|0|||
130196415|NCT02244463|468676964|FG003|Period 5: Phase II|Still On treatment|0|||
130196416|NCT02244463|468676965|FG004|Period 5: Phase II|Still On treatment|0|||
130196417|NCT02244463|468676966|FG005|Period 5: Phase II|Still On treatment|3|||
130196418|NCT01769508|468676967|FG000|Overall Study|Death|3|||
130196419|NCT01769508|468676967|FG000|Overall Study|Withdrawal by Subject|1|||
130196420|NCT01769508|468676967|FG000|Overall Study|Adverse Event|1|||
130196421|NCT01769508|468676967|FG000|Overall Study|Lost to Follow-up|1|||
130196422|NCT01598090|468676971|FG000|Treatment Period|Poor/non-compliance|0|||
130196423|NCT01598090|468676972|FG001|Treatment Period|Poor/non-compliance|2|||
130196424|NCT01598090|468676973|FG002|Treatment Period|Poor/non-compliance|0|||
130196425|NCT01598090|468676971|FG000|Treatment Period|No longer meet study criteria|0|||
130196426|NCT01598090|468676972|FG001|Treatment Period|No longer meet study criteria|1|||
130196427|NCT01598090|468676973|FG002|Treatment Period|No longer meet study criteria|0|||
130196428|NCT01598090|468676971|FG000|Treatment Period|Lack of Efficacy|5|||
130196429|NCT01598090|468676972|FG001|Treatment Period|Lack of Efficacy|14|||
130196430|NCT01598090|468676973|FG002|Treatment Period|Lack of Efficacy|6|||
130196431|NCT01598090|468676971|FG000|Treatment Period|Adverse Event|2|||
130196432|NCT01598090|468676972|FG001|Treatment Period|Adverse Event|33|||
130196433|NCT01598090|468676973|FG002|Treatment Period|Adverse Event|17|||
130196434|NCT01598090|468676971|FG000|Treatment Period|Other reasons|0|||
130196435|NCT01598090|468676972|FG001|Treatment Period|Other reasons|4|||
130196436|NCT01598090|468676973|FG002|Treatment Period|Other reasons|1|||
130196437|NCT01598090|468676971|FG000|Treatment Period|Withdrawal by Subject|3|||
130196438|NCT01598090|468676972|FG001|Treatment Period|Withdrawal by Subject|13|||
130196439|NCT01598090|468676973|FG002|Treatment Period|Withdrawal by Subject|10|||
130196440|NCT01598090|468676971|FG000|Treatment Period|Lost to Follow-up|1|||
130196441|NCT01598090|468676972|FG001|Treatment Period|Lost to Follow-up|5|||
130196442|NCT01598090|468676973|FG002|Treatment Period|Lost to Follow-up|1|||
130196443|NCT01598090|468676971|FG000|Follow-up Period|Death|0|||
130196444|NCT01598090|468676972|FG001|Follow-up Period|Death|1|||
130196445|NCT01598090|468676973|FG002|Follow-up Period|Death|0|||
130196446|NCT01598090|468676971|FG000|Follow-up Period|No longer required per protocol|1|||
130196447|NCT01598090|468676972|FG001|Follow-up Period|No longer required per protocol|3|||
130196448|NCT01598090|468676973|FG002|Follow-up Period|No longer required per protocol|2|||
130196449|NCT01598090|468676971|FG000|Follow-up Period|Not reported|0|||
130196450|NCT01598090|468676972|FG001|Follow-up Period|Not reported|10|||
130196451|NCT01598090|468676973|FG002|Follow-up Period|Not reported|4|||
130196452|NCT01598090|468676971|FG000|Follow-up Period|Withdrawal by Subject|0|||
130196453|NCT01598090|468676972|FG001|Follow-up Period|Withdrawal by Subject|3|||
130196454|NCT01598090|468676973|FG002|Follow-up Period|Withdrawal by Subject|2|||
130196455|NCT01598090|468676971|FG000|Follow-up Period|Other reasons|2|||
130196456|NCT01598090|468676972|FG001|Follow-up Period|Other reasons|8|||
130196457|NCT01598090|468676973|FG002|Follow-up Period|Other reasons|8|||
130196458|NCT01598090|468676971|FG000|Follow-up Period|Lost to Follow-up|2|||
130196459|NCT01598090|468676972|FG001|Follow-up Period|Lost to Follow-up|10|||
130196460|NCT01598090|468676973|FG002|Follow-up Period|Lost to Follow-up|12|||
130196461|NCT03615144|468676974|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
130196462|NCT03615144|468676975|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
130196463|NCT02587598|468676978|FG000|Overall Study|Death|4|||
130196464|NCT02587598|468676979|FG001|Overall Study|Death|8|||
130196465|NCT02587598|468676980|FG002|Overall Study|Death|4|||
130196466|NCT02587598|468676981|FG003|Overall Study|Death|16|||
130196467|NCT02587598|468676982|FG004|Overall Study|Death|9|||
130196468|NCT02587598|468676983|FG005|Overall Study|Death|4|||
130196469|NCT02587598|468676984|FG006|Overall Study|Death|6|||
130196470|NCT02587598|468676985|FG007|Overall Study|Death|7|||
130196471|NCT02587598|468676986|FG008|Overall Study|Death|9|||
130196472|NCT02587598|468676987|FG009|Overall Study|Death|1|||
130196473|NCT02587598|468676988|FG010|Overall Study|Death|3|||
130196474|NCT02587598|468676978|FG000|Overall Study|Study Terminated by the Sponsor|0|||
130196475|NCT02587598|468676979|FG001|Overall Study|Study Terminated by the Sponsor|1|||
130196476|NCT02587598|468676980|FG002|Overall Study|Study Terminated by the Sponsor|0|||
130196477|NCT02587598|468676981|FG003|Overall Study|Study Terminated by the Sponsor|3|||
130196478|NCT02587598|468676982|FG004|Overall Study|Study Terminated by the Sponsor|0|||
130196479|NCT02587598|468676983|FG005|Overall Study|Study Terminated by the Sponsor|1|||
130196480|NCT02587598|468676984|FG006|Overall Study|Study Terminated by the Sponsor|0|||
130196481|NCT02587598|468676985|FG007|Overall Study|Study Terminated by the Sponsor|0|||
130196482|NCT02587598|468676986|FG008|Overall Study|Study Terminated by the Sponsor|0|||
130196483|NCT02587598|468676987|FG009|Overall Study|Study Terminated by the Sponsor|1|||
130196484|NCT02587598|468676988|FG010|Overall Study|Study Terminated by the Sponsor|6|||
130196485|NCT02587598|468676978|FG000|Overall Study|Reason for study withdrawal not specified|0|||
130196486|NCT02587598|468676979|FG001|Overall Study|Reason for study withdrawal not specified|1|||
130196487|NCT02587598|468676980|FG002|Overall Study|Reason for study withdrawal not specified|0|||
130196488|NCT02587598|468676981|FG003|Overall Study|Reason for study withdrawal not specified|0|||
130196489|NCT02587598|468676982|FG004|Overall Study|Reason for study withdrawal not specified|0|||
130196490|NCT02587598|468676983|FG005|Overall Study|Reason for study withdrawal not specified|0|||
130196491|NCT02587598|468676984|FG006|Overall Study|Reason for study withdrawal not specified|0|||
130196492|NCT02587598|468676985|FG007|Overall Study|Reason for study withdrawal not specified|0|||
130196493|NCT02587598|468676986|FG008|Overall Study|Reason for study withdrawal not specified|0|||
130196494|NCT02587598|468676987|FG009|Overall Study|Reason for study withdrawal not specified|0|||
130196495|NCT02587598|468676988|FG010|Overall Study|Reason for study withdrawal not specified|0|||
130196496|NCT02587598|468676978|FG000|Overall Study|Withdrawal by Subject|0|||
130196497|NCT02587598|468676979|FG001|Overall Study|Withdrawal by Subject|1|||
130196498|NCT02587598|468676980|FG002|Overall Study|Withdrawal by Subject|0|||
130196499|NCT02587598|468676981|FG003|Overall Study|Withdrawal by Subject|2|||
130196500|NCT02587598|468676982|FG004|Overall Study|Withdrawal by Subject|3|||
130196501|NCT02587598|468676983|FG005|Overall Study|Withdrawal by Subject|1|||
130196502|NCT02587598|468676984|FG006|Overall Study|Withdrawal by Subject|0|||
130196503|NCT02587598|468676985|FG007|Overall Study|Withdrawal by Subject|0|||
130196504|NCT02587598|468676986|FG008|Overall Study|Withdrawal by Subject|0|||
130196505|NCT02587598|468676987|FG009|Overall Study|Withdrawal by Subject|1|||
130196506|NCT02587598|468676988|FG010|Overall Study|Withdrawal by Subject|2|||
130196507|NCT02587598|468676978|FG000|Overall Study|Physician Decision|0|||
130196508|NCT02587598|468676979|FG001|Overall Study|Physician Decision|0|||
130196509|NCT02587598|468676980|FG002|Overall Study|Physician Decision|0|||
130196510|NCT02587598|468676981|FG003|Overall Study|Physician Decision|0|||
130196511|NCT02587598|468676982|FG004|Overall Study|Physician Decision|0|||
130196512|NCT02587598|468676983|FG005|Overall Study|Physician Decision|0|||
130196513|NCT02587598|468676984|FG006|Overall Study|Physician Decision|0|||
130196514|NCT02587598|468676985|FG007|Overall Study|Physician Decision|0|||
130196515|NCT02587598|468676986|FG008|Overall Study|Physician Decision|0|||
130196516|NCT02587598|468676987|FG009|Overall Study|Physician Decision|0|||
130196517|NCT02587598|468676988|FG010|Overall Study|Physician Decision|3|||
130196518|NCT02394340|468676993|FG000|Overall Study|Failed drug screen test|1|||
130196519|NCT02394340|468676993|FG000|Overall Study|Adverse Event|1|||
130196520|NCT02828124|468676994|FG000|Overall Study|Disease Progression|1|||
130196521|NCT02828124|468676995|FG001|Overall Study|Disease Progression|2|||
130196522|NCT02828124|468676996|FG002|Overall Study|Disease Progression|1|||
130196523|NCT02828124|468676997|FG003|Overall Study|Disease Progression|4|||
130196524|NCT02828124|468676994|FG000|Overall Study|AE Unrelated to Study Drug|0|||
130196525|NCT02828124|468676995|FG001|Overall Study|AE Unrelated to Study Drug|0|||
130196526|NCT02828124|468676996|FG002|Overall Study|AE Unrelated to Study Drug|0|||
130196527|NCT02828124|468676997|FG003|Overall Study|AE Unrelated to Study Drug|1|||
130196528|NCT02828124|468676994|FG000|Overall Study|Subject Withdrew Consent|0|||
130196529|NCT02828124|468676995|FG001|Overall Study|Subject Withdrew Consent|0|||
130196530|NCT02828124|468676996|FG002|Overall Study|Subject Withdrew Consent|0|||
130196531|NCT02828124|468676997|FG003|Overall Study|Subject Withdrew Consent|1|||
130196532|NCT00256854|468676998|FG000|Overall Study|Withdrawal by Subject|2|||
130196533|NCT00256854|468676999|FG001|Overall Study|Withdrawal by Subject|3|||
130196534|NCT00256854|468677000|FG002|Overall Study|Withdrawal by Subject|0|||
130196535|NCT00256854|468677001|FG003|Overall Study|Withdrawal by Subject|0|||
130196536|NCT00256854|468677002|FG004|Overall Study|Withdrawal by Subject|0|||
130196537|NCT00256854|468677003|FG005|Overall Study|Withdrawal by Subject|0|||
130196538|NCT00256854|468676998|FG000|Overall Study|Lack of Efficacy|1|||
130196539|NCT00256854|468676999|FG001|Overall Study|Lack of Efficacy|0|||
130196540|NCT00256854|468677000|FG002|Overall Study|Lack of Efficacy|0|||
130196541|NCT00256854|468677001|FG003|Overall Study|Lack of Efficacy|0|||
130196542|NCT00256854|468677002|FG004|Overall Study|Lack of Efficacy|0|||
130196543|NCT00256854|468677003|FG005|Overall Study|Lack of Efficacy|0|||
130196544|NCT00256854|468676998|FG000|Overall Study|Protocol Violation|0|||
130196545|NCT00256854|468676999|FG001|Overall Study|Protocol Violation|1|||
130196546|NCT00256854|468677000|FG002|Overall Study|Protocol Violation|1|||
130196547|NCT00256854|468677001|FG003|Overall Study|Protocol Violation|1|||
130196548|NCT00256854|468677002|FG004|Overall Study|Protocol Violation|0|||
130196549|NCT00256854|468677003|FG005|Overall Study|Protocol Violation|0|||
130196550|NCT00256854|468676998|FG000|Overall Study|Adverse Event|0|||
130196551|NCT00256854|468676999|FG001|Overall Study|Adverse Event|0|||
130196552|NCT00256854|468677000|FG002|Overall Study|Adverse Event|2|||
130196553|NCT00256854|468677001|FG003|Overall Study|Adverse Event|2|||
130196554|NCT00256854|468677002|FG004|Overall Study|Adverse Event|0|||
130196555|NCT00256854|468677003|FG005|Overall Study|Adverse Event|1|||
130196556|NCT00256854|468676998|FG000|Overall Study|Not compliant with the study drug|0|||
130196557|NCT00256854|468676999|FG001|Overall Study|Not compliant with the study drug|0|||
130196558|NCT00256854|468677000|FG002|Overall Study|Not compliant with the study drug|0|||
130196559|NCT00256854|468677001|FG003|Overall Study|Not compliant with the study drug|0|||
130196560|NCT00256854|468677002|FG004|Overall Study|Not compliant with the study drug|1|||
130196561|NCT00256854|468677003|FG005|Overall Study|Not compliant with the study drug|0|||
130196562|NCT02353442|468677004|FG000|Overall Study|Withdrawal by Subject|3|||
130196563|NCT02353442|468677005|FG001|Overall Study|Withdrawal by Subject|4|||
130196564|NCT03514485|468677006|FG000|Overall Study|Lost to Follow-up|5|||
130196565|NCT03514485|468677007|FG001|Overall Study|Lost to Follow-up|3|||
130196566|NCT03514485|468677008|FG002|Overall Study|Lost to Follow-up|2|||
130196567|NCT03514485|468677009|FG003|Overall Study|Lost to Follow-up|0|||
130196568|NCT03514485|468677010|FG004|Overall Study|Lost to Follow-up|1|||
130196569|NCT03514485|468677011|FG005|Overall Study|Lost to Follow-up|4|||
130196570|NCT03514485|468677006|FG000|Overall Study|Withdrawal by Subject|0|||
130196571|NCT03514485|468677007|FG001|Overall Study|Withdrawal by Subject|1|||
130196572|NCT03514485|468677008|FG002|Overall Study|Withdrawal by Subject|3|||
130196573|NCT03514485|468677009|FG003|Overall Study|Withdrawal by Subject|1|||
130196574|NCT03514485|468677010|FG004|Overall Study|Withdrawal by Subject|2|||
130196575|NCT03514485|468677011|FG005|Overall Study|Withdrawal by Subject|1|||
130196576|NCT00791661|468677012|FG000|7 Day Wash-out|Adverse Event|0|||
130196577|NCT00791661|468677013|FG001|7 Day Wash-out|Adverse Event|0|||
130196578|NCT00791661|468677014|FG002|7 Day Wash-out|Adverse Event|1|||
130196579|NCT00791661|468677012|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
130196580|NCT00791661|468677013|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
130196581|NCT00791661|468677014|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
130196582|NCT01355575|468677017|FG000|Overall Study|Withdrawal by Subject|2|||
130196583|NCT02294396|468677018|FG000|Overall Study|Adverse Event|26|||
130196584|NCT02294396|468677019|FG001|Overall Study|Adverse Event|25|||
130196585|NCT02294396|468677020|FG002|Overall Study|Adverse Event|21|||
130196586|NCT02294396|468677021|FG003|Overall Study|Adverse Event|24|||
130196587|NCT02294396|468677018|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
130196588|NCT02294396|468677019|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
130196589|NCT02294396|468677020|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
130196590|NCT02294396|468677021|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
130196591|NCT02294396|468677018|FG000|Overall Study|Withdrawal by Subject|8|||
130196592|NCT02294396|468677019|FG001|Overall Study|Withdrawal by Subject|6|||
130196593|NCT02294396|468677020|FG002|Overall Study|Withdrawal by Subject|6|||
130196594|NCT02294396|468677021|FG003|Overall Study|Withdrawal by Subject|8|||
130196595|NCT02294396|468677018|FG000|Overall Study|Lost to Follow-up|0|||
130196596|NCT02294396|468677019|FG001|Overall Study|Lost to Follow-up|0|||
130196597|NCT02294396|468677020|FG002|Overall Study|Lost to Follow-up|1|||
130196598|NCT02294396|468677021|FG003|Overall Study|Lost to Follow-up|1|||
130196599|NCT02294396|468677018|FG000|Overall Study|Protocol Deviation|3|||
130196600|NCT02294396|468677019|FG001|Overall Study|Protocol Deviation|2|||
130196601|NCT02294396|468677020|FG002|Overall Study|Protocol Deviation|2|||
130196602|NCT02294396|468677021|FG003|Overall Study|Protocol Deviation|1|||
130196603|NCT02294396|468677018|FG000|Overall Study|Miscellaneous|2|||
130196604|NCT02294396|468677019|FG001|Overall Study|Miscellaneous|0|||
130196605|NCT02294396|468677020|FG002|Overall Study|Miscellaneous|5|||
130196606|NCT02294396|468677021|FG003|Overall Study|Miscellaneous|2|||
130196607|NCT02120833|468677022|FG000|Overall Study|Adverse Event|1|||
130196608|NCT02120833|468677023|FG001|Overall Study|Adverse Event|0|||
130196609|NCT02120833|468677022|FG000|Overall Study|Withdrawal by Subject|2|||
130196610|NCT02120833|468677023|FG001|Overall Study|Withdrawal by Subject|0|||
130196611|NCT02120833|468677022|FG000|Overall Study|Lost to Follow-up|1|||
130196612|NCT02120833|468677023|FG001|Overall Study|Lost to Follow-up|1|||
130196613|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
130196614|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
130196615|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130196616|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130196617|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
130196618|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130196619|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130196620|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
130196621|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130196622|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
130196623|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130196624|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
130196625|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130196626|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
130196627|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
130196628|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
130196629|NCT02438826|468677024|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
130196630|NCT02438826|468677025|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
130196631|NCT02438826|468677026|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
130196632|NCT02438826|468677027|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
130196633|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Adverse Event|11|||
130196634|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Adverse Event|6|||
130196635|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Adverse Event|0|||
130196636|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Adverse Event|0|||
130196637|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
130196638|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
130196639|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
130196640|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
130196641|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
130196642|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
130196643|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
130196644|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
130196645|NCT02438826|468677024|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
130196646|NCT02438826|468677025|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
130196647|NCT02438826|468677026|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
130196648|NCT02438826|468677027|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
130196649|NCT02438826|468677024|FG000|Post-Treatment Phase|Adverse Event|3|||
130196650|NCT02438826|468677025|FG001|Post-Treatment Phase|Adverse Event|0|||
130196651|NCT02438826|468677026|FG002|Post-Treatment Phase|Adverse Event|0|||
130196652|NCT02438826|468677027|FG003|Post-Treatment Phase|Adverse Event|0|||
130196653|NCT02438826|468677024|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
130196654|NCT02438826|468677025|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
130196655|NCT02438826|468677026|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
130196656|NCT02438826|468677027|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
130196657|NCT02438826|468677024|FG000|Post-Treatment Phase|Physician Decision|1|||
130196658|NCT02438826|468677025|FG001|Post-Treatment Phase|Physician Decision|0|||
130196659|NCT02438826|468677026|FG002|Post-Treatment Phase|Physician Decision|0|||
130196660|NCT02438826|468677027|FG003|Post-Treatment Phase|Physician Decision|0|||
130196661|NCT02438826|468677024|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
130196662|NCT02438826|468677025|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
130196663|NCT02438826|468677026|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
130196664|NCT02438826|468677027|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
130196665|NCT04105218|468677033|FG000|Overall Study|Withdrawal by Subject|3|||
130196666|NCT04105218|468677034|FG001|Overall Study|Withdrawal by Subject|2|||
130196667|NCT04105218|468677033|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
130196668|NCT04105218|468677034|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
130196669|NCT04105218|468677033|FG000|Overall Study|Failed screening tests|2|||
130196670|NCT04105218|468677034|FG001|Overall Study|Failed screening tests|1|||
130196671|NCT01435460|468677035|FG000|Overall Study|Adverse Event|2|||
130196672|NCT01435460|468677036|FG001|Overall Study|Adverse Event|1|||
130196673|NCT01435460|468677035|FG000|Overall Study|Lost to Follow-up|6|||
130196674|NCT01435460|468677036|FG001|Overall Study|Lost to Follow-up|1|||
130196675|NCT01435460|468677035|FG000|Overall Study|Withdrawal by Subject|1|||
130196676|NCT01435460|468677036|FG001|Overall Study|Withdrawal by Subject|3|||
130196677|NCT01435460|468677035|FG000|Overall Study|Protocol Violation|0|||
130196678|NCT01435460|468677036|FG001|Overall Study|Protocol Violation|1|||
130196679|NCT01435460|468677035|FG000|Overall Study|Did not meet eligibility criteria|2|||
130196680|NCT01435460|468677036|FG001|Overall Study|Did not meet eligibility criteria|0|||
130196681|NCT01706939|468677037|FG000|Pre Randomization|Screen Failure|1|||
130196682|NCT01706939|468677038|FG001|Pre Randomization|Screen Failure|0|||
130196683|NCT01706939|468677039|FG002|Pre Randomization|Screen Failure|0|||
130196684|NCT01706939|468677037|FG000|Pre Randomization|Ineligible for Randomization|1|||
130196685|NCT01706939|468677038|FG001|Pre Randomization|Ineligible for Randomization|0|||
130196686|NCT01706939|468677039|FG002|Pre Randomization|Ineligible for Randomization|0|||
130196687|NCT01706939|468677037|FG000|Pre Randomization|Withdrawal by Subject|1|||
130196688|NCT01706939|468677038|FG001|Pre Randomization|Withdrawal by Subject|0|||
130196689|NCT01706939|468677039|FG002|Pre Randomization|Withdrawal by Subject|0|||
130196690|NCT01706939|468677037|FG000|Randomization|Insufficient QoL survey compliance|0|||
130196691|NCT01706939|468677038|FG001|Randomization|Insufficient QoL survey compliance|1|||
130196692|NCT01706939|468677039|FG002|Randomization|Insufficient QoL survey compliance|1|||
130196693|NCT01706939|468677037|FG000|Randomization|Progression of disease|0|||
130196694|NCT01706939|468677038|FG001|Randomization|Progression of disease|2|||
130196695|NCT01706939|468677039|FG002|Randomization|Progression of disease|1|||
130196696|NCT01046903|468677041|FG000|Overall Study|Lost to Follow-up|16|||
130196697|NCT01046903|468677041|FG000|Overall Study|Adverse Event|4|||
130196698|NCT01046903|468677041|FG000|Overall Study|Withdrawal by Subject|3|||
130196699|NCT01046903|468677041|FG000|Overall Study|Other|5|||
130196700|NCT04152837|468677053|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
130196701|NCT04152837|468677053|FG000|Maintenance Period|Adverse Event|1|||
130196702|NCT04152837|468677053|FG000|Maintenance Period|Withdrawal by Subject|1|||
130196703|NCT04152837|468677053|FG000|Maintenance Period|Sponsor Termination of Study|2|||
130196704|NCT00101166|468677056|FG000|Overall Study|progressive disease|10|||
130196705|NCT00686829|468677057|FG000|Overall Study|Adverse Event|5|||
130196706|NCT00686829|468677057|FG000|Overall Study|Lack of Efficacy|6|||
130196707|NCT00686829|468677057|FG000|Overall Study|Lost to Follow-up|4|||
130196708|NCT00686829|468677057|FG000|Overall Study|Withdrawal by Subject|14|||
130196709|NCT00686829|468677057|FG000|Overall Study|Protocol Violation|3|||
130196710|NCT00686829|468677057|FG000|Overall Study|Sponsor discontinued VCV|47|||
130196711|NCT01217476|468677060|FG000|Overall Study|Adverse Event|6|||
130196712|NCT01217476|468677061|FG001|Overall Study|Adverse Event|1|||
130196713|NCT01217476|468677060|FG000|Overall Study|Physician Decision|0|||
130196714|NCT01217476|468677061|FG001|Overall Study|Physician Decision|1|||
130196715|NCT01217476|468677060|FG000|Overall Study|Withdrawal by Subject|3|||
130196716|NCT01217476|468677061|FG001|Overall Study|Withdrawal by Subject|3|||
130196717|NCT01217476|468677060|FG000|Overall Study|Surgery on the Target Limb|0|||
130196718|NCT01217476|468677061|FG001|Overall Study|Surgery on the Target Limb|2|||
130196719|NCT01217476|468677060|FG000|Overall Study|Protocol Deviation|1|||
130196720|NCT01217476|468677061|FG001|Overall Study|Protocol Deviation|0|||
130196721|NCT01217476|468677060|FG000|Overall Study|Other|2|||
130196722|NCT01217476|468677061|FG001|Overall Study|Other|0|||
130196723|NCT03033602|468677062|FG000|Overall Study|Withdrawal by Subject|11|||
130196724|NCT03033602|468677063|FG001|Overall Study|Withdrawal by Subject|21|||
130196725|NCT03033602|468677062|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
130196726|NCT03033602|468677063|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
130196727|NCT04445714|468677064|FG000|Overall Study|Discontinuation of the study|14|||
130196728|NCT04445714|468677064|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
130196729|NCT04445714|468677064|FG000|Overall Study|Withdrawal of Informed Consent|8|||
130196730|NCT01672710|468677065|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
130196731|NCT01672710|468677066|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
130196732|NCT01672710|468677065|FG000|3 Month Follow up|Lost to Follow-up|2|||
130196733|NCT01672710|468677066|FG001|3 Month Follow up|Lost to Follow-up|3|||
130196734|NCT01672710|468677065|FG000|3 Month Follow up|follow up due after termination date|4|||
130196735|NCT01672710|468677066|FG001|3 Month Follow up|follow up due after termination date|1|||
130196736|NCT04999163|468677067|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
130196737|NCT04999163|468677068|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
130196738|NCT04999163|468677067|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
130196739|NCT04999163|468677068|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
130196740|NCT04999163|468677067|FG000|Overall Study|Withdrawal by Subject|1|||
130196741|NCT04999163|468677068|FG001|Overall Study|Withdrawal by Subject|0|||
130196742|NCT01399047|468678949|FG000|Overall Study|Withdrawal by Subject|0|||
130196743|NCT01399047|468678950|FG001|Overall Study|Withdrawal by Subject|1|||
130196744|NCT01283334|468678958|FG000|Overall Study|Withdrawal by Subject|1|||
130196745|NCT01283334|468678958|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
130196746|NCT01283334|468678958|FG000|Overall Study|Adverse Event|4|||
130196747|NCT01283334|468678958|FG000|Overall Study|Physician Decision|1|||
130196748|NCT03467217|468678959|FG000|Overall Study|Trial stopped early|5|||
130196749|NCT03467217|468678960|FG001|Overall Study|Trial stopped early|2|||
130196750|NCT03467217|468678959|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
130196751|NCT03467217|468678960|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
130196752|NCT03467217|468678959|FG000|Overall Study|Lost to Follow-up|0|||
130196753|NCT03467217|468678960|FG001|Overall Study|Lost to Follow-up|2|||
130196754|NCT03233529|468678964|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
130196755|NCT03233529|468678964|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
130196756|NCT01177293|468678965|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
130196757|NCT01177293|468678966|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
130196758|NCT00160706|468678968|FG000|Overall Study|Adverse Event|53|||
130196759|NCT00160706|468678968|FG000|Overall Study|Adverse Event and Other Reason|105|||
130196760|NCT00160706|468678968|FG000|Overall Study|Protocol Violation|3|||
130196761|NCT00160706|468678968|FG000|Overall Study|Withdrawal by Subject|41|||
130196762|NCT00160706|468678968|FG000|Overall Study|Withdrawal by Subject and Other|12|||
130196763|NCT00160706|468678968|FG000|Overall Study|Physician Decision|10|||
130196764|NCT00160706|468678968|FG000|Overall Study|Physician Decision and Other|3|||
130196765|NCT00160706|468678968|FG000|Overall Study|Lost to Follow-up|4|||
130196766|NCT00160706|468678968|FG000|Overall Study|Lost to Follow-up and Other|1|||
130196767|NCT00160706|468678968|FG000|Overall Study|Lack of Efficacy|42|||
130196768|NCT00160706|468678968|FG000|Overall Study|Lack of Efficacy and Other|1|||
130196769|NCT00160706|468678968|FG000|Overall Study|Other Reason|11|||
130196770|NCT03214380|468678969|FG000|Lead-in|Adverse Event|3|||
130196771|NCT03214380|468678970|FG001|Lead-in|Adverse Event|0|||
130196772|NCT03214380|468678971|FG002|Lead-in|Adverse Event|0|||
130196773|NCT03214380|468678972|FG003|Lead-in|Adverse Event|1|||
130196774|NCT03214380|468678973|FG004|Lead-in|Adverse Event|0|||
130196775|NCT03214380|468678974|FG005|Lead-in|Adverse Event|0|||
130196776|NCT03214380|468678969|FG000|Lead-in|Lost to Follow-up|4|||
130196777|NCT03214380|468678970|FG001|Lead-in|Lost to Follow-up|0|||
130196778|NCT03214380|468678971|FG002|Lead-in|Lost to Follow-up|0|||
130196779|NCT03214380|468678972|FG003|Lead-in|Lost to Follow-up|1|||
130196780|NCT03214380|468678973|FG004|Lead-in|Lost to Follow-up|0|||
130196781|NCT03214380|468678974|FG005|Lead-in|Lost to Follow-up|0|||
130196782|NCT03214380|468678969|FG000|Lead-in|Eligibility Criteria|3|||
130196783|NCT03214380|468678970|FG001|Lead-in|Eligibility Criteria|0|||
130196784|NCT03214380|468678971|FG002|Lead-in|Eligibility Criteria|0|||
130196785|NCT03214380|468678972|FG003|Lead-in|Eligibility Criteria|0|||
130196786|NCT03214380|468678973|FG004|Lead-in|Eligibility Criteria|0|||
130196787|NCT03214380|468678974|FG005|Lead-in|Eligibility Criteria|0|||
130196788|NCT03214380|468678969|FG000|Lead-in|Physician Decision|6|||
130196789|NCT03214380|468678970|FG001|Lead-in|Physician Decision|0|||
130196790|NCT03214380|468678971|FG002|Lead-in|Physician Decision|0|||
130196791|NCT03214380|468678972|FG003|Lead-in|Physician Decision|0|||
130196792|NCT03214380|468678973|FG004|Lead-in|Physician Decision|0|||
130196793|NCT03214380|468678974|FG005|Lead-in|Physician Decision|0|||
130196794|NCT03214380|468678969|FG000|Lead-in|Protocol Deviation|7|||
130196795|NCT03214380|468678970|FG001|Lead-in|Protocol Deviation|0|||
130196796|NCT03214380|468678971|FG002|Lead-in|Protocol Deviation|0|||
130196797|NCT03214380|468678972|FG003|Lead-in|Protocol Deviation|3|||
130196798|NCT03214380|468678973|FG004|Lead-in|Protocol Deviation|0|||
130196799|NCT03214380|468678974|FG005|Lead-in|Protocol Deviation|0|||
130196800|NCT03214380|468678969|FG000|Lead-in|Withdrawal by Subject|41|||
130196801|NCT03214380|468678970|FG001|Lead-in|Withdrawal by Subject|0|||
130196802|NCT03214380|468678971|FG002|Lead-in|Withdrawal by Subject|0|||
130196803|NCT03214380|468678972|FG003|Lead-in|Withdrawal by Subject|14|||
130196804|NCT03214380|468678973|FG004|Lead-in|Withdrawal by Subject|0|||
130196805|NCT03214380|468678974|FG005|Lead-in|Withdrawal by Subject|0|||
130196806|NCT03214380|468678969|FG000|Lead-in|Family Emergency|1|||
130196807|NCT03214380|468678970|FG001|Lead-in|Family Emergency|0|||
130196808|NCT03214380|468678971|FG002|Lead-in|Family Emergency|0|||
130196809|NCT03214380|468678972|FG003|Lead-in|Family Emergency|0|||
130196810|NCT03214380|468678973|FG004|Lead-in|Family Emergency|0|||
130196811|NCT03214380|468678974|FG005|Lead-in|Family Emergency|0|||
130196812|NCT03214380|468678969|FG000|Lead-in|Natural Disaster|9|||
130196813|NCT03214380|468678970|FG001|Lead-in|Natural Disaster|0|||
130196814|NCT03214380|468678971|FG002|Lead-in|Natural Disaster|0|||
130196815|NCT03214380|468678972|FG003|Lead-in|Natural Disaster|0|||
130196816|NCT03214380|468678973|FG004|Lead-in|Natural Disaster|0|||
130196817|NCT03214380|468678974|FG005|Lead-in|Natural Disaster|0|||
130196818|NCT03214380|468678969|FG000|Lead-in|Non Compliance|1|||
130196819|NCT03214380|468678970|FG001|Lead-in|Non Compliance|0|||
130196820|NCT03214380|468678971|FG002|Lead-in|Non Compliance|0|||
130196821|NCT03214380|468678972|FG003|Lead-in|Non Compliance|0|||
130196822|NCT03214380|468678973|FG004|Lead-in|Non Compliance|0|||
130196823|NCT03214380|468678974|FG005|Lead-in|Non Compliance|0|||
130196824|NCT03214380|468678969|FG000|Lead-in|Participant Schedule|2|||
130196825|NCT03214380|468678970|FG001|Lead-in|Participant Schedule|0|||
130196826|NCT03214380|468678971|FG002|Lead-in|Participant Schedule|0|||
130196827|NCT03214380|468678972|FG003|Lead-in|Participant Schedule|0|||
130196828|NCT03214380|468678973|FG004|Lead-in|Participant Schedule|0|||
130196829|NCT03214380|468678974|FG005|Lead-in|Participant Schedule|0|||
130196830|NCT03214380|468678969|FG000|Treatment Period|Adverse Event|0|||
130196831|NCT03214380|468678970|FG001|Treatment Period|Adverse Event|1|||
130196832|NCT03214380|468678971|FG002|Treatment Period|Adverse Event|1|||
130196833|NCT03214380|468678972|FG003|Treatment Period|Adverse Event|0|||
130196834|NCT03214380|468678973|FG004|Treatment Period|Adverse Event|1|||
130196835|NCT03214380|468678974|FG005|Treatment Period|Adverse Event|0|||
130196836|NCT03214380|468678969|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
130196837|NCT03214380|468678970|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
130196838|NCT03214380|468678971|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
130196839|NCT03214380|468678972|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
130196840|NCT03214380|468678973|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
130196841|NCT03214380|468678974|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
130196842|NCT03214380|468678969|FG000|Treatment Period|Withdrawal by Subject|0|||
130196843|NCT03214380|468678970|FG001|Treatment Period|Withdrawal by Subject|10|||
130196844|NCT03214380|468678971|FG002|Treatment Period|Withdrawal by Subject|8|||
130196845|NCT03214380|468678972|FG003|Treatment Period|Withdrawal by Subject|0|||
130196846|NCT03214380|468678973|FG004|Treatment Period|Withdrawal by Subject|7|||
130196847|NCT03214380|468678974|FG005|Treatment Period|Withdrawal by Subject|11|||
130196848|NCT03214380|468678969|FG000|Treatment Period|Death|0|||
130196849|NCT03214380|468678970|FG001|Treatment Period|Death|1|||
130196850|NCT03214380|468678971|FG002|Treatment Period|Death|2|||
130196851|NCT03214380|468678972|FG003|Treatment Period|Death|0|||
130196852|NCT03214380|468678973|FG004|Treatment Period|Death|0|||
130196853|NCT03214380|468678974|FG005|Treatment Period|Death|0|||
130196854|NCT03214380|468678969|FG000|Treatment Period|Lost to Follow-up|0|||
130196855|NCT03214380|468678970|FG001|Treatment Period|Lost to Follow-up|6|||
130196856|NCT03214380|468678971|FG002|Treatment Period|Lost to Follow-up|3|||
130196857|NCT03214380|468678972|FG003|Treatment Period|Lost to Follow-up|0|||
130196858|NCT03214380|468678973|FG004|Treatment Period|Lost to Follow-up|0|||
130196859|NCT03214380|468678974|FG005|Treatment Period|Lost to Follow-up|0|||
130196860|NCT03214380|468678969|FG000|Treatment Period|Participant schedule|0|||
130196861|NCT03214380|468678970|FG001|Treatment Period|Participant schedule|0|||
130196862|NCT03214380|468678971|FG002|Treatment Period|Participant schedule|1|||
130196863|NCT03214380|468678972|FG003|Treatment Period|Participant schedule|0|||
130196864|NCT03214380|468678973|FG004|Treatment Period|Participant schedule|0|||
130196865|NCT03214380|468678974|FG005|Treatment Period|Participant schedule|0|||
130196866|NCT03214380|468678969|FG000|Treatment Period|Treatment Interruption|0|||
130196867|NCT03214380|468678970|FG001|Treatment Period|Treatment Interruption|0|||
130196868|NCT03214380|468678971|FG002|Treatment Period|Treatment Interruption|1|||
130196869|NCT03214380|468678972|FG003|Treatment Period|Treatment Interruption|0|||
130196870|NCT03214380|468678973|FG004|Treatment Period|Treatment Interruption|0|||
130196871|NCT03214380|468678974|FG005|Treatment Period|Treatment Interruption|0|||
130196872|NCT01905553|468678981|FG000|Period 2|Adverse Event|1|||
130196873|NCT01905553|468678982|FG001|Period 2|Adverse Event|0|||
130196874|NCT01014988|468678993|FG000|Overall Study|Adverse Event|20|||
130196875|NCT01014988|468678994|FG001|Overall Study|Adverse Event|0|||
130196876|NCT01014988|468678995|FG002|Overall Study|Adverse Event|1|||
130196877|NCT01014988|468678996|FG003|Overall Study|Adverse Event|0|||
130196878|NCT01014988|468678997|FG004|Overall Study|Adverse Event|1|||
130196879|NCT01014988|468678998|FG005|Overall Study|Adverse Event|3|||
130196880|NCT01014988|468678993|FG000|Overall Study|Lost to Follow-up|1|||
130196881|NCT01014988|468678994|FG001|Overall Study|Lost to Follow-up|0|||
130196882|NCT01014988|468678995|FG002|Overall Study|Lost to Follow-up|1|||
130196883|NCT01014988|468678996|FG003|Overall Study|Lost to Follow-up|0|||
130196884|NCT01014988|468678997|FG004|Overall Study|Lost to Follow-up|0|||
130196885|NCT01014988|468678998|FG005|Overall Study|Lost to Follow-up|0|||
130196886|NCT01014988|468678993|FG000|Overall Study|Physician Decision|1|||
130196887|NCT01014988|468678994|FG001|Overall Study|Physician Decision|0|||
130196888|NCT01014988|468678995|FG002|Overall Study|Physician Decision|0|||
130196889|NCT01014988|468678996|FG003|Overall Study|Physician Decision|0|||
130196890|NCT01014988|468678997|FG004|Overall Study|Physician Decision|0|||
130196891|NCT01014988|468678998|FG005|Overall Study|Physician Decision|0|||
130196892|NCT01014988|468678993|FG000|Overall Study|Withdrawal by Subject|1|||
130196893|NCT01014988|468678994|FG001|Overall Study|Withdrawal by Subject|0|||
130196894|NCT01014988|468678995|FG002|Overall Study|Withdrawal by Subject|0|||
130196895|NCT01014988|468678996|FG003|Overall Study|Withdrawal by Subject|0|||
130196896|NCT01014988|468678997|FG004|Overall Study|Withdrawal by Subject|0|||
130196897|NCT01014988|468678998|FG005|Overall Study|Withdrawal by Subject|0|||
130196898|NCT01683266|468678999|FG000|Overall Study|Adverse Event|5|||
130196899|NCT01683266|468679000|FG001|Overall Study|Adverse Event|4|||
130196900|NCT01683266|468678999|FG000|Overall Study|Lack of Efficacy|5|||
130196901|NCT01683266|468679000|FG001|Overall Study|Lack of Efficacy|2|||
130196902|NCT01683266|468678999|FG000|Overall Study|Protocol Violation|13|||
130196903|NCT01683266|468679000|FG001|Overall Study|Protocol Violation|6|||
130196904|NCT01683266|468678999|FG000|Overall Study|Personal Reason|17|||
130196905|NCT01683266|468679000|FG001|Overall Study|Personal Reason|25|||
130196906|NCT01683266|468678999|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
130196907|NCT01683266|468679000|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
130196908|NCT01683266|468678999|FG000|Overall Study|Lost to Follow-up|5|||
130196909|NCT01683266|468679000|FG001|Overall Study|Lost to Follow-up|0|||
130196910|NCT01683266|468678999|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
130196911|NCT01683266|468679000|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
130196912|NCT01683266|468678999|FG000|Overall Study|Nonserious Hypoglycemia|0|||
130196913|NCT01683266|468679000|FG001|Overall Study|Nonserious Hypoglycemia|3|||
130196914|NCT01683266|468678999|FG000|Overall Study|Perceived Lack of Efficacy|1|||
130196915|NCT01683266|468679000|FG001|Overall Study|Perceived Lack of Efficacy|1|||
130196916|NCT01683266|468678999|FG000|Overall Study|Possibly Hypoglycemia|1|||
130196917|NCT01683266|468679000|FG001|Overall Study|Possibly Hypoglycemia|0|||
130196918|NCT01683266|468678999|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
130196919|NCT01683266|468679000|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
130196920|NCT00626821|468679003|FG000|Overall Study|Adverse Event|44|||
130196921|NCT00626821|468679003|FG000|Overall Study|Protocol Violation|33|||
130196922|NCT00626821|468679003|FG000|Overall Study|Withdrawal by Subject|10|||
130196923|NCT00626821|468679003|FG000|Overall Study|Physician Decision|9|||
130196924|NCT00626821|468679003|FG000|Overall Study|Product dysfunction|21|||
130196925|NCT00626821|468679003|FG000|Overall Study|other/unknown reason|104|||
130196950|NCT01062113|468679017|FG000|Overall Study|Adverse Event|1|||
130196951|NCT01062113|468679018|FG001|Overall Study|Adverse Event|0|||
130196952|NCT01062113|468679019|FG002|Overall Study|Adverse Event|0|||
130196953|NCT01062113|468679017|FG000|Overall Study|Lack of Efficacy|38|||
130196954|NCT01062113|468679018|FG001|Overall Study|Lack of Efficacy|22|||
130196955|NCT01062113|468679019|FG002|Overall Study|Lack of Efficacy|31|||
130196956|NCT01062113|468679017|FG000|Overall Study|Withdrawal by Subject|1|||
130196957|NCT01062113|468679018|FG001|Overall Study|Withdrawal by Subject|0|||
130196958|NCT01062113|468679019|FG002|Overall Study|Withdrawal by Subject|0|||
130196959|NCT01471340|468679020|FG000|Overall Study|Death|5|||
130196960|NCT01471340|468679021|FG001|Overall Study|Death|4|||
130196961|NCT01471340|468679020|FG000|Overall Study|Lost to Follow-up|0|||
130196962|NCT01471340|468679021|FG001|Overall Study|Lost to Follow-up|1|||
130196963|NCT01471340|468679020|FG000|Overall Study|Investigational site closure|0|||
130196964|NCT01471340|468679021|FG001|Overall Study|Investigational site closure|1|||
130196965|NCT01471340|468679020|FG000|Overall Study|Invalid informed consent|1|||
130196966|NCT01471340|468679021|FG001|Overall Study|Invalid informed consent|0|||
130196967|NCT00526669|468679024|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
130196968|NCT00526669|468679025|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
130196969|NCT00526669|468679024|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
130196970|NCT00526669|468679025|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
130196971|NCT00526669|468679024|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
130196972|NCT00526669|468679025|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
130196973|NCT00526669|468679024|FG000|Combined Treatment Phase|Death|0|||
130196974|NCT00526669|468679025|FG001|Combined Treatment Phase|Death|2|||
130196975|NCT03499899|468679026|FG000|Overall Study|Adverse Event|2|||
130196976|NCT03499899|468679027|FG001|Overall Study|Adverse Event|3|||
130196977|NCT03499899|468679028|FG002|Overall Study|Adverse Event|3|||
130196978|NCT03499899|468679026|FG000|Overall Study|Death|0|||
130196979|NCT03499899|468679027|FG001|Overall Study|Death|0|||
130196980|NCT03499899|468679028|FG002|Overall Study|Death|1|||
130196981|NCT03499899|468679026|FG000|Overall Study|Physician Decision|3|||
130196982|NCT03499899|468679027|FG001|Overall Study|Physician Decision|6|||
130196983|NCT03499899|468679028|FG002|Overall Study|Physician Decision|6|||
130196984|NCT03499899|468679026|FG000|Overall Study|Progressive disease|15|||
130196985|NCT03499899|468679027|FG001|Overall Study|Progressive disease|23|||
130196986|NCT03499899|468679028|FG002|Overall Study|Progressive disease|23|||
130196987|NCT03499899|468679026|FG000|Overall Study|Patient decision|0|||
130196988|NCT03499899|468679027|FG001|Overall Study|Patient decision|1|||
130196989|NCT03499899|468679028|FG002|Overall Study|Patient decision|1|||
130196990|NCT03499899|468679026|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
130196991|NCT03499899|468679027|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
130196992|NCT03499899|468679028|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
130196993|NCT01082211|468679030|FG000|Overall Study|Protocol Violation|4|||
130196994|NCT01082211|468679030|FG000|Overall Study|No protocol treatment received|3|||
130196995|NCT04016779|468679043|FG000|Overall Study|Adverse Event|9|||
130196996|NCT04016779|468679044|FG001|Overall Study|Adverse Event|17|||
130196997|NCT04016779|468679043|FG000|Overall Study|Lack of Efficacy|4|||
130196998|NCT04016779|468679044|FG001|Overall Study|Lack of Efficacy|1|||
130196999|NCT04016779|468679043|FG000|Overall Study|Lost to Follow-up|5|||
130197000|NCT04016779|468679044|FG001|Overall Study|Lost to Follow-up|14|||
130197001|NCT04016779|468679043|FG000|Overall Study|Physician Decision|1|||
130197002|NCT04016779|468679044|FG001|Overall Study|Physician Decision|3|||
130197003|NCT04016779|468679043|FG000|Overall Study|Withdrawal by Subject|6|||
130197004|NCT04016779|468679044|FG001|Overall Study|Withdrawal by Subject|8|||
130197005|NCT04016779|468679043|FG000|Overall Study|Non-compliance with Study Drug|2|||
130197006|NCT04016779|468679044|FG001|Overall Study|Non-compliance with Study Drug|3|||
130197007|NCT04016779|468679043|FG000|Overall Study|Other, Multiple categories|17|||
130197008|NCT04016779|468679044|FG001|Overall Study|Other, Multiple categories|17|||
130197009|NCT02295020|468679045|FG000|Overall Study|Adverse Event|0|||
130197010|NCT02295020|468679046|FG001|Overall Study|Adverse Event|1|||
130197011|NCT02295020|468679045|FG000|Overall Study|Withdrawal by Subject|3|||
130197012|NCT02295020|468679046|FG001|Overall Study|Withdrawal by Subject|2|||
130197013|NCT06586788|468679048|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
130197014|NCT01053962|468679050|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130197015|NCT01053962|468679051|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130197016|NCT01053962|468679052|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
130197017|NCT01053962|468679053|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
130197018|NCT01053962|468679054|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
130197019|NCT01053962|468679050|FG000|Pretreatment Period|Venipuncture Failure|0|||
130197020|NCT01053962|468679051|FG001|Pretreatment Period|Venipuncture Failure|0|||
130197021|NCT01053962|468679052|FG002|Pretreatment Period|Venipuncture Failure|1|||
130197022|NCT01053962|468679053|FG003|Pretreatment Period|Venipuncture Failure|0|||
130197023|NCT01053962|468679054|FG004|Pretreatment Period|Venipuncture Failure|0|||
130197024|NCT01053962|468679050|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197025|NCT01053962|468679051|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
130197026|NCT01053962|468679052|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197027|NCT01053962|468679053|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197028|NCT01053962|468679054|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
130197029|NCT01053962|468679050|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197030|NCT01053962|468679051|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197031|NCT01053962|468679052|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197032|NCT01053962|468679053|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
130197033|NCT01053962|468679054|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
130197034|NCT01053962|468679050|FG000|Treatment Period|Lack of Efficacy|0|||
130197035|NCT01053962|468679051|FG001|Treatment Period|Lack of Efficacy|0|||
130197036|NCT01053962|468679052|FG002|Treatment Period|Lack of Efficacy|0|||
130197037|NCT01053962|468679053|FG003|Treatment Period|Lack of Efficacy|0|||
130197038|NCT01053962|468679054|FG004|Treatment Period|Lack of Efficacy|1|||
130197039|NCT01053962|468679050|FG000|Treatment Period|Adverse Event|0|||
130197040|NCT01053962|468679051|FG001|Treatment Period|Adverse Event|0|||
130197041|NCT01053962|468679052|FG002|Treatment Period|Adverse Event|0|||
130197042|NCT01053962|468679053|FG003|Treatment Period|Adverse Event|0|||
130197043|NCT01053962|468679054|FG004|Treatment Period|Adverse Event|1|||
130197044|NCT01053962|468679050|FG000|Treatment Period|Withdrawal by Subject|0|||
130197045|NCT01053962|468679051|FG001|Treatment Period|Withdrawal by Subject|0|||
130197046|NCT01053962|468679052|FG002|Treatment Period|Withdrawal by Subject|0|||
130197047|NCT01053962|468679053|FG003|Treatment Period|Withdrawal by Subject|0|||
130197048|NCT01053962|468679054|FG004|Treatment Period|Withdrawal by Subject|1|||
130197049|NCT01053962|468679050|FG000|Treatment Period|Noncompliance with protocol|1|||
130197050|NCT01053962|468679051|FG001|Treatment Period|Noncompliance with protocol|0|||
130197051|NCT01053962|468679052|FG002|Treatment Period|Noncompliance with protocol|0|||
130197052|NCT01053962|468679053|FG003|Treatment Period|Noncompliance with protocol|0|||
130197053|NCT01053962|468679054|FG004|Treatment Period|Noncompliance with protocol|0|||
130197054|NCT00679289|468679055|FG000|Overall Study|Progressive disease|4|||
130197055|NCT00679289|468679056|FG001|Overall Study|Progressive disease|5|||
130197056|NCT00679289|468679057|FG002|Overall Study|Progressive disease|18|||
130197057|NCT00679289|468679055|FG000|Overall Study|Withdrawal by Subject|0|||
130197058|NCT00679289|468679056|FG001|Overall Study|Withdrawal by Subject|1|||
130197059|NCT00679289|468679057|FG002|Overall Study|Withdrawal by Subject|1|||
130197060|NCT00679289|468679055|FG000|Overall Study|Adverse Event|0|||
130197061|NCT00679289|468679056|FG001|Overall Study|Adverse Event|0|||
130197062|NCT00679289|468679057|FG002|Overall Study|Adverse Event|3|||
130197063|NCT00679289|468679055|FG000|Overall Study|Physician Decision|1|||
130197064|NCT00679289|468679056|FG001|Overall Study|Physician Decision|0|||
130197065|NCT00679289|468679057|FG002|Overall Study|Physician Decision|1|||
130197066|NCT00937040|468679058|FG000|Overall Study|Adverse Event|5|||
130197067|NCT00937040|468679059|FG001|Overall Study|Adverse Event|8|||
130197068|NCT00937040|468679058|FG000|Overall Study|Lost to Follow-up|12|||
130197069|NCT00937040|468679059|FG001|Overall Study|Lost to Follow-up|12|||
130197070|NCT00937040|468679058|FG000|Overall Study|Protocol Violation|3|||
130197071|NCT00937040|468679059|FG001|Overall Study|Protocol Violation|0|||
130197072|NCT00937040|468679058|FG000|Overall Study|Withdrawal by Subject|13|||
130197073|NCT00937040|468679059|FG001|Overall Study|Withdrawal by Subject|7|||
130197074|NCT00937040|468679058|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
130197075|NCT00937040|468679059|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
130197076|NCT00937040|468679058|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
130197077|NCT00937040|468679059|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
130197078|NCT00638443|468679060|FG000|First Intervention|Adverse Event|2|||
130197079|NCT00638443|468679061|FG001|First Intervention|Adverse Event|1|||
130197080|NCT03502070|468679064|FG000|Overall Study|Withdrawal by Subject|1|||
130197081|NCT03502070|468679064|FG000|Overall Study|Screen Failure|1|||
130197082|NCT00595517|468679067|FG000|Overall Study|Adverse Event|6|||
130197083|NCT00595517|468679067|FG000|Overall Study|Withdrawal by Subject|4|||
130197084|NCT00595517|468679067|FG000|Overall Study|Protocol Violation|2|||
130197085|NCT00595517|468679067|FG000|Overall Study|Recurrence of ulcer|5|||
130197086|NCT00595517|468679067|FG000|Overall Study|usage of prohibited treatment|1|||
130197087|NCT00595517|468679067|FG000|Overall Study|No intention to attend regularly|1|||
130197088|NCT01167881|468679070|FG000|Overall Study|Adverse Event|47|||
130197089|NCT01167881|468679071|FG001|Overall Study|Adverse Event|51|||
130197090|NCT01167881|468679070|FG000|Overall Study|Lack of Efficacy|4|||
130197091|NCT01167881|468679071|FG001|Overall Study|Lack of Efficacy|7|||
130197092|NCT01167881|468679070|FG000|Overall Study|Non compliant with protocol|9|||
130197093|NCT01167881|468679071|FG001|Overall Study|Non compliant with protocol|18|||
130197094|NCT01167881|468679070|FG000|Overall Study|Lost to Follow-up|19|||
130197095|NCT01167881|468679071|FG001|Overall Study|Lost to Follow-up|20|||
130197096|NCT01167881|468679070|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
130197097|NCT01167881|468679071|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
130197098|NCT01167881|468679070|FG000|Overall Study|Not treated|4|||
130197099|NCT01167881|468679071|FG001|Overall Study|Not treated|0|||
130197100|NCT01167881|468679070|FG000|Overall Study|Other not defined above|31|||
130197101|NCT01167881|468679071|FG001|Overall Study|Other not defined above|55|||
130197102|NCT01894100|468679072|FG000|Overall Study|Lost to Follow-up|0|||
130197103|NCT01894100|468679073|FG001|Overall Study|Lost to Follow-up|1|||
130197104|NCT01894100|468679072|FG000|Overall Study|Withdrawal by Subject|3|||
130197105|NCT01894100|468679073|FG001|Overall Study|Withdrawal by Subject|0|||
130197106|NCT04013672|468679074|FG000|Overall Study|Withdrawal by Subject|3|||
130197107|NCT04013672|468679075|FG001|Overall Study|Withdrawal by Subject|0|||
130197108|NCT04013672|468679074|FG000|Overall Study|Death|1|||
130197109|NCT04013672|468679075|FG001|Overall Study|Death|0|||
130197110|NCT04013672|468679074|FG000|Overall Study|Physician Decision|5|||
130197111|NCT04013672|468679075|FG001|Overall Study|Physician Decision|0|||
130197112|NCT01827267|468679076|FG000|Overall Study|Did not receive study drug|1|||
130197113|NCT01827267|468679077|FG001|Overall Study|Did not receive study drug|1|||
130197114|NCT01827267|468679076|FG000|Overall Study|Physician Decision|1|||
130197115|NCT01827267|468679077|FG001|Overall Study|Physician Decision|0|||
130197116|NCT01827267|468679076|FG000|Overall Study|Disease Progression|1|||
130197117|NCT01827267|468679077|FG001|Overall Study|Disease Progression|1|||
130197118|NCT01827267|468679076|FG000|Overall Study|Sponsor Discontinued Study|2|||
130197119|NCT01827267|468679077|FG001|Overall Study|Sponsor Discontinued Study|8|||
130197120|NCT01827267|468679076|FG000|Overall Study|Still on study|0|||
130197121|NCT01827267|468679077|FG001|Overall Study|Still on study|2|||
130197122|NCT00813813|468679082|FG000|Overall Study|Withdrawal by Subject|1|||
130197123|NCT00813813|468679083|FG001|Overall Study|Withdrawal by Subject|1|||
130197124|NCT00813813|468679082|FG000|Overall Study|Lost to Follow-up|2|||
130197125|NCT00813813|468679083|FG001|Overall Study|Lost to Follow-up|7|||
130197126|NCT00813813|468679082|FG000|Overall Study|Other|0|||
130197127|NCT00813813|468679083|FG001|Overall Study|Other|1|||
130197128|NCT00986921|468679084|FG000|Overall Study|Physician Decision|1|||
130197129|NCT00986921|468679085|FG001|Overall Study|Physician Decision|0|||
130197130|NCT01684943|468679086|FG000|Overall Study|Inadequate Venous Access|3|||
130197131|NCT01684943|468679087|FG001|Overall Study|Inadequate Venous Access|0|||
130197132|NCT01684943|468679088|FG002|Overall Study|Inadequate Venous Access|0|||
130197133|NCT01684943|468679086|FG000|Overall Study|Principal Investigator Determination|1|||
130197134|NCT01684943|468679087|FG001|Overall Study|Principal Investigator Determination|0|||
130197135|NCT01684943|468679088|FG002|Overall Study|Principal Investigator Determination|0|||
130197136|NCT01684943|468679086|FG000|Overall Study|Excluded from Analysis|1|||
130197137|NCT01684943|468679087|FG001|Overall Study|Excluded from Analysis|1|||
130197138|NCT01684943|468679088|FG002|Overall Study|Excluded from Analysis|1|||
130197139|NCT01684943|468679086|FG000|Overall Study|Lost to Follow-up|3|||
130197140|NCT01684943|468679087|FG001|Overall Study|Lost to Follow-up|0|||
130197141|NCT01684943|468679088|FG002|Overall Study|Lost to Follow-up|0|||
130197142|NCT01684943|468679086|FG000|Overall Study|Planning Pregnancy|1|||
130197143|NCT01684943|468679087|FG001|Overall Study|Planning Pregnancy|0|||
130197144|NCT01684943|468679088|FG002|Overall Study|Planning Pregnancy|0|||
130197145|NCT00972816|468681380|FG000|Overall Study|Adverse Event|0|||
130197146|NCT00972816|468681381|FG001|Overall Study|Adverse Event|0|||
130197147|NCT00972816|468681382|FG002|Overall Study|Adverse Event|1|||
130197148|NCT00972816|468681383|FG003|Overall Study|Adverse Event|0|||
130197149|NCT00972816|468681384|FG004|Overall Study|Adverse Event|0|||
130197150|NCT00972816|468681385|FG005|Overall Study|Adverse Event|0|||
130197151|NCT00972816|468681386|FG006|Overall Study|Adverse Event|0|||
130197152|NCT00972816|468681387|FG007|Overall Study|Adverse Event|0|||
130197153|NCT00972816|468681380|FG000|Overall Study|Withdrawal by Subject|4|||
130197154|NCT00972816|468681381|FG001|Overall Study|Withdrawal by Subject|2|||
130197155|NCT00972816|468681382|FG002|Overall Study|Withdrawal by Subject|1|||
130197156|NCT00972816|468681383|FG003|Overall Study|Withdrawal by Subject|3|||
130197157|NCT00972816|468681384|FG004|Overall Study|Withdrawal by Subject|0|||
130197158|NCT00972816|468681385|FG005|Overall Study|Withdrawal by Subject|1|||
130197159|NCT00972816|468681386|FG006|Overall Study|Withdrawal by Subject|1|||
130197160|NCT00972816|468681387|FG007|Overall Study|Withdrawal by Subject|2|||
130197161|NCT00972816|468681380|FG000|Overall Study|Lost to Follow-up|11|||
130197162|NCT00972816|468681381|FG001|Overall Study|Lost to Follow-up|9|||
130197163|NCT00972816|468681382|FG002|Overall Study|Lost to Follow-up|7|||
130197164|NCT00972816|468681383|FG003|Overall Study|Lost to Follow-up|5|||
130197165|NCT00972816|468681384|FG004|Overall Study|Lost to Follow-up|11|||
130197166|NCT00972816|468681385|FG005|Overall Study|Lost to Follow-up|10|||
130197167|NCT00972816|468681386|FG006|Overall Study|Lost to Follow-up|7|||
130197168|NCT00972816|468681387|FG007|Overall Study|Lost to Follow-up|7|||
130197169|NCT00972816|468681380|FG000|Overall Study|Inappropriate enrolment|0|||
130197170|NCT00972816|468681381|FG001|Overall Study|Inappropriate enrolment|0|||
130197171|NCT00972816|468681382|FG002|Overall Study|Inappropriate enrolment|0|||
130197172|NCT00972816|468681383|FG003|Overall Study|Inappropriate enrolment|0|||
130197173|NCT00972816|468681384|FG004|Overall Study|Inappropriate enrolment|0|||
130197174|NCT00972816|468681385|FG005|Overall Study|Inappropriate enrolment|0|||
130197175|NCT00972816|468681386|FG006|Overall Study|Inappropriate enrolment|2|||
130197176|NCT00972816|468681387|FG007|Overall Study|Inappropriate enrolment|0|||
130197177|NCT00972816|468681380|FG000|Overall Study|Unable to classify|2|||
130197178|NCT00972816|468681381|FG001|Overall Study|Unable to classify|0|||
130197179|NCT00972816|468681382|FG002|Overall Study|Unable to classify|0|||
130197180|NCT00972816|468681383|FG003|Overall Study|Unable to classify|0|||
130197181|NCT00972816|468681384|FG004|Overall Study|Unable to classify|1|||
130197182|NCT00972816|468681385|FG005|Overall Study|Unable to classify|0|||
130197183|NCT00972816|468681386|FG006|Overall Study|Unable to classify|0|||
130197184|NCT00972816|468681387|FG007|Overall Study|Unable to classify|0|||
130197185|NCT03854370|468681390|FG000|Overall Study|samples not collected|1|||
130197186|NCT03854370|468681391|FG001|Overall Study|samples not collected|1|||
130197187|NCT03854370|468681392|FG002|Overall Study|samples not collected|1|||
130197188|NCT03854370|468681393|FG003|Overall Study|samples not collected|1|||
130197189|NCT00452673|468681394|FG000|Dose Escalation Period|Disease Progression|6|||
130197190|NCT00452673|468681395|FG001|Dose Escalation Period|Disease Progression|6|||
130197191|NCT00452673|468681396|FG002|Dose Escalation Period|Disease Progression|2|||
130197192|NCT00452673|468681397|FG003|Dose Escalation Period|Disease Progression|6|||
130197193|NCT00452673|468681398|FG004|Dose Escalation Period|Disease Progression|0|||
130197194|NCT00452673|468681394|FG000|Dose Escalation Period|study drug toxicity|1|||
130197195|NCT00452673|468681395|FG001|Dose Escalation Period|study drug toxicity|3|||
130197196|NCT00452673|468681396|FG002|Dose Escalation Period|study drug toxicity|3|||
130197197|NCT00452673|468681397|FG003|Dose Escalation Period|study drug toxicity|1|||
130197198|NCT00452673|468681398|FG004|Dose Escalation Period|study drug toxicity|0|||
130197199|NCT00452673|468681394|FG000|Dose Escalation Period|Other|0|||
130197200|NCT00452673|468681395|FG001|Dose Escalation Period|Other|0|||
130197201|NCT00452673|468681396|FG002|Dose Escalation Period|Other|1|||
130197202|NCT00452673|468681397|FG003|Dose Escalation Period|Other|0|||
130197203|NCT00452673|468681398|FG004|Dose Escalation Period|Other|0|||
130197204|NCT00452673|468681394|FG000|Dose Escalation Period|Adverse Event|0|||
130197205|NCT00452673|468681395|FG001|Dose Escalation Period|Adverse Event|0|||
130197206|NCT00452673|468681396|FG002|Dose Escalation Period|Adverse Event|0|||
130197207|NCT00452673|468681397|FG003|Dose Escalation Period|Adverse Event|1|||
130197208|NCT00452673|468681398|FG004|Dose Escalation Period|Adverse Event|0|||
130197209|NCT00452673|468681394|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
130197210|NCT00452673|468681395|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
130197211|NCT00452673|468681396|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
130197212|NCT00452673|468681397|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
130197213|NCT00452673|468681398|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
130197214|NCT00452673|468681394|FG000|Dose Expansion Period|Disease Progression|0|||
130197215|NCT00452673|468681395|FG001|Dose Expansion Period|Disease Progression|0|||
130197216|NCT00452673|468681396|FG002|Dose Expansion Period|Disease Progression|0|||
130197217|NCT00452673|468681397|FG003|Dose Expansion Period|Disease Progression|0|||
130197218|NCT00452673|468681398|FG004|Dose Expansion Period|Disease Progression|19|||
130197219|NCT00452673|468681394|FG000|Dose Expansion Period|Other|0|||
130197220|NCT00452673|468681395|FG001|Dose Expansion Period|Other|0|||
130197221|NCT00452673|468681396|FG002|Dose Expansion Period|Other|0|||
130197222|NCT00452673|468681397|FG003|Dose Expansion Period|Other|0|||
130197223|NCT00452673|468681398|FG004|Dose Expansion Period|Other|2|||
130197224|NCT02656290|468681399|FG000|Overall Study|Lost to Follow-up|1|||
130197225|NCT02656290|468681399|FG000|Overall Study|Reintervention|3|||
130197226|NCT01608087|468681402|FG000|Overall Study|Lost to Follow-up|0|||
130197227|NCT01608087|468681403|FG001|Overall Study|Lost to Follow-up|1|||
130197228|NCT01608087|468681404|FG002|Overall Study|Lost to Follow-up|0|||
130197229|NCT01608087|468681402|FG000|Overall Study|Other Reason|0|||
130197230|NCT01608087|468681403|FG001|Overall Study|Other Reason|1|||
130197231|NCT01608087|468681404|FG002|Overall Study|Other Reason|0|||
130197232|NCT00348595|468681405|FG000|Overall Study|Adverse Event|5|||
130197233|NCT00348595|468681406|FG001|Overall Study|Adverse Event|8|||
130197234|NCT01942486|468681413|FG000|Overall Study|Lost to Follow-up|27|||
130197235|NCT03728426|468681414|FG000|Overall Study|Death|3|||
130197236|NCT00231114|468681416|FG000|Randomized|Withdrawal by Subject|6|||
130197237|NCT00231114|468681417|FG001|Randomized|Withdrawal by Subject|3|||
130197238|NCT00231114|468681416|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
130197239|NCT00231114|468681417|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
130197240|NCT00231114|468681416|FG000|Post-Treatment Period|Lost to Follow-up|6|||
130197241|NCT00231114|468681417|FG001|Post-Treatment Period|Lost to Follow-up|1|||
130197242|NCT00231114|468681416|FG000|Post-Treatment Period|Physician Decision|1|||
130197243|NCT00231114|468681417|FG001|Post-Treatment Period|Physician Decision|0|||
130197244|NCT00231114|468681416|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
130197245|NCT00231114|468681417|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
130197246|NCT02048826|468681419|FG000|Overall Study|Withdrawal by Subject|1|||
130197247|NCT02048826|468681420|FG001|Overall Study|Withdrawal by Subject|0|||
130197248|NCT04470544|468681421|FG000|Overall Study|Withdrawal by Subject|4|||
130197249|NCT04470544|468681422|FG001|Overall Study|Withdrawal by Subject|6|||
130197250|NCT00712881|468681424|FG000|Overall Study|Adverse Event|3|||
130197251|NCT00712881|468681425|FG001|Overall Study|Adverse Event|3|||
130197252|NCT00712881|468681424|FG000|Overall Study|Withdrawal by Subject|1|||
130197253|NCT00712881|468681425|FG001|Overall Study|Withdrawal by Subject|1|||
130197254|NCT00712881|468681424|FG000|Overall Study|Disease Progression|2|||
130197255|NCT00712881|468681425|FG001|Overall Study|Disease Progression|1|||
130197256|NCT00712881|468681424|FG000|Overall Study|Lost to Follow-up|1|||
130197257|NCT00712881|468681425|FG001|Overall Study|Lost to Follow-up|1|||
130197258|NCT00712881|468681424|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
130197259|NCT00712881|468681425|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
130197260|NCT00712881|468681424|FG000|Overall Study|Protocol Violation|1|||
130197261|NCT00712881|468681425|FG001|Overall Study|Protocol Violation|1|||
130197262|NCT00712881|468681424|FG000|Overall Study|Randomized but not treated|1|||
130197263|NCT00712881|468681425|FG001|Overall Study|Randomized but not treated|0|||
130197264|NCT01194999|468681426|FG000|Overall Study|Lost to Follow-up|17|||
130197265|NCT01011465|468681427|FG000|Overall Study|Withdrawal by Subject|2|||
130197266|NCT01011465|468681428|FG001|Overall Study|Withdrawal by Subject|1|||
130197267|NCT01011465|468681429|FG002|Overall Study|Withdrawal by Subject|0|||
130197268|NCT01011465|468681430|FG003|Overall Study|Withdrawal by Subject|0|||
130197269|NCT01011465|468681431|FG004|Overall Study|Withdrawal by Subject|1|||
130197270|NCT01011465|468681432|FG005|Overall Study|Withdrawal by Subject|0|||
130197271|NCT01011465|468681433|FG006|Overall Study|Withdrawal by Subject|1|||
130197272|NCT01011465|468681434|FG007|Overall Study|Withdrawal by Subject|0|||
130197273|NCT00723008|468681436|FG000|Enrollment|Lost to Follow-up|1|||
130197274|NCT00723008|468681437|FG001|Enrollment|Lost to Follow-up|0|||
130197275|NCT00723008|468681436|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
130197276|NCT00723008|468681437|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
130197277|NCT00723008|468681436|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
130197278|NCT00723008|468681437|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
130197279|NCT00723008|468681436|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
130197280|NCT00723008|468681437|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
130197281|NCT00723008|468681436|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
130197282|NCT00723008|468681437|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
130197283|NCT00723008|468681436|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
130197284|NCT00723008|468681437|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
130197285|NCT05835011|468681439|FG000|Overall Study|Study Terminated by the Sponsor|1|||
130197286|NCT05835011|468681439|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
130197287|NCT03702010|468681452|FG000|Follow-up (30days)|Lack of Efficacy|2|||
130197288|NCT03702010|468681453|FG001|Follow-up (30days)|Lack of Efficacy|2|||
130197289|NCT01137110|468681454|FG000|Overall Study|Protocol Violation|1|||
130197290|NCT01137110|468681455|FG001|Overall Study|Protocol Violation|0|||
130197291|NCT03557931|468681456|FG000|Overall Study|Adverse Event|4|||
130197292|NCT03557931|468681457|FG001|Overall Study|Adverse Event|6|||
130197293|NCT03557931|468681458|FG002|Overall Study|Adverse Event|1|||
130197294|NCT03557931|468681456|FG000|Overall Study|Lost to Follow-up|4|||
130197295|NCT03557931|468681457|FG001|Overall Study|Lost to Follow-up|4|||
130197296|NCT03557931|468681458|FG002|Overall Study|Lost to Follow-up|1|||
130197297|NCT03557931|468681456|FG000|Overall Study|Protocol Violation|1|||
130197298|NCT03557931|468681457|FG001|Overall Study|Protocol Violation|4|||
130197299|NCT03557931|468681458|FG002|Overall Study|Protocol Violation|1|||
130197300|NCT03557931|468681456|FG000|Overall Study|Withdrawal by Subject|14|||
130197301|NCT03557931|468681457|FG001|Overall Study|Withdrawal by Subject|0|||
130197302|NCT03557931|468681458|FG002|Overall Study|Withdrawal by Subject|7|||
130197303|NCT03557931|468681456|FG000|Overall Study|Miscellaneous|8|||
130197304|NCT03557931|468681457|FG001|Overall Study|Miscellaneous|5|||
130197305|NCT03557931|468681458|FG002|Overall Study|Miscellaneous|3|||
130197306|NCT02829723|468681459|FG000|Overall Study|Adverse Event|0|||
130197307|NCT02829723|468681460|FG001|Overall Study|Adverse Event|0|||
130197308|NCT02829723|468681461|FG002|Overall Study|Adverse Event|1|||
130197309|NCT02829723|468681462|FG003|Overall Study|Adverse Event|1|||
130197310|NCT02829723|468681463|FG004|Overall Study|Adverse Event|0|||
130197311|NCT02829723|468681464|FG005|Overall Study|Adverse Event|0|||
130197312|NCT02829723|468681465|FG006|Overall Study|Adverse Event|0|||
130197313|NCT02829723|468681466|FG007|Overall Study|Adverse Event|1|||
130197314|NCT02829723|468681467|FG008|Overall Study|Adverse Event|0|||
130197315|NCT02829723|468681468|FG009|Overall Study|Adverse Event|0|||
130197316|NCT02829723|468681469|FG010|Overall Study|Adverse Event|0|||
130197317|NCT02829723|468681470|FG011|Overall Study|Adverse Event|0|||
130197318|NCT02829723|468681471|FG012|Overall Study|Adverse Event|0|||
130197319|NCT02829723|468681472|FG013|Overall Study|Adverse Event|0|||
130197320|NCT02829723|468681473|FG014|Overall Study|Adverse Event|1|||
130197321|NCT02829723|468681474|FG015|Overall Study|Adverse Event|1|||
130197322|NCT02829723|468681475|FG016|Overall Study|Adverse Event|1|||
130197323|NCT02829723|468681476|FG017|Overall Study|Adverse Event|2|||
130197324|NCT02829723|468681477|FG018|Overall Study|Adverse Event|1|||
130197325|NCT02829723|468681478|FG019|Overall Study|Adverse Event|1|||
130197326|NCT02829723|468681479|FG020|Overall Study|Adverse Event|3|||
130197327|NCT02829723|468681480|FG021|Overall Study|Adverse Event|0|||
130197328|NCT02829723|468681481|FG022|Overall Study|Adverse Event|0|||
130197329|NCT02829723|468681482|FG023|Overall Study|Adverse Event|1|||
130197330|NCT02829723|468681483|FG024|Overall Study|Adverse Event|1|||
130197331|NCT02829723|468681484|FG025|Overall Study|Adverse Event|3|||
130197332|NCT02829723|468681485|FG026|Overall Study|Adverse Event|5|||
130197333|NCT02829723|468681459|FG000|Overall Study|Death|1|||
130197334|NCT02829723|468681460|FG001|Overall Study|Death|0|||
130197335|NCT02829723|468681461|FG002|Overall Study|Death|1|||
130197336|NCT02829723|468681462|FG003|Overall Study|Death|1|||
130197337|NCT02829723|468681463|FG004|Overall Study|Death|0|||
130197338|NCT02829723|468681464|FG005|Overall Study|Death|0|||
130197339|NCT02829723|468681465|FG006|Overall Study|Death|2|||
130197340|NCT02829723|468681466|FG007|Overall Study|Death|0|||
130197341|NCT02829723|468681467|FG008|Overall Study|Death|1|||
130197342|NCT02829723|468681468|FG009|Overall Study|Death|0|||
130197343|NCT02829723|468681469|FG010|Overall Study|Death|0|||
130197344|NCT02829723|468681470|FG011|Overall Study|Death|0|||
130197345|NCT02829723|468681471|FG012|Overall Study|Death|2|||
130197346|NCT02829723|468681472|FG013|Overall Study|Death|1|||
130197347|NCT02829723|468681473|FG014|Overall Study|Death|0|||
130197348|NCT02829723|468681474|FG015|Overall Study|Death|0|||
130197349|NCT02829723|468681475|FG016|Overall Study|Death|0|||
130197350|NCT02829723|468681476|FG017|Overall Study|Death|0|||
130197351|NCT02829723|468681477|FG018|Overall Study|Death|0|||
130197352|NCT02829723|468681478|FG019|Overall Study|Death|0|||
130197353|NCT02829723|468681479|FG020|Overall Study|Death|0|||
130197354|NCT02829723|468681480|FG021|Overall Study|Death|2|||
130197355|NCT02829723|468681481|FG022|Overall Study|Death|0|||
130197356|NCT02829723|468681482|FG023|Overall Study|Death|0|||
130197357|NCT02829723|468681483|FG024|Overall Study|Death|0|||
130197358|NCT02829723|468681484|FG025|Overall Study|Death|1|||
130197359|NCT02829723|468681485|FG026|Overall Study|Death|2|||
130197360|NCT02829723|468681459|FG000|Overall Study|Physician Decision|0|||
130197361|NCT02829723|468681460|FG001|Overall Study|Physician Decision|0|||
130197362|NCT02829723|468681461|FG002|Overall Study|Physician Decision|0|||
130197363|NCT02829723|468681462|FG003|Overall Study|Physician Decision|0|||
130197364|NCT02829723|468681463|FG004|Overall Study|Physician Decision|0|||
130197365|NCT02829723|468681464|FG005|Overall Study|Physician Decision|0|||
130197366|NCT02829723|468681465|FG006|Overall Study|Physician Decision|0|||
130197367|NCT02829723|468681466|FG007|Overall Study|Physician Decision|0|||
130197368|NCT02829723|468681467|FG008|Overall Study|Physician Decision|0|||
130197369|NCT02829723|468681468|FG009|Overall Study|Physician Decision|1|||
130197370|NCT02829723|468681469|FG010|Overall Study|Physician Decision|1|||
130197371|NCT02829723|468681470|FG011|Overall Study|Physician Decision|0|||
130197372|NCT02829723|468681471|FG012|Overall Study|Physician Decision|0|||
130197373|NCT02829723|468681472|FG013|Overall Study|Physician Decision|1|||
130197374|NCT02829723|468681473|FG014|Overall Study|Physician Decision|0|||
130197375|NCT02829723|468681474|FG015|Overall Study|Physician Decision|0|||
130197376|NCT02829723|468681475|FG016|Overall Study|Physician Decision|2|||
130197377|NCT02829723|468681476|FG017|Overall Study|Physician Decision|0|||
130197378|NCT02829723|468681477|FG018|Overall Study|Physician Decision|0|||
130197379|NCT02829723|468681478|FG019|Overall Study|Physician Decision|0|||
130197380|NCT02829723|468681479|FG020|Overall Study|Physician Decision|0|||
130197381|NCT02829723|468681480|FG021|Overall Study|Physician Decision|0|||
130197382|NCT02829723|468681481|FG022|Overall Study|Physician Decision|1|||
130197383|NCT02829723|468681482|FG023|Overall Study|Physician Decision|1|||
130197384|NCT02829723|468681483|FG024|Overall Study|Physician Decision|1|||
130197385|NCT02829723|468681484|FG025|Overall Study|Physician Decision|1|||
130197386|NCT02829723|468681485|FG026|Overall Study|Physician Decision|3|||
130197387|NCT02829723|468681459|FG000|Overall Study|Progressive disease|4|||
130197388|NCT02829723|468681460|FG001|Overall Study|Progressive disease|6|||
130197389|NCT02829723|468681461|FG002|Overall Study|Progressive disease|3|||
130197390|NCT02829723|468681462|FG003|Overall Study|Progressive disease|3|||
130197391|NCT02829723|468681463|FG004|Overall Study|Progressive disease|3|||
130197392|NCT02829723|468681464|FG005|Overall Study|Progressive disease|5|||
130197393|NCT02829723|468681465|FG006|Overall Study|Progressive disease|4|||
130197394|NCT02829723|468681466|FG007|Overall Study|Progressive disease|6|||
130197395|NCT02829723|468681467|FG008|Overall Study|Progressive disease|8|||
130197396|NCT02829723|468681468|FG009|Overall Study|Progressive disease|4|||
130197397|NCT02829723|468681469|FG010|Overall Study|Progressive disease|9|||
130197398|NCT02829723|468681470|FG011|Overall Study|Progressive disease|0|||
130197399|NCT02829723|468681471|FG012|Overall Study|Progressive disease|3|||
130197400|NCT02829723|468681472|FG013|Overall Study|Progressive disease|4|||
130197401|NCT02829723|468681473|FG014|Overall Study|Progressive disease|2|||
130197402|NCT02829723|468681474|FG015|Overall Study|Progressive disease|4|||
130197403|NCT02829723|468681475|FG016|Overall Study|Progressive disease|5|||
130197404|NCT02829723|468681476|FG017|Overall Study|Progressive disease|3|||
130197405|NCT02829723|468681477|FG018|Overall Study|Progressive disease|4|||
130197406|NCT02829723|468681478|FG019|Overall Study|Progressive disease|4|||
130197407|NCT02829723|468681479|FG020|Overall Study|Progressive disease|7|||
130197408|NCT02829723|468681480|FG021|Overall Study|Progressive disease|6|||
130197409|NCT02829723|468681481|FG022|Overall Study|Progressive disease|3|||
130197410|NCT02829723|468681482|FG023|Overall Study|Progressive disease|3|||
130197411|NCT02829723|468681483|FG024|Overall Study|Progressive disease|3|||
130197412|NCT02829723|468681484|FG025|Overall Study|Progressive disease|16|||
130197413|NCT02829723|468681485|FG026|Overall Study|Progressive disease|10|||
130197414|NCT02829723|468681459|FG000|Overall Study|Subject/guardian decision|0|||
130197415|NCT02829723|468681460|FG001|Overall Study|Subject/guardian decision|1|||
130197416|NCT02829723|468681461|FG002|Overall Study|Subject/guardian decision|0|||
130197417|NCT02829723|468681462|FG003|Overall Study|Subject/guardian decision|1|||
130197418|NCT02829723|468681463|FG004|Overall Study|Subject/guardian decision|0|||
130197419|NCT02829723|468681464|FG005|Overall Study|Subject/guardian decision|0|||
130197420|NCT02829723|468681465|FG006|Overall Study|Subject/guardian decision|0|||
130197421|NCT02829723|468681466|FG007|Overall Study|Subject/guardian decision|1|||
130197422|NCT02829723|468681467|FG008|Overall Study|Subject/guardian decision|0|||
130197423|NCT02829723|468681468|FG009|Overall Study|Subject/guardian decision|0|||
130197424|NCT02829723|468681469|FG010|Overall Study|Subject/guardian decision|0|||
130197425|NCT02829723|468681470|FG011|Overall Study|Subject/guardian decision|0|||
130197426|NCT02829723|468681471|FG012|Overall Study|Subject/guardian decision|0|||
130197427|NCT02829723|468681472|FG013|Overall Study|Subject/guardian decision|0|||
130197428|NCT02829723|468681473|FG014|Overall Study|Subject/guardian decision|1|||
130197429|NCT02829723|468681474|FG015|Overall Study|Subject/guardian decision|0|||
130197430|NCT02829723|468681475|FG016|Overall Study|Subject/guardian decision|1|||
130197431|NCT02829723|468681476|FG017|Overall Study|Subject/guardian decision|0|||
130197432|NCT02829723|468681477|FG018|Overall Study|Subject/guardian decision|1|||
130197433|NCT02829723|468681478|FG019|Overall Study|Subject/guardian decision|0|||
130197434|NCT02829723|468681479|FG020|Overall Study|Subject/guardian decision|1|||
130197435|NCT02829723|468681480|FG021|Overall Study|Subject/guardian decision|0|||
130197436|NCT02829723|468681481|FG022|Overall Study|Subject/guardian decision|0|||
130197437|NCT02829723|468681482|FG023|Overall Study|Subject/guardian decision|1|||
130197438|NCT02829723|468681483|FG024|Overall Study|Subject/guardian decision|0|||
130197439|NCT02829723|468681484|FG025|Overall Study|Subject/guardian decision|1|||
130197440|NCT02829723|468681485|FG026|Overall Study|Subject/guardian decision|1|||
130197441|NCT02829723|468681459|FG000|Overall Study|Study terminated by sponsor|0|||
130197442|NCT02829723|468681460|FG001|Overall Study|Study terminated by sponsor|0|||
130197443|NCT02829723|468681461|FG002|Overall Study|Study terminated by sponsor|0|||
130197444|NCT02829723|468681462|FG003|Overall Study|Study terminated by sponsor|0|||
130197445|NCT02829723|468681463|FG004|Overall Study|Study terminated by sponsor|0|||
130197446|NCT02829723|468681464|FG005|Overall Study|Study terminated by sponsor|0|||
130197447|NCT02829723|468681465|FG006|Overall Study|Study terminated by sponsor|0|||
130197448|NCT02829723|468681466|FG007|Overall Study|Study terminated by sponsor|0|||
130197449|NCT02829723|468681467|FG008|Overall Study|Study terminated by sponsor|0|||
130197450|NCT02829723|468681468|FG009|Overall Study|Study terminated by sponsor|0|||
130197451|NCT02829723|468681469|FG010|Overall Study|Study terminated by sponsor|0|||
130197452|NCT02829723|468681470|FG011|Overall Study|Study terminated by sponsor|0|||
130197453|NCT02829723|468681471|FG012|Overall Study|Study terminated by sponsor|0|||
130197454|NCT02829723|468681472|FG013|Overall Study|Study terminated by sponsor|0|||
130197455|NCT02829723|468681473|FG014|Overall Study|Study terminated by sponsor|0|||
130197456|NCT02829723|468681474|FG015|Overall Study|Study terminated by sponsor|0|||
130197457|NCT02829723|468681475|FG016|Overall Study|Study terminated by sponsor|0|||
130197458|NCT02829723|468681476|FG017|Overall Study|Study terminated by sponsor|0|||
130197459|NCT02829723|468681477|FG018|Overall Study|Study terminated by sponsor|0|||
130197460|NCT02829723|468681478|FG019|Overall Study|Study terminated by sponsor|0|||
130197461|NCT02829723|468681479|FG020|Overall Study|Study terminated by sponsor|0|||
130197462|NCT02829723|468681480|FG021|Overall Study|Study terminated by sponsor|1|||
130197463|NCT02829723|468681481|FG022|Overall Study|Study terminated by sponsor|0|||
130197464|NCT02829723|468681482|FG023|Overall Study|Study terminated by sponsor|0|||
130197465|NCT02829723|468681483|FG024|Overall Study|Study terminated by sponsor|0|||
130197466|NCT02829723|468681484|FG025|Overall Study|Study terminated by sponsor|0|||
130197467|NCT02829723|468681485|FG026|Overall Study|Study terminated by sponsor|0|||
130197468|NCT02989649|468681486|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
130197469|NCT02989649|468681486|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
130197470|NCT02989649|468681486|FG000|Overall Study|Lost For Observation During Study|3|||
130197471|NCT02989649|468681486|FG000|Overall Study|Reason Not Specified|13|||
130197472|NCT02004886|468681487|FG000|Overall Study|Adverse Event|0|||
130197473|NCT02004886|468681488|FG001|Overall Study|Adverse Event|1|||
130197474|NCT02004886|468681489|FG002|Overall Study|Adverse Event|0|||
130197475|NCT02004886|468681490|FG003|Overall Study|Adverse Event|0|||
130197476|NCT02004886|468681487|FG000|Overall Study|Unable to attend future visits|1|||
130197477|NCT02004886|468681488|FG001|Overall Study|Unable to attend future visits|0|||
130197478|NCT02004886|468681489|FG002|Overall Study|Unable to attend future visits|0|||
130197479|NCT02004886|468681490|FG003|Overall Study|Unable to attend future visits|0|||
130197480|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
130197481|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
130197482|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
130197483|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
130197484|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
130197485|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
130197486|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
130197487|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
130197488|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
130197489|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
130197490|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Death|1|||
130197491|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Death|0|||
130197492|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
130197493|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
130197494|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
130197495|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
130197496|NCT01876784|468681493|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
130197497|NCT01876784|468681494|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
130197498|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
130197499|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
130197500|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Adverse Event|2|||
130197501|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Adverse Event|6|||
130197502|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
130197503|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
130197504|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Progressive disease|4|||
130197505|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Progressive disease|35|||
130197506|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
130197507|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
130197508|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
130197509|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
130197510|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Death|0|||
130197511|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Death|1|||
130197512|NCT01876784|468681493|FG000|Open-label Period (31 Months)|Other than specified above|9|||
130197513|NCT01876784|468681494|FG001|Open-label Period (31 Months)|Other than specified above|18|||
130197514|NCT03605862|468681495|FG000|Overall Study|Withdrawal by Subject|12|||
130197515|NCT03605862|468681496|FG001|Overall Study|Withdrawal by Subject|9|||
130197516|NCT03605862|468681495|FG000|Overall Study|Adverse Event|2|||
130197517|NCT03605862|468681496|FG001|Overall Study|Adverse Event|1|||
130197518|NCT03605862|468681495|FG000|Overall Study|Physician Decision|3|||
130197519|NCT03605862|468681496|FG001|Overall Study|Physician Decision|1|||
130197520|NCT03605862|468681495|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
130197521|NCT03605862|468681496|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
130197522|NCT03891862|468681497|FG000|Open-label Period|Adverse Event|2|||
130197523|NCT03891862|468681498|FG001|Open-label Period|Adverse Event|0|||
130197524|NCT03891862|468681499|FG002|Open-label Period|Adverse Event|0|||
130197525|NCT03891862|468681497|FG000|Open-label Period|Protocol Violation|5|||
130197526|NCT03891862|468681498|FG001|Open-label Period|Protocol Violation|0|||
130197527|NCT03891862|468681499|FG002|Open-label Period|Protocol Violation|0|||
130197528|NCT03891862|468681497|FG000|Open-label Period|Withdrawal by Subject|6|||
130197529|NCT03891862|468681498|FG001|Open-label Period|Withdrawal by Subject|0|||
130197530|NCT03891862|468681499|FG002|Open-label Period|Withdrawal by Subject|0|||
130197531|NCT03891862|468681497|FG000|Open-label Period|Death|1|||
130197532|NCT03891862|468681498|FG001|Open-label Period|Death|0|||
130197533|NCT03891862|468681499|FG002|Open-label Period|Death|0|||
130197534|NCT03891862|468681497|FG000|Open-label Period|Lost to Follow-up|2|||
130197535|NCT03891862|468681498|FG001|Open-label Period|Lost to Follow-up|0|||
130197536|NCT03891862|468681499|FG002|Open-label Period|Lost to Follow-up|0|||
130197537|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
130197538|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
130197539|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
130197540|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
130197541|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
130197542|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
130197543|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
130197544|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
130197545|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
130197546|NCT03891862|468681497|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
130197547|NCT03891862|468681498|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
130197548|NCT03891862|468681499|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
130197549|NCT05239494|468681500|FG000|Overall Study|Lost to Follow-up|1|||
130197550|NCT01194531|468681501|FG000|Overall Study|Withdrawal by Subject|1|||
130197551|NCT01194531|468681502|FG001|Overall Study|Withdrawal by Subject|0|||
130197552|NCT01194531|468681501|FG000|Overall Study|Protocol Violation|4|||
130197553|NCT01194531|468681502|FG001|Overall Study|Protocol Violation|1|||
130197554|NCT01194531|468681501|FG000|Overall Study|Physician Decision|0|||
130197555|NCT01194531|468681502|FG001|Overall Study|Physician Decision|2|||
130197556|NCT04603482|468681503|FG000|Overall Study|Lost to Follow-up|15|||
130197557|NCT04603482|468681504|FG001|Overall Study|Lost to Follow-up|15|||
130197558|NCT04603482|468681505|FG002|Overall Study|Lost to Follow-up|15|||
130197559|NCT00179673|468681506|FG000|Overall Study|Adverse Event|7|||
130197560|NCT00179673|468681506|FG000|Overall Study|Lack of Efficacy|15|||
130197561|NCT00179673|468681506|FG000|Overall Study|Withdrawal by Subject|3|||
130197562|NCT00179673|468681506|FG000|Overall Study|Death|4|||
130197563|NCT00179673|468681506|FG000|Overall Study|Other Observations and options|14|||
130197564|NCT00977314|468681509|FG000|Overall Study|Withdrawal by Subject|1|||
130197565|NCT00977314|468681510|FG001|Overall Study|Withdrawal by Subject|0|||
130197566|NCT00977314|468681509|FG000|Overall Study|Physician Decision|1|||
130197567|NCT00977314|468681510|FG001|Overall Study|Physician Decision|0|||
130197568|NCT02107859|468681511|FG000|Overall Study|Withdrawal by Subject|14|||
130197569|NCT02107859|468681511|FG000|Overall Study|Adverse Event|3|||
130197570|NCT02107859|468681511|FG000|Overall Study|Study closure|41|||
130197571|NCT02107859|468681511|FG000|Overall Study|Other than specified|3|||
130197572|NCT01094301|468681514|FG000|Trial Stage|Withdrawal by Subject|1|||
130197573|NCT01094301|468681514|FG000|Implant Stage|Adverse Event|1|||
130197574|NCT01094301|468681514|FG000|Implant Stage|Protocol Violation|1|||
130197575|NCT01094301|468681514|FG000|Implant Stage|Withdrawal by Subject|2|||
130197576|NCT01094301|468681514|FG000|Implant Stage|No return of pain|4|||
130197577|NCT00135512|468681515|FG000|Overall Study|Adverse Event|56|||
130197578|NCT00135512|468681515|FG000|Overall Study|Lack of Efficacy|25|||
130197579|NCT00135512|468681515|FG000|Overall Study|Other|42|||
130197580|NCT02235077|468681516|FG000|Overall Study|Death|5|||
130197581|NCT02235077|468681517|FG001|Overall Study|Death|7|||
130197582|NCT02235077|468681516|FG000|Overall Study|Lost to Follow-up|5|||
130197583|NCT02235077|468681517|FG001|Overall Study|Lost to Follow-up|6|||
130197584|NCT02235077|468681516|FG000|Overall Study|Withdrawal by Subject|8|||
130197585|NCT02235077|468681517|FG001|Overall Study|Withdrawal by Subject|5|||
130197586|NCT02235077|468681516|FG000|Overall Study|Physician Decision|0|||
130197587|NCT02235077|468681517|FG001|Overall Study|Physician Decision|1|||
130197588|NCT03852628|468681518|FG000|Overall Study|Lost to Follow-up|7|||
130197589|NCT03852628|468681519|FG001|Overall Study|Lost to Follow-up|6|||
130197590|NCT03852628|468681518|FG000|Overall Study|Lack of Efficacy|6|||
130197591|NCT03852628|468681519|FG001|Overall Study|Lack of Efficacy|6|||
130197592|NCT00586820|468681521|FG000|Overall Study|Unsuccessful PCI|1|||
130197593|NCT00586820|468681522|FG001|Overall Study|Unsuccessful PCI|0|||
130197594|NCT03887442|468681523|FG000|Overall Study|Adverse Event|1|||
130197595|NCT03887442|468681524|FG001|Overall Study|Adverse Event|0|||
130197596|NCT01868022|468681525|FG000|Overall Study|Withdrawal by Subject|0|||
130197597|NCT01868022|468681526|FG001|Overall Study|Withdrawal by Subject|0|||
130197598|NCT01868022|468681527|FG002|Overall Study|Withdrawal by Subject|1|||
130197599|NCT01868022|468681528|FG003|Overall Study|Withdrawal by Subject|1|||
130197600|NCT01868022|468681529|FG004|Overall Study|Withdrawal by Subject|0|||
130197601|NCT01868022|468681530|FG005|Overall Study|Withdrawal by Subject|0|||
130197602|NCT01868022|468681531|FG006|Overall Study|Withdrawal by Subject|0|||
130197603|NCT01868022|468681532|FG007|Overall Study|Withdrawal by Subject|1|||
130197604|NCT01868022|468681533|FG008|Overall Study|Withdrawal by Subject|0|||
130197605|NCT01868022|468681525|FG000|Overall Study|Adverse Event|0|||
130197606|NCT01868022|468681526|FG001|Overall Study|Adverse Event|0|||
130197607|NCT01868022|468681527|FG002|Overall Study|Adverse Event|0|||
130197608|NCT01868022|468681528|FG003|Overall Study|Adverse Event|0|||
130197609|NCT01868022|468681529|FG004|Overall Study|Adverse Event|2|||
130197610|NCT01868022|468681530|FG005|Overall Study|Adverse Event|0|||
130197611|NCT01868022|468681531|FG006|Overall Study|Adverse Event|0|||
130197612|NCT01868022|468681532|FG007|Overall Study|Adverse Event|2|||
130197613|NCT01868022|468681533|FG008|Overall Study|Adverse Event|2|||
130197614|NCT01868022|468681525|FG000|Overall Study|Physician Decision|0|||
130197615|NCT01868022|468681526|FG001|Overall Study|Physician Decision|0|||
130197616|NCT01868022|468681527|FG002|Overall Study|Physician Decision|0|||
130197617|NCT01868022|468681528|FG003|Overall Study|Physician Decision|0|||
130197618|NCT01868022|468681529|FG004|Overall Study|Physician Decision|0|||
130197619|NCT01868022|468681530|FG005|Overall Study|Physician Decision|1|||
130197620|NCT01868022|468681531|FG006|Overall Study|Physician Decision|0|||
130197621|NCT01868022|468681532|FG007|Overall Study|Physician Decision|2|||
130197622|NCT01868022|468681533|FG008|Overall Study|Physician Decision|0|||
130197623|NCT01868022|468681525|FG000|Overall Study|Study closed/terminated|0|||
130197624|NCT01868022|468681526|FG001|Overall Study|Study closed/terminated|0|||
130197625|NCT01868022|468681527|FG002|Overall Study|Study closed/terminated|0|||
130197626|NCT01868022|468681528|FG003|Overall Study|Study closed/terminated|0|||
130197627|NCT01868022|468681529|FG004|Overall Study|Study closed/terminated|0|||
130197628|NCT01868022|468681530|FG005|Overall Study|Study closed/terminated|0|||
130197629|NCT01868022|468681531|FG006|Overall Study|Study closed/terminated|0|||
130197630|NCT01868022|468681532|FG007|Overall Study|Study closed/terminated|1|||
130197631|NCT01868022|468681533|FG008|Overall Study|Study closed/terminated|0|||
130197632|NCT01868022|468681525|FG000|Overall Study|Ongoing|0|||
130197633|NCT01868022|468681526|FG001|Overall Study|Ongoing|0|||
130197634|NCT01868022|468681527|FG002|Overall Study|Ongoing|0|||
130197635|NCT01868022|468681528|FG003|Overall Study|Ongoing|0|||
130197636|NCT01868022|468681529|FG004|Overall Study|Ongoing|0|||
130197637|NCT01868022|468681530|FG005|Overall Study|Ongoing|0|||
130197638|NCT01868022|468681531|FG006|Overall Study|Ongoing|0|||
130197639|NCT01868022|468681532|FG007|Overall Study|Ongoing|3|||
130197640|NCT01868022|468681533|FG008|Overall Study|Ongoing|0|||
130197641|NCT01628198|468681534|FG000|Overall Study|Lost to Follow-up|7|||
130197642|NCT01628198|468681534|FG000|Overall Study|Withdrawal by Subject|10|||
130197643|NCT01628198|468681534|FG000|Overall Study|Screen failure|1|||
130197644|NCT00833482|468681543|FG000|Days 11-20|Adverse Event|0|||
130197645|NCT00833482|468681544|FG001|Days 11-20|Adverse Event|2|||
130197646|NCT00833482|468681545|FG002|Days 11-20|Adverse Event|0|||
130197647|NCT00833482|468681546|FG003|Days 11-20|Adverse Event|0|||
130197648|NCT00833482|468681547|FG004|Days 11-20|Adverse Event|0|||
130197649|NCT00833482|468681548|FG005|Days 11-20|Adverse Event|0|||
130197650|NCT00833482|468681543|FG000|Days 11-20|Withdrawal by Subject|0|||
130197651|NCT00833482|468681544|FG001|Days 11-20|Withdrawal by Subject|1|||
130197652|NCT00833482|468681545|FG002|Days 11-20|Withdrawal by Subject|0|||
130197653|NCT00833482|468681546|FG003|Days 11-20|Withdrawal by Subject|0|||
130197654|NCT00833482|468681547|FG004|Days 11-20|Withdrawal by Subject|0|||
130197655|NCT00833482|468681548|FG005|Days 11-20|Withdrawal by Subject|0|||
130197656|NCT00833482|468681543|FG000|Days 21-30|Adverse Event|0|||
130197657|NCT00833482|468681544|FG001|Days 21-30|Adverse Event|0|||
130197658|NCT00833482|468681545|FG002|Days 21-30|Adverse Event|1|||
130197659|NCT00833482|468681546|FG003|Days 21-30|Adverse Event|0|||
130197660|NCT00833482|468681547|FG004|Days 21-30|Adverse Event|0|||
130197661|NCT00833482|468681548|FG005|Days 21-30|Adverse Event|0|||
130197662|NCT00833482|468681543|FG000|Days 21-30|Withdrawal by Subject|0|||
130197663|NCT00833482|468681544|FG001|Days 21-30|Withdrawal by Subject|0|||
130197664|NCT00833482|468681545|FG002|Days 21-30|Withdrawal by Subject|0|||
130197665|NCT00833482|468681546|FG003|Days 21-30|Withdrawal by Subject|0|||
130197666|NCT00833482|468681547|FG004|Days 21-30|Withdrawal by Subject|1|||
130197667|NCT00833482|468681548|FG005|Days 21-30|Withdrawal by Subject|0|||
130197668|NCT02778074|468681549|FG000|Overall Study|Lost to Follow-up|7|||
130197669|NCT02778074|468681550|FG001|Overall Study|Lost to Follow-up|10|||
130197670|NCT03489707|468681551|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
130197671|NCT03489707|468681552|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
130197672|NCT03489707|468681551|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
130197673|NCT03489707|468681552|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
130197674|NCT01817582|468681553|FG000|Overall Study|Withdrawal by Subject|0|||
130197675|NCT01817582|468681554|FG001|Overall Study|Withdrawal by Subject|1|||
130197676|NCT01817582|468681555|FG002|Overall Study|Withdrawal by Subject|0|||
130197677|NCT01817582|468681553|FG000|Overall Study|Participant revealed masked treatment|1|||
130197678|NCT01817582|468681554|FG001|Overall Study|Participant revealed masked treatment|0|||
130197679|NCT01817582|468681555|FG002|Overall Study|Participant revealed masked treatment|0|||
130197680|NCT01817582|468681553|FG000|Overall Study|Randomized but exclusion criteria met|1|||
130197681|NCT01817582|468681554|FG001|Overall Study|Randomized but exclusion criteria met|0|||
130197682|NCT01817582|468681555|FG002|Overall Study|Randomized but exclusion criteria met|0|||
130197683|NCT02122887|468681558|FG000|Overall Study|Withdrawal by Subject|20|||
130197684|NCT02122887|468681559|FG001|Overall Study|Withdrawal by Subject|2|||
130197685|NCT00378508|468683257|FG000|Overall Study|Withdrawal by Subject|1|||
130197686|NCT00378508|468683258|FG001|Overall Study|Withdrawal by Subject|3|||
130197687|NCT00378508|468683257|FG000|Overall Study|Lost to Follow-up|1|||
130197688|NCT00378508|468683258|FG001|Overall Study|Lost to Follow-up|0|||
130197689|NCT03917472|468683262|FG000|Overall Study|Physician Decision|4|||
130197690|NCT03917472|468683263|FG001|Overall Study|Physician Decision|0|||
130197691|NCT03917472|468683262|FG000|Overall Study|Adverse Event|3|||
130197692|NCT03917472|468683263|FG001|Overall Study|Adverse Event|1|||
130197693|NCT03917472|468683262|FG000|Overall Study|Death|7|||
130197694|NCT03917472|468683263|FG001|Overall Study|Death|5|||
130197695|NCT03917472|468683262|FG000|Overall Study|Withdrawal by Subject|11|||
130197696|NCT03917472|468683263|FG001|Overall Study|Withdrawal by Subject|4|||
130197697|NCT03917472|468683262|FG000|Overall Study|Lost to Follow-up|10|||
130197698|NCT03917472|468683263|FG001|Overall Study|Lost to Follow-up|5|||
130197699|NCT01953601|468683267|FG000|Part 1 (Base Study)|Adverse Event|24|||
130197700|NCT01953601|468683268|FG001|Part 1 (Base Study)|Adverse Event|37|||
130197701|NCT01953601|468683269|FG002|Part 1 (Base Study)|Adverse Event|15|||
130197702|NCT01953601|468683267|FG000|Part 1 (Base Study)|Death|2|||
130197703|NCT01953601|468683268|FG001|Part 1 (Base Study)|Death|0|||
130197704|NCT01953601|468683269|FG002|Part 1 (Base Study)|Death|3|||
130197705|NCT01953601|468683267|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
130197706|NCT01953601|468683268|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
130197707|NCT01953601|468683269|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
130197708|NCT01953601|468683267|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
130197709|NCT01953601|468683268|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
130197710|NCT01953601|468683269|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
130197711|NCT01953601|468683267|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
130197712|NCT01953601|468683268|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
130197713|NCT01953601|468683269|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
130197714|NCT01953601|468683267|FG000|Part 1 (Base Study)|Physician Decision|3|||
130197715|NCT01953601|468683268|FG001|Part 1 (Base Study)|Physician Decision|7|||
130197716|NCT01953601|468683269|FG002|Part 1 (Base Study)|Physician Decision|4|||
130197717|NCT01953601|468683267|FG000|Part 1 (Base Study)|Screen failure|1|||
130197718|NCT01953601|468683268|FG001|Part 1 (Base Study)|Screen failure|0|||
130197719|NCT01953601|468683269|FG002|Part 1 (Base Study)|Screen failure|1|||
130197720|NCT01953601|468683267|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
130197721|NCT01953601|468683268|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
130197722|NCT01953601|468683269|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
130197723|NCT01953601|468683267|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
130197724|NCT01953601|468683268|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
130197725|NCT01953601|468683269|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
130197726|NCT01953601|468683267|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
130197727|NCT01953601|468683268|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
130197728|NCT01953601|468683269|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
130197729|NCT01953601|468683267|FG000|Part 1 (Base Study)|Subject moved|2|||
130197730|NCT01953601|468683268|FG001|Part 1 (Base Study)|Subject moved|2|||
130197731|NCT01953601|468683269|FG002|Part 1 (Base Study)|Subject moved|1|||
130197732|NCT01953601|468683267|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
130197733|NCT01953601|468683268|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
130197734|NCT01953601|468683269|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
130197735|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Adverse Event|1|||
130197736|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Adverse Event|1|||
130197737|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Adverse Event|10|||
130197738|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Death|0|||
130197739|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Death|3|||
130197740|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Death|0|||
130197741|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
130197742|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
130197743|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
130197744|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
130197745|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
130197746|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
130197747|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Physician Decision|2|||
130197748|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Physician Decision|0|||
130197749|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Physician Decision|2|||
130197750|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
130197751|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
130197752|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
130197753|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
130197754|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
130197755|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
130197756|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
130197757|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
130197758|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
130197759|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Subject moved|0|||
130197760|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Subject moved|0|||
130197761|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Subject moved|1|||
130197762|NCT01953601|468683267|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
130197763|NCT01953601|468683268|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
130197764|NCT01953601|468683269|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
130197765|NCT03991299|468683274|FG000|Overall Study|Study closed, sponsor decision|3|||
130197766|NCT03991299|468683274|FG000|Overall Study|Withdrawal by Subject|1|||
130197767|NCT04429555|468683277|FG000|Overall Study|Death|0|||
130197768|NCT04429555|468683278|FG001|Overall Study|Death|2|||
130197769|NCT04429555|468683277|FG000|Overall Study|Other|2|||
130197770|NCT04429555|468683278|FG001|Overall Study|Other|0|||
130197771|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
130197772|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
130197773|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
130197774|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
130197775|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
130197776|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197777|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197778|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197779|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
130197780|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
130197781|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130197782|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130197783|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
130197784|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
130197785|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
130197786|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Death|0|||
130197787|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Death|0|||
130197788|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Death|1|||
130197789|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Death|2|||
130197790|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Death|7|||
130197791|NCT00941863|468683281|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
130197792|NCT00941863|468683282|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
130197793|NCT00941863|468683283|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
130197794|NCT00941863|468683284|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
130197795|NCT00941863|468683285|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
130197796|NCT00941863|468683281|FG000|Continued After PCD|Withdrawal by Subject|0|||
130197797|NCT00941863|468683282|FG001|Continued After PCD|Withdrawal by Subject|0|||
130197798|NCT00941863|468683283|FG002|Continued After PCD|Withdrawal by Subject|0|||
130197799|NCT00941863|468683284|FG003|Continued After PCD|Withdrawal by Subject|0|||
130197800|NCT00941863|468683285|FG004|Continued After PCD|Withdrawal by Subject|1|||
130197801|NCT00941863|468683281|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197802|NCT00941863|468683282|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197803|NCT00941863|468683283|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197804|NCT00941863|468683284|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
130197805|NCT00941863|468683285|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
130197806|NCT04533412|468683289|FG000|Overall Study|Withdrawal by Subject|1|||
130197807|NCT04533412|468683290|FG001|Overall Study|Withdrawal by Subject|1|||
130197808|NCT04533412|468683289|FG000|Overall Study|Lost to Follow-up|1|||
130197809|NCT04533412|468683290|FG001|Overall Study|Lost to Follow-up|4|||
130197810|NCT05113979|468683291|FG000|Overall Study|Death|2|||
130197811|NCT05113979|468683291|FG000|Overall Study|Lost to Follow-up|1|||
130197812|NCT00968981|468683294|FG000|Overall Study|Adverse Event|2|||
130197813|NCT00968981|468683295|FG001|Overall Study|Adverse Event|0|||
130197814|NCT00968981|468683296|FG002|Overall Study|Adverse Event|0|||
130197815|NCT00968981|468683294|FG000|Overall Study|Disease Progression|14|||
130197816|NCT00968981|468683295|FG001|Overall Study|Disease Progression|16|||
130197817|NCT00968981|468683296|FG002|Overall Study|Disease Progression|13|||
130197818|NCT00968981|468683294|FG000|Overall Study|Lost to Follow-up|0|||
130197819|NCT00968981|468683295|FG001|Overall Study|Lost to Follow-up|0|||
130197820|NCT00968981|468683296|FG002|Overall Study|Lost to Follow-up|1|||
130197821|NCT00968981|468683294|FG000|Overall Study|Physician Decision|5|||
130197822|NCT00968981|468683295|FG001|Overall Study|Physician Decision|3|||
130197823|NCT00968981|468683296|FG002|Overall Study|Physician Decision|5|||
130197824|NCT00968981|468683294|FG000|Overall Study|Withdrawal by Subject|1|||
130197825|NCT00968981|468683295|FG001|Overall Study|Withdrawal by Subject|3|||
130197826|NCT00968981|468683296|FG002|Overall Study|Withdrawal by Subject|3|||
130197827|NCT01489254|468683299|FG000|Double-blind Part|Adverse Event|7|||
130197828|NCT01489254|468683300|FG001|Double-blind Part|Adverse Event|2|||
130197829|NCT01489254|468683301|FG002|Double-blind Part|Adverse Event|2|||
130197830|NCT01489254|468683302|FG003|Double-blind Part|Adverse Event|0|||
130197831|NCT01489254|468683299|FG000|Double-blind Part|Pregnancy|1|||
130197832|NCT01489254|468683300|FG001|Double-blind Part|Pregnancy|3|||
130197833|NCT01489254|468683301|FG002|Double-blind Part|Pregnancy|0|||
130197834|NCT01489254|468683302|FG003|Double-blind Part|Pregnancy|0|||
130197835|NCT01489254|468683299|FG000|Double-blind Part|Withdrawal by Subject|12|||
130197836|NCT01489254|468683300|FG001|Double-blind Part|Withdrawal by Subject|20|||
130197837|NCT01489254|468683301|FG002|Double-blind Part|Withdrawal by Subject|1|||
130197838|NCT01489254|468683302|FG003|Double-blind Part|Withdrawal by Subject|0|||
130197839|NCT01489254|468683299|FG000|Double-blind Part|Lost to Follow-up|1|||
130197840|NCT01489254|468683300|FG001|Double-blind Part|Lost to Follow-up|2|||
130197841|NCT01489254|468683301|FG002|Double-blind Part|Lost to Follow-up|0|||
130197842|NCT01489254|468683302|FG003|Double-blind Part|Lost to Follow-up|0|||
130197843|NCT01489254|468683299|FG000|Double-blind Part|Other reasons for not completing study|4|||
130197844|NCT01489254|468683300|FG001|Double-blind Part|Other reasons for not completing study|6|||
130197845|NCT01489254|468683301|FG002|Double-blind Part|Other reasons for not completing study|0|||
130197846|NCT01489254|468683302|FG003|Double-blind Part|Other reasons for not completing study|0|||
130197847|NCT01489254|468683299|FG000|Open-label Extension Part|Adverse Event|0|||
130197848|NCT01489254|468683300|FG001|Open-label Extension Part|Adverse Event|0|||
130197849|NCT01489254|468683301|FG002|Open-label Extension Part|Adverse Event|0|||
130197850|NCT01489254|468683302|FG003|Open-label Extension Part|Adverse Event|10|||
130197851|NCT01489254|468683299|FG000|Open-label Extension Part|Pregnancy|0|||
130197852|NCT01489254|468683300|FG001|Open-label Extension Part|Pregnancy|0|||
130197853|NCT01489254|468683301|FG002|Open-label Extension Part|Pregnancy|0|||
130197854|NCT01489254|468683302|FG003|Open-label Extension Part|Pregnancy|3|||
130197855|NCT01489254|468683299|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
130197856|NCT01489254|468683300|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
130197857|NCT01489254|468683301|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
130197858|NCT01489254|468683302|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
130197859|NCT01489254|468683299|FG000|Open-label Extension Part|Protocol Violation|0|||
130197860|NCT01489254|468683300|FG001|Open-label Extension Part|Protocol Violation|0|||
130197861|NCT01489254|468683301|FG002|Open-label Extension Part|Protocol Violation|0|||
130197862|NCT01489254|468683302|FG003|Open-label Extension Part|Protocol Violation|1|||
130197863|NCT01489254|468683299|FG000|Open-label Extension Part|Lost to Follow-up|0|||
130197864|NCT01489254|468683300|FG001|Open-label Extension Part|Lost to Follow-up|0|||
130197865|NCT01489254|468683301|FG002|Open-label Extension Part|Lost to Follow-up|0|||
130197866|NCT01489254|468683302|FG003|Open-label Extension Part|Lost to Follow-up|9|||
130197867|NCT01489254|468683299|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
130197868|NCT01489254|468683300|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
130197869|NCT01489254|468683301|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
130197870|NCT01489254|468683302|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
130197871|NCT00281632|468683310|FG000|Overall Study|Adverse Event|7|||
130197872|NCT00281632|468683310|FG000|Overall Study|Withdrawal by Subject|2|||
130197873|NCT00281632|468683310|FG000|Overall Study|Disease Progression|22|||
130197874|NCT00281632|468683310|FG000|Overall Study|Death|1|||
130197875|NCT00281632|468683310|FG000|Overall Study|Physician Decision|1|||
130197876|NCT00281632|468683310|FG000|Overall Study|Ongoing|3|||
130197877|NCT03990571|468683311|FG000|Overall Study|Withdrawal by Subject|1|||
130197878|NCT03990571|468683311|FG000|Overall Study|Insurance Issues|3|||
130197879|NCT03990571|468683311|FG000|Overall Study|Covid Restrictions|2|||
130197880|NCT00782184|468683318|FG000|Overall Study|Adverse Event|1|||
130197881|NCT00782184|468683319|FG001|Overall Study|Adverse Event|2|||
130197882|NCT00782184|468683318|FG000|Overall Study|Protocol Violation|0|||
130197883|NCT00782184|468683319|FG001|Overall Study|Protocol Violation|1|||
130197884|NCT00782184|468683318|FG000|Overall Study|Withdrawal by Subject|3|||
130197885|NCT00782184|468683319|FG001|Overall Study|Withdrawal by Subject|2|||
130197886|NCT03614078|468683320|FG000|Overall Study|Withdrawal by Subject|2|||
130197887|NCT03614078|468683321|FG001|Overall Study|Withdrawal by Subject|2|||
130197888|NCT03614078|468683322|FG002|Overall Study|Withdrawal by Subject|3|||
130197889|NCT03614078|468683320|FG000|Overall Study|Participant Did Not Return for Visit|0|||
130197890|NCT03614078|468683321|FG001|Overall Study|Participant Did Not Return for Visit|1|||
130197891|NCT03614078|468683322|FG002|Overall Study|Participant Did Not Return for Visit|0|||
130197892|NCT03614078|468683320|FG000|Overall Study|High Neutrophils|0|||
130197893|NCT03614078|468683321|FG001|Overall Study|High Neutrophils|0|||
130197894|NCT03614078|468683322|FG002|Overall Study|High Neutrophils|2|||
130197895|NCT03614078|468683320|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
130197896|NCT03614078|468683321|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
130197897|NCT03614078|468683322|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
130197898|NCT03614078|468683320|FG000|Overall Study|Exacerbation of Psoriasis|0|||
130197899|NCT03614078|468683321|FG001|Overall Study|Exacerbation of Psoriasis|1|||
130197900|NCT03614078|468683322|FG002|Overall Study|Exacerbation of Psoriasis|0|||
130197901|NCT03614078|468683320|FG000|Overall Study|Adverse Event|0|||
130197902|NCT03614078|468683321|FG001|Overall Study|Adverse Event|2|||
130197903|NCT03614078|468683322|FG002|Overall Study|Adverse Event|0|||
130197904|NCT03614078|468683320|FG000|Overall Study|Dizziness and Rash|0|||
130197905|NCT03614078|468683321|FG001|Overall Study|Dizziness and Rash|1|||
130197906|NCT03614078|468683322|FG002|Overall Study|Dizziness and Rash|0|||
130197907|NCT04143594|468683325|FG000|Overall Study|Withdrew consent|3|||
130197908|NCT04143594|468683326|FG001|Overall Study|Withdrew consent|10|||
130197909|NCT04143594|468683327|FG002|Overall Study|Withdrew consent|3|||
130197910|NCT04143594|468683328|FG003|Overall Study|Withdrew consent|1|||
130197911|NCT04143594|468683325|FG000|Overall Study|Lost to Follow-up|3|||
130197912|NCT04143594|468683326|FG001|Overall Study|Lost to Follow-up|5|||
130197913|NCT04143594|468683327|FG002|Overall Study|Lost to Follow-up|11|||
130197914|NCT04143594|468683328|FG003|Overall Study|Lost to Follow-up|0|||
130197915|NCT04143594|468683325|FG000|Overall Study|Investigator's discretion|2|||
130197916|NCT04143594|468683326|FG001|Overall Study|Investigator's discretion|2|||
130197917|NCT04143594|468683327|FG002|Overall Study|Investigator's discretion|0|||
130197918|NCT04143594|468683328|FG003|Overall Study|Investigator's discretion|0|||
130197919|NCT04143594|468683325|FG000|Overall Study|Randomized but never treated|0|||
130197920|NCT04143594|468683326|FG001|Overall Study|Randomized but never treated|0|||
130197921|NCT04143594|468683327|FG002|Overall Study|Randomized but never treated|0|||
130197922|NCT04143594|468683328|FG003|Overall Study|Randomized but never treated|1|||
130197923|NCT04143594|468683325|FG000|Overall Study|Death|1|||
130197924|NCT04143594|468683326|FG001|Overall Study|Death|0|||
130197925|NCT04143594|468683327|FG002|Overall Study|Death|1|||
130197926|NCT04143594|468683328|FG003|Overall Study|Death|0|||
130197927|NCT04143594|468683325|FG000|Overall Study|Adverse Event|1|||
130197928|NCT04143594|468683326|FG001|Overall Study|Adverse Event|0|||
130197929|NCT04143594|468683327|FG002|Overall Study|Adverse Event|0|||
130197930|NCT04143594|468683328|FG003|Overall Study|Adverse Event|0|||
130197931|NCT04143594|468683325|FG000|Overall Study|Pregnancy|0|||
130197932|NCT04143594|468683326|FG001|Overall Study|Pregnancy|0|||
130197933|NCT04143594|468683327|FG002|Overall Study|Pregnancy|1|||
130197934|NCT04143594|468683328|FG003|Overall Study|Pregnancy|0|||
130197935|NCT04143594|468683325|FG000|Overall Study|Lack of Efficacy|1|||
130197936|NCT04143594|468683326|FG001|Overall Study|Lack of Efficacy|1|||
130197937|NCT04143594|468683327|FG002|Overall Study|Lack of Efficacy|0|||
130197938|NCT04143594|468683328|FG003|Overall Study|Lack of Efficacy|0|||
130197939|NCT01054196|468683329|FG000|Overall Study|Physician Decision|0|||
130197940|NCT01054196|468683330|FG001|Overall Study|Physician Decision|0|||
130197941|NCT01054196|468683331|FG002|Overall Study|Physician Decision|0|||
130197942|NCT01054196|468683332|FG003|Overall Study|Physician Decision|1|||
130197943|NCT01054196|468683333|FG004|Overall Study|Physician Decision|0|||
130197944|NCT01054196|468683334|FG005|Overall Study|Physician Decision|0|||
130197945|NCT01054196|468683335|FG006|Overall Study|Physician Decision|1|||
130197946|NCT00492648|468683336|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
130197947|NCT00492648|468683337|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
130197948|NCT00282113|468683338|FG000|Overall Study|Removed at parents request|1|||
130197949|NCT00282113|468683339|FG001|Overall Study|Removed at parents request|0|||
130197950|NCT00282113|468683340|FG002|Overall Study|Removed at parents request|0|||
130197951|NCT02949843|468683341|FG000|Overall Study|Withdrawal by Subject|0|||
130197952|NCT02949843|468683342|FG001|Overall Study|Withdrawal by Subject|1|||
130197953|NCT02949843|468683343|FG002|Overall Study|Withdrawal by Subject|1|||
130197954|NCT01500187|468683345|FG000|Overall Study|Lost to Follow-up|6|||
130197955|NCT01500187|468683346|FG001|Overall Study|Lost to Follow-up|0|||
130197956|NCT01343277|468683363|FG000|Overall Study|Other|3|||
130197957|NCT01343277|468683364|FG001|Overall Study|Other|3|||
130197958|NCT01343277|468683363|FG000|Overall Study|Withdrawal by Subject|18|||
130197959|NCT01343277|468683364|FG001|Overall Study|Withdrawal by Subject|13|||
130197960|NCT01343277|468683363|FG000|Overall Study|Physician Decision|1|||
130197961|NCT01343277|468683364|FG001|Overall Study|Physician Decision|2|||
130197962|NCT01343277|468683363|FG000|Overall Study|Death|10|||
130197963|NCT01343277|468683364|FG001|Overall Study|Death|1|||
130197964|NCT01343277|468683363|FG000|Overall Study|Adverse Event|67|||
130197965|NCT01343277|468683364|FG001|Overall Study|Adverse Event|13|||
130197966|NCT01343277|468683363|FG000|Overall Study|Disease progression|270|||
130197967|NCT01343277|468683364|FG001|Overall Study|Disease progression|138|||
130197968|NCT01343277|468683363|FG000|Overall Study|Randomized not treated|6|||
130197969|NCT01343277|468683364|FG001|Overall Study|Randomized not treated|21|||
130197970|NCT01343277|468683363|FG000|Overall Study|Treatment ongoing|8|||
130197971|NCT01343277|468683364|FG001|Overall Study|Treatment ongoing|2|||
130197972|NCT01343277|468683363|FG000|Overall Study|Subsequent anticancer therapy|1|||
130197973|NCT01343277|468683364|FG001|Overall Study|Subsequent anticancer therapy|0|||
130197974|NCT01582178|468683365|FG000|Overall Study|Physician Decision|6|||
130197975|NCT01582178|468683366|FG001|Overall Study|Physician Decision|5|||
130197976|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
130197977|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
130197978|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
130197979|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
130197980|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130197981|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130197982|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
130197983|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
130197984|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
130197985|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130197986|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130197987|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
130197988|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
130197989|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
130197990|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
130197991|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
130197992|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130197993|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
130197994|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130197995|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
130197996|NCT00556933|468683370|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130197997|NCT00556933|468683371|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
130197998|NCT00556933|468683372|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130197999|NCT00556933|468683373|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
130198000|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
130198001|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
130198002|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
130198003|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
130198004|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
130198005|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
130198006|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
130198007|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
130198008|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
130198009|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
130198010|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
130198011|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
130198012|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
130198013|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
130198014|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
130198015|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
130198016|NCT00556933|468683370|FG000|CNI Withdrawal vs. Minimization|Death|0|||
130198017|NCT00556933|468683371|FG001|CNI Withdrawal vs. Minimization|Death|0|||
130198018|NCT00556933|468683372|FG002|CNI Withdrawal vs. Minimization|Death|0|||
130198019|NCT00556933|468683373|FG003|CNI Withdrawal vs. Minimization|Death|1|||
130198020|NCT01295827|468683380|FG000|Overall Study|Adverse Event|1|||
130198021|NCT01295827|468683381|FG001|Overall Study|Adverse Event|2|||
130198022|NCT01295827|468683382|FG002|Overall Study|Adverse Event|2|||
130198023|NCT01295827|468683383|FG003|Overall Study|Adverse Event|1|||
130198024|NCT01295827|468683384|FG004|Overall Study|Adverse Event|1|||
130198025|NCT01295827|468683385|FG005|Overall Study|Adverse Event|4|||
130198026|NCT01295827|468683386|FG006|Overall Study|Adverse Event|15|||
130198027|NCT01295827|468683387|FG007|Overall Study|Adverse Event|49|||
130198028|NCT01295827|468683388|FG008|Overall Study|Adverse Event|22|||
130198029|NCT01295827|468683389|FG009|Overall Study|Adverse Event|7|||
130198030|NCT01295827|468683390|FG010|Overall Study|Adverse Event|50|||
130198031|NCT01295827|468683391|FG011|Overall Study|Adverse Event|21|||
130198032|NCT01295827|468683392|FG012|Overall Study|Adverse Event|0|||
130198033|NCT01295827|468683393|FG013|Overall Study|Adverse Event|0|||
130198034|NCT01295827|468683394|FG014|Overall Study|Adverse Event|0|||
130198035|NCT01295827|468683380|FG000|Overall Study|Lost to Follow-up|0|||
130198036|NCT01295827|468683381|FG001|Overall Study|Lost to Follow-up|0|||
130198037|NCT01295827|468683382|FG002|Overall Study|Lost to Follow-up|3|||
130198038|NCT01295827|468683383|FG003|Overall Study|Lost to Follow-up|0|||
130198039|NCT01295827|468683384|FG004|Overall Study|Lost to Follow-up|1|||
130198040|NCT01295827|468683385|FG005|Overall Study|Lost to Follow-up|0|||
130198041|NCT01295827|468683386|FG006|Overall Study|Lost to Follow-up|4|||
130198042|NCT01295827|468683387|FG007|Overall Study|Lost to Follow-up|8|||
130198043|NCT01295827|468683388|FG008|Overall Study|Lost to Follow-up|7|||
130198044|NCT01295827|468683389|FG009|Overall Study|Lost to Follow-up|4|||
130198045|NCT01295827|468683390|FG010|Overall Study|Lost to Follow-up|7|||
130198046|NCT01295827|468683391|FG011|Overall Study|Lost to Follow-up|3|||
130198047|NCT01295827|468683392|FG012|Overall Study|Lost to Follow-up|0|||
130198048|NCT01295827|468683393|FG013|Overall Study|Lost to Follow-up|0|||
130198049|NCT01295827|468683394|FG014|Overall Study|Lost to Follow-up|0|||
130198050|NCT01295827|468683380|FG000|Overall Study|Not Reported|0|||
130198051|NCT01295827|468683381|FG001|Overall Study|Not Reported|0|||
130198052|NCT01295827|468683382|FG002|Overall Study|Not Reported|0|||
130198053|NCT01295827|468683383|FG003|Overall Study|Not Reported|1|||
130198054|NCT01295827|468683384|FG004|Overall Study|Not Reported|0|||
130198055|NCT01295827|468683385|FG005|Overall Study|Not Reported|0|||
130198056|NCT01295827|468683386|FG006|Overall Study|Not Reported|24|||
130198057|NCT01295827|468683387|FG007|Overall Study|Not Reported|58|||
130198058|NCT01295827|468683388|FG008|Overall Study|Not Reported|41|||
130198059|NCT01295827|468683389|FG009|Overall Study|Not Reported|2|||
130198060|NCT01295827|468683390|FG010|Overall Study|Not Reported|23|||
130198061|NCT01295827|468683391|FG011|Overall Study|Not Reported|13|||
130198062|NCT01295827|468683392|FG012|Overall Study|Not Reported|0|||
130198063|NCT01295827|468683393|FG013|Overall Study|Not Reported|0|||
130198064|NCT01295827|468683394|FG014|Overall Study|Not Reported|0|||
130198065|NCT01295827|468683380|FG000|Overall Study|Progressive Disease|2|||
130198066|NCT01295827|468683381|FG001|Overall Study|Progressive Disease|1|||
130198067|NCT01295827|468683382|FG002|Overall Study|Progressive Disease|5|||
130198068|NCT01295827|468683383|FG003|Overall Study|Progressive Disease|2|||
130198069|NCT01295827|468683384|FG004|Overall Study|Progressive Disease|0|||
130198070|NCT01295827|468683385|FG005|Overall Study|Progressive Disease|1|||
130198071|NCT01295827|468683386|FG006|Overall Study|Progressive Disease|87|||
130198072|NCT01295827|468683387|FG007|Overall Study|Progressive Disease|144|||
130198073|NCT01295827|468683388|FG008|Overall Study|Progressive Disease|85|||
130198074|NCT01295827|468683389|FG009|Overall Study|Progressive Disease|40|||
130198075|NCT01295827|468683390|FG010|Overall Study|Progressive Disease|175|||
130198076|NCT01295827|468683391|FG011|Overall Study|Progressive Disease|136|||
130198077|NCT01295827|468683392|FG012|Overall Study|Progressive Disease|0|||
130198078|NCT01295827|468683393|FG013|Overall Study|Progressive Disease|0|||
130198079|NCT01295827|468683394|FG014|Overall Study|Progressive Disease|0|||
130198080|NCT01295827|468683380|FG000|Overall Study|Screen Failure|0|||
130198081|NCT01295827|468683381|FG001|Overall Study|Screen Failure|0|||
130198082|NCT01295827|468683382|FG002|Overall Study|Screen Failure|0|||
130198083|NCT01295827|468683383|FG003|Overall Study|Screen Failure|0|||
130198084|NCT01295827|468683384|FG004|Overall Study|Screen Failure|0|||
130198085|NCT01295827|468683385|FG005|Overall Study|Screen Failure|0|||
130198086|NCT01295827|468683386|FG006|Overall Study|Screen Failure|2|||
130198087|NCT01295827|468683387|FG007|Overall Study|Screen Failure|2|||
130198088|NCT01295827|468683388|FG008|Overall Study|Screen Failure|2|||
130198089|NCT01295827|468683389|FG009|Overall Study|Screen Failure|0|||
130198090|NCT01295827|468683390|FG010|Overall Study|Screen Failure|1|||
130198091|NCT01295827|468683391|FG011|Overall Study|Screen Failure|0|||
130198092|NCT01295827|468683392|FG012|Overall Study|Screen Failure|0|||
130198093|NCT01295827|468683393|FG013|Overall Study|Screen Failure|0|||
130198094|NCT01295827|468683394|FG014|Overall Study|Screen Failure|0|||
130198095|NCT01295827|468683380|FG000|Overall Study|Withdrawal by Subject|1|||
130198096|NCT01295827|468683381|FG001|Overall Study|Withdrawal by Subject|0|||
130198097|NCT01295827|468683382|FG002|Overall Study|Withdrawal by Subject|2|||
130198098|NCT01295827|468683383|FG003|Overall Study|Withdrawal by Subject|0|||
130198099|NCT01295827|468683384|FG004|Overall Study|Withdrawal by Subject|0|||
130198100|NCT01295827|468683385|FG005|Overall Study|Withdrawal by Subject|1|||
130198101|NCT01295827|468683386|FG006|Overall Study|Withdrawal by Subject|13|||
130198102|NCT01295827|468683387|FG007|Overall Study|Withdrawal by Subject|35|||
130198103|NCT01295827|468683388|FG008|Overall Study|Withdrawal by Subject|11|||
130198104|NCT01295827|468683389|FG009|Overall Study|Withdrawal by Subject|2|||
130198105|NCT01295827|468683390|FG010|Overall Study|Withdrawal by Subject|18|||
130198106|NCT01295827|468683391|FG011|Overall Study|Withdrawal by Subject|13|||
130198107|NCT01295827|468683392|FG012|Overall Study|Withdrawal by Subject|0|||
130198108|NCT01295827|468683393|FG013|Overall Study|Withdrawal by Subject|0|||
130198109|NCT01295827|468683394|FG014|Overall Study|Withdrawal by Subject|0|||
130198110|NCT01295827|468683380|FG000|Overall Study|Other|0|||
130198111|NCT01295827|468683381|FG001|Overall Study|Other|0|||
130198112|NCT01295827|468683382|FG002|Overall Study|Other|0|||
130198113|NCT01295827|468683383|FG003|Overall Study|Other|0|||
130198114|NCT01295827|468683384|FG004|Overall Study|Other|0|||
130198115|NCT01295827|468683385|FG005|Overall Study|Other|0|||
130198116|NCT01295827|468683386|FG006|Overall Study|Other|1|||
130198117|NCT01295827|468683387|FG007|Overall Study|Other|1|||
130198118|NCT01295827|468683388|FG008|Overall Study|Other|1|||
130198119|NCT01295827|468683389|FG009|Overall Study|Other|0|||
130198120|NCT01295827|468683390|FG010|Overall Study|Other|2|||
130198121|NCT01295827|468683391|FG011|Overall Study|Other|0|||
130198122|NCT01295827|468683392|FG012|Overall Study|Other|0|||
130198123|NCT01295827|468683393|FG013|Overall Study|Other|0|||
130198124|NCT01295827|468683394|FG014|Overall Study|Other|0|||
130198125|NCT01668173|468683395|FG000|Overall Study|Adverse Event|3|||
130198126|NCT01668173|468683395|FG000|Overall Study|Trial suspension|4|||
130198127|NCT00746564|468683398|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
130198128|NCT02640677|468683402|FG000|Overall Study|Lost to Follow-up|1|||
130198129|NCT02640677|468683402|FG000|Overall Study|Withdrawal by Subject|1|||
130198130|NCT01516008|468683403|FG000|Overall Study|Adverse Event|0|||
130198131|NCT01516008|468683404|FG001|Overall Study|Adverse Event|2|||
130198132|NCT01516008|468683405|FG002|Overall Study|Adverse Event|7|||
130198133|NCT01516008|468683403|FG000|Overall Study|Lack of Efficacy|44|||
130198134|NCT01516008|468683404|FG001|Overall Study|Lack of Efficacy|14|||
130198135|NCT01516008|468683405|FG002|Overall Study|Lack of Efficacy|10|||
130198136|NCT01516008|468683403|FG000|Overall Study|Protocol Violation|1|||
130198137|NCT01516008|468683404|FG001|Overall Study|Protocol Violation|0|||
130198138|NCT01516008|468683405|FG002|Overall Study|Protocol Violation|0|||
130198139|NCT01516008|468683403|FG000|Overall Study|Reason not specified|0|||
130198140|NCT01516008|468683404|FG001|Overall Study|Reason not specified|0|||
130198141|NCT01516008|468683405|FG002|Overall Study|Reason not specified|1|||
130198142|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130198143|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
130198144|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
130198145|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
130198146|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
130198147|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
130198148|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
130198149|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
130198150|NCT03963232|468683409|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
130198151|NCT03963232|468683410|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
130198152|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Adverse Event|1|||
130198153|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Adverse Event|2|||
130198154|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
130198155|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
130198156|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
130198157|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
130198158|NCT03963232|468683409|FG000|Open-Label Treatment Phase|Pregnancy|1|||
130198159|NCT03963232|468683410|FG001|Open-Label Treatment Phase|Pregnancy|0|||
130198160|NCT03963232|468683409|FG000|Follow-up Phase|Withdrawal by Subject|7|||
130198161|NCT03963232|468683410|FG001|Follow-up Phase|Withdrawal by Subject|5|||
130198162|NCT03963232|468683409|FG000|Follow-up Phase|Protocol Violation|0|||
130198163|NCT03963232|468683410|FG001|Follow-up Phase|Protocol Violation|2|||
130198164|NCT03963232|468683409|FG000|Follow-up Phase|Adverse Event|0|||
130198165|NCT03963232|468683410|FG001|Follow-up Phase|Adverse Event|1|||
130198166|NCT03963232|468683409|FG000|Follow-up Phase|Lost to Follow-up|0|||
130198167|NCT03963232|468683410|FG001|Follow-up Phase|Lost to Follow-up|1|||
130198168|NCT03617770|468683411|FG000|Overall Study|Lost to Follow-up|1|||
130198169|NCT03617770|468683412|FG001|Overall Study|Lost to Follow-up|0|||
130198170|NCT00356135|468683413|FG000|Overall Study|Protocol Violation|1|||
130198171|NCT00356135|468683414|FG001|Overall Study|Protocol Violation|0|||
130198172|NCT00356135|468683415|FG002|Overall Study|Protocol Violation|0|||
130198173|NCT00356135|468683413|FG000|Overall Study|Adverse Event|1|||
130198174|NCT00356135|468683414|FG001|Overall Study|Adverse Event|0|||
130198175|NCT00356135|468683415|FG002|Overall Study|Adverse Event|0|||
130198176|NCT00356135|468683413|FG000|Overall Study|Lost to Follow-up|0|||
130198177|NCT00356135|468683414|FG001|Overall Study|Lost to Follow-up|0|||
130198178|NCT00356135|468683415|FG002|Overall Study|Lost to Follow-up|1|||
130198179|NCT00356135|468683413|FG000|Overall Study|Physician Decision|1|||
130198180|NCT00356135|468683414|FG001|Overall Study|Physician Decision|1|||
130198181|NCT00356135|468683415|FG002|Overall Study|Physician Decision|1|||
130198182|NCT00356135|468683413|FG000|Overall Study|Subject non-compliance|1|||
130198183|NCT00356135|468683414|FG001|Overall Study|Subject non-compliance|1|||
130198184|NCT00356135|468683415|FG002|Overall Study|Subject non-compliance|3|||
130198185|NCT03512210|468683417|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
130198186|NCT03512210|468683417|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
130198187|NCT03512210|468683417|FG000|Step 2:Post-MINMON|Death|2|||
130198188|NCT03512210|468683417|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
130198189|NCT03512210|468683417|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
130198190|NCT03725761|468683418|FG000|Overall Study|still on study|1|||
130198191|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
130198192|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
130198193|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
130198194|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
130198195|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
130198196|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
130198197|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130198198|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
130198199|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
130198200|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
130198201|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
130198202|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
130198203|NCT02836236|468686226|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
130198204|NCT02836236|468686227|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130198205|NCT02836236|468686228|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130198206|NCT02836236|468686229|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
130198207|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130198208|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
130198209|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
130198210|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
130198211|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130198212|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
130198213|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
130198214|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
130198215|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Death|0|||
130198216|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Death|0|||
130198217|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Death|1|||
130198218|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Death|1|||
130198219|NCT02836236|468686226|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130198220|NCT02836236|468686227|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130198221|NCT02836236|468686228|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
130198222|NCT02836236|468686229|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
130198223|NCT01806961|468686230|FG000|Overall Study|sponsor decision|16|||
130198224|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
130198225|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
130198226|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
130198227|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
130198228|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Death|0|||
130198229|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Death|0|||
130198230|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Death|1|||
130198231|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Death|0|||
130198232|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
130198233|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130198234|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130198235|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
130198236|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
130198237|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
130198238|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
130198239|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
130198240|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
130198241|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
130198242|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
130198243|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
130198244|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
130198245|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
130198246|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
130198247|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
130198248|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
130198249|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
130198250|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
130198251|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
130198252|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
130198253|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
130198254|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
130198255|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
130198256|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
130198257|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
130198258|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130198259|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
130198260|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
130198261|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
130198262|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
130198263|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
130198264|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
130198265|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
130198266|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
130198267|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
130198268|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Other|8|||
130198269|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Other|14|||
130198270|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Other|8|||
130198271|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Other|23|||
130198272|NCT01106677|468686231|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
130198273|NCT01106677|468686232|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
130198274|NCT01106677|468686233|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
130198275|NCT01106677|468686234|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
130198276|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130198277|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
130198278|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
130198279|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
130198280|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Death|0|||
130198281|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Death|0|||
130198282|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Death|0|||
130198283|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Death|1|||
130198284|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
130198285|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
130198286|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
130198287|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
130198288|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
130198289|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130198290|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130198291|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
130198292|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130198293|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
130198294|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
130198295|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
130198296|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
130198297|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130198298|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130198299|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
130198300|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130198301|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
130198302|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
130198303|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
130198304|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130198305|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
130198306|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
130198307|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
130198308|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130198309|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130198310|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
130198311|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
130198312|NCT01106677|468686231|FG000|Extension Period: Week 26 to Week 52|Other|6|||
130198313|NCT01106677|468686232|FG001|Extension Period: Week 26 to Week 52|Other|5|||
130198314|NCT01106677|468686233|FG002|Extension Period: Week 26 to Week 52|Other|8|||
130198315|NCT01106677|468686234|FG003|Extension Period: Week 26 to Week 52|Other|5|||
130198316|NCT03937908|468686235|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
130198317|NCT03937908|468686236|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
130198318|NCT00784238|468686237|FG000|Overall Study|Adverse Event|14|||
130198319|NCT00784238|468686237|FG000|Overall Study|Death|2|||
130198320|NCT00784238|468686237|FG000|Overall Study|Lack of Efficacy|33|||
130198321|NCT00784238|468686237|FG000|Overall Study|Lost to Follow-up|29|||
130198322|NCT00784238|468686237|FG000|Overall Study|Pregnancy|1|||
130198323|NCT00784238|468686237|FG000|Overall Study|Withdrawal by Subject|26|||
130198324|NCT00784238|468686237|FG000|Overall Study|Other|14|||
130198325|NCT03693612|468686238|FG000|Overall Study|Lost to Follow-up|0|||
130198326|NCT03693612|468686239|FG001|Overall Study|Lost to Follow-up|0|||
130198327|NCT03693612|468686240|FG002|Overall Study|Lost to Follow-up|0|||
130198328|NCT03693612|468686241|FG003|Overall Study|Lost to Follow-up|0|||
130198329|NCT03693612|468686242|FG004|Overall Study|Lost to Follow-up|1|||
130198330|NCT03693612|468686243|FG005|Overall Study|Lost to Follow-up|0|||
130198331|NCT03693612|468686244|FG006|Overall Study|Lost to Follow-up|0|||
130198332|NCT03693612|468686238|FG000|Overall Study|Withdrawal by Subject|0|||
130198333|NCT03693612|468686239|FG001|Overall Study|Withdrawal by Subject|0|||
130198334|NCT03693612|468686240|FG002|Overall Study|Withdrawal by Subject|1|||
130198335|NCT03693612|468686241|FG003|Overall Study|Withdrawal by Subject|0|||
130198336|NCT03693612|468686242|FG004|Overall Study|Withdrawal by Subject|2|||
130198337|NCT03693612|468686243|FG005|Overall Study|Withdrawal by Subject|0|||
130198338|NCT03693612|468686244|FG006|Overall Study|Withdrawal by Subject|0|||
130198339|NCT03693612|468686238|FG000|Overall Study|Study Terminated by Sponsor|0|||
130198340|NCT03693612|468686239|FG001|Overall Study|Study Terminated by Sponsor|1|||
130198341|NCT03693612|468686240|FG002|Overall Study|Study Terminated by Sponsor|0|||
130198342|NCT03693612|468686241|FG003|Overall Study|Study Terminated by Sponsor|0|||
130198343|NCT03693612|468686242|FG004|Overall Study|Study Terminated by Sponsor|3|||
130198344|NCT03693612|468686243|FG005|Overall Study|Study Terminated by Sponsor|0|||
130198345|NCT03693612|468686244|FG006|Overall Study|Study Terminated by Sponsor|0|||
130198346|NCT05318092|468686245|FG000|Overall Study|Lost to Follow-up|3|||
130198347|NCT05318092|468686245|FG000|Overall Study|Withdrawal by Subject|1|||
130198348|NCT04434469|468686246|FG000|Overall Study|Death|2|||
130198349|NCT04434469|468686247|FG001|Overall Study|Death|3|||
130198350|NCT04434469|468686248|FG002|Overall Study|Death|2|||
130198351|NCT04434469|468686249|FG003|Overall Study|Death|2|||
130198352|NCT04434469|468686250|FG004|Overall Study|Death|2|||
130198353|NCT04434469|468686251|FG005|Overall Study|Death|0|||
130198354|NCT04434469|468686246|FG000|Overall Study|Lost to Follow-up|0|||
130198355|NCT04434469|468686247|FG001|Overall Study|Lost to Follow-up|0|||
130198356|NCT04434469|468686248|FG002|Overall Study|Lost to Follow-up|0|||
130198357|NCT04434469|468686249|FG003|Overall Study|Lost to Follow-up|1|||
130198358|NCT04434469|468686250|FG004|Overall Study|Lost to Follow-up|1|||
130198359|NCT04434469|468686251|FG005|Overall Study|Lost to Follow-up|0|||
130198360|NCT04434469|468686246|FG000|Overall Study|Study terminated by sponsor|1|||
130198361|NCT04434469|468686247|FG001|Overall Study|Study terminated by sponsor|1|||
130198362|NCT04434469|468686248|FG002|Overall Study|Study terminated by sponsor|1|||
130198363|NCT04434469|468686249|FG003|Overall Study|Study terminated by sponsor|2|||
130198364|NCT04434469|468686250|FG004|Overall Study|Study terminated by sponsor|3|||
130198365|NCT04434469|468686251|FG005|Overall Study|Study terminated by sponsor|3|||
130198366|NCT04434469|468686246|FG000|Overall Study|Withdrawal by Subject|0|||
130198367|NCT04434469|468686247|FG001|Overall Study|Withdrawal by Subject|0|||
130198368|NCT04434469|468686248|FG002|Overall Study|Withdrawal by Subject|1|||
130198369|NCT04434469|468686249|FG003|Overall Study|Withdrawal by Subject|0|||
130198370|NCT04434469|468686250|FG004|Overall Study|Withdrawal by Subject|0|||
130198371|NCT04434469|468686251|FG005|Overall Study|Withdrawal by Subject|0|||
130198372|NCT01154296|468686254|FG000|Randomization and Intervention|Decided to decline|1|||
130198373|NCT01154296|468686255|FG001|Randomization and Intervention|Decided to decline|1|||
130198374|NCT01154296|468686254|FG000|Randomization and Intervention|Declined by staff|1|||
130198375|NCT01154296|468686255|FG001|Randomization and Intervention|Declined by staff|0|||
130198376|NCT01154296|468686254|FG000|Randomization and Intervention|Did not return|1|||
130198377|NCT01154296|468686255|FG001|Randomization and Intervention|Did not return|0|||
130198378|NCT01154296|468686254|FG000|Randomization and Intervention|Left before test|0|||
130198379|NCT01154296|468686255|FG001|Randomization and Intervention|Left before test|1|||
130198380|NCT01154296|468686254|FG000|Randomization and Intervention|Left clinic early|2|||
130198381|NCT01154296|468686255|FG001|Randomization and Intervention|Left clinic early|0|||
130198382|NCT01154296|468686254|FG000|6-month Follow-up|Lost contact|269|||
130198383|NCT01154296|468686255|FG001|6-month Follow-up|Lost contact|275|||
130198384|NCT01154296|468686254|FG000|6-month Follow-up|Incarcerated|37|||
130198385|NCT01154296|468686255|FG001|6-month Follow-up|Incarcerated|32|||
130198386|NCT01154296|468686254|FG000|6-month Follow-up|Withdrew consent|14|||
130198387|NCT01154296|468686255|FG001|6-month Follow-up|Withdrew consent|15|||
130198388|NCT01154296|468686254|FG000|6-month Follow-up|Death|3|||
130198389|NCT01154296|468686255|FG001|6-month Follow-up|Death|2|||
130198390|NCT01154296|468686254|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
130198391|NCT01154296|468686255|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
130198392|NCT02759055|468686256|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
130198393|NCT02759055|468686257|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
130198394|NCT03692325|468686269|FG000|Overall Study|Adverse Event|2|||
130198395|NCT03692325|468686269|FG000|Overall Study|Progression/Recurrence|2|||
130198396|NCT02461524|468686272|FG000|Overall Study|Death|16|||
130198397|NCT02461524|468686272|FG000|Overall Study|Withdrawal by Subject|4|||
130198398|NCT02461524|468686272|FG000|Overall Study|Device Explanted|5|||
130198399|NCT02461524|468686272|FG000|Overall Study|Missed Visit|6|||
130198400|NCT01936181|468686277|FG000|Randomised, Double-blind|Adverse Event|27|||
130198401|NCT01936181|468686278|FG001|Randomised, Double-blind|Adverse Event|21|||
130198402|NCT01936181|468686279|FG002|Randomised, Double-blind|Adverse Event|0|||
130198403|NCT01936181|468686280|FG003|Randomised, Double-blind|Adverse Event|0|||
130198404|NCT01936181|468686277|FG000|Randomised, Double-blind|Protocol Violation|1|||
130198405|NCT01936181|468686278|FG001|Randomised, Double-blind|Protocol Violation|5|||
130198406|NCT01936181|468686279|FG002|Randomised, Double-blind|Protocol Violation|0|||
130198407|NCT01936181|468686280|FG003|Randomised, Double-blind|Protocol Violation|0|||
130198408|NCT01936181|468686277|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
130198409|NCT01936181|468686278|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
130198410|NCT01936181|468686279|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
130198411|NCT01936181|468686280|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
130198412|NCT01936181|468686277|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
130198413|NCT01936181|468686278|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
130198414|NCT01936181|468686279|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
130198415|NCT01936181|468686280|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
130198416|NCT01936181|468686277|FG000|Randomised, Double-blind|Pregnancy|0|||
130198417|NCT01936181|468686278|FG001|Randomised, Double-blind|Pregnancy|1|||
130198418|NCT01936181|468686279|FG002|Randomised, Double-blind|Pregnancy|0|||
130198419|NCT01936181|468686280|FG003|Randomised, Double-blind|Pregnancy|0|||
130198420|NCT01936181|468686277|FG000|Randomised, Double-blind|Physician Decision|4|||
130198421|NCT01936181|468686278|FG001|Randomised, Double-blind|Physician Decision|4|||
130198422|NCT01936181|468686279|FG002|Randomised, Double-blind|Physician Decision|0|||
130198423|NCT01936181|468686280|FG003|Randomised, Double-blind|Physician Decision|0|||
130198424|NCT01936181|468686277|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
130198425|NCT01936181|468686278|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
130198426|NCT01936181|468686279|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
130198427|NCT01936181|468686280|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
130198428|NCT01936181|468686277|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
130198429|NCT01936181|468686278|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
130198430|NCT01936181|468686279|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
130198431|NCT01936181|468686280|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
130198432|NCT01936181|468686277|FG000|Transition-extension|Adverse Event|3|||
130198433|NCT01936181|468686278|FG001|Transition-extension|Adverse Event|0|||
130198434|NCT01936181|468686279|FG002|Transition-extension|Adverse Event|3|||
130198435|NCT01936181|468686280|FG003|Transition-extension|Adverse Event|1|||
130198436|NCT01936181|468686277|FG000|Transition-extension|Lost to Follow-up|3|||
130198437|NCT01936181|468686278|FG001|Transition-extension|Lost to Follow-up|0|||
130198438|NCT01936181|468686279|FG002|Transition-extension|Lost to Follow-up|1|||
130198439|NCT01936181|468686280|FG003|Transition-extension|Lost to Follow-up|2|||
130198440|NCT01936181|468686277|FG000|Transition-extension|Physician Decision|2|||
130198441|NCT01936181|468686278|FG001|Transition-extension|Physician Decision|0|||
130198442|NCT01936181|468686279|FG002|Transition-extension|Physician Decision|0|||
130198443|NCT01936181|468686280|FG003|Transition-extension|Physician Decision|1|||
130198444|NCT01936181|468686277|FG000|Transition-extension|Withdrawal by Subject|7|||
130198445|NCT01936181|468686278|FG001|Transition-extension|Withdrawal by Subject|0|||
130198446|NCT01936181|468686279|FG002|Transition-extension|Withdrawal by Subject|2|||
130198447|NCT01936181|468686280|FG003|Transition-extension|Withdrawal by Subject|1|||
130198448|NCT02817516|468686281|FG000|Overall Study|Other|0|||
130198449|NCT02817516|468686282|FG001|Overall Study|Other|0|||
130198450|NCT02817516|468686283|FG002|Overall Study|Other|1|||
130198451|NCT02817516|468686284|FG003|Overall Study|Other|0|||
130198452|NCT00664859|468686285|FG000|Overall Study|Adverse Event|2|||
130198453|NCT00664859|468686286|FG001|Overall Study|Adverse Event|1|||
130198454|NCT00664859|468686287|FG002|Overall Study|Adverse Event|3|||
130198455|NCT00664859|468686285|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
130198456|NCT00664859|468686286|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
130198457|NCT00664859|468686287|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
130198458|NCT00664859|468686285|FG000|Overall Study|Noncompliance with protocol|1|||
130198459|NCT00664859|468686286|FG001|Overall Study|Noncompliance with protocol|0|||
130198460|NCT00664859|468686287|FG002|Overall Study|Noncompliance with protocol|4|||
130198461|NCT00664859|468686285|FG000|Overall Study|Laboratory abnormality|2|||
130198462|NCT00664859|468686286|FG001|Overall Study|Laboratory abnormality|1|||
130198463|NCT00664859|468686287|FG002|Overall Study|Laboratory abnormality|4|||
130198464|NCT00664859|468686285|FG000|Overall Study|Withdrawal by Subject|4|||
130198465|NCT00664859|468686286|FG001|Overall Study|Withdrawal by Subject|1|||
130198466|NCT00664859|468686287|FG002|Overall Study|Withdrawal by Subject|3|||
130198467|NCT00664859|468686285|FG000|Overall Study|Lost to Follow-up|2|||
130198468|NCT00664859|468686286|FG001|Overall Study|Lost to Follow-up|2|||
130198469|NCT00664859|468686287|FG002|Overall Study|Lost to Follow-up|1|||
130198470|NCT00664859|468686285|FG000|Overall Study|Other|0|||
130198471|NCT00664859|468686286|FG001|Overall Study|Other|1|||
130198472|NCT00664859|468686287|FG002|Overall Study|Other|2|||
130198473|NCT01943851|468686288|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198474|NCT01943851|468686289|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198475|NCT01943851|468686290|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198476|NCT01943851|468686291|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198477|NCT01943851|468686292|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198478|NCT01943851|468686293|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198479|NCT01943851|468686294|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198480|NCT01943851|468686295|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198481|NCT01943851|468686296|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
130198482|NCT01943851|468686297|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198483|NCT01943851|468686298|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198484|NCT01943851|468686299|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198485|NCT01943851|468686300|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198486|NCT01943851|468686301|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198487|NCT01943851|468686302|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198488|NCT01943851|468686303|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198489|NCT01943851|468686304|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198490|NCT01943851|468686305|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
130198491|NCT01943851|468686288|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198492|NCT01943851|468686289|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198493|NCT01943851|468686290|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198494|NCT01943851|468686291|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198495|NCT01943851|468686292|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
130198496|NCT01943851|468686293|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198497|NCT01943851|468686294|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198498|NCT01943851|468686295|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
130198499|NCT01943851|468686296|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198500|NCT01943851|468686297|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198501|NCT01943851|468686298|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198502|NCT01943851|468686299|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198503|NCT01943851|468686300|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198504|NCT01943851|468686301|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198505|NCT01943851|468686302|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198506|NCT01943851|468686303|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198507|NCT01943851|468686304|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198508|NCT01943851|468686305|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
130198509|NCT01943851|468686288|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198510|NCT01943851|468686289|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198511|NCT01943851|468686290|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198512|NCT01943851|468686291|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198513|NCT01943851|468686292|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198514|NCT01943851|468686293|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198515|NCT01943851|468686294|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198516|NCT01943851|468686295|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198517|NCT01943851|468686296|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198518|NCT01943851|468686297|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198519|NCT01943851|468686298|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198520|NCT01943851|468686299|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198521|NCT01943851|468686300|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198522|NCT01943851|468686301|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
130198523|NCT01943851|468686302|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198524|NCT01943851|468686303|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198525|NCT01943851|468686304|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198526|NCT01943851|468686305|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
130198527|NCT01943851|468686288|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198528|NCT01943851|468686289|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198529|NCT01943851|468686290|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198530|NCT01943851|468686291|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198531|NCT01943851|468686292|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198532|NCT01943851|468686293|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198533|NCT01943851|468686294|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198534|NCT01943851|468686295|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198535|NCT01943851|468686296|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198536|NCT01943851|468686297|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198537|NCT01943851|468686298|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198538|NCT01943851|468686299|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198539|NCT01943851|468686300|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198540|NCT01943851|468686301|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198541|NCT01943851|468686302|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198542|NCT01943851|468686303|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
130198543|NCT01943851|468686304|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198544|NCT01943851|468686305|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
130198545|NCT01943851|468686288|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198546|NCT01943851|468686289|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198547|NCT01943851|468686290|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198548|NCT01943851|468686291|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198549|NCT01943851|468686292|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198550|NCT01943851|468686293|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198551|NCT01943851|468686294|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198552|NCT01943851|468686295|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198553|NCT01943851|468686296|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198554|NCT01943851|468686297|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198555|NCT01943851|468686298|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198556|NCT01943851|468686299|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198557|NCT01943851|468686300|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198558|NCT01943851|468686301|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198559|NCT01943851|468686302|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
130198560|NCT01943851|468686303|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
130198561|NCT01943851|468686304|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
130198562|NCT01943851|468686305|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
130198563|NCT00900757|468686306|FG000|Overall Study|screen failure|19|||
130198564|NCT00748189|468686307|FG000|Overall Study|Death|99|||
130198565|NCT00748189|468686308|FG001|Overall Study|Death|84|||
130198566|NCT00748189|468686307|FG000|Overall Study|Withdrawal by Subject|23|||
130198567|NCT00748189|468686308|FG001|Overall Study|Withdrawal by Subject|29|||
130198568|NCT00748189|468686307|FG000|Overall Study|Physician Decision|16|||
130198569|NCT00748189|468686308|FG001|Overall Study|Physician Decision|5|||
130198570|NCT00748189|468686307|FG000|Overall Study|Lost to Follow-up|8|||
130198571|NCT00748189|468686308|FG001|Overall Study|Lost to Follow-up|15|||
130198572|NCT00748189|468686307|FG000|Overall Study|Study terminated by Sponsor|70|||
130198573|NCT00748189|468686308|FG001|Overall Study|Study terminated by Sponsor|79|||
130198574|NCT03320850|468686309|FG000|Overall Study|Lost to Follow-up|0|||
130198575|NCT03320850|468686310|FG001|Overall Study|Lost to Follow-up|0|||
130198576|NCT03320850|468686311|FG002|Overall Study|Lost to Follow-up|0|||
130198577|NCT03320850|468686312|FG003|Overall Study|Lost to Follow-up|0|||
130198578|NCT03320850|468686313|FG004|Overall Study|Lost to Follow-up|1|||
130198579|NCT03320850|468686314|FG005|Overall Study|Lost to Follow-up|2|||
130198580|NCT03320850|468686315|FG006|Overall Study|Lost to Follow-up|2|||
130198581|NCT03320850|468686316|FG007|Overall Study|Lost to Follow-up|0|||
130198582|NCT03320850|468686317|FG008|Overall Study|Lost to Follow-up|6|||
130198583|NCT03320850|468686318|FG009|Overall Study|Lost to Follow-up|4|||
130198584|NCT03320850|468686309|FG000|Overall Study|Withdrawal by Subject|0|||
130198585|NCT03320850|468686310|FG001|Overall Study|Withdrawal by Subject|0|||
130198586|NCT03320850|468686311|FG002|Overall Study|Withdrawal by Subject|0|||
130198587|NCT03320850|468686312|FG003|Overall Study|Withdrawal by Subject|0|||
130198588|NCT03320850|468686313|FG004|Overall Study|Withdrawal by Subject|1|||
130198589|NCT03320850|468686314|FG005|Overall Study|Withdrawal by Subject|2|||
130198590|NCT03320850|468686315|FG006|Overall Study|Withdrawal by Subject|4|||
130198591|NCT03320850|468686316|FG007|Overall Study|Withdrawal by Subject|5|||
130198592|NCT03320850|468686317|FG008|Overall Study|Withdrawal by Subject|2|||
130198593|NCT03320850|468686318|FG009|Overall Study|Withdrawal by Subject|1|||
130198594|NCT03320850|468686309|FG000|Overall Study|Lack of Efficacy|0|||
130198595|NCT03320850|468686310|FG001|Overall Study|Lack of Efficacy|0|||
130198596|NCT03320850|468686311|FG002|Overall Study|Lack of Efficacy|0|||
130198597|NCT03320850|468686312|FG003|Overall Study|Lack of Efficacy|1|||
130198598|NCT03320850|468686313|FG004|Overall Study|Lack of Efficacy|0|||
130198599|NCT03320850|468686314|FG005|Overall Study|Lack of Efficacy|1|||
130198600|NCT03320850|468686315|FG006|Overall Study|Lack of Efficacy|0|||
130198601|NCT03320850|468686316|FG007|Overall Study|Lack of Efficacy|2|||
130198602|NCT03320850|468686317|FG008|Overall Study|Lack of Efficacy|0|||
130198603|NCT03320850|468686318|FG009|Overall Study|Lack of Efficacy|3|||
130198604|NCT03320850|468686309|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
130198605|NCT03320850|468686310|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
130198606|NCT03320850|468686311|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
130198607|NCT03320850|468686312|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
130198608|NCT03320850|468686313|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
130198609|NCT03320850|468686314|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
130198610|NCT03320850|468686315|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
130198611|NCT03320850|468686316|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
130198612|NCT03320850|468686317|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
130198613|NCT03320850|468686318|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
130198614|NCT03320850|468686309|FG000|Overall Study|Adverse Event|0|||
130198615|NCT03320850|468686310|FG001|Overall Study|Adverse Event|0|||
130198616|NCT03320850|468686311|FG002|Overall Study|Adverse Event|0|||
130198617|NCT03320850|468686312|FG003|Overall Study|Adverse Event|0|||
130198618|NCT03320850|468686313|FG004|Overall Study|Adverse Event|0|||
130198619|NCT03320850|468686314|FG005|Overall Study|Adverse Event|2|||
130198620|NCT03320850|468686315|FG006|Overall Study|Adverse Event|1|||
130198621|NCT03320850|468686316|FG007|Overall Study|Adverse Event|0|||
130198622|NCT03320850|468686317|FG008|Overall Study|Adverse Event|2|||
130198623|NCT03320850|468686318|FG009|Overall Study|Adverse Event|0|||
130198624|NCT03320850|468686309|FG000|Overall Study|Reason Not Specified|0|||
130198625|NCT03320850|468686310|FG001|Overall Study|Reason Not Specified|0|||
130198626|NCT03320850|468686311|FG002|Overall Study|Reason Not Specified|0|||
130198627|NCT03320850|468686312|FG003|Overall Study|Reason Not Specified|0|||
130198628|NCT03320850|468686313|FG004|Overall Study|Reason Not Specified|0|||
130198629|NCT03320850|468686314|FG005|Overall Study|Reason Not Specified|1|||
130198630|NCT03320850|468686315|FG006|Overall Study|Reason Not Specified|0|||
130198631|NCT03320850|468686316|FG007|Overall Study|Reason Not Specified|0|||
130198632|NCT03320850|468686317|FG008|Overall Study|Reason Not Specified|0|||
130198633|NCT03320850|468686318|FG009|Overall Study|Reason Not Specified|1|||
130198634|NCT04481191|468686319|FG000|Overall Study|Withdrawn by parent/guardian|15|||
130198635|NCT04481191|468686320|FG001|Overall Study|Withdrawn by parent/guardian|10|||
130198636|NCT00546117|468686321|FG000|Overall Study|Withdrawal by Subject|3|||
130198637|NCT00546117|468686322|FG001|Overall Study|Withdrawal by Subject|0|||
130198638|NCT00546117|468686321|FG000|Overall Study|Inability to schedule follow-up visit|1|||
130198639|NCT00546117|468686322|FG001|Overall Study|Inability to schedule follow-up visit|0|||
130198640|NCT01424514|468686323|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
130198641|NCT01424514|468686324|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
130198642|NCT01424514|468686323|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
130198643|NCT01424514|468686324|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
130198644|NCT02487771|468686327|FG000|Overall Study|Lost to Follow-up|2|||
130198645|NCT02487771|468686328|FG001|Overall Study|Lost to Follow-up|3|||
130198646|NCT02487771|468686327|FG000|Overall Study|Moved out of area|5|||
130198647|NCT02487771|468686328|FG001|Overall Study|Moved out of area|6|||
130198648|NCT02487771|468686327|FG000|Overall Study|Withdrawal by Subject|3|||
130198649|NCT02487771|468686328|FG001|Overall Study|Withdrawal by Subject|5|||
130198650|NCT02653170|468686329|FG000|Overall Study|Withdrawal by Subject|3|||
130198651|NCT02653170|468686330|FG001|Overall Study|Withdrawal by Subject|8|||
130198652|NCT02653170|468686331|FG002|Overall Study|Withdrawal by Subject|3|||
130198653|NCT02653170|468686329|FG000|Overall Study|withdrawn by study team|2|||
130198654|NCT02653170|468686330|FG001|Overall Study|withdrawn by study team|4|||
130198655|NCT02653170|468686331|FG002|Overall Study|withdrawn by study team|5|||
130198656|NCT02653170|468686329|FG000|Overall Study|Lost to Follow-up|12|||
130198657|NCT02653170|468686330|FG001|Overall Study|Lost to Follow-up|4|||
130198658|NCT02653170|468686331|FG002|Overall Study|Lost to Follow-up|10|||
130198659|NCT04984278|468686342|FG000|Period 1|Withdrawal by Subject|1|||
130198660|NCT04984278|468686343|FG001|Period 1|Withdrawal by Subject|0|||
130198661|NCT04984278|468686342|FG000|Period 1|Other|0|||
130198662|NCT04984278|468686343|FG001|Period 1|Other|1|||
130198663|NCT04984278|468686342|FG000|Period 2|Adverse Event|1|||
130198664|NCT04984278|468686343|FG001|Period 2|Adverse Event|0|||
130198665|NCT04984278|468686342|FG000|Period 2|Other|0|||
130198666|NCT04984278|468686343|FG001|Period 2|Other|1|||
130198667|NCT04304235|468686344|FG000|Overall Study|incomplete triage data|0|||
130198668|NCT04304235|468686345|FG001|Overall Study|incomplete triage data|69|||
130198669|NCT04304235|468686346|FG002|Overall Study|incomplete triage data|0|||
130198670|NCT04304235|468686347|FG003|Overall Study|incomplete triage data|0|||
130198671|NCT04304235|468686348|FG004|Overall Study|incomplete triage data|289|||
130198672|NCT04304235|468686349|FG005|Overall Study|incomplete triage data|123|||
130198673|NCT04304235|468686350|FG006|Overall Study|incomplete triage data|65|||
130198674|NCT00425061|468686351|FG000|Overall Study|Adverse Event|1|||
130198675|NCT00425061|468686352|FG001|Overall Study|Adverse Event|0|||
130198676|NCT00425061|468686353|FG002|Overall Study|Adverse Event|0|||
130198677|NCT00425061|468686354|FG003|Overall Study|Adverse Event|2|||
130198678|NCT00425061|468686355|FG004|Overall Study|Adverse Event|2|||
130198679|NCT00425061|468686356|FG005|Overall Study|Adverse Event|0|||
130198680|NCT00425061|468686357|FG006|Overall Study|Adverse Event|0|||
130198681|NCT00425061|468686351|FG000|Overall Study|Lost to Follow-up|0|||
130198682|NCT00425061|468686352|FG001|Overall Study|Lost to Follow-up|1|||
130198683|NCT00425061|468686353|FG002|Overall Study|Lost to Follow-up|0|||
130198684|NCT00425061|468686354|FG003|Overall Study|Lost to Follow-up|0|||
130198685|NCT00425061|468686355|FG004|Overall Study|Lost to Follow-up|0|||
130198686|NCT00425061|468686356|FG005|Overall Study|Lost to Follow-up|0|||
130198687|NCT00425061|468686357|FG006|Overall Study|Lost to Follow-up|0|||
130198688|NCT00425061|468686351|FG000|Overall Study|Protocol Violation|1|||
130198689|NCT00425061|468686352|FG001|Overall Study|Protocol Violation|0|||
130198690|NCT00425061|468686353|FG002|Overall Study|Protocol Violation|0|||
130198691|NCT00425061|468686354|FG003|Overall Study|Protocol Violation|0|||
130198692|NCT00425061|468686355|FG004|Overall Study|Protocol Violation|0|||
130198693|NCT00425061|468686356|FG005|Overall Study|Protocol Violation|0|||
130198694|NCT00425061|468686357|FG006|Overall Study|Protocol Violation|0|||
130198695|NCT00425061|468686351|FG000|Overall Study|Withdrawal by Subject|0|||
130198696|NCT00425061|468686352|FG001|Overall Study|Withdrawal by Subject|1|||
130198697|NCT00425061|468686353|FG002|Overall Study|Withdrawal by Subject|0|||
130198698|NCT00425061|468686354|FG003|Overall Study|Withdrawal by Subject|0|||
130198699|NCT00425061|468686355|FG004|Overall Study|Withdrawal by Subject|1|||
130198700|NCT00425061|468686356|FG005|Overall Study|Withdrawal by Subject|0|||
130198701|NCT00425061|468686357|FG006|Overall Study|Withdrawal by Subject|3|||
130198702|NCT00425061|468686351|FG000|Overall Study|Sponsor's request|0|||
130198703|NCT00425061|468686352|FG001|Overall Study|Sponsor's request|0|||
130198704|NCT00425061|468686353|FG002|Overall Study|Sponsor's request|0|||
130198705|NCT00425061|468686354|FG003|Overall Study|Sponsor's request|0|||
130198706|NCT00425061|468686355|FG004|Overall Study|Sponsor's request|19|||
130198707|NCT00425061|468686356|FG005|Overall Study|Sponsor's request|4|||
130198708|NCT00425061|468686357|FG006|Overall Study|Sponsor's request|15|||
130198709|NCT00425061|468686351|FG000|Overall Study|Physician Decision|0|||
130198710|NCT00425061|468686352|FG001|Overall Study|Physician Decision|0|||
130198711|NCT00425061|468686353|FG002|Overall Study|Physician Decision|0|||
130198712|NCT00425061|468686354|FG003|Overall Study|Physician Decision|0|||
130198713|NCT00425061|468686355|FG004|Overall Study|Physician Decision|1|||
130198714|NCT00425061|468686356|FG005|Overall Study|Physician Decision|0|||
130198715|NCT00425061|468686357|FG006|Overall Study|Physician Decision|0|||
130198716|NCT00425061|468686351|FG000|Overall Study|Other|0|||
130198717|NCT00425061|468686352|FG001|Overall Study|Other|0|||
130198718|NCT00425061|468686353|FG002|Overall Study|Other|0|||
130198719|NCT00425061|468686354|FG003|Overall Study|Other|0|||
130198720|NCT00425061|468686355|FG004|Overall Study|Other|3|||
130198721|NCT00425061|468686356|FG005|Overall Study|Other|0|||
130198722|NCT00425061|468686357|FG006|Overall Study|Other|1|||
130198723|NCT04720911|468686360|FG000|Overall Study|Withdrawal by Subject|0|||
130198724|NCT04720911|468686361|FG001|Overall Study|Withdrawal by Subject|1|||
130198725|NCT04720911|468686362|FG002|Overall Study|Withdrawal by Subject|0|||
130198726|NCT00090220|468686363|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
130198727|NCT00090220|468686364|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
130198728|NCT00090220|468686365|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198729|NCT00090220|468686366|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198730|NCT00090220|468686367|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198731|NCT00090220|468686368|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
130198732|NCT00090220|468686363|FG000|Base Study Vaccination Period|Adverse Event|6|||
130198733|NCT00090220|468686364|FG001|Base Study Vaccination Period|Adverse Event|1|||
130198734|NCT00090220|468686365|FG002|Base Study Vaccination Period|Adverse Event|0|||
130198735|NCT00090220|468686366|FG003|Base Study Vaccination Period|Adverse Event|0|||
130198736|NCT00090220|468686367|FG004|Base Study Vaccination Period|Adverse Event|0|||
130198737|NCT00090220|468686368|FG005|Base Study Vaccination Period|Adverse Event|0|||
130198738|NCT00090220|468686363|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
130198739|NCT00090220|468686364|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
130198740|NCT00090220|468686365|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
130198741|NCT00090220|468686366|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
130198742|NCT00090220|468686367|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
130198743|NCT00090220|468686368|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
130198744|NCT00090220|468686363|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
130198745|NCT00090220|468686364|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
130198746|NCT00090220|468686365|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198747|NCT00090220|468686366|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198748|NCT00090220|468686367|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198749|NCT00090220|468686368|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
130198750|NCT00090220|468686363|FG000|Base Study Vaccination Period|Patient Moved|6|||
130198751|NCT00090220|468686364|FG001|Base Study Vaccination Period|Patient Moved|2|||
130198752|NCT00090220|468686365|FG002|Base Study Vaccination Period|Patient Moved|0|||
130198753|NCT00090220|468686366|FG003|Base Study Vaccination Period|Patient Moved|0|||
130198754|NCT00090220|468686367|FG004|Base Study Vaccination Period|Patient Moved|0|||
130198755|NCT00090220|468686368|FG005|Base Study Vaccination Period|Patient Moved|0|||
130198756|NCT00090220|468686363|FG000|Base Study Vaccination Period|Other|4|||
130198757|NCT00090220|468686364|FG001|Base Study Vaccination Period|Other|4|||
130198758|NCT00090220|468686365|FG002|Base Study Vaccination Period|Other|0|||
130198759|NCT00090220|468686366|FG003|Base Study Vaccination Period|Other|0|||
130198760|NCT00090220|468686367|FG004|Base Study Vaccination Period|Other|0|||
130198761|NCT00090220|468686368|FG005|Base Study Vaccination Period|Other|0|||
130198762|NCT00090220|468686363|FG000|Base Study Follow-up Period|Adverse Event|6|||
130198763|NCT00090220|468686364|FG001|Base Study Follow-up Period|Adverse Event|1|||
130198764|NCT00090220|468686365|FG002|Base Study Follow-up Period|Adverse Event|0|||
130198765|NCT00090220|468686366|FG003|Base Study Follow-up Period|Adverse Event|0|||
130198766|NCT00090220|468686367|FG004|Base Study Follow-up Period|Adverse Event|0|||
130198767|NCT00090220|468686368|FG005|Base Study Follow-up Period|Adverse Event|0|||
130198768|NCT00090220|468686363|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
130198769|NCT00090220|468686364|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
130198770|NCT00090220|468686365|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
130198771|NCT00090220|468686366|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
130198772|NCT00090220|468686367|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
130198773|NCT00090220|468686368|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
130198774|NCT00090220|468686363|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
130198775|NCT00090220|468686364|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
130198776|NCT00090220|468686365|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198777|NCT00090220|468686366|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198778|NCT00090220|468686367|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198779|NCT00090220|468686368|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
130198780|NCT00090220|468686363|FG000|Base Study Follow-up Period|Patient Moved|20|||
130198781|NCT00090220|468686364|FG001|Base Study Follow-up Period|Patient Moved|28|||
130198782|NCT00090220|468686365|FG002|Base Study Follow-up Period|Patient Moved|0|||
130198783|NCT00090220|468686366|FG003|Base Study Follow-up Period|Patient Moved|0|||
130198784|NCT00090220|468686367|FG004|Base Study Follow-up Period|Patient Moved|0|||
130198785|NCT00090220|468686368|FG005|Base Study Follow-up Period|Patient Moved|0|||
130198786|NCT00090220|468686363|FG000|Base Study Follow-up Period|Other|19|||
130198787|NCT00090220|468686364|FG001|Base Study Follow-up Period|Other|21|||
130198788|NCT00090220|468686365|FG002|Base Study Follow-up Period|Other|0|||
130198789|NCT00090220|468686366|FG003|Base Study Follow-up Period|Other|0|||
130198790|NCT00090220|468686367|FG004|Base Study Follow-up Period|Other|0|||
130198791|NCT00090220|468686368|FG005|Base Study Follow-up Period|Other|0|||
130198792|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Adverse Event|0|||
130198793|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Adverse Event|0|||
130198794|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Adverse Event|4|||
130198795|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Adverse Event|0|||
130198796|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Adverse Event|0|||
130198797|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Adverse Event|0|||
130198798|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198799|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198800|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
130198801|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198802|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198803|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
130198804|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Moved|0|||
130198805|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Moved|0|||
130198806|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Moved|2|||
130198807|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Moved|1|||
130198808|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Moved|0|||
130198809|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Moved|0|||
130198810|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198811|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198812|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
130198813|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198814|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198815|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
130198816|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
130198817|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
130198818|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
130198819|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
130198820|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
130198821|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
130198822|NCT00090220|468686363|FG000|Extension 1 (EXT1)|Other reason|0|||
130198823|NCT00090220|468686364|FG001|Extension 1 (EXT1)|Other reason|0|||
130198824|NCT00090220|468686365|FG002|Extension 1 (EXT1)|Other reason|2|||
130198825|NCT00090220|468686366|FG003|Extension 1 (EXT1)|Other reason|0|||
130198826|NCT00090220|468686367|FG004|Extension 1 (EXT1)|Other reason|0|||
130198827|NCT00090220|468686368|FG005|Extension 1 (EXT1)|Other reason|0|||
130198828|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198829|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198830|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198831|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
130198832|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
130198833|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
130198834|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Death|0|||
130198835|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Death|0|||
130198836|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Death|0|||
130198837|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Death|0|||
130198838|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Death|1|||
130198839|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Death|1|||
130198840|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198841|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198842|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198843|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
130198844|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
130198845|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
130198846|NCT00090220|468686363|FG000|Long-term Follow-up (EXT2)|Other|0|||
130198847|NCT00090220|468686364|FG001|Long-term Follow-up (EXT2)|Other|0|||
130198848|NCT00090220|468686365|FG002|Long-term Follow-up (EXT2)|Other|0|||
130198849|NCT00090220|468686366|FG003|Long-term Follow-up (EXT2)|Other|0|||
130198850|NCT00090220|468686367|FG004|Long-term Follow-up (EXT2)|Other|1|||
130198851|NCT00090220|468686368|FG005|Long-term Follow-up (EXT2)|Other|0|||
130198852|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
130198853|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
130198854|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
130198855|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
130198856|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
130198857|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
130198858|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
130198859|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
130198860|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
130198861|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
130198862|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
130198863|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
130198864|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
130198865|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
130198866|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
130198867|NCT02137850|468686369|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
130198868|NCT02137850|468686370|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
130198869|NCT02137850|468686371|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
130198870|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198871|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
130198872|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198873|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
130198874|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
130198875|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
130198876|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
130198877|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
130198878|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
130198879|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
130198880|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
130198881|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
130198882|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Other|0|||
130198883|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Other|1|||
130198884|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Other|0|||
130198885|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
130198886|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
130198887|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
130198888|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Early site closure|0|||
130198889|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Early site closure|2|||
130198890|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Early site closure|0|||
130198891|NCT02137850|468686369|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
130198892|NCT02137850|468686370|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
130198893|NCT02137850|468686371|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
130198894|NCT02137850|468686369|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
130198895|NCT02137850|468686370|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
130198896|NCT02137850|468686371|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
130198897|NCT02137850|468686369|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
130198898|NCT02137850|468686370|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
130198899|NCT02137850|468686371|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
130198900|NCT02137850|468686369|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
130198901|NCT02137850|468686370|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
130198902|NCT02137850|468686371|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
130198903|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
130198904|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
130198905|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
130198906|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
130198907|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
130198908|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
130198909|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198910|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
130198911|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
130198912|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Other|0|||
130198913|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Other|1|||
130198914|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Other|0|||
130198915|NCT02137850|468686369|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
130198916|NCT02137850|468686370|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
130198917|NCT02137850|468686371|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
130198918|NCT00537316|468686372|FG000|Part 1|Adverse Event|7|||
130198919|NCT00537316|468686373|FG001|Part 1|Adverse Event|11|||
130198920|NCT00537316|468686374|FG002|Part 1|Adverse Event|8|||
130198921|NCT00537316|468686375|FG003|Part 1|Adverse Event|0|||
130198922|NCT00537316|468686376|FG004|Part 1|Adverse Event|0|||
130198923|NCT00537316|468686377|FG005|Part 1|Adverse Event|0|||
130198924|NCT00537316|468686378|FG006|Part 1|Adverse Event|0|||
130198925|NCT00537316|468686372|FG000|Part 1|Protocol defined clinical event|1|||
130198926|NCT00537316|468686373|FG001|Part 1|Protocol defined clinical event|0|||
130198927|NCT00537316|468686374|FG002|Part 1|Protocol defined clinical event|0|||
130198928|NCT00537316|468686375|FG003|Part 1|Protocol defined clinical event|0|||
130198929|NCT00537316|468686376|FG004|Part 1|Protocol defined clinical event|0|||
130198930|NCT00537316|468686377|FG005|Part 1|Protocol defined clinical event|0|||
130198931|NCT00537316|468686378|FG006|Part 1|Protocol defined clinical event|0|||
130198932|NCT00537316|468686372|FG000|Part 1|Lost to Follow-up|1|||
130198933|NCT00537316|468686373|FG001|Part 1|Lost to Follow-up|0|||
130198934|NCT00537316|468686374|FG002|Part 1|Lost to Follow-up|0|||
130198935|NCT00537316|468686375|FG003|Part 1|Lost to Follow-up|0|||
130198936|NCT00537316|468686376|FG004|Part 1|Lost to Follow-up|0|||
130198937|NCT00537316|468686377|FG005|Part 1|Lost to Follow-up|0|||
130198938|NCT00537316|468686378|FG006|Part 1|Lost to Follow-up|0|||
130198939|NCT00537316|468686372|FG000|Part 1|Withdrawal by Subject|3|||
130198940|NCT00537316|468686373|FG001|Part 1|Withdrawal by Subject|8|||
130198941|NCT00537316|468686374|FG002|Part 1|Withdrawal by Subject|4|||
130198942|NCT00537316|468686375|FG003|Part 1|Withdrawal by Subject|0|||
130198943|NCT00537316|468686376|FG004|Part 1|Withdrawal by Subject|0|||
130198944|NCT00537316|468686377|FG005|Part 1|Withdrawal by Subject|0|||
130198945|NCT00537316|468686378|FG006|Part 1|Withdrawal by Subject|0|||
130198946|NCT00537316|468686372|FG000|Part 1|Protocol Violation|1|||
130198947|NCT00537316|468686373|FG001|Part 1|Protocol Violation|5|||
130198948|NCT00537316|468686374|FG002|Part 1|Protocol Violation|1|||
130198949|NCT00537316|468686375|FG003|Part 1|Protocol Violation|0|||
130198950|NCT00537316|468686376|FG004|Part 1|Protocol Violation|0|||
130198951|NCT00537316|468686377|FG005|Part 1|Protocol Violation|0|||
130198952|NCT00537316|468686378|FG006|Part 1|Protocol Violation|0|||
130198953|NCT00537316|468686372|FG000|Part 1|Did not meet protocol eligibility|1|||
130198954|NCT00537316|468686373|FG001|Part 1|Did not meet protocol eligibility|3|||
130198955|NCT00537316|468686374|FG002|Part 1|Did not meet protocol eligibility|2|||
130198956|NCT00537316|468686375|FG003|Part 1|Did not meet protocol eligibility|0|||
130198957|NCT00537316|468686376|FG004|Part 1|Did not meet protocol eligibility|0|||
130198958|NCT00537316|468686377|FG005|Part 1|Did not meet protocol eligibility|0|||
130198959|NCT00537316|468686378|FG006|Part 1|Did not meet protocol eligibility|0|||
130198960|NCT00537316|468686372|FG000|Part 1|Administrative|0|||
130198961|NCT00537316|468686373|FG001|Part 1|Administrative|0|||
130198962|NCT00537316|468686374|FG002|Part 1|Administrative|2|||
130198963|NCT00537316|468686375|FG003|Part 1|Administrative|0|||
130198964|NCT00537316|468686376|FG004|Part 1|Administrative|0|||
130198965|NCT00537316|468686377|FG005|Part 1|Administrative|0|||
130198966|NCT00537316|468686378|FG006|Part 1|Administrative|0|||
130198967|NCT00537316|468686372|FG000|Part 2|Never entered follow-up|0|||
130198968|NCT00537316|468686373|FG001|Part 2|Never entered follow-up|0|||
130198969|NCT00537316|468686374|FG002|Part 2|Never entered follow-up|0|||
130198970|NCT00537316|468686375|FG003|Part 2|Never entered follow-up|0|||
130198971|NCT00537316|468686376|FG004|Part 2|Never entered follow-up|0|||
130198972|NCT00537316|468686377|FG005|Part 2|Never entered follow-up|0|||
130198973|NCT00537316|468686378|FG006|Part 2|Never entered follow-up|1|||
130198974|NCT00537316|468686372|FG000|Part 2|Adverse Event|4|||
130198975|NCT00537316|468686373|FG001|Part 2|Adverse Event|0|||
130198976|NCT00537316|468686374|FG002|Part 2|Adverse Event|2|||
130198977|NCT00537316|468686375|FG003|Part 2|Adverse Event|0|||
130198978|NCT00537316|468686376|FG004|Part 2|Adverse Event|0|||
130198979|NCT00537316|468686377|FG005|Part 2|Adverse Event|0|||
130198980|NCT00537316|468686378|FG006|Part 2|Adverse Event|0|||
130198981|NCT00537316|468686372|FG000|Part 2|Lost to Follow-up|1|||
130198982|NCT00537316|468686373|FG001|Part 2|Lost to Follow-up|0|||
130198983|NCT00537316|468686374|FG002|Part 2|Lost to Follow-up|2|||
130198984|NCT00537316|468686375|FG003|Part 2|Lost to Follow-up|0|||
130198985|NCT00537316|468686376|FG004|Part 2|Lost to Follow-up|0|||
130198986|NCT00537316|468686377|FG005|Part 2|Lost to Follow-up|0|||
130198987|NCT00537316|468686378|FG006|Part 2|Lost to Follow-up|0|||
130198988|NCT00537316|468686372|FG000|Part 2|Withdrawal by Subject|5|||
130198989|NCT00537316|468686373|FG001|Part 2|Withdrawal by Subject|1|||
130198990|NCT00537316|468686374|FG002|Part 2|Withdrawal by Subject|4|||
130198991|NCT00537316|468686375|FG003|Part 2|Withdrawal by Subject|0|||
130198992|NCT00537316|468686376|FG004|Part 2|Withdrawal by Subject|0|||
130198993|NCT00537316|468686377|FG005|Part 2|Withdrawal by Subject|0|||
130198994|NCT00537316|468686378|FG006|Part 2|Withdrawal by Subject|0|||
130198995|NCT00537316|468686372|FG000|Part 2|Administrative|16|||
130198996|NCT00537316|468686373|FG001|Part 2|Administrative|8|||
130198997|NCT00537316|468686374|FG002|Part 2|Administrative|24|||
130198998|NCT00537316|468686375|FG003|Part 2|Administrative|3|||
130198999|NCT00537316|468686376|FG004|Part 2|Administrative|1|||
130199000|NCT00537316|468686377|FG005|Part 2|Administrative|4|||
130199001|NCT00537316|468686378|FG006|Part 2|Administrative|1|||
130199002|NCT02651155|468686379|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
130199003|NCT02651155|468686380|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
130199004|NCT02651155|468686379|FG000|Overall Study|Voluntary Withdrawal|5|||
130199005|NCT02651155|468686380|FG001|Overall Study|Voluntary Withdrawal|0|||
130199006|NCT01609543|468686383|FG000|Overall Study|Disease Progression|28|||
130199007|NCT01609543|468686383|FG000|Overall Study|Adverse Event|5|||
130199008|NCT01609543|468686383|FG000|Overall Study|Withdrawal by Subject|1|||
130199009|NCT01609543|468686383|FG000|Overall Study|Protocol Violation|1|||
130199010|NCT01609543|468686383|FG000|Overall Study|Death|7|||
130199011|NCT00507819|468686384|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
130199012|NCT00507819|468686385|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
130199013|NCT03452488|468686387|FG000|Overall Study|Adverse Event|4|||
130199014|NCT03452488|468686388|FG001|Overall Study|Adverse Event|6|||
130199015|NCT03452488|468686389|FG002|Overall Study|Adverse Event|1|||
130199016|NCT03452488|468686387|FG000|Overall Study|Death|0|||
130199017|NCT03452488|468686388|FG001|Overall Study|Death|0|||
130199018|NCT03452488|468686389|FG002|Overall Study|Death|1|||
130199019|NCT03452488|468686387|FG000|Overall Study|Lost to Follow-up|1|||
130199020|NCT03452488|468686388|FG001|Overall Study|Lost to Follow-up|2|||
130199021|NCT03452488|468686389|FG002|Overall Study|Lost to Follow-up|0|||
130199022|NCT03452488|468686387|FG000|Overall Study|PI Decision|1|||
130199023|NCT03452488|468686388|FG001|Overall Study|PI Decision|0|||
130199024|NCT03452488|468686389|FG002|Overall Study|PI Decision|0|||
130199025|NCT03452488|468686387|FG000|Overall Study|Withdrew consent|4|||
130199026|NCT03452488|468686388|FG001|Overall Study|Withdrew consent|2|||
130199027|NCT03452488|468686389|FG002|Overall Study|Withdrew consent|2|||
130199028|NCT03452488|468686387|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
130199029|NCT03452488|468686388|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
130199030|NCT03452488|468686389|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
130199031|NCT03452488|468686387|FG000|Overall Study|Other|0|||
130199032|NCT03452488|468686388|FG001|Overall Study|Other|2|||
130199033|NCT03452488|468686389|FG002|Overall Study|Other|2|||
130199034|NCT01254318|468686394|FG000|Overall Study|Lost to Follow-up|5|||
130199035|NCT01254318|468686394|FG000|Overall Study|Death|47|||
130199036|NCT00330343|468686397|FG000|Overall Study|Lost to Follow-up|5|||
130199037|NCT01992653|468686398|FG000|Overall Study|Death|0|||
130199038|NCT01992653|468686399|FG001|Overall Study|Death|0|||
130199039|NCT01992653|468686400|FG002|Overall Study|Death|1|||
130199040|NCT01992653|468686401|FG003|Overall Study|Death|0|||
130199041|NCT01992653|468686402|FG004|Overall Study|Death|1|||
130199042|NCT01992653|468686403|FG005|Overall Study|Death|0|||
130199043|NCT01992653|468686404|FG006|Overall Study|Death|4|||
130199044|NCT01992653|468686405|FG007|Overall Study|Death|2|||
130199045|NCT01992653|468686398|FG000|Overall Study|Lost to Follow-up|0|||
130199046|NCT01992653|468686399|FG001|Overall Study|Lost to Follow-up|0|||
130199047|NCT01992653|468686400|FG002|Overall Study|Lost to Follow-up|0|||
130199048|NCT01992653|468686401|FG003|Overall Study|Lost to Follow-up|0|||
130199049|NCT01992653|468686402|FG004|Overall Study|Lost to Follow-up|0|||
130199050|NCT01992653|468686403|FG005|Overall Study|Lost to Follow-up|0|||
130199051|NCT01992653|468686404|FG006|Overall Study|Lost to Follow-up|0|||
130199052|NCT01992653|468686405|FG007|Overall Study|Lost to Follow-up|1|||
130199053|NCT01992653|468686398|FG000|Overall Study|Study Completed|0|||
130199054|NCT01992653|468686399|FG001|Overall Study|Study Completed|0|||
130199055|NCT01992653|468686400|FG002|Overall Study|Study Completed|0|||
130199056|NCT01992653|468686401|FG003|Overall Study|Study Completed|0|||
130199057|NCT01992653|468686402|FG004|Overall Study|Study Completed|0|||
130199058|NCT01992653|468686403|FG005|Overall Study|Study Completed|0|||
130199059|NCT01992653|468686404|FG006|Overall Study|Study Completed|0|||
130199060|NCT01992653|468686405|FG007|Overall Study|Study Completed|1|||
130199061|NCT01992653|468686398|FG000|Overall Study|Disease Progression|0|||
130199062|NCT01992653|468686399|FG001|Overall Study|Disease Progression|0|||
130199063|NCT01992653|468686400|FG002|Overall Study|Disease Progression|0|||
130199064|NCT01992653|468686401|FG003|Overall Study|Disease Progression|0|||
130199065|NCT01992653|468686402|FG004|Overall Study|Disease Progression|0|||
130199066|NCT01992653|468686403|FG005|Overall Study|Disease Progression|0|||
130199067|NCT01992653|468686404|FG006|Overall Study|Disease Progression|4|||
130199068|NCT01992653|468686405|FG007|Overall Study|Disease Progression|0|||
130199069|NCT02964208|468686408|FG000|Overall Study|Death|103|||
130199070|NCT02964208|468686408|FG000|Overall Study|Withdrawal by Subject|6|||
130199071|NCT02964208|468686408|FG000|Overall Study|Lost to Follow-up|6|||
130199072|NCT02964208|468686408|FG000|Overall Study|Unsuccessful Procedure|5|||
130199073|NCT02964208|468686408|FG000|Overall Study|Device Explant|1|||
130199074|NCT02964208|468686408|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
130199075|NCT01743560|468686409|FG000|Overall Study|Disease progression|26|||
130199076|NCT01743560|468686409|FG000|Overall Study|Adverse Event|8|||
130199077|NCT01743560|468686409|FG000|Overall Study|Death|3|||
130199078|NCT01743560|468686409|FG000|Overall Study|Withdrawal by Subject|2|||
130199079|NCT01743560|468686409|FG000|Overall Study|Protocol Violation|1|||
130199080|NCT01743560|468686409|FG000|Overall Study|>1 dose of study drug|3|||
130199081|NCT03226769|468686410|FG000|Overall Study|Withdrawal by Subject|0|||
130199082|NCT03226769|468686411|FG001|Overall Study|Withdrawal by Subject|1|||
130199083|NCT00940823|468686412|FG000|Overall Study|Death|8|||
130199084|NCT00940823|468686413|FG001|Overall Study|Death|12|||
130199085|NCT00940823|468686412|FG000|Overall Study|Lost to Follow-up|27|||
130199086|NCT00940823|468686413|FG001|Overall Study|Lost to Follow-up|20|||
130199087|NCT01758731|468686414|FG000|Overall Study|Physician Decision|1|||
130199088|NCT05270395|468686427|FG000|Overall Study|Lost to Follow-up|2|||
130199089|NCT05270395|468686428|FG001|Overall Study|Lost to Follow-up|2|||
130199090|NCT05270395|468686427|FG000|Overall Study|Death|1|||
130199091|NCT05270395|468686428|FG001|Overall Study|Death|2|||
130199092|NCT05270395|468686427|FG000|Overall Study|Study Team Withdrew|1|||
130199093|NCT05270395|468686428|FG001|Overall Study|Study Team Withdrew|0|||
130199094|NCT00199797|468688197|FG000|Overall Study|Progressive Disease|1|||
130199095|NCT00199797|468688197|FG000|Overall Study|Adverse Event|1|||
130199096|NCT00199797|468688197|FG000|Overall Study|Physician Decision|1|||
130199097|NCT04250350|468688203|FG000|Overall Study|Withdrawal by Subject|13|||
130199098|NCT04250350|468688203|FG000|Overall Study|Lost to Follow-up|8|||
130199099|NCT04250350|468688203|FG000|Overall Study|Adverse Event|5|||
130199100|NCT04250350|468688203|FG000|Overall Study|Lack of Efficacy|4|||
130199101|NCT04250350|468688203|FG000|Overall Study|Physician Decision|1|||
130199102|NCT04250350|468688203|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
130199103|NCT00784550|468688204|FG000|Overall Study|Adverse Event|12|||
130199104|NCT00784550|468688205|FG001|Overall Study|Adverse Event|10|||
130199105|NCT00784550|468688204|FG000|Overall Study|Lack of Efficacy|0|||
130199106|NCT00784550|468688205|FG001|Overall Study|Lack of Efficacy|1|||
130199107|NCT00784550|468688204|FG000|Overall Study|Protocol Violation|10|||
130199108|NCT00784550|468688205|FG001|Overall Study|Protocol Violation|10|||
130199109|NCT00784550|468688204|FG000|Overall Study|Lost to Follow-up|8|||
130199110|NCT00784550|468688205|FG001|Overall Study|Lost to Follow-up|5|||
130199111|NCT00784550|468688204|FG000|Overall Study|Physician Decision|2|||
130199112|NCT00784550|468688205|FG001|Overall Study|Physician Decision|3|||
130199113|NCT00784550|468688204|FG000|Overall Study|Withdrawal by Subject|4|||
130199114|NCT00784550|468688205|FG001|Overall Study|Withdrawal by Subject|13|||
130199115|NCT00688701|468688206|FG000|Overall Study|Adverse Event|1|||
130199116|NCT00688701|468688207|FG001|Overall Study|Adverse Event|0|||
130199117|NCT00688701|468688208|FG002|Overall Study|Adverse Event|5|||
130199118|NCT00688701|468688209|FG003|Overall Study|Adverse Event|3|||
130199119|NCT00688701|468688206|FG000|Overall Study|Lack of Efficacy|0|||
130199120|NCT00688701|468688207|FG001|Overall Study|Lack of Efficacy|1|||
130199121|NCT00688701|468688208|FG002|Overall Study|Lack of Efficacy|0|||
130199122|NCT00688701|468688209|FG003|Overall Study|Lack of Efficacy|0|||
130199123|NCT00688701|468688206|FG000|Overall Study|Withdrawal by Subject|3|||
130199124|NCT00688701|468688207|FG001|Overall Study|Withdrawal by Subject|3|||
130199125|NCT00688701|468688208|FG002|Overall Study|Withdrawal by Subject|4|||
130199126|NCT00688701|468688209|FG003|Overall Study|Withdrawal by Subject|8|||
130199127|NCT00688701|468688206|FG000|Overall Study|Poor compliance to protocol|0|||
130199128|NCT00688701|468688207|FG001|Overall Study|Poor compliance to protocol|1|||
130199129|NCT00688701|468688208|FG002|Overall Study|Poor compliance to protocol|1|||
130199130|NCT00688701|468688209|FG003|Overall Study|Poor compliance to protocol|0|||
130199131|NCT03875092|468688221|FG000|Overall Study|Adverse Event|2|||
130199132|NCT03875092|468688222|FG001|Overall Study|Adverse Event|5|||
130199133|NCT03875092|468688221|FG000|Overall Study|Death|44|||
130199134|NCT03875092|468688222|FG001|Overall Study|Death|51|||
130199135|NCT03875092|468688221|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
130199136|NCT03875092|468688222|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
130199137|NCT03205761|468688223|FG000|Overall Study|Withdrawal by Subject|1|||
130199138|NCT03205761|468688223|FG000|Overall Study|Progressive Disease|10|||
130199139|NCT04420585|468688224|FG000|Overall Study|Adverse Event|1|||
130199140|NCT04420585|468688224|FG000|Overall Study|Never initiated medication|2|||
130199141|NCT02163226|468688225|FG000|Overall Study|Death|2|||
130199142|NCT02163226|468688226|FG001|Overall Study|Death|1|||
130199143|NCT02163226|468688225|FG000|Overall Study|Withdrawal by Subject|5|||
130199144|NCT02163226|468688226|FG001|Overall Study|Withdrawal by Subject|2|||
130199145|NCT02163226|468688225|FG000|Overall Study|Returned home, local radiotherapy|3|||
130199146|NCT02163226|468688226|FG001|Overall Study|Returned home, local radiotherapy|0|||
130199147|NCT02163226|468688225|FG000|Overall Study|Repeat imaging showed no disease|2|||
130199148|NCT02163226|468688226|FG001|Overall Study|Repeat imaging showed no disease|0|||
130199149|NCT02163226|468688225|FG000|Overall Study|Incomplete radiotherapy|3|||
130199150|NCT02163226|468688226|FG001|Overall Study|Incomplete radiotherapy|0|||
130199151|NCT02163226|468688225|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
130199152|NCT02163226|468688226|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
130199153|NCT02163226|468688225|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
130199154|NCT02163226|468688226|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
130199155|NCT02163226|468688225|FG000|Overall Study|ineligible|0|||
130199156|NCT02163226|468688226|FG001|Overall Study|ineligible|3|||
130199157|NCT04114357|468688227|FG000|Baseline-Randomization|Adverse Event|2|||
130199158|NCT04114357|468688228|FG001|Baseline-Randomization|Adverse Event|1|||
130199159|NCT04114357|468688227|FG000|Baseline-Randomization|Lost to Follow-up|1|||
130199160|NCT04114357|468688228|FG001|Baseline-Randomization|Lost to Follow-up|1|||
130199161|NCT04114357|468688227|FG000|Cross-over|Adverse Event|0|||
130199162|NCT04114357|468688228|FG001|Cross-over|Adverse Event|1|||
130199163|NCT03558152|468688229|FG000|Overall Study|Adverse Event|0|||
130199164|NCT03558152|468688230|FG001|Overall Study|Adverse Event|0|||
130199165|NCT03558152|468688231|FG002|Overall Study|Adverse Event|1|||
130199166|NCT03558152|468688232|FG003|Overall Study|Adverse Event|1|||
130199167|NCT03558152|468688233|FG004|Overall Study|Adverse Event|2|||
130199168|NCT03558152|468688234|FG005|Overall Study|Adverse Event|1|||
130199169|NCT03558152|468688235|FG006|Overall Study|Adverse Event|1|||
130199170|NCT03558152|468688236|FG007|Overall Study|Adverse Event|0|||
130199171|NCT03558152|468688229|FG000|Overall Study|Death|0|||
130199172|NCT03558152|468688230|FG001|Overall Study|Death|0|||
130199173|NCT03558152|468688231|FG002|Overall Study|Death|0|||
130199174|NCT03558152|468688232|FG003|Overall Study|Death|0|||
130199175|NCT03558152|468688233|FG004|Overall Study|Death|1|||
130199176|NCT03558152|468688234|FG005|Overall Study|Death|0|||
130199177|NCT03558152|468688235|FG006|Overall Study|Death|0|||
130199178|NCT03558152|468688236|FG007|Overall Study|Death|0|||
130199179|NCT03558152|468688229|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
130199180|NCT03558152|468688230|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199181|NCT03558152|468688231|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199182|NCT03558152|468688232|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199183|NCT03558152|468688233|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199184|NCT03558152|468688234|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199185|NCT03558152|468688235|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199186|NCT03558152|468688236|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
130199187|NCT03558152|468688229|FG000|Overall Study|Miscalculation in mmcs|0|||
130199188|NCT03558152|468688230|FG001|Overall Study|Miscalculation in mmcs|0|||
130199189|NCT03558152|468688231|FG002|Overall Study|Miscalculation in mmcs|0|||
130199190|NCT03558152|468688232|FG003|Overall Study|Miscalculation in mmcs|0|||
130199191|NCT03558152|468688233|FG004|Overall Study|Miscalculation in mmcs|0|||
130199192|NCT03558152|468688234|FG005|Overall Study|Miscalculation in mmcs|0|||
130199193|NCT03558152|468688235|FG006|Overall Study|Miscalculation in mmcs|1|||
130199194|NCT03558152|468688236|FG007|Overall Study|Miscalculation in mmcs|0|||
130199195|NCT03558152|468688229|FG000|Overall Study|Mistake in calculation|0|||
130199196|NCT03558152|468688230|FG001|Overall Study|Mistake in calculation|0|||
130199197|NCT03558152|468688231|FG002|Overall Study|Mistake in calculation|0|||
130199198|NCT03558152|468688232|FG003|Overall Study|Mistake in calculation|1|||
130199199|NCT03558152|468688233|FG004|Overall Study|Mistake in calculation|0|||
130199200|NCT03558152|468688234|FG005|Overall Study|Mistake in calculation|0|||
130199201|NCT03558152|468688235|FG006|Overall Study|Mistake in calculation|0|||
130199202|NCT03558152|468688236|FG007|Overall Study|Mistake in calculation|0|||
130199203|NCT03558152|468688229|FG000|Overall Study|Mistake in evaluation of disease status|0|||
130199204|NCT03558152|468688230|FG001|Overall Study|Mistake in evaluation of disease status|0|||
130199205|NCT03558152|468688231|FG002|Overall Study|Mistake in evaluation of disease status|0|||
130199206|NCT03558152|468688232|FG003|Overall Study|Mistake in evaluation of disease status|0|||
130199207|NCT03558152|468688233|FG004|Overall Study|Mistake in evaluation of disease status|0|||
130199208|NCT03558152|468688234|FG005|Overall Study|Mistake in evaluation of disease status|0|||
130199209|NCT03558152|468688235|FG006|Overall Study|Mistake in evaluation of disease status|0|||
130199210|NCT03558152|468688236|FG007|Overall Study|Mistake in evaluation of disease status|1|||
130199211|NCT03558152|468688229|FG000|Overall Study|Physician Decision|0|||
130199212|NCT03558152|468688230|FG001|Overall Study|Physician Decision|0|||
130199213|NCT03558152|468688231|FG002|Overall Study|Physician Decision|0|||
130199214|NCT03558152|468688232|FG003|Overall Study|Physician Decision|0|||
130199215|NCT03558152|468688233|FG004|Overall Study|Physician Decision|0|||
130199216|NCT03558152|468688234|FG005|Overall Study|Physician Decision|0|||
130199217|NCT03558152|468688235|FG006|Overall Study|Physician Decision|1|||
130199218|NCT03558152|468688236|FG007|Overall Study|Physician Decision|0|||
130199219|NCT03558152|468688229|FG000|Overall Study|Withdrawal by Subject|2|||
130199220|NCT03558152|468688230|FG001|Overall Study|Withdrawal by Subject|3|||
130199221|NCT03558152|468688231|FG002|Overall Study|Withdrawal by Subject|2|||
130199222|NCT03558152|468688232|FG003|Overall Study|Withdrawal by Subject|1|||
130199223|NCT03558152|468688233|FG004|Overall Study|Withdrawal by Subject|1|||
130199224|NCT03558152|468688234|FG005|Overall Study|Withdrawal by Subject|1|||
130199225|NCT03558152|468688235|FG006|Overall Study|Withdrawal by Subject|3|||
130199226|NCT03558152|468688236|FG007|Overall Study|Withdrawal by Subject|2|||
130199227|NCT03558152|468688229|FG000|Overall Study|Lack of Efficacy|11|||
130199228|NCT03558152|468688230|FG001|Overall Study|Lack of Efficacy|11|||
130199229|NCT03558152|468688231|FG002|Overall Study|Lack of Efficacy|10|||
130199230|NCT03558152|468688232|FG003|Overall Study|Lack of Efficacy|11|||
130199231|NCT03558152|468688233|FG004|Overall Study|Lack of Efficacy|14|||
130199232|NCT03558152|468688234|FG005|Overall Study|Lack of Efficacy|12|||
130199233|NCT03558152|468688235|FG006|Overall Study|Lack of Efficacy|14|||
130199234|NCT03558152|468688236|FG007|Overall Study|Lack of Efficacy|13|||
130199235|NCT03558152|468688229|FG000|Overall Study|Protocol Violation|1|||
130199236|NCT03558152|468688230|FG001|Overall Study|Protocol Violation|1|||
130199237|NCT03558152|468688231|FG002|Overall Study|Protocol Violation|0|||
130199238|NCT03558152|468688232|FG003|Overall Study|Protocol Violation|1|||
130199239|NCT03558152|468688233|FG004|Overall Study|Protocol Violation|1|||
130199240|NCT03558152|468688234|FG005|Overall Study|Protocol Violation|0|||
130199241|NCT03558152|468688235|FG006|Overall Study|Protocol Violation|2|||
130199242|NCT03558152|468688236|FG007|Overall Study|Protocol Violation|0|||
130199243|NCT01300338|468688242|FG000|Overall Study|Lost to Follow-up|5|||
130199244|NCT01300338|468688243|FG001|Overall Study|Lost to Follow-up|0|||
130199245|NCT00970632|468688244|FG000|Overall Study|Adverse Event|2|||
130199246|NCT00970632|468688245|FG001|Overall Study|Adverse Event|2|||
130199247|NCT00970632|468688246|FG002|Overall Study|Adverse Event|1|||
130199248|NCT00970632|468688244|FG000|Overall Study|Lack of Efficacy|3|||
130199249|NCT00970632|468688245|FG001|Overall Study|Lack of Efficacy|0|||
130199250|NCT00970632|468688246|FG002|Overall Study|Lack of Efficacy|0|||
130199251|NCT00970632|468688244|FG000|Overall Study|Lost to Follow-up|3|||
130199252|NCT00970632|468688245|FG001|Overall Study|Lost to Follow-up|0|||
130199253|NCT00970632|468688246|FG002|Overall Study|Lost to Follow-up|2|||
130199254|NCT00970632|468688244|FG000|Overall Study|Protocol Violation|8|||
130199255|NCT00970632|468688245|FG001|Overall Study|Protocol Violation|5|||
130199256|NCT00970632|468688246|FG002|Overall Study|Protocol Violation|8|||
130199257|NCT00970632|468688244|FG000|Overall Study|Withdrawal by Subject|7|||
130199258|NCT00970632|468688245|FG001|Overall Study|Withdrawal by Subject|6|||
130199259|NCT00970632|468688246|FG002|Overall Study|Withdrawal by Subject|4|||
130199260|NCT00970632|468688244|FG000|Overall Study|Entry criteria not met|0|||
130199261|NCT00970632|468688245|FG001|Overall Study|Entry criteria not met|2|||
130199262|NCT00970632|468688246|FG002|Overall Study|Entry criteria not met|2|||
130199263|NCT00970632|468688244|FG000|Overall Study|Sponsor decision|1|||
130199264|NCT00970632|468688245|FG001|Overall Study|Sponsor decision|0|||
130199265|NCT00970632|468688246|FG002|Overall Study|Sponsor decision|1|||
130199266|NCT02002533|468688253|FG000|Overall Study|Withdrawal by Subject|6|||
130199267|NCT02002533|468688254|FG001|Overall Study|Withdrawal by Subject|13|||
130199268|NCT02002533|468688253|FG000|Overall Study|Protocol Violation|0|||
130199269|NCT02002533|468688254|FG001|Overall Study|Protocol Violation|1|||
130199270|NCT02002533|468688253|FG000|Overall Study|Adverse Event|0|||
130199271|NCT02002533|468688254|FG001|Overall Study|Adverse Event|3|||
130199272|NCT02002533|468688253|FG000|Overall Study|Lost to Follow-up|0|||
130199273|NCT02002533|468688254|FG001|Overall Study|Lost to Follow-up|1|||
130199274|NCT00976820|468688257|FG000|Overall Study|Lost to Follow-up|5|||
130199275|NCT00976820|468688258|FG001|Overall Study|Lost to Follow-up|16|||
130199276|NCT00976820|468688259|FG002|Overall Study|Lost to Follow-up|2|||
130199277|NCT00976820|468688260|FG003|Overall Study|Lost to Follow-up|3|||
130199278|NCT00976820|468688257|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
130199279|NCT00976820|468688258|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
130199280|NCT00976820|468688259|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
130199281|NCT00976820|468688260|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
130199282|NCT00976820|468688257|FG000|Overall Study|Withdrawal by Subject|2|||
130199283|NCT00976820|468688258|FG001|Overall Study|Withdrawal by Subject|4|||
130199284|NCT00976820|468688259|FG002|Overall Study|Withdrawal by Subject|1|||
130199285|NCT00976820|468688260|FG003|Overall Study|Withdrawal by Subject|4|||
130199286|NCT03261674|468688261|FG000|Overall Study|Lost to Follow-up|6|||
130199287|NCT03261674|468688262|FG001|Overall Study|Lost to Follow-up|7|||
130199288|NCT03261674|468688261|FG000|Overall Study|Protocol Violation|1|||
130199289|NCT03261674|468688262|FG001|Overall Study|Protocol Violation|4|||
130199290|NCT03261674|468688261|FG000|Overall Study|Withdrawal by Subject|1|||
130199291|NCT03261674|468688262|FG001|Overall Study|Withdrawal by Subject|4|||
130199292|NCT03261674|468688261|FG000|Overall Study|Physician Decision|1|||
130199293|NCT03261674|468688262|FG001|Overall Study|Physician Decision|0|||
130199294|NCT00623935|468688263|FG000|Overall Study|Death|1|||
130199295|NCT00623935|468688263|FG000|Overall Study|Patient Declined Transplant|1|||
130199296|NCT00747474|468688266|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199297|NCT00747474|468688267|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199298|NCT00747474|468688268|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199299|NCT00747474|468688269|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199300|NCT00747474|468688270|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199301|NCT00747474|468688271|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199302|NCT00747474|468688272|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199303|NCT00747474|468688273|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
130199304|NCT00747474|468688274|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199305|NCT00747474|468688275|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199306|NCT00747474|468688276|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199307|NCT00747474|468688277|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
130199308|NCT00890084|468688278|FG000|Overall Study|Adverse Event|16|||
130199309|NCT00890084|468688278|FG000|Overall Study|Lost to Follow-up|126|||
130199310|NCT02691936|468688284|FG000|Overall Study|Withdrawal by Subject|2|||
130199311|NCT02691936|468688285|FG001|Overall Study|Withdrawal by Subject|5|||
130199312|NCT01878084|468688286|FG000|Overall Study|Physician Decision|2|||
130199313|NCT00749684|468688287|FG000|Overall Study|Death|1|||
130199314|NCT00749684|468688287|FG000|Overall Study|Adverse Event|27|||
130199315|NCT00749684|468688287|FG000|Overall Study|Participant's Wish|10|||
130199316|NCT00749684|468688287|FG000|Overall Study|Not Documented|1|||
130199317|NCT00749684|468688287|FG000|Overall Study|Progressive Desease|31|||
130199318|NCT00749684|468688287|FG000|Overall Study|Therapy according to protocol + AE|2|||
130199319|NCT00749684|468688287|FG000|Overall Study|AE+discontinuation on participants wish|1|||
130199320|NCT00749684|468688287|FG000|Overall Study|Missing|9|||
130199321|NCT02892422|468688292|FG000|Overall Study|Enrolled not treated|4|||
130199322|NCT02892422|468688292|FG000|Overall Study|Adverse Event|38|||
130199323|NCT02892422|468688292|FG000|Overall Study|Lack of Efficacy|32|||
130199324|NCT02892422|468688292|FG000|Overall Study|Non-compliance with study drug|11|||
130199325|NCT02892422|468688292|FG000|Overall Study|Protocol Violation|4|||
130199326|NCT02892422|468688292|FG000|Overall Study|Withdrawal by Subject|56|||
130199327|NCT02892422|468688292|FG000|Overall Study|Lost to Follow-up|5|||
130199328|NCT02892422|468688292|FG000|Overall Study|sponsor information 16159A results|21|||
130199329|NCT02892422|468688292|FG000|Overall Study|withdrawal of consent|13|||
130199330|NCT02892422|468688292|FG000|Overall Study|exclusion criteria met|3|||
130199331|NCT02892422|468688292|FG000|Overall Study|moving elsewhere|4|||
130199332|NCT02892422|468688292|FG000|Overall Study|non-compliance|10|||
130199333|NCT02892422|468688292|FG000|Overall Study|patient legally incapable|1|||
130199334|NCT02892422|468688292|FG000|Overall Study|patient decision|7|||
130199335|NCT02892422|468688292|FG000|Overall Study|Investigator decision|1|||
130199336|NCT01023256|468688293|FG000|Overall Study|Protocol Violation|2|||
130199337|NCT01023256|468688294|FG001|Overall Study|Protocol Violation|3|||
130199338|NCT01023256|468688295|FG002|Overall Study|Protocol Violation|0|||
130199339|NCT01023256|468688296|FG003|Overall Study|Protocol Violation|0|||
130199340|NCT01023256|468688293|FG000|Overall Study|Randomized but not treated|1|||
130199341|NCT01023256|468688294|FG001|Overall Study|Randomized but not treated|0|||
130199342|NCT01023256|468688295|FG002|Overall Study|Randomized but not treated|1|||
130199343|NCT01023256|468688296|FG003|Overall Study|Randomized but not treated|0|||
130199344|NCT01023256|468688293|FG000|Overall Study|Other|1|||
130199345|NCT01023256|468688294|FG001|Overall Study|Other|0|||
130199346|NCT01023256|468688295|FG002|Overall Study|Other|0|||
130199347|NCT01023256|468688296|FG003|Overall Study|Other|2|||
130199348|NCT01023256|468688293|FG000|Overall Study|Adverse Event|0|||
130199349|NCT01023256|468688294|FG001|Overall Study|Adverse Event|0|||
130199350|NCT01023256|468688295|FG002|Overall Study|Adverse Event|0|||
130199351|NCT01023256|468688296|FG003|Overall Study|Adverse Event|1|||
130199352|NCT01023256|468688293|FG000|Overall Study|Withdrawal by Subject|0|||
130199353|NCT01023256|468688294|FG001|Overall Study|Withdrawal by Subject|0|||
130199354|NCT01023256|468688295|FG002|Overall Study|Withdrawal by Subject|0|||
130199355|NCT01023256|468688296|FG003|Overall Study|Withdrawal by Subject|2|||
130199356|NCT03155178|468688297|FG000|Overall Study|Did not meet treatment day baseline|7|||
130199357|NCT03155178|468688298|FG001|Overall Study|Did not meet treatment day baseline|7|||
130199358|NCT03155178|468688299|FG002|Overall Study|Did not meet treatment day baseline|7|||
130199359|NCT03155178|468688300|FG003|Overall Study|Did not meet treatment day baseline|7|||
130199360|NCT03089697|468688301|FG000|Overall Study|Adverse Event|1|||
130199361|NCT03089697|468688302|FG001|Overall Study|Adverse Event|2|||
130199362|NCT03089697|468688301|FG000|Overall Study|Withdrawal by Subject|1|||
130199363|NCT03089697|468688302|FG001|Overall Study|Withdrawal by Subject|0|||
130199364|NCT04323306|468688303|FG000|Overall Study|Physician Decision|1|||
130199365|NCT04323306|468688304|FG001|Overall Study|Physician Decision|0|||
130199366|NCT04323306|468688305|FG002|Overall Study|Physician Decision|0|||
130199367|NCT04323306|468688306|FG003|Overall Study|Physician Decision|0|||
130199368|NCT04323306|468688307|FG004|Overall Study|Physician Decision|0|||
130199369|NCT04323306|468688308|FG005|Overall Study|Physician Decision|0|||
130199370|NCT04323306|468688309|FG006|Overall Study|Physician Decision|0|||
130199371|NCT04323306|468688310|FG007|Overall Study|Physician Decision|0|||
130199372|NCT04323306|468688311|FG008|Overall Study|Physician Decision|0|||
130199373|NCT04323306|468688303|FG000|Overall Study|Withdrawal by Subject|0|||
130199374|NCT04323306|468688304|FG001|Overall Study|Withdrawal by Subject|0|||
130199375|NCT04323306|468688305|FG002|Overall Study|Withdrawal by Subject|0|||
130199376|NCT04323306|468688306|FG003|Overall Study|Withdrawal by Subject|0|||
130199377|NCT04323306|468688307|FG004|Overall Study|Withdrawal by Subject|0|||
130199378|NCT04323306|468688308|FG005|Overall Study|Withdrawal by Subject|1|||
130199379|NCT04323306|468688309|FG006|Overall Study|Withdrawal by Subject|3|||
130199380|NCT04323306|468688310|FG007|Overall Study|Withdrawal by Subject|0|||
130199381|NCT04323306|468688311|FG008|Overall Study|Withdrawal by Subject|1|||
130199382|NCT00834639|468688312|FG000|Second Intervention|Physician Decision|0|||
130199383|NCT00834639|468688313|FG001|Second Intervention|Physician Decision|2|||
130199384|NCT05129137|468688314|FG000|Second Period|Adverse Event|1|||
130199385|NCT05129137|468688315|FG001|Second Period|Adverse Event|0|||
130199386|NCT05129137|468688316|FG002|Second Period|Adverse Event|0|||
130199387|NCT05129137|468688317|FG003|Second Period|Adverse Event|0|||
130199388|NCT05129137|468688314|FG000|Second Period|Protocol Violation|0|||
130199389|NCT05129137|468688315|FG001|Second Period|Protocol Violation|0|||
130199390|NCT05129137|468688316|FG002|Second Period|Protocol Violation|0|||
130199391|NCT05129137|468688317|FG003|Second Period|Protocol Violation|1|||
130199392|NCT05129137|468688314|FG000|Third Period|Protocol Violation|0|||
130199393|NCT05129137|468688315|FG001|Third Period|Protocol Violation|0|||
130199394|NCT05129137|468688316|FG002|Third Period|Protocol Violation|0|||
130199395|NCT05129137|468688317|FG003|Third Period|Protocol Violation|1|||
130199396|NCT05129137|468688314|FG000|Forth Period|Protocol Violation|0|||
130199397|NCT05129137|468688315|FG001|Forth Period|Protocol Violation|1|||
130199398|NCT05129137|468688316|FG002|Forth Period|Protocol Violation|0|||
130199399|NCT05129137|468688317|FG003|Forth Period|Protocol Violation|0|||
130199400|NCT05129137|468688314|FG000|Forth Period|Withdrawal by Subject|0|||
130199401|NCT05129137|468688315|FG001|Forth Period|Withdrawal by Subject|0|||
130199402|NCT05129137|468688316|FG002|Forth Period|Withdrawal by Subject|1|||
130199403|NCT05129137|468688317|FG003|Forth Period|Withdrawal by Subject|0|||
130199404|NCT03382834|468688330|FG000|Step 1|Lost to Follow-up|0|||
130199405|NCT03382834|468688331|FG001|Step 1|Lost to Follow-up|1|||
130199406|NCT03382834|468688330|FG000|Step 2|Death|1|||
130199407|NCT03382834|468688331|FG001|Step 2|Death|0|||
130199408|NCT03382834|468688330|FG000|Step 2|Lost to Follow-up|2|||
130199409|NCT03382834|468688331|FG001|Step 2|Lost to Follow-up|2|||
130199410|NCT03382834|468688330|FG000|Step 2|Site Terminated by Sponsor|1|||
130199411|NCT03382834|468688331|FG001|Step 2|Site Terminated by Sponsor|0|||
130199412|NCT02387957|468688332|FG000|Overall Study|The study was discontinued|21|||
130199413|NCT02387957|468688333|FG001|Overall Study|The study was discontinued|21|||
130199414|NCT02387957|468688334|FG002|Overall Study|The study was discontinued|20|||
130199415|NCT03613649|468688335|FG000|Second Treatment|Lost to Follow-up|0|||
130199416|NCT03613649|468688336|FG001|Second Treatment|Lost to Follow-up|0|||
130199417|NCT03613649|468688337|FG002|Second Treatment|Lost to Follow-up|1|||
130199418|NCT03613649|468688338|FG003|Second Treatment|Lost to Follow-up|0|||
130199419|NCT03613649|468688339|FG004|Second Treatment|Lost to Follow-up|0|||
130199420|NCT03613649|468688340|FG005|Second Treatment|Lost to Follow-up|0|||
130199421|NCT03613649|468688341|FG006|Second Treatment|Lost to Follow-up|0|||
130199422|NCT03613649|468688342|FG007|Second Treatment|Lost to Follow-up|0|||
130199423|NCT03613649|468688343|FG008|Second Treatment|Lost to Follow-up|0|||
130199424|NCT03613649|468688344|FG009|Second Treatment|Lost to Follow-up|0|||
130199425|NCT03613649|468688345|FG010|Second Treatment|Lost to Follow-up|0|||
130199426|NCT03613649|468688346|FG011|Second Treatment|Lost to Follow-up|0|||
130199427|NCT03613649|468688335|FG000|Second Treatment|Withdrawal by Subject|0|||
130199428|NCT03613649|468688336|FG001|Second Treatment|Withdrawal by Subject|0|||
130199429|NCT03613649|468688337|FG002|Second Treatment|Withdrawal by Subject|0|||
130199430|NCT03613649|468688338|FG003|Second Treatment|Withdrawal by Subject|0|||
130199431|NCT03613649|468688339|FG004|Second Treatment|Withdrawal by Subject|1|||
130199432|NCT03613649|468688340|FG005|Second Treatment|Withdrawal by Subject|0|||
130199433|NCT03613649|468688341|FG006|Second Treatment|Withdrawal by Subject|0|||
130199434|NCT03613649|468688342|FG007|Second Treatment|Withdrawal by Subject|0|||
130199435|NCT03613649|468688343|FG008|Second Treatment|Withdrawal by Subject|0|||
130199436|NCT03613649|468688344|FG009|Second Treatment|Withdrawal by Subject|0|||
130199437|NCT03613649|468688345|FG010|Second Treatment|Withdrawal by Subject|0|||
130199438|NCT03613649|468688346|FG011|Second Treatment|Withdrawal by Subject|0|||
130199439|NCT03613649|468688335|FG000|Third Treatment|Lost to Follow-up|0|||
130199440|NCT03613649|468688336|FG001|Third Treatment|Lost to Follow-up|0|||
130199441|NCT03613649|468688337|FG002|Third Treatment|Lost to Follow-up|0|||
130199442|NCT03613649|468688338|FG003|Third Treatment|Lost to Follow-up|0|||
130199443|NCT03613649|468688339|FG004|Third Treatment|Lost to Follow-up|1|||
130199444|NCT03613649|468688340|FG005|Third Treatment|Lost to Follow-up|0|||
130199445|NCT03613649|468688341|FG006|Third Treatment|Lost to Follow-up|0|||
130199446|NCT03613649|468688342|FG007|Third Treatment|Lost to Follow-up|0|||
130199447|NCT03613649|468688343|FG008|Third Treatment|Lost to Follow-up|0|||
130199448|NCT03613649|468688344|FG009|Third Treatment|Lost to Follow-up|0|||
130199449|NCT03613649|468688345|FG010|Third Treatment|Lost to Follow-up|0|||
130199450|NCT03613649|468688346|FG011|Third Treatment|Lost to Follow-up|1|||
130199451|NCT03613649|468688335|FG000|Third Treatment|Protocol Violation|0|||
130199452|NCT03613649|468688336|FG001|Third Treatment|Protocol Violation|0|||
130199453|NCT03613649|468688337|FG002|Third Treatment|Protocol Violation|0|||
130199454|NCT03613649|468688338|FG003|Third Treatment|Protocol Violation|0|||
130199455|NCT03613649|468688339|FG004|Third Treatment|Protocol Violation|0|||
130199456|NCT03613649|468688340|FG005|Third Treatment|Protocol Violation|0|||
130199457|NCT03613649|468688341|FG006|Third Treatment|Protocol Violation|1|||
130199458|NCT03613649|468688342|FG007|Third Treatment|Protocol Violation|0|||
130199459|NCT03613649|468688343|FG008|Third Treatment|Protocol Violation|0|||
130199460|NCT03613649|468688344|FG009|Third Treatment|Protocol Violation|0|||
130199461|NCT03613649|468688345|FG010|Third Treatment|Protocol Violation|0|||
130199462|NCT03613649|468688346|FG011|Third Treatment|Protocol Violation|1|||
130199463|NCT03613649|468688335|FG000|Fourth Treatment|Protocol Violation|1|||
130199464|NCT03613649|468688336|FG001|Fourth Treatment|Protocol Violation|0|||
130199465|NCT03613649|468688337|FG002|Fourth Treatment|Protocol Violation|0|||
130199466|NCT03613649|468688338|FG003|Fourth Treatment|Protocol Violation|0|||
130199467|NCT03613649|468688339|FG004|Fourth Treatment|Protocol Violation|1|||
130199468|NCT03613649|468688340|FG005|Fourth Treatment|Protocol Violation|0|||
130199469|NCT03613649|468688341|FG006|Fourth Treatment|Protocol Violation|0|||
130199470|NCT03613649|468688342|FG007|Fourth Treatment|Protocol Violation|0|||
130199471|NCT03613649|468688343|FG008|Fourth Treatment|Protocol Violation|0|||
130199472|NCT03613649|468688344|FG009|Fourth Treatment|Protocol Violation|0|||
130199473|NCT03613649|468688345|FG010|Fourth Treatment|Protocol Violation|0|||
130199474|NCT03613649|468688346|FG011|Fourth Treatment|Protocol Violation|0|||
130199475|NCT03613649|468688335|FG000|Fourth Treatment|Physician Decision|0|||
130199476|NCT03613649|468688336|FG001|Fourth Treatment|Physician Decision|0|||
130199477|NCT03613649|468688337|FG002|Fourth Treatment|Physician Decision|0|||
130199478|NCT03613649|468688338|FG003|Fourth Treatment|Physician Decision|0|||
130199479|NCT03613649|468688339|FG004|Fourth Treatment|Physician Decision|0|||
130199480|NCT03613649|468688340|FG005|Fourth Treatment|Physician Decision|0|||
130199481|NCT03613649|468688341|FG006|Fourth Treatment|Physician Decision|1|||
130199482|NCT03613649|468688342|FG007|Fourth Treatment|Physician Decision|0|||
130199483|NCT03613649|468688343|FG008|Fourth Treatment|Physician Decision|0|||
130199484|NCT03613649|468688344|FG009|Fourth Treatment|Physician Decision|0|||
130199485|NCT03613649|468688345|FG010|Fourth Treatment|Physician Decision|0|||
130199486|NCT03613649|468688346|FG011|Fourth Treatment|Physician Decision|0|||
130199487|NCT00675428|468688347|FG000|Overall Study|Disease Progression|2|||
130199488|NCT00675428|468688348|FG001|Overall Study|Disease Progression|2|||
130199489|NCT00675428|468688347|FG000|Overall Study|No Disease Response After Cycle 6|0|||
130199490|NCT00675428|468688348|FG001|Overall Study|No Disease Response After Cycle 6|1|||
130199491|NCT00675428|468688347|FG000|Overall Study|Physician Decision|1|||
130199492|NCT00675428|468688348|FG001|Overall Study|Physician Decision|0|||
130199493|NCT00319592|468688349|FG000|Overall Study|Protocol Violation|1|||
130199494|NCT00319592|468688350|FG001|Overall Study|Protocol Violation|0|||
130199495|NCT00319592|468688349|FG000|Overall Study|Physician Decision|0|||
130199496|NCT00319592|468688350|FG001|Overall Study|Physician Decision|1|||
130199497|NCT00750139|468688353|FG000|Overall Study|Adverse Event|1|||
130199498|NCT00750139|468688354|FG001|Overall Study|Adverse Event|2|||
130199499|NCT00750139|468688355|FG002|Overall Study|Adverse Event|0|||
130199500|NCT00750139|468688356|FG003|Overall Study|Adverse Event|1|||
130199501|NCT00750139|468688353|FG000|Overall Study|Lost to Follow-up|17|||
130199502|NCT00750139|468688354|FG001|Overall Study|Lost to Follow-up|12|||
130199503|NCT00750139|468688355|FG002|Overall Study|Lost to Follow-up|15|||
130199504|NCT00750139|468688356|FG003|Overall Study|Lost to Follow-up|6|||
130199505|NCT00750139|468688353|FG000|Overall Study|Withdrawal by Subject|3|||
130199506|NCT00750139|468688354|FG001|Overall Study|Withdrawal by Subject|2|||
130199507|NCT00750139|468688355|FG002|Overall Study|Withdrawal by Subject|6|||
130199508|NCT00750139|468688356|FG003|Overall Study|Withdrawal by Subject|2|||
130199509|NCT00750139|468688353|FG000|Overall Study|Physician Decision|1|||
130199510|NCT00750139|468688354|FG001|Overall Study|Physician Decision|1|||
130199511|NCT00750139|468688355|FG002|Overall Study|Physician Decision|0|||
130199512|NCT00750139|468688356|FG003|Overall Study|Physician Decision|0|||
130199513|NCT00750139|468688353|FG000|Overall Study|Non-compliance|1|||
130199514|NCT00750139|468688354|FG001|Overall Study|Non-compliance|0|||
130199515|NCT00750139|468688355|FG002|Overall Study|Non-compliance|1|||
130199516|NCT00750139|468688356|FG003|Overall Study|Non-compliance|3|||
130199517|NCT00750139|468688353|FG000|Overall Study|Termination by sponsor|4|||
130199518|NCT00750139|468688354|FG001|Overall Study|Termination by sponsor|0|||
130199519|NCT00750139|468688355|FG002|Overall Study|Termination by sponsor|0|||
130199520|NCT00750139|468688356|FG003|Overall Study|Termination by sponsor|1|||
130199521|NCT00750139|468688353|FG000|Overall Study|Non-specific|62|||
130199522|NCT00750139|468688354|FG001|Overall Study|Non-specific|42|||
130199523|NCT00750139|468688355|FG002|Overall Study|Non-specific|79|||
130199524|NCT00750139|468688356|FG003|Overall Study|Non-specific|33|||
130199525|NCT04439214|468688360|FG000|Overall Study|Adverse Event|13|||
130199526|NCT04439214|468688360|FG000|Overall Study|Disease progression|16|||
130199527|NCT04439214|468688360|FG000|Overall Study|Death|1|||
130199528|NCT04439214|468688360|FG000|Overall Study|Withdrawal by Subject|2|||
130199529|NCT04439214|468688360|FG000|Overall Study|Declining health|1|||
130199530|NCT04439214|468688360|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
130199531|NCT04439214|468688360|FG000|Overall Study|Ineligible|5|||
130199532|NCT04553471|468688361|FG000|Overall Study|Did not start treatment on protocol|3|||
130199533|NCT04553471|468688361|FG000|Overall Study|Death|1|||
130199534|NCT00477750|468689747|FG000|Overall Study|Currently Receiving Treatment|11|||
130199535|NCT00601172|468689748|FG000|Overall Study|Adverse Event|43|||
130199536|NCT00601172|468689749|FG001|Overall Study|Adverse Event|32|||
130199537|NCT00601172|468689748|FG000|Overall Study|Lack of Efficacy|11|||
130199538|NCT00601172|468689749|FG001|Overall Study|Lack of Efficacy|12|||
130199539|NCT00601172|468689748|FG000|Overall Study|Protocol Violation|2|||
130199540|NCT00601172|468689749|FG001|Overall Study|Protocol Violation|5|||
130199541|NCT00601172|468689748|FG000|Overall Study|Lost to Follow-up|4|||
130199542|NCT00601172|468689749|FG001|Overall Study|Lost to Follow-up|3|||
130199543|NCT00601172|468689748|FG000|Overall Study|Physician Decision|27|||
130199544|NCT00601172|468689749|FG001|Overall Study|Physician Decision|28|||
130199545|NCT00601172|468689748|FG000|Overall Study|Withdrawal by Subject|35|||
130199546|NCT00601172|468689749|FG001|Overall Study|Withdrawal by Subject|27|||
130199547|NCT00601172|468689748|FG000|Overall Study|Did not meet continuation criteria|19|||
130199548|NCT00601172|468689749|FG001|Overall Study|Did not meet continuation criteria|20|||
130199549|NCT03030989|468689750|FG000|Overall Study|Fever|2|||
130199550|NCT03030989|468689751|FG001|Overall Study|Fever|2|||
130199551|NCT03030989|468689750|FG000|Overall Study|Rash|2|||
130199552|NCT03030989|468689751|FG001|Overall Study|Rash|1|||
130199553|NCT03030989|468689750|FG000|Overall Study|Fatigue/Overwhelmed|1|||
130199554|NCT03030989|468689751|FG001|Overall Study|Fatigue/Overwhelmed|5|||
130199555|NCT03030989|468689750|FG000|Overall Study|Positive Blood Cultures|2|||
130199556|NCT03030989|468689751|FG001|Overall Study|Positive Blood Cultures|1|||
130199557|NCT03030989|468689750|FG000|Overall Study|Line Removed|0|||
130199558|NCT03030989|468689751|FG001|Overall Study|Line Removed|2|||
130199559|NCT03030989|468689750|FG000|Overall Study|No longer interested|5|||
130199560|NCT03030989|468689751|FG001|Overall Study|No longer interested|3|||
130199561|NCT02706886|468689752|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
130199562|NCT02706886|468689753|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
130199563|NCT02706886|468689754|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
130199564|NCT02706886|468689755|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
130199565|NCT02706886|468689756|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
130199566|NCT02706886|468689757|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
130199567|NCT02706886|468689758|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
130199568|NCT02706886|468689759|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
130199569|NCT02706886|468689760|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
130199570|NCT01669174|468689767|FG000|Overall Study|Subject withdrew consent|2|||
130199571|NCT01669174|468689768|FG001|Overall Study|Subject withdrew consent|2|||
130199572|NCT01669174|468689767|FG000|Overall Study|Lost to Follow-up|1|||
130199573|NCT01669174|468689768|FG001|Overall Study|Lost to Follow-up|0|||
130199574|NCT01669174|468689767|FG000|Overall Study|Adverse Event|2|||
130199575|NCT01669174|468689768|FG001|Overall Study|Adverse Event|2|||
130199576|NCT01669174|468689767|FG000|Overall Study|Administrative problems|1|||
130199577|NCT01669174|468689768|FG001|Overall Study|Administrative problems|2|||
130199578|NCT04310397|468689771|FG000|Overall Study|Lack of Efficacy|3|||
130199579|NCT04310397|468689771|FG000|Overall Study|Withdrawal by Subject|1|||
130199580|NCT00723255|468689772|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
130199581|NCT00723255|468689772|FG000|Overall Study|Ineligible: Second primary|1|||
130199582|NCT00723255|468689772|FG000|Overall Study|Ineligible: Wrong Primary|2|||
130199583|NCT00614523|468689773|FG000|Overall Study|Adverse Event|4|||
130199584|NCT00614523|468689774|FG001|Overall Study|Adverse Event|20|||
130199585|NCT00614523|468689773|FG000|Overall Study|Death|5|||
130199586|NCT00614523|468689774|FG001|Overall Study|Death|8|||
130199587|NCT00614523|468689773|FG000|Overall Study|Lack of Efficacy|9|||
130199588|NCT00614523|468689774|FG001|Overall Study|Lack of Efficacy|11|||
130199589|NCT00614523|468689773|FG000|Overall Study|Lost to Follow-up|0|||
130199590|NCT00614523|468689774|FG001|Overall Study|Lost to Follow-up|1|||
130199591|NCT00614523|468689773|FG000|Overall Study|Protocol Violation|3|||
130199592|NCT00614523|468689774|FG001|Overall Study|Protocol Violation|2|||
130199593|NCT00614523|468689773|FG000|Overall Study|Withdrawal by Subject|12|||
130199594|NCT00614523|468689774|FG001|Overall Study|Withdrawal by Subject|22|||
130199595|NCT00614523|468689773|FG000|Overall Study|Other|6|||
130199596|NCT00614523|468689774|FG001|Overall Study|Other|11|||
130199597|NCT00614523|468689773|FG000|Overall Study|Ineligibility Determined|1|||
130199598|NCT00614523|468689774|FG001|Overall Study|Ineligibility Determined|2|||
130199599|NCT00614523|468689773|FG000|Overall Study|Disease Progression|0|||
130199600|NCT00614523|468689774|FG001|Overall Study|Disease Progression|8|||
130199601|NCT00614523|468689773|FG000|Overall Study|Administrative Decision|23|||
130199602|NCT00614523|468689774|FG001|Overall Study|Administrative Decision|46|||
130199603|NCT04598451|468689780|FG000|Overall Study|Adverse Event|3|||
130199604|NCT04598451|468689781|FG001|Overall Study|Adverse Event|2|||
130199605|NCT04598451|468689780|FG000|Overall Study|Withdrawal by Subject|3|||
130199606|NCT04598451|468689781|FG001|Overall Study|Withdrawal by Subject|7|||
130199607|NCT04598451|468689780|FG000|Overall Study|Lost to Follow-up|2|||
130199608|NCT04598451|468689781|FG001|Overall Study|Lost to Follow-up|0|||
130199609|NCT04598451|468689780|FG000|Overall Study|Physician Decision|4|||
130199610|NCT04598451|468689781|FG001|Overall Study|Physician Decision|1|||
130199611|NCT04598451|468689780|FG000|Overall Study|Requires Prohibited Medication|1|||
130199612|NCT04598451|468689781|FG001|Overall Study|Requires Prohibited Medication|0|||
130199613|NCT04598451|468689780|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
130199614|NCT04598451|468689781|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
130199615|NCT01482065|468689784|FG000|Overall Study|Withdrawal by Subject|0|||
130199616|NCT01482065|468689785|FG001|Overall Study|Withdrawal by Subject|1|||
130199617|NCT02005692|468689790|FG000|Overall Study|Protocol Violation|1|||
130199618|NCT02005692|468689790|FG000|Overall Study|Withdrawal by Subject|1|||
130199619|NCT02005692|468689790|FG000|Overall Study|Discharged earlier than anticipated|5|||
130199620|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
130199621|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
130199622|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
130199623|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
130199624|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
130199625|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
130199626|NCT01895270|468689791|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
130199627|NCT01895270|468689792|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
130199628|NCT01895270|468689791|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
130199629|NCT01895270|468689792|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
130199630|NCT01895270|468689791|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
130199631|NCT01895270|468689792|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
130199632|NCT01895270|468689791|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
130199633|NCT01895270|468689792|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
130199634|NCT02091375|468689794|FG000|Overall Study|Adverse Event|8|||
130199635|NCT02091375|468689795|FG001|Overall Study|Adverse Event|1|||
130199636|NCT02091375|468689794|FG000|Overall Study|Lost to Follow-up|0|||
130199637|NCT02091375|468689795|FG001|Overall Study|Lost to Follow-up|1|||
130199638|NCT02091375|468689794|FG000|Overall Study|Withdrawal by Subject|0|||
130199639|NCT02091375|468689795|FG001|Overall Study|Withdrawal by Subject|1|||
130199640|NCT02091375|468689794|FG000|Overall Study|Withdrawn by the investigator|1|||
130199641|NCT02091375|468689795|FG001|Overall Study|Withdrawn by the investigator|0|||
130199642|NCT01741792|468689796|FG000|Overall Study|Death|6|||
130199643|NCT01741792|468689797|FG001|Overall Study|Death|1|||
130199644|NCT01741792|468689798|FG002|Overall Study|Death|12|||
130199645|NCT04507256|468689803|FG000|Overall Study|Withdrawal by Subject|1|||
130199646|NCT04507256|468689804|FG001|Overall Study|Withdrawal by Subject|0|||
130199647|NCT04507256|468689805|FG002|Overall Study|Withdrawal by Subject|0|||
130199648|NCT04507256|468689806|FG003|Overall Study|Withdrawal by Subject|1|||
130199649|NCT04507256|468689807|FG004|Overall Study|Withdrawal by Subject|0|||
130199650|NCT04507256|468689808|FG005|Overall Study|Withdrawal by Subject|0|||
130199651|NCT00631410|468689809|FG000|Overall Study|Adverse Event|1|||
130199652|NCT00631410|468689810|FG001|Overall Study|Adverse Event|3|||
130199653|NCT00631410|468689809|FG000|Overall Study|Objective Progression or Relapse|4|||
130199654|NCT00631410|468689810|FG001|Overall Study|Objective Progression or Relapse|3|||
130199655|NCT00631410|468689809|FG000|Overall Study|Surgery|1|||
130199656|NCT00631410|468689810|FG001|Overall Study|Surgery|0|||
130199657|NCT02980341|468689815|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130199658|NCT02980341|468689816|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130199659|NCT02980341|468689817|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
130199660|NCT02980341|468689818|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
130199661|NCT02980341|468689819|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
130199662|NCT02980341|468689820|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199663|NCT02980341|468689821|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199664|NCT02980341|468689822|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199665|NCT02980341|468689823|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199666|NCT02980341|468689824|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199667|NCT02980341|468689825|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
130199668|NCT02980341|468689815|FG000|Dose Escalation|Clinical progression|0|||
130199669|NCT02980341|468689816|FG001|Dose Escalation|Clinical progression|0|||
130199670|NCT02980341|468689817|FG002|Dose Escalation|Clinical progression|2|||
130199671|NCT02980341|468689818|FG003|Dose Escalation|Clinical progression|1|||
130199672|NCT02980341|468689819|FG004|Dose Escalation|Clinical progression|0|||
130199673|NCT02980341|468689820|FG005|Dose Escalation|Clinical progression|0|||
130199674|NCT02980341|468689821|FG006|Dose Escalation|Clinical progression|0|||
130199675|NCT02980341|468689822|FG007|Dose Escalation|Clinical progression|0|||
130199676|NCT02980341|468689823|FG008|Dose Escalation|Clinical progression|0|||
130199677|NCT02980341|468689824|FG009|Dose Escalation|Clinical progression|0|||
130199678|NCT02980341|468689825|FG010|Dose Escalation|Clinical progression|0|||
130199679|NCT02980341|468689815|FG000|Dose Escalation|Adverse Event|0|||
130199680|NCT02980341|468689816|FG001|Dose Escalation|Adverse Event|0|||
130199681|NCT02980341|468689817|FG002|Dose Escalation|Adverse Event|1|||
130199682|NCT02980341|468689818|FG003|Dose Escalation|Adverse Event|2|||
130199683|NCT02980341|468689819|FG004|Dose Escalation|Adverse Event|2|||
130199684|NCT02980341|468689820|FG005|Dose Escalation|Adverse Event|0|||
130199685|NCT02980341|468689821|FG006|Dose Escalation|Adverse Event|0|||
130199686|NCT02980341|468689822|FG007|Dose Escalation|Adverse Event|0|||
130199687|NCT02980341|468689823|FG008|Dose Escalation|Adverse Event|0|||
130199688|NCT02980341|468689824|FG009|Dose Escalation|Adverse Event|0|||
130199689|NCT02980341|468689825|FG010|Dose Escalation|Adverse Event|0|||
130199690|NCT02980341|468689815|FG000|Dose Escalation|Withdrawal by Subject|0|||
130199691|NCT02980341|468689816|FG001|Dose Escalation|Withdrawal by Subject|0|||
130199692|NCT02980341|468689817|FG002|Dose Escalation|Withdrawal by Subject|1|||
130199693|NCT02980341|468689818|FG003|Dose Escalation|Withdrawal by Subject|0|||
130199694|NCT02980341|468689819|FG004|Dose Escalation|Withdrawal by Subject|0|||
130199695|NCT02980341|468689820|FG005|Dose Escalation|Withdrawal by Subject|0|||
130199696|NCT02980341|468689821|FG006|Dose Escalation|Withdrawal by Subject|0|||
130199697|NCT02980341|468689822|FG007|Dose Escalation|Withdrawal by Subject|0|||
130199698|NCT02980341|468689823|FG008|Dose Escalation|Withdrawal by Subject|0|||
130199699|NCT02980341|468689824|FG009|Dose Escalation|Withdrawal by Subject|0|||
130199700|NCT02980341|468689825|FG010|Dose Escalation|Withdrawal by Subject|0|||
130199701|NCT02980341|468689815|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199702|NCT02980341|468689816|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199703|NCT02980341|468689817|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199704|NCT02980341|468689818|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
130199705|NCT02980341|468689819|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199706|NCT02980341|468689820|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199707|NCT02980341|468689821|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199708|NCT02980341|468689822|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199709|NCT02980341|468689823|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199710|NCT02980341|468689824|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199711|NCT02980341|468689825|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
130199712|NCT02980341|468689815|FG000|Dose Escalation|Due to investigator's decision|0|||
130199713|NCT02980341|468689816|FG001|Dose Escalation|Due to investigator's decision|0|||
130199714|NCT02980341|468689817|FG002|Dose Escalation|Due to investigator's decision|0|||
130199715|NCT02980341|468689818|FG003|Dose Escalation|Due to investigator's decision|0|||
130199716|NCT02980341|468689819|FG004|Dose Escalation|Due to investigator's decision|1|||
130199717|NCT02980341|468689820|FG005|Dose Escalation|Due to investigator's decision|0|||
130199718|NCT02980341|468689821|FG006|Dose Escalation|Due to investigator's decision|0|||
130199719|NCT02980341|468689822|FG007|Dose Escalation|Due to investigator's decision|0|||
130199720|NCT02980341|468689823|FG008|Dose Escalation|Due to investigator's decision|0|||
130199721|NCT02980341|468689824|FG009|Dose Escalation|Due to investigator's decision|0|||
130199722|NCT02980341|468689825|FG010|Dose Escalation|Due to investigator's decision|0|||
130199723|NCT02980341|468689815|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199724|NCT02980341|468689816|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199725|NCT02980341|468689817|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199726|NCT02980341|468689818|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199727|NCT02980341|468689819|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199728|NCT02980341|468689820|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
130199729|NCT02980341|468689821|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
130199730|NCT02980341|468689822|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199731|NCT02980341|468689823|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199732|NCT02980341|468689824|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199733|NCT02980341|468689825|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
130199734|NCT02980341|468689815|FG000|Dose Finding|Adverse Event|0|||
130199735|NCT02980341|468689816|FG001|Dose Finding|Adverse Event|0|||
130199736|NCT02980341|468689817|FG002|Dose Finding|Adverse Event|0|||
130199737|NCT02980341|468689818|FG003|Dose Finding|Adverse Event|0|||
130199738|NCT02980341|468689819|FG004|Dose Finding|Adverse Event|0|||
130199739|NCT02980341|468689820|FG005|Dose Finding|Adverse Event|3|||
130199740|NCT02980341|468689821|FG006|Dose Finding|Adverse Event|0|||
130199741|NCT02980341|468689822|FG007|Dose Finding|Adverse Event|0|||
130199742|NCT02980341|468689823|FG008|Dose Finding|Adverse Event|0|||
130199743|NCT02980341|468689824|FG009|Dose Finding|Adverse Event|0|||
130199744|NCT02980341|468689825|FG010|Dose Finding|Adverse Event|0|||
130199745|NCT02980341|468689815|FG000|Dose Finding|Withdrawal by Subject|0|||
130199746|NCT02980341|468689816|FG001|Dose Finding|Withdrawal by Subject|0|||
130199747|NCT02980341|468689817|FG002|Dose Finding|Withdrawal by Subject|0|||
130199748|NCT02980341|468689818|FG003|Dose Finding|Withdrawal by Subject|0|||
130199749|NCT02980341|468689819|FG004|Dose Finding|Withdrawal by Subject|0|||
130199750|NCT02980341|468689820|FG005|Dose Finding|Withdrawal by Subject|1|||
130199751|NCT02980341|468689821|FG006|Dose Finding|Withdrawal by Subject|1|||
130199752|NCT02980341|468689822|FG007|Dose Finding|Withdrawal by Subject|0|||
130199753|NCT02980341|468689823|FG008|Dose Finding|Withdrawal by Subject|0|||
130199754|NCT02980341|468689824|FG009|Dose Finding|Withdrawal by Subject|0|||
130199755|NCT02980341|468689825|FG010|Dose Finding|Withdrawal by Subject|0|||
130199756|NCT02980341|468689815|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199757|NCT02980341|468689816|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199758|NCT02980341|468689817|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199759|NCT02980341|468689818|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199760|NCT02980341|468689819|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199761|NCT02980341|468689820|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199762|NCT02980341|468689821|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
130199763|NCT02980341|468689822|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
130199764|NCT02980341|468689823|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
130199765|NCT02980341|468689824|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
130199766|NCT02980341|468689825|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
130199767|NCT02980341|468689815|FG000|Dose Expansion|Clinical progression|0|||
130199768|NCT02980341|468689816|FG001|Dose Expansion|Clinical progression|0|||
130199769|NCT02980341|468689817|FG002|Dose Expansion|Clinical progression|0|||
130199770|NCT02980341|468689818|FG003|Dose Expansion|Clinical progression|0|||
130199771|NCT02980341|468689819|FG004|Dose Expansion|Clinical progression|0|||
130199772|NCT02980341|468689820|FG005|Dose Expansion|Clinical progression|0|||
130199773|NCT02980341|468689821|FG006|Dose Expansion|Clinical progression|0|||
130199774|NCT02980341|468689822|FG007|Dose Expansion|Clinical progression|4|||
130199775|NCT02980341|468689823|FG008|Dose Expansion|Clinical progression|3|||
130199776|NCT02980341|468689824|FG009|Dose Expansion|Clinical progression|1|||
130199777|NCT02980341|468689825|FG010|Dose Expansion|Clinical progression|4|||
130199778|NCT02980341|468689815|FG000|Dose Expansion|Adverse Event|0|||
130199779|NCT02980341|468689816|FG001|Dose Expansion|Adverse Event|0|||
130199780|NCT02980341|468689817|FG002|Dose Expansion|Adverse Event|0|||
130199781|NCT02980341|468689818|FG003|Dose Expansion|Adverse Event|0|||
130199782|NCT02980341|468689819|FG004|Dose Expansion|Adverse Event|0|||
130199783|NCT02980341|468689820|FG005|Dose Expansion|Adverse Event|0|||
130199784|NCT02980341|468689821|FG006|Dose Expansion|Adverse Event|0|||
130199785|NCT02980341|468689822|FG007|Dose Expansion|Adverse Event|3|||
130199786|NCT02980341|468689823|FG008|Dose Expansion|Adverse Event|0|||
130199787|NCT02980341|468689824|FG009|Dose Expansion|Adverse Event|1|||
130199788|NCT02980341|468689825|FG010|Dose Expansion|Adverse Event|3|||
130199789|NCT02980341|468689815|FG000|Dose Expansion|Death|0|||
130199790|NCT02980341|468689816|FG001|Dose Expansion|Death|0|||
130199791|NCT02980341|468689817|FG002|Dose Expansion|Death|0|||
130199792|NCT02980341|468689818|FG003|Dose Expansion|Death|0|||
130199793|NCT02980341|468689819|FG004|Dose Expansion|Death|0|||
130199794|NCT02980341|468689820|FG005|Dose Expansion|Death|0|||
130199795|NCT02980341|468689821|FG006|Dose Expansion|Death|0|||
130199796|NCT02980341|468689822|FG007|Dose Expansion|Death|0|||
130199797|NCT02980341|468689823|FG008|Dose Expansion|Death|2|||
130199798|NCT02980341|468689824|FG009|Dose Expansion|Death|1|||
130199799|NCT02980341|468689825|FG010|Dose Expansion|Death|0|||
130199800|NCT02980341|468689815|FG000|Dose Expansion|Withdrawal by Subject|0|||
130199801|NCT02980341|468689816|FG001|Dose Expansion|Withdrawal by Subject|0|||
130199802|NCT02980341|468689817|FG002|Dose Expansion|Withdrawal by Subject|0|||
130199803|NCT02980341|468689818|FG003|Dose Expansion|Withdrawal by Subject|0|||
130199804|NCT02980341|468689819|FG004|Dose Expansion|Withdrawal by Subject|0|||
130199805|NCT02980341|468689820|FG005|Dose Expansion|Withdrawal by Subject|0|||
130199806|NCT02980341|468689821|FG006|Dose Expansion|Withdrawal by Subject|0|||
130199807|NCT02980341|468689822|FG007|Dose Expansion|Withdrawal by Subject|2|||
130199808|NCT02980341|468689823|FG008|Dose Expansion|Withdrawal by Subject|0|||
130199809|NCT02980341|468689824|FG009|Dose Expansion|Withdrawal by Subject|1|||
130199810|NCT02980341|468689825|FG010|Dose Expansion|Withdrawal by Subject|0|||
130199811|NCT02980341|468689815|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199812|NCT02980341|468689816|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199813|NCT02980341|468689817|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199814|NCT02980341|468689818|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199815|NCT02980341|468689819|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199816|NCT02980341|468689820|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199817|NCT02980341|468689821|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199818|NCT02980341|468689822|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
130199819|NCT02980341|468689823|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199820|NCT02980341|468689824|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199821|NCT02980341|468689825|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
130199822|NCT02980341|468689815|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199823|NCT02980341|468689816|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199824|NCT02980341|468689817|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199825|NCT02980341|468689818|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199826|NCT02980341|468689819|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199827|NCT02980341|468689820|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199828|NCT02980341|468689821|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199829|NCT02980341|468689822|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199830|NCT02980341|468689823|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
130199831|NCT02980341|468689824|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199832|NCT02980341|468689825|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
130199833|NCT02980341|468689815|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199834|NCT02980341|468689816|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199835|NCT02980341|468689817|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199836|NCT02980341|468689818|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199837|NCT02980341|468689819|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199838|NCT02980341|468689820|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199839|NCT02980341|468689821|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199840|NCT02980341|468689822|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199841|NCT02980341|468689823|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
130199842|NCT02980341|468689824|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199843|NCT02980341|468689825|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
130199844|NCT02980341|468689815|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199845|NCT02980341|468689816|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199846|NCT02980341|468689817|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199847|NCT02980341|468689818|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199848|NCT02980341|468689819|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199849|NCT02980341|468689820|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199850|NCT02980341|468689821|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199851|NCT02980341|468689822|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199852|NCT02980341|468689823|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199853|NCT02980341|468689824|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
130199854|NCT02980341|468689825|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
130199855|NCT01647516|468689826|FG000|Induction Period (IP)|Physician Decision|2|||
130199856|NCT01647516|468689827|FG001|Induction Period (IP)|Physician Decision|0|||
130199857|NCT01647516|468689828|FG002|Induction Period (IP)|Physician Decision|0|||
130199858|NCT01647516|468689829|FG003|Induction Period (IP)|Physician Decision|0|||
130199859|NCT01647516|468689830|FG004|Induction Period (IP)|Physician Decision|0|||
130199860|NCT01647516|468689831|FG005|Induction Period (IP)|Physician Decision|0|||
130199861|NCT01647516|468689826|FG000|Induction Period (IP)|Adverse Event|1|||
130199862|NCT01647516|468689827|FG001|Induction Period (IP)|Adverse Event|2|||
130199863|NCT01647516|468689828|FG002|Induction Period (IP)|Adverse Event|0|||
130199864|NCT01647516|468689829|FG003|Induction Period (IP)|Adverse Event|0|||
130199865|NCT01647516|468689830|FG004|Induction Period (IP)|Adverse Event|0|||
130199866|NCT01647516|468689831|FG005|Induction Period (IP)|Adverse Event|0|||
130199867|NCT01647516|468689826|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
130199868|NCT01647516|468689827|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
130199869|NCT01647516|468689828|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
130199870|NCT01647516|468689829|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
130199871|NCT01647516|468689830|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
130199872|NCT01647516|468689831|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
130199873|NCT01647516|468689826|FG000|Induction Period (IP)|Participant Choice|0|||
130199874|NCT01647516|468689827|FG001|Induction Period (IP)|Participant Choice|0|||
130199875|NCT01647516|468689828|FG002|Induction Period (IP)|Participant Choice|1|||
130199876|NCT01647516|468689829|FG003|Induction Period (IP)|Participant Choice|0|||
130199877|NCT01647516|468689830|FG004|Induction Period (IP)|Participant Choice|0|||
130199878|NCT01647516|468689831|FG005|Induction Period (IP)|Participant Choice|0|||
130199879|NCT01647516|468689826|FG000|Induction Period (IP)|Lack of Efficacy|1|||
130199880|NCT01647516|468689827|FG001|Induction Period (IP)|Lack of Efficacy|0|||
130199881|NCT01647516|468689828|FG002|Induction Period (IP)|Lack of Efficacy|0|||
130199882|NCT01647516|468689829|FG003|Induction Period (IP)|Lack of Efficacy|0|||
130199883|NCT01647516|468689830|FG004|Induction Period (IP)|Lack of Efficacy|0|||
130199884|NCT01647516|468689831|FG005|Induction Period (IP)|Lack of Efficacy|0|||
130199885|NCT01647516|468689826|FG000|Induction Period (IP)|No study drug received|1|||
130199886|NCT01647516|468689827|FG001|Induction Period (IP)|No study drug received|1|||
130199887|NCT01647516|468689828|FG002|Induction Period (IP)|No study drug received|0|||
130199888|NCT01647516|468689829|FG003|Induction Period (IP)|No study drug received|0|||
130199889|NCT01647516|468689830|FG004|Induction Period (IP)|No study drug received|0|||
130199890|NCT01647516|468689831|FG005|Induction Period (IP)|No study drug received|0|||
130199891|NCT01647516|468689826|FG000|Maintenance Period (MP)|Adverse Event|2|||
130199892|NCT01647516|468689827|FG001|Maintenance Period (MP)|Adverse Event|1|||
130199893|NCT01647516|468689828|FG002|Maintenance Period (MP)|Adverse Event|0|||
130199894|NCT01647516|468689829|FG003|Maintenance Period (MP)|Adverse Event|0|||
130199895|NCT01647516|468689830|FG004|Maintenance Period (MP)|Adverse Event|0|||
130199896|NCT01647516|468689831|FG005|Maintenance Period (MP)|Adverse Event|0|||
130199897|NCT01647516|468689826|FG000|Maintenance Period (MP)|Non-compliance|1|||
130199898|NCT01647516|468689827|FG001|Maintenance Period (MP)|Non-compliance|0|||
130199899|NCT01647516|468689828|FG002|Maintenance Period (MP)|Non-compliance|0|||
130199900|NCT01647516|468689829|FG003|Maintenance Period (MP)|Non-compliance|0|||
130199901|NCT01647516|468689830|FG004|Maintenance Period (MP)|Non-compliance|0|||
130199902|NCT01647516|468689831|FG005|Maintenance Period (MP)|Non-compliance|0|||
130199903|NCT01647516|468689826|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199904|NCT01647516|468689827|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
130199905|NCT01647516|468689828|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
130199906|NCT01647516|468689829|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199907|NCT01647516|468689830|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199908|NCT01647516|468689831|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
130199909|NCT01647516|468689826|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
130199910|NCT01647516|468689827|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
130199911|NCT01647516|468689828|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
130199912|NCT01647516|468689829|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
130199913|NCT01647516|468689830|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
130199914|NCT01647516|468689831|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
130199915|NCT01647516|468689826|FG000|Open-Label Period|Adverse Event|0|||
130199916|NCT01647516|468689827|FG001|Open-Label Period|Adverse Event|0|||
130199917|NCT01647516|468689828|FG002|Open-Label Period|Adverse Event|0|||
130199918|NCT01647516|468689829|FG003|Open-Label Period|Adverse Event|5|||
130199919|NCT01647516|468689830|FG004|Open-Label Period|Adverse Event|6|||
130199920|NCT01647516|468689831|FG005|Open-Label Period|Adverse Event|3|||
130199921|NCT01647516|468689826|FG000|Open-Label Period|Pregnancy|0|||
130199922|NCT01647516|468689827|FG001|Open-Label Period|Pregnancy|0|||
130199923|NCT01647516|468689828|FG002|Open-Label Period|Pregnancy|0|||
130199924|NCT01647516|468689829|FG003|Open-Label Period|Pregnancy|0|||
130199925|NCT01647516|468689830|FG004|Open-Label Period|Pregnancy|0|||
130199926|NCT01647516|468689831|FG005|Open-Label Period|Pregnancy|1|||
130199927|NCT01647516|468689826|FG000|Open-Label Period|Non-compliance|0|||
130199928|NCT01647516|468689827|FG001|Open-Label Period|Non-compliance|0|||
130199929|NCT01647516|468689828|FG002|Open-Label Period|Non-compliance|0|||
130199930|NCT01647516|468689829|FG003|Open-Label Period|Non-compliance|1|||
130199931|NCT01647516|468689830|FG004|Open-Label Period|Non-compliance|0|||
130199932|NCT01647516|468689831|FG005|Open-Label Period|Non-compliance|1|||
130199933|NCT01647516|468689826|FG000|Open-Label Period|Physician Decision|0|||
130199934|NCT01647516|468689827|FG001|Open-Label Period|Physician Decision|0|||
130199935|NCT01647516|468689828|FG002|Open-Label Period|Physician Decision|0|||
130199936|NCT01647516|468689829|FG003|Open-Label Period|Physician Decision|1|||
130199937|NCT01647516|468689830|FG004|Open-Label Period|Physician Decision|1|||
130199938|NCT01647516|468689831|FG005|Open-Label Period|Physician Decision|0|||
130199939|NCT01647516|468689826|FG000|Open-Label Period|Withdrawal by Subject|0|||
130199940|NCT01647516|468689827|FG001|Open-Label Period|Withdrawal by Subject|0|||
130199941|NCT01647516|468689828|FG002|Open-Label Period|Withdrawal by Subject|0|||
130199942|NCT01647516|468689829|FG003|Open-Label Period|Withdrawal by Subject|9|||
130199943|NCT01647516|468689830|FG004|Open-Label Period|Withdrawal by Subject|11|||
130199944|NCT01647516|468689831|FG005|Open-Label Period|Withdrawal by Subject|6|||
130199945|NCT01647516|468689826|FG000|Open-Label Period|Lost to Follow-up|0|||
130199946|NCT01647516|468689827|FG001|Open-Label Period|Lost to Follow-up|0|||
130199947|NCT01647516|468689828|FG002|Open-Label Period|Lost to Follow-up|0|||
130199948|NCT01647516|468689829|FG003|Open-Label Period|Lost to Follow-up|1|||
130199949|NCT01647516|468689830|FG004|Open-Label Period|Lost to Follow-up|0|||
130199950|NCT01647516|468689831|FG005|Open-Label Period|Lost to Follow-up|1|||
130199951|NCT01647516|468689826|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130199952|NCT01647516|468689827|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130199953|NCT01647516|468689828|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
130199954|NCT01647516|468689829|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
130199955|NCT01647516|468689830|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
130199956|NCT01647516|468689831|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
130199957|NCT01647516|468689826|FG000|Open-Label Period|Lack of Efficacy|0|||
130199958|NCT01647516|468689827|FG001|Open-Label Period|Lack of Efficacy|0|||
130199959|NCT01647516|468689828|FG002|Open-Label Period|Lack of Efficacy|0|||
130199960|NCT01647516|468689829|FG003|Open-Label Period|Lack of Efficacy|7|||
130199961|NCT01647516|468689830|FG004|Open-Label Period|Lack of Efficacy|9|||
130199962|NCT01647516|468689831|FG005|Open-Label Period|Lack of Efficacy|10|||
130199963|NCT01647516|468689826|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130199964|NCT01647516|468689827|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130199965|NCT01647516|468689828|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
130199966|NCT01647516|468689829|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
130199967|NCT01647516|468689830|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
130199968|NCT01647516|468689831|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
130199969|NCT01647516|468689826|FG000|Open-Label Period|No completion / discontinuation visit|0|||
130199970|NCT01647516|468689827|FG001|Open-Label Period|No completion / discontinuation visit|0|||
130199971|NCT01647516|468689828|FG002|Open-Label Period|No completion / discontinuation visit|0|||
130199972|NCT01647516|468689829|FG003|Open-Label Period|No completion / discontinuation visit|0|||
130199973|NCT01647516|468689830|FG004|Open-Label Period|No completion / discontinuation visit|2|||
130199974|NCT01647516|468689831|FG005|Open-Label Period|No completion / discontinuation visit|1|||
130199975|NCT03193801|468689832|FG000|Overall Study|Physician Decision|2|||
130199976|NCT03193801|468689832|FG000|Overall Study|Withdrawal by Subject|1|||
130199977|NCT04964544|468689835|FG000|Overall Study|Screen failure or other uncategorised|10|||
130199978|NCT04964544|468689835|FG000|Overall Study|Physician Decision|4|||
130199979|NCT04964544|468689835|FG000|Overall Study|Lost to Follow-up|9|||
130199980|NCT04964544|468689835|FG000|Overall Study|Withdrawal by Subject|18|||
130199981|NCT04964544|468689835|FG000|Overall Study|Death|1|||
130199982|NCT01613222|468689836|FG000|Overall Study|Physician Decision|1|||
130199983|NCT01613222|468689836|FG000|Overall Study|Unable to place arterial line|1|||
130199984|NCT01613222|468689836|FG000|Overall Study|Reused disposable sensors|10|||
130199985|NCT03696108|468689837|FG000|Overall Study|Physician Decision|1|||
130199986|NCT03696108|468689838|FG001|Overall Study|Physician Decision|0|||
130199987|NCT03696108|468689837|FG000|Overall Study|Withdrawal by Subject|3|||
130199988|NCT03696108|468689838|FG001|Overall Study|Withdrawal by Subject|6|||
130199989|NCT03505593|468689839|FG000|Overall Study|Withdrawal by Subject|1|||
130199990|NCT03505593|468689839|FG000|Overall Study|Died before procedure|1|||
130199991|NCT03505593|468689839|FG000|Overall Study|Anatomical abnormality|1|||
130199992|NCT03505593|468689839|FG000|Overall Study|Unable to pass through esophagus|1|||
130199993|NCT03505593|468689839|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
130199994|NCT01899742|468689840|FG000|Overall Study|Adverse Event|5|||
130199995|NCT01899742|468689841|FG001|Overall Study|Adverse Event|4|||
130199996|NCT01899742|468689840|FG000|Overall Study|Lack of Efficacy|1|||
130199997|NCT01899742|468689841|FG001|Overall Study|Lack of Efficacy|5|||
130199998|NCT01899742|468689840|FG000|Overall Study|Protocol Violation|2|||
130199999|NCT01899742|468689841|FG001|Overall Study|Protocol Violation|2|||
130200000|NCT01899742|468689840|FG000|Overall Study|Withdrawal by Subject|9|||
130200001|NCT01899742|468689841|FG001|Overall Study|Withdrawal by Subject|5|||
130200002|NCT00089778|468689842|FG000|Overall Study|Protocol Violation|0|||
130200003|NCT00089778|468689843|FG001|Overall Study|Protocol Violation|0|||
130200004|NCT00089778|468689844|FG002|Overall Study|Protocol Violation|1|||
130200005|NCT01154088|468689847|FG000|Overall Study|Lost to Follow-up|4|||
130200006|NCT01154088|468689848|FG001|Overall Study|Lost to Follow-up|6|||
130200007|NCT01154088|468689849|FG002|Overall Study|Lost to Follow-up|7|||
130200008|NCT01104246|468689850|FG000|Overall Study|Withdrawal by Subject|1|||
130200009|NCT01104246|468689850|FG000|Overall Study|did not meet inclusion criteria|4|||
130200010|NCT01475851|468689851|FG000|Overall Study|Protocol defined stopping criteria|1|||
130200011|NCT01475851|468689852|FG001|Overall Study|Protocol defined stopping criteria|0|||
130200012|NCT01867294|468689855|FG000|Overall Study|Withdrawal by Subject|1|||
130200013|NCT01867294|468689856|FG001|Overall Study|Withdrawal by Subject|1|||
130200014|NCT01867294|468689857|FG002|Overall Study|Withdrawal by Subject|0|||
130200015|NCT01867294|468689858|FG003|Overall Study|Withdrawal by Subject|0|||
130200016|NCT02447497|468689859|FG000|Overall Study|Did not meet treatment day baseline.|6|||
130200017|NCT02447497|468689860|FG001|Overall Study|Did not meet treatment day baseline.|5|||
130200018|NCT02447497|468689861|FG002|Overall Study|Did not meet treatment day baseline.|2|||
130200019|NCT02447497|468689862|FG003|Overall Study|Did not meet treatment day baseline.|2|||
130200020|NCT02447497|468689859|FG000|Overall Study|Dressing was compromised|0|||
130200021|NCT02447497|468689860|FG001|Overall Study|Dressing was compromised|1|||
130200022|NCT02447497|468689861|FG002|Overall Study|Dressing was compromised|0|||
130200023|NCT02447497|468689862|FG003|Overall Study|Dressing was compromised|0|||
130200024|NCT02017912|468689863|FG000|Overall Study|Withdrawal by Subject|2|||
130200025|NCT02017912|468689864|FG001|Overall Study|Withdrawal by Subject|1|||
130200026|NCT02017912|468689863|FG000|Overall Study|miscellaneous|1|||
130200027|NCT02017912|468689864|FG001|Overall Study|miscellaneous|1|||
130200028|NCT01322035|468689865|FG000|Overall Study|Lost to Follow-up|8|||
130200029|NCT01322035|468689866|FG001|Overall Study|Lost to Follow-up|3|||
130200030|NCT02496091|468689870|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
130200031|NCT02272842|468689871|FG000|Overall Study|Lost to Follow-up|8|||
130200032|NCT02272842|468689872|FG001|Overall Study|Lost to Follow-up|8|||
130200033|NCT02272842|468689871|FG000|Overall Study|Withdrawal by Subject|8|||
130200034|NCT02272842|468689872|FG001|Overall Study|Withdrawal by Subject|2|||
130200035|NCT02396420|468689875|FG000|Overall Study|Death|1|||
130200036|NCT05033262|468689876|FG000|Overall Study|Lost to Follow-up|1|||
130200037|NCT05033262|468689877|FG001|Overall Study|Lost to Follow-up|0|||
130200038|NCT05033262|468689878|FG002|Overall Study|Lost to Follow-up|0|||
130200039|NCT05033262|468689879|FG003|Overall Study|Lost to Follow-up|1|||
130200040|NCT01273623|468689882|FG000|Overall Study|did not meet IVUS criteria|29|||
130200041|NCT01493284|468689885|FG000|Overall Study|Death|29|||
130200042|NCT01493284|468689885|FG000|Overall Study|Withdrawal by Subject|32|||
130200043|NCT00325156|468689886|FG000|Overall Study|Protocol Violation|8|||
130200044|NCT00325156|468689886|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
130200045|NCT00325156|468689886|FG000|Overall Study|Migrated/moved from study area|12|||
130200046|NCT00325156|468689886|FG000|Overall Study|Adverse event, non-fatal|3|||
130200047|NCT00325156|468689886|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
130200048|NCT00325156|468689886|FG000|Overall Study|Other|1|||
130200049|NCT00325156|468689886|FG000|Overall Study|Withdrawal by Subject|31|||
130200050|NCT00519428|468689887|FG000|Overall Study|Adverse Event|5|||
130200051|NCT00519428|468689888|FG001|Overall Study|Adverse Event|2|||
130200052|NCT00519428|468689889|FG002|Overall Study|Adverse Event|10|||
130200053|NCT00519428|468689887|FG000|Overall Study|Lost to Follow-up|7|||
130200054|NCT00519428|468689888|FG001|Overall Study|Lost to Follow-up|7|||
130200055|NCT00519428|468689889|FG002|Overall Study|Lost to Follow-up|6|||
130200056|NCT00519428|468689887|FG000|Overall Study|Withdrawal by Subject|8|||
130200057|NCT00519428|468689888|FG001|Overall Study|Withdrawal by Subject|3|||
130200058|NCT00519428|468689889|FG002|Overall Study|Withdrawal by Subject|7|||
130200059|NCT00519428|468689887|FG000|Overall Study|unstated|1|||
130200060|NCT00519428|468689888|FG001|Overall Study|unstated|3|||
130200061|NCT00519428|468689889|FG002|Overall Study|unstated|2|||
130200062|NCT04064411|468689890|FG000|Overall Study|Adverse Event|29|||
130200063|NCT04064411|468689891|FG001|Overall Study|Adverse Event|19|||
130200064|NCT04064411|468689890|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
130200065|NCT04064411|468689891|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
130200066|NCT04064411|468689890|FG000|Overall Study|Protocol Deviation|0|||
130200067|NCT04064411|468689891|FG001|Overall Study|Protocol Deviation|2|||
130200068|NCT04064411|468689890|FG000|Overall Study|Withdrawal by Subject|25|||
130200069|NCT04064411|468689891|FG001|Overall Study|Withdrawal by Subject|29|||
130200070|NCT04064411|468689890|FG000|Overall Study|Lost to Follow-up|5|||
130200071|NCT04064411|468689891|FG001|Overall Study|Lost to Follow-up|2|||
130200072|NCT04064411|468689890|FG000|Overall Study|Other than Specified|4|||
130200073|NCT04064411|468689891|FG001|Overall Study|Other than Specified|1|||
130200074|NCT04064411|468689890|FG000|Overall Study|Death|1|||
130200075|NCT04064411|468689891|FG001|Overall Study|Death|0|||
130200076|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
130200077|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
130200078|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
130200079|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200080|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200081|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200082|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
130200083|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200084|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
130200085|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
130200086|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200087|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200088|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200089|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
130200090|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
130200091|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
130200092|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200093|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200094|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200095|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200096|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
130200097|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200098|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
130200099|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200100|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200101|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200102|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200103|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
130200104|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
130200105|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200106|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
130200107|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200108|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200109|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200110|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
130200111|NCT03395184|468689892|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
130200112|NCT03395184|468689893|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
130200113|NCT03395184|468689894|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
130200114|NCT03395184|468689895|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
130200115|NCT03395184|468689896|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
130200116|NCT03395184|468689897|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
130200117|NCT03395184|468689898|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
130200118|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
130200119|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
130200120|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
130200121|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
130200122|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
130200123|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
130200124|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
130200125|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130200126|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130200127|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
130200128|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
130200129|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
130200130|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
130200131|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
130200132|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200133|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200134|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200135|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200136|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
130200137|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200138|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
130200139|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130200140|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130200141|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
130200142|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
130200143|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
130200144|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
130200145|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
130200146|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200147|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200148|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200149|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
130200150|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200151|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
130200152|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
130200153|NCT03395184|468689892|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130200154|NCT03395184|468689893|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130200155|NCT03395184|468689894|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
130200156|NCT03395184|468689895|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
130200157|NCT03395184|468689896|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
130200158|NCT03395184|468689897|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
130200159|NCT03395184|468689898|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
130200160|NCT03053063|468689904|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
130200161|NCT03053063|468689905|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
130200162|NCT03053063|468689906|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
130200163|NCT03053063|468689907|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
130200164|NCT03053063|468689904|FG000|Randomized Phase|Withdrew consent|8|||
130200165|NCT03053063|468689905|FG001|Randomized Phase|Withdrew consent|11|||
130200166|NCT03053063|468689906|FG002|Randomized Phase|Withdrew consent|5|||
130200167|NCT03053063|468689907|FG003|Randomized Phase|Withdrew consent|0|||
130200168|NCT03053063|468689904|FG000|Randomized Phase|Investigator's Discretion|8|||
130200169|NCT03053063|468689905|FG001|Randomized Phase|Investigator's Discretion|6|||
130200170|NCT03053063|468689906|FG002|Randomized Phase|Investigator's Discretion|2|||
130200171|NCT03053063|468689907|FG003|Randomized Phase|Investigator's Discretion|0|||
130200172|NCT03053063|468689904|FG000|Randomized Phase|Lost to Follow-up|3|||
130200173|NCT03053063|468689905|FG001|Randomized Phase|Lost to Follow-up|5|||
130200174|NCT03053063|468689906|FG002|Randomized Phase|Lost to Follow-up|1|||
130200175|NCT03053063|468689907|FG003|Randomized Phase|Lost to Follow-up|0|||
130200176|NCT03053063|468689904|FG000|Randomized Phase|Adverse Event|0|||
130200177|NCT03053063|468689905|FG001|Randomized Phase|Adverse Event|1|||
130200178|NCT03053063|468689906|FG002|Randomized Phase|Adverse Event|0|||
130200179|NCT03053063|468689907|FG003|Randomized Phase|Adverse Event|0|||
130200180|NCT03053063|468689904|FG000|Randomized Phase|Randomized but Never Treated|1|||
130200181|NCT03053063|468689905|FG001|Randomized Phase|Randomized but Never Treated|3|||
130200182|NCT03053063|468689906|FG002|Randomized Phase|Randomized but Never Treated|2|||
130200183|NCT03053063|468689907|FG003|Randomized Phase|Randomized but Never Treated|0|||
130200184|NCT03053063|468689904|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
130200185|NCT03053063|468689905|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
130200186|NCT03053063|468689906|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
130200187|NCT03053063|468689907|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
130200188|NCT03053063|468689904|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
130200189|NCT03053063|468689905|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
130200190|NCT03053063|468689906|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
130200191|NCT03053063|468689907|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
130200192|NCT03053063|468689904|FG000|Open-Label Phase|Death|0|||
130200193|NCT03053063|468689905|FG001|Open-Label Phase|Death|0|||
130200194|NCT03053063|468689906|FG002|Open-Label Phase|Death|0|||
130200195|NCT03053063|468689907|FG003|Open-Label Phase|Death|2|||
130200196|NCT03053063|468689904|FG000|Open-Label Phase|Investigator's discretion|0|||
130200197|NCT03053063|468689905|FG001|Open-Label Phase|Investigator's discretion|0|||
130200198|NCT03053063|468689906|FG002|Open-Label Phase|Investigator's discretion|0|||
130200199|NCT03053063|468689907|FG003|Open-Label Phase|Investigator's discretion|2|||
130200200|NCT01970475|468689909|FG000|Overall Study|Withdrawal by Subject|11|||
130200201|NCT01970475|468689910|FG001|Overall Study|Withdrawal by Subject|6|||
130200202|NCT01970475|468689909|FG000|Overall Study|Adverse Event|7|||
130200203|NCT01970475|468689910|FG001|Overall Study|Adverse Event|3|||
130200204|NCT01970475|468689909|FG000|Overall Study|Lost to Follow-up|2|||
130200205|NCT01970475|468689910|FG001|Overall Study|Lost to Follow-up|2|||
130200206|NCT01970475|468689909|FG000|Overall Study|Protocol Violation|1|||
130200207|NCT01970475|468689910|FG001|Overall Study|Protocol Violation|0|||
130200208|NCT01397786|468692709|FG000|Phase A|Lost to Follow-up|0|||
130200209|NCT01397786|468692710|FG001|Phase A|Lost to Follow-up|0|||
130200210|NCT01397786|468692711|FG002|Phase A|Lost to Follow-up|6|||
130200211|NCT01397786|468692709|FG000|Phase A|Adverse Event|0|||
130200212|NCT01397786|468692710|FG001|Phase A|Adverse Event|0|||
130200213|NCT01397786|468692711|FG002|Phase A|Adverse Event|8|||
130200214|NCT01397786|468692709|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
130200215|NCT01397786|468692710|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
130200216|NCT01397786|468692711|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
130200217|NCT01397786|468692709|FG000|Phase A|Physician Decision|0|||
130200218|NCT01397786|468692710|FG001|Phase A|Physician Decision|0|||
130200219|NCT01397786|468692711|FG002|Phase A|Physician Decision|1|||
130200220|NCT01397786|468692709|FG000|Phase A|Withdrawal by Subject|0|||
130200221|NCT01397786|468692710|FG001|Phase A|Withdrawal by Subject|0|||
130200222|NCT01397786|468692711|FG002|Phase A|Withdrawal by Subject|5|||
130200223|NCT01397786|468692709|FG000|Phase A|Lack of Efficacy|0|||
130200224|NCT01397786|468692710|FG001|Phase A|Lack of Efficacy|0|||
130200225|NCT01397786|468692711|FG002|Phase A|Lack of Efficacy|1|||
130200226|NCT01397786|468692709|FG000|Phase B|Lost to Follow-up|22|||
130200227|NCT01397786|468692710|FG001|Phase B|Lost to Follow-up|12|||
130200228|NCT01397786|468692711|FG002|Phase B|Lost to Follow-up|22|||
130200229|NCT01397786|468692709|FG000|Phase B|Adverse Event|109|||
130200230|NCT01397786|468692710|FG001|Phase B|Adverse Event|23|||
130200231|NCT01397786|468692711|FG002|Phase B|Adverse Event|27|||
130200232|NCT01397786|468692709|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
130200233|NCT01397786|468692710|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
130200234|NCT01397786|468692711|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
130200235|NCT01397786|468692709|FG000|Phase B|Physician Decision|9|||
130200236|NCT01397786|468692710|FG001|Phase B|Physician Decision|1|||
130200237|NCT01397786|468692711|FG002|Phase B|Physician Decision|3|||
130200238|NCT01397786|468692709|FG000|Phase B|Withdrawal by Subject|102|||
130200239|NCT01397786|468692710|FG001|Phase B|Withdrawal by Subject|45|||
130200240|NCT01397786|468692711|FG002|Phase B|Withdrawal by Subject|30|||
130200241|NCT01397786|468692709|FG000|Phase B|Protocol Deviation|1|||
130200242|NCT01397786|468692710|FG001|Phase B|Protocol Deviation|2|||
130200243|NCT01397786|468692711|FG002|Phase B|Protocol Deviation|4|||
130200244|NCT01397786|468692709|FG000|Phase B|Lack of Efficacy|22|||
130200245|NCT01397786|468692710|FG001|Phase B|Lack of Efficacy|7|||
130200246|NCT01397786|468692711|FG002|Phase B|Lack of Efficacy|14|||
130200247|NCT03339726|468692714|FG000|Overall Study|Withdrawal by Subject|1|||
130200248|NCT03339726|468692715|FG001|Overall Study|Withdrawal by Subject|0|||
130200249|NCT03339726|468692716|FG002|Overall Study|Withdrawal by Subject|0|||
130200250|NCT03339726|468692714|FG000|Overall Study|Lost to Follow-up|0|||
130200251|NCT03339726|468692715|FG001|Overall Study|Lost to Follow-up|1|||
130200252|NCT03339726|468692716|FG002|Overall Study|Lost to Follow-up|0|||
130200253|NCT01275755|468692717|FG000|Double-blind Treatment Period|Adverse Event|0|||
130200254|NCT01275755|468692718|FG001|Double-blind Treatment Period|Adverse Event|2|||
130200255|NCT01275755|468692717|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
130200256|NCT01275755|468692718|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
130200257|NCT01275755|468692717|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
130200258|NCT01275755|468692718|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130200259|NCT01275755|468692717|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
130200260|NCT01275755|468692718|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
130200261|NCT00636194|468692725|FG000|Overall Study|Study related symptoms and complaints|1|||
130200262|NCT00636194|468692726|FG001|Overall Study|Study related symptoms and complaints|0|||
130200263|NCT00636194|468692725|FG000|Overall Study|Protocol Violation|2|||
130200264|NCT00636194|468692726|FG001|Overall Study|Protocol Violation|0|||
130200265|NCT03962790|468692730|FG000|Period 1|Adverse Event|0|||
130200266|NCT03962790|468692731|FG001|Period 1|Adverse Event|1|||
130200267|NCT03962790|468692730|FG000|Period 1|Failed to meet all eligibility criteria|1|||
130200268|NCT03962790|468692731|FG001|Period 1|Failed to meet all eligibility criteria|1|||
130200269|NCT03962790|468692730|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
130200270|NCT03962790|468692731|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
130200271|NCT03962790|468692730|FG000|Period 1|Withdrawal by Subject|1|||
130200272|NCT03962790|468692731|FG001|Period 1|Withdrawal by Subject|0|||
130200273|NCT00381238|468692734|FG000|Overall Study|Adverse Event|3|||
130200274|NCT00381238|468692734|FG000|Overall Study|Protocol Violation|1|||
130200275|NCT00381238|468692734|FG000|Overall Study|Withdrawal by Subject|4|||
130200276|NCT00381238|468692734|FG000|Overall Study|Lack of Efficacy|2|||
130200277|NCT00381238|468692734|FG000|Overall Study|Withdrew by physician|1|||
130200278|NCT00381238|468692734|FG000|Overall Study|Disease progression|1|||
130200279|NCT02086448|468692737|FG000|Overall Study|Withdrawal by Subject|1|||
130200280|NCT02086448|468692738|FG001|Overall Study|Withdrawal by Subject|0|||
130200281|NCT02086448|468692739|FG002|Overall Study|Withdrawal by Subject|0|||
130200282|NCT02086448|468692740|FG003|Overall Study|Withdrawal by Subject|2|||
130200283|NCT03535194|468692743|FG000|Induction Period|Adverse Event|2|||
130200284|NCT03535194|468692744|FG001|Induction Period|Adverse Event|2|||
130200285|NCT03535194|468692745|FG002|Induction Period|Adverse Event|1|||
130200286|NCT03535194|468692746|FG003|Induction Period|Adverse Event|3|||
130200287|NCT03535194|468692747|FG004|Induction Period|Adverse Event|0|||
130200288|NCT03535194|468692743|FG000|Induction Period|Death|0|||
130200289|NCT03535194|468692744|FG001|Induction Period|Death|1|||
130200290|NCT03535194|468692745|FG002|Induction Period|Death|0|||
130200291|NCT03535194|468692746|FG003|Induction Period|Death|0|||
130200292|NCT03535194|468692747|FG004|Induction Period|Death|0|||
130200293|NCT03535194|468692743|FG000|Induction Period|Lack of Efficacy|1|||
130200294|NCT03535194|468692744|FG001|Induction Period|Lack of Efficacy|3|||
130200295|NCT03535194|468692745|FG002|Induction Period|Lack of Efficacy|2|||
130200296|NCT03535194|468692746|FG003|Induction Period|Lack of Efficacy|2|||
130200297|NCT03535194|468692747|FG004|Induction Period|Lack of Efficacy|0|||
130200298|NCT03535194|468692743|FG000|Induction Period|Lost to Follow-up|3|||
130200299|NCT03535194|468692744|FG001|Induction Period|Lost to Follow-up|5|||
130200300|NCT03535194|468692745|FG002|Induction Period|Lost to Follow-up|2|||
130200301|NCT03535194|468692746|FG003|Induction Period|Lost to Follow-up|3|||
130200302|NCT03535194|468692747|FG004|Induction Period|Lost to Follow-up|0|||
130200303|NCT03535194|468692743|FG000|Induction Period|Physician Decision|1|||
130200304|NCT03535194|468692744|FG001|Induction Period|Physician Decision|1|||
130200305|NCT03535194|468692745|FG002|Induction Period|Physician Decision|0|||
130200306|NCT03535194|468692746|FG003|Induction Period|Physician Decision|0|||
130200307|NCT03535194|468692747|FG004|Induction Period|Physician Decision|0|||
130200308|NCT03535194|468692743|FG000|Induction Period|Protocol Violation|1|||
130200309|NCT03535194|468692744|FG001|Induction Period|Protocol Violation|0|||
130200310|NCT03535194|468692745|FG002|Induction Period|Protocol Violation|0|||
130200311|NCT03535194|468692746|FG003|Induction Period|Protocol Violation|1|||
130200312|NCT03535194|468692747|FG004|Induction Period|Protocol Violation|0|||
130200313|NCT03535194|468692743|FG000|Induction Period|Screen Failure|0|||
130200314|NCT03535194|468692744|FG001|Induction Period|Screen Failure|1|||
130200315|NCT03535194|468692745|FG002|Induction Period|Screen Failure|0|||
130200316|NCT03535194|468692746|FG003|Induction Period|Screen Failure|0|||
130200317|NCT03535194|468692747|FG004|Induction Period|Screen Failure|0|||
130200318|NCT03535194|468692743|FG000|Induction Period|Withdrawal by Subject|3|||
130200319|NCT03535194|468692744|FG001|Induction Period|Withdrawal by Subject|4|||
130200320|NCT03535194|468692745|FG002|Induction Period|Withdrawal by Subject|3|||
130200321|NCT03535194|468692746|FG003|Induction Period|Withdrawal by Subject|2|||
130200322|NCT03535194|468692747|FG004|Induction Period|Withdrawal by Subject|0|||
130200323|NCT03535194|468692743|FG000|Maintenance Period|Adverse Event|6|||
130200324|NCT03535194|468692744|FG001|Maintenance Period|Adverse Event|5|||
130200325|NCT03535194|468692745|FG002|Maintenance Period|Adverse Event|1|||
130200326|NCT03535194|468692746|FG003|Maintenance Period|Adverse Event|11|||
130200327|NCT03535194|468692747|FG004|Maintenance Period|Adverse Event|4|||
130200328|NCT03535194|468692743|FG000|Maintenance Period|Lack of Efficacy|3|||
130200329|NCT03535194|468692744|FG001|Maintenance Period|Lack of Efficacy|2|||
130200330|NCT03535194|468692745|FG002|Maintenance Period|Lack of Efficacy|5|||
130200331|NCT03535194|468692746|FG003|Maintenance Period|Lack of Efficacy|9|||
130200332|NCT03535194|468692747|FG004|Maintenance Period|Lack of Efficacy|0|||
130200333|NCT03535194|468692743|FG000|Maintenance Period|Lost to Follow-up|4|||
130200334|NCT03535194|468692744|FG001|Maintenance Period|Lost to Follow-up|2|||
130200335|NCT03535194|468692745|FG002|Maintenance Period|Lost to Follow-up|1|||
130200336|NCT03535194|468692746|FG003|Maintenance Period|Lost to Follow-up|5|||
130200337|NCT03535194|468692747|FG004|Maintenance Period|Lost to Follow-up|2|||
130200338|NCT03535194|468692743|FG000|Maintenance Period|Other|1|||
130200339|NCT03535194|468692744|FG001|Maintenance Period|Other|2|||
130200340|NCT03535194|468692745|FG002|Maintenance Period|Other|0|||
130200341|NCT03535194|468692746|FG003|Maintenance Period|Other|0|||
130200342|NCT03535194|468692747|FG004|Maintenance Period|Other|0|||
130200343|NCT03535194|468692743|FG000|Maintenance Period|Physician Decision|1|||
130200344|NCT03535194|468692744|FG001|Maintenance Period|Physician Decision|2|||
130200345|NCT03535194|468692745|FG002|Maintenance Period|Physician Decision|0|||
130200346|NCT03535194|468692746|FG003|Maintenance Period|Physician Decision|2|||
130200347|NCT03535194|468692747|FG004|Maintenance Period|Physician Decision|0|||
130200348|NCT03535194|468692743|FG000|Maintenance Period|Pregnancy|0|||
130200349|NCT03535194|468692744|FG001|Maintenance Period|Pregnancy|0|||
130200350|NCT03535194|468692745|FG002|Maintenance Period|Pregnancy|0|||
130200351|NCT03535194|468692746|FG003|Maintenance Period|Pregnancy|2|||
130200352|NCT03535194|468692747|FG004|Maintenance Period|Pregnancy|0|||
130200353|NCT03535194|468692743|FG000|Maintenance Period|Protocol Violation|0|||
130200354|NCT03535194|468692744|FG001|Maintenance Period|Protocol Violation|1|||
130200355|NCT03535194|468692745|FG002|Maintenance Period|Protocol Violation|0|||
130200356|NCT03535194|468692746|FG003|Maintenance Period|Protocol Violation|0|||
130200357|NCT03535194|468692747|FG004|Maintenance Period|Protocol Violation|0|||
130200358|NCT03535194|468692743|FG000|Maintenance Period|Withdrawal by Subject|7|||
130200359|NCT03535194|468692744|FG001|Maintenance Period|Withdrawal by Subject|2|||
130200360|NCT03535194|468692745|FG002|Maintenance Period|Withdrawal by Subject|1|||
130200361|NCT03535194|468692746|FG003|Maintenance Period|Withdrawal by Subject|8|||
130200362|NCT03535194|468692747|FG004|Maintenance Period|Withdrawal by Subject|0|||
130200363|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Adverse Event|4|||
130200364|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Adverse Event|5|||
130200365|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Adverse Event|1|||
130200366|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Adverse Event|8|||
130200367|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Adverse Event|0|||
130200368|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
130200369|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
130200370|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
130200371|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
130200372|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
130200373|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
130200374|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
130200375|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
130200376|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
130200377|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
130200378|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Other|1|||
130200379|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Other|0|||
130200380|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Other|0|||
130200381|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Other|5|||
130200382|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Other|0|||
130200383|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Physician Decision|0|||
130200384|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Physician Decision|2|||
130200385|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Physician Decision|1|||
130200386|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Physician Decision|1|||
130200387|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Physician Decision|0|||
130200388|NCT03535194|468692743|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
130200389|NCT03535194|468692744|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
130200390|NCT03535194|468692745|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
130200391|NCT03535194|468692746|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
130200392|NCT03535194|468692747|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
130200393|NCT02682823|468692750|FG000|Overall Study|Withdrawal by Subject|0|||
130200394|NCT02682823|468692751|FG001|Overall Study|Withdrawal by Subject|0|||
130200395|NCT02682823|468692752|FG002|Overall Study|Withdrawal by Subject|1|||
130200396|NCT02682823|468692753|FG003|Overall Study|Withdrawal by Subject|0|||
130200397|NCT02682823|468692754|FG004|Overall Study|Withdrawal by Subject|1|||
130200398|NCT02682823|468692750|FG000|Overall Study|Protocol Deviation|0|||
130200399|NCT02682823|468692751|FG001|Overall Study|Protocol Deviation|1|||
130200400|NCT02682823|468692752|FG002|Overall Study|Protocol Deviation|0|||
130200401|NCT02682823|468692753|FG003|Overall Study|Protocol Deviation|0|||
130200402|NCT02682823|468692754|FG004|Overall Study|Protocol Deviation|0|||
130200403|NCT02682823|468692750|FG000|Overall Study|Adverse Event|0|||
130200404|NCT02682823|468692751|FG001|Overall Study|Adverse Event|0|||
130200405|NCT02682823|468692752|FG002|Overall Study|Adverse Event|0|||
130200406|NCT02682823|468692753|FG003|Overall Study|Adverse Event|1|||
130200407|NCT02682823|468692754|FG004|Overall Study|Adverse Event|0|||
130200408|NCT01938430|468692755|FG000|Overall Study|Randomized but Not Treated|0|||
130200409|NCT01938430|468692756|FG001|Overall Study|Randomized but Not Treated|0|||
130200410|NCT01938430|468692757|FG002|Overall Study|Randomized but Not Treated|0|||
130200411|NCT01938430|468692758|FG003|Overall Study|Randomized but Not Treated|0|||
130200412|NCT01938430|468692759|FG004|Overall Study|Randomized but Not Treated|0|||
130200413|NCT01938430|468692760|FG005|Overall Study|Randomized but Not Treated|0|||
130200414|NCT01938430|468692761|FG006|Overall Study|Randomized but Not Treated|0|||
130200415|NCT01938430|468692762|FG007|Overall Study|Randomized but Not Treated|0|||
130200416|NCT01938430|468692763|FG008|Overall Study|Randomized but Not Treated|0|||
130200417|NCT01938430|468692764|FG009|Overall Study|Randomized but Not Treated|0|||
130200418|NCT01938430|468692765|FG010|Overall Study|Randomized but Not Treated|1|||
130200419|NCT01938430|468692766|FG011|Overall Study|Randomized but Not Treated|0|||
130200420|NCT01938430|468692767|FG012|Overall Study|Randomized but Not Treated|0|||
130200421|NCT01938430|468692768|FG013|Overall Study|Randomized but Not Treated|1|||
130200422|NCT01938430|468692755|FG000|Overall Study|Adverse Event|0|||
130200423|NCT01938430|468692756|FG001|Overall Study|Adverse Event|0|||
130200424|NCT01938430|468692757|FG002|Overall Study|Adverse Event|0|||
130200425|NCT01938430|468692758|FG003|Overall Study|Adverse Event|0|||
130200426|NCT01938430|468692759|FG004|Overall Study|Adverse Event|0|||
130200427|NCT01938430|468692760|FG005|Overall Study|Adverse Event|0|||
130200428|NCT01938430|468692761|FG006|Overall Study|Adverse Event|1|||
130200429|NCT01938430|468692762|FG007|Overall Study|Adverse Event|0|||
130200430|NCT01938430|468692763|FG008|Overall Study|Adverse Event|0|||
130200431|NCT01938430|468692764|FG009|Overall Study|Adverse Event|0|||
130200432|NCT01938430|468692765|FG010|Overall Study|Adverse Event|0|||
130200433|NCT01938430|468692766|FG011|Overall Study|Adverse Event|0|||
130200434|NCT01938430|468692767|FG012|Overall Study|Adverse Event|0|||
130200435|NCT01938430|468692768|FG013|Overall Study|Adverse Event|0|||
130200436|NCT01938430|468692755|FG000|Overall Study|Death|1|||
130200437|NCT01938430|468692756|FG001|Overall Study|Death|2|||
130200438|NCT01938430|468692757|FG002|Overall Study|Death|2|||
130200439|NCT01938430|468692758|FG003|Overall Study|Death|1|||
130200440|NCT01938430|468692759|FG004|Overall Study|Death|0|||
130200441|NCT01938430|468692760|FG005|Overall Study|Death|0|||
130200442|NCT01938430|468692761|FG006|Overall Study|Death|1|||
130200443|NCT01938430|468692762|FG007|Overall Study|Death|1|||
130200444|NCT01938430|468692763|FG008|Overall Study|Death|2|||
130200445|NCT01938430|468692764|FG009|Overall Study|Death|3|||
130200446|NCT01938430|468692765|FG010|Overall Study|Death|0|||
130200447|NCT01938430|468692766|FG011|Overall Study|Death|0|||
130200448|NCT01938430|468692767|FG012|Overall Study|Death|0|||
130200449|NCT01938430|468692768|FG013|Overall Study|Death|0|||
130200450|NCT01938430|468692755|FG000|Overall Study|Investigator's Discretion|0|||
130200451|NCT01938430|468692756|FG001|Overall Study|Investigator's Discretion|0|||
130200452|NCT01938430|468692757|FG002|Overall Study|Investigator's Discretion|1|||
130200453|NCT01938430|468692758|FG003|Overall Study|Investigator's Discretion|0|||
130200454|NCT01938430|468692759|FG004|Overall Study|Investigator's Discretion|0|||
130200455|NCT01938430|468692760|FG005|Overall Study|Investigator's Discretion|0|||
130200456|NCT01938430|468692761|FG006|Overall Study|Investigator's Discretion|0|||
130200457|NCT01938430|468692762|FG007|Overall Study|Investigator's Discretion|0|||
130200458|NCT01938430|468692763|FG008|Overall Study|Investigator's Discretion|0|||
130200459|NCT01938430|468692764|FG009|Overall Study|Investigator's Discretion|0|||
130200460|NCT01938430|468692765|FG010|Overall Study|Investigator's Discretion|0|||
130200461|NCT01938430|468692766|FG011|Overall Study|Investigator's Discretion|0|||
130200462|NCT01938430|468692767|FG012|Overall Study|Investigator's Discretion|0|||
130200463|NCT01938430|468692768|FG013|Overall Study|Investigator's Discretion|0|||
130200464|NCT01938430|468692755|FG000|Overall Study|Lack of Efficacy|3|||
130200465|NCT01938430|468692756|FG001|Overall Study|Lack of Efficacy|1|||
130200466|NCT01938430|468692757|FG002|Overall Study|Lack of Efficacy|1|||
130200467|NCT01938430|468692758|FG003|Overall Study|Lack of Efficacy|1|||
130200468|NCT01938430|468692759|FG004|Overall Study|Lack of Efficacy|0|||
130200469|NCT01938430|468692760|FG005|Overall Study|Lack of Efficacy|0|||
130200470|NCT01938430|468692761|FG006|Overall Study|Lack of Efficacy|0|||
130200471|NCT01938430|468692762|FG007|Overall Study|Lack of Efficacy|0|||
130200472|NCT01938430|468692763|FG008|Overall Study|Lack of Efficacy|1|||
130200473|NCT01938430|468692764|FG009|Overall Study|Lack of Efficacy|0|||
130200474|NCT01938430|468692765|FG010|Overall Study|Lack of Efficacy|2|||
130200475|NCT01938430|468692766|FG011|Overall Study|Lack of Efficacy|1|||
130200476|NCT01938430|468692767|FG012|Overall Study|Lack of Efficacy|0|||
130200477|NCT01938430|468692768|FG013|Overall Study|Lack of Efficacy|0|||
130200478|NCT01938430|468692755|FG000|Overall Study|Lost to Follow-up|0|||
130200479|NCT01938430|468692756|FG001|Overall Study|Lost to Follow-up|0|||
130200480|NCT01938430|468692757|FG002|Overall Study|Lost to Follow-up|1|||
130200481|NCT01938430|468692758|FG003|Overall Study|Lost to Follow-up|0|||
130200482|NCT01938430|468692759|FG004|Overall Study|Lost to Follow-up|0|||
130200483|NCT01938430|468692760|FG005|Overall Study|Lost to Follow-up|1|||
130200484|NCT01938430|468692761|FG006|Overall Study|Lost to Follow-up|0|||
130200485|NCT01938430|468692762|FG007|Overall Study|Lost to Follow-up|0|||
130200486|NCT01938430|468692763|FG008|Overall Study|Lost to Follow-up|0|||
130200487|NCT01938430|468692764|FG009|Overall Study|Lost to Follow-up|0|||
130200488|NCT01938430|468692765|FG010|Overall Study|Lost to Follow-up|0|||
130200489|NCT01938430|468692766|FG011|Overall Study|Lost to Follow-up|0|||
130200490|NCT01938430|468692767|FG012|Overall Study|Lost to Follow-up|0|||
130200491|NCT01938430|468692768|FG013|Overall Study|Lost to Follow-up|0|||
130200492|NCT01938430|468692755|FG000|Overall Study|Withdrew Consent|0|||
130200493|NCT01938430|468692756|FG001|Overall Study|Withdrew Consent|0|||
130200494|NCT01938430|468692757|FG002|Overall Study|Withdrew Consent|0|||
130200495|NCT01938430|468692758|FG003|Overall Study|Withdrew Consent|0|||
130200496|NCT01938430|468692759|FG004|Overall Study|Withdrew Consent|0|||
130200497|NCT01938430|468692760|FG005|Overall Study|Withdrew Consent|0|||
130200498|NCT01938430|468692761|FG006|Overall Study|Withdrew Consent|0|||
130200499|NCT01938430|468692762|FG007|Overall Study|Withdrew Consent|0|||
130200500|NCT01938430|468692763|FG008|Overall Study|Withdrew Consent|1|||
130200501|NCT01938430|468692764|FG009|Overall Study|Withdrew Consent|0|||
130200502|NCT01938430|468692765|FG010|Overall Study|Withdrew Consent|0|||
130200503|NCT01938430|468692766|FG011|Overall Study|Withdrew Consent|0|||
130200504|NCT01938430|468692767|FG012|Overall Study|Withdrew Consent|0|||
130200505|NCT01938430|468692768|FG013|Overall Study|Withdrew Consent|0|||
130200506|NCT02662764|468692776|FG000|Overall Study|Adverse Event|6|||
130200507|NCT02662764|468692776|FG000|Overall Study|Lack of Efficacy|8|||
130200508|NCT02662764|468692776|FG000|Overall Study|Protocol Violation|1|||
130200509|NCT02662764|468692776|FG000|Overall Study|Withdrawal by Subject|5|||
130200510|NCT02662764|468692776|FG000|Overall Study|Device failure|4|||
130200511|NCT02662764|468692776|FG000|Overall Study|Patient changed treatment|1|||
130200512|NCT02662764|468692776|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
130200513|NCT05178641|468692777|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
130200514|NCT05178641|468692778|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
130200515|NCT05178641|468692777|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
130200516|NCT05178641|468692778|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
130200517|NCT01869699|468692779|FG000|Overall Study|Withdrawal by Subject|1|||
130200518|NCT01869699|468692780|FG001|Overall Study|Withdrawal by Subject|0|||
130200519|NCT00732758|468692781|FG000|Overall Study|Lost to Follow-up|8|||
130200520|NCT00732758|468692782|FG001|Overall Study|Lost to Follow-up|16|||
130200521|NCT04240457|468692785|FG000|Overall Study|Lost to Follow-up|5|||
130200522|NCT04240457|468692786|FG001|Overall Study|Lost to Follow-up|1|||
130200523|NCT01508130|468692790|FG000|Overall Study|Adverse Event|81|||
130200524|NCT01508130|468692791|FG001|Overall Study|Adverse Event|28|||
130200525|NCT01508130|468692790|FG000|Overall Study|Death|3|||
130200526|NCT01508130|468692791|FG001|Overall Study|Death|1|||
130200527|NCT01508130|468692790|FG000|Overall Study|Protocol Violation|2|||
130200528|NCT01508130|468692791|FG001|Overall Study|Protocol Violation|0|||
130200529|NCT01508130|468692790|FG000|Overall Study|Lost to Follow-up|25|||
130200530|NCT01508130|468692791|FG001|Overall Study|Lost to Follow-up|2|||
130200531|NCT01508130|468692790|FG000|Overall Study|Withdrawal by Subject|3|||
130200532|NCT01508130|468692791|FG001|Overall Study|Withdrawal by Subject|3|||
130200533|NCT01508130|468692790|FG000|Overall Study|Subject's substantial non-compliance|25|||
130200534|NCT01508130|468692791|FG001|Overall Study|Subject's substantial non-compliance|9|||
130200535|NCT01508130|468692790|FG000|Overall Study|Insufficient therapeutic response|74|||
130200536|NCT01508130|468692791|FG001|Overall Study|Insufficient therapeutic response|23|||
130200537|NCT01508130|468692790|FG000|Overall Study|Administrative|14|||
130200538|NCT01508130|468692791|FG001|Overall Study|Administrative|3|||
130200539|NCT01680159|468692792|FG000|Screening Period|Not meet criteria for dose-up period|7|||
130200540|NCT01680159|468692792|FG000|Increased Dose Period|Adverse Event|6|||
130200541|NCT01680159|468692792|FG000|Increased Dose Period|Withdrawal by Subject|2|||
130200542|NCT01252563|468692798|FG000|Overall Study|Contract Deviation|41|||
130200543|NCT01252563|468692798|FG000|Overall Study|Centralized Registration Deviation|30|||
130200544|NCT01252563|468692798|FG000|Overall Study|Lost to Follow-up|161|||
130200545|NCT01252563|468692798|FG000|Overall Study|No visit after first day of treatment|194|||
130200546|NCT01252563|468692798|FG000|Overall Study|No drug administration|6|||
130200547|NCT03429244|468692799|FG000|Overall Study|Withdrawal by Subject|2|||
130200548|NCT03429244|468692800|FG001|Overall Study|Withdrawal by Subject|1|||
130200549|NCT03429244|468692801|FG002|Overall Study|Withdrawal by Subject|1|||
130200550|NCT03843632|468692809|FG000|Overall Study|Withdrawal by Subject|1|||
130200551|NCT03843632|468692810|FG001|Overall Study|Withdrawal by Subject|0|||
130200552|NCT03843632|468692811|FG002|Overall Study|Withdrawal by Subject|0|||
130200553|NCT03843632|468692812|FG003|Overall Study|Withdrawal by Subject|0|||
130200554|NCT01820572|468692813|FG000|Randomization|Not Treated|2|||
130200555|NCT01820572|468692814|FG001|Randomization|Not Treated|1|||
130200556|NCT01820572|468692813|FG000|Treatment Period|Adverse Event|12|||
130200557|NCT01820572|468692814|FG001|Treatment Period|Adverse Event|7|||
130200558|NCT01820572|468692813|FG000|Treatment Period|Death|3|||
130200559|NCT01820572|468692814|FG001|Treatment Period|Death|3|||
130200560|NCT01820572|468692813|FG000|Treatment Period|Lack of Efficacy|1|||
130200561|NCT01820572|468692814|FG001|Treatment Period|Lack of Efficacy|0|||
130200562|NCT01820572|468692813|FG000|Treatment Period|poor/non compliance|0|||
130200563|NCT01820572|468692814|FG001|Treatment Period|poor/non compliance|3|||
130200564|NCT01820572|468692813|FG000|Treatment Period|request to discontinue|6|||
130200565|NCT01820572|468692814|FG001|Treatment Period|request to discontinue|11|||
130200566|NCT01820572|468692813|FG000|Treatment Period|No longer meets study criteria|3|||
130200567|NCT01820572|468692814|FG001|Treatment Period|No longer meets study criteria|10|||
130200568|NCT01820572|468692813|FG000|Treatment Period|withdrew consent|1|||
130200569|NCT01820572|468692814|FG001|Treatment Period|withdrew consent|2|||
130200570|NCT05036668|468692815|FG000|Overall Study|lost to follow Up|0|||
130200571|NCT05036668|468692816|FG001|Overall Study|lost to follow Up|0|||
130200572|NCT05036668|468692817|FG002|Overall Study|lost to follow Up|1|||
130200573|NCT00658775|468692820|FG000|Overall Study|Adverse Event|4|||
130200574|NCT00658775|468692821|FG001|Overall Study|Adverse Event|6|||
130200575|NCT00658775|468692820|FG000|Overall Study|Lost to Follow-up|17|||
130200576|NCT00658775|468692821|FG001|Overall Study|Lost to Follow-up|18|||
130200577|NCT00658775|468692820|FG000|Overall Study|Withdrawal by Subject|6|||
130200578|NCT00658775|468692821|FG001|Overall Study|Withdrawal by Subject|4|||
130200579|NCT00658775|468692820|FG000|Overall Study|Withdrawal of consent|8|||
130200580|NCT00658775|468692821|FG001|Overall Study|Withdrawal of consent|7|||
130200581|NCT00658775|468692820|FG000|Overall Study|Other|7|||
130200582|NCT00658775|468692821|FG001|Overall Study|Other|8|||
130200583|NCT00387010|468692822|FG000|Dose Titration Period|Adverse Event|12|||
130200584|NCT00387010|468692822|FG000|Dose Titration Period|Lack of Efficacy|5|||
130200585|NCT00387010|468692822|FG000|Dose Titration Period|Withdrawal by Subject|3|||
130200586|NCT00387010|468692822|FG000|Dose Titration Period|Protocol Violation|1|||
130200587|NCT00387010|468692822|FG000|Dose Titration Period|Lost to Follow-up|2|||
130200588|NCT00387010|468692822|FG000|Dose Titration Period|Noncompliance with study medication|8|||
130200589|NCT00387010|468692822|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
130200590|NCT00387010|468692822|FG000|Treatment Period|Adverse Event|4|||
130200591|NCT00387010|468692822|FG000|Treatment Period|Withdrawal by Subject|1|||
130200592|NCT00387010|468692822|FG000|Treatment Period|Noncompliance with study medication|2|||
130200593|NCT00387010|468692822|FG000|Treatment Period|Noncompliance with study procedures|3|||
130200594|NCT00387010|468692822|FG000|Treatment Period|Participant reported study drug stolen|1|||
130200595|NCT01931956|468692827|FG000|Overall Study|Death|42|||
130200596|NCT01931956|468692828|FG001|Overall Study|Death|7|||
130200597|NCT01931956|468692829|FG002|Overall Study|Death|379|||
130200598|NCT01931956|468692830|FG003|Overall Study|Death|96|||
130200599|NCT01931956|468692827|FG000|Overall Study|Withdrawal by Subject|5|||
130200600|NCT01931956|468692828|FG001|Overall Study|Withdrawal by Subject|0|||
130200601|NCT01931956|468692829|FG002|Overall Study|Withdrawal by Subject|70|||
130200602|NCT01931956|468692830|FG003|Overall Study|Withdrawal by Subject|30|||
130200603|NCT01931956|468692827|FG000|Overall Study|Lost to Follow-up|2|||
130200604|NCT01931956|468692828|FG001|Overall Study|Lost to Follow-up|0|||
130200605|NCT01931956|468692829|FG002|Overall Study|Lost to Follow-up|11|||
130200606|NCT01931956|468692830|FG003|Overall Study|Lost to Follow-up|7|||
130200607|NCT01931956|468692827|FG000|Overall Study|Expected|2|||
130200608|NCT01931956|468692828|FG001|Overall Study|Expected|0|||
130200609|NCT01931956|468692829|FG002|Overall Study|Expected|6|||
130200610|NCT01931956|468692830|FG003|Overall Study|Expected|0|||
130200611|NCT01931956|468692827|FG000|Overall Study|Not due|0|||
130200612|NCT01931956|468692828|FG001|Overall Study|Not due|0|||
130200613|NCT01931956|468692829|FG002|Overall Study|Not due|21|||
130200614|NCT01931956|468692830|FG003|Overall Study|Not due|0|||
130200615|NCT02847494|468692835|FG000|Overall Study|Lost to Follow-up|8|||
130200616|NCT02847494|468692836|FG001|Overall Study|Lost to Follow-up|5|||
130200617|NCT01901653|468692837|FG000|Overall Study|Death|2|||
130200618|NCT01901653|468692838|FG001|Overall Study|Death|1|||
130200619|NCT01901653|468692839|FG002|Overall Study|Death|8|||
130200620|NCT01901653|468692840|FG003|Overall Study|Death|3|||
130200621|NCT01901653|468692841|FG004|Overall Study|Death|2|||
130200622|NCT01901653|468692842|FG005|Overall Study|Death|2|||
130200623|NCT01901653|468692843|FG006|Overall Study|Death|6|||
130200624|NCT01901653|468692844|FG007|Overall Study|Death|9|||
130200625|NCT01901653|468692845|FG008|Overall Study|Death|1|||
130200626|NCT01901653|468692846|FG009|Overall Study|Death|16|||
130200627|NCT01901653|468692847|FG010|Overall Study|Death|2|||
130200628|NCT01901653|468692848|FG011|Overall Study|Death|15|||
130200629|NCT01901653|468692849|FG012|Overall Study|Death|4|||
130200630|NCT01901653|468692837|FG000|Overall Study|Lost to Follow-up|1|||
130200631|NCT01901653|468692838|FG001|Overall Study|Lost to Follow-up|0|||
130200632|NCT01901653|468692839|FG002|Overall Study|Lost to Follow-up|2|||
130200633|NCT01901653|468692840|FG003|Overall Study|Lost to Follow-up|0|||
130200634|NCT01901653|468692841|FG004|Overall Study|Lost to Follow-up|0|||
130200635|NCT01901653|468692842|FG005|Overall Study|Lost to Follow-up|1|||
130200636|NCT01901653|468692843|FG006|Overall Study|Lost to Follow-up|0|||
130200637|NCT01901653|468692844|FG007|Overall Study|Lost to Follow-up|1|||
130200638|NCT01901653|468692845|FG008|Overall Study|Lost to Follow-up|0|||
130200639|NCT01901653|468692846|FG009|Overall Study|Lost to Follow-up|0|||
130200640|NCT01901653|468692847|FG010|Overall Study|Lost to Follow-up|0|||
130200641|NCT01901653|468692848|FG011|Overall Study|Lost to Follow-up|0|||
130200642|NCT01901653|468692849|FG012|Overall Study|Lost to Follow-up|0|||
130200643|NCT01901653|468692837|FG000|Overall Study|Withdrawal by Subject|0|||
130200644|NCT01901653|468692838|FG001|Overall Study|Withdrawal by Subject|0|||
130200645|NCT01901653|468692839|FG002|Overall Study|Withdrawal by Subject|0|||
130200646|NCT01901653|468692840|FG003|Overall Study|Withdrawal by Subject|0|||
130200647|NCT01901653|468692841|FG004|Overall Study|Withdrawal by Subject|0|||
130200648|NCT01901653|468692842|FG005|Overall Study|Withdrawal by Subject|0|||
130200649|NCT01901653|468692843|FG006|Overall Study|Withdrawal by Subject|1|||
130200650|NCT01901653|468692844|FG007|Overall Study|Withdrawal by Subject|0|||
130200651|NCT01901653|468692845|FG008|Overall Study|Withdrawal by Subject|0|||
130200652|NCT01901653|468692846|FG009|Overall Study|Withdrawal by Subject|0|||
130200653|NCT01901653|468692847|FG010|Overall Study|Withdrawal by Subject|0|||
130200654|NCT01901653|468692848|FG011|Overall Study|Withdrawal by Subject|0|||
130200655|NCT01901653|468692849|FG012|Overall Study|Withdrawal by Subject|0|||
130200656|NCT01901653|468692837|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
130200657|NCT01901653|468692838|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
130200658|NCT01901653|468692839|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
130200659|NCT01901653|468692840|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
130200660|NCT01901653|468692841|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
130200661|NCT01901653|468692842|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
130200662|NCT01901653|468692843|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
130200663|NCT01901653|468692844|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
130200664|NCT01901653|468692845|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
130200665|NCT01901653|468692846|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
130200666|NCT01901653|468692847|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
130200667|NCT01901653|468692848|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
130200668|NCT01901653|468692849|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
130200669|NCT02841280|468692852|FG000|Overall Study|Adverse Event|2|||
130200670|NCT02841280|468692853|FG001|Overall Study|Adverse Event|1|||
130200671|NCT02841280|468692852|FG000|Overall Study|Death|1|||
130200672|NCT02841280|468692853|FG001|Overall Study|Death|0|||
130200673|NCT02841280|468692852|FG000|Overall Study|Lost to Follow-up|2|||
130200674|NCT02841280|468692853|FG001|Overall Study|Lost to Follow-up|2|||
130200675|NCT02841280|468692852|FG000|Overall Study|Withdrawal by Subject|7|||
130200676|NCT02841280|468692853|FG001|Overall Study|Withdrawal by Subject|3|||
130200677|NCT02841280|468692852|FG000|Overall Study|Stop Point: BP above threshold|2|||
130200678|NCT02841280|468692853|FG001|Overall Study|Stop Point: BP above threshold|0|||
130200679|NCT02727777|468692854|FG000|Overall Study|Screen Failure|2|||
130200680|NCT02727777|468692855|FG001|Overall Study|Screen Failure|0|||
130200681|NCT02727777|468692856|FG002|Overall Study|Screen Failure|0|||
130200682|NCT02727777|468692854|FG000|Overall Study|Progressive disease|2|||
130200683|NCT02727777|468692855|FG001|Overall Study|Progressive disease|0|||
130200684|NCT02727777|468692856|FG002|Overall Study|Progressive disease|0|||
130200685|NCT00957268|468692857|FG000|Overall Study|Voluntary Withdrawal|0|||
130200686|NCT00957268|468692858|FG001|Overall Study|Voluntary Withdrawal|0|||
130200687|NCT00957268|468692859|FG002|Overall Study|Voluntary Withdrawal|1|||
130200688|NCT00957268|468692860|FG003|Overall Study|Voluntary Withdrawal|0|||
130200689|NCT00957268|468692861|FG004|Overall Study|Voluntary Withdrawal|0|||
130200690|NCT01738503|468692863|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
130200691|NCT01738503|468692864|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200692|NCT01738503|468692865|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200693|NCT01738503|468692866|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200694|NCT01738503|468692867|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200695|NCT01738503|468692868|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200696|NCT01738503|468692869|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
130200697|NCT01738503|468692863|FG000|Treatment Period|Adverse Event|0|||
130200698|NCT01738503|468692864|FG001|Treatment Period|Adverse Event|1|||
130200699|NCT01738503|468692865|FG002|Treatment Period|Adverse Event|0|||
130200700|NCT01738503|468692866|FG003|Treatment Period|Adverse Event|1|||
130200701|NCT01738503|468692867|FG004|Treatment Period|Adverse Event|2|||
130200702|NCT01738503|468692868|FG005|Treatment Period|Adverse Event|2|||
130200703|NCT01738503|468692869|FG006|Treatment Period|Adverse Event|2|||
130200704|NCT01738503|468692863|FG000|Treatment Period|Lost to Follow-up|0|||
130200705|NCT01738503|468692864|FG001|Treatment Period|Lost to Follow-up|0|||
130200706|NCT01738503|468692865|FG002|Treatment Period|Lost to Follow-up|3|||
130200707|NCT01738503|468692866|FG003|Treatment Period|Lost to Follow-up|4|||
130200708|NCT01738503|468692867|FG004|Treatment Period|Lost to Follow-up|1|||
130200709|NCT01738503|468692868|FG005|Treatment Period|Lost to Follow-up|1|||
130200710|NCT01738503|468692869|FG006|Treatment Period|Lost to Follow-up|5|||
130200711|NCT01738503|468692863|FG000|Treatment Period|Withdrawal by Subject|0|||
130200712|NCT01738503|468692864|FG001|Treatment Period|Withdrawal by Subject|1|||
130200713|NCT01738503|468692865|FG002|Treatment Period|Withdrawal by Subject|0|||
130200714|NCT01738503|468692866|FG003|Treatment Period|Withdrawal by Subject|1|||
130200715|NCT01738503|468692867|FG004|Treatment Period|Withdrawal by Subject|1|||
130200716|NCT01738503|468692868|FG005|Treatment Period|Withdrawal by Subject|1|||
130200717|NCT01738503|468692869|FG006|Treatment Period|Withdrawal by Subject|1|||
130200718|NCT01738503|468692863|FG000|Treatment Period|Protocol Violation|0|||
130200719|NCT01738503|468692864|FG001|Treatment Period|Protocol Violation|3|||
130200720|NCT01738503|468692865|FG002|Treatment Period|Protocol Violation|1|||
130200721|NCT01738503|468692866|FG003|Treatment Period|Protocol Violation|0|||
130200722|NCT01738503|468692867|FG004|Treatment Period|Protocol Violation|4|||
130200723|NCT01738503|468692868|FG005|Treatment Period|Protocol Violation|2|||
130200724|NCT01738503|468692869|FG006|Treatment Period|Protocol Violation|0|||
130200725|NCT01738503|468692863|FG000|Treatment Period|Other|0|||
130200726|NCT01738503|468692864|FG001|Treatment Period|Other|0|||
130200727|NCT01738503|468692865|FG002|Treatment Period|Other|1|||
130200728|NCT01738503|468692866|FG003|Treatment Period|Other|0|||
130200729|NCT01738503|468692867|FG004|Treatment Period|Other|0|||
130200730|NCT01738503|468692868|FG005|Treatment Period|Other|0|||
130200731|NCT01738503|468692869|FG006|Treatment Period|Other|0|||
130200732|NCT01738503|468692863|FG000|PET Imaging Sub-study|Adverse Event|0|||
130200733|NCT01738503|468692864|FG001|PET Imaging Sub-study|Adverse Event|0|||
130200734|NCT01738503|468692865|FG002|PET Imaging Sub-study|Adverse Event|0|||
130200735|NCT01738503|468692866|FG003|PET Imaging Sub-study|Adverse Event|0|||
130200736|NCT01738503|468692867|FG004|PET Imaging Sub-study|Adverse Event|0|||
130200737|NCT01738503|468692868|FG005|PET Imaging Sub-study|Adverse Event|1|||
130200738|NCT01738503|468692869|FG006|PET Imaging Sub-study|Adverse Event|0|||
130200739|NCT01738503|468692863|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200740|NCT01738503|468692864|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200741|NCT01738503|468692865|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200742|NCT01738503|468692866|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200743|NCT01738503|468692867|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
130200744|NCT01738503|468692868|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
130200745|NCT01738503|468692869|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
130200746|NCT03005327|468692870|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130200747|NCT03005327|468692871|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130200748|NCT03005327|468692872|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
130200749|NCT03005327|468692873|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
130200750|NCT03005327|468692870|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130200751|NCT03005327|468692871|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
130200752|NCT03005327|468692872|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130200753|NCT03005327|468692873|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
130200754|NCT01340027|468692874|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
130200755|NCT01340027|468692875|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
130200756|NCT01340027|468692876|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
130200757|NCT01340027|468692877|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
130200758|NCT01340027|468692878|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
130200759|NCT01340027|468692879|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
130200760|NCT01340027|468692880|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
130200761|NCT01340027|468692881|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
130200762|NCT01340027|468692882|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
130200763|NCT01340027|468692883|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
130200764|NCT01340027|468692884|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
130200765|NCT01340027|468692885|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
130200766|NCT01340027|468692874|FG000|Overall Study|Adverse Event|0|||
130200767|NCT01340027|468692875|FG001|Overall Study|Adverse Event|1|||
130200768|NCT01340027|468692876|FG002|Overall Study|Adverse Event|2|||
130200769|NCT01340027|468692877|FG003|Overall Study|Adverse Event|0|||
130200770|NCT01340027|468692878|FG004|Overall Study|Adverse Event|1|||
130200771|NCT01340027|468692879|FG005|Overall Study|Adverse Event|2|||
130200772|NCT01340027|468692880|FG006|Overall Study|Adverse Event|2|||
130200773|NCT01340027|468692881|FG007|Overall Study|Adverse Event|1|||
130200774|NCT01340027|468692882|FG008|Overall Study|Adverse Event|4|||
130200775|NCT01340027|468692883|FG009|Overall Study|Adverse Event|1|||
130200776|NCT01340027|468692884|FG010|Overall Study|Adverse Event|1|||
130200777|NCT01340027|468692885|FG011|Overall Study|Adverse Event|3|||
130200778|NCT01340027|468692874|FG000|Overall Study|Lack of Efficacy|0|||
130200779|NCT01340027|468692875|FG001|Overall Study|Lack of Efficacy|0|||
130200780|NCT01340027|468692876|FG002|Overall Study|Lack of Efficacy|0|||
130200781|NCT01340027|468692877|FG003|Overall Study|Lack of Efficacy|0|||
130200782|NCT01340027|468692878|FG004|Overall Study|Lack of Efficacy|0|||
130200783|NCT01340027|468692879|FG005|Overall Study|Lack of Efficacy|0|||
130200784|NCT01340027|468692880|FG006|Overall Study|Lack of Efficacy|1|||
130200785|NCT01340027|468692881|FG007|Overall Study|Lack of Efficacy|1|||
130200786|NCT01340027|468692882|FG008|Overall Study|Lack of Efficacy|1|||
130200787|NCT01340027|468692883|FG009|Overall Study|Lack of Efficacy|0|||
130200788|NCT01340027|468692884|FG010|Overall Study|Lack of Efficacy|0|||
130200789|NCT01340027|468692885|FG011|Overall Study|Lack of Efficacy|0|||
130200790|NCT01340027|468692874|FG000|Overall Study|Lost to Follow-up|0|||
130200791|NCT01340027|468692875|FG001|Overall Study|Lost to Follow-up|1|||
130200792|NCT01340027|468692876|FG002|Overall Study|Lost to Follow-up|0|||
130200793|NCT01340027|468692877|FG003|Overall Study|Lost to Follow-up|0|||
130200794|NCT01340027|468692878|FG004|Overall Study|Lost to Follow-up|0|||
130200795|NCT01340027|468692879|FG005|Overall Study|Lost to Follow-up|0|||
130200796|NCT01340027|468692880|FG006|Overall Study|Lost to Follow-up|1|||
130200797|NCT01340027|468692881|FG007|Overall Study|Lost to Follow-up|0|||
130200798|NCT01340027|468692882|FG008|Overall Study|Lost to Follow-up|0|||
130200799|NCT01340027|468692883|FG009|Overall Study|Lost to Follow-up|1|||
130200800|NCT01340027|468692884|FG010|Overall Study|Lost to Follow-up|0|||
130200801|NCT01340027|468692885|FG011|Overall Study|Lost to Follow-up|0|||
130200802|NCT01340027|468692874|FG000|Overall Study|Protocol Violation|1|||
130200803|NCT01340027|468692875|FG001|Overall Study|Protocol Violation|2|||
130200804|NCT01340027|468692876|FG002|Overall Study|Protocol Violation|0|||
130200805|NCT01340027|468692877|FG003|Overall Study|Protocol Violation|0|||
130200806|NCT01340027|468692878|FG004|Overall Study|Protocol Violation|6|||
130200807|NCT01340027|468692879|FG005|Overall Study|Protocol Violation|0|||
130200808|NCT01340027|468692880|FG006|Overall Study|Protocol Violation|0|||
130200809|NCT01340027|468692881|FG007|Overall Study|Protocol Violation|1|||
130200810|NCT01340027|468692882|FG008|Overall Study|Protocol Violation|2|||
130200811|NCT01340027|468692883|FG009|Overall Study|Protocol Violation|2|||
130200812|NCT01340027|468692884|FG010|Overall Study|Protocol Violation|0|||
130200813|NCT01340027|468692885|FG011|Overall Study|Protocol Violation|0|||
130200814|NCT01340027|468692874|FG000|Overall Study|Withdrawal by Subject|4|||
130200815|NCT01340027|468692875|FG001|Overall Study|Withdrawal by Subject|3|||
130200816|NCT01340027|468692876|FG002|Overall Study|Withdrawal by Subject|1|||
130200817|NCT01340027|468692877|FG003|Overall Study|Withdrawal by Subject|3|||
130200818|NCT01340027|468692878|FG004|Overall Study|Withdrawal by Subject|3|||
130200819|NCT01340027|468692879|FG005|Overall Study|Withdrawal by Subject|2|||
130200820|NCT01340027|468692880|FG006|Overall Study|Withdrawal by Subject|3|||
130200821|NCT01340027|468692881|FG007|Overall Study|Withdrawal by Subject|4|||
130200822|NCT01340027|468692882|FG008|Overall Study|Withdrawal by Subject|1|||
130200823|NCT01340027|468692883|FG009|Overall Study|Withdrawal by Subject|2|||
130200824|NCT01340027|468692884|FG010|Overall Study|Withdrawal by Subject|0|||
130200825|NCT01340027|468692885|FG011|Overall Study|Withdrawal by Subject|1|||
130200826|NCT01340027|468692874|FG000|Overall Study|Miscellaneous|0|||
130200827|NCT01340027|468692875|FG001|Overall Study|Miscellaneous|0|||
130200828|NCT01340027|468692876|FG002|Overall Study|Miscellaneous|0|||
130200829|NCT01340027|468692877|FG003|Overall Study|Miscellaneous|1|||
130200830|NCT01340027|468692878|FG004|Overall Study|Miscellaneous|0|||
130200831|NCT01340027|468692879|FG005|Overall Study|Miscellaneous|0|||
130200832|NCT01340027|468692880|FG006|Overall Study|Miscellaneous|0|||
130200833|NCT01340027|468692881|FG007|Overall Study|Miscellaneous|0|||
130200834|NCT01340027|468692882|FG008|Overall Study|Miscellaneous|0|||
130200835|NCT01340027|468692883|FG009|Overall Study|Miscellaneous|0|||
130200836|NCT01340027|468692884|FG010|Overall Study|Miscellaneous|1|||
130200837|NCT01340027|468692885|FG011|Overall Study|Miscellaneous|0|||
130200838|NCT04687072|468692886|FG000|Overall Study|Adverse Event|2|||
130200839|NCT04687072|468692887|FG001|Overall Study|Adverse Event|0|||
130200840|NCT04687072|468692886|FG000|Overall Study|Death|1|||
130200841|NCT04687072|468692887|FG001|Overall Study|Death|0|||
130200842|NCT04687072|468692886|FG000|Overall Study|Lack of Efficacy|2|||
130200843|NCT04687072|468692887|FG001|Overall Study|Lack of Efficacy|1|||
130200844|NCT04687072|468692886|FG000|Overall Study|Physician Decision|1|||
130200845|NCT04687072|468692887|FG001|Overall Study|Physician Decision|0|||
130200846|NCT04687072|468692886|FG000|Overall Study|Pregnancy|1|||
130200847|NCT04687072|468692887|FG001|Overall Study|Pregnancy|0|||
130200848|NCT04687072|468692886|FG000|Overall Study|Requires Prohibited Medication|2|||
130200849|NCT04687072|468692887|FG001|Overall Study|Requires Prohibited Medication|0|||
130200850|NCT04687072|468692886|FG000|Overall Study|Withdrawal of Consent|11|||
130200851|NCT04687072|468692887|FG001|Overall Study|Withdrawal of Consent|6|||
130200852|NCT04687072|468692886|FG000|Overall Study|Miscellaneous|4|||
130200853|NCT04687072|468692887|FG001|Overall Study|Miscellaneous|1|||
130200854|NCT00915876|468692888|FG000|Overall Study|Adverse Event|0|||
130200855|NCT00915876|468692889|FG001|Overall Study|Adverse Event|1|||
130200856|NCT02572076|468692893|FG000|Overall Study|Protocol Violation|1|||
130200857|NCT00533702|468692896|FG000|Overall Study|Withdrawal by Subject|3|||
130200858|NCT00533702|468692897|FG001|Overall Study|Withdrawal by Subject|1|||
130200859|NCT00533702|468692896|FG000|Overall Study|Found ineligible after randomization|2|||
130200860|NCT00533702|468692897|FG001|Overall Study|Found ineligible after randomization|1|||
130200861|NCT06366087|468694621|FG000|Overall Study|Withdrawal by Subject|0|||
130200862|NCT06366087|468694622|FG001|Overall Study|Withdrawal by Subject|1|||
130200863|NCT00860249|468694624|FG000|Overall Study|trial was terminated prior to completion|21|||
130200864|NCT00860249|468694625|FG001|Overall Study|trial was terminated prior to completion|18|||
130200865|NCT00860249|468694626|FG002|Overall Study|trial was terminated prior to completion|21|||
130200866|NCT00174967|468694627|FG000|Overall Study|Adverse Event|1|||
130200867|NCT00174967|468694628|FG001|Overall Study|Adverse Event|2|||
130200868|NCT00174967|468694629|FG002|Overall Study|Adverse Event|2|||
130200869|NCT00174967|468694630|FG003|Overall Study|Adverse Event|1|||
130200870|NCT00174967|468694627|FG000|Overall Study|Gout Flare|0|||
130200871|NCT00174967|468694628|FG001|Overall Study|Gout Flare|0|||
130200872|NCT00174967|468694629|FG002|Overall Study|Gout Flare|0|||
130200873|NCT00174967|468694630|FG003|Overall Study|Gout Flare|1|||
130200874|NCT00174967|468694627|FG000|Overall Study|Other|0|||
130200875|NCT00174967|468694628|FG001|Overall Study|Other|1|||
130200876|NCT00174967|468694629|FG002|Overall Study|Other|0|||
130200877|NCT00174967|468694630|FG003|Overall Study|Other|0|||
130200878|NCT04934189|468694631|FG000|Overall Study|Lost to Follow-up|4|||
130200879|NCT04934189|468694631|FG000|Overall Study|Withdrawal by Subject|17|||
130200880|NCT01286168|468694639|FG000|Overall Study|Withdrawal by Subject|1|||
130200881|NCT01286168|468694639|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
130200882|NCT00843037|468694643|FG000|Overall Study|Lost to Follow-up|1|||
130200883|NCT02091960|468694646|FG000|Overall Study|Death|7|||
130200884|NCT02091960|468694646|FG000|Overall Study|Withdrawal by Subject|1|||
130200885|NCT02091960|468694646|FG000|Overall Study|Miscellaneous Reasons|37|||
130200886|NCT02738879|468694657|FG000|Overall Study|Adverse Event|1|||
130200887|NCT02738879|468694658|FG001|Overall Study|Adverse Event|1|||
130200888|NCT02738879|468694657|FG000|Overall Study|Death|0|||
130200889|NCT02738879|468694658|FG001|Overall Study|Death|2|||
130200890|NCT02738879|468694657|FG000|Overall Study|Lost to Follow-up|1|||
130200891|NCT02738879|468694658|FG001|Overall Study|Lost to Follow-up|5|||
130200892|NCT02738879|468694657|FG000|Overall Study|Protocol Violation|1|||
130200893|NCT02738879|468694658|FG001|Overall Study|Protocol Violation|3|||
130200894|NCT02738879|468694657|FG000|Overall Study|Physician Decision|3|||
130200895|NCT02738879|468694658|FG001|Overall Study|Physician Decision|4|||
130200896|NCT02738879|468694657|FG000|Overall Study|Pregnancy|0|||
130200897|NCT02738879|468694658|FG001|Overall Study|Pregnancy|1|||
130200898|NCT02738879|468694657|FG000|Overall Study|Screen Failure|1|||
130200899|NCT02738879|468694658|FG001|Overall Study|Screen Failure|2|||
130200900|NCT02738879|468694657|FG000|Overall Study|Site Discontinued Study Participation|1|||
130200901|NCT02738879|468694658|FG001|Overall Study|Site Discontinued Study Participation|0|||
130200902|NCT02738879|468694657|FG000|Overall Study|Withdrawal by Subject|5|||
130200903|NCT02738879|468694658|FG001|Overall Study|Withdrawal by Subject|7|||
130200904|NCT01438294|468694659|FG000|Overall Study|Lost to Follow-up|3|||
130200905|NCT01438294|468694660|FG001|Overall Study|Lost to Follow-up|7|||
130200906|NCT01346189|468694663|FG000|Overall Study|Withdrawal by Subject|7|||
130200907|NCT01346189|468694664|FG001|Overall Study|Withdrawal by Subject|5|||
130200908|NCT01346189|468694665|FG002|Overall Study|Withdrawal by Subject|3|||
130200909|NCT01346189|468694666|FG003|Overall Study|Withdrawal by Subject|5|||
130200910|NCT01346189|468694663|FG000|Overall Study|Physician Decision|4|||
130200911|NCT01346189|468694664|FG001|Overall Study|Physician Decision|0|||
130200912|NCT01346189|468694665|FG002|Overall Study|Physician Decision|0|||
130200913|NCT01346189|468694666|FG003|Overall Study|Physician Decision|0|||
130200914|NCT01346189|468694663|FG000|Overall Study|Moved|3|||
130200915|NCT01346189|468694664|FG001|Overall Study|Moved|0|||
130200916|NCT01346189|468694665|FG002|Overall Study|Moved|4|||
130200917|NCT01346189|468694666|FG003|Overall Study|Moved|0|||
130200918|NCT01346189|468694663|FG000|Overall Study|Other|2|||
130200919|NCT01346189|468694664|FG001|Overall Study|Other|4|||
130200920|NCT01346189|468694665|FG002|Overall Study|Other|7|||
130200921|NCT01346189|468694666|FG003|Overall Study|Other|3|||
130200922|NCT01346189|468694663|FG000|Overall Study|Death|0|||
130200923|NCT01346189|468694664|FG001|Overall Study|Death|3|||
130200924|NCT01346189|468694665|FG002|Overall Study|Death|0|||
130200925|NCT01346189|468694666|FG003|Overall Study|Death|0|||
130200926|NCT01346189|468694663|FG000|Overall Study|Non-health system primary care physician|0|||
130200927|NCT01346189|468694664|FG001|Overall Study|Non-health system primary care physician|5|||
130200928|NCT01346189|468694665|FG002|Overall Study|Non-health system primary care physician|0|||
130200929|NCT01346189|468694666|FG003|Overall Study|Non-health system primary care physician|0|||
130200930|NCT01346189|468694663|FG000|Overall Study|Travel|0|||
130200931|NCT01346189|468694664|FG001|Overall Study|Travel|0|||
130200932|NCT01346189|468694665|FG002|Overall Study|Travel|0|||
130200933|NCT01346189|468694666|FG003|Overall Study|Travel|3|||
130200934|NCT01730534|468694667|FG000|Overall Study|Withdrawal by Subject|97|||
130200935|NCT01730534|468694668|FG001|Overall Study|Withdrawal by Subject|127|||
130200936|NCT01730534|468694667|FG000|Overall Study|Lost to Follow-up|12|||
130200937|NCT01730534|468694668|FG001|Overall Study|Lost to Follow-up|18|||
130200938|NCT01895608|468694669|FG000|Overall Study|change in health status|0|||
130200939|NCT01895608|468694670|FG001|Overall Study|change in health status|1|||
130200940|NCT01895608|468694671|FG002|Overall Study|change in health status|1|||
130200941|NCT01895608|468694672|FG003|Overall Study|change in health status|0|||
130200942|NCT01895608|468694669|FG000|Overall Study|Withdrawal by Subject|0|||
130200943|NCT01895608|468694670|FG001|Overall Study|Withdrawal by Subject|0|||
130200944|NCT01895608|468694671|FG002|Overall Study|Withdrawal by Subject|2|||
130200945|NCT01895608|468694672|FG003|Overall Study|Withdrawal by Subject|0|||
130200946|NCT02855359|468694675|FG000|Overall Study|Death|2|||
130200947|NCT02855359|468694676|FG001|Overall Study|Death|2|||
130200948|NCT02855359|468694677|FG002|Overall Study|Death|0|||
130200949|NCT02855359|468694678|FG003|Overall Study|Death|0|||
130200950|NCT02855359|468694675|FG000|Overall Study|Study Termination by Sponsor|9|||
130200951|NCT02855359|468694676|FG001|Overall Study|Study Termination by Sponsor|11|||
130200952|NCT02855359|468694677|FG002|Overall Study|Study Termination by Sponsor|0|||
130200953|NCT02855359|468694678|FG003|Overall Study|Study Termination by Sponsor|0|||
130200954|NCT02833844|468694679|FG000|Double-Blind Period|Withdrawal by Subject|2|||
130200955|NCT02833844|468694680|FG001|Double-Blind Period|Withdrawal by Subject|3|||
130200956|NCT02833844|468694679|FG000|Double-Blind Period|Protocol Violation|0|||
130200957|NCT02833844|468694680|FG001|Double-Blind Period|Protocol Violation|4|||
130200958|NCT02833844|468694679|FG000|Open-Label Period|Death|0|||
130200959|NCT02833844|468694680|FG001|Open-Label Period|Death|2|||
130200960|NCT02833844|468694679|FG000|Open-Label Period|Lost to Follow-up|1|||
130200961|NCT02833844|468694680|FG001|Open-Label Period|Lost to Follow-up|0|||
130200962|NCT02833844|468694679|FG000|Open-Label Period|Withdrawal by Subject|1|||
130200963|NCT02833844|468694680|FG001|Open-Label Period|Withdrawal by Subject|0|||
130200964|NCT02541669|468694683|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130200965|NCT02541669|468694684|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130200966|NCT02541669|468694685|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130200967|NCT02541669|468694686|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
130200968|NCT02541669|468694687|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
130200969|NCT01084668|468694689|FG000|Overall Study|Lack of Efficacy|5|||
130200970|NCT01084668|468694689|FG000|Overall Study|Withdrawal by Subject|2|||
130200971|NCT01084668|468694689|FG000|Overall Study|Pregnancy|1|||
130200972|NCT01084668|468694689|FG000|Overall Study|Non-compliance|1|||
130200973|NCT00655733|468694696|FG000|Overall Study|Lost to Follow-up|2|||
130200974|NCT00655733|468694697|FG001|Overall Study|Lost to Follow-up|2|||
130200975|NCT00655733|468694696|FG000|Overall Study|Adverse Event|2|||
130200976|NCT00655733|468694697|FG001|Overall Study|Adverse Event|2|||
130200977|NCT00655733|468694696|FG000|Overall Study|Withdrawal by Subject|3|||
130200978|NCT00655733|468694697|FG001|Overall Study|Withdrawal by Subject|3|||
130200979|NCT00655733|468694696|FG000|Overall Study|Physician Decision|0|||
130200980|NCT00655733|468694697|FG001|Overall Study|Physician Decision|1|||
130200981|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
130200982|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130200983|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
130200984|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
130200985|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130200986|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
130200987|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Other|0|||
130200988|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Other|0|||
130200989|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Other|1|||
130200990|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Other|0|||
130200991|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Other|0|||
130200992|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Other|0|||
130200993|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200994|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
130200995|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200996|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200997|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200998|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
130200999|NCT02122770|468694698|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
130201000|NCT02122770|468694699|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
130201001|NCT02122770|468694700|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130201002|NCT02122770|468694701|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
130201003|NCT02122770|468694702|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130201004|NCT02122770|468694703|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
130201005|NCT02122770|468694698|FG000|Part B: Standard of Care|Adverse Event|0|||
130201006|NCT02122770|468694699|FG001|Part B: Standard of Care|Adverse Event|0|||
130201007|NCT02122770|468694700|FG002|Part B: Standard of Care|Adverse Event|0|||
130201008|NCT02122770|468694701|FG003|Part B: Standard of Care|Adverse Event|0|||
130201009|NCT02122770|468694702|FG004|Part B: Standard of Care|Adverse Event|4|||
130201010|NCT02122770|468694703|FG005|Part B: Standard of Care|Adverse Event|1|||
130201011|NCT02122770|468694698|FG000|Part B: Standard of Care|Other|0|||
130201012|NCT02122770|468694699|FG001|Part B: Standard of Care|Other|0|||
130201013|NCT02122770|468694700|FG002|Part B: Standard of Care|Other|0|||
130201014|NCT02122770|468694701|FG003|Part B: Standard of Care|Other|0|||
130201015|NCT02122770|468694702|FG004|Part B: Standard of Care|Other|0|||
130201016|NCT02122770|468694703|FG005|Part B: Standard of Care|Other|2|||
130201017|NCT02122770|468694698|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
130201018|NCT02122770|468694699|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
130201019|NCT02122770|468694700|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
130201020|NCT02122770|468694701|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
130201021|NCT02122770|468694702|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
130201022|NCT02122770|468694703|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
130201023|NCT02122770|468694698|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201024|NCT02122770|468694699|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201025|NCT02122770|468694700|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201026|NCT02122770|468694701|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201027|NCT02122770|468694702|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
130201028|NCT02122770|468694703|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
130201029|NCT02122770|468694698|FG000|Part B: Standard of Care|Progressive Disease|0|||
130201030|NCT02122770|468694699|FG001|Part B: Standard of Care|Progressive Disease|0|||
130201031|NCT02122770|468694700|FG002|Part B: Standard of Care|Progressive Disease|0|||
130201032|NCT02122770|468694701|FG003|Part B: Standard of Care|Progressive Disease|0|||
130201033|NCT02122770|468694702|FG004|Part B: Standard of Care|Progressive Disease|10|||
130201034|NCT02122770|468694703|FG005|Part B: Standard of Care|Progressive Disease|8|||
130201035|NCT01740128|468694704|FG000|Overall Study|Pregnancy|0|||
130201036|NCT01740128|468694705|FG001|Overall Study|Pregnancy|1|||
130201037|NCT01740128|468694704|FG000|Overall Study|Protocol Violation|1|||
130201038|NCT01740128|468694705|FG001|Overall Study|Protocol Violation|2|||
130201039|NCT01740128|468694704|FG000|Overall Study|Lost to Follow-up|2|||
130201040|NCT01740128|468694705|FG001|Overall Study|Lost to Follow-up|2|||
130201041|NCT01740128|468694704|FG000|Overall Study|Withdrawal by Subject|1|||
130201042|NCT01740128|468694705|FG001|Overall Study|Withdrawal by Subject|0|||
130201043|NCT01740128|468694704|FG000|Overall Study|Insufficient protocol compliance|2|||
130201044|NCT01740128|468694705|FG001|Overall Study|Insufficient protocol compliance|2|||
130201045|NCT02474589|468694706|FG000|Overall Study|Adverse Event|6|||
130201046|NCT02474589|468694707|FG001|Overall Study|Adverse Event|2|||
130201047|NCT02474589|468694706|FG000|Overall Study|Lost to Follow-up|6|||
130201048|NCT02474589|468694707|FG001|Overall Study|Lost to Follow-up|1|||
130201049|NCT02474589|468694706|FG000|Overall Study|Protocol Violation|4|||
130201050|NCT02474589|468694707|FG001|Overall Study|Protocol Violation|1|||
130201051|NCT02474589|468694706|FG000|Overall Study|Withdrawal by Subject|4|||
130201052|NCT02474589|468694707|FG001|Overall Study|Withdrawal by Subject|0|||
130201053|NCT02474589|468694706|FG000|Overall Study|Inability to complete study procedures|5|||
130201054|NCT02474589|468694707|FG001|Overall Study|Inability to complete study procedures|1|||
130201055|NCT02658734|468694710|FG000|Overall Study|Adverse Event|2|||
130201056|NCT02658734|468694710|FG000|Overall Study|Death|4|||
130201057|NCT02658734|468694710|FG000|Overall Study|Lost to Follow-up|7|||
130201058|NCT02658734|468694710|FG000|Overall Study|Withdrawal of Consent|16|||
130201059|NCT02658734|468694710|FG000|Overall Study|Disease Progression|28|||
130201060|NCT00459706|468694712|FG000|Overall Study|Adverse Event|19|||
130201061|NCT00459706|468694713|FG001|Overall Study|Adverse Event|13|||
130201062|NCT00459706|468694712|FG000|Overall Study|Withdrawal by Subject|1|||
130201063|NCT00459706|468694713|FG001|Overall Study|Withdrawal by Subject|6|||
130201064|NCT00459706|468694712|FG000|Overall Study|Physician Decision|2|||
130201065|NCT00459706|468694713|FG001|Overall Study|Physician Decision|0|||
130201066|NCT00459706|468694712|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
130201067|NCT00459706|468694713|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
130201068|NCT00459706|468694712|FG000|Overall Study|Protocol Violation|2|||
130201069|NCT00459706|468694713|FG001|Overall Study|Protocol Violation|1|||
130201070|NCT00459706|468694712|FG000|Overall Study|Failed to Return|1|||
130201071|NCT00459706|468694713|FG001|Overall Study|Failed to Return|0|||
130201072|NCT00459706|468694712|FG000|Overall Study|Other|0|||
130201073|NCT00459706|468694713|FG001|Overall Study|Other|1|||
130201074|NCT00189306|468694714|FG000|Treatment Period|Withdrawal by Subject|2|||
130201075|NCT00189306|468694714|FG000|Treatment Period|Adverse Event|2|||
130201076|NCT00189306|468694714|FG000|Treatment Period|Protocol Violation|1|||
130201077|NCT00189306|468694714|FG000|Posttreatment Period|Death|1|||
130201078|NCT00189306|468694714|FG000|Posttreatment Period|Withdrawal by Subject|2|||
130201079|NCT00189306|468694714|FG000|Posttreatment Period|Noncompliance|1|||
130201080|NCT00189306|468694714|FG000|Posttreatment Period|Target lesion excised|1|||
130201081|NCT00189306|468694714|FG000|Posttreatment Period|Protocol Violation|1|||
130201082|NCT00189306|468694714|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
130201083|NCT00189306|468694714|FG000|Posttreatment Period|Local skin reaction/sign|1|||
130201084|NCT00189306|468694714|FG000|Long-Term Follow-up|Adverse Event|2|||
130201085|NCT00189306|468694714|FG000|Long-Term Follow-up|Death|4|||
130201086|NCT00189306|468694714|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
130201087|NCT00189306|468694714|FG000|Long-Term Follow-up|Intercurrent disease|2|||
130201088|NCT00189306|468694714|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
130201089|NCT00189306|468694714|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
130201090|NCT03640481|468694715|FG000|Overall Study|Death|14|||
130201091|NCT03640481|468694716|FG001|Overall Study|Death|14|||
130201092|NCT03640481|468694717|FG002|Overall Study|Death|0|||
130201093|NCT03640481|468694718|FG003|Overall Study|Death|0|||
130201094|NCT03640481|468694715|FG000|Overall Study|Lost to Follow-up|2|||
130201095|NCT03640481|468694716|FG001|Overall Study|Lost to Follow-up|0|||
130201096|NCT03640481|468694717|FG002|Overall Study|Lost to Follow-up|0|||
130201097|NCT03640481|468694718|FG003|Overall Study|Lost to Follow-up|0|||
130201098|NCT03640481|468694715|FG000|Overall Study|Site terminated by sponsor|1|||
130201099|NCT03640481|468694716|FG001|Overall Study|Site terminated by sponsor|3|||
130201100|NCT03640481|468694717|FG002|Overall Study|Site terminated by sponsor|0|||
130201101|NCT03640481|468694718|FG003|Overall Study|Site terminated by sponsor|0|||
130201102|NCT03640481|468694715|FG000|Overall Study|Study terminated by sponsor|29|||
130201103|NCT03640481|468694716|FG001|Overall Study|Study terminated by sponsor|42|||
130201104|NCT03640481|468694717|FG002|Overall Study|Study terminated by sponsor|1|||
130201105|NCT03640481|468694718|FG003|Overall Study|Study terminated by sponsor|0|||
130201106|NCT03640481|468694715|FG000|Overall Study|Withdrawal by Subject|5|||
130201107|NCT03640481|468694716|FG001|Overall Study|Withdrawal by Subject|4|||
130201108|NCT03640481|468694717|FG002|Overall Study|Withdrawal by Subject|0|||
130201109|NCT03640481|468694718|FG003|Overall Study|Withdrawal by Subject|1|||
130201110|NCT03640481|468694715|FG000|Overall Study|Other|26|||
130201111|NCT03640481|468694716|FG001|Overall Study|Other|12|||
130201112|NCT03640481|468694717|FG002|Overall Study|Other|1|||
130201113|NCT03640481|468694718|FG003|Overall Study|Other|0|||
130201114|NCT03640481|468694715|FG000|Overall Study|Randomized, but not treated|1|||
130201115|NCT03640481|468694716|FG001|Overall Study|Randomized, but not treated|3|||
130201116|NCT03640481|468694717|FG002|Overall Study|Randomized, but not treated|0|||
130201117|NCT03640481|468694718|FG003|Overall Study|Randomized, but not treated|0|||
130201118|NCT00727844|468694719|FG000|Initial Randomization|Physician Decision|2|||
130201119|NCT00727844|468694720|FG001|Initial Randomization|Physician Decision|0|||
130201120|NCT00727844|468694721|FG002|Initial Randomization|Physician Decision|0|||
130201121|NCT00727844|468694722|FG003|Initial Randomization|Physician Decision|0|||
130201122|NCT00373958|468694723|FG000|Infant Series|Withdrawal by Subject|13|||
130201123|NCT00373958|468694724|FG001|Infant Series|Withdrawal by Subject|15|||
130201124|NCT00373958|468694723|FG000|Infant Series|Failed to return|8|||
130201125|NCT00373958|468694724|FG001|Infant Series|Failed to return|13|||
130201126|NCT00373958|468694723|FG000|Infant Series|Lost to Follow-up|6|||
130201127|NCT00373958|468694724|FG001|Infant Series|Lost to Follow-up|5|||
130201128|NCT00373958|468694723|FG000|Infant Series|Protocol Violation|3|||
130201129|NCT00373958|468694724|FG001|Infant Series|Protocol Violation|7|||
130201130|NCT00373958|468694723|FG000|Infant Series|Lost Kaiser coverage|4|||
130201131|NCT00373958|468694724|FG001|Infant Series|Lost Kaiser coverage|0|||
130201132|NCT00373958|468694723|FG000|Infant Series|Child relocated|1|||
130201133|NCT00373958|468694724|FG001|Infant Series|Child relocated|0|||
130201134|NCT00373958|468694723|FG000|Infant Series|Consent was not received|1|||
130201135|NCT00373958|468694724|FG001|Infant Series|Consent was not received|0|||
130201136|NCT00373958|468694723|FG000|Infant Series|Adverse Event|3|||
130201137|NCT00373958|468694724|FG001|Infant Series|Adverse Event|1|||
130201138|NCT00373958|468694723|FG000|Infant Series|Physician Decision|1|||
130201139|NCT00373958|468694724|FG001|Infant Series|Physician Decision|1|||
130201140|NCT00373958|468694723|FG000|Toddler Dose|Lost to Follow-up|5|||
130201141|NCT00373958|468694724|FG001|Toddler Dose|Lost to Follow-up|8|||
130201142|NCT00373958|468694723|FG000|Toddler Dose|Withdrawal by Subject|2|||
130201143|NCT00373958|468694724|FG001|Toddler Dose|Withdrawal by Subject|2|||
130201144|NCT00373958|468694723|FG000|Toddler Dose|Failed to return|1|||
130201145|NCT00373958|468694724|FG001|Toddler Dose|Failed to return|2|||
130201146|NCT00373958|468694723|FG000|Toddler Dose|Protocol Violation|0|||
130201147|NCT00373958|468694724|FG001|Toddler Dose|Protocol Violation|1|||
130201148|NCT00373958|468694723|FG000|Toddler Dose|Withdrawn after infant series|22|||
130201149|NCT00373958|468694724|FG001|Toddler Dose|Withdrawn after infant series|25|||
130201150|NCT01552915|468694725|FG000|Overall Study|Adverse Event|3|||
130201151|NCT01552915|468694726|FG001|Overall Study|Adverse Event|14|||
130201152|NCT01552915|468694727|FG002|Overall Study|Adverse Event|3|||
130201153|NCT01552915|468694725|FG000|Overall Study|Lost to Follow-up|4|||
130201154|NCT01552915|468694726|FG001|Overall Study|Lost to Follow-up|6|||
130201155|NCT01552915|468694727|FG002|Overall Study|Lost to Follow-up|5|||
130201156|NCT01552915|468694725|FG000|Overall Study|Withdrawal by Subject|6|||
130201157|NCT01552915|468694726|FG001|Overall Study|Withdrawal by Subject|4|||
130201158|NCT01552915|468694727|FG002|Overall Study|Withdrawal by Subject|5|||
130201159|NCT01552915|468694725|FG000|Overall Study|Protocol Violation|0|||
130201160|NCT01552915|468694726|FG001|Overall Study|Protocol Violation|4|||
130201161|NCT01552915|468694727|FG002|Overall Study|Protocol Violation|4|||
130201162|NCT01552915|468694725|FG000|Overall Study|Lack of Efficacy|8|||
130201163|NCT01552915|468694726|FG001|Overall Study|Lack of Efficacy|1|||
130201164|NCT01552915|468694727|FG002|Overall Study|Lack of Efficacy|4|||
130201165|NCT01552915|468694725|FG000|Overall Study|Other|2|||
130201166|NCT01552915|468694726|FG001|Overall Study|Other|0|||
130201167|NCT01552915|468694727|FG002|Overall Study|Other|6|||
130201168|NCT02457832|468694730|FG000|Training|Lost to Follow-up|10|||
130201169|NCT02457832|468694731|FG001|Training|Lost to Follow-up|6|||
130201170|NCT02457832|468694732|FG002|Training|Lost to Follow-up|3|||
130201171|NCT02457832|468694730|FG000|One Month Washout|Lost to Follow-up|0|||
130201172|NCT02457832|468694731|FG001|One Month Washout|Lost to Follow-up|1|||
130201173|NCT02457832|468694732|FG002|One Month Washout|Lost to Follow-up|1|||
130201174|NCT01880086|468694733|FG000|Overall Study|Lost to Follow-up|1|||
130201175|NCT01880086|468694734|FG001|Overall Study|Lost to Follow-up|1|||
130201176|NCT03403751|468694738|FG000|Overall Study|Death|5|||
130201177|NCT03403751|468694739|FG001|Overall Study|Death|6|||
130201178|NCT03403751|468694738|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
130201179|NCT03403751|468694739|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
130201180|NCT00520481|468694743|FG000|Overall Study|Adverse Event|4|||
130201181|NCT00520481|468694744|FG001|Overall Study|Adverse Event|1|||
130201182|NCT00520481|468694743|FG000|Overall Study|Withdrawal by Subject|3|||
130201183|NCT00520481|468694744|FG001|Overall Study|Withdrawal by Subject|0|||
130201184|NCT02091986|468694745|FG000|Overall Study|7 rand in error 1 patient decision|2|||
130201185|NCT02091986|468694746|FG001|Overall Study|7 rand in error 1 patient decision|3|||
130201186|NCT02091986|468694747|FG002|Overall Study|7 rand in error 1 patient decision|3|||
130201187|NCT02091986|468694745|FG000|Overall Study|Lost to Follow-up|1|||
130201188|NCT02091986|468694746|FG001|Overall Study|Lost to Follow-up|0|||
130201189|NCT02091986|468694747|FG002|Overall Study|Lost to Follow-up|0|||
130201190|NCT02091986|468694745|FG000|Overall Study|Withdrawal by Subject|4|||
130201191|NCT02091986|468694746|FG001|Overall Study|Withdrawal by Subject|8|||
130201192|NCT02091986|468694747|FG002|Overall Study|Withdrawal by Subject|3|||
130201193|NCT02091986|468694745|FG000|Overall Study|Adverse Event|0|||
130201194|NCT02091986|468694746|FG001|Overall Study|Adverse Event|0|||
130201195|NCT02091986|468694747|FG002|Overall Study|Adverse Event|2|||
130201196|NCT02537431|468694751|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
130201197|NCT00794040|468694752|FG000|Overall Study|Withdrawal by Subject|3|||
130201198|NCT00794040|468694753|FG001|Overall Study|Withdrawal by Subject|4|||
130201199|NCT00794040|468694752|FG000|Overall Study|Physician Decision|0|||
130201200|NCT00794040|468694753|FG001|Overall Study|Physician Decision|1|||
130201201|NCT03626363|468694754|FG000|Overall Study|Protocol Violation|4|||
130201202|NCT03626363|468694755|FG001|Overall Study|Protocol Violation|0|||
130201203|NCT03626363|468694754|FG000|Overall Study|Lost to Follow-up|5|||
130201204|NCT03626363|468694755|FG001|Overall Study|Lost to Follow-up|7|||
130201205|NCT02600845|468694756|FG000|Overall Study|Reason Not Specified|3|||
130201206|NCT02600845|468694756|FG000|Overall Study|Non-compliance with Study Procedures|10|||
130201207|NCT02600845|468694756|FG000|Overall Study|Consent Withdrawal|5|||
130201208|NCT04413552|468694757|FG000|Overall Study|Adverse Event|0|||
130201209|NCT04413552|468694758|FG001|Overall Study|Adverse Event|0|||
130201210|NCT04413552|468694759|FG002|Overall Study|Adverse Event|0|||
130201211|NCT04413552|468694760|FG003|Overall Study|Adverse Event|0|||
130201212|NCT04413552|468694761|FG004|Overall Study|Adverse Event|0|||
130201213|NCT04413552|468694762|FG005|Overall Study|Adverse Event|0|||
130201214|NCT04413552|468694763|FG006|Overall Study|Adverse Event|1|||
130201215|NCT04413552|468694764|FG007|Overall Study|Adverse Event|0|||
130201216|NCT04413552|468694765|FG008|Overall Study|Adverse Event|0|||
130201217|NCT04413552|468694766|FG009|Overall Study|Adverse Event|0|||
130201218|NCT04852679|468694767|FG000|Main Intervention Period|Withdrawal by Subject|3|||
130201219|NCT04852679|468694767|FG000|Main Intervention Period|Adverse Event|1|||
130201220|NCT04852679|468694767|FG000|Main Intervention Period|Progressive Disease|16|||
130201221|NCT04852679|468694767|FG000|Main Intervention Period|Refused study visit|1|||
130201222|NCT04852679|468694767|FG000|Independent Injection Period|Missed study visit|1|||
130201223|NCT01294696|468694768|FG000|Overall Study|Screening failures|7|||
130201224|NCT01294696|468694768|FG000|Overall Study|Protocol Violation|8|||
130201225|NCT01294696|468694768|FG000|Overall Study|Missing BPI Response|7|||
130201226|NCT01294696|468694768|FG000|Overall Study|Site closure|52|||
130201227|NCT01871402|468696455|FG000|Overall Study|Lost to Follow-up|1|||
130201228|NCT01871402|468696456|FG001|Overall Study|Lost to Follow-up|0|||
130201229|NCT01871402|468696455|FG000|Overall Study|Withdrawal by Subject|0|||
130201230|NCT01871402|468696456|FG001|Overall Study|Withdrawal by Subject|2|||
130201231|NCT01871402|468696455|FG000|Overall Study|Non-compliance|0|||
130201232|NCT01871402|468696456|FG001|Overall Study|Non-compliance|1|||
130201233|NCT04594941|468696457|FG000|Overall Study|Other|0|||
130201234|NCT04594941|468696458|FG001|Overall Study|Other|3|||
130201235|NCT04594941|468696459|FG002|Overall Study|Other|1|||
130201236|NCT04594941|468696460|FG003|Overall Study|Other|0|||
130201237|NCT02424630|468696461|FG000|Overall Study|No rotator cuff tear|1|||
130201238|NCT02424630|468696462|FG001|Overall Study|No rotator cuff tear|2|||
130201239|NCT02424630|468696461|FG000|Overall Study|Open procedure|0|||
130201240|NCT02424630|468696462|FG001|Overall Study|Open procedure|1|||
130201241|NCT02703272|468696463|FG000|Overall Study|Death|4|||
130201242|NCT02703272|468696464|FG001|Overall Study|Death|9|||
130201243|NCT02703272|468696465|FG002|Overall Study|Death|19|||
130201244|NCT02703272|468696466|FG003|Overall Study|Death|10|||
130201245|NCT02703272|468696463|FG000|Overall Study|Withdrawal by Subject|0|||
130201246|NCT02703272|468696464|FG001|Overall Study|Withdrawal by Subject|0|||
130201247|NCT02703272|468696465|FG002|Overall Study|Withdrawal by Subject|4|||
130201248|NCT02703272|468696466|FG003|Overall Study|Withdrawal by Subject|2|||
130201249|NCT02703272|468696463|FG000|Overall Study|Study Terminated by Sponsor|6|||
130201250|NCT02703272|468696464|FG001|Overall Study|Study Terminated by Sponsor|1|||
130201251|NCT02703272|468696465|FG002|Overall Study|Study Terminated by Sponsor|12|||
130201252|NCT02703272|468696466|FG003|Overall Study|Study Terminated by Sponsor|4|||
130201253|NCT02703272|468696463|FG000|Overall Study|Other|1|||
130201254|NCT02703272|468696464|FG001|Overall Study|Other|0|||
130201255|NCT02703272|468696465|FG002|Overall Study|Other|0|||
130201256|NCT02703272|468696466|FG003|Overall Study|Other|0|||
130201257|NCT02637895|468696467|FG000|Overall Study|Lost to Follow-up|4|||
130201258|NCT02637895|468696468|FG001|Overall Study|Lost to Follow-up|0|||
130201259|NCT02637895|468696467|FG000|Overall Study|Protocol Violation|0|||
130201260|NCT02637895|468696468|FG001|Overall Study|Protocol Violation|1|||
130201261|NCT02637895|468696467|FG000|Overall Study|Lack of Efficacy|1|||
130201262|NCT02637895|468696468|FG001|Overall Study|Lack of Efficacy|0|||
130201263|NCT02637895|468696467|FG000|Overall Study|Withdrawal by Subject|1|||
130201264|NCT02637895|468696468|FG001|Overall Study|Withdrawal by Subject|1|||
130201265|NCT02637895|468696467|FG000|Overall Study|Abnormal baseline lab|0|||
130201266|NCT02637895|468696468|FG001|Overall Study|Abnormal baseline lab|1|||
130201267|NCT02031640|468696469|FG000|Screening Period|Adverse Event|1|||
130201268|NCT02031640|468696470|FG001|Screening Period|Adverse Event|0|||
130201269|NCT02031640|468696471|FG002|Screening Period|Adverse Event|0|||
130201270|NCT02031640|468696472|FG003|Screening Period|Adverse Event|0|||
130201271|NCT02031640|468696473|FG004|Screening Period|Adverse Event|0|||
130201272|NCT02031640|468696474|FG005|Screening Period|Adverse Event|0|||
130201273|NCT02031640|468696469|FG000|Screening Period|Withdrawal by Subject|29|||
130201274|NCT02031640|468696470|FG001|Screening Period|Withdrawal by Subject|0|||
130201275|NCT02031640|468696471|FG002|Screening Period|Withdrawal by Subject|0|||
130201276|NCT02031640|468696472|FG003|Screening Period|Withdrawal by Subject|0|||
130201277|NCT02031640|468696473|FG004|Screening Period|Withdrawal by Subject|0|||
130201278|NCT02031640|468696474|FG005|Screening Period|Withdrawal by Subject|0|||
130201279|NCT02031640|468696469|FG000|Screening Period|Inclusion criteria not met|312|||
130201280|NCT02031640|468696470|FG001|Screening Period|Inclusion criteria not met|0|||
130201281|NCT02031640|468696471|FG002|Screening Period|Inclusion criteria not met|0|||
130201282|NCT02031640|468696472|FG003|Screening Period|Inclusion criteria not met|0|||
130201283|NCT02031640|468696473|FG004|Screening Period|Inclusion criteria not met|0|||
130201284|NCT02031640|468696474|FG005|Screening Period|Inclusion criteria not met|0|||
130201285|NCT02031640|468696469|FG000|Screening Period|Exclusion criteria met|30|||
130201286|NCT02031640|468696470|FG001|Screening Period|Exclusion criteria met|0|||
130201287|NCT02031640|468696471|FG002|Screening Period|Exclusion criteria met|0|||
130201288|NCT02031640|468696472|FG003|Screening Period|Exclusion criteria met|0|||
130201289|NCT02031640|468696473|FG004|Screening Period|Exclusion criteria met|0|||
130201290|NCT02031640|468696474|FG005|Screening Period|Exclusion criteria met|0|||
130201291|NCT02031640|468696469|FG000|Screening Period|Lost to Follow-up|14|||
130201292|NCT02031640|468696470|FG001|Screening Period|Lost to Follow-up|0|||
130201293|NCT02031640|468696471|FG002|Screening Period|Lost to Follow-up|0|||
130201294|NCT02031640|468696472|FG003|Screening Period|Lost to Follow-up|0|||
130201295|NCT02031640|468696473|FG004|Screening Period|Lost to Follow-up|0|||
130201296|NCT02031640|468696474|FG005|Screening Period|Lost to Follow-up|0|||
130201297|NCT02031640|468696469|FG000|Screening Period|Enrollment closed|26|||
130201298|NCT02031640|468696470|FG001|Screening Period|Enrollment closed|0|||
130201299|NCT02031640|468696471|FG002|Screening Period|Enrollment closed|0|||
130201300|NCT02031640|468696472|FG003|Screening Period|Enrollment closed|0|||
130201301|NCT02031640|468696473|FG004|Screening Period|Enrollment closed|0|||
130201302|NCT02031640|468696474|FG005|Screening Period|Enrollment closed|0|||
130201303|NCT02031640|468696469|FG000|Run-In Period|Adverse Event|4|||
130201304|NCT02031640|468696470|FG001|Run-In Period|Adverse Event|0|||
130201305|NCT02031640|468696471|FG002|Run-In Period|Adverse Event|0|||
130201306|NCT02031640|468696472|FG003|Run-In Period|Adverse Event|0|||
130201307|NCT02031640|468696473|FG004|Run-In Period|Adverse Event|0|||
130201308|NCT02031640|468696474|FG005|Run-In Period|Adverse Event|0|||
130201309|NCT02031640|468696469|FG000|Run-In Period|Withdrawal by Subject|17|||
130201310|NCT02031640|468696470|FG001|Run-In Period|Withdrawal by Subject|0|||
130201311|NCT02031640|468696471|FG002|Run-In Period|Withdrawal by Subject|0|||
130201312|NCT02031640|468696472|FG003|Run-In Period|Withdrawal by Subject|0|||
130201313|NCT02031640|468696473|FG004|Run-In Period|Withdrawal by Subject|0|||
130201314|NCT02031640|468696474|FG005|Run-In Period|Withdrawal by Subject|0|||
130201315|NCT02031640|468696469|FG000|Run-In Period|Inclusion criteria not met|38|||
130201316|NCT02031640|468696470|FG001|Run-In Period|Inclusion criteria not met|0|||
130201317|NCT02031640|468696471|FG002|Run-In Period|Inclusion criteria not met|0|||
130201318|NCT02031640|468696472|FG003|Run-In Period|Inclusion criteria not met|0|||
130201319|NCT02031640|468696473|FG004|Run-In Period|Inclusion criteria not met|0|||
130201320|NCT02031640|468696474|FG005|Run-In Period|Inclusion criteria not met|0|||
130201321|NCT02031640|468696469|FG000|Run-In Period|Exclusion criteria met|8|||
130201322|NCT02031640|468696470|FG001|Run-In Period|Exclusion criteria met|0|||
130201323|NCT02031640|468696471|FG002|Run-In Period|Exclusion criteria met|0|||
130201324|NCT02031640|468696472|FG003|Run-In Period|Exclusion criteria met|0|||
130201325|NCT02031640|468696473|FG004|Run-In Period|Exclusion criteria met|0|||
130201326|NCT02031640|468696474|FG005|Run-In Period|Exclusion criteria met|0|||
130201327|NCT02031640|468696469|FG000|Run-In Period|Randomization criteria not met|85|||
130201328|NCT02031640|468696470|FG001|Run-In Period|Randomization criteria not met|0|||
130201329|NCT02031640|468696471|FG002|Run-In Period|Randomization criteria not met|0|||
130201330|NCT02031640|468696472|FG003|Run-In Period|Randomization criteria not met|0|||
130201331|NCT02031640|468696473|FG004|Run-In Period|Randomization criteria not met|0|||
130201332|NCT02031640|468696474|FG005|Run-In Period|Randomization criteria not met|0|||
130201333|NCT02031640|468696469|FG000|Run-In Period|Various administrative reasons|17|||
130201334|NCT02031640|468696470|FG001|Run-In Period|Various administrative reasons|0|||
130201335|NCT02031640|468696471|FG002|Run-In Period|Various administrative reasons|0|||
130201336|NCT02031640|468696472|FG003|Run-In Period|Various administrative reasons|0|||
130201337|NCT02031640|468696473|FG004|Run-In Period|Various administrative reasons|0|||
130201338|NCT02031640|468696474|FG005|Run-In Period|Various administrative reasons|0|||
130201339|NCT02031640|468696469|FG000|Double-blind Treatment Period|Protocol deviation|0|||
130201340|NCT02031640|468696470|FG001|Double-blind Treatment Period|Protocol deviation|2|||
130201341|NCT02031640|468696471|FG002|Double-blind Treatment Period|Protocol deviation|0|||
130201342|NCT02031640|468696472|FG003|Double-blind Treatment Period|Protocol deviation|1|||
130201343|NCT02031640|468696473|FG004|Double-blind Treatment Period|Protocol deviation|3|||
130201344|NCT02031640|468696474|FG005|Double-blind Treatment Period|Protocol deviation|1|||
130201345|NCT02031640|468696469|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
130201346|NCT02031640|468696470|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
130201347|NCT02031640|468696471|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
130201348|NCT02031640|468696472|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
130201349|NCT02031640|468696473|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
130201350|NCT02031640|468696474|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
130201351|NCT02031640|468696469|FG000|Double-blind Treatment Period|Non-compliance|0|||
130201352|NCT02031640|468696470|FG001|Double-blind Treatment Period|Non-compliance|1|||
130201353|NCT02031640|468696471|FG002|Double-blind Treatment Period|Non-compliance|0|||
130201354|NCT02031640|468696472|FG003|Double-blind Treatment Period|Non-compliance|1|||
130201355|NCT02031640|468696473|FG004|Double-blind Treatment Period|Non-compliance|1|||
130201356|NCT02031640|468696474|FG005|Double-blind Treatment Period|Non-compliance|0|||
130201357|NCT02031640|468696469|FG000|Double-blind Treatment Period|Adverse Event|0|||
130201358|NCT02031640|468696470|FG001|Double-blind Treatment Period|Adverse Event|0|||
130201359|NCT02031640|468696471|FG002|Double-blind Treatment Period|Adverse Event|0|||
130201360|NCT02031640|468696472|FG003|Double-blind Treatment Period|Adverse Event|2|||
130201361|NCT02031640|468696473|FG004|Double-blind Treatment Period|Adverse Event|0|||
130201362|NCT02031640|468696474|FG005|Double-blind Treatment Period|Adverse Event|0|||
130201363|NCT02031640|468696469|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
130201364|NCT02031640|468696470|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
130201365|NCT02031640|468696471|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
130201366|NCT02031640|468696472|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
130201367|NCT02031640|468696473|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
130201368|NCT02031640|468696474|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
130201369|NCT02031640|468696469|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
130201370|NCT02031640|468696470|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
130201371|NCT02031640|468696471|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
130201372|NCT02031640|468696472|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
130201373|NCT02031640|468696473|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
130201374|NCT02031640|468696474|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
130201375|NCT03085238|468696479|FG000|Overall Study|Adverse Event|2|||
130201376|NCT03085238|468696479|FG000|Overall Study|Death|2|||
130201377|NCT05896527|468696480|FG000|Overall Study|Withdrawal by Subject|11|||
130201378|NCT05896527|468696481|FG001|Overall Study|Withdrawal by Subject|10|||
130201379|NCT05896527|468696482|FG002|Overall Study|Withdrawal by Subject|4|||
130201380|NCT05896527|468696483|FG003|Overall Study|Withdrawal by Subject|3|||
130201381|NCT05896527|468696484|FG004|Overall Study|Withdrawal by Subject|2|||
130201382|NCT05896527|468696480|FG000|Overall Study|Lost to Follow-up|0|||
130201383|NCT05896527|468696481|FG001|Overall Study|Lost to Follow-up|2|||
130201384|NCT05896527|468696482|FG002|Overall Study|Lost to Follow-up|2|||
130201385|NCT05896527|468696483|FG003|Overall Study|Lost to Follow-up|2|||
130201386|NCT05896527|468696484|FG004|Overall Study|Lost to Follow-up|1|||
130201387|NCT05896527|468696480|FG000|Overall Study|Significant protocol noncompliance|0|||
130201388|NCT05896527|468696481|FG001|Overall Study|Significant protocol noncompliance|1|||
130201389|NCT05896527|468696482|FG002|Overall Study|Significant protocol noncompliance|0|||
130201390|NCT05896527|468696483|FG003|Overall Study|Significant protocol noncompliance|0|||
130201391|NCT05896527|468696484|FG004|Overall Study|Significant protocol noncompliance|0|||
130201392|NCT05896527|468696480|FG000|Overall Study|Eligibility criteria not met|1|||
130201393|NCT05896527|468696481|FG001|Overall Study|Eligibility criteria not met|0|||
130201394|NCT05896527|468696482|FG002|Overall Study|Eligibility criteria not met|0|||
130201395|NCT05896527|468696483|FG003|Overall Study|Eligibility criteria not met|0|||
130201396|NCT05896527|468696484|FG004|Overall Study|Eligibility criteria not met|0|||
130201397|NCT05896527|468696480|FG000|Overall Study|Sponsor's decision|0|||
130201398|NCT05896527|468696481|FG001|Overall Study|Sponsor's decision|0|||
130201399|NCT05896527|468696482|FG002|Overall Study|Sponsor's decision|0|||
130201400|NCT05896527|468696483|FG003|Overall Study|Sponsor's decision|1|||
130201401|NCT05896527|468696484|FG004|Overall Study|Sponsor's decision|0|||
130201402|NCT05896527|468696480|FG000|Overall Study|Investigator's decision|0|||
130201403|NCT05896527|468696481|FG001|Overall Study|Investigator's decision|1|||
130201404|NCT05896527|468696482|FG002|Overall Study|Investigator's decision|0|||
130201405|NCT05896527|468696483|FG003|Overall Study|Investigator's decision|0|||
130201406|NCT05896527|468696484|FG004|Overall Study|Investigator's decision|0|||
130201407|NCT05896527|468696480|FG000|Overall Study|Pregnancy of his partner|0|||
130201408|NCT05896527|468696481|FG001|Overall Study|Pregnancy of his partner|0|||
130201409|NCT05896527|468696482|FG002|Overall Study|Pregnancy of his partner|0|||
130201410|NCT05896527|468696483|FG003|Overall Study|Pregnancy of his partner|1|||
130201411|NCT05896527|468696484|FG004|Overall Study|Pregnancy of his partner|0|||
130201412|NCT01279070|468696485|FG000|Overall Study|Withdrawal by Subject|2|||
130201413|NCT01279070|468696486|FG001|Overall Study|Withdrawal by Subject|3|||
130201414|NCT01279070|468696485|FG000|Overall Study|Acute exacerbation|3|||
130201415|NCT01279070|468696486|FG001|Overall Study|Acute exacerbation|1|||
130201416|NCT03781583|468696487|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
130201417|NCT03781583|468696488|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
130201418|NCT03781583|468696489|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
130201419|NCT03781583|468696490|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
130201420|NCT03781583|468696487|FG000|Overall Study|Technology did not work for that person in that environment|1|||
130201421|NCT03781583|468696488|FG001|Overall Study|Technology did not work for that person in that environment|0|||
130201422|NCT03781583|468696489|FG002|Overall Study|Technology did not work for that person in that environment|0|||
130201423|NCT03781583|468696490|FG003|Overall Study|Technology did not work for that person in that environment|0|||
130201424|NCT03781583|468696487|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
130201425|NCT03781583|468696488|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
130201426|NCT03781583|468696489|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
130201427|NCT03781583|468696490|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
130201428|NCT03781583|468696487|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130201429|NCT03781583|468696488|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
130201430|NCT03781583|468696489|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130201431|NCT03781583|468696490|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
130201432|NCT05139303|468696491|FG000|Overall Study|Lost to Follow-up|3|||
130201433|NCT05139303|468696492|FG001|Overall Study|Lost to Follow-up|0|||
130201434|NCT05139303|468696491|FG000|Overall Study|Adverse Event|1|||
130201435|NCT05139303|468696492|FG001|Overall Study|Adverse Event|0|||
130201436|NCT02222545|468696493|FG000|Overall Study|Adverse Event|1|||
130201437|NCT02222545|468696494|FG001|Overall Study|Adverse Event|0|||
130201438|NCT02222545|468696495|FG002|Overall Study|Adverse Event|2|||
130201439|NCT02222545|468696493|FG000|Overall Study|Death|0|||
130201440|NCT02222545|468696494|FG001|Overall Study|Death|0|||
130201441|NCT02222545|468696495|FG002|Overall Study|Death|9|||
130201442|NCT02222545|468696493|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
130201443|NCT02222545|468696494|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
130201444|NCT02222545|468696495|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
130201445|NCT02222545|468696493|FG000|Overall Study|Withdrawal by Subject|0|||
130201446|NCT02222545|468696494|FG001|Overall Study|Withdrawal by Subject|0|||
130201447|NCT02222545|468696495|FG002|Overall Study|Withdrawal by Subject|3|||
130201448|NCT02222545|468696493|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
130201449|NCT02222545|468696494|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
130201450|NCT02222545|468696495|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
130201451|NCT00761280|468696496|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
130201452|NCT00761280|468696497|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
130201453|NCT00761280|468696496|FG000|Randomization to First Dose|Sponsor decision|1|||
130201454|NCT00761280|468696497|FG001|Randomization to First Dose|Sponsor decision|0|||
130201455|NCT00761280|468696496|FG000|Randomization to First Dose|Other|1|||
130201456|NCT00761280|468696497|FG001|Randomization to First Dose|Other|0|||
130201457|NCT00761280|468696496|FG000|First Dose to End of Study|End of trial|5|||
130201458|NCT00761280|468696497|FG001|First Dose to End of Study|End of trial|5|||
130201459|NCT00761280|468696496|FG000|First Dose to End of Study|Progressive disease|5|||
130201460|NCT00761280|468696497|FG001|First Dose to End of Study|Progressive disease|3|||
130201461|NCT00761280|468696496|FG000|First Dose to End of Study|Sponsor decision|1|||
130201462|NCT00761280|468696497|FG001|First Dose to End of Study|Sponsor decision|2|||
130201463|NCT00761280|468696496|FG000|First Dose to End of Study|Death|1|||
130201464|NCT00761280|468696497|FG001|First Dose to End of Study|Death|0|||
130201465|NCT00761280|468696496|FG000|First Dose to End of Study|Lost to Follow-up|0|||
130201466|NCT00761280|468696497|FG001|First Dose to End of Study|Lost to Follow-up|1|||
130201467|NCT03875482|468696498|FG000|Overall Study|Adverse Event|0|||
130201468|NCT03875482|468696499|FG001|Overall Study|Adverse Event|1|||
130201469|NCT03875482|468696498|FG000|Overall Study|Withdrew consent|5|||
130201470|NCT03875482|468696499|FG001|Overall Study|Withdrew consent|6|||
130201471|NCT03875482|468696498|FG000|Overall Study|Lost to Follow-up|8|||
130201472|NCT03875482|468696499|FG001|Overall Study|Lost to Follow-up|2|||
130201473|NCT03875482|468696498|FG000|Overall Study|Lack of Efficacy|0|||
130201474|NCT03875482|468696499|FG001|Overall Study|Lack of Efficacy|11|||
130201475|NCT02045862|468696501|FG000|Overall Study|Death|0|||
130201476|NCT02045862|468696502|FG001|Overall Study|Death|0|||
130201477|NCT02045862|468696503|FG002|Overall Study|Death|1|||
130201478|NCT02045862|468696501|FG000|Overall Study|Miscellaneous|5|||
130201479|NCT02045862|468696502|FG001|Overall Study|Miscellaneous|0|||
130201480|NCT02045862|468696503|FG002|Overall Study|Miscellaneous|8|||
130201481|NCT02045862|468696501|FG000|Overall Study|Withdrawal by Patient|18|||
130201482|NCT02045862|468696502|FG001|Overall Study|Withdrawal by Patient|27|||
130201483|NCT02045862|468696503|FG002|Overall Study|Withdrawal by Patient|57|||
130201484|NCT02045862|468696501|FG000|Overall Study|Protocol Violation|0|||
130201485|NCT02045862|468696502|FG001|Overall Study|Protocol Violation|0|||
130201486|NCT02045862|468696503|FG002|Overall Study|Protocol Violation|6|||
130201487|NCT02045862|468696501|FG000|Overall Study|Lack of Efficacy|8|||
130201488|NCT02045862|468696502|FG001|Overall Study|Lack of Efficacy|4|||
130201489|NCT02045862|468696503|FG002|Overall Study|Lack of Efficacy|13|||
130201490|NCT02045862|468696501|FG000|Overall Study|Randomized but not Received Study Drug|0|||
130201491|NCT02045862|468696502|FG001|Overall Study|Randomized but not Received Study Drug|2|||
130201492|NCT02045862|468696503|FG002|Overall Study|Randomized but not Received Study Drug|8|||
130201493|NCT02045862|468696501|FG000|Overall Study|Adverse Event|7|||
130201494|NCT02045862|468696502|FG001|Overall Study|Adverse Event|5|||
130201495|NCT02045862|468696503|FG002|Overall Study|Adverse Event|27|||
130201496|NCT02045862|468696501|FG000|Overall Study|Lost to Follow-up|1|||
130201497|NCT02045862|468696502|FG001|Overall Study|Lost to Follow-up|2|||
130201498|NCT02045862|468696503|FG002|Overall Study|Lost to Follow-up|6|||
130201499|NCT02691013|468696504|FG000|Overall Study|Withdrawal by Subject|3|||
130201500|NCT02691013|468696505|FG001|Overall Study|Withdrawal by Subject|0|||
130201501|NCT02111785|468696509|FG000|Overall Study|Death|0|||
130201502|NCT02111785|468696510|FG001|Overall Study|Death|1|||
130201503|NCT02111785|468696511|FG002|Overall Study|Death|0|||
130201504|NCT02111785|468696512|FG003|Overall Study|Death|0|||
130201505|NCT01075646|468696515|FG000|Overall Study|Lost to Follow-up|4|||
130201506|NCT01075646|468696516|FG001|Overall Study|Lost to Follow-up|3|||
130201507|NCT01075646|468696517|FG002|Overall Study|Lost to Follow-up|1|||
130201508|NCT01075646|468696518|FG003|Overall Study|Lost to Follow-up|2|||
130201509|NCT01676896|468696522|FG000|Overall Study|Withdrawal by Subject|12|||
130201510|NCT01676896|468696523|FG001|Overall Study|Withdrawal by Subject|7|||
130201511|NCT01676896|468696524|FG002|Overall Study|Withdrawal by Subject|19|||
130201512|NCT02256982|468696525|FG000|Overall Study|Disease Progression|0|||
130201513|NCT02256982|468696526|FG001|Overall Study|Disease Progression|1|||
130201514|NCT02822573|468696527|FG000|Overall Study|Lost to Follow-up|5|||
130201515|NCT02822573|468696528|FG001|Overall Study|Lost to Follow-up|3|||
130201516|NCT02822573|468696527|FG000|Overall Study|Physician Decision|1|||
130201517|NCT02822573|468696528|FG001|Overall Study|Physician Decision|1|||
130201518|NCT02822573|468696527|FG000|Overall Study|Withdrawal by Subject|9|||
130201519|NCT02822573|468696528|FG001|Overall Study|Withdrawal by Subject|5|||
130201520|NCT02822573|468696527|FG000|Overall Study|Protocol Violation|6|||
130201521|NCT02822573|468696528|FG001|Overall Study|Protocol Violation|4|||
130201522|NCT02822573|468696527|FG000|Overall Study|Too sick or ill|2|||
130201523|NCT02822573|468696528|FG001|Overall Study|Too sick or ill|1|||
130201524|NCT02822573|468696527|FG000|Overall Study|Disease Progression|1|||
130201525|NCT02822573|468696528|FG001|Overall Study|Disease Progression|1|||
130201526|NCT02822573|468696527|FG000|Overall Study|No reason given|6|||
130201527|NCT02822573|468696528|FG001|Overall Study|No reason given|4|||
130201528|NCT01044290|468696529|FG000|Follow-up 1|Death|3|||
130201529|NCT01044290|468696530|FG001|Follow-up 1|Death|3|||
130201530|NCT01044290|468696531|FG002|Follow-up 1|Death|1|||
130201531|NCT01044290|468696529|FG000|Follow-up 1|Withdrawal by Subject|2|||
130201532|NCT01044290|468696530|FG001|Follow-up 1|Withdrawal by Subject|2|||
130201533|NCT01044290|468696531|FG002|Follow-up 1|Withdrawal by Subject|0|||
130201534|NCT01044290|468696529|FG000|Follow-Up 2|Death|0|||
130201535|NCT01044290|468696530|FG001|Follow-Up 2|Death|1|||
130201536|NCT01044290|468696531|FG002|Follow-Up 2|Death|1|||
130201537|NCT01044290|468696529|FG000|Follow-Up 2|Withdrawal by Subject|0|||
130201538|NCT01044290|468696530|FG001|Follow-Up 2|Withdrawal by Subject|1|||
130201539|NCT01044290|468696531|FG002|Follow-Up 2|Withdrawal by Subject|1|||
130201540|NCT00759785|468696537|FG000|Overall Study|Participant sample not evaluable|11|||
130201541|NCT00759785|468696538|FG001|Overall Study|Participant sample not evaluable|2|||
130201542|NCT00759785|468696537|FG000|Overall Study|Participant sample lost|0|||
130201543|NCT00759785|468696538|FG001|Overall Study|Participant sample lost|1|||
130201544|NCT00759785|468696537|FG000|Overall Study|Protocol Violation|1|||
130201545|NCT00759785|468696538|FG001|Overall Study|Protocol Violation|0|||
130201546|NCT00759785|468696537|FG000|Overall Study|Physician Decision|0|||
130201547|NCT00759785|468696538|FG001|Overall Study|Physician Decision|1|||
130201548|NCT00759785|468696537|FG000|Overall Study|Withdrawal by Subject|0|||
130201549|NCT00759785|468696538|FG001|Overall Study|Withdrawal by Subject|1|||
130201550|NCT01646021|468696539|FG000|Overall Study|Death|77|||
130201551|NCT01646021|468696540|FG001|Overall Study|Death|83|||
130201552|NCT01646021|468696539|FG000|Overall Study|Study Terminated by Sponsor|50|||
130201553|NCT01646021|468696540|FG001|Overall Study|Study Terminated by Sponsor|41|||
130201554|NCT01646021|468696539|FG000|Overall Study|Lost to Follow-up|2|||
130201555|NCT01646021|468696540|FG001|Overall Study|Lost to Follow-up|2|||
130201556|NCT01646021|468696539|FG000|Overall Study|Withdrawal by Subject|10|||
130201557|NCT01646021|468696540|FG001|Overall Study|Withdrawal by Subject|15|||
130201558|NCT01967706|468696548|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
130201559|NCT01967706|468696549|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
130201560|NCT01967706|468696550|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
130201561|NCT01967706|468696551|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
130201562|NCT02777970|468696552|FG000|Overall Study|Lost to Follow-up|0|||
130201563|NCT02777970|468696553|FG001|Overall Study|Lost to Follow-up|1|||
130201564|NCT02777970|468696554|FG002|Overall Study|Lost to Follow-up|0|||
130201565|NCT02777970|468696552|FG000|Overall Study|Protocol Violation|1|||
130201566|NCT02777970|468696553|FG001|Overall Study|Protocol Violation|0|||
130201567|NCT02777970|468696554|FG002|Overall Study|Protocol Violation|0|||
130201568|NCT02347891|468696555|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
130201569|NCT02347891|468696556|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
130201570|NCT02347891|468696555|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
130201571|NCT02347891|468696556|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
130201572|NCT01083186|468696562|FG000|Overall Study|Lost to Follow-up|48|||
130201573|NCT01083186|468696562|FG000|Overall Study|Consent Withdrawal|7|||
130201574|NCT01083186|468696562|FG000|Overall Study|Death|3|||
130201575|NCT01083186|468696562|FG000|Overall Study|Adverse Event|3|||
130201576|NCT01083186|468696562|FG000|Overall Study|Lack of Efficacy|2|||
130201577|NCT01083186|468696562|FG000|Overall Study|Hemodialysis Initiation|28|||
130201578|NCT01083186|468696562|FG000|Overall Study|Administrative Reasons|2|||
130201579|NCT01083186|468696562|FG000|Overall Study|Non-compliance to Study Treatment|1|||
130201580|NCT03419598|468696569|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
130201581|NCT04569968|468696570|FG000|Overall Study|Lost to Follow-up|2|||
130201582|NCT04569968|468696571|FG001|Overall Study|Lost to Follow-up|5|||
130201583|NCT04569968|468696570|FG000|Overall Study|Story of head and/or neck surgery|2|||
130201584|NCT04569968|468696571|FG001|Overall Study|Story of head and/or neck surgery|2|||
130201585|NCT04569968|468696570|FG000|Overall Study|Time of stroke onset|8|||
130201586|NCT04569968|468696571|FG001|Overall Study|Time of stroke onset|7|||
130201587|NCT04569968|468696570|FG000|Overall Study|Type of strokr|12|||
130201588|NCT04569968|468696571|FG001|Overall Study|Type of strokr|8|||
130201589|NCT04569968|468696570|FG000|Overall Study|Cooperation|8|||
130201590|NCT04569968|468696571|FG001|Overall Study|Cooperation|8|||
130201591|NCT04569968|468696570|FG000|Overall Study|Age interval|17|||
130201592|NCT04569968|468696571|FG001|Overall Study|Age interval|6|||
130201593|NCT04569968|468696570|FG000|Overall Study|Denial of participation to the study|0|||
130201594|NCT04569968|468696571|FG001|Overall Study|Denial of participation to the study|3|||
130201595|NCT04569968|468696570|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
130201596|NCT04569968|468696571|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
130201597|NCT04569968|468696570|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
130201598|NCT04569968|468696571|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
130201599|NCT04569968|468696570|FG000|Overall Study|Quarantine|1|||
130201600|NCT04569968|468696571|FG001|Overall Study|Quarantine|0|||
130201601|NCT04569968|468696570|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
130201602|NCT04569968|468696571|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
130201603|NCT04569968|468696570|FG000|Overall Study|Repetitive stroke|8|||
130201604|NCT04569968|468696571|FG001|Overall Study|Repetitive stroke|0|||
130201605|NCT04569968|468696570|FG000|Overall Study|Insufficient mastication|1|||
130201606|NCT04569968|468696571|FG001|Overall Study|Insufficient mastication|0|||
130201607|NCT04569968|468696570|FG000|Overall Study|Infection|1|||
130201608|NCT04569968|468696571|FG001|Overall Study|Infection|0|||
130201609|NCT02370667|468696572|FG000|Overall Study|Lost to Follow-up|0|||
130201610|NCT02370667|468696573|FG001|Overall Study|Lost to Follow-up|1|||
130201611|NCT02370667|468696574|FG002|Overall Study|Lost to Follow-up|0|||
130201612|NCT00976209|468696577|FG000|Treatment Period 1|Protocol Violation|1|||
130201613|NCT00976209|468696578|FG001|Treatment Period 1|Protocol Violation|0|||
130201614|NCT00976209|468696577|FG000|Treatment Period 1|Lost to Follow-up|2|||
130201615|NCT00976209|468696578|FG001|Treatment Period 1|Lost to Follow-up|0|||
130201616|NCT00976209|468696577|FG000|Treatment Period 1|Other|0|||
130201617|NCT00976209|468696578|FG001|Treatment Period 1|Other|1|||
130201618|NCT00976209|468696577|FG000|Wash-out Period|Adverse Event|1|||
130201619|NCT00976209|468696578|FG001|Wash-out Period|Adverse Event|2|||
130201620|NCT00976209|468696577|FG000|Wash-out Period|Lost to Follow-up|1|||
130201621|NCT00976209|468696578|FG001|Wash-out Period|Lost to Follow-up|0|||
130201622|NCT00976209|468696577|FG000|Wash-out Period|Protocol Violation|1|||
130201623|NCT00976209|468696578|FG001|Wash-out Period|Protocol Violation|0|||
130201624|NCT00976209|468696577|FG000|Wash-out Period|Other|1|||
130201625|NCT00976209|468696578|FG001|Wash-out Period|Other|0|||
130201626|NCT00976209|468696577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
130201627|NCT00976209|468696578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
130201628|NCT00976209|468696577|FG000|Treatment Period 2|Lost to Follow-up|0|||
130201629|NCT00976209|468696578|FG001|Treatment Period 2|Lost to Follow-up|1|||
130201630|NCT03197870|468696582|FG000|Overall Study|Adverse Event|9|||
130201631|NCT03197870|468696583|FG001|Overall Study|Adverse Event|4|||
130201632|NCT03197870|468696584|FG002|Overall Study|Adverse Event|6|||
130201633|NCT03197870|468696582|FG000|Overall Study|Withdrawal by Subject|2|||
130201634|NCT03197870|468696583|FG001|Overall Study|Withdrawal by Subject|3|||
130201635|NCT03197870|468696584|FG002|Overall Study|Withdrawal by Subject|0|||
130201636|NCT03197870|468696582|FG000|Overall Study|Lost to Follow-up|2|||
130201637|NCT03197870|468696583|FG001|Overall Study|Lost to Follow-up|2|||
130201638|NCT03197870|468696584|FG002|Overall Study|Lost to Follow-up|0|||
130201639|NCT03197870|468696582|FG000|Overall Study|data not available|1|||
130201640|NCT03197870|468696583|FG001|Overall Study|data not available|1|||
130201641|NCT03197870|468696584|FG002|Overall Study|data not available|0|||
130201642|NCT00978250|468696588|FG000|Overall Study|Late determination of ineligibility|0|||
130201643|NCT00978250|468696589|FG001|Overall Study|Late determination of ineligibility|1|||
130201644|NCT00978250|468696590|FG002|Overall Study|Late determination of ineligibility|0|||
130201645|NCT00978250|468696591|FG003|Overall Study|Late determination of ineligibility|1|||
130201646|NCT03973918|468696595|FG000|Overall Study|Adverse Event|0|||
130201647|NCT03973918|468696596|FG001|Overall Study|Adverse Event|0|||
130201648|NCT03973918|468696597|FG002|Overall Study|Adverse Event|0|||
130201649|NCT03973918|468696598|FG003|Overall Study|Adverse Event|1|||
130201650|NCT03973918|468696595|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130201651|NCT03973918|468696596|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
130201652|NCT03973918|468696597|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130201653|NCT03973918|468696598|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
130201654|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
130201655|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
130201656|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
130201657|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
130201658|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
130201659|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
130201660|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
130201661|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
130201662|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
130201663|NCT02951533|468696601|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
130201664|NCT02951533|468696602|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
130201665|NCT02951533|468696603|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
130201666|NCT02951533|468696601|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
130201667|NCT02951533|468696602|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
130201668|NCT02951533|468696603|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
130201669|NCT02951533|468696601|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
130201670|NCT02951533|468696602|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
130201671|NCT02951533|468696603|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
130201672|NCT02951533|468696601|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
130201673|NCT02951533|468696602|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
130201674|NCT02951533|468696603|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
130201675|NCT02951533|468696601|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
130201676|NCT02951533|468696602|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
130201677|NCT02951533|468696603|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
130201678|NCT02951533|468696601|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
130201679|NCT02951533|468696602|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
130201680|NCT02951533|468696603|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
130201681|NCT02951533|468696601|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
130201682|NCT02951533|468696602|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
130201683|NCT02951533|468696603|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
130201684|NCT02951533|468696601|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
130201685|NCT02951533|468696602|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
130201686|NCT02951533|468696603|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
130201687|NCT05174949|468696604|FG000|Overall Study|Physician Decision|1|||
130201688|NCT05174949|468696605|FG001|Overall Study|Physician Decision|2|||
130201689|NCT05174949|468696606|FG002|Overall Study|Physician Decision|0|||
130201690|NCT05174949|468696607|FG003|Overall Study|Physician Decision|1|||
130201691|NCT05174949|468696608|FG004|Overall Study|Physician Decision|0|||
130201692|NCT05174949|468696609|FG005|Overall Study|Physician Decision|0|||
130201693|NCT05174949|468696604|FG000|Overall Study|Withdrawal by Subject|0|||
130201694|NCT05174949|468696605|FG001|Overall Study|Withdrawal by Subject|1|||
130201695|NCT05174949|468696606|FG002|Overall Study|Withdrawal by Subject|0|||
130201696|NCT05174949|468696607|FG003|Overall Study|Withdrawal by Subject|0|||
130201697|NCT05174949|468696608|FG004|Overall Study|Withdrawal by Subject|0|||
130201698|NCT05174949|468696609|FG005|Overall Study|Withdrawal by Subject|0|||
130201699|NCT05174949|468696604|FG000|Overall Study|Lost to Follow-up|0|||
130201700|NCT05174949|468696605|FG001|Overall Study|Lost to Follow-up|0|||
130201701|NCT05174949|468696606|FG002|Overall Study|Lost to Follow-up|0|||
130201702|NCT05174949|468696607|FG003|Overall Study|Lost to Follow-up|1|||
130201703|NCT05174949|468696608|FG004|Overall Study|Lost to Follow-up|0|||
130201704|NCT05174949|468696609|FG005|Overall Study|Lost to Follow-up|0|||
130201705|NCT02029989|468696610|FG000|Overall Study|Withdrawal by Subject|1|||
130201706|NCT02029989|468696611|FG001|Overall Study|Withdrawal by Subject|0|||
130201707|NCT02029989|468696610|FG000|Overall Study|Withdrawal: Fear of needles|1|||
130201708|NCT02029989|468696611|FG001|Overall Study|Withdrawal: Fear of needles|0|||
130201709|NCT02029989|468696610|FG000|Overall Study|Change of location|2|||
130201710|NCT02029989|468696611|FG001|Overall Study|Change of location|3|||
130201711|NCT02029989|468696610|FG000|Overall Study|Physician Decision|2|||
130201712|NCT02029989|468696611|FG001|Overall Study|Physician Decision|0|||
130201713|NCT02029989|468696610|FG000|Overall Study|Lost to Follow-up|9|||
130201714|NCT02029989|468696611|FG001|Overall Study|Lost to Follow-up|7|||
130201715|NCT02029989|468696610|FG000|Overall Study|Death|0|||
130201716|NCT02029989|468696611|FG001|Overall Study|Death|1|||
130201717|NCT02029989|468696610|FG000|Overall Study|Protocol Violation|1|||
130201718|NCT02029989|468696611|FG001|Overall Study|Protocol Violation|0|||
130201719|NCT04351373|468696612|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
130201720|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
130201721|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
130201722|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
130201723|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
130201724|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
130201725|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
130201726|NCT00742508|468696621|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
130201727|NCT00742508|468696622|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
130201728|NCT00742508|468696621|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
130201729|NCT00742508|468696622|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
130201730|NCT04696354|468696625|FG000|Overall Study|Study termination|6|||
130201731|NCT04696354|468696626|FG001|Overall Study|Study termination|6|||
130201732|NCT02730377|468698980|FG000|Overall Study|Other|5|||
130201733|NCT02730377|468698981|FG001|Overall Study|Other|4|||
130201734|NCT02730377|468698980|FG000|Overall Study|Death|1|||
130201735|NCT02730377|468698981|FG001|Overall Study|Death|8|||
130201736|NCT02730377|468698980|FG000|Overall Study|Inadequate glycaemic control|368|||
130201737|NCT02730377|468698981|FG001|Overall Study|Inadequate glycaemic control|473|||
130201738|NCT02730377|468698980|FG000|Overall Study|Adverse Event|79|||
130201739|NCT02730377|468698981|FG001|Overall Study|Adverse Event|41|||
130201740|NCT02730377|468698980|FG000|Overall Study|Protocol Violation|23|||
130201741|NCT02730377|468698981|FG001|Overall Study|Protocol Violation|30|||
130201742|NCT02730377|468698980|FG000|Overall Study|Lack of Efficacy|4|||
130201743|NCT02730377|468698981|FG001|Overall Study|Lack of Efficacy|13|||
130201744|NCT02730377|468698980|FG000|Overall Study|Pregnancy|0|||
130201745|NCT02730377|468698981|FG001|Overall Study|Pregnancy|1|||
130201746|NCT02730377|468698980|FG000|Overall Study|Withdrawal by Subject|45|||
130201747|NCT02730377|468698981|FG001|Overall Study|Withdrawal by Subject|42|||
130201748|NCT02730377|468698980|FG000|Overall Study|Lost to Follow-up|25|||
130201749|NCT02730377|468698981|FG001|Overall Study|Lost to Follow-up|21|||
130201750|NCT04045132|468698984|FG000|Overall Study|Lost to Follow-up|3|||
130201751|NCT04045132|468698985|FG001|Overall Study|Lost to Follow-up|6|||
130201752|NCT02143791|468698988|FG000|Enrolled|Withdrawal by Subject|4|||
130201753|NCT02143791|468698988|FG000|Trial Stimulation|Lack of Efficacy|21|||
130201754|NCT02143791|468698988|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
130201755|NCT02143791|468698988|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
130201756|NCT02143791|468698988|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
130201757|NCT02143791|468698988|FG000|Any Programming (3-6 Months)|Missing Data|1|||
130201758|NCT02143791|468698988|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
130201759|NCT00401544|468698989|FG000|Overall Study|Adverse Event|5|||
130201760|NCT00401544|468698990|FG001|Overall Study|Adverse Event|1|||
130201761|NCT00401544|468698991|FG002|Overall Study|Adverse Event|1|||
130201762|NCT00401544|468698992|FG003|Overall Study|Adverse Event|1|||
130201763|NCT00401544|468698989|FG000|Overall Study|Death|3|||
130201764|NCT00401544|468698990|FG001|Overall Study|Death|6|||
130201765|NCT00401544|468698991|FG002|Overall Study|Death|2|||
130201766|NCT00401544|468698992|FG003|Overall Study|Death|5|||
130201767|NCT00401544|468698989|FG000|Overall Study|Lost to Follow-up|2|||
130201768|NCT00401544|468698990|FG001|Overall Study|Lost to Follow-up|0|||
130201769|NCT00401544|468698991|FG002|Overall Study|Lost to Follow-up|1|||
130201770|NCT00401544|468698992|FG003|Overall Study|Lost to Follow-up|1|||
130201771|NCT00401544|468698989|FG000|Overall Study|Withdrawal by Subject|7|||
130201772|NCT00401544|468698990|FG001|Overall Study|Withdrawal by Subject|6|||
130201773|NCT00401544|468698991|FG002|Overall Study|Withdrawal by Subject|6|||
130201774|NCT00401544|468698992|FG003|Overall Study|Withdrawal by Subject|5|||
130201775|NCT00401544|468698989|FG000|Overall Study|Physician Decision|1|||
130201776|NCT00401544|468698990|FG001|Overall Study|Physician Decision|3|||
130201777|NCT00401544|468698991|FG002|Overall Study|Physician Decision|0|||
130201778|NCT00401544|468698992|FG003|Overall Study|Physician Decision|0|||
130201779|NCT00401544|468698989|FG000|Overall Study|Ineligibility determined|0|||
130201780|NCT00401544|468698990|FG001|Overall Study|Ineligibility determined|1|||
130201781|NCT00401544|468698991|FG002|Overall Study|Ineligibility determined|0|||
130201782|NCT00401544|468698992|FG003|Overall Study|Ineligibility determined|2|||
130201783|NCT00401544|468698989|FG000|Overall Study|Disease progression|0|||
130201784|NCT00401544|468698990|FG001|Overall Study|Disease progression|1|||
130201785|NCT00401544|468698991|FG002|Overall Study|Disease progression|0|||
130201786|NCT00401544|468698992|FG003|Overall Study|Disease progression|0|||
130201787|NCT00401544|468698989|FG000|Overall Study|Other|0|||
130201788|NCT00401544|468698990|FG001|Overall Study|Other|0|||
130201789|NCT00401544|468698991|FG002|Overall Study|Other|2|||
130201790|NCT00401544|468698992|FG003|Overall Study|Other|2|||
130201791|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Adverse Event|6|||
130201792|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Adverse Event|14|||
130201793|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Death|3|||
130201794|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Death|1|||
130201795|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
130201796|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
130201797|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
130201798|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
130201799|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
130201800|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
130201801|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
130201802|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
130201803|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
130201804|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
130201805|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Physician Decision|2|||
130201806|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Physician Decision|4|||
130201807|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Pregnancy|2|||
130201808|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Pregnancy|1|||
130201809|NCT02275780|468699006|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
130201810|NCT02275780|468699007|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
130201811|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
130201812|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
130201813|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
130201814|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
130201815|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
130201816|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
130201817|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
130201818|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
130201819|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
130201820|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
130201821|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
130201822|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
130201823|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
130201824|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
130201825|NCT02275780|468699006|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
130201826|NCT02275780|468699007|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
130201827|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
130201828|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
130201829|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
130201830|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
130201831|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
130201832|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
130201833|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
130201834|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
130201835|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
130201836|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
130201837|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
130201838|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
130201839|NCT02275780|468699006|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
130201840|NCT02275780|468699007|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
130201841|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
130201842|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
130201843|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
130201844|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
130201845|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
130201846|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
130201847|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
130201848|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
130201849|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
130201850|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
130201851|NCT02275780|468699006|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
130201852|NCT02275780|468699007|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
130201853|NCT00738881|468699010|FG000|Overall Study|Withdrawal by Subject|0|||
130201854|NCT00738881|468699011|FG001|Overall Study|Withdrawal by Subject|2|||
130201855|NCT00348790|468699012|FG000|Completed Treatment|Withdrawal by Subject|4|||
130201856|NCT00348790|468699012|FG000|Completed Treatment|Disease progression|14|||
130201857|NCT00348790|468699012|FG000|Completed Treatment|Adverse Event|4|||
130201858|NCT00348790|468699012|FG000|Completed Treatment|Required surgery|2|||
130201859|NCT00348790|468699012|FG000|Completed Treatment|Unable to travel to study site|1|||
130201860|NCT04712019|468699014|FG000|Overall Study|Withdrawal by Subject|2|||
130201861|NCT04712019|468699015|FG001|Overall Study|Withdrawal by Subject|2|||
130201862|NCT04712019|468699014|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
130201863|NCT04712019|468699015|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
130201864|NCT01282164|468699016|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
130201865|NCT01282164|468699017|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
130201866|NCT04521621|468699018|FG000|Overall Study|Death|17|||
130201867|NCT04521621|468699019|FG001|Overall Study|Death|8|||
130201868|NCT04521621|468699020|FG002|Overall Study|Death|8|||
130201869|NCT04521621|468699021|FG003|Overall Study|Death|5|||
130201870|NCT04521621|468699022|FG004|Overall Study|Death|2|||
130201871|NCT04521621|468699023|FG005|Overall Study|Death|7|||
130201872|NCT04521621|468699024|FG006|Overall Study|Death|0|||
130201873|NCT04521621|468699025|FG007|Overall Study|Death|0|||
130201874|NCT04521621|468699018|FG000|Overall Study|Study Terminated by Sponsor|4|||
130201875|NCT04521621|468699019|FG001|Overall Study|Study Terminated by Sponsor|6|||
130201876|NCT04521621|468699020|FG002|Overall Study|Study Terminated by Sponsor|8|||
130201877|NCT04521621|468699021|FG003|Overall Study|Study Terminated by Sponsor|0|||
130201878|NCT04521621|468699022|FG004|Overall Study|Study Terminated by Sponsor|1|||
130201879|NCT04521621|468699023|FG005|Overall Study|Study Terminated by Sponsor|7|||
130201880|NCT04521621|468699024|FG006|Overall Study|Study Terminated by Sponsor|0|||
130201881|NCT04521621|468699025|FG007|Overall Study|Study Terminated by Sponsor|0|||
130201882|NCT04521621|468699018|FG000|Overall Study|Withdrawal by Subject|0|||
130201883|NCT04521621|468699019|FG001|Overall Study|Withdrawal by Subject|0|||
130201884|NCT04521621|468699020|FG002|Overall Study|Withdrawal by Subject|1|||
130201885|NCT04521621|468699021|FG003|Overall Study|Withdrawal by Subject|1|||
130201886|NCT04521621|468699022|FG004|Overall Study|Withdrawal by Subject|0|||
130201887|NCT04521621|468699023|FG005|Overall Study|Withdrawal by Subject|0|||
130201888|NCT04521621|468699024|FG006|Overall Study|Withdrawal by Subject|0|||
130201889|NCT04521621|468699025|FG007|Overall Study|Withdrawal by Subject|0|||
130201890|NCT04521621|468699018|FG000|Overall Study|Allocated in error without study intervention|1|||
130201891|NCT04521621|468699019|FG001|Overall Study|Allocated in error without study intervention|0|||
130201892|NCT04521621|468699020|FG002|Overall Study|Allocated in error without study intervention|0|||
130201893|NCT04521621|468699021|FG003|Overall Study|Allocated in error without study intervention|0|||
130201894|NCT04521621|468699022|FG004|Overall Study|Allocated in error without study intervention|0|||
130201895|NCT04521621|468699023|FG005|Overall Study|Allocated in error without study intervention|0|||
130201896|NCT04521621|468699024|FG006|Overall Study|Allocated in error without study intervention|0|||
130201897|NCT04521621|468699025|FG007|Overall Study|Allocated in error without study intervention|0|||
130201898|NCT05845567|468699033|FG000|Overall Study|Withdrawal by Subject|1|||
130201899|NCT00725608|468699034|FG000|Overall Study|Lost to Follow-up|60|||
130201900|NCT00725608|468699034|FG000|Overall Study|Adverse Event|14|||
130201901|NCT00725608|468699034|FG000|Overall Study|Individual reasons|86|||
130201902|NCT00725608|468699034|FG000|Overall Study|Other|7|||
130201903|NCT03409107|468699035|FG000|Overall Study|Withdrawal by Subject|4|||
130201904|NCT03409107|468699036|FG001|Overall Study|Withdrawal by Subject|2|||
130201905|NCT03409107|468699035|FG000|Overall Study|Physician Decision|1|||
130201906|NCT03409107|468699036|FG001|Overall Study|Physician Decision|0|||
130201907|NCT03409107|468699035|FG000|Overall Study|Lost to Follow-up|7|||
130201908|NCT03409107|468699036|FG001|Overall Study|Lost to Follow-up|2|||
130201909|NCT03409107|468699035|FG000|Overall Study|Adverse Event|5|||
130201910|NCT03409107|468699036|FG001|Overall Study|Adverse Event|3|||
130201911|NCT00535847|468699038|FG000|Overall Study|Adverse Event|5|||
130201912|NCT00535847|468699039|FG001|Overall Study|Adverse Event|3|||
130201913|NCT00535847|468699040|FG002|Overall Study|Adverse Event|2|||
130201914|NCT00535847|468699038|FG000|Overall Study|Non compliance|1|||
130201915|NCT00535847|468699039|FG001|Overall Study|Non compliance|1|||
130201916|NCT00535847|468699040|FG002|Overall Study|Non compliance|0|||
130201917|NCT00535847|468699038|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
130201918|NCT00535847|468699039|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
130201919|NCT00535847|468699040|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
130201920|NCT00423189|468699041|FG000|Overall Study|Death|0|||
130201921|NCT00423189|468699042|FG001|Overall Study|Death|1|||
130201922|NCT00423189|468699043|FG002|Overall Study|Death|0|||
130201923|NCT01459718|468699046|FG000|Overall Study|Physician Decision|1|||
130201924|NCT01459718|468699046|FG000|Overall Study|Lost to Follow-up|1|||
130201925|NCT01459718|468699046|FG000|Overall Study|Adverse Event|1|||
130201926|NCT01258075|468699052|FG000|Overall Study|Adverse Event|8|||
130201927|NCT01258075|468699053|FG001|Overall Study|Adverse Event|3|||
130201928|NCT01258075|468699052|FG000|Overall Study|Lost to Follow-up|11|||
130201929|NCT01258075|468699053|FG001|Overall Study|Lost to Follow-up|6|||
130201930|NCT01258075|468699052|FG000|Overall Study|Withdrawal by Subject|10|||
130201931|NCT01258075|468699053|FG001|Overall Study|Withdrawal by Subject|7|||
130201932|NCT01258075|468699052|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
130201933|NCT01258075|468699053|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
130201934|NCT01258075|468699052|FG000|Overall Study|Other|12|||
130201935|NCT01258075|468699053|FG001|Overall Study|Other|5|||
130201936|NCT01618019|468699055|FG000|Overall Study|Withdrawal by Subject|14|||
130201937|NCT01618019|468699056|FG001|Overall Study|Withdrawal by Subject|14|||
130201938|NCT01542034|468699057|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
130201939|NCT01542034|468699058|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
130201940|NCT01542034|468699057|FG000|Overall Study|Administrative decision|0|||
130201941|NCT01542034|468699058|FG001|Overall Study|Administrative decision|3|||
130201942|NCT01542034|468699057|FG000|Overall Study|Subject Noncompliance|1|||
130201943|NCT01542034|468699058|FG001|Overall Study|Subject Noncompliance|0|||
130201944|NCT01542034|468699057|FG000|Overall Study|Adverse Event|2|||
130201945|NCT01542034|468699058|FG001|Overall Study|Adverse Event|2|||
130201946|NCT01542034|468699057|FG000|Overall Study|Lost to Follow-up|7|||
130201947|NCT01542034|468699058|FG001|Overall Study|Lost to Follow-up|6|||
130201948|NCT02612610|468699059|FG000|Overall Study|Withdrawal by Subject|1|||
130201949|NCT02612610|468699060|FG001|Overall Study|Withdrawal by Subject|1|||
130201950|NCT02612610|468699061|FG002|Overall Study|Withdrawal by Subject|0|||
130201951|NCT02612610|468699062|FG003|Overall Study|Withdrawal by Subject|2|||
130201952|NCT02612610|468699059|FG000|Overall Study|Adverse Event|2|||
130201953|NCT02612610|468699060|FG001|Overall Study|Adverse Event|2|||
130201954|NCT02612610|468699061|FG002|Overall Study|Adverse Event|3|||
130201955|NCT02612610|468699062|FG003|Overall Study|Adverse Event|10|||
130201956|NCT02612610|468699059|FG000|Overall Study|Lost to Follow-up|0|||
130201957|NCT02612610|468699060|FG001|Overall Study|Lost to Follow-up|1|||
130201958|NCT02612610|468699061|FG002|Overall Study|Lost to Follow-up|0|||
130201959|NCT02612610|468699062|FG003|Overall Study|Lost to Follow-up|0|||
130201960|NCT02612610|468699059|FG000|Overall Study|Protocol Violation|0|||
130201961|NCT02612610|468699060|FG001|Overall Study|Protocol Violation|1|||
130201962|NCT02612610|468699061|FG002|Overall Study|Protocol Violation|1|||
130201963|NCT02612610|468699062|FG003|Overall Study|Protocol Violation|0|||
130201964|NCT02612610|468699059|FG000|Overall Study|Lack of Efficacy|1|||
130201965|NCT02612610|468699060|FG001|Overall Study|Lack of Efficacy|2|||
130201966|NCT02612610|468699061|FG002|Overall Study|Lack of Efficacy|0|||
130201967|NCT02612610|468699062|FG003|Overall Study|Lack of Efficacy|1|||
130201968|NCT02612610|468699059|FG000|Overall Study|Physician Decision|0|||
130201969|NCT02612610|468699060|FG001|Overall Study|Physician Decision|1|||
130201970|NCT02612610|468699061|FG002|Overall Study|Physician Decision|0|||
130201971|NCT02612610|468699062|FG003|Overall Study|Physician Decision|0|||
130201972|NCT02612610|468699059|FG000|Overall Study|Noncompliance|1|||
130201973|NCT02612610|468699060|FG001|Overall Study|Noncompliance|0|||
130201974|NCT02612610|468699061|FG002|Overall Study|Noncompliance|0|||
130201975|NCT02612610|468699062|FG003|Overall Study|Noncompliance|0|||
130201976|NCT02612610|468699059|FG000|Overall Study|Cough Improvement|0|||
130201977|NCT02612610|468699060|FG001|Overall Study|Cough Improvement|0|||
130201978|NCT02612610|468699061|FG002|Overall Study|Cough Improvement|1|||
130201979|NCT02612610|468699062|FG003|Overall Study|Cough Improvement|0|||
130201980|NCT01801280|468699063|FG000|Period 1|Withdrawal by Subject|0|||
130201981|NCT01801280|468699064|FG001|Period 1|Withdrawal by Subject|1|||
130201982|NCT01801280|468699065|FG002|Period 1|Withdrawal by Subject|0|||
130201983|NCT01801280|468699066|FG003|Period 1|Withdrawal by Subject|0|||
130201984|NCT01801280|468699063|FG000|Period 2|Withdrawal by Subject|1|||
130201985|NCT01801280|468699064|FG001|Period 2|Withdrawal by Subject|0|||
130201986|NCT01801280|468699065|FG002|Period 2|Withdrawal by Subject|0|||
130201987|NCT01801280|468699066|FG003|Period 2|Withdrawal by Subject|0|||
130201988|NCT01801280|468699063|FG000|Period 4|Protocol Violation|0|||
130201989|NCT01801280|468699064|FG001|Period 4|Protocol Violation|0|||
130201990|NCT01801280|468699065|FG002|Period 4|Protocol Violation|1|||
130201991|NCT01801280|468699066|FG003|Period 4|Protocol Violation|0|||
130201992|NCT00176644|468699067|FG000|Overall Study|Withdrawal by Subject|1|||
130201993|NCT02783729|468699068|FG000|Overall Study|Lack of Efficacy|1|||
130201994|NCT02783729|468699069|FG001|Overall Study|Lack of Efficacy|0|||
130201995|NCT02783729|468699070|FG002|Overall Study|Lack of Efficacy|0|||
130201996|NCT02783729|468699071|FG003|Overall Study|Lack of Efficacy|0|||
130201997|NCT02783729|468699068|FG000|Overall Study|Adverse Event|2|||
130201998|NCT02783729|468699069|FG001|Overall Study|Adverse Event|6|||
130201999|NCT02783729|468699070|FG002|Overall Study|Adverse Event|2|||
130202000|NCT02783729|468699071|FG003|Overall Study|Adverse Event|3|||
130202001|NCT02783729|468699068|FG000|Overall Study|Other|1|||
130202002|NCT02783729|468699069|FG001|Overall Study|Other|6|||
130202003|NCT02783729|468699070|FG002|Overall Study|Other|2|||
130202004|NCT02783729|468699071|FG003|Overall Study|Other|3|||
130202005|NCT02783729|468699068|FG000|Overall Study|Withdrawal by Subject|2|||
130202006|NCT02783729|468699069|FG001|Overall Study|Withdrawal by Subject|3|||
130202007|NCT02783729|468699070|FG002|Overall Study|Withdrawal by Subject|1|||
130202008|NCT02783729|468699071|FG003|Overall Study|Withdrawal by Subject|2|||
130202009|NCT02783729|468699068|FG000|Overall Study|Participant's choice|2|||
130202010|NCT02783729|468699069|FG001|Overall Study|Participant's choice|1|||
130202011|NCT02783729|468699070|FG002|Overall Study|Participant's choice|2|||
130202012|NCT02783729|468699071|FG003|Overall Study|Participant's choice|1|||
130202013|NCT02783729|468699068|FG000|Overall Study|Lost to Follow-up|2|||
130202014|NCT02783729|468699069|FG001|Overall Study|Lost to Follow-up|1|||
130202015|NCT02783729|468699070|FG002|Overall Study|Lost to Follow-up|1|||
130202016|NCT02783729|468699071|FG003|Overall Study|Lost to Follow-up|0|||
130202017|NCT02693171|468699072|FG000|Overall Study|Adverse Event|1|||
130202018|NCT02693171|468699072|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
130202019|NCT01866657|468699080|FG000|Overall Study|Surgery canceled|2|||
130202020|NCT01866657|468699081|FG001|Overall Study|Surgery canceled|0|||
130202021|NCT02288091|468699088|FG000|Overall Study|Lost to Follow-up|1|||
130202022|NCT02288091|468699088|FG000|Overall Study|Screen fail|7|||
130202023|NCT04021121|468699090|FG000|Overall Study|Death|3|||
130202024|NCT04021121|468699091|FG001|Overall Study|Death|3|||
130202025|NCT04021121|468699092|FG002|Overall Study|Death|5|||
130202026|NCT04021121|468699093|FG003|Overall Study|Death|4|||
130202027|NCT03099694|468699103|FG000|Overall Study|Withdrawal by Subject|11|||
130202028|NCT03099694|468699104|FG001|Overall Study|Withdrawal by Subject|13|||
130202029|NCT03099694|468699103|FG000|Overall Study|Lost to Follow-up|9|||
130202030|NCT03099694|468699104|FG001|Overall Study|Lost to Follow-up|5|||
130202031|NCT00471718|468699110|FG000|Overall Study|Adverse Event|3|||
130202032|NCT00471718|468699110|FG000|Overall Study|other complicating disease|1|||
130202033|NCT00471718|468699110|FG000|Overall Study|disease progression|22|||
130202034|NCT00471718|468699110|FG000|Overall Study|Withdrawal by Subject|1|||
130202035|NCT02880865|468699111|FG000|Overall Study|Adverse Event|1|||
130202036|NCT02880865|468699112|FG001|Overall Study|Adverse Event|0|||
130202037|NCT02880865|468699111|FG000|Overall Study|Withdrawal by Subject|0|||
130202038|NCT02880865|468699112|FG001|Overall Study|Withdrawal by Subject|2|||
130202039|NCT02880865|468699111|FG000|Overall Study|Physician Decision|0|||
130202040|NCT02880865|468699112|FG001|Overall Study|Physician Decision|1|||
130202041|NCT01446237|468699114|FG000|Overall Study|Adverse Event|1|||
130202042|NCT01446237|468699114|FG000|Overall Study|Lost to Follow-up|2|||
130202043|NCT01446237|468699114|FG000|Overall Study|Withdrawal by Subject|7|||
130202044|NCT01190267|468699117|FG000|Overall Study|Adverse Event|10|||
130202045|NCT01190267|468699118|FG001|Overall Study|Adverse Event|0|||
130202046|NCT01190267|468699117|FG000|Overall Study|Treatment Failure|8|||
130202047|NCT01190267|468699118|FG001|Overall Study|Treatment Failure|2|||
130202048|NCT01190267|468699117|FG000|Overall Study|Lost to Follow-up|2|||
130202049|NCT01190267|468699118|FG001|Overall Study|Lost to Follow-up|0|||
130202050|NCT01190267|468699117|FG000|Overall Study|Withdrawal by Subject|13|||
130202051|NCT01190267|468699118|FG001|Overall Study|Withdrawal by Subject|1|||
130202052|NCT01190267|468699117|FG000|Overall Study|Protocol Violation|8|||
130202053|NCT01190267|468699118|FG001|Overall Study|Protocol Violation|1|||
130202054|NCT04017832|468699121|FG000|Overall Study|Withdrawal by Subject|13|||
130202055|NCT04017832|468699122|FG001|Overall Study|Withdrawal by Subject|12|||
130202056|NCT04017832|468699123|FG002|Overall Study|Withdrawal by Subject|21|||
130202057|NCT04017832|468699124|FG003|Overall Study|Withdrawal by Subject|7|||
130202058|NCT04017832|468699121|FG000|Overall Study|Lost to Follow-up|0|||
130202059|NCT04017832|468699122|FG001|Overall Study|Lost to Follow-up|3|||
130202060|NCT04017832|468699123|FG002|Overall Study|Lost to Follow-up|3|||
130202061|NCT04017832|468699124|FG003|Overall Study|Lost to Follow-up|1|||
130202062|NCT04017832|468699121|FG000|Overall Study|Physician Decision|1|||
130202063|NCT04017832|468699122|FG001|Overall Study|Physician Decision|1|||
130202064|NCT04017832|468699123|FG002|Overall Study|Physician Decision|1|||
130202065|NCT04017832|468699124|FG003|Overall Study|Physician Decision|1|||
130202066|NCT04017832|468699121|FG000|Overall Study|Death|2|||
130202067|NCT04017832|468699122|FG001|Overall Study|Death|2|||
130202068|NCT04017832|468699123|FG002|Overall Study|Death|1|||
130202069|NCT04017832|468699124|FG003|Overall Study|Death|0|||
130202070|NCT02294175|468699126|FG000|Overall Study|Withdrawal by Subject|1|||
130202071|NCT02294175|468699127|FG001|Overall Study|Withdrawal by Subject|2|||
130202072|NCT02294175|468699126|FG000|Overall Study|pt taking excluded medication|3|||
130202073|NCT02294175|468699127|FG001|Overall Study|pt taking excluded medication|1|||
130202074|NCT02294175|468699126|FG000|Overall Study|Protocol Violation|1|||
130202075|NCT02294175|468699127|FG001|Overall Study|Protocol Violation|0|||
130202076|NCT02294175|468699126|FG000|Overall Study|Lost to Follow-up|0|||
130202077|NCT02294175|468699127|FG001|Overall Study|Lost to Follow-up|1|||
130202078|NCT02294175|468699126|FG000|Overall Study|wound healed|0|||
130202079|NCT02294175|468699127|FG001|Overall Study|wound healed|2|||
130202080|NCT00965341|468699131|FG000|Overall Study|Withdrew consent|1|||
130202081|NCT00965341|468699132|FG001|Overall Study|Withdrew consent|5|||
130202082|NCT00965341|468699131|FG000|Overall Study|Lost to Follow-up|1|||
130202083|NCT00965341|468699132|FG001|Overall Study|Lost to Follow-up|0|||
130202084|NCT00965341|468699131|FG000|Overall Study|Transportation issues|4|||
130202085|NCT00965341|468699132|FG001|Overall Study|Transportation issues|3|||
130202086|NCT01077739|468699138|FG000|Overall Study|Premature withdrawal|1|||
130202087|NCT01077739|468699139|FG001|Overall Study|Premature withdrawal|3|||
130202088|NCT01077739|468699138|FG000|Overall Study|Withdrawal by Subject|1|||
130202089|NCT01077739|468699139|FG001|Overall Study|Withdrawal by Subject|0|||
130202090|NCT01077739|468699138|FG000|Overall Study|Death|0|||
130202091|NCT01077739|468699139|FG001|Overall Study|Death|3|||
130202092|NCT01077739|468699138|FG000|Overall Study|Unacceptable toxicity|1|||
130202093|NCT01077739|468699139|FG001|Overall Study|Unacceptable toxicity|2|||
130202094|NCT01077739|468699138|FG000|Overall Study|Other|2|||
130202095|NCT01077739|468699139|FG001|Overall Study|Other|2|||
130202096|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
130202097|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
130202098|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
130202099|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
130202100|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
130202101|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
130202102|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
130202103|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
130202104|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
130202105|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
130202106|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
130202107|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
130202108|NCT00960986|468699140|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130202109|NCT00960986|468699141|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
130202110|NCT00960986|468699142|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130202111|NCT00960986|468699143|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
130202112|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
130202113|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
130202114|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
130202115|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
130202116|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Death|0|||
130202117|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Death|0|||
130202118|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Death|1|||
130202119|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Death|0|||
130202120|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130202121|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130202122|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
130202123|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
130202124|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
130202125|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
130202126|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
130202127|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
130202128|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130202129|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130202130|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
130202131|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
130202132|NCT00960986|468699140|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
130202133|NCT00960986|468699141|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
130202134|NCT00960986|468699142|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
130202135|NCT00960986|468699143|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
130202136|NCT04464720|468699144|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
130202137|NCT00954512|468699151|FG000|Overall Study|Withdrawal by Subject|0|||
130202138|NCT00954512|468699152|FG001|Overall Study|Withdrawal by Subject|0|||
130202139|NCT00954512|468699153|FG002|Overall Study|Withdrawal by Subject|0|||
130202140|NCT00954512|468699154|FG003|Overall Study|Withdrawal by Subject|0|||
130202141|NCT00954512|468699155|FG004|Overall Study|Withdrawal by Subject|0|||
130202142|NCT00954512|468699156|FG005|Overall Study|Withdrawal by Subject|1|||
130202143|NCT00954512|468699151|FG000|Overall Study|Adverse Event|0|||
130202144|NCT00954512|468699152|FG001|Overall Study|Adverse Event|0|||
130202145|NCT00954512|468699153|FG002|Overall Study|Adverse Event|0|||
130202146|NCT00954512|468699154|FG003|Overall Study|Adverse Event|0|||
130202147|NCT00954512|468699155|FG004|Overall Study|Adverse Event|1|||
130202148|NCT00954512|468699156|FG005|Overall Study|Adverse Event|2|||
130202149|NCT00954512|468699151|FG000|Overall Study|Physician Decision|0|||
130202150|NCT00954512|468699152|FG001|Overall Study|Physician Decision|1|||
130202151|NCT00954512|468699153|FG002|Overall Study|Physician Decision|0|||
130202152|NCT00954512|468699154|FG003|Overall Study|Physician Decision|1|||
130202153|NCT00954512|468699155|FG004|Overall Study|Physician Decision|0|||
130202154|NCT00954512|468699156|FG005|Overall Study|Physician Decision|0|||
130202155|NCT00954512|468699151|FG000|Overall Study|Symptomatic Deterioration|0|||
130202156|NCT00954512|468699152|FG001|Overall Study|Symptomatic Deterioration|1|||
130202157|NCT00954512|468699153|FG002|Overall Study|Symptomatic Deterioration|0|||
130202158|NCT00954512|468699154|FG003|Overall Study|Symptomatic Deterioration|0|||
130202159|NCT00954512|468699155|FG004|Overall Study|Symptomatic Deterioration|2|||
130202160|NCT00954512|468699156|FG005|Overall Study|Symptomatic Deterioration|0|||
130202161|NCT00954512|468699151|FG000|Overall Study|Progression of Disease|2|||
130202162|NCT00954512|468699152|FG001|Overall Study|Progression of Disease|1|||
130202163|NCT00954512|468699153|FG002|Overall Study|Progression of Disease|0|||
130202164|NCT00954512|468699154|FG003|Overall Study|Progression of Disease|1|||
130202165|NCT00954512|468699155|FG004|Overall Study|Progression of Disease|1|||
130202166|NCT00954512|468699156|FG005|Overall Study|Progression of Disease|1|||
130202167|NCT01794793|468699157|FG000|Treatment Period|Withdrawal by Subject|24|||
130202168|NCT01794793|468699157|FG000|Treatment Period|Lack of Efficacy|22|||
130202169|NCT01794793|468699157|FG000|Treatment Period|Adverse Event|17|||
130202170|NCT01794793|468699157|FG000|Treatment Period|Physician Decision|14|||
130202171|NCT01794793|468699157|FG000|Treatment Period|Lost to Follow-up|7|||
130202172|NCT01794793|468699157|FG000|Treatment Period|Death|6|||
130202173|NCT01794793|468699157|FG000|Treatment Period|Protocol Violation|5|||
130202174|NCT01794793|468699157|FG000|Treatment Period|administrative problem|3|||
130202175|NCT01794793|468699157|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
130202176|NCT01794793|468699157|FG000|Post-treatment Follow-up|Adverse Event|8|||
130202177|NCT01794793|468699157|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
130202178|NCT01794793|468699157|FG000|Post-treatment Follow-up|administrative problem|5|||
130202179|NCT01794793|468699157|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
130202180|NCT01794793|468699157|FG000|Post-treatment Follow-up|Protocol Violation|3|||
130202181|NCT03495154|468699158|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
130202182|NCT03495154|468699158|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
130202183|NCT03495154|468699158|FG000|Overall Study|Screen Failures During Surgery|6|||
130202184|NCT03495154|468699158|FG000|Overall Study|Death|2|||
130202185|NCT03495154|468699158|FG000|Overall Study|Lost to Follow-up|16|||
130202186|NCT03495154|468699158|FG000|Overall Study|Withdrawal by Subject|2|||
130202187|NCT03495154|468699158|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
130202188|NCT05685732|468699159|FG000|Overall Study|Withdrawal by Subject|2|||
130202189|NCT05685732|468699160|FG001|Overall Study|Withdrawal by Subject|0|||
130202190|NCT05685732|468699161|FG002|Overall Study|Withdrawal by Subject|2|||
130202191|NCT05685732|468699162|FG003|Overall Study|Withdrawal by Subject|3|||
130202192|NCT05685732|468699159|FG000|Overall Study|Protocol Violation|1|||
130202193|NCT05685732|468699160|FG001|Overall Study|Protocol Violation|2|||
130202194|NCT05685732|468699161|FG002|Overall Study|Protocol Violation|4|||
130202195|NCT05685732|468699162|FG003|Overall Study|Protocol Violation|1|||
130202196|NCT05685732|468699159|FG000|Overall Study|Lost to Follow-up|5|||
130202197|NCT05685732|468699160|FG001|Overall Study|Lost to Follow-up|1|||
130202198|NCT05685732|468699161|FG002|Overall Study|Lost to Follow-up|3|||
130202199|NCT05685732|468699162|FG003|Overall Study|Lost to Follow-up|1|||
130202200|NCT05685732|468699159|FG000|Overall Study|Adverse Event|2|||
130202201|NCT05685732|468699160|FG001|Overall Study|Adverse Event|1|||
130202202|NCT05685732|468699161|FG002|Overall Study|Adverse Event|0|||
130202203|NCT05685732|468699162|FG003|Overall Study|Adverse Event|0|||
130202204|NCT05685732|468699159|FG000|Overall Study|Physician Decision|1|||
130202205|NCT05685732|468699160|FG001|Overall Study|Physician Decision|0|||
130202206|NCT05685732|468699161|FG002|Overall Study|Physician Decision|0|||
130202207|NCT05685732|468699162|FG003|Overall Study|Physician Decision|0|||
130202208|NCT02640404|468699163|FG000|Overall Study|Protocol Violation|1|||
130202209|NCT02640404|468699164|FG001|Overall Study|Protocol Violation|0|||
130202210|NCT02640404|468699163|FG000|Overall Study|Withdrawal by Subject|1|||
130202211|NCT02640404|468699164|FG001|Overall Study|Withdrawal by Subject|0|||
130202212|NCT05397171|468699166|FG000|Overall Study|Death|2|||
130202213|NCT05397171|468699167|FG001|Overall Study|Death|3|||
130202214|NCT05397171|468699168|FG002|Overall Study|Death|3|||
130202215|NCT05397171|468699166|FG000|Overall Study|Study Terminated By Sponsor|1|||
130202216|NCT05397171|468699167|FG001|Overall Study|Study Terminated By Sponsor|2|||
130202217|NCT05397171|468699168|FG002|Overall Study|Study Terminated By Sponsor|3|||
130202218|NCT05397171|468699166|FG000|Overall Study|Withdrawal by Subject|0|||
130202219|NCT05397171|468699167|FG001|Overall Study|Withdrawal by Subject|1|||
130202220|NCT05397171|468699168|FG002|Overall Study|Withdrawal by Subject|1|||
130202221|NCT02100670|468699169|FG000|Overall Study|Adverse Event|10|||
130202222|NCT02100670|468699170|FG001|Overall Study|Adverse Event|3|||
130202223|NCT02100670|468699171|FG002|Overall Study|Adverse Event|3|||
130202224|NCT02100670|468699172|FG003|Overall Study|Adverse Event|0|||
130202225|NCT02100670|468699169|FG000|Overall Study|Lost to Follow-up|1|||
130202226|NCT02100670|468699170|FG001|Overall Study|Lost to Follow-up|0|||
130202227|NCT02100670|468699171|FG002|Overall Study|Lost to Follow-up|0|||
130202228|NCT02100670|468699172|FG003|Overall Study|Lost to Follow-up|0|||
130202229|NCT02100670|468699169|FG000|Overall Study|Protocol Violation|0|||
130202230|NCT02100670|468699170|FG001|Overall Study|Protocol Violation|1|||
130202231|NCT02100670|468699171|FG002|Overall Study|Protocol Violation|0|||
130202232|NCT02100670|468699172|FG003|Overall Study|Protocol Violation|1|||
130202233|NCT02100670|468699169|FG000|Overall Study|Withdrawal of Consent|0|||
130202234|NCT02100670|468699170|FG001|Overall Study|Withdrawal of Consent|1|||
130202235|NCT02100670|468699171|FG002|Overall Study|Withdrawal of Consent|1|||
130202236|NCT02100670|468699172|FG003|Overall Study|Withdrawal of Consent|0|||
130202237|NCT02100670|468699169|FG000|Overall Study|No swelling no pain|1|||
130202238|NCT02100670|468699170|FG001|Overall Study|No swelling no pain|0|||
130202239|NCT02100670|468699171|FG002|Overall Study|No swelling no pain|0|||
130202240|NCT02100670|468699172|FG003|Overall Study|No swelling no pain|0|||
130202241|NCT02100670|468699169|FG000|Overall Study|Poor Efficacy|0|||
130202242|NCT02100670|468699170|FG001|Overall Study|Poor Efficacy|1|||
130202243|NCT02100670|468699171|FG002|Overall Study|Poor Efficacy|0|||
130202244|NCT02100670|468699172|FG003|Overall Study|Poor Efficacy|0|||
130202245|NCT02100670|468699169|FG000|Overall Study|Physician Decision|0|||
130202246|NCT02100670|468699170|FG001|Overall Study|Physician Decision|1|||
130202247|NCT02100670|468699171|FG002|Overall Study|Physician Decision|0|||
130202248|NCT02100670|468699172|FG003|Overall Study|Physician Decision|0|||
130202249|NCT02100670|468699169|FG000|Overall Study|Withdrawal by Subject|1|||
130202250|NCT02100670|468699170|FG001|Overall Study|Withdrawal by Subject|0|||
130202251|NCT02100670|468699171|FG002|Overall Study|Withdrawal by Subject|0|||
130202252|NCT02100670|468699172|FG003|Overall Study|Withdrawal by Subject|0|||
130202253|NCT02234596|468699173|FG000|Overall Study|Participant not treated|2|||
130202254|NCT03634033|468700824|FG000|Overall Study|Did not have a post-assessment|384|||
130202255|NCT03634033|468700825|FG001|Overall Study|Did not have a post-assessment|291|||
130202256|NCT03634033|468700826|FG002|Overall Study|Did not have a post-assessment|114|||
130202257|NCT03634033|468700827|FG003|Overall Study|Did not have a post-assessment|161|||
130202258|NCT03634033|468700828|FG004|Overall Study|Did not have a post-assessment|5|||
130202259|NCT03634033|468700829|FG005|Overall Study|Did not have a post-assessment|0|||
130202260|NCT03634033|468700830|FG006|Overall Study|Did not have a post-assessment|0|||
130202261|NCT03634033|468700824|FG000|Overall Study|Death|0|||
130202262|NCT03634033|468700825|FG001|Overall Study|Death|0|||
130202263|NCT03634033|468700826|FG002|Overall Study|Death|0|||
130202264|NCT03634033|468700827|FG003|Overall Study|Death|0|||
130202265|NCT03634033|468700828|FG004|Overall Study|Death|0|||
130202266|NCT03634033|468700829|FG005|Overall Study|Death|7|||
130202267|NCT03634033|468700830|FG006|Overall Study|Death|7|||
130202268|NCT03634033|468700824|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202269|NCT03634033|468700825|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202270|NCT03634033|468700826|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202271|NCT03634033|468700827|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202272|NCT03634033|468700828|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
130202273|NCT03634033|468700829|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
130202274|NCT03634033|468700830|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
130202275|NCT03634033|468700824|FG000|Overall Study|Lost to Follow-up|0|||
130202276|NCT03634033|468700825|FG001|Overall Study|Lost to Follow-up|0|||
130202277|NCT03634033|468700826|FG002|Overall Study|Lost to Follow-up|0|||
130202278|NCT03634033|468700827|FG003|Overall Study|Lost to Follow-up|0|||
130202279|NCT03634033|468700828|FG004|Overall Study|Lost to Follow-up|0|||
130202280|NCT03634033|468700829|FG005|Overall Study|Lost to Follow-up|1|||
130202281|NCT03634033|468700830|FG006|Overall Study|Lost to Follow-up|2|||
130202282|NCT03634033|468700824|FG000|Overall Study|Withdrawal by Subject|0|||
130202283|NCT03634033|468700825|FG001|Overall Study|Withdrawal by Subject|0|||
130202284|NCT03634033|468700826|FG002|Overall Study|Withdrawal by Subject|0|||
130202285|NCT03634033|468700827|FG003|Overall Study|Withdrawal by Subject|0|||
130202286|NCT03634033|468700828|FG004|Overall Study|Withdrawal by Subject|0|||
130202287|NCT03634033|468700829|FG005|Overall Study|Withdrawal by Subject|0|||
130202288|NCT03634033|468700830|FG006|Overall Study|Withdrawal by Subject|1|||
130202289|NCT01944670|468700833|FG000|Overall Study|Lost to Follow-up|2|||
130202290|NCT00743288|468700834|FG000|Overall Study|Adverse Event|1|||
130202291|NCT00743288|468700835|FG001|Overall Study|Adverse Event|1|||
130202292|NCT00743288|468700836|FG002|Overall Study|Adverse Event|2|||
130202293|NCT00743288|468700837|FG003|Overall Study|Adverse Event|2|||
130202294|NCT00743288|468700838|FG004|Overall Study|Adverse Event|1|||
130202295|NCT00743288|468700839|FG005|Overall Study|Adverse Event|1|||
130202296|NCT00743288|468700840|FG006|Overall Study|Adverse Event|2|||
130202297|NCT00743288|468700834|FG000|Overall Study|Withdrawal by Subject|0|||
130202298|NCT00743288|468700835|FG001|Overall Study|Withdrawal by Subject|0|||
130202299|NCT00743288|468700836|FG002|Overall Study|Withdrawal by Subject|1|||
130202300|NCT00743288|468700837|FG003|Overall Study|Withdrawal by Subject|0|||
130202301|NCT00743288|468700838|FG004|Overall Study|Withdrawal by Subject|0|||
130202302|NCT00743288|468700839|FG005|Overall Study|Withdrawal by Subject|1|||
130202303|NCT00743288|468700840|FG006|Overall Study|Withdrawal by Subject|1|||
130202304|NCT00743288|468700834|FG000|Overall Study|Progressive disease (PD)|2|||
130202305|NCT00743288|468700835|FG001|Overall Study|Progressive disease (PD)|0|||
130202306|NCT00743288|468700836|FG002|Overall Study|Progressive disease (PD)|1|||
130202307|NCT00743288|468700837|FG003|Overall Study|Progressive disease (PD)|4|||
130202308|NCT00743288|468700838|FG004|Overall Study|Progressive disease (PD)|5|||
130202309|NCT00743288|468700839|FG005|Overall Study|Progressive disease (PD)|3|||
130202310|NCT00743288|468700840|FG006|Overall Study|Progressive disease (PD)|6|||
130202311|NCT00743288|468700834|FG000|Overall Study|Worsening of condition (Not PD)|0|||
130202312|NCT00743288|468700835|FG001|Overall Study|Worsening of condition (Not PD)|2|||
130202313|NCT00743288|468700836|FG002|Overall Study|Worsening of condition (Not PD)|1|||
130202314|NCT00743288|468700837|FG003|Overall Study|Worsening of condition (Not PD)|1|||
130202315|NCT00743288|468700838|FG004|Overall Study|Worsening of condition (Not PD)|0|||
130202316|NCT00743288|468700839|FG005|Overall Study|Worsening of condition (Not PD)|0|||
130202317|NCT00743288|468700840|FG006|Overall Study|Worsening of condition (Not PD)|0|||
130202318|NCT05903924|468700841|FG000|Overall Study|Lost to Follow-up|1|||
130202319|NCT05903924|468700842|FG001|Overall Study|Lost to Follow-up|0|||
130202320|NCT05903924|468700843|FG002|Overall Study|Lost to Follow-up|0|||
130202321|NCT04338269|468700844|FG000|Overall Study|Death|86|||
130202322|NCT04338269|468700845|FG001|Overall Study|Death|89|||
130202323|NCT04338269|468700844|FG000|Overall Study|Lost to Follow-up|1|||
130202324|NCT04338269|468700845|FG001|Overall Study|Lost to Follow-up|2|||
130202325|NCT04338269|468700844|FG000|Overall Study|Physician Decision|1|||
130202326|NCT04338269|468700845|FG001|Overall Study|Physician Decision|0|||
130202327|NCT04338269|468700844|FG000|Overall Study|Withdrawal by Subject|14|||
130202328|NCT04338269|468700845|FG001|Overall Study|Withdrawal by Subject|11|||
130202329|NCT02203851|468700849|FG000|Overall Study|Lost to Follow-up|4|||
130202330|NCT02203851|468700849|FG000|Overall Study|Withdrawal by Subject|6|||
130202331|NCT02203851|468700849|FG000|Overall Study|Other|1|||
130202332|NCT01632150|468700850|FG000|Overall Study|Disease progression|27|||
130202333|NCT01632150|468700850|FG000|Overall Study|Study drug toxicity|1|||
130202334|NCT01632150|468700850|FG000|Overall Study|Unrelated adverse event|7|||
130202335|NCT01632150|468700850|FG000|Overall Study|Withdrawal by Subject|2|||
130202336|NCT01632150|468700850|FG000|Overall Study|Patient underwent autologous transplant|1|||
130202337|NCT01632150|468700850|FG000|Overall Study|Moved to compassionate program|2|||
130202338|NCT03391232|468700853|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
130202339|NCT03391232|468700854|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
130202340|NCT03391232|468700853|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
130202341|NCT03391232|468700854|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
130202342|NCT01054300|468700858|FG000|Period 1|Adverse Event|1|||
130202343|NCT01054300|468700859|FG001|Period 1|Adverse Event|0|||
130202344|NCT01054300|468700860|FG002|Period 1|Adverse Event|0|||
130202345|NCT01054300|468700861|FG003|Period 1|Adverse Event|0|||
130202346|NCT01054300|468700858|FG000|Period 2|Withdrawal by Subject|0|||
130202347|NCT01054300|468700859|FG001|Period 2|Withdrawal by Subject|0|||
130202348|NCT01054300|468700860|FG002|Period 2|Withdrawal by Subject|1|||
130202349|NCT01054300|468700861|FG003|Period 2|Withdrawal by Subject|0|||
130202350|NCT00308087|468700866|FG000|Overall Study|Progressive Disease|19|||
130202351|NCT00308087|468700867|FG001|Overall Study|Progressive Disease|21|||
130202352|NCT00308087|468700866|FG000|Overall Study|Study Closure|11|||
130202353|NCT00308087|468700867|FG001|Overall Study|Study Closure|12|||
130202354|NCT00308087|468700866|FG000|Overall Study|Withdrawal by Subject|2|||
130202355|NCT00308087|468700867|FG001|Overall Study|Withdrawal by Subject|1|||
130202356|NCT00308087|468700866|FG000|Overall Study|Other|4|||
130202357|NCT00308087|468700867|FG001|Overall Study|Other|3|||
130202358|NCT00177307|468700868|FG000|Overall Study|Withdrawal by Subject|1|||
130202359|NCT02677038|468700872|FG000|Overall Study|Physician Decision|1|||
130202360|NCT02677038|468700872|FG000|Overall Study|Withdrawal by Subject|1|||
130202361|NCT03671564|468700873|FG000|Overall Study|Progressive Disease|3|||
130202362|NCT03671564|468700874|FG001|Overall Study|Progressive Disease|5|||
130202363|NCT03671564|468700875|FG002|Overall Study|Progressive Disease|3|||
130202364|NCT03671564|468700873|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
130202365|NCT03671564|468700874|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
130202366|NCT03671564|468700875|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
130202367|NCT03671564|468700873|FG000|Overall Study|Withdrawal by Subject|1|||
130202368|NCT03671564|468700874|FG001|Overall Study|Withdrawal by Subject|1|||
130202369|NCT03671564|468700875|FG002|Overall Study|Withdrawal by Subject|0|||
130202370|NCT00380081|468700876|FG000|Overall Study|Withdrawal by Subject|0|||
130202371|NCT00380081|468700877|FG001|Overall Study|Withdrawal by Subject|0|||
130202372|NCT00380081|468700878|FG002|Overall Study|Withdrawal by Subject|0|||
130202373|NCT00380081|468700879|FG003|Overall Study|Withdrawal by Subject|0|||
130202374|NCT00380081|468700880|FG004|Overall Study|Withdrawal by Subject|1|||
130202375|NCT00380081|468700881|FG005|Overall Study|Withdrawal by Subject|0|||
130202376|NCT00380081|468700876|FG000|Overall Study|Family Emergency|0|||
130202377|NCT00380081|468700877|FG001|Overall Study|Family Emergency|0|||
130202378|NCT00380081|468700878|FG002|Overall Study|Family Emergency|0|||
130202379|NCT00380081|468700879|FG003|Overall Study|Family Emergency|0|||
130202380|NCT00380081|468700880|FG004|Overall Study|Family Emergency|0|||
130202381|NCT00380081|468700881|FG005|Overall Study|Family Emergency|1|||
130202382|NCT05007041|468700882|FG000|Overall Study|Missing Diary Entries|0|||
130202383|NCT05007041|468700883|FG001|Overall Study|Missing Diary Entries|1|||
130202384|NCT01546168|468700886|FG000|Overall Study|Lost to Follow-up|1|||
130202385|NCT01546168|468700887|FG001|Overall Study|Lost to Follow-up|0|||
130202386|NCT01546168|468700886|FG000|Overall Study|Withdrawal by Subject|1|||
130202387|NCT01546168|468700887|FG001|Overall Study|Withdrawal by Subject|0|||
130202388|NCT01546168|468700886|FG000|Overall Study|ineligible after signing consent|2|||
130202389|NCT01546168|468700887|FG001|Overall Study|ineligible after signing consent|0|||
130202390|NCT02850016|468700888|FG000|Overall Study|Withdrawal by Subject|1|||
130202391|NCT02850016|468700889|FG001|Overall Study|Withdrawal by Subject|2|||
130202392|NCT02954653|468700890|FG000|Overall Study|Death|3|||
130202393|NCT02954653|468700891|FG001|Overall Study|Death|1|||
130202394|NCT02954653|468700892|FG002|Overall Study|Death|0|||
130202395|NCT02954653|468700893|FG003|Overall Study|Death|0|||
130202396|NCT02954653|468700894|FG004|Overall Study|Death|0|||
130202397|NCT02954653|468700895|FG005|Overall Study|Death|0|||
130202398|NCT02954653|468700896|FG006|Overall Study|Death|0|||
130202399|NCT02954653|468700897|FG007|Overall Study|Death|0|||
130202400|NCT02954653|468700898|FG008|Overall Study|Death|0|||
130202401|NCT02954653|468700890|FG000|Overall Study|Randomized but did not receive treatment|1|||
130202402|NCT02954653|468700891|FG001|Overall Study|Randomized but did not receive treatment|0|||
130202403|NCT02954653|468700892|FG002|Overall Study|Randomized but did not receive treatment|0|||
130202404|NCT02954653|468700893|FG003|Overall Study|Randomized but did not receive treatment|0|||
130202405|NCT02954653|468700894|FG004|Overall Study|Randomized but did not receive treatment|0|||
130202406|NCT02954653|468700895|FG005|Overall Study|Randomized but did not receive treatment|0|||
130202407|NCT02954653|468700896|FG006|Overall Study|Randomized but did not receive treatment|0|||
130202408|NCT02954653|468700897|FG007|Overall Study|Randomized but did not receive treatment|0|||
130202409|NCT02954653|468700898|FG008|Overall Study|Randomized but did not receive treatment|0|||
130202410|NCT02954653|468700890|FG000|Overall Study|Started another anti-cancer therapy|0|||
130202411|NCT02954653|468700891|FG001|Overall Study|Started another anti-cancer therapy|1|||
130202412|NCT02954653|468700892|FG002|Overall Study|Started another anti-cancer therapy|0|||
130202413|NCT02954653|468700893|FG003|Overall Study|Started another anti-cancer therapy|0|||
130202414|NCT02954653|468700894|FG004|Overall Study|Started another anti-cancer therapy|0|||
130202415|NCT02954653|468700895|FG005|Overall Study|Started another anti-cancer therapy|0|||
130202416|NCT02954653|468700896|FG006|Overall Study|Started another anti-cancer therapy|0|||
130202417|NCT02954653|468700897|FG007|Overall Study|Started another anti-cancer therapy|0|||
130202418|NCT02954653|468700898|FG008|Overall Study|Started another anti-cancer therapy|0|||
130202419|NCT02954653|468700890|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
130202420|NCT02954653|468700891|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
130202421|NCT02954653|468700892|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
130202422|NCT02954653|468700893|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
130202423|NCT02954653|468700894|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
130202424|NCT02954653|468700895|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
130202425|NCT02954653|468700896|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
130202426|NCT02954653|468700897|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
130202427|NCT02954653|468700898|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
130202428|NCT00070018|468700902|FG000|Overall Study|Adverse Event|2|||
130202429|NCT00070018|468700902|FG000|Overall Study|Lack of Efficacy|1|||
130202430|NCT00070018|468700902|FG000|Overall Study|Withdrawal by Subject|1|||
130202431|NCT02939716|468700903|FG000|Overall Study|scanner failure|0|||
130202432|NCT02939716|468700904|FG001|Overall Study|scanner failure|0|||
130202433|NCT02939716|468700905|FG002|Overall Study|scanner failure|0|||
130202434|NCT02939716|468700906|FG003|Overall Study|scanner failure|1|||
130202435|NCT02939716|468700907|FG004|Overall Study|scanner failure|1|||
130202436|NCT02939716|468700908|FG005|Overall Study|scanner failure|1|||
130202437|NCT02543892|468700912|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
130202438|NCT02543892|468700913|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
130202439|NCT02543892|468700914|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
130202440|NCT02543892|468700915|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
130202441|NCT02543892|468700916|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
130202442|NCT02543892|468700917|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
130202443|NCT02543892|468700918|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
130202444|NCT02543892|468700919|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
130202445|NCT02543892|468700912|FG000|Received Vaccination 2|Physician Decision|0|||
130202446|NCT02543892|468700913|FG001|Received Vaccination 2|Physician Decision|0|||
130202447|NCT02543892|468700914|FG002|Received Vaccination 2|Physician Decision|0|||
130202448|NCT02543892|468700915|FG003|Received Vaccination 2|Physician Decision|0|||
130202449|NCT02543892|468700916|FG004|Received Vaccination 2|Physician Decision|0|||
130202450|NCT02543892|468700917|FG005|Received Vaccination 2|Physician Decision|1|||
130202451|NCT02543892|468700918|FG006|Received Vaccination 2|Physician Decision|0|||
130202452|NCT02543892|468700919|FG007|Received Vaccination 2|Physician Decision|0|||
130202453|NCT02543892|468700912|FG000|Received Vaccination 2|Adverse Event|0|||
130202454|NCT02543892|468700913|FG001|Received Vaccination 2|Adverse Event|1|||
130202455|NCT02543892|468700914|FG002|Received Vaccination 2|Adverse Event|0|||
130202456|NCT02543892|468700915|FG003|Received Vaccination 2|Adverse Event|0|||
130202457|NCT02543892|468700916|FG004|Received Vaccination 2|Adverse Event|0|||
130202458|NCT02543892|468700917|FG005|Received Vaccination 2|Adverse Event|0|||
130202459|NCT02543892|468700918|FG006|Received Vaccination 2|Adverse Event|0|||
130202460|NCT02543892|468700919|FG007|Received Vaccination 2|Adverse Event|0|||
130202461|NCT02543892|468700912|FG000|Had Immunology Data|Withdrawal by Subject|0|||
130202462|NCT02543892|468700913|FG001|Had Immunology Data|Withdrawal by Subject|0|||
130202463|NCT02543892|468700914|FG002|Had Immunology Data|Withdrawal by Subject|0|||
130202464|NCT02543892|468700915|FG003|Had Immunology Data|Withdrawal by Subject|0|||
130202465|NCT02543892|468700916|FG004|Had Immunology Data|Withdrawal by Subject|0|||
130202466|NCT02543892|468700917|FG005|Had Immunology Data|Withdrawal by Subject|0|||
130202467|NCT02543892|468700918|FG006|Had Immunology Data|Withdrawal by Subject|1|||
130202468|NCT02543892|468700919|FG007|Had Immunology Data|Withdrawal by Subject|0|||
130202469|NCT01500213|468700922|FG000|Overall Study|Adverse Event|35|||
130202470|NCT01500213|468700923|FG001|Overall Study|Adverse Event|35|||
130202471|NCT01500213|468700922|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
130202472|NCT01500213|468700923|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
130202473|NCT01500213|468700922|FG000|Overall Study|Withdrawal by Subject|28|||
130202474|NCT01500213|468700923|FG001|Overall Study|Withdrawal by Subject|37|||
130202475|NCT01500213|468700922|FG000|Overall Study|Death|7|||
130202476|NCT01500213|468700923|FG001|Overall Study|Death|3|||
130202477|NCT01500213|468700922|FG000|Overall Study|Disease Progression|13|||
130202478|NCT01500213|468700923|FG001|Overall Study|Disease Progression|21|||
130202479|NCT01500213|468700922|FG000|Overall Study|Protocol Violation|19|||
130202480|NCT01500213|468700923|FG001|Overall Study|Protocol Violation|19|||
130202481|NCT01500213|468700922|FG000|Overall Study|Physician Decision|12|||
130202482|NCT01500213|468700923|FG001|Overall Study|Physician Decision|10|||
130202483|NCT01500213|468700922|FG000|Overall Study|Lack of Efficacy|9|||
130202484|NCT01500213|468700923|FG001|Overall Study|Lack of Efficacy|7|||
130202485|NCT01500213|468700922|FG000|Overall Study|Lost to Follow-up|3|||
130202486|NCT01500213|468700923|FG001|Overall Study|Lost to Follow-up|6|||
130202487|NCT01500213|468700922|FG000|Overall Study|Other Reasons|7|||
130202488|NCT01500213|468700923|FG001|Overall Study|Other Reasons|5|||
130202489|NCT00785213|468700924|FG000|Quinine Sulfate Alone|Adverse Event|4|||
130202490|NCT00785213|468700924|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
130202491|NCT00525902|468700925|FG000|Overall Study|Lack of Efficacy|1|||
130202492|NCT00985959|468700926|FG000|Overall Study|Adverse Event|0|||
130202493|NCT00985959|468700927|FG001|Overall Study|Adverse Event|0|||
130202494|NCT00985959|468700928|FG002|Overall Study|Adverse Event|19|||
130202495|NCT00985959|468700926|FG000|Overall Study|Withdrawal by Subject|0|||
130202496|NCT00985959|468700927|FG001|Overall Study|Withdrawal by Subject|0|||
130202497|NCT00985959|468700928|FG002|Overall Study|Withdrawal by Subject|8|||
130202498|NCT00985959|468700926|FG000|Overall Study|Progressive disease|1|||
130202499|NCT00985959|468700927|FG001|Overall Study|Progressive disease|2|||
130202500|NCT00985959|468700928|FG002|Overall Study|Progressive disease|8|||
130202501|NCT00985959|468700926|FG000|Overall Study|Unrecovered toxicity|0|||
130202502|NCT00985959|468700927|FG001|Overall Study|Unrecovered toxicity|0|||
130202503|NCT00985959|468700928|FG002|Overall Study|Unrecovered toxicity|7|||
130202504|NCT00985959|468700926|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
130202505|NCT00985959|468700927|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
130202506|NCT00985959|468700928|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
130202507|NCT00985959|468700926|FG000|Overall Study|Complete response observed over 2 cycles|0|||
130202508|NCT00985959|468700927|FG001|Overall Study|Complete response observed over 2 cycles|1|||
130202509|NCT00985959|468700928|FG002|Overall Study|Complete response observed over 2 cycles|4|||
130202510|NCT00985959|468700926|FG000|Overall Study|Other|0|||
130202511|NCT00985959|468700927|FG001|Overall Study|Other|0|||
130202512|NCT00985959|468700928|FG002|Overall Study|Other|11|||
130202513|NCT00844480|468700935|FG000|Overall Study|Withdrawal by Subject|2|||
130202514|NCT00844480|468700936|FG001|Overall Study|Withdrawal by Subject|3|||
130202515|NCT02858180|468700937|FG000|Overall Study|Lost to Follow-up|0|||
130202516|NCT02858180|468700938|FG001|Overall Study|Lost to Follow-up|2|||
130202517|NCT00526331|468700939|FG000|Overall Study|Sponsor Termination|55|||
130202518|NCT00979420|468700940|FG000|Overall Study|Adverse Event|1|||
130202519|NCT00979420|468700941|FG001|Overall Study|Adverse Event|0|||
130202520|NCT00979420|468700942|FG002|Overall Study|Adverse Event|0|||
130202521|NCT00979420|468700943|FG003|Overall Study|Adverse Event|0|||
130202522|NCT00979420|468700940|FG000|Overall Study|Lack of Efficacy|3|||
130202523|NCT00979420|468700941|FG001|Overall Study|Lack of Efficacy|0|||
130202524|NCT00979420|468700942|FG002|Overall Study|Lack of Efficacy|1|||
130202525|NCT00979420|468700943|FG003|Overall Study|Lack of Efficacy|1|||
130202526|NCT00979420|468700940|FG000|Overall Study|Other reasons not related to Viramune|3|||
130202527|NCT00979420|468700941|FG001|Overall Study|Other reasons not related to Viramune|0|||
130202528|NCT00979420|468700942|FG002|Overall Study|Other reasons not related to Viramune|0|||
130202529|NCT00979420|468700943|FG003|Overall Study|Other reasons not related to Viramune|1|||
130202530|NCT00574249|468700944|FG000|Overall Study|Adverse Event|6|||
130202531|NCT00574249|468700945|FG001|Overall Study|Adverse Event|18|||
130202532|NCT00574249|468700944|FG000|Overall Study|Lack of Efficacy|5|||
130202533|NCT00574249|468700945|FG001|Overall Study|Lack of Efficacy|3|||
130202534|NCT00574249|468700944|FG000|Overall Study|Lost to Follow-up|4|||
130202535|NCT00574249|468700945|FG001|Overall Study|Lost to Follow-up|3|||
130202536|NCT00574249|468700944|FG000|Overall Study|Protocol Violation|5|||
130202537|NCT00574249|468700945|FG001|Overall Study|Protocol Violation|2|||
130202538|NCT00574249|468700944|FG000|Overall Study|History of carcinoma|1|||
130202539|NCT00574249|468700945|FG001|Overall Study|History of carcinoma|0|||
130202540|NCT00574249|468700944|FG000|Overall Study|Withdrawal by Subject|3|||
130202541|NCT00574249|468700945|FG001|Overall Study|Withdrawal by Subject|0|||
130202542|NCT00574249|468700944|FG000|Overall Study|Physician Decision|1|||
130202543|NCT00574249|468700945|FG001|Overall Study|Physician Decision|0|||
130202544|NCT00574249|468700944|FG000|Overall Study|Pregnancy|1|||
130202545|NCT00574249|468700945|FG001|Overall Study|Pregnancy|0|||
130202546|NCT00574249|468700944|FG000|Overall Study|Excluded by company|0|||
130202547|NCT00574249|468700945|FG001|Overall Study|Excluded by company|1|||
130202548|NCT00574249|468700944|FG000|Overall Study|PPD test taken twice|0|||
130202549|NCT00574249|468700945|FG001|Overall Study|PPD test taken twice|1|||
130202550|NCT00347919|468700948|FG000|Overall Study|Lost to Follow-up|11|||
130202551|NCT00347919|468700949|FG001|Overall Study|Lost to Follow-up|13|||
130202552|NCT00347919|468700950|FG002|Overall Study|Lost to Follow-up|0|||
130202553|NCT00347919|468700948|FG000|Overall Study|Withdrawal by Subject|6|||
130202554|NCT00347919|468700949|FG001|Overall Study|Withdrawal by Subject|8|||
130202555|NCT00347919|468700950|FG002|Overall Study|Withdrawal by Subject|0|||
130202556|NCT00347919|468700948|FG000|Overall Study|Physician Decision|1|||
130202557|NCT00347919|468700949|FG001|Overall Study|Physician Decision|1|||
130202558|NCT00347919|468700950|FG002|Overall Study|Physician Decision|0|||
130202559|NCT00347919|468700948|FG000|Overall Study|Sponsor terminated study|15|||
130202560|NCT00347919|468700949|FG001|Overall Study|Sponsor terminated study|10|||
130202561|NCT00347919|468700950|FG002|Overall Study|Sponsor terminated study|16|||
130202562|NCT00347919|468700948|FG000|Overall Study|Death|35|||
130202563|NCT00347919|468700949|FG001|Overall Study|Death|42|||
130202564|NCT00347919|468700950|FG002|Overall Study|Death|19|||
130202565|NCT00347919|468700948|FG000|Overall Study|Par. Started Other Treatment|1|||
130202566|NCT00347919|468700949|FG001|Overall Study|Par. Started Other Treatment|1|||
130202567|NCT00347919|468700950|FG002|Overall Study|Par. Started Other Treatment|1|||
130202568|NCT00347919|468700948|FG000|Overall Study|Missing|2|||
130202569|NCT00347919|468700949|FG001|Overall Study|Missing|1|||
130202570|NCT00347919|468700950|FG002|Overall Study|Missing|2|||
130202571|NCT01382225|468700960|FG000|Overall Study|Adverse Event|3|||
130202572|NCT01382225|468700961|FG001|Overall Study|Adverse Event|2|||
130202573|NCT01382225|468700960|FG000|Overall Study|Protocol Violation|2|||
130202574|NCT01382225|468700961|FG001|Overall Study|Protocol Violation|1|||
130202575|NCT01382225|468700960|FG000|Overall Study|Subject Withdrew Consent|5|||
130202576|NCT01382225|468700961|FG001|Overall Study|Subject Withdrew Consent|2|||
130202577|NCT01382225|468700960|FG000|Overall Study|Other|4|||
130202578|NCT01382225|468700961|FG001|Overall Study|Other|2|||
130202579|NCT02548351|468700970|FG000|Overall Study|Withdrawal by Subject|149|||
130202580|NCT02548351|468700971|FG001|Overall Study|Withdrawal by Subject|154|||
130202581|NCT02548351|468700972|FG002|Overall Study|Withdrawal by Subject|152|||
130202582|NCT02548351|468700970|FG000|Overall Study|Death|11|||
130202583|NCT02548351|468700971|FG001|Overall Study|Death|15|||
130202584|NCT02548351|468700972|FG002|Overall Study|Death|12|||
130202585|NCT02548351|468700970|FG000|Overall Study|Adverse Event|22|||
130202586|NCT02548351|468700971|FG001|Overall Study|Adverse Event|56|||
130202587|NCT02548351|468700972|FG002|Overall Study|Adverse Event|36|||
130202588|NCT02548351|468700970|FG000|Overall Study|Study Terminated by Sponsor|549|||
130202589|NCT02548351|468700971|FG001|Overall Study|Study Terminated by Sponsor|509|||
130202590|NCT02548351|468700972|FG002|Overall Study|Study Terminated by Sponsor|528|||
130202591|NCT02548351|468700970|FG000|Overall Study|Site Closure|14|||
130202592|NCT02548351|468700971|FG001|Overall Study|Site Closure|5|||
130202593|NCT02548351|468700972|FG002|Overall Study|Site Closure|7|||
130202594|NCT02548351|468700970|FG000|Overall Study|Non-compliance with Study Drug|4|||
130202595|NCT02548351|468700971|FG001|Overall Study|Non-compliance with Study Drug|2|||
130202596|NCT02548351|468700972|FG002|Overall Study|Non-compliance with Study Drug|0|||
130202597|NCT02548351|468700970|FG000|Overall Study|Protocol Violation|2|||
130202598|NCT02548351|468700971|FG001|Overall Study|Protocol Violation|1|||
130202599|NCT02548351|468700972|FG002|Overall Study|Protocol Violation|2|||
130202600|NCT02548351|468700970|FG000|Overall Study|Physician Decision|11|||
130202601|NCT02548351|468700971|FG001|Overall Study|Physician Decision|18|||
130202602|NCT02548351|468700972|FG002|Overall Study|Physician Decision|11|||
130202603|NCT02548351|468700970|FG000|Overall Study|Lost to Follow-up|43|||
130202604|NCT02548351|468700971|FG001|Overall Study|Lost to Follow-up|50|||
130202605|NCT02548351|468700972|FG002|Overall Study|Lost to Follow-up|57|||
130202606|NCT02548351|468700970|FG000|Overall Study|Other|19|||
130202607|NCT02548351|468700971|FG001|Overall Study|Other|16|||
130202608|NCT02548351|468700972|FG002|Overall Study|Other|20|||
130202609|NCT02548351|468700970|FG000|Overall Study|Missing|1|||
130202610|NCT02548351|468700971|FG001|Overall Study|Missing|1|||
130202611|NCT02548351|468700972|FG002|Overall Study|Missing|0|||
130202612|NCT00125242|468700973|FG000|Overall Study|did not qualify|7|||
130202613|NCT00125242|468700974|FG001|Overall Study|did not qualify|2|||
130202614|NCT01664949|468700977|FG000|Overall Study|Adverse Event|11|||
130202615|NCT01664949|468700978|FG001|Overall Study|Adverse Event|12|||
130202616|NCT01664949|468700977|FG000|Overall Study|Lack of Efficacy|1|||
130202617|NCT01664949|468700978|FG001|Overall Study|Lack of Efficacy|1|||
130202618|NCT01664949|468700977|FG000|Overall Study|Lost to Follow-up|1|||
130202619|NCT01664949|468700978|FG001|Overall Study|Lost to Follow-up|2|||
130202620|NCT01664949|468700977|FG000|Overall Study|Personal Reasons|3|||
130202621|NCT01664949|468700978|FG001|Overall Study|Personal Reasons|4|||
130202622|NCT01664949|468700977|FG000|Overall Study|Protocol Violation|5|||
130202623|NCT01664949|468700978|FG001|Overall Study|Protocol Violation|5|||
130202624|NCT01664949|468700977|FG000|Overall Study|Other Miscellaneous Reasons|3|||
130202625|NCT01664949|468700978|FG001|Overall Study|Other Miscellaneous Reasons|1|||
130202626|NCT03003494|468700980|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
130202627|NCT05238025|468700983|FG000|Overall Study|Adverse Event|2|||
130202628|NCT05238025|468700984|FG001|Overall Study|Adverse Event|2|||
130202629|NCT05238025|468700983|FG000|Overall Study|Lost to Follow-up|334|||
130202630|NCT05238025|468700984|FG001|Overall Study|Lost to Follow-up|339|||
130202631|NCT05238025|468700983|FG000|Overall Study|Withdrawal by Subject|203|||
130202632|NCT05238025|468700984|FG001|Overall Study|Withdrawal by Subject|222|||
130202633|NCT05238025|468700983|FG000|Overall Study|Physician Decision|20|||
130202634|NCT05238025|468700984|FG001|Overall Study|Physician Decision|8|||
130202635|NCT05238025|468700983|FG000|Overall Study|Protocol Violation|6|||
130202636|NCT05238025|468700984|FG001|Overall Study|Protocol Violation|2|||
130202637|NCT05238025|468700983|FG000|Overall Study|Death|38|||
130202638|NCT05238025|468700984|FG001|Overall Study|Death|32|||
130202639|NCT05238025|468700983|FG000|Overall Study|Study terminated by Sponsor|6358|||
130202640|NCT05238025|468700984|FG001|Overall Study|Study terminated by Sponsor|6358|||
130202641|NCT05238025|468700983|FG000|Overall Study|Other Reason|669|||
130202642|NCT05238025|468700984|FG001|Overall Study|Other Reason|690|||
130202643|NCT01263782|468700986|FG000|Overall Study|Death|0|||
130202644|NCT01263782|468700987|FG001|Overall Study|Death|0|||
130202645|NCT01263782|468700988|FG002|Overall Study|Death|1|||
130202646|NCT01263782|468700989|FG003|Overall Study|Death|0|||
130202647|NCT01263782|468700986|FG000|Overall Study|Progressive disease|0|||
130202648|NCT01263782|468700987|FG001|Overall Study|Progressive disease|0|||
130202649|NCT01263782|468700988|FG002|Overall Study|Progressive disease|0|||
130202650|NCT01263782|468700989|FG003|Overall Study|Progressive disease|1|||
130202651|NCT01263782|468700986|FG000|Overall Study|Too early|0|||
130202652|NCT01263782|468700987|FG001|Overall Study|Too early|0|||
130202653|NCT01263782|468700988|FG002|Overall Study|Too early|1|||
130202654|NCT01263782|468700989|FG003|Overall Study|Too early|0|||
130202655|NCT01263782|468700986|FG000|Overall Study|Inevaluable|0|||
130202656|NCT01263782|468700987|FG001|Overall Study|Inevaluable|0|||
130202657|NCT01263782|468700988|FG002|Overall Study|Inevaluable|1|||
130202658|NCT01263782|468700989|FG003|Overall Study|Inevaluable|0|||
130202659|NCT04545567|468700990|FG000|Overall Study|tested positive for SARS-co-V2|1|||
130202660|NCT04545567|468700991|FG001|Overall Study|tested positive for SARS-co-V2|1|||
130202661|NCT04545567|468700990|FG000|Overall Study|Withdrawal by Subject|0|||
130202662|NCT04545567|468700991|FG001|Overall Study|Withdrawal by Subject|1|||
130202663|NCT03814720|468700994|FG000|Overall Study|Lost to Follow-up|0|||
130202664|NCT03814720|468700995|FG001|Overall Study|Lost to Follow-up|1|||
130202665|NCT03814720|468700996|FG002|Overall Study|Lost to Follow-up|0|||
130202666|NCT03814720|468700997|FG003|Overall Study|Lost to Follow-up|0|||
130202667|NCT03814720|468700998|FG004|Overall Study|Lost to Follow-up|0|||
130202668|NCT02135107|468700999|FG000|Treatment Period|Withdrawal by Subject|11|||
130202669|NCT02135107|468701000|FG001|Treatment Period|Withdrawal by Subject|0|||
130202670|NCT02135107|468701001|FG002|Treatment Period|Withdrawal by Subject|0|||
130202671|NCT02135107|468701002|FG003|Treatment Period|Withdrawal by Subject|0|||
130202672|NCT02135107|468700999|FG000|Treatment Period|Adverse Event|5|||
130202673|NCT02135107|468701000|FG001|Treatment Period|Adverse Event|2|||
130202674|NCT02135107|468701001|FG002|Treatment Period|Adverse Event|0|||
130202675|NCT02135107|468701002|FG003|Treatment Period|Adverse Event|0|||
130202676|NCT02135107|468700999|FG000|Treatment Period|Pregnancy|1|||
130202677|NCT02135107|468701000|FG001|Treatment Period|Pregnancy|0|||
130202678|NCT02135107|468701001|FG002|Treatment Period|Pregnancy|0|||
130202679|NCT02135107|468701002|FG003|Treatment Period|Pregnancy|0|||
130202680|NCT02135107|468700999|FG000|Treatment Period|Other|115|||
130202681|NCT02135107|468701000|FG001|Treatment Period|Other|24|||
130202682|NCT02135107|468701001|FG002|Treatment Period|Other|0|||
130202683|NCT02135107|468701002|FG003|Treatment Period|Other|0|||
130202684|NCT02135107|468700999|FG000|Maintenance Therapy Period|Adverse Event|0|||
130202685|NCT02135107|468701000|FG001|Maintenance Therapy Period|Adverse Event|0|||
130202686|NCT02135107|468701001|FG002|Maintenance Therapy Period|Adverse Event|3|||
130202687|NCT02135107|468701002|FG003|Maintenance Therapy Period|Adverse Event|7|||
130202688|NCT02135107|468700999|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
130202689|NCT02135107|468701000|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
130202690|NCT02135107|468701001|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
130202691|NCT02135107|468701002|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
130202692|NCT02135107|468700999|FG000|Maintenance Therapy Period|Pregnancy|0|||
130202693|NCT02135107|468701000|FG001|Maintenance Therapy Period|Pregnancy|0|||
130202694|NCT02135107|468701001|FG002|Maintenance Therapy Period|Pregnancy|0|||
130202695|NCT02135107|468701002|FG003|Maintenance Therapy Period|Pregnancy|1|||
130202696|NCT02135107|468700999|FG000|Maintenance Therapy Period|Other|0|||
130202697|NCT02135107|468701000|FG001|Maintenance Therapy Period|Other|0|||
130202698|NCT02135107|468701001|FG002|Maintenance Therapy Period|Other|7|||
130202699|NCT02135107|468701002|FG003|Maintenance Therapy Period|Other|8|||
130202700|NCT03197324|468701003|FG000|Overall Study|Adverse Event|0|||
130202701|NCT03197324|468701004|FG001|Overall Study|Adverse Event|1|||
130202702|NCT00877071|468701005|FG000|Overall Study|disease progression|2|||
130202703|NCT01984892|468701006|FG000|Overall Study|Progressive disease|7|||
130202704|NCT05723328|468701008|FG000|Overall Study|Investigator's Decision|5|||
130202705|NCT05723328|468701009|FG001|Overall Study|Investigator's Decision|2|||
130202706|NCT03055494|468702437|FG000|Overall Study|Lost to Follow-up|6|||
130202707|NCT03055494|468702438|FG001|Overall Study|Lost to Follow-up|0|||
130202708|NCT03055494|468702437|FG000|Overall Study|Physician Decision|2|||
130202709|NCT03055494|468702438|FG001|Overall Study|Physician Decision|0|||
130202710|NCT03055494|468702437|FG000|Overall Study|Withdrawal by Subject|1|||
130202711|NCT03055494|468702438|FG001|Overall Study|Withdrawal by Subject|0|||
130202712|NCT03055494|468702437|FG000|Overall Study|Adverse Event|0|||
130202713|NCT03055494|468702438|FG001|Overall Study|Adverse Event|1|||
130202714|NCT03055494|468702437|FG000|Overall Study|Non-compliance with study treatment|1|||
130202715|NCT03055494|468702438|FG001|Overall Study|Non-compliance with study treatment|0|||
130202716|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
130202717|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
130202718|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
130202719|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
130202720|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
130202721|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
130202722|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
130202723|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
130202724|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
130202725|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
130202726|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
130202727|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
130202728|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
130202729|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
130202730|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
130202731|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
130202732|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
130202733|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
130202734|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
130202735|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
130202736|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
130202737|NCT04488419|468702439|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
130202738|NCT04488419|468702440|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
130202739|NCT04488419|468702441|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
130202740|NCT04488419|468702439|FG000|Primary Analysis Population|Adverse Event|6|||
130202741|NCT04488419|468702440|FG001|Primary Analysis Population|Adverse Event|9|||
130202742|NCT04488419|468702441|FG002|Primary Analysis Population|Adverse Event|0|||
130202743|NCT04488419|468702439|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
130202744|NCT04488419|468702440|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
130202745|NCT04488419|468702441|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
130202746|NCT04488419|468702439|FG000|Primary Analysis Population|Protocol Violation|1|||
130202747|NCT04488419|468702440|FG001|Primary Analysis Population|Protocol Violation|1|||
130202748|NCT04488419|468702441|FG002|Primary Analysis Population|Protocol Violation|0|||
130202749|NCT04488419|468702439|FG000|Primary Analysis Population|Undetermined|7|||
130202750|NCT04488419|468702440|FG001|Primary Analysis Population|Undetermined|3|||
130202751|NCT04488419|468702441|FG002|Primary Analysis Population|Undetermined|0|||
130202752|NCT04488419|468702439|FG000|Primary Analysis Population|>1 Reason|2|||
130202753|NCT04488419|468702440|FG001|Primary Analysis Population|>1 Reason|4|||
130202754|NCT04488419|468702441|FG002|Primary Analysis Population|>1 Reason|0|||
130202755|NCT04166591|468702442|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130202756|NCT04166591|468702443|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130202757|NCT04166591|468702444|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202758|NCT04166591|468702445|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202759|NCT04166591|468702442|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
130202760|NCT04166591|468702443|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
130202761|NCT04166591|468702444|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202762|NCT04166591|468702445|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
130202763|NCT04161079|468702448|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
130202764|NCT02515994|468702449|FG000|Overall Study|Protocol Violation|3|||
130202765|NCT02515994|468702450|FG001|Overall Study|Protocol Violation|5|||
130202766|NCT02515994|468702449|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
130202767|NCT02515994|468702450|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
130202768|NCT02515994|468702449|FG000|Overall Study|Adverse Event|3|||
130202769|NCT02515994|468702450|FG001|Overall Study|Adverse Event|1|||
130202770|NCT02515994|468702449|FG000|Overall Study|Withdrawal by Subject|2|||
130202771|NCT02515994|468702450|FG001|Overall Study|Withdrawal by Subject|0|||
130202772|NCT04186806|468702459|FG000|Period 1: 7 Days|Adverse Event|1|||
130202773|NCT04186806|468702460|FG001|Period 1: 7 Days|Adverse Event|0|||
130202774|NCT04739722|468702468|FG000|Overall Study|Lost to Follow-up|5301|||
130202775|NCT04739722|468702468|FG000|Overall Study|Withdrawal by Subject|42|||
130202776|NCT04739722|468702468|FG000|Overall Study|Non Average-risk|1157|||
130202777|NCT03047720|468702472|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
130202778|NCT03047720|468702473|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
130202779|NCT00614120|468702474|FG000|Overall Study|Adverse Event|9|||
130202780|NCT00614120|468702475|FG001|Overall Study|Adverse Event|22|||
130202781|NCT00614120|468702476|FG002|Overall Study|Adverse Event|30|||
130202782|NCT00614120|468702477|FG003|Overall Study|Adverse Event|3|||
130202783|NCT00614120|468702474|FG000|Overall Study|Lack of Efficacy|3|||
130202784|NCT00614120|468702475|FG001|Overall Study|Lack of Efficacy|3|||
130202785|NCT00614120|468702476|FG002|Overall Study|Lack of Efficacy|2|||
130202786|NCT00614120|468702477|FG003|Overall Study|Lack of Efficacy|2|||
130202787|NCT00614120|468702474|FG000|Overall Study|Protocol Violation|2|||
130202788|NCT00614120|468702475|FG001|Overall Study|Protocol Violation|5|||
130202789|NCT00614120|468702476|FG002|Overall Study|Protocol Violation|3|||
130202790|NCT00614120|468702477|FG003|Overall Study|Protocol Violation|1|||
130202791|NCT00614120|468702474|FG000|Overall Study|Withdrawal criteria|1|||
130202792|NCT00614120|468702475|FG001|Overall Study|Withdrawal criteria|0|||
130202793|NCT00614120|468702476|FG002|Overall Study|Withdrawal criteria|0|||
130202794|NCT00614120|468702477|FG003|Overall Study|Withdrawal criteria|0|||
130202795|NCT00614120|468702474|FG000|Overall Study|Withdrawal by Subject|9|||
130202796|NCT00614120|468702475|FG001|Overall Study|Withdrawal by Subject|10|||
130202797|NCT00614120|468702476|FG002|Overall Study|Withdrawal by Subject|16|||
130202798|NCT00614120|468702477|FG003|Overall Study|Withdrawal by Subject|3|||
130202799|NCT00614120|468702474|FG000|Overall Study|Did not meet trial criteria|0|||
130202800|NCT00614120|468702475|FG001|Overall Study|Did not meet trial criteria|1|||
130202801|NCT00614120|468702476|FG002|Overall Study|Did not meet trial criteria|1|||
130202802|NCT00614120|468702477|FG003|Overall Study|Did not meet trial criteria|1|||
130202803|NCT00614120|468702474|FG000|Overall Study|hCG positive (not pregnant)|0|||
130202804|NCT00614120|468702475|FG001|Overall Study|hCG positive (not pregnant)|0|||
130202805|NCT00614120|468702476|FG002|Overall Study|hCG positive (not pregnant)|1|||
130202806|NCT00614120|468702477|FG003|Overall Study|hCG positive (not pregnant)|0|||
130202807|NCT00614120|468702474|FG000|Overall Study|Hypoglycaemia|0|||
130202808|NCT00614120|468702475|FG001|Overall Study|Hypoglycaemia|0|||
130202809|NCT00614120|468702476|FG002|Overall Study|Hypoglycaemia|0|||
130202810|NCT00614120|468702477|FG003|Overall Study|Hypoglycaemia|1|||
130202811|NCT00614120|468702474|FG000|Overall Study|Lack of trial product|3|||
130202812|NCT00614120|468702475|FG001|Overall Study|Lack of trial product|3|||
130202813|NCT00614120|468702476|FG002|Overall Study|Lack of trial product|2|||
130202814|NCT00614120|468702477|FG003|Overall Study|Lack of trial product|0|||
130202815|NCT00614120|468702474|FG000|Overall Study|Late syphilis, latent|1|||
130202816|NCT00614120|468702475|FG001|Overall Study|Late syphilis, latent|0|||
130202817|NCT00614120|468702476|FG002|Overall Study|Late syphilis, latent|0|||
130202818|NCT00614120|468702477|FG003|Overall Study|Late syphilis, latent|0|||
130202819|NCT00614120|468702474|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
130202820|NCT00614120|468702475|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
130202821|NCT00614120|468702476|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
130202822|NCT00614120|468702477|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
130202823|NCT00614120|468702474|FG000|Overall Study|Lost to Follow-up|1|||
130202824|NCT00614120|468702475|FG001|Overall Study|Lost to Follow-up|2|||
130202825|NCT00614120|468702476|FG002|Overall Study|Lost to Follow-up|3|||
130202826|NCT00614120|468702477|FG003|Overall Study|Lost to Follow-up|4|||
130202827|NCT01185509|468702478|FG000|Overall Study|Progression/Relapse|9|||
130202828|NCT01185509|468702479|FG001|Overall Study|Progression/Relapse|15|||
130202829|NCT01185509|468702478|FG000|Overall Study|Physician Decision|2|||
130202830|NCT01185509|468702479|FG001|Overall Study|Physician Decision|2|||
130202831|NCT01185509|468702478|FG000|Overall Study|Withdrawal by Subject|0|||
130202832|NCT01185509|468702479|FG001|Overall Study|Withdrawal by Subject|1|||
130202833|NCT01185509|468702478|FG000|Overall Study|Death|0|||
130202834|NCT01185509|468702479|FG001|Overall Study|Death|1|||
130202835|NCT01185509|468702478|FG000|Overall Study|Intercurrent Illness|0|||
130202836|NCT01185509|468702479|FG001|Overall Study|Intercurrent Illness|1|||
130202837|NCT03687372|468702480|FG000|Overall Study|Lost to Follow-up|12|||
130202838|NCT03687372|468702481|FG001|Overall Study|Lost to Follow-up|21|||
130202839|NCT03687372|468702480|FG000|Overall Study|Withdrawal by Subject|4|||
130202840|NCT03687372|468702481|FG001|Overall Study|Withdrawal by Subject|17|||
130202841|NCT03687372|468702480|FG000|Overall Study|Investigator Decision|1|||
130202842|NCT03687372|468702481|FG001|Overall Study|Investigator Decision|1|||
130202843|NCT00108485|468702484|FG000|Overall Study|Withdrawal by Subject|3|||
130202844|NCT00108485|468702485|FG001|Overall Study|Withdrawal by Subject|0|||
130202845|NCT00108485|468702484|FG000|Overall Study|Lost to Follow-up|0|||
130202846|NCT00108485|468702485|FG001|Overall Study|Lost to Follow-up|2|||
130202847|NCT00878969|468702488|FG000|Overall Study|Physician Decision|5|||
130202848|NCT00878969|468702489|FG001|Overall Study|Physician Decision|3|||
130202849|NCT00878969|468702490|FG002|Overall Study|Physician Decision|2|||
130202850|NCT00878969|468702488|FG000|Overall Study|Withdrawal by Subject|1|||
130202851|NCT00878969|468702489|FG001|Overall Study|Withdrawal by Subject|6|||
130202852|NCT00878969|468702490|FG002|Overall Study|Withdrawal by Subject|3|||
130202853|NCT00878969|468702488|FG000|Overall Study|kidney transplant|2|||
130202854|NCT00878969|468702489|FG001|Overall Study|kidney transplant|3|||
130202855|NCT00878969|468702490|FG002|Overall Study|kidney transplant|2|||
130202856|NCT00878969|468702488|FG000|Overall Study|Adverse Event|3|||
130202857|NCT00878969|468702489|FG001|Overall Study|Adverse Event|1|||
130202858|NCT00878969|468702490|FG002|Overall Study|Adverse Event|2|||
130202859|NCT00878969|468702488|FG000|Overall Study|Lost to Follow-up|2|||
130202860|NCT00878969|468702489|FG001|Overall Study|Lost to Follow-up|1|||
130202861|NCT00878969|468702490|FG002|Overall Study|Lost to Follow-up|0|||
130202862|NCT00878969|468702488|FG000|Overall Study|Protocol Violation|2|||
130202863|NCT00878969|468702489|FG001|Overall Study|Protocol Violation|0|||
130202864|NCT00878969|468702490|FG002|Overall Study|Protocol Violation|0|||
130202865|NCT00878969|468702488|FG000|Overall Study|Death|0|||
130202866|NCT00878969|468702489|FG001|Overall Study|Death|0|||
130202867|NCT00878969|468702490|FG002|Overall Study|Death|2|||
130202868|NCT00878969|468702488|FG000|Overall Study|Pregnancy|0|||
130202869|NCT00878969|468702489|FG001|Overall Study|Pregnancy|1|||
130202870|NCT00878969|468702490|FG002|Overall Study|Pregnancy|0|||
130202871|NCT03729570|468702491|FG000|Overall Study|Lost to Follow-up|16|||
130202872|NCT03729570|468702492|FG001|Overall Study|Lost to Follow-up|20|||
130202873|NCT03729570|468702491|FG000|Overall Study|Seroconversion|5|||
130202874|NCT03729570|468702492|FG001|Overall Study|Seroconversion|0|||
130202875|NCT03729570|468702491|FG000|Overall Study|Moved out of the city|1|||
130202876|NCT03729570|468702492|FG001|Overall Study|Moved out of the city|0|||
130202877|NCT03729570|468702491|FG000|Overall Study|Time Conflict|1|||
130202878|NCT03729570|468702492|FG001|Overall Study|Time Conflict|0|||
130202879|NCT03729570|468702491|FG000|Overall Study|Time Commitment|2|||
130202880|NCT03729570|468702492|FG001|Overall Study|Time Commitment|0|||
130202881|NCT03729570|468702491|FG000|Overall Study|Bad Experience|0|||
130202882|NCT03729570|468702492|FG001|Overall Study|Bad Experience|1|||
130202883|NCT03729570|468702491|FG000|Overall Study|No reason provided|2|||
130202884|NCT03729570|468702492|FG001|Overall Study|No reason provided|1|||
130202885|NCT03729570|468702491|FG000|Overall Study|Family Conflict|0|||
130202886|NCT03729570|468702492|FG001|Overall Study|Family Conflict|1|||
130202887|NCT03729570|468702491|FG000|Overall Study|Did not want to continue taking medications|0|||
130202888|NCT03729570|468702492|FG001|Overall Study|Did not want to continue taking medications|1|||
130202889|NCT03729570|468702491|FG000|Overall Study|Found another PrEP provider|1|||
130202890|NCT03729570|468702492|FG001|Overall Study|Found another PrEP provider|0|||
130202891|NCT03729570|468702491|FG000|Overall Study|Did not enjoy being in the control group|0|||
130202892|NCT03729570|468702492|FG001|Overall Study|Did not enjoy being in the control group|1|||
130202893|NCT01701193|468702495|FG000|Overall Study|Withdrawal by Subject|2|||
130202894|NCT01701193|468702496|FG001|Overall Study|Withdrawal by Subject|2|||
130202895|NCT01701193|468702497|FG002|Overall Study|Withdrawal by Subject|1|||
130202896|NCT01701193|468702498|FG003|Overall Study|Withdrawal by Subject|2|||
130202897|NCT01701193|468702495|FG000|Overall Study|Adverse Event|1|||
130202898|NCT01701193|468702496|FG001|Overall Study|Adverse Event|0|||
130202899|NCT01701193|468702497|FG002|Overall Study|Adverse Event|0|||
130202900|NCT01701193|468702498|FG003|Overall Study|Adverse Event|0|||
130202901|NCT00278148|468702499|FG000|Phase II - Expansion Phase|Disease progression|0|||
130202902|NCT00278148|468702500|FG001|Phase II - Expansion Phase|Disease progression|0|||
130202903|NCT00278148|468702501|FG002|Phase II - Expansion Phase|Disease progression|4|||
130202904|NCT00278148|468702499|FG000|Phase II - Expansion Phase|Adverse Event|0|||
130202905|NCT00278148|468702500|FG001|Phase II - Expansion Phase|Adverse Event|0|||
130202906|NCT00278148|468702501|FG002|Phase II - Expansion Phase|Adverse Event|2|||
130202907|NCT02407457|468702502|FG000|1 Month|Death|3|||
130202908|NCT02407457|468702503|FG001|1 Month|Death|0|||
130202909|NCT02407457|468702502|FG000|1 Month|Lost to Follow-up|1|||
130202910|NCT02407457|468702503|FG001|1 Month|Lost to Follow-up|1|||
130202911|NCT02407457|468702502|FG000|1 Month|missed visit|2|||
130202912|NCT02407457|468702503|FG001|1 Month|missed visit|5|||
130202913|NCT02407457|468702502|FG000|6-Month|Death|2|||
130202914|NCT02407457|468702503|FG001|6-Month|Death|8|||
130202915|NCT02407457|468702502|FG000|6-Month|Lost to Follow-up|2|||
130202916|NCT02407457|468702503|FG001|6-Month|Lost to Follow-up|2|||
130202917|NCT02407457|468702502|FG000|6-Month|missed visit|16|||
130202918|NCT02407457|468702503|FG001|6-Month|missed visit|14|||
130202919|NCT02407457|468702502|FG000|6-Month|Open Repair|0|||
130202920|NCT02407457|468702503|FG001|6-Month|Open Repair|1|||
130202921|NCT02407457|468702502|FG000|1 Year|Death|6|||
130202922|NCT02407457|468702503|FG001|1 Year|Death|11|||
130202923|NCT02407457|468702502|FG000|1 Year|Lost to Follow-up|3|||
130202924|NCT02407457|468702503|FG001|1 Year|Lost to Follow-up|2|||
130202925|NCT02407457|468702502|FG000|1 Year|Missed Visit|24|||
130202926|NCT02407457|468702503|FG001|1 Year|Missed Visit|14|||
130202927|NCT02407457|468702502|FG000|1 Year|Open Repair|0|||
130202928|NCT02407457|468702503|FG001|1 Year|Open Repair|1|||
130202929|NCT02407457|468702502|FG000|2-year|Death|14|||
130202930|NCT02407457|468702503|FG001|2-year|Death|8|||
130202931|NCT02407457|468702502|FG000|2-year|Lost to Follow-up|7|||
130202932|NCT02407457|468702503|FG001|2-year|Lost to Follow-up|10|||
130202933|NCT02407457|468702502|FG000|2-year|Missed Visit|13|||
130202934|NCT02407457|468702503|FG001|2-year|Missed Visit|15|||
130202935|NCT02407457|468702502|FG000|2-year|Open Repair|0|||
130202936|NCT02407457|468702503|FG001|2-year|Open Repair|2|||
130202937|NCT02407457|468702502|FG000|3-year|Death|11|||
130202938|NCT02407457|468702503|FG001|3-year|Death|10|||
130202939|NCT02407457|468702502|FG000|3-year|Lost to Follow-up|9|||
130202940|NCT02407457|468702503|FG001|3-year|Lost to Follow-up|10|||
130202941|NCT02407457|468702502|FG000|3-year|Missed Visit|19|||
130202942|NCT02407457|468702503|FG001|3-year|Missed Visit|16|||
130202943|NCT02407457|468702502|FG000|4-year|Death|18|||
130202944|NCT02407457|468702503|FG001|4-year|Death|10|||
130202945|NCT02407457|468702502|FG000|4-year|Lost to Follow-up|10|||
130202946|NCT02407457|468702503|FG001|4-year|Lost to Follow-up|12|||
130202947|NCT02407457|468702502|FG000|4-year|Missed Visit|18|||
130202948|NCT02407457|468702503|FG001|4-year|Missed Visit|16|||
130202949|NCT02407457|468702502|FG000|5-year|Death|10|||
130202950|NCT02407457|468702503|FG001|5-year|Death|3|||
130202951|NCT02407457|468702502|FG000|5-year|Lost to Follow-up|22|||
130202952|NCT02407457|468702503|FG001|5-year|Lost to Follow-up|13|||
130202953|NCT02407457|468702502|FG000|5-year|Missed Visit|9|||
130202954|NCT02407457|468702503|FG001|5-year|Missed Visit|1|||
130202955|NCT02083185|468702504|FG000|Overall Study|Lost to Follow-up|0|||
130202956|NCT02083185|468702505|FG001|Overall Study|Lost to Follow-up|3|||
130202957|NCT02083185|468702506|FG002|Overall Study|Lost to Follow-up|0|||
130202958|NCT02083185|468702504|FG000|Overall Study|Withdrawal by Subject|9|||
130202959|NCT02083185|468702505|FG001|Overall Study|Withdrawal by Subject|15|||
130202960|NCT02083185|468702506|FG002|Overall Study|Withdrawal by Subject|1|||
130202961|NCT02083185|468702504|FG000|Overall Study|Death|2|||
130202962|NCT02083185|468702505|FG001|Overall Study|Death|2|||
130202963|NCT02083185|468702506|FG002|Overall Study|Death|1|||
130202964|NCT02083185|468702504|FG000|Overall Study|Reason not Specified|9|||
130202965|NCT02083185|468702505|FG001|Overall Study|Reason not Specified|6|||
130202966|NCT02083185|468702506|FG002|Overall Study|Reason not Specified|5|||
130202967|NCT02083185|468702504|FG000|Overall Study|Study Terminated by Sponsor|0|||
130202968|NCT02083185|468702505|FG001|Overall Study|Study Terminated by Sponsor|1|||
130202969|NCT02083185|468702506|FG002|Overall Study|Study Terminated by Sponsor|0|||
130202970|NCT02083185|468702504|FG000|Overall Study|Did not Receive Study Drug|0|||
130202971|NCT02083185|468702505|FG001|Overall Study|Did not Receive Study Drug|2|||
130202972|NCT02083185|468702506|FG002|Overall Study|Did not Receive Study Drug|0|||
130202973|NCT01041976|468702507|FG000|Overall Study|Withdrawal by Subject|3|||
130202974|NCT01041976|468702508|FG001|Overall Study|Withdrawal by Subject|0|||
130202975|NCT01041976|468702507|FG000|Overall Study|Incarceration|2|||
130202976|NCT01041976|468702508|FG001|Overall Study|Incarceration|0|||
130202977|NCT01041976|468702507|FG000|Overall Study|Death|0|||
130202978|NCT01041976|468702508|FG001|Overall Study|Death|4|||
130202979|NCT03054064|468702509|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
130202980|NCT03054064|468702509|FG000|Overall Study|Investigator Decision|2|||
130202981|NCT03054064|468702509|FG000|Overall Study|Bladder Issue|1|||
130202982|NCT03054064|468702509|FG000|Overall Study|High Blood Pressure|1|||
130202983|NCT03054064|468702509|FG000|Overall Study|Change in Status|1|||
130202984|NCT03787303|468702510|FG000|Overall Study|Death|1|||
130202985|NCT03787303|468702510|FG000|Overall Study|Premature Termination of Study|1|||
130202986|NCT01384019|468702513|FG000|Overall Study|Withdrawal by Subject|3|||
130202987|NCT01384019|468702514|FG001|Overall Study|Withdrawal by Subject|0|||
130202988|NCT01384019|468702513|FG000|Overall Study|Death|1|||
130202989|NCT01384019|468702514|FG001|Overall Study|Death|0|||
130202990|NCT01384019|468702513|FG000|Overall Study|MRI refusal|6|||
130202991|NCT01384019|468702514|FG001|Overall Study|MRI refusal|6|||
130202992|NCT00767039|468702517|FG000|Overall Study|Death|5|||
130202993|NCT00767039|468702518|FG001|Overall Study|Death|2|||
130202994|NCT01826370|468702519|FG000|Overall Study|Protocol Violation|6|||
130202995|NCT01826370|468702519|FG000|Overall Study|Lost to Follow-up|12|||
130202996|NCT01826370|468702519|FG000|Overall Study|Other reason not defined above|2|||
130202997|NCT04416737|468702521|FG000|Week 1 (First Injection)|Physician Decision|0|||
130202998|NCT04416737|468702522|FG001|Week 1 (First Injection)|Physician Decision|1|||
130202999|NCT03332628|468702523|FG000|Overall Study|Physician Decision|2|||
130203000|NCT01472757|468702524|FG000|Overall Study|Withdrawal by Subject|1|||
130203001|NCT01472757|468702525|FG001|Overall Study|Withdrawal by Subject|2|||
130203002|NCT01472757|468702526|FG002|Overall Study|Withdrawal by Subject|2|||
130203003|NCT01472757|468702527|FG003|Overall Study|Withdrawal by Subject|0|||
130203004|NCT01472757|468702524|FG000|Overall Study|Asthma exacerbation|4|||
130203005|NCT01472757|468702525|FG001|Overall Study|Asthma exacerbation|1|||
130203006|NCT01472757|468702526|FG002|Overall Study|Asthma exacerbation|2|||
130203007|NCT01472757|468702527|FG003|Overall Study|Asthma exacerbation|1|||
130203008|NCT01472757|468702524|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
130203009|NCT01472757|468702525|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
130203010|NCT01472757|468702526|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
130203011|NCT01472757|468702527|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
130203012|NCT01472757|468702524|FG000|Overall Study|Protocol Violation|3|||
130203013|NCT01472757|468702525|FG001|Overall Study|Protocol Violation|2|||
130203014|NCT01472757|468702526|FG002|Overall Study|Protocol Violation|4|||
130203015|NCT01472757|468702527|FG003|Overall Study|Protocol Violation|4|||
130203016|NCT01472757|468702524|FG000|Overall Study|Other reasons|1|||
130203017|NCT01472757|468702525|FG001|Overall Study|Other reasons|0|||
130203018|NCT01472757|468702526|FG002|Overall Study|Other reasons|2|||
130203019|NCT01472757|468702527|FG003|Overall Study|Other reasons|2|||
130203020|NCT04489381|468702532|FG000|Overall Study|Lost to Follow-up|2|||
130203021|NCT04489381|468702533|FG001|Overall Study|Lost to Follow-up|3|||
130203022|NCT04489381|468702532|FG000|Overall Study|Withdrawal by Subject|1|||
130203023|NCT04489381|468702533|FG001|Overall Study|Withdrawal by Subject|0|||
130203024|NCT01259375|468702539|FG000|Overall Study|Adverse Event|1|||
130203025|NCT00478699|468702542|FG000|Overall Study|Inclusion Error|1|||
130203026|NCT00478699|468702543|FG001|Overall Study|Inclusion Error|7|||
130203027|NCT00478699|468702542|FG000|Overall Study|Not receive study treatment|6|||
130203028|NCT00478699|468702543|FG001|Overall Study|Not receive study treatment|30|||
130203029|NCT01043705|468702548|FG000|Overall Study|Death|28|||
130203030|NCT01043705|468702549|FG001|Overall Study|Death|60|||
130203031|NCT01043705|468702550|FG002|Overall Study|Death|26|||
130203032|NCT01043705|468702548|FG000|Overall Study|Lost to Follow-up|27|||
130203033|NCT01043705|468702549|FG001|Overall Study|Lost to Follow-up|12|||
130203034|NCT01043705|468702550|FG002|Overall Study|Lost to Follow-up|0|||
130203035|NCT01043705|468702548|FG000|Overall Study|Multiple Reasons|4|||
130203036|NCT01043705|468702549|FG001|Overall Study|Multiple Reasons|7|||
130203037|NCT01043705|468702550|FG002|Overall Study|Multiple Reasons|0|||
130203038|NCT01043705|468702548|FG000|Overall Study|Protocol Violation|2|||
130203039|NCT01043705|468702549|FG001|Overall Study|Protocol Violation|1|||
130203040|NCT01043705|468702550|FG002|Overall Study|Protocol Violation|0|||
130203041|NCT01043705|468702548|FG000|Overall Study|Withdrawal by Subject|8|||
130203042|NCT01043705|468702549|FG001|Overall Study|Withdrawal by Subject|6|||
130203043|NCT01043705|468702550|FG002|Overall Study|Withdrawal by Subject|0|||
130203044|NCT01043705|468702548|FG000|Overall Study|Site Closure|8|||
130203045|NCT01043705|468702549|FG001|Overall Study|Site Closure|0|||
130203046|NCT01043705|468702550|FG002|Overall Study|Site Closure|0|||
130203047|NCT01043705|468702548|FG000|Overall Study|Subsequent Procedure|9|||
130203048|NCT01043705|468702549|FG001|Overall Study|Subsequent Procedure|24|||
130203049|NCT01043705|468702550|FG002|Overall Study|Subsequent Procedure|29|||
130203050|NCT01043705|468702548|FG000|Overall Study|Adverse Event|0|||
130203051|NCT01043705|468702549|FG001|Overall Study|Adverse Event|2|||
130203052|NCT01043705|468702550|FG002|Overall Study|Adverse Event|0|||
130203053|NCT01043705|468702548|FG000|Overall Study|Screen Fail|21|||
130203054|NCT01043705|468702549|FG001|Overall Study|Screen Fail|0|||
130203055|NCT01043705|468702550|FG002|Overall Study|Screen Fail|0|||
130203056|NCT01043705|468702548|FG000|Overall Study|Other|0|||
130203057|NCT01043705|468702549|FG001|Overall Study|Other|19|||
130203058|NCT01043705|468702550|FG002|Overall Study|Other|25|||
130203059|NCT01123941|468702553|FG000|Overall Study|Lost to Follow-up|2|||
130203060|NCT01123941|468702554|FG001|Overall Study|Lost to Follow-up|1|||
130203061|NCT04601103|468702555|FG000|Overall Study|Needed crown & cleaning|0|||
130203062|NCT04601103|468702556|FG001|Overall Study|Needed crown & cleaning|0|||
130203063|NCT04601103|468702557|FG002|Overall Study|Needed crown & cleaning|1|||
130203064|NCT04601103|468702555|FG000|Overall Study|study was terminated|18|||
130203065|NCT04601103|468702556|FG001|Overall Study|study was terminated|18|||
130203066|NCT04601103|468702557|FG002|Overall Study|study was terminated|16|||
130203067|NCT06011161|468702558|FG000|Overall Study|Withdrawal by Subject|2|||
130203068|NCT06011161|468702558|FG000|Overall Study|Lost to Follow-up|5|||
130203069|NCT00381043|468702559|FG000|Overall Study|Lost to Follow-up|8|||
130203070|NCT00381043|468702560|FG001|Overall Study|Lost to Follow-up|6|||
130203071|NCT00381043|468702559|FG000|Overall Study|Withdrawal by Subject|3|||
130203072|NCT00381043|468702560|FG001|Overall Study|Withdrawal by Subject|1|||
130203073|NCT00381043|468702559|FG000|Overall Study|wanted more care|0|||
130203074|NCT00381043|468702560|FG001|Overall Study|wanted more care|1|||
130203075|NCT00381043|468702559|FG000|Overall Study|incarcerated|1|||
130203076|NCT00381043|468702560|FG001|Overall Study|incarcerated|0|||
130203077|NCT03045276|468702563|FG000|Intervention Phase|Withdrawal by Subject|7|||
130203078|NCT03045276|468702564|FG001|Intervention Phase|Withdrawal by Subject|2|||
130203079|NCT03045276|468702565|FG002|Intervention Phase|Withdrawal by Subject|3|||
130203080|NCT03045276|468702566|FG003|Intervention Phase|Withdrawal by Subject|7|||
130203081|NCT03045276|468702563|FG000|Intervention Phase|Developed exclusionary criteria|3|||
130203082|NCT03045276|468702564|FG001|Intervention Phase|Developed exclusionary criteria|3|||
130203083|NCT03045276|468702565|FG002|Intervention Phase|Developed exclusionary criteria|0|||
130203084|NCT03045276|468702566|FG003|Intervention Phase|Developed exclusionary criteria|0|||
130203085|NCT03045276|468702563|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
130203086|NCT03045276|468702564|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
130203087|NCT03045276|468702565|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
130203088|NCT03045276|468702566|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
130203089|NCT03045276|468702563|FG000|Follow-Up Phase|Lost to Follow-up|0|||
130203090|NCT03045276|468702564|FG001|Follow-Up Phase|Lost to Follow-up|1|||
130203091|NCT03045276|468702565|FG002|Follow-Up Phase|Lost to Follow-up|0|||
130203092|NCT03045276|468702566|FG003|Follow-Up Phase|Lost to Follow-up|1|||
130203093|NCT03045276|468702563|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
130203094|NCT03045276|468702564|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
130203095|NCT03045276|468702565|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
130203096|NCT03045276|468702566|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
130203097|NCT01597375|468702567|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
130203098|NCT01597375|468702568|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
130203099|NCT01597375|468702567|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
130203100|NCT01597375|468702568|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
130203101|NCT01597375|468702567|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
130203102|NCT01597375|468702568|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
130203103|NCT01597375|468702567|FG000|Washout (2 Weeks)|Adverse Event|1|||
130203104|NCT01597375|468702568|FG001|Washout (2 Weeks)|Adverse Event|0|||
130203105|NCT01597375|468702567|FG000|Second Intervention|Failed to react at both Aspirin|1|||
130203106|NCT01597375|468702568|FG001|Second Intervention|Failed to react at both Aspirin|1|||
130203107|NCT04713592|468702573|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130203108|NCT04713592|468702574|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
130203109|NCT04713592|468702575|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130203110|NCT04713592|468702576|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
130203111|NCT04713592|468702573|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
130203112|NCT04713592|468702574|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
130203113|NCT04713592|468702575|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
130203114|NCT04713592|468702576|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
130203115|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
130203116|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
130203117|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
130203118|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
130203119|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130203120|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
130203121|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
130203122|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
130203123|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
130203124|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
130203125|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
130203126|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
130203127|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130203128|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
130203129|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130203130|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
130203131|NCT04713592|468702573|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
130203132|NCT04713592|468702574|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
130203133|NCT04713592|468702575|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
130203134|NCT04713592|468702576|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
130203135|NCT02225366|468702579|FG000|Overall Study|Lack of Efficacy|1|||
130203136|NCT02225366|468702580|FG001|Overall Study|Lack of Efficacy|0|||
130203137|NCT03782298|468702581|FG000|Overall Study|Protocol Deviation|4|||
130203138|NCT01797081|468702582|FG000|Overall Study|Adverse Event|1|||
130203139|NCT01797081|468702583|FG001|Overall Study|Adverse Event|0|||
130203140|NCT01797081|468702584|FG002|Overall Study|Adverse Event|1|||
130203141|NCT01797081|468702585|FG003|Overall Study|Adverse Event|0|||
130203142|NCT01797081|468702582|FG000|Overall Study|Pregnancy|1|||
130203143|NCT01797081|468702583|FG001|Overall Study|Pregnancy|0|||
130203144|NCT01797081|468702584|FG002|Overall Study|Pregnancy|0|||
130203145|NCT01797081|468702585|FG003|Overall Study|Pregnancy|0|||
130203146|NCT01797081|468702582|FG000|Overall Study|Personal Reasons|12|||
130203147|NCT01797081|468702583|FG001|Overall Study|Personal Reasons|4|||
130203148|NCT01797081|468702584|FG002|Overall Study|Personal Reasons|4|||
130203149|NCT01797081|468702585|FG003|Overall Study|Personal Reasons|8|||
130203150|NCT01797081|468702582|FG000|Overall Study|Protocol Violation|0|||
130203151|NCT01797081|468702583|FG001|Overall Study|Protocol Violation|0|||
130203152|NCT01797081|468702584|FG002|Overall Study|Protocol Violation|0|||
130203153|NCT01797081|468702585|FG003|Overall Study|Protocol Violation|1|||
130203154|NCT02484651|468702592|FG000|Overall Study|Patients' data files were corrupted.|1|||
130203155|NCT02484651|468702593|FG001|Overall Study|Patients' data files were corrupted.|1|||
130203156|NCT02484651|468702592|FG000|Overall Study|BIS monitoring failed.|1|||
130203157|NCT02484651|468702593|FG001|Overall Study|BIS monitoring failed.|1|||
130203158|NCT02484651|468702592|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
130203159|NCT02484651|468702593|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
130203160|NCT02375555|468702597|FG000|Induction Period|Adverse Event|7|||
130203161|NCT02375555|468702597|FG000|Induction Period|Withdrawal by Subject|2|||
130203162|NCT02375555|468702597|FG000|Induction Period|Other|1|||
130203163|NCT02375555|468702597|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
130203164|NCT02375555|468702597|FG000|Maintenance Period|Adverse Event|2|||
130203165|NCT02375555|468702597|FG000|Maintenance Period|Withdrawal by Subject|4|||
130203166|NCT02375555|468702597|FG000|Maintenance Period|Death|1|||
130203167|NCT02375555|468702597|FG000|Maintenance Period|Disease Progression|5|||
130203168|NCT02375555|468702597|FG000|Maintenance Period|Patient Non-compliance|1|||
130203169|NCT02375555|468702597|FG000|Maintenance Period|Still on maintenance|16|||
130203170|NCT01744184|468702609|FG000|Overall Study|Adverse Event|1|||
130203171|NCT01744184|468702610|FG001|Overall Study|Adverse Event|0|||
130203172|NCT01744184|468702609|FG000|Overall Study|Withdrawal by Subject|0|||
130203173|NCT01744184|468702610|FG001|Overall Study|Withdrawal by Subject|1|||
130203174|NCT01095978|468702614|FG000|Overall Study|Did not take Klacid SR|2|||
130203175|NCT01095978|468702614|FG000|Overall Study|Adverse Event|1|||
130203176|NCT00808639|468702618|FG000|Overall Study|Disease progression before surgery.|1|||
130203177|NCT00197002|468704338|FG000|Overall Study|Adverse Event|0|||
130203178|NCT00197002|468704339|FG001|Overall Study|Adverse Event|1|||
130203179|NCT00197002|468704340|FG002|Overall Study|Adverse Event|0|||
130203180|NCT00197002|468704338|FG000|Overall Study|Protocol Violation|1|||
130203181|NCT00197002|468704339|FG001|Overall Study|Protocol Violation|0|||
130203182|NCT00197002|468704340|FG002|Overall Study|Protocol Violation|2|||
130203183|NCT00197002|468704338|FG000|Overall Study|Withdrawal by Subject|9|||
130203184|NCT00197002|468704339|FG001|Overall Study|Withdrawal by Subject|5|||
130203185|NCT00197002|468704340|FG002|Overall Study|Withdrawal by Subject|7|||
130203186|NCT00197002|468704338|FG000|Overall Study|Migrated/moved from study area|3|||
130203187|NCT00197002|468704339|FG001|Overall Study|Migrated/moved from study area|5|||
130203188|NCT00197002|468704340|FG002|Overall Study|Migrated/moved from study area|1|||
130203189|NCT00197002|468704338|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
130203190|NCT00197002|468704339|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
130203191|NCT00197002|468704340|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
130203192|NCT00197002|468704338|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
130203193|NCT00197002|468704339|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
130203194|NCT00197002|468704340|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
130203195|NCT00197002|468704338|FG000|Overall Study|Others|3|||
130203196|NCT00197002|468704339|FG001|Overall Study|Others|1|||
130203197|NCT00197002|468704340|FG002|Overall Study|Others|1|||
130203198|NCT02017717|468704341|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203199|NCT02017717|468704342|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203200|NCT02017717|468704343|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203201|NCT02017717|468704344|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203202|NCT02017717|468704345|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203203|NCT02017717|468704346|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203204|NCT02017717|468704347|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203205|NCT02017717|468704348|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
130203206|NCT02017717|468704349|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
130203207|NCT02017717|468704341|FG000|Before Treatment Period|Participant request to stop therapy|0|||
130203208|NCT02017717|468704342|FG001|Before Treatment Period|Participant request to stop therapy|0|||
130203209|NCT02017717|468704343|FG002|Before Treatment Period|Participant request to stop therapy|0|||
130203210|NCT02017717|468704344|FG003|Before Treatment Period|Participant request to stop therapy|0|||
130203211|NCT02017717|468704345|FG004|Before Treatment Period|Participant request to stop therapy|0|||
130203212|NCT02017717|468704346|FG005|Before Treatment Period|Participant request to stop therapy|0|||
130203213|NCT02017717|468704347|FG006|Before Treatment Period|Participant request to stop therapy|0|||
130203214|NCT02017717|468704348|FG007|Before Treatment Period|Participant request to stop therapy|0|||
130203215|NCT02017717|468704349|FG008|Before Treatment Period|Participant request to stop therapy|5|||
130203216|NCT02017717|468704341|FG000|Before Treatment Period|Participant withdrew consent|0|||
130203217|NCT02017717|468704342|FG001|Before Treatment Period|Participant withdrew consent|0|||
130203218|NCT02017717|468704343|FG002|Before Treatment Period|Participant withdrew consent|0|||
130203219|NCT02017717|468704344|FG003|Before Treatment Period|Participant withdrew consent|0|||
130203220|NCT02017717|468704345|FG004|Before Treatment Period|Participant withdrew consent|0|||
130203221|NCT02017717|468704346|FG005|Before Treatment Period|Participant withdrew consent|0|||
130203222|NCT02017717|468704347|FG006|Before Treatment Period|Participant withdrew consent|2|||
130203223|NCT02017717|468704348|FG007|Before Treatment Period|Participant withdrew consent|0|||
130203224|NCT02017717|468704349|FG008|Before Treatment Period|Participant withdrew consent|11|||
130203225|NCT02017717|468704341|FG000|Before Treatment Period|Lost to Follow-up|0|||
130203226|NCT02017717|468704342|FG001|Before Treatment Period|Lost to Follow-up|0|||
130203227|NCT02017717|468704343|FG002|Before Treatment Period|Lost to Follow-up|0|||
130203228|NCT02017717|468704344|FG003|Before Treatment Period|Lost to Follow-up|0|||
130203229|NCT02017717|468704345|FG004|Before Treatment Period|Lost to Follow-up|0|||
130203230|NCT02017717|468704346|FG005|Before Treatment Period|Lost to Follow-up|0|||
130203231|NCT02017717|468704347|FG006|Before Treatment Period|Lost to Follow-up|0|||
130203232|NCT02017717|468704348|FG007|Before Treatment Period|Lost to Follow-up|0|||
130203233|NCT02017717|468704349|FG008|Before Treatment Period|Lost to Follow-up|1|||
130203234|NCT02017717|468704341|FG000|Before Treatment Period|Participant no longer met criteria|0|||
130203235|NCT02017717|468704342|FG001|Before Treatment Period|Participant no longer met criteria|0|||
130203236|NCT02017717|468704343|FG002|Before Treatment Period|Participant no longer met criteria|0|||
130203237|NCT02017717|468704344|FG003|Before Treatment Period|Participant no longer met criteria|0|||
130203238|NCT02017717|468704345|FG004|Before Treatment Period|Participant no longer met criteria|0|||
130203239|NCT02017717|468704346|FG005|Before Treatment Period|Participant no longer met criteria|1|||
130203240|NCT02017717|468704347|FG006|Before Treatment Period|Participant no longer met criteria|0|||
130203241|NCT02017717|468704348|FG007|Before Treatment Period|Participant no longer met criteria|1|||
130203242|NCT02017717|468704349|FG008|Before Treatment Period|Participant no longer met criteria|2|||
130203243|NCT02017717|468704341|FG000|Before Treatment Period|other reason|0|||
130203244|NCT02017717|468704342|FG001|Before Treatment Period|other reason|0|||
130203245|NCT02017717|468704343|FG002|Before Treatment Period|other reason|0|||
130203246|NCT02017717|468704344|FG003|Before Treatment Period|other reason|0|||
130203247|NCT02017717|468704345|FG004|Before Treatment Period|other reason|0|||
130203248|NCT02017717|468704346|FG005|Before Treatment Period|other reason|0|||
130203249|NCT02017717|468704347|FG006|Before Treatment Period|other reason|0|||
130203250|NCT02017717|468704348|FG007|Before Treatment Period|other reason|0|||
130203251|NCT02017717|468704349|FG008|Before Treatment Period|other reason|1|||
130203252|NCT02017717|468704341|FG000|Treatment Period|Disease progression|7|||
130203253|NCT02017717|468704342|FG001|Treatment Period|Disease progression|9|||
130203254|NCT02017717|468704343|FG002|Treatment Period|Disease progression|12|||
130203255|NCT02017717|468704344|FG003|Treatment Period|Disease progression|20|||
130203256|NCT02017717|468704345|FG004|Treatment Period|Disease progression|26|||
130203257|NCT02017717|468704346|FG005|Treatment Period|Disease progression|16|||
130203258|NCT02017717|468704347|FG006|Treatment Period|Disease progression|22|||
130203259|NCT02017717|468704348|FG007|Treatment Period|Disease progression|165|||
130203260|NCT02017717|468704349|FG008|Treatment Period|Disease progression|135|||
130203261|NCT02017717|468704341|FG000|Treatment Period|Study drug toxicity|3|||
130203262|NCT02017717|468704342|FG001|Treatment Period|Study drug toxicity|0|||
130203263|NCT02017717|468704343|FG002|Treatment Period|Study drug toxicity|1|||
130203264|NCT02017717|468704344|FG003|Treatment Period|Study drug toxicity|4|||
130203265|NCT02017717|468704345|FG004|Treatment Period|Study drug toxicity|4|||
130203266|NCT02017717|468704346|FG005|Treatment Period|Study drug toxicity|5|||
130203267|NCT02017717|468704347|FG006|Treatment Period|Study drug toxicity|3|||
130203268|NCT02017717|468704348|FG007|Treatment Period|Study drug toxicity|7|||
130203269|NCT02017717|468704349|FG008|Treatment Period|Study drug toxicity|11|||
130203270|NCT02017717|468704341|FG000|Treatment Period|Death|0|||
130203271|NCT02017717|468704342|FG001|Treatment Period|Death|0|||
130203272|NCT02017717|468704343|FG002|Treatment Period|Death|1|||
130203273|NCT02017717|468704344|FG003|Treatment Period|Death|0|||
130203274|NCT02017717|468704345|FG004|Treatment Period|Death|0|||
130203275|NCT02017717|468704346|FG005|Treatment Period|Death|2|||
130203276|NCT02017717|468704347|FG006|Treatment Period|Death|0|||
130203277|NCT02017717|468704348|FG007|Treatment Period|Death|0|||
130203278|NCT02017717|468704349|FG008|Treatment Period|Death|0|||
130203279|NCT02017717|468704341|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
130203280|NCT02017717|468704342|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
130203281|NCT02017717|468704343|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
130203282|NCT02017717|468704344|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
130203283|NCT02017717|468704345|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
130203284|NCT02017717|468704346|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
130203285|NCT02017717|468704347|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
130203286|NCT02017717|468704348|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
130203287|NCT02017717|468704349|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
130203288|NCT02017717|468704341|FG000|Treatment Period|Participant request to stop therapy|0|||
130203289|NCT02017717|468704342|FG001|Treatment Period|Participant request to stop therapy|0|||
130203290|NCT02017717|468704343|FG002|Treatment Period|Participant request to stop therapy|3|||
130203291|NCT02017717|468704344|FG003|Treatment Period|Participant request to stop therapy|6|||
130203292|NCT02017717|468704345|FG004|Treatment Period|Participant request to stop therapy|0|||
130203293|NCT02017717|468704346|FG005|Treatment Period|Participant request to stop therapy|2|||
130203294|NCT02017717|468704347|FG006|Treatment Period|Participant request to stop therapy|1|||
130203295|NCT02017717|468704348|FG007|Treatment Period|Participant request to stop therapy|4|||
130203296|NCT02017717|468704349|FG008|Treatment Period|Participant request to stop therapy|7|||
130203297|NCT02017717|468704341|FG000|Treatment Period|Participant withdrew consent|0|||
130203298|NCT02017717|468704342|FG001|Treatment Period|Participant withdrew consent|0|||
130203299|NCT02017717|468704343|FG002|Treatment Period|Participant withdrew consent|1|||
130203300|NCT02017717|468704344|FG003|Treatment Period|Participant withdrew consent|0|||
130203301|NCT02017717|468704345|FG004|Treatment Period|Participant withdrew consent|0|||
130203302|NCT02017717|468704346|FG005|Treatment Period|Participant withdrew consent|2|||
130203303|NCT02017717|468704347|FG006|Treatment Period|Participant withdrew consent|0|||
130203304|NCT02017717|468704348|FG007|Treatment Period|Participant withdrew consent|1|||
130203305|NCT02017717|468704349|FG008|Treatment Period|Participant withdrew consent|4|||
130203306|NCT02017717|468704341|FG000|Treatment Period|Participant no longer met criteria|0|||
130203307|NCT02017717|468704342|FG001|Treatment Period|Participant no longer met criteria|0|||
130203308|NCT02017717|468704343|FG002|Treatment Period|Participant no longer met criteria|0|||
130203309|NCT02017717|468704344|FG003|Treatment Period|Participant no longer met criteria|0|||
130203310|NCT02017717|468704345|FG004|Treatment Period|Participant no longer met criteria|0|||
130203311|NCT02017717|468704346|FG005|Treatment Period|Participant no longer met criteria|0|||
130203312|NCT02017717|468704347|FG006|Treatment Period|Participant no longer met criteria|0|||
130203313|NCT02017717|468704348|FG007|Treatment Period|Participant no longer met criteria|0|||
130203314|NCT02017717|468704349|FG008|Treatment Period|Participant no longer met criteria|1|||
130203315|NCT02017717|468704341|FG000|Treatment Period|Other reasons|0|||
130203316|NCT02017717|468704342|FG001|Treatment Period|Other reasons|0|||
130203317|NCT02017717|468704343|FG002|Treatment Period|Other reasons|0|||
130203318|NCT02017717|468704344|FG003|Treatment Period|Other reasons|1|||
130203319|NCT02017717|468704345|FG004|Treatment Period|Other reasons|0|||
130203320|NCT02017717|468704346|FG005|Treatment Period|Other reasons|1|||
130203321|NCT02017717|468704347|FG006|Treatment Period|Other reasons|1|||
130203322|NCT02017717|468704348|FG007|Treatment Period|Other reasons|1|||
130203323|NCT02017717|468704349|FG008|Treatment Period|Other reasons|1|||
130203324|NCT02017717|468704341|FG000|Treatment Period|Maximum clinical benefit|0|||
130203325|NCT02017717|468704342|FG001|Treatment Period|Maximum clinical benefit|0|||
130203326|NCT02017717|468704343|FG002|Treatment Period|Maximum clinical benefit|0|||
130203327|NCT02017717|468704344|FG003|Treatment Period|Maximum clinical benefit|0|||
130203328|NCT02017717|468704345|FG004|Treatment Period|Maximum clinical benefit|0|||
130203329|NCT02017717|468704346|FG005|Treatment Period|Maximum clinical benefit|0|||
130203330|NCT02017717|468704347|FG006|Treatment Period|Maximum clinical benefit|0|||
130203331|NCT02017717|468704348|FG007|Treatment Period|Maximum clinical benefit|0|||
130203332|NCT02017717|468704349|FG008|Treatment Period|Maximum clinical benefit|1|||
130203333|NCT02017717|468704341|FG000|Treatment Period|Not reported|0|||
130203334|NCT02017717|468704342|FG001|Treatment Period|Not reported|1|||
130203335|NCT02017717|468704343|FG002|Treatment Period|Not reported|0|||
130203336|NCT02017717|468704344|FG003|Treatment Period|Not reported|0|||
130203337|NCT02017717|468704345|FG004|Treatment Period|Not reported|0|||
130203338|NCT02017717|468704346|FG005|Treatment Period|Not reported|0|||
130203339|NCT02017717|468704347|FG006|Treatment Period|Not reported|0|||
130203340|NCT02017717|468704348|FG007|Treatment Period|Not reported|0|||
130203341|NCT02017717|468704349|FG008|Treatment Period|Not reported|0|||
130203342|NCT00623597|468704354|FG000|Overall Study|Failed to return|1|||
130203343|NCT00623597|468704355|FG001|Overall Study|Failed to return|0|||
130203344|NCT02339155|468704359|FG000|Overall Study|Adverse Event|0|||
130203345|NCT02339155|468704360|FG001|Overall Study|Adverse Event|6|||
130203346|NCT02339155|468704359|FG000|Overall Study|Death|1|||
130203347|NCT02339155|468704360|FG001|Overall Study|Death|1|||
130203348|NCT02339155|468704359|FG000|Overall Study|Lost to Follow-up|8|||
130203349|NCT02339155|468704360|FG001|Overall Study|Lost to Follow-up|9|||
130203350|NCT02339155|468704359|FG000|Overall Study|Physician Decision|2|||
130203351|NCT02339155|468704360|FG001|Overall Study|Physician Decision|1|||
130203352|NCT02339155|468704359|FG000|Overall Study|Withdrawal by Subject|4|||
130203353|NCT02339155|468704360|FG001|Overall Study|Withdrawal by Subject|4|||
130203354|NCT01214252|468704363|FG000|Overall Study|Not eligible per protocol|82|||
130203355|NCT04327661|468704366|FG000|Overall Study|Withdrawal by Subject|1|||
130203356|NCT04327661|468704367|FG001|Overall Study|Withdrawal by Subject|0|||
130203357|NCT04327661|468704368|FG002|Overall Study|Withdrawal by Subject|0|||
130203358|NCT03427268|468704370|FG000|Overall Study|Progressive disease|25|||
130203359|NCT03427268|468704370|FG000|Overall Study|Never treated|2|||
130203360|NCT03427268|468704370|FG000|Overall Study|Compassionate use|1|||
130203361|NCT03427268|468704370|FG000|Overall Study|Withdrawal by Subject|1|||
130203362|NCT03427268|468704370|FG000|Overall Study|Adverse Event|3|||
130203363|NCT00345878|468704372|FG000|Overall Study|Adverse Event|1|||
130203364|NCT00345878|468704373|FG001|Overall Study|Adverse Event|0|||
130203365|NCT00345878|468704372|FG000|Overall Study|Lost to Follow-up|2|||
130203366|NCT00345878|468704373|FG001|Overall Study|Lost to Follow-up|1|||
130203367|NCT00345878|468704372|FG000|Overall Study|Other|1|||
130203368|NCT00345878|468704373|FG001|Overall Study|Other|0|||
130203369|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
130203370|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
130203371|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
130203372|NCT01995175|468704375|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
130203373|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
130203374|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
130203375|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
130203376|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
130203377|NCT01995175|468704375|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
130203378|NCT01877551|468704376|FG000|Overall Study|Physician Decision|0|||
130203379|NCT01877551|468704377|FG001|Overall Study|Physician Decision|1|||
130203380|NCT00984061|468704378|FG000|Clarithromycin Alone|Protocol Violation|1|||
130203381|NCT02659514|468704381|FG000|Overall Study|Adverse Event|3|||
130203382|NCT02659514|468704382|FG001|Overall Study|Adverse Event|12|||
130203383|NCT02659514|468704381|FG000|Overall Study|Disease Progression|23|||
130203384|NCT02659514|468704382|FG001|Overall Study|Disease Progression|13|||
130203385|NCT02659514|468704381|FG000|Overall Study|Withdrawal by Subject|0|||
130203386|NCT02659514|468704382|FG001|Overall Study|Withdrawal by Subject|4|||
130203387|NCT02659514|468704381|FG000|Overall Study|Lost to Follow-up|0|||
130203388|NCT02659514|468704382|FG001|Overall Study|Lost to Follow-up|1|||
130203389|NCT02659514|468704381|FG000|Overall Study|Death|6|||
130203390|NCT02659514|468704382|FG001|Overall Study|Death|1|||
130203391|NCT02659514|468704381|FG000|Overall Study|Reason Unspecified|0|||
130203392|NCT02659514|468704382|FG001|Overall Study|Reason Unspecified|3|||
130203393|NCT01968707|468704388|FG000|Overall Study|Did not meet treatment day baseline|49|||
130203394|NCT01968707|468704389|FG001|Overall Study|Did not meet treatment day baseline|12|||
130203395|NCT01968707|468704390|FG002|Overall Study|Did not meet treatment day baseline|41|||
130203396|NCT01968707|468704391|FG003|Overall Study|Did not meet treatment day baseline|44|||
130203397|NCT01968707|468704392|FG004|Overall Study|Did not meet treatment day baseline|36|||
130203398|NCT01968707|468704393|FG005|Overall Study|Did not meet treatment day baseline|11|||
130203399|NCT01968707|468704394|FG006|Overall Study|Did not meet treatment day baseline|34|||
130203400|NCT01968707|468704395|FG007|Overall Study|Did not meet treatment day baseline|35|||
130203401|NCT00916344|468704396|FG000|Overall Study|Death|2|||
130203402|NCT00916344|468704396|FG000|Overall Study|ICD upgrade|1|||
130203403|NCT00916344|468704396|FG000|Overall Study|Drop-out|5|||
130203404|NCT02062944|468704413|FG000|Overall Study|Lost to Follow-up|1|||
130203405|NCT02062944|468704413|FG000|Overall Study|New hemotological disorder identified|1|||
130203406|NCT02062944|468704413|FG000|Overall Study|Uncontrolled Hypertension|1|||
130203407|NCT02062944|468704413|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
130203408|NCT01088243|468704415|FG000|Overall Study|Adverse Event|1|||
130203409|NCT01088243|468704416|FG001|Overall Study|Adverse Event|0|||
130203410|NCT02231879|468704417|FG000|Overall Study|Adverse Event|2|||
130203411|NCT02231879|468704418|FG001|Overall Study|Adverse Event|1|||
130203412|NCT02231879|468704417|FG000|Overall Study|Lack of Efficacy|0|||
130203413|NCT02231879|468704418|FG001|Overall Study|Lack of Efficacy|1|||
130203414|NCT01210495|468704419|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
130203415|NCT01210495|468704420|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
130203416|NCT01210495|468704421|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
130203417|NCT01210495|468704422|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
130203418|NCT01210495|468704419|FG000|Overall Study|Death|14|||
130203419|NCT01210495|468704420|FG001|Overall Study|Death|7|||
130203420|NCT01210495|468704421|FG002|Overall Study|Death|112|||
130203421|NCT01210495|468704422|FG003|Overall Study|Death|54|||
130203422|NCT01210495|468704419|FG000|Overall Study|Study Terminated by Sponsor|0|||
130203423|NCT01210495|468704420|FG001|Overall Study|Study Terminated by Sponsor|0|||
130203424|NCT01210495|468704421|FG002|Overall Study|Study Terminated by Sponsor|4|||
130203425|NCT01210495|468704422|FG003|Overall Study|Study Terminated by Sponsor|11|||
130203426|NCT01210495|468704419|FG000|Overall Study|Lost to Follow-up|0|||
130203427|NCT01210495|468704420|FG001|Overall Study|Lost to Follow-up|0|||
130203428|NCT01210495|468704421|FG002|Overall Study|Lost to Follow-up|1|||
130203429|NCT01210495|468704422|FG003|Overall Study|Lost to Follow-up|1|||
130203430|NCT01210495|468704419|FG000|Overall Study|Other unspecified|0|||
130203431|NCT01210495|468704420|FG001|Overall Study|Other unspecified|0|||
130203432|NCT01210495|468704421|FG002|Overall Study|Other unspecified|6|||
130203433|NCT01210495|468704422|FG003|Overall Study|Other unspecified|0|||
130203434|NCT00454818|468704423|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
130203435|NCT00454818|468704424|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203436|NCT00454818|468704425|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203437|NCT00454818|468704426|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203438|NCT00454818|468704427|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
130203439|NCT00454818|468704423|FG000|Phase I: Open-label Dose-escalation|Death|0|||
130203440|NCT00454818|468704424|FG001|Phase I: Open-label Dose-escalation|Death|1|||
130203441|NCT00454818|468704425|FG002|Phase I: Open-label Dose-escalation|Death|0|||
130203442|NCT00454818|468704426|FG003|Phase I: Open-label Dose-escalation|Death|0|||
130203443|NCT00454818|468704427|FG004|Phase I: Open-label Dose-escalation|Death|0|||
130203444|NCT00454818|468704423|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130203445|NCT00454818|468704424|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130203446|NCT00454818|468704425|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
130203447|NCT00454818|468704426|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
130203448|NCT00454818|468704427|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
130203449|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130203450|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
130203451|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130203452|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
130203453|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
130203454|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Death|0|||
130203455|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Death|1|||
130203456|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Death|0|||
130203457|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Death|0|||
130203458|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Death|1|||
130203459|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130203460|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130203461|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
130203462|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
130203463|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
130203464|NCT00454818|468704423|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130203465|NCT00454818|468704424|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130203466|NCT00454818|468704425|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
130203467|NCT00454818|468704426|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
130203468|NCT00454818|468704427|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
130203469|NCT02505334|468704433|FG000|Main Treatment Period|Adverse Event|3|||
130203470|NCT02505334|468704434|FG001|Main Treatment Period|Adverse Event|3|||
130203471|NCT02505334|468704433|FG000|Main Treatment Period|Lack of Efficacy|7|||
130203472|NCT02505334|468704434|FG001|Main Treatment Period|Lack of Efficacy|17|||
130203473|NCT02505334|468704433|FG000|Main Treatment Period|Protocol Violation|0|||
130203474|NCT02505334|468704434|FG001|Main Treatment Period|Protocol Violation|1|||
130203475|NCT02505334|468704433|FG000|Main Treatment Period|Withdrawal by Subject|1|||
130203476|NCT02505334|468704434|FG001|Main Treatment Period|Withdrawal by Subject|8|||
130203477|NCT02505334|468704433|FG000|Main Treatment Period|Unclassified|4|||
130203478|NCT02505334|468704434|FG001|Main Treatment Period|Unclassified|10|||
130203479|NCT02505334|468704433|FG000|Extension Treatment Period|Adverse Event|5|||
130203480|NCT02505334|468704434|FG001|Extension Treatment Period|Adverse Event|0|||
130203481|NCT02505334|468704433|FG000|Extension Treatment Period|Lack of Efficacy|4|||
130203482|NCT02505334|468704434|FG001|Extension Treatment Period|Lack of Efficacy|0|||
130203483|NCT02505334|468704433|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
130203484|NCT02505334|468704434|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
130203485|NCT02505334|468704433|FG000|Extension Treatment Period|Unclassified|3|||
130203486|NCT02505334|468704434|FG001|Extension Treatment Period|Unclassified|0|||
130203487|NCT00581542|468704437|FG000|Overall Study|they met an exclusion criteria|2|||
130203488|NCT00581542|468704438|FG001|Overall Study|they met an exclusion criteria|2|||
130203489|NCT00581542|468704437|FG000|Overall Study|Lost to Follow-up|9|||
130203490|NCT00581542|468704438|FG001|Overall Study|Lost to Follow-up|21|||
130203491|NCT00656851|468704439|FG000|Overall Study|Withdrawal by Subject|0|||
130203492|NCT00656851|468704440|FG001|Overall Study|Withdrawal by Subject|4|||
130203493|NCT02291601|468704441|FG000|Abdomen|Did not qualify|333|||
130203494|NCT02291601|468704442|FG001|Abdomen|Did not qualify|54|||
130203495|NCT02291601|468704443|FG002|Abdomen|Did not qualify|339|||
130203496|NCT02291601|468704441|FG000|Groin|Did not qualify|183|||
130203497|NCT02291601|468704442|FG001|Groin|Did not qualify|30|||
130203498|NCT02291601|468704443|FG002|Groin|Did not qualify|177|||
130203499|NCT03379753|468704444|FG000|Overall Study|Withdrawal by Subject|2|||
130203500|NCT03379753|468704445|FG001|Overall Study|Withdrawal by Subject|1|||
130203501|NCT03379753|468704444|FG000|Overall Study|not having correct procedure|1|||
130203502|NCT03379753|468704445|FG001|Overall Study|not having correct procedure|2|||
130203503|NCT03379753|468704444|FG000|Overall Study|No primary outcome|12|||
130203504|NCT03379753|468704445|FG001|Overall Study|No primary outcome|22|||
130203505|NCT01032239|468704446|FG000|Overall Study|Lost to Follow-up|3|||
130203506|NCT01032239|468704447|FG001|Overall Study|Lost to Follow-up|2|||
130203507|NCT01032239|468704446|FG000|Overall Study|Withdrawal by Subject|2|||
130203508|NCT01032239|468704447|FG001|Overall Study|Withdrawal by Subject|3|||
130203509|NCT01032239|468704446|FG000|Overall Study|Death|1|||
130203510|NCT01032239|468704447|FG001|Overall Study|Death|0|||
130203511|NCT01032239|468704446|FG000|Overall Study|Protocol Violation|1|||
130203512|NCT01032239|468704447|FG001|Overall Study|Protocol Violation|0|||
130203513|NCT01940900|468704450|FG000|Overall Study|Physician Decision|4|||
130203514|NCT01940900|468704451|FG001|Overall Study|Physician Decision|0|||
130203515|NCT01940900|468704450|FG000|Overall Study|Adverse Event|10|||
130203516|NCT01940900|468704451|FG001|Overall Study|Adverse Event|15|||
130203517|NCT01940900|468704450|FG000|Overall Study|Withdrawal by Subject|11|||
130203518|NCT01940900|468704451|FG001|Overall Study|Withdrawal by Subject|15|||
130203519|NCT01940900|468704450|FG000|Overall Study|Lost to Follow-up|1|||
130203520|NCT01940900|468704451|FG001|Overall Study|Lost to Follow-up|0|||
130203521|NCT01940900|468704450|FG000|Overall Study|Sponsor Decision|1|||
130203522|NCT01940900|468704451|FG001|Overall Study|Sponsor Decision|0|||
130203523|NCT01940900|468704450|FG000|Overall Study|subject non-compliance|1|||
130203524|NCT01940900|468704451|FG001|Overall Study|subject non-compliance|1|||
130203525|NCT01940900|468704450|FG000|Overall Study|other|1|||
130203526|NCT01940900|468704451|FG001|Overall Study|other|0|||
130203527|NCT04972968|468704454|FG000|Overall Study|Adverse Event|3|||
130203528|NCT04972968|468704455|FG001|Overall Study|Adverse Event|1|||
130203529|NCT04972968|468704456|FG002|Overall Study|Adverse Event|1|||
130203530|NCT04972968|468704457|FG003|Overall Study|Adverse Event|7|||
130203531|NCT04972968|468704454|FG000|Overall Study|Lack of Efficacy|2|||
130203532|NCT04972968|468704455|FG001|Overall Study|Lack of Efficacy|1|||
130203533|NCT04972968|468704456|FG002|Overall Study|Lack of Efficacy|0|||
130203534|NCT04972968|468704457|FG003|Overall Study|Lack of Efficacy|0|||
130203535|NCT04972968|468704454|FG000|Overall Study|Withdrawal by Subject|7|||
130203536|NCT04972968|468704455|FG001|Overall Study|Withdrawal by Subject|4|||
130203537|NCT04972968|468704456|FG002|Overall Study|Withdrawal by Subject|3|||
130203538|NCT04972968|468704457|FG003|Overall Study|Withdrawal by Subject|2|||
130203539|NCT04972968|468704454|FG000|Overall Study|Study Terminated by Sponsor|25|||
130203540|NCT04972968|468704455|FG001|Overall Study|Study Terminated by Sponsor|28|||
130203541|NCT04972968|468704456|FG002|Overall Study|Study Terminated by Sponsor|32|||
130203542|NCT04972968|468704457|FG003|Overall Study|Study Terminated by Sponsor|27|||
130203543|NCT04972968|468704454|FG000|Overall Study|Other|1|||
130203544|NCT04972968|468704455|FG001|Overall Study|Other|0|||
130203545|NCT04972968|468704456|FG002|Overall Study|Other|1|||
130203546|NCT04972968|468704457|FG003|Overall Study|Other|1|||
130203547|NCT01698879|468704458|FG000|Overall Study|Withdrawal by Subject|1|||
130203548|NCT01698879|468704459|FG001|Overall Study|Withdrawal by Subject|0|||
130203549|NCT01698879|468704460|FG002|Overall Study|Withdrawal by Subject|0|||
130203550|NCT02419612|468704466|FG000|Short-term Treatment Period|Adverse Event|1|||
130203551|NCT02419612|468704467|FG001|Short-term Treatment Period|Adverse Event|1|||
130203552|NCT02419612|468704466|FG000|Short-term Treatment Period|Death|0|||
130203553|NCT02419612|468704467|FG001|Short-term Treatment Period|Death|2|||
130203554|NCT02419612|468704466|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
130203555|NCT02419612|468704467|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
130203556|NCT02419612|468704466|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
130203557|NCT02419612|468704467|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
130203558|NCT02419612|468704466|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
130203559|NCT02419612|468704467|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
130203560|NCT02419612|468704466|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
130203561|NCT02419612|468704467|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
130203562|NCT02419612|468704466|FG000|Short-term Treatment Period|Worsening of liver function|0|||
130203563|NCT02419612|468704467|FG001|Short-term Treatment Period|Worsening of liver function|1|||
130203564|NCT02419612|468704466|FG000|Short-term Treatment Period|Subject moved out of state|0|||
130203565|NCT02419612|468704467|FG001|Short-term Treatment Period|Subject moved out of state|1|||
130203566|NCT02419612|468704466|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
130203567|NCT02419612|468704467|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
130203568|NCT02419612|468704466|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
130203569|NCT02419612|468704467|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
130203570|NCT02419612|468704466|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
130203571|NCT02419612|468704467|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
130203572|NCT02419612|468704466|FG000|Long-term Treatment Period|Death|0|||
130203573|NCT02419612|468704467|FG001|Long-term Treatment Period|Death|1|||
130203574|NCT02419612|468704466|FG000|Long-term Treatment Period|Adverse Event|0|||
130203575|NCT02419612|468704467|FG001|Long-term Treatment Period|Adverse Event|5|||
130203576|NCT02419612|468704466|FG000|Long-term Treatment Period|Other|4|||
130203577|NCT02419612|468704467|FG001|Long-term Treatment Period|Other|4|||
130203578|NCT02419612|468704466|FG000|Long-term Treatment Period|Subject Decision|2|||
130203579|NCT02419612|468704467|FG001|Long-term Treatment Period|Subject Decision|4|||
130203580|NCT02419612|468704466|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
130203581|NCT02419612|468704467|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
130203582|NCT00474045|468704468|FG000|Overall Study|Adverse Event|18|||
130203583|NCT00474045|468704469|FG001|Overall Study|Adverse Event|8|||
130203584|NCT00474045|468704468|FG000|Overall Study|Unclassified|1|||
130203585|NCT00474045|468704469|FG001|Overall Study|Unclassified|3|||
130203586|NCT00474045|468704468|FG000|Overall Study|Lack of Efficacy|0|||
130203587|NCT00474045|468704469|FG001|Overall Study|Lack of Efficacy|9|||
130203588|NCT00474045|468704468|FG000|Overall Study|Lost to Follow-up|1|||
130203589|NCT00474045|468704469|FG001|Overall Study|Lost to Follow-up|1|||
130203590|NCT00474045|468704468|FG000|Overall Study|Protocol Violation|10|||
130203591|NCT00474045|468704469|FG001|Overall Study|Protocol Violation|12|||
130203592|NCT00474045|468704468|FG000|Overall Study|Withdrawal by Subject|16|||
130203593|NCT00474045|468704469|FG001|Overall Study|Withdrawal by Subject|18|||
130203594|NCT00474045|468704468|FG000|Overall Study|Withdrawal criteria|60|||
130203595|NCT00474045|468704469|FG001|Overall Study|Withdrawal criteria|50|||
130203596|NCT02009397|468704476|FG000|Overall Study|Protocol Violation|6|||
130203597|NCT02009397|468704476|FG000|Overall Study|Death|8|||
130203598|NCT02009397|468704476|FG000|Overall Study|Lost to Follow-up|6|||
130203599|NCT02278120|468704480|FG000|Treatment Period|Progressive disease|234|||
130203600|NCT02278120|468704481|FG001|Treatment Period|Progressive disease|260|||
130203601|NCT02278120|468704480|FG000|Treatment Period|Subject/guardian decision|23|||
130203602|NCT02278120|468704481|FG001|Treatment Period|Subject/guardian decision|20|||
130203603|NCT02278120|468704480|FG000|Treatment Period|Adverse Event|16|||
130203604|NCT02278120|468704481|FG001|Treatment Period|Adverse Event|14|||
130203605|NCT02278120|468704480|FG000|Treatment Period|Physician Decision|14|||
130203606|NCT02278120|468704481|FG001|Treatment Period|Physician Decision|27|||
130203607|NCT02278120|468704480|FG000|Treatment Period|Death|3|||
130203608|NCT02278120|468704481|FG001|Treatment Period|Death|3|||
130203609|NCT02278120|468704480|FG000|Treatment Period|Lost to Follow-up|2|||
130203610|NCT02278120|468704481|FG001|Treatment Period|Lost to Follow-up|0|||
130203611|NCT02278120|468704480|FG000|Treatment Period|Protocol deviation|0|||
130203612|NCT02278120|468704481|FG001|Treatment Period|Protocol deviation|2|||
130203613|NCT02278120|468704480|FG000|Treatment Period|Study terminated as per protocol|43|||
130203614|NCT02278120|468704481|FG001|Treatment Period|Study terminated as per protocol|11|||
130203615|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Death|0|||
130203616|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Death|1|||
130203617|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
130203618|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
130203619|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
130203620|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
130203621|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
130203622|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
130203623|NCT02278120|468704480|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130203624|NCT02278120|468704481|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
130203625|NCT01966068|468704485|FG000|Overall Study|Withdrawal by Subject|57|||
130203626|NCT01966068|468704485|FG000|Overall Study|Lost to Follow-up|81|||
130203627|NCT00191282|468704490|FG000|Overall Study|Adverse Event|5|||
130203628|NCT00191282|468704491|FG001|Overall Study|Adverse Event|6|||
130203629|NCT00191282|468704490|FG000|Overall Study|Death|51|||
130203630|NCT00191282|468704491|FG001|Overall Study|Death|51|||
130203631|NCT00191282|468704490|FG000|Overall Study|Lack of Efficacy|11|||
130203632|NCT00191282|468704491|FG001|Overall Study|Lack of Efficacy|6|||
130203633|NCT00191282|468704490|FG000|Overall Study|Noncompliance|14|||
130203634|NCT00191282|468704491|FG001|Overall Study|Noncompliance|17|||
130203635|NCT00191282|468704490|FG000|Overall Study|Patient moved|11|||
130203636|NCT00191282|468704491|FG001|Overall Study|Patient moved|14|||
130203637|NCT00191282|468704490|FG000|Overall Study|Withdrawal by Subject|59|||
130203638|NCT00191282|468704491|FG001|Overall Study|Withdrawal by Subject|44|||
130203639|NCT00191282|468704490|FG000|Overall Study|Physician Decision|18|||
130203640|NCT00191282|468704491|FG001|Overall Study|Physician Decision|15|||
130203641|NCT00191282|468704490|FG000|Overall Study|Protocol entry criteria not met|14|||
130203642|NCT00191282|468704491|FG001|Overall Study|Protocol entry criteria not met|9|||
130203643|NCT00191282|468704490|FG000|Overall Study|Protocol Violation|9|||
130203644|NCT00191282|468704491|FG001|Overall Study|Protocol Violation|12|||
130203645|NCT00191282|468704490|FG000|Overall Study|Severity of outcome|2|||
130203646|NCT00191282|468704491|FG001|Overall Study|Severity of outcome|5|||
130203647|NCT00191282|468704490|FG000|Overall Study|Sponsor's decision|2|||
130203648|NCT00191282|468704491|FG001|Overall Study|Sponsor's decision|2|||
130203649|NCT00191282|468704490|FG000|Overall Study|Lost to Follow-up|24|||
130203650|NCT00191282|468704491|FG001|Overall Study|Lost to Follow-up|31|||
130203651|NCT00102531|468704492|FG000|Overall Study|Adverse Event|0|||
130203652|NCT00102531|468704493|FG001|Overall Study|Adverse Event|1|||
130203653|NCT00102531|468704492|FG000|Overall Study|Disease Progression|5|||
130203654|NCT00102531|468704493|FG001|Overall Study|Disease Progression|9|||
130203655|NCT00102531|468704492|FG000|Overall Study|Physician Decision|0|||
130203656|NCT00102531|468704493|FG001|Overall Study|Physician Decision|1|||
130203657|NCT04756154|468704494|FG000|Overall Study|Did not meet treatment day baseline|30|||
130203658|NCT04756154|468704495|FG001|Overall Study|Did not meet treatment day baseline|28|||
130203659|NCT04756154|468704496|FG002|Overall Study|Did not meet treatment day baseline|7|||
130203660|NCT04756154|468704494|FG000|Overall Study|Did not return for final sample collection|1|||
130203661|NCT04756154|468704495|FG001|Overall Study|Did not return for final sample collection|1|||
130203662|NCT04756154|468704496|FG002|Overall Study|Did not return for final sample collection|0|||
130203663|NCT01790828|468704497|FG000|Overall Study|Other|34|||
130203664|NCT03589976|468704499|FG000|Overall Study|Death|5|||
130203665|NCT03589976|468704500|FG001|Overall Study|Death|1|||
130203666|NCT03589976|468704499|FG000|Overall Study|Adverse Event|5|||
130203667|NCT03589976|468704500|FG001|Overall Study|Adverse Event|1|||
130203668|NCT03589976|468704499|FG000|Overall Study|Withdrawal by Subject|4|||
130203669|NCT03589976|468704500|FG001|Overall Study|Withdrawal by Subject|1|||
130203670|NCT03589976|468704499|FG000|Overall Study|Lost to Follow-up|1|||
130203671|NCT03589976|468704500|FG001|Overall Study|Lost to Follow-up|0|||
130203672|NCT03589976|468704499|FG000|Overall Study|Other|4|||
130203673|NCT03589976|468704500|FG001|Overall Study|Other|3|||
130203674|NCT03721835|468704501|FG000|Overall Study|Participant not able to return|1|||
130203675|NCT03721835|468704501|FG000|Overall Study|Lost to Follow-up|1|||
130203676|NCT03721835|468704501|FG000|Overall Study|Revision of the components of the study device|2|||
130203677|NCT03721835|468704501|FG000|Overall Study|Sponsor terminated study|6|||
130203678|NCT03721835|468704501|FG000|Overall Study|Death|1|||
130203679|NCT03721835|468704501|FG000|Overall Study|Sponsor decision|1|||
130203680|NCT01390428|468705900|FG000|Overall Study|Elective Surgery|0|||
130203681|NCT01390428|468705901|FG001|Overall Study|Elective Surgery|0|||
130203682|NCT01390428|468705902|FG002|Overall Study|Elective Surgery|0|||
130203683|NCT01390428|468705903|FG003|Overall Study|Elective Surgery|0|||
130203684|NCT01390428|468705904|FG004|Overall Study|Elective Surgery|1|||
130203685|NCT01390428|468705905|FG005|Overall Study|Elective Surgery|0|||
130203686|NCT01390428|468705900|FG000|Overall Study|Withdrawal by Subject|0|||
130203687|NCT01390428|468705901|FG001|Overall Study|Withdrawal by Subject|0|||
130203688|NCT01390428|468705902|FG002|Overall Study|Withdrawal by Subject|1|||
130203689|NCT01390428|468705903|FG003|Overall Study|Withdrawal by Subject|0|||
130203690|NCT01390428|468705904|FG004|Overall Study|Withdrawal by Subject|0|||
130203691|NCT01390428|468705905|FG005|Overall Study|Withdrawal by Subject|0|||
130203692|NCT05079750|468705906|FG000|Overall Study|Lost to Follow-up|0|||
130203693|NCT05079750|468705907|FG001|Overall Study|Lost to Follow-up|0|||
130203694|NCT05079750|468705908|FG002|Overall Study|Lost to Follow-up|1|||
130203695|NCT05897827|468705909|FG000|Overall Study|Lost to Follow-up|33|||
130203696|NCT05897827|468705910|FG001|Overall Study|Lost to Follow-up|14|||
130203697|NCT05897827|468705909|FG000|Overall Study|Withdrawal by Subject|1|||
130203698|NCT05897827|468705910|FG001|Overall Study|Withdrawal by Subject|1|||
130203699|NCT02276053|468705913|FG000|Overall Study|Death|2|||
130203700|NCT02276053|468705913|FG000|Overall Study|Adverse Event|5|||
130203701|NCT02276053|468705913|FG000|Overall Study|Lack of Efficacy|2|||
130203702|NCT02276053|468705913|FG000|Overall Study|Withdrawal by Subject|1|||
130203703|NCT02276053|468705913|FG000|Overall Study|Patient does not meet selection criteria|3|||
130203704|NCT02276053|468705913|FG000|Overall Study|Patient needs to increase baseline AED|1|||
130203705|NCT04542499|468705916|FG000|Overall Study|Adverse Event|23|||
130203706|NCT04542499|468705917|FG001|Overall Study|Adverse Event|43|||
130203707|NCT04542499|468705916|FG000|Overall Study|Lack of Efficacy|5|||
130203708|NCT04542499|468705917|FG001|Overall Study|Lack of Efficacy|2|||
130203709|NCT04542499|468705916|FG000|Overall Study|Lost to Follow-up|3|||
130203710|NCT04542499|468705917|FG001|Overall Study|Lost to Follow-up|4|||
130203711|NCT04542499|468705916|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
130203712|NCT04542499|468705917|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
130203713|NCT04542499|468705916|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
130203714|NCT04542499|468705917|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
130203715|NCT04542499|468705916|FG000|Overall Study|Non-Compliance with Study Drug|0|||
130203716|NCT04542499|468705917|FG001|Overall Study|Non-Compliance with Study Drug|2|||
130203717|NCT04542499|468705916|FG000|Overall Study|Physician Decision|0|||
130203718|NCT04542499|468705917|FG001|Overall Study|Physician Decision|1|||
130203719|NCT04542499|468705916|FG000|Overall Study|Site Terminated by Sponsor|3|||
130203720|NCT04542499|468705917|FG001|Overall Study|Site Terminated by Sponsor|5|||
130203721|NCT04542499|468705916|FG000|Overall Study|Withdrawal by Subject|12|||
130203722|NCT04542499|468705917|FG001|Overall Study|Withdrawal by Subject|33|||
130203723|NCT04542499|468705916|FG000|Overall Study|Other|2|||
130203724|NCT04542499|468705917|FG001|Overall Study|Other|2|||
130203725|NCT04322539|468705924|FG000|Overall Study|Adverse Event|2|||
130203726|NCT04322539|468705925|FG001|Overall Study|Adverse Event|0|||
130203727|NCT04322539|468705924|FG000|Overall Study|Death|411|||
130203728|NCT04322539|468705925|FG001|Overall Study|Death|203|||
130203729|NCT04322539|468705924|FG000|Overall Study|Lost to Follow-up|3|||
130203730|NCT04322539|468705925|FG001|Overall Study|Lost to Follow-up|1|||
130203731|NCT04322539|468705924|FG000|Overall Study|Withdrawal of consent|14|||
130203732|NCT04322539|468705925|FG001|Overall Study|Withdrawal of consent|8|||
130203733|NCT04322539|468705924|FG000|Overall Study|Radiological Disease Progression|6|||
130203734|NCT04322539|468705925|FG001|Overall Study|Radiological Disease Progression|0|||
130203735|NCT04322539|468705924|FG000|Overall Study|Sponsor Decision|19|||
130203736|NCT04322539|468705925|FG001|Overall Study|Sponsor Decision|14|||
130203737|NCT04322539|468705924|FG000|Overall Study|Other|6|||
130203738|NCT04322539|468705925|FG001|Overall Study|Other|4|||
130203739|NCT01702532|468705928|FG000|Overall Study|Adverse Event|0|||
130203740|NCT01702532|468705929|FG001|Overall Study|Adverse Event|1|||
130203741|NCT03617861|468705930|FG000|Second Intervention (1 Day)|Adverse Event|0|||
130203742|NCT03617861|468705931|FG001|Second Intervention (1 Day)|Adverse Event|0|||
130203743|NCT03617861|468705932|FG002|Second Intervention (1 Day)|Adverse Event|1|||
130203744|NCT03617861|468705933|FG003|Second Intervention (1 Day)|Adverse Event|0|||
130203745|NCT01846221|468705943|FG000|Overall Study|Catheter Failure|2|||
130203746|NCT01846221|468705944|FG001|Overall Study|Catheter Failure|0|||
130203747|NCT01846221|468705943|FG000|Overall Study|Age Exclusion|1|||
130203748|NCT01846221|468705944|FG001|Overall Study|Age Exclusion|0|||
130203749|NCT01668966|468705945|FG000|Overall Study|Withdrawal by Subject|1|||
130203750|NCT01668966|468705945|FG000|Overall Study|Death|1|||
130203751|NCT01668966|468705945|FG000|Overall Study|Not treated|2|||
130203752|NCT02879994|468705946|FG000|Overall Study|off treatment early|7|||
130203753|NCT02879994|468705946|FG000|Overall Study|Adverse Event|2|||
130203754|NCT02879994|468705946|FG000|Overall Study|Death|2|||
130203755|NCT00552032|468705947|FG000|Overall Study|Withdrawal by Subject|2|||
130203756|NCT00552032|468705948|FG001|Overall Study|Withdrawal by Subject|2|||
130203757|NCT00552032|468705947|FG000|Overall Study|Protocol Violation|7|||
130203758|NCT00552032|468705948|FG001|Overall Study|Protocol Violation|12|||
130203759|NCT00552032|468705947|FG000|Overall Study|Lost to Follow-up|8|||
130203760|NCT00552032|468705948|FG001|Overall Study|Lost to Follow-up|5|||
130203761|NCT01643798|468705949|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
130203762|NCT01643798|468705950|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
130203763|NCT03602391|468705955|FG000|Overall Study|COVID-19|7|||
130203764|NCT03602391|468705956|FG001|Overall Study|COVID-19|6|||
130203765|NCT01097421|468705957|FG000|Overall Study|Adverse Event|8|||
130203766|NCT01097421|468705957|FG000|Overall Study|Protocol Violation|2|||
130203767|NCT01097421|468705957|FG000|Overall Study|Lost to Follow-up|1|||
130203768|NCT01097421|468705957|FG000|Overall Study|Withdrawal by Subject|3|||
130203769|NCT02035748|468705965|FG000|Overall Study|Adverse Event|5|||
130203770|NCT02035748|468705965|FG000|Overall Study|Death|3|||
130203771|NCT02035748|468705965|FG000|Overall Study|Lost to Follow-up|2|||
130203772|NCT02035748|468705965|FG000|Overall Study|Physician Decision|3|||
130203773|NCT02035748|468705965|FG000|Overall Study|Withdrawal by Subject|6|||
130203774|NCT02035748|468705965|FG000|Overall Study|Progressive Disease|1|||
130203775|NCT04495816|468705966|FG000|Overall Study|Lost to Follow-up|10|||
130203776|NCT04495816|468705967|FG001|Overall Study|Lost to Follow-up|4|||
130203777|NCT04495816|468705966|FG000|Overall Study|Withdrawal by Subject|3|||
130203778|NCT04495816|468705967|FG001|Overall Study|Withdrawal by Subject|5|||
130203779|NCT02052596|468705968|FG000|Active Phase|Adverse Event|3|||
130203780|NCT02052596|468705969|FG001|Active Phase|Adverse Event|2|||
130203781|NCT02052596|468705968|FG000|Active Phase|Lost to Follow-up|8|||
130203782|NCT02052596|468705969|FG001|Active Phase|Lost to Follow-up|11|||
130203783|NCT02052596|468705968|FG000|Active Phase|Protocol Violation|1|||
130203784|NCT02052596|468705969|FG001|Active Phase|Protocol Violation|2|||
130203785|NCT02052596|468705968|FG000|Active Phase|Withdrawal by Subject|3|||
130203786|NCT02052596|468705969|FG001|Active Phase|Withdrawal by Subject|4|||
130203787|NCT02052596|468705968|FG000|Active Phase|Enrolled in error|1|||
130203788|NCT02052596|468705969|FG001|Active Phase|Enrolled in error|0|||
130203789|NCT02052596|468705968|FG000|Active Phase|Lost due to Crohn's disease|0|||
130203790|NCT02052596|468705969|FG001|Active Phase|Lost due to Crohn's disease|1|||
130203791|NCT02052596|468705968|FG000|Safety Phase|Adverse Event|6|||
130203792|NCT02052596|468705969|FG001|Safety Phase|Adverse Event|3|||
130203793|NCT02052596|468705968|FG000|Safety Phase|Lost to Follow-up|11|||
130203794|NCT02052596|468705969|FG001|Safety Phase|Lost to Follow-up|18|||
130203795|NCT02052596|468705968|FG000|Safety Phase|Protocol Violation|1|||
130203796|NCT02052596|468705969|FG001|Safety Phase|Protocol Violation|2|||
130203797|NCT02052596|468705968|FG000|Safety Phase|Withdrawal by Subject|8|||
130203798|NCT02052596|468705969|FG001|Safety Phase|Withdrawal by Subject|11|||
130203799|NCT02052596|468705968|FG000|Safety Phase|Enrolled in error|1|||
130203800|NCT02052596|468705969|FG001|Safety Phase|Enrolled in error|0|||
130203801|NCT02052596|468705968|FG000|Safety Phase|Lost due to Crohn's disease|0|||
130203802|NCT02052596|468705969|FG001|Safety Phase|Lost due to Crohn's disease|1|||
130203803|NCT00558896|468705970|FG000|Overall Study|Adverse Event|1|||
130203804|NCT00558896|468705971|FG001|Overall Study|Adverse Event|1|||
130203805|NCT00558896|468705972|FG002|Overall Study|Adverse Event|1|||
130203806|NCT00558896|468705973|FG003|Overall Study|Adverse Event|3|||
130203807|NCT00558896|468705974|FG004|Overall Study|Adverse Event|4|||
130203808|NCT00558896|468705975|FG005|Overall Study|Adverse Event|10|||
130203809|NCT00558896|468705976|FG006|Overall Study|Adverse Event|3|||
130203810|NCT00558896|468705970|FG000|Overall Study|Death|3|||
130203811|NCT00558896|468705971|FG001|Overall Study|Death|0|||
130203812|NCT00558896|468705972|FG002|Overall Study|Death|2|||
130203813|NCT00558896|468705973|FG003|Overall Study|Death|3|||
130203814|NCT00558896|468705974|FG004|Overall Study|Death|2|||
130203815|NCT00558896|468705975|FG005|Overall Study|Death|2|||
130203816|NCT00558896|468705976|FG006|Overall Study|Death|6|||
130203817|NCT00558896|468705970|FG000|Overall Study|Withdrawal by Subject|2|||
130203818|NCT00558896|468705971|FG001|Overall Study|Withdrawal by Subject|1|||
130203819|NCT00558896|468705972|FG002|Overall Study|Withdrawal by Subject|1|||
130203820|NCT00558896|468705973|FG003|Overall Study|Withdrawal by Subject|1|||
130203821|NCT00558896|468705974|FG004|Overall Study|Withdrawal by Subject|1|||
130203822|NCT00558896|468705975|FG005|Overall Study|Withdrawal by Subject|5|||
130203823|NCT00558896|468705976|FG006|Overall Study|Withdrawal by Subject|5|||
130203824|NCT00558896|468705970|FG000|Overall Study|Alternative Treatment|2|||
130203825|NCT00558896|468705971|FG001|Overall Study|Alternative Treatment|2|||
130203826|NCT00558896|468705972|FG002|Overall Study|Alternative Treatment|0|||
130203827|NCT00558896|468705973|FG003|Overall Study|Alternative Treatment|2|||
130203828|NCT00558896|468705974|FG004|Overall Study|Alternative Treatment|6|||
130203829|NCT00558896|468705975|FG005|Overall Study|Alternative Treatment|7|||
130203830|NCT00558896|468705976|FG006|Overall Study|Alternative Treatment|1|||
130203831|NCT00558896|468705970|FG000|Overall Study|Physician discretion|3|||
130203832|NCT00558896|468705971|FG001|Overall Study|Physician discretion|2|||
130203833|NCT00558896|468705972|FG002|Overall Study|Physician discretion|1|||
130203834|NCT00558896|468705973|FG003|Overall Study|Physician discretion|2|||
130203835|NCT00558896|468705974|FG004|Overall Study|Physician discretion|1|||
130203836|NCT00558896|468705975|FG005|Overall Study|Physician discretion|3|||
130203837|NCT00558896|468705976|FG006|Overall Study|Physician discretion|3|||
130203838|NCT00558896|468705970|FG000|Overall Study|Continues on treatment|10|||
130203839|NCT00558896|468705971|FG001|Overall Study|Continues on treatment|1|||
130203840|NCT00558896|468705972|FG002|Overall Study|Continues on treatment|0|||
130203841|NCT00558896|468705973|FG003|Overall Study|Continues on treatment|1|||
130203842|NCT00558896|468705974|FG004|Overall Study|Continues on treatment|9|||
130203843|NCT00558896|468705975|FG005|Overall Study|Continues on treatment|25|||
130203844|NCT00558896|468705976|FG006|Overall Study|Continues on treatment|6|||
130203845|NCT00705718|468705977|FG000|Overall Study|Death|6|||
130203846|NCT00705718|468705978|FG001|Overall Study|Death|6|||
130203847|NCT00705718|468705977|FG000|Overall Study|Not due for Visit|0|||
130203848|NCT00705718|468705978|FG001|Overall Study|Not due for Visit|12|||
130203849|NCT00705718|468705977|FG000|Overall Study|Follow up not done|1|||
130203850|NCT00705718|468705978|FG001|Overall Study|Follow up not done|4|||
130203851|NCT06137703|468705979|FG000|Overall Study|Other|0|||
130203852|NCT06137703|468705980|FG001|Overall Study|Other|1|||
130203853|NCT06137703|468705981|FG002|Overall Study|Other|0|||
130203854|NCT06137703|468705982|FG003|Overall Study|Other|0|||
130203855|NCT06137703|468705979|FG000|Overall Study|Adverse Event|0|||
130203856|NCT06137703|468705980|FG001|Overall Study|Adverse Event|0|||
130203857|NCT06137703|468705981|FG002|Overall Study|Adverse Event|1|||
130203858|NCT06137703|468705982|FG003|Overall Study|Adverse Event|0|||
130203859|NCT04329091|468705985|FG000|Overall Study|Physician Decision|5|||
130203860|NCT00741091|468705988|FG000|Overall Study|Death|13|||
130203861|NCT00741091|468705988|FG000|Overall Study|Lost to Follow-up|16|||
130203862|NCT00741091|468705988|FG000|Overall Study|Withdrawal by Subject|6|||
130203863|NCT00741091|468705988|FG000|Overall Study|Missed Visit|22|||
130203864|NCT01527487|468705989|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
130203865|NCT01527487|468705990|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
130203866|NCT01527487|468705989|FG000|Overall Study|Disease Progression|4|||
130203867|NCT01527487|468705990|FG001|Overall Study|Disease Progression|1|||
130203868|NCT01527487|468705989|FG000|Overall Study|Adverse Event|1|||
130203869|NCT01527487|468705990|FG001|Overall Study|Adverse Event|1|||
130203870|NCT01527487|468705989|FG000|Overall Study|Death|0|||
130203871|NCT01527487|468705990|FG001|Overall Study|Death|1|||
130203872|NCT00723190|468705994|FG000|Overall Study|Withdrawal by Subject|45|||
130203873|NCT00723190|468705994|FG000|Overall Study|Lost to Follow-up|37|||
130203874|NCT00723190|468705994|FG000|Overall Study|Adverse Event|18|||
130203875|NCT00723190|468705994|FG000|Overall Study|Lack of Efficacy|16|||
130203876|NCT00723190|468705994|FG000|Overall Study|Protocol Violation|15|||
130203877|NCT00723190|468705994|FG000|Overall Study|Other-Premature Discontinuation|9|||
130203878|NCT00723190|468705994|FG000|Overall Study|Other-Not included in safety population|2|||
130203879|NCT03181503|468705995|FG000|Overall Study|Adverse Event|2|||
130203880|NCT03181503|468705996|FG001|Overall Study|Adverse Event|2|||
130203881|NCT03181503|468705995|FG000|Overall Study|Protocol Violation|1|||
130203882|NCT03181503|468705996|FG001|Overall Study|Protocol Violation|0|||
130203883|NCT03181503|468705995|FG000|Overall Study|Withdrawal by Subject|3|||
130203884|NCT03181503|468705996|FG001|Overall Study|Withdrawal by Subject|0|||
130203885|NCT03181503|468705995|FG000|Overall Study|Lost to Follow-up|1|||
130203886|NCT03181503|468705996|FG001|Overall Study|Lost to Follow-up|1|||
130203887|NCT00597506|468705997|FG000|Overall Study|Subject is being followed for survival|1|||
130203888|NCT03199612|468705998|FG000|Overall Study|Adverse Event|1|||
130203889|NCT03199612|468705999|FG001|Overall Study|Adverse Event|0|||
130203890|NCT00081731|468706004|FG000|Overall Study|scientific integrity issue|8|||
130203891|NCT00081731|468706005|FG001|Overall Study|scientific integrity issue|8|||
130203892|NCT02386345|468706006|FG000|Overall Study|Not treated|14|||
130203893|NCT02386345|468706006|FG000|Overall Study|Lost to Follow-up|1|||
130203894|NCT02386345|468706006|FG000|Overall Study|Adverse Event|5|||
130203895|NCT02386345|468706006|FG000|Overall Study|Repeat Procedure|10|||
130203896|NCT02386345|468706006|FG000|Overall Study|Did not complete 12-month follow-up|72|||
130203897|NCT02258542|468706007|FG000|Overall Study|eg. not made to the visit|7|||
130203898|NCT02258542|468706008|FG001|Overall Study|eg. not made to the visit|4|||
130203899|NCT02258542|468706009|FG002|Overall Study|eg. not made to the visit|0|||
130203900|NCT02258542|468706010|FG003|Overall Study|eg. not made to the visit|1|||
130203901|NCT02258542|468706007|FG000|Overall Study|study specific discount. criteria|1|||
130203902|NCT02258542|468706008|FG001|Overall Study|study specific discount. criteria|1|||
130203903|NCT02258542|468706009|FG002|Overall Study|study specific discount. criteria|0|||
130203904|NCT02258542|468706010|FG003|Overall Study|study specific discount. criteria|0|||
130203905|NCT02258542|468706007|FG000|Overall Study|Withdrawal by Subject|20|||
130203906|NCT02258542|468706008|FG001|Overall Study|Withdrawal by Subject|20|||
130203907|NCT02258542|468706009|FG002|Overall Study|Withdrawal by Subject|7|||
130203908|NCT02258542|468706010|FG003|Overall Study|Withdrawal by Subject|1|||
130203909|NCT02258542|468706007|FG000|Overall Study|Lost to Follow-up|5|||
130203910|NCT02258542|468706008|FG001|Overall Study|Lost to Follow-up|12|||
130203911|NCT02258542|468706009|FG002|Overall Study|Lost to Follow-up|1|||
130203912|NCT02258542|468706010|FG003|Overall Study|Lost to Follow-up|2|||
130203913|NCT02258542|468706007|FG000|Overall Study|Death|5|||
130203914|NCT02258542|468706008|FG001|Overall Study|Death|4|||
130203915|NCT02258542|468706009|FG002|Overall Study|Death|0|||
130203916|NCT02258542|468706010|FG003|Overall Study|Death|1|||
130203917|NCT02258542|468706007|FG000|Overall Study|Adverse Event|3|||
130203918|NCT02258542|468706008|FG001|Overall Study|Adverse Event|4|||
130203919|NCT02258542|468706009|FG002|Overall Study|Adverse Event|0|||
130203920|NCT02258542|468706010|FG003|Overall Study|Adverse Event|0|||
130203921|NCT02258542|468706007|FG000|Overall Study|Protocol Violation|1|||
130203922|NCT02258542|468706008|FG001|Overall Study|Protocol Violation|2|||
130203923|NCT02258542|468706009|FG002|Overall Study|Protocol Violation|0|||
130203924|NCT02258542|468706010|FG003|Overall Study|Protocol Violation|0|||
130203925|NCT02258542|468706007|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
130203926|NCT02258542|468706008|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
130203927|NCT02258542|468706009|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
130203928|NCT02258542|468706010|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
130203929|NCT00514904|468706025|FG000|Overall Study|Withdrawal by Subject|3|||
130203930|NCT00514904|468706026|FG001|Overall Study|Withdrawal by Subject|2|||
130203931|NCT00514904|468706025|FG000|Overall Study|Lost to Follow-up|21|||
130203932|NCT00514904|468706026|FG001|Overall Study|Lost to Follow-up|3|||
130203933|NCT02417961|468707079|FG000|Overall Study|Adverse Event|1|||
130203934|NCT02417961|468707079|FG000|Overall Study|Lost to Follow-up|1|||
130203935|NCT02417961|468707079|FG000|Overall Study|Withdrawal by Subject|2|||
130203936|NCT03197467|468707082|FG000|Overall Study|Withdrawal by Subject|1|||
130203937|NCT03666533|468707084|FG000|Overall Study|Lost to Follow-up|2|||
130203938|NCT03666533|468707085|FG001|Overall Study|Lost to Follow-up|2|||
130203939|NCT04392167|468707103|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
130203940|NCT04063657|468707104|FG000|Overall Study|Lost to Follow-up|1|||
130203941|NCT04063657|468707105|FG001|Overall Study|Lost to Follow-up|0|||
130203942|NCT03408444|468707106|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
130203943|NCT03408444|468707107|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130203944|NCT03408444|468707108|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130203945|NCT03408444|468707109|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
130203946|NCT03408444|468707106|FG000|Overall Study|Lens Discomfort|0|||
130203947|NCT03408444|468707107|FG001|Overall Study|Lens Discomfort|1|||
130203948|NCT03408444|468707108|FG002|Overall Study|Lens Discomfort|0|||
130203949|NCT03408444|468707109|FG003|Overall Study|Lens Discomfort|0|||
130203950|NCT03408444|468707106|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130203951|NCT03408444|468707107|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130203952|NCT03408444|468707108|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
130203953|NCT03408444|468707109|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
130203954|NCT03408444|468707106|FG000|Overall Study|Withdrawal by Subject|0|||
130203955|NCT03408444|468707107|FG001|Overall Study|Withdrawal by Subject|2|||
130203956|NCT03408444|468707108|FG002|Overall Study|Withdrawal by Subject|3|||
130203957|NCT03408444|468707109|FG003|Overall Study|Withdrawal by Subject|0|||
130203958|NCT03408444|468707106|FG000|Overall Study|Lost to Follow-up|0|||
130203959|NCT03408444|468707107|FG001|Overall Study|Lost to Follow-up|0|||
130203960|NCT03408444|468707108|FG002|Overall Study|Lost to Follow-up|1|||
130203961|NCT03408444|468707109|FG003|Overall Study|Lost to Follow-up|0|||
130203962|NCT03408444|468707106|FG000|Overall Study|Adverse Event|0|||
130203963|NCT03408444|468707107|FG001|Overall Study|Adverse Event|0|||
130203964|NCT03408444|468707108|FG002|Overall Study|Adverse Event|0|||
130203965|NCT03408444|468707109|FG003|Overall Study|Adverse Event|1|||
130203966|NCT03408444|468707106|FG000|Overall Study|Lens Handling Difficulties|0|||
130203967|NCT03408444|468707107|FG001|Overall Study|Lens Handling Difficulties|0|||
130203968|NCT03408444|468707108|FG002|Overall Study|Lens Handling Difficulties|1|||
130203969|NCT03408444|468707109|FG003|Overall Study|Lens Handling Difficulties|0|||
130203970|NCT03408444|468707106|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130203971|NCT03408444|468707107|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130203972|NCT03408444|468707108|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
130203973|NCT03408444|468707109|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
130203974|NCT04984681|468707110|FG000|Overall Study|Lost to Follow-up|3|||
130203975|NCT04984681|468707111|FG001|Overall Study|Lost to Follow-up|1|||
130203976|NCT01473394|468707114|FG000|Overall Study|Adverse Event|13|||
130203977|NCT01473394|468707115|FG001|Overall Study|Adverse Event|16|||
130203978|NCT01473394|468707114|FG000|Overall Study|Insufficient Therapeutic Response|4|||
130203979|NCT01473394|468707115|FG001|Overall Study|Insufficient Therapeutic Response|1|||
130203980|NCT01473394|468707114|FG000|Overall Study|Protocol Violation|7|||
130203981|NCT01473394|468707115|FG001|Overall Study|Protocol Violation|5|||
130203982|NCT01473394|468707114|FG000|Overall Study|Withdrew Consent|12|||
130203983|NCT01473394|468707115|FG001|Overall Study|Withdrew Consent|10|||
130203984|NCT01473394|468707114|FG000|Overall Study|Lost to Follow-up|9|||
130203985|NCT01473394|468707115|FG001|Overall Study|Lost to Follow-up|11|||
130203986|NCT01482962|468707118|FG000|Overall Study|Progressive Disease|65|||
130203987|NCT01482962|468707119|FG001|Overall Study|Progressive Disease|53|||
130203988|NCT01482962|468707118|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
130203989|NCT01482962|468707119|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
130203990|NCT01482962|468707118|FG000|Overall Study|Adverse Event|18|||
130203991|NCT01482962|468707119|FG001|Overall Study|Adverse Event|22|||
130203992|NCT01482962|468707118|FG000|Overall Study|Withdrawal by Participant|8|||
130203993|NCT01482962|468707119|FG001|Overall Study|Withdrawal by Participant|13|||
130203994|NCT01482962|468707118|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
130203995|NCT01482962|468707119|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
130203996|NCT01482962|468707118|FG000|Overall Study|Other Reason|1|||
130203997|NCT01482962|468707119|FG001|Overall Study|Other Reason|5|||
130203998|NCT01482962|468707118|FG000|Overall Study|Study Terminated by Sponsor|5|||
130203999|NCT01482962|468707119|FG001|Overall Study|Study Terminated by Sponsor|2|||
130204000|NCT01482962|468707118|FG000|Overall Study|Did not Receive Study Drug|1|||
130204001|NCT01482962|468707119|FG001|Overall Study|Did not Receive Study Drug|6|||
130204002|NCT00250458|468707123|FG000|Overall Study|Lost to Follow-up|4|||
130204003|NCT00250458|468707124|FG001|Overall Study|Lost to Follow-up|2|||
130204004|NCT00250458|468707123|FG000|Overall Study|Protocol Violation|0|||
130204005|NCT00250458|468707124|FG001|Overall Study|Protocol Violation|1|||
130204006|NCT00250458|468707123|FG000|Overall Study|Withdrawal by Subject|4|||
130204007|NCT00250458|468707124|FG001|Overall Study|Withdrawal by Subject|2|||
130204008|NCT00250458|468707123|FG000|Overall Study|Lack of Migraine Attack|20|||
130204009|NCT00250458|468707124|FG001|Overall Study|Lack of Migraine Attack|9|||
130204010|NCT00250458|468707123|FG000|Overall Study|Qualifying migraine but did not treat|3|||
130204011|NCT00250458|468707124|FG001|Overall Study|Qualifying migraine but did not treat|3|||
130204012|NCT00250458|468707123|FG000|Overall Study|Other|1|||
130204013|NCT00250458|468707124|FG001|Overall Study|Other|0|||
130204014|NCT01801358|468707125|FG000|Overall Study|Adverse Event|0|||
130204015|NCT01801358|468707126|FG001|Overall Study|Adverse Event|2|||
130204016|NCT01801358|468707127|FG002|Overall Study|Adverse Event|1|||
130204017|NCT01801358|468707128|FG003|Overall Study|Adverse Event|0|||
130204018|NCT01801358|468707129|FG004|Overall Study|Adverse Event|0|||
130204019|NCT01801358|468707130|FG005|Overall Study|Adverse Event|1|||
130204020|NCT01801358|468707125|FG000|Overall Study|Physician Decision|0|||
130204021|NCT01801358|468707126|FG001|Overall Study|Physician Decision|0|||
130204022|NCT01801358|468707127|FG002|Overall Study|Physician Decision|1|||
130204023|NCT01801358|468707128|FG003|Overall Study|Physician Decision|0|||
130204024|NCT01801358|468707129|FG004|Overall Study|Physician Decision|0|||
130204025|NCT01801358|468707130|FG005|Overall Study|Physician Decision|0|||
130204026|NCT01801358|468707125|FG000|Overall Study|Progressive Disease|6|||
130204027|NCT01801358|468707126|FG001|Overall Study|Progressive Disease|4|||
130204028|NCT01801358|468707127|FG002|Overall Study|Progressive Disease|4|||
130204029|NCT01801358|468707128|FG003|Overall Study|Progressive Disease|5|||
130204030|NCT01801358|468707129|FG004|Overall Study|Progressive Disease|6|||
130204031|NCT01801358|468707130|FG005|Overall Study|Progressive Disease|5|||
130204032|NCT01801358|468707125|FG000|Overall Study|Withdrawal by Subject|0|||
130204033|NCT01801358|468707126|FG001|Overall Study|Withdrawal by Subject|0|||
130204034|NCT01801358|468707127|FG002|Overall Study|Withdrawal by Subject|0|||
130204035|NCT01801358|468707128|FG003|Overall Study|Withdrawal by Subject|1|||
130204036|NCT01801358|468707129|FG004|Overall Study|Withdrawal by Subject|0|||
130204037|NCT01801358|468707130|FG005|Overall Study|Withdrawal by Subject|2|||
130204038|NCT01549041|468707138|FG000|Overall Study|Lack of Efficacy|2|||
130204039|NCT01549041|468707139|FG001|Overall Study|Lack of Efficacy|4|||
130204040|NCT01549041|468707138|FG000|Overall Study|Adverse Event|0|||
130204041|NCT01549041|468707139|FG001|Overall Study|Adverse Event|4|||
130204042|NCT01537068|468707144|FG000|Overall Study|Lost to Follow-up|2|||
130204043|NCT01537068|468707145|FG001|Overall Study|Lost to Follow-up|1|||
130204044|NCT01537068|468707144|FG000|Overall Study|Adverse Event|0|||
130204045|NCT01537068|468707145|FG001|Overall Study|Adverse Event|1|||
130204046|NCT01537068|468707144|FG000|Overall Study|Withdrawal by Subject|1|||
130204047|NCT01537068|468707145|FG001|Overall Study|Withdrawal by Subject|1|||
130204048|NCT01537068|468707144|FG000|Overall Study|Lack of Efficacy|1|||
130204049|NCT01537068|468707145|FG001|Overall Study|Lack of Efficacy|0|||
130204050|NCT00483704|468707146|FG000|Randomization|Withdrawal by Subject|19|||
130204051|NCT00483704|468707147|FG001|Randomization|Withdrawal by Subject|28|||
130204052|NCT00483704|468707148|FG002|Randomization|Withdrawal by Subject|18|||
130204053|NCT00483704|468707146|FG000|Randomization|Protocol Violation|14|||
130204054|NCT00483704|468707147|FG001|Randomization|Protocol Violation|25|||
130204055|NCT00483704|468707148|FG002|Randomization|Protocol Violation|22|||
130204056|NCT00483704|468707146|FG000|Randomization|Lost to Follow-up|14|||
130204057|NCT00483704|468707147|FG001|Randomization|Lost to Follow-up|14|||
130204058|NCT00483704|468707148|FG002|Randomization|Lost to Follow-up|19|||
130204059|NCT00483704|468707146|FG000|Randomization|Pregnancy|1|||
130204060|NCT00483704|468707147|FG001|Randomization|Pregnancy|0|||
130204061|NCT00483704|468707148|FG002|Randomization|Pregnancy|0|||
130204062|NCT00483704|468707146|FG000|Randomization|Physician Decision|2|||
130204063|NCT00483704|468707147|FG001|Randomization|Physician Decision|4|||
130204064|NCT00483704|468707148|FG002|Randomization|Physician Decision|0|||
130204065|NCT00483704|468707146|FG000|Randomization|Progressive disease|0|||
130204066|NCT00483704|468707147|FG001|Randomization|Progressive disease|0|||
130204067|NCT00483704|468707148|FG002|Randomization|Progressive disease|1|||
130204068|NCT00483704|468707146|FG000|Randomization|Lack of qualifying migraines|21|||
130204069|NCT00483704|468707147|FG001|Randomization|Lack of qualifying migraines|25|||
130204070|NCT00483704|468707148|FG002|Randomization|Lack of qualifying migraines|31|||
130204071|NCT00483704|468707146|FG000|Treatment|Lack of qualifying migraines|101|||
130204072|NCT00483704|468707147|FG001|Treatment|Lack of qualifying migraines|99|||
130204073|NCT00483704|468707148|FG002|Treatment|Lack of qualifying migraines|116|||
130204074|NCT00483704|468707146|FG000|Treatment|Adverse Event|3|||
130204075|NCT00483704|468707147|FG001|Treatment|Adverse Event|5|||
130204076|NCT00483704|468707148|FG002|Treatment|Adverse Event|4|||
130204077|NCT00483704|468707146|FG000|Treatment|Withdrawal by Subject|16|||
130204078|NCT00483704|468707147|FG001|Treatment|Withdrawal by Subject|12|||
130204079|NCT00483704|468707148|FG002|Treatment|Withdrawal by Subject|21|||
130204080|NCT00483704|468707146|FG000|Treatment|Protocol Violation|6|||
130204081|NCT00483704|468707147|FG001|Treatment|Protocol Violation|3|||
130204082|NCT00483704|468707148|FG002|Treatment|Protocol Violation|5|||
130204083|NCT00483704|468707146|FG000|Treatment|Lost to Follow-up|2|||
130204084|NCT00483704|468707147|FG001|Treatment|Lost to Follow-up|7|||
130204085|NCT00483704|468707148|FG002|Treatment|Lost to Follow-up|5|||
130204086|NCT00483704|468707146|FG000|Treatment|Lack of Efficacy|1|||
130204087|NCT00483704|468707147|FG001|Treatment|Lack of Efficacy|1|||
130204088|NCT00483704|468707148|FG002|Treatment|Lack of Efficacy|1|||
130204089|NCT00483704|468707146|FG000|Treatment|Pregnancy|0|||
130204090|NCT00483704|468707147|FG001|Treatment|Pregnancy|1|||
130204091|NCT00483704|468707148|FG002|Treatment|Pregnancy|0|||
130204092|NCT00483704|468707146|FG000|Treatment|Physician Decision|0|||
130204093|NCT00483704|468707147|FG001|Treatment|Physician Decision|1|||
130204094|NCT00483704|468707148|FG002|Treatment|Physician Decision|4|||
130204095|NCT04442269|468707149|FG000|Overall Study|Adverse Event|1|||
130204096|NCT04442269|468707150|FG001|Overall Study|Adverse Event|0|||
130204097|NCT04442269|468707149|FG000|Overall Study|Death|0|||
130204098|NCT04442269|468707150|FG001|Overall Study|Death|1|||
130204099|NCT04442269|468707149|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
130204100|NCT04442269|468707150|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
130204101|NCT04442269|468707149|FG000|Overall Study|Lost to Follow-up|1|||
130204102|NCT04442269|468707150|FG001|Overall Study|Lost to Follow-up|0|||
130204103|NCT04442269|468707149|FG000|Overall Study|Withdrawal by Subject|3|||
130204104|NCT04442269|468707150|FG001|Overall Study|Withdrawal by Subject|2|||
130204105|NCT04442269|468707149|FG000|Overall Study|Protocol Deviation|0|||
130204106|NCT04442269|468707150|FG001|Overall Study|Protocol Deviation|1|||
130204107|NCT04442269|468707149|FG000|Overall Study|Travel Limitations|1|||
130204108|NCT04442269|468707150|FG001|Overall Study|Travel Limitations|1|||
130204109|NCT01793688|468707151|FG000|Overall Study|Protocol Violation|2|||
130204110|NCT04450407|468707154|FG000|Overall Study|Withdrawal by Subject|10|||
130204111|NCT04450407|468707155|FG001|Overall Study|Withdrawal by Subject|1|||
130204112|NCT04450407|468707156|FG002|Overall Study|Withdrawal by Subject|4|||
130204113|NCT04450407|468707154|FG000|Overall Study|Adverse Event|0|||
130204114|NCT04450407|468707155|FG001|Overall Study|Adverse Event|0|||
130204115|NCT04450407|468707156|FG002|Overall Study|Adverse Event|1|||
130204116|NCT04450407|468707154|FG000|Overall Study|Lost to Follow-up|1|||
130204117|NCT04450407|468707155|FG001|Overall Study|Lost to Follow-up|0|||
130204118|NCT04450407|468707156|FG002|Overall Study|Lost to Follow-up|0|||
130204119|NCT04450407|468707154|FG000|Overall Study|Physician Decision|0|||
130204120|NCT04450407|468707155|FG001|Overall Study|Physician Decision|0|||
130204121|NCT04450407|468707156|FG002|Overall Study|Physician Decision|1|||
130204122|NCT04450407|468707154|FG000|Overall Study|Pregnancy|1|||
130204123|NCT04450407|468707155|FG001|Overall Study|Pregnancy|0|||
130204124|NCT04450407|468707156|FG002|Overall Study|Pregnancy|0|||
130204125|NCT04450407|468707154|FG000|Overall Study|Protocol Violation|2|||
130204126|NCT04450407|468707155|FG001|Overall Study|Protocol Violation|0|||
130204127|NCT04450407|468707156|FG002|Overall Study|Protocol Violation|0|||
130204128|NCT04450407|468707154|FG000|Overall Study|Investigational site terminated by sponsor|3|||
130204129|NCT04450407|468707155|FG001|Overall Study|Investigational site terminated by sponsor|0|||
130204130|NCT04450407|468707156|FG002|Overall Study|Investigational site terminated by sponsor|2|||
130204131|NCT03430895|468707160|FG000|Overall Study|Not Treated|2|||
130204132|NCT01317797|468707161|FG000|Overall Study|Other|0|||
130204133|NCT01317797|468707162|FG001|Overall Study|Other|1|||
130204134|NCT01317797|468707163|FG002|Overall Study|Other|0|||
130204135|NCT01317797|468707161|FG000|Overall Study|Withdrawal of Patient|0|||
130204136|NCT01317797|468707162|FG001|Overall Study|Withdrawal of Patient|0|||
130204137|NCT01317797|468707163|FG002|Overall Study|Withdrawal of Patient|1|||
130204138|NCT01645891|468707168|FG000|Overall Study|Adverse Event|6|||
130204139|NCT01645891|468707169|FG001|Overall Study|Adverse Event|10|||
130204140|NCT01645891|468707168|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
130204141|NCT01645891|468707169|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
130204142|NCT01645891|468707168|FG000|Overall Study|Withdrawal by Subject|3|||
130204143|NCT01645891|468707169|FG001|Overall Study|Withdrawal by Subject|3|||
130204144|NCT01645891|468707168|FG000|Overall Study|Protocol Violation|4|||
130204145|NCT01645891|468707169|FG001|Overall Study|Protocol Violation|0|||
130204146|NCT01645891|468707168|FG000|Overall Study|Lost to Follow-up|4|||
130204147|NCT01645891|468707169|FG001|Overall Study|Lost to Follow-up|1|||
130204148|NCT01645891|468707168|FG000|Overall Study|Death|0|||
130204149|NCT01645891|468707169|FG001|Overall Study|Death|2|||
130204150|NCT03026530|468707172|FG000|Overall Study|Lost to Follow-up|19|||
130204151|NCT03026530|468707173|FG001|Overall Study|Lost to Follow-up|24|||
130204152|NCT03026530|468707172|FG000|Overall Study|Protocol Violation|2|||
130204153|NCT03026530|468707173|FG001|Overall Study|Protocol Violation|5|||
130204154|NCT00138073|468707174|FG000|Overall Study|lack of resources|55|||
130204155|NCT00962091|468707176|FG000|Overall Study|Withdrawal by Subject|1|||
130204156|NCT00962091|468707177|FG001|Overall Study|Withdrawal by Subject|2|||
130204157|NCT00962091|468707178|FG002|Overall Study|Withdrawal by Subject|1|||
130204158|NCT00962091|468707179|FG003|Overall Study|Withdrawal by Subject|1|||
130204159|NCT00962091|468707180|FG004|Overall Study|Withdrawal by Subject|0|||
130204160|NCT00962091|468707181|FG005|Overall Study|Withdrawal by Subject|1|||
130204161|NCT00962091|468707182|FG006|Overall Study|Withdrawal by Subject|0|||
130204162|NCT00962091|468707176|FG000|Overall Study|Adverse Event|0|||
130204163|NCT00962091|468707177|FG001|Overall Study|Adverse Event|0|||
130204164|NCT00962091|468707178|FG002|Overall Study|Adverse Event|0|||
130204165|NCT00962091|468707179|FG003|Overall Study|Adverse Event|0|||
130204166|NCT00962091|468707180|FG004|Overall Study|Adverse Event|0|||
130204167|NCT00962091|468707181|FG005|Overall Study|Adverse Event|0|||
130204168|NCT00962091|468707182|FG006|Overall Study|Adverse Event|1|||
130204169|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204170|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204171|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
130204172|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204173|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204174|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204175|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204176|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204177|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204178|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204179|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204180|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204181|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204182|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
130204183|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
130204184|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204185|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204186|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204187|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204188|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204189|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204190|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204191|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204192|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204193|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204194|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204195|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204196|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
130204197|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130204198|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
130204199|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204200|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204201|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204202|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204203|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204204|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204205|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204206|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204207|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204208|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204209|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204210|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
130204211|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
130204212|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
130204213|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204214|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204215|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204216|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204217|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204218|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204219|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204220|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204221|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204222|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204223|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204224|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
130204225|NCT02326298|468707183|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204226|NCT02326298|468707184|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204227|NCT02326298|468707185|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
130204228|NCT02326298|468707186|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204229|NCT02326298|468707187|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204230|NCT02326298|468707188|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204231|NCT02326298|468707189|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204232|NCT02326298|468707190|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204233|NCT02326298|468707191|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204234|NCT02326298|468707192|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204235|NCT02326298|468707193|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204236|NCT02326298|468707194|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204237|NCT02326298|468707195|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204238|NCT02326298|468707196|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
130204239|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204240|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204241|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204242|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204243|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204244|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204245|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
130204246|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204247|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204248|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
130204249|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204250|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204251|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204252|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
130204253|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204254|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204255|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204256|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204257|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204258|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
130204259|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
130204260|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204261|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
130204262|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204263|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204264|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204265|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204266|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
130204267|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204268|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204269|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204270|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204271|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204272|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
130204273|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204274|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204275|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204276|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204277|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204278|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204279|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204280|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
130204281|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204282|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204283|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204284|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204285|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204286|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204287|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
130204288|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204289|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204290|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204291|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204292|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204293|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204294|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
130204295|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204296|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204297|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204298|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204299|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204300|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204301|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204302|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
130204303|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204304|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204305|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204306|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204307|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204308|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
130204309|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204310|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204311|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204312|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204313|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204314|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204315|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
130204316|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
130204317|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204318|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204319|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204320|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204321|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204322|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
130204323|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204324|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204325|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204326|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204327|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204328|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204329|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204330|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
130204331|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204332|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204333|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204334|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204335|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204336|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
130204337|NCT02326298|468707183|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204338|NCT02326298|468707184|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204339|NCT02326298|468707185|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204340|NCT02326298|468707186|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204341|NCT02326298|468707187|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204342|NCT02326298|468707188|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
130204343|NCT02326298|468707189|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204344|NCT02326298|468707190|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204345|NCT02326298|468707191|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204346|NCT02326298|468707192|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204347|NCT02326298|468707193|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204348|NCT02326298|468707194|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204349|NCT02326298|468707195|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204350|NCT02326298|468707196|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
130204351|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
130204352|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
130204353|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
130204354|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
130204355|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
130204356|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
130204357|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
130204358|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
130204359|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
130204360|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
130204361|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
130204362|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
130204363|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
130204364|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
130204365|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204366|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204367|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204368|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204369|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204370|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204371|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204372|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204373|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204374|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204375|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204376|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130204377|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
130204378|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
130204379|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204380|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204381|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204382|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204383|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204384|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204385|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204386|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204387|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204388|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204389|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204390|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130204391|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
130204392|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
130204393|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204394|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204395|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204396|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204397|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204398|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204399|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204400|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204401|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204402|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204403|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204404|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204405|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
130204406|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
130204407|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204408|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204409|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204410|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204411|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204412|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204413|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204414|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204415|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204416|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204417|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
130204418|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
130204419|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
130204420|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
130204421|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204422|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204423|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204424|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204425|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204426|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204427|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204428|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204429|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204430|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204431|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
130204432|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
130204433|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
130204434|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
130204435|NCT02326298|468707183|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204436|NCT02326298|468707184|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204437|NCT02326298|468707185|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204438|NCT02326298|468707186|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204439|NCT02326298|468707187|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204440|NCT02326298|468707188|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204441|NCT02326298|468707189|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204442|NCT02326298|468707190|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204443|NCT02326298|468707191|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204444|NCT02326298|468707192|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204445|NCT02326298|468707193|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
130204446|NCT02326298|468707194|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
130204447|NCT02326298|468707195|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
130204448|NCT02326298|468707196|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
130204449|NCT05072964|468707201|FG000|Overall Study|Withdrawal by Subject|4|||
130204450|NCT05072964|468707201|FG000|Overall Study|Death|1|||
130204451|NCT04743804|468708784|FG000|Overall Study|Other|1|||
130204452|NCT04743804|468708785|FG001|Overall Study|Other|0|||
130204453|NCT04743804|468708784|FG000|Overall Study|Withdrawal by Subject|0|||
130204454|NCT04743804|468708785|FG001|Overall Study|Withdrawal by Subject|1|||
130204455|NCT04743804|468708784|FG000|Overall Study|Study Terminated by Sponsor|1|||
130204456|NCT04743804|468708785|FG001|Overall Study|Study Terminated by Sponsor|4|||
130204457|NCT04743804|468708784|FG000|Overall Study|Physician Decision|0|||
130204458|NCT04743804|468708785|FG001|Overall Study|Physician Decision|1|||
130204459|NCT04743804|468708784|FG000|Overall Study|Death|3|||
130204460|NCT04743804|468708785|FG001|Overall Study|Death|0|||
130204461|NCT01632904|468708786|FG000|Overall Study|Adverse Event|4|||
130204462|NCT01632904|468708787|FG001|Overall Study|Adverse Event|1|||
130204463|NCT01632904|468708786|FG000|Overall Study|Physician Decision|0|||
130204464|NCT01632904|468708787|FG001|Overall Study|Physician Decision|1|||
130204465|NCT01632904|468708786|FG000|Overall Study|Subject decision|3|||
130204466|NCT01632904|468708787|FG001|Overall Study|Subject decision|2|||
130204467|NCT01632904|468708786|FG000|Overall Study|Disease Progression|0|||
130204468|NCT01632904|468708787|FG001|Overall Study|Disease Progression|1|||
130204469|NCT01632904|468708786|FG000|Overall Study|Reason for discontinuation not available|0|||
130204470|NCT01632904|468708787|FG001|Overall Study|Reason for discontinuation not available|1|||
130204471|NCT02059434|468708791|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
130204472|NCT02059434|468708792|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
130204473|NCT02059434|468708793|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
130204474|NCT02059434|468708794|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
130204475|NCT02059434|468708795|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
130204476|NCT02059434|468708796|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
130204477|NCT02059434|468708797|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
130204478|NCT02059434|468708798|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
130204479|NCT02059434|468708799|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
130204480|NCT02059434|468708791|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
130204481|NCT02059434|468708792|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
130204482|NCT02059434|468708793|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
130204483|NCT02059434|468708794|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
130204484|NCT02059434|468708795|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
130204485|NCT02059434|468708796|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
130204486|NCT02059434|468708797|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
130204487|NCT02059434|468708798|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
130204488|NCT02059434|468708799|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
130204489|NCT02059434|468708791|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
130204490|NCT02059434|468708792|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
130204491|NCT02059434|468708793|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
130204492|NCT02059434|468708794|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
130204493|NCT02059434|468708795|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
130204494|NCT02059434|468708796|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
130204495|NCT02059434|468708797|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
130204496|NCT02059434|468708798|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
130204497|NCT02059434|468708799|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
130204498|NCT02059434|468708791|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
130204499|NCT02059434|468708792|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
130204500|NCT02059434|468708793|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
130204501|NCT02059434|468708794|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
130204502|NCT02059434|468708795|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
130204503|NCT02059434|468708796|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
130204504|NCT02059434|468708797|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
130204505|NCT02059434|468708798|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
130204506|NCT02059434|468708799|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
130204507|NCT02059434|468708791|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204508|NCT02059434|468708792|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204509|NCT02059434|468708793|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204510|NCT02059434|468708794|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204511|NCT02059434|468708795|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204512|NCT02059434|468708796|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204513|NCT02059434|468708797|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204514|NCT02059434|468708798|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
130204515|NCT02059434|468708799|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
130204516|NCT01004406|468708804|FG000|Overall Study|Withdrawal by Subject|2|||
130204517|NCT01004406|468708805|FG001|Overall Study|Withdrawal by Subject|0|||
130204518|NCT01004406|468708804|FG000|Overall Study|Lost to Follow-up|1|||
130204519|NCT01004406|468708805|FG001|Overall Study|Lost to Follow-up|0|||
130204520|NCT02928770|468708806|FG000|Overall Study|Withdrawal by Subject|2|||
130204521|NCT03201874|468708807|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
130204522|NCT03201874|468708808|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
130204523|NCT03201874|468708807|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
130204524|NCT03201874|468708808|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
130204525|NCT02907593|468708811|FG000|Overall Study|Withdrawal by Subject|0|||
130204526|NCT02907593|468708812|FG001|Overall Study|Withdrawal by Subject|0|||
130204527|NCT02907593|468708813|FG002|Overall Study|Withdrawal by Subject|1|||
130204528|NCT02907593|468708814|FG003|Overall Study|Withdrawal by Subject|0|||
130204529|NCT03385304|468708815|FG000|Overall Study|Death|19|||
130204530|NCT03385304|468708816|FG001|Overall Study|Death|7|||
130204531|NCT03385304|468708815|FG000|Overall Study|Lost to Follow-up|17|||
130204532|NCT03385304|468708816|FG001|Overall Study|Lost to Follow-up|14|||
130204533|NCT03385304|468708815|FG000|Overall Study|Withdrawal by Subject|3|||
130204534|NCT03385304|468708816|FG001|Overall Study|Withdrawal by Subject|2|||
130204535|NCT03385304|468708815|FG000|Overall Study|Incarceration|2|||
130204536|NCT03385304|468708816|FG001|Overall Study|Incarceration|3|||
130204537|NCT01120249|468708817|FG000|Overall Study|No protocol treatment received|21|||
130204538|NCT01120249|468708818|FG001|Overall Study|No protocol treatment received|15|||
130204539|NCT01120249|468708817|FG000|Overall Study|Disease recurrence|107|||
130204540|NCT01120249|468708818|FG001|Overall Study|Disease recurrence|57|||
130204541|NCT01120249|468708817|FG000|Overall Study|Death|1|||
130204542|NCT01120249|468708818|FG001|Overall Study|Death|0|||
130204543|NCT01120249|468708817|FG000|Overall Study|Adverse Event|40|||
130204544|NCT01120249|468708818|FG001|Overall Study|Adverse Event|276|||
130204545|NCT01120249|468708817|FG000|Overall Study|Participant refusal|34|||
130204546|NCT01120249|468708818|FG001|Overall Study|Participant refusal|42|||
130204547|NCT01120249|468708817|FG000|Overall Study|Other reasons, not protocol specified|29|||
130204548|NCT01120249|468708818|FG001|Overall Study|Other reasons, not protocol specified|22|||
130204549|NCT01447446|468708819|FG000|Overall Study|Death|6|||
130204550|NCT01447446|468708820|FG001|Overall Study|Death|3|||
130204551|NCT01447446|468708821|FG002|Overall Study|Death|2|||
130204552|NCT01447446|468708822|FG003|Overall Study|Death|1|||
130204553|NCT01447446|468708823|FG004|Overall Study|Death|7|||
130204554|NCT01447446|468708824|FG005|Overall Study|Death|0|||
130204555|NCT01447446|468708819|FG000|Overall Study|Adverse Event|3|||
130204556|NCT01447446|468708820|FG001|Overall Study|Adverse Event|0|||
130204557|NCT01447446|468708821|FG002|Overall Study|Adverse Event|1|||
130204558|NCT01447446|468708822|FG003|Overall Study|Adverse Event|0|||
130204559|NCT01447446|468708823|FG004|Overall Study|Adverse Event|2|||
130204560|NCT01447446|468708824|FG005|Overall Study|Adverse Event|0|||
130204561|NCT01447446|468708819|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
130204562|NCT01447446|468708820|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
130204563|NCT01447446|468708821|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
130204564|NCT01447446|468708822|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
130204565|NCT01447446|468708823|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
130204566|NCT01447446|468708824|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
130204567|NCT01447446|468708819|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
130204568|NCT01447446|468708820|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
130204569|NCT01447446|468708821|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
130204570|NCT01447446|468708822|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
130204571|NCT01447446|468708823|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
130204572|NCT01447446|468708824|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
130204573|NCT01447446|468708819|FG000|Overall Study|Administrative/Other|34|||
130204574|NCT01447446|468708820|FG001|Overall Study|Administrative/Other|9|||
130204575|NCT01447446|468708821|FG002|Overall Study|Administrative/Other|10|||
130204576|NCT01447446|468708822|FG003|Overall Study|Administrative/Other|2|||
130204577|NCT01447446|468708823|FG004|Overall Study|Administrative/Other|33|||
130204578|NCT01447446|468708824|FG005|Overall Study|Administrative/Other|4|||
130204579|NCT01447446|468708819|FG000|Overall Study|SVR12 Assessment|13|||
130204580|NCT01447446|468708820|FG001|Overall Study|SVR12 Assessment|1|||
130204581|NCT01447446|468708821|FG002|Overall Study|SVR12 Assessment|2|||
130204582|NCT01447446|468708822|FG003|Overall Study|SVR12 Assessment|1|||
130204583|NCT01447446|468708823|FG004|Overall Study|SVR12 Assessment|5|||
130204584|NCT01447446|468708824|FG005|Overall Study|SVR12 Assessment|5|||
130204585|NCT01447446|468708819|FG000|Overall Study|New Treatment Started|8|||
130204586|NCT01447446|468708820|FG001|Overall Study|New Treatment Started|2|||
130204587|NCT01447446|468708821|FG002|Overall Study|New Treatment Started|1|||
130204588|NCT01447446|468708822|FG003|Overall Study|New Treatment Started|0|||
130204589|NCT01447446|468708823|FG004|Overall Study|New Treatment Started|2|||
130204590|NCT01447446|468708824|FG005|Overall Study|New Treatment Started|0|||
130204591|NCT01447446|468708819|FG000|Overall Study|Reason not Specified|1|||
130204592|NCT01447446|468708820|FG001|Overall Study|Reason not Specified|1|||
130204593|NCT01447446|468708821|FG002|Overall Study|Reason not Specified|1|||
130204594|NCT01447446|468708822|FG003|Overall Study|Reason not Specified|1|||
130204595|NCT01447446|468708823|FG004|Overall Study|Reason not Specified|1|||
130204596|NCT01447446|468708824|FG005|Overall Study|Reason not Specified|0|||
130204597|NCT01892085|468708834|FG000|Overall Study|Death|4|||
130204598|NCT01892085|468708835|FG001|Overall Study|Death|1|||
130204599|NCT01892085|468708836|FG002|Overall Study|Death|3|||
130204600|NCT01892085|468708834|FG000|Overall Study|Withdrawal by Subject|2|||
130204601|NCT01892085|468708835|FG001|Overall Study|Withdrawal by Subject|0|||
130204602|NCT01892085|468708836|FG002|Overall Study|Withdrawal by Subject|2|||
130204603|NCT01629823|468708837|FG000|Trial Period|Missed visit|11|||
130204604|NCT01629823|468708838|FG001|Trial Period|Missed visit|9|||
130204605|NCT01629823|468708839|FG002|Trial Period|Missed visit|8|||
130204606|NCT01629823|468708837|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130204607|NCT01629823|468708838|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130204608|NCT01629823|468708839|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
130204609|NCT01629823|468708837|FG000|Trial Period|Pregnancy|1|||
130204610|NCT01629823|468708838|FG001|Trial Period|Pregnancy|0|||
130204611|NCT01629823|468708839|FG002|Trial Period|Pregnancy|0|||
130204612|NCT01629823|468708837|FG000|Trial Period|Adverse Event|0|||
130204613|NCT01629823|468708838|FG001|Trial Period|Adverse Event|1|||
130204614|NCT01629823|468708839|FG002|Trial Period|Adverse Event|0|||
130204615|NCT01629823|468708837|FG000|Trial Period|Out-of-window visit|0|||
130204616|NCT01629823|468708838|FG001|Trial Period|Out-of-window visit|2|||
130204617|NCT01629823|468708839|FG002|Trial Period|Out-of-window visit|0|||
130204618|NCT01629823|468708837|FG000|Trial Period|Failed to hold medication|0|||
130204619|NCT01629823|468708838|FG001|Trial Period|Failed to hold medication|0|||
130204620|NCT01629823|468708839|FG002|Trial Period|Failed to hold medication|1|||
130204621|NCT01629823|468708837|FG000|Washout Period|Safety|2|||
130204622|NCT01629823|468708838|FG001|Washout Period|Safety|5|||
130204623|NCT01629823|468708839|FG002|Washout Period|Safety|0|||
130204624|NCT01629823|468708837|FG000|Washout Period|Pregnancy|1|||
130204625|NCT01629823|468708838|FG001|Washout Period|Pregnancy|0|||
130204626|NCT01629823|468708839|FG002|Washout Period|Pregnancy|0|||
130204627|NCT01629823|468708837|FG000|Washout Period|Protocol Violation|0|||
130204628|NCT01629823|468708838|FG001|Washout Period|Protocol Violation|1|||
130204629|NCT01629823|468708839|FG002|Washout Period|Protocol Violation|0|||
130204630|NCT02609724|468708840|FG000|Overall Study|Death|2|||
130204631|NCT02609724|468708841|FG001|Overall Study|Death|0|||
130204632|NCT02609724|468708842|FG002|Overall Study|Death|1|||
130204633|NCT02609724|468708840|FG000|Overall Study|Withdrawal by Subject|1|||
130204634|NCT02609724|468708841|FG001|Overall Study|Withdrawal by Subject|2|||
130204635|NCT02609724|468708842|FG002|Overall Study|Withdrawal by Subject|3|||
130204636|NCT02609724|468708840|FG000|Overall Study|Illness|2|||
130204637|NCT02609724|468708841|FG001|Overall Study|Illness|1|||
130204638|NCT02609724|468708842|FG002|Overall Study|Illness|0|||
130204639|NCT03077659|468708843|FG000|Overall Study|Withdrawal by Subject|0|||
130204640|NCT03077659|468708844|FG001|Overall Study|Withdrawal by Subject|0|||
130204641|NCT03077659|468708845|FG002|Overall Study|Withdrawal by Subject|1|||
130204642|NCT02844907|468708846|FG000|With Dexamethasone|No IV access|1|||
130204643|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
130204644|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
130204645|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
130204646|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
130204647|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
130204648|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
130204649|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130204650|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
130204651|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130204652|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
130204653|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204654|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204655|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
130204656|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204657|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
130204658|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204659|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204660|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
130204661|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204662|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
130204663|NCT00550862|468708847|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204664|NCT00550862|468708848|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
130204665|NCT00550862|468708849|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204666|NCT00550862|468708850|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204667|NCT00550862|468708851|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
130204668|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204669|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204670|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204671|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
130204672|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
130204673|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204674|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204675|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204676|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
130204677|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
130204678|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204679|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204680|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204681|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
130204682|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
130204683|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
130204684|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
130204685|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
130204686|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
130204687|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
130204688|NCT00550862|468708847|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204689|NCT00550862|468708848|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204690|NCT00550862|468708849|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204691|NCT00550862|468708850|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
130204692|NCT00550862|468708851|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
130204693|NCT03488225|468708854|FG000|Overall Study|Off Protocol Therapy|2|||
130204694|NCT03488225|468708854|FG000|Overall Study|Stem Cell Transplant|2|||
130204695|NCT00986986|468708855|FG000|Overall Study|Lost to Follow-up|0|||
130204696|NCT00986986|468708856|FG001|Overall Study|Lost to Follow-up|1|||
130204697|NCT02003963|468708859|FG000|Overall Study|Lost to Follow-up|2|||
130204698|NCT02003963|468708860|FG001|Overall Study|Lost to Follow-up|1|||
130204699|NCT05020366|468708862|FG000|Overall Study|Lost to Follow-up|2|||
130204700|NCT05020366|468708863|FG001|Overall Study|Lost to Follow-up|0|||
130204701|NCT05020366|468708862|FG000|Overall Study|Withdrawal by Subject|2|||
130204702|NCT05020366|468708863|FG001|Overall Study|Withdrawal by Subject|0|||
130204703|NCT03589326|468708865|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
130204704|NCT03589326|468708866|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
130204705|NCT03589326|468708865|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
130204706|NCT03589326|468708866|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
130204707|NCT03589326|468708865|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
130204708|NCT03589326|468708866|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
130204709|NCT03589326|468708865|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
130204710|NCT03589326|468708866|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
130204711|NCT03589326|468708865|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
130204712|NCT03589326|468708866|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
130204713|NCT04050124|468708867|FG000|Overall Study|Death|1|||
130204714|NCT04050124|468708868|FG001|Overall Study|Death|0|||
130204715|NCT00430352|468708870|FG000|Overall Study|Disease progression|58|||
130204716|NCT00430352|468708870|FG000|Overall Study|Withdrawal by Subject|11|||
130204717|NCT00430352|468708870|FG000|Overall Study|Adverse Event|16|||
130204718|NCT00430352|468708870|FG000|Overall Study|Death|5|||
130204719|NCT00430352|468708870|FG000|Overall Study|Other|48|||
130204720|NCT00819780|468708873|FG000|Overall Study|Did not receive study drug|3|||
130204721|NCT00819780|468708874|FG001|Overall Study|Did not receive study drug|4|||
130204722|NCT00819780|468708873|FG000|Overall Study|Still in treatment|25|||
130204723|NCT00819780|468708874|FG001|Overall Study|Still in treatment|17|||
130204724|NCT00150800|468708875|FG000|Overall Study|Adverse Event|89|||
130204725|NCT00150800|468708875|FG000|Overall Study|Death|18|||
130204726|NCT00150800|468708875|FG000|Overall Study|Lack of Efficacy|166|||
130204727|NCT00150800|468708875|FG000|Overall Study|Lost to Follow-up|58|||
130204728|NCT00150800|468708875|FG000|Overall Study|Subject's choice|90|||
130204729|NCT00150800|468708875|FG000|Overall Study|No compliance|18|||
130204730|NCT00150800|468708875|FG000|Overall Study|IP misshandling|1|||
130204731|NCT00150800|468708875|FG000|Overall Study|Site closure|24|||
130204732|NCT00150800|468708875|FG000|Overall Study|Protocol non-adherence|2|||
130204733|NCT00150800|468708875|FG000|Overall Study|Nobody to accompany patient|1|||
130204734|NCT00150800|468708875|FG000|Overall Study|Distance too long for patient|1|||
130204735|NCT00150800|468708875|FG000|Overall Study|Neurosurgery|2|||
130204736|NCT00150800|468708875|FG000|Overall Study|BRV monotherapy|1|||
130204737|NCT00150800|468708875|FG000|Overall Study|Visit refusal|3|||
130204738|NCT00150800|468708875|FG000|Overall Study|Sponsor's request|2|||
130204739|NCT00150800|468708875|FG000|Overall Study|Generalized Epilepsy|1|||
130204740|NCT00150800|468708875|FG000|Overall Study|Moved from area/country|8|||
130204741|NCT00150800|468708875|FG000|Overall Study|PI retiring|2|||
130204742|NCT00150800|468708875|FG000|Overall Study|PI leaving site|2|||
130204743|NCT00150800|468708875|FG000|Overall Study|Patient insurance|1|||
130204744|NCT00150800|468708875|FG000|Overall Study|Surgical intervention|4|||
130204745|NCT00150800|468708875|FG000|Overall Study|Pregnancy planned|1|||
130204746|NCT00150800|468708875|FG000|Overall Study|PI discontinuation request|1|||
130204747|NCT02089334|468708876|FG000|Overall Study|Withdrawal by Subject|0|||
130204748|NCT02089334|468708877|FG001|Overall Study|Withdrawal by Subject|0|||
130204749|NCT02089334|468708878|FG002|Overall Study|Withdrawal by Subject|0|||
130204750|NCT02089334|468708879|FG003|Overall Study|Withdrawal by Subject|2|||
130204751|NCT02089334|468708876|FG000|Overall Study|Adverse Event|0|||
130204752|NCT02089334|468708877|FG001|Overall Study|Adverse Event|0|||
130204753|NCT02089334|468708878|FG002|Overall Study|Adverse Event|0|||
130204754|NCT02089334|468708879|FG003|Overall Study|Adverse Event|2|||
130204755|NCT02089334|468708876|FG000|Overall Study|Progressive disease|0|||
130204756|NCT02089334|468708877|FG001|Overall Study|Progressive disease|0|||
130204757|NCT02089334|468708878|FG002|Overall Study|Progressive disease|0|||
130204758|NCT02089334|468708879|FG003|Overall Study|Progressive disease|2|||
130204759|NCT02089334|468708876|FG000|Overall Study|Physician Decision|0|||
130204760|NCT02089334|468708877|FG001|Overall Study|Physician Decision|0|||
130204761|NCT02089334|468708878|FG002|Overall Study|Physician Decision|1|||
130204762|NCT02089334|468708879|FG003|Overall Study|Physician Decision|1|||
130204763|NCT02832375|468708880|FG000|Overall Study|Lost to Follow-up|1|||
130204764|NCT02832375|468708881|FG001|Overall Study|Lost to Follow-up|0|||
130204765|NCT02832375|468708880|FG000|Overall Study|Withdrawal of Consent|1|||
130204766|NCT02832375|468708881|FG001|Overall Study|Withdrawal of Consent|0|||
130204767|NCT00084318|468708884|FG000|Overall Study|Withdrawal by Subject|5|||
130204768|NCT00084318|468708885|FG001|Overall Study|Withdrawal by Subject|2|||
130204769|NCT00084318|468708884|FG000|Overall Study|Protocol Violation|15|||
130204770|NCT00084318|468708885|FG001|Overall Study|Protocol Violation|11|||
130204771|NCT00084318|468708884|FG000|Overall Study|No protocol treatment|2|||
130204772|NCT00084318|468708885|FG001|Overall Study|No protocol treatment|0|||
130204773|NCT03301740|468708887|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
130204774|NCT03301740|468708888|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
130204775|NCT03301740|468708887|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
130204776|NCT03301740|468708888|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
130204777|NCT01037127|468708889|FG000|Overall Study|Lost to Follow-up|2|||
130204778|NCT01037127|468708890|FG001|Overall Study|Lost to Follow-up|4|||
130204779|NCT01037127|468708889|FG000|Overall Study|Physician Decision|1|||
130204780|NCT01037127|468708890|FG001|Overall Study|Physician Decision|0|||
130204781|NCT01037127|468708889|FG000|Overall Study|Study Closed Terminated|2|||
130204782|NCT01037127|468708890|FG001|Overall Study|Study Closed Terminated|17|||
130204783|NCT02637713|468708897|FG000|Overall Study|Screen Failure|2|||
130204784|NCT02847182|468708898|FG000|Overall Study|Withdrawal by Subject|0|||
130204785|NCT02847182|468708899|FG001|Overall Study|Withdrawal by Subject|1|||
130204786|NCT02345889|468708900|FG000|Overall Study|Inadequate Bowel Prep|17|||
130204787|NCT02345889|468708901|FG001|Overall Study|Inadequate Bowel Prep|16|||
130204788|NCT02345889|468708902|FG002|Overall Study|Inadequate Bowel Prep|18|||
130204789|NCT02345889|468708903|FG003|Overall Study|Inadequate Bowel Prep|14|||
130204790|NCT02345889|468708900|FG000|Overall Study|Polyposis identified during procedure|1|||
130204791|NCT02345889|468708901|FG001|Overall Study|Polyposis identified during procedure|1|||
130204792|NCT02345889|468708902|FG002|Overall Study|Polyposis identified during procedure|0|||
130204793|NCT02345889|468708903|FG003|Overall Study|Polyposis identified during procedure|1|||
130204794|NCT02345889|468708900|FG000|Overall Study|Recognized ineligible post-randomization|1|||
130204795|NCT02345889|468708901|FG001|Overall Study|Recognized ineligible post-randomization|0|||
130204796|NCT02345889|468708902|FG002|Overall Study|Recognized ineligible post-randomization|2|||
130204797|NCT02345889|468708903|FG003|Overall Study|Recognized ineligible post-randomization|1|||
130204798|NCT02345889|468708900|FG000|Overall Study|Ulcerative Colitis identified|1|||
130204799|NCT02345889|468708901|FG001|Overall Study|Ulcerative Colitis identified|0|||
130204800|NCT02345889|468708902|FG002|Overall Study|Ulcerative Colitis identified|0|||
130204801|NCT02345889|468708903|FG003|Overall Study|Ulcerative Colitis identified|0|||
130204802|NCT02345889|468708900|FG000|Overall Study|Cecum not intubated|1|||
130204803|NCT02345889|468708901|FG001|Overall Study|Cecum not intubated|0|||
130204804|NCT02345889|468708902|FG002|Overall Study|Cecum not intubated|0|||
130204805|NCT02345889|468708903|FG003|Overall Study|Cecum not intubated|0|||
130204806|NCT01173055|468708904|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
130204807|NCT01173055|468708905|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
130204808|NCT01173055|468708904|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
130204809|NCT01173055|468708905|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
130204810|NCT04325698|468708907|FG000|Overall Study|Study Terminated By Sponsor|1|||
130204811|NCT04325698|468708908|FG001|Overall Study|Study Terminated By Sponsor|1|||
130204812|NCT04325698|468708907|FG000|Overall Study|Withdrawal by Subject|0|||
130204813|NCT04325698|468708908|FG001|Overall Study|Withdrawal by Subject|2|||
130204814|NCT04253782|468708909|FG000|Overall Study|Death|2|||
130204815|NCT04253782|468708910|FG001|Overall Study|Death|0|||
130204816|NCT04216589|468708911|FG000|Overall Study|Withdrawal by Subject|2|||
130204817|NCT04216589|468708911|FG000|Overall Study|Protocol Violation|1|||
130204818|NCT04216589|468708911|FG000|Overall Study|Incarceration|1|||
130204819|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204820|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204821|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204822|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204823|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
130204824|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
130204825|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204826|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204827|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204828|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204829|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
130204830|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
130204831|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Adverse Event|0|||
130204832|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Adverse Event|0|||
130204833|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Adverse Event|0|||
130204834|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Adverse Event|0|||
130204835|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Adverse Event|0|||
130204836|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Adverse Event|2|||
130204837|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204838|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204839|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204840|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204841|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
130204842|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
130204843|NCT03191864|468708918|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204844|NCT03191864|468708919|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204845|NCT03191864|468708920|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204846|NCT03191864|468708921|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204847|NCT03191864|468708922|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
130204848|NCT03191864|468708923|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
130204849|NCT03191864|468708918|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204850|NCT03191864|468708919|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204851|NCT03191864|468708920|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
130204852|NCT03191864|468708921|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204853|NCT03191864|468708922|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
130204854|NCT03191864|468708923|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
130204855|NCT03191864|468708918|FG000|Part 1 - Induction|Adverse Event|0|||
130204856|NCT03191864|468708919|FG001|Part 1 - Induction|Adverse Event|2|||
130204857|NCT03191864|468708920|FG002|Part 1 - Induction|Adverse Event|0|||
130204858|NCT03191864|468708921|FG003|Part 1 - Induction|Adverse Event|1|||
130204859|NCT03191864|468708922|FG004|Part 1 - Induction|Adverse Event|0|||
130204860|NCT03191864|468708923|FG005|Part 1 - Induction|Adverse Event|2|||
130204861|NCT03191864|468708918|FG000|Part 1 - Induction|Randomized but never dosed|0|||
130204862|NCT03191864|468708919|FG001|Part 1 - Induction|Randomized but never dosed|0|||
130204863|NCT03191864|468708920|FG002|Part 1 - Induction|Randomized but never dosed|1|||
130204864|NCT03191864|468708921|FG003|Part 1 - Induction|Randomized but never dosed|0|||
130204865|NCT03191864|468708922|FG004|Part 1 - Induction|Randomized but never dosed|0|||
130204866|NCT03191864|468708923|FG005|Part 1 - Induction|Randomized but never dosed|0|||
130204867|NCT03191864|468708918|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
130204868|NCT03191864|468708919|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
130204869|NCT03191864|468708920|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
130204870|NCT03191864|468708921|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
130204871|NCT03191864|468708922|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
130204872|NCT03191864|468708923|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
130204873|NCT03191864|468708918|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204874|NCT03191864|468708919|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204875|NCT03191864|468708920|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
130204876|NCT03191864|468708921|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204877|NCT03191864|468708922|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204878|NCT03191864|468708923|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
130204879|NCT03191864|468708918|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
130204880|NCT03191864|468708919|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204881|NCT03191864|468708920|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204882|NCT03191864|468708921|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204883|NCT03191864|468708922|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204884|NCT03191864|468708923|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
130204885|NCT03191864|468708918|FG000|Part 2 - Maintenance|Physician Decision|1|||
130204886|NCT03191864|468708919|FG001|Part 2 - Maintenance|Physician Decision|0|||
130204887|NCT03191864|468708920|FG002|Part 2 - Maintenance|Physician Decision|0|||
130204888|NCT03191864|468708921|FG003|Part 2 - Maintenance|Physician Decision|0|||
130204889|NCT03191864|468708922|FG004|Part 2 - Maintenance|Physician Decision|0|||
130204890|NCT03191864|468708923|FG005|Part 2 - Maintenance|Physician Decision|0|||
130204891|NCT03191864|468708918|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
130204892|NCT03191864|468708919|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
130204893|NCT03191864|468708920|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
130204894|NCT03191864|468708921|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
130204895|NCT03191864|468708922|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
130204896|NCT03191864|468708923|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
130204897|NCT03191864|468708918|FG000|Part 2 - Maintenance|Adverse Event|0|||
130204898|NCT03191864|468708919|FG001|Part 2 - Maintenance|Adverse Event|0|||
130204899|NCT03191864|468708920|FG002|Part 2 - Maintenance|Adverse Event|0|||
130204900|NCT03191864|468708921|FG003|Part 2 - Maintenance|Adverse Event|0|||
130204901|NCT03191864|468708922|FG004|Part 2 - Maintenance|Adverse Event|1|||
130204902|NCT03191864|468708923|FG005|Part 2 - Maintenance|Adverse Event|0|||
130204903|NCT03191864|468708918|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
130204904|NCT03191864|468708919|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204905|NCT03191864|468708920|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204906|NCT03191864|468708921|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204907|NCT03191864|468708922|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
130204908|NCT03191864|468708923|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
130204909|NCT03191864|468708918|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204910|NCT03191864|468708919|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204911|NCT03191864|468708920|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204912|NCT03191864|468708921|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204913|NCT03191864|468708922|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
130204914|NCT03191864|468708923|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
130204915|NCT02342548|468708924|FG000|Overall Study|Adverse Event|12|||
130204916|NCT02342548|468708925|FG001|Overall Study|Adverse Event|17|||
130204917|NCT02342548|468708926|FG002|Overall Study|Adverse Event|13|||
130204918|NCT02342548|468708924|FG000|Overall Study|Lost to Follow-up|0|||
130204919|NCT02342548|468708925|FG001|Overall Study|Lost to Follow-up|1|||
130204920|NCT02342548|468708926|FG002|Overall Study|Lost to Follow-up|0|||
130204921|NCT02342548|468708924|FG000|Overall Study|Study terminated by sponsor|20|||
130204922|NCT02342548|468708925|FG001|Overall Study|Study terminated by sponsor|39|||
130204923|NCT02342548|468708926|FG002|Overall Study|Study terminated by sponsor|25|||
130204924|NCT02342548|468708924|FG000|Overall Study|Protocol Violation|0|||
130204925|NCT02342548|468708925|FG001|Overall Study|Protocol Violation|1|||
130204926|NCT02342548|468708926|FG002|Overall Study|Protocol Violation|0|||
130204927|NCT02342548|468708924|FG000|Overall Study|Withdrawal by Subject|1|||
130204928|NCT02342548|468708925|FG001|Overall Study|Withdrawal by Subject|3|||
130204929|NCT02342548|468708926|FG002|Overall Study|Withdrawal by Subject|4|||
130204930|NCT02342548|468708924|FG000|Overall Study|Other|1|||
130204931|NCT02342548|468708925|FG001|Overall Study|Other|1|||
130204932|NCT02342548|468708926|FG002|Overall Study|Other|1|||
130204933|NCT01047332|468708927|FG000|Overall Study|SEMS Obstruction|11|||
130204934|NCT01047332|468708928|FG001|Overall Study|SEMS Obstruction|20|||
130204935|NCT01047332|468708927|FG000|Overall Study|Died Unobstructed|38|||
130204936|NCT01047332|468708928|FG001|Overall Study|Died Unobstructed|41|||
130204937|NCT01047332|468708927|FG000|Overall Study|Lost to Follow-up|8|||
130204938|NCT01047332|468708928|FG001|Overall Study|Lost to Follow-up|3|||
130204939|NCT03521817|468708933|FG000|Overall Study|Protocol Violation|0|||
130204940|NCT03521817|468708934|FG001|Overall Study|Protocol Violation|1|||
130204941|NCT04240886|468710326|FG000|Treatment Phase|Death|4|||
130204942|NCT04240886|468710326|FG000|Treatment Phase|Discontinuation by Subject|1|||
130204943|NCT04240886|468710326|FG000|Treatment Phase|Adverse Event|5|||
130204944|NCT04240886|468710326|FG000|Follow-up Phase|Withdrawal by Subject|1|||
130204945|NCT04240886|468710326|FG000|Follow-up Phase|Discontinuation by Subject|1|||
130204946|NCT04240886|468710326|FG000|Follow-up Phase|Death|2|||
130204947|NCT04618471|468710327|FG000|Overall Study|Screen Failure|62|||
130204948|NCT04618471|468710327|FG000|Overall Study|Withdrawal by Subject|6|||
130204949|NCT04618471|468710327|FG000|Overall Study|Physician Decision|2|||
130204950|NCT04618471|468710327|FG000|Overall Study|Lost to Follow-up|1|||
130204951|NCT04618471|468710327|FG000|Overall Study|Various other reasons|2|||
130204952|NCT04618471|468710327|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
130204953|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130204954|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130204955|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
130204956|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
130204957|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
130204958|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
130204959|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204960|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
130204961|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204962|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204963|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204964|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
130204965|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
130204966|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
130204967|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130204968|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130204969|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
130204970|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
130204971|NCT01752634|468710328|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
130204972|NCT01752634|468710329|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130204973|NCT01752634|468710330|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
130204974|NCT01752634|468710331|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130204975|NCT01752634|468710332|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
130204976|NCT01752634|468710333|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
130204977|NCT01752634|468710328|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
130204978|NCT01752634|468710329|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
130204979|NCT01752634|468710330|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
130204980|NCT01752634|468710331|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
130204981|NCT01752634|468710332|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
130204982|NCT01752634|468710333|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
130204983|NCT01752634|468710328|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
130204984|NCT01752634|468710329|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
130204985|NCT01752634|468710330|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
130204986|NCT01752634|468710331|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
130204987|NCT01752634|468710332|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
130204988|NCT01752634|468710333|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
130204989|NCT01752634|468710328|FG000|Week 24 to Week 260|Physician Decision|1|||
130204990|NCT01752634|468710329|FG001|Week 24 to Week 260|Physician Decision|2|||
130204991|NCT01752634|468710330|FG002|Week 24 to Week 260|Physician Decision|4|||
130204992|NCT01752634|468710331|FG003|Week 24 to Week 260|Physician Decision|2|||
130204993|NCT01752634|468710332|FG004|Week 24 to Week 260|Physician Decision|1|||
130204994|NCT01752634|468710333|FG005|Week 24 to Week 260|Physician Decision|0|||
130204995|NCT01752634|468710328|FG000|Week 24 to Week 260|Death|0|||
130204996|NCT01752634|468710329|FG001|Week 24 to Week 260|Death|1|||
130204997|NCT01752634|468710330|FG002|Week 24 to Week 260|Death|0|||
130204998|NCT01752634|468710331|FG003|Week 24 to Week 260|Death|0|||
130204999|NCT01752634|468710332|FG004|Week 24 to Week 260|Death|0|||
130205000|NCT01752634|468710333|FG005|Week 24 to Week 260|Death|0|||
130205001|NCT01752634|468710328|FG000|Week 24 to Week 260|Pregnancy|0|||
130205002|NCT01752634|468710329|FG001|Week 24 to Week 260|Pregnancy|0|||
130205003|NCT01752634|468710330|FG002|Week 24 to Week 260|Pregnancy|1|||
130205004|NCT01752634|468710331|FG003|Week 24 to Week 260|Pregnancy|0|||
130205005|NCT01752634|468710332|FG004|Week 24 to Week 260|Pregnancy|0|||
130205006|NCT01752634|468710333|FG005|Week 24 to Week 260|Pregnancy|0|||
130205007|NCT01752634|468710328|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205008|NCT01752634|468710329|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205009|NCT01752634|468710330|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
130205010|NCT01752634|468710331|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205011|NCT01752634|468710332|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205012|NCT01752634|468710333|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
130205013|NCT01752634|468710328|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
130205014|NCT01752634|468710329|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
130205015|NCT01752634|468710330|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
130205016|NCT01752634|468710331|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
130205017|NCT01752634|468710332|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
130205018|NCT01752634|468710333|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
130205019|NCT01752634|468710328|FG000|Week 24 to Week 260|Adverse Event|4|||
130205020|NCT01752634|468710329|FG001|Week 24 to Week 260|Adverse Event|8|||
130205021|NCT01752634|468710330|FG002|Week 24 to Week 260|Adverse Event|8|||
130205022|NCT01752634|468710331|FG003|Week 24 to Week 260|Adverse Event|4|||
130205023|NCT01752634|468710332|FG004|Week 24 to Week 260|Adverse Event|2|||
130205024|NCT01752634|468710333|FG005|Week 24 to Week 260|Adverse Event|0|||
130205025|NCT01250171|468710334|FG000|Overall Study|Administrative reasons|1|||
130205026|NCT01250171|468710335|FG001|Overall Study|Administrative reasons|0|||
130205027|NCT01250171|468710336|FG002|Overall Study|Administrative reasons|0|||
130205028|NCT01451164|468710348|FG000|Overall Study|Adverse Event|19|||
130205029|NCT01451164|468710349|FG001|Overall Study|Adverse Event|12|||
130205030|NCT01451164|468710350|FG002|Overall Study|Adverse Event|18|||
130205031|NCT01451164|468710351|FG003|Overall Study|Adverse Event|21|||
130205032|NCT01451164|468710348|FG000|Overall Study|Withdrawal Criteria|1|||
130205033|NCT01451164|468710349|FG001|Overall Study|Withdrawal Criteria|1|||
130205034|NCT01451164|468710350|FG002|Overall Study|Withdrawal Criteria|1|||
130205035|NCT01451164|468710351|FG003|Overall Study|Withdrawal Criteria|1|||
130205036|NCT01451164|468710348|FG000|Overall Study|Physician Decision|2|||
130205037|NCT01451164|468710349|FG001|Overall Study|Physician Decision|0|||
130205038|NCT01451164|468710350|FG002|Overall Study|Physician Decision|1|||
130205039|NCT01451164|468710351|FG003|Overall Study|Physician Decision|0|||
130205040|NCT01451164|468710348|FG000|Overall Study|Withdrawal by Subject|14|||
130205041|NCT01451164|468710349|FG001|Overall Study|Withdrawal by Subject|11|||
130205042|NCT01451164|468710350|FG002|Overall Study|Withdrawal by Subject|16|||
130205043|NCT01451164|468710351|FG003|Overall Study|Withdrawal by Subject|17|||
130205044|NCT01451164|468710348|FG000|Overall Study|Protocol Violation|0|||
130205045|NCT01451164|468710349|FG001|Overall Study|Protocol Violation|1|||
130205046|NCT01451164|468710350|FG002|Overall Study|Protocol Violation|0|||
130205047|NCT01451164|468710351|FG003|Overall Study|Protocol Violation|0|||
130205048|NCT01451164|468710348|FG000|Overall Study|Lack of Efficacy|7|||
130205049|NCT01451164|468710349|FG001|Overall Study|Lack of Efficacy|9|||
130205050|NCT01451164|468710350|FG002|Overall Study|Lack of Efficacy|9|||
130205051|NCT01451164|468710351|FG003|Overall Study|Lack of Efficacy|7|||
130205052|NCT04599933|468710352|FG000|Overall Study|Adverse Event|4|||
130205053|NCT04599933|468710353|FG001|Overall Study|Adverse Event|1|||
130205054|NCT04599933|468710352|FG000|Overall Study|Withdrawal by Subject|4|||
130205055|NCT04599933|468710353|FG001|Overall Study|Withdrawal by Subject|2|||
130205056|NCT04599933|468710352|FG000|Overall Study|Lost to Follow-up|0|||
130205057|NCT04599933|468710353|FG001|Overall Study|Lost to Follow-up|1|||
130205058|NCT04599933|468710352|FG000|Overall Study|Physician Decision|0|||
130205059|NCT04599933|468710353|FG001|Overall Study|Physician Decision|1|||
130205060|NCT04599933|468710352|FG000|Overall Study|Screen Failure|1|||
130205061|NCT04599933|468710353|FG001|Overall Study|Screen Failure|2|||
130205062|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Adverse Event|0|||
130205063|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Adverse Event|1|||
130205064|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Adverse Event|0|||
130205065|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Adverse Event|0|||
130205066|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Adverse Event|0|||
130205067|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Adverse Event|0|||
130205068|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Death|0|||
130205069|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Death|0|||
130205070|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Death|1|||
130205071|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Death|0|||
130205072|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Death|0|||
130205073|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Death|0|||
130205074|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205075|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
130205076|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205077|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205078|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205079|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
130205080|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205081|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205082|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
130205083|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205084|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205085|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
130205086|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205087|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205088|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205089|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
130205090|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205091|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
130205092|NCT03226678|468710356|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
130205093|NCT03226678|468710357|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
130205094|NCT03226678|468710358|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205095|NCT03226678|468710359|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205096|NCT03226678|468710360|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205097|NCT03226678|468710361|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
130205098|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205099|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205100|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205101|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
130205102|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
130205103|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
130205104|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Death|0|||
130205105|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Death|0|||
130205106|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Death|0|||
130205107|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Death|0|||
130205108|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Death|0|||
130205109|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Death|1|||
130205110|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205111|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205112|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205113|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205114|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
130205115|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
130205116|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205117|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205118|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205119|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
130205120|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
130205121|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
130205122|NCT03226678|468710356|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205123|NCT03226678|468710357|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205124|NCT03226678|468710358|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205125|NCT03226678|468710359|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205126|NCT03226678|468710360|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
130205127|NCT03226678|468710361|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
130205128|NCT03117881|468710362|FG000|Baseline|Withdrawal by Subject|21|||
130205129|NCT03117881|468710363|FG001|Baseline|Withdrawal by Subject|10|||
130205130|NCT03117881|468710364|FG002|Baseline|Withdrawal by Subject|0|||
130205131|NCT03117881|468710362|FG000|Baseline|Lost to Follow-up|22|||
130205132|NCT03117881|468710363|FG001|Baseline|Lost to Follow-up|25|||
130205133|NCT03117881|468710364|FG002|Baseline|Lost to Follow-up|0|||
130205134|NCT03117881|468710362|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
130205135|NCT03117881|468710363|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
130205136|NCT03117881|468710364|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
130205137|NCT03117881|468710362|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
130205138|NCT03117881|468710363|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
130205139|NCT03117881|468710364|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
130205140|NCT03117881|468710362|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
130205141|NCT03117881|468710363|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
130205142|NCT03117881|468710364|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
130205143|NCT03117881|468710362|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
130205144|NCT03117881|468710363|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
130205145|NCT03117881|468710364|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
130205146|NCT03117881|468710362|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
130205147|NCT03117881|468710363|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
130205148|NCT03117881|468710364|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
130205149|NCT03117881|468710362|FG000|6-Month Follow-Up|Did not complete test|53|||
130205150|NCT03117881|468710363|FG001|6-Month Follow-Up|Did not complete test|25|||
130205151|NCT03117881|468710364|FG002|6-Month Follow-Up|Did not complete test|7|||
130205152|NCT03117881|468710362|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
130205153|NCT03117881|468710363|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
130205154|NCT03117881|468710364|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
130205155|NCT03117881|468710362|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
130205156|NCT03117881|468710363|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
130205157|NCT03117881|468710364|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
130205158|NCT03117881|468710362|FG000|12-Month Follow-Up|Did not complete test|40|||
130205159|NCT03117881|468710363|FG001|12-Month Follow-Up|Did not complete test|0|||
130205160|NCT03117881|468710364|FG002|12-Month Follow-Up|Did not complete test|0|||
130205161|NCT01027897|468710365|FG000|Overall Study|Protocol Violation|1|||
130205162|NCT01027897|468710365|FG000|Overall Study|Withdrawal by Subject|1|||
130205163|NCT02045732|468710368|FG000|Overall Study|At the discretion of the investigator|1|||
130205164|NCT02045732|468710369|FG001|Overall Study|At the discretion of the investigator|1|||
130205165|NCT00473824|468710370|FG000|Overall Study|Virologic Breakthrough|1|||
130205166|NCT00473824|468710371|FG001|Overall Study|Virologic Breakthrough|0|||
130205167|NCT00473824|468710370|FG000|Overall Study|Adverse Event|1|||
130205168|NCT00473824|468710371|FG001|Overall Study|Adverse Event|0|||
130205169|NCT00473824|468710370|FG000|Overall Study|Death|1|||
130205170|NCT00473824|468710371|FG001|Overall Study|Death|0|||
130205171|NCT00473824|468710370|FG000|Overall Study|Lost to Follow-up|1|||
130205172|NCT00473824|468710371|FG001|Overall Study|Lost to Follow-up|0|||
130205173|NCT00473824|468710370|FG000|Overall Study|Withdrawal by physician|1|||
130205174|NCT00473824|468710371|FG001|Overall Study|Withdrawal by physician|0|||
130205175|NCT02560623|468710372|FG000|Overall Study|Unable to swallow sponge|0|||
130205176|NCT02560623|468710373|FG001|Overall Study|Unable to swallow sponge|1|||
130205177|NCT02560623|468710374|FG002|Overall Study|Unable to swallow sponge|0|||
130205178|NCT02560623|468710375|FG003|Overall Study|Unable to swallow sponge|0|||
130205179|NCT02560623|468710372|FG000|Overall Study|Intervention prior to sponge administration|0|||
130205180|NCT02560623|468710373|FG001|Overall Study|Intervention prior to sponge administration|1|||
130205181|NCT02560623|468710374|FG002|Overall Study|Intervention prior to sponge administration|0|||
130205182|NCT02560623|468710375|FG003|Overall Study|Intervention prior to sponge administration|0|||
130205183|NCT05014815|468710376|FG000|Overall Study|Death|63|||
130205184|NCT05014815|468710377|FG001|Overall Study|Death|70|||
130205185|NCT05014815|468710376|FG000|Overall Study|Withdrawal by Subject|10|||
130205186|NCT05014815|468710377|FG001|Overall Study|Withdrawal by Subject|10|||
130205187|NCT05014815|468710376|FG000|Overall Study|Lost to Follow-up|4|||
130205188|NCT05014815|468710377|FG001|Overall Study|Lost to Follow-up|2|||
130205189|NCT05014815|468710376|FG000|Overall Study|Physician Decision|2|||
130205190|NCT05014815|468710377|FG001|Overall Study|Physician Decision|4|||
130205191|NCT04247880|468710378|FG000|Overall Study|Lost to Follow-up|24|||
130205192|NCT04247880|468710379|FG001|Overall Study|Lost to Follow-up|17|||
130205193|NCT04247880|468710378|FG000|Overall Study|Withdrawal by Subject|3|||
130205194|NCT04247880|468710379|FG001|Overall Study|Withdrawal by Subject|0|||
130205195|NCT06303167|468710380|FG000|Overall Study|Ineligible|1|||
130205196|NCT06303167|468710380|FG000|Overall Study|Never start protocol therapy|2|||
130205197|NCT06303167|468710380|FG000|Overall Study|Disease progression|16|||
130205198|NCT02453282|468710381|FG000|Overall Study|Death|275|||
130205199|NCT02453282|468710382|FG001|Overall Study|Death|277|||
130205200|NCT02453282|468710383|FG002|Overall Study|Death|296|||
130205201|NCT02453282|468710381|FG000|Overall Study|Lost to Follow-up|1|||
130205202|NCT02453282|468710382|FG001|Overall Study|Lost to Follow-up|0|||
130205203|NCT02453282|468710383|FG002|Overall Study|Lost to Follow-up|2|||
130205204|NCT02453282|468710381|FG000|Overall Study|Withdrawal by Subject|12|||
130205205|NCT02453282|468710382|FG001|Overall Study|Withdrawal by Subject|10|||
130205206|NCT02453282|468710383|FG002|Overall Study|Withdrawal by Subject|11|||
130205207|NCT02453282|468710381|FG000|Overall Study|Participants ongoing at data cut-off|85|||
130205208|NCT02453282|468710382|FG001|Overall Study|Participants ongoing at data cut-off|84|||
130205209|NCT02453282|468710383|FG002|Overall Study|Participants ongoing at data cut-off|62|||
130205210|NCT02453282|468710381|FG000|Overall Study|Other|1|||
130205211|NCT02453282|468710382|FG001|Overall Study|Other|1|||
130205212|NCT02453282|468710383|FG002|Overall Study|Other|1|||
130205213|NCT01661933|468710385|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
130205214|NCT01661933|468710385|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
130205215|NCT03536949|468710394|FG000|Overall Study|Adverse Event|4|||
130205216|NCT03536949|468710395|FG001|Overall Study|Adverse Event|0|||
130205217|NCT03536949|468710394|FG000|Overall Study|Lost to Follow-up|2|||
130205218|NCT03536949|468710395|FG001|Overall Study|Lost to Follow-up|1|||
130205219|NCT03536949|468710394|FG000|Overall Study|Withdrawal by Subject|6|||
130205220|NCT03536949|468710395|FG001|Overall Study|Withdrawal by Subject|0|||
130205221|NCT03536949|468710394|FG000|Overall Study|Non-compliance|2|||
130205222|NCT03536949|468710395|FG001|Overall Study|Non-compliance|1|||
130205223|NCT00435487|468710413|FG000|Overall Study|Death|3|||
130205224|NCT00435487|468710414|FG001|Overall Study|Death|4|||
130205225|NCT00435487|468710413|FG000|Overall Study|Adverse Event|0|||
130205226|NCT00435487|468710414|FG001|Overall Study|Adverse Event|3|||
130205227|NCT00435487|468710413|FG000|Overall Study|Lost to Follow-up|2|||
130205228|NCT00435487|468710414|FG001|Overall Study|Lost to Follow-up|2|||
130205229|NCT00435487|468710413|FG000|Overall Study|Other|5|||
130205230|NCT00435487|468710414|FG001|Overall Study|Other|2|||
130205231|NCT00435487|468710413|FG000|Overall Study|Withdrawal by Subject|2|||
130205232|NCT00435487|468710414|FG001|Overall Study|Withdrawal by Subject|1|||
130205233|NCT00435487|468710413|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
130205234|NCT00435487|468710414|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
130205235|NCT00435487|468710413|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
130205236|NCT00435487|468710414|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
130205237|NCT03301844|468710415|FG000|Overall Study|suspected colon cancer|1|||
130205238|NCT03301844|468710416|FG001|Overall Study|suspected colon cancer|1|||
130205239|NCT05087966|468710417|FG000|Overall Study|Lost to Follow-up|1|||
130205240|NCT05087966|468710417|FG000|Overall Study|Withdrawal by Subject|5|||
130205241|NCT01267201|468710418|FG000|First Intervention Period|Withdrawal by Subject|1|||
130205242|NCT01267201|468710419|FG001|First Intervention Period|Withdrawal by Subject|0|||
130205243|NCT01267201|468710420|FG002|First Intervention Period|Withdrawal by Subject|0|||
130205244|NCT01267201|468710421|FG003|First Intervention Period|Withdrawal by Subject|0|||
130205245|NCT01267201|468710422|FG004|First Intervention Period|Withdrawal by Subject|0|||
130205246|NCT01267201|468710423|FG005|First Intervention Period|Withdrawal by Subject|0|||
130205247|NCT01267201|468710418|FG000|Second Intervention Period|Withdrawal by Subject|0|||
130205248|NCT01267201|468710419|FG001|Second Intervention Period|Withdrawal by Subject|1|||
130205249|NCT01267201|468710420|FG002|Second Intervention Period|Withdrawal by Subject|0|||
130205250|NCT01267201|468710421|FG003|Second Intervention Period|Withdrawal by Subject|0|||
130205251|NCT01267201|468710422|FG004|Second Intervention Period|Withdrawal by Subject|0|||
130205252|NCT01267201|468710423|FG005|Second Intervention Period|Withdrawal by Subject|0|||
130205253|NCT00501059|468710424|FG000|Overall Study|Protocol Violation|80|||
130205254|NCT00501059|468710425|FG001|Overall Study|Protocol Violation|69|||
130205255|NCT00501059|468710424|FG000|Overall Study|Death|140|||
130205256|NCT00501059|468710425|FG001|Overall Study|Death|137|||
130205257|NCT00501059|468710424|FG000|Overall Study|Other|236|||
130205258|NCT00501059|468710425|FG001|Overall Study|Other|239|||
130205259|NCT00501059|468710424|FG000|Overall Study|Missing end-of-study page|91|||
130205260|NCT00501059|468710425|FG001|Overall Study|Missing end-of-study page|92|||
130205261|NCT00501059|468710424|FG000|Overall Study|Clinical endpoint reached|110|||
130205262|NCT00501059|468710425|FG001|Overall Study|Clinical endpoint reached|123|||
130205263|NCT00501059|468710424|FG000|Overall Study|Insufficient therapeutic effect|4|||
130205264|NCT00501059|468710425|FG001|Overall Study|Insufficient therapeutic effect|5|||
130205265|NCT00501059|468710424|FG000|Overall Study|Consent withdrawn by subject|817|||
130205266|NCT00501059|468710425|FG001|Overall Study|Consent withdrawn by subject|873|||
130205267|NCT00501059|468710424|FG000|Overall Study|Non-compliant with study treatment|23|||
130205268|NCT00501059|468710425|FG001|Overall Study|Non-compliant with study treatment|16|||
130205269|NCT00501059|468710424|FG000|Overall Study|Reason not given|3|||
130205270|NCT00501059|468710425|FG001|Overall Study|Reason not given|1|||
130205271|NCT00501059|468710424|FG000|Overall Study|Adverse Event|129|||
130205272|NCT00501059|468710425|FG001|Overall Study|Adverse Event|122|||
130205273|NCT00501059|468710424|FG000|Overall Study|Lost to Follow-up|210|||
130205274|NCT00501059|468710425|FG001|Overall Study|Lost to Follow-up|198|||
130205275|NCT00501059|468710424|FG000|Overall Study|Not treated|25|||
130205276|NCT00501059|468710425|FG001|Overall Study|Not treated|17|||
130205277|NCT00955968|468710429|FG000|Overall Study|Death|2|||
130205278|NCT00955968|468710430|FG001|Overall Study|Death|4|||
130205279|NCT00955968|468710429|FG000|Overall Study|Withdrawal by Subject|35|||
130205280|NCT00955968|468710430|FG001|Overall Study|Withdrawal by Subject|31|||
130205281|NCT00955968|468710429|FG000|Overall Study|Lost to Follow-up|45|||
130205282|NCT00955968|468710430|FG001|Overall Study|Lost to Follow-up|39|||
130205283|NCT00955968|468710429|FG000|Overall Study|Site closed|55|||
130205284|NCT00955968|468710430|FG001|Overall Study|Site closed|52|||
130205285|NCT04326439|468710435|FG000|Overall Study|Withdrawal by Subject|1|||
130205286|NCT04326439|468710436|FG001|Overall Study|Withdrawal by Subject|0|||
130205287|NCT04326439|468710435|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
130205288|NCT04326439|468710436|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
130205289|NCT04326439|468710435|FG000|Overall Study|Relapse after Induction 2|0|||
130205290|NCT04326439|468710436|FG001|Overall Study|Relapse after Induction 2|1|||
130205291|NCT04326439|468710435|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
130205292|NCT04326439|468710436|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
130205293|NCT00204477|468710439|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
130205294|NCT00204477|468710440|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
130205295|NCT00204477|468710439|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
130205296|NCT00204477|468710440|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
130205297|NCT04272606|468710443|FG000|Overall Study|Protocol Violation|1|||
130205298|NCT04272606|468710444|FG001|Overall Study|Protocol Violation|1|||
130205299|NCT04272606|468710443|FG000|Overall Study|Physician Decision|0|||
130205300|NCT04272606|468710444|FG001|Overall Study|Physician Decision|1|||
130205301|NCT00710684|468710445|FG000|Overall Study|Adverse Event|11|||
130205302|NCT00710684|468710446|FG001|Overall Study|Adverse Event|19|||
130205303|NCT00710684|468710447|FG002|Overall Study|Adverse Event|16|||
130205304|NCT00710684|468710445|FG000|Overall Study|Lack of Efficacy|4|||
130205305|NCT00710684|468710446|FG001|Overall Study|Lack of Efficacy|3|||
130205306|NCT00710684|468710447|FG002|Overall Study|Lack of Efficacy|5|||
130205307|NCT00710684|468710445|FG000|Overall Study|Protocol Violation|5|||
130205308|NCT00710684|468710446|FG001|Overall Study|Protocol Violation|5|||
130205309|NCT00710684|468710447|FG002|Overall Study|Protocol Violation|5|||
130205310|NCT00710684|468710445|FG000|Overall Study|Lost to Follow-up|4|||
130205311|NCT00710684|468710446|FG001|Overall Study|Lost to Follow-up|6|||
130205312|NCT00710684|468710447|FG002|Overall Study|Lost to Follow-up|7|||
130205313|NCT00710684|468710445|FG000|Overall Study|Physician Decision|0|||
130205314|NCT00710684|468710446|FG001|Overall Study|Physician Decision|2|||
130205315|NCT00710684|468710447|FG002|Overall Study|Physician Decision|4|||
130205316|NCT00710684|468710445|FG000|Overall Study|Withdrawal by Subject|24|||
130205317|NCT00710684|468710446|FG001|Overall Study|Withdrawal by Subject|18|||
130205318|NCT00710684|468710447|FG002|Overall Study|Withdrawal by Subject|11|||
130205319|NCT00710684|468710445|FG000|Overall Study|Missing|1|||
130205320|NCT00710684|468710446|FG001|Overall Study|Missing|0|||
130205321|NCT00710684|468710447|FG002|Overall Study|Missing|0|||
130205322|NCT00710684|468710445|FG000|Overall Study|Did not continue after week 24|25|||
130205323|NCT00710684|468710446|FG001|Overall Study|Did not continue after week 24|21|||
130205324|NCT00710684|468710447|FG002|Overall Study|Did not continue after week 24|16|||
130205325|NCT04778059|468710448|FG000|Overall Study|Death|2|||
130205326|NCT04778059|468710449|FG001|Overall Study|Death|2|||
130205327|NCT04778059|468710450|FG002|Overall Study|Death|1|||
130205328|NCT04778059|468710451|FG003|Overall Study|Death|1|||
130205329|NCT04778059|468710452|FG004|Overall Study|Death|1|||
130205330|NCT04778059|468710448|FG000|Overall Study|Lost to Follow-up|0|||
130205331|NCT04778059|468710449|FG001|Overall Study|Lost to Follow-up|0|||
130205332|NCT04778059|468710450|FG002|Overall Study|Lost to Follow-up|0|||
130205333|NCT04778059|468710451|FG003|Overall Study|Lost to Follow-up|0|||
130205334|NCT04778059|468710452|FG004|Overall Study|Lost to Follow-up|1|||
130205335|NCT04778059|468710448|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205336|NCT04778059|468710449|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205337|NCT04778059|468710450|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205338|NCT04778059|468710451|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
130205339|NCT04778059|468710452|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
130205340|NCT00157248|468710457|FG000|Overall Study|Adverse Event|36|||
130205341|NCT00157248|468710458|FG001|Overall Study|Adverse Event|25|||
130205342|NCT00157248|468710459|FG002|Overall Study|Adverse Event|13|||
130205343|NCT00157248|468710460|FG003|Overall Study|Adverse Event|33|||
130205344|NCT00157248|468710457|FG000|Overall Study|Protocol Violation|4|||
130205345|NCT00157248|468710458|FG001|Overall Study|Protocol Violation|0|||
130205346|NCT00157248|468710459|FG002|Overall Study|Protocol Violation|2|||
130205347|NCT00157248|468710460|FG003|Overall Study|Protocol Violation|2|||
130205348|NCT00157248|468710457|FG000|Overall Study|Lost to Follow-up|0|||
130205349|NCT00157248|468710458|FG001|Overall Study|Lost to Follow-up|1|||
130205350|NCT00157248|468710459|FG002|Overall Study|Lost to Follow-up|0|||
130205351|NCT00157248|468710460|FG003|Overall Study|Lost to Follow-up|0|||
130205352|NCT00157248|468710457|FG000|Overall Study|Withdrawal by Subject|1|||
130205353|NCT00157248|468710458|FG001|Overall Study|Withdrawal by Subject|4|||
130205354|NCT00157248|468710459|FG002|Overall Study|Withdrawal by Subject|3|||
130205355|NCT00157248|468710460|FG003|Overall Study|Withdrawal by Subject|3|||
130205356|NCT00157248|468710457|FG000|Overall Study|site closures, subject moving|7|||
130205357|NCT00157248|468710458|FG001|Overall Study|site closures, subject moving|7|||
130205358|NCT00157248|468710459|FG002|Overall Study|site closures, subject moving|3|||
130205359|NCT00157248|468710460|FG003|Overall Study|site closures, subject moving|9|||
130205360|NCT01306045|468710463|FG000|Met General Eligibility Criteria|Screen failures|193|||
130205361|NCT01306045|468710464|FG001|Met General Eligibility Criteria|Screen failures|11|||
130205362|NCT01306045|468710465|FG002|Met General Eligibility Criteria|Screen failures|8|||
130205363|NCT00787917|468710467|FG000|Blinded Treatment|Adverse Event|1|||
130205364|NCT00787917|468710468|FG001|Blinded Treatment|Adverse Event|0|||
130205365|NCT00787917|468710467|FG000|Blinded Treatment|Lack of Efficacy|1|||
130205366|NCT00787917|468710468|FG001|Blinded Treatment|Lack of Efficacy|0|||
130205367|NCT00787917|468710467|FG000|Blinded Treatment|Administrative problems|3|||
130205368|NCT00787917|468710468|FG001|Blinded Treatment|Administrative problems|2|||
130205369|NCT00787917|468710467|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
130205370|NCT00787917|468710468|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
130205371|NCT00787917|468710467|FG000|Open Label|Administrative problems|3|||
130205372|NCT00787917|468710468|FG001|Open Label|Administrative problems|0|||
130205373|NCT00778102|468710469|FG000|Overall Study|Adverse Event|8|||
130205374|NCT00778102|468710470|FG001|Overall Study|Adverse Event|5|||
130205375|NCT00778102|468710469|FG000|Overall Study|Death|1|||
130205376|NCT00778102|468710470|FG001|Overall Study|Death|1|||
130205377|NCT00778102|468710469|FG000|Overall Study|Lost to Follow-up|1|||
130205378|NCT00778102|468710470|FG001|Overall Study|Lost to Follow-up|0|||
130205379|NCT00778102|468710469|FG000|Overall Study|Violation of Selection Criteria|1|||
130205380|NCT00778102|468710470|FG001|Overall Study|Violation of Selection Criteria|1|||
130205381|NCT00778102|468710469|FG000|Overall Study|Protocol Violation|0|||
130205382|NCT00778102|468710470|FG001|Overall Study|Protocol Violation|1|||
130205383|NCT00778102|468710469|FG000|Overall Study|Refused Treatment|2|||
130205384|NCT00778102|468710470|FG001|Overall Study|Refused Treatment|3|||
130205385|NCT00778102|468710469|FG000|Overall Study|Withdrawal by Subject|1|||
130205386|NCT00778102|468710470|FG001|Overall Study|Withdrawal by Subject|1|||
130205387|NCT00778102|468710469|FG000|Overall Study|Administrative Reason|7|||
130205388|NCT00778102|468710470|FG001|Overall Study|Administrative Reason|10|||
130205389|NCT01328548|468710471|FG000|Overall Study|Death|3|||
130205390|NCT01328548|468710472|FG001|Overall Study|Death|0|||
130205391|NCT01328548|468710471|FG000|Overall Study|Protocol Violation|1|||
130205392|NCT01328548|468710472|FG001|Overall Study|Protocol Violation|0|||
130205393|NCT04557124|468712751|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
130205394|NCT04557124|468712752|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
130205395|NCT04557124|468712751|FG000|Mid-point (1 Month)|Missed testing|5|||
130205396|NCT04557124|468712752|FG001|Mid-point (1 Month)|Missed testing|4|||
130205397|NCT04557124|468712751|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
130205398|NCT04557124|468712752|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
130205399|NCT04557124|468712751|FG000|Post-testing (2 Months)|Missed testing|1|||
130205400|NCT04557124|468712752|FG001|Post-testing (2 Months)|Missed testing|5|||
130205401|NCT04557124|468712751|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
130205402|NCT04557124|468712752|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
130205403|NCT04557124|468712751|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
130205404|NCT04557124|468712752|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
130205405|NCT05128773|468712753|FG000|Overall Study|Sponsor decision to terminate study|3|||
130205406|NCT04250714|468712754|FG000|Overall Study|Treatment - withdrawal by subject|14|||
130205407|NCT04250714|468712754|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
130205408|NCT04250714|468712754|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
130205409|NCT04250714|468712754|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
130205410|NCT04250714|468712754|FG000|Overall Study|Treatment - Death|1|||
130205411|NCT04250714|468712754|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
130205412|NCT04250714|468712754|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
130205413|NCT04250714|468712754|FG000|Overall Study|Attempt|2|||
130205414|NCT04250714|468712754|FG000|Overall Study|Intent|7|||
130205415|NCT04676412|468712755|FG000|Overall Study|Death|28|||
130205416|NCT04676412|468712756|FG001|Overall Study|Death|31|||
130205417|NCT04676412|468712755|FG000|Overall Study|Lost to Follow-up|1|||
130205418|NCT04676412|468712756|FG001|Overall Study|Lost to Follow-up|2|||
130205419|NCT04676412|468712755|FG000|Overall Study|Sponsor Decision|20|||
130205420|NCT04676412|468712756|FG001|Overall Study|Sponsor Decision|23|||
130205421|NCT04676412|468712755|FG000|Overall Study|Withdrawal by Subject|0|||
130205422|NCT04676412|468712756|FG001|Overall Study|Withdrawal by Subject|2|||
130205423|NCT04697056|468712757|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
130205424|NCT04697056|468712758|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
130205425|NCT04550832|468712759|FG000|Overall Study|Adverse Event|0|||
130205426|NCT04550832|468712760|FG001|Overall Study|Adverse Event|0|||
130205427|NCT04550832|468712761|FG002|Overall Study|Adverse Event|2|||
130205428|NCT04550832|468712762|FG003|Overall Study|Adverse Event|0|||
130205429|NCT04550832|468712763|FG004|Overall Study|Adverse Event|1|||
130205430|NCT04823130|468712764|FG000|Overall Study|Withdrawal by Subject|2|||
130205431|NCT04823130|468712765|FG001|Overall Study|Withdrawal by Subject|3|||
130205432|NCT04823130|468712764|FG000|Overall Study|Failure to meet inclusion criteria|6|||
130205433|NCT04823130|468712765|FG001|Overall Study|Failure to meet inclusion criteria|4|||
130205434|NCT04823130|468712764|FG000|Overall Study|Other-unspecified|1|||
130205435|NCT04823130|468712765|FG001|Overall Study|Other-unspecified|0|||
130205436|NCT03315455|468712767|FG000|Overall Study|Ongoing in the Study|13|||
130205437|NCT03315455|468712768|FG001|Overall Study|Ongoing in the Study|24|||
130205438|NCT03315455|468712769|FG002|Overall Study|Ongoing in the Study|17|||
130205439|NCT03315455|468712770|FG003|Overall Study|Ongoing in the Study|15|||
130205440|NCT03315455|468712767|FG000|Overall Study|Withdrawal by Subject|0|||
130205441|NCT03315455|468712768|FG001|Overall Study|Withdrawal by Subject|1|||
130205442|NCT03315455|468712769|FG002|Overall Study|Withdrawal by Subject|0|||
130205443|NCT03315455|468712770|FG003|Overall Study|Withdrawal by Subject|0|||
130205444|NCT04439357|468712774|FG000|Overall Study|Disease Progression|4|||
130205445|NCT05906836|468712777|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
130205446|NCT05906836|468712777|FG000|Overall Study|Lost to Follow-up|1|||
130205447|NCT03030118|468712778|FG000|Overall Study|Achieved SLE Diagnosis|11|||
130205448|NCT03030118|468712779|FG001|Overall Study|Achieved SLE Diagnosis|10|||
130205449|NCT03030118|468712778|FG000|Overall Study|Adverse Event|1|||
130205450|NCT03030118|468712779|FG001|Overall Study|Adverse Event|1|||
130205451|NCT03030118|468712778|FG000|Overall Study|Pregnancy|2|||
130205452|NCT03030118|468712779|FG001|Overall Study|Pregnancy|2|||
130205453|NCT03030118|468712778|FG000|Overall Study|Lost to Follow-up|5|||
130205454|NCT03030118|468712779|FG001|Overall Study|Lost to Follow-up|6|||
130205455|NCT03030118|468712778|FG000|Overall Study|Concomitant Medications|1|||
130205456|NCT03030118|468712779|FG001|Overall Study|Concomitant Medications|1|||
130205457|NCT03030118|468712778|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
130205458|NCT03030118|468712779|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
130205459|NCT03030118|468712778|FG000|Overall Study|Other|2|||
130205460|NCT03030118|468712779|FG001|Overall Study|Other|0|||
130205461|NCT03030118|468712778|FG000|Overall Study|Withdrawal by Subject|26|||
130205462|NCT03030118|468712779|FG001|Overall Study|Withdrawal by Subject|21|||
130205463|NCT03030118|468712778|FG000|Overall Study|Protocol Violation|1|||
130205464|NCT03030118|468712779|FG001|Overall Study|Protocol Violation|6|||
130205465|NCT04529850|468712780|FG000|Overall Study|Death|2|||
130205466|NCT04529850|468712780|FG000|Overall Study|Physician Decision|1|||
130205467|NCT04529850|468712780|FG000|Overall Study|Withdrawal by Subject|2|||
130205468|NCT01911780|468712781|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
130205469|NCT01911780|468712782|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
130205470|NCT01911780|468712781|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
130205471|NCT01911780|468712782|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
130205472|NCT01911780|468712781|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
130205473|NCT01911780|468712782|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
130205474|NCT01911780|468712781|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
130205475|NCT01911780|468712782|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
130205476|NCT01911780|468712781|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
130205477|NCT01911780|468712782|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
130205478|NCT01911780|468712781|FG000|Extension Period (52 Weeks)|Personal reason|1|||
130205479|NCT01911780|468712782|FG001|Extension Period (52 Weeks)|Personal reason|1|||
130205480|NCT02720744|468712786|FG000|Overall Study|Protocol Violation|0|||
130205481|NCT02720744|468712787|FG001|Overall Study|Protocol Violation|2|||
130205482|NCT02720744|468712786|FG000|Overall Study|Pregnancy|2|||
130205483|NCT02720744|468712787|FG001|Overall Study|Pregnancy|0|||
130205484|NCT02720744|468712786|FG000|Overall Study|Lack of Efficacy|2|||
130205485|NCT02720744|468712787|FG001|Overall Study|Lack of Efficacy|8|||
130205486|NCT02720744|468712786|FG000|Overall Study|Adverse Event|21|||
130205487|NCT02720744|468712787|FG001|Overall Study|Adverse Event|3|||
130205488|NCT02720744|468712786|FG000|Overall Study|Withdrawal by Subject|11|||
130205489|NCT02720744|468712787|FG001|Overall Study|Withdrawal by Subject|11|||
130205490|NCT02720744|468712786|FG000|Overall Study|Lost to follow up|2|||
130205491|NCT02720744|468712787|FG001|Overall Study|Lost to follow up|0|||
130205492|NCT02720744|468712786|FG000|Overall Study|Non Compliance with Investigational Product|0|||
130205493|NCT02720744|468712787|FG001|Overall Study|Non Compliance with Investigational Product|1|||
130205494|NCT02720744|468712786|FG000|Overall Study|Excluded Concomitant Medication|0|||
130205495|NCT02720744|468712787|FG001|Overall Study|Excluded Concomitant Medication|1|||
130205496|NCT01199822|468712789|FG000|Overall Study|Investigator discontinued therapy|0|||
130205497|NCT01199822|468712790|FG001|Overall Study|Investigator discontinued therapy|1|||
130205498|NCT01199822|468712791|FG002|Overall Study|Investigator discontinued therapy|0|||
130205499|NCT00480493|468712792|FG000|Overall Study|moved|2|||
130205500|NCT00480493|468712793|FG001|Overall Study|moved|7|||
130205501|NCT03769675|468712794|FG000|Overall Study|Lost to Follow-up|1|||
130205502|NCT01032070|468712795|FG000|Overall Study|Disease progression|13|||
130205503|NCT01032070|468712796|FG001|Overall Study|Disease progression|8|||
130205504|NCT01032070|468712795|FG000|Overall Study|Medical or ethical reasons|0|||
130205505|NCT01032070|468712796|FG001|Overall Study|Medical or ethical reasons|2|||
130205506|NCT01032070|468712795|FG000|Overall Study|Withdrawal by Subject|0|||
130205507|NCT01032070|468712796|FG001|Overall Study|Withdrawal by Subject|2|||
130205508|NCT04027075|468712797|FG000|Overall Study|Lost to Follow-up|41|||
130205509|NCT04027075|468712798|FG001|Overall Study|Lost to Follow-up|22|||
130205510|NCT00738062|468712799|FG000|Open Label Treatment|Lack of Efficacy|5|||
130205511|NCT00738062|468712800|FG001|Open Label Treatment|Lack of Efficacy|0|||
130205512|NCT00738062|468712801|FG002|Open Label Treatment|Lack of Efficacy|0|||
130205513|NCT00738062|468712799|FG000|Open Label Treatment|Adverse Event|11|||
130205514|NCT00738062|468712800|FG001|Open Label Treatment|Adverse Event|0|||
130205515|NCT00738062|468712801|FG002|Open Label Treatment|Adverse Event|0|||
130205516|NCT00738062|468712799|FG000|Open Label Treatment|Protocol Violation|2|||
130205517|NCT00738062|468712800|FG001|Open Label Treatment|Protocol Violation|0|||
130205518|NCT00738062|468712801|FG002|Open Label Treatment|Protocol Violation|0|||
130205519|NCT00738062|468712799|FG000|Open Label Treatment|Withdrawal by Subject|9|||
130205520|NCT00738062|468712800|FG001|Open Label Treatment|Withdrawal by Subject|0|||
130205521|NCT00738062|468712801|FG002|Open Label Treatment|Withdrawal by Subject|0|||
130205522|NCT00738062|468712799|FG000|Open Label Treatment|Investigator Decision|1|||
130205523|NCT00738062|468712800|FG001|Open Label Treatment|Investigator Decision|0|||
130205524|NCT00738062|468712801|FG002|Open Label Treatment|Investigator Decision|0|||
130205525|NCT00738062|468712799|FG000|Open-Label Extension|Adverse Event|5|||
130205526|NCT00738062|468712800|FG001|Open-Label Extension|Adverse Event|0|||
130205527|NCT00738062|468712801|FG002|Open-Label Extension|Adverse Event|0|||
130205528|NCT00738062|468712799|FG000|Open-Label Extension|Physician Decision|1|||
130205529|NCT00738062|468712800|FG001|Open-Label Extension|Physician Decision|0|||
130205530|NCT00738062|468712801|FG002|Open-Label Extension|Physician Decision|0|||
130205531|NCT00738062|468712799|FG000|Open-Label Extension|Lack of Efficacy|2|||
130205532|NCT00738062|468712800|FG001|Open-Label Extension|Lack of Efficacy|0|||
130205533|NCT00738062|468712801|FG002|Open-Label Extension|Lack of Efficacy|0|||
130205534|NCT00738062|468712799|FG000|Open-Label Extension|Withdrawal by Subject|6|||
130205535|NCT00738062|468712800|FG001|Open-Label Extension|Withdrawal by Subject|0|||
130205536|NCT00738062|468712801|FG002|Open-Label Extension|Withdrawal by Subject|0|||
130205537|NCT00738062|468712799|FG000|Open-Label Extension|Protocol Violation|1|||
130205538|NCT00738062|468712800|FG001|Open-Label Extension|Protocol Violation|0|||
130205539|NCT00738062|468712801|FG002|Open-Label Extension|Protocol Violation|0|||
130205540|NCT00738062|468712799|FG000|Open-Label Extension|Study Terminated|2|||
130205541|NCT00738062|468712800|FG001|Open-Label Extension|Study Terminated|0|||
130205542|NCT00738062|468712801|FG002|Open-Label Extension|Study Terminated|0|||
130205543|NCT00426660|468712802|FG000|Overall Study|Death|14|||
130205544|NCT00426660|468712802|FG000|Overall Study|Adverse Event|23|||
130205545|NCT00426660|468712802|FG000|Overall Study|Insufficient Clinical Response|22|||
130205546|NCT00426660|468712802|FG000|Overall Study|Lost to Follow-up|15|||
130205547|NCT00426660|468712802|FG000|Overall Study|Other|23|||
130205548|NCT00426660|468712802|FG000|Overall Study|Withdrawal by Subject|18|||
130205549|NCT00426660|468712802|FG000|Overall Study|Protocol Violation|1|||
130205550|NCT00426660|468712802|FG000|Overall Study|Enrolled Not Treated|15|||
130205551|NCT02772276|468712803|FG000|Overall Study|Lost to Follow-up|0|||
130205552|NCT02772276|468712804|FG001|Overall Study|Lost to Follow-up|0|||
130205553|NCT02772276|468712805|FG002|Overall Study|Lost to Follow-up|0|||
130205554|NCT02772276|468712806|FG003|Overall Study|Lost to Follow-up|0|||
130205555|NCT02772276|468712807|FG004|Overall Study|Lost to Follow-up|0|||
130205556|NCT02772276|468712808|FG005|Overall Study|Lost to Follow-up|0|||
130205557|NCT02772276|468712809|FG006|Overall Study|Lost to Follow-up|1|||
130205558|NCT02772276|468712810|FG007|Overall Study|Lost to Follow-up|0|||
130205559|NCT02772276|468712811|FG008|Overall Study|Lost to Follow-up|0|||
130205560|NCT02772276|468712812|FG009|Overall Study|Lost to Follow-up|0|||
130205561|NCT02772276|468712813|FG010|Overall Study|Lost to Follow-up|0|||
130205562|NCT02772276|468712814|FG011|Overall Study|Lost to Follow-up|0|||
130205563|NCT02772276|468712815|FG012|Overall Study|Lost to Follow-up|0|||
130205564|NCT02772276|468712803|FG000|Overall Study|Withdrew consent|0|||
130205565|NCT02772276|468712804|FG001|Overall Study|Withdrew consent|0|||
130205566|NCT02772276|468712805|FG002|Overall Study|Withdrew consent|0|||
130205567|NCT02772276|468712806|FG003|Overall Study|Withdrew consent|0|||
130205568|NCT02772276|468712807|FG004|Overall Study|Withdrew consent|0|||
130205569|NCT02772276|468712808|FG005|Overall Study|Withdrew consent|0|||
130205570|NCT02772276|468712809|FG006|Overall Study|Withdrew consent|0|||
130205571|NCT02772276|468712810|FG007|Overall Study|Withdrew consent|1|||
130205572|NCT02772276|468712811|FG008|Overall Study|Withdrew consent|0|||
130205573|NCT02772276|468712812|FG009|Overall Study|Withdrew consent|0|||
130205574|NCT02772276|468712813|FG010|Overall Study|Withdrew consent|0|||
130205575|NCT02772276|468712814|FG011|Overall Study|Withdrew consent|0|||
130205576|NCT02772276|468712815|FG012|Overall Study|Withdrew consent|0|||
130205577|NCT00980174|468712816|FG000|Overall Study|Withdrawal by Subject|1|||
130205578|NCT00980174|468712817|FG001|Overall Study|Withdrawal by Subject|4|||
130205579|NCT00980174|468712816|FG000|Overall Study|Adverse Event|0|||
130205580|NCT00980174|468712817|FG001|Overall Study|Adverse Event|3|||
130205581|NCT00980174|468712816|FG000|Overall Study|Ineligibility determined|2|||
130205582|NCT00980174|468712817|FG001|Overall Study|Ineligibility determined|1|||
130205583|NCT00980174|468712816|FG000|Overall Study|Death|1|||
130205584|NCT00980174|468712817|FG001|Overall Study|Death|1|||
130205585|NCT00980174|468712816|FG000|Overall Study|Other|0|||
130205586|NCT00980174|468712817|FG001|Overall Study|Other|1|||
130205587|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
130205588|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
130205589|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
130205590|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
130205591|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
130205592|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
130205593|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
130205594|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
130205595|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
130205596|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
130205597|NCT00455520|468712818|FG000|Open Label Tapentadol Extended Release|All other|33|||
130205598|NCT00455520|468712819|FG001|Open Label Tapentadol Extended Release|All other|0|||
130205599|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
130205600|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
130205601|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
130205602|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
130205603|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
130205604|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
130205605|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
130205606|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
130205607|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
130205608|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
130205609|NCT00455520|468712818|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
130205610|NCT00455520|468712819|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
130205611|NCT00783224|468712824|FG000|Overall Study|Adverse Event|0|||
130205612|NCT00783224|468712825|FG001|Overall Study|Adverse Event|0|||
130205613|NCT00783224|468712826|FG002|Overall Study|Adverse Event|1|||
130205614|NCT00783224|468712827|FG003|Overall Study|Adverse Event|0|||
130205615|NCT00783224|468712824|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
130205616|NCT00783224|468712825|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
130205617|NCT00783224|468712826|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
130205618|NCT00783224|468712827|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
130205619|NCT00783224|468712824|FG000|Overall Study|Inappropriate as a study subject|0|||
130205620|NCT00783224|468712825|FG001|Overall Study|Inappropriate as a study subject|0|||
130205621|NCT00783224|468712826|FG002|Overall Study|Inappropriate as a study subject|0|||
130205622|NCT00783224|468712827|FG003|Overall Study|Inappropriate as a study subject|1|||
130205623|NCT04631107|468712830|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
130205624|NCT04631107|468712830|FG000|Second Intervention (1 Night)|Adverse Event|1|||
130205625|NCT04631107|468712830|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
130205626|NCT04631107|468712830|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
130205627|NCT05385224|468712834|FG000|Overall Study|Unable to swallow capsule|2|||
130205628|NCT05385224|468712834|FG000|Overall Study|Withdrawal by Subject|2|||
130205629|NCT05385224|468712834|FG000|Overall Study|Did not meet study criteria|1|||
130205630|NCT00551161|468712835|FG000|Overall Study|Withdrawal by Subject|1|||
130205631|NCT01935700|468712836|FG000|Overall Study|Withdrawal by Subject|1|||
130205632|NCT01935700|468712837|FG001|Overall Study|Withdrawal by Subject|0|||
130205633|NCT01935700|468712836|FG000|Overall Study|Physician Decision|4|||
130205634|NCT01935700|468712837|FG001|Overall Study|Physician Decision|0|||
130205635|NCT00096993|468712838|FG000|Overall Study|Death|1|||
130205636|NCT00096993|468712839|FG001|Overall Study|Death|0|||
130205637|NCT00096993|468712838|FG000|Overall Study|Disease progression|56|||
130205638|NCT00096993|468712839|FG001|Overall Study|Disease progression|53|||
130205639|NCT00096993|468712838|FG000|Overall Study|Adverse Event|2|||
130205640|NCT00096993|468712839|FG001|Overall Study|Adverse Event|8|||
130205641|NCT00096993|468712838|FG000|Overall Study|Subject's decision|3|||
130205642|NCT00096993|468712839|FG001|Overall Study|Subject's decision|1|||
130205643|NCT00096993|468712838|FG000|Overall Study|Physician Decision|2|||
130205644|NCT00096993|468712839|FG001|Overall Study|Physician Decision|1|||
130205645|NCT00096993|468712838|FG000|Overall Study|Non-compliance|0|||
130205646|NCT00096993|468712839|FG001|Overall Study|Non-compliance|1|||
130205647|NCT00096993|468712838|FG000|Overall Study|Other unspecified|1|||
130205648|NCT00096993|468712839|FG001|Overall Study|Other unspecified|1|||
130205649|NCT01935128|468712840|FG000|Overall Study|Death|1|||
130205650|NCT01935128|468712840|FG000|Overall Study|Adverse Event|6|||
130205651|NCT00772005|468712841|FG000|Overall Study|Adverse Event|9|||
130205652|NCT00772005|468712842|FG001|Overall Study|Adverse Event|14|||
130205653|NCT00772005|468712843|FG002|Overall Study|Adverse Event|10|||
130205654|NCT00772005|468712844|FG003|Overall Study|Adverse Event|13|||
130205655|NCT00772005|468712841|FG000|Overall Study|Lack of Efficacy|0|||
130205656|NCT00772005|468712842|FG001|Overall Study|Lack of Efficacy|1|||
130205657|NCT00772005|468712843|FG002|Overall Study|Lack of Efficacy|0|||
130205658|NCT00772005|468712844|FG003|Overall Study|Lack of Efficacy|0|||
130205659|NCT00772005|468712841|FG000|Overall Study|Withdrawal by Subject|3|||
130205660|NCT00772005|468712842|FG001|Overall Study|Withdrawal by Subject|7|||
130205661|NCT00772005|468712843|FG002|Overall Study|Withdrawal by Subject|10|||
130205662|NCT00772005|468712844|FG003|Overall Study|Withdrawal by Subject|2|||
130205663|NCT00772005|468712841|FG000|Overall Study|Protocol Violation|2|||
130205664|NCT00772005|468712842|FG001|Overall Study|Protocol Violation|4|||
130205665|NCT00772005|468712843|FG002|Overall Study|Protocol Violation|1|||
130205666|NCT00772005|468712844|FG003|Overall Study|Protocol Violation|6|||
130205667|NCT00772005|468712841|FG000|Overall Study|Lost to Follow-up|7|||
130205668|NCT00772005|468712842|FG001|Overall Study|Lost to Follow-up|3|||
130205669|NCT00772005|468712843|FG002|Overall Study|Lost to Follow-up|6|||
130205670|NCT00772005|468712844|FG003|Overall Study|Lost to Follow-up|3|||
130205671|NCT00772005|468712841|FG000|Overall Study|Non-compliance with study procedures|1|||
130205672|NCT00772005|468712842|FG001|Overall Study|Non-compliance with study procedures|1|||
130205673|NCT00772005|468712843|FG002|Overall Study|Non-compliance with study procedures|0|||
130205674|NCT00772005|468712844|FG003|Overall Study|Non-compliance with study procedures|1|||
130205675|NCT00772005|468712841|FG000|Overall Study|Non-compliance with drug administration|3|||
130205676|NCT00772005|468712842|FG001|Overall Study|Non-compliance with drug administration|0|||
130205677|NCT00772005|468712843|FG002|Overall Study|Non-compliance with drug administration|1|||
130205678|NCT00772005|468712844|FG003|Overall Study|Non-compliance with drug administration|1|||
130205679|NCT01440569|468712848|FG000|Main Study|Enrolled but not treated|1|||
130205680|NCT01440569|468712849|FG001|Main Study|Enrolled but not treated|0|||
130205681|NCT01440569|468712848|FG000|Main Study|Adverse Event|9|||
130205682|NCT01440569|468712849|FG001|Main Study|Adverse Event|0|||
130205683|NCT01440569|468712848|FG000|Main Study|Pregnancy|1|||
130205684|NCT01440569|468712849|FG001|Main Study|Pregnancy|0|||
130205685|NCT01440569|468712848|FG000|Main Study|Investigator's Discretion|1|||
130205686|NCT01440569|468712849|FG001|Main Study|Investigator's Discretion|1|||
130205687|NCT01440569|468712848|FG000|Main Study|Withdrew Consent|7|||
130205688|NCT01440569|468712849|FG001|Main Study|Withdrew Consent|1|||
130205689|NCT01440569|468712848|FG000|Main Study|Lost to Follow-up|13|||
130205690|NCT01440569|468712849|FG001|Main Study|Lost to Follow-up|2|||
130205691|NCT01440569|468712848|FG000|Main Study|Subject Non-Compliance|3|||
130205692|NCT01440569|468712849|FG001|Main Study|Subject Non-Compliance|0|||
130205693|NCT01440569|468712848|FG000|Main Study|Protocol Violation|1|||
130205694|NCT01440569|468712849|FG001|Main Study|Protocol Violation|0|||
130205695|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Adverse Event|3|||
130205696|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Adverse Event|0|||
130205697|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Pregnancy|1|||
130205698|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Pregnancy|0|||
130205699|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
130205700|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
130205701|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
130205702|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
130205703|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
130205704|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
130205705|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
130205706|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
130205707|NCT01440569|468712848|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
130205708|NCT01440569|468712849|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
130205709|NCT02431806|468712852|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
130205710|NCT02431806|468712853|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
130205711|NCT02431806|468712854|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
130205712|NCT02431806|468712855|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
130205713|NCT02431806|468712852|FG000|Double-blind Treatment Period|Adverse Event|4|||
130205714|NCT02431806|468712853|FG001|Double-blind Treatment Period|Adverse Event|7|||
130205715|NCT02431806|468712854|FG002|Double-blind Treatment Period|Adverse Event|11|||
130205716|NCT02431806|468712855|FG003|Double-blind Treatment Period|Adverse Event|7|||
130205717|NCT02431806|468712852|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
130205718|NCT02431806|468712853|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130205719|NCT02431806|468712854|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
130205720|NCT02431806|468712855|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
130205721|NCT02431806|468712852|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
130205722|NCT02431806|468712853|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
130205723|NCT02431806|468712854|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
130205724|NCT02431806|468712855|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
130205725|NCT02431806|468712852|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
130205726|NCT02431806|468712853|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
130205727|NCT02431806|468712854|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
130205728|NCT02431806|468712855|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
130205729|NCT02431806|468712852|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
130205730|NCT02431806|468712853|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
130205731|NCT02431806|468712854|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
130205732|NCT02431806|468712855|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
130205733|NCT02431806|468712852|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
130205734|NCT02431806|468712853|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
130205735|NCT02431806|468712854|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
130205736|NCT02431806|468712855|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
130205737|NCT03627416|468712856|FG000|Overall Study|Adverse Event|0|||
130205738|NCT03627416|468712857|FG001|Overall Study|Adverse Event|1|||
130205739|NCT01294371|468712858|FG000|Overall Study|Adverse Event|1|||
130205740|NCT01294371|468712858|FG000|Overall Study|Withdrawal by Subject|12|||
130205741|NCT01294371|468712858|FG000|Overall Study|Lost to Follow-up|6|||
130205742|NCT01294371|468712858|FG000|Overall Study|Administrative Reason|1|||
130205743|NCT01294371|468712858|FG000|Overall Study|Other|14|||
130205744|NCT05619536|468712859|FG000|Overall Study|Withdrawal by Subject|0|||
130205745|NCT05619536|468712860|FG001|Overall Study|Withdrawal by Subject|1|||
130205746|NCT05619536|468712861|FG002|Overall Study|Withdrawal by Subject|0|||
130205747|NCT05619536|468712862|FG003|Overall Study|Withdrawal by Subject|1|||
130205748|NCT05619536|468712859|FG000|Overall Study|Lost to Follow-up|0|||
130205749|NCT05619536|468712860|FG001|Overall Study|Lost to Follow-up|1|||
130205750|NCT05619536|468712861|FG002|Overall Study|Lost to Follow-up|1|||
130205751|NCT05619536|468712862|FG003|Overall Study|Lost to Follow-up|0|||
130205752|NCT03619902|468712863|FG000|Overall Study|Termination of Study by Investigator|1|||
130205753|NCT03619902|468712863|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
130205754|NCT02923245|468712864|FG000|Overall Study|ultrasound order was cancelled|2|||
130205755|NCT02923245|468712865|FG001|Overall Study|ultrasound order was cancelled|1|||
130205756|NCT02520427|468712866|FG000|Overall Study|Decision by sponsor|0|||
130205757|NCT02520427|468712867|FG001|Overall Study|Decision by sponsor|0|||
130205758|NCT02520427|468712868|FG002|Overall Study|Decision by sponsor|0|||
130205759|NCT02520427|468712869|FG003|Overall Study|Decision by sponsor|0|||
130205760|NCT02520427|468712870|FG004|Overall Study|Decision by sponsor|0|||
130205761|NCT02520427|468712871|FG005|Overall Study|Decision by sponsor|0|||
130205762|NCT02520427|468712872|FG006|Overall Study|Decision by sponsor|0|||
130205763|NCT02520427|468712873|FG007|Overall Study|Decision by sponsor|0|||
130205764|NCT02520427|468712874|FG008|Overall Study|Decision by sponsor|1|||
130205765|NCT02520427|468712875|FG009|Overall Study|Decision by sponsor|1|||
130205766|NCT02520427|468712876|FG010|Overall Study|Decision by sponsor|0|||
130205767|NCT02520427|468712877|FG011|Overall Study|Decision by sponsor|0|||
130205768|NCT02520427|468712878|FG012|Overall Study|Decision by sponsor|0|||
130205769|NCT02520427|468712879|FG013|Overall Study|Decision by sponsor|0|||
130205770|NCT02520427|468712880|FG014|Overall Study|Decision by sponsor|0|||
130205771|NCT02520427|468712881|FG015|Overall Study|Decision by sponsor|0|||
130205772|NCT02520427|468712882|FG016|Overall Study|Decision by sponsor|0|||
130205773|NCT02520427|468712883|FG017|Overall Study|Decision by sponsor|0|||
130205774|NCT02520427|468712884|FG018|Overall Study|Decision by sponsor|0|||
130205775|NCT02520427|468712885|FG019|Overall Study|Decision by sponsor|0|||
130205776|NCT02520427|468712886|FG020|Overall Study|Decision by sponsor|0|||
130205777|NCT02520427|468712887|FG021|Overall Study|Decision by sponsor|0|||
130205778|NCT02520427|468712888|FG022|Overall Study|Decision by sponsor|0|||
130205779|NCT02520427|468712889|FG023|Overall Study|Decision by sponsor|0|||
130205780|NCT02520427|468712890|FG024|Overall Study|Decision by sponsor|0|||
130205781|NCT02520427|468712891|FG025|Overall Study|Decision by sponsor|0|||
130205782|NCT02520427|468712866|FG000|Overall Study|Withdrawal by Subject|0|||
130205783|NCT02520427|468712867|FG001|Overall Study|Withdrawal by Subject|0|||
130205784|NCT02520427|468712868|FG002|Overall Study|Withdrawal by Subject|1|||
130205785|NCT02520427|468712869|FG003|Overall Study|Withdrawal by Subject|0|||
130205786|NCT02520427|468712870|FG004|Overall Study|Withdrawal by Subject|0|||
130205787|NCT02520427|468712871|FG005|Overall Study|Withdrawal by Subject|0|||
130205788|NCT02520427|468712872|FG006|Overall Study|Withdrawal by Subject|0|||
130205789|NCT02520427|468712873|FG007|Overall Study|Withdrawal by Subject|0|||
130205790|NCT02520427|468712874|FG008|Overall Study|Withdrawal by Subject|0|||
130205791|NCT02520427|468712875|FG009|Overall Study|Withdrawal by Subject|0|||
130205792|NCT02520427|468712876|FG010|Overall Study|Withdrawal by Subject|0|||
130205793|NCT02520427|468712877|FG011|Overall Study|Withdrawal by Subject|0|||
130205794|NCT02520427|468712878|FG012|Overall Study|Withdrawal by Subject|1|||
130205795|NCT02520427|468712879|FG013|Overall Study|Withdrawal by Subject|1|||
130205796|NCT02520427|468712880|FG014|Overall Study|Withdrawal by Subject|1|||
130205797|NCT02520427|468712881|FG015|Overall Study|Withdrawal by Subject|0|||
130205798|NCT02520427|468712882|FG016|Overall Study|Withdrawal by Subject|1|||
130205799|NCT02520427|468712883|FG017|Overall Study|Withdrawal by Subject|0|||
130205800|NCT02520427|468712884|FG018|Overall Study|Withdrawal by Subject|0|||
130205801|NCT02520427|468712885|FG019|Overall Study|Withdrawal by Subject|3|||
130205802|NCT02520427|468712886|FG020|Overall Study|Withdrawal by Subject|2|||
130205803|NCT02520427|468712887|FG021|Overall Study|Withdrawal by Subject|0|||
130205804|NCT02520427|468712888|FG022|Overall Study|Withdrawal by Subject|0|||
130205805|NCT02520427|468712889|FG023|Overall Study|Withdrawal by Subject|0|||
130205806|NCT02520427|468712890|FG024|Overall Study|Withdrawal by Subject|0|||
130205807|NCT02520427|468712891|FG025|Overall Study|Withdrawal by Subject|0|||
130205808|NCT02520427|468712866|FG000|Overall Study|Death|1|||
130205809|NCT02520427|468712867|FG001|Overall Study|Death|0|||
130205810|NCT02520427|468712868|FG002|Overall Study|Death|0|||
130205811|NCT02520427|468712869|FG003|Overall Study|Death|0|||
130205812|NCT02520427|468712870|FG004|Overall Study|Death|0|||
130205813|NCT02520427|468712871|FG005|Overall Study|Death|0|||
130205814|NCT02520427|468712872|FG006|Overall Study|Death|0|||
130205815|NCT02520427|468712873|FG007|Overall Study|Death|0|||
130205816|NCT02520427|468712874|FG008|Overall Study|Death|0|||
130205817|NCT02520427|468712875|FG009|Overall Study|Death|0|||
130205818|NCT02520427|468712876|FG010|Overall Study|Death|0|||
130205819|NCT02520427|468712877|FG011|Overall Study|Death|0|||
130205820|NCT02520427|468712878|FG012|Overall Study|Death|0|||
130205821|NCT02520427|468712879|FG013|Overall Study|Death|0|||
130205822|NCT02520427|468712880|FG014|Overall Study|Death|0|||
130205823|NCT02520427|468712881|FG015|Overall Study|Death|0|||
130205824|NCT02520427|468712882|FG016|Overall Study|Death|2|||
130205825|NCT02520427|468712883|FG017|Overall Study|Death|1|||
130205826|NCT02520427|468712884|FG018|Overall Study|Death|3|||
130205827|NCT02520427|468712885|FG019|Overall Study|Death|2|||
130205828|NCT02520427|468712886|FG020|Overall Study|Death|0|||
130205829|NCT02520427|468712887|FG021|Overall Study|Death|0|||
130205830|NCT02520427|468712888|FG022|Overall Study|Death|1|||
130205831|NCT02520427|468712889|FG023|Overall Study|Death|0|||
130205832|NCT02520427|468712890|FG024|Overall Study|Death|1|||
130205833|NCT02520427|468712891|FG025|Overall Study|Death|0|||
130205834|NCT02987972|468712894|FG000|Overall Study|Adverse Event|1|||
130205835|NCT02987972|468712895|FG001|Overall Study|Adverse Event|1|||
130205836|NCT02987972|468712896|FG002|Overall Study|Adverse Event|0|||
130205837|NCT02987972|468712894|FG000|Overall Study|Death|1|||
130205838|NCT02987972|468712895|FG001|Overall Study|Death|0|||
130205839|NCT02987972|468712896|FG002|Overall Study|Death|0|||
130205840|NCT02987972|468712894|FG000|Overall Study|Lack of Efficacy|9|||
130205841|NCT02987972|468712895|FG001|Overall Study|Lack of Efficacy|12|||
130205842|NCT02987972|468712896|FG002|Overall Study|Lack of Efficacy|12|||
130205843|NCT02987972|468712894|FG000|Overall Study|Lost to Follow-up|7|||
130205844|NCT02987972|468712895|FG001|Overall Study|Lost to Follow-up|8|||
130205845|NCT02987972|468712896|FG002|Overall Study|Lost to Follow-up|4|||
130205846|NCT02987972|468712894|FG000|Overall Study|Physician Decision|1|||
130205847|NCT02987972|468712895|FG001|Overall Study|Physician Decision|6|||
130205848|NCT02987972|468712896|FG002|Overall Study|Physician Decision|0|||
130205849|NCT02987972|468712894|FG000|Overall Study|Protocol Violation|2|||
130205850|NCT02987972|468712895|FG001|Overall Study|Protocol Violation|1|||
130205851|NCT02987972|468712896|FG002|Overall Study|Protocol Violation|5|||
130205852|NCT02987972|468712894|FG000|Overall Study|Withdrawal by Subject|22|||
130205853|NCT02987972|468712895|FG001|Overall Study|Withdrawal by Subject|17|||
130205854|NCT02987972|468712896|FG002|Overall Study|Withdrawal by Subject|21|||
130205855|NCT00073983|468712899|FG000|Overall Study|not evaluable|1|||
130205856|NCT03800836|468712900|FG000|Overall Study|Other|2|||
130205857|NCT03800836|468712901|FG001|Overall Study|Other|1|||
130205858|NCT03800836|468712902|FG002|Overall Study|Other|0|||
130205859|NCT03800836|468712903|FG003|Overall Study|Other|2|||
130205860|NCT03800836|468712904|FG004|Overall Study|Other|0|||
130205861|NCT03800836|468712905|FG005|Overall Study|Other|1|||
130205862|NCT03800836|468712900|FG000|Overall Study|Lost to Follow-up|2|||
130205863|NCT03800836|468712901|FG001|Overall Study|Lost to Follow-up|0|||
130205864|NCT03800836|468712902|FG002|Overall Study|Lost to Follow-up|1|||
130205865|NCT03800836|468712903|FG003|Overall Study|Lost to Follow-up|1|||
130205866|NCT03800836|468712904|FG004|Overall Study|Lost to Follow-up|3|||
130205867|NCT03800836|468712905|FG005|Overall Study|Lost to Follow-up|0|||
130205868|NCT03800836|468712900|FG000|Overall Study|Withdrawal by Subject|1|||
130205869|NCT03800836|468712901|FG001|Overall Study|Withdrawal by Subject|0|||
130205870|NCT03800836|468712902|FG002|Overall Study|Withdrawal by Subject|0|||
130205871|NCT03800836|468712903|FG003|Overall Study|Withdrawal by Subject|0|||
130205872|NCT03800836|468712904|FG004|Overall Study|Withdrawal by Subject|0|||
130205873|NCT03800836|468712905|FG005|Overall Study|Withdrawal by Subject|0|||
130205874|NCT03800836|468712900|FG000|Overall Study|Physician Decision|31|||
130205875|NCT03800836|468712901|FG001|Overall Study|Physician Decision|3|||
130205876|NCT03800836|468712902|FG002|Overall Study|Physician Decision|6|||
130205877|NCT03800836|468712903|FG003|Overall Study|Physician Decision|4|||
130205878|NCT03800836|468712904|FG004|Overall Study|Physician Decision|4|||
130205879|NCT03800836|468712905|FG005|Overall Study|Physician Decision|5|||
130205880|NCT03800836|468712900|FG000|Overall Study|Death|34|||
130205881|NCT03800836|468712901|FG001|Overall Study|Death|16|||
130205882|NCT03800836|468712902|FG002|Overall Study|Death|5|||
130205883|NCT03800836|468712903|FG003|Overall Study|Death|5|||
130205884|NCT03800836|468712904|FG004|Overall Study|Death|10|||
130205885|NCT03800836|468712905|FG005|Overall Study|Death|0|||
130205886|NCT03800836|468712900|FG000|Overall Study|Symptomatic Deterioration|1|||
130205887|NCT03800836|468712901|FG001|Overall Study|Symptomatic Deterioration|0|||
130205888|NCT03800836|468712902|FG002|Overall Study|Symptomatic Deterioration|1|||
130205889|NCT03800836|468712903|FG003|Overall Study|Symptomatic Deterioration|0|||
130205890|NCT03800836|468712904|FG004|Overall Study|Symptomatic Deterioration|0|||
130205891|NCT03800836|468712905|FG005|Overall Study|Symptomatic Deterioration|0|||
130205892|NCT05072106|468714239|FG000|Overall Study|Progressive disease|3|||
130205893|NCT05072106|468714240|FG001|Overall Study|Progressive disease|3|||
130205894|NCT05072106|468714239|FG000|Overall Study|Compassionate use|3|||
130205895|NCT05072106|468714240|FG001|Overall Study|Compassionate use|1|||
130205896|NCT05072106|468714239|FG000|Overall Study|Withdrawal by Subject|1|||
130205897|NCT05072106|468714240|FG001|Overall Study|Withdrawal by Subject|0|||
130205898|NCT03839459|468714241|FG000|Overall Study|Withdrawal by Subject|2|||
130205899|NCT03839459|468714241|FG000|Overall Study|progression of disease|3|||
130205900|NCT02542293|468714246|FG000|Overall Study|Death|367|||
130205901|NCT02542293|468714247|FG001|Overall Study|Death|377|||
130205902|NCT02542293|468714246|FG000|Overall Study|Withdrawal by Subject|8|||
130205903|NCT02542293|468714247|FG001|Overall Study|Withdrawal by Subject|19|||
130205904|NCT01458951|468714250|FG000|Overall Study|Other|1|||
130205905|NCT01458951|468714251|FG001|Overall Study|Other|0|||
130205906|NCT01458951|468714252|FG002|Overall Study|Other|0|||
130205907|NCT01458951|468714250|FG000|Overall Study|Protocol Violation|5|||
130205908|NCT01458951|468714251|FG001|Overall Study|Protocol Violation|1|||
130205909|NCT01458951|468714252|FG002|Overall Study|Protocol Violation|0|||
130205910|NCT01458951|468714250|FG000|Overall Study|Withdrawal by Subject|2|||
130205911|NCT01458951|468714251|FG001|Overall Study|Withdrawal by Subject|0|||
130205912|NCT01458951|468714252|FG002|Overall Study|Withdrawal by Subject|2|||
130205913|NCT01458951|468714250|FG000|Overall Study|Adverse Event|7|||
130205914|NCT01458951|468714251|FG001|Overall Study|Adverse Event|0|||
130205915|NCT01458951|468714252|FG002|Overall Study|Adverse Event|2|||
130205916|NCT01458951|468714250|FG000|Overall Study|Insufficient Clinical Response|17|||
130205917|NCT01458951|468714251|FG001|Overall Study|Insufficient Clinical Response|0|||
130205918|NCT01458951|468714252|FG002|Overall Study|Insufficient Clinical Response|11|||
130205919|NCT02963558|468714255|FG000|Overall Study|Withdrawn by investigator|1|||
130205920|NCT02963558|468714256|FG001|Overall Study|Withdrawn by investigator|0|||
130205921|NCT02963558|468714255|FG000|Overall Study|Withdrawal by Subject|0|||
130205922|NCT02963558|468714256|FG001|Overall Study|Withdrawal by Subject|1|||
130205923|NCT01573767|468714257|FG000|Overall Study|Adverse Event|0|||
130205924|NCT01573767|468714258|FG001|Overall Study|Adverse Event|1|||
130205925|NCT01573767|468714259|FG002|Overall Study|Adverse Event|0|||
130205926|NCT01573767|468714260|FG003|Overall Study|Adverse Event|1|||
130205927|NCT01573767|468714257|FG000|Overall Study|Lack of Efficacy|18|||
130205928|NCT01573767|468714258|FG001|Overall Study|Lack of Efficacy|15|||
130205929|NCT01573767|468714259|FG002|Overall Study|Lack of Efficacy|12|||
130205930|NCT01573767|468714260|FG003|Overall Study|Lack of Efficacy|17|||
130205931|NCT01573767|468714257|FG000|Overall Study|Protocol Violation|3|||
130205932|NCT01573767|468714258|FG001|Overall Study|Protocol Violation|1|||
130205933|NCT01573767|468714259|FG002|Overall Study|Protocol Violation|1|||
130205934|NCT01573767|468714260|FG003|Overall Study|Protocol Violation|3|||
130205935|NCT01573767|468714257|FG000|Overall Study|Lost to Follow-up|0|||
130205936|NCT01573767|468714258|FG001|Overall Study|Lost to Follow-up|1|||
130205937|NCT01573767|468714259|FG002|Overall Study|Lost to Follow-up|1|||
130205938|NCT01573767|468714260|FG003|Overall Study|Lost to Follow-up|1|||
130205939|NCT01573767|468714257|FG000|Overall Study|Physician Decision|1|||
130205940|NCT01573767|468714258|FG001|Overall Study|Physician Decision|2|||
130205941|NCT01573767|468714259|FG002|Overall Study|Physician Decision|0|||
130205942|NCT01573767|468714260|FG003|Overall Study|Physician Decision|2|||
130205943|NCT01573767|468714257|FG000|Overall Study|Withdrawal by Subject|0|||
130205944|NCT01573767|468714258|FG001|Overall Study|Withdrawal by Subject|1|||
130205945|NCT01573767|468714259|FG002|Overall Study|Withdrawal by Subject|0|||
130205946|NCT01573767|468714260|FG003|Overall Study|Withdrawal by Subject|0|||
130205947|NCT01371877|468714263|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
130205948|NCT01371877|468714264|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
130205949|NCT00869557|468714265|FG000|Randomized Phase|Lost to Follow-up|2|||
130205950|NCT00869557|468714266|FG001|Randomized Phase|Lost to Follow-up|1|||
130205951|NCT00869557|468714265|FG000|Randomized Phase|Investigator's Discretion|1|||
130205952|NCT00869557|468714266|FG001|Randomized Phase|Investigator's Discretion|0|||
130205953|NCT00869557|468714265|FG000|Randomized Phase|Withdrew Consent|0|||
130205954|NCT00869557|468714266|FG001|Randomized Phase|Withdrew Consent|1|||
130205955|NCT00869557|468714265|FG000|Extension Phase|Adverse Event|2|||
130205956|NCT00869557|468714266|FG001|Extension Phase|Adverse Event|2|||
130205957|NCT00869557|468714265|FG000|Extension Phase|Lack of Efficacy|1|||
130205958|NCT00869557|468714266|FG001|Extension Phase|Lack of Efficacy|0|||
130205959|NCT00869557|468714265|FG000|Extension Phase|Lost to Follow-up|3|||
130205960|NCT00869557|468714266|FG001|Extension Phase|Lost to Follow-up|1|||
130205961|NCT00869557|468714265|FG000|Extension Phase|Investigator's Discretion|2|||
130205962|NCT00869557|468714266|FG001|Extension Phase|Investigator's Discretion|0|||
130205963|NCT00869557|468714265|FG000|Extension Phase|Withdrew Consent|2|||
130205964|NCT00869557|468714266|FG001|Extension Phase|Withdrew Consent|0|||
130205965|NCT01143064|468714269|FG000|Overall Study|Death|109|||
130205966|NCT01143064|468714270|FG001|Overall Study|Death|91|||
130205967|NCT01143064|468714269|FG000|Overall Study|Adverse Event|0|||
130205968|NCT01143064|468714270|FG001|Overall Study|Adverse Event|1|||
130205969|NCT01143064|468714269|FG000|Overall Study|Withdrawal by Subject|7|||
130205970|NCT01143064|468714270|FG001|Overall Study|Withdrawal by Subject|5|||
130205971|NCT01143064|468714269|FG000|Overall Study|Lost to Follow-up|17|||
130205972|NCT01143064|468714270|FG001|Overall Study|Lost to Follow-up|14|||
130205973|NCT01143064|468714269|FG000|Overall Study|Physician Decision|0|||
130205974|NCT01143064|468714270|FG001|Overall Study|Physician Decision|4|||
130205975|NCT02255552|468714273|FG000|Overall Study|Participants enrolled into another study|0|||
130205976|NCT02255552|468714274|FG001|Overall Study|Participants enrolled into another study|11|||
130205977|NCT02255552|468714273|FG000|Overall Study|Withdrawal by Subject|1|||
130205978|NCT02255552|468714274|FG001|Overall Study|Withdrawal by Subject|4|||
130205979|NCT03747302|468714277|FG000|Overall Study|Withdrawal by Subject|1|||
130205980|NCT03747302|468714278|FG001|Overall Study|Withdrawal by Subject|2|||
130205981|NCT03448939|468714281|FG000|Overall Study|Adverse Event|5|||
130205982|NCT03448939|468714282|FG001|Overall Study|Adverse Event|1|||
130205983|NCT03448939|468714281|FG000|Overall Study|Lost to Follow-up|6|||
130205984|NCT03448939|468714282|FG001|Overall Study|Lost to Follow-up|6|||
130205985|NCT03448939|468714281|FG000|Overall Study|Pregnancy|1|||
130205986|NCT03448939|468714282|FG001|Overall Study|Pregnancy|1|||
130205987|NCT03448939|468714281|FG000|Overall Study|Withdrawal by Subject|9|||
130205988|NCT03448939|468714282|FG001|Overall Study|Withdrawal by Subject|3|||
130205989|NCT00894790|468714283|FG000|Overall Study|Protocol Violation|0|||
130205990|NCT00894790|468714284|FG001|Overall Study|Protocol Violation|1|||
130205991|NCT00894790|468714283|FG000|Overall Study|Lost to Follow-up|0|||
130205992|NCT00894790|468714284|FG001|Overall Study|Lost to Follow-up|1|||
130205993|NCT00894790|468714283|FG000|Overall Study|Did not meet entrance criteria|1|||
130205994|NCT00894790|468714284|FG001|Overall Study|Did not meet entrance criteria|0|||
130205995|NCT01472965|468714285|FG000|Overall Study|Withdrawal by Subject|1|||
130205996|NCT01472965|468714286|FG001|Overall Study|Withdrawal by Subject|0|||
130205997|NCT00628095|468714287|FG000|Overall Study|Adverse Event|5|||
130205998|NCT00628095|468714288|FG001|Overall Study|Adverse Event|3|||
130205999|NCT00628095|468714287|FG000|Overall Study|Lack of Efficacy|0|||
130206000|NCT00628095|468714288|FG001|Overall Study|Lack of Efficacy|3|||
130206001|NCT00628095|468714287|FG000|Overall Study|Withdrawal by Subject|2|||
130206002|NCT00628095|468714288|FG001|Overall Study|Withdrawal by Subject|0|||
130206003|NCT00628095|468714287|FG000|Overall Study|Other|0|||
130206004|NCT00628095|468714288|FG001|Overall Study|Other|1|||
130206005|NCT03235115|468714292|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206006|NCT03235115|468714293|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206007|NCT03235115|468714294|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206008|NCT03235115|468714295|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206009|NCT03235115|468714296|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
130206010|NCT03235115|468714297|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
130206011|NCT00006305|468714298|FG000|Overall Study|Withdrawal by Subject|17|||
130206012|NCT00006305|468714299|FG001|Overall Study|Withdrawal by Subject|10|||
130206013|NCT00006305|468714300|FG002|Overall Study|Withdrawal by Subject|15|||
130206014|NCT00006305|468714301|FG003|Overall Study|Withdrawal by Subject|14|||
130206015|NCT00662558|468714304|FG000|Overall Study|Adverse Event|21|||
130206016|NCT00662558|468714305|FG001|Overall Study|Adverse Event|59|||
130206017|NCT00662558|468714304|FG000|Overall Study|Lack of Efficacy|4|||
130206018|NCT00662558|468714305|FG001|Overall Study|Lack of Efficacy|7|||
130206019|NCT00662558|468714304|FG000|Overall Study|Lost to Follow-up|13|||
130206020|NCT00662558|468714305|FG001|Overall Study|Lost to Follow-up|10|||
130206021|NCT00662558|468714304|FG000|Overall Study|Other|9|||
130206022|NCT00662558|468714305|FG001|Overall Study|Other|14|||
130206023|NCT00662558|468714304|FG000|Overall Study|Withdrawal by Subject|7|||
130206024|NCT00662558|468714305|FG001|Overall Study|Withdrawal by Subject|12|||
130206025|NCT00662558|468714304|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
130206026|NCT00662558|468714305|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
130206027|NCT01711619|468714306|FG000|Overall Study|Early study termination|10|||
130206028|NCT01711619|468714307|FG001|Overall Study|Early study termination|14|||
130206029|NCT01711619|468714306|FG000|Overall Study|Withdrawal by Subject|3|||
130206030|NCT01711619|468714307|FG001|Overall Study|Withdrawal by Subject|7|||
130206031|NCT01711619|468714306|FG000|Overall Study|Protocol Violation|2|||
130206032|NCT01711619|468714307|FG001|Overall Study|Protocol Violation|3|||
130206033|NCT01711619|468714306|FG000|Overall Study|Adverse Event|2|||
130206034|NCT01711619|468714307|FG001|Overall Study|Adverse Event|0|||
130206035|NCT01711619|468714306|FG000|Overall Study|Lost to Follow-up|1|||
130206036|NCT01711619|468714307|FG001|Overall Study|Lost to Follow-up|0|||
130206037|NCT00503997|468714308|FG000|Overall Study|disease progression|1|||
130206038|NCT00503997|468714308|FG000|Overall Study|Adverse Event|5|||
130206039|NCT00503997|468714308|FG000|Overall Study|Death|1|||
130206040|NCT00503997|468714308|FG000|Overall Study|Withdrawal by Subject|1|||
130206041|NCT01195844|468714309|FG000|Overall Study|Fecal sample not collected|40|||
130206042|NCT01432275|468714313|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
130206043|NCT01432275|468714314|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
130206044|NCT01432275|468714313|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
130206045|NCT01432275|468714314|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
130206046|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
130206047|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
130206048|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
130206049|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
130206050|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
130206051|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
130206052|NCT01432275|468714313|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
130206053|NCT01432275|468714314|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
130206054|NCT01432275|468714313|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
130206055|NCT01432275|468714314|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
130206056|NCT01432275|468714313|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
130206057|NCT01432275|468714314|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
130206058|NCT01432275|468714313|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
130206059|NCT01432275|468714314|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
130206060|NCT02565706|468714315|FG000|Overall Study|Withdrawal by Subject|5|||
130206061|NCT02565706|468714316|FG001|Overall Study|Withdrawal by Subject|7|||
130206062|NCT02565706|468714317|FG002|Overall Study|Withdrawal by Subject|7|||
130206063|NCT02565706|468714318|FG003|Overall Study|Withdrawal by Subject|11|||
130206064|NCT02565706|468714315|FG000|Overall Study|Lost to Follow-up|72|||
130206065|NCT02565706|468714316|FG001|Overall Study|Lost to Follow-up|75|||
130206066|NCT02565706|468714317|FG002|Overall Study|Lost to Follow-up|82|||
130206067|NCT02565706|468714318|FG003|Overall Study|Lost to Follow-up|74|||
130206068|NCT00835679|468714324|FG000|Overall Study|Withdrawal by Subject|1|||
130206069|NCT00835679|468714325|FG001|Overall Study|Withdrawal by Subject|0|||
130206070|NCT00835679|468714326|FG002|Overall Study|Withdrawal by Subject|0|||
130206071|NCT00835679|468714327|FG003|Overall Study|Withdrawal by Subject|0|||
130206072|NCT03802565|468714330|FG000|Overall Study|Adverse Event|0|||
130206073|NCT03802565|468714331|FG001|Overall Study|Adverse Event|1|||
130206074|NCT03802565|468714332|FG002|Overall Study|Adverse Event|2|||
130206075|NCT03802565|468714333|FG003|Overall Study|Adverse Event|1|||
130206076|NCT03802565|468714334|FG004|Overall Study|Adverse Event|1|||
130206077|NCT03802565|468714330|FG000|Overall Study|Withdrawal by Subject|2|||
130206078|NCT03802565|468714331|FG001|Overall Study|Withdrawal by Subject|2|||
130206079|NCT03802565|468714332|FG002|Overall Study|Withdrawal by Subject|2|||
130206080|NCT03802565|468714333|FG003|Overall Study|Withdrawal by Subject|0|||
130206081|NCT03802565|468714334|FG004|Overall Study|Withdrawal by Subject|1|||
130206082|NCT03802565|468714330|FG000|Overall Study|Protocol Violation|2|||
130206083|NCT03802565|468714331|FG001|Overall Study|Protocol Violation|1|||
130206084|NCT03802565|468714332|FG002|Overall Study|Protocol Violation|4|||
130206085|NCT03802565|468714333|FG003|Overall Study|Protocol Violation|5|||
130206086|NCT03802565|468714334|FG004|Overall Study|Protocol Violation|1|||
130206087|NCT03802565|468714330|FG000|Overall Study|Lost to Follow-up|0|||
130206088|NCT03802565|468714331|FG001|Overall Study|Lost to Follow-up|0|||
130206089|NCT03802565|468714332|FG002|Overall Study|Lost to Follow-up|1|||
130206090|NCT03802565|468714333|FG003|Overall Study|Lost to Follow-up|0|||
130206091|NCT03802565|468714334|FG004|Overall Study|Lost to Follow-up|0|||
130206092|NCT03802565|468714330|FG000|Overall Study|Subjects Related to Each Other|1|||
130206093|NCT03802565|468714331|FG001|Overall Study|Subjects Related to Each Other|0|||
130206094|NCT03802565|468714332|FG002|Overall Study|Subjects Related to Each Other|0|||
130206095|NCT03802565|468714333|FG003|Overall Study|Subjects Related to Each Other|2|||
130206096|NCT03802565|468714334|FG004|Overall Study|Subjects Related to Each Other|1|||
130206097|NCT03802565|468714330|FG000|Overall Study|Elevated Enzymes|0|||
130206098|NCT03802565|468714331|FG001|Overall Study|Elevated Enzymes|0|||
130206099|NCT03802565|468714332|FG002|Overall Study|Elevated Enzymes|0|||
130206100|NCT03802565|468714333|FG003|Overall Study|Elevated Enzymes|0|||
130206101|NCT03802565|468714334|FG004|Overall Study|Elevated Enzymes|2|||
130206102|NCT05020899|468714335|FG000|8 Week Follow-up|Lost to Follow-up|3|||
130206103|NCT05020899|468714336|FG001|8 Week Follow-up|Lost to Follow-up|6|||
130206104|NCT05020899|468714335|FG000|12 Week Follow-up|Lost to Follow-up|1|||
130206105|NCT05020899|468714336|FG001|12 Week Follow-up|Lost to Follow-up|0|||
130206106|NCT05020899|468714335|FG000|12 Week Follow-up|Death|0|||
130206107|NCT05020899|468714336|FG001|12 Week Follow-up|Death|1|||
130206108|NCT02124759|468714337|FG000|Overall Study|Withdrawal by Subject|3|||
130206109|NCT02124759|468714338|FG001|Overall Study|Withdrawal by Subject|1|||
130206110|NCT02124759|468714339|FG002|Overall Study|Withdrawal by Subject|1|||
130206111|NCT02124759|468714337|FG000|Overall Study|Screen Fail|2|||
130206112|NCT02124759|468714338|FG001|Overall Study|Screen Fail|2|||
130206113|NCT02124759|468714339|FG002|Overall Study|Screen Fail|3|||
130206114|NCT01068626|468714340|FG000|Overall Study|Adverse Event|3|||
130206115|NCT01068626|468714341|FG001|Overall Study|Adverse Event|0|||
130206116|NCT01068626|468714340|FG000|Overall Study|Withdrawal by Subject|0|||
130206117|NCT01068626|468714341|FG001|Overall Study|Withdrawal by Subject|2|||
130206118|NCT01785849|468714344|FG000|Overall Study|Death|7|||
130206119|NCT01785849|468714345|FG001|Overall Study|Death|9|||
130206120|NCT01785849|468714344|FG000|Overall Study|Protocol Specified Criteria|29|||
130206121|NCT01785849|468714345|FG001|Overall Study|Protocol Specified Criteria|1|||
130206122|NCT01785849|468714344|FG000|Overall Study|Withdrawal by Subject|15|||
130206123|NCT01785849|468714345|FG001|Overall Study|Withdrawal by Subject|12|||
130206124|NCT01785849|468714344|FG000|Overall Study|Sponsor Decision|0|||
130206125|NCT01785849|468714345|FG001|Overall Study|Sponsor Decision|1|||
130206126|NCT01785849|468714344|FG000|Overall Study|Lost to Follow-up|10|||
130206127|NCT01785849|468714345|FG001|Overall Study|Lost to Follow-up|11|||
130206128|NCT04340843|468714346|FG000|Overall Study|Adverse Event|0|||
130206129|NCT04340843|468714347|FG001|Overall Study|Adverse Event|2|||
130206130|NCT04340843|468714346|FG000|Overall Study|Withdrawal by Subject|0|||
130206131|NCT04340843|468714347|FG001|Overall Study|Withdrawal by Subject|2|||
130206132|NCT04249622|468714348|FG000|Overall Study|Withdrawal by Subject|1|||
130206133|NCT04249622|468714349|FG001|Overall Study|Withdrawal by Subject|1|||
130206134|NCT04249622|468714348|FG000|Overall Study|Alternative therapy|1|||
130206135|NCT04249622|468714349|FG001|Overall Study|Alternative therapy|0|||
130206136|NCT04249622|468714348|FG000|Overall Study|Discontinuation of pertuzumab|1|||
130206137|NCT04249622|468714349|FG001|Overall Study|Discontinuation of pertuzumab|0|||
130206138|NCT01634659|468714353|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
130206139|NCT01634659|468714354|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
130206140|NCT01634659|468714353|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
130206141|NCT01634659|468714354|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
130206142|NCT00875433|468714355|FG000|Overall Study|Progressive disease|41|||
130206143|NCT00875433|468714355|FG000|Overall Study|Other Adverse Event|14|||
130206144|NCT00875433|468714355|FG000|Overall Study|Withdrawal by Subject|2|||
130206145|NCT00875433|468714355|FG000|Overall Study|Other|3|||
130206146|NCT00793624|468714356|FG000|Overall Study|Adverse Event|18|||
130206147|NCT00793624|468714357|FG001|Overall Study|Adverse Event|16|||
130206148|NCT00793624|468714358|FG002|Overall Study|Adverse Event|15|||
130206149|NCT00793624|468714359|FG003|Overall Study|Adverse Event|20|||
130206150|NCT00793624|468714356|FG000|Overall Study|Lost to Follow-up|2|||
130206151|NCT00793624|468714357|FG001|Overall Study|Lost to Follow-up|2|||
130206152|NCT00793624|468714358|FG002|Overall Study|Lost to Follow-up|4|||
130206153|NCT00793624|468714359|FG003|Overall Study|Lost to Follow-up|0|||
130206154|NCT00793624|468714356|FG000|Overall Study|Withdrawal by Subject|20|||
130206155|NCT00793624|468714357|FG001|Overall Study|Withdrawal by Subject|9|||
130206156|NCT00793624|468714358|FG002|Overall Study|Withdrawal by Subject|11|||
130206157|NCT00793624|468714359|FG003|Overall Study|Withdrawal by Subject|14|||
130206158|NCT00793624|468714356|FG000|Overall Study|Lack of Efficacy|9|||
130206159|NCT00793624|468714357|FG001|Overall Study|Lack of Efficacy|2|||
130206160|NCT00793624|468714358|FG002|Overall Study|Lack of Efficacy|1|||
130206161|NCT00793624|468714359|FG003|Overall Study|Lack of Efficacy|3|||
130206162|NCT00793624|468714356|FG000|Overall Study|Non compliance with protocol|2|||
130206163|NCT00793624|468714357|FG001|Overall Study|Non compliance with protocol|3|||
130206164|NCT00793624|468714358|FG002|Overall Study|Non compliance with protocol|2|||
130206165|NCT00793624|468714359|FG003|Overall Study|Non compliance with protocol|3|||
130206166|NCT00793624|468714356|FG000|Overall Study|Other reason not described above|6|||
130206167|NCT00793624|468714357|FG001|Overall Study|Other reason not described above|4|||
130206168|NCT00793624|468714358|FG002|Overall Study|Other reason not described above|6|||
130206169|NCT00793624|468714359|FG003|Overall Study|Other reason not described above|3|||
130206170|NCT02921750|468715614|FG000|Overall Study|Adverse Event|1|||
130206171|NCT02921750|468715615|FG001|Overall Study|Adverse Event|2|||
130206172|NCT02921750|468715614|FG000|Overall Study|Withdrawal by Subject|1|||
130206173|NCT02921750|468715615|FG001|Overall Study|Withdrawal by Subject|1|||
130206174|NCT02921750|468715614|FG000|Overall Study|Lost to Follow-up|3|||
130206175|NCT02921750|468715615|FG001|Overall Study|Lost to Follow-up|3|||
130206176|NCT02921750|468715614|FG000|Overall Study|Wound healed|3|||
130206177|NCT02921750|468715615|FG001|Overall Study|Wound healed|3|||
130206178|NCT02921750|468715614|FG000|Overall Study|Serious Adverse Event|1|||
130206179|NCT02921750|468715615|FG001|Overall Study|Serious Adverse Event|2|||
130206180|NCT03309696|468715616|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
130206181|NCT03309696|468715617|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
130206182|NCT03309696|468715618|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
130206183|NCT03309696|468715619|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
130206184|NCT05940077|468715620|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
130206185|NCT00328094|468715621|FG000|Overall Study|Physician Decision|3|||
130206186|NCT00328094|468715622|FG001|Overall Study|Physician Decision|3|||
130206187|NCT02368210|468715623|FG000|Overall Study|Withdrawal by Subject|1|||
130206188|NCT02368210|468715624|FG001|Overall Study|Withdrawal by Subject|0|||
130206189|NCT02368210|468715623|FG000|Overall Study|Adverse Event|0|||
130206190|NCT02368210|468715624|FG001|Overall Study|Adverse Event|1|||
130206191|NCT00078949|468715625|FG000|Overall Study|No treated|4|||
130206192|NCT00078949|468715626|FG001|Overall Study|No treated|5|||
130206193|NCT00078949|468715627|FG002|Overall Study|No treated|3|||
130206194|NCT00078949|468715628|FG003|Overall Study|No treated|3|||
130206195|NCT02309723|468715629|FG000|Overall Study|Withdrawal by Subject|24|||
130206196|NCT02309723|468715630|FG001|Overall Study|Withdrawal by Subject|23|||
130206197|NCT02309723|468715631|FG002|Overall Study|Withdrawal by Subject|24|||
130206198|NCT01565668|468715632|FG000|Overall Study|Death|2|||
130206199|NCT01565668|468715633|FG001|Overall Study|Death|1|||
130206200|NCT01565668|468715632|FG000|Overall Study|Lack of Efficacy|4|||
130206201|NCT01565668|468715633|FG001|Overall Study|Lack of Efficacy|2|||
130206202|NCT01565668|468715632|FG000|Overall Study|Participant went on Hospice Care|1|||
130206203|NCT01565668|468715633|FG001|Overall Study|Participant went on Hospice Care|0|||
130206204|NCT01565668|468715632|FG000|Overall Study|Adverse Event|6|||
130206205|NCT01565668|468715633|FG001|Overall Study|Adverse Event|1|||
130206206|NCT01565668|468715632|FG000|Overall Study|Randomized, but never received drug|0|||
130206207|NCT01565668|468715633|FG001|Overall Study|Randomized, but never received drug|2|||
130206208|NCT01565668|468715632|FG000|Overall Study|Progressive disease|13|||
130206209|NCT01565668|468715633|FG001|Overall Study|Progressive disease|14|||
130206210|NCT01565668|468715632|FG000|Overall Study|Withdrawal by Subject|1|||
130206211|NCT01565668|468715633|FG001|Overall Study|Withdrawal by Subject|3|||
130206212|NCT01565668|468715632|FG000|Overall Study|HSCT Transplant|11|||
130206213|NCT01565668|468715633|FG001|Overall Study|HSCT Transplant|15|||
130206214|NCT03570554|468715634|FG000|Overall Study|Non-compliance with study drug|0|||
130206215|NCT03570554|468715635|FG001|Overall Study|Non-compliance with study drug|0|||
130206216|NCT03570554|468715636|FG002|Overall Study|Non-compliance with study drug|1|||
130206217|NCT03570554|468715637|FG003|Overall Study|Non-compliance with study drug|0|||
130206218|NCT03570554|468715634|FG000|Overall Study|Adverse Event|0|||
130206219|NCT03570554|468715635|FG001|Overall Study|Adverse Event|0|||
130206220|NCT03570554|468715636|FG002|Overall Study|Adverse Event|0|||
130206221|NCT03570554|468715637|FG003|Overall Study|Adverse Event|1|||
130206222|NCT02604550|468715640|FG000|Overall Study|Lost to Follow-up|7|||
130206223|NCT02604550|468715641|FG001|Overall Study|Lost to Follow-up|6|||
130206224|NCT02604550|468715640|FG000|Overall Study|Withdrawal by Subject|0|||
130206225|NCT02604550|468715641|FG001|Overall Study|Withdrawal by Subject|1|||
130206226|NCT02604550|468715640|FG000|Overall Study|Incomplete data using paper journal|18|||
130206227|NCT02604550|468715641|FG001|Overall Study|Incomplete data using paper journal|19|||
130206228|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
130206229|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
130206230|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
130206231|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
130206232|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Death|1|||
130206233|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Death|1|||
130206234|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
130206235|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
130206236|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
130206237|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
130206238|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
130206239|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
130206240|NCT00033657|468715645|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
130206241|NCT00033657|468715646|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
130206242|NCT00033657|468715645|FG000|Surgical Resection|not complete resection|0|||
130206243|NCT00033657|468715646|FG001|Surgical Resection|not complete resection|3|||
130206244|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
130206245|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
130206246|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
130206247|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
130206248|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Death|2|||
130206249|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Death|1|||
130206250|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
130206251|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
130206252|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
130206253|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
130206254|NCT00033657|468715645|FG000|Adjuvant Chemotherapy|Other|0|||
130206255|NCT00033657|468715646|FG001|Adjuvant Chemotherapy|Other|2|||
130206256|NCT04093492|468715647|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
130206257|NCT04093492|468715648|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
130206258|NCT04093492|468715649|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
130206259|NCT04093492|468715650|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
130206260|NCT04093492|468715647|FG000|25 Weeks Gestational Age (GA)|No response|5|||
130206261|NCT04093492|468715648|FG001|25 Weeks Gestational Age (GA)|No response|5|||
130206262|NCT04093492|468715649|FG002|25 Weeks Gestational Age (GA)|No response|5|||
130206263|NCT04093492|468715650|FG003|25 Weeks Gestational Age (GA)|No response|2|||
130206264|NCT04093492|468715647|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130206265|NCT04093492|468715648|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130206266|NCT04093492|468715649|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
130206267|NCT04093492|468715650|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
130206268|NCT04093492|468715647|FG000|30 Weeks GA|Delivered before assessment|1|||
130206269|NCT04093492|468715648|FG001|30 Weeks GA|Delivered before assessment|2|||
130206270|NCT04093492|468715649|FG002|30 Weeks GA|Delivered before assessment|0|||
130206271|NCT04093492|468715650|FG003|30 Weeks GA|Delivered before assessment|0|||
130206272|NCT04093492|468715647|FG000|30 Weeks GA|No response|7|||
130206273|NCT04093492|468715648|FG001|30 Weeks GA|No response|5|||
130206274|NCT04093492|468715649|FG002|30 Weeks GA|No response|5|||
130206275|NCT04093492|468715650|FG003|30 Weeks GA|No response|2|||
130206276|NCT04093492|468715647|FG000|30 Weeks GA|Lost to Follow-up|0|||
130206277|NCT04093492|468715648|FG001|30 Weeks GA|Lost to Follow-up|1|||
130206278|NCT04093492|468715649|FG002|30 Weeks GA|Lost to Follow-up|0|||
130206279|NCT04093492|468715650|FG003|30 Weeks GA|Lost to Follow-up|0|||
130206280|NCT04093492|468715647|FG000|34 Weeks GA|Delivered before assessment|6|||
130206281|NCT04093492|468715648|FG001|34 Weeks GA|Delivered before assessment|3|||
130206282|NCT04093492|468715649|FG002|34 Weeks GA|Delivered before assessment|0|||
130206283|NCT04093492|468715650|FG003|34 Weeks GA|Delivered before assessment|0|||
130206284|NCT04093492|468715647|FG000|34 Weeks GA|No response|0|||
130206285|NCT04093492|468715648|FG001|34 Weeks GA|No response|7|||
130206286|NCT04093492|468715649|FG002|34 Weeks GA|No response|5|||
130206287|NCT04093492|468715650|FG003|34 Weeks GA|No response|3|||
130206288|NCT04093492|468715647|FG000|34 Weeks GA|Lost to Follow-up|0|||
130206289|NCT04093492|468715648|FG001|34 Weeks GA|Lost to Follow-up|1|||
130206290|NCT04093492|468715649|FG002|34 Weeks GA|Lost to Follow-up|0|||
130206291|NCT04093492|468715650|FG003|34 Weeks GA|Lost to Follow-up|0|||
130206292|NCT00329641|468715651|FG000|Overall Study|Did not start treatment|1|||
130206293|NCT00329641|468715651|FG000|Overall Study|Not eligible|1|||
130206294|NCT00329641|468715651|FG000|Overall Study|Adverse Event|3|||
130206295|NCT00329641|468715651|FG000|Overall Study|Other reason, not protocol specified|1|||
130206296|NCT02945254|468715654|FG000|Overall Study|Lost to Follow-up|1|||
130206297|NCT02945254|468715655|FG001|Overall Study|Lost to Follow-up|0|||
130206298|NCT02945254|468715654|FG000|Overall Study|Withdrawal by Subject|1|||
130206299|NCT02945254|468715655|FG001|Overall Study|Withdrawal by Subject|0|||
130206300|NCT03422159|468715656|FG000|Overall Study|Exclusion due to terminal disease|2|||
130206301|NCT03422159|468715657|FG001|Overall Study|Exclusion due to terminal disease|1|||
130206302|NCT02631070|468715662|FG000|Overall Study|Withdrawal by Subject|35|||
130206303|NCT02631070|468715663|FG001|Overall Study|Withdrawal by Subject|13|||
130206304|NCT02631070|468715662|FG000|Overall Study|Death|45|||
130206305|NCT02631070|468715663|FG001|Overall Study|Death|24|||
130206306|NCT02631070|468715662|FG000|Overall Study|Lost to Follow-up|5|||
130206307|NCT02631070|468715663|FG001|Overall Study|Lost to Follow-up|1|||
130206308|NCT02631070|468715662|FG000|Overall Study|Transition to rollover protocol|52|||
130206309|NCT02631070|468715663|FG001|Overall Study|Transition to rollover protocol|21|||
130206310|NCT02631070|468715662|FG000|Overall Study|Other reasons|12|||
130206311|NCT02631070|468715663|FG001|Overall Study|Other reasons|5|||
130206312|NCT00980018|468715669|FG000|Overall Study|Adverse Event|8|||
130206313|NCT00980018|468715669|FG000|Overall Study|Patient withdrew consent|3|||
130206314|NCT00980018|468715669|FG000|Overall Study|Lost to Follow-up|1|||
130206315|NCT00087126|468715670|FG000|Overall Study|Ineligible - second primary|1|||
130206316|NCT00087126|468715670|FG000|Overall Study|Never treated|1|||
130206317|NCT01832818|468715671|FG000|Overall Study|Lost to Follow-up|6|||
130206318|NCT00934856|468715674|FG000|Feasibility Part|Progressive disease|4|||
130206319|NCT00934856|468715675|FG001|Feasibility Part|Progressive disease|4|||
130206320|NCT00934856|468715676|FG002|Feasibility Part|Progressive disease|2|||
130206321|NCT00934856|468715677|FG003|Feasibility Part|Progressive disease|3|||
130206322|NCT00934856|468715678|FG004|Feasibility Part|Progressive disease|0|||
130206323|NCT00934856|468715679|FG005|Feasibility Part|Progressive disease|0|||
130206324|NCT00934856|468715674|FG000|Feasibility Part|Physician Decision|0|||
130206325|NCT00934856|468715675|FG001|Feasibility Part|Physician Decision|0|||
130206326|NCT00934856|468715676|FG002|Feasibility Part|Physician Decision|1|||
130206327|NCT00934856|468715677|FG003|Feasibility Part|Physician Decision|0|||
130206328|NCT00934856|468715678|FG004|Feasibility Part|Physician Decision|0|||
130206329|NCT00934856|468715679|FG005|Feasibility Part|Physician Decision|0|||
130206330|NCT00934856|468715674|FG000|Feasibility Part|Adverse Event|1|||
130206331|NCT00934856|468715675|FG001|Feasibility Part|Adverse Event|1|||
130206332|NCT00934856|468715676|FG002|Feasibility Part|Adverse Event|0|||
130206333|NCT00934856|468715677|FG003|Feasibility Part|Adverse Event|1|||
130206334|NCT00934856|468715678|FG004|Feasibility Part|Adverse Event|0|||
130206335|NCT00934856|468715679|FG005|Feasibility Part|Adverse Event|2|||
130206336|NCT00934856|468715674|FG000|Feasibility Part|Withdrawal by Subject|0|||
130206337|NCT00934856|468715675|FG001|Feasibility Part|Withdrawal by Subject|0|||
130206338|NCT00934856|468715676|FG002|Feasibility Part|Withdrawal by Subject|0|||
130206339|NCT00934856|468715677|FG003|Feasibility Part|Withdrawal by Subject|1|||
130206340|NCT00934856|468715678|FG004|Feasibility Part|Withdrawal by Subject|0|||
130206341|NCT00934856|468715679|FG005|Feasibility Part|Withdrawal by Subject|1|||
130206342|NCT00934856|468715674|FG000|Extension Part|Adverse Event|0|||
130206343|NCT00934856|468715675|FG001|Extension Part|Adverse Event|0|||
130206344|NCT00934856|468715676|FG002|Extension Part|Adverse Event|0|||
130206345|NCT00934856|468715677|FG003|Extension Part|Adverse Event|1|||
130206346|NCT00934856|468715678|FG004|Extension Part|Adverse Event|4|||
130206347|NCT00934856|468715679|FG005|Extension Part|Adverse Event|4|||
130206348|NCT00934856|468715674|FG000|Extension Part|Progressive disease|0|||
130206349|NCT00934856|468715675|FG001|Extension Part|Progressive disease|0|||
130206350|NCT00934856|468715676|FG002|Extension Part|Progressive disease|0|||
130206351|NCT00934856|468715677|FG003|Extension Part|Progressive disease|1|||
130206352|NCT00934856|468715678|FG004|Extension Part|Progressive disease|0|||
130206353|NCT00934856|468715679|FG005|Extension Part|Progressive disease|0|||
130206354|NCT00934856|468715674|FG000|Extension Part|Non-compliance with drug|0|||
130206355|NCT00934856|468715675|FG001|Extension Part|Non-compliance with drug|0|||
130206356|NCT00934856|468715676|FG002|Extension Part|Non-compliance with drug|0|||
130206357|NCT00934856|468715677|FG003|Extension Part|Non-compliance with drug|0|||
130206358|NCT00934856|468715678|FG004|Extension Part|Non-compliance with drug|0|||
130206359|NCT00934856|468715679|FG005|Extension Part|Non-compliance with drug|1|||
130206360|NCT01256385|468715680|FG000|Overall Study|Physician Decision|1|||
130206361|NCT01256385|468715681|FG001|Overall Study|Physician Decision|1|||
130206362|NCT01256385|468715680|FG000|Overall Study|Withdrawal by Subject|2|||
130206363|NCT01256385|468715681|FG001|Overall Study|Withdrawal by Subject|2|||
130206364|NCT00401960|468715684|FG000|Overall Study|Lost to Follow-up|3|||
130206365|NCT00401960|468715685|FG001|Overall Study|Lost to Follow-up|0|||
130206366|NCT00401960|468715684|FG000|Overall Study|Death|2|||
130206367|NCT00401960|468715685|FG001|Overall Study|Death|0|||
130206368|NCT02649426|468715686|FG000|Overall Study|Follow-up on going|1|||
130206369|NCT02649426|468715687|FG001|Overall Study|Follow-up on going|26|||
130206370|NCT02649426|468715688|FG002|Overall Study|Follow-up on going|28|||
130206371|NCT02649426|468715689|FG003|Overall Study|Follow-up on going|31|||
130206372|NCT01606202|468715690|FG000|Overall Study|Adverse Event|5|||
130206373|NCT01606202|468715691|FG001|Overall Study|Adverse Event|0|||
130206374|NCT01606202|468715690|FG000|Overall Study|Withdrawal by Subject|2|||
130206375|NCT01606202|468715691|FG001|Overall Study|Withdrawal by Subject|1|||
130206376|NCT01606202|468715690|FG000|Overall Study|Personal problems|0|||
130206377|NCT01606202|468715691|FG001|Overall Study|Personal problems|1|||
130206378|NCT01606202|468715690|FG000|Overall Study|Problems with administration|0|||
130206379|NCT01606202|468715691|FG001|Overall Study|Problems with administration|1|||
130206380|NCT02584959|468715692|FG000|Period 1|Withdrawn from study|3|||
130206381|NCT02584959|468715693|FG001|Period 1|Withdrawn from study|4|||
130206382|NCT02584959|468715694|FG002|Period 1|Withdrawn from study|0|||
130206383|NCT02584959|468715692|FG000|Period 2|Withdrawn from study|6|||
130206384|NCT02584959|468715693|FG001|Period 2|Withdrawn from study|1|||
130206385|NCT02584959|468715694|FG002|Period 2|Withdrawn from study|2|||
130206386|NCT00195494|468715699|FG000|Year 1|Adverse Event|0|||
130206387|NCT00195494|468715700|FG001|Year 1|Adverse Event|0|||
130206388|NCT00195494|468715701|FG002|Year 1|Adverse Event|0|||
130206389|NCT00195494|468715702|FG003|Year 1|Adverse Event|0|||
130206390|NCT00195494|468715703|FG004|Year 1|Adverse Event|34|||
130206391|NCT00195494|468715704|FG005|Year 1|Adverse Event|27|||
130206392|NCT00195494|468715699|FG000|Year 1|System Toxicity|0|||
130206393|NCT00195494|468715700|FG001|Year 1|System Toxicity|0|||
130206394|NCT00195494|468715701|FG002|Year 1|System Toxicity|0|||
130206395|NCT00195494|468715702|FG003|Year 1|System Toxicity|0|||
130206396|NCT00195494|468715703|FG004|Year 1|System Toxicity|0|||
130206397|NCT00195494|468715704|FG005|Year 1|System Toxicity|1|||
130206398|NCT00195494|468715699|FG000|Year 1|Lack of Efficacy|0|||
130206399|NCT00195494|468715700|FG001|Year 1|Lack of Efficacy|0|||
130206400|NCT00195494|468715701|FG002|Year 1|Lack of Efficacy|0|||
130206401|NCT00195494|468715702|FG003|Year 1|Lack of Efficacy|0|||
130206402|NCT00195494|468715703|FG004|Year 1|Lack of Efficacy|24|||
130206403|NCT00195494|468715704|FG005|Year 1|Lack of Efficacy|9|||
130206404|NCT00195494|468715699|FG000|Year 1|Compliance|0|||
130206405|NCT00195494|468715700|FG001|Year 1|Compliance|0|||
130206406|NCT00195494|468715701|FG002|Year 1|Compliance|0|||
130206407|NCT00195494|468715702|FG003|Year 1|Compliance|0|||
130206408|NCT00195494|468715703|FG004|Year 1|Compliance|5|||
130206409|NCT00195494|468715704|FG005|Year 1|Compliance|1|||
130206410|NCT00195494|468715699|FG000|Year 1|Lost to Follow-up|0|||
130206411|NCT00195494|468715700|FG001|Year 1|Lost to Follow-up|0|||
130206412|NCT00195494|468715701|FG002|Year 1|Lost to Follow-up|0|||
130206413|NCT00195494|468715702|FG003|Year 1|Lost to Follow-up|0|||
130206414|NCT00195494|468715703|FG004|Year 1|Lost to Follow-up|1|||
130206415|NCT00195494|468715704|FG005|Year 1|Lost to Follow-up|0|||
130206416|NCT00195494|468715699|FG000|Year 1|Missed >4 consecutive doses|0|||
130206417|NCT00195494|468715700|FG001|Year 1|Missed >4 consecutive doses|0|||
130206418|NCT00195494|468715701|FG002|Year 1|Missed >4 consecutive doses|0|||
130206419|NCT00195494|468715702|FG003|Year 1|Missed >4 consecutive doses|0|||
130206420|NCT00195494|468715703|FG004|Year 1|Missed >4 consecutive doses|3|||
130206421|NCT00195494|468715704|FG005|Year 1|Missed >4 consecutive doses|2|||
130206422|NCT00195494|468715699|FG000|Year 1|Protocol deviation|0|||
130206423|NCT00195494|468715700|FG001|Year 1|Protocol deviation|0|||
130206424|NCT00195494|468715701|FG002|Year 1|Protocol deviation|0|||
130206425|NCT00195494|468715702|FG003|Year 1|Protocol deviation|0|||
130206426|NCT00195494|468715703|FG004|Year 1|Protocol deviation|2|||
130206427|NCT00195494|468715704|FG005|Year 1|Protocol deviation|3|||
130206428|NCT00195494|468715699|FG000|Year 1|Physician Decision|0|||
130206429|NCT00195494|468715700|FG001|Year 1|Physician Decision|0|||
130206430|NCT00195494|468715701|FG002|Year 1|Physician Decision|0|||
130206431|NCT00195494|468715702|FG003|Year 1|Physician Decision|0|||
130206432|NCT00195494|468715703|FG004|Year 1|Physician Decision|1|||
130206433|NCT00195494|468715704|FG005|Year 1|Physician Decision|0|||
130206434|NCT00195494|468715699|FG000|Year 1|Withdrawal by Subject|0|||
130206435|NCT00195494|468715700|FG001|Year 1|Withdrawal by Subject|0|||
130206436|NCT00195494|468715701|FG002|Year 1|Withdrawal by Subject|0|||
130206437|NCT00195494|468715702|FG003|Year 1|Withdrawal by Subject|0|||
130206438|NCT00195494|468715703|FG004|Year 1|Withdrawal by Subject|8|||
130206439|NCT00195494|468715704|FG005|Year 1|Withdrawal by Subject|9|||
130206440|NCT00195494|468715699|FG000|Year 1|Protocol Violation|0|||
130206441|NCT00195494|468715700|FG001|Year 1|Protocol Violation|0|||
130206442|NCT00195494|468715701|FG002|Year 1|Protocol Violation|0|||
130206443|NCT00195494|468715702|FG003|Year 1|Protocol Violation|0|||
130206444|NCT00195494|468715703|FG004|Year 1|Protocol Violation|1|||
130206445|NCT00195494|468715704|FG005|Year 1|Protocol Violation|1|||
130206446|NCT00195494|468715699|FG000|Year 2|Adverse Event|3|||
130206447|NCT00195494|468715700|FG001|Year 2|Adverse Event|7|||
130206448|NCT00195494|468715701|FG002|Year 2|Adverse Event|5|||
130206449|NCT00195494|468715702|FG003|Year 2|Adverse Event|9|||
130206450|NCT00195494|468715703|FG004|Year 2|Adverse Event|0|||
130206451|NCT00195494|468715704|FG005|Year 2|Adverse Event|0|||
130206452|NCT00195494|468715699|FG000|Year 2|Lack of Efficacy|0|||
130206453|NCT00195494|468715700|FG001|Year 2|Lack of Efficacy|1|||
130206454|NCT00195494|468715701|FG002|Year 2|Lack of Efficacy|7|||
130206455|NCT00195494|468715702|FG003|Year 2|Lack of Efficacy|7|||
130206456|NCT00195494|468715703|FG004|Year 2|Lack of Efficacy|0|||
130206457|NCT00195494|468715704|FG005|Year 2|Lack of Efficacy|0|||
130206458|NCT00195494|468715699|FG000|Year 2|Compliance|1|||
130206459|NCT00195494|468715700|FG001|Year 2|Compliance|0|||
130206460|NCT00195494|468715701|FG002|Year 2|Compliance|0|||
130206461|NCT00195494|468715702|FG003|Year 2|Compliance|2|||
130206462|NCT00195494|468715703|FG004|Year 2|Compliance|0|||
130206463|NCT00195494|468715704|FG005|Year 2|Compliance|0|||
130206464|NCT00195494|468715699|FG000|Year 2|Lost to Follow-up|0|||
130206465|NCT00195494|468715700|FG001|Year 2|Lost to Follow-up|0|||
130206466|NCT00195494|468715701|FG002|Year 2|Lost to Follow-up|1|||
130206467|NCT00195494|468715702|FG003|Year 2|Lost to Follow-up|1|||
130206468|NCT00195494|468715703|FG004|Year 2|Lost to Follow-up|0|||
130206469|NCT00195494|468715704|FG005|Year 2|Lost to Follow-up|0|||
130206470|NCT00195494|468715699|FG000|Year 2|Missed >4 consecutive doses|1|||
130206471|NCT00195494|468715700|FG001|Year 2|Missed >4 consecutive doses|1|||
130206472|NCT00195494|468715701|FG002|Year 2|Missed >4 consecutive doses|1|||
130206473|NCT00195494|468715702|FG003|Year 2|Missed >4 consecutive doses|0|||
130206474|NCT00195494|468715703|FG004|Year 2|Missed >4 consecutive doses|0|||
130206475|NCT00195494|468715704|FG005|Year 2|Missed >4 consecutive doses|0|||
130206476|NCT00195494|468715699|FG000|Year 2|Protocol deviation|0|||
130206477|NCT00195494|468715700|FG001|Year 2|Protocol deviation|1|||
130206478|NCT00195494|468715701|FG002|Year 2|Protocol deviation|0|||
130206479|NCT00195494|468715702|FG003|Year 2|Protocol deviation|0|||
130206480|NCT00195494|468715703|FG004|Year 2|Protocol deviation|0|||
130206481|NCT00195494|468715704|FG005|Year 2|Protocol deviation|0|||
130206482|NCT00195494|468715699|FG000|Year 2|Physician Decision|1|||
130206483|NCT00195494|468715700|FG001|Year 2|Physician Decision|1|||
130206484|NCT00195494|468715701|FG002|Year 2|Physician Decision|0|||
130206485|NCT00195494|468715702|FG003|Year 2|Physician Decision|0|||
130206486|NCT00195494|468715703|FG004|Year 2|Physician Decision|0|||
130206487|NCT00195494|468715704|FG005|Year 2|Physician Decision|0|||
130206488|NCT00195494|468715699|FG000|Year 2|Withdrawal by Subject|1|||
130206489|NCT00195494|468715700|FG001|Year 2|Withdrawal by Subject|5|||
130206490|NCT00195494|468715701|FG002|Year 2|Withdrawal by Subject|4|||
130206491|NCT00195494|468715702|FG003|Year 2|Withdrawal by Subject|3|||
130206492|NCT00195494|468715703|FG004|Year 2|Withdrawal by Subject|0|||
130206493|NCT00195494|468715704|FG005|Year 2|Withdrawal by Subject|0|||
130206494|NCT00195494|468715699|FG000|Year 2|System toxicity|0|||
130206495|NCT00195494|468715700|FG001|Year 2|System toxicity|0|||
130206496|NCT00195494|468715701|FG002|Year 2|System toxicity|0|||
130206497|NCT00195494|468715702|FG003|Year 2|System toxicity|1|||
130206498|NCT00195494|468715703|FG004|Year 2|System toxicity|0|||
130206499|NCT00195494|468715704|FG005|Year 2|System toxicity|0|||
130206500|NCT02020512|468715705|FG000|Overall Study|Adverse Event|1|||
130206501|NCT02020512|468715705|FG000|Overall Study|Lost to Follow-up|3|||
130206502|NCT02020512|468715705|FG000|Overall Study|Protocol Violation|4|||
130206503|NCT04769739|468715714|FG000|Overall Study|Colorectal cancer obstruction|2|||
130206504|NCT04769739|468715715|FG001|Overall Study|Colorectal cancer obstruction|0|||
130206505|NCT04769739|468715716|FG002|Overall Study|Colorectal cancer obstruction|0|||
130206506|NCT04769739|468715717|FG003|Overall Study|Colorectal cancer obstruction|0|||
130206507|NCT04769739|468715714|FG000|Overall Study|Failed cecal intubation|1|||
130206508|NCT04769739|468715715|FG001|Overall Study|Failed cecal intubation|0|||
130206509|NCT04769739|468715716|FG002|Overall Study|Failed cecal intubation|0|||
130206510|NCT04769739|468715717|FG003|Overall Study|Failed cecal intubation|1|||
130206511|NCT04769739|468715714|FG000|Overall Study|Poor bowel preparation|0|||
130206512|NCT04769739|468715715|FG001|Overall Study|Poor bowel preparation|0|||
130206513|NCT04769739|468715716|FG002|Overall Study|Poor bowel preparation|0|||
130206514|NCT04769739|468715717|FG003|Overall Study|Poor bowel preparation|1|||
130206515|NCT03689543|468715718|FG000|Overall Study|Adverse Event|0|||
130206516|NCT03689543|468715719|FG001|Overall Study|Adverse Event|0|||
130206517|NCT03689543|468715720|FG002|Overall Study|Adverse Event|1|||
130206518|NCT00932451|468715721|FG000|Overall Study|Withdrawal by Subject|69|||
130206519|NCT00932451|468715721|FG000|Overall Study|Lost to Follow-up|22|||
130206520|NCT00932451|468715721|FG000|Overall Study|Death|726|||
130206521|NCT00932451|468715721|FG000|Overall Study|Other reasons|5|||
130206522|NCT02968433|468715739|FG000|Overall Study|Withdrawal by Subject|1|||
130206523|NCT00637806|468715740|FG000|Double-blind Phase|Study Discontinued|2|||
130206524|NCT00637806|468715741|FG001|Double-blind Phase|Study Discontinued|0|||
130206525|NCT00637806|468715742|FG002|Double-blind Phase|Study Discontinued|1|||
130206526|NCT00637806|468715743|FG003|Double-blind Phase|Study Discontinued|0|||
130206527|NCT00637806|468715740|FG000|Extension Phase|Study Discontinued|0|||
130206528|NCT00637806|468715741|FG001|Extension Phase|Study Discontinued|0|||
130206529|NCT00637806|468715742|FG002|Extension Phase|Study Discontinued|0|||
130206530|NCT00637806|468715743|FG003|Extension Phase|Study Discontinued|1|||
130206531|NCT00622336|468715744|FG000|Treatment Phase|Progression of Disease|181|||
130206532|NCT00622336|468715744|FG000|Treatment Phase|Adverse Event|46|||
130206533|NCT00622336|468715744|FG000|Treatment Phase|Other|40|||
130206534|NCT00622336|468715744|FG000|Treatment Phase|Death|14|||
130206535|NCT00622336|468715744|FG000|Treatment Phase|Lack of therapeutic effect|13|||
130206536|NCT00622336|468715744|FG000|Treatment Phase|Withdrawal by Subject|13|||
130206537|NCT00622336|468715744|FG000|Treatment Phase|Lost to Follow-up|2|||
130206538|NCT00622336|468715744|FG000|Extension Phase|Adverse Event|2|||
130206539|NCT00622336|468715744|FG000|Extension Phase|Progressive Disease|6|||
130206540|NCT00622336|468715744|FG000|Extension Phase|Lack of therapeutic effect|2|||
130206541|NCT00622336|468715744|FG000|Extension Phase|Withdrawal by Subject|1|||
130206542|NCT00622336|468715744|FG000|Extension Phase|Lost to Follow-up|1|||
130206543|NCT00622336|468715744|FG000|Extension Phase|Other|9|||
130206544|NCT04506905|468715747|FG000|Overall Study|Lost to Follow-up|1|||
130206545|NCT04506905|468715748|FG001|Overall Study|Lost to Follow-up|0|||
130206546|NCT04506905|468715749|FG002|Overall Study|Lost to Follow-up|0|||
130206547|NCT04506905|468715750|FG003|Overall Study|Lost to Follow-up|1|||
130206548|NCT04506905|468715751|FG004|Overall Study|Lost to Follow-up|0|||
130206549|NCT04506905|468715752|FG005|Overall Study|Lost to Follow-up|0|||
130206550|NCT04506905|468715753|FG006|Overall Study|Lost to Follow-up|0|||
130206551|NCT04506905|468715754|FG007|Overall Study|Lost to Follow-up|0|||
130206552|NCT04506905|468715755|FG008|Overall Study|Lost to Follow-up|0|||
130206553|NCT04506905|468715747|FG000|Overall Study|Withdrawal by Subject|0|||
130206554|NCT04506905|468715748|FG001|Overall Study|Withdrawal by Subject|0|||
130206555|NCT04506905|468715749|FG002|Overall Study|Withdrawal by Subject|0|||
130206556|NCT04506905|468715750|FG003|Overall Study|Withdrawal by Subject|2|||
130206557|NCT04506905|468715751|FG004|Overall Study|Withdrawal by Subject|0|||
130206558|NCT04506905|468715752|FG005|Overall Study|Withdrawal by Subject|0|||
130206559|NCT04506905|468715753|FG006|Overall Study|Withdrawal by Subject|0|||
130206560|NCT04506905|468715754|FG007|Overall Study|Withdrawal by Subject|0|||
130206561|NCT04506905|468715755|FG008|Overall Study|Withdrawal by Subject|0|||
130206562|NCT02502266|468716787|FG000|Overall Study|Adverse Event|0|||
130206563|NCT02502266|468716788|FG001|Overall Study|Adverse Event|0|||
130206564|NCT02502266|468716789|FG002|Overall Study|Adverse Event|0|||
130206565|NCT02502266|468716790|FG003|Overall Study|Adverse Event|0|||
130206566|NCT02502266|468716791|FG004|Overall Study|Adverse Event|1|||
130206567|NCT02502266|468716792|FG005|Overall Study|Adverse Event|1|||
130206568|NCT02502266|468716793|FG006|Overall Study|Adverse Event|1|||
130206569|NCT02502266|468716787|FG000|Overall Study|Withdrawal by Subject|30|||
130206570|NCT02502266|468716788|FG001|Overall Study|Withdrawal by Subject|15|||
130206571|NCT02502266|468716789|FG002|Overall Study|Withdrawal by Subject|16|||
130206572|NCT02502266|468716790|FG003|Overall Study|Withdrawal by Subject|0|||
130206573|NCT02502266|468716791|FG004|Overall Study|Withdrawal by Subject|0|||
130206574|NCT02502266|468716792|FG005|Overall Study|Withdrawal by Subject|0|||
130206575|NCT02502266|468716793|FG006|Overall Study|Withdrawal by Subject|0|||
130206576|NCT02502266|468716787|FG000|Overall Study|Still on Treatment|0|||
130206577|NCT02502266|468716788|FG001|Overall Study|Still on Treatment|0|||
130206578|NCT02502266|468716789|FG002|Overall Study|Still on Treatment|1|||
130206579|NCT02502266|468716790|FG003|Overall Study|Still on Treatment|0|||
130206580|NCT02502266|468716791|FG004|Overall Study|Still on Treatment|0|||
130206581|NCT02502266|468716792|FG005|Overall Study|Still on Treatment|0|||
130206582|NCT02502266|468716793|FG006|Overall Study|Still on Treatment|0|||
130206583|NCT02502266|468716787|FG000|Overall Study|Other Reasons|19|||
130206584|NCT02502266|468716788|FG001|Overall Study|Other Reasons|6|||
130206585|NCT02502266|468716789|FG002|Overall Study|Other Reasons|14|||
130206586|NCT02502266|468716790|FG003|Overall Study|Other Reasons|0|||
130206587|NCT02502266|468716791|FG004|Overall Study|Other Reasons|1|||
130206588|NCT02502266|468716792|FG005|Overall Study|Other Reasons|1|||
130206589|NCT02502266|468716793|FG006|Overall Study|Other Reasons|0|||
130206590|NCT02502266|468716787|FG000|Overall Study|Arm 4 Discontinued|0|||
130206591|NCT02502266|468716788|FG001|Overall Study|Arm 4 Discontinued|0|||
130206592|NCT02502266|468716789|FG002|Overall Study|Arm 4 Discontinued|0|||
130206593|NCT02502266|468716790|FG003|Overall Study|Arm 4 Discontinued|52|||
130206594|NCT02502266|468716791|FG004|Overall Study|Arm 4 Discontinued|0|||
130206595|NCT02502266|468716792|FG005|Overall Study|Arm 4 Discontinued|0|||
130206596|NCT02502266|468716793|FG006|Overall Study|Arm 4 Discontinued|0|||
130206597|NCT02502266|468716787|FG000|Overall Study|Never treated|0|||
130206598|NCT02502266|468716788|FG001|Overall Study|Never treated|0|||
130206599|NCT02502266|468716789|FG002|Overall Study|Never treated|0|||
130206600|NCT02502266|468716790|FG003|Overall Study|Never treated|0|||
130206601|NCT02502266|468716791|FG004|Overall Study|Never treated|0|||
130206602|NCT02502266|468716792|FG005|Overall Study|Never treated|1|||
130206603|NCT02502266|468716793|FG006|Overall Study|Never treated|0|||
130206604|NCT03605849|468716795|FG000|Overall Study|Adverse Event|20|||
130206605|NCT03605849|468716796|FG001|Overall Study|Adverse Event|21|||
130206606|NCT03605849|468716797|FG002|Overall Study|Adverse Event|29|||
130206607|NCT03605849|468716798|FG003|Overall Study|Adverse Event|11|||
130206608|NCT03605849|468716795|FG000|Overall Study|Lack of Efficacy|4|||
130206609|NCT03605849|468716796|FG001|Overall Study|Lack of Efficacy|7|||
130206610|NCT03605849|468716797|FG002|Overall Study|Lack of Efficacy|9|||
130206611|NCT03605849|468716798|FG003|Overall Study|Lack of Efficacy|2|||
130206612|NCT03605849|468716795|FG000|Overall Study|Lost to Follow-up|8|||
130206613|NCT03605849|468716796|FG001|Overall Study|Lost to Follow-up|8|||
130206614|NCT03605849|468716797|FG002|Overall Study|Lost to Follow-up|14|||
130206615|NCT03605849|468716798|FG003|Overall Study|Lost to Follow-up|11|||
130206616|NCT03605849|468716795|FG000|Overall Study|Non-compliance With IMP|6|||
130206617|NCT03605849|468716796|FG001|Overall Study|Non-compliance With IMP|5|||
130206618|NCT03605849|468716797|FG002|Overall Study|Non-compliance With IMP|2|||
130206619|NCT03605849|468716798|FG003|Overall Study|Non-compliance With IMP|1|||
130206620|NCT03605849|468716795|FG000|Overall Study|Protocol Deviation|1|||
130206621|NCT03605849|468716796|FG001|Overall Study|Protocol Deviation|2|||
130206622|NCT03605849|468716797|FG002|Overall Study|Protocol Deviation|1|||
130206623|NCT03605849|468716798|FG003|Overall Study|Protocol Deviation|3|||
130206624|NCT03605849|468716795|FG000|Overall Study|Withdrawal by Subject|33|||
130206625|NCT03605849|468716796|FG001|Overall Study|Withdrawal by Subject|28|||
130206626|NCT03605849|468716797|FG002|Overall Study|Withdrawal by Subject|30|||
130206627|NCT03605849|468716798|FG003|Overall Study|Withdrawal by Subject|28|||
130206628|NCT03605849|468716795|FG000|Overall Study|Site Terminated by Sponsor|0|||
130206629|NCT03605849|468716796|FG001|Overall Study|Site Terminated by Sponsor|0|||
130206630|NCT03605849|468716797|FG002|Overall Study|Site Terminated by Sponsor|0|||
130206631|NCT03605849|468716798|FG003|Overall Study|Site Terminated by Sponsor|1|||
130206632|NCT03605849|468716795|FG000|Overall Study|Physician Decision|2|||
130206633|NCT03605849|468716796|FG001|Overall Study|Physician Decision|1|||
130206634|NCT03605849|468716797|FG002|Overall Study|Physician Decision|2|||
130206635|NCT03605849|468716798|FG003|Overall Study|Physician Decision|1|||
130206636|NCT03605849|468716795|FG000|Overall Study|Enrolled, but not Treated|2|||
130206637|NCT03605849|468716796|FG001|Overall Study|Enrolled, but not Treated|2|||
130206638|NCT03605849|468716797|FG002|Overall Study|Enrolled, but not Treated|3|||
130206639|NCT03605849|468716798|FG003|Overall Study|Enrolled, but not Treated|2|||
130206640|NCT03605849|468716795|FG000|Overall Study|Other (COVID-19 Related)|0|||
130206641|NCT03605849|468716796|FG001|Overall Study|Other (COVID-19 Related)|1|||
130206642|NCT03605849|468716797|FG002|Overall Study|Other (COVID-19 Related)|1|||
130206643|NCT03605849|468716798|FG003|Overall Study|Other (COVID-19 Related)|0|||
130206644|NCT03605849|468716795|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
130206645|NCT03605849|468716796|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
130206646|NCT03605849|468716797|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
130206647|NCT03605849|468716798|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
130206648|NCT00577005|468716799|FG000|Overall Study|Lost to Follow-up|3|||
130206649|NCT00577005|468716800|FG001|Overall Study|Lost to Follow-up|2|||
130206650|NCT00577005|468716799|FG000|Overall Study|Withdrawal by Subject|2|||
130206651|NCT00577005|468716800|FG001|Overall Study|Withdrawal by Subject|1|||
130206652|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
130206653|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206654|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206655|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206656|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
130206657|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
130206658|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206659|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206660|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206661|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
130206662|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
130206663|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206664|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206665|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206666|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
130206667|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
130206668|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206669|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206670|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206671|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
130206672|NCT01004432|468716801|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
130206673|NCT01004432|468716802|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206674|NCT01004432|468716803|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206675|NCT01004432|468716804|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206676|NCT01004432|468716805|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
130206677|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
130206678|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
130206679|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
130206680|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
130206681|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
130206682|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
130206683|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
130206684|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
130206685|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
130206686|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
130206687|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
130206688|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
130206689|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
130206690|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
130206691|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
130206692|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206693|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206694|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206695|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
130206696|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
130206697|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
130206698|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
130206699|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
130206700|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
130206701|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
130206702|NCT01004432|468716801|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
130206703|NCT01004432|468716802|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
130206704|NCT01004432|468716803|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
130206705|NCT01004432|468716804|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
130206706|NCT01004432|468716805|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
130206707|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206708|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206709|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206710|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
130206711|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
130206712|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206713|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206714|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206715|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
130206716|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
130206717|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206718|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206719|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206720|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
130206721|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
130206722|NCT01004432|468716801|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206723|NCT01004432|468716802|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206724|NCT01004432|468716803|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206725|NCT01004432|468716804|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
130206726|NCT01004432|468716805|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
130206727|NCT02667626|468716806|FG000|Overall Study|Withdrawal by Subject|0|||
130206728|NCT02667626|468716807|FG001|Overall Study|Withdrawal by Subject|1|||
130206729|NCT00590538|468716808|FG000|Overall Study|Study terminated before completed|2|||
130206730|NCT02539134|468716809|FG000|Overall Study|Lost to Follow-up|1|||
130206731|NCT02539134|468716810|FG001|Overall Study|Lost to Follow-up|0|||
130206732|NCT02539134|468716811|FG002|Overall Study|Lost to Follow-up|0|||
130206733|NCT02539134|468716812|FG003|Overall Study|Lost to Follow-up|0|||
130206734|NCT02539134|468716813|FG004|Overall Study|Lost to Follow-up|0|||
130206735|NCT02539134|468716814|FG005|Overall Study|Lost to Follow-up|0|||
130206736|NCT00985426|468716815|FG000|Overall Study|Adverse Event|0|||
130206737|NCT00985426|468716816|FG001|Overall Study|Adverse Event|1|||
130206738|NCT00985426|468716815|FG000|Overall Study|Subject Non-Compliance|3|||
130206739|NCT00985426|468716816|FG001|Overall Study|Subject Non-Compliance|3|||
130206740|NCT00985426|468716815|FG000|Overall Study|Withdrawal by Subject|12|||
130206741|NCT00985426|468716816|FG001|Overall Study|Withdrawal by Subject|16|||
130206742|NCT00985426|468716815|FG000|Overall Study|Lost to Follow-up|8|||
130206743|NCT00985426|468716816|FG001|Overall Study|Lost to Follow-up|10|||
130206744|NCT00985426|468716815|FG000|Overall Study|Death|7|||
130206745|NCT00985426|468716816|FG001|Overall Study|Death|3|||
130206746|NCT00985426|468716815|FG000|Overall Study|Protocol Violation|2|||
130206747|NCT00985426|468716816|FG001|Overall Study|Protocol Violation|0|||
130206748|NCT00985426|468716815|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
130206749|NCT00985426|468716816|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
130206750|NCT02971800|468716817|FG000|Overall Study|Protocol Violation|1|||
130206751|NCT02971800|468716817|FG000|Overall Study|Withdrawal by Subject|1|||
130206752|NCT02971800|468716817|FG000|Overall Study|Exclusion criteria prior intervention|1|||
130206753|NCT02971800|468716817|FG000|Overall Study|Number evaluable participant already reached|4|||
130206754|NCT01149421|468716818|FG000|Overall Study|Adverse Event|22|||
130206755|NCT01149421|468716819|FG001|Overall Study|Adverse Event|6|||
130206756|NCT01149421|468716820|FG002|Overall Study|Adverse Event|11|||
130206757|NCT01149421|468716818|FG000|Overall Study|Withdrawal by Subject|20|||
130206758|NCT01149421|468716819|FG001|Overall Study|Withdrawal by Subject|12|||
130206759|NCT01149421|468716820|FG002|Overall Study|Withdrawal by Subject|13|||
130206760|NCT01149421|468716818|FG000|Overall Study|Sponsor Decision|0|||
130206761|NCT01149421|468716819|FG001|Overall Study|Sponsor Decision|1|||
130206762|NCT01149421|468716820|FG002|Overall Study|Sponsor Decision|1|||
130206763|NCT01149421|468716818|FG000|Overall Study|Lost to Follow-up|2|||
130206764|NCT01149421|468716819|FG001|Overall Study|Lost to Follow-up|4|||
130206765|NCT01149421|468716820|FG002|Overall Study|Lost to Follow-up|5|||
130206766|NCT01149421|468716818|FG000|Overall Study|Physician Decision|5|||
130206767|NCT01149421|468716819|FG001|Overall Study|Physician Decision|3|||
130206768|NCT01149421|468716820|FG002|Overall Study|Physician Decision|6|||
130206769|NCT01149421|468716818|FG000|Overall Study|Entry Criteria Not Met|1|||
130206770|NCT01149421|468716819|FG001|Overall Study|Entry Criteria Not Met|1|||
130206771|NCT01149421|468716820|FG002|Overall Study|Entry Criteria Not Met|2|||
130206772|NCT01149421|468716818|FG000|Overall Study|Protocol Violation|2|||
130206773|NCT01149421|468716819|FG001|Overall Study|Protocol Violation|2|||
130206774|NCT01149421|468716820|FG002|Overall Study|Protocol Violation|6|||
130206775|NCT03738800|468716825|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
130206776|NCT03738800|468716826|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
130206777|NCT03738800|468716827|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
130206778|NCT03738800|468716825|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
130206779|NCT03738800|468716826|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
130206780|NCT03738800|468716827|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
130206781|NCT03738800|468716825|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
130206782|NCT03738800|468716826|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
130206783|NCT03738800|468716827|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
130206784|NCT00766467|468716828|FG000|Overall Study|Withdrawal by Subject|7|||
130206785|NCT00766467|468716829|FG001|Overall Study|Withdrawal by Subject|2|||
130206786|NCT00766467|468716828|FG000|Overall Study|Adverse Event|1|||
130206787|NCT00766467|468716829|FG001|Overall Study|Adverse Event|1|||
130206788|NCT00766467|468716828|FG000|Overall Study|Protocol Violation|2|||
130206789|NCT00766467|468716829|FG001|Overall Study|Protocol Violation|4|||
130206790|NCT00766467|468716828|FG000|Overall Study|Tumor Progression on Study|0|||
130206791|NCT00766467|468716829|FG001|Overall Study|Tumor Progression on Study|1|||
130206792|NCT00766467|468716828|FG000|Overall Study|Physician Decision|1|||
130206793|NCT00766467|468716829|FG001|Overall Study|Physician Decision|0|||
130206794|NCT01404208|468716835|FG000|Overall Study|Discontinued|3|||
130206795|NCT01404208|468716836|FG001|Overall Study|Discontinued|0|||
130206796|NCT01522235|468716838|FG000|Overall Study|Physician Decision|1|||
130206797|NCT01522235|468716839|FG001|Overall Study|Physician Decision|1|||
130206798|NCT01870297|468716842|FG000|Overall Study|Adverse Event|0|||
130206799|NCT01870297|468716843|FG001|Overall Study|Adverse Event|0|||
130206800|NCT01870297|468716844|FG002|Overall Study|Adverse Event|0|||
130206801|NCT01870297|468716845|FG003|Overall Study|Adverse Event|0|||
130206802|NCT01870297|468716846|FG004|Overall Study|Adverse Event|2|||
130206803|NCT01870297|468716847|FG005|Overall Study|Adverse Event|0|||
130206804|NCT01870297|468716848|FG006|Overall Study|Adverse Event|0|||
130206805|NCT01870297|468716842|FG000|Overall Study|Lost to Follow-up|0|||
130206806|NCT01870297|468716843|FG001|Overall Study|Lost to Follow-up|1|||
130206807|NCT01870297|468716844|FG002|Overall Study|Lost to Follow-up|1|||
130206808|NCT01870297|468716845|FG003|Overall Study|Lost to Follow-up|0|||
130206809|NCT01870297|468716846|FG004|Overall Study|Lost to Follow-up|0|||
130206810|NCT01870297|468716847|FG005|Overall Study|Lost to Follow-up|0|||
130206811|NCT01870297|468716848|FG006|Overall Study|Lost to Follow-up|0|||
130206812|NCT01870297|468716842|FG000|Overall Study|Withdrawal by Subject|0|||
130206813|NCT01870297|468716843|FG001|Overall Study|Withdrawal by Subject|0|||
130206814|NCT01870297|468716844|FG002|Overall Study|Withdrawal by Subject|0|||
130206815|NCT01870297|468716845|FG003|Overall Study|Withdrawal by Subject|0|||
130206816|NCT01870297|468716846|FG004|Overall Study|Withdrawal by Subject|1|||
130206817|NCT01870297|468716847|FG005|Overall Study|Withdrawal by Subject|1|||
130206818|NCT01870297|468716848|FG006|Overall Study|Withdrawal by Subject|1|||
130206819|NCT01870297|468716842|FG000|Overall Study|Sponsor Decision|0|||
130206820|NCT01870297|468716843|FG001|Overall Study|Sponsor Decision|6|||
130206821|NCT01870297|468716844|FG002|Overall Study|Sponsor Decision|0|||
130206822|NCT01870297|468716845|FG003|Overall Study|Sponsor Decision|0|||
130206823|NCT01870297|468716846|FG004|Overall Study|Sponsor Decision|0|||
130206824|NCT01870297|468716847|FG005|Overall Study|Sponsor Decision|0|||
130206825|NCT01870297|468716848|FG006|Overall Study|Sponsor Decision|1|||
130206826|NCT00337779|468716849|FG000|Overall Study|Withdrawal by Subject|10|||
130206827|NCT00337779|468716850|FG001|Overall Study|Withdrawal by Subject|12|||
130206828|NCT00337779|468716849|FG000|Overall Study|Sponsor decision|1|||
130206829|NCT00337779|468716850|FG001|Overall Study|Sponsor decision|1|||
130206830|NCT00337779|468716849|FG000|Overall Study|Physician Decision|3|||
130206831|NCT00337779|468716850|FG001|Overall Study|Physician Decision|6|||
130206832|NCT00337779|468716849|FG000|Overall Study|Protocol Violation|1|||
130206833|NCT00337779|468716850|FG001|Overall Study|Protocol Violation|1|||
130206834|NCT00337779|468716849|FG000|Overall Study|Lost to Follow-up|6|||
130206835|NCT00337779|468716850|FG001|Overall Study|Lost to Follow-up|5|||
130206836|NCT00337779|468716849|FG000|Overall Study|Adverse Event|28|||
130206837|NCT00337779|468716850|FG001|Overall Study|Adverse Event|51|||
130206838|NCT00337779|468716849|FG000|Overall Study|Pregnancy|3|||
130206839|NCT00337779|468716850|FG001|Overall Study|Pregnancy|2|||
130206840|NCT00337779|468716849|FG000|Overall Study|Death|0|||
130206841|NCT00337779|468716850|FG001|Overall Study|Death|1|||
130206842|NCT03008278|468716851|FG000|Overall Study|Progressive Disease|0|||
130206843|NCT03008278|468716852|FG001|Overall Study|Progressive Disease|0|||
130206844|NCT03008278|468716853|FG002|Overall Study|Progressive Disease|32|||
130206845|NCT03008278|468716851|FG000|Overall Study|Adverse Event|0|||
130206846|NCT03008278|468716852|FG001|Overall Study|Adverse Event|0|||
130206847|NCT03008278|468716853|FG002|Overall Study|Adverse Event|4|||
130206848|NCT03008278|468716851|FG000|Overall Study|Withdrawal by Subject|0|||
130206849|NCT03008278|468716852|FG001|Overall Study|Withdrawal by Subject|0|||
130206850|NCT03008278|468716853|FG002|Overall Study|Withdrawal by Subject|3|||
130206851|NCT03008278|468716851|FG000|Overall Study|Physician Decision|0|||
130206852|NCT03008278|468716852|FG001|Overall Study|Physician Decision|2|||
130206853|NCT03008278|468716853|FG002|Overall Study|Physician Decision|0|||
130206854|NCT00513357|468716854|FG000|Overall Study|did not receive allocated placebo|2|||
130206855|NCT00513357|468716855|FG001|Overall Study|did not receive allocated placebo|3|||
130206856|NCT00513357|468716854|FG000|Overall Study|Adverse Event|4|||
130206857|NCT00513357|468716855|FG001|Overall Study|Adverse Event|2|||
130206858|NCT00513357|468716854|FG000|Overall Study|Death|2|||
130206859|NCT00513357|468716855|FG001|Overall Study|Death|0|||
130206860|NCT00513357|468716854|FG000|Overall Study|Withdrawal by Subject|5|||
130206861|NCT00513357|468716855|FG001|Overall Study|Withdrawal by Subject|4|||
130206862|NCT00513357|468716854|FG000|Overall Study|Disease Progression|2|||
130206863|NCT00513357|468716855|FG001|Overall Study|Disease Progression|1|||
130206864|NCT01162122|468716856|FG000|Overall Study|Withdrawal by Subject|52|||
130206865|NCT01162122|468716857|FG001|Overall Study|Withdrawal by Subject|43|||
130206866|NCT01162122|468716856|FG000|Overall Study|Lost to Follow-up|73|||
130206867|NCT01162122|468716857|FG001|Overall Study|Lost to Follow-up|91|||
130206868|NCT01162122|468716856|FG000|Overall Study|Adverse Event|3|||
130206869|NCT01162122|468716857|FG001|Overall Study|Adverse Event|2|||
130206870|NCT01162122|468716856|FG000|Overall Study|Death|51|||
130206871|NCT01162122|468716857|FG001|Overall Study|Death|46|||
130206872|NCT01162122|468716856|FG000|Overall Study|Protocol Violation|2|||
130206873|NCT01162122|468716857|FG001|Overall Study|Protocol Violation|2|||
130206874|NCT01162122|468716856|FG000|Overall Study|Inappropriate enrollment|5|||
130206875|NCT01162122|468716857|FG001|Overall Study|Inappropriate enrollment|4|||
130206876|NCT01162122|468716856|FG000|Overall Study|Administrative reason|1|||
130206877|NCT01162122|468716857|FG001|Overall Study|Administrative reason|1|||
130206878|NCT01162122|468716856|FG000|Overall Study|Unable to classify|3|||
130206879|NCT01162122|468716857|FG001|Overall Study|Unable to classify|7|||
130206880|NCT01162122|468716856|FG000|Overall Study|Missing primary reason|1|||
130206881|NCT01162122|468716857|FG001|Overall Study|Missing primary reason|0|||
130206882|NCT00422422|468716861|FG000|Overall Study|Lack of Efficacy|1|||
130206883|NCT00422422|468716861|FG000|Overall Study|Protocol Violation|1|||
130206884|NCT00422422|468716861|FG000|Overall Study|Withdrawal by Subject|2|||
130206885|NCT00422422|468716861|FG000|Overall Study|SAE, non-fatal|1|||
130206886|NCT00422422|468716861|FG000|Overall Study|AE, non-serious non-fatal|5|||
130206887|NCT03313310|468716862|FG000|Phase 2|Lost to Follow-up|4|||
130206888|NCT03313310|468716863|FG001|Phase 2|Lost to Follow-up|0|||
130206889|NCT03313310|468716862|FG000|Phase 3|Lost to Follow-up|0|||
130206890|NCT03313310|468716863|FG001|Phase 3|Lost to Follow-up|1|||
130206891|NCT01217385|468716864|FG000|Overall Study|Withdrawal by Subject|3|||
130206892|NCT01217385|468716864|FG000|Overall Study|DOSI not performed/not eval|12|||
130206893|NCT01217385|468716864|FG000|Overall Study|Central Path not Available|1|||
130206894|NCT01217385|468716864|FG000|Overall Study|Normal Breast TOI not available|10|||
130206895|NCT00090987|468716865|FG000|Overall Study|Adverse Event|5|||
130206896|NCT00090987|468716865|FG000|Overall Study|Lack of Efficacy|7|||
130206897|NCT00090987|468716865|FG000|Overall Study|Withdrawal by Subject|3|||
130206898|NCT00090987|468716865|FG000|Overall Study|alternative therapy|1|||
130206899|NCT00090987|468716865|FG000|Overall Study|Non-compliance|4|||
130206900|NCT00090987|468716865|FG000|Overall Study|Incarcerated|1|||
130206901|NCT02079636|468716867|FG000|Overall Study|Death|2|||
130206902|NCT02079636|468716868|FG001|Overall Study|Death|1|||
130206903|NCT02079636|468716869|FG002|Overall Study|Death|0|||
130206904|NCT02079636|468716870|FG003|Overall Study|Death|5|||
130206905|NCT02079636|468716871|FG004|Overall Study|Death|1|||
130206906|NCT02079636|468716872|FG005|Overall Study|Death|2|||
130206907|NCT02079636|468716873|FG006|Overall Study|Death|1|||
130206908|NCT02079636|468716874|FG007|Overall Study|Death|0|||
130206909|NCT02079636|468716875|FG008|Overall Study|Death|0|||
130206910|NCT02079636|468716876|FG009|Overall Study|Death|0|||
130206911|NCT02079636|468716877|FG010|Overall Study|Death|0|||
130206912|NCT02079636|468716878|FG011|Overall Study|Death|1|||
130206913|NCT02079636|468716879|FG012|Overall Study|Death|1|||
130206914|NCT02079636|468716880|FG013|Overall Study|Death|0|||
130206915|NCT02079636|468716881|FG014|Overall Study|Death|2|||
130206916|NCT02079636|468716867|FG000|Overall Study|Adverse Event|1|||
130206917|NCT02079636|468716868|FG001|Overall Study|Adverse Event|1|||
130206918|NCT02079636|468716869|FG002|Overall Study|Adverse Event|0|||
130206919|NCT02079636|468716870|FG003|Overall Study|Adverse Event|1|||
130206920|NCT02079636|468716871|FG004|Overall Study|Adverse Event|1|||
130206921|NCT02079636|468716872|FG005|Overall Study|Adverse Event|2|||
130206922|NCT02079636|468716873|FG006|Overall Study|Adverse Event|0|||
130206923|NCT02079636|468716874|FG007|Overall Study|Adverse Event|0|||
130206924|NCT02079636|468716875|FG008|Overall Study|Adverse Event|0|||
130206925|NCT02079636|468716876|FG009|Overall Study|Adverse Event|0|||
130206926|NCT02079636|468716877|FG010|Overall Study|Adverse Event|0|||
130206927|NCT02079636|468716878|FG011|Overall Study|Adverse Event|0|||
130206928|NCT02079636|468716879|FG012|Overall Study|Adverse Event|0|||
130206929|NCT02079636|468716880|FG013|Overall Study|Adverse Event|0|||
130206930|NCT02079636|468716881|FG014|Overall Study|Adverse Event|0|||
130206931|NCT02079636|468716867|FG000|Overall Study|Progressive disease|0|||
130206932|NCT02079636|468716868|FG001|Overall Study|Progressive disease|0|||
130206933|NCT02079636|468716869|FG002|Overall Study|Progressive disease|0|||
130206934|NCT02079636|468716870|FG003|Overall Study|Progressive disease|2|||
130206935|NCT02079636|468716871|FG004|Overall Study|Progressive disease|0|||
130206936|NCT02079636|468716872|FG005|Overall Study|Progressive disease|0|||
130206937|NCT02079636|468716873|FG006|Overall Study|Progressive disease|0|||
130206938|NCT02079636|468716874|FG007|Overall Study|Progressive disease|0|||
130206939|NCT02079636|468716875|FG008|Overall Study|Progressive disease|0|||
130206940|NCT02079636|468716876|FG009|Overall Study|Progressive disease|0|||
130206941|NCT02079636|468716877|FG010|Overall Study|Progressive disease|0|||
130206942|NCT02079636|468716878|FG011|Overall Study|Progressive disease|0|||
130206943|NCT02079636|468716879|FG012|Overall Study|Progressive disease|1|||
130206944|NCT02079636|468716880|FG013|Overall Study|Progressive disease|0|||
130206945|NCT02079636|468716881|FG014|Overall Study|Progressive disease|0|||
130206946|NCT02079636|468716867|FG000|Overall Study|Withdrawal by Subject|0|||
130206947|NCT02079636|468716868|FG001|Overall Study|Withdrawal by Subject|0|||
130206948|NCT02079636|468716869|FG002|Overall Study|Withdrawal by Subject|0|||
130206949|NCT02079636|468716870|FG003|Overall Study|Withdrawal by Subject|4|||
130206950|NCT02079636|468716871|FG004|Overall Study|Withdrawal by Subject|0|||
130206951|NCT02079636|468716872|FG005|Overall Study|Withdrawal by Subject|1|||
130206952|NCT02079636|468716873|FG006|Overall Study|Withdrawal by Subject|0|||
130206953|NCT02079636|468716874|FG007|Overall Study|Withdrawal by Subject|0|||
130206954|NCT02079636|468716875|FG008|Overall Study|Withdrawal by Subject|0|||
130206955|NCT02079636|468716876|FG009|Overall Study|Withdrawal by Subject|2|||
130206956|NCT02079636|468716877|FG010|Overall Study|Withdrawal by Subject|1|||
130206957|NCT02079636|468716878|FG011|Overall Study|Withdrawal by Subject|1|||
130206958|NCT02079636|468716879|FG012|Overall Study|Withdrawal by Subject|1|||
130206959|NCT02079636|468716880|FG013|Overall Study|Withdrawal by Subject|0|||
130206960|NCT02079636|468716881|FG014|Overall Study|Withdrawal by Subject|2|||
130206961|NCT02079636|468716867|FG000|Overall Study|Physician Decision|0|||
130206962|NCT02079636|468716868|FG001|Overall Study|Physician Decision|0|||
130206963|NCT02079636|468716869|FG002|Overall Study|Physician Decision|0|||
130206964|NCT02079636|468716870|FG003|Overall Study|Physician Decision|0|||
130206965|NCT02079636|468716871|FG004|Overall Study|Physician Decision|0|||
130206966|NCT02079636|468716872|FG005|Overall Study|Physician Decision|1|||
130206967|NCT02079636|468716873|FG006|Overall Study|Physician Decision|0|||
130206968|NCT02079636|468716874|FG007|Overall Study|Physician Decision|0|||
130206969|NCT02079636|468716875|FG008|Overall Study|Physician Decision|0|||
130206970|NCT02079636|468716876|FG009|Overall Study|Physician Decision|1|||
130206971|NCT02079636|468716877|FG010|Overall Study|Physician Decision|1|||
130206972|NCT02079636|468716878|FG011|Overall Study|Physician Decision|0|||
130206973|NCT02079636|468716879|FG012|Overall Study|Physician Decision|0|||
130206974|NCT02079636|468716880|FG013|Overall Study|Physician Decision|0|||
130206975|NCT02079636|468716881|FG014|Overall Study|Physician Decision|1|||
130206976|NCT02079636|468716867|FG000|Overall Study|Lost to Follow-up|0|||
130206977|NCT02079636|468716868|FG001|Overall Study|Lost to Follow-up|0|||
130206978|NCT02079636|468716869|FG002|Overall Study|Lost to Follow-up|0|||
130206979|NCT02079636|468716870|FG003|Overall Study|Lost to Follow-up|0|||
130206980|NCT02079636|468716871|FG004|Overall Study|Lost to Follow-up|0|||
130206981|NCT02079636|468716872|FG005|Overall Study|Lost to Follow-up|0|||
130206982|NCT02079636|468716873|FG006|Overall Study|Lost to Follow-up|0|||
130206983|NCT02079636|468716874|FG007|Overall Study|Lost to Follow-up|1|||
130206984|NCT02079636|468716875|FG008|Overall Study|Lost to Follow-up|0|||
130206985|NCT02079636|468716876|FG009|Overall Study|Lost to Follow-up|0|||
130206986|NCT02079636|468716877|FG010|Overall Study|Lost to Follow-up|0|||
130206987|NCT02079636|468716878|FG011|Overall Study|Lost to Follow-up|0|||
130206988|NCT02079636|468716879|FG012|Overall Study|Lost to Follow-up|0|||
130206989|NCT02079636|468716880|FG013|Overall Study|Lost to Follow-up|0|||
130206990|NCT02079636|468716881|FG014|Overall Study|Lost to Follow-up|0|||
130206991|NCT00725101|468716882|FG000|Overall Study|Death|3|||
130206992|NCT00725101|468716882|FG000|Overall Study|Lost to Follow-up|353|||
130206993|NCT00725101|468716882|FG000|Overall Study|Protocol Violation|1|||
130206994|NCT00725101|468716882|FG000|Overall Study|Withdrawal by Subject|127|||
130206995|NCT00725101|468716882|FG000|Overall Study|not specified/no reason given|11|||
130206996|NCT01592292|468716883|FG000|Overall Study|Follow-up loss|3|||
130206997|NCT01592292|468716884|FG001|Overall Study|Follow-up loss|3|||
130206998|NCT01592292|468716885|FG002|Overall Study|Follow-up loss|1|||
130206999|NCT01592292|468716886|FG003|Overall Study|Follow-up loss|0|||
130207000|NCT01592292|468716883|FG000|Overall Study|Withdrew consent|2|||
130207001|NCT01592292|468716884|FG001|Overall Study|Withdrew consent|1|||
130207002|NCT01592292|468716885|FG002|Overall Study|Withdrew consent|0|||
130207003|NCT01592292|468716886|FG003|Overall Study|Withdrew consent|0|||
130207004|NCT01592292|468716883|FG000|Overall Study|Other|1|||
130207005|NCT01592292|468716884|FG001|Overall Study|Other|1|||
130207006|NCT01592292|468716885|FG002|Overall Study|Other|2|||
130207007|NCT01592292|468716886|FG003|Overall Study|Other|1|||
130207008|NCT04148287|468716888|FG000|Overall Study|Death|2|||
130207009|NCT03164265|468716889|FG000|Overall Study|Physician Decision|3|||
130207010|NCT03912428|468716892|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130207011|NCT03912428|468716893|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
130207012|NCT03912428|468716894|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130207013|NCT03912428|468716895|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
130207014|NCT03912428|468716892|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
130207015|NCT03912428|468716893|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
130207016|NCT03912428|468716894|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
130207017|NCT03912428|468716895|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
130207018|NCT03912428|468716892|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130207019|NCT03912428|468716893|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130207020|NCT03912428|468716894|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
130207021|NCT03912428|468716895|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
130207022|NCT03233204|468716896|FG000|Overall Study|Adverse Event|1|||
130207023|NCT03233204|468716896|FG000|Overall Study|Death|1|||
130207024|NCT03233204|468716896|FG000|Overall Study|Withdrawal by Subject|1|||
130207025|NCT03233204|468716896|FG000|Overall Study|Progressive Disease|3|||
130207026|NCT02680834|468716897|FG000|Overall Study|Physician Decision|5|||
130207027|NCT02680834|468716898|FG001|Overall Study|Physician Decision|2|||
130207028|NCT02680834|468716897|FG000|Overall Study|Withdrawal by Subject|6|||
130207029|NCT02680834|468716898|FG001|Overall Study|Withdrawal by Subject|0|||
130207030|NCT02680834|468716897|FG000|Overall Study|Lost to Follow-up|0|||
130207031|NCT02680834|468716898|FG001|Overall Study|Lost to Follow-up|1|||
130207032|NCT02889835|468716899|FG000|Overall Study|Lost to Follow-up|13|||
130207033|NCT02889835|468716900|FG001|Overall Study|Lost to Follow-up|13|||
130207034|NCT02889835|468716901|FG002|Overall Study|Lost to Follow-up|13|||
130207035|NCT02889835|468716899|FG000|Overall Study|Withdrawal by Subject|2|||
130207036|NCT02889835|468716900|FG001|Overall Study|Withdrawal by Subject|2|||
130207037|NCT02889835|468716901|FG002|Overall Study|Withdrawal by Subject|2|||
130207038|NCT02889835|468716899|FG000|Overall Study|Protocol Violation|1|||
130207039|NCT02889835|468716900|FG001|Overall Study|Protocol Violation|1|||
130207040|NCT02889835|468716901|FG002|Overall Study|Protocol Violation|1|||
130207041|NCT02889835|468716899|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
130207042|NCT02889835|468716900|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
130207043|NCT02889835|468716901|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
130207044|NCT02889835|468716899|FG000|Overall Study|Death|1|||
130207045|NCT02889835|468716900|FG001|Overall Study|Death|1|||
130207046|NCT02889835|468716901|FG002|Overall Study|Death|1|||
